data_2hqr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hqr _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptp . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.513 -0.551 . . . . 65.120000000000005 109.513 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -140.4 152.25 45.59 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.332 -0.855 . . . . 73.310000000000002 109.182 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.9 t -116.32 138.83 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.651 -0.656 . . . . 71.420000000000002 109.708 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.3 tp -115.87 121.12 41.41 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.462 -0.774 . . . . 65.219999999999999 109.043 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.9 mt -117.68 107.03 13.71 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.044 -0.725 . . . . 71.439999999999998 109.044 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.411 HG22 HD13 ' A' ' 6' ' ' ILE . 76.7 mt -98.83 112.66 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.248 -0.907 . . . . 71.150000000000006 108.829 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.429 ' OE1' ' N ' ' A' ' 13' ' ' GLY . 68.8 tt0 -149.49 127.89 12.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.169 -0.957 . . . . 75.340000000000003 109.565 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -62.94 -32.82 74.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -0.874 . . . . 73.040000000000006 109.431 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -82.05 105.26 13.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -0.892 . . . . 72.420000000000002 109.457 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.8 m -64.87 -28.19 69.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.9 . . . . 72.340000000000003 109.783 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.0 t -63.73 -49.24 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.156 -0.965 . . . . 74.420000000000002 109.795 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.516 ' CD2' ' N ' ' A' ' 12' ' ' LEU . 3.5 mm? -69.85 -46.05 66.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.165 -0.959 . . . . 72.010000000000005 109.452 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.429 ' N ' ' OE1' ' A' ' 7' ' ' GLU . . . -66.13 -17.64 66.03 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.4 -1.88 . . . . 72.140000000000001 108.4 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.49 -57.59 4.98 Favored Glycine 0 N--CA 1.483 1.776 0 N-CA-C 109.589 -1.405 . . . . 72.329999999999998 109.589 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -53.0 -46.8 68.5 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.446 -1.032 . . . . 72.340000000000003 109.714 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.4 mm -61.24 -46.36 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.8 -1.187 . . . . 74.239999999999995 108.636 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.507 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 81.1 tt0 -46.54 -52.56 13.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 71.409999999999997 109.752 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -88.89 4.89 46.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.168 -0.958 . . . . 75.540000000000006 109.741 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.21 -63.54 1.79 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.958 -1.257 . . . . 62.149999999999999 109.958 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -72.62 -19.85 61.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.18 -1.188 . . . . 74.420000000000002 110.228 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 86.4 m-20 -52.79 -33.47 49.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.883 -1.136 . . . . 74.25 109.466 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 86.7 t -58.5 -31.92 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 72.109999999999999 109.333 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.415 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 11.5 mptt -74.05 -2.8 25.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 73.230000000000004 109.25 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.84 23.17 43.02 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.074 -1.21 . . . . 75.540000000000006 110.074 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -99.4 158.2 15.89 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.214 -1.168 . . . . 74.510000000000005 109.323 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.3 mtt -101.55 139.59 36.99 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.03 -1.1 . . . . 64.319999999999993 108.03 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.64 152.7 41.69 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.045 -1.035 . . . . 74.310000000000002 110.758 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -135.1 140.92 45.87 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.565 -0.902 . . . . 75.400000000000006 108.565 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -107.6 138.28 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.839 . . . . 75.129999999999995 109.004 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.7 p -134.95 168.86 18.32 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.453 -0.779 . . . . 71.420000000000002 109.491 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.436 ' OE2' ' OD2' ' A' ' 35' ' ' ASP . 4.3 pt-20 -87.41 -102.92 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 73.109999999999999 109.559 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.0 p -77.46 163.66 26.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 74.239999999999995 109.476 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mp -58.42 -29.85 66.43 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.45 -0.781 . . . . 71.530000000000001 110.026 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -49.89 -43.57 49.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.036 -1.04 . . . . 74.230000000000004 109.519 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.436 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 31.9 m-20 -66.8 -42.3 86.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.207 -0.933 . . . . 71.010000000000005 109.053 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.38 -42.54 95.95 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.489 -1.444 . . . . 61.409999999999997 109.489 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -65.73 -37.85 87.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -1.154 . . . . 74.340000000000003 109.336 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.443 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 68.3 t80 -78.64 -21.38 48.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.923 . . . . 75.329999999999998 109.581 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.6 tp -90.0 -32.79 16.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.197 -0.939 . . . . 74.329999999999998 109.853 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 40' ' ' MET . 3.4 ppp? -78.93 -29.42 44.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.151 -0.968 . . . . 70.319999999999993 110.637 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 31.4 p-10 -58.8 -34.28 71.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.795 -1.191 . . . . 71.219999999999999 109.845 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.541 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 14.7 pt -90.39 -26.42 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.084 -1.01 . . . . 74.409999999999997 110.05 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 40' ' ' MET . 93.6 mtt180 -127.36 138.9 53.13 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.386 -0.821 . . . . 75.409999999999997 109.41 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -92.66 152.55 19.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.132 -0.98 . . . . 75.420000000000002 109.594 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -133.83 154.44 51.02 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.517 -0.739 . . . . 74.230000000000004 109.254 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -94.44 -43.83 8.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.139 -0.976 . . . . 75.319999999999993 108.899 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.418 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -106.34 108.91 20.65 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.743 -0.836 . . . . 72.129999999999995 108.743 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 m -107.77 105.24 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.297 -1.001 . . . . 72.340000000000003 108.297 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.6 ttt -115.18 145.54 42.29 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.511 0.672 . . . . 74.109999999999999 109.556 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.415 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 1.6 p -144.51 133.16 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.487 -0.758 . . . . 71.239999999999995 110.19 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 t -98.54 4.57 48.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.499 -0.751 . . . . 73.109999999999999 109.454 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.415 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 52.6 m-20 -76.0 142.15 41.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.141 -0.974 . . . . 63.399999999999999 109.377 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.517 ' C ' ' H ' ' A' ' 55' ' ' ALA . 67.5 mttm -77.69 -42.76 33.38 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.282 -0.886 . . . . 65.439999999999998 110.647 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -70.63 14.54 0.13 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.027 -1.045 . . . . 73.129999999999995 109.874 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.29 -19.88 59.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 64.140000000000001 110.434 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.0 mt -42.0 -49.06 4.69 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.286 -0.884 . . . . 74.430000000000007 110.606 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.529 ' HG ' ' N ' ' A' ' 58' ' ' PHE . 91.9 p -68.56 -37.85 80.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.954 -1.092 . . . . 63.229999999999997 109.522 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.529 ' N ' ' HG ' ' A' ' 57' ' ' SER . 70.7 t80 -67.8 -63.57 1.03 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 74.439999999999998 109.914 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.7 m -49.25 -31.72 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.86 -1.15 . . . . 74.030000000000001 109.636 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.3 t -60.6 -53.33 58.77 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.149 -0.97 . . . . 73.540000000000006 109.11 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -67.87 -27.54 66.76 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.687 -1.205 . . . . 73.340000000000003 109.652 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.539 ' O ' ' N ' ' A' ' 66' ' ' HIS . 25.3 mm -56.34 -46.12 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.826 -1.172 . . . . 73.349999999999994 108.409 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -63.72 -40.47 96.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.13 -0.981 . . . . 74.420000000000002 108.354 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -67.58 -50.85 56.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.385 -0.822 . . . . 74.549999999999997 109.246 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.52 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 91.9 mttt -78.15 -12.09 59.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.603 -0.686 . . . . 75.219999999999999 110.048 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 62' ' ' ILE . 97.9 m-70 -157.69 70.9 0.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.93 . . . . 74.129999999999995 109.149 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.1 p -69.34 -23.9 63.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.199 -0.938 . . . . 73.239999999999995 110.015 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 82.3 p -90.83 49.87 1.72 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.141 -0.974 . . . . 71.439999999999998 110.074 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.4 tt -143.36 163.87 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.102 -0.998 . . . . 71.329999999999998 109.343 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.5 t -93.21 142.16 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.115 -0.991 . . . . 73.019999999999996 108.768 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.462 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 9.8 t -130.55 123.44 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.311 -0.868 . . . . 54.210000000000001 109.36 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 mt -129.6 100.3 5.47 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.533 -0.914 . . . . 74.209999999999994 108.533 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.9 p -96.12 154.04 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.375 -0.972 . . . . 74.409999999999997 108.375 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.4 m -122.57 171.91 8.77 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.78 -0.822 . . . . 72.310000000000002 108.78 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 77' ' ' ASN . 7.6 p -171.2 121.84 0.54 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.963 -1.085 . . . . 64.540000000000006 110.431 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.496 ' OD1' ' NZ ' ' A' ' 53' ' ' LYS . 56.3 p30 -70.65 8.04 0.95 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.501 -0.75 . . . . 74.129999999999995 109.875 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.439 ' H ' ' C ' ' A' ' 75' ' ' SER . 18.7 m120 -137.94 75.39 42.14 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.29 -0.881 . . . . 73.340000000000003 109.489 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -66.92 81.38 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.619 2.213 . . . . 71.319999999999993 111.237 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 26.5 m -103.31 151.91 22.16 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.733 -0.84 . . . . 62.530000000000001 108.733 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 p -60.12 -28.84 68.2 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.297 -0.877 . . . . 74.140000000000001 109.773 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -68.04 -41.54 81.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 71.420000000000002 109.865 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -74.3 -35.47 63.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.115 -0.99 . . . . 73.430000000000007 109.858 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -60.17 -54.13 49.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.204 -0.935 . . . . 74.219999999999999 109.941 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.3 m -61.96 -38.02 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.047 -1.033 . . . . 74.150000000000006 109.439 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -69.0 -26.48 65.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.151 -0.968 . . . . 72.540000000000006 109.37 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.75 -44.33 73.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.143 -0.973 . . . . 64.219999999999999 109.647 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -79.68 -29.19 40.75 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.168 -0.958 . . . . 74.340000000000003 109.084 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -75.18 -51.3 13.72 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.436 -0.79 . . . . 74.420000000000002 109.357 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -58.57 -50.05 75.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.482 -0.761 . . . . 74.519999999999996 109.714 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 147.66 69.1 0.01 OUTLIER Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.107 -1.197 . . . . 74.209999999999994 110.107 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -134.24 135.05 42.67 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.33 -1.1 . . . . 64.099999999999994 109.017 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.462 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 70.2 m-20 -79.66 -36.8 37.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.103 -0.998 . . . . 73.420000000000002 109.031 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -153.33 150.35 28.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.391 -0.818 . . . . 75.040000000000006 109.568 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.512 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -124.25 132.54 53.59 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.722 -0.844 . . . . 71.329999999999998 108.722 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.512 ' N ' ' CD1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -119.29 137.06 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 CA-C-O 121.66 0.743 . . . . 74.510000000000005 110.061 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.54 120.2 8.96 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 106.922 -1.51 . . . . 64.319999999999993 106.922 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.684 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -41.72 -55.88 5.39 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.161 -0.962 . . . . 74.510000000000005 111.862 -178.134 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 1.8 Cg_endo -39.55 -12.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.14 1.226 . . . . 73.109999999999999 113.02 -175.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.684 ' N ' ' O ' ' A' ' 97' ' ' LYS . 55.4 m-85 59.86 131.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.803 -0.56 . . . . 72.540000000000006 109.835 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.454 ' O ' ' OG ' ' A' ' 101' ' ' SER . 29.6 ttm-85 -72.59 -40.65 66.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.754 -1.216 . . . . 74.540000000000006 108.92 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.642 ' O ' ' N ' ' A' ' 103' ' ' LYS . 19.3 m -174.42 43.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.28 -0.887 . . . . 74.140000000000001 110.045 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.447 ' O ' ' N ' ' A' ' 105' ' ' LEU . 10.7 mm 47.47 -80.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.374 -0.829 . . . . 75.430000000000007 110.414 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.642 ' N ' ' O ' ' A' ' 101' ' ' SER . 20.3 tptm -43.93 -33.37 1.36 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.238 -0.914 . . . . 74.140000000000001 109.208 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.67 -44.52 96.04 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.408 -0.96 . . . . 63.240000000000002 108.408 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 102' ' ' ILE . 17.2 tp -66.02 -49.37 67.97 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.199 -0.667 . . . . 73.219999999999999 109.199 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 70.2 t -60.18 -40.01 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.119 -0.988 . . . . 74.540000000000006 109.404 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.68 -41.19 73.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.112 -0.992 . . . . 75.5 108.869 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.525 ' O ' ' NE ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -68.22 -33.95 75.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.403 -0.81 . . . . 74.409999999999997 109.018 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 88.6 mt -75.2 -29.3 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.168 -0.958 . . . . 73.239999999999995 109.019 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -75.78 -57.43 3.88 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.45 -0.781 . . . . 74.340000000000003 109.471 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -49.65 -45.26 48.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.327 -0.858 . . . . 73.319999999999993 109.335 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 61.6 ttm-85 -64.75 -34.06 77.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.267 -0.895 . . . . 74.420000000000002 109.555 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 37.8 mt -133.52 74.68 1.57 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.393 -0.817 . . . . 74.329999999999998 110.016 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.7 mtm180 -85.64 -77.66 0.29 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.143 -0.973 . . . . 74.439999999999998 108.543 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.44 ' O ' ' O ' ' A' ' 116' ' ' TRP . 18.8 t80 -85.39 -49.73 7.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 74.430000000000007 109.465 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.44 ' O ' ' O ' ' A' ' 115' ' ' PHE . 69.7 t-105 49.85 97.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.366 -0.833 . . . . 74.439999999999998 109.663 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.59 113.06 0.28 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.617 -1.393 . . . . 75.040000000000006 109.617 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 30.8 m -156.07 164.18 38.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -1.154 . . . . 70.109999999999999 109.583 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.476 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -158.47 123.43 4.27 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.697 -0.853 . . . . 65.239999999999995 108.697 -178.45 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.5 t -79.98 -28.99 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 74.219999999999999 109.795 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.3 mp -116.76 140.94 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.345 -0.847 . . . . 74.420000000000002 109.094 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -151.81 140.36 20.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.294 -0.878 . . . . 73.299999999999997 108.946 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.6 tp -160.65 121.23 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.224 -0.923 . . . . 75.340000000000003 109.174 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 60.23 -132.45 50.39 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.183 -1.567 . . . . 75.129999999999995 109.183 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -97.39 3.13 51.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.183 -1.187 . . . . 74.450000000000003 109.354 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.36 143.07 27.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.12 -0.988 . . . . 54.210000000000001 109.066 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.43 141.64 49.86 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.754 -0.832 . . . . 70.239999999999995 108.754 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.8 mt -137.85 125.09 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.409 -0.807 . . . . 72.430000000000007 109.125 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.2 m -121.56 95.94 47.84 Favored Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 109.356 -0.609 . . . . 71.109999999999999 109.356 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.15 -33.76 2.48 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.976 1.784 . . . . 75.140000000000001 112.099 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -56.43 -46.4 80.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.233 -0.917 . . . . 72.5 108.995 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -87.04 2.63 49.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.863 . . . . 73.140000000000001 109.196 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 55.0 72.71 0.46 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 75.329999999999998 109.863 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -161.65 143.51 11.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.349 -0.844 . . . . 71.230000000000004 109.367 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.5 tt -115.54 138.6 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.433 -0.951 . . . . 75.329999999999998 108.433 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.6 mt -126.99 127.13 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 109.055 -0.72 . . . . 71.109999999999999 109.055 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.418 ' O ' ' CD1' ' A' ' 137' ' ' TYR . 45.7 p90 -136.85 135.84 38.23 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.377 -0.827 . . . . 74.140000000000001 110.598 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp 55.79 31.02 16.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.515 -0.741 . . . . 75.400000000000006 110.755 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.23 16.81 79.1 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.631 -1.271 . . . . 72.239999999999995 110.911 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 65.4 mtt-85 -112.58 126.21 55.1 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.333 -1.098 . . . . 73.120000000000005 109.553 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -94.01 128.04 40.14 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.489 -0.757 . . . . 72.319999999999993 109.627 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 34.7 t -139.16 141.1 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.359 -0.838 . . . . 62.340000000000003 109.1 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.503 ' N ' ' OE1' ' A' ' 143' ' ' GLU . 48.6 mp0 -97.11 143.85 27.52 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.248 -0.907 . . . . 61.229999999999997 109.925 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.15 140.5 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.391 -0.818 . . . . 74.439999999999998 109.196 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.34 28.76 0.45 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 75.420000000000002 108.961 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.918 ' O ' ' CD1' ' A' ' 149' ' ' PHE . . . -86.93 -161.25 36.05 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.002 -1.239 . . . . 73.340000000000003 110.002 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.612 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 16.8 mttm -80.8 -38.04 1.0 Allowed Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.493 -1.004 . . . . 72.219999999999999 110.619 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 96.2 Cg_endo -89.46 19.9 1.17 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.456 2.104 . . . . 75.450000000000003 112.613 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.918 ' CD1' ' O ' ' A' ' 146' ' ' GLY . 5.3 p90 -94.81 -55.79 2.99 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.166 -0.959 . . . . 65.239999999999995 109.408 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.693 ' N ' ' CG ' ' A' ' 149' ' ' PHE . 6.1 pt-20 -53.14 -34.45 56.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.458 -0.776 . . . . 72.519999999999996 109.849 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.423 ' CG1' ' N ' ' A' ' 152' ' ' LEU . 8.3 p -63.03 -41.18 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.002 -1.061 . . . . 74.209999999999994 109.306 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.423 ' N ' ' CG1' ' A' ' 151' ' ' VAL . 0.2 OUTLIER -63.52 -46.97 83.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.898 . . . . 73.310000000000002 108.63 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 27.2 p -67.39 -27.71 67.32 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.111 -0.993 . . . . 74.310000000000002 109.164 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -61.1 -53.96 50.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.883 . . . . 75.450000000000003 109.826 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.4 -21.12 63.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.025 -1.047 . . . . 75.340000000000003 109.26 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.02 -43.38 92.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 62.140000000000001 108.96 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.525 ' C ' ' H ' ' A' ' 159' ' ' ARG . 59.0 mtm180 -77.24 -49.39 15.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 72.219999999999999 109.111 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -71.97 17.54 0.09 Allowed 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.002 -0.679 . . . . 74.120000000000005 109.422 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.525 ' H ' ' C ' ' A' ' 157' ' ' ARG . 35.4 ptt-85 -52.03 156.74 1.47 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.265 -0.897 . . . . 74.340000000000003 109.2 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.455 ' OD1' ' CD2' ' A' ' 216' ' ' TYR . 50.3 m-20 55.08 47.87 20.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.444 -0.785 . . . . 75.450000000000003 109.678 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -155.04 151.68 28.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.165 -0.959 . . . . 73.409999999999997 109.512 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.4 mt -89.51 138.37 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.224 -0.922 . . . . 74.409999999999997 109.458 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.6 t -139.43 131.01 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.345 -0.847 . . . . 72.530000000000001 109.317 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 16.2 t -78.25 164.72 24.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 74.120000000000005 109.691 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -63.63 -48.75 76.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.46 -0.775 . . . . 70.430000000000007 109.887 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -56.98 -37.03 71.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 74.319999999999993 110.102 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -53.91 -47.53 71.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.952 -1.092 . . . . 74.519999999999996 109.435 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 51.1 mt -60.27 -44.02 95.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.079 -1.013 . . . . 74.409999999999997 109.524 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 7.0 tp -54.93 -51.18 66.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.367 -0.833 . . . . 75.140000000000001 110.17 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -81.3 -11.75 59.25 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.152 -0.968 . . . . 65.030000000000001 110.685 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.52 -52.89 18.65 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.797 -1.189 . . . . 70.209999999999994 109.973 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.503 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 1.7 mp -85.18 -36.81 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.147 -0.971 . . . . 75.319999999999993 109.072 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.486 -0.758 . . . . 73.140000000000001 109.359 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 108.788 -0.819 . . . . 73.129999999999995 108.788 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 29.4 m -74.94 -14.97 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.344 -0.847 . . . . 74.019999999999996 109.716 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 34.5 mt -48.89 -43.17 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.153 -0.967 . . . . 72.329999999999998 109.63 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -53.08 -34.02 54.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.12 -0.988 . . . . 74.400000000000006 109.466 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.32 -49.0 21.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.482 -0.761 . . . . 74.319999999999993 110.179 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.88 96.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.006 -1.059 . . . . 73.230000000000004 110.161 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.421 ' CG2' ' N ' ' A' ' 189' ' ' ASN . 11.0 tp -66.3 -42.58 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 120.936 -1.103 . . . . 74.310000000000002 109.691 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.421 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 39.2 t30 -62.87 -43.05 99.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.197 -0.94 . . . . 73.439999999999998 109.353 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -65.33 -40.16 93.33 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.37 -0.831 . . . . 71.420000000000002 109.61 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 71.8 mt -65.96 -44.86 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.247 -0.908 . . . . 72.439999999999998 109.793 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -58.7 -38.87 79.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.149 -0.969 . . . . 64.219999999999999 109.712 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -79.15 -26.04 42.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -0.991 . . . . 74.319999999999993 110.336 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -91.07 -16.98 26.97 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.962 -1.087 . . . . 75.310000000000002 110.825 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' MET . . . . . 0.568 ' SD ' ' N ' ' A' ' 196' ' ' ASP . 2.2 ppp? -91.72 -41.81 10.5 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.713 -1.242 . . . . 74.019999999999996 110.43 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . 0.568 ' N ' ' SD ' ' A' ' 195' ' ' MET . 26.1 t70 -66.82 -37.04 83.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.934 -1.104 . . . . 74.019999999999996 110.103 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.412 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 0.1 OUTLIER -50.86 -63.54 1.84 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.96 -1.087 . . . . 75.430000000000007 109.156 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 40.8 Cg_endo -65.81 -58.27 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.527 1.485 . . . . 72.319999999999993 111.189 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.542 ' C ' ' H ' ' A' ' 201' ' ' ILE . 4.0 mm? -86.16 92.38 8.73 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.29 -1.004 . . . . 74.540000000000006 108.29 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -59.17 -0.22 0.69 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.968 -1.253 . . . . 61.509999999999998 109.968 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.542 ' H ' ' C ' ' A' ' 199' ' ' LEU . 26.0 mm -108.29 130.09 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.379 -1.071 . . . . 74.25 109.336 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 67.0 m -76.74 146.34 38.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 72.0 109.296 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 15.9 p -139.65 4.49 2.14 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.398 -0.813 . . . . 74.439999999999998 109.354 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 7.9 m -120.54 132.05 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.606 -0.684 . . . . 71.129999999999995 109.538 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -103.8 118.33 36.44 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.378 -0.826 . . . . 73.510000000000005 108.914 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.11 129.43 40.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.241 -0.912 . . . . 73.519999999999996 109.573 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 211' ' ' GLY . 19.9 t -144.54 131.13 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 72.150000000000006 108.944 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -56.78 -31.84 65.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 72.400000000000006 109.684 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 211' ' ' GLY . 72.9 mtt85 -63.72 137.54 58.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.91 . . . . 73.310000000000002 109.808 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 57.68 -78.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.475 -0.766 . . . . 71.540000000000006 110.026 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . -177.6 -114.94 0.42 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.29 -1.524 . . . . 74.450000000000003 109.29 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -113.24 135.07 54.23 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.426 -1.044 . . . . 75.540000000000006 109.289 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 21.8 ttp-105 -109.55 139.64 44.31 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.929 -0.767 . . . . 75.310000000000002 108.929 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.473 ' O ' ' SG ' ' A' ' 215' ' ' CYS . 58.7 m-85 -107.62 134.57 50.43 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.425 -0.797 . . . . 75.409999999999997 109.935 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 214' ' ' PHE . 99.3 m -155.02 156.25 35.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.479 -0.763 . . . . 74.140000000000001 109.262 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . 0.455 ' CD2' ' OD1' ' A' ' 160' ' ' ASP . 1.9 p90 -64.74 154.34 85.59 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.193 -0.942 . . . . 75.319999999999993 109.299 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo . . . . . 0 N--CA 1.492 1.392 0 C-N-CA 122.232 1.955 . . . . 73.109999999999999 111.943 179.827 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.589 ' SD ' ' CE2' ' B' ' 25' ' ' PHE . 16.7 ptp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.435 -0.58 . . . . 75.239999999999995 109.435 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.532 ' NH1' ' SD ' ' B' ' 26' ' ' MET . 92.8 mtt-85 -136.62 152.97 51.03 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.387 -0.821 . . . . 73.519999999999996 109.178 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 93.5 t -110.68 133.2 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.525 -0.735 . . . . 72.239999999999995 109.582 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 3.6 tp -105.72 118.22 36.03 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.61 -0.681 . . . . 73.340000000000003 109.686 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 15.3 mt -113.3 100.28 8.44 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.708 -0.849 . . . . 74.349999999999994 108.708 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 89.4 mt -86.97 99.66 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.04 -1.038 . . . . 63.439999999999998 109.015 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.415 ' OE2' ' OG ' ' B' ' 51' ' ' SER . 7.0 tp10 -146.69 137.61 24.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.46 -0.775 . . . . 74.519999999999996 108.913 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.452 ' H ' ' CD ' ' B' ' 8' ' ' LYS . 0.0 OUTLIER -78.39 -31.92 48.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 74.129999999999995 109.084 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -75.45 109.16 8.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.867 . . . . 74.230000000000004 109.552 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 29.3 m -67.43 -27.7 67.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.269 -0.895 . . . . 65.540000000000006 109.668 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 75.5 t -59.11 -52.44 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.236 -0.915 . . . . 75.549999999999997 109.668 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 91.6 mt -63.28 -35.76 81.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -0.962 . . . . 70.140000000000001 109.402 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.65 -25.02 75.99 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.826 -1.71 . . . . 75.400000000000006 108.826 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.04 -53.05 24.55 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.736 -1.345 . . . . 65.439999999999998 109.736 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -58.96 -47.17 86.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.35 -1.088 . . . . 72.200000000000003 109.97 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 37.0 mm -61.82 -39.23 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.738 -1.226 . . . . 75.150000000000006 108.816 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -55.04 -42.53 72.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.35 -0.844 . . . . 73.010000000000005 109.457 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -87.76 -2.82 58.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.168 -0.957 . . . . 74.299999999999997 109.381 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.63 -53.66 3.16 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 109.91 -1.276 . . . . 70.540000000000006 109.91 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -74.29 -19.84 60.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -1.147 . . . . 75.430000000000007 110.016 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -52.83 -32.4 44.12 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.085 -1.009 . . . . 73.200000000000003 109.52 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 97.5 t -61.94 -33.45 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.225 -0.922 . . . . 74.230000000000004 109.159 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.437 ' NZ ' ' OE1' ' B' ' 110' ' ' GLU . 16.4 mmtp -81.77 -5.4 58.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.856 . . . . 73.519999999999996 109.18 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.83 19.63 70.02 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.964 -1.254 . . . . 53.43 109.964 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.589 ' CE2' ' SD ' ' B' ' 1' ' ' MET . 7.4 m-85 -92.43 159.68 15.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.162 -1.199 . . . . 71.120000000000005 108.97 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' MET . . . . . 0.532 ' SD ' ' NH1' ' B' ' 2' ' ' ARG . 35.6 mtt -100.95 138.0 38.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.271 -0.893 . . . . 75.239999999999995 108.702 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.22 147.35 39.08 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.51 -0.744 . . . . 73.25 110.09 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -131.7 134.04 45.49 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.44 -0.948 . . . . 72.310000000000002 108.44 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -109.75 134.55 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.361 -0.837 . . . . 72.140000000000001 109.077 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.9 p -137.23 169.72 17.31 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.497 -0.752 . . . . 74.530000000000001 109.176 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -93.21 -107.34 0.12 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.191 -0.943 . . . . 71.019999999999996 109.679 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 68.2 p -78.75 168.45 19.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.906 . . . . 71.400000000000006 109.914 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 47.6 mt -51.53 -30.25 19.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.663 -0.648 . . . . 71.239999999999995 109.907 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -52.72 -51.18 61.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.097 -1.002 . . . . 74.319999999999993 109.772 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.82 -39.2 93.66 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.152 -0.968 . . . . 73.030000000000001 109.428 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.64 -39.39 78.06 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.559 -1.416 . . . . 60.43 109.559 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -69.06 -38.23 78.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -1.127 . . . . 74.430000000000007 109.874 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -80.6 -38.72 28.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.102 -0.999 . . . . 74.420000000000002 109.918 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 11.1 tp -69.23 -43.49 73.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.216 -0.927 . . . . 75.409999999999997 110.134 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.0 ppp? -66.59 -24.42 66.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.05 . . . . 61.439999999999998 109.916 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -61.28 -40.99 96.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.109 -0.995 . . . . 74.319999999999993 110.112 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 17.5 pt -81.25 -30.7 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.076 -1.015 . . . . 71.230000000000004 110.238 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.424 ' O ' ' O ' ' B' ' 40' ' ' MET . 78.1 mtt85 -129.93 141.22 50.81 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.395 -0.815 . . . . 73.409999999999997 109.623 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -97.18 147.32 24.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.282 -0.886 . . . . 63.539999999999999 109.289 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -123.6 145.79 48.66 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.524 -0.735 . . . . 73.109999999999999 109.38 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . 0.458 ' OD2' ' NE1' ' B' ' 116' ' ' TRP . 48.6 t0 -79.68 -42.29 25.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.232 -0.917 . . . . 62.219999999999999 109.355 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.23 115.65 30.78 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.872 -0.788 . . . . 73.120000000000005 108.872 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 72.6 t -99.62 97.24 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.967 -1.123 . . . . 74.109999999999999 107.967 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 19.9 ttt -110.31 134.09 52.62 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.608 0.718 . . . . 73.439999999999998 110.576 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.98 132.71 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.543 0.687 . . . . 73.400000000000006 109.364 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' SER . . . . . 0.415 ' OG ' ' OE2' ' B' ' 7' ' ' GLU . 16.8 p -102.11 12.3 37.0 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.465 -0.772 . . . . 73.209999999999994 109.81 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -77.14 143.54 39.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.158 -0.964 . . . . 70.409999999999997 109.603 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.504 ' C ' ' H ' ' B' ' 55' ' ' ALA . 94.2 mttt -63.79 -37.44 87.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 73.129999999999995 109.822 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -71.77 16.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.935 . . . . 75.209999999999994 109.645 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.504 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -57.19 -40.05 76.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 55.329999999999998 109.818 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -46.98 -42.22 17.6 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.164 -0.96 . . . . 72.420000000000002 109.733 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' SER . . . . . 0.434 ' O ' ' NH1' ' B' ' 61' ' ' ARG . 17.5 m -72.62 -43.08 63.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 73.040000000000006 109.648 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -64.52 -58.01 7.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.29 -0.881 . . . . 72.329999999999998 109.95 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 14.2 m -53.01 -36.96 25.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.512 -1.368 . . . . 74.540000000000006 109.609 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 23.3 t -54.93 -52.15 63.86 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.256 -0.903 . . . . 71.239999999999995 109.6 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.434 ' NH1' ' O ' ' B' ' 57' ' ' SER . 3.9 ptp85 -69.74 -34.09 73.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.989 . . . . 74.310000000000002 110.318 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 40.4 mm -69.75 -34.52 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.759 -1.213 . . . . 75.420000000000002 109.924 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -44.36 77.29 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.15 -0.969 . . . . 73.319999999999993 110.231 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.479 ' CG ' ' N ' ' B' ' 65' ' ' LYS . 9.6 pt-20 -79.41 -45.65 19.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.934 -1.104 . . . . 73.310000000000002 110.369 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.479 ' N ' ' CG ' ' B' ' 64' ' ' GLU . 57.9 mttp -66.95 -24.87 66.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.195 -0.941 . . . . 72.439999999999998 109.852 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . 0.429 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 79.4 m-70 -155.28 64.5 0.63 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.138 -0.976 . . . . 65.209999999999994 109.564 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.0 t -56.09 -34.05 65.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 73.099999999999994 109.823 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 44.8 t -70.18 47.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.936 . . . . 71.530000000000001 109.924 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 15.6 tt -145.46 156.35 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.121 -0.987 . . . . 74.400000000000006 109.176 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 31.8 t -93.92 144.95 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.08 -1.012 . . . . 75.120000000000005 109.315 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 25.3 t -131.46 125.32 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.446 -0.784 . . . . 73.200000000000003 110.002 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 6.3 tt -121.64 98.06 5.78 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.864 -0.791 . . . . 73.340000000000003 108.864 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 10.5 p -90.26 156.35 3.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 120.901 -1.124 . . . . 73.5 108.711 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 5.9 m -129.45 169.01 15.48 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.385 -0.968 . . . . 71.319999999999993 108.385 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.454 ' C ' ' H ' ' B' ' 77' ' ' ASN . 36.0 t -172.49 125.07 0.49 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.943 -1.098 . . . . 74.530000000000001 110.442 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -76.04 21.57 0.17 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.602 -0.686 . . . . 64.5 109.8 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . 0.454 ' H ' ' C ' ' B' ' 75' ' ' SER . 42.6 t-20 -146.75 58.77 4.62 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.137 -0.977 . . . . 74.25 109.986 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -57.96 83.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.389 2.059 . . . . 74.430000000000007 112.036 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 66.5 p -107.63 160.97 15.28 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.41 -0.959 . . . . 73.120000000000005 108.41 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.3 p -63.2 -22.68 67.02 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.22 -0.925 . . . . 75.409999999999997 109.782 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . 0.438 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 97.2 mt-10 -69.41 -46.53 66.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.099 -1.001 . . . . 72.239999999999995 109.435 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -72.86 -28.06 62.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 73.219999999999999 109.579 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 35.4 tp10 -62.15 -54.05 46.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 74.299999999999997 109.886 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.89 -38.0 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 73.310000000000002 109.89 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' HIS . . . . . 0.438 ' ND1' ' O ' ' B' ' 81' ' ' GLU . 32.4 m80 -67.05 -35.4 79.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.075 -1.015 . . . . 73.239999999999995 109.778 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.12 -42.12 94.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.965 -1.085 . . . . 55.329999999999998 110.043 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' PHE . . . . . 0.456 ' CE1' ' NH1' ' A' ' 108' ' ' ARG . 52.9 m-85 -81.81 -35.9 28.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.065 -1.022 . . . . 74.450000000000003 109.438 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -71.05 -45.53 63.66 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.302 -0.874 . . . . 64.040000000000006 109.778 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -64.07 -50.46 68.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.087 -1.008 . . . . 75.129999999999995 109.458 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 142.44 73.29 0.03 OUTLIER Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.144 -1.182 . . . . 75.420000000000002 110.144 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -127.83 131.91 49.48 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.394 -1.062 . . . . 73.420000000000002 108.805 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -70.12 -43.07 71.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.99 -1.069 . . . . 73.319999999999993 108.848 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' ASP . . . . . 0.533 ' N ' ' OD1' ' B' ' 93' ' ' ASP . 13.2 p-10 -154.09 153.95 32.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.528 -0.733 . . . . 73.040000000000006 109.053 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.497 ' C ' ' CD1' ' B' ' 94' ' ' TYR . 0.5 OUTLIER -127.43 125.68 41.02 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 109.056 -0.72 . . . . 74.310000000000002 109.056 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . 0.444 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 30.1 mm -114.16 141.18 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-O 121.878 0.847 . . . . 75.340000000000003 110.34 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.36 123.02 16.6 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.337 -1.357 . . . . 70.099999999999994 107.337 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.695 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -43.54 -55.46 8.51 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.129 -0.982 . . . . 65.430000000000007 111.879 -178.466 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 2.6 Cg_endo -40.44 -10.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.052 1.168 . . . . 63.520000000000003 113.213 -175.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . 0.695 ' N ' ' O ' ' B' ' 97' ' ' LYS . 44.7 m-85 59.03 118.7 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.621 -0.674 . . . . 75.129999999999995 109.539 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -65.07 -41.04 95.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.764 -1.21 . . . . 74.230000000000004 108.82 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' SER . . . . . 0.754 ' O ' ' N ' ' B' ' 103' ' ' LYS . 7.3 t -173.87 44.84 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.205 -0.934 . . . . 64.510000000000005 110.739 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 14.0 mm 49.25 -69.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-N 118.717 0.689 . . . . 74.439999999999998 110.563 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . 0.754 ' N ' ' O ' ' B' ' 101' ' ' SER . 1.3 mptm? -53.06 -29.42 30.06 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 107.919 -1.141 . . . . 72.299999999999997 107.919 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.44 -39.84 85.42 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.177 -1.046 . . . . 74.310000000000002 108.177 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 50.7 tp -68.17 -56.53 8.41 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.075 -0.713 . . . . 73.540000000000006 109.075 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 89.0 t -60.96 -40.45 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.225 -0.922 . . . . 72.030000000000001 109.585 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.39 -44.43 65.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.155 -0.965 . . . . 64.219999999999999 108.902 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 25.5 tpt85 -64.58 -34.62 78.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.337 -0.852 . . . . 75.310000000000002 109.105 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 72.4 mt -73.63 -30.48 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.216 -0.928 . . . . 55.439999999999998 108.75 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . 0.437 ' OE1' ' NZ ' ' B' ' 23' ' ' LYS . 88.9 tt0 -67.31 -58.69 4.35 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.457 -0.777 . . . . 65.310000000000002 109.311 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.93 -31.11 62.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.279 -0.888 . . . . 74.519999999999996 109.111 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -59.39 -47.18 86.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.251 -0.905 . . . . 72.040000000000006 109.191 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.04 100.9 2.53 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.066 -1.021 . . . . 75.349999999999994 109.585 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 20.3 mtm105 -90.65 -73.25 0.54 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.274 -0.891 . . . . 75.5 108.987 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -68.74 -35.64 77.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 73.040000000000006 109.937 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' TRP . . . . . 0.458 ' NE1' ' OD2' ' B' ' 46' ' ' ASP . 58.1 t90 52.01 84.87 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 74.450000000000003 109.482 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 157.44 131.16 1.29 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.714 -1.355 . . . . 64.209999999999994 109.714 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 26.9 t -164.22 169.0 18.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.35 -1.089 . . . . 71.400000000000006 109.41 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.1 139.21 14.5 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.81 -0.756 . . . . 74.209999999999994 109.031 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 14.7 t -105.52 -45.43 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.465 -0.772 . . . . 75.019999999999996 110.146 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . 0.434 HG23 HD12 ' B' ' 121' ' ' ILE . 9.2 mm -100.08 140.82 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.079 -1.013 . . . . 74.239999999999995 109.83 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -148.79 115.33 5.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.227 -0.921 . . . . 73.329999999999998 109.344 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.03 120.34 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.632 -0.877 . . . . 74.219999999999999 108.632 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.48 -139.26 48.7 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.382 -1.487 . . . . 72.409999999999997 109.382 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' B' ' 125' ' ' ASP . 14.9 p-10 -88.59 4.42 46.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.197 -1.178 . . . . 75.120000000000005 109.503 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.33 135.48 35.69 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.184 -0.947 . . . . 75.420000000000002 108.591 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 5.7 m -132.8 122.88 25.15 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.452 -0.78 . . . . 74.219999999999999 109.172 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 31.1 mm -114.3 125.67 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.376 -0.827 . . . . 60.329999999999998 109.626 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 61.4 m -111.57 90.16 12.01 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.862 -0.792 . . . . 72.310000000000002 108.862 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.84 -29.38 8.59 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.667 1.578 . . . . 75.129999999999995 111.93 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -64.59 -43.51 93.58 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.173 -0.955 . . . . 75.230000000000004 108.873 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.3 8.18 37.26 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.356 -0.84 . . . . 75.120000000000005 109.21 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 49.82 62.14 2.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.895 . . . . 75.129999999999995 109.57 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -149.77 130.05 13.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.216 -0.927 . . . . 75.109999999999999 109.392 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . 0.509 ' CG2' ' CE2' ' B' ' 137' ' ' TYR . 1.8 mp -108.9 141.24 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.522 -0.736 . . . . 70.319999999999993 109.089 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 25.7 mt -131.12 132.54 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 121.359 -0.838 . . . . 74.120000000000005 110.644 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . 0.509 ' CE2' ' CG2' ' B' ' 135' ' ' ILE . 48.9 m-85 -134.89 133.37 39.58 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.438 -0.789 . . . . 74.230000000000004 109.442 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . 0.779 ' CE ' ' O ' ' B' ' 198' ' ' PRO . 23.0 mttm 55.11 25.12 6.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 74.219999999999999 110.267 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.7 13.34 80.1 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.941 -1.264 . . . . 74.319999999999993 109.941 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -99.79 124.09 44.71 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.3 -1.117 . . . . 75.340000000000003 108.85 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -88.65 131.45 34.98 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.125 -0.984 . . . . 71.230000000000004 109.913 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.5 136.85 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.462 -0.774 . . . . 70.430000000000007 109.299 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -86.16 160.76 19.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.382 -0.824 . . . . 72.430000000000007 109.154 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 10.3 m -138.18 147.19 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.327 -0.858 . . . . 72.129999999999995 109.693 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 36.4 pttt -176.18 70.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 74.5 109.872 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 179.99 177.69 48.15 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.545 -1.312 . . . . 42.229999999999997 110.091 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . 0.624 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 8.0 mtmm -70.21 -37.28 7.07 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.419 -1.047 . . . . 73.299999999999997 110.388 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 32.5 Cg_exo -58.12 -39.87 81.66 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.061 1.841 . . . . 71.329999999999998 111.898 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -87.56 -22.53 24.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.877 . . . . 74.230000000000004 109.454 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -52.68 -53.03 53.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 72.340000000000003 109.368 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.5 -38.18 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.239 -0.913 . . . . 73.349999999999994 109.394 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . 0.49 ' O ' ' CD1' ' B' ' 155' ' ' LEU . 33.4 tp -56.37 -36.53 68.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.19 -0.944 . . . . 74.430000000000007 108.586 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.75 -20.37 50.11 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.954 -1.091 . . . . 75.209999999999994 109.357 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 154' ' ' HIS . . . . . 0.625 ' CE1' ' CE1' ' B' ' 158' ' ' HIS . 16.6 t-160 -68.21 -60.63 2.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.931 -1.106 . . . . 73.040000000000006 109.596 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . 0.49 ' CD1' ' O ' ' B' ' 152' ' ' LEU . 0.0 OUTLIER -64.91 -24.81 67.64 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.218 -0.926 . . . . 73.430000000000007 108.899 179.469 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . 0.449 ' N ' ' CD1' ' B' ' 155' ' ' LEU . . . -57.42 -42.46 82.39 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.969 -1.082 . . . . 75.319999999999993 108.593 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' B' ' 159' ' ' ARG . 59.8 mtp180 -87.55 -69.23 0.7 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.228 -0.92 . . . . 73.319999999999993 110.997 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 158' ' ' HIS . . . . . 0.625 ' CE1' ' CE1' ' B' ' 154' ' ' HIS . 10.6 p-80 -67.97 48.08 0.05 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.324 -0.95 . . . . 74.140000000000001 110.158 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' B' ' 157' ' ' ARG . 0.0 OUTLIER -83.78 176.98 8.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.932 -1.105 . . . . 73.420000000000002 108.84 179.276 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 53.0 t0 54.7 43.13 30.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.392 -0.817 . . . . 72.099999999999994 111.288 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -158.67 171.77 19.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.606 -1.309 . . . . 73.239999999999995 109.852 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 19.9 mm -73.18 140.47 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.327 -0.858 . . . . 72.310000000000002 109.536 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' B' ' 212' ' ' TYR . 41.0 t -133.59 111.82 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.473 -0.767 . . . . 75.030000000000001 109.343 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 8.9 t -92.22 166.08 12.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.139 -0.976 . . . . 74.219999999999999 109.001 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -59.51 -44.13 93.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.941 -1.099 . . . . 72.420000000000002 108.674 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.59 -24.72 67.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.285 -0.884 . . . . 63.450000000000003 108.956 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -61.06 -51.65 68.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.383 -0.823 . . . . 72.400000000000006 109.692 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 41.6 mt -61.46 -41.68 97.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 72.319999999999993 109.025 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -67.05 0.36 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.482 -0.762 . . . . 73.340000000000003 109.956 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -59.78 -17.51 36.15 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.936 -0.706 . . . . 73.099999999999994 109.829 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . 0.59 ' CB ' ' CE1' ' B' ' 154' ' ' HIS . . . -93.67 -3.8 51.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.801 -1.187 . . . . 62.130000000000003 108.702 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.57 ' O ' ' CG ' ' B' ' 173' ' ' TRP . 96.5 mt -133.06 -80.91 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.495 -0.753 . . . . 74.439999999999998 109.074 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 173' ' ' TRP . . . . . 0.57 ' CG ' ' O ' ' B' ' 172' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.514 2.744 0 CA-C-O 121.73 0.776 . . . . 72.230000000000004 109.314 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo . . . . . 0 N--CA 1.494 1.51 0 CA-C-O 121.212 0.422 . . . . 74.340000000000003 112.466 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 52.02 54.43 10.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.224 -0.923 . . . . 72.310000000000002 109.628 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 3.4 p -78.96 -28.64 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.205 -0.934 . . . . 65.420000000000002 110.12 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 38.8 mm -57.21 -33.93 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.912 -1.117 . . . . 75.030000000000001 111.154 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -61.26 -63.23 1.35 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.924 -1.11 . . . . 73.519999999999996 111.252 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 30.4 m -70.48 -32.75 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.792 -1.193 . . . . 74.349999999999994 110.562 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -67.24 -38.03 84.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.958 -1.089 . . . . 61.119999999999997 111.725 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 188' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' B' ' 189' ' ' ASN . 10.6 tp -79.62 -46.07 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 119.982 -1.699 . . . . 72.430000000000007 111.222 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 189' ' ' ASN . . . . . 0.447 ' N ' ' CG2' ' B' ' 188' ' ' ILE . 40.1 m-20 -59.33 -34.05 71.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.745 -1.222 . . . . 75.420000000000002 109.802 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -80.79 -51.86 8.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.047 -1.033 . . . . 74.140000000000001 110.0 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 68.6 mt -49.76 -36.14 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.265 -0.897 . . . . 74.030000000000001 109.512 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 192' ' ' ARG . . . . . 1.48 HH12 ' CG2' ' B' ' 204' ' ' VAL . 82.6 mtt-85 -72.75 -45.73 57.15 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.756 -0.831 . . . . 72.329999999999998 108.756 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -66.54 -12.12 56.14 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.351 -0.843 . . . . 73.099999999999994 108.949 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -108.47 -13.46 14.84 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.493 -0.754 . . . . 74.430000000000007 110.617 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 35.5 ttm -96.22 -54.67 3.21 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.87 -1.144 . . . . 74.329999999999998 110.362 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -55.89 -27.62 52.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 71.209999999999994 109.701 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . 0.436 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 40.2 mttt -66.3 -65.75 1.59 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 75.209999999999994 110.021 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 198' ' ' PRO . . . . . 0.779 ' O ' ' CE ' ' B' ' 138' ' ' LYS . 17.8 Cg_endo -58.55 -48.21 16.1 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.139 1.893 . . . . 75.319999999999993 112.745 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 9.5 mp -75.86 -43.29 46.39 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.98 -1.075 . . . . 72.25 110.048 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 83.43 -9.05 62.57 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.691 -1.364 . . . . 73.239999999999995 109.691 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 31.3 mm -110.25 130.02 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.451 -1.029 . . . . 54.299999999999997 109.481 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 61.3 p -82.58 142.78 31.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.294 -0.879 . . . . 74.310000000000002 109.507 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 203' ' ' THR . . . . . 0.436 ' OG1' ' CZ ' ' B' ' 214' ' ' PHE . 57.8 p -149.89 20.8 0.89 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.459 -0.776 . . . . 74.400000000000006 109.46 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 1.48 ' CG2' HH12 ' B' ' 192' ' ' ARG . 1.2 m -135.14 137.51 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.233 -0.917 . . . . 74.099999999999994 109.664 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -125.81 133.5 51.98 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.974 -0.75 . . . . 75.329999999999998 108.974 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 9.7 t -101.96 128.66 48.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.211 -0.931 . . . . 71.400000000000006 109.273 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 27.2 m -145.11 155.44 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.124 -0.985 . . . . 63.5 109.753 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -86.24 -13.05 47.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.276 -0.89 . . . . 74.450000000000003 109.815 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 64.7 mtp85 -55.45 -38.26 68.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.125 -0.984 . . . . 74.140000000000001 109.845 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 75.8 mtt-85 -148.44 -50.55 0.16 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.127 -0.983 . . . . 74.430000000000007 109.246 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 169.28 -113.82 0.53 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.455 -1.458 . . . . 70.109999999999999 109.455 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 212' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' B' ' 163' ' ' VAL . 65.0 m-85 -109.52 127.0 54.13 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.513 -0.992 . . . . 74.209999999999994 109.563 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 43.4 ttt180 -105.06 121.79 44.52 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.379 -0.826 . . . . 74.299999999999997 109.116 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . 0.436 ' CZ ' ' OG1' ' B' ' 203' ' ' THR . 8.3 t80 -94.53 118.61 31.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.297 -0.877 . . . . 74.340000000000003 109.007 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 35.6 t -119.97 136.58 54.48 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.724 -0.61 . . . . 72.209999999999994 109.633 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -58.89 149.32 65.75 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.275 -1.009 . . . . 72.310000000000002 108.275 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.73 -169.53 0.18 Allowed 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.999 1.799 . . . . 71.010000000000005 111.742 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 6.3 pttm . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.063 -1.023 . . . . 74.349999999999994 109.242 -179.851 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 tpp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.449 -0.575 . . . . 65.120000000000005 109.449 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.517 ' NH2' ' OD2' ' A' ' 28' ' ' ASP . 33.3 ttt85 -145.43 149.58 34.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.148 -0.97 . . . . 73.310000000000002 109.383 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 82.6 t -115.91 132.56 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.403 0.62 . . . . 71.420000000000002 109.768 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 tp -99.56 115.44 29.38 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.829 -0.804 . . . . 65.219999999999999 108.829 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 59.8 tp -114.61 104.01 11.57 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.554 -0.716 . . . . 71.439999999999998 109.357 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.6 mt -93.23 112.16 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.854 -1.154 . . . . 71.150000000000006 109.189 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -146.86 134.18 20.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.378 -0.827 . . . . 75.340000000000003 109.153 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.487 ' H ' ' CD ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -73.89 -30.63 62.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.957 . . . . 73.040000000000006 109.184 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -83.63 110.58 18.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.253 -0.904 . . . . 72.420000000000002 109.347 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.6 m -65.14 -32.82 74.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 72.340000000000003 109.911 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 81.4 t -64.23 -49.49 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 74.420000000000002 109.778 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.0 tp -60.93 -37.58 82.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 72.010000000000005 109.38 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.31 -27.88 62.95 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.684 -1.767 . . . . 72.140000000000001 108.684 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.09 -48.02 79.53 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.345 -1.502 . . . . 72.329999999999998 109.345 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -64.25 -43.54 94.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.389 -1.066 . . . . 72.340000000000003 109.579 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.9 mm -65.35 -38.34 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.837 -1.165 . . . . 74.239999999999995 108.519 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.423 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 14.9 tm-20 -61.22 -45.18 95.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.34 -0.85 . . . . 71.409999999999997 109.518 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -86.58 -1.41 57.63 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.138 -0.976 . . . . 75.540000000000006 109.642 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.36 -61.23 1.65 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.02 -1.632 . . . . 62.149999999999999 109.02 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pp -62.3 -29.09 70.19 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.487 -1.008 . . . . 74.420000000000002 109.031 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 24' ' ' GLY . 86.1 m-20 -51.64 -36.16 45.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 74.25 109.0 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.8 t -53.59 -34.19 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.611 -0.885 . . . . 72.109999999999999 108.611 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.8 mmtm -78.74 -4.83 51.2 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.685 -0.857 . . . . 73.230000000000004 108.685 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 21' ' ' ASN . . . 79.94 44.92 8.7 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.639 -0.984 . . . . 75.540000000000006 110.639 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -119.06 159.68 23.45 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.264 -1.139 . . . . 74.510000000000005 109.017 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.3 mmt -103.65 139.17 39.29 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.541 -0.911 . . . . 64.319999999999993 108.541 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.417 ' O ' ' OD1' ' A' ' 28' ' ' ASP . . . -143.96 160.4 40.89 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.285 -0.884 . . . . 74.310000000000002 109.841 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.517 ' OD2' ' NH2' ' A' ' 2' ' ' ARG . 79.3 m-20 -135.96 149.9 49.06 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.954 -0.758 . . . . 75.400000000000006 108.954 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.46 133.92 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.756 -0.831 . . . . 75.129999999999995 108.756 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 p -134.65 168.21 19.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.471 -0.768 . . . . 71.420000000000002 109.42 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -93.09 -106.37 0.12 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.224 -0.922 . . . . 73.109999999999999 109.612 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.8 p -79.8 168.19 19.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.123 -0.986 . . . . 74.239999999999995 109.909 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.7 mt -53.84 -29.98 43.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.465 -0.772 . . . . 71.530000000000001 109.778 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -55.27 -47.97 74.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.108 -0.995 . . . . 74.230000000000004 109.938 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.48 -44.6 70.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.096 -1.003 . . . . 71.010000000000005 109.58 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.45 -40.65 86.54 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.589 -1.404 . . . . 61.409999999999997 109.589 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -66.0 -45.42 81.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -1.115 . . . . 74.340000000000003 109.784 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.26 -40.37 74.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.101 -0.999 . . . . 75.329999999999998 109.664 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.42 ' C ' ' CD2' ' A' ' 39' ' ' LEU . 7.0 tt -70.5 -56.33 6.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.307 -0.871 . . . . 74.329999999999998 110.022 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.501 ' SD ' ' OH ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -55.75 -27.69 52.02 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.129 -0.982 . . . . 70.319999999999993 110.047 -179.096 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -62.36 -37.23 84.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.104 -0.998 . . . . 71.219999999999999 110.111 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.0 pt -91.6 -1.6 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.091 -1.006 . . . . 74.409999999999997 110.416 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 40' ' ' MET . 19.4 mmt85 -130.02 145.77 51.67 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.292 -0.88 . . . . 75.409999999999997 109.73 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -89.43 152.54 21.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.28 -0.888 . . . . 75.420000000000002 108.997 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.501 ' OH ' ' SD ' ' A' ' 40' ' ' MET . 6.4 p90 -153.13 176.52 11.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.072 -1.017 . . . . 74.230000000000004 109.857 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -132.34 -38.7 1.05 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.552 -0.718 . . . . 75.319999999999993 109.832 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.413 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -103.32 112.17 24.92 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.332 -0.855 . . . . 72.129999999999995 109.255 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 75.1 t -96.53 98.06 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.89 -0.781 . . . . 72.340000000000003 108.89 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.503 ' SD ' ' N ' ' A' ' 50' ' ' VAL . 3.3 tpp -110.08 127.76 55.04 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.626 0.727 . . . . 74.109999999999999 109.143 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.503 ' N ' ' SD ' ' A' ' 49' ' ' MET . 1.6 p -138.71 128.02 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.532 -0.73 . . . . 71.239999999999995 109.64 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.1 m -96.42 5.16 51.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.338 -0.851 . . . . 73.109999999999999 109.521 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -76.47 141.41 41.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.129 -0.982 . . . . 63.399999999999999 109.299 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 55' ' ' ALA . 18.4 pttp -77.69 -38.81 46.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.145 -0.972 . . . . 65.439999999999998 110.453 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -72.17 12.84 0.37 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.015 -1.053 . . . . 73.129999999999995 109.498 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.48 -21.02 58.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 64.140000000000001 110.596 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 55' ' ' ALA . 58.7 mt -40.71 -52.45 2.94 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.366 -0.834 . . . . 74.430000000000007 110.428 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -67.02 -32.72 74.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.983 -1.073 . . . . 63.229999999999997 108.908 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.449 ' N ' ' O ' ' A' ' 55' ' ' ALA . 53.4 t80 -66.46 -59.29 3.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.435 -0.791 . . . . 74.439999999999998 109.911 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.5 m -51.67 -34.14 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.561 -1.337 . . . . 74.030000000000001 109.476 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.1 t -58.07 -55.48 34.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.129 -0.982 . . . . 73.540000000000006 109.718 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -64.72 -27.72 69.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.08 -1.012 . . . . 73.340000000000003 109.782 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.7 mm -65.39 -42.29 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.894 -1.129 . . . . 73.349999999999994 109.886 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 67' ' ' SER . 1.9 mmmm -67.65 -46.99 70.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.169 -0.957 . . . . 74.420000000000002 110.402 -179.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.413 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 14.3 pt-20 -69.91 -41.46 74.63 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.594 -1.316 . . . . 74.549999999999997 109.535 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.413 ' N ' ' CG ' ' A' ' 64' ' ' GLU . 52.1 mtpt -73.85 -22.29 59.81 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.232 -0.917 . . . . 75.219999999999999 109.169 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.682 ' CE1' ' HZ3' ' A' ' 145' ' ' LYS . 78.7 m-70 -152.66 64.96 0.8 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.305 -0.872 . . . . 74.129999999999995 109.148 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 63' ' ' LYS . 22.7 t -59.23 -36.21 75.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.172 -0.955 . . . . 73.239999999999995 109.967 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.7 p -74.5 50.36 0.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.136 -0.978 . . . . 71.439999999999998 109.574 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 11.2 tt -145.65 168.38 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.165 -0.959 . . . . 71.329999999999998 109.472 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.6 t -104.11 152.78 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.336 -0.852 . . . . 73.019999999999996 109.154 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.8 t -143.55 120.71 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.15 -0.969 . . . . 54.210000000000001 109.197 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.495 ' O ' ' SD ' ' A' ' 49' ' ' MET . 3.5 mp -119.33 104.64 10.56 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.708 -0.849 . . . . 74.209999999999994 108.708 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.6 p -94.78 130.71 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.264 -0.898 . . . . 74.409999999999997 109.148 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.6 p -90.85 165.48 13.59 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.152 -0.967 . . . . 72.310000000000002 108.923 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 77' ' ' ASN . 11.8 m -159.53 115.65 2.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.031 -1.043 . . . . 64.540000000000006 109.91 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 49.9 p30 -72.64 11.23 0.67 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.376 -0.827 . . . . 74.129999999999995 109.128 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 79' ' ' THR . 4.4 t-20 -142.28 64.09 16.15 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.472 -0.767 . . . . 73.340000000000003 109.455 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.97 83.83 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.027 1.818 . . . . 71.319999999999993 111.716 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.488 ' N ' ' O ' ' A' ' 77' ' ' ASN . 28.5 p -115.38 156.6 25.26 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.194 -0.669 . . . . 62.530000000000001 109.194 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.2 t -64.64 -38.87 92.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.308 -0.87 . . . . 74.140000000000001 109.596 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.403 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 85.8 tt0 -55.41 -44.79 76.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 71.420000000000002 109.386 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -74.55 -30.51 61.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.144 -0.973 . . . . 73.430000000000007 109.478 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -63.06 -57.37 10.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.299 -0.875 . . . . 74.219999999999999 109.799 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.0 m -58.91 -42.85 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.109 -0.994 . . . . 74.150000000000006 109.343 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.403 ' ND1' ' O ' ' A' ' 81' ' ' GLU . 24.2 m170 -63.51 -21.05 66.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.932 . . . . 72.540000000000006 109.583 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.18 -48.74 19.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.076 -1.015 . . . . 64.219999999999999 110.024 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.57 ' CE2' ' CZ ' ' B' ' 108' ' ' ARG . 86.0 m-85 -81.0 -28.42 35.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.026 -1.046 . . . . 74.340000000000003 109.351 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -73.69 -42.73 60.88 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.223 -0.923 . . . . 74.420000000000002 109.689 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -68.61 -50.47 51.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.082 -1.011 . . . . 74.519999999999996 109.711 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.56 64.47 0.01 OUTLIER Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.138 -1.185 . . . . 74.209999999999994 110.138 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -130.33 141.15 50.6 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.393 -1.063 . . . . 64.099999999999994 109.046 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 0.9 OUTLIER -79.71 -39.19 31.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.086 -1.009 . . . . 73.420000000000002 109.562 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 71.2 m-20 -152.44 164.39 37.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 75.040000000000006 109.532 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.71 129.69 24.92 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.665 -0.865 . . . . 71.329999999999998 108.665 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.576 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -124.02 145.42 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 121.444 0.64 . . . . 74.510000000000005 110.066 -178.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.01 130.21 44.49 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.176 -1.046 . . . . 64.319999999999993 108.176 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.655 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -51.42 -54.03 43.27 Favored Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.056 -1.028 . . . . 74.510000000000005 111.506 -179.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.7 Cg_endo -42.13 -11.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.228 0 CA-C-N 119.681 0.922 . . . . 73.109999999999999 112.558 -176.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.655 ' N ' ' O ' ' A' ' 97' ' ' LYS . 57.9 m-85 59.94 135.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.859 -0.525 . . . . 72.540000000000006 110.009 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 44.1 mtt-85 -73.7 -45.06 54.54 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.083 -1.011 . . . . 74.540000000000006 109.86 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.732 ' O ' ' N ' ' A' ' 103' ' ' LYS . 42.4 t -164.41 32.56 0.07 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.838 -1.164 . . . . 74.140000000000001 111.201 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.0 mm 52.42 -70.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.494 -0.754 . . . . 75.430000000000007 110.168 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.732 ' N ' ' O ' ' A' ' 101' ' ' SER . 13.8 mptt -57.86 -26.64 62.35 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.006 -1.109 . . . . 74.140000000000001 108.006 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.53 -46.67 46.28 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.853 -0.739 . . . . 63.240000000000002 109.697 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.7 tp -63.32 -58.72 6.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.935 . . . . 73.219999999999999 109.615 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.417 ' CG2' ' N ' ' A' ' 107' ' ' ALA . 9.1 m -52.22 -40.94 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.966 -1.084 . . . . 74.540000000000006 109.471 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.417 ' N ' ' CG2' ' A' ' 106' ' ' VAL . . . -55.71 -43.09 76.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.134 -0.979 . . . . 75.5 108.557 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -64.08 -30.89 71.93 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.357 -0.839 . . . . 74.409999999999997 109.069 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 55.6 mt -71.36 -35.2 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 107.969 -1.123 . . . . 73.239999999999995 107.969 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 114' ' ' ARG . 81.6 tt0 -62.39 -34.57 76.99 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.097 -0.705 . . . . 74.340000000000003 109.097 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -76.36 -59.73 2.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 73.319999999999993 109.654 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.97 -9.71 1.47 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 74.420000000000002 109.483 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.6 tp -140.53 82.48 1.85 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.213 -0.929 . . . . 74.329999999999998 109.84 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 110' ' ' GLU . 2.1 mmt180 -152.05 -50.11 0.11 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.318 -0.864 . . . . 74.439999999999998 108.897 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -89.34 14.14 11.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.282 -0.886 . . . . 74.430000000000007 110.001 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.406 ' O ' ' CG ' ' A' ' 116' ' ' TRP . 34.9 p-90 -68.08 125.33 26.0 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.057 -1.027 . . . . 74.439999999999998 109.721 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.411 ' O ' ' OG ' ' A' ' 118' ' ' SER . . . 139.79 135.62 3.27 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.186 -1.565 . . . . 75.040000000000006 109.186 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 117' ' ' GLY . 69.1 m -166.35 171.02 12.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.071 -1.252 . . . . 70.109999999999999 110.1 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.08 103.31 2.2 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.726 -0.842 . . . . 65.239999999999995 108.726 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 97.4 t -72.04 -29.67 33.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.087 -1.008 . . . . 74.219999999999999 109.132 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.15 131.5 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.603 -0.888 . . . . 74.420000000000002 108.603 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -149.12 128.4 12.91 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.129 -0.982 . . . . 73.299999999999997 109.542 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.982 HG21 ' NH1' ' A' ' 159' ' ' ARG . 9.3 tp -161.39 136.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.309 -0.869 . . . . 75.340000000000003 109.499 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.565 ' C ' ' H ' ' A' ' 126' ' ' LEU . . . 59.13 -167.03 7.65 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.878 -1.289 . . . . 75.129999999999995 109.878 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -70.67 12.29 0.28 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.511 -0.993 . . . . 74.450000000000003 108.83 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.565 ' H ' ' C ' ' A' ' 124' ' ' GLY . 1.9 tt -110.06 131.2 55.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.698 -0.626 . . . . 54.210000000000001 109.514 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.8 p -131.0 142.87 50.38 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.325 -0.859 . . . . 70.239999999999995 108.716 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 94.6 mt -136.67 135.4 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.164 -0.96 . . . . 72.430000000000007 110.661 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.1 m -127.46 104.1 22.05 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.359 -0.978 . . . . 71.109999999999999 108.359 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.33 -25.38 2.65 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.475 2.116 . . . . 75.140000000000001 112.206 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -66.06 -38.46 88.37 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.307 -0.871 . . . . 72.5 108.843 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -98.08 9.06 43.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.375 -0.828 . . . . 73.140000000000001 109.64 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.67 ' HA ' ' HZ ' ' A' ' 149' ' ' PHE . 37.7 mt-10 47.72 60.48 3.5 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.206 -0.934 . . . . 75.329999999999998 109.617 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -154.03 130.6 10.67 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.047 -1.033 . . . . 71.230000000000004 110.098 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.419 ' CD1' ' HE1' ' A' ' 149' ' ' PHE . 2.2 mp -111.89 138.22 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.488 -0.93 . . . . 75.329999999999998 108.488 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 19.4 mt -125.72 131.54 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.409 -0.807 . . . . 71.109999999999999 108.9 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.548 ' HH ' ' NE ' ' A' ' 140' ' ' ARG . 10.3 p90 -139.12 139.22 37.58 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.099 -1.001 . . . . 74.140000000000001 109.984 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.1 mttt 53.73 27.87 7.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.522 -0.737 . . . . 75.400000000000006 110.175 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 77.88 14.08 82.73 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.905 -1.14 . . . . 72.239999999999995 110.437 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.548 ' NE ' ' HH ' ' A' ' 137' ' ' TYR . 19.1 mtp180 -105.27 133.13 50.54 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.472 -1.016 . . . . 73.120000000000005 108.78 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -90.82 129.3 36.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.322 -0.861 . . . . 72.319999999999993 110.224 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 t -128.14 108.63 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.357 -0.979 . . . . 62.340000000000003 108.357 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -92.48 102.07 14.52 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.054 -1.091 . . . . 61.229999999999997 108.054 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.3 m -115.61 139.76 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.7 0.762 . . . . 74.439999999999998 110.705 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.682 ' HZ3' ' CE1' ' A' ' 66' ' ' HIS . 39.0 pttt -160.53 125.39 3.77 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.856 -0.794 . . . . 75.420000000000002 108.856 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.37 -143.18 10.06 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.674 -1.37 . . . . 73.340000000000003 109.674 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -70.91 -59.27 3.64 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.346 -1.09 . . . . 72.219999999999999 110.486 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.84 4.9 1.23 Allowed 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.997 1.798 . . . . 75.450000000000003 112.785 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.67 ' HZ ' ' HA ' ' A' ' 133' ' ' GLU . 65.3 t80 -101.66 -54.82 2.65 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.234 -0.916 . . . . 65.239999999999995 110.319 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -46.98 -36.0 7.24 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.158 -0.964 . . . . 72.519999999999996 109.574 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.8 p -78.82 -31.26 15.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.169 -0.957 . . . . 74.209999999999994 109.137 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 13.8 tp -63.56 -38.81 92.53 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.127 -0.983 . . . . 73.310000000000002 109.039 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.415 ' H ' ' HG1' ' A' ' 153' ' ' THR . 14.1 p -75.91 -32.75 59.76 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.08 -1.013 . . . . 74.310000000000002 108.592 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.486 ' CD2' ' HE1' ' A' ' 158' ' ' HIS . 44.4 t-80 -55.13 -51.01 67.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.607 -0.683 . . . . 75.450000000000003 110.5 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.92 -33.41 65.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.988 -1.07 . . . . 75.340000000000003 109.887 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -50.45 -44.62 55.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.981 -1.074 . . . . 62.140000000000001 109.683 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 -77.66 -43.75 30.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.091 -1.006 . . . . 72.219999999999999 110.234 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.486 ' HE1' ' CD2' ' A' ' 154' ' ' HIS . 22.1 m170 -82.54 34.89 0.44 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 74.120000000000005 110.803 -178.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.982 ' NH1' HG21 ' A' ' 123' ' ' ILE . 30.8 ttp180 -64.61 169.28 5.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.807 -1.183 . . . . 74.340000000000003 107.927 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 4.4 p30 41.44 55.68 3.38 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.378 -0.826 . . . . 75.450000000000003 110.082 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -158.4 156.14 29.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 73.409999999999997 109.132 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.411 ' N ' ' CD1' ' A' ' 162' ' ' ILE . 2.5 mp -83.71 123.1 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.177 -0.952 . . . . 74.409999999999997 108.463 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 48.2 t -118.05 127.67 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.486 -0.759 . . . . 72.530000000000001 110.051 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.8 t -100.69 148.02 25.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.519 -0.738 . . . . 74.120000000000005 109.558 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.54 ' CB ' ' HZ1' ' A' ' 165' ' ' LYS . 8.1 mtpm? -49.41 -49.75 43.52 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.482 -0.761 . . . . 70.430000000000007 109.816 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -51.88 -36.93 50.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.069 -1.02 . . . . 74.319999999999993 109.476 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -59.03 -43.35 91.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.976 -1.078 . . . . 74.519999999999996 109.115 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 18.5 mt -56.14 -37.22 69.2 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.245 -0.909 . . . . 74.409999999999997 108.549 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 171' ' ' ALA . 92.8 mt -64.73 -74.68 0.1 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.566 -1.254 . . . . 75.140000000000001 109.019 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -45.92 -14.43 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.885 . . . . 65.030000000000001 110.516 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 169' ' ' LEU . . . -93.42 -37.54 11.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.063 -1.023 . . . . 70.209999999999994 111.428 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.416 ' N ' ' CD1' ' A' ' 172' ' ' ILE . 1.4 mp -95.42 -56.58 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 120.954 -1.091 . . . . 75.319999999999993 110.446 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.506 2.363 0 O-C-N 120.406 -1.434 . . . . 73.140000000000001 109.229 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 109.292 -0.633 . . . . 73.129999999999995 109.292 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.3 t -145.34 -31.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.235 -0.916 . . . . 74.019999999999996 110.176 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.536 ' H ' ' CD1' ' A' ' 184' ' ' ILE . 2.4 mp -57.85 -34.82 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.065 -1.022 . . . . 72.329999999999998 109.898 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -52.82 -50.05 64.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.242 -0.911 . . . . 74.400000000000006 109.641 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 16.7 m -77.8 -31.08 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.18 -0.95 . . . . 74.319999999999993 109.961 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.58 -51.08 68.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.926 -1.109 . . . . 73.230000000000004 109.915 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.421 ' CG2' ' N ' ' A' ' 189' ' ' ASN . 3.5 tp -68.03 -43.27 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.879 -1.138 . . . . 74.310000000000002 110.032 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.467 ' ND2' ' OE1' ' A' ' 193' ' ' GLN . 7.9 t-20 -60.38 -37.93 82.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.895 -1.128 . . . . 73.439999999999998 108.676 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -71.93 -50.87 25.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.551 -0.718 . . . . 71.420000000000002 110.618 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 69.5 mt -52.7 -58.5 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.053 -1.029 . . . . 72.439999999999998 109.914 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . 0.421 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 3.3 mtp85 -51.14 -41.92 60.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.075 -1.016 . . . . 64.219999999999999 109.008 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.467 ' OE1' ' ND2' ' A' ' 189' ' ' ASN . 16.4 mt-30 -71.02 -24.05 62.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.995 -1.066 . . . . 74.319999999999993 109.932 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.489 ' CB ' ' HZ2' ' A' ' 194' ' ' LYS . 4.7 mtpm? -101.0 -0.27 36.81 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.289 -0.882 . . . . 75.310000000000002 110.573 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -109.15 -19.11 13.46 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.2 -0.937 . . . . 74.019999999999996 110.02 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 192' ' ' ARG . 14.0 p-10 -98.28 -5.28 33.4 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.158 -0.964 . . . . 74.019999999999996 110.164 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 26.9 mttp -103.23 -64.86 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.125 0 O-C-N 121.355 -0.84 . . . . 75.430000000000007 110.575 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.447 ' CG ' ' O ' ' A' ' 194' ' ' LYS . 29.9 Cg_endo -61.42 -57.41 0.58 Allowed 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 121.966 1.777 . . . . 72.319999999999993 112.013 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.9 mp -69.55 -43.11 73.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 74.540000000000006 109.383 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 94.3 -26.97 14.8 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.254 -1.138 . . . . 61.509999999999998 110.254 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.51 ' N ' ' CD1' ' A' ' 201' ' ' ILE . 3.1 mp -98.68 133.54 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.97 -1.312 . . . . 74.25 110.289 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 14.6 m -106.14 139.18 41.07 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.118 -1.067 . . . . 72.0 108.118 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.4 p -141.58 42.96 1.74 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.063 -1.023 . . . . 74.439999999999998 110.128 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.529 ' CG1' ' CE2' ' A' ' 214' ' ' PHE . 1.0 OUTLIER -143.11 155.06 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.28 -0.888 . . . . 71.129999999999995 109.727 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -128.34 134.1 48.8 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.712 -0.847 . . . . 73.510000000000005 108.712 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.4 t -95.1 133.28 39.08 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.046 -1.034 . . . . 73.519999999999996 109.259 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 211' ' ' GLY . 10.5 p -156.25 142.78 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.787 -1.196 . . . . 72.150000000000006 109.531 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -64.85 -41.06 96.01 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.379 -0.825 . . . . 72.400000000000006 109.539 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 1.057 HH21 ' NH2' ' A' ' 213' ' ' ARG . 0.8 OUTLIER -58.12 152.8 16.07 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.824 -0.806 . . . . 73.310000000000002 108.824 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 209' ' ' ARG . 9.6 mpt_? 42.9 -94.17 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.23 -0.919 . . . . 71.540000000000006 109.789 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.541 ' O ' HG12 ' A' ' 207' ' ' VAL . . . -171.42 -114.09 0.31 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.469 -1.452 . . . . 74.450000000000003 109.469 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -111.06 140.34 45.68 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.478 -1.013 . . . . 75.540000000000006 109.055 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 1.057 ' NH2' HH21 ' A' ' 209' ' ' ARG . 36.6 mtt180 -105.51 142.65 34.88 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.319 -0.863 . . . . 75.310000000000002 109.677 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.529 ' CE2' ' CG1' ' A' ' 204' ' ' VAL . 33.8 m-85 -115.78 112.83 22.58 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.49 -0.93 . . . . 75.409999999999997 108.49 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 8.2 p -119.35 160.6 21.96 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.628 -0.67 . . . . 74.140000000000001 109.847 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . 0.462 ' CD1' ' O ' ' A' ' 217' ' ' PRO . 36.7 p90 -68.92 151.1 97.42 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.394 -0.816 . . . . 75.319999999999993 109.229 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.462 ' O ' ' CD1' ' A' ' 216' ' ' TYR . 84.4 Cg_exo . . . . . 0 N--CA 1.493 1.488 0 C-N-CA 122.28 1.987 . . . . 73.109999999999999 112.253 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.532 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.435 -0.58 . . . . 75.239999999999995 109.435 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.537 HH21 ' C ' ' B' ' 44' ' ' ASN . 8.1 ttp180 -139.89 150.38 44.53 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.357 -0.84 . . . . 73.519999999999996 109.067 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 92.6 t -116.03 129.93 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.537 -0.912 . . . . 72.239999999999995 108.537 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' B' ' 49' ' ' MET . 5.5 tp -101.89 118.34 36.72 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.513 -0.742 . . . . 73.340000000000003 110.002 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 16.4 mt -114.6 111.28 21.09 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 108.412 -0.958 . . . . 74.349999999999994 108.412 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 66.3 mt -107.94 115.4 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.417 -0.802 . . . . 63.439999999999998 109.246 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' B' ' 7' ' ' GLU . 1.4 pm0 -160.08 140.74 12.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 74.519999999999996 109.417 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -63.68 -31.15 72.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 74.129999999999995 109.319 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -86.5 106.97 17.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.252 -0.905 . . . . 74.230000000000004 109.524 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 47.8 m -72.44 -29.14 63.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 65.540000000000006 109.847 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 90.9 t -56.79 -49.97 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.155 -0.965 . . . . 75.549999999999997 109.657 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.506 ' CD2' ' N ' ' B' ' 12' ' ' LEU . 3.6 mm? -63.02 -35.21 79.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 70.140000000000001 109.188 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.78 -25.47 74.89 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 108.635 -1.786 . . . . 75.400000000000006 108.635 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.79 -54.13 27.05 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.36 -1.496 . . . . 65.439999999999998 109.36 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -57.42 -46.27 83.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.4 -1.059 . . . . 72.200000000000003 109.68 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 37.5 mm -62.52 -38.88 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.866 -1.146 . . . . 75.150000000000006 108.652 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.423 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 80.0 tt0 -61.79 -43.1 99.53 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.408 -0.807 . . . . 73.010000000000005 109.508 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -87.66 2.6 50.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.186 -0.946 . . . . 74.299999999999997 109.177 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.76 -55.95 2.06 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.457 -1.457 . . . . 70.540000000000006 109.457 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -71.44 -21.99 61.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.242 -1.151 . . . . 75.430000000000007 109.633 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 88.0 m-20 -52.44 -33.91 46.24 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.215 -0.928 . . . . 73.200000000000003 109.646 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 81.8 t -59.51 -32.71 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.152 -0.968 . . . . 74.230000000000004 109.212 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -79.23 -4.79 52.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.358 -0.839 . . . . 73.519999999999996 109.193 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.17 36.35 18.21 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.264 -1.135 . . . . 53.43 110.264 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -113.76 160.01 19.14 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.463 -1.022 . . . . 71.120000000000005 108.938 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.4 mmt -107.14 140.49 39.91 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.386 -0.821 . . . . 75.239999999999995 109.09 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.02 164.74 26.95 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.491 -0.755 . . . . 73.25 109.499 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -141.24 145.58 35.75 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.372 -0.83 . . . . 72.310000000000002 108.964 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 m -113.63 137.14 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.785 . . . . 72.140000000000001 109.068 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 10.0 p -144.56 164.47 30.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.288 -0.883 . . . . 74.530000000000001 109.367 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.447 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 1.6 pt-20 -91.57 -97.24 0.12 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.242 -0.911 . . . . 71.019999999999996 109.579 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 42.4 t -79.48 166.59 21.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.192 -0.942 . . . . 71.400000000000006 109.96 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' B' ' 37' ' ' GLU . 16.7 mt -55.25 -32.0 61.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.592 -0.693 . . . . 71.239999999999995 110.134 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -54.3 -44.86 72.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.09 -1.006 . . . . 74.319999999999993 110.2 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.447 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 19.0 m-20 -66.34 -42.96 87.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.051 -1.031 . . . . 73.030000000000001 109.651 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.58 -28.48 59.38 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.629 -1.388 . . . . 60.43 109.629 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' B' ' 33' ' ' LEU . 84.7 tt0 -67.18 -46.79 72.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -1.15 . . . . 74.430000000000007 109.695 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . 0.443 ' O ' ' OD1' ' B' ' 41' ' ' ASP . 70.2 t80 -75.06 -26.59 59.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.258 -0.901 . . . . 74.420000000000002 110.036 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 9.6 tp -84.84 -30.86 24.17 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.17 -0.956 . . . . 75.409999999999997 110.031 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.502 ' SD ' ' OH ' ' B' ' 45' ' ' TYR . 0.0 OUTLIER -86.83 -30.61 21.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.961 . . . . 61.439999999999998 110.317 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' B' ' 42' ' ' ILE . 56.2 p-10 -71.07 -21.4 62.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.878 -1.139 . . . . 74.319999999999993 110.043 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.528 ' N ' ' OD1' ' B' ' 41' ' ' ASP . 12.5 pt -80.94 -29.95 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.03 -1.044 . . . . 71.230000000000004 110.005 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.485 ' C ' ' NH2' ' B' ' 2' ' ' ARG . 26.2 mmt180 -129.13 171.13 12.71 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.376 -0.828 . . . . 73.409999999999997 109.791 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' ASN . . . . . 0.537 ' C ' HH21 ' B' ' 2' ' ' ARG . 24.5 m120 -98.87 154.21 18.21 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.076 -1.015 . . . . 63.539999999999999 109.809 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.586 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 1.3 p90 -140.52 -177.36 5.01 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.353 -0.842 . . . . 73.109999999999999 109.09 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . 0.443 ' OD2' ' CD1' ' B' ' 116' ' ' TRP . 63.4 t0 -133.28 -43.6 0.85 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.253 -0.904 . . . . 62.219999999999999 110.256 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.401 ' C ' ' CD1' ' B' ' 47' ' ' LEU . 0.5 OUTLIER -102.01 114.51 28.68 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.276 -0.89 . . . . 73.120000000000005 109.082 -179.597 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 50.6 t -98.63 97.37 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.238 -1.023 . . . . 74.109999999999999 108.238 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' MET . . . . . 0.457 ' O ' ' O ' ' B' ' 4' ' ' LEU . 22.5 ttt -111.82 130.37 55.83 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.716 0.769 . . . . 73.439999999999998 109.891 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.418 HG23 ' H ' ' B' ' 52' ' ' ASP . 0.4 OUTLIER -145.8 137.84 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.358 -0.839 . . . . 73.400000000000006 109.491 -179.579 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' SER . . . . . 0.49 ' CB ' ' HG ' ' B' ' 74' ' ' SER . 42.8 p -102.53 2.94 36.92 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.579 -0.701 . . . . 73.209999999999994 109.788 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.418 ' H ' HG23 ' B' ' 50' ' ' VAL . 27.4 m-20 -76.41 134.29 39.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.147 -0.97 . . . . 70.409999999999997 109.377 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.453 ' C ' ' H ' ' B' ' 55' ' ' ALA . 62.6 mttp -70.24 -37.79 75.05 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.275 -0.891 . . . . 73.129999999999995 110.46 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -69.96 6.71 1.13 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.969 -1.082 . . . . 75.209999999999994 109.703 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.453 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -75.35 -22.5 57.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 55.329999999999998 110.346 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 42.0 mt -44.46 -39.59 4.89 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.328 -0.857 . . . . 72.420000000000002 110.048 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 83.8 p -76.88 -37.39 55.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.041 -1.037 . . . . 73.040000000000006 109.466 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -66.08 -42.87 88.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.387 -0.821 . . . . 72.329999999999998 110.148 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.9 m -68.17 -37.74 78.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 120.68 -1.262 . . . . 74.540000000000006 109.121 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 9.5 t -53.84 -49.61 68.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 71.239999999999995 109.472 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -68.32 -35.6 78.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.138 -0.976 . . . . 74.310000000000002 110.069 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 5.4 mm -63.22 -39.35 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.806 -1.184 . . . . 75.420000000000002 109.903 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' B' ' 67' ' ' SER . 6.9 mtpm? -67.13 -50.97 59.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.076 -1.015 . . . . 73.319999999999993 110.42 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -69.32 -38.19 78.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.852 -1.155 . . . . 73.310000000000002 109.765 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.503 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 25.8 mtpp -78.77 -20.52 49.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 72.439999999999998 109.346 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . 0.503 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 97.9 m-70 -156.88 65.73 0.52 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 65.209999999999994 109.326 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.469 ' N ' ' O ' ' B' ' 63' ' ' LYS . 86.4 p -61.22 -30.63 70.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 73.099999999999994 109.984 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 78.6 p -69.01 47.06 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.152 -0.967 . . . . 71.530000000000001 109.785 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' B' ' 67' ' ' SER . 16.0 tt -146.43 163.99 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.152 -0.968 . . . . 74.400000000000006 109.541 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 41.3 t -103.33 148.96 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.308 -0.87 . . . . 75.120000000000005 109.504 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 t -135.66 124.51 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.3 -0.875 . . . . 73.200000000000003 109.841 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 tt -116.8 104.31 11.2 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.107 -0.701 . . . . 73.340000000000003 109.107 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.72 132.51 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.073 -1.017 . . . . 73.5 109.213 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' SER . . . . . 0.49 ' HG ' ' CB ' ' B' ' 51' ' ' SER . 7.8 p -93.56 170.78 9.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.143 -0.973 . . . . 71.319999999999993 109.154 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.437 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 11.9 t -152.1 122.81 7.42 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.942 -1.099 . . . . 74.530000000000001 110.523 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 51.3 p30 -68.2 1.36 2.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.461 -0.775 . . . . 64.5 109.745 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' B' ' 79' ' ' THR . 38.9 t-20 -171.55 81.3 0.5 Allowed Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.248 -0.907 . . . . 74.25 109.494 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -42.55 87.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.205 1.937 . . . . 74.430000000000007 111.943 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.505 ' N ' ' O ' ' B' ' 77' ' ' ASN . 3.0 p -100.5 155.83 17.62 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.177 -0.675 . . . . 73.120000000000005 109.177 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.2 -36.38 83.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.386 -0.821 . . . . 75.409999999999997 109.591 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -63.37 -40.81 98.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 72.239999999999995 109.93 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . 0.406 ' OE1' ' OH ' ' B' ' 94' ' ' TYR . 78.1 tt0 -73.57 -34.37 65.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.152 -0.967 . . . . 73.219999999999999 109.998 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.407 ' OE1' ' N ' ' B' ' 84' ' ' VAL . 14.6 tm-20 -61.88 -56.68 16.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 74.299999999999997 109.711 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.407 ' N ' ' OE1' ' B' ' 83' ' ' GLU . 34.6 m -58.66 -39.09 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.16 -0.962 . . . . 73.310000000000002 109.299 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -69.38 -28.02 65.82 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 73.239999999999995 109.403 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.25 -36.39 81.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.128 -0.982 . . . . 55.329999999999998 109.732 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -82.33 -38.41 24.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.058 -1.026 . . . . 74.450000000000003 108.879 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -70.47 -38.25 74.41 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.346 -0.846 . . . . 64.040000000000006 109.653 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -74.97 -57.56 3.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.933 . . . . 75.129999999999995 109.358 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 153.63 80.82 0.03 OUTLIER Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.036 -1.225 . . . . 75.420000000000002 110.036 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -139.82 115.43 10.05 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.247 -1.149 . . . . 73.420000000000002 109.256 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' B' ' 93' ' ' ASP . 18.9 t70 -73.9 -29.56 62.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.926 . . . . 73.319999999999993 108.864 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' B' ' 92' ' ' ASP . 48.2 m-20 -139.01 164.0 30.91 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.507 -0.923 . . . . 73.040000000000006 108.507 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.437 ' OH ' ' CB ' ' B' ' 75' ' ' SER . 89.1 t80 -151.14 103.32 3.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.126 -0.984 . . . . 74.310000000000002 109.26 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 28.0 mm -114.77 149.37 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 O-C-N 121.332 -0.855 . . . . 75.340000000000003 110.499 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.12 143.85 56.13 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.757 -1.201 . . . . 70.099999999999994 107.757 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.593 ' N ' ' CD ' ' B' ' 98' ' ' PRO . 0.0 OUTLIER -68.33 -40.8 21.82 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.857 -1.152 . . . . 65.430000000000007 111.104 -178.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' B' ' 97' ' ' LYS . 39.0 Cg_exo -52.01 -2.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.289 -2.595 0 CA-C-N 118.696 0.57 . . . . 63.520000000000003 112.188 -174.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . 0.59 ' H ' ' C ' ' B' ' 97' ' ' LYS . 58.5 m-85 54.69 95.28 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.711 -0.618 . . . . 75.129999999999995 110.68 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 36.2 mtt85 -56.1 -38.31 70.56 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.7 -1.222 . . . . 74.230000000000004 107.7 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 10.2 t -172.68 125.97 0.48 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.644 -0.873 . . . . 64.510000000000005 108.644 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 58.3 mt -50.26 -40.06 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.06 -1.025 . . . . 74.439999999999998 109.363 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -61.79 -38.23 87.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.201 -0.937 . . . . 72.299999999999997 109.193 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.71 -49.49 65.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 74.310000000000002 109.346 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 65.1 tp -62.28 -44.45 96.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 73.540000000000006 109.149 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.98 -39.94 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.217 -0.927 . . . . 72.030000000000001 109.484 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.37 -39.09 66.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.094 -1.004 . . . . 64.219999999999999 108.961 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . 0.57 ' CZ ' ' CE2' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -72.17 -34.66 68.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.421 -0.799 . . . . 75.310000000000002 109.42 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . 0.423 HD11 HG22 ' B' ' 109' ' ' ILE . 97.3 mt -75.53 -27.36 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.208 -0.933 . . . . 55.439999999999998 109.33 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -73.51 -56.68 4.72 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.343 -0.848 . . . . 65.310000000000002 109.477 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.72 -36.11 69.31 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 74.519999999999996 109.906 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . 0.45 ' NH2' HH22 ' B' ' 108' ' ' ARG . 0.0 OUTLIER -66.28 -51.4 57.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.171 -0.956 . . . . 72.040000000000006 110.179 -179.467 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' B' ' 116' ' ' TRP . 64.2 mt -74.8 -33.07 62.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.089 -1.007 . . . . 75.349999999999994 110.277 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -48.92 -37.57 20.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.936 -1.102 . . . . 75.5 109.456 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -81.08 -2.45 48.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.911 . . . . 73.040000000000006 109.3 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' TRP . . . . . 0.459 ' CZ3' ' NZ ' ' B' ' 134' ' ' LYS . 88.2 t90 -55.33 -35.79 65.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 74.450000000000003 109.577 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.32 106.69 2.43 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.614 -1.394 . . . . 64.209999999999994 109.614 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' SER . . . . . 0.462 ' C ' ' ND2' ' B' ' 119' ' ' ASN . 42.8 m -154.92 166.95 31.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -1.159 . . . . 71.400000000000006 109.702 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . 0.462 ' ND2' ' C ' ' B' ' 118' ' ' SER . 0.0 OUTLIER -158.0 120.78 3.83 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.875 -0.787 . . . . 74.209999999999994 108.875 -178.37 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 19.3 t -87.36 -43.08 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.146 -0.971 . . . . 75.019999999999996 109.395 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 16.1 mm -99.2 137.2 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.277 -0.89 . . . . 74.239999999999995 109.431 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -135.59 100.48 4.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.446 -0.784 . . . . 73.329999999999998 109.048 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 31.2 mm -113.53 132.18 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.5 -0.75 . . . . 74.219999999999999 109.472 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 44.16 -128.22 6.67 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.034 -1.226 . . . . 72.409999999999997 110.034 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -97.38 -10.25 25.88 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.323 -1.104 . . . . 75.120000000000005 109.711 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.97 137.13 36.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.137 -0.977 . . . . 75.420000000000002 109.298 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 27.6 p -119.62 144.99 46.83 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.589 -0.694 . . . . 74.219999999999999 109.441 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 56.2 mt -124.46 129.26 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.514 -0.741 . . . . 60.329999999999998 109.367 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 6.3 m -109.7 118.22 50.73 Favored Pre-proline 0 N--CA 1.497 1.876 0 N-CA-C 108.858 -0.794 . . . . 72.310000000000002 108.858 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.588 ' CB ' ' HE ' ' B' ' 157' ' ' ARG . 97.3 Cg_endo -79.18 -56.88 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.751 1.634 . . . . 75.129999999999995 112.211 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -59.74 -43.15 94.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.154 -0.966 . . . . 75.230000000000004 109.545 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -81.33 -12.84 58.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 75.120000000000005 109.303 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 52.07 55.07 9.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 75.129999999999995 109.363 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . 0.459 ' NZ ' ' CZ3' ' B' ' 116' ' ' TRP . 35.7 ttpt -137.19 133.7 35.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.482 -0.761 . . . . 75.109999999999999 109.267 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 13.5 tt -117.14 132.69 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.53 -0.731 . . . . 70.319999999999993 109.441 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 14.0 mt -112.04 125.07 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.55 -0.718 . . . . 74.120000000000005 109.146 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -139.75 140.35 36.71 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.326 -0.859 . . . . 74.230000000000004 109.728 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt 53.98 19.05 1.86 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.37 -0.831 . . . . 74.219999999999999 110.011 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.38 16.42 64.41 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 120.087 -1.054 . . . . 74.319999999999993 110.614 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -112.29 127.8 56.09 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.365 -1.079 . . . . 75.340000000000003 109.493 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -93.9 127.01 39.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.249 -0.907 . . . . 71.230000000000004 109.629 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 98.7 t -137.52 136.48 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.412 -0.805 . . . . 70.430000000000007 109.254 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . 0.457 ' CD ' ' N ' ' B' ' 143' ' ' GLU . 42.9 mp0 -92.82 144.31 25.41 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.219 -0.926 . . . . 72.430000000000007 109.45 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 34.1 m -143.55 125.84 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.195 -0.941 . . . . 72.129999999999995 109.17 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.37 117.45 11.81 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.379 -0.826 . . . . 74.5 109.255 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.7 171.02 33.22 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.515 -1.434 . . . . 42.229999999999997 109.515 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 4.4 mtmm -68.67 -38.26 11.73 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.202 -1.175 . . . . 73.299999999999997 109.961 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 36.1 Cg_exo -59.61 -34.85 96.51 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.105 1.87 . . . . 71.329999999999998 111.929 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -88.47 -18.07 29.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.368 -0.832 . . . . 74.230000000000004 109.622 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -57.45 -40.02 77.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 72.340000000000003 109.644 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 9.6 p -61.76 -39.09 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.943 . . . . 73.349999999999994 109.585 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 41.2 tp -60.56 -41.45 94.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 74.430000000000007 109.096 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 17.7 p -76.87 -30.99 56.48 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.261 -0.899 . . . . 75.209999999999994 109.258 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -58.4 -51.24 70.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 73.040000000000006 109.585 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 1.9 pp -72.99 -28.29 62.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -0.942 . . . . 73.430000000000007 109.542 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -54.47 -46.08 73.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.957 . . . . 75.319999999999993 109.507 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . 0.588 ' HE ' ' CB ' ' B' ' 130' ' ' PRO . 43.3 mtt85 -75.75 -43.96 44.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.203 -0.936 . . . . 73.319999999999993 109.457 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -77.04 26.37 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.349 -0.844 . . . . 74.140000000000001 109.903 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . 0.438 ' H ' ' C ' ' B' ' 157' ' ' ARG . 3.0 tpm_? -49.66 157.04 0.59 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.097 -1.002 . . . . 73.420000000000002 108.873 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' B' ' 160' ' ' ASP . 4.9 p-10 42.81 54.57 4.62 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.473 -0.767 . . . . 72.099999999999994 110.13 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -146.44 156.05 43.01 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.175 -0.953 . . . . 73.239999999999995 109.368 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 26.2 mt -98.91 138.98 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.263 -0.898 . . . . 72.310000000000002 109.379 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 9.5 m -140.73 143.52 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.33 -0.857 . . . . 75.030000000000001 109.57 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 164' ' ' SER . . . . . 0.494 ' HG ' ' H ' ' B' ' 167' ' ' GLN . 83.7 p -94.48 161.48 14.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.285 -0.884 . . . . 74.219999999999999 109.214 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -53.78 -38.55 64.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.2 -0.938 . . . . 72.420000000000002 109.255 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -64.54 -36.85 85.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.867 . . . . 63.450000000000003 109.445 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 167' ' ' GLN . . . . . 0.494 ' H ' ' HG ' ' B' ' 164' ' ' SER . 10.5 tm0? -56.26 -45.38 80.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.898 . . . . 72.400000000000006 109.123 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 33.1 mt -65.02 -33.83 76.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 72.319999999999993 108.919 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.401 ' CD2' ' C ' ' B' ' 169' ' ' LEU . 4.0 tt -53.53 -60.64 3.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.43 -0.794 . . . . 73.340000000000003 109.558 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -66.83 -27.85 67.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.371 -0.831 . . . . 73.099999999999994 110.232 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.26 -57.6 11.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.14 -0.975 . . . . 62.130000000000003 110.064 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.476 ' N ' ' CD1' ' B' ' 172' ' ' ILE . 2.0 mp -94.65 -59.0 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.06 -1.025 . . . . 74.439999999999998 109.291 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 23.2 m-90 . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.265 -0.897 . . . . 72.230000000000004 109.527 -179.843 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . 0.432 ' O ' ' OE1' ' B' ' 185' ' ' GLU . 67.4 Cg_endo . . . . . 0 N--CA 1.495 1.564 0 CA-C-O 121.294 0.456 . . . . 74.340000000000003 112.017 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 182' ' ' ASN . . . . . 0.426 ' O ' ' OE1' ' B' ' 185' ' ' GLU . 19.9 t-20 -61.65 -27.29 68.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 72.310000000000002 110.111 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 9.7 m -77.29 -17.53 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.097 -1.002 . . . . 65.420000000000002 110.114 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 87.9 mt -58.36 -52.41 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.103 -0.998 . . . . 75.030000000000001 110.034 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . 0.517 ' H ' ' CD ' ' B' ' 185' ' ' GLU . 1.6 pm0 -55.33 -33.93 63.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.134 -0.979 . . . . 73.519999999999996 109.318 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 91.7 t -75.26 -47.63 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 74.349999999999994 109.934 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.78 -50.18 65.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -0.999 . . . . 61.119999999999997 110.166 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 16.1 tt -57.79 -39.87 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.025 -1.047 . . . . 72.430000000000007 109.764 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -61.38 -46.37 90.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.104 -0.997 . . . . 75.420000000000002 109.545 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -68.51 -45.2 72.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 74.140000000000001 109.764 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 85.5 mt -54.98 -41.75 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.226 -0.921 . . . . 74.030000000000001 109.288 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -60.77 -47.15 87.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 72.329999999999998 109.287 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -66.21 -36.15 82.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.894 . . . . 73.099999999999994 109.533 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . 0.46 ' CB ' ' NZ ' ' B' ' 194' ' ' LYS . 7.8 mtpm? -81.29 -6.45 58.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.882 . . . . 74.430000000000007 109.566 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 28.1 ttt -92.92 -54.71 3.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.233 -0.917 . . . . 74.329999999999998 109.406 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 196' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' B' ' 200' ' ' GLY . 91.2 m-20 -62.6 -33.05 74.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 71.209999999999994 109.745 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . 0.449 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 0.0 OUTLIER -54.6 -65.15 1.43 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.17 -0.956 . . . . 75.209999999999994 109.785 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 198' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 36.9 Cg_endo -63.36 -53.44 1.45 Allowed 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.143 1.896 . . . . 75.319999999999993 112.213 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 29.7 mt -66.78 -34.28 77.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.19 -0.944 . . . . 72.25 109.679 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' B' ' 196' ' ' ASP . . . 80.41 -40.08 2.37 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.472 -1.451 . . . . 73.239999999999995 109.472 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 64.6 mt -93.67 137.49 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.273 -1.133 . . . . 54.299999999999997 109.279 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 28.6 p -81.4 134.21 35.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 74.310000000000002 109.361 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 25.9 p -131.3 -7.81 3.78 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.472 -0.767 . . . . 74.400000000000006 109.519 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 3.6 m -105.13 133.45 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.342 -0.848 . . . . 74.099999999999994 109.485 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -99.36 127.32 45.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.346 -0.846 . . . . 75.329999999999998 109.299 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.92 127.68 44.02 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.235 -0.915 . . . . 71.400000000000006 109.24 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' B' ' 211' ' ' GLY . 9.1 t -139.78 139.46 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.262 -0.899 . . . . 63.5 109.423 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -85.33 11.68 9.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.197 -0.94 . . . . 74.450000000000003 109.466 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 209' ' ' ARG . . . . . 0.429 ' CG ' ' H ' ' B' ' 210' ' ' ARG . 16.5 tpt85 -74.26 -128.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.924 . . . . 74.140000000000001 109.562 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . 0.429 ' H ' ' CG ' ' B' ' 209' ' ' ARG . 14.9 tpp180 -57.58 -42.12 82.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 74.430000000000007 109.696 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 211' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' B' ' 207' ' ' VAL . . . -173.8 -118.9 0.52 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.679 -1.368 . . . . 70.109999999999999 109.679 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 212' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' B' ' 212' ' ' TYR . 29.8 m-85 -123.93 156.4 36.4 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.566 -0.961 . . . . 74.209999999999994 109.319 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -134.47 145.55 48.94 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.555 -0.716 . . . . 74.299999999999997 109.082 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -115.78 138.47 51.1 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.449 -0.782 . . . . 74.340000000000003 109.178 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.3 p -156.19 166.54 33.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.43 -0.794 . . . . 72.209999999999994 109.219 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -61.44 149.53 83.31 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.176 -0.952 . . . . 72.310000000000002 108.998 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -38.99 144.87 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 122.047 1.831 . . . . 71.010000000000005 112.152 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . 0.512 ' CB ' ' NZ ' ' B' ' 218' ' ' LYS . 4.7 mtpm? . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.144 -0.972 . . . . 74.349999999999994 109.152 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.585 ' SD ' ' CE2' ' A' ' 25' ' ' PHE . 15.4 ptp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.415 -0.587 . . . . 65.120000000000005 109.415 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.3 mtt85 -140.94 156.23 46.11 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.321 -0.862 . . . . 73.310000000000002 109.283 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.99 130.64 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.643 -0.661 . . . . 71.420000000000002 109.722 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.428 ' C ' ' CD1' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -100.9 125.59 47.47 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.314 -0.995 . . . . 65.219999999999999 108.314 179.27 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tp -120.51 118.4 30.14 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.606 -0.684 . . . . 71.439999999999998 109.496 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.402 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 8.9 mt -105.14 123.77 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.357 -0.839 . . . . 71.150000000000006 109.056 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -167.42 138.14 2.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.072 -1.018 . . . . 75.340000000000003 109.697 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.64 ' HZ3' ' N ' ' A' ' 32' ' ' SER . 67.1 mmtt -84.32 -26.47 28.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 73.040000000000006 109.257 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -61.66 -154.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.355 -0.84 . . . . 72.420000000000002 109.5 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.1 p -148.83 -50.75 0.16 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.21 -0.932 . . . . 72.340000000000003 109.41 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.5 t -65.38 -39.8 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 74.420000000000002 109.521 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.556 ' CD2' ' HZ3' ' A' ' 97' ' ' LYS . 10.1 mp -63.18 -36.23 82.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 72.010000000000005 109.409 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.55 -35.15 26.57 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.501 -1.84 . . . . 72.140000000000001 108.501 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.94 -43.26 91.77 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 110.182 -1.167 . . . . 72.329999999999998 110.182 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -69.39 -41.17 76.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.939 -1.33 . . . . 72.340000000000003 109.306 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.7 mm -67.09 -40.28 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.825 -1.172 . . . . 74.239999999999995 108.135 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -62.75 -53.83 48.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.456 -0.777 . . . . 71.409999999999997 109.798 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -79.56 -1.0 35.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.176 -0.952 . . . . 75.540000000000006 109.771 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -85.73 -54.26 2.83 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.13 -1.588 . . . . 62.149999999999999 109.13 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pp -71.54 -28.31 63.78 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.4 -1.059 . . . . 74.420000000000002 109.315 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -53.98 -35.82 62.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -0.929 . . . . 74.25 109.124 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.3 t -55.46 -49.1 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.306 -0.871 . . . . 72.109999999999999 109.01 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -58.54 -54.59 45.3 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.689 -0.856 . . . . 73.230000000000004 108.689 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 138.21 36.5 0.15 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.829 -1.309 . . . . 75.540000000000006 109.829 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.585 ' CE2' ' SD ' ' A' ' 1' ' ' MET . 16.9 m-85 -111.99 155.19 24.17 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.374 -1.074 . . . . 74.510000000000005 108.962 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 7.2 mtp -101.97 139.14 38.01 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.19 -1.041 . . . . 64.319999999999993 108.19 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.422 ' O ' ' OD1' ' A' ' 28' ' ' ASP . . . -143.72 158.29 43.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.199 -0.938 . . . . 74.310000000000002 110.368 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 27' ' ' ALA . 87.7 m-20 -136.09 156.5 48.63 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.054 -0.721 . . . . 75.400000000000006 109.054 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 m -104.38 139.9 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.47 -0.937 . . . . 75.129999999999995 108.47 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 p -133.94 164.26 27.69 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.489 -0.757 . . . . 71.420000000000002 109.442 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.451 ' N ' ' OD2' ' A' ' 35' ' ' ASP . 5.6 pt-20 -97.64 -107.41 0.17 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.295 -0.878 . . . . 73.109999999999999 109.875 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.64 ' N ' ' HZ3' ' A' ' 8' ' ' LYS . 50.0 m -79.88 160.86 25.89 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.155 -0.966 . . . . 74.239999999999995 110.041 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.4 mt -48.58 -19.52 0.35 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.395 -0.816 . . . . 71.530000000000001 109.759 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -61.08 -54.47 44.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 74.230000000000004 110.58 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 36' ' ' GLY . 13.4 p-10 -68.57 -31.67 71.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.917 -1.114 . . . . 71.010000000000005 109.317 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.518 ' N ' ' OD1' ' A' ' 35' ' ' ASP . . . -68.77 -42.89 77.59 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.021 -1.632 . . . . 61.409999999999997 109.021 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.486 ' OE2' ' NH2' ' A' ' 61' ' ' ARG . 85.5 tt0 -71.22 -39.24 71.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.353 -1.086 . . . . 74.340000000000003 109.364 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -73.23 -31.81 64.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.971 . . . . 75.329999999999998 109.648 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.1 tp -70.65 -49.85 43.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.236 -0.915 . . . . 74.329999999999998 110.139 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 43' ' ' ARG . 22.8 ptm -63.45 -20.48 65.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.997 -1.064 . . . . 70.319999999999993 109.802 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -65.15 -38.49 90.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.098 -1.001 . . . . 71.219999999999999 109.956 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.8 pt -84.93 -31.33 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.059 -1.026 . . . . 74.409999999999997 110.254 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 40' ' ' MET . 79.5 mtm180 -130.31 153.5 48.59 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.304 -0.872 . . . . 75.409999999999997 109.595 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.954 ' CG ' ' OE2' ' A' ' 143' ' ' GLU . 29.4 m120 -97.93 155.89 16.87 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.251 -0.906 . . . . 75.420000000000002 109.529 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -135.84 155.32 50.51 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.463 -0.773 . . . . 74.230000000000004 109.277 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -96.08 -43.86 7.58 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.154 -0.966 . . . . 75.319999999999993 109.198 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.58 122.47 47.84 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.499 -0.926 . . . . 72.129999999999995 108.499 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.4 m -117.3 97.97 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.581 -0.896 . . . . 72.340000000000003 108.581 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.586 ' SD ' ' N ' ' A' ' 50' ' ' VAL . 0.3 OUTLIER -98.67 134.4 41.65 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.793 -0.818 . . . . 74.109999999999999 108.793 -179.346 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.586 ' N ' ' SD ' ' A' ' 49' ' ' MET . 1.3 p -136.43 125.51 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-O 121.774 0.797 . . . . 71.239999999999995 109.967 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.1 p -94.54 2.66 55.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.565 -0.709 . . . . 73.109999999999999 109.356 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -76.75 142.32 40.47 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.191 -0.943 . . . . 63.399999999999999 109.646 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.508 ' C ' ' H ' ' A' ' 55' ' ' ALA . 97.8 mttt -79.14 -38.52 35.84 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.312 -0.868 . . . . 65.439999999999998 110.212 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -67.93 7.99 0.46 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.051 -1.031 . . . . 73.129999999999995 109.585 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.34 -22.46 57.6 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.376 -0.827 . . . . 64.140000000000001 110.718 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 55' ' ' ALA . 55.1 mt -41.39 -51.24 3.76 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.399 -0.813 . . . . 74.430000000000007 110.361 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 t -67.86 -34.22 76.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.96 -1.088 . . . . 63.229999999999997 108.873 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 55' ' ' ALA . 48.2 t80 -66.81 -63.62 1.03 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.505 -0.747 . . . . 74.439999999999998 109.914 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.5 m -48.16 -34.29 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.795 -1.191 . . . . 74.030000000000001 109.617 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 61' ' ' ARG . 15.0 p -57.69 -56.32 23.45 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.208 -0.932 . . . . 73.540000000000006 109.133 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.637 HH21 ' NZ ' ' A' ' 65' ' ' LYS . 13.3 ptm180 -66.4 -28.73 68.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -1.0 . . . . 73.340000000000003 110.059 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 66' ' ' HIS . 25.1 mm -54.87 -41.42 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.666 -1.271 . . . . 73.349999999999994 107.96 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.517 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 43.4 mmtt -70.84 -40.08 72.58 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.605 -0.838 . . . . 74.420000000000002 109.056 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -67.83 -42.09 82.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 74.549999999999997 109.129 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.637 ' NZ ' HH21 ' A' ' 61' ' ' ARG . 48.6 mtpt -88.48 -14.4 37.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.614 -0.678 . . . . 75.219999999999999 110.076 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 62' ' ' ILE . 73.0 m-70 -155.22 72.17 0.81 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.146 -0.971 . . . . 74.129999999999995 109.342 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.3 p -73.69 -6.96 50.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.912 . . . . 73.239999999999995 109.765 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.2 p -100.19 42.87 1.08 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.27 -0.894 . . . . 71.439999999999998 110.072 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.7 tt -145.07 160.09 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.011 -1.056 . . . . 71.329999999999998 109.6 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t -98.13 130.43 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.212 -0.93 . . . . 73.019999999999996 108.766 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.29 130.75 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.499 -0.751 . . . . 54.210000000000001 109.323 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.513 ' O ' ' SD ' ' A' ' 49' ' ' MET . 8.6 tt -128.0 95.88 4.32 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.599 0.714 . . . . 74.209999999999994 109.202 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.4 p -91.39 164.89 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.005 -1.06 . . . . 74.409999999999997 109.203 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 72.0 m -138.87 169.7 17.31 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.204 -0.935 . . . . 72.310000000000002 109.026 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.498 ' C ' ' H ' ' A' ' 77' ' ' ASN . 1.2 p -175.53 128.52 0.26 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.053 -1.029 . . . . 64.540000000000006 110.086 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 48.7 p30 -67.33 41.6 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.509 -0.744 . . . . 74.129999999999995 109.633 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.498 ' H ' ' C ' ' A' ' 75' ' ' SER . 9.9 p30 -156.32 59.45 1.99 Allowed Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.026 -1.046 . . . . 73.340000000000003 110.449 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.68 76.22 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.145 1.896 . . . . 71.319999999999993 111.148 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.458 ' N ' ' O ' ' A' ' 77' ' ' ASN . 82.3 p -103.64 152.3 21.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.575 -0.703 . . . . 62.530000000000001 109.498 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.52 -34.6 78.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.463 -0.773 . . . . 74.140000000000001 109.27 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -67.04 -44.45 80.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 71.420000000000002 109.281 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -74.51 -31.55 62.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 73.430000000000007 109.383 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.493 ' OE1' ' N ' ' A' ' 84' ' ' VAL . 14.3 tm-20 -58.66 -56.72 18.56 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.225 -0.922 . . . . 74.219999999999999 109.555 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.493 ' N ' ' OE1' ' A' ' 83' ' ' GLU . 27.4 m -62.0 -40.64 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 74.150000000000006 109.29 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -61.13 -38.93 88.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.24 -0.913 . . . . 72.540000000000006 109.381 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.58 86.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 64.219999999999999 109.543 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -72.83 -33.23 66.03 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.417 -0.957 . . . . 74.340000000000003 108.417 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -66.56 -36.93 83.85 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.518 -0.738 . . . . 74.420000000000002 109.143 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -64.4 -49.83 70.01 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.361 -0.837 . . . . 74.519999999999996 109.411 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 142.43 31.88 0.12 Allowed Glycine 0 N--CA 1.498 2.775 0 N-CA-C 110.024 -1.23 . . . . 74.209999999999994 110.024 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.25 131.27 38.52 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.088 -1.242 . . . . 64.099999999999994 109.43 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.517 ' OD1' ' NZ ' ' A' ' 63' ' ' LYS . 42.1 m-20 -78.03 -29.35 49.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.108 -0.995 . . . . 73.420000000000002 109.113 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -149.88 147.59 28.12 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.911 -0.774 . . . . 75.040000000000006 108.911 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.461 ' OH ' ' OG ' ' A' ' 75' ' ' SER . 3.0 t80 -135.54 113.44 11.1 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.446 -0.784 . . . . 71.329999999999998 108.93 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.3 mm -107.35 150.22 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 CA-C-O 122.118 0.961 . . . . 74.510000000000005 110.918 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.95 125.54 25.75 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.51 -1.292 . . . . 64.319999999999993 107.51 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.675 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -45.12 -52.81 18.8 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.036 -1.04 . . . . 74.510000000000005 111.359 -179.061 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 1.6 Cg_endo -40.87 -12.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.112 0 CA-C-N 119.759 0.95 . . . . 73.109999999999999 112.601 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.675 ' N ' ' O ' ' A' ' 97' ' ' LYS . 49.2 m-85 56.69 104.71 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.763 -0.586 . . . . 72.540000000000006 110.383 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.8 ttm-85 -60.65 -39.08 87.0 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.02 -1.104 . . . . 74.540000000000006 108.02 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.1 t -174.45 140.08 0.61 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.916 -0.772 . . . . 74.140000000000001 108.916 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.2 mm -57.95 -37.07 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 75.430000000000007 109.157 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -64.3 -36.03 82.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 74.140000000000001 109.178 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.31 -48.91 73.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.144 -0.973 . . . . 63.240000000000002 109.406 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -67.82 -55.05 14.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.377 -0.827 . . . . 73.219999999999999 108.906 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 67.6 t -55.03 -49.02 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.932 -1.105 . . . . 74.540000000000006 109.425 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.51 -37.28 65.14 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.169 -0.957 . . . . 75.5 108.91 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.423 ' NH1' ' OE2' ' B' ' 83' ' ' GLU . 11.2 mmt85 -71.38 -30.02 65.63 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.357 -0.839 . . . . 74.409999999999997 109.389 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.67 -30.51 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 107.773 -1.195 . . . . 73.239999999999995 107.773 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -67.58 -52.48 38.1 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.837 -0.801 . . . . 74.340000000000003 108.837 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.444 ' CB ' ' CZ ' ' B' ' 87' ' ' PHE . . . -48.2 -44.09 32.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.446 -0.783 . . . . 73.319999999999993 109.477 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 75.1 mmt-85 -64.61 -32.7 74.47 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.33 -0.856 . . . . 74.420000000000002 109.702 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.1 mt -133.37 75.62 1.62 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.36 -0.837 . . . . 74.329999999999998 110.313 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -92.8 -79.51 0.39 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.089 -1.007 . . . . 74.439999999999998 108.426 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.457 ' CD2' ' O ' ' A' ' 115' ' ' PHE . 26.1 p90 -100.74 49.37 0.89 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.354 -0.841 . . . . 74.430000000000007 109.359 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 75.7 t-105 -67.05 112.58 4.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 74.439999999999998 109.424 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 159.74 111.39 0.29 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.889 -1.284 . . . . 75.040000000000006 109.889 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.416 ' HG ' ' N ' ' A' ' 119' ' ' ASN . 23.2 t -164.17 157.17 17.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -1.14 . . . . 70.109999999999999 109.523 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.595 ' ND2' ' N ' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -152.92 117.12 4.88 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.854 -0.795 . . . . 65.239999999999995 108.854 -178.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.433 HG23 ' OD1' ' A' ' 131' ' ' ASP . 18.7 t -77.63 -39.98 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.327 -0.858 . . . . 74.219999999999999 110.466 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 11.1 mm -104.46 130.36 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.105 -0.997 . . . . 74.420000000000002 109.675 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -129.36 136.36 49.9 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.453 -0.943 . . . . 73.299999999999997 108.453 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.442 ' CG2' ' O ' ' A' ' 123' ' ' ILE . 0.2 OUTLIER -149.99 121.87 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.018 -1.051 . . . . 75.340000000000003 109.599 -179.229 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.96 -129.49 12.23 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.038 -1.225 . . . . 75.129999999999995 110.038 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -93.88 -4.02 50.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.307 -1.114 . . . . 74.450000000000003 109.88 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.67 143.65 26.26 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.141 -0.974 . . . . 54.210000000000001 108.468 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.1 m -132.44 143.67 49.95 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.333 -0.854 . . . . 70.239999999999995 109.524 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.4 mt -134.84 140.38 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.457 -0.777 . . . . 72.430000000000007 109.748 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.1 m -128.31 109.05 19.46 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 108.949 -0.76 . . . . 71.109999999999999 108.949 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.52 -27.49 4.14 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.656 1.571 . . . . 75.140000000000001 111.712 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.433 ' OD1' HG23 ' A' ' 120' ' ' VAL . 1.9 m-20 -69.4 -37.15 77.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 72.5 109.093 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -88.98 -4.33 58.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.33 -0.856 . . . . 73.140000000000001 109.603 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 54.65 62.62 2.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.131 -0.981 . . . . 75.329999999999998 108.972 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -160.67 155.56 24.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.256 -0.903 . . . . 71.230000000000004 109.949 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.7 tt -124.94 137.61 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.631 -0.668 . . . . 75.329999999999998 109.349 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 24.9 mm -115.83 133.7 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.709 -0.849 . . . . 71.109999999999999 108.709 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -137.88 119.49 15.01 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.231 -0.918 . . . . 74.140000000000001 108.851 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.5 ' O ' ' CG ' ' A' ' 138' ' ' LYS . 25.4 ttpt 54.71 20.26 2.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.586 -0.696 . . . . 75.400000000000006 109.974 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.59 0.8 66.62 Favored Glycine 0 N--CA 1.499 2.877 0 O-C-N 120.862 -1.149 . . . . 72.239999999999995 110.71 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.498 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 1.9 mpt_? -89.99 124.84 35.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.963 -1.316 . . . . 73.120000000000005 108.645 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -87.9 130.39 34.93 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.245 -0.91 . . . . 72.319999999999993 109.755 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.7 t -138.45 143.13 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.433 -0.792 . . . . 62.340000000000003 109.739 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.954 ' OE2' ' CG ' ' A' ' 44' ' ' ASN . 91.1 mt-10 -95.9 142.16 28.47 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.868 -0.79 . . . . 61.229999999999997 108.868 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.2 m -138.05 137.88 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.147 -0.97 . . . . 74.439999999999998 109.758 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -168.54 41.87 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.287 -0.883 . . . . 75.420000000000002 109.856 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.25 -129.36 4.58 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 108.856 -1.697 . . . . 73.340000000000003 108.856 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.625 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 23.8 mttp -85.79 -32.29 0.45 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.273 -1.134 . . . . 72.219999999999999 110.846 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.778 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 86.9 Cg_endo -86.1 -18.14 3.59 Favored 'Trans proline' 0 N--CA 1.486 1.06 0 C-N-CA 122.06 1.84 . . . . 75.450000000000003 112.247 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -56.34 -48.83 75.97 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.828 -1.175 . . . . 65.239999999999995 107.828 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 172' ' ' ILE . 74.6 mt-10 -75.99 -42.02 49.43 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.053 -1.092 . . . . 72.519999999999996 108.053 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.778 ' HB ' ' HA ' ' A' ' 148' ' ' PRO . 1.1 t -56.27 -46.58 81.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.039 -1.097 . . . . 74.209999999999994 108.039 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 22.3 tp -66.66 -56.72 9.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.623 -0.673 . . . . 73.310000000000002 110.569 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.6 p -58.49 -35.84 72.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.906 -1.121 . . . . 74.310000000000002 110.03 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.411 ' CD2' ' HD2' ' A' ' 158' ' ' HIS . 22.4 t-80 -58.53 -56.94 15.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.003 -1.06 . . . . 75.450000000000003 110.367 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.54 -26.42 62.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.935 -1.103 . . . . 75.340000000000003 109.525 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.05 -44.23 91.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.958 -1.089 . . . . 62.140000000000001 108.592 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -79.67 -57.99 3.41 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.984 0.897 . . . . 72.219999999999999 109.415 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.411 ' HD2' ' CD2' ' A' ' 154' ' ' HIS . 98.0 m-70 -71.69 41.43 0.08 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.912 -0.586 . . . . 74.120000000000005 111.332 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -82.81 166.43 19.01 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.627 -1.296 . . . . 74.340000000000003 109.027 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.441 ' OD1' ' CE2' ' A' ' 216' ' ' TYR . 14.2 m-20 53.49 47.62 23.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.157 -0.964 . . . . 75.450000000000003 109.262 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -154.89 163.58 40.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.348 -0.845 . . . . 73.409999999999997 110.12 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.3 mm -98.64 136.7 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.42 -1.326 . . . . 74.409999999999997 107.42 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.8 148.18 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.996 -1.065 . . . . 72.530000000000001 110.486 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.7 p -97.08 165.47 12.05 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.609 -0.682 . . . . 74.120000000000005 109.685 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -66.95 -44.78 79.72 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.249 -0.907 . . . . 70.430000000000007 110.121 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -56.19 -40.31 73.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 74.319999999999993 109.923 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -58.05 -43.2 86.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.05 -1.031 . . . . 74.519999999999996 109.425 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 11.7 mt -56.47 -43.72 79.88 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.973 -1.08 . . . . 74.409999999999997 108.127 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 5.1 tt -49.16 -56.15 10.12 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.04 -1.038 . . . . 75.140000000000001 109.746 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -54.14 -37.71 64.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.559 -0.713 . . . . 65.030000000000001 112.507 -178.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.65 -32.11 13.54 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 120.531 -1.356 . . . . 70.209999999999994 113.517 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.43 ' O ' ' OE1' ' A' ' 150' ' ' GLU . 1.7 mp -77.88 -51.33 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.628 -1.295 . . . . 75.319999999999993 110.838 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.541 ' CG ' ' O ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.98 0 O-C-N 120.66 -1.275 . . . . 73.140000000000001 109.597 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 34.5 m120 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.187 0.518 . . . . 73.129999999999995 110.19 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.2 p -148.38 -32.25 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.147 -0.97 . . . . 74.019999999999996 109.325 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 6.0 mm -60.69 -43.27 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.181 -0.95 . . . . 72.329999999999998 109.211 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -64.91 -36.94 86.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 74.400000000000006 109.164 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 20.4 t -71.15 -32.33 47.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.117 -0.989 . . . . 74.319999999999993 109.139 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.39 -52.17 17.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.49 -0.757 . . . . 73.230000000000004 110.658 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 9.2 tp -56.85 -39.11 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.548 -1.345 . . . . 74.310000000000002 110.112 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -63.72 -56.71 13.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.83 -1.169 . . . . 73.439999999999998 110.958 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -65.65 -42.58 91.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.848 -1.158 . . . . 71.420000000000002 110.131 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 66.6 mt -51.72 -35.72 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.808 -1.182 . . . . 72.439999999999998 109.033 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 16.8 mtp-105 -67.29 -54.46 20.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.115 -0.991 . . . . 64.219999999999999 109.689 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -71.21 -14.06 62.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -0.91 . . . . 74.319999999999993 110.992 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.415 ' O ' ' CD ' ' A' ' 198' ' ' PRO . 43.8 mtpt -83.37 -41.24 18.41 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.844 -1.16 . . . . 75.310000000000002 110.709 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' MET . . . . . 1.052 ' HE3' HD21 ' A' ' 199' ' ' LEU . 45.8 mtp -81.83 36.99 0.46 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.095 -1.003 . . . . 74.019999999999996 110.699 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 197' ' ' LYS . 27.4 p30 -110.61 -39.09 4.99 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.12 -0.988 . . . . 74.019999999999996 109.988 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.597 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 5.6 tmtt? -91.23 -40.15 0.39 Allowed Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 120.91 -1.119 . . . . 75.430000000000007 110.065 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 24.4 Cg_exo -63.65 -61.22 0.13 Allowed 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.256 1.971 . . . . 72.319999999999993 111.823 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 1.052 HD21 ' HE3' ' A' ' 195' ' ' MET . 10.8 mp -71.42 -28.8 64.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 74.540000000000006 108.971 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 83.46 -14.9 38.09 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.626 -1.79 . . . . 61.509999999999998 108.626 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 21.2 mt -128.52 137.13 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.841 -0.799 . . . . 74.25 109.073 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 72.8 m -89.74 144.52 25.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.211 -0.93 . . . . 72.0 109.12 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.5 p -146.07 44.68 1.25 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.164 -0.96 . . . . 74.439999999999998 110.288 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 7.9 m -148.66 129.88 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.993 -1.067 . . . . 71.129999999999995 109.23 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -112.14 140.4 46.85 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.687 -0.633 . . . . 73.510000000000005 109.532 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 14.9 t -126.12 131.46 52.07 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.456 -0.778 . . . . 73.519999999999996 109.942 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.7 154.25 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.47 -0.937 . . . . 72.150000000000006 108.47 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -97.03 75.22 2.62 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.103 -0.998 . . . . 72.400000000000006 110.535 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -146.52 -33.22 0.31 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.175 -0.953 . . . . 73.310000000000002 109.249 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -147.3 -60.18 0.28 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.242 -0.911 . . . . 71.540000000000006 109.217 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -163.52 -119.75 0.5 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.517 -1.433 . . . . 74.450000000000003 109.517 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -125.31 152.05 45.21 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.63 -0.923 . . . . 75.540000000000006 109.153 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.92 129.05 48.53 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.545 -0.909 . . . . 75.310000000000002 108.545 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -105.86 126.26 51.96 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.357 -0.839 . . . . 75.409999999999997 109.193 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 44.1 t -149.49 158.59 44.31 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.788 -0.819 . . . . 74.140000000000001 108.788 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . 0.441 ' CE2' ' OD1' ' A' ' 160' ' ' ASP . 8.7 p90 -58.07 150.06 53.07 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.255 -0.903 . . . . 75.319999999999993 109.238 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 N--CA 1.494 1.545 0 C-N-CA 122.236 1.957 . . . . 73.109999999999999 111.173 179.52 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 54.4 ttm . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.442 -0.577 . . . . 75.239999999999995 109.442 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 57.5 ttm-85 -139.27 147.61 41.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.419 -0.8 . . . . 73.519999999999996 109.159 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 40.2 t -110.62 137.35 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.682 -0.636 . . . . 72.239999999999995 109.304 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 5.4 tp -113.98 117.55 31.64 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 109.366 -0.605 . . . . 73.340000000000003 109.366 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.39 97.67 5.68 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.171 -1.048 . . . . 74.349999999999994 108.171 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . 0.471 ' CG2' ' O ' ' B' ' 31' ' ' GLU . 65.1 mt -81.97 106.14 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.775 -1.203 . . . . 63.439999999999998 109.168 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.425 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 18.3 tp10 -140.18 129.9 24.43 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.481 -0.762 . . . . 74.519999999999996 109.125 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -64.8 -32.34 73.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 74.129999999999995 109.431 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -83.86 123.59 30.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 74.230000000000004 109.503 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 87.1 p -78.8 -26.68 44.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.263 -0.898 . . . . 65.540000000000006 109.689 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 98.3 t -63.12 -49.09 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 75.549999999999997 109.564 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.585 ' CD1' ' HZ2' ' B' ' 97' ' ' LYS . 3.6 mm? -64.78 -35.2 80.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 70.140000000000001 108.949 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.25 -26.6 71.76 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.314 -1.914 . . . . 75.400000000000006 108.314 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.29 -49.99 62.61 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.652 -1.379 . . . . 65.439999999999998 109.652 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -61.97 -43.91 97.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.285 -1.126 . . . . 72.200000000000003 109.706 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 35.8 mm -67.31 -37.55 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.689 -1.257 . . . . 75.150000000000006 108.702 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -65.97 -42.39 89.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -0.891 . . . . 73.010000000000005 109.355 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -87.43 1.35 53.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.169 -0.957 . . . . 74.299999999999997 109.204 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.57 -58.06 1.99 Allowed Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.361 -1.496 . . . . 70.540000000000006 109.361 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -68.54 -24.82 64.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.308 -1.113 . . . . 75.430000000000007 109.421 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -53.8 -36.01 61.98 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.184 -0.947 . . . . 73.200000000000003 109.447 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 58.0 t -54.52 -47.64 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.268 -0.895 . . . . 74.230000000000004 108.914 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -59.91 -54.89 40.88 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.948 -0.76 . . . . 73.519999999999996 108.948 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 132.9 41.85 0.18 Allowed Glycine 0 N--CA 1.499 2.868 0 N-CA-C 109.719 -1.353 . . . . 53.43 109.719 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -118.46 160.17 22.2 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.445 -1.033 . . . . 71.120000000000005 109.308 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 8.4 mmt -98.86 138.79 35.48 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.287 -1.005 . . . . 75.239999999999995 108.287 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.13 149.78 47.54 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.701 0.762 . . . . 73.25 110.326 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . 0.445 ' OD2' ' NH2' ' B' ' 43' ' ' ARG . 24.1 t70 -133.47 126.5 31.27 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.452 -1.314 . . . . 72.310000000000002 107.452 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 p -117.48 142.58 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.406 -0.809 . . . . 72.140000000000001 110.066 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -134.34 -153.16 0.51 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.751 -0.593 . . . . 74.530000000000001 109.413 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.471 ' O ' ' CG2' ' B' ' 6' ' ' ILE . 1.3 pt-20 -135.36 -87.56 0.36 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.422 -0.799 . . . . 71.019999999999996 109.531 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 61.8 m -79.46 152.03 30.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.963 -1.085 . . . . 71.400000000000006 109.571 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' B' ' 37' ' ' GLU . 43.8 mt -54.2 -41.71 68.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.864 . . . . 71.239999999999995 109.73 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -58.95 -40.8 85.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 74.319999999999993 109.795 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.425 ' OD2' ' OE2' ' B' ' 31' ' ' GLU . 92.7 m-20 -64.02 -40.26 95.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.147 -0.97 . . . . 73.030000000000001 109.212 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . 0.447 ' O ' ' CG ' ' B' ' 40' ' ' MET . . . -82.78 -27.89 40.37 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.642 -1.383 . . . . 60.43 109.642 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' B' ' 33' ' ' LEU . 81.7 tt0 -64.3 -41.32 96.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.188 -1.183 . . . . 74.430000000000007 109.727 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -80.54 -40.48 25.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.114 -0.992 . . . . 74.420000000000002 109.624 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 45.4 tp -68.02 -40.15 83.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 75.409999999999997 109.936 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.516 ' SD ' ' CE1' ' B' ' 45' ' ' TYR . 1.2 ppp? -74.05 -27.15 60.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.131 -0.981 . . . . 61.439999999999998 109.923 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -52.68 -36.07 56.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.167 -0.958 . . . . 74.319999999999993 110.041 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 9.3 pt -93.11 -20.48 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.092 -1.005 . . . . 71.230000000000004 110.314 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.445 ' NH2' ' OD2' ' B' ' 28' ' ' ASP . 34.8 mtm105 -104.71 156.81 17.66 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.192 -0.942 . . . . 73.409999999999997 109.902 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -91.29 167.72 12.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.381 -0.825 . . . . 63.539999999999999 109.035 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.516 ' CE1' ' SD ' ' B' ' 40' ' ' MET . 1.7 p90 -160.25 113.43 2.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.054 -1.029 . . . . 73.109999999999999 109.669 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -84.62 -37.73 20.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 62.219999999999999 108.859 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.406 ' C ' ' CD1' ' B' ' 47' ' ' LEU . 0.7 OUTLIER -109.76 109.46 20.16 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.666 -0.864 . . . . 73.120000000000005 108.666 179.524 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 78.4 t -95.97 111.18 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.604 -0.888 . . . . 74.109999999999999 108.604 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 12.2 ttt -128.18 135.31 49.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.486 -0.759 . . . . 73.439999999999998 109.551 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.521 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.8 OUTLIER -147.12 140.63 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.591 -0.693 . . . . 73.400000000000006 109.506 -179.332 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' SER . . . . . 0.606 ' CB ' ' HG ' ' B' ' 74' ' ' SER . 52.8 p -103.91 13.92 31.81 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.445 -0.784 . . . . 73.209999999999994 109.626 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.521 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 13.5 m-20 -78.34 140.7 38.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.164 -0.96 . . . . 70.409999999999997 109.502 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.419 ' C ' ' H ' ' B' ' 55' ' ' ALA . 29.9 mmtp -72.72 -38.37 67.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.18 -0.95 . . . . 73.129999999999995 110.002 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -74.05 10.19 1.3 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.123 -0.986 . . . . 75.209999999999994 109.663 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.419 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -68.09 -22.72 64.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 55.329999999999998 110.148 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 39.4 mt -43.83 -48.54 8.26 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.34 -0.85 . . . . 72.420000000000002 110.174 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 88.3 p -68.9 -33.82 74.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.926 -1.109 . . . . 73.040000000000006 108.943 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -66.21 -61.96 1.74 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.444 -0.785 . . . . 72.329999999999998 109.779 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.9 m -49.92 -34.59 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.715 -1.24 . . . . 74.540000000000006 109.719 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.5 m -57.81 -51.79 68.14 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.285 -0.884 . . . . 71.239999999999995 109.632 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.57 ' NH2' ' HZ2' ' B' ' 65' ' ' LYS . 10.4 ptm180 -70.71 -27.4 63.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.041 -1.037 . . . . 74.310000000000002 110.132 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' B' ' 66' ' ' HIS . 29.9 mm -63.17 -53.78 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.743 -1.223 . . . . 75.420000000000002 109.181 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.428 ' O ' ' OG ' ' B' ' 67' ' ' SER . 27.3 mmtp -59.73 -36.93 77.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.98 -1.075 . . . . 73.319999999999993 109.112 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -75.04 -38.16 61.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.365 -0.835 . . . . 73.310000000000002 109.477 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.57 ' HZ2' ' NH2' ' B' ' 61' ' ' ARG . 92.1 mttt -88.71 -18.46 27.81 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.166 -0.959 . . . . 72.439999999999998 110.722 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' B' ' 62' ' ' ILE . 77.7 m-70 -156.47 67.55 0.57 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.852 -1.155 . . . . 65.209999999999994 109.874 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' B' ' 63' ' ' LYS . 7.5 m -58.75 -29.18 66.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.277 -0.889 . . . . 73.099999999999994 109.553 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 86.4 p -66.56 -27.66 67.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.285 -0.885 . . . . 71.530000000000001 110.311 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 72.7 mt -79.42 157.34 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.022 -1.049 . . . . 74.400000000000006 109.592 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 87.2 t -94.62 160.68 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.284 -0.885 . . . . 75.120000000000005 109.891 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 t -136.22 133.28 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.296 -0.877 . . . . 73.200000000000003 108.908 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . 0.611 ' CD1' HH22 ' B' ' 108' ' ' ARG . 1.0 OUTLIER -133.52 104.67 6.5 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.752 0.787 . . . . 73.340000000000003 109.385 -179.21 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 84.3 t -92.26 130.39 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.928 . . . . 73.5 109.552 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' SER . . . . . 0.606 ' HG ' ' CB ' ' B' ' 51' ' ' SER . 11.8 p -89.79 170.33 10.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.038 . . . . 71.319999999999993 108.212 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 18.8 p -157.43 110.83 2.54 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.757 -1.214 . . . . 74.530000000000001 110.329 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -64.97 -34.41 78.37 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.428 -0.953 . . . . 64.5 108.428 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -109.87 75.54 0.86 Allowed Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 108.527 -0.916 . . . . 74.25 108.527 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.2 86.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 121.889 1.726 . . . . 74.430000000000007 112.198 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 1.6 t -105.53 150.93 24.91 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.571 -0.9 . . . . 73.120000000000005 108.571 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -32.63 74.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.112 -0.992 . . . . 75.409999999999997 109.475 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.56 -42.32 87.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 72.239999999999995 109.588 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -74.46 -26.78 60.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 73.219999999999999 109.327 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.423 ' OE2' ' NH1' ' A' ' 108' ' ' ARG . 86.7 tt0 -68.71 -51.33 42.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 74.299999999999997 109.804 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 29.4 m -63.28 -39.1 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.103 -0.998 . . . . 73.310000000000002 109.507 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -77.05 -21.07 55.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 73.239999999999995 109.41 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.15 -48.34 65.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.22 -0.925 . . . . 55.329999999999998 109.852 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' PHE . . . . . 0.444 ' CZ ' ' CB ' ' A' ' 111' ' ' ALA . 80.7 t80 -76.28 -33.0 59.1 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.988 -1.07 . . . . 74.450000000000003 108.963 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -62.15 -51.02 69.51 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.361 -0.837 . . . . 64.040000000000006 109.195 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -58.88 -49.79 76.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.53 -0.731 . . . . 75.129999999999995 109.831 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 153.23 35.87 0.03 OUTLIER Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.775 -1.202 . . . . 75.420000000000002 110.162 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -99.47 125.49 45.22 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.245 -1.15 . . . . 73.420000000000002 109.154 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -71.08 -33.39 70.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.046 -1.034 . . . . 73.319999999999993 108.941 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 36.2 t0 -153.13 164.93 37.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.513 -0.742 . . . . 73.040000000000006 109.191 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.531 ' CD1' ' O ' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -139.59 115.47 10.2 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.108 -0.701 . . . . 74.310000000000002 109.108 -178.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 29.1 mm -113.17 144.82 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 O-C-N 121.326 -0.859 . . . . 75.340000000000003 110.013 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.64 135.18 57.53 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.042 -1.096 . . . . 70.099999999999994 108.042 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.684 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -55.67 -56.42 29.98 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 120.984 -1.072 . . . . 65.430000000000007 111.46 -178.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 6.0 Cg_endo -42.33 -7.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 120.871 1.047 . . . . 63.520000000000003 112.945 -176.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . 0.684 ' N ' ' O ' ' B' ' 97' ' ' LYS . 68.8 m-85 60.44 115.17 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.661 -0.649 . . . . 75.129999999999995 109.475 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -56.57 -28.18 59.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.117 -0.989 . . . . 74.230000000000004 109.422 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' SER . . . . . 0.742 ' O ' ' N ' ' B' ' 103' ' ' LYS . 30.2 t -174.51 30.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.003 -1.061 . . . . 64.510000000000005 110.7 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 55.1 mt 52.29 -69.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.641 -0.662 . . . . 74.439999999999998 110.283 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . 0.742 ' N ' ' O ' ' B' ' 101' ' ' SER . 29.7 mmtp -59.62 -28.4 67.16 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.331 -0.989 . . . . 72.299999999999997 108.331 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.97 -44.8 91.64 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.462 -0.895 . . . . 74.310000000000002 108.595 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.55 ' CD2' ' NH2' ' B' ' 108' ' ' ARG . 1.3 tm? -57.19 -55.38 35.53 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.869 -0.789 . . . . 73.540000000000006 108.869 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.28 -39.24 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.749 -1.22 . . . . 72.030000000000001 109.741 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -47.7 -44.19 27.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 64.219999999999999 110.265 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . 0.611 HH22 ' CD1' ' B' ' 72' ' ' LEU . 13.9 ptt85 -79.96 -31.03 39.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.988 -1.07 . . . . 75.310000000000002 110.707 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 34.5 mt -71.77 -30.43 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.494 -1.379 . . . . 55.439999999999998 108.264 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' B' ' 113' ' ' LEU . 21.0 tt0 -72.85 -60.59 2.16 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.402 -0.919 . . . . 65.310000000000002 108.972 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -43.33 -44.66 5.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.68 -0.638 . . . . 74.519999999999996 109.981 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 64.9 ttp85 -66.13 -34.81 78.89 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.221 -0.925 . . . . 72.040000000000006 109.391 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' B' ' 110' ' ' GLU . 7.1 tp -97.24 -75.09 0.55 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.228 -0.92 . . . . 75.349999999999994 110.365 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' B' ' 113' ' ' LEU . 83.3 mtt180 47.14 96.55 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.278 -0.889 . . . . 75.5 109.571 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 45.46 86.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.524 -0.735 . . . . 73.040000000000006 110.076 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 81.4 t90 -59.04 146.92 36.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.872 . . . . 74.450000000000003 109.298 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 161.12 101.16 0.16 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.734 -1.346 . . . . 64.209999999999994 109.734 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 83.3 p -157.03 161.26 39.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.252 -1.146 . . . . 71.400000000000006 109.692 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.42 -177.57 5.73 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.784 -0.766 . . . . 74.209999999999994 109.151 -178.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 6.0 t -144.43 -36.92 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.31 -0.869 . . . . 75.019999999999996 109.303 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 47.5 mt -111.51 125.83 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.507 -0.745 . . . . 74.239999999999995 109.201 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -138.97 120.43 14.98 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.266 -0.896 . . . . 73.329999999999998 109.2 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 19.0 pt -154.98 142.79 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.16 -0.962 . . . . 74.219999999999999 109.778 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . 0.516 ' C ' ' H ' ' B' ' 126' ' ' LEU . . . 51.12 39.22 41.29 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.444 -1.062 . . . . 72.409999999999997 110.444 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 69.06 -13.88 0.33 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.303 -1.116 . . . . 75.120000000000005 109.935 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.516 ' H ' ' C ' ' B' ' 124' ' ' GLY . 1.1 mt -82.37 144.3 30.64 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.769 -1.197 . . . . 75.420000000000002 107.769 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 92.3 m -128.65 144.18 51.1 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.375 -0.828 . . . . 74.219999999999999 109.738 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 7.6 mt -141.06 140.93 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.434 -0.791 . . . . 60.329999999999998 109.519 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 70.5 m -117.92 123.64 29.43 Favored Pre-proline 0 N--CA 1.5 2.054 0 N-CA-C 108.965 -0.754 . . . . 72.310000000000002 108.965 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.27 -40.1 0.29 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.821 1.681 . . . . 75.129999999999995 112.196 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -66.42 -44.57 82.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.175 -0.953 . . . . 75.230000000000004 109.943 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . 0.5 ' N ' ' OE1' ' B' ' 132' ' ' GLU . 35.6 mp0 -84.85 -5.15 59.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.197 -0.939 . . . . 75.120000000000005 109.818 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 48.53 72.03 0.31 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.206 -0.934 . . . . 75.129999999999995 109.764 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -152.39 142.53 22.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.312 -0.867 . . . . 75.109999999999999 109.369 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 15.8 tt -115.49 132.19 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.436 -0.79 . . . . 70.319999999999993 109.125 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 61.9 mt -117.22 130.79 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 109.069 -0.715 . . . . 74.120000000000005 109.069 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -132.6 130.83 40.76 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.441 -0.787 . . . . 74.230000000000004 109.505 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . 0.516 ' O ' ' NH1' ' B' ' 140' ' ' ARG . 24.5 mmtm 53.55 32.82 14.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.307 -0.87 . . . . 74.219999999999999 110.49 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.25 -4.55 71.35 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 120.049 -1.072 . . . . 74.319999999999993 110.882 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . 0.516 ' NH1' ' O ' ' B' ' 138' ' ' LYS . 11.2 mpt_? -87.74 134.59 33.64 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.817 -1.402 . . . . 75.340000000000003 108.842 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -102.11 122.92 45.07 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.385 -0.822 . . . . 71.230000000000004 110.034 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 13.5 p -137.78 137.56 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.529 -0.915 . . . . 70.430000000000007 108.529 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -90.2 143.3 26.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.272 -0.893 . . . . 72.430000000000007 110.344 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 21.5 m -146.57 121.42 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.217 -1.031 . . . . 72.129999999999995 108.217 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . 0.409 ' CB ' ' HZ1' ' B' ' 145' ' ' LYS . 7.1 mtmm -139.68 126.48 20.72 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.18 -0.95 . . . . 74.5 109.484 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.16 171.39 33.17 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.473 -1.451 . . . . 42.229999999999997 109.473 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . 0.627 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 11.4 mttm -67.75 -38.81 15.87 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.235 -1.156 . . . . 73.299999999999997 109.886 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 30.0 Cg_exo -60.89 -38.14 71.94 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.265 1.977 . . . . 71.329999999999998 112.211 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -88.53 -17.83 29.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.237 -0.914 . . . . 74.230000000000004 109.732 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -54.34 -38.29 65.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 72.340000000000003 109.479 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 10.9 p -67.93 -38.68 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 73.349999999999994 109.74 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 31.3 tp -55.38 -47.07 76.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.91 . . . . 74.430000000000007 109.542 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 60.4 p -68.27 -32.23 72.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.165 -0.96 . . . . 75.209999999999994 109.619 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 154' ' ' HIS . . . . . 0.561 ' CE1' ' HD1' ' B' ' 158' ' ' HIS . 56.9 t-80 -56.67 -58.99 5.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.849 . . . . 73.040000000000006 110.339 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 pp -69.18 -22.73 63.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.082 -1.012 . . . . 73.430000000000007 109.923 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.92 -39.88 86.99 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.18 -0.95 . . . . 75.319999999999993 109.198 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -85.24 -34.59 21.94 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.181 -0.95 . . . . 73.319999999999993 109.758 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 158' ' ' HIS . . . . . 0.561 ' HD1' ' CE1' ' B' ' 154' ' ' HIS . 36.5 m80 -87.41 40.14 0.91 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.143 -0.973 . . . . 74.140000000000001 109.786 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -55.3 151.1 10.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 73.420000000000002 109.342 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' B' ' 214' ' ' PHE . 64.3 t0 52.28 68.18 0.86 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 72.099999999999994 109.592 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -160.1 147.32 16.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.144 -0.972 . . . . 73.239999999999995 109.797 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 12.2 mm -91.29 134.73 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.432 -0.951 . . . . 72.310000000000002 108.432 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 48.3 t -135.96 135.74 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.245 -0.909 . . . . 75.030000000000001 110.021 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 10.8 t -89.19 155.65 19.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.426 -0.796 . . . . 74.219999999999999 109.343 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -55.41 -31.68 62.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.385 -0.822 . . . . 72.420000000000002 109.794 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -57.29 -39.14 75.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 63.450000000000003 110.26 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -62.95 -43.43 98.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.012 -1.055 . . . . 72.400000000000006 109.8 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 20.0 mt -55.26 -59.09 5.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.15 -0.969 . . . . 72.319999999999993 109.102 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.418 ' C ' ' CD1' ' B' ' 169' ' ' LEU . 1.6 tm? -54.7 -65.33 0.6 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.078 -1.014 . . . . 73.340000000000003 109.284 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -46.4 -36.25 6.31 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 112.949 0.722 . . . . 73.099999999999994 112.949 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.05 -30.97 14.41 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.595 -1.316 . . . . 62.130000000000003 113.214 -176.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.416 ' N ' ' CD1' ' B' ' 172' ' ' ILE . 1.3 mp -84.94 -58.58 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 120.433 -1.417 . . . . 74.439999999999998 111.208 -177.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 173' ' ' TRP . . . . . 0.586 ' O ' ' CE3' ' B' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.834 0 O-C-N 120.609 -1.307 . . . . 72.230000000000004 109.76 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo . . . . . 0 N--CA 1.497 1.702 0 CA-C-O 121.601 0.584 . . . . 74.340000000000003 112.024 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 182' ' ' ASN . . . . . 0.523 ' C ' ' H ' ' B' ' 184' ' ' ILE . 43.4 t30 -170.4 -106.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.105 -0.997 . . . . 72.310000000000002 109.297 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 5.5 t 61.99 -3.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.454 -0.779 . . . . 65.420000000000002 109.818 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.523 ' H ' ' C ' ' B' ' 182' ' ' ASN . 28.5 mt -69.63 -38.11 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.904 -1.123 . . . . 75.030000000000001 108.425 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -55.23 -53.3 57.74 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.822 -0.549 . . . . 73.519999999999996 109.759 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 30.7 m -73.28 -31.75 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.121 -0.987 . . . . 74.349999999999994 110.02 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.44 -56.61 13.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.058 -1.027 . . . . 61.119999999999997 109.848 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 10.8 tp -63.01 -29.75 47.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.898 -1.126 . . . . 72.430000000000007 109.421 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -68.9 -56.0 9.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 75.420000000000002 110.186 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 190' ' ' GLN . . . . . 0.409 ' O ' ' CB ' ' B' ' 194' ' ' LYS . 15.7 pt20 -66.14 -39.78 90.12 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.001 -1.062 . . . . 74.140000000000001 109.35 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 55.6 mt -54.65 -37.71 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.985 -1.072 . . . . 74.030000000000001 109.528 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -68.03 -52.85 30.76 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.074 -1.016 . . . . 72.329999999999998 110.48 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 193' ' ' GLN . . . . . 0.41 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 45.8 mt-30 -76.88 -14.25 59.9 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.999 -1.063 . . . . 73.099999999999994 110.113 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' B' ' 190' ' ' GLN . 53.4 tttp -92.43 -27.42 17.49 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.388 -0.82 . . . . 74.430000000000007 110.445 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 195' ' ' MET . . . . . 0.431 ' C ' ' SD ' ' B' ' 195' ' ' MET . 1.9 ppp? -90.56 -30.93 16.93 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.068 -1.02 . . . . 74.329999999999998 109.812 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 196' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 28.0 p-10 -58.87 -32.71 69.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.981 . . . . 71.209999999999994 109.747 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . 0.51 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 7.6 mmtp -63.03 -64.91 2.49 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 75.209999999999994 109.935 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 198' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 33.0 Cg_endo -61.96 -53.07 2.3 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.185 1.924 . . . . 75.319999999999993 112.352 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' B' ' 201' ' ' ILE . 10.0 mp -65.58 -40.23 92.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.031 -1.043 . . . . 72.25 109.324 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 77.72 -40.16 1.81 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.574 -1.411 . . . . 73.239999999999995 109.574 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . 0.418 ' H ' ' C ' ' B' ' 199' ' ' LEU . 19.1 mm -97.65 146.25 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.24 -1.153 . . . . 54.299999999999997 109.478 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 38.8 t -85.75 141.07 29.96 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.23 -0.919 . . . . 74.310000000000002 109.245 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 13.8 p -142.7 18.22 2.0 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.181 -0.949 . . . . 74.400000000000006 109.904 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 21.9 m -140.7 137.05 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.189 -0.944 . . . . 74.099999999999994 109.437 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -116.34 135.68 53.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.576 -0.703 . . . . 75.329999999999998 109.342 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 1.4 p -93.59 132.23 38.11 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.174 -0.954 . . . . 71.400000000000006 108.946 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 25.5 t -138.92 143.66 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.331 -0.856 . . . . 63.5 109.539 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 208' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' B' ' 209' ' ' ARG . 91.4 mtt180 -60.07 164.89 3.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 74.450000000000003 109.611 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 209' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' B' ' 211' ' ' GLY . 80.4 mtm-85 52.46 176.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.868 . . . . 74.140000000000001 109.62 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 17.0 mmt85 53.85 -85.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.466 -0.771 . . . . 74.430000000000007 109.672 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 211' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' B' ' 209' ' ' ARG . . . 164.12 -96.66 0.14 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.482 -1.447 . . . . 70.109999999999999 109.482 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 212' ' ' TYR . . . . . 0.481 ' CD1' ' C ' ' B' ' 211' ' ' GLY . 52.8 m-85 -141.28 167.77 21.37 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.362 -1.081 . . . . 74.209999999999994 109.126 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -132.58 140.37 48.22 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.411 -0.806 . . . . 74.299999999999997 109.654 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . 0.512 ' O ' ' N ' ' B' ' 160' ' ' ASP . 2.3 m-85 -116.41 125.38 51.96 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.942 -0.762 . . . . 74.340000000000003 108.942 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . 0.592 ' HG ' ' N ' ' B' ' 216' ' ' TYR . 30.5 t -147.9 167.56 24.52 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.336 -0.852 . . . . 72.209999999999994 109.314 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . 0.592 ' N ' ' HG ' ' B' ' 215' ' ' CYS . 3.2 p90 -60.0 152.67 59.45 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.284 -0.885 . . . . 72.310000000000002 109.116 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.18 124.1 10.59 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.357 2.038 . . . . 71.010000000000005 112.044 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 8.1 tptp . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.2 -0.937 . . . . 74.349999999999994 110.356 179.744 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.8 ttm . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.399 -0.593 . . . . 65.120000000000005 109.399 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -137.62 146.1 43.53 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.436 -0.79 . . . . 73.310000000000002 109.305 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 79.2 t -115.81 133.32 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-O 121.451 0.643 . . . . 71.420000000000002 109.746 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.4 tp -103.48 116.95 33.35 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.417 -0.957 . . . . 65.219999999999999 108.417 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 59.0 tp -117.33 114.54 23.73 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.918 -0.771 . . . . 71.439999999999998 108.918 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 52.4 mt -109.41 116.29 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.851 -0.796 . . . . 71.150000000000006 108.851 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 13' ' ' GLY . 61.7 tt0 -146.7 131.11 17.62 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.334 -0.854 . . . . 75.340000000000003 109.425 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -61.98 -35.78 79.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 73.040000000000006 109.58 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -86.23 116.85 24.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 72.420000000000002 109.492 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.4 p -73.12 -27.29 61.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.917 . . . . 72.340000000000003 109.623 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.7 t -63.75 -49.57 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.184 -0.948 . . . . 74.420000000000002 109.673 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' A' ' 12' ' ' LEU . 3.5 mm? -67.83 -42.29 81.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.928 . . . . 72.010000000000005 109.128 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.51 ' N ' ' OE1' ' A' ' 7' ' ' GLU . . . -67.19 -19.79 70.57 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.354 -1.898 . . . . 72.140000000000001 108.354 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.38 -58.88 5.68 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.457 -1.457 . . . . 72.329999999999998 109.457 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -52.84 -42.78 65.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.399 -1.059 . . . . 72.340000000000003 109.464 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.3 mm -64.05 -38.65 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.943 -1.098 . . . . 74.239999999999995 108.807 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.42 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 72.6 tt0 -62.83 -52.49 62.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.837 . . . . 71.409999999999997 109.818 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -81.63 1.96 31.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -0.949 . . . . 75.540000000000006 109.632 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.24 -68.12 1.32 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.159 -1.576 . . . . 62.149999999999999 109.159 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp -56.16 -25.93 48.5 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.417 -1.049 . . . . 74.420000000000002 109.088 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 2.6 m120 -52.09 -33.95 41.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.305 -0.872 . . . . 74.25 109.212 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.3 t -55.52 -41.4 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 72.109999999999999 109.022 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.419 ' HZ3' ' CG1' ' A' ' 106' ' ' VAL . 2.1 mptm? -67.35 -22.58 65.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.358 -0.838 . . . . 73.230000000000004 108.994 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.14 38.42 4.32 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.153 -1.179 . . . . 75.540000000000006 110.153 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -112.74 159.33 19.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.413 -1.051 . . . . 74.510000000000005 108.62 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.0 mmt -99.63 138.55 36.56 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.304 -0.998 . . . . 64.319999999999993 108.304 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.13 160.51 40.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.902 . . . . 74.310000000000002 109.995 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -134.92 141.35 46.28 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.967 -0.753 . . . . 75.400000000000006 108.967 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -110.43 130.54 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.727 -0.842 . . . . 75.129999999999995 108.727 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.1 p -135.0 167.63 20.58 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.499 -0.75 . . . . 71.420000000000002 109.251 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.459 ' CG ' ' OD2' ' A' ' 35' ' ' ASP . 3.4 pt-20 -90.68 -99.86 0.1 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.245 -0.909 . . . . 73.109999999999999 109.564 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.0 p -78.77 166.59 22.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -0.867 . . . . 74.239999999999995 109.997 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 15.5 mt -56.02 -32.04 63.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.611 -0.68 . . . . 71.530000000000001 110.032 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -50.58 -45.83 57.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.031 -1.043 . . . . 74.230000000000004 109.793 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.459 ' OD2' ' CG ' ' A' ' 31' ' ' GLU . 67.9 m-20 -68.25 -43.05 78.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.054 -1.029 . . . . 71.010000000000005 109.364 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.43 -40.47 79.46 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.386 -1.486 . . . . 61.409999999999997 109.386 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -65.11 -38.92 92.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -1.113 . . . . 74.340000000000003 109.419 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -75.61 -36.73 60.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 75.329999999999998 109.48 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.7 tp -71.42 -45.76 61.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 74.329999999999998 109.905 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.444 ' O ' ' O ' ' A' ' 43' ' ' ARG . 3.2 ppp? -69.08 -20.37 64.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.074 -1.016 . . . . 70.319999999999993 109.857 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -60.73 -36.95 80.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.022 -1.049 . . . . 71.219999999999999 109.611 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.403 HD12 HG21 ' A' ' 42' ' ' ILE . 17.4 pt -89.23 -27.58 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.18 -0.95 . . . . 74.409999999999997 110.317 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 40' ' ' MET . 96.9 mtt180 -127.82 146.03 50.74 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.298 -0.877 . . . . 75.409999999999997 109.771 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -98.61 132.05 44.32 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.231 -0.918 . . . . 75.420000000000002 109.475 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -101.9 135.16 43.93 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.36 -0.838 . . . . 74.230000000000004 109.343 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -74.75 -35.26 62.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.948 . . . . 75.319999999999993 108.969 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.404 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 0.7 OUTLIER -112.72 115.8 29.11 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.426 -0.953 . . . . 72.129999999999995 108.426 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.2 t -99.11 97.04 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.27 -1.011 . . . . 72.340000000000003 108.27 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.2 ttt -109.22 134.07 52.22 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.536 0.684 . . . . 74.109999999999999 109.611 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 p -143.96 131.66 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.461 -0.775 . . . . 71.239999999999995 109.505 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.3 p -96.99 2.97 52.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.501 -0.749 . . . . 73.109999999999999 109.125 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -76.26 142.23 41.45 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.269 -0.895 . . . . 63.399999999999999 109.54 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.548 ' NZ ' ' H ' ' A' ' 76' ' ' ASP . 66.0 mmtt -79.07 -39.36 34.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 65.439999999999998 110.198 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -72.17 15.0 0.18 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.082 -1.011 . . . . 73.129999999999995 109.733 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.502 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.52 -19.75 59.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 64.140000000000001 110.411 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.629 ' CD1' ' HE2' ' A' ' 85' ' ' HIS . 22.0 mt -40.66 -50.22 3.05 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.428 -0.795 . . . . 74.430000000000007 110.473 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.0 m -68.14 -34.69 76.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.087 . . . . 63.229999999999997 109.262 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.414 ' N ' ' O ' ' A' ' 55' ' ' ALA . 55.9 t80 -65.81 -56.08 13.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -0.794 . . . . 74.439999999999998 110.115 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.6 m -54.57 -35.38 31.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 120.749 -1.219 . . . . 74.030000000000001 109.662 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.6 t -57.4 -54.48 46.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.097 -1.002 . . . . 73.540000000000006 109.655 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 ptp85 -66.05 -29.26 69.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.119 -0.988 . . . . 73.340000000000003 110.092 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.6 mm -65.63 -38.21 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.751 -1.218 . . . . 73.349999999999994 109.898 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.521 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 33.5 mmtt -69.63 -50.51 43.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.107 -0.996 . . . . 74.420000000000002 110.117 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -67.39 -35.46 79.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.762 -1.211 . . . . 74.549999999999997 109.767 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.471 ' C ' ' CG ' ' A' ' 66' ' ' HIS . 48.7 mtpt -81.77 -23.43 36.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.196 -0.94 . . . . 75.219999999999999 109.607 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.471 ' CG ' ' C ' ' A' ' 65' ' ' LYS . 59.4 m-70 -155.26 65.03 0.63 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.168 -0.957 . . . . 74.129999999999995 109.632 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 63' ' ' LYS . 33.1 t -61.06 -30.36 70.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.25 -0.906 . . . . 73.239999999999995 110.017 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.4 t -61.9 -19.83 63.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.958 . . . . 71.439999999999998 110.198 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 78.8 mt -87.81 152.97 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.1 -1.0 . . . . 71.329999999999998 109.945 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.3 t -92.95 160.63 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.351 -0.843 . . . . 73.019999999999996 109.518 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.2 t -134.59 129.81 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.348 -0.845 . . . . 54.210000000000001 109.898 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.2 tt -122.39 99.05 6.21 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.884 -0.784 . . . . 74.209999999999994 108.884 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.0 t -92.22 127.45 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.167 -0.958 . . . . 74.409999999999997 108.825 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.412 ' O ' ' OG ' ' A' ' 75' ' ' SER . 0.4 OUTLIER -92.97 -176.25 4.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.019 -1.051 . . . . 72.310000000000002 108.805 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.463 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 55.7 m -166.75 119.83 1.01 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.792 -1.193 . . . . 64.540000000000006 110.502 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.548 ' H ' ' NZ ' ' A' ' 53' ' ' LYS . 50.4 t0 -61.65 -32.33 72.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.541 -0.725 . . . . 74.129999999999995 109.807 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 79' ' ' THR . 44.8 t-20 -119.78 84.06 30.5 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.583 -0.698 . . . . 73.340000000000003 109.242 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -54.19 82.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.208 1.939 . . . . 71.319999999999993 111.341 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 77' ' ' ASN . 3.4 t -105.22 154.74 19.81 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.519 -0.738 . . . . 62.530000000000001 109.589 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.56 -32.61 73.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.402 -0.811 . . . . 74.140000000000001 109.78 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -55.08 -55.91 25.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 71.420000000000002 110.009 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.534 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 95.4 mt-10 -64.6 -35.39 80.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -0.957 . . . . 73.430000000000007 109.796 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.52 ' OE2' ' NH2' ' B' ' 108' ' ' ARG . 66.9 tt0 -63.91 -48.98 74.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.049 -1.032 . . . . 74.219999999999999 110.068 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.5 t -57.2 -57.56 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.167 -0.958 . . . . 74.150000000000006 110.313 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.629 ' HE2' ' CD1' ' A' ' 56' ' ' LEU . 1.3 p-80 -64.83 -41.11 96.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.942 -1.099 . . . . 72.540000000000006 109.515 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.57 ' N ' ' ND1' ' A' ' 85' ' ' HIS . . . -46.93 -37.69 9.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 64.219999999999999 109.833 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -78.43 -34.32 47.96 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.103 -0.998 . . . . 74.340000000000003 108.761 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -67.5 -40.47 85.18 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.414 -0.914 . . . . 74.420000000000002 109.432 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.571 ' NE2' ' N ' ' A' ' 89' ' ' GLN . 0.7 OUTLIER -65.14 -56.88 10.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 74.519999999999996 109.614 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 152.13 44.58 0.02 OUTLIER Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.724 -1.227 . . . . 74.209999999999994 110.249 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -96.2 133.28 40.7 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.083 -1.245 . . . . 64.099999999999994 109.222 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.521 ' OD2' ' NZ ' ' A' ' 63' ' ' LYS . 72.7 m-20 -90.96 -22.53 20.79 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.085 -1.009 . . . . 73.420000000000002 109.677 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 94' ' ' TYR . 18.7 t0 -149.61 154.81 39.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.22 -0.925 . . . . 75.040000000000006 109.265 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.516 ' N ' ' OD1' ' A' ' 93' ' ' ASP . 71.3 t80 -136.86 105.65 5.88 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.522 -0.736 . . . . 71.329999999999998 109.257 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 27.0 mm -111.47 155.69 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 O-C-N 121.127 -0.983 . . . . 74.510000000000005 110.735 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.4 128.73 36.27 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.657 -1.238 . . . . 64.319999999999993 107.657 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.687 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -50.83 -57.28 14.04 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.715 -1.241 . . . . 74.510000000000005 111.399 -178.496 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 5.2 Cg_endo -41.5 -9.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.066 1.177 . . . . 73.109999999999999 112.797 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.687 ' N ' ' O ' ' A' ' 97' ' ' LYS . 24.9 m-85 62.81 108.66 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.339 -0.615 . . . . 72.540000000000006 109.339 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.526 ' NH1' ' OE2' ' B' ' 83' ' ' GLU . 21.6 ttm105 -52.81 -33.26 48.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.848 -1.157 . . . . 74.540000000000006 108.374 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 103' ' ' LYS . 2.3 m 172.37 48.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.552 -0.717 . . . . 74.140000000000001 109.524 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 105' ' ' LEU . 13.1 mt 37.6 -77.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 121.835 -0.541 . . . . 75.430000000000007 111.982 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.692 ' N ' ' O ' ' A' ' 101' ' ' SER . 28.0 mmtp -38.03 -38.8 0.34 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.533 -0.729 . . . . 74.140000000000001 110.26 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.84 -43.51 68.37 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.206 -1.035 . . . . 63.240000000000002 108.206 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 102' ' ' ILE . 1.2 tt -60.85 -44.81 96.48 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.684 -0.858 . . . . 73.219999999999999 108.684 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.419 ' CG1' ' HZ3' ' A' ' 23' ' ' LYS . 15.6 t -69.43 -43.08 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 74.540000000000006 109.619 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.61 -42.61 62.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 75.5 109.174 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.75 -35.94 77.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 74.409999999999997 109.015 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.0 mt -70.87 -30.32 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.951 -1.093 . . . . 73.239999999999995 108.677 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -62.24 -53.47 54.71 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.381 -0.825 . . . . 74.340000000000003 108.782 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.09 -39.39 69.26 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.468 -0.77 . . . . 73.319999999999993 109.148 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 20.0 tpt85 -59.25 -32.63 70.17 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.265 -0.897 . . . . 74.420000000000002 109.145 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.4 tp -157.6 102.42 1.88 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.264 -0.898 . . . . 74.329999999999998 109.638 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.519 ' O ' ' CG ' ' A' ' 115' ' ' PHE . 23.1 mtm105 -94.84 -56.3 2.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.131 -0.981 . . . . 74.439999999999998 109.007 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.519 ' CG ' ' O ' ' A' ' 114' ' ' ARG . 82.4 m-85 -157.02 -58.14 0.09 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.182 -0.949 . . . . 74.430000000000007 109.213 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 62.7 m95 48.04 -122.59 1.53 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.317 -0.865 . . . . 74.439999999999998 109.695 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.1 43.38 56.8 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.152 -1.579 . . . . 75.040000000000006 109.152 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.1 m -100.37 147.97 25.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.375 -1.074 . . . . 70.109999999999999 109.564 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 121' ' ' ILE . 2.4 t30 -108.91 166.72 10.61 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.61 -0.681 . . . . 65.239999999999995 109.261 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.414 ' N ' ' CG ' ' A' ' 119' ' ' ASN . 4.4 t -124.68 -39.09 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.722 -0.611 . . . . 74.219999999999999 109.379 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.51 ' O ' ' ND2' ' A' ' 119' ' ' ASN . 17.1 mm -100.23 140.5 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.317 -0.864 . . . . 74.420000000000002 110.005 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.654 ' H ' HH12 ' A' ' 159' ' ' ARG . 86.4 mt-10 -135.61 119.31 17.15 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.382 -0.823 . . . . 73.299999999999997 108.901 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 37.8 mt -138.62 111.84 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.228 -0.92 . . . . 75.340000000000003 109.782 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 126' ' ' LEU . . . 65.61 46.51 83.98 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.209 -1.156 . . . . 75.129999999999995 110.209 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 67.25 -14.16 0.19 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.512 -0.993 . . . . 74.450000000000003 110.308 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.518 ' H ' ' C ' ' A' ' 124' ' ' GLY . 7.1 mt -76.99 155.24 32.76 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.61 -1.256 . . . . 54.210000000000001 107.61 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.88 129.28 46.63 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.368 -0.833 . . . . 70.239999999999995 109.49 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 74.8 mt -123.58 130.86 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.071 -0.714 . . . . 72.430000000000007 109.071 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.3 m -117.16 112.99 39.48 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 121.604 -0.685 . . . . 71.109999999999999 109.304 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.09 -51.09 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.106 1.871 . . . . 75.140000000000001 112.621 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -55.19 -45.68 75.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.063 -1.023 . . . . 72.5 109.532 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -81.53 -8.43 59.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 73.140000000000001 109.169 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 52.57 57.55 6.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.401 -0.812 . . . . 75.329999999999998 109.248 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -140.79 127.8 20.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.376 -0.828 . . . . 71.230000000000004 108.942 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.416 HG21 HD13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -107.08 126.32 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.362 -0.836 . . . . 75.329999999999998 109.147 -179.586 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.9 mt -117.86 126.76 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.532 -0.73 . . . . 71.109999999999999 109.951 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -137.25 142.66 42.01 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.355 -0.841 . . . . 74.140000000000001 108.954 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp 54.83 14.04 0.83 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.575 -0.703 . . . . 75.400000000000006 110.272 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 92.33 -6.56 78.23 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.49 -1.044 . . . . 72.239999999999995 110.49 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.473 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 1.0 OUTLIER -87.99 124.87 34.16 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.858 -1.378 . . . . 73.120000000000005 108.651 179.614 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -94.3 129.23 41.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.084 -1.01 . . . . 72.319999999999993 110.049 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.6 t -135.96 133.48 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.513 -0.742 . . . . 62.340000000000003 109.046 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -88.36 131.68 34.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.415 -0.803 . . . . 61.229999999999997 109.603 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.45 150.25 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.571 -0.9 . . . . 74.439999999999998 108.571 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -162.38 113.92 1.61 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.012 -1.055 . . . . 75.420000000000002 109.653 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' A' ' 150' ' ' GLU . . . 163.37 -169.07 38.32 Favored Glycine 0 N--CA 1.486 1.983 0 C-N-CA 119.511 -1.328 . . . . 73.340000000000003 109.899 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.504 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 41.7 mttp -78.06 -41.68 2.08 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.506 -0.996 . . . . 72.219999999999999 111.897 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 147' ' ' LYS . 36.7 Cg_endo -65.44 -30.38 52.93 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 CA-C-N 120.49 1.211 . . . . 75.450000000000003 111.891 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -94.38 -19.07 20.95 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.042 -1.037 . . . . 65.239999999999995 109.554 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.59 ' HB2' ' O ' ' A' ' 146' ' ' GLY . 34.9 tp10 -68.24 -43.32 78.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.356 -0.84 . . . . 72.519999999999996 108.907 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.0 p -61.66 -30.17 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.465 -0.939 . . . . 74.209999999999994 108.465 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 31.0 tp -65.61 -45.33 83.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.544 -0.723 . . . . 73.310000000000002 109.169 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.3 p -71.05 -30.1 66.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.945 . . . . 74.310000000000002 109.3 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -61.54 -53.46 56.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.168 -0.958 . . . . 75.450000000000003 109.742 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.4 pp -69.87 -22.65 63.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 75.340000000000003 109.33 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.67 -49.12 78.79 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.341 -0.85 . . . . 62.140000000000001 109.243 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.472 ' C ' ' H ' ' A' ' 159' ' ' ARG . 36.8 mtp180 -75.33 -44.39 45.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.025 -1.047 . . . . 72.219999999999999 109.164 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -77.71 26.43 0.18 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.255 -0.903 . . . . 74.120000000000005 109.412 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.722 ' CZ ' ' HH ' ' A' ' 216' ' ' TYR . 36.5 ptt180 -59.98 169.5 1.48 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.39 -0.819 . . . . 74.340000000000003 109.405 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.0 t0 46.47 65.49 1.19 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.316 -0.865 . . . . 75.450000000000003 109.484 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -169.94 149.67 3.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.123 -0.985 . . . . 73.409999999999997 109.792 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 75.5 mt -81.36 105.15 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.226 -1.027 . . . . 74.409999999999997 108.226 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 12.1 t -91.51 128.66 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.38 -0.825 . . . . 72.530000000000001 109.978 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.1 p -86.6 164.15 17.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.844 . . . . 74.120000000000005 109.052 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.482 ' CB ' ' NZ ' ' A' ' 165' ' ' LYS . 6.6 mtpm? -63.68 -48.12 78.46 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.257 -0.902 . . . . 70.430000000000007 110.185 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -56.0 -32.5 64.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.425 -0.797 . . . . 74.319999999999993 110.785 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -56.19 -56.06 25.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.973 -1.079 . . . . 74.519999999999996 110.119 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 51.2 mt -61.52 -41.69 97.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.165 -0.959 . . . . 74.409999999999997 110.372 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -62.24 -55.63 26.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.005 -1.06 . . . . 75.140000000000001 109.868 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 49.6 t0 -71.07 -13.18 61.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.134 -0.979 . . . . 65.030000000000001 110.45 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.97 -62.97 1.53 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.025 -1.047 . . . . 70.209999999999994 110.998 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.46 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 2.1 mp -73.23 -47.62 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 120.912 -1.117 . . . . 75.319999999999993 108.183 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 24.0 m-90 . . . . . 0 C--N 1.303 -1.436 0 N-CA-C 108.559 -0.904 . . . . 73.140000000000001 108.559 178.864 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.408 -0.59 . . . . 73.129999999999995 109.408 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.2 p -143.71 -14.11 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.201 -0.937 . . . . 74.019999999999996 110.294 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 6.1 tt -56.1 -23.08 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.743 -1.223 . . . . 72.329999999999998 109.738 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -58.23 -49.66 76.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 74.400000000000006 109.837 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 16.4 m -76.35 -25.02 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.89 -1.132 . . . . 74.319999999999993 109.663 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.19 -46.59 49.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.058 -1.026 . . . . 73.230000000000004 110.1 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.8 tp -67.95 -30.93 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.911 -1.118 . . . . 74.310000000000002 109.093 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -70.02 -57.42 5.02 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.372 -0.83 . . . . 73.439999999999998 109.99 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.439 ' CG ' ' N ' ' A' ' 191' ' ' ILE . 7.7 pt20 -63.06 -43.85 97.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 71.420000000000002 109.983 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.439 ' N ' ' CG ' ' A' ' 190' ' ' GLN . 51.0 mt -53.69 -49.29 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.112 -0.992 . . . . 72.439999999999998 109.165 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -54.63 -40.56 69.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.003 . . . . 64.219999999999999 109.249 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -62.51 -35.97 81.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.142 -0.973 . . . . 74.319999999999993 109.538 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -93.0 -0.05 57.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.207 -0.933 . . . . 75.310000000000002 110.382 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 31.9 ttm -95.72 -63.01 1.2 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.005 -1.059 . . . . 74.019999999999996 109.389 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 200' ' ' GLY . 84.5 m-20 -60.66 -29.08 69.07 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.439 -0.788 . . . . 74.019999999999996 110.095 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.438 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 30.7 mttm -58.64 -65.75 1.78 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.053 -1.03 . . . . 75.430000000000007 110.06 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 26.7 Cg_endo -60.96 -52.83 3.11 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.915 1.743 . . . . 72.319999999999993 112.108 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 201' ' ' ILE . 26.0 mt -66.35 -34.83 78.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.946 -1.096 . . . . 74.540000000000006 109.154 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 196' ' ' ASP . . . 77.65 -31.67 1.68 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.038 -1.625 . . . . 61.509999999999998 109.038 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.487 ' H ' ' C ' ' A' ' 199' ' ' LEU . 27.6 mm -95.89 129.45 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.41 -1.053 . . . . 74.25 109.286 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 64.9 m -78.8 139.22 38.42 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.603 -0.888 . . . . 72.0 108.603 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 38.5 p -142.57 13.77 1.95 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.216 -0.928 . . . . 74.439999999999998 109.814 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.33 131.77 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.765 -0.828 . . . . 71.129999999999995 108.765 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.41 ' OE1' ' SG ' ' A' ' 215' ' ' CYS . 30.1 mt-10 -117.01 123.45 46.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.636 -0.665 . . . . 73.510000000000005 109.509 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.99 98.93 10.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.319 -0.863 . . . . 73.519999999999996 108.715 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 208' ' ' ARG . 12.0 m -152.41 172.14 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.227 -0.921 . . . . 72.150000000000006 109.415 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 207' ' ' VAL . 70.2 mtt85 55.44 164.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.621 -0.674 . . . . 72.400000000000006 109.702 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.483 ' O ' ' N ' ' A' ' 211' ' ' GLY . 80.9 mtt85 -72.61 -126.11 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.21 -0.931 . . . . 73.310000000000002 109.398 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 75.6 mtp85 50.1 -91.44 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.3 -0.875 . . . . 71.540000000000006 109.928 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . -158.78 -97.7 0.13 Allowed Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.496 -1.335 . . . . 74.450000000000003 110.39 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -137.21 148.28 46.4 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.344 -1.092 . . . . 75.540000000000006 110.103 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -107.39 126.54 52.6 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.475 -0.766 . . . . 75.310000000000002 109.619 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -104.17 134.61 47.14 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.283 -1.006 . . . . 75.409999999999997 108.283 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . 0.41 ' SG ' ' OE1' ' A' ' 205' ' ' GLU . 31.1 p -153.51 164.43 38.24 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.173 -0.954 . . . . 74.140000000000001 109.926 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . 0.722 ' HH ' ' CZ ' ' A' ' 159' ' ' ARG . 42.3 m-85 -59.33 152.82 51.78 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 75.319999999999993 109.106 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 N--CA 1.493 1.485 0 C-N-CA 122.237 1.958 . . . . 73.109999999999999 111.407 179.219 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 32.0 tpp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.492 -0.558 . . . . 75.239999999999995 109.492 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.524 ' N ' ' OD2' ' B' ' 46' ' ' ASP . 78.4 mtm-85 -140.33 151.81 45.33 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.355 -0.841 . . . . 73.519999999999996 109.286 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.8 t -112.23 129.39 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.623 -0.673 . . . . 72.239999999999995 109.274 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 2.5 tp -104.46 121.12 42.78 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.579 -0.7 . . . . 73.340000000000003 109.566 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 11.1 mt -118.92 98.83 6.39 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 109.031 -0.729 . . . . 74.349999999999994 109.031 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 55.7 mt -84.1 98.86 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.834 -1.166 . . . . 63.439999999999998 108.664 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.43 ' OE2' ' OG ' ' B' ' 51' ' ' SER . 9.3 tp10 -140.97 130.59 24.06 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.293 -0.88 . . . . 74.519999999999996 109.485 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -66.06 -35.31 80.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.346 -0.846 . . . . 74.129999999999995 109.249 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -77.02 112.26 13.46 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.376 -0.828 . . . . 74.230000000000004 109.385 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 95.4 p -74.27 -30.29 62.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 65.540000000000006 110.158 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.45 ' CG1' ' N ' ' B' ' 12' ' ' LEU . 9.3 p -59.1 -45.38 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.005 -1.059 . . . . 75.549999999999997 109.704 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.45 ' N ' ' CG1' ' B' ' 11' ' ' VAL . 80.9 mt -65.06 -31.58 72.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.06 -1.025 . . . . 70.140000000000001 109.309 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.25 -28.04 62.77 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.649 -1.781 . . . . 75.400000000000006 108.649 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.62 -56.01 19.54 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.506 -1.437 . . . . 65.439999999999998 109.506 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.52 -41.85 90.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.342 -1.093 . . . . 72.200000000000003 109.515 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.69 -43.29 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.975 -1.078 . . . . 75.150000000000006 108.846 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.413 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 80.2 tt0 -58.53 -43.94 89.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.451 -0.78 . . . . 73.010000000000005 109.559 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -86.58 0.4 54.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.103 -0.998 . . . . 74.299999999999997 109.083 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.76 -58.63 1.89 Allowed Glycine 0 N--CA 1.484 1.894 0 N-CA-C 109.479 -1.448 . . . . 70.540000000000006 109.479 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -69.37 -22.31 63.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -1.144 . . . . 75.430000000000007 109.557 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . 0.413 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 2.0 m120 -51.67 -34.07 36.59 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.223 -0.923 . . . . 73.200000000000003 109.416 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 79.0 t -56.76 -39.91 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.093 -1.004 . . . . 74.230000000000004 108.884 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.448 ' CD ' ' N ' ' B' ' 23' ' ' LYS . 4.2 mptp? -70.59 -27.52 64.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.376 -0.828 . . . . 73.519999999999996 109.344 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.58 41.22 2.21 Favored Glycine 0 N--CA 1.499 2.893 0 N-CA-C 110.208 -1.157 . . . . 53.43 110.208 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -119.58 161.16 21.1 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.427 -1.043 . . . . 71.120000000000005 109.203 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 18.3 mmt -103.08 140.89 36.72 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.746 -0.835 . . . . 75.239999999999995 108.746 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . 0.419 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -137.53 154.45 49.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.303 -0.873 . . . . 73.25 110.167 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 96.1 m-20 -140.63 158.11 44.46 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.535 -0.913 . . . . 72.310000000000002 108.535 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 5.0 p -122.79 140.01 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.41 -0.806 . . . . 72.140000000000001 109.947 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.2 p -131.86 171.82 13.07 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.132 -0.692 . . . . 74.530000000000001 109.132 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -91.85 -107.09 0.1 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.235 -0.915 . . . . 71.019999999999996 109.792 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 33.3 t -78.79 168.87 19.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.292 -0.88 . . . . 71.400000000000006 110.022 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 39.0 mt -52.4 -30.91 31.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.593 -0.692 . . . . 71.239999999999995 109.877 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -53.9 -49.75 67.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.113 -0.992 . . . . 74.319999999999993 109.769 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -66.03 -44.79 83.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.153 -0.967 . . . . 73.030000000000001 109.365 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.61 -40.12 94.02 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.393 -1.483 . . . . 60.43 109.393 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -64.67 -43.85 92.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.337 -1.096 . . . . 74.430000000000007 109.456 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -71.29 -37.89 71.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.179 -0.95 . . . . 74.420000000000002 109.774 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 51.8 tp -69.51 -45.27 69.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 75.409999999999997 110.068 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.4 ppp? -74.29 -19.68 60.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.007 -1.058 . . . . 61.439999999999998 110.005 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.39 -41.81 80.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.105 -0.997 . . . . 74.319999999999993 109.697 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 pt -86.95 -41.44 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.122 -0.986 . . . . 71.230000000000004 109.854 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' B' ' 40' ' ' MET . 2.8 mpt_? -104.54 138.48 40.84 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.279 -0.888 . . . . 73.409999999999997 109.148 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' ASN . . . . . 0.478 ' C ' ' NH2' ' B' ' 2' ' ' ARG . 55.3 t-20 -100.59 89.89 4.08 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.377 -0.827 . . . . 63.539999999999999 109.205 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -63.56 149.22 46.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 73.109999999999999 109.275 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' B' ' 2' ' ' ARG . 3.9 p30 -80.42 -44.1 19.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 62.219999999999999 109.368 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.412 ' C ' ' CD1' ' B' ' 47' ' ' LEU . 0.6 OUTLIER -103.37 115.02 29.75 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.458 -0.941 . . . . 73.120000000000005 108.458 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 74.8 t -99.01 96.43 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.38 -0.97 . . . . 74.109999999999999 108.38 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 22.8 ttt -109.26 134.2 52.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.482 -0.761 . . . . 73.439999999999998 109.908 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.22 137.11 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.008 -0.738 . . . . 73.400000000000006 109.008 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' SER . . . . . 0.43 ' OG ' ' OE2' ' B' ' 7' ' ' GLU . 41.8 p -100.22 0.03 39.58 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.468 -0.77 . . . . 73.209999999999994 109.967 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -76.35 130.42 38.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 70.409999999999997 109.521 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.429 ' C ' ' N ' ' B' ' 55' ' ' ALA . 27.5 mtmm -66.51 -48.43 69.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 73.129999999999995 109.931 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -50.04 -16.52 0.3 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.144 -0.973 . . . . 75.209999999999994 109.367 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.429 ' N ' ' C ' ' B' ' 53' ' ' LYS . . . -59.68 -21.44 60.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.422 -0.799 . . . . 55.329999999999998 110.18 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 23.1 mt -43.02 -46.44 5.52 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.305 -0.872 . . . . 72.420000000000002 110.065 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 25.2 t -70.89 -34.32 71.46 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.05 -1.031 . . . . 73.040000000000006 109.347 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -67.45 -53.43 29.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.408 -0.808 . . . . 72.329999999999998 110.123 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.64 -33.89 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.825 -1.172 . . . . 74.540000000000006 109.73 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 9.3 t -59.74 -52.06 67.09 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.174 -0.953 . . . . 71.239999999999995 109.454 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -67.7 -27.79 67.12 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.007 -1.058 . . . . 74.310000000000002 109.876 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' B' ' 66' ' ' HIS . 4.7 mm -59.29 -51.63 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.932 -1.105 . . . . 75.420000000000002 109.083 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -60.41 -41.0 92.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.097 -1.002 . . . . 73.319999999999993 108.754 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -67.1 -51.73 50.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -0.862 . . . . 73.310000000000002 108.746 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -72.6 -74.76 0.16 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.599 -0.688 . . . . 72.439999999999998 109.554 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' B' ' 62' ' ' ILE . 90.2 m-70 -90.69 92.24 8.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.144 -0.973 . . . . 65.209999999999994 109.176 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 74.8 m -79.83 -27.64 40.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 73.099999999999994 109.876 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 51.7 p -87.11 47.69 1.54 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.188 -0.945 . . . . 71.530000000000001 110.153 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 15.9 tt -144.83 159.85 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.049 -1.032 . . . . 74.400000000000006 109.171 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 43.1 t -103.32 147.5 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.291 -0.881 . . . . 75.120000000000005 109.206 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 t -133.29 127.97 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.41 -0.806 . . . . 73.200000000000003 109.655 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 5.3 tt -122.65 105.29 9.95 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.617 -0.677 . . . . 73.340000000000003 109.423 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 14.8 p -94.25 132.44 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.012 -1.055 . . . . 73.5 109.497 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 9.5 p -89.63 171.63 9.54 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.985 -1.072 . . . . 71.319999999999993 108.723 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 27.4 p -152.54 112.05 3.91 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.817 -1.177 . . . . 74.530000000000001 110.713 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -74.28 -4.63 37.28 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.62 -0.881 . . . . 64.5 108.62 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -143.09 71.38 18.43 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 108.86 -0.793 . . . . 74.25 108.86 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.4 87.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.808 1.672 . . . . 74.430000000000007 111.701 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.431 ' OG1' ' OE2' ' B' ' 82' ' ' GLU . 44.3 p -107.43 155.77 19.67 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.683 -0.858 . . . . 73.120000000000005 108.683 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.1 p -61.01 -30.42 70.29 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.214 -0.929 . . . . 75.409999999999997 109.58 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.09 -43.01 88.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.921 . . . . 72.239999999999995 109.804 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' B' ' 82' ' ' GLU . 0.2 OUTLIER -66.29 -33.14 75.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 73.219999999999999 109.633 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.526 ' OE2' ' NH1' ' A' ' 100' ' ' ARG . 46.5 mt-10 -64.52 -46.51 82.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.017 -1.052 . . . . 74.299999999999997 109.535 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.06 -42.09 93.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.186 -0.946 . . . . 73.310000000000002 109.328 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' HIS . . . . . 0.438 ' O ' ' OE1' ' B' ' 89' ' ' GLN . 18.6 m170 -72.13 -20.33 61.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.215 -0.928 . . . . 73.239999999999995 109.639 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.24 -44.59 62.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.04 -1.038 . . . . 55.329999999999998 110.119 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -81.37 -35.23 31.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.002 -1.061 . . . . 74.450000000000003 109.487 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.95 -43.0 97.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.073 -1.017 . . . . 64.040000000000006 109.375 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . 0.438 ' OE1' ' O ' ' B' ' 85' ' ' HIS . 0.5 OUTLIER -67.91 -61.29 1.94 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 75.129999999999995 109.259 179.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 149.7 64.72 0.01 OUTLIER Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.732 -1.223 . . . . 75.420000000000002 110.154 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.51 134.44 55.22 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.493 -1.004 . . . . 73.420000000000002 108.971 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -68.22 -43.35 78.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.049 -1.032 . . . . 73.319999999999993 108.959 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' B' ' 93' ' ' ASP . 18.3 p-10 -153.81 165.14 36.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.449 -0.782 . . . . 73.040000000000006 109.253 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' B' ' 94' ' ' TYR . 0.2 OUTLIER -136.19 119.09 16.29 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.364 -0.606 . . . . 74.310000000000002 109.364 -178.345 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 28.6 mm -113.67 150.66 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 O-C-N 121.379 -0.826 . . . . 75.340000000000003 110.144 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.84 141.06 58.17 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.011 -1.107 . . . . 70.099999999999994 108.011 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.6 ' C ' ' H ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -68.85 -40.26 16.4 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.944 -1.098 . . . . 65.430000000000007 110.922 -178.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' B' ' 97' ' ' LYS . 34.0 Cg_exo -53.16 -0.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.289 -2.557 0 CA-C-N 118.697 0.571 . . . . 63.520000000000003 112.135 -174.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . 0.6 ' H ' ' C ' ' B' ' 97' ' ' LYS . 60.2 m-85 53.0 102.3 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.525 -0.734 . . . . 75.129999999999995 109.935 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 38.3 mtt-85 -57.63 -35.84 71.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.925 -1.109 . . . . 74.230000000000004 108.77 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' SER . . . . . 0.777 ' O ' ' N ' ' B' ' 103' ' ' LYS . 27.1 t -171.27 29.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -0.934 . . . . 64.510000000000005 110.77 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 18.7 mt 48.11 -68.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-N 118.539 0.609 . . . . 74.439999999999998 110.418 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . 0.777 ' N ' ' O ' ' B' ' 101' ' ' SER . 55.3 mttp -51.59 -31.72 25.96 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.693 -1.225 . . . . 72.299999999999997 107.693 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.84 -42.89 89.93 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.194 -1.039 . . . . 74.310000000000002 108.194 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 50.8 tp -60.79 -42.71 98.1 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.549 -0.908 . . . . 73.540000000000006 108.549 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 20.3 t -69.78 -34.23 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 72.030000000000001 109.229 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.51 -47.35 73.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.152 -0.968 . . . . 64.219999999999999 109.441 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . 0.52 ' NH2' ' OE2' ' A' ' 83' ' ' GLU . 26.2 ttm105 -69.28 -37.08 77.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 75.310000000000002 109.789 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 97.7 mt -70.16 -26.66 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.04 -1.038 . . . . 55.439999999999998 108.921 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -74.98 -56.91 4.27 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.455 -0.778 . . . . 65.310000000000002 109.94 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -52.0 -35.74 47.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.071 -1.018 . . . . 74.519999999999996 109.81 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 38.6 ttp85 -85.98 -57.02 3.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.113 -0.992 . . . . 72.040000000000006 110.545 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 35.2 tp -54.7 -36.46 64.71 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.086 -1.008 . . . . 75.349999999999994 110.409 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -46.71 -33.24 4.15 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.125 -0.984 . . . . 75.5 109.611 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' PHE . . . . . 0.532 ' O ' ' N ' ' B' ' 117' ' ' GLY . 11.2 m-85 -54.38 -29.71 49.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.859 . . . . 73.040000000000006 108.994 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 4.3 t-105 60.47 -75.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.444 -0.785 . . . . 74.450000000000003 109.59 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' B' ' 115' ' ' PHE . . . -163.18 -171.34 29.3 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.281 -1.528 . . . . 64.209999999999994 109.281 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' SER . . . . . 0.642 ' CB ' ' OE2' ' B' ' 132' ' ' GLU . 7.6 t -154.85 174.48 15.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.148 -1.207 . . . . 71.400000000000006 110.011 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.29 114.37 4.44 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.983 -0.687 . . . . 74.209999999999994 109.159 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 11.9 t -78.51 -39.97 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.264 -0.897 . . . . 75.019999999999996 109.73 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . 0.404 HG21 HD13 ' B' ' 121' ' ' ILE . 17.3 mm -101.7 127.45 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.231 -0.918 . . . . 74.239999999999995 109.365 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . 0.464 ' CD ' ' N ' ' B' ' 122' ' ' GLU . 1.0 OUTLIER -135.2 114.64 12.52 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.529 -0.732 . . . . 73.329999999999998 109.267 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 11.2 pt -140.97 137.35 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.216 -0.928 . . . . 74.219999999999999 109.2 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.18 -149.89 3.4 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.441 -1.464 . . . . 72.409999999999997 109.441 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -83.19 -0.39 49.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -1.168 . . . . 75.120000000000005 109.332 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.31 132.82 42.68 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.288 -0.882 . . . . 75.420000000000002 108.706 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 4.4 p -129.81 120.33 24.82 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.97 -0.752 . . . . 74.219999999999999 108.97 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.403 HD13 HG22 ' B' ' 128' ' ' ILE . 18.2 mm -107.24 144.68 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.492 -0.755 . . . . 60.329999999999998 109.042 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 3.4 m -126.84 79.44 72.31 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 121.446 -0.784 . . . . 72.310000000000002 109.7 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -50.96 -40.36 58.56 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.51 2.14 . . . . 75.129999999999995 112.132 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -68.01 -50.12 57.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.87 . . . . 75.230000000000004 109.934 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . 0.642 ' OE2' ' CB ' ' B' ' 118' ' ' SER . 88.7 mt-10 -82.38 -1.16 49.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.119 -0.988 . . . . 75.120000000000005 109.701 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 50.39 51.97 15.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.946 . . . . 75.129999999999995 109.235 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -138.19 136.84 37.01 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.371 -0.83 . . . . 75.109999999999999 109.242 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 7.8 tt -119.23 139.2 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.565 -0.709 . . . . 70.319999999999993 109.579 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 32.0 mt -126.36 125.17 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.8 -0.815 . . . . 74.120000000000005 108.8 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . 0.406 ' C ' ' H ' ' B' ' 139' ' ' GLY . 33.6 p90 -142.49 151.36 41.6 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.235 -1.024 . . . . 74.230000000000004 108.235 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 16.9 tptm 60.11 8.16 1.42 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.572 -0.851 . . . . 74.219999999999999 109.07 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' B' ' 137' ' ' TYR . . . 90.41 -8.82 79.18 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.866 -1.294 . . . . 74.319999999999993 109.866 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . 0.505 ' N ' ' CD ' ' B' ' 140' ' ' ARG . 0.5 OUTLIER -90.53 141.25 28.95 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.113 -1.228 . . . . 75.340000000000003 109.214 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -97.8 129.87 44.77 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.27 -0.894 . . . . 71.230000000000004 109.632 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 47.7 t -138.43 132.51 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.389 -0.819 . . . . 70.430000000000007 109.075 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -87.1 143.72 27.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.205 -0.934 . . . . 72.430000000000007 109.727 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.48 132.28 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.337 -0.852 . . . . 72.129999999999995 109.388 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . 0.897 ' O ' ' HE2' ' B' ' 149' ' ' PHE . 0.0 OUTLIER -148.89 124.73 10.56 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.119 -0.988 . . . . 74.5 109.23 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . 0.765 ' N ' ' HD2' ' B' ' 149' ' ' PHE . . . 155.63 178.27 29.68 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.532 -1.427 . . . . 42.229999999999997 109.532 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . 0.62 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 26.5 mtpt -70.88 -35.85 4.67 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.208 -1.172 . . . . 73.299999999999997 110.243 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 23.3 Cg_exo -63.49 -30.05 71.39 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.942 1.761 . . . . 71.329999999999998 111.772 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . 0.897 ' HE2' ' O ' ' B' ' 145' ' ' LYS . 0.2 OUTLIER -92.03 -28.22 17.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.404 -0.81 . . . . 74.230000000000004 109.079 -179.61 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -51.74 -35.89 45.11 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.363 -0.835 . . . . 72.340000000000003 109.802 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . 0.424 ' CG1' ' N ' ' B' ' 152' ' ' LEU . 11.4 p -63.36 -41.28 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.162 -0.961 . . . . 73.349999999999994 109.398 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . 0.424 ' N ' ' CG1' ' B' ' 151' ' ' VAL . 0.3 OUTLIER -58.5 -42.56 87.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.38 -0.825 . . . . 74.430000000000007 109.088 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 16.0 p -71.13 -34.3 70.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.085 -1.01 . . . . 75.209999999999994 110.218 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -59.13 -53.73 55.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.056 -1.027 . . . . 73.040000000000006 109.628 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.82 -23.57 61.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.946 -1.096 . . . . 73.430000000000007 109.526 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.38 -50.32 71.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.197 -0.94 . . . . 75.319999999999993 109.22 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . 0.523 ' C ' ' H ' ' B' ' 159' ' ' ARG . 13.8 mtp-105 -71.47 -47.61 54.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 73.319999999999993 108.851 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -75.84 32.76 0.12 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.507 -0.745 . . . . 74.140000000000001 109.013 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . 0.523 ' H ' ' C ' ' B' ' 157' ' ' ARG . 34.0 ptt180 -50.67 -33.94 24.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.423 -0.798 . . . . 73.420000000000002 110.389 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' B' ' 160' ' ' ASP . 18.4 p30 -121.49 79.25 1.52 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.33 -0.856 . . . . 72.099999999999994 109.697 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -171.72 156.5 4.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.305 -0.872 . . . . 73.239999999999995 109.644 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 162' ' ' ILE . . . . . 0.571 ' CD1' ' N ' ' B' ' 162' ' ' ILE . 1.9 mp -94.1 139.27 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.205 -0.935 . . . . 72.310000000000002 109.025 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 63.5 t -133.95 142.52 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.416 -0.802 . . . . 75.030000000000001 109.594 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 4.7 p -91.78 166.38 12.79 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.21 -0.931 . . . . 74.219999999999999 110.422 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -64.47 -46.09 84.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.511 -0.743 . . . . 72.420000000000002 109.987 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -57.97 -38.25 75.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 63.450000000000003 110.15 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 167' ' ' GLN . . . . . 0.423 ' O ' ' OD1' ' B' ' 170' ' ' ASP . 63.3 tp60 -58.56 -48.54 80.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 72.400000000000006 109.795 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 33.1 mt -60.17 -36.09 76.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.92 . . . . 72.319999999999993 109.551 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' B' ' 173' ' ' TRP . 3.6 tt -55.9 -68.89 0.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.364 -0.835 . . . . 73.340000000000003 109.756 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' B' ' 167' ' ' GLN . 26.4 p30 -64.37 -11.19 30.16 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.473 -0.767 . . . . 73.099999999999994 110.802 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.57 -58.5 3.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.979 -1.076 . . . . 62.130000000000003 110.224 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.474 ' N ' ' CD1' ' B' ' 172' ' ' ILE . 2.0 mp -94.38 -50.4 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.018 -1.051 . . . . 74.439999999999998 109.47 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 173' ' ' TRP . . . . . 0.441 ' O ' ' O ' ' B' ' 169' ' ' LEU . 16.1 m-90 . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.297 -0.877 . . . . 72.230000000000004 109.452 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo . . . . . 0 N--CA 1.495 1.606 0 CA-C-O 121.33 0.471 . . . . 74.340000000000003 111.989 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 182' ' ' ASN . . . . . 0.51 ' ND2' ' OE2' ' B' ' 185' ' ' GLU . 16.2 t-20 -72.23 -0.79 12.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 72.310000000000002 109.624 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 83.0 t -65.19 -29.01 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.257 -0.902 . . . . 65.420000000000002 109.66 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 61.7 mt -53.3 -40.71 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 75.030000000000001 110.102 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . 0.51 ' OE2' ' ND2' ' B' ' 182' ' ' ASN . 22.6 mt-10 -56.17 -37.39 69.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.041 -1.037 . . . . 73.519999999999996 108.881 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.92 -54.63 9.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.452 -0.78 . . . . 74.349999999999994 109.765 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -54.28 -36.96 64.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.274 -0.892 . . . . 61.119999999999997 110.465 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 188' ' ' ILE . . . . . 0.439 ' CG2' ' N ' ' B' ' 189' ' ' ASN . 7.7 tp -75.38 -43.54 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.681 -1.262 . . . . 72.430000000000007 109.667 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 189' ' ' ASN . . . . . 0.439 ' N ' ' CG2' ' B' ' 188' ' ' ILE . 11.3 m120 -61.65 -38.14 86.63 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.218 -0.926 . . . . 75.420000000000002 109.271 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -72.3 -47.72 47.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.952 . . . . 74.140000000000001 109.615 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . 0.441 ' O ' ' SD ' ' B' ' 195' ' ' MET . 57.4 mt -55.29 -40.52 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.155 -0.966 . . . . 74.030000000000001 109.093 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -63.06 -43.36 98.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 72.329999999999998 109.654 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -73.25 -30.83 63.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 73.099999999999994 109.87 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -82.01 -19.92 39.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.303 -0.873 . . . . 74.430000000000007 110.441 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 195' ' ' MET . . . . . 0.563 ' N ' ' SD ' ' B' ' 195' ' ' MET . 0.1 OUTLIER -99.7 -36.16 9.57 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.142 -0.974 . . . . 74.329999999999998 109.85 -179.666 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 196' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 58.2 p-10 -68.14 -19.57 64.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.086 -1.009 . . . . 71.209999999999994 110.113 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . 0.533 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 27.4 mttm -80.41 -64.87 0.29 Allowed Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.029 -1.045 . . . . 75.209999999999994 109.87 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 198' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 33.0 Cg_endo -61.9 -55.2 1.15 Allowed 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.314 2.009 . . . . 75.319999999999993 112.442 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . 0.519 ' C ' ' H ' ' B' ' 201' ' ' ILE . 15.5 mt -64.53 -37.03 86.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.084 -1.01 . . . . 72.25 109.627 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 74.09 -31.33 0.94 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.581 -1.408 . . . . 73.239999999999995 109.581 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . 0.519 ' H ' ' C ' ' B' ' 199' ' ' LEU . 66.4 mt -96.78 142.51 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.226 -1.161 . . . . 54.299999999999997 109.341 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 79.8 p -94.56 146.91 23.78 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.266 -0.896 . . . . 74.310000000000002 109.595 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 22.7 p -143.36 11.9 1.73 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.252 -0.905 . . . . 74.400000000000006 109.075 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.59 133.85 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.472 -0.767 . . . . 74.099999999999994 109.242 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -115.87 132.88 56.51 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.626 -0.671 . . . . 75.329999999999998 109.287 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.5 137.57 33.47 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.208 -0.932 . . . . 71.400000000000006 109.062 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.9 p -124.55 145.7 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.584 -0.697 . . . . 63.5 109.561 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -71.0 -11.53 61.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 74.450000000000003 109.904 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 70.0 ttt-85 -69.1 -108.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.126 -0.984 . . . . 74.140000000000001 109.623 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -146.83 121.4 9.76 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.827 -1.171 . . . . 74.430000000000007 109.853 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 94.47 171.84 37.98 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.68 -0.968 . . . . 70.109999999999999 110.68 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -115.74 171.34 7.81 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.213 -1.032 . . . . 74.209999999999994 108.213 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -132.24 132.64 43.27 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.215 -0.928 . . . . 74.299999999999997 109.597 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -113.35 123.46 50.17 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.978 -0.749 . . . . 74.340000000000003 108.978 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 2.2 p -139.92 164.34 30.26 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.447 -0.783 . . . . 72.209999999999994 109.044 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -61.87 149.78 84.5 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 72.310000000000002 109.104 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -38.52 133.82 0.89 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.144 1.896 . . . . 71.010000000000005 112.277 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 35.1 tttp . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.167 -0.958 . . . . 74.349999999999994 110.772 179.893 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.445 ' SD ' ' OD2' ' A' ' 46' ' ' ASP . 32.2 tpp . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.318 0.58 . . . . 65.120000000000005 109.441 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.572 ' NH2' ' CB ' ' A' ' 28' ' ' ASP . 75.5 ttt-85 -143.0 135.82 27.83 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.267 -0.895 . . . . 73.310000000000002 109.267 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.7 t -110.97 133.6 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.653 -0.654 . . . . 71.420000000000002 109.405 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.428 ' CD1' ' C ' ' A' ' 4' ' ' LEU . 0.3 OUTLIER -113.88 120.29 40.21 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.752 -0.833 . . . . 65.219999999999999 108.752 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.82 119.92 33.07 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.396 -0.965 . . . . 71.439999999999998 108.396 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.1 mt -97.31 130.38 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.25 -0.906 . . . . 71.150000000000006 109.351 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.529 ' C ' ' H ' ' A' ' 9' ' ' ASN . 10.8 pt-20 -171.57 -22.17 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.226 -0.921 . . . . 75.340000000000003 110.719 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt 69.18 -38.38 0.4 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.278 -0.889 . . . . 73.040000000000006 109.769 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 7' ' ' GLU . 26.8 m120 -64.88 103.12 0.67 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.143 -0.973 . . . . 72.420000000000002 109.419 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.1 m -61.15 -24.87 66.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.878 . . . . 72.340000000000003 109.633 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.9 t -70.03 -53.67 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.946 . . . . 74.420000000000002 109.728 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 12' ' ' LEU . 3.4 mm? -69.07 -36.76 77.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 72.010000000000005 109.35 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.512 ' N ' ' OE1' ' A' ' 7' ' ' GLU . . . -73.42 -28.03 66.61 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.481 -1.848 . . . . 72.140000000000001 108.481 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.38 -50.72 60.22 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.449 -1.46 . . . . 72.329999999999998 109.449 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -61.32 -45.99 92.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.347 -1.09 . . . . 72.340000000000003 109.76 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.7 mm -64.99 -37.11 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.751 -1.218 . . . . 74.239999999999995 108.68 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.475 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 84.1 tt0 -66.14 -47.03 75.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.368 -0.833 . . . . 71.409999999999997 109.794 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -85.24 2.98 41.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.098 -1.001 . . . . 75.540000000000006 109.324 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.85 -55.84 2.33 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.502 -1.439 . . . . 62.149999999999999 109.502 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -74.24 -21.87 59.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -1.124 . . . . 74.420000000000002 109.812 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 96.2 m-20 -54.07 -33.26 57.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.119 -0.988 . . . . 74.25 109.448 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.7 t -58.33 -47.08 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 72.109999999999999 108.959 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -59.98 -53.8 53.62 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.897 -0.779 . . . . 73.230000000000004 108.897 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 135.03 22.29 0.66 Allowed Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.761 -1.336 . . . . 75.540000000000006 109.761 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -98.86 160.37 14.31 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.218 -1.166 . . . . 74.510000000000005 109.424 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.2 mmm -100.97 139.31 36.84 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.601 -0.888 . . . . 64.319999999999993 108.601 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -127.75 154.28 45.56 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.577 -0.702 . . . . 74.310000000000002 109.783 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.572 ' CB ' ' NH2' ' A' ' 2' ' ' ARG . 24.2 t70 -142.6 132.24 23.92 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.71 -0.848 . . . . 75.400000000000006 108.71 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.7 m -100.22 130.52 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.907 . . . . 75.129999999999995 108.879 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.4 p -120.62 158.19 27.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.608 -0.683 . . . . 71.420000000000002 109.223 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -89.32 -94.29 0.11 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.397 -0.814 . . . . 73.109999999999999 109.605 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.2 p -79.29 152.49 30.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.205 -0.934 . . . . 74.239999999999995 110.022 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.3 mp -55.98 -37.34 68.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.49 -0.756 . . . . 71.530000000000001 109.795 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.54 -40.78 92.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 74.230000000000004 109.658 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -66.52 -40.37 89.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 71.010000000000005 109.331 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.31 -38.51 81.47 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.422 -1.471 . . . . 61.409999999999997 109.422 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -65.32 -39.93 93.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.378 -1.071 . . . . 74.340000000000003 109.523 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -78.94 -39.14 35.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.121 -0.987 . . . . 75.329999999999998 109.616 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.4 tt -67.74 -41.61 83.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.31 -0.869 . . . . 74.329999999999998 109.778 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.539 ' SD ' ' CE2' ' A' ' 45' ' ' TYR . 3.2 ppp? -74.83 -23.22 58.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.1 -1.0 . . . . 70.319999999999993 109.674 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -54.13 -37.27 64.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.117 -0.989 . . . . 71.219999999999999 109.891 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.5 pt -84.94 -33.35 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.154 -0.966 . . . . 74.409999999999997 110.148 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 40' ' ' MET . 97.2 mtt180 -95.86 167.11 11.46 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.058 -1.026 . . . . 75.409999999999997 109.933 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.409 ' C ' ' CD2' ' A' ' 45' ' ' TYR . 30.4 m120 -79.8 -174.95 4.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.127 -0.983 . . . . 75.420000000000002 109.056 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.539 ' CE2' ' SD ' ' A' ' 40' ' ' MET . 1.4 p90 -173.96 134.4 0.46 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.044 -1.035 . . . . 74.230000000000004 109.861 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.445 ' OD2' ' SD ' ' A' ' 1' ' ' MET . 87.2 m-20 -120.89 -51.95 2.12 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.485 -0.932 . . . . 75.319999999999993 108.485 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.435 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 1.7 tm? -106.32 111.1 23.54 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.049 -1.093 . . . . 72.129999999999995 108.049 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.22 101.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.599 -0.889 . . . . 72.340000000000003 108.599 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 7.7 ttt -105.39 140.3 38.72 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.458 -0.942 . . . . 74.109999999999999 108.458 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -140.04 129.31 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 71.239999999999995 109.847 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.7 m -109.79 9.06 24.79 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.827 -0.805 . . . . 73.109999999999999 108.827 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -77.45 159.66 29.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.376 -0.828 . . . . 63.399999999999999 109.933 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.534 ' C ' ' H ' ' A' ' 55' ' ' ALA . 62.5 mttp -81.86 173.15 12.53 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.714 -0.847 . . . . 65.439999999999998 108.714 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 56.2 5.94 0.21 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.117 -0.989 . . . . 73.129999999999995 108.916 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.534 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -68.65 -26.92 65.56 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.41 -0.806 . . . . 64.140000000000001 109.586 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.7 mt -45.14 -42.79 9.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.401 -0.812 . . . . 74.430000000000007 110.19 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.3 m -70.56 -37.38 73.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.999 -1.063 . . . . 63.229999999999997 109.819 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -64.76 -46.87 80.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 74.439999999999998 110.313 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.9 m -62.97 -36.92 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.654 -1.279 . . . . 74.030000000000001 109.555 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.8 t -55.84 -52.63 63.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.252 -0.905 . . . . 73.540000000000006 109.66 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -65.63 -32.71 74.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.127 -0.983 . . . . 73.340000000000003 109.987 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 mm -64.47 -35.89 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.871 -1.143 . . . . 73.349999999999994 109.63 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.665 ' HZ2' ' N ' ' A' ' 91' ' ' ALA . 26.6 mmtp -68.97 -50.87 45.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 74.420000000000002 110.262 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.438 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 15.7 pt-20 -70.1 -42.93 72.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.927 -1.108 . . . . 74.549999999999997 110.084 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.477 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 67.3 mttm -70.12 -24.6 63.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.94 . . . . 75.219999999999999 109.593 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.477 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 96.1 m-70 -155.85 64.2 0.59 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.921 . . . . 74.129999999999995 109.371 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.501 ' N ' ' O ' ' A' ' 63' ' ' LYS . 84.4 p -57.26 -25.48 59.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.306 -0.871 . . . . 73.239999999999995 109.763 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.5 t -75.34 45.61 0.3 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 71.439999999999998 109.89 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.7 tt -145.72 158.18 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.089 -1.007 . . . . 71.329999999999998 109.645 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.5 t -94.23 149.83 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.16 -0.962 . . . . 73.019999999999996 108.687 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.526 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 11.2 t -138.09 124.96 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.205 -0.934 . . . . 54.210000000000001 109.387 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 mp -124.8 99.52 6.19 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.686 -0.857 . . . . 74.209999999999994 108.686 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.4 p -86.89 160.14 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.183 -0.948 . . . . 74.409999999999997 108.891 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 75' ' ' SER . 19.8 m -135.5 160.36 38.71 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.371 -0.831 . . . . 72.310000000000002 109.631 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 74' ' ' SER . 70.3 m -168.57 154.74 6.95 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.275 -0.891 . . . . 64.540000000000006 110.133 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 0.4 OUTLIER -94.71 8.3 42.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.406 -0.809 . . . . 74.129999999999995 109.945 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' A' ' 79' ' ' THR . 37.6 t30 -129.19 56.68 25.31 Favored Pre-proline 0 N--CA 1.502 2.14 0 O-C-N 121.358 -0.839 . . . . 73.340000000000003 110.109 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.6 84.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.349 2.033 . . . . 71.319999999999993 111.913 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.43 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 42.5 m -114.03 150.17 34.32 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.741 -0.837 . . . . 62.530000000000001 108.741 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.07 -32.86 23.39 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.214 -0.929 . . . . 74.140000000000001 109.432 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.434 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 97.4 mt-10 -59.45 -36.73 76.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 71.420000000000002 109.69 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.421 ' OE2' ' OG ' ' A' ' 75' ' ' SER . 84.9 tt0 -75.84 -33.3 60.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.147 -0.971 . . . . 73.430000000000007 109.804 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.43 ' OE2' ' O ' ' A' ' 79' ' ' THR . 0.9 OUTLIER -68.69 -50.16 53.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.099 -1.001 . . . . 74.219999999999999 109.893 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.6 m -63.21 -42.95 98.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.027 -1.046 . . . . 74.150000000000006 109.615 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.434 ' ND1' ' O ' ' A' ' 81' ' ' GLU . 56.1 m80 -74.11 -25.44 59.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 72.540000000000006 109.78 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.43 -44.05 88.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.108 -0.995 . . . . 64.219999999999999 109.776 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -81.49 -34.01 31.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.011 -1.055 . . . . 74.340000000000003 109.027 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -68.1 -51.35 47.44 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.349 -0.844 . . . . 74.420000000000002 109.261 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -61.2 -50.24 73.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.487 -0.758 . . . . 74.519999999999996 109.704 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 147.64 71.08 0.01 OUTLIER Glycine 0 N--CA 1.495 2.587 0 C-N-CA 119.851 -1.166 . . . . 74.209999999999994 110.357 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.665 ' N ' ' HZ2' ' A' ' 63' ' ' LYS . . . -139.81 140.01 36.52 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.186 -1.185 . . . . 64.099999999999994 109.092 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 57.3 m-20 -83.76 -39.87 19.52 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.056 -1.028 . . . . 73.420000000000002 109.492 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 73.1 m-20 -150.29 164.15 36.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -0.879 . . . . 75.040000000000006 109.223 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.438 ' CE1' ' O ' ' A' ' 95' ' ' ILE . 1.6 t80 -135.77 132.34 36.66 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.46 -0.775 . . . . 71.329999999999998 109.315 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.438 ' O ' ' CE1' ' A' ' 94' ' ' TYR . 26.1 mm -115.05 148.26 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 121.453 -0.779 . . . . 74.510000000000005 110.076 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.32 121.31 16.64 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.975 -1.491 . . . . 64.319999999999993 106.975 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.705 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.5 OUTLIER -43.66 -58.4 4.56 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.057 -1.027 . . . . 74.510000000000005 111.649 -178.272 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 7.5 Cg_endo -43.97 0.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 121.419 1.412 . . . . 73.109999999999999 113.695 -175.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.705 ' N ' ' O ' ' A' ' 97' ' ' LYS . 51.5 m-85 58.21 116.04 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.681 -0.637 . . . . 72.540000000000006 109.761 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.522 ' NE ' ' OE2' ' B' ' 83' ' ' GLU . 12.6 ttm-85 -73.63 -33.93 64.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 74.540000000000006 109.775 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.75 ' O ' ' N ' ' A' ' 103' ' ' LYS . 30.5 t -172.68 26.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.856 -1.153 . . . . 74.140000000000001 111.139 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 87.2 mt 51.13 -70.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.519 -0.738 . . . . 75.430000000000007 110.357 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.75 ' N ' ' O ' ' A' ' 101' ' ' SER . 30.5 mmtm -56.07 -30.05 61.41 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.162 -1.051 . . . . 74.140000000000001 108.162 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.4 -47.75 84.24 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.392 -0.966 . . . . 63.240000000000002 108.392 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.63 -56.04 16.38 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.953 -0.758 . . . . 73.219999999999999 108.953 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 63.5 t -51.45 -40.55 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.74 -1.225 . . . . 74.540000000000006 109.018 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.21 -32.83 68.66 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.223 -0.923 . . . . 75.5 108.727 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 -77.96 -24.13 48.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -0.839 . . . . 74.409999999999997 110.333 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 81.7 mt -75.68 -38.98 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.801 -1.187 . . . . 73.239999999999995 108.869 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 114' ' ' ARG . 24.3 pt-20 -76.63 -32.5 58.06 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.298 -0.876 . . . . 74.340000000000003 109.605 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.49 -50.2 72.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.412 -0.805 . . . . 73.319999999999993 109.748 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -64.78 -46.07 83.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 74.420000000000002 109.495 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.6 mt -97.85 26.06 5.45 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.218 -0.926 . . . . 74.329999999999998 109.731 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 110' ' ' GLU . 0.8 OUTLIER -60.92 -53.13 61.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 74.439999999999998 109.383 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -86.62 50.85 2.08 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.176 -0.952 . . . . 74.430000000000007 109.412 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -88.28 132.4 34.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.247 -0.908 . . . . 74.439999999999998 109.869 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 118.99 92.3 1.44 Allowed Glycine 0 N--CA 1.501 2.972 0 N-CA-C 109.65 -1.38 . . . . 75.040000000000006 109.65 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 79.7 p -166.7 160.49 14.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.093 -1.239 . . . . 70.109999999999999 109.979 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 121' ' ' ILE . 8.2 t30 -146.06 142.82 28.95 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.51 -0.922 . . . . 65.239999999999995 108.51 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.2 t -93.54 -45.73 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.016 -1.053 . . . . 74.219999999999999 110.564 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.521 ' O ' ' ND2' ' A' ' 119' ' ' ASN . 12.4 mm -93.56 114.98 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 120.841 -1.162 . . . . 74.420000000000002 109.624 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -118.83 124.9 48.31 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.915 -0.772 . . . . 73.299999999999997 108.915 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.48 ' CG2' ' O ' ' A' ' 123' ' ' ILE . 5.9 tt -149.88 102.73 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.039 -1.038 . . . . 75.340000000000003 109.682 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 62.73 -135.6 44.17 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.198 -1.161 . . . . 75.129999999999995 110.198 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -87.74 -3.4 58.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.457 -1.025 . . . . 74.450000000000003 109.878 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.0 131.0 42.84 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.225 -0.922 . . . . 54.210000000000001 108.865 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.54 137.33 49.66 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.756 -0.831 . . . . 70.239999999999995 108.756 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 56.4 mt -131.17 127.88 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.473 -0.767 . . . . 72.430000000000007 109.204 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.52 103.15 50.23 Favored Pre-proline 0 N--CA 1.494 1.766 0 N-CA-C 109.059 -0.719 . . . . 71.109999999999999 109.059 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.76 -24.95 5.65 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.795 1.663 . . . . 75.140000000000001 111.781 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -62.54 -55.8 23.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.471 -0.768 . . . . 72.5 109.863 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -94.68 12.54 27.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.29 -0.881 . . . . 73.140000000000001 109.31 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 49.61 57.91 6.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 75.329999999999998 109.18 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 26.0 ttpt -133.89 132.84 40.79 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.556 -0.715 . . . . 71.230000000000004 109.673 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.9 tt -109.74 137.17 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 109.138 -0.689 . . . . 75.329999999999998 109.138 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.412 HD11 HG22 ' A' ' 136' ' ' ILE . 70.5 mt -121.27 118.9 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.495 -0.753 . . . . 71.109999999999999 109.193 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.474 ' C ' ' H ' ' A' ' 139' ' ' GLY . 65.3 t80 -142.76 151.3 41.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.349 -0.844 . . . . 74.140000000000001 108.978 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 1.147 ' HZ3' ' CB ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER 61.37 5.75 1.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.942 -1.099 . . . . 75.400000000000006 108.239 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 137' ' ' TYR . . . 86.12 13.04 69.61 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.091 -1.603 . . . . 72.239999999999995 109.091 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -103.44 142.79 33.64 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.589 -0.948 . . . . 73.120000000000005 108.782 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -107.97 116.11 31.36 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.05 -1.031 . . . . 72.319999999999993 108.823 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.14 138.48 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.437 -0.789 . . . . 62.340000000000003 109.066 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -82.29 147.86 28.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.401 -0.812 . . . . 61.229999999999997 109.931 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.1 m -146.38 125.0 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.368 -0.833 . . . . 74.439999999999998 109.489 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -158.01 134.37 9.52 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.445 -0.784 . . . . 75.420000000000002 109.184 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.13 -162.93 36.72 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.066 -1.214 . . . . 73.340000000000003 110.066 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.627 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 49.9 mtmt -82.49 -30.61 0.51 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.443 -1.034 . . . . 72.219999999999999 111.626 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 90.1 Cg_endo -86.94 -25.02 1.22 Allowed 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 121.801 1.667 . . . . 75.450000000000003 112.562 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -89.15 -12.92 39.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.158 -0.964 . . . . 65.239999999999995 109.802 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -61.11 -38.27 85.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.1 -1.0 . . . . 72.519999999999996 109.422 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.34 -28.96 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 74.209999999999994 109.0 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.18 -44.45 97.28 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.94 -0.763 . . . . 73.310000000000002 108.94 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.9 p -74.09 -37.9 64.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.206 -0.934 . . . . 74.310000000000002 110.231 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -54.76 -55.13 33.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.934 -1.104 . . . . 75.450000000000003 109.82 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.402 ' CD1' ' N ' ' A' ' 156' ' ' ALA . 4.6 pp -66.92 -33.47 75.67 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.207 -0.933 . . . . 75.340000000000003 109.197 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.402 ' N ' ' CD1' ' A' ' 155' ' ' LEU . . . -51.16 -41.24 60.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.192 -0.943 . . . . 62.140000000000001 108.949 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.522 ' C ' ' H ' ' A' ' 159' ' ' ARG . 62.6 mtp180 -89.06 -48.95 7.06 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.143 -0.973 . . . . 72.219999999999999 108.922 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -73.09 35.03 0.08 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.389 -0.819 . . . . 74.120000000000005 109.611 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.522 ' H ' ' C ' ' A' ' 157' ' ' ARG . 27.9 ptt180 -72.16 171.1 12.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.34 -0.85 . . . . 74.340000000000003 109.347 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.6 t70 52.51 44.04 30.42 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.192 -0.942 . . . . 75.450000000000003 109.609 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -148.25 162.92 38.51 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.181 -0.949 . . . . 73.409999999999997 109.448 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.414 HD12 HG22 ' A' ' 162' ' ' ILE . 96.6 mt -93.37 119.34 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.218 -0.926 . . . . 74.409999999999997 108.649 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 10.8 t -99.89 122.39 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.251 -0.905 . . . . 72.530000000000001 109.675 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.55 ' HG ' ' H ' ' A' ' 167' ' ' GLN . 10.2 p -84.07 164.68 19.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 74.120000000000005 108.911 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -63.27 -43.75 97.06 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.178 -0.951 . . . . 70.430000000000007 109.39 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.432 ' O ' ' OD2' ' A' ' 170' ' ' ASP . 49.0 mt-10 -72.12 -29.24 63.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 74.319999999999993 110.16 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.55 ' H ' ' HG ' ' A' ' 164' ' ' SER . 53.7 tt0 -57.32 -57.14 13.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.961 . . . . 74.519999999999996 110.037 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.2 pp -67.81 -36.52 80.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.974 -1.079 . . . . 74.409999999999997 110.056 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.441 ' C ' ' CD1' ' A' ' 169' ' ' LEU . 3.1 tm? -55.18 -52.91 61.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.927 -1.108 . . . . 75.140000000000001 108.867 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' A' ' 166' ' ' GLU . 2.6 p30 -72.38 -28.61 63.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.207 -0.933 . . . . 65.030000000000001 110.111 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -53.77 -52.16 61.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.149 -0.969 . . . . 70.209999999999994 110.358 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 12.8 mm -91.53 -28.92 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.071 -1.018 . . . . 75.319999999999993 110.015 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 16.2 m-90 . . . . . 0 N--CA 1.498 1.957 0 O-C-N 121.409 -0.807 . . . . 73.140000000000001 109.432 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.989 ' ND2' ' OE1' ' A' ' 185' ' ' GLU . 53.2 t-20 . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 121.321 0.581 . . . . 73.129999999999995 110.274 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 96.2 t -123.66 -13.77 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.567 -0.901 . . . . 74.019999999999996 108.567 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 96.0 mt -61.99 -42.44 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.464 -0.772 . . . . 72.329999999999998 109.832 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.989 ' OE1' ' ND2' ' A' ' 182' ' ' ASN . 11.5 pt-20 -51.48 -37.87 51.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.896 -1.128 . . . . 74.400000000000006 109.121 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 36.0 t -73.11 -32.33 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.452 -0.78 . . . . 74.319999999999993 109.372 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -79.33 -56.86 4.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.22 -0.925 . . . . 73.230000000000004 110.457 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.401 ' CG2' ' N ' ' A' ' 189' ' ' ASN . 3.4 tp -55.59 -39.01 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.858 -1.151 . . . . 74.310000000000002 109.776 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.45 ' OD1' ' NE2' ' A' ' 193' ' ' GLN . 25.8 t-20 -67.68 -54.68 17.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.335 -0.853 . . . . 73.439999999999998 111.779 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -62.26 -31.72 72.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.835 -1.166 . . . . 71.420000000000002 111.412 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 47.1 pt -69.15 -38.14 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.201 -1.562 . . . . 72.439999999999998 109.937 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.64 -42.21 99.47 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 117.986 -1.486 . . . . 64.219999999999999 108.238 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.45 ' NE2' ' OD1' ' A' ' 189' ' ' ASN . 79.5 mt-30 -64.52 -34.26 77.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.552 -0.718 . . . . 74.319999999999993 110.167 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.489 ' O ' ' CG ' ' A' ' 198' ' ' PRO . 15.0 mtpp -75.19 -25.71 58.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.155 -0.966 . . . . 75.310000000000002 110.634 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 74.8 mtm -95.97 4.38 52.74 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.972 -1.08 . . . . 74.019999999999996 109.475 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -113.67 -12.88 12.76 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.579 -0.7 . . . . 74.019999999999996 110.636 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.577 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 20.5 tttt -98.28 -41.04 0.24 Allowed Pre-proline 0 N--CA 1.502 2.132 0 O-C-N 120.949 -1.094 . . . . 75.430000000000007 110.87 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 85.5 Cg_endo -93.3 -64.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.906 2.404 . . . . 72.319999999999993 112.999 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 45.8 mt -50.18 -35.86 28.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.1 -1.0 . . . . 74.540000000000006 109.353 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 87.17 -9.75 71.47 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.761 -1.336 . . . . 61.509999999999998 109.761 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 17.2 mt -132.9 127.57 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.482 -1.01 . . . . 74.25 109.533 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.8 t -78.67 133.1 37.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.316 -0.865 . . . . 72.0 109.199 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.6 p -118.62 34.0 5.4 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.515 -0.74 . . . . 74.439999999999998 110.503 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 6.4 m -143.27 139.39 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.976 -1.078 . . . . 71.129999999999995 110.002 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -126.01 133.44 51.76 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.109 -0.7 . . . . 73.510000000000005 109.109 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.56 133.52 34.14 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.082 -1.011 . . . . 73.519999999999996 108.962 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 10.4 p -128.54 137.23 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.52 -0.738 . . . . 72.150000000000006 109.179 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -92.79 60.37 3.4 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.205 -0.934 . . . . 72.400000000000006 109.369 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.16 -61.51 0.32 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.497 -0.927 . . . . 73.310000000000002 108.497 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -104.43 -65.39 1.03 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.592 -0.692 . . . . 71.540000000000006 109.278 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -171.75 -105.86 0.19 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.347 -1.501 . . . . 74.450000000000003 109.347 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.34 123.38 39.27 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.456 -1.026 . . . . 75.540000000000006 108.632 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -89.51 146.49 24.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.367 -0.833 . . . . 75.310000000000002 110.963 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -123.57 114.4 19.99 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.502 -0.925 . . . . 75.409999999999997 108.502 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 18.5 p -140.45 159.41 42.27 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.385 -0.822 . . . . 74.140000000000001 109.077 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -59.04 142.47 85.4 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.079 -1.013 . . . . 75.319999999999993 108.729 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 C--N 1.313 -1.304 0 C-N-CA 122.085 1.857 . . . . 73.109999999999999 112.065 179.678 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.413 -0.588 . . . . 75.239999999999995 109.413 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 51.4 ttt85 -139.98 155.07 47.29 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.351 -0.843 . . . . 73.519999999999996 109.279 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 83.4 t -113.23 122.13 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.59 0.709 . . . . 72.239999999999995 109.73 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 2.6 tp -91.71 117.64 29.94 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.367 -0.975 . . . . 73.340000000000003 108.367 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 tt -118.95 120.15 36.42 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.437 -0.949 . . . . 74.349999999999994 108.437 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 19.0 mt -115.78 99.53 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.438 -0.789 . . . . 63.439999999999998 109.195 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.425 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 30.1 tp10 -125.17 139.64 53.57 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.578 -0.701 . . . . 74.519999999999996 109.295 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.485 ' HZ2' ' CG ' ' B' ' 52' ' ' ASP . 39.2 mmtm -70.39 -34.29 72.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.922 . . . . 74.129999999999995 109.374 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -90.72 118.89 30.5 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.284 -0.885 . . . . 74.230000000000004 109.576 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 18.9 t -70.37 -32.06 69.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.927 . . . . 65.540000000000006 109.56 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 82.7 t -64.27 -53.25 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.917 . . . . 75.549999999999997 109.734 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.21 -37.63 88.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.909 . . . . 70.140000000000001 109.003 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.05 -26.72 73.94 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.487 -1.845 . . . . 75.400000000000006 108.487 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.96 -54.2 32.25 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 109.623 -1.391 . . . . 65.439999999999998 109.623 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -58.3 -44.2 88.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.333 -1.098 . . . . 72.200000000000003 109.677 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 39.3 mm -64.33 -43.81 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.917 -1.114 . . . . 75.150000000000006 108.725 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -61.3 -43.53 98.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.411 -0.806 . . . . 73.010000000000005 109.816 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -87.06 2.45 49.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.098 -1.001 . . . . 74.299999999999997 109.444 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.73 -53.27 2.61 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.433 -1.467 . . . . 70.540000000000006 109.433 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -76.13 -20.09 57.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.314 -1.109 . . . . 75.430000000000007 109.704 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -58.59 -30.59 67.31 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.06 -1.025 . . . . 73.200000000000003 109.256 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 82.9 t -60.29 -34.66 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.355 -0.84 . . . . 74.230000000000004 109.114 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -68.55 -4.69 16.12 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.336 -0.852 . . . . 73.519999999999996 109.067 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.82 39.97 7.34 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.092 -1.203 . . . . 53.43 110.092 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -119.84 159.34 24.78 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.536 -0.979 . . . . 71.120000000000005 109.321 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 7.1 mmt -105.19 133.37 50.08 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.242 -1.022 . . . . 75.239999999999995 108.242 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.07 162.46 36.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.173 -0.954 . . . . 73.25 110.239 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -141.22 145.65 35.87 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.459 -0.776 . . . . 72.310000000000002 108.952 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -106.72 137.64 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.309 -0.869 . . . . 72.140000000000001 108.79 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 11.3 p -136.41 167.79 20.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.366 -0.834 . . . . 74.530000000000001 109.289 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.477 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 2.2 pt-20 -90.22 -100.05 0.1 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.153 -0.967 . . . . 71.019999999999996 109.898 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 32.8 t -78.96 166.21 22.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.958 . . . . 71.400000000000006 110.236 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 44.1 mt -53.91 -32.97 55.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.633 -0.667 . . . . 71.239999999999995 109.829 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -50.43 -48.31 56.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.121 -0.987 . . . . 74.319999999999993 109.695 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.477 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 65.9 m-20 -69.28 -41.33 76.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.169 -0.957 . . . . 73.030000000000001 109.501 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.18 -40.7 87.8 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.464 -1.454 . . . . 60.43 109.464 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -68.6 -42.69 77.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -1.151 . . . . 74.430000000000007 109.543 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . 0.448 ' O ' ' OD1' ' B' ' 41' ' ' ASP . 56.4 t80 -75.17 -21.9 58.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 74.420000000000002 110.053 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 28.5 tp -90.01 -39.16 13.13 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.14 -0.975 . . . . 75.409999999999997 110.044 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' B' ' 40' ' ' MET . 0.0 OUTLIER -78.13 -27.69 48.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.996 . . . . 61.439999999999998 110.528 -179.102 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' B' ' 42' ' ' ILE . 41.9 p-10 -68.02 -27.51 66.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.901 -1.124 . . . . 74.319999999999993 110.225 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.533 ' N ' ' OD1' ' B' ' 41' ' ' ASP . 13.8 pt -88.8 -15.47 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.004 -1.06 . . . . 71.230000000000004 110.419 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' B' ' 40' ' ' MET . 97.2 mtt180 -129.48 149.92 51.05 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.239 -0.913 . . . . 73.409999999999997 109.77 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -82.85 163.18 21.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.202 -0.937 . . . . 63.539999999999999 109.458 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 10.4 p90 -159.3 -179.04 7.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.92 . . . . 73.109999999999999 109.706 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -138.97 -32.85 0.66 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.475 -0.766 . . . . 62.219999999999999 109.428 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.08 115.1 29.59 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.357 -0.839 . . . . 73.120000000000005 109.004 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 56.0 t -102.55 98.01 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.51 -0.922 . . . . 74.109999999999999 108.51 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -117.06 129.07 55.76 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.776 0.798 . . . . 73.439999999999998 110.141 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.506 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.2 OUTLIER -141.65 135.68 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.78 0.8 . . . . 73.400000000000006 109.179 -179.622 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' SER . . . . . 0.425 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 53.2 p -99.3 18.29 17.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.599 -0.688 . . . . 73.209999999999994 109.599 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.506 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 37.6 m-20 -86.09 144.16 27.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.185 -0.947 . . . . 70.409999999999997 109.534 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.475 ' C ' ' H ' ' B' ' 55' ' ' ALA . 99.1 mttt -76.52 -42.6 42.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.276 -0.89 . . . . 73.129999999999995 110.201 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -71.01 10.72 0.5 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.108 -0.995 . . . . 75.209999999999994 109.727 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.475 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -67.13 -22.22 65.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 55.329999999999998 110.106 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 19.0 mt -44.68 -44.93 9.47 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.268 -0.895 . . . . 72.420000000000002 110.142 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' SER . . . . . 0.433 ' O ' ' OG ' ' B' ' 60' ' ' SER . 93.1 p -69.39 -37.96 77.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.991 -1.068 . . . . 73.040000000000006 109.284 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -65.07 -62.28 1.65 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.279 -0.888 . . . . 72.329999999999998 109.656 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 33.3 m -49.55 -33.64 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.555 -1.341 . . . . 74.540000000000006 109.661 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' B' ' 57' ' ' SER . 10.9 p -57.6 -51.26 70.23 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.202 -0.936 . . . . 71.239999999999995 109.472 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -70.05 -31.24 68.77 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.177 -1.009 . . . . 74.310000000000002 110.176 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.462 ' O ' ' N ' ' B' ' 66' ' ' HIS . 40.0 mm -66.68 -44.97 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.683 -1.261 . . . . 75.420000000000002 110.285 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -65.09 -44.94 87.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.195 -0.941 . . . . 73.319999999999993 110.818 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -73.86 -38.0 64.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.743 -1.223 . . . . 73.310000000000002 110.036 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.486 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 64.2 mttm -84.71 -17.04 39.69 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.099 -1.0 . . . . 72.439999999999998 109.711 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . 0.486 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 76.9 m-70 -155.63 68.72 0.66 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.053 -1.03 . . . . 65.209999999999994 109.618 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 85.6 p -67.6 -27.55 67.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.312 -0.867 . . . . 73.099999999999994 109.898 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 12.5 t -63.1 -19.22 64.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.148 -0.97 . . . . 71.530000000000001 110.069 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 63.1 mt -88.25 151.94 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.182 -0.949 . . . . 74.400000000000006 109.784 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 94.3 t -90.96 157.62 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.41 -0.806 . . . . 75.120000000000005 109.277 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 11.0 t -135.7 126.79 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.218 -0.926 . . . . 73.200000000000003 109.864 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . 0.402 ' C ' ' CD2' ' B' ' 72' ' ' LEU . 4.2 tt -116.88 105.32 12.23 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.787 -0.82 . . . . 73.340000000000003 108.787 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 71.1 t -98.06 131.23 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.033 -1.042 . . . . 73.5 109.541 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.9 p -95.23 169.26 10.21 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.239 -0.913 . . . . 71.319999999999993 109.137 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.474 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 36.2 t -157.19 117.02 3.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.007 -1.058 . . . . 74.530000000000001 110.292 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' B' ' 77' ' ' ASN . 52.8 p30 -71.28 -10.5 59.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.409 -0.807 . . . . 64.5 109.292 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' B' ' 79' ' ' THR . 84.5 m-20 -132.9 77.06 69.39 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 108.47 -0.937 . . . . 74.25 108.47 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -55.59 73.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.561 2.174 . . . . 74.430000000000007 111.894 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.516 ' N ' ' O ' ' B' ' 77' ' ' ASN . 6.9 t -97.43 150.73 20.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.257 -0.902 . . . . 73.120000000000005 109.308 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -26.37 68.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.523 -0.736 . . . . 75.409999999999997 110.225 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . 0.439 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 2.5 mp0 -64.27 -39.97 95.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.978 -1.076 . . . . 72.239999999999995 109.823 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' B' ' 82' ' ' GLU . 0.1 OUTLIER -78.51 -29.11 46.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.086 -1.009 . . . . 73.219999999999999 109.627 -179.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.522 ' OE2' ' NE ' ' A' ' 100' ' ' ARG . 87.1 mt-10 -64.94 -48.29 74.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.034 -1.041 . . . . 74.299999999999997 109.659 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 27.0 m -67.77 -42.65 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 73.310000000000002 109.485 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' HIS . . . . . 0.439 ' ND1' ' O ' ' B' ' 81' ' ' GLU . 42.4 m80 -69.2 -25.9 64.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.167 -0.958 . . . . 73.239999999999995 109.533 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.55 -45.57 71.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 55.329999999999998 109.846 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -79.35 -28.07 42.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.057 -1.027 . . . . 74.450000000000003 109.044 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 31.0 tp10 -75.98 -51.67 11.88 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.335 -0.853 . . . . 64.040000000000006 109.563 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -61.87 -50.42 72.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.414 -0.804 . . . . 75.129999999999995 109.745 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 151.75 72.81 0.01 OUTLIER Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.749 -1.215 . . . . 75.420000000000002 110.308 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -134.43 136.43 43.25 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.288 -1.125 . . . . 73.420000000000002 108.843 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -89.21 -23.15 22.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.09 -1.006 . . . . 73.319999999999993 109.56 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 11.2 t0 -152.03 163.57 39.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.277 -0.889 . . . . 73.040000000000006 109.358 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.518 ' N ' ' OD1' ' B' ' 93' ' ' ASP . 76.7 t80 -146.64 99.28 3.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.382 -0.823 . . . . 74.310000000000002 109.252 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 20.8 mm -106.37 151.01 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.388 0 O-C-N 121.227 -0.921 . . . . 75.340000000000003 109.961 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.15 139.28 57.47 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.991 -1.114 . . . . 70.099999999999994 107.991 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.656 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -58.38 -55.13 48.86 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 120.744 -1.222 . . . . 65.430000000000007 111.146 -179.067 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 3.5 Cg_endo -41.75 -12.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.188 0 CA-C-N 119.619 0.9 . . . . 63.520000000000003 112.383 -176.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . 0.656 ' N ' ' O ' ' B' ' 97' ' ' LYS . 51.0 m-85 57.87 104.33 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.865 -0.522 . . . . 75.129999999999995 110.256 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -55.52 -39.22 70.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.829 -1.169 . . . . 74.230000000000004 108.042 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 10.6 t -170.32 131.96 0.99 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.919 -0.771 . . . . 64.510000000000005 108.919 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 4.1 mm -51.71 -41.61 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.951 . . . . 74.439999999999998 109.1 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -60.37 -36.34 77.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.228 -0.92 . . . . 72.299999999999997 109.264 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.41 -48.53 64.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 74.310000000000002 109.557 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 60.0 tp -60.96 -48.93 79.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 73.540000000000006 109.433 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.73 -43.83 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.167 -0.958 . . . . 72.030000000000001 110.028 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.27 -43.32 64.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.06 -1.025 . . . . 64.219999999999999 109.211 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -68.35 -33.77 74.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.337 -0.852 . . . . 75.310000000000002 109.606 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 95.3 mt -72.35 -34.51 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.054 -1.029 . . . . 55.439999999999998 108.571 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' B' ' 114' ' ' ARG . 80.6 tt0 -58.55 -56.82 17.17 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.575 -0.85 . . . . 65.310000000000002 108.987 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.85 -40.34 69.54 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.477 -0.764 . . . . 74.519999999999996 110.157 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -38.28 63.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.995 -1.066 . . . . 72.040000000000006 108.896 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.86 54.22 1.05 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.987 -1.071 . . . . 75.349999999999994 109.942 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' B' ' 110' ' ' GLU . 4.9 tmt_? -72.06 -43.68 64.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.129 -0.982 . . . . 75.5 108.987 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' PHE . . . . . 0.488 ' O ' ' N ' ' B' ' 117' ' ' GLY . 96.2 m-85 -67.75 -0.84 4.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.332 -0.855 . . . . 73.040000000000006 109.502 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 66.01 -55.5 0.37 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.561 -0.712 . . . . 74.450000000000003 110.158 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . 0.492 ' C ' ' HG ' ' B' ' 118' ' ' SER . . . -154.42 171.83 32.93 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.897 -1.281 . . . . 64.209999999999994 109.897 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' SER . . . . . 0.492 ' HG ' ' C ' ' B' ' 117' ' ' GLY . 41.1 m -156.58 -175.51 5.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.38 -1.071 . . . . 71.400000000000006 109.662 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.15 122.95 5.73 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.822 -0.751 . . . . 74.209999999999994 109.112 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 9.9 t -85.15 -42.88 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.214 -0.929 . . . . 75.019999999999996 110.119 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . 0.407 HD13 HG23 ' B' ' 121' ' ' ILE . 15.7 mm -97.11 132.66 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.07 -1.019 . . . . 74.239999999999995 109.819 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -114.0 121.46 43.96 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.987 -0.745 . . . . 73.329999999999998 108.987 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.534 ' CD1' HH12 ' B' ' 159' ' ' ARG . 73.4 mt -132.47 121.39 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.355 -0.841 . . . . 74.219999999999999 109.478 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' B' ' 123' ' ' ILE . . . 40.29 -122.61 2.01 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 110.518 -1.033 . . . . 72.409999999999997 110.518 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -97.1 -13.6 22.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.349 -1.089 . . . . 75.120000000000005 109.698 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' B' ' 123' ' ' ILE . 0.1 OUTLIER -95.45 143.41 26.81 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.127 -0.983 . . . . 75.420000000000002 109.406 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 20.3 p -121.27 145.79 47.49 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.101 -0.703 . . . . 74.219999999999999 109.101 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 78.0 mt -125.49 138.87 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.501 -0.749 . . . . 60.329999999999998 109.891 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 5.8 t -118.58 114.66 35.92 Favored Pre-proline 0 N--CA 1.499 1.997 0 N-CA-C 108.723 -0.843 . . . . 72.310000000000002 108.723 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.92 -53.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.651 1.567 . . . . 75.129999999999995 112.162 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -61.52 -40.82 96.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.163 -0.96 . . . . 75.230000000000004 109.459 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' B' ' 133' ' ' GLU . 23.7 tp10 -87.39 7.96 26.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.216 -0.928 . . . . 75.120000000000005 109.359 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' B' ' 132' ' ' GLU . 17.9 pt-20 34.33 54.06 0.6 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.252 0.549 . . . . 75.129999999999995 111.142 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -139.05 146.4 40.74 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.284 -0.885 . . . . 75.109999999999999 109.177 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 14.3 tt -126.11 142.39 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.543 -0.723 . . . . 70.319999999999993 109.1 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 7.2 mt -120.63 136.04 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.611 -0.681 . . . . 74.120000000000005 109.63 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . 0.414 ' C ' ' H ' ' B' ' 139' ' ' GLY . 48.4 t80 -138.4 134.69 34.44 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.42 -0.955 . . . . 74.230000000000004 108.42 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . 0.443 ' CG ' ' O ' ' B' ' 138' ' ' LYS . 12.4 ttmt 56.41 9.34 0.52 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.465 -0.772 . . . . 74.219999999999999 109.361 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' B' ' 137' ' ' TYR . . . 96.7 3.62 59.44 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 110.225 -1.15 . . . . 74.319999999999993 110.225 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -89.5 126.39 35.57 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.114 -1.227 . . . . 75.340000000000003 108.803 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -91.85 120.32 32.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.248 -0.907 . . . . 71.230000000000004 109.683 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 7.9 p -134.69 140.95 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 108.777 -0.823 . . . . 70.430000000000007 108.777 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -94.01 157.84 15.91 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.188 -0.945 . . . . 72.430000000000007 110.241 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -150.28 139.05 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.455 -0.778 . . . . 72.129999999999995 108.934 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 26.3 pttt -165.89 77.94 0.26 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.184 -0.948 . . . . 74.5 109.543 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -156.99 -129.83 1.17 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.085 -1.606 . . . . 42.229999999999997 109.085 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . 0.632 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 73.2 mttt -80.32 -32.4 0.69 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.108 -1.231 . . . . 73.299999999999997 110.764 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . 0.632 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 71.5 Cg_endo -91.12 15.45 1.76 Allowed 'Trans proline' 0 N--CA 1.486 1.082 0 C-N-CA 122.203 1.935 . . . . 71.329999999999998 112.446 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -98.79 -59.13 1.79 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.238 -0.914 . . . . 74.230000000000004 109.345 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . 0.475 ' CG ' ' N ' ' B' ' 151' ' ' VAL . 18.6 pt-20 -61.09 -48.79 80.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.327 -0.858 . . . . 72.340000000000003 110.47 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . 0.475 ' N ' ' CG ' ' B' ' 150' ' ' GLU . 9.8 p -64.84 -43.39 96.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.811 -1.181 . . . . 73.349999999999994 110.449 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . 0.415 ' N ' ' CG1' ' B' ' 151' ' ' VAL . 12.9 tp -63.74 -53.62 48.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.14 -0.975 . . . . 74.430000000000007 110.518 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 16.5 p -72.23 -37.56 69.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.799 -1.188 . . . . 75.209999999999994 110.626 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -52.01 -53.49 41.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.76 -1.212 . . . . 73.040000000000006 109.706 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' B' ' 159' ' ' ARG . 2.7 pp -71.51 -23.09 61.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.93 -1.106 . . . . 73.430000000000007 109.865 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.66 -59.25 4.48 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.816 -1.177 . . . . 75.319999999999993 110.881 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -66.03 -47.73 73.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.601 -1.312 . . . . 73.319999999999993 108.84 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 158' ' ' HIS . . . . . 0.603 ' C ' ' H ' ' B' ' 160' ' ' ASP . 44.5 t-80 -67.51 -19.17 65.28 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.718 -1.216 . . . . 74.140000000000001 107.718 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . 0.723 ' O ' ' N ' ' B' ' 161' ' ' GLN . 7.2 tpt180 57.79 4.49 0.27 Allowed 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 107.287 -1.375 . . . . 73.420000000000002 107.287 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . 0.603 ' H ' ' C ' ' B' ' 158' ' ' HIS . 2.3 m-20 50.36 -40.22 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 123.228 0.611 . . . . 72.099999999999994 112.22 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . 0.723 ' N ' ' O ' ' B' ' 159' ' ' ARG . 24.1 mt-30 50.48 -142.63 0.65 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.215 -1.553 . . . . 73.239999999999995 109.138 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 162' ' ' ILE . . . . . 0.523 ' CD1' ' N ' ' B' ' 162' ' ' ILE . 1.9 mp -77.53 106.91 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.95 -1.094 . . . . 72.310000000000002 108.724 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 1.3 m -135.67 144.73 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.48 -0.763 . . . . 75.030000000000001 109.166 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 41.7 p -96.66 169.76 9.66 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.327 -0.858 . . . . 74.219999999999999 109.506 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -55.57 -39.68 70.98 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.297 -0.877 . . . . 72.420000000000002 109.168 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -62.74 -39.1 93.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.867 . . . . 63.450000000000003 109.313 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -60.13 -45.92 91.38 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.137 -0.977 . . . . 72.400000000000006 109.116 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 22.6 mt -61.94 -29.59 70.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.215 -0.928 . . . . 72.319999999999993 108.576 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 5.6 tt -66.81 -64.86 0.77 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.467 -0.771 . . . . 73.340000000000003 109.303 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -61.36 -17.44 53.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.878 . . . . 73.099999999999994 109.713 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.72 -61.0 2.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.292 -0.88 . . . . 62.130000000000003 110.123 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 8.2 mm -90.91 -54.33 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.128 -0.983 . . . . 74.439999999999998 109.401 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.311 -0.868 . . . . 72.230000000000004 109.166 179.901 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo . . . . . 0 N--CA 1.501 1.918 0 CA-C-O 121.422 0.509 . . . . 74.340000000000003 112.674 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -174.86 -23.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.198 -0.939 . . . . 72.310000000000002 108.889 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 11.6 p -53.43 -14.47 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.397 -0.815 . . . . 65.420000000000002 109.401 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 20.9 mm -54.3 -25.74 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -0.879 . . . . 75.030000000000001 109.681 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -55.84 -45.4 78.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -0.952 . . . . 73.519999999999996 109.928 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 9.6 m -80.72 -30.39 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.131 -0.981 . . . . 74.349999999999994 110.105 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.97 76.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.95 -1.094 . . . . 61.119999999999997 109.938 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 10.4 tp -74.89 -38.9 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.554 -1.342 . . . . 72.430000000000007 109.83 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -70.5 -35.99 73.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.878 . . . . 75.420000000000002 111.282 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 190' ' ' GLN . . . . . 0.458 ' CG ' ' N ' ' B' ' 191' ' ' ILE . 10.6 pt20 -76.67 -47.12 23.11 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.859 -1.151 . . . . 74.140000000000001 111.449 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . 0.458 ' N ' ' CG ' ' B' ' 190' ' ' GLN . 5.8 pt -65.0 -40.35 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.693 -1.255 . . . . 74.030000000000001 110.699 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -69.81 -42.97 72.98 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.026 -1.046 . . . . 72.329999999999998 111.005 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -74.21 -35.4 63.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.937 -1.102 . . . . 73.099999999999994 111.279 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 8.6 pttp -79.57 -24.35 42.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.82 -1.175 . . . . 74.430000000000007 110.54 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 195' ' ' MET . . . . . 0.483 ' SD ' ' OD1' ' B' ' 196' ' ' ASP . 3.5 ppp? -93.01 -38.2 11.78 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.0 -1.063 . . . . 74.329999999999998 110.519 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 196' ' ' ASP . . . . . 0.483 ' OD1' ' SD ' ' B' ' 195' ' ' MET . 85.3 m-20 -59.22 -38.23 79.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.035 -1.041 . . . . 71.209999999999994 110.646 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -63.28 -60.19 10.16 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.962 -1.086 . . . . 75.209999999999994 110.381 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 198' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.56 -59.58 0.24 Allowed 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 121.694 1.596 . . . . 75.319999999999993 112.402 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 10.6 mp -56.04 -42.45 76.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.994 -1.066 . . . . 72.25 109.203 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 82.34 -30.25 3.08 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.004 -1.239 . . . . 73.239999999999995 110.004 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . 0.415 HG22 HD11 ' B' ' 201' ' ' ILE . 24.9 mm -91.44 129.11 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.025 -1.279 . . . . 54.299999999999997 109.435 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 42.0 t -88.13 139.76 30.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.83 . . . . 74.310000000000002 108.992 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 25.2 p -139.59 25.62 2.38 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.31 -0.869 . . . . 74.400000000000006 109.304 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 23.1 m -143.86 145.86 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.245 -0.909 . . . . 74.099999999999994 109.873 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -114.35 137.65 51.54 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.72 -0.613 . . . . 75.329999999999998 109.576 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.58 111.43 23.8 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.289 -0.882 . . . . 71.400000000000006 108.969 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.7 t -138.36 142.38 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.286 -0.884 . . . . 63.5 109.498 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 208' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' B' ' 209' ' ' ARG . 32.7 ptt-85 -85.26 -24.65 27.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.216 -0.927 . . . . 74.450000000000003 109.642 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 209' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' B' ' 208' ' ' ARG . 96.0 mtt180 -57.5 -110.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.322 -0.861 . . . . 74.140000000000001 109.968 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 39.4 mmt-85 -51.12 -45.21 61.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.111 -0.993 . . . . 74.430000000000007 109.59 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 147.79 -130.83 3.64 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.35 -1.5 . . . . 70.109999999999999 109.35 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -104.59 131.24 52.24 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.365 -1.079 . . . . 74.209999999999994 108.779 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -105.01 146.52 28.94 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.437 -0.79 . . . . 74.299999999999997 109.902 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -128.39 104.12 7.53 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.408 -0.96 . . . . 74.340000000000003 108.408 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' B' ' 216' ' ' TYR . 50.8 t -127.66 169.01 14.26 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.2 -0.937 . . . . 72.209999999999994 110.49 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . 0.528 ' N ' ' SG ' ' B' ' 215' ' ' CYS . 47.6 m-85 -63.63 152.14 86.75 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.586 -0.696 . . . . 72.310000000000002 109.173 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.92 -162.08 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.212 1.941 . . . . 71.010000000000005 111.725 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 42.4 mttp . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.222 -0.924 . . . . 74.349999999999994 109.018 179.746 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.2 ttm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.435 -0.579 . . . . 65.120000000000005 109.435 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.437 ' N ' ' OD2' ' A' ' 46' ' ' ASP . 61.2 ttm-85 -143.08 150.75 39.94 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.263 -0.898 . . . . 73.310000000000002 109.322 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 81.4 t -120.25 134.82 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-O 121.5 0.667 . . . . 71.420000000000002 110.091 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.401 ' O ' ' O ' ' A' ' 49' ' ' MET . 8.9 tp -100.25 115.97 31.14 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.645 -0.872 . . . . 65.219999999999999 108.645 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 25.2 tp -117.39 99.55 7.08 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.582 -0.699 . . . . 71.439999999999998 109.756 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.485 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 7.8 mt -94.35 119.36 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.753 -1.217 . . . . 71.150000000000006 108.953 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -149.26 121.9 8.61 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.199 -0.938 . . . . 75.340000000000003 109.603 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -65.84 -32.97 74.79 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.265 -0.897 . . . . 73.040000000000006 108.996 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -87.27 107.34 18.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.355 -0.841 . . . . 72.420000000000002 109.363 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.2 t -65.99 -18.37 65.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 72.340000000000003 109.671 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.45 -55.82 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.16 -0.963 . . . . 74.420000000000002 109.904 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' A' ' 12' ' ' LEU . 3.5 mm? -69.39 -38.86 78.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.255 -0.903 . . . . 72.010000000000005 109.557 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.13 -28.67 63.84 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.693 -1.763 . . . . 72.140000000000001 108.693 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.28 -45.51 95.01 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.515 -1.434 . . . . 72.329999999999998 109.515 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -67.46 -45.91 74.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -1.129 . . . . 72.340000000000003 109.905 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.408 HD13 HG22 ' A' ' 16' ' ' ILE . 98.6 mt -64.0 -42.03 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.623 -1.298 . . . . 74.239999999999995 108.641 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -54.01 -50.81 65.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.901 . . . . 71.409999999999997 109.521 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -85.11 1.98 45.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.123 -0.986 . . . . 75.540000000000006 109.076 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.97 -60.73 2.01 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 109.737 -1.345 . . . . 62.149999999999999 109.737 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -69.46 -22.9 63.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.203 -1.175 . . . . 74.420000000000002 109.796 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -59.05 -32.89 70.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.04 -1.037 . . . . 74.25 109.339 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.4 t -58.71 -34.04 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.445 -0.785 . . . . 72.109999999999999 109.374 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.521 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 2.4 mptp? -68.39 -1.21 5.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 73.230000000000004 109.315 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.37 35.09 11.04 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.74 -1.344 . . . . 75.540000000000006 109.74 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -115.78 159.62 21.2 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.488 -1.007 . . . . 74.510000000000005 109.143 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.7 mmt -104.09 138.13 41.05 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.45 -0.945 . . . . 64.319999999999993 108.45 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.75 164.2 31.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.913 . . . . 74.310000000000002 109.771 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -139.08 149.88 45.08 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.434 -0.791 . . . . 75.400000000000006 108.977 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.48 129.0 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.705 -0.85 . . . . 75.129999999999995 108.705 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.3 p -133.1 167.93 19.44 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.452 -0.78 . . . . 71.420000000000002 109.752 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.485 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 3.0 pt-20 -98.6 -96.14 0.23 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.398 -0.814 . . . . 73.109999999999999 109.747 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.5 p -79.96 164.25 23.64 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.015 -1.053 . . . . 74.239999999999995 110.007 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 37' ' ' GLU . 21.8 mt -54.77 -38.95 67.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.513 -0.742 . . . . 71.530000000000001 109.819 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -52.57 -44.21 65.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 74.230000000000004 109.814 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -65.3 -42.47 93.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.107 -0.996 . . . . 71.010000000000005 109.665 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.03 -30.6 50.81 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.062 -1.215 . . . . 61.409999999999997 110.062 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 33' ' ' LEU . 78.2 tt0 -66.74 -46.45 75.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.126 -1.22 . . . . 74.340000000000003 110.099 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.442 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 48.2 m-85 -78.92 -24.11 44.27 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.092 -1.005 . . . . 75.329999999999998 109.959 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.8 tp -85.49 -29.23 24.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.005 -1.06 . . . . 74.329999999999998 109.81 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.562 ' SD ' ' CE1' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -86.82 -36.81 18.29 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.069 -1.02 . . . . 70.319999999999993 110.633 -179.164 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 30.5 p-10 -58.73 -30.77 67.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.935 -1.103 . . . . 71.219999999999999 110.238 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.531 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 10.1 pt -78.17 -31.64 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.071 -1.018 . . . . 74.409999999999997 110.104 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 40' ' ' MET . 79.9 mtt85 -108.44 171.82 7.19 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.341 -0.849 . . . . 75.409999999999997 109.682 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.514 ' ND2' ' H ' ' A' ' 45' ' ' TYR . 1.8 t-20 -86.93 148.73 25.22 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.203 -0.936 . . . . 75.420000000000002 109.184 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.565 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 0.5 OUTLIER -139.0 128.65 24.63 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.282 -0.886 . . . . 74.230000000000004 109.509 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.446 ' OD1' ' CD2' ' A' ' 113' ' ' LEU . 3.7 p30 -108.08 -41.99 4.78 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.844 -0.798 . . . . 75.319999999999993 108.844 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.8 112.84 25.97 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.074 -1.084 . . . . 72.129999999999995 108.074 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.24 96.86 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.445 -0.946 . . . . 72.340000000000003 108.445 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.405 ' C ' ' SD ' ' A' ' 49' ' ' MET . 0.8 OUTLIER -116.47 123.87 48.55 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.685 0.755 . . . . 74.109999999999999 109.857 -179.477 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.484 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 1.1 p -131.21 131.93 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 121.632 0.729 . . . . 71.239999999999995 109.41 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.2 p -91.38 3.5 54.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.522 -0.736 . . . . 73.109999999999999 109.303 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 1.6 m-20 -78.99 138.34 38.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.269 -0.894 . . . . 63.399999999999999 109.6 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.529 ' C ' ' H ' ' A' ' 55' ' ' ALA . 14.9 mmmt -76.83 -36.18 57.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.214 -0.929 . . . . 65.439999999999998 110.11 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -70.54 12.38 0.26 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.081 -1.012 . . . . 73.129999999999995 109.537 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.529 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -69.25 -20.9 63.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.412 -0.805 . . . . 64.140000000000001 110.399 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 55' ' ' ALA . 20.3 mt -40.0 -50.46 2.55 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.468 -0.77 . . . . 74.430000000000007 110.395 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.7 t -69.08 -33.56 73.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.033 -1.042 . . . . 63.229999999999997 108.957 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.466 ' N ' ' O ' ' A' ' 55' ' ' ALA . 50.9 t80 -66.91 -59.32 3.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.468 -0.77 . . . . 74.439999999999998 109.938 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.1 m -52.22 -34.14 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.715 -1.24 . . . . 74.030000000000001 109.492 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.5 m -58.49 -54.02 51.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.2 -0.938 . . . . 73.540000000000006 109.715 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -66.85 -27.86 67.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.111 -0.993 . . . . 73.340000000000003 109.978 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.6 mm -67.05 -45.73 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.901 -1.124 . . . . 73.349999999999994 110.185 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 67' ' ' SER . 53.7 mmtt -65.16 -46.44 80.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 74.420000000000002 110.645 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 6.6 pt-20 -70.35 -41.83 72.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.716 -1.24 . . . . 74.549999999999997 109.953 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.491 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 25.9 mtpp -76.29 -19.12 58.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.143 -0.973 . . . . 75.219999999999999 109.313 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.491 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 83.2 m-70 -156.29 68.1 0.6 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.888 . . . . 74.129999999999995 109.282 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 63' ' ' LYS . 82.5 p -65.49 -15.87 63.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 73.239999999999995 109.914 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 92.8 p -88.32 43.82 1.16 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.191 -0.943 . . . . 71.439999999999998 110.329 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.9 tt -145.11 169.13 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.989 -1.069 . . . . 71.329999999999998 109.582 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.1 t -102.1 148.66 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.263 -0.898 . . . . 73.019999999999996 109.424 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.5 t -131.5 126.49 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.376 -0.828 . . . . 54.210000000000001 109.76 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.8 tt -120.11 100.97 7.51 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.111 -0.7 . . . . 74.209999999999994 109.111 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.7 p -97.09 131.32 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.982 -1.074 . . . . 74.409999999999997 109.153 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 75' ' ' SER . 4.5 p -92.86 174.98 6.97 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.086 -1.009 . . . . 72.310000000000002 109.378 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.531 ' OG ' ' CE2' ' A' ' 94' ' ' TYR . 50.9 m -164.49 116.09 1.26 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.083 -1.01 . . . . 64.540000000000006 110.371 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.8 -28.56 68.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.525 -0.734 . . . . 74.129999999999995 109.306 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.516 ' OD1' ' NZ ' ' A' ' 53' ' ' LYS . 13.0 p30 -109.6 71.13 0.52 Allowed Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.657 -0.652 . . . . 73.340000000000003 109.41 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.01 80.45 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.654 1.569 . . . . 71.319999999999993 111.769 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 77' ' ' ASN . 1.8 t -104.72 162.49 13.25 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.656 -0.868 . . . . 62.530000000000001 108.656 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.8 p -71.36 -29.11 64.59 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.166 -0.959 . . . . 74.140000000000001 109.864 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -62.77 -45.57 92.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 71.420000000000002 109.475 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -76.49 -29.72 56.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.281 -0.887 . . . . 73.430000000000007 109.639 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -63.73 -57.01 11.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.954 . . . . 74.219999999999999 109.611 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.2 m -60.34 -42.18 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.14 -0.975 . . . . 74.150000000000006 108.987 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.504 ' CE1' HE21 ' A' ' 89' ' ' GLN . 82.4 t60 -62.95 -35.44 80.12 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.298 -0.876 . . . . 72.540000000000006 109.219 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.82 -37.38 84.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.416 -0.803 . . . . 64.219999999999999 109.861 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -77.08 -29.91 55.19 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.047 -1.033 . . . . 74.340000000000003 108.818 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.34 -36.3 68.79 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.714 -0.794 . . . . 74.420000000000002 109.229 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.504 HE21 ' CE1' ' A' ' 85' ' ' HIS . 90.2 mm-40 -66.58 -51.29 58.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.364 -0.835 . . . . 74.519999999999996 109.478 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.85 44.3 0.06 OUTLIER Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.742 -1.343 . . . . 74.209999999999994 109.742 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -99.72 135.88 40.47 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.21 -1.171 . . . . 64.099999999999994 109.416 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.524 ' OD2' ' NH1' ' A' ' 112' ' ' ARG . 45.9 t0 -82.38 -25.05 34.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 73.420000000000002 109.314 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.528 ' OD2' ' NH2' ' A' ' 112' ' ' ARG . 72.0 m-20 -149.75 155.76 40.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.349 -0.845 . . . . 75.040000000000006 109.249 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.531 ' CE2' ' OG ' ' A' ' 75' ' ' SER . 55.3 t80 -137.4 103.38 5.06 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.735 -0.839 . . . . 71.329999999999998 108.735 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.511 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -107.6 151.94 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.651 0.738 . . . . 74.510000000000005 110.001 -177.508 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.36 130.27 39.35 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.693 -1.225 . . . . 64.319999999999993 107.693 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.697 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -49.89 -55.67 22.34 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 120.988 -1.07 . . . . 74.510000000000005 111.835 -178.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 2.2 Cg_endo -40.21 -11.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 120.895 1.063 . . . . 73.109999999999999 113.101 -176.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.697 ' N ' ' O ' ' A' ' 97' ' ' LYS . 56.5 m-85 59.08 121.07 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.644 -0.66 . . . . 72.540000000000006 110.189 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.547 ' HE ' ' CB ' ' B' ' 80' ' ' SER . 0.0 OUTLIER -56.71 -46.63 81.15 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.047 -1.094 . . . . 74.540000000000006 108.047 179.077 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.764 ' O ' ' N ' ' A' ' 103' ' ' LYS . 22.7 t -175.11 53.69 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.236 -0.915 . . . . 74.140000000000001 110.498 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 11.4 mm 49.08 -69.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.591 -0.693 . . . . 75.430000000000007 110.796 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.764 ' N ' ' O ' ' A' ' 101' ' ' SER . 2.4 mppt? -55.29 -18.34 6.17 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.988 -1.116 . . . . 74.140000000000001 107.988 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.08 -97.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.582 -0.699 . . . . 63.240000000000002 110.405 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.437 ' CD2' ' N ' ' A' ' 105' ' ' LEU . 2.0 pt? -49.83 -36.18 25.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.137 -0.977 . . . . 73.219999999999999 110.226 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.48 -39.85 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.881 -1.137 . . . . 74.540000000000006 108.903 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 103' ' ' LYS . . . -64.13 -31.86 73.21 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.193 -0.942 . . . . 75.5 108.57 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.1 ttp-105 -81.91 -24.83 35.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.457 -0.777 . . . . 74.409999999999997 109.745 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.425 HG23 HD11 ' A' ' 109' ' ' ILE . 65.6 mt -75.53 -37.4 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.032 -1.043 . . . . 73.239999999999995 108.705 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.5 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 11.8 pt-20 -76.21 -35.33 59.1 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.561 -0.856 . . . . 74.340000000000003 109.353 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.71 -45.35 94.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.431 -0.793 . . . . 73.319999999999993 109.863 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.528 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 23.3 ttm180 -66.06 -50.83 62.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.119 -0.988 . . . . 74.420000000000002 109.596 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.446 ' CD2' ' OD1' ' A' ' 46' ' ' ASP . 10.1 mp -95.51 38.29 1.16 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.14 -0.975 . . . . 74.329999999999998 109.206 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.37 -55.2 5.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.262 -0.899 . . . . 74.439999999999998 109.176 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -85.07 13.53 6.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -0.869 . . . . 74.430000000000007 109.617 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 60.4 t-105 -48.98 105.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 74.439999999999998 109.537 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 157.85 -136.89 5.04 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.629 -1.388 . . . . 75.040000000000006 109.629 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.8 t 54.21 177.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.425 -1.044 . . . . 70.109999999999999 110.049 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.7 150.71 26.53 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.059 -0.719 . . . . 65.239999999999995 109.059 -178.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.0 t -90.31 -41.48 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.155 -0.966 . . . . 74.219999999999999 109.581 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 17.1 mm -100.13 135.84 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.348 -0.845 . . . . 74.420000000000002 109.586 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -148.54 127.18 12.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 73.299999999999997 109.048 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 6.5 tp -154.42 128.09 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 75.340000000000003 108.994 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 53.47 -139.4 35.02 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.946 -1.661 . . . . 75.129999999999995 108.946 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 125' ' ' ASP . 14.3 p-10 -93.51 6.39 48.38 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.089 -1.242 . . . . 74.450000000000003 109.154 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.05 135.14 38.23 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.638 -0.875 . . . . 54.210000000000001 108.638 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.1 m -131.97 138.63 48.38 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.405 -0.809 . . . . 70.239999999999995 109.408 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.8 mt -138.85 139.92 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.332 -0.855 . . . . 72.430000000000007 109.184 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.8 m -123.36 82.33 52.65 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.604 -0.685 . . . . 71.109999999999999 109.392 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.46 -41.09 75.93 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.56 2.174 . . . . 75.140000000000001 112.115 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -56.07 -44.78 79.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 72.5 109.064 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -87.15 2.13 50.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.409 -0.807 . . . . 73.140000000000001 108.868 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 1.299 ' HB3' ' CZ ' ' A' ' 149' ' ' PHE . 21.4 mt-10 49.71 61.75 3.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.422 -0.798 . . . . 75.329999999999998 109.058 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -149.02 135.61 19.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.252 -0.905 . . . . 71.230000000000004 109.808 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 11.6 tt -107.86 136.24 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.434 -0.95 . . . . 75.329999999999998 108.434 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 47.7 mt -128.86 125.18 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.364 -0.835 . . . . 71.109999999999999 109.947 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.431 ' N ' ' CD1' ' A' ' 137' ' ' TYR . 16.5 p90 -139.3 147.25 41.38 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.454 -0.779 . . . . 74.140000000000001 109.152 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 54.9 mttp 54.33 23.87 4.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.451 -0.78 . . . . 75.400000000000006 110.05 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 79.44 -1.35 77.15 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.44 -1.064 . . . . 72.239999999999995 110.44 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -90.17 135.53 33.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.953 -1.322 . . . . 73.120000000000005 108.89 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -101.52 131.07 47.88 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.401 -0.812 . . . . 72.319999999999993 109.695 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 49.8 t -137.81 127.65 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.956 -0.757 . . . . 62.340000000000003 108.956 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -81.36 139.28 35.43 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.254 -0.904 . . . . 61.229999999999997 109.336 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.404 ' O ' ' CD1' ' A' ' 149' ' ' PHE . 12.2 m -142.6 137.09 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.252 -0.905 . . . . 74.439999999999998 109.53 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 1.125 ' HA ' ' CG ' ' A' ' 149' ' ' PHE . 49.5 pttt -171.45 28.57 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 75.420000000000002 109.214 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.19 -145.8 3.33 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.93 -1.268 . . . . 73.340000000000003 109.93 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -70.87 -38.61 7.61 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 121.357 -1.084 . . . . 72.219999999999999 110.426 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 90.5 Cg_endo -86.66 11.82 3.17 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.008 1.806 . . . . 75.450000000000003 111.853 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 1.299 ' CZ ' ' HB3' ' A' ' 133' ' ' GLU . 32.3 t80 -79.75 -34.83 39.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.418 -0.801 . . . . 65.239999999999995 109.425 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -74.41 -38.03 63.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 72.519999999999996 110.168 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 152' ' ' LEU . 11.5 p -74.76 -40.58 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.09 -1.006 . . . . 74.209999999999994 109.506 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.419 ' N ' ' CG1' ' A' ' 151' ' ' VAL . 20.4 tp -58.94 -45.63 89.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 73.310000000000002 109.216 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.7 p -65.82 -37.08 85.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 74.310000000000002 109.373 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.419 ' CE1' ' HD1' ' A' ' 158' ' ' HIS . 18.3 t-80 -52.94 -54.96 27.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.374 -0.829 . . . . 75.450000000000003 109.94 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.4 pp -76.33 -19.6 58.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 75.340000000000003 110.067 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.28 94.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.009 -1.057 . . . . 62.140000000000001 109.464 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.481 ' C ' ' H ' ' A' ' 159' ' ' ARG . 60.4 mtp180 -79.55 -51.58 9.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.185 -0.947 . . . . 72.219999999999999 109.35 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.458 ' C ' ' H ' ' A' ' 160' ' ' ASP . 62.0 m170 -73.32 43.5 0.13 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.487 -0.758 . . . . 74.120000000000005 109.172 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.748 HH12 ' NE2' ' B' ' 161' ' ' GLN . 0.2 OUTLIER -74.72 30.77 0.09 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.579 -0.7 . . . . 74.340000000000003 110.213 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 158' ' ' HIS . 63.3 t0 -165.2 66.4 0.13 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.922 -1.111 . . . . 75.450000000000003 110.131 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.53 HE22 ' CG2' ' A' ' 163' ' ' VAL . 2.1 pp0? -177.89 178.75 0.93 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.125 -0.984 . . . . 73.409999999999997 109.802 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.428 HD12 HG22 ' A' ' 162' ' ' ILE . 14.1 mm -97.44 125.67 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.309 -0.869 . . . . 74.409999999999997 109.358 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.53 ' CG2' HE22 ' A' ' 161' ' ' GLN . 18.6 t -104.5 132.82 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.376 -0.827 . . . . 72.530000000000001 109.197 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.7 t -87.31 141.59 28.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.15 -0.969 . . . . 74.120000000000005 109.321 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 33.1 mttt -51.69 -45.63 63.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 70.430000000000007 108.77 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -56.55 -37.64 70.8 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 74.319999999999993 109.1 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.17 -40.87 71.17 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.158 -0.964 . . . . 74.519999999999996 109.296 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 74.8 mt -62.62 -49.17 76.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 74.409999999999997 109.918 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.4 tp -75.77 -65.46 0.9 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.787 -1.195 . . . . 75.140000000000001 109.84 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -39.45 -31.01 0.08 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 122.164 -0.335 . . . . 65.030000000000001 111.892 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.75 -39.88 9.64 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.774 -1.204 . . . . 70.209999999999994 112.519 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.528 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 1.3 mp -85.31 -60.16 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 120.535 -1.353 . . . . 75.319999999999993 111.709 -177.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.464 ' CD2' ' C ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 O-C-N 120.79 -1.194 . . . . 73.140000000000001 110.049 -177.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 108.395 -0.965 . . . . 73.129999999999995 108.395 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.05 -135.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.541 -0.724 . . . . 74.019999999999996 110.365 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 57.3 mt -62.9 -31.87 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.287 -0.883 . . . . 72.329999999999998 109.636 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -45.64 -56.3 5.36 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.594 -0.692 . . . . 74.400000000000006 110.3 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 87.3 t -80.9 -52.69 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -0.946 . . . . 74.319999999999993 110.54 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -46.06 -47.47 17.08 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.023 -1.048 . . . . 73.230000000000004 110.387 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.461 ' CG2' ' N ' ' A' ' 189' ' ' ASN . 0.2 OUTLIER -71.95 -46.86 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.837 -1.164 . . . . 74.310000000000002 109.693 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.461 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 46.8 t-20 -56.13 -40.88 74.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.951 -1.093 . . . . 73.439999999999998 110.334 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 194' ' ' LYS . 25.6 mt-30 -72.9 -48.24 38.91 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.027 -1.045 . . . . 71.420000000000002 110.298 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 58.5 mt -49.12 -36.18 8.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 120.65 -1.281 . . . . 72.439999999999998 110.242 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 20.7 mtm-85 -76.04 -59.21 2.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.856 -1.153 . . . . 64.219999999999999 111.057 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.43 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 86.6 mt-30 -71.08 -14.53 62.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.13 -0.981 . . . . 74.319999999999993 110.775 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 190' ' ' GLN . 33.3 ttpt -91.17 -36.88 13.7 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.17 -0.956 . . . . 75.310000000000002 110.042 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 9.3 tpt -89.89 -4.1 57.72 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.294 -0.879 . . . . 74.019999999999996 109.701 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 197' ' ' LYS . 33.7 p-10 -68.2 -44.31 76.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.089 -1.007 . . . . 74.019999999999996 110.652 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.537 ' N ' ' OD1' ' A' ' 196' ' ' ASP . 8.9 mttm -75.84 -53.44 2.42 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.944 -1.098 . . . . 75.430000000000007 110.017 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -47.03 -61.36 0.62 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.899 1.733 . . . . 72.319999999999993 112.214 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 33.8 tp -70.61 -43.72 68.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 74.540000000000006 109.314 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 91.38 -19.45 47.06 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.985 -1.246 . . . . 61.509999999999998 109.985 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 29.9 mm -111.32 133.44 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.415 -1.05 . . . . 74.25 109.576 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 14.4 t -85.35 134.42 34.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 72.0 109.123 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 43.9 p -144.23 29.05 1.32 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.238 -0.914 . . . . 74.439999999999998 109.595 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.48 125.2 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.386 -0.821 . . . . 71.129999999999995 109.483 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -107.12 129.07 54.88 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.485 -0.759 . . . . 73.510000000000005 109.147 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 81.0 p -93.35 120.71 33.94 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.21 -0.932 . . . . 73.519999999999996 109.414 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.49 143.1 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.366 -0.834 . . . . 72.150000000000006 109.051 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -75.69 -33.06 60.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 72.400000000000006 110.067 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 211' ' ' GLY . 44.9 mmm-85 -60.97 145.89 48.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.098 -1.001 . . . . 73.310000000000002 109.553 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 64.1 mtp85 48.64 -91.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.386 -0.821 . . . . 71.540000000000006 109.734 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . -160.27 -124.99 0.76 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.494 -1.443 . . . . 74.450000000000003 109.494 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -101.5 141.84 33.76 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.352 -1.087 . . . . 75.540000000000006 109.236 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.501 ' NH1' ' HG ' ' A' ' 215' ' ' CYS . 66.1 ttt-85 -109.03 127.28 53.96 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.514 -0.741 . . . . 75.310000000000002 109.789 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -109.66 124.02 50.47 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.646 -0.872 . . . . 75.409999999999997 108.646 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . 0.501 ' HG ' ' NH1' ' A' ' 213' ' ' ARG . 4.8 p -140.91 167.32 22.48 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.34 -0.85 . . . . 74.140000000000001 109.923 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -61.71 150.78 80.89 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.384 -0.823 . . . . 75.319999999999993 108.947 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo . . . . . 0 C--N 1.315 -1.189 0 C-N-CA 121.852 1.701 . . . . 73.109999999999999 111.99 179.804 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.573 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.418 -0.586 . . . . 75.239999999999995 109.418 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 1.217 ' CZ ' ' NH2' ' B' ' 43' ' ' ARG . 88.9 mtt-85 -131.21 142.34 50.17 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.507 -0.745 . . . . 73.519999999999996 109.721 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 88.2 t -107.7 123.07 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.611 -0.681 . . . . 72.239999999999995 109.709 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' B' ' 49' ' ' MET . 2.4 tp -91.24 114.43 26.95 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.094 -1.076 . . . . 73.340000000000003 108.094 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 4.4 tp -117.11 111.71 19.87 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.912 -0.773 . . . . 74.349999999999994 108.912 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 20.0 mt -106.59 123.58 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.445 -0.785 . . . . 63.439999999999998 109.02 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.439 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 21.8 tp10 -140.41 120.25 13.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.345 -0.847 . . . . 74.519999999999996 109.274 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -66.44 -30.81 71.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.158 -0.963 . . . . 74.129999999999995 109.283 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -64.24 -128.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.217 -0.927 . . . . 74.230000000000004 109.033 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 79.2 p -167.06 -66.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.11 -0.994 . . . . 65.540000000000006 109.658 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.52 -40.96 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 75.549999999999997 109.907 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -52.14 -43.23 63.93 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.024 -1.048 . . . . 70.140000000000001 108.725 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.94 -28.35 68.85 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 108.508 -1.837 . . . . 75.400000000000006 108.508 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.61 -51.52 53.42 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 109.72 -1.352 . . . . 65.439999999999998 109.72 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -60.82 -45.04 96.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -1.114 . . . . 72.200000000000003 109.931 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 5.6 mm -67.26 -38.73 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.828 -1.17 . . . . 75.150000000000006 108.924 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.525 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 84.0 tt0 -62.73 -42.52 99.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 73.010000000000005 109.791 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -88.58 -0.53 57.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.931 -1.106 . . . . 74.299999999999997 108.916 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.1 -53.39 3.32 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 109.551 -1.419 . . . . 70.540000000000006 109.551 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -73.83 -24.59 59.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -1.121 . . . . 75.430000000000007 109.654 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 96.2 m-20 -58.96 -34.75 72.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.158 -0.964 . . . . 73.200000000000003 109.485 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 90.9 t -55.74 -45.29 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.416 -0.802 . . . . 74.230000000000004 109.379 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 50.3 mmtt -54.2 -49.67 68.85 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.382 -0.824 . . . . 73.519999999999996 108.827 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.77 41.21 0.15 Allowed Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.1 -1.2 . . . . 53.43 110.1 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -120.38 160.13 23.69 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.395 -1.062 . . . . 71.120000000000005 109.532 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.1 mmt -100.47 139.41 36.2 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.957 -1.127 . . . . 75.239999999999995 107.957 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.28 160.43 41.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.168 -0.957 . . . . 73.25 110.314 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -135.2 141.31 45.82 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.607 -0.886 . . . . 72.310000000000002 108.607 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 1.1 m -107.59 126.96 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.332 -0.855 . . . . 72.140000000000001 109.103 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.7 p -125.13 161.85 25.9 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.616 -0.678 . . . . 74.530000000000001 109.25 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.466 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 1.7 pt-20 -88.2 -97.67 0.09 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.27 -0.894 . . . . 71.019999999999996 109.796 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.3 t -78.8 152.39 31.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.895 . . . . 71.400000000000006 110.007 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 mp -50.59 -26.29 5.14 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.562 -0.711 . . . . 71.239999999999995 109.711 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -58.61 -48.29 81.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.96 . . . . 74.319999999999993 109.872 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.466 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 68.5 m-20 -59.88 -43.74 94.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.969 . . . . 73.030000000000001 109.258 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.06 -29.59 68.71 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.2 -1.56 . . . . 60.43 109.2 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -65.66 -43.66 88.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.358 -1.084 . . . . 74.430000000000007 109.816 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -80.28 -33.5 37.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.997 -1.064 . . . . 74.420000000000002 109.57 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 11.3 tp -72.88 -39.23 66.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.345 -0.847 . . . . 75.409999999999997 109.776 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.43 ' O ' ' O ' ' B' ' 43' ' ' ARG . 2.9 ppp? -75.79 -21.93 56.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.962 . . . . 61.439999999999998 109.833 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -60.73 -35.85 77.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.135 -0.978 . . . . 74.319999999999993 109.531 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 11.3 pt -92.4 -24.81 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.28 -0.888 . . . . 71.230000000000004 110.031 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 1.217 ' NH2' ' CZ ' ' B' ' 2' ' ' ARG . 54.4 mtp180 -124.9 139.47 53.8 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.335 -0.853 . . . . 73.409999999999997 109.537 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -101.35 143.38 31.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.3 -0.875 . . . . 63.539999999999999 109.62 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -114.85 143.5 45.01 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.967 -0.753 . . . . 73.109999999999999 108.967 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' B' ' 2' ' ' ARG . 8.3 p-10 -82.08 -36.92 27.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.077 -1.015 . . . . 62.219999999999999 109.276 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.409 ' C ' ' CD1' ' B' ' 47' ' ' LEU . 0.8 OUTLIER -109.41 109.72 20.65 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.639 -0.875 . . . . 73.120000000000005 108.639 179.608 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 63.5 t -94.46 100.57 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.282 -0.886 . . . . 74.109999999999999 109.197 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 0.3 OUTLIER -116.93 124.98 50.76 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.669 -0.863 . . . . 73.439999999999998 108.669 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.406 HG21 ' H ' ' B' ' 52' ' ' ASP . 0.2 OUTLIER -143.85 130.43 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.278 -0.889 . . . . 73.400000000000006 109.342 -179.451 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' SER . . . . . 0.439 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 75.4 p -107.21 27.92 8.58 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.691 -0.631 . . . . 73.209999999999994 109.54 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.406 ' H ' HG21 ' B' ' 50' ' ' VAL . 44.8 m-20 -86.86 159.02 19.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -0.927 . . . . 70.409999999999997 109.486 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' B' ' 55' ' ' ALA . 94.0 mttt -81.63 175.8 10.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.321 -0.862 . . . . 73.129999999999995 109.375 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . 0.465 ' ND2' ' C ' ' B' ' 54' ' ' ASN . 0.3 OUTLIER 44.58 16.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.602 -0.686 . . . . 75.209999999999994 109.86 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' B' ' 53' ' ' LYS . . . -74.48 -20.55 59.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 55.329999999999998 109.185 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 24.6 mt -42.79 -46.73 5.3 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.631 -0.668 . . . . 72.420000000000002 110.342 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 58.7 m -65.54 -37.22 86.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.971 -1.081 . . . . 73.040000000000006 109.659 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -63.21 -59.99 4.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 72.329999999999998 109.898 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 15.4 m -49.59 -35.68 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.735 -1.228 . . . . 74.540000000000006 109.764 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' SER . . . . . 0.428 ' OG ' ' N ' ' B' ' 61' ' ' ARG . 13.0 p -58.11 -55.04 40.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.095 -1.003 . . . . 71.239999999999995 109.752 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.428 ' N ' ' OG ' ' B' ' 60' ' ' SER . 11.3 ptp180 -64.48 -27.47 69.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.064 -1.023 . . . . 74.310000000000002 110.042 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 28.2 mm -64.74 -41.54 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.784 -1.197 . . . . 75.420000000000002 109.936 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.539 ' NZ ' ' O ' ' B' ' 90' ' ' GLY . 19.1 mmtp -69.65 -48.83 58.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.94 -1.1 . . . . 73.319999999999993 110.551 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -66.7 -35.93 81.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.759 -1.213 . . . . 73.310000000000002 109.807 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.454 ' HZ1' ' HE2' ' B' ' 66' ' ' HIS . 9.7 mtpm? -82.13 -25.29 34.53 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.166 -0.959 . . . . 72.439999999999998 109.702 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . 0.454 ' HE2' ' HZ1' ' B' ' 65' ' ' LYS . 65.6 m-70 -152.73 68.01 0.83 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.164 -0.96 . . . . 65.209999999999994 109.516 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 86.6 p -64.4 -25.8 68.18 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.359 -0.838 . . . . 73.099999999999994 109.885 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 17.8 p -66.02 -9.19 28.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.179 -0.951 . . . . 71.530000000000001 109.883 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 56.9 mt -102.11 151.26 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.351 -0.843 . . . . 74.400000000000006 109.468 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' B' ' 71' ' ' VAL . 76.6 t -87.39 165.54 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.249 -0.907 . . . . 75.120000000000005 109.486 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.451 ' N ' ' CG1' ' B' ' 70' ' ' VAL . 2.9 t -145.7 122.71 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.966 -1.084 . . . . 73.200000000000003 109.824 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . 0.497 ' O ' ' SD ' ' B' ' 49' ' ' MET . 2.9 mp -120.36 105.4 10.87 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.483 -0.932 . . . . 73.340000000000003 108.483 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 14.7 p -95.35 130.91 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.209 -0.932 . . . . 73.5 109.019 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 2.5 p -89.5 170.19 10.72 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.104 -0.997 . . . . 71.319999999999993 109.203 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 26.4 t -161.22 114.54 1.95 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.092 -1.005 . . . . 74.530000000000001 109.942 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -62.8 -36.7 84.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.173 -0.954 . . . . 64.5 108.81 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . 0.407 ' OD1' ' N ' ' B' ' 77' ' ' ASN . 13.0 p-10 -112.39 87.4 9.34 Favored Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 108.668 -0.864 . . . . 74.25 108.668 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -72.16 78.78 1.82 Allowed 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.51 1.473 . . . . 74.430000000000007 111.875 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.409 ' HG1' ' H ' ' B' ' 82' ' ' GLU . 77.2 p -83.01 152.33 25.45 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.034 -1.098 . . . . 73.120000000000005 108.034 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' SER . . . . . 0.547 ' CB ' ' HE ' ' A' ' 100' ' ' ARG . 0.5 OUTLIER -63.96 -35.74 81.67 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.011 -1.056 . . . . 75.409999999999997 109.89 -179.239 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . 0.496 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 24.0 pt-20 -60.55 -36.82 79.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.129 -0.982 . . . . 72.239999999999995 109.373 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . 0.409 ' H ' ' HG1' ' B' ' 79' ' ' THR . 84.9 tt0 -73.63 -33.55 64.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.213 -0.929 . . . . 73.219999999999999 109.565 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -62.74 -52.36 63.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.901 . . . . 74.299999999999997 109.722 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 18.8 m -61.09 -39.3 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.111 -0.993 . . . . 73.310000000000002 109.34 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' HIS . . . . . 0.496 ' ND1' ' O ' ' B' ' 81' ' ' GLU . 25.0 m80 -66.59 -30.66 71.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 73.239999999999995 109.351 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.35 91.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 55.329999999999998 109.693 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -80.22 -35.04 36.79 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.185 -0.947 . . . . 74.450000000000003 109.019 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -63.13 -50.43 70.46 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.425 -0.797 . . . . 64.040000000000006 109.074 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -60.45 -52.68 64.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.544 -0.723 . . . . 75.129999999999995 109.836 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . 0.539 ' O ' ' NZ ' ' B' ' 63' ' ' LYS . . . 155.16 -15.08 0.49 Allowed Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.649 -1.262 . . . . 75.420000000000002 110.588 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -45.02 133.05 6.65 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.973 -1.31 . . . . 73.420000000000002 109.843 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' B' ' 93' ' ' ASP . 18.1 t0 -69.39 -42.56 74.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 73.319999999999993 109.362 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' B' ' 92' ' ' ASP . 72.9 m-20 -152.25 164.91 36.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.43 -0.794 . . . . 73.040000000000006 109.175 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.522 ' CD1' ' O ' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -138.54 127.76 24.28 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.902 -0.777 . . . . 74.310000000000002 108.902 -178.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . 0.562 ' N ' ' CD1' ' B' ' 95' ' ' ILE . 0.2 OUTLIER -123.82 151.91 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 121.451 0.643 . . . . 75.340000000000003 110.142 -178.654 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.62 138.48 58.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.186 -0.946 . . . . 70.099999999999994 108.541 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.672 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -59.73 -53.79 62.11 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 120.98 -1.075 . . . . 65.430000000000007 111.61 -179.321 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 4.0 Cg_endo -42.03 -9.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 120.648 0.899 . . . . 63.520000000000003 113.057 -176.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . 0.672 ' N ' ' O ' ' B' ' 97' ' ' LYS . 49.4 m-85 59.45 117.64 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.583 -0.698 . . . . 75.129999999999995 109.225 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -56.63 -38.21 71.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.84 -1.162 . . . . 74.230000000000004 108.882 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' SER . . . . . 0.731 ' O ' ' N ' ' B' ' 103' ' ' LYS . 33.3 t -174.59 41.27 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.119 -0.988 . . . . 64.510000000000005 110.728 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 63.7 mt 51.88 -69.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.546 -0.721 . . . . 74.439999999999998 110.232 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . 0.731 ' N ' ' O ' ' B' ' 101' ' ' SER . 28.2 mtmm -57.72 -18.8 23.23 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.776 -1.194 . . . . 72.299999999999997 107.776 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.45 -83.51 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.81 -0.556 . . . . 74.310000000000002 110.578 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -47.67 -32.75 6.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.878 -1.139 . . . . 73.540000000000006 109.858 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 99.2 t -65.33 -41.7 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.901 -1.124 . . . . 72.030000000000001 108.723 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.94 -33.56 67.13 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.317 -0.865 . . . . 64.219999999999999 108.962 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -83.41 -34.97 25.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.426 -0.796 . . . . 75.310000000000002 110.079 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 96.8 mt -72.54 -36.6 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.022 -1.048 . . . . 55.439999999999998 109.115 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . 0.435 ' CG ' ' N ' ' B' ' 111' ' ' ALA . 22.8 pt-20 -74.91 -44.79 46.78 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.444 -0.902 . . . . 65.310000000000002 109.214 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . 0.435 ' N ' ' CG ' ' B' ' 110' ' ' GLU . . . -50.4 -45.01 55.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.239 -0.913 . . . . 74.519999999999996 109.203 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -67.09 -38.13 85.15 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.29 -0.881 . . . . 72.040000000000006 109.689 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' B' ' 116' ' ' TRP . 24.0 mt -78.11 -26.26 47.9 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.22 -0.925 . . . . 75.349999999999994 110.496 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.465 ' O ' ' CE3' ' B' ' 116' ' ' TRP . 19.0 mmt180 -47.57 -40.54 19.38 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.88 -1.137 . . . . 75.5 109.689 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' PHE . . . . . 0.526 ' C ' ' H ' ' B' ' 117' ' ' GLY . 71.3 m-85 -68.02 -25.22 65.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.983 . . . . 73.040000000000006 109.455 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' TRP . . . . . 0.465 ' CE3' ' O ' ' B' ' 114' ' ' ARG . 5.4 m-90 53.34 6.36 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.384 -0.822 . . . . 74.450000000000003 109.827 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . 0.526 ' H ' ' C ' ' B' ' 115' ' ' PHE . . . 68.51 175.84 10.72 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.847 -1.301 . . . . 64.209999999999994 109.847 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 58.4 m -142.06 171.59 13.84 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.347 -1.09 . . . . 71.400000000000006 109.344 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . 0.544 HD22 ' C ' ' B' ' 121' ' ' ILE . 2.7 t30 -104.11 153.67 20.63 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.42 -0.8 . . . . 74.209999999999994 109.749 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 t -104.27 -42.51 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.415 -0.803 . . . . 75.019999999999996 109.859 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . 0.544 ' C ' HD22 ' B' ' 119' ' ' ASN . 12.2 mm -106.66 119.22 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.204 -0.935 . . . . 74.239999999999995 109.469 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -129.49 138.67 51.51 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.516 -0.74 . . . . 73.329999999999998 109.529 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.456 ' O ' ' CG2' ' B' ' 123' ' ' ILE . 0.2 OUTLIER -160.28 117.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 74.219999999999999 109.192 179.821 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 53.45 -141.39 31.2 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.623 -1.391 . . . . 72.409999999999997 109.623 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -86.14 -1.9 57.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.294 -1.121 . . . . 75.120000000000005 109.471 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.52 126.7 38.81 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.118 -1.067 . . . . 75.420000000000002 108.118 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 85.6 m -129.22 135.89 49.41 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.328 -0.857 . . . . 74.219999999999999 109.952 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 12.4 mt -129.17 136.04 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.555 -0.715 . . . . 60.329999999999998 109.338 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' SER . . . . . 0.459 ' O ' ' N ' ' B' ' 133' ' ' GLU . 53.0 m -124.49 81.46 59.61 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.626 -0.671 . . . . 72.310000000000002 109.582 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.41 -39.61 73.25 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.454 2.103 . . . . 75.129999999999995 111.712 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.68 -43.3 97.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.406 -0.809 . . . . 75.230000000000004 109.199 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -89.54 -4.64 57.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.389 -0.819 . . . . 75.120000000000005 108.791 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' B' ' 129' ' ' SER . 87.2 mt-10 52.52 56.74 7.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.453 -0.779 . . . . 75.129999999999995 109.763 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -151.83 139.02 19.25 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.303 -0.873 . . . . 75.109999999999999 109.404 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 7.7 tt -126.64 143.05 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.403 -0.811 . . . . 70.319999999999993 109.853 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 53.1 mt -115.6 131.73 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 109.114 -0.698 . . . . 74.120000000000005 109.114 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -138.02 138.23 38.64 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.609 -0.682 . . . . 74.230000000000004 110.491 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm 50.94 25.4 2.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.391 -0.818 . . . . 74.219999999999999 111.031 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.9 14.85 71.57 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.823 -1.179 . . . . 74.319999999999993 111.05 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -115.1 126.42 54.65 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.343 -1.093 . . . . 75.340000000000003 108.987 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -93.7 126.19 38.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.355 -0.841 . . . . 71.230000000000004 109.53 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 13.8 p -135.63 133.04 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.578 -0.897 . . . . 70.430000000000007 108.578 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' B' ' 143' ' ' GLU . 1.1 pm0 -94.86 137.37 34.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.201 -0.937 . . . . 72.430000000000007 108.588 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 11.6 m -140.02 141.01 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.102 -0.999 . . . . 72.129999999999995 110.323 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.27 31.92 0.24 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.711 -1.218 . . . . 74.5 107.711 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' B' ' 150' ' ' GLU . . . -78.24 -155.82 8.41 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.605 -1.398 . . . . 42.229999999999997 109.605 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . 0.744 ' HZ2' ' CB ' ' B' ' 147' ' ' LYS . 0.0 OUTLIER -88.39 -35.96 0.44 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.422 -1.046 . . . . 73.299999999999997 111.046 -179.566 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 47.7 Cg_endo -84.31 -42.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 121.931 1.754 . . . . 71.329999999999998 112.533 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -56.53 -19.37 15.31 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.76 -1.212 . . . . 74.230000000000004 109.037 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' B' ' 146' ' ' GLY . 27.1 mt-10 -60.68 -36.27 78.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 72.340000000000003 109.89 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 3.8 p -67.84 -38.15 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.977 -1.077 . . . . 73.349999999999994 110.072 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 20.0 tp -60.57 -41.77 95.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.342 -0.849 . . . . 74.430000000000007 109.613 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -69.9 -39.64 76.08 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.124 -0.985 . . . . 75.209999999999994 109.209 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 154' ' ' HIS . . . . . 0.493 ' CD2' ' HD1' ' B' ' 158' ' ' HIS . 14.7 t60 -56.76 -52.48 64.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.484 -0.76 . . . . 73.040000000000006 110.111 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 4.2 pp -72.0 -25.66 61.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.924 -1.11 . . . . 73.430000000000007 109.413 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -54.31 -42.47 70.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.023 -1.048 . . . . 75.319999999999993 108.346 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . 0.475 ' C ' ' H ' ' B' ' 159' ' ' ARG . 58.0 mtp180 -77.81 -52.32 9.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.453 -0.779 . . . . 73.319999999999993 109.21 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 158' ' ' HIS . . . . . 0.493 ' HD1' ' CD2' ' B' ' 154' ' ' HIS . 30.9 m80 -75.27 25.66 0.1 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.549 -0.72 . . . . 74.140000000000001 109.988 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . 0.475 ' H ' ' C ' ' B' ' 157' ' ' ARG . 47.4 ttp180 -52.57 -78.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 73.420000000000002 109.015 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . 0.933 ' OD2' ' CE2' ' B' ' 216' ' ' TYR . 9.1 t70 -65.2 74.95 0.05 Allowed 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.2 -0.937 . . . . 72.099999999999994 109.27 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . 0.748 ' NE2' HH12 ' A' ' 159' ' ' ARG . 38.2 tt0 -175.65 160.33 2.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 73.239999999999995 109.141 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 162' ' ' ILE . . . . . 0.418 HD11 HG21 ' B' ' 162' ' ' ILE . 17.1 mm -85.63 106.82 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.638 -0.875 . . . . 72.310000000000002 108.638 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 87.5 t -89.94 136.03 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.198 -0.939 . . . . 75.030000000000001 109.814 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 25.8 t -99.92 160.75 14.07 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.457 -0.777 . . . . 74.219999999999999 109.488 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . 0.437 ' HZ3' ' CB ' ' B' ' 165' ' ' LYS . 8.3 mtmp? -66.88 -40.01 87.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.472 -0.768 . . . . 72.420000000000002 110.047 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -66.36 -26.55 67.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 63.450000000000003 110.391 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -60.16 -57.69 11.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.99 -1.069 . . . . 72.400000000000006 109.662 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 25.9 mt -60.82 -36.72 79.8 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.127 -0.983 . . . . 72.319999999999993 108.856 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -56.39 -66.23 0.47 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.607 -0.683 . . . . 73.340000000000003 110.162 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -54.85 -31.68 59.82 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.717 -0.615 . . . . 73.099999999999994 111.85 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -92.18 -8.82 44.46 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.706 -1.246 . . . . 62.130000000000003 112.009 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.407 HG21 HD12 ' B' ' 172' ' ' ILE . 25.6 mm -112.74 -68.4 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 120.887 -1.133 . . . . 74.439999999999998 110.82 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 173' ' ' TRP . . . . . 0.481 ' C ' ' CD2' ' B' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.431 0 C-N-CA 118.653 -1.219 . . . . 72.230000000000004 107.915 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo . . . . . 0 N--CA 1.494 1.521 0 CA-C-O 121.284 0.452 . . . . 74.340000000000003 111.815 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -127.27 125.97 41.85 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.488 -0.93 . . . . 72.310000000000002 108.488 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 6.1 t -133.04 -13.89 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.305 -0.872 . . . . 65.420000000000002 109.701 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 4.6 tt -62.01 -25.13 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.458 -1.401 . . . . 75.030000000000001 109.164 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -61.38 -43.11 99.43 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.319 -0.863 . . . . 73.519999999999996 109.83 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 15.4 m -76.54 -27.39 17.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.836 -1.165 . . . . 74.349999999999994 108.254 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.28 -46.18 64.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 61.119999999999997 109.692 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 10.7 tp -71.8 -28.06 29.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 120.953 -1.092 . . . . 72.430000000000007 109.595 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 189' ' ' ASN . . . . . 0.446 ' O ' ' OE1' ' B' ' 193' ' ' GLN . 68.2 m-20 -68.2 -46.01 71.78 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.286 -0.884 . . . . 75.420000000000002 108.764 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -70.3 -47.17 62.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 74.140000000000001 109.534 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 63.7 mt -51.23 -34.83 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -0.906 . . . . 74.030000000000001 108.846 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -70.33 -42.28 72.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.883 . . . . 72.329999999999998 109.39 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 193' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' B' ' 189' ' ' ASN . 1.0 OUTLIER -75.45 -17.12 60.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.262 -0.899 . . . . 73.099999999999994 109.692 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -92.3 -25.05 18.76 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.18 -0.95 . . . . 74.430000000000007 110.361 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 195' ' ' MET . . . . . 0.608 ' N ' ' SD ' ' B' ' 195' ' ' MET . 0.0 OUTLIER -96.17 -32.01 12.69 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.133 -0.979 . . . . 74.329999999999998 110.141 -179.035 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 196' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 42.2 p-10 -67.97 -31.54 71.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.029 -1.044 . . . . 71.209999999999994 110.496 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . 0.47 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 46.1 mttt -70.12 -65.01 1.2 Allowed Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.969 -1.082 . . . . 75.209999999999994 110.56 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 198' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 19.8 Cg_endo -58.38 -58.57 0.71 Allowed 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.22 1.947 . . . . 75.319999999999993 112.741 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 37.1 mt -60.01 -55.51 33.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.062 -1.024 . . . . 72.25 109.874 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 97.49 -24.79 29.97 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.257 -1.137 . . . . 73.239999999999995 110.257 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 19.7 mt -106.36 127.06 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.162 -1.199 . . . . 54.299999999999997 109.706 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 53.9 p -82.48 141.05 33.0 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.458 -0.941 . . . . 74.310000000000002 108.458 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 11.9 p -142.6 19.43 2.02 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.113 -0.992 . . . . 74.400000000000006 109.585 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 5.3 t -125.94 141.58 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.499 -0.751 . . . . 74.099999999999994 109.78 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -119.82 107.6 13.36 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.313 -0.995 . . . . 75.329999999999998 108.313 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.17 120.13 20.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.958 . . . . 71.400000000000006 109.796 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.0 t -117.28 148.88 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 109.114 -0.698 . . . . 63.5 109.114 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -91.64 -1.63 57.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.191 -0.943 . . . . 74.450000000000003 109.44 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -76.19 -118.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.353 -0.842 . . . . 74.140000000000001 109.56 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -57.33 -47.74 80.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.197 -0.939 . . . . 74.430000000000007 109.977 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.85 -126.83 1.09 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.026 -1.229 . . . . 70.109999999999999 110.026 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -100.17 133.56 44.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.271 -1.135 . . . . 74.209999999999994 109.408 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -100.53 118.13 36.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.409 -0.807 . . . . 74.299999999999997 109.445 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -98.56 131.03 45.1 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.412 -0.805 . . . . 74.340000000000003 109.113 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 30.3 p -158.48 161.04 37.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 72.209999999999994 109.077 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . 0.933 ' CE2' ' OD2' ' B' ' 160' ' ' ASP . 1.6 m-85 -61.24 150.16 80.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.995 -1.065 . . . . 72.310000000000002 108.698 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.07 -55.65 0.13 Allowed 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.123 1.882 . . . . 71.010000000000005 111.561 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 62.8 mttm . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 108.385 -0.969 . . . . 74.349999999999994 108.385 179.817 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.3 ttm . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.474 -0.565 . . . . 65.120000000000005 109.474 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -144.56 141.68 29.65 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.196 -0.94 . . . . 73.310000000000002 109.182 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 80.2 t -112.55 134.86 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.562 0.696 . . . . 71.420000000000002 109.958 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.3 tp -103.2 118.58 37.12 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.101 -1.074 . . . . 65.219999999999999 108.101 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.9 tp -117.82 107.23 13.88 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.66 -0.65 . . . . 71.439999999999998 109.483 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.4 mt -98.36 101.5 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.327 -0.99 . . . . 71.150000000000006 108.327 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -131.42 124.11 29.58 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.61 -0.681 . . . . 75.340000000000003 109.465 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.43 ' HZ2' ' CG ' ' A' ' 52' ' ' ASP . 60.6 mttp -65.66 -34.46 78.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.277 -0.889 . . . . 73.040000000000006 109.15 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -87.07 112.2 21.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 72.420000000000002 109.227 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.6 m -65.7 -26.71 67.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 72.340000000000003 109.588 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.72 -52.75 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.193 -0.942 . . . . 74.420000000000002 109.774 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.1 mt -61.6 -34.83 76.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.977 . . . . 72.010000000000005 109.291 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.94 -26.96 71.43 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.566 -1.814 . . . . 72.140000000000001 108.566 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.13 -52.41 44.68 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 109.529 -1.428 . . . . 72.329999999999998 109.529 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -59.97 -45.09 93.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.372 -1.075 . . . . 72.340000000000003 109.824 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.4 mm -64.31 -38.55 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.795 -1.191 . . . . 74.239999999999995 108.828 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -62.89 -49.29 75.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.329 -0.857 . . . . 71.409999999999997 110.099 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -78.03 -7.34 56.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.077 -1.015 . . . . 75.540000000000006 109.815 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.77 -54.45 3.24 Favored Glycine 0 N--CA 1.483 1.824 0 N-CA-C 109.505 -1.438 . . . . 62.149999999999999 109.505 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.91 -24.13 61.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.376 -1.073 . . . . 74.420000000000002 109.489 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -56.04 -38.46 70.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.137 -0.977 . . . . 74.25 109.184 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.5 t -51.94 -47.53 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.271 -0.893 . . . . 72.109999999999999 109.05 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -53.81 -53.16 56.32 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.602 -0.888 . . . . 73.230000000000004 108.602 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.94 40.77 0.28 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.353 -1.499 . . . . 75.540000000000006 109.353 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -117.13 160.28 21.27 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.511 -0.994 . . . . 74.510000000000005 109.139 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.5 mmt -101.11 139.35 36.91 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.204 -1.036 . . . . 64.319999999999993 108.204 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.59 146.75 34.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.167 -0.958 . . . . 74.310000000000002 110.339 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -120.69 149.23 42.83 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.911 -0.774 . . . . 75.400000000000006 108.911 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 m -110.53 134.99 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.427 -0.796 . . . . 75.129999999999995 108.906 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.4 p -136.82 168.2 20.0 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.359 -0.838 . . . . 71.420000000000002 109.531 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -90.25 -105.61 0.09 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.329 -0.857 . . . . 73.109999999999999 109.662 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.5 p -81.16 169.11 17.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 74.239999999999995 110.07 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.5 mt -53.95 -32.67 54.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.579 -0.7 . . . . 71.530000000000001 109.521 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -49.81 -49.68 47.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 74.230000000000004 109.541 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -64.95 -51.83 59.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 71.010000000000005 109.31 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.36 -39.03 96.69 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.694 -1.362 . . . . 61.409999999999997 109.694 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -64.28 -47.06 80.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -1.141 . . . . 74.340000000000003 109.413 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -69.78 -35.3 74.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.067 -1.021 . . . . 75.329999999999998 109.19 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.424 ' C ' ' CD1' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -70.4 -65.53 0.72 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.84 . . . . 74.329999999999998 109.204 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 40' ' ' MET . 2.9 ppp? -48.47 -20.38 0.42 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.263 -0.898 . . . . 70.319999999999993 109.936 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -65.52 -43.24 90.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.075 -1.016 . . . . 71.219999999999999 110.091 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.3 pt -82.31 -26.71 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.172 -0.955 . . . . 74.409999999999997 110.195 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 40' ' ' MET . 99.4 mtt180 -129.96 143.7 50.94 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.35 -0.844 . . . . 75.409999999999997 109.507 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -97.59 151.09 20.42 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.214 -0.929 . . . . 75.420000000000002 109.556 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -127.51 141.08 51.75 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.529 -0.732 . . . . 74.230000000000004 109.252 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -78.05 -42.15 33.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 75.319999999999993 109.471 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.01 112.77 25.9 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.474 -0.766 . . . . 72.129999999999995 108.941 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.0 t -99.45 98.48 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.406 -0.961 . . . . 72.340000000000003 108.406 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.451 ' C ' ' SD ' ' A' ' 49' ' ' MET . 1.5 tmt? -114.99 135.94 53.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.617 -0.677 . . . . 74.109999999999999 109.834 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.459 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 1.1 p -143.59 131.19 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.78 0.8 . . . . 71.239999999999995 109.82 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.7 p -95.26 9.64 39.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.571 -0.706 . . . . 73.109999999999999 109.744 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.459 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 80.0 m-20 -77.04 141.48 40.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 63.399999999999999 109.514 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.531 ' C ' ' H ' ' A' ' 55' ' ' ALA . 92.2 mttt -75.1 -45.42 41.31 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.294 -0.879 . . . . 65.439999999999998 110.447 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -68.51 10.99 0.2 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.096 -1.002 . . . . 73.129999999999995 109.84 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -68.84 -22.49 64.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 64.140000000000001 110.28 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 52.4 mt -42.62 -50.34 5.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.297 -0.877 . . . . 74.430000000000007 110.401 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.1 m -68.74 -31.91 71.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.932 -1.105 . . . . 63.229999999999997 109.333 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -70.19 -56.57 6.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.463 -0.773 . . . . 74.439999999999998 110.2 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.4 m -55.03 -34.06 30.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.609 -1.307 . . . . 74.030000000000001 109.528 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.7 t -60.42 -54.89 40.1 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.287 -0.883 . . . . 73.540000000000006 109.499 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.653 HH21 ' NZ ' ' A' ' 65' ' ' LYS . 7.1 ptm180 -67.3 -25.52 66.07 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.045 -1.062 . . . . 73.340000000000003 109.967 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 66' ' ' HIS . 4.9 mm -59.87 -48.03 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.783 -1.198 . . . . 73.349999999999994 108.968 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -64.45 -45.19 88.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.023 -1.048 . . . . 74.420000000000002 108.87 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -60.86 -51.52 68.95 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.326 -0.99 . . . . 74.549999999999997 108.326 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.653 ' NZ ' HH21 ' A' ' 61' ' ' ARG . 93.1 mttt -71.81 -69.68 0.37 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.253 -0.647 . . . . 75.219999999999999 109.253 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 62' ' ' ILE . 86.5 m-70 -98.02 90.54 4.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.319 -0.863 . . . . 74.129999999999995 109.019 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 t -79.01 -40.1 32.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 73.239999999999995 109.914 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.8 t -78.15 57.92 1.93 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 71.439999999999998 109.611 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.6 tt -152.03 158.12 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.147 -0.97 . . . . 71.329999999999998 109.656 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.2 t -97.63 146.87 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.119 -0.988 . . . . 73.019999999999996 109.111 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.7 t -133.01 125.81 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.317 -0.864 . . . . 54.210000000000001 110.5 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.7 tt -122.87 100.03 6.69 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.652 -0.87 . . . . 74.209999999999994 108.652 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.7 p -92.69 153.55 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.76 -1.212 . . . . 74.409999999999997 109.221 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.7 m -127.54 166.54 17.8 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.257 -1.016 . . . . 72.310000000000002 108.257 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 77' ' ' ASN . 23.0 t -170.8 126.41 0.72 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.967 -1.083 . . . . 64.540000000000006 110.415 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 57.3 p30 -71.69 14.67 0.18 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.569 -0.707 . . . . 74.129999999999995 110.121 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.469 ' H ' ' C ' ' A' ' 75' ' ' SER . 22.6 m120 -138.43 73.91 41.82 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.195 -0.941 . . . . 73.340000000000003 109.933 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.6 76.53 4.49 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.682 2.255 . . . . 71.319999999999993 112.358 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.92 154.63 19.82 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.296 -1.001 . . . . 62.530000000000001 108.296 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.45 -25.08 2.33 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.171 -0.956 . . . . 74.140000000000001 109.738 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -69.72 -50.61 41.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.944 . . . . 71.420000000000002 110.149 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 77' ' ' ASN . 88.9 mt-10 -71.32 -27.74 63.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.097 -1.002 . . . . 73.430000000000007 110.162 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -64.21 -56.93 11.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.091 -1.005 . . . . 74.219999999999999 109.764 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.401 ' CG2' ' N ' ' A' ' 85' ' ' HIS . 17.9 m -66.13 -40.96 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 74.150000000000006 109.676 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.442 ' NE2' HE21 ' A' ' 89' ' ' GLN . 27.7 t-80 -64.7 -38.99 92.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.21 -0.931 . . . . 72.540000000000006 109.744 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.52 95.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 64.219999999999999 110.178 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.507 ' CE1' ' NH1' ' B' ' 108' ' ' ARG . 44.2 m-85 -72.84 -31.01 64.48 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.038 -1.039 . . . . 74.340000000000003 108.605 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -73.71 -34.73 64.95 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.412 -0.805 . . . . 74.420000000000002 109.261 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.442 HE21 ' NE2' ' A' ' 85' ' ' HIS . 76.9 mm-40 -62.86 -55.85 22.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.896 . . . . 74.519999999999996 109.441 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.63 29.0 0.08 OUTLIER Glycine 0 N--CA 1.498 2.804 0 C-N-CA 119.813 -1.184 . . . . 74.209999999999994 110.425 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.49 128.57 39.66 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.935 -1.332 . . . . 64.099999999999994 108.995 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.638 ' HB3' HH21 ' A' ' 112' ' ' ARG . 36.2 m-20 -64.68 -36.41 84.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.978 -1.076 . . . . 73.420000000000002 108.971 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 94' ' ' TYR . 62.8 t0 -152.53 145.65 24.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.373 -0.829 . . . . 75.040000000000006 108.943 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.497 ' CD1' ' C ' ' A' ' 94' ' ' TYR . 0.4 OUTLIER -123.15 121.54 36.23 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.985 -0.746 . . . . 71.329999999999998 108.985 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.496 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -108.98 141.92 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 121.789 0.804 . . . . 74.510000000000005 109.526 -178.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . -62.35 125.15 22.91 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.16 -1.422 . . . . 64.319999999999993 107.16 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.567 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -44.33 -57.13 6.86 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.004 -1.06 . . . . 74.510000000000005 111.102 -178.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 7.4 Cg_endo -44.2 90.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 CA-C-N 119.467 0.845 . . . . 73.109999999999999 111.17 -176.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.567 ' N ' ' O ' ' A' ' 97' ' ' LYS . 42.8 m-85 -44.18 104.26 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.625 -0.672 . . . . 72.540000000000006 109.97 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 31.2 ttm-85 -54.49 -25.6 26.38 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.595 -0.891 . . . . 74.540000000000006 108.595 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.738 ' O ' ' N ' ' A' ' 103' ' ' LYS . 15.7 t -178.07 24.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.398 -0.814 . . . . 74.140000000000001 109.866 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 87.9 mt 52.89 -70.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.66 -0.65 . . . . 75.430000000000007 109.609 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.738 ' N ' ' O ' ' A' ' 101' ' ' SER . 48.9 mttp -56.2 -23.04 32.83 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.517 -1.29 . . . . 74.140000000000001 107.517 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.08 -45.47 73.7 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.929 -1.137 . . . . 63.240000000000002 107.929 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.6 tp -65.48 -51.7 58.18 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.681 -0.859 . . . . 73.219999999999999 108.681 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 38.3 t -58.36 -42.73 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.108 -0.995 . . . . 74.540000000000006 108.654 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.87 -39.55 59.15 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.304 -0.872 . . . . 75.5 108.881 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 53.8 mtp180 -66.94 -35.6 80.33 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.192 -0.942 . . . . 74.409999999999997 108.811 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.9 mt -75.56 -26.76 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.21 -0.931 . . . . 73.239999999999995 108.992 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -65.4 -52.06 56.04 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.448 -0.783 . . . . 74.340000000000003 110.137 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -74.86 -29.35 61.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.111 -0.993 . . . . 73.319999999999993 110.382 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.638 HH21 ' HB3' ' A' ' 92' ' ' ASP . 33.9 ttt85 -61.03 -44.24 97.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.041 . . . . 74.420000000000002 109.895 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -150.79 82.58 1.34 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.8 -1.187 . . . . 74.329999999999998 109.745 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.01 -58.03 2.27 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.485 -0.932 . . . . 74.439999999999998 108.485 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -69.08 -58.04 4.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 74.430000000000007 109.662 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 46.22 85.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.232 -0.917 . . . . 74.439999999999998 109.662 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.99 99.41 0.12 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.3 -1.52 . . . . 75.040000000000006 109.3 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.7 t -152.61 162.67 40.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.197 -1.178 . . . . 70.109999999999999 109.894 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.545 ' ND2' ' N ' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -157.61 129.45 6.99 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.966 -0.753 . . . . 65.239999999999995 108.966 -178.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 17.3 t -91.11 -32.77 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.185 -0.947 . . . . 74.219999999999999 109.268 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 24.9 mm -107.53 137.23 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.934 -0.765 . . . . 74.420000000000002 108.934 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -148.89 136.6 20.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.067 -1.021 . . . . 73.299999999999997 109.982 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.5 pt -151.54 134.75 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.432 -0.793 . . . . 75.340000000000003 109.112 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 45.84 -142.28 4.58 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.747 -1.341 . . . . 75.129999999999995 109.747 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -85.59 -5.96 59.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.257 -1.143 . . . . 74.450000000000003 109.393 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.12 136.69 32.92 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.336 -0.987 . . . . 54.210000000000001 108.336 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.7 m -130.61 144.07 51.17 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.387 -0.82 . . . . 70.239999999999995 109.605 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 82.5 mt -133.28 137.69 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.291 -0.88 . . . . 72.430000000000007 109.475 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.4 m -121.77 85.22 44.38 Favored Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 109.069 -0.715 . . . . 71.109999999999999 109.069 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.89 -41.05 82.19 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.549 2.166 . . . . 75.140000000000001 112.237 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -59.05 -46.9 87.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 72.5 109.293 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -82.7 -7.06 59.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 73.140000000000001 109.153 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.408 ' OE2' ' O ' ' A' ' 144' ' ' VAL . 70.8 tt0 56.98 58.49 3.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.411 -0.806 . . . . 75.329999999999998 109.567 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -148.65 123.94 10.23 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.294 -0.879 . . . . 71.230000000000004 109.435 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.5 ' N ' ' CD1' ' A' ' 135' ' ' ILE . 1.6 mp -96.94 138.07 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.217 -0.927 . . . . 75.329999999999998 109.392 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.3 mm -115.11 127.89 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 109.023 -0.732 . . . . 71.109999999999999 109.023 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.449 ' OH ' ' O ' ' A' ' 199' ' ' LEU . 79.5 t80 -136.43 123.71 21.88 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.356 -0.84 . . . . 74.140000000000001 109.48 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 66.3 mttm 53.52 33.85 17.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.335 -0.853 . . . . 75.400000000000006 110.032 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.11 11.09 85.71 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.292 -1.123 . . . . 72.239999999999995 110.292 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 50.3 mtp85 -94.91 124.49 38.98 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.143 -1.21 . . . . 73.120000000000005 109.073 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -94.88 119.31 33.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.259 -0.901 . . . . 72.319999999999993 109.608 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.6 p -135.61 137.7 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.469 -0.769 . . . . 62.340000000000003 109.297 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 143' ' ' GLU . 46.1 mp0 -95.98 154.46 17.22 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.323 -0.86 . . . . 61.229999999999997 109.298 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.408 ' O ' ' OE2' ' A' ' 133' ' ' GLU . 29.9 m -139.61 144.09 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.365 -0.834 . . . . 74.439999999999998 109.551 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -168.47 21.77 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.937 . . . . 75.420000000000002 109.751 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.19 -174.93 50.63 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.333 -1.507 . . . . 73.340000000000003 109.333 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.633 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 5.8 ttpm? -83.14 -32.76 0.55 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.3 -1.118 . . . . 72.219999999999999 111.048 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 91.6 Cg_endo -89.37 -16.67 2.04 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 122.149 1.899 . . . . 75.450000000000003 112.733 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -81.99 -24.87 35.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.108 -0.995 . . . . 65.239999999999995 109.818 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.525 ' O ' ' ND1' ' A' ' 154' ' ' HIS . 95.8 mt-10 -51.53 -31.94 26.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.097 -1.002 . . . . 72.519999999999996 108.862 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.4 p -63.56 -36.76 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.438 -0.789 . . . . 74.209999999999994 109.07 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.427 ' CD1' ' SD ' ' A' ' 195' ' ' MET . 21.3 tp -62.92 -42.47 99.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 73.310000000000002 109.084 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.4 m -72.47 -36.88 68.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.403 -0.81 . . . . 74.310000000000002 109.864 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 150' ' ' GLU . 8.2 m80 -60.7 -52.71 63.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.122 -0.986 . . . . 75.450000000000003 110.182 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 159' ' ' ARG . 3.2 pp -68.89 -25.97 64.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.866 -1.146 . . . . 75.340000000000003 109.589 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.73 -52.68 64.03 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.136 -0.977 . . . . 62.140000000000001 109.241 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.525 ' HE ' ' CE1' ' A' ' 158' ' ' HIS . 5.0 ptm85 -68.28 -43.4 77.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.351 -0.843 . . . . 72.219999999999999 109.651 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.525 ' CE1' ' HE ' ' A' ' 157' ' ' ARG . 35.8 m80 -95.29 29.38 2.53 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.104 -0.998 . . . . 74.120000000000005 109.251 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 155' ' ' LEU . 27.8 ttt85 -60.13 -21.76 61.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.317 -0.865 . . . . 74.340000000000003 109.519 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 41.8 p30 -115.6 66.65 0.7 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.009 -0.737 . . . . 75.450000000000003 109.009 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 162' ' ' ILE . 10.3 tm0? -164.3 156.8 16.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.161 -0.962 . . . . 73.409999999999997 109.378 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.528 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 9.3 mm -82.33 123.99 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.214 -0.929 . . . . 74.409999999999997 109.312 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.62 136.95 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.508 -0.745 . . . . 72.530000000000001 109.628 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.0 p -91.86 159.69 15.66 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.329 -0.857 . . . . 74.120000000000005 109.425 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.4 mtmm -59.87 -45.55 92.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 70.430000000000007 109.486 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -62.85 -31.59 72.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 74.319999999999993 109.732 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -59.99 -44.98 94.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.125 -0.984 . . . . 74.519999999999996 109.456 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 37.7 mt -64.72 -44.19 91.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 74.409999999999997 109.578 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 11.8 tp -64.58 -43.8 92.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.306 -0.871 . . . . 75.140000000000001 109.528 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -75.2 -10.0 59.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 65.030000000000001 109.705 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.02 -54.75 3.98 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -0.915 . . . . 70.209999999999994 109.804 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.506 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 1.9 mp -88.04 -50.1 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.168 -0.957 . . . . 75.319999999999993 109.858 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 17.9 m-90 . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.069 -1.019 . . . . 73.140000000000001 109.881 -179.413 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 21.0 p30 . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.233 -0.655 . . . . 73.129999999999995 109.233 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.8 p -171.52 -29.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 74.019999999999996 109.367 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.424 HG22 HD12 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -53.57 -41.01 44.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.352 -0.843 . . . . 72.329999999999998 109.58 -179.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.4 ' N ' ' CG2' ' A' ' 184' ' ' ILE . 18.5 mt-10 -54.51 -38.45 66.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.849 -1.157 . . . . 74.400000000000006 109.375 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 2.3 t -75.46 -34.7 30.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.388 -0.82 . . . . 74.319999999999993 109.605 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.0 -51.04 23.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 73.230000000000004 109.869 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.2 tp -61.88 -32.62 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.984 -1.072 . . . . 74.310000000000002 109.745 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -66.31 -55.77 14.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.118 -0.989 . . . . 73.439999999999998 110.215 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -67.0 -41.53 86.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.038 -1.039 . . . . 71.420000000000002 109.665 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 71.6 mt -56.88 -44.43 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.098 -1.001 . . . . 72.439999999999998 109.136 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.4 mtp-105 -57.54 -44.14 84.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 64.219999999999999 108.947 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -67.28 -36.43 81.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.876 . . . . 74.319999999999993 109.332 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.495 ' O ' ' CG ' ' A' ' 198' ' ' PRO . 96.0 mttt -71.69 -15.8 62.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.867 . . . . 75.310000000000002 109.761 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' MET . . . . . 0.427 ' SD ' ' CD1' ' A' ' 152' ' ' LEU . 86.2 mmm -93.62 -15.45 25.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.097 -1.002 . . . . 74.019999999999996 109.968 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -102.82 -9.38 20.0 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.137 -0.977 . . . . 74.019999999999996 110.38 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.557 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 3.8 tmtp? -89.63 -42.45 0.43 Allowed Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.917 -1.114 . . . . 75.430000000000007 110.241 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 38.1 Cg_endo -90.4 -58.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.688 2.259 . . . . 72.319999999999993 112.493 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.462 ' C ' ' H ' ' A' ' 201' ' ' ILE . 3.3 mm? -61.3 -33.82 74.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.911 -1.118 . . . . 74.540000000000006 108.877 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 75.22 -15.94 3.94 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.689 -1.364 . . . . 61.509999999999998 109.689 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.462 ' H ' ' C ' ' A' ' 199' ' ' LEU . 6.1 mt -115.49 129.36 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.479 -1.013 . . . . 74.25 109.011 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 12.6 t -79.94 139.09 37.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.061 -1.024 . . . . 72.0 109.242 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.503 ' CG2' HH21 ' A' ' 159' ' ' ARG . 3.8 p -139.88 7.72 2.28 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.295 -0.878 . . . . 74.439999999999998 109.647 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.37 133.68 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.461 -0.774 . . . . 71.129999999999995 109.413 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 39.8 tp10 -114.45 133.95 55.36 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.55 -0.719 . . . . 73.510000000000005 109.394 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.7 p -99.42 139.96 34.31 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.285 -0.885 . . . . 73.519999999999996 109.261 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 211' ' ' GLY . 18.5 m -149.86 136.75 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.231 -0.918 . . . . 72.150000000000006 109.46 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -85.66 -13.65 47.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 72.400000000000006 109.343 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -55.16 -34.13 63.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.271 -0.893 . . . . 73.310000000000002 109.485 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 64.7 mtp85 -151.18 -63.12 0.19 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.263 -0.898 . . . . 71.540000000000006 109.405 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 207' ' ' VAL . . . -161.89 -114.14 0.32 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.657 -1.377 . . . . 74.450000000000003 109.657 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -126.2 124.31 40.16 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.601 -0.941 . . . . 75.540000000000006 109.474 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 26.1 ttm105 -90.28 121.48 32.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.36 -0.837 . . . . 75.310000000000002 109.006 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -95.96 123.98 39.78 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.304 -0.872 . . . . 75.409999999999997 109.337 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 44.2 t -154.84 152.22 29.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.434 -0.792 . . . . 74.140000000000001 109.069 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.36 145.0 84.82 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.089 -1.007 . . . . 75.319999999999993 108.791 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo . . . . . 0 N--CA 1.49 1.291 0 C-N-CA 122.212 1.941 . . . . 73.109999999999999 112.334 -179.926 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 53.2 ttm . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.478 -0.564 . . . . 75.239999999999995 109.478 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.58 ' NH1' ' HE ' ' B' ' 43' ' ' ARG . 39.9 ttt85 -139.8 146.73 39.79 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.375 -0.828 . . . . 73.519999999999996 109.397 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 73.2 t -118.0 137.11 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 121.583 0.706 . . . . 72.239999999999995 109.669 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 3.3 tp -108.8 117.65 34.73 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.576 -0.898 . . . . 73.340000000000003 108.576 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.404 ' CD1' ' SD ' ' B' ' 49' ' ' MET . 5.4 tp -119.4 101.42 7.94 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.071 -0.714 . . . . 74.349999999999994 109.071 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 53.8 mt -91.71 97.72 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.907 -1.12 . . . . 63.439999999999998 108.749 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.422 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 31.8 tp10 -123.42 136.79 54.8 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.611 0.72 . . . . 74.519999999999996 109.407 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -77.76 -32.74 52.78 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.526 -0.734 . . . . 74.129999999999995 109.308 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -90.02 115.41 27.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.364 -0.835 . . . . 74.230000000000004 109.367 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 15.6 t -65.78 -30.88 71.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.229 -0.919 . . . . 65.540000000000006 109.821 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 85.8 t -61.67 -50.29 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.133 -0.98 . . . . 75.549999999999997 109.791 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.514 ' CD2' ' N ' ' B' ' 12' ' ' LEU . 3.5 mm? -64.83 -31.34 72.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 70.140000000000001 109.439 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.26 -29.94 57.69 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.744 -1.743 . . . . 75.400000000000006 108.744 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.87 -51.64 54.17 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.584 -1.406 . . . . 65.439999999999998 109.584 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -63.17 -42.09 99.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.331 -1.099 . . . . 72.200000000000003 109.622 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 4.8 mm -65.41 -38.61 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.009 -1.057 . . . . 75.150000000000006 108.768 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -64.83 -54.37 32.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.382 -0.824 . . . . 73.010000000000005 109.986 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -72.64 -6.26 43.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.147 -0.971 . . . . 74.299999999999997 109.771 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.87 -55.35 2.83 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.657 -1.377 . . . . 70.540000000000006 109.657 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp -74.17 -23.42 59.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.38 -1.071 . . . . 75.430000000000007 109.802 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -53.74 -35.98 61.8 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.152 -0.968 . . . . 73.200000000000003 109.394 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 98.0 t -55.25 -42.31 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.205 -0.935 . . . . 74.230000000000004 109.198 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 18.7 mmtp -64.64 -13.02 51.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.309 -0.869 . . . . 73.519999999999996 108.685 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.06 32.3 23.77 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.125 -1.19 . . . . 53.43 110.125 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -102.37 159.24 15.59 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.243 -1.151 . . . . 71.120000000000005 108.48 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 15.5 mtt -100.01 137.84 37.91 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.288 -1.004 . . . . 75.239999999999995 108.288 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.57 150.86 39.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 73.25 109.984 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . 0.531 ' OD2' ' NH2' ' B' ' 2' ' ' ARG . 75.2 m-20 -126.16 144.35 50.79 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.822 -0.807 . . . . 72.310000000000002 108.822 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 1.4 p -112.13 129.07 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.716 -0.846 . . . . 72.140000000000001 108.716 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 6.8 p -134.1 167.85 19.89 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.533 -0.729 . . . . 74.530000000000001 109.455 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -93.79 -97.47 0.15 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.247 -0.908 . . . . 71.019999999999996 109.808 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 51.9 p -78.15 165.16 24.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.195 -0.941 . . . . 71.400000000000006 110.25 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' B' ' 37' ' ' GLU . 46.9 mt -55.01 -35.29 64.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.567 -0.708 . . . . 71.239999999999995 110.218 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -55.98 -44.19 78.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.053 -1.029 . . . . 74.319999999999993 109.831 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -62.47 -41.26 98.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.142 -0.974 . . . . 73.030000000000001 109.311 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . 0.438 ' O ' ' CG ' ' B' ' 40' ' ' MET . . . -80.63 -23.82 59.55 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.421 -1.472 . . . . 60.43 109.421 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' B' ' 33' ' ' LEU . 84.8 tt0 -66.43 -44.72 82.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -1.152 . . . . 74.430000000000007 109.661 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -79.3 -35.07 41.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.105 -0.997 . . . . 74.420000000000002 109.706 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 8.4 tt -73.82 -37.03 65.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 75.409999999999997 110.108 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.442 ' SD ' ' CE1' ' B' ' 45' ' ' TYR . 2.8 ppp? -76.15 -32.28 59.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.935 -1.103 . . . . 61.439999999999998 109.902 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -51.38 -37.03 46.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.926 . . . . 74.319999999999993 110.374 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 11.2 pt -78.94 -33.54 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.0 -1.062 . . . . 71.230000000000004 110.114 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.58 ' HE ' ' NH1' ' B' ' 2' ' ' ARG . 30.2 mmt-85 -93.96 168.6 10.86 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.906 -1.121 . . . . 73.409999999999997 110.024 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' ASN . . . . . 0.517 ' C ' ' CD1' ' B' ' 45' ' ' TYR . 30.9 p30 -92.85 -19.31 21.83 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.298 -0.876 . . . . 63.539999999999999 109.954 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.517 ' CD1' ' C ' ' B' ' 44' ' ' ASN . 11.0 p90 40.11 97.86 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.566 -0.709 . . . . 73.109999999999999 110.997 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -80.41 -38.04 31.0 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.056 -1.028 . . . . 62.219999999999999 109.1 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.64 114.36 28.42 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.745 -1.206 . . . . 73.120000000000005 107.745 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 65.4 t -99.07 97.78 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.224 -0.922 . . . . 74.109999999999999 108.846 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' MET . . . . . 0.404 ' SD ' ' CD1' ' B' ' 5' ' ' LEU . 25.5 ttt -113.58 131.4 56.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.554 -0.717 . . . . 73.439999999999998 109.782 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.435 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.5 OUTLIER -144.89 135.46 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.535 -0.728 . . . . 73.400000000000006 109.234 -179.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' SER . . . . . 0.573 ' CB ' ' HG ' ' B' ' 74' ' ' SER . 38.8 p -103.17 15.06 30.28 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.552 -0.718 . . . . 73.209999999999994 109.79 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.435 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 83.0 m-20 -77.83 144.92 36.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.104 -0.998 . . . . 70.409999999999997 109.467 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.481 ' C ' ' H ' ' B' ' 55' ' ' ALA . 41.6 mmtm -74.37 -43.31 57.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.224 -0.923 . . . . 73.129999999999995 110.164 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -72.86 13.14 0.41 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.07 -1.019 . . . . 75.209999999999994 109.786 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -69.34 -22.35 63.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 55.329999999999998 110.136 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 19.7 mt -42.04 -52.34 4.26 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.508 -0.745 . . . . 72.420000000000002 110.083 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' SER . . . . . 0.426 ' O ' ' OG ' ' B' ' 60' ' ' SER . 24.7 m -66.44 -35.07 79.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.956 -1.09 . . . . 73.040000000000006 109.082 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -65.26 -62.18 1.69 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.466 -0.771 . . . . 72.329999999999998 110.0 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 32.5 m -49.33 -34.08 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.637 -1.289 . . . . 74.540000000000006 109.962 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' B' ' 57' ' ' SER . 24.6 p -59.42 -53.66 55.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.052 -1.03 . . . . 71.239999999999995 109.739 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -66.24 -27.93 68.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.036 -1.04 . . . . 74.310000000000002 110.125 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 32.9 mm -65.5 -38.82 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.767 -1.208 . . . . 75.420000000000002 109.894 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -70.72 -47.81 57.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.028 -1.045 . . . . 73.319999999999993 110.598 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -69.77 -40.41 76.09 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.873 -1.142 . . . . 73.310000000000002 110.335 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.488 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 62.7 mttm -75.84 -24.31 55.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.13 -0.981 . . . . 72.439999999999998 109.979 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . 0.488 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 90.5 m-70 -155.71 64.48 0.6 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.116 -0.99 . . . . 65.209999999999994 109.719 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 22.8 t -57.2 -27.93 62.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -0.889 . . . . 73.099999999999994 109.606 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 92.0 p -65.17 -23.08 67.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 71.530000000000001 109.906 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 60.5 mt -82.32 158.45 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.186 -0.946 . . . . 74.400000000000006 109.533 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 70.3 t -98.83 150.82 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.288 -0.883 . . . . 75.120000000000005 109.608 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 16.2 t -130.38 126.51 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.386 -0.821 . . . . 73.200000000000003 109.95 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 6.5 tt -121.98 100.34 6.93 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 109.094 -0.706 . . . . 73.340000000000003 109.094 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 9.2 p -93.71 134.87 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.981 -1.075 . . . . 73.5 109.253 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' SER . . . . . 0.573 ' HG ' ' CB ' ' B' ' 51' ' ' SER . 11.9 p -96.08 172.19 8.14 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.219 -0.926 . . . . 71.319999999999993 109.228 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.603 ' CB ' ' HH ' ' B' ' 94' ' ' TYR . 33.6 t -156.23 112.99 3.13 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.98 -1.075 . . . . 74.530000000000001 110.183 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' B' ' 77' ' ' ASN . 54.5 p30 -70.64 -12.13 61.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 64.5 109.217 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . 0.449 ' N ' ' OD1' ' B' ' 76' ' ' ASP . 87.2 m-20 -134.3 73.84 68.32 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.686 -0.857 . . . . 74.25 108.686 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -50.1 84.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.649 2.233 . . . . 74.430000000000007 111.781 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.449 ' N ' ' O ' ' B' ' 77' ' ' ASN . 7.1 p -100.33 151.18 21.8 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.941 -0.762 . . . . 73.120000000000005 108.941 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.99 -29.93 69.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.176 -0.953 . . . . 75.409999999999997 109.064 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -65.66 -37.01 85.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.304 -0.872 . . . . 72.239999999999995 109.251 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -74.75 -30.81 61.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.185 -0.947 . . . . 73.219999999999999 109.584 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -69.3 -50.2 48.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.95 . . . . 74.299999999999997 109.817 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 28.3 m -62.1 -36.73 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.088 -1.008 . . . . 73.310000000000002 109.38 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -77.92 -20.11 53.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 73.239999999999995 109.544 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.6 -42.6 58.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.188 -0.945 . . . . 55.329999999999998 110.275 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -83.13 -29.48 28.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.956 -1.09 . . . . 74.450000000000003 109.238 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -75.86 -37.91 58.45 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.308 -0.87 . . . . 64.040000000000006 109.741 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . 0.482 ' CG ' ' N ' ' B' ' 90' ' ' GLY . 11.8 pt20 -73.02 -47.44 45.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.107 -0.995 . . . . 75.129999999999995 109.792 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . 0.482 ' N ' ' CG ' ' B' ' 89' ' ' GLN . . . 147.38 65.35 0.01 OUTLIER Glycine 0 N--CA 1.495 2.614 0 C-N-CA 119.776 -1.202 . . . . 75.420000000000002 110.395 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.24 138.15 53.6 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.363 -1.08 . . . . 73.420000000000002 108.978 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . 0.517 ' CG ' HH21 ' B' ' 112' ' ' ARG . 46.1 t0 -86.54 -26.18 24.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.097 -1.002 . . . . 73.319999999999993 109.608 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 14.4 t0 -152.41 153.09 32.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 73.040000000000006 109.578 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.603 ' HH ' ' CB ' ' B' ' 75' ' ' SER . 61.7 t80 -134.27 101.49 5.03 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.545 -0.909 . . . . 74.310000000000002 108.545 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . 0.421 HG22 HD12 ' B' ' 95' ' ' ILE . 23.1 mm -110.28 147.9 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.437 0 O-C-N 121.133 -0.98 . . . . 75.340000000000003 110.283 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.48 145.36 56.23 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.832 -1.173 . . . . 70.099999999999994 107.832 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.68 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -66.24 -56.53 15.93 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.671 -1.268 . . . . 65.430000000000007 111.58 -179.058 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 2.2 Cg_endo -39.88 -12.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 120.909 1.073 . . . . 63.520000000000003 112.824 -175.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . 0.68 ' N ' ' O ' ' B' ' 97' ' ' LYS . 53.7 m-85 59.59 137.09 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.86 -0.525 . . . . 75.129999999999995 110.315 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 50.8 mtt-85 -73.73 -40.28 63.67 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.982 -1.074 . . . . 74.230000000000004 108.808 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' SER . . . . . 0.753 ' O ' ' N ' ' B' ' 103' ' ' LYS . 34.4 t -168.1 33.8 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.162 -0.961 . . . . 64.510000000000005 110.782 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 37.3 mm 50.71 -69.62 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.567 -0.708 . . . . 74.439999999999998 110.341 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . 0.753 ' N ' ' O ' ' B' ' 101' ' ' SER . 40.3 mmtm -55.12 -30.49 59.87 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.865 -1.161 . . . . 72.299999999999997 107.865 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.78 -55.69 13.78 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.604 -0.839 . . . . 74.310000000000002 109.011 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 19.0 tp -58.05 -43.78 87.06 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.33 -0.856 . . . . 73.540000000000006 108.762 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.21 -47.88 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -0.93 . . . . 72.030000000000001 108.853 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -49.2 -38.01 24.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.14 -0.975 . . . . 64.219999999999999 108.885 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . 0.531 ' O ' ' NE ' ' B' ' 108' ' ' ARG . 0.0 OUTLIER -67.6 -35.25 78.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.476 -0.765 . . . . 75.310000000000002 108.97 179.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 64.3 mt -78.28 -29.94 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.066 -1.022 . . . . 55.439999999999998 109.435 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -67.9 -52.49 35.75 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.537 -0.727 . . . . 65.310000000000002 109.868 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.41 -38.04 74.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.194 -0.942 . . . . 74.519999999999996 110.035 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . 0.517 HH21 ' CG ' ' B' ' 92' ' ' ASP . 40.6 ttt85 -57.84 -35.6 71.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.993 -1.067 . . . . 72.040000000000006 109.704 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 tt -144.07 103.01 3.96 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.097 -1.002 . . . . 75.349999999999994 109.492 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.458 ' NE ' ' H ' ' B' ' 115' ' ' PHE . 0.1 OUTLIER -142.09 -164.37 1.79 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.43 -0.952 . . . . 75.5 108.43 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' PHE . . . . . 0.458 ' H ' ' NE ' ' B' ' 114' ' ' ARG . 45.4 m-85 51.88 32.34 9.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.042 -1.037 . . . . 73.040000000000006 109.294 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' TRP . . . . . 0.757 ' CE3' ' O ' ' B' ' 117' ' ' GLY . 74.4 t90 53.66 169.01 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.499 -0.751 . . . . 74.450000000000003 110.196 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . 0.757 ' O ' ' CE3' ' B' ' 116' ' ' TRP . . . -47.38 145.45 4.75 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.864 -1.294 . . . . 64.209999999999994 109.864 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' SER . . . . . 0.698 ' HG ' ' H ' ' B' ' 119' ' ' ASN . 43.0 t -94.22 172.87 7.94 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.425 -1.044 . . . . 71.400000000000006 109.406 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . 0.698 ' H ' ' HG ' ' B' ' 118' ' ' SER . 27.4 t-20 -142.24 178.86 7.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.311 -0.868 . . . . 74.209999999999994 109.043 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . 0.453 ' H ' ' CG ' ' B' ' 119' ' ' ASN . 18.8 t -140.16 -45.15 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.243 -0.911 . . . . 75.019999999999996 109.233 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 9.2 mm -97.89 111.14 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.057 -1.027 . . . . 74.239999999999995 108.501 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -128.23 105.49 8.39 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.496 -0.753 . . . . 73.329999999999998 109.287 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.402 ' O ' ' CG2' ' B' ' 123' ' ' ILE . 10.5 tp -145.2 122.79 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.165 -0.96 . . . . 74.219999999999999 109.077 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' B' ' 126' ' ' LEU . . . 54.86 -170.98 1.3 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.464 -1.855 . . . . 72.409999999999997 108.464 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.96 2.91 0.63 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.896 -1.356 . . . . 75.120000000000005 108.877 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.534 ' H ' ' C ' ' B' ' 124' ' ' GLY . 0.6 OUTLIER -91.73 117.21 29.55 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.685 -0.857 . . . . 75.420000000000002 108.685 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 83.0 m -125.11 140.92 52.46 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.475 -0.766 . . . . 74.219999999999999 108.964 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 6.3 mt -141.22 136.21 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.271 -0.893 . . . . 60.329999999999998 110.463 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 13.4 m -114.78 114.59 44.23 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.958 -0.756 . . . . 72.310000000000002 108.958 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -83.48 -40.12 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.248 1.965 . . . . 75.129999999999995 112.172 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -63.34 -49.72 72.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.392 -0.818 . . . . 75.230000000000004 109.492 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -81.83 -0.17 42.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.955 . . . . 75.120000000000005 109.278 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 50.34 74.25 0.23 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.123 -0.985 . . . . 75.129999999999995 109.605 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -159.33 129.64 5.76 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.075 -1.015 . . . . 75.109999999999999 109.351 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 12.4 tt -109.37 128.97 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.795 -0.817 . . . . 70.319999999999993 108.795 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 69.2 mt -116.39 126.48 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-O 121.535 0.683 . . . . 74.120000000000005 110.404 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -135.74 147.03 48.28 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.943 -0.762 . . . . 74.230000000000004 108.943 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm 54.03 36.11 23.77 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.554 -0.716 . . . . 74.219999999999999 110.719 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 64.5 7.75 28.64 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.985 -1.246 . . . . 74.319999999999993 109.985 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -107.04 124.48 49.71 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.478 -1.013 . . . . 75.340000000000003 108.536 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -80.92 143.2 32.82 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.416 -0.803 . . . . 71.230000000000004 109.882 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 22.5 t -134.3 129.92 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.64 -0.874 . . . . 70.430000000000007 108.64 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -83.2 149.41 26.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.343 -0.848 . . . . 72.430000000000007 109.662 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 144' ' ' VAL . . . . . 0.69 HG22 ' CZ ' ' B' ' 149' ' ' PHE . 2.5 m -153.05 144.42 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 72.129999999999995 109.384 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 27.2 pttt -175.47 101.86 0.08 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.239 -0.913 . . . . 74.5 109.262 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 177.52 174.16 43.65 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.663 -1.256 . . . . 42.229999999999997 110.246 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . 0.604 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 10.0 tttt -62.4 -42.4 79.86 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.457 -1.025 . . . . 73.299999999999997 109.706 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 23.3 Cg_exo -62.65 -32.45 79.0 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.575 2.184 . . . . 71.329999999999998 112.461 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . 0.69 ' CZ ' HG22 ' B' ' 144' ' ' VAL . 71.9 t80 -92.43 -15.35 27.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.129 -0.982 . . . . 74.230000000000004 109.886 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -60.88 -41.12 95.39 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.093 -1.004 . . . . 72.340000000000003 109.759 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 8.6 p -72.92 -40.6 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.223 -0.923 . . . . 73.349999999999994 110.051 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 21.1 tp -56.9 -31.21 64.66 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.268 -0.895 . . . . 74.430000000000007 109.119 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 153' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' B' ' 149' ' ' PHE . 0.2 OUTLIER -76.84 -46.67 23.88 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.488 -0.757 . . . . 75.209999999999994 109.183 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -50.29 -46.42 55.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.188 -0.945 . . . . 73.040000000000006 110.507 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 1.9 pp -73.77 -34.68 64.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.648 -1.283 . . . . 73.430000000000007 109.383 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -50.19 -35.8 27.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.096 -1.002 . . . . 75.319999999999993 108.951 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -79.16 -46.47 17.87 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.384 -0.823 . . . . 73.319999999999993 109.175 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -85.57 49.04 1.68 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.666 -0.646 . . . . 74.140000000000001 111.068 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . 0.519 ' NH2' ' OG1' ' B' ' 203' ' ' THR . 5.6 tpt180 -72.83 171.57 12.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.846 -1.159 . . . . 73.420000000000002 108.097 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . 0.4 ' H ' ' HG3' ' B' ' 159' ' ' ARG . 51.1 t0 54.48 60.24 3.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.828 -1.17 . . . . 72.099999999999994 109.566 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -171.58 147.23 2.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.309 -0.87 . . . . 73.239999999999995 109.312 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 21.8 mm -83.63 122.31 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 72.310000000000002 108.89 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 97.1 t -119.64 139.4 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.393 -0.817 . . . . 75.030000000000001 109.553 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 5.4 t -99.69 160.46 14.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.341 -0.849 . . . . 74.219999999999999 110.047 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . 0.468 ' HZ1' ' CG2' ' B' ' 184' ' ' ILE . 18.0 mtpp -61.55 -44.61 96.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.528 -0.733 . . . . 72.420000000000002 109.609 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -50.54 -39.75 49.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.477 -0.764 . . . . 63.450000000000003 110.254 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -59.29 -48.89 79.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.047 -1.033 . . . . 72.400000000000006 109.51 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 27.5 mt -58.31 -30.56 66.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.212 -0.93 . . . . 72.319999999999993 109.412 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.431 ' C ' ' CD1' ' B' ' 169' ' ' LEU . 2.3 tm? -66.92 -66.61 0.53 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.388 -0.82 . . . . 73.340000000000003 109.872 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.01 -2.07 6.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.311 -0.868 . . . . 73.099999999999994 110.874 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.91 -57.96 2.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.838 -1.164 . . . . 62.130000000000003 110.116 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.514 ' N ' ' CD1' ' B' ' 172' ' ' ILE . 1.9 mp -91.73 -45.39 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.955 -1.091 . . . . 74.439999999999998 110.123 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 16.5 m-90 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 120.909 -1.119 . . . . 72.230000000000004 108.686 179.796 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo . . . . . 0 N--CA 1.492 1.395 0 N-CA-C 112.914 0.313 . . . . 74.340000000000003 112.914 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 18.9 p30 -160.64 107.3 1.51 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.875 -1.14 . . . . 72.310000000000002 110.17 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 96.7 t -121.55 -36.0 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.489 -0.757 . . . . 65.420000000000002 109.477 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.468 ' CG2' ' HZ1' ' B' ' 165' ' ' LYS . 24.5 mm -60.84 -22.18 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 75.030000000000001 109.667 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.09 -42.0 99.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.123 -0.986 . . . . 73.519999999999996 110.259 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 5.2 m -79.42 -36.89 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.925 -1.109 . . . . 74.349999999999994 109.745 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.1 -46.84 64.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.12 -0.988 . . . . 61.119999999999997 109.714 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 188' ' ' ILE . . . . . 0.422 ' CG2' ' N ' ' B' ' 189' ' ' ASN . 9.1 tp -62.49 -42.51 96.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.088 -1.008 . . . . 72.430000000000007 110.028 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 189' ' ' ASN . . . . . 0.454 ' OD1' ' NH2' ' B' ' 192' ' ' ARG . 55.1 t30 -58.51 -43.69 89.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.024 . . . . 75.420000000000002 109.827 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -73.7 -38.03 65.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.176 -0.953 . . . . 74.140000000000001 110.319 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 60.9 mt -65.15 -49.14 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.136 -0.977 . . . . 74.030000000000001 110.824 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 192' ' ' ARG . . . . . 0.454 ' NH2' ' OD1' ' B' ' 189' ' ' ASN . 28.4 ptt180 -64.07 -37.33 87.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.84 -1.162 . . . . 72.329999999999998 108.131 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 193' ' ' GLN . . . . . 0.504 ' HG3' ' CE ' ' B' ' 197' ' ' LYS . 42.6 tt0 -65.18 -30.43 71.34 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.905 -1.146 . . . . 73.099999999999994 107.905 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . 0.629 ' O ' HD13 ' B' ' 199' ' ' LEU . 36.5 mtpt -93.44 2.74 56.37 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.084 -0.71 . . . . 74.430000000000007 109.084 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 195' ' ' MET . . . . . 1.208 ' HE3' ' OG1' ' B' ' 203' ' ' THR . 5.0 tpt -94.37 -22.31 18.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.959 -1.088 . . . . 74.329999999999998 109.703 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 196' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 5.1 m-20 -114.02 -27.35 7.74 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.107 -0.995 . . . . 71.209999999999994 111.918 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . 0.504 ' CE ' ' HG3' ' B' ' 193' ' ' GLN . 5.2 mtmm -79.06 -62.77 0.43 Allowed Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 120.427 -1.421 . . . . 75.209999999999994 111.288 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 198' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.66 -49.28 0.17 Allowed 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 121.787 1.658 . . . . 75.319999999999993 112.221 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . 0.629 HD13 ' O ' ' B' ' 194' ' ' LYS . 10.6 mp -54.35 -70.79 0.09 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.092 -1.005 . . . . 72.25 109.034 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 143.44 -59.15 0.53 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.51 -1.436 . . . . 73.239999999999995 109.51 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 29.3 mt -109.34 142.81 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.558 -0.966 . . . . 54.299999999999997 109.677 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 17.3 m -77.71 139.47 39.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.122 -0.987 . . . . 74.310000000000002 108.631 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 203' ' ' THR . . . . . 1.208 ' OG1' ' HE3' ' B' ' 195' ' ' MET . 70.7 p -129.55 5.96 5.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.439 -0.788 . . . . 74.400000000000006 109.759 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.881 HG12 ' HE1' ' B' ' 195' ' ' MET . 24.3 m -121.67 147.84 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.502 -0.749 . . . . 74.099999999999994 109.642 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -116.8 125.17 51.2 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.218 -0.66 . . . . 75.329999999999998 109.218 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.07 112.76 20.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.394 -0.817 . . . . 71.400000000000006 109.219 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.446 ' O ' ' O ' ' B' ' 211' ' ' GLY . 7.3 p -138.18 145.84 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.367 -0.833 . . . . 63.5 109.264 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -97.1 -15.78 20.81 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.105 -0.997 . . . . 74.450000000000003 110.11 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 66.5 mtt-85 -50.24 -39.83 45.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.154 -0.967 . . . . 74.140000000000001 109.859 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -140.04 -53.63 0.52 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.301 -0.875 . . . . 74.430000000000007 109.4 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 211' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' B' ' 207' ' ' VAL . . . 179.65 -102.31 0.16 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.468 -1.453 . . . . 70.109999999999999 109.468 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -136.48 135.31 38.49 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.346 -1.09 . . . . 74.209999999999994 108.948 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 43.5 mtt-85 -95.15 125.78 40.03 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.31 -0.869 . . . . 74.299999999999997 109.395 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -106.4 106.43 16.95 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.493 -0.754 . . . . 74.340000000000003 109.471 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 16.4 p -158.93 170.97 20.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.213 -0.93 . . . . 72.209999999999994 109.545 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -64.14 138.54 97.44 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 121.238 -0.914 . . . . 72.310000000000002 108.81 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 217' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' B' ' 218' ' ' LYS . 74.1 Cg_endo -73.54 77.34 2.59 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.248 1.966 . . . . 71.010000000000005 112.695 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' B' ' 217' ' ' PRO . 18.4 mttm . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.405 -0.809 . . . . 74.349999999999994 109.742 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.6 ' CE ' ' HE1' ' A' ' 116' ' ' TRP . 64.3 ttp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.492 -0.559 . . . . 65.120000000000005 109.492 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -138.03 151.43 47.87 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.342 -0.849 . . . . 73.310000000000002 109.297 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.8 t -116.79 135.53 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.748 -0.595 . . . . 71.420000000000002 109.632 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.74 122.73 48.53 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.36 -0.837 . . . . 65.219999999999999 109.181 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.0 mt -120.89 101.74 7.9 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.61 -0.681 . . . . 71.439999999999998 109.181 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.449 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 10.6 mt -79.27 104.61 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.781 -1.2 . . . . 71.150000000000006 108.753 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 9' ' ' ASN . 0.6 OUTLIER -139.16 123.19 17.86 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.306 -0.871 . . . . 75.340000000000003 109.215 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.44 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 68.3 mttm -65.35 -33.68 76.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 73.040000000000006 109.162 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.513 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 18.2 m120 -82.41 112.36 19.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 72.420000000000002 109.485 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 45.5 m -63.83 -26.31 68.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 72.340000000000003 109.653 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.29 -53.2 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.195 -0.941 . . . . 74.420000000000002 109.863 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.6 mt -61.42 -46.84 88.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 72.010000000000005 109.585 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.32 -17.1 71.99 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.517 -1.833 . . . . 72.140000000000001 108.517 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.4 -54.41 5.57 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.483 -1.447 . . . . 72.329999999999998 109.483 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -56.51 -44.9 81.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.425 -1.044 . . . . 72.340000000000003 109.783 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.2 mm -63.41 -34.99 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.822 -1.174 . . . . 74.239999999999995 108.798 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.449 ' CD ' HD22 ' A' ' 21' ' ' ASN . 14.2 tm-20 -57.91 -49.66 75.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.922 . . . . 71.409999999999997 109.102 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -87.52 3.47 47.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.26 -0.9 . . . . 75.540000000000006 109.262 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.66 -57.96 2.48 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.68 -1.368 . . . . 62.149999999999999 109.68 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -75.05 -19.98 59.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -1.146 . . . . 74.420000000000002 109.869 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.449 HD22 ' CD ' ' A' ' 17' ' ' GLU . 80.4 m-20 -51.29 -33.88 30.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.092 -1.005 . . . . 74.25 109.282 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.2 t -58.0 -46.95 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.322 -0.861 . . . . 72.109999999999999 108.938 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -56.91 -53.18 60.95 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.903 -0.777 . . . . 73.230000000000004 108.903 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 133.63 36.41 0.26 Allowed Glycine 0 N--CA 1.5 2.929 0 N-CA-C 109.735 -1.346 . . . . 75.540000000000006 109.735 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.59 ' CE2' ' SD ' ' A' ' 1' ' ' MET . 20.1 m-85 -119.39 160.02 23.1 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.483 -1.01 . . . . 74.510000000000005 109.344 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.2 mmt -104.22 140.34 37.98 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.571 -0.9 . . . . 64.319999999999993 108.571 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.417 ' O ' ' OD1' ' A' ' 28' ' ' ASP . . . -138.52 155.48 48.36 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.337 -0.852 . . . . 74.310000000000002 110.28 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 27' ' ' ALA . 82.1 m-20 -141.57 155.6 45.75 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.592 -0.892 . . . . 75.400000000000006 108.592 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.2 t -112.11 139.35 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.379 -0.826 . . . . 75.129999999999995 109.384 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.6 p -129.99 166.69 19.57 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.523 -0.736 . . . . 71.420000000000002 109.573 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.449 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 4.4 pt-20 -93.72 -102.98 0.13 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.348 -0.845 . . . . 73.109999999999999 109.809 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.7 p -79.31 168.88 18.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.115 -0.991 . . . . 74.239999999999995 109.891 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.0 mt -57.33 -33.32 67.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.521 -0.737 . . . . 71.530000000000001 109.742 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -51.27 -43.57 61.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 74.230000000000004 109.661 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -65.91 -41.92 90.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.154 -0.966 . . . . 71.010000000000005 109.373 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.25 -38.44 46.33 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.493 -1.443 . . . . 61.409999999999997 109.493 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.71 -38.18 90.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -1.135 . . . . 74.340000000000003 109.621 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -80.84 -39.47 26.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 75.329999999999998 109.717 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.9 tp -68.16 -46.35 70.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 74.329999999999998 110.077 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 41' ' ' ASP . 3.3 ppp? -62.73 -27.62 69.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.041 -1.037 . . . . 70.319999999999993 109.83 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 40' ' ' MET . 93.5 m-20 -63.49 -40.21 96.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.135 -0.978 . . . . 71.219999999999999 109.94 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.9 pt -84.0 -25.86 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.159 -0.963 . . . . 74.409999999999997 110.167 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 40' ' ' MET . 97.4 mtt180 -130.04 138.76 50.93 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.373 -0.829 . . . . 75.409999999999997 109.584 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -93.98 126.36 39.15 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.248 -0.908 . . . . 75.420000000000002 109.472 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -106.01 145.78 30.93 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.429 -0.794 . . . . 74.230000000000004 109.524 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -85.57 -44.56 12.54 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.274 -0.891 . . . . 75.319999999999993 109.078 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.417 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -105.56 108.41 19.9 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.585 -0.894 . . . . 72.129999999999995 108.585 179.641 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 m -104.33 101.86 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.31 -0.996 . . . . 72.340000000000003 108.31 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.6 ttt -108.37 143.02 37.83 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.688 -0.856 . . . . 74.109999999999999 108.688 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 p -144.15 132.34 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.361 -0.837 . . . . 71.239999999999995 109.933 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.0 m -98.98 2.29 46.23 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.481 -0.762 . . . . 73.109999999999999 109.472 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -76.14 139.12 41.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.192 -0.943 . . . . 63.399999999999999 109.427 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.53 ' C ' ' H ' ' A' ' 55' ' ' ALA . 61.6 mttp -73.62 -43.5 59.42 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.307 -0.871 . . . . 65.439999999999998 110.731 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -68.16 10.26 0.24 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.017 -1.052 . . . . 73.129999999999995 109.89 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.53 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.93 -22.18 56.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.893 . . . . 64.140000000000001 110.57 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' ALA . 64.0 mt -39.98 -51.59 2.51 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.511 -0.743 . . . . 74.430000000000007 110.498 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.427 ' O ' ' OG ' ' A' ' 60' ' ' SER . 24.9 m -68.75 -33.72 74.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.939 -1.1 . . . . 63.229999999999997 109.319 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.423 ' N ' ' O ' ' A' ' 55' ' ' ALA . 73.6 t80 -64.84 -48.42 74.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.386 -0.821 . . . . 74.439999999999998 110.088 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.61 -34.83 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.615 -1.303 . . . . 74.030000000000001 109.52 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 57' ' ' SER . 56.9 p -57.33 -49.64 75.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 73.540000000000006 109.542 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -69.41 -33.2 72.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.032 -1.043 . . . . 73.340000000000003 109.927 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mm -63.63 -35.41 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.828 -1.17 . . . . 73.349999999999994 109.747 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 67' ' ' SER . 11.5 mtpt -72.08 -51.05 23.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.123 -0.986 . . . . 74.420000000000002 110.461 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.431 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 14.6 pt-20 -67.24 -41.69 85.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.743 -1.223 . . . . 74.549999999999997 109.708 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.448 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 93.4 mttt -73.61 -24.42 60.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.878 . . . . 75.219999999999999 109.501 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.448 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 93.5 m-70 -154.93 65.88 0.66 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.229 -0.92 . . . . 74.129999999999995 109.293 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 63' ' ' LYS . 17.0 t -60.45 -32.56 71.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.392 -0.818 . . . . 73.239999999999995 110.038 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.1 m -67.59 46.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 71.439999999999998 109.859 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 67' ' ' SER . 13.8 tt -145.63 162.85 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.142 -0.974 . . . . 71.329999999999998 109.726 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.0 t -97.73 148.75 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.221 -0.924 . . . . 73.019999999999996 108.942 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.51 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 11.3 t -132.38 124.08 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.282 -0.886 . . . . 54.210000000000001 109.508 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 mt -128.07 99.26 5.41 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.319 -0.993 . . . . 74.209999999999994 108.319 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.3 t -93.12 149.56 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -0.869 . . . . 74.409999999999997 109.14 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.7 m -121.96 165.84 15.36 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.529 -0.915 . . . . 72.310000000000002 108.529 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.457 ' C ' ' H ' ' A' ' 77' ' ' ASN . 9.7 p -171.81 123.65 0.53 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.035 -1.041 . . . . 64.540000000000006 110.226 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 52.1 p30 -71.0 10.56 0.52 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.59 -0.694 . . . . 74.129999999999995 109.901 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.457 ' H ' ' C ' ' A' ' 75' ' ' SER . 5.8 p-10 -129.09 59.57 44.95 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.38 -0.825 . . . . 73.340000000000003 109.661 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -58.9 80.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.276 1.984 . . . . 71.319999999999993 112.047 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.403 ' N ' ' O ' ' A' ' 77' ' ' ASN . 72.6 p -104.28 151.56 23.27 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.621 -0.881 . . . . 62.530000000000001 108.621 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -30.8 69.53 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.228 -0.92 . . . . 74.140000000000001 109.363 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -67.15 -37.47 83.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.189 -0.945 . . . . 71.420000000000002 109.554 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.45 ' OE2' ' CB ' ' A' ' 75' ' ' SER . 79.4 tt0 -71.47 -32.62 68.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 73.430000000000007 109.722 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.476 ' OE2' ' CZ ' ' B' ' 100' ' ' ARG . 92.2 mt-10 -64.44 -50.95 65.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.918 . . . . 74.219999999999999 109.825 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.3 m -61.01 -36.32 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.157 -0.964 . . . . 74.150000000000006 109.252 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.429 ' O ' ' OE1' ' A' ' 89' ' ' GLN . 27.0 m80 -74.51 -26.65 60.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 72.540000000000006 109.599 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.53 -41.96 87.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.109 -0.995 . . . . 64.219999999999999 109.786 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -82.05 -35.12 29.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.042 -1.036 . . . . 74.340000000000003 109.08 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -62.08 -51.55 67.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.379 -0.825 . . . . 74.420000000000002 109.411 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.488 ' NE2' ' N ' ' A' ' 89' ' ' GLN . 0.9 OUTLIER -66.6 -58.26 5.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.531 -0.731 . . . . 74.519999999999996 109.686 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 158.17 75.27 0.02 OUTLIER Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.613 -1.279 . . . . 74.209999999999994 110.266 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -134.84 119.61 18.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.305 -1.115 . . . . 64.099999999999994 108.947 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 71.6 m-20 -71.36 -34.79 70.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.102 -0.999 . . . . 73.420000000000002 108.923 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.502 ' CG ' HH21 ' A' ' 112' ' ' ARG . 60.7 m-20 -153.16 152.5 31.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.451 -0.781 . . . . 75.040000000000006 109.046 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.434 ' OH ' ' OG ' ' A' ' 75' ' ' SER . 9.3 t80 -126.76 132.93 50.96 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.08 -0.711 . . . . 71.329999999999998 109.08 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.479 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 0.1 OUTLIER -121.57 142.38 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 CA-C-O 121.978 0.894 . . . . 74.510000000000005 110.442 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.52 119.86 10.61 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.599 -1.26 . . . . 64.319999999999993 107.599 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.677 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -43.9 -53.9 12.05 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 74.510000000000005 111.628 -178.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 2.3 Cg_endo -40.56 -10.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 120.955 1.103 . . . . 73.109999999999999 113.12 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.677 ' N ' ' O ' ' A' ' 97' ' ' LYS . 64.0 m-85 59.96 92.73 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.71 -0.619 . . . . 72.540000000000006 109.9 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.8 ttm105 -52.09 -39.03 59.14 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.354 -0.98 . . . . 74.540000000000006 108.354 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 t -172.41 134.41 0.68 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.493 -0.755 . . . . 74.140000000000001 109.025 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 81.8 mt -53.34 -40.1 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.127 -0.983 . . . . 75.430000000000007 109.26 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -66.79 -26.22 66.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 74.140000000000001 109.67 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.81 -48.58 21.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.171 -0.955 . . . . 63.240000000000002 109.856 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.445 ' C ' ' CD1' ' A' ' 105' ' ' LEU . 2.1 tm? -57.75 -54.05 51.24 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.207 -0.933 . . . . 73.219999999999999 109.442 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.421 ' CG1' ' N ' ' A' ' 107' ' ' ALA . 11.0 p -60.28 -41.9 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.099 -1.001 . . . . 74.540000000000006 109.52 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.421 ' N ' ' CG1' ' A' ' 106' ' ' VAL . . . -51.8 -36.63 48.47 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.17 -0.956 . . . . 75.5 108.925 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -71.87 -37.45 70.19 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.372 -0.83 . . . . 74.409999999999997 109.399 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 87.7 mt -67.11 -31.61 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 107.978 -1.119 . . . . 73.239999999999995 107.978 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 113' ' ' LEU . 78.5 tt0 -65.85 -57.55 7.66 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.637 -0.825 . . . . 74.340000000000003 108.927 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -46.21 -37.2 6.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.475 -0.766 . . . . 73.319999999999993 109.655 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.502 HH21 ' CG ' ' A' ' 93' ' ' ASP . 28.1 mmt180 -82.25 -14.46 55.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 74.420000000000002 110.103 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' ' 110' ' ' GLU . 80.4 mt -135.25 44.08 2.61 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.133 -0.979 . . . . 74.329999999999998 110.617 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -76.44 -39.19 54.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.848 -1.158 . . . . 74.439999999999998 108.846 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.529 ' CD2' ' O ' ' A' ' 116' ' ' TRP . 33.8 p90 -67.74 -10.98 57.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.424 -0.797 . . . . 74.430000000000007 109.977 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.6 ' HE1' ' CE ' ' A' ' 1' ' ' MET . 48.0 t90 50.29 -178.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.138 -0.976 . . . . 74.439999999999998 109.504 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.495 ' N ' ' CG ' ' A' ' 116' ' ' TRP . . . -50.96 143.18 15.0 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.351 -1.499 . . . . 75.040000000000006 109.351 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 87.9 p -157.6 -178.5 7.38 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -1.206 . . . . 70.109999999999999 110.068 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.38 -179.64 8.13 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.05 -0.722 . . . . 65.239999999999995 109.05 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.6 t -138.34 -36.6 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.42 -0.8 . . . . 74.219999999999999 109.125 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.523 ' N ' ' CD1' ' A' ' 121' ' ' ILE . 1.4 mp -90.4 136.41 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.995 . . . . 74.420000000000002 108.493 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -138.6 105.69 5.46 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.349 -0.844 . . . . 73.299999999999997 109.47 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 83.5 mt -108.94 109.78 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.962 -0.755 . . . . 75.340000000000003 108.962 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.8 -137.73 31.06 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.277 -1.529 . . . . 75.129999999999995 109.277 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -79.56 -3.83 48.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -1.191 . . . . 74.450000000000003 109.349 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.06 143.25 26.98 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.356 -0.979 . . . . 54.210000000000001 108.356 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 54.9 m -129.86 141.07 50.87 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.375 -0.828 . . . . 70.239999999999995 109.231 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.74 130.81 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.42 -0.8 . . . . 72.430000000000007 109.976 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.1 m -107.4 113.45 61.89 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.633 -0.667 . . . . 71.109999999999999 109.226 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.8 -53.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.92 1.746 . . . . 75.140000000000001 111.959 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -55.3 -44.65 75.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 72.5 109.316 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -83.52 -8.54 59.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.401 -0.812 . . . . 73.140000000000001 109.153 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 51.72 57.53 6.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 75.329999999999998 109.154 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -139.37 116.03 10.73 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.411 -0.806 . . . . 71.230000000000004 109.164 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.503 ' N ' ' CD1' ' A' ' 135' ' ' ILE . 1.4 mp -94.22 130.24 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.185 -0.947 . . . . 75.329999999999998 108.905 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 36.8 mt -115.91 129.41 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.561 -0.712 . . . . 71.109999999999999 109.575 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.502 ' C ' ' H ' ' A' ' 139' ' ' GLY . 77.5 t80 -141.58 151.19 42.96 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.512 -0.922 . . . . 74.140000000000001 108.512 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 46.1 tttp 55.94 5.63 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.851 . . . . 75.400000000000006 109.408 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 137' ' ' TYR . . . 93.86 -4.81 72.29 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.686 -1.366 . . . . 72.239999999999995 109.686 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.404 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 0.7 OUTLIER -89.71 139.7 30.3 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.247 -1.149 . . . . 73.120000000000005 109.299 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -86.71 137.19 32.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 72.319999999999993 109.162 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.1 t -135.26 128.12 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.43 -0.794 . . . . 62.340000000000003 109.531 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -93.37 134.34 35.69 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.306 -0.871 . . . . 61.229999999999997 109.048 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.1 m -149.48 140.56 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.106 -0.996 . . . . 74.439999999999998 109.556 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -163.54 18.83 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 75.420000000000002 109.776 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.3 161.09 54.16 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.844 -1.702 . . . . 73.340000000000003 108.844 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.562 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 4.8 tttp -56.44 -44.73 99.86 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.039 -1.271 . . . . 72.219999999999999 109.091 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 24.2 Cg_exo -62.58 -28.5 77.3 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.362 2.042 . . . . 75.450000000000003 112.122 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -80.67 -20.7 42.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.232 -0.918 . . . . 65.239999999999995 110.12 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -52.75 -32.96 46.14 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.067 -1.021 . . . . 72.519999999999996 108.965 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.4 p -64.95 -38.08 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.324 -0.86 . . . . 74.209999999999994 109.276 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 29.4 tp -60.86 -41.92 96.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.857 . . . . 73.310000000000002 109.322 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 20.0 p -74.35 -34.79 63.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.245 -0.909 . . . . 74.310000000000002 110.16 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.625 ' HD1' HH21 ' A' ' 157' ' ' ARG . 43.9 m-70 -60.9 -52.69 63.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.137 -0.977 . . . . 75.450000000000003 110.035 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 pp -68.52 -28.56 67.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.906 -1.121 . . . . 75.340000000000003 109.602 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.3 -47.59 78.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 62.140000000000001 109.377 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.625 HH21 ' HD1' ' A' ' 154' ' ' HIS . 67.9 mtm-85 -69.03 -58.69 3.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.965 . . . . 72.219999999999999 109.461 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -53.27 -47.67 68.94 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.811 -0.756 . . . . 74.120000000000005 109.457 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 161' ' ' GLN . 23.1 ttm180 44.97 -126.49 1.1 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.401 -0.812 . . . . 74.340000000000003 109.895 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 45.6 p-10 -50.08 90.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 75.450000000000003 109.561 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.844 ' OE1' ' OH ' ' B' ' 216' ' ' TYR . 1.4 tp-100 -171.53 149.54 2.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.246 -0.909 . . . . 73.409999999999997 109.325 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 65.3 mt -78.51 135.46 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.148 -0.97 . . . . 74.409999999999997 109.216 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 87.1 t -127.58 129.29 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.452 -0.78 . . . . 72.530000000000001 109.653 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.7 t -99.44 153.36 19.07 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.435 -0.791 . . . . 74.120000000000005 109.324 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.5 mtmm -56.97 -43.83 82.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.33 -0.856 . . . . 70.430000000000007 109.494 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -59.01 -34.26 71.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.341 -0.85 . . . . 74.319999999999993 109.575 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -63.91 -55.19 24.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.166 -0.959 . . . . 74.519999999999996 109.621 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 80.3 mt -47.64 -52.71 17.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.143 -0.973 . . . . 74.409999999999997 109.774 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.505 ' C ' ' H ' ' A' ' 171' ' ' ALA . 87.2 mt -57.62 -74.6 0.05 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.591 -1.318 . . . . 75.140000000000001 109.666 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -48.86 -11.01 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.973 -1.079 . . . . 65.030000000000001 110.459 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.505 ' H ' ' C ' ' A' ' 169' ' ' LEU . . . -95.43 -41.39 9.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.189 -0.945 . . . . 70.209999999999994 111.185 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.61 -47.18 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.917 -1.114 . . . . 75.319999999999993 109.688 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.626 ' CD1' ' O ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.251 0 O-C-N 120.668 -1.27 . . . . 73.140000000000001 109.188 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 14.9 p30 . . . . . 0 N--CA 1.494 1.754 0 N-CA-C 109.345 -0.613 . . . . 73.129999999999995 109.345 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.0 p -166.47 -27.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.852 . . . . 74.019999999999996 109.861 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 10.9 tp -50.97 -22.38 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.068 -1.02 . . . . 72.329999999999998 109.914 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.437 ' CG ' ' N ' ' A' ' 186' ' ' VAL . 18.9 pt-20 -70.05 -48.93 55.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.055 -1.028 . . . . 74.400000000000006 109.572 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.437 ' N ' ' CG ' ' A' ' 185' ' ' GLU . 14.1 m -72.04 -28.87 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.808 -1.183 . . . . 74.319999999999993 108.969 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -77.87 -55.42 5.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 73.230000000000004 110.069 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 11.2 tp -52.6 -33.37 18.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.675 -1.266 . . . . 74.310000000000002 109.324 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -72.76 -41.27 65.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.173 -0.954 . . . . 73.439999999999998 111.214 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.452 ' CG ' ' N ' ' A' ' 191' ' ' ILE . 1.0 OUTLIER -77.33 -46.37 23.12 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.586 -1.321 . . . . 71.420000000000002 111.029 -178.431 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.452 ' N ' ' CG ' ' A' ' 190' ' ' GLN . 6.5 pt -62.22 -41.01 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.717 -1.239 . . . . 72.439999999999998 109.971 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -69.21 -34.27 74.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.849 -1.157 . . . . 64.219999999999999 108.597 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -64.86 -39.58 93.78 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.694 -0.629 . . . . 74.319999999999993 110.082 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.422 ' O ' ' CD ' ' A' ' 198' ' ' PRO . 11.4 pttp -92.09 -2.55 56.57 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.047 -1.033 . . . . 75.310000000000002 110.549 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 48.2 ttp -93.75 -45.42 7.69 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.94 -1.1 . . . . 74.019999999999996 109.974 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -60.29 -33.02 71.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.07 -1.019 . . . . 74.019999999999996 110.385 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -64.4 -61.11 7.11 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.978 -1.076 . . . . 75.430000000000007 110.335 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.422 ' CD ' ' O ' ' A' ' 194' ' ' LYS . 31.5 Cg_endo -61.11 -55.52 1.25 Allowed 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.824 1.682 . . . . 72.319999999999993 111.844 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.531 ' C ' ' H ' ' A' ' 201' ' ' ILE . 10.0 mp -63.09 -36.9 85.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -0.942 . . . . 74.540000000000006 109.282 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 73.51 -23.73 0.98 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.598 -1.401 . . . . 61.509999999999998 109.598 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.531 ' H ' ' C ' ' A' ' 199' ' ' LEU . 13.6 mt -110.66 137.12 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.483 -1.01 . . . . 74.25 109.351 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 8.6 t -84.87 143.6 28.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.164 -0.96 . . . . 72.0 109.354 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.5 p -141.19 27.94 1.91 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.278 -0.889 . . . . 74.439999999999998 109.267 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.527 ' CG1' ' CE2' ' A' ' 214' ' ' PHE . 2.7 m -143.66 128.64 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.239 -0.913 . . . . 71.129999999999995 109.692 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -102.76 121.91 43.41 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.381 -0.825 . . . . 73.510000000000005 108.808 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.88 117.32 23.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.145 -0.972 . . . . 73.519999999999996 109.873 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.411 ' O ' ' O ' ' A' ' 211' ' ' GLY . 12.8 p -150.25 147.58 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.345 -0.847 . . . . 72.150000000000006 109.062 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -64.34 -130.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.144 -0.973 . . . . 72.400000000000006 109.479 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? 50.17 -106.02 0.21 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.91 . . . . 73.310000000000002 109.337 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -75.9 -59.08 2.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 71.540000000000006 109.486 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 207' ' ' VAL . . . 159.26 -109.57 0.41 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.641 -1.384 . . . . 74.450000000000003 109.641 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 212' ' ' TYR . 41.9 m-85 -109.73 134.91 51.45 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.522 -0.987 . . . . 75.540000000000006 109.369 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -107.31 132.5 53.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.509 -0.744 . . . . 75.310000000000002 109.476 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.527 ' CE2' ' CG1' ' A' ' 204' ' ' VAL . 43.8 m-85 -97.45 128.69 44.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.258 -0.901 . . . . 75.409999999999997 109.107 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 49.2 m -140.18 156.55 46.47 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.439 -0.788 . . . . 74.140000000000001 109.077 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -69.52 153.98 95.25 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.916 . . . . 75.319999999999993 109.183 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo . . . . . 0 N--CA 1.49 1.288 0 C-N-CA 122.478 2.119 . . . . 73.109999999999999 112.478 179.946 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.487 ' SD ' ' OD2' ' B' ' 46' ' ' ASP . 7.4 mtt . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.364 -0.606 . . . . 75.239999999999995 109.364 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -136.09 125.04 24.19 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.463 -0.773 . . . . 73.519999999999996 109.166 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.1 t -111.83 133.79 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-O 121.359 0.6 . . . . 72.239999999999995 109.564 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' B' ' 49' ' ' MET . 4.9 tp -101.73 120.47 40.4 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.488 -0.757 . . . . 73.340000000000003 109.174 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 17.3 mt -119.46 98.58 6.21 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.464 -0.772 . . . . 74.349999999999994 109.108 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 16.9 mt -83.48 98.8 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.872 -1.142 . . . . 63.439999999999998 108.469 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.423 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 33.8 tp10 -142.8 128.84 19.65 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.382 -0.824 . . . . 74.519999999999996 109.416 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -66.77 -31.36 71.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.9 . . . . 74.129999999999995 109.478 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -79.22 112.02 16.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 74.230000000000004 109.533 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 82.2 p -71.78 -25.28 61.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 65.540000000000006 109.698 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 82.3 t -62.57 -49.85 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -0.958 . . . . 75.549999999999997 109.623 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' B' ' 12' ' ' LEU . 3.8 mm? -67.04 -28.95 68.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 70.140000000000001 109.206 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.8 -23.18 64.82 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.745 -1.742 . . . . 75.400000000000006 108.745 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.47 -49.74 7.91 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.705 -1.358 . . . . 65.439999999999998 109.705 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.09 -42.56 99.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.1 -1.235 . . . . 72.200000000000003 109.048 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 6.0 mm -60.87 -35.59 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.259 -1.015 . . . . 75.150000000000006 108.259 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -63.1 -44.04 96.8 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.498 -0.751 . . . . 73.010000000000005 109.361 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -86.05 1.61 49.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.15 -0.969 . . . . 74.299999999999997 109.301 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.12 -53.32 2.69 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 109.446 -1.462 . . . . 70.540000000000006 109.446 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -77.41 -22.26 51.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -1.152 . . . . 75.430000000000007 109.793 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -52.5 -34.88 51.47 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.072 -1.017 . . . . 73.200000000000003 109.077 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 54.3 t -55.47 -45.93 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.351 -0.843 . . . . 74.230000000000004 108.867 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 49.3 mmtt -60.14 -53.33 59.03 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.491 -0.756 . . . . 73.519999999999996 109.035 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 133.56 35.72 0.28 Allowed Glycine 0 N--CA 1.5 2.965 0 N-CA-C 110.099 -1.201 . . . . 53.43 110.099 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -119.5 159.54 24.1 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.392 -1.064 . . . . 71.120000000000005 109.308 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 13.0 mmt -103.39 141.43 35.96 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.502 -0.925 . . . . 75.239999999999995 108.502 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . 0.429 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -133.41 157.6 45.16 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.393 -0.817 . . . . 73.25 110.265 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . 0.476 ' OD2' ' NH1' ' B' ' 43' ' ' ARG . 82.0 m-20 -142.84 160.37 40.45 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.677 -0.86 . . . . 72.310000000000002 108.677 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 5.0 p -121.43 139.76 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.364 -0.835 . . . . 72.140000000000001 109.718 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 10.2 p -133.52 165.21 25.41 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.59 -0.694 . . . . 74.530000000000001 109.213 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -91.72 -104.99 0.11 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.277 -0.889 . . . . 71.019999999999996 109.677 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 60.0 p -78.52 168.98 18.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 71.400000000000006 109.902 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 19.0 mt -53.65 -33.55 55.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.502 -0.749 . . . . 71.239999999999995 109.866 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -51.02 -48.95 61.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.099 -1.0 . . . . 74.319999999999993 109.499 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -64.37 -39.73 94.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 73.030000000000001 108.957 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.28 -36.21 63.55 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.295 -1.522 . . . . 60.43 109.295 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -66.16 -41.54 90.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -1.122 . . . . 74.430000000000007 109.472 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -79.44 -37.77 36.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.136 -0.977 . . . . 74.420000000000002 109.408 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 41.2 tp -68.48 -41.86 79.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 75.409999999999997 109.63 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.0 ppp? -73.53 -21.74 60.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.143 -0.973 . . . . 61.439999999999998 109.535 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -53.44 -38.34 63.46 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.012 -1.055 . . . . 74.319999999999993 108.936 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 8.6 pt -95.98 -33.19 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.351 -0.843 . . . . 71.230000000000004 109.651 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.476 ' NH1' ' OD2' ' B' ' 28' ' ' ASP . 93.1 mtt180 -96.32 138.57 33.72 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.081 -1.012 . . . . 73.409999999999997 109.593 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' ASN . . . . . 0.435 ' O ' ' O ' ' B' ' 45' ' ' TYR . 84.7 m-20 -81.08 -30.63 34.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.168 -0.957 . . . . 63.539999999999999 109.966 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' B' ' 44' ' ' ASN . 38.4 m-85 52.24 100.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.302 -0.874 . . . . 73.109999999999999 109.436 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . 0.487 ' OD2' ' SD ' ' B' ' 1' ' ' MET . 73.1 m-20 -70.11 -36.99 75.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.106 -0.996 . . . . 62.219999999999999 109.016 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' B' ' 47' ' ' LEU . 1.0 OUTLIER -107.01 111.58 24.14 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.673 -0.862 . . . . 73.120000000000005 108.673 179.567 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 53.1 t -94.89 99.8 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.299 -0.876 . . . . 74.109999999999999 109.378 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 1.8 tpp -113.55 130.02 56.44 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.774 -0.825 . . . . 73.439999999999998 108.774 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.463 ' N ' ' SD ' ' B' ' 49' ' ' MET . 0.2 OUTLIER -146.66 135.49 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 73.400000000000006 109.312 -179.505 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' SER . . . . . 0.516 ' CB ' ' HG ' ' B' ' 74' ' ' SER . 73.1 p -103.51 8.68 37.79 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.504 -0.748 . . . . 73.209999999999994 110.25 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.417 ' H ' HG22 ' B' ' 50' ' ' VAL . 56.4 m-20 -76.82 142.25 40.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.081 -1.012 . . . . 70.409999999999997 109.547 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.428 ' C ' ' H ' ' B' ' 55' ' ' ALA . 47.5 mtpt -74.3 -38.36 63.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 73.129999999999995 110.293 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -72.57 8.19 1.54 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.034 -1.041 . . . . 75.209999999999994 109.716 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.428 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -74.55 -21.24 59.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 55.329999999999998 110.222 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 71.1 mt -43.68 -41.11 4.57 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.318 -0.864 . . . . 72.420000000000002 110.224 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' SER . . . . . 0.425 ' O ' ' OG ' ' B' ' 60' ' ' SER . 27.4 t -72.92 -38.59 66.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.999 -1.063 . . . . 73.040000000000006 109.567 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -64.27 -49.58 71.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.343 -0.848 . . . . 72.329999999999998 110.135 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.15 -35.36 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.765 -1.209 . . . . 74.540000000000006 109.69 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' B' ' 57' ' ' SER . 59.8 p -58.22 -45.82 86.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.237 -0.914 . . . . 71.239999999999995 109.681 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' B' ' 65' ' ' LYS . 8.8 ptp180 -75.36 -30.78 60.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.058 -1.026 . . . . 74.310000000000002 110.076 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.453 ' O ' ' N ' ' B' ' 66' ' ' HIS . 5.0 mm -60.55 -51.91 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.745 -1.222 . . . . 75.420000000000002 109.24 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -63.1 -40.78 98.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.135 -0.978 . . . . 73.319999999999993 109.183 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -68.93 -38.88 79.79 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.512 -0.921 . . . . 73.310000000000002 108.512 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' B' ' 61' ' ' ARG . 14.4 mtpp -86.24 -74.23 0.43 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.285 -0.884 . . . . 72.439999999999998 109.481 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . 0.453 ' N ' ' O ' ' B' ' 62' ' ' ILE . 53.6 m-70 -98.08 87.43 3.95 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.226 -0.921 . . . . 65.209999999999994 109.524 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 23.2 t -78.46 -32.18 48.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 73.099999999999994 109.923 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 94.7 p -59.7 -23.51 63.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.233 -0.917 . . . . 71.530000000000001 109.643 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 57.3 mt -84.09 149.48 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.246 -0.909 . . . . 74.400000000000006 109.293 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.454 ' CG1' ' N ' ' B' ' 71' ' ' VAL . 75.8 t -91.08 164.49 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.247 -0.908 . . . . 75.120000000000005 109.637 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.454 ' N ' ' CG1' ' B' ' 70' ' ' VAL . 4.3 t -139.68 128.15 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.318 -0.864 . . . . 73.200000000000003 109.348 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . 0.497 ' O ' ' SD ' ' B' ' 49' ' ' MET . 0.6 OUTLIER -123.69 106.52 10.6 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.608 -0.886 . . . . 73.340000000000003 108.608 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 71.0 t -91.4 129.58 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.117 -0.989 . . . . 73.5 109.008 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' SER . . . . . 0.516 ' HG ' ' CB ' ' B' ' 51' ' ' SER . 6.8 p -90.36 171.25 9.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.917 -1.114 . . . . 71.319999999999993 108.987 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 13.6 p -155.76 112.34 3.16 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.927 -1.108 . . . . 74.530000000000001 110.261 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -67.2 -27.47 67.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.329 -0.857 . . . . 64.5 109.005 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' B' ' 79' ' ' THR . 13.5 t-20 -127.06 75.65 76.52 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.677 -0.86 . . . . 74.25 108.677 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -44.79 88.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.572 2.181 . . . . 74.430000000000007 111.777 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.471 ' N ' ' O ' ' B' ' 77' ' ' ASN . 17.1 m -104.04 148.65 25.98 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.59 0.71 . . . . 73.120000000000005 109.717 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -33.69 76.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.196 -0.94 . . . . 75.409999999999997 109.006 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -57.07 -39.42 74.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 72.239999999999995 109.036 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -71.91 -31.73 66.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.223 -0.923 . . . . 73.219999999999999 109.201 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.535 ' OE1' ' CD1' ' B' ' 94' ' ' TYR . 5.9 mm-40 -64.57 -56.55 13.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.22 -0.925 . . . . 74.299999999999997 110.027 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 29.9 m -57.59 -41.21 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 73.310000000000002 109.832 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -74.05 -25.15 59.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.152 -0.968 . . . . 73.239999999999995 109.59 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.26 -36.3 79.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 55.329999999999998 110.021 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -80.17 -33.73 38.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.119 -0.988 . . . . 74.450000000000003 108.892 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -69.75 -33.52 72.55 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.338 -0.851 . . . . 64.040000000000006 109.428 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -77.55 -67.53 0.71 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 75.129999999999995 109.499 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 156.86 66.02 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.011 -1.236 . . . . 75.420000000000002 110.011 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.68 124.64 46.75 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.444 -1.033 . . . . 73.420000000000002 109.054 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -69.98 -36.85 75.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.12 -0.987 . . . . 73.319999999999993 109.438 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' ASP . . . . . 0.471 ' OD2' ' CD ' ' B' ' 112' ' ' ARG . 11.6 m-20 -151.24 166.41 30.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.304 -0.873 . . . . 73.040000000000006 109.371 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.551 ' CD1' ' O ' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -140.21 114.15 8.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.607 -0.683 . . . . 74.310000000000002 109.191 -178.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 27.7 mm -114.34 146.26 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 O-C-N 121.224 -0.923 . . . . 75.340000000000003 109.685 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.78 139.54 58.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.936 -1.103 . . . . 70.099999999999994 108.139 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.685 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -58.49 -56.44 35.47 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.909 -1.12 . . . . 65.430000000000007 111.381 -179.034 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 5.0 Cg_endo -41.5 -8.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.022 1.148 . . . . 63.520000000000003 113.192 -176.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . 0.685 ' N ' ' O ' ' B' ' 97' ' ' LYS . 13.8 m-85 66.47 117.78 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.557 -0.714 . . . . 75.129999999999995 109.674 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . 0.476 ' CZ ' ' OE2' ' A' ' 83' ' ' GLU . 16.0 ttm180 -67.05 -29.55 69.37 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.968 -1.083 . . . . 74.230000000000004 108.754 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' SER . . . . . 0.737 ' O ' ' N ' ' B' ' 103' ' ' LYS . 40.6 t -174.78 28.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.192 -0.942 . . . . 64.510000000000005 110.671 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 8.6 mm 51.66 -69.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.645 -0.659 . . . . 74.439999999999998 110.064 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . 0.737 ' N ' ' O ' ' B' ' 101' ' ' SER . 86.3 mttt -56.64 -32.91 65.82 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.82 -1.178 . . . . 72.299999999999997 107.82 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.86 98.73 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.033 -1.099 . . . . 74.310000000000002 108.033 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 55.4 tp -64.63 -40.68 95.9 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.635 -0.876 . . . . 73.540000000000006 108.635 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 73.5 t -67.0 -41.02 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.348 -0.845 . . . . 72.030000000000001 109.527 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.02 -48.26 70.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.149 -0.97 . . . . 64.219999999999999 109.39 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -64.75 -32.24 73.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 75.310000000000002 109.732 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . 0.427 HD11 HG21 ' B' ' 109' ' ' ILE . 93.9 mt -74.44 -34.3 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.179 -0.951 . . . . 55.439999999999998 108.903 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . 0.465 ' O ' ' CG ' ' B' ' 114' ' ' ARG . 88.2 tt0 -66.09 -31.02 71.63 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.492 -0.755 . . . . 65.310000000000002 109.469 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.56 -56.6 5.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.201 -0.937 . . . . 74.519999999999996 109.944 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . 0.471 ' CD ' ' OD2' ' B' ' 93' ' ' ASP . 64.3 mtm-85 -69.43 -40.61 77.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.179 -0.951 . . . . 72.040000000000006 110.358 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 41.6 tp -63.52 -34.49 77.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.121 -0.987 . . . . 75.349999999999994 109.972 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.465 ' CG ' ' O ' ' B' ' 110' ' ' GLU . 11.0 mmm180 -74.26 167.37 21.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.152 -0.968 . . . . 75.5 109.353 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 52.26 51.15 16.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.885 . . . . 73.040000000000006 109.23 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -95.7 -66.24 0.92 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.308 -0.87 . . . . 74.450000000000003 109.898 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.05 144.04 48.61 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.19 -1.164 . . . . 64.209999999999994 110.19 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' SER . . . . . 0.927 ' N ' ' OE2' ' B' ' 132' ' ' GLU . 33.1 t -160.44 175.26 12.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.471 -1.017 . . . . 71.400000000000006 109.355 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . 0.554 ' N ' ' HG ' ' B' ' 118' ' ' SER . 0.0 OUTLIER -156.88 125.8 5.9 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.652 -0.819 . . . . 74.209999999999994 109.221 -178.216 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 20.5 t -99.32 -37.25 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.386 -0.822 . . . . 75.019999999999996 109.929 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 19.3 mm -101.89 128.37 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.197 -0.939 . . . . 74.239999999999995 109.584 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' B' ' 122' ' ' GLU . 17.9 pt-20 -151.06 121.99 7.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.319 -0.863 . . . . 73.329999999999998 109.473 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.55 ' N ' ' CD1' ' B' ' 123' ' ' ILE . 0.1 OUTLIER -146.46 133.93 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.155 -0.965 . . . . 74.219999999999999 109.335 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 63.33 -115.69 8.34 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.241 -1.543 . . . . 72.409999999999997 109.241 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . 0.891 ' OD2' ' HD3' ' B' ' 138' ' ' LYS . 13.3 t70 -120.59 6.31 10.55 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.596 -0.944 . . . . 75.120000000000005 109.245 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.78 128.56 42.76 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.334 -0.854 . . . . 75.420000000000002 108.769 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 61.4 m -120.4 132.11 55.1 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.5 -0.926 . . . . 74.219999999999999 108.5 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 8.0 mt -133.02 132.38 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.378 -0.826 . . . . 60.329999999999998 110.041 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 8.6 m -109.75 110.67 59.28 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.303 -0.999 . . . . 72.310000000000002 108.303 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.94 -36.98 1.26 Allowed 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.742 1.628 . . . . 75.129999999999995 113.071 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . 0.415 ' O ' ' OE1' ' B' ' 133' ' ' GLU . 6.8 t70 -70.33 -37.34 74.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.089 -1.007 . . . . 75.230000000000004 109.905 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . 0.927 ' OE2' ' N ' ' B' ' 118' ' ' SER . 81.4 mt-10 -83.21 -0.09 47.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.157 -0.964 . . . . 75.120000000000005 109.446 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . 0.415 ' OE1' ' O ' ' B' ' 131' ' ' ASP . 35.8 mp0 47.01 59.07 4.24 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 75.129999999999995 109.254 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . 0.453 ' HZ1' ' HB3' ' B' ' 141' ' ' GLU . 15.4 ttpp -156.72 130.35 8.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 75.109999999999999 109.247 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 2.9 tt -104.23 129.47 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.433 -0.792 . . . . 70.319999999999993 109.597 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 15.3 mt -110.11 122.5 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.566 -0.902 . . . . 74.120000000000005 108.566 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . 0.963 ' CE1' ' CB ' ' B' ' 140' ' ' ARG . 19.0 p90 -124.97 118.18 25.69 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.249 -0.907 . . . . 74.230000000000004 110.13 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . 0.891 ' HD3' ' OD2' ' B' ' 125' ' ' ASP . 25.8 mmtm 55.99 28.2 12.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.591 -0.693 . . . . 74.219999999999999 110.237 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 92.4 2.56 67.88 Favored Glycine 0 N--CA 1.496 2.643 0 O-C-N 121.172 -0.955 . . . . 74.319999999999993 110.944 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . 0.963 ' CB ' ' CE1' ' B' ' 137' ' ' TYR . 0.2 OUTLIER -95.66 121.84 37.78 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.759 -1.436 . . . . 75.340000000000003 108.79 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 141' ' ' GLU . . . . . 0.453 ' HB3' ' HZ1' ' B' ' 134' ' ' LYS . 74.4 mt-10 -94.94 118.29 31.56 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.267 -0.895 . . . . 71.230000000000004 109.58 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 6.6 t -122.52 132.82 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.751 -0.833 . . . . 70.430000000000007 108.751 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -92.86 123.12 35.9 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.273 -0.892 . . . . 72.430000000000007 109.869 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.32 138.93 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.886 -0.783 . . . . 72.129999999999995 108.886 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -161.7 83.24 0.6 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.355 -0.84 . . . . 74.5 109.84 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . 0.667 ' N ' ' HD2' ' B' ' 149' ' ' PHE . . . -164.47 177.8 39.97 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.071 -1.612 . . . . 42.229999999999997 109.071 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . 1.323 ' NZ ' ' O ' ' B' ' 172' ' ' ILE . 0.9 OUTLIER -68.21 -37.01 9.95 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.203 -1.174 . . . . 73.299999999999997 110.438 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 14.6 Cg_exo -66.23 -19.99 56.12 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.206 1.937 . . . . 71.329999999999998 112.048 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . 0.667 ' HD2' ' N ' ' B' ' 146' ' ' GLY . 0.5 OUTLIER -103.77 -29.76 10.82 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.493 -0.755 . . . . 74.230000000000004 109.343 -179.376 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . 0.428 ' O ' ' CD2' ' B' ' 154' ' ' HIS . 35.4 mt-10 -51.67 -31.5 26.01 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.199 -1.037 . . . . 72.340000000000003 108.199 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 13.2 p -67.96 -33.15 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.562 -0.711 . . . . 73.349999999999994 109.11 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 44.7 tp -65.24 -39.99 93.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.875 . . . . 74.430000000000007 109.602 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 6.0 p -76.36 -35.77 58.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.893 -1.129 . . . . 75.209999999999994 109.203 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 154' ' ' HIS . . . . . 0.428 ' CD2' ' O ' ' B' ' 150' ' ' GLU . 27.9 m170 -56.87 -48.76 77.39 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.117 -0.99 . . . . 73.040000000000006 110.174 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 pp -72.87 -27.64 62.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.7 -1.25 . . . . 73.430000000000007 108.884 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.56 -34.54 67.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 75.319999999999993 109.563 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 17.3 mtt180 -92.52 -52.2 4.76 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.897 -1.127 . . . . 73.319999999999993 109.9 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -53.42 -52.09 60.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 74.140000000000001 108.786 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . 0.464 ' O ' ' N ' ' B' ' 161' ' ' GLN . 89.2 mtm180 47.15 -114.81 0.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 73.420000000000002 109.259 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . 0.772 ' OD2' ' CE1' ' B' ' 216' ' ' TYR . 9.8 m-20 -55.36 91.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.109 -0.995 . . . . 72.099999999999994 109.083 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' B' ' 159' ' ' ARG . 50.1 tp60 -164.71 145.43 7.73 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.207 -0.933 . . . . 73.239999999999995 109.775 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 89.7 mt -109.32 126.29 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.505 -0.747 . . . . 72.310000000000002 109.178 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 19.7 m -137.03 144.42 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.965 -0.754 . . . . 75.030000000000001 108.965 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 164' ' ' SER . . . . . 0.455 ' H ' ' CD ' ' B' ' 167' ' ' GLN . 23.1 t -86.94 178.34 6.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.077 -1.015 . . . . 74.219999999999999 110.185 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -61.46 -55.42 31.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.842 . . . . 72.420000000000002 109.408 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . 0.464 ' H ' ' CD ' ' B' ' 166' ' ' GLU . 31.7 mp0 -51.91 -31.91 30.53 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.858 . . . . 63.450000000000003 110.116 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 167' ' ' GLN . . . . . 0.455 ' CD ' ' H ' ' B' ' 164' ' ' SER . 41.4 mt-30 -64.94 -43.32 93.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.074 -1.016 . . . . 72.400000000000006 109.607 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 51.7 mt -58.12 -37.29 74.31 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.191 -1.04 . . . . 72.319999999999993 108.191 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.25 -65.91 0.57 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.501 -0.75 . . . . 73.340000000000003 109.063 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -58.35 -28.09 64.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.561 -0.712 . . . . 73.099999999999994 109.902 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.88 -65.25 0.63 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.28 -0.888 . . . . 62.130000000000003 110.091 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 1.323 ' O ' ' NZ ' ' B' ' 147' ' ' LYS . 2.1 mp -98.82 -53.45 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.129 -0.982 . . . . 74.439999999999998 109.937 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 26.0 m-90 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.031 -1.043 . . . . 72.230000000000004 109.027 -179.584 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo . . . . . 0 N--CA 1.49 1.271 0 CA-C-O 121.128 0.387 . . . . 74.340000000000003 112.722 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -156.57 52.0 0.52 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.033 -1.042 . . . . 72.310000000000002 109.761 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 9.3 p -65.24 -21.37 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.193 -0.942 . . . . 65.420000000000002 109.634 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 36.8 mt -67.53 -40.54 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.239 -0.913 . . . . 75.030000000000001 110.621 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . 0.487 ' O ' ' ND2' ' B' ' 189' ' ' ASN . 64.6 mm-40 -61.9 -50.51 71.89 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.098 -1.001 . . . . 73.519999999999996 110.323 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 18.2 m -75.08 -25.51 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.151 -0.968 . . . . 74.349999999999994 110.172 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -76.04 -46.62 28.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.119 -0.988 . . . . 61.119999999999997 110.18 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 11.2 tp -69.88 -29.34 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.865 -1.147 . . . . 72.430000000000007 109.286 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 189' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' B' ' 185' ' ' GLU . 92.5 m-20 -72.79 -48.51 37.49 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.43 -0.794 . . . . 75.420000000000002 109.9 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 190' ' ' GLN . . . . . 0.46 ' CG ' ' N ' ' B' ' 191' ' ' ILE . 1.9 pt20 -72.96 -45.17 59.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.095 -1.003 . . . . 74.140000000000001 110.193 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . 0.46 ' N ' ' CG ' ' B' ' 190' ' ' GLN . 77.1 mt -54.28 -55.4 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.04 -1.038 . . . . 74.030000000000001 109.376 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -54.39 -48.22 71.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.122 -0.986 . . . . 72.329999999999998 110.026 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 193' ' ' GLN . . . . . 0.411 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 81.7 mt-30 -62.07 -31.62 72.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.047 -1.033 . . . . 73.099999999999994 109.575 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -91.05 -2.97 57.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.25 -0.906 . . . . 74.430000000000007 110.339 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 24.1 ttp -99.94 -5.08 28.84 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.13 -0.981 . . . . 74.329999999999998 109.876 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 196' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' B' ' 193' ' ' GLN . 5.9 p-10 -105.92 -15.24 14.97 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.364 -0.835 . . . . 71.209999999999994 109.329 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . 0.585 ' N ' ' CD ' ' B' ' 198' ' ' PRO . 10.3 tttm -80.13 -41.7 1.37 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.243 -0.911 . . . . 75.209999999999994 110.059 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 198' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' B' ' 197' ' ' LYS . 73.6 Cg_endo -87.39 -44.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.486 2.124 . . . . 75.319999999999993 111.988 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 17.9 mt -78.38 -35.03 47.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.047 -1.033 . . . . 72.25 109.302 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 83.13 -37.98 2.72 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.731 -1.348 . . . . 73.239999999999995 109.731 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 22.4 mm -102.07 139.19 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.263 -1.14 . . . . 54.299999999999997 109.639 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 19.9 m -86.49 137.93 32.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.283 -0.886 . . . . 74.310000000000002 108.949 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 6.7 p -134.98 29.22 3.45 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.39 -0.819 . . . . 74.400000000000006 109.307 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 16.7 m -132.28 145.95 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.549 -0.719 . . . . 74.099999999999994 109.187 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -126.25 138.11 53.58 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.487 -0.758 . . . . 75.329999999999998 109.721 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 206' ' ' THR . . . . . 0.706 ' HG1' ' NH1' ' B' ' 208' ' ' ARG . 0.1 OUTLIER -96.94 132.82 42.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.326 -0.859 . . . . 71.400000000000006 109.47 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 8.3 t -130.38 117.1 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.707 -0.849 . . . . 63.5 108.707 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 208' ' ' ARG . . . . . 0.706 ' NH1' ' HG1' ' B' ' 206' ' ' THR . 0.1 OUTLIER -68.92 -36.3 77.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.222 -0.924 . . . . 74.450000000000003 109.747 -179.486 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 62.1 mtm180 -50.77 -65.09 0.62 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.122 -0.986 . . . . 74.140000000000001 110.118 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -100.58 -77.85 0.53 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.249 -0.907 . . . . 74.430000000000007 109.932 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -164.89 -105.27 0.19 Allowed Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.619 -1.277 . . . . 70.109999999999999 110.162 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 212' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' B' ' 212' ' ' TYR . 42.2 m-85 -133.93 148.75 51.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.505 -0.997 . . . . 74.209999999999994 109.978 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -141.12 153.7 45.54 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.252 -1.018 . . . . 74.299999999999997 108.252 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . 0.427 ' C ' ' SG ' ' B' ' 215' ' ' CYS . 0.7 OUTLIER -117.77 148.65 41.86 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.393 -0.817 . . . . 74.340000000000003 110.557 -178.249 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' B' ' 214' ' ' PHE . 8.8 m -151.37 164.18 37.28 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.676 -0.861 . . . . 72.209999999999994 108.676 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . 0.844 ' OH ' ' OE1' ' A' ' 161' ' ' GLN . 0.2 OUTLIER -72.86 154.08 91.08 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 120.96 -1.088 . . . . 72.310000000000002 108.865 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.51 175.92 1.92 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.246 1.964 . . . . 71.010000000000005 111.626 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 13.8 mtmm . . . . . 0 C--N 1.301 -1.534 0 N-CA-C 108.689 -0.856 . . . . 74.349999999999994 108.689 -179.931 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.57 ' SD ' ' CE2' ' A' ' 25' ' ' PHE . 43.4 ttp . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.457 -0.571 . . . . 65.120000000000005 109.457 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -140.53 152.25 45.41 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.397 -0.814 . . . . 73.310000000000002 109.224 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.4 t -119.6 129.47 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.529 0.681 . . . . 71.420000000000002 109.574 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.4 tp -96.14 122.65 39.21 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.53 -0.731 . . . . 65.219999999999999 109.521 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 mp -117.2 129.84 56.2 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.129 -1.063 . . . . 71.439999999999998 108.129 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.4 mt -126.03 97.18 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.062 -1.088 . . . . 71.150000000000006 108.062 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -144.11 130.97 20.32 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.243 -0.91 . . . . 75.340000000000003 109.753 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -63.12 -35.2 79.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 73.040000000000006 109.33 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -76.54 96.58 4.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 72.420000000000002 109.29 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.8 m -61.47 -29.6 70.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.88 . . . . 72.340000000000003 109.909 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 12' ' ' LEU . 9.5 p -67.58 -44.59 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.085 -1.009 . . . . 74.420000000000002 109.981 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.44 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 80.9 mt -69.82 -47.72 61.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.046 -1.034 . . . . 72.010000000000005 109.242 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.6 -20.88 70.4 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 107.922 -2.071 . . . . 72.140000000000001 107.922 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.38 -58.06 6.9 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.667 -1.373 . . . . 72.329999999999998 109.667 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -52.82 -44.31 66.6 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.342 -1.093 . . . . 72.340000000000003 109.588 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.1 mt -66.85 -38.31 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.736 -1.227 . . . . 74.239999999999995 108.329 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.507 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 88.0 tt0 -60.23 -45.94 91.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 71.409999999999997 109.213 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -86.05 -1.23 57.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -0.928 . . . . 75.540000000000006 109.715 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.62 -54.98 3.11 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 109.813 -1.315 . . . . 62.149999999999999 109.813 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -75.12 -21.32 58.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.231 -1.158 . . . . 74.420000000000002 110.0 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 96.4 m-20 -57.61 -31.65 66.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.121 -0.987 . . . . 74.25 109.636 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 85.1 t -61.13 -25.79 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.318 -0.864 . . . . 72.109999999999999 109.467 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.521 ' NZ ' ' OE1' ' A' ' 110' ' ' GLU . 17.0 mmtp -83.04 6.17 19.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.87 . . . . 73.230000000000004 109.337 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.51 37.18 21.26 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.153 -1.179 . . . . 75.540000000000006 110.153 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.57 ' CE2' ' SD ' ' A' ' 1' ' ' MET . 11.5 m-85 -116.09 159.05 22.26 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.467 -1.02 . . . . 74.510000000000005 109.017 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.4 mmt -112.75 135.21 53.75 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.833 -0.803 . . . . 64.319999999999993 108.833 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.51 161.81 38.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.194 -0.941 . . . . 74.310000000000002 109.718 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -142.76 141.16 31.67 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.357 -0.84 . . . . 75.400000000000006 109.26 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 t -104.02 130.31 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.304 -0.872 . . . . 75.129999999999995 108.877 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.2 p -118.9 170.35 9.09 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.536 -0.728 . . . . 71.420000000000002 109.361 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -88.29 -100.76 0.08 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.183 -0.948 . . . . 73.109999999999999 109.858 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.0 p -78.23 166.61 22.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 74.239999999999995 110.167 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.9 mt -55.61 -39.08 70.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.645 -0.659 . . . . 71.530000000000001 110.041 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -50.39 -43.81 54.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.092 -1.005 . . . . 74.230000000000004 109.652 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -65.66 -36.74 84.53 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.201 -0.937 . . . . 71.010000000000005 109.158 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.94 -34.9 29.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.558 -1.417 . . . . 61.409999999999997 109.558 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -63.37 -40.73 98.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -1.141 . . . . 74.340000000000003 109.569 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -77.9 -37.63 47.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.088 -1.008 . . . . 75.329999999999998 109.333 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.6 tp -66.91 -41.82 86.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 74.329999999999998 109.599 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.448 ' C ' ' SD ' ' A' ' 40' ' ' MET . 3.3 ppp? -77.87 -15.77 58.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.144 -0.972 . . . . 70.319999999999993 109.648 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -55.33 -39.8 70.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.052 -1.03 . . . . 71.219999999999999 109.158 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.8 pt -95.26 -32.39 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.274 -0.892 . . . . 74.409999999999997 109.885 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 40' ' ' MET . 96.6 mtt180 -91.77 153.04 19.87 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.078 -1.013 . . . . 75.409999999999997 109.676 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 45' ' ' TYR . 14.5 p30 -91.86 -34.38 14.56 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.162 -0.961 . . . . 75.420000000000002 109.765 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 44' ' ' ASN . 38.3 m-85 51.97 99.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.292 -0.88 . . . . 74.230000000000004 109.484 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -68.77 -28.97 67.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.23 -0.918 . . . . 75.319999999999993 109.42 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.418 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -115.5 110.58 19.48 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.747 -0.834 . . . . 72.129999999999995 108.747 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.9 t -96.9 110.34 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.324 -0.86 . . . . 72.340000000000003 108.685 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.587 ' SD ' ' N ' ' A' ' 50' ' ' VAL . 1.5 tpt -122.4 130.35 53.01 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.539 -0.725 . . . . 74.109999999999999 109.549 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.587 ' N ' ' SD ' ' A' ' 49' ' ' MET . 1.1 p -138.84 130.43 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.695 0.76 . . . . 71.239999999999995 109.818 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.2 t -98.16 2.41 48.46 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.596 -0.69 . . . . 73.109999999999999 109.534 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -75.93 136.58 40.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.171 -0.956 . . . . 63.399999999999999 109.405 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.519 ' C ' ' H ' ' A' ' 55' ' ' ALA . 62.4 mttp -72.96 -42.24 63.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.306 -0.871 . . . . 65.439999999999998 110.617 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -69.19 11.23 0.23 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.039 -1.038 . . . . 73.129999999999995 109.747 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.519 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.35 -21.64 58.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 64.140000000000001 110.44 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 55' ' ' ALA . 74.5 mt -37.79 -53.21 1.29 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.7 -0.625 . . . . 74.430000000000007 110.818 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.6 t -65.65 -36.66 84.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.972 -1.08 . . . . 63.229999999999997 109.329 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.449 ' N ' ' O ' ' A' ' 55' ' ' ALA . 45.3 t80 -64.58 -63.03 1.23 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.327 -0.858 . . . . 74.439999999999998 109.83 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.1 m -48.36 -32.85 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.81 -1.181 . . . . 74.030000000000001 109.713 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.2 m -59.4 -52.79 64.12 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.201 -0.937 . . . . 73.540000000000006 109.348 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -68.78 -27.75 66.16 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 118.934 -1.107 . . . . 73.340000000000003 109.881 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.523 ' O ' ' N ' ' A' ' 66' ' ' HIS . 29.6 mm -59.21 -49.83 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 120.829 -1.17 . . . . 73.349999999999994 108.847 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.519 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 45.3 mmtt -59.79 -46.55 88.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.086 -1.009 . . . . 74.420000000000002 108.649 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -64.08 -42.86 96.81 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.942 -0.762 . . . . 74.549999999999997 108.942 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.472 ' C ' ' CG ' ' A' ' 66' ' ' HIS . 51.6 mtpt -76.95 -26.27 53.81 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.526 -0.734 . . . . 75.219999999999999 110.554 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 62' ' ' ILE . 56.9 m-70 -154.97 65.72 0.65 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.973 -1.079 . . . . 74.129999999999995 109.746 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 63' ' ' LYS . 33.8 t -59.28 -25.83 64.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.352 -0.842 . . . . 73.239999999999995 110.155 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.0 t -69.66 -14.77 62.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.17 -0.956 . . . . 71.439999999999998 110.493 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 79.0 mt -94.06 155.91 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.972 -1.08 . . . . 71.329999999999998 109.907 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.413 ' CG1' ' N ' ' A' ' 71' ' ' VAL . 90.2 t -85.02 162.76 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.364 -0.835 . . . . 73.019999999999996 109.696 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.527 ' N ' ' OD1' ' A' ' 92' ' ' ASP . 14.7 t -145.24 117.14 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.09 -1.006 . . . . 54.210000000000001 109.741 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.506 ' O ' ' SD ' ' A' ' 49' ' ' MET . 1.0 OUTLIER -115.46 99.92 7.71 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.219 -1.03 . . . . 74.209999999999994 108.219 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.6 p -96.48 152.6 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.127 -0.983 . . . . 74.409999999999997 108.774 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.5 m -132.42 172.33 12.6 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.215 -0.928 . . . . 72.310000000000002 109.364 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.501 ' C ' ' H ' ' A' ' 77' ' ' ASN . 3.4 t -173.84 128.96 0.4 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.322 -0.861 . . . . 64.540000000000006 110.044 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -66.59 43.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.558 -0.714 . . . . 74.129999999999995 109.639 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 79' ' ' THR . 15.9 m120 -160.15 60.89 1.51 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 73.340000000000003 109.828 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -57.18 74.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.979 1.786 . . . . 71.319999999999993 111.469 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 77' ' ' ASN . 16.9 m -107.49 151.6 25.35 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.003 -0.74 . . . . 62.530000000000001 109.003 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -25.33 68.19 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.357 -0.839 . . . . 74.140000000000001 109.497 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -63.83 -52.39 60.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 71.420000000000002 109.489 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.29 -32.43 70.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 73.430000000000007 109.707 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -60.31 -52.62 64.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 74.219999999999999 109.603 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.64 -40.27 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.936 . . . . 74.150000000000006 109.312 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -68.65 -29.19 67.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -0.856 . . . . 72.540000000000006 109.826 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.28 -43.19 82.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.193 -0.942 . . . . 64.219999999999999 110.039 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -80.23 -26.39 39.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.062 -1.024 . . . . 74.340000000000003 108.946 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -75.98 -51.47 12.32 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.43 -0.794 . . . . 74.420000000000002 109.391 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.48 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 1.6 pp0? -61.57 -43.23 99.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.526 -0.734 . . . . 74.519999999999996 109.736 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.48 ' N ' ' CD ' ' A' ' 89' ' ' GLN . . . 138.45 72.82 0.05 OUTLIER Glycine 0 N--CA 1.498 2.776 0 N-CA-C 109.982 -1.247 . . . . 74.209999999999994 109.982 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -133.17 133.21 42.52 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.358 -1.083 . . . . 64.099999999999994 108.878 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 71' ' ' VAL . 2.8 m-20 -71.48 -39.66 70.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.039 -1.038 . . . . 73.420000000000002 108.999 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 61.8 m-20 -154.24 147.17 24.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.365 -0.834 . . . . 75.040000000000006 109.358 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -121.54 112.61 18.7 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.553 -0.906 . . . . 71.329999999999998 108.553 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 23.3 mm -106.56 152.4 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 CA-C-O 122.16 0.981 . . . . 74.510000000000005 111.333 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.59 123.33 21.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.849 -1.167 . . . . 64.319999999999993 107.849 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.667 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -45.99 -54.23 17.86 Favored Pre-proline 0 C--N 1.301 -1.531 0 O-C-N 121.038 -1.039 . . . . 74.510000000000005 111.525 -178.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.3 Cg_endo -41.46 -11.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 120.754 0.969 . . . . 73.109999999999999 112.886 -176.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.667 ' N ' ' O ' ' A' ' 97' ' ' LYS . 59.5 m-85 59.52 121.92 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.737 -0.602 . . . . 72.540000000000006 109.607 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -68.8 -32.26 71.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.059 -1.026 . . . . 74.540000000000006 109.52 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.757 ' O ' ' N ' ' A' ' 103' ' ' LYS . 41.3 t -174.21 28.41 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.989 -1.069 . . . . 74.140000000000001 110.885 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.456 ' N ' ' CD1' ' A' ' 102' ' ' ILE . 2.6 mp 50.4 -69.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-N 118.638 0.654 . . . . 75.430000000000007 110.194 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.757 ' N ' ' O ' ' A' ' 101' ' ' SER . 1.0 OUTLIER -55.33 -31.18 61.49 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.899 -1.148 . . . . 74.140000000000001 107.899 179.257 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.81 80.05 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.574 -0.85 . . . . 63.240000000000002 108.752 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.424 ' C ' ' CD1' ' A' ' 105' ' ' LEU . 1.7 tm? -69.74 -54.62 12.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.44 -0.787 . . . . 73.219999999999999 108.923 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 53.8 t -52.77 -45.75 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.016 -1.052 . . . . 74.540000000000006 109.326 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.47 -42.25 67.03 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.13 -0.982 . . . . 75.5 108.385 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -62.58 -32.9 73.97 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.481 -0.762 . . . . 74.409999999999997 109.137 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 83.2 mt -74.35 -31.91 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.117 -0.99 . . . . 73.239999999999995 108.604 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.521 ' OE1' ' NZ ' ' A' ' 23' ' ' LYS . 75.0 tt0 -58.44 -52.11 67.02 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.492 -0.755 . . . . 74.340000000000003 109.314 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.29 -32.3 66.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.917 . . . . 73.319999999999993 109.658 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 24.0 tpt85 -54.52 -34.21 61.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 74.420000000000002 109.433 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.2 tp -151.74 108.87 3.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.181 -0.949 . . . . 74.329999999999998 109.504 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -144.46 -51.76 0.3 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.252 -0.905 . . . . 74.439999999999998 108.67 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -82.53 25.57 0.62 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.185 -0.947 . . . . 74.430000000000007 109.401 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.439 ' CG ' ' N ' ' A' ' 117' ' ' GLY . 60.4 p-90 -51.04 -40.0 57.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 74.439999999999998 109.721 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.439 ' N ' ' CG ' ' A' ' 116' ' ' TRP . . . -57.74 93.42 0.04 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.767 -1.333 . . . . 75.040000000000006 109.767 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.0 m -153.03 164.71 37.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.211 -1.17 . . . . 70.109999999999999 109.707 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -159.87 128.98 5.12 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.907 -0.775 . . . . 65.239999999999995 108.907 -178.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.7 t -83.86 -45.31 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.158 -0.964 . . . . 74.219999999999999 110.066 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.514 ' CG2' HH21 ' A' ' 159' ' ' ARG . 20.3 mm -102.64 130.94 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.314 -0.867 . . . . 74.420000000000002 109.812 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -121.39 128.58 52.36 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.986 -0.746 . . . . 73.299999999999997 108.986 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 126' ' ' LEU . 23.6 mt -141.03 112.65 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.181 -0.95 . . . . 75.340000000000003 109.45 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.63 -138.63 7.94 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.857 -1.297 . . . . 75.129999999999995 109.857 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -80.09 -11.47 59.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -1.165 . . . . 74.450000000000003 109.487 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 123' ' ' ILE . 0.8 OUTLIER -91.23 135.53 33.73 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.494 -0.928 . . . . 54.210000000000001 108.494 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.8 m -130.2 129.77 43.82 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.447 -0.783 . . . . 70.239999999999995 109.593 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.406 HG21 HD12 ' A' ' 128' ' ' ILE . 28.8 mm -112.87 139.71 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.902 -0.777 . . . . 72.430000000000007 108.902 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 133' ' ' GLU . 5.2 m -128.05 80.03 72.86 Favored Pre-proline 0 N--CA 1.5 2.039 0 O-C-N 121.456 -0.777 . . . . 71.109999999999999 109.697 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.46 -51.89 9.47 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.704 2.27 . . . . 75.140000000000001 112.082 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -53.68 -44.03 69.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 72.5 109.092 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -87.36 -1.98 58.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.346 -0.846 . . . . 73.140000000000001 109.163 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 129' ' ' SER . 34.6 mp0 50.05 72.51 0.32 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.91 . . . . 75.329999999999998 109.129 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -158.14 122.89 4.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.343 -0.848 . . . . 71.230000000000004 109.814 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 84.3 mt -101.56 126.76 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.422 -0.799 . . . . 75.329999999999998 108.922 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.0 mt -117.07 125.36 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.57 -0.706 . . . . 71.109999999999999 109.113 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.521 ' C ' ' H ' ' A' ' 139' ' ' GLY . 47.8 p90 -140.72 151.45 44.51 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.327 -0.858 . . . . 74.140000000000001 109.207 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.3 tptp 56.01 5.5 0.17 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.78 0.8 . . . . 75.400000000000006 109.15 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' A' ' 137' ' ' TYR . . . 95.93 -2.98 64.47 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.846 -1.302 . . . . 72.239999999999995 109.846 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.529 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 1.2 mpt_? -89.71 131.64 35.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.235 -1.156 . . . . 73.120000000000005 109.14 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -93.04 127.98 38.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.241 -0.912 . . . . 72.319999999999993 109.571 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 43.2 t -137.07 136.44 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.424 -0.798 . . . . 62.340000000000003 109.493 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -91.51 143.54 26.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.268 -0.895 . . . . 61.229999999999997 109.042 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 25.9 m -139.75 153.89 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.288 -0.883 . . . . 74.439999999999998 109.699 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -167.21 24.64 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.333 -0.854 . . . . 75.420000000000002 109.163 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.52 -169.79 45.16 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.824 -1.31 . . . . 73.340000000000003 109.824 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.625 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 14.2 tmtt? -82.11 -31.14 0.54 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.343 -1.093 . . . . 72.219999999999999 111.424 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 87.0 Cg_endo -86.64 -3.58 8.32 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 C-N-CA 121.781 1.654 . . . . 75.450000000000003 112.408 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -96.85 -29.87 13.47 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.183 -0.948 . . . . 65.239999999999995 109.18 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -59.2 -40.84 87.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.271 -0.893 . . . . 72.519999999999996 109.259 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 13.9 p -61.79 -34.09 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.226 -0.921 . . . . 74.209999999999994 108.894 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -45.44 92.62 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.514 -0.921 . . . . 73.310000000000002 108.514 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.0 p -74.39 -24.58 59.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.197 -0.94 . . . . 74.310000000000002 109.294 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -59.36 -51.13 71.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.905 . . . . 75.450000000000003 109.685 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.7 pp -76.36 -27.22 56.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.104 -0.998 . . . . 75.340000000000003 109.618 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -54.12 -46.26 72.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.094 -1.004 . . . . 62.140000000000001 109.375 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.507 ' C ' ' H ' ' A' ' 159' ' ' ARG . 66.4 mtp180 -77.01 -49.49 15.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.928 . . . . 72.219999999999999 109.382 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -72.2 34.2 0.06 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.636 -0.665 . . . . 74.120000000000005 110.042 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.514 HH21 ' CG2' ' A' ' 121' ' ' ILE . 19.1 ttm180 -59.51 150.44 26.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.131 -0.981 . . . . 74.340000000000003 109.133 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.479 ' OD1' ' SG ' ' A' ' 215' ' ' CYS . 62.2 m-20 53.05 46.93 25.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 75.450000000000003 109.544 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -149.71 150.95 32.88 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.23 -0.919 . . . . 73.409999999999997 109.312 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 58.3 mt -90.15 132.74 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.223 -0.923 . . . . 74.409999999999997 109.296 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 48.5 t -131.52 134.73 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.486 -0.759 . . . . 72.530000000000001 109.29 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.423 ' OG ' ' OE1' ' A' ' 166' ' ' GLU . 3.0 t -86.25 157.25 19.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.318 -0.863 . . . . 74.120000000000005 109.894 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -59.52 -44.08 93.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.437 -0.789 . . . . 70.430000000000007 109.627 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.423 ' OE1' ' OG ' ' A' ' 164' ' ' SER . 34.0 mp0 -59.56 -38.01 79.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 74.319999999999993 109.526 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -59.28 -40.66 86.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.138 -0.976 . . . . 74.519999999999996 109.096 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 62.5 mt -58.02 -54.09 50.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.186 -0.947 . . . . 74.409999999999997 108.925 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 170' ' ' ASP . 10.3 mp -61.5 -55.95 25.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 75.140000000000001 109.194 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 169' ' ' LEU . 17.3 t70 -35.86 -42.8 0.28 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.04 0.447 . . . . 65.030000000000001 111.256 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.63 -30.26 13.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.078 -1.014 . . . . 70.209999999999994 110.53 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.9 mm -84.9 -72.72 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 120.986 -1.071 . . . . 75.319999999999993 109.663 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.503 ' O ' ' CE3' ' A' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 108.395 -0.965 . . . . 73.140000000000001 108.395 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.481 ' OD1' ' CD1' ' A' ' 184' ' ' ILE . 5.9 t30 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.215 0.531 . . . . 73.129999999999995 110.04 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.8 m -142.17 9.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.277 -0.89 . . . . 74.019999999999996 109.144 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.481 ' CD1' ' OD1' ' A' ' 182' ' ' ASN . 2.1 mp -49.8 -42.22 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 72.329999999999998 109.452 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.548 ' H ' ' CD ' ' A' ' 185' ' ' GLU . 2.1 pm0 -47.05 -34.67 6.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.153 -0.967 . . . . 74.400000000000006 109.263 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 92.3 t -78.35 -51.63 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.263 -0.898 . . . . 74.319999999999993 109.395 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.97 71.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 73.230000000000004 110.069 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.442 ' CG2' ' N ' ' A' ' 189' ' ' ASN . 10.8 tp -58.51 -44.88 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.971 -1.08 . . . . 74.310000000000002 109.73 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.442 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 45.7 t-20 -56.71 -45.09 82.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.932 -1.105 . . . . 73.439999999999998 109.381 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -68.88 -40.91 78.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.86 . . . . 71.420000000000002 109.64 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 68.1 mt -64.94 -34.66 71.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.175 -0.953 . . . . 72.439999999999998 109.73 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -64.01 -56.76 12.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.219 -0.925 . . . . 64.219999999999999 109.683 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -65.46 -35.69 81.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.917 . . . . 74.319999999999993 109.949 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -70.93 -17.66 62.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.071 -1.018 . . . . 75.310000000000002 109.667 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 195' ' ' MET . 0.2 OUTLIER -89.95 -53.52 4.45 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.253 -0.904 . . . . 74.019999999999996 109.722 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 200' ' ' GLY . 60.0 m-20 -61.18 -38.39 86.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 74.019999999999996 110.408 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.451 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 19.4 mmtt -51.76 -65.62 0.94 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 120.951 -1.093 . . . . 75.430000000000007 109.831 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 37.7 Cg_endo -64.02 -55.57 0.61 Allowed 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.242 1.961 . . . . 72.319999999999993 112.399 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.2 mp -64.26 -38.67 91.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.091 -1.005 . . . . 74.540000000000006 109.531 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 196' ' ' ASP . . . 83.22 -40.21 2.82 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.605 -1.398 . . . . 61.509999999999998 109.605 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.501 ' N ' ' CD1' ' A' ' 201' ' ' ILE . 2.2 mp -92.6 139.48 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.248 -1.148 . . . . 74.25 109.319 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 34.1 t -88.06 140.37 29.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.187 -0.946 . . . . 72.0 109.235 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.437 ' HG1' ' CE ' ' A' ' 195' ' ' MET . 11.9 p -144.25 33.41 1.21 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.177 -0.952 . . . . 74.439999999999998 109.516 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.62 143.92 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.238 -0.914 . . . . 71.129999999999995 109.649 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -122.08 137.84 54.67 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.632 -0.668 . . . . 73.510000000000005 109.284 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.1 t -114.51 141.74 47.31 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.471 -0.768 . . . . 73.519999999999996 109.357 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 9.0 p -144.42 137.12 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.253 -0.904 . . . . 72.150000000000006 109.473 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -71.4 -34.34 70.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 72.400000000000006 109.808 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 22.4 ttm105 -51.45 -36.77 45.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 73.310000000000002 109.699 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -140.98 -155.7 0.61 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.329 -0.857 . . . . 71.540000000000006 109.195 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -79.1 -125.13 0.44 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.739 -1.344 . . . . 74.450000000000003 109.739 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 212' ' ' TYR . 30.1 m-85 -116.78 135.0 54.1 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.577 -0.954 . . . . 75.540000000000006 109.728 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 67.4 ttt-85 -104.92 127.97 52.97 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.581 -0.7 . . . . 75.310000000000002 109.157 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 160' ' ' ASP . 18.8 m-85 -100.95 130.63 46.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.258 -0.901 . . . . 75.409999999999997 109.334 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . 0.479 ' SG ' ' OD1' ' A' ' 160' ' ' ASP . 52.0 t -154.39 155.97 35.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.36 -0.837 . . . . 74.140000000000001 109.281 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -68.07 149.93 97.96 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.164 -0.96 . . . . 75.319999999999993 108.957 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.495 1.577 0 C-N-CA 122.189 1.926 . . . . 73.109999999999999 111.877 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.553 ' N ' ' CD2' ' B' ' 25' ' ' PHE . 12.7 mtt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.334 -0.617 . . . . 75.239999999999995 109.334 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -97.8 121.26 39.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.324 -0.86 . . . . 73.519999999999996 109.288 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 79.9 t -115.59 136.24 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.472 0.653 . . . . 72.239999999999995 109.618 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 5.5 tp -105.33 120.12 40.78 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.589 -0.695 . . . . 73.340000000000003 109.729 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 18.0 mt -118.08 96.83 5.51 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.706 -0.85 . . . . 74.349999999999994 108.706 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 69.5 mt -84.96 97.54 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.808 -1.183 . . . . 63.439999999999998 108.377 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.432 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 35.2 tp10 -135.62 133.03 37.82 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.484 -0.76 . . . . 74.519999999999996 109.535 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -66.67 -32.51 73.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.308 -0.87 . . . . 74.129999999999995 109.32 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -79.93 129.93 34.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 74.230000000000004 109.388 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 25.9 t -83.31 -32.32 26.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 65.540000000000006 109.849 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.43 ' CG1' ' N ' ' B' ' 12' ' ' LEU . 11.1 p -63.25 -44.3 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.141 -0.974 . . . . 75.549999999999997 109.865 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.43 ' N ' ' CG1' ' B' ' 11' ' ' VAL . 74.7 mt -66.58 -33.02 74.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.993 -1.067 . . . . 70.140000000000001 109.353 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.73 -23.32 64.72 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.804 -1.718 . . . . 75.400000000000006 108.804 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.7 -49.7 7.71 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.702 -1.359 . . . . 65.439999999999998 109.702 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -62.58 -43.5 98.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.113 -1.227 . . . . 72.200000000000003 109.161 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 97.3 mt -61.27 -35.67 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.075 -1.016 . . . . 75.150000000000006 108.445 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.476 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 78.7 tt0 -60.83 -44.76 96.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.439 -0.788 . . . . 73.010000000000005 109.333 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -85.15 -0.14 53.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.19 -0.944 . . . . 74.299999999999997 109.097 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.6 -55.54 2.42 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.652 -1.379 . . . . 70.540000000000006 109.652 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -75.05 -19.99 59.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.152 -1.205 . . . . 75.430000000000007 109.811 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 1.7 m120 -53.05 -32.94 49.63 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.103 -0.998 . . . . 73.200000000000003 109.328 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 79.2 t -58.02 -27.71 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 74.230000000000004 108.836 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -83.9 -4.51 58.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.445 -0.784 . . . . 73.519999999999996 109.152 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.13 33.55 32.34 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.05 -1.22 . . . . 53.43 110.05 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.553 ' CD2' ' N ' ' B' ' 1' ' ' MET . 9.0 m-85 -110.83 159.14 17.94 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.411 -1.052 . . . . 71.120000000000005 108.9 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 6.9 mmt -105.49 141.88 36.2 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.563 -0.903 . . . . 75.239999999999995 108.563 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . 0.424 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -138.0 156.53 47.73 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.193 -0.942 . . . . 73.25 110.277 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 77.9 m-20 -138.77 159.46 42.07 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.647 -0.871 . . . . 72.310000000000002 108.647 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 p -123.04 139.98 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.327 -0.858 . . . . 72.140000000000001 109.938 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.4 p -138.16 170.78 15.44 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.532 -0.73 . . . . 74.530000000000001 109.284 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -90.62 -106.05 0.09 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.315 -0.865 . . . . 71.019999999999996 110.01 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 59.9 p -80.47 168.13 19.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.151 -0.968 . . . . 71.400000000000006 110.068 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' B' ' 37' ' ' GLU . 15.1 mt -51.85 -31.33 27.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.455 -0.778 . . . . 71.239999999999995 109.852 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -52.82 -51.49 60.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.032 -1.043 . . . . 74.319999999999993 109.647 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -62.72 -40.61 97.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.134 -0.979 . . . . 73.030000000000001 108.957 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.7 -33.27 75.59 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.964 -1.654 . . . . 60.43 108.964 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' B' ' 33' ' ' LEU . 84.3 tt0 -66.86 -44.07 81.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.363 -1.081 . . . . 74.430000000000007 109.319 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -75.83 -35.63 59.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 74.420000000000002 109.447 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 12.1 tp -72.0 -39.51 69.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.842 . . . . 75.409999999999997 110.119 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.7 ppp? -77.63 -18.19 57.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.999 -1.063 . . . . 61.439999999999998 109.888 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -69.5 -42.46 74.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.109 -0.995 . . . . 74.319999999999993 109.538 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 2.4 pp -87.48 -16.42 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.867 . . . . 71.230000000000004 109.737 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' B' ' 40' ' ' MET . 13.6 tpp85 -130.64 138.56 50.14 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.44 -0.787 . . . . 73.409999999999997 109.42 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -98.59 129.13 45.11 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.316 -0.865 . . . . 63.539999999999999 109.103 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -108.38 136.87 47.3 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.425 -0.797 . . . . 73.109999999999999 109.568 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . 0.449 ' OD2' ' SD ' ' B' ' 1' ' ' MET . 92.5 m-20 -76.75 -41.83 43.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 62.219999999999999 108.709 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.73 115.72 31.0 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.394 -0.965 . . . . 73.120000000000005 108.394 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -100.61 97.61 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.564 -0.902 . . . . 74.109999999999999 108.564 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -116.51 130.72 56.91 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.41 -0.806 . . . . 73.439999999999998 110.217 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.506 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.3 OUTLIER -144.33 134.49 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.169 -0.678 . . . . 73.400000000000006 109.169 -179.605 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' SER . . . . . 0.432 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 19.1 p -95.43 16.4 17.02 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.385 -0.822 . . . . 73.209999999999994 109.792 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.506 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 53.4 m-20 -80.56 144.58 32.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.956 . . . . 70.409999999999997 109.578 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.477 ' NZ ' HD22 ' B' ' 54' ' ' ASN . 18.4 pttp -76.45 -36.01 58.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 73.129999999999995 109.986 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . 0.477 HD22 ' NZ ' ' B' ' 53' ' ' LYS . 22.5 m120 -74.43 10.88 1.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 75.209999999999994 109.685 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -67.17 -25.27 66.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 55.329999999999998 110.08 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 62.1 mt -47.34 -40.35 17.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.078 -1.014 . . . . 72.420000000000002 110.028 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' SER . . . . . 0.419 ' O ' ' OG ' ' B' ' 60' ' ' SER . 14.5 t -75.45 -41.71 55.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.944 -1.098 . . . . 73.040000000000006 109.829 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -64.12 -47.91 78.15 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.329 -0.857 . . . . 72.329999999999998 110.232 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 19.5 m -63.95 -36.81 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.64 -1.287 . . . . 74.540000000000006 109.694 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' B' ' 57' ' ' SER . 80.6 p -56.59 -45.48 81.38 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.247 -0.908 . . . . 71.239999999999995 109.774 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' B' ' 65' ' ' LYS . 10.5 ptp180 -74.82 -31.82 61.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.065 -1.022 . . . . 74.310000000000002 109.971 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' B' ' 66' ' ' HIS . 5.1 mm -59.74 -53.72 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.901 -1.125 . . . . 75.420000000000002 109.493 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 8.8 mmmm -62.28 -41.51 98.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.036 -1.04 . . . . 73.319999999999993 108.95 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -66.83 -39.64 87.72 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.305 -0.998 . . . . 73.310000000000002 108.305 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' B' ' 61' ' ' ARG . 92.6 mttt -87.3 -76.95 0.35 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.357 -0.839 . . . . 72.439999999999998 109.249 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' B' ' 62' ' ' ILE . 97.7 m-70 -91.94 92.33 8.27 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.212 -0.93 . . . . 65.209999999999994 109.039 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.483 ' O ' ' N ' ' B' ' 69' ' ' ILE . 25.6 t -78.56 -41.47 31.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 73.099999999999994 110.058 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 46.2 t -67.76 54.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.164 -0.96 . . . . 71.530000000000001 109.81 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.483 ' N ' ' O ' ' B' ' 67' ' ' SER . 16.6 tt -151.28 153.22 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.143 -0.973 . . . . 74.400000000000006 109.395 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 76.1 t -97.48 152.14 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.15 -0.969 . . . . 75.120000000000005 109.284 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 10.0 t -136.59 129.77 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.24 -0.913 . . . . 73.200000000000003 110.108 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . 0.401 ' CD2' ' C ' ' B' ' 72' ' ' LEU . 4.8 tt -121.17 106.24 11.34 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.911 -0.774 . . . . 73.340000000000003 108.911 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 77.8 t -93.09 128.21 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.154 -0.966 . . . . 73.5 109.433 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.48 157.92 16.29 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.347 -0.983 . . . . 71.319999999999993 108.347 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 40.0 m -156.02 134.38 11.54 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.841 -1.162 . . . . 74.530000000000001 110.789 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -87.18 7.63 27.42 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.499 -0.926 . . . . 64.5 108.499 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -135.91 59.83 31.43 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 108.749 -0.834 . . . . 74.25 108.749 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.468 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 19.4 Cg_endo -60.14 79.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.424 2.083 . . . . 74.430000000000007 111.736 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 68.9 p -106.98 151.87 24.73 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.852 -0.795 . . . . 73.120000000000005 108.852 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.56 -22.0 30.34 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.297 -0.877 . . . . 75.409999999999997 109.152 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -68.98 -49.26 59.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 72.239999999999995 109.31 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -74.9 -27.27 60.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 73.219999999999999 109.658 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.75 -56.03 23.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.174 -0.954 . . . . 74.299999999999997 109.657 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 35.2 m -64.71 -42.76 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.135 -0.978 . . . . 73.310000000000002 109.279 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' HIS . . . . . 0.632 ' CE1' HE21 ' B' ' 89' ' ' GLN . 66.2 t60 -60.76 -36.12 78.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -0.918 . . . . 73.239999999999995 109.207 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.46 -41.13 98.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.337 -0.852 . . . . 55.329999999999998 109.97 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -77.35 -39.16 48.46 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.028 -1.045 . . . . 74.450000000000003 108.852 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -65.03 -39.19 93.01 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.596 -0.842 . . . . 64.040000000000006 109.254 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . 0.632 HE21 ' CE1' ' B' ' 85' ' ' HIS . 68.9 mm-40 -62.19 -47.1 85.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 75.129999999999995 108.935 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 144.47 -6.3 1.68 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.006 -1.237 . . . . 75.420000000000002 110.006 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.92 133.79 26.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.038 -1.272 . . . . 73.420000000000002 109.285 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . 0.477 ' CG ' HH12 ' B' ' 112' ' ' ARG . 40.9 t0 -83.45 -18.68 37.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -0.93 . . . . 73.319999999999993 109.213 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -152.45 164.05 38.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.421 -0.799 . . . . 73.040000000000006 108.988 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.468 ' OH ' ' CB ' ' B' ' 78' ' ' PRO . 0.1 OUTLIER -150.85 107.3 3.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.189 -0.944 . . . . 74.310000000000002 108.931 -179.361 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 30.9 mm -114.82 159.87 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 O-C-N 121.485 -0.76 . . . . 75.340000000000003 109.94 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.96 128.32 35.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.18 -0.95 . . . . 70.099999999999994 108.556 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.687 ' O ' ' N ' ' B' ' 99' ' ' TYR . 1.8 tptt -49.08 -59.33 6.59 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.144 -0.973 . . . . 65.430000000000007 111.443 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 8.0 Cg_endo -44.24 -3.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.569 1.513 . . . . 63.520000000000003 113.015 -175.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . 0.687 ' N ' ' O ' ' B' ' 97' ' ' LYS . 48.5 m-85 62.18 123.38 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.91 -0.494 . . . . 75.129999999999995 109.795 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 17.9 ttm-85 -74.41 -37.66 63.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.942 -1.099 . . . . 74.230000000000004 109.237 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' SER . . . . . 0.767 ' O ' ' N ' ' B' ' 103' ' ' LYS . 48.3 t -173.8 35.45 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.951 -1.093 . . . . 64.510000000000005 111.303 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 36.8 mm 49.67 -70.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-N 118.995 0.816 . . . . 74.439999999999998 110.52 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . 0.767 ' N ' ' O ' ' B' ' 101' ' ' SER . 33.1 mmtm -54.08 -32.44 54.8 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.106 -1.072 . . . . 72.299999999999997 108.106 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.01 -45.75 76.59 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.342 -0.985 . . . . 74.310000000000002 108.342 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 64.2 tp -62.6 -44.18 96.94 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.72 -0.845 . . . . 73.540000000000006 108.72 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 76.5 t -66.79 -38.62 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.355 -0.841 . . . . 72.030000000000001 109.513 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.42 -46.48 69.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.225 -0.922 . . . . 64.219999999999999 109.49 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -69.56 -31.37 69.51 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.188 -0.945 . . . . 75.310000000000002 109.888 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 96.4 mt -74.06 -31.34 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.018 -1.051 . . . . 55.439999999999998 108.833 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -73.91 -58.56 3.22 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.645 -0.822 . . . . 65.310000000000002 109.367 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -50.99 -35.22 32.67 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.384 -0.823 . . . . 74.519999999999996 109.578 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . 0.477 HH12 ' CG ' ' B' ' 92' ' ' ASP . 5.6 tpt180 -65.7 -44.01 87.42 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.158 -0.964 . . . . 72.040000000000006 109.738 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 43.0 mt -134.28 64.01 1.61 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.365 -0.835 . . . . 75.349999999999994 109.963 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -60.55 -43.7 96.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.971 -1.081 . . . . 75.5 108.628 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -142.08 -109.21 0.13 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.389 -0.819 . . . . 73.040000000000006 109.357 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -148.21 162.7 38.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.272 -0.893 . . . . 74.450000000000003 109.184 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' B' ' 119' ' ' ASN . . . -70.11 153.72 52.18 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.525 -1.43 . . . . 64.209999999999994 109.525 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' SER . . . . . 0.427 ' O ' ' O ' ' B' ' 119' ' ' ASN . 29.5 p -82.65 30.55 0.42 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -1.182 . . . . 71.400000000000006 109.718 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . 0.609 ' N ' ' ND2' ' B' ' 119' ' ' ASN . 0.0 OUTLIER 55.07 170.24 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.495 -0.882 . . . . 74.209999999999994 109.629 177.602 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 11.0 t -119.88 -37.82 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.526 -0.734 . . . . 75.019999999999996 109.13 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 29.3 mm -110.94 132.79 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.437 -0.79 . . . . 74.239999999999995 109.491 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -152.98 117.14 4.87 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.196 -0.94 . . . . 73.329999999999998 109.495 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.695 HD11 ' HB3' ' B' ' 216' ' ' TYR . 11.5 tt -163.04 140.24 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.009 -1.057 . . . . 74.219999999999999 110.271 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' B' ' 126' ' ' LEU . . . 69.52 33.14 71.79 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.312 -1.115 . . . . 72.409999999999997 110.312 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 14.8 t0 69.51 -6.34 1.01 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.355 -1.086 . . . . 75.120000000000005 109.281 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.714 HD12 HD11 ' B' ' 199' ' ' LEU . 1.2 mt -91.12 144.35 25.73 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.031 -1.1 . . . . 75.420000000000002 108.031 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.46 126.31 40.27 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.357 -0.839 . . . . 74.219999999999999 109.004 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 73.6 mt -127.58 131.41 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.593 -0.692 . . . . 60.329999999999998 109.341 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 48.7 m -115.24 121.27 35.2 Favored Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 121.626 -0.671 . . . . 72.310000000000002 109.334 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -78.26 -44.25 0.16 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.572 1.515 . . . . 75.129999999999995 111.933 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . 0.791 ' O ' ' OE2' ' B' ' 133' ' ' GLU . 70.0 m-20 -62.91 -46.85 85.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.07 -1.019 . . . . 75.230000000000004 109.281 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . 0.478 ' O ' ' C ' ' B' ' 133' ' ' GLU . 41.7 mt-10 -86.84 5.72 35.31 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.252 -0.905 . . . . 75.120000000000005 109.182 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . 0.791 ' OE2' ' O ' ' B' ' 131' ' ' ASP . 0.6 OUTLIER 29.93 59.87 0.19 Allowed 'General case' 0 N--CA 1.509 2.502 0 CA-C-O 121.596 0.712 . . . . 75.129999999999995 110.447 -179.579 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -141.99 137.56 31.26 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.973 -0.751 . . . . 75.109999999999999 108.973 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 10.9 tt -111.05 138.97 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.217 -0.927 . . . . 70.319999999999993 109.874 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 18.0 mm -115.91 132.84 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.561 -0.712 . . . . 74.120000000000005 109.534 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -140.43 125.2 18.17 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.362 -0.836 . . . . 74.230000000000004 108.964 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 81.2 mttt 55.13 33.98 21.62 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.405 -0.809 . . . . 74.219999999999999 110.311 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 76.76 14.99 81.98 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 120.182 -1.009 . . . . 74.319999999999993 110.934 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -101.05 127.8 47.4 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.179 -1.189 . . . . 75.340000000000003 109.63 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -93.74 117.83 30.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.253 -0.904 . . . . 71.230000000000004 109.621 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 5.3 t -124.74 120.99 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.389 -0.819 . . . . 70.430000000000007 108.947 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -79.22 139.8 37.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.382 -0.824 . . . . 72.430000000000007 109.62 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.99 137.21 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.285 -0.884 . . . . 72.129999999999995 109.069 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 41.8 pttt -167.24 119.11 0.91 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 74.5 109.782 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 156.96 -177.21 33.97 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.082 -1.607 . . . . 42.229999999999997 109.082 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . 0.622 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 26.6 mmtm -69.05 -36.56 7.71 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.166 -1.197 . . . . 73.299999999999997 110.375 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 26.8 Cg_exo -61.3 -36.21 80.46 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.871 1.714 . . . . 71.329999999999998 111.597 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -90.6 -28.01 18.72 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.359 -0.838 . . . . 74.230000000000004 109.393 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -50.6 -49.42 56.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 72.340000000000003 109.696 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . 0.908 HG22 HG22 ' B' ' 191' ' ' ILE . 2.8 p -64.95 -34.28 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.088 -1.008 . . . . 73.349999999999994 109.038 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 10.5 tp -64.07 -36.85 85.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.172 -0.955 . . . . 74.430000000000007 108.605 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.39 -28.65 56.8 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.441 -0.787 . . . . 75.209999999999994 109.305 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 154' ' ' HIS . . . . . 1.029 ' CE1' ' CE1' ' B' ' 158' ' ' HIS . 1.3 t60 -63.43 -53.84 45.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.023 -1.048 . . . . 73.040000000000006 109.561 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.7 pp -66.61 -30.36 70.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.992 -1.067 . . . . 73.430000000000007 108.917 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.51 -51.22 60.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.101 -1.0 . . . . 75.319999999999993 109.016 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . 0.55 ' NH1' ' HA ' ' B' ' 154' ' ' HIS . 51.3 mtt85 -62.37 -51.39 67.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.029 -1.044 . . . . 73.319999999999993 108.773 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 158' ' ' HIS . . . . . 1.029 ' CE1' ' CE1' ' B' ' 154' ' ' HIS . 11.8 m80 -88.78 36.0 0.79 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.723 -0.61 . . . . 74.140000000000001 109.886 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . 0.402 HH12 ' CB ' ' B' ' 203' ' ' THR . 29.9 ttp85 -82.6 41.36 0.71 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.872 -1.142 . . . . 73.420000000000002 109.619 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . 0.743 ' HB3' ' HE1' ' B' ' 216' ' ' TYR . 3.9 p-10 -166.66 49.34 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 72.099999999999994 109.511 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -175.6 -171.54 0.48 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.346 -0.846 . . . . 73.239999999999995 109.79 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 86.9 mt -93.05 143.05 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.288 -0.883 . . . . 72.310000000000002 110.126 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 78.6 t -134.18 126.21 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.986 -0.746 . . . . 75.030000000000001 108.986 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 4.6 p -81.68 162.76 22.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.131 -0.98 . . . . 74.219999999999999 109.941 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -64.54 -51.54 62.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.422 -0.799 . . . . 72.420000000000002 110.137 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -58.38 -27.13 63.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.119 -0.988 . . . . 63.450000000000003 109.086 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -56.18 -50.95 69.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 72.400000000000006 108.906 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 79.6 mt -61.73 -36.19 80.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 72.319999999999993 108.933 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 5.9 tt -64.9 -61.48 2.14 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.453 -0.779 . . . . 73.340000000000003 109.695 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -62.38 -25.73 68.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.91 . . . . 73.099999999999994 110.479 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.03 -47.52 58.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.943 -1.098 . . . . 62.130000000000003 110.366 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 24.3 mm -99.7 -63.06 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.149 -0.969 . . . . 74.439999999999998 110.428 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 25.6 m-90 . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.081 -1.012 . . . . 72.230000000000004 109.961 -179.29 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo . . . . . 0 N--CA 1.498 1.736 0 CA-C-O 121.348 0.478 . . . . 74.340000000000003 112.441 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -179.04 -21.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.323 -0.861 . . . . 72.310000000000002 108.835 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 15.2 m -75.21 -10.13 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 65.420000000000002 109.546 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 50.9 mt -50.4 -25.96 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.923 . . . . 75.030000000000001 109.004 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . 0.413 ' O ' ' OD1' ' B' ' 189' ' ' ASN . 25.1 mm-40 -62.18 -38.57 89.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.387 -0.82 . . . . 73.519999999999996 109.381 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 2.1 t -77.45 -34.94 21.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.399 -0.813 . . . . 74.349999999999994 109.986 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -68.68 -39.36 80.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.861 -1.149 . . . . 61.119999999999997 110.634 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 188' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' B' ' 189' ' ' ASN . 10.6 tp -76.94 -42.13 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.786 -1.196 . . . . 72.430000000000007 109.769 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 189' ' ' ASN . . . . . 0.423 ' N ' ' CG2' ' B' ' 188' ' ' ILE . 18.6 m120 -70.33 -37.12 74.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 75.420000000000002 110.77 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 190' ' ' GLN . . . . . 0.429 ' CG ' ' N ' ' B' ' 191' ' ' ILE . 13.6 pt20 -71.45 -46.95 58.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.859 -1.15 . . . . 74.140000000000001 110.995 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . 0.908 HG22 HG22 ' B' ' 151' ' ' VAL . 6.5 pt -60.7 -38.97 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.485 -1.384 . . . . 74.030000000000001 109.379 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 192' ' ' ARG . . . . . 0.52 ' NH2' ' CD1' ' B' ' 212' ' ' TYR . 98.5 mtt180 -62.35 -35.79 80.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.029 -1.045 . . . . 72.329999999999998 109.474 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 193' ' ' GLN . . . . . 0.443 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 86.7 mt-30 -77.5 -25.91 50.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.228 -0.92 . . . . 73.099999999999994 110.384 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -78.71 -24.25 45.05 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.092 -1.005 . . . . 74.430000000000007 110.736 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 195' ' ' MET . . . . . 0.477 ' HE2' HG12 ' B' ' 204' ' ' VAL . 5.6 ptm -94.82 -35.7 11.97 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.921 -1.112 . . . . 74.329999999999998 110.568 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 196' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 52.9 p-10 -67.92 -24.04 65.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.985 -1.072 . . . . 71.209999999999994 110.772 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . 0.539 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 17.5 mttp -74.69 -62.23 0.97 Allowed Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.979 -1.076 . . . . 75.209999999999994 110.219 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 198' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -66.36 -39.51 17.04 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.082 1.855 . . . . 75.319999999999993 112.83 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . 0.714 HD11 HD12 ' B' ' 126' ' ' LEU . 58.1 mt -80.14 -55.77 4.7 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.881 -1.137 . . . . 72.25 110.142 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 95.91 -8.4 67.94 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.42 -1.472 . . . . 73.239999999999995 109.42 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 23.4 mm -105.36 135.93 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.325 -1.103 . . . . 54.299999999999997 109.349 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 47.7 t -90.15 133.36 34.93 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.146 -0.971 . . . . 74.310000000000002 108.723 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 203' ' ' THR . . . . . 0.402 ' CB ' HH12 ' B' ' 159' ' ' ARG . 43.7 p -146.83 50.25 1.12 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.022 -1.048 . . . . 74.400000000000006 110.226 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.477 HG12 ' HE2' ' B' ' 195' ' ' MET . 33.3 m -144.31 124.6 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 120.973 -1.08 . . . . 74.099999999999994 109.835 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -109.53 114.0 27.26 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.416 -0.957 . . . . 75.329999999999998 108.416 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 9.8 t -96.06 125.31 40.51 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.097 -1.002 . . . . 71.400000000000006 109.724 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.9 p -142.22 142.62 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.303 -0.873 . . . . 63.5 109.321 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -80.6 6.97 11.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 74.450000000000003 109.611 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -58.17 -39.4 78.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.22 -0.925 . . . . 74.140000000000001 109.818 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -160.37 -37.16 0.05 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.222 -0.924 . . . . 74.430000000000007 109.397 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.9 -150.5 9.96 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.438 -1.465 . . . . 70.109999999999999 109.438 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 212' ' ' TYR . . . . . 0.52 ' CD1' ' NH2' ' B' ' 192' ' ' ARG . 54.4 m-85 -93.11 137.92 32.02 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.137 -1.213 . . . . 74.209999999999994 109.033 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -111.46 118.37 35.6 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.55 -0.719 . . . . 74.299999999999997 109.78 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -96.05 131.67 42.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.349 -0.844 . . . . 74.340000000000003 109.024 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.0 t -145.06 169.5 17.99 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.17 -0.956 . . . . 72.209999999999994 109.946 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . 0.743 ' HE1' ' HB3' ' B' ' 160' ' ' ASP . 0.0 OUTLIER -74.74 159.09 83.96 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.414 -0.958 . . . . 72.310000000000002 108.414 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.82 133.1 56.05 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.298 1.999 . . . . 71.010000000000005 111.943 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . 0.427 ' HZ2' ' CB ' ' B' ' 218' ' ' LYS . 3.0 ttmp? . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 74.349999999999994 110.485 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 1.177 ' CE ' ' HA ' ' A' ' 115' ' ' PHE . 28.6 tpp . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.413 -0.588 . . . . 65.120000000000005 109.413 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -140.06 140.5 36.14 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.345 -0.847 . . . . 73.310000000000002 109.203 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.6 t -119.9 142.91 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.633 0.73 . . . . 71.420000000000002 110.402 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.3 tp -113.75 116.14 28.93 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.116 -1.068 . . . . 65.219999999999999 108.116 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.442 ' CD1' ' SD ' ' A' ' 49' ' ' MET . 3.6 tp -118.5 103.96 10.24 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.892 -0.781 . . . . 71.439999999999998 108.892 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 69.9 mt -95.71 104.3 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.115 -0.991 . . . . 71.150000000000006 108.742 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.416 ' OE2' ' ND2' ' A' ' 9' ' ' ASN . 28.7 tp10 -128.51 119.25 24.5 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.206 -0.664 . . . . 75.340000000000003 109.206 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.458 ' CB ' ' NZ ' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -84.19 -3.22 58.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.227 -0.921 . . . . 73.040000000000006 109.378 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.417 ' O ' ' OG ' ' A' ' 10' ' ' SER . 70.5 m-20 -81.73 -125.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.338 -0.851 . . . . 72.420000000000002 109.279 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 9' ' ' ASN . 25.3 m -165.88 -77.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.024 -1.047 . . . . 72.340000000000003 110.106 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.83 -44.09 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -0.885 . . . . 74.420000000000002 110.622 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.499 ' CD1' ' HZ2' ' A' ' 97' ' ' LYS . 3.5 mm? -58.8 -37.24 75.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.092 -1.005 . . . . 72.010000000000005 109.668 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.92 -32.52 39.96 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.727 -1.749 . . . . 72.140000000000001 108.727 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.21 -47.84 69.13 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 110.058 -1.217 . . . . 72.329999999999998 110.058 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.67 -43.56 93.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.011 -1.288 . . . . 72.340000000000003 109.382 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.8 mm -64.86 -43.97 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.817 -1.177 . . . . 74.239999999999995 108.492 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -58.83 -50.43 74.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.86 . . . . 71.409999999999997 109.468 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -80.7 1.53 29.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.196 -0.94 . . . . 75.540000000000006 109.585 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.08 -58.41 2.0 Allowed Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.958 -1.257 . . . . 62.149999999999999 109.958 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -75.85 -18.73 59.33 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.265 -1.138 . . . . 74.420000000000002 110.032 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -57.59 -31.35 66.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.107 -0.996 . . . . 74.25 109.623 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.4 t -62.37 -38.22 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.386 -0.821 . . . . 72.109999999999999 109.876 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.525 ' HZ3' ' HZ1' ' A' ' 103' ' ' LYS . 12.1 mptt -67.93 -1.82 6.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.325 -0.86 . . . . 73.230000000000004 109.726 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.09 27.03 27.01 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.826 -1.31 . . . . 75.540000000000006 109.826 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.661 ' CE1' ' CE2' ' A' ' 115' ' ' PHE . 13.8 m-85 -99.49 151.25 21.34 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.33 -1.1 . . . . 74.510000000000005 109.097 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 12.0 mtt -102.06 128.44 48.52 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.572 -1.269 . . . . 64.319999999999993 107.572 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.84 140.1 38.38 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.157 -0.965 . . . . 74.310000000000002 110.507 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -112.66 139.03 48.61 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.715 -0.846 . . . . 75.400000000000006 108.715 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -104.75 124.55 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.293 -0.88 . . . . 75.129999999999995 108.722 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.4 p -128.2 166.61 18.22 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.648 -0.658 . . . . 71.420000000000002 109.495 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -83.87 -102.95 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.22 -0.925 . . . . 73.109999999999999 109.446 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.0 p -81.37 161.16 23.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 74.239999999999995 109.457 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.8 mp -52.22 -28.23 17.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.375 -0.828 . . . . 71.530000000000001 109.5 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -49.25 -53.35 22.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.935 . . . . 74.230000000000004 109.5 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -60.58 -39.01 86.48 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.175 -0.953 . . . . 71.010000000000005 108.715 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.37 -34.83 80.77 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.106 -1.597 . . . . 61.409999999999997 109.106 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -66.98 -43.92 81.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -1.129 . . . . 74.340000000000003 109.351 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.447 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 36.6 t80 -76.81 -22.23 53.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.122 -0.986 . . . . 75.329999999999998 109.824 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.2 tp -87.42 -30.78 20.46 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.108 -0.995 . . . . 74.329999999999998 109.673 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.44 ' O ' ' O ' ' A' ' 43' ' ' ARG . 5.0 ppp? -86.36 -24.02 25.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.122 -0.986 . . . . 70.319999999999993 110.468 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 37.4 p-10 -59.37 -28.49 66.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.887 -1.133 . . . . 71.219999999999999 109.444 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.538 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 12.6 pt -92.24 -30.68 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.234 -0.916 . . . . 74.409999999999997 110.113 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 40' ' ' MET . 70.9 mmt-85 -130.03 148.31 51.87 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.386 -0.821 . . . . 75.409999999999997 109.645 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -98.66 160.11 14.5 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.252 -0.905 . . . . 75.420000000000002 109.483 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -131.02 160.11 35.55 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.496 -0.753 . . . . 74.230000000000004 109.241 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.745 ' OD2' ' CH2' ' A' ' 116' ' ' TRP . 5.4 m-20 -98.69 -45.21 6.13 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.267 -0.896 . . . . 75.319999999999993 109.474 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.403 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -102.18 108.84 20.36 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.45 -0.944 . . . . 72.129999999999995 108.45 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.7 t -97.25 100.78 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.339 -0.851 . . . . 72.340000000000003 109.248 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.448 ' C ' ' SD ' ' A' ' 49' ' ' MET . 2.0 tmt? -116.74 134.48 54.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.456 -0.777 . . . . 74.109999999999999 109.489 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.476 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 1.3 p -143.43 127.69 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.499 -0.751 . . . . 71.239999999999995 109.323 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.4 p -86.69 4.95 38.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.559 -0.713 . . . . 73.109999999999999 109.408 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.476 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 13.6 m-20 -79.92 138.9 37.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.937 . . . . 63.399999999999999 109.646 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.425 ' C ' ' H ' ' A' ' 55' ' ' ALA . 91.1 mttt -82.27 -32.75 29.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.269 -0.894 . . . . 65.439999999999998 109.938 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -73.21 8.93 1.42 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.195 -0.941 . . . . 73.129999999999995 109.714 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -74.93 -20.9 59.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.331 -0.856 . . . . 64.140000000000001 110.184 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 55' ' ' ALA . 31.3 mt -38.49 -45.0 0.99 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.604 -0.685 . . . . 74.430000000000007 110.706 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.3 p -74.47 -36.54 63.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.95 -1.093 . . . . 63.229999999999997 109.311 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 55' ' ' ALA . 64.6 t80 -65.07 -46.19 82.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.417 -0.802 . . . . 74.439999999999998 109.998 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.1 m -64.29 -37.41 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.703 -1.248 . . . . 74.030000000000001 109.307 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.1 t -53.54 -49.9 66.64 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.209 -0.932 . . . . 73.540000000000006 109.228 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -70.28 -36.22 74.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 73.340000000000003 110.243 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 mm -64.67 -34.12 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.642 -1.286 . . . . 73.349999999999994 109.432 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.484 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 44.0 mmtt -67.43 -51.58 49.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 74.420000000000002 109.868 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.443 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 17.1 pt-20 -72.38 -43.02 64.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.942 -1.099 . . . . 74.549999999999997 109.937 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.505 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 25.8 mtpp -70.14 -22.72 62.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 75.219999999999999 109.508 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.505 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 89.9 m-70 -156.35 64.31 0.55 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.923 . . . . 74.129999999999995 109.525 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 63' ' ' LYS . 30.7 p -60.19 -31.54 70.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.871 . . . . 73.239999999999995 109.737 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 87.7 p -68.6 47.84 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -0.915 . . . . 71.439999999999998 109.705 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.427 ' H ' ' C ' ' A' ' 67' ' ' SER . 14.3 tt -148.61 161.92 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.083 -1.011 . . . . 71.329999999999998 109.609 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.656 HG22 HD12 ' A' ' 113' ' ' LEU . 77.4 t -95.96 154.91 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.158 -0.964 . . . . 73.019999999999996 108.754 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.725 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 6.5 t -143.32 114.52 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.11 -0.994 . . . . 54.210000000000001 109.315 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.0 mp -111.12 100.14 8.86 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.55 -0.908 . . . . 74.209999999999994 108.55 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.4 t -93.14 120.4 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.345 -0.847 . . . . 74.409999999999997 108.91 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 m -97.84 172.84 7.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.284 -0.885 . . . . 72.310000000000002 108.763 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 77' ' ' ASN . 0.8 OUTLIER -173.98 120.72 0.29 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.982 -1.073 . . . . 64.540000000000006 110.203 -179.622 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -65.53 2.37 0.95 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.508 -0.745 . . . . 74.129999999999995 109.406 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.495 ' H ' ' C ' ' A' ' 75' ' ' SER . 80.2 m-20 -120.1 64.05 9.57 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 109.123 -0.695 . . . . 73.340000000000003 109.123 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.03 74.2 0.1 OUTLIER 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.11 1.873 . . . . 71.319999999999993 111.871 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.45 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 60.1 p -104.95 149.7 25.52 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.331 -0.988 . . . . 62.530000000000001 108.331 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -28.56 69.19 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.197 -0.939 . . . . 74.140000000000001 109.813 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.459 ' OE1' ' N ' ' A' ' 81' ' ' GLU . 40.8 mp0 -63.41 -38.08 89.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.112 -0.992 . . . . 71.420000000000002 109.876 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -77.05 -33.95 57.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.044 -1.035 . . . . 73.430000000000007 109.712 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -61.05 -52.57 64.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.056 -1.028 . . . . 74.219999999999999 109.461 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.9 m -62.67 -41.31 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -0.949 . . . . 74.150000000000006 109.387 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -65.8 -29.94 70.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.225 -0.922 . . . . 72.540000000000006 109.324 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.02 -37.05 80.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.917 . . . . 64.219999999999999 109.91 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -80.2 -34.05 37.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.106 -0.997 . . . . 74.340000000000003 108.839 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -73.64 -38.22 65.08 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.388 -0.82 . . . . 74.420000000000002 109.461 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -71.32 -60.86 2.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 74.519999999999996 109.374 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 155.71 70.88 0.01 OUTLIER Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.67 -1.252 . . . . 74.209999999999994 110.168 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -133.08 130.75 39.74 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.339 -1.095 . . . . 64.099999999999994 109.357 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.725 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 14.2 m-20 -69.51 -41.09 76.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 73.420000000000002 109.268 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.732 ' CG ' HH21 ' A' ' 112' ' ' ARG . 4.9 m-20 -146.32 163.0 36.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.834 . . . . 75.040000000000006 109.056 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.494 ' CE1' ' OE1' ' A' ' 83' ' ' GLU . 56.6 t80 -136.96 124.42 22.09 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.363 -0.977 . . . . 71.329999999999998 108.363 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.454 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 0.1 OUTLIER -126.12 149.83 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 CA-C-O 122.045 0.926 . . . . 74.510000000000005 111.232 -178.055 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.75 121.54 16.72 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.768 -1.197 . . . . 64.319999999999993 107.768 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.659 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -44.92 -55.43 10.94 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.197 -0.939 . . . . 74.510000000000005 111.629 -178.596 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.7 Cg_endo -41.56 -12.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 120.739 0.96 . . . . 73.109999999999999 112.538 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.659 ' N ' ' O ' ' A' ' 97' ' ' LYS . 55.2 m-85 59.86 124.88 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 109.583 -0.525 . . . . 72.540000000000006 109.583 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 32.6 ttm-85 -62.08 -38.79 90.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.876 -1.14 . . . . 74.540000000000006 109.353 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.793 ' O ' ' N ' ' A' ' 103' ' ' LYS . 6.3 t -172.99 46.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.129 -0.982 . . . . 74.140000000000001 110.473 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 92.2 mt 47.11 -68.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-O 121.228 0.537 . . . . 75.430000000000007 110.825 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.793 ' N ' ' O ' ' A' ' 101' ' ' SER . 13.8 mmmt -53.25 -34.0 55.38 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.238 -0.914 . . . . 74.140000000000001 108.843 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.39 -49.73 68.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.262 -0.899 . . . . 63.240000000000002 109.204 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.428 ' C ' ' CD1' ' A' ' 105' ' ' LEU . 2.0 tm? -57.73 -47.9 81.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.134 -0.979 . . . . 73.219999999999999 108.726 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.96 -40.2 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.964 -1.085 . . . . 74.540000000000006 109.85 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.17 -39.23 59.78 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.252 -0.905 . . . . 75.5 108.832 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 1.291 ' HB3' ' NH1' ' A' ' 112' ' ' ARG . 93.3 mtt180 -73.55 -29.82 62.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.028 -1.045 . . . . 74.409999999999997 109.933 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 47.5 mt -73.92 -44.94 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 120.891 -1.131 . . . . 73.239999999999995 109.218 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.449 ' CG ' ' N ' ' A' ' 111' ' ' ALA . 17.7 pt-20 -70.31 -47.93 58.87 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.816 -1.154 . . . . 74.340000000000003 109.717 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.449 ' N ' ' CG ' ' A' ' 110' ' ' GLU . . . -59.49 -29.84 68.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.889 -1.132 . . . . 73.319999999999993 109.578 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 1.291 ' NH1' ' HB3' ' A' ' 108' ' ' ARG . 53.0 mtt85 -72.79 -58.34 3.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.913 . . . . 74.420000000000002 109.175 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.713 HD23 ' O ' ' A' ' 112' ' ' ARG . 16.7 mt -126.35 65.13 1.24 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.502 -0.925 . . . . 74.329999999999998 108.502 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.549 ' O ' ' HE1' ' A' ' 1' ' ' MET . 29.1 mtm105 -39.94 -79.73 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.902 -0.499 . . . . 74.439999999999998 110.48 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 1.177 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 14.6 m-85 -163.18 96.48 0.88 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.029 -1.044 . . . . 74.430000000000007 108.698 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 1.01 ' CZ2' ' OE1' ' A' ' 132' ' ' GLU . 51.3 m0 -46.78 -93.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.247 -0.908 . . . . 74.439999999999998 109.861 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.15 17.85 18.42 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.078 -1.609 . . . . 75.040000000000006 109.078 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.4 p -103.56 166.76 10.22 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.366 -1.079 . . . . 70.109999999999999 109.771 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.658 HD22 ' N ' ' A' ' 128' ' ' ILE . 1.0 OUTLIER -164.18 127.89 2.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.329 -0.857 . . . . 65.239999999999995 108.98 179.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 18.4 t -82.98 -38.07 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.047 -1.033 . . . . 74.219999999999999 110.627 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.547 ' O ' ' ND2' ' A' ' 119' ' ' ASN . 14.9 mm -95.88 133.59 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.932 -1.105 . . . . 74.420000000000002 110.038 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -149.86 127.94 11.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.151 -0.968 . . . . 73.299999999999997 108.607 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' A' ' 125' ' ' ASP . 8.7 tp -153.32 132.38 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 75.340000000000003 109.54 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 55.93 -83.49 0.01 OUTLIER Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.62 -1.392 . . . . 75.129999999999995 109.62 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 123' ' ' ILE . 15.1 t0 -149.92 -4.84 0.36 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.253 -1.146 . . . . 74.450000000000003 109.334 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.05 141.32 28.66 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.074 -1.017 . . . . 54.210000000000001 108.842 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.32 133.1 43.62 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.896 -0.779 . . . . 70.239999999999995 108.896 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.658 ' N ' HD22 ' A' ' 119' ' ' ASN . 49.4 mt -130.02 134.83 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.378 -0.826 . . . . 72.430000000000007 109.554 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.429 ' HG ' ' HB2' ' A' ' 132' ' ' GLU . 5.0 t -108.72 111.78 60.82 Favored Pre-proline 0 N--CA 1.497 1.9 0 N-CA-C 108.524 -0.917 . . . . 71.109999999999999 108.524 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -83.18 -39.18 0.13 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.869 1.713 . . . . 75.140000000000001 112.815 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -65.86 -49.3 68.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.025 -1.047 . . . . 72.5 109.692 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 1.01 ' OE1' ' CZ2' ' A' ' 116' ' ' TRP . 5.8 mm-40 -81.48 -6.26 58.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.13 -0.981 . . . . 73.140000000000001 109.105 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 57.06 63.63 1.86 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 75.329999999999998 109.727 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -146.19 130.41 17.52 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.338 -0.851 . . . . 71.230000000000004 109.272 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 6.8 tt -106.57 140.81 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.345 -0.847 . . . . 75.329999999999998 108.87 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.4 mt -128.54 120.75 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.46 -0.775 . . . . 71.109999999999999 109.506 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -140.03 140.18 36.14 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.386 -0.821 . . . . 74.140000000000001 109.628 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 53.45 20.96 2.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.403 -0.811 . . . . 75.400000000000006 110.085 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.84 16.97 68.84 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.982 -1.104 . . . . 72.239999999999995 110.403 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 57.2 mtp85 -107.12 124.41 49.64 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.242 -1.152 . . . . 73.120000000000005 109.177 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -99.24 124.9 44.68 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.302 -0.874 . . . . 72.319999999999993 109.75 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.8 t -139.33 140.9 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.39 -0.819 . . . . 62.340000000000003 109.556 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -85.94 135.7 33.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.177 -0.952 . . . . 61.229999999999997 109.136 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.4 m -132.43 126.95 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.439 -0.788 . . . . 74.439999999999998 109.406 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.4 pttt -173.15 129.31 0.47 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.304 -0.873 . . . . 75.420000000000002 109.577 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.66 -141.19 6.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.703 -1.359 . . . . 73.340000000000003 109.703 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.547 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -85.09 -44.56 0.67 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.328 -1.101 . . . . 72.219999999999999 110.403 -179.271 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 69.6 Cg_endo -89.79 -7.85 4.5 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.73 2.287 . . . . 75.450000000000003 113.354 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -89.42 -32.84 17.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.719 -1.238 . . . . 65.239999999999995 110.035 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -50.18 -40.99 48.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.978 -1.076 . . . . 72.519999999999996 109.149 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.09 -33.59 64.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.252 -0.905 . . . . 74.209999999999994 109.246 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 7.0 tp -61.37 -40.88 95.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.91 . . . . 73.310000000000002 109.639 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.9 p -74.59 -34.89 62.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.095 -1.003 . . . . 74.310000000000002 109.041 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -52.81 -55.2 24.76 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.476 -0.765 . . . . 75.450000000000003 109.746 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 pp -72.13 -26.17 62.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.013 -1.055 . . . . 75.340000000000003 109.283 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.04 -29.39 60.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.084 -1.01 . . . . 62.140000000000001 108.716 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.526 ' C ' ' H ' ' A' ' 159' ' ' ARG . 52.4 mtt180 -97.89 -54.19 3.17 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.681 -0.859 . . . . 72.219999999999999 108.681 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.492 ' H ' ' HD1' ' A' ' 158' ' ' HIS . 5.3 m80 -69.94 43.34 0.06 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.456 -0.777 . . . . 74.120000000000005 109.141 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.548 ' O ' ' N ' ' A' ' 161' ' ' GLN . 32.2 mtm105 -53.57 -103.37 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.481 -0.762 . . . . 74.340000000000003 109.953 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -51.17 86.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.478 -0.764 . . . . 75.450000000000003 109.884 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -175.58 179.1 1.48 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.629 -0.878 . . . . 73.409999999999997 108.629 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.54 ' H ' ' CD ' ' A' ' 161' ' ' GLN . 66.6 mt -98.82 128.95 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.258 -0.901 . . . . 74.409999999999997 109.615 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 212' ' ' TYR . 77.2 t -108.99 113.94 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.509 -0.744 . . . . 72.530000000000001 109.535 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.574 ' HG ' ' H ' ' A' ' 167' ' ' GLN . 4.4 p -90.33 138.71 31.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 74.120000000000005 108.627 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -57.75 -37.09 73.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 70.430000000000007 109.186 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -64.29 -38.19 90.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 74.319999999999993 109.617 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.574 ' H ' ' HG ' ' A' ' 164' ' ' SER . 8.9 tp-100 -59.84 -41.12 90.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -0.968 . . . . 74.519999999999996 109.124 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 40.2 mt -61.88 -53.28 57.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.91 . . . . 74.409999999999997 109.306 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 11.8 tp -62.67 -60.83 2.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 75.140000000000001 109.635 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -40.75 -40.1 1.25 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.94 -0.475 . . . . 65.030000000000001 111.543 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.16 -31.23 14.23 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.859 -1.151 . . . . 70.209999999999994 111.784 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.3 mm -80.6 -69.3 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.72 -1.238 . . . . 75.319999999999993 109.807 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.512 ' O ' ' CE3' ' A' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 107.831 -1.174 . . . . 73.140000000000001 107.831 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.466 ' N ' ' OD1' ' A' ' 182' ' ' ASN . 6.3 p30 . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 108.737 -0.838 . . . . 73.129999999999995 108.737 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.5 p -145.94 -32.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.213 -0.929 . . . . 74.019999999999996 109.3 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.411 HG21 HD12 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -51.4 -31.21 11.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.449 -0.782 . . . . 72.329999999999998 109.09 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -56.32 -53.29 58.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.253 -0.905 . . . . 74.400000000000006 110.173 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.8 m -74.06 -25.25 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.996 -1.065 . . . . 74.319999999999993 109.805 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -71.55 -52.65 17.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 73.230000000000004 110.047 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 9.9 tp -64.31 -33.97 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.91 -1.119 . . . . 74.310000000000002 109.734 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -64.67 -54.85 25.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.995 . . . . 73.439999999999998 110.025 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -67.65 -39.45 84.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.002 -1.061 . . . . 71.420000000000002 109.884 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.403 HG22 HD13 ' A' ' 191' ' ' ILE . 67.2 mt -60.12 -49.35 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.016 -1.053 . . . . 72.439999999999998 109.373 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -52.85 -53.73 44.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.07 -1.019 . . . . 64.219999999999999 109.442 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.629 ' NE2' ' N ' ' A' ' 193' ' ' GLN . 0.1 OUTLIER -59.76 -36.52 76.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -0.871 . . . . 74.319999999999993 109.375 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -81.65 -3.95 54.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.175 -0.953 . . . . 75.310000000000002 110.112 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 32.5 ttp -108.82 -15.18 14.45 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.322 -0.861 . . . . 74.019999999999996 109.704 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -108.51 -16.45 14.21 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.422 -0.799 . . . . 74.019999999999996 109.869 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.628 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 31.5 tptt -78.69 -35.72 1.13 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.979 -1.076 . . . . 75.430000000000007 110.776 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 89.0 Cg_endo -90.36 -48.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.226 1.951 . . . . 72.319999999999993 112.279 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 74.1 mt -68.1 -31.95 71.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.14 -0.975 . . . . 74.540000000000006 109.19 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 73.13 0.22 50.92 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.77 -1.332 . . . . 61.509999999999998 109.77 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.8 mt -123.23 128.2 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.548 -0.972 . . . . 74.25 109.488 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 8.3 t -86.03 132.95 33.94 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.321 -0.992 . . . . 72.0 108.321 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.7 p -134.87 27.02 3.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.254 -0.904 . . . . 74.439999999999998 109.909 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 26.7 m -146.98 150.48 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.096 -1.003 . . . . 71.129999999999995 109.736 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -126.61 126.13 43.1 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.645 -0.659 . . . . 73.510000000000005 109.368 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.34 111.16 16.46 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.133 -0.979 . . . . 73.519999999999996 108.916 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 211' ' ' GLY . 21.3 t -115.09 132.51 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.558 -0.714 . . . . 72.150000000000006 109.783 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -73.53 -30.1 62.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.839 . . . . 72.400000000000006 109.7 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -58.48 -82.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.891 . . . . 73.310000000000002 110.312 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -82.24 -47.55 12.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.891 -1.131 . . . . 71.540000000000006 109.865 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 207' ' ' VAL . . . 152.42 -110.8 0.47 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.976 -1.65 . . . . 74.450000000000003 108.976 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 163' ' ' VAL . 79.6 m-85 -112.11 140.41 46.82 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.433 -1.04 . . . . 75.540000000000006 108.714 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 25.8 mtm180 -121.3 129.79 53.3 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.423 -0.798 . . . . 75.310000000000002 109.522 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -97.47 119.54 36.2 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.296 -0.878 . . . . 75.409999999999997 108.906 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 28.2 m -130.91 161.22 32.35 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.354 -0.841 . . . . 74.140000000000001 109.75 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -72.27 151.06 92.16 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 75.319999999999993 109.08 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo . . . . . 0 N--CA 1.488 1.19 0 C-N-CA 121.974 1.783 . . . . 73.109999999999999 112.079 179.711 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.447 ' SD ' ' CE2' ' B' ' 25' ' ' PHE . 51.5 ttm . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.512 -0.551 . . . . 75.239999999999995 109.512 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -137.1 139.71 41.44 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.416 -0.802 . . . . 73.519999999999996 109.307 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 90.3 t -110.05 133.92 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.597 -0.689 . . . . 72.239999999999995 109.698 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' B' ' 49' ' ' MET . 2.6 tp -102.92 119.21 38.44 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.556 -0.715 . . . . 73.340000000000003 109.166 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 19.5 mt -114.6 96.23 5.65 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.814 -0.81 . . . . 74.349999999999994 108.814 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 88.2 mt -81.43 98.19 3.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 O-C-N 120.727 -1.233 . . . . 63.439999999999998 108.494 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.435 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 28.3 tp10 -137.55 125.13 22.17 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.399 -0.813 . . . . 74.519999999999996 109.72 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -69.3 -31.17 69.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.31 -0.869 . . . . 74.129999999999995 108.896 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -85.25 112.19 20.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.379 -0.826 . . . . 74.230000000000004 109.447 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 96.9 p -68.09 -23.18 64.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.243 -0.911 . . . . 65.540000000000006 109.572 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 84.9 t -65.13 -52.62 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 75.549999999999997 109.614 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 62.3 mt -65.8 -37.4 86.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 70.140000000000001 109.686 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.29 -28.86 69.21 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.678 -1.769 . . . . 75.400000000000006 108.678 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.94 -53.26 41.97 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.721 -1.351 . . . . 65.439999999999998 109.721 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -58.96 -46.81 87.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.323 -1.104 . . . . 72.200000000000003 109.953 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 35.7 mm -64.52 -40.25 88.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.748 -1.22 . . . . 75.150000000000006 108.877 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -61.94 -44.65 96.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.364 -0.835 . . . . 73.010000000000005 109.446 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -85.48 1.72 47.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.187 -0.945 . . . . 74.299999999999997 108.964 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.4 -55.38 2.21 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 109.74 -1.344 . . . . 70.540000000000006 109.74 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -74.04 -19.7 60.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -1.184 . . . . 75.430000000000007 109.752 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -52.14 -32.78 37.15 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.17 -0.956 . . . . 73.200000000000003 109.521 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 79.4 t -58.7 -37.16 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.154 -0.966 . . . . 74.230000000000004 109.156 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -70.17 -13.81 62.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.362 -0.837 . . . . 73.519999999999996 109.41 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.44 38.78 6.99 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.844 -1.302 . . . . 53.43 109.844 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . 0.447 ' CE2' ' SD ' ' B' ' 1' ' ' MET . 15.6 m-85 -114.43 159.49 20.24 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.508 -0.995 . . . . 71.120000000000005 109.065 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.2 mmt -103.92 139.73 38.68 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.411 -0.959 . . . . 75.239999999999995 108.411 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . 0.41 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -139.95 154.93 47.33 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.272 -0.892 . . . . 73.25 110.096 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 83.1 m-20 -134.65 158.03 45.12 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.482 -0.933 . . . . 72.310000000000002 108.482 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.03 139.67 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.352 -0.843 . . . . 72.140000000000001 109.866 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 6.1 p -134.48 170.08 16.29 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.586 -0.696 . . . . 74.530000000000001 109.196 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -94.08 -105.77 0.13 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.165 -0.96 . . . . 71.019999999999996 109.774 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 37.3 t -78.2 173.64 12.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.236 -0.915 . . . . 71.400000000000006 110.059 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' B' ' 33' ' ' LEU . 3.7 mm? -55.27 -39.26 69.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.518 -0.739 . . . . 71.239999999999995 109.681 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -46.56 -45.74 18.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 74.319999999999993 110.031 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.59 -38.73 70.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.103 -0.998 . . . . 73.030000000000001 109.249 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.18 -42.7 91.03 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.18 -1.568 . . . . 60.43 109.18 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -67.94 -40.74 83.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.294 -1.121 . . . . 74.430000000000007 109.453 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -72.17 -37.55 69.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 74.420000000000002 109.841 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 21.7 tp -72.14 -48.23 45.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -0.931 . . . . 75.409999999999997 110.12 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.9 ppp? -66.95 -19.75 65.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.032 -1.043 . . . . 61.439999999999998 109.923 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -61.4 -40.72 95.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.081 -1.012 . . . . 74.319999999999993 110.058 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 19.0 pt -82.82 -29.73 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.129 -0.982 . . . . 71.230000000000004 110.278 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' B' ' 40' ' ' MET . 75.1 mtt85 -130.43 143.89 51.05 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.287 -0.883 . . . . 73.409999999999997 109.758 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -97.69 130.77 44.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.251 -0.906 . . . . 63.539999999999999 109.233 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -99.76 139.97 34.65 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.316 -0.865 . . . . 73.109999999999999 109.411 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -75.11 -37.06 61.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 62.219999999999999 109.237 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.59 116.93 30.28 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.641 -0.874 . . . . 73.120000000000005 108.641 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 72.3 t -98.43 98.22 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.354 -0.98 . . . . 74.109999999999999 108.354 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 0.5 OUTLIER -110.38 131.09 55.36 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.462 0.648 . . . . 73.439999999999998 109.288 -179.006 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.506 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.5 OUTLIER -145.73 135.6 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.437 -0.789 . . . . 73.400000000000006 109.607 -179.626 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' SER . . . . . 0.435 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 14.7 p -98.8 14.03 30.26 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.541 -0.724 . . . . 73.209999999999994 109.661 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.506 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 23.9 m-20 -82.9 140.3 32.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.184 -0.948 . . . . 70.409999999999997 109.468 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.48 ' C ' ' H ' ' B' ' 55' ' ' ALA . 14.4 mtpp -74.69 -39.73 61.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 73.129999999999995 110.134 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -71.41 10.98 0.52 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.108 -0.995 . . . . 75.209999999999994 109.695 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.48 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -66.27 -22.97 66.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 55.329999999999998 110.247 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.428 ' O ' ' OG ' ' B' ' 60' ' ' SER . 37.5 mt -45.72 -45.49 14.38 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.219 -0.926 . . . . 72.420000000000002 110.151 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 83.5 p -70.24 -38.39 75.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.892 -1.13 . . . . 73.040000000000006 109.364 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -66.19 -61.11 2.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.339 -0.851 . . . . 72.329999999999998 109.762 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 20.7 m -50.32 -34.8 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.546 -1.346 . . . . 74.540000000000006 109.7 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' B' ' 56' ' ' LEU . 44.8 m -56.77 -51.58 68.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.115 -0.991 . . . . 71.239999999999995 109.534 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -69.38 -32.14 70.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.981 -1.074 . . . . 74.310000000000002 110.19 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' B' ' 66' ' ' HIS . 39.5 mm -65.74 -42.41 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.676 -1.265 . . . . 75.420000000000002 110.133 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -65.78 -49.6 67.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.209 -0.932 . . . . 73.319999999999993 110.695 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' B' ' 65' ' ' LYS . 7.5 pt-20 -69.17 -41.62 76.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.7 -1.25 . . . . 73.310000000000002 109.838 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.496 ' O ' ' ND1' ' B' ' 66' ' ' HIS . 85.6 mttt -79.7 -18.69 50.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.25 -0.906 . . . . 72.439999999999998 109.563 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . 0.496 ' ND1' ' O ' ' B' ' 65' ' ' LYS . 69.1 m-70 -154.82 67.59 0.69 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.141 -0.974 . . . . 65.209999999999994 109.698 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 54.6 p -67.18 -25.0 65.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.176 -0.953 . . . . 73.099999999999994 109.553 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 24.0 m -64.08 -27.06 68.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.305 -0.872 . . . . 71.530000000000001 109.895 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 84.5 mt -81.23 152.99 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.156 -0.965 . . . . 74.400000000000006 109.687 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 67.2 t -94.81 154.18 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.356 -0.84 . . . . 75.120000000000005 109.181 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.412 ' N ' ' OD2' ' B' ' 92' ' ' ASP . 11.3 t -133.64 130.52 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.309 -0.87 . . . . 73.200000000000003 110.049 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . 0.508 ' O ' ' SD ' ' B' ' 49' ' ' MET . 6.5 tt -122.98 104.0 8.96 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.864 -0.791 . . . . 73.340000000000003 108.864 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 9.1 p -95.45 137.07 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.977 -1.077 . . . . 73.5 108.961 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 3.9 p -96.68 170.88 8.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.297 -0.877 . . . . 71.319999999999993 109.552 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.481 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 42.9 t -157.67 114.85 2.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.169 -0.957 . . . . 74.530000000000001 110.232 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' B' ' 77' ' ' ASN . 52.1 p-10 -66.6 -21.45 66.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.221 -0.924 . . . . 64.5 109.264 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . 0.517 ' N ' ' OD1' ' B' ' 76' ' ' ASP . 56.6 t-20 -126.53 75.95 74.08 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 108.633 -0.877 . . . . 74.25 108.633 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -44.31 85.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.32 2.013 . . . . 74.430000000000007 111.724 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.515 ' N ' ' O ' ' B' ' 77' ' ' ASN . 7.4 m -94.67 150.24 20.42 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.635 0.731 . . . . 73.120000000000005 110.065 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.9 p -76.78 -43.16 37.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.539 -0.726 . . . . 75.409999999999997 109.655 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -56.73 -35.24 68.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.135 -0.978 . . . . 72.239999999999995 109.012 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -74.2 -34.72 63.83 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.098 -1.001 . . . . 73.219999999999999 108.97 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.522 ' OE1' ' CG ' ' B' ' 94' ' ' TYR . 42.1 tp10 -65.84 -55.95 14.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.257 -0.902 . . . . 74.299999999999997 109.609 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 31.4 m -53.44 -41.93 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.994 -1.066 . . . . 73.310000000000002 108.968 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -74.26 -20.09 60.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.174 -0.954 . . . . 73.239999999999995 109.597 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.75 -40.87 79.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.945 -1.097 . . . . 55.329999999999998 110.428 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' PHE . . . . . 0.48 ' C ' ' CD1' ' B' ' 87' ' ' PHE . 0.5 OUTLIER -83.3 -30.48 27.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.871 -1.143 . . . . 74.450000000000003 109.112 -179.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -77.27 -44.37 30.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.11 -0.993 . . . . 64.040000000000006 109.25 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -65.44 -54.96 21.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.425 -0.797 . . . . 75.129999999999995 109.496 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 154.72 72.81 0.01 OUTLIER Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.608 -1.282 . . . . 75.420000000000002 110.472 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -140.44 140.87 35.48 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.272 -1.134 . . . . 73.420000000000002 108.84 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . 0.412 ' OD2' ' N ' ' B' ' 71' ' ' VAL . 54.3 m-20 -94.99 -22.99 17.58 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.06 -1.025 . . . . 73.319999999999993 109.824 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 17.4 t0 -151.78 158.32 43.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.09 -1.007 . . . . 73.040000000000006 109.609 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.522 ' CG ' ' OE1' ' B' ' 83' ' ' GLU . 55.8 t80 -142.9 104.91 4.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.478 -0.764 . . . . 74.310000000000002 108.969 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 27.2 mm -114.37 151.92 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.542 0 O-C-N 121.127 -0.983 . . . . 75.340000000000003 110.22 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.27 144.26 57.26 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.987 -1.116 . . . . 70.099999999999994 107.987 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.687 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -64.32 -54.42 38.63 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.765 -1.21 . . . . 65.430000000000007 111.516 -179.301 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 3.5 Cg_endo -41.45 -8.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 120.851 1.034 . . . . 63.520000000000003 113.341 -176.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . 0.687 ' N ' ' O ' ' B' ' 97' ' ' LYS . 44.7 m-85 59.06 110.22 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.366 -0.834 . . . . 75.129999999999995 109.322 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . 0.511 ' NH1' ' OE2' ' A' ' 83' ' ' GLU . 13.2 ttm180 -57.98 -34.2 69.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.009 -1.057 . . . . 74.230000000000004 108.88 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' SER . . . . . 0.778 ' O ' ' N ' ' B' ' 103' ' ' LYS . 47.9 t -174.26 32.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.148 -0.97 . . . . 64.510000000000005 110.836 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 49.9 mt 49.62 -69.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 118.745 0.702 . . . . 74.439999999999998 110.193 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . 0.778 ' N ' ' O ' ' B' ' 101' ' ' SER . 40.6 tptt -51.77 -31.17 25.76 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.603 -1.258 . . . . 72.299999999999997 107.603 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.97 -40.72 83.09 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.608 -0.886 . . . . 74.310000000000002 108.608 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 51.9 tp -66.22 -45.86 79.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.448 -0.782 . . . . 73.540000000000006 109.022 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 42.4 t -66.89 -41.1 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.919 . . . . 72.030000000000001 109.3 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.06 -45.22 64.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.254 -0.903 . . . . 64.219999999999999 109.375 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 67.2 ttt-85 -69.07 -33.52 73.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.911 . . . . 75.310000000000002 109.671 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . 0.411 HG21 HD12 ' B' ' 109' ' ' ILE . 96.6 mt -72.23 -29.11 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.104 -0.997 . . . . 55.439999999999998 108.767 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -67.72 -58.87 3.9 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.471 -0.891 . . . . 65.310000000000002 108.938 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -52.97 -32.11 44.34 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.305 -0.872 . . . . 74.519999999999996 109.108 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 25.6 tpt85 -58.9 -50.41 74.15 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.288 -0.883 . . . . 72.040000000000006 109.277 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 63.1 mt -146.19 103.52 3.72 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.174 -0.954 . . . . 75.349999999999994 109.995 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -98.47 107.48 19.95 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.465 -0.939 . . . . 75.5 108.465 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 78.1 t80 49.62 86.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 73.040000000000006 109.558 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 -82.39 142.79 31.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.194 -0.941 . . . . 74.450000000000003 109.45 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 163.27 86.39 0.06 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.599 -1.4 . . . . 64.209999999999994 109.599 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' SER . . . . . 0.451 ' O ' ' ND2' ' B' ' 119' ' ' ASN . 8.9 t -157.61 -175.26 5.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -1.128 . . . . 71.400000000000006 109.745 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' B' ' 118' ' ' SER . 0.0 OUTLIER -153.83 137.57 16.13 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.832 -0.747 . . . . 74.209999999999994 109.114 -178.205 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 6.9 t -71.8 -36.75 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 75.019999999999996 109.617 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . 0.406 HD13 HG23 ' B' ' 121' ' ' ILE . 20.8 mm -103.25 132.74 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.328 -0.858 . . . . 74.239999999999995 109.287 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -135.7 119.26 17.01 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.434 -0.791 . . . . 73.329999999999998 109.24 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 14.5 tt -145.67 130.5 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.262 -0.898 . . . . 74.219999999999999 109.235 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.46 -153.31 1.01 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.424 -1.47 . . . . 72.409999999999997 109.424 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -79.82 2.1 24.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.152 -1.205 . . . . 75.120000000000005 109.049 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.63 135.17 37.65 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.356 -0.979 . . . . 75.420000000000002 108.356 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 1.2 p -130.9 145.18 51.93 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.361 -0.837 . . . . 74.219999999999999 109.198 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 14.0 mt -133.69 140.41 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.446 -0.784 . . . . 60.329999999999998 109.066 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 3.6 t -123.02 81.89 50.87 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.635 -0.665 . . . . 72.310000000000002 109.307 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.67 -48.09 23.79 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.169 1.912 . . . . 75.129999999999995 112.589 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -52.57 -45.76 66.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.083 -1.011 . . . . 75.230000000000004 109.232 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -86.98 2.18 50.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.261 -0.9 . . . . 75.120000000000005 109.137 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 53.12 18.07 1.09 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 75.129999999999995 109.391 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -101.46 130.92 47.8 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.432 -0.793 . . . . 75.109999999999999 109.459 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 16.2 tt -113.12 133.24 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.536 -0.728 . . . . 70.319999999999993 109.095 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 2.5 mp -114.56 131.63 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.504 -0.748 . . . . 74.120000000000005 109.327 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -137.76 126.68 24.09 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.333 -0.854 . . . . 74.230000000000004 109.866 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp 52.76 34.78 16.98 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.369 -0.832 . . . . 74.219999999999999 110.413 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.35 13.89 82.78 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 120.041 -1.076 . . . . 74.319999999999993 110.723 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 53.0 mtt-85 -109.3 122.81 48.15 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.311 -1.111 . . . . 75.340000000000003 109.136 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -92.08 136.59 33.06 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.189 -0.944 . . . . 71.230000000000004 109.373 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.79 135.25 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.449 -0.782 . . . . 70.430000000000007 109.158 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -88.25 125.42 34.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.202 -0.936 . . . . 72.430000000000007 109.096 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 3.2 m -143.97 124.89 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.218 -0.926 . . . . 72.129999999999995 109.471 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -156.59 16.99 0.32 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.338 -0.852 . . . . 74.5 109.271 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -66.64 164.44 42.23 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.242 -1.543 . . . . 42.229999999999997 109.242 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . 0.569 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 2.8 tmtp? -58.11 -43.98 98.87 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.222 -1.163 . . . . 73.299999999999997 109.224 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 23.3 Cg_exo -63.56 -20.63 69.81 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.591 2.194 . . . . 71.329999999999998 112.331 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -89.24 -22.65 22.63 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.175 -0.953 . . . . 74.230000000000004 110.035 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -50.53 -41.87 54.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.078 -1.014 . . . . 72.340000000000003 109.444 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 11.0 p -66.53 -32.4 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.955 . . . . 73.349999999999994 109.084 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.79 -43.64 81.1 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.707 -0.849 . . . . 74.430000000000007 108.707 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 2.7 p -73.65 -30.73 63.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.103 -0.998 . . . . 75.209999999999994 109.193 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -55.02 -54.07 47.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.912 . . . . 73.040000000000006 109.744 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.04 -28.94 63.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.071 -1.018 . . . . 73.430000000000007 109.572 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.15 -49.84 65.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 75.319999999999993 109.583 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . 0.47 ' C ' ' H ' ' B' ' 159' ' ' ARG . 24.3 mtp180 -71.47 -44.94 63.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 73.319999999999993 109.387 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -74.94 20.47 0.13 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.415 -0.803 . . . . 74.140000000000001 109.793 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' B' ' 157' ' ' ARG . 6.6 mmt85 -54.3 173.51 0.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.042 -1.037 . . . . 73.420000000000002 108.88 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . 0.412 ' OD2' ' O ' ' B' ' 160' ' ' ASP . 4.6 p-10 42.37 47.47 4.25 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.544 -0.722 . . . . 72.099999999999994 110.276 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -161.32 157.76 25.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 73.239999999999995 109.459 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 162' ' ' ILE . . . . . 0.546 ' CD1' ' N ' ' B' ' 162' ' ' ILE . 1.8 mp -91.37 131.41 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.237 -0.915 . . . . 72.310000000000002 109.174 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 40.3 t -123.59 136.56 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.529 -0.732 . . . . 75.030000000000001 109.335 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 11.3 p -83.39 158.35 22.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 74.219999999999999 109.568 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -62.54 -43.51 98.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.861 . . . . 72.420000000000002 109.349 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -65.53 -34.5 78.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 63.450000000000003 109.888 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -50.76 -49.38 58.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.11 -0.994 . . . . 72.400000000000006 109.39 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 53.6 mt -66.42 -40.33 89.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.199 -0.938 . . . . 72.319999999999993 109.355 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 3.7 tt -48.99 -59.12 3.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 73.340000000000003 109.482 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' B' ' 171' ' ' ALA . 78.0 m-20 -67.88 -41.4 82.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 73.099999999999994 110.14 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' B' ' 170' ' ' ASP . . . -43.1 -47.72 6.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.376 -0.827 . . . . 62.130000000000003 110.586 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 16.4 mm -94.96 -9.94 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.056 -1.028 . . . . 74.439999999999998 110.267 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 . . . . . 0 N--CA 1.498 1.939 0 O-C-N 120.848 -1.158 . . . . 72.230000000000004 110.446 -179.796 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo . . . . . 0 N--CA 1.495 1.602 0 CA-C-O 121.36 0.483 . . . . 74.340000000000003 112.783 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 3.2 m120 61.32 39.52 15.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.398 -0.814 . . . . 72.310000000000002 109.411 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 25.4 t -79.33 -49.65 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.884 . . . . 65.420000000000002 109.802 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 27.7 mm -70.0 -24.85 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 75.030000000000001 110.183 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -64.18 -44.51 91.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.831 -1.168 . . . . 73.519999999999996 109.306 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 19.4 m -77.21 -31.85 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.203 -0.936 . . . . 74.349999999999994 109.59 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.2 -50.24 20.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.06 -1.025 . . . . 61.119999999999997 110.014 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 188' ' ' ILE . . . . . 0.457 ' CG2' ' N ' ' B' ' 189' ' ' ASN . 1.8 tt -59.43 -44.78 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.154 -0.966 . . . . 72.430000000000007 110.151 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 189' ' ' ASN . . . . . 0.457 ' N ' ' CG2' ' B' ' 188' ' ' ILE . 58.4 t30 -60.3 -43.58 96.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.091 -1.006 . . . . 75.420000000000002 109.584 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 190' ' ' GLN . . . . . 0.414 ' O ' ' CB ' ' B' ' 194' ' ' LYS . 15.1 mm-40 -68.64 -46.51 68.99 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.258 -0.901 . . . . 74.140000000000001 109.882 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 82.3 mt -54.47 -30.26 21.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 120.654 -1.279 . . . . 74.030000000000001 109.791 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 65.8 mtp85 -73.01 -60.84 2.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.013 -1.055 . . . . 72.329999999999998 110.871 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 193' ' ' GLN . . . . . 0.429 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 76.0 mt-30 -70.94 -32.8 69.81 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.027 -1.046 . . . . 73.099999999999994 110.252 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' B' ' 190' ' ' GLN . 20.7 ttpp -72.02 -26.82 62.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.478 -0.764 . . . . 74.430000000000007 110.696 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 17.4 tpt -92.44 -44.49 8.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.889 -1.132 . . . . 74.329999999999998 110.016 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 196' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 59.3 p30 -64.17 -19.65 65.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.034 -1.041 . . . . 71.209999999999994 110.086 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . 0.533 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 29.7 mttm -67.96 -64.75 1.74 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.081 -1.012 . . . . 75.209999999999994 109.198 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 198' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 39.7 Cg_endo -64.88 -50.99 1.88 Allowed 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.075 1.85 . . . . 75.319999999999993 110.976 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . 0.407 ' CD2' ' O ' ' B' ' 201' ' ' ILE . 0.0 OUTLIER -95.74 134.53 38.57 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.868 -1.16 . . . . 72.25 107.868 179.303 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . -97.96 -8.52 55.4 Favored Glycine 0 N--CA 1.498 2.816 0 O-C-N 121.083 -1.011 . . . . 73.239999999999995 110.615 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . 0.407 ' O ' ' CD2' ' B' ' 199' ' ' LEU . 70.2 mt -91.74 124.84 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.023 -1.281 . . . . 54.299999999999997 109.471 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 23.3 t -77.26 135.82 38.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 74.310000000000002 109.603 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 2.0 p -145.31 28.24 1.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.261 -0.899 . . . . 74.400000000000006 109.281 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 35.8 m -135.64 138.37 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.395 -0.816 . . . . 74.099999999999994 109.466 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -126.34 136.48 52.78 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.582 -0.699 . . . . 75.329999999999998 109.281 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 10.5 p -95.05 139.37 31.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.208 -0.933 . . . . 71.400000000000006 109.422 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.519 ' N ' ' O ' ' B' ' 211' ' ' GLY . 39.0 t -131.6 124.44 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.522 -0.736 . . . . 63.5 109.197 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 208' ' ' ARG . . . . . 0.467 ' CD ' ' N ' ' B' ' 208' ' ' ARG . 1.3 mpt_? -76.5 -34.93 58.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 74.450000000000003 109.822 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 209' ' ' ARG . . . . . 0.413 ' CD ' ' N ' ' B' ' 209' ' ' ARG . 11.7 mpt_? -56.17 -62.74 1.5 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.151 -0.968 . . . . 74.140000000000001 109.68 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 62.1 mmt-85 -98.81 -76.45 0.54 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.235 -0.915 . . . . 74.430000000000007 109.529 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 211' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' B' ' 207' ' ' VAL . . . -167.26 -107.41 0.2 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.528 -1.429 . . . . 70.109999999999999 109.528 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -120.58 133.96 55.33 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.592 -0.946 . . . . 74.209999999999994 109.346 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -104.77 126.53 51.95 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.494 -0.753 . . . . 74.299999999999997 109.083 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -101.96 125.89 48.75 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.348 -0.845 . . . . 74.340000000000003 109.276 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 20.5 p -142.76 154.26 44.08 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.336 -0.852 . . . . 72.209999999999994 109.378 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -63.96 154.24 82.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 72.310000000000002 108.865 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -38.23 147.3 0.11 Allowed 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.178 1.918 . . . . 71.010000000000005 111.902 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 21.1 mttp . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 74.349999999999994 111.355 -179.14 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.2 ttm . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.518 -0.549 . . . . 65.120000000000005 109.518 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.485 ' N ' ' OD2' ' A' ' 46' ' ' ASP . 97.6 mtt180 -129.65 156.77 43.71 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.497 -0.752 . . . . 73.310000000000002 109.17 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.0 t -118.65 124.44 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 CA-C-O 121.792 0.806 . . . . 71.420000000000002 110.014 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.1 tp -94.07 117.35 29.97 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.398 -0.964 . . . . 65.219999999999999 108.398 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.7 tt -119.44 119.43 33.88 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.092 -1.077 . . . . 71.439999999999998 108.092 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 56.3 mt -110.91 99.48 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.316 -0.865 . . . . 71.150000000000006 109.259 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' A' ' 30' ' ' THR . 36.2 tp10 -122.94 133.2 54.4 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.56 -0.712 . . . . 75.340000000000003 109.423 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -66.34 -34.47 78.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.242 -0.911 . . . . 73.040000000000006 109.555 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 10' ' ' SER . 21.6 p30 -82.98 -149.72 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.24 -0.913 . . . . 72.420000000000002 109.471 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.498 ' N ' ' OD1' ' A' ' 9' ' ' ASN . 20.9 p -152.55 -39.63 0.11 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.215 -0.928 . . . . 72.340000000000003 109.67 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.445 ' CG1' ' N ' ' A' ' 12' ' ' LEU . 11.1 p -64.39 -44.14 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 74.420000000000002 109.725 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.445 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 14.9 tp -65.28 -39.19 92.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 72.010000000000005 109.312 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.75 -28.03 69.78 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 108.035 -2.026 . . . . 72.140000000000001 108.035 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.12 -46.04 94.13 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 110.07 -1.212 . . . . 72.329999999999998 110.07 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -65.98 -47.15 75.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -1.203 . . . . 72.340000000000003 109.832 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.8 mm -65.51 -36.53 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.603 -1.311 . . . . 74.239999999999995 108.372 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.478 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 86.7 tt0 -65.54 -47.91 74.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.464 -0.773 . . . . 71.409999999999997 109.798 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -83.52 1.18 43.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.089 -1.007 . . . . 75.540000000000006 109.748 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.24 -55.17 2.54 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.567 -1.413 . . . . 62.149999999999999 109.567 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -76.23 -21.79 55.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -1.15 . . . . 74.420000000000002 109.917 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 92.9 m-20 -55.22 -32.28 62.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.034 -1.041 . . . . 74.25 109.345 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.3 t -60.02 -38.31 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 72.109999999999999 109.359 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.496 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 3.4 mptp? -62.68 -26.47 68.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.354 -0.842 . . . . 73.230000000000004 109.275 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.89 24.14 5.32 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 110.215 -1.154 . . . . 75.540000000000006 110.215 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -105.33 157.51 17.27 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.227 -1.16 . . . . 74.510000000000005 109.091 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.0 mmm -104.24 136.96 42.87 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.134 -1.061 . . . . 64.319999999999993 108.134 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.26 160.25 41.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.193 -0.942 . . . . 74.310000000000002 109.851 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -140.57 145.39 36.67 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.411 -0.806 . . . . 75.400000000000006 109.526 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 t -104.13 134.92 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.462 -0.94 . . . . 75.129999999999995 108.462 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.425 ' O ' ' O ' ' A' ' 7' ' ' GLU . 6.5 p -131.04 172.44 12.08 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.39 -0.819 . . . . 71.420000000000002 109.44 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -92.26 -104.54 0.11 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.24 -0.913 . . . . 73.109999999999999 110.001 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.4 p -78.8 167.41 21.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.245 -0.909 . . . . 74.239999999999995 110.269 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 35.7 mt -54.17 -29.62 46.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.635 -0.666 . . . . 71.530000000000001 109.857 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -47.79 -49.36 28.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.049 -1.032 . . . . 74.230000000000004 109.719 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -68.12 -38.39 82.19 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.142 -0.974 . . . . 71.010000000000005 109.222 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.84 -45.05 59.69 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.377 -1.489 . . . . 61.409999999999997 109.377 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -65.75 -38.44 89.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -1.103 . . . . 74.340000000000003 109.265 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -75.41 -37.52 60.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.151 -0.968 . . . . 75.329999999999998 109.679 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.3 tp -72.7 -47.55 46.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 74.329999999999998 110.101 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.495 ' SD ' ' OD1' ' A' ' 41' ' ' ASP . 3.7 ppp? -63.73 -28.71 70.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.105 -0.997 . . . . 70.319999999999993 110.083 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.495 ' OD1' ' SD ' ' A' ' 40' ' ' MET . 99.3 m-20 -65.6 -39.9 92.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.036 -1.04 . . . . 71.219999999999999 110.016 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.0 pt -82.88 -29.63 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.148 -0.97 . . . . 74.409999999999997 110.251 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 40' ' ' MET . 93.0 mtt180 -129.89 146.89 51.61 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.323 -0.861 . . . . 75.409999999999997 109.514 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -91.28 161.7 14.93 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.206 -0.934 . . . . 75.420000000000002 109.654 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -143.11 153.67 43.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.337 -0.852 . . . . 74.230000000000004 109.142 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.485 ' OD2' ' N ' ' A' ' 2' ' ' ARG . 3.8 p30 -95.41 -41.5 8.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.192 -0.943 . . . . 75.319999999999993 109.514 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.4 ' CD1' ' C ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER -104.84 115.76 30.85 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.433 -0.792 . . . . 72.129999999999995 109.05 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.5 t -101.49 97.8 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.389 -0.967 . . . . 72.340000000000003 108.389 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -114.27 130.66 56.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.491 -0.756 . . . . 74.109999999999999 110.303 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.419 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 1.5 p -138.4 129.36 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 121.728 0.775 . . . . 71.239999999999995 109.652 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.8 t -92.14 3.67 54.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.49 -0.757 . . . . 73.109999999999999 109.199 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.419 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 51.8 m-20 -76.28 138.07 40.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.305 -0.872 . . . . 63.399999999999999 109.509 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.516 ' C ' ' H ' ' A' ' 55' ' ' ALA . 28.1 mtmm -67.94 -35.25 78.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.179 -0.95 . . . . 65.439999999999998 110.049 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -71.36 17.08 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.153 -0.967 . . . . 73.129999999999995 109.734 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.516 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -60.29 -30.4 69.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 64.140000000000001 110.085 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.3 mt -46.07 -43.85 14.96 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.087 -1.008 . . . . 74.430000000000007 110.097 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 60' ' ' SER . 95.2 p -73.21 -40.23 64.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.93 -1.106 . . . . 63.229999999999997 109.627 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -65.13 -56.9 10.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.408 -0.807 . . . . 74.439999999999998 110.127 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.2 m -54.05 -38.2 37.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 120.839 -1.163 . . . . 74.030000000000001 109.638 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 57' ' ' SER . 46.2 p -54.83 -52.73 61.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.176 -0.952 . . . . 73.540000000000006 109.662 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -69.63 -29.81 67.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.088 -1.008 . . . . 73.340000000000003 110.342 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.476 ' O ' ' N ' ' A' ' 66' ' ' HIS . 6.1 mm -68.16 -47.9 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.639 -1.288 . . . . 73.349999999999994 110.357 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.409 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 41.4 mmtt -62.85 -43.7 98.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.065 -1.022 . . . . 74.420000000000002 110.691 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.403 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 7.0 pt-20 -73.55 -41.05 63.46 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.71 -1.244 . . . . 74.549999999999997 109.747 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.447 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 25.6 mtpp -78.17 -19.84 53.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.151 -0.968 . . . . 75.219999999999999 109.143 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.476 ' N ' ' O ' ' A' ' 62' ' ' ILE . 91.7 m-70 -154.94 69.46 0.73 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 74.129999999999995 109.222 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.0 p -63.58 -27.2 69.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.31 -0.869 . . . . 73.239999999999995 110.085 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.6 t -79.5 48.95 0.95 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.058 -1.026 . . . . 71.439999999999998 109.856 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.8 tt -146.68 156.59 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.084 -1.01 . . . . 71.329999999999998 109.456 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.9 t -92.81 154.15 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.171 -0.956 . . . . 73.019999999999996 109.51 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.518 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 21.3 t -135.96 125.99 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.299 -0.876 . . . . 54.210000000000001 110.074 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.413 ' C ' ' CD1' ' A' ' 72' ' ' LEU . 1.3 tm? -118.62 101.67 8.3 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.423 -0.955 . . . . 74.209999999999994 108.423 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -95.5 138.94 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.933 -1.104 . . . . 74.409999999999997 109.57 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.1 m -122.86 161.31 24.32 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.677 -0.86 . . . . 72.310000000000002 108.677 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 77' ' ' ASN . 3.0 p -172.2 121.43 0.45 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.999 -1.063 . . . . 64.540000000000006 109.971 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 50.8 p30 -64.31 63.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.701 -0.624 . . . . 74.129999999999995 109.931 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 75' ' ' SER . 2.9 p30 -177.14 53.65 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.201 -0.937 . . . . 73.340000000000003 109.669 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 77' ' ' ASN . 6.9 Cg_endo -48.84 84.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.365 2.043 . . . . 71.319999999999993 111.729 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.48 ' N ' ' O ' ' A' ' 77' ' ' ASN . 2.9 t -114.48 151.64 32.94 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.041 -0.725 . . . . 62.530000000000001 109.041 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -28.4 67.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 74.140000000000001 109.231 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -63.89 -41.09 97.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.279 -0.888 . . . . 71.420000000000002 109.829 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -76.91 -26.28 53.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.085 -1.009 . . . . 73.430000000000007 109.342 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -67.89 -46.47 71.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 74.219999999999999 109.683 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.4 m -68.89 -41.19 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.098 -1.002 . . . . 74.150000000000006 109.566 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -72.14 -31.59 66.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -0.935 . . . . 72.540000000000006 109.637 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.76 -39.49 91.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 64.219999999999999 110.114 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -77.39 -36.08 53.78 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.049 -1.032 . . . . 74.340000000000003 108.769 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -68.33 -38.56 81.64 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.383 -0.823 . . . . 74.420000000000002 109.305 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -64.39 -44.86 89.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 74.519999999999996 109.319 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.09 -15.86 1.02 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.036 -1.226 . . . . 74.209999999999994 110.036 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.68 132.85 31.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.047 -1.267 . . . . 64.099999999999994 109.393 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.518 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 71.0 m-20 -80.83 -33.28 34.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 73.420000000000002 109.409 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.507 ' CG ' HH21 ' A' ' 108' ' ' ARG . 65.3 m-20 -152.45 129.53 11.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.258 -0.901 . . . . 75.040000000000006 109.249 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.459 ' OH ' ' OG ' ' A' ' 75' ' ' SER . 3.8 t80 -104.5 116.42 32.07 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.875 -0.787 . . . . 71.329999999999998 108.875 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 23.8 mm -106.53 149.92 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-O 122.194 0.997 . . . . 74.510000000000005 111.319 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.79 117.65 11.65 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.842 -1.54 . . . . 64.319999999999993 106.842 177.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.665 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -43.59 -54.0 11.08 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.173 -0.954 . . . . 74.510000000000005 111.778 -178.283 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.2 Cg_endo -41.8 -11.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.237 0 CA-C-N 119.851 0.983 . . . . 73.109999999999999 112.565 -176.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.665 ' N ' ' O ' ' A' ' 97' ' ' LYS . 61.2 m-85 57.69 116.07 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.817 -0.552 . . . . 72.540000000000006 109.701 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -56.47 -38.11 71.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.849 -1.157 . . . . 74.540000000000006 108.776 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.78 ' O ' ' N ' ' A' ' 103' ' ' LYS . 9.9 t -173.56 40.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.251 -0.906 . . . . 74.140000000000001 110.688 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.5 mt 48.09 -69.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 CA-C-N 118.68 0.673 . . . . 75.430000000000007 110.505 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.78 ' N ' ' O ' ' A' ' 101' ' ' SER . 41.4 tptt -52.07 -31.22 29.34 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.181 -1.044 . . . . 74.140000000000001 108.181 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.66 -56.04 21.43 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.622 -0.831 . . . . 63.240000000000002 108.836 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.69 -56.18 20.04 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.65 -0.87 . . . . 73.219999999999999 108.65 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 87.4 t -48.44 -46.24 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.995 -1.065 . . . . 74.540000000000006 109.154 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.94 -35.73 62.05 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.212 -0.93 . . . . 75.5 108.553 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.53 ' NH1' ' CZ ' ' B' ' 87' ' ' PHE . 53.1 ttt85 -71.64 -29.43 64.63 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.435 -0.79 . . . . 74.409999999999997 109.681 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 87.0 mt -74.85 -32.92 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.978 -1.076 . . . . 73.239999999999995 108.498 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -74.47 -51.01 16.06 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.525 -0.734 . . . . 74.340000000000003 109.648 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.94 -43.3 69.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.901 . . . . 73.319999999999993 109.666 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -65.38 -39.9 92.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.193 -0.942 . . . . 74.420000000000002 109.612 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.96 94.07 2.72 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.13 -0.982 . . . . 74.329999999999998 109.269 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.4 mtm-85 -84.68 -70.89 0.55 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.14 -0.975 . . . . 74.439999999999998 108.881 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' A' ' 116' ' ' TRP . 30.4 p90 -163.16 -33.83 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.124 -0.985 . . . . 74.430000000000007 109.511 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.54 ' N ' ' CD1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER 38.44 -94.66 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.707 -0.62 . . . . 74.439999999999998 110.355 179.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 115' ' ' PHE . . . 76.88 72.45 1.11 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.503 -1.439 . . . . 75.040000000000006 109.503 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.552 ' O ' ' OG ' ' A' ' 129' ' ' SER . 0.3 OUTLIER -147.41 172.96 13.11 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.256 -1.143 . . . . 70.109999999999999 109.688 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.539 ' HA ' ' OG ' ' A' ' 129' ' ' SER . 0.0 OUTLIER -152.25 149.86 29.16 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.552 -0.717 . . . . 65.239999999999995 109.288 -178.23 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.91 -32.73 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.177 -0.952 . . . . 74.219999999999999 110.104 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 38.4 mm -116.33 106.34 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.416 -0.802 . . . . 74.420000000000002 109.183 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -109.01 115.96 31.07 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.475 -0.766 . . . . 73.299999999999997 109.443 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.406 ' O ' ' O ' ' A' ' 126' ' ' LEU . 29.1 mm -116.17 105.29 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.567 -0.708 . . . . 75.340000000000003 109.514 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 47.21 -143.87 5.41 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.935 -1.266 . . . . 75.129999999999995 109.935 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -66.82 -21.91 66.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.359 -1.083 . . . . 74.450000000000003 108.921 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' A' ' 123' ' ' ILE . 0.2 OUTLIER -80.59 113.39 18.75 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.827 -1.175 . . . . 54.210000000000001 107.827 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.9 m -108.33 144.23 36.13 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.36 -0.838 . . . . 70.239999999999995 109.342 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 77.1 mt -132.7 128.98 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.457 -0.777 . . . . 72.430000000000007 109.704 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.552 ' OG ' ' O ' ' A' ' 118' ' ' SER . 1.8 m -117.83 94.16 45.55 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 108.551 -0.907 . . . . 71.109999999999999 108.551 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.35 -22.6 10.82 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.557 1.505 . . . . 75.140000000000001 112.277 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.883 ' OD1' ' OE2' ' A' ' 132' ' ' GLU . 11.1 t70 -59.35 -48.96 79.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.067 -1.021 . . . . 72.5 109.282 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.883 ' OE2' ' OD1' ' A' ' 131' ' ' ASP . 7.9 mm-40 -97.36 9.17 43.04 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.205 -0.934 . . . . 73.140000000000001 108.938 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 53.61 80.54 0.11 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.56 -0.712 . . . . 75.329999999999998 110.438 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 9.5 ttpt -164.37 141.42 6.53 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.81 -0.811 . . . . 71.230000000000004 108.81 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.9 mt -118.2 149.51 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.531 -0.73 . . . . 75.329999999999998 109.765 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 65.5 mt -131.72 117.69 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.527 -0.916 . . . . 71.109999999999999 108.527 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -109.25 124.77 51.43 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.397 -0.815 . . . . 74.140000000000001 110.401 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.1 mtpp 48.94 25.84 1.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.467 -0.77 . . . . 75.400000000000006 110.61 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 92.51 14.28 55.77 Favored Glycine 0 N--CA 1.498 2.81 0 O-C-N 121.0 -1.063 . . . . 72.239999999999995 110.999 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -105.5 124.29 49.31 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.17 -1.194 . . . . 73.120000000000005 109.267 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -82.42 122.19 27.69 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.195 -0.941 . . . . 72.319999999999993 110.852 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.08 138.0 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.055 -1.091 . . . . 62.340000000000003 108.055 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -82.18 167.14 19.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.323 -0.86 . . . . 61.229999999999997 109.627 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 1.099 ' C ' ' HD2' ' A' ' 149' ' ' PHE . 6.0 m -129.6 128.15 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.797 -0.816 . . . . 74.439999999999998 108.797 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 1.481 ' HA ' ' CE2' ' A' ' 149' ' ' PHE . 32.7 pttt -175.52 -24.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.412 -0.805 . . . . 75.420000000000002 109.698 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 1.108 ' O ' ' CD1' ' A' ' 149' ' ' PHE . . . -64.97 -172.42 3.25 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.561 -1.416 . . . . 73.340000000000003 109.561 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.593 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 6.3 ttmt -70.27 -39.4 10.11 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.365 -1.08 . . . . 72.219999999999999 110.634 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 60.6 Cg_endo -84.94 15.46 2.21 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.126 1.884 . . . . 75.450000000000003 112.757 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 1.481 ' CE2' ' HA ' ' A' ' 145' ' ' LYS . 0.1 OUTLIER -97.31 -50.36 4.58 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.073 -1.017 . . . . 65.239999999999995 109.609 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 1.442 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 97.2 mt-10 -55.35 -44.0 75.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.418 -0.801 . . . . 72.519999999999996 109.596 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 13.1 p -63.77 -38.2 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 74.209999999999994 109.378 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -42.82 91.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.387 -0.821 . . . . 73.310000000000002 109.016 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.4 m -72.13 -28.84 63.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 74.310000000000002 109.44 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -63.08 -55.11 28.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.405 -0.81 . . . . 75.450000000000003 110.073 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 159' ' ' ARG . 3.6 pp -67.49 -26.76 66.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.04 -1.037 . . . . 75.340000000000003 109.083 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.02 -52.21 63.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.108 -0.995 . . . . 62.140000000000001 108.904 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -66.8 -52.6 42.06 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.282 -0.886 . . . . 72.219999999999999 109.145 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -88.5 37.62 0.83 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.549 -0.719 . . . . 74.120000000000005 109.544 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' ' 155' ' ' LEU . 55.4 ttt-85 -65.46 -17.85 64.86 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.118 -0.989 . . . . 74.340000000000003 109.783 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.9 72.8 1.31 Allowed 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.517 -0.92 . . . . 75.450000000000003 108.517 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -170.57 159.18 6.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.875 . . . . 73.409999999999997 109.539 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.4 mt -81.51 136.69 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.29 -0.881 . . . . 74.409999999999997 109.002 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 14.2 t -131.48 135.73 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.341 -0.849 . . . . 72.530000000000001 109.793 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.7 p -97.59 159.36 14.97 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.4 -0.812 . . . . 74.120000000000005 109.122 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -57.9 -36.08 71.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 70.430000000000007 109.899 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -64.16 -42.23 96.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.166 -0.959 . . . . 74.319999999999993 110.075 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -53.4 -49.94 66.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.086 -1.009 . . . . 74.519999999999996 109.415 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 34.5 mt -61.9 -39.76 93.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.174 -0.954 . . . . 74.409999999999997 109.398 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 173' ' ' TRP . 5.3 tt -55.5 -59.21 5.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.866 . . . . 75.140000000000001 109.763 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.88 -39.66 93.89 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.423 -0.798 . . . . 65.030000000000001 111.203 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -53.0 -55.39 23.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.929 -1.107 . . . . 70.209999999999994 111.08 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.525 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 1.9 mp -94.26 -59.69 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 120.83 -1.169 . . . . 75.319999999999993 110.237 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.458 ' O ' ' O ' ' A' ' 169' ' ' LEU . 24.3 m-90 . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 73.140000000000001 109.864 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 35.7 p30 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 120.856 0.36 . . . . 73.129999999999995 110.326 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 26.4 m -67.68 -16.1 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.854 -1.153 . . . . 74.019999999999996 109.518 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 184' ' ' ILE . 32.2 mm -59.82 -30.1 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.925 . . . . 72.329999999999998 109.369 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -58.14 -35.65 71.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.236 -0.915 . . . . 74.400000000000006 109.794 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 50.4 t -82.99 -45.45 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 74.319999999999993 109.084 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -60.71 -36.35 78.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 73.230000000000004 110.255 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.415 ' CG2' ' N ' ' A' ' 189' ' ' ASN . 9.4 tp -76.33 -42.98 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.781 -1.199 . . . . 74.310000000000002 109.102 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.415 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 69.4 m-20 -59.87 -33.89 72.41 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.198 -0.939 . . . . 73.439999999999998 109.082 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -79.68 -48.67 13.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.192 -0.942 . . . . 71.420000000000002 109.968 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 64.4 mt -55.96 -41.98 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.095 -1.003 . . . . 72.439999999999998 109.29 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -63.87 -49.64 71.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.121 -0.987 . . . . 64.219999999999999 109.269 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -62.0 -31.47 71.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 74.319999999999993 108.984 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.418 ' CB ' ' NZ ' ' A' ' 194' ' ' LYS . 7.5 mtpm? -84.79 -8.54 58.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.47 -0.769 . . . . 75.310000000000002 109.735 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 16.2 ttt -102.48 -39.56 7.07 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.45 -0.781 . . . . 74.019999999999996 110.421 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -75.02 -15.37 60.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.025 -1.047 . . . . 74.019999999999996 110.724 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.445 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 8.7 mmtm -80.58 -65.29 0.27 Allowed Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.902 -1.124 . . . . 75.430000000000007 109.964 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 24.7 Cg_endo -60.0 -49.6 9.37 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.345 2.03 . . . . 72.319999999999993 112.849 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.4 mp -66.2 -100.19 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.856 -1.152 . . . . 74.540000000000006 109.239 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 156.07 -39.31 0.59 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.132 -1.587 . . . . 61.509999999999998 109.132 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 20.5 mm -104.14 127.09 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.571 -0.958 . . . . 74.25 109.12 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 11.9 p -83.6 133.07 34.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.107 -0.995 . . . . 72.0 108.682 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.03 12.91 11.24 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.447 -0.783 . . . . 74.439999999999998 109.515 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.9 148.31 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.425 -0.797 . . . . 71.129999999999995 109.532 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -124.82 115.58 20.91 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.651 -0.655 . . . . 73.510000000000005 109.329 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.37 114.01 22.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.274 -0.891 . . . . 73.519999999999996 109.011 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 13.8 t -120.73 146.31 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.546 -0.721 . . . . 72.150000000000006 109.668 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -69.89 -36.44 75.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.372 -0.83 . . . . 72.400000000000006 109.547 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -73.28 160.18 32.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 73.310000000000002 109.736 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.509 ' N ' ' NE ' ' A' ' 210' ' ' ARG . 0.0 OUTLIER 47.86 -102.25 0.08 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.156 -0.965 . . . . 71.540000000000006 109.002 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -158.98 -114.22 0.38 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.08 -1.608 . . . . 74.450000000000003 109.08 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -108.79 133.74 52.43 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.513 -0.992 . . . . 75.540000000000006 108.929 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -112.04 128.45 56.19 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.342 -0.849 . . . . 75.310000000000002 110.585 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -98.27 128.53 44.76 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.627 -0.879 . . . . 75.409999999999997 108.627 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 8.9 t -149.98 168.96 22.32 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.03 -1.044 . . . . 74.140000000000001 110.453 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -60.95 131.46 91.74 Favored Pre-proline 0 N--CA 1.49 1.556 0 N-CA-C 109.361 -0.607 . . . . 75.319999999999993 109.361 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo . . . . . 0 N--CA 1.491 1.346 0 C-N-CA 122.291 1.994 . . . . 73.109999999999999 112.744 -179.852 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.591 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.458 -0.571 . . . . 75.239999999999995 109.458 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.433 ' O ' ' OD1' ' B' ' 46' ' ' ASP . 88.2 mtt180 -139.28 153.43 47.78 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.261 -0.9 . . . . 73.519999999999996 109.552 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 94.2 t -111.16 135.04 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.665 -0.647 . . . . 72.239999999999995 109.297 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 3.6 tp -106.84 118.28 36.26 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.526 -0.734 . . . . 73.340000000000003 109.707 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 16.9 mt -114.58 98.32 6.81 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.83 -0.804 . . . . 74.349999999999994 108.83 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 87.1 mt -84.79 96.98 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.743 -1.223 . . . . 63.439999999999998 108.772 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.435 ' OE2' ' OG ' ' B' ' 51' ' ' SER . 8.6 tp10 -141.91 127.86 19.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.353 -0.842 . . . . 74.519999999999996 109.46 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -66.74 -32.92 74.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 74.129999999999995 109.148 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -78.24 107.41 10.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.34 -0.85 . . . . 74.230000000000004 109.431 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 85.6 p -67.94 -23.77 65.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -0.879 . . . . 65.540000000000006 109.655 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.79 -49.77 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.148 -0.97 . . . . 75.549999999999997 109.687 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 80.7 mt -65.93 -37.44 86.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.157 -0.964 . . . . 70.140000000000001 109.572 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.74 -27.94 69.97 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.627 -1.789 . . . . 75.400000000000006 108.627 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.07 -53.44 36.92 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.581 -1.408 . . . . 65.439999999999998 109.581 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -58.54 -45.48 88.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.276 -1.132 . . . . 72.200000000000003 109.819 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 36.1 mm -65.63 -41.53 90.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.845 -1.159 . . . . 75.150000000000006 108.925 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -59.84 -44.5 94.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 73.010000000000005 109.513 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . 0.452 ' CD ' ' N ' ' B' ' 18' ' ' LYS . 1.1 mptm? -86.59 1.1 52.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.092 -1.005 . . . . 74.299999999999997 108.768 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.51 -59.39 1.83 Allowed Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.481 -1.448 . . . . 70.540000000000006 109.481 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -67.87 -22.69 65.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -1.141 . . . . 75.430000000000007 109.522 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -54.14 -34.31 60.04 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.139 -0.976 . . . . 73.200000000000003 109.238 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 56.1 t -57.48 -47.63 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.344 -0.847 . . . . 74.230000000000004 109.013 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -60.49 -53.97 51.12 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.428 -0.795 . . . . 73.519999999999996 109.005 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 136.7 38.87 0.15 Allowed Glycine 0 N--CA 1.5 2.931 0 N-CA-C 110.298 -1.121 . . . . 53.43 110.298 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -120.38 160.46 23.03 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.375 -1.073 . . . . 71.120000000000005 109.505 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.4 mmt -105.27 140.26 38.68 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.807 -0.812 . . . . 75.239999999999995 108.807 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . 0.431 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -135.23 159.26 42.12 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.429 -0.795 . . . . 73.25 109.818 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 89.2 m-20 -138.68 159.48 42.01 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.702 -0.851 . . . . 72.310000000000002 108.702 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 p -122.63 139.12 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.381 -0.825 . . . . 72.140000000000001 109.861 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 10.9 p -134.78 169.08 17.89 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.985 -0.746 . . . . 74.530000000000001 108.985 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -90.62 -107.57 0.09 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.165 -0.959 . . . . 71.019999999999996 109.787 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 82.3 p -79.09 168.61 19.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 71.400000000000006 109.993 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 50.5 mt -50.79 -31.3 16.52 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.6 -0.687 . . . . 71.239999999999995 109.843 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -51.62 -52.19 49.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.101 -0.999 . . . . 74.319999999999993 109.717 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.73 -40.89 96.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.17 -0.956 . . . . 73.030000000000001 109.354 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.24 -43.03 81.6 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.442 -1.463 . . . . 60.43 109.442 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -66.18 -38.69 88.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.321 -1.106 . . . . 74.430000000000007 109.549 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -75.13 -39.43 60.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 74.420000000000002 109.802 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 23.3 tp -72.88 -45.95 55.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.905 . . . . 75.409999999999997 110.112 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.4 ppp? -64.79 -27.06 68.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.004 -1.06 . . . . 61.439999999999998 109.84 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -58.49 -45.44 88.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.145 -0.972 . . . . 74.319999999999993 109.844 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 pt -88.93 -42.06 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.175 -0.953 . . . . 71.230000000000004 109.747 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' B' ' 40' ' ' MET . 10.7 mpt_? -96.73 144.04 27.1 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.077 -1.015 . . . . 73.409999999999997 108.983 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -103.77 150.81 23.74 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.382 -0.824 . . . . 63.539999999999999 109.248 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -137.78 139.67 40.17 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.329 -0.857 . . . . 73.109999999999999 109.321 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' B' ' 2' ' ' ARG . 7.9 p-10 -79.85 -36.86 36.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 62.219999999999999 109.253 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.05 116.39 31.86 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.93 -0.767 . . . . 73.120000000000005 108.93 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 46.4 t -100.31 98.44 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.233 -1.025 . . . . 74.109999999999999 108.233 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 20.6 ttt -112.89 133.38 54.9 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.569 -0.707 . . . . 73.439999999999998 110.051 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.46 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.7 OUTLIER -145.95 134.18 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.595 -0.69 . . . . 73.400000000000006 109.351 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' SER . . . . . 0.435 ' OG ' ' OE2' ' B' ' 7' ' ' GLU . 9.1 p -98.19 9.94 41.75 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.415 -0.803 . . . . 73.209999999999994 109.47 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.46 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 44.9 m-20 -76.06 138.86 41.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.203 -0.935 . . . . 70.409999999999997 109.539 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.465 ' C ' ' H ' ' B' ' 55' ' ' ALA . 60.2 mttm -73.62 -40.12 64.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 73.129999999999995 110.15 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -72.92 12.25 0.55 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.115 -0.99 . . . . 75.209999999999994 109.717 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.465 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -68.92 -21.54 64.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.903 . . . . 55.329999999999998 110.153 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' B' ' 55' ' ' ALA . 11.4 mt -41.7 -49.39 4.26 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.488 -0.757 . . . . 72.420000000000002 110.312 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' SER . . . . . 0.422 ' O ' ' OG ' ' B' ' 60' ' ' SER . 86.1 p -69.56 -34.68 74.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.986 -1.071 . . . . 73.040000000000006 109.098 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -66.67 -61.76 1.8 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.377 -0.827 . . . . 72.329999999999998 109.828 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 33.8 m -49.42 -35.31 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.611 -1.306 . . . . 74.540000000000006 109.716 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' B' ' 57' ' ' SER . 22.9 p -57.55 -53.69 55.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.188 -0.945 . . . . 71.239999999999995 109.714 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -66.91 -29.1 68.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.055 -1.028 . . . . 74.310000000000002 110.108 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 35.2 mm -66.06 -36.26 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.766 -1.208 . . . . 75.420000000000002 109.876 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.483 ' NZ ' ' CG2' ' B' ' 71' ' ' VAL . 29.1 mmtm -71.41 -49.4 42.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.038 -1.039 . . . . 73.319999999999993 110.278 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' B' ' 65' ' ' LYS . 13.8 pt-20 -68.85 -41.08 78.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.949 -1.094 . . . . 73.310000000000002 110.133 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.512 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 92.7 mttt -74.83 -23.52 58.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 72.439999999999998 109.825 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . 0.512 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 92.9 m-70 -156.69 63.96 0.53 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.145 -0.972 . . . . 65.209999999999994 109.67 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.452 ' N ' ' O ' ' B' ' 63' ' ' LYS . 23.7 t -57.14 -30.01 64.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -0.88 . . . . 73.099999999999994 109.581 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 39.8 m -61.56 -27.31 68.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -0.917 . . . . 71.530000000000001 109.998 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 73.7 mt -78.64 155.77 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.142 -0.973 . . . . 74.400000000000006 109.778 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 84.7 t -95.74 152.69 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.489 -0.757 . . . . 75.120000000000005 109.137 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.483 ' CG2' ' NZ ' ' B' ' 63' ' ' LYS . 39.5 t -133.04 127.9 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.336 -0.852 . . . . 73.200000000000003 109.81 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 8.0 tt -120.41 99.48 6.59 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.716 -0.846 . . . . 73.340000000000003 108.716 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.44 135.66 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 73.5 108.876 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.24 173.75 6.18 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.315 -0.866 . . . . 71.319999999999993 108.877 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 18.7 t -165.93 119.76 1.16 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.966 -1.084 . . . . 74.530000000000001 110.236 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -67.54 -15.84 63.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.381 -0.824 . . . . 64.5 109.284 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -116.91 69.08 4.6 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.674 -0.641 . . . . 74.25 109.293 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -62.73 78.06 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.91 1.74 . . . . 74.430000000000007 111.632 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.433 ' HG1' ' N ' ' B' ' 80' ' ' SER . 15.1 t -101.14 173.16 6.59 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.69 -0.856 . . . . 73.120000000000005 108.69 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' SER . . . . . 0.433 ' N ' ' HG1' ' B' ' 79' ' ' THR . 1.4 p -77.01 -26.25 53.6 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.164 -0.96 . . . . 75.409999999999997 110.489 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . 0.469 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 49.6 mp0 -66.86 -39.96 87.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.937 -1.102 . . . . 72.239999999999995 109.694 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -78.01 -33.82 51.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.194 -0.941 . . . . 73.219999999999999 109.686 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -62.55 -52.91 61.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -0.964 . . . . 74.299999999999997 109.718 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 26.4 m -63.72 -40.82 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.161 -0.962 . . . . 73.310000000000002 109.412 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' HIS . . . . . 0.469 ' ND1' ' O ' ' B' ' 81' ' ' GLU . 19.8 m80 -67.31 -31.27 71.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.905 . . . . 73.239999999999995 109.514 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.29 -41.7 93.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.922 . . . . 55.329999999999998 109.782 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' PHE . . . . . 0.53 ' CZ ' ' NH1' ' A' ' 108' ' ' ARG . 70.3 m-85 -80.29 -24.91 39.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.095 -1.003 . . . . 74.450000000000003 109.041 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -76.37 -51.92 10.93 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.386 -0.822 . . . . 64.040000000000006 109.437 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . 0.489 ' CG ' ' N ' ' B' ' 90' ' ' GLY . 11.5 pt20 -60.81 -47.19 87.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.515 -0.741 . . . . 75.129999999999995 109.774 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . 0.489 ' N ' ' CG ' ' B' ' 89' ' ' GLN . . . 140.15 71.55 0.04 OUTLIER Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.963 -1.255 . . . . 75.420000000000002 109.963 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.86 135.44 53.74 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.403 -1.057 . . . . 73.420000000000002 108.715 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . 0.522 ' OD1' ' NH1' ' B' ' 112' ' ' ARG . 24.6 t0 -85.0 -23.78 28.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.061 -1.024 . . . . 73.319999999999993 109.647 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' ASP . . . . . 0.524 ' OD2' ' NH1' ' B' ' 112' ' ' ARG . 57.3 m-20 -152.38 156.43 39.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.184 -0.948 . . . . 73.040000000000006 109.63 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -137.9 99.83 4.01 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.463 -0.94 . . . . 74.310000000000002 108.463 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 22.7 mm -106.98 147.3 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 O-C-N 120.989 -1.07 . . . . 75.340000000000003 110.833 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.76 125.74 26.81 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.915 -1.143 . . . . 70.099999999999994 107.915 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.677 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -45.94 -54.03 18.6 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.063 -1.023 . . . . 65.430000000000007 111.486 -178.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 3.3 Cg_endo -41.82 -10.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 120.796 0.997 . . . . 63.520000000000003 112.743 -176.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . 0.677 ' N ' ' O ' ' B' ' 97' ' ' LYS . 61.0 m-85 59.41 96.71 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.728 -0.608 . . . . 75.129999999999995 110.04 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -53.41 -39.37 64.28 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.101 -1.074 . . . . 74.230000000000004 108.101 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 9.1 t -174.27 128.62 0.36 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.886 -0.783 . . . . 64.510000000000005 108.886 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 59.0 mt -52.64 -36.14 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.035 -1.04 . . . . 74.439999999999998 108.868 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -61.87 -36.87 82.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.293 -0.88 . . . . 72.299999999999997 108.948 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.74 -53.64 14.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 74.310000000000002 109.347 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 25.0 tp -58.04 -49.75 75.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.926 . . . . 73.540000000000006 108.962 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 69.7 t -66.1 -39.88 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.063 -1.023 . . . . 72.030000000000001 109.853 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.78 -39.12 73.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.16 -0.962 . . . . 64.219999999999999 109.558 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -77.44 -25.04 50.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.875 . . . . 75.310000000000002 109.994 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . 0.409 HD11 HG21 ' B' ' 109' ' ' ILE . 90.4 mt -80.82 -43.37 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.039 -1.038 . . . . 55.439999999999998 109.445 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -68.15 -38.92 82.66 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.18 -0.95 . . . . 65.310000000000002 109.851 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.69 -49.18 66.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 74.519999999999996 109.838 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . 0.524 ' NH1' ' OD2' ' B' ' 93' ' ' ASP . 38.5 ttm180 -65.6 -43.87 88.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.932 . . . . 72.040000000000006 109.976 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.452 ' O ' ' CD1' ' B' ' 116' ' ' TRP . 4.3 tt -64.95 -55.45 19.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.154 -0.966 . . . . 75.349999999999994 109.335 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -50.7 -30.5 13.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.969 . . . . 75.5 109.674 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -84.64 4.48 32.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.202 -0.936 . . . . 73.040000000000006 109.807 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 116' ' ' TRP . . . . . 0.524 ' CD1' ' N ' ' B' ' 117' ' ' GLY . 0.3 OUTLIER -67.84 -19.85 65.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.009 -1.057 . . . . 74.450000000000003 109.662 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . 0.524 ' N ' ' CD1' ' B' ' 116' ' ' TRP . . . -67.73 113.13 5.24 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.702 -1.359 . . . . 64.209999999999994 109.702 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 53.1 p -153.46 164.52 38.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.279 -1.13 . . . . 71.400000000000006 109.687 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -158.23 166.17 33.05 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.876 -0.73 . . . . 74.209999999999994 109.043 -178.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -145.59 -43.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.291 -0.881 . . . . 75.019999999999996 109.31 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 28.5 mm -107.83 127.48 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.449 -0.782 . . . . 74.239999999999995 109.118 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -120.47 118.31 29.95 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.538 -0.726 . . . . 73.329999999999998 109.239 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 62.2 mt -123.48 108.42 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.938 -0.764 . . . . 74.219999999999999 108.938 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.74 -133.82 11.49 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.745 -1.342 . . . . 72.409999999999997 109.745 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -83.6 -2.25 55.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.222 -1.163 . . . . 75.120000000000005 109.399 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.18 146.04 24.16 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.473 -0.936 . . . . 75.420000000000002 108.473 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 89.3 m -130.08 134.71 47.56 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.576 -0.703 . . . . 74.219999999999999 109.212 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 21.5 mt -136.59 143.53 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.442 -0.786 . . . . 60.329999999999998 109.381 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 14.6 m -137.86 122.8 12.28 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.494 -0.754 . . . . 72.310000000000002 108.977 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -80.99 -39.95 0.19 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.994 1.796 . . . . 75.129999999999995 112.238 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -50.52 -51.31 48.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.145 -0.972 . . . . 75.230000000000004 109.428 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -86.07 -7.71 58.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.231 -0.918 . . . . 75.120000000000005 109.099 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 54.19 68.66 0.82 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.868 . . . . 75.129999999999995 109.35 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -148.6 143.38 26.53 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.228 -0.92 . . . . 75.109999999999999 109.734 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 18.1 tt -118.38 137.03 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.538 -0.726 . . . . 70.319999999999993 109.359 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 58.5 mt -126.19 123.86 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.504 -0.747 . . . . 74.120000000000005 109.144 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -140.52 144.12 35.8 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.303 -0.873 . . . . 74.230000000000004 110.113 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 31.3 mmtm 53.75 31.18 12.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.384 -0.823 . . . . 74.219999999999999 110.214 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 74.99 -6.4 27.41 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.983 -1.247 . . . . 74.319999999999993 109.983 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 12.2 mpt_? -87.96 129.43 35.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.129 -1.218 . . . . 75.340000000000003 108.838 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -98.82 130.58 45.25 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.351 -0.843 . . . . 71.230000000000004 109.675 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 66.8 t -137.12 132.12 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.444 -0.785 . . . . 70.430000000000007 109.244 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -83.15 134.92 34.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.898 . . . . 72.430000000000007 109.1 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.77 136.1 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.452 -0.78 . . . . 72.129999999999995 109.366 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.21 21.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 74.5 109.555 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.54 174.72 40.03 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.867 -1.293 . . . . 42.229999999999997 109.867 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -65.06 -61.67 5.87 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.447 -1.031 . . . . 73.299999999999997 110.096 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -54.2 -25.78 39.55 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.951 1.767 . . . . 71.329999999999998 111.87 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -87.59 -15.45 37.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.237 -0.914 . . . . 74.230000000000004 109.502 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -61.77 -45.34 94.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.162 -0.961 . . . . 72.340000000000003 109.471 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 8.8 p -56.99 -34.06 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.112 -0.992 . . . . 73.349999999999994 108.89 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.04 -49.71 76.27 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.535 -0.913 . . . . 74.430000000000007 108.535 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 16.3 m -70.57 -29.83 66.37 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.304 -0.873 . . . . 75.209999999999994 108.963 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -55.52 -59.89 4.2 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.193 -0.942 . . . . 73.040000000000006 109.987 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.79 -25.51 65.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.943 -1.098 . . . . 73.430000000000007 109.67 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.08 -43.88 74.31 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.048 -1.032 . . . . 75.319999999999993 109.931 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -83.22 -45.62 13.66 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.828 -1.17 . . . . 73.319999999999993 110.891 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 158' ' ' HIS . . . . . 0.482 ' O ' ' O ' ' B' ' 159' ' ' ARG . 51.3 m80 -50.52 -83.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.619 -1.301 . . . . 74.140000000000001 108.615 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' B' ' 158' ' ' HIS . 11.5 mmm180 56.26 153.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.596 -0.69 . . . . 73.420000000000002 110.509 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' B' ' 214' ' ' PHE . 20.4 t70 42.02 51.25 4.32 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.256 -0.903 . . . . 72.099999999999994 110.104 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -156.27 145.37 20.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.062 -1.024 . . . . 73.239999999999995 110.087 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 87.6 mt -89.19 125.66 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.747 -0.834 . . . . 72.310000000000002 108.747 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 14.7 p -135.84 136.65 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.323 -0.861 . . . . 75.030000000000001 109.248 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 11.7 t -81.54 166.45 20.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.318 -0.864 . . . . 74.219999999999999 110.524 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 18.4 mtpp -67.12 -46.1 75.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.623 -0.673 . . . . 72.420000000000002 109.896 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -58.59 -36.19 73.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.87 . . . . 63.450000000000003 110.28 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -55.14 -45.1 75.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.061 -1.024 . . . . 72.400000000000006 109.657 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 31.6 mt -66.28 -38.7 88.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.053 -1.03 . . . . 72.319999999999993 109.36 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.448 ' C ' ' CD1' ' B' ' 169' ' ' LEU . 3.1 tm? -55.35 -54.78 39.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.829 . . . . 73.340000000000003 108.996 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -68.94 -16.56 63.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 73.099999999999994 109.85 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.17 -57.87 3.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -0.937 . . . . 62.130000000000003 110.707 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.524 ' N ' ' CD1' ' B' ' 172' ' ' ILE . 1.7 mp -79.85 -44.78 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.989 -1.069 . . . . 74.439999999999998 109.239 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 19.7 m-90 . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.314 -0.866 . . . . 72.230000000000004 109.519 -179.861 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.488 1.203 0 CA-C-O 121.511 0.546 . . . . 74.340000000000003 111.735 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -148.59 -14.68 0.33 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.489 -0.757 . . . . 72.310000000000002 109.095 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.78 7.98 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.285 -0.884 . . . . 65.420000000000002 109.287 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 15.7 mm -55.75 -42.67 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.903 . . . . 75.030000000000001 109.475 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -53.84 -26.53 24.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 73.519999999999996 109.413 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 60.5 t -78.85 -54.68 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.053 -1.03 . . . . 74.349999999999994 109.149 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -51.89 -48.11 64.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 61.119999999999997 110.071 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 188' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' B' ' 189' ' ' ASN . 0.2 OUTLIER -61.82 -43.12 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.913 -1.117 . . . . 72.430000000000007 109.025 -179.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 189' ' ' ASN . . . . . 0.434 ' O ' ' OE1' ' B' ' 193' ' ' GLN . 41.4 t30 -61.48 -41.64 97.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.972 -1.08 . . . . 75.420000000000002 109.255 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -68.0 -42.52 80.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.947 . . . . 74.140000000000001 110.023 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 81.3 mt -59.85 -39.71 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.084 -1.01 . . . . 74.030000000000001 109.743 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -64.59 -40.45 95.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.116 -0.99 . . . . 72.329999999999998 109.781 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 193' ' ' GLN . . . . . 0.617 ' NE2' ' N ' ' B' ' 193' ' ' GLN . 0.2 OUTLIER -75.12 -37.83 61.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 73.099999999999994 110.376 -179.311 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' B' ' 198' ' ' PRO . 0.0 OUTLIER -73.6 -16.87 61.23 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.75 -1.219 . . . . 74.430000000000007 109.916 -179.293 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 21.9 ttp -94.52 -24.14 17.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.156 -0.965 . . . . 74.329999999999998 110.196 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 196' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' B' ' 193' ' ' GLN . 41.3 p30 -96.0 -3.76 44.41 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.987 -1.07 . . . . 71.209999999999994 110.532 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . 0.568 ' N ' ' CD ' ' B' ' 198' ' ' PRO . 20.6 tttm -92.01 -42.15 0.37 Allowed Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 120.862 -1.149 . . . . 75.209999999999994 110.053 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 198' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' B' ' 197' ' ' LYS . 17.7 Cg_endo -88.68 -51.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.596 2.198 . . . . 75.319999999999993 112.22 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' B' ' 199' ' ' LEU . 3.7 mm? -70.9 -40.06 72.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.948 -1.095 . . . . 72.25 109.347 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 85.35 -20.39 17.78 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.915 -1.274 . . . . 73.239999999999995 109.915 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 12.1 mt -103.75 137.83 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.335 -1.097 . . . . 54.299999999999997 109.354 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 38.6 t -95.38 137.85 33.86 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.242 -0.911 . . . . 74.310000000000002 109.393 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 21.4 p -142.33 34.11 1.49 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.34 -0.85 . . . . 74.400000000000006 109.146 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.53 133.41 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.497 -0.752 . . . . 74.099999999999994 109.615 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -113.94 132.7 55.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.666 -0.865 . . . . 75.329999999999998 108.666 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.45 140.37 29.82 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.256 -0.903 . . . . 71.400000000000006 109.896 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' B' ' 211' ' ' GLY . 19.8 t -138.51 123.43 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.492 -0.755 . . . . 63.5 109.006 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 -76.85 -43.51 35.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.186 -0.946 . . . . 74.450000000000003 109.914 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -51.7 -59.85 3.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.905 . . . . 74.140000000000001 109.876 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -94.71 -71.03 0.68 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.179 -0.951 . . . . 74.430000000000007 109.58 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 211' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' B' ' 207' ' ' VAL . . . 177.76 -93.71 0.09 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.349 -1.5 . . . . 70.109999999999999 109.349 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -135.49 141.07 45.25 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.45 -1.03 . . . . 74.209999999999994 109.518 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 65.3 ttt-85 -119.64 129.06 54.4 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.438 -0.949 . . . . 74.299999999999997 108.438 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . 0.529 ' O ' ' N ' ' B' ' 160' ' ' ASP . 29.5 m-85 -100.58 137.84 38.44 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.384 -0.822 . . . . 74.340000000000003 109.404 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . 0.539 ' HG ' ' H ' ' B' ' 216' ' ' TYR . 43.7 t -152.33 168.32 25.8 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.476 -0.765 . . . . 72.209999999999994 109.613 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . 0.539 ' H ' ' HG ' ' B' ' 215' ' ' CYS . 81.6 m-85 -75.35 150.41 84.98 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.253 -0.904 . . . . 72.310000000000002 109.374 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 217' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' B' ' 218' ' ' LYS . 97.4 Cg_endo -76.43 119.17 5.14 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.269 1.979 . . . . 71.010000000000005 112.171 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' B' ' 217' ' ' PRO . 41.0 mttp . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.462 -0.774 . . . . 74.349999999999994 109.384 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.6 ptm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.446 -0.575 . . . . 65.120000000000005 109.446 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -139.58 156.41 46.89 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.305 -0.872 . . . . 73.310000000000002 109.303 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 89.3 t -114.21 125.8 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.635 -0.665 . . . . 71.420000000000002 109.607 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.2 tp -100.03 118.74 37.05 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.832 -0.803 . . . . 65.219999999999999 108.832 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 tt -119.95 119.38 33.28 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.624 -0.672 . . . . 71.439999999999998 109.417 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.419 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 13.2 mt -106.45 116.89 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.352 -0.843 . . . . 71.150000000000006 108.792 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.462 ' OE1' ' CB ' ' A' ' 51' ' ' SER . 30.1 tp10 -151.37 127.63 10.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.149 -0.969 . . . . 75.340000000000003 109.491 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 9' ' ' ASN . 45.2 mtpt -77.82 -23.72 48.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 73.040000000000006 109.309 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.504 ' CG ' ' H ' ' A' ' 10' ' ' SER . 34.7 t-20 -59.68 -152.18 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.445 -0.785 . . . . 72.420000000000002 109.51 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.504 ' H ' ' CG ' ' A' ' 9' ' ' ASN . 47.6 m -156.08 -56.39 0.09 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 72.340000000000003 109.372 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.6 t -63.17 -45.49 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 74.420000000000002 109.493 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.512 ' CD2' ' N ' ' A' ' 12' ' ' LEU . 3.9 mm? -66.78 -36.43 82.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.259 -0.901 . . . . 72.010000000000005 109.289 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.11 -19.07 78.96 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 108.473 -1.851 . . . . 72.140000000000001 108.473 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.32 -50.77 4.94 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.922 -1.271 . . . . 72.329999999999998 109.922 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.14 -43.66 95.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.106 -1.232 . . . . 72.340000000000003 109.296 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 94.5 mt -61.63 -46.63 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.922 -1.111 . . . . 74.239999999999995 108.498 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -45.55 -52.47 10.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 71.409999999999997 109.798 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -89.48 4.41 49.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.181 -0.949 . . . . 75.540000000000006 109.596 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -85.02 -58.18 2.15 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.908 -1.277 . . . . 62.149999999999999 109.908 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.01 -19.06 60.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -1.165 . . . . 74.420000000000002 110.046 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -57.08 -38.25 73.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.974 . . . . 74.25 109.676 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.5 t -52.57 -32.02 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.215 -0.928 . . . . 72.109999999999999 109.123 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -75.2 -0.36 19.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.376 -0.827 . . . . 73.230000000000004 109.043 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.91 28.55 45.6 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.267 -1.133 . . . . 75.540000000000006 110.267 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -106.09 156.89 17.96 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.278 -1.13 . . . . 74.510000000000005 109.05 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.3 mmt -94.15 118.08 31.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.194 -0.942 . . . . 64.319999999999993 108.729 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -98.47 133.1 43.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.315 -0.866 . . . . 74.310000000000002 109.918 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -123.31 131.0 53.51 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 109.035 -0.728 . . . . 75.400000000000006 109.035 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.69 132.73 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.303 -0.999 . . . . 75.129999999999995 108.303 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 p -136.08 168.98 18.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.361 -0.837 . . . . 71.420000000000002 109.524 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.419 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 4.4 pt-20 -94.04 -103.47 0.14 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.301 -0.874 . . . . 73.109999999999999 109.836 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.5 t -78.54 166.78 22.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.256 -0.902 . . . . 74.239999999999995 110.157 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.0 mt -53.42 -33.7 54.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.621 -0.674 . . . . 71.530000000000001 109.733 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -52.51 -48.03 66.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 74.230000000000004 109.791 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -61.49 -37.61 84.28 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.141 -0.974 . . . . 71.010000000000005 109.11 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.26 -37.26 48.69 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.314 -1.515 . . . . 61.409999999999997 109.314 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -63.37 -39.03 93.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -1.126 . . . . 74.340000000000003 109.407 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -77.21 -37.99 52.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 75.329999999999998 109.513 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.3 tp -66.89 -46.21 75.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -0.867 . . . . 74.329999999999998 109.983 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.436 ' C ' ' SD ' ' A' ' 40' ' ' MET . 3.9 ppp? -70.09 -24.54 63.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.101 -1.0 . . . . 70.319999999999993 109.824 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -65.84 -40.42 91.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.048 -1.033 . . . . 71.219999999999999 109.951 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.2 pt -79.12 -34.01 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.103 -0.998 . . . . 74.409999999999997 110.074 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 40' ' ' MET . 30.3 mmt180 -130.25 147.69 52.0 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.327 -0.858 . . . . 75.409999999999997 109.356 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.593 ' N ' HD21 ' A' ' 44' ' ' ASN . 1.2 m120 -93.12 133.16 36.58 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.273 -0.892 . . . . 75.420000000000002 109.449 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -107.49 142.47 37.31 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.512 -0.743 . . . . 74.230000000000004 109.378 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -83.93 -42.15 16.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 75.319999999999993 109.236 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.404 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 0.5 OUTLIER -105.86 113.17 26.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.565 -0.71 . . . . 72.129999999999995 109.176 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.7 t -99.3 97.76 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.713 -0.847 . . . . 72.340000000000003 108.713 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.485 ' SD ' ' O ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -106.17 125.04 50.51 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.988 -0.745 . . . . 74.109999999999999 108.988 -179.678 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.01 133.2 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.664 0.745 . . . . 71.239999999999995 109.623 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.462 ' CB ' ' OE1' ' A' ' 7' ' ' GLU . 52.9 m -102.95 4.88 37.98 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.656 -0.652 . . . . 73.109999999999999 109.414 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -76.27 147.51 38.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -0.966 . . . . 63.399999999999999 109.613 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.464 ' C ' ' H ' ' A' ' 55' ' ' ALA . 25.6 pttm -81.92 -39.86 23.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.287 -0.883 . . . . 65.439999999999998 110.124 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -70.26 7.32 1.03 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.039 -1.038 . . . . 73.129999999999995 109.411 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.464 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -68.68 -21.78 64.41 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.384 -0.822 . . . . 64.140000000000001 110.433 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.427 ' O ' ' OG ' ' A' ' 60' ' ' SER . 63.2 mt -42.36 -47.73 4.95 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.196 -0.94 . . . . 74.430000000000007 110.546 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.2 m -70.96 -36.64 72.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.884 -1.135 . . . . 63.229999999999997 109.388 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -68.07 -61.06 2.03 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.594 -0.691 . . . . 74.439999999999998 110.158 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.6 m -51.61 -37.68 20.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.845 -1.159 . . . . 74.030000000000001 109.431 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 56' ' ' LEU . 61.6 m -56.3 -55.76 29.4 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.271 -0.893 . . . . 73.540000000000006 109.514 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -67.91 -26.89 66.21 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.049 -1.032 . . . . 73.340000000000003 110.24 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mm -57.36 -38.58 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.668 -1.27 . . . . 73.349999999999994 107.922 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 67' ' ' SER . 61.2 mmtt -72.76 -41.95 64.52 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.389 -0.819 . . . . 74.420000000000002 109.135 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -66.55 -51.44 56.49 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.143 -0.973 . . . . 74.549999999999997 109.229 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -69.57 -24.93 63.76 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.665 -0.647 . . . . 75.219999999999999 109.874 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -151.39 68.52 0.92 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.184 -0.947 . . . . 74.129999999999995 109.38 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 63' ' ' LYS . 96.9 p -57.93 -28.79 64.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 73.239999999999995 109.904 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 83.2 p -82.14 49.0 1.32 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.184 -0.948 . . . . 71.439999999999998 109.782 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.1 tt -142.06 155.9 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.258 -0.901 . . . . 71.329999999999998 109.571 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.8 t -95.59 149.87 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.146 -0.971 . . . . 73.019999999999996 108.773 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 t -140.17 127.33 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.163 -0.961 . . . . 54.210000000000001 109.875 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.485 ' O ' ' SD ' ' A' ' 49' ' ' MET . 2.4 tt -115.43 104.56 11.89 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.984 -0.747 . . . . 74.209999999999994 108.984 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.3 t -95.9 129.5 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.24 -0.913 . . . . 74.409999999999997 108.982 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.1 p -93.76 171.91 8.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.188 -0.945 . . . . 72.310000000000002 109.796 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.54 ' CB ' ' HH ' ' A' ' 94' ' ' TYR . 42.0 t -160.93 118.39 2.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.082 -1.011 . . . . 64.540000000000006 110.45 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -64.63 -29.01 70.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.623 -0.673 . . . . 74.129999999999995 109.72 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 79' ' ' THR . 35.5 m120 -122.07 80.55 43.27 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.528 -0.733 . . . . 73.340000000000003 109.428 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.12 87.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.323 2.016 . . . . 71.319999999999993 111.431 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.456 ' N ' ' O ' ' A' ' 77' ' ' ASN . 23.8 m -98.65 150.21 22.01 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.577 -0.702 . . . . 62.530000000000001 109.593 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.475 ' CB ' ' OG ' ' B' ' 101' ' ' SER . 0.0 OUTLIER -72.77 -41.15 65.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.35 -0.844 . . . . 74.140000000000001 109.189 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -57.57 -38.63 75.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.146 -0.971 . . . . 71.420000000000002 108.844 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -75.2 -26.02 58.68 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.352 -0.842 . . . . 73.430000000000007 109.191 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.525 ' OE1' ' CD2' ' A' ' 94' ' ' TYR . 36.7 tp10 -61.29 -57.63 11.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 74.219999999999999 109.65 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.0 m -63.82 -40.65 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 74.150000000000006 109.338 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -62.36 -34.65 77.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -0.904 . . . . 72.540000000000006 109.371 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.14 -39.81 93.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 64.219999999999999 109.969 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -78.26 -34.35 49.09 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.98 -1.075 . . . . 74.340000000000003 109.054 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -70.84 -36.84 73.08 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.299 -0.875 . . . . 74.420000000000002 109.592 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -68.39 -47.86 66.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 74.519999999999996 109.761 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.58 48.23 0.03 OUTLIER Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.949 -1.26 . . . . 74.209999999999994 109.949 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.82 133.26 54.14 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.425 -1.044 . . . . 64.099999999999994 109.382 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -84.67 -22.85 29.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.944 . . . . 73.420000000000002 109.133 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.532 ' OD2' ' NH2' ' A' ' 112' ' ' ARG . 19.6 t0 -150.61 163.3 38.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.399 -0.813 . . . . 75.040000000000006 109.325 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.54 ' HH ' ' CB ' ' A' ' 75' ' ' SER . 67.6 t80 -146.03 101.92 3.58 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.37 -0.832 . . . . 71.329999999999998 108.936 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 29.0 mm -112.19 156.04 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 O-C-N 121.29 -0.882 . . . . 74.510000000000005 110.464 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.11 146.52 54.19 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.417 -0.957 . . . . 64.319999999999993 108.417 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.676 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -68.19 -55.79 12.1 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.869 -1.144 . . . . 74.510000000000005 111.172 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 4.3 Cg_endo -41.59 -10.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 120.87 1.047 . . . . 73.109999999999999 112.967 -176.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.676 ' N ' ' O ' ' A' ' 97' ' ' LYS . 22.6 m-85 67.12 110.3 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.789 -0.57 . . . . 72.540000000000006 109.681 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -57.41 -33.78 68.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.972 -1.08 . . . . 74.540000000000006 108.185 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.775 ' O ' ' N ' ' A' ' 103' ' ' LYS . 47.5 t -175.63 24.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 74.140000000000001 110.167 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.4 mm 50.2 -67.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.791 -0.568 . . . . 75.430000000000007 110.028 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.775 ' N ' ' O ' ' A' ' 101' ' ' SER . 3.3 mptp? -54.5 -33.06 59.19 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.343 -1.354 . . . . 74.140000000000001 107.343 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.98 -41.54 74.3 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.988 -1.116 . . . . 63.240000000000002 107.988 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.9 tt -61.7 -46.49 89.44 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.974 -0.75 . . . . 73.219999999999999 108.974 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 90.4 t -62.99 -40.75 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.302 -0.873 . . . . 74.540000000000006 109.052 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.87 -39.71 62.85 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.315 -0.866 . . . . 75.5 108.859 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.52 ' HE ' ' CD ' ' B' ' 83' ' ' GLU . 50.3 mtt85 -69.0 -35.68 76.97 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.274 -0.891 . . . . 74.409999999999997 109.412 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.4 mt -69.4 -34.92 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.058 -1.026 . . . . 73.239999999999995 108.487 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -59.58 -55.57 32.84 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.751 -0.779 . . . . 74.340000000000003 109.446 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.5 -34.58 67.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 73.319999999999993 109.959 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.532 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 64.9 mtt85 -60.74 -37.69 82.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.001 -1.062 . . . . 74.420000000000002 110.022 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -155.06 68.74 0.7 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.681 -1.262 . . . . 74.329999999999998 110.373 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -53.66 89.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.102 -0.999 . . . . 74.439999999999998 108.784 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.506 ' N ' ' O ' ' A' ' 113' ' ' LEU . 69.0 m-85 52.9 89.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 74.430000000000007 109.599 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -87.0 141.96 28.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 74.439999999999998 109.304 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 163.36 98.39 0.13 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.683 -1.367 . . . . 75.040000000000006 109.683 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.477 ' O ' ' ND2' ' A' ' 119' ' ' ASN . 9.0 t -157.26 177.58 11.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -1.179 . . . . 70.109999999999999 109.666 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.477 ' ND2' ' O ' ' A' ' 118' ' ' SER . 0.4 OUTLIER -146.42 127.77 14.91 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.007 -0.677 . . . . 65.239999999999995 109.498 -177.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 86.6 t -72.87 -30.06 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.372 -0.83 . . . . 74.219999999999999 109.824 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.73 ' CG2' HH21 ' A' ' 159' ' ' ARG . 5.1 mp -118.66 131.88 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.427 -0.796 . . . . 74.420000000000002 109.913 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -142.33 107.73 5.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.426 -0.796 . . . . 73.299999999999997 108.997 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.59 HG12 ' CZ ' ' A' ' 159' ' ' ARG . 1.2 pp -130.71 142.44 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.458 -0.776 . . . . 75.340000000000003 109.027 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.72 -152.81 2.48 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.996 -1.642 . . . . 75.129999999999995 108.996 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -84.35 11.66 8.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.339 -1.094 . . . . 74.450000000000003 108.702 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.03 136.46 43.64 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.857 -0.794 . . . . 54.210000000000001 108.857 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 18.6 p -129.56 148.71 51.49 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.5 -0.75 . . . . 70.239999999999995 109.246 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.3 mt -139.04 136.06 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.393 -0.817 . . . . 72.430000000000007 110.028 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.8 m -126.11 98.76 32.45 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 108.68 -0.859 . . . . 71.109999999999999 108.68 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.46 -34.33 0.56 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.276 1.984 . . . . 75.140000000000001 112.734 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -58.09 -43.83 87.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.004 -1.06 . . . . 72.5 109.425 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -97.06 14.01 27.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.463 -0.773 . . . . 73.140000000000001 109.13 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 27.4 mp0 45.84 76.25 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.375 -0.828 . . . . 75.329999999999998 109.681 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -163.56 149.99 11.89 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.058 -1.026 . . . . 71.230000000000004 110.033 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 17.7 tt -137.68 143.96 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.318 -0.864 . . . . 75.329999999999998 109.314 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -122.46 131.78 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.477 -0.764 . . . . 71.109999999999999 109.728 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -138.58 128.75 25.63 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.348 -0.845 . . . . 74.140000000000001 108.737 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp 54.32 29.47 10.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.519 -0.738 . . . . 75.400000000000006 109.097 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 79.56 1.19 86.2 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.774 -0.931 . . . . 72.239999999999995 110.774 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.436 ' HD2' ' N ' ' A' ' 140' ' ' ARG . 9.2 mmm180 -88.79 124.15 33.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.859 -1.377 . . . . 73.120000000000005 108.909 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -88.81 136.35 33.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.286 -0.884 . . . . 72.319999999999993 109.014 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.0 t -131.84 127.8 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.371 -0.831 . . . . 62.340000000000003 109.591 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -88.27 122.7 32.1 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.69 -0.856 . . . . 61.229999999999997 108.69 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.6 m -141.88 138.57 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.03 -1.044 . . . . 74.439999999999998 109.867 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.51 39.14 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.443 -0.785 . . . . 75.420000000000002 109.191 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -107.9 -152.52 17.11 Favored Glycine 0 N--CA 1.502 3.036 0 N-CA-C 110.009 -1.236 . . . . 73.340000000000003 110.009 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.605 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 1.1 mtmp? -88.07 -37.62 0.46 Allowed Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.222 -1.164 . . . . 72.219999999999999 110.139 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 23.3 Cg_exo -63.29 -32.08 73.2 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.175 1.917 . . . . 75.450000000000003 111.418 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.507 ' CZ ' ' CG2' ' A' ' 153' ' ' THR . 43.7 t80 -86.69 -9.98 54.75 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.435 -0.791 . . . . 65.239999999999995 109.68 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.451 ' O ' ' OG1' ' A' ' 153' ' ' THR . 15.9 tt0 -66.96 -41.74 86.39 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.076 -1.015 . . . . 72.519999999999996 109.17 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.08 -35.11 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.983 -1.073 . . . . 74.209999999999994 109.223 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.488 HD13 HD22 ' A' ' 155' ' ' LEU . 15.9 tp -65.27 -33.35 75.78 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.181 -0.949 . . . . 73.310000000000002 108.967 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.507 ' CG2' ' CZ ' ' A' ' 149' ' ' PHE . 17.0 p -70.4 -32.39 70.01 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.177 -0.952 . . . . 74.310000000000002 108.437 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -64.38 -57.7 8.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.21 -0.931 . . . . 75.450000000000003 110.23 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.488 HD22 HD13 ' A' ' 152' ' ' LEU . 2.9 pp -65.38 -25.92 67.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.951 -1.093 . . . . 75.340000000000003 109.468 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.91 -51.55 69.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.008 -1.057 . . . . 62.140000000000001 108.988 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -74.17 -51.41 15.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.406 -0.809 . . . . 72.219999999999999 109.512 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.445 ' O ' ' O ' ' A' ' 159' ' ' ARG . 39.7 m80 -86.09 33.67 0.61 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.477 -0.765 . . . . 74.120000000000005 109.98 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.73 HH21 ' CG2' ' A' ' 121' ' ' ILE . 30.4 ttm-85 -46.96 -94.1 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.302 -0.874 . . . . 74.340000000000003 109.231 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.517 ' OD2' ' NE2' ' B' ' 161' ' ' GLN . 31.6 p-10 -52.4 89.36 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.953 -1.092 . . . . 75.450000000000003 109.219 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.535 ' NE2' ' O ' ' A' ' 162' ' ' ILE . 0.0 OUTLIER -173.33 154.01 2.54 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.109 -0.994 . . . . 73.409999999999997 109.434 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.535 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 52.5 mt -87.18 126.71 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.13 -0.981 . . . . 74.409999999999997 108.613 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 51.1 t -118.89 130.66 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.409 -0.807 . . . . 72.530000000000001 110.011 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 3.9 t -94.3 163.9 13.25 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.276 -0.89 . . . . 74.120000000000005 109.063 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -64.38 -43.58 94.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.067 -1.02 . . . . 70.430000000000007 109.554 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -58.92 -38.38 78.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 74.319999999999993 109.644 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -58.47 -46.18 87.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 74.519999999999996 109.513 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 77.7 mt -62.43 -39.31 92.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.155 -0.965 . . . . 74.409999999999997 109.311 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 173' ' ' TRP . 4.8 tt -54.77 -68.08 0.22 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.435 -0.791 . . . . 75.140000000000001 109.949 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.42 -37.08 79.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.305 -0.872 . . . . 65.030000000000001 110.751 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -50.79 -58.08 6.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.105 -0.997 . . . . 70.209999999999994 110.402 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.488 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 1.9 mp -93.27 -62.69 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.98 -1.075 . . . . 75.319999999999993 109.492 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.441 ' O ' ' O ' ' A' ' 169' ' ' LEU . 24.5 m-90 . . . . . 0 N--CA 1.488 1.454 0 O-C-N 121.38 -0.825 . . . . 73.140000000000001 110.06 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 109.531 -0.544 . . . . 73.129999999999995 109.531 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.8 p -58.29 -12.91 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 74.019999999999996 109.382 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 2.6 mp -59.92 -22.98 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.088 -1.007 . . . . 72.329999999999998 109.028 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -61.6 -45.35 94.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.208 -0.933 . . . . 74.400000000000006 110.027 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.1 m -75.32 -30.14 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.001 -1.062 . . . . 74.319999999999993 109.324 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -69.5 -50.67 43.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.097 -1.002 . . . . 73.230000000000004 110.025 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.3 tp -65.13 -39.26 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.84 -1.163 . . . . 74.310000000000002 110.503 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -58.36 -43.09 88.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.974 -1.079 . . . . 73.439999999999998 109.483 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -75.64 -47.72 25.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.347 -0.845 . . . . 71.420000000000002 110.072 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 63.6 mt -52.13 -47.91 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.13 -0.981 . . . . 72.439999999999998 109.46 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . 0.444 ' HE ' ' CG2' ' A' ' 204' ' ' VAL . 76.0 mtp180 -60.58 -51.3 70.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.322 -0.861 . . . . 64.219999999999999 109.988 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -61.59 -33.89 74.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.24 -0.913 . . . . 74.319999999999993 110.145 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.421 ' O ' ' CD ' ' A' ' 198' ' ' PRO . 9.3 pttm -86.81 -4.31 59.16 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.92 -1.112 . . . . 75.310000000000002 109.589 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 28.2 ttt -91.46 -57.2 2.85 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.16 -0.963 . . . . 74.019999999999996 109.189 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 200' ' ' GLY . 15.0 p-10 -65.19 -31.42 72.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.364 -0.835 . . . . 74.019999999999996 109.619 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.441 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 27.5 mttm -52.86 -65.26 1.14 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.103 -0.998 . . . . 75.430000000000007 109.579 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 38.5 Cg_endo -63.89 -54.92 0.76 Allowed 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.144 1.896 . . . . 72.319999999999993 112.066 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.485 ' C ' ' H ' ' A' ' 201' ' ' ILE . 65.4 mt -63.79 -28.87 70.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 74.540000000000006 109.211 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 196' ' ' ASP . . . 74.92 -26.61 1.15 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.789 -1.325 . . . . 61.509999999999998 109.789 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.485 ' H ' ' C ' ' A' ' 199' ' ' LEU . 11.0 mt -101.32 129.95 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.357 -1.084 . . . . 74.25 109.356 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 15.1 t -80.6 132.2 35.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.895 . . . . 72.0 109.265 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 62.6 p -136.11 3.72 2.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.432 -0.793 . . . . 74.439999999999998 108.949 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.444 ' CG2' ' HE ' ' A' ' 192' ' ' ARG . 28.6 m -104.36 138.09 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.499 -0.75 . . . . 71.129999999999995 109.292 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -122.96 136.34 54.82 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.6 -0.688 . . . . 73.510000000000005 109.572 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.13 132.35 44.51 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.231 -0.918 . . . . 73.519999999999996 109.047 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 5.1 m -135.14 136.29 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.371 -0.831 . . . . 72.150000000000006 109.48 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -81.34 -10.05 59.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.856 . . . . 72.400000000000006 109.16 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 18.8 mtp-105 -56.04 -43.28 77.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.92 . . . . 73.310000000000002 109.812 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -148.05 -66.76 0.25 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.221 -0.924 . . . . 71.540000000000006 109.524 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -148.45 -110.89 0.59 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.636 -1.386 . . . . 74.450000000000003 109.636 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.406 ' N ' ' CD1' ' A' ' 212' ' ' TYR . 41.4 m-85 -125.81 146.34 49.84 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.643 -0.916 . . . . 75.540000000000006 109.075 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -113.09 133.39 55.02 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.539 -0.726 . . . . 75.310000000000002 109.542 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -99.36 132.01 44.99 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.689 -0.856 . . . . 75.409999999999997 108.689 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 2.0 p -141.1 166.72 24.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.278 -0.889 . . . . 74.140000000000001 109.601 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -82.11 152.44 68.2 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 75.319999999999993 109.426 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo . . . . . 0 N--CA 1.49 1.308 0 C-N-CA 122.295 1.997 . . . . 73.109999999999999 112.266 179.491 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.594 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.406 -0.59 . . . . 75.239999999999995 109.406 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -131.77 145.89 51.85 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.512 -0.743 . . . . 73.519999999999996 109.129 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.2 t -117.03 139.65 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.582 -0.699 . . . . 72.239999999999995 109.907 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' B' ' 49' ' ' MET . 3.3 tp -109.01 118.7 37.47 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.568 -0.708 . . . . 73.340000000000003 109.386 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 21.7 mt -115.62 97.8 6.34 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.597 -0.89 . . . . 74.349999999999994 108.597 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 90.2 mt -85.8 97.41 5.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 120.863 -1.148 . . . . 63.439999999999998 108.987 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -120.52 128.04 52.74 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.543 -0.723 . . . . 74.519999999999996 109.635 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . 0.42 ' CD ' ' H ' ' B' ' 8' ' ' LYS . 0.0 OUTLIER -83.43 -22.12 32.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 74.129999999999995 108.773 179.447 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -78.6 -128.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.431 -0.793 . . . . 74.230000000000004 109.232 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' B' ' 11' ' ' VAL . 22.0 p -166.83 -55.54 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -0.866 . . . . 65.540000000000006 109.32 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.418 ' N ' ' OG ' ' B' ' 10' ' ' SER . 88.0 t -67.74 -42.77 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.288 -0.883 . . . . 75.549999999999997 109.652 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.48 ' CD2' ' N ' ' B' ' 12' ' ' LEU . 4.0 mm? -59.87 -42.23 93.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.338 -0.851 . . . . 70.140000000000001 109.532 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.75 -28.56 66.88 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.416 -1.874 . . . . 75.400000000000006 108.416 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.06 -47.94 80.49 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 109.828 -1.309 . . . . 65.439999999999998 109.828 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -63.76 -44.42 93.51 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.122 -1.222 . . . . 72.200000000000003 109.707 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 37.0 mm -66.7 -39.77 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.756 -1.215 . . . . 75.150000000000006 108.667 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.488 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 80.3 tt0 -63.72 -43.21 97.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.403 -0.811 . . . . 73.010000000000005 109.684 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp -86.81 0.45 54.81 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.09 -1.006 . . . . 74.299999999999997 109.366 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.49 -52.83 3.08 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.561 -1.416 . . . . 70.540000000000006 109.561 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -76.73 -21.56 55.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -1.102 . . . . 75.430000000000007 109.914 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 90.9 m-20 -56.43 -31.47 63.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.084 -1.01 . . . . 73.200000000000003 109.451 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 87.6 t -59.87 -35.02 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.317 -0.864 . . . . 74.230000000000004 109.354 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -70.68 -8.12 49.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.343 -0.848 . . . . 73.519999999999996 109.314 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.36 43.41 6.59 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.023 -1.231 . . . . 53.43 110.023 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -116.71 159.67 21.91 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.498 -1.001 . . . . 71.120000000000005 109.054 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 14.5 mmt -100.74 138.02 38.35 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.989 -1.115 . . . . 75.239999999999995 107.989 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.23 155.57 43.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.096 -1.002 . . . . 73.25 110.257 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -132.3 160.82 35.14 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.665 -0.865 . . . . 72.310000000000002 108.665 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 p -119.49 139.0 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.45 -0.781 . . . . 72.140000000000001 109.739 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 6.8 p -134.83 170.43 15.87 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.068 -0.716 . . . . 74.530000000000001 109.068 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.402 ' OE2' ' OD2' ' B' ' 35' ' ' ASP . 5.9 pt-20 -93.31 -107.81 0.12 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.219 -0.925 . . . . 71.019999999999996 109.82 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 54.8 p -78.94 168.16 20.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.25 -0.906 . . . . 71.400000000000006 110.025 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 61.0 mt -52.83 -29.41 27.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.548 -0.72 . . . . 71.239999999999995 109.754 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -52.71 -50.38 63.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.144 -0.972 . . . . 74.319999999999993 109.636 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.402 ' OD2' ' OE2' ' B' ' 31' ' ' GLU . 1.8 m-20 -64.66 -40.89 96.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.94 . . . . 73.030000000000001 109.481 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.02 -42.0 60.03 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.573 -1.411 . . . . 60.43 109.573 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.68 -37.75 87.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.304 -1.115 . . . . 74.430000000000007 109.748 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -80.64 -41.16 24.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.088 -1.007 . . . . 74.420000000000002 109.858 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 8.6 tt -70.21 -43.86 69.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.191 -0.943 . . . . 75.409999999999997 109.972 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.448 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.1 ppp? -62.62 -26.34 68.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.987 -1.07 . . . . 61.439999999999998 109.88 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -63.49 -39.85 95.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.054 -1.029 . . . . 74.319999999999993 110.027 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 20.9 pt -84.38 -26.29 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.095 -1.003 . . . . 71.230000000000004 110.166 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' B' ' 40' ' ' MET . 63.6 mmt-85 -129.69 138.59 51.24 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.305 -0.872 . . . . 73.409999999999997 109.348 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -93.62 159.59 15.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.162 -0.961 . . . . 63.539999999999999 109.825 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -136.63 150.47 48.55 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.447 -0.783 . . . . 73.109999999999999 109.212 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -91.5 -35.02 14.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.147 -0.971 . . . . 62.219999999999999 109.692 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.408 ' C ' ' CD1' ' B' ' 47' ' ' LEU . 0.9 OUTLIER -113.37 110.6 20.6 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.421 -0.799 . . . . 73.120000000000005 109.095 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 70.8 t -93.86 100.22 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.324 -0.86 . . . . 74.109999999999999 108.761 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' MET . . . . . 0.518 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 6.3 tpp -114.24 128.23 56.26 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.094 -0.706 . . . . 73.439999999999998 109.094 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.502 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.7 OUTLIER -144.01 136.66 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 73.400000000000006 109.803 -179.451 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 65.2 p -101.52 16.77 24.62 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.593 -0.692 . . . . 73.209999999999994 109.658 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.502 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 41.7 m-20 -83.59 136.22 34.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.22 -0.925 . . . . 70.409999999999997 109.331 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -71.93 -33.56 68.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.898 . . . . 73.129999999999995 110.184 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -76.91 3.7 11.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.098 -1.001 . . . . 75.209999999999994 110.097 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.403 ' O ' ' C ' ' B' ' 56' ' ' LEU . . . -71.39 -21.33 62.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 55.329999999999998 110.215 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' B' ' 55' ' ' ALA . 56.2 mt -42.98 -42.91 3.94 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.424 -0.797 . . . . 72.420000000000002 110.275 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' SER . . . . . 0.417 ' O ' ' OG ' ' B' ' 60' ' ' SER . 19.7 m -72.63 -37.22 68.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.045 -1.035 . . . . 73.040000000000006 109.459 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -67.44 -51.06 56.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.368 -0.832 . . . . 72.329999999999998 110.287 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.3 m -60.4 -35.11 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.783 -1.198 . . . . 74.540000000000006 109.542 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' B' ' 57' ' ' SER . 66.1 p -58.41 -50.84 72.26 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.269 -0.895 . . . . 71.239999999999995 109.289 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.48 ' HE ' ' CE ' ' B' ' 65' ' ' LYS . 12.2 ptm180 -68.85 -30.94 69.57 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 118.742 -1.183 . . . . 74.310000000000002 109.815 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.433 ' O ' ' N ' ' B' ' 66' ' ' HIS . 4.8 mm -54.56 -48.44 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.842 -1.161 . . . . 75.420000000000002 108.526 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.523 ' NZ ' ' OD2' ' B' ' 92' ' ' ASP . 50.3 mmtt -61.2 -42.94 99.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.141 -0.975 . . . . 73.319999999999993 108.435 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -65.65 -43.69 88.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.415 -0.803 . . . . 73.310000000000002 108.837 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.48 ' CE ' ' HE ' ' B' ' 61' ' ' ARG . 9.5 mtmp? -82.28 -77.54 0.23 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.662 -0.649 . . . . 72.439999999999998 109.964 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . 0.433 ' N ' ' O ' ' B' ' 62' ' ' ILE . 95.1 m-70 -97.53 87.69 4.17 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.165 -0.959 . . . . 65.209999999999994 109.727 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 71.0 p -79.34 -30.88 42.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.3 -0.875 . . . . 73.099999999999994 110.013 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 38.3 m -63.23 -28.89 70.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.19 -0.944 . . . . 71.530000000000001 110.0 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 58.3 mt -80.17 150.0 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.088 -1.008 . . . . 74.400000000000006 109.654 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.413 ' CG1' ' N ' ' B' ' 71' ' ' VAL . 98.8 t -88.37 165.62 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.378 -0.826 . . . . 75.120000000000005 109.387 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.516 ' N ' ' OD1' ' B' ' 92' ' ' ASP . 14.4 t -145.48 125.42 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.999 -1.063 . . . . 73.200000000000003 109.859 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . 0.518 ' O ' ' SD ' ' B' ' 49' ' ' MET . 0.8 OUTLIER -120.5 103.6 9.3 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.408 -0.96 . . . . 73.340000000000003 108.408 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 13.4 p -98.4 144.98 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.179 -0.951 . . . . 73.5 108.876 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.5 m -111.07 171.25 7.58 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.318 -0.864 . . . . 71.319999999999993 109.147 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.418 ' OG ' ' OE2' ' B' ' 82' ' ' GLU . 8.0 t -171.13 122.26 0.56 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.076 -1.015 . . . . 74.530000000000001 110.065 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 46.3 p30 -78.14 29.82 0.18 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.453 -0.779 . . . . 64.5 110.189 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . 0.414 ' N ' ' CD ' ' B' ' 78' ' ' PRO . 12.7 t-20 -150.47 55.13 1.67 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 120.939 -1.101 . . . . 74.25 109.862 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' B' ' 77' ' ' ASN . 12.0 Cg_endo -56.26 81.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.604 2.203 . . . . 74.430000000000007 112.397 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 29.4 m -109.35 149.69 29.12 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.317 -0.994 . . . . 73.120000000000005 108.317 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -30.66 66.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.144 -0.972 . . . . 75.409999999999997 109.213 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -64.53 -48.21 75.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 72.239999999999995 109.034 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . 0.418 ' OE2' ' OG ' ' B' ' 75' ' ' SER . 85.2 tt0 -69.89 -29.49 66.7 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.138 -0.976 . . . . 73.219999999999999 109.142 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.52 ' CD ' ' HE ' ' A' ' 108' ' ' ARG . 39.8 tp10 -56.21 -56.03 25.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.871 . . . . 74.299999999999997 109.192 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 8.2 m -60.46 -38.45 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.171 -0.956 . . . . 73.310000000000002 108.917 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 69.9 t60 -63.11 -34.03 76.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.303 -0.873 . . . . 73.239999999999995 109.437 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.18 90.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.197 -0.94 . . . . 55.329999999999998 109.74 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -76.56 -31.34 57.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.195 -0.941 . . . . 74.450000000000003 108.641 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -67.32 -46.31 73.87 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.731 -0.84 . . . . 64.040000000000006 108.731 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -59.48 -66.21 0.55 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.611 -0.681 . . . . 75.129999999999995 109.414 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 149.87 52.14 0.02 OUTLIER Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.167 -1.173 . . . . 75.420000000000002 110.167 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.6 132.23 54.08 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.31 -1.112 . . . . 73.420000000000002 109.067 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . 0.523 ' OD2' ' NZ ' ' B' ' 63' ' ' LYS . 3.4 m-20 -67.15 -38.11 84.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.033 -1.042 . . . . 73.319999999999993 108.873 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 48.2 t0 -152.11 156.65 40.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.442 -0.786 . . . . 73.040000000000006 108.939 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.482 ' C ' ' CD1' ' B' ' 94' ' ' TYR . 0.5 OUTLIER -125.29 126.54 45.27 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.179 -0.674 . . . . 74.310000000000002 109.179 -179.586 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . 0.435 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 25.8 mm -110.22 134.06 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 121.378 -0.826 . . . . 75.340000000000003 109.923 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' B' ' 97' ' ' LYS . . . -60.97 119.5 8.41 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.635 -1.617 . . . . 70.099999999999994 106.635 177.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.681 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -42.01 -55.36 6.3 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.032 -1.042 . . . . 65.430000000000007 111.574 -178.072 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 3.7 Cg_endo -41.64 -10.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 120.774 0.983 . . . . 63.520000000000003 112.57 -176.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . 0.681 ' N ' ' O ' ' B' ' 97' ' ' LYS . 58.6 m-85 58.83 104.98 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.845 -0.535 . . . . 75.129999999999995 109.719 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . 0.47 ' O ' ' OG ' ' B' ' 101' ' ' SER . 33.0 ttm-85 -62.0 -34.4 76.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.071 -1.018 . . . . 74.230000000000004 109.091 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 101' ' ' SER . . . . . 0.631 ' O ' ' N ' ' B' ' 103' ' ' LYS . 28.8 m -172.51 32.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.88 . . . . 64.510000000000005 110.253 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . 0.48 ' O ' ' N ' ' B' ' 104' ' ' ALA . 55.9 mt 49.09 -81.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.384 -0.823 . . . . 74.439999999999998 110.368 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . 0.631 ' N ' ' O ' ' B' ' 101' ' ' SER . 44.7 mtmt -45.57 -19.97 0.06 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.242 -0.911 . . . . 72.299999999999997 108.961 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' B' ' 102' ' ' ILE . . . -55.6 -67.5 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.509 -0.744 . . . . 74.310000000000002 109.545 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 3.1 pp -60.84 -36.76 79.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.961 -1.087 . . . . 73.540000000000006 109.555 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 14.5 t -56.92 -45.69 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.74 -1.225 . . . . 72.030000000000001 108.531 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.3 -31.04 67.13 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.337 -0.986 . . . . 64.219999999999999 108.337 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -79.41 -23.72 43.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.525 -0.735 . . . . 75.310000000000002 109.822 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 83.2 mt -78.24 -39.69 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.955 -1.091 . . . . 55.439999999999998 109.11 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -73.52 -41.39 63.11 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.329 -0.949 . . . . 65.310000000000002 109.417 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.15 -53.28 59.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.192 -0.942 . . . . 74.519999999999996 109.577 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 68.3 ttt-85 -64.97 -33.85 77.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 72.040000000000006 109.47 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.521 ' O ' ' CD2' ' B' ' 115' ' ' PHE . 60.3 tp -80.54 -90.82 0.06 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.93 . . . . 75.349999999999994 109.7 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.516 ' C ' ' H ' ' B' ' 116' ' ' TRP . 11.6 mmt180 47.17 -170.03 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.176 -0.952 . . . . 75.5 108.881 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 115' ' ' PHE . . . . . 0.521 ' CD2' ' O ' ' B' ' 113' ' ' LEU . 1.4 m-85 66.26 -39.76 0.33 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.336 -0.853 . . . . 73.040000000000006 109.849 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 116' ' ' TRP . . . . . 0.516 ' H ' ' C ' ' B' ' 114' ' ' ARG . 17.1 t90 53.3 43.13 31.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.012 -1.055 . . . . 74.450000000000003 109.203 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.49 77.0 1.09 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.817 -1.313 . . . . 64.209999999999994 109.817 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 2.3 t -80.92 -8.35 59.72 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.207 -1.172 . . . . 71.400000000000006 109.392 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . 0.674 ' ND2' ' HG ' ' B' ' 129' ' ' SER . 24.4 t-20 54.52 176.39 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.422 -0.798 . . . . 74.209999999999994 110.328 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . 0.476 ' H ' ' CG ' ' B' ' 119' ' ' ASN . 11.8 t -142.71 -36.2 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.72 -0.845 . . . . 75.019999999999996 108.72 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 25.6 mm -115.42 118.77 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.28 -1.008 . . . . 74.239999999999995 108.28 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -155.34 140.76 17.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.939 -1.101 . . . . 73.329999999999998 110.131 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 35.1 pt -149.02 145.23 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.998 -0.742 . . . . 74.219999999999999 108.998 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 45.8 -136.41 8.0 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.848 -1.301 . . . . 72.409999999999997 109.848 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -90.51 6.73 42.29 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.259 -1.142 . . . . 75.120000000000005 109.326 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.9 139.25 31.12 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.321 -0.862 . . . . 75.420000000000002 108.777 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 17.0 m -128.86 133.68 48.04 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.601 -0.888 . . . . 74.219999999999999 108.601 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.509 ' C ' HD22 ' B' ' 119' ' ' ASN . 42.0 mt -138.95 141.31 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.147 -0.971 . . . . 60.329999999999998 110.571 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 129' ' ' SER . . . . . 0.674 ' HG ' ' ND2' ' B' ' 119' ' ' ASN . 6.1 m -136.99 117.75 10.88 Favored Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 108.915 -0.772 . . . . 72.310000000000002 108.915 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.98 -48.74 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 121.958 1.772 . . . . 75.129999999999995 112.471 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -55.53 -37.41 67.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.211 -0.93 . . . . 75.230000000000004 109.836 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -80.76 -2.15 45.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.166 -0.959 . . . . 75.120000000000005 109.374 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 49.55 57.32 6.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.256 -0.903 . . . . 75.129999999999995 108.958 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -156.66 139.7 15.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -0.908 . . . . 75.109999999999999 109.545 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 55.3 mt -124.01 132.72 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.995 -0.743 . . . . 70.319999999999993 108.995 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 23.7 mt -125.57 131.25 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.502 -0.749 . . . . 74.120000000000005 110.318 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -125.62 129.24 49.24 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.697 -0.627 . . . . 74.230000000000004 109.483 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm 51.46 36.34 16.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.179 -0.951 . . . . 74.219999999999999 111.095 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.76 -1.34 83.83 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 120.065 -1.064 . . . . 74.319999999999993 111.5 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -87.14 124.62 33.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.714 -1.462 . . . . 75.340000000000003 108.927 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -84.03 123.88 30.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.368 -0.832 . . . . 71.230000000000004 109.496 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 97.2 t -127.72 133.28 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.474 -0.766 . . . . 70.430000000000007 109.45 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -98.93 142.84 29.93 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.242 -0.911 . . . . 72.430000000000007 109.44 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 20.6 m -146.32 152.29 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.149 -0.969 . . . . 72.129999999999995 109.906 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.11 115.79 0.08 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.358 -0.839 . . . . 74.5 109.407 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.59 -137.86 7.03 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.788 -1.325 . . . . 42.229999999999997 109.788 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . 0.58 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 0.0 OUTLIER -73.53 -43.83 7.1 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.272 -1.134 . . . . 73.299999999999997 109.539 -179.58 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 24.3 Cg_exo -62.67 -49.08 5.99 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.29 1.994 . . . . 71.329999999999998 111.144 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . 0.403 ' CE1' ' CG2' ' B' ' 153' ' ' THR . 25.1 t80 -58.06 -24.39 58.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.687 -0.633 . . . . 74.230000000000004 109.608 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . 0.41 ' OE1' ' O ' ' B' ' 172' ' ' ILE . 24.0 tt0 -72.11 -58.6 3.29 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.299 -0.876 . . . . 72.340000000000003 110.378 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.99 -33.58 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.801 -1.187 . . . . 73.349999999999994 109.468 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 3.8 mp -58.15 -41.47 83.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.118 -0.989 . . . . 74.430000000000007 108.781 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 153' ' ' THR . . . . . 0.403 ' CG2' ' CE1' ' B' ' 149' ' ' PHE . 1.9 p -80.6 -18.96 46.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.967 . . . . 75.209999999999994 110.235 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -71.16 -52.13 20.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.858 -1.151 . . . . 73.040000000000006 109.576 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . 0.502 ' CD1' ' N ' ' B' ' 156' ' ' ALA . 0.0 OUTLIER -77.92 -25.01 48.11 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.313 -0.867 . . . . 73.430000000000007 110.17 -179.164 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . 0.502 ' N ' ' CD1' ' B' ' 155' ' ' LEU . . . -63.38 -53.4 53.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.906 -1.121 . . . . 75.319999999999993 109.259 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -66.06 -54.5 25.01 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.267 -0.896 . . . . 73.319999999999993 108.877 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 158' ' ' HIS . . . . . 0.448 ' ND1' ' N ' ' B' ' 158' ' ' HIS . 2.1 m-70 -84.72 38.27 0.69 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.804 -0.56 . . . . 74.140000000000001 110.263 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -73.41 45.07 0.16 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.866 -1.146 . . . . 73.420000000000002 109.408 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' B' ' 160' ' ' ASP . 15.9 p-10 -169.81 62.13 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.076 -1.015 . . . . 72.099999999999994 109.294 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . 0.517 ' NE2' ' OD2' ' A' ' 160' ' ' ASP . 39.7 tp60 -169.87 164.51 9.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.07 -1.019 . . . . 73.239999999999995 109.831 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 45.4 mt -80.3 132.94 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.611 -0.885 . . . . 72.310000000000002 108.611 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 33.9 t -132.01 131.12 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.289 -0.882 . . . . 75.030000000000001 109.892 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 164' ' ' SER . . . . . 0.521 ' HG ' ' H ' ' B' ' 167' ' ' GLN . 11.2 p -99.68 159.94 14.67 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.708 -0.849 . . . . 74.219999999999999 108.708 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -55.76 -39.38 71.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.028 -1.045 . . . . 72.420000000000002 109.571 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.21 -39.6 93.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.149 -0.969 . . . . 63.450000000000003 109.809 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 167' ' ' GLN . . . . . 0.521 ' H ' ' HG ' ' B' ' 164' ' ' SER . 22.2 mm100 -53.3 -47.28 69.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.176 -0.953 . . . . 72.400000000000006 109.0 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 33.5 mt -55.87 -50.53 70.37 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.448 -0.945 . . . . 72.319999999999993 108.448 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 1.1 tt -49.9 -56.23 11.35 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.271 -0.893 . . . . 73.340000000000003 109.296 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -56.2 -39.21 72.08 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 112.833 0.679 . . . . 73.099999999999994 112.833 -178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -93.25 -18.83 22.03 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.451 -1.406 . . . . 62.130000000000003 113.408 -176.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.41 ' O ' ' OE1' ' B' ' 150' ' ' GLU . 1.3 mp -91.32 -53.87 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 120.375 -1.453 . . . . 74.439999999999998 111.07 -178.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 173' ' ' TRP . . . . . 0.536 ' O ' ' CG ' ' B' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.158 0 O-C-N 120.738 -1.226 . . . . 72.230000000000004 110.63 -177.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo . . . . . 0 N--CA 1.496 1.625 0 CA-C-O 121.224 0.427 . . . . 74.340000000000003 113.01 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -62.44 -33.5 74.92 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.199 -0.938 . . . . 72.310000000000002 111.072 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 87.2 t -66.67 -15.54 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.933 -1.104 . . . . 65.420000000000002 110.699 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 95.0 mt -60.87 -23.55 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.726 -1.234 . . . . 75.030000000000001 109.563 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . 0.449 ' CG ' ' N ' ' B' ' 186' ' ' VAL . 20.6 pt-20 -59.87 -43.95 94.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.283 -0.885 . . . . 73.519999999999996 109.883 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . 0.449 ' N ' ' CG ' ' B' ' 185' ' ' GLU . 2.7 p -76.98 -34.35 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.967 -1.083 . . . . 74.349999999999994 109.74 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -55.25 -52.59 62.9 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.881 -1.137 . . . . 61.119999999999997 109.588 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 8.3 tp -65.97 -37.83 80.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 120.973 -1.08 . . . . 72.430000000000007 109.603 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -58.5 -46.11 87.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.001 -1.062 . . . . 75.420000000000002 109.6 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -72.91 -47.23 47.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 74.140000000000001 110.087 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.5 mt -54.63 -40.55 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.026 -1.046 . . . . 74.030000000000001 109.463 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -62.49 -52.17 64.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.162 -0.961 . . . . 72.329999999999998 109.505 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -60.22 -38.42 83.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 73.099999999999994 109.464 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -73.25 -15.42 61.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.289 -0.882 . . . . 74.430000000000007 109.592 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 1.5 tpt -89.85 -57.13 2.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.271 -0.893 . . . . 74.329999999999998 110.098 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 196' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' B' ' 200' ' ' GLY . 95.2 m-20 -55.87 -38.35 70.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 71.209999999999994 110.998 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . 0.435 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 14.0 mtmm -54.96 -65.66 1.28 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.876 -1.14 . . . . 75.209999999999994 109.938 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 198' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 34.9 Cg_endo -63.11 -56.57 0.53 Allowed 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.084 1.856 . . . . 75.319999999999993 112.368 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . 0.46 ' C ' ' H ' ' B' ' 201' ' ' ILE . 9.1 mp -62.83 -32.15 73.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.137 -0.977 . . . . 72.25 109.478 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' B' ' 196' ' ' ASP . . . 74.14 -41.9 1.13 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.486 -1.446 . . . . 73.239999999999995 109.486 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . 0.46 ' H ' ' C ' ' B' ' 199' ' ' LEU . 4.0 mt -92.29 129.52 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.285 -1.126 . . . . 54.299999999999997 109.231 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 26.3 p -78.12 142.35 38.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.167 -0.958 . . . . 74.310000000000002 109.07 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 10.2 p -141.45 4.88 1.8 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.314 -0.867 . . . . 74.400000000000006 109.528 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 32.6 m -113.89 134.83 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.444 -0.785 . . . . 74.099999999999994 109.208 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . 0.531 ' OE2' ' N ' ' B' ' 205' ' ' GLU . 1.5 mp0 -106.76 136.22 46.95 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.448 -0.783 . . . . 75.329999999999998 109.508 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.36 119.21 34.42 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.209 -0.932 . . . . 71.400000000000006 109.018 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 4.8 t -131.58 130.77 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.447 -0.783 . . . . 63.5 109.59 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 208' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' B' ' 209' ' ' ARG . 65.9 ttt-85 -73.1 -28.59 62.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 74.450000000000003 109.446 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 209' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' B' ' 208' ' ' ARG . 52.4 mtp85 -55.6 -106.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 74.140000000000001 109.982 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -63.67 -66.19 0.58 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.019 . . . . 74.430000000000007 109.852 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 211' ' ' GLY . . . . . 0.68 ' H ' HH12 ' B' ' 213' ' ' ARG . . . 178.68 -119.89 0.68 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.834 -1.306 . . . . 70.109999999999999 109.834 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 212' ' ' TYR . . . . . 0.628 ' N ' ' NH2' ' B' ' 213' ' ' ARG . 78.2 m-85 -111.69 141.79 44.85 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.494 -1.004 . . . . 74.209999999999994 109.7 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . 0.68 HH12 ' H ' ' B' ' 211' ' ' GLY . 13.5 mmp_? -105.87 131.51 53.11 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.454 -0.779 . . . . 74.299999999999997 108.96 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . 0.43 ' C ' ' SG ' ' B' ' 215' ' ' CYS . 60.4 m-85 -108.45 107.27 17.74 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.348 -0.845 . . . . 74.340000000000003 108.972 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . 0.43 ' SG ' ' C ' ' B' ' 214' ' ' PHE . 4.2 m -148.64 169.43 20.37 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.309 -0.869 . . . . 72.209999999999994 109.53 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -79.32 150.34 73.76 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 72.310000000000002 109.117 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.77 -159.57 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.975 1.783 . . . . 71.010000000000005 111.243 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? . . . . . 0 N--CA 1.489 1.51 0 O-C-N 120.993 -1.067 . . . . 74.349999999999994 109.089 -179.814 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ptp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.469 -0.567 . . . . 65.120000000000005 109.469 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.1 ttt85 -144.24 156.47 44.3 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.277 -0.889 . . . . 73.310000000000002 109.238 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.5 t -117.04 129.21 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.59 0.709 . . . . 71.420000000000002 109.742 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 49' ' ' MET . 6.8 tp -99.86 116.76 32.68 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.902 -0.777 . . . . 65.219999999999999 108.902 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.4 tp -119.54 105.44 11.23 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.098 -0.704 . . . . 71.439999999999998 109.098 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.47 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 11.7 mt -96.36 131.9 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.071 -1.018 . . . . 71.150000000000006 109.539 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.499 ' CD ' ' N ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -163.14 131.83 3.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 75.340000000000003 109.409 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.474 ' H ' ' CD ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -76.74 -5.1 46.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -0.944 . . . . 73.040000000000006 108.898 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -74.67 -145.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.312 -0.868 . . . . 72.420000000000002 109.092 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.3 t -159.83 -69.84 0.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.107 -0.996 . . . . 72.340000000000003 109.662 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.2 p -64.76 -37.46 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 74.420000000000002 109.985 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -52.11 -41.34 62.39 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.978 -1.076 . . . . 72.010000000000005 108.756 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.25 -28.79 63.35 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.552 -1.819 . . . . 72.140000000000001 108.552 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.65 -46.43 92.15 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.696 -1.362 . . . . 72.329999999999998 109.696 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.28 -42.86 87.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.321 -1.106 . . . . 72.340000000000003 109.915 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.426 HG21 HD11 ' A' ' 16' ' ' ILE . 62.9 mt -69.55 -37.45 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.886 -1.134 . . . . 74.239999999999995 109.327 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -59.81 -45.94 90.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.137 -0.977 . . . . 71.409999999999997 109.488 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -86.33 -4.28 59.14 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.155 -0.966 . . . . 75.540000000000006 109.629 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.02 -57.45 2.52 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.312 -1.515 . . . . 62.149999999999999 109.312 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pp -66.31 -29.21 69.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.376 -1.073 . . . . 74.420000000000002 109.38 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -53.22 -35.1 59.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 74.25 109.35 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 82.1 t -55.52 -40.84 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.929 . . . . 72.109999999999999 109.095 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.459 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -70.25 -17.33 63.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.373 -0.83 . . . . 73.230000000000004 109.015 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.95 41.6 3.5 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.197 -1.161 . . . . 75.540000000000006 110.197 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -118.15 155.85 29.73 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.404 -1.057 . . . . 74.510000000000005 108.737 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.7 mmm -103.51 139.22 39.15 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.538 -0.912 . . . . 64.319999999999993 108.538 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.69 159.81 41.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.224 -0.923 . . . . 74.310000000000002 110.066 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -140.03 146.06 38.55 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.91 -0.774 . . . . 75.400000000000006 108.91 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.93 128.15 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.647 -0.872 . . . . 75.129999999999995 108.647 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.6 p -128.48 165.05 21.44 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.584 -0.697 . . . . 71.420000000000002 109.516 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.47 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 3.5 pt-20 -94.13 -99.34 0.15 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.284 -0.885 . . . . 73.109999999999999 109.643 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.5 p -79.56 165.51 22.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.167 -0.958 . . . . 74.239999999999995 110.034 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.0 mt -57.13 -36.3 70.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.496 -0.752 . . . . 71.530000000000001 109.991 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -54.14 -41.09 68.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.111 -0.993 . . . . 74.230000000000004 110.014 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.18 -40.08 65.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.125 -0.984 . . . . 71.010000000000005 109.867 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.97 -39.46 23.96 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.91 -1.276 . . . . 61.409999999999997 109.91 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.6 -49.02 74.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -1.136 . . . . 74.340000000000003 109.872 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -66.47 -35.75 81.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.144 -0.972 . . . . 75.329999999999998 110.039 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.6 tp -73.83 -51.58 15.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 74.329999999999998 110.344 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.42 ' O ' ' O ' ' A' ' 43' ' ' ARG . 11.7 ptm -65.3 -24.79 67.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.078 -1.014 . . . . 70.319999999999993 110.094 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -54.98 -42.0 71.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.079 -1.013 . . . . 71.219999999999999 109.891 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.1 pt -88.67 -34.68 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.164 -0.96 . . . . 74.409999999999997 109.964 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 40' ' ' MET . 86.2 mtt-85 -86.59 147.35 25.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.02 -1.05 . . . . 75.409999999999997 109.684 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -88.42 151.92 22.24 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.296 -0.877 . . . . 75.420000000000002 109.237 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 12.5 p90 -156.01 171.09 20.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.149 -0.969 . . . . 74.230000000000004 109.897 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 45' ' ' TYR . 89.8 m-20 -136.3 -31.87 0.88 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.53 -0.732 . . . . 75.319999999999993 109.426 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.02 108.62 19.86 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.361 -0.837 . . . . 72.129999999999995 108.818 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.3 t -97.82 97.8 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.323 -0.861 . . . . 72.340000000000003 109.438 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.429 ' O ' ' O ' ' A' ' 4' ' ' LEU . 4.5 ttt -113.89 127.48 56.0 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.455 -0.778 . . . . 74.109999999999999 109.213 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -133.5 137.61 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.635 -0.666 . . . . 71.239999999999995 109.47 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 t -103.92 4.07 34.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.589 -0.694 . . . . 73.109999999999999 109.647 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -76.84 140.01 40.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.15 -0.969 . . . . 63.399999999999999 109.532 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.512 ' C ' ' H ' ' A' ' 55' ' ' ALA . 37.9 mmtm -73.58 -42.32 61.73 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.291 -0.881 . . . . 65.439999999999998 110.104 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -70.95 13.98 0.17 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.113 -0.992 . . . . 73.129999999999995 109.682 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.01 -20.87 59.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 64.140000000000001 110.428 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 55' ' ' ALA . 36.3 mt -42.06 -50.84 4.67 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.39 -0.819 . . . . 74.430000000000007 110.019 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.9 m -66.12 -33.85 76.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.074 -1.016 . . . . 63.229999999999997 108.945 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.437 ' N ' ' O ' ' A' ' 55' ' ' ALA . 52.1 t80 -64.08 -62.1 1.84 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.358 -0.839 . . . . 74.439999999999998 109.574 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.2 m -49.21 -33.25 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.671 -1.268 . . . . 74.030000000000001 109.589 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.0 m -58.2 -51.66 68.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.207 -0.933 . . . . 73.540000000000006 109.583 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -69.21 -31.22 69.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.997 -1.064 . . . . 73.340000000000003 110.014 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.9 mm -65.87 -36.11 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.726 -1.234 . . . . 73.349999999999994 109.561 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -69.75 -46.38 66.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 74.420000000000002 110.428 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.431 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 7.0 pt-20 -74.53 -42.73 58.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.831 -1.168 . . . . 74.549999999999997 110.087 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.527 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 92.8 mttt -70.13 -27.9 64.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 75.219999999999999 109.484 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.527 ' ND1' ' O ' ' A' ' 65' ' ' LYS . 58.6 m-70 -150.13 67.12 0.97 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.367 -0.833 . . . . 74.129999999999995 109.224 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.3 p -60.44 -28.76 68.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 73.239999999999995 109.813 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.5 t -78.58 48.54 0.8 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.158 -0.964 . . . . 71.439999999999998 109.709 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.6 tt -144.81 166.72 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.094 -1.004 . . . . 71.329999999999998 109.344 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.6 t -98.05 156.06 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.182 -0.949 . . . . 73.019999999999996 109.404 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.9 t -142.63 120.86 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.286 -0.884 . . . . 54.210000000000001 108.816 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.4 mp -116.75 104.27 11.18 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.862 -0.792 . . . . 74.209999999999994 108.862 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 68.5 t -93.02 121.37 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 74.409999999999997 108.859 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.0 p -89.78 169.38 11.32 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.158 -0.964 . . . . 72.310000000000002 109.118 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.484 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 19.1 t -162.44 123.03 2.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.085 -1.01 . . . . 64.540000000000006 110.224 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 77' ' ' ASN . 54.1 p30 -78.49 -9.97 59.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.428 -0.795 . . . . 74.129999999999995 109.116 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 79' ' ' THR . 27.6 m120 -128.7 64.95 71.09 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.891 -0.781 . . . . 73.340000000000003 108.891 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -49.44 88.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.093 1.862 . . . . 71.319999999999993 111.871 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.425 ' N ' ' O ' ' A' ' 77' ' ' ASN . 24.5 m -105.83 149.24 26.68 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.706 -0.849 . . . . 62.530000000000001 108.706 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.3 -33.11 74.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 74.140000000000001 109.329 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.18 -38.73 87.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 71.420000000000002 109.363 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.422 ' OE1' ' OH ' ' A' ' 94' ' ' TYR . 85.1 tt0 -75.76 -31.81 59.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 73.430000000000007 109.498 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.51 -51.44 65.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 74.219999999999999 109.741 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.4 m -63.98 -42.82 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 74.150000000000006 109.605 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.622 ' CE1' ' NE2' ' A' ' 89' ' ' GLN . 7.0 t-80 -64.06 -32.54 74.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.186 -0.946 . . . . 72.540000000000006 109.509 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.37 -37.88 80.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 64.219999999999999 110.091 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -83.48 -36.93 23.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.053 -1.029 . . . . 74.340000000000003 109.294 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.85 -34.04 77.05 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.293 -0.879 . . . . 74.420000000000002 109.504 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.622 ' NE2' ' CE1' ' A' ' 85' ' ' HIS . 87.8 mt-30 -80.08 -60.03 2.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 74.519999999999996 109.776 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 157.36 59.12 0.01 OUTLIER Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.672 -1.252 . . . . 74.209999999999994 110.22 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.44 125.48 51.81 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.402 -1.058 . . . . 64.099999999999994 108.89 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 20.6 t70 -69.65 -35.59 75.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.002 -1.061 . . . . 73.420000000000002 109.271 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 67.9 m-20 -151.3 161.5 42.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.338 -0.851 . . . . 75.040000000000006 109.442 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.484 ' OH ' ' CB ' ' A' ' 75' ' ' SER . 86.9 t80 -134.98 119.19 17.68 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.563 -0.902 . . . . 71.329999999999998 108.563 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.494 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 0.1 OUTLIER -125.42 148.6 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 CA-C-O 121.701 0.762 . . . . 74.510000000000005 110.7 -178.191 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.51 133.77 49.07 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.822 -1.177 . . . . 64.319999999999993 107.822 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.682 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -53.67 -55.3 36.81 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 120.907 -1.12 . . . . 74.510000000000005 111.824 -178.794 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.5 Cg_endo -41.01 -10.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 120.943 1.095 . . . . 73.109999999999999 113.19 -175.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.682 ' N ' ' O ' ' A' ' 97' ' ' LYS . 56.8 m-85 58.99 118.89 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.661 -0.649 . . . . 72.540000000000006 109.802 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 46.7 mtt-85 -62.6 -41.68 99.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.824 -1.172 . . . . 74.540000000000006 109.528 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.753 ' O ' ' N ' ' A' ' 103' ' ' LYS . 44.5 t -165.92 31.13 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.0 -1.062 . . . . 74.140000000000001 110.75 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.3 mt 50.39 -70.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 118.588 0.631 . . . . 75.430000000000007 110.208 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.753 ' N ' ' O ' ' A' ' 101' ' ' SER . 9.1 mtpm? -53.47 -32.81 51.78 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.062 -1.088 . . . . 74.140000000000001 108.062 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.29 -52.13 60.09 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.439 -0.948 . . . . 63.240000000000002 108.439 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.0 tp -58.21 -41.4 83.96 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.518 -0.919 . . . . 73.219999999999999 108.518 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 84.1 t -61.99 -37.37 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.25 -0.906 . . . . 74.540000000000006 108.669 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.4 -35.49 70.1 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.345 -0.847 . . . . 75.5 108.9 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.527 ' NE ' ' OE2' ' B' ' 83' ' ' GLU . 93.8 mtt180 -79.86 -26.76 40.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.371 -0.831 . . . . 74.409999999999997 109.974 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.9 mt -80.3 -38.52 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.053 -1.029 . . . . 73.239999999999995 109.476 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -72.72 -36.88 67.89 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.236 -0.915 . . . . 74.340000000000003 109.207 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.23 -46.46 83.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.341 -0.849 . . . . 73.319999999999993 109.226 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.99 -39.36 81.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 74.420000000000002 108.793 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 tt -142.43 80.87 1.72 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.254 -0.904 . . . . 74.329999999999998 108.781 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.526 ' O ' ' CG ' ' A' ' 115' ' ' PHE . 86.2 mtm180 -65.88 -43.42 88.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 74.439999999999998 109.927 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.526 ' CG ' ' O ' ' A' ' 114' ' ' ARG . 96.3 m-85 -158.39 -84.98 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.159 -0.963 . . . . 74.430000000000007 109.581 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 83.7 t90 -154.16 154.12 33.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 74.439999999999998 109.442 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 158.17 65.72 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.443 -1.463 . . . . 75.040000000000006 109.443 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 83.0 p -156.76 96.9 1.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.296 -1.12 . . . . 70.109999999999999 109.48 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 128' ' ' ILE . 21.8 t-20 -154.69 174.22 15.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.296 -0.877 . . . . 65.239999999999995 109.314 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.489 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 4.2 t -142.59 -35.56 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.286 -0.884 . . . . 74.219999999999999 109.139 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 20.8 mm -104.7 126.45 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.338 -0.851 . . . . 74.420000000000002 109.179 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -139.53 120.99 15.07 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.361 -0.837 . . . . 73.299999999999997 109.336 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.4 ' O ' ' C ' ' A' ' 124' ' ' GLY . 10.2 pt -150.18 135.47 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.268 -0.895 . . . . 75.340000000000003 109.373 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 123' ' ' ILE . . . 43.87 -145.34 1.58 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.991 -1.244 . . . . 75.129999999999995 109.991 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -85.44 1.04 50.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -1.165 . . . . 74.450000000000003 109.274 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.45 131.42 38.66 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.39 -0.967 . . . . 54.210000000000001 108.39 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 51.3 m -131.08 133.79 46.0 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.437 -0.789 . . . . 70.239999999999995 109.62 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.518 ' O ' ' ND2' ' A' ' 119' ' ' ASN . 72.4 mt -131.95 133.81 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.473 -0.767 . . . . 72.430000000000007 109.147 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.505 ' OG ' ' ND2' ' A' ' 119' ' ' ASN . 70.9 m -119.73 85.01 32.41 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.651 -0.655 . . . . 71.109999999999999 109.581 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.43 -44.7 47.07 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.398 2.065 . . . . 75.140000000000001 111.886 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -61.81 -41.96 98.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 72.5 109.308 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -80.67 -8.16 59.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.301 -0.874 . . . . 73.140000000000001 108.78 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 56.24 59.75 3.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.417 -0.802 . . . . 75.329999999999998 109.552 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -155.85 134.63 11.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.206 -0.934 . . . . 71.230000000000004 109.62 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 97.6 mt -107.84 140.64 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.563 -0.711 . . . . 75.329999999999998 109.33 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.6 mp -128.35 122.15 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.397 -0.814 . . . . 71.109999999999999 109.613 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -138.69 140.23 38.71 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.814 -0.809 . . . . 74.140000000000001 108.814 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp 54.12 25.51 5.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.434 -0.791 . . . . 75.400000000000006 110.055 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.01 -7.85 58.76 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.985 -1.246 . . . . 72.239999999999995 109.985 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -88.64 128.07 35.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.087 -1.243 . . . . 73.120000000000005 109.056 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -97.97 139.0 34.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.33 -0.856 . . . . 72.319999999999993 109.636 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 13.5 p -136.76 138.75 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.461 -0.774 . . . . 62.340000000000003 109.072 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -93.86 140.92 29.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.255 -0.903 . . . . 61.229999999999997 109.543 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.02 154.01 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.303 -0.873 . . . . 74.439999999999998 109.322 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -171.08 43.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.116 -0.99 . . . . 75.420000000000002 109.899 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -164.03 -110.53 0.24 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.555 -1.418 . . . . 73.340000000000003 109.555 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.622 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 23.2 mmtp -73.29 -35.54 2.76 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.255 -1.144 . . . . 72.219999999999999 110.479 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 95.3 Cg_endo -91.4 21.96 0.74 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.464 2.109 . . . . 75.450000000000003 112.011 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -129.33 -55.54 1.17 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.56 -0.713 . . . . 65.239999999999995 109.748 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -58.61 -58.09 10.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.161 -0.962 . . . . 72.519999999999996 110.552 -178.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.6 -33.27 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.954 -1.091 . . . . 74.209999999999994 109.672 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.12 -41.68 99.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.062 -1.024 . . . . 73.310000000000002 108.676 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.409 ' H ' ' HG1' ' A' ' 153' ' ' THR . 16.6 p -74.5 -32.18 62.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.252 -0.905 . . . . 74.310000000000002 109.943 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -58.16 -50.87 72.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.172 -0.955 . . . . 75.450000000000003 109.61 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.7 pp -76.08 -26.09 56.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 75.340000000000003 109.791 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.58 -45.98 77.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 62.140000000000001 109.325 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -76.59 -44.24 35.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.195 -0.941 . . . . 72.219999999999999 108.936 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -82.41 26.43 0.56 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.514 -0.741 . . . . 74.120000000000005 109.244 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -49.66 -29.93 8.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.377 -0.827 . . . . 74.340000000000003 109.855 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 42.9 p30 -123.9 74.84 1.31 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.534 -0.728 . . . . 75.450000000000003 109.198 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 162' ' ' ILE . 13.8 tm0? -171.21 152.77 3.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.9 . . . . 73.409999999999997 109.517 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.511 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 71.4 mt -83.63 122.15 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.172 -0.955 . . . . 74.409999999999997 109.439 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.5 t -112.59 137.82 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.534 -0.729 . . . . 72.530000000000001 109.761 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 29.6 t -94.78 155.79 16.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.358 -0.839 . . . . 74.120000000000005 109.453 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.467 ' CB ' ' NZ ' ' A' ' 165' ' ' LYS . 8.7 mtpm? -56.92 -43.48 81.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 70.430000000000007 109.64 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -55.24 -37.14 66.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.923 . . . . 74.319999999999993 109.446 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -59.57 -41.91 91.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -0.939 . . . . 74.519999999999996 109.444 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 26.3 mt -63.65 -33.17 75.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.2 -0.938 . . . . 74.409999999999997 109.315 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 5.6 tt -64.71 -55.61 18.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.298 -0.876 . . . . 75.140000000000001 109.589 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -71.63 -32.6 68.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.256 -0.902 . . . . 65.030000000000001 110.295 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.52 -47.8 82.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.049 -1.032 . . . . 70.209999999999994 110.036 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.481 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 1.9 mp -96.96 -65.17 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.2 -0.938 . . . . 75.319999999999993 108.85 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.422 -0.799 . . . . 73.140000000000001 109.394 -179.892 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 49.2 p-10 . . . . . 0 N--CA 1.497 1.88 0 N-CA-C 109.765 -0.457 . . . . 73.129999999999995 109.765 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.46 -4.18 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.38 -0.825 . . . . 74.019999999999996 109.759 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.455 ' N ' ' CD1' ' A' ' 184' ' ' ILE . 1.9 mp -66.33 -29.35 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.949 -1.095 . . . . 72.329999999999998 109.141 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -61.7 -42.83 99.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 74.400000000000006 109.611 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 19.0 m -79.54 -28.49 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.09 -1.006 . . . . 74.319999999999993 109.379 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.51 -42.17 65.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.864 . . . . 73.230000000000004 109.795 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.5 tp -74.94 -29.95 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.986 -1.071 . . . . 74.310000000000002 109.314 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -70.64 -43.94 68.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.845 . . . . 73.439999999999998 110.099 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -75.56 -40.9 56.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.131 -0.981 . . . . 71.420000000000002 110.135 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 74.9 mt -60.47 -36.49 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.014 -1.054 . . . . 72.439999999999998 109.561 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 18.9 mtp-105 -71.38 -40.16 70.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.035 -1.041 . . . . 64.219999999999999 108.656 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.461 HE21 ' HZ2' ' A' ' 197' ' ' LYS . 49.4 tt0 -68.05 -35.2 77.84 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.577 -0.702 . . . . 74.319999999999993 109.133 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.411 ' O ' ' CD ' ' A' ' 198' ' ' PRO . 50.7 mtpt -85.19 -8.31 58.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.349 -0.844 . . . . 75.310000000000002 109.737 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 51.1 ttm -92.84 -57.21 2.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.185 -0.947 . . . . 74.019999999999996 109.559 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -59.12 -32.48 69.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 74.019999999999996 110.011 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.461 ' HZ2' HE21 ' A' ' 193' ' ' GLN . 54.1 mttt -57.13 -65.64 1.64 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.035 -1.041 . . . . 75.430000000000007 109.847 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 42.4 Cg_endo -64.77 -57.99 0.25 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 122.306 2.004 . . . . 72.319999999999993 112.546 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 15.3 mt -61.15 -42.75 99.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -0.958 . . . . 74.540000000000006 109.963 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 86.62 -37.63 3.15 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.78 -1.328 . . . . 61.509999999999998 109.78 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.557 ' N ' ' CD1' ' A' ' 201' ' ' ILE . 1.7 mp -92.41 141.53 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.132 -1.217 . . . . 74.25 109.371 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 59.5 p -85.55 145.23 27.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.888 . . . . 72.0 109.274 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.1 p -146.59 27.25 1.11 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.253 -0.904 . . . . 74.439999999999998 109.485 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 29.5 m -143.97 134.21 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.169 -0.957 . . . . 71.129999999999995 109.518 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -108.58 126.16 52.64 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.536 -0.727 . . . . 73.510000000000005 109.296 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.35 119.69 32.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.116 -0.99 . . . . 73.519999999999996 109.226 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 211' ' ' GLY . 34.9 m -147.82 140.74 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.224 -0.922 . . . . 72.150000000000006 109.616 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 75.1 ttt-85 -62.62 -25.51 68.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.85 . . . . 72.400000000000006 109.373 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 211' ' ' GLY . 76.1 mtt85 -47.17 103.92 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 73.310000000000002 109.786 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 60.51 -75.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.591 -0.693 . . . . 71.540000000000006 109.844 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . -158.41 -127.77 0.96 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.838 -1.305 . . . . 74.450000000000003 109.838 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -101.53 142.21 33.24 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.407 -1.054 . . . . 75.540000000000006 109.436 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -106.43 126.57 52.41 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.478 -0.764 . . . . 75.310000000000002 109.686 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -98.04 128.36 44.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.389 -0.82 . . . . 75.409999999999997 109.034 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 34.0 m -151.78 154.94 37.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.498 -0.751 . . . . 74.140000000000001 109.137 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . 0.45 ' O ' ' O ' ' A' ' 217' ' ' PRO . 7.4 p90 -65.14 153.14 89.95 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.153 -0.967 . . . . 75.319999999999993 109.279 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 216' ' ' TYR . 84.2 Cg_exo . . . . . 0 N--CA 1.493 1.479 0 C-N-CA 122.269 1.979 . . . . 73.109999999999999 112.408 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 52.5 ttm . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.487 -0.56 . . . . 75.239999999999995 109.487 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -139.87 148.78 42.56 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.303 -0.873 . . . . 73.519999999999996 109.354 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 93.6 t -113.91 137.71 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.583 -0.698 . . . . 72.239999999999995 109.452 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 3.5 tp -109.89 119.66 40.04 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.555 -0.716 . . . . 73.340000000000003 109.735 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 15.3 mt -117.23 96.33 5.38 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 108.615 -0.883 . . . . 74.349999999999994 108.615 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 87.2 mt -82.93 98.88 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.703 -1.248 . . . . 63.439999999999998 109.049 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.425 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 38.8 tp10 -130.78 129.72 42.8 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.506 -0.746 . . . . 74.519999999999996 109.556 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -64.96 -38.96 92.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.314 -0.866 . . . . 74.129999999999995 109.332 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -83.8 116.63 22.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 74.230000000000004 109.471 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 23.4 m -66.73 -27.01 67.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.9 . . . . 65.540000000000006 109.795 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -66.99 -51.56 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.15 -0.969 . . . . 75.549999999999997 109.844 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.501 ' N ' ' CD1' ' B' ' 12' ' ' LEU . 7.9 mp -62.96 -39.07 93.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.172 -0.955 . . . . 70.140000000000001 109.62 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.05 -29.34 64.9 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 108.551 -1.82 . . . . 75.400000000000006 108.551 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.91 -49.84 68.9 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.674 -1.37 . . . . 65.439999999999998 109.674 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -61.96 -46.98 86.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.309 -1.112 . . . . 72.200000000000003 109.786 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 5.7 mm -63.98 -40.14 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.757 -1.214 . . . . 75.150000000000006 108.632 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.505 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 73.1 tt0 -63.07 -44.27 96.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.412 -0.805 . . . . 73.010000000000005 109.554 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -85.53 1.55 48.49 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.071 -1.018 . . . . 74.299999999999997 109.588 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.93 -57.3 1.94 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.376 -1.49 . . . . 70.540000000000006 109.376 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -71.31 -20.85 62.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.424 -1.044 . . . . 75.430000000000007 109.648 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 89.6 m-20 -57.98 -30.81 66.33 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.992 -1.067 . . . . 73.200000000000003 109.278 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 92.9 t -59.05 -37.3 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.344 -0.847 . . . . 74.230000000000004 109.142 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -65.52 -21.4 66.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.371 -0.83 . . . . 73.519999999999996 109.398 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.32 39.87 2.52 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 110.11 -1.196 . . . . 53.43 110.11 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -120.2 160.98 21.85 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.474 -1.015 . . . . 71.120000000000005 109.208 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 3.8 mtt -100.45 139.84 35.56 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.262 -1.014 . . . . 75.239999999999995 108.262 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . 0.43 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -143.95 154.45 43.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.225 -0.922 . . . . 73.25 110.37 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 96.9 m-20 -138.87 155.01 48.44 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.173 -1.047 . . . . 72.310000000000002 108.173 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.43 139.74 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.338 -0.851 . . . . 72.140000000000001 109.985 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.5 p -130.47 171.08 13.38 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 109.144 -0.687 . . . . 74.530000000000001 109.144 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.42 ' OE2' ' OD2' ' B' ' 35' ' ' ASP . 5.4 pt-20 -91.69 -106.11 0.1 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.178 -0.951 . . . . 71.019999999999996 109.873 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 77.7 p -78.11 166.94 22.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.223 -0.923 . . . . 71.400000000000006 110.073 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 53.5 mt -51.34 -30.86 19.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.586 -0.696 . . . . 71.239999999999995 109.945 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.87 -51.01 65.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.092 -1.005 . . . . 74.319999999999993 109.885 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.42 ' OD2' ' OE2' ' B' ' 31' ' ' GLU . 2.3 m-20 -63.58 -39.44 94.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.121 -0.987 . . . . 73.030000000000001 109.264 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.81 -38.4 76.15 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.253 -1.539 . . . . 60.43 109.253 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -67.18 -38.36 85.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -1.113 . . . . 74.430000000000007 109.573 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -80.52 -36.93 32.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.155 -0.965 . . . . 74.420000000000002 109.661 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 10.5 tp -71.29 -42.67 68.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 75.409999999999997 110.091 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.443 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.3 ppp? -67.54 -25.26 65.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.039 -1.038 . . . . 61.439999999999998 109.977 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -60.62 -39.84 89.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.046 -1.034 . . . . 74.319999999999993 110.161 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 14.7 pt -81.21 -32.01 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.006 -1.059 . . . . 71.230000000000004 110.202 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' B' ' 40' ' ' MET . 25.2 mmt180 -130.28 141.52 50.6 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.297 -0.877 . . . . 73.409999999999997 109.548 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -98.48 132.71 43.7 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.28 -0.887 . . . . 63.539999999999999 109.437 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -102.37 138.28 39.51 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.353 -0.842 . . . . 73.109999999999999 109.513 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -75.82 -34.5 60.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 62.219999999999999 109.189 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.408 ' C ' ' CD1' ' B' ' 47' ' ' LEU . 0.8 OUTLIER -112.38 110.59 20.89 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.645 -0.872 . . . . 73.120000000000005 108.645 179.662 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 54.5 t -95.52 100.85 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.369 -0.832 . . . . 74.109999999999999 109.124 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' MET . . . . . 0.509 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 0.6 OUTLIER -114.93 129.54 56.73 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.2 -0.667 . . . . 73.439999999999998 109.2 -179.659 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.477 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.6 OUTLIER -144.69 132.29 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.457 -0.777 . . . . 73.400000000000006 109.233 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' SER . . . . . 0.425 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 24.9 p -94.57 11.57 30.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.392 -0.818 . . . . 73.209999999999994 109.662 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.477 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 35.9 m-20 -80.61 138.65 36.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.147 -0.971 . . . . 70.409999999999997 109.515 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.479 ' C ' ' H ' ' B' ' 55' ' ' ALA . 62.3 mttp -74.92 -38.53 61.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.206 -0.934 . . . . 73.129999999999995 110.029 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -71.03 9.9 0.64 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.171 -0.955 . . . . 75.209999999999994 109.619 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -66.4 -21.77 66.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 55.329999999999998 110.134 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 33.3 mt -42.82 -40.16 2.77 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.397 -0.814 . . . . 72.420000000000002 110.33 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 13.0 t -76.32 -39.97 52.64 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.946 -1.096 . . . . 73.040000000000006 109.563 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -65.1 -43.14 93.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.332 -0.855 . . . . 72.329999999999998 110.307 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.37 -37.62 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.697 -1.252 . . . . 74.540000000000006 109.509 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 40.4 m -55.24 -48.66 73.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 71.239999999999995 109.439 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -69.57 -34.41 74.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.115 -0.99 . . . . 74.310000000000002 110.134 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' B' ' 66' ' ' HIS . 5.4 mm -64.52 -40.33 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.785 -1.197 . . . . 75.420000000000002 109.8 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.521 ' NZ ' ' OD1' ' B' ' 92' ' ' ASP . 44.4 mmtt -65.44 -48.81 71.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.157 -0.964 . . . . 73.319999999999993 110.459 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -73.01 -37.54 66.92 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.841 -1.162 . . . . 73.310000000000002 110.035 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.47 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 46.4 mtpt -80.22 -22.04 42.22 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.11 -0.994 . . . . 72.439999999999998 109.757 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . 0.47 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 81.6 m-70 -155.68 65.92 0.61 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.136 -0.977 . . . . 65.209999999999994 109.623 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 9.7 t -60.44 -27.78 67.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 73.099999999999994 109.793 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 84.4 p -65.27 -24.82 67.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -0.92 . . . . 71.530000000000001 110.169 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 79.9 mt -79.81 152.89 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.103 -0.998 . . . . 74.400000000000006 109.677 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 69.4 t -92.44 159.44 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.287 -0.883 . . . . 75.120000000000005 109.468 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 11.7 t -137.96 120.92 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.184 -0.947 . . . . 73.200000000000003 109.877 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . 0.509 ' O ' ' SD ' ' B' ' 49' ' ' MET . 0.7 OUTLIER -111.04 105.12 13.77 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.16 -1.052 . . . . 73.340000000000003 108.16 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 94.6 t -95.68 131.9 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.107 -0.996 . . . . 73.5 109.535 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.08 162.38 13.42 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.434 -0.791 . . . . 71.319999999999993 109.103 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.473 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 25.1 p -153.92 136.64 15.24 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.96 -1.087 . . . . 74.530000000000001 110.646 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -90.43 4.42 51.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.372 -0.83 . . . . 64.5 109.119 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' B' ' 79' ' ' THR . 65.5 m-80 -142.31 68.5 21.52 Favored Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 108.663 -0.865 . . . . 74.25 108.663 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -54.71 79.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.347 2.031 . . . . 74.430000000000007 111.235 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.503 ' N ' ' O ' ' B' ' 77' ' ' ASN . 37.2 p -103.28 152.49 21.46 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.053 -0.721 . . . . 73.120000000000005 109.053 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -31.4 71.42 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.262 -0.899 . . . . 75.409999999999997 109.387 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -63.34 -48.24 78.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 72.239999999999995 109.493 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . 0.511 ' CD ' ' HH ' ' B' ' 94' ' ' TYR . 82.6 tt0 -71.7 -27.11 62.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 73.219999999999999 109.372 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.527 ' OE2' ' NE ' ' A' ' 108' ' ' ARG . 86.9 tt0 -63.03 -55.6 24.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.883 . . . . 74.299999999999997 109.887 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 22.9 m -61.93 -40.29 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.058 -1.026 . . . . 73.310000000000002 109.423 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -64.71 -31.69 73.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.166 -0.959 . . . . 73.239999999999995 109.483 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.48 -45.87 81.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.918 . . . . 55.329999999999998 110.256 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -79.87 -34.51 39.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.031 -1.043 . . . . 74.450000000000003 109.433 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -70.78 -40.33 72.66 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.248 -0.908 . . . . 64.040000000000006 109.57 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -65.12 -52.16 57.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -0.965 . . . . 75.129999999999995 109.412 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.24 59.43 0.02 OUTLIER Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.188 -1.165 . . . . 75.420000000000002 110.188 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.88 136.18 53.62 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.435 -1.039 . . . . 73.420000000000002 109.075 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . 0.521 ' OD1' ' NZ ' ' B' ' 63' ' ' LYS . 24.6 m-20 -82.16 -20.8 37.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.09 -1.006 . . . . 73.319999999999993 109.525 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -153.3 164.6 37.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 73.040000000000006 109.655 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.511 ' HH ' ' CD ' ' B' ' 82' ' ' GLU . 76.1 t80 -145.14 97.26 2.98 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.745 -0.835 . . . . 74.310000000000002 108.745 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 19.0 mm -104.73 142.01 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 121.163 -0.961 . . . . 75.340000000000003 109.928 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' B' ' 97' ' ' LYS . . . -60.74 124.29 19.99 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.467 -1.308 . . . . 70.099999999999994 107.467 178.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' B' ' 99' ' ' TYR . 2.1 tptt -43.35 -61.04 2.03 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.058 -1.026 . . . . 65.430000000000007 110.726 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 9.3 Cg_endo -45.02 89.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 120.566 0.844 . . . . 63.520000000000003 110.489 -176.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . 0.582 ' N ' ' O ' ' B' ' 97' ' ' LYS . 45.4 m-85 -39.75 97.76 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.229 0.537 . . . . 75.129999999999995 111.128 -176.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -53.27 -33.43 53.11 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.521 -1.288 . . . . 74.230000000000004 107.521 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 32.5 t -176.18 128.03 0.21 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.274 -1.01 . . . . 64.510000000000005 108.274 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . 0.411 HG22 HD12 ' B' ' 102' ' ' ILE . 19.6 mm -51.68 -36.22 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.017 -1.052 . . . . 74.439999999999998 108.903 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . 0.413 ' N ' ' CD ' ' B' ' 103' ' ' LYS . 11.8 mptt -67.23 -34.47 77.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.358 -0.839 . . . . 72.299999999999997 109.407 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.53 -58.72 3.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.241 -0.912 . . . . 74.310000000000002 109.771 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.443 ' C ' ' CD1' ' B' ' 105' ' ' LEU . 1.9 tm? -54.46 -53.33 55.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 73.540000000000006 109.275 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 88.3 t -61.62 -42.47 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.987 -1.071 . . . . 72.030000000000001 109.37 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.82 -38.28 55.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.137 -0.977 . . . . 64.219999999999999 108.907 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -70.25 -34.7 73.14 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.354 -0.841 . . . . 75.310000000000002 109.441 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 86.3 mt -75.93 -26.59 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.14 -0.975 . . . . 55.439999999999998 108.788 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -76.6 -57.78 3.66 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.458 -0.776 . . . . 65.310000000000002 109.618 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.51 -44.84 73.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 74.519999999999996 109.961 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -59.83 4.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.113 -0.992 . . . . 72.040000000000006 109.646 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 30.4 tp -60.61 -35.52 76.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.11 -0.994 . . . . 75.349999999999994 109.763 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.45 ' O ' ' CB ' ' B' ' 115' ' ' PHE . 14.1 mmt180 -53.62 160.3 1.33 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.073 -1.017 . . . . 75.5 109.252 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 115' ' ' PHE . . . . . 0.45 ' CB ' ' O ' ' B' ' 114' ' ' ARG . 4.9 t80 75.6 -4.15 2.43 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.519 -0.738 . . . . 73.040000000000006 109.535 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER 54.26 -171.76 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 74.450000000000003 109.773 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -92.92 5.1 75.9 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.487 -1.445 . . . . 64.209999999999994 109.487 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 11.8 t 49.57 -174.33 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.492 -1.005 . . . . 71.400000000000006 109.854 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.73 141.74 23.0 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.424 -0.797 . . . . 74.209999999999994 109.336 -178.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 23.8 t -86.87 -44.11 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.187 -0.945 . . . . 75.019999999999996 109.854 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 3.6 mm -117.5 154.37 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.238 -0.914 . . . . 74.239999999999995 109.434 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -143.62 130.85 20.8 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.325 -0.859 . . . . 73.329999999999998 109.049 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 17.8 mt -135.47 108.33 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.18 -0.95 . . . . 74.219999999999999 109.896 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' B' ' 126' ' ' LEU . . . 56.02 -155.41 12.58 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.229 -1.148 . . . . 72.409999999999997 110.229 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.99 -0.56 0.52 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.477 -1.013 . . . . 75.120000000000005 109.644 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.498 ' H ' ' C ' ' B' ' 124' ' ' GLY . 1.7 mt -94.22 148.6 22.04 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.237 -0.914 . . . . 75.420000000000002 109.405 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 7.0 m -126.33 132.33 51.64 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.109 -1.071 . . . . 74.219999999999999 108.109 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 88.8 mt -121.05 131.03 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.348 -0.845 . . . . 60.329999999999998 110.69 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 64.9 m -128.86 101.84 19.86 Favored Pre-proline 0 N--CA 1.495 1.824 0 N-CA-C 108.858 -0.793 . . . . 72.310000000000002 108.858 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -81.87 -40.32 0.15 Allowed 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.092 1.862 . . . . 75.129999999999995 111.918 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -52.97 -33.4 51.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.132 -0.98 . . . . 75.230000000000004 108.881 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -104.39 4.02 32.94 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.504 -0.747 . . . . 75.120000000000005 109.499 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . 0.433 ' OE1' ' CD2' ' B' ' 149' ' ' PHE . 49.0 mm-40 49.77 59.58 4.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.124 -0.985 . . . . 75.129999999999995 109.3 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -151.51 145.46 25.2 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.223 -0.923 . . . . 75.109999999999999 109.726 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . 0.412 HG22 ' HH ' ' B' ' 137' ' ' TYR . 4.5 mp -137.81 133.49 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 108.782 -0.821 . . . . 70.319999999999993 108.782 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 4.7 mm -107.18 137.1 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.533 -0.73 . . . . 74.120000000000005 109.606 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . 0.412 ' HH ' HG22 ' B' ' 135' ' ' ILE . 28.8 m-85 -126.04 130.97 52.2 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.181 -1.044 . . . . 74.230000000000004 108.181 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . 0.611 ' NZ ' ' HE ' ' B' ' 140' ' ' ARG . 23.3 ttpp 55.36 14.92 1.21 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.499 -0.751 . . . . 74.219999999999999 109.762 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.91 -0.11 66.74 Favored Glycine 0 N--CA 1.496 2.684 0 O-C-N 120.927 -1.108 . . . . 74.319999999999993 110.505 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . 0.611 ' HE ' ' NZ ' ' B' ' 138' ' ' LYS . 17.5 mtt-85 -89.94 137.27 32.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.208 -1.172 . . . . 75.340000000000003 108.449 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -82.94 126.98 33.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 71.230000000000004 110.419 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 39.9 t -126.81 128.81 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.912 -0.773 . . . . 70.430000000000007 108.912 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -94.2 147.28 23.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.978 -1.076 . . . . 72.430000000000007 109.228 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 144' ' ' VAL . . . . . 0.667 ' H ' ' NZ ' ' B' ' 145' ' ' LYS . 2.4 t -142.16 115.41 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.217 -0.927 . . . . 72.129999999999995 108.95 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . 0.667 ' NZ ' ' H ' ' B' ' 144' ' ' VAL . 0.1 OUTLIER -145.28 140.17 27.62 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.278 -0.888 . . . . 74.5 109.742 179.886 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 111.54 -114.39 3.62 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 110.666 -0.973 . . . . 42.229999999999997 110.666 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . 0.615 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 6.6 ttpm? -95.34 -29.82 0.27 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.57 -0.959 . . . . 73.299999999999997 112.42 -178.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 57.0 Cg_endo -80.47 -17.78 9.92 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 C-N-CA 121.482 1.455 . . . . 71.329999999999998 113.0 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . 0.433 ' CD2' ' OE1' ' B' ' 133' ' ' GLU . 1.1 p90 -85.54 -37.85 19.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.93 -1.107 . . . . 74.230000000000004 109.215 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . 0.426 ' N ' ' CG ' ' B' ' 149' ' ' PHE . 3.3 tm-20 -60.34 -46.7 88.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.533 -0.729 . . . . 72.340000000000003 109.974 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.89 -40.65 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.864 -1.148 . . . . 73.349999999999994 110.102 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 4.7 tt -66.65 -54.91 18.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.296 -0.877 . . . . 74.430000000000007 109.679 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 153' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' B' ' 149' ' ' PHE . 16.0 p -64.76 -32.44 74.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.004 -1.06 . . . . 75.209999999999994 110.555 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -59.2 -59.58 5.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.947 -1.095 . . . . 73.040000000000006 109.927 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . 0.829 HD13 ' CE2' ' B' ' 214' ' ' PHE . 1.9 pp -69.3 -21.48 63.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.028 -1.045 . . . . 73.430000000000007 109.946 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.89 -52.98 61.9 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.014 -1.054 . . . . 75.319999999999993 109.334 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . 0.496 ' C ' ' H ' ' B' ' 159' ' ' ARG . 16.5 mtm-85 -71.95 -51.62 21.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.18 -0.95 . . . . 73.319999999999993 109.79 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -74.79 36.19 0.11 Allowed 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.725 -0.79 . . . . 74.140000000000001 109.506 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . 0.496 ' H ' ' C ' ' B' ' 157' ' ' ARG . 30.2 ptt180 -59.91 166.05 2.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -0.86 . . . . 73.420000000000002 109.179 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 24.9 t70 43.66 64.24 1.32 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.253 -0.904 . . . . 72.099999999999994 109.88 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -157.3 159.21 37.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -0.965 . . . . 73.239999999999995 109.567 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 30.6 mt -93.77 114.02 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.218 -0.926 . . . . 72.310000000000002 109.139 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 4.0 m -115.13 129.78 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 121.527 0.679 . . . . 75.030000000000001 109.511 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 164' ' ' SER . . . . . 0.516 ' OG ' ' NE2' ' B' ' 167' ' ' GLN . 28.7 p -92.39 167.31 12.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -0.871 . . . . 74.219999999999999 109.125 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -51.69 -37.07 49.12 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.111 -0.993 . . . . 72.420000000000002 109.297 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -74.57 -25.46 59.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.146 -0.971 . . . . 63.450000000000003 110.559 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 167' ' ' GLN . . . . . 0.516 ' NE2' ' OG ' ' B' ' 164' ' ' SER . 0.0 OUTLIER -64.04 -56.14 17.17 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.618 -1.301 . . . . 72.400000000000006 108.792 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 47.1 mt -57.42 -57.21 13.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.102 -0.999 . . . . 72.319999999999993 108.916 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' B' ' 170' ' ' ASP . 1.9 mm? -50.55 -56.01 13.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.045 -1.034 . . . . 73.340000000000003 108.846 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' B' ' 169' ' ' LEU . 67.8 m-20 -41.69 -34.16 0.58 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.74 -0.6 . . . . 73.099999999999994 110.615 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -91.69 -37.72 12.86 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.102 -0.999 . . . . 62.130000000000003 110.729 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 3.7 mp -88.09 -68.41 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.893 -1.129 . . . . 74.439999999999998 109.442 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 173' ' ' TRP . . . . . 0.476 ' C ' ' CD2' ' B' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.505 -0.747 . . . . 72.230000000000004 109.47 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo . . . . . 0 N--CA 1.491 1.371 0 CA-C-O 121.15 0.396 . . . . 74.340000000000003 111.874 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 182' ' ' ASN . . . . . 0.813 ' OD1' ' OE2' ' B' ' 185' ' ' GLU . 45.5 t-20 49.33 60.9 3.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.136 -0.978 . . . . 72.310000000000002 110.006 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 4.1 p -119.09 4.65 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 108.994 -0.743 . . . . 65.420000000000002 108.994 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 35.2 mt -63.62 -53.53 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.058 -1.026 . . . . 75.030000000000001 109.914 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . 0.813 ' OE2' ' OD1' ' B' ' 182' ' ' ASN . 1.5 pm0 -61.5 -40.43 94.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 73.519999999999996 110.313 -178.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 97.2 t -73.99 -48.03 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.995 -1.066 . . . . 74.349999999999994 110.404 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -68.91 -47.27 66.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.059 -1.026 . . . . 61.119999999999997 110.704 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 7.5 tt -70.0 -36.6 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.741 -1.224 . . . . 72.430000000000007 110.917 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -65.42 -47.61 75.65 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.945 -1.097 . . . . 75.420000000000002 109.144 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 190' ' ' GLN . . . . . 0.761 ' HB3' ' HZ1' ' B' ' 194' ' ' LYS . 35.9 mm-40 -66.58 -46.29 76.46 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.229 -0.92 . . . . 74.140000000000001 110.023 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 65.1 mt -54.45 -42.0 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.825 -1.172 . . . . 74.030000000000001 109.684 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 24.1 mtp180 -59.94 -45.52 92.36 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.236 -0.915 . . . . 72.329999999999998 109.922 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -75.44 -32.86 60.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.223 -0.923 . . . . 73.099999999999994 110.159 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . 0.761 ' HZ1' ' HB3' ' B' ' 190' ' ' GLN . 39.1 mttp -71.84 -24.52 61.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.347 -0.846 . . . . 74.430000000000007 110.002 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 11.2 mtt -94.84 -12.14 27.53 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.036 -1.04 . . . . 74.329999999999998 109.473 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -102.03 -7.12 22.61 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.328 -0.857 . . . . 71.209999999999994 110.522 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . 0.457 ' N ' ' CD ' ' B' ' 198' ' ' PRO . 1.3 mmtt -95.77 -49.44 0.25 Allowed Pre-proline 0 N--CA 1.501 2.125 0 O-C-N 120.784 -1.198 . . . . 75.209999999999994 110.351 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 198' ' ' PRO . . . . . 0.509 ' CD ' ' O ' ' B' ' 194' ' ' LYS . 89.0 Cg_endo -83.97 -38.53 0.13 Allowed 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.279 1.986 . . . . 75.319999999999993 113.672 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 11.2 mt -75.73 -46.42 31.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.836 -1.165 . . . . 72.25 109.648 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 88.15 0.78 82.6 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.663 -1.775 . . . . 73.239999999999995 108.663 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 38.4 mt -125.53 125.62 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.583 -0.951 . . . . 54.299999999999997 109.296 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 27.3 p -85.78 137.16 32.99 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.836 -1.172 . . . . 74.310000000000002 107.836 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 67.7 p -137.98 11.73 2.86 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.109 -0.994 . . . . 74.400000000000006 110.125 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.46 128.37 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.304 -0.873 . . . . 74.099999999999994 109.407 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . 0.41 ' OE2' ' SG ' ' B' ' 215' ' ' CYS . 80.9 mt-10 -90.85 109.41 20.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.465 -0.772 . . . . 75.329999999999998 108.922 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 43.9 p -85.35 126.44 33.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.445 -0.784 . . . . 71.400000000000006 109.074 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 9.9 p -152.5 159.85 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.13 -0.982 . . . . 63.5 109.675 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -85.28 -38.97 18.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.154 -0.966 . . . . 74.450000000000003 109.914 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 209' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' B' ' 211' ' ' GLY . 80.5 mtm180 -55.85 150.69 12.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.021 -1.05 . . . . 74.140000000000001 109.512 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? 51.59 -90.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.215 -0.928 . . . . 74.430000000000007 108.805 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 211' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' B' ' 209' ' ' ARG . . . -171.79 -108.51 0.21 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.801 -1.719 . . . . 70.109999999999999 108.801 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -119.17 140.56 49.97 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.578 -0.954 . . . . 74.209999999999994 108.759 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -124.36 126.19 45.56 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.58 0.705 . . . . 74.299999999999997 110.106 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . 0.829 ' CE2' HD13 ' B' ' 155' ' ' LEU . 24.3 t80 -92.11 133.18 36.0 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.854 -0.795 . . . . 74.340000000000003 108.854 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . 0.41 ' SG ' ' OE2' ' B' ' 205' ' ' GLU . 2.6 p -147.1 166.34 27.2 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.987 -1.071 . . . . 72.209999999999994 109.706 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -72.44 151.23 91.8 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.222 -0.924 . . . . 72.310000000000002 108.654 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.07 160.92 46.57 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.157 1.905 . . . . 71.010000000000005 111.718 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 22.0 mttm . . . . . 0 C--N 1.303 -1.445 0 O-C-N 121.276 -0.89 . . . . 74.349999999999994 109.335 179.955 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptp . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.451 -0.574 . . . . 65.120000000000005 109.451 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -141.68 160.18 40.7 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.299 -0.875 . . . . 73.310000000000002 109.453 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.4 t -118.34 125.35 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.169 -0.678 . . . . 71.420000000000002 109.169 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.405 ' O ' ' O ' ' A' ' 49' ' ' MET . 4.8 tp -99.31 115.1 28.39 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.497 -0.752 . . . . 65.219999999999999 109.212 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.0 tp -119.68 110.08 16.4 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.337 -0.986 . . . . 71.439999999999998 108.337 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.435 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 16.9 mt -92.73 109.18 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.899 -1.125 . . . . 71.150000000000006 109.595 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -152.54 120.09 6.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.166 -0.959 . . . . 75.340000000000003 109.673 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -65.16 -38.46 90.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 73.040000000000006 109.451 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -67.66 106.16 2.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 72.420000000000002 109.567 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 91.0 p -66.64 -26.33 67.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.316 -0.865 . . . . 72.340000000000003 109.551 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.64 -53.68 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.158 -0.964 . . . . 74.420000000000002 109.691 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.495 ' N ' ' CD1' ' A' ' 12' ' ' LEU . 7.9 mp -65.18 -36.45 84.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 72.010000000000005 109.552 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.92 -27.49 64.49 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.54 -1.824 . . . . 72.140000000000001 108.54 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.04 -49.72 61.09 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.441 -1.464 . . . . 72.329999999999998 109.441 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -61.59 -44.86 96.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -1.138 . . . . 72.340000000000003 109.55 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.5 mm -63.64 -39.08 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.743 -1.223 . . . . 74.239999999999995 108.281 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -64.42 -52.12 59.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.499 -0.75 . . . . 71.409999999999997 109.975 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -77.72 -2.77 37.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 75.540000000000006 109.566 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.42 -49.94 3.99 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 108.989 -1.644 . . . . 62.149999999999999 108.989 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pp -75.7 -28.96 58.83 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.433 -1.039 . . . . 74.420000000000002 109.234 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -51.65 -34.32 37.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.202 -0.936 . . . . 74.25 108.815 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.0 t -54.76 -47.38 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.523 -0.917 . . . . 72.109999999999999 108.523 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -54.35 -54.81 35.44 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.23 -1.026 . . . . 73.230000000000004 108.23 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 130.74 40.42 0.24 Allowed Glycine 0 N--CA 1.499 2.847 0 N-CA-C 110.636 -0.986 . . . . 75.540000000000006 110.636 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -118.91 159.67 23.37 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.19 -1.183 . . . . 74.510000000000005 108.694 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 11.7 mmt -97.65 138.35 35.18 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.211 -1.033 . . . . 64.319999999999993 108.211 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.95 160.12 40.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 74.310000000000002 109.784 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -142.03 151.55 42.53 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.781 -0.822 . . . . 75.400000000000006 108.781 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 t -106.03 134.7 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.706 -0.85 . . . . 75.129999999999995 108.706 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.3 p -129.7 163.46 26.09 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.517 -0.739 . . . . 71.420000000000002 109.356 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.435 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 2.8 pt-20 -92.22 -97.46 0.13 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.317 -0.865 . . . . 73.109999999999999 109.69 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.3 p -78.26 166.38 22.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 74.239999999999995 110.071 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.4 mt -55.02 -38.06 67.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.601 -0.687 . . . . 71.530000000000001 110.028 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -53.47 -43.22 67.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.168 -0.957 . . . . 74.230000000000004 110.061 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -63.92 -37.7 88.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.026 -1.046 . . . . 71.010000000000005 109.595 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.24 -45.72 11.09 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.914 -1.274 . . . . 61.409999999999997 109.914 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -61.82 -36.88 82.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -1.137 . . . . 74.340000000000003 109.88 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.443 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 64.6 t80 -80.07 -26.21 39.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.901 . . . . 75.329999999999998 110.249 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.8 tp -86.63 -32.57 20.51 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.031 -1.043 . . . . 74.329999999999998 110.223 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.5 ' SD ' ' OH ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -83.16 -34.12 26.07 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.088 -1.008 . . . . 70.319999999999993 110.79 -178.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 35.2 p-10 -57.7 -30.43 65.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.035 -1.041 . . . . 71.219999999999999 110.529 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.53 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 7.9 pt -85.03 -38.22 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.864 -1.148 . . . . 74.409999999999997 110.485 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.436 ' O ' ' O ' ' A' ' 40' ' ' MET . 97.8 mtt180 -101.52 162.58 12.79 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.105 -0.997 . . . . 75.409999999999997 110.046 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -92.39 144.51 25.3 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.336 -0.853 . . . . 75.420000000000002 108.992 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.558 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 3.5 p90 -142.13 179.94 6.61 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.151 -0.968 . . . . 74.230000000000004 109.732 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -143.16 -32.39 0.47 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.321 -0.862 . . . . 75.319999999999993 109.767 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.24 113.31 26.32 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.345 -0.847 . . . . 72.129999999999995 109.086 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.0 t -101.27 99.54 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.797 -0.816 . . . . 72.340000000000003 108.797 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.405 ' O ' ' O ' ' A' ' 4' ' ' LEU . 26.5 ttt -114.55 132.24 56.39 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.561 0.696 . . . . 74.109999999999999 109.567 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -142.12 136.05 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.382 -0.824 . . . . 71.239999999999995 109.69 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.8 t -102.06 1.25 36.2 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.478 -0.764 . . . . 73.109999999999999 109.772 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -76.07 145.99 39.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.103 -0.998 . . . . 63.399999999999999 109.713 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.441 ' C ' ' H ' ' A' ' 55' ' ' ALA . 29.2 mmtp -78.01 -46.46 20.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.25 -0.906 . . . . 65.439999999999998 110.204 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -59.98 -4.63 0.79 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.154 -0.966 . . . . 73.129999999999995 109.908 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.441 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -62.92 -23.01 67.17 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.226 -0.921 . . . . 64.140000000000001 110.139 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 55' ' ' ALA . 14.5 mt -39.98 -54.56 2.19 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.603 -0.686 . . . . 74.430000000000007 110.71 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.6 p -68.39 -31.83 71.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.734 -1.229 . . . . 63.229999999999997 109.254 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.406 ' N ' ' O ' ' A' ' 55' ' ' ALA . 66.5 t80 -65.74 -46.99 76.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.395 -0.816 . . . . 74.439999999999998 110.242 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.8 m -63.06 -35.09 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.706 -1.246 . . . . 74.030000000000001 109.467 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 60.8 m -57.09 -51.33 69.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.18 -0.95 . . . . 73.540000000000006 109.419 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -67.64 -34.48 77.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.125 -0.984 . . . . 73.340000000000003 110.019 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.8 mm -63.32 -28.46 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.839 -1.163 . . . . 73.349999999999994 109.455 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.44 ' HZ1' ' CG ' ' A' ' 92' ' ' ASP . 30.8 mmtt -75.4 -57.86 3.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.074 -1.017 . . . . 74.420000000000002 109.784 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -62.37 -33.24 74.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.897 -1.127 . . . . 74.549999999999997 109.73 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 8.3 mtpm? -85.42 -18.66 32.99 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.18 -0.95 . . . . 75.219999999999999 109.844 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.523 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 98.7 m-70 -157.61 65.97 0.48 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.027 -1.046 . . . . 74.129999999999995 109.606 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 63' ' ' LYS . 16.6 m -66.12 -24.12 66.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.286 -0.884 . . . . 73.239999999999995 110.023 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 86.8 p -68.11 -21.47 64.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.154 -0.966 . . . . 71.439999999999998 110.427 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 58.3 mt -88.43 153.37 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.102 -0.998 . . . . 71.329999999999998 109.635 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.9 t -91.11 158.96 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.135 -0.978 . . . . 73.019999999999996 110.189 -179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.8 t -132.44 125.31 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.397 -0.814 . . . . 54.210000000000001 109.759 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 tt -118.34 101.91 8.55 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.491 -0.756 . . . . 74.209999999999994 109.125 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.0 t -91.61 137.21 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.189 -0.944 . . . . 74.409999999999997 109.707 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.8 156.55 19.51 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.492 -0.929 . . . . 72.310000000000002 108.492 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.433 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 27.9 t -153.66 132.25 12.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.04 -1.037 . . . . 64.540000000000006 109.786 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -89.44 3.26 52.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.386 -0.821 . . . . 74.129999999999995 108.904 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 79' ' ' THR . 2.5 p-10 -138.52 56.48 10.05 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.528 -0.733 . . . . 73.340000000000003 109.048 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -49.92 87.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.322 2.015 . . . . 71.319999999999993 111.339 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 77' ' ' ASN . 21.2 m -110.22 152.59 25.91 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.091 -0.707 . . . . 62.530000000000001 109.091 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.39 -34.24 64.19 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.43 -0.794 . . . . 74.140000000000001 109.755 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -65.15 -52.5 54.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 71.420000000000002 110.103 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -60.71 -33.34 72.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 73.430000000000007 109.824 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -64.04 -46.0 86.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 74.219999999999999 109.721 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.8 t -57.22 -46.73 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 74.150000000000006 109.758 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -68.12 -29.37 68.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 72.540000000000006 109.65 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.42 -43.43 96.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.149 -0.969 . . . . 64.219999999999999 109.993 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -83.86 -34.52 24.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.127 -0.983 . . . . 74.340000000000003 109.579 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -65.79 -46.07 80.06 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.309 -0.869 . . . . 74.420000000000002 108.772 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -63.43 -53.11 57.4 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.678 -0.639 . . . . 74.519999999999996 109.522 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 141.07 61.33 0.03 OUTLIER Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.247 -1.141 . . . . 74.209999999999994 110.247 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -110.84 132.32 54.3 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.377 -1.073 . . . . 64.099999999999994 109.026 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.44 ' CG ' ' HZ1' ' A' ' 63' ' ' LYS . 35.9 m-20 -85.31 -19.32 31.69 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.047 -1.033 . . . . 73.420000000000002 109.01 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.448 ' OD2' ' CZ ' ' A' ' 112' ' ' ARG . 60.0 m-20 -152.14 162.66 40.78 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.82 -0.808 . . . . 75.040000000000006 108.82 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.433 ' OH ' ' CB ' ' A' ' 75' ' ' SER . 87.4 t80 -150.56 95.57 2.26 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.609 -0.886 . . . . 71.329999999999998 108.609 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.3 mm -105.31 155.3 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.619 0 O-C-N 121.023 -1.048 . . . . 74.510000000000005 109.835 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.33 144.57 50.31 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 106.953 -1.499 . . . . 64.319999999999993 106.953 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.703 ' C ' ' H ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -67.58 -57.48 10.1 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 120.645 -1.284 . . . . 74.510000000000005 112.171 -178.097 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 99' ' ' TYR . 27.7 Cg_endo -53.92 9.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.3 -1.993 0 CA-C-N 119.927 1.01 . . . . 73.109999999999999 113.477 -173.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.703 ' H ' ' C ' ' A' ' 97' ' ' LYS . 14.5 m-85 57.01 124.86 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.19 -0.459 . . . . 72.540000000000006 110.688 177.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.6 mtt85 -66.93 -35.32 79.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.696 -1.253 . . . . 74.540000000000006 108.777 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.741 ' O ' ' N ' ' A' ' 103' ' ' LYS . 29.3 t -164.92 33.18 0.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 74.140000000000001 110.404 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.4 mt 51.77 -69.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.714 -0.616 . . . . 75.430000000000007 110.296 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.741 ' N ' ' O ' ' A' ' 101' ' ' SER . 13.0 mptt -56.37 -28.81 60.29 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.633 -1.247 . . . . 74.140000000000001 107.633 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.18 87.71 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.715 -0.794 . . . . 63.240000000000002 108.881 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -61.51 -55.95 25.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.354 -0.841 . . . . 73.219999999999999 108.75 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.7 t -56.34 -41.76 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.96 -1.087 . . . . 74.540000000000006 109.278 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.02 -42.54 49.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.933 . . . . 75.5 109.309 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.515 ' O ' ' NH1' ' A' ' 112' ' ' ARG . 15.5 mmp_? -69.61 -30.08 67.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 74.409999999999997 109.521 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 93.3 mt -77.92 -29.67 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.021 -1.049 . . . . 73.239999999999995 109.117 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -73.4 -58.77 3.07 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.272 -0.893 . . . . 74.340000000000003 109.911 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.81 -46.99 87.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.123 -0.985 . . . . 73.319999999999993 109.826 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.515 ' NH1' ' O ' ' A' ' 108' ' ' ARG . 22.2 ttp-105 -59.47 -31.53 69.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.181 -0.949 . . . . 74.420000000000002 109.44 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 12.4 tp -157.63 93.06 1.25 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 74.329999999999998 109.496 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 32.5 mtm-85 -78.39 -72.73 0.36 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.227 -0.92 . . . . 74.439999999999998 108.89 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' A' ' 117' ' ' GLY . 41.4 t80 -140.11 3.18 1.97 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.31 -0.869 . . . . 74.430000000000007 109.668 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.528 ' CG ' ' O ' ' A' ' 115' ' ' PHE . 48.9 p-90 40.96 21.27 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.569 -0.707 . . . . 74.439999999999998 110.362 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 115' ' ' PHE . . . -57.12 89.77 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.615 -1.394 . . . . 75.040000000000006 109.615 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 116' ' ' TRP . 85.8 p -156.16 163.65 39.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -1.152 . . . . 70.109999999999999 109.901 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.07 125.57 3.09 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.665 -0.865 . . . . 65.239999999999995 108.665 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.2 t -83.79 -50.25 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.165 -0.96 . . . . 74.219999999999999 109.868 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 17.6 mm -100.83 126.35 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.246 -0.909 . . . . 74.420000000000002 109.351 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -129.87 124.73 33.92 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.544 -0.722 . . . . 73.299999999999997 109.143 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 13.2 tt -146.71 130.21 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.284 -0.885 . . . . 75.340000000000003 109.424 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 45.94 -143.68 3.99 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.745 -1.342 . . . . 75.129999999999995 109.745 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -84.64 -3.93 58.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -1.138 . . . . 74.450000000000003 109.371 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.66 130.79 41.01 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.529 -0.915 . . . . 54.210000000000001 108.529 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.9 m -129.43 123.92 32.83 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.355 -0.84 . . . . 70.239999999999995 109.507 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 23.3 mm -110.26 140.69 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.55 -0.719 . . . . 72.430000000000007 109.103 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.9 m -128.08 78.99 74.59 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.49 -0.756 . . . . 71.109999999999999 109.33 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.85 -53.02 7.74 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.853 2.369 . . . . 75.140000000000001 112.573 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -54.08 -42.71 69.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.953 . . . . 72.5 109.451 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.492 ' OE1' ' N ' ' A' ' 132' ' ' GLU . 37.8 mp0 -88.72 -0.54 57.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.25 -0.906 . . . . 73.140000000000001 109.56 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 47.86 39.12 10.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 75.329999999999998 109.447 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.427 ' NZ ' ' CH2' ' A' ' 116' ' ' TRP . 1.0 OUTLIER -125.65 143.09 51.18 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.638 -0.663 . . . . 71.230000000000004 109.238 -179.727 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.8 tt -125.17 138.87 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.537 -0.727 . . . . 75.329999999999998 109.414 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 52.4 mt -119.14 125.94 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.605 -0.684 . . . . 71.109999999999999 109.178 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.504 ' CE2' ' CD ' ' A' ' 138' ' ' LYS . 46.1 t80 -137.43 132.51 33.51 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.56 -0.713 . . . . 74.140000000000001 109.127 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.524 ' O ' ' NH1' ' A' ' 140' ' ' ARG . 15.8 mtpp 55.64 25.21 7.84 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.504 -0.748 . . . . 75.400000000000006 109.956 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.26 -0.82 89.51 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.237 -1.145 . . . . 72.239999999999995 110.237 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.524 ' NH1' ' O ' ' A' ' 138' ' ' LYS . 9.6 mpt_? -88.9 125.79 35.1 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.017 -1.284 . . . . 73.120000000000005 109.088 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -97.8 116.9 30.94 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.274 -0.891 . . . . 72.319999999999993 109.471 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 13.8 p -139.02 141.75 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.341 -0.85 . . . . 62.340000000000003 109.265 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -88.57 147.67 24.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.196 -0.94 . . . . 61.229999999999997 109.381 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.3 m -137.17 140.61 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.419 -0.801 . . . . 74.439999999999998 109.577 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -165.83 121.99 1.34 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.883 . . . . 75.420000000000002 109.332 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 172.97 -164.45 36.48 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.579 -1.408 . . . . 73.340000000000003 109.579 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.665 ' NZ ' ' HE1' ' A' ' 173' ' ' TRP . 1.6 mtpm? -76.87 -34.76 1.31 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.235 -1.156 . . . . 72.219999999999999 111.071 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 97.0 Cg_endo -89.45 -5.4 5.51 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.166 1.91 . . . . 75.450000000000003 112.639 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -96.93 -32.71 11.9 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.214 -0.929 . . . . 65.239999999999995 109.725 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.524 ' O ' ' ND1' ' A' ' 154' ' ' HIS . 71.3 mm-40 -60.15 -40.45 89.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.113 -0.992 . . . . 72.519999999999996 109.181 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.8 p -61.03 -31.75 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.279 -0.888 . . . . 74.209999999999994 109.05 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.14 -46.91 78.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.39 -0.819 . . . . 73.310000000000002 109.267 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.5 p -72.43 -30.52 64.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.091 -1.006 . . . . 74.310000000000002 109.9 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 150' ' ' GLU . 1.5 m80 -59.04 -53.38 59.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 75.450000000000003 109.728 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.68 -25.19 62.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.109 -0.995 . . . . 75.340000000000003 109.49 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.01 -54.82 40.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.204 -0.935 . . . . 62.140000000000001 109.093 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -70.45 -50.22 40.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.247 -0.908 . . . . 72.219999999999999 108.991 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.526 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 40.0 m-70 -76.04 62.37 1.65 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.535 -0.728 . . . . 74.120000000000005 109.267 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.521 ' C ' HE22 ' A' ' 161' ' ' GLN . 48.0 ttp180 -98.79 139.67 34.13 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.303 -0.873 . . . . 74.340000000000003 109.33 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.647 ' N ' HE22 ' A' ' 161' ' ' GLN . 10.4 t0 80.02 60.92 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.662 -0.649 . . . . 75.450000000000003 110.77 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.647 HE22 ' N ' ' A' ' 160' ' ' ASP . 2.0 pm0 -167.27 170.61 11.47 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.933 -1.104 . . . . 73.409999999999997 109.782 178.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 13.6 mm -92.27 136.36 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.379 -0.826 . . . . 74.409999999999997 109.123 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 82.7 t -140.76 138.32 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.246 -0.909 . . . . 72.530000000000001 109.802 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 52.4 p -89.71 154.28 20.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.361 -0.837 . . . . 74.120000000000005 109.307 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.5 ' CD ' ' H ' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -60.83 -41.3 95.5 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.21 -0.931 . . . . 70.430000000000007 109.2 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.7 -35.83 66.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.237 -0.914 . . . . 74.319999999999993 109.736 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -56.23 -45.72 79.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.077 -1.014 . . . . 74.519999999999996 109.26 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 21.9 mt -59.79 -37.44 79.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.08 -1.012 . . . . 74.409999999999997 108.985 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.9 tt -59.53 -69.41 0.21 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.416 -0.803 . . . . 75.140000000000001 110.241 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -65.0 -33.5 76.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.157 -0.964 . . . . 65.030000000000001 111.005 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -52.65 -48.6 66.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.976 -1.077 . . . . 70.209999999999994 110.219 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.488 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 1.8 mp -94.09 -64.28 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.971 -1.081 . . . . 75.319999999999993 108.905 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.665 ' HE1' ' NZ ' ' A' ' 147' ' ' LYS . 25.8 m-90 . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.34 -0.85 . . . . 73.140000000000001 109.534 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.27 0.557 . . . . 73.129999999999995 110.311 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.2 m -153.16 16.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.292 -0.88 . . . . 74.019999999999996 109.232 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 61.8 mt -58.64 -38.95 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.183 -0.948 . . . . 72.329999999999998 109.475 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -50.45 -38.77 45.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 74.400000000000006 109.324 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 49.6 t -74.67 -36.38 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.227 -0.921 . . . . 74.319999999999993 109.47 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.413 ' O ' ' CG1' ' A' ' 191' ' ' ILE . . . -64.7 -52.81 55.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 73.230000000000004 109.601 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.9 -34.01 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.037 -1.039 . . . . 74.310000000000002 109.191 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -68.27 -57.68 5.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.055 -1.028 . . . . 73.439999999999998 110.394 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -64.15 -38.24 90.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.868 -1.145 . . . . 71.420000000000002 109.259 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.413 ' CG1' ' O ' ' A' ' 187' ' ' ALA . 3.4 mm -56.9 -34.19 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 72.439999999999998 108.745 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . 0.615 ' HE ' ' CG2' ' A' ' 204' ' ' VAL . 3.2 tpt180 -70.17 -43.13 71.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.505 -0.747 . . . . 64.219999999999999 109.784 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -77.51 -27.87 51.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.085 -1.009 . . . . 74.319999999999993 110.187 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -84.88 -21.84 29.59 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.157 -0.965 . . . . 75.310000000000002 110.593 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' MET . . . . . 0.567 ' SD ' ' N ' ' A' ' 196' ' ' ASP . 0.0 OUTLIER -93.77 -41.04 9.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.98 -1.075 . . . . 74.019999999999996 109.718 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . 0.567 ' N ' ' SD ' ' A' ' 195' ' ' MET . 31.5 p-10 -64.6 -34.41 78.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 74.019999999999996 109.696 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.498 ' N ' ' OD1' ' A' ' 196' ' ' ASP . 0.2 OUTLIER -57.2 -63.95 3.12 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.898 . . . . 75.430000000000007 109.678 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.427 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 37.2 Cg_endo -63.71 -57.26 0.38 Allowed 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.196 1.931 . . . . 72.319999999999993 112.064 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 49.0 mt -61.17 -33.09 72.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 74.540000000000006 109.556 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 73.55 -49.02 1.6 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.492 -1.443 . . . . 61.509999999999998 109.492 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.404 HG21 HD12 ' A' ' 201' ' ' ILE . 83.7 mt -92.17 138.24 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.211 -1.17 . . . . 74.25 109.278 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 34.7 m -77.83 147.43 35.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.283 -0.885 . . . . 72.0 109.52 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 8.2 p -142.54 21.13 2.03 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.325 -0.86 . . . . 74.439999999999998 109.223 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.615 ' CG2' ' HE ' ' A' ' 192' ' ' ARG . 20.3 m -135.22 147.96 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.461 -0.774 . . . . 71.129999999999995 109.25 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -123.48 133.34 54.05 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.497 -0.752 . . . . 73.510000000000005 109.392 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 29.0 p -99.24 138.08 36.84 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.381 -0.825 . . . . 73.519999999999996 109.394 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 38.6 t -144.6 136.85 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.202 -0.936 . . . . 72.150000000000006 109.391 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 70.2 ttp85 -80.82 88.26 5.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 72.400000000000006 109.393 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 47.3 ttt85 -171.0 -126.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 73.310000000000002 109.29 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -57.37 -39.72 76.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.109 -0.994 . . . . 71.540000000000006 109.418 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 167.59 -149.51 14.78 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.693 -1.363 . . . . 74.450000000000003 109.693 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -104.93 151.52 23.78 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.481 -1.011 . . . . 75.540000000000006 109.351 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -119.71 137.35 53.98 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.083 -0.71 . . . . 75.310000000000002 109.083 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.509 ' O ' ' N ' ' A' ' 160' ' ' ASP . 15.5 m-85 -106.07 126.94 52.8 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.431 -0.793 . . . . 75.409999999999997 109.377 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 52.9 t -153.11 160.27 42.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.432 -0.793 . . . . 74.140000000000001 109.06 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -63.45 151.69 87.13 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.071 -1.018 . . . . 75.319999999999993 109.072 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo . . . . . 0 N--CA 1.494 1.545 0 C-N-CA 122.381 2.054 . . . . 73.109999999999999 112.042 179.876 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 52.0 ttm . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.477 -0.564 . . . . 75.239999999999995 109.477 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 68.0 mtt85 -138.72 144.36 39.48 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.305 -0.872 . . . . 73.519999999999996 109.431 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 86.8 t -111.97 138.86 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 121.466 0.651 . . . . 72.239999999999995 109.756 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 2.7 tp -108.99 120.55 42.89 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.728 -0.607 . . . . 73.340000000000003 109.399 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 20.2 mt -118.17 110.44 17.58 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.533 -0.729 . . . . 74.349999999999994 109.039 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 26.7 mt -100.78 114.08 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.681 -0.859 . . . . 63.439999999999998 108.681 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.486 ' OE1' ' N ' ' B' ' 9' ' ' ASN . 1.8 pp20? -151.04 164.93 35.3 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.285 -0.885 . . . . 74.519999999999996 109.58 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -95.86 -24.39 16.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.252 -0.905 . . . . 74.129999999999995 109.542 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . 0.486 ' N ' ' OE1' ' B' ' 7' ' ' GLU . 28.7 m120 -91.15 109.79 21.06 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.211 -0.931 . . . . 74.230000000000004 109.697 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 32.3 t -62.44 -40.78 97.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.206 -0.934 . . . . 65.540000000000006 109.633 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 86.4 t -57.72 -44.32 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 75.549999999999997 109.214 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 7.6 tp -58.74 -35.47 72.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 70.140000000000001 108.841 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.04 -27.26 70.68 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 108.253 -1.939 . . . . 75.400000000000006 108.253 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.97 -52.28 49.16 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 109.536 -1.425 . . . . 65.439999999999998 109.536 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -59.75 -47.23 86.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.372 -1.075 . . . . 72.200000000000003 109.796 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 35.5 mm -64.03 -41.48 92.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.66 -1.275 . . . . 75.150000000000006 108.951 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -59.43 -45.22 92.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.224 -0.922 . . . . 73.010000000000005 109.156 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -84.07 0.14 49.52 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.223 -0.923 . . . . 74.299999999999997 109.557 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.5 -58.48 1.94 Allowed Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.544 -1.423 . . . . 70.540000000000006 109.544 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -71.34 -23.61 61.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.307 -1.114 . . . . 75.430000000000007 109.74 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' B' ' 24' ' ' GLY . 2.1 m120 -51.24 -36.17 40.56 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.143 -0.973 . . . . 73.200000000000003 109.495 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 46.5 t -53.86 -32.35 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.15 -0.969 . . . . 74.230000000000004 108.442 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm -81.64 -3.88 54.65 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.746 0.784 . . . . 73.519999999999996 108.891 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 21' ' ' ASN . . . 78.13 24.45 63.84 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.942 -1.263 . . . . 53.43 109.942 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -95.14 159.73 14.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.179 -1.189 . . . . 71.120000000000005 109.076 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 14.8 mmt -104.93 140.41 38.2 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.714 -0.847 . . . . 75.239999999999995 108.714 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.9 158.13 45.14 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.398 -0.814 . . . . 73.25 109.651 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -132.8 145.69 51.19 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.594 -0.891 . . . . 72.310000000000002 108.594 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 4.3 m -110.47 139.33 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.369 -0.832 . . . . 72.140000000000001 109.129 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.1 p -138.13 169.29 18.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.384 -0.822 . . . . 74.530000000000001 109.425 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.414 ' OE2' ' OD1' ' B' ' 35' ' ' ASP . 5.4 pt-20 -93.09 -106.99 0.12 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.342 -0.849 . . . . 71.019999999999996 109.431 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 77.3 p -79.47 168.17 19.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 71.400000000000006 109.776 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 22.7 mt -51.91 -29.81 21.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.537 -0.727 . . . . 71.239999999999995 109.856 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -52.29 -51.2 59.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.095 -1.003 . . . . 74.319999999999993 109.729 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.414 ' OD1' ' OE2' ' B' ' 31' ' ' GLU . 1.4 m-20 -63.1 -38.9 93.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -0.975 . . . . 73.030000000000001 109.261 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.97 -38.97 93.16 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.409 -1.476 . . . . 60.43 109.409 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -67.92 -42.85 80.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -1.114 . . . . 74.430000000000007 109.605 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -74.41 -34.15 63.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 74.420000000000002 109.641 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 21.0 tp -74.86 -50.0 18.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 75.409999999999997 110.078 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.439 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.7 ppp? -61.9 -27.69 68.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 61.439999999999998 109.907 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.81 -39.79 86.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 74.319999999999993 110.137 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 17.6 pt -87.06 -24.9 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.09 -1.006 . . . . 71.230000000000004 110.407 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.424 ' O ' ' O ' ' B' ' 40' ' ' MET . 91.3 mtt-85 -129.65 140.36 51.17 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.235 -0.916 . . . . 73.409999999999997 109.73 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -99.32 126.89 45.26 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.286 -0.884 . . . . 63.539999999999999 109.293 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -101.61 141.89 33.79 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.324 -0.86 . . . . 73.109999999999999 109.505 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -81.11 -31.71 34.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 62.219999999999999 109.021 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.408 ' C ' ' CD1' ' B' ' 47' ' ' LEU . 1.0 OUTLIER -114.9 110.6 19.9 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.691 -0.855 . . . . 73.120000000000005 108.691 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 62.3 t -95.52 101.13 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.28 -0.887 . . . . 74.109999999999999 109.074 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 14.4 ttt -116.43 132.7 56.6 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.592 0.71 . . . . 73.439999999999998 109.45 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.472 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.4 OUTLIER -144.49 139.49 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.465 -0.772 . . . . 73.400000000000006 109.364 -179.49 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 31.9 p -105.58 14.71 28.1 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.668 -0.645 . . . . 73.209999999999994 109.72 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.472 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 61.9 m-20 -82.7 144.96 29.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.214 -0.929 . . . . 70.409999999999997 109.266 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.453 ' C ' ' H ' ' B' ' 55' ' ' ALA . 15.4 pttm -77.68 -39.41 44.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.179 -0.951 . . . . 73.129999999999995 110.118 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -73.81 10.49 1.12 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.098 -1.001 . . . . 75.209999999999994 109.559 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.453 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -65.79 -21.21 66.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.351 -0.843 . . . . 55.329999999999998 110.036 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' B' ' 55' ' ' ALA . 47.7 mt -41.94 -43.68 3.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.433 -0.792 . . . . 72.420000000000002 110.517 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.3 p -75.96 -35.79 59.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.909 -1.12 . . . . 73.040000000000006 109.451 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -66.63 -40.78 88.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.411 -0.806 . . . . 72.329999999999998 110.353 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.06 -35.49 59.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 120.757 -1.214 . . . . 74.540000000000006 109.544 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 78.8 p -57.69 -46.86 83.74 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.12 -0.988 . . . . 71.239999999999995 109.314 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -69.69 -34.41 73.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.142 -0.974 . . . . 74.310000000000002 110.018 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 4.9 mm -62.2 -34.31 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.862 -1.149 . . . . 75.420000000000002 109.779 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.478 ' NZ ' ' OD2' ' B' ' 92' ' ' ASP . 12.0 mmtm -73.79 -52.88 11.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.099 -1.0 . . . . 73.319999999999993 110.178 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -66.24 -36.82 84.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.902 -1.123 . . . . 73.310000000000002 110.304 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.466 ' C ' ' CG ' ' B' ' 66' ' ' HIS . 29.3 mtmt -83.21 -23.56 32.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.133 -0.98 . . . . 72.439999999999998 110.258 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . 0.466 ' CG ' ' C ' ' B' ' 65' ' ' LYS . 37.0 m-70 -153.2 67.37 0.79 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.02 -1.05 . . . . 65.209999999999994 109.837 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' B' ' 63' ' ' LYS . 10.5 m -61.9 -30.86 71.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.935 . . . . 73.099999999999994 109.724 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 90.5 p -63.24 -24.58 67.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.251 -0.905 . . . . 71.530000000000001 110.356 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 81.1 mt -81.5 156.36 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.988 -1.07 . . . . 74.400000000000006 109.767 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 95.9 t -93.97 160.14 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.296 -0.877 . . . . 75.120000000000005 109.854 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.7 t -136.04 127.49 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.411 -0.806 . . . . 73.200000000000003 109.366 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.61 101.71 7.77 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.729 -0.841 . . . . 73.340000000000003 108.729 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 90.7 t -93.53 128.18 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.249 -0.907 . . . . 73.5 109.264 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 14.6 p -93.51 172.24 8.4 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.198 -0.939 . . . . 71.319999999999993 109.346 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 30.1 t -159.65 117.08 2.65 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.978 -1.077 . . . . 74.530000000000001 110.339 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -61.88 -36.34 80.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.384 -0.822 . . . . 64.5 109.84 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' B' ' 79' ' ' THR . 0.5 OUTLIER -118.52 82.73 19.94 Favored Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.572 -0.705 . . . . 74.25 109.227 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -47.71 84.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.235 1.957 . . . . 74.430000000000007 111.5 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.516 ' N ' ' O ' ' B' ' 77' ' ' ASN . 19.4 m -102.91 150.91 23.05 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.596 -0.69 . . . . 73.120000000000005 109.377 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.2 t -65.32 -35.41 80.9 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.344 -0.847 . . . . 75.409999999999997 109.704 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . 0.488 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 80.1 mm-40 -60.42 -44.75 95.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.134 -0.979 . . . . 72.239999999999995 109.565 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -75.79 -31.11 59.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 73.219999999999999 109.468 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -64.73 -54.05 37.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 74.299999999999997 109.834 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.411 ' CG2' ' N ' ' B' ' 85' ' ' HIS . 21.6 m -64.26 -43.37 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.098 -1.001 . . . . 73.310000000000002 109.396 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' HIS . . . . . 0.488 ' ND1' ' O ' ' B' ' 81' ' ' GLU . 23.2 m170 -63.18 -26.17 68.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.161 -0.962 . . . . 73.239999999999995 109.271 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . 0.405 ' O ' ' CB ' ' B' ' 91' ' ' ALA . . . -70.64 -46.86 62.5 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -0.878 . . . . 55.329999999999998 109.958 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -77.0 -32.09 56.96 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.01 -1.056 . . . . 74.450000000000003 109.384 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -72.67 -44.3 62.0 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.248 -0.907 . . . . 64.040000000000006 109.693 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -62.69 -52.13 64.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.191 -0.943 . . . . 75.129999999999995 109.905 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 156.45 44.74 0.02 OUTLIER Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.673 -1.251 . . . . 75.420000000000002 110.265 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' B' ' 86' ' ' ALA . . . -110.28 135.7 50.61 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.396 -1.061 . . . . 73.420000000000002 109.255 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . 0.478 ' OD2' ' NZ ' ' B' ' 63' ' ' LYS . 19.2 m-20 -85.37 -18.43 33.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.094 -1.004 . . . . 73.319999999999993 109.201 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -152.51 162.01 41.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.298 -0.876 . . . . 73.040000000000006 109.697 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -143.65 97.0 2.99 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.554 -0.906 . . . . 74.310000000000002 108.554 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 23.2 mm -108.1 156.29 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 121.255 -0.903 . . . . 75.340000000000003 110.431 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.6 152.12 45.94 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.262 -1.014 . . . . 70.099999999999994 108.262 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.694 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -74.87 -55.98 2.26 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 120.787 -1.195 . . . . 65.430000000000007 111.416 -179.562 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 2.6 Cg_endo -40.29 -10.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.034 1.156 . . . . 63.520000000000003 112.914 -175.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . 0.694 ' N ' ' O ' ' B' ' 97' ' ' LYS . 54.2 m-85 59.42 118.18 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.755 -0.59 . . . . 75.129999999999995 109.868 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -65.65 -33.31 75.6 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.208 -0.932 . . . . 74.230000000000004 109.452 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 101' ' ' SER . . . . . 0.766 ' O ' ' N ' ' B' ' 103' ' ' LYS . 34.2 t -171.32 27.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.961 -1.087 . . . . 64.510000000000005 110.888 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 16.2 mt 49.14 -67.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 CA-C-N 118.498 0.59 . . . . 74.439999999999998 110.336 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . 0.766 ' N ' ' O ' ' B' ' 101' ' ' SER . 43.4 mtpt -55.4 -32.77 62.93 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.903 -1.147 . . . . 72.299999999999997 107.903 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.11 -45.87 86.72 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.666 -0.864 . . . . 74.310000000000002 108.666 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 22.5 tp -68.31 -42.43 79.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.302 -0.874 . . . . 73.540000000000006 109.123 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 78.8 t -58.92 -45.72 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.174 -0.954 . . . . 72.030000000000001 108.893 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.17 -44.02 67.55 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.422 -0.955 . . . . 64.219999999999999 108.422 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -62.41 -39.04 91.98 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.819 -0.808 . . . . 75.310000000000002 108.819 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 91.1 mt -68.95 -28.96 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 108.043 -1.095 . . . . 55.439999999999998 108.043 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -68.56 -53.76 20.89 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.651 -0.87 . . . . 65.310000000000002 108.651 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -47.36 -40.32 17.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.448 -0.783 . . . . 74.519999999999996 109.081 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -62.85 -40.33 97.13 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.299 -0.876 . . . . 72.040000000000006 109.111 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 84.6 mt -137.97 77.44 1.63 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.318 -0.864 . . . . 75.349999999999994 109.505 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -74.54 -76.02 0.15 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.218 -0.926 . . . . 75.5 108.959 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 115' ' ' PHE . . . . . 0.525 ' O ' ' CG ' ' B' ' 116' ' ' TRP . 94.1 m-85 -82.84 -65.87 0.96 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 73.040000000000006 109.563 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 116' ' ' TRP . . . . . 0.525 ' CG ' ' O ' ' B' ' 115' ' ' PHE . 7.7 m-90 -158.13 -154.39 0.44 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.36 -0.838 . . . . 74.450000000000003 109.347 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -85.65 -138.09 4.54 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.696 -1.362 . . . . 64.209999999999994 109.696 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 10.9 t -151.95 176.85 11.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.305 -1.114 . . . . 71.400000000000006 109.911 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.9 163.81 37.8 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.787 -0.819 . . . . 74.209999999999994 108.787 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 10.1 t -136.5 -38.52 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.506 -0.746 . . . . 75.019999999999996 109.726 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . 0.442 HD11 HG23 ' B' ' 121' ' ' ILE . 27.1 mm -97.77 137.67 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.239 -0.913 . . . . 74.239999999999995 109.499 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . 0.95 ' OE1' ' O ' ' B' ' 122' ' ' GLU . 0.0 OUTLIER -137.74 132.61 33.04 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.476 -0.765 . . . . 73.329999999999998 109.374 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.516 ' CG2' ' HB2' ' B' ' 126' ' ' LEU . 4.9 tt -142.76 113.08 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.285 -0.884 . . . . 74.219999999999999 109.174 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.98 -116.95 5.49 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.262 -1.535 . . . . 72.409999999999997 109.262 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -106.33 3.38 27.49 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.481 -1.011 . . . . 75.120000000000005 108.987 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.516 ' HB2' ' CG2' ' B' ' 123' ' ' ILE . 0.3 OUTLIER -97.49 139.43 33.42 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.283 -1.006 . . . . 75.420000000000002 108.283 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 18.8 m -130.33 136.42 49.09 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.229 -0.919 . . . . 74.219999999999999 110.065 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 58.8 mt -128.96 142.9 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.533 -0.729 . . . . 60.329999999999998 109.464 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 2.0 m -122.44 126.84 26.06 Favored Pre-proline 0 N--CA 1.501 2.077 0 N-CA-C 109.144 -0.687 . . . . 72.310000000000002 109.144 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.71 -60.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.793 1.662 . . . . 75.129999999999995 112.998 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -53.9 -47.51 71.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.939 -1.1 . . . . 75.230000000000004 109.956 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -82.83 -9.77 59.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.121 -0.987 . . . . 75.120000000000005 110.063 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 48.51 75.41 0.14 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.977 -1.077 . . . . 75.129999999999995 109.178 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -149.17 130.56 14.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.189 -0.945 . . . . 75.109999999999999 109.54 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 7.5 tt -110.43 132.93 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.816 -0.809 . . . . 70.319999999999993 108.816 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 20.7 mm -111.26 127.42 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.407 -0.808 . . . . 74.120000000000005 109.407 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -142.81 141.54 31.66 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.983 -1.117 . . . . 74.230000000000004 107.983 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 68.3 tttt 55.93 13.61 1.16 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.335 -0.853 . . . . 74.219999999999999 109.705 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.68 5.24 84.49 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.384 -1.086 . . . . 74.319999999999993 110.384 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -96.09 141.81 29.03 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.13 -1.218 . . . . 75.340000000000003 109.04 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -96.24 123.76 39.99 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.311 -0.868 . . . . 71.230000000000004 109.339 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 36.1 t -134.74 132.83 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.38 -0.825 . . . . 70.430000000000007 109.153 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -90.58 157.58 17.43 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.032 -1.043 . . . . 72.430000000000007 109.516 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 6.0 m -137.69 140.66 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.408 -0.808 . . . . 72.129999999999995 109.817 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . 0.44 ' HZ2' ' HD1' ' B' ' 66' ' ' HIS . 22.9 pttt -176.64 89.54 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.408 -0.807 . . . . 74.5 109.593 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -157.15 -170.15 21.76 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.587 -1.405 . . . . 42.229999999999997 109.587 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . 0.628 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 29.3 ttpt -78.69 -31.03 0.71 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.262 -1.14 . . . . 73.299999999999997 110.974 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 85.1 Cg_endo -89.61 -29.34 0.23 Allowed 'Trans proline' 0 N--CA 1.486 1.069 0 C-N-CA 122.03 1.82 . . . . 71.329999999999998 112.764 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -85.1 -13.31 50.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.0 -1.063 . . . . 74.230000000000004 109.964 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -53.04 -40.68 64.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.097 -1.002 . . . . 72.340000000000003 109.268 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 12.5 p -69.24 -38.45 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 73.349999999999994 109.159 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.22 -44.11 32.76 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.57 -0.9 . . . . 74.430000000000007 108.57 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.14 -41.0 71.05 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.107 -0.996 . . . . 75.209999999999994 110.254 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 154' ' ' HIS . . . . . 0.585 ' HD1' HH21 ' B' ' 157' ' ' ARG . 34.6 t60 -58.39 -63.59 1.22 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.371 -0.831 . . . . 73.040000000000006 112.362 -177.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.23 -19.77 63.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.425 -1.422 . . . . 73.430000000000007 109.815 -178.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.96 -47.97 83.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.737 -1.227 . . . . 75.319999999999993 109.17 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . 0.585 HH21 ' HD1' ' B' ' 154' ' ' HIS . 23.2 ptt180 -76.86 -35.8 57.23 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.034 -1.041 . . . . 73.319999999999993 110.42 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 158' ' ' HIS . . . . . 0.424 ' ND1' ' HG3' ' B' ' 157' ' ' ARG . 1.6 m-70 -81.08 22.42 0.64 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.688 -1.257 . . . . 74.140000000000001 109.961 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 24.8 ttm-85 -59.36 163.03 4.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.125 -0.985 . . . . 73.420000000000002 109.06 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' B' ' 214' ' ' PHE . 14.8 t0 63.54 44.65 5.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.205 -0.934 . . . . 72.099999999999994 109.164 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . 0.908 ' NE2' ' O ' ' B' ' 162' ' ' ILE . 15.5 tm0? -158.16 155.25 28.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.353 -0.842 . . . . 73.239999999999995 109.613 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 162' ' ' ILE . . . . . 0.908 ' O ' ' NE2' ' B' ' 161' ' ' GLN . 10.3 mm -81.63 105.39 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.522 -0.918 . . . . 72.310000000000002 108.522 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 93.4 t -101.54 129.25 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.274 -0.892 . . . . 75.030000000000001 109.754 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 9.8 t -85.93 164.31 17.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.401 -0.812 . . . . 74.219999999999999 109.528 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -68.78 -46.39 68.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -0.848 . . . . 72.420000000000002 109.855 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -60.25 -24.89 65.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 63.450000000000003 109.859 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -59.26 -43.73 92.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.965 -1.085 . . . . 72.400000000000006 109.082 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 20.7 mt -71.96 -58.11 3.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.394 -0.816 . . . . 72.319999999999993 109.247 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.419 ' C ' ' CD1' ' B' ' 169' ' ' LEU . 2.1 tm? -50.1 -58.29 5.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.014 -1.054 . . . . 73.340000000000003 108.653 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -51.7 -32.66 31.0 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 112.183 0.438 . . . . 73.099999999999994 112.183 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.61 -30.77 14.18 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.802 -1.187 . . . . 62.130000000000003 112.952 -177.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.7 -63.13 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.458 -1.401 . . . . 74.439999999999998 109.467 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 173' ' ' TRP . . . . . 0.523 ' O ' ' CE3' ' B' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.538 0 N-CA-C 107.518 -1.29 . . . . 72.230000000000004 107.518 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_exo . . . . . 0 N--CA 1.489 1.213 0 CA-C-O 121.422 0.509 . . . . 74.340000000000003 112.019 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -164.1 122.73 1.88 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.369 -0.832 . . . . 72.310000000000002 109.061 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 10.5 m -137.71 11.87 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.244 -0.91 . . . . 65.420000000000002 108.692 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.4 HD11 HG21 ' B' ' 184' ' ' ILE . 0.2 OUTLIER -53.52 -30.64 18.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.639 -0.874 . . . . 75.030000000000001 108.639 179.749 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -57.33 -35.49 69.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.853 . . . . 73.519999999999996 108.994 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 3.7 t -75.32 -44.41 42.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.453 -0.78 . . . . 74.349999999999994 109.372 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -61.62 -48.46 80.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.251 -0.906 . . . . 61.119999999999997 110.459 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 9.4 tp -63.65 -42.12 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.778 -1.201 . . . . 72.430000000000007 110.285 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -63.59 -34.67 78.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.898 -1.126 . . . . 75.420000000000002 109.402 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -77.14 -50.36 13.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 74.140000000000001 110.15 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 82.0 mt -50.5 -46.37 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.178 -0.951 . . . . 74.030000000000001 109.438 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -62.68 -48.81 77.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.104 -0.997 . . . . 72.329999999999998 109.914 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 193' ' ' GLN . . . . . 0.45 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 25.6 mt-30 -63.67 -21.61 66.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.051 -1.031 . . . . 73.099999999999994 109.515 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . 0.431 ' O ' ' CD ' ' B' ' 198' ' ' PRO . 60.3 mttm -85.74 -38.47 18.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.206 -0.933 . . . . 74.430000000000007 110.405 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 88.8 mmm -91.79 13.2 18.96 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.888 -1.133 . . . . 74.329999999999998 109.99 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 196' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 50.8 p-10 -96.56 -20.98 17.96 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.06 -1.025 . . . . 71.209999999999994 109.744 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . 0.554 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 1.5 tttm -93.29 -45.54 0.31 Allowed Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.116 -0.99 . . . . 75.209999999999994 109.098 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 198' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' B' ' 197' ' ' LYS . 18.8 Cg_exo -65.12 -60.47 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.163 1.909 . . . . 75.319999999999993 111.324 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 30.8 mt -63.68 -38.8 92.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 72.25 109.007 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 78.44 -17.95 6.01 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.35 -1.1 . . . . 73.239999999999995 110.35 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 29.0 mm -110.31 131.78 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.278 -1.13 . . . . 54.299999999999997 110.017 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 2.0 t -83.8 135.16 34.63 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.632 -0.877 . . . . 74.310000000000002 108.632 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 3.9 p -141.37 30.43 1.75 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.141 -0.974 . . . . 74.400000000000006 109.463 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 25.6 m -137.14 142.4 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.507 -0.745 . . . . 74.099999999999994 109.296 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -125.58 114.5 18.81 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.022 -0.732 . . . . 75.329999999999998 109.022 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.42 110.1 21.21 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.186 -0.946 . . . . 71.400000000000006 109.917 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 10.6 p -112.45 131.09 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 107.896 -1.15 . . . . 63.5 107.896 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -47.92 -32.81 6.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.055 -1.028 . . . . 74.450000000000003 110.036 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 -66.34 148.45 51.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.093 -1.004 . . . . 74.140000000000001 109.41 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 51.37 -115.11 0.85 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.095 -1.003 . . . . 74.430000000000007 109.636 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -142.27 -92.73 0.18 Allowed Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.419 -1.473 . . . . 70.109999999999999 109.419 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -126.71 157.44 39.08 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.435 -1.038 . . . . 74.209999999999994 109.637 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -123.26 121.95 37.16 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.879 -0.785 . . . . 74.299999999999997 108.879 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' B' ' 160' ' ' ASP . 60.0 m-85 -101.49 123.92 46.32 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.369 -0.832 . . . . 74.340000000000003 110.372 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 1.9 p -147.59 164.38 33.64 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.117 -0.697 . . . . 72.209999999999994 109.117 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' B' ' 216' ' ' TYR . 0.0 OUTLIER -64.93 162.52 37.1 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.085 -1.01 . . . . 72.310000000000002 108.429 179.664 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -39.47 163.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.407 2.071 . . . . 71.010000000000005 112.267 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.121 -0.987 . . . . 74.349999999999994 109.723 -179.329 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.9 ptm . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.454 -0.573 . . . . 65.120000000000005 109.454 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -139.31 144.51 38.34 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.356 -0.84 . . . . 73.310000000000002 109.44 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 66.1 t -112.64 131.03 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.705 -0.622 . . . . 71.420000000000002 109.492 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.21 125.59 53.23 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.96 -0.756 . . . . 65.219999999999999 108.96 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 59.7 tp -120.95 102.94 8.68 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.629 -0.67 . . . . 71.439999999999998 109.244 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.8 mt -88.67 113.58 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.856 -1.153 . . . . 71.150000000000006 108.692 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 13' ' ' GLY . 55.8 tt0 -154.66 121.44 5.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.198 -0.939 . . . . 75.340000000000003 109.485 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -64.36 -31.29 72.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.307 -0.871 . . . . 73.040000000000006 109.43 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -73.9 103.21 4.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.324 -0.86 . . . . 72.420000000000002 109.372 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.4 t -66.4 -25.17 66.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 72.340000000000003 109.814 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.54 -50.67 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.168 -0.958 . . . . 74.420000000000002 109.697 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 12' ' ' LEU . 3.3 mm? -70.81 -41.95 70.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 72.010000000000005 109.398 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.513 ' N ' ' OE1' ' A' ' 7' ' ' GLU . . . -69.13 -24.85 75.81 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 108.475 -1.85 . . . . 72.140000000000001 108.475 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.51 -54.89 20.45 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 109.676 -1.37 . . . . 72.329999999999998 109.676 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -56.88 -45.75 82.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -1.104 . . . . 72.340000000000003 109.775 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.9 mm -64.54 -48.78 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.819 -1.176 . . . . 74.239999999999995 108.878 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.527 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 86.5 tt0 -45.6 -56.41 5.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -0.983 . . . . 71.409999999999997 109.854 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -85.61 3.83 39.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.124 -0.985 . . . . 75.540000000000006 109.128 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.59 -70.64 1.34 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.778 -1.329 . . . . 62.149999999999999 109.778 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.75 -21.97 56.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.213 -1.169 . . . . 74.420000000000002 109.491 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 93.4 m-20 -57.06 -37.84 72.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.253 -0.904 . . . . 74.25 109.634 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.7 t -53.97 -40.02 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 72.109999999999999 109.462 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -64.46 -22.13 66.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.27 -0.894 . . . . 73.230000000000004 109.233 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.46 38.28 2.65 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 110.335 -1.106 . . . . 75.540000000000006 110.335 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -117.92 159.28 23.39 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.335 -1.097 . . . . 74.510000000000005 108.905 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.7 mmt -90.8 114.51 26.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.112 -0.992 . . . . 64.319999999999993 108.574 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.433 ' O ' ' OD1' ' A' ' 28' ' ' ASP . . . -99.26 147.38 25.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.397 -0.814 . . . . 74.310000000000002 110.104 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 27' ' ' ALA . 82.4 m-20 -138.52 129.03 26.16 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.619 -0.882 . . . . 75.400000000000006 108.619 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.1 m -111.82 138.86 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.449 -0.782 . . . . 75.129999999999995 109.117 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 p -135.08 176.39 8.71 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.536 -0.728 . . . . 71.420000000000002 109.354 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -95.54 -108.16 0.14 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.163 -0.961 . . . . 73.109999999999999 110.017 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.2 p -78.84 167.15 21.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.899 . . . . 74.239999999999995 110.123 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.7 mt -50.82 -33.76 24.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.629 -0.669 . . . . 71.530000000000001 109.891 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -49.5 -52.27 30.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 74.230000000000004 109.624 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -61.95 -37.76 85.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.139 -0.976 . . . . 71.010000000000005 108.952 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.79 -39.17 90.0 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.278 -1.529 . . . . 61.409999999999997 109.278 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.57 -43.59 89.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.352 -1.087 . . . . 74.340000000000003 109.445 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -73.39 -38.03 65.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.153 -0.967 . . . . 75.329999999999998 109.504 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.0 tp -68.7 -44.99 72.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 74.329999999999998 109.771 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.448 ' C ' ' SD ' ' A' ' 40' ' ' MET . 3.4 ppp? -74.39 -17.13 60.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.087 -1.008 . . . . 70.319999999999993 109.687 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -55.43 -40.68 71.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.122 -0.986 . . . . 71.219999999999999 109.441 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.8 pt -88.08 -42.56 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.304 -0.872 . . . . 74.409999999999997 109.793 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 40' ' ' MET . 3.0 mpt_? -104.41 139.19 39.71 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.195 -0.94 . . . . 75.409999999999997 109.113 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.829 ' ND2' ' HZ2' ' A' ' 145' ' ' LYS . 16.8 t-20 -82.11 -24.36 35.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 75.420000000000002 109.782 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.485 ' O ' ' O ' ' A' ' 44' ' ' ASN . 57.2 m-85 57.4 136.65 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.684 0.754 . . . . 74.230000000000004 110.196 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -86.29 -50.45 6.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.948 -1.095 . . . . 75.319999999999993 108.945 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.426 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -104.93 107.39 18.34 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.411 -0.959 . . . . 72.129999999999995 108.411 179.406 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.19 104.79 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.127 -1.064 . . . . 72.340000000000003 108.127 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.8 ttt -113.69 144.51 42.81 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.545 0.688 . . . . 74.109999999999999 109.776 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.427 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 1.4 p -139.53 136.02 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.596 0.713 . . . . 71.239999999999995 109.567 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.7 m -104.79 10.33 34.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.68 -0.638 . . . . 73.109999999999999 109.402 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.427 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 69.8 m-20 -77.0 155.58 32.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 63.399999999999999 109.61 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.5 ' C ' ' H ' ' A' ' 55' ' ' ALA . 27.3 mtmm -76.38 -39.22 54.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.182 -0.949 . . . . 65.439999999999998 109.84 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -73.49 18.09 0.13 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.141 -0.974 . . . . 73.129999999999995 109.653 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.5 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -59.96 -35.56 75.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 64.140000000000001 110.012 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 23.7 mt -43.83 -52.66 6.58 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.449 -0.782 . . . . 74.430000000000007 110.251 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.2 m -65.9 -34.63 78.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.872 -1.142 . . . . 63.229999999999997 108.942 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -65.89 -62.9 1.24 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.488 -0.757 . . . . 74.439999999999998 110.079 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.5 m -48.44 -34.19 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.739 -1.226 . . . . 74.030000000000001 109.901 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.2 t -59.0 -55.24 37.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.128 -0.982 . . . . 73.540000000000006 109.692 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -65.59 -27.36 68.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.111 -0.993 . . . . 73.340000000000003 110.189 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.6 mm -66.25 -49.56 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.75 -1.219 . . . . 73.349999999999994 110.369 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.502 ' HZ2' ' C ' ' A' ' 90' ' ' GLY . 26.6 mmtp -63.62 -44.69 93.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.994 -1.066 . . . . 74.420000000000002 110.921 -178.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -71.02 -39.52 72.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.676 -1.265 . . . . 74.549999999999997 110.161 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.482 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 66.4 mttm -80.8 -19.49 44.64 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.116 -0.99 . . . . 75.219999999999999 109.675 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.482 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 93.1 m-70 -155.68 68.05 0.64 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 74.129999999999995 109.391 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 63' ' ' LYS . 18.4 m -59.21 -30.72 68.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.249 -0.907 . . . . 73.239999999999995 110.0 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.8 t -81.39 49.04 1.23 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.174 -0.954 . . . . 71.439999999999998 110.28 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 12.3 tt -143.4 157.8 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.096 -1.002 . . . . 71.329999999999998 109.307 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.4 t -91.75 141.53 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.001 -1.062 . . . . 73.019999999999996 108.81 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.2 t -127.52 121.99 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.297 -0.877 . . . . 54.210000000000001 109.34 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.61 103.15 9.43 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.336 -0.987 . . . . 74.209999999999994 108.336 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.0 p -98.64 128.5 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.396 -0.815 . . . . 74.409999999999997 109.109 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.5 p -89.31 175.33 7.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.06 -1.025 . . . . 72.310000000000002 109.489 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.481 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 22.8 t -164.6 118.95 1.38 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.158 -0.964 . . . . 64.540000000000006 110.265 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -70.5 -25.94 63.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.558 -0.714 . . . . 74.129999999999995 109.599 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 79' ' ' THR . 13.2 t-20 -112.64 68.9 1.03 Allowed Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.599 -0.688 . . . . 73.340000000000003 109.614 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.78 82.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.768 1.645 . . . . 71.319999999999993 111.777 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 77' ' ' ASN . 24.1 m -103.61 151.69 22.64 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.111 -0.7 . . . . 62.530000000000001 109.111 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -36.61 83.8 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -0.907 . . . . 74.140000000000001 109.471 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.02 -42.15 84.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.158 -0.964 . . . . 71.420000000000002 109.366 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -74.14 -30.35 62.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 73.430000000000007 109.607 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.522 ' OE1' ' CD1' ' A' ' 94' ' ' TYR . 46.8 tp10 -60.59 -54.76 41.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.958 . . . . 74.219999999999999 109.587 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.6 t -62.64 -41.72 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.249 -0.907 . . . . 74.150000000000006 109.421 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.518 ' NE2' ' OE1' ' A' ' 89' ' ' GLN . 47.7 t60 -64.41 -33.33 75.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.248 -0.908 . . . . 72.540000000000006 109.589 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.57 -45.18 91.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 64.219999999999999 109.747 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -77.24 -29.94 54.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.037 -1.039 . . . . 74.340000000000003 108.572 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -60.68 -50.74 72.28 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.384 -0.822 . . . . 74.420000000000002 108.885 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.518 ' OE1' ' NE2' ' A' ' 85' ' ' HIS . 28.2 mt-30 -63.24 -61.64 2.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.583 -0.698 . . . . 74.519999999999996 109.578 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.502 ' C ' ' HZ2' ' A' ' 63' ' ' LYS . . . 154.79 59.01 0.01 OUTLIER Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.796 -1.192 . . . . 74.209999999999994 110.266 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.72 134.61 51.21 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.254 -1.145 . . . . 64.099999999999994 108.978 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -75.4 -32.14 60.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.005 -1.059 . . . . 73.420000000000002 109.059 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.513 ' OD2' ' NE ' ' A' ' 108' ' ' ARG . 42.2 t0 -152.34 157.45 41.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.361 -0.837 . . . . 75.040000000000006 109.44 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.522 ' CD1' ' OE1' ' A' ' 83' ' ' GLU . 62.0 t80 -131.62 113.26 13.39 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.579 -0.897 . . . . 71.329999999999998 108.579 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.5 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 0.1 OUTLIER -117.26 152.08 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-O 121.646 0.736 . . . . 74.510000000000005 110.444 -178.192 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.93 138.72 48.3 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.27 -1.011 . . . . 64.319999999999993 108.27 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.684 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -60.71 -54.98 49.37 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.98 -1.075 . . . . 74.510000000000005 111.636 -179.192 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.4 Cg_endo -41.4 -10.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 120.749 0.966 . . . . 73.109999999999999 112.923 -175.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.684 ' N ' ' O ' ' A' ' 97' ' ' LYS . 57.4 m-85 59.42 100.31 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.752 -0.593 . . . . 72.540000000000006 110.076 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 19.1 ttm-85 -55.93 -40.23 72.83 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.082 -1.081 . . . . 74.540000000000006 108.082 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.7 t -173.79 128.82 0.4 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.796 -0.816 . . . . 74.140000000000001 108.796 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 51.3 mt -51.81 -40.54 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.941 . . . . 75.430000000000007 109.155 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.412 ' CD ' ' N ' ' A' ' 103' ' ' LYS . 2.7 mptp? -64.42 -35.58 81.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.154 -0.966 . . . . 74.140000000000001 109.38 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.03 -60.9 2.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.228 -0.92 . . . . 63.240000000000002 109.689 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.622 ' CD1' HH22 ' A' ' 108' ' ' ARG . 17.9 tp -55.9 -51.99 65.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 73.219999999999999 109.657 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 76.0 t -60.23 -42.4 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.062 -1.023 . . . . 74.540000000000006 109.383 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.3 -30.08 36.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.177 -0.952 . . . . 75.5 109.115 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.622 HH22 ' CD1' ' A' ' 105' ' ' LEU . 21.1 ttp-105 -83.14 -28.71 29.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 74.409999999999997 109.981 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 80.3 mt -74.74 -40.03 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.986 -1.071 . . . . 73.239999999999995 108.72 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 114' ' ' ARG . 24.8 pt-20 -72.26 -37.07 69.16 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.439 -0.904 . . . . 74.340000000000003 108.957 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -57.3 -45.4 84.2 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.343 -0.848 . . . . 73.319999999999993 109.15 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 68.5 ttt-85 -62.73 -41.5 99.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.27 -0.894 . . . . 74.420000000000002 109.387 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 42.6 mt -130.07 65.8 1.5 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.477 -0.764 . . . . 74.329999999999998 109.248 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' A' ' 110' ' ' GLU . 81.5 mtp180 -60.8 -29.85 69.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 74.439999999999998 109.429 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.427 ' CG ' ' O ' ' A' ' 114' ' ' ARG . 78.9 m-85 -156.64 78.88 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 74.430000000000007 109.567 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 33.4 p-90 -58.83 134.1 56.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 74.439999999999998 109.534 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 154.2 91.57 0.08 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.434 -1.466 . . . . 75.040000000000006 109.434 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.7 m -152.39 168.27 26.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.261 -1.14 . . . . 70.109999999999999 109.679 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.57 -179.61 8.14 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.823 -0.751 . . . . 65.239999999999995 109.117 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.9 t -139.69 -38.75 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.441 -0.787 . . . . 74.219999999999999 109.159 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.42 HD13 HG22 ' A' ' 121' ' ' ILE . 10.2 mm -106.32 131.66 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.245 -0.909 . . . . 74.420000000000002 109.208 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -128.32 99.36 5.39 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.407 -0.96 . . . . 73.299999999999997 108.407 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.914 HG13 ' NE ' ' A' ' 159' ' ' ARG . 26.9 mm -115.82 122.23 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.518 -0.739 . . . . 75.340000000000003 109.233 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.86 -160.38 0.29 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.789 -1.325 . . . . 75.129999999999995 109.789 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -66.67 -3.99 7.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -1.184 . . . . 74.450000000000003 109.666 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.16 134.99 34.77 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.091 -1.006 . . . . 54.210000000000001 109.101 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 27.0 m -119.89 131.4 55.23 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.786 -0.82 . . . . 70.239999999999995 108.786 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.4 mt -118.99 122.78 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-O 121.685 0.755 . . . . 72.430000000000007 109.125 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.7 m -107.79 109.12 62.16 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.732 -0.84 . . . . 71.109999999999999 108.732 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.548 ' CB ' ' HE ' ' A' ' 157' ' ' ARG . 94.9 Cg_endo -80.08 -29.95 2.4 Favored 'Trans proline' 0 N--CA 1.492 1.382 0 C-N-CA 121.967 1.778 . . . . 75.140000000000001 112.617 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -52.73 -69.16 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.113 -0.992 . . . . 72.5 109.258 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -82.3 4.52 23.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.361 -0.837 . . . . 73.140000000000001 109.05 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 54.19 81.25 0.1 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.491 -0.756 . . . . 75.329999999999998 109.456 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -149.43 136.0 19.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.244 -0.91 . . . . 71.230000000000004 109.553 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 11.6 tt -114.24 133.07 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.48 -0.763 . . . . 75.329999999999998 108.973 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 41.4 mt -124.74 115.43 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.847 -0.797 . . . . 71.109999999999999 108.847 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -130.61 134.66 47.17 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.456 -0.777 . . . . 74.140000000000001 109.762 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.462 ' O ' ' NH1' ' A' ' 140' ' ' ARG . 61.3 mttm 55.3 23.72 5.84 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.436 -0.79 . . . . 75.400000000000006 110.792 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 86.66 1.29 85.55 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.364 -1.094 . . . . 72.239999999999995 110.364 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.462 ' NH1' ' O ' ' A' ' 138' ' ' LYS . 11.1 mpt_? -88.94 126.55 35.45 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.06 -1.259 . . . . 73.120000000000005 108.838 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -100.01 127.36 46.23 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.398 -0.814 . . . . 72.319999999999993 109.86 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 24.0 t -137.65 136.2 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.366 -0.834 . . . . 62.340000000000003 109.491 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -97.94 142.69 29.36 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.34 -0.85 . . . . 61.229999999999997 109.532 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.2 m -155.53 154.74 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.161 -0.962 . . . . 74.439999999999998 109.76 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.829 ' HZ2' ' ND2' ' A' ' 44' ' ' ASN . 20.0 pttt 178.27 115.28 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.282 -0.886 . . . . 75.420000000000002 109.137 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.01 176.18 37.74 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.689 -1.365 . . . . 73.340000000000003 109.689 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.583 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 0.0 OUTLIER -60.09 -44.32 96.23 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.4 -1.059 . . . . 72.219999999999999 109.254 -179.651 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 39.5 Cg_exo -59.57 -36.2 93.44 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.374 2.05 . . . . 75.450000000000003 112.268 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -92.57 -14.71 27.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.258 -0.901 . . . . 65.239999999999995 109.63 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -54.93 -40.07 69.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.885 . . . . 72.519999999999996 109.865 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.6 p -61.12 -37.31 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.967 -1.083 . . . . 74.209999999999994 109.55 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 7.2 tp -62.9 -51.32 67.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.494 -0.754 . . . . 73.310000000000002 110.405 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.3 p -74.71 -29.02 61.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.098 -1.001 . . . . 74.310000000000002 110.057 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -57.32 -56.74 17.89 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.833 -1.167 . . . . 75.450000000000003 109.672 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.8 pp -72.15 -27.28 62.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.395 -0.816 . . . . 75.340000000000003 109.732 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.57 -52.88 58.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.961 -1.087 . . . . 62.140000000000001 108.72 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.635 ' HB2' ' HD1' ' A' ' 158' ' ' HIS . 52.7 mtt85 -65.18 -43.83 90.42 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.663 -0.866 . . . . 72.219999999999999 108.663 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.769 ' N ' ' HD1' ' A' ' 158' ' ' HIS . 0.2 OUTLIER -86.55 30.84 0.69 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.53 -0.731 . . . . 74.120000000000005 110.245 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.914 ' NE ' HG13 ' A' ' 123' ' ' ILE . 57.1 ttm-85 -51.46 156.79 1.17 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.983 -1.073 . . . . 74.340000000000003 108.419 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 1.02 ' HB2' ' HE1' ' A' ' 216' ' ' TYR . 26.4 t70 57.12 79.02 0.2 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.248 -0.908 . . . . 75.450000000000003 108.773 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -171.76 154.08 3.53 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.472 -0.768 . . . . 73.409999999999997 109.714 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.7 mt -86.7 115.85 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 74.409999999999997 109.109 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 90.5 t -113.7 120.68 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.374 -0.829 . . . . 72.530000000000001 108.867 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 40.4 t -85.72 163.61 18.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.828 . . . . 74.120000000000005 109.74 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -60.44 -47.82 84.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.519 -0.738 . . . . 70.430000000000007 109.794 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -58.61 -36.53 74.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -0.928 . . . . 74.319999999999993 109.337 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 60.9 tp60 -55.15 -44.55 75.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.197 -0.939 . . . . 74.519999999999996 108.866 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.93 -37.17 81.38 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.22 -0.925 . . . . 74.409999999999997 108.563 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.413 ' C ' ' CD2' ' A' ' 169' ' ' LEU . 4.4 tt -66.53 -60.15 2.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.418 -0.801 . . . . 75.140000000000001 109.296 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.75 -15.49 61.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.837 -0.539 . . . . 65.030000000000001 110.857 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.1 -49.32 7.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.913 -1.117 . . . . 70.209999999999994 111.075 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.403 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 2.3 mp -98.99 -53.55 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.023 -1.048 . . . . 75.319999999999993 110.453 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 23.1 m-90 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 120.896 -1.127 . . . . 73.140000000000001 109.683 -178.865 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 121.271 0.558 . . . . 73.129999999999995 109.913 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.0 p -141.75 -23.99 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.307 -0.871 . . . . 74.019999999999996 109.884 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 2.4 mp -56.42 -29.65 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 72.329999999999998 109.854 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -58.85 -39.78 82.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.07 -1.019 . . . . 74.400000000000006 109.332 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 1.5 t -73.27 -46.85 48.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.508 -0.745 . . . . 74.319999999999993 110.071 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.74 86.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 73.230000000000004 110.545 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.403 HG23 HD13 ' A' ' 188' ' ' ILE . 0.2 OUTLIER -61.48 -42.96 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.915 -1.116 . . . . 74.310000000000002 109.95 -178.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -62.67 -43.1 99.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.83 -1.169 . . . . 73.439999999999998 109.443 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -66.65 -46.31 76.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.87 . . . . 71.420000000000002 109.794 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 81.9 mt -57.11 -38.17 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.179 -0.951 . . . . 72.439999999999998 109.435 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 36.6 mtp180 -61.76 -42.37 98.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.142 -0.974 . . . . 64.219999999999999 109.333 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.427 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 49.2 mt-30 -76.45 -30.13 57.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.475 -0.766 . . . . 74.319999999999993 110.455 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -86.51 -15.6 39.53 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.161 -0.962 . . . . 75.310000000000002 110.243 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 27.1 ttt -93.44 -39.16 11.05 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.014 -1.054 . . . . 74.019999999999996 110.622 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 193' ' ' GLN . 28.2 p-10 -62.65 -32.28 73.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.192 -0.942 . . . . 74.019999999999996 110.712 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.427 ' N ' ' OD1' ' A' ' 196' ' ' ASP . 51.8 mttt -65.08 -64.77 2.35 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.948 -1.095 . . . . 75.430000000000007 110.209 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 21.6 Cg_endo -60.04 -48.94 10.78 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.906 1.738 . . . . 72.319999999999993 111.738 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -41.48 77.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 74.540000000000006 108.748 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 85.95 -46.61 3.65 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.915 -1.274 . . . . 61.509999999999998 109.915 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 30.3 mt -93.64 133.44 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.239 -1.154 . . . . 74.25 109.642 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 70.7 m -75.87 135.98 40.15 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.364 -0.976 . . . . 72.0 108.364 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 19.6 p -144.83 45.91 1.36 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.982 -1.074 . . . . 74.439999999999998 110.463 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.8 m -148.99 128.58 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.007 -1.058 . . . . 71.129999999999995 108.925 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.493 ' N ' ' CD ' ' A' ' 205' ' ' GLU . 7.6 mp0 -91.44 120.54 32.37 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.096 -1.003 . . . . 73.510000000000005 109.475 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 5.9 p -93.15 111.97 23.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.257 -0.902 . . . . 73.519999999999996 109.291 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.79 128.61 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.241 -0.912 . . . . 72.150000000000006 108.989 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -56.08 -43.66 78.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.093 -1.004 . . . . 72.400000000000006 109.49 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.571 ' O ' ' N ' ' A' ' 211' ' ' GLY . 77.5 mtt180 -57.51 146.48 29.75 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.158 -0.964 . . . . 73.310000000000002 108.533 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 56.46 -79.08 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.087 -0.708 . . . . 71.540000000000006 109.087 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . 168.01 -112.17 0.47 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.239 -1.544 . . . . 74.450000000000003 109.239 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -116.38 123.63 48.07 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.56 -0.964 . . . . 75.540000000000006 109.18 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -107.18 130.11 54.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.696 -0.627 . . . . 75.310000000000002 109.677 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.834 ' CE1' ' HG3' ' A' ' 159' ' ' ARG . 12.2 t80 -89.8 139.53 30.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.945 -1.097 . . . . 75.409999999999997 108.812 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 99.6 m -152.66 150.67 29.72 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.999 -1.112 . . . . 74.140000000000001 107.999 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . 1.02 ' HE1' ' HB2' ' A' ' 160' ' ' ASP . 0.0 OUTLIER -59.86 151.13 65.51 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 120.902 -1.124 . . . . 75.319999999999993 108.755 -179.454 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo . . . . . 0 N--CA 1.495 1.56 0 C-N-CA 122.295 1.997 . . . . 73.109999999999999 111.907 -179.798 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ptt? . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.38 -0.6 . . . . 75.239999999999995 109.38 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.605 ' NH1' ' NE ' ' B' ' 43' ' ' ARG . 66.4 mtp180 -126.59 142.07 51.66 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.568 -0.708 . . . . 73.519999999999996 109.386 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 92.8 t -118.79 130.28 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.608 0.718 . . . . 72.239999999999995 109.77 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 tp -98.5 116.73 31.37 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.933 -0.766 . . . . 73.340000000000003 108.933 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.04 109.14 17.62 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.183 -1.043 . . . . 74.349999999999994 108.183 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 77.0 mt -101.31 99.41 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.926 -1.109 . . . . 63.439999999999998 109.021 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -145.18 130.38 18.53 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.36 -0.838 . . . . 74.519999999999996 109.223 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.41 -33.69 76.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.347 -0.846 . . . . 74.129999999999995 109.67 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -74.14 105.56 5.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 74.230000000000004 109.457 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 23.4 t -68.15 -25.84 65.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.882 . . . . 65.540000000000006 109.758 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 89.0 t -62.76 -48.59 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.189 -0.944 . . . . 75.549999999999997 109.84 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.415 ' CD1' ' NZ ' ' B' ' 97' ' ' LYS . 28.5 mt -68.22 -25.95 65.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 70.140000000000001 109.585 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.39 -34.58 25.5 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.919 -1.672 . . . . 75.400000000000006 108.919 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.55 -46.8 83.05 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.847 -1.301 . . . . 65.439999999999998 109.847 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -67.25 -43.83 80.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.057 -1.261 . . . . 72.200000000000003 109.271 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 91.1 mt -63.51 -38.47 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.957 -1.089 . . . . 75.150000000000006 108.57 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -60.69 -42.98 98.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.34 -0.85 . . . . 73.010000000000005 109.376 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -86.79 -0.09 55.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.147 -0.971 . . . . 74.299999999999997 109.161 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.47 -56.49 2.25 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.489 -1.444 . . . . 70.540000000000006 109.489 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -72.13 -22.95 61.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -1.12 . . . . 75.430000000000007 109.613 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -52.56 -35.19 53.24 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.096 -1.002 . . . . 73.200000000000003 109.205 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 59.1 t -54.94 -46.12 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 74.230000000000004 108.842 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm -59.72 -53.36 58.88 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.884 -0.784 . . . . 73.519999999999996 108.884 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.27 36.77 0.23 Allowed Glycine 0 N--CA 1.5 2.901 0 N-CA-C 110.088 -1.205 . . . . 53.43 110.088 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -119.16 160.47 22.05 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.455 -1.027 . . . . 71.120000000000005 109.309 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 26.3 mtt -105.05 141.94 35.73 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.659 -0.867 . . . . 75.239999999999995 108.659 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.92 150.14 44.19 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.227 -0.921 . . . . 73.25 109.878 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' B' ' 28' ' ' ASP . 42.0 p30 -131.78 157.57 43.5 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.98 -0.748 . . . . 72.310000000000002 108.98 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.38 137.7 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.475 -0.765 . . . . 72.140000000000001 109.508 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.6 p -136.2 170.3 16.24 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.005 -0.739 . . . . 74.530000000000001 109.005 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -92.18 -107.32 0.11 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.199 -0.938 . . . . 71.019999999999996 109.935 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 60.2 p -78.54 169.67 17.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.225 -0.922 . . . . 71.400000000000006 110.189 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 56.4 mt -53.36 -33.16 52.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.601 -0.687 . . . . 71.239999999999995 109.815 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -51.26 -48.3 62.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 74.319999999999993 109.745 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -65.76 -43.79 87.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 73.030000000000001 109.409 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.02 -42.13 94.82 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.558 -1.417 . . . . 60.43 109.558 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -65.31 -41.3 94.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -1.122 . . . . 74.430000000000007 109.438 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . 0.452 ' O ' ' OD1' ' B' ' 41' ' ' ASP . 63.5 t80 -76.36 -21.3 56.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 74.420000000000002 109.892 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 12.5 tp -88.64 -36.47 16.24 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.078 -1.014 . . . . 75.409999999999997 109.875 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.3 ppp? -80.13 -29.09 38.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.175 -0.953 . . . . 61.439999999999998 110.474 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' B' ' 42' ' ' ILE . 30.4 p-10 -54.24 -32.27 55.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.966 -1.084 . . . . 74.319999999999993 109.758 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.547 ' N ' ' OD1' ' B' ' 41' ' ' ASP . 12.4 pt -84.39 -35.76 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.18 -0.95 . . . . 71.230000000000004 109.811 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.605 ' NE ' ' NH1' ' B' ' 2' ' ' ARG . 76.0 mtp180 -131.44 141.41 49.81 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.398 -0.813 . . . . 73.409999999999997 109.481 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -97.07 134.91 39.79 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.196 -0.94 . . . . 63.539999999999999 109.437 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -101.51 161.62 13.5 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.351 -0.843 . . . . 73.109999999999999 109.471 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -90.68 -42.51 10.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.178 -0.951 . . . . 62.219999999999999 109.236 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.407 ' C ' ' CD1' ' B' ' 47' ' ' LEU . 0.9 OUTLIER -104.3 109.78 21.75 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.782 -0.822 . . . . 73.120000000000005 108.782 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 66.4 t -92.59 99.11 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.252 -0.905 . . . . 74.109999999999999 108.611 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' MET . . . . . 0.517 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 3.5 tpp -113.75 129.77 56.53 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.643 -0.66 . . . . 73.439999999999998 109.574 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.462 ' N ' ' SD ' ' B' ' 49' ' ' MET . 0.3 OUTLIER -147.8 126.51 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.506 -0.746 . . . . 73.400000000000006 109.223 179.302 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 4.0 m -91.22 14.42 14.37 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.55 -0.718 . . . . 73.209999999999994 109.58 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.445 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 57.5 m-20 -75.92 145.36 40.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.152 -0.967 . . . . 70.409999999999997 109.485 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -77.42 -36.57 53.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 73.129999999999995 109.931 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -77.07 12.33 1.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -0.985 . . . . 75.209999999999994 109.492 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.72 -26.17 68.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.347 -0.846 . . . . 55.329999999999998 110.099 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 11.1 mp -45.89 -37.08 5.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.159 -0.963 . . . . 72.420000000000002 109.96 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 83.9 p -74.92 -46.22 37.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.031 -1.043 . . . . 73.040000000000006 109.901 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -64.83 -50.77 65.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 72.329999999999998 110.11 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 m -59.41 -36.7 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.755 -1.215 . . . . 74.540000000000006 109.764 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 33.2 t -57.48 -49.14 77.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 71.239999999999995 109.791 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -71.35 -27.7 63.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.031 -1.043 . . . . 74.310000000000002 109.88 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 4.8 mm -61.42 -51.25 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.839 -1.163 . . . . 75.420000000000002 109.261 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -64.28 -40.51 96.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.015 . . . . 73.319999999999993 109.326 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -68.43 -41.69 79.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.235 -0.915 . . . . 73.310000000000002 108.54 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -81.67 -76.98 0.23 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.371 -0.831 . . . . 72.439999999999998 109.224 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . 0.55 ' CE1' ' HZ1' ' B' ' 145' ' ' LYS . 73.1 m-70 -92.94 91.62 7.48 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.211 -0.93 . . . . 65.209999999999994 108.97 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 80.6 p -77.29 -30.49 54.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 73.099999999999994 110.067 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 53.1 p -82.71 54.02 2.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.124 -0.985 . . . . 71.530000000000001 109.702 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 16.7 tt -146.81 159.69 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.198 -0.939 . . . . 74.400000000000006 109.326 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 46.8 t -97.88 154.34 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.113 -0.992 . . . . 75.120000000000005 109.093 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 12.7 t -143.56 121.54 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.041 -1.037 . . . . 73.200000000000003 109.795 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . 0.517 ' O ' ' SD ' ' B' ' 49' ' ' MET . 3.2 mp -121.77 99.67 6.58 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.463 -0.94 . . . . 73.340000000000003 108.463 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 12.2 p -90.86 126.52 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 73.5 108.638 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.72 171.72 8.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.012 -1.055 . . . . 71.319999999999993 108.813 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.429 ' OG ' ' OE1' ' B' ' 82' ' ' GLU . 8.0 t -162.01 119.27 2.14 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.932 -1.105 . . . . 74.530000000000001 110.159 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.5 p30 -67.33 -1.09 4.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 64.5 109.389 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . 0.454 ' O ' ' N ' ' B' ' 79' ' ' THR . 11.9 p-10 -133.98 77.13 63.03 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 108.912 -0.773 . . . . 74.25 108.912 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.5 75.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.676 2.251 . . . . 74.430000000000007 112.033 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.454 ' N ' ' O ' ' B' ' 77' ' ' ASN . 75.1 p -98.74 148.28 24.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.128 -0.983 . . . . 73.120000000000005 109.197 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -32.62 74.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.91 . . . . 75.409999999999997 109.442 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.37 -33.19 74.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.008 . . . . 72.239999999999995 109.093 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . 0.429 ' OE1' ' OG ' ' B' ' 75' ' ' SER . 63.1 tt0 -73.12 -38.06 66.45 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.314 -0.866 . . . . 73.219999999999999 109.304 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' B' ' 83' ' ' GLU . 0.4 OUTLIER -57.62 -52.07 66.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 74.299999999999997 109.351 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 14.4 m -59.94 -38.96 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -0.969 . . . . 73.310000000000002 109.405 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -67.7 -35.42 78.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.118 -0.989 . . . . 73.239999999999995 109.303 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.56 -36.85 84.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 55.329999999999998 109.833 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -83.81 -38.64 21.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.045 -1.034 . . . . 74.450000000000003 109.238 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -68.22 -44.19 76.31 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.303 -0.873 . . . . 64.040000000000006 109.485 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -66.66 -48.91 67.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 75.129999999999995 109.595 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 141.65 75.45 0.04 OUTLIER Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.859 -1.296 . . . . 75.420000000000002 109.859 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -136.6 138.88 41.67 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.327 -1.102 . . . . 73.420000000000002 109.136 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.43 -44.25 52.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 73.319999999999993 109.348 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -153.81 166.1 33.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.352 -0.842 . . . . 73.040000000000006 109.531 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.527 ' CD1' ' O ' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -136.85 139.51 41.74 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.012 -0.736 . . . . 74.310000000000002 109.012 -178.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . 0.578 ' N ' ' CD1' ' B' ' 95' ' ' ILE . 0.5 OUTLIER -132.45 151.43 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.512 -0.743 . . . . 75.340000000000003 110.25 -179.328 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.5 124.65 23.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.814 -1.179 . . . . 70.099999999999994 108.101 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.667 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -47.0 -55.25 15.86 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.985 -1.072 . . . . 65.430000000000007 111.103 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 4.2 Cg_endo -41.93 -10.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.124 0 C-N-CA 120.853 1.035 . . . . 63.520000000000003 112.734 -177.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . 0.667 ' N ' ' O ' ' B' ' 97' ' ' LYS . 51.7 m-85 61.05 128.29 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.353 -0.61 . . . . 75.129999999999995 109.353 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -72.34 -29.66 64.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.961 -1.087 . . . . 74.230000000000004 109.42 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 101' ' ' SER . . . . . 0.719 ' O ' ' N ' ' B' ' 103' ' ' LYS . 30.2 t -175.08 31.6 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.944 -1.097 . . . . 64.510000000000005 111.115 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 36.8 mm 52.34 -70.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.48 -0.763 . . . . 74.439999999999998 110.129 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' B' ' 101' ' ' SER . 67.2 mmtt -57.99 -33.0 68.45 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.18 -1.044 . . . . 72.299999999999997 108.18 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.27 -44.32 96.81 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.176 -1.046 . . . . 74.310000000000002 108.176 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 17.4 tp -64.5 -46.68 81.95 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.565 -0.902 . . . . 73.540000000000006 108.565 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 76.9 t -58.86 -41.31 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.976 . . . . 72.030000000000001 109.165 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.23 -36.63 71.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.316 -0.865 . . . . 64.219999999999999 109.131 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 54.4 ttt85 -79.44 -26.89 41.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.306 -0.871 . . . . 75.310000000000002 109.906 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 93.7 mt -76.48 -43.71 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.032 -1.043 . . . . 55.439999999999998 108.731 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' B' ' 114' ' ' ARG . 23.9 pt-20 -70.25 -28.39 65.21 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.336 -0.945 . . . . 65.310000000000002 108.714 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.34 -49.24 74.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.409 -0.807 . . . . 74.519999999999996 109.397 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -61.5 -42.32 98.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.224 -0.922 . . . . 72.040000000000006 109.702 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 45.6 mt -120.0 49.51 1.39 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.458 -0.776 . . . . 75.349999999999994 109.569 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.529 ' N ' ' O ' ' B' ' 110' ' ' GLU . 1.2 tmt_? -65.37 -59.13 4.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -0.951 . . . . 75.5 109.232 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -69.36 -47.98 62.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 73.040000000000006 109.476 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 116' ' ' TRP . . . . . 0.526 ' O ' ' CD2' ' B' ' 116' ' ' TRP . 76.8 t90 45.83 58.59 4.24 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.313 -0.867 . . . . 74.450000000000003 109.791 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 171.13 94.69 0.1 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.414 -1.474 . . . . 64.209999999999994 109.414 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 48.7 m -144.9 170.63 15.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.295 -1.121 . . . . 71.400000000000006 109.637 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' B' ' 119' ' ' ASN . 0.0 OUTLIER -157.15 124.11 5.12 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.007 -0.738 . . . . 74.209999999999994 109.007 -178.386 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 77.7 t -77.95 -35.83 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 75.019999999999996 110.229 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 4.9 mp -113.54 140.86 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.334 -0.853 . . . . 74.239999999999995 109.544 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -145.48 119.22 9.21 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.194 -0.941 . . . . 73.329999999999998 109.566 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 6.8 pt -130.54 130.76 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.387 -0.821 . . . . 74.219999999999999 109.124 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 44.11 -136.27 5.48 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.797 -1.321 . . . . 72.409999999999997 109.797 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' B' ' 125' ' ' ASP . 20.3 p-10 -89.09 0.98 56.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -1.136 . . . . 75.120000000000005 109.035 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.0 134.63 40.12 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.36 -0.978 . . . . 75.420000000000002 108.36 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 8.4 m -130.17 143.72 50.94 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.393 -0.817 . . . . 74.219999999999999 109.471 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 25.2 mt -127.7 128.76 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.542 -0.724 . . . . 60.329999999999998 109.633 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 49.9 m -119.79 92.64 46.75 Favored Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 108.974 -0.75 . . . . 72.310000000000002 108.974 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.24 -22.27 9.85 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.134 1.889 . . . . 75.129999999999995 112.613 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -52.09 -46.33 65.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.033 -1.042 . . . . 75.230000000000004 108.985 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -103.13 16.47 26.52 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.385 -0.822 . . . . 75.120000000000005 109.021 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 51.77 58.3 5.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.222 -0.924 . . . . 75.129999999999995 108.866 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . 0.427 ' HZ3' ' CG ' ' B' ' 143' ' ' GLU . 18.2 ttmm -137.38 124.4 21.51 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.547 -0.72 . . . . 75.109999999999999 109.204 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 18.5 tt -107.09 129.9 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.368 -0.832 . . . . 70.319999999999993 109.097 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 5.7 mm -108.83 126.35 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.471 -0.768 . . . . 74.120000000000005 109.281 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . 0.52 ' C ' ' H ' ' B' ' 139' ' ' GLY . 78.8 t80 -140.26 148.01 40.83 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.526 -0.916 . . . . 74.230000000000004 108.526 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . 0.486 ' O ' ' NH1' ' B' ' 140' ' ' ARG . 40.3 tttp 54.54 6.27 0.11 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.344 -0.848 . . . . 74.219999999999999 109.619 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' B' ' 137' ' ' TYR . . . 94.61 -5.14 69.88 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.072 -1.211 . . . . 74.319999999999993 110.072 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . 0.511 ' N ' ' CD ' ' B' ' 140' ' ' ARG . 10.7 mpt_? -88.9 142.84 27.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.151 -1.206 . . . . 75.340000000000003 109.042 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -94.17 129.13 40.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.273 -0.892 . . . . 71.230000000000004 109.552 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 39.0 t -131.23 129.03 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.45 -0.781 . . . . 70.430000000000007 109.391 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . 0.427 ' CG ' ' HZ3' ' B' ' 134' ' ' LYS . 99.3 mt-10 -99.14 142.79 30.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.237 -0.915 . . . . 72.430000000000007 109.318 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 144' ' ' VAL . . . . . 0.505 ' CG2' ' CG ' ' B' ' 149' ' ' PHE . 11.9 p -141.5 157.05 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.297 -0.877 . . . . 72.129999999999995 109.593 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . 0.55 ' HZ1' ' CE1' ' B' ' 66' ' ' HIS . 13.2 ptpt -165.85 116.36 1.03 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.886 . . . . 74.5 109.635 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 168.34 -178.95 41.69 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.779 -1.728 . . . . 42.229999999999997 108.779 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . 0.563 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 1.3 mptp? -79.45 -44.22 1.63 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.052 -1.263 . . . . 73.299999999999997 109.558 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 25.3 Cg_exo -62.34 -15.69 46.62 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 122.552 2.168 . . . . 71.329999999999998 112.33 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . 0.505 ' CG ' ' CG2' ' B' ' 144' ' ' VAL . 23.3 m-85 -100.69 -35.5 9.45 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.359 -0.838 . . . . 74.230000000000004 110.153 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -58.06 -27.77 63.93 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.229 -0.919 . . . . 72.340000000000003 108.774 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' B' ' 152' ' ' LEU . 8.5 p -65.91 -44.89 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.207 -0.933 . . . . 73.349999999999994 108.515 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . 0.461 ' N ' ' CG1' ' B' ' 151' ' ' VAL . 32.3 tp -55.47 -41.86 73.53 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.745 -0.835 . . . . 74.430000000000007 108.745 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 18.6 p -71.35 -29.45 65.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.397 -0.814 . . . . 75.209999999999994 109.665 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -59.27 -57.44 13.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.062 -1.024 . . . . 73.040000000000006 109.719 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -23.52 64.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.049 -1.032 . . . . 73.430000000000007 109.053 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.26 -50.48 73.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.103 -0.998 . . . . 75.319999999999993 109.79 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . 0.42 ' C ' ' H ' ' B' ' 159' ' ' ARG . 45.9 mtt180 -71.1 -41.72 70.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.09 -1.006 . . . . 73.319999999999993 109.425 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -78.25 35.42 0.22 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.51 -0.744 . . . . 74.140000000000001 109.812 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . 0.582 ' NH1' ' CZ ' ' B' ' 214' ' ' PHE . 52.6 ttm-85 -70.24 163.14 27.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.967 . . . . 73.420000000000002 108.914 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 51.94 44.91 29.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.053 -1.03 . . . . 72.099999999999994 109.439 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -154.42 -175.82 5.59 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.279 -0.888 . . . . 73.239999999999995 109.944 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 70.1 mt -112.65 138.17 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.194 -0.669 . . . . 72.310000000000002 109.194 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.66 138.23 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.535 -0.728 . . . . 75.030000000000001 109.079 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 164' ' ' SER . . . . . 0.467 ' H ' HE21 ' B' ' 167' ' ' GLN . 13.5 p -92.8 161.5 14.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.308 -0.87 . . . . 74.219999999999999 109.882 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -62.71 -49.59 74.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.476 -0.765 . . . . 72.420000000000002 109.465 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . 0.519 ' H ' ' CD ' ' B' ' 166' ' ' GLU . 49.9 mp0 -62.11 -35.18 77.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.346 -0.846 . . . . 63.450000000000003 109.656 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 167' ' ' GLN . . . . . 0.467 HE21 ' H ' ' B' ' 164' ' ' SER . 9.5 tt0 -59.25 -35.87 74.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.161 -0.962 . . . . 72.400000000000006 109.433 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 92.1 mt -68.69 -50.34 51.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.127 -0.983 . . . . 72.319999999999993 109.492 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 9.4 mp -58.92 -43.84 91.18 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.141 -0.974 . . . . 73.340000000000003 109.264 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -75.93 -21.98 56.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.094 -1.004 . . . . 73.099999999999994 109.974 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.67 -46.86 65.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.9 -1.125 . . . . 62.130000000000003 109.66 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.557 ' N ' ' CD1' ' B' ' 172' ' ' ILE . 1.6 mp -94.56 -54.62 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.227 -0.92 . . . . 74.439999999999998 109.163 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 29.4 m-90 . . . . . 0 N--CA 1.494 1.758 0 O-C-N 121.213 -0.929 . . . . 72.230000000000004 109.724 -179.69 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 N--CA 1.493 1.455 0 CA-C-O 121.395 0.498 . . . . 74.340000000000003 111.259 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -148.79 -8.78 0.36 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.283 -0.886 . . . . 72.310000000000002 109.884 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 47.5 t -60.13 -24.15 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.087 -1.008 . . . . 65.420000000000002 109.618 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 41.8 mt -55.23 -48.23 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.353 -0.842 . . . . 75.030000000000001 110.625 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -63.47 -37.0 85.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 73.519999999999996 110.484 -178.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.78 -42.81 54.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.305 -0.872 . . . . 74.349999999999994 110.685 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.82 -47.32 47.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.788 -1.195 . . . . 61.119999999999997 110.491 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 188' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' B' ' 189' ' ' ASN . 9.3 tp -65.11 -41.94 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.021 -1.049 . . . . 72.430000000000007 110.48 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 189' ' ' ASN . . . . . 0.448 ' C ' HD21 ' B' ' 189' ' ' ASN . 0.5 OUTLIER -61.64 -47.47 85.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.998 -1.064 . . . . 75.420000000000002 109.959 -179.614 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -65.03 -50.97 64.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.154 -0.966 . . . . 74.140000000000001 110.05 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 75.8 mt -49.31 -34.22 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.125 -0.984 . . . . 74.030000000000001 109.752 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -48.57 64.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.113 -0.992 . . . . 72.329999999999998 108.98 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -71.18 -25.3 62.47 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.244 -0.91 . . . . 73.099999999999994 110.074 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -88.35 -19.91 26.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.371 -0.83 . . . . 74.430000000000007 109.862 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 6.2 ttt -103.57 -45.26 4.88 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.355 -0.841 . . . . 74.329999999999998 110.575 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -59.26 -40.29 85.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.081 -1.012 . . . . 71.209999999999994 110.471 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . 0.439 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 0.9 OUTLIER -58.22 -65.23 2.01 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.12 -0.988 . . . . 75.209999999999994 110.545 -179.268 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 198' ' ' PRO . . . . . 0.448 ' O ' ' CZ ' ' B' ' 137' ' ' TYR . 19.4 Cg_endo -56.88 -53.98 4.32 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.568 1.512 . . . . 75.319999999999993 112.238 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . 0.472 ' C ' ' H ' ' B' ' 201' ' ' ILE . 11.1 mp -63.1 -34.18 77.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.134 -0.979 . . . . 72.25 109.084 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 74.7 -37.15 1.03 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.706 -1.358 . . . . 73.239999999999995 109.706 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . 0.472 ' H ' ' C ' ' B' ' 199' ' ' LEU . 39.7 mm -93.15 132.5 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.285 -1.127 . . . . 54.299999999999997 109.386 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 14.4 t -77.22 135.16 38.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 74.310000000000002 108.861 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 203' ' ' THR . . . . . 0.454 ' O ' ' CE1' ' B' ' 214' ' ' PHE . 16.1 p -144.22 40.41 1.35 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.279 -0.888 . . . . 74.400000000000006 109.628 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 7.2 m -141.2 142.55 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.135 -0.978 . . . . 74.099999999999994 109.631 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -121.71 136.09 54.94 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.929 -0.767 . . . . 75.329999999999998 108.929 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.12 135.99 46.61 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.377 -0.827 . . . . 71.400000000000006 109.712 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 13.1 p -141.7 131.83 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.295 -0.878 . . . . 63.5 109.129 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -80.27 -25.08 39.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.172 -0.955 . . . . 74.450000000000003 109.814 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 60.1 mtp85 -48.85 -27.49 3.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 74.140000000000001 109.818 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -151.92 -67.74 0.17 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.088 -1.007 . . . . 74.430000000000007 109.694 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 211' ' ' GLY . . . . . 0.424 ' C ' ' CD1' ' B' ' 212' ' ' TYR . . . -162.84 -100.8 0.15 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.859 -1.296 . . . . 70.109999999999999 109.859 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 212' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' B' ' 211' ' ' GLY . 38.6 m-85 -137.17 158.38 44.58 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.458 -1.025 . . . . 74.209999999999994 109.389 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -130.96 125.88 34.56 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.548 -0.72 . . . . 74.299999999999997 109.694 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . 0.582 ' CZ ' ' NH1' ' B' ' 159' ' ' ARG . 0.3 OUTLIER -85.59 119.56 26.07 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.348 -0.982 . . . . 74.340000000000003 108.348 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 48.3 t -132.66 149.5 52.29 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.189 -0.671 . . . . 72.209999999999994 109.189 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.15 164.05 3.9 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.188 -0.945 . . . . 72.310000000000002 108.631 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.03 -161.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.658 2.239 . . . . 71.010000000000005 111.586 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 43.9 mttm . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.144 -0.972 . . . . 74.349999999999994 109.037 179.852 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.55 ' SD ' ' CE2' ' A' ' 25' ' ' PHE . 12.1 ptp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.442 -0.577 . . . . 65.120000000000005 109.442 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.3 mtt85 -141.49 149.58 41.1 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.319 -0.863 . . . . 73.310000000000002 109.315 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 80.3 t -114.45 141.04 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.633 -0.667 . . . . 71.420000000000002 109.495 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.6 tp -112.35 118.81 36.25 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.532 -0.73 . . . . 65.219999999999999 109.583 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 18.3 mt -115.74 101.94 9.27 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.479 -0.763 . . . . 71.439999999999998 109.18 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.401 HG21 HD11 ' A' ' 6' ' ' ILE . 76.6 mt -97.27 107.92 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.228 -0.92 . . . . 71.150000000000006 108.839 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.535 ' OE2' ' NZ ' ' A' ' 97' ' ' LYS . 53.5 tt0 -151.28 129.53 11.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.259 -0.901 . . . . 75.340000000000003 109.557 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -62.66 -33.04 74.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -0.895 . . . . 73.040000000000006 109.377 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -76.82 95.08 3.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.903 . . . . 72.420000000000002 109.329 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.0 t -61.11 -25.2 66.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.343 -0.848 . . . . 72.340000000000003 109.683 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.08 -53.95 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.964 . . . . 74.420000000000002 109.844 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 49.5 mt -64.37 -44.07 92.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.941 . . . . 72.010000000000005 109.678 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.29 -24.63 75.96 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.123 -1.991 . . . . 72.140000000000001 108.123 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.75 -57.0 10.56 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 109.702 -1.359 . . . . 72.329999999999998 109.702 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -53.5 -45.87 69.83 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.313 -1.11 . . . . 72.340000000000003 109.651 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 78.4 mt -67.34 -45.59 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.757 -1.214 . . . . 74.239999999999995 109.041 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -51.29 -48.39 62.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.127 -0.983 . . . . 71.409999999999997 109.358 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -86.59 -0.09 55.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.248 -0.907 . . . . 75.540000000000006 109.19 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.6 -59.03 2.43 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.847 -1.301 . . . . 62.149999999999999 109.847 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -71.49 -20.9 62.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -1.171 . . . . 74.420000000000002 109.938 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -57.65 -31.59 66.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.119 -0.988 . . . . 74.25 109.576 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.5 t -59.34 -29.76 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.871 . . . . 72.109999999999999 109.189 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.648 ' HZ2' ' NZ ' ' A' ' 103' ' ' LYS . 32.3 mmtt -76.51 5.44 7.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.423 -0.798 . . . . 73.230000000000004 109.267 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.57 25.39 56.73 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.12 -1.192 . . . . 75.540000000000006 110.12 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CE2' ' SD ' ' A' ' 1' ' ' MET . 8.7 m-85 -102.02 156.86 17.27 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.287 -1.125 . . . . 74.510000000000005 109.119 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.3 mmt -107.07 136.61 46.64 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.461 -0.941 . . . . 64.319999999999993 108.461 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.49 165.79 26.98 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.191 -0.943 . . . . 74.310000000000002 109.949 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.413 ' OD2' ' CD2' ' A' ' 39' ' ' LEU . 25.3 t70 -139.65 150.3 44.77 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.432 -0.792 . . . . 75.400000000000006 108.995 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.33 139.48 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.483 -0.761 . . . . 75.129999999999995 109.276 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 p -137.84 176.1 9.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.381 -0.824 . . . . 71.420000000000002 109.295 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -97.73 -104.47 0.19 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.331 -0.856 . . . . 73.109999999999999 109.77 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.3 m -77.99 166.57 22.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.227 -0.92 . . . . 74.239999999999995 110.158 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.4 mt -51.0 -35.46 34.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.606 -0.684 . . . . 71.530000000000001 109.853 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -51.9 -50.31 61.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.18 -0.95 . . . . 74.230000000000004 109.947 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -63.82 -40.06 95.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.108 -0.995 . . . . 71.010000000000005 109.247 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.05 -38.48 63.81 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.344 -1.502 . . . . 61.409999999999997 109.344 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -63.63 -42.92 98.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -1.121 . . . . 74.340000000000003 109.499 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -72.55 -34.04 67.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 75.329999999999998 109.555 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.413 ' CD2' ' OD2' ' A' ' 28' ' ' ASP . 21.1 tp -71.45 -49.54 40.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.891 . . . . 74.329999999999998 109.966 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 40' ' ' MET . 3.9 ppp? -67.67 -22.96 65.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.076 -1.015 . . . . 70.319999999999993 109.849 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -59.58 -38.06 80.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.178 -0.951 . . . . 71.219999999999999 110.002 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.3 pt -85.47 -29.82 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.157 -0.964 . . . . 74.409999999999997 110.325 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 40' ' ' MET . 65.8 mtt85 -130.39 144.67 51.53 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.237 -0.915 . . . . 75.409999999999997 109.784 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -99.07 127.62 45.04 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.308 -0.87 . . . . 75.420000000000002 109.24 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -99.66 145.36 27.68 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.298 -0.876 . . . . 74.230000000000004 109.534 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -79.1 -35.72 41.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 75.319999999999993 109.282 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.15 116.85 32.27 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.652 -0.87 . . . . 72.129999999999995 108.652 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 50.6 t -102.71 100.43 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.429 -0.952 . . . . 72.340000000000003 108.429 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.434 ' CE ' ' OH ' ' A' ' 99' ' ' TYR . 21.0 ttt -115.5 136.76 52.75 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.546 0.689 . . . . 74.109999999999999 110.079 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.458 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 1.5 p -145.07 132.22 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.57 -0.706 . . . . 71.239999999999995 109.628 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.0 m -92.78 2.03 56.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.457 -0.777 . . . . 73.109999999999999 109.253 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.458 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 51.5 m-20 -76.95 142.23 40.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 63.399999999999999 109.508 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.461 ' C ' ' H ' ' A' ' 55' ' ' ALA . 15.5 ptpt -81.15 -31.15 34.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.22 -0.925 . . . . 65.439999999999998 110.092 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -74.02 10.8 1.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.088 -1.008 . . . . 73.129999999999995 109.354 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.461 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -67.4 -21.05 65.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.427 -0.796 . . . . 64.140000000000001 110.253 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.6 mt -43.13 -48.42 6.33 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.255 -0.903 . . . . 74.430000000000007 110.067 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.2 m -68.75 -36.23 78.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.01 -1.056 . . . . 63.229999999999997 108.743 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -64.73 -64.86 0.77 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.368 -0.833 . . . . 74.439999999999998 109.579 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.1 m -48.27 -32.55 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.68 -1.263 . . . . 74.030000000000001 109.646 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.9 t -57.41 -50.53 72.71 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.227 -0.921 . . . . 73.540000000000006 109.074 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -72.33 -34.74 68.29 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.19 -1.004 . . . . 73.340000000000003 110.128 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.8 mm -67.36 -33.48 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.599 -1.313 . . . . 73.349999999999994 109.422 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -68.25 -48.9 63.83 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.231 -0.918 . . . . 74.420000000000002 110.248 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.414 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 17.2 pt-20 -75.39 -40.68 57.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.958 -1.089 . . . . 74.549999999999997 110.308 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.521 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 54.9 mttp -73.85 -21.68 60.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.198 -0.939 . . . . 75.219999999999999 110.015 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.521 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 84.4 m-70 -156.79 64.63 0.52 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.013 -1.054 . . . . 74.129999999999995 109.677 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.3 t -61.42 -28.15 69.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.935 . . . . 73.239999999999995 109.683 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 84.6 p -64.33 -20.73 66.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.266 -0.896 . . . . 71.439999999999998 110.107 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 78.3 mt -82.72 159.18 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.065 -1.022 . . . . 71.329999999999998 109.772 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.4 t -95.39 149.65 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.455 -0.778 . . . . 73.019999999999996 109.213 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.0 t -130.53 126.94 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.421 -0.799 . . . . 54.210000000000001 109.71 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.0 tt -121.89 101.95 7.88 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.493 -0.755 . . . . 74.209999999999994 109.063 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 69.4 t -90.37 145.88 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 74.409999999999997 109.154 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.7 m -128.54 155.6 44.63 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.325 -0.859 . . . . 72.310000000000002 108.751 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.6 m -165.47 144.32 6.32 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.979 -1.075 . . . . 64.540000000000006 110.68 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -86.88 19.83 2.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.482 -0.761 . . . . 74.129999999999995 109.753 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 79' ' ' THR . 55.4 t30 -138.91 55.58 7.95 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.302 -0.874 . . . . 73.340000000000003 109.397 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 77' ' ' ASN . 15.1 Cg_endo -57.5 77.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.364 2.043 . . . . 71.319999999999993 111.532 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 77' ' ' ASN . 12.5 t -102.81 171.84 7.18 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.56 -0.904 . . . . 62.530000000000001 108.56 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 p -75.74 -20.63 58.17 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.2 -0.938 . . . . 74.140000000000001 110.081 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.511 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 77.1 tt0 -69.52 -49.91 50.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.043 -1.036 . . . . 71.420000000000002 109.533 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -73.82 -27.6 61.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 73.430000000000007 109.576 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -61.26 -56.68 17.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 74.219999999999999 109.85 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.7 m -65.58 -43.61 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 74.150000000000006 109.812 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' A' ' 81' ' ' GLU . 32.2 m80 -63.44 -31.23 72.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.112 -0.993 . . . . 72.540000000000006 109.701 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.32 -45.56 79.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.085 -1.01 . . . . 64.219999999999999 109.809 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -79.98 -30.35 39.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.091 -1.005 . . . . 74.340000000000003 109.207 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -71.97 -51.58 21.25 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.309 -0.869 . . . . 74.420000000000002 109.254 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -60.68 -48.58 81.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.499 -0.751 . . . . 74.519999999999996 109.622 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.16 70.82 0.02 OUTLIER Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.332 -1.107 . . . . 74.209999999999994 110.332 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.02 125.1 43.97 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.439 -1.036 . . . . 64.099999999999994 108.634 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -77.09 -27.51 54.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.999 -1.063 . . . . 73.420000000000002 109.428 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 94' ' ' TYR . 13.3 t0 -151.81 162.38 41.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 75.040000000000006 109.059 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.526 ' N ' ' OD1' ' A' ' 93' ' ' ASP . 58.3 t80 -148.3 101.82 3.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.208 -0.933 . . . . 71.329999999999998 109.484 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.1 mm -104.83 150.65 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.475 0 O-C-N 121.179 -0.951 . . . . 74.510000000000005 110.682 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.38 123.71 20.73 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.408 -1.33 . . . . 64.319999999999993 107.408 178.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.683 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -43.18 -57.68 4.98 Favored Pre-proline 0 C--N 1.3 -1.583 0 O-C-N 121.217 -0.927 . . . . 74.510000000000005 112.298 -178.364 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 6.7 Cg_endo -43.27 -7.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 120.93 1.087 . . . . 73.109999999999999 112.49 -174.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.683 ' N ' ' O ' ' A' ' 97' ' ' LYS . 58.4 m-85 57.81 120.89 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.07 0.462 . . . . 72.540000000000006 110.268 178.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.529 ' NE ' ' OH ' ' B' ' 94' ' ' TYR . 56.5 mtt-85 -62.06 -44.58 96.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.02 -1.05 . . . . 74.540000000000006 109.327 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.84 ' O ' ' N ' ' A' ' 103' ' ' LYS . 13.0 t -171.83 47.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.091 -1.006 . . . . 74.140000000000001 110.696 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.3 mt 40.21 -66.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 CA-C-N 118.324 0.511 . . . . 75.430000000000007 111.562 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.84 ' N ' ' O ' ' A' ' 101' ' ' SER . 40.9 tptt -47.03 -26.87 1.14 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.098 -1.002 . . . . 74.140000000000001 109.025 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.38 -47.02 52.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.363 -0.836 . . . . 63.240000000000002 109.884 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -58.95 -57.23 14.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 73.219999999999999 109.324 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.2 p -52.58 -40.91 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.596 -1.315 . . . . 74.540000000000006 109.222 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.49 -44.04 62.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 75.5 109.19 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -66.22 -34.71 78.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.206 -0.934 . . . . 74.409999999999997 109.094 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.7 mt -72.09 -26.77 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.152 -0.967 . . . . 73.239999999999995 108.483 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.19 -58.28 5.74 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.689 -0.804 . . . . 74.340000000000003 109.399 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.31 -40.46 67.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.183 -0.948 . . . . 73.319999999999993 109.311 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.05 -31.06 71.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -0.866 . . . . 74.420000000000002 109.334 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.1 tt -156.14 98.21 1.85 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 74.329999999999998 109.597 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.3 mtm180 -92.04 -81.3 0.34 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.189 -0.944 . . . . 74.439999999999998 109.077 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -80.38 -81.93 0.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 74.430000000000007 109.554 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -149.67 -175.91 5.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.304 -0.873 . . . . 74.439999999999998 109.429 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.48 -155.06 4.95 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.395 -1.482 . . . . 75.040000000000006 109.395 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.452 ' C ' ' ND2' ' A' ' 119' ' ' ASN . 68.6 m -134.37 164.82 26.56 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.343 -1.092 . . . . 70.109999999999999 109.569 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.452 ' ND2' ' C ' ' A' ' 118' ' ' SER . 0.0 OUTLIER -139.67 127.15 21.55 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.083 -0.71 . . . . 65.239999999999995 109.083 -178.178 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 56.4 t -89.32 -20.63 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.312 -0.867 . . . . 74.219999999999999 109.551 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.7 mp -117.78 119.7 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.399 -0.813 . . . . 74.420000000000002 109.004 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -140.86 122.81 15.49 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.408 -0.808 . . . . 73.299999999999997 109.748 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.5 tt -138.33 130.78 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.383 -0.823 . . . . 75.340000000000003 109.143 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.62 -134.72 34.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.281 -1.528 . . . . 75.129999999999995 109.281 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.72 -9.06 45.14 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.07 -1.253 . . . . 74.450000000000003 109.462 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.35 135.73 33.77 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.971 -1.081 . . . . 54.210000000000001 108.915 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 44.2 p -129.33 139.18 51.83 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.457 -0.777 . . . . 70.239999999999995 109.122 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 81.3 mt -130.78 131.82 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.399 -0.813 . . . . 72.430000000000007 109.834 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.41 ' HG ' HD21 ' A' ' 119' ' ' ASN . 5.4 m -126.31 110.86 23.65 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.302 -0.999 . . . . 71.109999999999999 108.302 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.98 -38.47 0.82 Allowed 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.533 1.489 . . . . 75.140000000000001 112.046 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -65.35 -42.54 92.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.177 -0.952 . . . . 72.5 109.238 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 133' ' ' GLU . 44.7 mm-40 -87.82 11.48 15.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.333 -0.854 . . . . 73.140000000000001 109.708 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 132' ' ' GLU . 11.8 pt-20 33.48 61.78 0.43 Allowed 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.209 0.528 . . . . 75.329999999999998 110.846 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -152.74 148.42 27.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.081 -1.012 . . . . 71.230000000000004 110.213 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.2 tt -135.51 144.36 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.507 -0.746 . . . . 75.329999999999998 109.177 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 20.5 mt -125.49 135.37 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.63 -0.878 . . . . 71.109999999999999 108.63 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -139.38 135.68 33.94 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.086 -1.009 . . . . 74.140000000000001 110.271 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm 54.01 28.9 9.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.584 -0.698 . . . . 75.400000000000006 110.366 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.42 16.56 75.72 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 120.025 -1.083 . . . . 72.239999999999995 110.9 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -111.01 125.3 53.59 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.343 -1.093 . . . . 73.120000000000005 109.37 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -92.98 123.39 36.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.253 -0.904 . . . . 72.319999999999993 110.279 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.3 p -137.0 138.97 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.251 -1.018 . . . . 62.340000000000003 108.251 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.451 ' N ' ' CD ' ' A' ' 143' ' ' GLU . 19.3 mp0 -99.99 143.9 29.66 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.309 -0.869 . . . . 61.229999999999997 110.406 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.6 m -142.6 130.99 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.481 -0.933 . . . . 74.439999999999998 108.481 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.01 19.58 0.88 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.173 -0.954 . . . . 75.420000000000002 109.736 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.85 173.86 47.46 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.132 -1.587 . . . . 73.340000000000003 109.132 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.619 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 27.2 mttt -69.83 -37.17 7.46 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.138 -1.213 . . . . 72.219999999999999 110.162 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 19.1 Cg_exo -64.48 -18.62 63.56 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.09 1.86 . . . . 75.450000000000003 111.907 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -95.28 -30.9 13.72 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.214 -0.929 . . . . 65.239999999999995 110.009 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -50.43 -35.95 30.97 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.097 -1.002 . . . . 72.519999999999996 109.197 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.6 p -62.2 -33.37 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.138 -0.976 . . . . 74.209999999999994 109.091 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 9.5 tp -67.1 -39.3 86.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.823 . . . . 73.310000000000002 109.248 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 39.1 p -73.95 -29.7 62.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.066 -1.021 . . . . 74.310000000000002 109.388 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -61.81 -57.78 10.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.067 -1.021 . . . . 75.450000000000003 109.742 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 pp -64.43 -29.5 70.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.127 -0.983 . . . . 75.340000000000003 109.192 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.45 -45.83 69.63 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.236 -0.915 . . . . 62.140000000000001 109.046 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.411 ' C ' ' H ' ' A' ' 159' ' ' ARG . 34.6 mtt180 -73.05 -46.3 52.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.103 -0.998 . . . . 72.219999999999999 108.915 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.419 ' C ' ' H ' ' A' ' 160' ' ' ASP . 27.2 m170 -79.59 29.35 0.25 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.593 -0.692 . . . . 74.120000000000005 109.889 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.411 ' H ' ' C ' ' A' ' 157' ' ' ARG . 19.9 ttp-105 -71.29 44.7 0.09 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.162 -0.961 . . . . 74.340000000000003 109.563 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.419 ' H ' ' C ' ' A' ' 158' ' ' HIS . 6.9 t70 -171.26 46.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.88 -1.138 . . . . 75.450000000000003 109.915 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -168.39 178.55 4.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.023 -1.048 . . . . 73.409999999999997 109.975 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 66.7 mt -96.25 139.43 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.45 -0.781 . . . . 74.409999999999997 109.244 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 78.7 t -132.28 140.08 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.368 -0.832 . . . . 72.530000000000001 109.617 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 32.3 p -98.88 169.32 9.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.255 -0.903 . . . . 74.120000000000005 109.843 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -67.04 -46.79 73.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.52 -0.738 . . . . 70.430000000000007 109.982 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -53.73 -36.42 62.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.356 -0.84 . . . . 74.319999999999993 109.778 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -61.09 -49.32 77.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.158 -0.964 . . . . 74.519999999999996 109.525 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 38.7 mt -51.27 -40.6 59.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.077 -1.014 . . . . 74.409999999999997 109.027 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.4 ' C ' ' CD2' ' A' ' 169' ' ' LEU . 4.2 tt -60.65 -65.08 0.75 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.451 -0.781 . . . . 75.140000000000001 109.793 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -66.38 -10.92 48.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.214 -0.929 . . . . 65.030000000000001 110.591 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.25 -52.93 12.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.953 -1.092 . . . . 70.209999999999994 110.033 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.555 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 1.7 mp -95.77 -52.56 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.019 -1.051 . . . . 75.319999999999993 109.2 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 21.7 m-90 . . . . . 0 N--CA 1.495 1.807 0 O-C-N 121.333 -0.854 . . . . 73.140000000000001 109.259 -179.896 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.497 -0.556 . . . . 73.129999999999995 109.497 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 8.8 p -130.15 -13.69 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.347 -0.846 . . . . 74.019999999999996 110.556 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 58.6 mt -56.55 -27.83 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.749 -1.219 . . . . 72.329999999999998 109.235 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -53.12 -48.94 67.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.317 -0.864 . . . . 74.400000000000006 109.48 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 2.2 t -73.79 -28.63 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.474 -0.766 . . . . 74.319999999999993 109.982 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.44 -41.13 66.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.143 -0.973 . . . . 73.230000000000004 111.071 -178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.7 tp -76.4 -33.97 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.52 -1.363 . . . . 74.310000000000002 109.823 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -66.55 -55.72 14.16 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.272 -0.893 . . . . 73.439999999999998 110.14 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -61.85 -36.74 82.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 71.420000000000002 110.263 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 74.8 mt -69.4 -40.85 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.157 -0.965 . . . . 72.439999999999998 110.227 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 44.1 mtp85 -58.01 -39.12 77.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.88 -1.138 . . . . 64.219999999999999 108.985 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -78.06 -36.61 48.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 74.319999999999993 109.677 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.527 ' CB ' ' HZ1' ' A' ' 194' ' ' LYS . 8.5 mtpm? -84.46 2.51 40.54 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.185 -0.947 . . . . 75.310000000000002 110.49 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' MET . . . . . 1.034 ' HE1' ' CG1' ' A' ' 204' ' ' VAL . 44.3 ttp -99.58 -47.16 5.21 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.088 -1.007 . . . . 74.019999999999996 109.662 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -68.82 -32.05 71.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.89 . . . . 74.019999999999996 109.869 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.434 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 1.1 mmtm -55.2 -64.49 2.05 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.23 -0.919 . . . . 75.430000000000007 109.555 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 40.0 Cg_endo -64.17 -53.66 1.1 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.128 1.885 . . . . 72.319999999999993 112.236 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.9 mp -54.71 -56.61 17.41 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.971 -1.08 . . . . 74.540000000000006 109.643 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 100.35 -17.99 56.04 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 109.842 -1.303 . . . . 61.509999999999998 109.842 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 41.2 mt -128.16 147.78 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.341 -1.094 . . . . 74.25 109.104 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 17.5 t -77.96 136.6 38.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.971 -1.08 . . . . 72.0 109.278 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.21 15.87 1.88 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.203 -0.935 . . . . 74.439999999999998 109.302 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 1.034 ' CG1' ' HE1' ' A' ' 195' ' ' MET . 31.2 m -127.42 152.32 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.551 -0.718 . . . . 71.129999999999995 110.089 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -126.95 130.56 50.34 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.878 -0.786 . . . . 73.510000000000005 108.878 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 4.2 t -98.84 127.23 44.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.196 -0.94 . . . . 73.519999999999996 109.06 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 8.5 p -145.56 140.18 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.117 -0.989 . . . . 72.150000000000006 109.539 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -82.59 -25.28 33.4 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.263 -0.898 . . . . 72.400000000000006 109.597 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 13.2 mmt85 -49.45 -25.08 2.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.418 -0.801 . . . . 73.310000000000002 109.866 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -152.21 -74.29 0.14 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 71.540000000000006 109.448 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -166.91 -102.01 0.16 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.206 -1.558 . . . . 74.450000000000003 109.206 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -135.49 134.08 39.15 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.443 -1.034 . . . . 75.540000000000006 109.268 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -97.92 137.55 36.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.335 -0.853 . . . . 75.310000000000002 109.54 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.43 ' O ' ' SG ' ' A' ' 215' ' ' CYS . 44.1 m-85 -105.77 119.12 38.34 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.83 -0.804 . . . . 75.409999999999997 108.83 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . 0.43 ' SG ' ' O ' ' A' ' 214' ' ' PHE . 99.3 m -153.39 162.54 41.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.32 -0.862 . . . . 74.140000000000001 109.391 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -67.6 155.08 92.1 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 75.319999999999993 108.925 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo . . . . . 0 N--CA 1.49 1.275 0 C-N-CA 122.424 2.083 . . . . 73.109999999999999 112.033 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 54.7 ttm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.44 -0.578 . . . . 75.239999999999995 109.44 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -137.79 154.46 49.56 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.356 -0.84 . . . . 73.519999999999996 109.489 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 97.8 t -115.58 125.95 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 109.174 -0.676 . . . . 72.239999999999995 109.174 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' B' ' 49' ' ' MET . 4.4 tp -99.31 119.03 37.27 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.454 -0.779 . . . . 73.340000000000003 108.975 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . 0.418 ' CD1' ' SD ' ' B' ' 49' ' ' MET . 5.3 tp -120.45 100.29 7.06 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 108.959 -0.756 . . . . 74.349999999999994 108.959 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 45.7 mt -90.05 102.81 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.833 -1.167 . . . . 63.439999999999998 108.816 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.42 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 29.2 tp10 -133.2 128.87 36.91 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.501 -0.75 . . . . 74.519999999999996 109.371 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -65.49 -33.31 75.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.906 . . . . 74.129999999999995 109.168 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -88.43 111.56 21.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.346 -0.846 . . . . 74.230000000000004 109.387 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 83.1 p -69.06 -27.07 65.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.915 . . . . 65.540000000000006 109.586 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 77.7 t -61.92 -51.31 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 75.549999999999997 109.607 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 37.9 mt -64.35 -30.65 71.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 70.140000000000001 109.449 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.36 -29.91 57.57 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.623 -1.791 . . . . 75.400000000000006 108.623 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.41 -50.52 61.77 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.912 -1.275 . . . . 65.439999999999998 109.912 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -65.46 -41.53 93.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -1.165 . . . . 72.200000000000003 109.801 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 5.7 mm -67.66 -35.28 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.867 -1.145 . . . . 75.150000000000006 108.905 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -64.58 -46.39 82.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.872 . . . . 73.010000000000005 109.454 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -79.49 -9.16 59.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 74.299999999999997 109.468 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.57 -52.95 3.97 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 109.422 -1.471 . . . . 70.540000000000006 109.422 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pp -70.51 -27.83 64.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -1.089 . . . . 75.430000000000007 109.392 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.19 -34.87 61.57 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.229 -0.919 . . . . 73.200000000000003 109.21 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 49.0 t -54.36 -45.37 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.345 -0.847 . . . . 74.230000000000004 108.746 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.52 ' NZ ' ' OE1' ' B' ' 110' ' ' GLU . 23.6 mmtp -57.09 -51.64 68.48 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.607 -0.886 . . . . 73.519999999999996 108.607 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 127.66 41.12 0.3 Allowed Glycine 0 N--CA 1.5 2.907 0 N-CA-C 110.461 -1.056 . . . . 53.43 110.461 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -119.66 159.2 24.9 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.265 -1.138 . . . . 71.120000000000005 108.862 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 15.1 mmt -98.16 138.46 35.42 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.06 -1.089 . . . . 75.239999999999995 108.06 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.24 160.71 40.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.928 . . . . 73.25 110.261 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -142.84 152.84 42.59 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.663 -0.866 . . . . 72.310000000000002 108.663 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 p -114.02 137.1 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.37 -0.831 . . . . 72.140000000000001 109.238 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.6 p -134.41 170.07 16.3 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.576 -0.703 . . . . 74.530000000000001 109.457 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.479 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 1.9 pt-20 -94.4 -98.6 0.15 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.383 -0.823 . . . . 71.019999999999996 110.055 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 70.1 m -78.59 168.8 19.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.257 -0.902 . . . . 71.400000000000006 110.363 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 16.1 mt -56.76 -31.98 65.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.61 -0.681 . . . . 71.239999999999995 110.009 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -52.76 -44.07 66.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.131 -0.981 . . . . 74.319999999999993 109.861 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.479 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 64.1 m-20 -73.76 -39.58 64.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.107 -0.995 . . . . 73.030000000000001 109.553 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.3 -44.98 57.63 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.62 -1.392 . . . . 60.43 109.62 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.66 -43.32 84.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -1.153 . . . . 74.430000000000007 109.67 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -70.55 -39.85 73.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.131 -0.98 . . . . 74.420000000000002 110.099 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 25.0 tp -70.2 -44.07 69.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -0.948 . . . . 75.409999999999997 110.373 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.449 ' SD ' ' OH ' ' B' ' 45' ' ' TYR . 0.0 OUTLIER -74.49 -28.01 60.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.025 -1.047 . . . . 61.439999999999998 110.147 -179.204 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.21 -29.89 70.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.967 -1.083 . . . . 74.319999999999993 110.383 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 19.8 pt -86.34 -18.43 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.953 -1.092 . . . . 71.230000000000004 110.905 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' B' ' 40' ' ' MET . 59.0 mmt-85 -129.63 155.19 46.25 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.082 -1.011 . . . . 73.409999999999997 110.132 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -84.62 157.03 21.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.271 -0.893 . . . . 63.539999999999999 109.551 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.513 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 3.6 p90 -149.9 -174.89 4.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.208 -0.933 . . . . 73.109999999999999 109.393 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -141.5 -33.62 0.5 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.27 -0.894 . . . . 62.219999999999999 109.569 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.14 114.78 28.55 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.35 -0.844 . . . . 73.120000000000005 109.107 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 71.5 t -101.74 97.22 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.449 -0.945 . . . . 74.109999999999999 108.449 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' MET . . . . . 0.434 ' O ' ' O ' ' B' ' 4' ' ' LEU . 15.4 ttt -112.91 130.53 56.08 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.571 0.7 . . . . 73.439999999999998 109.849 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.424 HG23 ' H ' ' B' ' 52' ' ' ASP . 0.2 OUTLIER -145.05 138.85 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.4 -0.813 . . . . 73.400000000000006 109.311 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' SER . . . . . 0.42 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 53.0 p -105.46 2.29 28.44 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.548 -0.72 . . . . 73.209999999999994 110.412 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.424 ' H ' HG23 ' B' ' 50' ' ' VAL . 84.7 m-20 -75.7 147.01 39.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.987 -1.07 . . . . 70.409999999999997 109.629 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' B' ' 55' ' ' ALA . 62.3 mttp -73.35 -58.2 3.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.287 -0.883 . . . . 73.129999999999995 110.23 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -47.43 -12.85 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.089 -1.007 . . . . 75.209999999999994 109.904 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' B' ' 53' ' ' LYS . . . -58.67 -25.15 62.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.856 . . . . 55.329999999999998 110.598 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 97.7 mt -45.19 -47.44 12.49 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.065 -1.022 . . . . 72.420000000000002 109.827 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' SER . . . . . 0.408 ' O ' ' OG ' ' B' ' 60' ' ' SER . 21.5 m -68.81 -33.41 73.81 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.937 -1.102 . . . . 73.040000000000006 108.751 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -65.93 -60.68 2.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.422 -0.799 . . . . 72.329999999999998 109.77 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 31.4 m -50.0 -36.14 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.527 -1.358 . . . . 74.540000000000006 109.639 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' B' ' 57' ' ' SER . 22.5 p -56.56 -54.2 48.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.107 -0.996 . . . . 71.239999999999995 109.68 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.541 ' HE ' ' NZ ' ' B' ' 65' ' ' LYS . 5.9 ptm180 -66.02 -30.18 70.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.007 -1.058 . . . . 74.310000000000002 110.034 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 34.4 mm -65.08 -37.97 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.653 -1.28 . . . . 75.420000000000002 109.723 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' B' ' 67' ' ' SER . 25.0 mmtp -68.3 -51.87 39.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.063 -1.023 . . . . 73.319999999999993 110.302 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -67.47 -37.56 83.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.847 -1.158 . . . . 73.310000000000002 109.939 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.541 ' NZ ' ' HE ' ' B' ' 61' ' ' ARG . 92.9 mttt -81.55 -20.43 39.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -0.94 . . . . 72.439999999999998 109.707 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . 0.485 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 74.0 m-70 -155.89 64.77 0.58 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.129 -0.982 . . . . 65.209999999999994 109.701 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.404 ' N ' ' O ' ' B' ' 63' ' ' LYS . 9.4 t -63.47 -29.01 70.36 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 73.099999999999994 109.669 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 96.5 p -61.64 -25.96 67.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 71.530000000000001 110.045 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 65.6 mt -83.4 151.3 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.093 -1.004 . . . . 74.400000000000006 109.48 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 99.2 t -89.93 154.62 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.415 -0.803 . . . . 75.120000000000005 109.318 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 18.1 t -134.57 127.78 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.308 -0.87 . . . . 73.200000000000003 109.618 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . 0.409 ' C ' ' CD2' ' B' ' 72' ' ' LEU . 4.6 tt -118.91 102.66 8.95 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.455 0.645 . . . . 73.340000000000003 109.577 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 10.9 p -94.07 130.58 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.947 -1.096 . . . . 73.5 109.241 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 12.7 p -85.4 174.3 9.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.086 -1.009 . . . . 71.319999999999993 108.79 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 10.4 p -153.43 110.23 3.41 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.827 -1.171 . . . . 74.530000000000001 110.679 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -71.23 -21.7 62.09 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.499 -0.926 . . . . 64.5 108.499 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -126.64 73.38 74.61 Favored Pre-proline 0 N--CA 1.494 1.764 0 N-CA-C 108.601 -0.889 . . . . 74.25 108.601 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.18 81.51 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.778 1.652 . . . . 74.430000000000007 111.843 -178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.426 ' O ' ' OE2' ' B' ' 83' ' ' GLU . 4.3 t -110.08 152.12 26.37 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.736 -0.839 . . . . 73.120000000000005 108.736 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.6 t -50.88 -33.44 24.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 75.409999999999997 110.321 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -61.19 -37.29 82.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.999 -1.063 . . . . 72.239999999999995 110.236 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -78.93 -37.02 40.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.004 -1.06 . . . . 73.219999999999999 110.088 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.519 ' N ' ' OE1' ' B' ' 83' ' ' GLU . 0.3 OUTLIER -58.08 -50.51 73.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.098 -1.001 . . . . 74.299999999999997 109.615 -179.612 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 24.3 m -67.8 -39.87 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.121 -0.987 . . . . 73.310000000000002 109.542 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' HIS . . . . . 0.625 ' CE1' ' NE2' ' B' ' 89' ' ' GLN . 4.4 t-160 -66.41 -26.87 67.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.171 -0.955 . . . . 73.239999999999995 109.562 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.68 -42.72 60.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.123 -0.986 . . . . 55.329999999999998 110.115 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -82.37 -33.38 28.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.081 -1.012 . . . . 74.450000000000003 109.275 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -68.58 -34.38 75.7 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.355 -0.841 . . . . 64.040000000000006 109.572 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . 0.625 ' NE2' ' CE1' ' B' ' 85' ' ' HIS . 36.5 mt-30 -80.43 -63.61 1.37 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -0.953 . . . . 75.129999999999995 109.677 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 163.2 68.06 0.02 OUTLIER Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.401 -1.38 . . . . 75.420000000000002 110.435 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -127.18 137.29 52.9 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.455 -1.026 . . . . 73.420000000000002 108.837 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' B' ' 93' ' ' ASP . 14.2 t70 -80.89 -34.52 33.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.055 -1.028 . . . . 73.319999999999993 109.448 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' ASP . . . . . 0.512 ' OD1' ' NH2' ' B' ' 112' ' ' ARG . 57.9 m-20 -149.96 164.15 36.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.35 -0.844 . . . . 73.040000000000006 109.441 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.532 ' CD1' ' O ' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -140.17 112.97 8.09 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.684 -0.858 . . . . 74.310000000000002 108.684 -178.951 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 35.4 mm -114.46 147.79 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.368 -0.833 . . . . 75.340000000000003 110.124 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.47 139.52 58.58 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.172 -0.955 . . . . 70.099999999999994 108.558 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.601 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -69.17 -40.95 16.68 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.185 -0.947 . . . . 65.430000000000007 110.916 -179.19 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' B' ' 97' ' ' LYS . 33.1 Cg_exo -52.25 1.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.29 -2.518 0 CA-C-N 118.4 0.464 . . . . 63.520000000000003 112.833 -174.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . 0.601 ' N ' ' O ' ' B' ' 97' ' ' LYS . 45.7 m-85 55.55 99.19 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.453 -0.779 . . . . 75.129999999999995 109.722 178.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 34.9 ttm-85 -59.46 -36.09 75.3 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.009 -1.057 . . . . 74.230000000000004 108.724 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 101' ' ' SER . . . . . 0.737 ' O ' ' N ' ' B' ' 103' ' ' LYS . 12.6 t -173.84 39.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.234 -0.916 . . . . 64.510000000000005 110.688 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . 0.425 ' C ' ' N ' ' B' ' 104' ' ' ALA . 60.3 mt 51.92 -69.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.48 -0.763 . . . . 74.439999999999998 110.062 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . 0.737 ' N ' ' O ' ' B' ' 101' ' ' SER . 38.1 mmtm -56.65 -15.36 4.33 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.168 -1.419 . . . . 72.299999999999997 107.168 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.425 ' N ' ' C ' ' B' ' 102' ' ' ILE . . . -60.54 -78.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.349 -0.54 . . . . 74.310000000000002 110.189 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.442 ' H ' ' CD1' ' B' ' 105' ' ' LEU . 0.0 OUTLIER -51.9 -41.17 61.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.95 -1.094 . . . . 73.540000000000006 109.381 -179.151 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 27.6 t -57.84 -45.21 87.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.995 -1.066 . . . . 72.030000000000001 108.804 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.04 -30.86 62.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.21 -0.931 . . . . 64.219999999999999 108.787 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . 0.418 HH12 ' NH2' ' B' ' 112' ' ' ARG . 2.0 tpm_? -80.72 -24.77 38.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.428 -0.795 . . . . 75.310000000000002 109.649 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 93.9 mt -80.08 -38.93 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.114 -0.991 . . . . 55.439999999999998 109.391 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . 0.52 ' OE1' ' NZ ' ' B' ' 23' ' ' LYS . 22.7 pt-20 -72.58 -40.93 66.22 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.163 -0.961 . . . . 65.310000000000002 109.509 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.21 -44.26 95.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.929 . . . . 74.519999999999996 109.248 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . 0.512 ' NH2' ' OD1' ' B' ' 93' ' ' ASP . 56.2 ttm-85 -63.08 -31.73 72.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 72.040000000000006 109.443 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 13.4 tp -145.12 70.54 1.27 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.263 -0.898 . . . . 75.349999999999994 109.127 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' B' ' 110' ' ' GLU . 96.2 mtt180 -62.69 -46.22 89.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 75.5 109.709 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -81.62 -103.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 73.040000000000006 109.536 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -163.43 -28.63 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.101 -0.999 . . . . 74.450000000000003 109.759 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -167.94 -172.48 35.0 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.767 -1.333 . . . . 64.209999999999994 109.767 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 48.9 m -145.48 -172.04 3.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.369 -1.077 . . . . 71.400000000000006 109.382 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.82 160.74 43.68 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.671 -0.812 . . . . 74.209999999999994 109.406 -178.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 4.5 t -134.3 -38.1 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.484 -0.76 . . . . 75.019999999999996 109.176 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' B' ' 128' ' ' ILE . 27.6 mm -110.87 133.32 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.797 -0.816 . . . . 74.239999999999995 108.797 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -137.31 143.62 42.2 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.396 -0.815 . . . . 73.329999999999998 108.904 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.905 ' CD1' ' CZ ' ' B' ' 159' ' ' ARG . 19.5 tt -155.02 127.1 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 74.219999999999999 109.879 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 47.49 -151.56 2.07 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.723 -1.351 . . . . 72.409999999999997 109.723 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -75.75 -3.29 34.06 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.206 -1.173 . . . . 75.120000000000005 109.065 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.41 147.02 24.92 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.112 -1.07 . . . . 75.420000000000002 108.112 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 36.1 m -126.61 134.82 50.69 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.457 -0.777 . . . . 74.219999999999999 108.978 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' B' ' 121' ' ' ILE . 96.1 mt -126.2 124.15 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.54 -0.725 . . . . 60.329999999999998 109.675 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 18.8 m -123.89 109.21 30.08 Favored Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 109.198 -0.667 . . . . 72.310000000000002 109.198 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.96 -24.72 5.63 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.665 1.577 . . . . 75.129999999999995 111.629 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . 0.419 ' O ' ' OE2' ' B' ' 133' ' ' GLU . 26.3 t0 -62.0 -42.9 99.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 75.230000000000004 109.183 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -91.6 4.54 52.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.368 -0.833 . . . . 75.120000000000005 108.951 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . 0.419 ' OE2' ' O ' ' B' ' 131' ' ' ASP . 28.8 mp0 49.32 64.29 1.8 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.098 -1.001 . . . . 75.129999999999995 109.405 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -159.43 140.3 12.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.093 -1.004 . . . . 75.109999999999999 109.997 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 63.7 mt -118.98 137.23 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.631 -0.877 . . . . 70.319999999999993 108.631 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 15.2 mt -121.59 129.78 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.606 -0.684 . . . . 74.120000000000005 109.896 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -139.94 144.59 37.16 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.445 -0.784 . . . . 74.230000000000004 109.202 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 48.9 mttp 55.19 19.65 3.0 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.932 -0.766 . . . . 74.219999999999999 108.932 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.33 2.54 90.62 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.243 -1.143 . . . . 74.319999999999993 110.243 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . 0.405 ' N ' ' HD2' ' B' ' 140' ' ' ARG . 10.0 mmm-85 -89.85 129.13 36.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.249 . . . . 75.340000000000003 108.931 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -91.97 121.04 33.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.269 -0.894 . . . . 71.230000000000004 109.194 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 89.2 t -135.01 132.77 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.338 -0.851 . . . . 70.430000000000007 109.786 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -97.32 154.79 17.21 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.289 -0.882 . . . . 72.430000000000007 108.724 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 4.5 m -134.01 132.76 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.298 -0.876 . . . . 72.129999999999995 109.794 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . 0.527 ' N ' ' CD ' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -159.77 130.21 5.65 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.365 -0.834 . . . . 74.5 109.313 179.796 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 143.63 -120.63 1.52 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 108.946 -1.662 . . . . 42.229999999999997 108.946 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . 0.592 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 22.3 mtmt -101.86 -35.83 0.22 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.457 -1.026 . . . . 73.299999999999997 111.072 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . 0.88 ' O ' HD11 ' B' ' 152' ' ' LEU . 44.6 Cg_endo -92.56 8.92 2.69 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 122.264 1.976 . . . . 71.329999999999998 113.538 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . 0.46 ' CG ' ' N ' ' B' ' 150' ' ' GLU . 3.5 p90 -87.28 -40.71 14.26 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.732 -1.23 . . . . 74.230000000000004 110.215 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . 0.46 ' N ' ' CG ' ' B' ' 149' ' ' PHE . 16.4 pt-20 -69.08 -33.4 73.48 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.391 -0.818 . . . . 72.340000000000003 110.512 -178.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . 0.493 HG12 HD12 ' B' ' 152' ' ' LEU . 12.5 p -67.66 -39.14 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.822 -1.173 . . . . 73.349999999999994 109.039 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . 0.88 HD11 ' O ' ' B' ' 148' ' ' PRO . 9.6 mp -59.78 -53.04 62.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.377 -0.827 . . . . 74.430000000000007 109.475 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -72.75 -30.61 64.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.318 -0.864 . . . . 75.209999999999994 111.144 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -59.84 -52.08 66.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.606 -1.309 . . . . 73.040000000000006 109.995 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 pp -71.97 -29.53 64.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.943 -1.098 . . . . 73.430000000000007 110.001 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.77 -50.26 72.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.017 -1.052 . . . . 75.319999999999993 110.068 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . 0.532 ' C ' ' H ' ' B' ' 159' ' ' ARG . 68.9 mtp180 -72.99 -57.0 4.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.177 -0.952 . . . . 73.319999999999993 109.657 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -61.21 1.73 0.17 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.368 -0.832 . . . . 74.140000000000001 109.704 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . 1.631 HH21 ' CA ' ' B' ' 216' ' ' TYR . 26.7 ttt180 -53.09 165.39 0.32 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.119 -0.988 . . . . 73.420000000000002 109.881 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . 0.832 ' OD1' ' HG2' ' B' ' 159' ' ' ARG . 2.7 m-20 61.25 43.33 10.98 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.71 -0.619 . . . . 72.099999999999994 110.175 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -157.21 175.42 14.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.058 -1.026 . . . . 73.239999999999995 109.449 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 77.8 mt -93.6 132.19 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.656 -0.868 . . . . 72.310000000000002 108.656 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 96.8 t -128.76 138.6 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.403 -0.811 . . . . 75.030000000000001 109.86 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 37.6 t -101.04 169.08 9.19 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.454 -0.779 . . . . 74.219999999999999 109.933 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -68.63 -48.49 63.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.519 -0.738 . . . . 72.420000000000002 110.088 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.1 -41.88 79.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.295 -0.878 . . . . 63.450000000000003 110.791 -178.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 167' ' ' GLN . . . . . 0.425 ' O ' ' OD1' ' B' ' 170' ' ' ASP . 89.9 mt-30 -51.04 -38.51 51.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.048 -1.032 . . . . 72.400000000000006 110.072 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 71.9 mt -73.31 -40.53 64.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.994 -1.066 . . . . 72.319999999999993 109.635 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 1.9 tt -61.62 -42.35 98.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.405 -0.809 . . . . 73.340000000000003 109.7 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . 0.534 ' O ' ' CH2' ' B' ' 173' ' ' TRP . 22.9 p30 -86.2 -13.54 46.65 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 118.769 -1.172 . . . . 73.099999999999994 110.796 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . 0.4 ' N ' ' OD1' ' B' ' 170' ' ' ASP . . . -94.52 -38.03 11.1 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.837 -1.164 . . . . 62.130000000000003 111.056 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 60.6 mt -114.17 -9.98 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.26 -0.9 . . . . 74.439999999999998 110.589 -178.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 173' ' ' TRP . . . . . 0.534 ' CH2' ' O ' ' B' ' 170' ' ' ASP . 10.2 m95 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.43 -0.794 . . . . 72.230000000000004 109.632 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo . . . . . 0 N--CA 1.49 1.269 0 CA-C-O 121.195 0.414 . . . . 74.340000000000003 112.413 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -149.18 120.31 7.75 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.196 -0.94 . . . . 72.310000000000002 109.14 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 3.2 p -156.14 -15.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.259 -0.901 . . . . 65.420000000000002 110.868 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 29.0 mm -51.47 -31.11 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.738 -1.226 . . . . 75.030000000000001 109.502 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -54.59 -34.77 62.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.096 -1.003 . . . . 73.519999999999996 108.484 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 2.0 t -80.36 -57.22 5.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.491 -0.755 . . . . 74.349999999999994 109.366 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -51.78 -51.65 54.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.119 -0.988 . . . . 61.119999999999997 109.715 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 188' ' ' ILE . . . . . 0.439 ' CG2' ' N ' ' B' ' 189' ' ' ASN . 1.7 tt -57.68 -43.35 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.894 -1.129 . . . . 72.430000000000007 108.962 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 189' ' ' ASN . . . . . 0.439 ' N ' ' CG2' ' B' ' 188' ' ' ILE . 24.8 t-20 -62.11 -38.24 88.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.039 -1.038 . . . . 75.420000000000002 109.271 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -69.31 -50.47 46.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.922 . . . . 74.140000000000001 109.735 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 96.8 mt -53.34 -45.61 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.294 -0.879 . . . . 74.030000000000001 109.491 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -59.71 -42.75 93.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.898 . . . . 72.329999999999998 109.656 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -68.72 -38.13 79.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -0.944 . . . . 73.099999999999994 109.187 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . 0.49 ' O ' ' CG ' ' B' ' 198' ' ' PRO . 31.0 mttp -71.32 -13.24 61.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.371 -0.831 . . . . 74.430000000000007 109.24 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 30.0 mmm -101.47 -33.29 10.02 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.398 -0.814 . . . . 74.329999999999998 109.519 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -82.85 -12.5 57.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.097 -1.002 . . . . 71.209999999999994 110.454 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . 0.449 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 34.2 mttm -89.46 -65.95 0.16 Allowed Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 120.855 -1.153 . . . . 75.209999999999994 109.907 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 198' ' ' PRO . . . . . 0.49 ' CG ' ' O ' ' B' ' 194' ' ' LYS . 36.7 Cg_endo -63.56 -70.13 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.968 1.779 . . . . 75.319999999999993 112.122 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 7.6 mp -55.81 -38.82 70.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.116 -0.99 . . . . 72.25 108.777 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 77.69 5.63 86.39 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.792 -1.323 . . . . 73.239999999999995 109.792 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 16.1 mt -132.83 140.13 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.377 -1.072 . . . . 54.299999999999997 109.338 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 13.1 t -78.0 147.47 34.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 74.310000000000002 109.261 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 203' ' ' THR . . . . . 0.4 ' HB ' ' NH1' ' B' ' 159' ' ' ARG . 1.4 p -145.47 24.53 1.4 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.196 -0.94 . . . . 74.400000000000006 109.443 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 19.9 m -139.82 146.33 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.201 -0.937 . . . . 74.099999999999994 109.791 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -119.45 132.54 55.82 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.83 -0.804 . . . . 75.329999999999998 108.83 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 31.1 p -103.27 127.32 50.63 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.252 -0.905 . . . . 71.400000000000006 109.74 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 12.8 p -144.59 143.22 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.198 -0.939 . . . . 63.5 109.248 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 24.1 mtm105 -86.7 101.9 13.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.2 -0.938 . . . . 74.450000000000003 109.757 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -171.54 -76.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.378 -0.826 . . . . 74.140000000000001 108.82 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -107.56 -42.47 4.77 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.993 -0.743 . . . . 74.430000000000007 108.993 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 173.11 -119.8 0.78 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.408 -1.477 . . . . 70.109999999999999 109.408 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -129.71 156.66 43.92 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.468 -1.019 . . . . 74.209999999999994 109.17 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 52.4 mmt-85 -111.32 144.71 40.07 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.539 -0.725 . . . . 74.299999999999997 109.319 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -119.63 114.27 21.95 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.611 -0.681 . . . . 74.340000000000003 109.165 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 91.3 m -148.45 170.34 18.24 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.25 -0.906 . . . . 72.209999999999994 109.614 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . 1.631 ' CA ' HH21 ' B' ' 159' ' ' ARG . 38.0 p90 -74.27 150.58 87.5 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 72.310000000000002 109.513 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 217' ' ' PRO . . . . . 0.904 ' HD3' HH22 ' B' ' 159' ' ' ARG . 67.1 Cg_exo -37.2 156.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.358 2.039 . . . . 71.010000000000005 112.46 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.336 -0.853 . . . . 74.349999999999994 109.806 -179.765 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.592 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.409 -0.589 . . . . 65.120000000000005 109.409 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.707 ' HE ' HH21 ' A' ' 43' ' ' ARG . 81.2 mtt85 -136.34 150.19 48.74 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.376 -0.828 . . . . 73.310000000000002 109.358 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.3 t -113.76 129.42 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 121.576 0.703 . . . . 71.420000000000002 109.982 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.6 tp -98.25 118.45 34.93 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.37 -0.974 . . . . 65.219999999999999 108.37 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.8 tp -119.09 108.46 14.73 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.612 -0.68 . . . . 71.439999999999998 109.31 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.3 mt -101.2 109.72 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.514 -0.921 . . . . 71.150000000000006 108.514 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.426 ' OE1' ' CB ' ' A' ' 51' ' ' SER . 24.7 tp10 -137.96 123.69 19.89 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.437 -0.789 . . . . 75.340000000000003 109.452 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.1 tptt -68.66 -31.29 70.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.24 -0.912 . . . . 73.040000000000006 108.771 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -86.23 122.41 30.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.429 -0.794 . . . . 72.420000000000002 109.367 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.4 m -74.62 -20.7 59.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 72.340000000000003 109.728 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.2 t -71.38 -55.7 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.183 -0.948 . . . . 74.420000000000002 109.872 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 12' ' ' LEU . 3.5 mm? -67.85 -35.72 79.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.219 -0.926 . . . . 72.010000000000005 109.519 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.36 -31.07 57.63 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.758 -1.737 . . . . 72.140000000000001 108.758 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.98 -48.42 76.04 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.953 -1.259 . . . . 72.329999999999998 109.953 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -64.04 -46.65 83.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -1.174 . . . . 72.340000000000003 109.882 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.3 mm -64.65 -48.54 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.778 -1.201 . . . . 74.239999999999995 109.175 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -46.28 -56.93 5.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.182 -0.949 . . . . 71.409999999999997 109.812 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.481 ' HZ2' ' CB ' ' A' ' 18' ' ' LYS . 8.8 mtpm? -84.47 3.01 38.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.17 -0.956 . . . . 75.540000000000006 109.305 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.02 -65.95 1.71 Allowed Glycine 0 N--CA 1.483 1.786 0 N-CA-C 109.899 -1.28 . . . . 62.149999999999999 109.899 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -66.53 -23.39 66.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -1.173 . . . . 74.420000000000002 110.081 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -56.69 -35.95 69.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -0.991 . . . . 74.25 109.872 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 87.5 t -56.1 -39.36 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.164 -0.96 . . . . 72.109999999999999 109.579 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.408 ' NZ ' ' CG1' ' A' ' 106' ' ' VAL . 1.7 mptm? -63.63 -12.43 33.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 73.230000000000004 109.322 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.61 37.78 4.13 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.263 -1.135 . . . . 75.540000000000006 110.263 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -119.61 160.71 21.95 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.477 -1.013 . . . . 74.510000000000005 109.263 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.4 mmt -100.86 138.97 37.2 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.257 -1.016 . . . . 64.319999999999993 108.257 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.24 159.67 41.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.25 -0.906 . . . . 74.310000000000002 109.974 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -135.94 144.88 45.69 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.512 -0.742 . . . . 75.400000000000006 109.042 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.5 131.34 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.458 -0.776 . . . . 75.129999999999995 108.911 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.8 p -134.74 169.67 16.99 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.449 -0.782 . . . . 71.420000000000002 109.379 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -93.41 -103.22 0.13 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.304 -0.872 . . . . 73.109999999999999 109.718 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 t -78.78 166.83 22.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 74.239999999999995 110.012 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 20.4 mt -54.37 -31.94 55.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.552 -0.718 . . . . 71.530000000000001 109.82 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.16 -48.75 44.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 74.230000000000004 109.513 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.02 -38.32 90.72 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.156 -0.965 . . . . 71.010000000000005 108.914 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.85 -37.06 92.97 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.296 -1.522 . . . . 61.409999999999997 109.296 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -68.35 -42.91 78.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 74.340000000000003 109.462 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -71.78 -37.67 70.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 75.329999999999998 109.906 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.8 tp -75.9 -46.01 32.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 74.329999999999998 110.308 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.484 ' SD ' ' OD1' ' A' ' 41' ' ' ASP . 3.5 ppp? -65.24 -32.24 73.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.045 -1.034 . . . . 70.319999999999993 110.177 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.484 ' OD1' ' SD ' ' A' ' 40' ' ' MET . 87.1 m-20 -62.68 -39.58 94.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.067 -1.021 . . . . 71.219999999999999 110.03 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 25.8 pt -82.31 -29.44 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.066 -1.021 . . . . 74.409999999999997 110.176 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.707 HH21 ' HE ' ' A' ' 2' ' ' ARG . 73.6 mtp180 -130.07 140.51 50.82 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.342 -0.849 . . . . 75.409999999999997 109.596 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -90.25 157.66 17.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.214 -0.929 . . . . 75.420000000000002 109.488 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -138.04 150.89 47.34 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.391 -0.818 . . . . 74.230000000000004 109.345 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 2' ' ' ARG . 7.9 p-10 -95.21 -40.25 9.67 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.175 -0.953 . . . . 75.319999999999993 109.463 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.405 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 0.5 OUTLIER -102.97 109.66 21.29 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.397 -0.814 . . . . 72.129999999999995 109.059 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.7 t -95.08 97.67 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.193 -0.942 . . . . 72.340000000000003 108.616 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.1 ttm -111.44 131.51 55.15 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.481 -0.762 . . . . 74.109999999999999 109.595 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 p -141.0 133.0 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.479 -0.763 . . . . 71.239999999999995 109.818 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.426 ' CB ' ' OE1' ' A' ' 7' ' ' GLU . 59.9 p -100.85 7.01 43.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.608 -0.683 . . . . 73.109999999999999 109.538 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -76.04 141.12 42.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.135 -0.978 . . . . 63.399999999999999 109.465 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.51 ' C ' ' H ' ' A' ' 55' ' ' ALA . 68.0 mttm -73.43 -44.64 57.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.29 -0.881 . . . . 65.439999999999998 110.435 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -71.02 15.47 0.11 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.107 -0.996 . . . . 73.129999999999995 109.807 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.51 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -74.97 -21.61 59.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 64.140000000000001 110.334 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 55' ' ' ALA . 19.0 mt -40.49 -52.96 2.75 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.499 -0.751 . . . . 74.430000000000007 110.357 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.9 m -67.2 -32.86 74.2 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.053 -1.029 . . . . 63.229999999999997 109.141 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.43 ' N ' ' O ' ' A' ' 55' ' ' ALA . 63.0 t80 -66.06 -52.95 44.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.479 -0.763 . . . . 74.439999999999998 110.313 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 m -57.74 -34.57 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.701 -1.249 . . . . 74.030000000000001 109.709 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.1 m -59.02 -55.51 34.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.112 -0.993 . . . . 73.540000000000006 109.625 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -63.21 -28.08 69.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 73.340000000000003 110.142 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 mm -66.6 -31.79 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.951 -1.093 . . . . 73.349999999999994 109.898 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.525 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 23.1 mmtt -77.12 -50.23 13.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.057 -1.027 . . . . 74.420000000000002 110.267 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -67.62 -41.21 84.3 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.754 -1.217 . . . . 74.549999999999997 109.87 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.521 ' O ' ' NZ ' ' A' ' 145' ' ' LYS . 9.1 mtpm? -72.5 -26.24 61.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 75.219999999999999 109.75 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.583 ' CE1' ' HZ3' ' A' ' 145' ' ' LYS . 93.2 m-70 -153.19 65.93 0.77 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.16 -0.963 . . . . 74.129999999999995 109.301 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.476 ' N ' ' O ' ' A' ' 63' ' ' LYS . 18.0 m -56.45 -32.43 64.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 73.239999999999995 110.055 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 83.3 p -73.17 47.02 0.19 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 71.439999999999998 110.049 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.5 tt -146.48 159.07 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.051 -1.031 . . . . 71.329999999999998 109.45 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.5 t -95.57 154.26 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.12 -0.987 . . . . 73.019999999999996 109.106 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.4 t -142.66 118.69 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.123 -0.985 . . . . 54.210000000000001 109.823 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.6 mp -119.23 99.57 6.79 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.624 -0.88 . . . . 74.209999999999994 108.624 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.8 p -94.3 152.99 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.255 -1.017 . . . . 74.409999999999997 108.255 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.08 169.94 9.26 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.443 -0.785 . . . . 72.310000000000002 108.912 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.2 t -168.39 123.7 0.96 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.177 -0.952 . . . . 64.540000000000006 110.159 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 0.4 OUTLIER -76.12 15.84 0.51 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.466 -0.771 . . . . 74.129999999999995 110.024 -179.082 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.407 ' O ' ' N ' ' A' ' 79' ' ' THR . 30.7 m120 -139.88 58.61 11.65 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.152 -0.967 . . . . 73.340000000000003 110.115 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.44 84.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.393 2.062 . . . . 71.319999999999993 112.452 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.407 ' N ' ' O ' ' A' ' 77' ' ' ASN . 28.7 m -106.81 149.73 27.07 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.143 -1.058 . . . . 62.530000000000001 108.143 178.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.04 -32.16 71.78 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.008 -1.057 . . . . 74.140000000000001 109.367 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -64.44 -43.13 95.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.119 -0.988 . . . . 71.420000000000002 109.294 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -76.64 -35.74 57.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 73.430000000000007 109.602 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -57.74 -56.77 17.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.237 -0.914 . . . . 74.219999999999999 109.67 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.4 m -61.55 -39.75 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.131 -0.981 . . . . 74.150000000000006 109.273 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.663 ' HE2' ' NE2' ' A' ' 89' ' ' GLN . 72.7 t60 -60.22 -36.97 78.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.214 -0.929 . . . . 72.540000000000006 109.554 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.53 -45.83 88.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.195 -0.941 . . . . 64.219999999999999 109.829 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.615 ' CZ ' ' NH1' ' B' ' 108' ' ' ARG . 77.1 m-85 -74.96 -27.92 60.37 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.171 -0.955 . . . . 74.340000000000003 108.722 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -69.88 -50.23 44.54 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.521 -0.737 . . . . 74.420000000000002 109.297 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.663 ' NE2' ' HE2' ' A' ' 85' ' ' HIS . 84.8 mt-30 -58.01 -49.64 76.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.512 -0.742 . . . . 74.519999999999996 110.003 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 153.8 -10.76 0.5 Allowed Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.423 -1.37 . . . . 74.209999999999994 110.738 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.8 139.5 16.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.812 -1.405 . . . . 64.099999999999994 109.373 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.525 ' OD1' ' NZ ' ' A' ' 63' ' ' LYS . 11.4 m-20 -76.08 -40.01 54.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.103 -0.998 . . . . 73.420000000000002 109.32 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 94' ' ' TYR . 56.8 t0 -153.09 157.12 39.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.259 -0.9 . . . . 75.040000000000006 109.47 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.539 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -128.38 133.94 48.73 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.791 -0.818 . . . . 71.329999999999998 108.791 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.572 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -122.39 138.67 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 121.717 0.77 . . . . 74.510000000000005 110.242 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.8 119.98 8.15 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.027 -1.101 . . . . 64.319999999999993 108.027 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.694 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -43.95 -54.39 11.18 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 74.510000000000005 111.501 -178.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -38.51 -13.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 121.198 1.266 . . . . 73.109999999999999 113.202 -176.465 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.694 ' N ' ' O ' ' A' ' 97' ' ' LYS . 57.6 m-85 56.32 100.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.632 -0.668 . . . . 72.540000000000006 110.039 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.0 mtt85 -55.7 -42.87 75.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.786 -1.197 . . . . 74.540000000000006 108.21 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.3 t -169.1 132.23 1.31 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.855 -0.794 . . . . 74.140000000000001 108.855 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 62.4 mt -51.32 -43.8 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.148 -0.97 . . . . 75.430000000000007 109.327 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.417 ' CD ' ' N ' ' A' ' 103' ' ' LYS . 3.4 mptp? -62.07 -35.07 77.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 74.140000000000001 109.611 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.24 -55.82 10.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.13 -0.982 . . . . 63.240000000000002 109.883 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.4 tp -57.84 -56.75 17.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 73.219999999999999 109.702 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.408 ' CG1' ' NZ ' ' A' ' 23' ' ' LYS . 74.1 t -53.15 -43.71 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.971 -1.081 . . . . 74.540000000000006 109.546 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.55 -43.1 64.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.14 -0.975 . . . . 75.5 108.913 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -66.81 -37.1 83.87 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.362 -0.836 . . . . 74.409999999999997 109.333 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 65.1 mt -66.94 -33.82 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 107.879 -1.156 . . . . 73.239999999999995 107.879 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -59.6 -42.83 93.49 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.368 -0.975 . . . . 74.340000000000003 108.368 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -57.61 -50.33 73.5 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.354 -0.841 . . . . 73.319999999999993 109.497 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -59.16 -50.77 72.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.209 -0.932 . . . . 74.420000000000002 109.622 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.507 ' O ' ' CE2' ' A' ' 116' ' ' TRP . 53.2 mt -64.98 -36.61 84.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.046 -1.034 . . . . 74.329999999999998 109.646 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -56.34 -36.88 69.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -0.891 . . . . 74.439999999999998 109.595 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -78.2 54.6 1.39 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 74.430000000000007 109.431 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.507 ' CE2' ' O ' ' A' ' 113' ' ' LEU . 7.2 m-90 -59.66 148.74 32.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.928 . . . . 74.439999999999998 109.478 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -50.84 127.29 27.68 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.702 -1.359 . . . . 75.040000000000006 109.702 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.2 t -85.96 3.23 42.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -1.134 . . . . 70.109999999999999 109.424 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.517 ' CG ' ' H ' ' A' ' 120' ' ' VAL . 47.4 t30 52.53 -179.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 65.239999999999995 109.413 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.517 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 5.3 t -141.97 -45.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.304 -0.872 . . . . 74.219999999999999 109.61 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.0 mm -98.59 125.38 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.191 -0.943 . . . . 74.420000000000002 109.281 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 122' ' ' GLU . 1.3 pm0 -134.05 108.87 8.6 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.499 -0.751 . . . . 73.299999999999997 108.976 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 18.2 tt -134.88 131.08 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.466 -0.771 . . . . 75.340000000000003 109.113 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.08 -145.83 5.47 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.576 -1.409 . . . . 75.129999999999995 109.576 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -85.75 -0.62 55.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -1.185 . . . . 74.450000000000003 109.331 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.92 130.52 44.21 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.51 -0.922 . . . . 54.210000000000001 108.51 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.474 ' CG2' ' ND2' ' A' ' 119' ' ' ASN . 32.1 m -130.45 129.37 42.9 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.353 -0.842 . . . . 70.239999999999995 109.571 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 27.1 mm -113.67 133.3 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.414 -0.804 . . . . 72.430000000000007 109.195 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.417 ' OG ' ' OD1' ' A' ' 119' ' ' ASN . 3.5 m -115.87 96.59 47.2 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 109.13 -0.692 . . . . 71.109999999999999 109.13 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -78.46 -37.07 0.77 Allowed 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 121.839 1.693 . . . . 75.140000000000001 111.943 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -68.18 -43.51 77.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 72.5 109.255 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -90.23 -1.87 57.98 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.375 -0.828 . . . . 73.140000000000001 109.416 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 52.97 62.41 2.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.354 -0.841 . . . . 75.329999999999998 109.972 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -150.22 140.59 22.34 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.271 -0.893 . . . . 71.230000000000004 109.085 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 7.3 tt -121.68 135.32 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 108.93 -0.767 . . . . 75.329999999999998 108.93 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.8 mt -116.71 129.32 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.65 -0.656 . . . . 71.109999999999999 109.561 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.439 ' CE2' ' O ' ' A' ' 198' ' ' PRO . 54.8 t80 -138.46 138.05 37.76 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.589 -0.694 . . . . 74.140000000000001 109.199 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm 53.35 31.07 11.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.365 -0.834 . . . . 75.400000000000006 110.1 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 73.94 15.22 79.76 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 120.051 -1.071 . . . . 72.239999999999995 110.456 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -107.52 125.23 51.02 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.401 -1.058 . . . . 73.120000000000005 109.342 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -95.04 126.18 40.21 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.269 -0.894 . . . . 72.319999999999993 109.704 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.9 p -137.85 140.79 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.375 -0.828 . . . . 62.340000000000003 109.254 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -85.51 144.44 27.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.3 -0.875 . . . . 61.229999999999997 109.314 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.401 ' CG2' ' CD1' ' A' ' 149' ' ' PHE . 16.2 m -147.29 137.16 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.242 -0.911 . . . . 74.439999999999998 109.539 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.583 ' HZ3' ' CE1' ' A' ' 66' ' ' HIS . 43.7 pttt -156.59 20.36 0.34 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -0.861 . . . . 75.420000000000002 109.495 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.48 -178.92 51.73 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.297 -1.521 . . . . 73.340000000000003 109.297 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 13.5 ttmt -64.76 -39.89 43.27 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.185 -1.186 . . . . 72.219999999999999 109.82 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 25.4 Cg_exo -62.18 -24.63 76.44 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.324 2.016 . . . . 75.450000000000003 112.098 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.576 ' CZ ' ' CG2' ' A' ' 153' ' ' THR . 59.0 t80 -82.27 -42.02 19.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.13 -0.981 . . . . 65.239999999999995 110.003 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.466 ' O ' ' ND1' ' A' ' 154' ' ' HIS . 80.8 mm-40 -50.11 -45.47 52.89 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.134 -0.979 . . . . 72.519999999999996 109.36 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.8 p -72.05 -35.08 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.215 -0.928 . . . . 74.209999999999994 109.099 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 15.0 tp -60.5 -38.0 82.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 73.310000000000002 109.159 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.576 ' CG2' ' CZ ' ' A' ' 149' ' ' PHE . 16.8 p -71.74 -41.89 67.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.315 -0.865 . . . . 74.310000000000002 109.8 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.818 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 34.2 m80 -53.24 -51.62 61.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.31 -0.869 . . . . 75.450000000000003 110.038 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 pp -73.27 -24.38 60.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.932 -1.105 . . . . 75.340000000000003 109.601 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.4 -53.58 56.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.135 -0.978 . . . . 62.140000000000001 109.268 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 1.081 ' HG3' ' ND1' ' A' ' 158' ' ' HIS . 13.6 ptm180 -68.43 -34.95 76.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.913 . . . . 72.219999999999999 109.069 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 1.081 ' ND1' ' HG3' ' A' ' 157' ' ' ARG . 15.9 m80 -94.95 64.75 2.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.342 -0.849 . . . . 74.120000000000005 109.083 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.52 ' NH1' ' OG1' ' A' ' 203' ' ' THR . 2.1 tpm_? -81.22 -3.01 50.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.868 . . . . 74.340000000000003 110.173 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.514 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 57.4 p30 -144.85 57.67 1.29 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.987 -1.07 . . . . 75.450000000000003 110.075 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 160' ' ' ASP . 89.1 mm-40 -148.87 179.72 7.64 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.207 -0.933 . . . . 73.409999999999997 109.211 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 68.0 mt -105.64 123.48 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.896 -0.779 . . . . 74.409999999999997 108.896 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 72.9 t -117.41 130.27 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.48 -0.762 . . . . 72.530000000000001 109.472 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 86.1 p -97.05 159.29 14.99 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.286 -0.884 . . . . 74.120000000000005 109.483 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -60.14 -44.28 95.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 70.430000000000007 109.632 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -55.72 -33.33 64.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 74.319999999999993 109.252 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.427 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 61.8 tt0 -61.49 -46.21 90.99 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.277 -0.889 . . . . 74.519999999999996 109.295 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 34.1 mt -59.54 -30.88 68.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 74.409999999999997 108.886 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.4 tt -66.93 -74.38 0.11 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 75.140000000000001 109.608 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 167' ' ' GLN . 59.1 p30 -55.82 -8.45 0.42 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.504 -0.747 . . . . 65.030000000000001 111.063 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.21 -52.57 4.13 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.869 -1.144 . . . . 70.209999999999994 112.282 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.6 mp -99.31 -41.04 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 O-C-N 120.82 -1.175 . . . . 75.319999999999993 112.077 -177.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.503 ' CD2' ' C ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.8 0 O-C-N 120.39 -1.444 . . . . 73.140000000000001 109.081 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.317 0.579 . . . . 73.129999999999995 109.495 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 8.5 p -55.88 -14.27 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 74.019999999999996 109.935 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 96.0 mt -51.64 -42.4 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.942 . . . . 72.329999999999998 109.962 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.446 ' CG ' ' N ' ' A' ' 186' ' ' VAL . 19.8 pt-20 -61.63 -43.79 98.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.041 -1.037 . . . . 74.400000000000006 109.446 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . 0.446 ' N ' ' CG ' ' A' ' 185' ' ' GLU . 94.0 t -71.27 -30.41 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 74.319999999999993 109.292 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.12 -56.09 6.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.383 -0.823 . . . . 73.230000000000004 109.913 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.1 -26.29 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.809 -1.182 . . . . 74.310000000000002 109.631 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -73.45 -55.58 6.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.988 . . . . 73.439999999999998 109.962 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -68.2 -40.27 82.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.128 -0.983 . . . . 71.420000000000002 109.876 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 73.5 mt -55.68 -49.25 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.001 -1.062 . . . . 72.439999999999998 109.253 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 75.9 mtp85 -57.75 -44.69 86.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -0.977 . . . . 64.219999999999999 109.541 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -66.56 -36.85 83.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.893 . . . . 74.319999999999993 109.698 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.482 ' O ' ' CG ' ' A' ' 198' ' ' PRO . 16.4 mtpp -84.52 -2.41 57.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.913 . . . . 75.310000000000002 109.784 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 50.6 ttm -89.62 -28.41 19.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.182 -0.949 . . . . 74.019999999999996 109.555 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 197' ' ' LYS . 46.4 p30 -102.35 -10.95 19.02 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.251 -0.905 . . . . 74.019999999999996 110.303 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.576 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 14.6 tttt -77.59 -43.21 2.47 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.92 -1.113 . . . . 75.430000000000007 109.74 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 25.9 Cg_endo -88.18 -32.46 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.624 2.216 . . . . 72.319999999999993 112.304 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.54 ' N ' ' CD2' ' A' ' 199' ' ' LEU . 3.1 mm? -85.77 -98.31 0.07 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.913 -1.117 . . . . 74.540000000000006 109.211 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 152.2 -33.18 0.86 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.496 -1.441 . . . . 61.509999999999998 109.496 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 66.2 mt -96.4 128.93 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.291 -1.123 . . . . 74.25 109.529 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 25.0 p -79.87 132.74 36.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 72.0 108.962 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.52 ' OG1' ' NH1' ' A' ' 159' ' ' ARG . 5.2 p -141.69 40.25 1.7 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.293 -0.88 . . . . 74.439999999999998 109.666 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 17.1 m -138.96 139.03 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.325 -0.859 . . . . 71.129999999999995 109.333 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -125.41 129.17 49.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.536 -0.727 . . . . 73.510000000000005 109.174 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.08 140.85 37.19 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.349 -0.845 . . . . 73.519999999999996 109.32 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 10.5 p -139.65 141.47 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.299 -0.876 . . . . 72.150000000000006 109.332 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -92.61 52.89 1.96 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.234 -0.916 . . . . 72.400000000000006 109.542 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -146.24 -8.45 0.52 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.167 -0.958 . . . . 73.310000000000002 109.437 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -159.7 -69.0 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.186 -0.947 . . . . 71.540000000000006 109.327 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -172.31 -119.21 0.51 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.569 -1.413 . . . . 74.450000000000003 109.569 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -123.15 129.8 51.91 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.582 -0.952 . . . . 75.540000000000006 109.258 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -103.74 129.66 51.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.453 -0.78 . . . . 75.310000000000002 109.663 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -95.36 123.74 39.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.289 -0.882 . . . . 75.409999999999997 108.67 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 26.8 p -126.4 170.29 12.1 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 121.608 0.718 . . . . 74.140000000000001 110.32 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -78.43 140.55 60.34 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.899 -0.778 . . . . 75.319999999999993 108.899 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo . . . . . 0 N--CA 1.491 1.346 0 C-N-CA 122.06 1.84 . . . . 73.109999999999999 112.493 179.887 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 50.9 ttm . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.46 -0.57 . . . . 75.239999999999995 109.46 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -137.52 139.86 40.77 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.43 -0.794 . . . . 73.519999999999996 109.281 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.9 t -112.07 135.14 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.657 -0.652 . . . . 72.239999999999995 109.434 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.12 119.18 38.67 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.546 -0.721 . . . . 73.340000000000003 110.028 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 19.8 mt -118.55 97.17 5.61 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.644 -0.872 . . . . 74.349999999999994 108.644 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 66.8 mt -84.16 96.99 4.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.749 -1.219 . . . . 63.439999999999998 108.588 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.428 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 26.4 tp10 -134.03 132.1 39.64 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.494 -0.753 . . . . 74.519999999999996 109.375 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.7 -32.93 74.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 74.129999999999995 109.353 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -82.92 117.24 22.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 74.230000000000004 109.399 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 19.8 m -75.98 -32.27 59.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 65.540000000000006 110.026 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . 0.444 ' CG1' ' N ' ' B' ' 12' ' ' LEU . 8.9 p -60.02 -45.11 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.071 -1.018 . . . . 75.549999999999997 109.908 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.444 ' N ' ' CG1' ' B' ' 11' ' ' VAL . 77.2 mt -66.02 -35.44 80.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.012 -1.055 . . . . 70.140000000000001 109.349 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.5 -27.34 67.81 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.63 -1.788 . . . . 75.400000000000006 108.63 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.79 -54.94 25.28 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.603 -1.399 . . . . 65.439999999999998 109.603 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.39 -44.38 88.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.351 -1.088 . . . . 72.200000000000003 109.652 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 65.8 mt -65.94 -39.26 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.956 -1.09 . . . . 75.150000000000006 108.936 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.407 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 86.2 tt0 -59.69 -43.89 93.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.254 -0.904 . . . . 73.010000000000005 109.065 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -85.32 -1.6 57.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.184 -0.947 . . . . 74.299999999999997 109.109 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -85.11 -59.61 1.94 Allowed Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.695 -1.362 . . . . 70.540000000000006 109.695 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -68.55 -21.35 64.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -1.175 . . . . 75.430000000000007 109.707 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 2.3 m120 -51.79 -33.73 36.77 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.073 -1.017 . . . . 73.200000000000003 109.324 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 91.1 t -56.94 -36.82 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.179 -0.95 . . . . 74.230000000000004 108.904 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.402 ' N ' ' CD ' ' B' ' 23' ' ' LYS . 12.2 mptt -72.44 -13.12 61.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.442 -0.786 . . . . 73.519999999999996 109.212 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.52 39.25 6.35 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.045 -1.222 . . . . 53.43 110.045 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -119.23 159.94 23.12 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.515 -0.991 . . . . 71.120000000000005 109.18 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 48.4 mmm -106.03 140.65 38.69 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.721 -0.844 . . . . 75.239999999999995 108.721 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . 0.413 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -137.83 155.54 48.88 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.392 -0.817 . . . . 73.25 109.995 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 88.5 m-20 -136.41 157.23 47.29 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.424 -0.954 . . . . 72.310000000000002 108.424 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 p -122.19 139.12 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.404 -0.81 . . . . 72.140000000000001 109.749 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 2.6 p -138.05 173.49 11.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.521 -0.737 . . . . 74.530000000000001 109.416 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -98.52 -98.67 0.22 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.362 -0.836 . . . . 71.019999999999996 109.753 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 14.0 t -78.77 164.81 24.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.223 -0.923 . . . . 71.400000000000006 110.12 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 50.6 mt -53.06 -36.99 61.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.669 -0.644 . . . . 71.239999999999995 110.086 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.508 ' H ' ' CD ' ' B' ' 34' ' ' GLU . 45.1 mp0 -53.18 -46.49 68.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 74.319999999999993 109.964 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -61.42 -38.57 87.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.117 -0.989 . . . . 73.030000000000001 109.274 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.34 -33.75 87.5 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.331 -1.508 . . . . 60.43 109.331 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -69.3 -43.95 72.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -1.13 . . . . 74.430000000000007 109.743 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . 0.437 ' O ' ' OD1' ' B' ' 41' ' ' ASP . 65.9 m-85 -76.27 -22.48 55.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.141 -0.974 . . . . 74.420000000000002 110.046 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 60.3 tp -90.04 -34.31 16.0 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.081 -1.012 . . . . 75.409999999999997 109.871 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.445 ' O ' ' O ' ' B' ' 43' ' ' ARG . 2.5 ppp? -79.02 -28.1 43.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.153 -0.967 . . . . 61.439999999999998 110.405 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' B' ' 42' ' ' ILE . 39.0 p-10 -62.52 -27.02 68.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.914 -1.116 . . . . 74.319999999999993 110.041 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.542 ' N ' ' OD1' ' B' ' 41' ' ' ASP . 11.8 pt -99.27 -10.87 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.184 -0.948 . . . . 71.230000000000004 110.411 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' B' ' 40' ' ' MET . 98.6 mtt180 -130.23 155.67 45.88 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.247 -0.908 . . . . 73.409999999999997 109.812 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -80.1 169.02 18.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.203 -0.935 . . . . 63.539999999999999 109.323 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 1.7 p90 -156.36 92.37 1.32 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.134 -0.979 . . . . 73.109999999999999 109.263 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -76.55 -32.27 58.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.082 -1.011 . . . . 62.219999999999999 108.909 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.417 ' C ' ' CD1' ' B' ' 47' ' ' LEU . 0.8 OUTLIER -112.67 108.74 17.9 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.666 -0.865 . . . . 73.120000000000005 108.666 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 50.4 t -93.7 107.38 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.524 -0.917 . . . . 74.109999999999999 108.524 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.9 ttt -125.5 131.58 52.79 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.555 -0.715 . . . . 73.439999999999998 109.52 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.535 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.4 OUTLIER -145.87 138.69 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.465 -0.772 . . . . 73.400000000000006 109.803 -179.183 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' SER . . . . . 0.428 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 89.4 p -99.68 12.59 36.18 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.491 -0.755 . . . . 73.209999999999994 109.828 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.535 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 42.4 m-20 -81.77 134.37 35.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.073 -1.017 . . . . 70.409999999999997 109.561 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -71.3 -34.44 70.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.342 -0.849 . . . . 73.129999999999995 110.2 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -76.55 9.76 2.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.061 -1.024 . . . . 75.209999999999994 109.722 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' B' ' 56' ' ' LEU . . . -72.87 -21.18 60.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.19 -0.944 . . . . 55.329999999999998 110.254 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' B' ' 55' ' ' ALA . 69.5 mt -41.14 -52.7 3.25 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.496 -0.753 . . . . 72.420000000000002 110.364 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 19.8 t -65.05 -36.32 83.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.961 -1.087 . . . . 73.040000000000006 109.171 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -62.53 -61.76 2.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.327 -0.858 . . . . 72.329999999999998 109.649 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 22.4 m -49.75 -31.57 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.523 -1.36 . . . . 74.540000000000006 109.645 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' SER . . . . . 0.401 ' OG ' ' N ' ' B' ' 61' ' ' ARG . 5.8 p -58.61 -52.15 66.87 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.254 -0.904 . . . . 71.239999999999995 109.321 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.401 ' N ' ' OG ' ' B' ' 60' ' ' SER . 2.8 ptp180 -68.61 -31.86 71.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.075 -1.015 . . . . 74.310000000000002 110.0 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 40.6 mm -66.16 -40.08 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.723 -1.235 . . . . 75.420000000000002 109.879 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -65.83 -48.2 72.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 73.319999999999993 110.48 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -72.83 -37.19 67.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.826 -1.171 . . . . 73.310000000000002 110.12 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.484 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 66.4 mttm -81.49 -21.11 38.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.152 -0.968 . . . . 72.439999999999998 109.856 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . 0.484 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 72.0 m-70 -155.78 66.26 0.6 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.103 -0.998 . . . . 65.209999999999994 109.691 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.5 t -62.59 -33.53 75.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.21 -0.931 . . . . 73.099999999999994 109.87 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 51.1 m -57.29 -30.34 64.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.211 -0.93 . . . . 71.530000000000001 110.073 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 73.3 mt -76.13 153.35 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.112 -0.993 . . . . 74.400000000000006 109.532 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.428 ' CG1' ' N ' ' B' ' 71' ' ' VAL . 72.6 t -90.33 163.47 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.324 -0.86 . . . . 75.120000000000005 109.565 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.524 ' N ' ' OD2' ' B' ' 92' ' ' ASP . 12.9 t -139.81 126.57 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.239 -0.913 . . . . 73.200000000000003 109.544 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -124.94 99.93 6.36 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.727 -0.842 . . . . 73.340000000000003 108.727 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 76.0 t -91.15 145.63 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.899 . . . . 73.5 108.72 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 2.4 m -118.68 171.82 7.93 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.414 -0.804 . . . . 71.319999999999993 109.044 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.425 ' OG ' ' OH ' ' B' ' 94' ' ' TYR . 27.6 p -162.0 126.74 3.35 Favored 'General case' 0 N--CA 1.506 2.335 0 C-N-CA 118.699 -1.2 . . . . 74.530000000000001 111.284 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -65.35 -13.73 59.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.631 -0.668 . . . . 64.5 110.239 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' B' ' 79' ' ' THR . 10.1 p-10 -129.73 79.44 73.46 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 121.356 -0.84 . . . . 74.25 109.709 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -57.89 80.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.428 2.085 . . . . 74.430000000000007 111.277 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.438 ' N ' ' O ' ' B' ' 77' ' ' ASN . 66.6 p -106.48 151.25 25.21 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.933 -0.766 . . . . 73.120000000000005 108.933 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -24.17 61.52 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.37 -0.831 . . . . 75.409999999999997 109.32 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -67.93 -38.96 83.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 72.239999999999995 109.8 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -76.85 -34.57 57.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.136 -0.978 . . . . 73.219999999999999 109.77 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' B' ' 83' ' ' GLU . 0.4 OUTLIER -61.38 -51.58 68.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 74.299999999999997 109.635 -179.652 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 30.3 m -62.58 -45.81 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.975 -1.078 . . . . 73.310000000000002 109.356 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -61.79 -30.9 71.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.137 -0.977 . . . . 73.239999999999995 109.2 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.69 -39.73 91.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 55.329999999999998 109.995 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -83.72 -37.89 22.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.032 -1.042 . . . . 74.450000000000003 109.315 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -67.34 -41.17 85.65 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.306 -0.871 . . . . 64.040000000000006 109.542 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -69.57 -50.64 42.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 75.129999999999995 109.556 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 145.6 70.47 0.02 OUTLIER Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.907 -1.277 . . . . 75.420000000000002 109.907 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -129.24 131.25 47.01 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.392 -1.064 . . . . 73.420000000000002 108.881 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' B' ' 71' ' ' VAL . 56.8 m-20 -75.54 -35.54 60.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.064 -1.022 . . . . 73.319999999999993 109.078 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' ASP . . . . . 0.521 ' OD2' ' NH2' ' B' ' 112' ' ' ARG . 7.3 m-20 -153.89 155.3 35.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.385 -0.822 . . . . 73.040000000000006 109.388 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.425 ' OH ' ' OG ' ' B' ' 75' ' ' SER . 6.3 t80 -123.37 138.76 54.53 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.061 -0.718 . . . . 74.310000000000002 109.061 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . 0.583 ' N ' ' CD1' ' B' ' 95' ' ' ILE . 0.3 OUTLIER -130.1 139.68 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-O 122.069 0.937 . . . . 75.340000000000003 110.622 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.17 131.98 52.65 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.825 -1.546 . . . . 70.099999999999994 106.825 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.608 ' C ' ' H ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -61.99 -41.2 74.89 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 120.833 -1.167 . . . . 65.430000000000007 110.959 -178.179 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' B' ' 97' ' ' LYS . 37.3 Cg_exo -54.73 2.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.291 -2.486 0 CA-C-N 118.827 0.617 . . . . 63.520000000000003 112.202 -175.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . 0.608 ' H ' ' C ' ' B' ' 97' ' ' LYS . 50.4 m-85 54.83 106.56 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.614 -0.679 . . . . 75.129999999999995 109.848 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 19.7 ttm180 -61.62 -34.83 76.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 74.230000000000004 108.976 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 101' ' ' SER . . . . . 0.746 ' O ' ' N ' ' B' ' 103' ' ' LYS . 43.9 t -174.59 38.8 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.266 -0.896 . . . . 64.510000000000005 110.508 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 59.1 mt 50.17 -70.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.656 -0.652 . . . . 74.439999999999998 110.311 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . 0.746 ' N ' ' O ' ' B' ' 101' ' ' SER . 9.3 mtpm? -54.32 -21.03 8.28 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.953 -1.129 . . . . 72.299999999999997 107.953 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.21 -64.23 0.93 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.073 -0.651 . . . . 74.310000000000002 109.983 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 2.5 pp -62.29 -35.22 78.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.036 -1.04 . . . . 73.540000000000006 109.787 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 34.4 t -60.75 -44.21 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.876 -1.14 . . . . 72.030000000000001 108.605 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.23 -42.62 73.65 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.314 -0.995 . . . . 64.219999999999999 108.314 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . 0.615 ' NH1' ' CZ ' ' A' ' 87' ' ' PHE . 58.8 mtp85 -64.91 -34.07 77.51 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.412 -0.805 . . . . 75.310000000000002 108.974 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 92.4 mt -74.3 -27.69 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.488 -0.93 . . . . 55.439999999999998 108.488 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -75.31 -58.17 3.44 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.446 -0.784 . . . . 65.310000000000002 109.112 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -48.32 -42.87 32.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 74.519999999999996 109.43 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . 0.521 ' NH2' ' OD2' ' B' ' 93' ' ' ASP . 50.6 ttm-85 -61.36 -44.14 97.67 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.324 -0.86 . . . . 72.040000000000006 109.319 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 41.2 mt -134.8 75.78 1.59 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.43 -0.794 . . . . 75.349999999999994 109.313 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -68.1 -54.44 18.12 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.136 -0.978 . . . . 75.5 109.318 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 115' ' ' PHE . . . . . 0.521 ' O ' ' CG ' ' B' ' 116' ' ' TRP . 6.3 t80 -92.18 -76.97 0.44 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.186 -0.946 . . . . 73.040000000000006 109.436 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 116' ' ' TRP . . . . . 0.521 ' CG ' ' O ' ' B' ' 115' ' ' PHE . 4.0 m-90 -162.44 -173.22 3.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.053 -1.029 . . . . 74.450000000000003 109.294 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.17 176.22 0.93 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.455 -1.458 . . . . 64.209999999999994 109.455 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 118' ' ' SER . . . . . 0.471 ' C ' ' ND2' ' B' ' 119' ' ' ASN . 26.9 m -128.25 178.67 6.08 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.439 -1.036 . . . . 71.400000000000006 109.599 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . 0.471 ' ND2' ' C ' ' B' ' 118' ' ' SER . 0.0 OUTLIER -152.51 139.63 19.27 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.941 -0.704 . . . . 74.209999999999994 109.207 -178.023 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 14.2 t -86.08 -40.28 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.133 -0.979 . . . . 75.019999999999996 109.619 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 18.2 mm -105.57 134.39 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.309 -0.869 . . . . 74.239999999999995 108.838 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -157.26 131.16 8.19 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.076 -1.015 . . . . 73.329999999999998 109.036 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 3.8 tt -151.77 131.3 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 74.219999999999999 108.912 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.13 -143.11 41.34 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.997 -1.641 . . . . 72.409999999999997 108.997 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -85.65 3.48 40.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -1.192 . . . . 75.120000000000005 109.043 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 mt -92.61 125.88 37.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.352 -0.842 . . . . 75.420000000000002 108.741 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 17.4 m -123.77 140.36 53.06 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.153 -1.055 . . . . 74.219999999999999 108.153 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 5.0 mt -143.01 131.25 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.023 -1.048 . . . . 60.329999999999998 109.92 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 129' ' ' SER . . . . . 0.552 ' HB3' ' OE1' ' B' ' 132' ' ' GLU . 12.4 m -116.3 92.43 36.22 Favored Pre-proline 0 N--CA 1.495 1.814 0 N-CA-C 108.573 -0.899 . . . . 72.310000000000002 108.573 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -71.67 -27.91 17.82 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.354 1.369 . . . . 75.129999999999995 111.616 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . 0.557 ' HB2' ' OE2' ' B' ' 132' ' ' GLU . 74.4 m-20 -66.91 -42.22 85.78 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.144 -0.972 . . . . 75.230000000000004 108.88 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . 0.557 ' OE2' ' HB2' ' B' ' 131' ' ' ASP . 4.7 mp0 -87.27 6.08 35.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.328 -0.857 . . . . 75.120000000000005 109.307 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . 0.547 ' HA ' ' CE1' ' B' ' 149' ' ' PHE . 42.9 mt-10 51.03 54.55 11.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 75.129999999999995 109.446 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -150.54 145.97 26.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.212 -0.93 . . . . 75.109999999999999 109.527 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 8.3 tt -130.45 142.06 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.502 -0.749 . . . . 70.319999999999993 109.513 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 77.3 mt -129.71 124.61 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.525 -0.734 . . . . 74.120000000000005 109.561 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' B' ' 137' ' ' TYR . 18.2 p90 -142.33 152.72 43.21 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.234 -0.916 . . . . 74.230000000000004 109.66 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . 0.517 ' O ' ' NH1' ' B' ' 140' ' ' ARG . 51.3 mtpt 55.57 14.54 1.24 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.513 -0.742 . . . . 74.219999999999999 110.045 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.88 -15.77 58.45 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.144 -1.027 . . . . 74.319999999999993 110.587 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . 0.517 ' NH1' ' O ' ' B' ' 138' ' ' LYS . 10.3 mpt_? -87.26 143.16 27.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.957 -1.319 . . . . 75.340000000000003 108.846 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 141' ' ' GLU . . . . . 0.462 ' N ' ' CD ' ' B' ' 141' ' ' GLU . 21.2 mp0 -103.2 138.63 39.74 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.235 -0.915 . . . . 71.230000000000004 109.914 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 52.8 t -138.01 133.98 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.811 -0.811 . . . . 70.430000000000007 108.811 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -104.7 136.32 44.45 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.395 -0.816 . . . . 72.430000000000007 109.684 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 6.7 m -140.37 157.19 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.366 -0.834 . . . . 72.129999999999995 109.01 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -171.8 37.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.997 . . . . 74.5 109.839 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -133.25 -125.54 2.62 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 109.184 -1.566 . . . . 42.229999999999997 109.184 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . 0.611 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 33.8 tttm -76.13 -33.35 1.25 Allowed Pre-proline 0 N--CA 1.487 1.401 0 O-C-N 121.272 -1.134 . . . . 73.299999999999997 111.223 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 61.0 Cg_endo -85.22 11.77 3.27 Favored 'Trans proline' 0 N--CA 1.486 1.065 0 C-N-CA 121.854 1.702 . . . . 71.329999999999998 112.158 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . 0.547 ' CE1' ' HA ' ' B' ' 133' ' ' GLU . 13.0 t80 -110.24 -50.18 2.99 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.497 -0.752 . . . . 74.230000000000004 108.988 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -60.92 -49.79 76.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.33 -0.856 . . . . 72.340000000000003 111.099 -178.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.95 -40.23 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.91 -1.118 . . . . 73.349999999999994 110.131 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . 0.433 ' O ' ' CD1' ' B' ' 155' ' ' LEU . 16.4 tp -65.65 -40.19 92.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.117 -0.989 . . . . 74.430000000000007 109.937 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 153' ' ' THR . . . . . 0.534 HG22 ' CE1' ' B' ' 149' ' ' PHE . 14.3 p -77.62 -17.79 57.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.754 -1.216 . . . . 75.209999999999994 109.69 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -71.39 -54.23 11.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.877 -1.14 . . . . 73.040000000000006 109.607 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . 0.45 ' C ' ' CD2' ' B' ' 155' ' ' LEU . 0.0 OUTLIER -74.67 -21.17 59.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.16 -0.962 . . . . 73.430000000000007 109.455 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.9 -55.3 27.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.793 -1.192 . . . . 75.319999999999993 108.947 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -64.23 -52.23 59.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.047 -1.033 . . . . 73.319999999999993 108.838 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 158' ' ' HIS . . . . . 0.627 ' ND1' HE22 ' B' ' 161' ' ' GLN . 17.0 m-70 -88.52 42.43 1.07 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.563 -0.71 . . . . 74.140000000000001 110.15 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 22.2 ttp-105 -55.3 -77.58 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.06 -1.025 . . . . 73.420000000000002 109.368 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -65.3 82.74 0.05 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.375 -0.828 . . . . 72.099999999999994 109.396 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . 0.627 HE22 ' ND1' ' B' ' 158' ' ' HIS . 8.8 tt0 -170.46 154.36 4.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.268 -0.895 . . . . 73.239999999999995 109.496 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 162' ' ' ILE . . . . . 0.501 ' CD1' ' N ' ' B' ' 162' ' ' ILE . 2.9 mp -76.66 109.87 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.15 -0.969 . . . . 72.310000000000002 109.062 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.65 124.79 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.309 -0.869 . . . . 75.030000000000001 109.041 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 23.3 t -100.85 178.77 4.59 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.199 -0.938 . . . . 74.219999999999999 110.167 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . 0.627 ' HZ2' ' HH ' ' B' ' 212' ' ' TYR . 40.5 mttm -72.77 -56.83 4.68 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.003 0.906 . . . . 72.420000000000002 109.345 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . 0.723 ' O ' ' OD1' ' B' ' 170' ' ' ASP . 12.8 pt-20 -55.37 -27.99 51.03 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.368 -0.832 . . . . 63.450000000000003 109.535 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -60.28 -50.47 73.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.094 -1.004 . . . . 72.400000000000006 109.354 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 76.9 mt -59.27 -35.88 74.53 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.334 -0.854 . . . . 72.319999999999993 109.665 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' B' ' 172' ' ' ILE . 40.2 mt -65.54 -73.68 0.12 Allowed 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 117.692 -1.603 . . . . 73.340000000000003 109.303 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . 0.787 ' OD1' ' N ' ' B' ' 170' ' ' ASP . 0.0 OUTLIER -42.86 -21.45 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.311 0 O-C-N 120.173 -1.58 . . . . 73.099999999999994 110.233 178.578 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' B' ' 169' ' ' LEU . . . -88.12 -24.86 23.26 Favored 'General case' 0 C--N 1.283 -2.286 0 O-C-N 121.61 -0.682 . . . . 62.130000000000003 110.5 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' B' ' 169' ' ' LEU . 1.8 mp -113.93 -19.77 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.307 -0.871 . . . . 74.439999999999998 110.659 -178.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 173' ' ' TRP . . . . . 0.495 ' CZ3' ' CB ' ' B' ' 169' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.515 2.776 0 O-C-N 120.276 -1.515 . . . . 72.230000000000004 107.015 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo . . . . . 0 N--CA 1.488 1.196 0 N-CA-C 113.254 0.444 . . . . 74.340000000000003 113.254 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 12.6 m120 49.3 45.33 23.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.045 -1.034 . . . . 72.310000000000002 110.564 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.11 -23.99 16.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.259 -0.901 . . . . 65.420000000000002 109.767 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.499 HD13 HD11 ' B' ' 169' ' ' LEU . 54.2 mt -49.25 -39.78 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.114 -0.991 . . . . 75.030000000000001 110.576 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -53.61 -61.67 2.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.027 -1.045 . . . . 73.519999999999996 109.533 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 34.1 t -66.04 -40.79 88.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.486 -0.759 . . . . 74.349999999999994 110.405 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.9 -58.37 6.34 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.029 -1.044 . . . . 61.119999999999997 110.853 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 1.3 tt -56.03 -33.94 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.739 -1.225 . . . . 72.430000000000007 109.977 -178.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.99 -57.47 12.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.098 -1.001 . . . . 75.420000000000002 109.987 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -68.76 -41.05 79.39 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.159 -0.963 . . . . 74.140000000000001 110.548 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 77.5 mt -55.26 -38.75 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.817 -1.177 . . . . 74.030000000000001 108.932 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -64.97 -48.26 74.63 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.319 -0.863 . . . . 72.329999999999998 109.94 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -76.42 -20.06 57.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.043 -1.035 . . . . 73.099999999999994 111.12 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -90.73 -21.66 21.47 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.874 -1.141 . . . . 74.430000000000007 111.028 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 195' ' ' MET . . . . . 0.443 ' C ' ' SD ' ' B' ' 195' ' ' MET . 3.1 ppp? -88.35 -36.93 16.33 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.788 -1.195 . . . . 74.329999999999998 110.026 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -59.12 -42.85 91.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.16 -0.962 . . . . 71.209999999999994 110.348 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . 0.412 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 24.5 mttm -51.64 -64.45 1.44 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.974 . . . . 75.209999999999994 110.03 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 198' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 44.9 Cg_endo -65.71 -34.31 41.35 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.253 1.969 . . . . 75.319999999999993 112.613 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . 1.006 HD21 ' O ' ' B' ' 201' ' ' ILE . 13.3 tp -68.82 -43.75 74.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.176 -0.952 . . . . 72.25 109.69 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 92.92 -44.78 2.51 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.66 -1.376 . . . . 73.239999999999995 109.66 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . 1.006 ' O ' HD21 ' B' ' 199' ' ' LEU . 27.8 mm -110.31 133.81 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.397 -1.061 . . . . 54.299999999999997 109.28 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 9.0 t -77.64 135.49 38.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 74.310000000000002 109.451 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 71.2 p -143.02 44.11 1.57 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.28 -0.887 . . . . 74.400000000000006 109.24 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 17.5 m -139.03 140.89 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.377 -0.827 . . . . 74.099999999999994 109.871 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -124.76 114.79 19.73 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.779 -0.823 . . . . 75.329999999999998 108.779 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 68.4 p -96.68 123.22 40.3 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.139 -0.975 . . . . 71.400000000000006 109.468 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 6.4 t -142.94 144.31 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.131 -0.981 . . . . 63.5 109.466 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 31.5 ttm-85 -60.14 -35.53 75.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.444 -0.785 . . . . 74.450000000000003 110.042 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 209' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' B' ' 211' ' ' GLY . 18.0 mmm180 -65.96 142.46 57.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.114 -0.991 . . . . 74.140000000000001 109.728 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . 0.51 ' NH1' HH21 ' B' ' 213' ' ' ARG . 90.3 mtt180 55.79 -81.5 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.668 -0.645 . . . . 74.430000000000007 109.718 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 211' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' B' ' 209' ' ' ARG . . . -179.36 -98.98 0.12 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.825 -1.31 . . . . 70.109999999999999 109.825 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 212' ' ' TYR . . . . . 0.627 ' HH ' ' HZ2' ' B' ' 165' ' ' LYS . 6.4 m-85 -131.29 115.9 16.89 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.57 -0.959 . . . . 74.209999999999994 108.778 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . 0.51 HH21 ' NH1' ' B' ' 210' ' ' ARG . 35.4 ttm180 -93.1 128.11 38.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.421 -0.799 . . . . 74.299999999999997 109.976 -179.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -101.55 121.36 41.83 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.416 -0.957 . . . . 74.340000000000003 108.416 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.1 p -133.97 163.98 28.31 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.379 -0.825 . . . . 72.209999999999994 110.005 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -79.61 150.42 73.01 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.469 -0.769 . . . . 72.310000000000002 109.41 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.81 -101.5 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.282 1.988 . . . . 71.010000000000005 112.094 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 2.8 ptpp? . . . . . 0 N--CA 1.494 1.768 0 O-C-N 121.224 -0.922 . . . . 74.349999999999994 108.921 -179.937 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.596 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.427 -0.583 . . . . 65.120000000000005 109.427 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -137.61 148.97 46.26 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.445 -0.784 . . . . 73.310000000000002 109.319 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.0 t -118.06 125.09 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.66 -0.65 . . . . 71.420000000000002 109.724 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.436 ' C ' ' CD1' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -94.84 124.32 38.81 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.055 -1.028 . . . . 65.219999999999999 108.348 179.319 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 tp -120.57 123.89 43.98 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.039 -0.726 . . . . 71.439999999999998 109.039 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.407 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 9.5 mt -108.63 106.1 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.271 -0.893 . . . . 71.150000000000006 108.861 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.516 ' OE2' ' ND2' ' A' ' 9' ' ' ASN . 37.0 tp10 -138.24 122.88 18.62 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.359 -0.838 . . . . 75.340000000000003 109.536 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -86.41 -13.31 46.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.28 -0.887 . . . . 73.040000000000006 109.323 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.516 ' ND2' ' OE2' ' A' ' 7' ' ' GLU . 82.3 m-20 -69.37 -136.34 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.354 -0.842 . . . . 72.420000000000002 109.454 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 11' ' ' VAL . 35.1 p -158.1 -63.86 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.071 -1.018 . . . . 72.340000000000003 109.765 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.504 ' N ' ' OG ' ' A' ' 10' ' ' SER . 12.6 p -69.53 -41.22 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 74.420000000000002 109.881 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.401 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 45.8 mt -63.98 -36.4 83.85 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.174 -0.954 . . . . 72.010000000000005 109.515 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.8 -34.87 23.58 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.696 -1.762 . . . . 72.140000000000001 108.696 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.86 -44.14 89.81 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.948 -1.261 . . . . 72.329999999999998 109.948 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -67.92 -43.59 78.84 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.069 -1.253 . . . . 72.340000000000003 109.26 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.3 mt -65.64 -49.4 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.853 -1.154 . . . . 74.239999999999995 108.655 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.525 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 86.3 tt0 -46.08 -56.46 5.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.328 -0.858 . . . . 71.409999999999997 109.817 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -85.26 3.73 38.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 75.540000000000006 109.433 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.78 -67.1 1.61 Allowed Glycine 0 N--CA 1.484 1.841 0 N-CA-C 109.921 -1.271 . . . . 62.149999999999999 109.921 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -65.05 -22.77 67.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -1.205 . . . . 74.420000000000002 109.803 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 84.3 m-20 -57.35 -33.19 67.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.023 -1.048 . . . . 74.25 109.265 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.4 ' C ' ' H ' ' A' ' 24' ' ' GLY . 82.2 t -57.41 -33.46 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.343 -0.848 . . . . 72.109999999999999 109.384 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.418 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 11.8 mptt -70.24 2.54 3.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.879 . . . . 73.230000000000004 109.353 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 22' ' ' VAL . . . 85.13 35.62 12.18 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.181 -1.168 . . . . 75.540000000000006 110.181 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -119.55 160.55 22.21 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.495 -1.003 . . . . 74.510000000000005 109.218 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 45.3 mmm -103.61 137.39 41.73 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.053 -1.092 . . . . 64.319999999999993 108.053 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.77 159.99 41.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.106 -0.996 . . . . 74.310000000000002 110.101 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -141.74 155.86 45.62 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.399 -0.813 . . . . 75.400000000000006 109.081 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 p -109.85 139.49 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.365 -0.834 . . . . 75.129999999999995 108.903 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.7 p -134.21 165.26 25.52 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.454 -0.779 . . . . 71.420000000000002 109.432 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.407 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 3.9 pt-20 -91.53 -103.72 0.11 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.334 -0.854 . . . . 73.109999999999999 109.602 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.5 t -79.45 165.72 22.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 74.239999999999995 109.96 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.7 mt -52.5 -32.58 40.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.535 -0.728 . . . . 71.530000000000001 109.802 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -48.47 -50.62 30.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.145 -0.972 . . . . 74.230000000000004 109.787 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.31 -39.1 85.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.118 -0.989 . . . . 71.010000000000005 109.586 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.41 -36.52 34.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.839 -1.304 . . . . 61.409999999999997 109.839 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -64.89 -40.06 94.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -1.156 . . . . 74.340000000000003 109.928 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -81.62 -40.63 22.68 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.013 -1.054 . . . . 75.329999999999998 109.503 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.5 tp -66.05 -43.04 88.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 74.329999999999998 109.729 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.441 ' O ' ' O ' ' A' ' 43' ' ' ARG . 3.6 ppp? -69.44 -26.95 64.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.167 -0.958 . . . . 70.319999999999993 109.656 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -65.51 -39.84 92.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.948 . . . . 71.219999999999999 109.751 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.5 pt -83.8 -26.37 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.221 -0.925 . . . . 74.409999999999997 109.989 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 40' ' ' MET . 80.2 mtt85 -129.13 137.94 51.5 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.404 -0.81 . . . . 75.409999999999997 109.276 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -92.27 126.84 37.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.157 -0.964 . . . . 75.420000000000002 109.588 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -104.71 141.62 36.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.465 -0.772 . . . . 74.230000000000004 109.269 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -80.63 -35.47 33.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.228 -0.92 . . . . 75.319999999999993 109.804 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.43 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 1.1 tm? -124.55 113.82 18.58 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.795 -0.817 . . . . 72.129999999999995 108.795 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.434 ' O ' ' CG2' ' A' ' 48' ' ' VAL . 17.3 m -109.03 105.32 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.306 -0.871 . . . . 72.340000000000003 108.785 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.565 ' SD ' ' N ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -104.48 132.61 50.53 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.915 -1.143 . . . . 74.109999999999999 107.915 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.565 ' N ' ' SD ' ' A' ' 49' ' ' MET . 1.5 p -129.01 128.16 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.847 0.832 . . . . 71.239999999999995 110.352 -178.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.9 p -95.6 2.8 54.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.649 -0.657 . . . . 73.109999999999999 109.409 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.42 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 4.1 m-20 -76.48 150.59 36.64 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.179 -0.951 . . . . 63.399999999999999 109.552 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.503 ' C ' ' H ' ' A' ' 55' ' ' ALA . 18.7 pttp -85.88 -39.5 16.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.188 -0.945 . . . . 65.439999999999998 110.329 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -71.63 12.53 0.35 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.022 -1.049 . . . . 73.129999999999995 109.619 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.503 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.34 -21.52 58.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.849 . . . . 64.140000000000001 110.514 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.43 ' CD2' HE22 ' A' ' 89' ' ' GLN . 46.8 mt -39.96 -53.95 2.27 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.582 -0.699 . . . . 74.430000000000007 110.426 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 t -66.0 -35.7 81.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.984 -1.073 . . . . 63.229999999999997 109.164 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 55' ' ' ALA . 65.9 t80 -64.02 -62.42 1.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.39 -0.819 . . . . 74.439999999999998 109.763 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.8 m -49.33 -32.2 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.655 -1.278 . . . . 74.030000000000001 109.628 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.9 t -58.93 -52.06 67.36 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.263 -0.898 . . . . 73.540000000000006 109.501 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -68.8 -30.4 68.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.025 -1.047 . . . . 73.340000000000003 109.94 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 66' ' ' HIS . 31.7 mm -59.02 -44.41 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.868 -1.145 . . . . 73.349999999999994 110.083 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -74.29 -48.38 28.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.036 -1.04 . . . . 74.420000000000002 111.48 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.22 -36.11 82.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.611 -1.305 . . . . 74.549999999999997 109.861 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -92.18 -50.44 5.67 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.137 -0.977 . . . . 75.219999999999999 109.226 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.5 ' ND1' ' N ' ' A' ' 66' ' ' HIS . 0.5 OUTLIER -107.9 63.03 0.61 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.466 -0.771 . . . . 74.129999999999995 109.784 -179.467 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 t -65.94 -28.38 68.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.011 -1.055 . . . . 73.239999999999995 110.043 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.4 m -63.45 -31.0 72.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.258 -0.901 . . . . 71.439999999999998 110.627 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 58.8 mt -84.74 149.08 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.973 -1.079 . . . . 71.329999999999998 110.226 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.3 t -88.51 159.04 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.569 -0.9 . . . . 73.019999999999996 108.569 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.2 t -136.58 129.67 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.282 -0.886 . . . . 54.210000000000001 109.932 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.507 ' O ' ' SD ' ' A' ' 49' ' ' MET . 1.6 mt -127.08 100.81 6.27 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.909 -1.145 . . . . 74.209999999999994 107.909 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.0 p -96.37 154.65 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.368 -0.832 . . . . 74.409999999999997 109.282 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.435 ' O ' ' OG ' ' A' ' 75' ' ' SER . 0.4 OUTLIER -118.4 167.72 11.3 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.701 -0.851 . . . . 72.310000000000002 108.701 179.395 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 74' ' ' SER . 3.7 m -167.41 120.72 0.95 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.266 -0.897 . . . . 64.540000000000006 109.933 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -75.12 19.58 0.15 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.409 -0.807 . . . . 74.129999999999995 110.111 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.429 ' H ' ' C ' ' A' ' 75' ' ' SER . 34.7 t30 -142.48 58.41 7.4 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.129 -0.982 . . . . 73.340000000000003 109.826 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.4 82.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.342 2.028 . . . . 71.319999999999993 112.471 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 77' ' ' ASN . 44.8 m -114.2 150.99 33.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.227 -1.027 . . . . 62.530000000000001 108.227 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 t -53.45 -26.49 20.39 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.074 -1.016 . . . . 74.140000000000001 109.723 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -63.41 -47.67 81.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.163 -0.961 . . . . 71.420000000000002 109.813 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -72.64 -30.61 64.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.162 -0.962 . . . . 73.430000000000007 109.917 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.464 ' OE2' ' NE ' ' B' ' 108' ' ' ARG . 35.3 tt0 -62.04 -55.75 25.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 74.219999999999999 109.965 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.2 m -63.47 -36.49 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -0.961 . . . . 74.150000000000006 109.62 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -73.68 -19.59 60.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 72.540000000000006 109.711 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.73 -44.19 34.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.158 -0.964 . . . . 64.219999999999999 110.017 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -81.42 -29.74 33.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.078 -1.013 . . . . 74.340000000000003 109.217 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -75.75 -40.54 55.24 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.326 -0.859 . . . . 74.420000000000002 110.001 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.489 ' CG ' ' N ' ' A' ' 90' ' ' GLY . 11.1 pt20 -71.15 -46.91 60.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.042 -1.036 . . . . 74.519999999999996 109.841 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.489 ' N ' ' CG ' ' A' ' 89' ' ' GLN . . . 145.67 70.05 0.02 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.881 -1.288 . . . . 74.209999999999994 109.881 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -133.64 129.02 36.31 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.261 -1.141 . . . . 64.099999999999994 108.701 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 11.8 t70 -73.25 -40.12 64.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.912 -1.117 . . . . 73.420000000000002 108.875 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 63.6 m-20 -153.36 154.06 33.79 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.932 -0.766 . . . . 75.040000000000006 108.932 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -127.72 130.71 49.28 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.866 -0.791 . . . . 71.329999999999998 108.866 -179.597 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.553 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -118.74 142.54 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 CA-C-O 121.636 0.731 . . . . 74.510000000000005 110.14 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.12 119.89 8.69 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.982 -1.074 . . . . 64.319999999999993 108.139 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.697 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -43.22 -53.79 10.46 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.182 -0.949 . . . . 74.510000000000005 111.656 -179.168 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 1.4 Cg_endo -38.22 -11.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.27 1.314 . . . . 73.109999999999999 113.525 -176.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.697 ' N ' ' O ' ' A' ' 97' ' ' LYS . 56.4 m-85 57.88 103.27 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.454 -0.779 . . . . 72.540000000000006 109.638 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 61.2 mtm-85 -58.96 -49.93 75.98 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.071 -1.018 . . . . 74.540000000000006 109.148 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.822 ' O ' ' N ' ' A' ' 103' ' ' LYS . 3.2 t -174.5 67.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.138 -0.976 . . . . 74.140000000000001 110.631 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.561 ' N ' ' CD1' ' A' ' 102' ' ' ILE . 1.8 mp 35.6 -68.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 CA-C-O 121.213 0.53 . . . . 75.430000000000007 111.885 178.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.822 ' N ' ' O ' ' A' ' 101' ' ' SER . 28.3 mmtp -47.3 -15.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.867 -1.145 . . . . 74.140000000000001 109.096 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -60.79 -92.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.439 -0.788 . . . . 63.240000000000002 110.374 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -50.47 -33.27 20.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.053 -1.03 . . . . 73.219999999999999 110.392 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 66.2 t -65.46 -40.53 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.83 -1.168 . . . . 74.540000000000006 109.037 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.89 -39.6 81.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.218 -0.926 . . . . 75.5 108.516 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -68.43 -31.21 70.37 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.917 -0.771 . . . . 74.409999999999997 108.917 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 109' ' ' ILE . 86.4 mt -75.37 -34.65 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 108.294 -1.002 . . . . 73.239999999999995 108.294 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.407 ' OE2' ' NH1' ' A' ' 114' ' ' ARG . 82.5 tt0 -74.64 -57.81 3.69 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.472 -0.768 . . . . 74.340000000000003 109.184 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -49.62 -35.59 21.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.338 -0.851 . . . . 73.319999999999993 109.319 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 53.8 ttt85 -68.26 -39.47 82.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.339 -0.851 . . . . 74.420000000000002 109.865 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 34.8 mt -133.58 68.72 1.49 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.292 -0.88 . . . . 74.329999999999998 110.446 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.407 ' NH1' ' OE2' ' A' ' 110' ' ' GLU . 25.0 mtp85 -75.07 -43.09 55.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.941 -1.099 . . . . 74.439999999999998 108.341 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.478 ' N ' ' CD1' ' A' ' 115' ' ' PHE . 8.7 p90 -132.99 73.21 1.51 Allowed 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.825 -0.805 . . . . 74.430000000000007 108.825 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -56.26 -177.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.601 -0.687 . . . . 74.439999999999998 109.972 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.11 142.39 13.3 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.895 -1.282 . . . . 75.040000000000006 109.895 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.401 ' O ' ' O ' ' A' ' 119' ' ' ASN . 16.0 t -161.85 -61.16 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.346 -1.091 . . . . 70.109999999999999 109.129 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.427 HD22 ' N ' ' A' ' 128' ' ' ILE . 20.7 t-20 51.45 95.95 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.359 -0.838 . . . . 65.239999999999995 109.875 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.4 t -84.34 -19.41 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.049 -1.032 . . . . 74.219999999999999 109.158 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 22.4 mm -110.26 124.56 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.548 -0.72 . . . . 74.420000000000002 109.758 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -138.38 109.16 6.66 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.469 -0.938 . . . . 73.299999999999997 108.469 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.9 pt -142.05 122.03 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.243 -0.91 . . . . 75.340000000000003 109.338 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.03 -148.39 32.55 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.429 -1.468 . . . . 75.129999999999995 109.429 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -83.89 9.98 10.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.265 -1.138 . . . . 74.450000000000003 109.391 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.52 131.82 43.78 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.39 -0.819 . . . . 54.210000000000001 108.878 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 p -128.55 128.26 43.93 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.574 -0.899 . . . . 70.239999999999995 108.574 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.427 ' N ' HD22 ' A' ' 119' ' ' ASN . 21.2 mt -133.9 135.08 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.334 -0.854 . . . . 72.430000000000007 109.752 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.3 m -119.22 91.75 44.36 Favored Pre-proline 0 N--CA 1.497 1.893 0 N-CA-C 108.845 -0.798 . . . . 71.109999999999999 108.845 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.32 -25.84 6.67 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.226 1.95 . . . . 75.140000000000001 112.538 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -59.32 -40.37 86.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.088 -1.007 . . . . 72.5 108.83 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -97.63 5.78 48.92 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.5 -0.926 . . . . 73.140000000000001 108.5 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 56.81 61.2 2.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.257 -0.902 . . . . 75.329999999999998 109.03 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -149.75 148.35 29.12 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.349 -0.844 . . . . 71.230000000000004 109.543 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 13.1 tt -119.93 139.51 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.548 -0.72 . . . . 75.329999999999998 109.212 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.85 126.34 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.581 -0.699 . . . . 71.109999999999999 109.323 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.415 ' C ' ' H ' ' A' ' 139' ' ' GLY . 68.9 t80 -141.46 149.95 41.63 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.395 -0.815 . . . . 74.140000000000001 109.588 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 138' ' ' LYS . 54.6 tttt 55.9 9.59 0.47 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.495 -0.753 . . . . 75.400000000000006 109.715 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 137' ' ' TYR . . . 89.95 14.03 59.88 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.954 -1.258 . . . . 72.239999999999995 109.954 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -105.35 136.58 44.62 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.421 -1.046 . . . . 73.120000000000005 109.077 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -101.43 118.42 36.92 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.482 -0.761 . . . . 72.319999999999993 110.041 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 10.7 p -138.06 132.54 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.408 -0.808 . . . . 62.340000000000003 108.933 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.427 ' CG ' ' N ' ' A' ' 144' ' ' VAL . 29.5 tt0 -92.3 160.71 15.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -0.917 . . . . 61.229999999999997 110.357 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.455 ' CG2' ' CG ' ' A' ' 149' ' ' PHE . 13.5 p -143.41 140.81 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.182 -1.044 . . . . 74.439999999999998 108.182 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -152.26 113.25 4.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.773 -1.205 . . . . 75.420000000000002 110.399 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 176.89 -164.45 33.94 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.985 -1.646 . . . . 73.340000000000003 108.985 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.623 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 17.3 mtpp -91.19 -32.24 0.35 Allowed Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.055 -1.262 . . . . 72.219999999999999 111.499 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 85.8 Cg_endo -88.33 21.15 1.04 Allowed 'Trans proline' 0 N--CA 1.488 1.196 0 C-N-CA 122.131 1.887 . . . . 75.450000000000003 112.516 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.455 ' CG ' ' CG2' ' A' ' 144' ' ' VAL . 41.0 m-85 -125.65 -29.75 3.13 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.475 -0.766 . . . . 65.239999999999995 109.679 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -60.84 -34.05 73.98 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.909 -1.119 . . . . 72.519999999999996 108.606 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.04 -33.97 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.344 -0.984 . . . . 74.209999999999994 108.344 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 17.7 tp -62.26 -45.23 94.22 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.532 -0.914 . . . . 73.310000000000002 108.532 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.9 p -65.47 -37.61 87.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 74.310000000000002 108.957 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -53.45 -60.55 3.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.563 -0.71 . . . . 75.450000000000003 110.765 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.3 pp -65.0 -23.53 67.24 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.096 -1.002 . . . . 75.340000000000003 109.743 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.1 -40.01 84.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.976 -1.077 . . . . 62.140000000000001 108.852 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.421 ' C ' ' H ' ' A' ' 159' ' ' ARG . 10.0 mtt180 -86.1 -51.52 6.26 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.235 -0.916 . . . . 72.219999999999999 109.66 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -73.93 49.34 0.33 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 74.120000000000005 108.925 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.626 ' NH1' ' OD2' ' A' ' 160' ' ' ASP . 7.6 ptm180 -77.72 14.08 1.15 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.639 -0.663 . . . . 74.340000000000003 111.025 -178.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.626 ' OD2' ' NH1' ' A' ' 159' ' ' ARG . 64.2 m-20 -148.21 47.48 1.06 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.682 -1.262 . . . . 75.450000000000003 110.129 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 0.473 ' NE2' ' OD2' ' B' ' 160' ' ' ASP . 63.9 mt-30 -150.86 157.52 43.02 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.918 -1.114 . . . . 73.409999999999997 109.848 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.6 mt -86.05 117.85 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.527 -0.733 . . . . 74.409999999999997 109.716 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 1.269 ' HB ' ' CE1' ' A' ' 214' ' ' PHE . 44.6 t -108.17 130.02 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.941 -0.763 . . . . 72.530000000000001 108.941 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.7 t -96.11 168.05 10.84 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.164 -0.96 . . . . 74.120000000000005 110.167 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm -65.42 -55.0 20.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.401 -0.812 . . . . 70.430000000000007 109.75 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -56.32 -33.97 66.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.901 . . . . 74.319999999999993 109.651 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.6 tp60 -62.38 -42.76 99.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.314 -0.866 . . . . 74.519999999999996 108.968 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 9.1 mt -60.82 -37.51 82.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.397 -0.815 . . . . 74.409999999999997 109.12 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 5.0 tt -57.12 -58.76 6.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.337 -0.852 . . . . 75.140000000000001 109.114 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -68.56 -29.41 67.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.614 -0.679 . . . . 65.030000000000001 110.723 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.96 -67.8 0.28 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.028 -1.045 . . . . 70.209999999999994 110.377 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 2.1 mp -89.01 -50.44 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.003 -1.061 . . . . 75.319999999999993 109.554 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.056 -1.028 . . . . 73.140000000000001 109.156 -179.903 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.292 -0.633 . . . . 73.129999999999995 109.292 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.5 p -70.13 -18.8 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.444 -0.785 . . . . 74.019999999999996 109.802 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 21.7 mt -63.47 -30.68 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.156 -0.965 . . . . 72.329999999999998 109.923 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -63.0 -45.06 94.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.078 -1.014 . . . . 74.400000000000006 110.297 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 16.8 m -73.19 -25.46 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.991 -1.068 . . . . 74.319999999999993 109.401 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -78.02 -48.81 15.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.259 -0.901 . . . . 73.230000000000004 109.715 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.41 HD13 HG23 ' A' ' 188' ' ' ILE . 0.3 OUTLIER -67.64 -32.63 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.028 -1.045 . . . . 74.310000000000002 109.108 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.4 ' OD1' ' NE2' ' A' ' 193' ' ' GLN . 40.5 t30 -67.12 -48.56 67.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.508 -0.745 . . . . 73.439999999999998 110.367 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -72.7 -32.96 66.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.791 -1.193 . . . . 71.420000000000002 109.776 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 51.7 mt -63.56 -54.7 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.779 -1.201 . . . . 72.439999999999998 110.267 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -62.78 -34.84 78.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.692 -1.255 . . . . 64.219999999999999 109.781 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.431 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 45.1 mt-30 -78.04 -18.73 55.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 74.319999999999993 111.24 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -97.24 -28.26 14.15 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.791 -1.193 . . . . 75.310000000000002 110.722 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' MET . . . . . 0.51 ' SD ' ' O ' ' A' ' 195' ' ' MET . 4.1 ppp? -93.15 9.2 36.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.753 -1.217 . . . . 74.019999999999996 110.146 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 193' ' ' GLN . 27.9 p-10 -110.31 -32.97 6.77 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.227 -0.921 . . . . 74.019999999999996 110.386 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 66.8 tttt -75.15 -36.16 2.13 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.018 -1.051 . . . . 75.430000000000007 111.184 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 89.8 Cg_endo -87.77 -52.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.974 1.783 . . . . 72.319999999999993 112.475 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.9 mp -48.88 -75.69 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.988 -1.07 . . . . 74.540000000000006 109.301 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 148.94 -47.82 0.63 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.64 -1.384 . . . . 61.509999999999998 109.64 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 24.6 mt -120.07 133.5 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.587 -0.949 . . . . 74.25 109.388 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 12.6 m -77.79 146.27 35.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.868 . . . . 72.0 108.966 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 22.0 p -132.47 27.77 4.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.461 -0.775 . . . . 74.439999999999998 109.362 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.7 m -129.45 125.57 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.485 -0.759 . . . . 71.129999999999995 109.61 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -98.54 105.05 17.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.544 -0.722 . . . . 73.510000000000005 109.379 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 24.4 p -70.57 119.68 15.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 73.519999999999996 108.816 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 12.7 m -139.93 158.54 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.219 -0.925 . . . . 72.150000000000006 110.301 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -102.64 -7.15 22.0 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.745 -0.835 . . . . 72.400000000000006 108.745 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.976 ' NH2' ' NH1' ' A' ' 213' ' ' ARG . 53.8 ttp180 -65.04 -27.55 68.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.438 -0.789 . . . . 73.310000000000002 109.677 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -151.06 -72.33 0.16 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 71.540000000000006 109.235 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.467 ' C ' ' CD1' ' A' ' 212' ' ' TYR . . . -167.89 -80.1 0.04 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.614 -1.394 . . . . 74.450000000000003 109.614 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.467 ' CD1' ' C ' ' A' ' 211' ' ' GLY . 73.5 m-85 -149.67 129.17 13.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.143 -1.21 . . . . 75.540000000000006 109.194 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.976 ' NH1' ' NH2' ' A' ' 209' ' ' ARG . 6.0 mtp180 -99.31 116.32 31.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.339 -0.851 . . . . 75.310000000000002 109.1 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 1.269 ' CE1' ' HB ' ' A' ' 163' ' ' VAL . 32.9 m-85 -92.9 104.92 17.11 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.439 -0.948 . . . . 75.409999999999997 108.439 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 15.1 p -138.96 166.17 25.19 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.965 -0.754 . . . . 74.140000000000001 108.965 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . 0.881 ' CE2' ' O ' ' A' ' 217' ' ' PRO . 2.2 p90 -70.24 157.45 89.89 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.249 -0.907 . . . . 75.319999999999993 109.383 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.881 ' O ' ' CE2' ' A' ' 216' ' ' TYR . 51.3 Cg_exo . . . . . 0 N--CA 1.494 1.505 0 C-N-CA 121.923 1.749 . . . . 73.109999999999999 111.963 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ptp . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.427 -0.582 . . . . 75.239999999999995 109.427 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -139.65 149.62 43.96 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.346 -0.847 . . . . 73.519999999999996 109.404 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 86.2 t -114.37 138.02 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.679 -0.638 . . . . 72.239999999999995 109.443 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 5.9 tp -113.59 119.11 36.37 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.581 -0.7 . . . . 73.340000000000003 110.159 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 12.5 mt -120.31 98.72 6.19 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 108.793 -0.817 . . . . 74.349999999999994 108.793 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 44.9 mt -86.27 98.27 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.716 -1.24 . . . . 63.439999999999998 108.577 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.417 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 9.4 tp10 -136.0 131.32 34.87 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.414 -0.804 . . . . 74.519999999999996 109.423 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -66.03 -34.68 78.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.328 -0.858 . . . . 74.129999999999995 109.363 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -77.27 110.45 11.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.275 -0.89 . . . . 74.230000000000004 109.562 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 31.7 t -68.77 -23.01 64.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 65.540000000000006 109.682 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 93.9 t -68.21 -48.69 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.166 -0.959 . . . . 75.549999999999997 109.842 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' B' ' 12' ' ' LEU . 3.5 mm? -67.31 -30.41 70.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.936 . . . . 70.140000000000001 109.706 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.5 -33.71 27.44 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.125 -1.59 . . . . 75.400000000000006 109.125 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.7 -45.5 75.47 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.888 -1.285 . . . . 65.439999999999998 109.888 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' B' ' 16' ' ' ILE . 11.3 pt-20 -68.38 -44.72 74.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.097 -1.237 . . . . 72.200000000000003 109.26 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.42 ' N ' ' CG ' ' B' ' 15' ' ' GLU . 6.2 mm -60.5 -35.5 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.044 -1.035 . . . . 75.150000000000006 108.336 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -62.31 -46.84 86.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.541 -0.724 . . . . 73.010000000000005 109.563 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -83.22 0.75 44.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.117 -0.989 . . . . 74.299999999999997 109.317 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.26 -55.63 2.32 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 109.684 -1.366 . . . . 70.540000000000006 109.684 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -76.45 -17.88 59.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -1.105 . . . . 75.430000000000007 109.857 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -56.7 -30.53 63.55 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.965 -1.084 . . . . 73.200000000000003 109.272 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 73.5 t -59.49 -30.68 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 74.230000000000004 109.039 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -77.43 -7.44 56.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.419 -0.801 . . . . 73.519999999999996 109.318 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.61 39.78 7.04 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.587 -1.005 . . . . 53.43 110.587 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -120.23 158.87 26.09 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.379 -1.071 . . . . 71.120000000000005 109.194 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 50.0 mmm -106.98 138.76 42.54 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.476 -0.935 . . . . 75.239999999999995 108.476 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.41 160.97 40.16 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.113 -0.992 . . . . 73.25 110.131 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -141.35 156.73 45.8 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.787 -0.82 . . . . 72.310000000000002 108.787 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 p -118.84 139.78 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.392 -0.818 . . . . 72.140000000000001 109.58 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.1 p -133.64 169.99 16.2 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.57 -0.706 . . . . 74.530000000000001 109.396 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -93.13 -99.71 0.13 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.319 -0.863 . . . . 71.019999999999996 109.884 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -78.16 167.7 21.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.195 -0.941 . . . . 71.400000000000006 110.277 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 28.1 mt -56.52 -35.51 68.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.587 -0.695 . . . . 71.239999999999995 110.008 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -54.44 -42.38 70.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.108 -0.995 . . . . 74.319999999999993 109.883 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -66.58 -39.51 88.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.097 -1.002 . . . . 73.030000000000001 109.378 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.61 -40.82 58.53 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.546 -1.422 . . . . 60.43 109.546 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.99 -38.62 91.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.281 -1.129 . . . . 74.430000000000007 109.645 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -74.96 -39.66 61.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 74.420000000000002 109.845 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 21.2 tp -72.02 -49.6 35.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.937 . . . . 75.409999999999997 110.102 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' B' ' 40' ' ' MET . 1.9 ppp? -60.72 -30.42 69.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.138 -0.976 . . . . 61.439999999999998 109.938 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.82 -37.28 70.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.16 -0.963 . . . . 74.319999999999993 110.044 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 14.2 pt -100.62 0.03 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.292 -0.88 . . . . 71.230000000000004 110.351 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' B' ' 40' ' ' MET . 59.1 mmt-85 -130.96 152.8 49.88 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.288 -0.882 . . . . 73.409999999999997 109.875 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -83.94 165.61 18.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.318 -0.864 . . . . 63.539999999999999 109.095 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 1.9 p90 -156.2 102.08 2.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.029 -1.045 . . . . 73.109999999999999 109.881 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -79.18 -32.04 44.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.177 -0.952 . . . . 62.219999999999999 108.585 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.412 ' C ' ' CD1' ' B' ' 47' ' ' LEU . 0.7 OUTLIER -113.75 108.41 17.07 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.612 -0.884 . . . . 73.120000000000005 108.612 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 97.3 t -96.55 105.31 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.276 -0.89 . . . . 74.109999999999999 108.693 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 15.5 ttt -123.02 130.54 52.93 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.491 -0.756 . . . . 73.439999999999998 109.661 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.415 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.4 OUTLIER -145.28 134.03 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.594 -0.691 . . . . 73.400000000000006 109.153 -179.654 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' SER . . . . . 0.417 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 6.4 p -102.06 13.82 33.67 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.551 -0.718 . . . . 73.209999999999994 109.741 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.415 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 66.5 m-20 -76.75 148.1 36.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.145 -0.972 . . . . 70.409999999999997 109.712 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.437 ' C ' ' H ' ' B' ' 55' ' ' ALA . 65.5 mttp -78.05 -42.76 31.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.308 -0.87 . . . . 73.129999999999995 109.906 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -73.51 9.43 1.38 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.199 -0.938 . . . . 75.209999999999994 109.521 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.437 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -59.72 -22.89 62.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.374 -0.828 . . . . 55.329999999999998 109.826 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 56.2 mt -46.0 -34.29 3.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.331 -0.855 . . . . 72.420000000000002 109.933 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 18.5 m -77.1 -46.96 21.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.102 -0.999 . . . . 73.040000000000006 109.499 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -61.86 -53.32 57.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -0.943 . . . . 72.329999999999998 109.519 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.453 ' CG2' ' HZ3' ' B' ' 63' ' ' LYS . 14.1 m -56.25 -39.99 63.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.587 -1.321 . . . . 74.540000000000006 109.17 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' SER . . . . . 0.4 ' N ' ' CG2' ' B' ' 59' ' ' VAL . 28.0 t -51.6 -46.19 63.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.143 -0.973 . . . . 71.239999999999995 109.722 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' B' ' 65' ' ' LYS . 13.8 ptp180 -78.32 -34.27 48.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.863 -1.148 . . . . 74.310000000000002 110.566 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' B' ' 66' ' ' HIS . 33.4 mm -63.03 -45.95 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.452 -1.405 . . . . 75.420000000000002 108.464 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.453 ' HZ3' ' CG2' ' B' ' 59' ' ' VAL . 29.5 mttt -61.81 -40.52 95.55 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.624 -0.88 . . . . 73.319999999999993 108.624 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -75.37 -38.13 60.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.61 -0.681 . . . . 73.310000000000002 109.228 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.528 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 25.4 mtpp -83.94 -23.09 31.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.266 -0.896 . . . . 72.439999999999998 110.705 -178.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . 0.528 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 83.4 m-70 -156.75 66.4 0.54 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.903 -1.123 . . . . 65.209999999999994 109.912 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.2 t -59.29 -29.51 67.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.328 -0.857 . . . . 73.099999999999994 109.938 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 86.4 p -65.35 -34.74 79.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.153 -0.967 . . . . 71.530000000000001 110.683 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.4 ' CG2' ' N ' ' B' ' 70' ' ' VAL . 78.3 mt -65.71 160.89 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.912 -1.117 . . . . 74.400000000000006 109.61 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.4 ' N ' ' CG2' ' B' ' 69' ' ' ILE . 97.6 t -85.0 159.23 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.21 -0.931 . . . . 75.120000000000005 110.039 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.524 ' N ' ' OD1' ' B' ' 92' ' ' ASP . 11.0 t -143.48 111.42 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.075 -1.016 . . . . 73.200000000000003 109.316 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.06 99.62 8.68 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.544 -0.91 . . . . 73.340000000000003 108.544 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 79.1 t -95.13 127.83 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.237 -0.915 . . . . 73.5 108.963 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.1 m -103.22 173.52 6.27 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.443 -0.786 . . . . 71.319999999999993 109.666 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.48 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 23.0 t -166.28 122.97 1.32 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.168 -0.957 . . . . 74.530000000000001 110.298 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -62.01 -17.1 56.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.435 -0.79 . . . . 64.5 109.605 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' B' ' 79' ' ' THR . 47.2 t-20 -124.43 82.23 58.59 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.516 -0.74 . . . . 74.25 109.196 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.15 71.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.566 2.177 . . . . 74.430000000000007 112.003 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.517 ' N ' ' O ' ' B' ' 77' ' ' ASN . 17.0 m -88.13 152.27 22.11 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.102 -0.999 . . . . 73.120000000000005 109.418 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -37.86 88.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.892 . . . . 75.409999999999997 109.488 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -55.64 -46.88 77.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.951 . . . . 72.239999999999995 109.63 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . 0.4 ' OE1' ' OG ' ' B' ' 75' ' ' SER . 98.1 mt-10 -71.56 -30.93 66.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.896 . . . . 73.219999999999999 109.658 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' B' ' 84' ' ' VAL . 10.6 tm-20 -70.02 -56.23 7.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 74.299999999999997 109.851 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . 0.513 ' N ' ' OE1' ' B' ' 83' ' ' GLU . 13.1 m -63.27 -44.61 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.135 -0.978 . . . . 73.310000000000002 109.722 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' HIS . . . . . 0.441 ' N ' ' CG2' ' B' ' 84' ' ' VAL . 71.1 t60 -63.19 -40.26 97.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 73.239999999999995 109.456 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.04 -44.26 97.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.904 . . . . 55.329999999999998 109.588 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -74.13 -30.27 62.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.131 -0.981 . . . . 74.450000000000003 108.535 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -57.54 -50.42 73.16 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.681 -0.859 . . . . 64.040000000000006 108.681 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . 0.417 ' NE2' ' CD2' ' B' ' 85' ' ' HIS . 50.8 mt-30 -64.33 -38.31 90.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.62 -0.675 . . . . 75.129999999999995 109.462 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 139.49 10.31 0.82 Allowed Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.344 -1.102 . . . . 75.420000000000002 110.344 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -48.79 122.22 5.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.878 -1.366 . . . . 73.420000000000002 109.233 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' B' ' 71' ' ' VAL . 5.8 m-20 -63.68 -37.39 87.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.116 -0.99 . . . . 73.319999999999993 109.102 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 20.3 t0 -154.79 158.44 39.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.851 . . . . 73.040000000000006 109.751 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.52 ' N ' ' OD1' ' B' ' 93' ' ' ASP . 42.4 t80 -130.26 116.97 19.13 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.158 -1.053 . . . . 74.310000000000002 108.158 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . 0.579 ' H ' ' CD1' ' B' ' 95' ' ' ILE . 0.0 OUTLIER -119.42 156.75 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.503 0 CA-C-O 121.919 0.866 . . . . 75.340000000000003 110.797 -177.72 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.42 134.06 42.4 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.435 -1.32 . . . . 70.099999999999994 107.435 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.675 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -55.04 -55.57 37.61 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 120.773 -1.204 . . . . 65.430000000000007 111.791 -178.462 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 1.4 Cg_endo -39.44 -12.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 121.144 1.23 . . . . 63.520000000000003 113.213 -176.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . 0.675 ' N ' ' O ' ' B' ' 97' ' ' LYS . 53.3 m-85 56.5 104.13 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.508 -0.745 . . . . 75.129999999999995 109.728 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -55.24 -42.31 73.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.949 -1.095 . . . . 74.230000000000004 108.673 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 12.2 t -168.2 151.18 5.6 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.465 -0.772 . . . . 64.510000000000005 109.039 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 20.7 mm -55.52 -45.14 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.986 . . . . 74.439999999999998 109.362 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -68.91 -7.54 35.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 72.299999999999997 109.605 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.69 -77.99 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.073 -1.017 . . . . 74.310000000000002 109.786 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.414 ' CD2' ' H ' ' B' ' 105' ' ' LEU . 2.2 pt? -62.32 -36.67 82.89 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.066 -1.021 . . . . 73.540000000000006 110.092 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 80.7 t -60.36 -44.97 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.9 -1.125 . . . . 72.030000000000001 109.187 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.18 -33.49 72.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.173 -0.954 . . . . 64.219999999999999 108.751 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . 0.521 ' NH2' ' CG2' ' B' ' 95' ' ' ILE . 78.6 mtm180 -80.27 -24.97 39.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.43 -0.793 . . . . 75.310000000000002 109.872 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 67.0 mt -79.48 -47.01 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.022 -1.049 . . . . 55.439999999999998 108.649 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.68 -39.87 94.42 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.584 -0.847 . . . . 65.310000000000002 109.146 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.91 -35.96 82.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.345 -0.847 . . . . 74.519999999999996 109.217 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -61.94 -39.19 91.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.324 -0.86 . . . . 72.040000000000006 109.765 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.65 67.57 1.25 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.157 -0.965 . . . . 75.349999999999994 109.529 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.483 ' O ' ' CG ' ' B' ' 115' ' ' PHE . 50.2 mtp180 -57.28 -32.86 67.06 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.14 -0.975 . . . . 75.5 109.341 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 115' ' ' PHE . . . . . 0.483 ' CG ' ' O ' ' B' ' 114' ' ' ARG . 87.8 m-85 -157.67 91.14 1.12 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 73.040000000000006 109.515 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 116' ' ' TRP . . . . . 0.519 ' NE1' ' OE2' ' B' ' 141' ' ' GLU . 5.3 m-90 52.21 11.25 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 74.450000000000003 109.69 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' B' ' 115' ' ' PHE . . . 70.03 -112.4 4.37 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.849 -1.3 . . . . 64.209999999999994 109.849 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 84.4 p -150.62 -172.59 4.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.286 -1.126 . . . . 71.400000000000006 109.843 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.23 130.69 13.85 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.938 -0.705 . . . . 74.209999999999994 109.195 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 5.5 t -80.65 -42.72 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 75.019999999999996 110.117 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . 0.424 HG21 HD13 ' B' ' 121' ' ' ILE . 27.7 mm -112.67 121.41 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.442 -0.786 . . . . 74.239999999999995 109.234 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -154.65 138.84 16.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.251 -0.905 . . . . 73.329999999999998 109.392 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 0.551 ' N ' ' CD1' ' B' ' 123' ' ' ILE . 0.1 OUTLIER -147.08 157.1 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.267 -0.896 . . . . 74.219999999999999 109.492 179.721 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.85 -131.79 12.47 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.601 -1.4 . . . . 72.409999999999997 109.601 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -99.82 0.73 42.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.311 -1.111 . . . . 75.120000000000005 109.522 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.23 145.57 24.55 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.136 -0.977 . . . . 75.420000000000002 108.527 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 28.8 m -129.21 136.63 50.37 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.548 -0.72 . . . . 74.219999999999999 109.245 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' B' ' 121' ' ' ILE . 39.8 mt -136.02 136.34 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.398 -0.814 . . . . 60.329999999999998 109.645 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 7.3 m -127.58 80.27 72.15 Favored Pre-proline 0 N--CA 1.499 2.017 0 N-CA-C 109.15 -0.685 . . . . 72.310000000000002 109.15 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.41 -55.38 3.66 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.815 2.343 . . . . 75.129999999999995 112.612 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -51.82 -40.05 59.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -0.93 . . . . 75.230000000000004 109.627 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -84.6 0.17 51.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.203 -0.936 . . . . 75.120000000000005 109.461 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 52.39 60.32 3.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 75.129999999999995 109.618 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -151.34 130.43 12.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.867 . . . . 75.109999999999999 109.121 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 59.8 mt -118.1 133.81 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.547 -0.721 . . . . 70.319999999999993 109.528 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 70.5 mt -124.43 123.11 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 109.074 -0.713 . . . . 74.120000000000005 109.074 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -137.54 141.42 41.4 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.427 -0.796 . . . . 74.230000000000004 109.522 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . 0.518 ' NZ ' ' O ' ' B' ' 198' ' ' PRO . 50.7 mttp 54.45 26.19 6.88 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.565 -0.709 . . . . 74.219999999999999 110.085 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.88 -0.67 77.25 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.186 -1.166 . . . . 74.319999999999993 110.186 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -89.95 131.27 35.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.127 -1.219 . . . . 75.340000000000003 109.158 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 141' ' ' GLU . . . . . 0.519 ' OE2' ' NE1' ' B' ' 116' ' ' TRP . 95.5 mt-10 -97.1 125.11 41.35 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.331 -0.856 . . . . 71.230000000000004 109.472 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 96.0 t -137.49 135.1 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.387 -0.821 . . . . 70.430000000000007 109.199 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -88.93 151.07 22.54 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.325 -0.86 . . . . 72.430000000000007 109.389 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 22.2 m -90.85 137.77 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.177 -0.952 . . . . 72.129999999999995 109.792 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -171.19 56.05 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.337 -0.852 . . . . 74.5 109.511 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 178.65 176.82 46.83 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.869 -1.292 . . . . 42.229999999999997 109.869 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 15.2 mttt -70.65 -38.86 8.39 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.362 -1.081 . . . . 73.299999999999997 110.112 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 32.8 Cg_exo -57.73 -37.73 95.58 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.194 1.929 . . . . 71.329999999999998 111.83 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -87.99 -20.7 25.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.431 -0.793 . . . . 74.230000000000004 109.253 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -66.55 -41.77 88.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.302 -0.874 . . . . 72.340000000000003 109.639 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p -73.31 -32.6 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.187 -0.945 . . . . 73.349999999999994 109.58 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 23.1 tp -66.55 -43.42 85.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.209 -0.932 . . . . 74.430000000000007 109.952 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 25.8 m -72.53 -35.24 68.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.963 -1.086 . . . . 75.209999999999994 109.758 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 154' ' ' HIS . . . . . 0.551 ' CE1' ' NH2' ' B' ' 157' ' ' ARG . 1.6 m-70 -62.96 -48.84 77.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 73.040000000000006 110.259 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.0 pp -69.54 -27.09 64.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.811 -1.181 . . . . 73.430000000000007 109.294 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.62 -49.9 75.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.956 . . . . 75.319999999999993 109.499 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . 0.551 ' NH2' ' CE1' ' B' ' 154' ' ' HIS . 21.6 ptt180 -74.86 -36.11 62.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.242 -0.911 . . . . 73.319999999999993 109.934 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -87.98 18.2 4.39 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.08 -1.012 . . . . 74.140000000000001 109.776 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -62.04 161.25 11.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.139 -0.976 . . . . 73.420000000000002 109.266 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . 0.473 ' OD2' ' NE2' ' A' ' 161' ' ' GLN . 37.4 t0 59.73 49.47 8.11 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.329 -0.857 . . . . 72.099999999999994 109.585 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -157.66 145.21 18.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 73.239999999999995 109.292 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 94.9 mt -85.91 128.03 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -0.943 . . . . 72.310000000000002 109.192 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 5.3 m -132.24 139.35 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.456 -0.778 . . . . 75.030000000000001 109.585 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 58.4 p -86.45 172.14 10.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.223 -0.923 . . . . 74.219999999999999 109.302 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -59.58 -39.8 85.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.945 . . . . 72.420000000000002 109.59 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -57.29 -32.46 66.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 63.450000000000003 109.798 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -60.04 -48.7 80.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.96 . . . . 72.400000000000006 109.873 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 37.6 mt -62.37 -32.96 73.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.086 -1.009 . . . . 72.319999999999993 109.101 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 6.3 tt -57.18 -64.98 0.7 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.347 -0.846 . . . . 73.340000000000003 109.542 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -64.82 -31.81 73.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.229 -0.919 . . . . 73.099999999999994 110.143 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -48.39 -58.99 3.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.124 -0.985 . . . . 62.130000000000003 110.062 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.474 ' N ' ' CD1' ' B' ' 172' ' ' ILE . 2.1 mp -92.82 -59.14 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.056 -1.028 . . . . 74.439999999999998 109.318 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 11.2 m-90 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 72.230000000000004 109.62 -179.799 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo . . . . . 0 N--CA 1.492 1.4 0 CA-C-O 121.299 0.458 . . . . 74.340000000000003 112.392 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -69.21 -29.8 67.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 72.310000000000002 109.614 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 6.0 p -59.55 -27.61 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.287 -0.883 . . . . 65.420000000000002 110.014 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 35.2 mm -56.27 -25.87 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.179 -0.951 . . . . 75.030000000000001 109.688 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -58.69 -48.5 80.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 73.519999999999996 109.827 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 16.1 m -77.22 -26.42 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.102 -0.999 . . . . 74.349999999999994 109.865 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.26 -49.01 38.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.03 -1.044 . . . . 61.119999999999997 109.822 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 19.6 tt -66.87 -33.5 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.175 -0.953 . . . . 72.430000000000007 110.015 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -73.62 -40.62 63.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.112 -0.993 . . . . 75.420000000000002 111.163 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -78.17 -37.94 44.63 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.784 -1.198 . . . . 74.140000000000001 111.194 -178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 2.4 pp -69.7 -41.85 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.741 -1.224 . . . . 74.030000000000001 110.138 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -69.64 -39.02 77.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.872 -1.142 . . . . 72.329999999999998 109.661 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -67.64 -40.04 84.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.246 -0.909 . . . . 73.099999999999994 110.586 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . 0.468 ' O ' ' CD ' ' B' ' 198' ' ' PRO . 13.1 pttp -80.22 -13.43 59.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.964 -1.085 . . . . 74.430000000000007 110.074 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 51.5 ttm -91.87 -30.26 16.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.199 -0.938 . . . . 74.329999999999998 109.771 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 196' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' B' ' 200' ' ' GLY . 95.8 m-20 -68.7 -41.6 78.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 71.209999999999994 110.266 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . 0.401 ' N ' ' HD2' ' B' ' 198' ' ' PRO . 12.1 tmtt? -60.66 -55.41 45.2 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.042 -1.036 . . . . 75.209999999999994 110.806 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 198' ' ' PRO . . . . . 0.518 ' O ' ' NZ ' ' B' ' 138' ' ' LYS . 29.3 Cg_endo -60.78 -54.95 1.6 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.371 1.381 . . . . 75.319999999999993 111.829 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . 0.403 ' O ' ' NZ ' ' B' ' 138' ' ' LYS . 4.4 mm? -66.56 -45.67 78.6 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.084 -1.01 . . . . 72.25 108.878 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' B' ' 196' ' ' ASP . . . 87.13 -31.58 4.35 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.688 -1.365 . . . . 73.239999999999995 109.688 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . 0.512 ' N ' ' CD1' ' B' ' 201' ' ' ILE . 2.0 mp -92.21 138.34 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.245 -1.15 . . . . 54.299999999999997 109.087 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 29.2 t -87.51 139.78 30.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.284 -0.885 . . . . 74.310000000000002 109.271 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 10.2 p -144.84 22.17 1.6 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.212 -0.93 . . . . 74.400000000000006 109.687 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.11 143.1 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.247 -0.908 . . . . 74.099999999999994 109.663 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -126.35 135.42 51.46 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.569 -0.707 . . . . 75.329999999999998 109.124 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.6 138.0 35.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.322 -0.861 . . . . 71.400000000000006 109.304 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -148.69 141.78 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -0.954 . . . . 63.5 109.442 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -66.86 -41.41 87.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.916 . . . . 74.450000000000003 109.435 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 209' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' B' ' 211' ' ' GLY . 49.2 mtp85 -60.46 147.68 40.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.914 . . . . 74.140000000000001 109.553 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 49.87 -89.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.351 -0.843 . . . . 74.430000000000007 109.841 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 211' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' B' ' 209' ' ' ARG . . . -170.95 -100.82 0.14 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.776 -1.33 . . . . 70.109999999999999 109.776 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 212' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' B' ' 212' ' ' TYR . 25.5 m-85 -130.15 153.53 48.43 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.548 -0.972 . . . . 74.209999999999994 108.855 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 5.2 ptm85 -127.43 149.93 49.87 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.383 -0.823 . . . . 74.299999999999997 109.81 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -117.97 131.13 56.53 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.908 -0.775 . . . . 74.340000000000003 108.908 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 29.0 p -160.11 164.0 33.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.064 -1.023 . . . . 72.209999999999994 109.849 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -61.83 152.5 75.96 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.381 -0.825 . . . . 72.310000000000002 108.931 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -68.16 -156.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.151 1.901 . . . . 71.010000000000005 111.482 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.262 -0.899 . . . . 74.349999999999994 109.414 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 ttm . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.38 -0.6 . . . . 65.120000000000005 109.38 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -137.78 154.95 49.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.392 -0.818 . . . . 73.310000000000002 109.394 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 83.6 t -119.79 125.96 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.547 0.689 . . . . 71.420000000000002 109.79 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.3 tp -94.42 115.94 28.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.371 -0.974 . . . . 65.219999999999999 108.371 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.95 110.59 17.91 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.562 -0.903 . . . . 71.439999999999998 108.562 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.43 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 12.3 mt -94.41 105.26 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 120.791 -1.193 . . . . 71.150000000000006 109.507 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -139.52 124.72 18.92 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.241 -0.912 . . . . 75.340000000000003 109.259 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -71.83 -32.37 67.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 73.040000000000006 109.505 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -83.42 113.44 20.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.915 . . . . 72.420000000000002 109.462 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.2 p -68.07 -25.34 65.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 72.340000000000003 109.522 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.5 t -67.99 -53.59 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -0.925 . . . . 74.420000000000002 109.609 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.62 -38.85 84.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 72.010000000000005 108.951 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.51 -25.8 75.14 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 108.436 -1.866 . . . . 72.140000000000001 108.436 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.51 -58.05 10.13 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.477 -1.449 . . . . 72.329999999999998 109.477 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -53.26 -46.78 69.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.411 -1.053 . . . . 72.340000000000003 109.676 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 86.0 mt -64.52 -50.93 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.866 -1.146 . . . . 74.239999999999995 108.96 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -49.2 -52.91 23.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 71.409999999999997 109.708 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.405 ' CD ' ' N ' ' A' ' 18' ' ' LYS . 0.7 OUTLIER -83.51 2.44 36.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.139 -0.976 . . . . 75.540000000000006 109.444 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.23 -60.98 1.95 Allowed Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.909 -1.276 . . . . 62.149999999999999 109.909 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -72.66 -19.37 61.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -1.161 . . . . 74.420000000000002 110.034 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -56.87 -31.64 65.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.972 -1.08 . . . . 74.25 109.468 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.2 t -60.68 -28.92 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 72.109999999999999 109.327 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.422 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 11.5 mptt -76.55 -1.21 26.29 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.262 -0.899 . . . . 73.230000000000004 109.28 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.0 36.56 8.97 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.156 -1.177 . . . . 75.540000000000006 110.156 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -119.51 157.51 28.17 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.497 -1.002 . . . . 74.510000000000005 109.326 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.3 mmt -108.12 138.62 44.08 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.522 -0.918 . . . . 64.319999999999993 108.522 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.54 159.29 43.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.134 -0.979 . . . . 74.310000000000002 110.13 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -136.68 155.44 49.87 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.507 -0.746 . . . . 75.400000000000006 109.0 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.55 136.68 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.372 -0.83 . . . . 75.129999999999995 109.099 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.8 p -133.25 164.94 25.94 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.385 -0.822 . . . . 71.420000000000002 109.313 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.43 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 4.9 pt-20 -90.59 -105.73 0.1 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.259 -0.901 . . . . 73.109999999999999 109.853 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.5 p -78.23 170.63 16.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 74.239999999999995 109.961 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.9 mt -55.97 -30.87 62.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.564 -0.71 . . . . 71.530000000000001 109.794 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -50.41 -46.25 56.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 74.230000000000004 109.584 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.06 -39.41 90.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 71.010000000000005 109.418 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.34 -44.31 34.83 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.572 -1.411 . . . . 61.409999999999997 109.572 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -63.02 -37.29 86.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -1.139 . . . . 74.340000000000003 109.457 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -81.22 -38.09 27.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 75.329999999999998 109.655 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.4 tp -68.71 -46.65 68.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.31 -0.869 . . . . 74.329999999999998 109.937 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 41' ' ' ASP . 3.5 ppp? -63.09 -25.56 68.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.129 -0.982 . . . . 70.319999999999993 109.793 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 40' ' ' MET . 97.5 m-20 -66.51 -41.14 89.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.082 -1.011 . . . . 71.219999999999999 109.973 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.1 pt -82.82 -27.84 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.115 -0.991 . . . . 74.409999999999997 110.16 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 40' ' ' MET . 88.7 mtt-85 -129.74 144.46 51.3 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.336 -0.853 . . . . 75.409999999999997 109.449 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -91.51 154.13 19.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.239 -0.913 . . . . 75.420000000000002 109.521 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -134.76 157.6 46.32 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.491 -0.756 . . . . 74.230000000000004 109.176 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -102.7 -42.56 5.85 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.387 -0.821 . . . . 75.319999999999993 109.464 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.36 109.7 21.65 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.514 -0.741 . . . . 72.129999999999995 109.224 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.7 t -94.09 99.86 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.202 -0.937 . . . . 72.340000000000003 108.834 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.515 ' SD ' ' O ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -114.1 129.1 56.63 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.154 -0.684 . . . . 74.109999999999999 109.154 -179.603 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 p -134.64 133.13 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.536 -0.728 . . . . 71.239999999999995 109.89 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.5 p -96.83 1.41 50.64 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.543 -0.723 . . . . 73.109999999999999 109.435 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -76.19 141.51 41.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.198 -0.939 . . . . 63.399999999999999 109.416 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.508 ' C ' ' H ' ' A' ' 55' ' ' ALA . 0.7 OUTLIER -79.75 -38.58 32.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 65.439999999999998 110.204 -179.479 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -71.18 10.5 0.56 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.035 -1.04 . . . . 73.129999999999995 109.364 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -72.39 -20.51 61.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -0.831 . . . . 64.140000000000001 110.298 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 55' ' ' ALA . 68.7 mt -41.18 -47.65 3.32 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.509 -0.744 . . . . 74.430000000000007 110.296 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 60' ' ' SER . 23.2 m -70.28 -35.21 73.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.931 -1.105 . . . . 63.229999999999997 108.97 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.419 ' N ' ' O ' ' A' ' 55' ' ' ALA . 67.7 t80 -66.36 -59.26 3.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.392 -0.817 . . . . 74.439999999999998 109.849 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.4 m -52.36 -34.14 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.696 -1.253 . . . . 74.030000000000001 109.345 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 57' ' ' SER . 14.9 p -57.79 -51.83 67.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 73.540000000000006 109.732 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -69.32 -28.92 66.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.02 . . . . 73.340000000000003 109.983 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 66' ' ' HIS . 7.6 mm -67.08 -24.08 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.88 -1.138 . . . . 73.349999999999994 109.835 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -86.15 -53.33 5.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.034 -1.041 . . . . 74.420000000000002 110.562 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.443 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 14.9 pt-20 -63.78 -43.14 97.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.9 -1.125 . . . . 74.549999999999997 110.128 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.443 ' N ' ' CG ' ' A' ' 64' ' ' GLU . 78.2 mttt -79.02 -61.0 2.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 75.219999999999999 109.092 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.535 ' H ' ' HD1' ' A' ' 66' ' ' HIS . 0.2 OUTLIER -97.18 80.23 2.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.326 -0.859 . . . . 74.129999999999995 108.876 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.9 m -79.02 -25.9 43.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.015 -1.053 . . . . 73.239999999999995 110.22 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.3 t -82.55 51.77 1.93 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.114 -0.991 . . . . 71.439999999999998 110.208 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 15.3 tt -156.98 160.94 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.938 -1.101 . . . . 71.329999999999998 109.945 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.6 t -95.8 160.15 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.178 -0.951 . . . . 73.019999999999996 109.135 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 t -146.16 121.24 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.955 -1.091 . . . . 54.210000000000001 109.942 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.515 ' O ' ' SD ' ' A' ' 49' ' ' MET . 3.5 mp -119.83 103.41 9.32 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.116 -1.068 . . . . 74.209999999999994 108.116 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.9 p -95.8 146.27 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.487 -0.931 . . . . 74.409999999999997 108.487 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.454 ' O ' ' OG ' ' A' ' 75' ' ' SER . 0.5 OUTLIER -118.44 165.87 13.36 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.468 -0.77 . . . . 72.310000000000002 109.226 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 74' ' ' SER . 3.1 m -168.3 124.08 1.0 Allowed 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 119.393 -0.923 . . . . 64.540000000000006 110.242 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.52 1.45 1.19 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.552 -0.718 . . . . 74.129999999999995 109.809 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.439 ' H ' ' C ' ' A' ' 75' ' ' SER . 33.8 m120 -120.64 62.87 10.1 Favored Pre-proline 0 N--CA 1.501 2.101 0 O-C-N 121.396 -0.815 . . . . 73.340000000000003 110.198 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -62.99 77.9 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.157 1.905 . . . . 71.319999999999993 111.789 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.517 ' HG1' ' H ' ' A' ' 82' ' ' GLU . 77.9 p -104.36 151.72 23.13 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.566 -0.901 . . . . 62.530000000000001 108.566 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -31.9 66.8 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.243 -0.911 . . . . 74.140000000000001 109.309 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.511 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 78.0 mm-40 -66.29 -36.21 82.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.15 -0.969 . . . . 71.420000000000002 109.22 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.517 ' H ' ' HG1' ' A' ' 79' ' ' THR . 38.1 tp10 -71.17 -35.48 71.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.331 -0.856 . . . . 73.430000000000007 109.621 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.77 -52.57 64.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 74.219999999999999 109.689 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.6 m -60.52 -36.0 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.187 -0.946 . . . . 74.150000000000006 109.258 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' A' ' 81' ' ' GLU . 27.9 m80 -71.77 -31.15 66.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.274 -0.891 . . . . 72.540000000000006 109.561 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.17 -40.1 93.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 64.219999999999999 110.177 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -83.36 -37.64 23.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.954 -1.092 . . . . 74.340000000000003 109.32 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -68.21 -42.91 79.13 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.242 -0.911 . . . . 74.420000000000002 109.493 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -66.81 -49.95 64.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -0.996 . . . . 74.519999999999996 109.369 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 143.73 72.41 0.02 OUTLIER Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.017 -1.233 . . . . 74.209999999999994 110.017 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -138.25 124.16 20.04 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.242 -1.152 . . . . 64.099999999999994 109.201 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 13.9 t70 -61.13 -41.72 97.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 73.420000000000002 109.336 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 66.8 m-20 -152.05 159.34 43.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.325 -0.859 . . . . 75.040000000000006 109.337 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -124.14 131.71 53.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.605 -0.685 . . . . 71.329999999999998 109.449 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.5 mt -123.41 140.62 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-O 122.084 0.945 . . . . 74.510000000000005 110.381 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.0 121.49 13.12 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.901 -1.148 . . . . 64.319999999999993 107.901 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.694 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -45.46 -54.59 14.53 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.128 -0.983 . . . . 74.510000000000005 111.428 -178.756 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 2.5 Cg_endo -40.47 -9.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 121.08 1.187 . . . . 73.109999999999999 113.289 -176.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.694 ' N ' ' O ' ' A' ' 97' ' ' LYS . 67.5 m-85 58.6 99.39 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.514 -0.741 . . . . 72.540000000000006 109.007 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.4 ttm-85 -53.05 -41.62 64.98 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.169 -0.957 . . . . 74.540000000000006 109.37 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.822 ' O ' ' N ' ' A' ' 103' ' ' LYS . 23.1 t -172.86 36.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.982 -1.074 . . . . 74.140000000000001 110.929 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.41 HD13 HG22 ' A' ' 102' ' ' ILE . 96.6 mt 44.97 -68.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-N 118.693 0.679 . . . . 75.430000000000007 110.792 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.822 ' N ' ' O ' ' A' ' 101' ' ' SER . 21.3 tptm -49.22 -36.26 19.55 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.01 -1.056 . . . . 74.140000000000001 108.295 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.94 -40.91 83.22 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.189 -1.041 . . . . 63.240000000000002 108.189 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.8 -38.17 88.25 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.835 -0.802 . . . . 73.219999999999999 108.835 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.23 -42.13 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 74.540000000000006 109.353 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.44 -41.17 63.04 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.216 -0.927 . . . . 75.5 108.786 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.525 ' NE ' ' OE2' ' B' ' 83' ' ' GLU . 98.7 mtt180 -68.66 -37.84 79.96 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.35 -0.844 . . . . 74.409999999999997 109.282 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.62 -30.84 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.041 -1.037 . . . . 73.239999999999995 108.314 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -63.24 -54.81 31.55 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.777 -0.823 . . . . 74.340000000000003 108.777 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.11 -35.87 60.13 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.402 -0.811 . . . . 73.319999999999993 109.396 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -57.76 -48.95 78.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.216 -0.927 . . . . 74.420000000000002 109.25 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 78.6 mt -144.53 97.73 3.08 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.137 -0.977 . . . . 74.329999999999998 109.496 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.403 ' O ' ' CG ' ' A' ' 115' ' ' PHE . 42.0 mtp180 -85.12 -59.02 2.45 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.205 -0.935 . . . . 74.439999999999998 108.999 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.403 ' CG ' ' O ' ' A' ' 114' ' ' ARG . 56.9 m-85 -156.55 89.27 1.1 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.256 -0.902 . . . . 74.430000000000007 109.542 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.474 ' CD1' ' N ' ' A' ' 116' ' ' TRP . 7.8 p-90 -93.17 133.5 36.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.237 -0.915 . . . . 74.439999999999998 109.078 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 178.42 98.35 0.11 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.586 -1.406 . . . . 75.040000000000006 109.586 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.832 ' HB3' ' OE2' ' A' ' 132' ' ' GLU . 31.0 t -159.61 176.97 11.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -1.113 . . . . 70.109999999999999 109.495 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -158.12 120.02 3.63 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.841 -0.8 . . . . 65.239999999999995 108.841 -178.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.8 t -83.62 -25.93 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.073 -1.017 . . . . 74.219999999999999 109.056 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.432 HG23 HD13 ' A' ' 121' ' ' ILE . 28.2 mm -111.33 121.08 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.622 -0.881 . . . . 74.420000000000002 108.622 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -127.33 109.91 12.27 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.518 -0.738 . . . . 73.299999999999997 109.446 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.412 ' O ' ' C ' ' A' ' 124' ' ' GLY . 94.4 mt -112.67 124.64 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.63 -0.878 . . . . 75.340000000000003 108.63 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 123' ' ' ILE . . . -34.16 -44.22 0.37 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 112.109 -0.397 . . . . 75.129999999999995 112.109 -178.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -63.7 -56.38 16.14 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.987 -1.302 . . . . 74.450000000000003 109.94 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.408 ' H ' HD21 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -144.12 166.44 25.01 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.113 -0.992 . . . . 54.210000000000001 110.083 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.4 m -106.49 145.07 32.27 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.229 -0.919 . . . . 70.239999999999995 109.894 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.9 mt -137.24 134.62 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.165 -0.959 . . . . 72.430000000000007 109.76 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.7 t -121.53 113.42 32.07 Favored Pre-proline 0 N--CA 1.499 1.994 0 N-CA-C 109.24 -0.652 . . . . 71.109999999999999 109.24 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -81.05 -54.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.719 1.613 . . . . 75.140000000000001 112.109 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -55.57 -42.48 74.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 72.5 109.147 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.832 ' OE2' ' HB3' ' A' ' 118' ' ' SER . 72.1 mt-10 -82.56 -4.19 57.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.288 -0.883 . . . . 73.140000000000001 109.201 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 47.51 66.35 1.04 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.334 -0.854 . . . . 75.329999999999998 109.797 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -159.58 142.76 14.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.063 -1.023 . . . . 71.230000000000004 109.783 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.0 tt -126.94 138.36 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.468 -0.77 . . . . 75.329999999999998 109.897 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.1 mm -118.03 121.77 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.728 -0.842 . . . . 71.109999999999999 108.728 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -140.29 146.01 38.0 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.102 -0.998 . . . . 74.140000000000001 110.014 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 83.0 mttt 53.87 26.72 6.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.481 -0.762 . . . . 75.400000000000006 110.215 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.18 9.08 87.24 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 120.122 -1.037 . . . . 72.239999999999995 110.857 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 43.7 mtp180 -103.11 142.89 33.35 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.194 -1.18 . . . . 73.120000000000005 109.259 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -110.74 121.96 46.63 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.899 -0.778 . . . . 72.319999999999993 108.899 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.5 143.95 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 120.924 -1.11 . . . . 62.340000000000003 110.698 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.485 ' H ' ' CD ' ' A' ' 143' ' ' GLU . 2.1 pm0 -93.65 134.63 35.75 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.398 -1.334 . . . . 61.229999999999997 107.398 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.1 136.65 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 120.936 -1.103 . . . . 74.439999999999998 110.514 -178.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.13 104.11 0.99 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.643 -0.66 . . . . 75.420000000000002 109.498 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -166.88 -147.49 5.26 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.748 -1.341 . . . . 73.340000000000003 109.748 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.4 mttt -92.71 -59.72 0.21 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.212 -1.17 . . . . 72.219999999999999 110.691 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.751 ' HG2' ' CE1' ' A' ' 149' ' ' PHE . 21.7 Cg_endo -57.94 -15.18 21.07 Favored 'Trans proline' 0 N--CA 1.5 1.898 0 C-N-CA 121.913 1.742 . . . . 75.450000000000003 111.937 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.751 ' CE1' ' HG2' ' A' ' 148' ' ' PRO . 4.1 m-85 -98.8 -22.87 15.62 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.175 -0.953 . . . . 65.239999999999995 110.196 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -59.61 -35.63 74.71 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.77 -1.206 . . . . 72.519999999999996 108.848 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.3 p -70.45 -27.86 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.238 -0.914 . . . . 74.209999999999994 108.619 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 56.9 tp -64.48 -49.55 70.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.343 -0.848 . . . . 73.310000000000002 109.585 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.46 -33.46 74.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.816 -1.177 . . . . 74.310000000000002 108.691 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -54.24 -54.83 34.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.439 -0.788 . . . . 75.450000000000003 110.199 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.4 pp -75.26 -23.19 57.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.104 -0.998 . . . . 75.340000000000003 109.758 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.13 -38.44 68.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.159 -0.963 . . . . 62.140000000000001 108.753 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.504 ' C ' ' H ' ' A' ' 159' ' ' ARG . 45.1 mtp180 -86.8 -56.08 3.56 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.285 -1.005 . . . . 72.219999999999999 108.285 178.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.437 ' N ' ' CD2' ' A' ' 158' ' ' HIS . 8.0 m170 -68.92 47.77 0.06 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.573 -0.899 . . . . 74.120000000000005 108.573 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.504 ' H ' ' C ' ' A' ' 157' ' ' ARG . 63.9 mtm180 -53.4 -60.04 3.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.609 -0.682 . . . . 74.340000000000003 110.271 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -95.6 94.19 7.6 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.165 -0.96 . . . . 75.450000000000003 109.283 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . 1.362 ' NE2' ' O ' ' A' ' 162' ' ' ILE . 21.9 tm0? -170.16 142.85 2.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.025 -1.047 . . . . 73.409999999999997 109.938 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 1.362 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 2.0 mp -87.74 139.51 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.258 -1.016 . . . . 74.409999999999997 108.258 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.645 HG13 ' OE1' ' A' ' 161' ' ' GLN . 17.6 m -126.82 150.94 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.463 -0.773 . . . . 72.530000000000001 109.893 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 7.2 t -99.78 158.23 15.94 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.499 -0.751 . . . . 74.120000000000005 109.218 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.681 ' HZ2' ' HH ' ' A' ' 212' ' ' TYR . 65.3 mttm -55.67 -54.07 48.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.344 -0.847 . . . . 70.430000000000007 110.01 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -63.11 -27.97 69.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 74.319999999999993 110.343 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.441 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 46.1 tt0 -62.05 -54.37 42.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.005 -1.06 . . . . 74.519999999999996 110.08 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 48.9 mt -59.33 -44.78 92.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.884 -1.135 . . . . 74.409999999999997 109.36 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 173' ' ' TRP . 4.2 mm? -62.24 -53.04 60.96 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.147 -0.971 . . . . 75.140000000000001 109.731 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 167' ' ' GLN . 14.2 p30 -71.1 -4.93 27.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.016 -1.053 . . . . 65.030000000000001 110.174 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -83.15 -59.01 2.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.06 -1.025 . . . . 70.209999999999994 109.927 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.533 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 1.9 mp -85.59 -43.66 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.935 -1.103 . . . . 75.319999999999993 109.291 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . 0.458 ' O ' ' O ' ' A' ' 169' ' ' LEU . 23.5 m-90 . . . . . 0 N--CA 1.499 2.006 0 O-C-N 121.442 -0.786 . . . . 73.140000000000001 109.755 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.428 ' N ' ' OD1' ' A' ' 182' ' ' ASN . 25.1 p-10 . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.527 -0.545 . . . . 73.129999999999995 109.527 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.0 m -76.88 -0.53 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 74.019999999999996 109.415 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 50.6 mt -51.23 -46.85 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 72.329999999999998 109.546 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -56.0 -30.85 62.44 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.401 -0.812 . . . . 74.400000000000006 110.17 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 18.0 t -75.13 -53.18 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.041 -1.037 . . . . 74.319999999999993 110.735 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.8 -44.5 93.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.034 -1.041 . . . . 73.230000000000004 110.697 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 8.1 tp -69.84 -37.91 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.112 -0.993 . . . . 74.310000000000002 110.418 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -70.73 -48.61 53.61 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.111 -0.993 . . . . 73.439999999999998 110.738 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . 0.449 ' CG ' ' N ' ' A' ' 191' ' ' ILE . 7.1 pt20 -64.44 -45.59 86.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.909 -1.119 . . . . 71.420000000000002 110.145 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.449 ' N ' ' CG ' ' A' ' 190' ' ' GLN . 89.6 mt -59.53 -46.68 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.05 -1.031 . . . . 72.439999999999998 109.711 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 19.5 mtp-105 -60.01 -45.08 93.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.025 -1.047 . . . . 64.219999999999999 109.606 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -65.85 -29.29 69.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 74.319999999999993 109.589 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -93.88 -1.46 54.77 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.244 -0.91 . . . . 75.310000000000002 109.996 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 36.5 ttm -96.84 -60.47 1.59 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.04 -1.038 . . . . 74.019999999999996 109.907 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 41.8 t0 -54.94 -22.55 15.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.306 -0.871 . . . . 74.019999999999996 110.583 -178.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.432 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 1.3 mptm? -73.27 -65.81 0.63 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.917 -1.114 . . . . 75.430000000000007 110.221 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . 0.432 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 30.7 Cg_endo -62.18 -56.71 0.64 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.501 1.468 . . . . 72.319999999999993 112.355 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 18.8 mt -64.12 -40.49 96.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.176 -0.953 . . . . 74.540000000000006 109.763 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 86.3 -34.13 3.51 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.916 -1.674 . . . . 61.509999999999998 108.916 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 35.6 mm -111.58 134.82 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.614 -0.933 . . . . 74.25 108.895 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 59.5 p -95.08 166.15 12.07 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.287 -0.883 . . . . 72.0 110.345 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.434 ' O ' ' OG1' ' A' ' 203' ' ' THR . 0.0 OUTLIER -157.9 34.41 0.26 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.348 -0.982 . . . . 74.439999999999998 108.348 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 23.7 m -135.4 137.18 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.541 -0.724 . . . . 71.129999999999995 109.329 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -120.3 135.39 55.02 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.61 -0.681 . . . . 73.510000000000005 109.408 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.5 135.13 42.42 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.317 -0.865 . . . . 73.519999999999996 109.115 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.7 145.74 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.201 -0.937 . . . . 72.150000000000006 109.465 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -77.5 76.55 4.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.94 . . . . 72.400000000000006 109.502 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -164.01 -126.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.229 -0.919 . . . . 73.310000000000002 109.432 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 18.7 tpt85 -49.39 -43.21 44.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.946 . . . . 71.540000000000006 109.733 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 160.46 -111.47 0.48 Allowed Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.686 -1.245 . . . . 74.450000000000003 110.208 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.681 ' HH ' ' HZ2' ' A' ' 165' ' ' LYS . 28.9 m-85 -115.45 171.26 7.83 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.503 -0.998 . . . . 75.540000000000006 109.433 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -142.2 133.0 25.64 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.246 -0.909 . . . . 75.310000000000002 109.699 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.437 ' O ' ' O ' ' A' ' 159' ' ' ARG . 7.2 m-85 -105.4 131.54 52.7 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.88 -0.785 . . . . 75.409999999999997 108.88 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 21.3 t -157.08 150.55 24.21 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.942 -0.762 . . . . 74.140000000000001 108.942 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -61.77 150.54 81.86 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.047 -1.033 . . . . 75.319999999999993 108.913 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.497 1.718 0 C-N-CA 122.412 2.075 . . . . 73.109999999999999 112.455 -179.697 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.541 ' N ' ' CZ ' ' B' ' 2' ' ' ARG . 56.1 ttm . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.485 -0.561 . . . . 75.239999999999995 109.485 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.541 ' CZ ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -128.14 147.08 50.53 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.996 -0.742 . . . . 73.519999999999996 108.996 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 96.8 t -111.11 123.64 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.642 0.734 . . . . 72.239999999999995 109.947 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 1.8 tp -92.79 118.65 31.32 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.477 -0.934 . . . . 73.340000000000003 108.477 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tt -119.08 118.05 30.38 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.318 -0.993 . . . . 74.349999999999994 108.318 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 24.0 mt -111.51 98.4 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.365 -0.834 . . . . 63.439999999999998 108.779 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.423 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 24.6 tp10 -128.93 137.44 51.41 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.623 -0.673 . . . . 74.519999999999996 109.365 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.3 -32.95 73.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.281 -0.887 . . . . 74.129999999999995 109.454 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -90.88 125.0 35.61 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.253 -0.904 . . . . 74.230000000000004 109.514 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 49.5 m -74.93 -32.99 61.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 65.540000000000006 109.799 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 96.0 t -60.14 -46.77 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.149 -0.97 . . . . 75.549999999999997 109.728 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.507 ' CD2' ' N ' ' B' ' 12' ' ' LEU . 3.5 mm? -63.99 -36.48 84.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 70.140000000000001 109.411 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.56 -27.31 71.41 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 108.56 -1.816 . . . . 75.400000000000006 108.56 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.59 -53.18 40.36 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 109.543 -1.423 . . . . 65.439999999999998 109.543 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -58.97 -46.31 88.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.373 -1.075 . . . . 72.200000000000003 109.789 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 36.8 mm -64.45 -40.11 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.816 -1.177 . . . . 75.150000000000006 108.826 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.462 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 83.0 tt0 -61.62 -44.92 96.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.27 -0.894 . . . . 73.010000000000005 109.317 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -84.96 1.38 47.68 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 74.299999999999997 109.196 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.48 -55.42 2.33 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.618 -1.393 . . . . 70.540000000000006 109.618 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -75.7 -20.71 58.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -1.13 . . . . 75.430000000000007 109.839 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 82.5 m-20 -52.54 -33.74 46.9 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.037 -1.039 . . . . 73.200000000000003 109.547 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 75.9 t -58.2 -29.69 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.229 -0.919 . . . . 74.230000000000004 109.278 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -80.12 -7.47 58.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.295 -0.878 . . . . 73.519999999999996 109.485 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.57 40.47 7.75 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.327 -1.109 . . . . 53.43 110.327 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -119.12 160.29 22.37 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.428 -1.042 . . . . 71.120000000000005 109.096 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.7 mmt -105.15 139.63 39.53 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.631 -0.878 . . . . 75.239999999999995 108.631 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.2 155.72 46.01 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.255 -0.903 . . . . 73.25 110.086 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' B' ' 28' ' ' ASP . 2.1 p30 -137.56 140.07 40.82 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.9 -0.778 . . . . 72.310000000000002 108.9 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 p -104.61 138.42 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.489 -0.93 . . . . 72.140000000000001 108.489 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 16.0 p -136.79 166.5 23.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.35 -0.844 . . . . 74.530000000000001 109.306 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . 0.476 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 3.2 pt-20 -90.92 -98.17 0.11 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.242 -0.911 . . . . 71.019999999999996 109.772 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 24.0 t -78.37 165.18 24.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 71.400000000000006 110.166 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 20.7 mt -55.52 -30.65 61.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.577 -0.702 . . . . 71.239999999999995 109.957 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -53.27 -46.15 69.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.137 -0.977 . . . . 74.319999999999993 109.964 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.476 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 75.0 m-20 -67.33 -42.27 83.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.073 -1.017 . . . . 73.030000000000001 109.444 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.59 -39.23 78.79 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.478 -1.449 . . . . 60.43 109.478 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -67.39 -38.21 84.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.322 -1.104 . . . . 74.430000000000007 109.774 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -80.2 -39.66 28.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.089 -1.007 . . . . 74.420000000000002 109.888 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 39.1 tp -68.52 -37.64 80.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.923 . . . . 75.409999999999997 110.226 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.4 ppp? -76.29 -22.68 54.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.959 -1.088 . . . . 61.439999999999998 110.211 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -64.33 -40.8 96.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.021 -1.049 . . . . 74.319999999999993 110.193 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.8 pt -82.05 -42.0 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.052 -1.03 . . . . 71.230000000000004 110.178 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' B' ' 40' ' ' MET . 2.2 mpt_? -94.86 150.71 19.89 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.029 -1.044 . . . . 73.409999999999997 109.278 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -68.68 -162.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 63.539999999999999 109.081 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -179.11 154.78 0.69 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.008 -1.057 . . . . 73.109999999999999 109.927 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -136.98 -46.87 0.58 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.455 -0.778 . . . . 62.219999999999999 108.951 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.413 ' C ' ' CD1' ' B' ' 47' ' ' LEU . 0.9 OUTLIER -104.08 110.66 22.92 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.43 -0.952 . . . . 73.120000000000005 108.43 179.548 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 75.9 t -96.77 98.29 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.268 -0.895 . . . . 74.109999999999999 109.357 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' MET . . . . . 0.412 ' CE ' ' OG ' ' B' ' 74' ' ' SER . 3.8 ttt -113.71 130.29 56.45 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.623 0.725 . . . . 73.439999999999998 109.414 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.424 HG22 ' H ' ' B' ' 52' ' ' ASP . 0.3 OUTLIER -144.27 130.45 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.496 -0.753 . . . . 73.400000000000006 109.132 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' SER . . . . . 0.423 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 95.5 p -91.92 -2.2 56.91 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.519 -0.738 . . . . 73.209999999999994 110.014 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.424 ' H ' HG22 ' B' ' 50' ' ' VAL . 74.8 m-20 -75.58 138.01 41.18 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.136 -0.978 . . . . 70.409999999999997 109.703 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.523 ' C ' ' H ' ' B' ' 55' ' ' ALA . 25.7 mtmm -74.5 -50.23 19.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.252 -0.905 . . . . 73.129999999999995 109.993 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -50.41 -10.57 0.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.168 -0.958 . . . . 75.209999999999994 109.545 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.523 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -64.04 -20.66 66.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.406 -0.809 . . . . 55.329999999999998 110.28 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' B' ' 55' ' ' ALA . 29.5 mt -40.89 -50.11 3.22 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.444 -0.785 . . . . 72.420000000000002 110.224 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 23.2 m -69.77 -32.68 71.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.038 -1.039 . . . . 73.040000000000006 109.124 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' B' ' 55' ' ' ALA . 66.9 t80 -65.34 -45.52 83.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.355 -0.841 . . . . 72.329999999999998 110.068 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 12.0 m -65.57 -34.88 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.536 -1.353 . . . . 74.540000000000006 109.45 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 20.3 t -57.15 -50.2 73.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.231 -0.918 . . . . 71.239999999999995 109.569 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -66.79 -33.19 75.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 74.310000000000002 110.083 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 mm -65.93 -38.51 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.783 -1.198 . . . . 75.420000000000002 109.82 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . 0.432 ' O ' ' OG ' ' B' ' 67' ' ' SER . 56.7 mmtt -67.25 -46.99 72.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.998 -1.064 . . . . 73.319999999999993 110.519 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.434 ' CG ' ' N ' ' B' ' 65' ' ' LYS . 7.7 pt-20 -74.46 -43.15 57.43 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.804 -1.185 . . . . 73.310000000000002 110.224 -179.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.448 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 66.9 mttm -71.05 -23.63 62.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 72.439999999999998 109.807 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . 0.448 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 97.3 m-70 -155.0 65.94 0.65 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.135 -0.978 . . . . 65.209999999999994 109.462 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.452 ' O ' ' N ' ' B' ' 69' ' ' ILE . 36.1 m -54.46 -36.44 64.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.259 -0.9 . . . . 73.099999999999994 109.95 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 29.2 m -68.13 48.11 0.05 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.056 -1.028 . . . . 71.530000000000001 109.7 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . 0.452 ' N ' ' O ' ' B' ' 67' ' ' SER . 16.6 tt -144.16 154.31 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.246 -0.909 . . . . 74.400000000000006 109.27 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t -95.39 155.44 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.097 -1.002 . . . . 75.120000000000005 109.106 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 42.0 t -141.86 125.61 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.155 -0.966 . . . . 73.200000000000003 109.491 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.5 98.38 6.1 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.6 -0.889 . . . . 73.340000000000003 108.6 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 70.4 t -88.7 112.75 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 73.5 108.808 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' SER . . . . . 0.412 ' OG ' ' CE ' ' B' ' 49' ' ' MET . 0.6 OUTLIER -89.57 174.75 7.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.038 -1.039 . . . . 71.319999999999993 108.577 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.609 ' CB ' ' HH ' ' B' ' 94' ' ' TYR . 6.6 p -166.81 121.17 1.06 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.841 -1.162 . . . . 74.530000000000001 110.542 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -57.51 -32.01 66.61 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.518 -0.919 . . . . 64.5 108.518 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -111.88 90.86 13.91 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.635 -0.876 . . . . 74.25 108.635 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.93 72.19 6.27 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.939 1.759 . . . . 74.430000000000007 112.17 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 29.5 p -87.73 162.73 16.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.539 -0.726 . . . . 73.120000000000005 109.338 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -33.17 72.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.328 -0.857 . . . . 75.409999999999997 109.459 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . 0.519 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 76.9 mm-40 -63.45 -41.25 98.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.144 -0.973 . . . . 72.239999999999995 109.527 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . 0.532 ' CD ' ' HH ' ' B' ' 94' ' ' TYR . 76.4 tt0 -73.14 -30.4 63.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.146 -0.971 . . . . 73.219999999999999 109.58 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.525 ' OE2' ' NE ' ' A' ' 108' ' ' ARG . 36.6 tt0 -63.9 -56.06 18.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 74.299999999999997 109.668 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 30.9 m -58.14 -38.54 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.132 -0.98 . . . . 73.310000000000002 108.972 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' HIS . . . . . 0.519 ' ND1' ' O ' ' B' ' 81' ' ' GLU . 27.2 m170 -64.44 -29.08 70.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.257 -0.902 . . . . 73.239999999999995 109.093 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.16 -45.76 79.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.302 -0.874 . . . . 55.329999999999998 109.653 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -80.87 -31.74 35.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.997 -1.064 . . . . 74.450000000000003 109.085 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -64.33 -52.38 58.69 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.219 -0.926 . . . . 64.040000000000006 109.387 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . 0.502 ' NE2' ' N ' ' B' ' 89' ' ' GLN . 0.9 OUTLIER -64.71 -52.32 57.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.451 -0.781 . . . . 75.129999999999995 109.513 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.83 72.3 0.01 OUTLIER Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.103 -1.199 . . . . 75.420000000000002 110.103 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -129.17 134.64 48.11 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.451 -1.029 . . . . 73.420000000000002 108.951 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -76.95 -30.22 55.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.098 -1.001 . . . . 73.319999999999993 109.144 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 93' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 51.2 t0 -152.49 164.22 38.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.374 -0.829 . . . . 73.040000000000006 109.34 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.609 ' HH ' ' CB ' ' B' ' 75' ' ' SER . 86.4 t80 -140.21 121.06 14.47 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.481 -0.933 . . . . 74.310000000000002 108.481 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . 0.545 ' N ' ' CD1' ' B' ' 95' ' ' ILE . 0.0 OUTLIER -127.17 161.49 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 O-C-N 121.36 -0.838 . . . . 75.340000000000003 110.909 -178.017 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.16 129.57 35.31 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.72 -1.215 . . . . 70.099999999999994 107.72 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.688 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -50.77 -56.75 16.84 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 120.989 -1.069 . . . . 65.430000000000007 111.572 -178.544 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 4.5 Cg_endo -41.12 -8.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.116 1.211 . . . . 63.520000000000003 113.26 -175.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . 0.688 ' N ' ' O ' ' B' ' 97' ' ' LYS . 55.1 m-85 60.4 116.03 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.558 -0.714 . . . . 75.129999999999995 109.405 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 31.5 ttm-85 -59.94 -31.2 69.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.925 -1.109 . . . . 74.230000000000004 108.938 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 101' ' ' SER . . . . . 0.73 ' O ' ' N ' ' B' ' 103' ' ' LYS . 46.2 t -174.26 28.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.088 -1.007 . . . . 64.510000000000005 110.552 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 53.3 mt 51.23 -68.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.768 -0.583 . . . . 74.439999999999998 110.47 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . 0.73 ' N ' ' O ' ' B' ' 101' ' ' SER . 4.3 mmmm -58.04 -33.67 69.25 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.05 -1.093 . . . . 72.299999999999997 108.05 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.07 -44.41 95.86 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.368 -0.933 . . . . 74.310000000000002 108.499 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 17.8 tp -63.53 -49.15 74.63 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.838 -0.801 . . . . 73.540000000000006 108.838 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 90.0 t -58.52 -41.16 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 72.030000000000001 109.325 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.7 -36.05 69.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.151 -0.968 . . . . 64.219999999999999 109.202 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -79.79 -28.95 40.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.403 -0.811 . . . . 75.310000000000002 109.961 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.25 -46.09 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 120.978 -1.076 . . . . 55.439999999999998 108.785 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' B' ' 114' ' ' ARG . 23.9 pt-20 -66.22 -42.15 89.08 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.06 -1.056 . . . . 65.310000000000002 108.494 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . 0.417 ' N ' ' CG ' ' B' ' 110' ' ' GLU . . . -53.69 -39.13 64.9 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.58 -0.7 . . . . 74.519999999999996 109.418 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -65.14 -44.66 87.89 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.177 -0.952 . . . . 72.040000000000006 109.953 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . 0.59 ' C ' ' H ' ' B' ' 115' ' ' PHE . 58.1 mt -97.78 -60.12 1.63 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.107 -0.996 . . . . 75.349999999999994 110.768 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' B' ' 110' ' ' GLU . 58.0 mtp180 57.93 -4.85 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.466 -0.772 . . . . 75.5 110.262 -178.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 115' ' ' PHE . . . . . 0.59 ' H ' ' C ' ' B' ' 113' ' ' LEU . 63.4 t80 -171.74 -104.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.993 -1.067 . . . . 73.040000000000006 109.501 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 116' ' ' TRP . . . . . 0.443 ' N ' ' CD2' ' B' ' 115' ' ' PHE . 39.9 m95 -146.75 44.88 1.19 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.334 -0.854 . . . . 74.450000000000003 108.826 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.93 -140.96 26.56 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.216 -1.554 . . . . 64.209999999999994 109.216 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 9.2 t -151.58 138.68 19.17 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.167 -1.196 . . . . 71.400000000000006 109.395 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . 0.45 HD22 ' C ' ' B' ' 121' ' ' ILE . 35.1 t30 -86.54 169.44 12.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.257 -0.902 . . . . 74.209999999999994 109.653 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 11.0 t -137.6 -34.32 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.981 -0.748 . . . . 75.019999999999996 108.981 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . 0.45 ' C ' HD22 ' B' ' 119' ' ' ASN . 26.9 mm -112.31 134.27 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.546 -0.721 . . . . 74.239999999999995 109.147 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -148.42 133.72 18.47 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.193 -0.942 . . . . 73.329999999999998 109.609 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . 1.025 HD11 ' CD ' ' B' ' 159' ' ' ARG . 16.7 tt -149.49 123.96 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.792 -0.818 . . . . 74.219999999999999 108.792 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 54.87 -136.89 44.59 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.207 -1.557 . . . . 72.409999999999997 109.207 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -89.95 1.36 56.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.221 -1.164 . . . . 75.120000000000005 109.524 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.91 138.42 31.56 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.284 -0.885 . . . . 75.420000000000002 108.739 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 35.2 m -132.26 119.56 20.97 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.481 -0.762 . . . . 74.219999999999999 109.288 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . 0.424 ' O ' ' OD1' ' B' ' 119' ' ' ASN . 14.0 mm -117.98 147.08 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.543 -0.723 . . . . 60.329999999999998 109.304 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 129' ' ' SER . . . . . 0.404 ' C ' HH22 ' B' ' 157' ' ' ARG . 5.9 m -137.76 132.91 17.53 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.276 -0.89 . . . . 72.310000000000002 109.137 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -80.72 -49.43 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.174 1.916 . . . . 75.129999999999995 112.455 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -57.51 -49.9 74.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.912 . . . . 75.230000000000004 110.055 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -82.36 -9.33 59.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.091 -1.006 . . . . 75.120000000000005 109.749 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 47.94 69.03 0.58 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.093 -1.004 . . . . 75.129999999999995 109.274 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -139.18 141.22 37.97 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.453 -0.779 . . . . 75.109999999999999 109.353 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 2.8 tt -120.51 126.41 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.515 -0.741 . . . . 70.319999999999993 109.487 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 32.9 mm -115.2 121.82 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.653 -0.869 . . . . 74.120000000000005 108.653 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . 0.429 ' C ' ' H ' ' B' ' 139' ' ' GLY . 35.4 p90 -140.79 143.85 35.11 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.206 -0.934 . . . . 74.230000000000004 109.622 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' B' ' 138' ' ' LYS . 30.3 ttpt 54.57 9.5 0.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.547 -0.721 . . . . 74.219999999999999 109.804 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' B' ' 137' ' ' TYR . . . 91.55 16.65 51.95 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 110.04 -1.224 . . . . 74.319999999999993 110.04 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 41.6 mtt-85 -107.33 144.11 34.65 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.513 -0.992 . . . . 75.340000000000003 109.706 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -102.82 118.12 36.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.568 -0.707 . . . . 71.230000000000004 109.397 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 71.8 t -136.36 137.37 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.452 -0.78 . . . . 70.430000000000007 109.012 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -80.36 132.38 35.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.906 . . . . 72.430000000000007 109.531 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 5.4 p -73.1 133.27 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.159 -0.963 . . . . 72.129999999999995 109.064 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 35.3 pttt -170.4 66.3 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.9 . . . . 74.5 109.607 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 176.6 156.2 15.0 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.369 -1.492 . . . . 42.229999999999997 109.369 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . 0.615 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 19.3 mttt -65.23 -39.24 33.89 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.201 -1.176 . . . . 73.299999999999997 109.625 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 27.2 Cg_exo -61.54 -30.45 86.24 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.016 1.81 . . . . 71.329999999999998 111.218 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -94.94 -20.67 19.19 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.456 -0.778 . . . . 74.230000000000004 109.389 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -67.36 -39.23 85.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.273 -0.892 . . . . 72.340000000000003 109.486 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.45 -35.16 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 73.349999999999994 109.615 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . 0.417 ' O ' ' CD1' ' B' ' 155' ' ' LEU . 0.2 OUTLIER -67.27 -42.43 83.84 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.125 0.964 . . . . 74.430000000000007 109.308 -179.76 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 153' ' ' THR . . . . . 0.436 ' CG2' ' NH2' ' B' ' 157' ' ' ARG . 34.7 m -74.08 -26.51 60.41 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.03 -1.043 . . . . 75.209999999999994 110.872 -179.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -71.98 -59.98 2.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.045 -1.035 . . . . 73.040000000000006 109.867 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . 0.492 ' CD1' ' N ' ' B' ' 156' ' ' ALA . 0.0 OUTLIER -62.29 -20.98 64.86 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.929 -1.107 . . . . 73.430000000000007 108.735 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . 0.492 ' N ' ' CD1' ' B' ' 155' ' ' LEU . . . -61.86 -48.05 82.29 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 120.901 -1.125 . . . . 75.319999999999993 108.233 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . 0.436 ' NH2' ' CG2' ' B' ' 153' ' ' THR . 0.0 OUTLIER -72.72 -42.45 64.14 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.42 -0.912 . . . . 73.319999999999993 109.409 179.57 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -83.28 10.83 7.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.931 . . . . 74.140000000000001 110.389 -178.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . 1.025 ' CD ' HD11 ' B' ' 123' ' ' ILE . 10.4 ttp-105 -48.38 164.94 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.026 -1.046 . . . . 73.420000000000002 109.019 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 61.27 53.16 3.6 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.342 -0.849 . . . . 72.099999999999994 109.716 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -161.04 156.24 24.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.34 -0.85 . . . . 73.239999999999995 109.036 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 66.6 mt -88.86 132.49 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.997 -1.065 . . . . 72.310000000000002 108.896 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' B' ' 212' ' ' TYR . 40.1 t -141.57 136.78 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.24 -0.913 . . . . 75.030000000000001 110.353 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 164' ' ' SER . . . . . 0.608 ' HG ' ' N ' ' B' ' 165' ' ' LYS . 6.6 t -94.65 167.94 11.15 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.096 -1.002 . . . . 74.219999999999999 109.288 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . 1.072 ' NZ ' ' HA ' ' B' ' 185' ' ' GLU . 22.2 mttm -61.96 -38.22 87.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.028 -1.045 . . . . 72.420000000000002 109.865 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -52.96 -39.53 63.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 63.450000000000003 110.14 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -60.94 -48.14 83.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -0.951 . . . . 72.400000000000006 110.478 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 40.5 mt -57.31 -33.54 67.8 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.91 -1.119 . . . . 72.319999999999993 109.665 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' B' ' 173' ' ' TRP . 5.7 tt -65.38 -61.83 1.88 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.161 -0.962 . . . . 73.340000000000003 109.624 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -65.19 -28.63 69.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.36 -0.837 . . . . 73.099999999999994 110.568 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.94 -59.49 5.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.119 -0.988 . . . . 62.130000000000003 110.616 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . 0.519 ' N ' ' CD1' ' B' ' 172' ' ' ILE . 2.0 mp -86.75 -59.34 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.006 -1.059 . . . . 74.439999999999998 109.172 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 173' ' ' TRP . . . . . 0.428 ' O ' ' O ' ' B' ' 169' ' ' LEU . 23.0 m-90 . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 72.230000000000004 108.822 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo . . . . . 0 N--CA 1.496 1.665 0 CA-C-O 120.913 0.297 . . . . 74.340000000000003 112.651 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -149.57 -15.77 0.28 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.913 -1.117 . . . . 72.310000000000002 109.959 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 11.3 p -63.97 -17.86 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.19 -0.943 . . . . 65.420000000000002 109.984 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.494 ' H ' ' CD1' ' B' ' 184' ' ' ILE . 1.3 mp -49.74 -35.17 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.068 -1.02 . . . . 75.030000000000001 109.567 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . 1.072 ' HA ' ' NZ ' ' B' ' 165' ' ' LYS . 17.3 pt-20 -55.87 -36.54 67.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.994 -1.066 . . . . 73.519999999999996 109.215 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 9.2 t -75.42 -36.98 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 74.349999999999994 109.207 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.08 -55.03 28.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.36 -0.838 . . . . 61.119999999999997 109.868 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 188' ' ' ILE . . . . . 0.45 HG22 ' HZ2' ' B' ' 165' ' ' LYS . 5.4 tp -63.15 -33.93 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.098 -1.001 . . . . 72.430000000000007 109.927 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -69.04 -50.86 44.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 75.420000000000002 110.491 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -72.53 -39.08 67.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.035 -1.041 . . . . 74.140000000000001 110.157 -178.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 57.5 mt -57.22 -38.01 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.037 -1.039 . . . . 74.030000000000001 109.345 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -73.57 -44.13 58.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.037 -1.039 . . . . 72.329999999999998 109.96 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -70.5 -28.77 65.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.906 . . . . 73.099999999999994 110.601 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -82.97 -33.84 26.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.01 -1.056 . . . . 74.430000000000007 110.291 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 62.4 mtt -90.61 -40.8 11.71 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.053 -1.03 . . . . 74.329999999999998 110.863 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 196' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 51.1 p-10 -53.32 -20.43 4.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.929 -1.107 . . . . 71.209999999999994 110.488 -178.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . 0.524 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 4.1 mmtp -76.19 -65.63 0.42 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.852 -1.155 . . . . 75.209999999999994 109.537 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 198' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 48.2 Cg_endo -66.12 -45.39 5.82 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.246 1.964 . . . . 75.319999999999993 111.633 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 37.1 tp -65.05 -51.09 63.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.386 -0.821 . . . . 72.25 109.342 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 85.94 -33.2 3.59 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.91 -1.276 . . . . 73.239999999999995 109.91 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . 0.486 ' N ' ' CD1' ' B' ' 201' ' ' ILE . 2.5 mp -92.19 142.15 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.131 -1.217 . . . . 54.299999999999997 109.722 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 70.3 m -119.58 133.24 55.75 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.37 -0.974 . . . . 74.310000000000002 108.37 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 24.4 p -137.22 47.42 2.11 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.312 -0.867 . . . . 74.400000000000006 109.715 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 1.6 m -143.15 122.41 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.259 -0.9 . . . . 74.099999999999994 109.219 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -107.94 129.45 55.1 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.664 -0.865 . . . . 75.329999999999998 108.664 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.16 131.22 39.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.175 -0.953 . . . . 71.400000000000006 109.949 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 5.0 t -129.56 122.91 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.434 -0.951 . . . . 63.5 108.434 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -61.93 -26.07 67.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 74.450000000000003 110.065 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 -68.67 -88.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.033 -1.042 . . . . 74.140000000000001 109.83 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -65.3 -63.49 1.09 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.05 -1.032 . . . . 74.430000000000007 109.668 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 157.91 -105.81 0.28 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.452 -1.459 . . . . 70.109999999999999 109.452 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 212' ' ' TYR . . . . . 0.461 ' O ' ' O ' ' B' ' 163' ' ' VAL . 39.0 m-85 -120.16 135.87 54.81 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.613 -0.933 . . . . 74.209999999999994 109.618 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -125.5 134.13 52.14 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.446 -0.784 . . . . 74.299999999999997 108.944 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -90.77 131.28 36.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.406 -0.808 . . . . 74.340000000000003 109.289 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 26.7 p -153.74 167.97 27.83 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.173 -0.954 . . . . 72.209999999999994 109.803 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -63.52 148.44 93.88 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.42 -0.8 . . . . 72.310000000000002 109.213 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.82 162.63 27.88 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.11 1.873 . . . . 71.010000000000005 111.914 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 21.8 mttm . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.246 -0.909 . . . . 74.349999999999994 109.349 -179.796 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.597 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.436 -0.579 . . . . 65.120000000000005 109.436 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.404 ' CG ' HH11 ' A' ' 2' ' ' ARG . 2.0 ttt-85 -145.06 152.9 40.84 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.213 -0.929 . . . . 73.310000000000002 109.07 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 65.7 t -115.29 128.84 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.52 -0.738 . . . . 71.420000000000002 109.652 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 tp -100.39 117.08 33.85 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.516 -0.74 . . . . 65.219999999999999 109.136 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.2 tp -115.89 111.53 20.58 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.563 -0.71 . . . . 71.439999999999998 109.475 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.413 ' O ' ' OG ' ' A' ' 51' ' ' SER . 9.2 mt -102.24 113.42 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.213 -0.93 . . . . 71.150000000000006 108.96 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.476 ' OE1' ' CB ' ' A' ' 51' ' ' SER . 31.0 tp10 -148.41 126.88 12.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.205 -0.934 . . . . 75.340000000000003 109.572 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -69.09 -30.76 69.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -0.869 . . . . 73.040000000000006 109.173 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -84.97 114.29 22.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.34 -0.85 . . . . 72.420000000000002 109.422 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 77.2 p -70.19 -24.84 63.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.911 . . . . 72.340000000000003 109.62 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.65 -51.49 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.209 -0.932 . . . . 74.420000000000002 109.642 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.518 ' CD2' ' N ' ' A' ' 12' ' ' LEU . 3.5 mm? -66.91 -33.54 75.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 72.010000000000005 109.212 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.76 -23.3 75.36 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.674 -1.77 . . . . 72.140000000000001 108.674 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.74 -53.43 15.91 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.622 -1.391 . . . . 72.329999999999998 109.622 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -60.69 -43.37 97.83 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.35 -1.088 . . . . 72.340000000000003 109.736 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 96.2 mt -65.11 -32.5 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.891 -1.131 . . . . 74.239999999999995 109.034 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -58.01 -49.81 75.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 71.409999999999997 109.298 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -88.11 0.45 55.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.228 -0.92 . . . . 75.540000000000006 109.879 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.15 -57.82 2.58 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 110.002 -1.239 . . . . 62.149999999999999 110.002 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pp -74.58 -23.25 58.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -1.128 . . . . 74.420000000000002 110.052 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -51.47 -35.29 39.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.018 -1.052 . . . . 74.25 109.47 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.7 t -55.38 -41.3 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.97 . . . . 72.109999999999999 109.159 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.405 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 2.6 mptp? -63.17 -19.26 64.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.855 . . . . 73.230000000000004 109.026 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.85 40.64 4.88 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.553 -1.019 . . . . 75.540000000000006 110.553 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -119.04 160.43 22.04 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.421 -1.046 . . . . 74.510000000000005 108.502 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.8 mmt -90.14 124.33 34.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.051 -1.031 . . . . 64.319999999999993 108.872 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.25 138.58 37.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.417 -0.802 . . . . 74.310000000000002 110.059 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -127.82 126.89 42.54 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.508 -0.923 . . . . 75.400000000000006 108.508 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -106.11 130.78 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.729 -0.841 . . . . 75.129999999999995 108.729 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.9 p -135.67 160.58 38.07 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.5 -0.75 . . . . 71.420000000000002 109.485 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -89.0 -103.44 0.09 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.283 -0.886 . . . . 73.109999999999999 109.418 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.443 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 62.2 m -78.45 147.89 33.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.205 -0.934 . . . . 74.239999999999995 109.36 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.7 mp -49.1 -15.71 0.12 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.328 -0.857 . . . . 71.530000000000001 110.189 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 32' ' ' SER . 78.8 mm-40 -62.65 -53.33 56.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.012 -1.055 . . . . 74.230000000000004 110.05 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 36' ' ' GLY . 19.8 p-10 -67.73 -30.27 69.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.0 -1.062 . . . . 71.010000000000005 109.262 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.543 ' N ' ' OD1' ' A' ' 35' ' ' ASP . . . -75.25 -36.11 46.36 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.142 -1.583 . . . . 61.409999999999997 109.142 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -70.09 -46.88 63.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.339 -1.095 . . . . 74.340000000000003 109.459 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -69.05 -34.1 74.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.969 . . . . 75.329999999999998 109.862 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.7 tp -79.23 -51.33 9.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.217 -0.927 . . . . 74.329999999999998 110.226 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.456 ' SD ' ' OH ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -58.2 -27.85 64.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.101 -1.0 . . . . 70.319999999999993 109.934 -179.27 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -61.09 -39.68 90.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.109 -0.994 . . . . 71.219999999999999 109.849 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 42' ' ' ILE . 15.7 pt -91.44 1.39 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.072 -1.018 . . . . 74.409999999999997 110.076 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 40' ' ' MET . 86.2 mtt-85 -126.4 152.15 46.72 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.36 -0.838 . . . . 75.409999999999997 109.328 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -96.83 151.79 19.32 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.197 -0.94 . . . . 75.420000000000002 109.326 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.456 ' OH ' ' SD ' ' A' ' 40' ' ' MET . 10.0 p90 -154.76 175.23 13.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.243 -0.911 . . . . 74.230000000000004 109.646 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -135.76 -33.44 0.86 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.423 -0.798 . . . . 75.319999999999993 109.307 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.99 115.01 29.36 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.492 -0.755 . . . . 72.129999999999995 109.014 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.3 t -102.41 98.84 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.852 -0.796 . . . . 72.340000000000003 108.852 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.474 ' SD ' ' O ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -109.59 122.75 48.13 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.096 -0.705 . . . . 74.109999999999999 109.096 -179.615 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.6 p -130.87 130.02 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 121.602 0.715 . . . . 71.239999999999995 109.702 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.476 ' CB ' ' OE1' ' A' ' 7' ' ' GLU . 44.9 p -99.1 0.54 43.81 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.435 -0.791 . . . . 73.109999999999999 109.281 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -76.03 141.52 42.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.141 -0.974 . . . . 63.399999999999999 109.341 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.523 ' C ' ' H ' ' A' ' 55' ' ' ALA . 21.2 pttm -79.36 -38.51 34.87 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.252 -0.905 . . . . 65.439999999999998 110.449 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -70.59 11.25 0.38 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.977 -1.077 . . . . 73.129999999999995 109.494 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.523 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.77 -21.12 57.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.406 -0.809 . . . . 64.140000000000001 110.589 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 55' ' ' ALA . 73.6 mt -38.11 -48.47 1.24 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.498 -0.751 . . . . 74.430000000000007 111.025 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.2 m -71.93 -36.76 70.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.889 -1.132 . . . . 63.229999999999997 109.59 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -66.33 -47.01 74.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.397 -0.815 . . . . 74.439999999999998 110.594 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.3 m -64.14 -34.42 68.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 120.636 -1.29 . . . . 74.030000000000001 109.561 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.0 t -57.75 -55.12 38.92 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.182 -0.949 . . . . 73.540000000000006 109.317 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.667 HH21 ' NZ ' ' A' ' 65' ' ' LYS . 5.7 ptm180 -61.42 -31.27 71.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 73.340000000000003 109.868 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.9 mm -63.03 -37.18 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.996 -1.065 . . . . 73.349999999999994 109.778 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.417 ' HZ3' ' C ' ' A' ' 90' ' ' GLY . 26.4 mmtp -70.03 -54.24 14.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.036 -1.04 . . . . 74.420000000000002 110.315 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -64.85 -35.89 82.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.817 -1.177 . . . . 74.549999999999997 109.815 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.667 ' NZ ' HH21 ' A' ' 61' ' ' ARG . 46.4 mtpt -82.58 -23.3 34.5 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.063 -1.023 . . . . 75.219999999999999 109.818 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.477 ' CG ' ' C ' ' A' ' 65' ' ' LYS . 47.8 m-70 -154.38 65.53 0.69 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.043 -1.036 . . . . 74.129999999999995 109.64 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.8 t -64.69 -30.64 71.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.204 -0.935 . . . . 73.239999999999995 109.951 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 97.2 p -60.43 -17.87 47.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.168 -0.958 . . . . 71.439999999999998 110.014 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 53.7 mt -91.28 149.56 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.139 -0.975 . . . . 71.329999999999998 109.614 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 91.9 t -88.33 159.18 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.344 -0.847 . . . . 73.019999999999996 109.135 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.81 124.54 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.158 -0.963 . . . . 54.210000000000001 110.001 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.61 ' CD1' HH22 ' A' ' 108' ' ' ARG . 4.0 tt -113.43 99.09 7.51 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.617 -0.882 . . . . 74.209999999999994 108.617 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.6 t -96.71 123.22 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.364 -0.835 . . . . 74.409999999999997 108.816 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.82 -178.11 4.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.986 -1.071 . . . . 72.310000000000002 109.004 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.473 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 49.7 p -166.75 120.07 1.02 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.133 -0.979 . . . . 64.540000000000006 109.829 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -77.49 6.39 7.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.403 -0.811 . . . . 74.129999999999995 108.913 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 79' ' ' THR . 74.6 m-20 -142.24 64.96 17.63 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.947 -0.76 . . . . 73.340000000000003 108.947 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.6 81.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.919 1.746 . . . . 71.319999999999993 111.707 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 77' ' ' ASN . 41.1 p -100.56 161.89 13.3 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.776 -0.824 . . . . 62.530000000000001 108.776 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 p -66.52 -24.48 66.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.131 -0.981 . . . . 74.140000000000001 109.659 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -73.64 -38.98 64.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 71.420000000000002 109.769 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.41 ' OE1' ' OH ' ' A' ' 94' ' ' TYR . 96.1 mt-10 -70.92 -33.65 70.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.204 -0.935 . . . . 73.430000000000007 110.117 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.416 ' OE2' ' NE ' ' B' ' 100' ' ' ARG . 92.3 mt-10 -68.61 -55.8 10.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.005 -1.059 . . . . 74.219999999999999 109.745 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.9 m -60.61 -42.52 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.191 -0.943 . . . . 74.150000000000006 109.414 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.551 ' CE1' HE21 ' A' ' 89' ' ' GLN . 75.8 t60 -69.21 -31.58 70.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.32 -0.862 . . . . 72.540000000000006 109.498 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.89 -36.64 84.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.298 -0.876 . . . . 64.219999999999999 109.822 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -78.32 -33.25 49.36 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.09 -1.006 . . . . 74.340000000000003 108.756 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -72.97 -34.03 66.21 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.447 -0.783 . . . . 74.420000000000002 109.378 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.551 HE21 ' CE1' ' A' ' 85' ' ' HIS . 83.9 mm-40 -69.93 -62.33 1.43 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 74.519999999999996 109.484 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.417 ' C ' ' HZ3' ' A' ' 63' ' ' LYS . . . 152.56 54.96 0.01 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.908 -1.277 . . . . 74.209999999999994 109.908 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.37 135.85 53.7 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.416 -1.049 . . . . 64.099999999999994 109.431 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 20.0 t70 -82.15 -31.65 30.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 73.420000000000002 109.127 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 95.6 m-20 -141.77 160.16 40.74 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.417 -0.802 . . . . 75.040000000000006 109.204 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.473 ' OH ' ' CB ' ' A' ' 75' ' ' SER . 82.6 t80 -139.49 105.66 5.24 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.395 -0.815 . . . . 71.329999999999998 109.122 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 29.0 mm -111.62 157.82 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.221 -0.925 . . . . 74.510000000000005 110.674 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.81 125.16 28.93 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.831 -1.174 . . . . 64.319999999999993 107.831 178.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.674 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -45.23 -53.85 16.1 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.016 -1.053 . . . . 74.510000000000005 111.467 -178.801 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.7 Cg_endo -42.11 -10.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 CA-C-N 119.729 0.939 . . . . 73.109999999999999 112.643 -177.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.674 ' N ' ' O ' ' A' ' 97' ' ' LYS . 57.7 m-85 58.7 112.39 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.667 -0.646 . . . . 72.540000000000006 109.694 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.51 ' NE ' ' OE2' ' B' ' 83' ' ' GLU . 37.8 ttm-85 -58.58 -38.19 77.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.948 -1.095 . . . . 74.540000000000006 108.511 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.806 ' O ' ' N ' ' A' ' 103' ' ' LYS . 6.3 t -173.24 31.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -0.872 . . . . 74.140000000000001 110.338 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.428 ' O ' ' N ' ' A' ' 105' ' ' LEU . 6.4 mm 46.77 -67.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 CA-C-N 118.343 0.519 . . . . 75.430000000000007 110.462 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.806 ' N ' ' O ' ' A' ' 101' ' ' SER . 16.0 mtpp -50.7 -32.72 20.26 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.749 -1.22 . . . . 74.140000000000001 107.923 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.75 -38.34 80.05 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.921 -1.14 . . . . 63.240000000000002 107.921 178.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 102' ' ' ILE . 2.0 tt -70.0 -47.85 60.49 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.275 -0.639 . . . . 73.219999999999999 109.275 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.6 t -64.74 -44.59 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 74.540000000000006 109.192 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.24 -40.0 64.23 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.205 -0.935 . . . . 75.5 109.093 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.61 HH22 ' CD1' ' A' ' 72' ' ' LEU . 14.6 ttp-105 -72.58 -25.15 61.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.361 -0.837 . . . . 74.409999999999997 109.667 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.431 HG23 HD11 ' A' ' 109' ' ' ILE . 83.0 mt -80.12 -33.24 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.439 -1.319 . . . . 73.239999999999995 107.439 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -55.62 31.43 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.557 -1.275 . . . . 74.340000000000003 107.557 178.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.76 -40.42 69.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.653 -0.654 . . . . 73.319999999999993 109.586 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 10.6 mmp_? -56.15 -33.37 65.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.182 -0.948 . . . . 74.420000000000002 109.581 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.65 72.88 0.99 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.928 -1.108 . . . . 74.329999999999998 110.23 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.482 ' O ' ' N ' ' A' ' 116' ' ' TRP . 43.7 mtm180 -73.41 101.55 3.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.002 -1.061 . . . . 74.439999999999998 108.871 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 47.87 14.55 0.05 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.314 -0.866 . . . . 74.430000000000007 109.902 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' TRP . . . . . 0.482 ' N ' ' O ' ' A' ' 114' ' ' ARG . 94.9 m95 46.99 -164.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.166 -0.959 . . . . 74.439999999999998 109.675 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 168.1 40.52 0.02 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.491 -1.444 . . . . 75.040000000000006 109.491 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.6 m -83.98 -124.68 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.263 -1.139 . . . . 70.109999999999999 109.621 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 61.44 67.21 0.8 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 65.239999999999995 109.556 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.4 t -80.5 -25.76 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 74.219999999999999 109.337 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.8 mm -98.42 132.9 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.331 -0.855 . . . . 74.420000000000002 109.278 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -144.68 117.46 8.72 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.191 -0.943 . . . . 73.299999999999997 109.551 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.72 128.74 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.37 -0.831 . . . . 75.340000000000003 108.829 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.3 -136.25 16.81 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.519 -1.432 . . . . 75.129999999999995 109.519 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -91.53 -6.01 53.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.249 -1.148 . . . . 74.450000000000003 109.515 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.14 135.61 33.84 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.215 -0.928 . . . . 54.210000000000001 108.788 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 26.8 p -132.1 146.33 51.98 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.474 -0.766 . . . . 70.239999999999995 109.588 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.2 mt -134.61 136.7 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.324 -0.86 . . . . 72.430000000000007 109.63 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.3 t -113.89 124.78 30.43 Favored Pre-proline 0 N--CA 1.496 1.874 0 N-CA-C 109.023 -0.732 . . . . 71.109999999999999 109.023 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -80.58 -51.67 0.05 OUTLIER 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.635 1.557 . . . . 75.140000000000001 112.044 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -65.28 -44.22 88.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 72.5 109.73 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -80.98 -15.52 55.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 73.140000000000001 109.354 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 54.5 77.07 0.21 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 75.329999999999998 109.76 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -158.04 140.36 14.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 71.230000000000004 109.461 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.5 tt -120.22 133.45 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.539 -0.726 . . . . 75.329999999999998 109.6 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 26.7 mm -110.18 121.79 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.856 -0.794 . . . . 71.109999999999999 108.856 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.52 ' C ' ' H ' ' A' ' 139' ' ' GLY . 49.8 p90 -142.68 149.17 38.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.086 -1.009 . . . . 74.140000000000001 108.967 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 46.8 tttp 53.96 5.98 0.08 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.297 -0.877 . . . . 75.400000000000006 109.536 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' A' ' 137' ' ' TYR . . . 94.04 -6.71 72.88 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 110.079 -1.208 . . . . 72.239999999999995 110.079 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.416 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 1.0 OUTLIER -89.78 143.57 26.69 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.056 -1.261 . . . . 73.120000000000005 109.288 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -99.51 125.91 45.36 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.369 -0.832 . . . . 72.319999999999993 109.362 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.7 t -137.1 133.48 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.422 -0.798 . . . . 62.340000000000003 109.604 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.449 ' N ' ' OE1' ' A' ' 143' ' ' GLU . 45.5 mp0 -94.95 147.1 23.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.343 -0.848 . . . . 61.229999999999997 109.046 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.09 131.61 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.251 -0.906 . . . . 74.439999999999998 109.63 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.75 121.34 8.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.36 -0.837 . . . . 75.420000000000002 109.198 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.95 -143.29 10.09 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.917 -1.273 . . . . 73.340000000000003 109.917 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -70.67 -62.82 1.85 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.424 -1.045 . . . . 72.219999999999999 110.348 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -56.0 -19.68 27.11 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.934 1.756 . . . . 75.450000000000003 111.856 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -80.61 -44.49 18.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 65.239999999999995 109.189 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -60.94 -39.65 90.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 72.519999999999996 109.995 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.5 p -77.14 -38.61 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.135 -0.978 . . . . 74.209999999999994 110.053 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 15.0 tp -65.04 -42.8 93.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.121 -0.987 . . . . 73.310000000000002 109.737 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 42.9 p -72.98 -35.54 66.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.08 -1.013 . . . . 74.310000000000002 109.851 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -57.59 -52.01 67.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 75.450000000000003 109.632 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 pp -73.88 -24.4 59.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 75.340000000000003 109.846 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.41 -46.6 83.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.134 -0.979 . . . . 62.140000000000001 109.426 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.49 ' C ' ' H ' ' A' ' 159' ' ' ARG . 65.5 mtt180 -75.34 -44.07 47.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.229 -0.919 . . . . 72.219999999999999 109.335 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -75.71 22.78 0.13 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 74.120000000000005 109.406 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.49 ' H ' ' C ' ' A' ' 157' ' ' ARG . 37.2 ptt180 -56.82 165.23 1.26 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.249 -0.907 . . . . 74.340000000000003 109.49 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.432 ' OD2' ' OE1' ' B' ' 161' ' ' GLN . 50.2 t0 54.2 47.15 23.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 75.450000000000003 109.242 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -155.15 158.9 39.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.284 -0.885 . . . . 73.409999999999997 109.381 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 53.4 mt -85.03 120.05 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.209 -0.932 . . . . 74.409999999999997 109.331 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.403 ' O ' ' O ' ' A' ' 212' ' ' TYR . 40.0 t -107.76 130.36 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.419 -0.801 . . . . 72.530000000000001 109.497 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.9 m -100.9 153.04 19.83 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.361 -0.837 . . . . 74.120000000000005 109.358 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.413 ' CB ' ' HZ2' ' A' ' 165' ' ' LYS . 9.2 mtpm? -56.65 -35.47 68.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.9 . . . . 70.430000000000007 109.505 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -59.51 -37.6 78.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 74.319999999999993 109.629 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.431 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 93.4 mt-30 -62.56 -39.6 94.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 74.519999999999996 109.555 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 28.5 mt -64.95 -31.78 73.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.128 -0.982 . . . . 74.409999999999997 109.268 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.2 tt -66.38 -59.11 3.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.862 . . . . 75.140000000000001 110.098 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 167' ' ' GLN . 28.9 p-10 -73.64 -30.24 62.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.04 -1.038 . . . . 65.030000000000001 110.624 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.403 ' N ' ' OD1' ' A' ' 170' ' ' ASP . . . -59.98 -46.35 89.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.968 -1.083 . . . . 70.209999999999994 110.173 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.54 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 1.6 mp -94.67 -59.86 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.038 -1.039 . . . . 75.319999999999993 108.966 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 29.8 m-90 . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 73.140000000000001 109.769 -179.89 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 23.5 m120 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.204 0.526 . . . . 73.129999999999995 110.286 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.85 -4.31 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.4 -0.812 . . . . 74.019999999999996 109.569 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 3.0 mp -53.56 -37.76 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.01 -1.056 . . . . 72.329999999999998 109.503 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -55.23 -30.53 60.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -0.947 . . . . 74.400000000000006 109.421 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 94.1 t -79.23 -57.23 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.082 -1.011 . . . . 74.319999999999993 109.495 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -54.97 -47.19 74.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.157 -0.964 . . . . 73.230000000000004 109.875 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.416 HG22 HD12 ' A' ' 188' ' ' ILE . 0.2 OUTLIER -60.23 -44.2 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.085 -1.009 . . . . 74.310000000000002 109.061 -179.726 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.413 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 0.5 OUTLIER -60.35 -41.71 94.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.959 -1.088 . . . . 73.439999999999998 109.445 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -68.34 -45.13 73.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.93 . . . . 71.420000000000002 109.718 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 85.7 mt -56.41 -37.69 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.263 -0.898 . . . . 72.439999999999998 109.156 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -65.27 -40.68 94.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 64.219999999999999 109.512 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.431 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 14.8 mm100 -76.42 -26.61 55.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 74.319999999999993 110.025 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.425 ' CB ' ' NZ ' ' A' ' 194' ' ' LYS . 8.5 mtpm? -81.67 -25.26 35.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -0.946 . . . . 75.310000000000002 110.581 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 20.1 ptm -95.07 -36.32 11.57 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.033 -1.042 . . . . 74.019999999999996 110.116 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 197' ' ' LYS . 30.9 p-10 -66.04 -34.21 77.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.049 -1.032 . . . . 74.019999999999996 110.021 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.538 ' N ' ' OD1' ' A' ' 196' ' ' ASP . 11.0 ttpp -62.84 -60.87 8.64 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.013 -1.054 . . . . 75.430000000000007 109.876 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -59.04 -52.01 5.79 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.64 1.56 . . . . 72.319999999999993 111.407 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.478 ' N ' ' CD1' ' A' ' 199' ' ' LEU . 8.0 mp -92.53 125.15 37.04 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.345 -0.847 . . . . 74.540000000000006 109.118 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -77.79 -2.18 80.54 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.417 -1.473 . . . . 61.509999999999998 109.417 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 19.6 mt -108.32 137.54 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.501 -1.0 . . . . 74.25 109.392 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 23.1 t -93.23 143.5 26.2 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.26 -0.9 . . . . 72.0 109.4 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 49.2 p -130.58 10.05 5.14 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.511 -0.743 . . . . 74.439999999999998 109.353 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 5.9 m -132.01 142.72 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.504 -0.748 . . . . 71.129999999999995 109.328 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -126.0 134.81 51.36 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.644 -0.66 . . . . 73.510000000000005 109.364 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.0 95.67 8.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.2 -0.938 . . . . 73.519999999999996 109.203 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.573 ' CG1' ' NH1' ' A' ' 213' ' ' ARG . 11.2 p -164.41 170.65 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.96 . . . . 72.150000000000006 109.347 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' ARG . . . . . 0.657 ' HE ' ' NH2' ' A' ' 210' ' ' ARG . 6.2 tpt180 76.65 146.16 0.09 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.495 -0.753 . . . . 72.400000000000006 109.547 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -61.5 -34.29 75.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.361 -0.837 . . . . 73.310000000000002 109.792 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.657 ' NH2' ' HE ' ' A' ' 208' ' ' ARG . 0.2 OUTLIER -49.94 -50.92 44.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 71.540000000000006 109.092 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 148.29 -106.06 0.33 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.051 -1.22 . . . . 74.450000000000003 110.051 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 212' ' ' TYR . 20.3 m-85 -113.43 145.38 41.25 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.568 -0.96 . . . . 75.540000000000006 109.484 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.573 ' NH1' ' CG1' ' A' ' 207' ' ' VAL . 7.8 mtm-85 -117.42 135.09 54.13 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.521 -0.737 . . . . 75.310000000000002 109.226 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -100.01 128.1 46.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.281 -0.887 . . . . 75.409999999999997 109.379 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 3.6 p -141.46 156.4 45.77 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.378 -0.826 . . . . 74.140000000000001 109.29 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -68.83 152.85 96.55 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.91 . . . . 75.319999999999993 109.108 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo . . . . . 0 C--N 1.314 -1.26 0 C-N-CA 122.299 1.999 . . . . 73.109999999999999 112.254 179.698 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 1' ' ' MET . . . . . 0.591 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.401 -0.592 . . . . 75.239999999999995 109.401 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -140.15 147.5 40.26 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.358 -0.839 . . . . 73.519999999999996 109.46 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 93.3 t -114.99 123.29 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 121.596 0.712 . . . . 72.239999999999995 109.585 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 3.1 tp -91.34 118.05 30.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.898 . . . . 73.340000000000003 108.655 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 tt -118.08 117.0 28.02 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.49 -0.93 . . . . 74.349999999999994 108.49 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 78.2 mt -111.87 98.96 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.297 -0.877 . . . . 63.439999999999998 108.983 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.426 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 26.7 tp10 -129.31 135.68 49.06 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.516 -0.74 . . . . 74.519999999999996 109.434 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -67.83 -32.8 73.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 74.129999999999995 109.245 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -89.62 121.44 31.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.874 . . . . 74.230000000000004 109.47 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 23.2 m -73.7 -32.31 63.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 65.540000000000006 109.828 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 98.4 t -60.69 -47.65 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.14 -0.975 . . . . 75.549999999999997 109.829 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.508 ' CD2' ' N ' ' B' ' 12' ' ' LEU . 3.4 mm? -64.02 -33.27 75.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.155 -0.966 . . . . 70.140000000000001 109.297 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.39 -28.59 59.55 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.755 -1.738 . . . . 75.400000000000006 108.755 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.13 -50.13 62.32 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.299 -1.52 . . . . 65.439999999999998 109.299 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -62.2 -44.67 96.06 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.305 -1.114 . . . . 72.200000000000003 109.405 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.409 ' CD1' ' CZ ' ' B' ' 99' ' ' TYR . 5.3 mm -63.3 -35.62 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.884 -1.135 . . . . 75.150000000000006 108.399 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' B' ' 27' ' ' ALA . 43.4 tp10 -63.9 -49.11 73.95 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.329 -0.857 . . . . 73.010000000000005 109.224 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -80.53 0.56 33.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.97 . . . . 74.299999999999997 109.166 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.9 -62.35 1.52 Allowed Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.55 -1.42 . . . . 70.540000000000006 109.55 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -68.38 -23.64 64.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -1.154 . . . . 75.430000000000007 109.639 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -51.56 -35.01 39.28 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.055 -1.028 . . . . 73.200000000000003 109.381 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 74.9 t -55.22 -38.93 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.162 -0.961 . . . . 74.230000000000004 108.884 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' LYS . . . . . 0.412 ' N ' ' CD ' ' B' ' 23' ' ' LYS . 4.7 mptp? -70.14 -25.67 63.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.441 -0.787 . . . . 73.519999999999996 109.2 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.47 20.06 10.64 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 110.293 -1.123 . . . . 53.43 110.293 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -96.72 159.99 14.62 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.071 -1.252 . . . . 71.120000000000005 109.333 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 61.3 mmm -104.65 139.89 38.83 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.674 -0.861 . . . . 75.239999999999995 108.674 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . 0.426 ' O ' ' OE2' ' B' ' 17' ' ' GLU . . . -141.13 153.11 45.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.191 -0.943 . . . . 73.25 110.16 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -133.05 134.01 43.79 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.791 -0.818 . . . . 72.310000000000002 108.791 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.31 138.06 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.278 -1.008 . . . . 72.140000000000001 108.278 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.4 p -139.12 165.61 26.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.282 -0.886 . . . . 74.530000000000001 109.525 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -84.3 -99.58 0.05 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.889 . . . . 71.019999999999996 109.33 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 60.7 p -78.32 161.7 27.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 71.400000000000006 109.579 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' B' ' 37' ' ' GLU . 2.8 mp -56.85 -31.53 64.87 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.448 -0.783 . . . . 71.239999999999995 109.814 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -56.61 -43.67 80.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.108 -0.995 . . . . 74.319999999999993 109.637 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -63.18 -42.26 99.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.135 -0.978 . . . . 73.030000000000001 109.31 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.31 -30.88 48.61 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.45 -1.46 . . . . 60.43 109.45 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' B' ' 33' ' ' LEU . 14.8 tm-20 -63.7 -41.53 98.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -1.153 . . . . 74.430000000000007 109.462 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -74.28 -38.44 63.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 74.420000000000002 109.547 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 21.6 tp -68.65 -48.28 64.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 75.409999999999997 109.981 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' MET . . . . . 0.442 ' O ' ' O ' ' B' ' 43' ' ' ARG . 16.1 ptm -66.52 -23.84 66.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.116 -0.99 . . . . 61.439999999999998 109.789 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.26 -38.03 79.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.074 -1.016 . . . . 74.319999999999993 109.781 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 10.7 pt -97.61 -1.68 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.177 -0.952 . . . . 71.230000000000004 110.206 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' B' ' 40' ' ' MET . 31.1 mmt180 -125.99 155.48 41.34 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.317 -0.864 . . . . 73.409999999999997 109.593 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' B' ' 45' ' ' TYR . 53.9 t-20 -86.76 151.33 23.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.249 -0.907 . . . . 63.539999999999999 109.269 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' TYR . . . . . 0.559 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 1.3 p90 -142.77 115.8 8.84 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.16 -0.962 . . . . 73.109999999999999 109.518 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -90.57 -34.77 15.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.277 -0.889 . . . . 62.219999999999999 108.907 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.403 ' C ' ' CD1' ' B' ' 47' ' ' LEU . 0.9 OUTLIER -111.68 110.55 21.0 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.695 -0.854 . . . . 73.120000000000005 108.695 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 68.5 t -94.56 98.77 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.217 -0.927 . . . . 74.109999999999999 109.118 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 17.2 ttt -113.24 127.13 56.07 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.631 0.729 . . . . 73.439999999999998 109.581 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . 0.455 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.2 OUTLIER -145.0 133.91 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.394 -0.816 . . . . 73.400000000000006 109.38 -179.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' SER . . . . . 0.43 ' CB ' ' OG ' ' B' ' 74' ' ' SER . 53.0 p -100.31 17.43 21.43 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.603 -0.685 . . . . 73.209999999999994 109.908 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.455 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 82.9 m-20 -83.12 135.17 34.91 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.095 -1.003 . . . . 70.409999999999997 109.408 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.426 ' C ' ' H ' ' B' ' 55' ' ' ALA . 67.2 mmtt -70.16 -38.03 75.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.296 -0.878 . . . . 73.129999999999995 110.118 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' ASN . . . . . 0.577 ' H ' HD21 ' B' ' 54' ' ' ASN . 1.0 OUTLIER -75.62 13.0 0.87 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 75.209999999999994 109.875 -179.444 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.426 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -72.78 -21.73 60.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 55.329999999999998 110.113 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.419 ' O ' ' OG ' ' B' ' 60' ' ' SER . 33.5 mt -43.44 -35.98 1.8 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.322 -0.861 . . . . 72.420000000000002 110.438 -179.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 82.7 p -77.16 -47.59 19.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.941 -1.099 . . . . 73.040000000000006 109.825 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -63.94 -44.92 91.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 72.329999999999998 110.398 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 17.0 m -63.85 -40.24 88.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 120.668 -1.27 . . . . 74.540000000000006 109.685 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' B' ' 56' ' ' LEU . 59.2 m -53.71 -50.88 64.92 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.162 -0.961 . . . . 71.239999999999995 109.676 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.434 HH21 ' NZ ' ' B' ' 65' ' ' LYS . 11.9 ptm180 -67.8 -32.34 72.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.143 -0.973 . . . . 74.310000000000002 110.279 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' B' ' 66' ' ' HIS . 4.9 mm -63.6 -43.98 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.706 -1.246 . . . . 75.420000000000002 110.001 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -64.78 -50.51 66.52 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.222 -0.924 . . . . 73.319999999999993 110.571 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -68.84 -40.67 79.27 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.71 -1.244 . . . . 73.310000000000002 110.032 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.513 ' O ' ' ND1' ' B' ' 66' ' ' HIS . 45.2 mtpt -77.29 -29.69 53.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.125 -0.984 . . . . 72.439999999999998 109.724 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' HIS . . . . . 0.544 ' CE1' ' NZ ' ' B' ' 145' ' ' LYS . 42.3 m-70 -144.47 67.84 1.26 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.15 -0.969 . . . . 65.209999999999994 109.913 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 81.3 p -65.62 -25.68 67.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 73.099999999999994 109.231 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 4.2 t -62.18 -24.63 67.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.864 . . . . 71.530000000000001 109.647 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 74.3 mt -86.43 152.04 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.311 -0.868 . . . . 74.400000000000006 109.401 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 80.1 t -91.08 161.0 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.341 -0.85 . . . . 75.120000000000005 109.386 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 14.8 t -141.15 122.39 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.169 -0.957 . . . . 73.200000000000003 109.264 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 mp -117.66 103.09 9.69 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.76 -0.83 . . . . 73.340000000000003 108.76 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 70.9 t -90.12 118.69 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.314 -0.866 . . . . 73.5 108.677 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' SER . . . . . 0.43 ' OG ' ' CB ' ' B' ' 51' ' ' SER . 24.4 p -86.27 170.62 11.91 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.16 -0.962 . . . . 71.319999999999993 109.009 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' SER . . . . . 0.499 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 35.3 m -159.48 115.53 2.54 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.949 -1.095 . . . . 74.530000000000001 110.244 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -63.37 -22.93 67.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.44 -0.788 . . . . 64.5 109.69 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' B' ' 79' ' ' THR . 8.7 m-80 -125.09 79.33 65.73 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.505 -0.747 . . . . 74.25 109.623 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.13 86.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.494 2.129 . . . . 74.430000000000007 111.3 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.463 ' N ' ' O ' ' B' ' 77' ' ' ASN . 20.7 m -100.04 150.57 22.31 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.532 -0.73 . . . . 73.120000000000005 109.807 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 4.5 p -69.01 -38.01 79.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.412 -0.805 . . . . 75.409999999999997 109.661 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -63.03 -37.37 86.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.92 . . . . 72.239999999999995 109.669 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -71.76 -32.46 67.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.207 -0.933 . . . . 73.219999999999999 109.647 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' GLU . . . . . 0.51 ' OE2' ' NE ' ' A' ' 100' ' ' ARG . 95.0 mt-10 -64.87 -52.77 54.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.974 . . . . 74.299999999999997 109.749 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 18.6 m -60.24 -35.94 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.113 -0.992 . . . . 73.310000000000002 109.283 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -75.43 -27.43 58.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.271 -0.893 . . . . 73.239999999999995 109.464 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.68 -37.57 85.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.175 -0.953 . . . . 55.329999999999998 109.937 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -83.39 -36.26 24.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 74.450000000000003 109.22 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -71.9 -39.92 69.2 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.316 -0.865 . . . . 64.040000000000006 109.483 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -68.6 -50.12 53.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 75.129999999999995 109.4 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.65 69.84 0.01 OUTLIER Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.927 -1.13 . . . . 75.420000000000002 110.302 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -132.67 130.18 39.77 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.322 -1.105 . . . . 73.420000000000002 109.139 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -71.28 -33.81 70.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.918 . . . . 73.319999999999993 109.286 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 93' ' ' ASP . . . . . 0.437 ' OD2' ' NH2' ' B' ' 108' ' ' ARG . 14.1 t70 -152.25 161.8 42.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -0.843 . . . . 73.040000000000006 109.414 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 94' ' ' TYR . . . . . 0.499 ' OH ' ' CB ' ' B' ' 75' ' ' SER . 57.4 t80 -132.25 120.24 21.9 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.86 -0.792 . . . . 74.310000000000002 108.86 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . 0.53 ' N ' ' CD1' ' B' ' 95' ' ' ILE . 0.0 OUTLIER -128.08 154.63 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 CA-C-O 121.793 0.806 . . . . 75.340000000000003 110.493 -178.43 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.0 149.78 48.41 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.19 -1.041 . . . . 70.099999999999994 108.19 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . 0.665 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -74.24 -56.48 2.55 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.785 -1.197 . . . . 65.430000000000007 111.451 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 98' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 5.2 Cg_endo -41.95 -9.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 120.852 1.035 . . . . 63.520000000000003 112.944 -176.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 99' ' ' TYR . . . . . 0.665 ' N ' ' O ' ' B' ' 97' ' ' LYS . 34.0 m-85 61.19 125.71 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.652 -0.655 . . . . 75.129999999999995 109.438 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . 0.416 ' NE ' ' OE2' ' A' ' 83' ' ' GLU . 39.4 ttm-85 -66.35 -34.39 77.87 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.888 -1.133 . . . . 74.230000000000004 108.85 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 101' ' ' SER . . . . . 0.736 ' O ' ' N ' ' B' ' 103' ' ' LYS . 10.9 t -172.69 38.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.198 -0.938 . . . . 64.510000000000005 110.6 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 26.2 mm 50.91 -69.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.659 -0.651 . . . . 74.439999999999998 110.415 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 103' ' ' LYS . . . . . 0.736 ' N ' ' O ' ' B' ' 101' ' ' SER . 16.2 mtpp -57.46 -29.35 64.14 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.313 -0.995 . . . . 72.299999999999997 108.313 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.72 -46.54 81.84 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.542 -0.91 . . . . 74.310000000000002 108.542 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 13.0 tp -64.63 -54.45 31.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.478 -0.764 . . . . 73.540000000000006 109.011 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 23.4 t -57.85 -38.19 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.116 -0.99 . . . . 72.030000000000001 109.495 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.06 -48.26 70.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.25 -0.906 . . . . 64.219999999999999 109.616 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 108' ' ' ARG . . . . . 0.437 ' NH2' ' OD2' ' B' ' 93' ' ' ASP . 8.5 ttp-105 -68.73 -31.49 70.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 75.310000000000002 109.869 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . 0.421 HD11 HG21 ' B' ' 109' ' ' ILE . 96.8 mt -74.33 -26.3 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.047 -1.033 . . . . 55.439999999999998 108.941 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -71.7 -54.0 11.7 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.418 -0.801 . . . . 65.310000000000002 109.53 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.3 -43.41 78.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.105 -0.997 . . . . 74.519999999999996 109.379 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 9.0 tpm_? -69.79 -41.73 74.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.258 -0.902 . . . . 72.040000000000006 109.455 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 14.0 tp -96.55 65.13 2.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.25 -0.906 . . . . 75.349999999999994 109.775 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 114' ' ' ARG . . . . . 0.533 ' CA ' ' HE ' ' B' ' 114' ' ' ARG . 0.0 OUTLIER -142.48 -62.23 0.44 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.193 -0.942 . . . . 75.5 108.695 179.647 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -89.33 22.93 2.69 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.219 -0.925 . . . . 73.040000000000006 109.511 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -62.28 -35.64 79.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.165 -0.959 . . . . 74.450000000000003 109.665 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.29 128.84 33.88 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.911 -1.275 . . . . 64.209999999999994 109.911 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 97.5 p -159.45 166.52 30.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.359 -1.083 . . . . 71.400000000000006 110.093 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.4 137.06 12.21 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.693 -0.854 . . . . 74.209999999999994 108.693 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 5.2 t -107.88 -41.37 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.323 -0.861 . . . . 75.019999999999996 110.593 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 19.1 mm -97.95 140.3 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.048 -1.033 . . . . 74.239999999999995 109.924 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -148.75 131.6 16.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.404 -0.81 . . . . 73.329999999999998 109.33 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 10.9 tp -156.35 127.11 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 74.219999999999999 109.004 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.83 -155.31 4.29 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.1 -1.6 . . . . 72.409999999999997 109.1 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -76.86 2.18 15.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.157 -1.202 . . . . 75.120000000000005 108.938 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.46 134.37 38.38 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.644 -0.872 . . . . 75.420000000000002 108.644 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 3.3 m -131.7 141.46 49.56 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.363 -0.836 . . . . 74.219999999999999 109.153 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 54.1 mt -132.38 130.21 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.276 -0.89 . . . . 60.329999999999998 109.998 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 129' ' ' SER . . . . . 0.459 ' O ' ' N ' ' B' ' 133' ' ' GLU . 18.9 m -115.32 98.88 51.58 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 108.786 -0.82 . . . . 72.310000000000002 108.786 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.12 -40.7 2.31 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.39 1.394 . . . . 75.129999999999995 112.041 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -56.78 -36.54 69.97 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.895 -1.128 . . . . 75.230000000000004 108.161 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -98.07 -10.0 25.0 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.715 -0.846 . . . . 75.120000000000005 108.715 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' B' ' 129' ' ' SER . 30.0 mt-10 53.84 61.33 3.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.121 -0.987 . . . . 75.129999999999995 108.393 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -137.01 112.92 9.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.503 -0.748 . . . . 75.109999999999999 109.915 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.44 137.49 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 106.456 -1.683 . . . . 70.319999999999993 106.456 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 40.2 mt -129.23 120.8 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.258 -0.901 . . . . 74.120000000000005 110.319 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -142.62 144.11 32.68 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.465 -0.772 . . . . 74.230000000000004 109.342 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt 54.6 26.37 7.3 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.43 -0.794 . . . . 74.219999999999999 110.206 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 75.22 13.68 82.55 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.334 -1.106 . . . . 74.319999999999993 110.334 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 40.8 mtp85 -104.37 123.89 48.22 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.335 -1.097 . . . . 75.340000000000003 108.99 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -95.75 137.4 34.87 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.384 -0.822 . . . . 71.230000000000004 110.162 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 1.2 p -139.51 131.33 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.206 -0.933 . . . . 70.430000000000007 109.346 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -89.03 144.32 26.23 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.834 -1.172 . . . . 72.430000000000007 107.834 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 144' ' ' VAL . . . . . 0.518 ' HB ' ' CD1' ' B' ' 149' ' ' PHE . 5.9 m -132.11 150.21 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.263 -0.898 . . . . 72.129999999999995 109.782 -179.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 145' ' ' LYS . . . . . 0.544 ' NZ ' ' CE1' ' B' ' 66' ' ' HIS . 25.2 pttt -174.19 109.87 0.15 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.512 -0.743 . . . . 74.5 109.51 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . 0.99 ' O ' ' HG3' ' B' ' 150' ' ' GLU . . . 166.71 -160.21 33.77 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.422 -1.471 . . . . 42.229999999999997 109.422 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . 0.565 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 26.1 ttpt -87.37 -36.9 0.48 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.149 -1.207 . . . . 73.299999999999997 110.675 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 148' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 72.2 Cg_endo -85.12 4.61 6.68 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 121.566 1.511 . . . . 71.329999999999998 110.934 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 149' ' ' PHE . . . . . 0.518 ' CD1' ' HB ' ' B' ' 144' ' ' VAL . 41.3 m-85 -108.58 -40.0 5.23 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.496 0.665 . . . . 74.230000000000004 109.259 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 150' ' ' GLU . . . . . 0.99 ' HG3' ' O ' ' B' ' 146' ' ' GLY . 41.8 mt-10 -59.65 -34.4 72.77 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.167 -0.958 . . . . 72.340000000000003 108.512 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . 0.545 HG11 HD21 ' B' ' 152' ' ' LEU . 12.7 p -61.05 -40.84 87.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.639 -0.824 . . . . 73.349999999999994 108.854 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . 0.545 HD21 HG11 ' B' ' 151' ' ' VAL . 4.6 mm? -56.84 -52.39 65.3 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.711 -0.848 . . . . 74.430000000000007 108.711 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 153' ' ' THR . . . . . 0.467 ' H ' ' HG1' ' B' ' 153' ' ' THR . 1.6 p -62.36 -32.94 73.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.392 -0.818 . . . . 75.209999999999994 109.593 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -62.21 -56.15 21.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.991 -1.068 . . . . 73.040000000000006 109.463 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.64 -22.21 63.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.057 -1.027 . . . . 73.430000000000007 109.14 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.48 -49.99 74.49 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.127 -0.983 . . . . 75.319999999999993 108.653 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 157' ' ' ARG . . . . . 0.425 ' C ' ' H ' ' B' ' 159' ' ' ARG . 51.3 mtp85 -69.64 -52.8 22.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.332 -0.855 . . . . 73.319999999999993 109.041 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -76.74 20.35 0.24 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.467 -0.771 . . . . 74.140000000000001 110.313 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . 1.282 HH11 ' CB ' ' B' ' 159' ' ' ARG . 0.0 OUTLIER -50.02 -38.49 37.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.104 -0.998 . . . . 73.420000000000002 109.096 179.868 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -98.15 67.6 1.89 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.25 -0.906 . . . . 72.099999999999994 109.584 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 161' ' ' GLN . . . . . 0.432 ' OE1' ' OD2' ' A' ' 160' ' ' ASP . 9.6 tp-100 -171.08 161.93 6.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.142 -0.974 . . . . 73.239999999999995 109.675 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 162' ' ' ILE . . . . . 0.408 HD13 HG22 ' B' ' 162' ' ' ILE . 13.6 mm -82.88 142.82 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.472 -0.768 . . . . 72.310000000000002 109.727 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.27 128.52 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.462 -0.774 . . . . 75.030000000000001 109.269 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 52.5 p -98.79 153.7 18.56 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.181 -0.949 . . . . 74.219999999999999 109.92 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -52.24 -50.99 60.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.36 -0.838 . . . . 72.420000000000002 109.494 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -51.65 -39.71 58.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.372 -0.83 . . . . 63.450000000000003 109.907 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -65.86 -41.52 91.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.116 -0.99 . . . . 72.400000000000006 109.607 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 80.6 mt -52.02 -53.79 37.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.018 -1.051 . . . . 72.319999999999993 109.162 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 169' ' ' LEU . . . . . 0.576 ' O ' ' N ' ' B' ' 171' ' ' ALA . 52.4 mt -64.9 -67.9 0.4 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.341 -0.849 . . . . 73.340000000000003 110.059 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -42.91 -15.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.693 -0.629 . . . . 73.099999999999994 110.878 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 171' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' B' ' 169' ' ' LEU . . . -93.39 -41.12 10.0 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.93 -1.106 . . . . 62.130000000000003 112.196 -178.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 4.8 mp -123.47 -34.23 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.791 0 O-C-N 120.768 -1.208 . . . . 74.439999999999998 113.209 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 173' ' ' TRP . . . . . 0.476 ' CD2' ' C ' ' B' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.319 0 O-C-N 120.047 -1.658 . . . . 72.230000000000004 110.49 -177.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 181' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' B' ' 183' ' ' VAL . 93.4 Cg_exo . . . . . 0 N--CA 1.493 1.447 0 CA-C-O 121.198 0.416 . . . . 74.340000000000003 112.88 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 43.3 p30 -70.8 8.42 0.89 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.074 -1.017 . . . . 72.310000000000002 110.218 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 183' ' ' VAL . . . . . 0.429 ' H ' ' C ' ' B' ' 181' ' ' PRO . 12.3 p -66.83 -22.16 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.049 -1.032 . . . . 65.420000000000002 109.594 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 54.5 mt -54.52 -50.04 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 75.030000000000001 109.92 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -60.84 -40.98 94.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 73.519999999999996 109.887 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 3.6 t -69.35 -40.04 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.521 -0.737 . . . . 74.349999999999994 110.486 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.59 -53.68 9.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 61.119999999999997 110.031 -179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 11.0 tp -58.06 -25.4 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.96 . . . . 72.430000000000007 109.741 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -75.83 -56.97 4.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.256 -0.903 . . . . 75.420000000000002 110.52 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -65.32 -34.75 79.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.023 -1.048 . . . . 74.140000000000001 110.141 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 86.7 mt -63.69 -59.04 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.032 -1.042 . . . . 74.030000000000001 109.939 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 192' ' ' ARG . . . . . 0.655 HH21 HG21 ' B' ' 204' ' ' VAL . 21.0 mtp-105 -60.26 -35.86 76.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.166 -0.959 . . . . 72.329999999999998 109.622 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 193' ' ' GLN . . . . . 0.43 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 79.9 mm-40 -70.32 -33.95 72.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.183 -0.948 . . . . 73.099999999999994 109.452 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 194' ' ' LYS . . . . . 0.458 ' CB ' ' NZ ' ' B' ' 194' ' ' LYS . 7.3 mtpm? -79.58 -17.25 54.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.181 -0.949 . . . . 74.430000000000007 110.013 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 44.1 ttp -98.12 -11.52 22.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.139 -0.976 . . . . 74.329999999999998 110.372 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 196' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 57.3 p30 -107.91 -14.61 14.73 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.025 -1.047 . . . . 71.209999999999994 110.393 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . 0.594 ' N ' ' CD ' ' B' ' 198' ' ' PRO . 30.5 tttt -78.16 -40.8 1.95 Allowed Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 120.851 -1.156 . . . . 75.209999999999994 110.03 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 198' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' B' ' 197' ' ' LYS . 40.7 Cg_endo -89.47 -44.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.449 2.1 . . . . 75.319999999999993 112.473 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . 0.453 ' N ' ' CD1' ' B' ' 199' ' ' LEU . 9.1 mp -61.1 -54.03 49.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.862 -1.149 . . . . 72.25 109.085 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 99.74 -0.02 56.52 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.069 -1.212 . . . . 73.239999999999995 110.069 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 38.7 mt -130.79 145.25 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.373 -1.075 . . . . 54.299999999999997 109.25 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 28.7 t -97.85 135.28 39.82 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.295 -0.878 . . . . 74.310000000000002 109.252 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 203' ' ' THR . . . . . 0.523 ' HG1' HH21 ' B' ' 159' ' ' ARG . 6.8 p -135.09 5.62 3.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.344 -0.848 . . . . 74.400000000000006 109.277 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.655 HG21 HH21 ' B' ' 192' ' ' ARG . 16.2 m -108.42 139.17 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.448 -0.783 . . . . 74.099999999999994 109.479 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -125.2 128.72 48.78 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.55 -0.719 . . . . 75.329999999999998 109.372 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.87 124.45 40.85 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.242 -0.911 . . . . 71.400000000000006 109.451 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 207' ' ' VAL . . . . . 0.443 ' O ' ' O ' ' B' ' 208' ' ' ARG . 6.1 m -151.42 143.11 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.274 -0.891 . . . . 63.5 109.173 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 208' ' ' ARG . . . . . 0.484 ' O ' ' N ' ' B' ' 210' ' ' ARG . 19.3 tpt180 -58.61 -109.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.089 -1.007 . . . . 74.450000000000003 109.108 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 50.63 -94.84 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.955 -1.091 . . . . 74.140000000000001 109.386 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 210' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' B' ' 208' ' ' ARG . 67.3 mtt-85 -107.62 -55.31 2.37 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.737 -0.602 . . . . 74.430000000000007 109.771 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 211' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' B' ' 207' ' ' VAL . . . -174.42 -105.92 0.19 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.558 -1.417 . . . . 70.109999999999999 109.558 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -110.77 162.41 14.8 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.382 -1.07 . . . . 74.209999999999994 109.117 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 213' ' ' ARG . . . . . 0.677 HH12 ' CB ' ' B' ' 215' ' ' CYS . 35.4 ttt-85 -130.23 122.95 29.04 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.435 -0.791 . . . . 74.299999999999997 109.164 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 214' ' ' PHE . . . . . 0.538 ' HB3' ' O ' ' B' ' 159' ' ' ARG . 17.4 m-85 -104.13 124.67 49.51 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.447 -0.783 . . . . 74.340000000000003 109.317 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 215' ' ' CYS . . . . . 0.677 ' CB ' HH12 ' B' ' 213' ' ' ARG . 1.7 m -163.51 154.64 16.56 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.112 -0.992 . . . . 72.209999999999994 109.143 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -68.58 147.87 98.06 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 120.954 -1.091 . . . . 72.310000000000002 108.167 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.89 -103.81 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.122 1.882 . . . . 71.010000000000005 113.143 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 120.96 -1.087 . . . . 74.349999999999994 109.979 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptp . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.513 -0.551 . . . . 65.120000000000005 109.513 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -140.4 152.25 45.59 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.332 -0.855 . . . . 73.310000000000002 109.182 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.9 t -116.32 138.83 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.651 -0.656 . . . . 71.420000000000002 109.708 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.3 tp -115.87 121.12 41.41 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.462 -0.774 . . . . 65.219999999999999 109.043 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.9 mt -117.68 107.03 13.71 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.044 -0.725 . . . . 71.439999999999998 109.044 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.411 HG22 HD13 ' A' ' 6' ' ' ILE . 76.7 mt -98.83 112.66 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.248 -0.907 . . . . 71.150000000000006 108.829 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.429 ' OE1' ' N ' ' A' ' 13' ' ' GLY . 68.8 tt0 -149.49 127.89 12.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.169 -0.957 . . . . 75.340000000000003 109.565 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -62.94 -32.82 74.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -0.874 . . . . 73.040000000000006 109.431 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -82.05 105.26 13.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -0.892 . . . . 72.420000000000002 109.457 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.8 m -64.87 -28.19 69.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.9 . . . . 72.340000000000003 109.783 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.0 t -63.73 -49.24 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.156 -0.965 . . . . 74.420000000000002 109.795 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.516 ' CD2' ' N ' ' A' ' 12' ' ' LEU . 3.5 mm? -69.85 -46.05 66.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.165 -0.959 . . . . 72.010000000000005 109.452 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.429 ' N ' ' OE1' ' A' ' 7' ' ' GLU . . . -66.13 -17.64 66.03 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.4 -1.88 . . . . 72.140000000000001 108.4 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.49 -57.59 4.98 Favored Glycine 0 N--CA 1.483 1.776 0 N-CA-C 109.589 -1.405 . . . . 72.329999999999998 109.589 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -53.0 -46.8 68.5 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.446 -1.032 . . . . 72.340000000000003 109.714 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.4 mm -61.24 -46.36 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.8 -1.187 . . . . 74.239999999999995 108.636 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.507 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 81.1 tt0 -46.54 -52.56 13.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 71.409999999999997 109.752 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -88.89 4.89 46.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.168 -0.958 . . . . 75.540000000000006 109.741 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.21 -63.54 1.79 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.958 -1.257 . . . . 62.149999999999999 109.958 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -72.62 -19.85 61.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.18 -1.188 . . . . 74.420000000000002 110.228 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 86.4 m-20 -52.79 -33.47 49.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.883 -1.136 . . . . 74.25 109.466 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 86.7 t -58.5 -31.92 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 72.109999999999999 109.333 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.415 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 11.5 mptt -74.05 -2.8 25.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 73.230000000000004 109.25 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.84 23.17 43.02 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.074 -1.21 . . . . 75.540000000000006 110.074 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -99.4 158.2 15.89 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.214 -1.168 . . . . 74.510000000000005 109.323 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.3 mtt -101.55 139.59 36.99 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.03 -1.1 . . . . 64.319999999999993 108.03 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.64 152.7 41.69 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.045 -1.035 . . . . 74.310000000000002 110.758 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -135.1 140.92 45.87 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.565 -0.902 . . . . 75.400000000000006 108.565 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -107.6 138.28 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.839 . . . . 75.129999999999995 109.004 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.7 p -134.95 168.86 18.32 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.453 -0.779 . . . . 71.420000000000002 109.491 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.436 ' OE2' ' OD2' ' A' ' 35' ' ' ASP . 4.3 pt-20 -87.41 -102.92 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 73.109999999999999 109.559 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.0 p -77.46 163.66 26.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 74.239999999999995 109.476 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mp -58.42 -29.85 66.43 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.45 -0.781 . . . . 71.530000000000001 110.026 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -49.89 -43.57 49.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.036 -1.04 . . . . 74.230000000000004 109.519 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.436 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 31.9 m-20 -66.8 -42.3 86.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.207 -0.933 . . . . 71.010000000000005 109.053 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.38 -42.54 95.95 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.489 -1.444 . . . . 61.409999999999997 109.489 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -65.73 -37.85 87.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -1.154 . . . . 74.340000000000003 109.336 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.443 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 68.3 t80 -78.64 -21.38 48.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.923 . . . . 75.329999999999998 109.581 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.6 tp -90.0 -32.79 16.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.197 -0.939 . . . . 74.329999999999998 109.853 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 40' ' ' MET . 3.4 ppp? -78.93 -29.42 44.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.151 -0.968 . . . . 70.319999999999993 110.637 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 31.4 p-10 -58.8 -34.28 71.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.795 -1.191 . . . . 71.219999999999999 109.845 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.541 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 14.7 pt -90.39 -26.42 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.084 -1.01 . . . . 74.409999999999997 110.05 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 40' ' ' MET . 93.6 mtt180 -127.36 138.9 53.13 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.386 -0.821 . . . . 75.409999999999997 109.41 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -92.66 152.55 19.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.132 -0.98 . . . . 75.420000000000002 109.594 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -133.83 154.44 51.02 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.517 -0.739 . . . . 74.230000000000004 109.254 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -94.44 -43.83 8.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.139 -0.976 . . . . 75.319999999999993 108.899 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.418 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -106.34 108.91 20.65 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.743 -0.836 . . . . 72.129999999999995 108.743 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 m -107.77 105.24 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.297 -1.001 . . . . 72.340000000000003 108.297 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.6 ttt -115.18 145.54 42.29 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.511 0.672 . . . . 74.109999999999999 109.556 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.415 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 1.6 p -144.51 133.16 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.487 -0.758 . . . . 71.239999999999995 110.19 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 t -98.54 4.57 48.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.499 -0.751 . . . . 73.109999999999999 109.454 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.415 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 52.6 m-20 -76.0 142.15 41.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.141 -0.974 . . . . 63.399999999999999 109.377 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.517 ' C ' ' H ' ' A' ' 55' ' ' ALA . 67.5 mttm -77.69 -42.76 33.38 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.282 -0.886 . . . . 65.439999999999998 110.647 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -70.63 14.54 0.13 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.027 -1.045 . . . . 73.129999999999995 109.874 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.29 -19.88 59.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 64.140000000000001 110.434 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.0 mt -42.0 -49.06 4.69 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.286 -0.884 . . . . 74.430000000000007 110.606 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.529 ' HG ' ' N ' ' A' ' 58' ' ' PHE . 91.9 p -68.56 -37.85 80.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.954 -1.092 . . . . 63.229999999999997 109.522 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.529 ' N ' ' HG ' ' A' ' 57' ' ' SER . 70.7 t80 -67.8 -63.57 1.03 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 74.439999999999998 109.914 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.7 m -49.25 -31.72 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.86 -1.15 . . . . 74.030000000000001 109.636 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.3 t -60.6 -53.33 58.77 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.149 -0.97 . . . . 73.540000000000006 109.11 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -67.87 -27.54 66.76 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.687 -1.205 . . . . 73.340000000000003 109.652 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.539 ' O ' ' N ' ' A' ' 66' ' ' HIS . 25.3 mm -56.34 -46.12 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.826 -1.172 . . . . 73.349999999999994 108.409 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -63.72 -40.47 96.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.13 -0.981 . . . . 74.420000000000002 108.354 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -67.58 -50.85 56.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.385 -0.822 . . . . 74.549999999999997 109.246 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.52 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 91.9 mttt -78.15 -12.09 59.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.603 -0.686 . . . . 75.219999999999999 110.048 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 62' ' ' ILE . 97.9 m-70 -157.69 70.9 0.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.93 . . . . 74.129999999999995 109.149 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.1 p -69.34 -23.9 63.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.199 -0.938 . . . . 73.239999999999995 110.015 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 82.3 p -90.83 49.87 1.72 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.141 -0.974 . . . . 71.439999999999998 110.074 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.4 tt -143.36 163.87 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.102 -0.998 . . . . 71.329999999999998 109.343 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.5 t -93.21 142.16 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.115 -0.991 . . . . 73.019999999999996 108.768 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.462 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 9.8 t -130.55 123.44 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.311 -0.868 . . . . 54.210000000000001 109.36 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 mt -129.6 100.3 5.47 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.533 -0.914 . . . . 74.209999999999994 108.533 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.9 p -96.12 154.04 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.375 -0.972 . . . . 74.409999999999997 108.375 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.4 m -122.57 171.91 8.77 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.78 -0.822 . . . . 72.310000000000002 108.78 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 77' ' ' ASN . 7.6 p -171.2 121.84 0.54 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.963 -1.085 . . . . 64.540000000000006 110.431 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.496 ' OD1' ' NZ ' ' A' ' 53' ' ' LYS . 56.3 p30 -70.65 8.04 0.95 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.501 -0.75 . . . . 74.129999999999995 109.875 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.439 ' H ' ' C ' ' A' ' 75' ' ' SER . 18.7 m120 -137.94 75.39 42.14 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.29 -0.881 . . . . 73.340000000000003 109.489 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -66.92 81.38 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.619 2.213 . . . . 71.319999999999993 111.237 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 26.5 m -103.31 151.91 22.16 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.733 -0.84 . . . . 62.530000000000001 108.733 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 p -60.12 -28.84 68.2 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.297 -0.877 . . . . 74.140000000000001 109.773 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -68.04 -41.54 81.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 71.420000000000002 109.865 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -74.3 -35.47 63.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.115 -0.99 . . . . 73.430000000000007 109.858 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -60.17 -54.13 49.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.204 -0.935 . . . . 74.219999999999999 109.941 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.3 m -61.96 -38.02 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.047 -1.033 . . . . 74.150000000000006 109.439 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -69.0 -26.48 65.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.151 -0.968 . . . . 72.540000000000006 109.37 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.75 -44.33 73.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.143 -0.973 . . . . 64.219999999999999 109.647 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -79.68 -29.19 40.75 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.168 -0.958 . . . . 74.340000000000003 109.084 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -75.18 -51.3 13.72 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.436 -0.79 . . . . 74.420000000000002 109.357 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -58.57 -50.05 75.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.482 -0.761 . . . . 74.519999999999996 109.714 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 147.66 69.1 0.01 OUTLIER Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.107 -1.197 . . . . 74.209999999999994 110.107 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -134.24 135.05 42.67 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.33 -1.1 . . . . 64.099999999999994 109.017 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.462 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 70.2 m-20 -79.66 -36.8 37.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.103 -0.998 . . . . 73.420000000000002 109.031 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -153.33 150.35 28.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.391 -0.818 . . . . 75.040000000000006 109.568 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.512 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -124.25 132.54 53.59 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.722 -0.844 . . . . 71.329999999999998 108.722 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.512 ' N ' ' CD1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -119.29 137.06 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 CA-C-O 121.66 0.743 . . . . 74.510000000000005 110.061 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.54 120.2 8.96 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 106.922 -1.51 . . . . 64.319999999999993 106.922 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.684 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -41.72 -55.88 5.39 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.161 -0.962 . . . . 74.510000000000005 111.862 -178.134 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 1.8 Cg_endo -39.55 -12.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.14 1.226 . . . . 73.109999999999999 113.02 -175.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.684 ' N ' ' O ' ' A' ' 97' ' ' LYS . 55.4 m-85 59.86 131.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.803 -0.56 . . . . 72.540000000000006 109.835 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.454 ' O ' ' OG ' ' A' ' 101' ' ' SER . 29.6 ttm-85 -72.59 -40.65 66.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.754 -1.216 . . . . 74.540000000000006 108.92 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.642 ' O ' ' N ' ' A' ' 103' ' ' LYS . 19.3 m -174.42 43.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.28 -0.887 . . . . 74.140000000000001 110.045 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.447 ' O ' ' N ' ' A' ' 105' ' ' LEU . 10.7 mm 47.47 -80.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.374 -0.829 . . . . 75.430000000000007 110.414 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.642 ' N ' ' O ' ' A' ' 101' ' ' SER . 20.3 tptm -43.93 -33.37 1.36 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.238 -0.914 . . . . 74.140000000000001 109.208 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.67 -44.52 96.04 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.408 -0.96 . . . . 63.240000000000002 108.408 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 102' ' ' ILE . 17.2 tp -66.02 -49.37 67.97 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.199 -0.667 . . . . 73.219999999999999 109.199 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 70.2 t -60.18 -40.01 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.119 -0.988 . . . . 74.540000000000006 109.404 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.68 -41.19 73.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.112 -0.992 . . . . 75.5 108.869 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.525 ' O ' ' NE ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -68.22 -33.95 75.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.403 -0.81 . . . . 74.409999999999997 109.018 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 88.6 mt -75.2 -29.3 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.168 -0.958 . . . . 73.239999999999995 109.019 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -75.78 -57.43 3.88 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.45 -0.781 . . . . 74.340000000000003 109.471 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -49.65 -45.26 48.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.327 -0.858 . . . . 73.319999999999993 109.335 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 61.6 ttm-85 -64.75 -34.06 77.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.267 -0.895 . . . . 74.420000000000002 109.555 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 37.8 mt -133.52 74.68 1.57 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.393 -0.817 . . . . 74.329999999999998 110.016 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.7 mtm180 -85.64 -77.66 0.29 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.143 -0.973 . . . . 74.439999999999998 108.543 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.44 ' O ' ' O ' ' A' ' 116' ' ' TRP . 18.8 t80 -85.39 -49.73 7.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 74.430000000000007 109.465 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.44 ' O ' ' O ' ' A' ' 115' ' ' PHE . 69.7 t-105 49.85 97.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.366 -0.833 . . . . 74.439999999999998 109.663 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.59 113.06 0.28 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.617 -1.393 . . . . 75.040000000000006 109.617 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 30.8 m -156.07 164.18 38.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -1.154 . . . . 70.109999999999999 109.583 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.476 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -158.47 123.43 4.27 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.697 -0.853 . . . . 65.239999999999995 108.697 -178.45 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.5 t -79.98 -28.99 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 74.219999999999999 109.795 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.3 mp -116.76 140.94 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.345 -0.847 . . . . 74.420000000000002 109.094 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -151.81 140.36 20.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.294 -0.878 . . . . 73.299999999999997 108.946 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.6 tp -160.65 121.23 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.224 -0.923 . . . . 75.340000000000003 109.174 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 60.23 -132.45 50.39 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.183 -1.567 . . . . 75.129999999999995 109.183 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -97.39 3.13 51.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.183 -1.187 . . . . 74.450000000000003 109.354 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.36 143.07 27.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.12 -0.988 . . . . 54.210000000000001 109.066 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.43 141.64 49.86 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.754 -0.832 . . . . 70.239999999999995 108.754 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.8 mt -137.85 125.09 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.409 -0.807 . . . . 72.430000000000007 109.125 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.2 m -121.56 95.94 47.84 Favored Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 109.356 -0.609 . . . . 71.109999999999999 109.356 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.15 -33.76 2.48 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.976 1.784 . . . . 75.140000000000001 112.099 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -56.43 -46.4 80.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.233 -0.917 . . . . 72.5 108.995 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -87.04 2.63 49.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.863 . . . . 73.140000000000001 109.196 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 55.0 72.71 0.46 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 75.329999999999998 109.863 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -161.65 143.51 11.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.349 -0.844 . . . . 71.230000000000004 109.367 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.5 tt -115.54 138.6 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.433 -0.951 . . . . 75.329999999999998 108.433 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.6 mt -126.99 127.13 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 109.055 -0.72 . . . . 71.109999999999999 109.055 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.418 ' O ' ' CD1' ' A' ' 137' ' ' TYR . 45.7 p90 -136.85 135.84 38.23 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.377 -0.827 . . . . 74.140000000000001 110.598 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp 55.79 31.02 16.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.515 -0.741 . . . . 75.400000000000006 110.755 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.23 16.81 79.1 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.631 -1.271 . . . . 72.239999999999995 110.911 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 65.4 mtt-85 -112.58 126.21 55.1 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.333 -1.098 . . . . 73.120000000000005 109.553 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -94.01 128.04 40.14 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.489 -0.757 . . . . 72.319999999999993 109.627 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 34.7 t -139.16 141.1 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.359 -0.838 . . . . 62.340000000000003 109.1 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.503 ' N ' ' OE1' ' A' ' 143' ' ' GLU . 48.6 mp0 -97.11 143.85 27.52 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.248 -0.907 . . . . 61.229999999999997 109.925 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.15 140.5 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.391 -0.818 . . . . 74.439999999999998 109.196 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.34 28.76 0.45 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 75.420000000000002 108.961 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.918 ' O ' ' CD1' ' A' ' 149' ' ' PHE . . . -86.93 -161.25 36.05 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.002 -1.239 . . . . 73.340000000000003 110.002 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.612 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 16.8 mttm -80.8 -38.04 1.0 Allowed Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.493 -1.004 . . . . 72.219999999999999 110.619 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 96.2 Cg_endo -89.46 19.9 1.17 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.456 2.104 . . . . 75.450000000000003 112.613 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.918 ' CD1' ' O ' ' A' ' 146' ' ' GLY . 5.3 p90 -94.81 -55.79 2.99 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.166 -0.959 . . . . 65.239999999999995 109.408 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.693 ' N ' ' CG ' ' A' ' 149' ' ' PHE . 6.1 pt-20 -53.14 -34.45 56.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.458 -0.776 . . . . 72.519999999999996 109.849 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.423 ' CG1' ' N ' ' A' ' 152' ' ' LEU . 8.3 p -63.03 -41.18 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.002 -1.061 . . . . 74.209999999999994 109.306 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.423 ' N ' ' CG1' ' A' ' 151' ' ' VAL . 0.2 OUTLIER -63.52 -46.97 83.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.898 . . . . 73.310000000000002 108.63 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 27.2 p -67.39 -27.71 67.32 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.111 -0.993 . . . . 74.310000000000002 109.164 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -61.1 -53.96 50.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.883 . . . . 75.450000000000003 109.826 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.4 -21.12 63.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.025 -1.047 . . . . 75.340000000000003 109.26 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.02 -43.38 92.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 62.140000000000001 108.96 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.525 ' C ' ' H ' ' A' ' 159' ' ' ARG . 59.0 mtm180 -77.24 -49.39 15.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 72.219999999999999 109.111 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -71.97 17.54 0.09 Allowed 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.002 -0.679 . . . . 74.120000000000005 109.422 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.525 ' H ' ' C ' ' A' ' 157' ' ' ARG . 35.4 ptt-85 -52.03 156.74 1.47 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.265 -0.897 . . . . 74.340000000000003 109.2 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.455 ' OD1' ' CD2' ' A' ' 216' ' ' TYR . 50.3 m-20 55.08 47.87 20.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.444 -0.785 . . . . 75.450000000000003 109.678 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -155.04 151.68 28.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.165 -0.959 . . . . 73.409999999999997 109.512 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.4 mt -89.51 138.37 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.224 -0.922 . . . . 74.409999999999997 109.458 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.6 t -139.43 131.01 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.345 -0.847 . . . . 72.530000000000001 109.317 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 16.2 t -78.25 164.72 24.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 74.120000000000005 109.691 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -63.63 -48.75 76.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.46 -0.775 . . . . 70.430000000000007 109.887 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -56.98 -37.03 71.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 74.319999999999993 110.102 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -53.91 -47.53 71.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.952 -1.092 . . . . 74.519999999999996 109.435 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 51.1 mt -60.27 -44.02 95.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.079 -1.013 . . . . 74.409999999999997 109.524 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 7.0 tp -54.93 -51.18 66.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.367 -0.833 . . . . 75.140000000000001 110.17 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -81.3 -11.75 59.25 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.152 -0.968 . . . . 65.030000000000001 110.685 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.52 -52.89 18.65 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.797 -1.189 . . . . 70.209999999999994 109.973 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.503 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 1.7 mp -85.18 -36.81 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.147 -0.971 . . . . 75.319999999999993 109.072 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -108.88 74.73 0.92 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.486 -0.758 . . . . 73.140000000000001 109.359 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -86.67 -35.65 19.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.335 -0.853 . . . . 73.239999999999995 109.771 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -74.91 146.17 82.31 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.189 -0.944 . . . . 63.329999999999998 109.798 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -42.87 109.6 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.084 1.856 . . . . 72.510000000000005 112.723 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 179' ' ' VAL . 88.1 mt-10 -151.83 162.93 40.24 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.185 -0.947 . . . . 75.340000000000003 109.391 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 75.7 mtm -64.44 70.14 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 74.510000000000005 110.133 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.508 ' N ' ' O ' ' A' ' 177' ' ' GLU . 26.5 m -85.1 -42.4 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.151 -0.968 . . . . 65.219999999999999 109.205 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.572 ' O ' ' N ' ' A' ' 182' ' ' ASN . 82.4 m 47.73 92.22 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.172 -0.955 . . . . 73.219999999999999 109.342 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -47.37 76.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 122.446 2.097 . . . . 62.43 112.784 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.572 ' N ' ' O ' ' A' ' 180' ' ' THR . 6.8 t-20 -174.01 -20.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.327 -0.858 . . . . 73.129999999999995 108.788 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 29.4 m -74.94 -14.97 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.344 -0.847 . . . . 74.019999999999996 109.716 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 34.5 mt -48.89 -43.17 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.153 -0.967 . . . . 72.329999999999998 109.63 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -53.08 -34.02 54.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.12 -0.988 . . . . 74.400000000000006 109.466 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.32 -49.0 21.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.482 -0.761 . . . . 74.319999999999993 110.179 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.88 96.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.006 -1.059 . . . . 73.230000000000004 110.161 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.421 ' CG2' ' N ' ' A' ' 189' ' ' ASN . 11.0 tp -66.3 -42.58 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 120.936 -1.103 . . . . 74.310000000000002 109.691 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.421 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 39.2 t30 -62.87 -43.05 99.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.197 -0.94 . . . . 73.439999999999998 109.353 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -65.33 -40.16 93.33 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.37 -0.831 . . . . 71.420000000000002 109.61 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 71.8 mt -65.96 -44.86 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.247 -0.908 . . . . 72.439999999999998 109.793 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -58.7 -38.87 79.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.149 -0.969 . . . . 64.219999999999999 109.712 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -79.15 -26.04 42.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -0.991 . . . . 74.319999999999993 110.336 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -91.07 -16.98 26.97 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.962 -1.087 . . . . 75.310000000000002 110.825 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' MET . . . . . 0.568 ' SD ' ' N ' ' A' ' 196' ' ' ASP . 2.2 ppp? -91.72 -41.81 10.5 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.713 -1.242 . . . . 74.019999999999996 110.43 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . 0.568 ' N ' ' SD ' ' A' ' 195' ' ' MET . 26.1 t70 -66.82 -37.04 83.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.934 -1.104 . . . . 74.019999999999996 110.103 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.412 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 0.1 OUTLIER -50.86 -63.54 1.84 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.96 -1.087 . . . . 75.430000000000007 109.156 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 40.8 Cg_endo -65.81 -58.27 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.527 1.485 . . . . 72.319999999999993 111.189 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.542 ' C ' ' H ' ' A' ' 201' ' ' ILE . 4.0 mm? -86.16 92.38 8.73 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.29 -1.004 . . . . 74.540000000000006 108.29 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -59.17 -0.22 0.69 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.968 -1.253 . . . . 61.509999999999998 109.968 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.542 ' H ' ' C ' ' A' ' 199' ' ' LEU . 26.0 mm -108.29 130.09 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.379 -1.071 . . . . 74.25 109.336 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 67.0 m -76.74 146.34 38.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 72.0 109.296 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 15.9 p -139.65 4.49 2.14 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.398 -0.813 . . . . 74.439999999999998 109.354 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 7.9 m -120.54 132.05 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.606 -0.684 . . . . 71.129999999999995 109.538 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -103.8 118.33 36.44 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.378 -0.826 . . . . 73.510000000000005 108.914 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.11 129.43 40.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.241 -0.912 . . . . 73.519999999999996 109.573 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 211' ' ' GLY . 19.9 t -144.54 131.13 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 72.150000000000006 108.944 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -56.78 -31.84 65.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 72.400000000000006 109.684 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 211' ' ' GLY . 72.9 mtt85 -63.72 137.54 58.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.91 . . . . 73.310000000000002 109.808 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 57.68 -78.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.475 -0.766 . . . . 71.540000000000006 110.026 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . -177.6 -114.94 0.42 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.29 -1.524 . . . . 74.450000000000003 109.29 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -113.24 135.07 54.23 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.426 -1.044 . . . . 75.540000000000006 109.289 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 21.8 ttp-105 -109.55 139.64 44.31 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.929 -0.767 . . . . 75.310000000000002 108.929 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.473 ' O ' ' SG ' ' A' ' 215' ' ' CYS . 58.7 m-85 -107.62 134.57 50.43 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.425 -0.797 . . . . 75.409999999999997 109.935 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 214' ' ' PHE . 99.3 m -155.02 156.25 35.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.479 -0.763 . . . . 74.140000000000001 109.262 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . 0.455 ' CD2' ' OD1' ' A' ' 160' ' ' ASP . 1.9 p90 -64.74 154.34 85.59 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.193 -0.942 . . . . 75.319999999999993 109.299 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -39.45 151.94 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.232 1.955 . . . . 73.109999999999999 111.943 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.582 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 17.9 mttt -72.16 -39.0 6.14 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.103 -0.998 . . . . 75.25 110.856 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 87.9 Cg_endo -89.1 14.77 2.17 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.409 2.073 . . . . 75.099999999999994 112.466 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -57.03 -35.54 69.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.125 -0.984 . . . . 71.140000000000001 109.197 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 4.6 p -81.43 139.16 35.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.892 . . . . 71.129999999999995 109.347 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.407 ' N ' ' CD ' ' A' ' 222' ' ' GLU . 40.8 mp0 -67.22 -26.98 66.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 75.349999999999994 109.689 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.962 -1.018 . . . . 73.409999999999997 109.47 -179.926 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.589 ' SD ' ' CE2' ' B' ' 25' ' ' PHE . 16.7 ptp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.435 -0.58 . . . . 75.239999999999995 109.435 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.532 ' NH1' ' SD ' ' B' ' 26' ' ' MET . 92.8 mtt-85 -136.62 152.97 51.03 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.387 -0.821 . . . . 73.519999999999996 109.178 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 93.5 t -110.68 133.2 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.525 -0.735 . . . . 72.239999999999995 109.582 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 3.6 tp -105.72 118.22 36.03 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.61 -0.681 . . . . 73.340000000000003 109.686 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 15.3 mt -113.3 100.28 8.44 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.708 -0.849 . . . . 74.349999999999994 108.708 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 89.4 mt -86.97 99.66 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.04 -1.038 . . . . 63.439999999999998 109.015 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.415 ' OE2' ' OG ' ' B' ' 51' ' ' SER . 7.0 tp10 -146.69 137.61 24.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.46 -0.775 . . . . 74.519999999999996 108.913 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.452 ' H ' ' CD ' ' B' ' 8' ' ' LYS . 0.0 OUTLIER -78.39 -31.92 48.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 74.129999999999995 109.084 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -75.45 109.16 8.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.867 . . . . 74.230000000000004 109.552 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 29.3 m -67.43 -27.7 67.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.269 -0.895 . . . . 65.540000000000006 109.668 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 75.5 t -59.11 -52.44 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.236 -0.915 . . . . 75.549999999999997 109.668 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 91.6 mt -63.28 -35.76 81.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -0.962 . . . . 70.140000000000001 109.402 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.65 -25.02 75.99 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.826 -1.71 . . . . 75.400000000000006 108.826 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.04 -53.05 24.55 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.736 -1.345 . . . . 65.439999999999998 109.736 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -58.96 -47.17 86.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.35 -1.088 . . . . 72.200000000000003 109.97 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 37.0 mm -61.82 -39.23 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.738 -1.226 . . . . 75.150000000000006 108.816 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -55.04 -42.53 72.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.35 -0.844 . . . . 73.010000000000005 109.457 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -87.76 -2.82 58.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.168 -0.957 . . . . 74.299999999999997 109.381 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.63 -53.66 3.16 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 109.91 -1.276 . . . . 70.540000000000006 109.91 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -74.29 -19.84 60.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -1.147 . . . . 75.430000000000007 110.016 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -52.83 -32.4 44.12 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.085 -1.009 . . . . 73.200000000000003 109.52 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 97.5 t -61.94 -33.45 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.225 -0.922 . . . . 74.230000000000004 109.159 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.437 ' NZ ' ' OE1' ' B' ' 110' ' ' GLU . 16.4 mmtp -81.77 -5.4 58.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.856 . . . . 73.519999999999996 109.18 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.83 19.63 70.02 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.964 -1.254 . . . . 53.43 109.964 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.589 ' CE2' ' SD ' ' B' ' 1' ' ' MET . 7.4 m-85 -92.43 159.68 15.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.162 -1.199 . . . . 71.120000000000005 108.97 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' MET . . . . . 0.532 ' SD ' ' NH1' ' B' ' 2' ' ' ARG . 35.6 mtt -100.95 138.0 38.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.271 -0.893 . . . . 75.239999999999995 108.702 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.22 147.35 39.08 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.51 -0.744 . . . . 73.25 110.09 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -131.7 134.04 45.49 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.44 -0.948 . . . . 72.310000000000002 108.44 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -109.75 134.55 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.361 -0.837 . . . . 72.140000000000001 109.077 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.9 p -137.23 169.72 17.31 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.497 -0.752 . . . . 74.530000000000001 109.176 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -93.21 -107.34 0.12 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.191 -0.943 . . . . 71.019999999999996 109.679 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 68.2 p -78.75 168.45 19.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.906 . . . . 71.400000000000006 109.914 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 47.6 mt -51.53 -30.25 19.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.663 -0.648 . . . . 71.239999999999995 109.907 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -52.72 -51.18 61.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.097 -1.002 . . . . 74.319999999999993 109.772 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.82 -39.2 93.66 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.152 -0.968 . . . . 73.030000000000001 109.428 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.64 -39.39 78.06 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.559 -1.416 . . . . 60.43 109.559 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -69.06 -38.23 78.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -1.127 . . . . 74.430000000000007 109.874 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -80.6 -38.72 28.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.102 -0.999 . . . . 74.420000000000002 109.918 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 11.1 tp -69.23 -43.49 73.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.216 -0.927 . . . . 75.409999999999997 110.134 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.0 ppp? -66.59 -24.42 66.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.05 . . . . 61.439999999999998 109.916 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -61.28 -40.99 96.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.109 -0.995 . . . . 74.319999999999993 110.112 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 17.5 pt -81.25 -30.7 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.076 -1.015 . . . . 71.230000000000004 110.238 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.424 ' O ' ' O ' ' B' ' 40' ' ' MET . 78.1 mtt85 -129.93 141.22 50.81 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.395 -0.815 . . . . 73.409999999999997 109.623 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -97.18 147.32 24.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.282 -0.886 . . . . 63.539999999999999 109.289 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -123.6 145.79 48.66 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.524 -0.735 . . . . 73.109999999999999 109.38 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . 0.458 ' OD2' ' NE1' ' B' ' 116' ' ' TRP . 48.6 t0 -79.68 -42.29 25.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.232 -0.917 . . . . 62.219999999999999 109.355 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.23 115.65 30.78 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.872 -0.788 . . . . 73.120000000000005 108.872 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 72.6 t -99.62 97.24 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.967 -1.123 . . . . 74.109999999999999 107.967 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 19.9 ttt -110.31 134.09 52.62 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.608 0.718 . . . . 73.439999999999998 110.576 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -146.98 132.71 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.543 0.687 . . . . 73.400000000000006 109.364 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' SER . . . . . 0.415 ' OG ' ' OE2' ' B' ' 7' ' ' GLU . 16.8 p -102.11 12.3 37.0 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.465 -0.772 . . . . 73.209999999999994 109.81 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -77.14 143.54 39.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.158 -0.964 . . . . 70.409999999999997 109.603 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.504 ' C ' ' H ' ' B' ' 55' ' ' ALA . 94.2 mttt -63.79 -37.44 87.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 73.129999999999995 109.822 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -71.77 16.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.935 . . . . 75.209999999999994 109.645 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.504 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -57.19 -40.05 76.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 55.329999999999998 109.818 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -46.98 -42.22 17.6 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.164 -0.96 . . . . 72.420000000000002 109.733 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' SER . . . . . 0.434 ' O ' ' NH1' ' B' ' 61' ' ' ARG . 17.5 m -72.62 -43.08 63.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 73.040000000000006 109.648 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -64.52 -58.01 7.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.29 -0.881 . . . . 72.329999999999998 109.95 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 14.2 m -53.01 -36.96 25.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.512 -1.368 . . . . 74.540000000000006 109.609 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 23.3 t -54.93 -52.15 63.86 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.256 -0.903 . . . . 71.239999999999995 109.6 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.434 ' NH1' ' O ' ' B' ' 57' ' ' SER . 3.9 ptp85 -69.74 -34.09 73.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.989 . . . . 74.310000000000002 110.318 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 40.4 mm -69.75 -34.52 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.759 -1.213 . . . . 75.420000000000002 109.924 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -44.36 77.29 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.15 -0.969 . . . . 73.319999999999993 110.231 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.479 ' CG ' ' N ' ' B' ' 65' ' ' LYS . 9.6 pt-20 -79.41 -45.65 19.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.934 -1.104 . . . . 73.310000000000002 110.369 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.479 ' N ' ' CG ' ' B' ' 64' ' ' GLU . 57.9 mttp -66.95 -24.87 66.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.195 -0.941 . . . . 72.439999999999998 109.852 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.429 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 79.4 m-70 -155.28 64.5 0.63 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.138 -0.976 . . . . 65.209999999999994 109.564 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.0 t -56.09 -34.05 65.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 73.099999999999994 109.823 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 44.8 t -70.18 47.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.936 . . . . 71.530000000000001 109.924 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 15.6 tt -145.46 156.35 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.121 -0.987 . . . . 74.400000000000006 109.176 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 31.8 t -93.92 144.95 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.08 -1.012 . . . . 75.120000000000005 109.315 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 25.3 t -131.46 125.32 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.446 -0.784 . . . . 73.200000000000003 110.002 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 6.3 tt -121.64 98.06 5.78 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.864 -0.791 . . . . 73.340000000000003 108.864 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 10.5 p -90.26 156.35 3.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 120.901 -1.124 . . . . 73.5 108.711 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 5.9 m -129.45 169.01 15.48 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.385 -0.968 . . . . 71.319999999999993 108.385 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.454 ' C ' ' H ' ' B' ' 77' ' ' ASN . 36.0 t -172.49 125.07 0.49 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.943 -1.098 . . . . 74.530000000000001 110.442 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -76.04 21.57 0.17 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.602 -0.686 . . . . 64.5 109.8 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . 0.454 ' H ' ' C ' ' B' ' 75' ' ' SER . 42.6 t-20 -146.75 58.77 4.62 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.137 -0.977 . . . . 74.25 109.986 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -57.96 83.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.389 2.059 . . . . 74.430000000000007 112.036 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 66.5 p -107.63 160.97 15.28 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.41 -0.959 . . . . 73.120000000000005 108.41 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.3 p -63.2 -22.68 67.02 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.22 -0.925 . . . . 75.409999999999997 109.782 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . 0.438 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 97.2 mt-10 -69.41 -46.53 66.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.099 -1.001 . . . . 72.239999999999995 109.435 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -72.86 -28.06 62.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 73.219999999999999 109.579 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 35.4 tp10 -62.15 -54.05 46.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 74.299999999999997 109.886 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.89 -38.0 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 73.310000000000002 109.89 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' HIS . . . . . 0.438 ' ND1' ' O ' ' B' ' 81' ' ' GLU . 32.4 m80 -67.05 -35.4 79.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.075 -1.015 . . . . 73.239999999999995 109.778 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.12 -42.12 94.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.965 -1.085 . . . . 55.329999999999998 110.043 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' PHE . . . . . 0.456 ' CE1' ' NH1' ' A' ' 108' ' ' ARG . 52.9 m-85 -81.81 -35.9 28.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.065 -1.022 . . . . 74.450000000000003 109.438 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -71.05 -45.53 63.66 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.302 -0.874 . . . . 64.040000000000006 109.778 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -64.07 -50.46 68.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.087 -1.008 . . . . 75.129999999999995 109.458 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 142.44 73.29 0.03 OUTLIER Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.144 -1.182 . . . . 75.420000000000002 110.144 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -127.83 131.91 49.48 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.394 -1.062 . . . . 73.420000000000002 108.805 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -70.12 -43.07 71.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.99 -1.069 . . . . 73.319999999999993 108.848 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . 0.533 ' N ' ' OD1' ' B' ' 93' ' ' ASP . 13.2 p-10 -154.09 153.95 32.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.528 -0.733 . . . . 73.040000000000006 109.053 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.497 ' C ' ' CD1' ' B' ' 94' ' ' TYR . 0.5 OUTLIER -127.43 125.68 41.02 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 109.056 -0.72 . . . . 74.310000000000002 109.056 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.444 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 30.1 mm -114.16 141.18 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-O 121.878 0.847 . . . . 75.340000000000003 110.34 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.36 123.02 16.6 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.337 -1.357 . . . . 70.099999999999994 107.337 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.695 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -43.54 -55.46 8.51 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.129 -0.982 . . . . 65.430000000000007 111.879 -178.466 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 2.6 Cg_endo -40.44 -10.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.052 1.168 . . . . 63.520000000000003 113.213 -175.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . 0.695 ' N ' ' O ' ' B' ' 97' ' ' LYS . 44.7 m-85 59.03 118.7 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.621 -0.674 . . . . 75.129999999999995 109.539 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -65.07 -41.04 95.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.764 -1.21 . . . . 74.230000000000004 108.82 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' SER . . . . . 0.754 ' O ' ' N ' ' B' ' 103' ' ' LYS . 7.3 t -173.87 44.84 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.205 -0.934 . . . . 64.510000000000005 110.739 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 14.0 mm 49.25 -69.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-N 118.717 0.689 . . . . 74.439999999999998 110.563 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . 0.754 ' N ' ' O ' ' B' ' 101' ' ' SER . 1.3 mptm? -53.06 -29.42 30.06 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 107.919 -1.141 . . . . 72.299999999999997 107.919 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.44 -39.84 85.42 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.177 -1.046 . . . . 74.310000000000002 108.177 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 50.7 tp -68.17 -56.53 8.41 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.075 -0.713 . . . . 73.540000000000006 109.075 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 89.0 t -60.96 -40.45 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.225 -0.922 . . . . 72.030000000000001 109.585 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.39 -44.43 65.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.155 -0.965 . . . . 64.219999999999999 108.902 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 25.5 tpt85 -64.58 -34.62 78.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.337 -0.852 . . . . 75.310000000000002 109.105 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 72.4 mt -73.63 -30.48 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.216 -0.928 . . . . 55.439999999999998 108.75 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . 0.437 ' OE1' ' NZ ' ' B' ' 23' ' ' LYS . 88.9 tt0 -67.31 -58.69 4.35 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.457 -0.777 . . . . 65.310000000000002 109.311 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.93 -31.11 62.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.279 -0.888 . . . . 74.519999999999996 109.111 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -59.39 -47.18 86.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.251 -0.905 . . . . 72.040000000000006 109.191 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.04 100.9 2.53 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.066 -1.021 . . . . 75.349999999999994 109.585 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 20.3 mtm105 -90.65 -73.25 0.54 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.274 -0.891 . . . . 75.5 108.987 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -68.74 -35.64 77.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 73.040000000000006 109.937 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' TRP . . . . . 0.458 ' NE1' ' OD2' ' B' ' 46' ' ' ASP . 58.1 t90 52.01 84.87 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 74.450000000000003 109.482 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 157.44 131.16 1.29 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.714 -1.355 . . . . 64.209999999999994 109.714 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 26.9 t -164.22 169.0 18.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.35 -1.089 . . . . 71.400000000000006 109.41 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.1 139.21 14.5 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.81 -0.756 . . . . 74.209999999999994 109.031 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 14.7 t -105.52 -45.43 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.465 -0.772 . . . . 75.019999999999996 110.146 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . 0.434 HG23 HD12 ' B' ' 121' ' ' ILE . 9.2 mm -100.08 140.82 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.079 -1.013 . . . . 74.239999999999995 109.83 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -148.79 115.33 5.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.227 -0.921 . . . . 73.329999999999998 109.344 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.03 120.34 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.632 -0.877 . . . . 74.219999999999999 108.632 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.48 -139.26 48.7 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.382 -1.487 . . . . 72.409999999999997 109.382 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' B' ' 125' ' ' ASP . 14.9 p-10 -88.59 4.42 46.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.197 -1.178 . . . . 75.120000000000005 109.503 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.33 135.48 35.69 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.184 -0.947 . . . . 75.420000000000002 108.591 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 5.7 m -132.8 122.88 25.15 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.452 -0.78 . . . . 74.219999999999999 109.172 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 31.1 mm -114.3 125.67 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.376 -0.827 . . . . 60.329999999999998 109.626 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 61.4 m -111.57 90.16 12.01 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.862 -0.792 . . . . 72.310000000000002 108.862 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.84 -29.38 8.59 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.667 1.578 . . . . 75.129999999999995 111.93 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -64.59 -43.51 93.58 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.173 -0.955 . . . . 75.230000000000004 108.873 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.3 8.18 37.26 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.356 -0.84 . . . . 75.120000000000005 109.21 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 49.82 62.14 2.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.895 . . . . 75.129999999999995 109.57 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -149.77 130.05 13.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.216 -0.927 . . . . 75.109999999999999 109.392 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . 0.509 ' CG2' ' CE2' ' B' ' 137' ' ' TYR . 1.8 mp -108.9 141.24 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.522 -0.736 . . . . 70.319999999999993 109.089 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 25.7 mt -131.12 132.54 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 121.359 -0.838 . . . . 74.120000000000005 110.644 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . 0.509 ' CE2' ' CG2' ' B' ' 135' ' ' ILE . 48.9 m-85 -134.89 133.37 39.58 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.438 -0.789 . . . . 74.230000000000004 109.442 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . 0.779 ' CE ' ' O ' ' B' ' 198' ' ' PRO . 23.0 mttm 55.11 25.12 6.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 74.219999999999999 110.267 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.7 13.34 80.1 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.941 -1.264 . . . . 74.319999999999993 109.941 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -99.79 124.09 44.71 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.3 -1.117 . . . . 75.340000000000003 108.85 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -88.65 131.45 34.98 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.125 -0.984 . . . . 71.230000000000004 109.913 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.5 136.85 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.462 -0.774 . . . . 70.430000000000007 109.299 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -86.16 160.76 19.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.382 -0.824 . . . . 72.430000000000007 109.154 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 10.3 m -138.18 147.19 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.327 -0.858 . . . . 72.129999999999995 109.693 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 36.4 pttt -176.18 70.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 74.5 109.872 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 179.99 177.69 48.15 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.545 -1.312 . . . . 42.229999999999997 110.091 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 0.624 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 8.0 mtmm -70.21 -37.28 7.07 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.419 -1.047 . . . . 73.299999999999997 110.388 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 32.5 Cg_exo -58.12 -39.87 81.66 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.061 1.841 . . . . 71.329999999999998 111.898 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -87.56 -22.53 24.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.877 . . . . 74.230000000000004 109.454 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -52.68 -53.03 53.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 72.340000000000003 109.368 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 7.6 p -61.5 -38.18 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.239 -0.913 . . . . 73.349999999999994 109.394 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . 0.49 ' O ' ' CD1' ' B' ' 155' ' ' LEU . 33.4 tp -56.37 -36.53 68.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.19 -0.944 . . . . 74.430000000000007 108.586 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.75 -20.37 50.11 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.954 -1.091 . . . . 75.209999999999994 109.357 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . 0.625 ' CE1' ' CE1' ' B' ' 158' ' ' HIS . 16.6 t-160 -68.21 -60.63 2.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.931 -1.106 . . . . 73.040000000000006 109.596 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . 0.49 ' CD1' ' O ' ' B' ' 152' ' ' LEU . 0.0 OUTLIER -64.91 -24.81 67.64 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.218 -0.926 . . . . 73.430000000000007 108.899 179.469 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . 0.449 ' N ' ' CD1' ' B' ' 155' ' ' LEU . . . -57.42 -42.46 82.39 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.969 -1.082 . . . . 75.319999999999993 108.593 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' B' ' 159' ' ' ARG . 59.8 mtp180 -87.55 -69.23 0.7 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.228 -0.92 . . . . 73.319999999999993 110.997 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . 0.625 ' CE1' ' CE1' ' B' ' 154' ' ' HIS . 10.6 p-80 -67.97 48.08 0.05 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.324 -0.95 . . . . 74.140000000000001 110.158 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' B' ' 157' ' ' ARG . 0.0 OUTLIER -83.78 176.98 8.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.932 -1.105 . . . . 73.420000000000002 108.84 179.276 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 53.0 t0 54.7 43.13 30.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.392 -0.817 . . . . 72.099999999999994 111.288 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -158.67 171.77 19.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.606 -1.309 . . . . 73.239999999999995 109.852 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 19.9 mm -73.18 140.47 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.327 -0.858 . . . . 72.310000000000002 109.536 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' B' ' 212' ' ' TYR . 41.0 t -133.59 111.82 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.473 -0.767 . . . . 75.030000000000001 109.343 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 8.9 t -92.22 166.08 12.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.139 -0.976 . . . . 74.219999999999999 109.001 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -59.51 -44.13 93.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.941 -1.099 . . . . 72.420000000000002 108.674 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.59 -24.72 67.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.285 -0.884 . . . . 63.450000000000003 108.956 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -61.06 -51.65 68.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.383 -0.823 . . . . 72.400000000000006 109.692 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 41.6 mt -61.46 -41.68 97.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 72.319999999999993 109.025 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -67.05 0.36 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.482 -0.762 . . . . 73.340000000000003 109.956 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -59.78 -17.51 36.15 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.936 -0.706 . . . . 73.099999999999994 109.829 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . 0.59 ' CB ' ' CE1' ' B' ' 154' ' ' HIS . . . -93.67 -3.8 51.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.801 -1.187 . . . . 62.130000000000003 108.702 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.57 ' O ' ' CG ' ' B' ' 173' ' ' TRP . 96.5 mt -133.06 -80.91 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.495 -0.753 . . . . 74.439999999999998 109.074 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' TRP . . . . . 0.57 ' CG ' ' O ' ' B' ' 172' ' ' ILE . 0.0 OUTLIER 152.61 173.99 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.744 0 CA-C-O 121.73 0.776 . . . . 72.230000000000004 109.314 -179.594 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -165.28 -59.55 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.742 -0.599 . . . . 75.030000000000001 109.706 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . 0.411 ' N ' ' HD2' ' B' ' 176' ' ' PRO . 8.6 tt0 -69.33 -60.05 4.43 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 73.040000000000006 110.113 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' B' ' 175' ' ' GLU . 9.9 Cg_endo -51.2 -33.87 46.28 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.886 1.724 . . . . 74.129999999999995 111.871 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -84.14 4.32 30.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.16 -0.962 . . . . 72.439999999999998 109.246 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 69.3 mtp 49.35 28.64 2.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 72.109999999999999 109.227 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.45 170.72 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.198 -0.939 . . . . 75.310000000000002 108.897 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 54.8 p -74.83 129.49 83.26 Favored Pre-proline 0 C--N 1.303 -1.451 0 O-C-N 121.159 -0.963 . . . . 62.149999999999999 109.069 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -42.27 158.47 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.804 1.669 . . . . 74.340000000000003 112.466 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 52.02 54.43 10.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.224 -0.923 . . . . 72.310000000000002 109.628 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 3.4 p -78.96 -28.64 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.205 -0.934 . . . . 65.420000000000002 110.12 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 38.8 mm -57.21 -33.93 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.912 -1.117 . . . . 75.030000000000001 111.154 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -61.26 -63.23 1.35 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.924 -1.11 . . . . 73.519999999999996 111.252 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 30.4 m -70.48 -32.75 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.792 -1.193 . . . . 74.349999999999994 110.562 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -67.24 -38.03 84.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.958 -1.089 . . . . 61.119999999999997 111.725 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 188' ' ' ILE . . . . . 0.447 ' CG2' ' N ' ' B' ' 189' ' ' ASN . 10.6 tp -79.62 -46.07 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 119.982 -1.699 . . . . 72.430000000000007 111.222 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 189' ' ' ASN . . . . . 0.447 ' N ' ' CG2' ' B' ' 188' ' ' ILE . 40.1 m-20 -59.33 -34.05 71.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.745 -1.222 . . . . 75.420000000000002 109.802 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -80.79 -51.86 8.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.047 -1.033 . . . . 74.140000000000001 110.0 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 68.6 mt -49.76 -36.14 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.265 -0.897 . . . . 74.030000000000001 109.512 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 192' ' ' ARG . . . . . 1.48 HH12 ' CG2' ' B' ' 204' ' ' VAL . 82.6 mtt-85 -72.75 -45.73 57.15 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.756 -0.831 . . . . 72.329999999999998 108.756 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -66.54 -12.12 56.14 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.351 -0.843 . . . . 73.099999999999994 108.949 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -108.47 -13.46 14.84 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.493 -0.754 . . . . 74.430000000000007 110.617 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 35.5 ttm -96.22 -54.67 3.21 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.87 -1.144 . . . . 74.329999999999998 110.362 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -55.89 -27.62 52.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 71.209999999999994 109.701 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . 0.436 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 40.2 mttt -66.3 -65.75 1.59 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 75.209999999999994 110.021 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 198' ' ' PRO . . . . . 0.779 ' O ' ' CE ' ' B' ' 138' ' ' LYS . 17.8 Cg_endo -58.55 -48.21 16.1 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.139 1.893 . . . . 75.319999999999993 112.745 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 9.5 mp -75.86 -43.29 46.39 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.98 -1.075 . . . . 72.25 110.048 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 83.43 -9.05 62.57 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.691 -1.364 . . . . 73.239999999999995 109.691 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 31.3 mm -110.25 130.02 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.451 -1.029 . . . . 54.299999999999997 109.481 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 61.3 p -82.58 142.78 31.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.294 -0.879 . . . . 74.310000000000002 109.507 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 203' ' ' THR . . . . . 0.436 ' OG1' ' CZ ' ' B' ' 214' ' ' PHE . 57.8 p -149.89 20.8 0.89 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.459 -0.776 . . . . 74.400000000000006 109.46 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 1.48 ' CG2' HH12 ' B' ' 192' ' ' ARG . 1.2 m -135.14 137.51 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.233 -0.917 . . . . 74.099999999999994 109.664 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -125.81 133.5 51.98 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.974 -0.75 . . . . 75.329999999999998 108.974 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 9.7 t -101.96 128.66 48.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.211 -0.931 . . . . 71.400000000000006 109.273 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 27.2 m -145.11 155.44 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.124 -0.985 . . . . 63.5 109.753 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -86.24 -13.05 47.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.276 -0.89 . . . . 74.450000000000003 109.815 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 64.7 mtp85 -55.45 -38.26 68.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.125 -0.984 . . . . 74.140000000000001 109.845 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 75.8 mtt-85 -148.44 -50.55 0.16 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.127 -0.983 . . . . 74.430000000000007 109.246 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 169.28 -113.82 0.53 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.455 -1.458 . . . . 70.109999999999999 109.455 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' B' ' 163' ' ' VAL . 65.0 m-85 -109.52 127.0 54.13 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.513 -0.992 . . . . 74.209999999999994 109.563 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 43.4 ttt180 -105.06 121.79 44.52 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.379 -0.826 . . . . 74.299999999999997 109.116 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . 0.436 ' CZ ' ' OG1' ' B' ' 203' ' ' THR . 8.3 t80 -94.53 118.61 31.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.297 -0.877 . . . . 74.340000000000003 109.007 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 35.6 t -119.97 136.58 54.48 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.724 -0.61 . . . . 72.209999999999994 109.633 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -58.89 149.32 65.75 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.275 -1.009 . . . . 72.310000000000002 108.275 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.73 -169.53 0.18 Allowed 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.999 1.799 . . . . 71.010000000000005 111.742 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 6.3 pttm -47.68 153.39 1.08 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.063 -1.023 . . . . 74.349999999999994 109.242 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -38.05 102.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.444 2.096 . . . . 71.319999999999993 112.713 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -86.75 10.56 15.49 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.149 -0.969 . . . . 75.450000000000003 108.956 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 53.9 m -66.37 140.5 58.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.436 -0.79 . . . . 72.219999999999999 109.621 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -60.81 142.05 56.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.331 -0.856 . . . . 74.299999999999997 109.331 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.001 -1.0 . . . . 71.129999999999995 109.454 179.992 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 tpp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.449 -0.575 . . . . 65.120000000000005 109.449 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.517 ' NH2' ' OD2' ' A' ' 28' ' ' ASP . 33.3 ttt85 -145.43 149.58 34.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.148 -0.97 . . . . 73.310000000000002 109.383 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 82.6 t -115.91 132.56 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.403 0.62 . . . . 71.420000000000002 109.768 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 tp -99.56 115.44 29.38 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.829 -0.804 . . . . 65.219999999999999 108.829 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 59.8 tp -114.61 104.01 11.57 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.554 -0.716 . . . . 71.439999999999998 109.357 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.6 mt -93.23 112.16 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.854 -1.154 . . . . 71.150000000000006 109.189 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -146.86 134.18 20.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.378 -0.827 . . . . 75.340000000000003 109.153 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.487 ' H ' ' CD ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -73.89 -30.63 62.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.957 . . . . 73.040000000000006 109.184 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -83.63 110.58 18.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.253 -0.904 . . . . 72.420000000000002 109.347 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.6 m -65.14 -32.82 74.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 72.340000000000003 109.911 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 81.4 t -64.23 -49.49 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 74.420000000000002 109.778 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.0 tp -60.93 -37.58 82.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 72.010000000000005 109.38 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.31 -27.88 62.95 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.684 -1.767 . . . . 72.140000000000001 108.684 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.09 -48.02 79.53 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.345 -1.502 . . . . 72.329999999999998 109.345 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -64.25 -43.54 94.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.389 -1.066 . . . . 72.340000000000003 109.579 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.9 mm -65.35 -38.34 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.837 -1.165 . . . . 74.239999999999995 108.519 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.423 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 14.9 tm-20 -61.22 -45.18 95.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.34 -0.85 . . . . 71.409999999999997 109.518 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -86.58 -1.41 57.63 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.138 -0.976 . . . . 75.540000000000006 109.642 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.36 -61.23 1.65 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.02 -1.632 . . . . 62.149999999999999 109.02 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pp -62.3 -29.09 70.19 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.487 -1.008 . . . . 74.420000000000002 109.031 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 24' ' ' GLY . 86.1 m-20 -51.64 -36.16 45.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 74.25 109.0 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.8 t -53.59 -34.19 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.611 -0.885 . . . . 72.109999999999999 108.611 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.8 mmtm -78.74 -4.83 51.2 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.685 -0.857 . . . . 73.230000000000004 108.685 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 21' ' ' ASN . . . 79.94 44.92 8.7 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.639 -0.984 . . . . 75.540000000000006 110.639 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -119.06 159.68 23.45 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.264 -1.139 . . . . 74.510000000000005 109.017 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.3 mmt -103.65 139.17 39.29 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.541 -0.911 . . . . 64.319999999999993 108.541 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.417 ' O ' ' OD1' ' A' ' 28' ' ' ASP . . . -143.96 160.4 40.89 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.285 -0.884 . . . . 74.310000000000002 109.841 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.517 ' OD2' ' NH2' ' A' ' 2' ' ' ARG . 79.3 m-20 -135.96 149.9 49.06 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.954 -0.758 . . . . 75.400000000000006 108.954 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.46 133.92 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.756 -0.831 . . . . 75.129999999999995 108.756 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 p -134.65 168.21 19.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.471 -0.768 . . . . 71.420000000000002 109.42 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -93.09 -106.37 0.12 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.224 -0.922 . . . . 73.109999999999999 109.612 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.8 p -79.8 168.19 19.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.123 -0.986 . . . . 74.239999999999995 109.909 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.7 mt -53.84 -29.98 43.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.465 -0.772 . . . . 71.530000000000001 109.778 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -55.27 -47.97 74.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.108 -0.995 . . . . 74.230000000000004 109.938 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.48 -44.6 70.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.096 -1.003 . . . . 71.010000000000005 109.58 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.45 -40.65 86.54 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.589 -1.404 . . . . 61.409999999999997 109.589 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -66.0 -45.42 81.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -1.115 . . . . 74.340000000000003 109.784 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.26 -40.37 74.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.101 -0.999 . . . . 75.329999999999998 109.664 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.42 ' C ' ' CD2' ' A' ' 39' ' ' LEU . 7.0 tt -70.5 -56.33 6.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.307 -0.871 . . . . 74.329999999999998 110.022 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.501 ' SD ' ' OH ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -55.75 -27.69 52.02 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.129 -0.982 . . . . 70.319999999999993 110.047 -179.096 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -62.36 -37.23 84.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.104 -0.998 . . . . 71.219999999999999 110.111 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.0 pt -91.6 -1.6 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.091 -1.006 . . . . 74.409999999999997 110.416 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 40' ' ' MET . 19.4 mmt85 -130.02 145.77 51.67 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.292 -0.88 . . . . 75.409999999999997 109.73 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -89.43 152.54 21.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.28 -0.888 . . . . 75.420000000000002 108.997 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.501 ' OH ' ' SD ' ' A' ' 40' ' ' MET . 6.4 p90 -153.13 176.52 11.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.072 -1.017 . . . . 74.230000000000004 109.857 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -132.34 -38.7 1.05 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.552 -0.718 . . . . 75.319999999999993 109.832 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.413 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -103.32 112.17 24.92 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.332 -0.855 . . . . 72.129999999999995 109.255 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 75.1 t -96.53 98.06 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.89 -0.781 . . . . 72.340000000000003 108.89 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.503 ' SD ' ' N ' ' A' ' 50' ' ' VAL . 3.3 tpp -110.08 127.76 55.04 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.626 0.727 . . . . 74.109999999999999 109.143 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.503 ' N ' ' SD ' ' A' ' 49' ' ' MET . 1.6 p -138.71 128.02 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.532 -0.73 . . . . 71.239999999999995 109.64 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.1 m -96.42 5.16 51.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.338 -0.851 . . . . 73.109999999999999 109.521 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -76.47 141.41 41.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.129 -0.982 . . . . 63.399999999999999 109.299 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 55' ' ' ALA . 18.4 pttp -77.69 -38.81 46.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.145 -0.972 . . . . 65.439999999999998 110.453 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -72.17 12.84 0.37 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.015 -1.053 . . . . 73.129999999999995 109.498 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.48 -21.02 58.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 64.140000000000001 110.596 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 55' ' ' ALA . 58.7 mt -40.71 -52.45 2.94 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.366 -0.834 . . . . 74.430000000000007 110.428 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -67.02 -32.72 74.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.983 -1.073 . . . . 63.229999999999997 108.908 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.449 ' N ' ' O ' ' A' ' 55' ' ' ALA . 53.4 t80 -66.46 -59.29 3.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.435 -0.791 . . . . 74.439999999999998 109.911 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.5 m -51.67 -34.14 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.561 -1.337 . . . . 74.030000000000001 109.476 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.1 t -58.07 -55.48 34.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.129 -0.982 . . . . 73.540000000000006 109.718 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -64.72 -27.72 69.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.08 -1.012 . . . . 73.340000000000003 109.782 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.7 mm -65.39 -42.29 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.894 -1.129 . . . . 73.349999999999994 109.886 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 67' ' ' SER . 1.9 mmmm -67.65 -46.99 70.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.169 -0.957 . . . . 74.420000000000002 110.402 -179.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.413 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 14.3 pt-20 -69.91 -41.46 74.63 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.594 -1.316 . . . . 74.549999999999997 109.535 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.413 ' N ' ' CG ' ' A' ' 64' ' ' GLU . 52.1 mtpt -73.85 -22.29 59.81 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.232 -0.917 . . . . 75.219999999999999 109.169 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.682 ' CE1' ' HZ3' ' A' ' 145' ' ' LYS . 78.7 m-70 -152.66 64.96 0.8 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.305 -0.872 . . . . 74.129999999999995 109.148 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 63' ' ' LYS . 22.7 t -59.23 -36.21 75.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.172 -0.955 . . . . 73.239999999999995 109.967 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.7 p -74.5 50.36 0.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.136 -0.978 . . . . 71.439999999999998 109.574 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 11.2 tt -145.65 168.38 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.165 -0.959 . . . . 71.329999999999998 109.472 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.6 t -104.11 152.78 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.336 -0.852 . . . . 73.019999999999996 109.154 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.8 t -143.55 120.71 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.15 -0.969 . . . . 54.210000000000001 109.197 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.495 ' O ' ' SD ' ' A' ' 49' ' ' MET . 3.5 mp -119.33 104.64 10.56 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.708 -0.849 . . . . 74.209999999999994 108.708 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.6 p -94.78 130.71 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.264 -0.898 . . . . 74.409999999999997 109.148 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.6 p -90.85 165.48 13.59 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.152 -0.967 . . . . 72.310000000000002 108.923 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 77' ' ' ASN . 11.8 m -159.53 115.65 2.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.031 -1.043 . . . . 64.540000000000006 109.91 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 49.9 p30 -72.64 11.23 0.67 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.376 -0.827 . . . . 74.129999999999995 109.128 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 79' ' ' THR . 4.4 t-20 -142.28 64.09 16.15 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.472 -0.767 . . . . 73.340000000000003 109.455 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.97 83.83 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.027 1.818 . . . . 71.319999999999993 111.716 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.488 ' N ' ' O ' ' A' ' 77' ' ' ASN . 28.5 p -115.38 156.6 25.26 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.194 -0.669 . . . . 62.530000000000001 109.194 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.2 t -64.64 -38.87 92.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.308 -0.87 . . . . 74.140000000000001 109.596 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.403 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 85.8 tt0 -55.41 -44.79 76.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 71.420000000000002 109.386 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -74.55 -30.51 61.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.144 -0.973 . . . . 73.430000000000007 109.478 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -63.06 -57.37 10.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.299 -0.875 . . . . 74.219999999999999 109.799 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.0 m -58.91 -42.85 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.109 -0.994 . . . . 74.150000000000006 109.343 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.403 ' ND1' ' O ' ' A' ' 81' ' ' GLU . 24.2 m170 -63.51 -21.05 66.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.932 . . . . 72.540000000000006 109.583 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.18 -48.74 19.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.076 -1.015 . . . . 64.219999999999999 110.024 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.57 ' CE2' ' CZ ' ' B' ' 108' ' ' ARG . 86.0 m-85 -81.0 -28.42 35.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.026 -1.046 . . . . 74.340000000000003 109.351 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -73.69 -42.73 60.88 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.223 -0.923 . . . . 74.420000000000002 109.689 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -68.61 -50.47 51.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.082 -1.011 . . . . 74.519999999999996 109.711 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.56 64.47 0.01 OUTLIER Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.138 -1.185 . . . . 74.209999999999994 110.138 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -130.33 141.15 50.6 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.393 -1.063 . . . . 64.099999999999994 109.046 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 0.9 OUTLIER -79.71 -39.19 31.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.086 -1.009 . . . . 73.420000000000002 109.562 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 71.2 m-20 -152.44 164.39 37.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 75.040000000000006 109.532 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.71 129.69 24.92 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.665 -0.865 . . . . 71.329999999999998 108.665 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.576 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -124.02 145.42 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 121.444 0.64 . . . . 74.510000000000005 110.066 -178.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.01 130.21 44.49 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.176 -1.046 . . . . 64.319999999999993 108.176 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.655 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -51.42 -54.03 43.27 Favored Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.056 -1.028 . . . . 74.510000000000005 111.506 -179.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.7 Cg_endo -42.13 -11.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.228 0 CA-C-N 119.681 0.922 . . . . 73.109999999999999 112.558 -176.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.655 ' N ' ' O ' ' A' ' 97' ' ' LYS . 57.9 m-85 59.94 135.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.859 -0.525 . . . . 72.540000000000006 110.009 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 44.1 mtt-85 -73.7 -45.06 54.54 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.083 -1.011 . . . . 74.540000000000006 109.86 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.732 ' O ' ' N ' ' A' ' 103' ' ' LYS . 42.4 t -164.41 32.56 0.07 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.838 -1.164 . . . . 74.140000000000001 111.201 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.0 mm 52.42 -70.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.494 -0.754 . . . . 75.430000000000007 110.168 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.732 ' N ' ' O ' ' A' ' 101' ' ' SER . 13.8 mptt -57.86 -26.64 62.35 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.006 -1.109 . . . . 74.140000000000001 108.006 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.53 -46.67 46.28 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.853 -0.739 . . . . 63.240000000000002 109.697 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.7 tp -63.32 -58.72 6.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.935 . . . . 73.219999999999999 109.615 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.417 ' CG2' ' N ' ' A' ' 107' ' ' ALA . 9.1 m -52.22 -40.94 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.966 -1.084 . . . . 74.540000000000006 109.471 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.417 ' N ' ' CG2' ' A' ' 106' ' ' VAL . . . -55.71 -43.09 76.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.134 -0.979 . . . . 75.5 108.557 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -64.08 -30.89 71.93 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.357 -0.839 . . . . 74.409999999999997 109.069 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 55.6 mt -71.36 -35.2 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 107.969 -1.123 . . . . 73.239999999999995 107.969 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 114' ' ' ARG . 81.6 tt0 -62.39 -34.57 76.99 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.097 -0.705 . . . . 74.340000000000003 109.097 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -76.36 -59.73 2.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 73.319999999999993 109.654 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.97 -9.71 1.47 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 74.420000000000002 109.483 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.6 tp -140.53 82.48 1.85 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.213 -0.929 . . . . 74.329999999999998 109.84 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 110' ' ' GLU . 2.1 mmt180 -152.05 -50.11 0.11 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.318 -0.864 . . . . 74.439999999999998 108.897 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -89.34 14.14 11.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.282 -0.886 . . . . 74.430000000000007 110.001 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.406 ' O ' ' CG ' ' A' ' 116' ' ' TRP . 34.9 p-90 -68.08 125.33 26.0 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.057 -1.027 . . . . 74.439999999999998 109.721 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.411 ' O ' ' OG ' ' A' ' 118' ' ' SER . . . 139.79 135.62 3.27 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.186 -1.565 . . . . 75.040000000000006 109.186 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 117' ' ' GLY . 69.1 m -166.35 171.02 12.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.071 -1.252 . . . . 70.109999999999999 110.1 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.08 103.31 2.2 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.726 -0.842 . . . . 65.239999999999995 108.726 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 97.4 t -72.04 -29.67 33.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.087 -1.008 . . . . 74.219999999999999 109.132 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.15 131.5 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.603 -0.888 . . . . 74.420000000000002 108.603 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -149.12 128.4 12.91 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.129 -0.982 . . . . 73.299999999999997 109.542 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.982 HG21 ' NH1' ' A' ' 159' ' ' ARG . 9.3 tp -161.39 136.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.309 -0.869 . . . . 75.340000000000003 109.499 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.565 ' C ' ' H ' ' A' ' 126' ' ' LEU . . . 59.13 -167.03 7.65 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.878 -1.289 . . . . 75.129999999999995 109.878 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -70.67 12.29 0.28 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.511 -0.993 . . . . 74.450000000000003 108.83 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.565 ' H ' ' C ' ' A' ' 124' ' ' GLY . 1.9 tt -110.06 131.2 55.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.698 -0.626 . . . . 54.210000000000001 109.514 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.8 p -131.0 142.87 50.38 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.325 -0.859 . . . . 70.239999999999995 108.716 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 94.6 mt -136.67 135.4 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.164 -0.96 . . . . 72.430000000000007 110.661 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.1 m -127.46 104.1 22.05 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.359 -0.978 . . . . 71.109999999999999 108.359 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.33 -25.38 2.65 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.475 2.116 . . . . 75.140000000000001 112.206 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -66.06 -38.46 88.37 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.307 -0.871 . . . . 72.5 108.843 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -98.08 9.06 43.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.375 -0.828 . . . . 73.140000000000001 109.64 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.67 ' HA ' ' HZ ' ' A' ' 149' ' ' PHE . 37.7 mt-10 47.72 60.48 3.5 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.206 -0.934 . . . . 75.329999999999998 109.617 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -154.03 130.6 10.67 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.047 -1.033 . . . . 71.230000000000004 110.098 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.419 ' CD1' ' HE1' ' A' ' 149' ' ' PHE . 2.2 mp -111.89 138.22 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.488 -0.93 . . . . 75.329999999999998 108.488 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 19.4 mt -125.72 131.54 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.409 -0.807 . . . . 71.109999999999999 108.9 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.548 ' HH ' ' NE ' ' A' ' 140' ' ' ARG . 10.3 p90 -139.12 139.22 37.58 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.099 -1.001 . . . . 74.140000000000001 109.984 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.1 mttt 53.73 27.87 7.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.522 -0.737 . . . . 75.400000000000006 110.175 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 77.88 14.08 82.73 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.905 -1.14 . . . . 72.239999999999995 110.437 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.548 ' NE ' ' HH ' ' A' ' 137' ' ' TYR . 19.1 mtp180 -105.27 133.13 50.54 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.472 -1.016 . . . . 73.120000000000005 108.78 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -90.82 129.3 36.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.322 -0.861 . . . . 72.319999999999993 110.224 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 t -128.14 108.63 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.357 -0.979 . . . . 62.340000000000003 108.357 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -92.48 102.07 14.52 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.054 -1.091 . . . . 61.229999999999997 108.054 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.3 m -115.61 139.76 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.7 0.762 . . . . 74.439999999999998 110.705 -178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.682 ' HZ3' ' CE1' ' A' ' 66' ' ' HIS . 39.0 pttt -160.53 125.39 3.77 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.856 -0.794 . . . . 75.420000000000002 108.856 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.37 -143.18 10.06 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.674 -1.37 . . . . 73.340000000000003 109.674 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -70.91 -59.27 3.64 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.346 -1.09 . . . . 72.219999999999999 110.486 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.84 4.9 1.23 Allowed 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.997 1.798 . . . . 75.450000000000003 112.785 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.67 ' HZ ' ' HA ' ' A' ' 133' ' ' GLU . 65.3 t80 -101.66 -54.82 2.65 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.234 -0.916 . . . . 65.239999999999995 110.319 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.634 ' OE2' ' OE2' ' A' ' 177' ' ' GLU . 7.9 pt-20 -46.98 -36.0 7.24 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.158 -0.964 . . . . 72.519999999999996 109.574 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.8 p -78.82 -31.26 15.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.169 -0.957 . . . . 74.209999999999994 109.137 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 13.8 tp -63.56 -38.81 92.53 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.127 -0.983 . . . . 73.310000000000002 109.039 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.415 ' H ' ' HG1' ' A' ' 153' ' ' THR . 14.1 p -75.91 -32.75 59.76 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.08 -1.013 . . . . 74.310000000000002 108.592 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.486 ' CD2' ' HE1' ' A' ' 158' ' ' HIS . 44.4 t-80 -55.13 -51.01 67.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.607 -0.683 . . . . 75.450000000000003 110.5 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.92 -33.41 65.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.988 -1.07 . . . . 75.340000000000003 109.887 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -50.45 -44.62 55.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.981 -1.074 . . . . 62.140000000000001 109.683 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 -77.66 -43.75 30.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.091 -1.006 . . . . 72.219999999999999 110.234 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.486 ' HE1' ' CD2' ' A' ' 154' ' ' HIS . 22.1 m170 -82.54 34.89 0.44 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 74.120000000000005 110.803 -178.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.982 ' NH1' HG21 ' A' ' 123' ' ' ILE . 30.8 ttp180 -64.61 169.28 5.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.807 -1.183 . . . . 74.340000000000003 107.927 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 4.4 p30 41.44 55.68 3.38 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.378 -0.826 . . . . 75.450000000000003 110.082 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -158.4 156.14 29.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 73.409999999999997 109.132 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.411 ' N ' ' CD1' ' A' ' 162' ' ' ILE . 2.5 mp -83.71 123.1 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.177 -0.952 . . . . 74.409999999999997 108.463 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 48.2 t -118.05 127.67 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.486 -0.759 . . . . 72.530000000000001 110.051 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.8 t -100.69 148.02 25.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.519 -0.738 . . . . 74.120000000000005 109.558 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.54 ' CB ' ' HZ1' ' A' ' 165' ' ' LYS . 8.1 mtpm? -49.41 -49.75 43.52 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.482 -0.761 . . . . 70.430000000000007 109.816 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -51.88 -36.93 50.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.069 -1.02 . . . . 74.319999999999993 109.476 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -59.03 -43.35 91.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.976 -1.078 . . . . 74.519999999999996 109.115 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 18.5 mt -56.14 -37.22 69.2 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.245 -0.909 . . . . 74.409999999999997 108.549 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 171' ' ' ALA . 92.8 mt -64.73 -74.68 0.1 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.566 -1.254 . . . . 75.140000000000001 109.019 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -45.92 -14.43 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.885 . . . . 65.030000000000001 110.516 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 169' ' ' LEU . . . -93.42 -37.54 11.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.063 -1.023 . . . . 70.209999999999994 111.428 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.416 ' N ' ' CD1' ' A' ' 172' ' ' ILE . 1.4 mp -95.42 -56.58 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 120.954 -1.091 . . . . 75.319999999999993 110.446 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -82.52 143.88 30.79 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.406 -1.434 . . . . 73.140000000000001 109.229 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -172.27 -28.46 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.716 -0.615 . . . . 73.239999999999995 109.352 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.7 ' H ' ' CD ' ' A' ' 176' ' ' PRO . 13.5 tp10 -149.3 -38.76 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.204 -0.935 . . . . 63.329999999999998 111.133 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.7 ' CD ' ' H ' ' A' ' 175' ' ' GLU . 96.1 Cg_endo -95.23 -71.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.319 -1.0 0 C-N-CA 122.652 2.235 . . . . 72.510000000000005 112.6 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.634 ' OE2' ' OE2' ' A' ' 150' ' ' GLU . 47.9 mt-10 -59.23 155.59 13.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.213 -0.93 . . . . 75.340000000000003 109.657 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.426 ' O ' ' O ' ' A' ' 179' ' ' VAL . 17.0 ptt? -123.24 -5.64 8.33 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.034 -0.728 . . . . 74.510000000000005 109.034 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 178' ' ' MET . 3.3 t 48.96 99.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.47 -0.769 . . . . 65.219999999999999 110.442 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -56.05 163.38 2.28 Favored Pre-proline 0 N--CA 1.49 1.526 0 N-CA-C 107.657 -1.238 . . . . 73.219999999999999 107.657 178.71 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -37.84 -22.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.344 2.03 . . . . 62.43 112.352 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 180' ' ' THR . 35.3 p-10 -156.42 119.39 4.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.206 -0.934 . . . . 73.129999999999995 109.292 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.3 t -145.34 -31.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.235 -0.916 . . . . 74.019999999999996 110.176 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.536 ' H ' ' CD1' ' A' ' 184' ' ' ILE . 2.4 mp -57.85 -34.82 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.065 -1.022 . . . . 72.329999999999998 109.898 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -52.82 -50.05 64.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.242 -0.911 . . . . 74.400000000000006 109.641 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 16.7 m -77.8 -31.08 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.18 -0.95 . . . . 74.319999999999993 109.961 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.58 -51.08 68.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.926 -1.109 . . . . 73.230000000000004 109.915 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.421 ' CG2' ' N ' ' A' ' 189' ' ' ASN . 3.5 tp -68.03 -43.27 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.879 -1.138 . . . . 74.310000000000002 110.032 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.467 ' ND2' ' OE1' ' A' ' 193' ' ' GLN . 7.9 t-20 -60.38 -37.93 82.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.895 -1.128 . . . . 73.439999999999998 108.676 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -71.93 -50.87 25.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.551 -0.718 . . . . 71.420000000000002 110.618 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 69.5 mt -52.7 -58.5 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.053 -1.029 . . . . 72.439999999999998 109.914 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.421 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 3.3 mtp85 -51.14 -41.92 60.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.075 -1.016 . . . . 64.219999999999999 109.008 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.467 ' OE1' ' ND2' ' A' ' 189' ' ' ASN . 16.4 mt-30 -71.02 -24.05 62.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.995 -1.066 . . . . 74.319999999999993 109.932 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.489 ' CB ' ' HZ2' ' A' ' 194' ' ' LYS . 4.7 mtpm? -101.0 -0.27 36.81 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.289 -0.882 . . . . 75.310000000000002 110.573 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -109.15 -19.11 13.46 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.2 -0.937 . . . . 74.019999999999996 110.02 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 192' ' ' ARG . 14.0 p-10 -98.28 -5.28 33.4 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.158 -0.964 . . . . 74.019999999999996 110.164 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 26.9 mttp -103.23 -64.86 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.125 0 O-C-N 121.355 -0.84 . . . . 75.430000000000007 110.575 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.447 ' CG ' ' O ' ' A' ' 194' ' ' LYS . 29.9 Cg_endo -61.42 -57.41 0.58 Allowed 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 121.966 1.777 . . . . 72.319999999999993 112.013 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.9 mp -69.55 -43.11 73.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 74.540000000000006 109.383 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 94.3 -26.97 14.8 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.254 -1.138 . . . . 61.509999999999998 110.254 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.51 ' N ' ' CD1' ' A' ' 201' ' ' ILE . 3.1 mp -98.68 133.54 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.97 -1.312 . . . . 74.25 110.289 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 14.6 m -106.14 139.18 41.07 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.118 -1.067 . . . . 72.0 108.118 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.4 p -141.58 42.96 1.74 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.063 -1.023 . . . . 74.439999999999998 110.128 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.529 ' CG1' ' CE2' ' A' ' 214' ' ' PHE . 1.0 OUTLIER -143.11 155.06 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.28 -0.888 . . . . 71.129999999999995 109.727 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -128.34 134.1 48.8 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.712 -0.847 . . . . 73.510000000000005 108.712 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.4 t -95.1 133.28 39.08 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.046 -1.034 . . . . 73.519999999999996 109.259 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 211' ' ' GLY . 10.5 p -156.25 142.78 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.787 -1.196 . . . . 72.150000000000006 109.531 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -64.85 -41.06 96.01 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.379 -0.825 . . . . 72.400000000000006 109.539 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 1.057 HH21 ' NH2' ' A' ' 213' ' ' ARG . 0.8 OUTLIER -58.12 152.8 16.07 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.824 -0.806 . . . . 73.310000000000002 108.824 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 209' ' ' ARG . 9.6 mpt_? 42.9 -94.17 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.23 -0.919 . . . . 71.540000000000006 109.789 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.541 ' O ' HG12 ' A' ' 207' ' ' VAL . . . -171.42 -114.09 0.31 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.469 -1.452 . . . . 74.450000000000003 109.469 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -111.06 140.34 45.68 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.478 -1.013 . . . . 75.540000000000006 109.055 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 1.057 ' NH2' HH21 ' A' ' 209' ' ' ARG . 36.6 mtt180 -105.51 142.65 34.88 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.319 -0.863 . . . . 75.310000000000002 109.677 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.529 ' CE2' ' CG1' ' A' ' 204' ' ' VAL . 33.8 m-85 -115.78 112.83 22.58 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.49 -0.93 . . . . 75.409999999999997 108.49 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 8.2 p -119.35 160.6 21.96 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.628 -0.67 . . . . 74.140000000000001 109.847 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . 0.462 ' CD1' ' O ' ' A' ' 217' ' ' PRO . 36.7 p90 -68.92 151.1 97.42 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.394 -0.816 . . . . 75.319999999999993 109.229 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.462 ' O ' ' CD1' ' A' ' 216' ' ' TYR . 84.4 Cg_exo -37.07 154.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.28 1.987 . . . . 73.109999999999999 112.253 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.647 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 19.0 pttm -98.56 -19.06 0.21 Allowed Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.171 -0.956 . . . . 75.25 112.965 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 49.3 Cg_endo -87.57 -15.38 3.42 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.622 1.548 . . . . 75.099999999999994 112.346 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -51.06 -36.67 41.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.466 -0.771 . . . . 71.140000000000001 110.011 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 2.0 p -60.05 135.53 57.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.012 -1.055 . . . . 71.129999999999995 109.609 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -93.45 -160.99 0.8 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.327 -0.858 . . . . 75.349999999999994 109.671 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.983 -1.008 . . . . 73.409999999999997 109.374 -179.877 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.532 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.435 -0.58 . . . . 75.239999999999995 109.435 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.537 HH21 ' C ' ' B' ' 44' ' ' ASN . 8.1 ttp180 -139.89 150.38 44.53 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.357 -0.84 . . . . 73.519999999999996 109.067 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 92.6 t -116.03 129.93 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.537 -0.912 . . . . 72.239999999999995 108.537 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' B' ' 49' ' ' MET . 5.5 tp -101.89 118.34 36.72 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.513 -0.742 . . . . 73.340000000000003 110.002 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 16.4 mt -114.6 111.28 21.09 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 108.412 -0.958 . . . . 74.349999999999994 108.412 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 66.3 mt -107.94 115.4 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.417 -0.802 . . . . 63.439999999999998 109.246 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' B' ' 7' ' ' GLU . 1.4 pm0 -160.08 140.74 12.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 74.519999999999996 109.417 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -63.68 -31.15 72.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 74.129999999999995 109.319 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -86.5 106.97 17.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.252 -0.905 . . . . 74.230000000000004 109.524 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 47.8 m -72.44 -29.14 63.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 65.540000000000006 109.847 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 90.9 t -56.79 -49.97 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.155 -0.965 . . . . 75.549999999999997 109.657 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.506 ' CD2' ' N ' ' B' ' 12' ' ' LEU . 3.6 mm? -63.02 -35.21 79.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 70.140000000000001 109.188 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.78 -25.47 74.89 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 108.635 -1.786 . . . . 75.400000000000006 108.635 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.79 -54.13 27.05 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.36 -1.496 . . . . 65.439999999999998 109.36 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -57.42 -46.27 83.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.4 -1.059 . . . . 72.200000000000003 109.68 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 37.5 mm -62.52 -38.88 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.866 -1.146 . . . . 75.150000000000006 108.652 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.423 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 80.0 tt0 -61.79 -43.1 99.53 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.408 -0.807 . . . . 73.010000000000005 109.508 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -87.66 2.6 50.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.186 -0.946 . . . . 74.299999999999997 109.177 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.76 -55.95 2.06 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.457 -1.457 . . . . 70.540000000000006 109.457 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -71.44 -21.99 61.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.242 -1.151 . . . . 75.430000000000007 109.633 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 88.0 m-20 -52.44 -33.91 46.24 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.215 -0.928 . . . . 73.200000000000003 109.646 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 81.8 t -59.51 -32.71 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.152 -0.968 . . . . 74.230000000000004 109.212 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -79.23 -4.79 52.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.358 -0.839 . . . . 73.519999999999996 109.193 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.17 36.35 18.21 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.264 -1.135 . . . . 53.43 110.264 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -113.76 160.01 19.14 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.463 -1.022 . . . . 71.120000000000005 108.938 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.4 mmt -107.14 140.49 39.91 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.386 -0.821 . . . . 75.239999999999995 109.09 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.02 164.74 26.95 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.491 -0.755 . . . . 73.25 109.499 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -141.24 145.58 35.75 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.372 -0.83 . . . . 72.310000000000002 108.964 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 m -113.63 137.14 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.785 . . . . 72.140000000000001 109.068 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 10.0 p -144.56 164.47 30.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.288 -0.883 . . . . 74.530000000000001 109.367 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.447 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 1.6 pt-20 -91.57 -97.24 0.12 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.242 -0.911 . . . . 71.019999999999996 109.579 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 42.4 t -79.48 166.59 21.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.192 -0.942 . . . . 71.400000000000006 109.96 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' B' ' 37' ' ' GLU . 16.7 mt -55.25 -32.0 61.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.592 -0.693 . . . . 71.239999999999995 110.134 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -54.3 -44.86 72.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.09 -1.006 . . . . 74.319999999999993 110.2 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.447 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 19.0 m-20 -66.34 -42.96 87.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.051 -1.031 . . . . 73.030000000000001 109.651 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.58 -28.48 59.38 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.629 -1.388 . . . . 60.43 109.629 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' B' ' 33' ' ' LEU . 84.7 tt0 -67.18 -46.79 72.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -1.15 . . . . 74.430000000000007 109.695 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . 0.443 ' O ' ' OD1' ' B' ' 41' ' ' ASP . 70.2 t80 -75.06 -26.59 59.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.258 -0.901 . . . . 74.420000000000002 110.036 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 9.6 tp -84.84 -30.86 24.17 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.17 -0.956 . . . . 75.409999999999997 110.031 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.502 ' SD ' ' OH ' ' B' ' 45' ' ' TYR . 0.0 OUTLIER -86.83 -30.61 21.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.961 . . . . 61.439999999999998 110.317 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' B' ' 42' ' ' ILE . 56.2 p-10 -71.07 -21.4 62.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.878 -1.139 . . . . 74.319999999999993 110.043 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.528 ' N ' ' OD1' ' B' ' 41' ' ' ASP . 12.5 pt -80.94 -29.95 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.03 -1.044 . . . . 71.230000000000004 110.005 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.485 ' C ' ' NH2' ' B' ' 2' ' ' ARG . 26.2 mmt180 -129.13 171.13 12.71 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.376 -0.828 . . . . 73.409999999999997 109.791 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . 0.537 ' C ' HH21 ' B' ' 2' ' ' ARG . 24.5 m120 -98.87 154.21 18.21 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.076 -1.015 . . . . 63.539999999999999 109.809 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.586 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 1.3 p90 -140.52 -177.36 5.01 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.353 -0.842 . . . . 73.109999999999999 109.09 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . 0.443 ' OD2' ' CD1' ' B' ' 116' ' ' TRP . 63.4 t0 -133.28 -43.6 0.85 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.253 -0.904 . . . . 62.219999999999999 110.256 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.401 ' C ' ' CD1' ' B' ' 47' ' ' LEU . 0.5 OUTLIER -102.01 114.51 28.68 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.276 -0.89 . . . . 73.120000000000005 109.082 -179.597 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 50.6 t -98.63 97.37 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.238 -1.023 . . . . 74.109999999999999 108.238 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' MET . . . . . 0.457 ' O ' ' O ' ' B' ' 4' ' ' LEU . 22.5 ttt -111.82 130.37 55.83 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.716 0.769 . . . . 73.439999999999998 109.891 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.418 HG23 ' H ' ' B' ' 52' ' ' ASP . 0.4 OUTLIER -145.8 137.84 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.358 -0.839 . . . . 73.400000000000006 109.491 -179.579 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' SER . . . . . 0.49 ' CB ' ' HG ' ' B' ' 74' ' ' SER . 42.8 p -102.53 2.94 36.92 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.579 -0.701 . . . . 73.209999999999994 109.788 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.418 ' H ' HG23 ' B' ' 50' ' ' VAL . 27.4 m-20 -76.41 134.29 39.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.147 -0.97 . . . . 70.409999999999997 109.377 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.453 ' C ' ' H ' ' B' ' 55' ' ' ALA . 62.6 mttp -70.24 -37.79 75.05 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.275 -0.891 . . . . 73.129999999999995 110.46 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -69.96 6.71 1.13 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.969 -1.082 . . . . 75.209999999999994 109.703 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.453 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -75.35 -22.5 57.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 55.329999999999998 110.346 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 42.0 mt -44.46 -39.59 4.89 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.328 -0.857 . . . . 72.420000000000002 110.048 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 83.8 p -76.88 -37.39 55.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.041 -1.037 . . . . 73.040000000000006 109.466 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -66.08 -42.87 88.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.387 -0.821 . . . . 72.329999999999998 110.148 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.9 m -68.17 -37.74 78.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 120.68 -1.262 . . . . 74.540000000000006 109.121 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 9.5 t -53.84 -49.61 68.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 71.239999999999995 109.472 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -68.32 -35.6 78.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.138 -0.976 . . . . 74.310000000000002 110.069 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 5.4 mm -63.22 -39.35 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.806 -1.184 . . . . 75.420000000000002 109.903 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' B' ' 67' ' ' SER . 6.9 mtpm? -67.13 -50.97 59.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.076 -1.015 . . . . 73.319999999999993 110.42 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -69.32 -38.19 78.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.852 -1.155 . . . . 73.310000000000002 109.765 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.503 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 25.8 mtpp -78.77 -20.52 49.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 72.439999999999998 109.346 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.503 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 97.9 m-70 -156.88 65.73 0.52 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 65.209999999999994 109.326 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.469 ' N ' ' O ' ' B' ' 63' ' ' LYS . 86.4 p -61.22 -30.63 70.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 73.099999999999994 109.984 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 78.6 p -69.01 47.06 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.152 -0.967 . . . . 71.530000000000001 109.785 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' B' ' 67' ' ' SER . 16.0 tt -146.43 163.99 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.152 -0.968 . . . . 74.400000000000006 109.541 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 41.3 t -103.33 148.96 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.308 -0.87 . . . . 75.120000000000005 109.504 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 t -135.66 124.51 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.3 -0.875 . . . . 73.200000000000003 109.841 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 tt -116.8 104.31 11.2 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.107 -0.701 . . . . 73.340000000000003 109.107 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.72 132.51 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.073 -1.017 . . . . 73.5 109.213 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.49 ' HG ' ' CB ' ' B' ' 51' ' ' SER . 7.8 p -93.56 170.78 9.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.143 -0.973 . . . . 71.319999999999993 109.154 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.437 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 11.9 t -152.1 122.81 7.42 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.942 -1.099 . . . . 74.530000000000001 110.523 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 51.3 p30 -68.2 1.36 2.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.461 -0.775 . . . . 64.5 109.745 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' B' ' 79' ' ' THR . 38.9 t-20 -171.55 81.3 0.5 Allowed Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.248 -0.907 . . . . 74.25 109.494 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -42.55 87.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.205 1.937 . . . . 74.430000000000007 111.943 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.505 ' N ' ' O ' ' B' ' 77' ' ' ASN . 3.0 p -100.5 155.83 17.62 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.177 -0.675 . . . . 73.120000000000005 109.177 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.2 -36.38 83.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.386 -0.821 . . . . 75.409999999999997 109.591 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -63.37 -40.81 98.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 72.239999999999995 109.93 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . 0.406 ' OE1' ' OH ' ' B' ' 94' ' ' TYR . 78.1 tt0 -73.57 -34.37 65.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.152 -0.967 . . . . 73.219999999999999 109.998 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.407 ' OE1' ' N ' ' B' ' 84' ' ' VAL . 14.6 tm-20 -61.88 -56.68 16.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 74.299999999999997 109.711 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.407 ' N ' ' OE1' ' B' ' 83' ' ' GLU . 34.6 m -58.66 -39.09 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.16 -0.962 . . . . 73.310000000000002 109.299 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -69.38 -28.02 65.82 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 73.239999999999995 109.403 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.25 -36.39 81.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.128 -0.982 . . . . 55.329999999999998 109.732 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -82.33 -38.41 24.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.058 -1.026 . . . . 74.450000000000003 108.879 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -70.47 -38.25 74.41 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.346 -0.846 . . . . 64.040000000000006 109.653 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -74.97 -57.56 3.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.933 . . . . 75.129999999999995 109.358 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 153.63 80.82 0.03 OUTLIER Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.036 -1.225 . . . . 75.420000000000002 110.036 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -139.82 115.43 10.05 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.247 -1.149 . . . . 73.420000000000002 109.256 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' B' ' 93' ' ' ASP . 18.9 t70 -73.9 -29.56 62.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.926 . . . . 73.319999999999993 108.864 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' B' ' 92' ' ' ASP . 48.2 m-20 -139.01 164.0 30.91 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.507 -0.923 . . . . 73.040000000000006 108.507 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.437 ' OH ' ' CB ' ' B' ' 75' ' ' SER . 89.1 t80 -151.14 103.32 3.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.126 -0.984 . . . . 74.310000000000002 109.26 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 28.0 mm -114.77 149.37 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 O-C-N 121.332 -0.855 . . . . 75.340000000000003 110.499 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.12 143.85 56.13 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.757 -1.201 . . . . 70.099999999999994 107.757 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.593 ' N ' ' CD ' ' B' ' 98' ' ' PRO . 0.0 OUTLIER -68.33 -40.8 21.82 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.857 -1.152 . . . . 65.430000000000007 111.104 -178.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' B' ' 97' ' ' LYS . 39.0 Cg_exo -52.01 -2.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.289 -2.595 0 CA-C-N 118.696 0.57 . . . . 63.520000000000003 112.188 -174.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . 0.59 ' H ' ' C ' ' B' ' 97' ' ' LYS . 58.5 m-85 54.69 95.28 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.711 -0.618 . . . . 75.129999999999995 110.68 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 36.2 mtt85 -56.1 -38.31 70.56 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.7 -1.222 . . . . 74.230000000000004 107.7 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 10.2 t -172.68 125.97 0.48 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.644 -0.873 . . . . 64.510000000000005 108.644 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 58.3 mt -50.26 -40.06 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.06 -1.025 . . . . 74.439999999999998 109.363 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -61.79 -38.23 87.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.201 -0.937 . . . . 72.299999999999997 109.193 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.71 -49.49 65.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 74.310000000000002 109.346 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 65.1 tp -62.28 -44.45 96.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 73.540000000000006 109.149 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.98 -39.94 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.217 -0.927 . . . . 72.030000000000001 109.484 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.37 -39.09 66.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.094 -1.004 . . . . 64.219999999999999 108.961 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 0.57 ' CZ ' ' CE2' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -72.17 -34.66 68.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.421 -0.799 . . . . 75.310000000000002 109.42 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . 0.423 HD11 HG22 ' B' ' 109' ' ' ILE . 97.3 mt -75.53 -27.36 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.208 -0.933 . . . . 55.439999999999998 109.33 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -73.51 -56.68 4.72 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.343 -0.848 . . . . 65.310000000000002 109.477 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.72 -36.11 69.31 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 74.519999999999996 109.906 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . 0.45 ' NH2' HH22 ' B' ' 108' ' ' ARG . 0.0 OUTLIER -66.28 -51.4 57.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.171 -0.956 . . . . 72.040000000000006 110.179 -179.467 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' B' ' 116' ' ' TRP . 64.2 mt -74.8 -33.07 62.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.089 -1.007 . . . . 75.349999999999994 110.277 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -48.92 -37.57 20.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.936 -1.102 . . . . 75.5 109.456 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -81.08 -2.45 48.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.911 . . . . 73.040000000000006 109.3 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' TRP . . . . . 0.459 ' CZ3' ' NZ ' ' B' ' 134' ' ' LYS . 88.2 t90 -55.33 -35.79 65.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 74.450000000000003 109.577 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.32 106.69 2.43 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.614 -1.394 . . . . 64.209999999999994 109.614 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' SER . . . . . 0.462 ' C ' ' ND2' ' B' ' 119' ' ' ASN . 42.8 m -154.92 166.95 31.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -1.159 . . . . 71.400000000000006 109.702 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . 0.462 ' ND2' ' C ' ' B' ' 118' ' ' SER . 0.0 OUTLIER -158.0 120.78 3.83 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.875 -0.787 . . . . 74.209999999999994 108.875 -178.37 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 19.3 t -87.36 -43.08 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.146 -0.971 . . . . 75.019999999999996 109.395 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 16.1 mm -99.2 137.2 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.277 -0.89 . . . . 74.239999999999995 109.431 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -135.59 100.48 4.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.446 -0.784 . . . . 73.329999999999998 109.048 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 31.2 mm -113.53 132.18 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.5 -0.75 . . . . 74.219999999999999 109.472 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 44.16 -128.22 6.67 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.034 -1.226 . . . . 72.409999999999997 110.034 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -97.38 -10.25 25.88 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.323 -1.104 . . . . 75.120000000000005 109.711 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.97 137.13 36.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.137 -0.977 . . . . 75.420000000000002 109.298 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 27.6 p -119.62 144.99 46.83 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.589 -0.694 . . . . 74.219999999999999 109.441 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 56.2 mt -124.46 129.26 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.514 -0.741 . . . . 60.329999999999998 109.367 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 6.3 m -109.7 118.22 50.73 Favored Pre-proline 0 N--CA 1.497 1.876 0 N-CA-C 108.858 -0.794 . . . . 72.310000000000002 108.858 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.588 ' CB ' ' HE ' ' B' ' 157' ' ' ARG . 97.3 Cg_endo -79.18 -56.88 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.751 1.634 . . . . 75.129999999999995 112.211 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -59.74 -43.15 94.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.154 -0.966 . . . . 75.230000000000004 109.545 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -81.33 -12.84 58.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 75.120000000000005 109.303 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 52.07 55.07 9.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 75.129999999999995 109.363 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . 0.459 ' NZ ' ' CZ3' ' B' ' 116' ' ' TRP . 35.7 ttpt -137.19 133.7 35.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.482 -0.761 . . . . 75.109999999999999 109.267 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 13.5 tt -117.14 132.69 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.53 -0.731 . . . . 70.319999999999993 109.441 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 14.0 mt -112.04 125.07 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.55 -0.718 . . . . 74.120000000000005 109.146 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -139.75 140.35 36.71 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.326 -0.859 . . . . 74.230000000000004 109.728 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt 53.98 19.05 1.86 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.37 -0.831 . . . . 74.219999999999999 110.011 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.38 16.42 64.41 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 120.087 -1.054 . . . . 74.319999999999993 110.614 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -112.29 127.8 56.09 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.365 -1.079 . . . . 75.340000000000003 109.493 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -93.9 127.01 39.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.249 -0.907 . . . . 71.230000000000004 109.629 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 98.7 t -137.52 136.48 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.412 -0.805 . . . . 70.430000000000007 109.254 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . 0.457 ' CD ' ' N ' ' B' ' 143' ' ' GLU . 42.9 mp0 -92.82 144.31 25.41 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.219 -0.926 . . . . 72.430000000000007 109.45 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 34.1 m -143.55 125.84 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.195 -0.941 . . . . 72.129999999999995 109.17 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.37 117.45 11.81 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.379 -0.826 . . . . 74.5 109.255 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.7 171.02 33.22 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.515 -1.434 . . . . 42.229999999999997 109.515 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 4.4 mtmm -68.67 -38.26 11.73 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.202 -1.175 . . . . 73.299999999999997 109.961 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 36.1 Cg_exo -59.61 -34.85 96.51 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.105 1.87 . . . . 71.329999999999998 111.929 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -88.47 -18.07 29.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.368 -0.832 . . . . 74.230000000000004 109.622 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -57.45 -40.02 77.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 72.340000000000003 109.644 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 9.6 p -61.76 -39.09 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.943 . . . . 73.349999999999994 109.585 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 41.2 tp -60.56 -41.45 94.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 74.430000000000007 109.096 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 17.7 p -76.87 -30.99 56.48 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.261 -0.899 . . . . 75.209999999999994 109.258 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -58.4 -51.24 70.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 73.040000000000006 109.585 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 1.9 pp -72.99 -28.29 62.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -0.942 . . . . 73.430000000000007 109.542 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -54.47 -46.08 73.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.957 . . . . 75.319999999999993 109.507 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.588 ' HE ' ' CB ' ' B' ' 130' ' ' PRO . 43.3 mtt85 -75.75 -43.96 44.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.203 -0.936 . . . . 73.319999999999993 109.457 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -77.04 26.37 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.349 -0.844 . . . . 74.140000000000001 109.903 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . 0.438 ' H ' ' C ' ' B' ' 157' ' ' ARG . 3.0 tpm_? -49.66 157.04 0.59 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.097 -1.002 . . . . 73.420000000000002 108.873 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' B' ' 160' ' ' ASP . 4.9 p-10 42.81 54.57 4.62 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.473 -0.767 . . . . 72.099999999999994 110.13 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -146.44 156.05 43.01 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.175 -0.953 . . . . 73.239999999999995 109.368 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 26.2 mt -98.91 138.98 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.263 -0.898 . . . . 72.310000000000002 109.379 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 9.5 m -140.73 143.52 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.33 -0.857 . . . . 75.030000000000001 109.57 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' SER . . . . . 0.494 ' HG ' ' H ' ' B' ' 167' ' ' GLN . 83.7 p -94.48 161.48 14.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.285 -0.884 . . . . 74.219999999999999 109.214 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -53.78 -38.55 64.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.2 -0.938 . . . . 72.420000000000002 109.255 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -64.54 -36.85 85.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.867 . . . . 63.450000000000003 109.445 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' GLN . . . . . 0.494 ' H ' ' HG ' ' B' ' 164' ' ' SER . 10.5 tm0? -56.26 -45.38 80.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.898 . . . . 72.400000000000006 109.123 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 33.1 mt -65.02 -33.83 76.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 72.319999999999993 108.919 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.401 ' CD2' ' C ' ' B' ' 169' ' ' LEU . 4.0 tt -53.53 -60.64 3.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.43 -0.794 . . . . 73.340000000000003 109.558 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -66.83 -27.85 67.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.371 -0.831 . . . . 73.099999999999994 110.232 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.26 -57.6 11.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.14 -0.975 . . . . 62.130000000000003 110.064 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.476 ' N ' ' CD1' ' B' ' 172' ' ' ILE . 2.0 mp -94.65 -59.0 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.06 -1.025 . . . . 74.439999999999998 109.291 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 23.2 m-90 -89.61 89.75 7.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.265 -0.897 . . . . 72.230000000000004 109.527 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' B' ' 175' ' ' GLU . 14.6 pt-20 -100.23 -171.15 1.98 Allowed 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.584 -0.895 . . . . 75.030000000000001 108.584 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' B' ' 174' ' ' GLU . 29.6 mt-10 56.54 152.93 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 109.734 -0.469 . . . . 73.040000000000006 109.734 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -38.91 109.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 122.172 1.915 . . . . 74.129999999999995 112.294 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -143.54 123.99 13.94 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.208 -0.932 . . . . 72.439999999999998 109.299 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 178' ' ' MET . . . . . 0.505 ' C ' ' H ' ' B' ' 180' ' ' THR . 65.4 mtt -85.5 20.35 2.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.245 -0.91 . . . . 72.109999999999999 109.449 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 179' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' B' ' 180' ' ' THR . 13.1 m -51.01 -10.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 75.310000000000002 109.641 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 180' ' ' THR . . . . . 0.505 ' H ' ' C ' ' B' ' 178' ' ' MET . 3.2 m 61.96 134.17 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 N-CA-C 109.162 -0.681 . . . . 62.149999999999999 109.162 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . 0.432 ' O ' ' OE1' ' B' ' 185' ' ' GLU . 67.4 Cg_endo -73.25 -10.07 23.84 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 121.826 1.684 . . . . 74.340000000000003 112.017 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 182' ' ' ASN . . . . . 0.426 ' O ' ' OE1' ' B' ' 185' ' ' GLU . 19.9 t-20 -61.65 -27.29 68.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 72.310000000000002 110.111 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 9.7 m -77.29 -17.53 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.097 -1.002 . . . . 65.420000000000002 110.114 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 87.9 mt -58.36 -52.41 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.103 -0.998 . . . . 75.030000000000001 110.034 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . 0.517 ' H ' ' CD ' ' B' ' 185' ' ' GLU . 1.6 pm0 -55.33 -33.93 63.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.134 -0.979 . . . . 73.519999999999996 109.318 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 91.7 t -75.26 -47.63 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 74.349999999999994 109.934 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.78 -50.18 65.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -0.999 . . . . 61.119999999999997 110.166 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 16.1 tt -57.79 -39.87 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.025 -1.047 . . . . 72.430000000000007 109.764 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -61.38 -46.37 90.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.104 -0.997 . . . . 75.420000000000002 109.545 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -68.51 -45.2 72.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 74.140000000000001 109.764 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 85.5 mt -54.98 -41.75 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.226 -0.921 . . . . 74.030000000000001 109.288 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -60.77 -47.15 87.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 72.329999999999998 109.287 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -66.21 -36.15 82.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.894 . . . . 73.099999999999994 109.533 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . 0.46 ' CB ' ' NZ ' ' B' ' 194' ' ' LYS . 7.8 mtpm? -81.29 -6.45 58.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.882 . . . . 74.430000000000007 109.566 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 28.1 ttt -92.92 -54.71 3.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.233 -0.917 . . . . 74.329999999999998 109.406 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 196' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' B' ' 200' ' ' GLY . 91.2 m-20 -62.6 -33.05 74.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 71.209999999999994 109.745 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . 0.449 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 0.0 OUTLIER -54.6 -65.15 1.43 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.17 -0.956 . . . . 75.209999999999994 109.785 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 198' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 36.9 Cg_endo -63.36 -53.44 1.45 Allowed 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.143 1.896 . . . . 75.319999999999993 112.213 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 29.7 mt -66.78 -34.28 77.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.19 -0.944 . . . . 72.25 109.679 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' B' ' 196' ' ' ASP . . . 80.41 -40.08 2.37 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.472 -1.451 . . . . 73.239999999999995 109.472 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 64.6 mt -93.67 137.49 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.273 -1.133 . . . . 54.299999999999997 109.279 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 28.6 p -81.4 134.21 35.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 74.310000000000002 109.361 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 25.9 p -131.3 -7.81 3.78 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.472 -0.767 . . . . 74.400000000000006 109.519 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 3.6 m -105.13 133.45 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.342 -0.848 . . . . 74.099999999999994 109.485 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -99.36 127.32 45.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.346 -0.846 . . . . 75.329999999999998 109.299 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.92 127.68 44.02 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.235 -0.915 . . . . 71.400000000000006 109.24 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' B' ' 211' ' ' GLY . 9.1 t -139.78 139.46 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.262 -0.899 . . . . 63.5 109.423 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -85.33 11.68 9.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.197 -0.94 . . . . 74.450000000000003 109.466 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . 0.429 ' CG ' ' H ' ' B' ' 210' ' ' ARG . 16.5 tpt85 -74.26 -128.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.924 . . . . 74.140000000000001 109.562 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . 0.429 ' H ' ' CG ' ' B' ' 209' ' ' ARG . 14.9 tpp180 -57.58 -42.12 82.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 74.430000000000007 109.696 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' B' ' 207' ' ' VAL . . . -173.8 -118.9 0.52 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.679 -1.368 . . . . 70.109999999999999 109.679 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' B' ' 212' ' ' TYR . 29.8 m-85 -123.93 156.4 36.4 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.566 -0.961 . . . . 74.209999999999994 109.319 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -134.47 145.55 48.94 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.555 -0.716 . . . . 74.299999999999997 109.082 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -115.78 138.47 51.1 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.449 -0.782 . . . . 74.340000000000003 109.178 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.3 p -156.19 166.54 33.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.43 -0.794 . . . . 72.209999999999994 109.219 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -61.44 149.53 83.31 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.176 -0.952 . . . . 72.310000000000002 108.998 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -38.99 144.87 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 122.047 1.831 . . . . 71.010000000000005 112.152 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . 0.512 ' CB ' ' NZ ' ' B' ' 218' ' ' LYS . 4.7 mtpm? -49.91 -64.48 1.22 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.144 -0.972 . . . . 74.349999999999994 109.152 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' B' ' 218' ' ' LYS . 38.7 Cg_endo -64.55 137.5 55.15 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.03 1.82 . . . . 71.319999999999993 111.691 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -176.84 28.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 75.450000000000003 109.351 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 10.1 p -156.53 120.26 4.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 72.219999999999999 109.38 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' B' ' 223' ' ' GLU . 22.5 pt-20 -68.1 -26.69 65.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -0.901 . . . . 74.299999999999997 109.55 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' B' ' 222' ' ' GLU . 69.6 tt0 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.033 -0.984 . . . . 71.129999999999995 109.519 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.585 ' SD ' ' CE2' ' A' ' 25' ' ' PHE . 15.4 ptp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.415 -0.587 . . . . 65.120000000000005 109.415 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.3 mtt85 -140.94 156.23 46.11 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.321 -0.862 . . . . 73.310000000000002 109.283 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.99 130.64 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.643 -0.661 . . . . 71.420000000000002 109.722 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.428 ' C ' ' CD1' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -100.9 125.59 47.47 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.314 -0.995 . . . . 65.219999999999999 108.314 179.27 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 tp -120.51 118.4 30.14 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.606 -0.684 . . . . 71.439999999999998 109.496 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.402 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 8.9 mt -105.14 123.77 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.357 -0.839 . . . . 71.150000000000006 109.056 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -167.42 138.14 2.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.072 -1.018 . . . . 75.340000000000003 109.697 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.64 ' HZ3' ' N ' ' A' ' 32' ' ' SER . 67.1 mmtt -84.32 -26.47 28.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 73.040000000000006 109.257 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -61.66 -154.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.355 -0.84 . . . . 72.420000000000002 109.5 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.1 p -148.83 -50.75 0.16 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.21 -0.932 . . . . 72.340000000000003 109.41 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.5 t -65.38 -39.8 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 74.420000000000002 109.521 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.556 ' CD2' ' HZ3' ' A' ' 97' ' ' LYS . 10.1 mp -63.18 -36.23 82.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 72.010000000000005 109.409 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.55 -35.15 26.57 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.501 -1.84 . . . . 72.140000000000001 108.501 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.94 -43.26 91.77 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 110.182 -1.167 . . . . 72.329999999999998 110.182 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -69.39 -41.17 76.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.939 -1.33 . . . . 72.340000000000003 109.306 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.7 mm -67.09 -40.28 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.825 -1.172 . . . . 74.239999999999995 108.135 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -62.75 -53.83 48.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.456 -0.777 . . . . 71.409999999999997 109.798 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -79.56 -1.0 35.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.176 -0.952 . . . . 75.540000000000006 109.771 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -85.73 -54.26 2.83 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.13 -1.588 . . . . 62.149999999999999 109.13 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pp -71.54 -28.31 63.78 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.4 -1.059 . . . . 74.420000000000002 109.315 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -53.98 -35.82 62.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -0.929 . . . . 74.25 109.124 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.3 t -55.46 -49.1 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.306 -0.871 . . . . 72.109999999999999 109.01 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -58.54 -54.59 45.3 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.689 -0.856 . . . . 73.230000000000004 108.689 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 138.21 36.5 0.15 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.829 -1.309 . . . . 75.540000000000006 109.829 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.585 ' CE2' ' SD ' ' A' ' 1' ' ' MET . 16.9 m-85 -111.99 155.19 24.17 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.374 -1.074 . . . . 74.510000000000005 108.962 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 7.2 mtp -101.97 139.14 38.01 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.19 -1.041 . . . . 64.319999999999993 108.19 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.422 ' O ' ' OD1' ' A' ' 28' ' ' ASP . . . -143.72 158.29 43.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.199 -0.938 . . . . 74.310000000000002 110.368 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 27' ' ' ALA . 87.7 m-20 -136.09 156.5 48.63 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.054 -0.721 . . . . 75.400000000000006 109.054 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 m -104.38 139.9 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.47 -0.937 . . . . 75.129999999999995 108.47 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 p -133.94 164.26 27.69 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.489 -0.757 . . . . 71.420000000000002 109.442 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.451 ' N ' ' OD2' ' A' ' 35' ' ' ASP . 5.6 pt-20 -97.64 -107.41 0.17 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.295 -0.878 . . . . 73.109999999999999 109.875 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.64 ' N ' ' HZ3' ' A' ' 8' ' ' LYS . 50.0 m -79.88 160.86 25.89 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.155 -0.966 . . . . 74.239999999999995 110.041 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.4 mt -48.58 -19.52 0.35 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.395 -0.816 . . . . 71.530000000000001 109.759 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -61.08 -54.47 44.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 74.230000000000004 110.58 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 36' ' ' GLY . 13.4 p-10 -68.57 -31.67 71.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.917 -1.114 . . . . 71.010000000000005 109.317 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.518 ' N ' ' OD1' ' A' ' 35' ' ' ASP . . . -68.77 -42.89 77.59 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.021 -1.632 . . . . 61.409999999999997 109.021 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.486 ' OE2' ' NH2' ' A' ' 61' ' ' ARG . 85.5 tt0 -71.22 -39.24 71.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.353 -1.086 . . . . 74.340000000000003 109.364 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -73.23 -31.81 64.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.971 . . . . 75.329999999999998 109.648 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.1 tp -70.65 -49.85 43.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.236 -0.915 . . . . 74.329999999999998 110.139 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 43' ' ' ARG . 22.8 ptm -63.45 -20.48 65.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.997 -1.064 . . . . 70.319999999999993 109.802 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -65.15 -38.49 90.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.098 -1.001 . . . . 71.219999999999999 109.956 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.8 pt -84.93 -31.33 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.059 -1.026 . . . . 74.409999999999997 110.254 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 40' ' ' MET . 79.5 mtm180 -130.31 153.5 48.59 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.304 -0.872 . . . . 75.409999999999997 109.595 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.954 ' CG ' ' OE2' ' A' ' 143' ' ' GLU . 29.4 m120 -97.93 155.89 16.87 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.251 -0.906 . . . . 75.420000000000002 109.529 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -135.84 155.32 50.51 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.463 -0.773 . . . . 74.230000000000004 109.277 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -96.08 -43.86 7.58 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.154 -0.966 . . . . 75.319999999999993 109.198 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.58 122.47 47.84 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.499 -0.926 . . . . 72.129999999999995 108.499 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.4 m -117.3 97.97 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.581 -0.896 . . . . 72.340000000000003 108.581 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.586 ' SD ' ' N ' ' A' ' 50' ' ' VAL . 0.3 OUTLIER -98.67 134.4 41.65 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.793 -0.818 . . . . 74.109999999999999 108.793 -179.346 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.586 ' N ' ' SD ' ' A' ' 49' ' ' MET . 1.3 p -136.43 125.51 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-O 121.774 0.797 . . . . 71.239999999999995 109.967 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.1 p -94.54 2.66 55.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.565 -0.709 . . . . 73.109999999999999 109.356 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -76.75 142.32 40.47 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.191 -0.943 . . . . 63.399999999999999 109.646 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.508 ' C ' ' H ' ' A' ' 55' ' ' ALA . 97.8 mttt -79.14 -38.52 35.84 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.312 -0.868 . . . . 65.439999999999998 110.212 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -67.93 7.99 0.46 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.051 -1.031 . . . . 73.129999999999995 109.585 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.34 -22.46 57.6 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.376 -0.827 . . . . 64.140000000000001 110.718 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 55' ' ' ALA . 55.1 mt -41.39 -51.24 3.76 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.399 -0.813 . . . . 74.430000000000007 110.361 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 t -67.86 -34.22 76.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.96 -1.088 . . . . 63.229999999999997 108.873 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 55' ' ' ALA . 48.2 t80 -66.81 -63.62 1.03 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.505 -0.747 . . . . 74.439999999999998 109.914 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.5 m -48.16 -34.29 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.795 -1.191 . . . . 74.030000000000001 109.617 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 61' ' ' ARG . 15.0 p -57.69 -56.32 23.45 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.208 -0.932 . . . . 73.540000000000006 109.133 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.637 HH21 ' NZ ' ' A' ' 65' ' ' LYS . 13.3 ptm180 -66.4 -28.73 68.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -1.0 . . . . 73.340000000000003 110.059 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 66' ' ' HIS . 25.1 mm -54.87 -41.42 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.666 -1.271 . . . . 73.349999999999994 107.96 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.517 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 43.4 mmtt -70.84 -40.08 72.58 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.605 -0.838 . . . . 74.420000000000002 109.056 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -67.83 -42.09 82.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 74.549999999999997 109.129 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.637 ' NZ ' HH21 ' A' ' 61' ' ' ARG . 48.6 mtpt -88.48 -14.4 37.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.614 -0.678 . . . . 75.219999999999999 110.076 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 62' ' ' ILE . 73.0 m-70 -155.22 72.17 0.81 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.146 -0.971 . . . . 74.129999999999995 109.342 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.3 p -73.69 -6.96 50.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.912 . . . . 73.239999999999995 109.765 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.2 p -100.19 42.87 1.08 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.27 -0.894 . . . . 71.439999999999998 110.072 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.7 tt -145.07 160.09 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.011 -1.056 . . . . 71.329999999999998 109.6 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t -98.13 130.43 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.212 -0.93 . . . . 73.019999999999996 108.766 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.29 130.75 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.499 -0.751 . . . . 54.210000000000001 109.323 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.513 ' O ' ' SD ' ' A' ' 49' ' ' MET . 8.6 tt -128.0 95.88 4.32 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.599 0.714 . . . . 74.209999999999994 109.202 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.4 p -91.39 164.89 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.005 -1.06 . . . . 74.409999999999997 109.203 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 72.0 m -138.87 169.7 17.31 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.204 -0.935 . . . . 72.310000000000002 109.026 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.498 ' C ' ' H ' ' A' ' 77' ' ' ASN . 1.2 p -175.53 128.52 0.26 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.053 -1.029 . . . . 64.540000000000006 110.086 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 48.7 p30 -67.33 41.6 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.509 -0.744 . . . . 74.129999999999995 109.633 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.498 ' H ' ' C ' ' A' ' 75' ' ' SER . 9.9 p30 -156.32 59.45 1.99 Allowed Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.026 -1.046 . . . . 73.340000000000003 110.449 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.68 76.22 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.145 1.896 . . . . 71.319999999999993 111.148 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.458 ' N ' ' O ' ' A' ' 77' ' ' ASN . 82.3 p -103.64 152.3 21.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.575 -0.703 . . . . 62.530000000000001 109.498 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.52 -34.6 78.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.463 -0.773 . . . . 74.140000000000001 109.27 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -67.04 -44.45 80.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 71.420000000000002 109.281 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -74.51 -31.55 62.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 73.430000000000007 109.383 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.493 ' OE1' ' N ' ' A' ' 84' ' ' VAL . 14.3 tm-20 -58.66 -56.72 18.56 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.225 -0.922 . . . . 74.219999999999999 109.555 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.493 ' N ' ' OE1' ' A' ' 83' ' ' GLU . 27.4 m -62.0 -40.64 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 74.150000000000006 109.29 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -61.13 -38.93 88.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.24 -0.913 . . . . 72.540000000000006 109.381 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.58 86.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 64.219999999999999 109.543 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -72.83 -33.23 66.03 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.417 -0.957 . . . . 74.340000000000003 108.417 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -66.56 -36.93 83.85 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.518 -0.738 . . . . 74.420000000000002 109.143 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -64.4 -49.83 70.01 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.361 -0.837 . . . . 74.519999999999996 109.411 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 142.43 31.88 0.12 Allowed Glycine 0 N--CA 1.498 2.775 0 N-CA-C 110.024 -1.23 . . . . 74.209999999999994 110.024 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.25 131.27 38.52 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.088 -1.242 . . . . 64.099999999999994 109.43 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.517 ' OD1' ' NZ ' ' A' ' 63' ' ' LYS . 42.1 m-20 -78.03 -29.35 49.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.108 -0.995 . . . . 73.420000000000002 109.113 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -149.88 147.59 28.12 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.911 -0.774 . . . . 75.040000000000006 108.911 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.461 ' OH ' ' OG ' ' A' ' 75' ' ' SER . 3.0 t80 -135.54 113.44 11.1 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.446 -0.784 . . . . 71.329999999999998 108.93 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.3 mm -107.35 150.22 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 CA-C-O 122.118 0.961 . . . . 74.510000000000005 110.918 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.95 125.54 25.75 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.51 -1.292 . . . . 64.319999999999993 107.51 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.675 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -45.12 -52.81 18.8 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.036 -1.04 . . . . 74.510000000000005 111.359 -179.061 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 1.6 Cg_endo -40.87 -12.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.112 0 CA-C-N 119.759 0.95 . . . . 73.109999999999999 112.601 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.675 ' N ' ' O ' ' A' ' 97' ' ' LYS . 49.2 m-85 56.69 104.71 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.763 -0.586 . . . . 72.540000000000006 110.383 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.8 ttm-85 -60.65 -39.08 87.0 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.02 -1.104 . . . . 74.540000000000006 108.02 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.1 t -174.45 140.08 0.61 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.916 -0.772 . . . . 74.140000000000001 108.916 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.2 mm -57.95 -37.07 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 75.430000000000007 109.157 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.5 mppt? -64.3 -36.03 82.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 74.140000000000001 109.178 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.31 -48.91 73.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.144 -0.973 . . . . 63.240000000000002 109.406 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -67.82 -55.05 14.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.377 -0.827 . . . . 73.219999999999999 108.906 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 67.6 t -55.03 -49.02 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.932 -1.105 . . . . 74.540000000000006 109.425 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.51 -37.28 65.14 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.169 -0.957 . . . . 75.5 108.91 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.423 ' NH1' ' OE2' ' B' ' 83' ' ' GLU . 11.2 mmt85 -71.38 -30.02 65.63 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.357 -0.839 . . . . 74.409999999999997 109.389 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.67 -30.51 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 107.773 -1.195 . . . . 73.239999999999995 107.773 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -67.58 -52.48 38.1 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.837 -0.801 . . . . 74.340000000000003 108.837 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.444 ' CB ' ' CZ ' ' B' ' 87' ' ' PHE . . . -48.2 -44.09 32.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.446 -0.783 . . . . 73.319999999999993 109.477 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 75.1 mmt-85 -64.61 -32.7 74.47 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.33 -0.856 . . . . 74.420000000000002 109.702 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.1 mt -133.37 75.62 1.62 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.36 -0.837 . . . . 74.329999999999998 110.313 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -92.8 -79.51 0.39 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.089 -1.007 . . . . 74.439999999999998 108.426 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.457 ' CD2' ' O ' ' A' ' 115' ' ' PHE . 26.1 p90 -100.74 49.37 0.89 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.354 -0.841 . . . . 74.430000000000007 109.359 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 75.7 t-105 -67.05 112.58 4.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 74.439999999999998 109.424 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 159.74 111.39 0.29 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.889 -1.284 . . . . 75.040000000000006 109.889 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.416 ' HG ' ' N ' ' A' ' 119' ' ' ASN . 23.2 t -164.17 157.17 17.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -1.14 . . . . 70.109999999999999 109.523 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.595 ' ND2' ' N ' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -152.92 117.12 4.88 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.854 -0.795 . . . . 65.239999999999995 108.854 -178.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.433 HG23 ' OD1' ' A' ' 131' ' ' ASP . 18.7 t -77.63 -39.98 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.327 -0.858 . . . . 74.219999999999999 110.466 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 11.1 mm -104.46 130.36 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.105 -0.997 . . . . 74.420000000000002 109.675 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -129.36 136.36 49.9 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.453 -0.943 . . . . 73.299999999999997 108.453 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.442 ' CG2' ' O ' ' A' ' 123' ' ' ILE . 0.2 OUTLIER -149.99 121.87 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.018 -1.051 . . . . 75.340000000000003 109.599 -179.229 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.96 -129.49 12.23 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.038 -1.225 . . . . 75.129999999999995 110.038 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -93.88 -4.02 50.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.307 -1.114 . . . . 74.450000000000003 109.88 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.67 143.65 26.26 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.141 -0.974 . . . . 54.210000000000001 108.468 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.1 m -132.44 143.67 49.95 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.333 -0.854 . . . . 70.239999999999995 109.524 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.4 mt -134.84 140.38 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.457 -0.777 . . . . 72.430000000000007 109.748 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.1 m -128.31 109.05 19.46 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 108.949 -0.76 . . . . 71.109999999999999 108.949 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.52 -27.49 4.14 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.656 1.571 . . . . 75.140000000000001 111.712 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.433 ' OD1' HG23 ' A' ' 120' ' ' VAL . 1.9 m-20 -69.4 -37.15 77.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 72.5 109.093 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -88.98 -4.33 58.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.33 -0.856 . . . . 73.140000000000001 109.603 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 54.65 62.62 2.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.131 -0.981 . . . . 75.329999999999998 108.972 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -160.67 155.56 24.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.256 -0.903 . . . . 71.230000000000004 109.949 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 4.7 tt -124.94 137.61 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.631 -0.668 . . . . 75.329999999999998 109.349 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 24.9 mm -115.83 133.7 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.709 -0.849 . . . . 71.109999999999999 108.709 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -137.88 119.49 15.01 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.231 -0.918 . . . . 74.140000000000001 108.851 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.5 ' O ' ' CG ' ' A' ' 138' ' ' LYS . 25.4 ttpt 54.71 20.26 2.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.586 -0.696 . . . . 75.400000000000006 109.974 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.59 0.8 66.62 Favored Glycine 0 N--CA 1.499 2.877 0 O-C-N 120.862 -1.149 . . . . 72.239999999999995 110.71 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.498 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 1.9 mpt_? -89.99 124.84 35.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.963 -1.316 . . . . 73.120000000000005 108.645 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -87.9 130.39 34.93 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.245 -0.91 . . . . 72.319999999999993 109.755 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.7 t -138.45 143.13 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.433 -0.792 . . . . 62.340000000000003 109.739 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.954 ' OE2' ' CG ' ' A' ' 44' ' ' ASN . 91.1 mt-10 -95.9 142.16 28.47 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.868 -0.79 . . . . 61.229999999999997 108.868 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.2 m -138.05 137.88 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.147 -0.97 . . . . 74.439999999999998 109.758 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -168.54 41.87 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.287 -0.883 . . . . 75.420000000000002 109.856 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.25 -129.36 4.58 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 108.856 -1.697 . . . . 73.340000000000003 108.856 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.625 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 23.8 mttp -85.79 -32.29 0.45 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.273 -1.134 . . . . 72.219999999999999 110.846 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.778 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 86.9 Cg_endo -86.1 -18.14 3.59 Favored 'Trans proline' 0 N--CA 1.486 1.06 0 C-N-CA 122.06 1.84 . . . . 75.450000000000003 112.247 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -56.34 -48.83 75.97 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.828 -1.175 . . . . 65.239999999999995 107.828 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 172' ' ' ILE . 74.6 mt-10 -75.99 -42.02 49.43 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.053 -1.092 . . . . 72.519999999999996 108.053 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.778 ' HB ' ' HA ' ' A' ' 148' ' ' PRO . 1.1 t -56.27 -46.58 81.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.039 -1.097 . . . . 74.209999999999994 108.039 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 22.3 tp -66.66 -56.72 9.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.623 -0.673 . . . . 73.310000000000002 110.569 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.6 p -58.49 -35.84 72.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.906 -1.121 . . . . 74.310000000000002 110.03 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.411 ' CD2' ' HD2' ' A' ' 158' ' ' HIS . 22.4 t-80 -58.53 -56.94 15.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.003 -1.06 . . . . 75.450000000000003 110.367 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.54 -26.42 62.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.935 -1.103 . . . . 75.340000000000003 109.525 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.05 -44.23 91.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.958 -1.089 . . . . 62.140000000000001 108.592 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -79.67 -57.99 3.41 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.984 0.897 . . . . 72.219999999999999 109.415 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.411 ' HD2' ' CD2' ' A' ' 154' ' ' HIS . 98.0 m-70 -71.69 41.43 0.08 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.912 -0.586 . . . . 74.120000000000005 111.332 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -82.81 166.43 19.01 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.627 -1.296 . . . . 74.340000000000003 109.027 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.441 ' OD1' ' CE2' ' A' ' 216' ' ' TYR . 14.2 m-20 53.49 47.62 23.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.157 -0.964 . . . . 75.450000000000003 109.262 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -154.89 163.58 40.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.348 -0.845 . . . . 73.409999999999997 110.12 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.3 mm -98.64 136.7 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.42 -1.326 . . . . 74.409999999999997 107.42 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.8 148.18 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.996 -1.065 . . . . 72.530000000000001 110.486 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.7 p -97.08 165.47 12.05 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.609 -0.682 . . . . 74.120000000000005 109.685 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -66.95 -44.78 79.72 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.249 -0.907 . . . . 70.430000000000007 110.121 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -56.19 -40.31 73.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 74.319999999999993 109.923 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -58.05 -43.2 86.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.05 -1.031 . . . . 74.519999999999996 109.425 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 11.7 mt -56.47 -43.72 79.88 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.973 -1.08 . . . . 74.409999999999997 108.127 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 5.1 tt -49.16 -56.15 10.12 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.04 -1.038 . . . . 75.140000000000001 109.746 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -54.14 -37.71 64.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.559 -0.713 . . . . 65.030000000000001 112.507 -178.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.65 -32.11 13.54 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 120.531 -1.356 . . . . 70.209999999999994 113.517 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.43 ' O ' ' OE1' ' A' ' 150' ' ' GLU . 1.7 mp -77.88 -51.33 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.628 -1.295 . . . . 75.319999999999993 110.838 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.541 ' CG ' ' O ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -86.43 8.7 20.69 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.66 -1.275 . . . . 73.140000000000001 109.597 -178.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -46.53 -66.67 0.37 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.977 -1.077 . . . . 73.239999999999995 109.79 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.39 -61.57 0.26 Allowed Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.073 -1.017 . . . . 63.329999999999998 109.782 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.59 123.46 10.18 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.967 1.778 . . . . 72.510000000000005 111.265 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -92.36 127.64 37.91 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.872 -1.142 . . . . 75.340000000000003 110.616 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.543 ' HG3' ' CE ' ' A' ' 147' ' ' LYS . 0.0 OUTLIER -173.54 44.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.834 -1.172 . . . . 74.510000000000005 107.834 179.197 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 3.4 t -93.85 145.86 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.449 -0.782 . . . . 65.219999999999999 108.915 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 182' ' ' ASN . 0.4 OUTLIER -150.89 156.24 35.63 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.229 -0.92 . . . . 73.219999999999999 108.686 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -37.8 -24.23 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.362 2.042 . . . . 62.43 112.487 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.503 ' N ' ' O ' ' A' ' 180' ' ' THR . 34.5 m120 -157.91 96.06 1.45 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.073 -1.017 . . . . 73.129999999999995 110.19 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.2 p -148.38 -32.25 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.147 -0.97 . . . . 74.019999999999996 109.325 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 6.0 mm -60.69 -43.27 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.181 -0.95 . . . . 72.329999999999998 109.211 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -64.91 -36.94 86.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 74.400000000000006 109.164 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 20.4 t -71.15 -32.33 47.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.117 -0.989 . . . . 74.319999999999993 109.139 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.39 -52.17 17.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.49 -0.757 . . . . 73.230000000000004 110.658 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 9.2 tp -56.85 -39.11 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.548 -1.345 . . . . 74.310000000000002 110.112 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -63.72 -56.71 13.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.83 -1.169 . . . . 73.439999999999998 110.958 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -65.65 -42.58 91.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.848 -1.158 . . . . 71.420000000000002 110.131 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 66.6 mt -51.72 -35.72 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.808 -1.182 . . . . 72.439999999999998 109.033 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 16.8 mtp-105 -67.29 -54.46 20.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.115 -0.991 . . . . 64.219999999999999 109.689 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -71.21 -14.06 62.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -0.91 . . . . 74.319999999999993 110.992 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.415 ' O ' ' CD ' ' A' ' 198' ' ' PRO . 43.8 mtpt -83.37 -41.24 18.41 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.844 -1.16 . . . . 75.310000000000002 110.709 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' MET . . . . . 1.052 ' HE3' HD21 ' A' ' 199' ' ' LEU . 45.8 mtp -81.83 36.99 0.46 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.095 -1.003 . . . . 74.019999999999996 110.699 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 197' ' ' LYS . 27.4 p30 -110.61 -39.09 4.99 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.12 -0.988 . . . . 74.019999999999996 109.988 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.597 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 5.6 tmtt? -91.23 -40.15 0.39 Allowed Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 120.91 -1.119 . . . . 75.430000000000007 110.065 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 24.4 Cg_exo -63.65 -61.22 0.13 Allowed 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.256 1.971 . . . . 72.319999999999993 111.823 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 1.052 HD21 ' HE3' ' A' ' 195' ' ' MET . 10.8 mp -71.42 -28.8 64.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 74.540000000000006 108.971 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 83.46 -14.9 38.09 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.626 -1.79 . . . . 61.509999999999998 108.626 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 21.2 mt -128.52 137.13 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.841 -0.799 . . . . 74.25 109.073 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 72.8 m -89.74 144.52 25.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.211 -0.93 . . . . 72.0 109.12 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.5 p -146.07 44.68 1.25 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.164 -0.96 . . . . 74.439999999999998 110.288 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 7.9 m -148.66 129.88 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.993 -1.067 . . . . 71.129999999999995 109.23 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -112.14 140.4 46.85 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.687 -0.633 . . . . 73.510000000000005 109.532 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 14.9 t -126.12 131.46 52.07 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.456 -0.778 . . . . 73.519999999999996 109.942 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.7 154.25 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.47 -0.937 . . . . 72.150000000000006 108.47 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -97.03 75.22 2.62 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.103 -0.998 . . . . 72.400000000000006 110.535 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -146.52 -33.22 0.31 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.175 -0.953 . . . . 73.310000000000002 109.249 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -147.3 -60.18 0.28 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.242 -0.911 . . . . 71.540000000000006 109.217 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -163.52 -119.75 0.5 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.517 -1.433 . . . . 74.450000000000003 109.517 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -125.31 152.05 45.21 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.63 -0.923 . . . . 75.540000000000006 109.153 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.92 129.05 48.53 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.545 -0.909 . . . . 75.310000000000002 108.545 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -105.86 126.26 51.96 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.357 -0.839 . . . . 75.409999999999997 109.193 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 44.1 t -149.49 158.59 44.31 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.788 -0.819 . . . . 74.140000000000001 108.788 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . 0.441 ' CE2' ' OD1' ' A' ' 160' ' ' ASP . 8.7 p90 -58.07 150.06 53.07 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.255 -0.903 . . . . 75.319999999999993 109.238 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.36 -41.09 2.65 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.236 1.957 . . . . 73.109999999999999 111.173 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 32.0 pttt -153.56 152.27 27.0 Favored Pre-proline 0 N--CA 1.49 1.559 0 N-CA-C 108.783 -0.821 . . . . 75.25 108.783 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -35.91 105.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.608 2.205 . . . . 75.099999999999994 112.701 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -93.28 100.24 12.63 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.164 -0.96 . . . . 71.140000000000001 109.353 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 22.5 p -159.9 168.35 25.95 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.166 -0.959 . . . . 71.129999999999995 109.957 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -85.3 158.68 20.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.228 -0.92 . . . . 75.349999999999994 109.039 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.989 -1.005 . . . . 73.409999999999997 109.379 -179.895 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 54.4 ttm . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.442 -0.577 . . . . 75.239999999999995 109.442 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 57.5 ttm-85 -139.27 147.61 41.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.419 -0.8 . . . . 73.519999999999996 109.159 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 40.2 t -110.62 137.35 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.682 -0.636 . . . . 72.239999999999995 109.304 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 5.4 tp -113.98 117.55 31.64 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 109.366 -0.605 . . . . 73.340000000000003 109.366 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.39 97.67 5.68 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.171 -1.048 . . . . 74.349999999999994 108.171 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.471 ' CG2' ' O ' ' B' ' 31' ' ' GLU . 65.1 mt -81.97 106.14 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.775 -1.203 . . . . 63.439999999999998 109.168 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.425 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 18.3 tp10 -140.18 129.9 24.43 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.481 -0.762 . . . . 74.519999999999996 109.125 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -64.8 -32.34 73.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 74.129999999999995 109.431 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -83.86 123.59 30.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 74.230000000000004 109.503 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 87.1 p -78.8 -26.68 44.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.263 -0.898 . . . . 65.540000000000006 109.689 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 98.3 t -63.12 -49.09 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 75.549999999999997 109.564 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.585 ' CD1' ' HZ2' ' B' ' 97' ' ' LYS . 3.6 mm? -64.78 -35.2 80.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 70.140000000000001 108.949 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.25 -26.6 71.76 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.314 -1.914 . . . . 75.400000000000006 108.314 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.29 -49.99 62.61 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.652 -1.379 . . . . 65.439999999999998 109.652 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -61.97 -43.91 97.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.285 -1.126 . . . . 72.200000000000003 109.706 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 35.8 mm -67.31 -37.55 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.689 -1.257 . . . . 75.150000000000006 108.702 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -65.97 -42.39 89.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -0.891 . . . . 73.010000000000005 109.355 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -87.43 1.35 53.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.169 -0.957 . . . . 74.299999999999997 109.204 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.57 -58.06 1.99 Allowed Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.361 -1.496 . . . . 70.540000000000006 109.361 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -68.54 -24.82 64.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.308 -1.113 . . . . 75.430000000000007 109.421 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -53.8 -36.01 61.98 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.184 -0.947 . . . . 73.200000000000003 109.447 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 58.0 t -54.52 -47.64 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.268 -0.895 . . . . 74.230000000000004 108.914 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -59.91 -54.89 40.88 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.948 -0.76 . . . . 73.519999999999996 108.948 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 132.9 41.85 0.18 Allowed Glycine 0 N--CA 1.499 2.868 0 N-CA-C 109.719 -1.353 . . . . 53.43 109.719 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -118.46 160.17 22.2 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.445 -1.033 . . . . 71.120000000000005 109.308 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 8.4 mmt -98.86 138.79 35.48 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.287 -1.005 . . . . 75.239999999999995 108.287 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.13 149.78 47.54 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.701 0.762 . . . . 73.25 110.326 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . 0.445 ' OD2' ' NH2' ' B' ' 43' ' ' ARG . 24.1 t70 -133.47 126.5 31.27 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.452 -1.314 . . . . 72.310000000000002 107.452 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 p -117.48 142.58 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.406 -0.809 . . . . 72.140000000000001 110.066 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -134.34 -153.16 0.51 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.751 -0.593 . . . . 74.530000000000001 109.413 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.471 ' O ' ' CG2' ' B' ' 6' ' ' ILE . 1.3 pt-20 -135.36 -87.56 0.36 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.422 -0.799 . . . . 71.019999999999996 109.531 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 61.8 m -79.46 152.03 30.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.963 -1.085 . . . . 71.400000000000006 109.571 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' B' ' 37' ' ' GLU . 43.8 mt -54.2 -41.71 68.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.864 . . . . 71.239999999999995 109.73 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -58.95 -40.8 85.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 74.319999999999993 109.795 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.425 ' OD2' ' OE2' ' B' ' 31' ' ' GLU . 92.7 m-20 -64.02 -40.26 95.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.147 -0.97 . . . . 73.030000000000001 109.212 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . 0.447 ' O ' ' CG ' ' B' ' 40' ' ' MET . . . -82.78 -27.89 40.37 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.642 -1.383 . . . . 60.43 109.642 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' B' ' 33' ' ' LEU . 81.7 tt0 -64.3 -41.32 96.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.188 -1.183 . . . . 74.430000000000007 109.727 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -80.54 -40.48 25.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.114 -0.992 . . . . 74.420000000000002 109.624 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 45.4 tp -68.02 -40.15 83.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 75.409999999999997 109.936 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.516 ' SD ' ' CE1' ' B' ' 45' ' ' TYR . 1.2 ppp? -74.05 -27.15 60.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.131 -0.981 . . . . 61.439999999999998 109.923 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -52.68 -36.07 56.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.167 -0.958 . . . . 74.319999999999993 110.041 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 9.3 pt -93.11 -20.48 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.092 -1.005 . . . . 71.230000000000004 110.314 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.445 ' NH2' ' OD2' ' B' ' 28' ' ' ASP . 34.8 mtm105 -104.71 156.81 17.66 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.192 -0.942 . . . . 73.409999999999997 109.902 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -91.29 167.72 12.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.381 -0.825 . . . . 63.539999999999999 109.035 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.516 ' CE1' ' SD ' ' B' ' 40' ' ' MET . 1.7 p90 -160.25 113.43 2.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.054 -1.029 . . . . 73.109999999999999 109.669 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -84.62 -37.73 20.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 62.219999999999999 108.859 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.406 ' C ' ' CD1' ' B' ' 47' ' ' LEU . 0.7 OUTLIER -109.76 109.46 20.16 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.666 -0.864 . . . . 73.120000000000005 108.666 179.524 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 78.4 t -95.97 111.18 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.604 -0.888 . . . . 74.109999999999999 108.604 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 12.2 ttt -128.18 135.31 49.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.486 -0.759 . . . . 73.439999999999998 109.551 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.521 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.8 OUTLIER -147.12 140.63 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.591 -0.693 . . . . 73.400000000000006 109.506 -179.332 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' SER . . . . . 0.606 ' CB ' ' HG ' ' B' ' 74' ' ' SER . 52.8 p -103.91 13.92 31.81 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.445 -0.784 . . . . 73.209999999999994 109.626 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.521 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 13.5 m-20 -78.34 140.7 38.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.164 -0.96 . . . . 70.409999999999997 109.502 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.419 ' C ' ' H ' ' B' ' 55' ' ' ALA . 29.9 mmtp -72.72 -38.37 67.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.18 -0.95 . . . . 73.129999999999995 110.002 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -74.05 10.19 1.3 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.123 -0.986 . . . . 75.209999999999994 109.663 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.419 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -68.09 -22.72 64.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 55.329999999999998 110.148 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 39.4 mt -43.83 -48.54 8.26 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.34 -0.85 . . . . 72.420000000000002 110.174 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 88.3 p -68.9 -33.82 74.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.926 -1.109 . . . . 73.040000000000006 108.943 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -66.21 -61.96 1.74 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.444 -0.785 . . . . 72.329999999999998 109.779 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.9 m -49.92 -34.59 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.715 -1.24 . . . . 74.540000000000006 109.719 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.5 m -57.81 -51.79 68.14 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.285 -0.884 . . . . 71.239999999999995 109.632 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.57 ' NH2' ' HZ2' ' B' ' 65' ' ' LYS . 10.4 ptm180 -70.71 -27.4 63.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.041 -1.037 . . . . 74.310000000000002 110.132 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' B' ' 66' ' ' HIS . 29.9 mm -63.17 -53.78 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.743 -1.223 . . . . 75.420000000000002 109.181 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.428 ' O ' ' OG ' ' B' ' 67' ' ' SER . 27.3 mmtp -59.73 -36.93 77.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.98 -1.075 . . . . 73.319999999999993 109.112 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -75.04 -38.16 61.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.365 -0.835 . . . . 73.310000000000002 109.477 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.57 ' HZ2' ' NH2' ' B' ' 61' ' ' ARG . 92.1 mttt -88.71 -18.46 27.81 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.166 -0.959 . . . . 72.439999999999998 110.722 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' B' ' 62' ' ' ILE . 77.7 m-70 -156.47 67.55 0.57 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.852 -1.155 . . . . 65.209999999999994 109.874 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' B' ' 63' ' ' LYS . 7.5 m -58.75 -29.18 66.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.277 -0.889 . . . . 73.099999999999994 109.553 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 86.4 p -66.56 -27.66 67.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.285 -0.885 . . . . 71.530000000000001 110.311 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 72.7 mt -79.42 157.34 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.022 -1.049 . . . . 74.400000000000006 109.592 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 87.2 t -94.62 160.68 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.284 -0.885 . . . . 75.120000000000005 109.891 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 t -136.22 133.28 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.296 -0.877 . . . . 73.200000000000003 108.908 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.611 ' CD1' HH22 ' B' ' 108' ' ' ARG . 1.0 OUTLIER -133.52 104.67 6.5 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.752 0.787 . . . . 73.340000000000003 109.385 -179.21 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 84.3 t -92.26 130.39 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.928 . . . . 73.5 109.552 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.606 ' HG ' ' CB ' ' B' ' 51' ' ' SER . 11.8 p -89.79 170.33 10.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.038 . . . . 71.319999999999993 108.212 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 18.8 p -157.43 110.83 2.54 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.757 -1.214 . . . . 74.530000000000001 110.329 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -64.97 -34.41 78.37 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.428 -0.953 . . . . 64.5 108.428 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -109.87 75.54 0.86 Allowed Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 108.527 -0.916 . . . . 74.25 108.527 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.2 86.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 121.889 1.726 . . . . 74.430000000000007 112.198 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 1.6 t -105.53 150.93 24.91 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.571 -0.9 . . . . 73.120000000000005 108.571 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -32.63 74.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.112 -0.992 . . . . 75.409999999999997 109.475 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.56 -42.32 87.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 72.239999999999995 109.588 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -74.46 -26.78 60.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 73.219999999999999 109.327 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.423 ' OE2' ' NH1' ' A' ' 108' ' ' ARG . 86.7 tt0 -68.71 -51.33 42.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 74.299999999999997 109.804 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 29.4 m -63.28 -39.1 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.103 -0.998 . . . . 73.310000000000002 109.507 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -77.05 -21.07 55.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 73.239999999999995 109.41 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.15 -48.34 65.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.22 -0.925 . . . . 55.329999999999998 109.852 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' PHE . . . . . 0.444 ' CZ ' ' CB ' ' A' ' 111' ' ' ALA . 80.7 t80 -76.28 -33.0 59.1 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.988 -1.07 . . . . 74.450000000000003 108.963 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -62.15 -51.02 69.51 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.361 -0.837 . . . . 64.040000000000006 109.195 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -58.88 -49.79 76.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.53 -0.731 . . . . 75.129999999999995 109.831 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 153.23 35.87 0.03 OUTLIER Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.775 -1.202 . . . . 75.420000000000002 110.162 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -99.47 125.49 45.22 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.245 -1.15 . . . . 73.420000000000002 109.154 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -71.08 -33.39 70.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.046 -1.034 . . . . 73.319999999999993 108.941 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 36.2 t0 -153.13 164.93 37.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.513 -0.742 . . . . 73.040000000000006 109.191 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.531 ' CD1' ' O ' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -139.59 115.47 10.2 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.108 -0.701 . . . . 74.310000000000002 109.108 -178.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 29.1 mm -113.17 144.82 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 O-C-N 121.326 -0.859 . . . . 75.340000000000003 110.013 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.64 135.18 57.53 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.042 -1.096 . . . . 70.099999999999994 108.042 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.684 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -55.67 -56.42 29.98 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 120.984 -1.072 . . . . 65.430000000000007 111.46 -178.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 6.0 Cg_endo -42.33 -7.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 120.871 1.047 . . . . 63.520000000000003 112.945 -176.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . 0.684 ' N ' ' O ' ' B' ' 97' ' ' LYS . 68.8 m-85 60.44 115.17 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.661 -0.649 . . . . 75.129999999999995 109.475 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -56.57 -28.18 59.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.117 -0.989 . . . . 74.230000000000004 109.422 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' SER . . . . . 0.742 ' O ' ' N ' ' B' ' 103' ' ' LYS . 30.2 t -174.51 30.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.003 -1.061 . . . . 64.510000000000005 110.7 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 55.1 mt 52.29 -69.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.641 -0.662 . . . . 74.439999999999998 110.283 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . 0.742 ' N ' ' O ' ' B' ' 101' ' ' SER . 29.7 mmtp -59.62 -28.4 67.16 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.331 -0.989 . . . . 72.299999999999997 108.331 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.97 -44.8 91.64 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.462 -0.895 . . . . 74.310000000000002 108.595 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.55 ' CD2' ' NH2' ' B' ' 108' ' ' ARG . 1.3 tm? -57.19 -55.38 35.53 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.869 -0.789 . . . . 73.540000000000006 108.869 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.28 -39.24 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.749 -1.22 . . . . 72.030000000000001 109.741 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -47.7 -44.19 27.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 64.219999999999999 110.265 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 0.611 HH22 ' CD1' ' B' ' 72' ' ' LEU . 13.9 ptt85 -79.96 -31.03 39.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.988 -1.07 . . . . 75.310000000000002 110.707 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 34.5 mt -71.77 -30.43 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.494 -1.379 . . . . 55.439999999999998 108.264 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' B' ' 113' ' ' LEU . 21.0 tt0 -72.85 -60.59 2.16 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.402 -0.919 . . . . 65.310000000000002 108.972 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -43.33 -44.66 5.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.68 -0.638 . . . . 74.519999999999996 109.981 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 64.9 ttp85 -66.13 -34.81 78.89 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.221 -0.925 . . . . 72.040000000000006 109.391 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' B' ' 110' ' ' GLU . 7.1 tp -97.24 -75.09 0.55 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.228 -0.92 . . . . 75.349999999999994 110.365 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' B' ' 113' ' ' LEU . 83.3 mtt180 47.14 96.55 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.278 -0.889 . . . . 75.5 109.571 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 45.46 86.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.524 -0.735 . . . . 73.040000000000006 110.076 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 81.4 t90 -59.04 146.92 36.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.872 . . . . 74.450000000000003 109.298 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 161.12 101.16 0.16 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.734 -1.346 . . . . 64.209999999999994 109.734 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 83.3 p -157.03 161.26 39.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.252 -1.146 . . . . 71.400000000000006 109.692 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.42 -177.57 5.73 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.784 -0.766 . . . . 74.209999999999994 109.151 -178.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 6.0 t -144.43 -36.92 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.31 -0.869 . . . . 75.019999999999996 109.303 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 47.5 mt -111.51 125.83 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.507 -0.745 . . . . 74.239999999999995 109.201 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -138.97 120.43 14.98 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.266 -0.896 . . . . 73.329999999999998 109.2 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 19.0 pt -154.98 142.79 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.16 -0.962 . . . . 74.219999999999999 109.778 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . 0.516 ' C ' ' H ' ' B' ' 126' ' ' LEU . . . 51.12 39.22 41.29 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.444 -1.062 . . . . 72.409999999999997 110.444 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 69.06 -13.88 0.33 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.303 -1.116 . . . . 75.120000000000005 109.935 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.516 ' H ' ' C ' ' B' ' 124' ' ' GLY . 1.1 mt -82.37 144.3 30.64 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.769 -1.197 . . . . 75.420000000000002 107.769 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 92.3 m -128.65 144.18 51.1 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.375 -0.828 . . . . 74.219999999999999 109.738 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 7.6 mt -141.06 140.93 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.434 -0.791 . . . . 60.329999999999998 109.519 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 70.5 m -117.92 123.64 29.43 Favored Pre-proline 0 N--CA 1.5 2.054 0 N-CA-C 108.965 -0.754 . . . . 72.310000000000002 108.965 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.27 -40.1 0.29 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.821 1.681 . . . . 75.129999999999995 112.196 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -66.42 -44.57 82.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.175 -0.953 . . . . 75.230000000000004 109.943 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . 0.5 ' N ' ' OE1' ' B' ' 132' ' ' GLU . 35.6 mp0 -84.85 -5.15 59.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.197 -0.939 . . . . 75.120000000000005 109.818 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 48.53 72.03 0.31 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.206 -0.934 . . . . 75.129999999999995 109.764 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -152.39 142.53 22.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.312 -0.867 . . . . 75.109999999999999 109.369 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 15.8 tt -115.49 132.19 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.436 -0.79 . . . . 70.319999999999993 109.125 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 61.9 mt -117.22 130.79 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 109.069 -0.715 . . . . 74.120000000000005 109.069 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -132.6 130.83 40.76 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.441 -0.787 . . . . 74.230000000000004 109.505 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . 0.516 ' O ' ' NH1' ' B' ' 140' ' ' ARG . 24.5 mmtm 53.55 32.82 14.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.307 -0.87 . . . . 74.219999999999999 110.49 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.25 -4.55 71.35 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 120.049 -1.072 . . . . 74.319999999999993 110.882 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . 0.516 ' NH1' ' O ' ' B' ' 138' ' ' LYS . 11.2 mpt_? -87.74 134.59 33.64 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.817 -1.402 . . . . 75.340000000000003 108.842 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -102.11 122.92 45.07 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.385 -0.822 . . . . 71.230000000000004 110.034 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 13.5 p -137.78 137.56 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.529 -0.915 . . . . 70.430000000000007 108.529 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -90.2 143.3 26.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.272 -0.893 . . . . 72.430000000000007 110.344 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 21.5 m -146.57 121.42 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.217 -1.031 . . . . 72.129999999999995 108.217 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . 0.409 ' CB ' ' HZ1' ' B' ' 145' ' ' LYS . 7.1 mtmm -139.68 126.48 20.72 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.18 -0.95 . . . . 74.5 109.484 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.16 171.39 33.17 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.473 -1.451 . . . . 42.229999999999997 109.473 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 0.873 ' HD3' ' OE1' ' B' ' 175' ' ' GLU . 11.4 mttm -67.75 -38.81 15.87 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.235 -1.156 . . . . 73.299999999999997 109.886 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 30.0 Cg_exo -60.89 -38.14 71.94 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.265 1.977 . . . . 71.329999999999998 112.211 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -88.53 -17.83 29.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.237 -0.914 . . . . 74.230000000000004 109.732 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -54.34 -38.29 65.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 72.340000000000003 109.479 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 10.9 p -67.93 -38.68 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 73.349999999999994 109.74 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 31.3 tp -55.38 -47.07 76.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.91 . . . . 74.430000000000007 109.542 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 60.4 p -68.27 -32.23 72.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.165 -0.96 . . . . 75.209999999999994 109.619 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . 0.561 ' CE1' ' HD1' ' B' ' 158' ' ' HIS . 56.9 t-80 -56.67 -58.99 5.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.849 . . . . 73.040000000000006 110.339 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 pp -69.18 -22.73 63.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.082 -1.012 . . . . 73.430000000000007 109.923 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.92 -39.88 86.99 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.18 -0.95 . . . . 75.319999999999993 109.198 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -85.24 -34.59 21.94 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.181 -0.95 . . . . 73.319999999999993 109.758 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . 0.561 ' HD1' ' CE1' ' B' ' 154' ' ' HIS . 36.5 m80 -87.41 40.14 0.91 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.143 -0.973 . . . . 74.140000000000001 109.786 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -55.3 151.1 10.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 73.420000000000002 109.342 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' B' ' 214' ' ' PHE . 64.3 t0 52.28 68.18 0.86 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 72.099999999999994 109.592 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -160.1 147.32 16.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.144 -0.972 . . . . 73.239999999999995 109.797 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 12.2 mm -91.29 134.73 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.432 -0.951 . . . . 72.310000000000002 108.432 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 48.3 t -135.96 135.74 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.245 -0.909 . . . . 75.030000000000001 110.021 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 10.8 t -89.19 155.65 19.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.426 -0.796 . . . . 74.219999999999999 109.343 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -55.41 -31.68 62.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.385 -0.822 . . . . 72.420000000000002 109.794 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -57.29 -39.14 75.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 63.450000000000003 110.26 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -62.95 -43.43 98.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.012 -1.055 . . . . 72.400000000000006 109.8 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 20.0 mt -55.26 -59.09 5.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.15 -0.969 . . . . 72.319999999999993 109.102 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.418 ' C ' ' CD1' ' B' ' 169' ' ' LEU . 1.6 tm? -54.7 -65.33 0.6 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.078 -1.014 . . . . 73.340000000000003 109.284 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -46.4 -36.25 6.31 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 112.949 0.722 . . . . 73.099999999999994 112.949 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.05 -30.97 14.41 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.595 -1.316 . . . . 62.130000000000003 113.214 -176.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.416 ' N ' ' CD1' ' B' ' 172' ' ' ILE . 1.3 mp -84.94 -58.58 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 120.433 -1.417 . . . . 74.439999999999998 111.208 -177.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' TRP . . . . . 0.586 ' O ' ' CE3' ' B' ' 173' ' ' TRP . 0.0 OUTLIER -64.99 131.47 46.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.609 -1.307 . . . . 72.230000000000004 109.76 -178.463 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . 0.402 ' H ' ' HD2' ' B' ' 176' ' ' PRO . 87.1 tt0 -175.97 -31.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.529 -0.732 . . . . 75.030000000000001 109.734 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . 0.873 ' OE1' ' HD3' ' B' ' 147' ' ' LYS . 4.0 mp0 -87.44 -34.71 0.45 Allowed Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.067 -1.021 . . . . 73.040000000000006 111.613 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' B' ' 175' ' ' GLU . 96.7 Cg_endo -90.34 -44.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 122.319 2.013 . . . . 74.129999999999995 112.327 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 49.14 12.22 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 72.439999999999998 109.751 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 178' ' ' MET . . . . . 0.508 ' H ' ' C ' ' B' ' 176' ' ' PRO . 11.2 tpt -112.11 3.29 17.21 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.45 -0.945 . . . . 72.109999999999999 108.45 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 19.0 m -76.16 148.99 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.384 -0.823 . . . . 75.310000000000002 109.66 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 180' ' ' THR . . . . . 0.473 ' O ' ' N ' ' B' ' 182' ' ' ASN . 0.9 OUTLIER -60.86 155.5 52.51 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 108.604 -0.887 . . . . 62.149999999999999 108.604 179.57 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.06 43.84 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.451 2.101 . . . . 74.340000000000003 112.024 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 182' ' ' ASN . . . . . 0.523 ' C ' ' H ' ' B' ' 184' ' ' ILE . 43.4 t30 -170.4 -106.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.105 -0.997 . . . . 72.310000000000002 109.297 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 5.5 t 61.99 -3.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.454 -0.779 . . . . 65.420000000000002 109.818 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.523 ' H ' ' C ' ' B' ' 182' ' ' ASN . 28.5 mt -69.63 -38.11 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.904 -1.123 . . . . 75.030000000000001 108.425 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -55.23 -53.3 57.74 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.822 -0.549 . . . . 73.519999999999996 109.759 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 30.7 m -73.28 -31.75 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.121 -0.987 . . . . 74.349999999999994 110.02 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.44 -56.61 13.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.058 -1.027 . . . . 61.119999999999997 109.848 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 10.8 tp -63.01 -29.75 47.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.898 -1.126 . . . . 72.430000000000007 109.421 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -68.9 -56.0 9.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 75.420000000000002 110.186 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . 0.409 ' O ' ' CB ' ' B' ' 194' ' ' LYS . 15.7 pt20 -66.14 -39.78 90.12 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.001 -1.062 . . . . 74.140000000000001 109.35 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 55.6 mt -54.65 -37.71 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.985 -1.072 . . . . 74.030000000000001 109.528 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -68.03 -52.85 30.76 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.074 -1.016 . . . . 72.329999999999998 110.48 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 193' ' ' GLN . . . . . 0.41 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 45.8 mt-30 -76.88 -14.25 59.9 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.999 -1.063 . . . . 73.099999999999994 110.113 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' B' ' 190' ' ' GLN . 53.4 tttp -92.43 -27.42 17.49 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.388 -0.82 . . . . 74.430000000000007 110.445 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 195' ' ' MET . . . . . 0.431 ' C ' ' SD ' ' B' ' 195' ' ' MET . 1.9 ppp? -90.56 -30.93 16.93 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.068 -1.02 . . . . 74.329999999999998 109.812 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 196' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 28.0 p-10 -58.87 -32.71 69.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.981 . . . . 71.209999999999994 109.747 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . 0.51 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 7.6 mmtp -63.03 -64.91 2.49 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 75.209999999999994 109.935 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 198' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 33.0 Cg_endo -61.96 -53.07 2.3 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.185 1.924 . . . . 75.319999999999993 112.352 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' B' ' 201' ' ' ILE . 10.0 mp -65.58 -40.23 92.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.031 -1.043 . . . . 72.25 109.324 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 77.72 -40.16 1.81 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.574 -1.411 . . . . 73.239999999999995 109.574 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . 0.418 ' H ' ' C ' ' B' ' 199' ' ' LEU . 19.1 mm -97.65 146.25 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.24 -1.153 . . . . 54.299999999999997 109.478 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 38.8 t -85.75 141.07 29.96 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.23 -0.919 . . . . 74.310000000000002 109.245 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 13.8 p -142.7 18.22 2.0 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.181 -0.949 . . . . 74.400000000000006 109.904 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 21.9 m -140.7 137.05 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.189 -0.944 . . . . 74.099999999999994 109.437 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -116.34 135.68 53.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.576 -0.703 . . . . 75.329999999999998 109.342 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 1.4 p -93.59 132.23 38.11 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.174 -0.954 . . . . 71.400000000000006 108.946 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 25.5 t -138.92 143.66 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.331 -0.856 . . . . 63.5 109.539 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 208' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' B' ' 209' ' ' ARG . 91.4 mtt180 -60.07 164.89 3.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 74.450000000000003 109.611 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' B' ' 211' ' ' GLY . 80.4 mtm-85 52.46 176.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.868 . . . . 74.140000000000001 109.62 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 17.0 mmt85 53.85 -85.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.466 -0.771 . . . . 74.430000000000007 109.672 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' B' ' 209' ' ' ARG . . . 164.12 -96.66 0.14 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.482 -1.447 . . . . 70.109999999999999 109.482 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' TYR . . . . . 0.481 ' CD1' ' C ' ' B' ' 211' ' ' GLY . 52.8 m-85 -141.28 167.77 21.37 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.362 -1.081 . . . . 74.209999999999994 109.126 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -132.58 140.37 48.22 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.411 -0.806 . . . . 74.299999999999997 109.654 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . 0.512 ' O ' ' N ' ' B' ' 160' ' ' ASP . 2.3 m-85 -116.41 125.38 51.96 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.942 -0.762 . . . . 74.340000000000003 108.942 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . 0.592 ' HG ' ' N ' ' B' ' 216' ' ' TYR . 30.5 t -147.9 167.56 24.52 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.336 -0.852 . . . . 72.209999999999994 109.314 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . 0.592 ' N ' ' HG ' ' B' ' 215' ' ' CYS . 3.2 p90 -60.0 152.67 59.45 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.284 -0.885 . . . . 72.310000000000002 109.116 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.18 124.1 10.59 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.357 2.038 . . . . 71.010000000000005 112.044 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . 0.638 ' N ' ' CD ' ' B' ' 219' ' ' PRO . 8.1 tptp -74.54 -35.62 2.23 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.2 -0.937 . . . . 74.349999999999994 110.356 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' B' ' 218' ' ' LYS . 32.1 Cg_exo -58.32 -22.0 55.6 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.076 1.851 . . . . 71.319999999999993 112.144 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -72.61 121.62 20.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 75.450000000000003 109.54 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 43.1 t -88.1 134.18 33.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.315 -0.866 . . . . 72.219999999999999 109.432 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -85.13 134.76 34.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 74.299999999999997 109.385 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.055 -0.974 . . . . 71.129999999999995 109.407 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.8 ttm . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.399 -0.593 . . . . 65.120000000000005 109.399 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -137.62 146.1 43.53 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.436 -0.79 . . . . 73.310000000000002 109.305 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 79.2 t -115.81 133.32 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-O 121.451 0.643 . . . . 71.420000000000002 109.746 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.4 tp -103.48 116.95 33.35 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.417 -0.957 . . . . 65.219999999999999 108.417 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 59.0 tp -117.33 114.54 23.73 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.918 -0.771 . . . . 71.439999999999998 108.918 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 52.4 mt -109.41 116.29 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.851 -0.796 . . . . 71.150000000000006 108.851 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 13' ' ' GLY . 61.7 tt0 -146.7 131.11 17.62 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.334 -0.854 . . . . 75.340000000000003 109.425 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -61.98 -35.78 79.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 73.040000000000006 109.58 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -86.23 116.85 24.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 72.420000000000002 109.492 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.4 p -73.12 -27.29 61.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.917 . . . . 72.340000000000003 109.623 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.7 t -63.75 -49.57 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.184 -0.948 . . . . 74.420000000000002 109.673 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' A' ' 12' ' ' LEU . 3.5 mm? -67.83 -42.29 81.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.928 . . . . 72.010000000000005 109.128 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.51 ' N ' ' OE1' ' A' ' 7' ' ' GLU . . . -67.19 -19.79 70.57 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.354 -1.898 . . . . 72.140000000000001 108.354 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.38 -58.88 5.68 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.457 -1.457 . . . . 72.329999999999998 109.457 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -52.84 -42.78 65.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.399 -1.059 . . . . 72.340000000000003 109.464 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.3 mm -64.05 -38.65 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.943 -1.098 . . . . 74.239999999999995 108.807 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.42 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 72.6 tt0 -62.83 -52.49 62.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.837 . . . . 71.409999999999997 109.818 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -81.63 1.96 31.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -0.949 . . . . 75.540000000000006 109.632 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.24 -68.12 1.32 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.159 -1.576 . . . . 62.149999999999999 109.159 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp -56.16 -25.93 48.5 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.417 -1.049 . . . . 74.420000000000002 109.088 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 2.6 m120 -52.09 -33.95 41.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.305 -0.872 . . . . 74.25 109.212 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.3 t -55.52 -41.4 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 72.109999999999999 109.022 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.419 ' HZ3' ' CG1' ' A' ' 106' ' ' VAL . 2.1 mptm? -67.35 -22.58 65.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.358 -0.838 . . . . 73.230000000000004 108.994 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.14 38.42 4.32 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.153 -1.179 . . . . 75.540000000000006 110.153 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -112.74 159.33 19.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.413 -1.051 . . . . 74.510000000000005 108.62 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.0 mmt -99.63 138.55 36.56 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.304 -0.998 . . . . 64.319999999999993 108.304 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.13 160.51 40.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.902 . . . . 74.310000000000002 109.995 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -134.92 141.35 46.28 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.967 -0.753 . . . . 75.400000000000006 108.967 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -110.43 130.54 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.727 -0.842 . . . . 75.129999999999995 108.727 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.1 p -135.0 167.63 20.58 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.499 -0.75 . . . . 71.420000000000002 109.251 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.459 ' CG ' ' OD2' ' A' ' 35' ' ' ASP . 3.4 pt-20 -90.68 -99.86 0.1 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.245 -0.909 . . . . 73.109999999999999 109.564 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.0 p -78.77 166.59 22.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -0.867 . . . . 74.239999999999995 109.997 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 15.5 mt -56.02 -32.04 63.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.611 -0.68 . . . . 71.530000000000001 110.032 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -50.58 -45.83 57.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.031 -1.043 . . . . 74.230000000000004 109.793 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.459 ' OD2' ' CG ' ' A' ' 31' ' ' GLU . 67.9 m-20 -68.25 -43.05 78.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.054 -1.029 . . . . 71.010000000000005 109.364 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.43 -40.47 79.46 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.386 -1.486 . . . . 61.409999999999997 109.386 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -65.11 -38.92 92.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -1.113 . . . . 74.340000000000003 109.419 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -75.61 -36.73 60.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 75.329999999999998 109.48 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.7 tp -71.42 -45.76 61.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 74.329999999999998 109.905 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.444 ' O ' ' O ' ' A' ' 43' ' ' ARG . 3.2 ppp? -69.08 -20.37 64.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.074 -1.016 . . . . 70.319999999999993 109.857 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -60.73 -36.95 80.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.022 -1.049 . . . . 71.219999999999999 109.611 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.403 HD12 HG21 ' A' ' 42' ' ' ILE . 17.4 pt -89.23 -27.58 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.18 -0.95 . . . . 74.409999999999997 110.317 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 40' ' ' MET . 96.9 mtt180 -127.82 146.03 50.74 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.298 -0.877 . . . . 75.409999999999997 109.771 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -98.61 132.05 44.32 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.231 -0.918 . . . . 75.420000000000002 109.475 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -101.9 135.16 43.93 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.36 -0.838 . . . . 74.230000000000004 109.343 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -74.75 -35.26 62.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.948 . . . . 75.319999999999993 108.969 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.404 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 0.7 OUTLIER -112.72 115.8 29.11 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.426 -0.953 . . . . 72.129999999999995 108.426 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.2 t -99.11 97.04 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.27 -1.011 . . . . 72.340000000000003 108.27 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.2 ttt -109.22 134.07 52.22 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.536 0.684 . . . . 74.109999999999999 109.611 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 p -143.96 131.66 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.461 -0.775 . . . . 71.239999999999995 109.505 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.3 p -96.99 2.97 52.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.501 -0.749 . . . . 73.109999999999999 109.125 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -76.26 142.23 41.45 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.269 -0.895 . . . . 63.399999999999999 109.54 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.548 ' NZ ' ' H ' ' A' ' 76' ' ' ASP . 66.0 mmtt -79.07 -39.36 34.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 65.439999999999998 110.198 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -72.17 15.0 0.18 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.082 -1.011 . . . . 73.129999999999995 109.733 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.502 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.52 -19.75 59.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 64.140000000000001 110.411 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.629 ' CD1' ' HE2' ' A' ' 85' ' ' HIS . 22.0 mt -40.66 -50.22 3.05 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.428 -0.795 . . . . 74.430000000000007 110.473 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.0 m -68.14 -34.69 76.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.087 . . . . 63.229999999999997 109.262 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.414 ' N ' ' O ' ' A' ' 55' ' ' ALA . 55.9 t80 -65.81 -56.08 13.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -0.794 . . . . 74.439999999999998 110.115 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.6 m -54.57 -35.38 31.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 120.749 -1.219 . . . . 74.030000000000001 109.662 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.6 t -57.4 -54.48 46.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.097 -1.002 . . . . 73.540000000000006 109.655 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 ptp85 -66.05 -29.26 69.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.119 -0.988 . . . . 73.340000000000003 110.092 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.6 mm -65.63 -38.21 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.751 -1.218 . . . . 73.349999999999994 109.898 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.521 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 33.5 mmtt -69.63 -50.51 43.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.107 -0.996 . . . . 74.420000000000002 110.117 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -67.39 -35.46 79.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.762 -1.211 . . . . 74.549999999999997 109.767 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.471 ' C ' ' CG ' ' A' ' 66' ' ' HIS . 48.7 mtpt -81.77 -23.43 36.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.196 -0.94 . . . . 75.219999999999999 109.607 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.471 ' CG ' ' C ' ' A' ' 65' ' ' LYS . 59.4 m-70 -155.26 65.03 0.63 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.168 -0.957 . . . . 74.129999999999995 109.632 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 63' ' ' LYS . 33.1 t -61.06 -30.36 70.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.25 -0.906 . . . . 73.239999999999995 110.017 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.4 t -61.9 -19.83 63.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.958 . . . . 71.439999999999998 110.198 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 78.8 mt -87.81 152.97 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.1 -1.0 . . . . 71.329999999999998 109.945 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.3 t -92.95 160.63 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.351 -0.843 . . . . 73.019999999999996 109.518 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.2 t -134.59 129.81 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.348 -0.845 . . . . 54.210000000000001 109.898 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.2 tt -122.39 99.05 6.21 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.884 -0.784 . . . . 74.209999999999994 108.884 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.0 t -92.22 127.45 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.167 -0.958 . . . . 74.409999999999997 108.825 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.412 ' O ' ' OG ' ' A' ' 75' ' ' SER . 0.4 OUTLIER -92.97 -176.25 4.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.019 -1.051 . . . . 72.310000000000002 108.805 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.463 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 55.7 m -166.75 119.83 1.01 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.792 -1.193 . . . . 64.540000000000006 110.502 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.548 ' H ' ' NZ ' ' A' ' 53' ' ' LYS . 50.4 t0 -61.65 -32.33 72.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.541 -0.725 . . . . 74.129999999999995 109.807 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 79' ' ' THR . 44.8 t-20 -119.78 84.06 30.5 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.583 -0.698 . . . . 73.340000000000003 109.242 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -54.19 82.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.208 1.939 . . . . 71.319999999999993 111.341 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 77' ' ' ASN . 3.4 t -105.22 154.74 19.81 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.519 -0.738 . . . . 62.530000000000001 109.589 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.56 -32.61 73.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.402 -0.811 . . . . 74.140000000000001 109.78 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -55.08 -55.91 25.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 71.420000000000002 110.009 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.534 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 95.4 mt-10 -64.6 -35.39 80.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -0.957 . . . . 73.430000000000007 109.796 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.52 ' OE2' ' NH2' ' B' ' 108' ' ' ARG . 66.9 tt0 -63.91 -48.98 74.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.049 -1.032 . . . . 74.219999999999999 110.068 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.5 t -57.2 -57.56 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.167 -0.958 . . . . 74.150000000000006 110.313 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.629 ' HE2' ' CD1' ' A' ' 56' ' ' LEU . 1.3 p-80 -64.83 -41.11 96.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.942 -1.099 . . . . 72.540000000000006 109.515 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.57 ' N ' ' ND1' ' A' ' 85' ' ' HIS . . . -46.93 -37.69 9.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 64.219999999999999 109.833 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -78.43 -34.32 47.96 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.103 -0.998 . . . . 74.340000000000003 108.761 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -67.5 -40.47 85.18 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.414 -0.914 . . . . 74.420000000000002 109.432 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.571 ' NE2' ' N ' ' A' ' 89' ' ' GLN . 0.7 OUTLIER -65.14 -56.88 10.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 74.519999999999996 109.614 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 152.13 44.58 0.02 OUTLIER Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.724 -1.227 . . . . 74.209999999999994 110.249 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -96.2 133.28 40.7 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.083 -1.245 . . . . 64.099999999999994 109.222 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.521 ' OD2' ' NZ ' ' A' ' 63' ' ' LYS . 72.7 m-20 -90.96 -22.53 20.79 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.085 -1.009 . . . . 73.420000000000002 109.677 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 94' ' ' TYR . 18.7 t0 -149.61 154.81 39.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.22 -0.925 . . . . 75.040000000000006 109.265 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.516 ' N ' ' OD1' ' A' ' 93' ' ' ASP . 71.3 t80 -136.86 105.65 5.88 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.522 -0.736 . . . . 71.329999999999998 109.257 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 27.0 mm -111.47 155.69 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 O-C-N 121.127 -0.983 . . . . 74.510000000000005 110.735 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.4 128.73 36.27 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.657 -1.238 . . . . 64.319999999999993 107.657 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.687 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -50.83 -57.28 14.04 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.715 -1.241 . . . . 74.510000000000005 111.399 -178.496 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 5.2 Cg_endo -41.5 -9.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.066 1.177 . . . . 73.109999999999999 112.797 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.687 ' N ' ' O ' ' A' ' 97' ' ' LYS . 24.9 m-85 62.81 108.66 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.339 -0.615 . . . . 72.540000000000006 109.339 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.526 ' NH1' ' OE2' ' B' ' 83' ' ' GLU . 21.6 ttm105 -52.81 -33.26 48.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.848 -1.157 . . . . 74.540000000000006 108.374 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 103' ' ' LYS . 2.3 m 172.37 48.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.552 -0.717 . . . . 74.140000000000001 109.524 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 105' ' ' LEU . 13.1 mt 37.6 -77.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 121.835 -0.541 . . . . 75.430000000000007 111.982 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.692 ' N ' ' O ' ' A' ' 101' ' ' SER . 28.0 mmtp -38.03 -38.8 0.34 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.533 -0.729 . . . . 74.140000000000001 110.26 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.84 -43.51 68.37 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.206 -1.035 . . . . 63.240000000000002 108.206 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 102' ' ' ILE . 1.2 tt -60.85 -44.81 96.48 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.684 -0.858 . . . . 73.219999999999999 108.684 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.419 ' CG1' ' HZ3' ' A' ' 23' ' ' LYS . 15.6 t -69.43 -43.08 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 74.540000000000006 109.619 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.61 -42.61 62.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 75.5 109.174 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.75 -35.94 77.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 74.409999999999997 109.015 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.0 mt -70.87 -30.32 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.951 -1.093 . . . . 73.239999999999995 108.677 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -62.24 -53.47 54.71 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.381 -0.825 . . . . 74.340000000000003 108.782 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.09 -39.39 69.26 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.468 -0.77 . . . . 73.319999999999993 109.148 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 20.0 tpt85 -59.25 -32.63 70.17 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.265 -0.897 . . . . 74.420000000000002 109.145 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.4 tp -157.6 102.42 1.88 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.264 -0.898 . . . . 74.329999999999998 109.638 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.519 ' O ' ' CG ' ' A' ' 115' ' ' PHE . 23.1 mtm105 -94.84 -56.3 2.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.131 -0.981 . . . . 74.439999999999998 109.007 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.519 ' CG ' ' O ' ' A' ' 114' ' ' ARG . 82.4 m-85 -157.02 -58.14 0.09 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.182 -0.949 . . . . 74.430000000000007 109.213 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 62.7 m95 48.04 -122.59 1.53 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.317 -0.865 . . . . 74.439999999999998 109.695 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.1 43.38 56.8 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.152 -1.579 . . . . 75.040000000000006 109.152 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.1 m -100.37 147.97 25.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.375 -1.074 . . . . 70.109999999999999 109.564 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 121' ' ' ILE . 2.4 t30 -108.91 166.72 10.61 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.61 -0.681 . . . . 65.239999999999995 109.261 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.414 ' N ' ' CG ' ' A' ' 119' ' ' ASN . 4.4 t -124.68 -39.09 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.722 -0.611 . . . . 74.219999999999999 109.379 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.51 ' O ' ' ND2' ' A' ' 119' ' ' ASN . 17.1 mm -100.23 140.5 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.317 -0.864 . . . . 74.420000000000002 110.005 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.654 ' H ' HH12 ' A' ' 159' ' ' ARG . 86.4 mt-10 -135.61 119.31 17.15 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.382 -0.823 . . . . 73.299999999999997 108.901 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 37.8 mt -138.62 111.84 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.228 -0.92 . . . . 75.340000000000003 109.782 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 126' ' ' LEU . . . 65.61 46.51 83.98 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.209 -1.156 . . . . 75.129999999999995 110.209 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.893 ' HA ' ' OE2' ' A' ' 223' ' ' GLU . 3.6 m-20 67.25 -14.16 0.19 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.512 -0.993 . . . . 74.450000000000003 110.308 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.518 ' H ' ' C ' ' A' ' 124' ' ' GLY . 7.1 mt -76.99 155.24 32.76 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.61 -1.256 . . . . 54.210000000000001 107.61 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.88 129.28 46.63 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.368 -0.833 . . . . 70.239999999999995 109.49 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 74.8 mt -123.58 130.86 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.071 -0.714 . . . . 72.430000000000007 109.071 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.3 m -117.16 112.99 39.48 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 121.604 -0.685 . . . . 71.109999999999999 109.304 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.09 -51.09 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.106 1.871 . . . . 75.140000000000001 112.621 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -55.19 -45.68 75.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.063 -1.023 . . . . 72.5 109.532 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -81.53 -8.43 59.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 73.140000000000001 109.169 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 52.57 57.55 6.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.401 -0.812 . . . . 75.329999999999998 109.248 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -140.79 127.8 20.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.376 -0.828 . . . . 71.230000000000004 108.942 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.416 HG21 HD13 ' A' ' 135' ' ' ILE . 0.2 OUTLIER -107.08 126.32 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.362 -0.836 . . . . 75.329999999999998 109.147 -179.586 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.9 mt -117.86 126.76 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.532 -0.73 . . . . 71.109999999999999 109.951 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -137.25 142.66 42.01 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.355 -0.841 . . . . 74.140000000000001 108.954 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp 54.83 14.04 0.83 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.575 -0.703 . . . . 75.400000000000006 110.272 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 92.33 -6.56 78.23 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.49 -1.044 . . . . 72.239999999999995 110.49 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.473 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 1.0 OUTLIER -87.99 124.87 34.16 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.858 -1.378 . . . . 73.120000000000005 108.651 179.614 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -94.3 129.23 41.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.084 -1.01 . . . . 72.319999999999993 110.049 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.6 t -135.96 133.48 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.513 -0.742 . . . . 62.340000000000003 109.046 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -88.36 131.68 34.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.415 -0.803 . . . . 61.229999999999997 109.603 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.45 150.25 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.571 -0.9 . . . . 74.439999999999998 108.571 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -162.38 113.92 1.61 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.012 -1.055 . . . . 75.420000000000002 109.653 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' A' ' 150' ' ' GLU . . . 163.37 -169.07 38.32 Favored Glycine 0 N--CA 1.486 1.983 0 C-N-CA 119.511 -1.328 . . . . 73.340000000000003 109.899 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.504 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 41.7 mttp -78.06 -41.68 2.08 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.506 -0.996 . . . . 72.219999999999999 111.897 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 147' ' ' LYS . 36.7 Cg_endo -65.44 -30.38 52.93 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 CA-C-N 120.49 1.211 . . . . 75.450000000000003 111.891 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -94.38 -19.07 20.95 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.042 -1.037 . . . . 65.239999999999995 109.554 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.59 ' HB2' ' O ' ' A' ' 146' ' ' GLY . 34.9 tp10 -68.24 -43.32 78.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.356 -0.84 . . . . 72.519999999999996 108.907 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.0 p -61.66 -30.17 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.465 -0.939 . . . . 74.209999999999994 108.465 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 31.0 tp -65.61 -45.33 83.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.544 -0.723 . . . . 73.310000000000002 109.169 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.3 p -71.05 -30.1 66.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.945 . . . . 74.310000000000002 109.3 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -61.54 -53.46 56.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.168 -0.958 . . . . 75.450000000000003 109.742 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.4 pp -69.87 -22.65 63.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 75.340000000000003 109.33 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.67 -49.12 78.79 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.341 -0.85 . . . . 62.140000000000001 109.243 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.472 ' C ' ' H ' ' A' ' 159' ' ' ARG . 36.8 mtp180 -75.33 -44.39 45.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.025 -1.047 . . . . 72.219999999999999 109.164 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -77.71 26.43 0.18 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.255 -0.903 . . . . 74.120000000000005 109.412 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.722 ' CZ ' ' HH ' ' A' ' 216' ' ' TYR . 36.5 ptt180 -59.98 169.5 1.48 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.39 -0.819 . . . . 74.340000000000003 109.405 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.0 t0 46.47 65.49 1.19 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.316 -0.865 . . . . 75.450000000000003 109.484 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -169.94 149.67 3.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.123 -0.985 . . . . 73.409999999999997 109.792 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 75.5 mt -81.36 105.15 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.226 -1.027 . . . . 74.409999999999997 108.226 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 12.1 t -91.51 128.66 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.38 -0.825 . . . . 72.530000000000001 109.978 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.1 p -86.6 164.15 17.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.844 . . . . 74.120000000000005 109.052 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.482 ' CB ' ' NZ ' ' A' ' 165' ' ' LYS . 6.6 mtpm? -63.68 -48.12 78.46 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.257 -0.902 . . . . 70.430000000000007 110.185 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -56.0 -32.5 64.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.425 -0.797 . . . . 74.319999999999993 110.785 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -56.19 -56.06 25.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.973 -1.079 . . . . 74.519999999999996 110.119 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 51.2 mt -61.52 -41.69 97.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.165 -0.959 . . . . 74.409999999999997 110.372 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -62.24 -55.63 26.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.005 -1.06 . . . . 75.140000000000001 109.868 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 49.6 t0 -71.07 -13.18 61.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.134 -0.979 . . . . 65.030000000000001 110.45 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.97 -62.97 1.53 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.025 -1.047 . . . . 70.209999999999994 110.998 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.46 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 2.1 mp -73.23 -47.62 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 120.912 -1.117 . . . . 75.319999999999993 108.183 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 24.0 m-90 -95.18 119.4 33.62 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.559 -0.904 . . . . 73.140000000000001 108.559 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -151.66 -53.56 0.13 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.215 -0.928 . . . . 73.239999999999995 108.708 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 177' ' ' GLU . 12.4 mt-10 -60.16 154.89 48.72 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.001 -1.111 . . . . 63.329999999999998 108.001 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.421 ' C ' ' O ' ' A' ' 175' ' ' GLU . 32.2 Cg_exo -30.94 88.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.74 2.293 . . . . 72.510000000000005 112.478 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 175' ' ' GLU . 33.9 mm-40 -127.3 160.02 32.6 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 109.166 -0.679 . . . . 75.340000000000003 109.166 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 65.2 mtt -103.38 93.07 4.77 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.421 -0.8 . . . . 74.510000000000005 109.345 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 35.9 m -100.46 135.41 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.285 -0.885 . . . . 65.219999999999999 109.221 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.4 p -68.8 148.61 97.99 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.166 -0.959 . . . . 73.219999999999999 108.527 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.432 ' O ' ' OD1' ' A' ' 182' ' ' ASN . 99.1 Cg_exo -39.98 -30.67 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 121.974 1.783 . . . . 62.43 112.282 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 181' ' ' PRO . 69.7 m-80 -155.77 112.8 3.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.384 -0.823 . . . . 73.129999999999995 109.408 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.2 p -143.71 -14.11 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.201 -0.937 . . . . 74.019999999999996 110.294 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 6.1 tt -56.1 -23.08 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.743 -1.223 . . . . 72.329999999999998 109.738 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -58.23 -49.66 76.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 74.400000000000006 109.837 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 16.4 m -76.35 -25.02 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.89 -1.132 . . . . 74.319999999999993 109.663 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.19 -46.59 49.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.058 -1.026 . . . . 73.230000000000004 110.1 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.8 tp -67.95 -30.93 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.911 -1.118 . . . . 74.310000000000002 109.093 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -70.02 -57.42 5.02 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.372 -0.83 . . . . 73.439999999999998 109.99 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.439 ' CG ' ' N ' ' A' ' 191' ' ' ILE . 7.7 pt20 -63.06 -43.85 97.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 71.420000000000002 109.983 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.439 ' N ' ' CG ' ' A' ' 190' ' ' GLN . 51.0 mt -53.69 -49.29 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.112 -0.992 . . . . 72.439999999999998 109.165 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -54.63 -40.56 69.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.003 . . . . 64.219999999999999 109.249 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -62.51 -35.97 81.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.142 -0.973 . . . . 74.319999999999993 109.538 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -93.0 -0.05 57.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.207 -0.933 . . . . 75.310000000000002 110.382 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 31.9 ttm -95.72 -63.01 1.2 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.005 -1.059 . . . . 74.019999999999996 109.389 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 200' ' ' GLY . 84.5 m-20 -60.66 -29.08 69.07 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.439 -0.788 . . . . 74.019999999999996 110.095 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.438 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 30.7 mttm -58.64 -65.75 1.78 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.053 -1.03 . . . . 75.430000000000007 110.06 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 26.7 Cg_endo -60.96 -52.83 3.11 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.915 1.743 . . . . 72.319999999999993 112.108 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 201' ' ' ILE . 26.0 mt -66.35 -34.83 78.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.946 -1.096 . . . . 74.540000000000006 109.154 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 196' ' ' ASP . . . 77.65 -31.67 1.68 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.038 -1.625 . . . . 61.509999999999998 109.038 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.487 ' H ' ' C ' ' A' ' 199' ' ' LEU . 27.6 mm -95.89 129.45 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.41 -1.053 . . . . 74.25 109.286 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 64.9 m -78.8 139.22 38.42 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.603 -0.888 . . . . 72.0 108.603 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 38.5 p -142.57 13.77 1.95 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.216 -0.928 . . . . 74.439999999999998 109.814 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.33 131.77 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.765 -0.828 . . . . 71.129999999999995 108.765 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.41 ' OE1' ' SG ' ' A' ' 215' ' ' CYS . 30.1 mt-10 -117.01 123.45 46.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.636 -0.665 . . . . 73.510000000000005 109.509 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.99 98.93 10.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.319 -0.863 . . . . 73.519999999999996 108.715 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 208' ' ' ARG . 12.0 m -152.41 172.14 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.227 -0.921 . . . . 72.150000000000006 109.415 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 207' ' ' VAL . 70.2 mtt85 55.44 164.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.621 -0.674 . . . . 72.400000000000006 109.702 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.483 ' O ' ' N ' ' A' ' 211' ' ' GLY . 80.9 mtt85 -72.61 -126.11 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.21 -0.931 . . . . 73.310000000000002 109.398 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 75.6 mtp85 50.1 -91.44 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.3 -0.875 . . . . 71.540000000000006 109.928 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . -158.78 -97.7 0.13 Allowed Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.496 -1.335 . . . . 74.450000000000003 110.39 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -137.21 148.28 46.4 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.344 -1.092 . . . . 75.540000000000006 110.103 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -107.39 126.54 52.6 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.475 -0.766 . . . . 75.310000000000002 109.619 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -104.17 134.61 47.14 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.283 -1.006 . . . . 75.409999999999997 108.283 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . 0.41 ' SG ' ' OE1' ' A' ' 205' ' ' GLU . 31.1 p -153.51 164.43 38.24 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.173 -0.954 . . . . 74.140000000000001 109.926 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . 0.722 ' HH ' ' CZ ' ' A' ' 159' ' ' ARG . 42.3 m-85 -59.33 152.82 51.78 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 75.319999999999993 109.106 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.13 -45.32 0.46 Allowed 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.237 1.958 . . . . 73.109999999999999 111.407 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 220' ' ' ALA . 0.0 OUTLIER -161.65 151.48 14.0 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.827 -0.805 . . . . 75.25 108.827 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -38.8 86.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 122.209 1.939 . . . . 75.099999999999994 112.488 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.582 ' HB3' ' OE1' ' A' ' 223' ' ' GLU . . . -70.91 -63.56 1.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.068 -1.02 . . . . 71.140000000000001 109.463 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 95.3 m 49.19 -112.13 0.51 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.145 -0.972 . . . . 71.129999999999995 109.467 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -75.38 138.08 41.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.125 -0.984 . . . . 75.349999999999994 109.688 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.893 ' OE2' ' HA ' ' A' ' 125' ' ' ASP . 11.0 pt-20 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.024 -0.989 . . . . 73.409999999999997 109.538 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 32.0 tpp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.492 -0.558 . . . . 75.239999999999995 109.492 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.524 ' N ' ' OD2' ' B' ' 46' ' ' ASP . 78.4 mtm-85 -140.33 151.81 45.33 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.355 -0.841 . . . . 73.519999999999996 109.286 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.8 t -112.23 129.39 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.623 -0.673 . . . . 72.239999999999995 109.274 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 2.5 tp -104.46 121.12 42.78 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.579 -0.7 . . . . 73.340000000000003 109.566 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 11.1 mt -118.92 98.83 6.39 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 109.031 -0.729 . . . . 74.349999999999994 109.031 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 55.7 mt -84.1 98.86 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.834 -1.166 . . . . 63.439999999999998 108.664 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.43 ' OE2' ' OG ' ' B' ' 51' ' ' SER . 9.3 tp10 -140.97 130.59 24.06 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.293 -0.88 . . . . 74.519999999999996 109.485 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -66.06 -35.31 80.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.346 -0.846 . . . . 74.129999999999995 109.249 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -77.02 112.26 13.46 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.376 -0.828 . . . . 74.230000000000004 109.385 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 95.4 p -74.27 -30.29 62.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 65.540000000000006 110.158 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.45 ' CG1' ' N ' ' B' ' 12' ' ' LEU . 9.3 p -59.1 -45.38 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.005 -1.059 . . . . 75.549999999999997 109.704 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.45 ' N ' ' CG1' ' B' ' 11' ' ' VAL . 80.9 mt -65.06 -31.58 72.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.06 -1.025 . . . . 70.140000000000001 109.309 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.25 -28.04 62.77 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.649 -1.781 . . . . 75.400000000000006 108.649 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.62 -56.01 19.54 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.506 -1.437 . . . . 65.439999999999998 109.506 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.52 -41.85 90.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.342 -1.093 . . . . 72.200000000000003 109.515 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.69 -43.29 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.975 -1.078 . . . . 75.150000000000006 108.846 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.413 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 80.2 tt0 -58.53 -43.94 89.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.451 -0.78 . . . . 73.010000000000005 109.559 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -86.58 0.4 54.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.103 -0.998 . . . . 74.299999999999997 109.083 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.76 -58.63 1.89 Allowed Glycine 0 N--CA 1.484 1.894 0 N-CA-C 109.479 -1.448 . . . . 70.540000000000006 109.479 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -69.37 -22.31 63.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -1.144 . . . . 75.430000000000007 109.557 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . 0.413 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 2.0 m120 -51.67 -34.07 36.59 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.223 -0.923 . . . . 73.200000000000003 109.416 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 79.0 t -56.76 -39.91 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.093 -1.004 . . . . 74.230000000000004 108.884 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.448 ' CD ' ' N ' ' B' ' 23' ' ' LYS . 4.2 mptp? -70.59 -27.52 64.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.376 -0.828 . . . . 73.519999999999996 109.344 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.58 41.22 2.21 Favored Glycine 0 N--CA 1.499 2.893 0 N-CA-C 110.208 -1.157 . . . . 53.43 110.208 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -119.58 161.16 21.1 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.427 -1.043 . . . . 71.120000000000005 109.203 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 18.3 mmt -103.08 140.89 36.72 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.746 -0.835 . . . . 75.239999999999995 108.746 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . 0.419 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -137.53 154.45 49.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.303 -0.873 . . . . 73.25 110.167 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 96.1 m-20 -140.63 158.11 44.46 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.535 -0.913 . . . . 72.310000000000002 108.535 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 5.0 p -122.79 140.01 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.41 -0.806 . . . . 72.140000000000001 109.947 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.2 p -131.86 171.82 13.07 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.132 -0.692 . . . . 74.530000000000001 109.132 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -91.85 -107.09 0.1 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.235 -0.915 . . . . 71.019999999999996 109.792 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 33.3 t -78.79 168.87 19.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.292 -0.88 . . . . 71.400000000000006 110.022 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 39.0 mt -52.4 -30.91 31.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.593 -0.692 . . . . 71.239999999999995 109.877 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -53.9 -49.75 67.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.113 -0.992 . . . . 74.319999999999993 109.769 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -66.03 -44.79 83.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.153 -0.967 . . . . 73.030000000000001 109.365 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.61 -40.12 94.02 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.393 -1.483 . . . . 60.43 109.393 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -64.67 -43.85 92.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.337 -1.096 . . . . 74.430000000000007 109.456 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -71.29 -37.89 71.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.179 -0.95 . . . . 74.420000000000002 109.774 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 51.8 tp -69.51 -45.27 69.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 75.409999999999997 110.068 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.4 ppp? -74.29 -19.68 60.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.007 -1.058 . . . . 61.439999999999998 110.005 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.39 -41.81 80.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.105 -0.997 . . . . 74.319999999999993 109.697 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 pt -86.95 -41.44 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.122 -0.986 . . . . 71.230000000000004 109.854 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' B' ' 40' ' ' MET . 2.8 mpt_? -104.54 138.48 40.84 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.279 -0.888 . . . . 73.409999999999997 109.148 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . 0.478 ' C ' ' NH2' ' B' ' 2' ' ' ARG . 55.3 t-20 -100.59 89.89 4.08 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.377 -0.827 . . . . 63.539999999999999 109.205 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -63.56 149.22 46.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 73.109999999999999 109.275 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' B' ' 2' ' ' ARG . 3.9 p30 -80.42 -44.1 19.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 62.219999999999999 109.368 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.412 ' C ' ' CD1' ' B' ' 47' ' ' LEU . 0.6 OUTLIER -103.37 115.02 29.75 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.458 -0.941 . . . . 73.120000000000005 108.458 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 74.8 t -99.01 96.43 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.38 -0.97 . . . . 74.109999999999999 108.38 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 22.8 ttt -109.26 134.2 52.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.482 -0.761 . . . . 73.439999999999998 109.908 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.22 137.11 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.008 -0.738 . . . . 73.400000000000006 109.008 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' SER . . . . . 0.43 ' OG ' ' OE2' ' B' ' 7' ' ' GLU . 41.8 p -100.22 0.03 39.58 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.468 -0.77 . . . . 73.209999999999994 109.967 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -76.35 130.42 38.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 70.409999999999997 109.521 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.429 ' C ' ' N ' ' B' ' 55' ' ' ALA . 27.5 mtmm -66.51 -48.43 69.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 73.129999999999995 109.931 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -50.04 -16.52 0.3 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.144 -0.973 . . . . 75.209999999999994 109.367 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.429 ' N ' ' C ' ' B' ' 53' ' ' LYS . . . -59.68 -21.44 60.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.422 -0.799 . . . . 55.329999999999998 110.18 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 23.1 mt -43.02 -46.44 5.52 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.305 -0.872 . . . . 72.420000000000002 110.065 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 25.2 t -70.89 -34.32 71.46 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.05 -1.031 . . . . 73.040000000000006 109.347 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -67.45 -53.43 29.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.408 -0.808 . . . . 72.329999999999998 110.123 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.64 -33.89 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.825 -1.172 . . . . 74.540000000000006 109.73 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 9.3 t -59.74 -52.06 67.09 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.174 -0.953 . . . . 71.239999999999995 109.454 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -67.7 -27.79 67.12 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.007 -1.058 . . . . 74.310000000000002 109.876 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' B' ' 66' ' ' HIS . 4.7 mm -59.29 -51.63 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.932 -1.105 . . . . 75.420000000000002 109.083 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -60.41 -41.0 92.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.097 -1.002 . . . . 73.319999999999993 108.754 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -67.1 -51.73 50.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -0.862 . . . . 73.310000000000002 108.746 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -72.6 -74.76 0.16 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.599 -0.688 . . . . 72.439999999999998 109.554 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.409 ' N ' ' O ' ' B' ' 62' ' ' ILE . 90.2 m-70 -90.69 92.24 8.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.144 -0.973 . . . . 65.209999999999994 109.176 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 74.8 m -79.83 -27.64 40.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 73.099999999999994 109.876 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 51.7 p -87.11 47.69 1.54 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.188 -0.945 . . . . 71.530000000000001 110.153 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 15.9 tt -144.83 159.85 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.049 -1.032 . . . . 74.400000000000006 109.171 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 43.1 t -103.32 147.5 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.291 -0.881 . . . . 75.120000000000005 109.206 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 t -133.29 127.97 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.41 -0.806 . . . . 73.200000000000003 109.655 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 5.3 tt -122.65 105.29 9.95 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.617 -0.677 . . . . 73.340000000000003 109.423 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 14.8 p -94.25 132.44 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.012 -1.055 . . . . 73.5 109.497 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 9.5 p -89.63 171.63 9.54 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.985 -1.072 . . . . 71.319999999999993 108.723 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 27.4 p -152.54 112.05 3.91 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.817 -1.177 . . . . 74.530000000000001 110.713 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -74.28 -4.63 37.28 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.62 -0.881 . . . . 64.5 108.62 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -143.09 71.38 18.43 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 108.86 -0.793 . . . . 74.25 108.86 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.4 87.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.808 1.672 . . . . 74.430000000000007 111.701 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.431 ' OG1' ' OE2' ' B' ' 82' ' ' GLU . 44.3 p -107.43 155.77 19.67 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.683 -0.858 . . . . 73.120000000000005 108.683 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.1 p -61.01 -30.42 70.29 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.214 -0.929 . . . . 75.409999999999997 109.58 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.09 -43.01 88.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.921 . . . . 72.239999999999995 109.804 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' B' ' 82' ' ' GLU . 0.2 OUTLIER -66.29 -33.14 75.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 73.219999999999999 109.633 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.526 ' OE2' ' NH1' ' A' ' 100' ' ' ARG . 46.5 mt-10 -64.52 -46.51 82.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.017 -1.052 . . . . 74.299999999999997 109.535 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.06 -42.09 93.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.186 -0.946 . . . . 73.310000000000002 109.328 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' HIS . . . . . 0.438 ' O ' ' OE1' ' B' ' 89' ' ' GLN . 18.6 m170 -72.13 -20.33 61.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.215 -0.928 . . . . 73.239999999999995 109.639 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.24 -44.59 62.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.04 -1.038 . . . . 55.329999999999998 110.119 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -81.37 -35.23 31.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.002 -1.061 . . . . 74.450000000000003 109.487 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.95 -43.0 97.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.073 -1.017 . . . . 64.040000000000006 109.375 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . 0.438 ' OE1' ' O ' ' B' ' 85' ' ' HIS . 0.5 OUTLIER -67.91 -61.29 1.94 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 75.129999999999995 109.259 179.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 149.7 64.72 0.01 OUTLIER Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.732 -1.223 . . . . 75.420000000000002 110.154 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.51 134.44 55.22 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.493 -1.004 . . . . 73.420000000000002 108.971 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -68.22 -43.35 78.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.049 -1.032 . . . . 73.319999999999993 108.959 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' B' ' 93' ' ' ASP . 18.3 p-10 -153.81 165.14 36.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.449 -0.782 . . . . 73.040000000000006 109.253 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' B' ' 94' ' ' TYR . 0.2 OUTLIER -136.19 119.09 16.29 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.364 -0.606 . . . . 74.310000000000002 109.364 -178.345 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 28.6 mm -113.67 150.66 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 O-C-N 121.379 -0.826 . . . . 75.340000000000003 110.144 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.84 141.06 58.17 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.011 -1.107 . . . . 70.099999999999994 108.011 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.6 ' C ' ' H ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -68.85 -40.26 16.4 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.944 -1.098 . . . . 65.430000000000007 110.922 -178.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' B' ' 97' ' ' LYS . 34.0 Cg_exo -53.16 -0.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.289 -2.557 0 CA-C-N 118.697 0.571 . . . . 63.520000000000003 112.135 -174.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . 0.6 ' H ' ' C ' ' B' ' 97' ' ' LYS . 60.2 m-85 53.0 102.3 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.525 -0.734 . . . . 75.129999999999995 109.935 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 38.3 mtt-85 -57.63 -35.84 71.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.925 -1.109 . . . . 74.230000000000004 108.77 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' SER . . . . . 0.777 ' O ' ' N ' ' B' ' 103' ' ' LYS . 27.1 t -171.27 29.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -0.934 . . . . 64.510000000000005 110.77 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 18.7 mt 48.11 -68.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-N 118.539 0.609 . . . . 74.439999999999998 110.418 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . 0.777 ' N ' ' O ' ' B' ' 101' ' ' SER . 55.3 mttp -51.59 -31.72 25.96 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.693 -1.225 . . . . 72.299999999999997 107.693 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.84 -42.89 89.93 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.194 -1.039 . . . . 74.310000000000002 108.194 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 50.8 tp -60.79 -42.71 98.1 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.549 -0.908 . . . . 73.540000000000006 108.549 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 20.3 t -69.78 -34.23 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 72.030000000000001 109.229 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.51 -47.35 73.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.152 -0.968 . . . . 64.219999999999999 109.441 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 0.52 ' NH2' ' OE2' ' A' ' 83' ' ' GLU . 26.2 ttm105 -69.28 -37.08 77.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 75.310000000000002 109.789 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 97.7 mt -70.16 -26.66 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.04 -1.038 . . . . 55.439999999999998 108.921 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -74.98 -56.91 4.27 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.455 -0.778 . . . . 65.310000000000002 109.94 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -52.0 -35.74 47.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.071 -1.018 . . . . 74.519999999999996 109.81 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 38.6 ttp85 -85.98 -57.02 3.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.113 -0.992 . . . . 72.040000000000006 110.545 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 35.2 tp -54.7 -36.46 64.71 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.086 -1.008 . . . . 75.349999999999994 110.409 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -46.71 -33.24 4.15 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.125 -0.984 . . . . 75.5 109.611 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' PHE . . . . . 0.532 ' O ' ' N ' ' B' ' 117' ' ' GLY . 11.2 m-85 -54.38 -29.71 49.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.859 . . . . 73.040000000000006 108.994 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 4.3 t-105 60.47 -75.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.444 -0.785 . . . . 74.450000000000003 109.59 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' B' ' 115' ' ' PHE . . . -163.18 -171.34 29.3 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.281 -1.528 . . . . 64.209999999999994 109.281 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' SER . . . . . 0.642 ' CB ' ' OE2' ' B' ' 132' ' ' GLU . 7.6 t -154.85 174.48 15.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.148 -1.207 . . . . 71.400000000000006 110.011 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.29 114.37 4.44 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.983 -0.687 . . . . 74.209999999999994 109.159 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 11.9 t -78.51 -39.97 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.264 -0.897 . . . . 75.019999999999996 109.73 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . 0.404 HG21 HD13 ' B' ' 121' ' ' ILE . 17.3 mm -101.7 127.45 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.231 -0.918 . . . . 74.239999999999995 109.365 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . 0.464 ' CD ' ' N ' ' B' ' 122' ' ' GLU . 1.0 OUTLIER -135.2 114.64 12.52 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.529 -0.732 . . . . 73.329999999999998 109.267 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 11.2 pt -140.97 137.35 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.216 -0.928 . . . . 74.219999999999999 109.2 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.18 -149.89 3.4 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.441 -1.464 . . . . 72.409999999999997 109.441 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -83.19 -0.39 49.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -1.168 . . . . 75.120000000000005 109.332 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.31 132.82 42.68 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.288 -0.882 . . . . 75.420000000000002 108.706 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 4.4 p -129.81 120.33 24.82 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.97 -0.752 . . . . 74.219999999999999 108.97 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.403 HD13 HG22 ' B' ' 128' ' ' ILE . 18.2 mm -107.24 144.68 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.492 -0.755 . . . . 60.329999999999998 109.042 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 3.4 m -126.84 79.44 72.31 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 121.446 -0.784 . . . . 72.310000000000002 109.7 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -50.96 -40.36 58.56 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.51 2.14 . . . . 75.129999999999995 112.132 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -68.01 -50.12 57.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.87 . . . . 75.230000000000004 109.934 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . 0.642 ' OE2' ' CB ' ' B' ' 118' ' ' SER . 88.7 mt-10 -82.38 -1.16 49.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.119 -0.988 . . . . 75.120000000000005 109.701 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 50.39 51.97 15.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.946 . . . . 75.129999999999995 109.235 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -138.19 136.84 37.01 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.371 -0.83 . . . . 75.109999999999999 109.242 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 7.8 tt -119.23 139.2 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.565 -0.709 . . . . 70.319999999999993 109.579 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 32.0 mt -126.36 125.17 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.8 -0.815 . . . . 74.120000000000005 108.8 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . 0.406 ' C ' ' H ' ' B' ' 139' ' ' GLY . 33.6 p90 -142.49 151.36 41.6 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.235 -1.024 . . . . 74.230000000000004 108.235 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 16.9 tptm 60.11 8.16 1.42 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.572 -0.851 . . . . 74.219999999999999 109.07 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' B' ' 137' ' ' TYR . . . 90.41 -8.82 79.18 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.866 -1.294 . . . . 74.319999999999993 109.866 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . 0.505 ' N ' ' CD ' ' B' ' 140' ' ' ARG . 0.5 OUTLIER -90.53 141.25 28.95 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.113 -1.228 . . . . 75.340000000000003 109.214 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -97.8 129.87 44.77 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.27 -0.894 . . . . 71.230000000000004 109.632 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 47.7 t -138.43 132.51 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.389 -0.819 . . . . 70.430000000000007 109.075 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -87.1 143.72 27.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.205 -0.934 . . . . 72.430000000000007 109.727 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.48 132.28 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.337 -0.852 . . . . 72.129999999999995 109.388 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . 0.897 ' O ' ' HE2' ' B' ' 149' ' ' PHE . 0.0 OUTLIER -148.89 124.73 10.56 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.119 -0.988 . . . . 74.5 109.23 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . 0.765 ' N ' ' HD2' ' B' ' 149' ' ' PHE . . . 155.63 178.27 29.68 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.532 -1.427 . . . . 42.229999999999997 109.532 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 0.62 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 26.5 mtpt -70.88 -35.85 4.67 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.208 -1.172 . . . . 73.299999999999997 110.243 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 23.3 Cg_exo -63.49 -30.05 71.39 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.942 1.761 . . . . 71.329999999999998 111.772 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . 0.897 ' HE2' ' O ' ' B' ' 145' ' ' LYS . 0.2 OUTLIER -92.03 -28.22 17.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.404 -0.81 . . . . 74.230000000000004 109.079 -179.61 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -51.74 -35.89 45.11 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.363 -0.835 . . . . 72.340000000000003 109.802 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . 0.424 ' CG1' ' N ' ' B' ' 152' ' ' LEU . 11.4 p -63.36 -41.28 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.162 -0.961 . . . . 73.349999999999994 109.398 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . 0.424 ' N ' ' CG1' ' B' ' 151' ' ' VAL . 0.3 OUTLIER -58.5 -42.56 87.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.38 -0.825 . . . . 74.430000000000007 109.088 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 16.0 p -71.13 -34.3 70.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.085 -1.01 . . . . 75.209999999999994 110.218 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -59.13 -53.73 55.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.056 -1.027 . . . . 73.040000000000006 109.628 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.82 -23.57 61.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.946 -1.096 . . . . 73.430000000000007 109.526 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.38 -50.32 71.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.197 -0.94 . . . . 75.319999999999993 109.22 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.523 ' C ' ' H ' ' B' ' 159' ' ' ARG . 13.8 mtp-105 -71.47 -47.61 54.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 73.319999999999993 108.851 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -75.84 32.76 0.12 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.507 -0.745 . . . . 74.140000000000001 109.013 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . 0.523 ' H ' ' C ' ' B' ' 157' ' ' ARG . 34.0 ptt180 -50.67 -33.94 24.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.423 -0.798 . . . . 73.420000000000002 110.389 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' B' ' 160' ' ' ASP . 18.4 p30 -121.49 79.25 1.52 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.33 -0.856 . . . . 72.099999999999994 109.697 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -171.72 156.5 4.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.305 -0.872 . . . . 73.239999999999995 109.644 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' ILE . . . . . 0.571 ' CD1' ' N ' ' B' ' 162' ' ' ILE . 1.9 mp -94.1 139.27 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.205 -0.935 . . . . 72.310000000000002 109.025 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 63.5 t -133.95 142.52 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.416 -0.802 . . . . 75.030000000000001 109.594 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 4.7 p -91.78 166.38 12.79 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.21 -0.931 . . . . 74.219999999999999 110.422 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -64.47 -46.09 84.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.511 -0.743 . . . . 72.420000000000002 109.987 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -57.97 -38.25 75.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 63.450000000000003 110.15 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' GLN . . . . . 0.423 ' O ' ' OD1' ' B' ' 170' ' ' ASP . 63.3 tp60 -58.56 -48.54 80.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 72.400000000000006 109.795 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 33.1 mt -60.17 -36.09 76.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.92 . . . . 72.319999999999993 109.551 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' B' ' 173' ' ' TRP . 3.6 tt -55.9 -68.89 0.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.364 -0.835 . . . . 73.340000000000003 109.756 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' B' ' 167' ' ' GLN . 26.4 p30 -64.37 -11.19 30.16 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.473 -0.767 . . . . 73.099999999999994 110.802 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.57 -58.5 3.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.979 -1.076 . . . . 62.130000000000003 110.224 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.474 ' N ' ' CD1' ' B' ' 172' ' ' ILE . 2.0 mp -94.38 -50.4 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.018 -1.051 . . . . 74.439999999999998 109.47 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' TRP . . . . . 0.441 ' O ' ' O ' ' B' ' 169' ' ' LEU . 16.1 m-90 -95.72 124.32 39.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.297 -0.877 . . . . 72.230000000000004 109.452 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -154.02 -34.67 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.164 -0.96 . . . . 75.030000000000001 109.512 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . 0.595 ' N ' ' CD ' ' B' ' 176' ' ' PRO . 0.0 OUTLIER -72.93 -39.95 5.74 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.114 -0.992 . . . . 73.040000000000006 109.681 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' B' ' 175' ' ' GLU . 71.0 Cg_endo -92.68 68.0 0.66 Allowed 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.648 2.232 . . . . 74.129999999999995 112.19 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -63.84 -11.07 24.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.283 -0.886 . . . . 72.439999999999998 109.804 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 13.5 mmt -59.8 -27.72 66.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 72.109999999999999 110.13 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 25.1 m -61.95 152.57 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.109 -0.994 . . . . 75.310000000000002 109.783 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 1.2 p -78.64 154.03 78.52 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.334 -0.854 . . . . 62.149999999999999 109.362 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -75.66 -26.13 10.2 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.479 2.119 . . . . 74.340000000000003 111.989 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 182' ' ' ASN . . . . . 0.51 ' ND2' ' OE2' ' B' ' 185' ' ' GLU . 16.2 t-20 -72.23 -0.79 12.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 72.310000000000002 109.624 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 83.0 t -65.19 -29.01 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.257 -0.902 . . . . 65.420000000000002 109.66 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 61.7 mt -53.3 -40.71 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 75.030000000000001 110.102 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . 0.51 ' OE2' ' ND2' ' B' ' 182' ' ' ASN . 22.6 mt-10 -56.17 -37.39 69.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.041 -1.037 . . . . 73.519999999999996 108.881 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.92 -54.63 9.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.452 -0.78 . . . . 74.349999999999994 109.765 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -54.28 -36.96 64.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.274 -0.892 . . . . 61.119999999999997 110.465 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 188' ' ' ILE . . . . . 0.439 ' CG2' ' N ' ' B' ' 189' ' ' ASN . 7.7 tp -75.38 -43.54 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.681 -1.262 . . . . 72.430000000000007 109.667 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 189' ' ' ASN . . . . . 0.439 ' N ' ' CG2' ' B' ' 188' ' ' ILE . 11.3 m120 -61.65 -38.14 86.63 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.218 -0.926 . . . . 75.420000000000002 109.271 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -72.3 -47.72 47.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.952 . . . . 74.140000000000001 109.615 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . 0.441 ' O ' ' SD ' ' B' ' 195' ' ' MET . 57.4 mt -55.29 -40.52 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.155 -0.966 . . . . 74.030000000000001 109.093 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -63.06 -43.36 98.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 72.329999999999998 109.654 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -73.25 -30.83 63.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 73.099999999999994 109.87 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -82.01 -19.92 39.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.303 -0.873 . . . . 74.430000000000007 110.441 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 195' ' ' MET . . . . . 0.563 ' N ' ' SD ' ' B' ' 195' ' ' MET . 0.1 OUTLIER -99.7 -36.16 9.57 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.142 -0.974 . . . . 74.329999999999998 109.85 -179.666 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 196' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 58.2 p-10 -68.14 -19.57 64.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.086 -1.009 . . . . 71.209999999999994 110.113 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . 0.533 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 27.4 mttm -80.41 -64.87 0.29 Allowed Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.029 -1.045 . . . . 75.209999999999994 109.87 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 198' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 33.0 Cg_endo -61.9 -55.2 1.15 Allowed 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.314 2.009 . . . . 75.319999999999993 112.442 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . 0.519 ' C ' ' H ' ' B' ' 201' ' ' ILE . 15.5 mt -64.53 -37.03 86.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.084 -1.01 . . . . 72.25 109.627 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 74.09 -31.33 0.94 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.581 -1.408 . . . . 73.239999999999995 109.581 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . 0.519 ' H ' ' C ' ' B' ' 199' ' ' LEU . 66.4 mt -96.78 142.51 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.226 -1.161 . . . . 54.299999999999997 109.341 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 79.8 p -94.56 146.91 23.78 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.266 -0.896 . . . . 74.310000000000002 109.595 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 22.7 p -143.36 11.9 1.73 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.252 -0.905 . . . . 74.400000000000006 109.075 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.59 133.85 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.472 -0.767 . . . . 74.099999999999994 109.242 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -115.87 132.88 56.51 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.626 -0.671 . . . . 75.329999999999998 109.287 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.5 137.57 33.47 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.208 -0.932 . . . . 71.400000000000006 109.062 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.9 p -124.55 145.7 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.584 -0.697 . . . . 63.5 109.561 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -71.0 -11.53 61.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 74.450000000000003 109.904 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 70.0 ttt-85 -69.1 -108.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.126 -0.984 . . . . 74.140000000000001 109.623 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -146.83 121.4 9.76 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.827 -1.171 . . . . 74.430000000000007 109.853 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 94.47 171.84 37.98 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.68 -0.968 . . . . 70.109999999999999 110.68 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -115.74 171.34 7.81 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.213 -1.032 . . . . 74.209999999999994 108.213 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -132.24 132.64 43.27 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.215 -0.928 . . . . 74.299999999999997 109.597 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -113.35 123.46 50.17 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.978 -0.749 . . . . 74.340000000000003 108.978 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 2.2 p -139.92 164.34 30.26 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.447 -0.783 . . . . 72.209999999999994 109.044 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -61.87 149.78 84.5 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 72.310000000000002 109.104 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -38.52 133.82 0.89 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.144 1.896 . . . . 71.010000000000005 112.277 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . 0.637 ' N ' ' CD ' ' B' ' 219' ' ' PRO . 35.1 tttp -76.81 -34.38 1.27 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.167 -0.958 . . . . 74.349999999999994 110.772 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' B' ' 218' ' ' LYS . 47.4 Cg_exo -55.98 -12.87 7.9 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.928 1.752 . . . . 71.319999999999993 111.892 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -62.58 131.43 49.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.37 -0.831 . . . . 75.450000000000003 109.37 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 32.1 p -157.2 34.73 0.28 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.256 -0.903 . . . . 72.219999999999999 109.398 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -84.57 160.89 20.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 74.299999999999997 109.427 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . 0.455 ' OE1' ' N ' ' B' ' 223' ' ' GLU . 38.9 mp0 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.026 -0.988 . . . . 71.129999999999995 109.609 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.445 ' SD ' ' OD2' ' A' ' 46' ' ' ASP . 32.2 tpp . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.318 0.58 . . . . 65.120000000000005 109.441 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.572 ' NH2' ' CB ' ' A' ' 28' ' ' ASP . 75.5 ttt-85 -143.0 135.82 27.83 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.267 -0.895 . . . . 73.310000000000002 109.267 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.7 t -110.97 133.6 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.653 -0.654 . . . . 71.420000000000002 109.405 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.428 ' CD1' ' C ' ' A' ' 4' ' ' LEU . 0.3 OUTLIER -113.88 120.29 40.21 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.752 -0.833 . . . . 65.219999999999999 108.752 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.82 119.92 33.07 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.396 -0.965 . . . . 71.439999999999998 108.396 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.1 mt -97.31 130.38 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.25 -0.906 . . . . 71.150000000000006 109.351 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.529 ' C ' ' H ' ' A' ' 9' ' ' ASN . 10.8 pt-20 -171.57 -22.17 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.226 -0.921 . . . . 75.340000000000003 110.719 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt 69.18 -38.38 0.4 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.278 -0.889 . . . . 73.040000000000006 109.769 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 7' ' ' GLU . 26.8 m120 -64.88 103.12 0.67 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.143 -0.973 . . . . 72.420000000000002 109.419 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.1 m -61.15 -24.87 66.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.878 . . . . 72.340000000000003 109.633 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.9 t -70.03 -53.67 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.946 . . . . 74.420000000000002 109.728 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 12' ' ' LEU . 3.4 mm? -69.07 -36.76 77.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 72.010000000000005 109.35 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.512 ' N ' ' OE1' ' A' ' 7' ' ' GLU . . . -73.42 -28.03 66.61 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.481 -1.848 . . . . 72.140000000000001 108.481 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.38 -50.72 60.22 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.449 -1.46 . . . . 72.329999999999998 109.449 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -61.32 -45.99 92.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.347 -1.09 . . . . 72.340000000000003 109.76 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.7 mm -64.99 -37.11 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.751 -1.218 . . . . 74.239999999999995 108.68 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.475 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 84.1 tt0 -66.14 -47.03 75.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.368 -0.833 . . . . 71.409999999999997 109.794 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -85.24 2.98 41.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.098 -1.001 . . . . 75.540000000000006 109.324 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.85 -55.84 2.33 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.502 -1.439 . . . . 62.149999999999999 109.502 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -74.24 -21.87 59.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -1.124 . . . . 74.420000000000002 109.812 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 96.2 m-20 -54.07 -33.26 57.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.119 -0.988 . . . . 74.25 109.448 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.7 t -58.33 -47.08 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 72.109999999999999 108.959 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -59.98 -53.8 53.62 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.897 -0.779 . . . . 73.230000000000004 108.897 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 135.03 22.29 0.66 Allowed Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.761 -1.336 . . . . 75.540000000000006 109.761 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -98.86 160.37 14.31 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.218 -1.166 . . . . 74.510000000000005 109.424 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.2 mmm -100.97 139.31 36.84 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.601 -0.888 . . . . 64.319999999999993 108.601 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -127.75 154.28 45.56 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.577 -0.702 . . . . 74.310000000000002 109.783 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.572 ' CB ' ' NH2' ' A' ' 2' ' ' ARG . 24.2 t70 -142.6 132.24 23.92 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.71 -0.848 . . . . 75.400000000000006 108.71 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.7 m -100.22 130.52 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.907 . . . . 75.129999999999995 108.879 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.4 p -120.62 158.19 27.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.608 -0.683 . . . . 71.420000000000002 109.223 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -89.32 -94.29 0.11 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.397 -0.814 . . . . 73.109999999999999 109.605 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.2 p -79.29 152.49 30.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.205 -0.934 . . . . 74.239999999999995 110.022 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.3 mp -55.98 -37.34 68.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.49 -0.756 . . . . 71.530000000000001 109.795 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.54 -40.78 92.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 74.230000000000004 109.658 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -66.52 -40.37 89.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 71.010000000000005 109.331 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.31 -38.51 81.47 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.422 -1.471 . . . . 61.409999999999997 109.422 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -65.32 -39.93 93.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.378 -1.071 . . . . 74.340000000000003 109.523 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -78.94 -39.14 35.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.121 -0.987 . . . . 75.329999999999998 109.616 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.4 tt -67.74 -41.61 83.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.31 -0.869 . . . . 74.329999999999998 109.778 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.539 ' SD ' ' CE2' ' A' ' 45' ' ' TYR . 3.2 ppp? -74.83 -23.22 58.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.1 -1.0 . . . . 70.319999999999993 109.674 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -54.13 -37.27 64.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.117 -0.989 . . . . 71.219999999999999 109.891 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.5 pt -84.94 -33.35 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.154 -0.966 . . . . 74.409999999999997 110.148 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 40' ' ' MET . 97.2 mtt180 -95.86 167.11 11.46 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.058 -1.026 . . . . 75.409999999999997 109.933 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.409 ' C ' ' CD2' ' A' ' 45' ' ' TYR . 30.4 m120 -79.8 -174.95 4.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.127 -0.983 . . . . 75.420000000000002 109.056 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.539 ' CE2' ' SD ' ' A' ' 40' ' ' MET . 1.4 p90 -173.96 134.4 0.46 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.044 -1.035 . . . . 74.230000000000004 109.861 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.445 ' OD2' ' SD ' ' A' ' 1' ' ' MET . 87.2 m-20 -120.89 -51.95 2.12 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.485 -0.932 . . . . 75.319999999999993 108.485 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.435 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 1.7 tm? -106.32 111.1 23.54 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.049 -1.093 . . . . 72.129999999999995 108.049 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.22 101.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.599 -0.889 . . . . 72.340000000000003 108.599 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 7.7 ttt -105.39 140.3 38.72 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.458 -0.942 . . . . 74.109999999999999 108.458 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -140.04 129.31 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 71.239999999999995 109.847 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.7 m -109.79 9.06 24.79 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.827 -0.805 . . . . 73.109999999999999 108.827 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -77.45 159.66 29.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.376 -0.828 . . . . 63.399999999999999 109.933 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.534 ' C ' ' H ' ' A' ' 55' ' ' ALA . 62.5 mttp -81.86 173.15 12.53 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.714 -0.847 . . . . 65.439999999999998 108.714 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 56.2 5.94 0.21 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.117 -0.989 . . . . 73.129999999999995 108.916 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.534 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -68.65 -26.92 65.56 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.41 -0.806 . . . . 64.140000000000001 109.586 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.7 mt -45.14 -42.79 9.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.401 -0.812 . . . . 74.430000000000007 110.19 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.3 m -70.56 -37.38 73.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.999 -1.063 . . . . 63.229999999999997 109.819 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -64.76 -46.87 80.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 74.439999999999998 110.313 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.9 m -62.97 -36.92 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.654 -1.279 . . . . 74.030000000000001 109.555 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.8 t -55.84 -52.63 63.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.252 -0.905 . . . . 73.540000000000006 109.66 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -65.63 -32.71 74.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.127 -0.983 . . . . 73.340000000000003 109.987 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 mm -64.47 -35.89 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.871 -1.143 . . . . 73.349999999999994 109.63 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.665 ' HZ2' ' N ' ' A' ' 91' ' ' ALA . 26.6 mmtp -68.97 -50.87 45.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 74.420000000000002 110.262 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.438 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 15.7 pt-20 -70.1 -42.93 72.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.927 -1.108 . . . . 74.549999999999997 110.084 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.477 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 67.3 mttm -70.12 -24.6 63.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.94 . . . . 75.219999999999999 109.593 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.477 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 96.1 m-70 -155.85 64.2 0.59 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.921 . . . . 74.129999999999995 109.371 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.501 ' N ' ' O ' ' A' ' 63' ' ' LYS . 84.4 p -57.26 -25.48 59.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.306 -0.871 . . . . 73.239999999999995 109.763 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.5 t -75.34 45.61 0.3 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 71.439999999999998 109.89 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.7 tt -145.72 158.18 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.089 -1.007 . . . . 71.329999999999998 109.645 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.5 t -94.23 149.83 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.16 -0.962 . . . . 73.019999999999996 108.687 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.526 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 11.2 t -138.09 124.96 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.205 -0.934 . . . . 54.210000000000001 109.387 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 mp -124.8 99.52 6.19 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.686 -0.857 . . . . 74.209999999999994 108.686 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.4 p -86.89 160.14 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.183 -0.948 . . . . 74.409999999999997 108.891 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 75' ' ' SER . 19.8 m -135.5 160.36 38.71 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.371 -0.831 . . . . 72.310000000000002 109.631 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 74' ' ' SER . 70.3 m -168.57 154.74 6.95 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.275 -0.891 . . . . 64.540000000000006 110.133 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 0.4 OUTLIER -94.71 8.3 42.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.406 -0.809 . . . . 74.129999999999995 109.945 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' A' ' 79' ' ' THR . 37.6 t30 -129.19 56.68 25.31 Favored Pre-proline 0 N--CA 1.502 2.14 0 O-C-N 121.358 -0.839 . . . . 73.340000000000003 110.109 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.6 84.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.349 2.033 . . . . 71.319999999999993 111.913 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.43 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 42.5 m -114.03 150.17 34.32 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.741 -0.837 . . . . 62.530000000000001 108.741 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.07 -32.86 23.39 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.214 -0.929 . . . . 74.140000000000001 109.432 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.434 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 97.4 mt-10 -59.45 -36.73 76.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 71.420000000000002 109.69 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.421 ' OE2' ' OG ' ' A' ' 75' ' ' SER . 84.9 tt0 -75.84 -33.3 60.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.147 -0.971 . . . . 73.430000000000007 109.804 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.43 ' OE2' ' O ' ' A' ' 79' ' ' THR . 0.9 OUTLIER -68.69 -50.16 53.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.099 -1.001 . . . . 74.219999999999999 109.893 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.6 m -63.21 -42.95 98.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.027 -1.046 . . . . 74.150000000000006 109.615 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.434 ' ND1' ' O ' ' A' ' 81' ' ' GLU . 56.1 m80 -74.11 -25.44 59.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 72.540000000000006 109.78 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.43 -44.05 88.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.108 -0.995 . . . . 64.219999999999999 109.776 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -81.49 -34.01 31.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.011 -1.055 . . . . 74.340000000000003 109.027 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -68.1 -51.35 47.44 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.349 -0.844 . . . . 74.420000000000002 109.261 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -61.2 -50.24 73.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.487 -0.758 . . . . 74.519999999999996 109.704 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 147.64 71.08 0.01 OUTLIER Glycine 0 N--CA 1.495 2.587 0 C-N-CA 119.851 -1.166 . . . . 74.209999999999994 110.357 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.665 ' N ' ' HZ2' ' A' ' 63' ' ' LYS . . . -139.81 140.01 36.52 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.186 -1.185 . . . . 64.099999999999994 109.092 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 57.3 m-20 -83.76 -39.87 19.52 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.056 -1.028 . . . . 73.420000000000002 109.492 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 73.1 m-20 -150.29 164.15 36.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -0.879 . . . . 75.040000000000006 109.223 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.438 ' CE1' ' O ' ' A' ' 95' ' ' ILE . 1.6 t80 -135.77 132.34 36.66 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.46 -0.775 . . . . 71.329999999999998 109.315 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.438 ' O ' ' CE1' ' A' ' 94' ' ' TYR . 26.1 mm -115.05 148.26 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 121.453 -0.779 . . . . 74.510000000000005 110.076 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.32 121.31 16.64 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.975 -1.491 . . . . 64.319999999999993 106.975 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.705 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.5 OUTLIER -43.66 -58.4 4.56 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.057 -1.027 . . . . 74.510000000000005 111.649 -178.272 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 7.5 Cg_endo -43.97 0.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 121.419 1.412 . . . . 73.109999999999999 113.695 -175.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.705 ' N ' ' O ' ' A' ' 97' ' ' LYS . 51.5 m-85 58.21 116.04 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.681 -0.637 . . . . 72.540000000000006 109.761 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.522 ' NE ' ' OE2' ' B' ' 83' ' ' GLU . 12.6 ttm-85 -73.63 -33.93 64.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 74.540000000000006 109.775 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.75 ' O ' ' N ' ' A' ' 103' ' ' LYS . 30.5 t -172.68 26.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.856 -1.153 . . . . 74.140000000000001 111.139 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 87.2 mt 51.13 -70.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.519 -0.738 . . . . 75.430000000000007 110.357 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.75 ' N ' ' O ' ' A' ' 101' ' ' SER . 30.5 mmtm -56.07 -30.05 61.41 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.162 -1.051 . . . . 74.140000000000001 108.162 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.4 -47.75 84.24 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.392 -0.966 . . . . 63.240000000000002 108.392 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.63 -56.04 16.38 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.953 -0.758 . . . . 73.219999999999999 108.953 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 63.5 t -51.45 -40.55 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.74 -1.225 . . . . 74.540000000000006 109.018 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.21 -32.83 68.66 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.223 -0.923 . . . . 75.5 108.727 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 -77.96 -24.13 48.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -0.839 . . . . 74.409999999999997 110.333 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 81.7 mt -75.68 -38.98 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.801 -1.187 . . . . 73.239999999999995 108.869 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 114' ' ' ARG . 24.3 pt-20 -76.63 -32.5 58.06 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.298 -0.876 . . . . 74.340000000000003 109.605 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.49 -50.2 72.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.412 -0.805 . . . . 73.319999999999993 109.748 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -64.78 -46.07 83.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 74.420000000000002 109.495 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.6 mt -97.85 26.06 5.45 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.218 -0.926 . . . . 74.329999999999998 109.731 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 110' ' ' GLU . 0.8 OUTLIER -60.92 -53.13 61.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 74.439999999999998 109.383 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -86.62 50.85 2.08 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.176 -0.952 . . . . 74.430000000000007 109.412 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -88.28 132.4 34.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.247 -0.908 . . . . 74.439999999999998 109.869 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 118.99 92.3 1.44 Allowed Glycine 0 N--CA 1.501 2.972 0 N-CA-C 109.65 -1.38 . . . . 75.040000000000006 109.65 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 79.7 p -166.7 160.49 14.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.093 -1.239 . . . . 70.109999999999999 109.979 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 121' ' ' ILE . 8.2 t30 -146.06 142.82 28.95 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.51 -0.922 . . . . 65.239999999999995 108.51 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.2 t -93.54 -45.73 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.016 -1.053 . . . . 74.219999999999999 110.564 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.521 ' O ' ' ND2' ' A' ' 119' ' ' ASN . 12.4 mm -93.56 114.98 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 120.841 -1.162 . . . . 74.420000000000002 109.624 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -118.83 124.9 48.31 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.915 -0.772 . . . . 73.299999999999997 108.915 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.48 ' CG2' ' O ' ' A' ' 123' ' ' ILE . 5.9 tt -149.88 102.73 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.039 -1.038 . . . . 75.340000000000003 109.682 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 62.73 -135.6 44.17 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.198 -1.161 . . . . 75.129999999999995 110.198 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -87.74 -3.4 58.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.457 -1.025 . . . . 74.450000000000003 109.878 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.0 131.0 42.84 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.225 -0.922 . . . . 54.210000000000001 108.865 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.54 137.33 49.66 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.756 -0.831 . . . . 70.239999999999995 108.756 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 56.4 mt -131.17 127.88 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.473 -0.767 . . . . 72.430000000000007 109.204 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.52 103.15 50.23 Favored Pre-proline 0 N--CA 1.494 1.766 0 N-CA-C 109.059 -0.719 . . . . 71.109999999999999 109.059 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.76 -24.95 5.65 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.795 1.663 . . . . 75.140000000000001 111.781 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -62.54 -55.8 23.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.471 -0.768 . . . . 72.5 109.863 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -94.68 12.54 27.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.29 -0.881 . . . . 73.140000000000001 109.31 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 49.61 57.91 6.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 75.329999999999998 109.18 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 26.0 ttpt -133.89 132.84 40.79 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.556 -0.715 . . . . 71.230000000000004 109.673 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.9 tt -109.74 137.17 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 109.138 -0.689 . . . . 75.329999999999998 109.138 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.412 HD11 HG22 ' A' ' 136' ' ' ILE . 70.5 mt -121.27 118.9 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.495 -0.753 . . . . 71.109999999999999 109.193 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.474 ' C ' ' H ' ' A' ' 139' ' ' GLY . 65.3 t80 -142.76 151.3 41.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.349 -0.844 . . . . 74.140000000000001 108.978 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 1.147 ' HZ3' ' CB ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER 61.37 5.75 1.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.942 -1.099 . . . . 75.400000000000006 108.239 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 137' ' ' TYR . . . 86.12 13.04 69.61 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.091 -1.603 . . . . 72.239999999999995 109.091 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -103.44 142.79 33.64 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.589 -0.948 . . . . 73.120000000000005 108.782 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -107.97 116.11 31.36 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.05 -1.031 . . . . 72.319999999999993 108.823 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.14 138.48 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.437 -0.789 . . . . 62.340000000000003 109.066 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -82.29 147.86 28.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.401 -0.812 . . . . 61.229999999999997 109.931 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.1 m -146.38 125.0 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.368 -0.833 . . . . 74.439999999999998 109.489 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -158.01 134.37 9.52 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.445 -0.784 . . . . 75.420000000000002 109.184 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.13 -162.93 36.72 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.066 -1.214 . . . . 73.340000000000003 110.066 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.627 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 49.9 mtmt -82.49 -30.61 0.51 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.443 -1.034 . . . . 72.219999999999999 111.626 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 90.1 Cg_endo -86.94 -25.02 1.22 Allowed 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 121.801 1.667 . . . . 75.450000000000003 112.562 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -89.15 -12.92 39.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.158 -0.964 . . . . 65.239999999999995 109.802 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -61.11 -38.27 85.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.1 -1.0 . . . . 72.519999999999996 109.422 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.34 -28.96 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 74.209999999999994 109.0 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.18 -44.45 97.28 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.94 -0.763 . . . . 73.310000000000002 108.94 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.9 p -74.09 -37.9 64.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.206 -0.934 . . . . 74.310000000000002 110.231 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -54.76 -55.13 33.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.934 -1.104 . . . . 75.450000000000003 109.82 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.402 ' CD1' ' N ' ' A' ' 156' ' ' ALA . 4.6 pp -66.92 -33.47 75.67 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.207 -0.933 . . . . 75.340000000000003 109.197 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.402 ' N ' ' CD1' ' A' ' 155' ' ' LEU . . . -51.16 -41.24 60.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.192 -0.943 . . . . 62.140000000000001 108.949 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.522 ' C ' ' H ' ' A' ' 159' ' ' ARG . 62.6 mtp180 -89.06 -48.95 7.06 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.143 -0.973 . . . . 72.219999999999999 108.922 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -73.09 35.03 0.08 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.389 -0.819 . . . . 74.120000000000005 109.611 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.522 ' H ' ' C ' ' A' ' 157' ' ' ARG . 27.9 ptt180 -72.16 171.1 12.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.34 -0.85 . . . . 74.340000000000003 109.347 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.6 t70 52.51 44.04 30.42 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.192 -0.942 . . . . 75.450000000000003 109.609 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -148.25 162.92 38.51 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.181 -0.949 . . . . 73.409999999999997 109.448 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.414 HD12 HG22 ' A' ' 162' ' ' ILE . 96.6 mt -93.37 119.34 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.218 -0.926 . . . . 74.409999999999997 108.649 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 10.8 t -99.89 122.39 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.251 -0.905 . . . . 72.530000000000001 109.675 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.55 ' HG ' ' H ' ' A' ' 167' ' ' GLN . 10.2 p -84.07 164.68 19.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 74.120000000000005 108.911 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -63.27 -43.75 97.06 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.178 -0.951 . . . . 70.430000000000007 109.39 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.432 ' O ' ' OD2' ' A' ' 170' ' ' ASP . 49.0 mt-10 -72.12 -29.24 63.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 74.319999999999993 110.16 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.55 ' H ' ' HG ' ' A' ' 164' ' ' SER . 53.7 tt0 -57.32 -57.14 13.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.961 . . . . 74.519999999999996 110.037 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 2.2 pp -67.81 -36.52 80.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.974 -1.079 . . . . 74.409999999999997 110.056 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.441 ' C ' ' CD1' ' A' ' 169' ' ' LEU . 3.1 tm? -55.18 -52.91 61.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.927 -1.108 . . . . 75.140000000000001 108.867 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' A' ' 166' ' ' GLU . 2.6 p30 -72.38 -28.61 63.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.207 -0.933 . . . . 65.030000000000001 110.111 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -53.77 -52.16 61.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.149 -0.969 . . . . 70.209999999999994 110.358 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 12.8 mm -91.53 -28.92 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.071 -1.018 . . . . 75.319999999999993 110.015 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 16.2 m-90 -124.28 62.69 1.1 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.409 -0.807 . . . . 73.140000000000001 109.432 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -66.93 -33.76 76.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.341 -0.849 . . . . 73.239999999999995 108.869 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -82.24 150.48 64.36 Favored Pre-proline 0 N--CA 1.487 1.398 0 N-CA-C 108.684 -0.858 . . . . 63.329999999999998 108.684 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -39.87 -51.31 3.06 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 121.989 1.793 . . . . 72.510000000000005 112.315 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 44.62 -166.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.489 -0.757 . . . . 75.340000000000003 109.595 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 70.5 mtp -95.59 57.46 1.91 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.05 -1.031 . . . . 74.510000000000005 109.662 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 69.8 t -83.39 121.26 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 65.219999999999999 109.143 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.501 ' OG1' ' CG2' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -80.78 166.75 37.24 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.117 -0.989 . . . . 73.219999999999999 108.471 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -47.76 -31.81 15.6 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.36 2.04 . . . . 62.43 112.884 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.989 ' ND2' ' OE1' ' A' ' 185' ' ' GLU . 53.2 t-20 -143.76 97.02 2.99 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.123 -0.986 . . . . 73.129999999999995 110.274 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.501 ' CG2' ' OG1' ' A' ' 180' ' ' THR . 96.2 t -123.66 -13.77 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.567 -0.901 . . . . 74.019999999999996 108.567 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 96.0 mt -61.99 -42.44 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.464 -0.772 . . . . 72.329999999999998 109.832 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.989 ' OE1' ' ND2' ' A' ' 182' ' ' ASN . 11.5 pt-20 -51.48 -37.87 51.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.896 -1.128 . . . . 74.400000000000006 109.121 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 36.0 t -73.11 -32.33 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.452 -0.78 . . . . 74.319999999999993 109.372 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -79.33 -56.86 4.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.22 -0.925 . . . . 73.230000000000004 110.457 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.401 ' CG2' ' N ' ' A' ' 189' ' ' ASN . 3.4 tp -55.59 -39.01 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.858 -1.151 . . . . 74.310000000000002 109.776 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.45 ' OD1' ' NE2' ' A' ' 193' ' ' GLN . 25.8 t-20 -67.68 -54.68 17.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.335 -0.853 . . . . 73.439999999999998 111.779 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -62.26 -31.72 72.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.835 -1.166 . . . . 71.420000000000002 111.412 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 47.1 pt -69.15 -38.14 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.201 -1.562 . . . . 72.439999999999998 109.937 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.64 -42.21 99.47 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 117.986 -1.486 . . . . 64.219999999999999 108.238 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.45 ' NE2' ' OD1' ' A' ' 189' ' ' ASN . 79.5 mt-30 -64.52 -34.26 77.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.552 -0.718 . . . . 74.319999999999993 110.167 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.489 ' O ' ' CG ' ' A' ' 198' ' ' PRO . 15.0 mtpp -75.19 -25.71 58.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.155 -0.966 . . . . 75.310000000000002 110.634 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 74.8 mtm -95.97 4.38 52.74 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.972 -1.08 . . . . 74.019999999999996 109.475 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -113.67 -12.88 12.76 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.579 -0.7 . . . . 74.019999999999996 110.636 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.577 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 20.5 tttt -98.28 -41.04 0.24 Allowed Pre-proline 0 N--CA 1.502 2.132 0 O-C-N 120.949 -1.094 . . . . 75.430000000000007 110.87 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 85.5 Cg_endo -93.3 -64.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.906 2.404 . . . . 72.319999999999993 112.999 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 45.8 mt -50.18 -35.86 28.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.1 -1.0 . . . . 74.540000000000006 109.353 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 87.17 -9.75 71.47 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.761 -1.336 . . . . 61.509999999999998 109.761 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 17.2 mt -132.9 127.57 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.482 -1.01 . . . . 74.25 109.533 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.8 t -78.67 133.1 37.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.316 -0.865 . . . . 72.0 109.199 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.6 p -118.62 34.0 5.4 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.515 -0.74 . . . . 74.439999999999998 110.503 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 6.4 m -143.27 139.39 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.976 -1.078 . . . . 71.129999999999995 110.002 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -126.01 133.44 51.76 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.109 -0.7 . . . . 73.510000000000005 109.109 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.56 133.52 34.14 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.082 -1.011 . . . . 73.519999999999996 108.962 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 10.4 p -128.54 137.23 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.52 -0.738 . . . . 72.150000000000006 109.179 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -92.79 60.37 3.4 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.205 -0.934 . . . . 72.400000000000006 109.369 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.16 -61.51 0.32 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.497 -0.927 . . . . 73.310000000000002 108.497 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -104.43 -65.39 1.03 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.592 -0.692 . . . . 71.540000000000006 109.278 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -171.75 -105.86 0.19 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.347 -1.501 . . . . 74.450000000000003 109.347 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.34 123.38 39.27 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.456 -1.026 . . . . 75.540000000000006 108.632 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -89.51 146.49 24.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.367 -0.833 . . . . 75.310000000000002 110.963 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -123.57 114.4 19.99 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.502 -0.925 . . . . 75.409999999999997 108.502 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 18.5 p -140.45 159.41 42.27 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.385 -0.822 . . . . 74.140000000000001 109.077 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -59.04 142.47 85.4 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.079 -1.013 . . . . 75.319999999999993 108.729 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.412 ' O ' ' C ' ' A' ' 218' ' ' LYS . 46.8 Cg_endo -82.16 16.75 1.69 Allowed 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 122.085 1.857 . . . . 73.109999999999999 112.065 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 217' ' ' PRO . 44.8 tttt -43.74 -55.06 9.49 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.203 -0.935 . . . . 75.25 109.921 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.47 -7.6 20.56 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.568 1.512 . . . . 75.099999999999994 111.187 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 217' ' ' PRO . . . -55.75 -38.57 69.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.42 -0.8 . . . . 71.140000000000001 110.554 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 11.5 t -136.86 149.15 47.51 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.307 -0.871 . . . . 71.129999999999995 109.646 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -110.43 6.9 22.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.594 -0.691 . . . . 75.349999999999994 109.442 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.975 -1.012 . . . . 73.409999999999997 109.388 -179.935 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.413 -0.588 . . . . 75.239999999999995 109.413 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 51.4 ttt85 -139.98 155.07 47.29 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.351 -0.843 . . . . 73.519999999999996 109.279 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 83.4 t -113.23 122.13 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.59 0.709 . . . . 72.239999999999995 109.73 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 2.6 tp -91.71 117.64 29.94 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.367 -0.975 . . . . 73.340000000000003 108.367 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 tt -118.95 120.15 36.42 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.437 -0.949 . . . . 74.349999999999994 108.437 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 19.0 mt -115.78 99.53 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.438 -0.789 . . . . 63.439999999999998 109.195 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.425 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 30.1 tp10 -125.17 139.64 53.57 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.578 -0.701 . . . . 74.519999999999996 109.295 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.485 ' HZ2' ' CG ' ' B' ' 52' ' ' ASP . 39.2 mmtm -70.39 -34.29 72.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.922 . . . . 74.129999999999995 109.374 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -90.72 118.89 30.5 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.284 -0.885 . . . . 74.230000000000004 109.576 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 18.9 t -70.37 -32.06 69.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.927 . . . . 65.540000000000006 109.56 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 82.7 t -64.27 -53.25 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.917 . . . . 75.549999999999997 109.734 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.21 -37.63 88.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.909 . . . . 70.140000000000001 109.003 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.05 -26.72 73.94 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.487 -1.845 . . . . 75.400000000000006 108.487 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.96 -54.2 32.25 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 109.623 -1.391 . . . . 65.439999999999998 109.623 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -58.3 -44.2 88.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.333 -1.098 . . . . 72.200000000000003 109.677 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 39.3 mm -64.33 -43.81 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.917 -1.114 . . . . 75.150000000000006 108.725 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -61.3 -43.53 98.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.411 -0.806 . . . . 73.010000000000005 109.816 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 16.3 mtpp -87.06 2.45 49.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.098 -1.001 . . . . 74.299999999999997 109.444 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.73 -53.27 2.61 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.433 -1.467 . . . . 70.540000000000006 109.433 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -76.13 -20.09 57.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.314 -1.109 . . . . 75.430000000000007 109.704 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -58.59 -30.59 67.31 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.06 -1.025 . . . . 73.200000000000003 109.256 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 82.9 t -60.29 -34.66 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.355 -0.84 . . . . 74.230000000000004 109.114 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -68.55 -4.69 16.12 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.336 -0.852 . . . . 73.519999999999996 109.067 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.82 39.97 7.34 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.092 -1.203 . . . . 53.43 110.092 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -119.84 159.34 24.78 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.536 -0.979 . . . . 71.120000000000005 109.321 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 7.1 mmt -105.19 133.37 50.08 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.242 -1.022 . . . . 75.239999999999995 108.242 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.07 162.46 36.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.173 -0.954 . . . . 73.25 110.239 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -141.22 145.65 35.87 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.459 -0.776 . . . . 72.310000000000002 108.952 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -106.72 137.64 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.309 -0.869 . . . . 72.140000000000001 108.79 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 11.3 p -136.41 167.79 20.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.366 -0.834 . . . . 74.530000000000001 109.289 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.477 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 2.2 pt-20 -90.22 -100.05 0.1 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.153 -0.967 . . . . 71.019999999999996 109.898 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 32.8 t -78.96 166.21 22.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.958 . . . . 71.400000000000006 110.236 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 44.1 mt -53.91 -32.97 55.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.633 -0.667 . . . . 71.239999999999995 109.829 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -50.43 -48.31 56.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.121 -0.987 . . . . 74.319999999999993 109.695 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.477 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 65.9 m-20 -69.28 -41.33 76.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.169 -0.957 . . . . 73.030000000000001 109.501 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.18 -40.7 87.8 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.464 -1.454 . . . . 60.43 109.464 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -68.6 -42.69 77.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -1.151 . . . . 74.430000000000007 109.543 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . 0.448 ' O ' ' OD1' ' B' ' 41' ' ' ASP . 56.4 t80 -75.17 -21.9 58.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 74.420000000000002 110.053 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 28.5 tp -90.01 -39.16 13.13 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.14 -0.975 . . . . 75.409999999999997 110.044 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' B' ' 40' ' ' MET . 0.0 OUTLIER -78.13 -27.69 48.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.996 . . . . 61.439999999999998 110.528 -179.102 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' B' ' 42' ' ' ILE . 41.9 p-10 -68.02 -27.51 66.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.901 -1.124 . . . . 74.319999999999993 110.225 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.533 ' N ' ' OD1' ' B' ' 41' ' ' ASP . 13.8 pt -88.8 -15.47 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.004 -1.06 . . . . 71.230000000000004 110.419 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' B' ' 40' ' ' MET . 97.2 mtt180 -129.48 149.92 51.05 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.239 -0.913 . . . . 73.409999999999997 109.77 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -82.85 163.18 21.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.202 -0.937 . . . . 63.539999999999999 109.458 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 10.4 p90 -159.3 -179.04 7.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.92 . . . . 73.109999999999999 109.706 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -138.97 -32.85 0.66 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.475 -0.766 . . . . 62.219999999999999 109.428 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.08 115.1 29.59 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.357 -0.839 . . . . 73.120000000000005 109.004 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 56.0 t -102.55 98.01 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.51 -0.922 . . . . 74.109999999999999 108.51 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -117.06 129.07 55.76 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.776 0.798 . . . . 73.439999999999998 110.141 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.506 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.2 OUTLIER -141.65 135.68 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.78 0.8 . . . . 73.400000000000006 109.179 -179.622 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' SER . . . . . 0.425 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 53.2 p -99.3 18.29 17.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.599 -0.688 . . . . 73.209999999999994 109.599 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.506 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 37.6 m-20 -86.09 144.16 27.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.185 -0.947 . . . . 70.409999999999997 109.534 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.475 ' C ' ' H ' ' B' ' 55' ' ' ALA . 99.1 mttt -76.52 -42.6 42.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.276 -0.89 . . . . 73.129999999999995 110.201 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -71.01 10.72 0.5 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.108 -0.995 . . . . 75.209999999999994 109.727 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.475 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -67.13 -22.22 65.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 55.329999999999998 110.106 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 19.0 mt -44.68 -44.93 9.47 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.268 -0.895 . . . . 72.420000000000002 110.142 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' SER . . . . . 0.433 ' O ' ' OG ' ' B' ' 60' ' ' SER . 93.1 p -69.39 -37.96 77.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.991 -1.068 . . . . 73.040000000000006 109.284 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -65.07 -62.28 1.65 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.279 -0.888 . . . . 72.329999999999998 109.656 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 33.3 m -49.55 -33.64 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.555 -1.341 . . . . 74.540000000000006 109.661 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' B' ' 57' ' ' SER . 10.9 p -57.6 -51.26 70.23 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.202 -0.936 . . . . 71.239999999999995 109.472 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -70.05 -31.24 68.77 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.177 -1.009 . . . . 74.310000000000002 110.176 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.462 ' O ' ' N ' ' B' ' 66' ' ' HIS . 40.0 mm -66.68 -44.97 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.683 -1.261 . . . . 75.420000000000002 110.285 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -65.09 -44.94 87.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.195 -0.941 . . . . 73.319999999999993 110.818 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -73.86 -38.0 64.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.743 -1.223 . . . . 73.310000000000002 110.036 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.486 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 64.2 mttm -84.71 -17.04 39.69 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.099 -1.0 . . . . 72.439999999999998 109.711 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.486 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 76.9 m-70 -155.63 68.72 0.66 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.053 -1.03 . . . . 65.209999999999994 109.618 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 85.6 p -67.6 -27.55 67.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.312 -0.867 . . . . 73.099999999999994 109.898 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 12.5 t -63.1 -19.22 64.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.148 -0.97 . . . . 71.530000000000001 110.069 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 63.1 mt -88.25 151.94 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.182 -0.949 . . . . 74.400000000000006 109.784 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 94.3 t -90.96 157.62 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.41 -0.806 . . . . 75.120000000000005 109.277 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 11.0 t -135.7 126.79 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.218 -0.926 . . . . 73.200000000000003 109.864 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.402 ' C ' ' CD2' ' B' ' 72' ' ' LEU . 4.2 tt -116.88 105.32 12.23 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.787 -0.82 . . . . 73.340000000000003 108.787 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 71.1 t -98.06 131.23 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.033 -1.042 . . . . 73.5 109.541 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.9 p -95.23 169.26 10.21 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.239 -0.913 . . . . 71.319999999999993 109.137 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.474 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 36.2 t -157.19 117.02 3.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.007 -1.058 . . . . 74.530000000000001 110.292 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' B' ' 77' ' ' ASN . 52.8 p30 -71.28 -10.5 59.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.409 -0.807 . . . . 64.5 109.292 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' B' ' 79' ' ' THR . 84.5 m-20 -132.9 77.06 69.39 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 108.47 -0.937 . . . . 74.25 108.47 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -55.59 73.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.561 2.174 . . . . 74.430000000000007 111.894 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.516 ' N ' ' O ' ' B' ' 77' ' ' ASN . 6.9 t -97.43 150.73 20.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.257 -0.902 . . . . 73.120000000000005 109.308 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -26.37 68.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.523 -0.736 . . . . 75.409999999999997 110.225 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . 0.439 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 2.5 mp0 -64.27 -39.97 95.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.978 -1.076 . . . . 72.239999999999995 109.823 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' B' ' 82' ' ' GLU . 0.1 OUTLIER -78.51 -29.11 46.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.086 -1.009 . . . . 73.219999999999999 109.627 -179.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.522 ' OE2' ' NE ' ' A' ' 100' ' ' ARG . 87.1 mt-10 -64.94 -48.29 74.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.034 -1.041 . . . . 74.299999999999997 109.659 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 27.0 m -67.77 -42.65 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 73.310000000000002 109.485 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' HIS . . . . . 0.439 ' ND1' ' O ' ' B' ' 81' ' ' GLU . 42.4 m80 -69.2 -25.9 64.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.167 -0.958 . . . . 73.239999999999995 109.533 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.55 -45.57 71.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 55.329999999999998 109.846 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -79.35 -28.07 42.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.057 -1.027 . . . . 74.450000000000003 109.044 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 31.0 tp10 -75.98 -51.67 11.88 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.335 -0.853 . . . . 64.040000000000006 109.563 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -61.87 -50.42 72.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.414 -0.804 . . . . 75.129999999999995 109.745 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 151.75 72.81 0.01 OUTLIER Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.749 -1.215 . . . . 75.420000000000002 110.308 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -134.43 136.43 43.25 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.288 -1.125 . . . . 73.420000000000002 108.843 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -89.21 -23.15 22.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.09 -1.006 . . . . 73.319999999999993 109.56 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 11.2 t0 -152.03 163.57 39.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.277 -0.889 . . . . 73.040000000000006 109.358 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.518 ' N ' ' OD1' ' B' ' 93' ' ' ASP . 76.7 t80 -146.64 99.28 3.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.382 -0.823 . . . . 74.310000000000002 109.252 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 20.8 mm -106.37 151.01 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.388 0 O-C-N 121.227 -0.921 . . . . 75.340000000000003 109.961 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.15 139.28 57.47 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.991 -1.114 . . . . 70.099999999999994 107.991 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.656 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -58.38 -55.13 48.86 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 120.744 -1.222 . . . . 65.430000000000007 111.146 -179.067 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 3.5 Cg_endo -41.75 -12.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.188 0 CA-C-N 119.619 0.9 . . . . 63.520000000000003 112.383 -176.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . 0.656 ' N ' ' O ' ' B' ' 97' ' ' LYS . 51.0 m-85 57.87 104.33 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.865 -0.522 . . . . 75.129999999999995 110.256 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -55.52 -39.22 70.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.829 -1.169 . . . . 74.230000000000004 108.042 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 10.6 t -170.32 131.96 0.99 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.919 -0.771 . . . . 64.510000000000005 108.919 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 4.1 mm -51.71 -41.61 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.951 . . . . 74.439999999999998 109.1 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -60.37 -36.34 77.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.228 -0.92 . . . . 72.299999999999997 109.264 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.41 -48.53 64.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 74.310000000000002 109.557 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 60.0 tp -60.96 -48.93 79.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 73.540000000000006 109.433 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.73 -43.83 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.167 -0.958 . . . . 72.030000000000001 110.028 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.27 -43.32 64.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.06 -1.025 . . . . 64.219999999999999 109.211 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -68.35 -33.77 74.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.337 -0.852 . . . . 75.310000000000002 109.606 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 95.3 mt -72.35 -34.51 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.054 -1.029 . . . . 55.439999999999998 108.571 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' B' ' 114' ' ' ARG . 80.6 tt0 -58.55 -56.82 17.17 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.575 -0.85 . . . . 65.310000000000002 108.987 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.85 -40.34 69.54 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.477 -0.764 . . . . 74.519999999999996 110.157 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -38.28 63.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.995 -1.066 . . . . 72.040000000000006 108.896 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.86 54.22 1.05 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.987 -1.071 . . . . 75.349999999999994 109.942 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' B' ' 110' ' ' GLU . 4.9 tmt_? -72.06 -43.68 64.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.129 -0.982 . . . . 75.5 108.987 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' PHE . . . . . 0.488 ' O ' ' N ' ' B' ' 117' ' ' GLY . 96.2 m-85 -67.75 -0.84 4.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.332 -0.855 . . . . 73.040000000000006 109.502 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 66.01 -55.5 0.37 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.561 -0.712 . . . . 74.450000000000003 110.158 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . 0.492 ' C ' ' HG ' ' B' ' 118' ' ' SER . . . -154.42 171.83 32.93 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.897 -1.281 . . . . 64.209999999999994 109.897 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' SER . . . . . 0.492 ' HG ' ' C ' ' B' ' 117' ' ' GLY . 41.1 m -156.58 -175.51 5.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.38 -1.071 . . . . 71.400000000000006 109.662 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.15 122.95 5.73 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.822 -0.751 . . . . 74.209999999999994 109.112 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 9.9 t -85.15 -42.88 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.214 -0.929 . . . . 75.019999999999996 110.119 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . 0.407 HD13 HG23 ' B' ' 121' ' ' ILE . 15.7 mm -97.11 132.66 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.07 -1.019 . . . . 74.239999999999995 109.819 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -114.0 121.46 43.96 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.987 -0.745 . . . . 73.329999999999998 108.987 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.534 ' CD1' HH12 ' B' ' 159' ' ' ARG . 73.4 mt -132.47 121.39 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.355 -0.841 . . . . 74.219999999999999 109.478 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' B' ' 123' ' ' ILE . . . 40.29 -122.61 2.01 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 110.518 -1.033 . . . . 72.409999999999997 110.518 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -97.1 -13.6 22.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.349 -1.089 . . . . 75.120000000000005 109.698 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' B' ' 123' ' ' ILE . 0.1 OUTLIER -95.45 143.41 26.81 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.127 -0.983 . . . . 75.420000000000002 109.406 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 20.3 p -121.27 145.79 47.49 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.101 -0.703 . . . . 74.219999999999999 109.101 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 78.0 mt -125.49 138.87 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.501 -0.749 . . . . 60.329999999999998 109.891 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 5.8 t -118.58 114.66 35.92 Favored Pre-proline 0 N--CA 1.499 1.997 0 N-CA-C 108.723 -0.843 . . . . 72.310000000000002 108.723 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.92 -53.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.651 1.567 . . . . 75.129999999999995 112.162 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -61.52 -40.82 96.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.163 -0.96 . . . . 75.230000000000004 109.459 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' B' ' 133' ' ' GLU . 23.7 tp10 -87.39 7.96 26.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.216 -0.928 . . . . 75.120000000000005 109.359 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' B' ' 132' ' ' GLU . 17.9 pt-20 34.33 54.06 0.6 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.252 0.549 . . . . 75.129999999999995 111.142 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -139.05 146.4 40.74 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.284 -0.885 . . . . 75.109999999999999 109.177 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 14.3 tt -126.11 142.39 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.543 -0.723 . . . . 70.319999999999993 109.1 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 7.2 mt -120.63 136.04 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.611 -0.681 . . . . 74.120000000000005 109.63 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . 0.414 ' C ' ' H ' ' B' ' 139' ' ' GLY . 48.4 t80 -138.4 134.69 34.44 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.42 -0.955 . . . . 74.230000000000004 108.42 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . 0.443 ' CG ' ' O ' ' B' ' 138' ' ' LYS . 12.4 ttmt 56.41 9.34 0.52 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.465 -0.772 . . . . 74.219999999999999 109.361 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' B' ' 137' ' ' TYR . . . 96.7 3.62 59.44 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 110.225 -1.15 . . . . 74.319999999999993 110.225 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -89.5 126.39 35.57 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.114 -1.227 . . . . 75.340000000000003 108.803 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -91.85 120.32 32.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.248 -0.907 . . . . 71.230000000000004 109.683 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 7.9 p -134.69 140.95 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 108.777 -0.823 . . . . 70.430000000000007 108.777 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -94.01 157.84 15.91 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.188 -0.945 . . . . 72.430000000000007 110.241 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -150.28 139.05 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.455 -0.778 . . . . 72.129999999999995 108.934 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 26.3 pttt -165.89 77.94 0.26 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.184 -0.948 . . . . 74.5 109.543 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -156.99 -129.83 1.17 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.085 -1.606 . . . . 42.229999999999997 109.085 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 0.632 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 73.2 mttt -80.32 -32.4 0.69 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.108 -1.231 . . . . 73.299999999999997 110.764 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . 0.632 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 71.5 Cg_endo -91.12 15.45 1.76 Allowed 'Trans proline' 0 N--CA 1.486 1.082 0 C-N-CA 122.203 1.935 . . . . 71.329999999999998 112.446 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -98.79 -59.13 1.79 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.238 -0.914 . . . . 74.230000000000004 109.345 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . 0.475 ' CG ' ' N ' ' B' ' 151' ' ' VAL . 18.6 pt-20 -61.09 -48.79 80.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.327 -0.858 . . . . 72.340000000000003 110.47 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . 0.475 ' N ' ' CG ' ' B' ' 150' ' ' GLU . 9.8 p -64.84 -43.39 96.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.811 -1.181 . . . . 73.349999999999994 110.449 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . 0.415 ' N ' ' CG1' ' B' ' 151' ' ' VAL . 12.9 tp -63.74 -53.62 48.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.14 -0.975 . . . . 74.430000000000007 110.518 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 16.5 p -72.23 -37.56 69.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.799 -1.188 . . . . 75.209999999999994 110.626 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -52.01 -53.49 41.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.76 -1.212 . . . . 73.040000000000006 109.706 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' B' ' 159' ' ' ARG . 2.7 pp -71.51 -23.09 61.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.93 -1.106 . . . . 73.430000000000007 109.865 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.66 -59.25 4.48 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.816 -1.177 . . . . 75.319999999999993 110.881 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -66.03 -47.73 73.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.601 -1.312 . . . . 73.319999999999993 108.84 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . 0.603 ' C ' ' H ' ' B' ' 160' ' ' ASP . 44.5 t-80 -67.51 -19.17 65.28 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.718 -1.216 . . . . 74.140000000000001 107.718 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . 0.723 ' O ' ' N ' ' B' ' 161' ' ' GLN . 7.2 tpt180 57.79 4.49 0.27 Allowed 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 107.287 -1.375 . . . . 73.420000000000002 107.287 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . 0.603 ' H ' ' C ' ' B' ' 158' ' ' HIS . 2.3 m-20 50.36 -40.22 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 123.228 0.611 . . . . 72.099999999999994 112.22 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . 0.723 ' N ' ' O ' ' B' ' 159' ' ' ARG . 24.1 mt-30 50.48 -142.63 0.65 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.215 -1.553 . . . . 73.239999999999995 109.138 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' ILE . . . . . 0.523 ' CD1' ' N ' ' B' ' 162' ' ' ILE . 1.9 mp -77.53 106.91 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.95 -1.094 . . . . 72.310000000000002 108.724 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 1.3 m -135.67 144.73 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.48 -0.763 . . . . 75.030000000000001 109.166 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 41.7 p -96.66 169.76 9.66 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.327 -0.858 . . . . 74.219999999999999 109.506 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -55.57 -39.68 70.98 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.297 -0.877 . . . . 72.420000000000002 109.168 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -62.74 -39.1 93.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.867 . . . . 63.450000000000003 109.313 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -60.13 -45.92 91.38 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.137 -0.977 . . . . 72.400000000000006 109.116 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 22.6 mt -61.94 -29.59 70.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.215 -0.928 . . . . 72.319999999999993 108.576 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 5.6 tt -66.81 -64.86 0.77 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.467 -0.771 . . . . 73.340000000000003 109.303 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -61.36 -17.44 53.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.878 . . . . 73.099999999999994 109.713 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.72 -61.0 2.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.292 -0.88 . . . . 62.130000000000003 110.123 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 8.2 mm -90.91 -54.33 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.128 -0.983 . . . . 74.439999999999998 109.401 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -90.4 111.07 22.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.311 -0.868 . . . . 72.230000000000004 109.166 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -140.01 -31.53 0.65 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.41 -0.806 . . . . 75.030000000000001 109.37 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . 0.551 ' C ' ' H ' ' B' ' 177' ' ' GLU . 0.7 OUTLIER -59.8 -177.53 0.11 Allowed Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 108.414 -0.958 . . . . 73.040000000000006 108.414 179.708 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' B' ' 175' ' ' GLU . 43.8 Cg_exo -57.19 8.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 122.459 2.106 . . . . 74.129999999999995 112.73 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . 0.551 ' H ' ' C ' ' B' ' 175' ' ' GLU . 79.0 mm-40 -50.97 -41.46 59.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.124 -0.985 . . . . 72.439999999999998 109.551 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 67.4 mtt 46.63 52.46 11.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.183 -0.948 . . . . 72.109999999999999 109.674 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 10.2 m -71.5 142.85 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.201 -0.937 . . . . 75.310000000000002 109.614 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 180' ' ' THR . . . . . 0.597 ' O ' ' N ' ' B' ' 182' ' ' ASN . 69.1 p -43.54 106.68 0.51 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.55 -0.719 . . . . 62.149999999999999 109.919 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -51.36 70.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 122.232 1.955 . . . . 74.340000000000003 112.674 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 182' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' B' ' 180' ' ' THR . 28.5 t-20 -174.86 -23.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.198 -0.939 . . . . 72.310000000000002 108.889 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 11.6 p -53.43 -14.47 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.397 -0.815 . . . . 65.420000000000002 109.401 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 20.9 mm -54.3 -25.74 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -0.879 . . . . 75.030000000000001 109.681 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -55.84 -45.4 78.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -0.952 . . . . 73.519999999999996 109.928 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 9.6 m -80.72 -30.39 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.131 -0.981 . . . . 74.349999999999994 110.105 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.97 76.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.95 -1.094 . . . . 61.119999999999997 109.938 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 10.4 tp -74.89 -38.9 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.554 -1.342 . . . . 72.430000000000007 109.83 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -70.5 -35.99 73.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.878 . . . . 75.420000000000002 111.282 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . 0.458 ' CG ' ' N ' ' B' ' 191' ' ' ILE . 10.6 pt20 -76.67 -47.12 23.11 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.859 -1.151 . . . . 74.140000000000001 111.449 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . 0.458 ' N ' ' CG ' ' B' ' 190' ' ' GLN . 5.8 pt -65.0 -40.35 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.693 -1.255 . . . . 74.030000000000001 110.699 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -69.81 -42.97 72.98 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.026 -1.046 . . . . 72.329999999999998 111.005 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -74.21 -35.4 63.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.937 -1.102 . . . . 73.099999999999994 111.279 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 8.6 pttp -79.57 -24.35 42.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.82 -1.175 . . . . 74.430000000000007 110.54 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 195' ' ' MET . . . . . 0.483 ' SD ' ' OD1' ' B' ' 196' ' ' ASP . 3.5 ppp? -93.01 -38.2 11.78 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.0 -1.063 . . . . 74.329999999999998 110.519 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 196' ' ' ASP . . . . . 0.483 ' OD1' ' SD ' ' B' ' 195' ' ' MET . 85.3 m-20 -59.22 -38.23 79.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.035 -1.041 . . . . 71.209999999999994 110.646 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -63.28 -60.19 10.16 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.962 -1.086 . . . . 75.209999999999994 110.381 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 198' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.56 -59.58 0.24 Allowed 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 121.694 1.596 . . . . 75.319999999999993 112.402 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 10.6 mp -56.04 -42.45 76.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.994 -1.066 . . . . 72.25 109.203 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 82.34 -30.25 3.08 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.004 -1.239 . . . . 73.239999999999995 110.004 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . 0.415 HG22 HD11 ' B' ' 201' ' ' ILE . 24.9 mm -91.44 129.11 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.025 -1.279 . . . . 54.299999999999997 109.435 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 42.0 t -88.13 139.76 30.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.83 . . . . 74.310000000000002 108.992 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 25.2 p -139.59 25.62 2.38 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.31 -0.869 . . . . 74.400000000000006 109.304 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 23.1 m -143.86 145.86 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.245 -0.909 . . . . 74.099999999999994 109.873 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -114.35 137.65 51.54 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.72 -0.613 . . . . 75.329999999999998 109.576 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.58 111.43 23.8 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.289 -0.882 . . . . 71.400000000000006 108.969 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.7 t -138.36 142.38 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.286 -0.884 . . . . 63.5 109.498 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 208' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' B' ' 209' ' ' ARG . 32.7 ptt-85 -85.26 -24.65 27.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.216 -0.927 . . . . 74.450000000000003 109.642 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' B' ' 208' ' ' ARG . 96.0 mtt180 -57.5 -110.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.322 -0.861 . . . . 74.140000000000001 109.968 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 39.4 mmt-85 -51.12 -45.21 61.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.111 -0.993 . . . . 74.430000000000007 109.59 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 147.79 -130.83 3.64 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.35 -1.5 . . . . 70.109999999999999 109.35 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -104.59 131.24 52.24 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.365 -1.079 . . . . 74.209999999999994 108.779 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -105.01 146.52 28.94 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.437 -0.79 . . . . 74.299999999999997 109.902 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -128.39 104.12 7.53 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.408 -0.96 . . . . 74.340000000000003 108.408 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' B' ' 216' ' ' TYR . 50.8 t -127.66 169.01 14.26 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.2 -0.937 . . . . 72.209999999999994 110.49 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . 0.528 ' N ' ' SG ' ' B' ' 215' ' ' CYS . 47.6 m-85 -63.63 152.14 86.75 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.586 -0.696 . . . . 72.310000000000002 109.173 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.92 -162.08 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.212 1.941 . . . . 71.010000000000005 111.725 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -47.73 154.36 0.95 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.222 -0.924 . . . . 74.349999999999994 109.018 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -37.09 124.31 0.44 Allowed 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.364 2.043 . . . . 71.319999999999993 112.286 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . 0.469 ' C ' ' H ' ' B' ' 222' ' ' GLU . . . -97.34 39.29 1.2 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.281 -0.887 . . . . 75.450000000000003 109.771 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 5.5 p -77.03 32.19 0.14 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.166 -0.959 . . . . 72.219999999999999 109.647 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.469 ' H ' ' C ' ' B' ' 220' ' ' ALA . 27.6 mp0 48.5 -171.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 74.299999999999997 109.557 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 118.031 -0.985 . . . . 71.129999999999995 109.277 -179.9 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.2 ttm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.435 -0.579 . . . . 65.120000000000005 109.435 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.437 ' N ' ' OD2' ' A' ' 46' ' ' ASP . 61.2 ttm-85 -143.08 150.75 39.94 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.263 -0.898 . . . . 73.310000000000002 109.322 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 81.4 t -120.25 134.82 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-O 121.5 0.667 . . . . 71.420000000000002 110.091 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.401 ' O ' ' O ' ' A' ' 49' ' ' MET . 8.9 tp -100.25 115.97 31.14 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.645 -0.872 . . . . 65.219999999999999 108.645 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 25.2 tp -117.39 99.55 7.08 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.582 -0.699 . . . . 71.439999999999998 109.756 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.485 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 7.8 mt -94.35 119.36 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.753 -1.217 . . . . 71.150000000000006 108.953 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -149.26 121.9 8.61 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.199 -0.938 . . . . 75.340000000000003 109.603 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -65.84 -32.97 74.79 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.265 -0.897 . . . . 73.040000000000006 108.996 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -87.27 107.34 18.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.355 -0.841 . . . . 72.420000000000002 109.363 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.2 t -65.99 -18.37 65.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 72.340000000000003 109.671 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.45 -55.82 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.16 -0.963 . . . . 74.420000000000002 109.904 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' A' ' 12' ' ' LEU . 3.5 mm? -69.39 -38.86 78.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.255 -0.903 . . . . 72.010000000000005 109.557 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.13 -28.67 63.84 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.693 -1.763 . . . . 72.140000000000001 108.693 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.28 -45.51 95.01 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.515 -1.434 . . . . 72.329999999999998 109.515 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -67.46 -45.91 74.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -1.129 . . . . 72.340000000000003 109.905 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.408 HD13 HG22 ' A' ' 16' ' ' ILE . 98.6 mt -64.0 -42.03 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.623 -1.298 . . . . 74.239999999999995 108.641 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -54.01 -50.81 65.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.901 . . . . 71.409999999999997 109.521 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -85.11 1.98 45.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.123 -0.986 . . . . 75.540000000000006 109.076 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.97 -60.73 2.01 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 109.737 -1.345 . . . . 62.149999999999999 109.737 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -69.46 -22.9 63.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.203 -1.175 . . . . 74.420000000000002 109.796 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -59.05 -32.89 70.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.04 -1.037 . . . . 74.25 109.339 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.4 t -58.71 -34.04 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.445 -0.785 . . . . 72.109999999999999 109.374 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 2.4 mptp? -68.39 -1.21 5.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 73.230000000000004 109.315 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.37 35.09 11.04 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.74 -1.344 . . . . 75.540000000000006 109.74 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -115.78 159.62 21.2 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.488 -1.007 . . . . 74.510000000000005 109.143 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.7 mmt -104.09 138.13 41.05 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.45 -0.945 . . . . 64.319999999999993 108.45 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.75 164.2 31.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.913 . . . . 74.310000000000002 109.771 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -139.08 149.88 45.08 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.434 -0.791 . . . . 75.400000000000006 108.977 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.48 129.0 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.705 -0.85 . . . . 75.129999999999995 108.705 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.3 p -133.1 167.93 19.44 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.452 -0.78 . . . . 71.420000000000002 109.752 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.485 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 3.0 pt-20 -98.6 -96.14 0.23 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.398 -0.814 . . . . 73.109999999999999 109.747 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.5 p -79.96 164.25 23.64 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.015 -1.053 . . . . 74.239999999999995 110.007 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 37' ' ' GLU . 21.8 mt -54.77 -38.95 67.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.513 -0.742 . . . . 71.530000000000001 109.819 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -52.57 -44.21 65.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 74.230000000000004 109.814 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -65.3 -42.47 93.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.107 -0.996 . . . . 71.010000000000005 109.665 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.03 -30.6 50.81 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.062 -1.215 . . . . 61.409999999999997 110.062 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 33' ' ' LEU . 78.2 tt0 -66.74 -46.45 75.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.126 -1.22 . . . . 74.340000000000003 110.099 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.442 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 48.2 m-85 -78.92 -24.11 44.27 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.092 -1.005 . . . . 75.329999999999998 109.959 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.8 tp -85.49 -29.23 24.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.005 -1.06 . . . . 74.329999999999998 109.81 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.562 ' SD ' ' CE1' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -86.82 -36.81 18.29 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.069 -1.02 . . . . 70.319999999999993 110.633 -179.164 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 30.5 p-10 -58.73 -30.77 67.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.935 -1.103 . . . . 71.219999999999999 110.238 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.531 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 10.1 pt -78.17 -31.64 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.071 -1.018 . . . . 74.409999999999997 110.104 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 40' ' ' MET . 79.9 mtt85 -108.44 171.82 7.19 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.341 -0.849 . . . . 75.409999999999997 109.682 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.514 ' ND2' ' H ' ' A' ' 45' ' ' TYR . 1.8 t-20 -86.93 148.73 25.22 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.203 -0.936 . . . . 75.420000000000002 109.184 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.565 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 0.5 OUTLIER -139.0 128.65 24.63 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.282 -0.886 . . . . 74.230000000000004 109.509 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.446 ' OD1' ' CD2' ' A' ' 113' ' ' LEU . 3.7 p30 -108.08 -41.99 4.78 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.844 -0.798 . . . . 75.319999999999993 108.844 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.8 112.84 25.97 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.074 -1.084 . . . . 72.129999999999995 108.074 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.24 96.86 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.445 -0.946 . . . . 72.340000000000003 108.445 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.405 ' C ' ' SD ' ' A' ' 49' ' ' MET . 0.8 OUTLIER -116.47 123.87 48.55 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.685 0.755 . . . . 74.109999999999999 109.857 -179.477 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.484 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 1.1 p -131.21 131.93 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 121.632 0.729 . . . . 71.239999999999995 109.41 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.2 p -91.38 3.5 54.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.522 -0.736 . . . . 73.109999999999999 109.303 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 1.6 m-20 -78.99 138.34 38.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.269 -0.894 . . . . 63.399999999999999 109.6 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.529 ' C ' ' H ' ' A' ' 55' ' ' ALA . 14.9 mmmt -76.83 -36.18 57.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.214 -0.929 . . . . 65.439999999999998 110.11 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -70.54 12.38 0.26 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.081 -1.012 . . . . 73.129999999999995 109.537 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.529 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -69.25 -20.9 63.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.412 -0.805 . . . . 64.140000000000001 110.399 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 55' ' ' ALA . 20.3 mt -40.0 -50.46 2.55 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.468 -0.77 . . . . 74.430000000000007 110.395 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.7 t -69.08 -33.56 73.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.033 -1.042 . . . . 63.229999999999997 108.957 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.466 ' N ' ' O ' ' A' ' 55' ' ' ALA . 50.9 t80 -66.91 -59.32 3.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.468 -0.77 . . . . 74.439999999999998 109.938 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.1 m -52.22 -34.14 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.715 -1.24 . . . . 74.030000000000001 109.492 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.5 m -58.49 -54.02 51.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.2 -0.938 . . . . 73.540000000000006 109.715 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -66.85 -27.86 67.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.111 -0.993 . . . . 73.340000000000003 109.978 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.6 mm -67.05 -45.73 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.901 -1.124 . . . . 73.349999999999994 110.185 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 67' ' ' SER . 53.7 mmtt -65.16 -46.44 80.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 74.420000000000002 110.645 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 6.6 pt-20 -70.35 -41.83 72.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.716 -1.24 . . . . 74.549999999999997 109.953 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.491 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 25.9 mtpp -76.29 -19.12 58.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.143 -0.973 . . . . 75.219999999999999 109.313 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.491 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 83.2 m-70 -156.29 68.1 0.6 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.888 . . . . 74.129999999999995 109.282 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 63' ' ' LYS . 82.5 p -65.49 -15.87 63.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 73.239999999999995 109.914 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 92.8 p -88.32 43.82 1.16 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.191 -0.943 . . . . 71.439999999999998 110.329 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.9 tt -145.11 169.13 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.989 -1.069 . . . . 71.329999999999998 109.582 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.1 t -102.1 148.66 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.263 -0.898 . . . . 73.019999999999996 109.424 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.5 t -131.5 126.49 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.376 -0.828 . . . . 54.210000000000001 109.76 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.8 tt -120.11 100.97 7.51 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.111 -0.7 . . . . 74.209999999999994 109.111 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.7 p -97.09 131.32 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.982 -1.074 . . . . 74.409999999999997 109.153 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 75' ' ' SER . 4.5 p -92.86 174.98 6.97 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.086 -1.009 . . . . 72.310000000000002 109.378 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.531 ' OG ' ' CE2' ' A' ' 94' ' ' TYR . 50.9 m -164.49 116.09 1.26 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.083 -1.01 . . . . 64.540000000000006 110.371 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.8 -28.56 68.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.525 -0.734 . . . . 74.129999999999995 109.306 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.516 ' OD1' ' NZ ' ' A' ' 53' ' ' LYS . 13.0 p30 -109.6 71.13 0.52 Allowed Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.657 -0.652 . . . . 73.340000000000003 109.41 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.01 80.45 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.654 1.569 . . . . 71.319999999999993 111.769 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 77' ' ' ASN . 1.8 t -104.72 162.49 13.25 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.656 -0.868 . . . . 62.530000000000001 108.656 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.8 p -71.36 -29.11 64.59 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.166 -0.959 . . . . 74.140000000000001 109.864 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -62.77 -45.57 92.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 71.420000000000002 109.475 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -76.49 -29.72 56.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.281 -0.887 . . . . 73.430000000000007 109.639 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -63.73 -57.01 11.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.954 . . . . 74.219999999999999 109.611 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.2 m -60.34 -42.18 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.14 -0.975 . . . . 74.150000000000006 108.987 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.504 ' CE1' HE21 ' A' ' 89' ' ' GLN . 82.4 t60 -62.95 -35.44 80.12 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.298 -0.876 . . . . 72.540000000000006 109.219 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.82 -37.38 84.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.416 -0.803 . . . . 64.219999999999999 109.861 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -77.08 -29.91 55.19 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.047 -1.033 . . . . 74.340000000000003 108.818 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.34 -36.3 68.79 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.714 -0.794 . . . . 74.420000000000002 109.229 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.504 HE21 ' CE1' ' A' ' 85' ' ' HIS . 90.2 mm-40 -66.58 -51.29 58.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.364 -0.835 . . . . 74.519999999999996 109.478 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.85 44.3 0.06 OUTLIER Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.742 -1.343 . . . . 74.209999999999994 109.742 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -99.72 135.88 40.47 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.21 -1.171 . . . . 64.099999999999994 109.416 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.524 ' OD2' ' NH1' ' A' ' 112' ' ' ARG . 45.9 t0 -82.38 -25.05 34.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 73.420000000000002 109.314 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.528 ' OD2' ' NH2' ' A' ' 112' ' ' ARG . 72.0 m-20 -149.75 155.76 40.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.349 -0.845 . . . . 75.040000000000006 109.249 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.531 ' CE2' ' OG ' ' A' ' 75' ' ' SER . 55.3 t80 -137.4 103.38 5.06 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.735 -0.839 . . . . 71.329999999999998 108.735 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.511 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -107.6 151.94 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.651 0.738 . . . . 74.510000000000005 110.001 -177.508 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.36 130.27 39.35 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.693 -1.225 . . . . 64.319999999999993 107.693 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.697 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -49.89 -55.67 22.34 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 120.988 -1.07 . . . . 74.510000000000005 111.835 -178.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 2.2 Cg_endo -40.21 -11.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 120.895 1.063 . . . . 73.109999999999999 113.101 -176.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.697 ' N ' ' O ' ' A' ' 97' ' ' LYS . 56.5 m-85 59.08 121.07 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.644 -0.66 . . . . 72.540000000000006 110.189 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.547 ' HE ' ' CB ' ' B' ' 80' ' ' SER . 0.0 OUTLIER -56.71 -46.63 81.15 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.047 -1.094 . . . . 74.540000000000006 108.047 179.077 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.764 ' O ' ' N ' ' A' ' 103' ' ' LYS . 22.7 t -175.11 53.69 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.236 -0.915 . . . . 74.140000000000001 110.498 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 11.4 mm 49.08 -69.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.591 -0.693 . . . . 75.430000000000007 110.796 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.764 ' N ' ' O ' ' A' ' 101' ' ' SER . 2.4 mppt? -55.29 -18.34 6.17 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.988 -1.116 . . . . 74.140000000000001 107.988 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.08 -97.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.582 -0.699 . . . . 63.240000000000002 110.405 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.437 ' CD2' ' N ' ' A' ' 105' ' ' LEU . 2.0 pt? -49.83 -36.18 25.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.137 -0.977 . . . . 73.219999999999999 110.226 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.48 -39.85 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.881 -1.137 . . . . 74.540000000000006 108.903 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 103' ' ' LYS . . . -64.13 -31.86 73.21 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.193 -0.942 . . . . 75.5 108.57 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.1 ttp-105 -81.91 -24.83 35.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.457 -0.777 . . . . 74.409999999999997 109.745 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.425 HG23 HD11 ' A' ' 109' ' ' ILE . 65.6 mt -75.53 -37.4 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.032 -1.043 . . . . 73.239999999999995 108.705 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.5 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 11.8 pt-20 -76.21 -35.33 59.1 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.561 -0.856 . . . . 74.340000000000003 109.353 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.71 -45.35 94.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.431 -0.793 . . . . 73.319999999999993 109.863 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.528 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 23.3 ttm180 -66.06 -50.83 62.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.119 -0.988 . . . . 74.420000000000002 109.596 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.446 ' CD2' ' OD1' ' A' ' 46' ' ' ASP . 10.1 mp -95.51 38.29 1.16 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.14 -0.975 . . . . 74.329999999999998 109.206 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.37 -55.2 5.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.262 -0.899 . . . . 74.439999999999998 109.176 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -85.07 13.53 6.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -0.869 . . . . 74.430000000000007 109.617 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 60.4 t-105 -48.98 105.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 74.439999999999998 109.537 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 157.85 -136.89 5.04 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.629 -1.388 . . . . 75.040000000000006 109.629 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.8 t 54.21 177.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.425 -1.044 . . . . 70.109999999999999 110.049 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.7 150.71 26.53 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.059 -0.719 . . . . 65.239999999999995 109.059 -178.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.0 t -90.31 -41.48 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.155 -0.966 . . . . 74.219999999999999 109.581 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 17.1 mm -100.13 135.84 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.348 -0.845 . . . . 74.420000000000002 109.586 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -148.54 127.18 12.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 73.299999999999997 109.048 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 6.5 tp -154.42 128.09 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 75.340000000000003 108.994 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 53.47 -139.4 35.02 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.946 -1.661 . . . . 75.129999999999995 108.946 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 125' ' ' ASP . 14.3 p-10 -93.51 6.39 48.38 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.089 -1.242 . . . . 74.450000000000003 109.154 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.05 135.14 38.23 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.638 -0.875 . . . . 54.210000000000001 108.638 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.1 m -131.97 138.63 48.38 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.405 -0.809 . . . . 70.239999999999995 109.408 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.8 mt -138.85 139.92 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.332 -0.855 . . . . 72.430000000000007 109.184 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.8 m -123.36 82.33 52.65 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.604 -0.685 . . . . 71.109999999999999 109.392 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.46 -41.09 75.93 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.56 2.174 . . . . 75.140000000000001 112.115 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -56.07 -44.78 79.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 72.5 109.064 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -87.15 2.13 50.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.409 -0.807 . . . . 73.140000000000001 108.868 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 1.299 ' HB3' ' CZ ' ' A' ' 149' ' ' PHE . 21.4 mt-10 49.71 61.75 3.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.422 -0.798 . . . . 75.329999999999998 109.058 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -149.02 135.61 19.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.252 -0.905 . . . . 71.230000000000004 109.808 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 11.6 tt -107.86 136.24 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.434 -0.95 . . . . 75.329999999999998 108.434 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 47.7 mt -128.86 125.18 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.364 -0.835 . . . . 71.109999999999999 109.947 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.431 ' N ' ' CD1' ' A' ' 137' ' ' TYR . 16.5 p90 -139.3 147.25 41.38 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.454 -0.779 . . . . 74.140000000000001 109.152 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 54.9 mttp 54.33 23.87 4.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.451 -0.78 . . . . 75.400000000000006 110.05 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 79.44 -1.35 77.15 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.44 -1.064 . . . . 72.239999999999995 110.44 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -90.17 135.53 33.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.953 -1.322 . . . . 73.120000000000005 108.89 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -101.52 131.07 47.88 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.401 -0.812 . . . . 72.319999999999993 109.695 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 49.8 t -137.81 127.65 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.956 -0.757 . . . . 62.340000000000003 108.956 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -81.36 139.28 35.43 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.254 -0.904 . . . . 61.229999999999997 109.336 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.404 ' O ' ' CD1' ' A' ' 149' ' ' PHE . 12.2 m -142.6 137.09 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.252 -0.905 . . . . 74.439999999999998 109.53 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 1.125 ' HA ' ' CG ' ' A' ' 149' ' ' PHE . 49.5 pttt -171.45 28.57 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 75.420000000000002 109.214 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.19 -145.8 3.33 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.93 -1.268 . . . . 73.340000000000003 109.93 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -70.87 -38.61 7.61 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 121.357 -1.084 . . . . 72.219999999999999 110.426 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 90.5 Cg_endo -86.66 11.82 3.17 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.008 1.806 . . . . 75.450000000000003 111.853 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 1.299 ' CZ ' ' HB3' ' A' ' 133' ' ' GLU . 32.3 t80 -79.75 -34.83 39.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.418 -0.801 . . . . 65.239999999999995 109.425 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -74.41 -38.03 63.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 72.519999999999996 110.168 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 152' ' ' LEU . 11.5 p -74.76 -40.58 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.09 -1.006 . . . . 74.209999999999994 109.506 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.419 ' N ' ' CG1' ' A' ' 151' ' ' VAL . 20.4 tp -58.94 -45.63 89.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 73.310000000000002 109.216 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.7 p -65.82 -37.08 85.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 74.310000000000002 109.373 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.419 ' CE1' ' HD1' ' A' ' 158' ' ' HIS . 18.3 t-80 -52.94 -54.96 27.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.374 -0.829 . . . . 75.450000000000003 109.94 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 4.4 pp -76.33 -19.6 58.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 75.340000000000003 110.067 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.28 94.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.009 -1.057 . . . . 62.140000000000001 109.464 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.481 ' C ' ' H ' ' A' ' 159' ' ' ARG . 60.4 mtp180 -79.55 -51.58 9.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.185 -0.947 . . . . 72.219999999999999 109.35 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.458 ' C ' ' H ' ' A' ' 160' ' ' ASP . 62.0 m170 -73.32 43.5 0.13 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.487 -0.758 . . . . 74.120000000000005 109.172 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.748 HH12 ' NE2' ' B' ' 161' ' ' GLN . 0.2 OUTLIER -74.72 30.77 0.09 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.579 -0.7 . . . . 74.340000000000003 110.213 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 158' ' ' HIS . 63.3 t0 -165.2 66.4 0.13 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.922 -1.111 . . . . 75.450000000000003 110.131 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.53 HE22 ' CG2' ' A' ' 163' ' ' VAL . 2.1 pp0? -177.89 178.75 0.93 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.125 -0.984 . . . . 73.409999999999997 109.802 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.428 HD12 HG22 ' A' ' 162' ' ' ILE . 14.1 mm -97.44 125.67 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.309 -0.869 . . . . 74.409999999999997 109.358 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.53 ' CG2' HE22 ' A' ' 161' ' ' GLN . 18.6 t -104.5 132.82 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.376 -0.827 . . . . 72.530000000000001 109.197 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.7 t -87.31 141.59 28.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.15 -0.969 . . . . 74.120000000000005 109.321 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 33.1 mttt -51.69 -45.63 63.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 70.430000000000007 108.77 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -56.55 -37.64 70.8 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 74.319999999999993 109.1 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.17 -40.87 71.17 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.158 -0.964 . . . . 74.519999999999996 109.296 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 74.8 mt -62.62 -49.17 76.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 74.409999999999997 109.918 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.4 tp -75.77 -65.46 0.9 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.787 -1.195 . . . . 75.140000000000001 109.84 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -39.45 -31.01 0.08 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 122.164 -0.335 . . . . 65.030000000000001 111.892 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.75 -39.88 9.64 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.774 -1.204 . . . . 70.209999999999994 112.519 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.528 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 1.3 mp -85.31 -60.16 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 120.535 -1.353 . . . . 75.319999999999993 111.709 -177.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.464 ' CD2' ' C ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -61.96 -7.14 3.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.79 -1.194 . . . . 73.140000000000001 110.049 -177.83 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.9 -24.91 59.84 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.962 -1.086 . . . . 73.239999999999995 110.133 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.451 ' CB ' ' CD ' ' A' ' 176' ' ' PRO . 1.7 mp0 -79.38 -66.17 0.28 Allowed Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 120.828 -1.17 . . . . 63.329999999999998 110.054 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' A' ' 175' ' ' GLU . 41.3 Cg_endo -64.53 -32.47 59.06 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.198 1.932 . . . . 72.510000000000005 111.579 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 52.86 22.3 2.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.495 -0.753 . . . . 75.340000000000003 110.379 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.449 ' O ' ' O ' ' A' ' 179' ' ' VAL . 26.6 ttt -77.75 -49.58 14.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.032 -1.042 . . . . 74.510000000000005 108.947 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 178' ' ' MET . 0.5 OUTLIER 60.08 128.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-O 121.675 0.75 . . . . 65.219999999999999 109.107 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 5.3 p -151.42 153.52 32.44 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.28 -0.887 . . . . 73.219999999999999 108.796 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 183' ' ' VAL . 59.9 Cg_exo -35.92 -37.18 0.22 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 122.342 2.028 . . . . 62.43 112.017 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -76.01 46.17 0.38 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.395 -0.965 . . . . 73.129999999999995 108.395 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.422 ' H ' ' C ' ' A' ' 181' ' ' PRO . 26.8 m -62.05 -135.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.541 -0.724 . . . . 74.019999999999996 110.365 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 57.3 mt -62.9 -31.87 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.287 -0.883 . . . . 72.329999999999998 109.636 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -45.64 -56.3 5.36 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.594 -0.692 . . . . 74.400000000000006 110.3 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 87.3 t -80.9 -52.69 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -0.946 . . . . 74.319999999999993 110.54 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -46.06 -47.47 17.08 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.023 -1.048 . . . . 73.230000000000004 110.387 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.461 ' CG2' ' N ' ' A' ' 189' ' ' ASN . 0.2 OUTLIER -71.95 -46.86 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.837 -1.164 . . . . 74.310000000000002 109.693 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.461 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 46.8 t-20 -56.13 -40.88 74.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.951 -1.093 . . . . 73.439999999999998 110.334 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 194' ' ' LYS . 25.6 mt-30 -72.9 -48.24 38.91 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.027 -1.045 . . . . 71.420000000000002 110.298 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 58.5 mt -49.12 -36.18 8.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 120.65 -1.281 . . . . 72.439999999999998 110.242 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 20.7 mtm-85 -76.04 -59.21 2.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.856 -1.153 . . . . 64.219999999999999 111.057 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.43 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 86.6 mt-30 -71.08 -14.53 62.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.13 -0.981 . . . . 74.319999999999993 110.775 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 190' ' ' GLN . 33.3 ttpt -91.17 -36.88 13.7 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.17 -0.956 . . . . 75.310000000000002 110.042 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 9.3 tpt -89.89 -4.1 57.72 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.294 -0.879 . . . . 74.019999999999996 109.701 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 197' ' ' LYS . 33.7 p-10 -68.2 -44.31 76.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.089 -1.007 . . . . 74.019999999999996 110.652 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.537 ' N ' ' OD1' ' A' ' 196' ' ' ASP . 8.9 mttm -75.84 -53.44 2.42 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.944 -1.098 . . . . 75.430000000000007 110.017 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -47.03 -61.36 0.62 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.899 1.733 . . . . 72.319999999999993 112.214 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 33.8 tp -70.61 -43.72 68.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 74.540000000000006 109.314 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 91.38 -19.45 47.06 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.985 -1.246 . . . . 61.509999999999998 109.985 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 29.9 mm -111.32 133.44 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.415 -1.05 . . . . 74.25 109.576 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 14.4 t -85.35 134.42 34.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 72.0 109.123 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 43.9 p -144.23 29.05 1.32 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.238 -0.914 . . . . 74.439999999999998 109.595 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.48 125.2 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.386 -0.821 . . . . 71.129999999999995 109.483 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -107.12 129.07 54.88 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.485 -0.759 . . . . 73.510000000000005 109.147 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 81.0 p -93.35 120.71 33.94 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.21 -0.932 . . . . 73.519999999999996 109.414 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.49 143.1 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.366 -0.834 . . . . 72.150000000000006 109.051 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -75.69 -33.06 60.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 72.400000000000006 110.067 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 211' ' ' GLY . 44.9 mmm-85 -60.97 145.89 48.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.098 -1.001 . . . . 73.310000000000002 109.553 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 64.1 mtp85 48.64 -91.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.386 -0.821 . . . . 71.540000000000006 109.734 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . -160.27 -124.99 0.76 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.494 -1.443 . . . . 74.450000000000003 109.494 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -101.5 141.84 33.76 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.352 -1.087 . . . . 75.540000000000006 109.236 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.501 ' NH1' ' HG ' ' A' ' 215' ' ' CYS . 66.1 ttt-85 -109.03 127.28 53.96 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.514 -0.741 . . . . 75.310000000000002 109.789 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -109.66 124.02 50.47 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.646 -0.872 . . . . 75.409999999999997 108.646 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . 0.501 ' HG ' ' NH1' ' A' ' 213' ' ' ARG . 4.8 p -140.91 167.32 22.48 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.34 -0.85 . . . . 74.140000000000001 109.923 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -61.71 150.78 80.89 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.384 -0.823 . . . . 75.319999999999993 108.947 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -39.46 137.91 0.88 Allowed 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 121.852 1.701 . . . . 73.109999999999999 111.99 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.605 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 2.8 tppt? -76.96 -36.49 1.59 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.114 -0.991 . . . . 75.25 110.375 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 75.5 Cg_endo -91.48 32.43 0.3 Allowed 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 122.431 2.088 . . . . 75.099999999999994 112.419 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -53.69 134.46 41.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.154 -0.966 . . . . 71.140000000000001 109.448 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 74.8 m -83.26 -34.14 25.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.307 -0.871 . . . . 71.129999999999995 109.572 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 48.07 21.25 0.31 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 75.349999999999994 109.611 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.042 -0.98 . . . . 73.409999999999997 109.473 -179.908 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.573 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.418 -0.586 . . . . 75.239999999999995 109.418 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 1.217 ' CZ ' ' NH2' ' B' ' 43' ' ' ARG . 88.9 mtt-85 -131.21 142.34 50.17 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.507 -0.745 . . . . 73.519999999999996 109.721 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 88.2 t -107.7 123.07 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.611 -0.681 . . . . 72.239999999999995 109.709 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' B' ' 49' ' ' MET . 2.4 tp -91.24 114.43 26.95 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.094 -1.076 . . . . 73.340000000000003 108.094 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 4.4 tp -117.11 111.71 19.87 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.912 -0.773 . . . . 74.349999999999994 108.912 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 20.0 mt -106.59 123.58 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.445 -0.785 . . . . 63.439999999999998 109.02 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.439 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 21.8 tp10 -140.41 120.25 13.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.345 -0.847 . . . . 74.519999999999996 109.274 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -66.44 -30.81 71.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.158 -0.963 . . . . 74.129999999999995 109.283 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -64.24 -128.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.217 -0.927 . . . . 74.230000000000004 109.033 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 79.2 p -167.06 -66.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.11 -0.994 . . . . 65.540000000000006 109.658 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.52 -40.96 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 75.549999999999997 109.907 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -52.14 -43.23 63.93 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.024 -1.048 . . . . 70.140000000000001 108.725 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.94 -28.35 68.85 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 108.508 -1.837 . . . . 75.400000000000006 108.508 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.61 -51.52 53.42 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 109.72 -1.352 . . . . 65.439999999999998 109.72 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -60.82 -45.04 96.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -1.114 . . . . 72.200000000000003 109.931 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 5.6 mm -67.26 -38.73 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.828 -1.17 . . . . 75.150000000000006 108.924 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.525 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 84.0 tt0 -62.73 -42.52 99.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 73.010000000000005 109.791 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -88.58 -0.53 57.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.931 -1.106 . . . . 74.299999999999997 108.916 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.1 -53.39 3.32 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 109.551 -1.419 . . . . 70.540000000000006 109.551 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -73.83 -24.59 59.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -1.121 . . . . 75.430000000000007 109.654 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 96.2 m-20 -58.96 -34.75 72.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.158 -0.964 . . . . 73.200000000000003 109.485 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 90.9 t -55.74 -45.29 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.416 -0.802 . . . . 74.230000000000004 109.379 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 50.3 mmtt -54.2 -49.67 68.85 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.382 -0.824 . . . . 73.519999999999996 108.827 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.77 41.21 0.15 Allowed Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.1 -1.2 . . . . 53.43 110.1 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -120.38 160.13 23.69 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.395 -1.062 . . . . 71.120000000000005 109.532 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.1 mmt -100.47 139.41 36.2 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.957 -1.127 . . . . 75.239999999999995 107.957 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.28 160.43 41.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.168 -0.957 . . . . 73.25 110.314 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -135.2 141.31 45.82 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.607 -0.886 . . . . 72.310000000000002 108.607 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 1.1 m -107.59 126.96 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.332 -0.855 . . . . 72.140000000000001 109.103 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.7 p -125.13 161.85 25.9 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.616 -0.678 . . . . 74.530000000000001 109.25 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.466 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 1.7 pt-20 -88.2 -97.67 0.09 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.27 -0.894 . . . . 71.019999999999996 109.796 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.3 t -78.8 152.39 31.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.895 . . . . 71.400000000000006 110.007 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 1.6 mp -50.59 -26.29 5.14 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.562 -0.711 . . . . 71.239999999999995 109.711 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -58.61 -48.29 81.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.96 . . . . 74.319999999999993 109.872 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.466 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 68.5 m-20 -59.88 -43.74 94.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.969 . . . . 73.030000000000001 109.258 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.06 -29.59 68.71 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.2 -1.56 . . . . 60.43 109.2 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -65.66 -43.66 88.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.358 -1.084 . . . . 74.430000000000007 109.816 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -80.28 -33.5 37.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.997 -1.064 . . . . 74.420000000000002 109.57 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 11.3 tp -72.88 -39.23 66.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.345 -0.847 . . . . 75.409999999999997 109.776 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.43 ' O ' ' O ' ' B' ' 43' ' ' ARG . 2.9 ppp? -75.79 -21.93 56.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.962 . . . . 61.439999999999998 109.833 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -60.73 -35.85 77.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.135 -0.978 . . . . 74.319999999999993 109.531 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 11.3 pt -92.4 -24.81 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.28 -0.888 . . . . 71.230000000000004 110.031 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 1.217 ' NH2' ' CZ ' ' B' ' 2' ' ' ARG . 54.4 mtp180 -124.9 139.47 53.8 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.335 -0.853 . . . . 73.409999999999997 109.537 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -101.35 143.38 31.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.3 -0.875 . . . . 63.539999999999999 109.62 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -114.85 143.5 45.01 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.967 -0.753 . . . . 73.109999999999999 108.967 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' B' ' 2' ' ' ARG . 8.3 p-10 -82.08 -36.92 27.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.077 -1.015 . . . . 62.219999999999999 109.276 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.409 ' C ' ' CD1' ' B' ' 47' ' ' LEU . 0.8 OUTLIER -109.41 109.72 20.65 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.639 -0.875 . . . . 73.120000000000005 108.639 179.608 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 63.5 t -94.46 100.57 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.282 -0.886 . . . . 74.109999999999999 109.197 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 0.3 OUTLIER -116.93 124.98 50.76 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.669 -0.863 . . . . 73.439999999999998 108.669 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.406 HG21 ' H ' ' B' ' 52' ' ' ASP . 0.2 OUTLIER -143.85 130.43 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.278 -0.889 . . . . 73.400000000000006 109.342 -179.451 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' SER . . . . . 0.439 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 75.4 p -107.21 27.92 8.58 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.691 -0.631 . . . . 73.209999999999994 109.54 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.406 ' H ' HG21 ' B' ' 50' ' ' VAL . 44.8 m-20 -86.86 159.02 19.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -0.927 . . . . 70.409999999999997 109.486 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' B' ' 55' ' ' ALA . 94.0 mttt -81.63 175.8 10.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.321 -0.862 . . . . 73.129999999999995 109.375 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . 0.465 ' ND2' ' C ' ' B' ' 54' ' ' ASN . 0.3 OUTLIER 44.58 16.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.602 -0.686 . . . . 75.209999999999994 109.86 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' B' ' 53' ' ' LYS . . . -74.48 -20.55 59.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 55.329999999999998 109.185 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 24.6 mt -42.79 -46.73 5.3 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.631 -0.668 . . . . 72.420000000000002 110.342 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 58.7 m -65.54 -37.22 86.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.971 -1.081 . . . . 73.040000000000006 109.659 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -63.21 -59.99 4.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 72.329999999999998 109.898 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 15.4 m -49.59 -35.68 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.735 -1.228 . . . . 74.540000000000006 109.764 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' SER . . . . . 0.428 ' OG ' ' N ' ' B' ' 61' ' ' ARG . 13.0 p -58.11 -55.04 40.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.095 -1.003 . . . . 71.239999999999995 109.752 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.428 ' N ' ' OG ' ' B' ' 60' ' ' SER . 11.3 ptp180 -64.48 -27.47 69.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.064 -1.023 . . . . 74.310000000000002 110.042 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 28.2 mm -64.74 -41.54 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.784 -1.197 . . . . 75.420000000000002 109.936 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.539 ' NZ ' ' O ' ' B' ' 90' ' ' GLY . 19.1 mmtp -69.65 -48.83 58.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.94 -1.1 . . . . 73.319999999999993 110.551 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -66.7 -35.93 81.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.759 -1.213 . . . . 73.310000000000002 109.807 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.454 ' HZ1' ' HE2' ' B' ' 66' ' ' HIS . 9.7 mtpm? -82.13 -25.29 34.53 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.166 -0.959 . . . . 72.439999999999998 109.702 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.454 ' HE2' ' HZ1' ' B' ' 65' ' ' LYS . 65.6 m-70 -152.73 68.01 0.83 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.164 -0.96 . . . . 65.209999999999994 109.516 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 86.6 p -64.4 -25.8 68.18 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.359 -0.838 . . . . 73.099999999999994 109.885 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 17.8 p -66.02 -9.19 28.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.179 -0.951 . . . . 71.530000000000001 109.883 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 56.9 mt -102.11 151.26 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.351 -0.843 . . . . 74.400000000000006 109.468 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' B' ' 71' ' ' VAL . 76.6 t -87.39 165.54 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.249 -0.907 . . . . 75.120000000000005 109.486 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.451 ' N ' ' CG1' ' B' ' 70' ' ' VAL . 2.9 t -145.7 122.71 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.966 -1.084 . . . . 73.200000000000003 109.824 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.497 ' O ' ' SD ' ' B' ' 49' ' ' MET . 2.9 mp -120.36 105.4 10.87 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.483 -0.932 . . . . 73.340000000000003 108.483 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 14.7 p -95.35 130.91 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.209 -0.932 . . . . 73.5 109.019 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 2.5 p -89.5 170.19 10.72 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.104 -0.997 . . . . 71.319999999999993 109.203 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 26.4 t -161.22 114.54 1.95 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.092 -1.005 . . . . 74.530000000000001 109.942 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -62.8 -36.7 84.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.173 -0.954 . . . . 64.5 108.81 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . 0.407 ' OD1' ' N ' ' B' ' 77' ' ' ASN . 13.0 p-10 -112.39 87.4 9.34 Favored Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 108.668 -0.864 . . . . 74.25 108.668 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -72.16 78.78 1.82 Allowed 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.51 1.473 . . . . 74.430000000000007 111.875 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.409 ' HG1' ' H ' ' B' ' 82' ' ' GLU . 77.2 p -83.01 152.33 25.45 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.034 -1.098 . . . . 73.120000000000005 108.034 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' SER . . . . . 0.547 ' CB ' ' HE ' ' A' ' 100' ' ' ARG . 0.5 OUTLIER -63.96 -35.74 81.67 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.011 -1.056 . . . . 75.409999999999997 109.89 -179.239 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . 0.496 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 24.0 pt-20 -60.55 -36.82 79.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.129 -0.982 . . . . 72.239999999999995 109.373 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . 0.409 ' H ' ' HG1' ' B' ' 79' ' ' THR . 84.9 tt0 -73.63 -33.55 64.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.213 -0.929 . . . . 73.219999999999999 109.565 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -62.74 -52.36 63.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.901 . . . . 74.299999999999997 109.722 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 18.8 m -61.09 -39.3 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.111 -0.993 . . . . 73.310000000000002 109.34 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' HIS . . . . . 0.496 ' ND1' ' O ' ' B' ' 81' ' ' GLU . 25.0 m80 -66.59 -30.66 71.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 73.239999999999995 109.351 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.37 -43.35 91.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 55.329999999999998 109.693 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -80.22 -35.04 36.79 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.185 -0.947 . . . . 74.450000000000003 109.019 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -63.13 -50.43 70.46 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.425 -0.797 . . . . 64.040000000000006 109.074 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -60.45 -52.68 64.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.544 -0.723 . . . . 75.129999999999995 109.836 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . 0.539 ' O ' ' NZ ' ' B' ' 63' ' ' LYS . . . 155.16 -15.08 0.49 Allowed Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.649 -1.262 . . . . 75.420000000000002 110.588 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -45.02 133.05 6.65 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.973 -1.31 . . . . 73.420000000000002 109.843 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' B' ' 93' ' ' ASP . 18.1 t0 -69.39 -42.56 74.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 73.319999999999993 109.362 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' B' ' 92' ' ' ASP . 72.9 m-20 -152.25 164.91 36.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.43 -0.794 . . . . 73.040000000000006 109.175 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.522 ' CD1' ' O ' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -138.54 127.76 24.28 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.902 -0.777 . . . . 74.310000000000002 108.902 -178.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.562 ' N ' ' CD1' ' B' ' 95' ' ' ILE . 0.2 OUTLIER -123.82 151.91 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 121.451 0.643 . . . . 75.340000000000003 110.142 -178.654 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.62 138.48 58.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.186 -0.946 . . . . 70.099999999999994 108.541 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.672 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -59.73 -53.79 62.11 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 120.98 -1.075 . . . . 65.430000000000007 111.61 -179.321 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 4.0 Cg_endo -42.03 -9.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 120.648 0.899 . . . . 63.520000000000003 113.057 -176.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . 0.672 ' N ' ' O ' ' B' ' 97' ' ' LYS . 49.4 m-85 59.45 117.64 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.583 -0.698 . . . . 75.129999999999995 109.225 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -56.63 -38.21 71.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.84 -1.162 . . . . 74.230000000000004 108.882 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' SER . . . . . 0.731 ' O ' ' N ' ' B' ' 103' ' ' LYS . 33.3 t -174.59 41.27 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.119 -0.988 . . . . 64.510000000000005 110.728 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 63.7 mt 51.88 -69.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.546 -0.721 . . . . 74.439999999999998 110.232 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . 0.731 ' N ' ' O ' ' B' ' 101' ' ' SER . 28.2 mtmm -57.72 -18.8 23.23 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.776 -1.194 . . . . 72.299999999999997 107.776 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.45 -83.51 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.81 -0.556 . . . . 74.310000000000002 110.578 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -47.67 -32.75 6.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.878 -1.139 . . . . 73.540000000000006 109.858 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 99.2 t -65.33 -41.7 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.901 -1.124 . . . . 72.030000000000001 108.723 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.94 -33.56 67.13 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.317 -0.865 . . . . 64.219999999999999 108.962 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -83.41 -34.97 25.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.426 -0.796 . . . . 75.310000000000002 110.079 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 96.8 mt -72.54 -36.6 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.022 -1.048 . . . . 55.439999999999998 109.115 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . 0.435 ' CG ' ' N ' ' B' ' 111' ' ' ALA . 22.8 pt-20 -74.91 -44.79 46.78 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.444 -0.902 . . . . 65.310000000000002 109.214 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . 0.435 ' N ' ' CG ' ' B' ' 110' ' ' GLU . . . -50.4 -45.01 55.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.239 -0.913 . . . . 74.519999999999996 109.203 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -67.09 -38.13 85.15 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.29 -0.881 . . . . 72.040000000000006 109.689 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' B' ' 116' ' ' TRP . 24.0 mt -78.11 -26.26 47.9 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.22 -0.925 . . . . 75.349999999999994 110.496 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.465 ' O ' ' CE3' ' B' ' 116' ' ' TRP . 19.0 mmt180 -47.57 -40.54 19.38 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.88 -1.137 . . . . 75.5 109.689 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' PHE . . . . . 0.526 ' C ' ' H ' ' B' ' 117' ' ' GLY . 71.3 m-85 -68.02 -25.22 65.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.983 . . . . 73.040000000000006 109.455 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' TRP . . . . . 0.465 ' CE3' ' O ' ' B' ' 114' ' ' ARG . 5.4 m-90 53.34 6.36 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.384 -0.822 . . . . 74.450000000000003 109.827 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . 0.526 ' H ' ' C ' ' B' ' 115' ' ' PHE . . . 68.51 175.84 10.72 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.847 -1.301 . . . . 64.209999999999994 109.847 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 58.4 m -142.06 171.59 13.84 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.347 -1.09 . . . . 71.400000000000006 109.344 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . 0.544 HD22 ' C ' ' B' ' 121' ' ' ILE . 2.7 t30 -104.11 153.67 20.63 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.42 -0.8 . . . . 74.209999999999994 109.749 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 t -104.27 -42.51 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.415 -0.803 . . . . 75.019999999999996 109.859 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . 0.544 ' C ' HD22 ' B' ' 119' ' ' ASN . 12.2 mm -106.66 119.22 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.204 -0.935 . . . . 74.239999999999995 109.469 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -129.49 138.67 51.51 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.516 -0.74 . . . . 73.329999999999998 109.529 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.456 ' O ' ' CG2' ' B' ' 123' ' ' ILE . 0.2 OUTLIER -160.28 117.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 74.219999999999999 109.192 179.821 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 53.45 -141.39 31.2 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.623 -1.391 . . . . 72.409999999999997 109.623 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -86.14 -1.9 57.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.294 -1.121 . . . . 75.120000000000005 109.471 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.52 126.7 38.81 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.118 -1.067 . . . . 75.420000000000002 108.118 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 85.6 m -129.22 135.89 49.41 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.328 -0.857 . . . . 74.219999999999999 109.952 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 12.4 mt -129.17 136.04 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.555 -0.715 . . . . 60.329999999999998 109.338 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' SER . . . . . 0.459 ' O ' ' N ' ' B' ' 133' ' ' GLU . 53.0 m -124.49 81.46 59.61 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.626 -0.671 . . . . 72.310000000000002 109.582 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.41 -39.61 73.25 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.454 2.103 . . . . 75.129999999999995 111.712 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.68 -43.3 97.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.406 -0.809 . . . . 75.230000000000004 109.199 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -89.54 -4.64 57.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.389 -0.819 . . . . 75.120000000000005 108.791 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' B' ' 129' ' ' SER . 87.2 mt-10 52.52 56.74 7.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.453 -0.779 . . . . 75.129999999999995 109.763 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -151.83 139.02 19.25 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.303 -0.873 . . . . 75.109999999999999 109.404 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 7.7 tt -126.64 143.05 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.403 -0.811 . . . . 70.319999999999993 109.853 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 53.1 mt -115.6 131.73 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 109.114 -0.698 . . . . 74.120000000000005 109.114 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -138.02 138.23 38.64 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.609 -0.682 . . . . 74.230000000000004 110.491 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm 50.94 25.4 2.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.391 -0.818 . . . . 74.219999999999999 111.031 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.9 14.85 71.57 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.823 -1.179 . . . . 74.319999999999993 111.05 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -115.1 126.42 54.65 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.343 -1.093 . . . . 75.340000000000003 108.987 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -93.7 126.19 38.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.355 -0.841 . . . . 71.230000000000004 109.53 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 13.8 p -135.63 133.04 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.578 -0.897 . . . . 70.430000000000007 108.578 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' B' ' 143' ' ' GLU . 1.1 pm0 -94.86 137.37 34.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.201 -0.937 . . . . 72.430000000000007 108.588 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 11.6 m -140.02 141.01 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.102 -0.999 . . . . 72.129999999999995 110.323 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.27 31.92 0.24 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.711 -1.218 . . . . 74.5 107.711 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' B' ' 150' ' ' GLU . . . -78.24 -155.82 8.41 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.605 -1.398 . . . . 42.229999999999997 109.605 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 0.744 ' HZ2' ' CB ' ' B' ' 147' ' ' LYS . 0.0 OUTLIER -88.39 -35.96 0.44 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.422 -1.046 . . . . 73.299999999999997 111.046 -179.566 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 47.7 Cg_endo -84.31 -42.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 121.931 1.754 . . . . 71.329999999999998 112.533 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -56.53 -19.37 15.31 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.76 -1.212 . . . . 74.230000000000004 109.037 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' B' ' 146' ' ' GLY . 27.1 mt-10 -60.68 -36.27 78.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 72.340000000000003 109.89 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 3.8 p -67.84 -38.15 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.977 -1.077 . . . . 73.349999999999994 110.072 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 20.0 tp -60.57 -41.77 95.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.342 -0.849 . . . . 74.430000000000007 109.613 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -69.9 -39.64 76.08 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.124 -0.985 . . . . 75.209999999999994 109.209 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . 0.493 ' CD2' ' HD1' ' B' ' 158' ' ' HIS . 14.7 t60 -56.76 -52.48 64.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.484 -0.76 . . . . 73.040000000000006 110.111 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 4.2 pp -72.0 -25.66 61.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.924 -1.11 . . . . 73.430000000000007 109.413 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -54.31 -42.47 70.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.023 -1.048 . . . . 75.319999999999993 108.346 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.475 ' C ' ' H ' ' B' ' 159' ' ' ARG . 58.0 mtp180 -77.81 -52.32 9.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.453 -0.779 . . . . 73.319999999999993 109.21 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . 0.493 ' HD1' ' CD2' ' B' ' 154' ' ' HIS . 30.9 m80 -75.27 25.66 0.1 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.549 -0.72 . . . . 74.140000000000001 109.988 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . 0.475 ' H ' ' C ' ' B' ' 157' ' ' ARG . 47.4 ttp180 -52.57 -78.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 73.420000000000002 109.015 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . 0.933 ' OD2' ' CE2' ' B' ' 216' ' ' TYR . 9.1 t70 -65.2 74.95 0.05 Allowed 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.2 -0.937 . . . . 72.099999999999994 109.27 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . 0.748 ' NE2' HH12 ' A' ' 159' ' ' ARG . 38.2 tt0 -175.65 160.33 2.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 73.239999999999995 109.141 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' ILE . . . . . 0.418 HD11 HG21 ' B' ' 162' ' ' ILE . 17.1 mm -85.63 106.82 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.638 -0.875 . . . . 72.310000000000002 108.638 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 87.5 t -89.94 136.03 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.198 -0.939 . . . . 75.030000000000001 109.814 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 25.8 t -99.92 160.75 14.07 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.457 -0.777 . . . . 74.219999999999999 109.488 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . 0.437 ' HZ3' ' CB ' ' B' ' 165' ' ' LYS . 8.3 mtmp? -66.88 -40.01 87.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.472 -0.768 . . . . 72.420000000000002 110.047 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -66.36 -26.55 67.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 63.450000000000003 110.391 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -60.16 -57.69 11.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.99 -1.069 . . . . 72.400000000000006 109.662 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 25.9 mt -60.82 -36.72 79.8 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.127 -0.983 . . . . 72.319999999999993 108.856 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -56.39 -66.23 0.47 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.607 -0.683 . . . . 73.340000000000003 110.162 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -54.85 -31.68 59.82 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.717 -0.615 . . . . 73.099999999999994 111.85 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -92.18 -8.82 44.46 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.706 -1.246 . . . . 62.130000000000003 112.009 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.407 HG21 HD12 ' B' ' 172' ' ' ILE . 25.6 mm -112.74 -68.4 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 120.887 -1.133 . . . . 74.439999999999998 110.82 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' TRP . . . . . 0.481 ' C ' ' CD2' ' B' ' 173' ' ' TRP . 0.0 OUTLIER -56.91 161.37 2.97 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 118.653 -1.219 . . . . 72.230000000000004 107.915 -179.249 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' B' ' 175' ' ' GLU . 47.4 tp10 -172.59 -30.94 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.702 -0.851 . . . . 75.030000000000001 108.702 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' B' ' 177' ' ' GLU . 9.2 pt-20 -51.13 177.01 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 107.965 -1.124 . . . . 73.040000000000006 107.965 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -61.29 49.08 0.09 OUTLIER 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.876 1.717 . . . . 74.129999999999995 112.601 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' B' ' 175' ' ' GLU . 99.6 mt-10 44.9 -122.9 0.97 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.381 -0.824 . . . . 72.439999999999998 109.939 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 64.8 mtp 52.84 20.47 1.63 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.298 -0.877 . . . . 72.109999999999999 109.641 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 179' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' B' ' 180' ' ' THR . 3.9 t -85.26 48.49 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.163 -1.051 . . . . 75.310000000000002 108.163 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 180' ' ' THR . . . . . 0.463 ' O ' ' O ' ' B' ' 179' ' ' VAL . 0.0 OUTLIER 55.11 165.95 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.532 -0.914 . . . . 62.149999999999999 108.532 -179.171 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -47.63 -69.71 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.859 1.706 . . . . 74.340000000000003 111.815 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -127.27 125.97 41.85 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.488 -0.93 . . . . 72.310000000000002 108.488 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 6.1 t -133.04 -13.89 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.305 -0.872 . . . . 65.420000000000002 109.701 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 4.6 tt -62.01 -25.13 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.458 -1.401 . . . . 75.030000000000001 109.164 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -61.38 -43.11 99.43 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.319 -0.863 . . . . 73.519999999999996 109.83 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 15.4 m -76.54 -27.39 17.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.836 -1.165 . . . . 74.349999999999994 108.254 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.28 -46.18 64.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 61.119999999999997 109.692 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 10.7 tp -71.8 -28.06 29.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 120.953 -1.092 . . . . 72.430000000000007 109.595 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 189' ' ' ASN . . . . . 0.446 ' O ' ' OE1' ' B' ' 193' ' ' GLN . 68.2 m-20 -68.2 -46.01 71.78 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.286 -0.884 . . . . 75.420000000000002 108.764 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -70.3 -47.17 62.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 74.140000000000001 109.534 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 63.7 mt -51.23 -34.83 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -0.906 . . . . 74.030000000000001 108.846 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -70.33 -42.28 72.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.883 . . . . 72.329999999999998 109.39 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 193' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' B' ' 189' ' ' ASN . 1.0 OUTLIER -75.45 -17.12 60.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.262 -0.899 . . . . 73.099999999999994 109.692 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -92.3 -25.05 18.76 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.18 -0.95 . . . . 74.430000000000007 110.361 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 195' ' ' MET . . . . . 0.608 ' N ' ' SD ' ' B' ' 195' ' ' MET . 0.0 OUTLIER -96.17 -32.01 12.69 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.133 -0.979 . . . . 74.329999999999998 110.141 -179.035 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 196' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 42.2 p-10 -67.97 -31.54 71.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.029 -1.044 . . . . 71.209999999999994 110.496 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . 0.47 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 46.1 mttt -70.12 -65.01 1.2 Allowed Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.969 -1.082 . . . . 75.209999999999994 110.56 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 198' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 19.8 Cg_endo -58.38 -58.57 0.71 Allowed 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.22 1.947 . . . . 75.319999999999993 112.741 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 37.1 mt -60.01 -55.51 33.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.062 -1.024 . . . . 72.25 109.874 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 97.49 -24.79 29.97 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.257 -1.137 . . . . 73.239999999999995 110.257 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 19.7 mt -106.36 127.06 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.162 -1.199 . . . . 54.299999999999997 109.706 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 53.9 p -82.48 141.05 33.0 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.458 -0.941 . . . . 74.310000000000002 108.458 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 11.9 p -142.6 19.43 2.02 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.113 -0.992 . . . . 74.400000000000006 109.585 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 5.3 t -125.94 141.58 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.499 -0.751 . . . . 74.099999999999994 109.78 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -119.82 107.6 13.36 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.313 -0.995 . . . . 75.329999999999998 108.313 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.17 120.13 20.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.958 . . . . 71.400000000000006 109.796 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 3.0 t -117.28 148.88 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 109.114 -0.698 . . . . 63.5 109.114 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -91.64 -1.63 57.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.191 -0.943 . . . . 74.450000000000003 109.44 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -76.19 -118.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.353 -0.842 . . . . 74.140000000000001 109.56 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -57.33 -47.74 80.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.197 -0.939 . . . . 74.430000000000007 109.977 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.85 -126.83 1.09 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.026 -1.229 . . . . 70.109999999999999 110.026 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -100.17 133.56 44.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.271 -1.135 . . . . 74.209999999999994 109.408 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -100.53 118.13 36.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.409 -0.807 . . . . 74.299999999999997 109.445 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -98.56 131.03 45.1 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.412 -0.805 . . . . 74.340000000000003 109.113 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 30.3 p -158.48 161.04 37.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 72.209999999999994 109.077 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . 0.933 ' CE2' ' OD2' ' B' ' 160' ' ' ASP . 1.6 m-85 -61.24 150.16 80.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.995 -1.065 . . . . 72.310000000000002 108.698 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.07 -55.65 0.13 Allowed 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.123 1.882 . . . . 71.010000000000005 111.561 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -151.41 151.51 29.13 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 108.385 -0.969 . . . . 74.349999999999994 108.385 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -34.61 117.7 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.536 2.157 . . . . 71.319999999999993 112.622 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -92.77 154.67 18.15 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.402 -0.811 . . . . 75.450000000000003 109.617 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 27.1 p -96.1 135.87 37.3 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.28 -0.888 . . . . 72.219999999999999 109.481 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -155.91 137.61 14.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.903 . . . . 74.299999999999997 109.368 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.001 -1.0 . . . . 71.129999999999995 109.413 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.3 ttm . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.474 -0.565 . . . . 65.120000000000005 109.474 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -144.56 141.68 29.65 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.196 -0.94 . . . . 73.310000000000002 109.182 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 80.2 t -112.55 134.86 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.562 0.696 . . . . 71.420000000000002 109.958 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.3 tp -103.2 118.58 37.12 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.101 -1.074 . . . . 65.219999999999999 108.101 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.9 tp -117.82 107.23 13.88 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.66 -0.65 . . . . 71.439999999999998 109.483 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.4 mt -98.36 101.5 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.327 -0.99 . . . . 71.150000000000006 108.327 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -131.42 124.11 29.58 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.61 -0.681 . . . . 75.340000000000003 109.465 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.43 ' HZ2' ' CG ' ' A' ' 52' ' ' ASP . 60.6 mttp -65.66 -34.46 78.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.277 -0.889 . . . . 73.040000000000006 109.15 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -87.07 112.2 21.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 72.420000000000002 109.227 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.6 m -65.7 -26.71 67.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 72.340000000000003 109.588 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.72 -52.75 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.193 -0.942 . . . . 74.420000000000002 109.774 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.1 mt -61.6 -34.83 76.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.977 . . . . 72.010000000000005 109.291 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.94 -26.96 71.43 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.566 -1.814 . . . . 72.140000000000001 108.566 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.13 -52.41 44.68 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 109.529 -1.428 . . . . 72.329999999999998 109.529 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -59.97 -45.09 93.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.372 -1.075 . . . . 72.340000000000003 109.824 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.4 mm -64.31 -38.55 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.795 -1.191 . . . . 74.239999999999995 108.828 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -62.89 -49.29 75.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.329 -0.857 . . . . 71.409999999999997 110.099 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -78.03 -7.34 56.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.077 -1.015 . . . . 75.540000000000006 109.815 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.77 -54.45 3.24 Favored Glycine 0 N--CA 1.483 1.824 0 N-CA-C 109.505 -1.438 . . . . 62.149999999999999 109.505 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.91 -24.13 61.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.376 -1.073 . . . . 74.420000000000002 109.489 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -56.04 -38.46 70.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.137 -0.977 . . . . 74.25 109.184 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.5 t -51.94 -47.53 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.271 -0.893 . . . . 72.109999999999999 109.05 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -53.81 -53.16 56.32 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.602 -0.888 . . . . 73.230000000000004 108.602 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.94 40.77 0.28 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.353 -1.499 . . . . 75.540000000000006 109.353 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -117.13 160.28 21.27 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.511 -0.994 . . . . 74.510000000000005 109.139 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.5 mmt -101.11 139.35 36.91 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.204 -1.036 . . . . 64.319999999999993 108.204 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.59 146.75 34.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.167 -0.958 . . . . 74.310000000000002 110.339 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -120.69 149.23 42.83 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.911 -0.774 . . . . 75.400000000000006 108.911 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 m -110.53 134.99 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.427 -0.796 . . . . 75.129999999999995 108.906 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.4 p -136.82 168.2 20.0 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.359 -0.838 . . . . 71.420000000000002 109.531 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -90.25 -105.61 0.09 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.329 -0.857 . . . . 73.109999999999999 109.662 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.5 p -81.16 169.11 17.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 74.239999999999995 110.07 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.5 mt -53.95 -32.67 54.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.579 -0.7 . . . . 71.530000000000001 109.521 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -49.81 -49.68 47.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 74.230000000000004 109.541 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -64.95 -51.83 59.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 71.010000000000005 109.31 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.36 -39.03 96.69 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.694 -1.362 . . . . 61.409999999999997 109.694 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -64.28 -47.06 80.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -1.141 . . . . 74.340000000000003 109.413 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -69.78 -35.3 74.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.067 -1.021 . . . . 75.329999999999998 109.19 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.424 ' C ' ' CD1' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -70.4 -65.53 0.72 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.84 . . . . 74.329999999999998 109.204 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 40' ' ' MET . 2.9 ppp? -48.47 -20.38 0.42 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.263 -0.898 . . . . 70.319999999999993 109.936 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -65.52 -43.24 90.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.075 -1.016 . . . . 71.219999999999999 110.091 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.3 pt -82.31 -26.71 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.172 -0.955 . . . . 74.409999999999997 110.195 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 40' ' ' MET . 99.4 mtt180 -129.96 143.7 50.94 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.35 -0.844 . . . . 75.409999999999997 109.507 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -97.59 151.09 20.42 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.214 -0.929 . . . . 75.420000000000002 109.556 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -127.51 141.08 51.75 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.529 -0.732 . . . . 74.230000000000004 109.252 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -78.05 -42.15 33.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 75.319999999999993 109.471 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.01 112.77 25.9 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.474 -0.766 . . . . 72.129999999999995 108.941 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.0 t -99.45 98.48 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.406 -0.961 . . . . 72.340000000000003 108.406 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.451 ' C ' ' SD ' ' A' ' 49' ' ' MET . 1.5 tmt? -114.99 135.94 53.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.617 -0.677 . . . . 74.109999999999999 109.834 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.459 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 1.1 p -143.59 131.19 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.78 0.8 . . . . 71.239999999999995 109.82 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.7 p -95.26 9.64 39.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.571 -0.706 . . . . 73.109999999999999 109.744 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.459 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 80.0 m-20 -77.04 141.48 40.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 63.399999999999999 109.514 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.531 ' C ' ' H ' ' A' ' 55' ' ' ALA . 92.2 mttt -75.1 -45.42 41.31 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.294 -0.879 . . . . 65.439999999999998 110.447 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -68.51 10.99 0.2 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.096 -1.002 . . . . 73.129999999999995 109.84 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.531 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -68.84 -22.49 64.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 64.140000000000001 110.28 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 52.4 mt -42.62 -50.34 5.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.297 -0.877 . . . . 74.430000000000007 110.401 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.1 m -68.74 -31.91 71.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.932 -1.105 . . . . 63.229999999999997 109.333 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -70.19 -56.57 6.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.463 -0.773 . . . . 74.439999999999998 110.2 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.4 m -55.03 -34.06 30.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.609 -1.307 . . . . 74.030000000000001 109.528 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.7 t -60.42 -54.89 40.1 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.287 -0.883 . . . . 73.540000000000006 109.499 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.653 HH21 ' NZ ' ' A' ' 65' ' ' LYS . 7.1 ptm180 -67.3 -25.52 66.07 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.045 -1.062 . . . . 73.340000000000003 109.967 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 66' ' ' HIS . 4.9 mm -59.87 -48.03 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.783 -1.198 . . . . 73.349999999999994 108.968 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -64.45 -45.19 88.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.023 -1.048 . . . . 74.420000000000002 108.87 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -60.86 -51.52 68.95 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.326 -0.99 . . . . 74.549999999999997 108.326 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.653 ' NZ ' HH21 ' A' ' 61' ' ' ARG . 93.1 mttt -71.81 -69.68 0.37 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.253 -0.647 . . . . 75.219999999999999 109.253 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 62' ' ' ILE . 86.5 m-70 -98.02 90.54 4.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.319 -0.863 . . . . 74.129999999999995 109.019 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 t -79.01 -40.1 32.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 73.239999999999995 109.914 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.8 t -78.15 57.92 1.93 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 71.439999999999998 109.611 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.6 tt -152.03 158.12 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.147 -0.97 . . . . 71.329999999999998 109.656 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.2 t -97.63 146.87 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.119 -0.988 . . . . 73.019999999999996 109.111 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.7 t -133.01 125.81 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.317 -0.864 . . . . 54.210000000000001 110.5 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.7 tt -122.87 100.03 6.69 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.652 -0.87 . . . . 74.209999999999994 108.652 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.7 p -92.69 153.55 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.76 -1.212 . . . . 74.409999999999997 109.221 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.7 m -127.54 166.54 17.8 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.257 -1.016 . . . . 72.310000000000002 108.257 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 77' ' ' ASN . 23.0 t -170.8 126.41 0.72 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.967 -1.083 . . . . 64.540000000000006 110.415 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 57.3 p30 -71.69 14.67 0.18 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.569 -0.707 . . . . 74.129999999999995 110.121 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.469 ' H ' ' C ' ' A' ' 75' ' ' SER . 22.6 m120 -138.43 73.91 41.82 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.195 -0.941 . . . . 73.340000000000003 109.933 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.6 76.53 4.49 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.682 2.255 . . . . 71.319999999999993 112.358 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.92 154.63 19.82 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.296 -1.001 . . . . 62.530000000000001 108.296 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.45 -25.08 2.33 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.171 -0.956 . . . . 74.140000000000001 109.738 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -69.72 -50.61 41.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.944 . . . . 71.420000000000002 110.149 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 77' ' ' ASN . 88.9 mt-10 -71.32 -27.74 63.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.097 -1.002 . . . . 73.430000000000007 110.162 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -64.21 -56.93 11.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.091 -1.005 . . . . 74.219999999999999 109.764 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.401 ' CG2' ' N ' ' A' ' 85' ' ' HIS . 17.9 m -66.13 -40.96 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 74.150000000000006 109.676 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.442 ' NE2' HE21 ' A' ' 89' ' ' GLN . 27.7 t-80 -64.7 -38.99 92.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.21 -0.931 . . . . 72.540000000000006 109.744 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.52 95.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 64.219999999999999 110.178 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.507 ' CE1' ' NH1' ' B' ' 108' ' ' ARG . 44.2 m-85 -72.84 -31.01 64.48 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.038 -1.039 . . . . 74.340000000000003 108.605 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -73.71 -34.73 64.95 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.412 -0.805 . . . . 74.420000000000002 109.261 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.442 HE21 ' NE2' ' A' ' 85' ' ' HIS . 76.9 mm-40 -62.86 -55.85 22.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.896 . . . . 74.519999999999996 109.441 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.63 29.0 0.08 OUTLIER Glycine 0 N--CA 1.498 2.804 0 C-N-CA 119.813 -1.184 . . . . 74.209999999999994 110.425 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.49 128.57 39.66 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.935 -1.332 . . . . 64.099999999999994 108.995 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.638 ' HB3' HH21 ' A' ' 112' ' ' ARG . 36.2 m-20 -64.68 -36.41 84.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.978 -1.076 . . . . 73.420000000000002 108.971 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 94' ' ' TYR . 62.8 t0 -152.53 145.65 24.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.373 -0.829 . . . . 75.040000000000006 108.943 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.497 ' CD1' ' C ' ' A' ' 94' ' ' TYR . 0.4 OUTLIER -123.15 121.54 36.23 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.985 -0.746 . . . . 71.329999999999998 108.985 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.496 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -108.98 141.92 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 121.789 0.804 . . . . 74.510000000000005 109.526 -178.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . -62.35 125.15 22.91 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.16 -1.422 . . . . 64.319999999999993 107.16 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.567 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -44.33 -57.13 6.86 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.004 -1.06 . . . . 74.510000000000005 111.102 -178.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 7.4 Cg_endo -44.2 90.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 CA-C-N 119.467 0.845 . . . . 73.109999999999999 111.17 -176.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.567 ' N ' ' O ' ' A' ' 97' ' ' LYS . 42.8 m-85 -44.18 104.26 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.625 -0.672 . . . . 72.540000000000006 109.97 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 31.2 ttm-85 -54.49 -25.6 26.38 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.595 -0.891 . . . . 74.540000000000006 108.595 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.738 ' O ' ' N ' ' A' ' 103' ' ' LYS . 15.7 t -178.07 24.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.398 -0.814 . . . . 74.140000000000001 109.866 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 87.9 mt 52.89 -70.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.66 -0.65 . . . . 75.430000000000007 109.609 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.738 ' N ' ' O ' ' A' ' 101' ' ' SER . 48.9 mttp -56.2 -23.04 32.83 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.517 -1.29 . . . . 74.140000000000001 107.517 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.08 -45.47 73.7 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.929 -1.137 . . . . 63.240000000000002 107.929 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.6 tp -65.48 -51.7 58.18 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.681 -0.859 . . . . 73.219999999999999 108.681 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 38.3 t -58.36 -42.73 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.108 -0.995 . . . . 74.540000000000006 108.654 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.87 -39.55 59.15 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.304 -0.872 . . . . 75.5 108.881 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 53.8 mtp180 -66.94 -35.6 80.33 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.192 -0.942 . . . . 74.409999999999997 108.811 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.9 mt -75.56 -26.76 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.21 -0.931 . . . . 73.239999999999995 108.992 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -65.4 -52.06 56.04 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.448 -0.783 . . . . 74.340000000000003 110.137 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -74.86 -29.35 61.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.111 -0.993 . . . . 73.319999999999993 110.382 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.638 HH21 ' HB3' ' A' ' 92' ' ' ASP . 33.9 ttt85 -61.03 -44.24 97.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.041 . . . . 74.420000000000002 109.895 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -150.79 82.58 1.34 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.8 -1.187 . . . . 74.329999999999998 109.745 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.01 -58.03 2.27 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.485 -0.932 . . . . 74.439999999999998 108.485 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -69.08 -58.04 4.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 74.430000000000007 109.662 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 46.22 85.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.232 -0.917 . . . . 74.439999999999998 109.662 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.99 99.41 0.12 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.3 -1.52 . . . . 75.040000000000006 109.3 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.7 t -152.61 162.67 40.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.197 -1.178 . . . . 70.109999999999999 109.894 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.545 ' ND2' ' N ' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -157.61 129.45 6.99 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.966 -0.753 . . . . 65.239999999999995 108.966 -178.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 17.3 t -91.11 -32.77 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.185 -0.947 . . . . 74.219999999999999 109.268 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 24.9 mm -107.53 137.23 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.934 -0.765 . . . . 74.420000000000002 108.934 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -148.89 136.6 20.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.067 -1.021 . . . . 73.299999999999997 109.982 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.5 pt -151.54 134.75 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.432 -0.793 . . . . 75.340000000000003 109.112 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 45.84 -142.28 4.58 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.747 -1.341 . . . . 75.129999999999995 109.747 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -85.59 -5.96 59.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.257 -1.143 . . . . 74.450000000000003 109.393 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.12 136.69 32.92 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.336 -0.987 . . . . 54.210000000000001 108.336 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.7 m -130.61 144.07 51.17 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.387 -0.82 . . . . 70.239999999999995 109.605 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 82.5 mt -133.28 137.69 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.291 -0.88 . . . . 72.430000000000007 109.475 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.4 m -121.77 85.22 44.38 Favored Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 109.069 -0.715 . . . . 71.109999999999999 109.069 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.89 -41.05 82.19 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.549 2.166 . . . . 75.140000000000001 112.237 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -59.05 -46.9 87.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 72.5 109.293 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -82.7 -7.06 59.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 73.140000000000001 109.153 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.408 ' OE2' ' O ' ' A' ' 144' ' ' VAL . 70.8 tt0 56.98 58.49 3.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.411 -0.806 . . . . 75.329999999999998 109.567 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -148.65 123.94 10.23 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.294 -0.879 . . . . 71.230000000000004 109.435 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.5 ' N ' ' CD1' ' A' ' 135' ' ' ILE . 1.6 mp -96.94 138.07 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.217 -0.927 . . . . 75.329999999999998 109.392 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.3 mm -115.11 127.89 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 109.023 -0.732 . . . . 71.109999999999999 109.023 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.449 ' OH ' ' O ' ' A' ' 199' ' ' LEU . 79.5 t80 -136.43 123.71 21.88 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.356 -0.84 . . . . 74.140000000000001 109.48 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 66.3 mttm 53.52 33.85 17.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.335 -0.853 . . . . 75.400000000000006 110.032 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.11 11.09 85.71 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.292 -1.123 . . . . 72.239999999999995 110.292 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 50.3 mtp85 -94.91 124.49 38.98 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.143 -1.21 . . . . 73.120000000000005 109.073 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -94.88 119.31 33.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.259 -0.901 . . . . 72.319999999999993 109.608 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.6 p -135.61 137.7 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.469 -0.769 . . . . 62.340000000000003 109.297 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 143' ' ' GLU . 46.1 mp0 -95.98 154.46 17.22 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.323 -0.86 . . . . 61.229999999999997 109.298 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.408 ' O ' ' OE2' ' A' ' 133' ' ' GLU . 29.9 m -139.61 144.09 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.365 -0.834 . . . . 74.439999999999998 109.551 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -168.47 21.77 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.937 . . . . 75.420000000000002 109.751 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.19 -174.93 50.63 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.333 -1.507 . . . . 73.340000000000003 109.333 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.633 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 5.8 ttpm? -83.14 -32.76 0.55 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.3 -1.118 . . . . 72.219999999999999 111.048 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 91.6 Cg_endo -89.37 -16.67 2.04 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 122.149 1.899 . . . . 75.450000000000003 112.733 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -81.99 -24.87 35.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.108 -0.995 . . . . 65.239999999999995 109.818 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.525 ' O ' ' ND1' ' A' ' 154' ' ' HIS . 95.8 mt-10 -51.53 -31.94 26.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.097 -1.002 . . . . 72.519999999999996 108.862 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.4 p -63.56 -36.76 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.438 -0.789 . . . . 74.209999999999994 109.07 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.427 ' CD1' ' SD ' ' A' ' 195' ' ' MET . 21.3 tp -62.92 -42.47 99.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 73.310000000000002 109.084 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.4 m -72.47 -36.88 68.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.403 -0.81 . . . . 74.310000000000002 109.864 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 150' ' ' GLU . 8.2 m80 -60.7 -52.71 63.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.122 -0.986 . . . . 75.450000000000003 110.182 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 159' ' ' ARG . 3.2 pp -68.89 -25.97 64.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.866 -1.146 . . . . 75.340000000000003 109.589 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.73 -52.68 64.03 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.136 -0.977 . . . . 62.140000000000001 109.241 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.525 ' HE ' ' CE1' ' A' ' 158' ' ' HIS . 5.0 ptm85 -68.28 -43.4 77.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.351 -0.843 . . . . 72.219999999999999 109.651 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.525 ' CE1' ' HE ' ' A' ' 157' ' ' ARG . 35.8 m80 -95.29 29.38 2.53 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.104 -0.998 . . . . 74.120000000000005 109.251 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 155' ' ' LEU . 27.8 ttt85 -60.13 -21.76 61.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.317 -0.865 . . . . 74.340000000000003 109.519 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 41.8 p30 -115.6 66.65 0.7 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.009 -0.737 . . . . 75.450000000000003 109.009 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 162' ' ' ILE . 10.3 tm0? -164.3 156.8 16.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.161 -0.962 . . . . 73.409999999999997 109.378 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.528 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 9.3 mm -82.33 123.99 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.214 -0.929 . . . . 74.409999999999997 109.312 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.62 136.95 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.508 -0.745 . . . . 72.530000000000001 109.628 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.0 p -91.86 159.69 15.66 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.329 -0.857 . . . . 74.120000000000005 109.425 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.4 mtmm -59.87 -45.55 92.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 70.430000000000007 109.486 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -62.85 -31.59 72.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 74.319999999999993 109.732 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -59.99 -44.98 94.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.125 -0.984 . . . . 74.519999999999996 109.456 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 37.7 mt -64.72 -44.19 91.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 74.409999999999997 109.578 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 11.8 tp -64.58 -43.8 92.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.306 -0.871 . . . . 75.140000000000001 109.528 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -75.2 -10.0 59.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 65.030000000000001 109.705 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.02 -54.75 3.98 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -0.915 . . . . 70.209999999999994 109.804 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.506 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 1.9 mp -88.04 -50.1 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.168 -0.957 . . . . 75.319999999999993 109.858 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 17.9 m-90 -85.67 -93.65 0.08 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.069 -1.019 . . . . 73.140000000000001 109.881 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 175' ' ' GLU . 42.8 tt0 73.01 -130.71 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.742 -0.599 . . . . 73.239999999999995 109.558 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.532 ' C ' ' H ' ' A' ' 177' ' ' GLU . 2.9 mm-40 50.88 179.94 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.104 -0.997 . . . . 63.329999999999998 108.477 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -61.8 35.33 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.136 1.89 . . . . 72.510000000000005 112.198 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.532 ' H ' ' C ' ' A' ' 175' ' ' GLU . 76.8 mm-40 49.38 50.23 18.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.187 -0.946 . . . . 75.340000000000003 109.657 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 66.9 mtt -56.42 -31.44 63.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 74.510000000000005 109.163 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 35.0 m -72.83 169.93 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.323 -0.861 . . . . 65.219999999999999 109.57 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.1 p -56.27 152.04 24.88 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 73.219999999999999 109.281 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -38.34 -67.15 0.11 Allowed 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 122.259 1.973 . . . . 62.43 112.126 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -93.22 147.09 23.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.36 -0.838 . . . . 73.129999999999995 109.233 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.8 p -171.52 -29.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 74.019999999999996 109.367 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.424 HG22 HD12 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -53.57 -41.01 44.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.352 -0.843 . . . . 72.329999999999998 109.58 -179.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.4 ' N ' ' CG2' ' A' ' 184' ' ' ILE . 18.5 mt-10 -54.51 -38.45 66.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.849 -1.157 . . . . 74.400000000000006 109.375 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 2.3 t -75.46 -34.7 30.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.388 -0.82 . . . . 74.319999999999993 109.605 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.0 -51.04 23.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 73.230000000000004 109.869 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.2 tp -61.88 -32.62 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.984 -1.072 . . . . 74.310000000000002 109.745 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -66.31 -55.77 14.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.118 -0.989 . . . . 73.439999999999998 110.215 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -67.0 -41.53 86.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.038 -1.039 . . . . 71.420000000000002 109.665 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 71.6 mt -56.88 -44.43 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.098 -1.001 . . . . 72.439999999999998 109.136 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.4 mtp-105 -57.54 -44.14 84.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 64.219999999999999 108.947 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -67.28 -36.43 81.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.876 . . . . 74.319999999999993 109.332 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.495 ' O ' ' CG ' ' A' ' 198' ' ' PRO . 96.0 mttt -71.69 -15.8 62.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.867 . . . . 75.310000000000002 109.761 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' MET . . . . . 0.427 ' SD ' ' CD1' ' A' ' 152' ' ' LEU . 86.2 mmm -93.62 -15.45 25.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.097 -1.002 . . . . 74.019999999999996 109.968 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -102.82 -9.38 20.0 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.137 -0.977 . . . . 74.019999999999996 110.38 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.557 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 3.8 tmtp? -89.63 -42.45 0.43 Allowed Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.917 -1.114 . . . . 75.430000000000007 110.241 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 38.1 Cg_endo -90.4 -58.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.688 2.259 . . . . 72.319999999999993 112.493 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.462 ' C ' ' H ' ' A' ' 201' ' ' ILE . 3.3 mm? -61.3 -33.82 74.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.911 -1.118 . . . . 74.540000000000006 108.877 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 75.22 -15.94 3.94 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.689 -1.364 . . . . 61.509999999999998 109.689 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.462 ' H ' ' C ' ' A' ' 199' ' ' LEU . 6.1 mt -115.49 129.36 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.479 -1.013 . . . . 74.25 109.011 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 12.6 t -79.94 139.09 37.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.061 -1.024 . . . . 72.0 109.242 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.503 ' CG2' HH21 ' A' ' 159' ' ' ARG . 3.8 p -139.88 7.72 2.28 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.295 -0.878 . . . . 74.439999999999998 109.647 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.37 133.68 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.461 -0.774 . . . . 71.129999999999995 109.413 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 39.8 tp10 -114.45 133.95 55.36 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.55 -0.719 . . . . 73.510000000000005 109.394 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.7 p -99.42 139.96 34.31 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.285 -0.885 . . . . 73.519999999999996 109.261 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 211' ' ' GLY . 18.5 m -149.86 136.75 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.231 -0.918 . . . . 72.150000000000006 109.46 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -85.66 -13.65 47.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 72.400000000000006 109.343 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -55.16 -34.13 63.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.271 -0.893 . . . . 73.310000000000002 109.485 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 64.7 mtp85 -151.18 -63.12 0.19 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.263 -0.898 . . . . 71.540000000000006 109.405 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 207' ' ' VAL . . . -161.89 -114.14 0.32 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.657 -1.377 . . . . 74.450000000000003 109.657 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -126.2 124.31 40.16 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.601 -0.941 . . . . 75.540000000000006 109.474 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 26.1 ttm105 -90.28 121.48 32.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.36 -0.837 . . . . 75.310000000000002 109.006 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -95.96 123.98 39.78 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.304 -0.872 . . . . 75.409999999999997 109.337 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 44.2 t -154.84 152.22 29.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.434 -0.792 . . . . 74.140000000000001 109.069 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.36 145.0 84.82 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.089 -1.007 . . . . 75.319999999999993 108.791 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.436 ' O ' ' CB ' ' A' ' 220' ' ' ALA . 61.7 Cg_endo -81.19 9.47 3.83 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.212 1.941 . . . . 73.109999999999999 112.334 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 217' ' ' PRO . 30.1 tptt -45.22 -54.4 14.36 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.079 -1.013 . . . . 75.25 108.943 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.18 4.46 5.82 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.594 1.529 . . . . 75.099999999999994 111.156 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 217' ' ' PRO . . . -54.09 146.79 13.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.358 -0.839 . . . . 71.140000000000001 109.893 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 32.6 t -101.77 138.75 38.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.449 -0.782 . . . . 71.129999999999995 109.446 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 49.53 72.64 0.29 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 75.349999999999994 109.53 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 118.018 -0.991 . . . . 73.409999999999997 109.47 179.921 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 53.2 ttm . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.478 -0.564 . . . . 75.239999999999995 109.478 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.58 ' NH1' ' HE ' ' B' ' 43' ' ' ARG . 39.9 ttt85 -139.8 146.73 39.79 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.375 -0.828 . . . . 73.519999999999996 109.397 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 73.2 t -118.0 137.11 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 121.583 0.706 . . . . 72.239999999999995 109.669 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 3.3 tp -108.8 117.65 34.73 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.576 -0.898 . . . . 73.340000000000003 108.576 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.404 ' CD1' ' SD ' ' B' ' 49' ' ' MET . 5.4 tp -119.4 101.42 7.94 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.071 -0.714 . . . . 74.349999999999994 109.071 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 53.8 mt -91.71 97.72 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.907 -1.12 . . . . 63.439999999999998 108.749 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.422 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 31.8 tp10 -123.42 136.79 54.8 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.611 0.72 . . . . 74.519999999999996 109.407 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -77.76 -32.74 52.78 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.526 -0.734 . . . . 74.129999999999995 109.308 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -90.02 115.41 27.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.364 -0.835 . . . . 74.230000000000004 109.367 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 15.6 t -65.78 -30.88 71.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.229 -0.919 . . . . 65.540000000000006 109.821 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 85.8 t -61.67 -50.29 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.133 -0.98 . . . . 75.549999999999997 109.791 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.514 ' CD2' ' N ' ' B' ' 12' ' ' LEU . 3.5 mm? -64.83 -31.34 72.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 70.140000000000001 109.439 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.26 -29.94 57.69 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.744 -1.743 . . . . 75.400000000000006 108.744 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.87 -51.64 54.17 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.584 -1.406 . . . . 65.439999999999998 109.584 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -63.17 -42.09 99.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.331 -1.099 . . . . 72.200000000000003 109.622 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 4.8 mm -65.41 -38.61 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.009 -1.057 . . . . 75.150000000000006 108.768 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -64.83 -54.37 32.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.382 -0.824 . . . . 73.010000000000005 109.986 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -72.64 -6.26 43.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.147 -0.971 . . . . 74.299999999999997 109.771 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.87 -55.35 2.83 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.657 -1.377 . . . . 70.540000000000006 109.657 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp -74.17 -23.42 59.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.38 -1.071 . . . . 75.430000000000007 109.802 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -53.74 -35.98 61.8 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.152 -0.968 . . . . 73.200000000000003 109.394 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 98.0 t -55.25 -42.31 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.205 -0.935 . . . . 74.230000000000004 109.198 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 18.7 mmtp -64.64 -13.02 51.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.309 -0.869 . . . . 73.519999999999996 108.685 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.06 32.3 23.77 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.125 -1.19 . . . . 53.43 110.125 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -102.37 159.24 15.59 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.243 -1.151 . . . . 71.120000000000005 108.48 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 15.5 mtt -100.01 137.84 37.91 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.288 -1.004 . . . . 75.239999999999995 108.288 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.57 150.86 39.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 73.25 109.984 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . 0.531 ' OD2' ' NH2' ' B' ' 2' ' ' ARG . 75.2 m-20 -126.16 144.35 50.79 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.822 -0.807 . . . . 72.310000000000002 108.822 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 1.4 p -112.13 129.07 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.716 -0.846 . . . . 72.140000000000001 108.716 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 6.8 p -134.1 167.85 19.89 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.533 -0.729 . . . . 74.530000000000001 109.455 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -93.79 -97.47 0.15 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.247 -0.908 . . . . 71.019999999999996 109.808 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 51.9 p -78.15 165.16 24.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.195 -0.941 . . . . 71.400000000000006 110.25 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' B' ' 37' ' ' GLU . 46.9 mt -55.01 -35.29 64.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.567 -0.708 . . . . 71.239999999999995 110.218 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -55.98 -44.19 78.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.053 -1.029 . . . . 74.319999999999993 109.831 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -62.47 -41.26 98.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.142 -0.974 . . . . 73.030000000000001 109.311 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . 0.438 ' O ' ' CG ' ' B' ' 40' ' ' MET . . . -80.63 -23.82 59.55 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.421 -1.472 . . . . 60.43 109.421 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' B' ' 33' ' ' LEU . 84.8 tt0 -66.43 -44.72 82.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -1.152 . . . . 74.430000000000007 109.661 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -79.3 -35.07 41.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.105 -0.997 . . . . 74.420000000000002 109.706 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 8.4 tt -73.82 -37.03 65.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 75.409999999999997 110.108 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.442 ' SD ' ' CE1' ' B' ' 45' ' ' TYR . 2.8 ppp? -76.15 -32.28 59.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.935 -1.103 . . . . 61.439999999999998 109.902 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -51.38 -37.03 46.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.926 . . . . 74.319999999999993 110.374 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 11.2 pt -78.94 -33.54 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.0 -1.062 . . . . 71.230000000000004 110.114 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.58 ' HE ' ' NH1' ' B' ' 2' ' ' ARG . 30.2 mmt-85 -93.96 168.6 10.86 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.906 -1.121 . . . . 73.409999999999997 110.024 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . 0.517 ' C ' ' CD1' ' B' ' 45' ' ' TYR . 30.9 p30 -92.85 -19.31 21.83 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.298 -0.876 . . . . 63.539999999999999 109.954 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.517 ' CD1' ' C ' ' B' ' 44' ' ' ASN . 11.0 p90 40.11 97.86 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.566 -0.709 . . . . 73.109999999999999 110.997 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -80.41 -38.04 31.0 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.056 -1.028 . . . . 62.219999999999999 109.1 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.64 114.36 28.42 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.745 -1.206 . . . . 73.120000000000005 107.745 179.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 65.4 t -99.07 97.78 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.224 -0.922 . . . . 74.109999999999999 108.846 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' MET . . . . . 0.404 ' SD ' ' CD1' ' B' ' 5' ' ' LEU . 25.5 ttt -113.58 131.4 56.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.554 -0.717 . . . . 73.439999999999998 109.782 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.435 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.5 OUTLIER -144.89 135.46 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.535 -0.728 . . . . 73.400000000000006 109.234 -179.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' SER . . . . . 0.573 ' CB ' ' HG ' ' B' ' 74' ' ' SER . 38.8 p -103.17 15.06 30.28 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.552 -0.718 . . . . 73.209999999999994 109.79 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.435 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 83.0 m-20 -77.83 144.92 36.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.104 -0.998 . . . . 70.409999999999997 109.467 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.481 ' C ' ' H ' ' B' ' 55' ' ' ALA . 41.6 mmtm -74.37 -43.31 57.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.224 -0.923 . . . . 73.129999999999995 110.164 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -72.86 13.14 0.41 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.07 -1.019 . . . . 75.209999999999994 109.786 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -69.34 -22.35 63.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 55.329999999999998 110.136 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 19.7 mt -42.04 -52.34 4.26 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.508 -0.745 . . . . 72.420000000000002 110.083 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' SER . . . . . 0.426 ' O ' ' OG ' ' B' ' 60' ' ' SER . 24.7 m -66.44 -35.07 79.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.956 -1.09 . . . . 73.040000000000006 109.082 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -65.26 -62.18 1.69 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.466 -0.771 . . . . 72.329999999999998 110.0 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 32.5 m -49.33 -34.08 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.637 -1.289 . . . . 74.540000000000006 109.962 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' B' ' 57' ' ' SER . 24.6 p -59.42 -53.66 55.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.052 -1.03 . . . . 71.239999999999995 109.739 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -66.24 -27.93 68.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.036 -1.04 . . . . 74.310000000000002 110.125 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 32.9 mm -65.5 -38.82 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.767 -1.208 . . . . 75.420000000000002 109.894 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -70.72 -47.81 57.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.028 -1.045 . . . . 73.319999999999993 110.598 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -69.77 -40.41 76.09 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.873 -1.142 . . . . 73.310000000000002 110.335 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.488 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 62.7 mttm -75.84 -24.31 55.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.13 -0.981 . . . . 72.439999999999998 109.979 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.488 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 90.5 m-70 -155.71 64.48 0.6 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.116 -0.99 . . . . 65.209999999999994 109.719 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 22.8 t -57.2 -27.93 62.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -0.889 . . . . 73.099999999999994 109.606 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 92.0 p -65.17 -23.08 67.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 71.530000000000001 109.906 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 60.5 mt -82.32 158.45 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.186 -0.946 . . . . 74.400000000000006 109.533 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 70.3 t -98.83 150.82 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.288 -0.883 . . . . 75.120000000000005 109.608 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 16.2 t -130.38 126.51 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.386 -0.821 . . . . 73.200000000000003 109.95 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 6.5 tt -121.98 100.34 6.93 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 109.094 -0.706 . . . . 73.340000000000003 109.094 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 9.2 p -93.71 134.87 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.981 -1.075 . . . . 73.5 109.253 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.573 ' HG ' ' CB ' ' B' ' 51' ' ' SER . 11.9 p -96.08 172.19 8.14 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.219 -0.926 . . . . 71.319999999999993 109.228 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.603 ' CB ' ' HH ' ' B' ' 94' ' ' TYR . 33.6 t -156.23 112.99 3.13 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.98 -1.075 . . . . 74.530000000000001 110.183 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' B' ' 77' ' ' ASN . 54.5 p30 -70.64 -12.13 61.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 64.5 109.217 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . 0.449 ' N ' ' OD1' ' B' ' 76' ' ' ASP . 87.2 m-20 -134.3 73.84 68.32 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.686 -0.857 . . . . 74.25 108.686 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -50.1 84.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.649 2.233 . . . . 74.430000000000007 111.781 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.449 ' N ' ' O ' ' B' ' 77' ' ' ASN . 7.1 p -100.33 151.18 21.8 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.941 -0.762 . . . . 73.120000000000005 108.941 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.99 -29.93 69.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.176 -0.953 . . . . 75.409999999999997 109.064 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -65.66 -37.01 85.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.304 -0.872 . . . . 72.239999999999995 109.251 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -74.75 -30.81 61.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.185 -0.947 . . . . 73.219999999999999 109.584 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -69.3 -50.2 48.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.95 . . . . 74.299999999999997 109.817 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 28.3 m -62.1 -36.73 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.088 -1.008 . . . . 73.310000000000002 109.38 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -77.92 -20.11 53.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 73.239999999999995 109.544 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.6 -42.6 58.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.188 -0.945 . . . . 55.329999999999998 110.275 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -83.13 -29.48 28.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.956 -1.09 . . . . 74.450000000000003 109.238 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -75.86 -37.91 58.45 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.308 -0.87 . . . . 64.040000000000006 109.741 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . 0.482 ' CG ' ' N ' ' B' ' 90' ' ' GLY . 11.8 pt20 -73.02 -47.44 45.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.107 -0.995 . . . . 75.129999999999995 109.792 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . 0.482 ' N ' ' CG ' ' B' ' 89' ' ' GLN . . . 147.38 65.35 0.01 OUTLIER Glycine 0 N--CA 1.495 2.614 0 C-N-CA 119.776 -1.202 . . . . 75.420000000000002 110.395 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.24 138.15 53.6 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.363 -1.08 . . . . 73.420000000000002 108.978 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . 0.517 ' CG ' HH21 ' B' ' 112' ' ' ARG . 46.1 t0 -86.54 -26.18 24.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.097 -1.002 . . . . 73.319999999999993 109.608 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 14.4 t0 -152.41 153.09 32.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 73.040000000000006 109.578 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.603 ' HH ' ' CB ' ' B' ' 75' ' ' SER . 61.7 t80 -134.27 101.49 5.03 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.545 -0.909 . . . . 74.310000000000002 108.545 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.421 HG22 HD12 ' B' ' 95' ' ' ILE . 23.1 mm -110.28 147.9 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.437 0 O-C-N 121.133 -0.98 . . . . 75.340000000000003 110.283 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.48 145.36 56.23 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.832 -1.173 . . . . 70.099999999999994 107.832 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.68 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -66.24 -56.53 15.93 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.671 -1.268 . . . . 65.430000000000007 111.58 -179.058 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 2.2 Cg_endo -39.88 -12.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 120.909 1.073 . . . . 63.520000000000003 112.824 -175.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . 0.68 ' N ' ' O ' ' B' ' 97' ' ' LYS . 53.7 m-85 59.59 137.09 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.86 -0.525 . . . . 75.129999999999995 110.315 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 50.8 mtt-85 -73.73 -40.28 63.67 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.982 -1.074 . . . . 74.230000000000004 108.808 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' SER . . . . . 0.753 ' O ' ' N ' ' B' ' 103' ' ' LYS . 34.4 t -168.1 33.8 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.162 -0.961 . . . . 64.510000000000005 110.782 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 37.3 mm 50.71 -69.62 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.567 -0.708 . . . . 74.439999999999998 110.341 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . 0.753 ' N ' ' O ' ' B' ' 101' ' ' SER . 40.3 mmtm -55.12 -30.49 59.87 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.865 -1.161 . . . . 72.299999999999997 107.865 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.78 -55.69 13.78 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.604 -0.839 . . . . 74.310000000000002 109.011 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 19.0 tp -58.05 -43.78 87.06 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.33 -0.856 . . . . 73.540000000000006 108.762 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.21 -47.88 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -0.93 . . . . 72.030000000000001 108.853 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -49.2 -38.01 24.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.14 -0.975 . . . . 64.219999999999999 108.885 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 0.531 ' O ' ' NE ' ' B' ' 108' ' ' ARG . 0.0 OUTLIER -67.6 -35.25 78.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.476 -0.765 . . . . 75.310000000000002 108.97 179.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 64.3 mt -78.28 -29.94 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.066 -1.022 . . . . 55.439999999999998 109.435 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -67.9 -52.49 35.75 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.537 -0.727 . . . . 65.310000000000002 109.868 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.41 -38.04 74.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.194 -0.942 . . . . 74.519999999999996 110.035 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . 0.517 HH21 ' CG ' ' B' ' 92' ' ' ASP . 40.6 ttt85 -57.84 -35.6 71.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.993 -1.067 . . . . 72.040000000000006 109.704 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 tt -144.07 103.01 3.96 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.097 -1.002 . . . . 75.349999999999994 109.492 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.458 ' NE ' ' H ' ' B' ' 115' ' ' PHE . 0.1 OUTLIER -142.09 -164.37 1.79 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.43 -0.952 . . . . 75.5 108.43 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' PHE . . . . . 0.458 ' H ' ' NE ' ' B' ' 114' ' ' ARG . 45.4 m-85 51.88 32.34 9.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.042 -1.037 . . . . 73.040000000000006 109.294 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' TRP . . . . . 0.757 ' CE3' ' O ' ' B' ' 117' ' ' GLY . 74.4 t90 53.66 169.01 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.499 -0.751 . . . . 74.450000000000003 110.196 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . 0.757 ' O ' ' CE3' ' B' ' 116' ' ' TRP . . . -47.38 145.45 4.75 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.864 -1.294 . . . . 64.209999999999994 109.864 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' SER . . . . . 0.698 ' HG ' ' H ' ' B' ' 119' ' ' ASN . 43.0 t -94.22 172.87 7.94 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.425 -1.044 . . . . 71.400000000000006 109.406 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . 0.698 ' H ' ' HG ' ' B' ' 118' ' ' SER . 27.4 t-20 -142.24 178.86 7.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.311 -0.868 . . . . 74.209999999999994 109.043 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . 0.453 ' H ' ' CG ' ' B' ' 119' ' ' ASN . 18.8 t -140.16 -45.15 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.243 -0.911 . . . . 75.019999999999996 109.233 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 9.2 mm -97.89 111.14 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.057 -1.027 . . . . 74.239999999999995 108.501 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -128.23 105.49 8.39 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.496 -0.753 . . . . 73.329999999999998 109.287 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.402 ' O ' ' CG2' ' B' ' 123' ' ' ILE . 10.5 tp -145.2 122.79 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.165 -0.96 . . . . 74.219999999999999 109.077 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' B' ' 126' ' ' LEU . . . 54.86 -170.98 1.3 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.464 -1.855 . . . . 72.409999999999997 108.464 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.96 2.91 0.63 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.896 -1.356 . . . . 75.120000000000005 108.877 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.534 ' H ' ' C ' ' B' ' 124' ' ' GLY . 0.6 OUTLIER -91.73 117.21 29.55 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.685 -0.857 . . . . 75.420000000000002 108.685 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 83.0 m -125.11 140.92 52.46 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.475 -0.766 . . . . 74.219999999999999 108.964 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 6.3 mt -141.22 136.21 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.271 -0.893 . . . . 60.329999999999998 110.463 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 13.4 m -114.78 114.59 44.23 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.958 -0.756 . . . . 72.310000000000002 108.958 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -83.48 -40.12 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.248 1.965 . . . . 75.129999999999995 112.172 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -63.34 -49.72 72.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.392 -0.818 . . . . 75.230000000000004 109.492 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -81.83 -0.17 42.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.955 . . . . 75.120000000000005 109.278 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 50.34 74.25 0.23 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.123 -0.985 . . . . 75.129999999999995 109.605 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -159.33 129.64 5.76 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.075 -1.015 . . . . 75.109999999999999 109.351 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 12.4 tt -109.37 128.97 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.795 -0.817 . . . . 70.319999999999993 108.795 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 69.2 mt -116.39 126.48 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-O 121.535 0.683 . . . . 74.120000000000005 110.404 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -135.74 147.03 48.28 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.943 -0.762 . . . . 74.230000000000004 108.943 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm 54.03 36.11 23.77 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.554 -0.716 . . . . 74.219999999999999 110.719 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 64.5 7.75 28.64 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.985 -1.246 . . . . 74.319999999999993 109.985 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -107.04 124.48 49.71 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.478 -1.013 . . . . 75.340000000000003 108.536 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -80.92 143.2 32.82 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.416 -0.803 . . . . 71.230000000000004 109.882 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 22.5 t -134.3 129.92 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.64 -0.874 . . . . 70.430000000000007 108.64 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -83.2 149.41 26.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.343 -0.848 . . . . 72.430000000000007 109.662 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . 0.69 HG22 ' CZ ' ' B' ' 149' ' ' PHE . 2.5 m -153.05 144.42 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 72.129999999999995 109.384 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 27.2 pttt -175.47 101.86 0.08 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.239 -0.913 . . . . 74.5 109.262 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 177.52 174.16 43.65 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.663 -1.256 . . . . 42.229999999999997 110.246 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 0.604 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 10.0 tttt -62.4 -42.4 79.86 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.457 -1.025 . . . . 73.299999999999997 109.706 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 23.3 Cg_exo -62.65 -32.45 79.0 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.575 2.184 . . . . 71.329999999999998 112.461 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . 0.69 ' CZ ' HG22 ' B' ' 144' ' ' VAL . 71.9 t80 -92.43 -15.35 27.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.129 -0.982 . . . . 74.230000000000004 109.886 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -60.88 -41.12 95.39 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.093 -1.004 . . . . 72.340000000000003 109.759 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 8.6 p -72.92 -40.6 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.223 -0.923 . . . . 73.349999999999994 110.051 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 21.1 tp -56.9 -31.21 64.66 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.268 -0.895 . . . . 74.430000000000007 109.119 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' B' ' 149' ' ' PHE . 0.2 OUTLIER -76.84 -46.67 23.88 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.488 -0.757 . . . . 75.209999999999994 109.183 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -50.29 -46.42 55.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.188 -0.945 . . . . 73.040000000000006 110.507 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 1.9 pp -73.77 -34.68 64.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.648 -1.283 . . . . 73.430000000000007 109.383 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -50.19 -35.8 27.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.096 -1.002 . . . . 75.319999999999993 108.951 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -79.16 -46.47 17.87 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.384 -0.823 . . . . 73.319999999999993 109.175 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -85.57 49.04 1.68 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.666 -0.646 . . . . 74.140000000000001 111.068 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . 0.519 ' NH2' ' OG1' ' B' ' 203' ' ' THR . 5.6 tpt180 -72.83 171.57 12.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.846 -1.159 . . . . 73.420000000000002 108.097 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . 0.4 ' H ' ' HG3' ' B' ' 159' ' ' ARG . 51.1 t0 54.48 60.24 3.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.828 -1.17 . . . . 72.099999999999994 109.566 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -171.58 147.23 2.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.309 -0.87 . . . . 73.239999999999995 109.312 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 21.8 mm -83.63 122.31 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 72.310000000000002 108.89 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 97.1 t -119.64 139.4 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.393 -0.817 . . . . 75.030000000000001 109.553 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 5.4 t -99.69 160.46 14.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.341 -0.849 . . . . 74.219999999999999 110.047 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . 0.468 ' HZ1' ' CG2' ' B' ' 184' ' ' ILE . 18.0 mtpp -61.55 -44.61 96.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.528 -0.733 . . . . 72.420000000000002 109.609 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -50.54 -39.75 49.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.477 -0.764 . . . . 63.450000000000003 110.254 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -59.29 -48.89 79.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.047 -1.033 . . . . 72.400000000000006 109.51 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 27.5 mt -58.31 -30.56 66.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.212 -0.93 . . . . 72.319999999999993 109.412 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.431 ' C ' ' CD1' ' B' ' 169' ' ' LEU . 2.3 tm? -66.92 -66.61 0.53 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.388 -0.82 . . . . 73.340000000000003 109.872 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.01 -2.07 6.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.311 -0.868 . . . . 73.099999999999994 110.874 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.91 -57.96 2.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.838 -1.164 . . . . 62.130000000000003 110.116 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.514 ' N ' ' CD1' ' B' ' 172' ' ' ILE . 1.9 mp -91.73 -45.39 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.955 -1.091 . . . . 74.439999999999998 110.123 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' TRP . . . . . 0.525 ' O ' ' N ' ' B' ' 175' ' ' GLU . 16.5 m-90 -77.53 -5.28 49.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.909 -1.119 . . . . 72.230000000000004 108.686 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 45.18 -90.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.56 -0.712 . . . . 75.030000000000001 110.262 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' B' ' 177' ' ' GLU . 1.6 mt-10 -167.39 -52.42 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.955 -1.091 . . . . 73.040000000000006 109.997 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.462 ' HD2' ' H ' ' B' ' 175' ' ' GLU . 82.3 Cg_exo -45.34 -9.23 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.001 1.801 . . . . 74.129999999999995 112.4 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' B' ' 175' ' ' GLU . 70.8 mm-40 -82.04 161.34 22.98 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.176 -0.953 . . . . 72.439999999999998 109.468 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 178' ' ' MET . . . . . 0.437 ' O ' ' O ' ' B' ' 179' ' ' VAL . 21.6 ttt -67.24 -41.22 86.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 72.109999999999999 109.407 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 179' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' B' ' 178' ' ' MET . 48.9 t 52.59 103.24 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.502 -0.749 . . . . 75.310000000000002 109.896 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 180' ' ' THR . . . . . 0.542 ' O ' ' N ' ' B' ' 182' ' ' ASN . 1.6 p -80.17 155.6 74.6 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 108.375 -0.972 . . . . 62.149999999999999 108.375 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -39.68 -16.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.357 2.038 . . . . 74.340000000000003 112.914 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 182' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' B' ' 180' ' ' THR . 18.9 p30 -160.64 107.3 1.51 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.875 -1.14 . . . . 72.310000000000002 110.17 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 96.7 t -121.55 -36.0 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.489 -0.757 . . . . 65.420000000000002 109.477 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.468 ' CG2' ' HZ1' ' B' ' 165' ' ' LYS . 24.5 mm -60.84 -22.18 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 75.030000000000001 109.667 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.09 -42.0 99.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.123 -0.986 . . . . 73.519999999999996 110.259 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 5.2 m -79.42 -36.89 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.925 -1.109 . . . . 74.349999999999994 109.745 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.1 -46.84 64.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.12 -0.988 . . . . 61.119999999999997 109.714 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 188' ' ' ILE . . . . . 0.422 ' CG2' ' N ' ' B' ' 189' ' ' ASN . 9.1 tp -62.49 -42.51 96.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.088 -1.008 . . . . 72.430000000000007 110.028 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 189' ' ' ASN . . . . . 0.454 ' OD1' ' NH2' ' B' ' 192' ' ' ARG . 55.1 t30 -58.51 -43.69 89.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.024 . . . . 75.420000000000002 109.827 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -73.7 -38.03 65.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.176 -0.953 . . . . 74.140000000000001 110.319 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 60.9 mt -65.15 -49.14 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.136 -0.977 . . . . 74.030000000000001 110.824 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 192' ' ' ARG . . . . . 0.454 ' NH2' ' OD1' ' B' ' 189' ' ' ASN . 28.4 ptt180 -64.07 -37.33 87.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.84 -1.162 . . . . 72.329999999999998 108.131 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 193' ' ' GLN . . . . . 0.504 ' HG3' ' CE ' ' B' ' 197' ' ' LYS . 42.6 tt0 -65.18 -30.43 71.34 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.905 -1.146 . . . . 73.099999999999994 107.905 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . 0.629 ' O ' HD13 ' B' ' 199' ' ' LEU . 36.5 mtpt -93.44 2.74 56.37 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.084 -0.71 . . . . 74.430000000000007 109.084 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 195' ' ' MET . . . . . 1.208 ' HE3' ' OG1' ' B' ' 203' ' ' THR . 5.0 tpt -94.37 -22.31 18.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.959 -1.088 . . . . 74.329999999999998 109.703 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 196' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 5.1 m-20 -114.02 -27.35 7.74 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.107 -0.995 . . . . 71.209999999999994 111.918 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . 0.504 ' CE ' ' HG3' ' B' ' 193' ' ' GLN . 5.2 mtmm -79.06 -62.77 0.43 Allowed Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 120.427 -1.421 . . . . 75.209999999999994 111.288 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 198' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.66 -49.28 0.17 Allowed 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 121.787 1.658 . . . . 75.319999999999993 112.221 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . 0.629 HD13 ' O ' ' B' ' 194' ' ' LYS . 10.6 mp -54.35 -70.79 0.09 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.092 -1.005 . . . . 72.25 109.034 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 143.44 -59.15 0.53 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.51 -1.436 . . . . 73.239999999999995 109.51 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 29.3 mt -109.34 142.81 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.558 -0.966 . . . . 54.299999999999997 109.677 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 17.3 m -77.71 139.47 39.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.122 -0.987 . . . . 74.310000000000002 108.631 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 203' ' ' THR . . . . . 1.208 ' OG1' ' HE3' ' B' ' 195' ' ' MET . 70.7 p -129.55 5.96 5.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.439 -0.788 . . . . 74.400000000000006 109.759 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.881 HG12 ' HE1' ' B' ' 195' ' ' MET . 24.3 m -121.67 147.84 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.502 -0.749 . . . . 74.099999999999994 109.642 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -116.8 125.17 51.2 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.218 -0.66 . . . . 75.329999999999998 109.218 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.07 112.76 20.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.394 -0.817 . . . . 71.400000000000006 109.219 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.446 ' O ' ' O ' ' B' ' 211' ' ' GLY . 7.3 p -138.18 145.84 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.367 -0.833 . . . . 63.5 109.264 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -97.1 -15.78 20.81 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.105 -0.997 . . . . 74.450000000000003 110.11 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 66.5 mtt-85 -50.24 -39.83 45.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.154 -0.967 . . . . 74.140000000000001 109.859 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -140.04 -53.63 0.52 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.301 -0.875 . . . . 74.430000000000007 109.4 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' B' ' 207' ' ' VAL . . . 179.65 -102.31 0.16 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.468 -1.453 . . . . 70.109999999999999 109.468 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -136.48 135.31 38.49 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.346 -1.09 . . . . 74.209999999999994 108.948 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 43.5 mtt-85 -95.15 125.78 40.03 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.31 -0.869 . . . . 74.299999999999997 109.395 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -106.4 106.43 16.95 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.493 -0.754 . . . . 74.340000000000003 109.471 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 16.4 p -158.93 170.97 20.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.213 -0.93 . . . . 72.209999999999994 109.545 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -64.14 138.54 97.44 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 121.238 -0.914 . . . . 72.310000000000002 108.81 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' B' ' 218' ' ' LYS . 74.1 Cg_endo -73.54 77.34 2.59 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.248 1.966 . . . . 71.010000000000005 112.695 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' B' ' 220' ' ' ALA . 18.4 mttm 59.23 151.15 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.405 -0.809 . . . . 74.349999999999994 109.742 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -44.98 85.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.66 1.573 . . . . 71.319999999999993 111.325 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' B' ' 218' ' ' LYS . . . -93.14 -26.32 17.48 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.016 -1.053 . . . . 75.450000000000003 110.446 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 42.4 t -49.18 -30.89 7.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.876 -1.14 . . . . 72.219999999999999 109.674 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 49.17 44.91 23.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.128 -0.983 . . . . 74.299999999999997 109.764 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.123 -0.985 . . . . 71.129999999999995 109.751 179.594 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.6 ' CE ' ' HE1' ' A' ' 116' ' ' TRP . 64.3 ttp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.492 -0.559 . . . . 65.120000000000005 109.492 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -138.03 151.43 47.87 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.342 -0.849 . . . . 73.310000000000002 109.297 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.8 t -116.79 135.53 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.748 -0.595 . . . . 71.420000000000002 109.632 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.74 122.73 48.53 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.36 -0.837 . . . . 65.219999999999999 109.181 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.0 mt -120.89 101.74 7.9 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.61 -0.681 . . . . 71.439999999999998 109.181 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.449 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 10.6 mt -79.27 104.61 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.781 -1.2 . . . . 71.150000000000006 108.753 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 9' ' ' ASN . 0.6 OUTLIER -139.16 123.19 17.86 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.306 -0.871 . . . . 75.340000000000003 109.215 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.44 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 68.3 mttm -65.35 -33.68 76.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 73.040000000000006 109.162 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.513 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 18.2 m120 -82.41 112.36 19.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 72.420000000000002 109.485 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 45.5 m -63.83 -26.31 68.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 72.340000000000003 109.653 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.29 -53.2 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.195 -0.941 . . . . 74.420000000000002 109.863 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.6 mt -61.42 -46.84 88.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 72.010000000000005 109.585 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.32 -17.1 71.99 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.517 -1.833 . . . . 72.140000000000001 108.517 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.4 -54.41 5.57 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.483 -1.447 . . . . 72.329999999999998 109.483 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -56.51 -44.9 81.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.425 -1.044 . . . . 72.340000000000003 109.783 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.2 mm -63.41 -34.99 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.822 -1.174 . . . . 74.239999999999995 108.798 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.449 ' CD ' HD22 ' A' ' 21' ' ' ASN . 14.2 tm-20 -57.91 -49.66 75.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.922 . . . . 71.409999999999997 109.102 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -87.52 3.47 47.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.26 -0.9 . . . . 75.540000000000006 109.262 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.66 -57.96 2.48 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.68 -1.368 . . . . 62.149999999999999 109.68 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -75.05 -19.98 59.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -1.146 . . . . 74.420000000000002 109.869 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.449 HD22 ' CD ' ' A' ' 17' ' ' GLU . 80.4 m-20 -51.29 -33.88 30.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.092 -1.005 . . . . 74.25 109.282 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.2 t -58.0 -46.95 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.322 -0.861 . . . . 72.109999999999999 108.938 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -56.91 -53.18 60.95 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.903 -0.777 . . . . 73.230000000000004 108.903 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 133.63 36.41 0.26 Allowed Glycine 0 N--CA 1.5 2.929 0 N-CA-C 109.735 -1.346 . . . . 75.540000000000006 109.735 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.59 ' CE2' ' SD ' ' A' ' 1' ' ' MET . 20.1 m-85 -119.39 160.02 23.1 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.483 -1.01 . . . . 74.510000000000005 109.344 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.2 mmt -104.22 140.34 37.98 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.571 -0.9 . . . . 64.319999999999993 108.571 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.417 ' O ' ' OD1' ' A' ' 28' ' ' ASP . . . -138.52 155.48 48.36 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.337 -0.852 . . . . 74.310000000000002 110.28 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 27' ' ' ALA . 82.1 m-20 -141.57 155.6 45.75 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.592 -0.892 . . . . 75.400000000000006 108.592 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.2 t -112.11 139.35 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.379 -0.826 . . . . 75.129999999999995 109.384 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.6 p -129.99 166.69 19.57 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.523 -0.736 . . . . 71.420000000000002 109.573 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.449 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 4.4 pt-20 -93.72 -102.98 0.13 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.348 -0.845 . . . . 73.109999999999999 109.809 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.7 p -79.31 168.88 18.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.115 -0.991 . . . . 74.239999999999995 109.891 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.0 mt -57.33 -33.32 67.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.521 -0.737 . . . . 71.530000000000001 109.742 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -51.27 -43.57 61.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 74.230000000000004 109.661 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -65.91 -41.92 90.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.154 -0.966 . . . . 71.010000000000005 109.373 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.25 -38.44 46.33 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.493 -1.443 . . . . 61.409999999999997 109.493 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.71 -38.18 90.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -1.135 . . . . 74.340000000000003 109.621 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -80.84 -39.47 26.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 75.329999999999998 109.717 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.9 tp -68.16 -46.35 70.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 74.329999999999998 110.077 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 41' ' ' ASP . 3.3 ppp? -62.73 -27.62 69.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.041 -1.037 . . . . 70.319999999999993 109.83 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 40' ' ' MET . 93.5 m-20 -63.49 -40.21 96.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.135 -0.978 . . . . 71.219999999999999 109.94 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.9 pt -84.0 -25.86 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.159 -0.963 . . . . 74.409999999999997 110.167 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 40' ' ' MET . 97.4 mtt180 -130.04 138.76 50.93 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.373 -0.829 . . . . 75.409999999999997 109.584 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -93.98 126.36 39.15 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.248 -0.908 . . . . 75.420000000000002 109.472 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -106.01 145.78 30.93 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.429 -0.794 . . . . 74.230000000000004 109.524 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -85.57 -44.56 12.54 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.274 -0.891 . . . . 75.319999999999993 109.078 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.417 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -105.56 108.41 19.9 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.585 -0.894 . . . . 72.129999999999995 108.585 179.641 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.0 m -104.33 101.86 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.31 -0.996 . . . . 72.340000000000003 108.31 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.6 ttt -108.37 143.02 37.83 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.688 -0.856 . . . . 74.109999999999999 108.688 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 p -144.15 132.34 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.361 -0.837 . . . . 71.239999999999995 109.933 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.0 m -98.98 2.29 46.23 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.481 -0.762 . . . . 73.109999999999999 109.472 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -76.14 139.12 41.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.192 -0.943 . . . . 63.399999999999999 109.427 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.53 ' C ' ' H ' ' A' ' 55' ' ' ALA . 61.6 mttp -73.62 -43.5 59.42 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.307 -0.871 . . . . 65.439999999999998 110.731 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -68.16 10.26 0.24 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.017 -1.052 . . . . 73.129999999999995 109.89 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.53 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.93 -22.18 56.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.893 . . . . 64.140000000000001 110.57 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' ALA . 64.0 mt -39.98 -51.59 2.51 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.511 -0.743 . . . . 74.430000000000007 110.498 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.427 ' O ' ' OG ' ' A' ' 60' ' ' SER . 24.9 m -68.75 -33.72 74.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.939 -1.1 . . . . 63.229999999999997 109.319 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.423 ' N ' ' O ' ' A' ' 55' ' ' ALA . 73.6 t80 -64.84 -48.42 74.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.386 -0.821 . . . . 74.439999999999998 110.088 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.61 -34.83 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.615 -1.303 . . . . 74.030000000000001 109.52 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 57' ' ' SER . 56.9 p -57.33 -49.64 75.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 73.540000000000006 109.542 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -69.41 -33.2 72.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.032 -1.043 . . . . 73.340000000000003 109.927 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.1 mm -63.63 -35.41 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.828 -1.17 . . . . 73.349999999999994 109.747 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 67' ' ' SER . 11.5 mtpt -72.08 -51.05 23.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.123 -0.986 . . . . 74.420000000000002 110.461 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.431 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 14.6 pt-20 -67.24 -41.69 85.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.743 -1.223 . . . . 74.549999999999997 109.708 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.448 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 93.4 mttt -73.61 -24.42 60.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.878 . . . . 75.219999999999999 109.501 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.448 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 93.5 m-70 -154.93 65.88 0.66 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.229 -0.92 . . . . 74.129999999999995 109.293 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 63' ' ' LYS . 17.0 t -60.45 -32.56 71.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.392 -0.818 . . . . 73.239999999999995 110.038 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.1 m -67.59 46.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 71.439999999999998 109.859 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 67' ' ' SER . 13.8 tt -145.63 162.85 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.142 -0.974 . . . . 71.329999999999998 109.726 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.0 t -97.73 148.75 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.221 -0.924 . . . . 73.019999999999996 108.942 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.51 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 11.3 t -132.38 124.08 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.282 -0.886 . . . . 54.210000000000001 109.508 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 mt -128.07 99.26 5.41 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.319 -0.993 . . . . 74.209999999999994 108.319 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.3 t -93.12 149.56 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -0.869 . . . . 74.409999999999997 109.14 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.7 m -121.96 165.84 15.36 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.529 -0.915 . . . . 72.310000000000002 108.529 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.457 ' C ' ' H ' ' A' ' 77' ' ' ASN . 9.7 p -171.81 123.65 0.53 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.035 -1.041 . . . . 64.540000000000006 110.226 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 52.1 p30 -71.0 10.56 0.52 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.59 -0.694 . . . . 74.129999999999995 109.901 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.457 ' H ' ' C ' ' A' ' 75' ' ' SER . 5.8 p-10 -129.09 59.57 44.95 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.38 -0.825 . . . . 73.340000000000003 109.661 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -58.9 80.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.276 1.984 . . . . 71.319999999999993 112.047 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.403 ' N ' ' O ' ' A' ' 77' ' ' ASN . 72.6 p -104.28 151.56 23.27 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.621 -0.881 . . . . 62.530000000000001 108.621 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -30.8 69.53 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.228 -0.92 . . . . 74.140000000000001 109.363 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -67.15 -37.47 83.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.189 -0.945 . . . . 71.420000000000002 109.554 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.45 ' OE2' ' CB ' ' A' ' 75' ' ' SER . 79.4 tt0 -71.47 -32.62 68.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 73.430000000000007 109.722 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.476 ' OE2' ' CZ ' ' B' ' 100' ' ' ARG . 92.2 mt-10 -64.44 -50.95 65.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.918 . . . . 74.219999999999999 109.825 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.3 m -61.01 -36.32 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.157 -0.964 . . . . 74.150000000000006 109.252 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.429 ' O ' ' OE1' ' A' ' 89' ' ' GLN . 27.0 m80 -74.51 -26.65 60.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 72.540000000000006 109.599 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.53 -41.96 87.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.109 -0.995 . . . . 64.219999999999999 109.786 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -82.05 -35.12 29.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.042 -1.036 . . . . 74.340000000000003 109.08 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -62.08 -51.55 67.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.379 -0.825 . . . . 74.420000000000002 109.411 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.488 ' NE2' ' N ' ' A' ' 89' ' ' GLN . 0.9 OUTLIER -66.6 -58.26 5.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.531 -0.731 . . . . 74.519999999999996 109.686 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 158.17 75.27 0.02 OUTLIER Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.613 -1.279 . . . . 74.209999999999994 110.266 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -134.84 119.61 18.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.305 -1.115 . . . . 64.099999999999994 108.947 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 71.6 m-20 -71.36 -34.79 70.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.102 -0.999 . . . . 73.420000000000002 108.923 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.502 ' CG ' HH21 ' A' ' 112' ' ' ARG . 60.7 m-20 -153.16 152.5 31.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.451 -0.781 . . . . 75.040000000000006 109.046 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.434 ' OH ' ' OG ' ' A' ' 75' ' ' SER . 9.3 t80 -126.76 132.93 50.96 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.08 -0.711 . . . . 71.329999999999998 109.08 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.479 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 0.1 OUTLIER -121.57 142.38 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 CA-C-O 121.978 0.894 . . . . 74.510000000000005 110.442 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.52 119.86 10.61 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.599 -1.26 . . . . 64.319999999999993 107.599 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.677 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -43.9 -53.9 12.05 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 74.510000000000005 111.628 -178.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 2.3 Cg_endo -40.56 -10.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 120.955 1.103 . . . . 73.109999999999999 113.12 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.677 ' N ' ' O ' ' A' ' 97' ' ' LYS . 64.0 m-85 59.96 92.73 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.71 -0.619 . . . . 72.540000000000006 109.9 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.8 ttm105 -52.09 -39.03 59.14 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.354 -0.98 . . . . 74.540000000000006 108.354 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 t -172.41 134.41 0.68 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.493 -0.755 . . . . 74.140000000000001 109.025 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 81.8 mt -53.34 -40.1 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.127 -0.983 . . . . 75.430000000000007 109.26 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -66.79 -26.22 66.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 74.140000000000001 109.67 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.81 -48.58 21.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.171 -0.955 . . . . 63.240000000000002 109.856 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.445 ' C ' ' CD1' ' A' ' 105' ' ' LEU . 2.1 tm? -57.75 -54.05 51.24 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.207 -0.933 . . . . 73.219999999999999 109.442 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.421 ' CG1' ' N ' ' A' ' 107' ' ' ALA . 11.0 p -60.28 -41.9 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.099 -1.001 . . . . 74.540000000000006 109.52 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.421 ' N ' ' CG1' ' A' ' 106' ' ' VAL . . . -51.8 -36.63 48.47 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.17 -0.956 . . . . 75.5 108.925 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -71.87 -37.45 70.19 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.372 -0.83 . . . . 74.409999999999997 109.399 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 87.7 mt -67.11 -31.61 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 107.978 -1.119 . . . . 73.239999999999995 107.978 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 113' ' ' LEU . 78.5 tt0 -65.85 -57.55 7.66 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.637 -0.825 . . . . 74.340000000000003 108.927 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -46.21 -37.2 6.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.475 -0.766 . . . . 73.319999999999993 109.655 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.502 HH21 ' CG ' ' A' ' 93' ' ' ASP . 28.1 mmt180 -82.25 -14.46 55.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 74.420000000000002 110.103 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' ' 110' ' ' GLU . 80.4 mt -135.25 44.08 2.61 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.133 -0.979 . . . . 74.329999999999998 110.617 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -76.44 -39.19 54.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.848 -1.158 . . . . 74.439999999999998 108.846 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.529 ' CD2' ' O ' ' A' ' 116' ' ' TRP . 33.8 p90 -67.74 -10.98 57.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.424 -0.797 . . . . 74.430000000000007 109.977 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.6 ' HE1' ' CE ' ' A' ' 1' ' ' MET . 48.0 t90 50.29 -178.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.138 -0.976 . . . . 74.439999999999998 109.504 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.495 ' N ' ' CG ' ' A' ' 116' ' ' TRP . . . -50.96 143.18 15.0 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.351 -1.499 . . . . 75.040000000000006 109.351 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 87.9 p -157.6 -178.5 7.38 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -1.206 . . . . 70.109999999999999 110.068 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.38 -179.64 8.13 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.05 -0.722 . . . . 65.239999999999995 109.05 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.6 t -138.34 -36.6 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.42 -0.8 . . . . 74.219999999999999 109.125 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.523 ' N ' ' CD1' ' A' ' 121' ' ' ILE . 1.4 mp -90.4 136.41 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.995 . . . . 74.420000000000002 108.493 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -138.6 105.69 5.46 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.349 -0.844 . . . . 73.299999999999997 109.47 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 83.5 mt -108.94 109.78 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.962 -0.755 . . . . 75.340000000000003 108.962 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.8 -137.73 31.06 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.277 -1.529 . . . . 75.129999999999995 109.277 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -79.56 -3.83 48.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -1.191 . . . . 74.450000000000003 109.349 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.06 143.25 26.98 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.356 -0.979 . . . . 54.210000000000001 108.356 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 54.9 m -129.86 141.07 50.87 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.375 -0.828 . . . . 70.239999999999995 109.231 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.74 130.81 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.42 -0.8 . . . . 72.430000000000007 109.976 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.1 m -107.4 113.45 61.89 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.633 -0.667 . . . . 71.109999999999999 109.226 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.8 -53.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.92 1.746 . . . . 75.140000000000001 111.959 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -55.3 -44.65 75.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 72.5 109.316 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -83.52 -8.54 59.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.401 -0.812 . . . . 73.140000000000001 109.153 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 51.72 57.53 6.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 75.329999999999998 109.154 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -139.37 116.03 10.73 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.411 -0.806 . . . . 71.230000000000004 109.164 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.503 ' N ' ' CD1' ' A' ' 135' ' ' ILE . 1.4 mp -94.22 130.24 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.185 -0.947 . . . . 75.329999999999998 108.905 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 36.8 mt -115.91 129.41 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.561 -0.712 . . . . 71.109999999999999 109.575 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.502 ' C ' ' H ' ' A' ' 139' ' ' GLY . 77.5 t80 -141.58 151.19 42.96 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.512 -0.922 . . . . 74.140000000000001 108.512 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 46.1 tttp 55.94 5.63 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.851 . . . . 75.400000000000006 109.408 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 137' ' ' TYR . . . 93.86 -4.81 72.29 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.686 -1.366 . . . . 72.239999999999995 109.686 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.404 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 0.7 OUTLIER -89.71 139.7 30.3 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.247 -1.149 . . . . 73.120000000000005 109.299 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -86.71 137.19 32.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 72.319999999999993 109.162 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.1 t -135.26 128.12 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.43 -0.794 . . . . 62.340000000000003 109.531 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -93.37 134.34 35.69 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.306 -0.871 . . . . 61.229999999999997 109.048 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.1 m -149.48 140.56 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.106 -0.996 . . . . 74.439999999999998 109.556 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -163.54 18.83 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 75.420000000000002 109.776 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.3 161.09 54.16 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.844 -1.702 . . . . 73.340000000000003 108.844 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.562 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 4.8 tttp -56.44 -44.73 99.86 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.039 -1.271 . . . . 72.219999999999999 109.091 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 24.2 Cg_exo -62.58 -28.5 77.3 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.362 2.042 . . . . 75.450000000000003 112.122 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -80.67 -20.7 42.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.232 -0.918 . . . . 65.239999999999995 110.12 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -52.75 -32.96 46.14 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.067 -1.021 . . . . 72.519999999999996 108.965 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.4 p -64.95 -38.08 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.324 -0.86 . . . . 74.209999999999994 109.276 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 29.4 tp -60.86 -41.92 96.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.857 . . . . 73.310000000000002 109.322 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 20.0 p -74.35 -34.79 63.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.245 -0.909 . . . . 74.310000000000002 110.16 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.625 ' HD1' HH21 ' A' ' 157' ' ' ARG . 43.9 m-70 -60.9 -52.69 63.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.137 -0.977 . . . . 75.450000000000003 110.035 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 pp -68.52 -28.56 67.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.906 -1.121 . . . . 75.340000000000003 109.602 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.3 -47.59 78.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 62.140000000000001 109.377 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.625 HH21 ' HD1' ' A' ' 154' ' ' HIS . 67.9 mtm-85 -69.03 -58.69 3.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.965 . . . . 72.219999999999999 109.461 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -53.27 -47.67 68.94 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.811 -0.756 . . . . 74.120000000000005 109.457 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 161' ' ' GLN . 23.1 ttm180 44.97 -126.49 1.1 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.401 -0.812 . . . . 74.340000000000003 109.895 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 45.6 p-10 -50.08 90.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 75.450000000000003 109.561 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.844 ' OE1' ' OH ' ' B' ' 216' ' ' TYR . 1.4 tp-100 -171.53 149.54 2.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.246 -0.909 . . . . 73.409999999999997 109.325 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 65.3 mt -78.51 135.46 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.148 -0.97 . . . . 74.409999999999997 109.216 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 87.1 t -127.58 129.29 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.452 -0.78 . . . . 72.530000000000001 109.653 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.7 t -99.44 153.36 19.07 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.435 -0.791 . . . . 74.120000000000005 109.324 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.5 mtmm -56.97 -43.83 82.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.33 -0.856 . . . . 70.430000000000007 109.494 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -59.01 -34.26 71.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.341 -0.85 . . . . 74.319999999999993 109.575 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -63.91 -55.19 24.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.166 -0.959 . . . . 74.519999999999996 109.621 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 80.3 mt -47.64 -52.71 17.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.143 -0.973 . . . . 74.409999999999997 109.774 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.505 ' C ' ' H ' ' A' ' 171' ' ' ALA . 87.2 mt -57.62 -74.6 0.05 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.591 -1.318 . . . . 75.140000000000001 109.666 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -48.86 -11.01 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.973 -1.079 . . . . 65.030000000000001 110.459 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.505 ' H ' ' C ' ' A' ' 169' ' ' LEU . . . -95.43 -41.39 9.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.189 -0.945 . . . . 70.209999999999994 111.185 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.439 ' O ' ' OE1' ' A' ' 175' ' ' GLU . 1.7 mp -84.61 -47.18 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.917 -1.114 . . . . 75.319999999999993 109.688 -178.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.626 ' CD1' ' O ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -81.41 0.48 37.33 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.668 -1.27 . . . . 73.140000000000001 109.188 -179.752 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.472 ' C ' ' O ' ' A' ' 173' ' ' TRP . 76.6 tt0 -36.87 -34.9 0.08 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.237 -0.914 . . . . 73.239999999999995 110.563 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.48 ' OE1' ' N ' ' A' ' 175' ' ' GLU . 0.8 OUTLIER -89.79 151.17 45.21 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 107.629 -1.249 . . . . 63.329999999999998 107.629 178.458 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.423 ' C ' ' O ' ' A' ' 175' ' ' GLU . 23.5 Cg_exo -28.48 88.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 122.943 2.429 . . . . 72.510000000000005 113.178 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.48 ' O ' ' CD1' ' A' ' 173' ' ' TRP . 48.7 tp10 -158.26 75.92 0.75 Allowed 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.04 0.924 . . . . 75.340000000000003 108.735 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 77.7 mtp -53.84 115.53 2.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.238 -0.914 . . . . 74.510000000000005 110.254 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 1.7 m -102.75 140.36 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.388 -0.967 . . . . 65.219999999999999 108.388 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 25.9 p -53.72 150.52 13.42 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.152 -0.967 . . . . 73.219999999999999 109.673 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -40.38 -29.72 0.41 Allowed 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.17 1.913 . . . . 62.43 111.958 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -141.31 134.24 29.01 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.343 -0.848 . . . . 73.129999999999995 109.345 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.0 p -166.47 -27.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.852 . . . . 74.019999999999996 109.861 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 10.9 tp -50.97 -22.38 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.068 -1.02 . . . . 72.329999999999998 109.914 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.437 ' CG ' ' N ' ' A' ' 186' ' ' VAL . 18.9 pt-20 -70.05 -48.93 55.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.055 -1.028 . . . . 74.400000000000006 109.572 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.437 ' N ' ' CG ' ' A' ' 185' ' ' GLU . 14.1 m -72.04 -28.87 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.808 -1.183 . . . . 74.319999999999993 108.969 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -77.87 -55.42 5.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 73.230000000000004 110.069 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 11.2 tp -52.6 -33.37 18.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.675 -1.266 . . . . 74.310000000000002 109.324 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -72.76 -41.27 65.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.173 -0.954 . . . . 73.439999999999998 111.214 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.452 ' CG ' ' N ' ' A' ' 191' ' ' ILE . 1.0 OUTLIER -77.33 -46.37 23.12 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.586 -1.321 . . . . 71.420000000000002 111.029 -178.431 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.452 ' N ' ' CG ' ' A' ' 190' ' ' GLN . 6.5 pt -62.22 -41.01 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.717 -1.239 . . . . 72.439999999999998 109.971 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -69.21 -34.27 74.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.849 -1.157 . . . . 64.219999999999999 108.597 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -64.86 -39.58 93.78 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.694 -0.629 . . . . 74.319999999999993 110.082 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.422 ' O ' ' CD ' ' A' ' 198' ' ' PRO . 11.4 pttp -92.09 -2.55 56.57 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.047 -1.033 . . . . 75.310000000000002 110.549 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 48.2 ttp -93.75 -45.42 7.69 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.94 -1.1 . . . . 74.019999999999996 109.974 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -60.29 -33.02 71.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.07 -1.019 . . . . 74.019999999999996 110.385 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -64.4 -61.11 7.11 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.978 -1.076 . . . . 75.430000000000007 110.335 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.422 ' CD ' ' O ' ' A' ' 194' ' ' LYS . 31.5 Cg_endo -61.11 -55.52 1.25 Allowed 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.824 1.682 . . . . 72.319999999999993 111.844 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.531 ' C ' ' H ' ' A' ' 201' ' ' ILE . 10.0 mp -63.09 -36.9 85.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -0.942 . . . . 74.540000000000006 109.282 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 73.51 -23.73 0.98 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.598 -1.401 . . . . 61.509999999999998 109.598 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.531 ' H ' ' C ' ' A' ' 199' ' ' LEU . 13.6 mt -110.66 137.12 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.483 -1.01 . . . . 74.25 109.351 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 8.6 t -84.87 143.6 28.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.164 -0.96 . . . . 72.0 109.354 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.5 p -141.19 27.94 1.91 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.278 -0.889 . . . . 74.439999999999998 109.267 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.527 ' CG1' ' CE2' ' A' ' 214' ' ' PHE . 2.7 m -143.66 128.64 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.239 -0.913 . . . . 71.129999999999995 109.692 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -102.76 121.91 43.41 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.381 -0.825 . . . . 73.510000000000005 108.808 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.88 117.32 23.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.145 -0.972 . . . . 73.519999999999996 109.873 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.411 ' O ' ' O ' ' A' ' 211' ' ' GLY . 12.8 p -150.25 147.58 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.345 -0.847 . . . . 72.150000000000006 109.062 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -64.34 -130.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.144 -0.973 . . . . 72.400000000000006 109.479 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? 50.17 -106.02 0.21 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.91 . . . . 73.310000000000002 109.337 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -75.9 -59.08 2.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 71.540000000000006 109.486 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 207' ' ' VAL . . . 159.26 -109.57 0.41 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.641 -1.384 . . . . 74.450000000000003 109.641 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 212' ' ' TYR . 41.9 m-85 -109.73 134.91 51.45 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.522 -0.987 . . . . 75.540000000000006 109.369 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -107.31 132.5 53.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.509 -0.744 . . . . 75.310000000000002 109.476 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.527 ' CE2' ' CG1' ' A' ' 204' ' ' VAL . 43.8 m-85 -97.45 128.69 44.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.258 -0.901 . . . . 75.409999999999997 109.107 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 49.2 m -140.18 156.55 46.47 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.439 -0.788 . . . . 74.140000000000001 109.077 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -69.52 153.98 95.25 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.916 . . . . 75.319999999999993 109.183 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -36.85 150.0 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 122.478 2.119 . . . . 73.109999999999999 112.478 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.518 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 12.4 tttt -65.05 -46.27 73.78 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 75.25 109.633 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 90.9 Cg_endo -88.78 125.64 1.68 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 122.567 2.178 . . . . 75.099999999999994 112.213 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -170.91 76.81 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 71.140000000000001 109.537 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . 0.497 ' C ' ' H ' ' A' ' 223' ' ' GLU . 73.8 m -57.65 -38.92 75.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 71.129999999999995 109.344 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 49.45 12.23 0.06 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.899 . . . . 75.349999999999994 109.618 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.497 ' H ' ' C ' ' A' ' 221' ' ' CYS . 96.5 mt-10 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.972 -1.014 . . . . 73.409999999999997 109.629 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.487 ' SD ' ' OD2' ' B' ' 46' ' ' ASP . 7.4 mtt . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.364 -0.606 . . . . 75.239999999999995 109.364 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -136.09 125.04 24.19 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.463 -0.773 . . . . 73.519999999999996 109.166 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.1 t -111.83 133.79 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-O 121.359 0.6 . . . . 72.239999999999995 109.564 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' B' ' 49' ' ' MET . 4.9 tp -101.73 120.47 40.4 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.488 -0.757 . . . . 73.340000000000003 109.174 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 17.3 mt -119.46 98.58 6.21 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.464 -0.772 . . . . 74.349999999999994 109.108 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 16.9 mt -83.48 98.8 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.872 -1.142 . . . . 63.439999999999998 108.469 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.423 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 33.8 tp10 -142.8 128.84 19.65 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.382 -0.824 . . . . 74.519999999999996 109.416 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -66.77 -31.36 71.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.9 . . . . 74.129999999999995 109.478 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -79.22 112.02 16.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 74.230000000000004 109.533 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 82.2 p -71.78 -25.28 61.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 65.540000000000006 109.698 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 82.3 t -62.57 -49.85 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -0.958 . . . . 75.549999999999997 109.623 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' B' ' 12' ' ' LEU . 3.8 mm? -67.04 -28.95 68.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 70.140000000000001 109.206 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.8 -23.18 64.82 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.745 -1.742 . . . . 75.400000000000006 108.745 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.47 -49.74 7.91 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.705 -1.358 . . . . 65.439999999999998 109.705 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.09 -42.56 99.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.1 -1.235 . . . . 72.200000000000003 109.048 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 6.0 mm -60.87 -35.59 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.259 -1.015 . . . . 75.150000000000006 108.259 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -63.1 -44.04 96.8 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.498 -0.751 . . . . 73.010000000000005 109.361 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -86.05 1.61 49.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.15 -0.969 . . . . 74.299999999999997 109.301 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.12 -53.32 2.69 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 109.446 -1.462 . . . . 70.540000000000006 109.446 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -77.41 -22.26 51.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -1.152 . . . . 75.430000000000007 109.793 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -52.5 -34.88 51.47 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.072 -1.017 . . . . 73.200000000000003 109.077 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 54.3 t -55.47 -45.93 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.351 -0.843 . . . . 74.230000000000004 108.867 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 49.3 mmtt -60.14 -53.33 59.03 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.491 -0.756 . . . . 73.519999999999996 109.035 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 133.56 35.72 0.28 Allowed Glycine 0 N--CA 1.5 2.965 0 N-CA-C 110.099 -1.201 . . . . 53.43 110.099 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -119.5 159.54 24.1 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.392 -1.064 . . . . 71.120000000000005 109.308 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 13.0 mmt -103.39 141.43 35.96 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.502 -0.925 . . . . 75.239999999999995 108.502 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . 0.429 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -133.41 157.6 45.16 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.393 -0.817 . . . . 73.25 110.265 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . 0.476 ' OD2' ' NH1' ' B' ' 43' ' ' ARG . 82.0 m-20 -142.84 160.37 40.45 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.677 -0.86 . . . . 72.310000000000002 108.677 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 5.0 p -121.43 139.76 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.364 -0.835 . . . . 72.140000000000001 109.718 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 10.2 p -133.52 165.21 25.41 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.59 -0.694 . . . . 74.530000000000001 109.213 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -91.72 -104.99 0.11 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.277 -0.889 . . . . 71.019999999999996 109.677 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 60.0 p -78.52 168.98 18.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 71.400000000000006 109.902 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 19.0 mt -53.65 -33.55 55.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.502 -0.749 . . . . 71.239999999999995 109.866 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -51.02 -48.95 61.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.099 -1.0 . . . . 74.319999999999993 109.499 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -64.37 -39.73 94.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 73.030000000000001 108.957 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.28 -36.21 63.55 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.295 -1.522 . . . . 60.43 109.295 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -66.16 -41.54 90.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -1.122 . . . . 74.430000000000007 109.472 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -79.44 -37.77 36.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.136 -0.977 . . . . 74.420000000000002 109.408 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 41.2 tp -68.48 -41.86 79.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 75.409999999999997 109.63 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.0 ppp? -73.53 -21.74 60.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.143 -0.973 . . . . 61.439999999999998 109.535 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -53.44 -38.34 63.46 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.012 -1.055 . . . . 74.319999999999993 108.936 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 8.6 pt -95.98 -33.19 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.351 -0.843 . . . . 71.230000000000004 109.651 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.476 ' NH1' ' OD2' ' B' ' 28' ' ' ASP . 93.1 mtt180 -96.32 138.57 33.72 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.081 -1.012 . . . . 73.409999999999997 109.593 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . 0.435 ' O ' ' O ' ' B' ' 45' ' ' TYR . 84.7 m-20 -81.08 -30.63 34.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.168 -0.957 . . . . 63.539999999999999 109.966 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' B' ' 44' ' ' ASN . 38.4 m-85 52.24 100.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.302 -0.874 . . . . 73.109999999999999 109.436 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . 0.487 ' OD2' ' SD ' ' B' ' 1' ' ' MET . 73.1 m-20 -70.11 -36.99 75.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.106 -0.996 . . . . 62.219999999999999 109.016 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.402 ' C ' ' CD1' ' B' ' 47' ' ' LEU . 1.0 OUTLIER -107.01 111.58 24.14 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.673 -0.862 . . . . 73.120000000000005 108.673 179.567 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 53.1 t -94.89 99.8 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.299 -0.876 . . . . 74.109999999999999 109.378 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 1.8 tpp -113.55 130.02 56.44 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.774 -0.825 . . . . 73.439999999999998 108.774 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.463 ' N ' ' SD ' ' B' ' 49' ' ' MET . 0.2 OUTLIER -146.66 135.49 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 73.400000000000006 109.312 -179.505 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' SER . . . . . 0.516 ' CB ' ' HG ' ' B' ' 74' ' ' SER . 73.1 p -103.51 8.68 37.79 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.504 -0.748 . . . . 73.209999999999994 110.25 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.417 ' H ' HG22 ' B' ' 50' ' ' VAL . 56.4 m-20 -76.82 142.25 40.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.081 -1.012 . . . . 70.409999999999997 109.547 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.428 ' C ' ' H ' ' B' ' 55' ' ' ALA . 47.5 mtpt -74.3 -38.36 63.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 73.129999999999995 110.293 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -72.57 8.19 1.54 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.034 -1.041 . . . . 75.209999999999994 109.716 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.428 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -74.55 -21.24 59.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 55.329999999999998 110.222 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 71.1 mt -43.68 -41.11 4.57 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.318 -0.864 . . . . 72.420000000000002 110.224 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' SER . . . . . 0.425 ' O ' ' OG ' ' B' ' 60' ' ' SER . 27.4 t -72.92 -38.59 66.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.999 -1.063 . . . . 73.040000000000006 109.567 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -64.27 -49.58 71.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.343 -0.848 . . . . 72.329999999999998 110.135 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.15 -35.36 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.765 -1.209 . . . . 74.540000000000006 109.69 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' B' ' 57' ' ' SER . 59.8 p -58.22 -45.82 86.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.237 -0.914 . . . . 71.239999999999995 109.681 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' B' ' 65' ' ' LYS . 8.8 ptp180 -75.36 -30.78 60.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.058 -1.026 . . . . 74.310000000000002 110.076 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.453 ' O ' ' N ' ' B' ' 66' ' ' HIS . 5.0 mm -60.55 -51.91 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.745 -1.222 . . . . 75.420000000000002 109.24 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -63.1 -40.78 98.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.135 -0.978 . . . . 73.319999999999993 109.183 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -68.93 -38.88 79.79 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.512 -0.921 . . . . 73.310000000000002 108.512 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' B' ' 61' ' ' ARG . 14.4 mtpp -86.24 -74.23 0.43 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.285 -0.884 . . . . 72.439999999999998 109.481 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.453 ' N ' ' O ' ' B' ' 62' ' ' ILE . 53.6 m-70 -98.08 87.43 3.95 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.226 -0.921 . . . . 65.209999999999994 109.524 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 23.2 t -78.46 -32.18 48.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 73.099999999999994 109.923 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 94.7 p -59.7 -23.51 63.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.233 -0.917 . . . . 71.530000000000001 109.643 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 57.3 mt -84.09 149.48 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.246 -0.909 . . . . 74.400000000000006 109.293 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.454 ' CG1' ' N ' ' B' ' 71' ' ' VAL . 75.8 t -91.08 164.49 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.247 -0.908 . . . . 75.120000000000005 109.637 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.454 ' N ' ' CG1' ' B' ' 70' ' ' VAL . 4.3 t -139.68 128.15 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.318 -0.864 . . . . 73.200000000000003 109.348 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.497 ' O ' ' SD ' ' B' ' 49' ' ' MET . 0.6 OUTLIER -123.69 106.52 10.6 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.608 -0.886 . . . . 73.340000000000003 108.608 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 71.0 t -91.4 129.58 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.117 -0.989 . . . . 73.5 109.008 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.516 ' HG ' ' CB ' ' B' ' 51' ' ' SER . 6.8 p -90.36 171.25 9.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.917 -1.114 . . . . 71.319999999999993 108.987 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 13.6 p -155.76 112.34 3.16 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.927 -1.108 . . . . 74.530000000000001 110.261 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -67.2 -27.47 67.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.329 -0.857 . . . . 64.5 109.005 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' B' ' 79' ' ' THR . 13.5 t-20 -127.06 75.65 76.52 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.677 -0.86 . . . . 74.25 108.677 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -44.79 88.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.572 2.181 . . . . 74.430000000000007 111.777 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.471 ' N ' ' O ' ' B' ' 77' ' ' ASN . 17.1 m -104.04 148.65 25.98 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.59 0.71 . . . . 73.120000000000005 109.717 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -33.69 76.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.196 -0.94 . . . . 75.409999999999997 109.006 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -57.07 -39.42 74.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 72.239999999999995 109.036 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -71.91 -31.73 66.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.223 -0.923 . . . . 73.219999999999999 109.201 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.535 ' OE1' ' CD1' ' B' ' 94' ' ' TYR . 5.9 mm-40 -64.57 -56.55 13.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.22 -0.925 . . . . 74.299999999999997 110.027 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 29.9 m -57.59 -41.21 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 73.310000000000002 109.832 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -74.05 -25.15 59.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.152 -0.968 . . . . 73.239999999999995 109.59 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.26 -36.3 79.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 55.329999999999998 110.021 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -80.17 -33.73 38.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.119 -0.988 . . . . 74.450000000000003 108.892 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -69.75 -33.52 72.55 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.338 -0.851 . . . . 64.040000000000006 109.428 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -77.55 -67.53 0.71 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 75.129999999999995 109.499 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 156.86 66.02 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.011 -1.236 . . . . 75.420000000000002 110.011 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.68 124.64 46.75 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.444 -1.033 . . . . 73.420000000000002 109.054 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -69.98 -36.85 75.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.12 -0.987 . . . . 73.319999999999993 109.438 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . 0.471 ' OD2' ' CD ' ' B' ' 112' ' ' ARG . 11.6 m-20 -151.24 166.41 30.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.304 -0.873 . . . . 73.040000000000006 109.371 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.551 ' CD1' ' O ' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -140.21 114.15 8.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.607 -0.683 . . . . 74.310000000000002 109.191 -178.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 27.7 mm -114.34 146.26 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 O-C-N 121.224 -0.923 . . . . 75.340000000000003 109.685 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.78 139.54 58.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.936 -1.103 . . . . 70.099999999999994 108.139 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.685 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -58.49 -56.44 35.47 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.909 -1.12 . . . . 65.430000000000007 111.381 -179.034 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 5.0 Cg_endo -41.5 -8.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.022 1.148 . . . . 63.520000000000003 113.192 -176.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . 0.685 ' N ' ' O ' ' B' ' 97' ' ' LYS . 13.8 m-85 66.47 117.78 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.557 -0.714 . . . . 75.129999999999995 109.674 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . 0.476 ' CZ ' ' OE2' ' A' ' 83' ' ' GLU . 16.0 ttm180 -67.05 -29.55 69.37 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.968 -1.083 . . . . 74.230000000000004 108.754 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' SER . . . . . 0.737 ' O ' ' N ' ' B' ' 103' ' ' LYS . 40.6 t -174.78 28.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.192 -0.942 . . . . 64.510000000000005 110.671 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 8.6 mm 51.66 -69.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.645 -0.659 . . . . 74.439999999999998 110.064 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . 0.737 ' N ' ' O ' ' B' ' 101' ' ' SER . 86.3 mttt -56.64 -32.91 65.82 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.82 -1.178 . . . . 72.299999999999997 107.82 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.86 98.73 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.033 -1.099 . . . . 74.310000000000002 108.033 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 55.4 tp -64.63 -40.68 95.9 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.635 -0.876 . . . . 73.540000000000006 108.635 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 73.5 t -67.0 -41.02 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.348 -0.845 . . . . 72.030000000000001 109.527 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.02 -48.26 70.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.149 -0.97 . . . . 64.219999999999999 109.39 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -64.75 -32.24 73.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 75.310000000000002 109.732 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . 0.427 HD11 HG21 ' B' ' 109' ' ' ILE . 93.9 mt -74.44 -34.3 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.179 -0.951 . . . . 55.439999999999998 108.903 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . 0.465 ' O ' ' CG ' ' B' ' 114' ' ' ARG . 88.2 tt0 -66.09 -31.02 71.63 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.492 -0.755 . . . . 65.310000000000002 109.469 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.56 -56.6 5.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.201 -0.937 . . . . 74.519999999999996 109.944 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . 0.471 ' CD ' ' OD2' ' B' ' 93' ' ' ASP . 64.3 mtm-85 -69.43 -40.61 77.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.179 -0.951 . . . . 72.040000000000006 110.358 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 41.6 tp -63.52 -34.49 77.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.121 -0.987 . . . . 75.349999999999994 109.972 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.465 ' CG ' ' O ' ' B' ' 110' ' ' GLU . 11.0 mmm180 -74.26 167.37 21.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.152 -0.968 . . . . 75.5 109.353 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 52.26 51.15 16.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.885 . . . . 73.040000000000006 109.23 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -95.7 -66.24 0.92 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.308 -0.87 . . . . 74.450000000000003 109.898 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.05 144.04 48.61 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.19 -1.164 . . . . 64.209999999999994 110.19 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' SER . . . . . 0.927 ' N ' ' OE2' ' B' ' 132' ' ' GLU . 33.1 t -160.44 175.26 12.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.471 -1.017 . . . . 71.400000000000006 109.355 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . 0.554 ' N ' ' HG ' ' B' ' 118' ' ' SER . 0.0 OUTLIER -156.88 125.8 5.9 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.652 -0.819 . . . . 74.209999999999994 109.221 -178.216 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 20.5 t -99.32 -37.25 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.386 -0.822 . . . . 75.019999999999996 109.929 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 19.3 mm -101.89 128.37 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.197 -0.939 . . . . 74.239999999999995 109.584 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' B' ' 122' ' ' GLU . 17.9 pt-20 -151.06 121.99 7.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.319 -0.863 . . . . 73.329999999999998 109.473 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.55 ' N ' ' CD1' ' B' ' 123' ' ' ILE . 0.1 OUTLIER -146.46 133.93 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.155 -0.965 . . . . 74.219999999999999 109.335 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 63.33 -115.69 8.34 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.241 -1.543 . . . . 72.409999999999997 109.241 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . 0.891 ' OD2' ' HD3' ' B' ' 138' ' ' LYS . 13.3 t70 -120.59 6.31 10.55 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.596 -0.944 . . . . 75.120000000000005 109.245 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.78 128.56 42.76 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.334 -0.854 . . . . 75.420000000000002 108.769 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 61.4 m -120.4 132.11 55.1 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.5 -0.926 . . . . 74.219999999999999 108.5 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 8.0 mt -133.02 132.38 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.378 -0.826 . . . . 60.329999999999998 110.041 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 8.6 m -109.75 110.67 59.28 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.303 -0.999 . . . . 72.310000000000002 108.303 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.94 -36.98 1.26 Allowed 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.742 1.628 . . . . 75.129999999999995 113.071 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . 0.415 ' O ' ' OE1' ' B' ' 133' ' ' GLU . 6.8 t70 -70.33 -37.34 74.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.089 -1.007 . . . . 75.230000000000004 109.905 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . 0.927 ' OE2' ' N ' ' B' ' 118' ' ' SER . 81.4 mt-10 -83.21 -0.09 47.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.157 -0.964 . . . . 75.120000000000005 109.446 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.415 ' OE1' ' O ' ' B' ' 131' ' ' ASP . 35.8 mp0 47.01 59.07 4.24 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 75.129999999999995 109.254 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . 0.453 ' HZ1' ' HB3' ' B' ' 141' ' ' GLU . 15.4 ttpp -156.72 130.35 8.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 75.109999999999999 109.247 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 2.9 tt -104.23 129.47 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.433 -0.792 . . . . 70.319999999999993 109.597 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 15.3 mt -110.11 122.5 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.566 -0.902 . . . . 74.120000000000005 108.566 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . 0.963 ' CE1' ' CB ' ' B' ' 140' ' ' ARG . 19.0 p90 -124.97 118.18 25.69 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.249 -0.907 . . . . 74.230000000000004 110.13 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . 0.891 ' HD3' ' OD2' ' B' ' 125' ' ' ASP . 25.8 mmtm 55.99 28.2 12.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.591 -0.693 . . . . 74.219999999999999 110.237 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 92.4 2.56 67.88 Favored Glycine 0 N--CA 1.496 2.643 0 O-C-N 121.172 -0.955 . . . . 74.319999999999993 110.944 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . 0.963 ' CB ' ' CE1' ' B' ' 137' ' ' TYR . 0.2 OUTLIER -95.66 121.84 37.78 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.759 -1.436 . . . . 75.340000000000003 108.79 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' GLU . . . . . 0.453 ' HB3' ' HZ1' ' B' ' 134' ' ' LYS . 74.4 mt-10 -94.94 118.29 31.56 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.267 -0.895 . . . . 71.230000000000004 109.58 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 6.6 t -122.52 132.82 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.751 -0.833 . . . . 70.430000000000007 108.751 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -92.86 123.12 35.9 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.273 -0.892 . . . . 72.430000000000007 109.869 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.32 138.93 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.886 -0.783 . . . . 72.129999999999995 108.886 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -161.7 83.24 0.6 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.355 -0.84 . . . . 74.5 109.84 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . 0.667 ' N ' ' HD2' ' B' ' 149' ' ' PHE . . . -164.47 177.8 39.97 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.071 -1.612 . . . . 42.229999999999997 109.071 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 1.323 ' NZ ' ' O ' ' B' ' 172' ' ' ILE . 0.9 OUTLIER -68.21 -37.01 9.95 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.203 -1.174 . . . . 73.299999999999997 110.438 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 14.6 Cg_exo -66.23 -19.99 56.12 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.206 1.937 . . . . 71.329999999999998 112.048 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . 0.667 ' HD2' ' N ' ' B' ' 146' ' ' GLY . 0.5 OUTLIER -103.77 -29.76 10.82 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.493 -0.755 . . . . 74.230000000000004 109.343 -179.376 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . 0.428 ' O ' ' CD2' ' B' ' 154' ' ' HIS . 35.4 mt-10 -51.67 -31.5 26.01 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.199 -1.037 . . . . 72.340000000000003 108.199 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 13.2 p -67.96 -33.15 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.562 -0.711 . . . . 73.349999999999994 109.11 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 44.7 tp -65.24 -39.99 93.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.875 . . . . 74.430000000000007 109.602 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 6.0 p -76.36 -35.77 58.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.893 -1.129 . . . . 75.209999999999994 109.203 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . 0.428 ' CD2' ' O ' ' B' ' 150' ' ' GLU . 27.9 m170 -56.87 -48.76 77.39 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.117 -0.99 . . . . 73.040000000000006 110.174 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 pp -72.87 -27.64 62.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.7 -1.25 . . . . 73.430000000000007 108.884 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.56 -34.54 67.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 75.319999999999993 109.563 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 17.3 mtt180 -92.52 -52.2 4.76 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.897 -1.127 . . . . 73.319999999999993 109.9 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -53.42 -52.09 60.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 74.140000000000001 108.786 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . 0.464 ' O ' ' N ' ' B' ' 161' ' ' GLN . 89.2 mtm180 47.15 -114.81 0.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 73.420000000000002 109.259 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . 0.772 ' OD2' ' CE1' ' B' ' 216' ' ' TYR . 9.8 m-20 -55.36 91.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.109 -0.995 . . . . 72.099999999999994 109.083 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' B' ' 159' ' ' ARG . 50.1 tp60 -164.71 145.43 7.73 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.207 -0.933 . . . . 73.239999999999995 109.775 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 89.7 mt -109.32 126.29 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.505 -0.747 . . . . 72.310000000000002 109.178 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 19.7 m -137.03 144.42 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.965 -0.754 . . . . 75.030000000000001 108.965 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' SER . . . . . 0.455 ' H ' ' CD ' ' B' ' 167' ' ' GLN . 23.1 t -86.94 178.34 6.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.077 -1.015 . . . . 74.219999999999999 110.185 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -61.46 -55.42 31.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.842 . . . . 72.420000000000002 109.408 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . 0.464 ' H ' ' CD ' ' B' ' 166' ' ' GLU . 31.7 mp0 -51.91 -31.91 30.53 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.858 . . . . 63.450000000000003 110.116 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' GLN . . . . . 0.455 ' CD ' ' H ' ' B' ' 164' ' ' SER . 41.4 mt-30 -64.94 -43.32 93.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.074 -1.016 . . . . 72.400000000000006 109.607 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 51.7 mt -58.12 -37.29 74.31 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.191 -1.04 . . . . 72.319999999999993 108.191 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.25 -65.91 0.57 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.501 -0.75 . . . . 73.340000000000003 109.063 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -58.35 -28.09 64.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.561 -0.712 . . . . 73.099999999999994 109.902 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.88 -65.25 0.63 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.28 -0.888 . . . . 62.130000000000003 110.091 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 1.323 ' O ' ' NZ ' ' B' ' 147' ' ' LYS . 2.1 mp -98.82 -53.45 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.129 -0.982 . . . . 74.439999999999998 109.937 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 26.0 m-90 -77.55 61.37 2.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.031 -1.043 . . . . 72.230000000000004 109.027 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -47.07 -53.75 11.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.529 -0.732 . . . . 75.030000000000001 109.749 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . 0.468 ' N ' ' CD ' ' B' ' 176' ' ' PRO . 2.2 tt0 -178.89 -48.87 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 120.862 -1.149 . . . . 73.040000000000006 109.903 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' B' ' 175' ' ' GLU . 39.3 Cg_exo -57.07 -23.39 52.28 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.123 1.882 . . . . 74.129999999999995 112.24 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . 1.064 ' HG2' ' HD3' ' B' ' 147' ' ' LYS . 31.7 mp0 -75.58 176.99 7.1 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.093 -1.004 . . . . 72.439999999999998 109.544 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 178' ' ' MET . . . . . 0.452 ' N ' ' SD ' ' B' ' 178' ' ' MET . 0.9 OUTLIER -90.96 125.96 35.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.408 -0.808 . . . . 72.109999999999999 108.863 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 2.3 t -116.58 138.87 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.636 -0.665 . . . . 75.310000000000002 109.694 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 180' ' ' THR . . . . . 0.538 ' O ' ' N ' ' B' ' 182' ' ' ASN . 7.2 p -111.83 152.5 44.23 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 108.836 -0.801 . . . . 62.149999999999999 108.836 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -36.75 -23.71 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 122.26 1.974 . . . . 74.340000000000003 112.722 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 182' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' B' ' 180' ' ' THR . 11.2 m-80 -156.57 52.0 0.52 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.033 -1.042 . . . . 72.310000000000002 109.761 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 9.3 p -65.24 -21.37 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.193 -0.942 . . . . 65.420000000000002 109.634 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 36.8 mt -67.53 -40.54 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.239 -0.913 . . . . 75.030000000000001 110.621 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . 0.487 ' O ' ' ND2' ' B' ' 189' ' ' ASN . 64.6 mm-40 -61.9 -50.51 71.89 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.098 -1.001 . . . . 73.519999999999996 110.323 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 18.2 m -75.08 -25.51 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.151 -0.968 . . . . 74.349999999999994 110.172 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -76.04 -46.62 28.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.119 -0.988 . . . . 61.119999999999997 110.18 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 11.2 tp -69.88 -29.34 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.865 -1.147 . . . . 72.430000000000007 109.286 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 189' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' B' ' 185' ' ' GLU . 92.5 m-20 -72.79 -48.51 37.49 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.43 -0.794 . . . . 75.420000000000002 109.9 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . 0.46 ' CG ' ' N ' ' B' ' 191' ' ' ILE . 1.9 pt20 -72.96 -45.17 59.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.095 -1.003 . . . . 74.140000000000001 110.193 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . 0.46 ' N ' ' CG ' ' B' ' 190' ' ' GLN . 77.1 mt -54.28 -55.4 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.04 -1.038 . . . . 74.030000000000001 109.376 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -54.39 -48.22 71.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.122 -0.986 . . . . 72.329999999999998 110.026 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 193' ' ' GLN . . . . . 0.411 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 81.7 mt-30 -62.07 -31.62 72.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.047 -1.033 . . . . 73.099999999999994 109.575 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -91.05 -2.97 57.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.25 -0.906 . . . . 74.430000000000007 110.339 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 24.1 ttp -99.94 -5.08 28.84 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.13 -0.981 . . . . 74.329999999999998 109.876 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 196' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' B' ' 193' ' ' GLN . 5.9 p-10 -105.92 -15.24 14.97 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.364 -0.835 . . . . 71.209999999999994 109.329 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . 0.585 ' N ' ' CD ' ' B' ' 198' ' ' PRO . 10.3 tttm -80.13 -41.7 1.37 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.243 -0.911 . . . . 75.209999999999994 110.059 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 198' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' B' ' 197' ' ' LYS . 73.6 Cg_endo -87.39 -44.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.486 2.124 . . . . 75.319999999999993 111.988 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 17.9 mt -78.38 -35.03 47.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.047 -1.033 . . . . 72.25 109.302 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 83.13 -37.98 2.72 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.731 -1.348 . . . . 73.239999999999995 109.731 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 22.4 mm -102.07 139.19 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.263 -1.14 . . . . 54.299999999999997 109.639 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 19.9 m -86.49 137.93 32.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.283 -0.886 . . . . 74.310000000000002 108.949 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 6.7 p -134.98 29.22 3.45 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.39 -0.819 . . . . 74.400000000000006 109.307 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 16.7 m -132.28 145.95 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.549 -0.719 . . . . 74.099999999999994 109.187 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -126.25 138.11 53.58 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.487 -0.758 . . . . 75.329999999999998 109.721 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 206' ' ' THR . . . . . 0.706 ' HG1' ' NH1' ' B' ' 208' ' ' ARG . 0.1 OUTLIER -96.94 132.82 42.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.326 -0.859 . . . . 71.400000000000006 109.47 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 8.3 t -130.38 117.1 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.707 -0.849 . . . . 63.5 108.707 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 208' ' ' ARG . . . . . 0.706 ' NH1' ' HG1' ' B' ' 206' ' ' THR . 0.1 OUTLIER -68.92 -36.3 77.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.222 -0.924 . . . . 74.450000000000003 109.747 -179.486 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 62.1 mtm180 -50.77 -65.09 0.62 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.122 -0.986 . . . . 74.140000000000001 110.118 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -100.58 -77.85 0.53 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.249 -0.907 . . . . 74.430000000000007 109.932 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -164.89 -105.27 0.19 Allowed Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.619 -1.277 . . . . 70.109999999999999 110.162 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' B' ' 212' ' ' TYR . 42.2 m-85 -133.93 148.75 51.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.505 -0.997 . . . . 74.209999999999994 109.978 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -141.12 153.7 45.54 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.252 -1.018 . . . . 74.299999999999997 108.252 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . 0.427 ' C ' ' SG ' ' B' ' 215' ' ' CYS . 0.7 OUTLIER -117.77 148.65 41.86 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.393 -0.817 . . . . 74.340000000000003 110.557 -178.249 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' B' ' 214' ' ' PHE . 8.8 m -151.37 164.18 37.28 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.676 -0.861 . . . . 72.209999999999994 108.676 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . 0.844 ' OH ' ' OE1' ' A' ' 161' ' ' GLN . 0.2 OUTLIER -72.86 154.08 91.08 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 120.96 -1.088 . . . . 72.310000000000002 108.865 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.51 175.92 1.92 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.246 1.964 . . . . 71.010000000000005 111.626 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' B' ' 219' ' ' PRO . 13.8 mtmm -52.65 157.13 2.75 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 108.689 -0.856 . . . . 74.349999999999994 108.689 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' B' ' 218' ' ' LYS . 21.4 Cg_exo -30.39 100.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 122.861 2.374 . . . . 71.319999999999993 112.807 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -116.19 135.12 54.19 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.655 -0.653 . . . . 75.450000000000003 109.314 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' CYS . . . . . 0.518 ' HG ' ' H ' ' B' ' 222' ' ' GLU . 14.2 t -165.55 -177.85 4.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.152 -0.968 . . . . 72.219999999999999 109.378 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.518 ' H ' ' HG ' ' B' ' 221' ' ' CYS . 51.3 mt-10 -57.47 169.55 0.64 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.152 -0.967 . . . . 74.299999999999997 109.324 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 117.966 -1.016 . . . . 71.129999999999995 109.169 179.581 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.57 ' SD ' ' CE2' ' A' ' 25' ' ' PHE . 43.4 ttp . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.457 -0.571 . . . . 65.120000000000005 109.457 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -140.53 152.25 45.41 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.397 -0.814 . . . . 73.310000000000002 109.224 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.4 t -119.6 129.47 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.529 0.681 . . . . 71.420000000000002 109.574 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.4 tp -96.14 122.65 39.21 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.53 -0.731 . . . . 65.219999999999999 109.521 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 mp -117.2 129.84 56.2 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.129 -1.063 . . . . 71.439999999999998 108.129 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.4 mt -126.03 97.18 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.062 -1.088 . . . . 71.150000000000006 108.062 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -144.11 130.97 20.32 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.243 -0.91 . . . . 75.340000000000003 109.753 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -63.12 -35.2 79.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 73.040000000000006 109.33 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -76.54 96.58 4.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 72.420000000000002 109.29 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.8 m -61.47 -29.6 70.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.88 . . . . 72.340000000000003 109.909 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 12' ' ' LEU . 9.5 p -67.58 -44.59 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.085 -1.009 . . . . 74.420000000000002 109.981 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.44 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 80.9 mt -69.82 -47.72 61.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.046 -1.034 . . . . 72.010000000000005 109.242 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.6 -20.88 70.4 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 107.922 -2.071 . . . . 72.140000000000001 107.922 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.38 -58.06 6.9 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.667 -1.373 . . . . 72.329999999999998 109.667 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -52.82 -44.31 66.6 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.342 -1.093 . . . . 72.340000000000003 109.588 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.1 mt -66.85 -38.31 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.736 -1.227 . . . . 74.239999999999995 108.329 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.507 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 88.0 tt0 -60.23 -45.94 91.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 71.409999999999997 109.213 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -86.05 -1.23 57.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -0.928 . . . . 75.540000000000006 109.715 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.62 -54.98 3.11 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 109.813 -1.315 . . . . 62.149999999999999 109.813 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -75.12 -21.32 58.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.231 -1.158 . . . . 74.420000000000002 110.0 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 96.4 m-20 -57.61 -31.65 66.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.121 -0.987 . . . . 74.25 109.636 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 85.1 t -61.13 -25.79 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.318 -0.864 . . . . 72.109999999999999 109.467 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' NZ ' ' OE1' ' A' ' 110' ' ' GLU . 17.0 mmtp -83.04 6.17 19.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.87 . . . . 73.230000000000004 109.337 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.51 37.18 21.26 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.153 -1.179 . . . . 75.540000000000006 110.153 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.57 ' CE2' ' SD ' ' A' ' 1' ' ' MET . 11.5 m-85 -116.09 159.05 22.26 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.467 -1.02 . . . . 74.510000000000005 109.017 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.4 mmt -112.75 135.21 53.75 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.833 -0.803 . . . . 64.319999999999993 108.833 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.51 161.81 38.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.194 -0.941 . . . . 74.310000000000002 109.718 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -142.76 141.16 31.67 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.357 -0.84 . . . . 75.400000000000006 109.26 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 t -104.02 130.31 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.304 -0.872 . . . . 75.129999999999995 108.877 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.2 p -118.9 170.35 9.09 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.536 -0.728 . . . . 71.420000000000002 109.361 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -88.29 -100.76 0.08 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.183 -0.948 . . . . 73.109999999999999 109.858 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.0 p -78.23 166.61 22.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 74.239999999999995 110.167 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.9 mt -55.61 -39.08 70.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.645 -0.659 . . . . 71.530000000000001 110.041 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -50.39 -43.81 54.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.092 -1.005 . . . . 74.230000000000004 109.652 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -65.66 -36.74 84.53 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.201 -0.937 . . . . 71.010000000000005 109.158 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.94 -34.9 29.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.558 -1.417 . . . . 61.409999999999997 109.558 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -63.37 -40.73 98.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -1.141 . . . . 74.340000000000003 109.569 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -77.9 -37.63 47.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.088 -1.008 . . . . 75.329999999999998 109.333 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.6 tp -66.91 -41.82 86.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 74.329999999999998 109.599 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.448 ' C ' ' SD ' ' A' ' 40' ' ' MET . 3.3 ppp? -77.87 -15.77 58.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.144 -0.972 . . . . 70.319999999999993 109.648 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -55.33 -39.8 70.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.052 -1.03 . . . . 71.219999999999999 109.158 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.8 pt -95.26 -32.39 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.274 -0.892 . . . . 74.409999999999997 109.885 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 40' ' ' MET . 96.6 mtt180 -91.77 153.04 19.87 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.078 -1.013 . . . . 75.409999999999997 109.676 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 45' ' ' TYR . 14.5 p30 -91.86 -34.38 14.56 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.162 -0.961 . . . . 75.420000000000002 109.765 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 44' ' ' ASN . 38.3 m-85 51.97 99.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.292 -0.88 . . . . 74.230000000000004 109.484 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -68.77 -28.97 67.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.23 -0.918 . . . . 75.319999999999993 109.42 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.418 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -115.5 110.58 19.48 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.747 -0.834 . . . . 72.129999999999995 108.747 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.9 t -96.9 110.34 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.324 -0.86 . . . . 72.340000000000003 108.685 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.587 ' SD ' ' N ' ' A' ' 50' ' ' VAL . 1.5 tpt -122.4 130.35 53.01 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.539 -0.725 . . . . 74.109999999999999 109.549 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.587 ' N ' ' SD ' ' A' ' 49' ' ' MET . 1.1 p -138.84 130.43 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.695 0.76 . . . . 71.239999999999995 109.818 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.2 t -98.16 2.41 48.46 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.596 -0.69 . . . . 73.109999999999999 109.534 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -75.93 136.58 40.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.171 -0.956 . . . . 63.399999999999999 109.405 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.519 ' C ' ' H ' ' A' ' 55' ' ' ALA . 62.4 mttp -72.96 -42.24 63.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.306 -0.871 . . . . 65.439999999999998 110.617 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -69.19 11.23 0.23 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.039 -1.038 . . . . 73.129999999999995 109.747 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.519 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.35 -21.64 58.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 64.140000000000001 110.44 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 55' ' ' ALA . 74.5 mt -37.79 -53.21 1.29 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.7 -0.625 . . . . 74.430000000000007 110.818 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.6 t -65.65 -36.66 84.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.972 -1.08 . . . . 63.229999999999997 109.329 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.449 ' N ' ' O ' ' A' ' 55' ' ' ALA . 45.3 t80 -64.58 -63.03 1.23 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.327 -0.858 . . . . 74.439999999999998 109.83 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.1 m -48.36 -32.85 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.81 -1.181 . . . . 74.030000000000001 109.713 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.2 m -59.4 -52.79 64.12 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.201 -0.937 . . . . 73.540000000000006 109.348 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -68.78 -27.75 66.16 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 118.934 -1.107 . . . . 73.340000000000003 109.881 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.523 ' O ' ' N ' ' A' ' 66' ' ' HIS . 29.6 mm -59.21 -49.83 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 120.829 -1.17 . . . . 73.349999999999994 108.847 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.519 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 45.3 mmtt -59.79 -46.55 88.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.086 -1.009 . . . . 74.420000000000002 108.649 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -64.08 -42.86 96.81 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.942 -0.762 . . . . 74.549999999999997 108.942 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.472 ' C ' ' CG ' ' A' ' 66' ' ' HIS . 51.6 mtpt -76.95 -26.27 53.81 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.526 -0.734 . . . . 75.219999999999999 110.554 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 62' ' ' ILE . 56.9 m-70 -154.97 65.72 0.65 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.973 -1.079 . . . . 74.129999999999995 109.746 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 63' ' ' LYS . 33.8 t -59.28 -25.83 64.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.352 -0.842 . . . . 73.239999999999995 110.155 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.0 t -69.66 -14.77 62.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.17 -0.956 . . . . 71.439999999999998 110.493 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 79.0 mt -94.06 155.91 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.972 -1.08 . . . . 71.329999999999998 109.907 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.413 ' CG1' ' N ' ' A' ' 71' ' ' VAL . 90.2 t -85.02 162.76 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.364 -0.835 . . . . 73.019999999999996 109.696 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.527 ' N ' ' OD1' ' A' ' 92' ' ' ASP . 14.7 t -145.24 117.14 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.09 -1.006 . . . . 54.210000000000001 109.741 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.506 ' O ' ' SD ' ' A' ' 49' ' ' MET . 1.0 OUTLIER -115.46 99.92 7.71 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.219 -1.03 . . . . 74.209999999999994 108.219 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.6 p -96.48 152.6 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.127 -0.983 . . . . 74.409999999999997 108.774 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.5 m -132.42 172.33 12.6 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.215 -0.928 . . . . 72.310000000000002 109.364 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.501 ' C ' ' H ' ' A' ' 77' ' ' ASN . 3.4 t -173.84 128.96 0.4 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.322 -0.861 . . . . 64.540000000000006 110.044 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -66.59 43.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.558 -0.714 . . . . 74.129999999999995 109.639 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 79' ' ' THR . 15.9 m120 -160.15 60.89 1.51 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 73.340000000000003 109.828 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -57.18 74.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.979 1.786 . . . . 71.319999999999993 111.469 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 77' ' ' ASN . 16.9 m -107.49 151.6 25.35 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.003 -0.74 . . . . 62.530000000000001 109.003 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -25.33 68.19 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.357 -0.839 . . . . 74.140000000000001 109.497 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -63.83 -52.39 60.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 71.420000000000002 109.489 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.29 -32.43 70.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 73.430000000000007 109.707 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -60.31 -52.62 64.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 74.219999999999999 109.603 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.64 -40.27 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.936 . . . . 74.150000000000006 109.312 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -68.65 -29.19 67.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -0.856 . . . . 72.540000000000006 109.826 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.28 -43.19 82.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.193 -0.942 . . . . 64.219999999999999 110.039 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -80.23 -26.39 39.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.062 -1.024 . . . . 74.340000000000003 108.946 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -75.98 -51.47 12.32 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.43 -0.794 . . . . 74.420000000000002 109.391 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.48 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 1.6 pp0? -61.57 -43.23 99.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.526 -0.734 . . . . 74.519999999999996 109.736 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.48 ' N ' ' CD ' ' A' ' 89' ' ' GLN . . . 138.45 72.82 0.05 OUTLIER Glycine 0 N--CA 1.498 2.776 0 N-CA-C 109.982 -1.247 . . . . 74.209999999999994 109.982 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -133.17 133.21 42.52 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.358 -1.083 . . . . 64.099999999999994 108.878 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 71' ' ' VAL . 2.8 m-20 -71.48 -39.66 70.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.039 -1.038 . . . . 73.420000000000002 108.999 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 61.8 m-20 -154.24 147.17 24.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.365 -0.834 . . . . 75.040000000000006 109.358 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -121.54 112.61 18.7 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.553 -0.906 . . . . 71.329999999999998 108.553 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 23.3 mm -106.56 152.4 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 CA-C-O 122.16 0.981 . . . . 74.510000000000005 111.333 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.59 123.33 21.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.849 -1.167 . . . . 64.319999999999993 107.849 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.667 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -45.99 -54.23 17.86 Favored Pre-proline 0 C--N 1.301 -1.531 0 O-C-N 121.038 -1.039 . . . . 74.510000000000005 111.525 -178.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.3 Cg_endo -41.46 -11.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 120.754 0.969 . . . . 73.109999999999999 112.886 -176.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.667 ' N ' ' O ' ' A' ' 97' ' ' LYS . 59.5 m-85 59.52 121.92 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.737 -0.602 . . . . 72.540000000000006 109.607 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -68.8 -32.26 71.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.059 -1.026 . . . . 74.540000000000006 109.52 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.757 ' O ' ' N ' ' A' ' 103' ' ' LYS . 41.3 t -174.21 28.41 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.989 -1.069 . . . . 74.140000000000001 110.885 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.456 ' N ' ' CD1' ' A' ' 102' ' ' ILE . 2.6 mp 50.4 -69.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-N 118.638 0.654 . . . . 75.430000000000007 110.194 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.757 ' N ' ' O ' ' A' ' 101' ' ' SER . 1.0 OUTLIER -55.33 -31.18 61.49 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.899 -1.148 . . . . 74.140000000000001 107.899 179.257 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.81 80.05 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.574 -0.85 . . . . 63.240000000000002 108.752 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.424 ' C ' ' CD1' ' A' ' 105' ' ' LEU . 1.7 tm? -69.74 -54.62 12.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.44 -0.787 . . . . 73.219999999999999 108.923 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 53.8 t -52.77 -45.75 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.016 -1.052 . . . . 74.540000000000006 109.326 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.47 -42.25 67.03 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.13 -0.982 . . . . 75.5 108.385 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -62.58 -32.9 73.97 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.481 -0.762 . . . . 74.409999999999997 109.137 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 83.2 mt -74.35 -31.91 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.117 -0.99 . . . . 73.239999999999995 108.604 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.521 ' OE1' ' NZ ' ' A' ' 23' ' ' LYS . 75.0 tt0 -58.44 -52.11 67.02 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.492 -0.755 . . . . 74.340000000000003 109.314 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.29 -32.3 66.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.917 . . . . 73.319999999999993 109.658 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 24.0 tpt85 -54.52 -34.21 61.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 74.420000000000002 109.433 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.2 tp -151.74 108.87 3.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.181 -0.949 . . . . 74.329999999999998 109.504 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.4 mmt180 -144.46 -51.76 0.3 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.252 -0.905 . . . . 74.439999999999998 108.67 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -82.53 25.57 0.62 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.185 -0.947 . . . . 74.430000000000007 109.401 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.439 ' CG ' ' N ' ' A' ' 117' ' ' GLY . 60.4 p-90 -51.04 -40.0 57.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 74.439999999999998 109.721 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.439 ' N ' ' CG ' ' A' ' 116' ' ' TRP . . . -57.74 93.42 0.04 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.767 -1.333 . . . . 75.040000000000006 109.767 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.0 m -153.03 164.71 37.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.211 -1.17 . . . . 70.109999999999999 109.707 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -159.87 128.98 5.12 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.907 -0.775 . . . . 65.239999999999995 108.907 -178.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.7 t -83.86 -45.31 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.158 -0.964 . . . . 74.219999999999999 110.066 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.514 ' CG2' HH21 ' A' ' 159' ' ' ARG . 20.3 mm -102.64 130.94 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.314 -0.867 . . . . 74.420000000000002 109.812 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -121.39 128.58 52.36 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.986 -0.746 . . . . 73.299999999999997 108.986 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 126' ' ' LEU . 23.6 mt -141.03 112.65 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.181 -0.95 . . . . 75.340000000000003 109.45 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.63 -138.63 7.94 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.857 -1.297 . . . . 75.129999999999995 109.857 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -80.09 -11.47 59.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -1.165 . . . . 74.450000000000003 109.487 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 123' ' ' ILE . 0.8 OUTLIER -91.23 135.53 33.73 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.494 -0.928 . . . . 54.210000000000001 108.494 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.8 m -130.2 129.77 43.82 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.447 -0.783 . . . . 70.239999999999995 109.593 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.406 HG21 HD12 ' A' ' 128' ' ' ILE . 28.8 mm -112.87 139.71 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.902 -0.777 . . . . 72.430000000000007 108.902 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 133' ' ' GLU . 5.2 m -128.05 80.03 72.86 Favored Pre-proline 0 N--CA 1.5 2.039 0 O-C-N 121.456 -0.777 . . . . 71.109999999999999 109.697 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.46 -51.89 9.47 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.704 2.27 . . . . 75.140000000000001 112.082 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -53.68 -44.03 69.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 72.5 109.092 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -87.36 -1.98 58.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.346 -0.846 . . . . 73.140000000000001 109.163 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 129' ' ' SER . 34.6 mp0 50.05 72.51 0.32 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.91 . . . . 75.329999999999998 109.129 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -158.14 122.89 4.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.343 -0.848 . . . . 71.230000000000004 109.814 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 84.3 mt -101.56 126.76 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.422 -0.799 . . . . 75.329999999999998 108.922 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.0 mt -117.07 125.36 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.57 -0.706 . . . . 71.109999999999999 109.113 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.521 ' C ' ' H ' ' A' ' 139' ' ' GLY . 47.8 p90 -140.72 151.45 44.51 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.327 -0.858 . . . . 74.140000000000001 109.207 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.3 tptp 56.01 5.5 0.17 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.78 0.8 . . . . 75.400000000000006 109.15 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' A' ' 137' ' ' TYR . . . 95.93 -2.98 64.47 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.846 -1.302 . . . . 72.239999999999995 109.846 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.529 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 1.2 mpt_? -89.71 131.64 35.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.235 -1.156 . . . . 73.120000000000005 109.14 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -93.04 127.98 38.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.241 -0.912 . . . . 72.319999999999993 109.571 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 43.2 t -137.07 136.44 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.424 -0.798 . . . . 62.340000000000003 109.493 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -91.51 143.54 26.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.268 -0.895 . . . . 61.229999999999997 109.042 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 25.9 m -139.75 153.89 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.288 -0.883 . . . . 74.439999999999998 109.699 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -167.21 24.64 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.333 -0.854 . . . . 75.420000000000002 109.163 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.52 -169.79 45.16 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.824 -1.31 . . . . 73.340000000000003 109.824 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.625 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 14.2 tmtt? -82.11 -31.14 0.54 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.343 -1.093 . . . . 72.219999999999999 111.424 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 87.0 Cg_endo -86.64 -3.58 8.32 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 C-N-CA 121.781 1.654 . . . . 75.450000000000003 112.408 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -96.85 -29.87 13.47 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.183 -0.948 . . . . 65.239999999999995 109.18 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -59.2 -40.84 87.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.271 -0.893 . . . . 72.519999999999996 109.259 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 13.9 p -61.79 -34.09 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.226 -0.921 . . . . 74.209999999999994 108.894 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -45.44 92.62 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.514 -0.921 . . . . 73.310000000000002 108.514 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.0 p -74.39 -24.58 59.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.197 -0.94 . . . . 74.310000000000002 109.294 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -59.36 -51.13 71.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.905 . . . . 75.450000000000003 109.685 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.7 pp -76.36 -27.22 56.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.104 -0.998 . . . . 75.340000000000003 109.618 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -54.12 -46.26 72.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.094 -1.004 . . . . 62.140000000000001 109.375 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.507 ' C ' ' H ' ' A' ' 159' ' ' ARG . 66.4 mtp180 -77.01 -49.49 15.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.928 . . . . 72.219999999999999 109.382 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -72.2 34.2 0.06 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.636 -0.665 . . . . 74.120000000000005 110.042 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.514 HH21 ' CG2' ' A' ' 121' ' ' ILE . 19.1 ttm180 -59.51 150.44 26.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.131 -0.981 . . . . 74.340000000000003 109.133 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.479 ' OD1' ' SG ' ' A' ' 215' ' ' CYS . 62.2 m-20 53.05 46.93 25.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 75.450000000000003 109.544 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -149.71 150.95 32.88 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.23 -0.919 . . . . 73.409999999999997 109.312 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 58.3 mt -90.15 132.74 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.223 -0.923 . . . . 74.409999999999997 109.296 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 48.5 t -131.52 134.73 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.486 -0.759 . . . . 72.530000000000001 109.29 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.423 ' OG ' ' OE1' ' A' ' 166' ' ' GLU . 3.0 t -86.25 157.25 19.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.318 -0.863 . . . . 74.120000000000005 109.894 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -59.52 -44.08 93.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.437 -0.789 . . . . 70.430000000000007 109.627 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.423 ' OE1' ' OG ' ' A' ' 164' ' ' SER . 34.0 mp0 -59.56 -38.01 79.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 74.319999999999993 109.526 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -59.28 -40.66 86.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.138 -0.976 . . . . 74.519999999999996 109.096 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 62.5 mt -58.02 -54.09 50.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.186 -0.947 . . . . 74.409999999999997 108.925 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 170' ' ' ASP . 10.3 mp -61.5 -55.95 25.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 75.140000000000001 109.194 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 169' ' ' LEU . 17.3 t70 -35.86 -42.8 0.28 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.04 0.447 . . . . 65.030000000000001 111.256 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.63 -30.26 13.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.078 -1.014 . . . . 70.209999999999994 110.53 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.9 mm -84.9 -72.72 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 120.986 -1.071 . . . . 75.319999999999993 109.663 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.503 ' O ' ' CE3' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -53.25 145.3 14.15 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.395 -0.965 . . . . 73.140000000000001 108.395 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -172.25 -103.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.399 -0.813 . . . . 73.239999999999995 109.129 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.438 ' CB ' ' CD ' ' A' ' 176' ' ' PRO . 8.8 mm-40 -53.5 -64.53 1.67 Allowed Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 120.926 -1.109 . . . . 63.329999999999998 109.107 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 175' ' ' GLU . 38.5 Cg_endo -64.66 77.73 0.19 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.049 1.833 . . . . 72.510000000000005 111.541 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.4 ' C ' ' N ' ' A' ' 179' ' ' VAL . 96.1 mt-10 -75.6 -128.02 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.176 -0.952 . . . . 75.340000000000003 109.686 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.479 ' C ' ' H ' ' A' ' 180' ' ' THR . 63.2 mtt 50.05 19.49 0.48 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.026 -1.046 . . . . 74.510000000000005 109.069 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 180' ' ' THR . 18.5 m -76.38 21.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.448 -0.783 . . . . 65.219999999999999 109.752 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.479 ' H ' ' C ' ' A' ' 178' ' ' MET . 4.3 p 58.82 151.32 0.08 OUTLIER Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.574 -0.704 . . . . 73.219999999999999 109.785 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -41.17 -52.13 3.61 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.09 1.86 . . . . 62.43 112.663 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.481 ' OD1' ' CD1' ' A' ' 184' ' ' ILE . 5.9 t30 -158.14 118.09 3.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.118 -0.989 . . . . 73.129999999999995 110.04 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.8 m -142.17 9.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.277 -0.89 . . . . 74.019999999999996 109.144 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.481 ' CD1' ' OD1' ' A' ' 182' ' ' ASN . 2.1 mp -49.8 -42.22 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 72.329999999999998 109.452 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.548 ' H ' ' CD ' ' A' ' 185' ' ' GLU . 2.1 pm0 -47.05 -34.67 6.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.153 -0.967 . . . . 74.400000000000006 109.263 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 92.3 t -78.35 -51.63 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.263 -0.898 . . . . 74.319999999999993 109.395 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.97 71.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 73.230000000000004 110.069 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.442 ' CG2' ' N ' ' A' ' 189' ' ' ASN . 10.8 tp -58.51 -44.88 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.971 -1.08 . . . . 74.310000000000002 109.73 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.442 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 45.7 t-20 -56.71 -45.09 82.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.932 -1.105 . . . . 73.439999999999998 109.381 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -68.88 -40.91 78.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.86 . . . . 71.420000000000002 109.64 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 68.1 mt -64.94 -34.66 71.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.175 -0.953 . . . . 72.439999999999998 109.73 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -64.01 -56.76 12.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.219 -0.925 . . . . 64.219999999999999 109.683 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -65.46 -35.69 81.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.917 . . . . 74.319999999999993 109.949 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -70.93 -17.66 62.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.071 -1.018 . . . . 75.310000000000002 109.667 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 195' ' ' MET . 0.2 OUTLIER -89.95 -53.52 4.45 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.253 -0.904 . . . . 74.019999999999996 109.722 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 200' ' ' GLY . 60.0 m-20 -61.18 -38.39 86.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 74.019999999999996 110.408 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.451 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 19.4 mmtt -51.76 -65.62 0.94 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 120.951 -1.093 . . . . 75.430000000000007 109.831 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 37.7 Cg_endo -64.02 -55.57 0.61 Allowed 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.242 1.961 . . . . 72.319999999999993 112.399 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.2 mp -64.26 -38.67 91.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.091 -1.005 . . . . 74.540000000000006 109.531 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 196' ' ' ASP . . . 83.22 -40.21 2.82 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.605 -1.398 . . . . 61.509999999999998 109.605 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.501 ' N ' ' CD1' ' A' ' 201' ' ' ILE . 2.2 mp -92.6 139.48 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.248 -1.148 . . . . 74.25 109.319 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 34.1 t -88.06 140.37 29.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.187 -0.946 . . . . 72.0 109.235 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.437 ' HG1' ' CE ' ' A' ' 195' ' ' MET . 11.9 p -144.25 33.41 1.21 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.177 -0.952 . . . . 74.439999999999998 109.516 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.62 143.92 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.238 -0.914 . . . . 71.129999999999995 109.649 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -122.08 137.84 54.67 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.632 -0.668 . . . . 73.510000000000005 109.284 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.1 t -114.51 141.74 47.31 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.471 -0.768 . . . . 73.519999999999996 109.357 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 9.0 p -144.42 137.12 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.253 -0.904 . . . . 72.150000000000006 109.473 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -71.4 -34.34 70.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 72.400000000000006 109.808 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 22.4 ttm105 -51.45 -36.77 45.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 73.310000000000002 109.699 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -140.98 -155.7 0.61 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.329 -0.857 . . . . 71.540000000000006 109.195 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -79.1 -125.13 0.44 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.739 -1.344 . . . . 74.450000000000003 109.739 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 212' ' ' TYR . 30.1 m-85 -116.78 135.0 54.1 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.577 -0.954 . . . . 75.540000000000006 109.728 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 67.4 ttt-85 -104.92 127.97 52.97 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.581 -0.7 . . . . 75.310000000000002 109.157 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 160' ' ' ASP . 18.8 m-85 -100.95 130.63 46.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.258 -0.901 . . . . 75.409999999999997 109.334 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . 0.479 ' SG ' ' OD1' ' A' ' 160' ' ' ASP . 52.0 t -154.39 155.97 35.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.36 -0.837 . . . . 74.140000000000001 109.281 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -68.07 149.93 97.96 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.164 -0.96 . . . . 75.319999999999993 108.957 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.01 -98.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.189 1.926 . . . . 73.109999999999999 111.877 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 220' ' ' ALA . 0.1 OUTLIER -68.09 153.71 94.98 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.172 -0.955 . . . . 75.25 108.846 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -37.85 -22.27 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 122.271 1.981 . . . . 75.099999999999994 112.382 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 218' ' ' LYS . . . 50.07 21.49 0.75 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 71.140000000000001 109.498 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 223' ' ' GLU . 76.7 m -151.97 -11.65 0.19 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.308 -0.87 . . . . 71.129999999999995 109.257 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 47.75 -92.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 75.349999999999994 109.629 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 221' ' ' CYS . 78.2 mm-40 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 118.015 -0.993 . . . . 73.409999999999997 109.464 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.553 ' N ' ' CD2' ' B' ' 25' ' ' PHE . 12.7 mtt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.334 -0.617 . . . . 75.239999999999995 109.334 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -97.8 121.26 39.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.324 -0.86 . . . . 73.519999999999996 109.288 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 79.9 t -115.59 136.24 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.472 0.653 . . . . 72.239999999999995 109.618 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 5.5 tp -105.33 120.12 40.78 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.589 -0.695 . . . . 73.340000000000003 109.729 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 18.0 mt -118.08 96.83 5.51 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.706 -0.85 . . . . 74.349999999999994 108.706 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 69.5 mt -84.96 97.54 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.808 -1.183 . . . . 63.439999999999998 108.377 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.432 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 35.2 tp10 -135.62 133.03 37.82 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.484 -0.76 . . . . 74.519999999999996 109.535 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -66.67 -32.51 73.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.308 -0.87 . . . . 74.129999999999995 109.32 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -79.93 129.93 34.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 74.230000000000004 109.388 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 25.9 t -83.31 -32.32 26.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 65.540000000000006 109.849 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.43 ' CG1' ' N ' ' B' ' 12' ' ' LEU . 11.1 p -63.25 -44.3 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.141 -0.974 . . . . 75.549999999999997 109.865 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.43 ' N ' ' CG1' ' B' ' 11' ' ' VAL . 74.7 mt -66.58 -33.02 74.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.993 -1.067 . . . . 70.140000000000001 109.353 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.73 -23.32 64.72 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.804 -1.718 . . . . 75.400000000000006 108.804 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.7 -49.7 7.71 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.702 -1.359 . . . . 65.439999999999998 109.702 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -62.58 -43.5 98.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.113 -1.227 . . . . 72.200000000000003 109.161 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 97.3 mt -61.27 -35.67 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.075 -1.016 . . . . 75.150000000000006 108.445 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.476 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 78.7 tt0 -60.83 -44.76 96.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.439 -0.788 . . . . 73.010000000000005 109.333 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -85.15 -0.14 53.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.19 -0.944 . . . . 74.299999999999997 109.097 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.6 -55.54 2.42 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.652 -1.379 . . . . 70.540000000000006 109.652 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -75.05 -19.99 59.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.152 -1.205 . . . . 75.430000000000007 109.811 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 1.7 m120 -53.05 -32.94 49.63 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.103 -0.998 . . . . 73.200000000000003 109.328 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 79.2 t -58.02 -27.71 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 74.230000000000004 108.836 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -83.9 -4.51 58.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.445 -0.784 . . . . 73.519999999999996 109.152 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.13 33.55 32.34 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.05 -1.22 . . . . 53.43 110.05 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.553 ' CD2' ' N ' ' B' ' 1' ' ' MET . 9.0 m-85 -110.83 159.14 17.94 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.411 -1.052 . . . . 71.120000000000005 108.9 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 6.9 mmt -105.49 141.88 36.2 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.563 -0.903 . . . . 75.239999999999995 108.563 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . 0.424 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -138.0 156.53 47.73 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.193 -0.942 . . . . 73.25 110.277 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 77.9 m-20 -138.77 159.46 42.07 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.647 -0.871 . . . . 72.310000000000002 108.647 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 p -123.04 139.98 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.327 -0.858 . . . . 72.140000000000001 109.938 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.4 p -138.16 170.78 15.44 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.532 -0.73 . . . . 74.530000000000001 109.284 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -90.62 -106.05 0.09 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.315 -0.865 . . . . 71.019999999999996 110.01 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 59.9 p -80.47 168.13 19.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.151 -0.968 . . . . 71.400000000000006 110.068 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' B' ' 37' ' ' GLU . 15.1 mt -51.85 -31.33 27.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.455 -0.778 . . . . 71.239999999999995 109.852 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -52.82 -51.49 60.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.032 -1.043 . . . . 74.319999999999993 109.647 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -62.72 -40.61 97.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.134 -0.979 . . . . 73.030000000000001 108.957 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.7 -33.27 75.59 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.964 -1.654 . . . . 60.43 108.964 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' B' ' 33' ' ' LEU . 84.3 tt0 -66.86 -44.07 81.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.363 -1.081 . . . . 74.430000000000007 109.319 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -75.83 -35.63 59.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 74.420000000000002 109.447 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 12.1 tp -72.0 -39.51 69.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.842 . . . . 75.409999999999997 110.119 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.7 ppp? -77.63 -18.19 57.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.999 -1.063 . . . . 61.439999999999998 109.888 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -69.5 -42.46 74.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.109 -0.995 . . . . 74.319999999999993 109.538 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 2.4 pp -87.48 -16.42 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.867 . . . . 71.230000000000004 109.737 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' B' ' 40' ' ' MET . 13.6 tpp85 -130.64 138.56 50.14 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.44 -0.787 . . . . 73.409999999999997 109.42 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -98.59 129.13 45.11 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.316 -0.865 . . . . 63.539999999999999 109.103 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -108.38 136.87 47.3 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.425 -0.797 . . . . 73.109999999999999 109.568 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . 0.449 ' OD2' ' SD ' ' B' ' 1' ' ' MET . 92.5 m-20 -76.75 -41.83 43.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 62.219999999999999 108.709 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.73 115.72 31.0 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.394 -0.965 . . . . 73.120000000000005 108.394 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 62.1 t -100.61 97.61 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.564 -0.902 . . . . 74.109999999999999 108.564 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -116.51 130.72 56.91 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.41 -0.806 . . . . 73.439999999999998 110.217 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.506 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.3 OUTLIER -144.33 134.49 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.169 -0.678 . . . . 73.400000000000006 109.169 -179.605 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' SER . . . . . 0.432 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 19.1 p -95.43 16.4 17.02 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.385 -0.822 . . . . 73.209999999999994 109.792 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.506 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 53.4 m-20 -80.56 144.58 32.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.956 . . . . 70.409999999999997 109.578 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.477 ' NZ ' HD22 ' B' ' 54' ' ' ASN . 18.4 pttp -76.45 -36.01 58.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 73.129999999999995 109.986 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . 0.477 HD22 ' NZ ' ' B' ' 53' ' ' LYS . 22.5 m120 -74.43 10.88 1.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 75.209999999999994 109.685 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -67.17 -25.27 66.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 55.329999999999998 110.08 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 62.1 mt -47.34 -40.35 17.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.078 -1.014 . . . . 72.420000000000002 110.028 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' SER . . . . . 0.419 ' O ' ' OG ' ' B' ' 60' ' ' SER . 14.5 t -75.45 -41.71 55.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.944 -1.098 . . . . 73.040000000000006 109.829 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -64.12 -47.91 78.15 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.329 -0.857 . . . . 72.329999999999998 110.232 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 19.5 m -63.95 -36.81 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.64 -1.287 . . . . 74.540000000000006 109.694 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' B' ' 57' ' ' SER . 80.6 p -56.59 -45.48 81.38 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.247 -0.908 . . . . 71.239999999999995 109.774 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' B' ' 65' ' ' LYS . 10.5 ptp180 -74.82 -31.82 61.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.065 -1.022 . . . . 74.310000000000002 109.971 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' B' ' 66' ' ' HIS . 5.1 mm -59.74 -53.72 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.901 -1.125 . . . . 75.420000000000002 109.493 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 8.8 mmmm -62.28 -41.51 98.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.036 -1.04 . . . . 73.319999999999993 108.95 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -66.83 -39.64 87.72 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.305 -0.998 . . . . 73.310000000000002 108.305 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' B' ' 61' ' ' ARG . 92.6 mttt -87.3 -76.95 0.35 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.357 -0.839 . . . . 72.439999999999998 109.249 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' B' ' 62' ' ' ILE . 97.7 m-70 -91.94 92.33 8.27 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.212 -0.93 . . . . 65.209999999999994 109.039 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.483 ' O ' ' N ' ' B' ' 69' ' ' ILE . 25.6 t -78.56 -41.47 31.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 73.099999999999994 110.058 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 46.2 t -67.76 54.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.164 -0.96 . . . . 71.530000000000001 109.81 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.483 ' N ' ' O ' ' B' ' 67' ' ' SER . 16.6 tt -151.28 153.22 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.143 -0.973 . . . . 74.400000000000006 109.395 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 76.1 t -97.48 152.14 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.15 -0.969 . . . . 75.120000000000005 109.284 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 10.0 t -136.59 129.77 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.24 -0.913 . . . . 73.200000000000003 110.108 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.401 ' CD2' ' C ' ' B' ' 72' ' ' LEU . 4.8 tt -121.17 106.24 11.34 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.911 -0.774 . . . . 73.340000000000003 108.911 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 77.8 t -93.09 128.21 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.154 -0.966 . . . . 73.5 109.433 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.48 157.92 16.29 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.347 -0.983 . . . . 71.319999999999993 108.347 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 40.0 m -156.02 134.38 11.54 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.841 -1.162 . . . . 74.530000000000001 110.789 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -87.18 7.63 27.42 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.499 -0.926 . . . . 64.5 108.499 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -135.91 59.83 31.43 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 108.749 -0.834 . . . . 74.25 108.749 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.468 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 19.4 Cg_endo -60.14 79.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.424 2.083 . . . . 74.430000000000007 111.736 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 68.9 p -106.98 151.87 24.73 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.852 -0.795 . . . . 73.120000000000005 108.852 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.56 -22.0 30.34 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.297 -0.877 . . . . 75.409999999999997 109.152 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -68.98 -49.26 59.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 72.239999999999995 109.31 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -74.9 -27.27 60.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 73.219999999999999 109.658 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.75 -56.03 23.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.174 -0.954 . . . . 74.299999999999997 109.657 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 35.2 m -64.71 -42.76 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.135 -0.978 . . . . 73.310000000000002 109.279 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' HIS . . . . . 0.632 ' CE1' HE21 ' B' ' 89' ' ' GLN . 66.2 t60 -60.76 -36.12 78.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -0.918 . . . . 73.239999999999995 109.207 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.46 -41.13 98.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.337 -0.852 . . . . 55.329999999999998 109.97 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -77.35 -39.16 48.46 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.028 -1.045 . . . . 74.450000000000003 108.852 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -65.03 -39.19 93.01 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.596 -0.842 . . . . 64.040000000000006 109.254 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . 0.632 HE21 ' CE1' ' B' ' 85' ' ' HIS . 68.9 mm-40 -62.19 -47.1 85.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 75.129999999999995 108.935 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 144.47 -6.3 1.68 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.006 -1.237 . . . . 75.420000000000002 110.006 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.92 133.79 26.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.038 -1.272 . . . . 73.420000000000002 109.285 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . 0.477 ' CG ' HH12 ' B' ' 112' ' ' ARG . 40.9 t0 -83.45 -18.68 37.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -0.93 . . . . 73.319999999999993 109.213 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -152.45 164.05 38.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.421 -0.799 . . . . 73.040000000000006 108.988 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.468 ' OH ' ' CB ' ' B' ' 78' ' ' PRO . 0.1 OUTLIER -150.85 107.3 3.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.189 -0.944 . . . . 74.310000000000002 108.931 -179.361 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 30.9 mm -114.82 159.87 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 O-C-N 121.485 -0.76 . . . . 75.340000000000003 109.94 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.96 128.32 35.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.18 -0.95 . . . . 70.099999999999994 108.556 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.687 ' O ' ' N ' ' B' ' 99' ' ' TYR . 1.8 tptt -49.08 -59.33 6.59 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.144 -0.973 . . . . 65.430000000000007 111.443 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 8.0 Cg_endo -44.24 -3.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.569 1.513 . . . . 63.520000000000003 113.015 -175.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . 0.687 ' N ' ' O ' ' B' ' 97' ' ' LYS . 48.5 m-85 62.18 123.38 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.91 -0.494 . . . . 75.129999999999995 109.795 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 17.9 ttm-85 -74.41 -37.66 63.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.942 -1.099 . . . . 74.230000000000004 109.237 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' SER . . . . . 0.767 ' O ' ' N ' ' B' ' 103' ' ' LYS . 48.3 t -173.8 35.45 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.951 -1.093 . . . . 64.510000000000005 111.303 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 36.8 mm 49.67 -70.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-N 118.995 0.816 . . . . 74.439999999999998 110.52 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . 0.767 ' N ' ' O ' ' B' ' 101' ' ' SER . 33.1 mmtm -54.08 -32.44 54.8 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.106 -1.072 . . . . 72.299999999999997 108.106 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.01 -45.75 76.59 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.342 -0.985 . . . . 74.310000000000002 108.342 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 64.2 tp -62.6 -44.18 96.94 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.72 -0.845 . . . . 73.540000000000006 108.72 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 76.5 t -66.79 -38.62 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.355 -0.841 . . . . 72.030000000000001 109.513 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.42 -46.48 69.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.225 -0.922 . . . . 64.219999999999999 109.49 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -69.56 -31.37 69.51 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.188 -0.945 . . . . 75.310000000000002 109.888 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 96.4 mt -74.06 -31.34 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.018 -1.051 . . . . 55.439999999999998 108.833 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -73.91 -58.56 3.22 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.645 -0.822 . . . . 65.310000000000002 109.367 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -50.99 -35.22 32.67 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.384 -0.823 . . . . 74.519999999999996 109.578 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . 0.477 HH12 ' CG ' ' B' ' 92' ' ' ASP . 5.6 tpt180 -65.7 -44.01 87.42 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.158 -0.964 . . . . 72.040000000000006 109.738 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 43.0 mt -134.28 64.01 1.61 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.365 -0.835 . . . . 75.349999999999994 109.963 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -60.55 -43.7 96.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.971 -1.081 . . . . 75.5 108.628 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -142.08 -109.21 0.13 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.389 -0.819 . . . . 73.040000000000006 109.357 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -148.21 162.7 38.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.272 -0.893 . . . . 74.450000000000003 109.184 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' B' ' 119' ' ' ASN . . . -70.11 153.72 52.18 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.525 -1.43 . . . . 64.209999999999994 109.525 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' SER . . . . . 0.427 ' O ' ' O ' ' B' ' 119' ' ' ASN . 29.5 p -82.65 30.55 0.42 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -1.182 . . . . 71.400000000000006 109.718 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . 0.609 ' N ' ' ND2' ' B' ' 119' ' ' ASN . 0.0 OUTLIER 55.07 170.24 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.495 -0.882 . . . . 74.209999999999994 109.629 177.602 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 11.0 t -119.88 -37.82 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.526 -0.734 . . . . 75.019999999999996 109.13 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 29.3 mm -110.94 132.79 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.437 -0.79 . . . . 74.239999999999995 109.491 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -152.98 117.14 4.87 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.196 -0.94 . . . . 73.329999999999998 109.495 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.695 HD11 ' HB3' ' B' ' 216' ' ' TYR . 11.5 tt -163.04 140.24 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.009 -1.057 . . . . 74.219999999999999 110.271 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' B' ' 126' ' ' LEU . . . 69.52 33.14 71.79 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.312 -1.115 . . . . 72.409999999999997 110.312 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 14.8 t0 69.51 -6.34 1.01 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.355 -1.086 . . . . 75.120000000000005 109.281 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.714 HD12 HD11 ' B' ' 199' ' ' LEU . 1.2 mt -91.12 144.35 25.73 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.031 -1.1 . . . . 75.420000000000002 108.031 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.46 126.31 40.27 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.357 -0.839 . . . . 74.219999999999999 109.004 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 73.6 mt -127.58 131.41 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.593 -0.692 . . . . 60.329999999999998 109.341 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 48.7 m -115.24 121.27 35.2 Favored Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 121.626 -0.671 . . . . 72.310000000000002 109.334 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -78.26 -44.25 0.16 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.572 1.515 . . . . 75.129999999999995 111.933 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . 0.791 ' O ' ' OE2' ' B' ' 133' ' ' GLU . 70.0 m-20 -62.91 -46.85 85.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.07 -1.019 . . . . 75.230000000000004 109.281 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . 0.478 ' O ' ' C ' ' B' ' 133' ' ' GLU . 41.7 mt-10 -86.84 5.72 35.31 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.252 -0.905 . . . . 75.120000000000005 109.182 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.791 ' OE2' ' O ' ' B' ' 131' ' ' ASP . 0.6 OUTLIER 29.93 59.87 0.19 Allowed 'General case' 0 N--CA 1.509 2.502 0 CA-C-O 121.596 0.712 . . . . 75.129999999999995 110.447 -179.579 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -141.99 137.56 31.26 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.973 -0.751 . . . . 75.109999999999999 108.973 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 10.9 tt -111.05 138.97 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.217 -0.927 . . . . 70.319999999999993 109.874 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 18.0 mm -115.91 132.84 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.561 -0.712 . . . . 74.120000000000005 109.534 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -140.43 125.2 18.17 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.362 -0.836 . . . . 74.230000000000004 108.964 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 81.2 mttt 55.13 33.98 21.62 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.405 -0.809 . . . . 74.219999999999999 110.311 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 76.76 14.99 81.98 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 120.182 -1.009 . . . . 74.319999999999993 110.934 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -101.05 127.8 47.4 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.179 -1.189 . . . . 75.340000000000003 109.63 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -93.74 117.83 30.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.253 -0.904 . . . . 71.230000000000004 109.621 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 5.3 t -124.74 120.99 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.389 -0.819 . . . . 70.430000000000007 108.947 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -79.22 139.8 37.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.382 -0.824 . . . . 72.430000000000007 109.62 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.99 137.21 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.285 -0.884 . . . . 72.129999999999995 109.069 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 41.8 pttt -167.24 119.11 0.91 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 74.5 109.782 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 156.96 -177.21 33.97 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.082 -1.607 . . . . 42.229999999999997 109.082 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 0.622 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 26.6 mmtm -69.05 -36.56 7.71 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.166 -1.197 . . . . 73.299999999999997 110.375 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 26.8 Cg_exo -61.3 -36.21 80.46 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.871 1.714 . . . . 71.329999999999998 111.597 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -90.6 -28.01 18.72 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.359 -0.838 . . . . 74.230000000000004 109.393 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -50.6 -49.42 56.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 72.340000000000003 109.696 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . 0.908 HG22 HG22 ' B' ' 191' ' ' ILE . 2.8 p -64.95 -34.28 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.088 -1.008 . . . . 73.349999999999994 109.038 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 10.5 tp -64.07 -36.85 85.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.172 -0.955 . . . . 74.430000000000007 108.605 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.39 -28.65 56.8 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.441 -0.787 . . . . 75.209999999999994 109.305 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . 1.029 ' CE1' ' CE1' ' B' ' 158' ' ' HIS . 1.3 t60 -63.43 -53.84 45.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.023 -1.048 . . . . 73.040000000000006 109.561 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.7 pp -66.61 -30.36 70.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.992 -1.067 . . . . 73.430000000000007 108.917 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.51 -51.22 60.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.101 -1.0 . . . . 75.319999999999993 109.016 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.55 ' NH1' ' HA ' ' B' ' 154' ' ' HIS . 51.3 mtt85 -62.37 -51.39 67.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.029 -1.044 . . . . 73.319999999999993 108.773 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . 1.029 ' CE1' ' CE1' ' B' ' 154' ' ' HIS . 11.8 m80 -88.78 36.0 0.79 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.723 -0.61 . . . . 74.140000000000001 109.886 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . 0.402 HH12 ' CB ' ' B' ' 203' ' ' THR . 29.9 ttp85 -82.6 41.36 0.71 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.872 -1.142 . . . . 73.420000000000002 109.619 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . 0.743 ' HB3' ' HE1' ' B' ' 216' ' ' TYR . 3.9 p-10 -166.66 49.34 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 72.099999999999994 109.511 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -175.6 -171.54 0.48 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.346 -0.846 . . . . 73.239999999999995 109.79 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 86.9 mt -93.05 143.05 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.288 -0.883 . . . . 72.310000000000002 110.126 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 78.6 t -134.18 126.21 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.986 -0.746 . . . . 75.030000000000001 108.986 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 4.6 p -81.68 162.76 22.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.131 -0.98 . . . . 74.219999999999999 109.941 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -64.54 -51.54 62.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.422 -0.799 . . . . 72.420000000000002 110.137 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -58.38 -27.13 63.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.119 -0.988 . . . . 63.450000000000003 109.086 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -56.18 -50.95 69.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 72.400000000000006 108.906 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 79.6 mt -61.73 -36.19 80.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 72.319999999999993 108.933 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 5.9 tt -64.9 -61.48 2.14 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.453 -0.779 . . . . 73.340000000000003 109.695 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -62.38 -25.73 68.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.91 . . . . 73.099999999999994 110.479 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.03 -47.52 58.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.943 -1.098 . . . . 62.130000000000003 110.366 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 24.3 mm -99.7 -63.06 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.149 -0.969 . . . . 74.439999999999998 110.428 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' TRP . . . . . 1.175 ' CD1' HG11 ' B' ' 179' ' ' VAL . 25.6 m-90 -77.98 65.53 3.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.081 -1.012 . . . . 72.230000000000004 109.961 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -80.37 -43.42 21.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.165 -0.959 . . . . 75.030000000000001 110.0 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . 0.644 ' H ' ' CD ' ' B' ' 176' ' ' PRO . 13.9 tm-20 -167.55 -35.42 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 120.916 -1.115 . . . . 73.040000000000006 111.399 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.644 ' CD ' ' H ' ' B' ' 175' ' ' GLU . 24.7 Cg_exo -64.12 -30.06 65.34 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 121.507 1.472 . . . . 74.129999999999995 111.235 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . 0.777 ' O ' ' HD1' ' B' ' 173' ' ' TRP . 81.0 mm-40 -119.46 92.29 3.75 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.535 -0.913 . . . . 72.439999999999998 108.535 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 26.3 ttt -68.75 135.33 51.09 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.351 -0.843 . . . . 72.109999999999999 109.515 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 179' ' ' VAL . . . . . 1.175 HG11 ' CD1' ' B' ' 173' ' ' TRP . 31.7 m -141.5 167.24 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.493 -0.754 . . . . 75.310000000000002 109.733 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 180' ' ' THR . . . . . 0.578 ' O ' ' N ' ' B' ' 182' ' ' ASN . 22.1 m -101.01 121.21 53.01 Favored Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 108.927 -0.768 . . . . 62.149999999999999 108.927 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -44.77 80.48 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.838 1.692 . . . . 74.340000000000003 112.441 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 182' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' B' ' 180' ' ' THR . 10.6 t-20 -179.04 -21.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.323 -0.861 . . . . 72.310000000000002 108.835 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 15.2 m -75.21 -10.13 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 65.420000000000002 109.546 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 50.9 mt -50.4 -25.96 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.923 . . . . 75.030000000000001 109.004 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . 0.413 ' O ' ' OD1' ' B' ' 189' ' ' ASN . 25.1 mm-40 -62.18 -38.57 89.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.387 -0.82 . . . . 73.519999999999996 109.381 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 2.1 t -77.45 -34.94 21.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.399 -0.813 . . . . 74.349999999999994 109.986 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -68.68 -39.36 80.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.861 -1.149 . . . . 61.119999999999997 110.634 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 188' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' B' ' 189' ' ' ASN . 10.6 tp -76.94 -42.13 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.786 -1.196 . . . . 72.430000000000007 109.769 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 189' ' ' ASN . . . . . 0.423 ' N ' ' CG2' ' B' ' 188' ' ' ILE . 18.6 m120 -70.33 -37.12 74.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 75.420000000000002 110.77 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . 0.429 ' CG ' ' N ' ' B' ' 191' ' ' ILE . 13.6 pt20 -71.45 -46.95 58.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.859 -1.15 . . . . 74.140000000000001 110.995 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . 0.908 HG22 HG22 ' B' ' 151' ' ' VAL . 6.5 pt -60.7 -38.97 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.485 -1.384 . . . . 74.030000000000001 109.379 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 192' ' ' ARG . . . . . 0.52 ' NH2' ' CD1' ' B' ' 212' ' ' TYR . 98.5 mtt180 -62.35 -35.79 80.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.029 -1.045 . . . . 72.329999999999998 109.474 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 193' ' ' GLN . . . . . 0.443 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 86.7 mt-30 -77.5 -25.91 50.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.228 -0.92 . . . . 73.099999999999994 110.384 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -78.71 -24.25 45.05 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.092 -1.005 . . . . 74.430000000000007 110.736 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 195' ' ' MET . . . . . 0.477 ' HE2' HG12 ' B' ' 204' ' ' VAL . 5.6 ptm -94.82 -35.7 11.97 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.921 -1.112 . . . . 74.329999999999998 110.568 -178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 196' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 52.9 p-10 -67.92 -24.04 65.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.985 -1.072 . . . . 71.209999999999994 110.772 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . 0.539 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 17.5 mttp -74.69 -62.23 0.97 Allowed Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.979 -1.076 . . . . 75.209999999999994 110.219 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 198' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -66.36 -39.51 17.04 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.082 1.855 . . . . 75.319999999999993 112.83 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . 0.714 HD11 HD12 ' B' ' 126' ' ' LEU . 58.1 mt -80.14 -55.77 4.7 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.881 -1.137 . . . . 72.25 110.142 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 95.91 -8.4 67.94 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.42 -1.472 . . . . 73.239999999999995 109.42 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 23.4 mm -105.36 135.93 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.325 -1.103 . . . . 54.299999999999997 109.349 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 47.7 t -90.15 133.36 34.93 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.146 -0.971 . . . . 74.310000000000002 108.723 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 203' ' ' THR . . . . . 0.402 ' CB ' HH12 ' B' ' 159' ' ' ARG . 43.7 p -146.83 50.25 1.12 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.022 -1.048 . . . . 74.400000000000006 110.226 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.477 HG12 ' HE2' ' B' ' 195' ' ' MET . 33.3 m -144.31 124.6 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 120.973 -1.08 . . . . 74.099999999999994 109.835 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -109.53 114.0 27.26 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.416 -0.957 . . . . 75.329999999999998 108.416 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 9.8 t -96.06 125.31 40.51 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.097 -1.002 . . . . 71.400000000000006 109.724 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.9 p -142.22 142.62 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.303 -0.873 . . . . 63.5 109.321 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -80.6 6.97 11.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 74.450000000000003 109.611 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -58.17 -39.4 78.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.22 -0.925 . . . . 74.140000000000001 109.818 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -160.37 -37.16 0.05 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.222 -0.924 . . . . 74.430000000000007 109.397 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.9 -150.5 9.96 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.438 -1.465 . . . . 70.109999999999999 109.438 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' TYR . . . . . 0.52 ' CD1' ' NH2' ' B' ' 192' ' ' ARG . 54.4 m-85 -93.11 137.92 32.02 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.137 -1.213 . . . . 74.209999999999994 109.033 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -111.46 118.37 35.6 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.55 -0.719 . . . . 74.299999999999997 109.78 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -96.05 131.67 42.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.349 -0.844 . . . . 74.340000000000003 109.024 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.0 t -145.06 169.5 17.99 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.17 -0.956 . . . . 72.209999999999994 109.946 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . 0.743 ' HE1' ' HB3' ' B' ' 160' ' ' ASP . 0.0 OUTLIER -74.74 159.09 83.96 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.414 -0.958 . . . . 72.310000000000002 108.414 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.82 133.1 56.05 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.298 1.999 . . . . 71.010000000000005 111.943 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . 0.628 ' N ' ' CD ' ' B' ' 219' ' ' PRO . 3.0 ttmp? -80.21 -35.2 0.88 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 74.349999999999994 110.485 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . 0.784 ' O ' ' N ' ' B' ' 221' ' ' CYS . 24.9 Cg_exo -61.37 -1.1 1.67 Allowed 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.531 1.488 . . . . 71.319999999999993 111.457 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . 0.765 ' C ' ' OE2' ' B' ' 223' ' ' GLU . . . -57.04 55.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.374 -0.829 . . . . 75.450000000000003 109.636 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' CYS . . . . . 0.784 ' N ' ' O ' ' B' ' 219' ' ' PRO . 31.8 p -78.65 -31.78 46.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.111 -0.993 . . . . 72.219999999999999 109.279 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -58.81 -14.79 9.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 74.299999999999997 109.091 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . 0.765 ' OE2' ' C ' ' B' ' 220' ' ' ALA . 1.6 pm0 . . . . . 0 N--CA 1.499 2.0 0 CA-C-O 117.967 -1.016 . . . . 71.129999999999995 109.135 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 1.177 ' CE ' ' HA ' ' A' ' 115' ' ' PHE . 28.6 tpp . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.413 -0.588 . . . . 65.120000000000005 109.413 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -140.06 140.5 36.14 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.345 -0.847 . . . . 73.310000000000002 109.203 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.6 t -119.9 142.91 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.633 0.73 . . . . 71.420000000000002 110.402 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.3 tp -113.75 116.14 28.93 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.116 -1.068 . . . . 65.219999999999999 108.116 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.442 ' CD1' ' SD ' ' A' ' 49' ' ' MET . 3.6 tp -118.5 103.96 10.24 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.892 -0.781 . . . . 71.439999999999998 108.892 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 69.9 mt -95.71 104.3 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.115 -0.991 . . . . 71.150000000000006 108.742 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.416 ' OE2' ' ND2' ' A' ' 9' ' ' ASN . 28.7 tp10 -128.51 119.25 24.5 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.206 -0.664 . . . . 75.340000000000003 109.206 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.458 ' CB ' ' NZ ' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -84.19 -3.22 58.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.227 -0.921 . . . . 73.040000000000006 109.378 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.417 ' O ' ' OG ' ' A' ' 10' ' ' SER . 70.5 m-20 -81.73 -125.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.338 -0.851 . . . . 72.420000000000002 109.279 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 9' ' ' ASN . 25.3 m -165.88 -77.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.024 -1.047 . . . . 72.340000000000003 110.106 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.83 -44.09 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -0.885 . . . . 74.420000000000002 110.622 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.499 ' CD1' ' HZ2' ' A' ' 97' ' ' LYS . 3.5 mm? -58.8 -37.24 75.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.092 -1.005 . . . . 72.010000000000005 109.668 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.92 -32.52 39.96 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.727 -1.749 . . . . 72.140000000000001 108.727 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.21 -47.84 69.13 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 110.058 -1.217 . . . . 72.329999999999998 110.058 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.67 -43.56 93.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.011 -1.288 . . . . 72.340000000000003 109.382 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.8 mm -64.86 -43.97 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.817 -1.177 . . . . 74.239999999999995 108.492 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -58.83 -50.43 74.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.86 . . . . 71.409999999999997 109.468 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -80.7 1.53 29.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.196 -0.94 . . . . 75.540000000000006 109.585 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.08 -58.41 2.0 Allowed Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.958 -1.257 . . . . 62.149999999999999 109.958 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -75.85 -18.73 59.33 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.265 -1.138 . . . . 74.420000000000002 110.032 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -57.59 -31.35 66.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.107 -0.996 . . . . 74.25 109.623 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.4 t -62.37 -38.22 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.386 -0.821 . . . . 72.109999999999999 109.876 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.525 ' HZ3' ' HZ1' ' A' ' 103' ' ' LYS . 12.1 mptt -67.93 -1.82 6.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.325 -0.86 . . . . 73.230000000000004 109.726 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.09 27.03 27.01 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.826 -1.31 . . . . 75.540000000000006 109.826 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.661 ' CE1' ' CE2' ' A' ' 115' ' ' PHE . 13.8 m-85 -99.49 151.25 21.34 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.33 -1.1 . . . . 74.510000000000005 109.097 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 12.0 mtt -102.06 128.44 48.52 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.572 -1.269 . . . . 64.319999999999993 107.572 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.84 140.1 38.38 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.157 -0.965 . . . . 74.310000000000002 110.507 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -112.66 139.03 48.61 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.715 -0.846 . . . . 75.400000000000006 108.715 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -104.75 124.55 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.293 -0.88 . . . . 75.129999999999995 108.722 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.4 p -128.2 166.61 18.22 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.648 -0.658 . . . . 71.420000000000002 109.495 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -83.87 -102.95 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.22 -0.925 . . . . 73.109999999999999 109.446 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.0 p -81.37 161.16 23.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 74.239999999999995 109.457 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.8 mp -52.22 -28.23 17.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.375 -0.828 . . . . 71.530000000000001 109.5 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -49.25 -53.35 22.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.935 . . . . 74.230000000000004 109.5 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -60.58 -39.01 86.48 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.175 -0.953 . . . . 71.010000000000005 108.715 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.37 -34.83 80.77 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.106 -1.597 . . . . 61.409999999999997 109.106 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -66.98 -43.92 81.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -1.129 . . . . 74.340000000000003 109.351 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.447 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 36.6 t80 -76.81 -22.23 53.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.122 -0.986 . . . . 75.329999999999998 109.824 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.2 tp -87.42 -30.78 20.46 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.108 -0.995 . . . . 74.329999999999998 109.673 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.44 ' O ' ' O ' ' A' ' 43' ' ' ARG . 5.0 ppp? -86.36 -24.02 25.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.122 -0.986 . . . . 70.319999999999993 110.468 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 37.4 p-10 -59.37 -28.49 66.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.887 -1.133 . . . . 71.219999999999999 109.444 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.538 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 12.6 pt -92.24 -30.68 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.234 -0.916 . . . . 74.409999999999997 110.113 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 40' ' ' MET . 70.9 mmt-85 -130.03 148.31 51.87 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.386 -0.821 . . . . 75.409999999999997 109.645 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -98.66 160.11 14.5 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.252 -0.905 . . . . 75.420000000000002 109.483 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -131.02 160.11 35.55 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.496 -0.753 . . . . 74.230000000000004 109.241 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.745 ' OD2' ' CH2' ' A' ' 116' ' ' TRP . 5.4 m-20 -98.69 -45.21 6.13 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.267 -0.896 . . . . 75.319999999999993 109.474 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.403 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -102.18 108.84 20.36 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.45 -0.944 . . . . 72.129999999999995 108.45 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.7 t -97.25 100.78 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.339 -0.851 . . . . 72.340000000000003 109.248 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.448 ' C ' ' SD ' ' A' ' 49' ' ' MET . 2.0 tmt? -116.74 134.48 54.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.456 -0.777 . . . . 74.109999999999999 109.489 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.476 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 1.3 p -143.43 127.69 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.499 -0.751 . . . . 71.239999999999995 109.323 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.4 p -86.69 4.95 38.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.559 -0.713 . . . . 73.109999999999999 109.408 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.476 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 13.6 m-20 -79.92 138.9 37.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.937 . . . . 63.399999999999999 109.646 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.425 ' C ' ' H ' ' A' ' 55' ' ' ALA . 91.1 mttt -82.27 -32.75 29.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.269 -0.894 . . . . 65.439999999999998 109.938 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -73.21 8.93 1.42 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.195 -0.941 . . . . 73.129999999999995 109.714 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -74.93 -20.9 59.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.331 -0.856 . . . . 64.140000000000001 110.184 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 55' ' ' ALA . 31.3 mt -38.49 -45.0 0.99 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.604 -0.685 . . . . 74.430000000000007 110.706 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.3 p -74.47 -36.54 63.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.95 -1.093 . . . . 63.229999999999997 109.311 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 55' ' ' ALA . 64.6 t80 -65.07 -46.19 82.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.417 -0.802 . . . . 74.439999999999998 109.998 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.1 m -64.29 -37.41 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.703 -1.248 . . . . 74.030000000000001 109.307 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.1 t -53.54 -49.9 66.64 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.209 -0.932 . . . . 73.540000000000006 109.228 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -70.28 -36.22 74.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 73.340000000000003 110.243 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 mm -64.67 -34.12 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.642 -1.286 . . . . 73.349999999999994 109.432 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.484 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 44.0 mmtt -67.43 -51.58 49.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 74.420000000000002 109.868 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.443 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 17.1 pt-20 -72.38 -43.02 64.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.942 -1.099 . . . . 74.549999999999997 109.937 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.505 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 25.8 mtpp -70.14 -22.72 62.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 75.219999999999999 109.508 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.505 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 89.9 m-70 -156.35 64.31 0.55 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.923 . . . . 74.129999999999995 109.525 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 63' ' ' LYS . 30.7 p -60.19 -31.54 70.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.871 . . . . 73.239999999999995 109.737 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 87.7 p -68.6 47.84 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -0.915 . . . . 71.439999999999998 109.705 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.427 ' H ' ' C ' ' A' ' 67' ' ' SER . 14.3 tt -148.61 161.92 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.083 -1.011 . . . . 71.329999999999998 109.609 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.656 HG22 HD12 ' A' ' 113' ' ' LEU . 77.4 t -95.96 154.91 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.158 -0.964 . . . . 73.019999999999996 108.754 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.725 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 6.5 t -143.32 114.52 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.11 -0.994 . . . . 54.210000000000001 109.315 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.0 mp -111.12 100.14 8.86 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.55 -0.908 . . . . 74.209999999999994 108.55 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.4 t -93.14 120.4 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.345 -0.847 . . . . 74.409999999999997 108.91 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 m -97.84 172.84 7.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.284 -0.885 . . . . 72.310000000000002 108.763 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 77' ' ' ASN . 0.8 OUTLIER -173.98 120.72 0.29 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.982 -1.073 . . . . 64.540000000000006 110.203 -179.622 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -65.53 2.37 0.95 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.508 -0.745 . . . . 74.129999999999995 109.406 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.495 ' H ' ' C ' ' A' ' 75' ' ' SER . 80.2 m-20 -120.1 64.05 9.57 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 109.123 -0.695 . . . . 73.340000000000003 109.123 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.03 74.2 0.1 OUTLIER 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.11 1.873 . . . . 71.319999999999993 111.871 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.45 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 60.1 p -104.95 149.7 25.52 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.331 -0.988 . . . . 62.530000000000001 108.331 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -28.56 69.19 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.197 -0.939 . . . . 74.140000000000001 109.813 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.459 ' OE1' ' N ' ' A' ' 81' ' ' GLU . 40.8 mp0 -63.41 -38.08 89.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.112 -0.992 . . . . 71.420000000000002 109.876 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -77.05 -33.95 57.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.044 -1.035 . . . . 73.430000000000007 109.712 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -61.05 -52.57 64.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.056 -1.028 . . . . 74.219999999999999 109.461 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.9 m -62.67 -41.31 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -0.949 . . . . 74.150000000000006 109.387 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -65.8 -29.94 70.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.225 -0.922 . . . . 72.540000000000006 109.324 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.02 -37.05 80.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.917 . . . . 64.219999999999999 109.91 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -80.2 -34.05 37.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.106 -0.997 . . . . 74.340000000000003 108.839 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -73.64 -38.22 65.08 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.388 -0.82 . . . . 74.420000000000002 109.461 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -71.32 -60.86 2.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 74.519999999999996 109.374 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 155.71 70.88 0.01 OUTLIER Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.67 -1.252 . . . . 74.209999999999994 110.168 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -133.08 130.75 39.74 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.339 -1.095 . . . . 64.099999999999994 109.357 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.725 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 14.2 m-20 -69.51 -41.09 76.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 73.420000000000002 109.268 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.732 ' CG ' HH21 ' A' ' 112' ' ' ARG . 4.9 m-20 -146.32 163.0 36.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.834 . . . . 75.040000000000006 109.056 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.494 ' CE1' ' OE1' ' A' ' 83' ' ' GLU . 56.6 t80 -136.96 124.42 22.09 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.363 -0.977 . . . . 71.329999999999998 108.363 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.454 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 0.1 OUTLIER -126.12 149.83 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 CA-C-O 122.045 0.926 . . . . 74.510000000000005 111.232 -178.055 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.75 121.54 16.72 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.768 -1.197 . . . . 64.319999999999993 107.768 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.659 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -44.92 -55.43 10.94 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.197 -0.939 . . . . 74.510000000000005 111.629 -178.596 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.7 Cg_endo -41.56 -12.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 120.739 0.96 . . . . 73.109999999999999 112.538 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.659 ' N ' ' O ' ' A' ' 97' ' ' LYS . 55.2 m-85 59.86 124.88 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 109.583 -0.525 . . . . 72.540000000000006 109.583 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 32.6 ttm-85 -62.08 -38.79 90.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.876 -1.14 . . . . 74.540000000000006 109.353 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.793 ' O ' ' N ' ' A' ' 103' ' ' LYS . 6.3 t -172.99 46.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.129 -0.982 . . . . 74.140000000000001 110.473 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 92.2 mt 47.11 -68.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-O 121.228 0.537 . . . . 75.430000000000007 110.825 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.793 ' N ' ' O ' ' A' ' 101' ' ' SER . 13.8 mmmt -53.25 -34.0 55.38 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.238 -0.914 . . . . 74.140000000000001 108.843 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.39 -49.73 68.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.262 -0.899 . . . . 63.240000000000002 109.204 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.428 ' C ' ' CD1' ' A' ' 105' ' ' LEU . 2.0 tm? -57.73 -47.9 81.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.134 -0.979 . . . . 73.219999999999999 108.726 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.96 -40.2 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.964 -1.085 . . . . 74.540000000000006 109.85 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.17 -39.23 59.78 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.252 -0.905 . . . . 75.5 108.832 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 1.291 ' HB3' ' NH1' ' A' ' 112' ' ' ARG . 93.3 mtt180 -73.55 -29.82 62.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.028 -1.045 . . . . 74.409999999999997 109.933 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 47.5 mt -73.92 -44.94 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 120.891 -1.131 . . . . 73.239999999999995 109.218 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.449 ' CG ' ' N ' ' A' ' 111' ' ' ALA . 17.7 pt-20 -70.31 -47.93 58.87 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.816 -1.154 . . . . 74.340000000000003 109.717 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.449 ' N ' ' CG ' ' A' ' 110' ' ' GLU . . . -59.49 -29.84 68.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.889 -1.132 . . . . 73.319999999999993 109.578 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 1.291 ' NH1' ' HB3' ' A' ' 108' ' ' ARG . 53.0 mtt85 -72.79 -58.34 3.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.913 . . . . 74.420000000000002 109.175 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.713 HD23 ' O ' ' A' ' 112' ' ' ARG . 16.7 mt -126.35 65.13 1.24 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.502 -0.925 . . . . 74.329999999999998 108.502 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.549 ' O ' ' HE1' ' A' ' 1' ' ' MET . 29.1 mtm105 -39.94 -79.73 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.902 -0.499 . . . . 74.439999999999998 110.48 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 1.177 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 14.6 m-85 -163.18 96.48 0.88 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.029 -1.044 . . . . 74.430000000000007 108.698 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 1.01 ' CZ2' ' OE1' ' A' ' 132' ' ' GLU . 51.3 m0 -46.78 -93.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.247 -0.908 . . . . 74.439999999999998 109.861 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.15 17.85 18.42 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.078 -1.609 . . . . 75.040000000000006 109.078 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.4 p -103.56 166.76 10.22 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.366 -1.079 . . . . 70.109999999999999 109.771 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.658 HD22 ' N ' ' A' ' 128' ' ' ILE . 1.0 OUTLIER -164.18 127.89 2.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.329 -0.857 . . . . 65.239999999999995 108.98 179.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 18.4 t -82.98 -38.07 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.047 -1.033 . . . . 74.219999999999999 110.627 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.547 ' O ' ' ND2' ' A' ' 119' ' ' ASN . 14.9 mm -95.88 133.59 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.932 -1.105 . . . . 74.420000000000002 110.038 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -149.86 127.94 11.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.151 -0.968 . . . . 73.299999999999997 108.607 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' A' ' 125' ' ' ASP . 8.7 tp -153.32 132.38 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 75.340000000000003 109.54 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 55.93 -83.49 0.01 OUTLIER Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.62 -1.392 . . . . 75.129999999999995 109.62 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 123' ' ' ILE . 15.1 t0 -149.92 -4.84 0.36 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.253 -1.146 . . . . 74.450000000000003 109.334 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.05 141.32 28.66 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.074 -1.017 . . . . 54.210000000000001 108.842 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.32 133.1 43.62 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.896 -0.779 . . . . 70.239999999999995 108.896 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.658 ' N ' HD22 ' A' ' 119' ' ' ASN . 49.4 mt -130.02 134.83 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.378 -0.826 . . . . 72.430000000000007 109.554 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.429 ' HG ' ' HB2' ' A' ' 132' ' ' GLU . 5.0 t -108.72 111.78 60.82 Favored Pre-proline 0 N--CA 1.497 1.9 0 N-CA-C 108.524 -0.917 . . . . 71.109999999999999 108.524 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -83.18 -39.18 0.13 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.869 1.713 . . . . 75.140000000000001 112.815 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -65.86 -49.3 68.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.025 -1.047 . . . . 72.5 109.692 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 1.01 ' OE1' ' CZ2' ' A' ' 116' ' ' TRP . 5.8 mm-40 -81.48 -6.26 58.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.13 -0.981 . . . . 73.140000000000001 109.105 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 57.06 63.63 1.86 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 75.329999999999998 109.727 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -146.19 130.41 17.52 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.338 -0.851 . . . . 71.230000000000004 109.272 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 6.8 tt -106.57 140.81 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.345 -0.847 . . . . 75.329999999999998 108.87 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.4 mt -128.54 120.75 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.46 -0.775 . . . . 71.109999999999999 109.506 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -140.03 140.18 36.14 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.386 -0.821 . . . . 74.140000000000001 109.628 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 53.45 20.96 2.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.403 -0.811 . . . . 75.400000000000006 110.085 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.84 16.97 68.84 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.982 -1.104 . . . . 72.239999999999995 110.403 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 57.2 mtp85 -107.12 124.41 49.64 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.242 -1.152 . . . . 73.120000000000005 109.177 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -99.24 124.9 44.68 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.302 -0.874 . . . . 72.319999999999993 109.75 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.8 t -139.33 140.9 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.39 -0.819 . . . . 62.340000000000003 109.556 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -85.94 135.7 33.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.177 -0.952 . . . . 61.229999999999997 109.136 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.4 m -132.43 126.95 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.439 -0.788 . . . . 74.439999999999998 109.406 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.4 pttt -173.15 129.31 0.47 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.304 -0.873 . . . . 75.420000000000002 109.577 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.66 -141.19 6.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.703 -1.359 . . . . 73.340000000000003 109.703 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.547 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -85.09 -44.56 0.67 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.328 -1.101 . . . . 72.219999999999999 110.403 -179.271 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 69.6 Cg_endo -89.79 -7.85 4.5 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.73 2.287 . . . . 75.450000000000003 113.354 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -89.42 -32.84 17.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.719 -1.238 . . . . 65.239999999999995 110.035 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -50.18 -40.99 48.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.978 -1.076 . . . . 72.519999999999996 109.149 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.09 -33.59 64.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.252 -0.905 . . . . 74.209999999999994 109.246 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 7.0 tp -61.37 -40.88 95.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.91 . . . . 73.310000000000002 109.639 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.9 p -74.59 -34.89 62.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.095 -1.003 . . . . 74.310000000000002 109.041 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -52.81 -55.2 24.76 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.476 -0.765 . . . . 75.450000000000003 109.746 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 pp -72.13 -26.17 62.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.013 -1.055 . . . . 75.340000000000003 109.283 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.04 -29.39 60.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.084 -1.01 . . . . 62.140000000000001 108.716 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.526 ' C ' ' H ' ' A' ' 159' ' ' ARG . 52.4 mtt180 -97.89 -54.19 3.17 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.681 -0.859 . . . . 72.219999999999999 108.681 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.492 ' H ' ' HD1' ' A' ' 158' ' ' HIS . 5.3 m80 -69.94 43.34 0.06 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.456 -0.777 . . . . 74.120000000000005 109.141 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.548 ' O ' ' N ' ' A' ' 161' ' ' GLN . 32.2 mtm105 -53.57 -103.37 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.481 -0.762 . . . . 74.340000000000003 109.953 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -51.17 86.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.478 -0.764 . . . . 75.450000000000003 109.884 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -175.58 179.1 1.48 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.629 -0.878 . . . . 73.409999999999997 108.629 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.54 ' H ' ' CD ' ' A' ' 161' ' ' GLN . 66.6 mt -98.82 128.95 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.258 -0.901 . . . . 74.409999999999997 109.615 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 212' ' ' TYR . 77.2 t -108.99 113.94 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.509 -0.744 . . . . 72.530000000000001 109.535 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.574 ' HG ' ' H ' ' A' ' 167' ' ' GLN . 4.4 p -90.33 138.71 31.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 74.120000000000005 108.627 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -57.75 -37.09 73.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 70.430000000000007 109.186 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -64.29 -38.19 90.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 74.319999999999993 109.617 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.574 ' H ' ' HG ' ' A' ' 164' ' ' SER . 8.9 tp-100 -59.84 -41.12 90.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -0.968 . . . . 74.519999999999996 109.124 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 40.2 mt -61.88 -53.28 57.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.91 . . . . 74.409999999999997 109.306 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 11.8 tp -62.67 -60.83 2.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 75.140000000000001 109.635 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -40.75 -40.1 1.25 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.94 -0.475 . . . . 65.030000000000001 111.543 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.16 -31.23 14.23 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.859 -1.151 . . . . 70.209999999999994 111.784 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.3 mm -80.6 -69.3 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.72 -1.238 . . . . 75.319999999999993 109.807 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.512 ' O ' ' CE3' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -59.07 145.71 41.15 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.831 -1.174 . . . . 73.140000000000001 107.831 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -172.1 -76.37 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.662 -0.866 . . . . 73.239999999999995 108.662 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.606 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 2.4 tt0 -82.6 -42.81 0.93 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.122 -0.986 . . . . 63.329999999999998 108.572 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 14.6 Cg_exo -67.95 44.23 0.27 Allowed 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.593 2.195 . . . . 72.510000000000005 111.687 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -54.66 -4.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -0.954 . . . . 75.340000000000003 110.168 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.521 ' H ' ' C ' ' A' ' 176' ' ' PRO . 23.5 ttt -53.87 -26.54 25.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.041 -1.037 . . . . 74.510000000000005 109.25 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 18.7 m -64.46 137.21 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 65.219999999999999 109.485 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.5 p -64.71 153.27 88.11 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 73.219999999999999 108.843 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -36.71 -56.16 0.76 Allowed 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.395 2.064 . . . . 62.43 112.042 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.466 ' N ' ' OD1' ' A' ' 182' ' ' ASN . 6.3 p30 -93.79 114.66 26.98 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.265 -0.897 . . . . 73.129999999999995 108.737 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.5 p -145.94 -32.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.213 -0.929 . . . . 74.019999999999996 109.3 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.411 HG21 HD12 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -51.4 -31.21 11.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.449 -0.782 . . . . 72.329999999999998 109.09 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -56.32 -53.29 58.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.253 -0.905 . . . . 74.400000000000006 110.173 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.8 m -74.06 -25.25 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.996 -1.065 . . . . 74.319999999999993 109.805 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -71.55 -52.65 17.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 73.230000000000004 110.047 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 9.9 tp -64.31 -33.97 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.91 -1.119 . . . . 74.310000000000002 109.734 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -64.67 -54.85 25.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.995 . . . . 73.439999999999998 110.025 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -67.65 -39.45 84.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.002 -1.061 . . . . 71.420000000000002 109.884 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.403 HG22 HD13 ' A' ' 191' ' ' ILE . 67.2 mt -60.12 -49.35 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.016 -1.053 . . . . 72.439999999999998 109.373 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -52.85 -53.73 44.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.07 -1.019 . . . . 64.219999999999999 109.442 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.629 ' NE2' ' N ' ' A' ' 193' ' ' GLN . 0.1 OUTLIER -59.76 -36.52 76.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -0.871 . . . . 74.319999999999993 109.375 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -81.65 -3.95 54.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.175 -0.953 . . . . 75.310000000000002 110.112 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 32.5 ttp -108.82 -15.18 14.45 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.322 -0.861 . . . . 74.019999999999996 109.704 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -108.51 -16.45 14.21 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.422 -0.799 . . . . 74.019999999999996 109.869 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.628 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 31.5 tptt -78.69 -35.72 1.13 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.979 -1.076 . . . . 75.430000000000007 110.776 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 89.0 Cg_endo -90.36 -48.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.226 1.951 . . . . 72.319999999999993 112.279 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 74.1 mt -68.1 -31.95 71.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.14 -0.975 . . . . 74.540000000000006 109.19 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 73.13 0.22 50.92 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.77 -1.332 . . . . 61.509999999999998 109.77 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.8 mt -123.23 128.2 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.548 -0.972 . . . . 74.25 109.488 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 8.3 t -86.03 132.95 33.94 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.321 -0.992 . . . . 72.0 108.321 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.7 p -134.87 27.02 3.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.254 -0.904 . . . . 74.439999999999998 109.909 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 26.7 m -146.98 150.48 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.096 -1.003 . . . . 71.129999999999995 109.736 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -126.61 126.13 43.1 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.645 -0.659 . . . . 73.510000000000005 109.368 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.34 111.16 16.46 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.133 -0.979 . . . . 73.519999999999996 108.916 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 211' ' ' GLY . 21.3 t -115.09 132.51 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.558 -0.714 . . . . 72.150000000000006 109.783 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -73.53 -30.1 62.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.839 . . . . 72.400000000000006 109.7 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -58.48 -82.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.891 . . . . 73.310000000000002 110.312 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -82.24 -47.55 12.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.891 -1.131 . . . . 71.540000000000006 109.865 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 207' ' ' VAL . . . 152.42 -110.8 0.47 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.976 -1.65 . . . . 74.450000000000003 108.976 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 163' ' ' VAL . 79.6 m-85 -112.11 140.41 46.82 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.433 -1.04 . . . . 75.540000000000006 108.714 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 25.8 mtm180 -121.3 129.79 53.3 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.423 -0.798 . . . . 75.310000000000002 109.522 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -97.47 119.54 36.2 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.296 -0.878 . . . . 75.409999999999997 108.906 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 28.2 m -130.91 161.22 32.35 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.354 -0.841 . . . . 74.140000000000001 109.75 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -72.27 151.06 92.16 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 75.319999999999993 109.08 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -39.68 135.02 1.42 Allowed 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 121.974 1.783 . . . . 73.109999999999999 112.079 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 9.5 tptp -78.27 -38.26 1.55 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.114 -0.991 . . . . 75.25 110.003 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 50.7 Cg_exo -56.02 -34.63 92.93 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.191 1.927 . . . . 75.099999999999994 111.952 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -62.75 113.13 2.84 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.35 -0.843 . . . . 71.140000000000001 109.149 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . 0.562 ' O ' ' N ' ' A' ' 223' ' ' GLU . 26.3 t -160.92 144.95 13.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 71.129999999999995 109.825 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 60.85 -67.75 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.732 -0.605 . . . . 75.349999999999994 110.159 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 221' ' ' CYS . 90.3 mt-10 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.01 -0.995 . . . . 73.409999999999997 109.831 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.447 ' SD ' ' CE2' ' B' ' 25' ' ' PHE . 51.5 ttm . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.512 -0.551 . . . . 75.239999999999995 109.512 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -137.1 139.71 41.44 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.416 -0.802 . . . . 73.519999999999996 109.307 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 90.3 t -110.05 133.92 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.597 -0.689 . . . . 72.239999999999995 109.698 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' B' ' 49' ' ' MET . 2.6 tp -102.92 119.21 38.44 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.556 -0.715 . . . . 73.340000000000003 109.166 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 19.5 mt -114.6 96.23 5.65 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.814 -0.81 . . . . 74.349999999999994 108.814 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 88.2 mt -81.43 98.19 3.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 O-C-N 120.727 -1.233 . . . . 63.439999999999998 108.494 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.435 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 28.3 tp10 -137.55 125.13 22.17 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.399 -0.813 . . . . 74.519999999999996 109.72 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -69.3 -31.17 69.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.31 -0.869 . . . . 74.129999999999995 108.896 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -85.25 112.19 20.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.379 -0.826 . . . . 74.230000000000004 109.447 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 96.9 p -68.09 -23.18 64.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.243 -0.911 . . . . 65.540000000000006 109.572 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 84.9 t -65.13 -52.62 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 75.549999999999997 109.614 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 62.3 mt -65.8 -37.4 86.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 70.140000000000001 109.686 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.29 -28.86 69.21 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.678 -1.769 . . . . 75.400000000000006 108.678 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.94 -53.26 41.97 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.721 -1.351 . . . . 65.439999999999998 109.721 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -58.96 -46.81 87.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.323 -1.104 . . . . 72.200000000000003 109.953 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 35.7 mm -64.52 -40.25 88.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.748 -1.22 . . . . 75.150000000000006 108.877 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -61.94 -44.65 96.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.364 -0.835 . . . . 73.010000000000005 109.446 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -85.48 1.72 47.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.187 -0.945 . . . . 74.299999999999997 108.964 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.4 -55.38 2.21 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 109.74 -1.344 . . . . 70.540000000000006 109.74 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -74.04 -19.7 60.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -1.184 . . . . 75.430000000000007 109.752 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -52.14 -32.78 37.15 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.17 -0.956 . . . . 73.200000000000003 109.521 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 79.4 t -58.7 -37.16 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.154 -0.966 . . . . 74.230000000000004 109.156 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -70.17 -13.81 62.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.362 -0.837 . . . . 73.519999999999996 109.41 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.44 38.78 6.99 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.844 -1.302 . . . . 53.43 109.844 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . 0.447 ' CE2' ' SD ' ' B' ' 1' ' ' MET . 15.6 m-85 -114.43 159.49 20.24 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.508 -0.995 . . . . 71.120000000000005 109.065 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.2 mmt -103.92 139.73 38.68 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.411 -0.959 . . . . 75.239999999999995 108.411 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . 0.41 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -139.95 154.93 47.33 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.272 -0.892 . . . . 73.25 110.096 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 83.1 m-20 -134.65 158.03 45.12 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.482 -0.933 . . . . 72.310000000000002 108.482 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.03 139.67 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.352 -0.843 . . . . 72.140000000000001 109.866 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 6.1 p -134.48 170.08 16.29 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.586 -0.696 . . . . 74.530000000000001 109.196 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -94.08 -105.77 0.13 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.165 -0.96 . . . . 71.019999999999996 109.774 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 37.3 t -78.2 173.64 12.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.236 -0.915 . . . . 71.400000000000006 110.059 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' B' ' 33' ' ' LEU . 3.7 mm? -55.27 -39.26 69.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.518 -0.739 . . . . 71.239999999999995 109.681 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -46.56 -45.74 18.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 74.319999999999993 110.031 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.59 -38.73 70.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.103 -0.998 . . . . 73.030000000000001 109.249 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.18 -42.7 91.03 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.18 -1.568 . . . . 60.43 109.18 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -67.94 -40.74 83.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.294 -1.121 . . . . 74.430000000000007 109.453 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -72.17 -37.55 69.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 74.420000000000002 109.841 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 21.7 tp -72.14 -48.23 45.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -0.931 . . . . 75.409999999999997 110.12 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.9 ppp? -66.95 -19.75 65.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.032 -1.043 . . . . 61.439999999999998 109.923 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -61.4 -40.72 95.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.081 -1.012 . . . . 74.319999999999993 110.058 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 19.0 pt -82.82 -29.73 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.129 -0.982 . . . . 71.230000000000004 110.278 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' B' ' 40' ' ' MET . 75.1 mtt85 -130.43 143.89 51.05 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.287 -0.883 . . . . 73.409999999999997 109.758 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -97.69 130.77 44.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.251 -0.906 . . . . 63.539999999999999 109.233 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -99.76 139.97 34.65 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.316 -0.865 . . . . 73.109999999999999 109.411 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -75.11 -37.06 61.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 62.219999999999999 109.237 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.59 116.93 30.28 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.641 -0.874 . . . . 73.120000000000005 108.641 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 72.3 t -98.43 98.22 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.354 -0.98 . . . . 74.109999999999999 108.354 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 0.5 OUTLIER -110.38 131.09 55.36 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.462 0.648 . . . . 73.439999999999998 109.288 -179.006 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.506 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.5 OUTLIER -145.73 135.6 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.437 -0.789 . . . . 73.400000000000006 109.607 -179.626 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' SER . . . . . 0.435 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 14.7 p -98.8 14.03 30.26 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.541 -0.724 . . . . 73.209999999999994 109.661 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.506 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 23.9 m-20 -82.9 140.3 32.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.184 -0.948 . . . . 70.409999999999997 109.468 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.48 ' C ' ' H ' ' B' ' 55' ' ' ALA . 14.4 mtpp -74.69 -39.73 61.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 73.129999999999995 110.134 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -71.41 10.98 0.52 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.108 -0.995 . . . . 75.209999999999994 109.695 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.48 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -66.27 -22.97 66.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 55.329999999999998 110.247 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.428 ' O ' ' OG ' ' B' ' 60' ' ' SER . 37.5 mt -45.72 -45.49 14.38 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.219 -0.926 . . . . 72.420000000000002 110.151 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 83.5 p -70.24 -38.39 75.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.892 -1.13 . . . . 73.040000000000006 109.364 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -66.19 -61.11 2.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.339 -0.851 . . . . 72.329999999999998 109.762 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 20.7 m -50.32 -34.8 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.546 -1.346 . . . . 74.540000000000006 109.7 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' B' ' 56' ' ' LEU . 44.8 m -56.77 -51.58 68.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.115 -0.991 . . . . 71.239999999999995 109.534 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -69.38 -32.14 70.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.981 -1.074 . . . . 74.310000000000002 110.19 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' B' ' 66' ' ' HIS . 39.5 mm -65.74 -42.41 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.676 -1.265 . . . . 75.420000000000002 110.133 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -65.78 -49.6 67.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.209 -0.932 . . . . 73.319999999999993 110.695 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' B' ' 65' ' ' LYS . 7.5 pt-20 -69.17 -41.62 76.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.7 -1.25 . . . . 73.310000000000002 109.838 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.496 ' O ' ' ND1' ' B' ' 66' ' ' HIS . 85.6 mttt -79.7 -18.69 50.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.25 -0.906 . . . . 72.439999999999998 109.563 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.496 ' ND1' ' O ' ' B' ' 65' ' ' LYS . 69.1 m-70 -154.82 67.59 0.69 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.141 -0.974 . . . . 65.209999999999994 109.698 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 54.6 p -67.18 -25.0 65.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.176 -0.953 . . . . 73.099999999999994 109.553 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 24.0 m -64.08 -27.06 68.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.305 -0.872 . . . . 71.530000000000001 109.895 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 84.5 mt -81.23 152.99 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.156 -0.965 . . . . 74.400000000000006 109.687 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 67.2 t -94.81 154.18 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.356 -0.84 . . . . 75.120000000000005 109.181 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.412 ' N ' ' OD2' ' B' ' 92' ' ' ASP . 11.3 t -133.64 130.52 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.309 -0.87 . . . . 73.200000000000003 110.049 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.508 ' O ' ' SD ' ' B' ' 49' ' ' MET . 6.5 tt -122.98 104.0 8.96 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.864 -0.791 . . . . 73.340000000000003 108.864 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 9.1 p -95.45 137.07 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.977 -1.077 . . . . 73.5 108.961 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 3.9 p -96.68 170.88 8.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.297 -0.877 . . . . 71.319999999999993 109.552 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.481 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 42.9 t -157.67 114.85 2.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.169 -0.957 . . . . 74.530000000000001 110.232 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' B' ' 77' ' ' ASN . 52.1 p-10 -66.6 -21.45 66.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.221 -0.924 . . . . 64.5 109.264 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . 0.517 ' N ' ' OD1' ' B' ' 76' ' ' ASP . 56.6 t-20 -126.53 75.95 74.08 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 108.633 -0.877 . . . . 74.25 108.633 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -44.31 85.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.32 2.013 . . . . 74.430000000000007 111.724 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.515 ' N ' ' O ' ' B' ' 77' ' ' ASN . 7.4 m -94.67 150.24 20.42 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.635 0.731 . . . . 73.120000000000005 110.065 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.9 p -76.78 -43.16 37.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.539 -0.726 . . . . 75.409999999999997 109.655 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -56.73 -35.24 68.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.135 -0.978 . . . . 72.239999999999995 109.012 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -74.2 -34.72 63.83 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.098 -1.001 . . . . 73.219999999999999 108.97 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.522 ' OE1' ' CG ' ' B' ' 94' ' ' TYR . 42.1 tp10 -65.84 -55.95 14.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.257 -0.902 . . . . 74.299999999999997 109.609 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 31.4 m -53.44 -41.93 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.994 -1.066 . . . . 73.310000000000002 108.968 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -74.26 -20.09 60.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.174 -0.954 . . . . 73.239999999999995 109.597 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.75 -40.87 79.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.945 -1.097 . . . . 55.329999999999998 110.428 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' PHE . . . . . 0.48 ' C ' ' CD1' ' B' ' 87' ' ' PHE . 0.5 OUTLIER -83.3 -30.48 27.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.871 -1.143 . . . . 74.450000000000003 109.112 -179.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -77.27 -44.37 30.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.11 -0.993 . . . . 64.040000000000006 109.25 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -65.44 -54.96 21.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.425 -0.797 . . . . 75.129999999999995 109.496 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 154.72 72.81 0.01 OUTLIER Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.608 -1.282 . . . . 75.420000000000002 110.472 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -140.44 140.87 35.48 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.272 -1.134 . . . . 73.420000000000002 108.84 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . 0.412 ' OD2' ' N ' ' B' ' 71' ' ' VAL . 54.3 m-20 -94.99 -22.99 17.58 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.06 -1.025 . . . . 73.319999999999993 109.824 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 17.4 t0 -151.78 158.32 43.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.09 -1.007 . . . . 73.040000000000006 109.609 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.522 ' CG ' ' OE1' ' B' ' 83' ' ' GLU . 55.8 t80 -142.9 104.91 4.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.478 -0.764 . . . . 74.310000000000002 108.969 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 27.2 mm -114.37 151.92 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.542 0 O-C-N 121.127 -0.983 . . . . 75.340000000000003 110.22 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.27 144.26 57.26 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.987 -1.116 . . . . 70.099999999999994 107.987 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.687 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -64.32 -54.42 38.63 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.765 -1.21 . . . . 65.430000000000007 111.516 -179.301 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 3.5 Cg_endo -41.45 -8.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 120.851 1.034 . . . . 63.520000000000003 113.341 -176.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . 0.687 ' N ' ' O ' ' B' ' 97' ' ' LYS . 44.7 m-85 59.06 110.22 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.366 -0.834 . . . . 75.129999999999995 109.322 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . 0.511 ' NH1' ' OE2' ' A' ' 83' ' ' GLU . 13.2 ttm180 -57.98 -34.2 69.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.009 -1.057 . . . . 74.230000000000004 108.88 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' SER . . . . . 0.778 ' O ' ' N ' ' B' ' 103' ' ' LYS . 47.9 t -174.26 32.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.148 -0.97 . . . . 64.510000000000005 110.836 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 49.9 mt 49.62 -69.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 118.745 0.702 . . . . 74.439999999999998 110.193 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . 0.778 ' N ' ' O ' ' B' ' 101' ' ' SER . 40.6 tptt -51.77 -31.17 25.76 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.603 -1.258 . . . . 72.299999999999997 107.603 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.97 -40.72 83.09 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.608 -0.886 . . . . 74.310000000000002 108.608 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 51.9 tp -66.22 -45.86 79.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.448 -0.782 . . . . 73.540000000000006 109.022 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 42.4 t -66.89 -41.1 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.919 . . . . 72.030000000000001 109.3 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.06 -45.22 64.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.254 -0.903 . . . . 64.219999999999999 109.375 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 67.2 ttt-85 -69.07 -33.52 73.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.911 . . . . 75.310000000000002 109.671 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . 0.411 HG21 HD12 ' B' ' 109' ' ' ILE . 96.6 mt -72.23 -29.11 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.104 -0.997 . . . . 55.439999999999998 108.767 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -67.72 -58.87 3.9 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.471 -0.891 . . . . 65.310000000000002 108.938 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -52.97 -32.11 44.34 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.305 -0.872 . . . . 74.519999999999996 109.108 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 25.6 tpt85 -58.9 -50.41 74.15 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.288 -0.883 . . . . 72.040000000000006 109.277 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 63.1 mt -146.19 103.52 3.72 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.174 -0.954 . . . . 75.349999999999994 109.995 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -98.47 107.48 19.95 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.465 -0.939 . . . . 75.5 108.465 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 78.1 t80 49.62 86.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 73.040000000000006 109.558 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 -82.39 142.79 31.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.194 -0.941 . . . . 74.450000000000003 109.45 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 163.27 86.39 0.06 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.599 -1.4 . . . . 64.209999999999994 109.599 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' SER . . . . . 0.451 ' O ' ' ND2' ' B' ' 119' ' ' ASN . 8.9 t -157.61 -175.26 5.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -1.128 . . . . 71.400000000000006 109.745 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' B' ' 118' ' ' SER . 0.0 OUTLIER -153.83 137.57 16.13 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.832 -0.747 . . . . 74.209999999999994 109.114 -178.205 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 6.9 t -71.8 -36.75 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 75.019999999999996 109.617 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . 0.406 HD13 HG23 ' B' ' 121' ' ' ILE . 20.8 mm -103.25 132.74 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.328 -0.858 . . . . 74.239999999999995 109.287 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -135.7 119.26 17.01 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.434 -0.791 . . . . 73.329999999999998 109.24 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 14.5 tt -145.67 130.5 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.262 -0.898 . . . . 74.219999999999999 109.235 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.46 -153.31 1.01 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.424 -1.47 . . . . 72.409999999999997 109.424 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -79.82 2.1 24.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.152 -1.205 . . . . 75.120000000000005 109.049 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.63 135.17 37.65 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.356 -0.979 . . . . 75.420000000000002 108.356 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 1.2 p -130.9 145.18 51.93 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.361 -0.837 . . . . 74.219999999999999 109.198 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 14.0 mt -133.69 140.41 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.446 -0.784 . . . . 60.329999999999998 109.066 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 3.6 t -123.02 81.89 50.87 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.635 -0.665 . . . . 72.310000000000002 109.307 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.67 -48.09 23.79 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.169 1.912 . . . . 75.129999999999995 112.589 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -52.57 -45.76 66.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.083 -1.011 . . . . 75.230000000000004 109.232 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -86.98 2.18 50.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.261 -0.9 . . . . 75.120000000000005 109.137 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 53.12 18.07 1.09 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 75.129999999999995 109.391 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -101.46 130.92 47.8 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.432 -0.793 . . . . 75.109999999999999 109.459 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 16.2 tt -113.12 133.24 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.536 -0.728 . . . . 70.319999999999993 109.095 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 2.5 mp -114.56 131.63 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.504 -0.748 . . . . 74.120000000000005 109.327 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -137.76 126.68 24.09 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.333 -0.854 . . . . 74.230000000000004 109.866 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp 52.76 34.78 16.98 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.369 -0.832 . . . . 74.219999999999999 110.413 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.35 13.89 82.78 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 120.041 -1.076 . . . . 74.319999999999993 110.723 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 53.0 mtt-85 -109.3 122.81 48.15 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.311 -1.111 . . . . 75.340000000000003 109.136 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -92.08 136.59 33.06 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.189 -0.944 . . . . 71.230000000000004 109.373 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.79 135.25 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.449 -0.782 . . . . 70.430000000000007 109.158 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -88.25 125.42 34.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.202 -0.936 . . . . 72.430000000000007 109.096 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 3.2 m -143.97 124.89 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.218 -0.926 . . . . 72.129999999999995 109.471 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -156.59 16.99 0.32 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.338 -0.852 . . . . 74.5 109.271 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -66.64 164.44 42.23 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.242 -1.543 . . . . 42.229999999999997 109.242 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 0.569 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 2.8 tmtp? -58.11 -43.98 98.87 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.222 -1.163 . . . . 73.299999999999997 109.224 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 23.3 Cg_exo -63.56 -20.63 69.81 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.591 2.194 . . . . 71.329999999999998 112.331 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -89.24 -22.65 22.63 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.175 -0.953 . . . . 74.230000000000004 110.035 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -50.53 -41.87 54.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.078 -1.014 . . . . 72.340000000000003 109.444 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 11.0 p -66.53 -32.4 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.955 . . . . 73.349999999999994 109.084 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.79 -43.64 81.1 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.707 -0.849 . . . . 74.430000000000007 108.707 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 2.7 p -73.65 -30.73 63.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.103 -0.998 . . . . 75.209999999999994 109.193 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -55.02 -54.07 47.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.912 . . . . 73.040000000000006 109.744 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.04 -28.94 63.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.071 -1.018 . . . . 73.430000000000007 109.572 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.15 -49.84 65.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 75.319999999999993 109.583 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.47 ' C ' ' H ' ' B' ' 159' ' ' ARG . 24.3 mtp180 -71.47 -44.94 63.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 73.319999999999993 109.387 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -74.94 20.47 0.13 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.415 -0.803 . . . . 74.140000000000001 109.793 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . 0.47 ' H ' ' C ' ' B' ' 157' ' ' ARG . 6.6 mmt85 -54.3 173.51 0.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.042 -1.037 . . . . 73.420000000000002 108.88 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . 0.412 ' OD2' ' O ' ' B' ' 160' ' ' ASP . 4.6 p-10 42.37 47.47 4.25 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.544 -0.722 . . . . 72.099999999999994 110.276 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -161.32 157.76 25.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 73.239999999999995 109.459 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' ILE . . . . . 0.546 ' CD1' ' N ' ' B' ' 162' ' ' ILE . 1.8 mp -91.37 131.41 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.237 -0.915 . . . . 72.310000000000002 109.174 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 40.3 t -123.59 136.56 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.529 -0.732 . . . . 75.030000000000001 109.335 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 11.3 p -83.39 158.35 22.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 74.219999999999999 109.568 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -62.54 -43.51 98.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.861 . . . . 72.420000000000002 109.349 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -65.53 -34.5 78.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 63.450000000000003 109.888 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -50.76 -49.38 58.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.11 -0.994 . . . . 72.400000000000006 109.39 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 53.6 mt -66.42 -40.33 89.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.199 -0.938 . . . . 72.319999999999993 109.355 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 3.7 tt -48.99 -59.12 3.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 73.340000000000003 109.482 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' B' ' 174' ' ' GLU . 78.0 m-20 -67.88 -41.4 82.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 73.099999999999994 110.14 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' B' ' 170' ' ' ASP . . . -43.1 -47.72 6.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.376 -0.827 . . . . 62.130000000000003 110.586 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 16.4 mm -94.96 -9.94 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.056 -1.028 . . . . 74.439999999999998 110.267 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -147.69 49.66 1.07 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.848 -1.158 . . . . 72.230000000000004 110.446 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' B' ' 170' ' ' ASP . 88.2 tt0 -76.08 -32.57 59.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.011 -1.055 . . . . 75.030000000000001 108.995 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' B' ' 177' ' ' GLU . 28.5 mt-10 -57.06 154.27 20.6 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.35 -0.844 . . . . 73.040000000000006 109.187 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -41.45 -14.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.437 2.092 . . . . 74.129999999999995 112.828 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' B' ' 175' ' ' GLU . 77.8 mm-40 -46.19 121.96 3.65 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.138 -0.976 . . . . 72.439999999999998 109.807 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 63.9 mtm -89.34 122.37 32.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.895 . . . . 72.109999999999999 109.394 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 1.2 m -103.12 143.58 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.426 -0.796 . . . . 75.310000000000002 109.19 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 180' ' ' THR . . . . . 0.443 ' O ' ' O ' ' B' ' 181' ' ' PRO . 22.7 m -63.41 135.16 96.13 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.337 -0.852 . . . . 62.149999999999999 109.484 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' B' ' 180' ' ' THR . 95.8 Cg_exo -41.11 171.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.181 1.921 . . . . 74.340000000000003 112.783 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 3.2 m120 61.32 39.52 15.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.398 -0.814 . . . . 72.310000000000002 109.411 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 25.4 t -79.33 -49.65 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.884 . . . . 65.420000000000002 109.802 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 27.7 mm -70.0 -24.85 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 75.030000000000001 110.183 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -64.18 -44.51 91.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.831 -1.168 . . . . 73.519999999999996 109.306 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 19.4 m -77.21 -31.85 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.203 -0.936 . . . . 74.349999999999994 109.59 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.2 -50.24 20.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.06 -1.025 . . . . 61.119999999999997 110.014 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 188' ' ' ILE . . . . . 0.457 ' CG2' ' N ' ' B' ' 189' ' ' ASN . 1.8 tt -59.43 -44.78 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.154 -0.966 . . . . 72.430000000000007 110.151 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 189' ' ' ASN . . . . . 0.457 ' N ' ' CG2' ' B' ' 188' ' ' ILE . 58.4 t30 -60.3 -43.58 96.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.091 -1.006 . . . . 75.420000000000002 109.584 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . 0.414 ' O ' ' CB ' ' B' ' 194' ' ' LYS . 15.1 mm-40 -68.64 -46.51 68.99 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.258 -0.901 . . . . 74.140000000000001 109.882 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 82.3 mt -54.47 -30.26 21.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 120.654 -1.279 . . . . 74.030000000000001 109.791 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 65.8 mtp85 -73.01 -60.84 2.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.013 -1.055 . . . . 72.329999999999998 110.871 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 193' ' ' GLN . . . . . 0.429 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 76.0 mt-30 -70.94 -32.8 69.81 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.027 -1.046 . . . . 73.099999999999994 110.252 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' B' ' 190' ' ' GLN . 20.7 ttpp -72.02 -26.82 62.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.478 -0.764 . . . . 74.430000000000007 110.696 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 17.4 tpt -92.44 -44.49 8.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.889 -1.132 . . . . 74.329999999999998 110.016 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 196' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 59.3 p30 -64.17 -19.65 65.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.034 -1.041 . . . . 71.209999999999994 110.086 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . 0.533 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 29.7 mttm -67.96 -64.75 1.74 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.081 -1.012 . . . . 75.209999999999994 109.198 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 198' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 39.7 Cg_endo -64.88 -50.99 1.88 Allowed 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.075 1.85 . . . . 75.319999999999993 110.976 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . 0.407 ' CD2' ' O ' ' B' ' 201' ' ' ILE . 0.0 OUTLIER -95.74 134.53 38.57 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.868 -1.16 . . . . 72.25 107.868 179.303 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . -97.96 -8.52 55.4 Favored Glycine 0 N--CA 1.498 2.816 0 O-C-N 121.083 -1.011 . . . . 73.239999999999995 110.615 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . 0.407 ' O ' ' CD2' ' B' ' 199' ' ' LEU . 70.2 mt -91.74 124.84 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.023 -1.281 . . . . 54.299999999999997 109.471 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 23.3 t -77.26 135.82 38.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 74.310000000000002 109.603 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 2.0 p -145.31 28.24 1.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.261 -0.899 . . . . 74.400000000000006 109.281 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 35.8 m -135.64 138.37 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.395 -0.816 . . . . 74.099999999999994 109.466 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -126.34 136.48 52.78 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.582 -0.699 . . . . 75.329999999999998 109.281 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 10.5 p -95.05 139.37 31.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.208 -0.933 . . . . 71.400000000000006 109.422 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.519 ' N ' ' O ' ' B' ' 211' ' ' GLY . 39.0 t -131.6 124.44 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.522 -0.736 . . . . 63.5 109.197 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 208' ' ' ARG . . . . . 0.467 ' CD ' ' N ' ' B' ' 208' ' ' ARG . 1.3 mpt_? -76.5 -34.93 58.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 74.450000000000003 109.822 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . 0.413 ' CD ' ' N ' ' B' ' 209' ' ' ARG . 11.7 mpt_? -56.17 -62.74 1.5 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.151 -0.968 . . . . 74.140000000000001 109.68 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 62.1 mmt-85 -98.81 -76.45 0.54 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.235 -0.915 . . . . 74.430000000000007 109.529 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' B' ' 207' ' ' VAL . . . -167.26 -107.41 0.2 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.528 -1.429 . . . . 70.109999999999999 109.528 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -120.58 133.96 55.33 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.592 -0.946 . . . . 74.209999999999994 109.346 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -104.77 126.53 51.95 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.494 -0.753 . . . . 74.299999999999997 109.083 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -101.96 125.89 48.75 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.348 -0.845 . . . . 74.340000000000003 109.276 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 20.5 p -142.76 154.26 44.08 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.336 -0.852 . . . . 72.209999999999994 109.378 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -63.96 154.24 82.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 72.310000000000002 108.865 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -38.23 147.3 0.11 Allowed 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.178 1.918 . . . . 71.010000000000005 111.902 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . 0.588 ' N ' ' CD ' ' B' ' 219' ' ' PRO . 21.1 mttp -72.95 -36.6 3.47 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 74.349999999999994 111.355 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' B' ' 218' ' ' LYS . 86.9 Cg_endo -87.88 12.85 2.76 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.108 1.872 . . . . 71.319999999999993 112.135 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -60.81 145.71 48.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 75.450000000000003 109.321 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 36.3 t -140.36 154.3 46.69 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.324 -0.86 . . . . 72.219999999999999 109.396 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -157.54 164.6 37.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.892 . . . . 74.299999999999997 109.363 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.011 -0.995 . . . . 71.129999999999995 109.42 -179.911 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.2 ttm . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.518 -0.549 . . . . 65.120000000000005 109.518 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.485 ' N ' ' OD2' ' A' ' 46' ' ' ASP . 97.6 mtt180 -129.65 156.77 43.71 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.497 -0.752 . . . . 73.310000000000002 109.17 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.0 t -118.65 124.44 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 CA-C-O 121.792 0.806 . . . . 71.420000000000002 110.014 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.1 tp -94.07 117.35 29.97 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.398 -0.964 . . . . 65.219999999999999 108.398 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.7 tt -119.44 119.43 33.88 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.092 -1.077 . . . . 71.439999999999998 108.092 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 56.3 mt -110.91 99.48 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.316 -0.865 . . . . 71.150000000000006 109.259 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' A' ' 30' ' ' THR . 36.2 tp10 -122.94 133.2 54.4 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.56 -0.712 . . . . 75.340000000000003 109.423 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -66.34 -34.47 78.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.242 -0.911 . . . . 73.040000000000006 109.555 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 10' ' ' SER . 21.6 p30 -82.98 -149.72 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.24 -0.913 . . . . 72.420000000000002 109.471 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.498 ' N ' ' OD1' ' A' ' 9' ' ' ASN . 20.9 p -152.55 -39.63 0.11 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.215 -0.928 . . . . 72.340000000000003 109.67 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.445 ' CG1' ' N ' ' A' ' 12' ' ' LEU . 11.1 p -64.39 -44.14 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 74.420000000000002 109.725 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.445 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 14.9 tp -65.28 -39.19 92.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 72.010000000000005 109.312 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.75 -28.03 69.78 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 108.035 -2.026 . . . . 72.140000000000001 108.035 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.12 -46.04 94.13 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 110.07 -1.212 . . . . 72.329999999999998 110.07 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -65.98 -47.15 75.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -1.203 . . . . 72.340000000000003 109.832 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.8 mm -65.51 -36.53 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.603 -1.311 . . . . 74.239999999999995 108.372 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.478 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 86.7 tt0 -65.54 -47.91 74.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.464 -0.773 . . . . 71.409999999999997 109.798 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -83.52 1.18 43.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.089 -1.007 . . . . 75.540000000000006 109.748 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.24 -55.17 2.54 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.567 -1.413 . . . . 62.149999999999999 109.567 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -76.23 -21.79 55.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -1.15 . . . . 74.420000000000002 109.917 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 92.9 m-20 -55.22 -32.28 62.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.034 -1.041 . . . . 74.25 109.345 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.3 t -60.02 -38.31 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 72.109999999999999 109.359 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.496 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 3.4 mptp? -62.68 -26.47 68.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.354 -0.842 . . . . 73.230000000000004 109.275 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.89 24.14 5.32 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 110.215 -1.154 . . . . 75.540000000000006 110.215 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -105.33 157.51 17.27 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.227 -1.16 . . . . 74.510000000000005 109.091 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.0 mmm -104.24 136.96 42.87 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.134 -1.061 . . . . 64.319999999999993 108.134 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.26 160.25 41.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.193 -0.942 . . . . 74.310000000000002 109.851 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -140.57 145.39 36.67 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.411 -0.806 . . . . 75.400000000000006 109.526 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 t -104.13 134.92 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.462 -0.94 . . . . 75.129999999999995 108.462 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.425 ' O ' ' O ' ' A' ' 7' ' ' GLU . 6.5 p -131.04 172.44 12.08 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.39 -0.819 . . . . 71.420000000000002 109.44 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -92.26 -104.54 0.11 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.24 -0.913 . . . . 73.109999999999999 110.001 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.4 p -78.8 167.41 21.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.245 -0.909 . . . . 74.239999999999995 110.269 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 35.7 mt -54.17 -29.62 46.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.635 -0.666 . . . . 71.530000000000001 109.857 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -47.79 -49.36 28.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.049 -1.032 . . . . 74.230000000000004 109.719 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -68.12 -38.39 82.19 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.142 -0.974 . . . . 71.010000000000005 109.222 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.84 -45.05 59.69 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.377 -1.489 . . . . 61.409999999999997 109.377 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -65.75 -38.44 89.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -1.103 . . . . 74.340000000000003 109.265 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -75.41 -37.52 60.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.151 -0.968 . . . . 75.329999999999998 109.679 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.3 tp -72.7 -47.55 46.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 74.329999999999998 110.101 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.495 ' SD ' ' OD1' ' A' ' 41' ' ' ASP . 3.7 ppp? -63.73 -28.71 70.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.105 -0.997 . . . . 70.319999999999993 110.083 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.495 ' OD1' ' SD ' ' A' ' 40' ' ' MET . 99.3 m-20 -65.6 -39.9 92.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.036 -1.04 . . . . 71.219999999999999 110.016 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.0 pt -82.88 -29.63 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.148 -0.97 . . . . 74.409999999999997 110.251 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 40' ' ' MET . 93.0 mtt180 -129.89 146.89 51.61 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.323 -0.861 . . . . 75.409999999999997 109.514 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -91.28 161.7 14.93 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.206 -0.934 . . . . 75.420000000000002 109.654 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -143.11 153.67 43.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.337 -0.852 . . . . 74.230000000000004 109.142 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.485 ' OD2' ' N ' ' A' ' 2' ' ' ARG . 3.8 p30 -95.41 -41.5 8.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.192 -0.943 . . . . 75.319999999999993 109.514 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.4 ' CD1' ' C ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER -104.84 115.76 30.85 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.433 -0.792 . . . . 72.129999999999995 109.05 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.5 t -101.49 97.8 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.389 -0.967 . . . . 72.340000000000003 108.389 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -114.27 130.66 56.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.491 -0.756 . . . . 74.109999999999999 110.303 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.419 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 1.5 p -138.4 129.36 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 121.728 0.775 . . . . 71.239999999999995 109.652 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.8 t -92.14 3.67 54.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.49 -0.757 . . . . 73.109999999999999 109.199 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.419 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 51.8 m-20 -76.28 138.07 40.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.305 -0.872 . . . . 63.399999999999999 109.509 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.516 ' C ' ' H ' ' A' ' 55' ' ' ALA . 28.1 mtmm -67.94 -35.25 78.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.179 -0.95 . . . . 65.439999999999998 110.049 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -71.36 17.08 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.153 -0.967 . . . . 73.129999999999995 109.734 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.516 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -60.29 -30.4 69.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 64.140000000000001 110.085 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.3 mt -46.07 -43.85 14.96 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.087 -1.008 . . . . 74.430000000000007 110.097 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 60' ' ' SER . 95.2 p -73.21 -40.23 64.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.93 -1.106 . . . . 63.229999999999997 109.627 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -65.13 -56.9 10.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.408 -0.807 . . . . 74.439999999999998 110.127 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.2 m -54.05 -38.2 37.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 120.839 -1.163 . . . . 74.030000000000001 109.638 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 57' ' ' SER . 46.2 p -54.83 -52.73 61.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.176 -0.952 . . . . 73.540000000000006 109.662 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -69.63 -29.81 67.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.088 -1.008 . . . . 73.340000000000003 110.342 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.476 ' O ' ' N ' ' A' ' 66' ' ' HIS . 6.1 mm -68.16 -47.9 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.639 -1.288 . . . . 73.349999999999994 110.357 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 41.4 mmtt -62.85 -43.7 98.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.065 -1.022 . . . . 74.420000000000002 110.691 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.403 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 7.0 pt-20 -73.55 -41.05 63.46 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.71 -1.244 . . . . 74.549999999999997 109.747 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.447 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 25.6 mtpp -78.17 -19.84 53.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.151 -0.968 . . . . 75.219999999999999 109.143 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.476 ' N ' ' O ' ' A' ' 62' ' ' ILE . 91.7 m-70 -154.94 69.46 0.73 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 74.129999999999995 109.222 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.0 p -63.58 -27.2 69.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.31 -0.869 . . . . 73.239999999999995 110.085 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.6 t -79.5 48.95 0.95 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.058 -1.026 . . . . 71.439999999999998 109.856 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.8 tt -146.68 156.59 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.084 -1.01 . . . . 71.329999999999998 109.456 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.9 t -92.81 154.15 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.171 -0.956 . . . . 73.019999999999996 109.51 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.518 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 21.3 t -135.96 125.99 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.299 -0.876 . . . . 54.210000000000001 110.074 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.413 ' C ' ' CD1' ' A' ' 72' ' ' LEU . 1.3 tm? -118.62 101.67 8.3 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.423 -0.955 . . . . 74.209999999999994 108.423 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -95.5 138.94 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.933 -1.104 . . . . 74.409999999999997 109.57 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.1 m -122.86 161.31 24.32 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.677 -0.86 . . . . 72.310000000000002 108.677 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 77' ' ' ASN . 3.0 p -172.2 121.43 0.45 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.999 -1.063 . . . . 64.540000000000006 109.971 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 50.8 p30 -64.31 63.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.701 -0.624 . . . . 74.129999999999995 109.931 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 75' ' ' SER . 2.9 p30 -177.14 53.65 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.201 -0.937 . . . . 73.340000000000003 109.669 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 77' ' ' ASN . 6.9 Cg_endo -48.84 84.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.365 2.043 . . . . 71.319999999999993 111.729 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.48 ' N ' ' O ' ' A' ' 77' ' ' ASN . 2.9 t -114.48 151.64 32.94 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.041 -0.725 . . . . 62.530000000000001 109.041 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -28.4 67.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 74.140000000000001 109.231 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -63.89 -41.09 97.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.279 -0.888 . . . . 71.420000000000002 109.829 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -76.91 -26.28 53.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.085 -1.009 . . . . 73.430000000000007 109.342 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -67.89 -46.47 71.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 74.219999999999999 109.683 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.4 m -68.89 -41.19 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.098 -1.002 . . . . 74.150000000000006 109.566 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -72.14 -31.59 66.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -0.935 . . . . 72.540000000000006 109.637 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.76 -39.49 91.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 64.219999999999999 110.114 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -77.39 -36.08 53.78 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.049 -1.032 . . . . 74.340000000000003 108.769 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -68.33 -38.56 81.64 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.383 -0.823 . . . . 74.420000000000002 109.305 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -64.39 -44.86 89.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 74.519999999999996 109.319 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.09 -15.86 1.02 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.036 -1.226 . . . . 74.209999999999994 110.036 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -51.68 132.85 31.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.047 -1.267 . . . . 64.099999999999994 109.393 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.518 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 71.0 m-20 -80.83 -33.28 34.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 73.420000000000002 109.409 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.507 ' CG ' HH21 ' A' ' 108' ' ' ARG . 65.3 m-20 -152.45 129.53 11.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.258 -0.901 . . . . 75.040000000000006 109.249 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.459 ' OH ' ' OG ' ' A' ' 75' ' ' SER . 3.8 t80 -104.5 116.42 32.07 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.875 -0.787 . . . . 71.329999999999998 108.875 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 23.8 mm -106.53 149.92 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-O 122.194 0.997 . . . . 74.510000000000005 111.319 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.79 117.65 11.65 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.842 -1.54 . . . . 64.319999999999993 106.842 177.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.665 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -43.59 -54.0 11.08 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.173 -0.954 . . . . 74.510000000000005 111.778 -178.283 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.2 Cg_endo -41.8 -11.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.237 0 CA-C-N 119.851 0.983 . . . . 73.109999999999999 112.565 -176.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.665 ' N ' ' O ' ' A' ' 97' ' ' LYS . 61.2 m-85 57.69 116.07 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.817 -0.552 . . . . 72.540000000000006 109.701 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -56.47 -38.11 71.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.849 -1.157 . . . . 74.540000000000006 108.776 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.78 ' O ' ' N ' ' A' ' 103' ' ' LYS . 9.9 t -173.56 40.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.251 -0.906 . . . . 74.140000000000001 110.688 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.5 mt 48.09 -69.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 CA-C-N 118.68 0.673 . . . . 75.430000000000007 110.505 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.78 ' N ' ' O ' ' A' ' 101' ' ' SER . 41.4 tptt -52.07 -31.22 29.34 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.181 -1.044 . . . . 74.140000000000001 108.181 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.66 -56.04 21.43 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.622 -0.831 . . . . 63.240000000000002 108.836 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.69 -56.18 20.04 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.65 -0.87 . . . . 73.219999999999999 108.65 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 87.4 t -48.44 -46.24 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.995 -1.065 . . . . 74.540000000000006 109.154 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.94 -35.73 62.05 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.212 -0.93 . . . . 75.5 108.553 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.53 ' NH1' ' CZ ' ' B' ' 87' ' ' PHE . 53.1 ttt85 -71.64 -29.43 64.63 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.435 -0.79 . . . . 74.409999999999997 109.681 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 87.0 mt -74.85 -32.92 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.978 -1.076 . . . . 73.239999999999995 108.498 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -74.47 -51.01 16.06 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.525 -0.734 . . . . 74.340000000000003 109.648 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.94 -43.3 69.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.901 . . . . 73.319999999999993 109.666 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 82.7 mtm180 -65.38 -39.9 92.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.193 -0.942 . . . . 74.420000000000002 109.612 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 mp -139.96 94.07 2.72 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.13 -0.982 . . . . 74.329999999999998 109.269 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.4 mtm-85 -84.68 -70.89 0.55 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.14 -0.975 . . . . 74.439999999999998 108.881 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' A' ' 116' ' ' TRP . 30.4 p90 -163.16 -33.83 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.124 -0.985 . . . . 74.430000000000007 109.511 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.54 ' N ' ' CD1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER 38.44 -94.66 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.707 -0.62 . . . . 74.439999999999998 110.355 179.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 115' ' ' PHE . . . 76.88 72.45 1.11 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.503 -1.439 . . . . 75.040000000000006 109.503 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.552 ' O ' ' OG ' ' A' ' 129' ' ' SER . 0.3 OUTLIER -147.41 172.96 13.11 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.256 -1.143 . . . . 70.109999999999999 109.688 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.539 ' HA ' ' OG ' ' A' ' 129' ' ' SER . 0.0 OUTLIER -152.25 149.86 29.16 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.552 -0.717 . . . . 65.239999999999995 109.288 -178.23 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.91 -32.73 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.177 -0.952 . . . . 74.219999999999999 110.104 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 38.4 mm -116.33 106.34 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.416 -0.802 . . . . 74.420000000000002 109.183 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -109.01 115.96 31.07 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.475 -0.766 . . . . 73.299999999999997 109.443 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.406 ' O ' ' O ' ' A' ' 126' ' ' LEU . 29.1 mm -116.17 105.29 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.567 -0.708 . . . . 75.340000000000003 109.514 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 47.21 -143.87 5.41 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.935 -1.266 . . . . 75.129999999999995 109.935 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -66.82 -21.91 66.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.359 -1.083 . . . . 74.450000000000003 108.921 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' A' ' 123' ' ' ILE . 0.2 OUTLIER -80.59 113.39 18.75 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.827 -1.175 . . . . 54.210000000000001 107.827 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.9 m -108.33 144.23 36.13 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.36 -0.838 . . . . 70.239999999999995 109.342 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 77.1 mt -132.7 128.98 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.457 -0.777 . . . . 72.430000000000007 109.704 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.552 ' OG ' ' O ' ' A' ' 118' ' ' SER . 1.8 m -117.83 94.16 45.55 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 108.551 -0.907 . . . . 71.109999999999999 108.551 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.35 -22.6 10.82 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.557 1.505 . . . . 75.140000000000001 112.277 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.883 ' OD1' ' OE2' ' A' ' 132' ' ' GLU . 11.1 t70 -59.35 -48.96 79.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.067 -1.021 . . . . 72.5 109.282 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.883 ' OE2' ' OD1' ' A' ' 131' ' ' ASP . 7.9 mm-40 -97.36 9.17 43.04 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.205 -0.934 . . . . 73.140000000000001 108.938 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 53.61 80.54 0.11 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.56 -0.712 . . . . 75.329999999999998 110.438 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 9.5 ttpt -164.37 141.42 6.53 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.81 -0.811 . . . . 71.230000000000004 108.81 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 88.9 mt -118.2 149.51 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.531 -0.73 . . . . 75.329999999999998 109.765 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 65.5 mt -131.72 117.69 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.527 -0.916 . . . . 71.109999999999999 108.527 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -109.25 124.77 51.43 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.397 -0.815 . . . . 74.140000000000001 110.401 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.1 mtpp 48.94 25.84 1.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.467 -0.77 . . . . 75.400000000000006 110.61 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 92.51 14.28 55.77 Favored Glycine 0 N--CA 1.498 2.81 0 O-C-N 121.0 -1.063 . . . . 72.239999999999995 110.999 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -105.5 124.29 49.31 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.17 -1.194 . . . . 73.120000000000005 109.267 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -82.42 122.19 27.69 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.195 -0.941 . . . . 72.319999999999993 110.852 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.08 138.0 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.055 -1.091 . . . . 62.340000000000003 108.055 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -82.18 167.14 19.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.323 -0.86 . . . . 61.229999999999997 109.627 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 1.099 ' C ' ' HD2' ' A' ' 149' ' ' PHE . 6.0 m -129.6 128.15 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.797 -0.816 . . . . 74.439999999999998 108.797 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 1.481 ' HA ' ' CE2' ' A' ' 149' ' ' PHE . 32.7 pttt -175.52 -24.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.412 -0.805 . . . . 75.420000000000002 109.698 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 1.108 ' O ' ' CD1' ' A' ' 149' ' ' PHE . . . -64.97 -172.42 3.25 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.561 -1.416 . . . . 73.340000000000003 109.561 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.593 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 6.3 ttmt -70.27 -39.4 10.11 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.365 -1.08 . . . . 72.219999999999999 110.634 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 60.6 Cg_endo -84.94 15.46 2.21 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.126 1.884 . . . . 75.450000000000003 112.757 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 1.481 ' CE2' ' HA ' ' A' ' 145' ' ' LYS . 0.1 OUTLIER -97.31 -50.36 4.58 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.073 -1.017 . . . . 65.239999999999995 109.609 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 1.442 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 97.2 mt-10 -55.35 -44.0 75.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.418 -0.801 . . . . 72.519999999999996 109.596 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 13.1 p -63.77 -38.2 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 74.209999999999994 109.378 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -42.82 91.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.387 -0.821 . . . . 73.310000000000002 109.016 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.4 m -72.13 -28.84 63.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 74.310000000000002 109.44 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -63.08 -55.11 28.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.405 -0.81 . . . . 75.450000000000003 110.073 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 159' ' ' ARG . 3.6 pp -67.49 -26.76 66.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.04 -1.037 . . . . 75.340000000000003 109.083 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.02 -52.21 63.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.108 -0.995 . . . . 62.140000000000001 108.904 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -66.8 -52.6 42.06 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.282 -0.886 . . . . 72.219999999999999 109.145 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -88.5 37.62 0.83 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.549 -0.719 . . . . 74.120000000000005 109.544 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' ' 155' ' ' LEU . 55.4 ttt-85 -65.46 -17.85 64.86 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.118 -0.989 . . . . 74.340000000000003 109.783 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.9 72.8 1.31 Allowed 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.517 -0.92 . . . . 75.450000000000003 108.517 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -170.57 159.18 6.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.875 . . . . 73.409999999999997 109.539 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.4 mt -81.51 136.69 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.29 -0.881 . . . . 74.409999999999997 109.002 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 14.2 t -131.48 135.73 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.341 -0.849 . . . . 72.530000000000001 109.793 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.7 p -97.59 159.36 14.97 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.4 -0.812 . . . . 74.120000000000005 109.122 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -57.9 -36.08 71.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 70.430000000000007 109.899 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -64.16 -42.23 96.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.166 -0.959 . . . . 74.319999999999993 110.075 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -53.4 -49.94 66.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.086 -1.009 . . . . 74.519999999999996 109.415 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 34.5 mt -61.9 -39.76 93.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.174 -0.954 . . . . 74.409999999999997 109.398 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 173' ' ' TRP . 5.3 tt -55.5 -59.21 5.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.866 . . . . 75.140000000000001 109.763 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.88 -39.66 93.89 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.423 -0.798 . . . . 65.030000000000001 111.203 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -53.0 -55.39 23.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.929 -1.107 . . . . 70.209999999999994 111.08 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.525 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 1.9 mp -94.26 -59.69 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 120.83 -1.169 . . . . 75.319999999999993 110.237 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.458 ' O ' ' O ' ' A' ' 169' ' ' LEU . 24.3 m-90 -81.33 119.7 24.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 73.140000000000001 109.864 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.412 ' H ' ' HD2' ' A' ' 176' ' ' PRO . 74.8 tt0 -143.66 -51.69 0.33 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.97 -1.081 . . . . 73.239999999999995 110.122 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.625 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 27.6 mt-10 -86.58 -33.62 0.45 Allowed Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 120.99 -1.069 . . . . 63.329999999999998 111.654 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 58.3 Cg_exo -52.73 -48.9 19.57 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 121.97 1.78 . . . . 72.510000000000005 112.408 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 46.0 -157.45 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.263 -0.898 . . . . 75.340000000000003 109.572 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 59.7 mtt 54.71 27.44 8.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.223 -0.923 . . . . 74.510000000000005 109.666 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 9.5 m -134.25 144.38 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.493 -0.755 . . . . 65.219999999999999 109.22 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.86 152.6 96.23 Favored Pre-proline 0 N--CA 1.487 1.407 0 O-C-N 121.05 -1.031 . . . . 73.219999999999999 108.321 179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.6 -24.67 11.69 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.348 2.032 . . . . 62.43 112.251 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 35.7 p30 -81.63 5.54 17.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.887 . . . . 73.129999999999995 110.326 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 26.4 m -67.68 -16.1 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.854 -1.153 . . . . 74.019999999999996 109.518 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.402 HG21 HD13 ' A' ' 184' ' ' ILE . 32.2 mm -59.82 -30.1 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.925 . . . . 72.329999999999998 109.369 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -58.14 -35.65 71.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.236 -0.915 . . . . 74.400000000000006 109.794 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 50.4 t -82.99 -45.45 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 74.319999999999993 109.084 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -60.71 -36.35 78.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 73.230000000000004 110.255 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.415 ' CG2' ' N ' ' A' ' 189' ' ' ASN . 9.4 tp -76.33 -42.98 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.781 -1.199 . . . . 74.310000000000002 109.102 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.415 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 69.4 m-20 -59.87 -33.89 72.41 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.198 -0.939 . . . . 73.439999999999998 109.082 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -79.68 -48.67 13.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.192 -0.942 . . . . 71.420000000000002 109.968 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 64.4 mt -55.96 -41.98 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.095 -1.003 . . . . 72.439999999999998 109.29 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -63.87 -49.64 71.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.121 -0.987 . . . . 64.219999999999999 109.269 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -62.0 -31.47 71.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 74.319999999999993 108.984 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.418 ' CB ' ' NZ ' ' A' ' 194' ' ' LYS . 7.5 mtpm? -84.79 -8.54 58.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.47 -0.769 . . . . 75.310000000000002 109.735 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 16.2 ttt -102.48 -39.56 7.07 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.45 -0.781 . . . . 74.019999999999996 110.421 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -75.02 -15.37 60.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.025 -1.047 . . . . 74.019999999999996 110.724 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.445 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 8.7 mmtm -80.58 -65.29 0.27 Allowed Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.902 -1.124 . . . . 75.430000000000007 109.964 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 24.7 Cg_endo -60.0 -49.6 9.37 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.345 2.03 . . . . 72.319999999999993 112.849 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.4 mp -66.2 -100.19 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.856 -1.152 . . . . 74.540000000000006 109.239 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 156.07 -39.31 0.59 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.132 -1.587 . . . . 61.509999999999998 109.132 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 20.5 mm -104.14 127.09 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.571 -0.958 . . . . 74.25 109.12 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 11.9 p -83.6 133.07 34.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.107 -0.995 . . . . 72.0 108.682 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.03 12.91 11.24 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.447 -0.783 . . . . 74.439999999999998 109.515 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.9 148.31 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.425 -0.797 . . . . 71.129999999999995 109.532 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -124.82 115.58 20.91 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.651 -0.655 . . . . 73.510000000000005 109.329 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.37 114.01 22.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.274 -0.891 . . . . 73.519999999999996 109.011 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 13.8 t -120.73 146.31 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.546 -0.721 . . . . 72.150000000000006 109.668 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -69.89 -36.44 75.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.372 -0.83 . . . . 72.400000000000006 109.547 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -73.28 160.18 32.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 73.310000000000002 109.736 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.509 ' N ' ' NE ' ' A' ' 210' ' ' ARG . 0.0 OUTLIER 47.86 -102.25 0.08 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.156 -0.965 . . . . 71.540000000000006 109.002 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -158.98 -114.22 0.38 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.08 -1.608 . . . . 74.450000000000003 109.08 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -108.79 133.74 52.43 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.513 -0.992 . . . . 75.540000000000006 108.929 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -112.04 128.45 56.19 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.342 -0.849 . . . . 75.310000000000002 110.585 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -98.27 128.53 44.76 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.627 -0.879 . . . . 75.409999999999997 108.627 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 8.9 t -149.98 168.96 22.32 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.03 -1.044 . . . . 74.140000000000001 110.453 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -60.95 131.46 91.74 Favored Pre-proline 0 N--CA 1.49 1.556 0 N-CA-C 109.361 -0.607 . . . . 75.319999999999993 109.361 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -36.83 143.09 0.13 Allowed 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.291 1.994 . . . . 73.109999999999999 112.744 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 72.9 tttt -92.8 -32.36 0.32 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.439 -0.788 . . . . 75.25 111.697 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 93.0 Cg_endo -86.15 31.49 0.47 Allowed 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 121.944 1.763 . . . . 75.099999999999994 112.049 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -95.25 170.28 9.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.401 -0.812 . . . . 71.140000000000001 109.128 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 6.1 t 61.07 158.51 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.354 -0.841 . . . . 71.129999999999995 109.456 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -90.7 138.63 31.42 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.073 -1.017 . . . . 75.349999999999994 109.538 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 117.983 -1.008 . . . . 73.409999999999997 109.399 179.988 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.591 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.458 -0.571 . . . . 75.239999999999995 109.458 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.433 ' O ' ' OD1' ' B' ' 46' ' ' ASP . 88.2 mtt180 -139.28 153.43 47.78 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.261 -0.9 . . . . 73.519999999999996 109.552 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 94.2 t -111.16 135.04 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.665 -0.647 . . . . 72.239999999999995 109.297 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 3.6 tp -106.84 118.28 36.26 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.526 -0.734 . . . . 73.340000000000003 109.707 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 16.9 mt -114.58 98.32 6.81 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.83 -0.804 . . . . 74.349999999999994 108.83 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 87.1 mt -84.79 96.98 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.743 -1.223 . . . . 63.439999999999998 108.772 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.435 ' OE2' ' OG ' ' B' ' 51' ' ' SER . 8.6 tp10 -141.91 127.86 19.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.353 -0.842 . . . . 74.519999999999996 109.46 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -66.74 -32.92 74.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 74.129999999999995 109.148 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -78.24 107.41 10.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.34 -0.85 . . . . 74.230000000000004 109.431 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 85.6 p -67.94 -23.77 65.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -0.879 . . . . 65.540000000000006 109.655 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.79 -49.77 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.148 -0.97 . . . . 75.549999999999997 109.687 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 80.7 mt -65.93 -37.44 86.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.157 -0.964 . . . . 70.140000000000001 109.572 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.74 -27.94 69.97 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.627 -1.789 . . . . 75.400000000000006 108.627 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.07 -53.44 36.92 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.581 -1.408 . . . . 65.439999999999998 109.581 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -58.54 -45.48 88.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.276 -1.132 . . . . 72.200000000000003 109.819 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 36.1 mm -65.63 -41.53 90.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.845 -1.159 . . . . 75.150000000000006 108.925 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -59.84 -44.5 94.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 73.010000000000005 109.513 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . 0.452 ' CD ' ' N ' ' B' ' 18' ' ' LYS . 1.1 mptm? -86.59 1.1 52.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.092 -1.005 . . . . 74.299999999999997 108.768 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.51 -59.39 1.83 Allowed Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.481 -1.448 . . . . 70.540000000000006 109.481 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -67.87 -22.69 65.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -1.141 . . . . 75.430000000000007 109.522 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -54.14 -34.31 60.04 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.139 -0.976 . . . . 73.200000000000003 109.238 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 56.1 t -57.48 -47.63 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.344 -0.847 . . . . 74.230000000000004 109.013 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -60.49 -53.97 51.12 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.428 -0.795 . . . . 73.519999999999996 109.005 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 136.7 38.87 0.15 Allowed Glycine 0 N--CA 1.5 2.931 0 N-CA-C 110.298 -1.121 . . . . 53.43 110.298 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -120.38 160.46 23.03 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.375 -1.073 . . . . 71.120000000000005 109.505 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.4 mmt -105.27 140.26 38.68 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.807 -0.812 . . . . 75.239999999999995 108.807 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . 0.431 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -135.23 159.26 42.12 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.429 -0.795 . . . . 73.25 109.818 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 89.2 m-20 -138.68 159.48 42.01 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.702 -0.851 . . . . 72.310000000000002 108.702 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 p -122.63 139.12 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.381 -0.825 . . . . 72.140000000000001 109.861 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 10.9 p -134.78 169.08 17.89 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.985 -0.746 . . . . 74.530000000000001 108.985 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -90.62 -107.57 0.09 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.165 -0.959 . . . . 71.019999999999996 109.787 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 82.3 p -79.09 168.61 19.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 71.400000000000006 109.993 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 50.5 mt -50.79 -31.3 16.52 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.6 -0.687 . . . . 71.239999999999995 109.843 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -51.62 -52.19 49.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.101 -0.999 . . . . 74.319999999999993 109.717 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.73 -40.89 96.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.17 -0.956 . . . . 73.030000000000001 109.354 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.24 -43.03 81.6 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.442 -1.463 . . . . 60.43 109.442 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -66.18 -38.69 88.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.321 -1.106 . . . . 74.430000000000007 109.549 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -75.13 -39.43 60.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 74.420000000000002 109.802 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 23.3 tp -72.88 -45.95 55.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.905 . . . . 75.409999999999997 110.112 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.4 ppp? -64.79 -27.06 68.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.004 -1.06 . . . . 61.439999999999998 109.84 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -58.49 -45.44 88.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.145 -0.972 . . . . 74.319999999999993 109.844 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 pt -88.93 -42.06 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.175 -0.953 . . . . 71.230000000000004 109.747 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' B' ' 40' ' ' MET . 10.7 mpt_? -96.73 144.04 27.1 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.077 -1.015 . . . . 73.409999999999997 108.983 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -103.77 150.81 23.74 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.382 -0.824 . . . . 63.539999999999999 109.248 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -137.78 139.67 40.17 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.329 -0.857 . . . . 73.109999999999999 109.321 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' B' ' 2' ' ' ARG . 7.9 p-10 -79.85 -36.86 36.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 62.219999999999999 109.253 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.05 116.39 31.86 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.93 -0.767 . . . . 73.120000000000005 108.93 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 46.4 t -100.31 98.44 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.233 -1.025 . . . . 74.109999999999999 108.233 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 20.6 ttt -112.89 133.38 54.9 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.569 -0.707 . . . . 73.439999999999998 110.051 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.46 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.7 OUTLIER -145.95 134.18 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.595 -0.69 . . . . 73.400000000000006 109.351 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' SER . . . . . 0.435 ' OG ' ' OE2' ' B' ' 7' ' ' GLU . 9.1 p -98.19 9.94 41.75 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.415 -0.803 . . . . 73.209999999999994 109.47 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.46 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 44.9 m-20 -76.06 138.86 41.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.203 -0.935 . . . . 70.409999999999997 109.539 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.465 ' C ' ' H ' ' B' ' 55' ' ' ALA . 60.2 mttm -73.62 -40.12 64.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 73.129999999999995 110.15 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -72.92 12.25 0.55 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.115 -0.99 . . . . 75.209999999999994 109.717 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.465 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -68.92 -21.54 64.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.903 . . . . 55.329999999999998 110.153 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' B' ' 55' ' ' ALA . 11.4 mt -41.7 -49.39 4.26 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.488 -0.757 . . . . 72.420000000000002 110.312 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' SER . . . . . 0.422 ' O ' ' OG ' ' B' ' 60' ' ' SER . 86.1 p -69.56 -34.68 74.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.986 -1.071 . . . . 73.040000000000006 109.098 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -66.67 -61.76 1.8 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.377 -0.827 . . . . 72.329999999999998 109.828 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 33.8 m -49.42 -35.31 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.611 -1.306 . . . . 74.540000000000006 109.716 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' B' ' 57' ' ' SER . 22.9 p -57.55 -53.69 55.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.188 -0.945 . . . . 71.239999999999995 109.714 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -66.91 -29.1 68.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.055 -1.028 . . . . 74.310000000000002 110.108 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 35.2 mm -66.06 -36.26 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.766 -1.208 . . . . 75.420000000000002 109.876 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.483 ' NZ ' ' CG2' ' B' ' 71' ' ' VAL . 29.1 mmtm -71.41 -49.4 42.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.038 -1.039 . . . . 73.319999999999993 110.278 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' B' ' 65' ' ' LYS . 13.8 pt-20 -68.85 -41.08 78.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.949 -1.094 . . . . 73.310000000000002 110.133 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.512 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 92.7 mttt -74.83 -23.52 58.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 72.439999999999998 109.825 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.512 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 92.9 m-70 -156.69 63.96 0.53 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.145 -0.972 . . . . 65.209999999999994 109.67 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.452 ' N ' ' O ' ' B' ' 63' ' ' LYS . 23.7 t -57.14 -30.01 64.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -0.88 . . . . 73.099999999999994 109.581 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 39.8 m -61.56 -27.31 68.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -0.917 . . . . 71.530000000000001 109.998 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 73.7 mt -78.64 155.77 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.142 -0.973 . . . . 74.400000000000006 109.778 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 84.7 t -95.74 152.69 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.489 -0.757 . . . . 75.120000000000005 109.137 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.483 ' CG2' ' NZ ' ' B' ' 63' ' ' LYS . 39.5 t -133.04 127.9 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.336 -0.852 . . . . 73.200000000000003 109.81 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 8.0 tt -120.41 99.48 6.59 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.716 -0.846 . . . . 73.340000000000003 108.716 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.44 135.66 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 73.5 108.876 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.24 173.75 6.18 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.315 -0.866 . . . . 71.319999999999993 108.877 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 18.7 t -165.93 119.76 1.16 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.966 -1.084 . . . . 74.530000000000001 110.236 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -67.54 -15.84 63.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.381 -0.824 . . . . 64.5 109.284 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -116.91 69.08 4.6 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.674 -0.641 . . . . 74.25 109.293 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -62.73 78.06 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.91 1.74 . . . . 74.430000000000007 111.632 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.433 ' HG1' ' N ' ' B' ' 80' ' ' SER . 15.1 t -101.14 173.16 6.59 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.69 -0.856 . . . . 73.120000000000005 108.69 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' SER . . . . . 0.433 ' N ' ' HG1' ' B' ' 79' ' ' THR . 1.4 p -77.01 -26.25 53.6 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.164 -0.96 . . . . 75.409999999999997 110.489 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . 0.469 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 49.6 mp0 -66.86 -39.96 87.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.937 -1.102 . . . . 72.239999999999995 109.694 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -78.01 -33.82 51.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.194 -0.941 . . . . 73.219999999999999 109.686 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -62.55 -52.91 61.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -0.964 . . . . 74.299999999999997 109.718 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 26.4 m -63.72 -40.82 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.161 -0.962 . . . . 73.310000000000002 109.412 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' HIS . . . . . 0.469 ' ND1' ' O ' ' B' ' 81' ' ' GLU . 19.8 m80 -67.31 -31.27 71.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.905 . . . . 73.239999999999995 109.514 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.29 -41.7 93.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.922 . . . . 55.329999999999998 109.782 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' PHE . . . . . 0.53 ' CZ ' ' NH1' ' A' ' 108' ' ' ARG . 70.3 m-85 -80.29 -24.91 39.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.095 -1.003 . . . . 74.450000000000003 109.041 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -76.37 -51.92 10.93 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.386 -0.822 . . . . 64.040000000000006 109.437 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . 0.489 ' CG ' ' N ' ' B' ' 90' ' ' GLY . 11.5 pt20 -60.81 -47.19 87.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.515 -0.741 . . . . 75.129999999999995 109.774 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . 0.489 ' N ' ' CG ' ' B' ' 89' ' ' GLN . . . 140.15 71.55 0.04 OUTLIER Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.963 -1.255 . . . . 75.420000000000002 109.963 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.86 135.44 53.74 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.403 -1.057 . . . . 73.420000000000002 108.715 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . 0.522 ' OD1' ' NH1' ' B' ' 112' ' ' ARG . 24.6 t0 -85.0 -23.78 28.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.061 -1.024 . . . . 73.319999999999993 109.647 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . 0.524 ' OD2' ' NH1' ' B' ' 112' ' ' ARG . 57.3 m-20 -152.38 156.43 39.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.184 -0.948 . . . . 73.040000000000006 109.63 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -137.9 99.83 4.01 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.463 -0.94 . . . . 74.310000000000002 108.463 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 22.7 mm -106.98 147.3 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 O-C-N 120.989 -1.07 . . . . 75.340000000000003 110.833 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.76 125.74 26.81 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.915 -1.143 . . . . 70.099999999999994 107.915 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.677 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -45.94 -54.03 18.6 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.063 -1.023 . . . . 65.430000000000007 111.486 -178.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 3.3 Cg_endo -41.82 -10.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 120.796 0.997 . . . . 63.520000000000003 112.743 -176.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . 0.677 ' N ' ' O ' ' B' ' 97' ' ' LYS . 61.0 m-85 59.41 96.71 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.728 -0.608 . . . . 75.129999999999995 110.04 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -53.41 -39.37 64.28 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.101 -1.074 . . . . 74.230000000000004 108.101 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 9.1 t -174.27 128.62 0.36 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.886 -0.783 . . . . 64.510000000000005 108.886 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 59.0 mt -52.64 -36.14 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.035 -1.04 . . . . 74.439999999999998 108.868 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -61.87 -36.87 82.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.293 -0.88 . . . . 72.299999999999997 108.948 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.74 -53.64 14.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 74.310000000000002 109.347 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 25.0 tp -58.04 -49.75 75.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.926 . . . . 73.540000000000006 108.962 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 69.7 t -66.1 -39.88 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.063 -1.023 . . . . 72.030000000000001 109.853 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.78 -39.12 73.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.16 -0.962 . . . . 64.219999999999999 109.558 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -77.44 -25.04 50.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.875 . . . . 75.310000000000002 109.994 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . 0.409 HD11 HG21 ' B' ' 109' ' ' ILE . 90.4 mt -80.82 -43.37 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.039 -1.038 . . . . 55.439999999999998 109.445 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -68.15 -38.92 82.66 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.18 -0.95 . . . . 65.310000000000002 109.851 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.69 -49.18 66.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 74.519999999999996 109.838 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . 0.524 ' NH1' ' OD2' ' B' ' 93' ' ' ASP . 38.5 ttm180 -65.6 -43.87 88.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.932 . . . . 72.040000000000006 109.976 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.452 ' O ' ' CD1' ' B' ' 116' ' ' TRP . 4.3 tt -64.95 -55.45 19.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.154 -0.966 . . . . 75.349999999999994 109.335 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -50.7 -30.5 13.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.969 . . . . 75.5 109.674 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -84.64 4.48 32.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.202 -0.936 . . . . 73.040000000000006 109.807 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' TRP . . . . . 0.524 ' CD1' ' N ' ' B' ' 117' ' ' GLY . 0.3 OUTLIER -67.84 -19.85 65.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.009 -1.057 . . . . 74.450000000000003 109.662 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . 0.524 ' N ' ' CD1' ' B' ' 116' ' ' TRP . . . -67.73 113.13 5.24 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.702 -1.359 . . . . 64.209999999999994 109.702 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 53.1 p -153.46 164.52 38.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.279 -1.13 . . . . 71.400000000000006 109.687 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -158.23 166.17 33.05 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.876 -0.73 . . . . 74.209999999999994 109.043 -178.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -145.59 -43.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.291 -0.881 . . . . 75.019999999999996 109.31 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 28.5 mm -107.83 127.48 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.449 -0.782 . . . . 74.239999999999995 109.118 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -120.47 118.31 29.95 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.538 -0.726 . . . . 73.329999999999998 109.239 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 62.2 mt -123.48 108.42 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.938 -0.764 . . . . 74.219999999999999 108.938 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.74 -133.82 11.49 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.745 -1.342 . . . . 72.409999999999997 109.745 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -83.6 -2.25 55.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.222 -1.163 . . . . 75.120000000000005 109.399 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.18 146.04 24.16 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.473 -0.936 . . . . 75.420000000000002 108.473 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 89.3 m -130.08 134.71 47.56 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.576 -0.703 . . . . 74.219999999999999 109.212 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 21.5 mt -136.59 143.53 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.442 -0.786 . . . . 60.329999999999998 109.381 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 14.6 m -137.86 122.8 12.28 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.494 -0.754 . . . . 72.310000000000002 108.977 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -80.99 -39.95 0.19 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.994 1.796 . . . . 75.129999999999995 112.238 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -50.52 -51.31 48.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.145 -0.972 . . . . 75.230000000000004 109.428 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -86.07 -7.71 58.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.231 -0.918 . . . . 75.120000000000005 109.099 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 54.19 68.66 0.82 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.868 . . . . 75.129999999999995 109.35 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -148.6 143.38 26.53 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.228 -0.92 . . . . 75.109999999999999 109.734 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 18.1 tt -118.38 137.03 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.538 -0.726 . . . . 70.319999999999993 109.359 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 58.5 mt -126.19 123.86 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.504 -0.747 . . . . 74.120000000000005 109.144 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -140.52 144.12 35.8 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.303 -0.873 . . . . 74.230000000000004 110.113 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 31.3 mmtm 53.75 31.18 12.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.384 -0.823 . . . . 74.219999999999999 110.214 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 74.99 -6.4 27.41 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.983 -1.247 . . . . 74.319999999999993 109.983 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 12.2 mpt_? -87.96 129.43 35.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.129 -1.218 . . . . 75.340000000000003 108.838 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -98.82 130.58 45.25 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.351 -0.843 . . . . 71.230000000000004 109.675 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 66.8 t -137.12 132.12 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.444 -0.785 . . . . 70.430000000000007 109.244 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -83.15 134.92 34.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.898 . . . . 72.430000000000007 109.1 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.77 136.1 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.452 -0.78 . . . . 72.129999999999995 109.366 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.21 21.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 74.5 109.555 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.54 174.72 40.03 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.867 -1.293 . . . . 42.229999999999997 109.867 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -65.06 -61.67 5.87 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.447 -1.031 . . . . 73.299999999999997 110.096 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -54.2 -25.78 39.55 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.951 1.767 . . . . 71.329999999999998 111.87 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -87.59 -15.45 37.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.237 -0.914 . . . . 74.230000000000004 109.502 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -61.77 -45.34 94.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.162 -0.961 . . . . 72.340000000000003 109.471 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 8.8 p -56.99 -34.06 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.112 -0.992 . . . . 73.349999999999994 108.89 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.04 -49.71 76.27 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.535 -0.913 . . . . 74.430000000000007 108.535 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 16.3 m -70.57 -29.83 66.37 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.304 -0.873 . . . . 75.209999999999994 108.963 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -55.52 -59.89 4.2 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.193 -0.942 . . . . 73.040000000000006 109.987 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.79 -25.51 65.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.943 -1.098 . . . . 73.430000000000007 109.67 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.08 -43.88 74.31 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.048 -1.032 . . . . 75.319999999999993 109.931 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -83.22 -45.62 13.66 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.828 -1.17 . . . . 73.319999999999993 110.891 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . 0.482 ' O ' ' O ' ' B' ' 159' ' ' ARG . 51.3 m80 -50.52 -83.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.619 -1.301 . . . . 74.140000000000001 108.615 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' B' ' 158' ' ' HIS . 11.5 mmm180 56.26 153.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.596 -0.69 . . . . 73.420000000000002 110.509 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' B' ' 214' ' ' PHE . 20.4 t70 42.02 51.25 4.32 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.256 -0.903 . . . . 72.099999999999994 110.104 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -156.27 145.37 20.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.062 -1.024 . . . . 73.239999999999995 110.087 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 87.6 mt -89.19 125.66 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.747 -0.834 . . . . 72.310000000000002 108.747 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 14.7 p -135.84 136.65 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.323 -0.861 . . . . 75.030000000000001 109.248 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 11.7 t -81.54 166.45 20.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.318 -0.864 . . . . 74.219999999999999 110.524 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 18.4 mtpp -67.12 -46.1 75.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.623 -0.673 . . . . 72.420000000000002 109.896 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -58.59 -36.19 73.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.87 . . . . 63.450000000000003 110.28 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -55.14 -45.1 75.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.061 -1.024 . . . . 72.400000000000006 109.657 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 31.6 mt -66.28 -38.7 88.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.053 -1.03 . . . . 72.319999999999993 109.36 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.448 ' C ' ' CD1' ' B' ' 169' ' ' LEU . 3.1 tm? -55.35 -54.78 39.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.829 . . . . 73.340000000000003 108.996 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -68.94 -16.56 63.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 73.099999999999994 109.85 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.17 -57.87 3.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -0.937 . . . . 62.130000000000003 110.707 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.524 ' N ' ' CD1' ' B' ' 172' ' ' ILE . 1.7 mp -79.85 -44.78 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.989 -1.069 . . . . 74.439999999999998 109.239 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 19.7 m-90 -94.39 56.68 2.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.314 -0.866 . . . . 72.230000000000004 109.519 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' B' ' 175' ' ' GLU . 69.2 tt0 -65.34 -6.69 10.65 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.263 -0.898 . . . . 75.030000000000001 109.005 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' B' ' 177' ' ' GLU . 2.5 mt-10 -48.9 173.98 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.377 -0.971 . . . . 73.040000000000006 108.377 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -58.26 40.7 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.298 1.999 . . . . 74.129999999999995 112.714 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' B' ' 175' ' ' GLU . 75.1 mm-40 50.2 -131.0 2.0 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.264 -0.898 . . . . 72.439999999999998 109.747 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 83.7 mmm 49.92 15.33 0.17 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.198 -0.939 . . . . 72.109999999999999 109.422 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 179' ' ' VAL . . . . . 0.435 ' N ' ' C ' ' B' ' 177' ' ' GLU . 2.9 m -82.36 -111.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 75.310000000000002 109.344 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 73.7 p -134.9 78.71 53.67 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.406 -0.809 . . . . 62.149999999999999 109.282 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.02 38.8 0.75 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.246 1.964 . . . . 74.340000000000003 111.735 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -148.59 -14.68 0.33 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.489 -0.757 . . . . 72.310000000000002 109.095 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.78 7.98 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.285 -0.884 . . . . 65.420000000000002 109.287 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 15.7 mm -55.75 -42.67 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.903 . . . . 75.030000000000001 109.475 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -53.84 -26.53 24.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 73.519999999999996 109.413 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 60.5 t -78.85 -54.68 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.053 -1.03 . . . . 74.349999999999994 109.149 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -51.89 -48.11 64.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 61.119999999999997 110.071 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 188' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' B' ' 189' ' ' ASN . 0.2 OUTLIER -61.82 -43.12 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.913 -1.117 . . . . 72.430000000000007 109.025 -179.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 189' ' ' ASN . . . . . 0.434 ' O ' ' OE1' ' B' ' 193' ' ' GLN . 41.4 t30 -61.48 -41.64 97.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.972 -1.08 . . . . 75.420000000000002 109.255 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -68.0 -42.52 80.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.947 . . . . 74.140000000000001 110.023 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 81.3 mt -59.85 -39.71 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.084 -1.01 . . . . 74.030000000000001 109.743 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -64.59 -40.45 95.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.116 -0.99 . . . . 72.329999999999998 109.781 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 193' ' ' GLN . . . . . 0.617 ' NE2' ' N ' ' B' ' 193' ' ' GLN . 0.2 OUTLIER -75.12 -37.83 61.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 73.099999999999994 110.376 -179.311 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' B' ' 198' ' ' PRO . 0.0 OUTLIER -73.6 -16.87 61.23 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.75 -1.219 . . . . 74.430000000000007 109.916 -179.293 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 21.9 ttp -94.52 -24.14 17.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.156 -0.965 . . . . 74.329999999999998 110.196 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 196' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' B' ' 193' ' ' GLN . 41.3 p30 -96.0 -3.76 44.41 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.987 -1.07 . . . . 71.209999999999994 110.532 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . 0.568 ' N ' ' CD ' ' B' ' 198' ' ' PRO . 20.6 tttm -92.01 -42.15 0.37 Allowed Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 120.862 -1.149 . . . . 75.209999999999994 110.053 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 198' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' B' ' 197' ' ' LYS . 17.7 Cg_endo -88.68 -51.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.596 2.198 . . . . 75.319999999999993 112.22 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' B' ' 199' ' ' LEU . 3.7 mm? -70.9 -40.06 72.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.948 -1.095 . . . . 72.25 109.347 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 85.35 -20.39 17.78 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.915 -1.274 . . . . 73.239999999999995 109.915 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 12.1 mt -103.75 137.83 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.335 -1.097 . . . . 54.299999999999997 109.354 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 38.6 t -95.38 137.85 33.86 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.242 -0.911 . . . . 74.310000000000002 109.393 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 21.4 p -142.33 34.11 1.49 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.34 -0.85 . . . . 74.400000000000006 109.146 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.53 133.41 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.497 -0.752 . . . . 74.099999999999994 109.615 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -113.94 132.7 55.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.666 -0.865 . . . . 75.329999999999998 108.666 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.45 140.37 29.82 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.256 -0.903 . . . . 71.400000000000006 109.896 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' B' ' 211' ' ' GLY . 19.8 t -138.51 123.43 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.492 -0.755 . . . . 63.5 109.006 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 -76.85 -43.51 35.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.186 -0.946 . . . . 74.450000000000003 109.914 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -51.7 -59.85 3.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.905 . . . . 74.140000000000001 109.876 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -94.71 -71.03 0.68 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.179 -0.951 . . . . 74.430000000000007 109.58 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' B' ' 207' ' ' VAL . . . 177.76 -93.71 0.09 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.349 -1.5 . . . . 70.109999999999999 109.349 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -135.49 141.07 45.25 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.45 -1.03 . . . . 74.209999999999994 109.518 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 65.3 ttt-85 -119.64 129.06 54.4 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.438 -0.949 . . . . 74.299999999999997 108.438 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . 0.529 ' O ' ' N ' ' B' ' 160' ' ' ASP . 29.5 m-85 -100.58 137.84 38.44 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.384 -0.822 . . . . 74.340000000000003 109.404 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . 0.539 ' HG ' ' H ' ' B' ' 216' ' ' TYR . 43.7 t -152.33 168.32 25.8 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.476 -0.765 . . . . 72.209999999999994 109.613 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . 0.539 ' H ' ' HG ' ' B' ' 215' ' ' CYS . 81.6 m-85 -75.35 150.41 84.98 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.253 -0.904 . . . . 72.310000000000002 109.374 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 217' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' B' ' 218' ' ' LYS . 97.4 Cg_endo -76.43 119.17 5.14 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.269 1.979 . . . . 71.010000000000005 112.171 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' B' ' 220' ' ' ALA . 41.0 mttp 59.17 151.21 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.462 -0.774 . . . . 74.349999999999994 109.384 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . 0.421 ' C ' ' N ' ' B' ' 221' ' ' CYS . 84.0 Cg_exo -39.19 -22.05 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.936 1.757 . . . . 71.319999999999993 112.042 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' B' ' 218' ' ' LYS . . . 48.86 17.55 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.313 -0.867 . . . . 75.450000000000003 109.587 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 221' ' ' CYS . . . . . 0.421 ' N ' ' C ' ' B' ' 219' ' ' PRO . 42.1 t -136.22 152.61 50.94 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.407 -0.808 . . . . 72.219999999999999 109.317 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -155.92 158.79 38.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.258 -0.901 . . . . 74.299999999999997 109.376 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.045 -0.979 . . . . 71.129999999999995 109.462 -179.888 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.6 ptm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.446 -0.575 . . . . 65.120000000000005 109.446 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -139.58 156.41 46.89 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.305 -0.872 . . . . 73.310000000000002 109.303 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 89.3 t -114.21 125.8 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.635 -0.665 . . . . 71.420000000000002 109.607 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.2 tp -100.03 118.74 37.05 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.832 -0.803 . . . . 65.219999999999999 108.832 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 tt -119.95 119.38 33.28 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.624 -0.672 . . . . 71.439999999999998 109.417 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.419 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 13.2 mt -106.45 116.89 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.352 -0.843 . . . . 71.150000000000006 108.792 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.462 ' OE1' ' CB ' ' A' ' 51' ' ' SER . 30.1 tp10 -151.37 127.63 10.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.149 -0.969 . . . . 75.340000000000003 109.491 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 9' ' ' ASN . 45.2 mtpt -77.82 -23.72 48.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 73.040000000000006 109.309 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.504 ' CG ' ' H ' ' A' ' 10' ' ' SER . 34.7 t-20 -59.68 -152.18 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.445 -0.785 . . . . 72.420000000000002 109.51 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.504 ' H ' ' CG ' ' A' ' 9' ' ' ASN . 47.6 m -156.08 -56.39 0.09 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 72.340000000000003 109.372 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.6 t -63.17 -45.49 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 74.420000000000002 109.493 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.512 ' CD2' ' N ' ' A' ' 12' ' ' LEU . 3.9 mm? -66.78 -36.43 82.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.259 -0.901 . . . . 72.010000000000005 109.289 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.11 -19.07 78.96 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 108.473 -1.851 . . . . 72.140000000000001 108.473 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.32 -50.77 4.94 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.922 -1.271 . . . . 72.329999999999998 109.922 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.14 -43.66 95.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.106 -1.232 . . . . 72.340000000000003 109.296 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 94.5 mt -61.63 -46.63 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.922 -1.111 . . . . 74.239999999999995 108.498 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -45.55 -52.47 10.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 71.409999999999997 109.798 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -89.48 4.41 49.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.181 -0.949 . . . . 75.540000000000006 109.596 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -85.02 -58.18 2.15 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.908 -1.277 . . . . 62.149999999999999 109.908 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.01 -19.06 60.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -1.165 . . . . 74.420000000000002 110.046 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -57.08 -38.25 73.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.974 . . . . 74.25 109.676 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.5 t -52.57 -32.02 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.215 -0.928 . . . . 72.109999999999999 109.123 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -75.2 -0.36 19.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.376 -0.827 . . . . 73.230000000000004 109.043 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.91 28.55 45.6 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.267 -1.133 . . . . 75.540000000000006 110.267 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -106.09 156.89 17.96 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.278 -1.13 . . . . 74.510000000000005 109.05 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.3 mmt -94.15 118.08 31.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.194 -0.942 . . . . 64.319999999999993 108.729 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -98.47 133.1 43.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.315 -0.866 . . . . 74.310000000000002 109.918 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -123.31 131.0 53.51 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 109.035 -0.728 . . . . 75.400000000000006 109.035 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.69 132.73 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.303 -0.999 . . . . 75.129999999999995 108.303 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 p -136.08 168.98 18.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.361 -0.837 . . . . 71.420000000000002 109.524 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.419 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 4.4 pt-20 -94.04 -103.47 0.14 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.301 -0.874 . . . . 73.109999999999999 109.836 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.5 t -78.54 166.78 22.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.256 -0.902 . . . . 74.239999999999995 110.157 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.0 mt -53.42 -33.7 54.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.621 -0.674 . . . . 71.530000000000001 109.733 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -52.51 -48.03 66.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 74.230000000000004 109.791 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -61.49 -37.61 84.28 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.141 -0.974 . . . . 71.010000000000005 109.11 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.26 -37.26 48.69 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.314 -1.515 . . . . 61.409999999999997 109.314 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -63.37 -39.03 93.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -1.126 . . . . 74.340000000000003 109.407 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -77.21 -37.99 52.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 75.329999999999998 109.513 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.3 tp -66.89 -46.21 75.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -0.867 . . . . 74.329999999999998 109.983 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.436 ' C ' ' SD ' ' A' ' 40' ' ' MET . 3.9 ppp? -70.09 -24.54 63.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.101 -1.0 . . . . 70.319999999999993 109.824 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -65.84 -40.42 91.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.048 -1.033 . . . . 71.219999999999999 109.951 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.2 pt -79.12 -34.01 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.103 -0.998 . . . . 74.409999999999997 110.074 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 40' ' ' MET . 30.3 mmt180 -130.25 147.69 52.0 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.327 -0.858 . . . . 75.409999999999997 109.356 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.593 ' N ' HD21 ' A' ' 44' ' ' ASN . 1.2 m120 -93.12 133.16 36.58 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.273 -0.892 . . . . 75.420000000000002 109.449 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -107.49 142.47 37.31 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.512 -0.743 . . . . 74.230000000000004 109.378 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -83.93 -42.15 16.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 75.319999999999993 109.236 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.404 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 0.5 OUTLIER -105.86 113.17 26.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.565 -0.71 . . . . 72.129999999999995 109.176 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.7 t -99.3 97.76 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.713 -0.847 . . . . 72.340000000000003 108.713 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.485 ' SD ' ' O ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -106.17 125.04 50.51 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.988 -0.745 . . . . 74.109999999999999 108.988 -179.678 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.01 133.2 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.664 0.745 . . . . 71.239999999999995 109.623 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.462 ' CB ' ' OE1' ' A' ' 7' ' ' GLU . 52.9 m -102.95 4.88 37.98 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.656 -0.652 . . . . 73.109999999999999 109.414 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -76.27 147.51 38.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -0.966 . . . . 63.399999999999999 109.613 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.464 ' C ' ' H ' ' A' ' 55' ' ' ALA . 25.6 pttm -81.92 -39.86 23.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.287 -0.883 . . . . 65.439999999999998 110.124 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -70.26 7.32 1.03 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.039 -1.038 . . . . 73.129999999999995 109.411 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.464 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -68.68 -21.78 64.41 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.384 -0.822 . . . . 64.140000000000001 110.433 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.427 ' O ' ' OG ' ' A' ' 60' ' ' SER . 63.2 mt -42.36 -47.73 4.95 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.196 -0.94 . . . . 74.430000000000007 110.546 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.2 m -70.96 -36.64 72.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.884 -1.135 . . . . 63.229999999999997 109.388 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -68.07 -61.06 2.03 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.594 -0.691 . . . . 74.439999999999998 110.158 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.6 m -51.61 -37.68 20.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.845 -1.159 . . . . 74.030000000000001 109.431 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 56' ' ' LEU . 61.6 m -56.3 -55.76 29.4 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.271 -0.893 . . . . 73.540000000000006 109.514 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -67.91 -26.89 66.21 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.049 -1.032 . . . . 73.340000000000003 110.24 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mm -57.36 -38.58 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.668 -1.27 . . . . 73.349999999999994 107.922 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 67' ' ' SER . 61.2 mmtt -72.76 -41.95 64.52 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.389 -0.819 . . . . 74.420000000000002 109.135 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -66.55 -51.44 56.49 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.143 -0.973 . . . . 74.549999999999997 109.229 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -69.57 -24.93 63.76 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.665 -0.647 . . . . 75.219999999999999 109.874 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -151.39 68.52 0.92 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.184 -0.947 . . . . 74.129999999999995 109.38 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 63' ' ' LYS . 96.9 p -57.93 -28.79 64.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 73.239999999999995 109.904 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 83.2 p -82.14 49.0 1.32 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.184 -0.948 . . . . 71.439999999999998 109.782 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.1 tt -142.06 155.9 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.258 -0.901 . . . . 71.329999999999998 109.571 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.8 t -95.59 149.87 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.146 -0.971 . . . . 73.019999999999996 108.773 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 t -140.17 127.33 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.163 -0.961 . . . . 54.210000000000001 109.875 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.485 ' O ' ' SD ' ' A' ' 49' ' ' MET . 2.4 tt -115.43 104.56 11.89 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.984 -0.747 . . . . 74.209999999999994 108.984 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.3 t -95.9 129.5 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.24 -0.913 . . . . 74.409999999999997 108.982 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.1 p -93.76 171.91 8.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.188 -0.945 . . . . 72.310000000000002 109.796 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.54 ' CB ' ' HH ' ' A' ' 94' ' ' TYR . 42.0 t -160.93 118.39 2.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.082 -1.011 . . . . 64.540000000000006 110.45 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -64.63 -29.01 70.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.623 -0.673 . . . . 74.129999999999995 109.72 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 79' ' ' THR . 35.5 m120 -122.07 80.55 43.27 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.528 -0.733 . . . . 73.340000000000003 109.428 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.12 87.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.323 2.016 . . . . 71.319999999999993 111.431 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.456 ' N ' ' O ' ' A' ' 77' ' ' ASN . 23.8 m -98.65 150.21 22.01 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.577 -0.702 . . . . 62.530000000000001 109.593 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.475 ' CB ' ' OG ' ' B' ' 101' ' ' SER . 0.0 OUTLIER -72.77 -41.15 65.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.35 -0.844 . . . . 74.140000000000001 109.189 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -57.57 -38.63 75.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.146 -0.971 . . . . 71.420000000000002 108.844 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -75.2 -26.02 58.68 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.352 -0.842 . . . . 73.430000000000007 109.191 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.525 ' OE1' ' CD2' ' A' ' 94' ' ' TYR . 36.7 tp10 -61.29 -57.63 11.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 74.219999999999999 109.65 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.0 m -63.82 -40.65 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 74.150000000000006 109.338 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -62.36 -34.65 77.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -0.904 . . . . 72.540000000000006 109.371 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.14 -39.81 93.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 64.219999999999999 109.969 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -78.26 -34.35 49.09 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.98 -1.075 . . . . 74.340000000000003 109.054 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -70.84 -36.84 73.08 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.299 -0.875 . . . . 74.420000000000002 109.592 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -68.39 -47.86 66.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 74.519999999999996 109.761 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.58 48.23 0.03 OUTLIER Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.949 -1.26 . . . . 74.209999999999994 109.949 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.82 133.26 54.14 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.425 -1.044 . . . . 64.099999999999994 109.382 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -84.67 -22.85 29.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.944 . . . . 73.420000000000002 109.133 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.532 ' OD2' ' NH2' ' A' ' 112' ' ' ARG . 19.6 t0 -150.61 163.3 38.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.399 -0.813 . . . . 75.040000000000006 109.325 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.54 ' HH ' ' CB ' ' A' ' 75' ' ' SER . 67.6 t80 -146.03 101.92 3.58 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.37 -0.832 . . . . 71.329999999999998 108.936 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 29.0 mm -112.19 156.04 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 O-C-N 121.29 -0.882 . . . . 74.510000000000005 110.464 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.11 146.52 54.19 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.417 -0.957 . . . . 64.319999999999993 108.417 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.676 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -68.19 -55.79 12.1 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.869 -1.144 . . . . 74.510000000000005 111.172 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 4.3 Cg_endo -41.59 -10.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 120.87 1.047 . . . . 73.109999999999999 112.967 -176.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.676 ' N ' ' O ' ' A' ' 97' ' ' LYS . 22.6 m-85 67.12 110.3 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.789 -0.57 . . . . 72.540000000000006 109.681 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -57.41 -33.78 68.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.972 -1.08 . . . . 74.540000000000006 108.185 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.775 ' O ' ' N ' ' A' ' 103' ' ' LYS . 47.5 t -175.63 24.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 74.140000000000001 110.167 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.4 mm 50.2 -67.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.791 -0.568 . . . . 75.430000000000007 110.028 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.775 ' N ' ' O ' ' A' ' 101' ' ' SER . 3.3 mptp? -54.5 -33.06 59.19 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.343 -1.354 . . . . 74.140000000000001 107.343 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.98 -41.54 74.3 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.988 -1.116 . . . . 63.240000000000002 107.988 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.9 tt -61.7 -46.49 89.44 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.974 -0.75 . . . . 73.219999999999999 108.974 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 90.4 t -62.99 -40.75 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.302 -0.873 . . . . 74.540000000000006 109.052 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.87 -39.71 62.85 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.315 -0.866 . . . . 75.5 108.859 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.52 ' HE ' ' CD ' ' B' ' 83' ' ' GLU . 50.3 mtt85 -69.0 -35.68 76.97 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.274 -0.891 . . . . 74.409999999999997 109.412 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.4 mt -69.4 -34.92 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.058 -1.026 . . . . 73.239999999999995 108.487 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -59.58 -55.57 32.84 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.751 -0.779 . . . . 74.340000000000003 109.446 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.5 -34.58 67.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 73.319999999999993 109.959 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.532 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 64.9 mtt85 -60.74 -37.69 82.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.001 -1.062 . . . . 74.420000000000002 110.022 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -155.06 68.74 0.7 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.681 -1.262 . . . . 74.329999999999998 110.373 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -53.66 89.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.102 -0.999 . . . . 74.439999999999998 108.784 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.506 ' N ' ' O ' ' A' ' 113' ' ' LEU . 69.0 m-85 52.9 89.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 74.430000000000007 109.599 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -87.0 141.96 28.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 74.439999999999998 109.304 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 163.36 98.39 0.13 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.683 -1.367 . . . . 75.040000000000006 109.683 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.477 ' O ' ' ND2' ' A' ' 119' ' ' ASN . 9.0 t -157.26 177.58 11.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -1.179 . . . . 70.109999999999999 109.666 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.477 ' ND2' ' O ' ' A' ' 118' ' ' SER . 0.4 OUTLIER -146.42 127.77 14.91 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.007 -0.677 . . . . 65.239999999999995 109.498 -177.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 86.6 t -72.87 -30.06 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.372 -0.83 . . . . 74.219999999999999 109.824 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.73 ' CG2' HH21 ' A' ' 159' ' ' ARG . 5.1 mp -118.66 131.88 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.427 -0.796 . . . . 74.420000000000002 109.913 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -142.33 107.73 5.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.426 -0.796 . . . . 73.299999999999997 108.997 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.59 HG12 ' CZ ' ' A' ' 159' ' ' ARG . 1.2 pp -130.71 142.44 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.458 -0.776 . . . . 75.340000000000003 109.027 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.72 -152.81 2.48 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.996 -1.642 . . . . 75.129999999999995 108.996 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -84.35 11.66 8.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.339 -1.094 . . . . 74.450000000000003 108.702 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.03 136.46 43.64 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.857 -0.794 . . . . 54.210000000000001 108.857 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 18.6 p -129.56 148.71 51.49 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.5 -0.75 . . . . 70.239999999999995 109.246 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.3 mt -139.04 136.06 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.393 -0.817 . . . . 72.430000000000007 110.028 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.8 m -126.11 98.76 32.45 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 108.68 -0.859 . . . . 71.109999999999999 108.68 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.46 -34.33 0.56 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.276 1.984 . . . . 75.140000000000001 112.734 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -58.09 -43.83 87.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.004 -1.06 . . . . 72.5 109.425 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -97.06 14.01 27.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.463 -0.773 . . . . 73.140000000000001 109.13 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 27.4 mp0 45.84 76.25 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.375 -0.828 . . . . 75.329999999999998 109.681 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -163.56 149.99 11.89 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.058 -1.026 . . . . 71.230000000000004 110.033 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 17.7 tt -137.68 143.96 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.318 -0.864 . . . . 75.329999999999998 109.314 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -122.46 131.78 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.477 -0.764 . . . . 71.109999999999999 109.728 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -138.58 128.75 25.63 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.348 -0.845 . . . . 74.140000000000001 108.737 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp 54.32 29.47 10.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.519 -0.738 . . . . 75.400000000000006 109.097 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 79.56 1.19 86.2 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.774 -0.931 . . . . 72.239999999999995 110.774 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.436 ' HD2' ' N ' ' A' ' 140' ' ' ARG . 9.2 mmm180 -88.79 124.15 33.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.859 -1.377 . . . . 73.120000000000005 108.909 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -88.81 136.35 33.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.286 -0.884 . . . . 72.319999999999993 109.014 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.0 t -131.84 127.8 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.371 -0.831 . . . . 62.340000000000003 109.591 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -88.27 122.7 32.1 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.69 -0.856 . . . . 61.229999999999997 108.69 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.6 m -141.88 138.57 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.03 -1.044 . . . . 74.439999999999998 109.867 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.51 39.14 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.443 -0.785 . . . . 75.420000000000002 109.191 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -107.9 -152.52 17.11 Favored Glycine 0 N--CA 1.502 3.036 0 N-CA-C 110.009 -1.236 . . . . 73.340000000000003 110.009 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.605 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 1.1 mtmp? -88.07 -37.62 0.46 Allowed Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.222 -1.164 . . . . 72.219999999999999 110.139 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 23.3 Cg_exo -63.29 -32.08 73.2 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.175 1.917 . . . . 75.450000000000003 111.418 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.507 ' CZ ' ' CG2' ' A' ' 153' ' ' THR . 43.7 t80 -86.69 -9.98 54.75 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.435 -0.791 . . . . 65.239999999999995 109.68 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.451 ' O ' ' OG1' ' A' ' 153' ' ' THR . 15.9 tt0 -66.96 -41.74 86.39 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.076 -1.015 . . . . 72.519999999999996 109.17 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.08 -35.11 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.983 -1.073 . . . . 74.209999999999994 109.223 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.488 HD13 HD22 ' A' ' 155' ' ' LEU . 15.9 tp -65.27 -33.35 75.78 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.181 -0.949 . . . . 73.310000000000002 108.967 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.507 ' CG2' ' CZ ' ' A' ' 149' ' ' PHE . 17.0 p -70.4 -32.39 70.01 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.177 -0.952 . . . . 74.310000000000002 108.437 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -64.38 -57.7 8.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.21 -0.931 . . . . 75.450000000000003 110.23 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.488 HD22 HD13 ' A' ' 152' ' ' LEU . 2.9 pp -65.38 -25.92 67.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.951 -1.093 . . . . 75.340000000000003 109.468 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.91 -51.55 69.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.008 -1.057 . . . . 62.140000000000001 108.988 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -74.17 -51.41 15.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.406 -0.809 . . . . 72.219999999999999 109.512 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.445 ' O ' ' O ' ' A' ' 159' ' ' ARG . 39.7 m80 -86.09 33.67 0.61 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.477 -0.765 . . . . 74.120000000000005 109.98 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.73 HH21 ' CG2' ' A' ' 121' ' ' ILE . 30.4 ttm-85 -46.96 -94.1 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.302 -0.874 . . . . 74.340000000000003 109.231 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.517 ' OD2' ' NE2' ' B' ' 161' ' ' GLN . 31.6 p-10 -52.4 89.36 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.953 -1.092 . . . . 75.450000000000003 109.219 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.535 ' NE2' ' O ' ' A' ' 162' ' ' ILE . 0.0 OUTLIER -173.33 154.01 2.54 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.109 -0.994 . . . . 73.409999999999997 109.434 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.535 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 52.5 mt -87.18 126.71 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.13 -0.981 . . . . 74.409999999999997 108.613 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 51.1 t -118.89 130.66 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.409 -0.807 . . . . 72.530000000000001 110.011 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 3.9 t -94.3 163.9 13.25 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.276 -0.89 . . . . 74.120000000000005 109.063 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -64.38 -43.58 94.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.067 -1.02 . . . . 70.430000000000007 109.554 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -58.92 -38.38 78.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 74.319999999999993 109.644 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -58.47 -46.18 87.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 74.519999999999996 109.513 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 77.7 mt -62.43 -39.31 92.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.155 -0.965 . . . . 74.409999999999997 109.311 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 173' ' ' TRP . 4.8 tt -54.77 -68.08 0.22 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.435 -0.791 . . . . 75.140000000000001 109.949 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.42 -37.08 79.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.305 -0.872 . . . . 65.030000000000001 110.751 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -50.79 -58.08 6.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.105 -0.997 . . . . 70.209999999999994 110.402 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.488 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 1.9 mp -93.27 -62.69 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.98 -1.075 . . . . 75.319999999999993 109.492 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.441 ' O ' ' O ' ' A' ' 169' ' ' LEU . 24.5 m-90 -81.37 118.29 22.54 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.38 -0.825 . . . . 73.140000000000001 110.06 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -144.39 -55.0 0.34 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.292 -0.88 . . . . 73.239999999999995 108.859 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.561 ' O ' ' N ' ' A' ' 177' ' ' GLU . 4.6 mp0 -55.33 155.1 10.1 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 107.989 -1.115 . . . . 63.329999999999998 107.989 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -33.66 83.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.798 2.332 . . . . 72.510000000000005 112.621 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.561 ' N ' ' O ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -92.74 -25.65 18.1 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.661 -0.649 . . . . 75.340000000000003 110.124 -179.338 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.505 ' N ' ' CD ' ' A' ' 177' ' ' GLU . 66.5 mtm 56.14 19.92 4.12 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.268 -0.895 . . . . 74.510000000000005 110.558 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 34.9 m -87.33 154.93 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.786 -1.196 . . . . 65.219999999999999 109.116 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 38.2 p -70.13 149.72 96.13 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.168 -0.958 . . . . 73.219999999999999 109.496 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.9 32.15 0.42 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.242 1.961 . . . . 62.43 112.184 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -143.88 -9.63 0.7 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.171 -0.956 . . . . 73.129999999999995 109.531 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.8 p -58.29 -12.91 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 74.019999999999996 109.382 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 2.6 mp -59.92 -22.98 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.088 -1.007 . . . . 72.329999999999998 109.028 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -61.6 -45.35 94.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.208 -0.933 . . . . 74.400000000000006 110.027 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.1 m -75.32 -30.14 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.001 -1.062 . . . . 74.319999999999993 109.324 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -69.5 -50.67 43.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.097 -1.002 . . . . 73.230000000000004 110.025 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.3 tp -65.13 -39.26 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.84 -1.163 . . . . 74.310000000000002 110.503 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -58.36 -43.09 88.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.974 -1.079 . . . . 73.439999999999998 109.483 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -75.64 -47.72 25.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.347 -0.845 . . . . 71.420000000000002 110.072 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 63.6 mt -52.13 -47.91 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.13 -0.981 . . . . 72.439999999999998 109.46 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.444 ' HE ' ' CG2' ' A' ' 204' ' ' VAL . 76.0 mtp180 -60.58 -51.3 70.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.322 -0.861 . . . . 64.219999999999999 109.988 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -61.59 -33.89 74.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.24 -0.913 . . . . 74.319999999999993 110.145 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.421 ' O ' ' CD ' ' A' ' 198' ' ' PRO . 9.3 pttm -86.81 -4.31 59.16 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.92 -1.112 . . . . 75.310000000000002 109.589 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 28.2 ttt -91.46 -57.2 2.85 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.16 -0.963 . . . . 74.019999999999996 109.189 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 200' ' ' GLY . 15.0 p-10 -65.19 -31.42 72.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.364 -0.835 . . . . 74.019999999999996 109.619 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.441 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 27.5 mttm -52.86 -65.26 1.14 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.103 -0.998 . . . . 75.430000000000007 109.579 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 38.5 Cg_endo -63.89 -54.92 0.76 Allowed 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.144 1.896 . . . . 72.319999999999993 112.066 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.485 ' C ' ' H ' ' A' ' 201' ' ' ILE . 65.4 mt -63.79 -28.87 70.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 74.540000000000006 109.211 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 196' ' ' ASP . . . 74.92 -26.61 1.15 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.789 -1.325 . . . . 61.509999999999998 109.789 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.485 ' H ' ' C ' ' A' ' 199' ' ' LEU . 11.0 mt -101.32 129.95 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.357 -1.084 . . . . 74.25 109.356 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 15.1 t -80.6 132.2 35.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.895 . . . . 72.0 109.265 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 62.6 p -136.11 3.72 2.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.432 -0.793 . . . . 74.439999999999998 108.949 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.444 ' CG2' ' HE ' ' A' ' 192' ' ' ARG . 28.6 m -104.36 138.09 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.499 -0.75 . . . . 71.129999999999995 109.292 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -122.96 136.34 54.82 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.6 -0.688 . . . . 73.510000000000005 109.572 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.13 132.35 44.51 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.231 -0.918 . . . . 73.519999999999996 109.047 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 5.1 m -135.14 136.29 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.371 -0.831 . . . . 72.150000000000006 109.48 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -81.34 -10.05 59.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.856 . . . . 72.400000000000006 109.16 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 18.8 mtp-105 -56.04 -43.28 77.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.92 . . . . 73.310000000000002 109.812 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -148.05 -66.76 0.25 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.221 -0.924 . . . . 71.540000000000006 109.524 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -148.45 -110.89 0.59 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.636 -1.386 . . . . 74.450000000000003 109.636 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.406 ' N ' ' CD1' ' A' ' 212' ' ' TYR . 41.4 m-85 -125.81 146.34 49.84 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.643 -0.916 . . . . 75.540000000000006 109.075 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -113.09 133.39 55.02 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.539 -0.726 . . . . 75.310000000000002 109.542 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -99.36 132.01 44.99 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.689 -0.856 . . . . 75.409999999999997 108.689 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 2.0 p -141.1 166.72 24.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.278 -0.889 . . . . 74.140000000000001 109.601 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -82.11 152.44 68.2 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 75.319999999999993 109.426 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -39.13 142.17 0.36 Allowed 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 122.295 1.997 . . . . 73.109999999999999 112.266 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.604 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 53.9 mmtt -84.37 -33.68 0.53 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 75.25 111.058 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 97.7 Cg_endo -88.43 19.21 1.36 Allowed 'Trans proline' 0 N--CA 1.487 1.139 0 C-N-CA 122.029 1.819 . . . . 75.099999999999994 112.077 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.97 -41.17 74.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 71.140000000000001 109.593 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 19.4 m 53.27 50.28 17.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.165 -0.96 . . . . 71.129999999999995 109.399 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -59.87 158.72 10.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.298 -0.876 . . . . 75.349999999999994 109.531 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.015 -0.993 . . . . 73.409999999999997 109.585 -179.994 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.594 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.406 -0.59 . . . . 75.239999999999995 109.406 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -131.77 145.89 51.85 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.512 -0.743 . . . . 73.519999999999996 109.129 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.2 t -117.03 139.65 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.582 -0.699 . . . . 72.239999999999995 109.907 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' B' ' 49' ' ' MET . 3.3 tp -109.01 118.7 37.47 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.568 -0.708 . . . . 73.340000000000003 109.386 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 21.7 mt -115.62 97.8 6.34 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.597 -0.89 . . . . 74.349999999999994 108.597 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 90.2 mt -85.8 97.41 5.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 120.863 -1.148 . . . . 63.439999999999998 108.987 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -120.52 128.04 52.74 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.543 -0.723 . . . . 74.519999999999996 109.635 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . 0.42 ' CD ' ' H ' ' B' ' 8' ' ' LYS . 0.0 OUTLIER -83.43 -22.12 32.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 74.129999999999995 108.773 179.447 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -78.6 -128.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.431 -0.793 . . . . 74.230000000000004 109.232 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' B' ' 11' ' ' VAL . 22.0 p -166.83 -55.54 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -0.866 . . . . 65.540000000000006 109.32 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.418 ' N ' ' OG ' ' B' ' 10' ' ' SER . 88.0 t -67.74 -42.77 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.288 -0.883 . . . . 75.549999999999997 109.652 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.48 ' CD2' ' N ' ' B' ' 12' ' ' LEU . 4.0 mm? -59.87 -42.23 93.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.338 -0.851 . . . . 70.140000000000001 109.532 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.75 -28.56 66.88 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.416 -1.874 . . . . 75.400000000000006 108.416 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.06 -47.94 80.49 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 109.828 -1.309 . . . . 65.439999999999998 109.828 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -63.76 -44.42 93.51 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.122 -1.222 . . . . 72.200000000000003 109.707 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 37.0 mm -66.7 -39.77 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.756 -1.215 . . . . 75.150000000000006 108.667 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.488 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 80.3 tt0 -63.72 -43.21 97.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.403 -0.811 . . . . 73.010000000000005 109.684 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp -86.81 0.45 54.81 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.09 -1.006 . . . . 74.299999999999997 109.366 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.49 -52.83 3.08 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.561 -1.416 . . . . 70.540000000000006 109.561 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -76.73 -21.56 55.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -1.102 . . . . 75.430000000000007 109.914 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 90.9 m-20 -56.43 -31.47 63.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.084 -1.01 . . . . 73.200000000000003 109.451 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 87.6 t -59.87 -35.02 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.317 -0.864 . . . . 74.230000000000004 109.354 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -70.68 -8.12 49.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.343 -0.848 . . . . 73.519999999999996 109.314 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.36 43.41 6.59 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.023 -1.231 . . . . 53.43 110.023 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -116.71 159.67 21.91 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.498 -1.001 . . . . 71.120000000000005 109.054 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 14.5 mmt -100.74 138.02 38.35 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.989 -1.115 . . . . 75.239999999999995 107.989 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.23 155.57 43.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.096 -1.002 . . . . 73.25 110.257 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -132.3 160.82 35.14 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.665 -0.865 . . . . 72.310000000000002 108.665 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 p -119.49 139.0 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.45 -0.781 . . . . 72.140000000000001 109.739 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 6.8 p -134.83 170.43 15.87 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.068 -0.716 . . . . 74.530000000000001 109.068 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.402 ' OE2' ' OD2' ' B' ' 35' ' ' ASP . 5.9 pt-20 -93.31 -107.81 0.12 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.219 -0.925 . . . . 71.019999999999996 109.82 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 54.8 p -78.94 168.16 20.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.25 -0.906 . . . . 71.400000000000006 110.025 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 61.0 mt -52.83 -29.41 27.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.548 -0.72 . . . . 71.239999999999995 109.754 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -52.71 -50.38 63.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.144 -0.972 . . . . 74.319999999999993 109.636 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.402 ' OD2' ' OE2' ' B' ' 31' ' ' GLU . 1.8 m-20 -64.66 -40.89 96.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.94 . . . . 73.030000000000001 109.481 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.02 -42.0 60.03 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.573 -1.411 . . . . 60.43 109.573 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.68 -37.75 87.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.304 -1.115 . . . . 74.430000000000007 109.748 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -80.64 -41.16 24.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.088 -1.007 . . . . 74.420000000000002 109.858 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 8.6 tt -70.21 -43.86 69.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.191 -0.943 . . . . 75.409999999999997 109.972 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.448 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.1 ppp? -62.62 -26.34 68.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.987 -1.07 . . . . 61.439999999999998 109.88 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -63.49 -39.85 95.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.054 -1.029 . . . . 74.319999999999993 110.027 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 20.9 pt -84.38 -26.29 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.095 -1.003 . . . . 71.230000000000004 110.166 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' B' ' 40' ' ' MET . 63.6 mmt-85 -129.69 138.59 51.24 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.305 -0.872 . . . . 73.409999999999997 109.348 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -93.62 159.59 15.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.162 -0.961 . . . . 63.539999999999999 109.825 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -136.63 150.47 48.55 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.447 -0.783 . . . . 73.109999999999999 109.212 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -91.5 -35.02 14.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.147 -0.971 . . . . 62.219999999999999 109.692 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.408 ' C ' ' CD1' ' B' ' 47' ' ' LEU . 0.9 OUTLIER -113.37 110.6 20.6 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.421 -0.799 . . . . 73.120000000000005 109.095 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 70.8 t -93.86 100.22 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.324 -0.86 . . . . 74.109999999999999 108.761 179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' MET . . . . . 0.518 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 6.3 tpp -114.24 128.23 56.26 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.094 -0.706 . . . . 73.439999999999998 109.094 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.502 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.7 OUTLIER -144.01 136.66 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 73.400000000000006 109.803 -179.451 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 65.2 p -101.52 16.77 24.62 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.593 -0.692 . . . . 73.209999999999994 109.658 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.502 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 41.7 m-20 -83.59 136.22 34.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.22 -0.925 . . . . 70.409999999999997 109.331 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -71.93 -33.56 68.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.898 . . . . 73.129999999999995 110.184 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -76.91 3.7 11.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.098 -1.001 . . . . 75.209999999999994 110.097 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.403 ' O ' ' C ' ' B' ' 56' ' ' LEU . . . -71.39 -21.33 62.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 55.329999999999998 110.215 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' B' ' 55' ' ' ALA . 56.2 mt -42.98 -42.91 3.94 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.424 -0.797 . . . . 72.420000000000002 110.275 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' SER . . . . . 0.417 ' O ' ' OG ' ' B' ' 60' ' ' SER . 19.7 m -72.63 -37.22 68.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.045 -1.035 . . . . 73.040000000000006 109.459 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -67.44 -51.06 56.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.368 -0.832 . . . . 72.329999999999998 110.287 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.3 m -60.4 -35.11 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.783 -1.198 . . . . 74.540000000000006 109.542 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' B' ' 57' ' ' SER . 66.1 p -58.41 -50.84 72.26 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.269 -0.895 . . . . 71.239999999999995 109.289 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.48 ' HE ' ' CE ' ' B' ' 65' ' ' LYS . 12.2 ptm180 -68.85 -30.94 69.57 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 118.742 -1.183 . . . . 74.310000000000002 109.815 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.433 ' O ' ' N ' ' B' ' 66' ' ' HIS . 4.8 mm -54.56 -48.44 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.842 -1.161 . . . . 75.420000000000002 108.526 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.523 ' NZ ' ' OD2' ' B' ' 92' ' ' ASP . 50.3 mmtt -61.2 -42.94 99.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.141 -0.975 . . . . 73.319999999999993 108.435 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -65.65 -43.69 88.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.415 -0.803 . . . . 73.310000000000002 108.837 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.48 ' CE ' ' HE ' ' B' ' 61' ' ' ARG . 9.5 mtmp? -82.28 -77.54 0.23 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.662 -0.649 . . . . 72.439999999999998 109.964 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.433 ' N ' ' O ' ' B' ' 62' ' ' ILE . 95.1 m-70 -97.53 87.69 4.17 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.165 -0.959 . . . . 65.209999999999994 109.727 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 71.0 p -79.34 -30.88 42.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.3 -0.875 . . . . 73.099999999999994 110.013 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 38.3 m -63.23 -28.89 70.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.19 -0.944 . . . . 71.530000000000001 110.0 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 58.3 mt -80.17 150.0 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.088 -1.008 . . . . 74.400000000000006 109.654 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.413 ' CG1' ' N ' ' B' ' 71' ' ' VAL . 98.8 t -88.37 165.62 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.378 -0.826 . . . . 75.120000000000005 109.387 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.516 ' N ' ' OD1' ' B' ' 92' ' ' ASP . 14.4 t -145.48 125.42 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.999 -1.063 . . . . 73.200000000000003 109.859 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.518 ' O ' ' SD ' ' B' ' 49' ' ' MET . 0.8 OUTLIER -120.5 103.6 9.3 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.408 -0.96 . . . . 73.340000000000003 108.408 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 13.4 p -98.4 144.98 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.179 -0.951 . . . . 73.5 108.876 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.5 m -111.07 171.25 7.58 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.318 -0.864 . . . . 71.319999999999993 109.147 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.418 ' OG ' ' OE2' ' B' ' 82' ' ' GLU . 8.0 t -171.13 122.26 0.56 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.076 -1.015 . . . . 74.530000000000001 110.065 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 46.3 p30 -78.14 29.82 0.18 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.453 -0.779 . . . . 64.5 110.189 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . 0.414 ' N ' ' CD ' ' B' ' 78' ' ' PRO . 12.7 t-20 -150.47 55.13 1.67 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 120.939 -1.101 . . . . 74.25 109.862 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' B' ' 77' ' ' ASN . 12.0 Cg_endo -56.26 81.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.604 2.203 . . . . 74.430000000000007 112.397 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 29.4 m -109.35 149.69 29.12 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.317 -0.994 . . . . 73.120000000000005 108.317 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -30.66 66.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.144 -0.972 . . . . 75.409999999999997 109.213 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -64.53 -48.21 75.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 72.239999999999995 109.034 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . 0.418 ' OE2' ' OG ' ' B' ' 75' ' ' SER . 85.2 tt0 -69.89 -29.49 66.7 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.138 -0.976 . . . . 73.219999999999999 109.142 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.52 ' CD ' ' HE ' ' A' ' 108' ' ' ARG . 39.8 tp10 -56.21 -56.03 25.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.871 . . . . 74.299999999999997 109.192 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 8.2 m -60.46 -38.45 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.171 -0.956 . . . . 73.310000000000002 108.917 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 69.9 t60 -63.11 -34.03 76.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.303 -0.873 . . . . 73.239999999999995 109.437 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.18 90.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.197 -0.94 . . . . 55.329999999999998 109.74 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -76.56 -31.34 57.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.195 -0.941 . . . . 74.450000000000003 108.641 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -67.32 -46.31 73.87 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.731 -0.84 . . . . 64.040000000000006 108.731 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -59.48 -66.21 0.55 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.611 -0.681 . . . . 75.129999999999995 109.414 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 149.87 52.14 0.02 OUTLIER Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.167 -1.173 . . . . 75.420000000000002 110.167 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.6 132.23 54.08 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.31 -1.112 . . . . 73.420000000000002 109.067 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . 0.523 ' OD2' ' NZ ' ' B' ' 63' ' ' LYS . 3.4 m-20 -67.15 -38.11 84.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.033 -1.042 . . . . 73.319999999999993 108.873 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 48.2 t0 -152.11 156.65 40.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.442 -0.786 . . . . 73.040000000000006 108.939 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.482 ' C ' ' CD1' ' B' ' 94' ' ' TYR . 0.5 OUTLIER -125.29 126.54 45.27 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.179 -0.674 . . . . 74.310000000000002 109.179 -179.586 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.435 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 25.8 mm -110.22 134.06 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 121.378 -0.826 . . . . 75.340000000000003 109.923 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' B' ' 97' ' ' LYS . . . -60.97 119.5 8.41 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.635 -1.617 . . . . 70.099999999999994 106.635 177.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.681 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -42.01 -55.36 6.3 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.032 -1.042 . . . . 65.430000000000007 111.574 -178.072 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 3.7 Cg_endo -41.64 -10.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 120.774 0.983 . . . . 63.520000000000003 112.57 -176.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . 0.681 ' N ' ' O ' ' B' ' 97' ' ' LYS . 58.6 m-85 58.83 104.98 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.845 -0.535 . . . . 75.129999999999995 109.719 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . 0.47 ' O ' ' OG ' ' B' ' 101' ' ' SER . 33.0 ttm-85 -62.0 -34.4 76.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.071 -1.018 . . . . 74.230000000000004 109.091 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' SER . . . . . 0.631 ' O ' ' N ' ' B' ' 103' ' ' LYS . 28.8 m -172.51 32.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.88 . . . . 64.510000000000005 110.253 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . 0.48 ' O ' ' N ' ' B' ' 104' ' ' ALA . 55.9 mt 49.09 -81.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.384 -0.823 . . . . 74.439999999999998 110.368 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . 0.631 ' N ' ' O ' ' B' ' 101' ' ' SER . 44.7 mtmt -45.57 -19.97 0.06 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.242 -0.911 . . . . 72.299999999999997 108.961 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' B' ' 102' ' ' ILE . . . -55.6 -67.5 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.509 -0.744 . . . . 74.310000000000002 109.545 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 3.1 pp -60.84 -36.76 79.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.961 -1.087 . . . . 73.540000000000006 109.555 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 14.5 t -56.92 -45.69 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.74 -1.225 . . . . 72.030000000000001 108.531 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.3 -31.04 67.13 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.337 -0.986 . . . . 64.219999999999999 108.337 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -79.41 -23.72 43.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.525 -0.735 . . . . 75.310000000000002 109.822 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 83.2 mt -78.24 -39.69 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.955 -1.091 . . . . 55.439999999999998 109.11 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -73.52 -41.39 63.11 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.329 -0.949 . . . . 65.310000000000002 109.417 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.15 -53.28 59.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.192 -0.942 . . . . 74.519999999999996 109.577 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 68.3 ttt-85 -64.97 -33.85 77.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 72.040000000000006 109.47 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.521 ' O ' ' CD2' ' B' ' 115' ' ' PHE . 60.3 tp -80.54 -90.82 0.06 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.93 . . . . 75.349999999999994 109.7 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.516 ' C ' ' H ' ' B' ' 116' ' ' TRP . 11.6 mmt180 47.17 -170.03 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.176 -0.952 . . . . 75.5 108.881 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' PHE . . . . . 0.521 ' CD2' ' O ' ' B' ' 113' ' ' LEU . 1.4 m-85 66.26 -39.76 0.33 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.336 -0.853 . . . . 73.040000000000006 109.849 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' TRP . . . . . 0.516 ' H ' ' C ' ' B' ' 114' ' ' ARG . 17.1 t90 53.3 43.13 31.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.012 -1.055 . . . . 74.450000000000003 109.203 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.49 77.0 1.09 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.817 -1.313 . . . . 64.209999999999994 109.817 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 2.3 t -80.92 -8.35 59.72 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.207 -1.172 . . . . 71.400000000000006 109.392 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . 0.674 ' ND2' ' HG ' ' B' ' 129' ' ' SER . 24.4 t-20 54.52 176.39 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.422 -0.798 . . . . 74.209999999999994 110.328 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . 0.476 ' H ' ' CG ' ' B' ' 119' ' ' ASN . 11.8 t -142.71 -36.2 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.72 -0.845 . . . . 75.019999999999996 108.72 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 25.6 mm -115.42 118.77 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.28 -1.008 . . . . 74.239999999999995 108.28 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -155.34 140.76 17.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.939 -1.101 . . . . 73.329999999999998 110.131 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 35.1 pt -149.02 145.23 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.998 -0.742 . . . . 74.219999999999999 108.998 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 45.8 -136.41 8.0 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.848 -1.301 . . . . 72.409999999999997 109.848 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -90.51 6.73 42.29 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.259 -1.142 . . . . 75.120000000000005 109.326 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.9 139.25 31.12 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.321 -0.862 . . . . 75.420000000000002 108.777 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 17.0 m -128.86 133.68 48.04 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.601 -0.888 . . . . 74.219999999999999 108.601 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.509 ' C ' HD22 ' B' ' 119' ' ' ASN . 42.0 mt -138.95 141.31 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.147 -0.971 . . . . 60.329999999999998 110.571 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 129' ' ' SER . . . . . 0.674 ' HG ' ' ND2' ' B' ' 119' ' ' ASN . 6.1 m -136.99 117.75 10.88 Favored Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 108.915 -0.772 . . . . 72.310000000000002 108.915 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.98 -48.74 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 121.958 1.772 . . . . 75.129999999999995 112.471 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -55.53 -37.41 67.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.211 -0.93 . . . . 75.230000000000004 109.836 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -80.76 -2.15 45.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.166 -0.959 . . . . 75.120000000000005 109.374 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 49.55 57.32 6.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.256 -0.903 . . . . 75.129999999999995 108.958 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -156.66 139.7 15.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -0.908 . . . . 75.109999999999999 109.545 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 55.3 mt -124.01 132.72 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.995 -0.743 . . . . 70.319999999999993 108.995 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 23.7 mt -125.57 131.25 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.502 -0.749 . . . . 74.120000000000005 110.318 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -125.62 129.24 49.24 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.697 -0.627 . . . . 74.230000000000004 109.483 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm 51.46 36.34 16.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.179 -0.951 . . . . 74.219999999999999 111.095 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.76 -1.34 83.83 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 120.065 -1.064 . . . . 74.319999999999993 111.5 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -87.14 124.62 33.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.714 -1.462 . . . . 75.340000000000003 108.927 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -84.03 123.88 30.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.368 -0.832 . . . . 71.230000000000004 109.496 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 97.2 t -127.72 133.28 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.474 -0.766 . . . . 70.430000000000007 109.45 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -98.93 142.84 29.93 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.242 -0.911 . . . . 72.430000000000007 109.44 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 20.6 m -146.32 152.29 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.149 -0.969 . . . . 72.129999999999995 109.906 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.11 115.79 0.08 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.358 -0.839 . . . . 74.5 109.407 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.59 -137.86 7.03 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.788 -1.325 . . . . 42.229999999999997 109.788 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 0.58 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 0.0 OUTLIER -73.53 -43.83 7.1 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.272 -1.134 . . . . 73.299999999999997 109.539 -179.58 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 24.3 Cg_exo -62.67 -49.08 5.99 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.29 1.994 . . . . 71.329999999999998 111.144 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . 0.403 ' CE1' ' CG2' ' B' ' 153' ' ' THR . 25.1 t80 -58.06 -24.39 58.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.687 -0.633 . . . . 74.230000000000004 109.608 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . 0.41 ' OE1' ' O ' ' B' ' 172' ' ' ILE . 24.0 tt0 -72.11 -58.6 3.29 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.299 -0.876 . . . . 72.340000000000003 110.378 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.99 -33.58 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.801 -1.187 . . . . 73.349999999999994 109.468 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 3.8 mp -58.15 -41.47 83.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.118 -0.989 . . . . 74.430000000000007 108.781 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.403 ' CG2' ' CE1' ' B' ' 149' ' ' PHE . 1.9 p -80.6 -18.96 46.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.967 . . . . 75.209999999999994 110.235 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -71.16 -52.13 20.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.858 -1.151 . . . . 73.040000000000006 109.576 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . 0.502 ' CD1' ' N ' ' B' ' 156' ' ' ALA . 0.0 OUTLIER -77.92 -25.01 48.11 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.313 -0.867 . . . . 73.430000000000007 110.17 -179.164 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . 0.502 ' N ' ' CD1' ' B' ' 155' ' ' LEU . . . -63.38 -53.4 53.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.906 -1.121 . . . . 75.319999999999993 109.259 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -66.06 -54.5 25.01 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.267 -0.896 . . . . 73.319999999999993 108.877 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . 0.448 ' ND1' ' N ' ' B' ' 158' ' ' HIS . 2.1 m-70 -84.72 38.27 0.69 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.804 -0.56 . . . . 74.140000000000001 110.263 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -73.41 45.07 0.16 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.866 -1.146 . . . . 73.420000000000002 109.408 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' B' ' 160' ' ' ASP . 15.9 p-10 -169.81 62.13 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.076 -1.015 . . . . 72.099999999999994 109.294 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . 0.517 ' NE2' ' OD2' ' A' ' 160' ' ' ASP . 39.7 tp60 -169.87 164.51 9.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.07 -1.019 . . . . 73.239999999999995 109.831 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 45.4 mt -80.3 132.94 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.611 -0.885 . . . . 72.310000000000002 108.611 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 33.9 t -132.01 131.12 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.289 -0.882 . . . . 75.030000000000001 109.892 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 164' ' ' SER . . . . . 0.521 ' HG ' ' H ' ' B' ' 167' ' ' GLN . 11.2 p -99.68 159.94 14.67 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.708 -0.849 . . . . 74.219999999999999 108.708 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -55.76 -39.38 71.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.028 -1.045 . . . . 72.420000000000002 109.571 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.21 -39.6 93.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.149 -0.969 . . . . 63.450000000000003 109.809 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 167' ' ' GLN . . . . . 0.521 ' H ' ' HG ' ' B' ' 164' ' ' SER . 22.2 mm100 -53.3 -47.28 69.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.176 -0.953 . . . . 72.400000000000006 109.0 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 33.5 mt -55.87 -50.53 70.37 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.448 -0.945 . . . . 72.319999999999993 108.448 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 1.1 tt -49.9 -56.23 11.35 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.271 -0.893 . . . . 73.340000000000003 109.296 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -56.2 -39.21 72.08 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 112.833 0.679 . . . . 73.099999999999994 112.833 -178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -93.25 -18.83 22.03 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.451 -1.406 . . . . 62.130000000000003 113.408 -176.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.41 ' O ' ' OE1' ' B' ' 150' ' ' GLU . 1.3 mp -91.32 -53.87 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 120.375 -1.453 . . . . 74.439999999999998 111.07 -178.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 173' ' ' TRP . . . . . 0.536 ' O ' ' CG ' ' B' ' 173' ' ' TRP . 0.0 OUTLIER -87.57 13.0 11.08 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.738 -1.226 . . . . 72.230000000000004 110.63 -177.542 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -48.36 -33.15 8.57 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.022 -1.049 . . . . 75.030000000000001 109.672 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' B' ' 177' ' ' GLU . 14.5 mt-10 -87.83 157.32 51.97 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 107.911 -1.144 . . . . 73.040000000000006 107.911 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' B' ' 175' ' ' GLU . 52.7 Cg_exo -34.0 86.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.581 2.187 . . . . 74.129999999999995 111.997 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' B' ' 175' ' ' GLU . 50.0 mt-10 -142.85 172.47 12.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.558 -0.714 . . . . 72.439999999999998 109.63 -178.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 3.7 tpt -142.79 70.33 1.32 Allowed 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.325 -0.991 . . . . 72.109999999999999 108.325 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 179' ' ' VAL . . . . . 0.513 ' O ' ' O ' ' B' ' 180' ' ' THR . 23.6 m -77.37 -10.97 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.522 -0.736 . . . . 75.310000000000002 110.761 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 180' ' ' THR . . . . . 0.513 ' O ' ' O ' ' B' ' 179' ' ' VAL . 0.9 OUTLIER 55.31 154.77 0.06 OUTLIER Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.773 -0.58 . . . . 62.149999999999999 109.439 -179.408 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.41 -54.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.203 1.936 . . . . 74.340000000000003 113.01 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -62.44 -33.5 74.92 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.199 -0.938 . . . . 72.310000000000002 111.072 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 87.2 t -66.67 -15.54 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.933 -1.104 . . . . 65.420000000000002 110.699 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 95.0 mt -60.87 -23.55 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.726 -1.234 . . . . 75.030000000000001 109.563 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . 0.449 ' CG ' ' N ' ' B' ' 186' ' ' VAL . 20.6 pt-20 -59.87 -43.95 94.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.283 -0.885 . . . . 73.519999999999996 109.883 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . 0.449 ' N ' ' CG ' ' B' ' 185' ' ' GLU . 2.7 p -76.98 -34.35 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.967 -1.083 . . . . 74.349999999999994 109.74 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -55.25 -52.59 62.9 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.881 -1.137 . . . . 61.119999999999997 109.588 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 8.3 tp -65.97 -37.83 80.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 120.973 -1.08 . . . . 72.430000000000007 109.603 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -58.5 -46.11 87.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.001 -1.062 . . . . 75.420000000000002 109.6 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -72.91 -47.23 47.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 74.140000000000001 110.087 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.5 mt -54.63 -40.55 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.026 -1.046 . . . . 74.030000000000001 109.463 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -62.49 -52.17 64.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.162 -0.961 . . . . 72.329999999999998 109.505 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -60.22 -38.42 83.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 73.099999999999994 109.464 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -73.25 -15.42 61.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.289 -0.882 . . . . 74.430000000000007 109.592 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 1.5 tpt -89.85 -57.13 2.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.271 -0.893 . . . . 74.329999999999998 110.098 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 196' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' B' ' 200' ' ' GLY . 95.2 m-20 -55.87 -38.35 70.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 71.209999999999994 110.998 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . 0.435 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 14.0 mtmm -54.96 -65.66 1.28 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.876 -1.14 . . . . 75.209999999999994 109.938 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 198' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 34.9 Cg_endo -63.11 -56.57 0.53 Allowed 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.084 1.856 . . . . 75.319999999999993 112.368 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . 0.46 ' C ' ' H ' ' B' ' 201' ' ' ILE . 9.1 mp -62.83 -32.15 73.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.137 -0.977 . . . . 72.25 109.478 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' B' ' 196' ' ' ASP . . . 74.14 -41.9 1.13 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.486 -1.446 . . . . 73.239999999999995 109.486 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . 0.46 ' H ' ' C ' ' B' ' 199' ' ' LEU . 4.0 mt -92.29 129.52 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.285 -1.126 . . . . 54.299999999999997 109.231 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 26.3 p -78.12 142.35 38.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.167 -0.958 . . . . 74.310000000000002 109.07 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 10.2 p -141.45 4.88 1.8 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.314 -0.867 . . . . 74.400000000000006 109.528 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 32.6 m -113.89 134.83 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.444 -0.785 . . . . 74.099999999999994 109.208 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . 0.531 ' OE2' ' N ' ' B' ' 205' ' ' GLU . 1.5 mp0 -106.76 136.22 46.95 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.448 -0.783 . . . . 75.329999999999998 109.508 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.36 119.21 34.42 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.209 -0.932 . . . . 71.400000000000006 109.018 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 4.8 t -131.58 130.77 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.447 -0.783 . . . . 63.5 109.59 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 208' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' B' ' 209' ' ' ARG . 65.9 ttt-85 -73.1 -28.59 62.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 74.450000000000003 109.446 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' B' ' 208' ' ' ARG . 52.4 mtp85 -55.6 -106.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 74.140000000000001 109.982 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -63.67 -66.19 0.58 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.019 . . . . 74.430000000000007 109.852 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . 0.68 ' H ' HH12 ' B' ' 213' ' ' ARG . . . 178.68 -119.89 0.68 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.834 -1.306 . . . . 70.109999999999999 109.834 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 212' ' ' TYR . . . . . 0.628 ' N ' ' NH2' ' B' ' 213' ' ' ARG . 78.2 m-85 -111.69 141.79 44.85 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.494 -1.004 . . . . 74.209999999999994 109.7 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . 0.68 HH12 ' H ' ' B' ' 211' ' ' GLY . 13.5 mmp_? -105.87 131.51 53.11 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.454 -0.779 . . . . 74.299999999999997 108.96 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . 0.43 ' C ' ' SG ' ' B' ' 215' ' ' CYS . 60.4 m-85 -108.45 107.27 17.74 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.348 -0.845 . . . . 74.340000000000003 108.972 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . 0.43 ' SG ' ' C ' ' B' ' 214' ' ' PHE . 4.2 m -148.64 169.43 20.37 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.309 -0.869 . . . . 72.209999999999994 109.53 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -79.32 150.34 73.76 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 72.310000000000002 109.117 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.77 -159.57 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.975 1.783 . . . . 71.010000000000005 111.243 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -56.56 151.24 31.03 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 120.993 -1.067 . . . . 74.349999999999994 109.089 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -35.41 93.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.616 2.211 . . . . 71.319999999999993 112.353 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.66 -22.1 21.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.345 -0.847 . . . . 75.450000000000003 109.904 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 221' ' ' CYS . . . . . 0.524 ' SG ' ' N ' ' B' ' 222' ' ' GLU . 24.3 t -148.3 160.73 42.68 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.086 -1.009 . . . . 72.219999999999999 109.839 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.524 ' N ' ' SG ' ' B' ' 221' ' ' CYS . 78.7 tt0 -159.29 149.28 18.96 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.879 -0.786 . . . . 74.299999999999997 108.879 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.063 -1.023 . . . . 71.129999999999995 109.375 -179.988 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ptp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.469 -0.567 . . . . 65.120000000000005 109.469 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.1 ttt85 -144.24 156.47 44.3 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.277 -0.889 . . . . 73.310000000000002 109.238 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.5 t -117.04 129.21 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.59 0.709 . . . . 71.420000000000002 109.742 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 49' ' ' MET . 6.8 tp -99.86 116.76 32.68 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.902 -0.777 . . . . 65.219999999999999 108.902 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.4 tp -119.54 105.44 11.23 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.098 -0.704 . . . . 71.439999999999998 109.098 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.47 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 11.7 mt -96.36 131.9 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.071 -1.018 . . . . 71.150000000000006 109.539 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.499 ' CD ' ' N ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -163.14 131.83 3.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 75.340000000000003 109.409 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.474 ' H ' ' CD ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -76.74 -5.1 46.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -0.944 . . . . 73.040000000000006 108.898 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -74.67 -145.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.312 -0.868 . . . . 72.420000000000002 109.092 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.3 t -159.83 -69.84 0.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.107 -0.996 . . . . 72.340000000000003 109.662 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.2 p -64.76 -37.46 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 74.420000000000002 109.985 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -52.11 -41.34 62.39 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.978 -1.076 . . . . 72.010000000000005 108.756 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.25 -28.79 63.35 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.552 -1.819 . . . . 72.140000000000001 108.552 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.65 -46.43 92.15 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.696 -1.362 . . . . 72.329999999999998 109.696 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.28 -42.86 87.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.321 -1.106 . . . . 72.340000000000003 109.915 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.426 HG21 HD11 ' A' ' 16' ' ' ILE . 62.9 mt -69.55 -37.45 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.886 -1.134 . . . . 74.239999999999995 109.327 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -59.81 -45.94 90.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.137 -0.977 . . . . 71.409999999999997 109.488 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -86.33 -4.28 59.14 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.155 -0.966 . . . . 75.540000000000006 109.629 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.02 -57.45 2.52 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.312 -1.515 . . . . 62.149999999999999 109.312 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pp -66.31 -29.21 69.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.376 -1.073 . . . . 74.420000000000002 109.38 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -53.22 -35.1 59.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 74.25 109.35 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 82.1 t -55.52 -40.84 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.929 . . . . 72.109999999999999 109.095 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.459 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -70.25 -17.33 63.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.373 -0.83 . . . . 73.230000000000004 109.015 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.95 41.6 3.5 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.197 -1.161 . . . . 75.540000000000006 110.197 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -118.15 155.85 29.73 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.404 -1.057 . . . . 74.510000000000005 108.737 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.7 mmm -103.51 139.22 39.15 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.538 -0.912 . . . . 64.319999999999993 108.538 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.69 159.81 41.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.224 -0.923 . . . . 74.310000000000002 110.066 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -140.03 146.06 38.55 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.91 -0.774 . . . . 75.400000000000006 108.91 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.93 128.15 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.647 -0.872 . . . . 75.129999999999995 108.647 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.6 p -128.48 165.05 21.44 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.584 -0.697 . . . . 71.420000000000002 109.516 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.47 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 3.5 pt-20 -94.13 -99.34 0.15 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.284 -0.885 . . . . 73.109999999999999 109.643 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.5 p -79.56 165.51 22.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.167 -0.958 . . . . 74.239999999999995 110.034 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.0 mt -57.13 -36.3 70.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.496 -0.752 . . . . 71.530000000000001 109.991 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -54.14 -41.09 68.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.111 -0.993 . . . . 74.230000000000004 110.014 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.18 -40.08 65.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.125 -0.984 . . . . 71.010000000000005 109.867 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.97 -39.46 23.96 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.91 -1.276 . . . . 61.409999999999997 109.91 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.6 -49.02 74.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -1.136 . . . . 74.340000000000003 109.872 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -66.47 -35.75 81.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.144 -0.972 . . . . 75.329999999999998 110.039 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.6 tp -73.83 -51.58 15.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 74.329999999999998 110.344 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.42 ' O ' ' O ' ' A' ' 43' ' ' ARG . 11.7 ptm -65.3 -24.79 67.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.078 -1.014 . . . . 70.319999999999993 110.094 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -54.98 -42.0 71.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.079 -1.013 . . . . 71.219999999999999 109.891 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.1 pt -88.67 -34.68 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.164 -0.96 . . . . 74.409999999999997 109.964 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 40' ' ' MET . 86.2 mtt-85 -86.59 147.35 25.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.02 -1.05 . . . . 75.409999999999997 109.684 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -88.42 151.92 22.24 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.296 -0.877 . . . . 75.420000000000002 109.237 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 12.5 p90 -156.01 171.09 20.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.149 -0.969 . . . . 74.230000000000004 109.897 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 45' ' ' TYR . 89.8 m-20 -136.3 -31.87 0.88 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.53 -0.732 . . . . 75.319999999999993 109.426 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.02 108.62 19.86 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.361 -0.837 . . . . 72.129999999999995 108.818 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.3 t -97.82 97.8 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.323 -0.861 . . . . 72.340000000000003 109.438 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.429 ' O ' ' O ' ' A' ' 4' ' ' LEU . 4.5 ttt -113.89 127.48 56.0 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.455 -0.778 . . . . 74.109999999999999 109.213 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -133.5 137.61 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.635 -0.666 . . . . 71.239999999999995 109.47 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 t -103.92 4.07 34.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.589 -0.694 . . . . 73.109999999999999 109.647 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -76.84 140.01 40.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.15 -0.969 . . . . 63.399999999999999 109.532 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.512 ' C ' ' H ' ' A' ' 55' ' ' ALA . 37.9 mmtm -73.58 -42.32 61.73 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.291 -0.881 . . . . 65.439999999999998 110.104 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -70.95 13.98 0.17 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.113 -0.992 . . . . 73.129999999999995 109.682 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.512 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.01 -20.87 59.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 64.140000000000001 110.428 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 55' ' ' ALA . 36.3 mt -42.06 -50.84 4.67 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.39 -0.819 . . . . 74.430000000000007 110.019 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.9 m -66.12 -33.85 76.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.074 -1.016 . . . . 63.229999999999997 108.945 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.437 ' N ' ' O ' ' A' ' 55' ' ' ALA . 52.1 t80 -64.08 -62.1 1.84 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.358 -0.839 . . . . 74.439999999999998 109.574 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.2 m -49.21 -33.25 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.671 -1.268 . . . . 74.030000000000001 109.589 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.0 m -58.2 -51.66 68.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.207 -0.933 . . . . 73.540000000000006 109.583 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -69.21 -31.22 69.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.997 -1.064 . . . . 73.340000000000003 110.014 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.9 mm -65.87 -36.11 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.726 -1.234 . . . . 73.349999999999994 109.561 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -69.75 -46.38 66.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 74.420000000000002 110.428 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.431 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 7.0 pt-20 -74.53 -42.73 58.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.831 -1.168 . . . . 74.549999999999997 110.087 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.527 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 92.8 mttt -70.13 -27.9 64.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 75.219999999999999 109.484 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.527 ' ND1' ' O ' ' A' ' 65' ' ' LYS . 58.6 m-70 -150.13 67.12 0.97 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.367 -0.833 . . . . 74.129999999999995 109.224 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.3 p -60.44 -28.76 68.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 73.239999999999995 109.813 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.5 t -78.58 48.54 0.8 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.158 -0.964 . . . . 71.439999999999998 109.709 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.6 tt -144.81 166.72 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.094 -1.004 . . . . 71.329999999999998 109.344 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.6 t -98.05 156.06 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.182 -0.949 . . . . 73.019999999999996 109.404 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.9 t -142.63 120.86 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.286 -0.884 . . . . 54.210000000000001 108.816 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.4 mp -116.75 104.27 11.18 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.862 -0.792 . . . . 74.209999999999994 108.862 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 68.5 t -93.02 121.37 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 74.409999999999997 108.859 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.0 p -89.78 169.38 11.32 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.158 -0.964 . . . . 72.310000000000002 109.118 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.484 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 19.1 t -162.44 123.03 2.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.085 -1.01 . . . . 64.540000000000006 110.224 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 77' ' ' ASN . 54.1 p30 -78.49 -9.97 59.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.428 -0.795 . . . . 74.129999999999995 109.116 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 79' ' ' THR . 27.6 m120 -128.7 64.95 71.09 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.891 -0.781 . . . . 73.340000000000003 108.891 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -49.44 88.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.093 1.862 . . . . 71.319999999999993 111.871 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.425 ' N ' ' O ' ' A' ' 77' ' ' ASN . 24.5 m -105.83 149.24 26.68 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.706 -0.849 . . . . 62.530000000000001 108.706 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.3 -33.11 74.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 74.140000000000001 109.329 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.18 -38.73 87.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 71.420000000000002 109.363 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.422 ' OE1' ' OH ' ' A' ' 94' ' ' TYR . 85.1 tt0 -75.76 -31.81 59.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 73.430000000000007 109.498 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.51 -51.44 65.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 74.219999999999999 109.741 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.4 m -63.98 -42.82 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 74.150000000000006 109.605 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.622 ' CE1' ' NE2' ' A' ' 89' ' ' GLN . 7.0 t-80 -64.06 -32.54 74.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.186 -0.946 . . . . 72.540000000000006 109.509 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.37 -37.88 80.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 64.219999999999999 110.091 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -83.48 -36.93 23.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.053 -1.029 . . . . 74.340000000000003 109.294 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.85 -34.04 77.05 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.293 -0.879 . . . . 74.420000000000002 109.504 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.622 ' NE2' ' CE1' ' A' ' 85' ' ' HIS . 87.8 mt-30 -80.08 -60.03 2.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 74.519999999999996 109.776 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 157.36 59.12 0.01 OUTLIER Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.672 -1.252 . . . . 74.209999999999994 110.22 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.44 125.48 51.81 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.402 -1.058 . . . . 64.099999999999994 108.89 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 20.6 t70 -69.65 -35.59 75.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.002 -1.061 . . . . 73.420000000000002 109.271 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 67.9 m-20 -151.3 161.5 42.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.338 -0.851 . . . . 75.040000000000006 109.442 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.484 ' OH ' ' CB ' ' A' ' 75' ' ' SER . 86.9 t80 -134.98 119.19 17.68 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.563 -0.902 . . . . 71.329999999999998 108.563 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.494 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 0.1 OUTLIER -125.42 148.6 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 CA-C-O 121.701 0.762 . . . . 74.510000000000005 110.7 -178.191 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.51 133.77 49.07 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.822 -1.177 . . . . 64.319999999999993 107.822 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.682 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -53.67 -55.3 36.81 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 120.907 -1.12 . . . . 74.510000000000005 111.824 -178.794 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.5 Cg_endo -41.01 -10.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 120.943 1.095 . . . . 73.109999999999999 113.19 -175.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.682 ' N ' ' O ' ' A' ' 97' ' ' LYS . 56.8 m-85 58.99 118.89 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.661 -0.649 . . . . 72.540000000000006 109.802 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 46.7 mtt-85 -62.6 -41.68 99.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.824 -1.172 . . . . 74.540000000000006 109.528 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.753 ' O ' ' N ' ' A' ' 103' ' ' LYS . 44.5 t -165.92 31.13 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.0 -1.062 . . . . 74.140000000000001 110.75 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.3 mt 50.39 -70.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 118.588 0.631 . . . . 75.430000000000007 110.208 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.753 ' N ' ' O ' ' A' ' 101' ' ' SER . 9.1 mtpm? -53.47 -32.81 51.78 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.062 -1.088 . . . . 74.140000000000001 108.062 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.29 -52.13 60.09 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.439 -0.948 . . . . 63.240000000000002 108.439 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.0 tp -58.21 -41.4 83.96 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.518 -0.919 . . . . 73.219999999999999 108.518 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 84.1 t -61.99 -37.37 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.25 -0.906 . . . . 74.540000000000006 108.669 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.4 -35.49 70.1 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.345 -0.847 . . . . 75.5 108.9 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.527 ' NE ' ' OE2' ' B' ' 83' ' ' GLU . 93.8 mtt180 -79.86 -26.76 40.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.371 -0.831 . . . . 74.409999999999997 109.974 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.9 mt -80.3 -38.52 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.053 -1.029 . . . . 73.239999999999995 109.476 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -72.72 -36.88 67.89 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.236 -0.915 . . . . 74.340000000000003 109.207 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.23 -46.46 83.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.341 -0.849 . . . . 73.319999999999993 109.226 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.99 -39.36 81.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 74.420000000000002 108.793 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 tt -142.43 80.87 1.72 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.254 -0.904 . . . . 74.329999999999998 108.781 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.526 ' O ' ' CG ' ' A' ' 115' ' ' PHE . 86.2 mtm180 -65.88 -43.42 88.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 74.439999999999998 109.927 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.526 ' CG ' ' O ' ' A' ' 114' ' ' ARG . 96.3 m-85 -158.39 -84.98 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.159 -0.963 . . . . 74.430000000000007 109.581 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 83.7 t90 -154.16 154.12 33.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 74.439999999999998 109.442 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 158.17 65.72 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.443 -1.463 . . . . 75.040000000000006 109.443 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 83.0 p -156.76 96.9 1.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.296 -1.12 . . . . 70.109999999999999 109.48 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 128' ' ' ILE . 21.8 t-20 -154.69 174.22 15.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.296 -0.877 . . . . 65.239999999999995 109.314 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.489 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 4.2 t -142.59 -35.56 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.286 -0.884 . . . . 74.219999999999999 109.139 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 20.8 mm -104.7 126.45 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.338 -0.851 . . . . 74.420000000000002 109.179 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -139.53 120.99 15.07 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.361 -0.837 . . . . 73.299999999999997 109.336 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.4 ' O ' ' C ' ' A' ' 124' ' ' GLY . 10.2 pt -150.18 135.47 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.268 -0.895 . . . . 75.340000000000003 109.373 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 123' ' ' ILE . . . 43.87 -145.34 1.58 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.991 -1.244 . . . . 75.129999999999995 109.991 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -85.44 1.04 50.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -1.165 . . . . 74.450000000000003 109.274 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.45 131.42 38.66 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.39 -0.967 . . . . 54.210000000000001 108.39 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 51.3 m -131.08 133.79 46.0 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.437 -0.789 . . . . 70.239999999999995 109.62 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.518 ' O ' ' ND2' ' A' ' 119' ' ' ASN . 72.4 mt -131.95 133.81 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.473 -0.767 . . . . 72.430000000000007 109.147 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.505 ' OG ' ' ND2' ' A' ' 119' ' ' ASN . 70.9 m -119.73 85.01 32.41 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.651 -0.655 . . . . 71.109999999999999 109.581 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.43 -44.7 47.07 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.398 2.065 . . . . 75.140000000000001 111.886 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -61.81 -41.96 98.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 72.5 109.308 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -80.67 -8.16 59.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.301 -0.874 . . . . 73.140000000000001 108.78 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 56.24 59.75 3.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.417 -0.802 . . . . 75.329999999999998 109.552 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -155.85 134.63 11.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.206 -0.934 . . . . 71.230000000000004 109.62 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 97.6 mt -107.84 140.64 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.563 -0.711 . . . . 75.329999999999998 109.33 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.6 mp -128.35 122.15 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.397 -0.814 . . . . 71.109999999999999 109.613 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -138.69 140.23 38.71 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.814 -0.809 . . . . 74.140000000000001 108.814 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp 54.12 25.51 5.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.434 -0.791 . . . . 75.400000000000006 110.055 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.01 -7.85 58.76 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.985 -1.246 . . . . 72.239999999999995 109.985 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -88.64 128.07 35.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.087 -1.243 . . . . 73.120000000000005 109.056 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -97.97 139.0 34.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.33 -0.856 . . . . 72.319999999999993 109.636 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 13.5 p -136.76 138.75 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.461 -0.774 . . . . 62.340000000000003 109.072 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -93.86 140.92 29.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.255 -0.903 . . . . 61.229999999999997 109.543 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.02 154.01 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.303 -0.873 . . . . 74.439999999999998 109.322 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -171.08 43.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.116 -0.99 . . . . 75.420000000000002 109.899 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -164.03 -110.53 0.24 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.555 -1.418 . . . . 73.340000000000003 109.555 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.622 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 23.2 mmtp -73.29 -35.54 2.76 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.255 -1.144 . . . . 72.219999999999999 110.479 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 95.3 Cg_endo -91.4 21.96 0.74 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.464 2.109 . . . . 75.450000000000003 112.011 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -129.33 -55.54 1.17 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.56 -0.713 . . . . 65.239999999999995 109.748 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -58.61 -58.09 10.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.161 -0.962 . . . . 72.519999999999996 110.552 -178.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.6 -33.27 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.954 -1.091 . . . . 74.209999999999994 109.672 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.12 -41.68 99.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.062 -1.024 . . . . 73.310000000000002 108.676 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.409 ' H ' ' HG1' ' A' ' 153' ' ' THR . 16.6 p -74.5 -32.18 62.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.252 -0.905 . . . . 74.310000000000002 109.943 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -58.16 -50.87 72.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.172 -0.955 . . . . 75.450000000000003 109.61 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.7 pp -76.08 -26.09 56.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 75.340000000000003 109.791 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.58 -45.98 77.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 62.140000000000001 109.325 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -76.59 -44.24 35.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.195 -0.941 . . . . 72.219999999999999 108.936 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -82.41 26.43 0.56 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.514 -0.741 . . . . 74.120000000000005 109.244 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -49.66 -29.93 8.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.377 -0.827 . . . . 74.340000000000003 109.855 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 42.9 p30 -123.9 74.84 1.31 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.534 -0.728 . . . . 75.450000000000003 109.198 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 162' ' ' ILE . 13.8 tm0? -171.21 152.77 3.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.9 . . . . 73.409999999999997 109.517 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.511 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 71.4 mt -83.63 122.15 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.172 -0.955 . . . . 74.409999999999997 109.439 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.5 t -112.59 137.82 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.534 -0.729 . . . . 72.530000000000001 109.761 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 29.6 t -94.78 155.79 16.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.358 -0.839 . . . . 74.120000000000005 109.453 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.467 ' CB ' ' NZ ' ' A' ' 165' ' ' LYS . 8.7 mtpm? -56.92 -43.48 81.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 70.430000000000007 109.64 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -55.24 -37.14 66.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.923 . . . . 74.319999999999993 109.446 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -59.57 -41.91 91.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -0.939 . . . . 74.519999999999996 109.444 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 26.3 mt -63.65 -33.17 75.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.2 -0.938 . . . . 74.409999999999997 109.315 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 5.6 tt -64.71 -55.61 18.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.298 -0.876 . . . . 75.140000000000001 109.589 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -71.63 -32.6 68.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.256 -0.902 . . . . 65.030000000000001 110.295 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -58.52 -47.8 82.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.049 -1.032 . . . . 70.209999999999994 110.036 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.481 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 1.9 mp -96.96 -65.17 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.2 -0.938 . . . . 75.319999999999993 108.85 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 -85.04 89.03 7.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.422 -0.799 . . . . 73.140000000000001 109.394 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -98.26 -74.09 0.59 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.317 -0.864 . . . . 73.239999999999995 109.758 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 177' ' ' GLU . 29.8 mt-10 -60.27 152.15 64.59 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.233 -0.917 . . . . 63.329999999999998 109.408 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -40.55 83.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.348 2.032 . . . . 72.510000000000005 112.888 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 175' ' ' GLU . 42.6 mm-40 -90.96 12.58 19.18 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.886 -1.134 . . . . 75.340000000000003 108.967 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 70.8 mtm 52.02 67.01 1.04 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.867 . . . . 74.510000000000005 109.324 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 33.5 m -131.93 150.78 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.51 -0.744 . . . . 65.219999999999999 109.372 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.529 ' O ' ' N ' ' A' ' 182' ' ' ASN . 16.3 m -91.6 113.24 58.03 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.283 -0.886 . . . . 73.219999999999999 109.14 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -44.06 -11.57 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.036 1.824 . . . . 62.43 112.814 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 180' ' ' THR . 49.2 p-10 -95.79 46.71 1.09 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.074 -1.016 . . . . 73.129999999999995 109.765 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.46 -4.18 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.38 -0.825 . . . . 74.019999999999996 109.759 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.455 ' N ' ' CD1' ' A' ' 184' ' ' ILE . 1.9 mp -66.33 -29.35 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.949 -1.095 . . . . 72.329999999999998 109.141 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -61.7 -42.83 99.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 74.400000000000006 109.611 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 19.0 m -79.54 -28.49 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.09 -1.006 . . . . 74.319999999999993 109.379 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.51 -42.17 65.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.864 . . . . 73.230000000000004 109.795 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.5 tp -74.94 -29.95 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.986 -1.071 . . . . 74.310000000000002 109.314 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -70.64 -43.94 68.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.845 . . . . 73.439999999999998 110.099 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -75.56 -40.9 56.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.131 -0.981 . . . . 71.420000000000002 110.135 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 74.9 mt -60.47 -36.49 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.014 -1.054 . . . . 72.439999999999998 109.561 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 18.9 mtp-105 -71.38 -40.16 70.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.035 -1.041 . . . . 64.219999999999999 108.656 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.461 HE21 ' HZ2' ' A' ' 197' ' ' LYS . 49.4 tt0 -68.05 -35.2 77.84 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.577 -0.702 . . . . 74.319999999999993 109.133 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.411 ' O ' ' CD ' ' A' ' 198' ' ' PRO . 50.7 mtpt -85.19 -8.31 58.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.349 -0.844 . . . . 75.310000000000002 109.737 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 51.1 ttm -92.84 -57.21 2.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.185 -0.947 . . . . 74.019999999999996 109.559 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -59.12 -32.48 69.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 74.019999999999996 110.011 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.461 ' HZ2' HE21 ' A' ' 193' ' ' GLN . 54.1 mttt -57.13 -65.64 1.64 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.035 -1.041 . . . . 75.430000000000007 109.847 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 42.4 Cg_endo -64.77 -57.99 0.25 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 122.306 2.004 . . . . 72.319999999999993 112.546 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 15.3 mt -61.15 -42.75 99.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -0.958 . . . . 74.540000000000006 109.963 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 86.62 -37.63 3.15 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.78 -1.328 . . . . 61.509999999999998 109.78 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.557 ' N ' ' CD1' ' A' ' 201' ' ' ILE . 1.7 mp -92.41 141.53 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.132 -1.217 . . . . 74.25 109.371 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 59.5 p -85.55 145.23 27.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.888 . . . . 72.0 109.274 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.1 p -146.59 27.25 1.11 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.253 -0.904 . . . . 74.439999999999998 109.485 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 29.5 m -143.97 134.21 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.169 -0.957 . . . . 71.129999999999995 109.518 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -108.58 126.16 52.64 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.536 -0.727 . . . . 73.510000000000005 109.296 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.35 119.69 32.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.116 -0.99 . . . . 73.519999999999996 109.226 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 211' ' ' GLY . 34.9 m -147.82 140.74 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.224 -0.922 . . . . 72.150000000000006 109.616 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 75.1 ttt-85 -62.62 -25.51 68.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.85 . . . . 72.400000000000006 109.373 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 211' ' ' GLY . 76.1 mtt85 -47.17 103.92 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 73.310000000000002 109.786 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 60.51 -75.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.591 -0.693 . . . . 71.540000000000006 109.844 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . -158.41 -127.77 0.96 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.838 -1.305 . . . . 74.450000000000003 109.838 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -101.53 142.21 33.24 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.407 -1.054 . . . . 75.540000000000006 109.436 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -106.43 126.57 52.41 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.478 -0.764 . . . . 75.310000000000002 109.686 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -98.04 128.36 44.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.389 -0.82 . . . . 75.409999999999997 109.034 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 34.0 m -151.78 154.94 37.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.498 -0.751 . . . . 74.140000000000001 109.137 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . 0.45 ' O ' ' O ' ' A' ' 217' ' ' PRO . 7.4 p90 -65.14 153.14 89.95 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.153 -0.967 . . . . 75.319999999999993 109.279 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 216' ' ' TYR . 84.2 Cg_exo -42.94 176.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.269 1.979 . . . . 73.109999999999999 112.408 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 220' ' ' ALA . 10.9 ptpt -46.38 154.82 0.61 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.313 -0.867 . . . . 75.25 108.811 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -33.7 85.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.683 2.256 . . . . 75.099999999999994 112.601 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 218' ' ' LYS . . . -61.52 -30.68 70.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.472 -0.767 . . . . 71.140000000000001 109.484 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 222' ' ' GLU . 30.4 p -54.64 -37.52 65.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 71.129999999999995 109.558 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.402 ' N ' ' SG ' ' A' ' 221' ' ' CYS . 96.5 mt-10 -60.03 140.95 56.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 75.349999999999994 109.361 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.402 ' OXT' ' O ' ' A' ' 222' ' ' GLU . 96.9 mt-10 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.0 -1.0 . . . . 73.409999999999997 109.444 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 52.5 ttm . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.487 -0.56 . . . . 75.239999999999995 109.487 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -139.87 148.78 42.56 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.303 -0.873 . . . . 73.519999999999996 109.354 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 93.6 t -113.91 137.71 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.583 -0.698 . . . . 72.239999999999995 109.452 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 3.5 tp -109.89 119.66 40.04 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.555 -0.716 . . . . 73.340000000000003 109.735 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 15.3 mt -117.23 96.33 5.38 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 108.615 -0.883 . . . . 74.349999999999994 108.615 178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 87.2 mt -82.93 98.88 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.703 -1.248 . . . . 63.439999999999998 109.049 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.425 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 38.8 tp10 -130.78 129.72 42.8 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.506 -0.746 . . . . 74.519999999999996 109.556 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -64.96 -38.96 92.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.314 -0.866 . . . . 74.129999999999995 109.332 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -83.8 116.63 22.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 74.230000000000004 109.471 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 23.4 m -66.73 -27.01 67.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.9 . . . . 65.540000000000006 109.795 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -66.99 -51.56 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.15 -0.969 . . . . 75.549999999999997 109.844 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.501 ' N ' ' CD1' ' B' ' 12' ' ' LEU . 7.9 mp -62.96 -39.07 93.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.172 -0.955 . . . . 70.140000000000001 109.62 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.05 -29.34 64.9 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 108.551 -1.82 . . . . 75.400000000000006 108.551 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.91 -49.84 68.9 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.674 -1.37 . . . . 65.439999999999998 109.674 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -61.96 -46.98 86.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.309 -1.112 . . . . 72.200000000000003 109.786 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 5.7 mm -63.98 -40.14 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.757 -1.214 . . . . 75.150000000000006 108.632 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.505 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 73.1 tt0 -63.07 -44.27 96.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.412 -0.805 . . . . 73.010000000000005 109.554 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -85.53 1.55 48.49 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.071 -1.018 . . . . 74.299999999999997 109.588 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.93 -57.3 1.94 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.376 -1.49 . . . . 70.540000000000006 109.376 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -71.31 -20.85 62.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.424 -1.044 . . . . 75.430000000000007 109.648 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 89.6 m-20 -57.98 -30.81 66.33 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.992 -1.067 . . . . 73.200000000000003 109.278 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 92.9 t -59.05 -37.3 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.344 -0.847 . . . . 74.230000000000004 109.142 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -65.52 -21.4 66.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.371 -0.83 . . . . 73.519999999999996 109.398 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.32 39.87 2.52 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 110.11 -1.196 . . . . 53.43 110.11 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -120.2 160.98 21.85 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.474 -1.015 . . . . 71.120000000000005 109.208 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 3.8 mtt -100.45 139.84 35.56 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.262 -1.014 . . . . 75.239999999999995 108.262 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . 0.43 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -143.95 154.45 43.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.225 -0.922 . . . . 73.25 110.37 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 96.9 m-20 -138.87 155.01 48.44 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.173 -1.047 . . . . 72.310000000000002 108.173 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.43 139.74 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.338 -0.851 . . . . 72.140000000000001 109.985 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.5 p -130.47 171.08 13.38 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 109.144 -0.687 . . . . 74.530000000000001 109.144 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.42 ' OE2' ' OD2' ' B' ' 35' ' ' ASP . 5.4 pt-20 -91.69 -106.11 0.1 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.178 -0.951 . . . . 71.019999999999996 109.873 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 77.7 p -78.11 166.94 22.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.223 -0.923 . . . . 71.400000000000006 110.073 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 53.5 mt -51.34 -30.86 19.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.586 -0.696 . . . . 71.239999999999995 109.945 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.87 -51.01 65.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.092 -1.005 . . . . 74.319999999999993 109.885 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.42 ' OD2' ' OE2' ' B' ' 31' ' ' GLU . 2.3 m-20 -63.58 -39.44 94.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.121 -0.987 . . . . 73.030000000000001 109.264 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.81 -38.4 76.15 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.253 -1.539 . . . . 60.43 109.253 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -67.18 -38.36 85.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -1.113 . . . . 74.430000000000007 109.573 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -80.52 -36.93 32.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.155 -0.965 . . . . 74.420000000000002 109.661 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 10.5 tp -71.29 -42.67 68.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 75.409999999999997 110.091 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.443 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.3 ppp? -67.54 -25.26 65.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.039 -1.038 . . . . 61.439999999999998 109.977 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -60.62 -39.84 89.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.046 -1.034 . . . . 74.319999999999993 110.161 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 14.7 pt -81.21 -32.01 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.006 -1.059 . . . . 71.230000000000004 110.202 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' B' ' 40' ' ' MET . 25.2 mmt180 -130.28 141.52 50.6 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.297 -0.877 . . . . 73.409999999999997 109.548 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -98.48 132.71 43.7 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.28 -0.887 . . . . 63.539999999999999 109.437 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -102.37 138.28 39.51 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.353 -0.842 . . . . 73.109999999999999 109.513 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -75.82 -34.5 60.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 62.219999999999999 109.189 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.408 ' C ' ' CD1' ' B' ' 47' ' ' LEU . 0.8 OUTLIER -112.38 110.59 20.89 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.645 -0.872 . . . . 73.120000000000005 108.645 179.662 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 54.5 t -95.52 100.85 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.369 -0.832 . . . . 74.109999999999999 109.124 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' MET . . . . . 0.509 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 0.6 OUTLIER -114.93 129.54 56.73 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.2 -0.667 . . . . 73.439999999999998 109.2 -179.659 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.477 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.6 OUTLIER -144.69 132.29 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.457 -0.777 . . . . 73.400000000000006 109.233 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' SER . . . . . 0.425 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 24.9 p -94.57 11.57 30.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.392 -0.818 . . . . 73.209999999999994 109.662 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.477 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 35.9 m-20 -80.61 138.65 36.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.147 -0.971 . . . . 70.409999999999997 109.515 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.479 ' C ' ' H ' ' B' ' 55' ' ' ALA . 62.3 mttp -74.92 -38.53 61.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.206 -0.934 . . . . 73.129999999999995 110.029 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -71.03 9.9 0.64 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.171 -0.955 . . . . 75.209999999999994 109.619 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -66.4 -21.77 66.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 55.329999999999998 110.134 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 33.3 mt -42.82 -40.16 2.77 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.397 -0.814 . . . . 72.420000000000002 110.33 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 13.0 t -76.32 -39.97 52.64 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.946 -1.096 . . . . 73.040000000000006 109.563 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -65.1 -43.14 93.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.332 -0.855 . . . . 72.329999999999998 110.307 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.37 -37.62 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.697 -1.252 . . . . 74.540000000000006 109.509 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 40.4 m -55.24 -48.66 73.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 71.239999999999995 109.439 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -69.57 -34.41 74.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.115 -0.99 . . . . 74.310000000000002 110.134 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' B' ' 66' ' ' HIS . 5.4 mm -64.52 -40.33 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.785 -1.197 . . . . 75.420000000000002 109.8 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.521 ' NZ ' ' OD1' ' B' ' 92' ' ' ASP . 44.4 mmtt -65.44 -48.81 71.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.157 -0.964 . . . . 73.319999999999993 110.459 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -73.01 -37.54 66.92 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.841 -1.162 . . . . 73.310000000000002 110.035 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.47 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 46.4 mtpt -80.22 -22.04 42.22 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.11 -0.994 . . . . 72.439999999999998 109.757 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.47 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 81.6 m-70 -155.68 65.92 0.61 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.136 -0.977 . . . . 65.209999999999994 109.623 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 9.7 t -60.44 -27.78 67.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 73.099999999999994 109.793 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 84.4 p -65.27 -24.82 67.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -0.92 . . . . 71.530000000000001 110.169 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 79.9 mt -79.81 152.89 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.103 -0.998 . . . . 74.400000000000006 109.677 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 69.4 t -92.44 159.44 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.287 -0.883 . . . . 75.120000000000005 109.468 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 11.7 t -137.96 120.92 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.184 -0.947 . . . . 73.200000000000003 109.877 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.509 ' O ' ' SD ' ' B' ' 49' ' ' MET . 0.7 OUTLIER -111.04 105.12 13.77 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.16 -1.052 . . . . 73.340000000000003 108.16 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 94.6 t -95.68 131.9 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.107 -0.996 . . . . 73.5 109.535 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.08 162.38 13.42 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.434 -0.791 . . . . 71.319999999999993 109.103 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.473 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 25.1 p -153.92 136.64 15.24 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.96 -1.087 . . . . 74.530000000000001 110.646 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -90.43 4.42 51.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.372 -0.83 . . . . 64.5 109.119 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' B' ' 79' ' ' THR . 65.5 m-80 -142.31 68.5 21.52 Favored Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 108.663 -0.865 . . . . 74.25 108.663 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -54.71 79.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.347 2.031 . . . . 74.430000000000007 111.235 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.503 ' N ' ' O ' ' B' ' 77' ' ' ASN . 37.2 p -103.28 152.49 21.46 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.053 -0.721 . . . . 73.120000000000005 109.053 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -31.4 71.42 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.262 -0.899 . . . . 75.409999999999997 109.387 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -63.34 -48.24 78.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 72.239999999999995 109.493 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . 0.511 ' CD ' ' HH ' ' B' ' 94' ' ' TYR . 82.6 tt0 -71.7 -27.11 62.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 73.219999999999999 109.372 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.527 ' OE2' ' NE ' ' A' ' 108' ' ' ARG . 86.9 tt0 -63.03 -55.6 24.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.883 . . . . 74.299999999999997 109.887 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 22.9 m -61.93 -40.29 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.058 -1.026 . . . . 73.310000000000002 109.423 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 21.5 m170 -64.71 -31.69 73.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.166 -0.959 . . . . 73.239999999999995 109.483 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.48 -45.87 81.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.918 . . . . 55.329999999999998 110.256 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -79.87 -34.51 39.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.031 -1.043 . . . . 74.450000000000003 109.433 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -70.78 -40.33 72.66 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.248 -0.908 . . . . 64.040000000000006 109.57 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -65.12 -52.16 57.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -0.965 . . . . 75.129999999999995 109.412 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.24 59.43 0.02 OUTLIER Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.188 -1.165 . . . . 75.420000000000002 110.188 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.88 136.18 53.62 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.435 -1.039 . . . . 73.420000000000002 109.075 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . 0.521 ' OD1' ' NZ ' ' B' ' 63' ' ' LYS . 24.6 m-20 -82.16 -20.8 37.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.09 -1.006 . . . . 73.319999999999993 109.525 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -153.3 164.6 37.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 73.040000000000006 109.655 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.511 ' HH ' ' CD ' ' B' ' 82' ' ' GLU . 76.1 t80 -145.14 97.26 2.98 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.745 -0.835 . . . . 74.310000000000002 108.745 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 19.0 mm -104.73 142.01 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 121.163 -0.961 . . . . 75.340000000000003 109.928 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' B' ' 97' ' ' LYS . . . -60.74 124.29 19.99 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.467 -1.308 . . . . 70.099999999999994 107.467 178.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' B' ' 99' ' ' TYR . 2.1 tptt -43.35 -61.04 2.03 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.058 -1.026 . . . . 65.430000000000007 110.726 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 9.3 Cg_endo -45.02 89.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 120.566 0.844 . . . . 63.520000000000003 110.489 -176.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . 0.582 ' N ' ' O ' ' B' ' 97' ' ' LYS . 45.4 m-85 -39.75 97.76 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.229 0.537 . . . . 75.129999999999995 111.128 -176.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -53.27 -33.43 53.11 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.521 -1.288 . . . . 74.230000000000004 107.521 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 32.5 t -176.18 128.03 0.21 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.274 -1.01 . . . . 64.510000000000005 108.274 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . 0.411 HG22 HD12 ' B' ' 102' ' ' ILE . 19.6 mm -51.68 -36.22 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.017 -1.052 . . . . 74.439999999999998 108.903 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . 0.413 ' N ' ' CD ' ' B' ' 103' ' ' LYS . 11.8 mptt -67.23 -34.47 77.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.358 -0.839 . . . . 72.299999999999997 109.407 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.53 -58.72 3.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.241 -0.912 . . . . 74.310000000000002 109.771 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.443 ' C ' ' CD1' ' B' ' 105' ' ' LEU . 1.9 tm? -54.46 -53.33 55.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 73.540000000000006 109.275 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 88.3 t -61.62 -42.47 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.987 -1.071 . . . . 72.030000000000001 109.37 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.82 -38.28 55.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.137 -0.977 . . . . 64.219999999999999 108.907 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -70.25 -34.7 73.14 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.354 -0.841 . . . . 75.310000000000002 109.441 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 86.3 mt -75.93 -26.59 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.14 -0.975 . . . . 55.439999999999998 108.788 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -76.6 -57.78 3.66 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.458 -0.776 . . . . 65.310000000000002 109.618 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.51 -44.84 73.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 74.519999999999996 109.961 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -59.83 4.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.113 -0.992 . . . . 72.040000000000006 109.646 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 30.4 tp -60.61 -35.52 76.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.11 -0.994 . . . . 75.349999999999994 109.763 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.45 ' O ' ' CB ' ' B' ' 115' ' ' PHE . 14.1 mmt180 -53.62 160.3 1.33 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.073 -1.017 . . . . 75.5 109.252 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' PHE . . . . . 0.45 ' CB ' ' O ' ' B' ' 114' ' ' ARG . 4.9 t80 75.6 -4.15 2.43 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.519 -0.738 . . . . 73.040000000000006 109.535 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER 54.26 -171.76 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 74.450000000000003 109.773 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -92.92 5.1 75.9 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.487 -1.445 . . . . 64.209999999999994 109.487 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 11.8 t 49.57 -174.33 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.492 -1.005 . . . . 71.400000000000006 109.854 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.73 141.74 23.0 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.424 -0.797 . . . . 74.209999999999994 109.336 -178.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 23.8 t -86.87 -44.11 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.187 -0.945 . . . . 75.019999999999996 109.854 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 3.6 mm -117.5 154.37 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.238 -0.914 . . . . 74.239999999999995 109.434 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -143.62 130.85 20.8 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.325 -0.859 . . . . 73.329999999999998 109.049 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 17.8 mt -135.47 108.33 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.18 -0.95 . . . . 74.219999999999999 109.896 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' B' ' 126' ' ' LEU . . . 56.02 -155.41 12.58 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.229 -1.148 . . . . 72.409999999999997 110.229 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.99 -0.56 0.52 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.477 -1.013 . . . . 75.120000000000005 109.644 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.498 ' H ' ' C ' ' B' ' 124' ' ' GLY . 1.7 mt -94.22 148.6 22.04 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.237 -0.914 . . . . 75.420000000000002 109.405 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 7.0 m -126.33 132.33 51.64 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.109 -1.071 . . . . 74.219999999999999 108.109 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 88.8 mt -121.05 131.03 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.348 -0.845 . . . . 60.329999999999998 110.69 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 64.9 m -128.86 101.84 19.86 Favored Pre-proline 0 N--CA 1.495 1.824 0 N-CA-C 108.858 -0.793 . . . . 72.310000000000002 108.858 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -81.87 -40.32 0.15 Allowed 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.092 1.862 . . . . 75.129999999999995 111.918 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -52.97 -33.4 51.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.132 -0.98 . . . . 75.230000000000004 108.881 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -104.39 4.02 32.94 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.504 -0.747 . . . . 75.120000000000005 109.499 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.433 ' OE1' ' CD2' ' B' ' 149' ' ' PHE . 49.0 mm-40 49.77 59.58 4.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.124 -0.985 . . . . 75.129999999999995 109.3 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -151.51 145.46 25.2 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.223 -0.923 . . . . 75.109999999999999 109.726 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . 0.412 HG22 ' HH ' ' B' ' 137' ' ' TYR . 4.5 mp -137.81 133.49 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 108.782 -0.821 . . . . 70.319999999999993 108.782 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 4.7 mm -107.18 137.1 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.533 -0.73 . . . . 74.120000000000005 109.606 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . 0.412 ' HH ' HG22 ' B' ' 135' ' ' ILE . 28.8 m-85 -126.04 130.97 52.2 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.181 -1.044 . . . . 74.230000000000004 108.181 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . 0.611 ' NZ ' ' HE ' ' B' ' 140' ' ' ARG . 23.3 ttpp 55.36 14.92 1.21 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.499 -0.751 . . . . 74.219999999999999 109.762 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.91 -0.11 66.74 Favored Glycine 0 N--CA 1.496 2.684 0 O-C-N 120.927 -1.108 . . . . 74.319999999999993 110.505 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . 0.611 ' HE ' ' NZ ' ' B' ' 138' ' ' LYS . 17.5 mtt-85 -89.94 137.27 32.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.208 -1.172 . . . . 75.340000000000003 108.449 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -82.94 126.98 33.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 71.230000000000004 110.419 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 39.9 t -126.81 128.81 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.912 -0.773 . . . . 70.430000000000007 108.912 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -94.2 147.28 23.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.978 -1.076 . . . . 72.430000000000007 109.228 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . 0.667 ' H ' ' NZ ' ' B' ' 145' ' ' LYS . 2.4 t -142.16 115.41 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.217 -0.927 . . . . 72.129999999999995 108.95 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . 0.667 ' NZ ' ' H ' ' B' ' 144' ' ' VAL . 0.1 OUTLIER -145.28 140.17 27.62 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.278 -0.888 . . . . 74.5 109.742 179.886 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 111.54 -114.39 3.62 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 110.666 -0.973 . . . . 42.229999999999997 110.666 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 0.615 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 6.6 ttpm? -95.34 -29.82 0.27 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.57 -0.959 . . . . 73.299999999999997 112.42 -178.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 57.0 Cg_endo -80.47 -17.78 9.92 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 C-N-CA 121.482 1.455 . . . . 71.329999999999998 113.0 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . 0.433 ' CD2' ' OE1' ' B' ' 133' ' ' GLU . 1.1 p90 -85.54 -37.85 19.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.93 -1.107 . . . . 74.230000000000004 109.215 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . 0.426 ' N ' ' CG ' ' B' ' 149' ' ' PHE . 3.3 tm-20 -60.34 -46.7 88.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.533 -0.729 . . . . 72.340000000000003 109.974 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.89 -40.65 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.864 -1.148 . . . . 73.349999999999994 110.102 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 4.7 tt -66.65 -54.91 18.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.296 -0.877 . . . . 74.430000000000007 109.679 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' B' ' 149' ' ' PHE . 16.0 p -64.76 -32.44 74.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.004 -1.06 . . . . 75.209999999999994 110.555 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -59.2 -59.58 5.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.947 -1.095 . . . . 73.040000000000006 109.927 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . 0.829 HD13 ' CE2' ' B' ' 214' ' ' PHE . 1.9 pp -69.3 -21.48 63.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.028 -1.045 . . . . 73.430000000000007 109.946 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.89 -52.98 61.9 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.014 -1.054 . . . . 75.319999999999993 109.334 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.496 ' C ' ' H ' ' B' ' 159' ' ' ARG . 16.5 mtm-85 -71.95 -51.62 21.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.18 -0.95 . . . . 73.319999999999993 109.79 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -74.79 36.19 0.11 Allowed 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.725 -0.79 . . . . 74.140000000000001 109.506 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . 0.496 ' H ' ' C ' ' B' ' 157' ' ' ARG . 30.2 ptt180 -59.91 166.05 2.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -0.86 . . . . 73.420000000000002 109.179 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 24.9 t70 43.66 64.24 1.32 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.253 -0.904 . . . . 72.099999999999994 109.88 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -157.3 159.21 37.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -0.965 . . . . 73.239999999999995 109.567 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 30.6 mt -93.77 114.02 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.218 -0.926 . . . . 72.310000000000002 109.139 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 4.0 m -115.13 129.78 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 121.527 0.679 . . . . 75.030000000000001 109.511 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 164' ' ' SER . . . . . 0.516 ' OG ' ' NE2' ' B' ' 167' ' ' GLN . 28.7 p -92.39 167.31 12.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -0.871 . . . . 74.219999999999999 109.125 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -51.69 -37.07 49.12 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.111 -0.993 . . . . 72.420000000000002 109.297 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -74.57 -25.46 59.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.146 -0.971 . . . . 63.450000000000003 110.559 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 167' ' ' GLN . . . . . 0.516 ' NE2' ' OG ' ' B' ' 164' ' ' SER . 0.0 OUTLIER -64.04 -56.14 17.17 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.618 -1.301 . . . . 72.400000000000006 108.792 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 47.1 mt -57.42 -57.21 13.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.102 -0.999 . . . . 72.319999999999993 108.916 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' B' ' 170' ' ' ASP . 1.9 mm? -50.55 -56.01 13.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.045 -1.034 . . . . 73.340000000000003 108.846 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' B' ' 169' ' ' LEU . 67.8 m-20 -41.69 -34.16 0.58 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.74 -0.6 . . . . 73.099999999999994 110.615 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -91.69 -37.72 12.86 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.102 -0.999 . . . . 62.130000000000003 110.729 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.578 ' C ' ' H ' ' B' ' 174' ' ' GLU . 3.7 mp -88.09 -68.41 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.893 -1.129 . . . . 74.439999999999998 109.442 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 173' ' ' TRP . . . . . 0.476 ' C ' ' CD2' ' B' ' 173' ' ' TRP . 0.0 OUTLIER -54.26 -2.38 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.505 -0.747 . . . . 72.230000000000004 109.47 -179.27 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . 0.578 ' H ' ' C ' ' B' ' 172' ' ' ILE . 48.4 tt0 -48.43 -18.79 0.26 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.101 -0.999 . . . . 75.030000000000001 109.861 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . 0.46 ' CB ' ' CD ' ' B' ' 176' ' ' PRO . 0.6 OUTLIER -53.04 -176.91 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.201 -0.937 . . . . 73.040000000000006 108.709 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.46 ' CD ' ' CB ' ' B' ' 175' ' ' GLU . 37.6 Cg_exo -60.37 40.39 0.06 OUTLIER 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 122.563 2.176 . . . . 74.129999999999995 112.513 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' B' ' 175' ' ' GLU . 97.6 mt-10 46.98 -161.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.185 -0.947 . . . . 72.439999999999998 109.836 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 53.8 mmm 55.72 39.01 30.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.337 -0.852 . . . . 72.109999999999999 109.504 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 179' ' ' VAL . . . . . 0.402 ' O ' ' OG1' ' B' ' 180' ' ' THR . 2.7 m -109.51 72.63 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.566 -0.709 . . . . 75.310000000000002 109.402 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 180' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' B' ' 179' ' ' VAL . 4.0 p 45.86 83.0 0.22 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.46 -0.775 . . . . 62.149999999999999 109.813 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -51.47 164.77 0.77 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.046 1.831 . . . . 74.340000000000003 111.874 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 182' ' ' ASN . . . . . 0.813 ' OD1' ' OE2' ' B' ' 185' ' ' GLU . 45.5 t-20 49.33 60.9 3.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.136 -0.978 . . . . 72.310000000000002 110.006 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 4.1 p -119.09 4.65 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 108.994 -0.743 . . . . 65.420000000000002 108.994 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 35.2 mt -63.62 -53.53 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.058 -1.026 . . . . 75.030000000000001 109.914 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . 0.813 ' OE2' ' OD1' ' B' ' 182' ' ' ASN . 1.5 pm0 -61.5 -40.43 94.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 73.519999999999996 110.313 -178.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 97.2 t -73.99 -48.03 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.995 -1.066 . . . . 74.349999999999994 110.404 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -68.91 -47.27 66.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.059 -1.026 . . . . 61.119999999999997 110.704 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 7.5 tt -70.0 -36.6 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.741 -1.224 . . . . 72.430000000000007 110.917 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -65.42 -47.61 75.65 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.945 -1.097 . . . . 75.420000000000002 109.144 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . 0.761 ' HB3' ' HZ1' ' B' ' 194' ' ' LYS . 35.9 mm-40 -66.58 -46.29 76.46 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.229 -0.92 . . . . 74.140000000000001 110.023 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 65.1 mt -54.45 -42.0 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.825 -1.172 . . . . 74.030000000000001 109.684 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 24.1 mtp180 -59.94 -45.52 92.36 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.236 -0.915 . . . . 72.329999999999998 109.922 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -75.44 -32.86 60.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.223 -0.923 . . . . 73.099999999999994 110.159 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . 0.761 ' HZ1' ' HB3' ' B' ' 190' ' ' GLN . 39.1 mttp -71.84 -24.52 61.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.347 -0.846 . . . . 74.430000000000007 110.002 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 11.2 mtt -94.84 -12.14 27.53 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.036 -1.04 . . . . 74.329999999999998 109.473 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -102.03 -7.12 22.61 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.328 -0.857 . . . . 71.209999999999994 110.522 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . 0.457 ' N ' ' CD ' ' B' ' 198' ' ' PRO . 1.3 mmtt -95.77 -49.44 0.25 Allowed Pre-proline 0 N--CA 1.501 2.125 0 O-C-N 120.784 -1.198 . . . . 75.209999999999994 110.351 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 198' ' ' PRO . . . . . 0.509 ' CD ' ' O ' ' B' ' 194' ' ' LYS . 89.0 Cg_endo -83.97 -38.53 0.13 Allowed 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.279 1.986 . . . . 75.319999999999993 113.672 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 11.2 mt -75.73 -46.42 31.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.836 -1.165 . . . . 72.25 109.648 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 88.15 0.78 82.6 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.663 -1.775 . . . . 73.239999999999995 108.663 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 38.4 mt -125.53 125.62 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.583 -0.951 . . . . 54.299999999999997 109.296 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 27.3 p -85.78 137.16 32.99 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.836 -1.172 . . . . 74.310000000000002 107.836 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 67.7 p -137.98 11.73 2.86 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.109 -0.994 . . . . 74.400000000000006 110.125 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.46 128.37 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.304 -0.873 . . . . 74.099999999999994 109.407 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . 0.41 ' OE2' ' SG ' ' B' ' 215' ' ' CYS . 80.9 mt-10 -90.85 109.41 20.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.465 -0.772 . . . . 75.329999999999998 108.922 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 43.9 p -85.35 126.44 33.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.445 -0.784 . . . . 71.400000000000006 109.074 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 9.9 p -152.5 159.85 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.13 -0.982 . . . . 63.5 109.675 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -85.28 -38.97 18.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.154 -0.966 . . . . 74.450000000000003 109.914 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' B' ' 211' ' ' GLY . 80.5 mtm180 -55.85 150.69 12.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.021 -1.05 . . . . 74.140000000000001 109.512 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? 51.59 -90.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.215 -0.928 . . . . 74.430000000000007 108.805 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' B' ' 209' ' ' ARG . . . -171.79 -108.51 0.21 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.801 -1.719 . . . . 70.109999999999999 108.801 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -119.17 140.56 49.97 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.578 -0.954 . . . . 74.209999999999994 108.759 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -124.36 126.19 45.56 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.58 0.705 . . . . 74.299999999999997 110.106 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . 0.829 ' CE2' HD13 ' B' ' 155' ' ' LEU . 24.3 t80 -92.11 133.18 36.0 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.854 -0.795 . . . . 74.340000000000003 108.854 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . 0.41 ' SG ' ' OE2' ' B' ' 205' ' ' GLU . 2.6 p -147.1 166.34 27.2 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.987 -1.071 . . . . 72.209999999999994 109.706 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -72.44 151.23 91.8 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.222 -0.924 . . . . 72.310000000000002 108.654 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.07 160.92 46.57 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.157 1.905 . . . . 71.010000000000005 111.718 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . 0.492 ' O ' ' SG ' ' B' ' 221' ' ' CYS . 22.0 mttm -49.4 -64.13 1.35 Allowed Pre-proline 0 C--N 1.303 -1.445 0 O-C-N 121.276 -0.89 . . . . 74.349999999999994 109.335 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' B' ' 218' ' ' LYS . 37.5 Cg_endo -64.48 -171.9 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.879 1.719 . . . . 71.319999999999993 111.421 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 46.23 59.44 3.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.227 -0.921 . . . . 75.450000000000003 109.806 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 221' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' B' ' 218' ' ' LYS . 16.4 p -167.16 150.18 6.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -0.922 . . . . 72.219999999999999 109.17 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 47.87 91.29 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.139 -0.975 . . . . 74.299999999999997 109.434 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.019 -0.991 . . . . 71.129999999999995 109.639 179.928 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptp . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.451 -0.574 . . . . 65.120000000000005 109.451 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -141.68 160.18 40.7 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.299 -0.875 . . . . 73.310000000000002 109.453 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.4 t -118.34 125.35 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.169 -0.678 . . . . 71.420000000000002 109.169 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.405 ' O ' ' O ' ' A' ' 49' ' ' MET . 4.8 tp -99.31 115.1 28.39 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.497 -0.752 . . . . 65.219999999999999 109.212 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.0 tp -119.68 110.08 16.4 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.337 -0.986 . . . . 71.439999999999998 108.337 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.435 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 16.9 mt -92.73 109.18 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.899 -1.125 . . . . 71.150000000000006 109.595 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -152.54 120.09 6.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.166 -0.959 . . . . 75.340000000000003 109.673 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -65.16 -38.46 90.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 73.040000000000006 109.451 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -67.66 106.16 2.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 72.420000000000002 109.567 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 91.0 p -66.64 -26.33 67.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.316 -0.865 . . . . 72.340000000000003 109.551 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.64 -53.68 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.158 -0.964 . . . . 74.420000000000002 109.691 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.495 ' N ' ' CD1' ' A' ' 12' ' ' LEU . 7.9 mp -65.18 -36.45 84.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 72.010000000000005 109.552 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.92 -27.49 64.49 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.54 -1.824 . . . . 72.140000000000001 108.54 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.04 -49.72 61.09 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.441 -1.464 . . . . 72.329999999999998 109.441 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -61.59 -44.86 96.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -1.138 . . . . 72.340000000000003 109.55 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.5 mm -63.64 -39.08 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.743 -1.223 . . . . 74.239999999999995 108.281 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -64.42 -52.12 59.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.499 -0.75 . . . . 71.409999999999997 109.975 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -77.72 -2.77 37.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 75.540000000000006 109.566 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.42 -49.94 3.99 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 108.989 -1.644 . . . . 62.149999999999999 108.989 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pp -75.7 -28.96 58.83 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.433 -1.039 . . . . 74.420000000000002 109.234 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -51.65 -34.32 37.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.202 -0.936 . . . . 74.25 108.815 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.0 t -54.76 -47.38 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.523 -0.917 . . . . 72.109999999999999 108.523 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -54.35 -54.81 35.44 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.23 -1.026 . . . . 73.230000000000004 108.23 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 130.74 40.42 0.24 Allowed Glycine 0 N--CA 1.499 2.847 0 N-CA-C 110.636 -0.986 . . . . 75.540000000000006 110.636 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -118.91 159.67 23.37 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.19 -1.183 . . . . 74.510000000000005 108.694 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 11.7 mmt -97.65 138.35 35.18 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.211 -1.033 . . . . 64.319999999999993 108.211 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.95 160.12 40.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 74.310000000000002 109.784 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -142.03 151.55 42.53 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.781 -0.822 . . . . 75.400000000000006 108.781 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 t -106.03 134.7 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.706 -0.85 . . . . 75.129999999999995 108.706 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.3 p -129.7 163.46 26.09 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.517 -0.739 . . . . 71.420000000000002 109.356 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.435 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 2.8 pt-20 -92.22 -97.46 0.13 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.317 -0.865 . . . . 73.109999999999999 109.69 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.3 p -78.26 166.38 22.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 74.239999999999995 110.071 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.4 mt -55.02 -38.06 67.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.601 -0.687 . . . . 71.530000000000001 110.028 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -53.47 -43.22 67.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.168 -0.957 . . . . 74.230000000000004 110.061 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -63.92 -37.7 88.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.026 -1.046 . . . . 71.010000000000005 109.595 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.24 -45.72 11.09 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.914 -1.274 . . . . 61.409999999999997 109.914 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -61.82 -36.88 82.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -1.137 . . . . 74.340000000000003 109.88 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.443 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 64.6 t80 -80.07 -26.21 39.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.901 . . . . 75.329999999999998 110.249 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.8 tp -86.63 -32.57 20.51 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.031 -1.043 . . . . 74.329999999999998 110.223 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.5 ' SD ' ' OH ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -83.16 -34.12 26.07 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.088 -1.008 . . . . 70.319999999999993 110.79 -178.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 35.2 p-10 -57.7 -30.43 65.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.035 -1.041 . . . . 71.219999999999999 110.529 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.53 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 7.9 pt -85.03 -38.22 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.864 -1.148 . . . . 74.409999999999997 110.485 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.436 ' O ' ' O ' ' A' ' 40' ' ' MET . 97.8 mtt180 -101.52 162.58 12.79 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.105 -0.997 . . . . 75.409999999999997 110.046 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -92.39 144.51 25.3 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.336 -0.853 . . . . 75.420000000000002 108.992 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.558 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 3.5 p90 -142.13 179.94 6.61 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.151 -0.968 . . . . 74.230000000000004 109.732 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -143.16 -32.39 0.47 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.321 -0.862 . . . . 75.319999999999993 109.767 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.24 113.31 26.32 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.345 -0.847 . . . . 72.129999999999995 109.086 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.0 t -101.27 99.54 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.797 -0.816 . . . . 72.340000000000003 108.797 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.405 ' O ' ' O ' ' A' ' 4' ' ' LEU . 26.5 ttt -114.55 132.24 56.39 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.561 0.696 . . . . 74.109999999999999 109.567 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -142.12 136.05 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.382 -0.824 . . . . 71.239999999999995 109.69 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.8 t -102.06 1.25 36.2 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.478 -0.764 . . . . 73.109999999999999 109.772 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -76.07 145.99 39.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.103 -0.998 . . . . 63.399999999999999 109.713 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.441 ' C ' ' H ' ' A' ' 55' ' ' ALA . 29.2 mmtp -78.01 -46.46 20.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.25 -0.906 . . . . 65.439999999999998 110.204 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -59.98 -4.63 0.79 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.154 -0.966 . . . . 73.129999999999995 109.908 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.441 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -62.92 -23.01 67.17 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.226 -0.921 . . . . 64.140000000000001 110.139 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 55' ' ' ALA . 14.5 mt -39.98 -54.56 2.19 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.603 -0.686 . . . . 74.430000000000007 110.71 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.6 p -68.39 -31.83 71.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.734 -1.229 . . . . 63.229999999999997 109.254 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.406 ' N ' ' O ' ' A' ' 55' ' ' ALA . 66.5 t80 -65.74 -46.99 76.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.395 -0.816 . . . . 74.439999999999998 110.242 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.8 m -63.06 -35.09 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.706 -1.246 . . . . 74.030000000000001 109.467 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 60.8 m -57.09 -51.33 69.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.18 -0.95 . . . . 73.540000000000006 109.419 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -67.64 -34.48 77.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.125 -0.984 . . . . 73.340000000000003 110.019 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.8 mm -63.32 -28.46 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.839 -1.163 . . . . 73.349999999999994 109.455 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.44 ' HZ1' ' CG ' ' A' ' 92' ' ' ASP . 30.8 mmtt -75.4 -57.86 3.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.074 -1.017 . . . . 74.420000000000002 109.784 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -62.37 -33.24 74.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.897 -1.127 . . . . 74.549999999999997 109.73 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 8.3 mtpm? -85.42 -18.66 32.99 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.18 -0.95 . . . . 75.219999999999999 109.844 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.523 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 98.7 m-70 -157.61 65.97 0.48 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.027 -1.046 . . . . 74.129999999999995 109.606 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 63' ' ' LYS . 16.6 m -66.12 -24.12 66.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.286 -0.884 . . . . 73.239999999999995 110.023 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 86.8 p -68.11 -21.47 64.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.154 -0.966 . . . . 71.439999999999998 110.427 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 58.3 mt -88.43 153.37 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.102 -0.998 . . . . 71.329999999999998 109.635 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.9 t -91.11 158.96 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.135 -0.978 . . . . 73.019999999999996 110.189 -179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.8 t -132.44 125.31 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.397 -0.814 . . . . 54.210000000000001 109.759 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.5 tt -118.34 101.91 8.55 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.491 -0.756 . . . . 74.209999999999994 109.125 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.0 t -91.61 137.21 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.189 -0.944 . . . . 74.409999999999997 109.707 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.8 156.55 19.51 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.492 -0.929 . . . . 72.310000000000002 108.492 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.433 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 27.9 t -153.66 132.25 12.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.04 -1.037 . . . . 64.540000000000006 109.786 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -89.44 3.26 52.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.386 -0.821 . . . . 74.129999999999995 108.904 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 79' ' ' THR . 2.5 p-10 -138.52 56.48 10.05 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.528 -0.733 . . . . 73.340000000000003 109.048 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -49.92 87.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.322 2.015 . . . . 71.319999999999993 111.339 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 77' ' ' ASN . 21.2 m -110.22 152.59 25.91 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.091 -0.707 . . . . 62.530000000000001 109.091 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.39 -34.24 64.19 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.43 -0.794 . . . . 74.140000000000001 109.755 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -65.15 -52.5 54.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 71.420000000000002 110.103 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -60.71 -33.34 72.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 73.430000000000007 109.824 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -64.04 -46.0 86.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 74.219999999999999 109.721 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.8 t -57.22 -46.73 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 74.150000000000006 109.758 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -68.12 -29.37 68.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 72.540000000000006 109.65 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.42 -43.43 96.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.149 -0.969 . . . . 64.219999999999999 109.993 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -83.86 -34.52 24.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.127 -0.983 . . . . 74.340000000000003 109.579 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -65.79 -46.07 80.06 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.309 -0.869 . . . . 74.420000000000002 108.772 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -63.43 -53.11 57.4 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.678 -0.639 . . . . 74.519999999999996 109.522 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 141.07 61.33 0.03 OUTLIER Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.247 -1.141 . . . . 74.209999999999994 110.247 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -110.84 132.32 54.3 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.377 -1.073 . . . . 64.099999999999994 109.026 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.44 ' CG ' ' HZ1' ' A' ' 63' ' ' LYS . 35.9 m-20 -85.31 -19.32 31.69 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.047 -1.033 . . . . 73.420000000000002 109.01 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.448 ' OD2' ' CZ ' ' A' ' 112' ' ' ARG . 60.0 m-20 -152.14 162.66 40.78 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.82 -0.808 . . . . 75.040000000000006 108.82 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.433 ' OH ' ' CB ' ' A' ' 75' ' ' SER . 87.4 t80 -150.56 95.57 2.26 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.609 -0.886 . . . . 71.329999999999998 108.609 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.3 mm -105.31 155.3 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.619 0 O-C-N 121.023 -1.048 . . . . 74.510000000000005 109.835 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.33 144.57 50.31 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 106.953 -1.499 . . . . 64.319999999999993 106.953 177.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.703 ' C ' ' H ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -67.58 -57.48 10.1 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 120.645 -1.284 . . . . 74.510000000000005 112.171 -178.097 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 99' ' ' TYR . 27.7 Cg_endo -53.92 9.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.3 -1.993 0 CA-C-N 119.927 1.01 . . . . 73.109999999999999 113.477 -173.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.703 ' H ' ' C ' ' A' ' 97' ' ' LYS . 14.5 m-85 57.01 124.86 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.19 -0.459 . . . . 72.540000000000006 110.688 177.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.6 mtt85 -66.93 -35.32 79.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.696 -1.253 . . . . 74.540000000000006 108.777 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.741 ' O ' ' N ' ' A' ' 103' ' ' LYS . 29.3 t -164.92 33.18 0.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 74.140000000000001 110.404 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.4 mt 51.77 -69.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.714 -0.616 . . . . 75.430000000000007 110.296 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.741 ' N ' ' O ' ' A' ' 101' ' ' SER . 13.0 mptt -56.37 -28.81 60.29 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.633 -1.247 . . . . 74.140000000000001 107.633 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.18 87.71 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.715 -0.794 . . . . 63.240000000000002 108.881 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -61.51 -55.95 25.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.354 -0.841 . . . . 73.219999999999999 108.75 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.7 t -56.34 -41.76 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.96 -1.087 . . . . 74.540000000000006 109.278 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.02 -42.54 49.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.933 . . . . 75.5 109.309 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.515 ' O ' ' NH1' ' A' ' 112' ' ' ARG . 15.5 mmp_? -69.61 -30.08 67.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 74.409999999999997 109.521 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 93.3 mt -77.92 -29.67 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.021 -1.049 . . . . 73.239999999999995 109.117 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -73.4 -58.77 3.07 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.272 -0.893 . . . . 74.340000000000003 109.911 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.81 -46.99 87.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.123 -0.985 . . . . 73.319999999999993 109.826 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.515 ' NH1' ' O ' ' A' ' 108' ' ' ARG . 22.2 ttp-105 -59.47 -31.53 69.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.181 -0.949 . . . . 74.420000000000002 109.44 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 12.4 tp -157.63 93.06 1.25 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 74.329999999999998 109.496 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 32.5 mtm-85 -78.39 -72.73 0.36 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.227 -0.92 . . . . 74.439999999999998 108.89 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' A' ' 117' ' ' GLY . 41.4 t80 -140.11 3.18 1.97 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.31 -0.869 . . . . 74.430000000000007 109.668 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.528 ' CG ' ' O ' ' A' ' 115' ' ' PHE . 48.9 p-90 40.96 21.27 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.569 -0.707 . . . . 74.439999999999998 110.362 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 115' ' ' PHE . . . -57.12 89.77 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.615 -1.394 . . . . 75.040000000000006 109.615 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 116' ' ' TRP . 85.8 p -156.16 163.65 39.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -1.152 . . . . 70.109999999999999 109.901 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.07 125.57 3.09 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.665 -0.865 . . . . 65.239999999999995 108.665 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.2 t -83.79 -50.25 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.165 -0.96 . . . . 74.219999999999999 109.868 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 17.6 mm -100.83 126.35 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.246 -0.909 . . . . 74.420000000000002 109.351 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -129.87 124.73 33.92 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.544 -0.722 . . . . 73.299999999999997 109.143 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 13.2 tt -146.71 130.21 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.284 -0.885 . . . . 75.340000000000003 109.424 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 45.94 -143.68 3.99 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.745 -1.342 . . . . 75.129999999999995 109.745 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -84.64 -3.93 58.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -1.138 . . . . 74.450000000000003 109.371 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.66 130.79 41.01 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.529 -0.915 . . . . 54.210000000000001 108.529 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.9 m -129.43 123.92 32.83 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.355 -0.84 . . . . 70.239999999999995 109.507 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 23.3 mm -110.26 140.69 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.55 -0.719 . . . . 72.430000000000007 109.103 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.9 m -128.08 78.99 74.59 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.49 -0.756 . . . . 71.109999999999999 109.33 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.85 -53.02 7.74 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.853 2.369 . . . . 75.140000000000001 112.573 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -54.08 -42.71 69.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.953 . . . . 72.5 109.451 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.492 ' OE1' ' N ' ' A' ' 132' ' ' GLU . 37.8 mp0 -88.72 -0.54 57.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.25 -0.906 . . . . 73.140000000000001 109.56 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 47.86 39.12 10.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 75.329999999999998 109.447 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.427 ' NZ ' ' CH2' ' A' ' 116' ' ' TRP . 1.0 OUTLIER -125.65 143.09 51.18 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.638 -0.663 . . . . 71.230000000000004 109.238 -179.727 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.8 tt -125.17 138.87 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.537 -0.727 . . . . 75.329999999999998 109.414 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 52.4 mt -119.14 125.94 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.605 -0.684 . . . . 71.109999999999999 109.178 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.504 ' CE2' ' CD ' ' A' ' 138' ' ' LYS . 46.1 t80 -137.43 132.51 33.51 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.56 -0.713 . . . . 74.140000000000001 109.127 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.524 ' O ' ' NH1' ' A' ' 140' ' ' ARG . 15.8 mtpp 55.64 25.21 7.84 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.504 -0.748 . . . . 75.400000000000006 109.956 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.26 -0.82 89.51 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.237 -1.145 . . . . 72.239999999999995 110.237 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.524 ' NH1' ' O ' ' A' ' 138' ' ' LYS . 9.6 mpt_? -88.9 125.79 35.1 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.017 -1.284 . . . . 73.120000000000005 109.088 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -97.8 116.9 30.94 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.274 -0.891 . . . . 72.319999999999993 109.471 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 13.8 p -139.02 141.75 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.341 -0.85 . . . . 62.340000000000003 109.265 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -88.57 147.67 24.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.196 -0.94 . . . . 61.229999999999997 109.381 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.3 m -137.17 140.61 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.419 -0.801 . . . . 74.439999999999998 109.577 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -165.83 121.99 1.34 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.883 . . . . 75.420000000000002 109.332 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 172.97 -164.45 36.48 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.579 -1.408 . . . . 73.340000000000003 109.579 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.665 ' NZ ' ' HE1' ' A' ' 173' ' ' TRP . 1.6 mtpm? -76.87 -34.76 1.31 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.235 -1.156 . . . . 72.219999999999999 111.071 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 97.0 Cg_endo -89.45 -5.4 5.51 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.166 1.91 . . . . 75.450000000000003 112.639 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -96.93 -32.71 11.9 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.214 -0.929 . . . . 65.239999999999995 109.725 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.524 ' O ' ' ND1' ' A' ' 154' ' ' HIS . 71.3 mm-40 -60.15 -40.45 89.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.113 -0.992 . . . . 72.519999999999996 109.181 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.8 p -61.03 -31.75 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.279 -0.888 . . . . 74.209999999999994 109.05 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.14 -46.91 78.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.39 -0.819 . . . . 73.310000000000002 109.267 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.5 p -72.43 -30.52 64.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.091 -1.006 . . . . 74.310000000000002 109.9 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 150' ' ' GLU . 1.5 m80 -59.04 -53.38 59.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 75.450000000000003 109.728 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.68 -25.19 62.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.109 -0.995 . . . . 75.340000000000003 109.49 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.01 -54.82 40.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.204 -0.935 . . . . 62.140000000000001 109.093 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -70.45 -50.22 40.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.247 -0.908 . . . . 72.219999999999999 108.991 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.526 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 40.0 m-70 -76.04 62.37 1.65 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.535 -0.728 . . . . 74.120000000000005 109.267 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.521 ' C ' HE22 ' A' ' 161' ' ' GLN . 48.0 ttp180 -98.79 139.67 34.13 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.303 -0.873 . . . . 74.340000000000003 109.33 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.647 ' N ' HE22 ' A' ' 161' ' ' GLN . 10.4 t0 80.02 60.92 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.662 -0.649 . . . . 75.450000000000003 110.77 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.647 HE22 ' N ' ' A' ' 160' ' ' ASP . 2.0 pm0 -167.27 170.61 11.47 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.933 -1.104 . . . . 73.409999999999997 109.782 178.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 13.6 mm -92.27 136.36 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.379 -0.826 . . . . 74.409999999999997 109.123 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 82.7 t -140.76 138.32 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.246 -0.909 . . . . 72.530000000000001 109.802 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 52.4 p -89.71 154.28 20.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.361 -0.837 . . . . 74.120000000000005 109.307 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.5 ' CD ' ' H ' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -60.83 -41.3 95.5 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.21 -0.931 . . . . 70.430000000000007 109.2 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.7 -35.83 66.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.237 -0.914 . . . . 74.319999999999993 109.736 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -56.23 -45.72 79.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.077 -1.014 . . . . 74.519999999999996 109.26 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 21.9 mt -59.79 -37.44 79.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.08 -1.012 . . . . 74.409999999999997 108.985 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.9 tt -59.53 -69.41 0.21 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.416 -0.803 . . . . 75.140000000000001 110.241 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.417 ' O ' ' OE1' ' A' ' 174' ' ' GLU . 3.9 p30 -65.0 -33.5 76.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.157 -0.964 . . . . 65.030000000000001 111.005 -178.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -52.65 -48.6 66.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.976 -1.077 . . . . 70.209999999999994 110.219 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.488 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 1.8 mp -94.09 -64.28 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.971 -1.081 . . . . 75.319999999999993 108.905 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.665 ' HE1' ' NZ ' ' A' ' 147' ' ' LYS . 25.8 m-90 -81.32 80.15 7.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.34 -0.85 . . . . 73.140000000000001 109.534 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.417 ' OE1' ' O ' ' A' ' 170' ' ' ASP . 42.5 tp10 -89.3 -58.25 2.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.239 -0.913 . . . . 73.239999999999995 109.875 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.622 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 7.3 tt0 -79.34 -37.03 1.16 Allowed Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.144 -0.973 . . . . 63.329999999999998 110.775 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 31.5 Cg_exo -58.81 62.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.402 2.068 . . . . 72.510000000000005 112.511 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 175' ' ' GLU . 97.9 mt-10 -65.57 -24.45 67.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.003 -1.061 . . . . 75.340000000000003 109.748 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 79.4 mtp -50.47 -27.19 6.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.943 . . . . 74.510000000000005 109.771 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 28.1 m -52.26 149.51 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.168 -0.957 . . . . 65.219999999999999 109.531 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.4 p -49.45 152.83 2.09 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 73.219999999999999 109.046 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.14 -8.33 20.87 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.387 2.058 . . . . 62.43 112.896 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -161.18 99.08 1.18 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.872 -1.142 . . . . 73.129999999999995 110.311 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.2 m -153.16 16.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.292 -0.88 . . . . 74.019999999999996 109.232 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 61.8 mt -58.64 -38.95 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.183 -0.948 . . . . 72.329999999999998 109.475 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -50.45 -38.77 45.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 74.400000000000006 109.324 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 49.6 t -74.67 -36.38 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.227 -0.921 . . . . 74.319999999999993 109.47 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.413 ' O ' ' CG1' ' A' ' 191' ' ' ILE . . . -64.7 -52.81 55.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 73.230000000000004 109.601 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.9 -34.01 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.037 -1.039 . . . . 74.310000000000002 109.191 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -68.27 -57.68 5.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.055 -1.028 . . . . 73.439999999999998 110.394 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -64.15 -38.24 90.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.868 -1.145 . . . . 71.420000000000002 109.259 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.413 ' CG1' ' O ' ' A' ' 187' ' ' ALA . 3.4 mm -56.9 -34.19 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 72.439999999999998 108.745 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.615 ' HE ' ' CG2' ' A' ' 204' ' ' VAL . 3.2 tpt180 -70.17 -43.13 71.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.505 -0.747 . . . . 64.219999999999999 109.784 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -77.51 -27.87 51.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.085 -1.009 . . . . 74.319999999999993 110.187 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -84.88 -21.84 29.59 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.157 -0.965 . . . . 75.310000000000002 110.593 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' MET . . . . . 0.567 ' SD ' ' N ' ' A' ' 196' ' ' ASP . 0.0 OUTLIER -93.77 -41.04 9.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.98 -1.075 . . . . 74.019999999999996 109.718 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . 0.567 ' N ' ' SD ' ' A' ' 195' ' ' MET . 31.5 p-10 -64.6 -34.41 78.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 74.019999999999996 109.696 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.498 ' N ' ' OD1' ' A' ' 196' ' ' ASP . 0.2 OUTLIER -57.2 -63.95 3.12 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.898 . . . . 75.430000000000007 109.678 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.427 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 37.2 Cg_endo -63.71 -57.26 0.38 Allowed 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.196 1.931 . . . . 72.319999999999993 112.064 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 49.0 mt -61.17 -33.09 72.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 74.540000000000006 109.556 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 73.55 -49.02 1.6 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.492 -1.443 . . . . 61.509999999999998 109.492 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.404 HG21 HD12 ' A' ' 201' ' ' ILE . 83.7 mt -92.17 138.24 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.211 -1.17 . . . . 74.25 109.278 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 34.7 m -77.83 147.43 35.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.283 -0.885 . . . . 72.0 109.52 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 8.2 p -142.54 21.13 2.03 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.325 -0.86 . . . . 74.439999999999998 109.223 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.615 ' CG2' ' HE ' ' A' ' 192' ' ' ARG . 20.3 m -135.22 147.96 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.461 -0.774 . . . . 71.129999999999995 109.25 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -123.48 133.34 54.05 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.497 -0.752 . . . . 73.510000000000005 109.392 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 29.0 p -99.24 138.08 36.84 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.381 -0.825 . . . . 73.519999999999996 109.394 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 38.6 t -144.6 136.85 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.202 -0.936 . . . . 72.150000000000006 109.391 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 70.2 ttp85 -80.82 88.26 5.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 72.400000000000006 109.393 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 47.3 ttt85 -171.0 -126.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 73.310000000000002 109.29 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -57.37 -39.72 76.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.109 -0.994 . . . . 71.540000000000006 109.418 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 167.59 -149.51 14.78 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.693 -1.363 . . . . 74.450000000000003 109.693 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -104.93 151.52 23.78 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.481 -1.011 . . . . 75.540000000000006 109.351 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -119.71 137.35 53.98 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.083 -0.71 . . . . 75.310000000000002 109.083 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.509 ' O ' ' N ' ' A' ' 160' ' ' ASP . 15.5 m-85 -106.07 126.94 52.8 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.431 -0.793 . . . . 75.409999999999997 109.377 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 52.9 t -153.11 160.27 42.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.432 -0.793 . . . . 74.140000000000001 109.06 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -63.45 151.69 87.13 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.071 -1.018 . . . . 75.319999999999993 109.072 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.481 ' O ' ' O ' ' A' ' 218' ' ' LYS . 84.1 Cg_endo -75.72 122.62 6.97 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.381 2.054 . . . . 73.109999999999999 112.042 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 217' ' ' PRO . 32.7 mttp 56.64 155.31 0.07 OUTLIER Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.662 -0.649 . . . . 75.25 109.445 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.72 -15.59 26.85 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.259 1.973 . . . . 75.099999999999994 111.681 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . 46.94 -170.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 71.140000000000001 109.801 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 28.3 p -81.45 145.82 30.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 71.129999999999995 109.657 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.43 -31.76 72.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.306 -0.871 . . . . 75.349999999999994 109.493 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.033 -0.984 . . . . 73.409999999999997 109.455 -179.985 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 52.0 ttm . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.477 -0.564 . . . . 75.239999999999995 109.477 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 68.0 mtt85 -138.72 144.36 39.48 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.305 -0.872 . . . . 73.519999999999996 109.431 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 86.8 t -111.97 138.86 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 121.466 0.651 . . . . 72.239999999999995 109.756 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 2.7 tp -108.99 120.55 42.89 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.728 -0.607 . . . . 73.340000000000003 109.399 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 20.2 mt -118.17 110.44 17.58 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.533 -0.729 . . . . 74.349999999999994 109.039 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 26.7 mt -100.78 114.08 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.681 -0.859 . . . . 63.439999999999998 108.681 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.486 ' OE1' ' N ' ' B' ' 9' ' ' ASN . 1.8 pp20? -151.04 164.93 35.3 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.285 -0.885 . . . . 74.519999999999996 109.58 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -95.86 -24.39 16.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.252 -0.905 . . . . 74.129999999999995 109.542 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . 0.486 ' N ' ' OE1' ' B' ' 7' ' ' GLU . 28.7 m120 -91.15 109.79 21.06 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.211 -0.931 . . . . 74.230000000000004 109.697 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 32.3 t -62.44 -40.78 97.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.206 -0.934 . . . . 65.540000000000006 109.633 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 86.4 t -57.72 -44.32 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 75.549999999999997 109.214 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 7.6 tp -58.74 -35.47 72.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 70.140000000000001 108.841 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.04 -27.26 70.68 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 108.253 -1.939 . . . . 75.400000000000006 108.253 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.97 -52.28 49.16 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 109.536 -1.425 . . . . 65.439999999999998 109.536 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -59.75 -47.23 86.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.372 -1.075 . . . . 72.200000000000003 109.796 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 35.5 mm -64.03 -41.48 92.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.66 -1.275 . . . . 75.150000000000006 108.951 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -59.43 -45.22 92.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.224 -0.922 . . . . 73.010000000000005 109.156 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -84.07 0.14 49.52 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.223 -0.923 . . . . 74.299999999999997 109.557 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.5 -58.48 1.94 Allowed Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.544 -1.423 . . . . 70.540000000000006 109.544 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -71.34 -23.61 61.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.307 -1.114 . . . . 75.430000000000007 109.74 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' B' ' 24' ' ' GLY . 2.1 m120 -51.24 -36.17 40.56 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.143 -0.973 . . . . 73.200000000000003 109.495 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 46.5 t -53.86 -32.35 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.15 -0.969 . . . . 74.230000000000004 108.442 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm -81.64 -3.88 54.65 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.746 0.784 . . . . 73.519999999999996 108.891 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 21' ' ' ASN . . . 78.13 24.45 63.84 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.942 -1.263 . . . . 53.43 109.942 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -95.14 159.73 14.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.179 -1.189 . . . . 71.120000000000005 109.076 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 14.8 mmt -104.93 140.41 38.2 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.714 -0.847 . . . . 75.239999999999995 108.714 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.9 158.13 45.14 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.398 -0.814 . . . . 73.25 109.651 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -132.8 145.69 51.19 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.594 -0.891 . . . . 72.310000000000002 108.594 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 4.3 m -110.47 139.33 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.369 -0.832 . . . . 72.140000000000001 109.129 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.1 p -138.13 169.29 18.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.384 -0.822 . . . . 74.530000000000001 109.425 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.414 ' OE2' ' OD1' ' B' ' 35' ' ' ASP . 5.4 pt-20 -93.09 -106.99 0.12 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.342 -0.849 . . . . 71.019999999999996 109.431 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 77.3 p -79.47 168.17 19.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 71.400000000000006 109.776 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 22.7 mt -51.91 -29.81 21.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.537 -0.727 . . . . 71.239999999999995 109.856 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -52.29 -51.2 59.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.095 -1.003 . . . . 74.319999999999993 109.729 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.414 ' OD1' ' OE2' ' B' ' 31' ' ' GLU . 1.4 m-20 -63.1 -38.9 93.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -0.975 . . . . 73.030000000000001 109.261 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.97 -38.97 93.16 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.409 -1.476 . . . . 60.43 109.409 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -67.92 -42.85 80.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -1.114 . . . . 74.430000000000007 109.605 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -74.41 -34.15 63.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 74.420000000000002 109.641 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 21.0 tp -74.86 -50.0 18.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 75.409999999999997 110.078 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.439 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.7 ppp? -61.9 -27.69 68.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 61.439999999999998 109.907 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.81 -39.79 86.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 74.319999999999993 110.137 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 17.6 pt -87.06 -24.9 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.09 -1.006 . . . . 71.230000000000004 110.407 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.424 ' O ' ' O ' ' B' ' 40' ' ' MET . 91.3 mtt-85 -129.65 140.36 51.17 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.235 -0.916 . . . . 73.409999999999997 109.73 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -99.32 126.89 45.26 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.286 -0.884 . . . . 63.539999999999999 109.293 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -101.61 141.89 33.79 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.324 -0.86 . . . . 73.109999999999999 109.505 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -81.11 -31.71 34.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 62.219999999999999 109.021 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.408 ' C ' ' CD1' ' B' ' 47' ' ' LEU . 1.0 OUTLIER -114.9 110.6 19.9 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.691 -0.855 . . . . 73.120000000000005 108.691 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 62.3 t -95.52 101.13 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.28 -0.887 . . . . 74.109999999999999 109.074 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 14.4 ttt -116.43 132.7 56.6 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.592 0.71 . . . . 73.439999999999998 109.45 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.472 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.4 OUTLIER -144.49 139.49 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.465 -0.772 . . . . 73.400000000000006 109.364 -179.49 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 31.9 p -105.58 14.71 28.1 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.668 -0.645 . . . . 73.209999999999994 109.72 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.472 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 61.9 m-20 -82.7 144.96 29.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.214 -0.929 . . . . 70.409999999999997 109.266 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.453 ' C ' ' H ' ' B' ' 55' ' ' ALA . 15.4 pttm -77.68 -39.41 44.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.179 -0.951 . . . . 73.129999999999995 110.118 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -73.81 10.49 1.12 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.098 -1.001 . . . . 75.209999999999994 109.559 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.453 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -65.79 -21.21 66.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.351 -0.843 . . . . 55.329999999999998 110.036 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' B' ' 55' ' ' ALA . 47.7 mt -41.94 -43.68 3.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.433 -0.792 . . . . 72.420000000000002 110.517 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.3 p -75.96 -35.79 59.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.909 -1.12 . . . . 73.040000000000006 109.451 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -66.63 -40.78 88.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.411 -0.806 . . . . 72.329999999999998 110.353 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.06 -35.49 59.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 120.757 -1.214 . . . . 74.540000000000006 109.544 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 78.8 p -57.69 -46.86 83.74 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.12 -0.988 . . . . 71.239999999999995 109.314 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -69.69 -34.41 73.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.142 -0.974 . . . . 74.310000000000002 110.018 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 4.9 mm -62.2 -34.31 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.862 -1.149 . . . . 75.420000000000002 109.779 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.478 ' NZ ' ' OD2' ' B' ' 92' ' ' ASP . 12.0 mmtm -73.79 -52.88 11.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.099 -1.0 . . . . 73.319999999999993 110.178 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -66.24 -36.82 84.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.902 -1.123 . . . . 73.310000000000002 110.304 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.466 ' C ' ' CG ' ' B' ' 66' ' ' HIS . 29.3 mtmt -83.21 -23.56 32.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.133 -0.98 . . . . 72.439999999999998 110.258 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.466 ' CG ' ' C ' ' B' ' 65' ' ' LYS . 37.0 m-70 -153.2 67.37 0.79 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.02 -1.05 . . . . 65.209999999999994 109.837 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' B' ' 63' ' ' LYS . 10.5 m -61.9 -30.86 71.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.935 . . . . 73.099999999999994 109.724 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 90.5 p -63.24 -24.58 67.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.251 -0.905 . . . . 71.530000000000001 110.356 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 81.1 mt -81.5 156.36 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.988 -1.07 . . . . 74.400000000000006 109.767 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 95.9 t -93.97 160.14 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.296 -0.877 . . . . 75.120000000000005 109.854 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.7 t -136.04 127.49 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.411 -0.806 . . . . 73.200000000000003 109.366 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.61 101.71 7.77 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.729 -0.841 . . . . 73.340000000000003 108.729 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 90.7 t -93.53 128.18 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.249 -0.907 . . . . 73.5 109.264 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 14.6 p -93.51 172.24 8.4 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.198 -0.939 . . . . 71.319999999999993 109.346 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 30.1 t -159.65 117.08 2.65 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.978 -1.077 . . . . 74.530000000000001 110.339 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -61.88 -36.34 80.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.384 -0.822 . . . . 64.5 109.84 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' B' ' 79' ' ' THR . 0.5 OUTLIER -118.52 82.73 19.94 Favored Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.572 -0.705 . . . . 74.25 109.227 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -47.71 84.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.235 1.957 . . . . 74.430000000000007 111.5 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.516 ' N ' ' O ' ' B' ' 77' ' ' ASN . 19.4 m -102.91 150.91 23.05 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.596 -0.69 . . . . 73.120000000000005 109.377 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.2 t -65.32 -35.41 80.9 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.344 -0.847 . . . . 75.409999999999997 109.704 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . 0.488 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 80.1 mm-40 -60.42 -44.75 95.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.134 -0.979 . . . . 72.239999999999995 109.565 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -75.79 -31.11 59.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 73.219999999999999 109.468 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -64.73 -54.05 37.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 74.299999999999997 109.834 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.411 ' CG2' ' N ' ' B' ' 85' ' ' HIS . 21.6 m -64.26 -43.37 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.098 -1.001 . . . . 73.310000000000002 109.396 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' HIS . . . . . 0.488 ' ND1' ' O ' ' B' ' 81' ' ' GLU . 23.2 m170 -63.18 -26.17 68.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.161 -0.962 . . . . 73.239999999999995 109.271 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . 0.405 ' O ' ' CB ' ' B' ' 91' ' ' ALA . . . -70.64 -46.86 62.5 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -0.878 . . . . 55.329999999999998 109.958 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -77.0 -32.09 56.96 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.01 -1.056 . . . . 74.450000000000003 109.384 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -72.67 -44.3 62.0 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.248 -0.907 . . . . 64.040000000000006 109.693 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -62.69 -52.13 64.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.191 -0.943 . . . . 75.129999999999995 109.905 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 156.45 44.74 0.02 OUTLIER Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.673 -1.251 . . . . 75.420000000000002 110.265 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' B' ' 86' ' ' ALA . . . -110.28 135.7 50.61 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.396 -1.061 . . . . 73.420000000000002 109.255 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . 0.478 ' OD2' ' NZ ' ' B' ' 63' ' ' LYS . 19.2 m-20 -85.37 -18.43 33.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.094 -1.004 . . . . 73.319999999999993 109.201 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -152.51 162.01 41.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.298 -0.876 . . . . 73.040000000000006 109.697 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -143.65 97.0 2.99 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.554 -0.906 . . . . 74.310000000000002 108.554 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 23.2 mm -108.1 156.29 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 121.255 -0.903 . . . . 75.340000000000003 110.431 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.6 152.12 45.94 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.262 -1.014 . . . . 70.099999999999994 108.262 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.694 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -74.87 -55.98 2.26 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 120.787 -1.195 . . . . 65.430000000000007 111.416 -179.562 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 2.6 Cg_endo -40.29 -10.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.034 1.156 . . . . 63.520000000000003 112.914 -175.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . 0.694 ' N ' ' O ' ' B' ' 97' ' ' LYS . 54.2 m-85 59.42 118.18 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.755 -0.59 . . . . 75.129999999999995 109.868 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -65.65 -33.31 75.6 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.208 -0.932 . . . . 74.230000000000004 109.452 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' SER . . . . . 0.766 ' O ' ' N ' ' B' ' 103' ' ' LYS . 34.2 t -171.32 27.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.961 -1.087 . . . . 64.510000000000005 110.888 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 16.2 mt 49.14 -67.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 CA-C-N 118.498 0.59 . . . . 74.439999999999998 110.336 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . 0.766 ' N ' ' O ' ' B' ' 101' ' ' SER . 43.4 mtpt -55.4 -32.77 62.93 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.903 -1.147 . . . . 72.299999999999997 107.903 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.11 -45.87 86.72 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.666 -0.864 . . . . 74.310000000000002 108.666 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 22.5 tp -68.31 -42.43 79.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.302 -0.874 . . . . 73.540000000000006 109.123 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 78.8 t -58.92 -45.72 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.174 -0.954 . . . . 72.030000000000001 108.893 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.17 -44.02 67.55 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.422 -0.955 . . . . 64.219999999999999 108.422 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -62.41 -39.04 91.98 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.819 -0.808 . . . . 75.310000000000002 108.819 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 91.1 mt -68.95 -28.96 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 108.043 -1.095 . . . . 55.439999999999998 108.043 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -68.56 -53.76 20.89 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.651 -0.87 . . . . 65.310000000000002 108.651 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -47.36 -40.32 17.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.448 -0.783 . . . . 74.519999999999996 109.081 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -62.85 -40.33 97.13 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.299 -0.876 . . . . 72.040000000000006 109.111 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 84.6 mt -137.97 77.44 1.63 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.318 -0.864 . . . . 75.349999999999994 109.505 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -74.54 -76.02 0.15 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.218 -0.926 . . . . 75.5 108.959 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' PHE . . . . . 0.525 ' O ' ' CG ' ' B' ' 116' ' ' TRP . 94.1 m-85 -82.84 -65.87 0.96 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 73.040000000000006 109.563 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' TRP . . . . . 0.525 ' CG ' ' O ' ' B' ' 115' ' ' PHE . 7.7 m-90 -158.13 -154.39 0.44 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.36 -0.838 . . . . 74.450000000000003 109.347 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -85.65 -138.09 4.54 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.696 -1.362 . . . . 64.209999999999994 109.696 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 10.9 t -151.95 176.85 11.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.305 -1.114 . . . . 71.400000000000006 109.911 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.9 163.81 37.8 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.787 -0.819 . . . . 74.209999999999994 108.787 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 10.1 t -136.5 -38.52 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.506 -0.746 . . . . 75.019999999999996 109.726 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . 0.442 HD11 HG23 ' B' ' 121' ' ' ILE . 27.1 mm -97.77 137.67 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.239 -0.913 . . . . 74.239999999999995 109.499 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . 0.95 ' OE1' ' O ' ' B' ' 122' ' ' GLU . 0.0 OUTLIER -137.74 132.61 33.04 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.476 -0.765 . . . . 73.329999999999998 109.374 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.516 ' CG2' ' HB2' ' B' ' 126' ' ' LEU . 4.9 tt -142.76 113.08 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.285 -0.884 . . . . 74.219999999999999 109.174 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.98 -116.95 5.49 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.262 -1.535 . . . . 72.409999999999997 109.262 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -106.33 3.38 27.49 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.481 -1.011 . . . . 75.120000000000005 108.987 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.516 ' HB2' ' CG2' ' B' ' 123' ' ' ILE . 0.3 OUTLIER -97.49 139.43 33.42 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.283 -1.006 . . . . 75.420000000000002 108.283 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 18.8 m -130.33 136.42 49.09 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.229 -0.919 . . . . 74.219999999999999 110.065 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 58.8 mt -128.96 142.9 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.533 -0.729 . . . . 60.329999999999998 109.464 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 2.0 m -122.44 126.84 26.06 Favored Pre-proline 0 N--CA 1.501 2.077 0 N-CA-C 109.144 -0.687 . . . . 72.310000000000002 109.144 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.71 -60.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.793 1.662 . . . . 75.129999999999995 112.998 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -53.9 -47.51 71.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.939 -1.1 . . . . 75.230000000000004 109.956 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -82.83 -9.77 59.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.121 -0.987 . . . . 75.120000000000005 110.063 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 48.51 75.41 0.14 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.977 -1.077 . . . . 75.129999999999995 109.178 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -149.17 130.56 14.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.189 -0.945 . . . . 75.109999999999999 109.54 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 7.5 tt -110.43 132.93 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.816 -0.809 . . . . 70.319999999999993 108.816 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 20.7 mm -111.26 127.42 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.407 -0.808 . . . . 74.120000000000005 109.407 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -142.81 141.54 31.66 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.983 -1.117 . . . . 74.230000000000004 107.983 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 68.3 tttt 55.93 13.61 1.16 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.335 -0.853 . . . . 74.219999999999999 109.705 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.68 5.24 84.49 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.384 -1.086 . . . . 74.319999999999993 110.384 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -96.09 141.81 29.03 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.13 -1.218 . . . . 75.340000000000003 109.04 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -96.24 123.76 39.99 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.311 -0.868 . . . . 71.230000000000004 109.339 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 36.1 t -134.74 132.83 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.38 -0.825 . . . . 70.430000000000007 109.153 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -90.58 157.58 17.43 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.032 -1.043 . . . . 72.430000000000007 109.516 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 6.0 m -137.69 140.66 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.408 -0.808 . . . . 72.129999999999995 109.817 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . 0.44 ' HZ2' ' HD1' ' B' ' 66' ' ' HIS . 22.9 pttt -176.64 89.54 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.408 -0.807 . . . . 74.5 109.593 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -157.15 -170.15 21.76 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.587 -1.405 . . . . 42.229999999999997 109.587 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 0.628 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 29.3 ttpt -78.69 -31.03 0.71 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.262 -1.14 . . . . 73.299999999999997 110.974 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 85.1 Cg_endo -89.61 -29.34 0.23 Allowed 'Trans proline' 0 N--CA 1.486 1.069 0 C-N-CA 122.03 1.82 . . . . 71.329999999999998 112.764 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -85.1 -13.31 50.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.0 -1.063 . . . . 74.230000000000004 109.964 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -53.04 -40.68 64.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.097 -1.002 . . . . 72.340000000000003 109.268 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 12.5 p -69.24 -38.45 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 73.349999999999994 109.159 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.22 -44.11 32.76 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.57 -0.9 . . . . 74.430000000000007 108.57 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.14 -41.0 71.05 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.107 -0.996 . . . . 75.209999999999994 110.254 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . 0.585 ' HD1' HH21 ' B' ' 157' ' ' ARG . 34.6 t60 -58.39 -63.59 1.22 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.371 -0.831 . . . . 73.040000000000006 112.362 -177.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.23 -19.77 63.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.425 -1.422 . . . . 73.430000000000007 109.815 -178.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.96 -47.97 83.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.737 -1.227 . . . . 75.319999999999993 109.17 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.585 HH21 ' HD1' ' B' ' 154' ' ' HIS . 23.2 ptt180 -76.86 -35.8 57.23 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.034 -1.041 . . . . 73.319999999999993 110.42 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . 0.424 ' ND1' ' HG3' ' B' ' 157' ' ' ARG . 1.6 m-70 -81.08 22.42 0.64 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.688 -1.257 . . . . 74.140000000000001 109.961 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 24.8 ttm-85 -59.36 163.03 4.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.125 -0.985 . . . . 73.420000000000002 109.06 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' B' ' 214' ' ' PHE . 14.8 t0 63.54 44.65 5.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.205 -0.934 . . . . 72.099999999999994 109.164 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . 0.908 ' NE2' ' O ' ' B' ' 162' ' ' ILE . 15.5 tm0? -158.16 155.25 28.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.353 -0.842 . . . . 73.239999999999995 109.613 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 162' ' ' ILE . . . . . 0.908 ' O ' ' NE2' ' B' ' 161' ' ' GLN . 10.3 mm -81.63 105.39 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.522 -0.918 . . . . 72.310000000000002 108.522 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 93.4 t -101.54 129.25 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.274 -0.892 . . . . 75.030000000000001 109.754 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 9.8 t -85.93 164.31 17.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.401 -0.812 . . . . 74.219999999999999 109.528 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -68.78 -46.39 68.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -0.848 . . . . 72.420000000000002 109.855 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -60.25 -24.89 65.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 63.450000000000003 109.859 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -59.26 -43.73 92.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.965 -1.085 . . . . 72.400000000000006 109.082 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 20.7 mt -71.96 -58.11 3.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.394 -0.816 . . . . 72.319999999999993 109.247 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.419 ' C ' ' CD1' ' B' ' 169' ' ' LEU . 2.1 tm? -50.1 -58.29 5.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.014 -1.054 . . . . 73.340000000000003 108.653 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -51.7 -32.66 31.0 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 112.183 0.438 . . . . 73.099999999999994 112.183 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.61 -30.77 14.18 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.802 -1.187 . . . . 62.130000000000003 112.952 -177.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.7 -63.13 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.458 -1.401 . . . . 74.439999999999998 109.467 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 173' ' ' TRP . . . . . 0.523 ' O ' ' CE3' ' B' ' 173' ' ' TRP . 0.0 OUTLIER -66.47 143.22 57.22 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.518 -1.29 . . . . 72.230000000000004 107.518 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -170.7 -75.63 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.748 -1.22 . . . . 75.030000000000001 109.635 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -66.59 -53.4 29.4 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.226 -0.921 . . . . 73.040000000000006 109.33 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -81.95 85.45 1.7 Allowed 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.86 1.707 . . . . 74.129999999999995 111.876 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -83.51 -130.68 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.919 . . . . 72.439999999999998 109.854 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 4.4 ttt 54.78 16.15 1.33 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.083 -1.011 . . . . 72.109999999999999 108.764 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 14.1 m -81.62 152.67 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.83 . . . . 75.310000000000002 109.918 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -50.2 157.33 1.18 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 62.149999999999999 109.223 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_exo -39.02 -57.46 0.96 Allowed 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 122.167 1.912 . . . . 74.340000000000003 112.019 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -164.1 122.73 1.88 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.369 -0.832 . . . . 72.310000000000002 109.061 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 10.5 m -137.71 11.87 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.244 -0.91 . . . . 65.420000000000002 108.692 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.4 HD11 HG21 ' B' ' 184' ' ' ILE . 0.2 OUTLIER -53.52 -30.64 18.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.639 -0.874 . . . . 75.030000000000001 108.639 179.749 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -57.33 -35.49 69.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.853 . . . . 73.519999999999996 108.994 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 3.7 t -75.32 -44.41 42.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.453 -0.78 . . . . 74.349999999999994 109.372 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -61.62 -48.46 80.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.251 -0.906 . . . . 61.119999999999997 110.459 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 9.4 tp -63.65 -42.12 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.778 -1.201 . . . . 72.430000000000007 110.285 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -63.59 -34.67 78.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.898 -1.126 . . . . 75.420000000000002 109.402 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -77.14 -50.36 13.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 74.140000000000001 110.15 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 82.0 mt -50.5 -46.37 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.178 -0.951 . . . . 74.030000000000001 109.438 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -62.68 -48.81 77.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.104 -0.997 . . . . 72.329999999999998 109.914 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 193' ' ' GLN . . . . . 0.45 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 25.6 mt-30 -63.67 -21.61 66.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.051 -1.031 . . . . 73.099999999999994 109.515 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . 0.431 ' O ' ' CD ' ' B' ' 198' ' ' PRO . 60.3 mttm -85.74 -38.47 18.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.206 -0.933 . . . . 74.430000000000007 110.405 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 88.8 mmm -91.79 13.2 18.96 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.888 -1.133 . . . . 74.329999999999998 109.99 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 196' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 50.8 p-10 -96.56 -20.98 17.96 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.06 -1.025 . . . . 71.209999999999994 109.744 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . 0.554 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 1.5 tttm -93.29 -45.54 0.31 Allowed Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.116 -0.99 . . . . 75.209999999999994 109.098 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 198' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' B' ' 197' ' ' LYS . 18.8 Cg_exo -65.12 -60.47 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.163 1.909 . . . . 75.319999999999993 111.324 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 30.8 mt -63.68 -38.8 92.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 72.25 109.007 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 78.44 -17.95 6.01 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.35 -1.1 . . . . 73.239999999999995 110.35 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 29.0 mm -110.31 131.78 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.278 -1.13 . . . . 54.299999999999997 110.017 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 2.0 t -83.8 135.16 34.63 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.632 -0.877 . . . . 74.310000000000002 108.632 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 3.9 p -141.37 30.43 1.75 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.141 -0.974 . . . . 74.400000000000006 109.463 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 25.6 m -137.14 142.4 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.507 -0.745 . . . . 74.099999999999994 109.296 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -125.58 114.5 18.81 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.022 -0.732 . . . . 75.329999999999998 109.022 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.42 110.1 21.21 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.186 -0.946 . . . . 71.400000000000006 109.917 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 10.6 p -112.45 131.09 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 107.896 -1.15 . . . . 63.5 107.896 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -47.92 -32.81 6.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.055 -1.028 . . . . 74.450000000000003 110.036 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 -66.34 148.45 51.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.093 -1.004 . . . . 74.140000000000001 109.41 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 51.37 -115.11 0.85 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.095 -1.003 . . . . 74.430000000000007 109.636 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -142.27 -92.73 0.18 Allowed Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.419 -1.473 . . . . 70.109999999999999 109.419 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -126.71 157.44 39.08 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.435 -1.038 . . . . 74.209999999999994 109.637 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -123.26 121.95 37.16 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.879 -0.785 . . . . 74.299999999999997 108.879 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' B' ' 160' ' ' ASP . 60.0 m-85 -101.49 123.92 46.32 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.369 -0.832 . . . . 74.340000000000003 110.372 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 1.9 p -147.59 164.38 33.64 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.117 -0.697 . . . . 72.209999999999994 109.117 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' B' ' 216' ' ' TYR . 0.0 OUTLIER -64.93 162.52 37.1 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.085 -1.01 . . . . 72.310000000000002 108.429 179.664 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -39.47 163.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.407 2.071 . . . . 71.010000000000005 112.267 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . 0.46 ' C ' ' H ' ' B' ' 220' ' ' ALA . 19.4 mtmt -84.55 -63.7 0.24 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.121 -0.987 . . . . 74.349999999999994 109.723 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' B' ' 218' ' ' LYS . 67.3 Cg_endo -70.41 34.38 0.23 Allowed 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.167 1.912 . . . . 71.319999999999993 111.443 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . 0.46 ' H ' ' C ' ' B' ' 218' ' ' LYS . . . -47.77 142.77 4.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.375 -0.828 . . . . 75.450000000000003 109.87 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 93.8 m -86.25 127.72 34.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.455 -0.778 . . . . 72.219999999999999 109.114 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -64.51 136.02 56.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 74.299999999999997 109.786 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.022 -0.99 . . . . 71.129999999999995 109.379 179.545 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.9 ptm . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.454 -0.573 . . . . 65.120000000000005 109.454 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -139.31 144.51 38.34 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.356 -0.84 . . . . 73.310000000000002 109.44 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 66.1 t -112.64 131.03 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.705 -0.622 . . . . 71.420000000000002 109.492 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.21 125.59 53.23 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.96 -0.756 . . . . 65.219999999999999 108.96 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 59.7 tp -120.95 102.94 8.68 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.629 -0.67 . . . . 71.439999999999998 109.244 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.8 mt -88.67 113.58 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.856 -1.153 . . . . 71.150000000000006 108.692 179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 13' ' ' GLY . 55.8 tt0 -154.66 121.44 5.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.198 -0.939 . . . . 75.340000000000003 109.485 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -64.36 -31.29 72.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.307 -0.871 . . . . 73.040000000000006 109.43 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -73.9 103.21 4.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.324 -0.86 . . . . 72.420000000000002 109.372 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.4 t -66.4 -25.17 66.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 72.340000000000003 109.814 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.54 -50.67 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.168 -0.958 . . . . 74.420000000000002 109.697 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 12' ' ' LEU . 3.3 mm? -70.81 -41.95 70.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 72.010000000000005 109.398 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.513 ' N ' ' OE1' ' A' ' 7' ' ' GLU . . . -69.13 -24.85 75.81 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 108.475 -1.85 . . . . 72.140000000000001 108.475 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.51 -54.89 20.45 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 109.676 -1.37 . . . . 72.329999999999998 109.676 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -56.88 -45.75 82.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -1.104 . . . . 72.340000000000003 109.775 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.9 mm -64.54 -48.78 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.819 -1.176 . . . . 74.239999999999995 108.878 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.527 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 86.5 tt0 -45.6 -56.41 5.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -0.983 . . . . 71.409999999999997 109.854 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -85.61 3.83 39.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.124 -0.985 . . . . 75.540000000000006 109.128 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.59 -70.64 1.34 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.778 -1.329 . . . . 62.149999999999999 109.778 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.75 -21.97 56.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.213 -1.169 . . . . 74.420000000000002 109.491 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 93.4 m-20 -57.06 -37.84 72.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.253 -0.904 . . . . 74.25 109.634 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.7 t -53.97 -40.02 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 72.109999999999999 109.462 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -64.46 -22.13 66.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.27 -0.894 . . . . 73.230000000000004 109.233 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.46 38.28 2.65 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 110.335 -1.106 . . . . 75.540000000000006 110.335 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -117.92 159.28 23.39 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.335 -1.097 . . . . 74.510000000000005 108.905 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.7 mmt -90.8 114.51 26.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.112 -0.992 . . . . 64.319999999999993 108.574 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.433 ' O ' ' OD1' ' A' ' 28' ' ' ASP . . . -99.26 147.38 25.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.397 -0.814 . . . . 74.310000000000002 110.104 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 27' ' ' ALA . 82.4 m-20 -138.52 129.03 26.16 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.619 -0.882 . . . . 75.400000000000006 108.619 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.1 m -111.82 138.86 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.449 -0.782 . . . . 75.129999999999995 109.117 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 p -135.08 176.39 8.71 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.536 -0.728 . . . . 71.420000000000002 109.354 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -95.54 -108.16 0.14 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.163 -0.961 . . . . 73.109999999999999 110.017 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.2 p -78.84 167.15 21.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.899 . . . . 74.239999999999995 110.123 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.7 mt -50.82 -33.76 24.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.629 -0.669 . . . . 71.530000000000001 109.891 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -49.5 -52.27 30.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 74.230000000000004 109.624 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -61.95 -37.76 85.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.139 -0.976 . . . . 71.010000000000005 108.952 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.79 -39.17 90.0 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.278 -1.529 . . . . 61.409999999999997 109.278 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.57 -43.59 89.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.352 -1.087 . . . . 74.340000000000003 109.445 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -73.39 -38.03 65.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.153 -0.967 . . . . 75.329999999999998 109.504 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.0 tp -68.7 -44.99 72.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 74.329999999999998 109.771 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.448 ' C ' ' SD ' ' A' ' 40' ' ' MET . 3.4 ppp? -74.39 -17.13 60.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.087 -1.008 . . . . 70.319999999999993 109.687 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -55.43 -40.68 71.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.122 -0.986 . . . . 71.219999999999999 109.441 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.8 pt -88.08 -42.56 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.304 -0.872 . . . . 74.409999999999997 109.793 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 40' ' ' MET . 3.0 mpt_? -104.41 139.19 39.71 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.195 -0.94 . . . . 75.409999999999997 109.113 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.829 ' ND2' ' HZ2' ' A' ' 145' ' ' LYS . 16.8 t-20 -82.11 -24.36 35.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 75.420000000000002 109.782 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.485 ' O ' ' O ' ' A' ' 44' ' ' ASN . 57.2 m-85 57.4 136.65 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.684 0.754 . . . . 74.230000000000004 110.196 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -86.29 -50.45 6.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.948 -1.095 . . . . 75.319999999999993 108.945 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.426 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -104.93 107.39 18.34 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.411 -0.959 . . . . 72.129999999999995 108.411 179.406 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.19 104.79 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.127 -1.064 . . . . 72.340000000000003 108.127 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.8 ttt -113.69 144.51 42.81 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.545 0.688 . . . . 74.109999999999999 109.776 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.427 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 1.4 p -139.53 136.02 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.596 0.713 . . . . 71.239999999999995 109.567 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.7 m -104.79 10.33 34.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.68 -0.638 . . . . 73.109999999999999 109.402 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.427 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 69.8 m-20 -77.0 155.58 32.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 63.399999999999999 109.61 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.5 ' C ' ' H ' ' A' ' 55' ' ' ALA . 27.3 mtmm -76.38 -39.22 54.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.182 -0.949 . . . . 65.439999999999998 109.84 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -73.49 18.09 0.13 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.141 -0.974 . . . . 73.129999999999995 109.653 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.5 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -59.96 -35.56 75.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 64.140000000000001 110.012 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 23.7 mt -43.83 -52.66 6.58 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.449 -0.782 . . . . 74.430000000000007 110.251 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.2 m -65.9 -34.63 78.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.872 -1.142 . . . . 63.229999999999997 108.942 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -65.89 -62.9 1.24 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.488 -0.757 . . . . 74.439999999999998 110.079 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.5 m -48.44 -34.19 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.739 -1.226 . . . . 74.030000000000001 109.901 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.2 t -59.0 -55.24 37.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.128 -0.982 . . . . 73.540000000000006 109.692 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -65.59 -27.36 68.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.111 -0.993 . . . . 73.340000000000003 110.189 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.6 mm -66.25 -49.56 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.75 -1.219 . . . . 73.349999999999994 110.369 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.502 ' HZ2' ' C ' ' A' ' 90' ' ' GLY . 26.6 mmtp -63.62 -44.69 93.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.994 -1.066 . . . . 74.420000000000002 110.921 -178.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -71.02 -39.52 72.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.676 -1.265 . . . . 74.549999999999997 110.161 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.482 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 66.4 mttm -80.8 -19.49 44.64 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.116 -0.99 . . . . 75.219999999999999 109.675 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.482 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 93.1 m-70 -155.68 68.05 0.64 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 74.129999999999995 109.391 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 63' ' ' LYS . 18.4 m -59.21 -30.72 68.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.249 -0.907 . . . . 73.239999999999995 110.0 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.8 t -81.39 49.04 1.23 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.174 -0.954 . . . . 71.439999999999998 110.28 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 12.3 tt -143.4 157.8 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.096 -1.002 . . . . 71.329999999999998 109.307 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.4 t -91.75 141.53 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.001 -1.062 . . . . 73.019999999999996 108.81 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.2 t -127.52 121.99 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.297 -0.877 . . . . 54.210000000000001 109.34 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.61 103.15 9.43 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.336 -0.987 . . . . 74.209999999999994 108.336 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.0 p -98.64 128.5 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.396 -0.815 . . . . 74.409999999999997 109.109 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.5 p -89.31 175.33 7.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.06 -1.025 . . . . 72.310000000000002 109.489 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.481 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 22.8 t -164.6 118.95 1.38 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.158 -0.964 . . . . 64.540000000000006 110.265 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -70.5 -25.94 63.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.558 -0.714 . . . . 74.129999999999995 109.599 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 79' ' ' THR . 13.2 t-20 -112.64 68.9 1.03 Allowed Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.599 -0.688 . . . . 73.340000000000003 109.614 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.78 82.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.768 1.645 . . . . 71.319999999999993 111.777 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 77' ' ' ASN . 24.1 m -103.61 151.69 22.64 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.111 -0.7 . . . . 62.530000000000001 109.111 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -36.61 83.8 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -0.907 . . . . 74.140000000000001 109.471 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.02 -42.15 84.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.158 -0.964 . . . . 71.420000000000002 109.366 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -74.14 -30.35 62.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 73.430000000000007 109.607 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.522 ' OE1' ' CD1' ' A' ' 94' ' ' TYR . 46.8 tp10 -60.59 -54.76 41.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.958 . . . . 74.219999999999999 109.587 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.6 t -62.64 -41.72 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.249 -0.907 . . . . 74.150000000000006 109.421 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.518 ' NE2' ' OE1' ' A' ' 89' ' ' GLN . 47.7 t60 -64.41 -33.33 75.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.248 -0.908 . . . . 72.540000000000006 109.589 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.57 -45.18 91.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 64.219999999999999 109.747 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -77.24 -29.94 54.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.037 -1.039 . . . . 74.340000000000003 108.572 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -60.68 -50.74 72.28 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.384 -0.822 . . . . 74.420000000000002 108.885 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.518 ' OE1' ' NE2' ' A' ' 85' ' ' HIS . 28.2 mt-30 -63.24 -61.64 2.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.583 -0.698 . . . . 74.519999999999996 109.578 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.502 ' C ' ' HZ2' ' A' ' 63' ' ' LYS . . . 154.79 59.01 0.01 OUTLIER Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.796 -1.192 . . . . 74.209999999999994 110.266 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.72 134.61 51.21 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.254 -1.145 . . . . 64.099999999999994 108.978 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -75.4 -32.14 60.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.005 -1.059 . . . . 73.420000000000002 109.059 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.513 ' OD2' ' NE ' ' A' ' 108' ' ' ARG . 42.2 t0 -152.34 157.45 41.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.361 -0.837 . . . . 75.040000000000006 109.44 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.522 ' CD1' ' OE1' ' A' ' 83' ' ' GLU . 62.0 t80 -131.62 113.26 13.39 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.579 -0.897 . . . . 71.329999999999998 108.579 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.5 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 0.1 OUTLIER -117.26 152.08 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-O 121.646 0.736 . . . . 74.510000000000005 110.444 -178.192 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.93 138.72 48.3 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.27 -1.011 . . . . 64.319999999999993 108.27 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.684 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -60.71 -54.98 49.37 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.98 -1.075 . . . . 74.510000000000005 111.636 -179.192 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.4 Cg_endo -41.4 -10.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 120.749 0.966 . . . . 73.109999999999999 112.923 -175.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.684 ' N ' ' O ' ' A' ' 97' ' ' LYS . 57.4 m-85 59.42 100.31 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.752 -0.593 . . . . 72.540000000000006 110.076 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 19.1 ttm-85 -55.93 -40.23 72.83 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.082 -1.081 . . . . 74.540000000000006 108.082 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.7 t -173.79 128.82 0.4 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.796 -0.816 . . . . 74.140000000000001 108.796 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 51.3 mt -51.81 -40.54 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.941 . . . . 75.430000000000007 109.155 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.412 ' CD ' ' N ' ' A' ' 103' ' ' LYS . 2.7 mptp? -64.42 -35.58 81.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.154 -0.966 . . . . 74.140000000000001 109.38 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.03 -60.9 2.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.228 -0.92 . . . . 63.240000000000002 109.689 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.622 ' CD1' HH22 ' A' ' 108' ' ' ARG . 17.9 tp -55.9 -51.99 65.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 73.219999999999999 109.657 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 76.0 t -60.23 -42.4 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.062 -1.023 . . . . 74.540000000000006 109.383 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.3 -30.08 36.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.177 -0.952 . . . . 75.5 109.115 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.622 HH22 ' CD1' ' A' ' 105' ' ' LEU . 21.1 ttp-105 -83.14 -28.71 29.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 74.409999999999997 109.981 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 80.3 mt -74.74 -40.03 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.986 -1.071 . . . . 73.239999999999995 108.72 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 114' ' ' ARG . 24.8 pt-20 -72.26 -37.07 69.16 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.439 -0.904 . . . . 74.340000000000003 108.957 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -57.3 -45.4 84.2 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.343 -0.848 . . . . 73.319999999999993 109.15 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 68.5 ttt-85 -62.73 -41.5 99.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.27 -0.894 . . . . 74.420000000000002 109.387 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 42.6 mt -130.07 65.8 1.5 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.477 -0.764 . . . . 74.329999999999998 109.248 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' A' ' 110' ' ' GLU . 81.5 mtp180 -60.8 -29.85 69.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 74.439999999999998 109.429 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.427 ' CG ' ' O ' ' A' ' 114' ' ' ARG . 78.9 m-85 -156.64 78.88 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 74.430000000000007 109.567 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 33.4 p-90 -58.83 134.1 56.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 74.439999999999998 109.534 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 154.2 91.57 0.08 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.434 -1.466 . . . . 75.040000000000006 109.434 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.7 m -152.39 168.27 26.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.261 -1.14 . . . . 70.109999999999999 109.679 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.57 -179.61 8.14 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.823 -0.751 . . . . 65.239999999999995 109.117 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.9 t -139.69 -38.75 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.441 -0.787 . . . . 74.219999999999999 109.159 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.42 HD13 HG22 ' A' ' 121' ' ' ILE . 10.2 mm -106.32 131.66 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.245 -0.909 . . . . 74.420000000000002 109.208 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -128.32 99.36 5.39 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.407 -0.96 . . . . 73.299999999999997 108.407 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.914 HG13 ' NE ' ' A' ' 159' ' ' ARG . 26.9 mm -115.82 122.23 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.518 -0.739 . . . . 75.340000000000003 109.233 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.86 -160.38 0.29 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.789 -1.325 . . . . 75.129999999999995 109.789 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -66.67 -3.99 7.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -1.184 . . . . 74.450000000000003 109.666 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.16 134.99 34.77 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.091 -1.006 . . . . 54.210000000000001 109.101 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 27.0 m -119.89 131.4 55.23 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.786 -0.82 . . . . 70.239999999999995 108.786 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.4 mt -118.99 122.78 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-O 121.685 0.755 . . . . 72.430000000000007 109.125 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.7 m -107.79 109.12 62.16 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.732 -0.84 . . . . 71.109999999999999 108.732 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.548 ' CB ' ' HE ' ' A' ' 157' ' ' ARG . 94.9 Cg_endo -80.08 -29.95 2.4 Favored 'Trans proline' 0 N--CA 1.492 1.382 0 C-N-CA 121.967 1.778 . . . . 75.140000000000001 112.617 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -52.73 -69.16 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.113 -0.992 . . . . 72.5 109.258 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -82.3 4.52 23.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.361 -0.837 . . . . 73.140000000000001 109.05 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 54.19 81.25 0.1 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.491 -0.756 . . . . 75.329999999999998 109.456 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -149.43 136.0 19.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.244 -0.91 . . . . 71.230000000000004 109.553 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 11.6 tt -114.24 133.07 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.48 -0.763 . . . . 75.329999999999998 108.973 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 41.4 mt -124.74 115.43 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.847 -0.797 . . . . 71.109999999999999 108.847 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -130.61 134.66 47.17 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.456 -0.777 . . . . 74.140000000000001 109.762 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.462 ' O ' ' NH1' ' A' ' 140' ' ' ARG . 61.3 mttm 55.3 23.72 5.84 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.436 -0.79 . . . . 75.400000000000006 110.792 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 86.66 1.29 85.55 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.364 -1.094 . . . . 72.239999999999995 110.364 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.462 ' NH1' ' O ' ' A' ' 138' ' ' LYS . 11.1 mpt_? -88.94 126.55 35.45 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.06 -1.259 . . . . 73.120000000000005 108.838 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -100.01 127.36 46.23 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.398 -0.814 . . . . 72.319999999999993 109.86 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 24.0 t -137.65 136.2 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.366 -0.834 . . . . 62.340000000000003 109.491 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -97.94 142.69 29.36 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.34 -0.85 . . . . 61.229999999999997 109.532 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.2 m -155.53 154.74 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.161 -0.962 . . . . 74.439999999999998 109.76 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.829 ' HZ2' ' ND2' ' A' ' 44' ' ' ASN . 20.0 pttt 178.27 115.28 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.282 -0.886 . . . . 75.420000000000002 109.137 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.01 176.18 37.74 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.689 -1.365 . . . . 73.340000000000003 109.689 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.583 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 0.0 OUTLIER -60.09 -44.32 96.23 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.4 -1.059 . . . . 72.219999999999999 109.254 -179.651 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 39.5 Cg_exo -59.57 -36.2 93.44 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.374 2.05 . . . . 75.450000000000003 112.268 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -92.57 -14.71 27.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.258 -0.901 . . . . 65.239999999999995 109.63 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -54.93 -40.07 69.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.885 . . . . 72.519999999999996 109.865 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.6 p -61.12 -37.31 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.967 -1.083 . . . . 74.209999999999994 109.55 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 7.2 tp -62.9 -51.32 67.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.494 -0.754 . . . . 73.310000000000002 110.405 -179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.3 p -74.71 -29.02 61.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.098 -1.001 . . . . 74.310000000000002 110.057 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -57.32 -56.74 17.89 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.833 -1.167 . . . . 75.450000000000003 109.672 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.8 pp -72.15 -27.28 62.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.395 -0.816 . . . . 75.340000000000003 109.732 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.57 -52.88 58.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.961 -1.087 . . . . 62.140000000000001 108.72 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.635 ' HB2' ' HD1' ' A' ' 158' ' ' HIS . 52.7 mtt85 -65.18 -43.83 90.42 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.663 -0.866 . . . . 72.219999999999999 108.663 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.769 ' N ' ' HD1' ' A' ' 158' ' ' HIS . 0.2 OUTLIER -86.55 30.84 0.69 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.53 -0.731 . . . . 74.120000000000005 110.245 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.914 ' NE ' HG13 ' A' ' 123' ' ' ILE . 57.1 ttm-85 -51.46 156.79 1.17 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.983 -1.073 . . . . 74.340000000000003 108.419 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 1.02 ' HB2' ' HE1' ' A' ' 216' ' ' TYR . 26.4 t70 57.12 79.02 0.2 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.248 -0.908 . . . . 75.450000000000003 108.773 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -171.76 154.08 3.53 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.472 -0.768 . . . . 73.409999999999997 109.714 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.7 mt -86.7 115.85 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 74.409999999999997 109.109 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 90.5 t -113.7 120.68 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.374 -0.829 . . . . 72.530000000000001 108.867 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 40.4 t -85.72 163.61 18.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.828 . . . . 74.120000000000005 109.74 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -60.44 -47.82 84.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.519 -0.738 . . . . 70.430000000000007 109.794 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -58.61 -36.53 74.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -0.928 . . . . 74.319999999999993 109.337 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 60.9 tp60 -55.15 -44.55 75.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.197 -0.939 . . . . 74.519999999999996 108.866 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.93 -37.17 81.38 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.22 -0.925 . . . . 74.409999999999997 108.563 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.413 ' C ' ' CD2' ' A' ' 169' ' ' LEU . 4.4 tt -66.53 -60.15 2.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.418 -0.801 . . . . 75.140000000000001 109.296 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.75 -15.49 61.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.837 -0.539 . . . . 65.030000000000001 110.857 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.1 -49.32 7.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.913 -1.117 . . . . 70.209999999999994 111.075 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.403 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 2.3 mp -98.99 -53.55 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.023 -1.048 . . . . 75.319999999999993 110.453 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 23.1 m-90 -89.02 35.54 0.79 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.896 -1.127 . . . . 73.140000000000001 109.683 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -50.11 -34.39 21.86 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.351 -0.843 . . . . 73.239999999999995 108.818 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' A' ' 175' ' ' GLU . 14.6 mp0 -83.1 154.11 66.88 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 108.672 -0.862 . . . . 63.329999999999998 108.672 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.508 ' O ' ' N ' ' A' ' 178' ' ' MET . 89.5 Cg_exo -38.5 -57.37 0.89 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.075 1.85 . . . . 72.510000000000005 111.995 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 45.34 16.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 75.340000000000003 109.839 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.508 ' N ' ' O ' ' A' ' 176' ' ' PRO . 12.6 ttt 47.91 71.67 0.32 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.334 -0.854 . . . . 74.510000000000005 109.868 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 28.4 m -123.06 140.09 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.487 -0.758 . . . . 65.219999999999999 108.969 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 49.8 p -85.43 146.31 44.26 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.188 -0.945 . . . . 73.219999999999999 109.419 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -41.88 -56.58 1.87 Allowed 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.06 1.84 . . . . 62.43 112.486 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -88.98 86.1 6.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.243 -0.91 . . . . 73.129999999999995 109.913 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.0 p -141.75 -23.99 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.307 -0.871 . . . . 74.019999999999996 109.884 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 2.4 mp -56.42 -29.65 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 72.329999999999998 109.854 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -58.85 -39.78 82.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.07 -1.019 . . . . 74.400000000000006 109.332 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 1.5 t -73.27 -46.85 48.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.508 -0.745 . . . . 74.319999999999993 110.071 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.74 86.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 73.230000000000004 110.545 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.403 HG23 HD13 ' A' ' 188' ' ' ILE . 0.2 OUTLIER -61.48 -42.96 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.915 -1.116 . . . . 74.310000000000002 109.95 -178.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -62.67 -43.1 99.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.83 -1.169 . . . . 73.439999999999998 109.443 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -66.65 -46.31 76.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.87 . . . . 71.420000000000002 109.794 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 81.9 mt -57.11 -38.17 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.179 -0.951 . . . . 72.439999999999998 109.435 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 36.6 mtp180 -61.76 -42.37 98.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.142 -0.974 . . . . 64.219999999999999 109.333 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.427 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 49.2 mt-30 -76.45 -30.13 57.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.475 -0.766 . . . . 74.319999999999993 110.455 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -86.51 -15.6 39.53 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.161 -0.962 . . . . 75.310000000000002 110.243 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 27.1 ttt -93.44 -39.16 11.05 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.014 -1.054 . . . . 74.019999999999996 110.622 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 193' ' ' GLN . 28.2 p-10 -62.65 -32.28 73.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.192 -0.942 . . . . 74.019999999999996 110.712 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.427 ' N ' ' OD1' ' A' ' 196' ' ' ASP . 51.8 mttt -65.08 -64.77 2.35 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.948 -1.095 . . . . 75.430000000000007 110.209 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 21.6 Cg_endo -60.04 -48.94 10.78 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.906 1.738 . . . . 72.319999999999993 111.738 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -41.48 77.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 74.540000000000006 108.748 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 85.95 -46.61 3.65 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.915 -1.274 . . . . 61.509999999999998 109.915 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 30.3 mt -93.64 133.44 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.239 -1.154 . . . . 74.25 109.642 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 70.7 m -75.87 135.98 40.15 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.364 -0.976 . . . . 72.0 108.364 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 19.6 p -144.83 45.91 1.36 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.982 -1.074 . . . . 74.439999999999998 110.463 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.8 m -148.99 128.58 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.007 -1.058 . . . . 71.129999999999995 108.925 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.493 ' N ' ' CD ' ' A' ' 205' ' ' GLU . 7.6 mp0 -91.44 120.54 32.37 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.096 -1.003 . . . . 73.510000000000005 109.475 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 5.9 p -93.15 111.97 23.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.257 -0.902 . . . . 73.519999999999996 109.291 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.79 128.61 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.241 -0.912 . . . . 72.150000000000006 108.989 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -56.08 -43.66 78.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.093 -1.004 . . . . 72.400000000000006 109.49 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.571 ' O ' ' N ' ' A' ' 211' ' ' GLY . 77.5 mtt180 -57.51 146.48 29.75 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.158 -0.964 . . . . 73.310000000000002 108.533 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 56.46 -79.08 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.087 -0.708 . . . . 71.540000000000006 109.087 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . 168.01 -112.17 0.47 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.239 -1.544 . . . . 74.450000000000003 109.239 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -116.38 123.63 48.07 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.56 -0.964 . . . . 75.540000000000006 109.18 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -107.18 130.11 54.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.696 -0.627 . . . . 75.310000000000002 109.677 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.834 ' CE1' ' HG3' ' A' ' 159' ' ' ARG . 12.2 t80 -89.8 139.53 30.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.945 -1.097 . . . . 75.409999999999997 108.812 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 99.6 m -152.66 150.67 29.72 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.999 -1.112 . . . . 74.140000000000001 107.999 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . 1.02 ' HE1' ' HB2' ' A' ' 160' ' ' ASP . 0.0 OUTLIER -59.86 151.13 65.51 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 120.902 -1.124 . . . . 75.319999999999993 108.755 -179.454 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.3 -81.7 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.295 1.997 . . . . 73.109999999999999 111.907 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.518 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 4.7 tmtm? -170.34 -44.92 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.982 -1.074 . . . . 75.25 109.728 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 18.9 Cg_exo -66.36 -9.86 25.46 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.212 1.941 . . . . 75.099999999999994 111.794 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -54.54 100.44 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.243 -0.911 . . . . 71.140000000000001 108.936 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 25.6 m -64.21 126.1 26.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.451 -0.781 . . . . 71.129999999999995 109.807 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.428 ' O ' ' OXT' ' A' ' 223' ' ' GLU . 74.0 tt0 -90.7 124.65 35.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.314 -0.866 . . . . 75.349999999999994 108.672 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.428 ' OXT' ' O ' ' A' ' 222' ' ' GLU . 38.6 tp10 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.092 -0.956 . . . . 73.409999999999997 109.499 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ptt? . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.38 -0.6 . . . . 75.239999999999995 109.38 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.605 ' NH1' ' NE ' ' B' ' 43' ' ' ARG . 66.4 mtp180 -126.59 142.07 51.66 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.568 -0.708 . . . . 73.519999999999996 109.386 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 92.8 t -118.79 130.28 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.608 0.718 . . . . 72.239999999999995 109.77 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 tp -98.5 116.73 31.37 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.933 -0.766 . . . . 73.340000000000003 108.933 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.04 109.14 17.62 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.183 -1.043 . . . . 74.349999999999994 108.183 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 77.0 mt -101.31 99.41 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.926 -1.109 . . . . 63.439999999999998 109.021 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -145.18 130.38 18.53 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.36 -0.838 . . . . 74.519999999999996 109.223 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.41 -33.69 76.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.347 -0.846 . . . . 74.129999999999995 109.67 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -74.14 105.56 5.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 74.230000000000004 109.457 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 23.4 t -68.15 -25.84 65.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.882 . . . . 65.540000000000006 109.758 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 89.0 t -62.76 -48.59 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.189 -0.944 . . . . 75.549999999999997 109.84 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.415 ' CD1' ' NZ ' ' B' ' 97' ' ' LYS . 28.5 mt -68.22 -25.95 65.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 70.140000000000001 109.585 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.39 -34.58 25.5 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.919 -1.672 . . . . 75.400000000000006 108.919 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.55 -46.8 83.05 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.847 -1.301 . . . . 65.439999999999998 109.847 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -67.25 -43.83 80.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.057 -1.261 . . . . 72.200000000000003 109.271 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 91.1 mt -63.51 -38.47 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.957 -1.089 . . . . 75.150000000000006 108.57 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -60.69 -42.98 98.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.34 -0.85 . . . . 73.010000000000005 109.376 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -86.79 -0.09 55.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.147 -0.971 . . . . 74.299999999999997 109.161 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.47 -56.49 2.25 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.489 -1.444 . . . . 70.540000000000006 109.489 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -72.13 -22.95 61.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -1.12 . . . . 75.430000000000007 109.613 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -52.56 -35.19 53.24 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.096 -1.002 . . . . 73.200000000000003 109.205 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 59.1 t -54.94 -46.12 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 74.230000000000004 108.842 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 35.1 mmtm -59.72 -53.36 58.88 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.884 -0.784 . . . . 73.519999999999996 108.884 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.27 36.77 0.23 Allowed Glycine 0 N--CA 1.5 2.901 0 N-CA-C 110.088 -1.205 . . . . 53.43 110.088 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -119.16 160.47 22.05 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.455 -1.027 . . . . 71.120000000000005 109.309 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 26.3 mtt -105.05 141.94 35.73 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.659 -0.867 . . . . 75.239999999999995 108.659 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.92 150.14 44.19 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.227 -0.921 . . . . 73.25 109.878 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' B' ' 28' ' ' ASP . 42.0 p30 -131.78 157.57 43.5 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.98 -0.748 . . . . 72.310000000000002 108.98 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.38 137.7 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.475 -0.765 . . . . 72.140000000000001 109.508 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.6 p -136.2 170.3 16.24 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.005 -0.739 . . . . 74.530000000000001 109.005 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -92.18 -107.32 0.11 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.199 -0.938 . . . . 71.019999999999996 109.935 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 60.2 p -78.54 169.67 17.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.225 -0.922 . . . . 71.400000000000006 110.189 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 56.4 mt -53.36 -33.16 52.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.601 -0.687 . . . . 71.239999999999995 109.815 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -51.26 -48.3 62.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 74.319999999999993 109.745 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -65.76 -43.79 87.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 73.030000000000001 109.409 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.02 -42.13 94.82 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.558 -1.417 . . . . 60.43 109.558 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -65.31 -41.3 94.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -1.122 . . . . 74.430000000000007 109.438 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . 0.452 ' O ' ' OD1' ' B' ' 41' ' ' ASP . 63.5 t80 -76.36 -21.3 56.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 74.420000000000002 109.892 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 12.5 tp -88.64 -36.47 16.24 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.078 -1.014 . . . . 75.409999999999997 109.875 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.3 ppp? -80.13 -29.09 38.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.175 -0.953 . . . . 61.439999999999998 110.474 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' B' ' 42' ' ' ILE . 30.4 p-10 -54.24 -32.27 55.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.966 -1.084 . . . . 74.319999999999993 109.758 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.547 ' N ' ' OD1' ' B' ' 41' ' ' ASP . 12.4 pt -84.39 -35.76 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.18 -0.95 . . . . 71.230000000000004 109.811 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.605 ' NE ' ' NH1' ' B' ' 2' ' ' ARG . 76.0 mtp180 -131.44 141.41 49.81 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.398 -0.813 . . . . 73.409999999999997 109.481 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -97.07 134.91 39.79 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.196 -0.94 . . . . 63.539999999999999 109.437 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -101.51 161.62 13.5 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.351 -0.843 . . . . 73.109999999999999 109.471 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -90.68 -42.51 10.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.178 -0.951 . . . . 62.219999999999999 109.236 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.407 ' C ' ' CD1' ' B' ' 47' ' ' LEU . 0.9 OUTLIER -104.3 109.78 21.75 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.782 -0.822 . . . . 73.120000000000005 108.782 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 66.4 t -92.59 99.11 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.252 -0.905 . . . . 74.109999999999999 108.611 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' MET . . . . . 0.517 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 3.5 tpp -113.75 129.77 56.53 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.643 -0.66 . . . . 73.439999999999998 109.574 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.462 ' N ' ' SD ' ' B' ' 49' ' ' MET . 0.3 OUTLIER -147.8 126.51 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.506 -0.746 . . . . 73.400000000000006 109.223 179.302 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 4.0 m -91.22 14.42 14.37 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.55 -0.718 . . . . 73.209999999999994 109.58 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.445 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 57.5 m-20 -75.92 145.36 40.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.152 -0.967 . . . . 70.409999999999997 109.485 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -77.42 -36.57 53.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 73.129999999999995 109.931 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -77.07 12.33 1.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -0.985 . . . . 75.209999999999994 109.492 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.72 -26.17 68.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.347 -0.846 . . . . 55.329999999999998 110.099 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 11.1 mp -45.89 -37.08 5.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.159 -0.963 . . . . 72.420000000000002 109.96 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 83.9 p -74.92 -46.22 37.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.031 -1.043 . . . . 73.040000000000006 109.901 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -64.83 -50.77 65.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 72.329999999999998 110.11 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 m -59.41 -36.7 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.755 -1.215 . . . . 74.540000000000006 109.764 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 33.2 t -57.48 -49.14 77.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 71.239999999999995 109.791 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -71.35 -27.7 63.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.031 -1.043 . . . . 74.310000000000002 109.88 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 4.8 mm -61.42 -51.25 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.839 -1.163 . . . . 75.420000000000002 109.261 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -64.28 -40.51 96.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.015 . . . . 73.319999999999993 109.326 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -68.43 -41.69 79.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.235 -0.915 . . . . 73.310000000000002 108.54 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -81.67 -76.98 0.23 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.371 -0.831 . . . . 72.439999999999998 109.224 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.55 ' CE1' ' HZ1' ' B' ' 145' ' ' LYS . 73.1 m-70 -92.94 91.62 7.48 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.211 -0.93 . . . . 65.209999999999994 108.97 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 80.6 p -77.29 -30.49 54.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 73.099999999999994 110.067 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 53.1 p -82.71 54.02 2.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.124 -0.985 . . . . 71.530000000000001 109.702 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 16.7 tt -146.81 159.69 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.198 -0.939 . . . . 74.400000000000006 109.326 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 46.8 t -97.88 154.34 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.113 -0.992 . . . . 75.120000000000005 109.093 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 12.7 t -143.56 121.54 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.041 -1.037 . . . . 73.200000000000003 109.795 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.517 ' O ' ' SD ' ' B' ' 49' ' ' MET . 3.2 mp -121.77 99.67 6.58 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.463 -0.94 . . . . 73.340000000000003 108.463 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 12.2 p -90.86 126.52 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 73.5 108.638 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.72 171.72 8.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.012 -1.055 . . . . 71.319999999999993 108.813 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.429 ' OG ' ' OE1' ' B' ' 82' ' ' GLU . 8.0 t -162.01 119.27 2.14 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.932 -1.105 . . . . 74.530000000000001 110.159 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.5 p30 -67.33 -1.09 4.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 64.5 109.389 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . 0.454 ' O ' ' N ' ' B' ' 79' ' ' THR . 11.9 p-10 -133.98 77.13 63.03 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 108.912 -0.773 . . . . 74.25 108.912 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.5 75.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.676 2.251 . . . . 74.430000000000007 112.033 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.454 ' N ' ' O ' ' B' ' 77' ' ' ASN . 75.1 p -98.74 148.28 24.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.128 -0.983 . . . . 73.120000000000005 109.197 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -32.62 74.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.91 . . . . 75.409999999999997 109.442 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.37 -33.19 74.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.008 . . . . 72.239999999999995 109.093 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . 0.429 ' OE1' ' OG ' ' B' ' 75' ' ' SER . 63.1 tt0 -73.12 -38.06 66.45 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.314 -0.866 . . . . 73.219999999999999 109.304 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' B' ' 83' ' ' GLU . 0.4 OUTLIER -57.62 -52.07 66.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 74.299999999999997 109.351 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 14.4 m -59.94 -38.96 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -0.969 . . . . 73.310000000000002 109.405 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -67.7 -35.42 78.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.118 -0.989 . . . . 73.239999999999995 109.303 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.56 -36.85 84.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 55.329999999999998 109.833 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -83.81 -38.64 21.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.045 -1.034 . . . . 74.450000000000003 109.238 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -68.22 -44.19 76.31 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.303 -0.873 . . . . 64.040000000000006 109.485 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -66.66 -48.91 67.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 75.129999999999995 109.595 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 141.65 75.45 0.04 OUTLIER Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.859 -1.296 . . . . 75.420000000000002 109.859 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -136.6 138.88 41.67 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.327 -1.102 . . . . 73.420000000000002 109.136 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.43 -44.25 52.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 73.319999999999993 109.348 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -153.81 166.1 33.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.352 -0.842 . . . . 73.040000000000006 109.531 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.527 ' CD1' ' O ' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -136.85 139.51 41.74 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.012 -0.736 . . . . 74.310000000000002 109.012 -178.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.578 ' N ' ' CD1' ' B' ' 95' ' ' ILE . 0.5 OUTLIER -132.45 151.43 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.512 -0.743 . . . . 75.340000000000003 110.25 -179.328 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.5 124.65 23.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.814 -1.179 . . . . 70.099999999999994 108.101 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.667 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -47.0 -55.25 15.86 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.985 -1.072 . . . . 65.430000000000007 111.103 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 4.2 Cg_endo -41.93 -10.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.124 0 C-N-CA 120.853 1.035 . . . . 63.520000000000003 112.734 -177.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . 0.667 ' N ' ' O ' ' B' ' 97' ' ' LYS . 51.7 m-85 61.05 128.29 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.353 -0.61 . . . . 75.129999999999995 109.353 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -72.34 -29.66 64.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.961 -1.087 . . . . 74.230000000000004 109.42 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' SER . . . . . 0.719 ' O ' ' N ' ' B' ' 103' ' ' LYS . 30.2 t -175.08 31.6 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.944 -1.097 . . . . 64.510000000000005 111.115 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 36.8 mm 52.34 -70.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.48 -0.763 . . . . 74.439999999999998 110.129 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' B' ' 101' ' ' SER . 67.2 mmtt -57.99 -33.0 68.45 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.18 -1.044 . . . . 72.299999999999997 108.18 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.27 -44.32 96.81 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.176 -1.046 . . . . 74.310000000000002 108.176 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 17.4 tp -64.5 -46.68 81.95 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.565 -0.902 . . . . 73.540000000000006 108.565 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 76.9 t -58.86 -41.31 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.976 . . . . 72.030000000000001 109.165 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.23 -36.63 71.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.316 -0.865 . . . . 64.219999999999999 109.131 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 54.4 ttt85 -79.44 -26.89 41.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.306 -0.871 . . . . 75.310000000000002 109.906 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 93.7 mt -76.48 -43.71 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.032 -1.043 . . . . 55.439999999999998 108.731 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' B' ' 114' ' ' ARG . 23.9 pt-20 -70.25 -28.39 65.21 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.336 -0.945 . . . . 65.310000000000002 108.714 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.34 -49.24 74.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.409 -0.807 . . . . 74.519999999999996 109.397 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -61.5 -42.32 98.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.224 -0.922 . . . . 72.040000000000006 109.702 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 45.6 mt -120.0 49.51 1.39 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.458 -0.776 . . . . 75.349999999999994 109.569 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.529 ' N ' ' O ' ' B' ' 110' ' ' GLU . 1.2 tmt_? -65.37 -59.13 4.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -0.951 . . . . 75.5 109.232 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -69.36 -47.98 62.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 73.040000000000006 109.476 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' TRP . . . . . 0.526 ' O ' ' CD2' ' B' ' 116' ' ' TRP . 76.8 t90 45.83 58.59 4.24 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.313 -0.867 . . . . 74.450000000000003 109.791 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 171.13 94.69 0.1 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.414 -1.474 . . . . 64.209999999999994 109.414 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 48.7 m -144.9 170.63 15.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.295 -1.121 . . . . 71.400000000000006 109.637 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' B' ' 119' ' ' ASN . 0.0 OUTLIER -157.15 124.11 5.12 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.007 -0.738 . . . . 74.209999999999994 109.007 -178.386 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 77.7 t -77.95 -35.83 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 75.019999999999996 110.229 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 4.9 mp -113.54 140.86 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.334 -0.853 . . . . 74.239999999999995 109.544 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -145.48 119.22 9.21 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.194 -0.941 . . . . 73.329999999999998 109.566 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 6.8 pt -130.54 130.76 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.387 -0.821 . . . . 74.219999999999999 109.124 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 44.11 -136.27 5.48 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.797 -1.321 . . . . 72.409999999999997 109.797 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' B' ' 125' ' ' ASP . 20.3 p-10 -89.09 0.98 56.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -1.136 . . . . 75.120000000000005 109.035 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.0 134.63 40.12 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.36 -0.978 . . . . 75.420000000000002 108.36 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 8.4 m -130.17 143.72 50.94 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.393 -0.817 . . . . 74.219999999999999 109.471 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 25.2 mt -127.7 128.76 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.542 -0.724 . . . . 60.329999999999998 109.633 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 49.9 m -119.79 92.64 46.75 Favored Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 108.974 -0.75 . . . . 72.310000000000002 108.974 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.24 -22.27 9.85 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.134 1.889 . . . . 75.129999999999995 112.613 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -52.09 -46.33 65.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.033 -1.042 . . . . 75.230000000000004 108.985 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -103.13 16.47 26.52 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.385 -0.822 . . . . 75.120000000000005 109.021 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 51.77 58.3 5.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.222 -0.924 . . . . 75.129999999999995 108.866 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . 0.427 ' HZ3' ' CG ' ' B' ' 143' ' ' GLU . 18.2 ttmm -137.38 124.4 21.51 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.547 -0.72 . . . . 75.109999999999999 109.204 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 18.5 tt -107.09 129.9 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.368 -0.832 . . . . 70.319999999999993 109.097 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 5.7 mm -108.83 126.35 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.471 -0.768 . . . . 74.120000000000005 109.281 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . 0.52 ' C ' ' H ' ' B' ' 139' ' ' GLY . 78.8 t80 -140.26 148.01 40.83 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.526 -0.916 . . . . 74.230000000000004 108.526 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . 0.486 ' O ' ' NH1' ' B' ' 140' ' ' ARG . 40.3 tttp 54.54 6.27 0.11 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.344 -0.848 . . . . 74.219999999999999 109.619 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' B' ' 137' ' ' TYR . . . 94.61 -5.14 69.88 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.072 -1.211 . . . . 74.319999999999993 110.072 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . 0.511 ' N ' ' CD ' ' B' ' 140' ' ' ARG . 10.7 mpt_? -88.9 142.84 27.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.151 -1.206 . . . . 75.340000000000003 109.042 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -94.17 129.13 40.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.273 -0.892 . . . . 71.230000000000004 109.552 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 39.0 t -131.23 129.03 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.45 -0.781 . . . . 70.430000000000007 109.391 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . 0.427 ' CG ' ' HZ3' ' B' ' 134' ' ' LYS . 99.3 mt-10 -99.14 142.79 30.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.237 -0.915 . . . . 72.430000000000007 109.318 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . 0.505 ' CG2' ' CG ' ' B' ' 149' ' ' PHE . 11.9 p -141.5 157.05 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.297 -0.877 . . . . 72.129999999999995 109.593 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . 0.55 ' HZ1' ' CE1' ' B' ' 66' ' ' HIS . 13.2 ptpt -165.85 116.36 1.03 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.886 . . . . 74.5 109.635 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 168.34 -178.95 41.69 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.779 -1.728 . . . . 42.229999999999997 108.779 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 0.563 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 1.3 mptp? -79.45 -44.22 1.63 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.052 -1.263 . . . . 73.299999999999997 109.558 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 25.3 Cg_exo -62.34 -15.69 46.62 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 122.552 2.168 . . . . 71.329999999999998 112.33 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . 0.505 ' CG ' ' CG2' ' B' ' 144' ' ' VAL . 23.3 m-85 -100.69 -35.5 9.45 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.359 -0.838 . . . . 74.230000000000004 110.153 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -58.06 -27.77 63.93 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.229 -0.919 . . . . 72.340000000000003 108.774 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' B' ' 152' ' ' LEU . 8.5 p -65.91 -44.89 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.207 -0.933 . . . . 73.349999999999994 108.515 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . 0.461 ' N ' ' CG1' ' B' ' 151' ' ' VAL . 32.3 tp -55.47 -41.86 73.53 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.745 -0.835 . . . . 74.430000000000007 108.745 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 18.6 p -71.35 -29.45 65.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.397 -0.814 . . . . 75.209999999999994 109.665 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -59.27 -57.44 13.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.062 -1.024 . . . . 73.040000000000006 109.719 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -23.52 64.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.049 -1.032 . . . . 73.430000000000007 109.053 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.26 -50.48 73.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.103 -0.998 . . . . 75.319999999999993 109.79 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.42 ' C ' ' H ' ' B' ' 159' ' ' ARG . 45.9 mtt180 -71.1 -41.72 70.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.09 -1.006 . . . . 73.319999999999993 109.425 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -78.25 35.42 0.22 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.51 -0.744 . . . . 74.140000000000001 109.812 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . 0.582 ' NH1' ' CZ ' ' B' ' 214' ' ' PHE . 52.6 ttm-85 -70.24 163.14 27.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.967 . . . . 73.420000000000002 108.914 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 51.94 44.91 29.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.053 -1.03 . . . . 72.099999999999994 109.439 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -154.42 -175.82 5.59 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.279 -0.888 . . . . 73.239999999999995 109.944 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 70.1 mt -112.65 138.17 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.194 -0.669 . . . . 72.310000000000002 109.194 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.66 138.23 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.535 -0.728 . . . . 75.030000000000001 109.079 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 164' ' ' SER . . . . . 0.467 ' H ' HE21 ' B' ' 167' ' ' GLN . 13.5 p -92.8 161.5 14.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.308 -0.87 . . . . 74.219999999999999 109.882 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -62.71 -49.59 74.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.476 -0.765 . . . . 72.420000000000002 109.465 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . 0.519 ' H ' ' CD ' ' B' ' 166' ' ' GLU . 49.9 mp0 -62.11 -35.18 77.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.346 -0.846 . . . . 63.450000000000003 109.656 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 167' ' ' GLN . . . . . 0.467 HE21 ' H ' ' B' ' 164' ' ' SER . 9.5 tt0 -59.25 -35.87 74.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.161 -0.962 . . . . 72.400000000000006 109.433 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 92.1 mt -68.69 -50.34 51.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.127 -0.983 . . . . 72.319999999999993 109.492 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 9.4 mp -58.92 -43.84 91.18 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.141 -0.974 . . . . 73.340000000000003 109.264 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -75.93 -21.98 56.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.094 -1.004 . . . . 73.099999999999994 109.974 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.67 -46.86 65.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.9 -1.125 . . . . 62.130000000000003 109.66 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.557 ' N ' ' CD1' ' B' ' 172' ' ' ILE . 1.6 mp -94.56 -54.62 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.227 -0.92 . . . . 74.439999999999998 109.163 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 29.4 m-90 -93.79 68.56 3.93 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.213 -0.929 . . . . 72.230000000000004 109.724 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . 0.563 ' H ' ' CD ' ' B' ' 174' ' ' GLU . 1.5 pm0 -76.83 -31.89 57.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.265 -0.897 . . . . 75.030000000000001 108.924 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.14 154.21 83.14 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.319 -0.863 . . . . 73.040000000000006 108.699 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.48 65.16 2.23 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.039 1.826 . . . . 74.129999999999995 111.098 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -81.98 -166.62 1.28 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.402 -0.811 . . . . 72.439999999999998 109.655 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 17.9 ttt -99.49 63.59 1.27 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.311 -0.868 . . . . 72.109999999999999 109.593 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 68.9 t -87.9 124.27 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.141 -0.974 . . . . 75.310000000000002 109.468 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 180' ' ' THR . . . . . 0.466 ' C ' ' H ' ' B' ' 182' ' ' ASN . 2.9 p -85.39 151.76 56.8 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 62.149999999999999 108.734 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.66 38.04 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.084 1.856 . . . . 74.340000000000003 111.259 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 182' ' ' ASN . . . . . 0.466 ' H ' ' C ' ' B' ' 180' ' ' THR . 51.5 p-10 -148.79 -8.78 0.36 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.283 -0.886 . . . . 72.310000000000002 109.884 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 47.5 t -60.13 -24.15 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.087 -1.008 . . . . 65.420000000000002 109.618 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 41.8 mt -55.23 -48.23 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.353 -0.842 . . . . 75.030000000000001 110.625 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -63.47 -37.0 85.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 73.519999999999996 110.484 -178.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.78 -42.81 54.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.305 -0.872 . . . . 74.349999999999994 110.685 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.82 -47.32 47.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.788 -1.195 . . . . 61.119999999999997 110.491 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 188' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' B' ' 189' ' ' ASN . 9.3 tp -65.11 -41.94 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.021 -1.049 . . . . 72.430000000000007 110.48 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 189' ' ' ASN . . . . . 0.448 ' C ' HD21 ' B' ' 189' ' ' ASN . 0.5 OUTLIER -61.64 -47.47 85.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.998 -1.064 . . . . 75.420000000000002 109.959 -179.614 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -65.03 -50.97 64.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.154 -0.966 . . . . 74.140000000000001 110.05 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 75.8 mt -49.31 -34.22 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.125 -0.984 . . . . 74.030000000000001 109.752 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -48.57 64.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.113 -0.992 . . . . 72.329999999999998 108.98 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -71.18 -25.3 62.47 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.244 -0.91 . . . . 73.099999999999994 110.074 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -88.35 -19.91 26.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.371 -0.83 . . . . 74.430000000000007 109.862 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 6.2 ttt -103.57 -45.26 4.88 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.355 -0.841 . . . . 74.329999999999998 110.575 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -59.26 -40.29 85.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.081 -1.012 . . . . 71.209999999999994 110.471 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . 0.439 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 0.9 OUTLIER -58.22 -65.23 2.01 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.12 -0.988 . . . . 75.209999999999994 110.545 -179.268 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 198' ' ' PRO . . . . . 0.448 ' O ' ' CZ ' ' B' ' 137' ' ' TYR . 19.4 Cg_endo -56.88 -53.98 4.32 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.568 1.512 . . . . 75.319999999999993 112.238 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . 0.472 ' C ' ' H ' ' B' ' 201' ' ' ILE . 11.1 mp -63.1 -34.18 77.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.134 -0.979 . . . . 72.25 109.084 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 74.7 -37.15 1.03 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.706 -1.358 . . . . 73.239999999999995 109.706 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . 0.472 ' H ' ' C ' ' B' ' 199' ' ' LEU . 39.7 mm -93.15 132.5 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.285 -1.127 . . . . 54.299999999999997 109.386 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 14.4 t -77.22 135.16 38.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 74.310000000000002 108.861 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 203' ' ' THR . . . . . 0.454 ' O ' ' CE1' ' B' ' 214' ' ' PHE . 16.1 p -144.22 40.41 1.35 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.279 -0.888 . . . . 74.400000000000006 109.628 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 7.2 m -141.2 142.55 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.135 -0.978 . . . . 74.099999999999994 109.631 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -121.71 136.09 54.94 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.929 -0.767 . . . . 75.329999999999998 108.929 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.12 135.99 46.61 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.377 -0.827 . . . . 71.400000000000006 109.712 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 13.1 p -141.7 131.83 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.295 -0.878 . . . . 63.5 109.129 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -80.27 -25.08 39.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.172 -0.955 . . . . 74.450000000000003 109.814 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 60.1 mtp85 -48.85 -27.49 3.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 74.140000000000001 109.818 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -151.92 -67.74 0.17 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.088 -1.007 . . . . 74.430000000000007 109.694 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . 0.424 ' C ' ' CD1' ' B' ' 212' ' ' TYR . . . -162.84 -100.8 0.15 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.859 -1.296 . . . . 70.109999999999999 109.859 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 212' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' B' ' 211' ' ' GLY . 38.6 m-85 -137.17 158.38 44.58 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.458 -1.025 . . . . 74.209999999999994 109.389 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -130.96 125.88 34.56 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.548 -0.72 . . . . 74.299999999999997 109.694 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . 0.582 ' CZ ' ' NH1' ' B' ' 159' ' ' ARG . 0.3 OUTLIER -85.59 119.56 26.07 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.348 -0.982 . . . . 74.340000000000003 108.348 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 48.3 t -132.66 149.5 52.29 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.189 -0.671 . . . . 72.209999999999994 109.189 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.15 164.05 3.9 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.188 -0.945 . . . . 72.310000000000002 108.631 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.03 -161.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.658 2.239 . . . . 71.010000000000005 111.586 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' B' ' 220' ' ' ALA . 43.9 mttm -57.9 152.74 36.7 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.144 -0.972 . . . . 74.349999999999994 109.037 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -35.5 87.36 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 122.513 2.142 . . . . 71.319999999999993 112.592 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' B' ' 218' ' ' LYS . . . -64.86 -33.13 75.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.313 -0.867 . . . . 75.450000000000003 109.733 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 71.7 m -80.11 123.84 28.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.171 -0.956 . . . . 72.219999999999999 109.486 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -60.89 140.23 57.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 74.299999999999997 109.473 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.983 -1.008 . . . . 71.129999999999995 109.785 -179.923 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.55 ' SD ' ' CE2' ' A' ' 25' ' ' PHE . 12.1 ptp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.442 -0.577 . . . . 65.120000000000005 109.442 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.3 mtt85 -141.49 149.58 41.1 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.319 -0.863 . . . . 73.310000000000002 109.315 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 80.3 t -114.45 141.04 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.633 -0.667 . . . . 71.420000000000002 109.495 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.6 tp -112.35 118.81 36.25 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.532 -0.73 . . . . 65.219999999999999 109.583 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 18.3 mt -115.74 101.94 9.27 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.479 -0.763 . . . . 71.439999999999998 109.18 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.401 HG21 HD11 ' A' ' 6' ' ' ILE . 76.6 mt -97.27 107.92 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.228 -0.92 . . . . 71.150000000000006 108.839 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.535 ' OE2' ' NZ ' ' A' ' 97' ' ' LYS . 53.5 tt0 -151.28 129.53 11.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.259 -0.901 . . . . 75.340000000000003 109.557 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -62.66 -33.04 74.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -0.895 . . . . 73.040000000000006 109.377 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -76.82 95.08 3.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.903 . . . . 72.420000000000002 109.329 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.0 t -61.11 -25.2 66.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.343 -0.848 . . . . 72.340000000000003 109.683 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.08 -53.95 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.964 . . . . 74.420000000000002 109.844 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 49.5 mt -64.37 -44.07 92.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.941 . . . . 72.010000000000005 109.678 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.29 -24.63 75.96 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.123 -1.991 . . . . 72.140000000000001 108.123 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.75 -57.0 10.56 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 109.702 -1.359 . . . . 72.329999999999998 109.702 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -53.5 -45.87 69.83 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.313 -1.11 . . . . 72.340000000000003 109.651 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 78.4 mt -67.34 -45.59 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.757 -1.214 . . . . 74.239999999999995 109.041 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -51.29 -48.39 62.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.127 -0.983 . . . . 71.409999999999997 109.358 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.3 ttpp -86.59 -0.09 55.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.248 -0.907 . . . . 75.540000000000006 109.19 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.6 -59.03 2.43 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.847 -1.301 . . . . 62.149999999999999 109.847 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -71.49 -20.9 62.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -1.171 . . . . 74.420000000000002 109.938 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -57.65 -31.59 66.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.119 -0.988 . . . . 74.25 109.576 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.5 t -59.34 -29.76 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.871 . . . . 72.109999999999999 109.189 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.648 ' HZ2' ' NZ ' ' A' ' 103' ' ' LYS . 32.3 mmtt -76.51 5.44 7.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.423 -0.798 . . . . 73.230000000000004 109.267 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.57 25.39 56.73 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.12 -1.192 . . . . 75.540000000000006 110.12 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CE2' ' SD ' ' A' ' 1' ' ' MET . 8.7 m-85 -102.02 156.86 17.27 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.287 -1.125 . . . . 74.510000000000005 109.119 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.3 mmt -107.07 136.61 46.64 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.461 -0.941 . . . . 64.319999999999993 108.461 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.49 165.79 26.98 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.191 -0.943 . . . . 74.310000000000002 109.949 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.413 ' OD2' ' CD2' ' A' ' 39' ' ' LEU . 25.3 t70 -139.65 150.3 44.77 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.432 -0.792 . . . . 75.400000000000006 108.995 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.33 139.48 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.483 -0.761 . . . . 75.129999999999995 109.276 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 p -137.84 176.1 9.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.381 -0.824 . . . . 71.420000000000002 109.295 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -97.73 -104.47 0.19 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.331 -0.856 . . . . 73.109999999999999 109.77 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.3 m -77.99 166.57 22.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.227 -0.92 . . . . 74.239999999999995 110.158 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.4 mt -51.0 -35.46 34.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.606 -0.684 . . . . 71.530000000000001 109.853 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -51.9 -50.31 61.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.18 -0.95 . . . . 74.230000000000004 109.947 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -63.82 -40.06 95.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.108 -0.995 . . . . 71.010000000000005 109.247 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.05 -38.48 63.81 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.344 -1.502 . . . . 61.409999999999997 109.344 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -63.63 -42.92 98.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -1.121 . . . . 74.340000000000003 109.499 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -72.55 -34.04 67.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 75.329999999999998 109.555 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.413 ' CD2' ' OD2' ' A' ' 28' ' ' ASP . 21.1 tp -71.45 -49.54 40.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.891 . . . . 74.329999999999998 109.966 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 40' ' ' MET . 3.9 ppp? -67.67 -22.96 65.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.076 -1.015 . . . . 70.319999999999993 109.849 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -59.58 -38.06 80.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.178 -0.951 . . . . 71.219999999999999 110.002 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.3 pt -85.47 -29.82 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.157 -0.964 . . . . 74.409999999999997 110.325 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 40' ' ' MET . 65.8 mtt85 -130.39 144.67 51.53 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.237 -0.915 . . . . 75.409999999999997 109.784 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -99.07 127.62 45.04 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.308 -0.87 . . . . 75.420000000000002 109.24 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -99.66 145.36 27.68 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.298 -0.876 . . . . 74.230000000000004 109.534 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -79.1 -35.72 41.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 75.319999999999993 109.282 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.15 116.85 32.27 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.652 -0.87 . . . . 72.129999999999995 108.652 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 50.6 t -102.71 100.43 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.429 -0.952 . . . . 72.340000000000003 108.429 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.434 ' CE ' ' OH ' ' A' ' 99' ' ' TYR . 21.0 ttt -115.5 136.76 52.75 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.546 0.689 . . . . 74.109999999999999 110.079 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.458 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 1.5 p -145.07 132.22 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.57 -0.706 . . . . 71.239999999999995 109.628 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.0 m -92.78 2.03 56.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.457 -0.777 . . . . 73.109999999999999 109.253 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.458 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 51.5 m-20 -76.95 142.23 40.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 63.399999999999999 109.508 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.461 ' C ' ' H ' ' A' ' 55' ' ' ALA . 15.5 ptpt -81.15 -31.15 34.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.22 -0.925 . . . . 65.439999999999998 110.092 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -74.02 10.8 1.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.088 -1.008 . . . . 73.129999999999995 109.354 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.461 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -67.4 -21.05 65.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.427 -0.796 . . . . 64.140000000000001 110.253 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.6 mt -43.13 -48.42 6.33 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.255 -0.903 . . . . 74.430000000000007 110.067 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.2 m -68.75 -36.23 78.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.01 -1.056 . . . . 63.229999999999997 108.743 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -64.73 -64.86 0.77 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.368 -0.833 . . . . 74.439999999999998 109.579 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.1 m -48.27 -32.55 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.68 -1.263 . . . . 74.030000000000001 109.646 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.9 t -57.41 -50.53 72.71 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.227 -0.921 . . . . 73.540000000000006 109.074 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -72.33 -34.74 68.29 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.19 -1.004 . . . . 73.340000000000003 110.128 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.8 mm -67.36 -33.48 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.599 -1.313 . . . . 73.349999999999994 109.422 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -68.25 -48.9 63.83 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.231 -0.918 . . . . 74.420000000000002 110.248 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.414 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 17.2 pt-20 -75.39 -40.68 57.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.958 -1.089 . . . . 74.549999999999997 110.308 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.521 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 54.9 mttp -73.85 -21.68 60.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.198 -0.939 . . . . 75.219999999999999 110.015 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.521 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 84.4 m-70 -156.79 64.63 0.52 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.013 -1.054 . . . . 74.129999999999995 109.677 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.3 t -61.42 -28.15 69.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.935 . . . . 73.239999999999995 109.683 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 84.6 p -64.33 -20.73 66.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.266 -0.896 . . . . 71.439999999999998 110.107 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 78.3 mt -82.72 159.18 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.065 -1.022 . . . . 71.329999999999998 109.772 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.4 t -95.39 149.65 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.455 -0.778 . . . . 73.019999999999996 109.213 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.0 t -130.53 126.94 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.421 -0.799 . . . . 54.210000000000001 109.71 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.0 tt -121.89 101.95 7.88 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.493 -0.755 . . . . 74.209999999999994 109.063 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 69.4 t -90.37 145.88 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 74.409999999999997 109.154 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.7 m -128.54 155.6 44.63 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.325 -0.859 . . . . 72.310000000000002 108.751 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.6 m -165.47 144.32 6.32 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.979 -1.075 . . . . 64.540000000000006 110.68 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -86.88 19.83 2.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.482 -0.761 . . . . 74.129999999999995 109.753 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 79' ' ' THR . 55.4 t30 -138.91 55.58 7.95 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.302 -0.874 . . . . 73.340000000000003 109.397 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 77' ' ' ASN . 15.1 Cg_endo -57.5 77.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.364 2.043 . . . . 71.319999999999993 111.532 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 77' ' ' ASN . 12.5 t -102.81 171.84 7.18 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.56 -0.904 . . . . 62.530000000000001 108.56 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 p -75.74 -20.63 58.17 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.2 -0.938 . . . . 74.140000000000001 110.081 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.511 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 77.1 tt0 -69.52 -49.91 50.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.043 -1.036 . . . . 71.420000000000002 109.533 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -73.82 -27.6 61.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 73.430000000000007 109.576 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -61.26 -56.68 17.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 74.219999999999999 109.85 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.7 m -65.58 -43.61 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 74.150000000000006 109.812 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' A' ' 81' ' ' GLU . 32.2 m80 -63.44 -31.23 72.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.112 -0.993 . . . . 72.540000000000006 109.701 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.32 -45.56 79.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.085 -1.01 . . . . 64.219999999999999 109.809 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -79.98 -30.35 39.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.091 -1.005 . . . . 74.340000000000003 109.207 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -71.97 -51.58 21.25 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.309 -0.869 . . . . 74.420000000000002 109.254 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -60.68 -48.58 81.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.499 -0.751 . . . . 74.519999999999996 109.622 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.16 70.82 0.02 OUTLIER Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.332 -1.107 . . . . 74.209999999999994 110.332 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.02 125.1 43.97 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.439 -1.036 . . . . 64.099999999999994 108.634 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -77.09 -27.51 54.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.999 -1.063 . . . . 73.420000000000002 109.428 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 94' ' ' TYR . 13.3 t0 -151.81 162.38 41.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 75.040000000000006 109.059 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.526 ' N ' ' OD1' ' A' ' 93' ' ' ASP . 58.3 t80 -148.3 101.82 3.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.208 -0.933 . . . . 71.329999999999998 109.484 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.1 mm -104.83 150.65 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.475 0 O-C-N 121.179 -0.951 . . . . 74.510000000000005 110.682 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.38 123.71 20.73 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.408 -1.33 . . . . 64.319999999999993 107.408 178.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.683 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -43.18 -57.68 4.98 Favored Pre-proline 0 C--N 1.3 -1.583 0 O-C-N 121.217 -0.927 . . . . 74.510000000000005 112.298 -178.364 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 6.7 Cg_endo -43.27 -7.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 120.93 1.087 . . . . 73.109999999999999 112.49 -174.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.683 ' N ' ' O ' ' A' ' 97' ' ' LYS . 58.4 m-85 57.81 120.89 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.07 0.462 . . . . 72.540000000000006 110.268 178.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.529 ' NE ' ' OH ' ' B' ' 94' ' ' TYR . 56.5 mtt-85 -62.06 -44.58 96.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.02 -1.05 . . . . 74.540000000000006 109.327 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.84 ' O ' ' N ' ' A' ' 103' ' ' LYS . 13.0 t -171.83 47.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.091 -1.006 . . . . 74.140000000000001 110.696 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.3 mt 40.21 -66.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 CA-C-N 118.324 0.511 . . . . 75.430000000000007 111.562 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.84 ' N ' ' O ' ' A' ' 101' ' ' SER . 40.9 tptt -47.03 -26.87 1.14 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.098 -1.002 . . . . 74.140000000000001 109.025 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.38 -47.02 52.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.363 -0.836 . . . . 63.240000000000002 109.884 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -58.95 -57.23 14.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 73.219999999999999 109.324 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.2 p -52.58 -40.91 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.596 -1.315 . . . . 74.540000000000006 109.222 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.49 -44.04 62.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 75.5 109.19 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -66.22 -34.71 78.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.206 -0.934 . . . . 74.409999999999997 109.094 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.7 mt -72.09 -26.77 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.152 -0.967 . . . . 73.239999999999995 108.483 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.19 -58.28 5.74 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.689 -0.804 . . . . 74.340000000000003 109.399 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.31 -40.46 67.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.183 -0.948 . . . . 73.319999999999993 109.311 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.05 -31.06 71.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -0.866 . . . . 74.420000000000002 109.334 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.1 tt -156.14 98.21 1.85 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 74.329999999999998 109.597 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.3 mtm180 -92.04 -81.3 0.34 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.189 -0.944 . . . . 74.439999999999998 109.077 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -80.38 -81.93 0.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 74.430000000000007 109.554 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -149.67 -175.91 5.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.304 -0.873 . . . . 74.439999999999998 109.429 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.48 -155.06 4.95 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.395 -1.482 . . . . 75.040000000000006 109.395 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.452 ' C ' ' ND2' ' A' ' 119' ' ' ASN . 68.6 m -134.37 164.82 26.56 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.343 -1.092 . . . . 70.109999999999999 109.569 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.452 ' ND2' ' C ' ' A' ' 118' ' ' SER . 0.0 OUTLIER -139.67 127.15 21.55 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.083 -0.71 . . . . 65.239999999999995 109.083 -178.178 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 56.4 t -89.32 -20.63 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.312 -0.867 . . . . 74.219999999999999 109.551 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.7 mp -117.78 119.7 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.399 -0.813 . . . . 74.420000000000002 109.004 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -140.86 122.81 15.49 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.408 -0.808 . . . . 73.299999999999997 109.748 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 15.5 tt -138.33 130.78 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.383 -0.823 . . . . 75.340000000000003 109.143 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.62 -134.72 34.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.281 -1.528 . . . . 75.129999999999995 109.281 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.72 -9.06 45.14 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.07 -1.253 . . . . 74.450000000000003 109.462 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.35 135.73 33.77 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.971 -1.081 . . . . 54.210000000000001 108.915 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 44.2 p -129.33 139.18 51.83 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.457 -0.777 . . . . 70.239999999999995 109.122 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 81.3 mt -130.78 131.82 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.399 -0.813 . . . . 72.430000000000007 109.834 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.41 ' HG ' HD21 ' A' ' 119' ' ' ASN . 5.4 m -126.31 110.86 23.65 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.302 -0.999 . . . . 71.109999999999999 108.302 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.98 -38.47 0.82 Allowed 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.533 1.489 . . . . 75.140000000000001 112.046 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -65.35 -42.54 92.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.177 -0.952 . . . . 72.5 109.238 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 133' ' ' GLU . 44.7 mm-40 -87.82 11.48 15.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.333 -0.854 . . . . 73.140000000000001 109.708 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 132' ' ' GLU . 11.8 pt-20 33.48 61.78 0.43 Allowed 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.209 0.528 . . . . 75.329999999999998 110.846 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -152.74 148.42 27.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.081 -1.012 . . . . 71.230000000000004 110.213 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.2 tt -135.51 144.36 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.507 -0.746 . . . . 75.329999999999998 109.177 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 20.5 mt -125.49 135.37 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.63 -0.878 . . . . 71.109999999999999 108.63 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -139.38 135.68 33.94 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.086 -1.009 . . . . 74.140000000000001 110.271 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm 54.01 28.9 9.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.584 -0.698 . . . . 75.400000000000006 110.366 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.42 16.56 75.72 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 120.025 -1.083 . . . . 72.239999999999995 110.9 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -111.01 125.3 53.59 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.343 -1.093 . . . . 73.120000000000005 109.37 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -92.98 123.39 36.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.253 -0.904 . . . . 72.319999999999993 110.279 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.3 p -137.0 138.97 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.251 -1.018 . . . . 62.340000000000003 108.251 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.451 ' N ' ' CD ' ' A' ' 143' ' ' GLU . 19.3 mp0 -99.99 143.9 29.66 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.309 -0.869 . . . . 61.229999999999997 110.406 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.6 m -142.6 130.99 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.481 -0.933 . . . . 74.439999999999998 108.481 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.01 19.58 0.88 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.173 -0.954 . . . . 75.420000000000002 109.736 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.85 173.86 47.46 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.132 -1.587 . . . . 73.340000000000003 109.132 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.619 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 27.2 mttt -69.83 -37.17 7.46 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.138 -1.213 . . . . 72.219999999999999 110.162 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 19.1 Cg_exo -64.48 -18.62 63.56 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.09 1.86 . . . . 75.450000000000003 111.907 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -95.28 -30.9 13.72 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.214 -0.929 . . . . 65.239999999999995 110.009 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -50.43 -35.95 30.97 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.097 -1.002 . . . . 72.519999999999996 109.197 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.6 p -62.2 -33.37 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.138 -0.976 . . . . 74.209999999999994 109.091 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 9.5 tp -67.1 -39.3 86.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.823 . . . . 73.310000000000002 109.248 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 39.1 p -73.95 -29.7 62.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.066 -1.021 . . . . 74.310000000000002 109.388 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -61.81 -57.78 10.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.067 -1.021 . . . . 75.450000000000003 109.742 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 pp -64.43 -29.5 70.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.127 -0.983 . . . . 75.340000000000003 109.192 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.45 -45.83 69.63 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.236 -0.915 . . . . 62.140000000000001 109.046 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.411 ' C ' ' H ' ' A' ' 159' ' ' ARG . 34.6 mtt180 -73.05 -46.3 52.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.103 -0.998 . . . . 72.219999999999999 108.915 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.419 ' C ' ' H ' ' A' ' 160' ' ' ASP . 27.2 m170 -79.59 29.35 0.25 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.593 -0.692 . . . . 74.120000000000005 109.889 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.411 ' H ' ' C ' ' A' ' 157' ' ' ARG . 19.9 ttp-105 -71.29 44.7 0.09 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.162 -0.961 . . . . 74.340000000000003 109.563 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.419 ' H ' ' C ' ' A' ' 158' ' ' HIS . 6.9 t70 -171.26 46.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.88 -1.138 . . . . 75.450000000000003 109.915 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -168.39 178.55 4.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.023 -1.048 . . . . 73.409999999999997 109.975 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 66.7 mt -96.25 139.43 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.45 -0.781 . . . . 74.409999999999997 109.244 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 78.7 t -132.28 140.08 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.368 -0.832 . . . . 72.530000000000001 109.617 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 32.3 p -98.88 169.32 9.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.255 -0.903 . . . . 74.120000000000005 109.843 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -67.04 -46.79 73.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.52 -0.738 . . . . 70.430000000000007 109.982 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -53.73 -36.42 62.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.356 -0.84 . . . . 74.319999999999993 109.778 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -61.09 -49.32 77.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.158 -0.964 . . . . 74.519999999999996 109.525 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 38.7 mt -51.27 -40.6 59.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.077 -1.014 . . . . 74.409999999999997 109.027 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.4 ' C ' ' CD2' ' A' ' 169' ' ' LEU . 4.2 tt -60.65 -65.08 0.75 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.451 -0.781 . . . . 75.140000000000001 109.793 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -66.38 -10.92 48.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.214 -0.929 . . . . 65.030000000000001 110.591 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.25 -52.93 12.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.953 -1.092 . . . . 70.209999999999994 110.033 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.555 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 1.7 mp -95.77 -52.56 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.019 -1.051 . . . . 75.319999999999993 109.2 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 21.7 m-90 -96.4 113.07 24.62 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.333 -0.854 . . . . 73.140000000000001 109.259 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.486 ' N ' ' CD ' ' A' ' 174' ' ' GLU . 2.3 pm0 -147.01 8.17 0.94 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.162 -0.961 . . . . 73.239999999999995 109.491 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 0.5 OUTLIER 177.69 -50.47 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.287 -0.883 . . . . 63.329999999999998 109.471 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 91.0 Cg_exo -45.43 -38.47 15.78 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.004 1.803 . . . . 72.510000000000005 112.401 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -147.92 145.13 28.5 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.175 -0.953 . . . . 75.340000000000003 109.689 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 71.3 mtm -89.96 126.77 35.86 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.439 -0.788 . . . . 74.510000000000005 109.104 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 28.5 m -133.9 139.86 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.401 -0.812 . . . . 65.219999999999999 109.776 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 26.0 m -73.5 135.74 78.5 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.334 -0.987 . . . . 73.219999999999999 108.334 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.2 -12.63 35.7 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 121.685 1.59 . . . . 62.43 112.391 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -81.28 34.32 0.36 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.188 -0.945 . . . . 73.129999999999995 109.497 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 8.8 p -130.15 -13.69 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.347 -0.846 . . . . 74.019999999999996 110.556 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 58.6 mt -56.55 -27.83 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.749 -1.219 . . . . 72.329999999999998 109.235 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -53.12 -48.94 67.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.317 -0.864 . . . . 74.400000000000006 109.48 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 2.2 t -73.79 -28.63 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.474 -0.766 . . . . 74.319999999999993 109.982 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.44 -41.13 66.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.143 -0.973 . . . . 73.230000000000004 111.071 -178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.7 tp -76.4 -33.97 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.52 -1.363 . . . . 74.310000000000002 109.823 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -66.55 -55.72 14.16 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.272 -0.893 . . . . 73.439999999999998 110.14 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -61.85 -36.74 82.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 71.420000000000002 110.263 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 74.8 mt -69.4 -40.85 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.157 -0.965 . . . . 72.439999999999998 110.227 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 44.1 mtp85 -58.01 -39.12 77.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.88 -1.138 . . . . 64.219999999999999 108.985 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -78.06 -36.61 48.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 74.319999999999993 109.677 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.527 ' CB ' ' HZ1' ' A' ' 194' ' ' LYS . 8.5 mtpm? -84.46 2.51 40.54 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.185 -0.947 . . . . 75.310000000000002 110.49 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' MET . . . . . 1.034 ' HE1' ' CG1' ' A' ' 204' ' ' VAL . 44.3 ttp -99.58 -47.16 5.21 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.088 -1.007 . . . . 74.019999999999996 109.662 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -68.82 -32.05 71.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.89 . . . . 74.019999999999996 109.869 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.434 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 1.1 mmtm -55.2 -64.49 2.05 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.23 -0.919 . . . . 75.430000000000007 109.555 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 40.0 Cg_endo -64.17 -53.66 1.1 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.128 1.885 . . . . 72.319999999999993 112.236 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.9 mp -54.71 -56.61 17.41 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.971 -1.08 . . . . 74.540000000000006 109.643 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 100.35 -17.99 56.04 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 109.842 -1.303 . . . . 61.509999999999998 109.842 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 41.2 mt -128.16 147.78 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.341 -1.094 . . . . 74.25 109.104 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 17.5 t -77.96 136.6 38.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.971 -1.08 . . . . 72.0 109.278 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.21 15.87 1.88 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.203 -0.935 . . . . 74.439999999999998 109.302 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 1.034 ' CG1' ' HE1' ' A' ' 195' ' ' MET . 31.2 m -127.42 152.32 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.551 -0.718 . . . . 71.129999999999995 110.089 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -126.95 130.56 50.34 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.878 -0.786 . . . . 73.510000000000005 108.878 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 4.2 t -98.84 127.23 44.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.196 -0.94 . . . . 73.519999999999996 109.06 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 8.5 p -145.56 140.18 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.117 -0.989 . . . . 72.150000000000006 109.539 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -82.59 -25.28 33.4 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.263 -0.898 . . . . 72.400000000000006 109.597 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 13.2 mmt85 -49.45 -25.08 2.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.418 -0.801 . . . . 73.310000000000002 109.866 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -152.21 -74.29 0.14 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 71.540000000000006 109.448 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -166.91 -102.01 0.16 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.206 -1.558 . . . . 74.450000000000003 109.206 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -135.49 134.08 39.15 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.443 -1.034 . . . . 75.540000000000006 109.268 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -97.92 137.55 36.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.335 -0.853 . . . . 75.310000000000002 109.54 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.43 ' O ' ' SG ' ' A' ' 215' ' ' CYS . 44.1 m-85 -105.77 119.12 38.34 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.83 -0.804 . . . . 75.409999999999997 108.83 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . 0.43 ' SG ' ' O ' ' A' ' 214' ' ' PHE . 99.3 m -153.39 162.54 41.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.32 -0.862 . . . . 74.140000000000001 109.391 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -67.6 155.08 92.1 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 75.319999999999993 108.925 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -36.14 138.91 0.17 Allowed 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 122.424 2.083 . . . . 73.109999999999999 112.033 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.582 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 34.7 tttt -68.5 -39.28 14.91 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.156 -0.965 . . . . 75.25 110.647 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 52.3 Cg_exo -54.44 -7.38 0.78 Allowed 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.98 1.787 . . . . 75.099999999999994 111.829 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.424 ' H ' ' C ' ' A' ' 218' ' ' LYS . . . -65.47 -54.19 31.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.345 -0.847 . . . . 71.140000000000001 109.826 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 46.3 m 47.5 -139.08 0.66 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.123 -0.986 . . . . 71.129999999999995 109.293 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -59.62 -39.8 85.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.099 -1.0 . . . . 75.349999999999994 109.219 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.982 -1.009 . . . . 73.409999999999997 109.537 -179.93 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 54.7 ttm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.44 -0.578 . . . . 75.239999999999995 109.44 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -137.79 154.46 49.56 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.356 -0.84 . . . . 73.519999999999996 109.489 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 97.8 t -115.58 125.95 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 109.174 -0.676 . . . . 72.239999999999995 109.174 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' B' ' 49' ' ' MET . 4.4 tp -99.31 119.03 37.27 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.454 -0.779 . . . . 73.340000000000003 108.975 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.418 ' CD1' ' SD ' ' B' ' 49' ' ' MET . 5.3 tp -120.45 100.29 7.06 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 108.959 -0.756 . . . . 74.349999999999994 108.959 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 45.7 mt -90.05 102.81 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.833 -1.167 . . . . 63.439999999999998 108.816 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.42 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 29.2 tp10 -133.2 128.87 36.91 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.501 -0.75 . . . . 74.519999999999996 109.371 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -65.49 -33.31 75.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.906 . . . . 74.129999999999995 109.168 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -88.43 111.56 21.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.346 -0.846 . . . . 74.230000000000004 109.387 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 83.1 p -69.06 -27.07 65.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.915 . . . . 65.540000000000006 109.586 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 77.7 t -61.92 -51.31 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 75.549999999999997 109.607 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 37.9 mt -64.35 -30.65 71.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 70.140000000000001 109.449 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.36 -29.91 57.57 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.623 -1.791 . . . . 75.400000000000006 108.623 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.41 -50.52 61.77 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.912 -1.275 . . . . 65.439999999999998 109.912 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -65.46 -41.53 93.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -1.165 . . . . 72.200000000000003 109.801 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 5.7 mm -67.66 -35.28 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.867 -1.145 . . . . 75.150000000000006 108.905 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -64.58 -46.39 82.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.872 . . . . 73.010000000000005 109.454 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -79.49 -9.16 59.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 74.299999999999997 109.468 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.57 -52.95 3.97 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 109.422 -1.471 . . . . 70.540000000000006 109.422 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pp -70.51 -27.83 64.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -1.089 . . . . 75.430000000000007 109.392 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.19 -34.87 61.57 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.229 -0.919 . . . . 73.200000000000003 109.21 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 49.0 t -54.36 -45.37 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.345 -0.847 . . . . 74.230000000000004 108.746 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.52 ' NZ ' ' OE1' ' B' ' 110' ' ' GLU . 23.6 mmtp -57.09 -51.64 68.48 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.607 -0.886 . . . . 73.519999999999996 108.607 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 127.66 41.12 0.3 Allowed Glycine 0 N--CA 1.5 2.907 0 N-CA-C 110.461 -1.056 . . . . 53.43 110.461 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -119.66 159.2 24.9 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.265 -1.138 . . . . 71.120000000000005 108.862 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 15.1 mmt -98.16 138.46 35.42 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.06 -1.089 . . . . 75.239999999999995 108.06 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.24 160.71 40.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.928 . . . . 73.25 110.261 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -142.84 152.84 42.59 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.663 -0.866 . . . . 72.310000000000002 108.663 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 p -114.02 137.1 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.37 -0.831 . . . . 72.140000000000001 109.238 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.6 p -134.41 170.07 16.3 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.576 -0.703 . . . . 74.530000000000001 109.457 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.479 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 1.9 pt-20 -94.4 -98.6 0.15 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.383 -0.823 . . . . 71.019999999999996 110.055 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 70.1 m -78.59 168.8 19.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.257 -0.902 . . . . 71.400000000000006 110.363 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 16.1 mt -56.76 -31.98 65.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.61 -0.681 . . . . 71.239999999999995 110.009 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -52.76 -44.07 66.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.131 -0.981 . . . . 74.319999999999993 109.861 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.479 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 64.1 m-20 -73.76 -39.58 64.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.107 -0.995 . . . . 73.030000000000001 109.553 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.3 -44.98 57.63 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.62 -1.392 . . . . 60.43 109.62 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.66 -43.32 84.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -1.153 . . . . 74.430000000000007 109.67 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -70.55 -39.85 73.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.131 -0.98 . . . . 74.420000000000002 110.099 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 25.0 tp -70.2 -44.07 69.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -0.948 . . . . 75.409999999999997 110.373 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.449 ' SD ' ' OH ' ' B' ' 45' ' ' TYR . 0.0 OUTLIER -74.49 -28.01 60.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.025 -1.047 . . . . 61.439999999999998 110.147 -179.204 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.21 -29.89 70.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.967 -1.083 . . . . 74.319999999999993 110.383 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 19.8 pt -86.34 -18.43 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.953 -1.092 . . . . 71.230000000000004 110.905 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' B' ' 40' ' ' MET . 59.0 mmt-85 -129.63 155.19 46.25 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.082 -1.011 . . . . 73.409999999999997 110.132 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -84.62 157.03 21.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.271 -0.893 . . . . 63.539999999999999 109.551 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.513 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 3.6 p90 -149.9 -174.89 4.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.208 -0.933 . . . . 73.109999999999999 109.393 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -141.5 -33.62 0.5 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.27 -0.894 . . . . 62.219999999999999 109.569 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.14 114.78 28.55 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.35 -0.844 . . . . 73.120000000000005 109.107 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 71.5 t -101.74 97.22 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.449 -0.945 . . . . 74.109999999999999 108.449 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' MET . . . . . 0.434 ' O ' ' O ' ' B' ' 4' ' ' LEU . 15.4 ttt -112.91 130.53 56.08 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.571 0.7 . . . . 73.439999999999998 109.849 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.424 HG23 ' H ' ' B' ' 52' ' ' ASP . 0.2 OUTLIER -145.05 138.85 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.4 -0.813 . . . . 73.400000000000006 109.311 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' SER . . . . . 0.42 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 53.0 p -105.46 2.29 28.44 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.548 -0.72 . . . . 73.209999999999994 110.412 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.424 ' H ' HG23 ' B' ' 50' ' ' VAL . 84.7 m-20 -75.7 147.01 39.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.987 -1.07 . . . . 70.409999999999997 109.629 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' B' ' 55' ' ' ALA . 62.3 mttp -73.35 -58.2 3.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.287 -0.883 . . . . 73.129999999999995 110.23 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -47.43 -12.85 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.089 -1.007 . . . . 75.209999999999994 109.904 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' B' ' 53' ' ' LYS . . . -58.67 -25.15 62.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.856 . . . . 55.329999999999998 110.598 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 97.7 mt -45.19 -47.44 12.49 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.065 -1.022 . . . . 72.420000000000002 109.827 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' SER . . . . . 0.408 ' O ' ' OG ' ' B' ' 60' ' ' SER . 21.5 m -68.81 -33.41 73.81 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.937 -1.102 . . . . 73.040000000000006 108.751 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -65.93 -60.68 2.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.422 -0.799 . . . . 72.329999999999998 109.77 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 31.4 m -50.0 -36.14 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.527 -1.358 . . . . 74.540000000000006 109.639 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' B' ' 57' ' ' SER . 22.5 p -56.56 -54.2 48.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.107 -0.996 . . . . 71.239999999999995 109.68 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.541 ' HE ' ' NZ ' ' B' ' 65' ' ' LYS . 5.9 ptm180 -66.02 -30.18 70.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.007 -1.058 . . . . 74.310000000000002 110.034 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 34.4 mm -65.08 -37.97 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.653 -1.28 . . . . 75.420000000000002 109.723 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' B' ' 67' ' ' SER . 25.0 mmtp -68.3 -51.87 39.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.063 -1.023 . . . . 73.319999999999993 110.302 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -67.47 -37.56 83.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.847 -1.158 . . . . 73.310000000000002 109.939 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.541 ' NZ ' ' HE ' ' B' ' 61' ' ' ARG . 92.9 mttt -81.55 -20.43 39.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -0.94 . . . . 72.439999999999998 109.707 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.485 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 74.0 m-70 -155.89 64.77 0.58 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.129 -0.982 . . . . 65.209999999999994 109.701 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.404 ' N ' ' O ' ' B' ' 63' ' ' LYS . 9.4 t -63.47 -29.01 70.36 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 73.099999999999994 109.669 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 96.5 p -61.64 -25.96 67.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 71.530000000000001 110.045 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 65.6 mt -83.4 151.3 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.093 -1.004 . . . . 74.400000000000006 109.48 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 99.2 t -89.93 154.62 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.415 -0.803 . . . . 75.120000000000005 109.318 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 18.1 t -134.57 127.78 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.308 -0.87 . . . . 73.200000000000003 109.618 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . 0.409 ' C ' ' CD2' ' B' ' 72' ' ' LEU . 4.6 tt -118.91 102.66 8.95 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.455 0.645 . . . . 73.340000000000003 109.577 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 10.9 p -94.07 130.58 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.947 -1.096 . . . . 73.5 109.241 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 12.7 p -85.4 174.3 9.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.086 -1.009 . . . . 71.319999999999993 108.79 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 10.4 p -153.43 110.23 3.41 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.827 -1.171 . . . . 74.530000000000001 110.679 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -71.23 -21.7 62.09 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.499 -0.926 . . . . 64.5 108.499 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -126.64 73.38 74.61 Favored Pre-proline 0 N--CA 1.494 1.764 0 N-CA-C 108.601 -0.889 . . . . 74.25 108.601 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.18 81.51 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.778 1.652 . . . . 74.430000000000007 111.843 -178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.426 ' O ' ' OE2' ' B' ' 83' ' ' GLU . 4.3 t -110.08 152.12 26.37 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.736 -0.839 . . . . 73.120000000000005 108.736 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.6 t -50.88 -33.44 24.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 75.409999999999997 110.321 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -61.19 -37.29 82.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.999 -1.063 . . . . 72.239999999999995 110.236 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 34.2 tp10 -78.93 -37.02 40.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.004 -1.06 . . . . 73.219999999999999 110.088 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.519 ' N ' ' OE1' ' B' ' 83' ' ' GLU . 0.3 OUTLIER -58.08 -50.51 73.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.098 -1.001 . . . . 74.299999999999997 109.615 -179.612 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 24.3 m -67.8 -39.87 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.121 -0.987 . . . . 73.310000000000002 109.542 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' HIS . . . . . 0.625 ' CE1' ' NE2' ' B' ' 89' ' ' GLN . 4.4 t-160 -66.41 -26.87 67.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.171 -0.955 . . . . 73.239999999999995 109.562 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.68 -42.72 60.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.123 -0.986 . . . . 55.329999999999998 110.115 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -82.37 -33.38 28.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.081 -1.012 . . . . 74.450000000000003 109.275 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -68.58 -34.38 75.7 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.355 -0.841 . . . . 64.040000000000006 109.572 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . 0.625 ' NE2' ' CE1' ' B' ' 85' ' ' HIS . 36.5 mt-30 -80.43 -63.61 1.37 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -0.953 . . . . 75.129999999999995 109.677 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 163.2 68.06 0.02 OUTLIER Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.401 -1.38 . . . . 75.420000000000002 110.435 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -127.18 137.29 52.9 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.455 -1.026 . . . . 73.420000000000002 108.837 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' B' ' 93' ' ' ASP . 14.2 t70 -80.89 -34.52 33.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.055 -1.028 . . . . 73.319999999999993 109.448 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . 0.512 ' OD1' ' NH2' ' B' ' 112' ' ' ARG . 57.9 m-20 -149.96 164.15 36.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.35 -0.844 . . . . 73.040000000000006 109.441 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.532 ' CD1' ' O ' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -140.17 112.97 8.09 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.684 -0.858 . . . . 74.310000000000002 108.684 -178.951 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 35.4 mm -114.46 147.79 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.368 -0.833 . . . . 75.340000000000003 110.124 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.47 139.52 58.58 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.172 -0.955 . . . . 70.099999999999994 108.558 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.601 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -69.17 -40.95 16.68 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.185 -0.947 . . . . 65.430000000000007 110.916 -179.19 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' B' ' 97' ' ' LYS . 33.1 Cg_exo -52.25 1.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.29 -2.518 0 CA-C-N 118.4 0.464 . . . . 63.520000000000003 112.833 -174.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . 0.601 ' N ' ' O ' ' B' ' 97' ' ' LYS . 45.7 m-85 55.55 99.19 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.453 -0.779 . . . . 75.129999999999995 109.722 178.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 34.9 ttm-85 -59.46 -36.09 75.3 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.009 -1.057 . . . . 74.230000000000004 108.724 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' SER . . . . . 0.737 ' O ' ' N ' ' B' ' 103' ' ' LYS . 12.6 t -173.84 39.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.234 -0.916 . . . . 64.510000000000005 110.688 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . 0.425 ' C ' ' N ' ' B' ' 104' ' ' ALA . 60.3 mt 51.92 -69.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.48 -0.763 . . . . 74.439999999999998 110.062 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . 0.737 ' N ' ' O ' ' B' ' 101' ' ' SER . 38.1 mmtm -56.65 -15.36 4.33 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.168 -1.419 . . . . 72.299999999999997 107.168 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.425 ' N ' ' C ' ' B' ' 102' ' ' ILE . . . -60.54 -78.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.349 -0.54 . . . . 74.310000000000002 110.189 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.442 ' H ' ' CD1' ' B' ' 105' ' ' LEU . 0.0 OUTLIER -51.9 -41.17 61.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.95 -1.094 . . . . 73.540000000000006 109.381 -179.151 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 27.6 t -57.84 -45.21 87.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.995 -1.066 . . . . 72.030000000000001 108.804 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.04 -30.86 62.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.21 -0.931 . . . . 64.219999999999999 108.787 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 0.418 HH12 ' NH2' ' B' ' 112' ' ' ARG . 2.0 tpm_? -80.72 -24.77 38.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.428 -0.795 . . . . 75.310000000000002 109.649 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 93.9 mt -80.08 -38.93 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.114 -0.991 . . . . 55.439999999999998 109.391 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . 0.52 ' OE1' ' NZ ' ' B' ' 23' ' ' LYS . 22.7 pt-20 -72.58 -40.93 66.22 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.163 -0.961 . . . . 65.310000000000002 109.509 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.21 -44.26 95.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.929 . . . . 74.519999999999996 109.248 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . 0.512 ' NH2' ' OD1' ' B' ' 93' ' ' ASP . 56.2 ttm-85 -63.08 -31.73 72.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 72.040000000000006 109.443 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 13.4 tp -145.12 70.54 1.27 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.263 -0.898 . . . . 75.349999999999994 109.127 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' B' ' 110' ' ' GLU . 96.2 mtt180 -62.69 -46.22 89.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 75.5 109.709 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -81.62 -103.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 73.040000000000006 109.536 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -163.43 -28.63 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.101 -0.999 . . . . 74.450000000000003 109.759 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -167.94 -172.48 35.0 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.767 -1.333 . . . . 64.209999999999994 109.767 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 48.9 m -145.48 -172.04 3.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.369 -1.077 . . . . 71.400000000000006 109.382 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.82 160.74 43.68 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.671 -0.812 . . . . 74.209999999999994 109.406 -178.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 4.5 t -134.3 -38.1 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.484 -0.76 . . . . 75.019999999999996 109.176 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' B' ' 128' ' ' ILE . 27.6 mm -110.87 133.32 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.797 -0.816 . . . . 74.239999999999995 108.797 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -137.31 143.62 42.2 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.396 -0.815 . . . . 73.329999999999998 108.904 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.905 ' CD1' ' CZ ' ' B' ' 159' ' ' ARG . 19.5 tt -155.02 127.1 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 74.219999999999999 109.879 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 47.49 -151.56 2.07 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.723 -1.351 . . . . 72.409999999999997 109.723 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -75.75 -3.29 34.06 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.206 -1.173 . . . . 75.120000000000005 109.065 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.41 147.02 24.92 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.112 -1.07 . . . . 75.420000000000002 108.112 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 36.1 m -126.61 134.82 50.69 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.457 -0.777 . . . . 74.219999999999999 108.978 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' B' ' 121' ' ' ILE . 96.1 mt -126.2 124.15 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.54 -0.725 . . . . 60.329999999999998 109.675 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 18.8 m -123.89 109.21 30.08 Favored Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 109.198 -0.667 . . . . 72.310000000000002 109.198 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.96 -24.72 5.63 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.665 1.577 . . . . 75.129999999999995 111.629 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . 0.419 ' O ' ' OE2' ' B' ' 133' ' ' GLU . 26.3 t0 -62.0 -42.9 99.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 75.230000000000004 109.183 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -91.6 4.54 52.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.368 -0.833 . . . . 75.120000000000005 108.951 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.419 ' OE2' ' O ' ' B' ' 131' ' ' ASP . 28.8 mp0 49.32 64.29 1.8 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.098 -1.001 . . . . 75.129999999999995 109.405 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -159.43 140.3 12.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.093 -1.004 . . . . 75.109999999999999 109.997 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 63.7 mt -118.98 137.23 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.631 -0.877 . . . . 70.319999999999993 108.631 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 15.2 mt -121.59 129.78 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.606 -0.684 . . . . 74.120000000000005 109.896 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -139.94 144.59 37.16 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.445 -0.784 . . . . 74.230000000000004 109.202 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 48.9 mttp 55.19 19.65 3.0 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.932 -0.766 . . . . 74.219999999999999 108.932 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.33 2.54 90.62 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.243 -1.143 . . . . 74.319999999999993 110.243 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . 0.405 ' N ' ' HD2' ' B' ' 140' ' ' ARG . 10.0 mmm-85 -89.85 129.13 36.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.249 . . . . 75.340000000000003 108.931 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -91.97 121.04 33.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.269 -0.894 . . . . 71.230000000000004 109.194 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 89.2 t -135.01 132.77 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.338 -0.851 . . . . 70.430000000000007 109.786 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -97.32 154.79 17.21 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.289 -0.882 . . . . 72.430000000000007 108.724 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 4.5 m -134.01 132.76 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.298 -0.876 . . . . 72.129999999999995 109.794 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . 0.527 ' N ' ' CD ' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -159.77 130.21 5.65 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.365 -0.834 . . . . 74.5 109.313 179.796 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 143.63 -120.63 1.52 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 108.946 -1.662 . . . . 42.229999999999997 108.946 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 0.592 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 22.3 mtmt -101.86 -35.83 0.22 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.457 -1.026 . . . . 73.299999999999997 111.072 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . 0.88 ' O ' HD11 ' B' ' 152' ' ' LEU . 44.6 Cg_endo -92.56 8.92 2.69 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 122.264 1.976 . . . . 71.329999999999998 113.538 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . 0.46 ' CG ' ' N ' ' B' ' 150' ' ' GLU . 3.5 p90 -87.28 -40.71 14.26 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.732 -1.23 . . . . 74.230000000000004 110.215 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . 0.46 ' N ' ' CG ' ' B' ' 149' ' ' PHE . 16.4 pt-20 -69.08 -33.4 73.48 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.391 -0.818 . . . . 72.340000000000003 110.512 -178.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . 0.493 HG12 HD12 ' B' ' 152' ' ' LEU . 12.5 p -67.66 -39.14 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.822 -1.173 . . . . 73.349999999999994 109.039 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . 0.88 HD11 ' O ' ' B' ' 148' ' ' PRO . 9.6 mp -59.78 -53.04 62.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.377 -0.827 . . . . 74.430000000000007 109.475 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -72.75 -30.61 64.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.318 -0.864 . . . . 75.209999999999994 111.144 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -59.84 -52.08 66.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.606 -1.309 . . . . 73.040000000000006 109.995 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 pp -71.97 -29.53 64.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.943 -1.098 . . . . 73.430000000000007 110.001 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.77 -50.26 72.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.017 -1.052 . . . . 75.319999999999993 110.068 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.532 ' C ' ' H ' ' B' ' 159' ' ' ARG . 68.9 mtp180 -72.99 -57.0 4.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.177 -0.952 . . . . 73.319999999999993 109.657 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -61.21 1.73 0.17 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.368 -0.832 . . . . 74.140000000000001 109.704 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . 1.631 HH21 ' CA ' ' B' ' 216' ' ' TYR . 26.7 ttt180 -53.09 165.39 0.32 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.119 -0.988 . . . . 73.420000000000002 109.881 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . 0.832 ' OD1' ' HG2' ' B' ' 159' ' ' ARG . 2.7 m-20 61.25 43.33 10.98 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.71 -0.619 . . . . 72.099999999999994 110.175 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -157.21 175.42 14.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.058 -1.026 . . . . 73.239999999999995 109.449 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 77.8 mt -93.6 132.19 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.656 -0.868 . . . . 72.310000000000002 108.656 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 96.8 t -128.76 138.6 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.403 -0.811 . . . . 75.030000000000001 109.86 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 37.6 t -101.04 169.08 9.19 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.454 -0.779 . . . . 74.219999999999999 109.933 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -68.63 -48.49 63.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.519 -0.738 . . . . 72.420000000000002 110.088 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.1 -41.88 79.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.295 -0.878 . . . . 63.450000000000003 110.791 -178.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 167' ' ' GLN . . . . . 0.425 ' O ' ' OD1' ' B' ' 170' ' ' ASP . 89.9 mt-30 -51.04 -38.51 51.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.048 -1.032 . . . . 72.400000000000006 110.072 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 71.9 mt -73.31 -40.53 64.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.994 -1.066 . . . . 72.319999999999993 109.635 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 1.9 tt -61.62 -42.35 98.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.405 -0.809 . . . . 73.340000000000003 109.7 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . 0.534 ' O ' ' CH2' ' B' ' 173' ' ' TRP . 22.9 p30 -86.2 -13.54 46.65 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 118.769 -1.172 . . . . 73.099999999999994 110.796 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . 0.4 ' N ' ' OD1' ' B' ' 170' ' ' ASP . . . -94.52 -38.03 11.1 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.837 -1.164 . . . . 62.130000000000003 111.056 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 60.6 mt -114.17 -9.98 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.26 -0.9 . . . . 74.439999999999998 110.589 -178.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 173' ' ' TRP . . . . . 0.569 ' O ' ' N ' ' B' ' 175' ' ' GLU . 10.2 m95 71.72 -1.8 2.69 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.43 -0.794 . . . . 72.230000000000004 109.632 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 63.72 -59.79 0.18 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.947 -0.701 . . . . 75.030000000000001 110.662 177.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . 0.569 ' N ' ' O ' ' B' ' 173' ' ' TRP . 7.0 mt-10 -149.81 162.78 27.14 Favored Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 107.533 -1.284 . . . . 73.040000000000006 107.533 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' B' ' 175' ' ' GLU . 54.5 Cg_exo -34.94 -73.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.231 1.954 . . . . 74.129999999999995 111.459 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . 0.528 ' C ' ' H ' ' B' ' 179' ' ' VAL . 78.5 mt-10 -157.35 -1.69 0.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -0.926 . . . . 72.439999999999998 108.84 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 7.2 tpt -69.37 5.97 1.17 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.529 -0.915 . . . . 72.109999999999999 108.529 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 179' ' ' VAL . . . . . 0.528 ' H ' ' C ' ' B' ' 177' ' ' GLU . 7.6 p -46.06 152.52 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.56 -0.713 . . . . 75.310000000000002 109.986 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 180' ' ' THR . . . . . 0.536 ' O ' ' N ' ' B' ' 182' ' ' ASN . 3.0 p -135.66 154.49 78.17 Favored Pre-proline 0 N--CA 1.497 1.893 0 N-CA-C 108.687 -0.857 . . . . 62.149999999999999 108.687 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -37.18 -23.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 122.31 2.007 . . . . 74.340000000000003 112.413 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 182' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' B' ' 180' ' ' THR . 3.1 p-10 -149.18 120.31 7.75 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.196 -0.94 . . . . 72.310000000000002 109.14 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 3.2 p -156.14 -15.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.259 -0.901 . . . . 65.420000000000002 110.868 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 29.0 mm -51.47 -31.11 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.738 -1.226 . . . . 75.030000000000001 109.502 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -54.59 -34.77 62.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.096 -1.003 . . . . 73.519999999999996 108.484 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 2.0 t -80.36 -57.22 5.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.491 -0.755 . . . . 74.349999999999994 109.366 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -51.78 -51.65 54.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.119 -0.988 . . . . 61.119999999999997 109.715 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 188' ' ' ILE . . . . . 0.439 ' CG2' ' N ' ' B' ' 189' ' ' ASN . 1.7 tt -57.68 -43.35 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.894 -1.129 . . . . 72.430000000000007 108.962 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 189' ' ' ASN . . . . . 0.439 ' N ' ' CG2' ' B' ' 188' ' ' ILE . 24.8 t-20 -62.11 -38.24 88.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.039 -1.038 . . . . 75.420000000000002 109.271 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -69.31 -50.47 46.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.922 . . . . 74.140000000000001 109.735 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 96.8 mt -53.34 -45.61 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.294 -0.879 . . . . 74.030000000000001 109.491 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -59.71 -42.75 93.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.898 . . . . 72.329999999999998 109.656 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -68.72 -38.13 79.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -0.944 . . . . 73.099999999999994 109.187 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . 0.49 ' O ' ' CG ' ' B' ' 198' ' ' PRO . 31.0 mttp -71.32 -13.24 61.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.371 -0.831 . . . . 74.430000000000007 109.24 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 30.0 mmm -101.47 -33.29 10.02 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.398 -0.814 . . . . 74.329999999999998 109.519 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -82.85 -12.5 57.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.097 -1.002 . . . . 71.209999999999994 110.454 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . 0.449 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 34.2 mttm -89.46 -65.95 0.16 Allowed Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 120.855 -1.153 . . . . 75.209999999999994 109.907 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 198' ' ' PRO . . . . . 0.49 ' CG ' ' O ' ' B' ' 194' ' ' LYS . 36.7 Cg_endo -63.56 -70.13 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.968 1.779 . . . . 75.319999999999993 112.122 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 7.6 mp -55.81 -38.82 70.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.116 -0.99 . . . . 72.25 108.777 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 77.69 5.63 86.39 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.792 -1.323 . . . . 73.239999999999995 109.792 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 16.1 mt -132.83 140.13 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.377 -1.072 . . . . 54.299999999999997 109.338 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 13.1 t -78.0 147.47 34.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 74.310000000000002 109.261 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 203' ' ' THR . . . . . 0.4 ' HB ' ' NH1' ' B' ' 159' ' ' ARG . 1.4 p -145.47 24.53 1.4 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.196 -0.94 . . . . 74.400000000000006 109.443 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 19.9 m -139.82 146.33 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.201 -0.937 . . . . 74.099999999999994 109.791 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -119.45 132.54 55.82 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.83 -0.804 . . . . 75.329999999999998 108.83 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 31.1 p -103.27 127.32 50.63 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.252 -0.905 . . . . 71.400000000000006 109.74 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 12.8 p -144.59 143.22 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.198 -0.939 . . . . 63.5 109.248 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 24.1 mtm105 -86.7 101.9 13.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.2 -0.938 . . . . 74.450000000000003 109.757 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -171.54 -76.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.378 -0.826 . . . . 74.140000000000001 108.82 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -107.56 -42.47 4.77 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.993 -0.743 . . . . 74.430000000000007 108.993 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 173.11 -119.8 0.78 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.408 -1.477 . . . . 70.109999999999999 109.408 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -129.71 156.66 43.92 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.468 -1.019 . . . . 74.209999999999994 109.17 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 52.4 mmt-85 -111.32 144.71 40.07 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.539 -0.725 . . . . 74.299999999999997 109.319 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -119.63 114.27 21.95 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.611 -0.681 . . . . 74.340000000000003 109.165 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 91.3 m -148.45 170.34 18.24 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.25 -0.906 . . . . 72.209999999999994 109.614 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . 1.631 ' CA ' HH21 ' B' ' 159' ' ' ARG . 38.0 p90 -74.27 150.58 87.5 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 72.310000000000002 109.513 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 217' ' ' PRO . . . . . 0.904 ' HD3' HH22 ' B' ' 159' ' ' ARG . 67.1 Cg_exo -37.2 156.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.358 2.039 . . . . 71.010000000000005 112.46 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . 0.449 ' CB ' ' CD ' ' B' ' 219' ' ' PRO . 2.7 mptm? -65.18 -64.95 2.17 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.336 -0.853 . . . . 74.349999999999994 109.806 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' B' ' 218' ' ' LYS . 30.1 Cg_endo -60.94 -33.35 92.54 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.257 1.971 . . . . 71.319999999999993 112.295 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 54.94 26.51 7.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.108 -0.995 . . . . 75.450000000000003 109.391 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 4.5 t 62.8 40.73 9.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 72.219999999999999 109.349 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -81.56 149.8 28.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 74.299999999999997 109.657 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.951 -1.024 . . . . 71.129999999999995 109.337 179.664 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.592 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.409 -0.589 . . . . 65.120000000000005 109.409 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.707 ' HE ' HH21 ' A' ' 43' ' ' ARG . 81.2 mtt85 -136.34 150.19 48.74 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.376 -0.828 . . . . 73.310000000000002 109.358 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.3 t -113.76 129.42 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 121.576 0.703 . . . . 71.420000000000002 109.982 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.6 tp -98.25 118.45 34.93 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.37 -0.974 . . . . 65.219999999999999 108.37 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.8 tp -119.09 108.46 14.73 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.612 -0.68 . . . . 71.439999999999998 109.31 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 46.3 mt -101.2 109.72 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.514 -0.921 . . . . 71.150000000000006 108.514 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.426 ' OE1' ' CB ' ' A' ' 51' ' ' SER . 24.7 tp10 -137.96 123.69 19.89 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.437 -0.789 . . . . 75.340000000000003 109.452 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.1 tptt -68.66 -31.29 70.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.24 -0.912 . . . . 73.040000000000006 108.771 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -86.23 122.41 30.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.429 -0.794 . . . . 72.420000000000002 109.367 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.4 m -74.62 -20.7 59.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 72.340000000000003 109.728 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.2 t -71.38 -55.7 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.183 -0.948 . . . . 74.420000000000002 109.872 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 12' ' ' LEU . 3.5 mm? -67.85 -35.72 79.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.219 -0.926 . . . . 72.010000000000005 109.519 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.36 -31.07 57.63 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.758 -1.737 . . . . 72.140000000000001 108.758 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.98 -48.42 76.04 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.953 -1.259 . . . . 72.329999999999998 109.953 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -64.04 -46.65 83.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -1.174 . . . . 72.340000000000003 109.882 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.3 mm -64.65 -48.54 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.778 -1.201 . . . . 74.239999999999995 109.175 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -46.28 -56.93 5.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.182 -0.949 . . . . 71.409999999999997 109.812 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.481 ' HZ2' ' CB ' ' A' ' 18' ' ' LYS . 8.8 mtpm? -84.47 3.01 38.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.17 -0.956 . . . . 75.540000000000006 109.305 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.02 -65.95 1.71 Allowed Glycine 0 N--CA 1.483 1.786 0 N-CA-C 109.899 -1.28 . . . . 62.149999999999999 109.899 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -66.53 -23.39 66.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -1.173 . . . . 74.420000000000002 110.081 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -56.69 -35.95 69.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -0.991 . . . . 74.25 109.872 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 87.5 t -56.1 -39.36 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.164 -0.96 . . . . 72.109999999999999 109.579 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.408 ' NZ ' ' CG1' ' A' ' 106' ' ' VAL . 1.7 mptm? -63.63 -12.43 33.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 73.230000000000004 109.322 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.61 37.78 4.13 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.263 -1.135 . . . . 75.540000000000006 110.263 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -119.61 160.71 21.95 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.477 -1.013 . . . . 74.510000000000005 109.263 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.4 mmt -100.86 138.97 37.2 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.257 -1.016 . . . . 64.319999999999993 108.257 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.24 159.67 41.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.25 -0.906 . . . . 74.310000000000002 109.974 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -135.94 144.88 45.69 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.512 -0.742 . . . . 75.400000000000006 109.042 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.5 131.34 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.458 -0.776 . . . . 75.129999999999995 108.911 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.8 p -134.74 169.67 16.99 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.449 -0.782 . . . . 71.420000000000002 109.379 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -93.41 -103.22 0.13 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.304 -0.872 . . . . 73.109999999999999 109.718 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 t -78.78 166.83 22.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 74.239999999999995 110.012 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 20.4 mt -54.37 -31.94 55.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.552 -0.718 . . . . 71.530000000000001 109.82 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.16 -48.75 44.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 74.230000000000004 109.513 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.02 -38.32 90.72 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.156 -0.965 . . . . 71.010000000000005 108.914 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.85 -37.06 92.97 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.296 -1.522 . . . . 61.409999999999997 109.296 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -68.35 -42.91 78.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 74.340000000000003 109.462 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -71.78 -37.67 70.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 75.329999999999998 109.906 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.8 tp -75.9 -46.01 32.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 74.329999999999998 110.308 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.484 ' SD ' ' OD1' ' A' ' 41' ' ' ASP . 3.5 ppp? -65.24 -32.24 73.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.045 -1.034 . . . . 70.319999999999993 110.177 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.484 ' OD1' ' SD ' ' A' ' 40' ' ' MET . 87.1 m-20 -62.68 -39.58 94.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.067 -1.021 . . . . 71.219999999999999 110.03 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 25.8 pt -82.31 -29.44 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.066 -1.021 . . . . 74.409999999999997 110.176 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.707 HH21 ' HE ' ' A' ' 2' ' ' ARG . 73.6 mtp180 -130.07 140.51 50.82 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.342 -0.849 . . . . 75.409999999999997 109.596 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -90.25 157.66 17.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.214 -0.929 . . . . 75.420000000000002 109.488 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -138.04 150.89 47.34 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.391 -0.818 . . . . 74.230000000000004 109.345 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 2' ' ' ARG . 7.9 p-10 -95.21 -40.25 9.67 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.175 -0.953 . . . . 75.319999999999993 109.463 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.405 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 0.5 OUTLIER -102.97 109.66 21.29 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.397 -0.814 . . . . 72.129999999999995 109.059 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 78.7 t -95.08 97.67 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.193 -0.942 . . . . 72.340000000000003 108.616 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.1 ttm -111.44 131.51 55.15 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.481 -0.762 . . . . 74.109999999999999 109.595 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 p -141.0 133.0 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.479 -0.763 . . . . 71.239999999999995 109.818 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.426 ' CB ' ' OE1' ' A' ' 7' ' ' GLU . 59.9 p -100.85 7.01 43.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.608 -0.683 . . . . 73.109999999999999 109.538 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -76.04 141.12 42.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.135 -0.978 . . . . 63.399999999999999 109.465 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.51 ' C ' ' H ' ' A' ' 55' ' ' ALA . 68.0 mttm -73.43 -44.64 57.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.29 -0.881 . . . . 65.439999999999998 110.435 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -71.02 15.47 0.11 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.107 -0.996 . . . . 73.129999999999995 109.807 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.51 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -74.97 -21.61 59.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 64.140000000000001 110.334 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 55' ' ' ALA . 19.0 mt -40.49 -52.96 2.75 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.499 -0.751 . . . . 74.430000000000007 110.357 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.9 m -67.2 -32.86 74.2 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.053 -1.029 . . . . 63.229999999999997 109.141 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.43 ' N ' ' O ' ' A' ' 55' ' ' ALA . 63.0 t80 -66.06 -52.95 44.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.479 -0.763 . . . . 74.439999999999998 110.313 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 m -57.74 -34.57 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.701 -1.249 . . . . 74.030000000000001 109.709 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.1 m -59.02 -55.51 34.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.112 -0.993 . . . . 73.540000000000006 109.625 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -63.21 -28.08 69.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 73.340000000000003 110.142 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.2 mm -66.6 -31.79 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.951 -1.093 . . . . 73.349999999999994 109.898 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.525 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 23.1 mmtt -77.12 -50.23 13.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.057 -1.027 . . . . 74.420000000000002 110.267 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -67.62 -41.21 84.3 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.754 -1.217 . . . . 74.549999999999997 109.87 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.521 ' O ' ' NZ ' ' A' ' 145' ' ' LYS . 9.1 mtpm? -72.5 -26.24 61.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 75.219999999999999 109.75 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.583 ' CE1' ' HZ3' ' A' ' 145' ' ' LYS . 93.2 m-70 -153.19 65.93 0.77 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.16 -0.963 . . . . 74.129999999999995 109.301 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.476 ' N ' ' O ' ' A' ' 63' ' ' LYS . 18.0 m -56.45 -32.43 64.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 73.239999999999995 110.055 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 83.3 p -73.17 47.02 0.19 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 71.439999999999998 110.049 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.5 tt -146.48 159.07 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.051 -1.031 . . . . 71.329999999999998 109.45 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.5 t -95.57 154.26 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.12 -0.987 . . . . 73.019999999999996 109.106 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.4 t -142.66 118.69 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.123 -0.985 . . . . 54.210000000000001 109.823 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.6 mp -119.23 99.57 6.79 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.624 -0.88 . . . . 74.209999999999994 108.624 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.8 p -94.3 152.99 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.255 -1.017 . . . . 74.409999999999997 108.255 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.08 169.94 9.26 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.443 -0.785 . . . . 72.310000000000002 108.912 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.2 t -168.39 123.7 0.96 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.177 -0.952 . . . . 64.540000000000006 110.159 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 0.4 OUTLIER -76.12 15.84 0.51 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.466 -0.771 . . . . 74.129999999999995 110.024 -179.082 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.407 ' O ' ' N ' ' A' ' 79' ' ' THR . 30.7 m120 -139.88 58.61 11.65 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.152 -0.967 . . . . 73.340000000000003 110.115 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.44 84.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.393 2.062 . . . . 71.319999999999993 112.452 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.407 ' N ' ' O ' ' A' ' 77' ' ' ASN . 28.7 m -106.81 149.73 27.07 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.143 -1.058 . . . . 62.530000000000001 108.143 178.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.04 -32.16 71.78 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.008 -1.057 . . . . 74.140000000000001 109.367 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -64.44 -43.13 95.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.119 -0.988 . . . . 71.420000000000002 109.294 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -76.64 -35.74 57.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 73.430000000000007 109.602 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -57.74 -56.77 17.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.237 -0.914 . . . . 74.219999999999999 109.67 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.4 m -61.55 -39.75 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.131 -0.981 . . . . 74.150000000000006 109.273 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.663 ' HE2' ' NE2' ' A' ' 89' ' ' GLN . 72.7 t60 -60.22 -36.97 78.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.214 -0.929 . . . . 72.540000000000006 109.554 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.53 -45.83 88.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.195 -0.941 . . . . 64.219999999999999 109.829 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.615 ' CZ ' ' NH1' ' B' ' 108' ' ' ARG . 77.1 m-85 -74.96 -27.92 60.37 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.171 -0.955 . . . . 74.340000000000003 108.722 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -69.88 -50.23 44.54 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.521 -0.737 . . . . 74.420000000000002 109.297 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.663 ' NE2' ' HE2' ' A' ' 85' ' ' HIS . 84.8 mt-30 -58.01 -49.64 76.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.512 -0.742 . . . . 74.519999999999996 110.003 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 153.8 -10.76 0.5 Allowed Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.423 -1.37 . . . . 74.209999999999994 110.738 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.8 139.5 16.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.812 -1.405 . . . . 64.099999999999994 109.373 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.525 ' OD1' ' NZ ' ' A' ' 63' ' ' LYS . 11.4 m-20 -76.08 -40.01 54.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.103 -0.998 . . . . 73.420000000000002 109.32 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 94' ' ' TYR . 56.8 t0 -153.09 157.12 39.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.259 -0.9 . . . . 75.040000000000006 109.47 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.539 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -128.38 133.94 48.73 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.791 -0.818 . . . . 71.329999999999998 108.791 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.572 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -122.39 138.67 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 121.717 0.77 . . . . 74.510000000000005 110.242 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.8 119.98 8.15 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.027 -1.101 . . . . 64.319999999999993 108.027 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.694 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -43.95 -54.39 11.18 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 74.510000000000005 111.501 -178.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -38.51 -13.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 121.198 1.266 . . . . 73.109999999999999 113.202 -176.465 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.694 ' N ' ' O ' ' A' ' 97' ' ' LYS . 57.6 m-85 56.32 100.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.632 -0.668 . . . . 72.540000000000006 110.039 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.0 mtt85 -55.7 -42.87 75.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.786 -1.197 . . . . 74.540000000000006 108.21 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.3 t -169.1 132.23 1.31 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.855 -0.794 . . . . 74.140000000000001 108.855 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 62.4 mt -51.32 -43.8 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.148 -0.97 . . . . 75.430000000000007 109.327 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.417 ' CD ' ' N ' ' A' ' 103' ' ' LYS . 3.4 mptp? -62.07 -35.07 77.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 74.140000000000001 109.611 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.24 -55.82 10.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.13 -0.982 . . . . 63.240000000000002 109.883 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.4 tp -57.84 -56.75 17.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 73.219999999999999 109.702 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.408 ' CG1' ' NZ ' ' A' ' 23' ' ' LYS . 74.1 t -53.15 -43.71 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.971 -1.081 . . . . 74.540000000000006 109.546 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.55 -43.1 64.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.14 -0.975 . . . . 75.5 108.913 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -66.81 -37.1 83.87 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.362 -0.836 . . . . 74.409999999999997 109.333 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 65.1 mt -66.94 -33.82 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 107.879 -1.156 . . . . 73.239999999999995 107.879 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -59.6 -42.83 93.49 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.368 -0.975 . . . . 74.340000000000003 108.368 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -57.61 -50.33 73.5 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.354 -0.841 . . . . 73.319999999999993 109.497 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -59.16 -50.77 72.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.209 -0.932 . . . . 74.420000000000002 109.622 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.507 ' O ' ' CE2' ' A' ' 116' ' ' TRP . 53.2 mt -64.98 -36.61 84.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.046 -1.034 . . . . 74.329999999999998 109.646 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -56.34 -36.88 69.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -0.891 . . . . 74.439999999999998 109.595 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -78.2 54.6 1.39 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 74.430000000000007 109.431 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.507 ' CE2' ' O ' ' A' ' 113' ' ' LEU . 7.2 m-90 -59.66 148.74 32.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.928 . . . . 74.439999999999998 109.478 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -50.84 127.29 27.68 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.702 -1.359 . . . . 75.040000000000006 109.702 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.2 t -85.96 3.23 42.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -1.134 . . . . 70.109999999999999 109.424 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.517 ' CG ' ' H ' ' A' ' 120' ' ' VAL . 47.4 t30 52.53 -179.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 65.239999999999995 109.413 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.517 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 5.3 t -141.97 -45.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.304 -0.872 . . . . 74.219999999999999 109.61 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.0 mm -98.59 125.38 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.191 -0.943 . . . . 74.420000000000002 109.281 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 122' ' ' GLU . 1.3 pm0 -134.05 108.87 8.6 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.499 -0.751 . . . . 73.299999999999997 108.976 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 18.2 tt -134.88 131.08 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.466 -0.771 . . . . 75.340000000000003 109.113 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.08 -145.83 5.47 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.576 -1.409 . . . . 75.129999999999995 109.576 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -85.75 -0.62 55.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -1.185 . . . . 74.450000000000003 109.331 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.92 130.52 44.21 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.51 -0.922 . . . . 54.210000000000001 108.51 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.474 ' CG2' ' ND2' ' A' ' 119' ' ' ASN . 32.1 m -130.45 129.37 42.9 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.353 -0.842 . . . . 70.239999999999995 109.571 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 27.1 mm -113.67 133.3 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.414 -0.804 . . . . 72.430000000000007 109.195 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.417 ' OG ' ' OD1' ' A' ' 119' ' ' ASN . 3.5 m -115.87 96.59 47.2 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 109.13 -0.692 . . . . 71.109999999999999 109.13 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -78.46 -37.07 0.77 Allowed 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 121.839 1.693 . . . . 75.140000000000001 111.943 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -68.18 -43.51 77.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 72.5 109.255 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -90.23 -1.87 57.98 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.375 -0.828 . . . . 73.140000000000001 109.416 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 52.97 62.41 2.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.354 -0.841 . . . . 75.329999999999998 109.972 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -150.22 140.59 22.34 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.271 -0.893 . . . . 71.230000000000004 109.085 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 7.3 tt -121.68 135.32 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 108.93 -0.767 . . . . 75.329999999999998 108.93 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.8 mt -116.71 129.32 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.65 -0.656 . . . . 71.109999999999999 109.561 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.439 ' CE2' ' O ' ' A' ' 198' ' ' PRO . 54.8 t80 -138.46 138.05 37.76 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.589 -0.694 . . . . 74.140000000000001 109.199 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm 53.35 31.07 11.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.365 -0.834 . . . . 75.400000000000006 110.1 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 73.94 15.22 79.76 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 120.051 -1.071 . . . . 72.239999999999995 110.456 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -107.52 125.23 51.02 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.401 -1.058 . . . . 73.120000000000005 109.342 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -95.04 126.18 40.21 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.269 -0.894 . . . . 72.319999999999993 109.704 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.9 p -137.85 140.79 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.375 -0.828 . . . . 62.340000000000003 109.254 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -85.51 144.44 27.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.3 -0.875 . . . . 61.229999999999997 109.314 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.401 ' CG2' ' CD1' ' A' ' 149' ' ' PHE . 16.2 m -147.29 137.16 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.242 -0.911 . . . . 74.439999999999998 109.539 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.583 ' HZ3' ' CE1' ' A' ' 66' ' ' HIS . 43.7 pttt -156.59 20.36 0.34 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -0.861 . . . . 75.420000000000002 109.495 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.48 -178.92 51.73 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.297 -1.521 . . . . 73.340000000000003 109.297 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 13.5 ttmt -64.76 -39.89 43.27 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.185 -1.186 . . . . 72.219999999999999 109.82 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 25.4 Cg_exo -62.18 -24.63 76.44 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.324 2.016 . . . . 75.450000000000003 112.098 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.576 ' CZ ' ' CG2' ' A' ' 153' ' ' THR . 59.0 t80 -82.27 -42.02 19.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.13 -0.981 . . . . 65.239999999999995 110.003 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.466 ' O ' ' ND1' ' A' ' 154' ' ' HIS . 80.8 mm-40 -50.11 -45.47 52.89 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.134 -0.979 . . . . 72.519999999999996 109.36 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.8 p -72.05 -35.08 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.215 -0.928 . . . . 74.209999999999994 109.099 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 15.0 tp -60.5 -38.0 82.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 73.310000000000002 109.159 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.576 ' CG2' ' CZ ' ' A' ' 149' ' ' PHE . 16.8 p -71.74 -41.89 67.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.315 -0.865 . . . . 74.310000000000002 109.8 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.818 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 34.2 m80 -53.24 -51.62 61.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.31 -0.869 . . . . 75.450000000000003 110.038 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 pp -73.27 -24.38 60.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.932 -1.105 . . . . 75.340000000000003 109.601 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.4 -53.58 56.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.135 -0.978 . . . . 62.140000000000001 109.268 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 1.081 ' HG3' ' ND1' ' A' ' 158' ' ' HIS . 13.6 ptm180 -68.43 -34.95 76.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.913 . . . . 72.219999999999999 109.069 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 1.081 ' ND1' ' HG3' ' A' ' 157' ' ' ARG . 15.9 m80 -94.95 64.75 2.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.342 -0.849 . . . . 74.120000000000005 109.083 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.52 ' NH1' ' OG1' ' A' ' 203' ' ' THR . 2.1 tpm_? -81.22 -3.01 50.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.868 . . . . 74.340000000000003 110.173 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.514 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 57.4 p30 -144.85 57.67 1.29 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.987 -1.07 . . . . 75.450000000000003 110.075 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 160' ' ' ASP . 89.1 mm-40 -148.87 179.72 7.64 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.207 -0.933 . . . . 73.409999999999997 109.211 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 68.0 mt -105.64 123.48 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.896 -0.779 . . . . 74.409999999999997 108.896 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 72.9 t -117.41 130.27 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.48 -0.762 . . . . 72.530000000000001 109.472 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 86.1 p -97.05 159.29 14.99 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.286 -0.884 . . . . 74.120000000000005 109.483 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -60.14 -44.28 95.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 70.430000000000007 109.632 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -55.72 -33.33 64.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 74.319999999999993 109.252 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.427 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 61.8 tt0 -61.49 -46.21 90.99 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.277 -0.889 . . . . 74.519999999999996 109.295 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 34.1 mt -59.54 -30.88 68.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 74.409999999999997 108.886 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.4 tt -66.93 -74.38 0.11 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 75.140000000000001 109.608 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 167' ' ' GLN . 59.1 p30 -55.82 -8.45 0.42 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.504 -0.747 . . . . 65.030000000000001 111.063 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.21 -52.57 4.13 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.869 -1.144 . . . . 70.209999999999994 112.282 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.525 ' C ' ' H ' ' A' ' 174' ' ' GLU . 4.6 mp -99.31 -41.04 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 O-C-N 120.82 -1.175 . . . . 75.319999999999993 112.077 -177.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.503 ' CD2' ' C ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -63.02 2.64 0.31 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.39 -1.444 . . . . 73.140000000000001 109.081 -178.852 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.525 ' H ' ' C ' ' A' ' 172' ' ' ILE . 2.9 pp20? -50.01 -15.96 0.25 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.081 -1.012 . . . . 73.239999999999995 109.506 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 177' ' ' GLU . 0.7 OUTLIER -53.74 -176.5 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 108.2 -1.037 . . . . 63.329999999999998 108.2 179.583 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 175' ' ' GLU . 31.4 Cg_exo -59.4 35.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 122.549 2.166 . . . . 72.510000000000005 112.664 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 175' ' ' GLU . 96.0 mt-10 48.17 -160.18 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.118 -0.989 . . . . 75.340000000000003 109.783 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.493 ' O ' ' SD ' ' A' ' 178' ' ' MET . 0.5 OUTLIER 60.49 52.58 4.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.328 -0.858 . . . . 74.510000000000005 108.903 -179.748 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.418 ' O ' ' OG1' ' A' ' 180' ' ' THR . 4.4 m -137.43 36.18 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.361 -0.837 . . . . 65.219999999999999 109.281 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 179' ' ' VAL . 3.0 p 47.27 78.38 0.4 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 73.219999999999999 109.46 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -46.54 -32.68 11.83 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.554 2.169 . . . . 62.43 112.545 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -74.54 -12.25 60.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.072 -1.018 . . . . 73.129999999999995 109.495 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 8.5 p -55.88 -14.27 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 74.019999999999996 109.935 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 96.0 mt -51.64 -42.4 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.942 . . . . 72.329999999999998 109.962 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.446 ' CG ' ' N ' ' A' ' 186' ' ' VAL . 19.8 pt-20 -61.63 -43.79 98.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.041 -1.037 . . . . 74.400000000000006 109.446 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . 0.446 ' N ' ' CG ' ' A' ' 185' ' ' GLU . 94.0 t -71.27 -30.41 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 74.319999999999993 109.292 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.12 -56.09 6.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.383 -0.823 . . . . 73.230000000000004 109.913 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.1 -26.29 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.809 -1.182 . . . . 74.310000000000002 109.631 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -73.45 -55.58 6.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.988 . . . . 73.439999999999998 109.962 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -68.2 -40.27 82.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.128 -0.983 . . . . 71.420000000000002 109.876 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 73.5 mt -55.68 -49.25 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.001 -1.062 . . . . 72.439999999999998 109.253 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 75.9 mtp85 -57.75 -44.69 86.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -0.977 . . . . 64.219999999999999 109.541 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -66.56 -36.85 83.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.893 . . . . 74.319999999999993 109.698 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.482 ' O ' ' CG ' ' A' ' 198' ' ' PRO . 16.4 mtpp -84.52 -2.41 57.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.913 . . . . 75.310000000000002 109.784 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 50.6 ttm -89.62 -28.41 19.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.182 -0.949 . . . . 74.019999999999996 109.555 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 197' ' ' LYS . 46.4 p30 -102.35 -10.95 19.02 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.251 -0.905 . . . . 74.019999999999996 110.303 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.576 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 14.6 tttt -77.59 -43.21 2.47 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.92 -1.113 . . . . 75.430000000000007 109.74 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 25.9 Cg_endo -88.18 -32.46 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.624 2.216 . . . . 72.319999999999993 112.304 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.54 ' N ' ' CD2' ' A' ' 199' ' ' LEU . 3.1 mm? -85.77 -98.31 0.07 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.913 -1.117 . . . . 74.540000000000006 109.211 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 152.2 -33.18 0.86 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.496 -1.441 . . . . 61.509999999999998 109.496 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 66.2 mt -96.4 128.93 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.291 -1.123 . . . . 74.25 109.529 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 25.0 p -79.87 132.74 36.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 72.0 108.962 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.52 ' OG1' ' NH1' ' A' ' 159' ' ' ARG . 5.2 p -141.69 40.25 1.7 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.293 -0.88 . . . . 74.439999999999998 109.666 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 17.1 m -138.96 139.03 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.325 -0.859 . . . . 71.129999999999995 109.333 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -125.41 129.17 49.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.536 -0.727 . . . . 73.510000000000005 109.174 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.08 140.85 37.19 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.349 -0.845 . . . . 73.519999999999996 109.32 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 10.5 p -139.65 141.47 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.299 -0.876 . . . . 72.150000000000006 109.332 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -92.61 52.89 1.96 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.234 -0.916 . . . . 72.400000000000006 109.542 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -146.24 -8.45 0.52 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.167 -0.958 . . . . 73.310000000000002 109.437 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -159.7 -69.0 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.186 -0.947 . . . . 71.540000000000006 109.327 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -172.31 -119.21 0.51 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.569 -1.413 . . . . 74.450000000000003 109.569 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -123.15 129.8 51.91 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.582 -0.952 . . . . 75.540000000000006 109.258 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -103.74 129.66 51.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.453 -0.78 . . . . 75.310000000000002 109.663 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -95.36 123.74 39.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.289 -0.882 . . . . 75.409999999999997 108.67 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 26.8 p -126.4 170.29 12.1 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 121.608 0.718 . . . . 74.140000000000001 110.32 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -78.43 140.55 60.34 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.899 -0.778 . . . . 75.319999999999993 108.899 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -37.7 136.02 0.48 Allowed 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.06 1.84 . . . . 73.109999999999999 112.493 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.622 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 22.4 mttp -78.15 -36.54 1.34 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 75.25 110.489 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 47.4 Cg_exo -56.08 -19.09 25.32 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.086 1.857 . . . . 75.099999999999994 112.052 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -63.0 146.87 52.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.322 -0.861 . . . . 71.140000000000001 109.346 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 16.7 t -155.56 -53.12 0.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.189 -0.945 . . . . 71.129999999999995 109.478 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 38.4 mp0 46.47 -111.12 0.31 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 75.349999999999994 109.68 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 118.015 -0.993 . . . . 73.409999999999997 109.495 -179.998 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 50.9 ttm . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.46 -0.57 . . . . 75.239999999999995 109.46 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -137.52 139.86 40.77 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.43 -0.794 . . . . 73.519999999999996 109.281 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.9 t -112.07 135.14 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.657 -0.652 . . . . 72.239999999999995 109.434 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.12 119.18 38.67 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.546 -0.721 . . . . 73.340000000000003 110.028 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 19.8 mt -118.55 97.17 5.61 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.644 -0.872 . . . . 74.349999999999994 108.644 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 66.8 mt -84.16 96.99 4.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.749 -1.219 . . . . 63.439999999999998 108.588 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.428 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 26.4 tp10 -134.03 132.1 39.64 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.494 -0.753 . . . . 74.519999999999996 109.375 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.7 -32.93 74.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 74.129999999999995 109.353 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -82.92 117.24 22.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 74.230000000000004 109.399 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 19.8 m -75.98 -32.27 59.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 65.540000000000006 110.026 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . 0.444 ' CG1' ' N ' ' B' ' 12' ' ' LEU . 8.9 p -60.02 -45.11 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.071 -1.018 . . . . 75.549999999999997 109.908 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.444 ' N ' ' CG1' ' B' ' 11' ' ' VAL . 77.2 mt -66.02 -35.44 80.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.012 -1.055 . . . . 70.140000000000001 109.349 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.5 -27.34 67.81 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.63 -1.788 . . . . 75.400000000000006 108.63 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.79 -54.94 25.28 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.603 -1.399 . . . . 65.439999999999998 109.603 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -58.39 -44.38 88.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.351 -1.088 . . . . 72.200000000000003 109.652 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 65.8 mt -65.94 -39.26 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.956 -1.09 . . . . 75.150000000000006 108.936 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.407 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 86.2 tt0 -59.69 -43.89 93.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.254 -0.904 . . . . 73.010000000000005 109.065 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -85.32 -1.6 57.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.184 -0.947 . . . . 74.299999999999997 109.109 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -85.11 -59.61 1.94 Allowed Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.695 -1.362 . . . . 70.540000000000006 109.695 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -68.55 -21.35 64.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -1.175 . . . . 75.430000000000007 109.707 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 2.3 m120 -51.79 -33.73 36.77 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.073 -1.017 . . . . 73.200000000000003 109.324 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 91.1 t -56.94 -36.82 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.179 -0.95 . . . . 74.230000000000004 108.904 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.402 ' N ' ' CD ' ' B' ' 23' ' ' LYS . 12.2 mptt -72.44 -13.12 61.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.442 -0.786 . . . . 73.519999999999996 109.212 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.52 39.25 6.35 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.045 -1.222 . . . . 53.43 110.045 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -119.23 159.94 23.12 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.515 -0.991 . . . . 71.120000000000005 109.18 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 48.4 mmm -106.03 140.65 38.69 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.721 -0.844 . . . . 75.239999999999995 108.721 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . 0.413 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -137.83 155.54 48.88 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.392 -0.817 . . . . 73.25 109.995 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 88.5 m-20 -136.41 157.23 47.29 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.424 -0.954 . . . . 72.310000000000002 108.424 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 p -122.19 139.12 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.404 -0.81 . . . . 72.140000000000001 109.749 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 2.6 p -138.05 173.49 11.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.521 -0.737 . . . . 74.530000000000001 109.416 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -98.52 -98.67 0.22 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.362 -0.836 . . . . 71.019999999999996 109.753 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 14.0 t -78.77 164.81 24.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.223 -0.923 . . . . 71.400000000000006 110.12 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 50.6 mt -53.06 -36.99 61.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.669 -0.644 . . . . 71.239999999999995 110.086 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.508 ' H ' ' CD ' ' B' ' 34' ' ' GLU . 45.1 mp0 -53.18 -46.49 68.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 74.319999999999993 109.964 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -61.42 -38.57 87.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.117 -0.989 . . . . 73.030000000000001 109.274 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.34 -33.75 87.5 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.331 -1.508 . . . . 60.43 109.331 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -69.3 -43.95 72.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -1.13 . . . . 74.430000000000007 109.743 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . 0.437 ' O ' ' OD1' ' B' ' 41' ' ' ASP . 65.9 m-85 -76.27 -22.48 55.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.141 -0.974 . . . . 74.420000000000002 110.046 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 60.3 tp -90.04 -34.31 16.0 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.081 -1.012 . . . . 75.409999999999997 109.871 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.445 ' O ' ' O ' ' B' ' 43' ' ' ARG . 2.5 ppp? -79.02 -28.1 43.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.153 -0.967 . . . . 61.439999999999998 110.405 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' B' ' 42' ' ' ILE . 39.0 p-10 -62.52 -27.02 68.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.914 -1.116 . . . . 74.319999999999993 110.041 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.542 ' N ' ' OD1' ' B' ' 41' ' ' ASP . 11.8 pt -99.27 -10.87 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.184 -0.948 . . . . 71.230000000000004 110.411 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' B' ' 40' ' ' MET . 98.6 mtt180 -130.23 155.67 45.88 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.247 -0.908 . . . . 73.409999999999997 109.812 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -80.1 169.02 18.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.203 -0.935 . . . . 63.539999999999999 109.323 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 1.7 p90 -156.36 92.37 1.32 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.134 -0.979 . . . . 73.109999999999999 109.263 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -76.55 -32.27 58.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.082 -1.011 . . . . 62.219999999999999 108.909 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.417 ' C ' ' CD1' ' B' ' 47' ' ' LEU . 0.8 OUTLIER -112.67 108.74 17.9 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.666 -0.865 . . . . 73.120000000000005 108.666 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 50.4 t -93.7 107.38 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.524 -0.917 . . . . 74.109999999999999 108.524 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.9 ttt -125.5 131.58 52.79 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.555 -0.715 . . . . 73.439999999999998 109.52 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.535 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.4 OUTLIER -145.87 138.69 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.465 -0.772 . . . . 73.400000000000006 109.803 -179.183 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' SER . . . . . 0.428 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 89.4 p -99.68 12.59 36.18 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.491 -0.755 . . . . 73.209999999999994 109.828 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.535 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 42.4 m-20 -81.77 134.37 35.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.073 -1.017 . . . . 70.409999999999997 109.561 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -71.3 -34.44 70.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.342 -0.849 . . . . 73.129999999999995 110.2 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -76.55 9.76 2.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.061 -1.024 . . . . 75.209999999999994 109.722 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' B' ' 56' ' ' LEU . . . -72.87 -21.18 60.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.19 -0.944 . . . . 55.329999999999998 110.254 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' B' ' 55' ' ' ALA . 69.5 mt -41.14 -52.7 3.25 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.496 -0.753 . . . . 72.420000000000002 110.364 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 19.8 t -65.05 -36.32 83.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.961 -1.087 . . . . 73.040000000000006 109.171 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -62.53 -61.76 2.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.327 -0.858 . . . . 72.329999999999998 109.649 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 22.4 m -49.75 -31.57 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.523 -1.36 . . . . 74.540000000000006 109.645 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' SER . . . . . 0.401 ' OG ' ' N ' ' B' ' 61' ' ' ARG . 5.8 p -58.61 -52.15 66.87 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.254 -0.904 . . . . 71.239999999999995 109.321 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.401 ' N ' ' OG ' ' B' ' 60' ' ' SER . 2.8 ptp180 -68.61 -31.86 71.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.075 -1.015 . . . . 74.310000000000002 110.0 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 40.6 mm -66.16 -40.08 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.723 -1.235 . . . . 75.420000000000002 109.879 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -65.83 -48.2 72.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 73.319999999999993 110.48 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -72.83 -37.19 67.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.826 -1.171 . . . . 73.310000000000002 110.12 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.484 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 66.4 mttm -81.49 -21.11 38.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.152 -0.968 . . . . 72.439999999999998 109.856 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.484 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 72.0 m-70 -155.78 66.26 0.6 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.103 -0.998 . . . . 65.209999999999994 109.691 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.5 t -62.59 -33.53 75.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.21 -0.931 . . . . 73.099999999999994 109.87 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 51.1 m -57.29 -30.34 64.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.211 -0.93 . . . . 71.530000000000001 110.073 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 73.3 mt -76.13 153.35 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.112 -0.993 . . . . 74.400000000000006 109.532 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.428 ' CG1' ' N ' ' B' ' 71' ' ' VAL . 72.6 t -90.33 163.47 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.324 -0.86 . . . . 75.120000000000005 109.565 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.524 ' N ' ' OD2' ' B' ' 92' ' ' ASP . 12.9 t -139.81 126.57 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.239 -0.913 . . . . 73.200000000000003 109.544 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -124.94 99.93 6.36 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.727 -0.842 . . . . 73.340000000000003 108.727 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 76.0 t -91.15 145.63 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.899 . . . . 73.5 108.72 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 2.4 m -118.68 171.82 7.93 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.414 -0.804 . . . . 71.319999999999993 109.044 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.425 ' OG ' ' OH ' ' B' ' 94' ' ' TYR . 27.6 p -162.0 126.74 3.35 Favored 'General case' 0 N--CA 1.506 2.335 0 C-N-CA 118.699 -1.2 . . . . 74.530000000000001 111.284 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -65.35 -13.73 59.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.631 -0.668 . . . . 64.5 110.239 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' B' ' 79' ' ' THR . 10.1 p-10 -129.73 79.44 73.46 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 121.356 -0.84 . . . . 74.25 109.709 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -57.89 80.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.428 2.085 . . . . 74.430000000000007 111.277 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.438 ' N ' ' O ' ' B' ' 77' ' ' ASN . 66.6 p -106.48 151.25 25.21 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.933 -0.766 . . . . 73.120000000000005 108.933 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -24.17 61.52 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.37 -0.831 . . . . 75.409999999999997 109.32 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -67.93 -38.96 83.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 72.239999999999995 109.8 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -76.85 -34.57 57.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.136 -0.978 . . . . 73.219999999999999 109.77 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' B' ' 83' ' ' GLU . 0.4 OUTLIER -61.38 -51.58 68.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 74.299999999999997 109.635 -179.652 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 30.3 m -62.58 -45.81 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.975 -1.078 . . . . 73.310000000000002 109.356 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -61.79 -30.9 71.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.137 -0.977 . . . . 73.239999999999995 109.2 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.69 -39.73 91.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 55.329999999999998 109.995 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -83.72 -37.89 22.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.032 -1.042 . . . . 74.450000000000003 109.315 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -67.34 -41.17 85.65 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.306 -0.871 . . . . 64.040000000000006 109.542 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -69.57 -50.64 42.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 75.129999999999995 109.556 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 145.6 70.47 0.02 OUTLIER Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.907 -1.277 . . . . 75.420000000000002 109.907 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -129.24 131.25 47.01 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.392 -1.064 . . . . 73.420000000000002 108.881 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' B' ' 71' ' ' VAL . 56.8 m-20 -75.54 -35.54 60.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.064 -1.022 . . . . 73.319999999999993 109.078 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . 0.521 ' OD2' ' NH2' ' B' ' 112' ' ' ARG . 7.3 m-20 -153.89 155.3 35.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.385 -0.822 . . . . 73.040000000000006 109.388 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.425 ' OH ' ' OG ' ' B' ' 75' ' ' SER . 6.3 t80 -123.37 138.76 54.53 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.061 -0.718 . . . . 74.310000000000002 109.061 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.583 ' N ' ' CD1' ' B' ' 95' ' ' ILE . 0.3 OUTLIER -130.1 139.68 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-O 122.069 0.937 . . . . 75.340000000000003 110.622 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.17 131.98 52.65 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.825 -1.546 . . . . 70.099999999999994 106.825 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.608 ' C ' ' H ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -61.99 -41.2 74.89 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 120.833 -1.167 . . . . 65.430000000000007 110.959 -178.179 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' B' ' 97' ' ' LYS . 37.3 Cg_exo -54.73 2.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.291 -2.486 0 CA-C-N 118.827 0.617 . . . . 63.520000000000003 112.202 -175.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . 0.608 ' H ' ' C ' ' B' ' 97' ' ' LYS . 50.4 m-85 54.83 106.56 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.614 -0.679 . . . . 75.129999999999995 109.848 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 19.7 ttm180 -61.62 -34.83 76.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 74.230000000000004 108.976 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' SER . . . . . 0.746 ' O ' ' N ' ' B' ' 103' ' ' LYS . 43.9 t -174.59 38.8 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.266 -0.896 . . . . 64.510000000000005 110.508 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 59.1 mt 50.17 -70.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.656 -0.652 . . . . 74.439999999999998 110.311 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . 0.746 ' N ' ' O ' ' B' ' 101' ' ' SER . 9.3 mtpm? -54.32 -21.03 8.28 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.953 -1.129 . . . . 72.299999999999997 107.953 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.21 -64.23 0.93 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.073 -0.651 . . . . 74.310000000000002 109.983 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 2.5 pp -62.29 -35.22 78.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.036 -1.04 . . . . 73.540000000000006 109.787 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 34.4 t -60.75 -44.21 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.876 -1.14 . . . . 72.030000000000001 108.605 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.23 -42.62 73.65 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.314 -0.995 . . . . 64.219999999999999 108.314 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 0.615 ' NH1' ' CZ ' ' A' ' 87' ' ' PHE . 58.8 mtp85 -64.91 -34.07 77.51 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.412 -0.805 . . . . 75.310000000000002 108.974 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 92.4 mt -74.3 -27.69 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.488 -0.93 . . . . 55.439999999999998 108.488 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -75.31 -58.17 3.44 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.446 -0.784 . . . . 65.310000000000002 109.112 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -48.32 -42.87 32.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 74.519999999999996 109.43 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . 0.521 ' NH2' ' OD2' ' B' ' 93' ' ' ASP . 50.6 ttm-85 -61.36 -44.14 97.67 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.324 -0.86 . . . . 72.040000000000006 109.319 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 41.2 mt -134.8 75.78 1.59 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.43 -0.794 . . . . 75.349999999999994 109.313 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -68.1 -54.44 18.12 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.136 -0.978 . . . . 75.5 109.318 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' PHE . . . . . 0.521 ' O ' ' CG ' ' B' ' 116' ' ' TRP . 6.3 t80 -92.18 -76.97 0.44 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.186 -0.946 . . . . 73.040000000000006 109.436 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' TRP . . . . . 0.521 ' CG ' ' O ' ' B' ' 115' ' ' PHE . 4.0 m-90 -162.44 -173.22 3.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.053 -1.029 . . . . 74.450000000000003 109.294 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.17 176.22 0.93 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.455 -1.458 . . . . 64.209999999999994 109.455 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' SER . . . . . 0.471 ' C ' ' ND2' ' B' ' 119' ' ' ASN . 26.9 m -128.25 178.67 6.08 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.439 -1.036 . . . . 71.400000000000006 109.599 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . 0.471 ' ND2' ' C ' ' B' ' 118' ' ' SER . 0.0 OUTLIER -152.51 139.63 19.27 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.941 -0.704 . . . . 74.209999999999994 109.207 -178.023 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 14.2 t -86.08 -40.28 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.133 -0.979 . . . . 75.019999999999996 109.619 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 18.2 mm -105.57 134.39 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.309 -0.869 . . . . 74.239999999999995 108.838 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -157.26 131.16 8.19 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.076 -1.015 . . . . 73.329999999999998 109.036 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 3.8 tt -151.77 131.3 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 74.219999999999999 108.912 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.13 -143.11 41.34 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.997 -1.641 . . . . 72.409999999999997 108.997 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -85.65 3.48 40.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -1.192 . . . . 75.120000000000005 109.043 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 mt -92.61 125.88 37.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.352 -0.842 . . . . 75.420000000000002 108.741 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 17.4 m -123.77 140.36 53.06 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.153 -1.055 . . . . 74.219999999999999 108.153 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 5.0 mt -143.01 131.25 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.023 -1.048 . . . . 60.329999999999998 109.92 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 129' ' ' SER . . . . . 0.552 ' HB3' ' OE1' ' B' ' 132' ' ' GLU . 12.4 m -116.3 92.43 36.22 Favored Pre-proline 0 N--CA 1.495 1.814 0 N-CA-C 108.573 -0.899 . . . . 72.310000000000002 108.573 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -71.67 -27.91 17.82 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.354 1.369 . . . . 75.129999999999995 111.616 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . 0.557 ' HB2' ' OE2' ' B' ' 132' ' ' GLU . 74.4 m-20 -66.91 -42.22 85.78 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.144 -0.972 . . . . 75.230000000000004 108.88 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . 0.557 ' OE2' ' HB2' ' B' ' 131' ' ' ASP . 4.7 mp0 -87.27 6.08 35.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.328 -0.857 . . . . 75.120000000000005 109.307 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.547 ' HA ' ' CE1' ' B' ' 149' ' ' PHE . 42.9 mt-10 51.03 54.55 11.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 75.129999999999995 109.446 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -150.54 145.97 26.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.212 -0.93 . . . . 75.109999999999999 109.527 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 8.3 tt -130.45 142.06 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.502 -0.749 . . . . 70.319999999999993 109.513 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 77.3 mt -129.71 124.61 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.525 -0.734 . . . . 74.120000000000005 109.561 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' B' ' 137' ' ' TYR . 18.2 p90 -142.33 152.72 43.21 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.234 -0.916 . . . . 74.230000000000004 109.66 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . 0.517 ' O ' ' NH1' ' B' ' 140' ' ' ARG . 51.3 mtpt 55.57 14.54 1.24 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.513 -0.742 . . . . 74.219999999999999 110.045 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.88 -15.77 58.45 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.144 -1.027 . . . . 74.319999999999993 110.587 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . 0.517 ' NH1' ' O ' ' B' ' 138' ' ' LYS . 10.3 mpt_? -87.26 143.16 27.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.957 -1.319 . . . . 75.340000000000003 108.846 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 141' ' ' GLU . . . . . 0.462 ' N ' ' CD ' ' B' ' 141' ' ' GLU . 21.2 mp0 -103.2 138.63 39.74 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.235 -0.915 . . . . 71.230000000000004 109.914 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 52.8 t -138.01 133.98 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.811 -0.811 . . . . 70.430000000000007 108.811 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -104.7 136.32 44.45 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.395 -0.816 . . . . 72.430000000000007 109.684 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 6.7 m -140.37 157.19 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.366 -0.834 . . . . 72.129999999999995 109.01 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -171.8 37.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.997 . . . . 74.5 109.839 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -133.25 -125.54 2.62 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 109.184 -1.566 . . . . 42.229999999999997 109.184 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 0.689 ' HB2' ' HE2' ' B' ' 178' ' ' MET . 33.8 tttm -76.13 -33.35 1.25 Allowed Pre-proline 0 N--CA 1.487 1.401 0 O-C-N 121.272 -1.134 . . . . 73.299999999999997 111.223 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 61.0 Cg_endo -85.22 11.77 3.27 Favored 'Trans proline' 0 N--CA 1.486 1.065 0 C-N-CA 121.854 1.702 . . . . 71.329999999999998 112.158 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . 0.547 ' CE1' ' HA ' ' B' ' 133' ' ' GLU . 13.0 t80 -110.24 -50.18 2.99 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.497 -0.752 . . . . 74.230000000000004 108.988 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -60.92 -49.79 76.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.33 -0.856 . . . . 72.340000000000003 111.099 -178.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 11.8 p -70.95 -40.23 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.91 -1.118 . . . . 73.349999999999994 110.131 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . 0.433 ' O ' ' CD1' ' B' ' 155' ' ' LEU . 16.4 tp -65.65 -40.19 92.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.117 -0.989 . . . . 74.430000000000007 109.937 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.534 HG22 ' CE1' ' B' ' 149' ' ' PHE . 14.3 p -77.62 -17.79 57.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.754 -1.216 . . . . 75.209999999999994 109.69 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -71.39 -54.23 11.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.877 -1.14 . . . . 73.040000000000006 109.607 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . 0.45 ' C ' ' CD2' ' B' ' 155' ' ' LEU . 0.0 OUTLIER -74.67 -21.17 59.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.16 -0.962 . . . . 73.430000000000007 109.455 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.9 -55.3 27.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.793 -1.192 . . . . 75.319999999999993 108.947 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -64.23 -52.23 59.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.047 -1.033 . . . . 73.319999999999993 108.838 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . 0.627 ' ND1' HE22 ' B' ' 161' ' ' GLN . 17.0 m-70 -88.52 42.43 1.07 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.563 -0.71 . . . . 74.140000000000001 110.15 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 22.2 ttp-105 -55.3 -77.58 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.06 -1.025 . . . . 73.420000000000002 109.368 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -65.3 82.74 0.05 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.375 -0.828 . . . . 72.099999999999994 109.396 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . 0.627 HE22 ' ND1' ' B' ' 158' ' ' HIS . 8.8 tt0 -170.46 154.36 4.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.268 -0.895 . . . . 73.239999999999995 109.496 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 162' ' ' ILE . . . . . 0.501 ' CD1' ' N ' ' B' ' 162' ' ' ILE . 2.9 mp -76.66 109.87 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.15 -0.969 . . . . 72.310000000000002 109.062 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.65 124.79 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.309 -0.869 . . . . 75.030000000000001 109.041 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 23.3 t -100.85 178.77 4.59 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.199 -0.938 . . . . 74.219999999999999 110.167 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . 0.627 ' HZ2' ' HH ' ' B' ' 212' ' ' TYR . 40.5 mttm -72.77 -56.83 4.68 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.003 0.906 . . . . 72.420000000000002 109.345 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . 0.723 ' O ' ' OD1' ' B' ' 170' ' ' ASP . 12.8 pt-20 -55.37 -27.99 51.03 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.368 -0.832 . . . . 63.450000000000003 109.535 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -60.28 -50.47 73.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.094 -1.004 . . . . 72.400000000000006 109.354 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 76.9 mt -59.27 -35.88 74.53 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.334 -0.854 . . . . 72.319999999999993 109.665 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' B' ' 172' ' ' ILE . 40.2 mt -65.54 -73.68 0.12 Allowed 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 117.692 -1.603 . . . . 73.340000000000003 109.303 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . 0.787 ' OD1' ' N ' ' B' ' 170' ' ' ASP . 0.0 OUTLIER -42.86 -21.45 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.311 0 O-C-N 120.173 -1.58 . . . . 73.099999999999994 110.233 178.578 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' B' ' 169' ' ' LEU . . . -88.12 -24.86 23.26 Favored 'General case' 0 C--N 1.283 -2.286 0 O-C-N 121.61 -0.682 . . . . 62.130000000000003 110.5 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' B' ' 174' ' ' GLU . 1.8 mp -113.93 -19.77 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.307 -0.871 . . . . 74.439999999999998 110.659 -178.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 173' ' ' TRP . . . . . 0.495 ' CZ3' ' CB ' ' B' ' 169' ' ' LEU . 0.1 OUTLIER -52.05 94.97 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.776 0 O-C-N 120.276 -1.515 . . . . 72.230000000000004 107.015 178.132 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' B' ' 172' ' ' ILE . 35.2 tt0 -176.94 167.43 2.5 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.476 -1.675 . . . . 75.030000000000001 106.476 -178.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . 0.619 ' O ' ' N ' ' B' ' 177' ' ' GLU . 59.4 mt-10 62.55 153.47 0.11 Allowed Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 106.597 -1.631 . . . . 73.040000000000006 106.597 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.517 ' O ' ' C ' ' B' ' 177' ' ' GLU . 26.6 Cg_exo -33.72 80.18 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.603 2.202 . . . . 74.129999999999995 113.474 -177.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . 0.619 ' N ' ' O ' ' B' ' 175' ' ' GLU . 2.2 mm-40 15.63 98.34 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 CA-C-O 121.359 0.6 . . . . 72.439999999999998 112.136 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 178' ' ' MET . . . . . 0.689 ' HE2' ' HB2' ' B' ' 147' ' ' LYS . 0.1 OUTLIER -108.61 21.32 17.44 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.757 -0.831 . . . . 72.109999999999999 108.757 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.6 132.89 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 O-C-N 121.653 -0.654 . . . . 75.310000000000002 109.365 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.8 159.67 52.44 Favored Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 108.873 -0.788 . . . . 62.149999999999999 108.873 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -37.84 110.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 123.037 2.492 . . . . 74.340000000000003 113.254 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 12.6 m120 49.3 45.33 23.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.045 -1.034 . . . . 72.310000000000002 110.564 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.11 -23.99 16.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.259 -0.901 . . . . 65.420000000000002 109.767 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.499 HD13 HD11 ' B' ' 169' ' ' LEU . 54.2 mt -49.25 -39.78 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.114 -0.991 . . . . 75.030000000000001 110.576 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -53.61 -61.67 2.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.027 -1.045 . . . . 73.519999999999996 109.533 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 34.1 t -66.04 -40.79 88.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.486 -0.759 . . . . 74.349999999999994 110.405 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.9 -58.37 6.34 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.029 -1.044 . . . . 61.119999999999997 110.853 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 1.3 tt -56.03 -33.94 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.739 -1.225 . . . . 72.430000000000007 109.977 -178.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.99 -57.47 12.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.098 -1.001 . . . . 75.420000000000002 109.987 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -68.76 -41.05 79.39 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.159 -0.963 . . . . 74.140000000000001 110.548 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 77.5 mt -55.26 -38.75 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.817 -1.177 . . . . 74.030000000000001 108.932 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -64.97 -48.26 74.63 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.319 -0.863 . . . . 72.329999999999998 109.94 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -76.42 -20.06 57.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.043 -1.035 . . . . 73.099999999999994 111.12 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -90.73 -21.66 21.47 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.874 -1.141 . . . . 74.430000000000007 111.028 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 195' ' ' MET . . . . . 0.443 ' C ' ' SD ' ' B' ' 195' ' ' MET . 3.1 ppp? -88.35 -36.93 16.33 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.788 -1.195 . . . . 74.329999999999998 110.026 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -59.12 -42.85 91.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.16 -0.962 . . . . 71.209999999999994 110.348 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . 0.412 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 24.5 mttm -51.64 -64.45 1.44 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.974 . . . . 75.209999999999994 110.03 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 198' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 44.9 Cg_endo -65.71 -34.31 41.35 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.253 1.969 . . . . 75.319999999999993 112.613 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . 1.006 HD21 ' O ' ' B' ' 201' ' ' ILE . 13.3 tp -68.82 -43.75 74.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.176 -0.952 . . . . 72.25 109.69 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 92.92 -44.78 2.51 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.66 -1.376 . . . . 73.239999999999995 109.66 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . 1.006 ' O ' HD21 ' B' ' 199' ' ' LEU . 27.8 mm -110.31 133.81 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.397 -1.061 . . . . 54.299999999999997 109.28 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 9.0 t -77.64 135.49 38.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 74.310000000000002 109.451 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 71.2 p -143.02 44.11 1.57 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.28 -0.887 . . . . 74.400000000000006 109.24 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 17.5 m -139.03 140.89 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.377 -0.827 . . . . 74.099999999999994 109.871 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -124.76 114.79 19.73 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.779 -0.823 . . . . 75.329999999999998 108.779 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 68.4 p -96.68 123.22 40.3 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.139 -0.975 . . . . 71.400000000000006 109.468 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 6.4 t -142.94 144.31 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.131 -0.981 . . . . 63.5 109.466 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 31.5 ttm-85 -60.14 -35.53 75.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.444 -0.785 . . . . 74.450000000000003 110.042 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' B' ' 211' ' ' GLY . 18.0 mmm180 -65.96 142.46 57.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.114 -0.991 . . . . 74.140000000000001 109.728 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . 0.51 ' NH1' HH21 ' B' ' 213' ' ' ARG . 90.3 mtt180 55.79 -81.5 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.668 -0.645 . . . . 74.430000000000007 109.718 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' B' ' 209' ' ' ARG . . . -179.36 -98.98 0.12 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.825 -1.31 . . . . 70.109999999999999 109.825 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 212' ' ' TYR . . . . . 0.627 ' HH ' ' HZ2' ' B' ' 165' ' ' LYS . 6.4 m-85 -131.29 115.9 16.89 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.57 -0.959 . . . . 74.209999999999994 108.778 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . 0.51 HH21 ' NH1' ' B' ' 210' ' ' ARG . 35.4 ttm180 -93.1 128.11 38.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.421 -0.799 . . . . 74.299999999999997 109.976 -179.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -101.55 121.36 41.83 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.416 -0.957 . . . . 74.340000000000003 108.416 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.1 p -133.97 163.98 28.31 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.379 -0.825 . . . . 72.209999999999994 110.005 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -79.61 150.42 73.01 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.469 -0.769 . . . . 72.310000000000002 109.41 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.81 -101.5 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.282 1.988 . . . . 71.010000000000005 112.094 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' B' ' 220' ' ' ALA . 2.8 ptpp? -92.02 153.93 43.38 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.224 -0.922 . . . . 74.349999999999994 108.921 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -36.95 -25.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.602 2.201 . . . . 71.319999999999993 112.757 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' B' ' 218' ' ' LYS . . . 52.08 35.76 17.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 75.450000000000003 109.602 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 26.0 p -84.16 136.29 34.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.254 -0.904 . . . . 72.219999999999999 109.543 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -59.69 137.91 57.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 74.299999999999997 109.567 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.996 -1.002 . . . . 71.129999999999995 109.574 179.977 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.596 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.427 -0.583 . . . . 65.120000000000005 109.427 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -137.61 148.97 46.26 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.445 -0.784 . . . . 73.310000000000002 109.319 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.0 t -118.06 125.09 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.66 -0.65 . . . . 71.420000000000002 109.724 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.436 ' C ' ' CD1' ' A' ' 4' ' ' LEU . 0.2 OUTLIER -94.84 124.32 38.81 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.055 -1.028 . . . . 65.219999999999999 108.348 179.319 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 tp -120.57 123.89 43.98 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.039 -0.726 . . . . 71.439999999999998 109.039 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.407 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 9.5 mt -108.63 106.1 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.271 -0.893 . . . . 71.150000000000006 108.861 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.516 ' OE2' ' ND2' ' A' ' 9' ' ' ASN . 37.0 tp10 -138.24 122.88 18.62 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.359 -0.838 . . . . 75.340000000000003 109.536 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -86.41 -13.31 46.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.28 -0.887 . . . . 73.040000000000006 109.323 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.516 ' ND2' ' OE2' ' A' ' 7' ' ' GLU . 82.3 m-20 -69.37 -136.34 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.354 -0.842 . . . . 72.420000000000002 109.454 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 11' ' ' VAL . 35.1 p -158.1 -63.86 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.071 -1.018 . . . . 72.340000000000003 109.765 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.504 ' N ' ' OG ' ' A' ' 10' ' ' SER . 12.6 p -69.53 -41.22 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 74.420000000000002 109.881 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.401 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 45.8 mt -63.98 -36.4 83.85 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.174 -0.954 . . . . 72.010000000000005 109.515 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.8 -34.87 23.58 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.696 -1.762 . . . . 72.140000000000001 108.696 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.86 -44.14 89.81 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.948 -1.261 . . . . 72.329999999999998 109.948 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -67.92 -43.59 78.84 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.069 -1.253 . . . . 72.340000000000003 109.26 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.3 mt -65.64 -49.4 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.853 -1.154 . . . . 74.239999999999995 108.655 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.525 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 86.3 tt0 -46.08 -56.46 5.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.328 -0.858 . . . . 71.409999999999997 109.817 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -85.26 3.73 38.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 75.540000000000006 109.433 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.78 -67.1 1.61 Allowed Glycine 0 N--CA 1.484 1.841 0 N-CA-C 109.921 -1.271 . . . . 62.149999999999999 109.921 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -65.05 -22.77 67.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -1.205 . . . . 74.420000000000002 109.803 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 84.3 m-20 -57.35 -33.19 67.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.023 -1.048 . . . . 74.25 109.265 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.4 ' C ' ' H ' ' A' ' 24' ' ' GLY . 82.2 t -57.41 -33.46 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.343 -0.848 . . . . 72.109999999999999 109.384 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.418 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 11.8 mptt -70.24 2.54 3.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.879 . . . . 73.230000000000004 109.353 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 22' ' ' VAL . . . 85.13 35.62 12.18 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.181 -1.168 . . . . 75.540000000000006 110.181 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -119.55 160.55 22.21 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.495 -1.003 . . . . 74.510000000000005 109.218 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 45.3 mmm -103.61 137.39 41.73 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.053 -1.092 . . . . 64.319999999999993 108.053 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.77 159.99 41.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.106 -0.996 . . . . 74.310000000000002 110.101 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -141.74 155.86 45.62 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.399 -0.813 . . . . 75.400000000000006 109.081 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 p -109.85 139.49 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.365 -0.834 . . . . 75.129999999999995 108.903 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.7 p -134.21 165.26 25.52 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.454 -0.779 . . . . 71.420000000000002 109.432 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.407 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 3.9 pt-20 -91.53 -103.72 0.11 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.334 -0.854 . . . . 73.109999999999999 109.602 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.5 t -79.45 165.72 22.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 74.239999999999995 109.96 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.7 mt -52.5 -32.58 40.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.535 -0.728 . . . . 71.530000000000001 109.802 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -48.47 -50.62 30.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.145 -0.972 . . . . 74.230000000000004 109.787 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.31 -39.1 85.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.118 -0.989 . . . . 71.010000000000005 109.586 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.41 -36.52 34.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.839 -1.304 . . . . 61.409999999999997 109.839 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -64.89 -40.06 94.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -1.156 . . . . 74.340000000000003 109.928 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -81.62 -40.63 22.68 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.013 -1.054 . . . . 75.329999999999998 109.503 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.5 tp -66.05 -43.04 88.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 74.329999999999998 109.729 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.441 ' O ' ' O ' ' A' ' 43' ' ' ARG . 3.6 ppp? -69.44 -26.95 64.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.167 -0.958 . . . . 70.319999999999993 109.656 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -65.51 -39.84 92.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.948 . . . . 71.219999999999999 109.751 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.5 pt -83.8 -26.37 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.221 -0.925 . . . . 74.409999999999997 109.989 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 40' ' ' MET . 80.2 mtt85 -129.13 137.94 51.5 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.404 -0.81 . . . . 75.409999999999997 109.276 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -92.27 126.84 37.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.157 -0.964 . . . . 75.420000000000002 109.588 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -104.71 141.62 36.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.465 -0.772 . . . . 74.230000000000004 109.269 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -80.63 -35.47 33.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.228 -0.92 . . . . 75.319999999999993 109.804 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.43 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 1.1 tm? -124.55 113.82 18.58 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.795 -0.817 . . . . 72.129999999999995 108.795 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.434 ' O ' ' CG2' ' A' ' 48' ' ' VAL . 17.3 m -109.03 105.32 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.306 -0.871 . . . . 72.340000000000003 108.785 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.565 ' SD ' ' N ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -104.48 132.61 50.53 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.915 -1.143 . . . . 74.109999999999999 107.915 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.565 ' N ' ' SD ' ' A' ' 49' ' ' MET . 1.5 p -129.01 128.16 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.847 0.832 . . . . 71.239999999999995 110.352 -178.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.9 p -95.6 2.8 54.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.649 -0.657 . . . . 73.109999999999999 109.409 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.42 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 4.1 m-20 -76.48 150.59 36.64 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.179 -0.951 . . . . 63.399999999999999 109.552 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.503 ' C ' ' H ' ' A' ' 55' ' ' ALA . 18.7 pttp -85.88 -39.5 16.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.188 -0.945 . . . . 65.439999999999998 110.329 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -71.63 12.53 0.35 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.022 -1.049 . . . . 73.129999999999995 109.619 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.503 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.34 -21.52 58.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.849 . . . . 64.140000000000001 110.514 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.43 ' CD2' HE22 ' A' ' 89' ' ' GLN . 46.8 mt -39.96 -53.95 2.27 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.582 -0.699 . . . . 74.430000000000007 110.426 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 t -66.0 -35.7 81.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.984 -1.073 . . . . 63.229999999999997 109.164 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 55' ' ' ALA . 65.9 t80 -64.02 -62.42 1.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.39 -0.819 . . . . 74.439999999999998 109.763 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.8 m -49.33 -32.2 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.655 -1.278 . . . . 74.030000000000001 109.628 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.9 t -58.93 -52.06 67.36 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.263 -0.898 . . . . 73.540000000000006 109.501 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -68.8 -30.4 68.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.025 -1.047 . . . . 73.340000000000003 109.94 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' A' ' 66' ' ' HIS . 31.7 mm -59.02 -44.41 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.868 -1.145 . . . . 73.349999999999994 110.083 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -74.29 -48.38 28.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.036 -1.04 . . . . 74.420000000000002 111.48 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.22 -36.11 82.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.611 -1.305 . . . . 74.549999999999997 109.861 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -92.18 -50.44 5.67 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.137 -0.977 . . . . 75.219999999999999 109.226 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.5 ' ND1' ' N ' ' A' ' 66' ' ' HIS . 0.5 OUTLIER -107.9 63.03 0.61 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.466 -0.771 . . . . 74.129999999999995 109.784 -179.467 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 t -65.94 -28.38 68.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.011 -1.055 . . . . 73.239999999999995 110.043 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.4 m -63.45 -31.0 72.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.258 -0.901 . . . . 71.439999999999998 110.627 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 58.8 mt -84.74 149.08 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.973 -1.079 . . . . 71.329999999999998 110.226 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.3 t -88.51 159.04 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.569 -0.9 . . . . 73.019999999999996 108.569 179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.2 t -136.58 129.67 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.282 -0.886 . . . . 54.210000000000001 109.932 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.507 ' O ' ' SD ' ' A' ' 49' ' ' MET . 1.6 mt -127.08 100.81 6.27 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.909 -1.145 . . . . 74.209999999999994 107.909 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.0 p -96.37 154.65 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.368 -0.832 . . . . 74.409999999999997 109.282 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.435 ' O ' ' OG ' ' A' ' 75' ' ' SER . 0.4 OUTLIER -118.4 167.72 11.3 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.701 -0.851 . . . . 72.310000000000002 108.701 179.395 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 74' ' ' SER . 3.7 m -167.41 120.72 0.95 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.266 -0.897 . . . . 64.540000000000006 109.933 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -75.12 19.58 0.15 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.409 -0.807 . . . . 74.129999999999995 110.111 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.429 ' H ' ' C ' ' A' ' 75' ' ' SER . 34.7 t30 -142.48 58.41 7.4 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.129 -0.982 . . . . 73.340000000000003 109.826 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.4 82.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.342 2.028 . . . . 71.319999999999993 112.471 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 77' ' ' ASN . 44.8 m -114.2 150.99 33.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.227 -1.027 . . . . 62.530000000000001 108.227 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 t -53.45 -26.49 20.39 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.074 -1.016 . . . . 74.140000000000001 109.723 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -63.41 -47.67 81.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.163 -0.961 . . . . 71.420000000000002 109.813 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -72.64 -30.61 64.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.162 -0.962 . . . . 73.430000000000007 109.917 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.464 ' OE2' ' NE ' ' B' ' 108' ' ' ARG . 35.3 tt0 -62.04 -55.75 25.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 74.219999999999999 109.965 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.2 m -63.47 -36.49 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -0.961 . . . . 74.150000000000006 109.62 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -73.68 -19.59 60.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 72.540000000000006 109.711 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -76.73 -44.19 34.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.158 -0.964 . . . . 64.219999999999999 110.017 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -81.42 -29.74 33.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.078 -1.013 . . . . 74.340000000000003 109.217 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -75.75 -40.54 55.24 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.326 -0.859 . . . . 74.420000000000002 110.001 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.489 ' CG ' ' N ' ' A' ' 90' ' ' GLY . 11.1 pt20 -71.15 -46.91 60.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.042 -1.036 . . . . 74.519999999999996 109.841 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.489 ' N ' ' CG ' ' A' ' 89' ' ' GLN . . . 145.67 70.05 0.02 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.881 -1.288 . . . . 74.209999999999994 109.881 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -133.64 129.02 36.31 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.261 -1.141 . . . . 64.099999999999994 108.701 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 11.8 t70 -73.25 -40.12 64.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.912 -1.117 . . . . 73.420000000000002 108.875 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 63.6 m-20 -153.36 154.06 33.79 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.932 -0.766 . . . . 75.040000000000006 108.932 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -127.72 130.71 49.28 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.866 -0.791 . . . . 71.329999999999998 108.866 -179.597 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.553 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -118.74 142.54 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 CA-C-O 121.636 0.731 . . . . 74.510000000000005 110.14 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.12 119.89 8.69 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.982 -1.074 . . . . 64.319999999999993 108.139 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.697 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -43.22 -53.79 10.46 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.182 -0.949 . . . . 74.510000000000005 111.656 -179.168 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 1.4 Cg_endo -38.22 -11.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.27 1.314 . . . . 73.109999999999999 113.525 -176.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.697 ' N ' ' O ' ' A' ' 97' ' ' LYS . 56.4 m-85 57.88 103.27 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.454 -0.779 . . . . 72.540000000000006 109.638 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 61.2 mtm-85 -58.96 -49.93 75.98 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.071 -1.018 . . . . 74.540000000000006 109.148 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.822 ' O ' ' N ' ' A' ' 103' ' ' LYS . 3.2 t -174.5 67.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.138 -0.976 . . . . 74.140000000000001 110.631 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.561 ' N ' ' CD1' ' A' ' 102' ' ' ILE . 1.8 mp 35.6 -68.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 CA-C-O 121.213 0.53 . . . . 75.430000000000007 111.885 178.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.822 ' N ' ' O ' ' A' ' 101' ' ' SER . 28.3 mmtp -47.3 -15.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.867 -1.145 . . . . 74.140000000000001 109.096 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -60.79 -92.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.439 -0.788 . . . . 63.240000000000002 110.374 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -50.47 -33.27 20.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.053 -1.03 . . . . 73.219999999999999 110.392 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 66.2 t -65.46 -40.53 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.83 -1.168 . . . . 74.540000000000006 109.037 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.89 -39.6 81.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.218 -0.926 . . . . 75.5 108.516 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -68.43 -31.21 70.37 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.917 -0.771 . . . . 74.409999999999997 108.917 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 109' ' ' ILE . 86.4 mt -75.37 -34.65 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 108.294 -1.002 . . . . 73.239999999999995 108.294 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.407 ' OE2' ' NH1' ' A' ' 114' ' ' ARG . 82.5 tt0 -74.64 -57.81 3.69 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.472 -0.768 . . . . 74.340000000000003 109.184 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -49.62 -35.59 21.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.338 -0.851 . . . . 73.319999999999993 109.319 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 53.8 ttt85 -68.26 -39.47 82.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.339 -0.851 . . . . 74.420000000000002 109.865 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 34.8 mt -133.58 68.72 1.49 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.292 -0.88 . . . . 74.329999999999998 110.446 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.407 ' NH1' ' OE2' ' A' ' 110' ' ' GLU . 25.0 mtp85 -75.07 -43.09 55.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.941 -1.099 . . . . 74.439999999999998 108.341 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.478 ' N ' ' CD1' ' A' ' 115' ' ' PHE . 8.7 p90 -132.99 73.21 1.51 Allowed 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.825 -0.805 . . . . 74.430000000000007 108.825 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -56.26 -177.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.601 -0.687 . . . . 74.439999999999998 109.972 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.11 142.39 13.3 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.895 -1.282 . . . . 75.040000000000006 109.895 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.401 ' O ' ' O ' ' A' ' 119' ' ' ASN . 16.0 t -161.85 -61.16 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.346 -1.091 . . . . 70.109999999999999 109.129 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.427 HD22 ' N ' ' A' ' 128' ' ' ILE . 20.7 t-20 51.45 95.95 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.359 -0.838 . . . . 65.239999999999995 109.875 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.4 t -84.34 -19.41 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.049 -1.032 . . . . 74.219999999999999 109.158 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 22.4 mm -110.26 124.56 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.548 -0.72 . . . . 74.420000000000002 109.758 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -138.38 109.16 6.66 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.469 -0.938 . . . . 73.299999999999997 108.469 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.9 pt -142.05 122.03 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.243 -0.91 . . . . 75.340000000000003 109.338 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.03 -148.39 32.55 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.429 -1.468 . . . . 75.129999999999995 109.429 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -83.89 9.98 10.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.265 -1.138 . . . . 74.450000000000003 109.391 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.52 131.82 43.78 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.39 -0.819 . . . . 54.210000000000001 108.878 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 p -128.55 128.26 43.93 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.574 -0.899 . . . . 70.239999999999995 108.574 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.427 ' N ' HD22 ' A' ' 119' ' ' ASN . 21.2 mt -133.9 135.08 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.334 -0.854 . . . . 72.430000000000007 109.752 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.3 m -119.22 91.75 44.36 Favored Pre-proline 0 N--CA 1.497 1.893 0 N-CA-C 108.845 -0.798 . . . . 71.109999999999999 108.845 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.32 -25.84 6.67 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.226 1.95 . . . . 75.140000000000001 112.538 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -59.32 -40.37 86.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.088 -1.007 . . . . 72.5 108.83 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -97.63 5.78 48.92 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.5 -0.926 . . . . 73.140000000000001 108.5 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 56.81 61.2 2.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.257 -0.902 . . . . 75.329999999999998 109.03 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -149.75 148.35 29.12 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.349 -0.844 . . . . 71.230000000000004 109.543 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 13.1 tt -119.93 139.51 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.548 -0.72 . . . . 75.329999999999998 109.212 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.85 126.34 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.581 -0.699 . . . . 71.109999999999999 109.323 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.415 ' C ' ' H ' ' A' ' 139' ' ' GLY . 68.9 t80 -141.46 149.95 41.63 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.395 -0.815 . . . . 74.140000000000001 109.588 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 138' ' ' LYS . 54.6 tttt 55.9 9.59 0.47 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.495 -0.753 . . . . 75.400000000000006 109.715 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 137' ' ' TYR . . . 89.95 14.03 59.88 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.954 -1.258 . . . . 72.239999999999995 109.954 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -105.35 136.58 44.62 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.421 -1.046 . . . . 73.120000000000005 109.077 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -101.43 118.42 36.92 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.482 -0.761 . . . . 72.319999999999993 110.041 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 10.7 p -138.06 132.54 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.408 -0.808 . . . . 62.340000000000003 108.933 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.427 ' CG ' ' N ' ' A' ' 144' ' ' VAL . 29.5 tt0 -92.3 160.71 15.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -0.917 . . . . 61.229999999999997 110.357 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.455 ' CG2' ' CG ' ' A' ' 149' ' ' PHE . 13.5 p -143.41 140.81 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.182 -1.044 . . . . 74.439999999999998 108.182 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -152.26 113.25 4.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.773 -1.205 . . . . 75.420000000000002 110.399 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 176.89 -164.45 33.94 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.985 -1.646 . . . . 73.340000000000003 108.985 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.623 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 17.3 mtpp -91.19 -32.24 0.35 Allowed Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.055 -1.262 . . . . 72.219999999999999 111.499 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 85.8 Cg_endo -88.33 21.15 1.04 Allowed 'Trans proline' 0 N--CA 1.488 1.196 0 C-N-CA 122.131 1.887 . . . . 75.450000000000003 112.516 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.455 ' CG ' ' CG2' ' A' ' 144' ' ' VAL . 41.0 m-85 -125.65 -29.75 3.13 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.475 -0.766 . . . . 65.239999999999995 109.679 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -60.84 -34.05 73.98 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.909 -1.119 . . . . 72.519999999999996 108.606 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.04 -33.97 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.344 -0.984 . . . . 74.209999999999994 108.344 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 17.7 tp -62.26 -45.23 94.22 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.532 -0.914 . . . . 73.310000000000002 108.532 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.9 p -65.47 -37.61 87.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 74.310000000000002 108.957 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -53.45 -60.55 3.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.563 -0.71 . . . . 75.450000000000003 110.765 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.3 pp -65.0 -23.53 67.24 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.096 -1.002 . . . . 75.340000000000003 109.743 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.1 -40.01 84.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.976 -1.077 . . . . 62.140000000000001 108.852 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.421 ' C ' ' H ' ' A' ' 159' ' ' ARG . 10.0 mtt180 -86.1 -51.52 6.26 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.235 -0.916 . . . . 72.219999999999999 109.66 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -73.93 49.34 0.33 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 74.120000000000005 108.925 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.626 ' NH1' ' OD2' ' A' ' 160' ' ' ASP . 7.6 ptm180 -77.72 14.08 1.15 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.639 -0.663 . . . . 74.340000000000003 111.025 -178.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.626 ' OD2' ' NH1' ' A' ' 159' ' ' ARG . 64.2 m-20 -148.21 47.48 1.06 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.682 -1.262 . . . . 75.450000000000003 110.129 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 0.473 ' NE2' ' OD2' ' B' ' 160' ' ' ASP . 63.9 mt-30 -150.86 157.52 43.02 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.918 -1.114 . . . . 73.409999999999997 109.848 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.6 mt -86.05 117.85 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.527 -0.733 . . . . 74.409999999999997 109.716 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 1.269 ' HB ' ' CE1' ' A' ' 214' ' ' PHE . 44.6 t -108.17 130.02 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.941 -0.763 . . . . 72.530000000000001 108.941 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.7 t -96.11 168.05 10.84 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.164 -0.96 . . . . 74.120000000000005 110.167 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm -65.42 -55.0 20.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.401 -0.812 . . . . 70.430000000000007 109.75 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -56.32 -33.97 66.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.901 . . . . 74.319999999999993 109.651 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.6 tp60 -62.38 -42.76 99.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.314 -0.866 . . . . 74.519999999999996 108.968 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 9.1 mt -60.82 -37.51 82.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.397 -0.815 . . . . 74.409999999999997 109.12 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 5.0 tt -57.12 -58.76 6.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.337 -0.852 . . . . 75.140000000000001 109.114 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -68.56 -29.41 67.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.614 -0.679 . . . . 65.030000000000001 110.723 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.96 -67.8 0.28 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.028 -1.045 . . . . 70.209999999999994 110.377 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 2.1 mp -89.01 -50.44 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.003 -1.061 . . . . 75.319999999999993 109.554 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -87.94 73.64 9.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.056 -1.028 . . . . 73.140000000000001 109.156 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -83.23 23.93 0.84 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.296 -0.877 . . . . 73.239999999999995 110.14 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -78.34 173.88 6.92 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.104 -0.998 . . . . 63.329999999999998 108.421 179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -65.91 43.49 0.17 Allowed 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.919 1.746 . . . . 72.510000000000005 112.311 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.509 ' C ' ' H ' ' A' ' 179' ' ' VAL . 95.3 mt-10 48.63 -141.3 0.61 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.087 -1.008 . . . . 75.340000000000003 109.383 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 14.9 ttt 57.03 6.84 0.36 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 74.510000000000005 109.032 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.509 ' H ' ' C ' ' A' ' 177' ' ' GLU . 3.7 m -108.72 74.5 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.494 -0.754 . . . . 65.219999999999999 109.753 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 179' ' ' VAL . 41.8 p 46.38 93.59 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 73.219999999999999 109.455 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -75.93 -38.07 1.36 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.83 1.687 . . . . 62.43 113.065 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -76.7 8.11 3.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.832 -1.167 . . . . 73.129999999999995 109.292 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.5 p -70.13 -18.8 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.444 -0.785 . . . . 74.019999999999996 109.802 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 21.7 mt -63.47 -30.68 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.156 -0.965 . . . . 72.329999999999998 109.923 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -63.0 -45.06 94.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.078 -1.014 . . . . 74.400000000000006 110.297 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 16.8 m -73.19 -25.46 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.991 -1.068 . . . . 74.319999999999993 109.401 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -78.02 -48.81 15.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.259 -0.901 . . . . 73.230000000000004 109.715 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.41 HD13 HG23 ' A' ' 188' ' ' ILE . 0.3 OUTLIER -67.64 -32.63 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.028 -1.045 . . . . 74.310000000000002 109.108 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.4 ' OD1' ' NE2' ' A' ' 193' ' ' GLN . 40.5 t30 -67.12 -48.56 67.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.508 -0.745 . . . . 73.439999999999998 110.367 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -72.7 -32.96 66.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.791 -1.193 . . . . 71.420000000000002 109.776 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 51.7 mt -63.56 -54.7 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.779 -1.201 . . . . 72.439999999999998 110.267 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -62.78 -34.84 78.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.692 -1.255 . . . . 64.219999999999999 109.781 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.431 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 45.1 mt-30 -78.04 -18.73 55.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 74.319999999999993 111.24 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -97.24 -28.26 14.15 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.791 -1.193 . . . . 75.310000000000002 110.722 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' MET . . . . . 0.51 ' SD ' ' O ' ' A' ' 195' ' ' MET . 4.1 ppp? -93.15 9.2 36.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.753 -1.217 . . . . 74.019999999999996 110.146 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 193' ' ' GLN . 27.9 p-10 -110.31 -32.97 6.77 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.227 -0.921 . . . . 74.019999999999996 110.386 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 66.8 tttt -75.15 -36.16 2.13 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.018 -1.051 . . . . 75.430000000000007 111.184 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 89.8 Cg_endo -87.77 -52.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.974 1.783 . . . . 72.319999999999993 112.475 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.9 mp -48.88 -75.69 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.988 -1.07 . . . . 74.540000000000006 109.301 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 148.94 -47.82 0.63 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.64 -1.384 . . . . 61.509999999999998 109.64 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 24.6 mt -120.07 133.5 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.587 -0.949 . . . . 74.25 109.388 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 12.6 m -77.79 146.27 35.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.868 . . . . 72.0 108.966 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 22.0 p -132.47 27.77 4.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.461 -0.775 . . . . 74.439999999999998 109.362 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.7 m -129.45 125.57 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.485 -0.759 . . . . 71.129999999999995 109.61 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -98.54 105.05 17.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.544 -0.722 . . . . 73.510000000000005 109.379 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 24.4 p -70.57 119.68 15.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 73.519999999999996 108.816 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 12.7 m -139.93 158.54 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.219 -0.925 . . . . 72.150000000000006 110.301 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -102.64 -7.15 22.0 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.745 -0.835 . . . . 72.400000000000006 108.745 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.976 ' NH2' ' NH1' ' A' ' 213' ' ' ARG . 53.8 ttp180 -65.04 -27.55 68.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.438 -0.789 . . . . 73.310000000000002 109.677 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -151.06 -72.33 0.16 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 71.540000000000006 109.235 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.467 ' C ' ' CD1' ' A' ' 212' ' ' TYR . . . -167.89 -80.1 0.04 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.614 -1.394 . . . . 74.450000000000003 109.614 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.467 ' CD1' ' C ' ' A' ' 211' ' ' GLY . 73.5 m-85 -149.67 129.17 13.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.143 -1.21 . . . . 75.540000000000006 109.194 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.976 ' NH1' ' NH2' ' A' ' 209' ' ' ARG . 6.0 mtp180 -99.31 116.32 31.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.339 -0.851 . . . . 75.310000000000002 109.1 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 1.269 ' CE1' ' HB ' ' A' ' 163' ' ' VAL . 32.9 m-85 -92.9 104.92 17.11 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.439 -0.948 . . . . 75.409999999999997 108.439 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 15.1 p -138.96 166.17 25.19 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.965 -0.754 . . . . 74.140000000000001 108.965 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . 0.881 ' CE2' ' O ' ' A' ' 217' ' ' PRO . 2.2 p90 -70.24 157.45 89.89 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.249 -0.907 . . . . 75.319999999999993 109.383 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.881 ' O ' ' CE2' ' A' ' 216' ' ' TYR . 51.3 Cg_exo -49.9 161.13 1.02 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.923 1.749 . . . . 73.109999999999999 111.963 178.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 13.8 mtpt -80.82 -61.39 0.41 Allowed Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.153 -0.967 . . . . 75.25 109.757 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -61.91 -51.08 4.17 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.872 1.715 . . . . 75.099999999999994 112.006 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . 51.26 68.13 0.84 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.088 -1.007 . . . . 71.140000000000001 108.992 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . 0.435 ' SG ' ' N ' ' A' ' 222' ' ' GLU . 51.0 t -170.4 -108.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 71.129999999999995 109.133 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.435 ' N ' ' SG ' ' A' ' 221' ' ' CYS . 74.6 tt0 47.91 88.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.058 -1.026 . . . . 75.349999999999994 109.666 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.4 ' H ' ' CD ' ' A' ' 223' ' ' GLU . 1.2 pm0 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.039 -1.038 . . . . 73.409999999999997 109.768 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ptp . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.427 -0.582 . . . . 75.239999999999995 109.427 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -139.65 149.62 43.96 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.346 -0.847 . . . . 73.519999999999996 109.404 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 86.2 t -114.37 138.02 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.679 -0.638 . . . . 72.239999999999995 109.443 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 5.9 tp -113.59 119.11 36.37 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.581 -0.7 . . . . 73.340000000000003 110.159 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 12.5 mt -120.31 98.72 6.19 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 108.793 -0.817 . . . . 74.349999999999994 108.793 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 44.9 mt -86.27 98.27 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.716 -1.24 . . . . 63.439999999999998 108.577 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.417 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 9.4 tp10 -136.0 131.32 34.87 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.414 -0.804 . . . . 74.519999999999996 109.423 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -66.03 -34.68 78.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.328 -0.858 . . . . 74.129999999999995 109.363 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -77.27 110.45 11.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.275 -0.89 . . . . 74.230000000000004 109.562 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 31.7 t -68.77 -23.01 64.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 65.540000000000006 109.682 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 93.9 t -68.21 -48.69 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.166 -0.959 . . . . 75.549999999999997 109.842 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' B' ' 12' ' ' LEU . 3.5 mm? -67.31 -30.41 70.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.936 . . . . 70.140000000000001 109.706 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.5 -33.71 27.44 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.125 -1.59 . . . . 75.400000000000006 109.125 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.7 -45.5 75.47 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.888 -1.285 . . . . 65.439999999999998 109.888 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' B' ' 16' ' ' ILE . 11.3 pt-20 -68.38 -44.72 74.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.097 -1.237 . . . . 72.200000000000003 109.26 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.42 ' N ' ' CG ' ' B' ' 15' ' ' GLU . 6.2 mm -60.5 -35.5 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.044 -1.035 . . . . 75.150000000000006 108.336 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -62.31 -46.84 86.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.541 -0.724 . . . . 73.010000000000005 109.563 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -83.22 0.75 44.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.117 -0.989 . . . . 74.299999999999997 109.317 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.26 -55.63 2.32 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 109.684 -1.366 . . . . 70.540000000000006 109.684 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -76.45 -17.88 59.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -1.105 . . . . 75.430000000000007 109.857 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -56.7 -30.53 63.55 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.965 -1.084 . . . . 73.200000000000003 109.272 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 73.5 t -59.49 -30.68 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 74.230000000000004 109.039 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -77.43 -7.44 56.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.419 -0.801 . . . . 73.519999999999996 109.318 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.61 39.78 7.04 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.587 -1.005 . . . . 53.43 110.587 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -120.23 158.87 26.09 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.379 -1.071 . . . . 71.120000000000005 109.194 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 50.0 mmm -106.98 138.76 42.54 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.476 -0.935 . . . . 75.239999999999995 108.476 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.41 160.97 40.16 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.113 -0.992 . . . . 73.25 110.131 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -141.35 156.73 45.8 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.787 -0.82 . . . . 72.310000000000002 108.787 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 p -118.84 139.78 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.392 -0.818 . . . . 72.140000000000001 109.58 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.1 p -133.64 169.99 16.2 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.57 -0.706 . . . . 74.530000000000001 109.396 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -93.13 -99.71 0.13 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.319 -0.863 . . . . 71.019999999999996 109.884 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -78.16 167.7 21.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.195 -0.941 . . . . 71.400000000000006 110.277 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 28.1 mt -56.52 -35.51 68.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.587 -0.695 . . . . 71.239999999999995 110.008 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -54.44 -42.38 70.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.108 -0.995 . . . . 74.319999999999993 109.883 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -66.58 -39.51 88.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.097 -1.002 . . . . 73.030000000000001 109.378 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.61 -40.82 58.53 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.546 -1.422 . . . . 60.43 109.546 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.99 -38.62 91.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.281 -1.129 . . . . 74.430000000000007 109.645 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -74.96 -39.66 61.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 74.420000000000002 109.845 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 21.2 tp -72.02 -49.6 35.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.937 . . . . 75.409999999999997 110.102 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' B' ' 40' ' ' MET . 1.9 ppp? -60.72 -30.42 69.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.138 -0.976 . . . . 61.439999999999998 109.938 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.82 -37.28 70.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.16 -0.963 . . . . 74.319999999999993 110.044 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 14.2 pt -100.62 0.03 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.292 -0.88 . . . . 71.230000000000004 110.351 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' B' ' 40' ' ' MET . 59.1 mmt-85 -130.96 152.8 49.88 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.288 -0.882 . . . . 73.409999999999997 109.875 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -83.94 165.61 18.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.318 -0.864 . . . . 63.539999999999999 109.095 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 1.9 p90 -156.2 102.08 2.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.029 -1.045 . . . . 73.109999999999999 109.881 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -79.18 -32.04 44.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.177 -0.952 . . . . 62.219999999999999 108.585 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.412 ' C ' ' CD1' ' B' ' 47' ' ' LEU . 0.7 OUTLIER -113.75 108.41 17.07 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.612 -0.884 . . . . 73.120000000000005 108.612 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 97.3 t -96.55 105.31 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.276 -0.89 . . . . 74.109999999999999 108.693 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 15.5 ttt -123.02 130.54 52.93 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.491 -0.756 . . . . 73.439999999999998 109.661 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.415 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.4 OUTLIER -145.28 134.03 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.594 -0.691 . . . . 73.400000000000006 109.153 -179.654 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' SER . . . . . 0.417 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 6.4 p -102.06 13.82 33.67 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.551 -0.718 . . . . 73.209999999999994 109.741 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.415 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 66.5 m-20 -76.75 148.1 36.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.145 -0.972 . . . . 70.409999999999997 109.712 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.437 ' C ' ' H ' ' B' ' 55' ' ' ALA . 65.5 mttp -78.05 -42.76 31.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.308 -0.87 . . . . 73.129999999999995 109.906 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -73.51 9.43 1.38 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.199 -0.938 . . . . 75.209999999999994 109.521 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.437 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -59.72 -22.89 62.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.374 -0.828 . . . . 55.329999999999998 109.826 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 56.2 mt -46.0 -34.29 3.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.331 -0.855 . . . . 72.420000000000002 109.933 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 18.5 m -77.1 -46.96 21.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.102 -0.999 . . . . 73.040000000000006 109.499 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -61.86 -53.32 57.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -0.943 . . . . 72.329999999999998 109.519 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.453 ' CG2' ' HZ3' ' B' ' 63' ' ' LYS . 14.1 m -56.25 -39.99 63.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.587 -1.321 . . . . 74.540000000000006 109.17 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' SER . . . . . 0.4 ' N ' ' CG2' ' B' ' 59' ' ' VAL . 28.0 t -51.6 -46.19 63.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.143 -0.973 . . . . 71.239999999999995 109.722 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.442 ' O ' ' N ' ' B' ' 65' ' ' LYS . 13.8 ptp180 -78.32 -34.27 48.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.863 -1.148 . . . . 74.310000000000002 110.566 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' B' ' 66' ' ' HIS . 33.4 mm -63.03 -45.95 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.452 -1.405 . . . . 75.420000000000002 108.464 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.453 ' HZ3' ' CG2' ' B' ' 59' ' ' VAL . 29.5 mttt -61.81 -40.52 95.55 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.624 -0.88 . . . . 73.319999999999993 108.624 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -75.37 -38.13 60.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.61 -0.681 . . . . 73.310000000000002 109.228 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.528 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 25.4 mtpp -83.94 -23.09 31.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.266 -0.896 . . . . 72.439999999999998 110.705 -178.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.528 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 83.4 m-70 -156.75 66.4 0.54 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.903 -1.123 . . . . 65.209999999999994 109.912 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.2 t -59.29 -29.51 67.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.328 -0.857 . . . . 73.099999999999994 109.938 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 86.4 p -65.35 -34.74 79.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.153 -0.967 . . . . 71.530000000000001 110.683 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.4 ' CG2' ' N ' ' B' ' 70' ' ' VAL . 78.3 mt -65.71 160.89 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.912 -1.117 . . . . 74.400000000000006 109.61 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.4 ' N ' ' CG2' ' B' ' 69' ' ' ILE . 97.6 t -85.0 159.23 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.21 -0.931 . . . . 75.120000000000005 110.039 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.524 ' N ' ' OD1' ' B' ' 92' ' ' ASP . 11.0 t -143.48 111.42 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.075 -1.016 . . . . 73.200000000000003 109.316 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.06 99.62 8.68 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.544 -0.91 . . . . 73.340000000000003 108.544 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 79.1 t -95.13 127.83 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.237 -0.915 . . . . 73.5 108.963 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.1 m -103.22 173.52 6.27 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.443 -0.786 . . . . 71.319999999999993 109.666 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.48 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 23.0 t -166.28 122.97 1.32 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.168 -0.957 . . . . 74.530000000000001 110.298 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -62.01 -17.1 56.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.435 -0.79 . . . . 64.5 109.605 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' B' ' 79' ' ' THR . 47.2 t-20 -124.43 82.23 58.59 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.516 -0.74 . . . . 74.25 109.196 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.15 71.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.566 2.177 . . . . 74.430000000000007 112.003 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.517 ' N ' ' O ' ' B' ' 77' ' ' ASN . 17.0 m -88.13 152.27 22.11 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.102 -0.999 . . . . 73.120000000000005 109.418 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -37.86 88.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.892 . . . . 75.409999999999997 109.488 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -55.64 -46.88 77.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.951 . . . . 72.239999999999995 109.63 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . 0.4 ' OE1' ' OG ' ' B' ' 75' ' ' SER . 98.1 mt-10 -71.56 -30.93 66.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.896 . . . . 73.219999999999999 109.658 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' B' ' 84' ' ' VAL . 10.6 tm-20 -70.02 -56.23 7.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 74.299999999999997 109.851 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . 0.513 ' N ' ' OE1' ' B' ' 83' ' ' GLU . 13.1 m -63.27 -44.61 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.135 -0.978 . . . . 73.310000000000002 109.722 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' HIS . . . . . 0.441 ' N ' ' CG2' ' B' ' 84' ' ' VAL . 71.1 t60 -63.19 -40.26 97.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 73.239999999999995 109.456 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.04 -44.26 97.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.904 . . . . 55.329999999999998 109.588 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -74.13 -30.27 62.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.131 -0.981 . . . . 74.450000000000003 108.535 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -57.54 -50.42 73.16 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.681 -0.859 . . . . 64.040000000000006 108.681 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . 0.417 ' NE2' ' CD2' ' B' ' 85' ' ' HIS . 50.8 mt-30 -64.33 -38.31 90.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.62 -0.675 . . . . 75.129999999999995 109.462 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 139.49 10.31 0.82 Allowed Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.344 -1.102 . . . . 75.420000000000002 110.344 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -48.79 122.22 5.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.878 -1.366 . . . . 73.420000000000002 109.233 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' B' ' 71' ' ' VAL . 5.8 m-20 -63.68 -37.39 87.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.116 -0.99 . . . . 73.319999999999993 109.102 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 20.3 t0 -154.79 158.44 39.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.851 . . . . 73.040000000000006 109.751 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.52 ' N ' ' OD1' ' B' ' 93' ' ' ASP . 42.4 t80 -130.26 116.97 19.13 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.158 -1.053 . . . . 74.310000000000002 108.158 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.579 ' H ' ' CD1' ' B' ' 95' ' ' ILE . 0.0 OUTLIER -119.42 156.75 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.503 0 CA-C-O 121.919 0.866 . . . . 75.340000000000003 110.797 -177.72 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.42 134.06 42.4 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.435 -1.32 . . . . 70.099999999999994 107.435 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.675 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -55.04 -55.57 37.61 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 120.773 -1.204 . . . . 65.430000000000007 111.791 -178.462 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 1.4 Cg_endo -39.44 -12.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 121.144 1.23 . . . . 63.520000000000003 113.213 -176.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . 0.675 ' N ' ' O ' ' B' ' 97' ' ' LYS . 53.3 m-85 56.5 104.13 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.508 -0.745 . . . . 75.129999999999995 109.728 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -55.24 -42.31 73.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.949 -1.095 . . . . 74.230000000000004 108.673 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 12.2 t -168.2 151.18 5.6 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.465 -0.772 . . . . 64.510000000000005 109.039 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 20.7 mm -55.52 -45.14 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.986 . . . . 74.439999999999998 109.362 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -68.91 -7.54 35.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 72.299999999999997 109.605 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.69 -77.99 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.073 -1.017 . . . . 74.310000000000002 109.786 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.414 ' CD2' ' H ' ' B' ' 105' ' ' LEU . 2.2 pt? -62.32 -36.67 82.89 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.066 -1.021 . . . . 73.540000000000006 110.092 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 80.7 t -60.36 -44.97 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.9 -1.125 . . . . 72.030000000000001 109.187 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.18 -33.49 72.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.173 -0.954 . . . . 64.219999999999999 108.751 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 0.521 ' NH2' ' CG2' ' B' ' 95' ' ' ILE . 78.6 mtm180 -80.27 -24.97 39.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.43 -0.793 . . . . 75.310000000000002 109.872 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 67.0 mt -79.48 -47.01 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.022 -1.049 . . . . 55.439999999999998 108.649 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.68 -39.87 94.42 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.584 -0.847 . . . . 65.310000000000002 109.146 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.91 -35.96 82.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.345 -0.847 . . . . 74.519999999999996 109.217 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -61.94 -39.19 91.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.324 -0.86 . . . . 72.040000000000006 109.765 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.65 67.57 1.25 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.157 -0.965 . . . . 75.349999999999994 109.529 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.483 ' O ' ' CG ' ' B' ' 115' ' ' PHE . 50.2 mtp180 -57.28 -32.86 67.06 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.14 -0.975 . . . . 75.5 109.341 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' PHE . . . . . 0.483 ' CG ' ' O ' ' B' ' 114' ' ' ARG . 87.8 m-85 -157.67 91.14 1.12 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 73.040000000000006 109.515 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' TRP . . . . . 0.519 ' NE1' ' OE2' ' B' ' 141' ' ' GLU . 5.3 m-90 52.21 11.25 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 74.450000000000003 109.69 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' B' ' 115' ' ' PHE . . . 70.03 -112.4 4.37 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.849 -1.3 . . . . 64.209999999999994 109.849 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 84.4 p -150.62 -172.59 4.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.286 -1.126 . . . . 71.400000000000006 109.843 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.23 130.69 13.85 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.938 -0.705 . . . . 74.209999999999994 109.195 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 5.5 t -80.65 -42.72 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 75.019999999999996 110.117 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . 0.424 HG21 HD13 ' B' ' 121' ' ' ILE . 27.7 mm -112.67 121.41 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.442 -0.786 . . . . 74.239999999999995 109.234 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -154.65 138.84 16.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.251 -0.905 . . . . 73.329999999999998 109.392 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 0.551 ' N ' ' CD1' ' B' ' 123' ' ' ILE . 0.1 OUTLIER -147.08 157.1 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.267 -0.896 . . . . 74.219999999999999 109.492 179.721 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.85 -131.79 12.47 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.601 -1.4 . . . . 72.409999999999997 109.601 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -99.82 0.73 42.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.311 -1.111 . . . . 75.120000000000005 109.522 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.23 145.57 24.55 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.136 -0.977 . . . . 75.420000000000002 108.527 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 28.8 m -129.21 136.63 50.37 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.548 -0.72 . . . . 74.219999999999999 109.245 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' B' ' 121' ' ' ILE . 39.8 mt -136.02 136.34 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.398 -0.814 . . . . 60.329999999999998 109.645 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 7.3 m -127.58 80.27 72.15 Favored Pre-proline 0 N--CA 1.499 2.017 0 N-CA-C 109.15 -0.685 . . . . 72.310000000000002 109.15 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.41 -55.38 3.66 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.815 2.343 . . . . 75.129999999999995 112.612 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -51.82 -40.05 59.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -0.93 . . . . 75.230000000000004 109.627 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -84.6 0.17 51.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.203 -0.936 . . . . 75.120000000000005 109.461 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 52.39 60.32 3.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 75.129999999999995 109.618 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -151.34 130.43 12.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.867 . . . . 75.109999999999999 109.121 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 59.8 mt -118.1 133.81 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.547 -0.721 . . . . 70.319999999999993 109.528 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 70.5 mt -124.43 123.11 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 109.074 -0.713 . . . . 74.120000000000005 109.074 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -137.54 141.42 41.4 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.427 -0.796 . . . . 74.230000000000004 109.522 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . 0.518 ' NZ ' ' O ' ' B' ' 198' ' ' PRO . 50.7 mttp 54.45 26.19 6.88 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.565 -0.709 . . . . 74.219999999999999 110.085 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.88 -0.67 77.25 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.186 -1.166 . . . . 74.319999999999993 110.186 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -89.95 131.27 35.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.127 -1.219 . . . . 75.340000000000003 109.158 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 141' ' ' GLU . . . . . 0.519 ' OE2' ' NE1' ' B' ' 116' ' ' TRP . 95.5 mt-10 -97.1 125.11 41.35 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.331 -0.856 . . . . 71.230000000000004 109.472 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 96.0 t -137.49 135.1 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.387 -0.821 . . . . 70.430000000000007 109.199 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -88.93 151.07 22.54 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.325 -0.86 . . . . 72.430000000000007 109.389 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 22.2 m -90.85 137.77 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.177 -0.952 . . . . 72.129999999999995 109.792 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -171.19 56.05 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.337 -0.852 . . . . 74.5 109.511 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 178.65 176.82 46.83 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.869 -1.292 . . . . 42.229999999999997 109.869 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 15.2 mttt -70.65 -38.86 8.39 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.362 -1.081 . . . . 73.299999999999997 110.112 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 32.8 Cg_exo -57.73 -37.73 95.58 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.194 1.929 . . . . 71.329999999999998 111.83 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -87.99 -20.7 25.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.431 -0.793 . . . . 74.230000000000004 109.253 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -66.55 -41.77 88.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.302 -0.874 . . . . 72.340000000000003 109.639 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p -73.31 -32.6 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.187 -0.945 . . . . 73.349999999999994 109.58 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 23.1 tp -66.55 -43.42 85.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.209 -0.932 . . . . 74.430000000000007 109.952 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 25.8 m -72.53 -35.24 68.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.963 -1.086 . . . . 75.209999999999994 109.758 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . 0.551 ' CE1' ' NH2' ' B' ' 157' ' ' ARG . 1.6 m-70 -62.96 -48.84 77.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 73.040000000000006 110.259 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.0 pp -69.54 -27.09 64.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.811 -1.181 . . . . 73.430000000000007 109.294 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.62 -49.9 75.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.956 . . . . 75.319999999999993 109.499 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.551 ' NH2' ' CE1' ' B' ' 154' ' ' HIS . 21.6 ptt180 -74.86 -36.11 62.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.242 -0.911 . . . . 73.319999999999993 109.934 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -87.98 18.2 4.39 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.08 -1.012 . . . . 74.140000000000001 109.776 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -62.04 161.25 11.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.139 -0.976 . . . . 73.420000000000002 109.266 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . 0.473 ' OD2' ' NE2' ' A' ' 161' ' ' GLN . 37.4 t0 59.73 49.47 8.11 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.329 -0.857 . . . . 72.099999999999994 109.585 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -157.66 145.21 18.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 73.239999999999995 109.292 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 94.9 mt -85.91 128.03 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -0.943 . . . . 72.310000000000002 109.192 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 5.3 m -132.24 139.35 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.456 -0.778 . . . . 75.030000000000001 109.585 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 58.4 p -86.45 172.14 10.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.223 -0.923 . . . . 74.219999999999999 109.302 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -59.58 -39.8 85.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.945 . . . . 72.420000000000002 109.59 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -57.29 -32.46 66.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 63.450000000000003 109.798 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -60.04 -48.7 80.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.96 . . . . 72.400000000000006 109.873 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 37.6 mt -62.37 -32.96 73.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.086 -1.009 . . . . 72.319999999999993 109.101 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 6.3 tt -57.18 -64.98 0.7 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.347 -0.846 . . . . 73.340000000000003 109.542 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -64.82 -31.81 73.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.229 -0.919 . . . . 73.099999999999994 110.143 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -48.39 -58.99 3.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.124 -0.985 . . . . 62.130000000000003 110.062 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.474 ' N ' ' CD1' ' B' ' 172' ' ' ILE . 2.1 mp -92.82 -59.14 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.056 -1.028 . . . . 74.439999999999998 109.318 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 11.2 m-90 -78.5 66.4 4.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 72.230000000000004 109.62 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -83.61 -33.85 25.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.21 -0.931 . . . . 75.030000000000001 109.966 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -76.15 149.92 82.63 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.031 -1.043 . . . . 73.040000000000006 109.743 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -42.7 120.17 1.7 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.11 1.874 . . . . 74.129999999999995 112.364 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -145.23 -5.26 0.68 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.125 -0.984 . . . . 72.439999999999998 109.392 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 66.0 mtt 49.93 57.14 6.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.159 -0.963 . . . . 72.109999999999999 109.576 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 3.7 m -92.72 144.42 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.228 -0.92 . . . . 75.310000000000002 109.711 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 180' ' ' THR . . . . . 0.447 ' O ' ' N ' ' B' ' 182' ' ' ASN . 75.0 p -86.23 117.75 69.23 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.367 -0.833 . . . . 62.149999999999999 108.828 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -41.08 -22.93 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.778 1.652 . . . . 74.340000000000003 112.392 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 182' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' B' ' 180' ' ' THR . 43.5 t-20 -69.21 -29.8 67.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 72.310000000000002 109.614 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 6.0 p -59.55 -27.61 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.287 -0.883 . . . . 65.420000000000002 110.014 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 35.2 mm -56.27 -25.87 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.179 -0.951 . . . . 75.030000000000001 109.688 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -58.69 -48.5 80.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 73.519999999999996 109.827 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 16.1 m -77.22 -26.42 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.102 -0.999 . . . . 74.349999999999994 109.865 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.26 -49.01 38.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.03 -1.044 . . . . 61.119999999999997 109.822 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 19.6 tt -66.87 -33.5 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.175 -0.953 . . . . 72.430000000000007 110.015 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -73.62 -40.62 63.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.112 -0.993 . . . . 75.420000000000002 111.163 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -78.17 -37.94 44.63 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.784 -1.198 . . . . 74.140000000000001 111.194 -178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 2.4 pp -69.7 -41.85 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.741 -1.224 . . . . 74.030000000000001 110.138 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -69.64 -39.02 77.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.872 -1.142 . . . . 72.329999999999998 109.661 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -67.64 -40.04 84.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.246 -0.909 . . . . 73.099999999999994 110.586 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . 0.468 ' O ' ' CD ' ' B' ' 198' ' ' PRO . 13.1 pttp -80.22 -13.43 59.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.964 -1.085 . . . . 74.430000000000007 110.074 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 51.5 ttm -91.87 -30.26 16.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.199 -0.938 . . . . 74.329999999999998 109.771 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 196' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' B' ' 200' ' ' GLY . 95.8 m-20 -68.7 -41.6 78.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 71.209999999999994 110.266 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . 0.401 ' N ' ' HD2' ' B' ' 198' ' ' PRO . 12.1 tmtt? -60.66 -55.41 45.2 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.042 -1.036 . . . . 75.209999999999994 110.806 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 198' ' ' PRO . . . . . 0.518 ' O ' ' NZ ' ' B' ' 138' ' ' LYS . 29.3 Cg_endo -60.78 -54.95 1.6 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.371 1.381 . . . . 75.319999999999993 111.829 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . 0.403 ' O ' ' NZ ' ' B' ' 138' ' ' LYS . 4.4 mm? -66.56 -45.67 78.6 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.084 -1.01 . . . . 72.25 108.878 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' B' ' 196' ' ' ASP . . . 87.13 -31.58 4.35 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.688 -1.365 . . . . 73.239999999999995 109.688 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . 0.512 ' N ' ' CD1' ' B' ' 201' ' ' ILE . 2.0 mp -92.21 138.34 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.245 -1.15 . . . . 54.299999999999997 109.087 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 29.2 t -87.51 139.78 30.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.284 -0.885 . . . . 74.310000000000002 109.271 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 10.2 p -144.84 22.17 1.6 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.212 -0.93 . . . . 74.400000000000006 109.687 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.11 143.1 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.247 -0.908 . . . . 74.099999999999994 109.663 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -126.35 135.42 51.46 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.569 -0.707 . . . . 75.329999999999998 109.124 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.6 138.0 35.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.322 -0.861 . . . . 71.400000000000006 109.304 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -148.69 141.78 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -0.954 . . . . 63.5 109.442 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -66.86 -41.41 87.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.916 . . . . 74.450000000000003 109.435 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' B' ' 211' ' ' GLY . 49.2 mtp85 -60.46 147.68 40.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.914 . . . . 74.140000000000001 109.553 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 49.87 -89.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.351 -0.843 . . . . 74.430000000000007 109.841 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' B' ' 209' ' ' ARG . . . -170.95 -100.82 0.14 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.776 -1.33 . . . . 70.109999999999999 109.776 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 212' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' B' ' 212' ' ' TYR . 25.5 m-85 -130.15 153.53 48.43 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.548 -0.972 . . . . 74.209999999999994 108.855 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 5.2 ptm85 -127.43 149.93 49.87 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.383 -0.823 . . . . 74.299999999999997 109.81 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -117.97 131.13 56.53 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.908 -0.775 . . . . 74.340000000000003 108.908 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 29.0 p -160.11 164.0 33.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.064 -1.023 . . . . 72.209999999999994 109.849 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -61.83 152.5 75.96 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.381 -0.825 . . . . 72.310000000000002 108.931 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -68.16 -156.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.151 1.901 . . . . 71.010000000000005 111.482 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' B' ' 220' ' ' ALA . 51.2 mtpt -44.94 153.05 0.52 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.262 -0.899 . . . . 74.349999999999994 109.414 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -34.03 -26.45 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.831 2.354 . . . . 71.319999999999993 113.04 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' B' ' 218' ' ' LYS . . . 50.98 -165.18 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.057 -1.027 . . . . 75.450000000000003 109.456 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 23.9 p -71.96 8.75 1.12 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 72.219999999999999 109.565 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' B' ' 220' ' ' ALA . 77.1 mm-40 47.41 39.11 8.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.165 -0.959 . . . . 74.299999999999997 109.572 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.051 -0.976 . . . . 71.129999999999995 109.541 -179.873 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 ttm . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.38 -0.6 . . . . 65.120000000000005 109.38 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -137.78 154.95 49.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.392 -0.818 . . . . 73.310000000000002 109.394 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 83.6 t -119.79 125.96 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.547 0.689 . . . . 71.420000000000002 109.79 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.3 tp -94.42 115.94 28.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.371 -0.974 . . . . 65.219999999999999 108.371 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.95 110.59 17.91 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.562 -0.903 . . . . 71.439999999999998 108.562 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.43 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 12.3 mt -94.41 105.26 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 120.791 -1.193 . . . . 71.150000000000006 109.507 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -139.52 124.72 18.92 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.241 -0.912 . . . . 75.340000000000003 109.259 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -71.83 -32.37 67.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 73.040000000000006 109.505 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -83.42 113.44 20.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.915 . . . . 72.420000000000002 109.462 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.2 p -68.07 -25.34 65.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 72.340000000000003 109.522 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.5 t -67.99 -53.59 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -0.925 . . . . 74.420000000000002 109.609 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.62 -38.85 84.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 72.010000000000005 108.951 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.51 -25.8 75.14 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 108.436 -1.866 . . . . 72.140000000000001 108.436 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.51 -58.05 10.13 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.477 -1.449 . . . . 72.329999999999998 109.477 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -53.26 -46.78 69.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.411 -1.053 . . . . 72.340000000000003 109.676 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 86.0 mt -64.52 -50.93 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.866 -1.146 . . . . 74.239999999999995 108.96 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -49.2 -52.91 23.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 71.409999999999997 109.708 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.405 ' CD ' ' N ' ' A' ' 18' ' ' LYS . 0.7 OUTLIER -83.51 2.44 36.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.139 -0.976 . . . . 75.540000000000006 109.444 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.23 -60.98 1.95 Allowed Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.909 -1.276 . . . . 62.149999999999999 109.909 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -72.66 -19.37 61.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -1.161 . . . . 74.420000000000002 110.034 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -56.87 -31.64 65.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.972 -1.08 . . . . 74.25 109.468 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.2 t -60.68 -28.92 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 72.109999999999999 109.327 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.422 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 11.5 mptt -76.55 -1.21 26.29 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.262 -0.899 . . . . 73.230000000000004 109.28 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.0 36.56 8.97 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.156 -1.177 . . . . 75.540000000000006 110.156 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -119.51 157.51 28.17 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.497 -1.002 . . . . 74.510000000000005 109.326 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.3 mmt -108.12 138.62 44.08 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.522 -0.918 . . . . 64.319999999999993 108.522 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.54 159.29 43.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.134 -0.979 . . . . 74.310000000000002 110.13 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -136.68 155.44 49.87 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.507 -0.746 . . . . 75.400000000000006 109.0 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.55 136.68 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.372 -0.83 . . . . 75.129999999999995 109.099 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.8 p -133.25 164.94 25.94 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.385 -0.822 . . . . 71.420000000000002 109.313 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.43 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 4.9 pt-20 -90.59 -105.73 0.1 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.259 -0.901 . . . . 73.109999999999999 109.853 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.5 p -78.23 170.63 16.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 74.239999999999995 109.961 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.9 mt -55.97 -30.87 62.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.564 -0.71 . . . . 71.530000000000001 109.794 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -50.41 -46.25 56.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 74.230000000000004 109.584 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.06 -39.41 90.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 71.010000000000005 109.418 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.34 -44.31 34.83 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.572 -1.411 . . . . 61.409999999999997 109.572 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -63.02 -37.29 86.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -1.139 . . . . 74.340000000000003 109.457 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -81.22 -38.09 27.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 75.329999999999998 109.655 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.4 tp -68.71 -46.65 68.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.31 -0.869 . . . . 74.329999999999998 109.937 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 41' ' ' ASP . 3.5 ppp? -63.09 -25.56 68.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.129 -0.982 . . . . 70.319999999999993 109.793 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 40' ' ' MET . 97.5 m-20 -66.51 -41.14 89.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.082 -1.011 . . . . 71.219999999999999 109.973 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.1 pt -82.82 -27.84 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.115 -0.991 . . . . 74.409999999999997 110.16 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 40' ' ' MET . 88.7 mtt-85 -129.74 144.46 51.3 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.336 -0.853 . . . . 75.409999999999997 109.449 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -91.51 154.13 19.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.239 -0.913 . . . . 75.420000000000002 109.521 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -134.76 157.6 46.32 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.491 -0.756 . . . . 74.230000000000004 109.176 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -102.7 -42.56 5.85 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.387 -0.821 . . . . 75.319999999999993 109.464 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.36 109.7 21.65 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.514 -0.741 . . . . 72.129999999999995 109.224 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.7 t -94.09 99.86 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.202 -0.937 . . . . 72.340000000000003 108.834 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.515 ' SD ' ' O ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -114.1 129.1 56.63 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.154 -0.684 . . . . 74.109999999999999 109.154 -179.603 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.3 p -134.64 133.13 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.536 -0.728 . . . . 71.239999999999995 109.89 -179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.5 p -96.83 1.41 50.64 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.543 -0.723 . . . . 73.109999999999999 109.435 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -76.19 141.51 41.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.198 -0.939 . . . . 63.399999999999999 109.416 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.508 ' C ' ' H ' ' A' ' 55' ' ' ALA . 0.7 OUTLIER -79.75 -38.58 32.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 65.439999999999998 110.204 -179.479 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -71.18 10.5 0.56 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.035 -1.04 . . . . 73.129999999999995 109.364 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -72.39 -20.51 61.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -0.831 . . . . 64.140000000000001 110.298 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 55' ' ' ALA . 68.7 mt -41.18 -47.65 3.32 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.509 -0.744 . . . . 74.430000000000007 110.296 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 60' ' ' SER . 23.2 m -70.28 -35.21 73.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.931 -1.105 . . . . 63.229999999999997 108.97 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.419 ' N ' ' O ' ' A' ' 55' ' ' ALA . 67.7 t80 -66.36 -59.26 3.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.392 -0.817 . . . . 74.439999999999998 109.849 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.4 m -52.36 -34.14 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.696 -1.253 . . . . 74.030000000000001 109.345 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 57' ' ' SER . 14.9 p -57.79 -51.83 67.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 73.540000000000006 109.732 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -69.32 -28.92 66.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.02 . . . . 73.340000000000003 109.983 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' A' ' 66' ' ' HIS . 7.6 mm -67.08 -24.08 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.88 -1.138 . . . . 73.349999999999994 109.835 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -86.15 -53.33 5.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.034 -1.041 . . . . 74.420000000000002 110.562 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.443 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 14.9 pt-20 -63.78 -43.14 97.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.9 -1.125 . . . . 74.549999999999997 110.128 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.443 ' N ' ' CG ' ' A' ' 64' ' ' GLU . 78.2 mttt -79.02 -61.0 2.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 75.219999999999999 109.092 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.535 ' H ' ' HD1' ' A' ' 66' ' ' HIS . 0.2 OUTLIER -97.18 80.23 2.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.326 -0.859 . . . . 74.129999999999995 108.876 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.9 m -79.02 -25.9 43.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.015 -1.053 . . . . 73.239999999999995 110.22 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.3 t -82.55 51.77 1.93 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.114 -0.991 . . . . 71.439999999999998 110.208 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 15.3 tt -156.98 160.94 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.938 -1.101 . . . . 71.329999999999998 109.945 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.6 t -95.8 160.15 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.178 -0.951 . . . . 73.019999999999996 109.135 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 t -146.16 121.24 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.955 -1.091 . . . . 54.210000000000001 109.942 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.515 ' O ' ' SD ' ' A' ' 49' ' ' MET . 3.5 mp -119.83 103.41 9.32 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.116 -1.068 . . . . 74.209999999999994 108.116 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.9 p -95.8 146.27 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.487 -0.931 . . . . 74.409999999999997 108.487 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.454 ' O ' ' OG ' ' A' ' 75' ' ' SER . 0.5 OUTLIER -118.44 165.87 13.36 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.468 -0.77 . . . . 72.310000000000002 109.226 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 74' ' ' SER . 3.1 m -168.3 124.08 1.0 Allowed 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 119.393 -0.923 . . . . 64.540000000000006 110.242 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.52 1.45 1.19 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.552 -0.718 . . . . 74.129999999999995 109.809 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.439 ' H ' ' C ' ' A' ' 75' ' ' SER . 33.8 m120 -120.64 62.87 10.1 Favored Pre-proline 0 N--CA 1.501 2.101 0 O-C-N 121.396 -0.815 . . . . 73.340000000000003 110.198 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -62.99 77.9 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.157 1.905 . . . . 71.319999999999993 111.789 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.517 ' HG1' ' H ' ' A' ' 82' ' ' GLU . 77.9 p -104.36 151.72 23.13 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.566 -0.901 . . . . 62.530000000000001 108.566 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -31.9 66.8 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.243 -0.911 . . . . 74.140000000000001 109.309 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.511 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 78.0 mm-40 -66.29 -36.21 82.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.15 -0.969 . . . . 71.420000000000002 109.22 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.517 ' H ' ' HG1' ' A' ' 79' ' ' THR . 38.1 tp10 -71.17 -35.48 71.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.331 -0.856 . . . . 73.430000000000007 109.621 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.77 -52.57 64.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 74.219999999999999 109.689 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.6 m -60.52 -36.0 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.187 -0.946 . . . . 74.150000000000006 109.258 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' A' ' 81' ' ' GLU . 27.9 m80 -71.77 -31.15 66.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.274 -0.891 . . . . 72.540000000000006 109.561 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.17 -40.1 93.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 64.219999999999999 110.177 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -83.36 -37.64 23.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.954 -1.092 . . . . 74.340000000000003 109.32 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -68.21 -42.91 79.13 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.242 -0.911 . . . . 74.420000000000002 109.493 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -66.81 -49.95 64.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -0.996 . . . . 74.519999999999996 109.369 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 143.73 72.41 0.02 OUTLIER Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.017 -1.233 . . . . 74.209999999999994 110.017 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -138.25 124.16 20.04 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.242 -1.152 . . . . 64.099999999999994 109.201 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 13.9 t70 -61.13 -41.72 97.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 73.420000000000002 109.336 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 66.8 m-20 -152.05 159.34 43.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.325 -0.859 . . . . 75.040000000000006 109.337 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -124.14 131.71 53.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.605 -0.685 . . . . 71.329999999999998 109.449 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.5 mt -123.41 140.62 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-O 122.084 0.945 . . . . 74.510000000000005 110.381 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.0 121.49 13.12 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.901 -1.148 . . . . 64.319999999999993 107.901 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.694 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -45.46 -54.59 14.53 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.128 -0.983 . . . . 74.510000000000005 111.428 -178.756 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 2.5 Cg_endo -40.47 -9.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 121.08 1.187 . . . . 73.109999999999999 113.289 -176.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.694 ' N ' ' O ' ' A' ' 97' ' ' LYS . 67.5 m-85 58.6 99.39 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.514 -0.741 . . . . 72.540000000000006 109.007 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.4 ttm-85 -53.05 -41.62 64.98 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.169 -0.957 . . . . 74.540000000000006 109.37 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.822 ' O ' ' N ' ' A' ' 103' ' ' LYS . 23.1 t -172.86 36.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.982 -1.074 . . . . 74.140000000000001 110.929 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.41 HD13 HG22 ' A' ' 102' ' ' ILE . 96.6 mt 44.97 -68.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-N 118.693 0.679 . . . . 75.430000000000007 110.792 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.822 ' N ' ' O ' ' A' ' 101' ' ' SER . 21.3 tptm -49.22 -36.26 19.55 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.01 -1.056 . . . . 74.140000000000001 108.295 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.94 -40.91 83.22 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.189 -1.041 . . . . 63.240000000000002 108.189 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.8 -38.17 88.25 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.835 -0.802 . . . . 73.219999999999999 108.835 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.23 -42.13 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 74.540000000000006 109.353 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.44 -41.17 63.04 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.216 -0.927 . . . . 75.5 108.786 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.525 ' NE ' ' OE2' ' B' ' 83' ' ' GLU . 98.7 mtt180 -68.66 -37.84 79.96 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.35 -0.844 . . . . 74.409999999999997 109.282 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.62 -30.84 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.041 -1.037 . . . . 73.239999999999995 108.314 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -63.24 -54.81 31.55 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.777 -0.823 . . . . 74.340000000000003 108.777 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.11 -35.87 60.13 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.402 -0.811 . . . . 73.319999999999993 109.396 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -57.76 -48.95 78.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.216 -0.927 . . . . 74.420000000000002 109.25 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 78.6 mt -144.53 97.73 3.08 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.137 -0.977 . . . . 74.329999999999998 109.496 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.403 ' O ' ' CG ' ' A' ' 115' ' ' PHE . 42.0 mtp180 -85.12 -59.02 2.45 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.205 -0.935 . . . . 74.439999999999998 108.999 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.403 ' CG ' ' O ' ' A' ' 114' ' ' ARG . 56.9 m-85 -156.55 89.27 1.1 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.256 -0.902 . . . . 74.430000000000007 109.542 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.474 ' CD1' ' N ' ' A' ' 116' ' ' TRP . 7.8 p-90 -93.17 133.5 36.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.237 -0.915 . . . . 74.439999999999998 109.078 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 178.42 98.35 0.11 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.586 -1.406 . . . . 75.040000000000006 109.586 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.832 ' HB3' ' OE2' ' A' ' 132' ' ' GLU . 31.0 t -159.61 176.97 11.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -1.113 . . . . 70.109999999999999 109.495 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -158.12 120.02 3.63 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.841 -0.8 . . . . 65.239999999999995 108.841 -178.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.8 t -83.62 -25.93 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.073 -1.017 . . . . 74.219999999999999 109.056 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.432 HG23 HD13 ' A' ' 121' ' ' ILE . 28.2 mm -111.33 121.08 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.622 -0.881 . . . . 74.420000000000002 108.622 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -127.33 109.91 12.27 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.518 -0.738 . . . . 73.299999999999997 109.446 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.412 ' O ' ' C ' ' A' ' 124' ' ' GLY . 94.4 mt -112.67 124.64 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.63 -0.878 . . . . 75.340000000000003 108.63 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 123' ' ' ILE . . . -34.16 -44.22 0.37 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 112.109 -0.397 . . . . 75.129999999999995 112.109 -178.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -63.7 -56.38 16.14 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.987 -1.302 . . . . 74.450000000000003 109.94 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.408 ' H ' HD21 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -144.12 166.44 25.01 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.113 -0.992 . . . . 54.210000000000001 110.083 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.4 m -106.49 145.07 32.27 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.229 -0.919 . . . . 70.239999999999995 109.894 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.9 mt -137.24 134.62 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.165 -0.959 . . . . 72.430000000000007 109.76 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.7 t -121.53 113.42 32.07 Favored Pre-proline 0 N--CA 1.499 1.994 0 N-CA-C 109.24 -0.652 . . . . 71.109999999999999 109.24 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -81.05 -54.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.719 1.613 . . . . 75.140000000000001 112.109 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -55.57 -42.48 74.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 72.5 109.147 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.832 ' OE2' ' HB3' ' A' ' 118' ' ' SER . 72.1 mt-10 -82.56 -4.19 57.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.288 -0.883 . . . . 73.140000000000001 109.201 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 47.51 66.35 1.04 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.334 -0.854 . . . . 75.329999999999998 109.797 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -159.58 142.76 14.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.063 -1.023 . . . . 71.230000000000004 109.783 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.0 tt -126.94 138.36 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.468 -0.77 . . . . 75.329999999999998 109.897 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.1 mm -118.03 121.77 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.728 -0.842 . . . . 71.109999999999999 108.728 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -140.29 146.01 38.0 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.102 -0.998 . . . . 74.140000000000001 110.014 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 83.0 mttt 53.87 26.72 6.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.481 -0.762 . . . . 75.400000000000006 110.215 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.18 9.08 87.24 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 120.122 -1.037 . . . . 72.239999999999995 110.857 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 43.7 mtp180 -103.11 142.89 33.35 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.194 -1.18 . . . . 73.120000000000005 109.259 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -110.74 121.96 46.63 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.899 -0.778 . . . . 72.319999999999993 108.899 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.5 143.95 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 120.924 -1.11 . . . . 62.340000000000003 110.698 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.485 ' H ' ' CD ' ' A' ' 143' ' ' GLU . 2.1 pm0 -93.65 134.63 35.75 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.398 -1.334 . . . . 61.229999999999997 107.398 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.1 136.65 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 120.936 -1.103 . . . . 74.439999999999998 110.514 -178.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.13 104.11 0.99 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.643 -0.66 . . . . 75.420000000000002 109.498 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -166.88 -147.49 5.26 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.748 -1.341 . . . . 73.340000000000003 109.748 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.4 mttt -92.71 -59.72 0.21 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.212 -1.17 . . . . 72.219999999999999 110.691 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.751 ' HG2' ' CE1' ' A' ' 149' ' ' PHE . 21.7 Cg_endo -57.94 -15.18 21.07 Favored 'Trans proline' 0 N--CA 1.5 1.898 0 C-N-CA 121.913 1.742 . . . . 75.450000000000003 111.937 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.751 ' CE1' ' HG2' ' A' ' 148' ' ' PRO . 4.1 m-85 -98.8 -22.87 15.62 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.175 -0.953 . . . . 65.239999999999995 110.196 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -59.61 -35.63 74.71 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.77 -1.206 . . . . 72.519999999999996 108.848 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.3 p -70.45 -27.86 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.238 -0.914 . . . . 74.209999999999994 108.619 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 56.9 tp -64.48 -49.55 70.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.343 -0.848 . . . . 73.310000000000002 109.585 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.46 -33.46 74.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.816 -1.177 . . . . 74.310000000000002 108.691 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -54.24 -54.83 34.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.439 -0.788 . . . . 75.450000000000003 110.199 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.4 pp -75.26 -23.19 57.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.104 -0.998 . . . . 75.340000000000003 109.758 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.13 -38.44 68.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.159 -0.963 . . . . 62.140000000000001 108.753 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.504 ' C ' ' H ' ' A' ' 159' ' ' ARG . 45.1 mtp180 -86.8 -56.08 3.56 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.285 -1.005 . . . . 72.219999999999999 108.285 178.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.437 ' N ' ' CD2' ' A' ' 158' ' ' HIS . 8.0 m170 -68.92 47.77 0.06 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.573 -0.899 . . . . 74.120000000000005 108.573 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.504 ' H ' ' C ' ' A' ' 157' ' ' ARG . 63.9 mtm180 -53.4 -60.04 3.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.609 -0.682 . . . . 74.340000000000003 110.271 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -95.6 94.19 7.6 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.165 -0.96 . . . . 75.450000000000003 109.283 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . 1.362 ' NE2' ' O ' ' A' ' 162' ' ' ILE . 21.9 tm0? -170.16 142.85 2.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.025 -1.047 . . . . 73.409999999999997 109.938 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 1.362 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 2.0 mp -87.74 139.51 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.258 -1.016 . . . . 74.409999999999997 108.258 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.645 HG13 ' OE1' ' A' ' 161' ' ' GLN . 17.6 m -126.82 150.94 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.463 -0.773 . . . . 72.530000000000001 109.893 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 7.2 t -99.78 158.23 15.94 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.499 -0.751 . . . . 74.120000000000005 109.218 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.681 ' HZ2' ' HH ' ' A' ' 212' ' ' TYR . 65.3 mttm -55.67 -54.07 48.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.344 -0.847 . . . . 70.430000000000007 110.01 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -63.11 -27.97 69.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 74.319999999999993 110.343 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.441 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 46.1 tt0 -62.05 -54.37 42.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.005 -1.06 . . . . 74.519999999999996 110.08 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 48.9 mt -59.33 -44.78 92.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.884 -1.135 . . . . 74.409999999999997 109.36 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 173' ' ' TRP . 4.2 mm? -62.24 -53.04 60.96 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.147 -0.971 . . . . 75.140000000000001 109.731 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 167' ' ' GLN . 14.2 p30 -71.1 -4.93 27.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.016 -1.053 . . . . 65.030000000000001 110.174 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -83.15 -59.01 2.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.06 -1.025 . . . . 70.209999999999994 109.927 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.533 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 1.9 mp -85.59 -43.66 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.935 -1.103 . . . . 75.319999999999993 109.291 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . 0.458 ' O ' ' O ' ' A' ' 169' ' ' LEU . 23.5 m-90 -106.49 115.46 30.24 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.442 -0.786 . . . . 73.140000000000001 109.755 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -144.23 19.65 1.74 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.882 -1.137 . . . . 73.239999999999995 109.209 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.548 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 0.9 OUTLIER -172.74 -44.63 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 63.329999999999998 109.623 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 37.0 Cg_exo -60.66 -60.72 0.23 Allowed 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.091 1.861 . . . . 72.510000000000005 111.747 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.534 ' C ' ' H ' ' A' ' 179' ' ' VAL . 61.0 mm-40 -86.24 152.95 22.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.203 -0.936 . . . . 75.340000000000003 109.281 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.539 ' O ' ' N ' ' A' ' 180' ' ' THR . 32.0 ttm -60.81 -1.24 0.38 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.936 . . . . 74.510000000000005 108.922 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.534 ' H ' ' C ' ' A' ' 177' ' ' GLU . 0.3 OUTLIER 38.17 23.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.412 0.625 . . . . 65.219999999999999 110.763 179.616 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 178' ' ' MET . 60.0 m -47.59 135.63 10.15 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.01 -1.056 . . . . 73.219999999999999 108.843 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.01 72.54 1.56 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.637 1.558 . . . . 62.43 111.723 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.428 ' N ' ' OD1' ' A' ' 182' ' ' ASN . 25.1 p-10 -168.36 -26.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.312 -0.868 . . . . 73.129999999999995 109.527 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.0 m -76.88 -0.53 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 74.019999999999996 109.415 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 50.6 mt -51.23 -46.85 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 72.329999999999998 109.546 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -56.0 -30.85 62.44 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.401 -0.812 . . . . 74.400000000000006 110.17 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 18.0 t -75.13 -53.18 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.041 -1.037 . . . . 74.319999999999993 110.735 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.8 -44.5 93.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.034 -1.041 . . . . 73.230000000000004 110.697 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 8.1 tp -69.84 -37.91 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.112 -0.993 . . . . 74.310000000000002 110.418 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -70.73 -48.61 53.61 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.111 -0.993 . . . . 73.439999999999998 110.738 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . 0.449 ' CG ' ' N ' ' A' ' 191' ' ' ILE . 7.1 pt20 -64.44 -45.59 86.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.909 -1.119 . . . . 71.420000000000002 110.145 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.449 ' N ' ' CG ' ' A' ' 190' ' ' GLN . 89.6 mt -59.53 -46.68 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.05 -1.031 . . . . 72.439999999999998 109.711 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 19.5 mtp-105 -60.01 -45.08 93.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.025 -1.047 . . . . 64.219999999999999 109.606 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -65.85 -29.29 69.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 74.319999999999993 109.589 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -93.88 -1.46 54.77 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.244 -0.91 . . . . 75.310000000000002 109.996 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 36.5 ttm -96.84 -60.47 1.59 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.04 -1.038 . . . . 74.019999999999996 109.907 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 41.8 t0 -54.94 -22.55 15.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.306 -0.871 . . . . 74.019999999999996 110.583 -178.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.432 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 1.3 mptm? -73.27 -65.81 0.63 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.917 -1.114 . . . . 75.430000000000007 110.221 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . 0.432 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 30.7 Cg_endo -62.18 -56.71 0.64 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.501 1.468 . . . . 72.319999999999993 112.355 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 18.8 mt -64.12 -40.49 96.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.176 -0.953 . . . . 74.540000000000006 109.763 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 86.3 -34.13 3.51 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.916 -1.674 . . . . 61.509999999999998 108.916 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 35.6 mm -111.58 134.82 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.614 -0.933 . . . . 74.25 108.895 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 59.5 p -95.08 166.15 12.07 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.287 -0.883 . . . . 72.0 110.345 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.434 ' O ' ' OG1' ' A' ' 203' ' ' THR . 0.0 OUTLIER -157.9 34.41 0.26 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.348 -0.982 . . . . 74.439999999999998 108.348 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 23.7 m -135.4 137.18 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.541 -0.724 . . . . 71.129999999999995 109.329 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -120.3 135.39 55.02 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.61 -0.681 . . . . 73.510000000000005 109.408 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.5 135.13 42.42 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.317 -0.865 . . . . 73.519999999999996 109.115 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.7 145.74 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.201 -0.937 . . . . 72.150000000000006 109.465 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -77.5 76.55 4.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.94 . . . . 72.400000000000006 109.502 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -164.01 -126.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.229 -0.919 . . . . 73.310000000000002 109.432 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 18.7 tpt85 -49.39 -43.21 44.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.946 . . . . 71.540000000000006 109.733 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 160.46 -111.47 0.48 Allowed Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.686 -1.245 . . . . 74.450000000000003 110.208 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.681 ' HH ' ' HZ2' ' A' ' 165' ' ' LYS . 28.9 m-85 -115.45 171.26 7.83 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.503 -0.998 . . . . 75.540000000000006 109.433 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -142.2 133.0 25.64 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.246 -0.909 . . . . 75.310000000000002 109.699 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.437 ' O ' ' O ' ' A' ' 159' ' ' ARG . 7.2 m-85 -105.4 131.54 52.7 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.88 -0.785 . . . . 75.409999999999997 108.88 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 21.3 t -157.08 150.55 24.21 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.942 -0.762 . . . . 74.140000000000001 108.942 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -61.77 150.54 81.86 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.047 -1.033 . . . . 75.319999999999993 108.913 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.5 -159.89 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.412 2.075 . . . . 73.109999999999999 112.455 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.88 162.14 0.2 Allowed Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.542 -0.724 . . . . 75.25 109.315 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -41.44 111.73 0.18 Allowed 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.875 1.717 . . . . 75.099999999999994 111.83 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -57.34 -37.52 72.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.293 -0.879 . . . . 71.140000000000001 110.035 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 18.2 p -157.18 177.6 11.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.038 -1.039 . . . . 71.129999999999995 109.93 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -143.43 -47.1 0.29 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.401 -0.812 . . . . 75.349999999999994 109.093 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.009 -0.996 . . . . 73.409999999999997 109.416 179.889 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.541 ' N ' ' CZ ' ' B' ' 2' ' ' ARG . 56.1 ttm . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.485 -0.561 . . . . 75.239999999999995 109.485 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.541 ' CZ ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -128.14 147.08 50.53 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.996 -0.742 . . . . 73.519999999999996 108.996 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 96.8 t -111.11 123.64 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.642 0.734 . . . . 72.239999999999995 109.947 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 1.8 tp -92.79 118.65 31.32 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.477 -0.934 . . . . 73.340000000000003 108.477 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 1.2 tt -119.08 118.05 30.38 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.318 -0.993 . . . . 74.349999999999994 108.318 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 24.0 mt -111.51 98.4 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.365 -0.834 . . . . 63.439999999999998 108.779 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.423 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 24.6 tp10 -128.93 137.44 51.41 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.623 -0.673 . . . . 74.519999999999996 109.365 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.3 -32.95 73.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.281 -0.887 . . . . 74.129999999999995 109.454 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -90.88 125.0 35.61 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.253 -0.904 . . . . 74.230000000000004 109.514 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 49.5 m -74.93 -32.99 61.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 65.540000000000006 109.799 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 96.0 t -60.14 -46.77 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.149 -0.97 . . . . 75.549999999999997 109.728 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.507 ' CD2' ' N ' ' B' ' 12' ' ' LEU . 3.5 mm? -63.99 -36.48 84.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 70.140000000000001 109.411 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.56 -27.31 71.41 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 108.56 -1.816 . . . . 75.400000000000006 108.56 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.59 -53.18 40.36 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 109.543 -1.423 . . . . 65.439999999999998 109.543 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -58.97 -46.31 88.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.373 -1.075 . . . . 72.200000000000003 109.789 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 36.8 mm -64.45 -40.11 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.816 -1.177 . . . . 75.150000000000006 108.826 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.462 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 83.0 tt0 -61.62 -44.92 96.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.27 -0.894 . . . . 73.010000000000005 109.317 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -84.96 1.38 47.68 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 74.299999999999997 109.196 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.48 -55.42 2.33 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.618 -1.393 . . . . 70.540000000000006 109.618 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -75.7 -20.71 58.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -1.13 . . . . 75.430000000000007 109.839 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 82.5 m-20 -52.54 -33.74 46.9 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.037 -1.039 . . . . 73.200000000000003 109.547 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 75.9 t -58.2 -29.69 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.229 -0.919 . . . . 74.230000000000004 109.278 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -80.12 -7.47 58.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.295 -0.878 . . . . 73.519999999999996 109.485 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.57 40.47 7.75 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.327 -1.109 . . . . 53.43 110.327 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -119.12 160.29 22.37 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.428 -1.042 . . . . 71.120000000000005 109.096 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.7 mmt -105.15 139.63 39.53 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.631 -0.878 . . . . 75.239999999999995 108.631 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.2 155.72 46.01 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.255 -0.903 . . . . 73.25 110.086 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' B' ' 28' ' ' ASP . 2.1 p30 -137.56 140.07 40.82 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.9 -0.778 . . . . 72.310000000000002 108.9 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 p -104.61 138.42 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.489 -0.93 . . . . 72.140000000000001 108.489 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 16.0 p -136.79 166.5 23.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.35 -0.844 . . . . 74.530000000000001 109.306 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . 0.476 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 3.2 pt-20 -90.92 -98.17 0.11 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.242 -0.911 . . . . 71.019999999999996 109.772 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 24.0 t -78.37 165.18 24.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 71.400000000000006 110.166 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 20.7 mt -55.52 -30.65 61.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.577 -0.702 . . . . 71.239999999999995 109.957 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -53.27 -46.15 69.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.137 -0.977 . . . . 74.319999999999993 109.964 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.476 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 75.0 m-20 -67.33 -42.27 83.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.073 -1.017 . . . . 73.030000000000001 109.444 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.59 -39.23 78.79 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.478 -1.449 . . . . 60.43 109.478 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -67.39 -38.21 84.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.322 -1.104 . . . . 74.430000000000007 109.774 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -80.2 -39.66 28.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.089 -1.007 . . . . 74.420000000000002 109.888 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 39.1 tp -68.52 -37.64 80.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.923 . . . . 75.409999999999997 110.226 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.4 ppp? -76.29 -22.68 54.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.959 -1.088 . . . . 61.439999999999998 110.211 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -64.33 -40.8 96.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.021 -1.049 . . . . 74.319999999999993 110.193 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.8 pt -82.05 -42.0 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.052 -1.03 . . . . 71.230000000000004 110.178 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' B' ' 40' ' ' MET . 2.2 mpt_? -94.86 150.71 19.89 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.029 -1.044 . . . . 73.409999999999997 109.278 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -68.68 -162.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 63.539999999999999 109.081 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -179.11 154.78 0.69 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.008 -1.057 . . . . 73.109999999999999 109.927 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -136.98 -46.87 0.58 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.455 -0.778 . . . . 62.219999999999999 108.951 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.413 ' C ' ' CD1' ' B' ' 47' ' ' LEU . 0.9 OUTLIER -104.08 110.66 22.92 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.43 -0.952 . . . . 73.120000000000005 108.43 179.548 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 75.9 t -96.77 98.29 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.268 -0.895 . . . . 74.109999999999999 109.357 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' MET . . . . . 0.412 ' CE ' ' OG ' ' B' ' 74' ' ' SER . 3.8 ttt -113.71 130.29 56.45 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.623 0.725 . . . . 73.439999999999998 109.414 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.424 HG22 ' H ' ' B' ' 52' ' ' ASP . 0.3 OUTLIER -144.27 130.45 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.496 -0.753 . . . . 73.400000000000006 109.132 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' SER . . . . . 0.423 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 95.5 p -91.92 -2.2 56.91 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.519 -0.738 . . . . 73.209999999999994 110.014 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.424 ' H ' HG22 ' B' ' 50' ' ' VAL . 74.8 m-20 -75.58 138.01 41.18 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.136 -0.978 . . . . 70.409999999999997 109.703 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.523 ' C ' ' H ' ' B' ' 55' ' ' ALA . 25.7 mtmm -74.5 -50.23 19.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.252 -0.905 . . . . 73.129999999999995 109.993 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -50.41 -10.57 0.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.168 -0.958 . . . . 75.209999999999994 109.545 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.523 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -64.04 -20.66 66.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.406 -0.809 . . . . 55.329999999999998 110.28 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' B' ' 55' ' ' ALA . 29.5 mt -40.89 -50.11 3.22 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.444 -0.785 . . . . 72.420000000000002 110.224 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 23.2 m -69.77 -32.68 71.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.038 -1.039 . . . . 73.040000000000006 109.124 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' B' ' 55' ' ' ALA . 66.9 t80 -65.34 -45.52 83.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.355 -0.841 . . . . 72.329999999999998 110.068 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 12.0 m -65.57 -34.88 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.536 -1.353 . . . . 74.540000000000006 109.45 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 20.3 t -57.15 -50.2 73.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.231 -0.918 . . . . 71.239999999999995 109.569 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -66.79 -33.19 75.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 74.310000000000002 110.083 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 20.6 mm -65.93 -38.51 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.783 -1.198 . . . . 75.420000000000002 109.82 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . 0.432 ' O ' ' OG ' ' B' ' 67' ' ' SER . 56.7 mmtt -67.25 -46.99 72.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.998 -1.064 . . . . 73.319999999999993 110.519 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.434 ' CG ' ' N ' ' B' ' 65' ' ' LYS . 7.7 pt-20 -74.46 -43.15 57.43 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.804 -1.185 . . . . 73.310000000000002 110.224 -179.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.448 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 66.9 mttm -71.05 -23.63 62.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 72.439999999999998 109.807 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.448 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 97.3 m-70 -155.0 65.94 0.65 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.135 -0.978 . . . . 65.209999999999994 109.462 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.452 ' O ' ' N ' ' B' ' 69' ' ' ILE . 36.1 m -54.46 -36.44 64.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.259 -0.9 . . . . 73.099999999999994 109.95 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 29.2 m -68.13 48.11 0.05 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.056 -1.028 . . . . 71.530000000000001 109.7 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . 0.452 ' N ' ' O ' ' B' ' 67' ' ' SER . 16.6 tt -144.16 154.31 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.246 -0.909 . . . . 74.400000000000006 109.27 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t -95.39 155.44 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.097 -1.002 . . . . 75.120000000000005 109.106 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 42.0 t -141.86 125.61 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.155 -0.966 . . . . 73.200000000000003 109.491 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.5 98.38 6.1 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.6 -0.889 . . . . 73.340000000000003 108.6 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 70.4 t -88.7 112.75 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 73.5 108.808 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.412 ' OG ' ' CE ' ' B' ' 49' ' ' MET . 0.6 OUTLIER -89.57 174.75 7.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.038 -1.039 . . . . 71.319999999999993 108.577 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.609 ' CB ' ' HH ' ' B' ' 94' ' ' TYR . 6.6 p -166.81 121.17 1.06 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.841 -1.162 . . . . 74.530000000000001 110.542 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -57.51 -32.01 66.61 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.518 -0.919 . . . . 64.5 108.518 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -111.88 90.86 13.91 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.635 -0.876 . . . . 74.25 108.635 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.93 72.19 6.27 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.939 1.759 . . . . 74.430000000000007 112.17 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 29.5 p -87.73 162.73 16.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.539 -0.726 . . . . 73.120000000000005 109.338 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -33.17 72.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.328 -0.857 . . . . 75.409999999999997 109.459 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . 0.519 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 76.9 mm-40 -63.45 -41.25 98.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.144 -0.973 . . . . 72.239999999999995 109.527 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . 0.532 ' CD ' ' HH ' ' B' ' 94' ' ' TYR . 76.4 tt0 -73.14 -30.4 63.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.146 -0.971 . . . . 73.219999999999999 109.58 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.525 ' OE2' ' NE ' ' A' ' 108' ' ' ARG . 36.6 tt0 -63.9 -56.06 18.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 74.299999999999997 109.668 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 30.9 m -58.14 -38.54 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.132 -0.98 . . . . 73.310000000000002 108.972 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' HIS . . . . . 0.519 ' ND1' ' O ' ' B' ' 81' ' ' GLU . 27.2 m170 -64.44 -29.08 70.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.257 -0.902 . . . . 73.239999999999995 109.093 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.16 -45.76 79.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.302 -0.874 . . . . 55.329999999999998 109.653 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -80.87 -31.74 35.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.997 -1.064 . . . . 74.450000000000003 109.085 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -64.33 -52.38 58.69 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.219 -0.926 . . . . 64.040000000000006 109.387 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . 0.502 ' NE2' ' N ' ' B' ' 89' ' ' GLN . 0.9 OUTLIER -64.71 -52.32 57.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.451 -0.781 . . . . 75.129999999999995 109.513 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.83 72.3 0.01 OUTLIER Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.103 -1.199 . . . . 75.420000000000002 110.103 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -129.17 134.64 48.11 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.451 -1.029 . . . . 73.420000000000002 108.951 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -76.95 -30.22 55.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.098 -1.001 . . . . 73.319999999999993 109.144 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 51.2 t0 -152.49 164.22 38.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.374 -0.829 . . . . 73.040000000000006 109.34 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.609 ' HH ' ' CB ' ' B' ' 75' ' ' SER . 86.4 t80 -140.21 121.06 14.47 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.481 -0.933 . . . . 74.310000000000002 108.481 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.545 ' N ' ' CD1' ' B' ' 95' ' ' ILE . 0.0 OUTLIER -127.17 161.49 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 O-C-N 121.36 -0.838 . . . . 75.340000000000003 110.909 -178.017 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.16 129.57 35.31 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.72 -1.215 . . . . 70.099999999999994 107.72 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.688 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -50.77 -56.75 16.84 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 120.989 -1.069 . . . . 65.430000000000007 111.572 -178.544 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 4.5 Cg_endo -41.12 -8.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.116 1.211 . . . . 63.520000000000003 113.26 -175.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . 0.688 ' N ' ' O ' ' B' ' 97' ' ' LYS . 55.1 m-85 60.4 116.03 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.558 -0.714 . . . . 75.129999999999995 109.405 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 31.5 ttm-85 -59.94 -31.2 69.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.925 -1.109 . . . . 74.230000000000004 108.938 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' SER . . . . . 0.73 ' O ' ' N ' ' B' ' 103' ' ' LYS . 46.2 t -174.26 28.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.088 -1.007 . . . . 64.510000000000005 110.552 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 53.3 mt 51.23 -68.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.768 -0.583 . . . . 74.439999999999998 110.47 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . 0.73 ' N ' ' O ' ' B' ' 101' ' ' SER . 4.3 mmmm -58.04 -33.67 69.25 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.05 -1.093 . . . . 72.299999999999997 108.05 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.07 -44.41 95.86 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.368 -0.933 . . . . 74.310000000000002 108.499 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 17.8 tp -63.53 -49.15 74.63 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.838 -0.801 . . . . 73.540000000000006 108.838 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 90.0 t -58.52 -41.16 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 72.030000000000001 109.325 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.7 -36.05 69.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.151 -0.968 . . . . 64.219999999999999 109.202 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -79.79 -28.95 40.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.403 -0.811 . . . . 75.310000000000002 109.961 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.25 -46.09 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 120.978 -1.076 . . . . 55.439999999999998 108.785 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' B' ' 114' ' ' ARG . 23.9 pt-20 -66.22 -42.15 89.08 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.06 -1.056 . . . . 65.310000000000002 108.494 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . 0.417 ' N ' ' CG ' ' B' ' 110' ' ' GLU . . . -53.69 -39.13 64.9 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.58 -0.7 . . . . 74.519999999999996 109.418 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -65.14 -44.66 87.89 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.177 -0.952 . . . . 72.040000000000006 109.953 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . 0.59 ' C ' ' H ' ' B' ' 115' ' ' PHE . 58.1 mt -97.78 -60.12 1.63 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.107 -0.996 . . . . 75.349999999999994 110.768 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' B' ' 110' ' ' GLU . 58.0 mtp180 57.93 -4.85 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.466 -0.772 . . . . 75.5 110.262 -178.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 115' ' ' PHE . . . . . 0.59 ' H ' ' C ' ' B' ' 113' ' ' LEU . 63.4 t80 -171.74 -104.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.993 -1.067 . . . . 73.040000000000006 109.501 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 116' ' ' TRP . . . . . 0.443 ' N ' ' CD2' ' B' ' 115' ' ' PHE . 39.9 m95 -146.75 44.88 1.19 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.334 -0.854 . . . . 74.450000000000003 108.826 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.93 -140.96 26.56 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.216 -1.554 . . . . 64.209999999999994 109.216 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 9.2 t -151.58 138.68 19.17 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.167 -1.196 . . . . 71.400000000000006 109.395 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . 0.45 HD22 ' C ' ' B' ' 121' ' ' ILE . 35.1 t30 -86.54 169.44 12.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.257 -0.902 . . . . 74.209999999999994 109.653 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 11.0 t -137.6 -34.32 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.981 -0.748 . . . . 75.019999999999996 108.981 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . 0.45 ' C ' HD22 ' B' ' 119' ' ' ASN . 26.9 mm -112.31 134.27 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.546 -0.721 . . . . 74.239999999999995 109.147 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -148.42 133.72 18.47 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.193 -0.942 . . . . 73.329999999999998 109.609 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . 1.025 HD11 ' CD ' ' B' ' 159' ' ' ARG . 16.7 tt -149.49 123.96 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.792 -0.818 . . . . 74.219999999999999 108.792 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 54.87 -136.89 44.59 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.207 -1.557 . . . . 72.409999999999997 109.207 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -89.95 1.36 56.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.221 -1.164 . . . . 75.120000000000005 109.524 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.91 138.42 31.56 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.284 -0.885 . . . . 75.420000000000002 108.739 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 35.2 m -132.26 119.56 20.97 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.481 -0.762 . . . . 74.219999999999999 109.288 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . 0.424 ' O ' ' OD1' ' B' ' 119' ' ' ASN . 14.0 mm -117.98 147.08 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.543 -0.723 . . . . 60.329999999999998 109.304 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 129' ' ' SER . . . . . 0.404 ' C ' HH22 ' B' ' 157' ' ' ARG . 5.9 m -137.76 132.91 17.53 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.276 -0.89 . . . . 72.310000000000002 109.137 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -80.72 -49.43 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.174 1.916 . . . . 75.129999999999995 112.455 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -57.51 -49.9 74.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.912 . . . . 75.230000000000004 110.055 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -82.36 -9.33 59.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.091 -1.006 . . . . 75.120000000000005 109.749 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 47.94 69.03 0.58 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.093 -1.004 . . . . 75.129999999999995 109.274 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -139.18 141.22 37.97 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.453 -0.779 . . . . 75.109999999999999 109.353 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 2.8 tt -120.51 126.41 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.515 -0.741 . . . . 70.319999999999993 109.487 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 32.9 mm -115.2 121.82 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.653 -0.869 . . . . 74.120000000000005 108.653 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . 0.429 ' C ' ' H ' ' B' ' 139' ' ' GLY . 35.4 p90 -140.79 143.85 35.11 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.206 -0.934 . . . . 74.230000000000004 109.622 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' B' ' 138' ' ' LYS . 30.3 ttpt 54.57 9.5 0.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.547 -0.721 . . . . 74.219999999999999 109.804 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' B' ' 137' ' ' TYR . . . 91.55 16.65 51.95 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 110.04 -1.224 . . . . 74.319999999999993 110.04 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 41.6 mtt-85 -107.33 144.11 34.65 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.513 -0.992 . . . . 75.340000000000003 109.706 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -102.82 118.12 36.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.568 -0.707 . . . . 71.230000000000004 109.397 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 71.8 t -136.36 137.37 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.452 -0.78 . . . . 70.430000000000007 109.012 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -80.36 132.38 35.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.906 . . . . 72.430000000000007 109.531 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 5.4 p -73.1 133.27 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.159 -0.963 . . . . 72.129999999999995 109.064 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 35.3 pttt -170.4 66.3 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.9 . . . . 74.5 109.607 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 176.6 156.2 15.0 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.369 -1.492 . . . . 42.229999999999997 109.369 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 0.615 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 19.3 mttt -65.23 -39.24 33.89 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.201 -1.176 . . . . 73.299999999999997 109.625 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 27.2 Cg_exo -61.54 -30.45 86.24 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.016 1.81 . . . . 71.329999999999998 111.218 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -94.94 -20.67 19.19 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.456 -0.778 . . . . 74.230000000000004 109.389 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -67.36 -39.23 85.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.273 -0.892 . . . . 72.340000000000003 109.486 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.45 -35.16 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 73.349999999999994 109.615 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . 0.417 ' O ' ' CD1' ' B' ' 155' ' ' LEU . 0.2 OUTLIER -67.27 -42.43 83.84 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.125 0.964 . . . . 74.430000000000007 109.308 -179.76 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.436 ' CG2' ' NH2' ' B' ' 157' ' ' ARG . 34.7 m -74.08 -26.51 60.41 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.03 -1.043 . . . . 75.209999999999994 110.872 -179.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -71.98 -59.98 2.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.045 -1.035 . . . . 73.040000000000006 109.867 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . 0.492 ' CD1' ' N ' ' B' ' 156' ' ' ALA . 0.0 OUTLIER -62.29 -20.98 64.86 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.929 -1.107 . . . . 73.430000000000007 108.735 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . 0.492 ' N ' ' CD1' ' B' ' 155' ' ' LEU . . . -61.86 -48.05 82.29 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 120.901 -1.125 . . . . 75.319999999999993 108.233 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.436 ' NH2' ' CG2' ' B' ' 153' ' ' THR . 0.0 OUTLIER -72.72 -42.45 64.14 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.42 -0.912 . . . . 73.319999999999993 109.409 179.57 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -83.28 10.83 7.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.931 . . . . 74.140000000000001 110.389 -178.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . 1.025 ' CD ' HD11 ' B' ' 123' ' ' ILE . 10.4 ttp-105 -48.38 164.94 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.026 -1.046 . . . . 73.420000000000002 109.019 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 61.27 53.16 3.6 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.342 -0.849 . . . . 72.099999999999994 109.716 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -161.04 156.24 24.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.34 -0.85 . . . . 73.239999999999995 109.036 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 66.6 mt -88.86 132.49 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.997 -1.065 . . . . 72.310000000000002 108.896 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' B' ' 212' ' ' TYR . 40.1 t -141.57 136.78 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.24 -0.913 . . . . 75.030000000000001 110.353 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 164' ' ' SER . . . . . 0.608 ' HG ' ' N ' ' B' ' 165' ' ' LYS . 6.6 t -94.65 167.94 11.15 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.096 -1.002 . . . . 74.219999999999999 109.288 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . 1.072 ' NZ ' ' HA ' ' B' ' 185' ' ' GLU . 22.2 mttm -61.96 -38.22 87.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.028 -1.045 . . . . 72.420000000000002 109.865 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -52.96 -39.53 63.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 63.450000000000003 110.14 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -60.94 -48.14 83.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -0.951 . . . . 72.400000000000006 110.478 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 40.5 mt -57.31 -33.54 67.8 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.91 -1.119 . . . . 72.319999999999993 109.665 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' B' ' 173' ' ' TRP . 5.7 tt -65.38 -61.83 1.88 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.161 -0.962 . . . . 73.340000000000003 109.624 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -65.19 -28.63 69.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.36 -0.837 . . . . 73.099999999999994 110.568 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.94 -59.49 5.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.119 -0.988 . . . . 62.130000000000003 110.616 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.519 ' N ' ' CD1' ' B' ' 172' ' ' ILE . 2.0 mp -86.75 -59.34 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.006 -1.059 . . . . 74.439999999999998 109.172 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 173' ' ' TRP . . . . . 0.428 ' O ' ' O ' ' B' ' 169' ' ' LEU . 23.0 m-90 -80.72 133.72 35.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 72.230000000000004 108.822 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -163.19 -35.01 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.976 -1.078 . . . . 75.030000000000001 110.426 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . 0.613 ' N ' ' CD ' ' B' ' 176' ' ' PRO . 8.8 tt0 -80.37 -35.81 0.91 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.001 -1.062 . . . . 73.040000000000006 111.049 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' B' ' 175' ' ' GLU . 95.8 Cg_endo -90.94 -41.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 122.432 2.088 . . . . 74.129999999999995 112.795 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 49.45 14.49 0.11 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.096 -1.002 . . . . 72.439999999999998 109.5 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 178' ' ' MET . . . . . 0.45 ' H ' ' C ' ' B' ' 176' ' ' PRO . 54.8 mtp -74.55 -26.77 60.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.221 -0.924 . . . . 72.109999999999999 110.027 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 29.1 m -61.32 143.02 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.994 -1.066 . . . . 75.310000000000002 109.445 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 25.2 p -66.84 150.34 97.79 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.142 -0.974 . . . . 62.149999999999999 109.263 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -76.58 31.73 0.41 Allowed 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.324 2.016 . . . . 74.340000000000003 112.651 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -149.57 -15.77 0.28 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.913 -1.117 . . . . 72.310000000000002 109.959 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 11.3 p -63.97 -17.86 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.19 -0.943 . . . . 65.420000000000002 109.984 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.494 ' H ' ' CD1' ' B' ' 184' ' ' ILE . 1.3 mp -49.74 -35.17 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.068 -1.02 . . . . 75.030000000000001 109.567 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . 1.072 ' HA ' ' NZ ' ' B' ' 165' ' ' LYS . 17.3 pt-20 -55.87 -36.54 67.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.994 -1.066 . . . . 73.519999999999996 109.215 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 9.2 t -75.42 -36.98 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 74.349999999999994 109.207 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.08 -55.03 28.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.36 -0.838 . . . . 61.119999999999997 109.868 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 188' ' ' ILE . . . . . 0.45 HG22 ' HZ2' ' B' ' 165' ' ' LYS . 5.4 tp -63.15 -33.93 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.098 -1.001 . . . . 72.430000000000007 109.927 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -69.04 -50.86 44.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 75.420000000000002 110.491 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -72.53 -39.08 67.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.035 -1.041 . . . . 74.140000000000001 110.157 -178.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 57.5 mt -57.22 -38.01 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.037 -1.039 . . . . 74.030000000000001 109.345 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -73.57 -44.13 58.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.037 -1.039 . . . . 72.329999999999998 109.96 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -70.5 -28.77 65.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.906 . . . . 73.099999999999994 110.601 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -82.97 -33.84 26.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.01 -1.056 . . . . 74.430000000000007 110.291 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 62.4 mtt -90.61 -40.8 11.71 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.053 -1.03 . . . . 74.329999999999998 110.863 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 196' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 51.1 p-10 -53.32 -20.43 4.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.929 -1.107 . . . . 71.209999999999994 110.488 -178.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . 0.524 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 4.1 mmtp -76.19 -65.63 0.42 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.852 -1.155 . . . . 75.209999999999994 109.537 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 198' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 48.2 Cg_endo -66.12 -45.39 5.82 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.246 1.964 . . . . 75.319999999999993 111.633 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 37.1 tp -65.05 -51.09 63.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.386 -0.821 . . . . 72.25 109.342 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 85.94 -33.2 3.59 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.91 -1.276 . . . . 73.239999999999995 109.91 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . 0.486 ' N ' ' CD1' ' B' ' 201' ' ' ILE . 2.5 mp -92.19 142.15 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.131 -1.217 . . . . 54.299999999999997 109.722 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 70.3 m -119.58 133.24 55.75 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.37 -0.974 . . . . 74.310000000000002 108.37 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 24.4 p -137.22 47.42 2.11 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.312 -0.867 . . . . 74.400000000000006 109.715 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 1.6 m -143.15 122.41 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.259 -0.9 . . . . 74.099999999999994 109.219 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -107.94 129.45 55.1 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.664 -0.865 . . . . 75.329999999999998 108.664 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.16 131.22 39.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.175 -0.953 . . . . 71.400000000000006 109.949 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 5.0 t -129.56 122.91 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.434 -0.951 . . . . 63.5 108.434 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -61.93 -26.07 67.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 74.450000000000003 110.065 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 -68.67 -88.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.033 -1.042 . . . . 74.140000000000001 109.83 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -65.3 -63.49 1.09 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.05 -1.032 . . . . 74.430000000000007 109.668 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 157.91 -105.81 0.28 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.452 -1.459 . . . . 70.109999999999999 109.452 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 212' ' ' TYR . . . . . 0.461 ' O ' ' O ' ' B' ' 163' ' ' VAL . 39.0 m-85 -120.16 135.87 54.81 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.613 -0.933 . . . . 74.209999999999994 109.618 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -125.5 134.13 52.14 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.446 -0.784 . . . . 74.299999999999997 108.944 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -90.77 131.28 36.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.406 -0.808 . . . . 74.340000000000003 109.289 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 26.7 p -153.74 167.97 27.83 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.173 -0.954 . . . . 72.209999999999994 109.803 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . 0.685 ' HD2' ' HB2' ' B' ' 220' ' ' ALA . 27.5 p90 -63.52 148.44 93.88 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.42 -0.8 . . . . 72.310000000000002 109.213 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.82 162.63 27.88 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.11 1.873 . . . . 71.010000000000005 111.914 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . 0.44 ' CB ' ' CD ' ' B' ' 219' ' ' PRO . 21.8 mttm -51.22 -64.67 1.25 Allowed Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.246 -0.909 . . . . 74.349999999999994 109.349 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . 0.44 ' CD ' ' CB ' ' B' ' 218' ' ' LYS . 49.0 Cg_endo -66.5 83.67 0.29 Allowed 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.195 1.93 . . . . 71.319999999999993 111.782 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . 0.685 ' HB2' ' HD2' ' B' ' 216' ' ' TYR . . . -122.19 129.08 51.95 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.519 -0.738 . . . . 75.450000000000003 109.274 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 65.4 m -145.25 133.96 22.23 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.31 -0.869 . . . . 72.219999999999999 109.236 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.25 -31.12 68.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.303 -0.873 . . . . 74.299999999999997 109.504 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.038 -0.982 . . . . 71.129999999999995 109.409 -179.968 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.597 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.436 -0.579 . . . . 65.120000000000005 109.436 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.404 ' CG ' HH11 ' A' ' 2' ' ' ARG . 2.0 ttt-85 -145.06 152.9 40.84 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.213 -0.929 . . . . 73.310000000000002 109.07 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 65.7 t -115.29 128.84 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.52 -0.738 . . . . 71.420000000000002 109.652 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 tp -100.39 117.08 33.85 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.516 -0.74 . . . . 65.219999999999999 109.136 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.2 tp -115.89 111.53 20.58 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.563 -0.71 . . . . 71.439999999999998 109.475 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.413 ' O ' ' OG ' ' A' ' 51' ' ' SER . 9.2 mt -102.24 113.42 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.213 -0.93 . . . . 71.150000000000006 108.96 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.476 ' OE1' ' CB ' ' A' ' 51' ' ' SER . 31.0 tp10 -148.41 126.88 12.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.205 -0.934 . . . . 75.340000000000003 109.572 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -69.09 -30.76 69.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -0.869 . . . . 73.040000000000006 109.173 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -84.97 114.29 22.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.34 -0.85 . . . . 72.420000000000002 109.422 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 77.2 p -70.19 -24.84 63.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.911 . . . . 72.340000000000003 109.62 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.65 -51.49 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.209 -0.932 . . . . 74.420000000000002 109.642 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.518 ' CD2' ' N ' ' A' ' 12' ' ' LEU . 3.5 mm? -66.91 -33.54 75.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 72.010000000000005 109.212 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.76 -23.3 75.36 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.674 -1.77 . . . . 72.140000000000001 108.674 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.74 -53.43 15.91 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.622 -1.391 . . . . 72.329999999999998 109.622 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -60.69 -43.37 97.83 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.35 -1.088 . . . . 72.340000000000003 109.736 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 96.2 mt -65.11 -32.5 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.891 -1.131 . . . . 74.239999999999995 109.034 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -58.01 -49.81 75.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 71.409999999999997 109.298 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -88.11 0.45 55.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.228 -0.92 . . . . 75.540000000000006 109.879 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.15 -57.82 2.58 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 110.002 -1.239 . . . . 62.149999999999999 110.002 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pp -74.58 -23.25 58.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -1.128 . . . . 74.420000000000002 110.052 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -51.47 -35.29 39.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.018 -1.052 . . . . 74.25 109.47 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.7 t -55.38 -41.3 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.97 . . . . 72.109999999999999 109.159 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.405 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 2.6 mptp? -63.17 -19.26 64.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.855 . . . . 73.230000000000004 109.026 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.85 40.64 4.88 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.553 -1.019 . . . . 75.540000000000006 110.553 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -119.04 160.43 22.04 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.421 -1.046 . . . . 74.510000000000005 108.502 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.8 mmt -90.14 124.33 34.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.051 -1.031 . . . . 64.319999999999993 108.872 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.25 138.58 37.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.417 -0.802 . . . . 74.310000000000002 110.059 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -127.82 126.89 42.54 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.508 -0.923 . . . . 75.400000000000006 108.508 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -106.11 130.78 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.729 -0.841 . . . . 75.129999999999995 108.729 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.9 p -135.67 160.58 38.07 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.5 -0.75 . . . . 71.420000000000002 109.485 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -89.0 -103.44 0.09 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.283 -0.886 . . . . 73.109999999999999 109.418 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.443 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 62.2 m -78.45 147.89 33.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.205 -0.934 . . . . 74.239999999999995 109.36 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.7 mp -49.1 -15.71 0.12 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.328 -0.857 . . . . 71.530000000000001 110.189 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 32' ' ' SER . 78.8 mm-40 -62.65 -53.33 56.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.012 -1.055 . . . . 74.230000000000004 110.05 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 36' ' ' GLY . 19.8 p-10 -67.73 -30.27 69.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.0 -1.062 . . . . 71.010000000000005 109.262 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.543 ' N ' ' OD1' ' A' ' 35' ' ' ASP . . . -75.25 -36.11 46.36 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.142 -1.583 . . . . 61.409999999999997 109.142 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -70.09 -46.88 63.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.339 -1.095 . . . . 74.340000000000003 109.459 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -69.05 -34.1 74.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.969 . . . . 75.329999999999998 109.862 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.7 tp -79.23 -51.33 9.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.217 -0.927 . . . . 74.329999999999998 110.226 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.456 ' SD ' ' OH ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -58.2 -27.85 64.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.101 -1.0 . . . . 70.319999999999993 109.934 -179.27 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -61.09 -39.68 90.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.109 -0.994 . . . . 71.219999999999999 109.849 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 42' ' ' ILE . 15.7 pt -91.44 1.39 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.072 -1.018 . . . . 74.409999999999997 110.076 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 40' ' ' MET . 86.2 mtt-85 -126.4 152.15 46.72 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.36 -0.838 . . . . 75.409999999999997 109.328 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -96.83 151.79 19.32 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.197 -0.94 . . . . 75.420000000000002 109.326 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.456 ' OH ' ' SD ' ' A' ' 40' ' ' MET . 10.0 p90 -154.76 175.23 13.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.243 -0.911 . . . . 74.230000000000004 109.646 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -135.76 -33.44 0.86 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.423 -0.798 . . . . 75.319999999999993 109.307 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.99 115.01 29.36 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.492 -0.755 . . . . 72.129999999999995 109.014 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.3 t -102.41 98.84 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.852 -0.796 . . . . 72.340000000000003 108.852 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.474 ' SD ' ' O ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -109.59 122.75 48.13 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.096 -0.705 . . . . 74.109999999999999 109.096 -179.615 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.6 p -130.87 130.02 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 121.602 0.715 . . . . 71.239999999999995 109.702 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.476 ' CB ' ' OE1' ' A' ' 7' ' ' GLU . 44.9 p -99.1 0.54 43.81 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.435 -0.791 . . . . 73.109999999999999 109.281 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -76.03 141.52 42.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.141 -0.974 . . . . 63.399999999999999 109.341 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.523 ' C ' ' H ' ' A' ' 55' ' ' ALA . 21.2 pttm -79.36 -38.51 34.87 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.252 -0.905 . . . . 65.439999999999998 110.449 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -70.59 11.25 0.38 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.977 -1.077 . . . . 73.129999999999995 109.494 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.523 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.77 -21.12 57.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.406 -0.809 . . . . 64.140000000000001 110.589 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 55' ' ' ALA . 73.6 mt -38.11 -48.47 1.24 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.498 -0.751 . . . . 74.430000000000007 111.025 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.2 m -71.93 -36.76 70.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.889 -1.132 . . . . 63.229999999999997 109.59 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -66.33 -47.01 74.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.397 -0.815 . . . . 74.439999999999998 110.594 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.3 m -64.14 -34.42 68.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 120.636 -1.29 . . . . 74.030000000000001 109.561 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.0 t -57.75 -55.12 38.92 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.182 -0.949 . . . . 73.540000000000006 109.317 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.667 HH21 ' NZ ' ' A' ' 65' ' ' LYS . 5.7 ptm180 -61.42 -31.27 71.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 73.340000000000003 109.868 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.9 mm -63.03 -37.18 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.996 -1.065 . . . . 73.349999999999994 109.778 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.417 ' HZ3' ' C ' ' A' ' 90' ' ' GLY . 26.4 mmtp -70.03 -54.24 14.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.036 -1.04 . . . . 74.420000000000002 110.315 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -64.85 -35.89 82.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.817 -1.177 . . . . 74.549999999999997 109.815 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.667 ' NZ ' HH21 ' A' ' 61' ' ' ARG . 46.4 mtpt -82.58 -23.3 34.5 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.063 -1.023 . . . . 75.219999999999999 109.818 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.477 ' CG ' ' C ' ' A' ' 65' ' ' LYS . 47.8 m-70 -154.38 65.53 0.69 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.043 -1.036 . . . . 74.129999999999995 109.64 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.8 t -64.69 -30.64 71.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.204 -0.935 . . . . 73.239999999999995 109.951 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 97.2 p -60.43 -17.87 47.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.168 -0.958 . . . . 71.439999999999998 110.014 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 53.7 mt -91.28 149.56 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.139 -0.975 . . . . 71.329999999999998 109.614 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 91.9 t -88.33 159.18 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.344 -0.847 . . . . 73.019999999999996 109.135 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.81 124.54 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.158 -0.963 . . . . 54.210000000000001 110.001 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.61 ' CD1' HH22 ' A' ' 108' ' ' ARG . 4.0 tt -113.43 99.09 7.51 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.617 -0.882 . . . . 74.209999999999994 108.617 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.6 t -96.71 123.22 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.364 -0.835 . . . . 74.409999999999997 108.816 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.82 -178.11 4.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.986 -1.071 . . . . 72.310000000000002 109.004 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.473 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 49.7 p -166.75 120.07 1.02 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.133 -0.979 . . . . 64.540000000000006 109.829 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -77.49 6.39 7.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.403 -0.811 . . . . 74.129999999999995 108.913 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 79' ' ' THR . 74.6 m-20 -142.24 64.96 17.63 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.947 -0.76 . . . . 73.340000000000003 108.947 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.6 81.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.919 1.746 . . . . 71.319999999999993 111.707 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 77' ' ' ASN . 41.1 p -100.56 161.89 13.3 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.776 -0.824 . . . . 62.530000000000001 108.776 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 p -66.52 -24.48 66.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.131 -0.981 . . . . 74.140000000000001 109.659 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -73.64 -38.98 64.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 71.420000000000002 109.769 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.41 ' OE1' ' OH ' ' A' ' 94' ' ' TYR . 96.1 mt-10 -70.92 -33.65 70.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.204 -0.935 . . . . 73.430000000000007 110.117 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.416 ' OE2' ' NE ' ' B' ' 100' ' ' ARG . 92.3 mt-10 -68.61 -55.8 10.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.005 -1.059 . . . . 74.219999999999999 109.745 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.9 m -60.61 -42.52 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.191 -0.943 . . . . 74.150000000000006 109.414 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.551 ' CE1' HE21 ' A' ' 89' ' ' GLN . 75.8 t60 -69.21 -31.58 70.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.32 -0.862 . . . . 72.540000000000006 109.498 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.89 -36.64 84.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.298 -0.876 . . . . 64.219999999999999 109.822 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -78.32 -33.25 49.36 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.09 -1.006 . . . . 74.340000000000003 108.756 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -72.97 -34.03 66.21 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.447 -0.783 . . . . 74.420000000000002 109.378 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.551 HE21 ' CE1' ' A' ' 85' ' ' HIS . 83.9 mm-40 -69.93 -62.33 1.43 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 74.519999999999996 109.484 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.417 ' C ' ' HZ3' ' A' ' 63' ' ' LYS . . . 152.56 54.96 0.01 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.908 -1.277 . . . . 74.209999999999994 109.908 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.37 135.85 53.7 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.416 -1.049 . . . . 64.099999999999994 109.431 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 20.0 t70 -82.15 -31.65 30.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 73.420000000000002 109.127 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 95.6 m-20 -141.77 160.16 40.74 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.417 -0.802 . . . . 75.040000000000006 109.204 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.473 ' OH ' ' CB ' ' A' ' 75' ' ' SER . 82.6 t80 -139.49 105.66 5.24 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.395 -0.815 . . . . 71.329999999999998 109.122 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 29.0 mm -111.62 157.82 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.221 -0.925 . . . . 74.510000000000005 110.674 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.81 125.16 28.93 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.831 -1.174 . . . . 64.319999999999993 107.831 178.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.674 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -45.23 -53.85 16.1 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.016 -1.053 . . . . 74.510000000000005 111.467 -178.801 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.7 Cg_endo -42.11 -10.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 CA-C-N 119.729 0.939 . . . . 73.109999999999999 112.643 -177.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.674 ' N ' ' O ' ' A' ' 97' ' ' LYS . 57.7 m-85 58.7 112.39 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.667 -0.646 . . . . 72.540000000000006 109.694 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.51 ' NE ' ' OE2' ' B' ' 83' ' ' GLU . 37.8 ttm-85 -58.58 -38.19 77.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.948 -1.095 . . . . 74.540000000000006 108.511 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.806 ' O ' ' N ' ' A' ' 103' ' ' LYS . 6.3 t -173.24 31.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -0.872 . . . . 74.140000000000001 110.338 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.428 ' O ' ' N ' ' A' ' 105' ' ' LEU . 6.4 mm 46.77 -67.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 CA-C-N 118.343 0.519 . . . . 75.430000000000007 110.462 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.806 ' N ' ' O ' ' A' ' 101' ' ' SER . 16.0 mtpp -50.7 -32.72 20.26 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.749 -1.22 . . . . 74.140000000000001 107.923 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.75 -38.34 80.05 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.921 -1.14 . . . . 63.240000000000002 107.921 178.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 102' ' ' ILE . 2.0 tt -70.0 -47.85 60.49 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.275 -0.639 . . . . 73.219999999999999 109.275 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.6 t -64.74 -44.59 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 74.540000000000006 109.192 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.24 -40.0 64.23 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.205 -0.935 . . . . 75.5 109.093 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.61 HH22 ' CD1' ' A' ' 72' ' ' LEU . 14.6 ttp-105 -72.58 -25.15 61.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.361 -0.837 . . . . 74.409999999999997 109.667 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.431 HG23 HD11 ' A' ' 109' ' ' ILE . 83.0 mt -80.12 -33.24 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.439 -1.319 . . . . 73.239999999999995 107.439 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -55.62 31.43 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.557 -1.275 . . . . 74.340000000000003 107.557 178.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.76 -40.42 69.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.653 -0.654 . . . . 73.319999999999993 109.586 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 10.6 mmp_? -56.15 -33.37 65.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.182 -0.948 . . . . 74.420000000000002 109.581 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.65 72.88 0.99 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.928 -1.108 . . . . 74.329999999999998 110.23 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.482 ' O ' ' N ' ' A' ' 116' ' ' TRP . 43.7 mtm180 -73.41 101.55 3.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.002 -1.061 . . . . 74.439999999999998 108.871 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 47.87 14.55 0.05 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.314 -0.866 . . . . 74.430000000000007 109.902 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.482 ' N ' ' O ' ' A' ' 114' ' ' ARG . 94.9 m95 46.99 -164.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.166 -0.959 . . . . 74.439999999999998 109.675 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 168.1 40.52 0.02 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.491 -1.444 . . . . 75.040000000000006 109.491 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.6 m -83.98 -124.68 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.263 -1.139 . . . . 70.109999999999999 109.621 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 61.44 67.21 0.8 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 65.239999999999995 109.556 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.4 t -80.5 -25.76 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 74.219999999999999 109.337 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.8 mm -98.42 132.9 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.331 -0.855 . . . . 74.420000000000002 109.278 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -144.68 117.46 8.72 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.191 -0.943 . . . . 73.299999999999997 109.551 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.72 128.74 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.37 -0.831 . . . . 75.340000000000003 108.829 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.3 -136.25 16.81 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.519 -1.432 . . . . 75.129999999999995 109.519 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -91.53 -6.01 53.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.249 -1.148 . . . . 74.450000000000003 109.515 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.14 135.61 33.84 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.215 -0.928 . . . . 54.210000000000001 108.788 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 26.8 p -132.1 146.33 51.98 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.474 -0.766 . . . . 70.239999999999995 109.588 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.2 mt -134.61 136.7 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.324 -0.86 . . . . 72.430000000000007 109.63 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.3 t -113.89 124.78 30.43 Favored Pre-proline 0 N--CA 1.496 1.874 0 N-CA-C 109.023 -0.732 . . . . 71.109999999999999 109.023 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -80.58 -51.67 0.05 OUTLIER 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.635 1.557 . . . . 75.140000000000001 112.044 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -65.28 -44.22 88.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 72.5 109.73 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -80.98 -15.52 55.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 73.140000000000001 109.354 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 54.5 77.07 0.21 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 75.329999999999998 109.76 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -158.04 140.36 14.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 71.230000000000004 109.461 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.5 tt -120.22 133.45 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.539 -0.726 . . . . 75.329999999999998 109.6 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 26.7 mm -110.18 121.79 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.856 -0.794 . . . . 71.109999999999999 108.856 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.52 ' C ' ' H ' ' A' ' 139' ' ' GLY . 49.8 p90 -142.68 149.17 38.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.086 -1.009 . . . . 74.140000000000001 108.967 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 46.8 tttp 53.96 5.98 0.08 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.297 -0.877 . . . . 75.400000000000006 109.536 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' A' ' 137' ' ' TYR . . . 94.04 -6.71 72.88 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 110.079 -1.208 . . . . 72.239999999999995 110.079 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.416 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 1.0 OUTLIER -89.78 143.57 26.69 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.056 -1.261 . . . . 73.120000000000005 109.288 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -99.51 125.91 45.36 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.369 -0.832 . . . . 72.319999999999993 109.362 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.7 t -137.1 133.48 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.422 -0.798 . . . . 62.340000000000003 109.604 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.449 ' N ' ' OE1' ' A' ' 143' ' ' GLU . 45.5 mp0 -94.95 147.1 23.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.343 -0.848 . . . . 61.229999999999997 109.046 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.09 131.61 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.251 -0.906 . . . . 74.439999999999998 109.63 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.75 121.34 8.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.36 -0.837 . . . . 75.420000000000002 109.198 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.95 -143.29 10.09 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.917 -1.273 . . . . 73.340000000000003 109.917 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -70.67 -62.82 1.85 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.424 -1.045 . . . . 72.219999999999999 110.348 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -56.0 -19.68 27.11 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.934 1.756 . . . . 75.450000000000003 111.856 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -80.61 -44.49 18.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 65.239999999999995 109.189 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -60.94 -39.65 90.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 72.519999999999996 109.995 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.5 p -77.14 -38.61 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.135 -0.978 . . . . 74.209999999999994 110.053 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 15.0 tp -65.04 -42.8 93.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.121 -0.987 . . . . 73.310000000000002 109.737 -179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 42.9 p -72.98 -35.54 66.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.08 -1.013 . . . . 74.310000000000002 109.851 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -57.59 -52.01 67.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 75.450000000000003 109.632 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 pp -73.88 -24.4 59.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 75.340000000000003 109.846 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.41 -46.6 83.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.134 -0.979 . . . . 62.140000000000001 109.426 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.49 ' C ' ' H ' ' A' ' 159' ' ' ARG . 65.5 mtt180 -75.34 -44.07 47.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.229 -0.919 . . . . 72.219999999999999 109.335 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -75.71 22.78 0.13 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 74.120000000000005 109.406 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.49 ' H ' ' C ' ' A' ' 157' ' ' ARG . 37.2 ptt180 -56.82 165.23 1.26 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.249 -0.907 . . . . 74.340000000000003 109.49 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.432 ' OD2' ' OE1' ' B' ' 161' ' ' GLN . 50.2 t0 54.2 47.15 23.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 75.450000000000003 109.242 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -155.15 158.9 39.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.284 -0.885 . . . . 73.409999999999997 109.381 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 53.4 mt -85.03 120.05 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.209 -0.932 . . . . 74.409999999999997 109.331 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.403 ' O ' ' O ' ' A' ' 212' ' ' TYR . 40.0 t -107.76 130.36 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.419 -0.801 . . . . 72.530000000000001 109.497 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.9 m -100.9 153.04 19.83 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.361 -0.837 . . . . 74.120000000000005 109.358 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.413 ' CB ' ' HZ2' ' A' ' 165' ' ' LYS . 9.2 mtpm? -56.65 -35.47 68.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.9 . . . . 70.430000000000007 109.505 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -59.51 -37.6 78.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 74.319999999999993 109.629 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.431 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 93.4 mt-30 -62.56 -39.6 94.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 74.519999999999996 109.555 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 28.5 mt -64.95 -31.78 73.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.128 -0.982 . . . . 74.409999999999997 109.268 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 4.2 tt -66.38 -59.11 3.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.862 . . . . 75.140000000000001 110.098 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 167' ' ' GLN . 28.9 p-10 -73.64 -30.24 62.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.04 -1.038 . . . . 65.030000000000001 110.624 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.403 ' N ' ' OD1' ' A' ' 170' ' ' ASP . . . -59.98 -46.35 89.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.968 -1.083 . . . . 70.209999999999994 110.173 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.54 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 1.6 mp -94.67 -59.86 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.038 -1.039 . . . . 75.319999999999993 108.966 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 29.8 m-90 -91.54 104.07 16.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 73.140000000000001 109.769 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -116.9 159.38 22.51 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.64 -0.874 . . . . 73.239999999999995 108.64 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 64.2 150.27 0.11 Allowed Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 108.762 -0.829 . . . . 63.329999999999998 108.762 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -33.36 138.01 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.677 2.251 . . . . 72.510000000000005 112.679 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.41 ' OE1' ' N ' ' A' ' 179' ' ' VAL . 0.0 OUTLIER -155.76 179.11 9.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.379 -0.826 . . . . 75.340000000000003 109.527 -179.129 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 17.4 ttt -104.5 42.09 1.24 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.892 -0.781 . . . . 74.510000000000005 108.892 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.41 ' N ' ' OE1' ' A' ' 177' ' ' GLU . 75.6 t -68.06 138.7 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 65.219999999999999 109.623 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.6 m -69.56 135.01 88.38 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 73.219999999999999 108.759 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 182' ' ' ASN . 69.4 Cg_exo -37.72 109.34 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 121.992 1.795 . . . . 62.43 112.648 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 181' ' ' PRO . 23.5 m120 52.0 101.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.4 -0.812 . . . . 73.129999999999995 110.286 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.8 p -138.85 -4.31 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.4 -0.812 . . . . 74.019999999999996 109.569 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 3.0 mp -53.56 -37.76 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.01 -1.056 . . . . 72.329999999999998 109.503 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -55.23 -30.53 60.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -0.947 . . . . 74.400000000000006 109.421 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 94.1 t -79.23 -57.23 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.082 -1.011 . . . . 74.319999999999993 109.495 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -54.97 -47.19 74.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.157 -0.964 . . . . 73.230000000000004 109.875 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.416 HG22 HD12 ' A' ' 188' ' ' ILE . 0.2 OUTLIER -60.23 -44.2 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.085 -1.009 . . . . 74.310000000000002 109.061 -179.726 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.413 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 0.5 OUTLIER -60.35 -41.71 94.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.959 -1.088 . . . . 73.439999999999998 109.445 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -68.34 -45.13 73.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.93 . . . . 71.420000000000002 109.718 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 85.7 mt -56.41 -37.69 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.263 -0.898 . . . . 72.439999999999998 109.156 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -65.27 -40.68 94.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 64.219999999999999 109.512 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.431 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 14.8 mm100 -76.42 -26.61 55.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 74.319999999999993 110.025 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.425 ' CB ' ' NZ ' ' A' ' 194' ' ' LYS . 8.5 mtpm? -81.67 -25.26 35.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -0.946 . . . . 75.310000000000002 110.581 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 20.1 ptm -95.07 -36.32 11.57 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.033 -1.042 . . . . 74.019999999999996 110.116 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 197' ' ' LYS . 30.9 p-10 -66.04 -34.21 77.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.049 -1.032 . . . . 74.019999999999996 110.021 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.538 ' N ' ' OD1' ' A' ' 196' ' ' ASP . 11.0 ttpp -62.84 -60.87 8.64 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.013 -1.054 . . . . 75.430000000000007 109.876 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -59.04 -52.01 5.79 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.64 1.56 . . . . 72.319999999999993 111.407 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.478 ' N ' ' CD1' ' A' ' 199' ' ' LEU . 8.0 mp -92.53 125.15 37.04 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.345 -0.847 . . . . 74.540000000000006 109.118 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -77.79 -2.18 80.54 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.417 -1.473 . . . . 61.509999999999998 109.417 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 19.6 mt -108.32 137.54 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.501 -1.0 . . . . 74.25 109.392 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 23.1 t -93.23 143.5 26.2 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.26 -0.9 . . . . 72.0 109.4 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 49.2 p -130.58 10.05 5.14 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.511 -0.743 . . . . 74.439999999999998 109.353 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 5.9 m -132.01 142.72 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.504 -0.748 . . . . 71.129999999999995 109.328 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -126.0 134.81 51.36 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.644 -0.66 . . . . 73.510000000000005 109.364 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.0 95.67 8.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.2 -0.938 . . . . 73.519999999999996 109.203 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.573 ' CG1' ' NH1' ' A' ' 213' ' ' ARG . 11.2 p -164.41 170.65 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.96 . . . . 72.150000000000006 109.347 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' ARG . . . . . 0.657 ' HE ' ' NH2' ' A' ' 210' ' ' ARG . 6.2 tpt180 76.65 146.16 0.09 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.495 -0.753 . . . . 72.400000000000006 109.547 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -61.5 -34.29 75.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.361 -0.837 . . . . 73.310000000000002 109.792 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.657 ' NH2' ' HE ' ' A' ' 208' ' ' ARG . 0.2 OUTLIER -49.94 -50.92 44.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 71.540000000000006 109.092 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 148.29 -106.06 0.33 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.051 -1.22 . . . . 74.450000000000003 110.051 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 212' ' ' TYR . 20.3 m-85 -113.43 145.38 41.25 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.568 -0.96 . . . . 75.540000000000006 109.484 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.573 ' NH1' ' CG1' ' A' ' 207' ' ' VAL . 7.8 mtm-85 -117.42 135.09 54.13 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.521 -0.737 . . . . 75.310000000000002 109.226 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -100.01 128.1 46.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.281 -0.887 . . . . 75.409999999999997 109.379 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 3.6 p -141.46 156.4 45.77 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.378 -0.826 . . . . 74.140000000000001 109.29 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -68.83 152.85 96.55 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.91 . . . . 75.319999999999993 109.108 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -38.03 146.67 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.299 1.999 . . . . 73.109999999999999 112.254 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.435 ' CB ' ' CD ' ' A' ' 219' ' ' PRO . 26.7 mtpt -55.94 -64.61 2.12 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 75.25 109.489 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' A' ' 218' ' ' LYS . 33.7 Cg_endo -62.63 -31.5 79.45 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.078 1.852 . . . . 75.099999999999994 111.904 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . 48.03 -144.96 0.35 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 71.140000000000001 109.575 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' CYS . . . . . 0.405 ' O ' ' O ' ' A' ' 222' ' ' GLU . 20.9 p -59.68 -31.3 69.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.258 -0.901 . . . . 71.129999999999995 109.407 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 221' ' ' CYS . 86.4 tt0 49.04 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 75.349999999999994 109.511 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.056 -0.974 . . . . 73.409999999999997 109.457 179.95 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.591 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.401 -0.592 . . . . 75.239999999999995 109.401 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -140.15 147.5 40.26 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.358 -0.839 . . . . 73.519999999999996 109.46 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 93.3 t -114.99 123.29 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 121.596 0.712 . . . . 72.239999999999995 109.585 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 3.1 tp -91.34 118.05 30.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.898 . . . . 73.340000000000003 108.655 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 tt -118.08 117.0 28.02 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.49 -0.93 . . . . 74.349999999999994 108.49 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 78.2 mt -111.87 98.96 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.297 -0.877 . . . . 63.439999999999998 108.983 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.426 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 26.7 tp10 -129.31 135.68 49.06 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.516 -0.74 . . . . 74.519999999999996 109.434 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -67.83 -32.8 73.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 74.129999999999995 109.245 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -89.62 121.44 31.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.874 . . . . 74.230000000000004 109.47 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 23.2 m -73.7 -32.31 63.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 65.540000000000006 109.828 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 98.4 t -60.69 -47.65 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.14 -0.975 . . . . 75.549999999999997 109.829 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.508 ' CD2' ' N ' ' B' ' 12' ' ' LEU . 3.4 mm? -64.02 -33.27 75.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.155 -0.966 . . . . 70.140000000000001 109.297 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.39 -28.59 59.55 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.755 -1.738 . . . . 75.400000000000006 108.755 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.13 -50.13 62.32 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.299 -1.52 . . . . 65.439999999999998 109.299 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -62.2 -44.67 96.06 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.305 -1.114 . . . . 72.200000000000003 109.405 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.409 ' CD1' ' CZ ' ' B' ' 99' ' ' TYR . 5.3 mm -63.3 -35.62 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.884 -1.135 . . . . 75.150000000000006 108.399 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' B' ' 27' ' ' ALA . 43.4 tp10 -63.9 -49.11 73.95 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.329 -0.857 . . . . 73.010000000000005 109.224 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -80.53 0.56 33.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.97 . . . . 74.299999999999997 109.166 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.9 -62.35 1.52 Allowed Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.55 -1.42 . . . . 70.540000000000006 109.55 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -68.38 -23.64 64.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -1.154 . . . . 75.430000000000007 109.639 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -51.56 -35.01 39.28 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.055 -1.028 . . . . 73.200000000000003 109.381 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 74.9 t -55.22 -38.93 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.162 -0.961 . . . . 74.230000000000004 108.884 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' LYS . . . . . 0.412 ' N ' ' CD ' ' B' ' 23' ' ' LYS . 4.7 mptp? -70.14 -25.67 63.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.441 -0.787 . . . . 73.519999999999996 109.2 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.47 20.06 10.64 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 110.293 -1.123 . . . . 53.43 110.293 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -96.72 159.99 14.62 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.071 -1.252 . . . . 71.120000000000005 109.333 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 61.3 mmm -104.65 139.89 38.83 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.674 -0.861 . . . . 75.239999999999995 108.674 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . 0.426 ' O ' ' OE2' ' B' ' 17' ' ' GLU . . . -141.13 153.11 45.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.191 -0.943 . . . . 73.25 110.16 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -133.05 134.01 43.79 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.791 -0.818 . . . . 72.310000000000002 108.791 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.31 138.06 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.278 -1.008 . . . . 72.140000000000001 108.278 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.4 p -139.12 165.61 26.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.282 -0.886 . . . . 74.530000000000001 109.525 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -84.3 -99.58 0.05 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.889 . . . . 71.019999999999996 109.33 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 60.7 p -78.32 161.7 27.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 71.400000000000006 109.579 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' B' ' 37' ' ' GLU . 2.8 mp -56.85 -31.53 64.87 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.448 -0.783 . . . . 71.239999999999995 109.814 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -56.61 -43.67 80.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.108 -0.995 . . . . 74.319999999999993 109.637 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -63.18 -42.26 99.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.135 -0.978 . . . . 73.030000000000001 109.31 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.31 -30.88 48.61 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.45 -1.46 . . . . 60.43 109.45 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' B' ' 33' ' ' LEU . 14.8 tm-20 -63.7 -41.53 98.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -1.153 . . . . 74.430000000000007 109.462 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -74.28 -38.44 63.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 74.420000000000002 109.547 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 21.6 tp -68.65 -48.28 64.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 75.409999999999997 109.981 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' MET . . . . . 0.442 ' O ' ' O ' ' B' ' 43' ' ' ARG . 16.1 ptm -66.52 -23.84 66.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.116 -0.99 . . . . 61.439999999999998 109.789 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.26 -38.03 79.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.074 -1.016 . . . . 74.319999999999993 109.781 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 10.7 pt -97.61 -1.68 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.177 -0.952 . . . . 71.230000000000004 110.206 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' B' ' 40' ' ' MET . 31.1 mmt180 -125.99 155.48 41.34 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.317 -0.864 . . . . 73.409999999999997 109.593 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' B' ' 45' ' ' TYR . 53.9 t-20 -86.76 151.33 23.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.249 -0.907 . . . . 63.539999999999999 109.269 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' TYR . . . . . 0.559 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 1.3 p90 -142.77 115.8 8.84 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.16 -0.962 . . . . 73.109999999999999 109.518 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -90.57 -34.77 15.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.277 -0.889 . . . . 62.219999999999999 108.907 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.403 ' C ' ' CD1' ' B' ' 47' ' ' LEU . 0.9 OUTLIER -111.68 110.55 21.0 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.695 -0.854 . . . . 73.120000000000005 108.695 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 68.5 t -94.56 98.77 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.217 -0.927 . . . . 74.109999999999999 109.118 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 17.2 ttt -113.24 127.13 56.07 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.631 0.729 . . . . 73.439999999999998 109.581 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . 0.455 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.2 OUTLIER -145.0 133.91 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.394 -0.816 . . . . 73.400000000000006 109.38 -179.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' SER . . . . . 0.43 ' CB ' ' OG ' ' B' ' 74' ' ' SER . 53.0 p -100.31 17.43 21.43 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.603 -0.685 . . . . 73.209999999999994 109.908 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.455 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 82.9 m-20 -83.12 135.17 34.91 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.095 -1.003 . . . . 70.409999999999997 109.408 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.426 ' C ' ' H ' ' B' ' 55' ' ' ALA . 67.2 mmtt -70.16 -38.03 75.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.296 -0.878 . . . . 73.129999999999995 110.118 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' ASN . . . . . 0.577 ' H ' HD21 ' B' ' 54' ' ' ASN . 1.0 OUTLIER -75.62 13.0 0.87 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 75.209999999999994 109.875 -179.444 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.426 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -72.78 -21.73 60.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 55.329999999999998 110.113 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.419 ' O ' ' OG ' ' B' ' 60' ' ' SER . 33.5 mt -43.44 -35.98 1.8 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.322 -0.861 . . . . 72.420000000000002 110.438 -179.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 82.7 p -77.16 -47.59 19.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.941 -1.099 . . . . 73.040000000000006 109.825 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -63.94 -44.92 91.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 72.329999999999998 110.398 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 17.0 m -63.85 -40.24 88.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 120.668 -1.27 . . . . 74.540000000000006 109.685 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' B' ' 56' ' ' LEU . 59.2 m -53.71 -50.88 64.92 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.162 -0.961 . . . . 71.239999999999995 109.676 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.434 HH21 ' NZ ' ' B' ' 65' ' ' LYS . 11.9 ptm180 -67.8 -32.34 72.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.143 -0.973 . . . . 74.310000000000002 110.279 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' B' ' 66' ' ' HIS . 4.9 mm -63.6 -43.98 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.706 -1.246 . . . . 75.420000000000002 110.001 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -64.78 -50.51 66.52 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.222 -0.924 . . . . 73.319999999999993 110.571 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -68.84 -40.67 79.27 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.71 -1.244 . . . . 73.310000000000002 110.032 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.513 ' O ' ' ND1' ' B' ' 66' ' ' HIS . 45.2 mtpt -77.29 -29.69 53.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.125 -0.984 . . . . 72.439999999999998 109.724 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.544 ' CE1' ' NZ ' ' B' ' 145' ' ' LYS . 42.3 m-70 -144.47 67.84 1.26 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.15 -0.969 . . . . 65.209999999999994 109.913 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 81.3 p -65.62 -25.68 67.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 73.099999999999994 109.231 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 4.2 t -62.18 -24.63 67.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.864 . . . . 71.530000000000001 109.647 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 74.3 mt -86.43 152.04 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.311 -0.868 . . . . 74.400000000000006 109.401 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 80.1 t -91.08 161.0 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.341 -0.85 . . . . 75.120000000000005 109.386 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 14.8 t -141.15 122.39 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.169 -0.957 . . . . 73.200000000000003 109.264 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 mp -117.66 103.09 9.69 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.76 -0.83 . . . . 73.340000000000003 108.76 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 70.9 t -90.12 118.69 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.314 -0.866 . . . . 73.5 108.677 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' SER . . . . . 0.43 ' OG ' ' CB ' ' B' ' 51' ' ' SER . 24.4 p -86.27 170.62 11.91 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.16 -0.962 . . . . 71.319999999999993 109.009 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' SER . . . . . 0.499 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 35.3 m -159.48 115.53 2.54 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.949 -1.095 . . . . 74.530000000000001 110.244 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -63.37 -22.93 67.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.44 -0.788 . . . . 64.5 109.69 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' B' ' 79' ' ' THR . 8.7 m-80 -125.09 79.33 65.73 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.505 -0.747 . . . . 74.25 109.623 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.13 86.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.494 2.129 . . . . 74.430000000000007 111.3 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.463 ' N ' ' O ' ' B' ' 77' ' ' ASN . 20.7 m -100.04 150.57 22.31 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.532 -0.73 . . . . 73.120000000000005 109.807 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 4.5 p -69.01 -38.01 79.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.412 -0.805 . . . . 75.409999999999997 109.661 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -63.03 -37.37 86.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.92 . . . . 72.239999999999995 109.669 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -71.76 -32.46 67.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.207 -0.933 . . . . 73.219999999999999 109.647 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.51 ' OE2' ' NE ' ' A' ' 100' ' ' ARG . 95.0 mt-10 -64.87 -52.77 54.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.974 . . . . 74.299999999999997 109.749 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 18.6 m -60.24 -35.94 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.113 -0.992 . . . . 73.310000000000002 109.283 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -75.43 -27.43 58.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.271 -0.893 . . . . 73.239999999999995 109.464 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.68 -37.57 85.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.175 -0.953 . . . . 55.329999999999998 109.937 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -83.39 -36.26 24.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 74.450000000000003 109.22 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -71.9 -39.92 69.2 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.316 -0.865 . . . . 64.040000000000006 109.483 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -68.6 -50.12 53.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 75.129999999999995 109.4 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.65 69.84 0.01 OUTLIER Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.927 -1.13 . . . . 75.420000000000002 110.302 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -132.67 130.18 39.77 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.322 -1.105 . . . . 73.420000000000002 109.139 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -71.28 -33.81 70.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.918 . . . . 73.319999999999993 109.286 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . 0.437 ' OD2' ' NH2' ' B' ' 108' ' ' ARG . 14.1 t70 -152.25 161.8 42.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -0.843 . . . . 73.040000000000006 109.414 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' TYR . . . . . 0.499 ' OH ' ' CB ' ' B' ' 75' ' ' SER . 57.4 t80 -132.25 120.24 21.9 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.86 -0.792 . . . . 74.310000000000002 108.86 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . 0.53 ' N ' ' CD1' ' B' ' 95' ' ' ILE . 0.0 OUTLIER -128.08 154.63 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 CA-C-O 121.793 0.806 . . . . 75.340000000000003 110.493 -178.43 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.0 149.78 48.41 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.19 -1.041 . . . . 70.099999999999994 108.19 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . 0.665 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -74.24 -56.48 2.55 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.785 -1.197 . . . . 65.430000000000007 111.451 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 5.2 Cg_endo -41.95 -9.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 120.852 1.035 . . . . 63.520000000000003 112.944 -176.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' TYR . . . . . 0.665 ' N ' ' O ' ' B' ' 97' ' ' LYS . 34.0 m-85 61.19 125.71 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.652 -0.655 . . . . 75.129999999999995 109.438 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . 0.416 ' NE ' ' OE2' ' A' ' 83' ' ' GLU . 39.4 ttm-85 -66.35 -34.39 77.87 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.888 -1.133 . . . . 74.230000000000004 108.85 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' SER . . . . . 0.736 ' O ' ' N ' ' B' ' 103' ' ' LYS . 10.9 t -172.69 38.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.198 -0.938 . . . . 64.510000000000005 110.6 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 26.2 mm 50.91 -69.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.659 -0.651 . . . . 74.439999999999998 110.415 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' LYS . . . . . 0.736 ' N ' ' O ' ' B' ' 101' ' ' SER . 16.2 mtpp -57.46 -29.35 64.14 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.313 -0.995 . . . . 72.299999999999997 108.313 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.72 -46.54 81.84 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.542 -0.91 . . . . 74.310000000000002 108.542 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 13.0 tp -64.63 -54.45 31.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.478 -0.764 . . . . 73.540000000000006 109.011 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 23.4 t -57.85 -38.19 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.116 -0.99 . . . . 72.030000000000001 109.495 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.06 -48.26 70.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.25 -0.906 . . . . 64.219999999999999 109.616 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 108' ' ' ARG . . . . . 0.437 ' NH2' ' OD2' ' B' ' 93' ' ' ASP . 8.5 ttp-105 -68.73 -31.49 70.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 75.310000000000002 109.869 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . 0.421 HD11 HG21 ' B' ' 109' ' ' ILE . 96.8 mt -74.33 -26.3 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.047 -1.033 . . . . 55.439999999999998 108.941 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -71.7 -54.0 11.7 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.418 -0.801 . . . . 65.310000000000002 109.53 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.3 -43.41 78.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.105 -0.997 . . . . 74.519999999999996 109.379 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 9.0 tpm_? -69.79 -41.73 74.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.258 -0.902 . . . . 72.040000000000006 109.455 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 14.0 tp -96.55 65.13 2.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.25 -0.906 . . . . 75.349999999999994 109.775 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 114' ' ' ARG . . . . . 0.533 ' CA ' ' HE ' ' B' ' 114' ' ' ARG . 0.0 OUTLIER -142.48 -62.23 0.44 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.193 -0.942 . . . . 75.5 108.695 179.647 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -89.33 22.93 2.69 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.219 -0.925 . . . . 73.040000000000006 109.511 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -62.28 -35.64 79.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.165 -0.959 . . . . 74.450000000000003 109.665 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.29 128.84 33.88 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.911 -1.275 . . . . 64.209999999999994 109.911 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 97.5 p -159.45 166.52 30.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.359 -1.083 . . . . 71.400000000000006 110.093 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.4 137.06 12.21 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.693 -0.854 . . . . 74.209999999999994 108.693 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 5.2 t -107.88 -41.37 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.323 -0.861 . . . . 75.019999999999996 110.593 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 19.1 mm -97.95 140.3 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.048 -1.033 . . . . 74.239999999999995 109.924 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -148.75 131.6 16.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.404 -0.81 . . . . 73.329999999999998 109.33 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 10.9 tp -156.35 127.11 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 74.219999999999999 109.004 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.83 -155.31 4.29 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.1 -1.6 . . . . 72.409999999999997 109.1 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -76.86 2.18 15.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.157 -1.202 . . . . 75.120000000000005 108.938 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.46 134.37 38.38 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.644 -0.872 . . . . 75.420000000000002 108.644 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 3.3 m -131.7 141.46 49.56 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.363 -0.836 . . . . 74.219999999999999 109.153 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 54.1 mt -132.38 130.21 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.276 -0.89 . . . . 60.329999999999998 109.998 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 129' ' ' SER . . . . . 0.459 ' O ' ' N ' ' B' ' 133' ' ' GLU . 18.9 m -115.32 98.88 51.58 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 108.786 -0.82 . . . . 72.310000000000002 108.786 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.12 -40.7 2.31 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.39 1.394 . . . . 75.129999999999995 112.041 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -56.78 -36.54 69.97 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.895 -1.128 . . . . 75.230000000000004 108.161 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -98.07 -10.0 25.0 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.715 -0.846 . . . . 75.120000000000005 108.715 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' B' ' 129' ' ' SER . 30.0 mt-10 53.84 61.33 3.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.121 -0.987 . . . . 75.129999999999995 108.393 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -137.01 112.92 9.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.503 -0.748 . . . . 75.109999999999999 109.915 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.44 137.49 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 106.456 -1.683 . . . . 70.319999999999993 106.456 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 40.2 mt -129.23 120.8 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.258 -0.901 . . . . 74.120000000000005 110.319 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -142.62 144.11 32.68 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.465 -0.772 . . . . 74.230000000000004 109.342 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt 54.6 26.37 7.3 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.43 -0.794 . . . . 74.219999999999999 110.206 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 75.22 13.68 82.55 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.334 -1.106 . . . . 74.319999999999993 110.334 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 40.8 mtp85 -104.37 123.89 48.22 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.335 -1.097 . . . . 75.340000000000003 108.99 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -95.75 137.4 34.87 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.384 -0.822 . . . . 71.230000000000004 110.162 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 1.2 p -139.51 131.33 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.206 -0.933 . . . . 70.430000000000007 109.346 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -89.03 144.32 26.23 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.834 -1.172 . . . . 72.430000000000007 107.834 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 144' ' ' VAL . . . . . 0.518 ' HB ' ' CD1' ' B' ' 149' ' ' PHE . 5.9 m -132.11 150.21 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.263 -0.898 . . . . 72.129999999999995 109.782 -179.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 145' ' ' LYS . . . . . 0.544 ' NZ ' ' CE1' ' B' ' 66' ' ' HIS . 25.2 pttt -174.19 109.87 0.15 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.512 -0.743 . . . . 74.5 109.51 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . 0.99 ' O ' ' HG3' ' B' ' 150' ' ' GLU . . . 166.71 -160.21 33.77 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.422 -1.471 . . . . 42.229999999999997 109.422 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . 1.289 ' NZ ' ' HG3' ' B' ' 176' ' ' PRO . 26.1 ttpt -87.37 -36.9 0.48 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.149 -1.207 . . . . 73.299999999999997 110.675 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 148' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 72.2 Cg_endo -85.12 4.61 6.68 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 121.566 1.511 . . . . 71.329999999999998 110.934 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 149' ' ' PHE . . . . . 0.518 ' CD1' ' HB ' ' B' ' 144' ' ' VAL . 41.3 m-85 -108.58 -40.0 5.23 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.496 0.665 . . . . 74.230000000000004 109.259 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . 0.99 ' HG3' ' O ' ' B' ' 146' ' ' GLY . 41.8 mt-10 -59.65 -34.4 72.77 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.167 -0.958 . . . . 72.340000000000003 108.512 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . 0.545 HG11 HD21 ' B' ' 152' ' ' LEU . 12.7 p -61.05 -40.84 87.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.639 -0.824 . . . . 73.349999999999994 108.854 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . 0.545 HD21 HG11 ' B' ' 151' ' ' VAL . 4.6 mm? -56.84 -52.39 65.3 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.711 -0.848 . . . . 74.430000000000007 108.711 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 153' ' ' THR . . . . . 0.467 ' H ' ' HG1' ' B' ' 153' ' ' THR . 1.6 p -62.36 -32.94 73.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.392 -0.818 . . . . 75.209999999999994 109.593 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -62.21 -56.15 21.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.991 -1.068 . . . . 73.040000000000006 109.463 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.64 -22.21 63.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.057 -1.027 . . . . 73.430000000000007 109.14 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.48 -49.99 74.49 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.127 -0.983 . . . . 75.319999999999993 108.653 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.425 ' C ' ' H ' ' B' ' 159' ' ' ARG . 51.3 mtp85 -69.64 -52.8 22.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.332 -0.855 . . . . 73.319999999999993 109.041 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -76.74 20.35 0.24 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.467 -0.771 . . . . 74.140000000000001 110.313 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . 1.282 HH11 ' CB ' ' B' ' 159' ' ' ARG . 0.0 OUTLIER -50.02 -38.49 37.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.104 -0.998 . . . . 73.420000000000002 109.096 179.868 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -98.15 67.6 1.89 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.25 -0.906 . . . . 72.099999999999994 109.584 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 161' ' ' GLN . . . . . 0.432 ' OE1' ' OD2' ' A' ' 160' ' ' ASP . 9.6 tp-100 -171.08 161.93 6.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.142 -0.974 . . . . 73.239999999999995 109.675 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 162' ' ' ILE . . . . . 0.408 HD13 HG22 ' B' ' 162' ' ' ILE . 13.6 mm -82.88 142.82 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.472 -0.768 . . . . 72.310000000000002 109.727 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.27 128.52 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.462 -0.774 . . . . 75.030000000000001 109.269 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 52.5 p -98.79 153.7 18.56 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.181 -0.949 . . . . 74.219999999999999 109.92 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -52.24 -50.99 60.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.36 -0.838 . . . . 72.420000000000002 109.494 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -51.65 -39.71 58.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.372 -0.83 . . . . 63.450000000000003 109.907 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -65.86 -41.52 91.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.116 -0.99 . . . . 72.400000000000006 109.607 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 80.6 mt -52.02 -53.79 37.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.018 -1.051 . . . . 72.319999999999993 109.162 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 169' ' ' LEU . . . . . 0.576 ' O ' ' N ' ' B' ' 171' ' ' ALA . 52.4 mt -64.9 -67.9 0.4 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.341 -0.849 . . . . 73.340000000000003 110.059 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -42.91 -15.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.693 -0.629 . . . . 73.099999999999994 110.878 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 171' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' B' ' 169' ' ' LEU . . . -93.39 -41.12 10.0 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.93 -1.106 . . . . 62.130000000000003 112.196 -178.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 172' ' ' ILE . . . . . 0.568 ' C ' ' H ' ' B' ' 174' ' ' GLU . 4.8 mp -123.47 -34.23 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.791 0 O-C-N 120.768 -1.208 . . . . 74.439999999999998 113.209 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 173' ' ' TRP . . . . . 0.476 ' CD2' ' C ' ' B' ' 173' ' ' TRP . 0.0 OUTLIER -61.48 7.2 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.319 0 O-C-N 120.047 -1.658 . . . . 72.230000000000004 110.49 -177.984 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . 0.568 ' H ' ' C ' ' B' ' 172' ' ' ILE . 56.9 tt0 -72.01 -16.24 62.06 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.006 -1.059 . . . . 75.030000000000001 109.578 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 175' ' ' GLU . . . . . 0.405 ' CB ' ' CD ' ' B' ' 176' ' ' PRO . 5.6 mt-10 -83.44 -65.65 0.22 Allowed Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.039 -1.038 . . . . 73.040000000000006 109.887 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 176' ' ' PRO . . . . . 1.289 ' HG3' ' NZ ' ' B' ' 147' ' ' LYS . 59.2 Cg_endo -69.89 -62.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.763 1.642 . . . . 74.129999999999995 112.235 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . 0.434 ' H ' ' HG2' ' B' ' 176' ' ' PRO . 7.2 tt0 71.43 -30.34 0.21 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.363 -0.836 . . . . 72.439999999999998 109.319 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 178' ' ' MET . . . . . 0.555 ' H ' ' C ' ' B' ' 176' ' ' PRO . 22.0 mtt -66.17 -22.67 66.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.144 -0.973 . . . . 72.109999999999999 109.01 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 4.7 m -47.66 156.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.612 -0.68 . . . . 75.310000000000002 109.727 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 180' ' ' THR . . . . . 0.43 ' O ' ' N ' ' B' ' 183' ' ' VAL . 73.4 p -92.71 144.98 29.48 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.196 -0.94 . . . . 62.149999999999999 109.191 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 181' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' B' ' 183' ' ' VAL . 93.4 Cg_exo -39.81 -42.52 3.08 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.122 1.881 . . . . 74.340000000000003 112.88 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 182' ' ' ASN . . . . . 0.428 ' OD1' ' OG1' ' B' ' 180' ' ' THR . 43.3 p30 -70.8 8.42 0.89 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.074 -1.017 . . . . 72.310000000000002 110.218 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 183' ' ' VAL . . . . . 0.43 ' N ' ' O ' ' B' ' 180' ' ' THR . 12.3 p -66.83 -22.16 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.049 -1.032 . . . . 65.420000000000002 109.594 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 54.5 mt -54.52 -50.04 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 75.030000000000001 109.92 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -60.84 -40.98 94.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 73.519999999999996 109.887 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 3.6 t -69.35 -40.04 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.521 -0.737 . . . . 74.349999999999994 110.486 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.59 -53.68 9.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 61.119999999999997 110.031 -179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 11.0 tp -58.06 -25.4 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.96 . . . . 72.430000000000007 109.741 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -75.83 -56.97 4.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.256 -0.903 . . . . 75.420000000000002 110.52 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -65.32 -34.75 79.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.023 -1.048 . . . . 74.140000000000001 110.141 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 86.7 mt -63.69 -59.04 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.032 -1.042 . . . . 74.030000000000001 109.939 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 192' ' ' ARG . . . . . 0.655 HH21 HG21 ' B' ' 204' ' ' VAL . 21.0 mtp-105 -60.26 -35.86 76.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.166 -0.959 . . . . 72.329999999999998 109.622 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 193' ' ' GLN . . . . . 0.43 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 79.9 mm-40 -70.32 -33.95 72.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.183 -0.948 . . . . 73.099999999999994 109.452 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 194' ' ' LYS . . . . . 0.458 ' CB ' ' NZ ' ' B' ' 194' ' ' LYS . 7.3 mtpm? -79.58 -17.25 54.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.181 -0.949 . . . . 74.430000000000007 110.013 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 44.1 ttp -98.12 -11.52 22.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.139 -0.976 . . . . 74.329999999999998 110.372 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 196' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 57.3 p30 -107.91 -14.61 14.73 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.025 -1.047 . . . . 71.209999999999994 110.393 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . 0.594 ' N ' ' CD ' ' B' ' 198' ' ' PRO . 30.5 tttt -78.16 -40.8 1.95 Allowed Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 120.851 -1.156 . . . . 75.209999999999994 110.03 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 198' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' B' ' 197' ' ' LYS . 40.7 Cg_endo -89.47 -44.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.449 2.1 . . . . 75.319999999999993 112.473 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . 0.453 ' N ' ' CD1' ' B' ' 199' ' ' LEU . 9.1 mp -61.1 -54.03 49.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.862 -1.149 . . . . 72.25 109.085 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 99.74 -0.02 56.52 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.069 -1.212 . . . . 73.239999999999995 110.069 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 38.7 mt -130.79 145.25 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.373 -1.075 . . . . 54.299999999999997 109.25 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 28.7 t -97.85 135.28 39.82 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.295 -0.878 . . . . 74.310000000000002 109.252 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 203' ' ' THR . . . . . 0.523 ' HG1' HH21 ' B' ' 159' ' ' ARG . 6.8 p -135.09 5.62 3.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.344 -0.848 . . . . 74.400000000000006 109.277 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.655 HG21 HH21 ' B' ' 192' ' ' ARG . 16.2 m -108.42 139.17 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.448 -0.783 . . . . 74.099999999999994 109.479 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -125.2 128.72 48.78 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.55 -0.719 . . . . 75.329999999999998 109.372 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.87 124.45 40.85 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.242 -0.911 . . . . 71.400000000000006 109.451 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . 0.443 ' O ' ' O ' ' B' ' 208' ' ' ARG . 6.1 m -151.42 143.11 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.274 -0.891 . . . . 63.5 109.173 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 208' ' ' ARG . . . . . 0.484 ' O ' ' N ' ' B' ' 210' ' ' ARG . 19.3 tpt180 -58.61 -109.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.089 -1.007 . . . . 74.450000000000003 109.108 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 50.63 -94.84 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.955 -1.091 . . . . 74.140000000000001 109.386 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' B' ' 208' ' ' ARG . 67.3 mtt-85 -107.62 -55.31 2.37 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.737 -0.602 . . . . 74.430000000000007 109.771 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 211' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' B' ' 207' ' ' VAL . . . -174.42 -105.92 0.19 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.558 -1.417 . . . . 70.109999999999999 109.558 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -110.77 162.41 14.8 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.382 -1.07 . . . . 74.209999999999994 109.117 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 213' ' ' ARG . . . . . 0.677 HH12 ' CB ' ' B' ' 215' ' ' CYS . 35.4 ttt-85 -130.23 122.95 29.04 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.435 -0.791 . . . . 74.299999999999997 109.164 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 214' ' ' PHE . . . . . 0.538 ' HB3' ' O ' ' B' ' 159' ' ' ARG . 17.4 m-85 -104.13 124.67 49.51 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.447 -0.783 . . . . 74.340000000000003 109.317 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 215' ' ' CYS . . . . . 0.677 ' CB ' HH12 ' B' ' 213' ' ' ARG . 1.7 m -163.51 154.64 16.56 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.112 -0.992 . . . . 72.209999999999994 109.143 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -68.58 147.87 98.06 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 120.954 -1.091 . . . . 72.310000000000002 108.167 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.89 -103.81 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.122 1.882 . . . . 71.010000000000005 113.143 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.78 148.02 81.77 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.96 -1.087 . . . . 74.349999999999994 109.979 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -38.84 101.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.352 2.035 . . . . 71.319999999999993 112.529 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -76.47 -170.03 1.39 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.127 -0.983 . . . . 75.450000000000003 109.276 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 32.9 m 52.89 -173.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.291 -0.881 . . . . 72.219999999999999 109.614 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.463 ' CD ' ' N ' ' B' ' 223' ' ' GLU . 3.4 tm-20 -87.88 140.59 29.35 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.233 -0.917 . . . . 74.299999999999997 109.426 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . 0.463 ' N ' ' CD ' ' B' ' 222' ' ' GLU . 3.9 pt-20 . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 117.966 -1.016 . . . . 71.129999999999995 109.4 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptp . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.513 -0.551 . . . . 65.12 109.513 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -140.4 152.25 45.59 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.332 -0.855 . . . . 72.33 109.182 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.9 t -116.32 138.83 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.651 -0.656 . . . . 71.42 109.708 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.546 HD11 ' CG1' ' A' ' 6' ' ' ILE . 2.3 tp -115.87 121.12 41.41 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.462 -0.774 . . . . 65.12 109.043 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 4' ' ' LEU . 16.9 mt -117.68 107.03 13.71 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.044 -0.725 . . . . 62.43 109.044 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.546 ' CG1' HD11 ' A' ' 4' ' ' LEU . 76.7 mt -98.83 112.66 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.248 -0.907 . . . . 71.15 108.829 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.429 ' OE1' ' N ' ' A' ' 13' ' ' GLY . 68.8 tt0 -149.49 127.89 12.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.169 -0.957 . . . . 75.34 109.565 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -62.94 -32.82 74.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -0.874 . . . . 72.44 109.431 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -82.05 105.26 13.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -0.892 . . . . 63.02 109.457 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.8 m -64.87 -28.19 69.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.9 . . . . 72.34 109.783 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.0 t -63.73 -49.24 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.156 -0.965 . . . . 74.02 109.795 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.573 HD13 ' OE2' ' A' ' 15' ' ' GLU . 3.5 mm? -69.85 -46.05 66.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.165 -0.959 . . . . 71.43 109.452 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.429 ' N ' ' OE1' ' A' ' 7' ' ' GLU . . . -66.13 -17.64 66.03 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.4 -1.88 . . . . 61.32 108.4 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.49 -57.59 4.98 Favored Glycine 0 N--CA 1.483 1.776 0 N-CA-C 109.589 -1.405 . . . . 71.2 109.589 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.573 ' OE2' HD13 ' A' ' 12' ' ' LEU . 13.1 pt-20 -53.0 -46.8 68.5 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.446 -1.032 . . . . 71.32 109.714 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.4 mm -61.24 -46.36 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.8 -1.187 . . . . 63.23 108.636 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.507 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 81.1 tt0 -46.54 -52.56 13.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 51.11 109.752 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -88.89 4.89 46.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.168 -0.958 . . . . 73.34 109.741 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.21 -63.54 1.79 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.958 -1.257 . . . . 62.15 109.958 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.496 HD23 ' N ' ' A' ' 20' ' ' LEU . 1.8 pt? -72.62 -19.85 61.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.18 -1.188 . . . . 73.51 110.228 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 86.4 m-20 -52.79 -33.47 49.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.883 -1.136 . . . . 74.25 109.466 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 86.7 t -58.5 -31.92 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 70.04 109.333 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.415 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 11.5 mptt -74.05 -2.8 25.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 73.23 109.25 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.84 23.17 43.02 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.074 -1.21 . . . . 75.54 110.074 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -99.4 158.2 15.89 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.214 -1.168 . . . . 73.43 109.323 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.3 mtt -101.55 139.59 36.99 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.03 -1.1 . . . . 43.24 108.03 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.64 152.7 41.69 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.045 -1.035 . . . . 62.11 110.758 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -135.1 140.92 45.87 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.565 -0.902 . . . . 74.42 108.565 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -107.6 138.28 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.839 . . . . 72.15 109.004 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.7 p -134.95 168.86 18.32 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.453 -0.779 . . . . 71.42 109.491 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.436 ' OE2' ' OD2' ' A' ' 35' ' ' ASP . 4.3 pt-20 -87.41 -102.92 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 72.33 109.559 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.0 p -77.46 163.66 26.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 74.24 109.476 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.515 ' H ' HD12 ' A' ' 33' ' ' LEU . 3.0 mp -58.42 -29.85 66.43 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.45 -0.781 . . . . 71.53 110.026 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -49.89 -43.57 49.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.036 -1.04 . . . . 74.23 109.519 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.436 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 31.9 m-20 -66.8 -42.3 86.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.207 -0.933 . . . . 54.03 109.053 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.38 -42.54 95.95 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.489 -1.444 . . . . 61.41 109.489 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -65.73 -37.85 87.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -1.154 . . . . 74.34 109.336 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.443 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 68.3 t80 -78.64 -21.38 48.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.923 . . . . 75.33 109.581 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.6 tp -90.0 -32.79 16.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.197 -0.939 . . . . 74.33 109.853 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 40' ' ' MET . 3.4 ppp? -78.93 -29.42 44.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.151 -0.968 . . . . 70.32 110.637 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 31.4 p-10 -58.8 -34.28 71.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.795 -1.191 . . . . 71.22 109.845 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.541 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 14.7 pt -90.39 -26.42 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.084 -1.01 . . . . 74.14 110.05 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 40' ' ' MET . 93.6 mtt180 -127.36 138.9 53.13 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.386 -0.821 . . . . 72.24 109.41 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -92.66 152.55 19.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.132 -0.98 . . . . 75.42 109.594 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -133.83 154.44 51.02 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.517 -0.739 . . . . 74.23 109.254 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -94.44 -43.83 8.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.139 -0.976 . . . . 72.04 108.899 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.503 HD13 ' C ' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -106.34 108.91 20.65 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.743 -0.836 . . . . 72.13 108.743 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.445 ' N ' HD13 ' A' ' 47' ' ' LEU . 2.3 m -107.77 105.24 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.297 -1.001 . . . . 72.34 108.297 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.6 ttt -115.18 145.54 42.29 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.511 0.672 . . . . 74.11 109.556 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.547 HG22 ' H ' ' A' ' 52' ' ' ASP . 1.6 p -144.51 133.16 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.487 -0.758 . . . . 61.12 110.19 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 t -98.54 4.57 48.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.499 -0.751 . . . . 73.11 109.454 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.547 ' H ' HG22 ' A' ' 50' ' ' VAL . 52.6 m-20 -76.0 142.15 41.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.141 -0.974 . . . . 52.55 109.377 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 55' ' ' ALA . 67.5 mttm -77.69 -42.76 33.38 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.282 -0.886 . . . . 44.22 110.647 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -70.63 14.54 0.13 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.027 -1.045 . . . . 70.44 109.874 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.29 -19.88 59.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 64.14 110.434 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.0 mt -42.0 -49.06 4.69 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.286 -0.884 . . . . 44.14 110.606 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.9 p -68.56 -37.85 80.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.954 -1.092 . . . . 55.23 109.522 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.52 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 70.7 t80 -67.8 -63.57 1.03 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 74.44 109.914 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.7 m -49.25 -31.72 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.86 -1.15 . . . . 74.03 109.636 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.3 t -60.6 -53.33 58.77 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.149 -0.97 . . . . 64.3 109.11 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -67.87 -27.54 66.76 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.687 -1.205 . . . . 64.44 109.652 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.539 ' O ' ' N ' ' A' ' 66' ' ' HIS . 25.3 mm -56.34 -46.12 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.826 -1.172 . . . . 63.21 108.409 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -63.72 -40.47 96.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.13 -0.981 . . . . 74.42 108.354 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -67.58 -50.85 56.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.385 -0.822 . . . . 70.32 109.246 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.52 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 91.9 mttt -78.15 -12.09 59.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.603 -0.686 . . . . 75.22 110.048 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.578 ' O ' HG22 ' A' ' 69' ' ' ILE . 97.9 m-70 -157.69 70.9 0.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.93 . . . . 74.13 109.149 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.1 p -69.34 -23.9 63.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.199 -0.938 . . . . 73.24 110.015 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 82.3 p -90.83 49.87 1.72 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.141 -0.974 . . . . 61.01 110.074 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 66' ' ' HIS . 13.4 tt -143.36 163.87 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.102 -0.998 . . . . 71.33 109.343 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.417 ' HB ' HD22 ' A' ' 47' ' ' LEU . 46.5 t -93.21 142.16 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.115 -0.991 . . . . 72.13 108.768 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.462 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 9.8 t -130.55 123.44 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.311 -0.868 . . . . 54.21 109.36 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 mt -129.6 100.3 5.47 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.533 -0.914 . . . . 50.24 108.533 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.666 ' O ' HD12 ' A' ' 95' ' ' ILE . 14.9 p -96.12 154.04 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.375 -0.972 . . . . 74.41 108.375 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.4 m -122.57 171.91 8.77 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.78 -0.822 . . . . 72.31 108.78 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.414 ' C ' ' H ' ' A' ' 77' ' ' ASN . 7.6 p -171.2 121.84 0.54 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.963 -1.085 . . . . 64.54 110.431 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' NZ ' ' A' ' 53' ' ' LYS . 56.3 p30 -70.65 8.04 0.95 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.501 -0.75 . . . . 74.13 109.875 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.414 ' H ' ' C ' ' A' ' 75' ' ' SER . 89.5 m-20 -137.94 75.39 42.14 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.29 -0.881 . . . . 73.34 109.489 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -66.92 81.38 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.619 2.213 . . . . 63.22 111.237 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 81' ' ' GLU . 26.5 m -103.31 151.91 22.16 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.733 -0.84 . . . . 62.53 108.733 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 p -60.12 -28.84 68.2 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.297 -0.877 . . . . 73.44 109.773 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.402 ' H ' HG22 ' A' ' 79' ' ' THR . 86.8 tt0 -68.04 -41.54 81.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 71.42 109.865 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -74.3 -35.47 63.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.115 -0.99 . . . . 73.43 109.858 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.42 ' OE1' ' HB1' ' B' ' 104' ' ' ALA . 87.4 tt0 -60.17 -54.13 49.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.204 -0.935 . . . . 74.22 109.941 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 85' ' ' HIS . 34.3 m -61.96 -38.02 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.047 -1.033 . . . . 73.2 109.439 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.423 ' N ' HG23 ' A' ' 84' ' ' VAL . 19.4 m170 -69.0 -26.48 65.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.151 -0.968 . . . . 53.33 109.37 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -68.75 -44.33 73.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.143 -0.973 . . . . 64.11 109.647 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -79.68 -29.19 40.75 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.168 -0.958 . . . . 74.34 109.084 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -75.18 -51.3 13.72 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.436 -0.79 . . . . 74.42 109.357 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -58.57 -50.05 75.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.482 -0.761 . . . . 74.24 109.714 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 147.66 69.1 0.01 OUTLIER Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.107 -1.197 . . . . 61.51 110.107 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -134.24 135.05 42.67 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.33 -1.1 . . . . 55.33 109.017 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.462 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 70.2 m-20 -79.66 -36.8 37.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.103 -0.998 . . . . 73.42 109.031 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -153.33 150.35 28.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.391 -0.818 . . . . 75.04 109.568 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.512 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -124.25 132.54 53.59 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.722 -0.844 . . . . 71.33 108.722 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.825 ' H ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -119.29 137.06 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 CA-C-O 121.66 0.743 . . . . 71.13 110.061 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.54 120.2 8.96 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 106.922 -1.51 . . . . 64.32 106.922 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.684 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -41.72 -55.88 5.39 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.161 -0.962 . . . . 62.2 111.862 -178.134 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 1.8 Cg_endo -39.55 -12.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.14 1.226 . . . . 73.11 113.02 -175.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.684 ' N ' ' O ' ' A' ' 97' ' ' LYS . 55.4 m-85 59.86 131.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.803 -0.56 . . . . 65.22 109.835 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 29.6 ttm-85 -72.59 -40.65 66.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.754 -1.216 . . . . 72.35 108.92 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.642 ' O ' ' N ' ' A' ' 103' ' ' LYS . 19.3 m -174.42 43.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.28 -0.887 . . . . 71.32 110.045 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.447 ' O ' ' N ' ' A' ' 105' ' ' LEU . 10.7 mm 47.47 -80.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.374 -0.829 . . . . 75.43 110.414 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.642 ' N ' ' O ' ' A' ' 101' ' ' SER . 20.3 tptm -43.93 -33.37 1.36 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.238 -0.914 . . . . 71.41 109.208 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.67 -44.52 96.04 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.408 -0.96 . . . . 63.24 108.408 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 102' ' ' ILE . 17.2 tp -66.02 -49.37 67.97 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.199 -0.667 . . . . 73.22 109.199 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 70.2 t -60.18 -40.01 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.119 -0.988 . . . . 60.11 109.404 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.68 -41.19 73.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.112 -0.992 . . . . 70.42 108.869 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.525 ' NE ' ' O ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -68.22 -33.95 75.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.403 -0.81 . . . . 74.41 109.018 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 88.6 mt -75.2 -29.3 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.168 -0.958 . . . . 62.54 109.019 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -75.78 -57.43 3.88 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.45 -0.781 . . . . 74.34 109.471 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -49.65 -45.26 48.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.327 -0.858 . . . . 73.32 109.335 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 61.6 ttm-85 -64.75 -34.06 77.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.267 -0.895 . . . . 52.41 109.555 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 37.8 mt -133.52 74.68 1.57 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.393 -0.817 . . . . 65.24 110.016 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.7 mtm180 -85.64 -77.66 0.29 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.143 -0.973 . . . . 64.45 108.543 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.44 ' O ' ' O ' ' A' ' 116' ' ' TRP . 18.8 t80 -85.39 -49.73 7.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 74.43 109.465 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.44 ' O ' ' O ' ' A' ' 115' ' ' PHE . 69.7 t-105 49.85 97.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.366 -0.833 . . . . 74.42 109.663 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.59 113.06 0.28 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.617 -1.393 . . . . 75.04 109.617 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 30.8 m -156.07 164.18 38.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -1.154 . . . . 61.14 109.583 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.476 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -158.47 123.43 4.27 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.697 -0.853 . . . . 65.24 108.697 -178.45 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.414 ' HB ' HD12 ' A' ' 121' ' ' ILE . 46.5 t -79.98 -28.99 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 73.11 109.795 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.46 HD11 ' HG2' ' A' ' 157' ' ' ARG . 5.3 mp -116.76 140.94 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.345 -0.847 . . . . 72.24 109.094 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -151.81 140.36 20.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.294 -0.878 . . . . 72.34 108.946 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 123' ' ' ILE . 4.6 tp -160.65 121.23 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.224 -0.923 . . . . 71.44 109.174 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 60.23 -132.45 50.39 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.183 -1.567 . . . . 73.4 109.183 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -97.39 3.13 51.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.183 -1.187 . . . . 74.45 109.354 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.36 143.07 27.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.12 -0.988 . . . . 54.21 109.066 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.43 141.64 49.86 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.754 -0.832 . . . . 54.5 108.754 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.8 mt -137.85 125.09 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.409 -0.807 . . . . 45.15 109.125 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.2 m -121.56 95.94 47.84 Favored Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 109.356 -0.609 . . . . 71.11 109.356 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.15 -33.76 2.48 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.976 1.784 . . . . 65.41 112.099 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -56.43 -46.4 80.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.233 -0.917 . . . . 63.32 108.995 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -87.04 2.63 49.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.863 . . . . 72.52 109.196 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 55.0 72.71 0.46 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 75.33 109.863 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -161.65 143.51 11.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.349 -0.844 . . . . 71.23 109.367 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.5 tt -115.54 138.6 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.433 -0.951 . . . . 74.02 108.433 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.6 mt -126.99 127.13 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 109.055 -0.72 . . . . 60.23 109.055 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.418 ' CD1' ' O ' ' A' ' 137' ' ' TYR . 45.7 p90 -136.85 135.84 38.23 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.377 -0.827 . . . . 62.32 110.598 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp 55.79 31.02 16.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.515 -0.741 . . . . 75.4 110.755 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.23 16.81 79.1 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.631 -1.271 . . . . 72.24 110.911 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 65.4 mtt-85 -112.58 126.21 55.1 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.333 -1.098 . . . . 71.22 109.553 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -94.01 128.04 40.14 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.489 -0.757 . . . . 71.42 109.627 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 34.7 t -139.16 141.1 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.359 -0.838 . . . . 53.02 109.1 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.499 ' N ' ' OE1' ' A' ' 143' ' ' GLU . 48.6 mp0 -97.11 143.85 27.52 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.248 -0.907 . . . . 60.45 109.925 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.15 140.5 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.391 -0.818 . . . . 74.44 109.196 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.34 28.76 0.45 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 65.15 108.961 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.918 ' O ' ' CD1' ' A' ' 149' ' ' PHE . . . -86.93 -161.25 36.05 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.002 -1.239 . . . . 73.34 110.002 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.612 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 16.8 mttm -80.8 -38.04 1.0 Allowed Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.493 -1.004 . . . . 72.22 110.619 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 96.2 Cg_endo -89.46 19.9 1.17 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.456 2.104 . . . . 65.23 112.613 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.918 ' CD1' ' O ' ' A' ' 146' ' ' GLY . 5.3 p90 -94.81 -55.79 2.99 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.166 -0.959 . . . . 60.11 109.408 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.693 ' N ' ' CG ' ' A' ' 149' ' ' PHE . 6.1 pt-20 -53.14 -34.45 56.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.458 -0.776 . . . . 64.21 109.849 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.488 HG13 ' N ' ' A' ' 152' ' ' LEU . 8.3 p -63.03 -41.18 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.002 -1.061 . . . . 72.02 109.306 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.489 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.2 OUTLIER -63.52 -46.97 83.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.898 . . . . 73.31 108.63 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 27.2 p -67.39 -27.71 67.32 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.111 -0.993 . . . . 74.31 109.164 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -61.1 -53.96 50.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.883 . . . . 74.31 109.826 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.684 HD12 ' N ' ' A' ' 156' ' ' ALA . 3.9 pp -69.4 -21.12 63.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.025 -1.047 . . . . 75.34 109.26 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.684 ' N ' HD12 ' A' ' 155' ' ' LEU . . . -65.02 -43.38 92.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 62.14 108.96 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.501 ' C ' ' H ' ' A' ' 159' ' ' ARG . 59.0 mtm180 -77.24 -49.39 15.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 61.03 109.111 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -71.97 17.54 0.09 Allowed 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.002 -0.679 . . . . 74.12 109.422 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.501 ' H ' ' C ' ' A' ' 157' ' ' ARG . 35.4 ptt-85 -52.03 156.74 1.47 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.265 -0.897 . . . . 71.13 109.2 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.455 ' OD1' ' CD2' ' A' ' 216' ' ' TYR . 50.3 m-20 55.08 47.87 20.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.444 -0.785 . . . . 75.45 109.678 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -155.04 151.68 28.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.165 -0.959 . . . . 73.41 109.512 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.4 mt -89.51 138.37 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.224 -0.922 . . . . 74.41 109.458 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.6 t -139.43 131.01 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.345 -0.847 . . . . 72.31 109.317 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 16.2 t -78.25 164.72 24.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 74.12 109.691 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -63.63 -48.75 76.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.46 -0.775 . . . . 70.43 109.887 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -56.98 -37.03 71.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 73.52 110.102 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -53.91 -47.53 71.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.952 -1.092 . . . . 74.52 109.435 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 51.1 mt -60.27 -44.02 95.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.079 -1.013 . . . . 72.31 109.524 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 7.0 tp -54.93 -51.18 66.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.367 -0.833 . . . . 53.33 110.17 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -81.3 -11.75 59.25 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.152 -0.968 . . . . 62.44 110.685 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.52 -52.89 18.65 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.797 -1.189 . . . . 60.21 109.973 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.66 HD12 ' N ' ' A' ' 172' ' ' ILE . 1.7 mp -85.18 -36.81 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.147 -0.971 . . . . 75.32 109.072 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.486 -0.758 . . . . 73.14 109.359 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 108.788 -0.819 . . . . 64.54 108.788 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 29.4 m -74.94 -14.97 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.344 -0.847 . . . . 74.02 109.716 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.416 ' O ' HG22 ' A' ' 188' ' ' ILE . 34.5 mt -48.89 -43.17 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.153 -0.967 . . . . 72.33 109.63 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -53.08 -34.02 54.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.12 -0.988 . . . . 74.4 109.466 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.32 -49.0 21.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.482 -0.761 . . . . 70.42 110.179 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.88 96.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.006 -1.059 . . . . 52.11 110.161 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.479 HG23 ' N ' ' A' ' 189' ' ' ASN . 11.0 tp -66.3 -42.58 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 120.936 -1.103 . . . . 71.4 109.691 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.479 ' N ' HG23 ' A' ' 188' ' ' ILE . 39.2 t30 -62.87 -43.05 99.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.197 -0.94 . . . . 73.44 109.353 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -65.33 -40.16 93.33 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.37 -0.831 . . . . 71.42 109.61 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 71.8 mt -65.96 -44.86 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.247 -0.908 . . . . 61.55 109.793 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -58.7 -38.87 79.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.149 -0.969 . . . . 63.34 109.712 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -79.15 -26.04 42.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -0.991 . . . . 61.24 110.336 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -91.07 -16.98 26.97 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.962 -1.087 . . . . 75.13 110.825 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' MET . . . . . 0.568 ' SD ' ' N ' ' A' ' 196' ' ' ASP . 2.2 ppp? -91.72 -41.81 10.5 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.713 -1.242 . . . . 74.02 110.43 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ASP . . . . . 0.568 ' N ' ' SD ' ' A' ' 195' ' ' MET . 26.1 t70 -66.82 -37.04 83.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.934 -1.104 . . . . 74.02 110.103 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.412 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 0.1 OUTLIER -50.86 -63.54 1.84 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.96 -1.087 . . . . 75.43 109.156 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 40.8 Cg_endo -65.81 -58.27 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.527 1.485 . . . . 72.32 111.189 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.499 ' C ' ' H ' ' A' ' 201' ' ' ILE . 4.0 mm? -86.16 92.38 8.73 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.29 -1.004 . . . . 74.54 108.29 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -59.17 -0.22 0.69 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.968 -1.253 . . . . 61.51 109.968 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.499 ' H ' ' C ' ' A' ' 199' ' ' LEU . 26.0 mm -108.29 130.09 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.379 -1.071 . . . . 61.22 109.336 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 67.0 m -76.74 146.34 38.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 72.0 109.296 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 15.9 p -139.65 4.49 2.14 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.398 -0.813 . . . . 74.44 109.354 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 204' ' ' VAL . 7.9 m -120.54 132.05 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.606 -0.684 . . . . 64.35 109.538 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -103.8 118.33 36.44 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.378 -0.826 . . . . 71.41 108.914 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 206' ' ' THR . 0.0 OUTLIER -94.11 129.43 40.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.241 -0.912 . . . . 73.52 109.573 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.507 HG21 HH12 ' A' ' 213' ' ' ARG . 19.9 t -144.54 131.13 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 71.02 108.944 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -56.78 -31.84 65.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 72.12 109.684 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 211' ' ' GLY . 72.9 mtt85 -63.72 137.54 58.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.91 . . . . 64.41 109.808 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 57.68 -78.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.475 -0.766 . . . . 71.54 110.026 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . -177.6 -114.94 0.42 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.29 -1.524 . . . . 72.03 109.29 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -113.24 135.07 54.23 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.426 -1.044 . . . . 75.54 109.289 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.507 HH12 HG21 ' A' ' 207' ' ' VAL . 21.8 ttp-105 -109.55 139.64 44.31 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.929 -0.767 . . . . 75.31 108.929 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.442 ' O ' ' SG ' ' A' ' 215' ' ' CYS . 58.7 m-85 -107.62 134.57 50.43 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.425 -0.797 . . . . 75.41 109.935 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 214' ' ' PHE . 99.3 m -155.02 156.25 35.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.479 -0.763 . . . . 74.14 109.262 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' TYR . . . . . 0.455 ' CD2' ' OD1' ' A' ' 160' ' ' ASP . 1.9 p90 -64.74 154.34 85.59 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.193 -0.942 . . . . 75.32 109.299 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo . . . . . 0 N--CA 1.492 1.392 0 C-N-CA 122.232 1.955 . . . . 73.11 111.943 179.827 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.589 ' SD ' ' CE2' ' B' ' 25' ' ' PHE . 16.7 ptp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.435 -0.58 . . . . 71.14 109.435 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.532 ' NH1' ' SD ' ' B' ' 26' ' ' MET . 92.8 mtt-85 -136.62 152.97 51.03 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.387 -0.821 . . . . 73.23 109.178 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 93.5 t -110.68 133.2 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.525 -0.735 . . . . 72.24 109.582 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.431 HD11 ' CG1' ' B' ' 6' ' ' ILE . 3.6 tp -105.72 118.22 36.03 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.61 -0.681 . . . . 54.33 109.686 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.42 ' N ' HD12 ' B' ' 4' ' ' LEU . 15.3 mt -113.3 100.28 8.44 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.708 -0.849 . . . . 74.35 108.708 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.689 HD12 ' HB ' ' B' ' 50' ' ' VAL . 89.4 mt -86.97 99.66 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.04 -1.038 . . . . 42.55 109.015 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.447 ' CD ' ' HG ' ' B' ' 51' ' ' SER . 7.0 tp10 -146.69 137.61 24.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.46 -0.775 . . . . 74.52 108.913 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.524 ' CD ' ' H ' ' B' ' 8' ' ' LYS . 0.0 OUTLIER -78.39 -31.92 48.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 62.55 109.084 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 9' ' ' ASN . . . . . 0.4 ' H ' ' HG3' ' B' ' 7' ' ' GLU . 93.3 m-20 -75.45 109.16 8.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.867 . . . . 73.11 109.552 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 29.3 m -67.43 -27.7 67.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.269 -0.895 . . . . 65.54 109.668 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 75.5 t -59.11 -52.44 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.236 -0.915 . . . . 75.55 109.668 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.535 HD13 ' NZ ' ' B' ' 97' ' ' LYS . 91.6 mt -63.28 -35.76 81.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -0.962 . . . . 70.14 109.402 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.65 -25.02 75.99 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.826 -1.71 . . . . 75.4 108.826 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.04 -53.05 24.55 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.736 -1.345 . . . . 65.44 109.736 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -58.96 -47.17 86.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.35 -1.088 . . . . 60.21 109.97 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 37.0 mm -61.82 -39.23 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.738 -1.226 . . . . 75.15 108.816 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -55.04 -42.53 72.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.35 -0.844 . . . . 73.01 109.457 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -87.76 -2.82 58.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.168 -0.957 . . . . 74.3 109.381 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.63 -53.66 3.16 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 109.91 -1.276 . . . . 70.54 109.91 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.458 HD21 ' HB2' ' B' ' 27' ' ' ALA . 1.4 pt? -74.29 -19.84 60.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -1.147 . . . . 71.34 110.016 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -52.83 -32.4 44.12 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.085 -1.009 . . . . 64.41 109.52 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 97.5 t -61.94 -33.45 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.225 -0.922 . . . . 74.23 109.159 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' B' ' 110' ' ' GLU . 16.4 mmtp -81.77 -5.4 58.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.856 . . . . 63.42 109.18 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.83 19.63 70.02 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.964 -1.254 . . . . 53.43 109.964 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.589 ' CE2' ' SD ' ' B' ' 1' ' ' MET . 7.4 m-85 -92.43 159.68 15.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.162 -1.199 . . . . 71.12 108.97 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' MET . . . . . 0.532 ' SD ' ' NH1' ' B' ' 2' ' ' ARG . 35.6 mtt -100.95 138.0 38.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.271 -0.893 . . . . 75.24 108.702 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.458 ' HB2' HD21 ' B' ' 20' ' ' LEU . . . -114.22 147.35 39.08 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.51 -0.744 . . . . 72.12 110.09 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -131.7 134.04 45.49 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.44 -0.948 . . . . 72.31 108.44 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -109.75 134.55 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.361 -0.837 . . . . 64.43 109.077 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.9 p -137.23 169.72 17.31 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.497 -0.752 . . . . 65.41 109.176 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -93.21 -107.34 0.12 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.191 -0.943 . . . . 71.02 109.679 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 68.2 p -78.75 168.45 19.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.906 . . . . 51.11 109.914 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.414 HD22 ' CG ' ' B' ' 58' ' ' PHE . 47.6 mt -51.53 -30.25 19.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.663 -0.648 . . . . 71.24 109.907 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -52.72 -51.18 61.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.097 -1.002 . . . . 74.32 109.772 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.82 -39.2 93.66 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.152 -0.968 . . . . 73.03 109.428 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.64 -39.39 78.06 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.559 -1.416 . . . . 30.21 109.559 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -69.06 -38.23 78.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -1.127 . . . . 74.42 109.874 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -80.6 -38.72 28.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.102 -0.999 . . . . 74.42 109.918 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 11.1 tp -69.23 -43.49 73.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.216 -0.927 . . . . 75.41 110.134 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.0 ppp? -66.59 -24.42 66.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.05 . . . . 60.41 109.916 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -61.28 -40.99 96.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.109 -0.995 . . . . 53.23 110.112 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.46 HD12 ' NH1' ' B' ' 43' ' ' ARG . 17.5 pt -81.25 -30.7 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.076 -1.015 . . . . 71.23 110.238 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.46 ' NH1' HD12 ' B' ' 42' ' ' ILE . 78.1 mtt85 -129.93 141.22 50.81 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.395 -0.815 . . . . 72.22 109.623 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -97.18 147.32 24.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.282 -0.886 . . . . 63.54 109.289 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -123.6 145.79 48.66 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.524 -0.735 . . . . 64.35 109.38 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' ASP . . . . . 0.458 ' OD2' ' NE1' ' B' ' 116' ' ' TRP . 48.6 t0 -79.68 -42.29 25.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.232 -0.917 . . . . 62.22 109.355 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.547 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.5 OUTLIER -104.23 115.65 30.78 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.872 -0.788 . . . . 73.12 108.872 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.547 ' N ' HD13 ' B' ' 47' ' ' LEU . 72.6 t -99.62 97.24 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.967 -1.123 . . . . 65.11 107.967 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 19.9 ttt -110.31 134.09 52.62 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.608 0.718 . . . . 73.44 110.576 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.689 ' HB ' HD12 ' B' ' 6' ' ' ILE . 1.0 OUTLIER -146.98 132.71 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.543 0.687 . . . . 34.5 109.364 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 51' ' ' SER . . . . . 0.447 ' HG ' ' CD ' ' B' ' 7' ' ' GLU . 16.8 p -102.11 12.3 37.0 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.465 -0.772 . . . . 73.21 109.81 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.501 ' H ' HG22 ' B' ' 50' ' ' VAL . 55.9 m-20 -77.14 143.54 39.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.158 -0.964 . . . . 70.41 109.603 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.488 ' C ' ' H ' ' B' ' 55' ' ' ALA . 94.2 mttt -63.79 -37.44 87.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 65.0 109.822 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -71.77 16.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.935 . . . . 75.21 109.645 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.488 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -57.19 -40.05 76.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 55.33 109.818 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.517 ' N ' HD12 ' B' ' 56' ' ' LEU . 10.8 mp -46.98 -42.22 17.6 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.164 -0.96 . . . . 63.14 109.733 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' SER . . . . . 0.434 ' O ' ' NH1' ' B' ' 61' ' ' ARG . 17.5 m -72.62 -43.08 63.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 63.5 109.648 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' PHE . . . . . 0.414 ' CG ' HD22 ' B' ' 33' ' ' LEU . 50.9 t80 -64.52 -58.01 7.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.29 -0.881 . . . . 72.33 109.95 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.424 HG23 ' N ' ' B' ' 60' ' ' SER . 14.2 m -53.01 -36.96 25.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.512 -1.368 . . . . 74.54 109.609 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 60' ' ' SER . . . . . 0.424 ' N ' HG23 ' B' ' 59' ' ' VAL . 23.3 t -54.93 -52.15 63.86 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.256 -0.903 . . . . 71.24 109.6 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.434 ' NH1' ' O ' ' B' ' 57' ' ' SER . 3.9 ptp85 -69.74 -34.09 73.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.989 . . . . 74.31 110.318 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 40.4 mm -69.75 -34.52 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.759 -1.213 . . . . 72.14 109.924 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -44.36 77.29 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.15 -0.969 . . . . 73.32 110.231 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.479 ' CG ' ' N ' ' B' ' 65' ' ' LYS . 9.6 pt-20 -79.41 -45.65 19.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.934 -1.104 . . . . 73.12 110.369 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.479 ' N ' ' CG ' ' B' ' 64' ' ' GLU . 57.9 mttp -66.95 -24.87 66.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.195 -0.941 . . . . 72.44 109.852 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.584 ' O ' HG22 ' B' ' 69' ' ' ILE . 79.4 m-70 -155.28 64.5 0.63 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.138 -0.976 . . . . 63.31 109.564 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.426 ' O ' ' N ' ' B' ' 69' ' ' ILE . 8.0 t -56.09 -34.05 65.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 73.1 109.823 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 44.8 t -70.18 47.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.936 . . . . 71.53 109.924 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.584 HG22 ' O ' ' B' ' 66' ' ' HIS . 15.6 tt -145.46 156.35 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.121 -0.987 . . . . 74.4 109.176 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 31.8 t -93.92 144.95 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.08 -1.012 . . . . 75.12 109.315 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 25.3 t -131.46 125.32 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.446 -0.784 . . . . 73.2 110.002 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.549 ' C ' HD23 ' B' ' 72' ' ' LEU . 6.3 tt -121.64 98.06 5.78 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.864 -0.791 . . . . 73.34 108.864 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.408 HG22 ' N ' ' B' ' 74' ' ' SER . 10.5 p -90.26 156.35 3.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 120.901 -1.124 . . . . 73.5 108.711 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 74' ' ' SER . . . . . 0.408 ' N ' HG22 ' B' ' 73' ' ' VAL . 5.9 m -129.45 169.01 15.48 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.385 -0.968 . . . . 64.34 108.385 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.423 ' C ' ' H ' ' B' ' 77' ' ' ASN . 36.0 t -172.49 125.07 0.49 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.943 -1.098 . . . . 74.53 110.442 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -76.04 21.57 0.17 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.602 -0.686 . . . . 64.5 109.8 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 77' ' ' ASN . . . . . 0.423 ' H ' ' C ' ' B' ' 75' ' ' SER . 42.6 t-20 -146.75 58.77 4.62 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.137 -0.977 . . . . 74.25 109.986 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -57.96 83.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.389 2.059 . . . . 74.43 112.036 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 66.5 p -107.63 160.97 15.28 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.41 -0.959 . . . . 73.12 108.41 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.3 p -63.2 -22.68 67.02 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.22 -0.925 . . . . 71.01 109.782 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' GLU . . . . . 0.438 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 97.2 mt-10 -69.41 -46.53 66.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.099 -1.001 . . . . 63.2 109.435 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -72.86 -28.06 62.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 73.22 109.579 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 35.4 tp10 -62.15 -54.05 46.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 74.3 109.886 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.41 HG23 ' N ' ' B' ' 85' ' ' HIS . 27.2 m -65.89 -38.0 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 73.31 109.89 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 85' ' ' HIS . . . . . 0.438 ' ND1' ' O ' ' B' ' 81' ' ' GLU . 32.4 m80 -67.05 -35.4 79.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.075 -1.015 . . . . 73.24 109.778 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.12 -42.12 94.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.965 -1.085 . . . . 55.33 110.043 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 87' ' ' PHE . . . . . 0.456 ' CE1' ' NH1' ' A' ' 108' ' ' ARG . 52.9 m-85 -81.81 -35.9 28.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.065 -1.022 . . . . 74.14 109.438 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -71.05 -45.53 63.66 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.302 -0.874 . . . . 64.04 109.778 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -64.07 -50.46 68.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.087 -1.008 . . . . 72.35 109.458 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 142.44 73.29 0.03 OUTLIER Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.144 -1.182 . . . . 65.2 110.144 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -127.83 131.91 49.48 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.394 -1.062 . . . . 52.23 108.805 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -70.12 -43.07 71.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.99 -1.069 . . . . 73.32 108.848 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' B' ' 93' ' ' ASP . 13.2 p-10 -154.09 153.95 32.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.528 -0.733 . . . . 72.22 109.053 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.497 ' CD1' ' C ' ' B' ' 94' ' ' TYR . 0.5 OUTLIER -127.43 125.68 41.02 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 109.056 -0.72 . . . . 64.42 109.056 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 0.444 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 30.1 mm -114.16 141.18 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-O 121.878 0.847 . . . . 72.23 110.34 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.36 123.02 16.6 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.337 -1.357 . . . . 25.24 107.337 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.695 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -43.54 -55.46 8.51 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.129 -0.982 . . . . 64.32 111.879 -178.466 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 98' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 2.6 Cg_endo -40.44 -10.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.052 1.168 . . . . 63.33 113.213 -175.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 99' ' ' TYR . . . . . 0.695 ' N ' ' O ' ' B' ' 97' ' ' LYS . 44.7 m-85 59.03 118.7 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.621 -0.674 . . . . 75.13 109.539 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -65.07 -41.04 95.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.764 -1.21 . . . . 74.23 108.82 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 101' ' ' SER . . . . . 0.754 ' O ' ' N ' ' B' ' 103' ' ' LYS . 7.3 t -173.87 44.84 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.205 -0.934 . . . . 63.34 110.739 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 14.0 mm 49.25 -69.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-N 118.717 0.689 . . . . 74.44 110.563 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.754 ' N ' ' O ' ' B' ' 101' ' ' SER . 1.3 mptm? -53.06 -29.42 30.06 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 107.919 -1.141 . . . . 71.11 107.919 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.42 ' HB1' ' OE1' ' A' ' 83' ' ' GLU . . . -67.44 -39.84 85.42 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.177 -1.046 . . . . 71.45 108.177 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 50.7 tp -68.17 -56.53 8.41 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.075 -0.713 . . . . 51.31 109.075 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 89.0 t -60.96 -40.45 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.225 -0.922 . . . . 65.23 109.585 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.39 -44.43 65.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.155 -0.965 . . . . 24.32 108.902 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 25.5 tpt85 -64.58 -34.62 78.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.337 -0.852 . . . . 75.31 109.105 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 72.4 mt -73.63 -30.48 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.216 -0.928 . . . . 54.24 108.75 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 110' ' ' GLU . . . . . 0.408 ' OE1' ' NZ ' ' B' ' 23' ' ' LYS . 88.9 tt0 -67.31 -58.69 4.35 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.457 -0.777 . . . . 65.31 109.311 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.93 -31.11 62.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.279 -0.888 . . . . 72.24 109.111 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -59.39 -47.18 86.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.251 -0.905 . . . . 72.04 109.191 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.04 100.9 2.53 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.066 -1.021 . . . . 75.35 109.585 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 20.3 mtm105 -90.65 -73.25 0.54 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.274 -0.891 . . . . 75.5 108.987 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -68.74 -35.64 77.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 65.33 109.937 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 116' ' ' TRP . . . . . 0.458 ' NE1' ' OD2' ' B' ' 46' ' ' ASP . 58.1 t90 52.01 84.87 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 74.45 109.482 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 157.44 131.16 1.29 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.714 -1.355 . . . . 44.21 109.714 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 26.9 t -164.22 169.0 18.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.35 -1.089 . . . . 71.4 109.41 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.1 139.21 14.5 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.81 -0.756 . . . . 72.32 109.031 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 14.7 t -105.52 -45.43 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.465 -0.772 . . . . 75.02 110.146 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 9.2 mm -100.08 140.82 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.079 -1.013 . . . . 51.41 109.83 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -148.79 115.33 5.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.227 -0.921 . . . . 71.53 109.344 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.472 ' N ' HD13 ' B' ' 123' ' ' ILE . 0.0 OUTLIER -134.03 120.34 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.632 -0.877 . . . . 72.43 108.632 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.48 -139.26 48.7 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.382 -1.487 . . . . 51.23 109.382 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -88.59 4.42 46.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.197 -1.178 . . . . 74.2 109.503 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.33 135.48 35.69 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.184 -0.947 . . . . 75.42 108.591 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 5.7 m -132.8 122.88 25.15 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.452 -0.78 . . . . 74.22 109.172 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.613 HG21 ' HB1' ' B' ' 156' ' ' ALA . 31.1 mm -114.3 125.67 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.376 -0.827 . . . . 60.33 109.626 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 61.4 m -111.57 90.16 12.01 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.862 -0.792 . . . . 72.31 108.862 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.84 -29.38 8.59 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.667 1.578 . . . . 75.13 111.93 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -64.59 -43.51 93.58 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.173 -0.955 . . . . 75.23 108.873 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.3 8.18 37.26 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.356 -0.84 . . . . 72.43 109.21 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 49.82 62.14 2.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.895 . . . . 75.13 109.57 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 134' ' ' LYS . . . . . 0.589 ' C ' HD12 ' B' ' 135' ' ' ILE . 19.3 ttpp -149.77 130.05 13.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.216 -0.927 . . . . 73.22 109.392 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 135' ' ' ILE . . . . . 0.589 HD12 ' C ' ' B' ' 134' ' ' LYS . 1.8 mp -108.9 141.24 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.522 -0.736 . . . . 64.14 109.089 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 25.7 mt -131.12 132.54 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 121.359 -0.838 . . . . 71.22 110.644 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 137' ' ' TYR . . . . . 0.509 ' CE2' ' CG2' ' B' ' 135' ' ' ILE . 48.9 m-85 -134.89 133.37 39.58 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.438 -0.789 . . . . 64.22 109.442 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 138' ' ' LYS . . . . . 0.779 ' CE ' ' O ' ' B' ' 198' ' ' PRO . 23.0 mttm 55.11 25.12 6.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 72.02 110.267 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.7 13.34 80.1 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.941 -1.264 . . . . 74.32 109.941 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -99.79 124.09 44.71 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.3 -1.117 . . . . 75.34 108.85 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -88.65 131.45 34.98 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.125 -0.984 . . . . 71.23 109.913 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.5 136.85 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.462 -0.774 . . . . 70.43 109.299 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -86.16 160.76 19.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.382 -0.824 . . . . 72.43 109.154 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 144' ' ' VAL . . . . . 0.563 HG11 HD13 ' B' ' 135' ' ' ILE . 10.3 m -138.18 147.19 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.327 -0.858 . . . . 72.13 109.693 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 36.4 pttt -176.18 70.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 72.02 109.872 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 179.99 177.69 48.15 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.545 -1.312 . . . . 42.23 110.091 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 147' ' ' LYS . . . . . 0.624 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 8.0 mtmm -70.21 -37.28 7.07 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.419 -1.047 . . . . 73.3 110.388 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 148' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 32.5 Cg_exo -58.12 -39.87 81.66 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.061 1.841 . . . . 71.33 111.898 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -87.56 -22.53 24.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.877 . . . . 74.23 109.454 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -52.68 -53.03 53.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 72.34 109.368 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.43 HG13 ' N ' ' B' ' 152' ' ' LEU . 7.6 p -61.5 -38.18 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.239 -0.913 . . . . 73.35 109.394 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.49 ' O ' ' CD1' ' B' ' 155' ' ' LEU . 33.4 tp -56.37 -36.53 68.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.19 -0.944 . . . . 55.24 108.586 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.75 -20.37 50.11 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.954 -1.091 . . . . 70.01 109.357 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 154' ' ' HIS . . . . . 0.54 ' CE1' ' CE1' ' B' ' 158' ' ' HIS . 4.8 t60 -68.21 -60.63 2.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.931 -1.106 . . . . 65.32 109.596 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 155' ' ' LEU . . . . . 0.923 HD13 ' N ' ' B' ' 156' ' ' ALA . 0.0 OUTLIER -64.91 -24.81 67.64 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.218 -0.926 . . . . 71.54 108.899 179.469 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 156' ' ' ALA . . . . . 0.923 ' N ' HD13 ' B' ' 155' ' ' LEU . . . -57.42 -42.46 82.39 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.969 -1.082 . . . . 75.32 108.593 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 157' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' B' ' 159' ' ' ARG . 59.8 mtp180 -87.55 -69.23 0.7 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.228 -0.92 . . . . 73.32 110.997 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 158' ' ' HIS . . . . . 0.582 ' CG ' ' O ' ' B' ' 158' ' ' HIS . 10.6 p-80 -67.97 48.08 0.05 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.324 -0.95 . . . . 74.14 110.158 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 159' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' B' ' 157' ' ' ARG . 0.0 OUTLIER -83.78 176.98 8.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.932 -1.105 . . . . 61.41 108.84 179.276 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 53.0 t0 54.7 43.13 30.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.392 -0.817 . . . . 72.1 111.288 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -158.67 171.77 19.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.606 -1.309 . . . . 72.25 109.852 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 19.9 mm -73.18 140.47 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.327 -0.858 . . . . 72.31 109.536 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 163' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' B' ' 212' ' ' TYR . 41.0 t -133.59 111.82 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.473 -0.767 . . . . 64.21 109.343 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 8.9 t -92.22 166.08 12.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.139 -0.976 . . . . 74.22 109.001 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -59.51 -44.13 93.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.941 -1.099 . . . . 65.31 108.674 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.59 -24.72 67.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.285 -0.884 . . . . 63.45 108.956 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -61.06 -51.65 68.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.383 -0.823 . . . . 72.4 109.692 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 41.6 mt -61.46 -41.68 97.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 72.32 109.025 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -67.05 0.36 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.482 -0.762 . . . . 73.34 109.956 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -59.78 -17.51 36.15 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.936 -0.706 . . . . 72.1 109.829 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -93.67 -3.8 51.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.801 -1.187 . . . . 62.13 108.702 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 0.57 ' O ' ' CG ' ' B' ' 173' ' ' TRP . 96.5 mt -133.06 -80.91 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.495 -0.753 . . . . 71.42 109.074 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 173' ' ' TRP . . . . . 0.57 ' CG ' ' O ' ' B' ' 172' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.514 2.744 0 CA-C-O 121.73 0.776 . . . . 72.23 109.314 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo . . . . . 0 N--CA 1.494 1.51 0 CA-C-O 121.212 0.422 . . . . 65.22 112.466 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 4.5 m120 52.02 54.43 10.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.224 -0.923 . . . . 72.31 109.628 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 3.4 p -78.96 -28.64 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.205 -0.934 . . . . 63.32 110.12 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.449 ' O ' HG22 ' B' ' 188' ' ' ILE . 38.8 mm -57.21 -33.93 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.912 -1.117 . . . . 75.03 111.154 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -61.26 -63.23 1.35 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.924 -1.11 . . . . 64.11 111.252 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 30.4 m -70.48 -32.75 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.792 -1.193 . . . . 73.0 110.562 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 187' ' ' ALA . . . . . 0.446 ' O ' HD12 ' B' ' 191' ' ' ILE . . . -67.24 -38.03 84.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.958 -1.089 . . . . 61.12 111.725 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 188' ' ' ILE . . . . . 0.564 HG23 ' N ' ' B' ' 189' ' ' ASN . 10.6 tp -79.62 -46.07 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 119.982 -1.699 . . . . 72.43 111.222 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 189' ' ' ASN . . . . . 0.564 ' N ' HG23 ' B' ' 188' ' ' ILE . 40.1 m-20 -59.33 -34.05 71.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.745 -1.222 . . . . 65.14 109.802 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -80.79 -51.86 8.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.047 -1.033 . . . . 63.24 110.0 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 191' ' ' ILE . . . . . 0.446 HD12 ' O ' ' B' ' 187' ' ' ALA . 68.6 mt -49.76 -36.14 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.265 -0.897 . . . . 74.03 109.512 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 192' ' ' ARG . . . . . 1.49 HH12 ' CG2' ' B' ' 204' ' ' VAL . 82.6 mtt-85 -72.75 -45.73 57.15 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.756 -0.831 . . . . 72.24 108.756 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -66.54 -12.12 56.14 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.351 -0.843 . . . . 73.1 108.949 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -108.47 -13.46 14.84 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.493 -0.754 . . . . 72.11 110.617 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 35.5 ttm -96.22 -54.67 3.21 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.87 -1.144 . . . . 44.33 110.362 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -55.89 -27.62 52.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 71.21 109.701 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 197' ' ' LYS . . . . . 0.436 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 40.2 mttt -66.3 -65.75 1.59 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 75.21 110.021 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 198' ' ' PRO . . . . . 0.779 ' O ' ' CE ' ' B' ' 138' ' ' LYS . 17.8 Cg_endo -58.55 -48.21 16.1 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.139 1.893 . . . . 75.32 112.745 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 199' ' ' LEU . . . . . 0.43 ' N ' HD12 ' B' ' 199' ' ' LEU . 9.5 mp -75.86 -43.29 46.39 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.98 -1.075 . . . . 72.25 110.048 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 83.43 -9.05 62.57 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.691 -1.364 . . . . 64.53 109.691 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 31.3 mm -110.25 130.02 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.451 -1.029 . . . . 44.23 109.481 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 61.3 p -82.58 142.78 31.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.294 -0.879 . . . . 54.01 109.507 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 203' ' ' THR . . . . . 0.419 ' OG1' ' CZ ' ' B' ' 214' ' ' PHE . 57.8 p -149.89 20.8 0.89 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.459 -0.776 . . . . 74.4 109.46 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 1.49 ' CG2' HH12 ' B' ' 192' ' ' ARG . 1.2 m -135.14 137.51 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.233 -0.917 . . . . 72.12 109.664 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -125.81 133.5 51.98 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.974 -0.75 . . . . 65.41 108.974 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 206' ' ' THR . . . . . 0.474 ' O ' HG23 ' B' ' 206' ' ' THR . 9.7 t -101.96 128.66 48.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.211 -0.931 . . . . 71.33 109.273 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 27.2 m -145.11 155.44 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.124 -0.985 . . . . 63.5 109.753 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -86.24 -13.05 47.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.276 -0.89 . . . . 74.45 109.815 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 64.7 mtp85 -55.45 -38.26 68.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.125 -0.984 . . . . 74.14 109.845 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 75.8 mtt-85 -148.44 -50.55 0.16 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.127 -0.983 . . . . 74.43 109.246 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 169.28 -113.82 0.53 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.455 -1.458 . . . . 64.45 109.455 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 212' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' B' ' 163' ' ' VAL . 65.0 m-85 -109.52 127.0 54.13 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.513 -0.992 . . . . 74.21 109.563 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 43.4 ttt180 -105.06 121.79 44.52 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.379 -0.826 . . . . 74.03 109.116 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 214' ' ' PHE . . . . . 0.906 ' CE2' HD23 ' B' ' 155' ' ' LEU . 8.3 t80 -94.53 118.61 31.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.297 -0.877 . . . . 74.34 109.007 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 35.6 t -119.97 136.58 54.48 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.724 -0.61 . . . . 64.33 109.633 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -58.89 149.32 65.75 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.275 -1.009 . . . . 70.04 108.275 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.73 -169.53 0.18 Allowed 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.999 1.799 . . . . 65.11 111.742 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 6.3 pttm . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.063 -1.023 . . . . 73.15 109.242 -179.851 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 tpp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.449 -0.575 . . . . 65.12 109.449 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.517 ' NH2' ' OD2' ' A' ' 28' ' ' ASP . 33.3 ttt85 -145.43 149.58 34.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.148 -0.97 . . . . 72.33 109.383 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 82.6 t -115.91 132.56 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.403 0.62 . . . . 71.42 109.768 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 5' ' ' LEU . 4.1 tp -99.56 115.44 29.38 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.829 -0.804 . . . . 65.12 108.829 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 4' ' ' LEU . 59.8 tp -114.61 104.01 11.57 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.554 -0.716 . . . . 62.43 109.357 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.6 mt -93.23 112.16 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.854 -1.154 . . . . 71.15 109.189 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -146.86 134.18 20.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.378 -0.827 . . . . 75.34 109.153 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.564 ' H ' ' CD ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -73.89 -30.63 62.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.957 . . . . 72.44 109.184 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -83.63 110.58 18.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.253 -0.904 . . . . 63.02 109.347 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.6 m -65.14 -32.82 74.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 72.34 109.911 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 81.4 t -64.23 -49.49 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 74.02 109.778 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.0 tp -60.93 -37.58 82.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 71.43 109.38 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.31 -27.88 62.95 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.684 -1.767 . . . . 61.32 108.684 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.09 -48.02 79.53 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.345 -1.502 . . . . 71.2 109.345 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -64.25 -43.54 94.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.389 -1.066 . . . . 71.32 109.579 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.9 mm -65.35 -38.34 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.837 -1.165 . . . . 63.23 108.519 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.44 ' CD ' HD21 ' A' ' 21' ' ' ASN . 14.9 tm-20 -61.22 -45.18 95.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.34 -0.85 . . . . 51.11 109.518 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -86.58 -1.41 57.63 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.138 -0.976 . . . . 73.34 109.642 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.36 -61.23 1.65 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.02 -1.632 . . . . 62.15 109.02 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pp -62.3 -29.09 70.19 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.487 -1.008 . . . . 73.51 109.031 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.44 HD21 ' CD ' ' A' ' 17' ' ' GLU . 86.1 m-20 -51.64 -36.16 45.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 74.25 109.0 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.8 t -53.59 -34.19 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.611 -0.885 . . . . 70.04 108.611 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.468 ' NZ ' HG21 ' A' ' 106' ' ' VAL . 28.8 mmtm -78.74 -4.83 51.2 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.685 -0.857 . . . . 73.23 108.685 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.94 44.92 8.7 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.639 -0.984 . . . . 75.54 110.639 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -119.06 159.68 23.45 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.264 -1.139 . . . . 73.43 109.017 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.3 mmt -103.65 139.17 39.29 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.541 -0.911 . . . . 43.24 108.541 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.417 ' O ' ' OD1' ' A' ' 28' ' ' ASP . . . -143.96 160.4 40.89 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.285 -0.884 . . . . 62.11 109.841 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.517 ' OD2' ' NH2' ' A' ' 2' ' ' ARG . 79.3 m-20 -135.96 149.9 49.06 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.954 -0.758 . . . . 74.42 108.954 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.46 133.92 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.756 -0.831 . . . . 72.15 108.756 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 p -134.65 168.21 19.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.471 -0.768 . . . . 71.42 109.42 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -93.09 -106.37 0.12 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.224 -0.922 . . . . 72.33 109.612 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.8 p -79.8 168.19 19.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.123 -0.986 . . . . 74.24 109.909 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.7 mt -53.84 -29.98 43.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.465 -0.772 . . . . 71.53 109.778 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -55.27 -47.97 74.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.108 -0.995 . . . . 74.23 109.938 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.48 -44.6 70.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.096 -1.003 . . . . 54.03 109.58 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.45 -40.65 86.54 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.589 -1.404 . . . . 61.41 109.589 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -66.0 -45.42 81.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -1.115 . . . . 74.34 109.784 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.26 -40.37 74.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.101 -0.999 . . . . 75.33 109.664 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.656 ' C ' HD23 ' A' ' 39' ' ' LEU . 7.0 tt -70.5 -56.33 6.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.307 -0.871 . . . . 74.33 110.022 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.49 ' SD ' ' OH ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -55.75 -27.69 52.02 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.129 -0.982 . . . . 70.32 110.047 -179.096 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -62.36 -37.23 84.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.104 -0.998 . . . . 71.22 110.111 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.0 pt -91.6 -1.6 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.091 -1.006 . . . . 74.14 110.416 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 40' ' ' MET . 19.4 mmt85 -130.02 145.77 51.67 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.292 -0.88 . . . . 72.24 109.73 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -89.43 152.54 21.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.28 -0.888 . . . . 75.42 108.997 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.49 ' OH ' ' SD ' ' A' ' 40' ' ' MET . 6.4 p90 -153.13 176.52 11.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.072 -1.017 . . . . 74.23 109.857 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -132.34 -38.7 1.05 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.552 -0.718 . . . . 72.04 109.832 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.523 HD13 ' C ' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -103.32 112.17 24.92 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.332 -0.855 . . . . 72.13 109.255 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.513 ' N ' HD13 ' A' ' 47' ' ' LEU . 75.1 t -96.53 98.06 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.89 -0.781 . . . . 72.34 108.89 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.503 ' SD ' ' N ' ' A' ' 50' ' ' VAL . 3.3 tpp -110.08 127.76 55.04 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.626 0.727 . . . . 74.11 109.143 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.503 ' N ' ' SD ' ' A' ' 49' ' ' MET . 1.6 p -138.71 128.02 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.532 -0.73 . . . . 61.12 109.64 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.1 m -96.42 5.16 51.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.338 -0.851 . . . . 73.11 109.521 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.432 ' H ' HG22 ' A' ' 50' ' ' VAL . 54.3 m-20 -76.47 141.41 41.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.129 -0.982 . . . . 52.55 109.299 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.448 ' C ' ' H ' ' A' ' 55' ' ' ALA . 18.4 pttp -77.69 -38.81 46.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.145 -0.972 . . . . 44.22 110.453 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -72.17 12.84 0.37 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.015 -1.053 . . . . 70.44 109.498 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -75.48 -21.02 58.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 64.14 110.596 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 55' ' ' ALA . 58.7 mt -40.71 -52.45 2.94 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.366 -0.834 . . . . 44.14 110.428 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -67.02 -32.72 74.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.983 -1.073 . . . . 55.23 108.908 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.634 ' CE2' HD11 ' A' ' 62' ' ' ILE . 53.4 t80 -66.46 -59.29 3.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.435 -0.791 . . . . 74.44 109.911 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.5 m -51.67 -34.14 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.561 -1.337 . . . . 74.03 109.476 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.1 t -58.07 -55.48 34.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.129 -0.982 . . . . 64.3 109.718 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -64.72 -27.72 69.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.08 -1.012 . . . . 64.44 109.782 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.634 HD11 ' CE2' ' A' ' 58' ' ' PHE . 5.7 mm -65.39 -42.29 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.894 -1.129 . . . . 63.21 109.886 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 67' ' ' SER . 1.9 mmmm -67.65 -46.99 70.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.169 -0.957 . . . . 74.42 110.402 -179.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.413 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 14.3 pt-20 -69.91 -41.46 74.63 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.594 -1.316 . . . . 70.32 109.535 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.413 ' N ' ' CG ' ' A' ' 64' ' ' GLU . 52.1 mtpt -73.85 -22.29 59.81 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.232 -0.917 . . . . 75.22 109.169 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.612 ' O ' HG22 ' A' ' 69' ' ' ILE . 67.7 m80 -152.66 64.96 0.8 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.305 -0.872 . . . . 74.13 109.148 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 63' ' ' LYS . 22.7 t -59.23 -36.21 75.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.172 -0.955 . . . . 73.24 109.967 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.7 p -74.5 50.36 0.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.136 -0.978 . . . . 61.01 109.574 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 66' ' ' HIS . 11.2 tt -145.65 168.38 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.165 -0.959 . . . . 71.33 109.472 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.6 t -104.11 152.78 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.336 -0.852 . . . . 72.13 109.154 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.439 ' H ' ' HB2' ' A' ' 92' ' ' ASP . 4.8 t -143.55 120.71 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.15 -0.969 . . . . 54.21 109.197 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.547 ' HG ' HD11 ' A' ' 95' ' ' ILE . 3.5 mp -119.33 104.64 10.56 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.708 -0.849 . . . . 50.24 108.708 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 73' ' ' VAL . 13.6 p -94.78 130.71 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.264 -0.898 . . . . 74.41 109.148 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.6 p -90.85 165.48 13.59 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.152 -0.967 . . . . 72.31 108.923 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.442 ' C ' ' H ' ' A' ' 77' ' ' ASN . 11.8 m -159.53 115.65 2.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.031 -1.043 . . . . 64.54 109.91 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 49.9 p30 -72.64 11.23 0.67 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.376 -0.827 . . . . 74.13 109.128 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 79' ' ' THR . 4.4 t-20 -142.28 64.09 16.15 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.472 -0.767 . . . . 73.34 109.455 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.97 83.83 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.027 1.818 . . . . 63.22 111.716 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.488 ' N ' ' O ' ' A' ' 77' ' ' ASN . 28.5 p -115.38 156.6 25.26 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.194 -0.669 . . . . 62.53 109.194 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.2 t -64.64 -38.87 92.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.308 -0.87 . . . . 73.44 109.596 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.403 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 85.8 tt0 -55.41 -44.79 76.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 71.42 109.386 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -74.55 -30.51 61.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.144 -0.973 . . . . 73.43 109.478 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -63.06 -57.37 10.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.299 -0.875 . . . . 74.22 109.799 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.493 HG23 ' N ' ' A' ' 85' ' ' HIS . 30.0 m -58.91 -42.85 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.109 -0.994 . . . . 73.2 109.343 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.493 ' N ' HG23 ' A' ' 84' ' ' VAL . 24.2 m170 -63.51 -21.05 66.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.932 . . . . 53.33 109.583 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -76.18 -48.74 19.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.076 -1.015 . . . . 64.11 110.024 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.57 ' CE2' ' CZ ' ' B' ' 108' ' ' ARG . 86.0 m-85 -81.0 -28.42 35.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.026 -1.046 . . . . 74.34 109.351 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -73.69 -42.73 60.88 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.223 -0.923 . . . . 74.42 109.689 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -68.61 -50.47 51.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.082 -1.011 . . . . 74.24 109.711 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.56 64.47 0.01 OUTLIER Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.138 -1.185 . . . . 61.51 110.138 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -130.33 141.15 50.6 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.393 -1.063 . . . . 55.33 109.046 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.439 ' HB2' ' H ' ' A' ' 71' ' ' VAL . 0.9 OUTLIER -79.71 -39.19 31.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.086 -1.009 . . . . 73.42 109.562 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 71.2 m-20 -152.44 164.39 37.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 75.04 109.532 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.71 129.69 24.92 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.665 -0.865 . . . . 71.33 108.665 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.809 ' N ' HD12 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -124.02 145.42 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 121.444 0.64 . . . . 71.13 110.066 -178.864 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.01 130.21 44.49 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.176 -1.046 . . . . 64.32 108.176 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.655 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -51.42 -54.03 43.27 Favored Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.056 -1.028 . . . . 62.2 111.506 -179.0 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.7 Cg_endo -42.13 -11.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.228 0 CA-C-N 119.681 0.922 . . . . 73.11 112.558 -176.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.655 ' N ' ' O ' ' A' ' 97' ' ' LYS . 57.9 m-85 59.94 135.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.859 -0.525 . . . . 65.22 110.009 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 44.1 mtt-85 -73.7 -45.06 54.54 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.083 -1.011 . . . . 72.35 109.86 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.732 ' O ' ' N ' ' A' ' 103' ' ' LYS . 42.4 t -164.41 32.56 0.07 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.838 -1.164 . . . . 71.32 111.201 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.0 mm 52.42 -70.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.494 -0.754 . . . . 75.43 110.168 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.732 ' N ' ' O ' ' A' ' 101' ' ' SER . 13.8 mptt -57.86 -26.64 62.35 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.006 -1.109 . . . . 71.41 108.006 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.53 -46.67 46.28 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.853 -0.739 . . . . 63.24 109.697 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.7 tp -63.32 -58.72 6.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.935 . . . . 73.22 109.615 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.486 HG23 ' N ' ' A' ' 107' ' ' ALA . 9.1 m -52.22 -40.94 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.966 -1.084 . . . . 60.11 109.471 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.486 ' N ' HG23 ' A' ' 106' ' ' VAL . . . -55.71 -43.09 76.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.134 -0.979 . . . . 70.42 108.557 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -64.08 -30.89 71.93 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.357 -0.839 . . . . 74.41 109.069 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 55.6 mt -71.36 -35.2 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 107.969 -1.123 . . . . 62.54 107.969 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 114' ' ' ARG . 81.6 tt0 -62.39 -34.57 76.99 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.097 -0.705 . . . . 74.34 109.097 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.523 ' HB1' ' CE1' ' B' ' 87' ' ' PHE . . . -76.36 -59.73 2.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 73.32 109.654 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.412 ' H ' ' HD2' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -57.97 -9.71 1.47 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 52.41 109.483 -179.766 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.6 tp -140.53 82.48 1.85 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.213 -0.929 . . . . 65.24 109.84 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 110' ' ' GLU . 2.1 mmt180 -152.05 -50.11 0.11 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.318 -0.864 . . . . 64.45 108.897 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -89.34 14.14 11.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.282 -0.886 . . . . 74.43 110.001 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.406 ' O ' ' CG ' ' A' ' 116' ' ' TRP . 34.9 p-90 -68.08 125.33 26.0 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.057 -1.027 . . . . 74.42 109.721 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.409 ' O ' ' OG ' ' A' ' 118' ' ' SER . . . 139.79 135.62 3.27 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.186 -1.565 . . . . 75.04 109.186 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 117' ' ' GLY . 69.1 m -166.35 171.02 12.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.071 -1.252 . . . . 61.14 110.1 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.08 103.31 2.2 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.726 -0.842 . . . . 65.24 108.726 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 97.4 t -72.04 -29.67 33.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.087 -1.008 . . . . 73.11 109.132 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.15 131.5 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.603 -0.888 . . . . 72.24 108.603 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -149.12 128.4 12.91 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.129 -0.982 . . . . 72.34 109.542 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.864 HG21 ' NH1' ' A' ' 159' ' ' ARG . 9.3 tp -161.39 136.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.309 -0.869 . . . . 71.44 109.499 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 126' ' ' LEU . . . 59.13 -167.03 7.65 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.878 -1.289 . . . . 73.4 109.878 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -70.67 12.29 0.28 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.511 -0.993 . . . . 74.45 108.83 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.534 ' H ' ' C ' ' A' ' 124' ' ' GLY . 1.9 tt -110.06 131.2 55.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.698 -0.626 . . . . 54.21 109.514 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.8 p -131.0 142.87 50.38 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.325 -0.859 . . . . 54.5 108.716 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.46 HG21 ' CB ' ' A' ' 156' ' ' ALA . 94.6 mt -136.67 135.4 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.164 -0.96 . . . . 45.15 110.661 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.1 m -127.46 104.1 22.05 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.359 -0.978 . . . . 71.11 108.359 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.33 -25.38 2.65 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.475 2.116 . . . . 65.41 112.206 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -66.06 -38.46 88.37 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.307 -0.871 . . . . 63.32 108.843 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -98.08 9.06 43.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.375 -0.828 . . . . 72.52 109.64 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.675 ' HA ' ' HZ ' ' A' ' 149' ' ' PHE . 37.7 mt-10 47.72 60.48 3.5 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.206 -0.934 . . . . 75.33 109.617 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.512 ' C ' HD12 ' A' ' 135' ' ' ILE . 36.0 ttpt -154.03 130.6 10.67 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.047 -1.033 . . . . 71.23 110.098 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.561 HD12 ' N ' ' A' ' 135' ' ' ILE . 2.2 mp -111.89 138.22 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.488 -0.93 . . . . 74.02 108.488 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 19.4 mt -125.72 131.54 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.409 -0.807 . . . . 60.23 108.9 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.417 ' CE2' ' O ' ' A' ' 198' ' ' PRO . 10.3 p90 -139.12 139.22 37.58 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.099 -1.001 . . . . 62.32 109.984 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.1 mttt 53.73 27.87 7.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.522 -0.737 . . . . 75.4 110.175 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 77.88 14.08 82.73 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.905 -1.14 . . . . 72.24 110.437 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 -105.27 133.13 50.54 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.472 -1.016 . . . . 71.22 108.78 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -90.82 129.3 36.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.322 -0.861 . . . . 71.42 110.224 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 t -128.14 108.63 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.357 -0.979 . . . . 53.02 108.357 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -92.48 102.07 14.52 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.054 -1.091 . . . . 60.45 108.054 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.514 HG23 ' CD1' ' A' ' 149' ' ' PHE . 1.3 m -115.61 139.76 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.7 0.762 . . . . 74.44 110.705 -178.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -160.53 125.39 3.77 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.856 -0.794 . . . . 65.15 108.856 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.37 -143.18 10.06 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.674 -1.37 . . . . 73.34 109.674 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -70.91 -59.27 3.64 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.346 -1.09 . . . . 72.22 110.486 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.84 4.9 1.23 Allowed 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.997 1.798 . . . . 65.23 112.785 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.675 ' HZ ' ' HA ' ' A' ' 133' ' ' GLU . 65.3 t80 -101.66 -54.82 2.65 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.234 -0.916 . . . . 60.11 110.319 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.4 ' CD ' HG23 ' A' ' 172' ' ' ILE . 7.9 pt-20 -46.98 -36.0 7.24 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.158 -0.964 . . . . 64.21 109.574 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.8 p -78.82 -31.26 15.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.169 -0.957 . . . . 72.02 109.137 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.532 HD11 ' SD ' ' A' ' 195' ' ' MET . 13.8 tp -63.56 -38.81 92.53 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.127 -0.983 . . . . 73.31 109.039 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.1 p -75.91 -32.75 59.76 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.08 -1.013 . . . . 74.31 108.592 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.462 ' O ' ' CD2' ' A' ' 158' ' ' HIS . 44.4 t-80 -55.13 -51.01 67.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.607 -0.683 . . . . 74.31 110.5 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.92 -33.41 65.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.988 -1.07 . . . . 75.34 109.887 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.46 ' CB ' HG21 ' A' ' 128' ' ' ILE . . . -50.45 -44.62 55.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.981 -1.074 . . . . 62.14 109.683 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 -77.66 -43.75 30.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.091 -1.006 . . . . 61.03 110.234 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.462 ' CD2' ' O ' ' A' ' 154' ' ' HIS . 34.0 m-70 -82.54 34.89 0.44 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 74.12 110.803 -178.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.864 ' NH1' HG21 ' A' ' 123' ' ' ILE . 30.8 ttp180 -64.61 169.28 5.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.807 -1.183 . . . . 71.13 107.927 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 4.4 p30 41.44 55.68 3.38 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.378 -0.826 . . . . 75.45 110.082 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -158.4 156.14 29.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 73.41 109.132 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.624 HD12 ' N ' ' A' ' 162' ' ' ILE . 2.5 mp -83.71 123.1 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.177 -0.952 . . . . 74.41 108.463 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 48.2 t -118.05 127.67 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.486 -0.759 . . . . 72.31 110.051 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.8 t -100.69 148.02 25.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.519 -0.738 . . . . 74.12 109.558 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -49.41 -49.75 43.52 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.482 -0.761 . . . . 70.43 109.816 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -51.88 -36.93 50.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.069 -1.02 . . . . 73.52 109.476 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -59.03 -43.35 91.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.976 -1.078 . . . . 74.52 109.115 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 18.5 mt -56.14 -37.22 69.2 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.245 -0.909 . . . . 72.31 108.549 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.603 HD21 ' CG1' ' A' ' 184' ' ' ILE . 92.8 mt -64.73 -74.68 0.1 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.566 -1.254 . . . . 53.33 109.019 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -45.92 -14.43 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.885 . . . . 62.44 110.516 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 169' ' ' LEU . . . -93.42 -37.54 11.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.063 -1.023 . . . . 60.21 111.428 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.416 ' N ' ' CD1' ' A' ' 172' ' ' ILE . 1.4 mp -95.42 -56.58 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 120.954 -1.091 . . . . 75.32 110.446 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.506 2.363 0 O-C-N 120.406 -1.434 . . . . 73.14 109.229 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 109.292 -0.633 . . . . 64.54 109.292 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.3 t -145.34 -31.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.235 -0.916 . . . . 74.02 110.176 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.875 ' H ' HD12 ' A' ' 184' ' ' ILE . 2.4 mp -57.85 -34.82 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.065 -1.022 . . . . 72.33 109.898 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -52.82 -50.05 64.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.242 -0.911 . . . . 74.4 109.641 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 186' ' ' VAL . 16.7 m -77.8 -31.08 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.18 -0.95 . . . . 70.42 109.961 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.58 -51.08 68.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.926 -1.109 . . . . 52.11 109.915 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.424 HG23 ' N ' ' A' ' 189' ' ' ASN . 3.5 tp -68.03 -43.27 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.879 -1.138 . . . . 71.4 110.032 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.467 ' ND2' ' OE1' ' A' ' 193' ' ' GLN . 7.9 t-20 -60.38 -37.93 82.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.895 -1.128 . . . . 73.44 108.676 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -71.93 -50.87 25.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.551 -0.718 . . . . 71.42 110.618 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 69.5 mt -52.7 -58.5 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.053 -1.029 . . . . 61.55 109.914 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ARG . . . . . 0.421 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 3.3 mtp85 -51.14 -41.92 60.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.075 -1.016 . . . . 63.34 109.008 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.467 ' OE1' ' ND2' ' A' ' 189' ' ' ASN . 16.4 mt-30 -71.02 -24.05 62.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.995 -1.066 . . . . 61.24 109.932 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.447 ' O ' ' CG ' ' A' ' 198' ' ' PRO . 4.7 mtpm? -101.0 -0.27 36.81 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.289 -0.882 . . . . 75.13 110.573 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' MET . . . . . 0.532 ' SD ' HD11 ' A' ' 152' ' ' LEU . 0.6 OUTLIER -109.15 -19.11 13.46 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.2 -0.937 . . . . 74.02 110.02 -179.367 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 192' ' ' ARG . 14.0 p-10 -98.28 -5.28 33.4 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.158 -0.964 . . . . 74.02 110.164 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.485 ' H ' ' HD2' ' A' ' 198' ' ' PRO . 26.9 mttp -103.23 -64.86 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.125 0 O-C-N 121.355 -0.84 . . . . 75.43 110.575 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.485 ' HD2' ' H ' ' A' ' 197' ' ' LYS . 29.9 Cg_endo -61.42 -57.41 0.58 Allowed 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 121.966 1.777 . . . . 72.32 112.013 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.9 mp -69.55 -43.11 73.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 74.54 109.383 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 94.3 -26.97 14.8 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.254 -1.138 . . . . 61.51 110.254 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.755 HD12 ' N ' ' A' ' 201' ' ' ILE . 3.1 mp -98.68 133.54 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.97 -1.312 . . . . 61.22 110.289 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 14.6 m -106.14 139.18 41.07 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.118 -1.067 . . . . 72.0 108.118 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.4 p -141.58 42.96 1.74 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.063 -1.023 . . . . 74.44 110.128 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.529 ' CG1' ' CE2' ' A' ' 214' ' ' PHE . 1.0 OUTLIER -143.11 155.06 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.28 -0.888 . . . . 64.35 109.727 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -128.34 134.1 48.8 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.712 -0.847 . . . . 71.41 108.712 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.4 t -95.1 133.28 39.08 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.046 -1.034 . . . . 73.52 109.259 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 10.5 p -156.25 142.78 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.787 -1.196 . . . . 71.02 109.531 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -64.85 -41.06 96.01 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.379 -0.825 . . . . 72.12 109.539 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 1.077 HH21 ' NH2' ' A' ' 213' ' ' ARG . 0.8 OUTLIER -58.12 152.8 16.07 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.824 -0.806 . . . . 64.41 108.824 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 209' ' ' ARG . 9.6 mpt_? 42.9 -94.17 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.23 -0.919 . . . . 71.54 109.789 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . -171.42 -114.09 0.31 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.469 -1.452 . . . . 72.03 109.469 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -111.06 140.34 45.68 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.478 -1.013 . . . . 75.54 109.055 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 1.077 ' NH2' HH21 ' A' ' 209' ' ' ARG . 36.6 mtt180 -105.51 142.65 34.88 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.319 -0.863 . . . . 75.31 109.677 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.529 ' CE2' ' CG1' ' A' ' 204' ' ' VAL . 33.8 m-85 -115.78 112.83 22.58 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.49 -0.93 . . . . 75.41 108.49 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 8.2 p -119.35 160.6 21.96 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.628 -0.67 . . . . 74.14 109.847 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' TYR . . . . . 0.462 ' CD1' ' O ' ' A' ' 217' ' ' PRO . 36.7 p90 -68.92 151.1 97.42 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.394 -0.816 . . . . 75.32 109.229 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.462 ' O ' ' CD1' ' A' ' 216' ' ' TYR . 84.4 Cg_exo . . . . . 0 N--CA 1.493 1.488 0 C-N-CA 122.28 1.987 . . . . 73.11 112.253 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.527 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.435 -0.58 . . . . 71.14 109.435 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.557 HH21 ' C ' ' B' ' 44' ' ' ASN . 8.1 ttp180 -139.89 150.38 44.53 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.357 -0.84 . . . . 73.23 109.067 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 92.6 t -116.03 129.93 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.537 -0.912 . . . . 72.24 108.537 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.582 HD21 HD11 ' B' ' 6' ' ' ILE . 5.5 tp -101.89 118.34 36.72 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.513 -0.742 . . . . 54.33 110.002 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 16.4 mt -114.6 111.28 21.09 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 108.412 -0.958 . . . . 74.35 108.412 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.656 HD12 ' HB ' ' B' ' 50' ' ' VAL . 66.3 mt -107.94 115.4 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.417 -0.802 . . . . 42.55 109.246 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' B' ' 7' ' ' GLU . 1.4 pm0 -160.08 140.74 12.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 74.52 109.417 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -63.68 -31.15 72.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 62.55 109.319 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -86.5 106.97 17.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.252 -0.905 . . . . 73.11 109.524 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 47.8 m -72.44 -29.14 63.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 65.54 109.847 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 90.9 t -56.79 -49.97 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.155 -0.965 . . . . 75.55 109.657 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.519 HD22 ' N ' ' B' ' 12' ' ' LEU . 3.6 mm? -63.02 -35.21 79.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 70.14 109.188 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.78 -25.47 74.89 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 108.635 -1.786 . . . . 75.4 108.635 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.79 -54.13 27.05 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.36 -1.496 . . . . 65.44 109.36 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -57.42 -46.27 83.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.4 -1.059 . . . . 60.21 109.68 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 37.5 mm -62.52 -38.88 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.866 -1.146 . . . . 75.15 108.652 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.423 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 80.0 tt0 -61.79 -43.1 99.53 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.408 -0.807 . . . . 73.01 109.508 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -87.66 2.6 50.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.186 -0.946 . . . . 74.3 109.177 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.76 -55.95 2.06 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.457 -1.457 . . . . 70.54 109.457 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -71.44 -21.99 61.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.242 -1.151 . . . . 71.34 109.633 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 88.0 m-20 -52.44 -33.91 46.24 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.215 -0.928 . . . . 64.41 109.646 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 81.8 t -59.51 -32.71 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.152 -0.968 . . . . 74.23 109.212 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -79.23 -4.79 52.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.358 -0.839 . . . . 63.42 109.193 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.17 36.35 18.21 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.264 -1.135 . . . . 53.43 110.264 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -113.76 160.01 19.14 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.463 -1.022 . . . . 71.12 108.938 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.4 mmt -107.14 140.49 39.91 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.386 -0.821 . . . . 75.24 109.09 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.02 164.74 26.95 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.491 -0.755 . . . . 72.12 109.499 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -141.24 145.58 35.75 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.372 -0.83 . . . . 72.31 108.964 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 m -113.63 137.14 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.785 . . . . 64.43 109.068 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 10.0 p -144.56 164.47 30.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.288 -0.883 . . . . 65.41 109.367 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.447 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 1.6 pt-20 -91.57 -97.24 0.12 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.242 -0.911 . . . . 71.02 109.579 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 42.4 t -79.48 166.59 21.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.192 -0.942 . . . . 51.11 109.96 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' B' ' 37' ' ' GLU . 16.7 mt -55.25 -32.0 61.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.592 -0.693 . . . . 71.24 110.134 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -54.3 -44.86 72.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.09 -1.006 . . . . 74.32 110.2 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.447 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 19.0 m-20 -66.34 -42.96 87.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.051 -1.031 . . . . 73.03 109.651 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.58 -28.48 59.38 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.629 -1.388 . . . . 30.21 109.629 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' B' ' 33' ' ' LEU . 84.7 tt0 -67.18 -46.79 72.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -1.15 . . . . 74.42 109.695 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' TYR . . . . . 0.443 ' O ' ' OD1' ' B' ' 41' ' ' ASP . 70.2 t80 -75.06 -26.59 59.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.258 -0.901 . . . . 74.42 110.036 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 9.6 tp -84.84 -30.86 24.17 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.17 -0.956 . . . . 75.41 110.031 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' MET . . . . . 0.489 ' SD ' ' OH ' ' B' ' 45' ' ' TYR . 0.0 OUTLIER -86.83 -30.61 21.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.961 . . . . 60.41 110.317 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' B' ' 42' ' ' ILE . 56.2 p-10 -71.07 -21.4 62.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.878 -1.139 . . . . 53.23 110.043 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.528 ' N ' ' OD1' ' B' ' 41' ' ' ASP . 12.5 pt -80.94 -29.95 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.03 -1.044 . . . . 71.23 110.005 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.485 ' C ' ' NH2' ' B' ' 2' ' ' ARG . 26.2 mmt180 -129.13 171.13 12.71 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.376 -0.828 . . . . 72.22 109.791 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' ASN . . . . . 0.557 ' C ' HH21 ' B' ' 2' ' ' ARG . 24.5 m120 -98.87 154.21 18.21 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.076 -1.015 . . . . 63.54 109.809 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.586 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 1.3 p90 -140.52 -177.36 5.01 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.353 -0.842 . . . . 64.35 109.09 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' ASP . . . . . 0.443 ' OD2' ' CD1' ' B' ' 116' ' ' TRP . 63.4 t0 -133.28 -43.6 0.85 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.253 -0.904 . . . . 62.22 110.256 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.533 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.5 OUTLIER -102.01 114.51 28.68 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.276 -0.89 . . . . 73.12 109.082 -179.597 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.533 ' N ' HD13 ' B' ' 47' ' ' LEU . 50.6 t -98.63 97.37 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.238 -1.023 . . . . 65.11 108.238 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.457 ' O ' ' O ' ' B' ' 4' ' ' LEU . 22.5 ttt -111.82 130.37 55.83 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.716 0.769 . . . . 73.44 109.891 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.656 ' HB ' HD12 ' B' ' 6' ' ' ILE . 0.4 OUTLIER -145.8 137.84 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.358 -0.839 . . . . 34.5 109.491 -179.579 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 42.8 p -102.53 2.94 36.92 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.579 -0.701 . . . . 73.21 109.788 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.412 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 27.4 m-20 -76.41 134.29 39.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.147 -0.97 . . . . 70.41 109.377 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' B' ' 55' ' ' ALA . 62.6 mttp -70.24 -37.79 75.05 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.275 -0.891 . . . . 65.0 110.46 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -69.96 6.71 1.13 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.969 -1.082 . . . . 75.21 109.703 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.418 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -75.35 -22.5 57.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 55.33 110.346 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 42.0 mt -44.46 -39.59 4.89 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.328 -0.857 . . . . 63.14 110.048 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 83.8 p -76.88 -37.39 55.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.041 -1.037 . . . . 63.5 109.466 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -66.08 -42.87 88.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.387 -0.821 . . . . 72.33 110.148 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.406 HG23 ' N ' ' B' ' 60' ' ' SER . 35.9 m -68.17 -37.74 78.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 120.68 -1.262 . . . . 74.54 109.121 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 60' ' ' SER . . . . . 0.406 ' N ' HG23 ' B' ' 59' ' ' VAL . 9.5 t -53.84 -49.61 68.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 71.24 109.472 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -68.32 -35.6 78.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.138 -0.976 . . . . 74.31 110.069 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 5.4 mm -63.22 -39.35 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.806 -1.184 . . . . 72.14 109.903 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' B' ' 67' ' ' SER . 6.9 mtpm? -67.13 -50.97 59.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.076 -1.015 . . . . 73.32 110.42 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -69.32 -38.19 78.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.852 -1.155 . . . . 73.12 109.765 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.503 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 25.8 mtpp -78.77 -20.52 49.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 72.44 109.346 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.55 ' O ' HG22 ' B' ' 69' ' ' ILE . 97.9 m-70 -156.88 65.73 0.52 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 63.31 109.326 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.469 ' N ' ' O ' ' B' ' 63' ' ' LYS . 86.4 p -61.22 -30.63 70.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 73.1 109.984 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 78.6 p -69.01 47.06 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.152 -0.967 . . . . 71.53 109.785 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.55 HG22 ' O ' ' B' ' 66' ' ' HIS . 16.0 tt -146.43 163.99 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.152 -0.968 . . . . 74.4 109.541 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 41.3 t -103.33 148.96 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.308 -0.87 . . . . 75.12 109.504 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 t -135.66 124.51 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.3 -0.875 . . . . 73.2 109.841 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.546 ' C ' HD23 ' B' ' 72' ' ' LEU . 4.5 tt -116.8 104.31 11.2 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.107 -0.701 . . . . 73.34 109.107 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.72 132.51 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.073 -1.017 . . . . 73.5 109.213 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 7.8 p -93.56 170.78 9.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.143 -0.973 . . . . 64.34 109.154 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.437 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 11.9 t -152.1 122.81 7.42 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.942 -1.099 . . . . 74.53 110.523 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 51.3 p30 -68.2 1.36 2.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.461 -0.775 . . . . 64.5 109.745 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 77' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' B' ' 79' ' ' THR . 38.9 t-20 -171.55 81.3 0.5 Allowed Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.248 -0.907 . . . . 74.25 109.494 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.464 ' CG ' ' HB2' ' B' ' 96' ' ' ALA . 97.4 Cg_exo -42.55 87.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.205 1.937 . . . . 74.43 111.943 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.505 ' N ' ' O ' ' B' ' 77' ' ' ASN . 3.0 p -100.5 155.83 17.62 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.177 -0.675 . . . . 73.12 109.177 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.2 -36.38 83.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.386 -0.821 . . . . 71.01 109.591 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -63.37 -40.81 98.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 63.2 109.93 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 82' ' ' GLU . . . . . 0.418 ' OE1' ' OG ' ' B' ' 75' ' ' SER . 78.1 tt0 -73.57 -34.37 65.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.152 -0.967 . . . . 73.22 109.998 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.407 ' OE1' ' N ' ' B' ' 84' ' ' VAL . 14.6 tm-20 -61.88 -56.68 16.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 74.3 109.711 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.445 HG23 ' N ' ' B' ' 85' ' ' HIS . 34.6 m -58.66 -39.09 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.16 -0.962 . . . . 73.31 109.299 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 85' ' ' HIS . . . . . 0.445 ' N ' HG23 ' B' ' 84' ' ' VAL . 19.7 m170 -69.38 -28.02 65.82 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 73.24 109.403 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.25 -36.39 81.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.128 -0.982 . . . . 55.33 109.732 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 87' ' ' PHE . . . . . 0.523 ' CE1' ' HB1' ' A' ' 111' ' ' ALA . 68.5 t80 -82.33 -38.41 24.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.058 -1.026 . . . . 74.14 108.879 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -70.47 -38.25 74.41 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.346 -0.846 . . . . 64.04 109.653 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -74.97 -57.56 3.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.933 . . . . 72.35 109.358 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 153.63 80.82 0.03 OUTLIER Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.036 -1.225 . . . . 65.2 110.036 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -139.82 115.43 10.05 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.247 -1.149 . . . . 52.23 109.256 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' B' ' 93' ' ' ASP . 18.9 t70 -73.9 -29.56 62.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.926 . . . . 73.32 108.864 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 93' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' B' ' 92' ' ' ASP . 48.2 m-20 -139.01 164.0 30.91 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.507 -0.923 . . . . 72.22 108.507 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.437 ' OH ' ' CB ' ' B' ' 75' ' ' SER . 89.1 t80 -151.14 103.32 3.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.126 -0.984 . . . . 64.42 109.26 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 28.0 mm -114.77 149.37 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 O-C-N 121.332 -0.855 . . . . 72.23 110.499 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 96' ' ' ALA . . . . . 0.498 ' HB1' ' HD2' ' B' ' 98' ' ' PRO . . . -62.12 143.85 56.13 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.757 -1.201 . . . . 25.24 107.757 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.593 ' N ' ' CD ' ' B' ' 98' ' ' PRO . 0.0 OUTLIER -68.33 -40.8 21.82 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.857 -1.152 . . . . 64.32 111.104 -178.701 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 98' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' B' ' 97' ' ' LYS . 39.0 Cg_exo -52.01 -2.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.289 -2.595 0 CA-C-N 118.696 0.57 . . . . 63.33 112.188 -174.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 99' ' ' TYR . . . . . 0.578 ' N ' ' O ' ' B' ' 97' ' ' LYS . 58.5 m-85 54.69 95.28 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.711 -0.618 . . . . 75.13 110.68 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 36.2 mtt85 -56.1 -38.31 70.56 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.7 -1.222 . . . . 74.23 107.7 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 10.2 t -172.68 125.97 0.48 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.644 -0.873 . . . . 63.34 108.644 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 102' ' ' ILE . . . . . 0.4 ' H ' HG13 ' B' ' 102' ' ' ILE . 58.3 mt -50.26 -40.06 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.06 -1.025 . . . . 74.44 109.363 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -61.79 -38.23 87.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.201 -0.937 . . . . 71.11 109.193 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.71 -49.49 65.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 71.45 109.346 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.401 HD11 HD11 ' B' ' 72' ' ' LEU . 65.1 tp -62.28 -44.45 96.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 51.31 109.149 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.98 -39.94 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.217 -0.927 . . . . 65.23 109.484 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.37 -39.09 66.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.094 -1.004 . . . . 24.32 108.961 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 108' ' ' ARG . . . . . 0.57 ' CZ ' ' CE2' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -72.17 -34.66 68.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.421 -0.799 . . . . 75.31 109.42 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 97.3 mt -75.53 -27.36 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.208 -0.933 . . . . 54.24 109.33 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -73.51 -56.68 4.72 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.343 -0.848 . . . . 65.31 109.477 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.72 -36.11 69.31 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 72.24 109.906 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 112' ' ' ARG . . . . . 0.467 ' NH2' HH22 ' B' ' 108' ' ' ARG . 0.0 OUTLIER -66.28 -51.4 57.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.171 -0.956 . . . . 72.04 110.179 -179.467 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' B' ' 116' ' ' TRP . 64.2 mt -74.8 -33.07 62.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.089 -1.007 . . . . 75.35 110.277 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -48.92 -37.57 20.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.936 -1.102 . . . . 75.5 109.456 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -81.08 -2.45 48.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.911 . . . . 65.33 109.3 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 116' ' ' TRP . . . . . 0.443 ' CD1' ' OD2' ' B' ' 46' ' ' ASP . 88.2 t90 -55.33 -35.79 65.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 74.45 109.577 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.32 106.69 2.43 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.614 -1.394 . . . . 44.21 109.614 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 42.8 m -154.92 166.95 31.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -1.159 . . . . 71.4 109.702 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -158.0 120.78 3.83 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.875 -0.787 . . . . 72.32 108.875 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 19.3 t -87.36 -43.08 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.146 -0.971 . . . . 75.02 109.395 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 16.1 mm -99.2 137.2 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.277 -0.89 . . . . 51.41 109.431 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -135.59 100.48 4.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.446 -0.784 . . . . 71.53 109.048 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 31.2 mm -113.53 132.18 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.5 -0.75 . . . . 72.43 109.472 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 44.16 -128.22 6.67 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.034 -1.226 . . . . 51.23 110.034 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -97.38 -10.25 25.88 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.323 -1.104 . . . . 74.2 109.711 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.458 ' H ' HD23 ' B' ' 126' ' ' LEU . 0.2 OUTLIER -96.97 137.13 36.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.137 -0.977 . . . . 75.42 109.298 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 27.6 p -119.62 144.99 46.83 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.589 -0.694 . . . . 74.22 109.441 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 56.2 mt -124.46 129.26 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.514 -0.741 . . . . 60.33 109.367 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 6.3 m -109.7 118.22 50.73 Favored Pre-proline 0 N--CA 1.497 1.876 0 N-CA-C 108.858 -0.794 . . . . 72.31 108.858 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.618 ' CB ' ' HE ' ' B' ' 157' ' ' ARG . 97.3 Cg_endo -79.18 -56.88 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.751 1.634 . . . . 75.13 112.211 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -59.74 -43.15 94.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.154 -0.966 . . . . 75.23 109.545 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -81.33 -12.84 58.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 72.43 109.303 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 52.07 55.07 9.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 75.13 109.363 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 134' ' ' LYS . . . . . 0.409 ' NZ ' ' CZ3' ' B' ' 116' ' ' TRP . 35.7 ttpt -137.19 133.7 35.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.482 -0.761 . . . . 73.22 109.267 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 135' ' ' ILE . . . . . 0.403 HG23 ' O ' ' B' ' 135' ' ' ILE . 13.5 tt -117.14 132.69 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.53 -0.731 . . . . 64.14 109.441 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 14.0 mt -112.04 125.07 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.55 -0.718 . . . . 71.22 109.146 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -139.75 140.35 36.71 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.326 -0.859 . . . . 64.22 109.728 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt 53.98 19.05 1.86 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.37 -0.831 . . . . 72.02 110.011 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.38 16.42 64.41 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 120.087 -1.054 . . . . 74.32 110.614 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -112.29 127.8 56.09 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.365 -1.079 . . . . 75.34 109.493 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -93.9 127.01 39.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.249 -0.907 . . . . 71.23 109.629 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 98.7 t -137.52 136.48 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.412 -0.805 . . . . 70.43 109.254 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 143' ' ' GLU . . . . . 0.457 ' CD ' ' N ' ' B' ' 143' ' ' GLU . 42.9 mp0 -92.82 144.31 25.41 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.219 -0.926 . . . . 72.43 109.45 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 144' ' ' VAL . . . . . 0.472 ' O ' HG23 ' B' ' 144' ' ' VAL . 34.1 m -143.55 125.84 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.195 -0.941 . . . . 72.13 109.17 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.37 117.45 11.81 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.379 -0.826 . . . . 72.02 109.255 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.7 171.02 33.22 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.515 -1.434 . . . . 42.23 109.515 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 147' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 4.4 mtmm -68.67 -38.26 11.73 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.202 -1.175 . . . . 73.3 109.961 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 148' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 36.1 Cg_exo -59.61 -34.85 96.51 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.105 1.87 . . . . 71.33 111.929 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -88.47 -18.07 29.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.368 -0.832 . . . . 74.23 109.622 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -57.45 -40.02 77.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 72.34 109.644 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.46 HG13 ' N ' ' B' ' 152' ' ' LEU . 9.6 p -61.76 -39.09 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.943 . . . . 73.35 109.585 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.46 ' N ' HG13 ' B' ' 151' ' ' VAL . 41.2 tp -60.56 -41.45 94.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 55.24 109.096 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 17.7 p -76.87 -30.99 56.48 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.261 -0.899 . . . . 70.01 109.258 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -58.4 -51.24 70.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 65.32 109.585 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 155' ' ' LEU . . . . . 0.478 HD13 HH22 ' B' ' 159' ' ' ARG . 1.9 pp -72.99 -28.29 62.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -0.942 . . . . 71.54 109.542 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -54.47 -46.08 73.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.957 . . . . 75.32 109.507 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 157' ' ' ARG . . . . . 0.618 ' HE ' ' CB ' ' B' ' 130' ' ' PRO . 43.3 mtt85 -75.75 -43.96 44.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.203 -0.936 . . . . 73.32 109.457 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -77.04 26.37 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.349 -0.844 . . . . 74.14 109.903 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 159' ' ' ARG . . . . . 0.478 HH22 HD13 ' B' ' 155' ' ' LEU . 3.0 tpm_? -49.66 157.04 0.59 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.097 -1.002 . . . . 61.41 108.873 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 160' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' B' ' 160' ' ' ASP . 4.9 p-10 42.81 54.57 4.62 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.473 -0.767 . . . . 72.1 110.13 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -146.44 156.05 43.01 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.175 -0.953 . . . . 72.25 109.368 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 26.2 mt -98.91 138.98 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.263 -0.898 . . . . 72.31 109.379 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 9.5 m -140.73 143.52 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.33 -0.857 . . . . 64.21 109.57 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 83.7 p -94.48 161.48 14.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.285 -0.884 . . . . 74.22 109.214 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -53.78 -38.55 64.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.2 -0.938 . . . . 65.31 109.255 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -64.54 -36.85 85.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.867 . . . . 63.45 109.445 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 10.5 tm0? -56.26 -45.38 80.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.898 . . . . 72.4 109.123 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 33.1 mt -65.02 -33.83 76.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 72.32 108.919 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.562 HD23 ' C ' ' B' ' 169' ' ' LEU . 4.0 tt -53.53 -60.64 3.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.43 -0.794 . . . . 73.34 109.558 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -66.83 -27.85 67.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.371 -0.831 . . . . 72.1 110.232 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.26 -57.6 11.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.14 -0.975 . . . . 62.13 110.064 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 0.684 ' N ' HD12 ' B' ' 172' ' ' ILE . 2.0 mp -94.65 -59.0 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.06 -1.025 . . . . 71.42 109.291 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 23.2 m-90 . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.265 -0.897 . . . . 72.23 109.527 -179.843 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 181' ' ' PRO . . . . . 0.432 ' O ' ' OE1' ' B' ' 185' ' ' GLU . 67.4 Cg_endo . . . . . 0 N--CA 1.495 1.564 0 CA-C-O 121.294 0.456 . . . . 65.22 112.017 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 182' ' ' ASN . . . . . 0.426 ' O ' ' OE1' ' B' ' 185' ' ' GLU . 19.9 t-20 -61.65 -27.29 68.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 72.31 110.111 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 9.7 m -77.29 -17.53 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.097 -1.002 . . . . 63.32 110.114 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 87.9 mt -58.36 -52.41 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.103 -0.998 . . . . 75.03 110.034 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 185' ' ' GLU . . . . . 0.63 ' CD ' ' H ' ' B' ' 185' ' ' GLU . 1.6 pm0 -55.33 -33.93 63.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.134 -0.979 . . . . 64.11 109.318 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 91.7 t -75.26 -47.63 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 73.0 109.934 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.78 -50.18 65.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -0.999 . . . . 61.12 110.166 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 188' ' ' ILE . . . . . 0.431 HG23 ' N ' ' B' ' 189' ' ' ASN . 16.1 tt -57.79 -39.87 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.025 -1.047 . . . . 72.43 109.764 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 189' ' ' ASN . . . . . 0.431 ' N ' HG23 ' B' ' 188' ' ' ILE . 47.6 t30 -61.38 -46.37 90.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.104 -0.997 . . . . 65.14 109.545 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -68.51 -45.2 72.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 63.24 109.764 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 85.5 mt -54.98 -41.75 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.226 -0.921 . . . . 74.03 109.288 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -60.77 -47.15 87.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 72.24 109.287 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -66.21 -36.15 82.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.894 . . . . 73.1 109.533 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 194' ' ' LYS . . . . . 0.46 ' NZ ' ' CB ' ' B' ' 194' ' ' LYS . 7.8 mtpm? -81.29 -6.45 58.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.882 . . . . 72.11 109.566 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 28.1 ttt -92.92 -54.71 3.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.233 -0.917 . . . . 44.33 109.406 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 196' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' B' ' 200' ' ' GLY . 91.2 m-20 -62.6 -33.05 74.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 71.21 109.745 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 197' ' ' LYS . . . . . 0.449 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 0.0 OUTLIER -54.6 -65.15 1.43 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.17 -0.956 . . . . 75.21 109.785 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 198' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 36.9 Cg_endo -63.36 -53.44 1.45 Allowed 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.143 1.896 . . . . 75.32 112.213 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 29.7 mt -66.78 -34.28 77.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.19 -0.944 . . . . 72.25 109.679 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 200' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' B' ' 196' ' ' ASP . . . 80.41 -40.08 2.37 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.472 -1.451 . . . . 64.53 109.472 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 64.6 mt -93.67 137.49 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.273 -1.133 . . . . 44.23 109.279 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 28.6 p -81.4 134.21 35.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 54.01 109.361 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 25.9 p -131.3 -7.81 3.78 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.472 -0.767 . . . . 74.4 109.519 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 3.6 m -105.13 133.45 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.342 -0.848 . . . . 72.12 109.485 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -99.36 127.32 45.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.346 -0.846 . . . . 65.41 109.299 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.92 127.68 44.02 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.235 -0.915 . . . . 71.33 109.24 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.503 HG12 ' H ' ' B' ' 209' ' ' ARG . 9.1 t -139.78 139.46 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.262 -0.899 . . . . 63.5 109.423 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -85.33 11.68 9.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.197 -0.94 . . . . 74.45 109.466 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 209' ' ' ARG . . . . . 0.503 ' H ' HG12 ' B' ' 207' ' ' VAL . 16.5 tpt85 -74.26 -128.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.924 . . . . 74.14 109.562 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -57.58 -42.12 82.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 74.43 109.696 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 211' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' B' ' 207' ' ' VAL . . . -173.8 -118.9 0.52 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.679 -1.368 . . . . 64.45 109.679 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 212' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' B' ' 212' ' ' TYR . 29.8 m-85 -123.93 156.4 36.4 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.566 -0.961 . . . . 74.21 109.319 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -134.47 145.55 48.94 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.555 -0.716 . . . . 74.03 109.082 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -115.78 138.47 51.1 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.449 -0.782 . . . . 74.34 109.178 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.3 p -156.19 166.54 33.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.43 -0.794 . . . . 64.33 109.219 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -61.44 149.53 83.31 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.176 -0.952 . . . . 70.04 108.998 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -38.99 144.87 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 122.047 1.831 . . . . 65.11 112.152 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 218' ' ' LYS . . . . . 0.512 ' NZ ' ' CB ' ' B' ' 218' ' ' LYS . 4.7 mtpm? . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.144 -0.972 . . . . 73.15 109.152 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.585 ' SD ' ' CE2' ' A' ' 25' ' ' PHE . 15.4 ptp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.415 -0.587 . . . . 65.12 109.415 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.3 mtt85 -140.94 156.23 46.11 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.321 -0.862 . . . . 72.33 109.283 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.99 130.64 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.643 -0.661 . . . . 71.42 109.722 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.828 HD12 ' N ' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -100.9 125.59 47.47 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.314 -0.995 . . . . 65.12 108.314 179.27 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.828 ' N ' HD12 ' A' ' 4' ' ' LEU . 3.4 tp -120.51 118.4 30.14 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.606 -0.684 . . . . 62.43 109.496 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.588 HG12 HD11 ' A' ' 4' ' ' LEU . 8.9 mt -105.14 123.77 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.357 -0.839 . . . . 71.15 109.056 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -167.42 138.14 2.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.072 -1.018 . . . . 75.34 109.697 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.609 ' HZ3' ' C ' ' A' ' 31' ' ' GLU . 67.1 mmtt -84.32 -26.47 28.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 72.44 109.257 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -61.66 -154.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.355 -0.84 . . . . 63.02 109.5 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.1 p -148.83 -50.75 0.16 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.21 -0.932 . . . . 72.34 109.41 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.5 t -65.38 -39.8 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 74.02 109.521 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 12' ' ' LEU . 10.1 mp -63.18 -36.23 82.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 71.43 109.409 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.55 -35.15 26.57 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.501 -1.84 . . . . 61.32 108.501 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.94 -43.26 91.77 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 110.182 -1.167 . . . . 71.2 110.182 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -69.39 -41.17 76.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.939 -1.33 . . . . 71.32 109.306 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.7 mm -67.09 -40.28 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.825 -1.172 . . . . 63.23 108.135 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -62.75 -53.83 48.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.456 -0.777 . . . . 51.11 109.798 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -79.56 -1.0 35.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.176 -0.952 . . . . 73.34 109.771 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -85.73 -54.26 2.83 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.13 -1.588 . . . . 62.15 109.13 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pp -71.54 -28.31 63.78 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.4 -1.059 . . . . 73.51 109.315 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -53.98 -35.82 62.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -0.929 . . . . 74.25 109.124 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.3 t -55.46 -49.1 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.306 -0.871 . . . . 70.04 109.01 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.438 ' NZ ' HG11 ' A' ' 106' ' ' VAL . 35.9 mmtm -58.54 -54.59 45.3 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.689 -0.856 . . . . 73.23 108.689 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 138.21 36.5 0.15 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.829 -1.309 . . . . 75.54 109.829 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.585 ' CE2' ' SD ' ' A' ' 1' ' ' MET . 16.9 m-85 -111.99 155.19 24.17 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.374 -1.074 . . . . 73.43 108.962 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 7.2 mtp -101.97 139.14 38.01 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.19 -1.041 . . . . 43.24 108.19 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.422 ' O ' ' OD1' ' A' ' 28' ' ' ASP . . . -143.72 158.29 43.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.199 -0.938 . . . . 62.11 110.368 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 27' ' ' ALA . 87.7 m-20 -136.09 156.5 48.63 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.054 -0.721 . . . . 74.42 109.054 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 m -104.38 139.9 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.47 -0.937 . . . . 72.15 108.47 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 p -133.94 164.26 27.69 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.489 -0.757 . . . . 71.42 109.442 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.609 ' C ' ' HZ3' ' A' ' 8' ' ' LYS . 5.6 pt-20 -97.64 -107.41 0.17 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.295 -0.878 . . . . 72.33 109.875 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.516 ' N ' ' HZ3' ' A' ' 8' ' ' LYS . 50.0 m -79.88 160.86 25.89 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.155 -0.966 . . . . 74.24 110.041 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.4 mt -48.58 -19.52 0.35 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.395 -0.816 . . . . 71.53 109.759 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -61.08 -54.47 44.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 74.23 110.58 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 36' ' ' GLY . 13.4 p-10 -68.57 -31.67 71.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.917 -1.114 . . . . 54.03 109.317 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.518 ' N ' ' OD1' ' A' ' 35' ' ' ASP . . . -68.77 -42.89 77.59 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.021 -1.632 . . . . 61.41 109.021 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.486 ' OE2' ' NH2' ' A' ' 61' ' ' ARG . 85.5 tt0 -71.22 -39.24 71.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.353 -1.086 . . . . 74.34 109.364 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -73.23 -31.81 64.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.971 . . . . 75.33 109.648 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.1 tp -70.65 -49.85 43.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.236 -0.915 . . . . 74.33 110.139 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 43' ' ' ARG . 22.8 ptm -63.45 -20.48 65.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.997 -1.064 . . . . 70.32 109.802 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -65.15 -38.49 90.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.098 -1.001 . . . . 71.22 109.956 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.8 pt -84.93 -31.33 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.059 -1.026 . . . . 74.14 110.254 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 40' ' ' MET . 79.5 mtm180 -130.31 153.5 48.59 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.304 -0.872 . . . . 72.24 109.595 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.954 ' CG ' ' OE2' ' A' ' 143' ' ' GLU . 29.4 m120 -97.93 155.89 16.87 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.251 -0.906 . . . . 75.42 109.529 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -135.84 155.32 50.51 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.463 -0.773 . . . . 74.23 109.277 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -96.08 -43.86 7.58 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.154 -0.966 . . . . 72.04 109.198 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.63 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.8 OUTLIER -110.58 122.47 47.84 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.499 -0.926 . . . . 72.13 108.499 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.63 ' N ' HD13 ' A' ' 47' ' ' LEU . 15.4 m -117.3 97.97 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.581 -0.896 . . . . 72.34 108.581 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.586 ' SD ' ' N ' ' A' ' 50' ' ' VAL . 0.3 OUTLIER -98.67 134.4 41.65 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.793 -0.818 . . . . 74.11 108.793 -179.346 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.586 ' N ' ' SD ' ' A' ' 49' ' ' MET . 1.3 p -136.43 125.51 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-O 121.774 0.797 . . . . 61.12 109.967 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.1 p -94.54 2.66 55.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.565 -0.709 . . . . 73.11 109.356 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -76.75 142.32 40.47 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.191 -0.943 . . . . 52.55 109.646 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.474 ' C ' ' H ' ' A' ' 55' ' ' ALA . 97.8 mttt -79.14 -38.52 35.84 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.312 -0.868 . . . . 44.22 110.212 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -67.93 7.99 0.46 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.051 -1.031 . . . . 70.44 109.585 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.34 -22.46 57.6 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.376 -0.827 . . . . 64.14 110.718 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 55' ' ' ALA . 55.1 mt -41.39 -51.24 3.76 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.399 -0.813 . . . . 44.14 110.361 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 t -67.86 -34.22 76.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.96 -1.088 . . . . 55.23 108.873 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.562 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 48.2 t80 -66.81 -63.62 1.03 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.505 -0.747 . . . . 74.44 109.914 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.5 m -48.16 -34.29 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.795 -1.191 . . . . 74.03 109.617 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 61' ' ' ARG . 15.0 p -57.69 -56.32 23.45 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.208 -0.932 . . . . 64.3 109.133 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.645 HH21 ' NZ ' ' A' ' 65' ' ' LYS . 13.3 ptm180 -66.4 -28.73 68.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -1.0 . . . . 64.44 110.059 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.562 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 25.1 mm -54.87 -41.42 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.666 -1.271 . . . . 63.21 107.96 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.522 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 43.4 mmtt -70.84 -40.08 72.58 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.605 -0.838 . . . . 74.42 109.056 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -67.83 -42.09 82.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 70.32 109.129 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.645 ' NZ ' HH21 ' A' ' 61' ' ' ARG . 48.6 mtpt -88.48 -14.4 37.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.614 -0.678 . . . . 75.22 110.076 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 62' ' ' ILE . 73.0 m-70 -155.22 72.17 0.81 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.146 -0.971 . . . . 74.13 109.342 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.3 p -73.69 -6.96 50.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.912 . . . . 73.24 109.765 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.2 p -100.19 42.87 1.08 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.27 -0.894 . . . . 61.01 110.072 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 66' ' ' HIS . 14.7 tt -145.07 160.09 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.011 -1.056 . . . . 71.33 109.6 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t -98.13 130.43 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.212 -0.93 . . . . 72.13 108.766 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.29 130.75 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.499 -0.751 . . . . 54.21 109.323 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.513 ' O ' ' SD ' ' A' ' 49' ' ' MET . 8.6 tt -128.0 95.88 4.32 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.599 0.714 . . . . 50.24 109.202 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.52 HG22 ' N ' ' A' ' 74' ' ' SER . 14.4 p -91.39 164.89 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.005 -1.06 . . . . 74.41 109.203 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.52 ' N ' HG22 ' A' ' 73' ' ' VAL . 72.0 m -138.87 169.7 17.31 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.204 -0.935 . . . . 72.31 109.026 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 77' ' ' ASN . 1.2 p -175.53 128.52 0.26 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.053 -1.029 . . . . 64.54 110.086 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.425 ' N ' ' HB2' ' A' ' 97' ' ' LYS . 48.7 p30 -67.33 41.6 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.509 -0.744 . . . . 74.13 109.633 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.565 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 1.8 p-10 -156.32 59.45 1.99 Allowed Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.026 -1.046 . . . . 73.34 110.449 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.68 76.22 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.145 1.896 . . . . 63.22 111.148 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.458 ' N ' ' O ' ' A' ' 77' ' ' ASN . 82.3 p -103.64 152.3 21.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.575 -0.703 . . . . 62.53 109.498 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.52 -34.6 78.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.463 -0.773 . . . . 73.44 109.27 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -67.04 -44.45 80.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 71.42 109.281 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -74.51 -31.55 62.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 73.43 109.383 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.493 ' OE1' ' N ' ' A' ' 84' ' ' VAL . 14.3 tm-20 -58.66 -56.72 18.56 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.225 -0.922 . . . . 74.22 109.555 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.493 ' N ' ' OE1' ' A' ' 83' ' ' GLU . 27.4 m -62.0 -40.64 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 73.2 109.29 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.454 ' N ' HG23 ' A' ' 84' ' ' VAL . 22.8 t-80 -61.13 -38.93 88.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.24 -0.913 . . . . 53.33 109.381 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.58 86.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 64.11 109.543 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.409 ' CE1' ' HB1' ' B' ' 111' ' ' ALA . 17.3 t80 -72.83 -33.23 66.03 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.417 -0.957 . . . . 74.34 108.417 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -66.56 -36.93 83.85 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.518 -0.738 . . . . 74.42 109.143 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -64.4 -49.83 70.01 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.361 -0.837 . . . . 74.24 109.411 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 142.43 31.88 0.12 Allowed Glycine 0 N--CA 1.498 2.775 0 N-CA-C 110.024 -1.23 . . . . 61.51 110.024 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.25 131.27 38.52 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.088 -1.242 . . . . 55.33 109.43 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.522 ' OD2' ' NZ ' ' A' ' 63' ' ' LYS . 42.1 m-20 -78.03 -29.35 49.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.108 -0.995 . . . . 73.42 109.113 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.423 ' OD2' HD11 ' A' ' 95' ' ' ILE . 25.2 t70 -149.88 147.59 28.12 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.911 -0.774 . . . . 75.04 108.911 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -135.54 113.44 11.1 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.446 -0.784 . . . . 71.33 108.93 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.423 HD11 ' OD2' ' A' ' 93' ' ' ASP . 20.3 mm -107.35 150.22 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 CA-C-O 122.118 0.961 . . . . 71.13 110.918 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.95 125.54 25.75 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.51 -1.292 . . . . 64.32 107.51 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.675 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -45.12 -52.81 18.8 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.036 -1.04 . . . . 62.2 111.359 -179.061 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 1.6 Cg_endo -40.87 -12.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.112 0 CA-C-N 119.759 0.95 . . . . 73.11 112.601 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.675 ' N ' ' O ' ' A' ' 97' ' ' LYS . 49.2 m-85 56.69 104.71 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.763 -0.586 . . . . 65.22 110.383 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.8 ttm-85 -60.65 -39.08 87.0 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.02 -1.104 . . . . 72.35 108.02 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.1 t -174.45 140.08 0.61 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.916 -0.772 . . . . 71.32 108.916 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.2 mm -57.95 -37.07 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 75.43 109.157 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.428 ' HE2' ' H ' ' A' ' 103' ' ' LYS . 1.5 mppt? -64.3 -36.03 82.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 71.41 109.178 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.31 -48.91 73.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.144 -0.973 . . . . 63.24 109.406 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.453 HD13 ' C ' ' A' ' 105' ' ' LEU . 2.1 tm? -67.82 -55.05 14.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.377 -0.827 . . . . 73.22 108.906 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.438 HG11 ' NZ ' ' A' ' 23' ' ' LYS . 67.6 t -55.03 -49.02 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.932 -1.105 . . . . 60.11 109.425 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.51 -37.28 65.14 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.169 -0.957 . . . . 70.42 108.91 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.423 ' NH1' ' OE2' ' B' ' 83' ' ' GLU . 11.2 mmt85 -71.38 -30.02 65.63 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.357 -0.839 . . . . 74.41 109.389 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.67 -30.51 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 107.773 -1.195 . . . . 62.54 107.773 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -67.58 -52.48 38.1 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.837 -0.801 . . . . 74.34 108.837 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.444 ' CB ' ' CZ ' ' B' ' 87' ' ' PHE . . . -48.2 -44.09 32.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.446 -0.783 . . . . 73.32 109.477 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 75.1 mmt-85 -64.61 -32.7 74.47 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.33 -0.856 . . . . 52.41 109.702 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.1 mt -133.37 75.62 1.62 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.36 -0.837 . . . . 65.24 110.313 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -92.8 -79.51 0.39 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.089 -1.007 . . . . 64.45 108.426 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.457 ' CD2' ' O ' ' A' ' 115' ' ' PHE . 26.1 p90 -100.74 49.37 0.89 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.354 -0.841 . . . . 74.43 109.359 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 75.7 t-105 -67.05 112.58 4.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 74.42 109.424 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 159.74 111.39 0.29 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.889 -1.284 . . . . 75.04 109.889 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.2 t -164.17 157.17 17.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -1.14 . . . . 61.14 109.523 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.443 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -152.92 117.12 4.88 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.854 -0.795 . . . . 65.24 108.854 -178.51 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.506 HG21 ' OD1' ' A' ' 131' ' ' ASP . 18.7 t -77.63 -39.98 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.327 -0.858 . . . . 73.11 110.466 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 11.1 mm -104.46 130.36 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.105 -0.997 . . . . 72.24 109.675 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -129.36 136.36 49.9 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.453 -0.943 . . . . 72.34 108.453 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.622 HD13 ' N ' ' A' ' 124' ' ' GLY . 0.2 OUTLIER -149.99 121.87 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.018 -1.051 . . . . 71.44 109.599 -179.229 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.622 ' N ' HD13 ' A' ' 123' ' ' ILE . . . 46.96 -129.49 12.23 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.038 -1.225 . . . . 73.4 110.038 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -93.88 -4.02 50.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.307 -1.114 . . . . 74.45 109.88 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.67 143.65 26.26 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.141 -0.974 . . . . 54.21 108.468 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.1 m -132.44 143.67 49.95 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.333 -0.854 . . . . 54.5 109.524 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.4 mt -134.84 140.38 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.457 -0.777 . . . . 45.15 109.748 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.1 m -128.31 109.05 19.46 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 108.949 -0.76 . . . . 71.11 108.949 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.52 -27.49 4.14 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.656 1.571 . . . . 65.41 111.712 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.506 ' OD1' HG21 ' A' ' 120' ' ' VAL . 1.9 m-20 -69.4 -37.15 77.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 63.32 109.093 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -88.98 -4.33 58.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.33 -0.856 . . . . 72.52 109.603 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 54.65 62.62 2.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.131 -0.981 . . . . 75.33 108.972 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -160.67 155.56 24.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.256 -0.903 . . . . 71.23 109.949 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.533 HD12 ' CD2' ' A' ' 152' ' ' LEU . 4.7 tt -124.94 137.61 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.631 -0.668 . . . . 74.02 109.349 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 24.9 mm -115.83 133.7 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.709 -0.849 . . . . 60.23 108.709 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -137.88 119.49 15.01 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.231 -0.918 . . . . 62.32 108.851 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.5 ' CG ' ' O ' ' A' ' 138' ' ' LYS . 25.4 ttpt 54.71 20.26 2.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.586 -0.696 . . . . 75.4 109.974 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.59 0.8 66.62 Favored Glycine 0 N--CA 1.499 2.877 0 O-C-N 120.862 -1.149 . . . . 72.24 110.71 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.498 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 1.9 mpt_? -89.99 124.84 35.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.963 -1.316 . . . . 71.22 108.645 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -87.9 130.39 34.93 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.245 -0.91 . . . . 71.42 109.755 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.7 t -138.45 143.13 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.433 -0.792 . . . . 53.02 109.739 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.954 ' OE2' ' CG ' ' A' ' 44' ' ' ASN . 91.1 mt-10 -95.9 142.16 28.47 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.868 -0.79 . . . . 60.45 108.868 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.2 m -138.05 137.88 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.147 -0.97 . . . . 74.44 109.758 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -168.54 41.87 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.287 -0.883 . . . . 65.15 109.856 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.25 -129.36 4.58 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 108.856 -1.697 . . . . 73.34 108.856 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.625 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 23.8 mttp -85.79 -32.29 0.45 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.273 -1.134 . . . . 72.22 110.846 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.853 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 86.9 Cg_endo -86.1 -18.14 3.59 Favored 'Trans proline' 0 N--CA 1.486 1.06 0 C-N-CA 122.06 1.84 . . . . 65.23 112.247 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -56.34 -48.83 75.97 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.828 -1.175 . . . . 60.11 107.828 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 172' ' ' ILE . 74.6 mt-10 -75.99 -42.02 49.43 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.053 -1.092 . . . . 64.21 108.053 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.853 ' HB ' ' HA ' ' A' ' 148' ' ' PRO . 1.1 t -56.27 -46.58 81.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.039 -1.097 . . . . 72.02 108.039 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.533 ' CD2' HD12 ' A' ' 135' ' ' ILE . 22.3 tp -66.66 -56.72 9.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.623 -0.673 . . . . 73.31 110.569 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.6 p -58.49 -35.84 72.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.906 -1.121 . . . . 74.31 110.03 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -58.53 -56.94 15.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.003 -1.06 . . . . 74.31 110.367 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.54 -26.42 62.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.935 -1.103 . . . . 75.34 109.525 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.05 -44.23 91.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.958 -1.089 . . . . 62.14 108.592 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -79.67 -57.99 3.41 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.984 0.897 . . . . 61.03 109.415 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -71.69 41.43 0.08 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.912 -0.586 . . . . 74.12 111.332 -177.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -82.81 166.43 19.01 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.627 -1.296 . . . . 71.13 109.027 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.441 ' OD1' ' CE2' ' A' ' 216' ' ' TYR . 14.2 m-20 53.49 47.62 23.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.157 -0.964 . . . . 75.45 109.262 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -154.89 163.58 40.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.348 -0.845 . . . . 73.41 110.12 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.3 mm -98.64 136.7 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.42 -1.326 . . . . 74.41 107.42 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.8 148.18 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.996 -1.065 . . . . 72.31 110.486 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.7 p -97.08 165.47 12.05 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.609 -0.682 . . . . 74.12 109.685 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -66.95 -44.78 79.72 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.249 -0.907 . . . . 70.43 110.121 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -56.19 -40.31 73.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 73.52 109.923 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -58.05 -43.2 86.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.05 -1.031 . . . . 74.52 109.425 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 11.7 mt -56.47 -43.72 79.88 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.973 -1.08 . . . . 72.31 108.127 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.514 ' C ' HD23 ' A' ' 169' ' ' LEU . 5.1 tt -49.16 -56.15 10.12 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.04 -1.038 . . . . 53.33 109.746 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -54.14 -37.71 64.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.559 -0.713 . . . . 62.44 112.507 -178.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.65 -32.11 13.54 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 120.531 -1.356 . . . . 60.21 113.517 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.43 ' O ' ' OE1' ' A' ' 150' ' ' GLU . 1.7 mp -77.88 -51.33 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.628 -1.295 . . . . 75.32 110.838 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.541 ' CG ' ' O ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.98 0 O-C-N 120.66 -1.275 . . . . 73.14 109.597 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 34.5 m120 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.187 0.518 . . . . 64.54 110.19 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.2 p -148.38 -32.25 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.147 -0.97 . . . . 74.02 109.325 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 6.0 mm -60.69 -43.27 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.181 -0.95 . . . . 72.33 109.211 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -64.91 -36.94 86.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 74.4 109.164 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 20.4 t -71.15 -32.33 47.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.117 -0.989 . . . . 70.42 109.139 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.39 -52.17 17.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.49 -0.757 . . . . 52.11 110.658 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.401 HG21 ' CZ ' ' A' ' 212' ' ' TYR . 9.2 tp -56.85 -39.11 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.548 -1.345 . . . . 71.4 110.112 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -63.72 -56.71 13.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.83 -1.169 . . . . 73.44 110.958 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -65.65 -42.58 91.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.848 -1.158 . . . . 71.42 110.131 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 66.6 mt -51.72 -35.72 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.808 -1.182 . . . . 61.55 109.033 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ARG . . . . . 0.407 HH11 ' HB2' ' A' ' 192' ' ' ARG . 16.8 mtp-105 -67.29 -54.46 20.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.115 -0.991 . . . . 63.34 109.689 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -71.21 -14.06 62.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -0.91 . . . . 61.24 110.992 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.415 ' O ' ' CD ' ' A' ' 198' ' ' PRO . 43.8 mtpt -83.37 -41.24 18.41 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.844 -1.16 . . . . 75.13 110.709 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' MET . . . . . 1.024 ' HE2' HD22 ' A' ' 199' ' ' LEU . 45.8 mtp -81.83 36.99 0.46 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.095 -1.003 . . . . 74.02 110.699 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 197' ' ' LYS . 27.4 p30 -110.61 -39.09 4.99 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.12 -0.988 . . . . 74.02 109.988 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.597 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 5.6 tmtt? -91.23 -40.15 0.39 Allowed Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 120.91 -1.119 . . . . 75.43 110.065 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 24.4 Cg_exo -63.65 -61.22 0.13 Allowed 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.256 1.971 . . . . 72.32 111.823 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 1.024 HD22 ' HE2' ' A' ' 195' ' ' MET . 10.8 mp -71.42 -28.8 64.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 74.54 108.971 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 83.46 -14.9 38.09 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.626 -1.79 . . . . 61.51 108.626 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 21.2 mt -128.52 137.13 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.841 -0.799 . . . . 61.22 109.073 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 72.8 m -89.74 144.52 25.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.211 -0.93 . . . . 72.0 109.12 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.5 p -146.07 44.68 1.25 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.164 -0.96 . . . . 74.44 110.288 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 7.9 m -148.66 129.88 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.993 -1.067 . . . . 64.35 109.23 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -112.14 140.4 46.85 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.687 -0.633 . . . . 71.41 109.532 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.458 ' O ' HG23 ' A' ' 206' ' ' THR . 14.9 t -126.12 131.46 52.07 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.456 -0.778 . . . . 73.52 109.942 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.7 154.25 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.47 -0.937 . . . . 71.02 108.47 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -97.03 75.22 2.62 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.103 -0.998 . . . . 72.12 110.535 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -146.52 -33.22 0.31 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.175 -0.953 . . . . 64.41 109.249 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -147.3 -60.18 0.28 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.242 -0.911 . . . . 71.54 109.217 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -163.52 -119.75 0.5 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.517 -1.433 . . . . 72.03 109.517 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.401 ' CZ ' HG21 ' A' ' 188' ' ' ILE . 43.5 m-85 -125.31 152.05 45.21 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.63 -0.923 . . . . 75.54 109.153 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.92 129.05 48.53 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.545 -0.909 . . . . 75.31 108.545 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -105.86 126.26 51.96 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.357 -0.839 . . . . 75.41 109.193 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 44.1 t -149.49 158.59 44.31 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.788 -0.819 . . . . 74.14 108.788 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' TYR . . . . . 0.441 ' CE2' ' OD1' ' A' ' 160' ' ' ASP . 8.7 p90 -58.07 150.06 53.07 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.255 -0.903 . . . . 75.32 109.238 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 N--CA 1.494 1.545 0 C-N-CA 122.236 1.957 . . . . 73.11 111.173 179.52 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 54.4 ttm . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.442 -0.577 . . . . 71.14 109.442 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 57.5 ttm-85 -139.27 147.61 41.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.419 -0.8 . . . . 73.23 109.159 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 40.2 t -110.62 137.35 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.682 -0.636 . . . . 72.24 109.304 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.408 HD11 ' CG1' ' B' ' 6' ' ' ILE . 5.4 tp -113.98 117.55 31.64 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 109.366 -0.605 . . . . 54.33 109.366 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.496 ' N ' HD23 ' B' ' 5' ' ' LEU . 0.1 OUTLIER -120.39 97.67 5.68 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.171 -1.048 . . . . 74.35 108.171 178.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.471 ' CG2' ' O ' ' B' ' 31' ' ' GLU . 65.1 mt -81.97 106.14 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.775 -1.203 . . . . 42.55 109.168 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.425 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 18.3 tp10 -140.18 129.9 24.43 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.481 -0.762 . . . . 74.52 109.125 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -64.8 -32.34 73.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 62.55 109.431 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -83.86 123.59 30.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 73.11 109.503 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 87.1 p -78.8 -26.68 44.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.263 -0.898 . . . . 65.54 109.689 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 98.3 t -63.12 -49.09 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 75.55 109.564 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.566 HD22 ' N ' ' B' ' 12' ' ' LEU . 3.6 mm? -64.78 -35.2 80.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 70.14 108.949 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.25 -26.6 71.76 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.314 -1.914 . . . . 75.4 108.314 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.29 -49.99 62.61 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.652 -1.379 . . . . 65.44 109.652 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -61.97 -43.91 97.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.285 -1.126 . . . . 60.21 109.706 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 35.8 mm -67.31 -37.55 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.689 -1.257 . . . . 75.15 108.702 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -65.97 -42.39 89.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -0.891 . . . . 73.01 109.355 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -87.43 1.35 53.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.169 -0.957 . . . . 74.3 109.204 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.57 -58.06 1.99 Allowed Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.361 -1.496 . . . . 70.54 109.361 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' B' ' 27' ' ' ALA . 1.6 pt? -68.54 -24.82 64.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.308 -1.113 . . . . 71.34 109.421 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -53.8 -36.01 61.98 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.184 -0.947 . . . . 64.41 109.447 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 58.0 t -54.52 -47.64 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.268 -0.895 . . . . 74.23 108.914 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -59.91 -54.89 40.88 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.948 -0.76 . . . . 63.42 108.948 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 132.9 41.85 0.18 Allowed Glycine 0 N--CA 1.499 2.868 0 N-CA-C 109.719 -1.353 . . . . 53.43 109.719 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -118.46 160.17 22.2 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.445 -1.033 . . . . 71.12 109.308 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 8.4 mmt -98.86 138.79 35.48 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.287 -1.005 . . . . 75.24 108.287 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.468 ' HB1' HD21 ' B' ' 5' ' ' LEU . . . -125.13 149.78 47.54 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.701 0.762 . . . . 72.12 110.326 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ASP . . . . . 0.445 ' OD2' ' NH2' ' B' ' 43' ' ' ARG . 24.1 t70 -133.47 126.5 31.27 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.452 -1.314 . . . . 72.31 107.452 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 p -117.48 142.58 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.406 -0.809 . . . . 64.43 110.066 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -134.34 -153.16 0.51 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.751 -0.593 . . . . 65.41 109.413 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.471 ' O ' ' CG2' ' B' ' 6' ' ' ILE . 1.3 pt-20 -135.36 -87.56 0.36 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.422 -0.799 . . . . 71.02 109.531 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 61.8 m -79.46 152.03 30.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.963 -1.085 . . . . 51.11 109.571 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' B' ' 37' ' ' GLU . 43.8 mt -54.2 -41.71 68.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.864 . . . . 71.24 109.73 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -58.95 -40.8 85.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 74.32 109.795 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.425 ' OD2' ' OE2' ' B' ' 31' ' ' GLU . 92.7 m-20 -64.02 -40.26 95.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.147 -0.97 . . . . 73.03 109.212 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' GLY . . . . . 0.447 ' O ' ' CG ' ' B' ' 40' ' ' MET . . . -82.78 -27.89 40.37 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.642 -1.383 . . . . 30.21 109.642 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' B' ' 33' ' ' LEU . 81.7 tt0 -64.3 -41.32 96.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.188 -1.183 . . . . 74.42 109.727 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -80.54 -40.48 25.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.114 -0.992 . . . . 74.42 109.624 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 45.4 tp -68.02 -40.15 83.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 75.41 109.936 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' MET . . . . . 0.516 ' SD ' ' CE1' ' B' ' 45' ' ' TYR . 1.2 ppp? -74.05 -27.15 60.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.131 -0.981 . . . . 60.41 109.923 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -52.68 -36.07 56.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.167 -0.958 . . . . 53.23 110.041 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 9.3 pt -93.11 -20.48 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.092 -1.005 . . . . 71.23 110.314 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.445 ' NH2' ' OD2' ' B' ' 28' ' ' ASP . 34.8 mtm105 -104.71 156.81 17.66 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.192 -0.942 . . . . 72.22 109.902 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -91.29 167.72 12.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.381 -0.825 . . . . 63.54 109.035 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.516 ' CE1' ' SD ' ' B' ' 40' ' ' MET . 1.7 p90 -160.25 113.43 2.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.054 -1.029 . . . . 64.35 109.669 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -84.62 -37.73 20.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 62.22 108.859 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.504 HD13 ' C ' ' B' ' 47' ' ' LEU . 0.7 OUTLIER -109.76 109.46 20.16 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.666 -0.864 . . . . 73.12 108.666 179.524 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.444 ' N ' HD13 ' B' ' 47' ' ' LEU . 78.4 t -95.97 111.18 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.604 -0.888 . . . . 65.11 108.604 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 12.2 ttt -128.18 135.31 49.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.486 -0.759 . . . . 73.44 109.551 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.69 HG22 ' H ' ' B' ' 52' ' ' ASP . 0.8 OUTLIER -147.12 140.63 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.591 -0.693 . . . . 34.5 109.506 -179.332 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 51' ' ' SER . . . . . 0.425 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 52.8 p -103.91 13.92 31.81 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.445 -0.784 . . . . 73.21 109.626 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.69 ' H ' HG22 ' B' ' 50' ' ' VAL . 13.5 m-20 -78.34 140.7 38.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.164 -0.96 . . . . 70.41 109.502 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -72.72 -38.37 67.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.18 -0.95 . . . . 65.0 110.002 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -74.05 10.19 1.3 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.123 -0.986 . . . . 75.21 109.663 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.09 -22.72 64.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 55.33 110.148 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 39.4 mt -43.83 -48.54 8.26 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.34 -0.85 . . . . 63.14 110.174 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 88.3 p -68.9 -33.82 74.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.926 -1.109 . . . . 63.5 108.943 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' PHE . . . . . 0.468 ' CZ ' HD11 ' B' ' 62' ' ' ILE . 61.0 t80 -66.21 -61.96 1.74 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.444 -0.785 . . . . 72.33 109.779 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.9 m -49.92 -34.59 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.715 -1.24 . . . . 74.54 109.719 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.5 m -57.81 -51.79 68.14 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.285 -0.884 . . . . 71.24 109.632 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.627 ' NH2' ' HZ3' ' B' ' 65' ' ' LYS . 10.4 ptm180 -70.71 -27.4 63.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.041 -1.037 . . . . 74.31 110.132 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' B' ' 66' ' ' HIS . 29.9 mm -63.17 -53.78 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.743 -1.223 . . . . 72.14 109.181 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -59.73 -36.93 77.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.98 -1.075 . . . . 73.32 109.112 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -75.04 -38.16 61.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.365 -0.835 . . . . 73.12 109.477 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.627 ' HZ3' ' NH2' ' B' ' 61' ' ' ARG . 92.1 mttt -88.71 -18.46 27.81 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.166 -0.959 . . . . 72.44 110.722 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' B' ' 62' ' ' ILE . 77.7 m-70 -156.47 67.55 0.57 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.852 -1.155 . . . . 63.31 109.874 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 7.5 m -58.75 -29.18 66.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.277 -0.889 . . . . 73.1 109.553 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 86.4 p -66.56 -27.66 67.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.285 -0.885 . . . . 71.53 110.311 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.424 HG22 ' N ' ' B' ' 70' ' ' VAL . 72.7 mt -79.42 157.34 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.022 -1.049 . . . . 74.4 109.592 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.507 HG12 ' N ' ' B' ' 71' ' ' VAL . 87.2 t -94.62 160.68 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.284 -0.885 . . . . 75.12 109.891 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.507 ' N ' HG12 ' B' ' 70' ' ' VAL . 3.6 t -136.22 133.28 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.296 -0.877 . . . . 73.2 108.908 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.633 ' CD1' HH22 ' B' ' 108' ' ' ARG . 1.0 OUTLIER -133.52 104.67 6.5 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.752 0.787 . . . . 73.34 109.385 -179.21 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 84.3 t -92.26 130.39 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.928 . . . . 73.5 109.552 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 11.8 p -89.79 170.33 10.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.038 . . . . 64.34 108.212 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 18.8 p -157.43 110.83 2.54 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.757 -1.214 . . . . 74.53 110.329 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -64.97 -34.41 78.37 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.428 -0.953 . . . . 64.5 108.428 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -109.87 75.54 0.86 Allowed Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 108.527 -0.916 . . . . 74.25 108.527 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.2 86.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 121.889 1.726 . . . . 74.43 112.198 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.564 HG23 ' H ' ' B' ' 82' ' ' GLU . 1.6 t -105.53 150.93 24.91 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.571 -0.9 . . . . 73.12 108.571 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -32.63 74.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.112 -0.992 . . . . 71.01 109.475 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.56 -42.32 87.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 63.2 109.588 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 82' ' ' GLU . . . . . 0.564 ' H ' HG23 ' B' ' 79' ' ' THR . 85.6 tt0 -74.46 -26.78 60.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 73.22 109.327 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.423 ' OE2' ' NH1' ' A' ' 108' ' ' ARG . 86.7 tt0 -68.71 -51.33 42.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 74.3 109.804 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.416 HG23 ' N ' ' B' ' 85' ' ' HIS . 29.4 m -63.28 -39.1 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.103 -0.998 . . . . 73.31 109.507 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 85' ' ' HIS . . . . . 0.416 ' N ' HG23 ' B' ' 84' ' ' VAL . 22.9 m80 -77.05 -21.07 55.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 73.24 109.41 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -68.15 -48.34 65.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.22 -0.925 . . . . 55.33 109.852 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 87' ' ' PHE . . . . . 0.444 ' CZ ' ' CB ' ' A' ' 111' ' ' ALA . 80.7 t80 -76.28 -33.0 59.1 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.988 -1.07 . . . . 74.14 108.963 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -62.15 -51.02 69.51 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.361 -0.837 . . . . 64.04 109.195 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -58.88 -49.79 76.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.53 -0.731 . . . . 72.35 109.831 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 153.23 35.87 0.03 OUTLIER Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.775 -1.202 . . . . 65.2 110.162 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 91' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -99.47 125.49 45.22 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.245 -1.15 . . . . 52.23 109.154 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -71.08 -33.39 70.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.046 -1.034 . . . . 73.32 108.941 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 93' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 36.2 t0 -153.13 164.93 37.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.513 -0.742 . . . . 72.22 109.191 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.531 ' O ' ' CD1' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -139.59 115.47 10.2 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.108 -0.701 . . . . 64.42 109.108 -178.667 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 0.483 HD11 ' OD2' ' B' ' 93' ' ' ASP . 29.1 mm -113.17 144.82 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 O-C-N 121.326 -0.859 . . . . 72.23 110.013 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.64 135.18 57.53 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.042 -1.096 . . . . 25.24 108.042 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.684 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -55.67 -56.42 29.98 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 120.984 -1.072 . . . . 64.32 111.46 -178.892 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 98' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 6.0 Cg_endo -42.33 -7.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 120.871 1.047 . . . . 63.33 112.945 -176.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 99' ' ' TYR . . . . . 0.684 ' N ' ' O ' ' B' ' 97' ' ' LYS . 68.8 m-85 60.44 115.17 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.661 -0.649 . . . . 75.13 109.475 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -56.57 -28.18 59.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.117 -0.989 . . . . 74.23 109.422 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 101' ' ' SER . . . . . 0.742 ' O ' ' N ' ' B' ' 103' ' ' LYS . 30.2 t -174.51 30.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.003 -1.061 . . . . 63.34 110.7 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 55.1 mt 52.29 -69.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.641 -0.662 . . . . 74.44 110.283 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.742 ' N ' ' O ' ' B' ' 101' ' ' SER . 29.7 mmtp -59.62 -28.4 67.16 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.331 -0.989 . . . . 71.11 108.331 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.97 -44.8 91.64 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.462 -0.895 . . . . 71.45 108.595 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.687 HD13 ' C ' ' B' ' 105' ' ' LEU . 1.3 tm? -57.19 -55.38 35.53 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.869 -0.789 . . . . 51.31 108.869 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 106' ' ' VAL . . . . . 0.625 ' N ' HD13 ' B' ' 105' ' ' LEU . 21.7 t -63.28 -39.24 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.749 -1.22 . . . . 65.23 109.741 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -47.7 -44.19 27.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 24.32 110.265 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 108' ' ' ARG . . . . . 0.633 HH22 ' CD1' ' B' ' 72' ' ' LEU . 13.9 ptt85 -79.96 -31.03 39.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.988 -1.07 . . . . 75.31 110.707 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 34.5 mt -71.77 -30.43 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.494 -1.379 . . . . 54.24 108.264 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 110' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' B' ' 113' ' ' LEU . 21.0 tt0 -72.85 -60.59 2.16 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.402 -0.919 . . . . 65.31 108.972 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 111' ' ' ALA . . . . . 0.409 ' HB1' ' CE1' ' A' ' 87' ' ' PHE . . . -43.33 -44.66 5.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.68 -0.638 . . . . 72.24 109.981 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 112' ' ' ARG . . . . . 0.437 HH21 HD23 ' B' ' 47' ' ' LEU . 64.9 ttp85 -66.13 -34.81 78.89 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.221 -0.925 . . . . 72.04 109.391 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' B' ' 110' ' ' GLU . 7.1 tp -97.24 -75.09 0.55 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.228 -0.92 . . . . 75.35 110.365 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' B' ' 113' ' ' LEU . 83.3 mtt180 47.14 96.55 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.278 -0.889 . . . . 75.5 109.571 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 45.46 86.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.524 -0.735 . . . . 65.33 110.076 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 81.4 t90 -59.04 146.92 36.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.872 . . . . 74.45 109.298 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 161.12 101.16 0.16 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.734 -1.346 . . . . 44.21 109.734 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 83.3 p -157.03 161.26 39.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.252 -1.146 . . . . 71.4 109.692 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.42 -177.57 5.73 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.784 -0.766 . . . . 72.32 109.151 -178.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 6.0 t -144.43 -36.92 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.31 -0.869 . . . . 75.02 109.303 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 47.5 mt -111.51 125.83 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.507 -0.745 . . . . 51.41 109.201 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.416 ' O ' HG23 ' B' ' 123' ' ' ILE . 77.0 mt-10 -138.97 120.43 14.98 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.266 -0.896 . . . . 71.53 109.2 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.416 HG23 ' O ' ' B' ' 122' ' ' GLU . 19.0 pt -154.98 142.79 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.16 -0.962 . . . . 72.43 109.778 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 124' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' B' ' 126' ' ' LEU . . . 51.12 39.22 41.29 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.444 -1.062 . . . . 51.23 110.444 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 69.06 -13.88 0.33 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.303 -1.116 . . . . 74.2 109.935 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.52 HD22 ' CD1' ' B' ' 137' ' ' TYR . 1.1 mt -82.37 144.3 30.64 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.769 -1.197 . . . . 75.42 107.769 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 92.3 m -128.65 144.18 51.1 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.375 -0.828 . . . . 74.22 109.738 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 7.6 mt -141.06 140.93 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.434 -0.791 . . . . 60.33 109.519 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 70.5 m -117.92 123.64 29.43 Favored Pre-proline 0 N--CA 1.5 2.054 0 N-CA-C 108.965 -0.754 . . . . 72.31 108.965 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.27 -40.1 0.29 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.821 1.681 . . . . 75.13 112.196 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -66.42 -44.57 82.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.175 -0.953 . . . . 75.23 109.943 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 132' ' ' GLU . . . . . 0.5 ' N ' ' OE1' ' B' ' 132' ' ' GLU . 35.6 mp0 -84.85 -5.15 59.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.197 -0.939 . . . . 72.43 109.818 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 48.53 72.03 0.31 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.206 -0.934 . . . . 75.13 109.764 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -152.39 142.53 22.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.312 -0.867 . . . . 73.22 109.369 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 135' ' ' ILE . . . . . 0.409 ' O ' HG23 ' B' ' 135' ' ' ILE . 15.8 tt -115.49 132.19 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.436 -0.79 . . . . 64.14 109.125 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 61.9 mt -117.22 130.79 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 109.069 -0.715 . . . . 71.22 109.069 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 137' ' ' TYR . . . . . 0.52 ' CD1' HD22 ' B' ' 126' ' ' LEU . 64.3 t80 -132.6 130.83 40.76 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.441 -0.787 . . . . 64.22 109.505 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 138' ' ' LYS . . . . . 0.516 ' O ' ' NH1' ' B' ' 140' ' ' ARG . 24.5 mmtm 53.55 32.82 14.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.307 -0.87 . . . . 72.02 110.49 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.25 -4.55 71.35 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 120.049 -1.072 . . . . 74.32 110.882 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 140' ' ' ARG . . . . . 0.516 ' NH1' ' O ' ' B' ' 138' ' ' LYS . 11.2 mpt_? -87.74 134.59 33.64 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.817 -1.402 . . . . 75.34 108.842 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -102.11 122.92 45.07 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.385 -0.822 . . . . 71.23 110.034 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 13.5 p -137.78 137.56 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.529 -0.915 . . . . 70.43 108.529 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -90.2 143.3 26.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.272 -0.893 . . . . 72.43 110.344 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 144' ' ' VAL . . . . . 0.535 ' O ' HG23 ' B' ' 144' ' ' VAL . 21.5 m -146.57 121.42 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.217 -1.031 . . . . 72.13 108.217 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 7.1 mtmm -139.68 126.48 20.72 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.18 -0.95 . . . . 72.02 109.484 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.16 171.39 33.17 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.473 -1.451 . . . . 42.23 109.473 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 147' ' ' LYS . . . . . 0.627 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 11.4 mttm -67.75 -38.81 15.87 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.235 -1.156 . . . . 73.3 109.886 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 148' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 30.0 Cg_exo -60.89 -38.14 71.94 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.265 1.977 . . . . 71.33 112.211 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -88.53 -17.83 29.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.237 -0.914 . . . . 74.23 109.732 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -54.34 -38.29 65.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 72.34 109.479 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.458 HG13 ' N ' ' B' ' 152' ' ' LEU . 10.9 p -67.93 -38.68 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 73.35 109.74 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.458 ' N ' HG13 ' B' ' 151' ' ' VAL . 31.3 tp -55.38 -47.07 76.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.91 . . . . 55.24 109.542 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 60.4 p -68.27 -32.23 72.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.165 -0.96 . . . . 70.01 109.619 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -56.67 -58.99 5.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.849 . . . . 65.32 110.339 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 pp -69.18 -22.73 63.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.082 -1.012 . . . . 71.54 109.923 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.92 -39.88 86.99 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.18 -0.95 . . . . 75.32 109.198 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -85.24 -34.59 21.94 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.181 -0.95 . . . . 73.32 109.758 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -87.41 40.14 0.91 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.143 -0.973 . . . . 74.14 109.786 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -55.3 151.1 10.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 61.41 109.342 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 160' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' B' ' 214' ' ' PHE . 64.3 t0 52.28 68.18 0.86 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 72.1 109.592 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -160.1 147.32 16.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.144 -0.972 . . . . 72.25 109.797 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 12.2 mm -91.29 134.73 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.432 -0.951 . . . . 72.31 108.432 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 48.3 t -135.96 135.74 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.245 -0.909 . . . . 64.21 110.021 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 10.8 t -89.19 155.65 19.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.426 -0.796 . . . . 74.22 109.343 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -55.41 -31.68 62.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.385 -0.822 . . . . 65.31 109.794 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -57.29 -39.14 75.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 63.45 110.26 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -62.95 -43.43 98.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.012 -1.055 . . . . 72.4 109.8 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 20.0 mt -55.26 -59.09 5.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.15 -0.969 . . . . 72.32 109.102 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.566 HD13 ' C ' ' B' ' 169' ' ' LEU . 1.6 tm? -54.7 -65.33 0.6 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.078 -1.014 . . . . 73.34 109.284 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -46.4 -36.25 6.31 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 112.949 0.722 . . . . 72.1 112.949 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.05 -30.97 14.41 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.595 -1.316 . . . . 62.13 113.214 -176.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 0.416 ' CD1' ' N ' ' B' ' 172' ' ' ILE . 1.3 mp -84.94 -58.58 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 120.433 -1.417 . . . . 71.42 111.208 -177.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 173' ' ' TRP . . . . . 0.586 ' O ' ' CE3' ' B' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.834 0 O-C-N 120.609 -1.307 . . . . 72.23 109.76 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo . . . . . 0 N--CA 1.497 1.702 0 CA-C-O 121.601 0.584 . . . . 65.22 112.024 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 182' ' ' ASN . . . . . 0.5 ' C ' ' H ' ' B' ' 184' ' ' ILE . 43.4 t30 -170.4 -106.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.105 -0.997 . . . . 72.31 109.297 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 5.5 t 61.99 -3.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.454 -0.779 . . . . 63.32 109.818 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.5 ' H ' ' C ' ' B' ' 182' ' ' ASN . 28.5 mt -69.63 -38.11 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.904 -1.123 . . . . 75.03 108.425 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -55.23 -53.3 57.74 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.822 -0.549 . . . . 64.11 109.759 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 30.7 m -73.28 -31.75 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.121 -0.987 . . . . 73.0 110.02 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.44 -56.61 13.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.058 -1.027 . . . . 61.12 109.848 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 10.8 tp -63.01 -29.75 47.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.898 -1.126 . . . . 72.43 109.421 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -68.9 -56.0 9.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 65.14 110.186 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 190' ' ' GLN . . . . . 0.409 ' O ' ' CB ' ' B' ' 194' ' ' LYS . 15.7 pt20 -66.14 -39.78 90.12 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.001 -1.062 . . . . 63.24 109.35 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 55.6 mt -54.65 -37.71 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.985 -1.072 . . . . 74.03 109.528 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -68.03 -52.85 30.76 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.074 -1.016 . . . . 72.24 110.48 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 193' ' ' GLN . . . . . 0.41 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 45.8 mt-30 -76.88 -14.25 59.9 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.999 -1.063 . . . . 73.1 110.113 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 194' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' B' ' 190' ' ' GLN . 53.4 tttp -92.43 -27.42 17.49 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.388 -0.82 . . . . 72.11 110.445 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 195' ' ' MET . . . . . 0.431 ' C ' ' SD ' ' B' ' 195' ' ' MET . 1.9 ppp? -90.56 -30.93 16.93 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.068 -1.02 . . . . 44.33 109.812 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 196' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 28.0 p-10 -58.87 -32.71 69.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.981 . . . . 71.21 109.747 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 197' ' ' LYS . . . . . 0.51 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 7.6 mmtp -63.03 -64.91 2.49 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 75.21 109.935 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 198' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 33.0 Cg_endo -61.96 -53.07 2.3 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.185 1.924 . . . . 75.32 112.352 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 199' ' ' LEU . . . . . 0.49 ' N ' HD12 ' B' ' 199' ' ' LEU . 10.0 mp -65.58 -40.23 92.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.031 -1.043 . . . . 72.25 109.324 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 77.72 -40.16 1.81 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.574 -1.411 . . . . 64.53 109.574 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 19.1 mm -97.65 146.25 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.24 -1.153 . . . . 44.23 109.478 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 38.8 t -85.75 141.07 29.96 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.23 -0.919 . . . . 54.01 109.245 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 13.8 p -142.7 18.22 2.0 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.181 -0.949 . . . . 74.4 109.904 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 21.9 m -140.7 137.05 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.189 -0.944 . . . . 72.12 109.437 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -116.34 135.68 53.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.576 -0.703 . . . . 65.41 109.342 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 1.4 p -93.59 132.23 38.11 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.174 -0.954 . . . . 71.33 108.946 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 25.5 t -138.92 143.66 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.331 -0.856 . . . . 63.5 109.539 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 208' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' B' ' 209' ' ' ARG . 91.4 mtt180 -60.07 164.89 3.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 74.45 109.611 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 209' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' B' ' 211' ' ' GLY . 80.4 mtm-85 52.46 176.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.868 . . . . 74.14 109.62 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 17.0 mmt85 53.85 -85.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.466 -0.771 . . . . 74.43 109.672 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 211' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' B' ' 209' ' ' ARG . . . 164.12 -96.66 0.14 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.482 -1.447 . . . . 64.45 109.482 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 212' ' ' TYR . . . . . 0.481 ' CD1' ' C ' ' B' ' 211' ' ' GLY . 52.8 m-85 -141.28 167.77 21.37 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.362 -1.081 . . . . 74.21 109.126 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -132.58 140.37 48.22 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.411 -0.806 . . . . 74.03 109.654 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 214' ' ' PHE . . . . . 0.512 ' O ' ' N ' ' B' ' 160' ' ' ASP . 2.3 m-85 -116.41 125.38 51.96 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.942 -0.762 . . . . 74.34 108.942 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 215' ' ' CYS . . . . . 0.577 ' SG ' ' N ' ' B' ' 216' ' ' TYR . 30.5 t -147.9 167.56 24.52 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.336 -0.852 . . . . 64.33 109.314 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 216' ' ' TYR . . . . . 0.577 ' N ' ' SG ' ' B' ' 215' ' ' CYS . 3.2 p90 -60.0 152.67 59.45 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.284 -0.885 . . . . 70.04 109.116 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.18 124.1 10.59 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.357 2.038 . . . . 65.11 112.044 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 8.1 tptp . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.2 -0.937 . . . . 73.15 110.356 179.744 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.8 ttm . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.399 -0.593 . . . . 65.12 109.399 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -137.62 146.1 43.53 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.436 -0.79 . . . . 72.33 109.305 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 79.2 t -115.81 133.32 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-O 121.451 0.643 . . . . 71.42 109.746 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.544 HD11 ' CG1' ' A' ' 6' ' ' ILE . 2.4 tp -103.48 116.95 33.35 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.417 -0.957 . . . . 65.12 108.417 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 59.0 tp -117.33 114.54 23.73 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.918 -0.771 . . . . 62.43 108.918 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.544 ' CG1' HD11 ' A' ' 4' ' ' LEU . 52.4 mt -109.41 116.29 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.851 -0.796 . . . . 71.15 108.851 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 13' ' ' GLY . 61.7 tt0 -146.7 131.11 17.62 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.334 -0.854 . . . . 75.34 109.425 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -61.98 -35.78 79.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 72.44 109.58 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -86.23 116.85 24.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 63.02 109.492 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.4 p -73.12 -27.29 61.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.917 . . . . 72.34 109.623 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.7 t -63.75 -49.57 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.184 -0.948 . . . . 74.02 109.673 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.5 mm? -67.83 -42.29 81.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.928 . . . . 71.43 109.128 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.51 ' N ' ' OE1' ' A' ' 7' ' ' GLU . . . -67.19 -19.79 70.57 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.354 -1.898 . . . . 61.32 108.354 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.38 -58.88 5.68 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.457 -1.457 . . . . 71.2 109.457 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -52.84 -42.78 65.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.399 -1.059 . . . . 71.32 109.464 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.3 mm -64.05 -38.65 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.943 -1.098 . . . . 63.23 108.807 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -62.83 -52.49 62.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.837 . . . . 51.11 109.818 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -81.63 1.96 31.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -0.949 . . . . 73.34 109.632 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.24 -68.12 1.32 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.159 -1.576 . . . . 62.15 109.159 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp -56.16 -25.93 48.5 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.417 -1.049 . . . . 73.51 109.088 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -52.09 -33.95 41.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.305 -0.872 . . . . 74.25 109.212 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.3 t -55.52 -41.4 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 70.04 109.022 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.451 ' HZ2' ' CG1' ' A' ' 106' ' ' VAL . 2.1 mptm? -67.35 -22.58 65.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.358 -0.838 . . . . 73.23 108.994 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.14 38.42 4.32 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.153 -1.179 . . . . 75.54 110.153 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -112.74 159.33 19.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.413 -1.051 . . . . 73.43 108.62 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.0 mmt -99.63 138.55 36.56 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.304 -0.998 . . . . 43.24 108.304 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.13 160.51 40.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.902 . . . . 62.11 109.995 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -134.92 141.35 46.28 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.967 -0.753 . . . . 74.42 108.967 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -110.43 130.54 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.727 -0.842 . . . . 72.15 108.727 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.1 p -135.0 167.63 20.58 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.499 -0.75 . . . . 71.42 109.251 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.459 ' CG ' ' OD2' ' A' ' 35' ' ' ASP . 3.4 pt-20 -90.68 -99.86 0.1 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.245 -0.909 . . . . 72.33 109.564 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.0 p -78.77 166.59 22.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -0.867 . . . . 74.24 109.997 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 15.5 mt -56.02 -32.04 63.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.611 -0.68 . . . . 71.53 110.032 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -50.58 -45.83 57.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.031 -1.043 . . . . 74.23 109.793 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.459 ' OD2' ' CG ' ' A' ' 31' ' ' GLU . 67.9 m-20 -68.25 -43.05 78.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.054 -1.029 . . . . 54.03 109.364 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.43 -40.47 79.46 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.386 -1.486 . . . . 61.41 109.386 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -65.11 -38.92 92.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -1.113 . . . . 74.34 109.419 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -75.61 -36.73 60.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 75.33 109.48 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.7 tp -71.42 -45.76 61.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 74.33 109.905 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.444 ' O ' ' O ' ' A' ' 43' ' ' ARG . 3.2 ppp? -69.08 -20.37 64.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.074 -1.016 . . . . 70.32 109.857 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -60.73 -36.95 80.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.022 -1.049 . . . . 71.22 109.611 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.4 pt -89.23 -27.58 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.18 -0.95 . . . . 74.14 110.317 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 40' ' ' MET . 96.9 mtt180 -127.82 146.03 50.74 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.298 -0.877 . . . . 72.24 109.771 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.491 ' OD1' HD11 ' A' ' 69' ' ' ILE . 60.8 t30 -98.61 132.05 44.32 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.231 -0.918 . . . . 75.42 109.475 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -101.9 135.16 43.93 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.36 -0.838 . . . . 74.23 109.343 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -74.75 -35.26 62.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.948 . . . . 72.04 108.969 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.555 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.7 OUTLIER -112.72 115.8 29.11 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.426 -0.953 . . . . 72.13 108.426 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.555 ' N ' HD13 ' A' ' 47' ' ' LEU . 39.2 t -99.11 97.04 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.27 -1.011 . . . . 72.34 108.27 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.2 ttt -109.22 134.07 52.22 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.536 0.684 . . . . 74.11 109.611 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.444 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 1.3 p -143.96 131.66 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.461 -0.775 . . . . 61.12 109.505 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.3 p -96.99 2.97 52.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.501 -0.749 . . . . 73.11 109.125 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.444 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 47.5 m-20 -76.26 142.23 41.45 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.269 -0.895 . . . . 52.55 109.54 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.566 ' NZ ' ' H ' ' A' ' 76' ' ' ASP . 66.0 mmtt -79.07 -39.36 34.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 44.22 110.198 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -72.17 15.0 0.18 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.082 -1.011 . . . . 70.44 109.733 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.459 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.52 -19.75 59.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 64.14 110.411 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.531 HD13 ' NE2' ' A' ' 85' ' ' HIS . 22.0 mt -40.66 -50.22 3.05 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.428 -0.795 . . . . 44.14 110.473 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.0 m -68.14 -34.69 76.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.087 . . . . 55.23 109.262 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.534 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 55.9 t80 -65.81 -56.08 13.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -0.794 . . . . 74.44 110.115 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.6 m -54.57 -35.38 31.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 120.749 -1.219 . . . . 74.03 109.662 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.6 t -57.4 -54.48 46.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.097 -1.002 . . . . 64.3 109.655 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 ptp85 -66.05 -29.26 69.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.119 -0.988 . . . . 64.44 110.092 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.534 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 5.6 mm -65.63 -38.21 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.751 -1.218 . . . . 63.21 109.898 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.521 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 33.5 mmtt -69.63 -50.51 43.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.107 -0.996 . . . . 74.42 110.117 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -67.39 -35.46 79.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.762 -1.211 . . . . 70.32 109.767 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.471 ' C ' ' CG ' ' A' ' 66' ' ' HIS . 48.7 mtpt -81.77 -23.43 36.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.196 -0.94 . . . . 75.22 109.607 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.471 ' CG ' ' C ' ' A' ' 65' ' ' LYS . 59.4 m-70 -155.26 65.03 0.63 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.168 -0.957 . . . . 74.13 109.632 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 63' ' ' LYS . 33.1 t -61.06 -30.36 70.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.25 -0.906 . . . . 73.24 110.017 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.4 t -61.9 -19.83 63.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.958 . . . . 61.01 110.198 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.491 HD11 ' OD1' ' A' ' 44' ' ' ASN . 78.8 mt -87.81 152.97 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.1 -1.0 . . . . 71.33 109.945 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 71' ' ' VAL . 48.3 t -92.95 160.63 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.351 -0.843 . . . . 72.13 109.518 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.461 ' N ' HG12 ' A' ' 70' ' ' VAL . 43.2 t -134.59 129.81 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.348 -0.845 . . . . 54.21 109.898 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.2 tt -122.39 99.05 6.21 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.884 -0.784 . . . . 50.24 108.884 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.0 t -92.22 127.45 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.167 -0.958 . . . . 74.41 108.825 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.412 ' O ' ' OG ' ' A' ' 75' ' ' SER . 0.4 OUTLIER -92.97 -176.25 4.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.019 -1.051 . . . . 72.31 108.805 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.463 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 55.7 m -166.75 119.83 1.01 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.792 -1.193 . . . . 64.54 110.502 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.566 ' H ' ' NZ ' ' A' ' 53' ' ' LYS . 50.4 t0 -61.65 -32.33 72.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.541 -0.725 . . . . 74.13 109.807 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 79' ' ' THR . 44.8 t-20 -119.78 84.06 30.5 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.583 -0.698 . . . . 73.34 109.242 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -54.19 82.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.208 1.939 . . . . 63.22 111.341 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.493 HG23 ' H ' ' A' ' 82' ' ' GLU . 3.4 t -105.22 154.74 19.81 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.519 -0.738 . . . . 62.53 109.589 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.56 -32.61 73.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.402 -0.811 . . . . 73.44 109.78 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -55.08 -55.91 25.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 71.42 110.009 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.534 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 95.4 mt-10 -64.6 -35.39 80.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -0.957 . . . . 73.43 109.796 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.52 ' OE2' ' NH2' ' B' ' 108' ' ' ARG . 66.9 tt0 -63.91 -48.98 74.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.049 -1.032 . . . . 74.22 110.068 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.5 t -57.2 -57.56 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.167 -0.958 . . . . 73.2 110.313 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.57 ' ND1' ' N ' ' A' ' 86' ' ' ALA . 1.3 p-80 -64.83 -41.11 96.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.942 -1.099 . . . . 53.33 109.515 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.57 ' N ' ' ND1' ' A' ' 85' ' ' HIS . . . -46.93 -37.69 9.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 64.11 109.833 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -78.43 -34.32 47.96 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.103 -0.998 . . . . 74.34 108.761 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -67.5 -40.47 85.18 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.414 -0.914 . . . . 74.42 109.432 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.571 ' N ' ' NE2' ' A' ' 89' ' ' GLN . 0.7 OUTLIER -65.14 -56.88 10.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 74.24 109.614 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 152.13 44.58 0.02 OUTLIER Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.724 -1.227 . . . . 61.51 110.249 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -96.2 133.28 40.7 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.083 -1.245 . . . . 55.33 109.222 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.521 ' OD1' ' NZ ' ' A' ' 63' ' ' LYS . 72.7 m-20 -90.96 -22.53 20.79 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.085 -1.009 . . . . 73.42 109.677 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 94' ' ' TYR . 18.7 t0 -149.61 154.81 39.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.22 -0.925 . . . . 75.04 109.265 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.516 ' N ' ' OD1' ' A' ' 93' ' ' ASP . 71.3 t80 -136.86 105.65 5.88 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.522 -0.736 . . . . 71.33 109.257 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.409 HG22 ' N ' ' A' ' 96' ' ' ALA . 27.0 mm -111.47 155.69 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 O-C-N 121.127 -0.983 . . . . 71.13 110.735 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.409 ' N ' HG22 ' A' ' 95' ' ' ILE . . . -74.4 128.73 36.27 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.657 -1.238 . . . . 64.32 107.657 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.687 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -50.83 -57.28 14.04 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.715 -1.241 . . . . 62.2 111.399 -178.496 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 5.2 Cg_endo -41.5 -9.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.066 1.177 . . . . 73.11 112.797 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.687 ' N ' ' O ' ' A' ' 97' ' ' LYS . 24.9 m-85 62.81 108.66 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.339 -0.615 . . . . 65.22 109.339 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.526 ' NH1' ' OE2' ' B' ' 83' ' ' GLU . 21.6 ttm105 -52.81 -33.26 48.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.848 -1.157 . . . . 72.35 108.374 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 103' ' ' LYS . 2.3 m 172.37 48.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.552 -0.717 . . . . 71.32 109.524 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 105' ' ' LEU . 13.1 mt 37.6 -77.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 121.835 -0.541 . . . . 75.43 111.982 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.692 ' N ' ' O ' ' A' ' 101' ' ' SER . 28.0 mmtp -38.03 -38.8 0.34 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.533 -0.729 . . . . 71.41 110.26 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' B' ' 80' ' ' SER . . . -70.84 -43.51 68.37 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.206 -1.035 . . . . 63.24 108.206 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 102' ' ' ILE . 1.2 tt -60.85 -44.81 96.48 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.684 -0.858 . . . . 73.22 108.684 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.451 ' CG1' ' HZ2' ' A' ' 23' ' ' LYS . 15.6 t -69.43 -43.08 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 60.11 109.619 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.61 -42.61 62.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 70.42 109.174 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.75 -35.94 77.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 74.41 109.015 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.0 mt -70.87 -30.32 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.951 -1.093 . . . . 62.54 108.677 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -62.24 -53.47 54.71 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.381 -0.825 . . . . 74.34 108.782 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.09 -39.39 69.26 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.468 -0.77 . . . . 73.32 109.148 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 20.0 tpt85 -59.25 -32.63 70.17 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.265 -0.897 . . . . 52.41 109.145 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.4 tp -157.6 102.42 1.88 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.264 -0.898 . . . . 65.24 109.638 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.519 ' O ' ' CG ' ' A' ' 115' ' ' PHE . 23.1 mtm105 -94.84 -56.3 2.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.131 -0.981 . . . . 64.45 109.007 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.519 ' CG ' ' O ' ' A' ' 114' ' ' ARG . 82.4 m-85 -157.02 -58.14 0.09 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.182 -0.949 . . . . 74.43 109.213 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 62.7 m95 48.04 -122.59 1.53 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.317 -0.865 . . . . 74.42 109.695 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.1 43.38 56.8 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.152 -1.579 . . . . 75.04 109.152 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.1 m -100.37 147.97 25.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.375 -1.074 . . . . 61.14 109.564 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.541 HD21 ' C ' ' A' ' 121' ' ' ILE . 2.4 t30 -108.91 166.72 10.61 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.61 -0.681 . . . . 65.24 109.261 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.414 ' N ' ' CG ' ' A' ' 119' ' ' ASN . 4.4 t -124.68 -39.09 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.722 -0.611 . . . . 73.11 109.379 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.541 ' C ' HD21 ' A' ' 119' ' ' ASN . 17.1 mm -100.23 140.5 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.317 -0.864 . . . . 72.24 110.005 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.743 ' H ' HH12 ' A' ' 159' ' ' ARG . 86.4 mt-10 -135.61 119.31 17.15 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.382 -0.823 . . . . 72.34 108.901 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 37.8 mt -138.62 111.84 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.228 -0.92 . . . . 71.44 109.782 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 126' ' ' LEU . . . 65.61 46.51 83.98 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.209 -1.156 . . . . 73.4 110.209 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 67.25 -14.16 0.19 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.512 -0.993 . . . . 74.45 110.308 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.49 ' H ' ' C ' ' A' ' 124' ' ' GLY . 7.1 mt -76.99 155.24 32.76 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.61 -1.256 . . . . 54.21 107.61 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.88 129.28 46.63 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.368 -0.833 . . . . 54.5 109.49 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 74.8 mt -123.58 130.86 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.071 -0.714 . . . . 45.15 109.071 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.3 m -117.16 112.99 39.48 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 121.604 -0.685 . . . . 71.11 109.304 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.09 -51.09 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.106 1.871 . . . . 65.41 112.621 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -55.19 -45.68 75.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.063 -1.023 . . . . 63.32 109.532 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -81.53 -8.43 59.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 72.52 109.169 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 52.57 57.55 6.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.401 -0.812 . . . . 75.33 109.248 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -140.79 127.8 20.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.376 -0.828 . . . . 71.23 108.942 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.666 HD13 ' N ' ' A' ' 136' ' ' ILE . 0.2 OUTLIER -107.08 126.32 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.362 -0.836 . . . . 74.02 109.147 -179.586 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.666 ' N ' HD13 ' A' ' 135' ' ' ILE . 40.9 mt -117.86 126.76 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.532 -0.73 . . . . 60.23 109.951 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -137.25 142.66 42.01 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.355 -0.841 . . . . 62.32 108.954 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp 54.83 14.04 0.83 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.575 -0.703 . . . . 75.4 110.272 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 92.33 -6.56 78.23 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.49 -1.044 . . . . 72.24 110.49 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.473 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 1.0 OUTLIER -87.99 124.87 34.16 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.858 -1.378 . . . . 71.22 108.651 179.614 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -94.3 129.23 41.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.084 -1.01 . . . . 71.42 110.049 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.6 t -135.96 133.48 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.513 -0.742 . . . . 53.02 109.046 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -88.36 131.68 34.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.415 -0.803 . . . . 60.45 109.603 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.45 150.25 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.571 -0.9 . . . . 74.44 108.571 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -162.38 113.92 1.61 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.012 -1.055 . . . . 65.15 109.653 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.608 ' O ' ' HB2' ' A' ' 150' ' ' GLU . . . 163.37 -169.07 38.32 Favored Glycine 0 N--CA 1.486 1.983 0 C-N-CA 119.511 -1.328 . . . . 73.34 109.899 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.54 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 41.7 mttp -78.06 -41.68 2.08 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.506 -0.996 . . . . 72.22 111.897 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 147' ' ' LYS . 36.7 Cg_endo -65.44 -30.38 52.93 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 CA-C-N 120.49 1.211 . . . . 65.23 111.891 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -94.38 -19.07 20.95 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.042 -1.037 . . . . 60.11 109.554 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.608 ' HB2' ' O ' ' A' ' 146' ' ' GLY . 34.9 tp10 -68.24 -43.32 78.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.356 -0.84 . . . . 64.21 108.907 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.0 p -61.66 -30.17 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.465 -0.939 . . . . 72.02 108.465 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 31.0 tp -65.61 -45.33 83.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.544 -0.723 . . . . 73.31 109.169 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.3 p -71.05 -30.1 66.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.945 . . . . 74.31 109.3 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -61.54 -53.46 56.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.168 -0.958 . . . . 74.31 109.742 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 156' ' ' ALA . 4.4 pp -69.87 -22.65 63.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 75.34 109.33 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.718 ' N ' HD12 ' A' ' 155' ' ' LEU . . . -60.67 -49.12 78.79 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.341 -0.85 . . . . 62.14 109.243 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.424 ' C ' ' H ' ' A' ' 159' ' ' ARG . 36.8 mtp180 -75.33 -44.39 45.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.025 -1.047 . . . . 61.03 109.164 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -77.71 26.43 0.18 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.255 -0.903 . . . . 74.12 109.412 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.743 HH12 ' H ' ' A' ' 122' ' ' GLU . 36.5 ptt180 -59.98 169.5 1.48 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.39 -0.819 . . . . 71.13 109.405 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.0 t0 46.47 65.49 1.19 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.316 -0.865 . . . . 75.45 109.484 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -169.94 149.67 3.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.123 -0.985 . . . . 73.41 109.792 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.402 HG21 ' HE ' ' A' ' 210' ' ' ARG . 75.5 mt -81.36 105.15 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.226 -1.027 . . . . 74.41 108.226 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 12.1 t -91.51 128.66 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.38 -0.825 . . . . 72.31 109.978 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.1 p -86.6 164.15 17.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.844 . . . . 74.12 109.052 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.482 ' NZ ' ' CB ' ' A' ' 165' ' ' LYS . 6.6 mtpm? -63.68 -48.12 78.46 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.257 -0.902 . . . . 70.43 110.185 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -56.0 -32.5 64.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.425 -0.797 . . . . 73.52 110.785 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -56.19 -56.06 25.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.973 -1.079 . . . . 74.52 110.119 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 51.2 mt -61.52 -41.69 97.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.165 -0.959 . . . . 72.31 110.372 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.547 HD13 ' C ' ' A' ' 169' ' ' LEU . 1.6 tm? -62.24 -55.63 26.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.005 -1.06 . . . . 53.33 109.868 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 49.6 t0 -71.07 -13.18 61.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.134 -0.979 . . . . 62.44 110.45 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.97 -62.97 1.53 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.025 -1.047 . . . . 60.21 110.998 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.688 HD12 ' N ' ' A' ' 172' ' ' ILE . 2.1 mp -73.23 -47.62 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 120.912 -1.117 . . . . 75.32 108.183 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 24.0 m-90 . . . . . 0 C--N 1.303 -1.436 0 N-CA-C 108.559 -0.904 . . . . 73.14 108.559 178.864 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.408 -0.59 . . . . 64.54 109.408 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.411 ' O ' HG22 ' A' ' 183' ' ' VAL . 3.2 p -143.71 -14.11 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.201 -0.937 . . . . 74.02 110.294 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 6.1 tt -56.1 -23.08 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.743 -1.223 . . . . 72.33 109.738 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -58.23 -49.66 76.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 74.4 109.837 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 16.4 m -76.35 -25.02 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.89 -1.132 . . . . 70.42 109.663 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.19 -46.59 49.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.058 -1.026 . . . . 52.11 110.1 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.8 tp -67.95 -30.93 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.911 -1.118 . . . . 71.4 109.093 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -70.02 -57.42 5.02 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.372 -0.83 . . . . 73.44 109.99 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.439 ' CG ' ' N ' ' A' ' 191' ' ' ILE . 7.7 pt20 -63.06 -43.85 97.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 71.42 109.983 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.439 ' N ' ' CG ' ' A' ' 190' ' ' GLN . 51.0 mt -53.69 -49.29 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.112 -0.992 . . . . 61.55 109.165 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -54.63 -40.56 69.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.003 . . . . 63.34 109.249 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -62.51 -35.97 81.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.142 -0.973 . . . . 61.24 109.538 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -93.0 -0.05 57.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.207 -0.933 . . . . 75.13 110.382 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 31.9 ttm -95.72 -63.01 1.2 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.005 -1.059 . . . . 74.02 109.389 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 200' ' ' GLY . 84.5 m-20 -60.66 -29.08 69.07 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.439 -0.788 . . . . 74.02 110.095 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.438 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 30.7 mttm -58.64 -65.75 1.78 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.053 -1.03 . . . . 75.43 110.06 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 26.7 Cg_endo -60.96 -52.83 3.11 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.915 1.743 . . . . 72.32 112.108 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' A' ' 201' ' ' ILE . 26.0 mt -66.35 -34.83 78.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.946 -1.096 . . . . 74.54 109.154 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 196' ' ' ASP . . . 77.65 -31.67 1.68 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.038 -1.625 . . . . 61.51 109.038 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.459 ' H ' ' C ' ' A' ' 199' ' ' LEU . 27.6 mm -95.89 129.45 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.41 -1.053 . . . . 61.22 109.286 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 64.9 m -78.8 139.22 38.42 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.603 -0.888 . . . . 72.0 108.603 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 38.5 p -142.57 13.77 1.95 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.216 -0.928 . . . . 74.44 109.814 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.33 131.77 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.765 -0.828 . . . . 64.35 108.765 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.41 ' OE1' ' SG ' ' A' ' 215' ' ' CYS . 30.1 mt-10 -117.01 123.45 46.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.636 -0.665 . . . . 71.41 109.509 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.99 98.93 10.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.319 -0.863 . . . . 73.52 108.715 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 208' ' ' ARG . 12.0 m -152.41 172.14 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.227 -0.921 . . . . 71.02 109.415 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 207' ' ' VAL . 70.2 mtt85 55.44 164.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.621 -0.674 . . . . 72.12 109.702 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.483 ' O ' ' N ' ' A' ' 211' ' ' GLY . 80.9 mtt85 -72.61 -126.11 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.21 -0.931 . . . . 64.41 109.398 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.402 ' HE ' HG21 ' A' ' 162' ' ' ILE . 75.6 mtp85 50.1 -91.44 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.3 -0.875 . . . . 71.54 109.928 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . -158.78 -97.7 0.13 Allowed Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.496 -1.335 . . . . 72.03 110.39 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -137.21 148.28 46.4 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.344 -1.092 . . . . 75.54 110.103 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -107.39 126.54 52.6 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.475 -0.766 . . . . 75.31 109.619 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.623 ' CE2' HD13 ' A' ' 155' ' ' LEU . 8.6 t80 -104.17 134.61 47.14 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.283 -1.006 . . . . 75.41 108.283 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' CYS . . . . . 0.41 ' SG ' ' OE1' ' A' ' 205' ' ' GLU . 31.1 p -153.51 164.43 38.24 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.173 -0.954 . . . . 74.14 109.926 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -59.33 152.82 51.78 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 75.32 109.106 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 N--CA 1.493 1.485 0 C-N-CA 122.237 1.958 . . . . 73.11 111.407 179.219 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.414 ' SD ' HD11 ' B' ' 113' ' ' LEU . 32.0 tpp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.492 -0.558 . . . . 71.14 109.492 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.524 ' N ' ' OD2' ' B' ' 46' ' ' ASP . 78.4 mtm-85 -140.33 151.81 45.33 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.355 -0.841 . . . . 73.23 109.286 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.8 t -112.23 129.39 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.623 -0.673 . . . . 72.24 109.274 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.509 HD12 ' N ' ' B' ' 5' ' ' LEU . 2.5 tp -104.46 121.12 42.78 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.579 -0.7 . . . . 54.33 109.566 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.509 ' N ' HD12 ' B' ' 4' ' ' LEU . 11.1 mt -118.92 98.83 6.39 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 109.031 -0.729 . . . . 74.35 109.031 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.462 ' CG1' HD11 ' B' ' 4' ' ' LEU . 55.7 mt -84.1 98.86 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.834 -1.166 . . . . 42.55 108.664 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.43 ' OE2' ' OG ' ' B' ' 51' ' ' SER . 9.3 tp10 -140.97 130.59 24.06 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.293 -0.88 . . . . 74.52 109.485 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -66.06 -35.31 80.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.346 -0.846 . . . . 62.55 109.249 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -77.02 112.26 13.46 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.376 -0.828 . . . . 73.11 109.385 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 95.4 p -74.27 -30.29 62.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 65.54 110.158 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.555 HG13 ' N ' ' B' ' 12' ' ' LEU . 9.3 p -59.1 -45.38 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.005 -1.059 . . . . 75.55 109.704 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.555 ' N ' HG13 ' B' ' 11' ' ' VAL . 80.9 mt -65.06 -31.58 72.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.06 -1.025 . . . . 70.14 109.309 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.25 -28.04 62.77 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.649 -1.781 . . . . 75.4 108.649 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.62 -56.01 19.54 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.506 -1.437 . . . . 65.44 109.506 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.52 -41.85 90.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.342 -1.093 . . . . 60.21 109.515 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.69 -43.29 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.975 -1.078 . . . . 75.15 108.846 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -58.53 -43.94 89.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.451 -0.78 . . . . 73.01 109.559 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -86.58 0.4 54.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.103 -0.998 . . . . 74.3 109.083 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.76 -58.63 1.89 Allowed Glycine 0 N--CA 1.484 1.894 0 N-CA-C 109.479 -1.448 . . . . 70.54 109.479 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -69.37 -22.31 63.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -1.144 . . . . 71.34 109.557 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 29.3 m-20 -51.67 -34.07 36.59 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.223 -0.923 . . . . 64.41 109.416 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 79.0 t -56.76 -39.91 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.093 -1.004 . . . . 74.23 108.884 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.448 ' CD ' ' N ' ' B' ' 23' ' ' LYS . 4.2 mptp? -70.59 -27.52 64.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.376 -0.828 . . . . 63.42 109.344 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.58 41.22 2.21 Favored Glycine 0 N--CA 1.499 2.893 0 N-CA-C 110.208 -1.157 . . . . 53.43 110.208 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.405 ' CZ ' HD23 ' B' ' 113' ' ' LEU . 54.0 m-85 -119.58 161.16 21.1 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.427 -1.043 . . . . 71.12 109.203 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 18.3 mmt -103.08 140.89 36.72 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.746 -0.835 . . . . 75.24 108.746 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.419 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -137.53 154.45 49.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.303 -0.873 . . . . 72.12 110.167 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 96.1 m-20 -140.63 158.11 44.46 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.535 -0.913 . . . . 72.31 108.535 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 5.0 p -122.79 140.01 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.41 -0.806 . . . . 64.43 109.947 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.2 p -131.86 171.82 13.07 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.132 -0.692 . . . . 65.41 109.132 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -91.85 -107.09 0.1 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.235 -0.915 . . . . 71.02 109.792 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 33.3 t -78.79 168.87 19.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.292 -0.88 . . . . 51.11 110.022 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 39.0 mt -52.4 -30.91 31.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.593 -0.692 . . . . 71.24 109.877 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -53.9 -49.75 67.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.113 -0.992 . . . . 74.32 109.769 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -66.03 -44.79 83.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.153 -0.967 . . . . 73.03 109.365 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.61 -40.12 94.02 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.393 -1.483 . . . . 30.21 109.393 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -64.67 -43.85 92.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.337 -1.096 . . . . 74.42 109.456 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -71.29 -37.89 71.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.179 -0.95 . . . . 74.42 109.774 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 51.8 tp -69.51 -45.27 69.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 75.41 110.068 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' MET . . . . . 0.449 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.4 ppp? -74.29 -19.68 60.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.007 -1.058 . . . . 60.41 110.005 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.39 -41.81 80.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.105 -0.997 . . . . 53.23 109.697 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 pt -86.95 -41.44 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.122 -0.986 . . . . 71.23 109.854 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' B' ' 40' ' ' MET . 2.8 mpt_? -104.54 138.48 40.84 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.279 -0.888 . . . . 72.22 109.148 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' ASN . . . . . 0.478 ' C ' ' NH2' ' B' ' 2' ' ' ARG . 55.3 t-20 -100.59 89.89 4.08 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.377 -0.827 . . . . 63.54 109.205 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -63.56 149.22 46.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 64.35 109.275 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' B' ' 2' ' ' ARG . 3.9 p30 -80.42 -44.1 19.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 62.22 109.368 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.545 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.6 OUTLIER -103.37 115.02 29.75 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.458 -0.941 . . . . 73.12 108.458 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.545 ' N ' HD13 ' B' ' 47' ' ' LEU . 74.8 t -99.01 96.43 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.38 -0.97 . . . . 65.11 108.38 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 22.8 ttt -109.26 134.2 52.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.482 -0.761 . . . . 73.44 109.908 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.22 137.11 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.008 -0.738 . . . . 34.5 109.008 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 51' ' ' SER . . . . . 0.43 ' OG ' ' OE2' ' B' ' 7' ' ' GLU . 41.8 p -100.22 0.03 39.58 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.468 -0.77 . . . . 73.21 109.967 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -76.35 130.42 38.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 70.41 109.521 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.429 ' C ' ' N ' ' B' ' 55' ' ' ALA . 27.5 mtmm -66.51 -48.43 69.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 65.0 109.931 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -50.04 -16.52 0.3 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.144 -0.973 . . . . 75.21 109.367 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.429 ' N ' ' C ' ' B' ' 53' ' ' LYS . . . -59.68 -21.44 60.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.422 -0.799 . . . . 55.33 110.18 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 23.1 mt -43.02 -46.44 5.52 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.305 -0.872 . . . . 63.14 110.065 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 25.2 t -70.89 -34.32 71.46 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.05 -1.031 . . . . 63.5 109.347 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' PHE . . . . . 0.495 ' CE2' HD11 ' B' ' 62' ' ' ILE . 73.4 t80 -67.45 -53.43 29.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.408 -0.808 . . . . 72.33 110.123 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.64 -33.89 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.825 -1.172 . . . . 74.54 109.73 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 9.3 t -59.74 -52.06 67.09 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.174 -0.953 . . . . 71.24 109.454 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -67.7 -27.79 67.12 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.007 -1.058 . . . . 74.31 109.876 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.495 HD11 ' CE2' ' B' ' 58' ' ' PHE . 4.7 mm -59.29 -51.63 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.932 -1.105 . . . . 72.14 109.083 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -60.41 -41.0 92.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.097 -1.002 . . . . 73.32 108.754 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -67.1 -51.73 50.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -0.862 . . . . 73.12 108.746 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -72.6 -74.76 0.16 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.599 -0.688 . . . . 72.44 109.554 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.505 ' O ' HG22 ' B' ' 69' ' ' ILE . 90.2 m-70 -90.69 92.24 8.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.144 -0.973 . . . . 63.31 109.176 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 74.8 m -79.83 -27.64 40.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 73.1 109.876 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 51.7 p -87.11 47.69 1.54 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.188 -0.945 . . . . 71.53 110.153 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.505 HG22 ' O ' ' B' ' 66' ' ' HIS . 15.9 tt -144.83 159.85 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.049 -1.032 . . . . 74.4 109.171 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.494 HG21 ' NH1' ' B' ' 112' ' ' ARG . 43.1 t -103.32 147.5 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.291 -0.881 . . . . 75.12 109.206 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 t -133.29 127.97 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.41 -0.806 . . . . 73.2 109.655 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.548 ' C ' HD23 ' B' ' 72' ' ' LEU . 5.3 tt -122.65 105.29 9.95 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.617 -0.677 . . . . 73.34 109.423 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.435 ' O ' HG13 ' B' ' 73' ' ' VAL . 14.8 p -94.25 132.44 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.012 -1.055 . . . . 73.5 109.497 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 9.5 p -89.63 171.63 9.54 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.985 -1.072 . . . . 64.34 108.723 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 27.4 p -152.54 112.05 3.91 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.817 -1.177 . . . . 74.53 110.713 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -74.28 -4.63 37.28 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.62 -0.881 . . . . 64.5 108.62 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -143.09 71.38 18.43 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 108.86 -0.793 . . . . 74.25 108.86 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.4 87.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.808 1.672 . . . . 74.43 111.701 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.43 ' OG1' ' OE2' ' B' ' 82' ' ' GLU . 44.3 p -107.43 155.77 19.67 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.683 -0.858 . . . . 73.12 108.683 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 80' ' ' SER . . . . . 0.403 ' HB2' ' HB2' ' A' ' 104' ' ' ALA . 1.1 p -61.01 -30.42 70.29 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.214 -0.929 . . . . 71.01 109.58 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.09 -43.01 88.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.921 . . . . 63.2 109.804 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 82' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' B' ' 82' ' ' GLU . 0.2 OUTLIER -66.29 -33.14 75.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 73.22 109.633 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.526 ' OE2' ' NH1' ' A' ' 100' ' ' ARG . 46.5 mt-10 -64.52 -46.51 82.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.017 -1.052 . . . . 74.3 109.535 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.06 -42.09 93.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.186 -0.946 . . . . 73.31 109.328 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 85' ' ' HIS . . . . . 0.438 ' O ' ' OE1' ' B' ' 89' ' ' GLN . 18.6 m170 -72.13 -20.33 61.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.215 -0.928 . . . . 73.24 109.639 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.24 -44.59 62.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.04 -1.038 . . . . 55.33 110.119 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -81.37 -35.23 31.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.002 -1.061 . . . . 74.14 109.487 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.95 -43.0 97.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.073 -1.017 . . . . 64.04 109.375 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' GLN . . . . . 0.438 ' OE1' ' O ' ' B' ' 85' ' ' HIS . 0.5 OUTLIER -67.91 -61.29 1.94 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 72.35 109.259 179.833 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 149.7 64.72 0.01 OUTLIER Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.732 -1.223 . . . . 65.2 110.154 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.51 134.44 55.22 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.493 -1.004 . . . . 52.23 108.971 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -68.22 -43.35 78.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.049 -1.032 . . . . 73.32 108.959 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 93' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' B' ' 93' ' ' ASP . 18.3 p-10 -153.81 165.14 36.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.449 -0.782 . . . . 72.22 109.253 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.537 ' O ' ' CD1' ' B' ' 94' ' ' TYR . 0.2 OUTLIER -136.19 119.09 16.29 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.364 -0.606 . . . . 64.42 109.364 -178.345 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 28.6 mm -113.67 150.66 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 O-C-N 121.379 -0.826 . . . . 72.23 110.144 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' ALA . . . . . 0.491 ' HB1' ' HD2' ' B' ' 98' ' ' PRO . . . -61.84 141.06 58.17 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.011 -1.107 . . . . 25.24 108.011 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.594 ' N ' ' CD ' ' B' ' 98' ' ' PRO . 0.0 OUTLIER -68.85 -40.26 16.4 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.944 -1.098 . . . . 64.32 110.922 -178.931 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 98' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' B' ' 97' ' ' LYS . 34.0 Cg_exo -53.16 -0.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.289 -2.557 0 CA-C-N 118.697 0.571 . . . . 63.33 112.135 -174.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 99' ' ' TYR . . . . . 0.566 ' N ' ' O ' ' B' ' 97' ' ' LYS . 60.2 m-85 53.0 102.3 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.525 -0.734 . . . . 75.13 109.935 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 38.3 mtt-85 -57.63 -35.84 71.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.925 -1.109 . . . . 74.23 108.77 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 101' ' ' SER . . . . . 0.777 ' O ' ' N ' ' B' ' 103' ' ' LYS . 27.1 t -171.27 29.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -0.934 . . . . 63.34 110.77 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 18.7 mt 48.11 -68.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-N 118.539 0.609 . . . . 74.44 110.418 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.777 ' N ' ' O ' ' B' ' 101' ' ' SER . 55.3 mttp -51.59 -31.72 25.96 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.693 -1.225 . . . . 71.11 107.693 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.84 -42.89 89.93 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.194 -1.039 . . . . 71.45 108.194 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 50.8 tp -60.79 -42.71 98.1 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.549 -0.908 . . . . 51.31 108.549 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 20.3 t -69.78 -34.23 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 65.23 109.229 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.51 -47.35 73.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.152 -0.968 . . . . 24.32 109.441 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 108' ' ' ARG . . . . . 0.52 ' NH2' ' OE2' ' A' ' 83' ' ' GLU . 26.2 ttm105 -69.28 -37.08 77.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 75.31 109.789 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 97.7 mt -70.16 -26.66 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.04 -1.038 . . . . 54.24 108.921 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -74.98 -56.91 4.27 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.455 -0.778 . . . . 65.31 109.94 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -52.0 -35.74 47.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.071 -1.018 . . . . 72.24 109.81 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 112' ' ' ARG . . . . . 0.532 HH21 HD23 ' B' ' 47' ' ' LEU . 38.6 ttp85 -85.98 -57.02 3.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.113 -0.992 . . . . 72.04 110.545 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.414 HD11 ' SD ' ' B' ' 1' ' ' MET . 35.2 tp -54.7 -36.46 64.71 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.086 -1.008 . . . . 75.35 110.409 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -46.71 -33.24 4.15 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.125 -0.984 . . . . 75.5 109.611 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 115' ' ' PHE . . . . . 0.532 ' O ' ' N ' ' B' ' 117' ' ' GLY . 11.2 m-85 -54.38 -29.71 49.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.859 . . . . 65.33 108.994 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 4.3 t-105 60.47 -75.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.444 -0.785 . . . . 74.45 109.59 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 117' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' B' ' 115' ' ' PHE . . . -163.18 -171.34 29.3 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.281 -1.528 . . . . 44.21 109.281 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 118' ' ' SER . . . . . 0.642 ' CB ' ' OE2' ' B' ' 132' ' ' GLU . 7.6 t -154.85 174.48 15.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.148 -1.207 . . . . 71.4 110.011 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.29 114.37 4.44 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.983 -0.687 . . . . 72.32 109.159 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 11.9 t -78.51 -39.97 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.264 -0.897 . . . . 75.02 109.73 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 17.3 mm -101.7 127.45 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.231 -0.918 . . . . 51.41 109.365 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.464 ' CD ' ' N ' ' B' ' 122' ' ' GLU . 1.0 OUTLIER -135.2 114.64 12.52 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.529 -0.732 . . . . 71.53 109.267 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 11.2 pt -140.97 137.35 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.216 -0.928 . . . . 72.43 109.2 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.18 -149.89 3.4 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.441 -1.464 . . . . 51.23 109.441 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -83.19 -0.39 49.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -1.168 . . . . 74.2 109.332 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.31 132.82 42.68 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.288 -0.882 . . . . 75.42 108.706 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 4.4 p -129.81 120.33 24.82 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.97 -0.752 . . . . 74.22 108.97 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 18.2 mm -107.24 144.68 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.492 -0.755 . . . . 60.33 109.042 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 3.4 m -126.84 79.44 72.31 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 121.446 -0.784 . . . . 72.31 109.7 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -50.96 -40.36 58.56 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.51 2.14 . . . . 75.13 112.132 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -68.01 -50.12 57.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.87 . . . . 75.23 109.934 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 132' ' ' GLU . . . . . 0.642 ' OE2' ' CB ' ' B' ' 118' ' ' SER . 88.7 mt-10 -82.38 -1.16 49.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.119 -0.988 . . . . 72.43 109.701 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 50.39 51.97 15.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.946 . . . . 75.13 109.235 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -138.19 136.84 37.01 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.371 -0.83 . . . . 73.22 109.242 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 7.8 tt -119.23 139.2 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.565 -0.709 . . . . 64.14 109.579 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 32.0 mt -126.36 125.17 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.8 -0.815 . . . . 71.22 108.8 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -142.49 151.36 41.6 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.235 -1.024 . . . . 64.22 108.235 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 16.9 tptm 60.11 8.16 1.42 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.572 -0.851 . . . . 72.02 109.07 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.41 -8.82 79.18 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.866 -1.294 . . . . 74.32 109.866 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 140' ' ' ARG . . . . . 0.505 ' CD ' ' N ' ' B' ' 140' ' ' ARG . 0.5 OUTLIER -90.53 141.25 28.95 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.113 -1.228 . . . . 75.34 109.214 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -97.8 129.87 44.77 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.27 -0.894 . . . . 71.23 109.632 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 47.7 t -138.43 132.51 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.389 -0.819 . . . . 70.43 109.075 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -87.1 143.72 27.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.205 -0.934 . . . . 72.43 109.727 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.48 132.28 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.337 -0.852 . . . . 72.13 109.388 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 145' ' ' LYS . . . . . 0.899 ' O ' ' HE2' ' B' ' 149' ' ' PHE . 0.0 OUTLIER -148.89 124.73 10.56 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.119 -0.988 . . . . 72.02 109.23 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 146' ' ' GLY . . . . . 0.765 ' N ' ' HD2' ' B' ' 149' ' ' PHE . . . 155.63 178.27 29.68 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.532 -1.427 . . . . 42.23 109.532 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 147' ' ' LYS . . . . . 0.62 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 26.5 mtpt -70.88 -35.85 4.67 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.208 -1.172 . . . . 73.3 110.243 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 148' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 23.3 Cg_exo -63.49 -30.05 71.39 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.942 1.761 . . . . 71.33 111.772 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 149' ' ' PHE . . . . . 0.899 ' HE2' ' O ' ' B' ' 145' ' ' LYS . 0.2 OUTLIER -92.03 -28.22 17.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.404 -0.81 . . . . 74.23 109.079 -179.61 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -51.74 -35.89 45.11 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.363 -0.835 . . . . 72.34 109.802 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.527 HG13 ' N ' ' B' ' 152' ' ' LEU . 11.4 p -63.36 -41.28 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.162 -0.961 . . . . 73.35 109.398 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.553 HD13 ' O ' ' B' ' 152' ' ' LEU . 0.3 OUTLIER -58.5 -42.56 87.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.38 -0.825 . . . . 55.24 109.088 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 16.0 p -71.13 -34.3 70.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.085 -1.01 . . . . 70.01 110.218 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -59.13 -53.73 55.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.056 -1.027 . . . . 65.32 109.628 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.82 -23.57 61.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.946 -1.096 . . . . 71.54 109.526 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.38 -50.32 71.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.197 -0.94 . . . . 75.32 109.22 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 157' ' ' ARG . . . . . 0.483 ' C ' ' H ' ' B' ' 159' ' ' ARG . 13.8 mtp-105 -71.47 -47.61 54.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 73.32 108.851 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -75.84 32.76 0.12 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.507 -0.745 . . . . 74.14 109.013 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 159' ' ' ARG . . . . . 0.483 ' H ' ' C ' ' B' ' 157' ' ' ARG . 34.0 ptt180 -50.67 -33.94 24.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.423 -0.798 . . . . 61.41 110.389 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 160' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' B' ' 160' ' ' ASP . 18.4 p30 -121.49 79.25 1.52 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.33 -0.856 . . . . 72.1 109.697 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -171.72 156.5 4.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.305 -0.872 . . . . 72.25 109.644 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 162' ' ' ILE . . . . . 0.795 HD12 ' N ' ' B' ' 162' ' ' ILE . 1.9 mp -94.1 139.27 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.205 -0.935 . . . . 72.31 109.025 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 63.5 t -133.95 142.52 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.416 -0.802 . . . . 64.21 109.594 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 4.7 p -91.78 166.38 12.79 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.21 -0.931 . . . . 74.22 110.422 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -64.47 -46.09 84.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.511 -0.743 . . . . 65.31 109.987 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -57.97 -38.25 75.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 63.45 110.15 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 167' ' ' GLN . . . . . 0.423 ' O ' ' OD1' ' B' ' 170' ' ' ASP . 63.3 tp60 -58.56 -48.54 80.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 72.4 109.795 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 33.1 mt -60.17 -36.09 76.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.92 . . . . 72.32 109.551 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.546 HD23 ' C ' ' B' ' 169' ' ' LEU . 3.6 tt -55.9 -68.89 0.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.364 -0.835 . . . . 73.34 109.756 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 170' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' B' ' 167' ' ' GLN . 26.4 p30 -64.37 -11.19 30.16 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.473 -0.767 . . . . 72.1 110.802 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.57 -58.5 3.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.979 -1.076 . . . . 62.13 110.224 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 0.684 ' N ' HD12 ' B' ' 172' ' ' ILE . 2.0 mp -94.38 -50.4 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.018 -1.051 . . . . 71.42 109.47 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 173' ' ' TRP . . . . . 0.441 ' O ' ' O ' ' B' ' 169' ' ' LEU . 16.1 m-90 . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.297 -0.877 . . . . 72.23 109.452 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo . . . . . 0 N--CA 1.495 1.606 0 CA-C-O 121.33 0.471 . . . . 65.22 111.989 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -72.23 -0.79 12.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 72.31 109.624 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 83.0 t -65.19 -29.01 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.257 -0.902 . . . . 63.32 109.66 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 61.7 mt -53.3 -40.71 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 75.03 110.102 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 185' ' ' GLU . . . . . 0.583 ' O ' ' ND2' ' B' ' 189' ' ' ASN . 22.6 mt-10 -56.17 -37.39 69.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.041 -1.037 . . . . 64.11 108.881 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.92 -54.63 9.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.452 -0.78 . . . . 73.0 109.765 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -54.28 -36.96 64.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.274 -0.892 . . . . 61.12 110.465 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 188' ' ' ILE . . . . . 0.439 ' CG2' ' N ' ' B' ' 189' ' ' ASN . 7.7 tp -75.38 -43.54 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.681 -1.262 . . . . 72.43 109.667 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 189' ' ' ASN . . . . . 0.583 ' ND2' ' O ' ' B' ' 185' ' ' GLU . 51.8 m-20 -61.65 -38.14 86.63 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.218 -0.926 . . . . 65.14 109.271 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -72.3 -47.72 47.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.952 . . . . 63.24 109.615 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 191' ' ' ILE . . . . . 0.441 ' O ' ' SD ' ' B' ' 195' ' ' MET . 57.4 mt -55.29 -40.52 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.155 -0.966 . . . . 74.03 109.093 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -63.06 -43.36 98.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 72.24 109.654 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -73.25 -30.83 63.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 73.1 109.87 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -82.01 -19.92 39.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.303 -0.873 . . . . 72.11 110.441 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 195' ' ' MET . . . . . 0.563 ' N ' ' SD ' ' B' ' 195' ' ' MET . 0.1 OUTLIER -99.7 -36.16 9.57 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.142 -0.974 . . . . 44.33 109.85 -179.666 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 196' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 58.2 p-10 -68.14 -19.57 64.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.086 -1.009 . . . . 71.21 110.113 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 197' ' ' LYS . . . . . 0.533 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 27.4 mttm -80.41 -64.87 0.29 Allowed Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.029 -1.045 . . . . 75.21 109.87 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 198' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 33.0 Cg_endo -61.9 -55.2 1.15 Allowed 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.314 2.009 . . . . 75.32 112.442 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 199' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' B' ' 201' ' ' ILE . 15.5 mt -64.53 -37.03 86.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.084 -1.01 . . . . 72.25 109.627 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 74.09 -31.33 0.94 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.581 -1.408 . . . . 64.53 109.581 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 201' ' ' ILE . . . . . 0.476 ' H ' ' C ' ' B' ' 199' ' ' LEU . 66.4 mt -96.78 142.51 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.226 -1.161 . . . . 44.23 109.341 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 79.8 p -94.56 146.91 23.78 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.266 -0.896 . . . . 54.01 109.595 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 22.7 p -143.36 11.9 1.73 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.252 -0.905 . . . . 74.4 109.075 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.405 ' O ' HG23 ' B' ' 204' ' ' VAL . 16.1 m -135.59 133.85 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.472 -0.767 . . . . 72.12 109.242 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -115.87 132.88 56.51 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.626 -0.671 . . . . 65.41 109.287 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.5 137.57 33.47 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.208 -0.932 . . . . 71.33 109.062 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.573 HG22 ' H ' ' B' ' 209' ' ' ARG . 7.9 p -124.55 145.7 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.584 -0.697 . . . . 63.5 109.561 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -71.0 -11.53 61.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 74.45 109.904 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 209' ' ' ARG . . . . . 0.573 ' H ' HG22 ' B' ' 207' ' ' VAL . 70.0 ttt-85 -69.1 -108.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.126 -0.984 . . . . 74.14 109.623 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -146.83 121.4 9.76 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.827 -1.171 . . . . 74.43 109.853 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 94.47 171.84 37.98 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.68 -0.968 . . . . 64.45 110.68 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -115.74 171.34 7.81 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.213 -1.032 . . . . 74.21 108.213 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -132.24 132.64 43.27 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.215 -0.928 . . . . 74.03 109.597 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -113.35 123.46 50.17 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.978 -0.749 . . . . 74.34 108.978 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 2.2 p -139.92 164.34 30.26 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.447 -0.783 . . . . 64.33 109.044 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -61.87 149.78 84.5 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 70.04 109.104 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -38.52 133.82 0.89 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.144 1.896 . . . . 65.11 112.277 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 35.1 tttp . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.167 -0.958 . . . . 73.15 110.772 179.893 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.445 ' SD ' ' OD2' ' A' ' 46' ' ' ASP . 32.2 tpp . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.318 0.58 . . . . 65.12 109.441 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.572 ' NH2' ' CB ' ' A' ' 28' ' ' ASP . 75.5 ttt-85 -143.0 135.82 27.83 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.267 -0.895 . . . . 72.33 109.267 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.7 t -110.97 133.6 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.653 -0.654 . . . . 71.42 109.405 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.738 HD12 ' N ' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -113.88 120.29 40.21 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.752 -0.833 . . . . 65.12 108.752 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.738 ' N ' HD12 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -121.82 119.92 33.07 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.396 -0.965 . . . . 62.43 108.396 179.37 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.566 HG12 HD11 ' A' ' 4' ' ' LEU . 7.1 mt -97.31 130.38 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.25 -0.906 . . . . 71.15 109.351 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 13' ' ' GLY . 10.8 pt-20 -171.57 -22.17 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.226 -0.921 . . . . 75.34 110.719 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt 69.18 -38.38 0.4 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.278 -0.889 . . . . 72.44 109.769 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.484 ' H ' ' C ' ' A' ' 7' ' ' GLU . 26.8 m120 -64.88 103.12 0.67 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.143 -0.973 . . . . 63.02 109.419 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.1 m -61.15 -24.87 66.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.878 . . . . 72.34 109.633 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.9 t -70.03 -53.67 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.946 . . . . 74.02 109.728 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.578 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.4 mm? -69.07 -36.76 77.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 71.43 109.35 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.512 ' N ' ' OE1' ' A' ' 7' ' ' GLU . . . -73.42 -28.03 66.61 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.481 -1.848 . . . . 61.32 108.481 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.38 -50.72 60.22 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.449 -1.46 . . . . 71.2 109.449 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.414 ' H ' ' HG2' ' A' ' 15' ' ' GLU . 7.4 pt-20 -61.32 -45.99 92.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.347 -1.09 . . . . 71.32 109.76 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.7 mm -64.99 -37.11 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.751 -1.218 . . . . 63.23 108.68 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.475 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 84.1 tt0 -66.14 -47.03 75.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.368 -0.833 . . . . 51.11 109.794 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -85.24 2.98 41.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.098 -1.001 . . . . 73.34 109.324 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.85 -55.84 2.33 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.502 -1.439 . . . . 62.15 109.502 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 27' ' ' ALA . 1.4 pt? -74.24 -21.87 59.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -1.124 . . . . 73.51 109.812 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 96.2 m-20 -54.07 -33.26 57.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.119 -0.988 . . . . 74.25 109.448 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.7 t -58.33 -47.08 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 70.04 108.959 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -59.98 -53.8 53.62 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.897 -0.779 . . . . 73.23 108.897 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 135.03 22.29 0.66 Allowed Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.761 -1.336 . . . . 75.54 109.761 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -98.86 160.37 14.31 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.218 -1.166 . . . . 73.43 109.424 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.2 mmm -100.97 139.31 36.84 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.601 -0.888 . . . . 43.24 108.601 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.443 ' HB1' HD21 ' A' ' 5' ' ' LEU . . . -127.75 154.28 45.56 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.577 -0.702 . . . . 62.11 109.783 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.572 ' CB ' ' NH2' ' A' ' 2' ' ' ARG . 24.2 t70 -142.6 132.24 23.92 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.71 -0.848 . . . . 74.42 108.71 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.7 m -100.22 130.52 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.907 . . . . 72.15 108.879 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.4 p -120.62 158.19 27.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.608 -0.683 . . . . 71.42 109.223 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -89.32 -94.29 0.11 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.397 -0.814 . . . . 72.33 109.605 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.2 p -79.29 152.49 30.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.205 -0.934 . . . . 74.24 110.022 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.557 ' H ' HD12 ' A' ' 33' ' ' LEU . 2.3 mp -55.98 -37.34 68.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.49 -0.756 . . . . 71.53 109.795 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.54 -40.78 92.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 74.23 109.658 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -66.52 -40.37 89.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 54.03 109.331 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.31 -38.51 81.47 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.422 -1.471 . . . . 61.41 109.422 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -65.32 -39.93 93.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.378 -1.071 . . . . 74.34 109.523 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -78.94 -39.14 35.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.121 -0.987 . . . . 75.33 109.616 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.4 tt -67.74 -41.61 83.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.31 -0.869 . . . . 74.33 109.778 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.539 ' SD ' ' CE2' ' A' ' 45' ' ' TYR . 3.2 ppp? -74.83 -23.22 58.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.1 -1.0 . . . . 70.32 109.674 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -54.13 -37.27 64.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.117 -0.989 . . . . 71.22 109.891 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.405 HG12 ' H ' ' A' ' 42' ' ' ILE . 9.5 pt -84.94 -33.35 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.154 -0.966 . . . . 74.14 110.148 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 40' ' ' MET . 97.2 mtt180 -95.86 167.11 11.46 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.058 -1.026 . . . . 72.24 109.933 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.409 ' C ' ' CD2' ' A' ' 45' ' ' TYR . 30.4 m120 -79.8 -174.95 4.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.127 -0.983 . . . . 75.42 109.056 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.539 ' CE2' ' SD ' ' A' ' 40' ' ' MET . 1.4 p90 -173.96 134.4 0.46 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.044 -1.035 . . . . 74.23 109.861 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.445 ' OD2' ' SD ' ' A' ' 1' ' ' MET . 87.2 m-20 -120.89 -51.95 2.12 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.485 -0.932 . . . . 72.04 108.485 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.569 HD13 ' C ' ' A' ' 47' ' ' LEU . 1.7 tm? -106.32 111.1 23.54 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.049 -1.093 . . . . 72.13 108.049 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.467 ' N ' HD13 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -109.22 101.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.599 -0.889 . . . . 72.34 108.599 179.36 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 7.7 ttt -105.39 140.3 38.72 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.458 -0.942 . . . . 74.11 108.458 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -140.04 129.31 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 61.12 109.847 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.7 m -109.79 9.06 24.79 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.827 -0.805 . . . . 73.11 108.827 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -77.45 159.66 29.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.376 -0.828 . . . . 52.55 109.933 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.494 ' C ' ' H ' ' A' ' 55' ' ' ALA . 62.5 mttp -81.86 173.15 12.53 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.714 -0.847 . . . . 44.22 108.714 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 56.2 5.94 0.21 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.117 -0.989 . . . . 70.44 108.916 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -68.65 -26.92 65.56 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.41 -0.806 . . . . 64.14 109.586 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.604 HD13 HE22 ' A' ' 89' ' ' GLN . 43.7 mt -45.14 -42.79 9.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.401 -0.812 . . . . 44.14 110.19 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.3 m -70.56 -37.38 73.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.999 -1.063 . . . . 55.23 109.819 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.572 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 85.0 t80 -64.76 -46.87 80.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 74.44 110.313 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.9 m -62.97 -36.92 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.654 -1.279 . . . . 74.03 109.555 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.8 t -55.84 -52.63 63.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.252 -0.905 . . . . 64.3 109.66 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -65.63 -32.71 74.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.127 -0.983 . . . . 64.44 109.987 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.572 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 5.2 mm -64.47 -35.89 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.871 -1.143 . . . . 63.21 109.63 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.544 ' HZ2' ' C ' ' A' ' 90' ' ' GLY . 26.6 mmtp -68.97 -50.87 45.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 74.42 110.262 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.438 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 15.7 pt-20 -70.1 -42.93 72.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.927 -1.108 . . . . 70.32 110.084 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.477 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 67.3 mttm -70.12 -24.6 63.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.94 . . . . 75.22 109.593 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.542 ' O ' HG22 ' A' ' 69' ' ' ILE . 96.1 m-70 -155.85 64.2 0.59 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.921 . . . . 74.13 109.371 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.501 ' N ' ' O ' ' A' ' 63' ' ' LYS . 84.4 p -57.26 -25.48 59.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.306 -0.871 . . . . 73.24 109.763 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.5 t -75.34 45.61 0.3 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 61.01 109.89 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.542 HG22 ' O ' ' A' ' 66' ' ' HIS . 13.7 tt -145.72 158.18 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.089 -1.007 . . . . 71.33 109.645 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.5 t -94.23 149.83 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.16 -0.962 . . . . 72.13 108.687 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.526 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 11.2 t -138.09 124.96 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.205 -0.934 . . . . 54.21 109.387 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 mp -124.8 99.52 6.19 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.686 -0.857 . . . . 50.24 108.686 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.47 HG22 ' N ' ' A' ' 74' ' ' SER . 10.4 p -86.89 160.14 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.183 -0.948 . . . . 74.41 108.891 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.47 ' N ' HG22 ' A' ' 73' ' ' VAL . 19.8 m -135.5 160.36 38.71 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.371 -0.831 . . . . 72.31 109.631 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 74' ' ' SER . 70.3 m -168.57 154.74 6.95 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.275 -0.891 . . . . 64.54 110.133 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 0.4 OUTLIER -94.71 8.3 42.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.406 -0.809 . . . . 74.13 109.945 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' A' ' 79' ' ' THR . 18.3 t-20 -129.19 56.68 25.31 Favored Pre-proline 0 N--CA 1.502 2.14 0 O-C-N 121.358 -0.839 . . . . 73.34 110.109 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.6 84.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.349 2.033 . . . . 63.22 111.913 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.43 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 42.5 m -114.03 150.17 34.32 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.741 -0.837 . . . . 62.53 108.741 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.07 -32.86 23.39 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.214 -0.929 . . . . 73.44 109.432 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.434 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 97.4 mt-10 -59.45 -36.73 76.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 71.42 109.69 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 84.9 tt0 -75.84 -33.3 60.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.147 -0.971 . . . . 73.43 109.804 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.43 ' OE2' ' O ' ' A' ' 79' ' ' THR . 0.9 OUTLIER -68.69 -50.16 53.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.099 -1.001 . . . . 74.22 109.893 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.52 HG23 ' N ' ' A' ' 85' ' ' HIS . 34.6 m -63.21 -42.95 98.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.027 -1.046 . . . . 73.2 109.615 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.52 ' N ' HG23 ' A' ' 84' ' ' VAL . 56.1 m80 -74.11 -25.44 59.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 53.33 109.78 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 82' ' ' GLU . . . -65.43 -44.05 88.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.108 -0.995 . . . . 64.11 109.776 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.445 ' CZ ' ' HB1' ' B' ' 111' ' ' ALA . 66.4 t80 -81.49 -34.01 31.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.011 -1.055 . . . . 74.34 109.027 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -68.1 -51.35 47.44 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.349 -0.844 . . . . 74.42 109.261 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.604 HE22 HD13 ' A' ' 56' ' ' LEU . 95.7 mt-30 -61.2 -50.24 73.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.487 -0.758 . . . . 74.24 109.704 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.544 ' C ' ' HZ2' ' A' ' 63' ' ' LYS . . . 147.64 71.08 0.01 OUTLIER Glycine 0 N--CA 1.495 2.587 0 C-N-CA 119.851 -1.166 . . . . 61.51 110.357 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -139.81 140.01 36.52 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.186 -1.185 . . . . 55.33 109.092 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 57.3 m-20 -83.76 -39.87 19.52 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.056 -1.028 . . . . 73.42 109.492 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 73.1 m-20 -150.29 164.15 36.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -0.879 . . . . 75.04 109.223 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.438 ' CE1' ' O ' ' A' ' 95' ' ' ILE . 1.6 t80 -135.77 132.34 36.66 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.46 -0.775 . . . . 71.33 109.315 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.438 ' O ' ' CE1' ' A' ' 94' ' ' TYR . 26.1 mm -115.05 148.26 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 121.453 -0.779 . . . . 71.13 110.076 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.32 121.31 16.64 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.975 -1.491 . . . . 64.32 106.975 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.705 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.5 OUTLIER -43.66 -58.4 4.56 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.057 -1.027 . . . . 62.2 111.649 -178.272 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 7.5 Cg_endo -43.97 0.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 121.419 1.412 . . . . 73.11 113.695 -175.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.705 ' N ' ' O ' ' A' ' 97' ' ' LYS . 51.5 m-85 58.21 116.04 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.681 -0.637 . . . . 65.22 109.761 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.522 ' NE ' ' OE2' ' B' ' 83' ' ' GLU . 12.6 ttm-85 -73.63 -33.93 64.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 72.35 109.775 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.75 ' O ' ' N ' ' A' ' 103' ' ' LYS . 30.5 t -172.68 26.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.856 -1.153 . . . . 71.32 111.139 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 87.2 mt 51.13 -70.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.519 -0.738 . . . . 75.43 110.357 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.75 ' N ' ' O ' ' A' ' 101' ' ' SER . 30.5 mmtm -56.07 -30.05 61.41 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.162 -1.051 . . . . 71.41 108.162 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.4 -47.75 84.24 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.392 -0.966 . . . . 63.24 108.392 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.724 HD13 ' N ' ' A' ' 106' ' ' VAL . 0.7 OUTLIER -64.63 -56.04 16.38 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.953 -0.758 . . . . 73.22 108.953 179.602 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.724 ' N ' HD13 ' A' ' 105' ' ' LEU . 63.5 t -51.45 -40.55 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.74 -1.225 . . . . 60.11 109.018 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.21 -32.83 68.66 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.223 -0.923 . . . . 70.42 108.727 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 -77.96 -24.13 48.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -0.839 . . . . 74.41 110.333 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 81.7 mt -75.68 -38.98 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.801 -1.187 . . . . 62.54 108.869 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 114' ' ' ARG . 24.3 pt-20 -76.63 -32.5 58.06 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.298 -0.876 . . . . 74.34 109.605 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.49 -50.2 72.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.412 -0.805 . . . . 73.32 109.748 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -64.78 -46.07 83.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 52.41 109.495 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.6 mt -97.85 26.06 5.45 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.218 -0.926 . . . . 65.24 109.731 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 110' ' ' GLU . 0.8 OUTLIER -60.92 -53.13 61.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 64.45 109.383 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -86.62 50.85 2.08 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.176 -0.952 . . . . 74.43 109.412 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -88.28 132.4 34.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.247 -0.908 . . . . 74.42 109.869 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 118.99 92.3 1.44 Allowed Glycine 0 N--CA 1.501 2.972 0 N-CA-C 109.65 -1.38 . . . . 75.04 109.65 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 79.7 p -166.7 160.49 14.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.093 -1.239 . . . . 61.14 109.979 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 121' ' ' ILE . 8.2 t30 -146.06 142.82 28.95 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.51 -0.922 . . . . 65.24 108.51 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.2 t -93.54 -45.73 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.016 -1.053 . . . . 73.11 110.564 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.521 ' O ' ' ND2' ' A' ' 119' ' ' ASN . 12.4 mm -93.56 114.98 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 120.841 -1.162 . . . . 72.24 109.624 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -118.83 124.9 48.31 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.915 -0.772 . . . . 72.34 108.915 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.681 HG23 ' O ' ' A' ' 123' ' ' ILE . 5.9 tt -149.88 102.73 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.039 -1.038 . . . . 71.44 109.682 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 62.73 -135.6 44.17 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.198 -1.161 . . . . 73.4 110.198 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -87.74 -3.4 58.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.457 -1.025 . . . . 74.45 109.878 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.0 131.0 42.84 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.225 -0.922 . . . . 54.21 108.865 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.54 137.33 49.66 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.756 -0.831 . . . . 54.5 108.756 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.412 ' H ' HD21 ' A' ' 119' ' ' ASN . 56.4 mt -131.17 127.88 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.473 -0.767 . . . . 45.15 109.204 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.52 103.15 50.23 Favored Pre-proline 0 N--CA 1.494 1.766 0 N-CA-C 109.059 -0.719 . . . . 71.11 109.059 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.76 -24.95 5.65 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.795 1.663 . . . . 65.41 111.781 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -62.54 -55.8 23.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.471 -0.768 . . . . 63.32 109.863 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -94.68 12.54 27.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.29 -0.881 . . . . 72.52 109.31 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 49.61 57.91 6.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 75.33 109.18 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 26.0 ttpt -133.89 132.84 40.79 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.556 -0.715 . . . . 71.23 109.673 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.9 tt -109.74 137.17 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 109.138 -0.689 . . . . 74.02 109.138 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 70.5 mt -121.27 118.9 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.495 -0.753 . . . . 60.23 109.193 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.42 ' C ' ' H ' ' A' ' 139' ' ' GLY . 65.3 t80 -142.76 151.3 41.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.349 -0.844 . . . . 62.32 108.978 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 1.047 ' HZ3' ' HB3' ' A' ' 138' ' ' LYS . 0.0 OUTLIER 61.37 5.75 1.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.942 -1.099 . . . . 75.4 108.239 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 137' ' ' TYR . . . 86.12 13.04 69.61 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.091 -1.603 . . . . 72.24 109.091 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -103.44 142.79 33.64 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.589 -0.948 . . . . 71.22 108.782 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -107.97 116.11 31.36 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.05 -1.031 . . . . 71.42 108.823 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.14 138.48 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.437 -0.789 . . . . 53.02 109.066 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -82.29 147.86 28.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.401 -0.812 . . . . 60.45 109.931 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.4 HG23 ' CE2' ' A' ' 149' ' ' PHE . 2.1 m -146.38 125.0 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.368 -0.833 . . . . 74.44 109.489 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -158.01 134.37 9.52 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.445 -0.784 . . . . 65.15 109.184 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.13 -162.93 36.72 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.066 -1.214 . . . . 73.34 110.066 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.627 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 49.9 mtmt -82.49 -30.61 0.51 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.443 -1.034 . . . . 72.22 111.626 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 90.1 Cg_endo -86.94 -25.02 1.22 Allowed 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 121.801 1.667 . . . . 65.23 112.562 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.479 ' CE2' HG23 ' A' ' 153' ' ' THR . 85.7 t80 -89.15 -12.92 39.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.158 -0.964 . . . . 60.11 109.802 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -61.11 -38.27 85.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.1 -1.0 . . . . 64.21 109.422 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.34 -28.96 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 72.02 109.0 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.3 OUTLIER -61.18 -44.45 97.28 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.94 -0.763 . . . . 73.31 108.94 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.479 HG23 ' CE2' ' A' ' 149' ' ' PHE . 1.9 p -74.09 -37.9 64.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.206 -0.934 . . . . 74.31 110.231 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -54.76 -55.13 33.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.934 -1.104 . . . . 74.31 109.82 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.756 HD12 ' N ' ' A' ' 156' ' ' ALA . 4.6 pp -66.92 -33.47 75.67 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.207 -0.933 . . . . 75.34 109.197 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.756 ' N ' HD12 ' A' ' 155' ' ' LEU . . . -51.16 -41.24 60.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.192 -0.943 . . . . 62.14 108.949 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 159' ' ' ARG . 62.6 mtp180 -89.06 -48.95 7.06 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.143 -0.973 . . . . 61.03 108.922 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -73.09 35.03 0.08 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.389 -0.819 . . . . 74.12 109.611 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.48 ' H ' ' C ' ' A' ' 157' ' ' ARG . 27.9 ptt180 -72.16 171.1 12.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.34 -0.85 . . . . 71.13 109.347 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.6 t70 52.51 44.04 30.42 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.192 -0.942 . . . . 75.45 109.609 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -148.25 162.92 38.51 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.181 -0.949 . . . . 73.41 109.448 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.6 mt -93.37 119.34 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.218 -0.926 . . . . 74.41 108.649 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 10.8 t -99.89 122.39 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.251 -0.905 . . . . 72.31 109.675 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.2 p -84.07 164.68 19.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 74.12 108.911 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -63.27 -43.75 97.06 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.178 -0.951 . . . . 70.43 109.39 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.432 ' O ' ' OD2' ' A' ' 170' ' ' ASP . 49.0 mt-10 -72.12 -29.24 63.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 73.52 110.16 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -57.32 -57.14 13.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.961 . . . . 74.52 110.037 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 169' ' ' LEU . 2.2 pp -67.81 -36.52 80.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.974 -1.079 . . . . 72.31 110.056 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.651 HD13 ' C ' ' A' ' 169' ' ' LEU . 3.1 tm? -55.18 -52.91 61.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.927 -1.108 . . . . 53.33 108.867 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' A' ' 166' ' ' GLU . 2.6 p30 -72.38 -28.61 63.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.207 -0.933 . . . . 62.44 110.111 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -53.77 -52.16 61.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.149 -0.969 . . . . 60.21 110.358 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 12.8 mm -91.53 -28.92 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.071 -1.018 . . . . 75.32 110.015 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 16.2 m-90 . . . . . 0 N--CA 1.498 1.957 0 O-C-N 121.409 -0.807 . . . . 73.14 109.432 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.989 ' ND2' ' OE1' ' A' ' 185' ' ' GLU . 53.2 t-20 . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 121.321 0.581 . . . . 64.54 110.274 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 183' ' ' VAL . 96.2 t -123.66 -13.77 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.567 -0.901 . . . . 74.02 108.567 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 96.0 mt -61.99 -42.44 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.464 -0.772 . . . . 72.33 109.832 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.989 ' OE1' ' ND2' ' A' ' 182' ' ' ASN . 11.5 pt-20 -51.48 -37.87 51.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.896 -1.128 . . . . 74.4 109.121 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 36.0 t -73.11 -32.33 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.452 -0.78 . . . . 70.42 109.372 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -79.33 -56.86 4.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.22 -0.925 . . . . 52.11 110.457 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.439 HG23 ' N ' ' A' ' 189' ' ' ASN . 3.4 tp -55.59 -39.01 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.858 -1.151 . . . . 71.4 109.776 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.449 ' ND2' ' OE1' ' A' ' 193' ' ' GLN . 4.3 t30 -67.68 -54.68 17.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.335 -0.853 . . . . 73.44 111.779 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -62.26 -31.72 72.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.835 -1.166 . . . . 71.42 111.412 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 47.1 pt -69.15 -38.14 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.201 -1.562 . . . . 61.55 109.937 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.64 -42.21 99.47 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 117.986 -1.486 . . . . 63.34 108.238 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.449 ' OE1' ' ND2' ' A' ' 189' ' ' ASN . 23.0 mt-30 -64.52 -34.26 77.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.552 -0.718 . . . . 61.24 110.167 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.489 ' O ' ' CG ' ' A' ' 198' ' ' PRO . 15.0 mtpp -75.19 -25.71 58.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.155 -0.966 . . . . 75.13 110.634 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 74.8 mtm -95.97 4.38 52.74 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.972 -1.08 . . . . 74.02 109.475 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -113.67 -12.88 12.76 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.579 -0.7 . . . . 74.02 110.636 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.577 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 20.5 tttt -98.28 -41.04 0.24 Allowed Pre-proline 0 N--CA 1.502 2.132 0 O-C-N 120.949 -1.094 . . . . 75.43 110.87 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 85.5 Cg_endo -93.3 -64.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.906 2.404 . . . . 72.32 112.999 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 45.8 mt -50.18 -35.86 28.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.1 -1.0 . . . . 74.54 109.353 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 87.17 -9.75 71.47 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.761 -1.336 . . . . 61.51 109.761 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 17.2 mt -132.9 127.57 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.482 -1.01 . . . . 61.22 109.533 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.8 t -78.67 133.1 37.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.316 -0.865 . . . . 72.0 109.199 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.6 p -118.62 34.0 5.4 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.515 -0.74 . . . . 74.44 110.503 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 6.4 m -143.27 139.39 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.976 -1.078 . . . . 64.35 110.002 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -126.01 133.44 51.76 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.109 -0.7 . . . . 71.41 109.109 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.56 133.52 34.14 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.082 -1.011 . . . . 73.52 108.962 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 10.4 p -128.54 137.23 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.52 -0.738 . . . . 71.02 109.179 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -92.79 60.37 3.4 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.205 -0.934 . . . . 72.12 109.369 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.16 -61.51 0.32 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.497 -0.927 . . . . 64.41 108.497 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -104.43 -65.39 1.03 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.592 -0.692 . . . . 71.54 109.278 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -171.75 -105.86 0.19 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.347 -1.501 . . . . 72.03 109.347 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.34 123.38 39.27 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.456 -1.026 . . . . 75.54 108.632 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -89.51 146.49 24.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.367 -0.833 . . . . 75.31 110.963 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.609 ' CE2' HD13 ' A' ' 155' ' ' LEU . 11.5 t80 -123.57 114.4 19.99 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.502 -0.925 . . . . 75.41 108.502 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 18.5 p -140.45 159.41 42.27 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.385 -0.822 . . . . 74.14 109.077 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -59.04 142.47 85.4 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.079 -1.013 . . . . 75.32 108.729 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 C--N 1.313 -1.304 0 C-N-CA 122.085 1.857 . . . . 73.11 112.065 179.678 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.413 -0.588 . . . . 71.14 109.413 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 51.4 ttt85 -139.98 155.07 47.29 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.351 -0.843 . . . . 73.23 109.279 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 83.4 t -113.23 122.13 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.59 0.709 . . . . 72.24 109.73 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.541 HD11 ' CG1' ' B' ' 6' ' ' ILE . 2.6 tp -91.71 117.64 29.94 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.367 -0.975 . . . . 54.33 108.367 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.506 HD23 ' N ' ' B' ' 6' ' ' ILE . 4.2 tt -118.95 120.15 36.42 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.437 -0.949 . . . . 74.35 108.437 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.541 ' CG1' HD11 ' B' ' 4' ' ' LEU . 19.0 mt -115.78 99.53 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.438 -0.789 . . . . 42.55 109.195 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.425 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 30.1 tp10 -125.17 139.64 53.57 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.578 -0.701 . . . . 74.52 109.295 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.443 ' NZ ' ' OD1' ' B' ' 52' ' ' ASP . 39.2 mmtm -70.39 -34.29 72.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.922 . . . . 62.55 109.374 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -90.72 118.89 30.5 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.284 -0.885 . . . . 73.11 109.576 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 18.9 t -70.37 -32.06 69.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.927 . . . . 65.54 109.56 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 82.7 t -64.27 -53.25 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.917 . . . . 75.55 109.734 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.512 HD13 ' O ' ' B' ' 12' ' ' LEU . 0.2 OUTLIER -64.21 -37.63 88.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.909 . . . . 70.14 109.003 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.05 -26.72 73.94 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.487 -1.845 . . . . 75.4 108.487 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.96 -54.2 32.25 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 109.623 -1.391 . . . . 65.44 109.623 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' B' ' 15' ' ' GLU . 7.2 pt-20 -58.3 -44.2 88.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.333 -1.098 . . . . 60.21 109.677 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.484 ' CD1' HD12 ' B' ' 102' ' ' ILE . 39.3 mm -64.33 -43.81 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.917 -1.114 . . . . 75.15 108.725 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -61.3 -43.53 98.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.411 -0.806 . . . . 73.01 109.816 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.405 ' HB3' ' HZ2' ' B' ' 18' ' ' LYS . 16.3 mtpp -87.06 2.45 49.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.098 -1.001 . . . . 74.3 109.444 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.73 -53.27 2.61 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.433 -1.467 . . . . 70.54 109.433 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -76.13 -20.09 57.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.314 -1.109 . . . . 71.34 109.704 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -58.59 -30.59 67.31 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.06 -1.025 . . . . 64.41 109.256 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 82.9 t -60.29 -34.66 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.355 -0.84 . . . . 74.23 109.114 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -68.55 -4.69 16.12 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.336 -0.852 . . . . 63.42 109.067 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.82 39.97 7.34 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.092 -1.203 . . . . 53.43 110.092 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -119.84 159.34 24.78 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.536 -0.979 . . . . 71.12 109.321 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 7.1 mmt -105.19 133.37 50.08 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.242 -1.022 . . . . 75.24 108.242 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.07 162.46 36.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.173 -0.954 . . . . 72.12 110.239 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -141.22 145.65 35.87 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.459 -0.776 . . . . 72.31 108.952 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -106.72 137.64 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.309 -0.869 . . . . 64.43 108.79 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 11.3 p -136.41 167.79 20.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.366 -0.834 . . . . 65.41 109.289 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.477 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 2.2 pt-20 -90.22 -100.05 0.1 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.153 -0.967 . . . . 71.02 109.898 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 32.8 t -78.96 166.21 22.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.958 . . . . 51.11 110.236 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 44.1 mt -53.91 -32.97 55.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.633 -0.667 . . . . 71.24 109.829 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -50.43 -48.31 56.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.121 -0.987 . . . . 74.32 109.695 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.477 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 65.9 m-20 -69.28 -41.33 76.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.169 -0.957 . . . . 73.03 109.501 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.18 -40.7 87.8 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.464 -1.454 . . . . 30.21 109.464 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -68.6 -42.69 77.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -1.151 . . . . 74.42 109.543 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' TYR . . . . . 0.448 ' O ' ' OD1' ' B' ' 41' ' ' ASP . 56.4 t80 -75.17 -21.9 58.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 74.42 110.053 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 28.5 tp -90.01 -39.16 13.13 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.14 -0.975 . . . . 75.41 110.044 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' MET . . . . . 0.449 ' SD ' ' C ' ' B' ' 40' ' ' MET . 0.0 OUTLIER -78.13 -27.69 48.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.996 . . . . 60.41 110.528 -179.102 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' B' ' 42' ' ' ILE . 41.9 p-10 -68.02 -27.51 66.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.901 -1.124 . . . . 53.23 110.225 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.533 ' N ' ' OD1' ' B' ' 41' ' ' ASP . 13.8 pt -88.8 -15.47 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.004 -1.06 . . . . 71.23 110.419 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' B' ' 40' ' ' MET . 97.2 mtt180 -129.48 149.92 51.05 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.239 -0.913 . . . . 72.22 109.77 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -82.85 163.18 21.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.202 -0.937 . . . . 63.54 109.458 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 10.4 p90 -159.3 -179.04 7.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.92 . . . . 64.35 109.706 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -138.97 -32.85 0.66 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.475 -0.766 . . . . 62.22 109.428 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.501 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.3 OUTLIER -107.08 115.1 29.59 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.357 -0.839 . . . . 73.12 109.004 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.501 ' N ' HD13 ' B' ' 47' ' ' LEU . 56.0 t -102.55 98.01 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.51 -0.922 . . . . 65.11 108.51 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -117.06 129.07 55.76 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.776 0.798 . . . . 73.44 110.141 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.624 HG22 ' H ' ' B' ' 52' ' ' ASP . 0.2 OUTLIER -141.65 135.68 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.78 0.8 . . . . 34.5 109.179 -179.622 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 51' ' ' SER . . . . . 0.425 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 53.2 p -99.3 18.29 17.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.599 -0.688 . . . . 73.21 109.599 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.624 ' H ' HG22 ' B' ' 50' ' ' VAL . 37.6 m-20 -86.09 144.16 27.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.185 -0.947 . . . . 70.41 109.534 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.449 ' C ' ' H ' ' B' ' 55' ' ' ALA . 99.1 mttt -76.52 -42.6 42.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.276 -0.89 . . . . 65.0 110.201 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -71.01 10.72 0.5 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.108 -0.995 . . . . 75.21 109.727 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -67.13 -22.22 65.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 55.33 110.106 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.42 ' HG ' ' H ' ' B' ' 56' ' ' LEU . 19.0 mt -44.68 -44.93 9.47 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.268 -0.895 . . . . 63.14 110.142 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 93.1 p -69.39 -37.96 77.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.991 -1.068 . . . . 63.5 109.284 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -65.07 -62.28 1.65 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.279 -0.888 . . . . 72.33 109.656 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 33.3 m -49.55 -33.64 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.555 -1.341 . . . . 74.54 109.661 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 10.9 p -57.6 -51.26 70.23 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.202 -0.936 . . . . 71.24 109.472 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.418 ' HG2' ' H ' ' B' ' 61' ' ' ARG . 6.7 ptp180 -70.05 -31.24 68.77 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.177 -1.009 . . . . 74.31 110.176 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' B' ' 66' ' ' HIS . 40.0 mm -66.68 -44.97 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.683 -1.261 . . . . 72.14 110.285 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -65.09 -44.94 87.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.195 -0.941 . . . . 73.32 110.818 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -73.86 -38.0 64.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.743 -1.223 . . . . 73.12 110.036 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.486 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 64.2 mttm -84.71 -17.04 39.69 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.099 -1.0 . . . . 72.44 109.711 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.486 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 76.9 m-70 -155.63 68.72 0.66 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.053 -1.03 . . . . 63.31 109.618 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 85.6 p -67.6 -27.55 67.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.312 -0.867 . . . . 73.1 109.898 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 12.5 t -63.1 -19.22 64.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.148 -0.97 . . . . 71.53 110.069 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 63.1 mt -88.25 151.94 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.182 -0.949 . . . . 74.4 109.784 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.419 HG12 ' N ' ' B' ' 71' ' ' VAL . 94.3 t -90.96 157.62 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.41 -0.806 . . . . 75.12 109.277 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.419 ' N ' HG12 ' B' ' 70' ' ' VAL . 11.0 t -135.7 126.79 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.218 -0.926 . . . . 73.2 109.864 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.555 ' C ' HD23 ' B' ' 72' ' ' LEU . 4.2 tt -116.88 105.32 12.23 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.787 -0.82 . . . . 73.34 108.787 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 71.1 t -98.06 131.23 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.033 -1.042 . . . . 73.5 109.541 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.9 p -95.23 169.26 10.21 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.239 -0.913 . . . . 64.34 109.137 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.474 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 36.2 t -157.19 117.02 3.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.007 -1.058 . . . . 74.53 110.292 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 76' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' B' ' 77' ' ' ASN . 52.8 p30 -71.28 -10.5 59.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.409 -0.807 . . . . 64.5 109.292 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' B' ' 79' ' ' THR . 84.5 m-20 -132.9 77.06 69.39 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 108.47 -0.937 . . . . 74.25 108.47 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -55.59 73.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.561 2.174 . . . . 74.43 111.894 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.542 HG23 ' H ' ' B' ' 82' ' ' GLU . 6.9 t -97.43 150.73 20.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.257 -0.902 . . . . 73.12 109.308 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -26.37 68.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.523 -0.736 . . . . 71.01 110.225 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' B' ' 81' ' ' GLU . 2.5 mp0 -64.27 -39.97 95.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.978 -1.076 . . . . 63.2 109.823 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 82' ' ' GLU . . . . . 0.542 ' H ' HG23 ' B' ' 79' ' ' THR . 0.1 OUTLIER -78.51 -29.11 46.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.086 -1.009 . . . . 73.22 109.627 -179.775 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.522 ' OE2' ' NE ' ' A' ' 100' ' ' ARG . 87.1 mt-10 -64.94 -48.29 74.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.034 -1.041 . . . . 74.3 109.659 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.479 HG23 ' N ' ' B' ' 85' ' ' HIS . 27.0 m -67.77 -42.65 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 73.31 109.485 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 85' ' ' HIS . . . . . 0.479 ' N ' HG23 ' B' ' 84' ' ' VAL . 42.4 m80 -69.2 -25.9 64.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.167 -0.958 . . . . 73.24 109.533 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -68.55 -45.57 71.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 55.33 109.846 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -79.35 -28.07 42.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.057 -1.027 . . . . 74.14 109.044 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 31.0 tp10 -75.98 -51.67 11.88 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.335 -0.853 . . . . 64.04 109.563 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -61.87 -50.42 72.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.414 -0.804 . . . . 72.35 109.745 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 151.75 72.81 0.01 OUTLIER Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.749 -1.215 . . . . 65.2 110.308 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 91' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -134.43 136.43 43.25 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.288 -1.125 . . . . 52.23 108.843 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -89.21 -23.15 22.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.09 -1.006 . . . . 73.32 109.56 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 93' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 11.2 t0 -152.03 163.57 39.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.277 -0.889 . . . . 72.22 109.358 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.518 ' N ' ' OD1' ' B' ' 93' ' ' ASP . 76.7 t80 -146.64 99.28 3.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.382 -0.823 . . . . 64.42 109.252 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 20.8 mm -106.37 151.01 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.388 0 O-C-N 121.227 -0.921 . . . . 72.23 109.961 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.15 139.28 57.47 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.991 -1.114 . . . . 25.24 107.991 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.656 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -58.38 -55.13 48.86 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 120.744 -1.222 . . . . 64.32 111.146 -179.067 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 98' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 3.5 Cg_endo -41.75 -12.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.188 0 CA-C-N 119.619 0.9 . . . . 63.33 112.383 -176.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 99' ' ' TYR . . . . . 0.656 ' N ' ' O ' ' B' ' 97' ' ' LYS . 51.0 m-85 57.87 104.33 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.865 -0.522 . . . . 75.13 110.256 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -55.52 -39.22 70.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.829 -1.169 . . . . 74.23 108.042 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 10.6 t -170.32 131.96 0.99 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.919 -0.771 . . . . 63.34 108.919 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' ILE . . . . . 0.484 HD12 ' CD1' ' B' ' 16' ' ' ILE . 4.1 mm -51.71 -41.61 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.951 . . . . 74.44 109.1 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -60.37 -36.34 77.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.228 -0.92 . . . . 71.11 109.264 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.41 -48.53 64.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 71.45 109.557 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 60.0 tp -60.96 -48.93 79.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 51.31 109.433 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.73 -43.83 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.167 -0.958 . . . . 65.23 110.028 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.27 -43.32 64.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.06 -1.025 . . . . 24.32 109.211 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -68.35 -33.77 74.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.337 -0.852 . . . . 75.31 109.606 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 95.3 mt -72.35 -34.51 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.054 -1.029 . . . . 54.24 108.571 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 110' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' B' ' 114' ' ' ARG . 80.6 tt0 -58.55 -56.82 17.17 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.575 -0.85 . . . . 65.31 108.987 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 111' ' ' ALA . . . . . 0.445 ' HB1' ' CZ ' ' A' ' 87' ' ' PHE . . . -54.85 -40.34 69.54 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.477 -0.764 . . . . 72.24 110.157 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 112' ' ' ARG . . . . . 0.401 HH12 ' HB2' ' B' ' 93' ' ' ASP . 0.0 OUTLIER -53.6 -38.28 63.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.995 -1.066 . . . . 72.04 108.896 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.86 54.22 1.05 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.987 -1.071 . . . . 75.35 109.942 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' B' ' 110' ' ' GLU . 4.9 tmt_? -72.06 -43.68 64.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.129 -0.982 . . . . 75.5 108.987 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 115' ' ' PHE . . . . . 0.488 ' O ' ' N ' ' B' ' 117' ' ' GLY . 96.2 m-85 -67.75 -0.84 4.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.332 -0.855 . . . . 65.33 109.502 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 66.01 -55.5 0.37 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.561 -0.712 . . . . 74.45 110.158 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 117' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' B' ' 115' ' ' PHE . . . -154.42 171.83 32.93 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.897 -1.281 . . . . 44.21 109.897 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 41.1 m -156.58 -175.51 5.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.38 -1.071 . . . . 71.4 109.662 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.15 122.95 5.73 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.822 -0.751 . . . . 72.32 109.112 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 9.9 t -85.15 -42.88 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.214 -0.929 . . . . 75.02 110.119 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 15.7 mm -97.11 132.66 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.07 -1.019 . . . . 51.41 109.819 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -114.0 121.46 43.96 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.987 -0.745 . . . . 71.53 108.987 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.551 ' CD1' HH12 ' B' ' 159' ' ' ARG . 73.4 mt -132.47 121.39 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.355 -0.841 . . . . 72.43 109.478 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 124' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' B' ' 123' ' ' ILE . . . 40.29 -122.61 2.01 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 110.518 -1.033 . . . . 51.23 110.518 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -97.1 -13.6 22.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.349 -1.089 . . . . 74.2 109.698 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' B' ' 123' ' ' ILE . 0.1 OUTLIER -95.45 143.41 26.81 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.127 -0.983 . . . . 75.42 109.406 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 20.3 p -121.27 145.79 47.49 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.101 -0.703 . . . . 74.22 109.101 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 78.0 mt -125.49 138.87 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.501 -0.749 . . . . 60.33 109.891 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 5.8 t -118.58 114.66 35.92 Favored Pre-proline 0 N--CA 1.499 1.997 0 N-CA-C 108.723 -0.843 . . . . 72.31 108.723 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.92 -53.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.651 1.567 . . . . 75.13 112.162 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -61.52 -40.82 96.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.163 -0.96 . . . . 75.23 109.459 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 132' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' B' ' 133' ' ' GLU . 23.7 tp10 -87.39 7.96 26.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.216 -0.928 . . . . 72.43 109.359 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 133' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' B' ' 132' ' ' GLU . 17.9 pt-20 34.33 54.06 0.6 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.252 0.549 . . . . 75.13 111.142 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -139.05 146.4 40.74 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.284 -0.885 . . . . 73.22 109.177 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 14.3 tt -126.11 142.39 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.543 -0.723 . . . . 64.14 109.1 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 7.2 mt -120.63 136.04 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.611 -0.681 . . . . 71.22 109.63 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -138.4 134.69 34.44 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.42 -0.955 . . . . 64.22 108.42 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 138' ' ' LYS . . . . . 0.443 ' CG ' ' O ' ' B' ' 138' ' ' LYS . 12.4 ttmt 56.41 9.34 0.52 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.465 -0.772 . . . . 72.02 109.361 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 96.7 3.62 59.44 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 110.225 -1.15 . . . . 74.32 110.225 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -89.5 126.39 35.57 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.114 -1.227 . . . . 75.34 108.803 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -91.85 120.32 32.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.248 -0.907 . . . . 71.23 109.683 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 7.9 p -134.69 140.95 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 108.777 -0.823 . . . . 70.43 108.777 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -94.01 157.84 15.91 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.188 -0.945 . . . . 72.43 110.241 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -150.28 139.05 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.455 -0.778 . . . . 72.13 108.934 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 26.3 pttt -165.89 77.94 0.26 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.184 -0.948 . . . . 72.02 109.543 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -156.99 -129.83 1.17 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.085 -1.606 . . . . 42.23 109.085 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 147' ' ' LYS . . . . . 0.632 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 73.2 mttt -80.32 -32.4 0.69 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.108 -1.231 . . . . 73.3 110.764 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 148' ' ' PRO . . . . . 0.632 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 71.5 Cg_endo -91.12 15.45 1.76 Allowed 'Trans proline' 0 N--CA 1.486 1.082 0 C-N-CA 122.203 1.935 . . . . 71.33 112.446 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -98.79 -59.13 1.79 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.238 -0.914 . . . . 74.23 109.345 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 150' ' ' GLU . . . . . 0.475 ' CG ' ' N ' ' B' ' 151' ' ' VAL . 18.6 pt-20 -61.09 -48.79 80.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.327 -0.858 . . . . 72.34 110.47 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.525 HG13 ' N ' ' B' ' 152' ' ' LEU . 9.8 p -64.84 -43.39 96.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.811 -1.181 . . . . 73.35 110.449 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.525 ' N ' HG13 ' B' ' 151' ' ' VAL . 12.9 tp -63.74 -53.62 48.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.14 -0.975 . . . . 55.24 110.518 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 16.5 p -72.23 -37.56 69.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.799 -1.188 . . . . 70.01 110.626 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -52.01 -53.49 41.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.76 -1.212 . . . . 65.32 109.706 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 155' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' B' ' 159' ' ' ARG . 2.7 pp -71.51 -23.09 61.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.93 -1.106 . . . . 71.54 109.865 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.66 -59.25 4.48 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.816 -1.177 . . . . 75.32 110.881 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -66.03 -47.73 73.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.601 -1.312 . . . . 73.32 108.84 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 158' ' ' HIS . . . . . 0.608 ' C ' ' H ' ' B' ' 160' ' ' ASP . 44.5 t-80 -67.51 -19.17 65.28 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.718 -1.216 . . . . 74.14 107.718 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 159' ' ' ARG . . . . . 0.723 ' O ' ' N ' ' B' ' 161' ' ' GLN . 7.2 tpt180 57.79 4.49 0.27 Allowed 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 107.287 -1.375 . . . . 61.41 107.287 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 160' ' ' ASP . . . . . 0.608 ' H ' ' C ' ' B' ' 158' ' ' HIS . 2.3 m-20 50.36 -40.22 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 123.228 0.611 . . . . 72.1 112.22 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 161' ' ' GLN . . . . . 0.723 ' N ' ' O ' ' B' ' 159' ' ' ARG . 76.8 mt-30 50.48 -142.63 0.65 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.215 -1.553 . . . . 72.25 109.138 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 162' ' ' ILE . . . . . 0.741 HD12 ' N ' ' B' ' 162' ' ' ILE . 1.9 mp -77.53 106.91 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.95 -1.094 . . . . 72.31 108.724 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 163' ' ' VAL . . . . . 0.588 HG13 ' O ' ' B' ' 160' ' ' ASP . 1.3 m -135.67 144.73 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.48 -0.763 . . . . 64.21 109.166 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 41.7 p -96.66 169.76 9.66 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.327 -0.858 . . . . 74.22 109.506 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -55.57 -39.68 70.98 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.297 -0.877 . . . . 65.31 109.168 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -62.74 -39.1 93.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.867 . . . . 63.45 109.313 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -60.13 -45.92 91.38 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.137 -0.977 . . . . 72.4 109.116 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 22.6 mt -61.94 -29.59 70.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.215 -0.928 . . . . 72.32 108.576 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.52 HD23 ' C ' ' B' ' 169' ' ' LEU . 5.6 tt -66.81 -64.86 0.77 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.467 -0.771 . . . . 73.34 109.303 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -61.36 -17.44 53.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.878 . . . . 72.1 109.713 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.72 -61.0 2.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.292 -0.88 . . . . 62.13 110.123 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 8.2 mm -90.91 -54.33 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.128 -0.983 . . . . 71.42 109.401 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.311 -0.868 . . . . 72.23 109.166 179.901 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo . . . . . 0 N--CA 1.501 1.918 0 CA-C-O 121.422 0.509 . . . . 65.22 112.674 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -174.86 -23.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.198 -0.939 . . . . 72.31 108.889 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 183' ' ' VAL . . . . . 0.43 ' O ' HG22 ' B' ' 186' ' ' VAL . 11.6 p -53.43 -14.47 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.397 -0.815 . . . . 63.32 109.401 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 20.9 mm -54.3 -25.74 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -0.879 . . . . 75.03 109.681 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -55.84 -45.4 78.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -0.952 . . . . 64.11 109.928 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 186' ' ' VAL . . . . . 0.435 HG22 ' H ' ' B' ' 186' ' ' VAL . 9.6 m -80.72 -30.39 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.131 -0.981 . . . . 73.0 110.105 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.97 76.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.95 -1.094 . . . . 61.12 109.938 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 188' ' ' ILE . . . . . 0.452 HG23 ' N ' ' B' ' 189' ' ' ASN . 10.4 tp -74.89 -38.9 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.554 -1.342 . . . . 72.43 109.83 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 189' ' ' ASN . . . . . 0.452 ' N ' HG23 ' B' ' 188' ' ' ILE . 21.7 t-20 -70.5 -35.99 73.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.878 . . . . 65.14 111.282 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 190' ' ' GLN . . . . . 0.458 ' CG ' ' N ' ' B' ' 191' ' ' ILE . 10.6 pt20 -76.67 -47.12 23.11 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.859 -1.151 . . . . 63.24 111.449 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 191' ' ' ILE . . . . . 0.458 ' N ' ' CG ' ' B' ' 190' ' ' GLN . 5.8 pt -65.0 -40.35 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.693 -1.255 . . . . 74.03 110.699 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -69.81 -42.97 72.98 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.026 -1.046 . . . . 72.24 111.005 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -74.21 -35.4 63.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.937 -1.102 . . . . 73.1 111.279 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 8.6 pttp -79.57 -24.35 42.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.82 -1.175 . . . . 72.11 110.54 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 195' ' ' MET . . . . . 0.483 ' SD ' ' OD1' ' B' ' 196' ' ' ASP . 3.5 ppp? -93.01 -38.2 11.78 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.0 -1.063 . . . . 44.33 110.519 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 196' ' ' ASP . . . . . 0.483 ' OD1' ' SD ' ' B' ' 195' ' ' MET . 85.3 m-20 -59.22 -38.23 79.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.035 -1.041 . . . . 71.21 110.646 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -63.28 -60.19 10.16 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.962 -1.086 . . . . 75.21 110.381 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 198' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.56 -59.58 0.24 Allowed 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 121.694 1.596 . . . . 75.32 112.402 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 199' ' ' LEU . . . . . 0.474 ' N ' HD12 ' B' ' 199' ' ' LEU . 10.6 mp -56.04 -42.45 76.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.994 -1.066 . . . . 72.25 109.203 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 82.34 -30.25 3.08 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.004 -1.239 . . . . 64.53 110.004 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 24.9 mm -91.44 129.11 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.025 -1.279 . . . . 44.23 109.435 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 42.0 t -88.13 139.76 30.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.83 . . . . 54.01 108.992 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 25.2 p -139.59 25.62 2.38 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.31 -0.869 . . . . 74.4 109.304 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.512 HG12 ' CD2' ' B' ' 214' ' ' PHE . 23.1 m -143.86 145.86 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.245 -0.909 . . . . 72.12 109.873 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -114.35 137.65 51.54 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.72 -0.613 . . . . 65.41 109.576 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.58 111.43 23.8 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.289 -0.882 . . . . 71.33 108.969 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.413 HG12 ' H ' ' B' ' 209' ' ' ARG . 3.7 t -138.36 142.38 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.286 -0.884 . . . . 63.5 109.498 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 208' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' B' ' 209' ' ' ARG . 32.7 ptt-85 -85.26 -24.65 27.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.216 -0.927 . . . . 74.45 109.642 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 209' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' B' ' 208' ' ' ARG . 96.0 mtt180 -57.5 -110.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.322 -0.861 . . . . 74.14 109.968 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 39.4 mmt-85 -51.12 -45.21 61.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.111 -0.993 . . . . 74.43 109.59 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 147.79 -130.83 3.64 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.35 -1.5 . . . . 64.45 109.35 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -104.59 131.24 52.24 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.365 -1.079 . . . . 74.21 108.779 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -105.01 146.52 28.94 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.437 -0.79 . . . . 74.03 109.902 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 214' ' ' PHE . . . . . 0.512 ' CD2' HG12 ' B' ' 204' ' ' VAL . 27.9 m-85 -128.39 104.12 7.53 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.408 -0.96 . . . . 74.34 108.408 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 215' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' B' ' 216' ' ' TYR . 50.8 t -127.66 169.01 14.26 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.2 -0.937 . . . . 64.33 110.49 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 216' ' ' TYR . . . . . 0.528 ' N ' ' SG ' ' B' ' 215' ' ' CYS . 47.6 m-85 -63.63 152.14 86.75 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.586 -0.696 . . . . 70.04 109.173 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.92 -162.08 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.212 1.941 . . . . 65.11 111.725 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 42.4 mttp . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.222 -0.924 . . . . 73.15 109.018 179.746 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.2 ttm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.435 -0.579 . . . . 65.12 109.435 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.437 ' N ' ' OD2' ' A' ' 46' ' ' ASP . 61.2 ttm-85 -143.08 150.75 39.94 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.263 -0.898 . . . . 72.33 109.322 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 81.4 t -120.25 134.82 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-O 121.5 0.667 . . . . 71.42 110.091 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.401 ' O ' ' O ' ' A' ' 49' ' ' MET . 8.9 tp -100.25 115.97 31.14 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.645 -0.872 . . . . 65.12 108.645 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.482 HD12 ' SD ' ' A' ' 49' ' ' MET . 25.2 tp -117.39 99.55 7.08 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.582 -0.699 . . . . 62.43 109.756 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.485 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 7.8 mt -94.35 119.36 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.753 -1.217 . . . . 71.15 108.953 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -149.26 121.9 8.61 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.199 -0.938 . . . . 75.34 109.603 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -65.84 -32.97 74.79 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.265 -0.897 . . . . 72.44 108.996 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -87.27 107.34 18.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.355 -0.841 . . . . 63.02 109.363 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.2 t -65.99 -18.37 65.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 72.34 109.671 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.45 -55.82 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.16 -0.963 . . . . 74.02 109.904 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.603 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.5 mm? -69.39 -38.86 78.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.255 -0.903 . . . . 71.43 109.557 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.13 -28.67 63.84 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.693 -1.763 . . . . 61.32 108.693 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.28 -45.51 95.01 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.515 -1.434 . . . . 71.2 109.515 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.598 ' OE2' HD13 ' A' ' 12' ' ' LEU . 15.0 pt-20 -67.46 -45.91 74.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -1.129 . . . . 71.32 109.905 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 98.6 mt -64.0 -42.03 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.623 -1.298 . . . . 63.23 108.641 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -54.01 -50.81 65.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.901 . . . . 51.11 109.521 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -85.11 1.98 45.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.123 -0.986 . . . . 73.34 109.076 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.97 -60.73 2.01 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 109.737 -1.345 . . . . 62.15 109.737 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -69.46 -22.9 63.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.203 -1.175 . . . . 73.51 109.796 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -59.05 -32.89 70.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.04 -1.037 . . . . 74.25 109.339 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.4 t -58.71 -34.04 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.445 -0.785 . . . . 70.04 109.374 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.521 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 2.4 mptp? -68.39 -1.21 5.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 73.23 109.315 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.37 35.09 11.04 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.74 -1.344 . . . . 75.54 109.74 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -115.78 159.62 21.2 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.488 -1.007 . . . . 73.43 109.143 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.7 mmt -104.09 138.13 41.05 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.45 -0.945 . . . . 43.24 108.45 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.75 164.2 31.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.913 . . . . 62.11 109.771 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -139.08 149.88 45.08 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.434 -0.791 . . . . 74.42 108.977 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.48 129.0 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.705 -0.85 . . . . 72.15 108.705 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.3 p -133.1 167.93 19.44 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.452 -0.78 . . . . 71.42 109.752 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.485 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 3.0 pt-20 -98.6 -96.14 0.23 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.398 -0.814 . . . . 72.33 109.747 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.5 p -79.96 164.25 23.64 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.015 -1.053 . . . . 74.24 110.007 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 37' ' ' GLU . 21.8 mt -54.77 -38.95 67.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.513 -0.742 . . . . 71.53 109.819 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -52.57 -44.21 65.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 74.23 109.814 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -65.3 -42.47 93.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.107 -0.996 . . . . 54.03 109.665 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.03 -30.6 50.81 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.062 -1.215 . . . . 61.41 110.062 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 33' ' ' LEU . 78.2 tt0 -66.74 -46.45 75.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.126 -1.22 . . . . 74.34 110.099 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.442 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 48.2 m-85 -78.92 -24.11 44.27 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.092 -1.005 . . . . 75.33 109.959 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.8 tp -85.49 -29.23 24.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.005 -1.06 . . . . 74.33 109.81 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.562 ' SD ' ' CE1' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -86.82 -36.81 18.29 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.069 -1.02 . . . . 70.32 110.633 -179.164 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 30.5 p-10 -58.73 -30.77 67.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.935 -1.103 . . . . 71.22 110.238 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.531 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 10.1 pt -78.17 -31.64 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.071 -1.018 . . . . 74.14 110.104 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 40' ' ' MET . 79.9 mtt85 -108.44 171.82 7.19 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.341 -0.849 . . . . 72.24 109.682 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -86.93 148.73 25.22 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.203 -0.936 . . . . 75.42 109.184 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.565 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 0.5 OUTLIER -139.0 128.65 24.63 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.282 -0.886 . . . . 74.23 109.509 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.446 ' OD1' ' CD2' ' A' ' 113' ' ' LEU . 3.7 p30 -108.08 -41.99 4.78 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.844 -0.798 . . . . 72.04 108.844 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.473 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.3 OUTLIER -103.8 112.84 25.97 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.074 -1.084 . . . . 72.13 108.074 179.335 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.473 ' N ' HD13 ' A' ' 47' ' ' LEU . 21.9 t -100.24 96.86 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.445 -0.946 . . . . 72.34 108.445 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.482 ' SD ' HD12 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -116.47 123.87 48.55 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.685 0.755 . . . . 74.11 109.857 -179.477 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.58 HG22 ' H ' ' A' ' 52' ' ' ASP . 1.1 p -131.21 131.93 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 121.632 0.729 . . . . 61.12 109.41 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.2 p -91.38 3.5 54.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.522 -0.736 . . . . 73.11 109.303 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.58 ' H ' HG22 ' A' ' 50' ' ' VAL . 1.6 m-20 -78.99 138.34 38.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.269 -0.894 . . . . 52.55 109.6 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.516 ' NZ ' ' OD1' ' A' ' 77' ' ' ASN . 14.9 mmmt -76.83 -36.18 57.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.214 -0.929 . . . . 44.22 110.11 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -70.54 12.38 0.26 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.081 -1.012 . . . . 70.44 109.537 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -69.25 -20.9 63.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.412 -0.805 . . . . 64.14 110.399 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 55' ' ' ALA . 20.3 mt -40.0 -50.46 2.55 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.468 -0.77 . . . . 44.14 110.395 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.7 t -69.08 -33.56 73.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.033 -1.042 . . . . 55.23 108.957 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.615 ' CE2' HD11 ' A' ' 62' ' ' ILE . 50.9 t80 -66.91 -59.32 3.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.468 -0.77 . . . . 74.44 109.938 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.1 m -52.22 -34.14 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.715 -1.24 . . . . 74.03 109.492 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.5 m -58.49 -54.02 51.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.2 -0.938 . . . . 64.3 109.715 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -66.85 -27.86 67.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.111 -0.993 . . . . 64.44 109.978 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.615 HD11 ' CE2' ' A' ' 58' ' ' PHE . 5.6 mm -67.05 -45.73 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.901 -1.124 . . . . 63.21 110.185 -179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 67' ' ' SER . 53.7 mmtt -65.16 -46.44 80.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 74.42 110.645 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 6.6 pt-20 -70.35 -41.83 72.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.716 -1.24 . . . . 70.32 109.953 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.491 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 25.9 mtpp -76.29 -19.12 58.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.143 -0.973 . . . . 75.22 109.313 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.532 ' O ' HG22 ' A' ' 69' ' ' ILE . 83.2 m-70 -156.29 68.1 0.6 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.888 . . . . 74.13 109.282 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 63' ' ' LYS . 82.5 p -65.49 -15.87 63.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 73.24 109.914 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 92.8 p -88.32 43.82 1.16 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.191 -0.943 . . . . 61.01 110.329 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 66' ' ' HIS . 16.9 tt -145.11 169.13 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.989 -1.069 . . . . 71.33 109.582 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.1 t -102.1 148.66 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.263 -0.898 . . . . 72.13 109.424 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.5 t -131.5 126.49 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.376 -0.828 . . . . 54.21 109.76 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.553 HD23 ' C ' ' A' ' 72' ' ' LEU . 3.8 tt -120.11 100.97 7.51 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.111 -0.7 . . . . 50.24 109.111 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 73' ' ' VAL . 8.7 p -97.09 131.32 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.982 -1.074 . . . . 74.41 109.153 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 75' ' ' SER . 4.5 p -92.86 174.98 6.97 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.086 -1.009 . . . . 72.31 109.378 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.472 ' OG ' ' CE2' ' A' ' 94' ' ' TYR . 50.9 m -164.49 116.09 1.26 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.083 -1.01 . . . . 64.54 110.371 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.8 -28.56 68.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.525 -0.734 . . . . 74.13 109.306 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.516 ' OD1' ' NZ ' ' A' ' 53' ' ' LYS . 13.0 p30 -109.6 71.13 0.52 Allowed Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.657 -0.652 . . . . 73.34 109.41 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.01 80.45 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.654 1.569 . . . . 63.22 111.769 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.63 HG23 ' H ' ' A' ' 82' ' ' GLU . 1.8 t -104.72 162.49 13.25 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.656 -0.868 . . . . 62.53 108.656 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.8 p -71.36 -29.11 64.59 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.166 -0.959 . . . . 73.44 109.864 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -62.77 -45.57 92.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 71.42 109.475 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.63 ' H ' HG23 ' A' ' 79' ' ' THR . 74.8 tt0 -76.49 -29.72 56.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.281 -0.887 . . . . 73.43 109.639 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -63.73 -57.01 11.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.954 . . . . 74.22 109.611 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.519 HG23 ' N ' ' A' ' 85' ' ' HIS . 27.2 m -60.34 -42.18 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.14 -0.975 . . . . 73.2 108.987 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.519 ' N ' HG23 ' A' ' 84' ' ' VAL . 82.4 t60 -62.95 -35.44 80.12 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.298 -0.876 . . . . 53.33 109.219 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.82 -37.38 84.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.416 -0.803 . . . . 64.11 109.861 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -77.08 -29.91 55.19 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.047 -1.033 . . . . 74.34 108.818 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.34 -36.3 68.79 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.714 -0.794 . . . . 74.42 109.229 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -66.58 -51.29 58.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.364 -0.835 . . . . 74.24 109.478 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.85 44.3 0.06 OUTLIER Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.742 -1.343 . . . . 61.51 109.742 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -99.72 135.88 40.47 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.21 -1.171 . . . . 55.33 109.416 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.524 ' OD2' ' NH1' ' A' ' 112' ' ' ARG . 45.9 t0 -82.38 -25.05 34.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 73.42 109.314 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.528 ' OD2' ' NH2' ' A' ' 112' ' ' ARG . 72.0 m-20 -149.75 155.76 40.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.349 -0.845 . . . . 75.04 109.249 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.472 ' CE2' ' OG ' ' A' ' 75' ' ' SER . 55.3 t80 -137.4 103.38 5.06 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.735 -0.839 . . . . 71.33 108.735 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.511 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -107.6 151.94 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.651 0.738 . . . . 71.13 110.001 -177.508 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.36 130.27 39.35 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.693 -1.225 . . . . 64.32 107.693 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.697 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -49.89 -55.67 22.34 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 120.988 -1.07 . . . . 62.2 111.835 -178.624 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 2.2 Cg_endo -40.21 -11.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 120.895 1.063 . . . . 73.11 113.101 -176.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.697 ' N ' ' O ' ' A' ' 97' ' ' LYS . 56.5 m-85 59.08 121.07 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.644 -0.66 . . . . 65.22 110.189 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.587 ' HE ' ' CB ' ' B' ' 80' ' ' SER . 0.0 OUTLIER -56.71 -46.63 81.15 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.047 -1.094 . . . . 72.35 108.047 179.077 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.764 ' O ' ' N ' ' A' ' 103' ' ' LYS . 22.7 t -175.11 53.69 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.236 -0.915 . . . . 71.32 110.498 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 11.4 mm 49.08 -69.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.591 -0.693 . . . . 75.43 110.796 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.764 ' N ' ' O ' ' A' ' 101' ' ' SER . 2.4 mppt? -55.29 -18.34 6.17 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.988 -1.116 . . . . 71.41 107.988 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.08 -97.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.582 -0.699 . . . . 63.24 110.405 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.632 ' N ' HD23 ' A' ' 105' ' ' LEU . 2.0 pt? -49.83 -36.18 25.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.137 -0.977 . . . . 73.22 110.226 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.48 -39.85 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.881 -1.137 . . . . 60.11 108.903 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 103' ' ' LYS . . . -64.13 -31.86 73.21 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.193 -0.942 . . . . 70.42 108.57 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.1 ttp-105 -81.91 -24.83 35.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.457 -0.777 . . . . 74.41 109.745 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 65.6 mt -75.53 -37.4 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.032 -1.043 . . . . 62.54 108.705 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.442 ' OE1' ' NZ ' ' A' ' 23' ' ' LYS . 11.8 pt-20 -76.21 -35.33 59.1 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.561 -0.856 . . . . 74.34 109.353 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.71 -45.35 94.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.431 -0.793 . . . . 73.32 109.863 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.528 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 23.3 ttm180 -66.06 -50.83 62.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.119 -0.988 . . . . 52.41 109.596 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 113' ' ' LEU . 10.1 mp -95.51 38.29 1.16 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.14 -0.975 . . . . 65.24 109.206 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.37 -55.2 5.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.262 -0.899 . . . . 64.45 109.176 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -85.07 13.53 6.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -0.869 . . . . 74.43 109.617 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 60.4 t-105 -48.98 105.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 74.42 109.537 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 157.85 -136.89 5.04 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.629 -1.388 . . . . 75.04 109.629 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.8 t 54.21 177.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.425 -1.044 . . . . 61.14 110.049 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.7 150.71 26.53 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.059 -0.719 . . . . 65.24 109.059 -178.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.0 t -90.31 -41.48 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.155 -0.966 . . . . 73.11 109.581 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 17.1 mm -100.13 135.84 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.348 -0.845 . . . . 72.24 109.586 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -148.54 127.18 12.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 72.34 109.048 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.436 ' O ' HG23 ' A' ' 123' ' ' ILE . 6.5 tp -154.42 128.09 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 71.44 108.994 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 53.47 -139.4 35.02 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.946 -1.661 . . . . 73.4 108.946 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 125' ' ' ASP . 14.3 p-10 -93.51 6.39 48.38 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.089 -1.242 . . . . 74.45 109.154 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.05 135.14 38.23 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.638 -0.875 . . . . 54.21 108.638 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.1 m -131.97 138.63 48.38 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.405 -0.809 . . . . 54.5 109.408 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.8 mt -138.85 139.92 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.332 -0.855 . . . . 45.15 109.184 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.8 m -123.36 82.33 52.65 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.604 -0.685 . . . . 71.11 109.392 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.46 -41.09 75.93 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.56 2.174 . . . . 65.41 112.115 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -56.07 -44.78 79.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 63.32 109.064 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -87.15 2.13 50.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.409 -0.807 . . . . 72.52 108.868 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 1.28 ' HB3' ' CZ ' ' A' ' 149' ' ' PHE . 21.4 mt-10 49.71 61.75 3.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.422 -0.798 . . . . 75.33 109.058 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -149.02 135.61 19.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.252 -0.905 . . . . 71.23 109.808 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 11.6 tt -107.86 136.24 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.434 -0.95 . . . . 74.02 108.434 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 47.7 mt -128.86 125.18 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.364 -0.835 . . . . 60.23 109.947 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 137' ' ' TYR . 16.5 p90 -139.3 147.25 41.38 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.454 -0.779 . . . . 62.32 109.152 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 54.9 mttp 54.33 23.87 4.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.451 -0.78 . . . . 75.4 110.05 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 79.44 -1.35 77.15 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.44 -1.064 . . . . 72.24 110.44 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -90.17 135.53 33.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.953 -1.322 . . . . 71.22 108.89 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -101.52 131.07 47.88 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.401 -0.812 . . . . 71.42 109.695 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 49.8 t -137.81 127.65 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.956 -0.757 . . . . 53.02 108.956 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -81.36 139.28 35.43 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.254 -0.904 . . . . 60.45 109.336 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.404 ' O ' ' CD1' ' A' ' 149' ' ' PHE . 12.2 m -142.6 137.09 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.252 -0.905 . . . . 74.44 109.53 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 1.136 ' HA ' ' CG ' ' A' ' 149' ' ' PHE . 49.5 pttt -171.45 28.57 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 65.15 109.214 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.19 -145.8 3.33 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.93 -1.268 . . . . 73.34 109.93 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -70.87 -38.61 7.61 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 121.357 -1.084 . . . . 72.22 110.426 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 90.5 Cg_endo -86.66 11.82 3.17 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.008 1.806 . . . . 65.23 111.853 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 1.28 ' CZ ' ' HB3' ' A' ' 133' ' ' GLU . 32.3 t80 -79.75 -34.83 39.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.418 -0.801 . . . . 60.11 109.425 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -74.41 -38.03 63.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 64.21 110.168 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.518 HG13 ' N ' ' A' ' 152' ' ' LEU . 11.5 p -74.76 -40.58 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.09 -1.006 . . . . 72.02 109.506 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.518 ' N ' HG13 ' A' ' 151' ' ' VAL . 20.4 tp -58.94 -45.63 89.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 73.31 109.216 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.7 p -65.82 -37.08 85.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 74.31 109.373 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -52.94 -54.96 27.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.374 -0.829 . . . . 74.31 109.94 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.67 HD12 ' N ' ' A' ' 156' ' ' ALA . 4.4 pp -76.33 -19.6 58.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 75.34 110.067 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.67 ' N ' HD12 ' A' ' 155' ' ' LEU . . . -61.68 -45.28 94.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.009 -1.057 . . . . 62.14 109.464 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.445 ' C ' ' H ' ' A' ' 159' ' ' ARG . 60.4 mtp180 -79.55 -51.58 9.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.185 -0.947 . . . . 61.03 109.35 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.406 ' C ' ' H ' ' A' ' 160' ' ' ASP . 62.0 m170 -73.32 43.5 0.13 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.487 -0.758 . . . . 74.12 109.172 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.445 ' H ' ' C ' ' A' ' 157' ' ' ARG . 0.2 OUTLIER -74.72 30.77 0.09 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.579 -0.7 . . . . 71.13 110.213 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 158' ' ' HIS . 63.3 t0 -165.2 66.4 0.13 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.922 -1.111 . . . . 75.45 110.131 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.562 HE22 ' CG2' ' A' ' 163' ' ' VAL . 2.1 pp0? -177.89 178.75 0.93 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.125 -0.984 . . . . 73.41 109.802 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 14.1 mm -97.44 125.67 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.309 -0.869 . . . . 74.41 109.358 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.562 ' CG2' HE22 ' A' ' 161' ' ' GLN . 18.6 t -104.5 132.82 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.376 -0.827 . . . . 72.31 109.197 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.7 t -87.31 141.59 28.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.15 -0.969 . . . . 74.12 109.321 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.439 ' O ' HD13 ' A' ' 184' ' ' ILE . 33.1 mttt -51.69 -45.63 63.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 70.43 108.77 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -56.55 -37.64 70.8 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 73.52 109.1 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.17 -40.87 71.17 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.158 -0.964 . . . . 74.52 109.296 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 74.8 mt -62.62 -49.17 76.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 72.31 109.918 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.4 tp -75.77 -65.46 0.9 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.787 -1.195 . . . . 53.33 109.84 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -39.45 -31.01 0.08 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 122.164 -0.335 . . . . 62.44 111.892 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.75 -39.88 9.64 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.774 -1.204 . . . . 60.21 112.519 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.528 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 1.3 mp -85.31 -60.16 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 120.535 -1.353 . . . . 75.32 111.709 -177.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.464 ' CD2' ' C ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 O-C-N 120.79 -1.194 . . . . 73.14 110.049 -177.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 108.395 -0.965 . . . . 64.54 108.395 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.406 HG23 ' H ' ' A' ' 185' ' ' GLU . 26.8 m -62.05 -135.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.541 -0.724 . . . . 74.02 110.365 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 165' ' ' LYS . 57.3 mt -62.9 -31.87 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.287 -0.883 . . . . 72.33 109.636 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.406 ' H ' HG23 ' A' ' 183' ' ' VAL . 47.4 tt0 -45.64 -56.3 5.36 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.594 -0.692 . . . . 74.4 110.3 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 87.3 t -80.9 -52.69 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -0.946 . . . . 70.42 110.54 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -46.06 -47.47 17.08 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.023 -1.048 . . . . 52.11 110.387 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.509 ' O ' HD13 ' A' ' 188' ' ' ILE . 0.2 OUTLIER -71.95 -46.86 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.837 -1.164 . . . . 71.4 109.693 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.461 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 46.8 t-20 -56.13 -40.88 74.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.951 -1.093 . . . . 73.44 110.334 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 194' ' ' LYS . 25.6 mt-30 -72.9 -48.24 38.91 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.027 -1.045 . . . . 71.42 110.298 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 58.5 mt -49.12 -36.18 8.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 120.65 -1.281 . . . . 61.55 110.242 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 20.7 mtm-85 -76.04 -59.21 2.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.856 -1.153 . . . . 63.34 111.057 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.43 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 86.6 mt-30 -71.08 -14.53 62.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.13 -0.981 . . . . 61.24 110.775 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 190' ' ' GLN . 33.3 ttpt -91.17 -36.88 13.7 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.17 -0.956 . . . . 75.13 110.042 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 9.3 tpt -89.89 -4.1 57.72 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.294 -0.879 . . . . 74.02 109.701 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 197' ' ' LYS . 33.7 p-10 -68.2 -44.31 76.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.089 -1.007 . . . . 74.02 110.652 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.537 ' N ' ' OD1' ' A' ' 196' ' ' ASP . 8.9 mttm -75.84 -53.44 2.42 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.944 -1.098 . . . . 75.43 110.017 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -47.03 -61.36 0.62 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.899 1.733 . . . . 72.32 112.214 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 33.8 tp -70.61 -43.72 68.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 74.54 109.314 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 91.38 -19.45 47.06 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.985 -1.246 . . . . 61.51 109.985 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 29.9 mm -111.32 133.44 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.415 -1.05 . . . . 61.22 109.576 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 14.4 t -85.35 134.42 34.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 72.0 109.123 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 43.9 p -144.23 29.05 1.32 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.238 -0.914 . . . . 74.44 109.595 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.48 125.2 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.386 -0.821 . . . . 64.35 109.483 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -107.12 129.07 54.88 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.485 -0.759 . . . . 71.41 109.147 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 81.0 p -93.35 120.71 33.94 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.21 -0.932 . . . . 73.52 109.414 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.51 HG22 ' H ' ' A' ' 209' ' ' ARG . 7.3 p -137.49 143.1 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.366 -0.834 . . . . 71.02 109.051 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -75.69 -33.06 60.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 72.12 110.067 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 211' ' ' GLY . 44.9 mmm-85 -60.97 145.89 48.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.098 -1.001 . . . . 64.41 109.553 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 64.1 mtp85 48.64 -91.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.386 -0.821 . . . . 71.54 109.734 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . -160.27 -124.99 0.76 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.494 -1.443 . . . . 72.03 109.494 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -101.5 141.84 33.76 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.352 -1.087 . . . . 75.54 109.236 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.474 ' NH1' ' SG ' ' A' ' 215' ' ' CYS . 66.1 ttt-85 -109.03 127.28 53.96 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.514 -0.741 . . . . 75.31 109.789 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -109.66 124.02 50.47 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.646 -0.872 . . . . 75.41 108.646 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' CYS . . . . . 0.474 ' SG ' ' NH1' ' A' ' 213' ' ' ARG . 4.8 p -140.91 167.32 22.48 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.34 -0.85 . . . . 74.14 109.923 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -61.71 150.78 80.89 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.384 -0.823 . . . . 75.32 108.947 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo . . . . . 0 C--N 1.315 -1.189 0 C-N-CA 121.852 1.701 . . . . 73.11 111.99 179.804 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.566 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.418 -0.586 . . . . 71.14 109.418 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 1.217 ' CZ ' ' NH2' ' B' ' 43' ' ' ARG . 88.9 mtt-85 -131.21 142.34 50.17 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.507 -0.745 . . . . 73.23 109.721 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 88.2 t -107.7 123.07 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.611 -0.681 . . . . 72.24 109.709 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.58 HD11 ' CG1' ' B' ' 6' ' ' ILE . 2.4 tp -91.24 114.43 26.95 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.094 -1.076 . . . . 54.33 108.094 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 4.4 tp -117.11 111.71 19.87 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.912 -0.773 . . . . 74.35 108.912 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.58 ' CG1' HD11 ' B' ' 4' ' ' LEU . 20.0 mt -106.59 123.58 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.445 -0.785 . . . . 42.55 109.02 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -140.41 120.25 13.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.345 -0.847 . . . . 74.52 109.274 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -66.44 -30.81 71.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.158 -0.963 . . . . 62.55 109.283 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -64.24 -128.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.217 -0.927 . . . . 73.11 109.033 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 79.2 p -167.06 -66.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.11 -0.994 . . . . 65.54 109.658 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.472 HG13 ' N ' ' B' ' 12' ' ' LEU . 9.6 p -67.52 -40.96 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 75.55 109.907 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.472 ' N ' HG13 ' B' ' 11' ' ' VAL . 3.6 mm? -52.14 -43.23 63.93 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.024 -1.048 . . . . 70.14 108.725 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.94 -28.35 68.85 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 108.508 -1.837 . . . . 75.4 108.508 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.61 -51.52 53.42 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 109.72 -1.352 . . . . 65.44 109.72 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -60.82 -45.04 96.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -1.114 . . . . 60.21 109.931 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 5.6 mm -67.26 -38.73 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.828 -1.17 . . . . 75.15 108.924 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.525 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 84.0 tt0 -62.73 -42.52 99.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 73.01 109.791 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -88.58 -0.53 57.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.931 -1.106 . . . . 74.3 108.916 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.1 -53.39 3.32 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 109.551 -1.419 . . . . 70.54 109.551 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -73.83 -24.59 59.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -1.121 . . . . 71.34 109.654 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 96.2 m-20 -58.96 -34.75 72.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.158 -0.964 . . . . 64.41 109.485 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 90.9 t -55.74 -45.29 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.416 -0.802 . . . . 74.23 109.379 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 50.3 mmtt -54.2 -49.67 68.85 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.382 -0.824 . . . . 63.42 108.827 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.77 41.21 0.15 Allowed Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.1 -1.2 . . . . 53.43 110.1 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -120.38 160.13 23.69 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.395 -1.062 . . . . 71.12 109.532 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.1 mmt -100.47 139.41 36.2 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.957 -1.127 . . . . 75.24 107.957 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.28 160.43 41.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.168 -0.957 . . . . 72.12 110.314 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -135.2 141.31 45.82 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.607 -0.886 . . . . 72.31 108.607 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 1.1 m -107.59 126.96 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.332 -0.855 . . . . 64.43 109.103 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.7 p -125.13 161.85 25.9 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.616 -0.678 . . . . 65.41 109.25 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.466 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 1.7 pt-20 -88.2 -97.67 0.09 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.27 -0.894 . . . . 71.02 109.796 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.3 t -78.8 152.39 31.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.895 . . . . 51.11 110.007 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.564 ' H ' HD12 ' B' ' 33' ' ' LEU . 1.6 mp -50.59 -26.29 5.14 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.562 -0.711 . . . . 71.24 109.711 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -58.61 -48.29 81.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.96 . . . . 74.32 109.872 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.466 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 68.5 m-20 -59.88 -43.74 94.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.969 . . . . 73.03 109.258 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.06 -29.59 68.71 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.2 -1.56 . . . . 30.21 109.2 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -65.66 -43.66 88.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.358 -1.084 . . . . 74.42 109.816 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -80.28 -33.5 37.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.997 -1.064 . . . . 74.42 109.57 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 11.3 tp -72.88 -39.23 66.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.345 -0.847 . . . . 75.41 109.776 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' MET . . . . . 0.43 ' O ' ' O ' ' B' ' 43' ' ' ARG . 2.9 ppp? -75.79 -21.93 56.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.962 . . . . 60.41 109.833 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -60.73 -35.85 77.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.135 -0.978 . . . . 53.23 109.531 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 11.3 pt -92.4 -24.81 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.28 -0.888 . . . . 71.23 110.031 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 1.217 ' NH2' ' CZ ' ' B' ' 2' ' ' ARG . 54.4 mtp180 -124.9 139.47 53.8 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.335 -0.853 . . . . 72.22 109.537 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -101.35 143.38 31.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.3 -0.875 . . . . 63.54 109.62 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -114.85 143.5 45.01 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.967 -0.753 . . . . 64.35 108.967 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' B' ' 2' ' ' ARG . 8.3 p-10 -82.08 -36.92 27.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.077 -1.015 . . . . 62.22 109.276 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.508 ' C ' HD13 ' B' ' 47' ' ' LEU . 0.8 OUTLIER -109.41 109.72 20.65 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.639 -0.875 . . . . 73.12 108.639 179.608 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.446 ' N ' HD13 ' B' ' 47' ' ' LEU . 63.5 t -94.46 100.57 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.282 -0.886 . . . . 65.11 109.197 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 0.3 OUTLIER -116.93 124.98 50.76 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.669 -0.863 . . . . 73.44 108.669 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.85 130.43 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.278 -0.889 . . . . 34.5 109.342 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 75.4 p -107.21 27.92 8.58 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.691 -0.631 . . . . 73.21 109.54 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -86.86 159.02 19.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -0.927 . . . . 70.41 109.486 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' B' ' 55' ' ' ALA . 94.0 mttt -81.63 175.8 10.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.321 -0.862 . . . . 65.0 109.375 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' ASN . . . . . 0.465 ' ND2' ' C ' ' B' ' 54' ' ' ASN . 0.3 OUTLIER 44.58 16.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.602 -0.686 . . . . 75.21 109.86 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' B' ' 53' ' ' LYS . . . -74.48 -20.55 59.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 55.33 109.185 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 24.6 mt -42.79 -46.73 5.3 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.631 -0.668 . . . . 63.14 110.342 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 58.7 m -65.54 -37.22 86.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.971 -1.081 . . . . 63.5 109.659 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' PHE . . . . . 0.467 ' CZ ' HD11 ' B' ' 62' ' ' ILE . 67.1 t80 -63.21 -59.99 4.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 72.33 109.898 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 15.4 m -49.59 -35.68 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.735 -1.228 . . . . 74.54 109.764 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' SER . . . . . 0.428 ' OG ' ' N ' ' B' ' 61' ' ' ARG . 13.0 p -58.11 -55.04 40.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.095 -1.003 . . . . 71.24 109.752 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.428 ' N ' ' OG ' ' B' ' 60' ' ' SER . 11.3 ptp180 -64.48 -27.47 69.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.064 -1.023 . . . . 74.31 110.042 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.467 HD11 ' CZ ' ' B' ' 58' ' ' PHE . 28.2 mm -64.74 -41.54 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.784 -1.197 . . . . 72.14 109.936 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.476 ' NZ ' ' O ' ' B' ' 90' ' ' GLY . 19.1 mmtp -69.65 -48.83 58.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.94 -1.1 . . . . 73.32 110.551 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -66.7 -35.93 81.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.759 -1.213 . . . . 73.12 109.807 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.421 ' C ' ' CG ' ' B' ' 66' ' ' HIS . 9.7 mtpm? -82.13 -25.29 34.53 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.166 -0.959 . . . . 72.44 109.702 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.421 ' CG ' ' C ' ' B' ' 65' ' ' LYS . 65.6 m-70 -152.73 68.01 0.83 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.164 -0.96 . . . . 63.31 109.516 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 86.6 p -64.4 -25.8 68.18 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.359 -0.838 . . . . 73.1 109.885 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 17.8 p -66.02 -9.19 28.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.179 -0.951 . . . . 71.53 109.883 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 56.9 mt -102.11 151.26 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.351 -0.843 . . . . 74.4 109.468 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.551 HG12 ' N ' ' B' ' 71' ' ' VAL . 76.6 t -87.39 165.54 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.249 -0.907 . . . . 75.12 109.486 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.551 ' N ' HG12 ' B' ' 70' ' ' VAL . 2.9 t -145.7 122.71 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.966 -1.084 . . . . 73.2 109.824 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.521 ' HG ' HD11 ' B' ' 95' ' ' ILE . 2.9 mp -120.36 105.4 10.87 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.483 -0.932 . . . . 73.34 108.483 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.463 ' O ' HG13 ' B' ' 73' ' ' VAL . 14.7 p -95.35 130.91 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.209 -0.932 . . . . 73.5 109.019 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 2.5 p -89.5 170.19 10.72 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.104 -0.997 . . . . 64.34 109.203 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 26.4 t -161.22 114.54 1.95 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.092 -1.005 . . . . 74.53 109.942 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -62.8 -36.7 84.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.173 -0.954 . . . . 64.5 108.81 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 77' ' ' ASN . . . . . 0.407 ' OD1' ' N ' ' B' ' 77' ' ' ASN . 13.0 p-10 -112.39 87.4 9.34 Favored Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 108.668 -0.864 . . . . 74.25 108.668 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -72.16 78.78 1.82 Allowed 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.51 1.473 . . . . 74.43 111.875 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 77.2 p -83.01 152.33 25.45 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.034 -1.098 . . . . 73.12 108.034 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' SER . . . . . 0.587 ' CB ' ' HE ' ' A' ' 100' ' ' ARG . 0.5 OUTLIER -63.96 -35.74 81.67 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.011 -1.056 . . . . 71.01 109.89 -179.239 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 81' ' ' GLU . . . . . 0.496 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 24.0 pt-20 -60.55 -36.82 79.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.129 -0.982 . . . . 63.2 109.373 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -73.63 -33.55 64.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.213 -0.929 . . . . 73.22 109.565 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -62.74 -52.36 63.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.901 . . . . 74.3 109.722 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 18.8 m -61.09 -39.3 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.111 -0.993 . . . . 73.31 109.34 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' HIS . . . . . 0.496 ' ND1' ' O ' ' B' ' 81' ' ' GLU . 25.0 m80 -66.59 -30.66 71.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 73.24 109.351 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -65.37 -43.35 91.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 55.33 109.693 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -80.22 -35.04 36.79 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.185 -0.947 . . . . 74.14 109.019 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -63.13 -50.43 70.46 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.425 -0.797 . . . . 64.04 109.074 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -60.45 -52.68 64.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.544 -0.723 . . . . 72.35 109.836 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 90' ' ' GLY . . . . . 0.476 ' O ' ' NZ ' ' B' ' 63' ' ' LYS . . . 155.16 -15.08 0.49 Allowed Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.649 -1.262 . . . . 65.2 110.588 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 91' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -45.02 133.05 6.65 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.973 -1.31 . . . . 52.23 109.843 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' B' ' 93' ' ' ASP . 18.1 t0 -69.39 -42.56 74.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 73.32 109.362 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 93' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' B' ' 92' ' ' ASP . 72.9 m-20 -152.25 164.91 36.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.43 -0.794 . . . . 72.22 109.175 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.522 ' O ' ' CD1' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -138.54 127.76 24.28 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.902 -0.777 . . . . 64.42 108.902 -178.784 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 0.786 ' N ' HD12 ' B' ' 95' ' ' ILE . 0.2 OUTLIER -123.82 151.91 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 121.451 0.643 . . . . 72.23 110.142 -178.654 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.62 138.48 58.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.186 -0.946 . . . . 25.24 108.541 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.672 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -59.73 -53.79 62.11 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 120.98 -1.075 . . . . 64.32 111.61 -179.321 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 98' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 4.0 Cg_endo -42.03 -9.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 120.648 0.899 . . . . 63.33 113.057 -176.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 99' ' ' TYR . . . . . 0.672 ' N ' ' O ' ' B' ' 97' ' ' LYS . 49.4 m-85 59.45 117.64 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.583 -0.698 . . . . 75.13 109.225 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -56.63 -38.21 71.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.84 -1.162 . . . . 74.23 108.882 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 101' ' ' SER . . . . . 0.731 ' O ' ' N ' ' B' ' 103' ' ' LYS . 33.3 t -174.59 41.27 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.119 -0.988 . . . . 63.34 110.728 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 63.7 mt 51.88 -69.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.546 -0.721 . . . . 74.44 110.232 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.731 ' N ' ' O ' ' B' ' 101' ' ' SER . 28.2 mtmm -57.72 -18.8 23.23 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.776 -1.194 . . . . 71.11 107.776 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.45 -83.51 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.81 -0.556 . . . . 71.45 110.578 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.732 HD23 ' H ' ' B' ' 105' ' ' LEU . 1.5 pt? -47.67 -32.75 6.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.878 -1.139 . . . . 51.31 109.858 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 99.2 t -65.33 -41.7 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.901 -1.124 . . . . 65.23 108.723 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.94 -33.56 67.13 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.317 -0.865 . . . . 24.32 108.962 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -83.41 -34.97 25.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.426 -0.796 . . . . 75.31 110.079 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 96.8 mt -72.54 -36.6 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.022 -1.048 . . . . 54.24 109.115 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 110' ' ' GLU . . . . . 0.435 ' CG ' ' N ' ' B' ' 111' ' ' ALA . 22.8 pt-20 -74.91 -44.79 46.78 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.444 -0.902 . . . . 65.31 109.214 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 111' ' ' ALA . . . . . 0.435 ' N ' ' CG ' ' B' ' 110' ' ' GLU . . . -50.4 -45.01 55.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.239 -0.913 . . . . 72.24 109.203 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -67.09 -38.13 85.15 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.29 -0.881 . . . . 72.04 109.689 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' B' ' 116' ' ' TRP . 24.0 mt -78.11 -26.26 47.9 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.22 -0.925 . . . . 75.35 110.496 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.465 ' O ' ' CE3' ' B' ' 116' ' ' TRP . 19.0 mmt180 -47.57 -40.54 19.38 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.88 -1.137 . . . . 75.5 109.689 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 115' ' ' PHE . . . . . 0.48 ' C ' ' H ' ' B' ' 117' ' ' GLY . 71.3 m-85 -68.02 -25.22 65.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.983 . . . . 65.33 109.455 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 116' ' ' TRP . . . . . 0.465 ' CE3' ' O ' ' B' ' 114' ' ' ARG . 5.4 m-90 53.34 6.36 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.384 -0.822 . . . . 74.45 109.827 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 117' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' B' ' 115' ' ' PHE . . . 68.51 175.84 10.72 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.847 -1.301 . . . . 44.21 109.847 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 58.4 m -142.06 171.59 13.84 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.347 -1.09 . . . . 71.4 109.344 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 119' ' ' ASN . . . . . 0.575 HD21 ' C ' ' B' ' 121' ' ' ILE . 2.7 t30 -104.11 153.67 20.63 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.42 -0.8 . . . . 72.32 109.749 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 t -104.27 -42.51 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.415 -0.803 . . . . 75.02 109.859 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 121' ' ' ILE . . . . . 0.575 ' C ' HD21 ' B' ' 119' ' ' ASN . 12.2 mm -106.66 119.22 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.204 -0.935 . . . . 51.41 109.469 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -129.49 138.67 51.51 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.516 -0.74 . . . . 71.53 109.529 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.572 HD13 ' N ' ' B' ' 124' ' ' GLY . 0.2 OUTLIER -160.28 117.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 72.43 109.192 179.821 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 124' ' ' GLY . . . . . 0.572 ' N ' HD13 ' B' ' 123' ' ' ILE . . . 53.45 -141.39 31.2 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.623 -1.391 . . . . 51.23 109.623 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -86.14 -1.9 57.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.294 -1.121 . . . . 74.2 109.471 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.52 126.7 38.81 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.118 -1.067 . . . . 75.42 108.118 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 85.6 m -129.22 135.89 49.41 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.328 -0.857 . . . . 74.22 109.952 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 12.4 mt -129.17 136.04 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.555 -0.715 . . . . 60.33 109.338 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 129' ' ' SER . . . . . 0.459 ' O ' ' N ' ' B' ' 133' ' ' GLU . 53.0 m -124.49 81.46 59.61 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.626 -0.671 . . . . 72.31 109.582 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.41 -39.61 73.25 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.454 2.103 . . . . 75.13 111.712 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.68 -43.3 97.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.406 -0.809 . . . . 75.23 109.199 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -89.54 -4.64 57.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.389 -0.819 . . . . 72.43 108.791 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 133' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' B' ' 129' ' ' SER . 87.2 mt-10 52.52 56.74 7.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.453 -0.779 . . . . 75.13 109.763 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -151.83 139.02 19.25 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.303 -0.873 . . . . 73.22 109.404 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 7.7 tt -126.64 143.05 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.403 -0.811 . . . . 64.14 109.853 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 53.1 mt -115.6 131.73 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 109.114 -0.698 . . . . 71.22 109.114 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -138.02 138.23 38.64 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.609 -0.682 . . . . 64.22 110.491 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm 50.94 25.4 2.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.391 -0.818 . . . . 72.02 111.031 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.9 14.85 71.57 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.823 -1.179 . . . . 74.32 111.05 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -115.1 126.42 54.65 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.343 -1.093 . . . . 75.34 108.987 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -93.7 126.19 38.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.355 -0.841 . . . . 71.23 109.53 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 13.8 p -135.63 133.04 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.578 -0.897 . . . . 70.43 108.578 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 143' ' ' GLU . . . . . 0.568 ' CD ' ' H ' ' B' ' 143' ' ' GLU . 1.1 pm0 -94.86 137.37 34.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.201 -0.937 . . . . 72.43 108.588 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 11.6 m -140.02 141.01 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.102 -0.999 . . . . 72.13 110.323 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.27 31.92 0.24 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.711 -1.218 . . . . 72.02 107.711 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 146' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' B' ' 150' ' ' GLU . . . -78.24 -155.82 8.41 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.605 -1.398 . . . . 42.23 109.605 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 147' ' ' LYS . . . . . 0.62 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 0.0 OUTLIER -88.39 -35.96 0.44 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.422 -1.046 . . . . 73.3 111.046 -179.566 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 148' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 47.7 Cg_endo -84.31 -42.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 121.931 1.754 . . . . 71.33 112.533 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -56.53 -19.37 15.31 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.76 -1.212 . . . . 74.23 109.037 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 150' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' B' ' 146' ' ' GLY . 27.1 mt-10 -60.68 -36.27 78.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 72.34 109.89 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.472 HG11 HD13 ' B' ' 191' ' ' ILE . 3.8 p -67.84 -38.15 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.977 -1.077 . . . . 73.35 110.072 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 20.0 tp -60.57 -41.77 95.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.342 -0.849 . . . . 55.24 109.613 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -69.9 -39.64 76.08 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.124 -0.985 . . . . 70.01 109.209 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 154' ' ' HIS . . . . . 0.515 ' CD2' ' HD1' ' B' ' 158' ' ' HIS . 14.7 t60 -56.76 -52.48 64.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.484 -0.76 . . . . 65.32 110.111 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 155' ' ' LEU . . . . . 0.545 HD12 ' N ' ' B' ' 156' ' ' ALA . 4.2 pp -72.0 -25.66 61.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.924 -1.11 . . . . 71.54 109.413 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 156' ' ' ALA . . . . . 0.545 ' N ' HD12 ' B' ' 155' ' ' LEU . . . -54.31 -42.47 70.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.023 -1.048 . . . . 75.32 108.346 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 157' ' ' ARG . . . . . 0.426 ' C ' ' H ' ' B' ' 159' ' ' ARG . 58.0 mtp180 -77.81 -52.32 9.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.453 -0.779 . . . . 73.32 109.21 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 158' ' ' HIS . . . . . 0.607 ' HB3' HE21 ' B' ' 161' ' ' GLN . 30.9 m80 -75.27 25.66 0.1 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.549 -0.72 . . . . 74.14 109.988 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 159' ' ' ARG . . . . . 0.474 ' O ' ' N ' ' B' ' 161' ' ' GLN . 47.4 ttp180 -52.57 -78.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 61.41 109.015 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 160' ' ' ASP . . . . . 0.933 ' OD2' ' CE2' ' B' ' 216' ' ' TYR . 9.1 t70 -65.2 74.95 0.05 Allowed 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.2 -0.937 . . . . 72.1 109.27 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 161' ' ' GLN . . . . . 0.607 HE21 ' HB3' ' B' ' 158' ' ' HIS . 17.3 tt0 -175.65 160.33 2.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 72.25 109.141 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 17.1 mm -85.63 106.82 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.638 -0.875 . . . . 72.31 108.638 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 87.5 t -89.94 136.03 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.198 -0.939 . . . . 64.21 109.814 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 25.8 t -99.92 160.75 14.07 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.457 -0.777 . . . . 74.22 109.488 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -66.88 -40.01 87.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.472 -0.768 . . . . 65.31 110.047 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -66.36 -26.55 67.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 63.45 110.391 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -60.16 -57.69 11.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.99 -1.069 . . . . 72.4 109.662 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 25.9 mt -60.82 -36.72 79.8 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.127 -0.983 . . . . 72.32 108.856 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.5 HD13 ' C ' ' B' ' 169' ' ' LEU . 1.3 tm? -56.39 -66.23 0.47 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.607 -0.683 . . . . 73.34 110.162 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -54.85 -31.68 59.82 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.717 -0.615 . . . . 72.1 111.85 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -92.18 -8.82 44.46 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.706 -1.246 . . . . 62.13 112.009 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 25.6 mm -112.74 -68.4 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 120.887 -1.133 . . . . 71.42 110.82 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 173' ' ' TRP . . . . . 0.481 ' C ' ' CD2' ' B' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.431 0 C-N-CA 118.653 -1.219 . . . . 72.23 107.915 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo . . . . . 0 N--CA 1.494 1.521 0 CA-C-O 121.284 0.452 . . . . 65.22 111.815 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -127.27 125.97 41.85 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.488 -0.93 . . . . 72.31 108.488 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 183' ' ' VAL . . . . . 0.442 ' O ' HG22 ' B' ' 186' ' ' VAL . 6.1 t -133.04 -13.89 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.305 -0.872 . . . . 63.32 109.701 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 4.6 tt -62.01 -25.13 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.458 -1.401 . . . . 75.03 109.164 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -61.38 -43.11 99.43 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.319 -0.863 . . . . 64.11 109.83 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 186' ' ' VAL . . . . . 0.442 HG22 ' O ' ' B' ' 183' ' ' VAL . 15.4 m -76.54 -27.39 17.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.836 -1.165 . . . . 73.0 108.254 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.28 -46.18 64.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 61.12 109.692 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 10.7 tp -71.8 -28.06 29.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 120.953 -1.092 . . . . 72.43 109.595 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 189' ' ' ASN . . . . . 0.446 ' O ' ' OE1' ' B' ' 193' ' ' GLN . 68.2 m-20 -68.2 -46.01 71.78 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.286 -0.884 . . . . 65.14 108.764 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -70.3 -47.17 62.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 63.24 109.534 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 191' ' ' ILE . . . . . 0.472 HD13 HG11 ' B' ' 151' ' ' VAL . 63.7 mt -51.23 -34.83 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -0.906 . . . . 74.03 108.846 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 192' ' ' ARG . . . . . 0.434 HH22 HG21 ' B' ' 206' ' ' THR . 68.0 mtp180 -70.33 -42.28 72.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.883 . . . . 72.24 109.39 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 193' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' B' ' 189' ' ' ASN . 1.0 OUTLIER -75.45 -17.12 60.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.262 -0.899 . . . . 73.1 109.692 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -92.3 -25.05 18.76 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.18 -0.95 . . . . 72.11 110.361 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 195' ' ' MET . . . . . 0.608 ' SD ' ' N ' ' B' ' 195' ' ' MET . 0.0 OUTLIER -96.17 -32.01 12.69 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.133 -0.979 . . . . 44.33 110.141 -179.035 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 196' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 42.2 p-10 -67.97 -31.54 71.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.029 -1.044 . . . . 71.21 110.496 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 197' ' ' LYS . . . . . 0.47 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 46.1 mttt -70.12 -65.01 1.2 Allowed Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.969 -1.082 . . . . 75.21 110.56 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 198' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 19.8 Cg_endo -58.38 -58.57 0.71 Allowed 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.22 1.947 . . . . 75.32 112.741 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 37.1 mt -60.01 -55.51 33.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.062 -1.024 . . . . 72.25 109.874 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 97.49 -24.79 29.97 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.257 -1.137 . . . . 64.53 110.257 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 201' ' ' ILE . . . . . 0.412 HG21 HD13 ' B' ' 201' ' ' ILE . 19.7 mt -106.36 127.06 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.162 -1.199 . . . . 44.23 109.706 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 53.9 p -82.48 141.05 33.0 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.458 -0.941 . . . . 54.01 108.458 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 11.9 p -142.6 19.43 2.02 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.113 -0.992 . . . . 74.4 109.585 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.429 HG22 ' CE2' ' B' ' 214' ' ' PHE . 5.3 t -125.94 141.58 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.499 -0.751 . . . . 72.12 109.78 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -119.82 107.6 13.36 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.313 -0.995 . . . . 65.41 108.313 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 206' ' ' THR . . . . . 0.443 ' H ' HG22 ' B' ' 206' ' ' THR . 0.0 OUTLIER -75.17 120.13 20.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.958 . . . . 71.33 109.796 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.49 HG12 ' H ' ' B' ' 209' ' ' ARG . 3.0 t -117.28 148.88 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 109.114 -0.698 . . . . 63.5 109.114 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -91.64 -1.63 57.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.191 -0.943 . . . . 74.45 109.44 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 209' ' ' ARG . . . . . 0.49 ' H ' HG12 ' B' ' 207' ' ' VAL . 31.4 mmt180 -76.19 -118.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.353 -0.842 . . . . 74.14 109.56 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -57.33 -47.74 80.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.197 -0.939 . . . . 74.43 109.977 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.85 -126.83 1.09 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.026 -1.229 . . . . 64.45 110.026 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -100.17 133.56 44.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.271 -1.135 . . . . 74.21 109.408 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -100.53 118.13 36.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.409 -0.807 . . . . 74.03 109.445 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 214' ' ' PHE . . . . . 0.429 ' CE2' HG22 ' B' ' 204' ' ' VAL . 26.2 m-85 -98.56 131.03 45.1 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.412 -0.805 . . . . 74.34 109.113 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 30.3 p -158.48 161.04 37.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 64.33 109.077 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 216' ' ' TYR . . . . . 0.933 ' CE2' ' OD2' ' B' ' 160' ' ' ASP . 1.6 m-85 -61.24 150.16 80.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.995 -1.065 . . . . 70.04 108.698 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.07 -55.65 0.13 Allowed 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.123 1.882 . . . . 65.11 111.561 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 62.8 mttm . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 108.385 -0.969 . . . . 73.15 108.385 179.817 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.3 ttm . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.474 -0.565 . . . . 65.12 109.474 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -144.56 141.68 29.65 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.196 -0.94 . . . . 72.33 109.182 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 80.2 t -112.55 134.86 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.562 0.696 . . . . 71.42 109.958 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.552 HD11 ' CG1' ' A' ' 6' ' ' ILE . 1.3 tp -103.2 118.58 37.12 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.101 -1.074 . . . . 65.12 108.101 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.552 HD12 ' SD ' ' A' ' 49' ' ' MET . 3.9 tp -117.82 107.23 13.88 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.66 -0.65 . . . . 62.43 109.483 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.552 ' CG1' HD11 ' A' ' 4' ' ' LEU . 37.4 mt -98.36 101.5 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.327 -0.99 . . . . 71.15 108.327 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -131.42 124.11 29.58 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.61 -0.681 . . . . 75.34 109.465 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -65.66 -34.46 78.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.277 -0.889 . . . . 72.44 109.15 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -87.07 112.2 21.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 63.02 109.227 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.6 m -65.7 -26.71 67.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 72.34 109.588 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.72 -52.75 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.193 -0.942 . . . . 74.02 109.774 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.1 mt -61.6 -34.83 76.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.977 . . . . 71.43 109.291 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.94 -26.96 71.43 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.566 -1.814 . . . . 61.32 108.566 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.13 -52.41 44.68 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 109.529 -1.428 . . . . 71.2 109.529 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -59.97 -45.09 93.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.372 -1.075 . . . . 71.32 109.824 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.4 mm -64.31 -38.55 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.795 -1.191 . . . . 63.23 108.828 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -62.89 -49.29 75.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.329 -0.857 . . . . 51.11 110.099 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -78.03 -7.34 56.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.077 -1.015 . . . . 73.34 109.815 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.77 -54.45 3.24 Favored Glycine 0 N--CA 1.483 1.824 0 N-CA-C 109.505 -1.438 . . . . 62.15 109.505 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.91 -24.13 61.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.376 -1.073 . . . . 73.51 109.489 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -56.04 -38.46 70.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.137 -0.977 . . . . 74.25 109.184 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.5 t -51.94 -47.53 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.271 -0.893 . . . . 70.04 109.05 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -53.81 -53.16 56.32 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.602 -0.888 . . . . 73.23 108.602 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.94 40.77 0.28 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.353 -1.499 . . . . 75.54 109.353 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -117.13 160.28 21.27 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.511 -0.994 . . . . 73.43 109.139 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.5 mmt -101.11 139.35 36.91 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.204 -1.036 . . . . 43.24 108.204 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.59 146.75 34.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.167 -0.958 . . . . 62.11 110.339 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -120.69 149.23 42.83 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.911 -0.774 . . . . 74.42 108.911 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 m -110.53 134.99 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.427 -0.796 . . . . 72.15 108.906 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.4 p -136.82 168.2 20.0 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.359 -0.838 . . . . 71.42 109.531 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -90.25 -105.61 0.09 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.329 -0.857 . . . . 72.33 109.662 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.5 p -81.16 169.11 17.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 74.24 110.07 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.5 mt -53.95 -32.67 54.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.579 -0.7 . . . . 71.53 109.521 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -49.81 -49.68 47.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 74.23 109.541 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -64.95 -51.83 59.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 54.03 109.31 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.36 -39.03 96.69 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.694 -1.362 . . . . 61.41 109.694 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -64.28 -47.06 80.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -1.141 . . . . 74.34 109.413 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -69.78 -35.3 74.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.067 -1.021 . . . . 75.33 109.19 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.424 ' CD1' ' C ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -70.4 -65.53 0.72 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.84 . . . . 74.33 109.204 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 40' ' ' MET . 2.9 ppp? -48.47 -20.38 0.42 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.263 -0.898 . . . . 70.32 109.936 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -65.52 -43.24 90.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.075 -1.016 . . . . 71.22 110.091 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.3 pt -82.31 -26.71 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.172 -0.955 . . . . 74.14 110.195 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 40' ' ' MET . 99.4 mtt180 -129.96 143.7 50.94 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.35 -0.844 . . . . 72.24 109.507 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -97.59 151.09 20.42 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.214 -0.929 . . . . 75.42 109.556 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -127.51 141.08 51.75 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.529 -0.732 . . . . 74.23 109.252 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -78.05 -42.15 33.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 72.04 109.471 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.61 HD23 HD21 ' A' ' 113' ' ' LEU . 0.3 OUTLIER -104.01 112.77 25.9 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.474 -0.766 . . . . 72.13 108.941 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.461 ' N ' HD13 ' A' ' 47' ' ' LEU . 74.0 t -99.45 98.48 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.406 -0.961 . . . . 72.34 108.406 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.552 ' SD ' HD12 ' A' ' 5' ' ' LEU . 1.5 tmt? -114.99 135.94 53.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.617 -0.677 . . . . 74.11 109.834 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.6 HG22 ' H ' ' A' ' 52' ' ' ASP . 1.1 p -143.59 131.19 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.78 0.8 . . . . 61.12 109.82 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.7 p -95.26 9.64 39.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.571 -0.706 . . . . 73.11 109.744 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.6 ' H ' HG22 ' A' ' 50' ' ' VAL . 80.0 m-20 -77.04 141.48 40.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 52.55 109.514 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.48 ' C ' ' H ' ' A' ' 55' ' ' ALA . 92.2 mttt -75.1 -45.42 41.31 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.294 -0.879 . . . . 44.22 110.447 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -68.51 10.99 0.2 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.096 -1.002 . . . . 70.44 109.84 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.48 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -68.84 -22.49 64.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 64.14 110.28 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 52.4 mt -42.62 -50.34 5.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.297 -0.877 . . . . 44.14 110.401 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.1 m -68.74 -31.91 71.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.932 -1.105 . . . . 55.23 109.333 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.605 ' CE2' HD11 ' A' ' 62' ' ' ILE . 58.3 t80 -70.19 -56.57 6.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.463 -0.773 . . . . 74.44 110.2 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.4 m -55.03 -34.06 30.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.609 -1.307 . . . . 74.03 109.528 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.7 t -60.42 -54.89 40.1 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.287 -0.883 . . . . 64.3 109.499 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.667 HH21 ' NZ ' ' A' ' 65' ' ' LYS . 7.1 ptm180 -67.3 -25.52 66.07 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.045 -1.062 . . . . 64.44 109.967 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.605 HD11 ' CE2' ' A' ' 58' ' ' PHE . 4.9 mm -59.87 -48.03 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.783 -1.198 . . . . 63.21 108.968 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -64.45 -45.19 88.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.023 -1.048 . . . . 74.42 108.87 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -60.86 -51.52 68.95 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.326 -0.99 . . . . 70.32 108.326 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.667 ' NZ ' HH21 ' A' ' 61' ' ' ARG . 93.1 mttt -71.81 -69.68 0.37 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.253 -0.647 . . . . 75.22 109.253 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 62' ' ' ILE . 86.5 m-70 -98.02 90.54 4.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.319 -0.863 . . . . 74.13 109.019 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 t -79.01 -40.1 32.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 73.24 109.914 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.8 t -78.15 57.92 1.93 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 61.01 109.611 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 66' ' ' HIS . 14.6 tt -152.03 158.12 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.147 -0.97 . . . . 71.33 109.656 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.2 t -97.63 146.87 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.119 -0.988 . . . . 72.13 109.111 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.7 t -133.01 125.81 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.317 -0.864 . . . . 54.21 110.5 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.526 HD23 ' C ' ' A' ' 72' ' ' LEU . 3.7 tt -122.87 100.03 6.69 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.652 -0.87 . . . . 50.24 108.652 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.7 p -92.69 153.55 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.76 -1.212 . . . . 74.41 109.221 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.7 m -127.54 166.54 17.8 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.257 -1.016 . . . . 72.31 108.257 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 77' ' ' ASN . 23.0 t -170.8 126.41 0.72 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.967 -1.083 . . . . 64.54 110.415 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 57.3 p30 -71.69 14.67 0.18 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.569 -0.707 . . . . 74.13 110.121 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.427 ' H ' ' C ' ' A' ' 75' ' ' SER . 22.6 m120 -138.43 73.91 41.82 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.195 -0.941 . . . . 73.34 109.933 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.6 76.53 4.49 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.682 2.255 . . . . 63.22 112.358 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.415 HG23 ' H ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -104.92 154.63 19.82 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.296 -1.001 . . . . 62.53 108.296 178.999 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.45 -25.08 2.33 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.171 -0.956 . . . . 73.44 109.738 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -69.72 -50.61 41.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.944 . . . . 71.42 110.149 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 77' ' ' ASN . 88.9 mt-10 -71.32 -27.74 63.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.097 -1.002 . . . . 73.43 110.162 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -64.21 -56.93 11.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.091 -1.005 . . . . 74.22 109.764 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.522 HG23 ' N ' ' A' ' 85' ' ' HIS . 17.9 m -66.13 -40.96 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 73.2 109.676 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.522 ' N ' HG23 ' A' ' 84' ' ' VAL . 27.7 t-80 -64.7 -38.99 92.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.21 -0.931 . . . . 53.33 109.744 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.52 95.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 64.11 110.178 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.507 ' CE1' ' NH1' ' B' ' 108' ' ' ARG . 44.2 m-85 -72.84 -31.01 64.48 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.038 -1.039 . . . . 74.34 108.605 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -73.71 -34.73 64.95 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.412 -0.805 . . . . 74.42 109.261 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -62.86 -55.85 22.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.896 . . . . 74.24 109.441 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.63 29.0 0.08 OUTLIER Glycine 0 N--CA 1.498 2.804 0 C-N-CA 119.813 -1.184 . . . . 61.51 110.425 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.49 128.57 39.66 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.935 -1.332 . . . . 55.33 108.995 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.669 ' HB3' HH21 ' A' ' 112' ' ' ARG . 36.2 m-20 -64.68 -36.41 84.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.978 -1.076 . . . . 73.42 108.971 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 94' ' ' TYR . 62.8 t0 -152.53 145.65 24.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.373 -0.829 . . . . 75.04 108.943 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.497 ' CD1' ' C ' ' A' ' 94' ' ' TYR . 0.4 OUTLIER -123.15 121.54 36.23 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.985 -0.746 . . . . 71.33 108.985 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.496 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -108.98 141.92 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 121.789 0.804 . . . . 71.13 109.526 -178.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . -62.35 125.15 22.91 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.16 -1.422 . . . . 64.32 107.16 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.567 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -44.33 -57.13 6.86 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.004 -1.06 . . . . 62.2 111.102 -178.697 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 7.4 Cg_endo -44.2 90.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 CA-C-N 119.467 0.845 . . . . 73.11 111.17 -176.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.567 ' N ' ' O ' ' A' ' 97' ' ' LYS . 42.8 m-85 -44.18 104.26 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.625 -0.672 . . . . 65.22 109.97 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 31.2 ttm-85 -54.49 -25.6 26.38 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.595 -0.891 . . . . 72.35 108.595 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.751 ' O ' ' N ' ' A' ' 103' ' ' LYS . 15.7 t -178.07 24.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.398 -0.814 . . . . 71.32 109.866 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 87.9 mt 52.89 -70.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.66 -0.65 . . . . 75.43 109.609 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.751 ' N ' ' O ' ' A' ' 101' ' ' SER . 48.9 mttp -56.2 -23.04 32.83 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.517 -1.29 . . . . 71.41 107.517 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' A' ' 101' ' ' SER . . . -68.08 -45.47 73.7 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.929 -1.137 . . . . 63.24 107.929 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.6 tp -65.48 -51.7 58.18 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.681 -0.859 . . . . 73.22 108.681 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 38.3 t -58.36 -42.73 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.108 -0.995 . . . . 60.11 108.654 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.87 -39.55 59.15 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.304 -0.872 . . . . 70.42 108.881 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 53.8 mtp180 -66.94 -35.6 80.33 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.192 -0.942 . . . . 74.41 108.811 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.9 mt -75.56 -26.76 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.21 -0.931 . . . . 62.54 108.992 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -65.4 -52.06 56.04 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.448 -0.783 . . . . 74.34 110.137 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -74.86 -29.35 61.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.111 -0.993 . . . . 73.32 110.382 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.669 HH21 ' HB3' ' A' ' 92' ' ' ASP . 33.9 ttt85 -61.03 -44.24 97.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.041 . . . . 52.41 109.895 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.61 HD21 HD23 ' A' ' 47' ' ' LEU . 0.4 OUTLIER -150.79 82.58 1.34 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.8 -1.187 . . . . 65.24 109.745 179.277 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.401 ' HA ' ' HE ' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -95.01 -58.03 2.27 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.485 -0.932 . . . . 64.45 108.485 179.489 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -69.08 -58.04 4.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 74.43 109.662 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 46.22 85.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.232 -0.917 . . . . 74.42 109.662 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.99 99.41 0.12 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.3 -1.52 . . . . 75.04 109.3 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.7 t -152.61 162.67 40.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.197 -1.178 . . . . 61.14 109.894 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.61 129.45 6.99 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.966 -0.753 . . . . 65.24 108.966 -178.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 17.3 t -91.11 -32.77 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.185 -0.947 . . . . 73.11 109.268 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 24.9 mm -107.53 137.23 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.934 -0.765 . . . . 72.24 108.934 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -148.89 136.6 20.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.067 -1.021 . . . . 72.34 109.982 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.5 pt -151.54 134.75 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.432 -0.793 . . . . 71.44 109.112 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 45.84 -142.28 4.58 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.747 -1.341 . . . . 73.4 109.747 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -85.59 -5.96 59.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.257 -1.143 . . . . 74.45 109.393 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.429 HD22 ' CD1' ' A' ' 137' ' ' TYR . 0.7 OUTLIER -91.12 136.69 32.92 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.336 -0.987 . . . . 54.21 108.336 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.7 m -130.61 144.07 51.17 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.387 -0.82 . . . . 54.5 109.605 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 82.5 mt -133.28 137.69 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.291 -0.88 . . . . 45.15 109.475 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.4 m -121.77 85.22 44.38 Favored Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 109.069 -0.715 . . . . 71.11 109.069 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.89 -41.05 82.19 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.549 2.166 . . . . 65.41 112.237 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -59.05 -46.9 87.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 63.32 109.293 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -82.7 -7.06 59.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 72.52 109.153 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.408 ' OE2' ' O ' ' A' ' 144' ' ' VAL . 70.8 tt0 56.98 58.49 3.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.411 -0.806 . . . . 75.33 109.567 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.45 ' C ' HD12 ' A' ' 135' ' ' ILE . 32.3 ttpt -148.65 123.94 10.23 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.294 -0.879 . . . . 71.23 109.435 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.593 HD12 ' N ' ' A' ' 135' ' ' ILE . 1.6 mp -96.94 138.07 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.217 -0.927 . . . . 74.02 109.392 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.3 mm -115.11 127.89 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 109.023 -0.732 . . . . 60.23 109.023 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.429 ' CD1' HD22 ' A' ' 126' ' ' LEU . 79.5 t80 -136.43 123.71 21.88 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.356 -0.84 . . . . 62.32 109.48 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 66.3 mttm 53.52 33.85 17.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.335 -0.853 . . . . 75.4 110.032 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.11 11.09 85.71 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.292 -1.123 . . . . 72.24 110.292 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 50.3 mtp85 -94.91 124.49 38.98 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.143 -1.21 . . . . 71.22 109.073 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -94.88 119.31 33.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.259 -0.901 . . . . 71.42 109.608 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.6 p -135.61 137.7 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.469 -0.769 . . . . 53.02 109.297 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.505 ' N ' ' OE1' ' A' ' 143' ' ' GLU . 46.1 mp0 -95.98 154.46 17.22 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.323 -0.86 . . . . 60.45 109.298 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.408 ' O ' ' OE2' ' A' ' 133' ' ' GLU . 29.9 m -139.61 144.09 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.365 -0.834 . . . . 74.44 109.551 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -168.47 21.77 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.937 . . . . 65.15 109.751 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.19 -174.93 50.63 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.333 -1.507 . . . . 73.34 109.333 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.633 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 5.8 ttpm? -83.14 -32.76 0.55 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.3 -1.118 . . . . 72.22 111.048 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 91.6 Cg_endo -89.37 -16.67 2.04 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 122.149 1.899 . . . . 65.23 112.733 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -81.99 -24.87 35.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.108 -0.995 . . . . 60.11 109.818 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.525 ' O ' ' ND1' ' A' ' 154' ' ' HIS . 95.8 mt-10 -51.53 -31.94 26.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.097 -1.002 . . . . 64.21 108.862 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 148' ' ' PRO . 5.4 p -63.56 -36.76 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.438 -0.789 . . . . 72.02 109.07 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.427 ' CD1' ' SD ' ' A' ' 195' ' ' MET . 21.3 tp -62.92 -42.47 99.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 73.31 109.084 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.4 m -72.47 -36.88 68.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.403 -0.81 . . . . 74.31 109.864 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 150' ' ' GLU . 8.2 m80 -60.7 -52.71 63.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.122 -0.986 . . . . 74.31 110.182 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 159' ' ' ARG . 3.2 pp -68.89 -25.97 64.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.866 -1.146 . . . . 75.34 109.589 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.73 -52.68 64.03 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.136 -0.977 . . . . 62.14 109.241 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.0 ptm85 -68.28 -43.4 77.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.351 -0.843 . . . . 61.03 109.651 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -95.29 29.38 2.53 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.104 -0.998 . . . . 74.12 109.251 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.584 HH21 HG21 ' A' ' 203' ' ' THR . 27.8 ttt85 -60.13 -21.76 61.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.317 -0.865 . . . . 71.13 109.519 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 160' ' ' ASP . 41.8 p30 -115.6 66.65 0.7 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.009 -0.737 . . . . 75.45 109.009 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.572 ' NE2' ' O ' ' A' ' 162' ' ' ILE . 1.2 tm0? -164.3 156.8 16.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.161 -0.962 . . . . 73.41 109.378 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.572 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 9.3 mm -82.33 123.99 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.214 -0.929 . . . . 74.41 109.312 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.412 HG11 HD21 ' A' ' 168' ' ' LEU . 21.5 t -120.62 136.95 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.508 -0.745 . . . . 72.31 109.628 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.0 p -91.86 159.69 15.66 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.329 -0.857 . . . . 74.12 109.425 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.4 mtmm -59.87 -45.55 92.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 70.43 109.486 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -62.85 -31.59 72.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 73.52 109.732 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -59.99 -44.98 94.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.125 -0.984 . . . . 74.52 109.456 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.412 HD21 HG11 ' A' ' 163' ' ' VAL . 37.7 mt -64.72 -44.19 91.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 72.31 109.578 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 11.8 tp -64.58 -43.8 92.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.306 -0.871 . . . . 53.33 109.528 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -75.2 -10.0 59.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 62.44 109.705 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.02 -54.75 3.98 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -0.915 . . . . 60.21 109.804 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.699 HD12 ' N ' ' A' ' 172' ' ' ILE . 1.9 mp -88.04 -50.1 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.168 -0.957 . . . . 75.32 109.858 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 17.9 m-90 . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.069 -1.019 . . . . 73.14 109.881 -179.413 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 21.0 p30 . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.233 -0.655 . . . . 64.54 109.233 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.8 p -171.52 -29.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 74.02 109.367 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.562 ' O ' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -53.57 -41.01 44.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.352 -0.843 . . . . 72.33 109.58 -179.73 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.4 ' N ' ' CG2' ' A' ' 184' ' ' ILE . 18.5 mt-10 -54.51 -38.45 66.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.849 -1.157 . . . . 74.4 109.375 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 2.3 t -75.46 -34.7 30.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.388 -0.82 . . . . 70.42 109.605 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.0 -51.04 23.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 52.11 109.869 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.2 tp -61.88 -32.62 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.984 -1.072 . . . . 71.4 109.745 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -66.31 -55.77 14.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.118 -0.989 . . . . 73.44 110.215 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -67.0 -41.53 86.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.038 -1.039 . . . . 71.42 109.665 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 71.6 mt -56.88 -44.43 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.098 -1.001 . . . . 61.55 109.136 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.4 mtp-105 -57.54 -44.14 84.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 63.34 108.947 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -67.28 -36.43 81.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.876 . . . . 61.24 109.332 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.495 ' O ' ' CG ' ' A' ' 198' ' ' PRO . 96.0 mttt -71.69 -15.8 62.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.867 . . . . 75.13 109.761 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' MET . . . . . 0.427 ' SD ' ' CD1' ' A' ' 152' ' ' LEU . 86.2 mmm -93.62 -15.45 25.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.097 -1.002 . . . . 74.02 109.968 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -102.82 -9.38 20.0 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.137 -0.977 . . . . 74.02 110.38 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.557 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 3.8 tmtp? -89.63 -42.45 0.43 Allowed Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.917 -1.114 . . . . 75.43 110.241 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 38.1 Cg_endo -90.4 -58.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.688 2.259 . . . . 72.32 112.493 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.605 HD22 ' N ' ' A' ' 199' ' ' LEU . 3.3 mm? -61.3 -33.82 74.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.911 -1.118 . . . . 74.54 108.877 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 75.22 -15.94 3.94 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.689 -1.364 . . . . 61.51 109.689 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.413 ' H ' ' C ' ' A' ' 199' ' ' LEU . 6.1 mt -115.49 129.36 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.479 -1.013 . . . . 61.22 109.011 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 12.6 t -79.94 139.09 37.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.061 -1.024 . . . . 72.0 109.242 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.584 HG21 HH21 ' A' ' 159' ' ' ARG . 3.8 p -139.88 7.72 2.28 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.295 -0.878 . . . . 74.44 109.647 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.37 133.68 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.461 -0.774 . . . . 64.35 109.413 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 39.8 tp10 -114.45 133.95 55.36 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.55 -0.719 . . . . 71.41 109.394 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.7 p -99.42 139.96 34.31 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.285 -0.885 . . . . 73.52 109.261 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 211' ' ' GLY . 18.5 m -149.86 136.75 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.231 -0.918 . . . . 71.02 109.46 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -85.66 -13.65 47.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 72.12 109.343 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -55.16 -34.13 63.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.271 -0.893 . . . . 64.41 109.485 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 64.7 mtp85 -151.18 -63.12 0.19 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.263 -0.898 . . . . 71.54 109.405 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 207' ' ' VAL . . . -161.89 -114.14 0.32 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.657 -1.377 . . . . 72.03 109.657 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -126.2 124.31 40.16 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.601 -0.941 . . . . 75.54 109.474 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 26.1 ttm105 -90.28 121.48 32.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.36 -0.837 . . . . 75.31 109.006 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -95.96 123.98 39.78 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.304 -0.872 . . . . 75.41 109.337 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 44.2 t -154.84 152.22 29.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.434 -0.792 . . . . 74.14 109.069 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.36 145.0 84.82 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.089 -1.007 . . . . 75.32 108.791 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo . . . . . 0 N--CA 1.49 1.291 0 C-N-CA 122.212 1.941 . . . . 73.11 112.334 -179.926 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 53.2 ttm . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.478 -0.564 . . . . 71.14 109.478 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.609 ' NH1' ' HE ' ' B' ' 43' ' ' ARG . 39.9 ttt85 -139.8 146.73 39.79 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.375 -0.828 . . . . 73.23 109.397 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 73.2 t -118.0 137.11 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 121.583 0.706 . . . . 72.24 109.669 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.52 HD11 ' CG1' ' B' ' 6' ' ' ILE . 3.3 tp -108.8 117.65 34.73 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.576 -0.898 . . . . 54.33 108.576 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.407 ' N ' HD12 ' B' ' 4' ' ' LEU . 5.4 tp -119.4 101.42 7.94 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.071 -0.714 . . . . 74.35 109.071 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.52 ' CG1' HD11 ' B' ' 4' ' ' LEU . 53.8 mt -91.71 97.72 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.907 -1.12 . . . . 42.55 108.749 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.422 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 31.8 tp10 -123.42 136.79 54.8 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.611 0.72 . . . . 74.52 109.407 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -77.76 -32.74 52.78 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.526 -0.734 . . . . 62.55 109.308 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -90.02 115.41 27.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.364 -0.835 . . . . 73.11 109.367 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 15.6 t -65.78 -30.88 71.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.229 -0.919 . . . . 65.54 109.821 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 85.8 t -61.67 -50.29 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.133 -0.98 . . . . 75.55 109.791 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.614 HD12 ' NZ ' ' B' ' 97' ' ' LYS . 3.5 mm? -64.83 -31.34 72.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 70.14 109.439 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.26 -29.94 57.69 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.744 -1.743 . . . . 75.4 108.744 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.87 -51.64 54.17 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.584 -1.406 . . . . 65.44 109.584 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -63.17 -42.09 99.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.331 -1.099 . . . . 60.21 109.622 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 4.8 mm -65.41 -38.61 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.009 -1.057 . . . . 75.15 108.768 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -64.83 -54.37 32.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.382 -0.824 . . . . 73.01 109.986 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -72.64 -6.26 43.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.147 -0.971 . . . . 74.3 109.771 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.87 -55.35 2.83 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.657 -1.377 . . . . 70.54 109.657 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp -74.17 -23.42 59.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.38 -1.071 . . . . 71.34 109.802 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -53.74 -35.98 61.8 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.152 -0.968 . . . . 64.41 109.394 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 98.0 t -55.25 -42.31 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.205 -0.935 . . . . 74.23 109.198 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 18.7 mmtp -64.64 -13.02 51.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.309 -0.869 . . . . 63.42 108.685 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.06 32.3 23.77 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.125 -1.19 . . . . 53.43 110.125 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -102.37 159.24 15.59 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.243 -1.151 . . . . 71.12 108.48 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 15.5 mtt -100.01 137.84 37.91 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.288 -1.004 . . . . 75.24 108.288 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.57 150.86 39.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 72.12 109.984 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ASP . . . . . 0.531 ' OD2' ' NH2' ' B' ' 2' ' ' ARG . 75.2 m-20 -126.16 144.35 50.79 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.822 -0.807 . . . . 72.31 108.822 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 1.4 p -112.13 129.07 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.716 -0.846 . . . . 64.43 108.716 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 6.8 p -134.1 167.85 19.89 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.533 -0.729 . . . . 65.41 109.455 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -93.79 -97.47 0.15 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.247 -0.908 . . . . 71.02 109.808 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 51.9 p -78.15 165.16 24.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.195 -0.941 . . . . 51.11 110.25 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' B' ' 37' ' ' GLU . 46.9 mt -55.01 -35.29 64.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.567 -0.708 . . . . 71.24 110.218 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -55.98 -44.19 78.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.053 -1.029 . . . . 74.32 109.831 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -62.47 -41.26 98.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.142 -0.974 . . . . 73.03 109.311 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' GLY . . . . . 0.438 ' O ' ' CG ' ' B' ' 40' ' ' MET . . . -80.63 -23.82 59.55 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.421 -1.472 . . . . 30.21 109.421 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' B' ' 33' ' ' LEU . 84.8 tt0 -66.43 -44.72 82.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -1.152 . . . . 74.42 109.661 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -79.3 -35.07 41.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.105 -0.997 . . . . 74.42 109.706 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 8.4 tt -73.82 -37.03 65.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 75.41 110.108 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' MET . . . . . 0.442 ' SD ' ' CE1' ' B' ' 45' ' ' TYR . 2.8 ppp? -76.15 -32.28 59.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.935 -1.103 . . . . 60.41 109.902 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -51.38 -37.03 46.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.926 . . . . 53.23 110.374 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.404 HG12 ' H ' ' B' ' 42' ' ' ILE . 11.2 pt -78.94 -33.54 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.0 -1.062 . . . . 71.23 110.114 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.609 ' HE ' ' NH1' ' B' ' 2' ' ' ARG . 30.2 mmt-85 -93.96 168.6 10.86 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.906 -1.121 . . . . 72.22 110.024 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' ASN . . . . . 0.517 ' C ' ' CD1' ' B' ' 45' ' ' TYR . 30.9 p30 -92.85 -19.31 21.83 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.298 -0.876 . . . . 63.54 109.954 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.517 ' CD1' ' C ' ' B' ' 44' ' ' ASN . 11.0 p90 40.11 97.86 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.566 -0.709 . . . . 64.35 110.997 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -80.41 -38.04 31.0 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.056 -1.028 . . . . 62.22 109.1 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.464 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.3 OUTLIER -106.64 114.36 28.42 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.745 -1.206 . . . . 73.12 107.745 179.255 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.464 ' N ' HD13 ' B' ' 47' ' ' LEU . 65.4 t -99.07 97.78 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.224 -0.922 . . . . 65.11 108.846 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.404 ' SD ' ' CD1' ' B' ' 5' ' ' LEU . 25.5 ttt -113.58 131.4 56.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.554 -0.717 . . . . 73.44 109.782 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.516 HG22 ' H ' ' B' ' 52' ' ' ASP . 0.5 OUTLIER -144.89 135.46 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.535 -0.728 . . . . 34.5 109.234 -179.765 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 51' ' ' SER . . . . . 0.422 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 38.8 p -103.17 15.06 30.28 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.552 -0.718 . . . . 73.21 109.79 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.516 ' H ' HG22 ' B' ' 50' ' ' VAL . 83.0 m-20 -77.83 144.92 36.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.104 -0.998 . . . . 70.41 109.467 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' B' ' 55' ' ' ALA . 41.6 mmtm -74.37 -43.31 57.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.224 -0.923 . . . . 65.0 110.164 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -72.86 13.14 0.41 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.07 -1.019 . . . . 75.21 109.786 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.438 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -69.34 -22.35 63.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 55.33 110.136 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 19.7 mt -42.04 -52.34 4.26 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.508 -0.745 . . . . 63.14 110.083 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 24.7 m -66.44 -35.07 79.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.956 -1.09 . . . . 63.5 109.082 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' PHE . . . . . 0.431 ' CZ ' HD11 ' B' ' 62' ' ' ILE . 57.4 t80 -65.26 -62.18 1.69 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.466 -0.771 . . . . 72.33 110.0 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 32.5 m -49.33 -34.08 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.637 -1.289 . . . . 74.54 109.962 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 24.6 p -59.42 -53.66 55.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.052 -1.03 . . . . 71.24 109.739 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -66.24 -27.93 68.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.036 -1.04 . . . . 74.31 110.125 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.431 HD11 ' CZ ' ' B' ' 58' ' ' PHE . 32.9 mm -65.5 -38.82 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.767 -1.208 . . . . 72.14 109.894 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -70.72 -47.81 57.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.028 -1.045 . . . . 73.32 110.598 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -69.77 -40.41 76.09 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.873 -1.142 . . . . 73.12 110.335 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.488 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 62.7 mttm -75.84 -24.31 55.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.13 -0.981 . . . . 72.44 109.979 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.488 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 90.5 m-70 -155.71 64.48 0.6 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.116 -0.99 . . . . 63.31 109.719 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 22.8 t -57.2 -27.93 62.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -0.889 . . . . 73.1 109.606 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 92.0 p -65.17 -23.08 67.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 71.53 109.906 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.403 HG22 ' N ' ' B' ' 70' ' ' VAL . 60.5 mt -82.32 158.45 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.186 -0.946 . . . . 74.4 109.533 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.403 ' N ' HG22 ' B' ' 69' ' ' ILE . 70.3 t -98.83 150.82 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.288 -0.883 . . . . 75.12 109.608 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 16.2 t -130.38 126.51 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.386 -0.821 . . . . 73.2 109.95 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 6.5 tt -121.98 100.34 6.93 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 109.094 -0.706 . . . . 73.34 109.094 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 9.2 p -93.71 134.87 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.981 -1.075 . . . . 73.5 109.253 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 11.9 p -96.08 172.19 8.14 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.219 -0.926 . . . . 64.34 109.228 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.461 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 33.6 t -156.23 112.99 3.13 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.98 -1.075 . . . . 74.53 110.183 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 76' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' B' ' 77' ' ' ASN . 54.5 p30 -70.64 -12.13 61.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 64.5 109.217 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' ASN . . . . . 0.449 ' N ' ' OD1' ' B' ' 76' ' ' ASP . 87.2 m-20 -134.3 73.84 68.32 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.686 -0.857 . . . . 74.25 108.686 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -50.1 84.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.649 2.233 . . . . 74.43 111.781 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.449 ' N ' ' O ' ' B' ' 77' ' ' ASN . 7.1 p -100.33 151.18 21.8 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.941 -0.762 . . . . 73.12 108.941 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.99 -29.93 69.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.176 -0.953 . . . . 71.01 109.064 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -65.66 -37.01 85.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.304 -0.872 . . . . 63.2 109.251 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -74.75 -30.81 61.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.185 -0.947 . . . . 73.22 109.584 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -69.3 -50.2 48.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.95 . . . . 74.3 109.817 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.404 HG23 ' N ' ' B' ' 85' ' ' HIS . 28.3 m -62.1 -36.73 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.088 -1.008 . . . . 73.31 109.38 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 85' ' ' HIS . . . . . 0.404 ' N ' HG23 ' B' ' 84' ' ' VAL . 16.6 m80 -77.92 -20.11 53.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 73.24 109.544 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.6 -42.6 58.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.188 -0.945 . . . . 55.33 110.275 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -83.13 -29.48 28.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.956 -1.09 . . . . 74.14 109.238 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -75.86 -37.91 58.45 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.308 -0.87 . . . . 64.04 109.741 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 89' ' ' GLN . . . . . 0.482 ' CG ' ' N ' ' B' ' 90' ' ' GLY . 11.8 pt20 -73.02 -47.44 45.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.107 -0.995 . . . . 72.35 109.792 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 90' ' ' GLY . . . . . 0.482 ' N ' ' CG ' ' B' ' 89' ' ' GLN . . . 147.38 65.35 0.01 OUTLIER Glycine 0 N--CA 1.495 2.614 0 C-N-CA 119.776 -1.202 . . . . 65.2 110.395 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.24 138.15 53.6 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.363 -1.08 . . . . 52.23 108.978 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.53 ' CG ' HH21 ' B' ' 112' ' ' ARG . 46.1 t0 -86.54 -26.18 24.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.097 -1.002 . . . . 73.32 109.608 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 93' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 14.4 t0 -152.41 153.09 32.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 72.22 109.578 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.512 ' N ' ' OD1' ' B' ' 93' ' ' ASP . 61.7 t80 -134.27 101.49 5.03 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.545 -0.909 . . . . 64.42 108.545 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 23.1 mm -110.28 147.9 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.437 0 O-C-N 121.133 -0.98 . . . . 72.23 110.283 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.48 145.36 56.23 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.832 -1.173 . . . . 25.24 107.832 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.68 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -66.24 -56.53 15.93 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.671 -1.268 . . . . 64.32 111.58 -179.058 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 98' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 2.2 Cg_endo -39.88 -12.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 120.909 1.073 . . . . 63.33 112.824 -175.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 99' ' ' TYR . . . . . 0.68 ' N ' ' O ' ' B' ' 97' ' ' LYS . 53.7 m-85 59.59 137.09 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.86 -0.525 . . . . 75.13 110.315 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 50.8 mtt-85 -73.73 -40.28 63.67 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.982 -1.074 . . . . 74.23 108.808 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 101' ' ' SER . . . . . 0.753 ' O ' ' N ' ' B' ' 103' ' ' LYS . 34.4 t -168.1 33.8 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.162 -0.961 . . . . 63.34 110.782 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 37.3 mm 50.71 -69.62 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.567 -0.708 . . . . 74.44 110.341 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.753 ' N ' ' O ' ' B' ' 101' ' ' SER . 40.3 mmtm -55.12 -30.49 59.87 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.865 -1.161 . . . . 71.11 107.865 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.78 -55.69 13.78 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.604 -0.839 . . . . 71.45 109.011 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 19.0 tp -58.05 -43.78 87.06 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.33 -0.856 . . . . 51.31 108.762 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.21 -47.88 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -0.93 . . . . 65.23 108.853 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -49.2 -38.01 24.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.14 -0.975 . . . . 24.32 108.885 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 108' ' ' ARG . . . . . 0.531 ' O ' ' NE ' ' B' ' 108' ' ' ARG . 0.0 OUTLIER -67.6 -35.25 78.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.476 -0.765 . . . . 75.31 108.97 179.446 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 64.3 mt -78.28 -29.94 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.066 -1.022 . . . . 54.24 109.435 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -67.9 -52.49 35.75 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.537 -0.727 . . . . 65.31 109.868 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.41 -38.04 74.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.194 -0.942 . . . . 72.24 110.035 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 112' ' ' ARG . . . . . 0.53 HH21 ' CG ' ' B' ' 92' ' ' ASP . 40.6 ttt85 -57.84 -35.6 71.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.993 -1.067 . . . . 72.04 109.704 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.415 HD23 ' C ' ' B' ' 113' ' ' LEU . 2.9 tt -144.07 103.01 3.96 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.097 -1.002 . . . . 75.35 109.492 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.484 ' NE ' ' H ' ' B' ' 115' ' ' PHE . 0.1 OUTLIER -142.09 -164.37 1.79 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.43 -0.952 . . . . 75.5 108.43 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 115' ' ' PHE . . . . . 0.484 ' H ' ' NE ' ' B' ' 114' ' ' ARG . 45.4 m-85 51.88 32.34 9.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.042 -1.037 . . . . 65.33 109.294 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 116' ' ' TRP . . . . . 0.757 ' CE3' ' O ' ' B' ' 117' ' ' GLY . 74.4 t90 53.66 169.01 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.499 -0.751 . . . . 74.45 110.196 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 117' ' ' GLY . . . . . 0.757 ' O ' ' CE3' ' B' ' 116' ' ' TRP . . . -47.38 145.45 4.75 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.864 -1.294 . . . . 44.21 109.864 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 43.0 t -94.22 172.87 7.94 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.425 -1.044 . . . . 71.4 109.406 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 119' ' ' ASN . . . . . 0.421 ' CG ' ' H ' ' B' ' 120' ' ' VAL . 27.4 t-20 -142.24 178.86 7.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.311 -0.868 . . . . 72.32 109.043 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 120' ' ' VAL . . . . . 0.421 ' H ' ' CG ' ' B' ' 119' ' ' ASN . 18.8 t -140.16 -45.15 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.243 -0.911 . . . . 75.02 109.233 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 9.2 mm -97.89 111.14 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.057 -1.027 . . . . 51.41 108.501 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -128.23 105.49 8.39 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.496 -0.753 . . . . 71.53 109.287 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.494 ' O ' HG23 ' B' ' 123' ' ' ILE . 10.5 tp -145.2 122.79 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.165 -0.96 . . . . 72.43 109.077 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 124' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' B' ' 126' ' ' LEU . . . 54.86 -170.98 1.3 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.464 -1.855 . . . . 51.23 108.464 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.96 2.91 0.63 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.896 -1.356 . . . . 74.2 108.877 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.489 ' H ' ' C ' ' B' ' 124' ' ' GLY . 0.6 OUTLIER -91.73 117.21 29.55 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.685 -0.857 . . . . 75.42 108.685 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 83.0 m -125.11 140.92 52.46 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.475 -0.766 . . . . 74.22 108.964 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 6.3 mt -141.22 136.21 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.271 -0.893 . . . . 60.33 110.463 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 13.4 m -114.78 114.59 44.23 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.958 -0.756 . . . . 72.31 108.958 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.453 ' HB3' ' HE ' ' B' ' 157' ' ' ARG . 86.4 Cg_endo -83.48 -40.12 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.248 1.965 . . . . 75.13 112.172 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -63.34 -49.72 72.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.392 -0.818 . . . . 75.23 109.492 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -81.83 -0.17 42.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.955 . . . . 72.43 109.278 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 50.34 74.25 0.23 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.123 -0.985 . . . . 75.13 109.605 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -159.33 129.64 5.76 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.075 -1.015 . . . . 73.22 109.351 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 12.4 tt -109.37 128.97 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.795 -0.817 . . . . 64.14 108.795 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 69.2 mt -116.39 126.48 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-O 121.535 0.683 . . . . 71.22 110.404 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -135.74 147.03 48.28 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.943 -0.762 . . . . 64.22 108.943 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm 54.03 36.11 23.77 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.554 -0.716 . . . . 72.02 110.719 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 64.5 7.75 28.64 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.985 -1.246 . . . . 74.32 109.985 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -107.04 124.48 49.71 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.478 -1.013 . . . . 75.34 108.536 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 141' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' B' ' 141' ' ' GLU . 32.2 mp0 -80.92 143.2 32.82 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.416 -0.803 . . . . 71.23 109.882 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 22.5 t -134.3 129.92 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.64 -0.874 . . . . 70.43 108.64 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -83.2 149.41 26.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.343 -0.848 . . . . 72.43 109.662 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 144' ' ' VAL . . . . . 0.547 HG21 ' CZ ' ' B' ' 149' ' ' PHE . 2.5 m -153.05 144.42 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 72.13 109.384 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 27.2 pttt -175.47 101.86 0.08 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.239 -0.913 . . . . 72.02 109.262 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 177.52 174.16 43.65 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.663 -1.256 . . . . 42.23 110.246 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 147' ' ' LYS . . . . . 0.604 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 10.0 tttt -62.4 -42.4 79.86 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.457 -1.025 . . . . 73.3 109.706 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 148' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 23.3 Cg_exo -62.65 -32.45 79.0 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.575 2.184 . . . . 71.33 112.461 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 149' ' ' PHE . . . . . 0.547 ' CZ ' HG21 ' B' ' 144' ' ' VAL . 71.9 t80 -92.43 -15.35 27.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.129 -0.982 . . . . 74.23 109.886 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -60.88 -41.12 95.39 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.093 -1.004 . . . . 72.34 109.759 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.492 HG13 ' N ' ' B' ' 152' ' ' LEU . 8.6 p -72.92 -40.6 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.223 -0.923 . . . . 73.35 110.051 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.492 ' N ' HG13 ' B' ' 151' ' ' VAL . 21.1 tp -56.9 -31.21 64.66 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.268 -0.895 . . . . 55.24 109.119 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' B' ' 149' ' ' PHE . 0.2 OUTLIER -76.84 -46.67 23.88 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.488 -0.757 . . . . 70.01 109.183 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -50.29 -46.42 55.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.188 -0.945 . . . . 65.32 110.507 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 155' ' ' LEU . . . . . 0.434 HD12 ' N ' ' B' ' 156' ' ' ALA . 1.9 pp -73.77 -34.68 64.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.648 -1.283 . . . . 71.54 109.383 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 156' ' ' ALA . . . . . 0.434 ' N ' HD12 ' B' ' 155' ' ' LEU . . . -50.19 -35.8 27.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.096 -1.002 . . . . 75.32 108.951 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 157' ' ' ARG . . . . . 0.453 ' HE ' ' HB3' ' B' ' 130' ' ' PRO . 85.6 mtt180 -79.16 -46.47 17.87 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.384 -0.823 . . . . 73.32 109.175 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -85.57 49.04 1.68 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.666 -0.646 . . . . 74.14 111.068 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 159' ' ' ARG . . . . . 0.519 ' NH2' ' OG1' ' B' ' 203' ' ' THR . 5.6 tpt180 -72.83 171.57 12.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.846 -1.159 . . . . 61.41 108.097 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 51.1 t0 54.48 60.24 3.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.828 -1.17 . . . . 72.1 109.566 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -171.58 147.23 2.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.309 -0.87 . . . . 72.25 109.312 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 21.8 mm -83.63 122.31 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 72.31 108.89 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 97.1 t -119.64 139.4 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.393 -0.817 . . . . 64.21 109.553 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 5.4 t -99.69 160.46 14.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.341 -0.849 . . . . 74.22 110.047 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 165' ' ' LYS . . . . . 0.444 ' HZ2' ' CG2' ' B' ' 184' ' ' ILE . 18.0 mtpp -61.55 -44.61 96.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.528 -0.733 . . . . 65.31 109.609 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -50.54 -39.75 49.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.477 -0.764 . . . . 63.45 110.254 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -59.29 -48.89 79.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.047 -1.033 . . . . 72.4 109.51 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 27.5 mt -58.31 -30.56 66.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.212 -0.93 . . . . 72.32 109.412 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.614 HD13 ' C ' ' B' ' 169' ' ' LEU . 2.3 tm? -66.92 -66.61 0.53 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.388 -0.82 . . . . 73.34 109.872 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.01 -2.07 6.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.311 -0.868 . . . . 72.1 110.874 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.91 -57.96 2.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.838 -1.164 . . . . 62.13 110.116 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 0.711 ' N ' HD12 ' B' ' 172' ' ' ILE . 1.9 mp -91.73 -45.39 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.955 -1.091 . . . . 71.42 110.123 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 16.5 m-90 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 120.909 -1.119 . . . . 72.23 108.686 179.796 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo . . . . . 0 N--CA 1.492 1.395 0 N-CA-C 112.914 0.313 . . . . 65.22 112.914 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 18.9 p30 -160.64 107.3 1.51 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.875 -1.14 . . . . 72.31 110.17 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 96.7 t -121.55 -36.0 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.489 -0.757 . . . . 63.32 109.477 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.444 ' CG2' ' HZ2' ' B' ' 165' ' ' LYS . 24.5 mm -60.84 -22.18 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 75.03 109.667 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.09 -42.0 99.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.123 -0.986 . . . . 64.11 110.259 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 186' ' ' VAL . . . . . 0.408 HG22 ' H ' ' B' ' 186' ' ' VAL . 5.2 m -79.42 -36.89 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.925 -1.109 . . . . 73.0 109.745 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.1 -46.84 64.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.12 -0.988 . . . . 61.12 109.714 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 188' ' ' ILE . . . . . 0.444 HG23 ' N ' ' B' ' 189' ' ' ASN . 9.1 tp -62.49 -42.51 96.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.088 -1.008 . . . . 72.43 110.028 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 189' ' ' ASN . . . . . 0.454 ' OD1' ' NH2' ' B' ' 192' ' ' ARG . 55.1 t30 -58.51 -43.69 89.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.024 . . . . 65.14 109.827 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -73.7 -38.03 65.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.176 -0.953 . . . . 63.24 110.319 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 60.9 mt -65.15 -49.14 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.136 -0.977 . . . . 74.03 110.824 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 192' ' ' ARG . . . . . 0.454 ' NH2' ' OD1' ' B' ' 189' ' ' ASN . 28.4 ptt180 -64.07 -37.33 87.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.84 -1.162 . . . . 72.24 108.131 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 193' ' ' GLN . . . . . 0.524 ' HG3' ' CE ' ' B' ' 197' ' ' LYS . 42.6 tt0 -65.18 -30.43 71.34 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.905 -1.146 . . . . 73.1 107.905 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 194' ' ' LYS . . . . . 0.648 ' O ' HD13 ' B' ' 199' ' ' LEU . 36.5 mtpt -93.44 2.74 56.37 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.084 -0.71 . . . . 72.11 109.084 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 195' ' ' MET . . . . . 0.881 ' HE2' ' OG1' ' B' ' 203' ' ' THR . 5.0 tpt -94.37 -22.31 18.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.959 -1.088 . . . . 44.33 109.703 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 196' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 5.1 m-20 -114.02 -27.35 7.74 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.107 -0.995 . . . . 71.21 111.918 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 197' ' ' LYS . . . . . 0.524 ' CE ' ' HG3' ' B' ' 193' ' ' GLN . 5.2 mtmm -79.06 -62.77 0.43 Allowed Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 120.427 -1.421 . . . . 75.21 111.288 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 198' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.66 -49.28 0.17 Allowed 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 121.787 1.658 . . . . 75.32 112.221 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 199' ' ' LEU . . . . . 0.648 HD13 ' O ' ' B' ' 194' ' ' LYS . 10.6 mp -54.35 -70.79 0.09 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.092 -1.005 . . . . 72.25 109.034 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 143.44 -59.15 0.53 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.51 -1.436 . . . . 64.53 109.51 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 29.3 mt -109.34 142.81 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.558 -0.966 . . . . 44.23 109.677 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 17.3 m -77.71 139.47 39.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.122 -0.987 . . . . 54.01 108.631 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 203' ' ' THR . . . . . 0.881 ' OG1' ' HE2' ' B' ' 195' ' ' MET . 70.7 p -129.55 5.96 5.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.439 -0.788 . . . . 74.4 109.759 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.472 HG13 ' HE2' ' B' ' 195' ' ' MET . 24.3 m -121.67 147.84 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.502 -0.749 . . . . 72.12 109.642 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -116.8 125.17 51.2 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.218 -0.66 . . . . 65.41 109.218 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 206' ' ' THR . . . . . 0.413 HG22 ' H ' ' B' ' 206' ' ' THR . 0.1 OUTLIER -84.07 112.76 20.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.394 -0.817 . . . . 71.33 109.219 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.612 HG22 ' H ' ' B' ' 209' ' ' ARG . 7.3 p -138.18 145.84 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.367 -0.833 . . . . 63.5 109.264 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 208' ' ' ARG . . . . . 0.405 ' H ' ' HG2' ' B' ' 208' ' ' ARG . 36.0 ptt180 -97.1 -15.78 20.81 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.105 -0.997 . . . . 74.45 110.11 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 209' ' ' ARG . . . . . 0.612 ' H ' HG22 ' B' ' 207' ' ' VAL . 66.5 mtt-85 -50.24 -39.83 45.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.154 -0.967 . . . . 74.14 109.859 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -140.04 -53.63 0.52 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.301 -0.875 . . . . 74.43 109.4 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 211' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' B' ' 207' ' ' VAL . . . 179.65 -102.31 0.16 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.468 -1.453 . . . . 64.45 109.468 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -136.48 135.31 38.49 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.346 -1.09 . . . . 74.21 108.948 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 43.5 mtt-85 -95.15 125.78 40.03 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.31 -0.869 . . . . 74.03 109.395 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 214' ' ' PHE . . . . . 0.416 ' CD2' HG12 ' B' ' 204' ' ' VAL . 79.8 m-85 -106.4 106.43 16.95 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.493 -0.754 . . . . 74.34 109.471 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 16.4 p -158.93 170.97 20.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.213 -0.93 . . . . 64.33 109.545 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -64.14 138.54 97.44 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 121.238 -0.914 . . . . 70.04 108.81 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 217' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' B' ' 218' ' ' LYS . 74.1 Cg_endo -73.54 77.34 2.59 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.248 1.966 . . . . 65.11 112.695 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 218' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' B' ' 217' ' ' PRO . 18.4 mttm . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.405 -0.809 . . . . 73.15 109.742 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.638 ' CE ' ' HE1' ' A' ' 116' ' ' TRP . 64.3 ttp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.492 -0.559 . . . . 65.12 109.492 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -138.03 151.43 47.87 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.342 -0.849 . . . . 72.33 109.297 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.8 t -116.79 135.53 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.748 -0.595 . . . . 71.42 109.632 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 5' ' ' LEU . 0.7 OUTLIER -112.74 122.73 48.53 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.36 -0.837 . . . . 65.12 109.181 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.718 ' N ' HD12 ' A' ' 4' ' ' LEU . 11.0 mt -120.89 101.74 7.9 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.61 -0.681 . . . . 62.43 109.181 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.537 HG12 HD11 ' A' ' 4' ' ' LEU . 10.6 mt -79.27 104.61 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.781 -1.2 . . . . 71.15 108.753 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 9' ' ' ASN . 0.6 OUTLIER -139.16 123.19 17.86 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.306 -0.871 . . . . 75.34 109.215 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.44 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 68.3 mttm -65.35 -33.68 76.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 72.44 109.162 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.513 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 77.0 m-20 -82.41 112.36 19.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 63.02 109.485 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 45.5 m -63.83 -26.31 68.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 72.34 109.653 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.29 -53.2 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.195 -0.941 . . . . 74.02 109.863 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.6 mt -61.42 -46.84 88.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 71.43 109.585 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.32 -17.1 71.99 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.517 -1.833 . . . . 61.32 108.517 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.4 -54.41 5.57 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.483 -1.447 . . . . 71.2 109.483 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -56.51 -44.9 81.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.425 -1.044 . . . . 71.32 109.783 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.2 mm -63.41 -34.99 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.822 -1.174 . . . . 63.23 108.798 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.48 ' CD ' HD21 ' A' ' 21' ' ' ASN . 14.2 tm-20 -57.91 -49.66 75.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.922 . . . . 51.11 109.102 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -87.52 3.47 47.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.26 -0.9 . . . . 73.34 109.262 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.66 -57.96 2.48 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.68 -1.368 . . . . 62.15 109.68 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -75.05 -19.98 59.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -1.146 . . . . 73.51 109.869 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.48 HD21 ' CD ' ' A' ' 17' ' ' GLU . 80.4 m-20 -51.29 -33.88 30.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.092 -1.005 . . . . 74.25 109.282 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.2 t -58.0 -46.95 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.322 -0.861 . . . . 70.04 108.938 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -56.91 -53.18 60.95 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.903 -0.777 . . . . 73.23 108.903 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 133.63 36.41 0.26 Allowed Glycine 0 N--CA 1.5 2.929 0 N-CA-C 109.735 -1.346 . . . . 75.54 109.735 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.59 ' CE2' ' SD ' ' A' ' 1' ' ' MET . 20.1 m-85 -119.39 160.02 23.1 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.483 -1.01 . . . . 73.43 109.344 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.2 mmt -104.22 140.34 37.98 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.571 -0.9 . . . . 43.24 108.571 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.417 ' O ' ' OD1' ' A' ' 28' ' ' ASP . . . -138.52 155.48 48.36 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.337 -0.852 . . . . 62.11 110.28 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 27' ' ' ALA . 82.1 m-20 -141.57 155.6 45.75 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.592 -0.892 . . . . 74.42 108.592 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.2 t -112.11 139.35 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.379 -0.826 . . . . 72.15 109.384 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.6 p -129.99 166.69 19.57 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.523 -0.736 . . . . 71.42 109.573 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.449 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 4.4 pt-20 -93.72 -102.98 0.13 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.348 -0.845 . . . . 72.33 109.809 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.7 p -79.31 168.88 18.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.115 -0.991 . . . . 74.24 109.891 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.0 mt -57.33 -33.32 67.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.521 -0.737 . . . . 71.53 109.742 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -51.27 -43.57 61.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 74.23 109.661 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -65.91 -41.92 90.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.154 -0.966 . . . . 54.03 109.373 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.25 -38.44 46.33 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.493 -1.443 . . . . 61.41 109.493 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.71 -38.18 90.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -1.135 . . . . 74.34 109.621 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -80.84 -39.47 26.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 75.33 109.717 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.9 tp -68.16 -46.35 70.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 74.33 110.077 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 41' ' ' ASP . 3.3 ppp? -62.73 -27.62 69.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.041 -1.037 . . . . 70.32 109.83 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 40' ' ' MET . 93.5 m-20 -63.49 -40.21 96.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.135 -0.978 . . . . 71.22 109.94 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.9 pt -84.0 -25.86 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.159 -0.963 . . . . 74.14 110.167 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 40' ' ' MET . 97.4 mtt180 -130.04 138.76 50.93 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.373 -0.829 . . . . 72.24 109.584 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -93.98 126.36 39.15 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.248 -0.908 . . . . 75.42 109.472 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -106.01 145.78 30.93 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.429 -0.794 . . . . 74.23 109.524 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -85.57 -44.56 12.54 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.274 -0.891 . . . . 72.04 109.078 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.537 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -105.56 108.41 19.9 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.585 -0.894 . . . . 72.13 108.585 179.641 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.432 ' N ' HD13 ' A' ' 47' ' ' LEU . 2.0 m -104.33 101.86 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.31 -0.996 . . . . 72.34 108.31 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.6 ttt -108.37 143.02 37.83 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.688 -0.856 . . . . 74.11 108.688 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' A' ' 55' ' ' ALA . 1.3 p -144.15 132.34 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.361 -0.837 . . . . 61.12 109.933 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.0 m -98.98 2.29 46.23 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.481 -0.762 . . . . 73.11 109.472 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -76.14 139.12 41.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.192 -0.943 . . . . 52.55 109.427 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.481 ' C ' ' H ' ' A' ' 55' ' ' ALA . 61.6 mttp -73.62 -43.5 59.42 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.307 -0.871 . . . . 44.22 110.731 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -68.16 10.26 0.24 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.017 -1.052 . . . . 70.44 109.89 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.93 -22.18 56.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.893 . . . . 64.14 110.57 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' ALA . 64.0 mt -39.98 -51.59 2.51 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.511 -0.743 . . . . 44.14 110.498 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.9 m -68.75 -33.72 74.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.939 -1.1 . . . . 55.23 109.319 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.539 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 73.6 t80 -64.84 -48.42 74.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.386 -0.821 . . . . 74.44 110.088 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.61 -34.83 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.615 -1.303 . . . . 74.03 109.52 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.9 p -57.33 -49.64 75.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 64.3 109.542 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -69.41 -33.2 72.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.032 -1.043 . . . . 64.44 109.927 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.539 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 5.1 mm -63.63 -35.41 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.828 -1.17 . . . . 63.21 109.747 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 67' ' ' SER . 11.5 mtpt -72.08 -51.05 23.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.123 -0.986 . . . . 74.42 110.461 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.431 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 14.6 pt-20 -67.24 -41.69 85.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.743 -1.223 . . . . 70.32 109.708 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.448 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 93.4 mttt -73.61 -24.42 60.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.878 . . . . 75.22 109.501 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.518 ' O ' HG22 ' A' ' 69' ' ' ILE . 93.5 m-70 -154.93 65.88 0.66 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.229 -0.92 . . . . 74.13 109.293 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 63' ' ' LYS . 17.0 t -60.45 -32.56 71.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.392 -0.818 . . . . 73.24 110.038 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.1 m -67.59 46.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 61.01 109.859 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 66' ' ' HIS . 13.8 tt -145.63 162.85 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.142 -0.974 . . . . 71.33 109.726 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.537 ' HB ' HD22 ' A' ' 47' ' ' LEU . 45.0 t -97.73 148.75 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.221 -0.924 . . . . 72.13 108.942 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.51 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 11.3 t -132.38 124.08 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.282 -0.886 . . . . 54.21 109.508 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.525 HD12 HD21 ' A' ' 47' ' ' LEU . 2.1 mt -128.07 99.26 5.41 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.319 -0.993 . . . . 50.24 108.319 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.603 ' O ' HD12 ' A' ' 95' ' ' ILE . 64.3 t -93.12 149.56 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -0.869 . . . . 74.41 109.14 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.7 m -121.96 165.84 15.36 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.529 -0.915 . . . . 72.31 108.529 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.45 ' CB ' ' OE2' ' A' ' 82' ' ' GLU . 9.7 p -171.81 123.65 0.53 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.035 -1.041 . . . . 64.54 110.226 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 52.1 p30 -71.0 10.56 0.52 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.59 -0.694 . . . . 74.13 109.901 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.445 ' H ' ' C ' ' A' ' 75' ' ' SER . 5.8 p-10 -129.09 59.57 44.95 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.38 -0.825 . . . . 73.34 109.661 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -58.9 80.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.276 1.984 . . . . 63.22 112.047 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.403 ' N ' ' O ' ' A' ' 77' ' ' ASN . 72.6 p -104.28 151.56 23.27 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.621 -0.881 . . . . 62.53 108.621 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -30.8 69.53 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.228 -0.92 . . . . 73.44 109.363 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -67.15 -37.47 83.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.189 -0.945 . . . . 71.42 109.554 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.45 ' OE2' ' CB ' ' A' ' 75' ' ' SER . 79.4 tt0 -71.47 -32.62 68.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 73.43 109.722 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.476 ' OE2' ' CZ ' ' B' ' 100' ' ' ARG . 92.2 mt-10 -64.44 -50.95 65.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.918 . . . . 74.22 109.825 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.3 m -61.01 -36.32 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.157 -0.964 . . . . 73.2 109.252 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.429 ' O ' ' OE1' ' A' ' 89' ' ' GLN . 27.0 m80 -74.51 -26.65 60.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 53.33 109.599 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -66.53 -41.96 87.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.109 -0.995 . . . . 64.11 109.786 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.479 ' CZ ' ' HB1' ' B' ' 111' ' ' ALA . 89.1 t80 -82.05 -35.12 29.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.042 -1.036 . . . . 74.34 109.08 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -62.08 -51.55 67.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.379 -0.825 . . . . 74.42 109.411 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.488 ' N ' ' NE2' ' A' ' 89' ' ' GLN . 0.9 OUTLIER -66.6 -58.26 5.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.531 -0.731 . . . . 74.24 109.686 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 158.17 75.27 0.02 OUTLIER Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.613 -1.279 . . . . 61.51 110.266 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -134.84 119.61 18.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.305 -1.115 . . . . 55.33 108.947 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 71.6 m-20 -71.36 -34.79 70.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.102 -0.999 . . . . 73.42 108.923 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.517 ' CG ' HH21 ' A' ' 112' ' ' ARG . 60.7 m-20 -153.16 152.5 31.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.451 -0.781 . . . . 75.04 109.046 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.423 ' OH ' ' OG ' ' A' ' 75' ' ' SER . 9.3 t80 -126.76 132.93 50.96 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.08 -0.711 . . . . 71.33 109.08 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.798 HD12 ' H ' ' A' ' 95' ' ' ILE . 0.1 OUTLIER -121.57 142.38 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 CA-C-O 121.978 0.894 . . . . 71.13 110.442 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.52 119.86 10.61 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.599 -1.26 . . . . 64.32 107.599 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.677 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -43.9 -53.9 12.05 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 62.2 111.628 -178.683 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 2.3 Cg_endo -40.56 -10.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 120.955 1.103 . . . . 73.11 113.12 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.677 ' N ' ' O ' ' A' ' 97' ' ' LYS . 64.0 m-85 59.96 92.73 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.71 -0.619 . . . . 65.22 109.9 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.8 ttm105 -52.09 -39.03 59.14 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.354 -0.98 . . . . 72.35 108.354 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 t -172.41 134.41 0.68 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.493 -0.755 . . . . 71.32 109.025 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 81.8 mt -53.34 -40.1 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.127 -0.983 . . . . 75.43 109.26 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -66.79 -26.22 66.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 71.41 109.67 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.81 -48.58 21.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.171 -0.955 . . . . 63.24 109.856 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.7 ' C ' HD13 ' A' ' 105' ' ' LEU . 2.1 tm? -57.75 -54.05 51.24 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.207 -0.933 . . . . 73.22 109.442 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.526 HG13 ' N ' ' A' ' 107' ' ' ALA . 11.0 p -60.28 -41.9 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.099 -1.001 . . . . 60.11 109.52 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.526 ' N ' HG13 ' A' ' 106' ' ' VAL . . . -51.8 -36.63 48.47 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.17 -0.956 . . . . 70.42 108.925 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -71.87 -37.45 70.19 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.372 -0.83 . . . . 74.41 109.399 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 87.7 mt -67.11 -31.61 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 107.978 -1.119 . . . . 62.54 107.978 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 113' ' ' LEU . 78.5 tt0 -65.85 -57.55 7.66 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.637 -0.825 . . . . 74.34 108.927 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -46.21 -37.2 6.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.475 -0.766 . . . . 73.32 109.655 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.517 HH21 ' CG ' ' A' ' 93' ' ' ASP . 28.1 mmt180 -82.25 -14.46 55.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 52.41 110.103 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' ' 110' ' ' GLU . 80.4 mt -135.25 44.08 2.61 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.133 -0.979 . . . . 65.24 110.617 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -76.44 -39.19 54.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.848 -1.158 . . . . 64.45 108.846 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.529 ' CD2' ' O ' ' A' ' 116' ' ' TRP . 33.8 p90 -67.74 -10.98 57.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.424 -0.797 . . . . 74.43 109.977 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.638 ' HE1' ' CE ' ' A' ' 1' ' ' MET . 48.0 t90 50.29 -178.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.138 -0.976 . . . . 74.42 109.504 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.495 ' N ' ' CG ' ' A' ' 116' ' ' TRP . . . -50.96 143.18 15.0 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.351 -1.499 . . . . 75.04 109.351 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 87.9 p -157.6 -178.5 7.38 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -1.206 . . . . 61.14 110.068 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.38 -179.64 8.13 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.05 -0.722 . . . . 65.24 109.05 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.6 t -138.34 -36.6 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.42 -0.8 . . . . 73.11 109.125 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.55 ' N ' HD12 ' A' ' 121' ' ' ILE . 1.4 mp -90.4 136.41 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.995 . . . . 72.24 108.493 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -138.6 105.69 5.46 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.349 -0.844 . . . . 72.34 109.47 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 83.5 mt -108.94 109.78 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.962 -0.755 . . . . 71.44 108.962 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.8 -137.73 31.06 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.277 -1.529 . . . . 73.4 109.277 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -79.56 -3.83 48.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -1.191 . . . . 74.45 109.349 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.45 HD22 ' CE1' ' A' ' 137' ' ' TYR . 0.5 OUTLIER -89.06 143.25 26.98 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.356 -0.979 . . . . 54.21 108.356 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 54.9 m -129.86 141.07 50.87 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.375 -0.828 . . . . 54.5 109.231 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.74 130.81 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.42 -0.8 . . . . 45.15 109.976 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.1 m -107.4 113.45 61.89 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.633 -0.667 . . . . 71.11 109.226 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.8 -53.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.92 1.746 . . . . 65.41 111.959 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -55.3 -44.65 75.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 63.32 109.316 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -83.52 -8.54 59.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.401 -0.812 . . . . 72.52 109.153 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 51.72 57.53 6.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 75.33 109.154 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -139.37 116.03 10.73 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.411 -0.806 . . . . 71.23 109.164 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.543 ' N ' HD12 ' A' ' 135' ' ' ILE . 1.4 mp -94.22 130.24 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.185 -0.947 . . . . 74.02 108.905 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 36.8 mt -115.91 129.41 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.561 -0.712 . . . . 60.23 109.575 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.466 ' C ' ' H ' ' A' ' 139' ' ' GLY . 77.5 t80 -141.58 151.19 42.96 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.512 -0.922 . . . . 62.32 108.512 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 46.1 tttp 55.94 5.63 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.851 . . . . 75.4 109.408 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 137' ' ' TYR . . . 93.86 -4.81 72.29 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.686 -1.366 . . . . 72.24 109.686 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.404 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 0.7 OUTLIER -89.71 139.7 30.3 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.247 -1.149 . . . . 71.22 109.299 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -86.71 137.19 32.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 71.42 109.162 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.1 t -135.26 128.12 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.43 -0.794 . . . . 53.02 109.531 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -93.37 134.34 35.69 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.306 -0.871 . . . . 60.45 109.048 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.413 ' CG2' HD13 ' A' ' 135' ' ' ILE . 15.1 m -149.48 140.56 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.106 -0.996 . . . . 74.44 109.556 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -163.54 18.83 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 65.15 109.776 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.3 161.09 54.16 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.844 -1.702 . . . . 73.34 108.844 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.562 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 4.8 tttp -56.44 -44.73 99.86 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.039 -1.271 . . . . 72.22 109.091 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 24.2 Cg_exo -62.58 -28.5 77.3 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.362 2.042 . . . . 65.23 112.122 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -80.67 -20.7 42.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.232 -0.918 . . . . 60.11 110.12 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -52.75 -32.96 46.14 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.067 -1.021 . . . . 64.21 108.965 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 148' ' ' PRO . 6.4 p -64.95 -38.08 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.324 -0.86 . . . . 72.02 109.276 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 29.4 tp -60.86 -41.92 96.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.857 . . . . 73.31 109.322 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 20.0 p -74.35 -34.79 63.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.245 -0.909 . . . . 74.31 110.16 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.569 ' ND1' ' NH2' ' A' ' 157' ' ' ARG . 43.9 m-70 -60.9 -52.69 63.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.137 -0.977 . . . . 74.31 110.035 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 pp -68.52 -28.56 67.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.906 -1.121 . . . . 75.34 109.602 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.3 -47.59 78.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 62.14 109.377 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.569 ' NH2' ' ND1' ' A' ' 154' ' ' HIS . 67.9 mtm-85 -69.03 -58.69 3.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.965 . . . . 61.03 109.461 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -53.27 -47.67 68.94 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.811 -0.756 . . . . 74.12 109.457 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 161' ' ' GLN . 23.1 ttm180 44.97 -126.49 1.1 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.401 -0.812 . . . . 71.13 109.895 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 45.6 p-10 -50.08 90.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 75.45 109.561 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.844 ' OE1' ' OH ' ' B' ' 216' ' ' TYR . 1.4 tp-100 -171.53 149.54 2.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.246 -0.909 . . . . 73.41 109.325 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 65.3 mt -78.51 135.46 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.148 -0.97 . . . . 74.41 109.216 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 87.1 t -127.58 129.29 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.452 -0.78 . . . . 72.31 109.653 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.7 t -99.44 153.36 19.07 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.435 -0.791 . . . . 74.12 109.324 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.5 mtmm -56.97 -43.83 82.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.33 -0.856 . . . . 70.43 109.494 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -59.01 -34.26 71.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.341 -0.85 . . . . 73.52 109.575 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -63.91 -55.19 24.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.166 -0.959 . . . . 74.52 109.621 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 80.3 mt -47.64 -52.71 17.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.143 -0.973 . . . . 72.31 109.774 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 171' ' ' ALA . 87.2 mt -57.62 -74.6 0.05 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.591 -1.318 . . . . 53.33 109.666 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -48.86 -11.01 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.973 -1.079 . . . . 62.44 110.459 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 169' ' ' LEU . . . -95.43 -41.39 9.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.189 -0.945 . . . . 60.21 111.185 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.61 -47.18 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.917 -1.114 . . . . 75.32 109.688 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.626 ' O ' ' CD1' ' A' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.251 0 O-C-N 120.668 -1.27 . . . . 73.14 109.188 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 14.9 p30 . . . . . 0 N--CA 1.494 1.754 0 N-CA-C 109.345 -0.613 . . . . 64.54 109.345 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.0 p -166.47 -27.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.852 . . . . 74.02 109.861 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 10.9 tp -50.97 -22.38 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.068 -1.02 . . . . 72.33 109.914 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.437 ' CG ' ' N ' ' A' ' 186' ' ' VAL . 18.9 pt-20 -70.05 -48.93 55.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.055 -1.028 . . . . 74.4 109.572 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.437 ' N ' ' CG ' ' A' ' 185' ' ' GLU . 14.1 m -72.04 -28.87 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.808 -1.183 . . . . 70.42 108.969 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -77.87 -55.42 5.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 52.11 110.069 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.411 HD12 HD11 ' A' ' 191' ' ' ILE . 11.2 tp -52.6 -33.37 18.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.675 -1.266 . . . . 71.4 109.324 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -72.76 -41.27 65.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.173 -0.954 . . . . 73.44 111.214 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.452 ' CG ' ' N ' ' A' ' 191' ' ' ILE . 11.8 pt20 -77.33 -46.37 23.12 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.586 -1.321 . . . . 71.42 111.029 -178.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.452 ' N ' ' CG ' ' A' ' 190' ' ' GLN . 6.5 pt -62.22 -41.01 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.717 -1.239 . . . . 61.55 109.971 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -69.21 -34.27 74.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.849 -1.157 . . . . 63.34 108.597 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -64.86 -39.58 93.78 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.694 -0.629 . . . . 61.24 110.082 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.422 ' O ' ' CD ' ' A' ' 198' ' ' PRO . 11.4 pttp -92.09 -2.55 56.57 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.047 -1.033 . . . . 75.13 110.549 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 48.2 ttp -93.75 -45.42 7.69 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.94 -1.1 . . . . 74.02 109.974 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -60.29 -33.02 71.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.07 -1.019 . . . . 74.02 110.385 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -64.4 -61.11 7.11 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.978 -1.076 . . . . 75.43 110.335 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.422 ' CD ' ' O ' ' A' ' 194' ' ' LYS . 31.5 Cg_endo -61.11 -55.52 1.25 Allowed 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.824 1.682 . . . . 72.32 111.844 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.495 ' C ' ' H ' ' A' ' 201' ' ' ILE . 10.0 mp -63.09 -36.9 85.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -0.942 . . . . 74.54 109.282 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 73.51 -23.73 0.98 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.598 -1.401 . . . . 61.51 109.598 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.495 ' H ' ' C ' ' A' ' 199' ' ' LEU . 13.6 mt -110.66 137.12 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.483 -1.01 . . . . 61.22 109.351 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 8.6 t -84.87 143.6 28.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.164 -0.96 . . . . 72.0 109.354 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.5 p -141.19 27.94 1.91 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.278 -0.889 . . . . 74.44 109.267 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.527 ' CG1' ' CE2' ' A' ' 214' ' ' PHE . 2.7 m -143.66 128.64 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.239 -0.913 . . . . 64.35 109.692 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -102.76 121.91 43.41 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.381 -0.825 . . . . 71.41 108.808 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.425 ' H ' HG22 ' A' ' 206' ' ' THR . 0.0 OUTLIER -84.88 117.32 23.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.145 -0.972 . . . . 73.52 109.873 -179.614 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.411 ' O ' ' O ' ' A' ' 211' ' ' GLY . 12.8 p -150.25 147.58 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.345 -0.847 . . . . 71.02 109.062 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -64.34 -130.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.144 -0.973 . . . . 72.12 109.479 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? 50.17 -106.02 0.21 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.91 . . . . 64.41 109.337 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -75.9 -59.08 2.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 71.54 109.486 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 207' ' ' VAL . . . 159.26 -109.57 0.41 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.641 -1.384 . . . . 72.03 109.641 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 212' ' ' TYR . 41.9 m-85 -109.73 134.91 51.45 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.522 -0.987 . . . . 75.54 109.369 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -107.31 132.5 53.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.509 -0.744 . . . . 75.31 109.476 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.527 ' CE2' ' CG1' ' A' ' 204' ' ' VAL . 43.8 m-85 -97.45 128.69 44.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.258 -0.901 . . . . 75.41 109.107 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 49.2 m -140.18 156.55 46.47 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.439 -0.788 . . . . 74.14 109.077 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -69.52 153.98 95.25 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.916 . . . . 75.32 109.183 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo . . . . . 0 N--CA 1.49 1.288 0 C-N-CA 122.478 2.119 . . . . 73.11 112.478 179.946 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.487 ' SD ' ' OD2' ' B' ' 46' ' ' ASP . 7.4 mtt . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.364 -0.606 . . . . 71.14 109.364 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -136.09 125.04 24.19 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.463 -0.773 . . . . 73.23 109.166 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.1 t -111.83 133.79 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-O 121.359 0.6 . . . . 72.24 109.564 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.443 HD12 ' N ' ' B' ' 5' ' ' LEU . 4.9 tp -101.73 120.47 40.4 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.488 -0.757 . . . . 54.33 109.174 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.443 ' N ' HD12 ' B' ' 4' ' ' LEU . 17.3 mt -119.46 98.58 6.21 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.464 -0.772 . . . . 74.35 109.108 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.453 HD12 ' HB ' ' B' ' 50' ' ' VAL . 16.9 mt -83.48 98.8 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.872 -1.142 . . . . 42.55 108.469 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' B' ' 9' ' ' ASN . 33.8 tp10 -142.8 128.84 19.65 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.382 -0.824 . . . . 74.52 109.416 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -66.77 -31.36 71.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.9 . . . . 62.55 109.478 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' ASN . . . . . 0.404 ' H ' ' HG3' ' B' ' 7' ' ' GLU . 94.7 m-20 -79.22 112.02 16.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 73.11 109.533 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 82.2 p -71.78 -25.28 61.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 65.54 109.698 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 82.3 t -62.57 -49.85 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -0.958 . . . . 75.55 109.623 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.574 ' N ' HD22 ' B' ' 12' ' ' LEU . 3.8 mm? -67.04 -28.95 68.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 70.14 109.206 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.8 -23.18 64.82 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.745 -1.742 . . . . 75.4 108.745 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.47 -49.74 7.91 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.705 -1.358 . . . . 65.44 109.705 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.09 -42.56 99.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.1 -1.235 . . . . 60.21 109.048 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 6.0 mm -60.87 -35.59 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.259 -1.015 . . . . 75.15 108.259 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -63.1 -44.04 96.8 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.498 -0.751 . . . . 73.01 109.361 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -86.05 1.61 49.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.15 -0.969 . . . . 74.3 109.301 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.12 -53.32 2.69 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 109.446 -1.462 . . . . 70.54 109.446 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -77.41 -22.26 51.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -1.152 . . . . 71.34 109.793 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -52.5 -34.88 51.47 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.072 -1.017 . . . . 64.41 109.077 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 54.3 t -55.47 -45.93 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.351 -0.843 . . . . 74.23 108.867 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 49.3 mmtt -60.14 -53.33 59.03 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.491 -0.756 . . . . 63.42 109.035 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 133.56 35.72 0.28 Allowed Glycine 0 N--CA 1.5 2.965 0 N-CA-C 110.099 -1.201 . . . . 53.43 110.099 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -119.5 159.54 24.1 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.392 -1.064 . . . . 71.12 109.308 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 13.0 mmt -103.39 141.43 35.96 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.502 -0.925 . . . . 75.24 108.502 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.429 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -133.41 157.6 45.16 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.393 -0.817 . . . . 72.12 110.265 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' ASP . . . . . 0.476 ' OD2' ' NH1' ' B' ' 43' ' ' ARG . 82.0 m-20 -142.84 160.37 40.45 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.677 -0.86 . . . . 72.31 108.677 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 5.0 p -121.43 139.76 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.364 -0.835 . . . . 64.43 109.718 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 10.2 p -133.52 165.21 25.41 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.59 -0.694 . . . . 65.41 109.213 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -91.72 -104.99 0.11 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.277 -0.889 . . . . 71.02 109.677 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 60.0 p -78.52 168.98 18.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 51.11 109.902 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' B' ' 37' ' ' GLU . 19.0 mt -53.65 -33.55 55.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.502 -0.749 . . . . 71.24 109.866 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -51.02 -48.95 61.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.099 -1.0 . . . . 74.32 109.499 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -64.37 -39.73 94.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 73.03 108.957 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.28 -36.21 63.55 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.295 -1.522 . . . . 30.21 109.295 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' B' ' 33' ' ' LEU . 83.8 tt0 -66.16 -41.54 90.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -1.122 . . . . 74.42 109.472 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -79.44 -37.77 36.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.136 -0.977 . . . . 74.42 109.408 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 41.2 tp -68.48 -41.86 79.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 75.41 109.63 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.0 ppp? -73.53 -21.74 60.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.143 -0.973 . . . . 60.41 109.535 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -53.44 -38.34 63.46 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.012 -1.055 . . . . 53.23 108.936 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 8.6 pt -95.98 -33.19 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.351 -0.843 . . . . 71.23 109.651 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.476 ' NH1' ' OD2' ' B' ' 28' ' ' ASP . 93.1 mtt180 -96.32 138.57 33.72 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.081 -1.012 . . . . 72.22 109.593 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' ASN . . . . . 0.435 ' O ' ' O ' ' B' ' 45' ' ' TYR . 84.7 m-20 -81.08 -30.63 34.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.168 -0.957 . . . . 63.54 109.966 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' B' ' 44' ' ' ASN . 38.4 m-85 52.24 100.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.302 -0.874 . . . . 64.35 109.436 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' ASP . . . . . 0.487 ' OD2' ' SD ' ' B' ' 1' ' ' MET . 73.1 m-20 -70.11 -36.99 75.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.106 -0.996 . . . . 62.22 109.016 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.522 ' C ' HD13 ' B' ' 47' ' ' LEU . 1.0 OUTLIER -107.01 111.58 24.14 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.673 -0.862 . . . . 73.12 108.673 179.567 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.475 ' N ' HD13 ' B' ' 47' ' ' LEU . 53.1 t -94.89 99.8 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.299 -0.876 . . . . 65.11 109.378 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 1.8 tpp -113.55 130.02 56.44 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.774 -0.825 . . . . 73.44 108.774 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.463 ' N ' ' SD ' ' B' ' 49' ' ' MET . 0.2 OUTLIER -146.66 135.49 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 34.5 109.312 -179.505 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 73.1 p -103.51 8.68 37.79 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.504 -0.748 . . . . 73.21 110.25 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -76.82 142.25 40.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.081 -1.012 . . . . 70.41 109.547 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -74.3 -38.36 63.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 65.0 110.293 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -72.57 8.19 1.54 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.034 -1.041 . . . . 75.21 109.716 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.55 -21.24 59.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 55.33 110.222 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 71.1 mt -43.68 -41.11 4.57 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.318 -0.864 . . . . 63.14 110.224 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 27.4 t -72.92 -38.59 66.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.999 -1.063 . . . . 63.5 109.567 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' PHE . . . . . 0.605 ' CE2' HD11 ' B' ' 62' ' ' ILE . 50.4 t80 -64.27 -49.58 71.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.343 -0.848 . . . . 72.33 110.135 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.15 -35.36 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.765 -1.209 . . . . 74.54 109.69 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 59.8 p -58.22 -45.82 86.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.237 -0.914 . . . . 71.24 109.681 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' B' ' 65' ' ' LYS . 8.8 ptp180 -75.36 -30.78 60.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.058 -1.026 . . . . 74.31 110.076 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.605 HD11 ' CE2' ' B' ' 58' ' ' PHE . 5.0 mm -60.55 -51.91 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.745 -1.222 . . . . 72.14 109.24 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -63.1 -40.78 98.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.135 -0.978 . . . . 73.32 109.183 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -68.93 -38.88 79.79 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.512 -0.921 . . . . 73.12 108.512 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' B' ' 61' ' ' ARG . 14.4 mtpp -86.24 -74.23 0.43 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.285 -0.884 . . . . 72.44 109.481 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.453 ' N ' ' O ' ' B' ' 62' ' ' ILE . 53.6 m-70 -98.08 87.43 3.95 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.226 -0.921 . . . . 63.31 109.524 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 23.2 t -78.46 -32.18 48.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 73.1 109.923 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 94.7 p -59.7 -23.51 63.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.233 -0.917 . . . . 71.53 109.643 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.407 HG21 HD13 ' B' ' 69' ' ' ILE . 57.3 mt -84.09 149.48 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.246 -0.909 . . . . 74.4 109.293 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.562 HG12 ' N ' ' B' ' 71' ' ' VAL . 75.8 t -91.08 164.49 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.247 -0.908 . . . . 75.12 109.637 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.562 ' N ' HG12 ' B' ' 70' ' ' VAL . 4.3 t -139.68 128.15 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.318 -0.864 . . . . 73.2 109.348 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.497 ' O ' ' SD ' ' B' ' 49' ' ' MET . 0.6 OUTLIER -123.69 106.52 10.6 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.608 -0.886 . . . . 73.34 108.608 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 71.0 t -91.4 129.58 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.117 -0.989 . . . . 73.5 109.008 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 6.8 p -90.36 171.25 9.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.917 -1.114 . . . . 64.34 108.987 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.424 ' C ' ' H ' ' B' ' 97' ' ' LYS . 13.6 p -155.76 112.34 3.16 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.927 -1.108 . . . . 74.53 110.261 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -67.2 -27.47 67.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.329 -0.857 . . . . 64.5 109.005 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' B' ' 79' ' ' THR . 13.5 t-20 -127.06 75.65 76.52 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.677 -0.86 . . . . 74.25 108.677 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -44.79 88.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.572 2.181 . . . . 74.43 111.777 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.471 ' N ' ' O ' ' B' ' 77' ' ' ASN . 17.1 m -104.04 148.65 25.98 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.59 0.71 . . . . 73.12 109.717 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -33.69 76.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.196 -0.94 . . . . 71.01 109.006 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 81' ' ' GLU . . . . . 0.434 ' H ' HG22 ' B' ' 79' ' ' THR . 84.2 tt0 -57.07 -39.42 74.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 63.2 109.036 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -71.91 -31.73 66.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.223 -0.923 . . . . 73.22 109.201 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.535 ' OE1' ' CD1' ' B' ' 94' ' ' TYR . 5.9 mm-40 -64.57 -56.55 13.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.22 -0.925 . . . . 74.3 110.027 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.437 HG23 ' N ' ' B' ' 85' ' ' HIS . 29.9 m -57.59 -41.21 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 73.31 109.832 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 85' ' ' HIS . . . . . 0.437 ' N ' HG23 ' B' ' 84' ' ' VAL . 60.5 t60 -74.05 -25.15 59.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.152 -0.968 . . . . 73.24 109.59 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.26 -36.3 79.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 55.33 110.021 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -80.17 -33.73 38.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.119 -0.988 . . . . 74.14 108.892 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -69.75 -33.52 72.55 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.338 -0.851 . . . . 64.04 109.428 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -77.55 -67.53 0.71 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 72.35 109.499 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 156.86 66.02 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.011 -1.236 . . . . 65.2 110.011 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.68 124.64 46.75 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.444 -1.033 . . . . 52.23 109.054 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -69.98 -36.85 75.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.12 -0.987 . . . . 73.32 109.438 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 93' ' ' ASP . . . . . 0.471 ' OD2' ' CD ' ' B' ' 112' ' ' ARG . 11.6 m-20 -151.24 166.41 30.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.304 -0.873 . . . . 72.22 109.371 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.551 ' O ' ' CD1' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -140.21 114.15 8.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.607 -0.683 . . . . 64.42 109.191 -178.697 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 27.7 mm -114.34 146.26 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 O-C-N 121.224 -0.923 . . . . 72.23 109.685 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.78 139.54 58.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.936 -1.103 . . . . 25.24 108.139 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.685 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -58.49 -56.44 35.47 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.909 -1.12 . . . . 64.32 111.381 -179.034 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 98' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 5.0 Cg_endo -41.5 -8.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.022 1.148 . . . . 63.33 113.192 -176.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 99' ' ' TYR . . . . . 0.685 ' N ' ' O ' ' B' ' 97' ' ' LYS . 13.8 m-85 66.47 117.78 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.557 -0.714 . . . . 75.13 109.674 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 100' ' ' ARG . . . . . 0.476 ' CZ ' ' OE2' ' A' ' 83' ' ' GLU . 16.0 ttm180 -67.05 -29.55 69.37 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.968 -1.083 . . . . 74.23 108.754 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 101' ' ' SER . . . . . 0.752 ' O ' ' N ' ' B' ' 103' ' ' LYS . 40.6 t -174.78 28.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.192 -0.942 . . . . 63.34 110.671 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 8.6 mm 51.66 -69.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.645 -0.659 . . . . 74.44 110.064 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.752 ' N ' ' O ' ' B' ' 101' ' ' SER . 86.3 mttt -56.64 -32.91 65.82 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.82 -1.178 . . . . 71.11 107.82 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.86 98.73 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.033 -1.099 . . . . 71.45 108.033 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 55.4 tp -64.63 -40.68 95.9 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.635 -0.876 . . . . 51.31 108.635 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 73.5 t -67.0 -41.02 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.348 -0.845 . . . . 65.23 109.527 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.02 -48.26 70.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.149 -0.97 . . . . 24.32 109.39 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -64.75 -32.24 73.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 75.31 109.732 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 93.9 mt -74.44 -34.3 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.179 -0.951 . . . . 54.24 108.903 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 110' ' ' GLU . . . . . 0.465 ' O ' ' CG ' ' B' ' 114' ' ' ARG . 88.2 tt0 -66.09 -31.02 71.63 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.492 -0.755 . . . . 65.31 109.469 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 111' ' ' ALA . . . . . 0.479 ' HB1' ' CZ ' ' A' ' 87' ' ' PHE . . . -72.56 -56.6 5.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.201 -0.937 . . . . 72.24 109.944 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 112' ' ' ARG . . . . . 0.471 ' CD ' ' OD2' ' B' ' 93' ' ' ASP . 64.3 mtm-85 -69.43 -40.61 77.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.179 -0.951 . . . . 72.04 110.358 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 41.6 tp -63.52 -34.49 77.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.121 -0.987 . . . . 75.35 109.972 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.465 ' CG ' ' O ' ' B' ' 110' ' ' GLU . 11.0 mmm180 -74.26 167.37 21.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.152 -0.968 . . . . 75.5 109.353 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 52.26 51.15 16.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.885 . . . . 65.33 109.23 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -95.7 -66.24 0.92 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.308 -0.87 . . . . 74.45 109.898 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.05 144.04 48.61 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.19 -1.164 . . . . 44.21 110.19 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 118' ' ' SER . . . . . 0.927 ' N ' ' OE2' ' B' ' 132' ' ' GLU . 33.1 t -160.44 175.26 12.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.471 -1.017 . . . . 71.4 109.355 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.88 125.8 5.9 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.652 -0.819 . . . . 72.32 109.221 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 20.5 t -99.32 -37.25 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.386 -0.822 . . . . 75.02 109.929 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 19.3 mm -101.89 128.37 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.197 -0.939 . . . . 51.41 109.584 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' B' ' 122' ' ' GLU . 17.9 pt-20 -151.06 121.99 7.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.319 -0.863 . . . . 71.53 109.473 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.797 HD13 ' H ' ' B' ' 123' ' ' ILE . 0.1 OUTLIER -146.46 133.93 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.155 -0.965 . . . . 72.43 109.335 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 63.33 -115.69 8.34 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.241 -1.543 . . . . 51.23 109.241 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 125' ' ' ASP . . . . . 0.884 ' OD2' ' HD3' ' B' ' 138' ' ' LYS . 13.3 t70 -120.59 6.31 10.55 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.596 -0.944 . . . . 74.2 109.245 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.78 128.56 42.76 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.334 -0.854 . . . . 75.42 108.769 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 61.4 m -120.4 132.11 55.1 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.5 -0.926 . . . . 74.22 108.5 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 8.0 mt -133.02 132.38 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.378 -0.826 . . . . 60.33 110.041 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 8.6 m -109.75 110.67 59.28 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.303 -0.999 . . . . 72.31 108.303 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.94 -36.98 1.26 Allowed 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.742 1.628 . . . . 75.13 113.071 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 131' ' ' ASP . . . . . 0.415 ' O ' ' OE1' ' B' ' 133' ' ' GLU . 6.8 t70 -70.33 -37.34 74.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.089 -1.007 . . . . 75.23 109.905 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 132' ' ' GLU . . . . . 0.927 ' OE2' ' N ' ' B' ' 118' ' ' SER . 81.4 mt-10 -83.21 -0.09 47.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.157 -0.964 . . . . 72.43 109.446 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 133' ' ' GLU . . . . . 0.415 ' OE1' ' O ' ' B' ' 131' ' ' ASP . 35.8 mp0 47.01 59.07 4.24 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 75.13 109.254 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 15.4 ttpp -156.72 130.35 8.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 73.22 109.247 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 2.9 tt -104.23 129.47 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.433 -0.792 . . . . 64.14 109.597 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.417 HG21 HD13 ' B' ' 136' ' ' ILE . 15.3 mt -110.11 122.5 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.566 -0.902 . . . . 71.22 108.566 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 137' ' ' TYR . . . . . 0.963 ' CE1' ' CB ' ' B' ' 140' ' ' ARG . 19.0 p90 -124.97 118.18 25.69 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.249 -0.907 . . . . 64.22 110.13 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 138' ' ' LYS . . . . . 0.884 ' HD3' ' OD2' ' B' ' 125' ' ' ASP . 25.8 mmtm 55.99 28.2 12.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.591 -0.693 . . . . 72.02 110.237 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 92.4 2.56 67.88 Favored Glycine 0 N--CA 1.496 2.643 0 O-C-N 121.172 -0.955 . . . . 74.32 110.944 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 140' ' ' ARG . . . . . 0.963 ' CB ' ' CE1' ' B' ' 137' ' ' TYR . 0.2 OUTLIER -95.66 121.84 37.78 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.759 -1.436 . . . . 75.34 108.79 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -94.94 118.29 31.56 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.267 -0.895 . . . . 71.23 109.58 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 6.6 t -122.52 132.82 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.751 -0.833 . . . . 70.43 108.751 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -92.86 123.12 35.9 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.273 -0.892 . . . . 72.43 109.869 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.32 138.93 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.886 -0.783 . . . . 72.13 108.886 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -161.7 83.24 0.6 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.355 -0.84 . . . . 72.02 109.84 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 146' ' ' GLY . . . . . 0.666 ' N ' ' HD2' ' B' ' 149' ' ' PHE . . . -164.47 177.8 39.97 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.071 -1.612 . . . . 42.23 109.071 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 147' ' ' LYS . . . . . 1.323 ' NZ ' ' O ' ' B' ' 172' ' ' ILE . 0.9 OUTLIER -68.21 -37.01 9.95 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.203 -1.174 . . . . 73.3 110.438 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 148' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 14.6 Cg_exo -66.23 -19.99 56.12 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.206 1.937 . . . . 71.33 112.048 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 149' ' ' PHE . . . . . 0.666 ' HD2' ' N ' ' B' ' 146' ' ' GLY . 0.5 OUTLIER -103.77 -29.76 10.82 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.493 -0.755 . . . . 74.23 109.343 -179.376 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 150' ' ' GLU . . . . . 0.428 ' O ' ' CD2' ' B' ' 154' ' ' HIS . 35.4 mt-10 -51.67 -31.5 26.01 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.199 -1.037 . . . . 72.34 108.199 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 13.2 p -67.96 -33.15 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.562 -0.711 . . . . 73.35 109.11 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 44.7 tp -65.24 -39.99 93.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.875 . . . . 55.24 109.602 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 6.0 p -76.36 -35.77 58.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.893 -1.129 . . . . 70.01 109.203 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 154' ' ' HIS . . . . . 0.428 ' CD2' ' O ' ' B' ' 150' ' ' GLU . 27.9 m170 -56.87 -48.76 77.39 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.117 -0.99 . . . . 65.32 110.174 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 pp -72.87 -27.64 62.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.7 -1.25 . . . . 71.54 108.884 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.56 -34.54 67.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 75.32 109.563 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 17.3 mtt180 -92.52 -52.2 4.76 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.897 -1.127 . . . . 73.32 109.9 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -53.42 -52.09 60.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 74.14 108.786 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 159' ' ' ARG . . . . . 0.464 ' O ' ' N ' ' B' ' 161' ' ' GLN . 89.2 mtm180 47.15 -114.81 0.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 61.41 109.259 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 160' ' ' ASP . . . . . 0.772 ' OD2' ' CE1' ' B' ' 216' ' ' TYR . 9.8 m-20 -55.36 91.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.109 -0.995 . . . . 72.1 109.083 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 161' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' B' ' 159' ' ' ARG . 50.1 tp60 -164.71 145.43 7.73 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.207 -0.933 . . . . 72.25 109.775 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 89.7 mt -109.32 126.29 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.505 -0.747 . . . . 72.31 109.178 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 19.7 m -137.03 144.42 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.965 -0.754 . . . . 64.21 108.965 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 164' ' ' SER . . . . . 0.469 ' H ' ' CD ' ' B' ' 167' ' ' GLN . 23.1 t -86.94 178.34 6.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.077 -1.015 . . . . 74.22 110.185 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -61.46 -55.42 31.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.842 . . . . 65.31 109.408 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 166' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' B' ' 166' ' ' GLU . 31.7 mp0 -51.91 -31.91 30.53 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.858 . . . . 63.45 110.116 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 167' ' ' GLN . . . . . 0.469 ' CD ' ' H ' ' B' ' 164' ' ' SER . 41.4 mt-30 -64.94 -43.32 93.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.074 -1.016 . . . . 72.4 109.607 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 51.7 mt -58.12 -37.29 74.31 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.191 -1.04 . . . . 72.32 108.191 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.25 -65.91 0.57 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.501 -0.75 . . . . 73.34 109.063 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -58.35 -28.09 64.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.561 -0.712 . . . . 72.1 109.902 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.88 -65.25 0.63 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.28 -0.888 . . . . 62.13 110.091 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 1.323 ' O ' ' NZ ' ' B' ' 147' ' ' LYS . 2.1 mp -98.82 -53.45 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.129 -0.982 . . . . 71.42 109.937 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 26.0 m-90 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.031 -1.043 . . . . 72.23 109.027 -179.584 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo . . . . . 0 N--CA 1.49 1.271 0 CA-C-O 121.128 0.387 . . . . 65.22 112.722 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -156.57 52.0 0.52 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.033 -1.042 . . . . 72.31 109.761 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 9.3 p -65.24 -21.37 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.193 -0.942 . . . . 63.32 109.634 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 36.8 mt -67.53 -40.54 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.239 -0.913 . . . . 75.03 110.621 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 185' ' ' GLU . . . . . 0.487 ' O ' ' ND2' ' B' ' 189' ' ' ASN . 64.6 mm-40 -61.9 -50.51 71.89 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.098 -1.001 . . . . 64.11 110.323 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 18.2 m -75.08 -25.51 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.151 -0.968 . . . . 73.0 110.172 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -76.04 -46.62 28.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.119 -0.988 . . . . 61.12 110.18 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 11.2 tp -69.88 -29.34 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.865 -1.147 . . . . 72.43 109.286 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 189' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' B' ' 185' ' ' GLU . 92.5 m-20 -72.79 -48.51 37.49 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.43 -0.794 . . . . 65.14 109.9 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 190' ' ' GLN . . . . . 0.46 ' CG ' ' N ' ' B' ' 191' ' ' ILE . 14.9 pt20 -72.96 -45.17 59.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.095 -1.003 . . . . 63.24 110.193 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 191' ' ' ILE . . . . . 0.46 ' N ' ' CG ' ' B' ' 190' ' ' GLN . 77.1 mt -54.28 -55.4 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.04 -1.038 . . . . 74.03 109.376 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -54.39 -48.22 71.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.122 -0.986 . . . . 72.24 110.026 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 193' ' ' GLN . . . . . 0.411 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 81.7 mt-30 -62.07 -31.62 72.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.047 -1.033 . . . . 73.1 109.575 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -91.05 -2.97 57.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.25 -0.906 . . . . 72.11 110.339 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 24.1 ttp -99.94 -5.08 28.84 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.13 -0.981 . . . . 44.33 109.876 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 196' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' B' ' 193' ' ' GLN . 5.9 p-10 -105.92 -15.24 14.97 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.364 -0.835 . . . . 71.21 109.329 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 197' ' ' LYS . . . . . 0.585 ' N ' ' CD ' ' B' ' 198' ' ' PRO . 10.3 tttm -80.13 -41.7 1.37 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.243 -0.911 . . . . 75.21 110.059 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 198' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' B' ' 197' ' ' LYS . 73.6 Cg_endo -87.39 -44.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.486 2.124 . . . . 75.32 111.988 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 17.9 mt -78.38 -35.03 47.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.047 -1.033 . . . . 72.25 109.302 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 83.13 -37.98 2.72 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.731 -1.348 . . . . 64.53 109.731 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 22.4 mm -102.07 139.19 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.263 -1.14 . . . . 44.23 109.639 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 19.9 m -86.49 137.93 32.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.283 -0.886 . . . . 54.01 108.949 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 6.7 p -134.98 29.22 3.45 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.39 -0.819 . . . . 74.4 109.307 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 16.7 m -132.28 145.95 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.549 -0.719 . . . . 72.12 109.187 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -126.25 138.11 53.58 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.487 -0.758 . . . . 65.41 109.721 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 206' ' ' THR . . . . . 0.539 HG23 HH12 ' B' ' 208' ' ' ARG . 0.1 OUTLIER -96.94 132.82 42.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.326 -0.859 . . . . 71.33 109.47 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 8.3 t -130.38 117.1 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.707 -0.849 . . . . 63.5 108.707 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 208' ' ' ARG . . . . . 0.723 ' H ' ' NE ' ' B' ' 208' ' ' ARG . 0.1 OUTLIER -68.92 -36.3 77.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.222 -0.924 . . . . 74.45 109.747 -179.486 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 62.1 mtm180 -50.77 -65.09 0.62 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.122 -0.986 . . . . 74.14 110.118 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -100.58 -77.85 0.53 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.249 -0.907 . . . . 74.43 109.932 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -164.89 -105.27 0.19 Allowed Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.619 -1.277 . . . . 64.45 110.162 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 212' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' B' ' 212' ' ' TYR . 42.2 m-85 -133.93 148.75 51.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.505 -0.997 . . . . 74.21 109.978 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -141.12 153.7 45.54 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.252 -1.018 . . . . 74.03 108.252 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 214' ' ' PHE . . . . . 0.427 ' C ' ' SG ' ' B' ' 215' ' ' CYS . 0.7 OUTLIER -117.77 148.65 41.86 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.393 -0.817 . . . . 74.34 110.557 -178.249 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 215' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' B' ' 214' ' ' PHE . 8.8 m -151.37 164.18 37.28 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.676 -0.861 . . . . 64.33 108.676 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 216' ' ' TYR . . . . . 0.844 ' OH ' ' OE1' ' A' ' 161' ' ' GLN . 0.2 OUTLIER -72.86 154.08 91.08 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 120.96 -1.088 . . . . 70.04 108.865 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.51 175.92 1.92 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.246 1.964 . . . . 65.11 111.626 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 13.8 mtmm . . . . . 0 C--N 1.301 -1.534 0 N-CA-C 108.689 -0.856 . . . . 73.15 108.689 -179.931 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.57 ' SD ' ' CE2' ' A' ' 25' ' ' PHE . 43.4 ttp . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.457 -0.571 . . . . 65.12 109.457 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -140.53 152.25 45.41 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.397 -0.814 . . . . 72.33 109.224 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.682 HG13 ' HB3' ' A' ' 47' ' ' LEU . 39.4 t -119.6 129.47 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.529 0.681 . . . . 71.42 109.574 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.572 HD11 ' CG1' ' A' ' 6' ' ' ILE . 1.4 tp -96.14 122.65 39.21 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.53 -0.731 . . . . 65.12 109.521 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.448 ' N ' HD12 ' A' ' 4' ' ' LEU . 4.2 mp -117.2 129.84 56.2 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.129 -1.063 . . . . 62.43 108.129 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.572 ' CG1' HD11 ' A' ' 4' ' ' LEU . 38.4 mt -126.03 97.18 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.062 -1.088 . . . . 71.15 108.062 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -144.11 130.97 20.32 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.243 -0.91 . . . . 75.34 109.753 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -63.12 -35.2 79.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 72.44 109.33 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -76.54 96.58 4.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 63.02 109.29 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.8 m -61.47 -29.6 70.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.88 . . . . 72.34 109.909 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.516 HG13 ' N ' ' A' ' 12' ' ' LEU . 9.5 p -67.58 -44.59 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.085 -1.009 . . . . 74.02 109.981 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.516 ' N ' HG13 ' A' ' 11' ' ' VAL . 80.9 mt -69.82 -47.72 61.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.046 -1.034 . . . . 71.43 109.242 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.6 -20.88 70.4 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 107.922 -2.071 . . . . 61.32 107.922 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.38 -58.06 6.9 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.667 -1.373 . . . . 71.2 109.667 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.402 ' H ' ' HG2' ' A' ' 15' ' ' GLU . 12.2 pt-20 -52.82 -44.31 66.6 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.342 -1.093 . . . . 71.32 109.588 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.1 mt -66.85 -38.31 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.736 -1.227 . . . . 63.23 108.329 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.507 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 88.0 tt0 -60.23 -45.94 91.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 51.11 109.213 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -86.05 -1.23 57.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -0.928 . . . . 73.34 109.715 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.62 -54.98 3.11 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 109.813 -1.315 . . . . 62.15 109.813 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -75.12 -21.32 58.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.231 -1.158 . . . . 73.51 110.0 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 96.4 m-20 -57.61 -31.65 66.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.121 -0.987 . . . . 74.25 109.636 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 85.1 t -61.13 -25.79 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.318 -0.864 . . . . 70.04 109.467 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.521 ' NZ ' ' OE1' ' A' ' 110' ' ' GLU . 17.0 mmtp -83.04 6.17 19.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.87 . . . . 73.23 109.337 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.51 37.18 21.26 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.153 -1.179 . . . . 75.54 110.153 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.57 ' CE2' ' SD ' ' A' ' 1' ' ' MET . 11.5 m-85 -116.09 159.05 22.26 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.467 -1.02 . . . . 73.43 109.017 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.4 mmt -112.75 135.21 53.75 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.833 -0.803 . . . . 43.24 108.833 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.51 161.81 38.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.194 -0.941 . . . . 62.11 109.718 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -142.76 141.16 31.67 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.357 -0.84 . . . . 74.42 109.26 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 t -104.02 130.31 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.304 -0.872 . . . . 72.15 108.877 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.2 p -118.9 170.35 9.09 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.536 -0.728 . . . . 71.42 109.361 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -88.29 -100.76 0.08 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.183 -0.948 . . . . 72.33 109.858 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.0 p -78.23 166.61 22.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 74.24 110.167 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' A' ' 37' ' ' GLU . 13.9 mt -55.61 -39.08 70.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.645 -0.659 . . . . 71.53 110.041 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -50.39 -43.81 54.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.092 -1.005 . . . . 74.23 109.652 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -65.66 -36.74 84.53 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.201 -0.937 . . . . 54.03 109.158 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.94 -34.9 29.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.558 -1.417 . . . . 61.41 109.558 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 33' ' ' LEU . 81.4 tt0 -63.37 -40.73 98.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -1.141 . . . . 74.34 109.569 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -77.9 -37.63 47.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.088 -1.008 . . . . 75.33 109.333 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.6 tp -66.91 -41.82 86.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 74.33 109.599 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.448 ' C ' ' SD ' ' A' ' 40' ' ' MET . 3.3 ppp? -77.87 -15.77 58.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.144 -0.972 . . . . 70.32 109.648 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -55.33 -39.8 70.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.052 -1.03 . . . . 71.22 109.158 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.8 pt -95.26 -32.39 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.274 -0.892 . . . . 74.14 109.885 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 40' ' ' MET . 96.6 mtt180 -91.77 153.04 19.87 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.078 -1.013 . . . . 72.24 109.676 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 45' ' ' TYR . 14.5 p30 -91.86 -34.38 14.56 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.162 -0.961 . . . . 75.42 109.765 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 44' ' ' ASN . 38.3 m-85 51.97 99.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.292 -0.88 . . . . 74.23 109.484 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -68.77 -28.97 67.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.23 -0.918 . . . . 72.04 109.42 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.682 ' HB3' HG13 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -115.5 110.58 19.48 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.747 -0.834 . . . . 72.13 108.747 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.465 ' N ' HD13 ' A' ' 47' ' ' LEU . 65.9 t -96.9 110.34 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.324 -0.86 . . . . 72.34 108.685 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.587 ' SD ' ' N ' ' A' ' 50' ' ' VAL . 1.5 tpt -122.4 130.35 53.01 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.539 -0.725 . . . . 74.11 109.549 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.587 ' N ' ' SD ' ' A' ' 49' ' ' MET . 1.1 p -138.84 130.43 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.695 0.76 . . . . 61.12 109.818 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.2 t -98.16 2.41 48.46 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.596 -0.69 . . . . 73.11 109.534 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -75.93 136.58 40.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.171 -0.956 . . . . 52.55 109.405 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.489 ' C ' ' H ' ' A' ' 55' ' ' ALA . 62.4 mttp -72.96 -42.24 63.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.306 -0.871 . . . . 44.22 110.617 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -69.19 11.23 0.23 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.039 -1.038 . . . . 70.44 109.747 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.489 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.35 -21.64 58.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 64.14 110.44 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 55' ' ' ALA . 74.5 mt -37.79 -53.21 1.29 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.7 -0.625 . . . . 44.14 110.818 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.6 t -65.65 -36.66 84.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.972 -1.08 . . . . 55.23 109.329 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.466 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 45.3 t80 -64.58 -63.03 1.23 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.327 -0.858 . . . . 74.44 109.83 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.1 m -48.36 -32.85 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.81 -1.181 . . . . 74.03 109.713 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.2 m -59.4 -52.79 64.12 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.201 -0.937 . . . . 64.3 109.348 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -68.78 -27.75 66.16 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 118.934 -1.107 . . . . 64.44 109.881 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.523 ' O ' ' N ' ' A' ' 66' ' ' HIS . 29.6 mm -59.21 -49.83 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 120.829 -1.17 . . . . 63.21 108.847 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.519 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 45.3 mmtt -59.79 -46.55 88.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.086 -1.009 . . . . 74.42 108.649 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -64.08 -42.86 96.81 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.942 -0.762 . . . . 70.32 108.942 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.472 ' C ' ' CG ' ' A' ' 66' ' ' HIS . 51.6 mtpt -76.95 -26.27 53.81 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.526 -0.734 . . . . 75.22 110.554 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 62' ' ' ILE . 56.9 m-70 -154.97 65.72 0.65 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.973 -1.079 . . . . 74.13 109.746 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 63' ' ' LYS . 33.8 t -59.28 -25.83 64.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.352 -0.842 . . . . 73.24 110.155 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.0 t -69.66 -14.77 62.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.17 -0.956 . . . . 61.01 110.493 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.473 HD12 ' CB ' ' A' ' 66' ' ' HIS . 79.0 mt -94.06 155.91 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.972 -1.08 . . . . 71.33 109.907 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 71' ' ' VAL . 90.2 t -85.02 162.76 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.364 -0.835 . . . . 72.13 109.696 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.535 ' N ' HG12 ' A' ' 70' ' ' VAL . 14.7 t -145.24 117.14 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.09 -1.006 . . . . 54.21 109.741 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.506 ' O ' ' SD ' ' A' ' 49' ' ' MET . 1.0 OUTLIER -115.46 99.92 7.71 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.219 -1.03 . . . . 50.24 108.219 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.6 p -96.48 152.6 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.127 -0.983 . . . . 74.41 108.774 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.5 m -132.42 172.33 12.6 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.215 -0.928 . . . . 72.31 109.364 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 77' ' ' ASN . 3.4 t -173.84 128.96 0.4 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.322 -0.861 . . . . 64.54 110.044 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -66.59 43.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.558 -0.714 . . . . 74.13 109.639 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 75' ' ' SER . 15.9 m120 -160.15 60.89 1.51 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 73.34 109.828 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -57.18 74.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.979 1.786 . . . . 63.22 111.469 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 77' ' ' ASN . 16.9 m -107.49 151.6 25.35 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.003 -0.74 . . . . 62.53 109.003 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -25.33 68.19 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.357 -0.839 . . . . 73.44 109.497 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -63.83 -52.39 60.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 71.42 109.489 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.29 -32.43 70.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 73.43 109.707 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -60.31 -52.62 64.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 74.22 109.603 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.64 -40.27 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.936 . . . . 73.2 109.312 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -68.65 -29.19 67.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -0.856 . . . . 53.33 109.826 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -67.28 -43.19 82.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.193 -0.942 . . . . 64.11 110.039 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -80.23 -26.39 39.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.062 -1.024 . . . . 74.34 108.946 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -75.98 -51.47 12.32 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.43 -0.794 . . . . 74.42 109.391 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.48 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 1.6 pp0? -61.57 -43.23 99.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.526 -0.734 . . . . 74.24 109.736 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.48 ' N ' ' CD ' ' A' ' 89' ' ' GLN . . . 138.45 72.82 0.05 OUTLIER Glycine 0 N--CA 1.498 2.776 0 N-CA-C 109.982 -1.247 . . . . 61.51 109.982 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.407 ' HB2' HE21 ' A' ' 89' ' ' GLN . . . -133.17 133.21 42.52 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.358 -1.083 . . . . 55.33 108.878 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 71' ' ' VAL . 2.8 m-20 -71.48 -39.66 70.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.039 -1.038 . . . . 73.42 108.999 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 61.8 m-20 -154.24 147.17 24.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.365 -0.834 . . . . 75.04 109.358 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -121.54 112.61 18.7 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.553 -0.906 . . . . 71.33 108.553 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 23.3 mm -106.56 152.4 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 CA-C-O 122.16 0.981 . . . . 71.13 111.333 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.59 123.33 21.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.849 -1.167 . . . . 64.32 107.849 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.667 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -45.99 -54.23 17.86 Favored Pre-proline 0 C--N 1.301 -1.531 0 O-C-N 121.038 -1.039 . . . . 62.2 111.525 -178.805 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.3 Cg_endo -41.46 -11.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 120.754 0.969 . . . . 73.11 112.886 -176.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.667 ' N ' ' O ' ' A' ' 97' ' ' LYS . 59.5 m-85 59.52 121.92 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.737 -0.602 . . . . 65.22 109.607 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -68.8 -32.26 71.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.059 -1.026 . . . . 72.35 109.52 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.765 ' O ' ' N ' ' A' ' 103' ' ' LYS . 41.3 t -174.21 28.41 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.989 -1.069 . . . . 71.32 110.885 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.695 HD12 ' N ' ' A' ' 102' ' ' ILE . 2.6 mp 50.4 -69.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-N 118.638 0.654 . . . . 75.43 110.194 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.765 ' N ' ' O ' ' A' ' 101' ' ' SER . 1.0 OUTLIER -55.33 -31.18 61.49 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.899 -1.148 . . . . 71.41 107.899 179.257 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.81 80.05 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.574 -0.85 . . . . 63.24 108.752 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.682 HD13 ' C ' ' A' ' 105' ' ' LEU . 1.7 tm? -69.74 -54.62 12.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.44 -0.787 . . . . 73.22 108.923 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.546 ' N ' HD13 ' A' ' 105' ' ' LEU . 53.8 t -52.77 -45.75 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.016 -1.052 . . . . 60.11 109.326 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.47 -42.25 67.03 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.13 -0.982 . . . . 70.42 108.385 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -62.58 -32.9 73.97 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.481 -0.762 . . . . 74.41 109.137 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 83.2 mt -74.35 -31.91 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.117 -0.99 . . . . 62.54 108.604 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.521 ' OE1' ' NZ ' ' A' ' 23' ' ' LYS . 75.0 tt0 -58.44 -52.11 67.02 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.492 -0.755 . . . . 74.34 109.314 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.29 -32.3 66.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.917 . . . . 73.32 109.658 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.5 ' NH2' HG22 ' A' ' 70' ' ' VAL . 24.0 tpt85 -54.52 -34.21 61.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 52.41 109.433 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.2 tp -151.74 108.87 3.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.181 -0.949 . . . . 65.24 109.504 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.4 ' HE ' ' HG3' ' A' ' 110' ' ' GLU . 4.4 mmt180 -144.46 -51.76 0.3 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.252 -0.905 . . . . 64.45 108.67 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -82.53 25.57 0.62 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.185 -0.947 . . . . 74.43 109.401 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.439 ' CG ' ' N ' ' A' ' 117' ' ' GLY . 60.4 p-90 -51.04 -40.0 57.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 74.42 109.721 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.439 ' N ' ' CG ' ' A' ' 116' ' ' TRP . . . -57.74 93.42 0.04 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.767 -1.333 . . . . 75.04 109.767 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.0 m -153.03 164.71 37.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.211 -1.17 . . . . 61.14 109.707 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -159.87 128.98 5.12 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.907 -0.775 . . . . 65.24 108.907 -178.332 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.7 t -83.86 -45.31 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.158 -0.964 . . . . 73.11 110.066 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.533 ' CG2' HH21 ' A' ' 159' ' ' ARG . 20.3 mm -102.64 130.94 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.314 -0.867 . . . . 72.24 109.812 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -121.39 128.58 52.36 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.986 -0.746 . . . . 72.34 108.986 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 126' ' ' LEU . 23.6 mt -141.03 112.65 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.181 -0.95 . . . . 71.44 109.45 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.63 -138.63 7.94 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.857 -1.297 . . . . 73.4 109.857 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -80.09 -11.47 59.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -1.165 . . . . 74.45 109.487 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 123' ' ' ILE . 0.8 OUTLIER -91.23 135.53 33.73 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.494 -0.928 . . . . 54.21 108.494 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.8 m -130.2 129.77 43.82 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.447 -0.783 . . . . 54.5 109.593 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 28.8 mm -112.87 139.71 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.902 -0.777 . . . . 45.15 108.902 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 133' ' ' GLU . 5.2 m -128.05 80.03 72.86 Favored Pre-proline 0 N--CA 1.5 2.039 0 O-C-N 121.456 -0.777 . . . . 71.11 109.697 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.46 -51.89 9.47 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.704 2.27 . . . . 65.41 112.082 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -53.68 -44.03 69.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 63.32 109.092 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -87.36 -1.98 58.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.346 -0.846 . . . . 72.52 109.163 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 129' ' ' SER . 34.6 mp0 50.05 72.51 0.32 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.91 . . . . 75.33 109.129 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -158.14 122.89 4.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.343 -0.848 . . . . 71.23 109.814 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 84.3 mt -101.56 126.76 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.422 -0.799 . . . . 74.02 108.922 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.0 mt -117.07 125.36 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.57 -0.706 . . . . 60.23 109.113 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.492 ' C ' ' H ' ' A' ' 139' ' ' GLY . 47.8 p90 -140.72 151.45 44.51 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.327 -0.858 . . . . 62.32 109.207 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.3 tptp 56.01 5.5 0.17 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.78 0.8 . . . . 75.4 109.15 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 137' ' ' TYR . . . 95.93 -2.98 64.47 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.846 -1.302 . . . . 72.24 109.846 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.529 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 1.2 mpt_? -89.71 131.64 35.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.235 -1.156 . . . . 71.22 109.14 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -93.04 127.98 38.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.241 -0.912 . . . . 71.42 109.571 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 43.2 t -137.07 136.44 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.424 -0.798 . . . . 53.02 109.493 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -91.51 143.54 26.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.268 -0.895 . . . . 60.45 109.042 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 25.9 m -139.75 153.89 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.288 -0.883 . . . . 74.44 109.699 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -167.21 24.64 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.333 -0.854 . . . . 65.15 109.163 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.52 -169.79 45.16 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.824 -1.31 . . . . 73.34 109.824 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.625 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 14.2 tmtt? -82.11 -31.14 0.54 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.343 -1.093 . . . . 72.22 111.424 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 87.0 Cg_endo -86.64 -3.58 8.32 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 C-N-CA 121.781 1.654 . . . . 65.23 112.408 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -96.85 -29.87 13.47 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.183 -0.948 . . . . 60.11 109.18 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -59.2 -40.84 87.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.271 -0.893 . . . . 64.21 109.259 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.461 HG11 HD13 ' A' ' 191' ' ' ILE . 13.9 p -61.79 -34.09 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.226 -0.921 . . . . 72.02 108.894 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.2 OUTLIER -59.94 -45.44 92.62 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.514 -0.921 . . . . 73.31 108.514 179.627 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.0 p -74.39 -24.58 59.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.197 -0.94 . . . . 74.31 109.294 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -59.36 -51.13 71.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.905 . . . . 74.31 109.685 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.7 pp -76.36 -27.22 56.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.104 -0.998 . . . . 75.34 109.618 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -54.12 -46.26 72.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.094 -1.004 . . . . 62.14 109.375 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.475 ' C ' ' H ' ' A' ' 159' ' ' ARG . 66.4 mtp180 -77.01 -49.49 15.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.928 . . . . 61.03 109.382 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -72.2 34.2 0.06 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.636 -0.665 . . . . 74.12 110.042 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.533 HH21 ' CG2' ' A' ' 121' ' ' ILE . 19.1 ttm180 -59.51 150.44 26.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.131 -0.981 . . . . 71.13 109.133 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 214' ' ' PHE . 62.2 m-20 53.05 46.93 25.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 75.45 109.544 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -149.71 150.95 32.88 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.23 -0.919 . . . . 73.41 109.312 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 58.3 mt -90.15 132.74 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.223 -0.923 . . . . 74.41 109.296 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 48.5 t -131.52 134.73 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.486 -0.759 . . . . 72.31 109.29 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.423 ' OG ' ' OE1' ' A' ' 166' ' ' GLU . 3.0 t -86.25 157.25 19.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.318 -0.863 . . . . 74.12 109.894 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -59.52 -44.08 93.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.437 -0.789 . . . . 70.43 109.627 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' A' ' 166' ' ' GLU . 34.0 mp0 -59.56 -38.01 79.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 73.52 109.526 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -59.28 -40.66 86.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.138 -0.976 . . . . 74.52 109.096 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 62.5 mt -58.02 -54.09 50.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.186 -0.947 . . . . 72.31 108.925 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 169' ' ' LEU . 10.3 mp -61.5 -55.95 25.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 53.33 109.194 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 169' ' ' LEU . 17.3 t70 -35.86 -42.8 0.28 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.04 0.447 . . . . 62.44 111.256 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.63 -30.26 13.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.078 -1.014 . . . . 60.21 110.53 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.9 mm -84.9 -72.72 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 120.986 -1.071 . . . . 75.32 109.663 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.503 ' O ' ' CE3' ' A' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 108.395 -0.965 . . . . 73.14 108.395 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.481 ' OD1' ' CD1' ' A' ' 184' ' ' ILE . 5.9 t30 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.215 0.531 . . . . 64.54 110.04 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.8 m -142.17 9.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.277 -0.89 . . . . 74.02 109.144 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.745 ' H ' HD12 ' A' ' 184' ' ' ILE . 2.1 mp -49.8 -42.22 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 72.33 109.452 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.629 ' CD ' ' H ' ' A' ' 185' ' ' GLU . 2.1 pm0 -47.05 -34.67 6.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.153 -0.967 . . . . 74.4 109.263 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 92.3 t -78.35 -51.63 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.263 -0.898 . . . . 70.42 109.395 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.97 71.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 52.11 110.069 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.529 HG23 ' N ' ' A' ' 189' ' ' ASN . 10.8 tp -58.51 -44.88 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.971 -1.08 . . . . 71.4 109.73 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.529 ' N ' HG23 ' A' ' 188' ' ' ILE . 45.7 t-20 -56.71 -45.09 82.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.932 -1.105 . . . . 73.44 109.381 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -68.88 -40.91 78.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.86 . . . . 71.42 109.64 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.461 HD13 HG11 ' A' ' 151' ' ' VAL . 68.1 mt -64.94 -34.66 71.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.175 -0.953 . . . . 61.55 109.73 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -64.01 -56.76 12.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.219 -0.925 . . . . 63.34 109.683 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -65.46 -35.69 81.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.917 . . . . 61.24 109.949 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -70.93 -17.66 62.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.071 -1.018 . . . . 75.13 109.667 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' MET . . . . . 0.444 ' SD ' ' C ' ' A' ' 195' ' ' MET . 0.2 OUTLIER -89.95 -53.52 4.45 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.253 -0.904 . . . . 74.02 109.722 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 200' ' ' GLY . 60.0 m-20 -61.18 -38.39 86.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 74.02 110.408 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.451 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 19.4 mmtt -51.76 -65.62 0.94 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 120.951 -1.093 . . . . 75.43 109.831 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 37.7 Cg_endo -64.02 -55.57 0.61 Allowed 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.242 1.961 . . . . 72.32 112.399 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 199' ' ' LEU . 10.2 mp -64.26 -38.67 91.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.091 -1.005 . . . . 74.54 109.531 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 196' ' ' ASP . . . 83.22 -40.21 2.82 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.605 -1.398 . . . . 61.51 109.605 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.71 HD12 ' N ' ' A' ' 201' ' ' ILE . 2.2 mp -92.6 139.48 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.248 -1.148 . . . . 61.22 109.319 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 34.1 t -88.06 140.37 29.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.187 -0.946 . . . . 72.0 109.235 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 11.9 p -144.25 33.41 1.21 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.177 -0.952 . . . . 74.44 109.516 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.62 143.92 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.238 -0.914 . . . . 64.35 109.649 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -122.08 137.84 54.67 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.632 -0.668 . . . . 71.41 109.284 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.1 t -114.51 141.74 47.31 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.471 -0.768 . . . . 73.52 109.357 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.457 HG22 ' H ' ' A' ' 209' ' ' ARG . 9.0 p -144.42 137.12 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.253 -0.904 . . . . 71.02 109.473 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -71.4 -34.34 70.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 72.12 109.808 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.457 ' H ' HG22 ' A' ' 207' ' ' VAL . 22.4 ttm105 -51.45 -36.77 45.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 64.41 109.699 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -140.98 -155.7 0.61 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.329 -0.857 . . . . 71.54 109.195 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -79.1 -125.13 0.44 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.739 -1.344 . . . . 72.03 109.739 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 212' ' ' TYR . 30.1 m-85 -116.78 135.0 54.1 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.577 -0.954 . . . . 75.54 109.728 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 67.4 ttt-85 -104.92 127.97 52.97 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.581 -0.7 . . . . 75.31 109.157 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 160' ' ' ASP . 18.8 m-85 -100.95 130.63 46.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.258 -0.901 . . . . 75.41 109.334 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' CYS . . . . . 0.401 ' SG ' ' OD1' ' A' ' 160' ' ' ASP . 52.0 t -154.39 155.97 35.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.36 -0.837 . . . . 74.14 109.281 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -68.07 149.93 97.96 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.164 -0.96 . . . . 75.32 108.957 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.495 1.577 0 C-N-CA 122.189 1.926 . . . . 73.11 111.877 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.553 ' N ' ' CD2' ' B' ' 25' ' ' PHE . 12.7 mtt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.334 -0.617 . . . . 71.14 109.334 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -97.8 121.26 39.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.324 -0.86 . . . . 73.23 109.288 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 79.9 t -115.59 136.24 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.472 0.653 . . . . 72.24 109.618 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.431 HD12 ' N ' ' B' ' 5' ' ' LEU . 5.5 tp -105.33 120.12 40.78 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.589 -0.695 . . . . 54.33 109.729 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.431 ' N ' HD12 ' B' ' 4' ' ' LEU . 18.0 mt -118.08 96.83 5.51 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.706 -0.85 . . . . 74.35 108.706 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.675 HD12 ' HB ' ' B' ' 50' ' ' VAL . 69.5 mt -84.96 97.54 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.808 -1.183 . . . . 42.55 108.377 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.431 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 35.2 tp10 -135.62 133.03 37.82 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.484 -0.76 . . . . 74.52 109.535 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -66.67 -32.51 73.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.308 -0.87 . . . . 62.55 109.32 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' ASN . . . . . 0.41 ' H ' ' HG3' ' B' ' 7' ' ' GLU . 89.7 m-20 -79.93 129.93 34.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 73.11 109.388 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 25.9 t -83.31 -32.32 26.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 65.54 109.849 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.54 HG13 ' N ' ' B' ' 12' ' ' LEU . 11.1 p -63.25 -44.3 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.141 -0.974 . . . . 75.55 109.865 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.54 ' N ' HG13 ' B' ' 11' ' ' VAL . 74.7 mt -66.58 -33.02 74.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.993 -1.067 . . . . 70.14 109.353 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.73 -23.32 64.72 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.804 -1.718 . . . . 75.4 108.804 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.7 -49.7 7.71 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.702 -1.359 . . . . 65.44 109.702 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -62.58 -43.5 98.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.113 -1.227 . . . . 60.21 109.161 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 97.3 mt -61.27 -35.67 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.075 -1.016 . . . . 75.15 108.445 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -60.83 -44.76 96.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.439 -0.788 . . . . 73.01 109.333 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -85.15 -0.14 53.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.19 -0.944 . . . . 74.3 109.097 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.6 -55.54 2.42 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.652 -1.379 . . . . 70.54 109.652 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -75.05 -19.99 59.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.152 -1.205 . . . . 71.34 109.811 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 -53.05 -32.94 49.63 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.103 -0.998 . . . . 64.41 109.328 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 79.2 t -58.02 -27.71 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 74.23 108.836 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -83.9 -4.51 58.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.445 -0.784 . . . . 63.42 109.152 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.13 33.55 32.34 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.05 -1.22 . . . . 53.43 110.05 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.553 ' CD2' ' N ' ' B' ' 1' ' ' MET . 9.0 m-85 -110.83 159.14 17.94 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.411 -1.052 . . . . 71.12 108.9 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 6.9 mmt -105.49 141.88 36.2 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.563 -0.903 . . . . 75.24 108.563 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.424 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -138.0 156.53 47.73 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.193 -0.942 . . . . 72.12 110.277 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 77.9 m-20 -138.77 159.46 42.07 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.647 -0.871 . . . . 72.31 108.647 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 p -123.04 139.98 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.327 -0.858 . . . . 64.43 109.938 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.4 p -138.16 170.78 15.44 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.532 -0.73 . . . . 65.41 109.284 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -90.62 -106.05 0.09 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.315 -0.865 . . . . 71.02 110.01 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 59.9 p -80.47 168.13 19.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.151 -0.968 . . . . 51.11 110.068 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' B' ' 37' ' ' GLU . 15.1 mt -51.85 -31.33 27.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.455 -0.778 . . . . 71.24 109.852 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -52.82 -51.49 60.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.032 -1.043 . . . . 74.32 109.647 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -62.72 -40.61 97.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.134 -0.979 . . . . 73.03 108.957 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.7 -33.27 75.59 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.964 -1.654 . . . . 30.21 108.964 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' B' ' 33' ' ' LEU . 84.3 tt0 -66.86 -44.07 81.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.363 -1.081 . . . . 74.42 109.319 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -75.83 -35.63 59.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 74.42 109.447 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 12.1 tp -72.0 -39.51 69.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.842 . . . . 75.41 110.119 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' MET . . . . . 0.449 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.7 ppp? -77.63 -18.19 57.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.999 -1.063 . . . . 60.41 109.888 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -69.5 -42.46 74.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.109 -0.995 . . . . 53.23 109.538 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 2.4 pp -87.48 -16.42 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.867 . . . . 71.23 109.737 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' B' ' 40' ' ' MET . 13.6 tpp85 -130.64 138.56 50.14 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.44 -0.787 . . . . 72.22 109.42 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -98.59 129.13 45.11 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.316 -0.865 . . . . 63.54 109.103 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -108.38 136.87 47.3 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.425 -0.797 . . . . 64.35 109.568 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' ASP . . . . . 0.449 ' OD2' ' SD ' ' B' ' 1' ' ' MET . 92.5 m-20 -76.75 -41.83 43.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 62.22 108.709 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.519 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.3 OUTLIER -103.73 115.72 31.0 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.394 -0.965 . . . . 73.12 108.394 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.519 ' N ' HD13 ' B' ' 47' ' ' LEU . 62.1 t -100.61 97.61 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.564 -0.902 . . . . 65.11 108.564 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -116.51 130.72 56.91 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.41 -0.806 . . . . 73.44 110.217 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.681 HG22 ' H ' ' B' ' 52' ' ' ASP . 0.3 OUTLIER -144.33 134.49 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.169 -0.678 . . . . 34.5 109.169 -179.605 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 51' ' ' SER . . . . . 0.431 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 19.1 p -95.43 16.4 17.02 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.385 -0.822 . . . . 73.21 109.792 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.681 ' H ' HG22 ' B' ' 50' ' ' VAL . 53.4 m-20 -80.56 144.58 32.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.956 . . . . 70.41 109.578 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -76.45 -36.01 58.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 65.0 109.986 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -74.43 10.88 1.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 75.21 109.685 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.17 -25.27 66.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 55.33 110.08 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 62.1 mt -47.34 -40.35 17.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.078 -1.014 . . . . 63.14 110.028 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 14.5 t -75.45 -41.71 55.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.944 -1.098 . . . . 63.5 109.829 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' PHE . . . . . 0.421 ' CE2' HD11 ' B' ' 62' ' ' ILE . 63.0 t80 -64.12 -47.91 78.15 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.329 -0.857 . . . . 72.33 110.232 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.43 HG23 ' N ' ' B' ' 60' ' ' SER . 19.5 m -63.95 -36.81 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.64 -1.287 . . . . 74.54 109.694 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 60' ' ' SER . . . . . 0.43 ' N ' HG23 ' B' ' 59' ' ' VAL . 80.6 p -56.59 -45.48 81.38 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.247 -0.908 . . . . 71.24 109.774 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' B' ' 65' ' ' LYS . 10.5 ptp180 -74.82 -31.82 61.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.065 -1.022 . . . . 74.31 109.971 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' B' ' 66' ' ' HIS . 5.1 mm -59.74 -53.72 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.901 -1.125 . . . . 72.14 109.493 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.498 ' HZ3' ' HB3' ' B' ' 63' ' ' LYS . 8.8 mmmm -62.28 -41.51 98.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.036 -1.04 . . . . 73.32 108.95 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -66.83 -39.64 87.72 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.305 -0.998 . . . . 73.12 108.305 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' B' ' 61' ' ' ARG . 92.6 mttt -87.3 -76.95 0.35 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.357 -0.839 . . . . 72.44 109.249 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.512 ' O ' HG22 ' B' ' 69' ' ' ILE . 97.7 m-70 -91.94 92.33 8.27 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.212 -0.93 . . . . 63.31 109.039 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.483 ' O ' ' N ' ' B' ' 69' ' ' ILE . 25.6 t -78.56 -41.47 31.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 73.1 110.058 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 46.2 t -67.76 54.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.164 -0.96 . . . . 71.53 109.81 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.512 HG22 ' O ' ' B' ' 66' ' ' HIS . 16.6 tt -151.28 153.22 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.143 -0.973 . . . . 74.4 109.395 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.415 HG13 HH12 ' B' ' 112' ' ' ARG . 76.1 t -97.48 152.14 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.15 -0.969 . . . . 75.12 109.284 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 10.0 t -136.59 129.77 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.24 -0.913 . . . . 73.2 110.108 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.559 ' C ' HD23 ' B' ' 72' ' ' LEU . 4.8 tt -121.17 106.24 11.34 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.911 -0.774 . . . . 73.34 108.911 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 77.8 t -93.09 128.21 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.154 -0.966 . . . . 73.5 109.433 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.48 157.92 16.29 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.347 -0.983 . . . . 64.34 108.347 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 40.0 m -156.02 134.38 11.54 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.841 -1.162 . . . . 74.53 110.789 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -87.18 7.63 27.42 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.499 -0.926 . . . . 64.5 108.499 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -135.91 59.83 31.43 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 108.749 -0.834 . . . . 74.25 108.749 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.468 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 19.4 Cg_endo -60.14 79.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.424 2.083 . . . . 74.43 111.736 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 68.9 p -106.98 151.87 24.73 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.852 -0.795 . . . . 73.12 108.852 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.56 -22.0 30.34 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.297 -0.877 . . . . 71.01 109.152 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -68.98 -49.26 59.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 63.2 109.31 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -74.9 -27.27 60.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 73.22 109.658 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.75 -56.03 23.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.174 -0.954 . . . . 74.3 109.657 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.514 HG23 ' N ' ' B' ' 85' ' ' HIS . 35.2 m -64.71 -42.76 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.135 -0.978 . . . . 73.31 109.279 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 85' ' ' HIS . . . . . 0.514 ' N ' HG23 ' B' ' 84' ' ' VAL . 66.2 t60 -60.76 -36.12 78.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -0.918 . . . . 73.24 109.207 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.46 -41.13 98.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.337 -0.852 . . . . 55.33 109.97 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -77.35 -39.16 48.46 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.028 -1.045 . . . . 74.14 108.852 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -65.03 -39.19 93.01 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.596 -0.842 . . . . 64.04 109.254 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -62.19 -47.1 85.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 72.35 108.935 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 144.47 -6.3 1.68 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.006 -1.237 . . . . 65.2 110.006 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.92 133.79 26.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.038 -1.272 . . . . 52.23 109.285 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.488 ' CG ' HH12 ' B' ' 112' ' ' ARG . 40.9 t0 -83.45 -18.68 37.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -0.93 . . . . 73.32 109.213 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -152.45 164.05 38.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.421 -0.799 . . . . 72.22 108.988 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.468 ' OH ' ' CB ' ' B' ' 78' ' ' PRO . 0.1 OUTLIER -150.85 107.3 3.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.189 -0.944 . . . . 64.42 108.931 -179.361 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 0.478 HG22 ' N ' ' B' ' 96' ' ' ALA . 30.9 mm -114.82 159.87 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 O-C-N 121.485 -0.76 . . . . 72.23 109.94 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 96' ' ' ALA . . . . . 0.478 ' N ' HG22 ' B' ' 95' ' ' ILE . . . -70.96 128.32 35.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.18 -0.95 . . . . 25.24 108.556 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.687 ' O ' ' N ' ' B' ' 99' ' ' TYR . 1.8 tptt -49.08 -59.33 6.59 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.144 -0.973 . . . . 64.32 111.443 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 98' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 8.0 Cg_endo -44.24 -3.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.569 1.513 . . . . 63.33 113.015 -175.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 99' ' ' TYR . . . . . 0.687 ' N ' ' O ' ' B' ' 97' ' ' LYS . 48.5 m-85 62.18 123.38 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.91 -0.494 . . . . 75.13 109.795 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 17.9 ttm-85 -74.41 -37.66 63.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.942 -1.099 . . . . 74.23 109.237 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 101' ' ' SER . . . . . 0.767 ' O ' ' N ' ' B' ' 103' ' ' LYS . 48.3 t -173.8 35.45 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.951 -1.093 . . . . 63.34 111.303 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 36.8 mm 49.67 -70.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-N 118.995 0.816 . . . . 74.44 110.52 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.767 ' N ' ' O ' ' B' ' 101' ' ' SER . 33.1 mmtm -54.08 -32.44 54.8 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.106 -1.072 . . . . 71.11 108.106 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.01 -45.75 76.59 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.342 -0.985 . . . . 71.45 108.342 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 64.2 tp -62.6 -44.18 96.94 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.72 -0.845 . . . . 51.31 108.72 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 76.5 t -66.79 -38.62 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.355 -0.841 . . . . 65.23 109.513 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.42 -46.48 69.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.225 -0.922 . . . . 24.32 109.49 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -69.56 -31.37 69.51 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.188 -0.945 . . . . 75.31 109.888 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 96.4 mt -74.06 -31.34 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.018 -1.051 . . . . 54.24 108.833 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -73.91 -58.56 3.22 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.645 -0.822 . . . . 65.31 109.367 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -50.99 -35.22 32.67 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.384 -0.823 . . . . 72.24 109.578 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 112' ' ' ARG . . . . . 0.488 HH12 ' CG ' ' B' ' 92' ' ' ASP . 5.6 tpt180 -65.7 -44.01 87.42 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.158 -0.964 . . . . 72.04 109.738 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 43.0 mt -134.28 64.01 1.61 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.365 -0.835 . . . . 75.35 109.963 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -60.55 -43.7 96.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.971 -1.081 . . . . 75.5 108.628 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -142.08 -109.21 0.13 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.389 -0.819 . . . . 65.33 109.357 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -148.21 162.7 38.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.272 -0.893 . . . . 74.45 109.184 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.11 153.72 52.18 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.525 -1.43 . . . . 44.21 109.525 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 118' ' ' SER . . . . . 0.427 ' O ' ' O ' ' B' ' 119' ' ' ASN . 29.5 p -82.65 30.55 0.42 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -1.182 . . . . 71.4 109.718 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 119' ' ' ASN . . . . . 0.46 ' N ' ' OD1' ' B' ' 119' ' ' ASN . 0.0 OUTLIER 55.07 170.24 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.495 -0.882 . . . . 72.32 109.629 177.602 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 11.0 t -119.88 -37.82 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.526 -0.734 . . . . 75.02 109.13 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 29.3 mm -110.94 132.79 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.437 -0.79 . . . . 51.41 109.491 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -152.98 117.14 4.87 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.196 -0.94 . . . . 71.53 109.495 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.701 HD11 ' HB3' ' B' ' 216' ' ' TYR . 11.5 tt -163.04 140.24 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.009 -1.057 . . . . 72.43 110.271 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 124' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' B' ' 126' ' ' LEU . . . 69.52 33.14 71.79 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.312 -1.115 . . . . 51.23 110.312 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 14.8 t0 69.51 -6.34 1.01 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.355 -1.086 . . . . 74.2 109.281 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.723 HD13 HD13 ' B' ' 199' ' ' LEU . 1.2 mt -91.12 144.35 25.73 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.031 -1.1 . . . . 75.42 108.031 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.46 126.31 40.27 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.357 -0.839 . . . . 74.22 109.004 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 73.6 mt -127.58 131.41 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.593 -0.692 . . . . 60.33 109.341 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 48.7 m -115.24 121.27 35.2 Favored Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 121.626 -0.671 . . . . 72.31 109.334 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -78.26 -44.25 0.16 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.572 1.515 . . . . 75.13 111.933 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 131' ' ' ASP . . . . . 0.791 ' O ' ' OE2' ' B' ' 133' ' ' GLU . 70.0 m-20 -62.91 -46.85 85.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.07 -1.019 . . . . 75.23 109.281 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 132' ' ' GLU . . . . . 0.478 ' O ' ' C ' ' B' ' 133' ' ' GLU . 41.7 mt-10 -86.84 5.72 35.31 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.252 -0.905 . . . . 72.43 109.182 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 133' ' ' GLU . . . . . 0.791 ' OE2' ' O ' ' B' ' 131' ' ' ASP . 0.6 OUTLIER 29.93 59.87 0.19 Allowed 'General case' 0 N--CA 1.509 2.502 0 CA-C-O 121.596 0.712 . . . . 75.13 110.447 -179.579 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -141.99 137.56 31.26 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.973 -0.751 . . . . 73.22 108.973 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 10.9 tt -111.05 138.97 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.217 -0.927 . . . . 64.14 109.874 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 18.0 mm -115.91 132.84 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.561 -0.712 . . . . 71.22 109.534 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -140.43 125.2 18.17 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.362 -0.836 . . . . 64.22 108.964 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 81.2 mttt 55.13 33.98 21.62 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.405 -0.809 . . . . 72.02 110.311 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 76.76 14.99 81.98 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 120.182 -1.009 . . . . 74.32 110.934 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -101.05 127.8 47.4 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.179 -1.189 . . . . 75.34 109.63 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -93.74 117.83 30.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.253 -0.904 . . . . 71.23 109.621 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 5.3 t -124.74 120.99 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.389 -0.819 . . . . 70.43 108.947 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -79.22 139.8 37.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.382 -0.824 . . . . 72.43 109.62 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.99 137.21 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.285 -0.884 . . . . 72.13 109.069 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 41.8 pttt -167.24 119.11 0.91 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 72.02 109.782 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 156.96 -177.21 33.97 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.082 -1.607 . . . . 42.23 109.082 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 147' ' ' LYS . . . . . 0.622 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 26.6 mmtm -69.05 -36.56 7.71 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.166 -1.197 . . . . 73.3 110.375 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 148' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 26.8 Cg_exo -61.3 -36.21 80.46 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.871 1.714 . . . . 71.33 111.597 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -90.6 -28.01 18.72 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.359 -0.838 . . . . 74.23 109.393 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -50.6 -49.42 56.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 72.34 109.696 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.647 HG22 HG21 ' B' ' 191' ' ' ILE . 2.8 p -64.95 -34.28 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.088 -1.008 . . . . 73.35 109.038 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 10.5 tp -64.07 -36.85 85.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.172 -0.955 . . . . 55.24 108.605 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.39 -28.65 56.8 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.441 -0.787 . . . . 70.01 109.305 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 154' ' ' HIS . . . . . 0.724 ' CD2' ' CD2' ' B' ' 158' ' ' HIS . 22.1 t-160 -63.43 -53.84 45.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.023 -1.048 . . . . 65.32 109.561 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 155' ' ' LEU . . . . . 0.412 ' CD2' HD12 ' B' ' 191' ' ' ILE . 2.7 pp -66.61 -30.36 70.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.992 -1.067 . . . . 71.54 108.917 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.51 -51.22 60.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.101 -1.0 . . . . 75.32 109.016 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 157' ' ' ARG . . . . . 0.559 ' NH1' ' HA ' ' B' ' 154' ' ' HIS . 51.3 mtt85 -62.37 -51.39 67.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.029 -1.044 . . . . 73.32 108.773 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 158' ' ' HIS . . . . . 0.724 ' CD2' ' CD2' ' B' ' 154' ' ' HIS . 32.7 m-70 -88.78 36.0 0.79 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.723 -0.61 . . . . 74.14 109.886 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 159' ' ' ARG . . . . . 0.419 HH12 ' CB ' ' B' ' 203' ' ' THR . 29.9 ttp85 -82.6 41.36 0.71 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.872 -1.142 . . . . 61.41 109.619 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 160' ' ' ASP . . . . . 0.764 ' HB3' ' HE1' ' B' ' 216' ' ' TYR . 3.9 p-10 -166.66 49.34 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 72.1 109.511 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -175.6 -171.54 0.48 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.346 -0.846 . . . . 72.25 109.79 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 86.9 mt -93.05 143.05 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.288 -0.883 . . . . 72.31 110.126 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 78.6 t -134.18 126.21 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.986 -0.746 . . . . 64.21 108.986 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 4.6 p -81.68 162.76 22.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.131 -0.98 . . . . 74.22 109.941 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -64.54 -51.54 62.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.422 -0.799 . . . . 65.31 110.137 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -58.38 -27.13 63.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.119 -0.988 . . . . 63.45 109.086 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -56.18 -50.95 69.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 72.4 108.906 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 79.6 mt -61.73 -36.19 80.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 72.32 108.933 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.526 HD23 ' C ' ' B' ' 169' ' ' LEU . 5.9 tt -64.9 -61.48 2.14 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.453 -0.779 . . . . 73.34 109.695 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -62.38 -25.73 68.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.91 . . . . 72.1 110.479 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.03 -47.52 58.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.943 -1.098 . . . . 62.13 110.366 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 24.3 mm -99.7 -63.06 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.149 -0.969 . . . . 71.42 110.428 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 25.6 m-90 . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.081 -1.012 . . . . 72.23 109.961 -179.29 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo . . . . . 0 N--CA 1.498 1.736 0 CA-C-O 121.348 0.478 . . . . 65.22 112.441 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -179.04 -21.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.323 -0.861 . . . . 72.31 108.835 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 15.2 m -75.21 -10.13 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 63.32 109.546 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.402 ' H ' HG13 ' B' ' 184' ' ' ILE . 50.9 mt -50.4 -25.96 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.923 . . . . 75.03 109.004 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -62.18 -38.57 89.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.387 -0.82 . . . . 64.11 109.381 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 186' ' ' VAL . . . . . 0.419 ' H ' HG23 ' B' ' 186' ' ' VAL . 2.1 t -77.45 -34.94 21.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.399 -0.813 . . . . 73.0 109.986 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -68.68 -39.36 80.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.861 -1.149 . . . . 61.12 110.634 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 188' ' ' ILE . . . . . 0.525 HG23 ' N ' ' B' ' 189' ' ' ASN . 10.6 tp -76.94 -42.13 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.786 -1.196 . . . . 72.43 109.769 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 189' ' ' ASN . . . . . 0.525 ' N ' HG23 ' B' ' 188' ' ' ILE . 52.5 m-80 -70.33 -37.12 74.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 65.14 110.77 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 190' ' ' GLN . . . . . 0.429 ' CG ' ' N ' ' B' ' 191' ' ' ILE . 13.6 pt20 -71.45 -46.95 58.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.859 -1.15 . . . . 63.24 110.995 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 191' ' ' ILE . . . . . 0.647 HG21 HG22 ' B' ' 151' ' ' VAL . 6.5 pt -60.7 -38.97 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.485 -1.384 . . . . 74.03 109.379 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 192' ' ' ARG . . . . . 0.52 ' NH2' ' CD1' ' B' ' 212' ' ' TYR . 98.5 mtt180 -62.35 -35.79 80.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.029 -1.045 . . . . 72.24 109.474 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 193' ' ' GLN . . . . . 0.443 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 86.7 mt-30 -77.5 -25.91 50.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.228 -0.92 . . . . 73.1 110.384 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -78.71 -24.25 45.05 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.092 -1.005 . . . . 72.11 110.736 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 5.6 ptm -94.82 -35.7 11.97 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.921 -1.112 . . . . 44.33 110.568 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 196' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 52.9 p-10 -67.92 -24.04 65.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.985 -1.072 . . . . 71.21 110.772 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 197' ' ' LYS . . . . . 0.539 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 17.5 mttp -74.69 -62.23 0.97 Allowed Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.979 -1.076 . . . . 75.21 110.219 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 198' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -66.36 -39.51 17.04 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.082 1.855 . . . . 75.32 112.83 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 199' ' ' LEU . . . . . 0.723 HD13 HD13 ' B' ' 126' ' ' LEU . 58.1 mt -80.14 -55.77 4.7 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.881 -1.137 . . . . 72.25 110.142 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 95.91 -8.4 67.94 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.42 -1.472 . . . . 64.53 109.42 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 23.4 mm -105.36 135.93 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.325 -1.103 . . . . 44.23 109.349 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 47.7 t -90.15 133.36 34.93 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.146 -0.971 . . . . 54.01 108.723 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 203' ' ' THR . . . . . 0.419 ' CB ' HH12 ' B' ' 159' ' ' ARG . 43.7 p -146.83 50.25 1.12 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.022 -1.048 . . . . 74.4 110.226 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.475 HG23 ' O ' ' B' ' 204' ' ' VAL . 33.3 m -144.31 124.6 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 120.973 -1.08 . . . . 72.12 109.835 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -109.53 114.0 27.26 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.416 -0.957 . . . . 65.41 108.416 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 206' ' ' THR . . . . . 0.497 ' O ' HG23 ' B' ' 206' ' ' THR . 9.8 t -96.06 125.31 40.51 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.097 -1.002 . . . . 71.33 109.724 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.537 HG22 ' H ' ' B' ' 209' ' ' ARG . 7.9 p -142.22 142.62 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.303 -0.873 . . . . 63.5 109.321 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -80.6 6.97 11.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 74.45 109.611 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 209' ' ' ARG . . . . . 0.537 ' H ' HG22 ' B' ' 207' ' ' VAL . 14.2 tpt180 -58.17 -39.4 78.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.22 -0.925 . . . . 74.14 109.818 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -160.37 -37.16 0.05 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.222 -0.924 . . . . 74.43 109.397 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.9 -150.5 9.96 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.438 -1.465 . . . . 64.45 109.438 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 212' ' ' TYR . . . . . 0.52 ' CD1' ' NH2' ' B' ' 192' ' ' ARG . 54.4 m-85 -93.11 137.92 32.02 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.137 -1.213 . . . . 74.21 109.033 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -111.46 118.37 35.6 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.55 -0.719 . . . . 74.03 109.78 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -96.05 131.67 42.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.349 -0.844 . . . . 74.34 109.024 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.0 t -145.06 169.5 17.99 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.17 -0.956 . . . . 64.33 109.946 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 216' ' ' TYR . . . . . 0.764 ' HE1' ' HB3' ' B' ' 160' ' ' ASP . 0.0 OUTLIER -74.74 159.09 83.96 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.414 -0.958 . . . . 70.04 108.414 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.82 133.1 56.05 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.298 1.999 . . . . 65.11 111.943 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 73.15 110.485 -179.871 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 1.176 ' CE ' ' HA ' ' A' ' 115' ' ' PHE . 28.6 tpp . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.413 -0.588 . . . . 65.12 109.413 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -140.06 140.5 36.14 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.345 -0.847 . . . . 72.33 109.203 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.6 t -119.9 142.91 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.633 0.73 . . . . 71.42 110.402 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.503 HD11 ' CG1' ' A' ' 6' ' ' ILE . 3.3 tp -113.75 116.14 28.93 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.116 -1.068 . . . . 65.12 108.116 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.561 HD12 ' SD ' ' A' ' 49' ' ' MET . 3.6 tp -118.5 103.96 10.24 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.892 -0.781 . . . . 62.43 108.892 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.503 ' CG1' HD11 ' A' ' 4' ' ' LEU . 69.9 mt -95.71 104.3 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.115 -0.991 . . . . 71.15 108.742 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.438 ' HG3' ' H ' ' A' ' 9' ' ' ASN . 28.7 tp10 -128.51 119.25 24.5 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.206 -0.664 . . . . 75.34 109.206 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.458 ' NZ ' ' CB ' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -84.19 -3.22 58.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.227 -0.921 . . . . 72.44 109.378 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.438 ' H ' ' HG3' ' A' ' 7' ' ' GLU . 70.5 m-20 -81.73 -125.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.338 -0.851 . . . . 63.02 109.279 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.3 m -165.88 -77.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.024 -1.047 . . . . 72.34 110.106 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.83 -44.09 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -0.885 . . . . 74.02 110.622 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.518 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.5 mm? -58.8 -37.24 75.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.092 -1.005 . . . . 71.43 109.668 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.92 -32.52 39.96 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.727 -1.749 . . . . 61.32 108.727 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.21 -47.84 69.13 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 110.058 -1.217 . . . . 71.2 110.058 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.67 -43.56 93.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.011 -1.288 . . . . 71.32 109.382 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.8 mm -64.86 -43.97 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.817 -1.177 . . . . 63.23 108.492 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -58.83 -50.43 74.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.86 . . . . 51.11 109.468 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -80.7 1.53 29.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.196 -0.94 . . . . 73.34 109.585 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.08 -58.41 2.0 Allowed Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.958 -1.257 . . . . 62.15 109.958 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -75.85 -18.73 59.33 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.265 -1.138 . . . . 73.51 110.032 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -57.59 -31.35 66.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.107 -0.996 . . . . 74.25 109.623 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.4 t -62.37 -38.22 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.386 -0.821 . . . . 70.04 109.876 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.497 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 12.1 mptt -67.93 -1.82 6.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.325 -0.86 . . . . 73.23 109.726 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.09 27.03 27.01 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.826 -1.31 . . . . 75.54 109.826 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.661 ' CE1' ' CE2' ' A' ' 115' ' ' PHE . 13.8 m-85 -99.49 151.25 21.34 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.33 -1.1 . . . . 73.43 109.097 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 12.0 mtt -102.06 128.44 48.52 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.572 -1.269 . . . . 43.24 107.572 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.84 140.1 38.38 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.157 -0.965 . . . . 62.11 110.507 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -112.66 139.03 48.61 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.715 -0.846 . . . . 74.42 108.715 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -104.75 124.55 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.293 -0.88 . . . . 72.15 108.722 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.4 p -128.2 166.61 18.22 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.648 -0.658 . . . . 71.42 109.495 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -83.87 -102.95 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.22 -0.925 . . . . 72.33 109.446 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.0 p -81.37 161.16 23.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 74.24 109.457 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.458 ' H ' HD12 ' A' ' 33' ' ' LEU . 2.8 mp -52.22 -28.23 17.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.375 -0.828 . . . . 71.53 109.5 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -49.25 -53.35 22.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.935 . . . . 74.23 109.5 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -60.58 -39.01 86.48 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.175 -0.953 . . . . 54.03 108.715 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.37 -34.83 80.77 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.106 -1.597 . . . . 61.41 109.106 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -66.98 -43.92 81.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -1.129 . . . . 74.34 109.351 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.447 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 36.6 t80 -76.81 -22.23 53.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.122 -0.986 . . . . 75.33 109.824 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.2 tp -87.42 -30.78 20.46 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.108 -0.995 . . . . 74.33 109.673 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.44 ' O ' ' O ' ' A' ' 43' ' ' ARG . 5.0 ppp? -86.36 -24.02 25.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.122 -0.986 . . . . 70.32 110.468 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 37.4 p-10 -59.37 -28.49 66.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.887 -1.133 . . . . 71.22 109.444 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.538 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 12.6 pt -92.24 -30.68 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.234 -0.916 . . . . 74.14 110.113 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 40' ' ' MET . 70.9 mmt-85 -130.03 148.31 51.87 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.386 -0.821 . . . . 72.24 109.645 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -98.66 160.11 14.5 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.252 -0.905 . . . . 75.42 109.483 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -131.02 160.11 35.55 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.496 -0.753 . . . . 74.23 109.241 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.745 ' OD2' ' CH2' ' A' ' 116' ' ' TRP . 5.4 m-20 -98.69 -45.21 6.13 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.267 -0.896 . . . . 72.04 109.474 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.403 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -102.18 108.84 20.36 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.45 -0.944 . . . . 72.13 108.45 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.7 t -97.25 100.78 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.339 -0.851 . . . . 72.34 109.248 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.561 ' SD ' HD12 ' A' ' 5' ' ' LEU . 2.0 tmt? -116.74 134.48 54.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.456 -0.777 . . . . 74.11 109.489 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.654 HG22 ' H ' ' A' ' 52' ' ' ASP . 1.3 p -143.43 127.69 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.499 -0.751 . . . . 61.12 109.323 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.4 p -86.69 4.95 38.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.559 -0.713 . . . . 73.11 109.408 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.654 ' H ' HG22 ' A' ' 50' ' ' VAL . 13.6 m-20 -79.92 138.9 37.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.937 . . . . 52.55 109.646 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -82.27 -32.75 29.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.269 -0.894 . . . . 44.22 109.938 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -73.21 8.93 1.42 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.195 -0.941 . . . . 70.44 109.714 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -74.93 -20.9 59.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.331 -0.856 . . . . 64.14 110.184 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 55' ' ' ALA . 31.3 mt -38.49 -45.0 0.99 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.604 -0.685 . . . . 44.14 110.706 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.3 p -74.47 -36.54 63.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.95 -1.093 . . . . 55.23 109.311 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.666 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 64.6 t80 -65.07 -46.19 82.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.417 -0.802 . . . . 74.44 109.998 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.1 m -64.29 -37.41 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.703 -1.248 . . . . 74.03 109.307 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.1 t -53.54 -49.9 66.64 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.209 -0.932 . . . . 64.3 109.228 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -70.28 -36.22 74.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 64.44 110.243 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.666 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 5.2 mm -64.67 -34.12 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.642 -1.286 . . . . 63.21 109.432 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.565 ' HZ3' ' CG ' ' A' ' 92' ' ' ASP . 44.0 mmtt -67.43 -51.58 49.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 74.42 109.868 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.443 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 17.1 pt-20 -72.38 -43.02 64.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.942 -1.099 . . . . 70.32 109.937 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.505 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 25.8 mtpp -70.14 -22.72 62.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 75.22 109.508 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.511 ' O ' HG22 ' A' ' 69' ' ' ILE . 89.9 m-70 -156.35 64.31 0.55 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.923 . . . . 74.13 109.525 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 69' ' ' ILE . 30.7 p -60.19 -31.54 70.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.871 . . . . 73.24 109.737 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 87.7 p -68.6 47.84 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -0.915 . . . . 61.01 109.705 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 66' ' ' HIS . 14.3 tt -148.61 161.92 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.083 -1.011 . . . . 71.33 109.609 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.599 HG21 HD11 ' A' ' 113' ' ' LEU . 77.4 t -95.96 154.91 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.158 -0.964 . . . . 72.13 108.754 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.725 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 6.5 t -143.32 114.52 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.11 -0.994 . . . . 54.21 109.315 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.0 mp -111.12 100.14 8.86 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.55 -0.908 . . . . 50.24 108.55 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.4 t -93.14 120.4 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.345 -0.847 . . . . 74.41 108.91 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 m -97.84 172.84 7.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.284 -0.885 . . . . 72.31 108.763 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.448 ' C ' ' H ' ' A' ' 77' ' ' ASN . 0.8 OUTLIER -173.98 120.72 0.29 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.982 -1.073 . . . . 64.54 110.203 -179.622 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -65.53 2.37 0.95 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.508 -0.745 . . . . 74.13 109.406 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 75' ' ' SER . 80.2 m-20 -120.1 64.05 9.57 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 109.123 -0.695 . . . . 73.34 109.123 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.03 74.2 0.1 OUTLIER 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.11 1.873 . . . . 63.22 111.871 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.45 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 60.1 p -104.95 149.7 25.52 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.331 -0.988 . . . . 62.53 108.331 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -28.56 69.19 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.197 -0.939 . . . . 73.44 109.813 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.459 ' OE1' ' N ' ' A' ' 81' ' ' GLU . 40.8 mp0 -63.41 -38.08 89.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.112 -0.992 . . . . 71.42 109.876 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -77.05 -33.95 57.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.044 -1.035 . . . . 73.43 109.712 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -61.05 -52.57 64.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.056 -1.028 . . . . 74.22 109.461 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.473 HG23 ' N ' ' A' ' 85' ' ' HIS . 26.9 m -62.67 -41.31 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -0.949 . . . . 73.2 109.387 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.473 ' N ' HG23 ' A' ' 84' ' ' VAL . 6.6 t-80 -65.8 -29.94 70.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.225 -0.922 . . . . 53.33 109.324 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.02 -37.05 80.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.917 . . . . 64.11 109.91 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -80.2 -34.05 37.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.106 -0.997 . . . . 74.34 108.839 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -73.64 -38.22 65.08 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.388 -0.82 . . . . 74.42 109.461 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -71.32 -60.86 2.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 74.24 109.374 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 155.71 70.88 0.01 OUTLIER Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.67 -1.252 . . . . 61.51 110.168 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -133.08 130.75 39.74 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.339 -1.095 . . . . 55.33 109.357 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.725 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 14.2 m-20 -69.51 -41.09 76.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 73.42 109.268 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.752 ' CG ' HH21 ' A' ' 112' ' ' ARG . 4.9 m-20 -146.32 163.0 36.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.834 . . . . 75.04 109.056 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.494 ' CE1' ' OE1' ' A' ' 83' ' ' GLU . 56.6 t80 -136.96 124.42 22.09 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.363 -0.977 . . . . 71.33 108.363 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.683 ' H ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -126.12 149.83 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 CA-C-O 122.045 0.926 . . . . 71.13 111.232 -178.055 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.75 121.54 16.72 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.768 -1.197 . . . . 64.32 107.768 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.659 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -44.92 -55.43 10.94 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.197 -0.939 . . . . 62.2 111.629 -178.596 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.7 Cg_endo -41.56 -12.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 120.739 0.96 . . . . 73.11 112.538 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.659 ' N ' ' O ' ' A' ' 97' ' ' LYS . 55.2 m-85 59.86 124.88 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 109.583 -0.525 . . . . 65.22 109.583 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 32.6 ttm-85 -62.08 -38.79 90.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.876 -1.14 . . . . 72.35 109.353 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.794 ' O ' ' N ' ' A' ' 103' ' ' LYS . 6.3 t -172.99 46.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.129 -0.982 . . . . 71.32 110.473 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 92.2 mt 47.11 -68.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-O 121.228 0.537 . . . . 75.43 110.825 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.794 ' N ' ' O ' ' A' ' 101' ' ' SER . 13.8 mmmt -53.25 -34.0 55.38 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.238 -0.914 . . . . 71.41 108.843 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.39 -49.73 68.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.262 -0.899 . . . . 63.24 109.204 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.695 HD13 ' C ' ' A' ' 105' ' ' LEU . 2.0 tm? -57.73 -47.9 81.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.134 -0.979 . . . . 73.22 108.726 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.96 -40.2 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.964 -1.085 . . . . 60.11 109.85 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.635 ' HB1' ' CE2' ' B' ' 87' ' ' PHE . . . -52.17 -39.23 59.78 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.252 -0.905 . . . . 70.42 108.832 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 1.27 ' HB3' ' NH1' ' A' ' 112' ' ' ARG . 93.3 mtt180 -73.55 -29.82 62.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.028 -1.045 . . . . 74.41 109.933 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 47.5 mt -73.92 -44.94 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 120.891 -1.131 . . . . 62.54 109.218 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.449 ' CG ' ' N ' ' A' ' 111' ' ' ALA . 17.7 pt-20 -70.31 -47.93 58.87 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.816 -1.154 . . . . 74.34 109.717 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.449 ' N ' ' CG ' ' A' ' 110' ' ' GLU . . . -59.49 -29.84 68.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.889 -1.132 . . . . 73.32 109.578 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 1.27 ' NH1' ' HB3' ' A' ' 108' ' ' ARG . 53.0 mtt85 -72.79 -58.34 3.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.913 . . . . 52.41 109.175 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 112' ' ' ARG . 16.7 mt -126.35 65.13 1.24 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.502 -0.925 . . . . 65.24 108.502 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.469 ' O ' ' CD2' ' A' ' 115' ' ' PHE . 29.1 mtm105 -39.94 -79.73 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.902 -0.499 . . . . 64.45 110.48 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 1.176 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 14.6 m-85 -163.18 96.48 0.88 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.029 -1.044 . . . . 74.43 108.698 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 1.01 ' CZ2' ' OE1' ' A' ' 132' ' ' GLU . 51.3 m0 -46.78 -93.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.247 -0.908 . . . . 74.42 109.861 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.15 17.85 18.42 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.078 -1.609 . . . . 75.04 109.078 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.4 p -103.56 166.76 10.22 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.366 -1.079 . . . . 61.14 109.771 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -164.18 127.89 2.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.329 -0.857 . . . . 65.24 108.98 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 18.4 t -82.98 -38.07 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.047 -1.033 . . . . 73.11 110.627 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.404 HG23 ' HE ' ' A' ' 159' ' ' ARG . 14.9 mm -95.88 133.59 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.932 -1.105 . . . . 72.24 110.038 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -149.86 127.94 11.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.151 -0.968 . . . . 72.34 108.607 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' A' ' 125' ' ' ASP . 8.7 tp -153.32 132.38 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 71.44 109.54 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 55.93 -83.49 0.01 OUTLIER Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.62 -1.392 . . . . 73.4 109.62 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 123' ' ' ILE . 15.1 t0 -149.92 -4.84 0.36 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.253 -1.146 . . . . 74.45 109.334 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.05 141.32 28.66 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.074 -1.017 . . . . 54.21 108.842 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.32 133.1 43.62 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.896 -0.779 . . . . 54.5 108.896 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 49.4 mt -130.02 134.83 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.378 -0.826 . . . . 45.15 109.554 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.0 t -108.72 111.78 60.82 Favored Pre-proline 0 N--CA 1.497 1.9 0 N-CA-C 108.524 -0.917 . . . . 71.11 108.524 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -83.18 -39.18 0.13 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.869 1.713 . . . . 65.41 112.815 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -65.86 -49.3 68.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.025 -1.047 . . . . 63.32 109.692 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 1.01 ' OE1' ' CZ2' ' A' ' 116' ' ' TRP . 5.8 mm-40 -81.48 -6.26 58.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.13 -0.981 . . . . 72.52 109.105 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 57.06 63.63 1.86 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 75.33 109.727 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -146.19 130.41 17.52 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.338 -0.851 . . . . 71.23 109.272 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 6.8 tt -106.57 140.81 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.345 -0.847 . . . . 74.02 108.87 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.4 mt -128.54 120.75 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.46 -0.775 . . . . 60.23 109.506 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -140.03 140.18 36.14 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.386 -0.821 . . . . 62.32 109.628 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 53.45 20.96 2.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.403 -0.811 . . . . 75.4 110.085 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.84 16.97 68.84 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.982 -1.104 . . . . 72.24 110.403 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 57.2 mtp85 -107.12 124.41 49.64 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.242 -1.152 . . . . 71.22 109.177 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -99.24 124.9 44.68 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.302 -0.874 . . . . 71.42 109.75 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.8 t -139.33 140.9 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.39 -0.819 . . . . 53.02 109.556 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -85.94 135.7 33.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.177 -0.952 . . . . 60.45 109.136 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.4 m -132.43 126.95 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.439 -0.788 . . . . 74.44 109.406 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.4 pttt -173.15 129.31 0.47 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.304 -0.873 . . . . 65.15 109.577 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.66 -141.19 6.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.703 -1.359 . . . . 73.34 109.703 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.547 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -85.09 -44.56 0.67 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.328 -1.101 . . . . 72.22 110.403 -179.271 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 69.6 Cg_endo -89.79 -7.85 4.5 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.73 2.287 . . . . 65.23 113.354 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -89.42 -32.84 17.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.719 -1.238 . . . . 60.11 110.035 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -50.18 -40.99 48.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.978 -1.076 . . . . 64.21 109.149 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.09 -33.59 64.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.252 -0.905 . . . . 72.02 109.246 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 7.0 tp -61.37 -40.88 95.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.91 . . . . 73.31 109.639 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.9 p -74.59 -34.89 62.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.095 -1.003 . . . . 74.31 109.041 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -52.81 -55.2 24.76 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.476 -0.765 . . . . 74.31 109.746 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 pp -72.13 -26.17 62.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.013 -1.055 . . . . 75.34 109.283 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.04 -29.39 60.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.084 -1.01 . . . . 62.14 108.716 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.461 ' C ' ' H ' ' A' ' 159' ' ' ARG . 52.4 mtt180 -97.89 -54.19 3.17 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.681 -0.859 . . . . 61.03 108.681 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.431 ' N ' ' ND1' ' A' ' 158' ' ' HIS . 5.3 m80 -69.94 43.34 0.06 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.456 -0.777 . . . . 74.12 109.141 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.548 ' O ' ' N ' ' A' ' 161' ' ' GLN . 32.2 mtm105 -53.57 -103.37 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.481 -0.762 . . . . 71.13 109.953 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -51.17 86.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.478 -0.764 . . . . 75.45 109.884 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -175.58 179.1 1.48 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.629 -0.878 . . . . 73.41 108.629 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.529 ' H ' ' CD ' ' A' ' 161' ' ' GLN . 66.6 mt -98.82 128.95 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.258 -0.901 . . . . 74.41 109.615 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 212' ' ' TYR . 77.2 t -108.99 113.94 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.509 -0.744 . . . . 72.31 109.535 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 4.4 p -90.33 138.71 31.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 74.12 108.627 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -57.75 -37.09 73.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 70.43 109.186 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -64.29 -38.19 90.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 73.52 109.617 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 62.8 tp60 -59.84 -41.12 90.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -0.968 . . . . 74.52 109.124 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 40.2 mt -61.88 -53.28 57.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.91 . . . . 72.31 109.306 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 11.8 tp -62.67 -60.83 2.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 53.33 109.635 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -40.75 -40.1 1.25 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.94 -0.475 . . . . 62.44 111.543 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.16 -31.23 14.23 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.859 -1.151 . . . . 60.21 111.784 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.3 mm -80.6 -69.3 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.72 -1.238 . . . . 75.32 109.807 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.512 ' O ' ' CE3' ' A' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 107.831 -1.174 . . . . 73.14 107.831 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 182' ' ' ASN . 6.3 p30 . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 108.737 -0.838 . . . . 64.54 108.737 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.5 p -145.94 -32.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.213 -0.929 . . . . 74.02 109.3 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.576 ' O ' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -51.4 -31.21 11.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.449 -0.782 . . . . 72.33 109.09 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -56.32 -53.29 58.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.253 -0.905 . . . . 74.4 110.173 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.8 m -74.06 -25.25 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.996 -1.065 . . . . 70.42 109.805 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -71.55 -52.65 17.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 52.11 110.047 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 9.9 tp -64.31 -33.97 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.91 -1.119 . . . . 71.4 109.734 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.519 ' O ' ' NE2' ' A' ' 193' ' ' GLN . 65.4 t30 -64.67 -54.85 25.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.995 . . . . 73.44 110.025 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -67.65 -39.45 84.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.002 -1.061 . . . . 71.42 109.884 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 67.2 mt -60.12 -49.35 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.016 -1.053 . . . . 61.55 109.373 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -52.85 -53.73 44.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.07 -1.019 . . . . 63.34 109.442 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 189' ' ' ASN . 0.9 OUTLIER -59.76 -36.52 76.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -0.871 . . . . 61.24 109.375 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -81.65 -3.95 54.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.175 -0.953 . . . . 75.13 110.112 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 32.5 ttp -108.82 -15.18 14.45 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.322 -0.861 . . . . 74.02 109.704 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -108.51 -16.45 14.21 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.422 -0.799 . . . . 74.02 109.869 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.628 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 31.5 tptt -78.69 -35.72 1.13 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.979 -1.076 . . . . 75.43 110.776 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 89.0 Cg_endo -90.36 -48.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.226 1.951 . . . . 72.32 112.279 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 74.1 mt -68.1 -31.95 71.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.14 -0.975 . . . . 74.54 109.19 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 73.13 0.22 50.92 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.77 -1.332 . . . . 61.51 109.77 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.8 mt -123.23 128.2 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.548 -0.972 . . . . 61.22 109.488 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 8.3 t -86.03 132.95 33.94 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.321 -0.992 . . . . 72.0 108.321 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.7 p -134.87 27.02 3.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.254 -0.904 . . . . 74.44 109.909 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 26.7 m -146.98 150.48 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.096 -1.003 . . . . 64.35 109.736 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -126.61 126.13 43.1 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.645 -0.659 . . . . 71.41 109.368 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.34 111.16 16.46 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.133 -0.979 . . . . 73.52 108.916 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.09 132.51 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.558 -0.714 . . . . 71.02 109.783 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -73.53 -30.1 62.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.839 . . . . 72.12 109.7 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -58.48 -82.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.891 . . . . 64.41 110.312 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -82.24 -47.55 12.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.891 -1.131 . . . . 71.54 109.865 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 152.42 -110.8 0.47 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.976 -1.65 . . . . 72.03 108.976 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 163' ' ' VAL . 79.6 m-85 -112.11 140.41 46.82 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.433 -1.04 . . . . 75.54 108.714 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 25.8 mtm180 -121.3 129.79 53.3 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.423 -0.798 . . . . 75.31 109.522 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -97.47 119.54 36.2 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.296 -0.878 . . . . 75.41 108.906 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 28.2 m -130.91 161.22 32.35 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.354 -0.841 . . . . 74.14 109.75 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -72.27 151.06 92.16 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 75.32 109.08 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo . . . . . 0 N--CA 1.488 1.19 0 C-N-CA 121.974 1.783 . . . . 73.11 112.079 179.711 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.447 ' SD ' ' CE2' ' B' ' 25' ' ' PHE . 51.5 ttm . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.512 -0.551 . . . . 71.14 109.512 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -137.1 139.71 41.44 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.416 -0.802 . . . . 73.23 109.307 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 90.3 t -110.05 133.92 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.597 -0.689 . . . . 72.24 109.698 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.462 HD12 ' N ' ' B' ' 5' ' ' LEU . 2.6 tp -102.92 119.21 38.44 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.556 -0.715 . . . . 54.33 109.166 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.462 ' N ' HD12 ' B' ' 4' ' ' LEU . 19.5 mt -114.6 96.23 5.65 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.814 -0.81 . . . . 74.35 108.814 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.676 HD12 ' HB ' ' B' ' 50' ' ' VAL . 88.2 mt -81.43 98.19 3.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 O-C-N 120.727 -1.233 . . . . 42.55 108.494 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.434 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 28.3 tp10 -137.55 125.13 22.17 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.399 -0.813 . . . . 74.52 109.72 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -69.3 -31.17 69.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.31 -0.869 . . . . 62.55 108.896 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -85.25 112.19 20.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.379 -0.826 . . . . 73.11 109.447 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 96.9 p -68.09 -23.18 64.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.243 -0.911 . . . . 65.54 109.572 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 84.9 t -65.13 -52.62 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 75.55 109.614 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.469 HD23 ' OE2' ' B' ' 15' ' ' GLU . 62.3 mt -65.8 -37.4 86.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 70.14 109.686 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.29 -28.86 69.21 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.678 -1.769 . . . . 75.4 108.678 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.94 -53.26 41.97 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.721 -1.351 . . . . 65.44 109.721 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.469 ' OE2' HD23 ' B' ' 12' ' ' LEU . 15.0 pt-20 -58.96 -46.81 87.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.323 -1.104 . . . . 60.21 109.953 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 35.7 mm -64.52 -40.25 88.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.748 -1.22 . . . . 75.15 108.877 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -61.94 -44.65 96.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.364 -0.835 . . . . 73.01 109.446 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -85.48 1.72 47.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.187 -0.945 . . . . 74.3 108.964 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.4 -55.38 2.21 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 109.74 -1.344 . . . . 70.54 109.74 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -74.04 -19.7 60.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -1.184 . . . . 71.34 109.752 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -52.14 -32.78 37.15 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.17 -0.956 . . . . 64.41 109.521 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 79.4 t -58.7 -37.16 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.154 -0.966 . . . . 74.23 109.156 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -70.17 -13.81 62.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.362 -0.837 . . . . 63.42 109.41 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.44 38.78 6.99 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.844 -1.302 . . . . 53.43 109.844 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' PHE . . . . . 0.447 ' CE2' ' SD ' ' B' ' 1' ' ' MET . 15.6 m-85 -114.43 159.49 20.24 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.508 -0.995 . . . . 71.12 109.065 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.2 mmt -103.92 139.73 38.68 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.411 -0.959 . . . . 75.24 108.411 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.41 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -139.95 154.93 47.33 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.272 -0.892 . . . . 72.12 110.096 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 83.1 m-20 -134.65 158.03 45.12 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.482 -0.933 . . . . 72.31 108.482 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.03 139.67 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.352 -0.843 . . . . 64.43 109.866 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 6.1 p -134.48 170.08 16.29 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.586 -0.696 . . . . 65.41 109.196 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -94.08 -105.77 0.13 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.165 -0.96 . . . . 71.02 109.774 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 37.3 t -78.2 173.64 12.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.236 -0.915 . . . . 51.11 110.059 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.653 HD12 ' CG ' ' B' ' 58' ' ' PHE . 3.7 mm? -55.27 -39.26 69.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.518 -0.739 . . . . 71.24 109.681 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -46.56 -45.74 18.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 74.32 110.031 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.59 -38.73 70.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.103 -0.998 . . . . 73.03 109.249 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.18 -42.7 91.03 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.18 -1.568 . . . . 30.21 109.18 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -67.94 -40.74 83.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.294 -1.121 . . . . 74.42 109.453 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -72.17 -37.55 69.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 74.42 109.841 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 21.7 tp -72.14 -48.23 45.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -0.931 . . . . 75.41 110.12 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' MET . . . . . 0.445 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.9 ppp? -66.95 -19.75 65.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.032 -1.043 . . . . 60.41 109.923 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -61.4 -40.72 95.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.081 -1.012 . . . . 53.23 110.058 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.438 HD12 ' NH1' ' B' ' 43' ' ' ARG . 19.0 pt -82.82 -29.73 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.129 -0.982 . . . . 71.23 110.278 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.438 ' NH1' HD12 ' B' ' 42' ' ' ILE . 75.1 mtt85 -130.43 143.89 51.05 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.287 -0.883 . . . . 72.22 109.758 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -97.69 130.77 44.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.251 -0.906 . . . . 63.54 109.233 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -99.76 139.97 34.65 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.316 -0.865 . . . . 64.35 109.411 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -75.11 -37.06 61.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 62.22 109.237 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.566 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.9 OUTLIER -113.59 116.93 30.28 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.641 -0.874 . . . . 73.12 108.641 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.566 ' N ' HD13 ' B' ' 47' ' ' LEU . 72.3 t -98.43 98.22 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.354 -0.98 . . . . 65.11 108.354 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 0.5 OUTLIER -110.38 131.09 55.36 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.462 0.648 . . . . 73.44 109.288 -179.006 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.676 ' HB ' HD12 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -145.73 135.6 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.437 -0.789 . . . . 34.5 109.607 -179.626 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 51' ' ' SER . . . . . 0.434 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 14.7 p -98.8 14.03 30.26 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.541 -0.724 . . . . 73.21 109.661 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.631 ' H ' HG22 ' B' ' 50' ' ' VAL . 23.9 m-20 -82.9 140.3 32.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.184 -0.948 . . . . 70.41 109.468 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' B' ' 55' ' ' ALA . 14.4 mtpp -74.69 -39.73 61.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 65.0 110.134 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -71.41 10.98 0.52 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.108 -0.995 . . . . 75.21 109.695 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -66.27 -22.97 66.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 55.33 110.247 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 37.5 mt -45.72 -45.49 14.38 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.219 -0.926 . . . . 63.14 110.151 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 83.5 p -70.24 -38.39 75.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.892 -1.13 . . . . 63.5 109.364 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' PHE . . . . . 0.653 ' CG ' HD12 ' B' ' 33' ' ' LEU . 48.9 t80 -66.19 -61.11 2.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.339 -0.851 . . . . 72.33 109.762 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 20.7 m -50.32 -34.8 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.546 -1.346 . . . . 74.54 109.7 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 44.8 m -56.77 -51.58 68.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.115 -0.991 . . . . 71.24 109.534 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -69.38 -32.14 70.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.981 -1.074 . . . . 74.31 110.19 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' B' ' 66' ' ' HIS . 39.5 mm -65.74 -42.41 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.676 -1.265 . . . . 72.14 110.133 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -65.78 -49.6 67.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.209 -0.932 . . . . 73.32 110.695 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' B' ' 65' ' ' LYS . 7.5 pt-20 -69.17 -41.62 76.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.7 -1.25 . . . . 73.12 109.838 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.496 ' O ' ' ND1' ' B' ' 66' ' ' HIS . 85.6 mttt -79.7 -18.69 50.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.25 -0.906 . . . . 72.44 109.563 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.496 ' ND1' ' O ' ' B' ' 65' ' ' LYS . 69.1 m-70 -154.82 67.59 0.69 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.141 -0.974 . . . . 63.31 109.698 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 54.6 p -67.18 -25.0 65.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.176 -0.953 . . . . 73.1 109.553 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 24.0 m -64.08 -27.06 68.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.305 -0.872 . . . . 71.53 109.895 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 84.5 mt -81.23 152.99 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.156 -0.965 . . . . 74.4 109.687 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 67.2 t -94.81 154.18 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.356 -0.84 . . . . 75.12 109.181 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.427 ' H ' ' HB2' ' B' ' 92' ' ' ASP . 11.3 t -133.64 130.52 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.309 -0.87 . . . . 73.2 110.049 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.508 ' O ' ' SD ' ' B' ' 49' ' ' MET . 6.5 tt -122.98 104.0 8.96 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.864 -0.791 . . . . 73.34 108.864 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 9.1 p -95.45 137.07 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.977 -1.077 . . . . 73.5 108.961 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 3.9 p -96.68 170.88 8.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.297 -0.877 . . . . 64.34 109.552 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.481 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 42.9 t -157.67 114.85 2.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.169 -0.957 . . . . 74.53 110.232 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 76' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' B' ' 77' ' ' ASN . 52.1 p-10 -66.6 -21.45 66.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.221 -0.924 . . . . 64.5 109.264 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 77' ' ' ASN . . . . . 0.517 ' N ' ' OD1' ' B' ' 76' ' ' ASP . 56.6 t-20 -126.53 75.95 74.08 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 108.633 -0.877 . . . . 74.25 108.633 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -44.31 85.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.32 2.013 . . . . 74.43 111.724 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.515 ' N ' ' O ' ' B' ' 77' ' ' ASN . 7.4 m -94.67 150.24 20.42 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.635 0.731 . . . . 73.12 110.065 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.9 p -76.78 -43.16 37.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.539 -0.726 . . . . 71.01 109.655 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -56.73 -35.24 68.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.135 -0.978 . . . . 63.2 109.012 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -74.2 -34.72 63.83 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.098 -1.001 . . . . 73.22 108.97 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.522 ' OE1' ' CG ' ' B' ' 94' ' ' TYR . 42.1 tp10 -65.84 -55.95 14.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.257 -0.902 . . . . 74.3 109.609 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.459 HG23 ' N ' ' B' ' 85' ' ' HIS . 31.4 m -53.44 -41.93 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.994 -1.066 . . . . 73.31 108.968 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 85' ' ' HIS . . . . . 0.459 ' N ' HG23 ' B' ' 84' ' ' VAL . 46.6 m80 -74.26 -20.09 60.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.174 -0.954 . . . . 73.24 109.597 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -68.75 -40.87 79.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.945 -1.097 . . . . 55.33 110.428 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 87' ' ' PHE . . . . . 0.635 ' CE2' ' HB1' ' A' ' 107' ' ' ALA . 0.5 OUTLIER -83.3 -30.48 27.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.871 -1.143 . . . . 74.14 109.112 -179.777 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -77.27 -44.37 30.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.11 -0.993 . . . . 64.04 109.25 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -65.44 -54.96 21.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.425 -0.797 . . . . 72.35 109.496 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 154.72 72.81 0.01 OUTLIER Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.608 -1.282 . . . . 65.2 110.472 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -140.44 140.87 35.48 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.272 -1.134 . . . . 52.23 108.84 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.427 ' HB2' ' H ' ' B' ' 71' ' ' VAL . 54.3 m-20 -94.99 -22.99 17.58 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.06 -1.025 . . . . 73.32 109.824 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 93' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 17.4 t0 -151.78 158.32 43.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.09 -1.007 . . . . 72.22 109.609 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.522 ' CG ' ' OE1' ' B' ' 83' ' ' GLU . 55.8 t80 -142.9 104.91 4.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.478 -0.764 . . . . 64.42 108.969 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 27.2 mm -114.37 151.92 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.542 0 O-C-N 121.127 -0.983 . . . . 72.23 110.22 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.27 144.26 57.26 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.987 -1.116 . . . . 25.24 107.987 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.687 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -64.32 -54.42 38.63 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.765 -1.21 . . . . 64.32 111.516 -179.301 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 98' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 3.5 Cg_endo -41.45 -8.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 120.851 1.034 . . . . 63.33 113.341 -176.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 99' ' ' TYR . . . . . 0.687 ' N ' ' O ' ' B' ' 97' ' ' LYS . 44.7 m-85 59.06 110.22 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.366 -0.834 . . . . 75.13 109.322 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 100' ' ' ARG . . . . . 0.511 ' NH1' ' OE2' ' A' ' 83' ' ' GLU . 13.2 ttm180 -57.98 -34.2 69.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.009 -1.057 . . . . 74.23 108.88 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 101' ' ' SER . . . . . 0.778 ' O ' ' N ' ' B' ' 103' ' ' LYS . 47.9 t -174.26 32.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.148 -0.97 . . . . 63.34 110.836 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 49.9 mt 49.62 -69.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 118.745 0.702 . . . . 74.44 110.193 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.778 ' N ' ' O ' ' B' ' 101' ' ' SER . 40.6 tptt -51.77 -31.17 25.76 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.603 -1.258 . . . . 71.11 107.603 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.97 -40.72 83.09 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.608 -0.886 . . . . 71.45 108.608 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 51.9 tp -66.22 -45.86 79.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.448 -0.782 . . . . 51.31 109.022 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 42.4 t -66.89 -41.1 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.919 . . . . 65.23 109.3 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.06 -45.22 64.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.254 -0.903 . . . . 24.32 109.375 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 67.2 ttt-85 -69.07 -33.52 73.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.911 . . . . 75.31 109.671 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 96.6 mt -72.23 -29.11 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.104 -0.997 . . . . 54.24 108.767 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -67.72 -58.87 3.9 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.471 -0.891 . . . . 65.31 108.938 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -52.97 -32.11 44.34 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.305 -0.872 . . . . 72.24 109.108 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 25.6 tpt85 -58.9 -50.41 74.15 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.288 -0.883 . . . . 72.04 109.277 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 63.1 mt -146.19 103.52 3.72 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.174 -0.954 . . . . 75.35 109.995 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -98.47 107.48 19.95 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.465 -0.939 . . . . 75.5 108.465 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 78.1 t80 49.62 86.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 65.33 109.558 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 -82.39 142.79 31.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.194 -0.941 . . . . 74.45 109.45 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 163.27 86.39 0.06 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.599 -1.4 . . . . 44.21 109.599 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 8.9 t -157.61 -175.26 5.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -1.128 . . . . 71.4 109.745 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.83 137.57 16.13 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.832 -0.747 . . . . 72.32 109.114 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 6.9 t -71.8 -36.75 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 75.02 109.617 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 20.8 mm -103.25 132.74 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.328 -0.858 . . . . 51.41 109.287 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -135.7 119.26 17.01 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.434 -0.791 . . . . 71.53 109.24 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.436 ' O ' HG23 ' B' ' 123' ' ' ILE . 14.5 tt -145.67 130.5 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.262 -0.898 . . . . 72.43 109.235 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.46 -153.31 1.01 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.424 -1.47 . . . . 51.23 109.424 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -79.82 2.1 24.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.152 -1.205 . . . . 74.2 109.049 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.63 135.17 37.65 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.356 -0.979 . . . . 75.42 108.356 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 1.2 p -130.9 145.18 51.93 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.361 -0.837 . . . . 74.22 109.198 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 14.0 mt -133.69 140.41 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.446 -0.784 . . . . 60.33 109.066 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 3.6 t -123.02 81.89 50.87 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.635 -0.665 . . . . 72.31 109.307 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.67 -48.09 23.79 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.169 1.912 . . . . 75.13 112.589 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -52.57 -45.76 66.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.083 -1.011 . . . . 75.23 109.232 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -86.98 2.18 50.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.261 -0.9 . . . . 72.43 109.137 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 53.12 18.07 1.09 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 75.13 109.391 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -101.46 130.92 47.8 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.432 -0.793 . . . . 73.22 109.459 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 135' ' ' ILE . . . . . 0.428 HG23 ' O ' ' B' ' 135' ' ' ILE . 16.2 tt -113.12 133.24 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.536 -0.728 . . . . 64.14 109.095 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 2.5 mp -114.56 131.63 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.504 -0.748 . . . . 71.22 109.327 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -137.76 126.68 24.09 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.333 -0.854 . . . . 64.22 109.866 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp 52.76 34.78 16.98 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.369 -0.832 . . . . 72.02 110.413 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.35 13.89 82.78 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 120.041 -1.076 . . . . 74.32 110.723 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 53.0 mtt-85 -109.3 122.81 48.15 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.311 -1.111 . . . . 75.34 109.136 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -92.08 136.59 33.06 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.189 -0.944 . . . . 71.23 109.373 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.79 135.25 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.449 -0.782 . . . . 70.43 109.158 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -88.25 125.42 34.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.202 -0.936 . . . . 72.43 109.096 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 3.2 m -143.97 124.89 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.218 -0.926 . . . . 72.13 109.471 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -156.59 16.99 0.32 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.338 -0.852 . . . . 72.02 109.271 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -66.64 164.44 42.23 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.242 -1.543 . . . . 42.23 109.242 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 147' ' ' LYS . . . . . 0.569 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 2.8 tmtp? -58.11 -43.98 98.87 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.222 -1.163 . . . . 73.3 109.224 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 148' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 23.3 Cg_exo -63.56 -20.63 69.81 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.591 2.194 . . . . 71.33 112.331 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 149' ' ' PHE . . . . . 0.491 ' CE2' HG23 ' B' ' 153' ' ' THR . 86.1 t80 -89.24 -22.65 22.63 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.175 -0.953 . . . . 74.23 110.035 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -50.53 -41.87 54.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.078 -1.014 . . . . 72.34 109.444 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 11.0 p -66.53 -32.4 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.955 . . . . 73.35 109.084 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.522 HD13 ' O ' ' B' ' 152' ' ' LEU . 0.2 OUTLIER -56.79 -43.64 81.1 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.707 -0.849 . . . . 55.24 108.707 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.491 HG23 ' CE2' ' B' ' 149' ' ' PHE . 2.7 p -73.65 -30.73 63.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.103 -0.998 . . . . 70.01 109.193 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -55.02 -54.07 47.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.912 . . . . 65.32 109.744 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.04 -28.94 63.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.071 -1.018 . . . . 71.54 109.572 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.15 -49.84 65.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 75.32 109.583 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 157' ' ' ARG . . . . . 0.427 ' C ' ' H ' ' B' ' 159' ' ' ARG . 24.3 mtp180 -71.47 -44.94 63.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 73.32 109.387 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -74.94 20.47 0.13 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.415 -0.803 . . . . 74.14 109.793 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 159' ' ' ARG . . . . . 0.427 ' H ' ' C ' ' B' ' 157' ' ' ARG . 6.6 mmt85 -54.3 173.51 0.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.042 -1.037 . . . . 61.41 108.88 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 160' ' ' ASP . . . . . 0.412 ' OD2' ' O ' ' B' ' 160' ' ' ASP . 4.6 p-10 42.37 47.47 4.25 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.544 -0.722 . . . . 72.1 110.276 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -161.32 157.76 25.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 72.25 109.459 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 162' ' ' ILE . . . . . 0.745 HD12 ' N ' ' B' ' 162' ' ' ILE . 1.8 mp -91.37 131.41 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.237 -0.915 . . . . 72.31 109.174 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 163' ' ' VAL . . . . . 0.405 HG11 HD21 ' B' ' 168' ' ' LEU . 40.3 t -123.59 136.56 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.529 -0.732 . . . . 64.21 109.335 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 11.3 p -83.39 158.35 22.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 74.22 109.568 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -62.54 -43.51 98.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.861 . . . . 65.31 109.349 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -65.53 -34.5 78.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 63.45 109.888 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -50.76 -49.38 58.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.11 -0.994 . . . . 72.4 109.39 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 168' ' ' LEU . . . . . 0.405 HD21 HG11 ' B' ' 163' ' ' VAL . 53.6 mt -66.42 -40.33 89.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.199 -0.938 . . . . 72.32 109.355 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.507 HD23 ' C ' ' B' ' 169' ' ' LEU . 3.7 tt -48.99 -59.12 3.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 73.34 109.482 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 170' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' B' ' 171' ' ' ALA . 78.0 m-20 -67.88 -41.4 82.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 72.1 110.14 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 171' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' B' ' 170' ' ' ASP . . . -43.1 -47.72 6.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.376 -0.827 . . . . 62.13 110.586 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 16.4 mm -94.96 -9.94 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.056 -1.028 . . . . 71.42 110.267 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 . . . . . 0 N--CA 1.498 1.939 0 O-C-N 120.848 -1.158 . . . . 72.23 110.446 -179.796 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo . . . . . 0 N--CA 1.495 1.602 0 CA-C-O 121.36 0.483 . . . . 65.22 112.783 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 3.2 m120 61.32 39.52 15.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.398 -0.814 . . . . 72.31 109.411 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 25.4 t -79.33 -49.65 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.884 . . . . 63.32 109.802 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.432 ' O ' HG22 ' B' ' 188' ' ' ILE . 27.7 mm -70.0 -24.85 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 75.03 110.183 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -64.18 -44.51 91.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.831 -1.168 . . . . 64.11 109.306 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 19.4 m -77.21 -31.85 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.203 -0.936 . . . . 73.0 109.59 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.2 -50.24 20.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.06 -1.025 . . . . 61.12 110.014 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 188' ' ' ILE . . . . . 0.625 HD12 ' CZ ' ' B' ' 212' ' ' TYR . 1.8 tt -59.43 -44.78 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.154 -0.966 . . . . 72.43 110.151 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 189' ' ' ASN . . . . . 0.521 ' N ' HG23 ' B' ' 188' ' ' ILE . 58.4 t30 -60.3 -43.58 96.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.091 -1.006 . . . . 65.14 109.584 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 190' ' ' GLN . . . . . 0.414 ' O ' ' CB ' ' B' ' 194' ' ' LYS . 15.1 mm-40 -68.64 -46.51 68.99 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.258 -0.901 . . . . 63.24 109.882 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 82.3 mt -54.47 -30.26 21.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 120.654 -1.279 . . . . 74.03 109.791 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 65.8 mtp85 -73.01 -60.84 2.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.013 -1.055 . . . . 72.24 110.871 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 193' ' ' GLN . . . . . 0.429 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 76.0 mt-30 -70.94 -32.8 69.81 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.027 -1.046 . . . . 73.1 110.252 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 194' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' B' ' 190' ' ' GLN . 20.7 ttpp -72.02 -26.82 62.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.478 -0.764 . . . . 72.11 110.696 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 17.4 tpt -92.44 -44.49 8.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.889 -1.132 . . . . 44.33 110.016 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 196' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 59.3 p30 -64.17 -19.65 65.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.034 -1.041 . . . . 71.21 110.086 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 197' ' ' LYS . . . . . 0.533 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 29.7 mttm -67.96 -64.75 1.74 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.081 -1.012 . . . . 75.21 109.198 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 198' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 39.7 Cg_endo -64.88 -50.99 1.88 Allowed 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.075 1.85 . . . . 75.32 110.976 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 199' ' ' LEU . . . . . 0.903 HD21 ' O ' ' B' ' 201' ' ' ILE . 0.0 OUTLIER -95.74 134.53 38.57 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.868 -1.16 . . . . 72.25 107.868 179.303 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . -97.96 -8.52 55.4 Favored Glycine 0 N--CA 1.498 2.816 0 O-C-N 121.083 -1.011 . . . . 64.53 110.615 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 201' ' ' ILE . . . . . 0.903 ' O ' HD21 ' B' ' 199' ' ' LEU . 70.2 mt -91.74 124.84 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.023 -1.281 . . . . 44.23 109.471 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 23.3 t -77.26 135.82 38.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 54.01 109.603 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 2.0 p -145.31 28.24 1.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.261 -0.899 . . . . 74.4 109.281 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 35.8 m -135.64 138.37 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.395 -0.816 . . . . 72.12 109.466 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -126.34 136.48 52.78 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.582 -0.699 . . . . 65.41 109.281 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 10.5 p -95.05 139.37 31.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.208 -0.933 . . . . 71.33 109.422 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.462 ' N ' ' O ' ' B' ' 211' ' ' GLY . 39.0 t -131.6 124.44 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.522 -0.736 . . . . 63.5 109.197 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 208' ' ' ARG . . . . . 0.467 ' N ' ' CD ' ' B' ' 208' ' ' ARG . 1.3 mpt_? -76.5 -34.93 58.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 74.45 109.822 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 209' ' ' ARG . . . . . 0.413 ' N ' ' CD ' ' B' ' 209' ' ' ARG . 11.7 mpt_? -56.17 -62.74 1.5 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.151 -0.968 . . . . 74.14 109.68 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 62.1 mmt-85 -98.81 -76.45 0.54 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.235 -0.915 . . . . 74.43 109.529 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 211' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' B' ' 207' ' ' VAL . . . -167.26 -107.41 0.2 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.528 -1.429 . . . . 64.45 109.528 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 212' ' ' TYR . . . . . 0.625 ' CZ ' HD12 ' B' ' 188' ' ' ILE . 2.9 m-85 -120.58 133.96 55.33 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.592 -0.946 . . . . 74.21 109.346 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -104.77 126.53 51.95 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.494 -0.753 . . . . 74.03 109.083 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -101.96 125.89 48.75 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.348 -0.845 . . . . 74.34 109.276 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 20.5 p -142.76 154.26 44.08 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.336 -0.852 . . . . 64.33 109.378 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -63.96 154.24 82.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 70.04 108.865 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -38.23 147.3 0.11 Allowed 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.178 1.918 . . . . 65.11 111.902 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 21.1 mttp . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 73.15 111.355 -179.14 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.2 ttm . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.518 -0.549 . . . . 65.12 109.518 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.485 ' N ' ' OD2' ' A' ' 46' ' ' ASP . 97.6 mtt180 -129.65 156.77 43.71 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.497 -0.752 . . . . 72.33 109.17 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.0 t -118.65 124.44 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 CA-C-O 121.792 0.806 . . . . 71.42 110.014 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.518 HD11 ' CG1' ' A' ' 6' ' ' ILE . 2.1 tp -94.07 117.35 29.97 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.398 -0.964 . . . . 65.12 108.398 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 6' ' ' ILE . 3.7 tt -119.44 119.43 33.88 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.092 -1.077 . . . . 62.43 108.092 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.539 ' N ' HD23 ' A' ' 5' ' ' LEU . 56.3 mt -110.91 99.48 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.316 -0.865 . . . . 71.15 109.259 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' A' ' 30' ' ' THR . 36.2 tp10 -122.94 133.2 54.4 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.56 -0.712 . . . . 75.34 109.423 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -66.34 -34.47 78.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.242 -0.911 . . . . 72.44 109.555 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 10' ' ' SER . 21.6 p30 -82.98 -149.72 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.24 -0.913 . . . . 63.02 109.471 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.498 ' N ' ' OD1' ' A' ' 9' ' ' ASN . 20.9 p -152.55 -39.63 0.11 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.215 -0.928 . . . . 72.34 109.67 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.556 HG13 ' N ' ' A' ' 12' ' ' LEU . 11.1 p -64.39 -44.14 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 74.02 109.725 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.556 ' N ' HG13 ' A' ' 11' ' ' VAL . 14.9 tp -65.28 -39.19 92.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 71.43 109.312 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.75 -28.03 69.78 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 108.035 -2.026 . . . . 61.32 108.035 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.12 -46.04 94.13 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 110.07 -1.212 . . . . 71.2 110.07 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -65.98 -47.15 75.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -1.203 . . . . 71.32 109.832 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.8 mm -65.51 -36.53 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.603 -1.311 . . . . 63.23 108.372 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.478 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 86.7 tt0 -65.54 -47.91 74.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.464 -0.773 . . . . 51.11 109.798 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -83.52 1.18 43.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.089 -1.007 . . . . 73.34 109.748 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.24 -55.17 2.54 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.567 -1.413 . . . . 62.15 109.567 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.402 HD23 ' N ' ' A' ' 21' ' ' ASN . 1.3 pt? -76.23 -21.79 55.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -1.15 . . . . 73.51 109.917 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 92.9 m-20 -55.22 -32.28 62.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.034 -1.041 . . . . 74.25 109.345 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.3 t -60.02 -38.31 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 70.04 109.359 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.496 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 3.4 mptp? -62.68 -26.47 68.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.354 -0.842 . . . . 73.23 109.275 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.89 24.14 5.32 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 110.215 -1.154 . . . . 75.54 110.215 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -105.33 157.51 17.27 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.227 -1.16 . . . . 73.43 109.091 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.0 mmm -104.24 136.96 42.87 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.134 -1.061 . . . . 43.24 108.134 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.26 160.25 41.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.193 -0.942 . . . . 62.11 109.851 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -140.57 145.39 36.67 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.411 -0.806 . . . . 74.42 109.526 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 t -104.13 134.92 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.462 -0.94 . . . . 72.15 108.462 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.425 ' O ' ' O ' ' A' ' 7' ' ' GLU . 6.5 p -131.04 172.44 12.08 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.39 -0.819 . . . . 71.42 109.44 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -92.26 -104.54 0.11 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.24 -0.913 . . . . 72.33 110.001 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.4 p -78.8 167.41 21.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.245 -0.909 . . . . 74.24 110.269 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 35.7 mt -54.17 -29.62 46.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.635 -0.666 . . . . 71.53 109.857 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -47.79 -49.36 28.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.049 -1.032 . . . . 74.23 109.719 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -68.12 -38.39 82.19 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.142 -0.974 . . . . 54.03 109.222 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.84 -45.05 59.69 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.377 -1.489 . . . . 61.41 109.377 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -65.75 -38.44 89.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -1.103 . . . . 74.34 109.265 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -75.41 -37.52 60.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.151 -0.968 . . . . 75.33 109.679 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.3 tp -72.7 -47.55 46.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 74.33 110.101 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.495 ' SD ' ' OD1' ' A' ' 41' ' ' ASP . 3.7 ppp? -63.73 -28.71 70.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.105 -0.997 . . . . 70.32 110.083 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.495 ' OD1' ' SD ' ' A' ' 40' ' ' MET . 99.3 m-20 -65.6 -39.9 92.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.036 -1.04 . . . . 71.22 110.016 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.0 pt -82.88 -29.63 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.148 -0.97 . . . . 74.14 110.251 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 40' ' ' MET . 93.0 mtt180 -129.89 146.89 51.61 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.323 -0.861 . . . . 72.24 109.514 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -91.28 161.7 14.93 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.206 -0.934 . . . . 75.42 109.654 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -143.11 153.67 43.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.337 -0.852 . . . . 74.23 109.142 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.485 ' OD2' ' N ' ' A' ' 2' ' ' ARG . 3.8 p30 -95.41 -41.5 8.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.192 -0.943 . . . . 72.04 109.514 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.525 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.3 OUTLIER -104.84 115.76 30.85 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.433 -0.792 . . . . 72.13 109.05 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.525 ' N ' HD13 ' A' ' 47' ' ' LEU . 74.5 t -101.49 97.8 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.389 -0.967 . . . . 72.34 108.389 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -114.27 130.66 56.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.491 -0.756 . . . . 74.11 110.303 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.561 HG22 ' H ' ' A' ' 52' ' ' ASP . 1.5 p -138.4 129.36 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 121.728 0.775 . . . . 61.12 109.652 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.8 t -92.14 3.67 54.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.49 -0.757 . . . . 73.11 109.199 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.561 ' H ' HG22 ' A' ' 50' ' ' VAL . 51.8 m-20 -76.28 138.07 40.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.305 -0.872 . . . . 52.55 109.509 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.493 ' C ' ' H ' ' A' ' 55' ' ' ALA . 28.1 mtmm -67.94 -35.25 78.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.179 -0.95 . . . . 44.22 110.049 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -71.36 17.08 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.153 -0.967 . . . . 70.44 109.734 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -60.29 -30.4 69.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 64.14 110.085 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.412 ' HG ' ' H ' ' A' ' 56' ' ' LEU . 22.3 mt -46.07 -43.85 14.96 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.087 -1.008 . . . . 44.14 110.097 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.2 p -73.21 -40.23 64.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.93 -1.106 . . . . 55.23 109.627 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.63 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 58.8 t80 -65.13 -56.9 10.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.408 -0.807 . . . . 74.44 110.127 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.459 HG23 ' N ' ' A' ' 60' ' ' SER . 17.2 m -54.05 -38.2 37.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 120.839 -1.163 . . . . 74.03 109.638 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.459 ' N ' HG23 ' A' ' 59' ' ' VAL . 46.2 p -54.83 -52.73 61.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.176 -0.952 . . . . 64.3 109.662 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -69.63 -29.81 67.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.088 -1.008 . . . . 64.44 110.342 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.63 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 6.1 mm -68.16 -47.9 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.639 -1.288 . . . . 63.21 110.357 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.466 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 41.4 mmtt -62.85 -43.7 98.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.065 -1.022 . . . . 74.42 110.691 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.403 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 7.0 pt-20 -73.55 -41.05 63.46 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.71 -1.244 . . . . 70.32 109.747 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.447 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 25.6 mtpp -78.17 -19.84 53.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.151 -0.968 . . . . 75.22 109.143 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.572 ' O ' HG22 ' A' ' 69' ' ' ILE . 91.7 m-70 -154.94 69.46 0.73 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 74.13 109.222 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.0 p -63.58 -27.2 69.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.31 -0.869 . . . . 73.24 110.085 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.6 t -79.5 48.95 0.95 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.058 -1.026 . . . . 61.01 109.856 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.572 HG22 ' O ' ' A' ' 66' ' ' HIS . 13.8 tt -146.68 156.59 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.084 -1.01 . . . . 71.33 109.456 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.9 t -92.81 154.15 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.171 -0.956 . . . . 72.13 109.51 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.518 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 21.3 t -135.96 125.99 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.299 -0.876 . . . . 54.21 110.074 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.533 ' C ' HD13 ' A' ' 72' ' ' LEU . 1.3 tm? -118.62 101.67 8.3 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.423 -0.955 . . . . 50.24 108.423 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -95.5 138.94 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.933 -1.104 . . . . 74.41 109.57 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.1 m -122.86 161.31 24.32 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.677 -0.86 . . . . 72.31 108.677 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 77' ' ' ASN . 3.0 p -172.2 121.43 0.45 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.999 -1.063 . . . . 64.54 109.971 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.415 ' N ' ' HB2' ' A' ' 97' ' ' LYS . 50.8 p30 -64.31 63.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.701 -0.624 . . . . 74.13 109.931 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 75' ' ' SER . 2.9 p30 -177.14 53.65 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.201 -0.937 . . . . 73.34 109.669 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 77' ' ' ASN . 6.9 Cg_endo -48.84 84.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.365 2.043 . . . . 63.22 111.729 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.712 HG23 ' H ' ' A' ' 82' ' ' GLU . 2.9 t -114.48 151.64 32.94 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.041 -0.725 . . . . 62.53 109.041 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -28.4 67.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 73.44 109.231 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -63.89 -41.09 97.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.279 -0.888 . . . . 71.42 109.829 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.712 ' H ' HG23 ' A' ' 79' ' ' THR . 37.8 tp10 -76.91 -26.28 53.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.085 -1.009 . . . . 73.43 109.342 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -67.89 -46.47 71.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 74.22 109.683 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 85' ' ' HIS . 29.4 m -68.89 -41.19 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.098 -1.002 . . . . 73.2 109.566 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.441 ' N ' HG23 ' A' ' 84' ' ' VAL . 73.5 t60 -72.14 -31.59 66.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -0.935 . . . . 53.33 109.637 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -65.76 -39.49 91.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 64.11 110.114 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -77.39 -36.08 53.78 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.049 -1.032 . . . . 74.34 108.769 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -68.33 -38.56 81.64 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.383 -0.823 . . . . 74.42 109.305 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 21.7 mm100 -64.39 -44.86 89.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 74.24 109.319 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.09 -15.86 1.02 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.036 -1.226 . . . . 61.51 110.036 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -51.68 132.85 31.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.047 -1.267 . . . . 55.33 109.393 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.518 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 71.0 m-20 -80.83 -33.28 34.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 73.42 109.409 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.527 ' CG ' HH21 ' A' ' 108' ' ' ARG . 65.3 m-20 -152.45 129.53 11.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.258 -0.901 . . . . 75.04 109.249 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -104.5 116.42 32.07 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.875 -0.787 . . . . 71.33 108.875 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.43 HG12 HD11 ' A' ' 72' ' ' LEU . 23.8 mm -106.53 149.92 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-O 122.194 0.997 . . . . 71.13 111.319 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.79 117.65 11.65 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.842 -1.54 . . . . 64.32 106.842 177.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.665 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -43.59 -54.0 11.08 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.173 -0.954 . . . . 62.2 111.778 -178.283 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.2 Cg_endo -41.8 -11.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.237 0 CA-C-N 119.851 0.983 . . . . 73.11 112.565 -176.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.665 ' N ' ' O ' ' A' ' 97' ' ' LYS . 61.2 m-85 57.69 116.07 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.817 -0.552 . . . . 65.22 109.701 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -56.47 -38.11 71.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.849 -1.157 . . . . 72.35 108.776 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.786 ' O ' ' N ' ' A' ' 103' ' ' LYS . 9.9 t -173.56 40.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.251 -0.906 . . . . 71.32 110.688 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.5 mt 48.09 -69.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 CA-C-N 118.68 0.673 . . . . 75.43 110.505 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.786 ' N ' ' O ' ' A' ' 101' ' ' SER . 41.4 tptt -52.07 -31.22 29.34 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.181 -1.044 . . . . 71.41 108.181 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.66 -56.04 21.43 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.622 -0.831 . . . . 63.24 108.836 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.724 HD13 ' N ' ' A' ' 106' ' ' VAL . 0.7 OUTLIER -62.69 -56.18 20.04 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.65 -0.87 . . . . 73.22 108.65 179.638 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.724 ' N ' HD13 ' A' ' 105' ' ' LEU . 87.4 t -48.44 -46.24 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.995 -1.065 . . . . 60.11 109.154 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.94 -35.73 62.05 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.212 -0.93 . . . . 70.42 108.553 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.53 ' NH1' ' CZ ' ' B' ' 87' ' ' PHE . 53.1 ttt85 -71.64 -29.43 64.63 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.435 -0.79 . . . . 74.41 109.681 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 87.0 mt -74.85 -32.92 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.978 -1.076 . . . . 62.54 108.498 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -74.47 -51.01 16.06 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.525 -0.734 . . . . 74.34 109.648 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.94 -43.3 69.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.901 . . . . 73.32 109.666 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.409 ' CB ' HD12 ' A' ' 113' ' ' LEU . 82.7 mtm180 -65.38 -39.9 92.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.193 -0.942 . . . . 52.41 109.612 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.409 HD12 ' CB ' ' A' ' 112' ' ' ARG . 5.3 mp -139.96 94.07 2.72 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.13 -0.982 . . . . 65.24 109.269 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.4 mtm-85 -84.68 -70.89 0.55 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.14 -0.975 . . . . 64.45 108.881 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' A' ' 116' ' ' TRP . 30.4 p90 -163.16 -33.83 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.124 -0.985 . . . . 74.43 109.511 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.54 ' N ' ' CD1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER 38.44 -94.66 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.707 -0.62 . . . . 74.42 110.355 179.727 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 115' ' ' PHE . . . 76.88 72.45 1.11 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.503 -1.439 . . . . 75.04 109.503 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.537 ' O ' ' OG ' ' A' ' 129' ' ' SER . 0.3 OUTLIER -147.41 172.96 13.11 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.256 -1.143 . . . . 61.14 109.688 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.542 ' HA ' ' OG ' ' A' ' 129' ' ' SER . 0.0 OUTLIER -152.25 149.86 29.16 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.552 -0.717 . . . . 65.24 109.288 -178.23 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.91 -32.73 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.177 -0.952 . . . . 73.11 110.104 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 38.4 mm -116.33 106.34 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.416 -0.802 . . . . 72.24 109.183 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -109.01 115.96 31.07 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.475 -0.766 . . . . 72.34 109.443 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.406 ' O ' ' O ' ' A' ' 126' ' ' LEU . 29.1 mm -116.17 105.29 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.567 -0.708 . . . . 71.44 109.514 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 47.21 -143.87 5.41 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.935 -1.266 . . . . 73.4 109.935 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -66.82 -21.91 66.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.359 -1.083 . . . . 74.45 108.921 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.49 HD23 ' N ' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -80.59 113.39 18.75 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.827 -1.175 . . . . 54.21 107.827 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.9 m -108.33 144.23 36.13 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.36 -0.838 . . . . 54.5 109.342 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 77.1 mt -132.7 128.98 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.457 -0.777 . . . . 45.15 109.704 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.542 ' OG ' ' HA ' ' A' ' 119' ' ' ASN . 1.8 m -117.83 94.16 45.55 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 108.551 -0.907 . . . . 71.11 108.551 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.35 -22.6 10.82 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.557 1.505 . . . . 65.41 112.277 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.883 ' OD1' ' OE2' ' A' ' 132' ' ' GLU . 11.1 t70 -59.35 -48.96 79.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.067 -1.021 . . . . 63.32 109.282 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.883 ' OE2' ' OD1' ' A' ' 131' ' ' ASP . 7.9 mm-40 -97.36 9.17 43.04 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.205 -0.934 . . . . 72.52 108.938 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 53.61 80.54 0.11 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.56 -0.712 . . . . 75.33 110.438 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 9.5 ttpt -164.37 141.42 6.53 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.81 -0.811 . . . . 71.23 108.81 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.527 HG21 ' CE2' ' A' ' 137' ' ' TYR . 88.9 mt -118.2 149.51 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.531 -0.73 . . . . 74.02 109.765 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 65.5 mt -131.72 117.69 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.527 -0.916 . . . . 60.23 108.527 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.527 ' CE2' HG21 ' A' ' 135' ' ' ILE . 44.9 m-85 -109.25 124.77 51.43 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.397 -0.815 . . . . 62.32 110.401 -178.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.1 mtpp 48.94 25.84 1.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.467 -0.77 . . . . 75.4 110.61 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 92.51 14.28 55.77 Favored Glycine 0 N--CA 1.498 2.81 0 O-C-N 121.0 -1.063 . . . . 72.24 110.999 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -105.5 124.29 49.31 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.17 -1.194 . . . . 71.22 109.267 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -82.42 122.19 27.69 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.195 -0.941 . . . . 71.42 110.852 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.08 138.0 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.055 -1.091 . . . . 53.02 108.055 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -82.18 167.14 19.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.323 -0.86 . . . . 60.45 109.627 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 1.098 ' C ' ' HD2' ' A' ' 149' ' ' PHE . 6.0 m -129.6 128.15 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.797 -0.816 . . . . 74.44 108.797 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 1.482 ' HA ' ' CE2' ' A' ' 149' ' ' PHE . 32.7 pttt -175.52 -24.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.412 -0.805 . . . . 65.15 109.698 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 1.108 ' O ' ' CD1' ' A' ' 149' ' ' PHE . . . -64.97 -172.42 3.25 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.561 -1.416 . . . . 73.34 109.561 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.593 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 6.3 ttmt -70.27 -39.4 10.11 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.365 -1.08 . . . . 72.22 110.634 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 60.6 Cg_endo -84.94 15.46 2.21 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.126 1.884 . . . . 65.23 112.757 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 1.482 ' CE2' ' HA ' ' A' ' 145' ' ' LYS . 0.1 OUTLIER -97.31 -50.36 4.58 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.073 -1.017 . . . . 60.11 109.609 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 1.443 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 97.2 mt-10 -55.35 -44.0 75.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.418 -0.801 . . . . 64.21 109.596 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.46 HG13 ' N ' ' A' ' 152' ' ' LEU . 13.1 p -63.77 -38.2 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 72.02 109.378 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.2 OUTLIER -59.22 -42.82 91.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.387 -0.821 . . . . 73.31 109.016 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.4 m -72.13 -28.84 63.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 74.31 109.44 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -63.08 -55.11 28.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.405 -0.81 . . . . 74.31 110.073 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 159' ' ' ARG . 3.6 pp -67.49 -26.76 66.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.04 -1.037 . . . . 75.34 109.083 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.02 -52.21 63.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.108 -0.995 . . . . 62.14 108.904 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -66.8 -52.6 42.06 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.282 -0.886 . . . . 61.03 109.145 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -88.5 37.62 0.83 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.549 -0.719 . . . . 74.12 109.544 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' ' 155' ' ' LEU . 55.4 ttt-85 -65.46 -17.85 64.86 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.118 -0.989 . . . . 71.13 109.783 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.9 72.8 1.31 Allowed 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.517 -0.92 . . . . 75.45 108.517 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -170.57 159.18 6.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.875 . . . . 73.41 109.539 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.4 mt -81.51 136.69 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.29 -0.881 . . . . 74.41 109.002 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 14.2 t -131.48 135.73 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.341 -0.849 . . . . 72.31 109.793 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.7 p -97.59 159.36 14.97 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.4 -0.812 . . . . 74.12 109.122 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -57.9 -36.08 71.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 70.43 109.899 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -64.16 -42.23 96.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.166 -0.959 . . . . 73.52 110.075 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -53.4 -49.94 66.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.086 -1.009 . . . . 74.52 109.415 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 34.5 mt -61.9 -39.76 93.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.174 -0.954 . . . . 72.31 109.398 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.475 ' C ' HD23 ' A' ' 169' ' ' LEU . 5.3 tt -55.5 -59.21 5.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.866 . . . . 53.33 109.763 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.88 -39.66 93.89 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.423 -0.798 . . . . 62.44 111.203 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -53.0 -55.39 23.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.929 -1.107 . . . . 60.21 111.08 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.742 HD12 ' N ' ' A' ' 172' ' ' ILE . 1.9 mp -94.26 -59.69 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 120.83 -1.169 . . . . 75.32 110.237 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.458 ' O ' ' O ' ' A' ' 169' ' ' LEU . 24.3 m-90 . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 73.14 109.864 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 35.7 p30 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 120.856 0.36 . . . . 64.54 110.326 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 26.4 m -67.68 -16.1 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.854 -1.153 . . . . 74.02 109.518 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.448 ' O ' HG22 ' A' ' 188' ' ' ILE . 32.2 mm -59.82 -30.1 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.925 . . . . 72.33 109.369 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -58.14 -35.65 71.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.236 -0.915 . . . . 74.4 109.794 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 50.4 t -82.99 -45.45 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 70.42 109.084 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -60.71 -36.35 78.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 52.11 110.255 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 189' ' ' ASN . 9.4 tp -76.33 -42.98 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.781 -1.199 . . . . 71.4 109.102 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.492 ' N ' HG23 ' A' ' 188' ' ' ILE . 69.4 m-20 -59.87 -33.89 72.41 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.198 -0.939 . . . . 73.44 109.082 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -79.68 -48.67 13.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.192 -0.942 . . . . 71.42 109.968 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.444 HD13 HG21 ' A' ' 151' ' ' VAL . 64.4 mt -55.96 -41.98 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.095 -1.003 . . . . 61.55 109.29 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -63.87 -49.64 71.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.121 -0.987 . . . . 63.34 109.269 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -62.0 -31.47 71.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 61.24 108.984 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.418 ' NZ ' ' CB ' ' A' ' 194' ' ' LYS . 7.5 mtpm? -84.79 -8.54 58.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.47 -0.769 . . . . 75.13 109.735 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 16.2 ttt -102.48 -39.56 7.07 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.45 -0.781 . . . . 74.02 110.421 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -75.02 -15.37 60.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.025 -1.047 . . . . 74.02 110.724 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.445 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 8.7 mmtm -80.58 -65.29 0.27 Allowed Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.902 -1.124 . . . . 75.43 109.964 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 24.7 Cg_endo -60.0 -49.6 9.37 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.345 2.03 . . . . 72.32 112.849 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 199' ' ' LEU . 10.4 mp -66.2 -100.19 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.856 -1.152 . . . . 74.54 109.239 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 156.07 -39.31 0.59 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.132 -1.587 . . . . 61.51 109.132 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 20.5 mm -104.14 127.09 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.571 -0.958 . . . . 61.22 109.12 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 11.9 p -83.6 133.07 34.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.107 -0.995 . . . . 72.0 108.682 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.03 12.91 11.24 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.447 -0.783 . . . . 74.44 109.515 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.9 148.31 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.425 -0.797 . . . . 64.35 109.532 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -124.82 115.58 20.91 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.651 -0.655 . . . . 71.41 109.329 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.37 114.01 22.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.274 -0.891 . . . . 73.52 109.011 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 209' ' ' ARG . 13.8 t -120.73 146.31 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.546 -0.721 . . . . 71.02 109.668 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -69.89 -36.44 75.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.372 -0.83 . . . . 72.12 109.547 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.412 ' H ' HG12 ' A' ' 207' ' ' VAL . 80.8 mtm180 -73.28 160.18 32.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 64.41 109.736 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.562 ' H ' ' NE ' ' A' ' 210' ' ' ARG . 0.0 OUTLIER 47.86 -102.25 0.08 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.156 -0.965 . . . . 71.54 109.002 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -158.98 -114.22 0.38 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.08 -1.608 . . . . 72.03 109.08 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -108.79 133.74 52.43 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.513 -0.992 . . . . 75.54 108.929 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -112.04 128.45 56.19 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.342 -0.849 . . . . 75.31 110.585 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -98.27 128.53 44.76 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.627 -0.879 . . . . 75.41 108.627 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 8.9 t -149.98 168.96 22.32 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.03 -1.044 . . . . 74.14 110.453 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -60.95 131.46 91.74 Favored Pre-proline 0 N--CA 1.49 1.556 0 N-CA-C 109.361 -0.607 . . . . 75.32 109.361 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo . . . . . 0 N--CA 1.491 1.346 0 C-N-CA 122.291 1.994 . . . . 73.11 112.744 -179.852 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.591 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.458 -0.571 . . . . 71.14 109.458 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.433 ' O ' ' OD1' ' B' ' 46' ' ' ASP . 88.2 mtt180 -139.28 153.43 47.78 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.261 -0.9 . . . . 73.23 109.552 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 94.2 t -111.16 135.04 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.665 -0.647 . . . . 72.24 109.297 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.448 HD11 ' CG1' ' B' ' 6' ' ' ILE . 3.6 tp -106.84 118.28 36.26 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.526 -0.734 . . . . 54.33 109.707 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.436 ' N ' HD12 ' B' ' 4' ' ' LEU . 16.9 mt -114.58 98.32 6.81 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.83 -0.804 . . . . 74.35 108.83 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.692 HD12 ' HB ' ' B' ' 50' ' ' VAL . 87.1 mt -84.79 96.98 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.743 -1.223 . . . . 42.55 108.772 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.525 ' CD ' ' HG ' ' B' ' 51' ' ' SER . 8.6 tp10 -141.91 127.86 19.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.353 -0.842 . . . . 74.52 109.46 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -66.74 -32.92 74.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 62.55 109.148 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 9' ' ' ASN . . . . . 0.413 ' H ' ' HG3' ' B' ' 7' ' ' GLU . 99.5 m-20 -78.24 107.41 10.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.34 -0.85 . . . . 73.11 109.431 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 85.6 p -67.94 -23.77 65.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -0.879 . . . . 65.54 109.655 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.79 -49.77 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.148 -0.97 . . . . 75.55 109.687 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 80.7 mt -65.93 -37.44 86.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.157 -0.964 . . . . 70.14 109.572 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.74 -27.94 69.97 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.627 -1.789 . . . . 75.4 108.627 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.07 -53.44 36.92 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.581 -1.408 . . . . 65.44 109.581 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -58.54 -45.48 88.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.276 -1.132 . . . . 60.21 109.819 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 36.1 mm -65.63 -41.53 90.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.845 -1.159 . . . . 75.15 108.925 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -59.84 -44.5 94.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 73.01 109.513 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.452 ' N ' ' CD ' ' B' ' 18' ' ' LYS . 1.1 mptm? -86.59 1.1 52.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.092 -1.005 . . . . 74.3 108.768 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.51 -59.39 1.83 Allowed Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.481 -1.448 . . . . 70.54 109.481 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -67.87 -22.69 65.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -1.141 . . . . 71.34 109.522 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -54.14 -34.31 60.04 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.139 -0.976 . . . . 64.41 109.238 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 56.1 t -57.48 -47.63 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.344 -0.847 . . . . 74.23 109.013 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.445 ' NZ ' HG11 ' B' ' 106' ' ' VAL . 31.9 mmtm -60.49 -53.97 51.12 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.428 -0.795 . . . . 63.42 109.005 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 136.7 38.87 0.15 Allowed Glycine 0 N--CA 1.5 2.931 0 N-CA-C 110.298 -1.121 . . . . 53.43 110.298 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -120.38 160.46 23.03 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.375 -1.073 . . . . 71.12 109.505 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.4 mmt -105.27 140.26 38.68 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.807 -0.812 . . . . 75.24 108.807 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.431 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -135.23 159.26 42.12 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.429 -0.795 . . . . 72.12 109.818 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 28' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 89.2 m-20 -138.68 159.48 42.01 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.702 -0.851 . . . . 72.31 108.702 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 p -122.63 139.12 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.381 -0.825 . . . . 64.43 109.861 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 10.9 p -134.78 169.08 17.89 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.985 -0.746 . . . . 65.41 108.985 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -90.62 -107.57 0.09 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.165 -0.959 . . . . 71.02 109.787 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 82.3 p -79.09 168.61 19.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 51.11 109.993 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 50.5 mt -50.79 -31.3 16.52 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.6 -0.687 . . . . 71.24 109.843 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -51.62 -52.19 49.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.101 -0.999 . . . . 74.32 109.717 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.73 -40.89 96.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.17 -0.956 . . . . 73.03 109.354 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.24 -43.03 81.6 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.442 -1.463 . . . . 30.21 109.442 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -66.18 -38.69 88.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.321 -1.106 . . . . 74.42 109.549 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -75.13 -39.43 60.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 74.42 109.802 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 23.3 tp -72.88 -45.95 55.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.905 . . . . 75.41 110.112 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' MET . . . . . 0.449 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.4 ppp? -64.79 -27.06 68.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.004 -1.06 . . . . 60.41 109.84 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -58.49 -45.44 88.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.145 -0.972 . . . . 53.23 109.844 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 pt -88.93 -42.06 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.175 -0.953 . . . . 71.23 109.747 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' B' ' 40' ' ' MET . 10.7 mpt_? -96.73 144.04 27.1 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.077 -1.015 . . . . 72.22 108.983 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -103.77 150.81 23.74 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.382 -0.824 . . . . 63.54 109.248 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -137.78 139.67 40.17 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.329 -0.857 . . . . 64.35 109.321 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 46' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' B' ' 2' ' ' ARG . 7.9 p-10 -79.85 -36.86 36.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 62.22 109.253 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.555 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.5 OUTLIER -108.05 116.39 31.86 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.93 -0.767 . . . . 73.12 108.93 179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.555 ' N ' HD13 ' B' ' 47' ' ' LEU . 46.4 t -100.31 98.44 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.233 -1.025 . . . . 65.11 108.233 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 20.6 ttt -112.89 133.38 54.9 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.569 -0.707 . . . . 73.44 110.051 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.692 ' HB ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -145.95 134.18 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.595 -0.69 . . . . 34.5 109.351 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 51' ' ' SER . . . . . 0.525 ' HG ' ' CD ' ' B' ' 7' ' ' GLU . 9.1 p -98.19 9.94 41.75 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.415 -0.803 . . . . 73.21 109.47 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.559 ' H ' HG22 ' B' ' 50' ' ' VAL . 44.9 m-20 -76.06 138.86 41.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.203 -0.935 . . . . 70.41 109.539 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.439 ' C ' ' H ' ' B' ' 55' ' ' ALA . 60.2 mttm -73.62 -40.12 64.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 65.0 110.15 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -72.92 12.25 0.55 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.115 -0.99 . . . . 75.21 109.717 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -68.92 -21.54 64.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.903 . . . . 55.33 110.153 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' B' ' 55' ' ' ALA . 11.4 mt -41.7 -49.39 4.26 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.488 -0.757 . . . . 63.14 110.312 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 86.1 p -69.56 -34.68 74.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.986 -1.071 . . . . 63.5 109.098 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 58' ' ' PHE . . . . . 0.407 ' CZ ' HD11 ' B' ' 62' ' ' ILE . 59.0 t80 -66.67 -61.76 1.8 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.377 -0.827 . . . . 72.33 109.828 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 33.8 m -49.42 -35.31 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.611 -1.306 . . . . 74.54 109.716 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 22.9 p -57.55 -53.69 55.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.188 -0.945 . . . . 71.24 109.714 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -66.91 -29.1 68.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.055 -1.028 . . . . 74.31 110.108 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.407 HD11 ' CZ ' ' B' ' 58' ' ' PHE . 35.2 mm -66.06 -36.26 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.766 -1.208 . . . . 72.14 109.876 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.483 ' NZ ' ' CG2' ' B' ' 71' ' ' VAL . 29.1 mmtm -71.41 -49.4 42.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.038 -1.039 . . . . 73.32 110.278 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' B' ' 65' ' ' LYS . 13.8 pt-20 -68.85 -41.08 78.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.949 -1.094 . . . . 73.12 110.133 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.512 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 92.7 mttt -74.83 -23.52 58.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 72.44 109.825 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.512 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 92.9 m-70 -156.69 63.96 0.53 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.145 -0.972 . . . . 63.31 109.67 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.452 ' N ' ' O ' ' B' ' 63' ' ' LYS . 23.7 t -57.14 -30.01 64.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -0.88 . . . . 73.1 109.581 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 39.8 m -61.56 -27.31 68.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -0.917 . . . . 71.53 109.998 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 73.7 mt -78.64 155.77 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.142 -0.973 . . . . 74.4 109.778 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 84.7 t -95.74 152.69 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.489 -0.757 . . . . 75.12 109.137 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.483 ' CG2' ' NZ ' ' B' ' 63' ' ' LYS . 39.5 t -133.04 127.9 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.336 -0.852 . . . . 73.2 109.81 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 8.0 tt -120.41 99.48 6.59 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.716 -0.846 . . . . 73.34 108.716 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.44 135.66 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 73.5 108.876 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.24 173.75 6.18 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.315 -0.866 . . . . 64.34 108.877 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 18.7 t -165.93 119.76 1.16 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.966 -1.084 . . . . 74.53 110.236 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -67.54 -15.84 63.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.381 -0.824 . . . . 64.5 109.284 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -116.91 69.08 4.6 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.674 -0.641 . . . . 74.25 109.293 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -62.73 78.06 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.91 1.74 . . . . 74.43 111.632 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.492 HG23 ' H ' ' B' ' 82' ' ' GLU . 15.1 t -101.14 173.16 6.59 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.69 -0.856 . . . . 73.12 108.69 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.4 p -77.01 -26.25 53.6 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.164 -0.96 . . . . 71.01 110.489 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 81' ' ' GLU . . . . . 0.469 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 49.6 mp0 -66.86 -39.96 87.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.937 -1.102 . . . . 63.2 109.694 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 82' ' ' GLU . . . . . 0.492 ' H ' HG23 ' B' ' 79' ' ' THR . 97.8 mt-10 -78.01 -33.82 51.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.194 -0.941 . . . . 73.22 109.686 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -62.55 -52.91 61.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -0.964 . . . . 74.3 109.718 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.504 HG23 ' N ' ' B' ' 85' ' ' HIS . 26.4 m -63.72 -40.82 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.161 -0.962 . . . . 73.31 109.412 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 85' ' ' HIS . . . . . 0.504 ' N ' HG23 ' B' ' 84' ' ' VAL . 19.8 m80 -67.31 -31.27 71.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.905 . . . . 73.24 109.514 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.29 -41.7 93.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.922 . . . . 55.33 109.782 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 87' ' ' PHE . . . . . 0.53 ' CZ ' ' NH1' ' A' ' 108' ' ' ARG . 70.3 m-85 -80.29 -24.91 39.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.095 -1.003 . . . . 74.14 109.041 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -76.37 -51.92 10.93 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.386 -0.822 . . . . 64.04 109.437 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 89' ' ' GLN . . . . . 0.489 ' CG ' ' N ' ' B' ' 90' ' ' GLY . 11.5 pt20 -60.81 -47.19 87.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.515 -0.741 . . . . 72.35 109.774 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 90' ' ' GLY . . . . . 0.489 ' N ' ' CG ' ' B' ' 89' ' ' GLN . . . 140.15 71.55 0.04 OUTLIER Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.963 -1.255 . . . . 65.2 109.963 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.86 135.44 53.74 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.403 -1.057 . . . . 52.23 108.715 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.522 ' OD1' ' NH1' ' B' ' 112' ' ' ARG . 24.6 t0 -85.0 -23.78 28.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.061 -1.024 . . . . 73.32 109.647 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 93' ' ' ASP . . . . . 0.524 ' OD2' ' NH1' ' B' ' 112' ' ' ARG . 57.3 m-20 -152.38 156.43 39.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.184 -0.948 . . . . 72.22 109.63 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -137.9 99.83 4.01 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.463 -0.94 . . . . 64.42 108.463 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 22.7 mm -106.98 147.3 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 O-C-N 120.989 -1.07 . . . . 72.23 110.833 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.76 125.74 26.81 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.915 -1.143 . . . . 25.24 107.915 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.677 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -45.94 -54.03 18.6 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.063 -1.023 . . . . 64.32 111.486 -178.75 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 98' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 3.3 Cg_endo -41.82 -10.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 120.796 0.997 . . . . 63.33 112.743 -176.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 99' ' ' TYR . . . . . 0.677 ' N ' ' O ' ' B' ' 97' ' ' LYS . 61.0 m-85 59.41 96.71 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.728 -0.608 . . . . 75.13 110.04 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -53.41 -39.37 64.28 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.101 -1.074 . . . . 74.23 108.101 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 9.1 t -174.27 128.62 0.36 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.886 -0.783 . . . . 63.34 108.886 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 59.0 mt -52.64 -36.14 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.035 -1.04 . . . . 74.44 108.868 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' B' ' 107' ' ' ALA . 62.8 mmtt -61.87 -36.87 82.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.293 -0.88 . . . . 71.11 108.948 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.74 -53.64 14.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 71.45 109.347 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 25.0 tp -58.04 -49.75 75.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.926 . . . . 51.31 108.962 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 106' ' ' VAL . . . . . 0.445 HG11 ' NZ ' ' B' ' 23' ' ' LYS . 69.7 t -66.1 -39.88 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.063 -1.023 . . . . 65.23 109.853 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 107' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' B' ' 103' ' ' LYS . . . -56.78 -39.12 73.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.16 -0.962 . . . . 24.32 109.558 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -77.44 -25.04 50.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.875 . . . . 75.31 109.994 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 90.4 mt -80.82 -43.37 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.039 -1.038 . . . . 54.24 109.445 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -68.15 -38.92 82.66 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.18 -0.95 . . . . 65.31 109.851 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.69 -49.18 66.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 72.24 109.838 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 112' ' ' ARG . . . . . 0.524 ' NH1' ' OD2' ' B' ' 93' ' ' ASP . 38.5 ttm180 -65.6 -43.87 88.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.932 . . . . 72.04 109.976 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.491 HD23 ' C ' ' B' ' 113' ' ' LEU . 4.3 tt -64.95 -55.45 19.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.154 -0.966 . . . . 75.35 109.335 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -50.7 -30.5 13.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.969 . . . . 75.5 109.674 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -84.64 4.48 32.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.202 -0.936 . . . . 65.33 109.807 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 116' ' ' TRP . . . . . 0.524 ' CD1' ' N ' ' B' ' 117' ' ' GLY . 0.3 OUTLIER -67.84 -19.85 65.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.009 -1.057 . . . . 74.45 109.662 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 117' ' ' GLY . . . . . 0.524 ' N ' ' CD1' ' B' ' 116' ' ' TRP . . . -67.73 113.13 5.24 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.702 -1.359 . . . . 44.21 109.702 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 53.1 p -153.46 164.52 38.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.279 -1.13 . . . . 71.4 109.687 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -158.23 166.17 33.05 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.876 -0.73 . . . . 72.32 109.043 -178.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -145.59 -43.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.291 -0.881 . . . . 75.02 109.31 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 121' ' ' ILE . . . . . 0.481 HG21 ' O ' ' B' ' 156' ' ' ALA . 28.5 mm -107.83 127.48 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.449 -0.782 . . . . 51.41 109.118 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -120.47 118.31 29.95 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.538 -0.726 . . . . 71.53 109.239 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 62.2 mt -123.48 108.42 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.938 -0.764 . . . . 72.43 108.938 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.74 -133.82 11.49 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.745 -1.342 . . . . 51.23 109.745 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -83.6 -2.25 55.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.222 -1.163 . . . . 74.2 109.399 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.554 HD13 HD12 ' B' ' 199' ' ' LEU . 0.6 OUTLIER -91.18 146.04 24.16 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.473 -0.936 . . . . 75.42 108.473 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 89.3 m -130.08 134.71 47.56 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.576 -0.703 . . . . 74.22 109.212 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 21.5 mt -136.59 143.53 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.442 -0.786 . . . . 60.33 109.381 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 14.6 m -137.86 122.8 12.28 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.494 -0.754 . . . . 72.31 108.977 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -80.99 -39.95 0.19 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.994 1.796 . . . . 75.13 112.238 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -50.52 -51.31 48.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.145 -0.972 . . . . 75.23 109.428 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -86.07 -7.71 58.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.231 -0.918 . . . . 72.43 109.099 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 54.19 68.66 0.82 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.868 . . . . 75.13 109.35 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -148.6 143.38 26.53 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.228 -0.92 . . . . 73.22 109.734 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 18.1 tt -118.38 137.03 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.538 -0.726 . . . . 64.14 109.359 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 58.5 mt -126.19 123.86 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.504 -0.747 . . . . 71.22 109.144 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -140.52 144.12 35.8 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.303 -0.873 . . . . 64.22 110.113 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 31.3 mmtm 53.75 31.18 12.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.384 -0.823 . . . . 72.02 110.214 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 74.99 -6.4 27.41 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.983 -1.247 . . . . 74.32 109.983 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 12.2 mpt_? -87.96 129.43 35.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.129 -1.218 . . . . 75.34 108.838 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -98.82 130.58 45.25 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.351 -0.843 . . . . 71.23 109.675 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 66.8 t -137.12 132.12 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.444 -0.785 . . . . 70.43 109.244 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -83.15 134.92 34.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.898 . . . . 72.43 109.1 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.77 136.1 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.452 -0.78 . . . . 72.13 109.366 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.21 21.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 72.02 109.555 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.54 174.72 40.03 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.867 -1.293 . . . . 42.23 109.867 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 147' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' B' ' 148' ' ' PRO . 12.4 mtpp -65.06 -61.67 5.87 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.447 -1.031 . . . . 73.3 110.096 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 148' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' B' ' 147' ' ' LYS . 11.9 Cg_endo -54.2 -25.78 39.55 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.951 1.767 . . . . 71.33 111.87 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -87.59 -15.45 37.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.237 -0.914 . . . . 74.23 109.502 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -61.77 -45.34 94.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.162 -0.961 . . . . 72.34 109.471 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 8.8 p -56.99 -34.06 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.112 -0.992 . . . . 73.35 108.89 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.437 HD13 ' O ' ' B' ' 152' ' ' LEU . 0.2 OUTLIER -61.04 -49.71 76.27 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.535 -0.913 . . . . 55.24 108.535 179.502 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 16.3 m -70.57 -29.83 66.37 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.304 -0.873 . . . . 70.01 108.963 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -55.52 -59.89 4.2 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.193 -0.942 . . . . 65.32 109.987 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.79 -25.51 65.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.943 -1.098 . . . . 71.54 109.67 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 156' ' ' ALA . . . . . 0.481 ' O ' HG21 ' B' ' 121' ' ' ILE . . . -55.08 -43.88 74.31 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.048 -1.032 . . . . 75.32 109.931 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -83.22 -45.62 13.66 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.828 -1.17 . . . . 73.32 110.891 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 158' ' ' HIS . . . . . 0.482 ' O ' ' O ' ' B' ' 159' ' ' ARG . 51.3 m80 -50.52 -83.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.619 -1.301 . . . . 74.14 108.615 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 159' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' B' ' 158' ' ' HIS . 11.5 mmm180 56.26 153.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.596 -0.69 . . . . 61.41 110.509 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 160' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' B' ' 214' ' ' PHE . 20.4 t70 42.02 51.25 4.32 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.256 -0.903 . . . . 72.1 110.104 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -156.27 145.37 20.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.062 -1.024 . . . . 72.25 110.087 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 87.6 mt -89.19 125.66 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.747 -0.834 . . . . 72.31 108.747 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 14.7 p -135.84 136.65 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.323 -0.861 . . . . 64.21 109.248 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 11.7 t -81.54 166.45 20.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.318 -0.864 . . . . 74.22 110.524 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 18.4 mtpp -67.12 -46.1 75.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.623 -0.673 . . . . 65.31 109.896 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -58.59 -36.19 73.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.87 . . . . 63.45 110.28 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -55.14 -45.1 75.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.061 -1.024 . . . . 72.4 109.657 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 31.6 mt -66.28 -38.7 88.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.053 -1.03 . . . . 72.32 109.36 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.682 HD13 ' C ' ' B' ' 169' ' ' LEU . 3.1 tm? -55.35 -54.78 39.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.829 . . . . 73.34 108.996 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -68.94 -16.56 63.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 72.1 109.85 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.17 -57.87 3.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -0.937 . . . . 62.13 110.707 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 0.696 ' N ' HD12 ' B' ' 172' ' ' ILE . 1.7 mp -79.85 -44.78 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.989 -1.069 . . . . 71.42 109.239 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 19.7 m-90 . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.314 -0.866 . . . . 72.23 109.519 -179.861 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.488 1.203 0 CA-C-O 121.511 0.546 . . . . 65.22 111.735 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -148.59 -14.68 0.33 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.489 -0.757 . . . . 72.31 109.095 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.78 7.98 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.285 -0.884 . . . . 63.32 109.287 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 15.7 mm -55.75 -42.67 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.903 . . . . 75.03 109.475 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -53.84 -26.53 24.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 64.11 109.413 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 60.5 t -78.85 -54.68 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.053 -1.03 . . . . 73.0 109.149 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -51.89 -48.11 64.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 61.12 110.071 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 188' ' ' ILE . . . . . 0.525 HD13 ' O ' ' B' ' 188' ' ' ILE . 0.2 OUTLIER -61.82 -43.12 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.913 -1.117 . . . . 72.43 109.025 -179.61 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 189' ' ' ASN . . . . . 0.572 ' O ' ' NE2' ' B' ' 193' ' ' GLN . 41.4 t30 -61.48 -41.64 97.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.972 -1.08 . . . . 65.14 109.255 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -68.0 -42.52 80.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.947 . . . . 63.24 110.023 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 81.3 mt -59.85 -39.71 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.084 -1.01 . . . . 74.03 109.743 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -64.59 -40.45 95.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.116 -0.99 . . . . 72.24 109.781 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 193' ' ' GLN . . . . . 0.572 ' NE2' ' O ' ' B' ' 189' ' ' ASN . 1.2 mp0 -75.12 -37.83 61.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 73.1 110.376 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 194' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' B' ' 198' ' ' PRO . 0.0 OUTLIER -73.6 -16.87 61.23 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.75 -1.219 . . . . 72.11 109.916 -179.293 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 21.9 ttp -94.52 -24.14 17.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.156 -0.965 . . . . 44.33 110.196 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 196' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' B' ' 193' ' ' GLN . 41.3 p30 -96.0 -3.76 44.41 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.987 -1.07 . . . . 71.21 110.532 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 197' ' ' LYS . . . . . 0.568 ' N ' ' CD ' ' B' ' 198' ' ' PRO . 20.6 tttm -92.01 -42.15 0.37 Allowed Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 120.862 -1.149 . . . . 75.21 110.053 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 198' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' B' ' 197' ' ' LYS . 17.7 Cg_endo -88.68 -51.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.596 2.198 . . . . 75.32 112.22 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 199' ' ' LEU . . . . . 0.597 HD22 ' N ' ' B' ' 199' ' ' LEU . 3.7 mm? -70.9 -40.06 72.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.948 -1.095 . . . . 72.25 109.347 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 85.35 -20.39 17.78 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.915 -1.274 . . . . 64.53 109.915 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 12.1 mt -103.75 137.83 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.335 -1.097 . . . . 44.23 109.354 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 38.6 t -95.38 137.85 33.86 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.242 -0.911 . . . . 54.01 109.393 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 21.4 p -142.33 34.11 1.49 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.34 -0.85 . . . . 74.4 109.146 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.53 133.41 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.497 -0.752 . . . . 72.12 109.615 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -113.94 132.7 55.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.666 -0.865 . . . . 65.41 108.666 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.45 140.37 29.82 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.256 -0.903 . . . . 71.33 109.896 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' B' ' 211' ' ' GLY . 19.8 t -138.51 123.43 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.492 -0.755 . . . . 63.5 109.006 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 -76.85 -43.51 35.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.186 -0.946 . . . . 74.45 109.914 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -51.7 -59.85 3.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.905 . . . . 74.14 109.876 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -94.71 -71.03 0.68 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.179 -0.951 . . . . 74.43 109.58 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 211' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' B' ' 207' ' ' VAL . . . 177.76 -93.71 0.09 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.349 -1.5 . . . . 64.45 109.349 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -135.49 141.07 45.25 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.45 -1.03 . . . . 74.21 109.518 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 65.3 ttt-85 -119.64 129.06 54.4 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.438 -0.949 . . . . 74.03 108.438 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 214' ' ' PHE . . . . . 0.529 ' O ' ' N ' ' B' ' 160' ' ' ASP . 29.5 m-85 -100.58 137.84 38.44 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.384 -0.822 . . . . 74.34 109.404 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 215' ' ' CYS . . . . . 0.454 ' SG ' ' N ' ' B' ' 216' ' ' TYR . 43.7 t -152.33 168.32 25.8 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.476 -0.765 . . . . 64.33 109.613 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 216' ' ' TYR . . . . . 0.454 ' N ' ' SG ' ' B' ' 215' ' ' CYS . 81.6 m-85 -75.35 150.41 84.98 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.253 -0.904 . . . . 70.04 109.374 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 217' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' B' ' 218' ' ' LYS . 97.4 Cg_endo -76.43 119.17 5.14 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.269 1.979 . . . . 65.11 112.171 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 218' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' B' ' 217' ' ' PRO . 41.0 mttp . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.462 -0.774 . . . . 73.15 109.384 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.6 ptm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.446 -0.575 . . . . 65.12 109.446 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -139.58 156.41 46.89 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.305 -0.872 . . . . 72.33 109.303 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 89.3 t -114.21 125.8 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.635 -0.665 . . . . 71.42 109.607 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 5' ' ' LEU . 2.2 tp -100.03 118.74 37.05 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.832 -0.803 . . . . 65.12 108.832 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.466 ' CD1' HG21 ' A' ' 16' ' ' ILE . 7.5 tt -119.95 119.38 33.28 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.624 -0.672 . . . . 62.43 109.417 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.419 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 13.2 mt -106.45 116.89 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.352 -0.843 . . . . 71.15 108.792 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.462 ' OE1' ' CB ' ' A' ' 51' ' ' SER . 30.1 tp10 -151.37 127.63 10.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.149 -0.969 . . . . 75.34 109.491 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 9' ' ' ASN . 45.2 mtpt -77.82 -23.72 48.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 72.44 109.309 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 10' ' ' SER . 34.7 t-20 -59.68 -152.18 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.445 -0.785 . . . . 63.02 109.51 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.497 ' N ' ' OD1' ' A' ' 9' ' ' ASN . 47.6 m -156.08 -56.39 0.09 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 72.34 109.372 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.6 t -63.17 -45.49 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 74.02 109.493 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.9 mm? -66.78 -36.43 82.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.259 -0.901 . . . . 71.43 109.289 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.11 -19.07 78.96 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 108.473 -1.851 . . . . 61.32 108.473 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.32 -50.77 4.94 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.922 -1.271 . . . . 71.2 109.922 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.14 -43.66 95.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.106 -1.232 . . . . 71.32 109.296 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.559 ' O ' HD23 ' A' ' 20' ' ' LEU . 94.5 mt -61.63 -46.63 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.922 -1.111 . . . . 63.23 108.498 178.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -45.55 -52.47 10.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 51.11 109.798 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -89.48 4.41 49.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.181 -0.949 . . . . 73.34 109.596 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -85.02 -58.18 2.15 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.908 -1.277 . . . . 62.15 109.908 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.559 HD23 ' O ' ' A' ' 16' ' ' ILE . 0.6 OUTLIER -75.01 -19.06 60.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -1.165 . . . . 73.51 110.046 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 -57.08 -38.25 73.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.974 . . . . 74.25 109.676 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.5 t -52.57 -32.02 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.215 -0.928 . . . . 70.04 109.123 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -75.2 -0.36 19.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.376 -0.827 . . . . 73.23 109.043 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.91 28.55 45.6 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.267 -1.133 . . . . 75.54 110.267 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -106.09 156.89 17.96 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.278 -1.13 . . . . 73.43 109.05 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.3 mmt -94.15 118.08 31.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.194 -0.942 . . . . 43.24 108.729 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -98.47 133.1 43.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.315 -0.866 . . . . 62.11 109.918 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -123.31 131.0 53.51 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 109.035 -0.728 . . . . 74.42 109.035 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.69 132.73 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.303 -0.999 . . . . 72.15 108.303 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 p -136.08 168.98 18.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.361 -0.837 . . . . 71.42 109.524 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.419 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 4.4 pt-20 -94.04 -103.47 0.14 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.301 -0.874 . . . . 72.33 109.836 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.5 t -78.54 166.78 22.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.256 -0.902 . . . . 74.24 110.157 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.0 mt -53.42 -33.7 54.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.621 -0.674 . . . . 71.53 109.733 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -52.51 -48.03 66.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 74.23 109.791 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -61.49 -37.61 84.28 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.141 -0.974 . . . . 54.03 109.11 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.26 -37.26 48.69 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.314 -1.515 . . . . 61.41 109.314 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -63.37 -39.03 93.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -1.126 . . . . 74.34 109.407 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -77.21 -37.99 52.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 75.33 109.513 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.3 tp -66.89 -46.21 75.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -0.867 . . . . 74.33 109.983 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.436 ' C ' ' SD ' ' A' ' 40' ' ' MET . 3.9 ppp? -70.09 -24.54 63.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.101 -1.0 . . . . 70.32 109.824 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -65.84 -40.42 91.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.048 -1.033 . . . . 71.22 109.951 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.2 pt -79.12 -34.01 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.103 -0.998 . . . . 74.14 110.074 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 40' ' ' MET . 30.3 mmt180 -130.25 147.69 52.0 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.327 -0.858 . . . . 72.24 109.356 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -93.12 133.16 36.58 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.273 -0.892 . . . . 75.42 109.449 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -107.49 142.47 37.31 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.512 -0.743 . . . . 74.23 109.378 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -83.93 -42.15 16.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 72.04 109.236 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.508 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.5 OUTLIER -105.86 113.17 26.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.565 -0.71 . . . . 72.13 109.176 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.508 ' N ' HD13 ' A' ' 47' ' ' LEU . 78.7 t -99.3 97.76 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.713 -0.847 . . . . 72.34 108.713 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.485 ' SD ' ' O ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -106.17 125.04 50.51 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.988 -0.745 . . . . 74.11 108.988 -179.678 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.01 133.2 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.664 0.745 . . . . 61.12 109.623 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.462 ' CB ' ' OE1' ' A' ' 7' ' ' GLU . 52.9 m -102.95 4.88 37.98 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.656 -0.652 . . . . 73.11 109.414 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -76.27 147.51 38.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -0.966 . . . . 52.55 109.613 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.429 ' C ' ' H ' ' A' ' 55' ' ' ALA . 25.6 pttm -81.92 -39.86 23.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.287 -0.883 . . . . 44.22 110.124 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -70.26 7.32 1.03 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.039 -1.038 . . . . 70.44 109.411 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -68.68 -21.78 64.41 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.384 -0.822 . . . . 64.14 110.433 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 55' ' ' ALA . 63.2 mt -42.36 -47.73 4.95 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.196 -0.94 . . . . 44.14 110.546 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.2 m -70.96 -36.64 72.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.884 -1.135 . . . . 55.23 109.388 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.655 ' CE2' HD11 ' A' ' 62' ' ' ILE . 58.1 t80 -68.07 -61.06 2.03 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.594 -0.691 . . . . 74.44 110.158 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 60' ' ' SER . 21.6 m -51.61 -37.68 20.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.845 -1.159 . . . . 74.03 109.431 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.467 ' N ' HG23 ' A' ' 59' ' ' VAL . 61.6 m -56.3 -55.76 29.4 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.271 -0.893 . . . . 64.3 109.514 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -67.91 -26.89 66.21 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.049 -1.032 . . . . 64.44 110.24 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.655 HD11 ' CE2' ' A' ' 58' ' ' PHE . 5.9 mm -57.36 -38.58 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.668 -1.27 . . . . 63.21 107.922 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 67' ' ' SER . 61.2 mmtt -72.76 -41.95 64.52 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.389 -0.819 . . . . 74.42 109.135 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -66.55 -51.44 56.49 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.143 -0.973 . . . . 70.32 109.229 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -69.57 -24.93 63.76 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.665 -0.647 . . . . 75.22 109.874 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.586 ' O ' HG22 ' A' ' 69' ' ' ILE . 96.7 m-70 -151.39 68.52 0.92 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.184 -0.947 . . . . 74.13 109.38 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 63' ' ' LYS . 96.9 p -57.93 -28.79 64.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 73.24 109.904 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 83.2 p -82.14 49.0 1.32 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.184 -0.948 . . . . 61.01 109.782 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.586 HG22 ' O ' ' A' ' 66' ' ' HIS . 13.1 tt -142.06 155.9 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.258 -0.901 . . . . 71.33 109.571 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.8 t -95.59 149.87 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.146 -0.971 . . . . 72.13 108.773 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 t -140.17 127.33 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.163 -0.961 . . . . 54.21 109.875 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.491 HD23 ' C ' ' A' ' 72' ' ' LEU . 2.4 tt -115.43 104.56 11.89 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.984 -0.747 . . . . 50.24 108.984 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.3 t -95.9 129.5 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.24 -0.913 . . . . 74.41 108.982 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.1 p -93.76 171.91 8.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.188 -0.945 . . . . 72.31 109.796 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.473 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 42.0 t -160.93 118.39 2.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.082 -1.011 . . . . 64.54 110.45 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -64.63 -29.01 70.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.623 -0.673 . . . . 74.13 109.72 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 79' ' ' THR . 35.5 m120 -122.07 80.55 43.27 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.528 -0.733 . . . . 73.34 109.428 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.12 87.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.323 2.016 . . . . 63.22 111.431 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.456 ' N ' ' O ' ' A' ' 77' ' ' ASN . 23.8 m -98.65 150.21 22.01 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.577 -0.702 . . . . 62.53 109.593 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.475 ' CB ' ' OG ' ' B' ' 101' ' ' SER . 0.0 OUTLIER -72.77 -41.15 65.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.35 -0.844 . . . . 73.44 109.189 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -57.57 -38.63 75.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.146 -0.971 . . . . 71.42 108.844 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -75.2 -26.02 58.68 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.352 -0.842 . . . . 73.43 109.191 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.525 ' OE1' ' CD2' ' A' ' 94' ' ' TYR . 36.7 tp10 -61.29 -57.63 11.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 74.22 109.65 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.482 HG23 ' N ' ' A' ' 85' ' ' HIS . 22.0 m -63.82 -40.65 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 73.2 109.338 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.482 ' N ' HG23 ' A' ' 84' ' ' VAL . 10.5 t-80 -62.36 -34.65 77.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -0.904 . . . . 53.33 109.371 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.14 -39.81 93.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 64.11 109.969 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -78.26 -34.35 49.09 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.98 -1.075 . . . . 74.34 109.054 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -70.84 -36.84 73.08 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.299 -0.875 . . . . 74.42 109.592 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -68.39 -47.86 66.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 74.24 109.761 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.58 48.23 0.03 OUTLIER Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.949 -1.26 . . . . 61.51 109.949 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.82 133.26 54.14 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.425 -1.044 . . . . 55.33 109.382 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -84.67 -22.85 29.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.944 . . . . 73.42 109.133 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.532 ' OD2' ' NH2' ' A' ' 112' ' ' ARG . 19.6 t0 -150.61 163.3 38.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.399 -0.813 . . . . 75.04 109.325 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.525 ' CD2' ' OE1' ' A' ' 83' ' ' GLU . 67.6 t80 -146.03 101.92 3.58 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.37 -0.832 . . . . 71.33 108.936 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 96' ' ' ALA . 29.0 mm -112.19 156.04 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 O-C-N 121.29 -0.882 . . . . 71.13 110.464 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.402 ' N ' HG22 ' A' ' 95' ' ' ILE . . . -67.11 146.52 54.19 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.417 -0.957 . . . . 64.32 108.417 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.676 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -68.19 -55.79 12.1 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.869 -1.144 . . . . 62.2 111.172 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 4.3 Cg_endo -41.59 -10.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 120.87 1.047 . . . . 73.11 112.967 -176.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.676 ' N ' ' O ' ' A' ' 97' ' ' LYS . 22.6 m-85 67.12 110.3 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.789 -0.57 . . . . 65.22 109.681 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -57.41 -33.78 68.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.972 -1.08 . . . . 72.35 108.185 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.775 ' O ' ' N ' ' A' ' 103' ' ' LYS . 47.5 t -175.63 24.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 71.32 110.167 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.4 mm 50.2 -67.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.791 -0.568 . . . . 75.43 110.028 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.775 ' N ' ' O ' ' A' ' 101' ' ' SER . 3.3 mptp? -54.5 -33.06 59.19 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.343 -1.354 . . . . 71.41 107.343 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.98 -41.54 74.3 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.988 -1.116 . . . . 63.24 107.988 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.9 tt -61.7 -46.49 89.44 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.974 -0.75 . . . . 73.22 108.974 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 90.4 t -62.99 -40.75 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.302 -0.873 . . . . 60.11 109.052 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.87 -39.71 62.85 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.315 -0.866 . . . . 70.42 108.859 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.558 ' HE ' ' CD ' ' B' ' 83' ' ' GLU . 50.3 mtt85 -69.0 -35.68 76.97 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.274 -0.891 . . . . 74.41 109.412 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.4 mt -69.4 -34.92 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.058 -1.026 . . . . 62.54 108.487 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -59.58 -55.57 32.84 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.751 -0.779 . . . . 74.34 109.446 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.5 -34.58 67.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 73.32 109.959 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.532 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 64.9 mtt85 -60.74 -37.69 82.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.001 -1.062 . . . . 52.41 110.022 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -155.06 68.74 0.7 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.681 -1.262 . . . . 65.24 110.373 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -53.66 89.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.102 -0.999 . . . . 64.45 108.784 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.506 ' N ' ' O ' ' A' ' 113' ' ' LEU . 69.0 m-85 52.9 89.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 74.43 109.599 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.412 ' HE1' ' HB3' ' A' ' 132' ' ' GLU . 74.6 t-105 -87.0 141.96 28.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 74.42 109.304 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 163.36 98.39 0.13 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.683 -1.367 . . . . 75.04 109.683 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.0 t -157.26 177.58 11.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -1.179 . . . . 61.14 109.666 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -146.42 127.77 14.91 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.007 -0.677 . . . . 65.24 109.498 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 86.6 t -72.87 -30.06 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.372 -0.83 . . . . 73.11 109.824 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.747 ' CG2' HH21 ' A' ' 159' ' ' ARG . 5.1 mp -118.66 131.88 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.427 -0.796 . . . . 72.24 109.913 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -142.33 107.73 5.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.426 -0.796 . . . . 72.34 108.997 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.588 HG12 ' CZ ' ' A' ' 159' ' ' ARG . 1.2 pp -130.71 142.44 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.458 -0.776 . . . . 71.44 109.027 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.72 -152.81 2.48 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.996 -1.642 . . . . 73.4 108.996 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -84.35 11.66 8.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.339 -1.094 . . . . 74.45 108.702 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.03 136.46 43.64 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.857 -0.794 . . . . 54.21 108.857 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 18.6 p -129.56 148.71 51.49 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.5 -0.75 . . . . 54.5 109.246 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.3 mt -139.04 136.06 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.393 -0.817 . . . . 45.15 110.028 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.8 m -126.11 98.76 32.45 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 108.68 -0.859 . . . . 71.11 108.68 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.46 -34.33 0.56 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.276 1.984 . . . . 65.41 112.734 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -58.09 -43.83 87.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.004 -1.06 . . . . 63.32 109.425 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.412 ' HB3' ' HE1' ' A' ' 116' ' ' TRP . 4.5 pt-20 -97.06 14.01 27.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.463 -0.773 . . . . 72.52 109.13 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 27.4 mp0 45.84 76.25 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.375 -0.828 . . . . 75.33 109.681 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -163.56 149.99 11.89 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.058 -1.026 . . . . 71.23 110.033 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.582 ' C ' HD13 ' A' ' 136' ' ' ILE . 17.7 tt -137.68 143.96 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.318 -0.864 . . . . 74.02 109.314 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.582 HD13 ' C ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -122.46 131.78 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.477 -0.764 . . . . 60.23 109.728 -179.297 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -138.58 128.75 25.63 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.348 -0.845 . . . . 62.32 108.737 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp 54.32 29.47 10.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.519 -0.738 . . . . 75.4 109.097 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 79.56 1.19 86.2 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.774 -0.931 . . . . 72.24 110.774 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.436 ' HD2' ' N ' ' A' ' 140' ' ' ARG . 9.2 mmm180 -88.79 124.15 33.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.859 -1.377 . . . . 71.22 108.909 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.447 ' HG2' HD12 ' A' ' 136' ' ' ILE . 95.0 mt-10 -88.81 136.35 33.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.286 -0.884 . . . . 71.42 109.014 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.0 t -131.84 127.8 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.371 -0.831 . . . . 53.02 109.591 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -88.27 122.7 32.1 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.69 -0.856 . . . . 60.45 108.69 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.6 m -141.88 138.57 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.03 -1.044 . . . . 74.44 109.867 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.51 39.14 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.443 -0.785 . . . . 65.15 109.191 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -107.9 -152.52 17.11 Favored Glycine 0 N--CA 1.502 3.036 0 N-CA-C 110.009 -1.236 . . . . 73.34 110.009 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.605 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 1.1 mtmp? -88.07 -37.62 0.46 Allowed Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.222 -1.164 . . . . 72.22 110.139 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 23.3 Cg_exo -63.29 -32.08 73.2 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.175 1.917 . . . . 65.23 111.418 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.507 ' CZ ' ' CG2' ' A' ' 153' ' ' THR . 43.7 t80 -86.69 -9.98 54.75 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.435 -0.791 . . . . 60.11 109.68 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.451 ' O ' ' OG1' ' A' ' 153' ' ' THR . 15.9 tt0 -66.96 -41.74 86.39 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.076 -1.015 . . . . 64.21 109.17 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.08 -35.11 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.983 -1.073 . . . . 72.02 109.223 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.692 HD12 HD21 ' A' ' 155' ' ' LEU . 15.9 tp -65.27 -33.35 75.78 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.181 -0.949 . . . . 73.31 108.967 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.507 ' CG2' ' CZ ' ' A' ' 149' ' ' PHE . 17.0 p -70.4 -32.39 70.01 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.177 -0.952 . . . . 74.31 108.437 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -64.38 -57.7 8.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.21 -0.931 . . . . 74.31 110.23 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.692 HD21 HD12 ' A' ' 152' ' ' LEU . 2.9 pp -65.38 -25.92 67.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.951 -1.093 . . . . 75.34 109.468 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.91 -51.55 69.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.008 -1.057 . . . . 62.14 108.988 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -74.17 -51.41 15.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.406 -0.809 . . . . 61.03 109.512 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.445 ' O ' ' O ' ' A' ' 159' ' ' ARG . 39.7 m80 -86.09 33.67 0.61 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.477 -0.765 . . . . 74.12 109.98 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.747 HH21 ' CG2' ' A' ' 121' ' ' ILE . 30.4 ttm-85 -46.96 -94.1 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.302 -0.874 . . . . 71.13 109.231 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.517 ' OD2' ' NE2' ' B' ' 161' ' ' GLN . 31.6 p-10 -52.4 89.36 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.953 -1.092 . . . . 75.45 109.219 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.535 ' NE2' ' O ' ' A' ' 162' ' ' ILE . 0.0 OUTLIER -173.33 154.01 2.54 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.109 -0.994 . . . . 73.41 109.434 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.535 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 52.5 mt -87.18 126.71 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.13 -0.981 . . . . 74.41 108.613 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.492 HG11 HD21 ' A' ' 168' ' ' LEU . 51.1 t -118.89 130.66 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.409 -0.807 . . . . 72.31 110.011 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 3.9 t -94.3 163.9 13.25 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.276 -0.89 . . . . 74.12 109.063 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -64.38 -43.58 94.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.067 -1.02 . . . . 70.43 109.554 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -58.92 -38.38 78.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 73.52 109.644 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -58.47 -46.18 87.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 74.52 109.513 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.492 HD21 HG11 ' A' ' 163' ' ' VAL . 77.7 mt -62.43 -39.31 92.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.155 -0.965 . . . . 72.31 109.311 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.511 ' C ' HD23 ' A' ' 169' ' ' LEU . 4.8 tt -54.77 -68.08 0.22 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.435 -0.791 . . . . 53.33 109.949 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.42 -37.08 79.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.305 -0.872 . . . . 62.44 110.751 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -50.79 -58.08 6.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.105 -0.997 . . . . 60.21 110.402 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.697 HD12 ' N ' ' A' ' 172' ' ' ILE . 1.9 mp -93.27 -62.69 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.98 -1.075 . . . . 75.32 109.492 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.441 ' O ' ' O ' ' A' ' 169' ' ' LEU . 24.5 m-90 . . . . . 0 N--CA 1.488 1.454 0 O-C-N 121.38 -0.825 . . . . 73.14 110.06 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 109.531 -0.544 . . . . 64.54 109.531 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.433 ' O ' HG22 ' A' ' 186' ' ' VAL . 11.8 p -58.29 -12.91 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 74.02 109.382 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.57 ' N ' HD12 ' A' ' 184' ' ' ILE . 2.6 mp -59.92 -22.98 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.088 -1.007 . . . . 72.33 109.028 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -61.6 -45.35 94.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.208 -0.933 . . . . 74.4 110.027 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 183' ' ' VAL . 12.1 m -75.32 -30.14 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.001 -1.062 . . . . 70.42 109.324 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -69.5 -50.67 43.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.097 -1.002 . . . . 52.11 110.025 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.446 HG23 ' N ' ' A' ' 189' ' ' ASN . 10.3 tp -65.13 -39.26 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.84 -1.163 . . . . 71.4 110.503 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.446 ' N ' HG23 ' A' ' 188' ' ' ILE . 11.6 t-20 -58.36 -43.09 88.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.974 -1.079 . . . . 73.44 109.483 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -75.64 -47.72 25.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.347 -0.845 . . . . 71.42 110.072 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 63.6 mt -52.13 -47.91 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.13 -0.981 . . . . 61.55 109.46 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ARG . . . . . 0.476 ' HE ' ' CG2' ' A' ' 204' ' ' VAL . 76.0 mtp180 -60.58 -51.3 70.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.322 -0.861 . . . . 63.34 109.988 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -61.59 -33.89 74.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.24 -0.913 . . . . 61.24 110.145 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.421 ' O ' ' CD ' ' A' ' 198' ' ' PRO . 9.3 pttm -86.81 -4.31 59.16 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.92 -1.112 . . . . 75.13 109.589 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 28.2 ttt -91.46 -57.2 2.85 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.16 -0.963 . . . . 74.02 109.189 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 200' ' ' GLY . 15.0 p-10 -65.19 -31.42 72.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.364 -0.835 . . . . 74.02 109.619 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.441 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 27.5 mttm -52.86 -65.26 1.14 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.103 -0.998 . . . . 75.43 109.579 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 38.5 Cg_endo -63.89 -54.92 0.76 Allowed 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.144 1.896 . . . . 72.32 112.066 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' A' ' 201' ' ' ILE . 65.4 mt -63.79 -28.87 70.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 74.54 109.211 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 196' ' ' ASP . . . 74.92 -26.61 1.15 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.789 -1.325 . . . . 61.51 109.789 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.466 ' H ' ' C ' ' A' ' 199' ' ' LEU . 11.0 mt -101.32 129.95 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.357 -1.084 . . . . 61.22 109.356 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 15.1 t -80.6 132.2 35.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.895 . . . . 72.0 109.265 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 62.6 p -136.11 3.72 2.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.432 -0.793 . . . . 74.44 108.949 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.476 ' CG2' ' HE ' ' A' ' 192' ' ' ARG . 28.6 m -104.36 138.09 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.499 -0.75 . . . . 64.35 109.292 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -122.96 136.34 54.82 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.6 -0.688 . . . . 71.41 109.572 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.13 132.35 44.51 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.231 -0.918 . . . . 73.52 109.047 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 5.1 m -135.14 136.29 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.371 -0.831 . . . . 71.02 109.48 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -81.34 -10.05 59.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.856 . . . . 72.12 109.16 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 18.8 mtp-105 -56.04 -43.28 77.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.92 . . . . 64.41 109.812 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -148.05 -66.76 0.25 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.221 -0.924 . . . . 71.54 109.524 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -148.45 -110.89 0.59 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.636 -1.386 . . . . 72.03 109.636 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.406 ' N ' ' CD1' ' A' ' 212' ' ' TYR . 41.4 m-85 -125.81 146.34 49.84 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.643 -0.916 . . . . 75.54 109.075 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -113.09 133.39 55.02 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.539 -0.726 . . . . 75.31 109.542 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -99.36 132.01 44.99 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.689 -0.856 . . . . 75.41 108.689 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 2.0 p -141.1 166.72 24.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.278 -0.889 . . . . 74.14 109.601 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -82.11 152.44 68.2 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 75.32 109.426 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo . . . . . 0 N--CA 1.49 1.308 0 C-N-CA 122.295 1.997 . . . . 73.11 112.266 179.491 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.573 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.406 -0.59 . . . . 71.14 109.406 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -131.77 145.89 51.85 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.512 -0.743 . . . . 73.23 109.129 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.2 t -117.03 139.65 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.582 -0.699 . . . . 72.24 109.907 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.495 HD11 ' CG1' ' B' ' 6' ' ' ILE . 3.3 tp -109.01 118.7 37.47 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.568 -0.708 . . . . 54.33 109.386 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.466 ' N ' HD12 ' B' ' 4' ' ' LEU . 21.7 mt -115.62 97.8 6.34 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.597 -0.89 . . . . 74.35 108.597 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.683 HD12 ' HB ' ' B' ' 50' ' ' VAL . 90.2 mt -85.8 97.41 5.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 120.863 -1.148 . . . . 42.55 108.987 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.407 ' HG3' ' H ' ' B' ' 9' ' ' ASN . 45.8 tp10 -120.52 128.04 52.74 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.543 -0.723 . . . . 74.52 109.635 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 8' ' ' LYS . . . . . 0.491 ' CD ' ' H ' ' B' ' 8' ' ' LYS . 0.0 OUTLIER -83.43 -22.12 32.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 62.55 108.773 179.447 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 9' ' ' ASN . . . . . 0.471 ' ND2' HD23 ' B' ' 12' ' ' LEU . 37.0 t-20 -78.6 -128.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.431 -0.793 . . . . 73.11 109.232 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 10' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' B' ' 11' ' ' VAL . 22.0 p -166.83 -55.54 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -0.866 . . . . 65.54 109.32 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.418 ' N ' ' OG ' ' B' ' 10' ' ' SER . 88.0 t -67.74 -42.77 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.288 -0.883 . . . . 75.55 109.652 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.583 HD13 ' OE2' ' B' ' 15' ' ' GLU . 4.0 mm? -59.87 -42.23 93.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.338 -0.851 . . . . 70.14 109.532 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.75 -28.56 66.88 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.416 -1.874 . . . . 75.4 108.416 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.06 -47.94 80.49 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 109.828 -1.309 . . . . 65.44 109.828 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.583 ' OE2' HD13 ' B' ' 12' ' ' LEU . 15.7 pt-20 -63.76 -44.42 93.51 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.122 -1.222 . . . . 60.21 109.707 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 37.0 mm -66.7 -39.77 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.756 -1.215 . . . . 75.15 108.667 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.488 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 80.3 tt0 -63.72 -43.21 97.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.403 -0.811 . . . . 73.01 109.684 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp -86.81 0.45 54.81 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.09 -1.006 . . . . 74.3 109.366 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.49 -52.83 3.08 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.561 -1.416 . . . . 70.54 109.561 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.403 HD23 ' N ' ' B' ' 21' ' ' ASN . 1.4 pt? -76.73 -21.56 55.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -1.102 . . . . 71.34 109.914 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 21' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 90.9 m-20 -56.43 -31.47 63.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.084 -1.01 . . . . 64.41 109.451 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 87.6 t -59.87 -35.02 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.317 -0.864 . . . . 74.23 109.354 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -70.68 -8.12 49.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.343 -0.848 . . . . 63.42 109.314 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.36 43.41 6.59 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.023 -1.231 . . . . 53.43 110.023 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -116.71 159.67 21.91 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.498 -1.001 . . . . 71.12 109.054 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 14.5 mmt -100.74 138.02 38.35 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.989 -1.115 . . . . 75.24 107.989 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.23 155.57 43.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.096 -1.002 . . . . 72.12 110.257 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -132.3 160.82 35.14 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.665 -0.865 . . . . 72.31 108.665 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 p -119.49 139.0 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.45 -0.781 . . . . 64.43 109.739 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 6.8 p -134.83 170.43 15.87 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.068 -0.716 . . . . 65.41 109.068 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.402 ' OE2' ' OD2' ' B' ' 35' ' ' ASP . 5.9 pt-20 -93.31 -107.81 0.12 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.219 -0.925 . . . . 71.02 109.82 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 54.8 p -78.94 168.16 20.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.25 -0.906 . . . . 51.11 110.025 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 61.0 mt -52.83 -29.41 27.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.548 -0.72 . . . . 71.24 109.754 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -52.71 -50.38 63.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.144 -0.972 . . . . 74.32 109.636 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.402 ' OD2' ' OE2' ' B' ' 31' ' ' GLU . 1.8 m-20 -64.66 -40.89 96.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.94 . . . . 73.03 109.481 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.02 -42.0 60.03 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.573 -1.411 . . . . 30.21 109.573 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.68 -37.75 87.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.304 -1.115 . . . . 74.42 109.748 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -80.64 -41.16 24.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.088 -1.007 . . . . 74.42 109.858 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 8.6 tt -70.21 -43.86 69.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.191 -0.943 . . . . 75.41 109.972 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' MET . . . . . 0.448 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.1 ppp? -62.62 -26.34 68.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.987 -1.07 . . . . 60.41 109.88 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -63.49 -39.85 95.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.054 -1.029 . . . . 53.23 110.027 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 20.9 pt -84.38 -26.29 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.095 -1.003 . . . . 71.23 110.166 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' B' ' 40' ' ' MET . 63.6 mmt-85 -129.69 138.59 51.24 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.305 -0.872 . . . . 72.22 109.348 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -93.62 159.59 15.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.162 -0.961 . . . . 63.54 109.825 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -136.63 150.47 48.55 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.447 -0.783 . . . . 64.35 109.212 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -91.5 -35.02 14.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.147 -0.971 . . . . 62.22 109.692 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.512 HD13 ' C ' ' B' ' 47' ' ' LEU . 0.9 OUTLIER -113.37 110.6 20.6 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.421 -0.799 . . . . 73.12 109.095 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.464 ' N ' HD13 ' B' ' 47' ' ' LEU . 70.8 t -93.86 100.22 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.324 -0.86 . . . . 65.11 108.761 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.518 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 6.3 tpp -114.24 128.23 56.26 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.094 -0.706 . . . . 73.44 109.094 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.686 HG22 ' H ' ' B' ' 52' ' ' ASP . 0.7 OUTLIER -144.01 136.66 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 34.5 109.803 -179.451 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 65.2 p -101.52 16.77 24.62 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.593 -0.692 . . . . 73.21 109.658 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.686 ' H ' HG22 ' B' ' 50' ' ' VAL . 41.7 m-20 -83.59 136.22 34.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.22 -0.925 . . . . 70.41 109.331 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -71.93 -33.56 68.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.898 . . . . 65.0 110.184 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -76.91 3.7 11.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.098 -1.001 . . . . 75.21 110.097 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.403 ' O ' ' C ' ' B' ' 56' ' ' LEU . . . -71.39 -21.33 62.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 55.33 110.215 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.529 ' O ' ' NE2' ' B' ' 89' ' ' GLN . 56.2 mt -42.98 -42.91 3.94 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.424 -0.797 . . . . 63.14 110.275 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 19.7 m -72.63 -37.22 68.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.045 -1.035 . . . . 63.5 109.459 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' PHE . . . . . 0.568 ' CE2' HD11 ' B' ' 62' ' ' ILE . 69.1 t80 -67.44 -51.06 56.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.368 -0.832 . . . . 72.33 110.287 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.3 m -60.4 -35.11 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.783 -1.198 . . . . 74.54 109.542 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 66.1 p -58.41 -50.84 72.26 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.269 -0.895 . . . . 71.24 109.289 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.505 ' HE ' ' CE ' ' B' ' 65' ' ' LYS . 12.2 ptm180 -68.85 -30.94 69.57 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 118.742 -1.183 . . . . 74.31 109.815 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.568 HD11 ' CE2' ' B' ' 58' ' ' PHE . 4.8 mm -54.56 -48.44 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.842 -1.161 . . . . 72.14 108.526 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.523 ' NZ ' ' OD2' ' B' ' 92' ' ' ASP . 50.3 mmtt -61.2 -42.94 99.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.141 -0.975 . . . . 73.32 108.435 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -65.65 -43.69 88.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.415 -0.803 . . . . 73.12 108.837 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.505 ' CE ' ' HE ' ' B' ' 61' ' ' ARG . 9.5 mtmp? -82.28 -77.54 0.23 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.662 -0.649 . . . . 72.44 109.964 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.433 ' N ' ' O ' ' B' ' 62' ' ' ILE . 95.1 m-70 -97.53 87.69 4.17 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.165 -0.959 . . . . 63.31 109.727 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 71.0 p -79.34 -30.88 42.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.3 -0.875 . . . . 73.1 110.013 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 38.3 m -63.23 -28.89 70.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.19 -0.944 . . . . 71.53 110.0 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 58.3 mt -80.17 150.0 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.088 -1.008 . . . . 74.4 109.654 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.553 HG12 ' N ' ' B' ' 71' ' ' VAL . 98.8 t -88.37 165.62 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.378 -0.826 . . . . 75.12 109.387 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.553 ' N ' HG12 ' B' ' 70' ' ' VAL . 14.4 t -145.48 125.42 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.999 -1.063 . . . . 73.2 109.859 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.518 ' O ' ' SD ' ' B' ' 49' ' ' MET . 0.8 OUTLIER -120.5 103.6 9.3 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.408 -0.96 . . . . 73.34 108.408 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 13.4 p -98.4 144.98 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.179 -0.951 . . . . 73.5 108.876 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.5 m -111.07 171.25 7.58 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.318 -0.864 . . . . 64.34 109.147 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 8.0 t -171.13 122.26 0.56 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.076 -1.015 . . . . 74.53 110.065 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 46.3 p30 -78.14 29.82 0.18 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.453 -0.779 . . . . 64.5 110.189 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 77' ' ' ASN . . . . . 0.414 ' N ' ' CD ' ' B' ' 78' ' ' PRO . 12.7 t-20 -150.47 55.13 1.67 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 120.939 -1.101 . . . . 74.25 109.862 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' B' ' 77' ' ' ASN . 12.0 Cg_endo -56.26 81.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.604 2.203 . . . . 74.43 112.397 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.416 HG22 ' H ' ' B' ' 81' ' ' GLU . 29.4 m -109.35 149.69 29.12 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.317 -0.994 . . . . 73.12 108.317 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -30.66 66.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.144 -0.972 . . . . 71.01 109.213 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 81' ' ' GLU . . . . . 0.416 ' H ' HG22 ' B' ' 79' ' ' THR . 84.1 tt0 -64.53 -48.21 75.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 63.2 109.034 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -69.89 -29.49 66.7 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.138 -0.976 . . . . 73.22 109.142 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.558 ' CD ' ' HE ' ' A' ' 108' ' ' ARG . 39.8 tp10 -56.21 -56.03 25.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.871 . . . . 74.3 109.192 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 8.2 m -60.46 -38.45 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.171 -0.956 . . . . 73.31 108.917 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 69.9 t60 -63.11 -34.03 76.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.303 -0.873 . . . . 73.24 109.437 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.18 90.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.197 -0.94 . . . . 55.33 109.74 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -76.56 -31.34 57.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.195 -0.941 . . . . 74.14 108.641 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -67.32 -46.31 73.87 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.731 -0.84 . . . . 64.04 108.731 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 89' ' ' GLN . . . . . 0.529 ' NE2' ' O ' ' B' ' 56' ' ' LEU . 18.9 mm100 -59.48 -66.21 0.55 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.611 -0.681 . . . . 72.35 109.414 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 149.87 52.14 0.02 OUTLIER Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.167 -1.173 . . . . 65.2 110.167 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.6 132.23 54.08 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.31 -1.112 . . . . 52.23 109.067 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.523 ' OD2' ' NZ ' ' B' ' 63' ' ' LYS . 3.4 m-20 -67.15 -38.11 84.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.033 -1.042 . . . . 73.32 108.873 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 93' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 48.2 t0 -152.11 156.65 40.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.442 -0.786 . . . . 72.22 108.939 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.482 ' CD1' ' C ' ' B' ' 94' ' ' TYR . 0.5 OUTLIER -125.29 126.54 45.27 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.179 -0.674 . . . . 64.42 109.179 -179.586 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 0.435 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 25.8 mm -110.22 134.06 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 121.378 -0.826 . . . . 72.23 109.923 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 96' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' B' ' 97' ' ' LYS . . . -60.97 119.5 8.41 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.635 -1.617 . . . . 25.24 106.635 177.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.681 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -42.01 -55.36 6.3 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.032 -1.042 . . . . 64.32 111.574 -178.072 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 98' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 3.7 Cg_endo -41.64 -10.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 120.774 0.983 . . . . 63.33 112.57 -176.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 99' ' ' TYR . . . . . 0.681 ' N ' ' O ' ' B' ' 97' ' ' LYS . 58.6 m-85 58.83 104.98 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.845 -0.535 . . . . 75.13 109.719 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 33.0 ttm-85 -62.0 -34.4 76.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.071 -1.018 . . . . 74.23 109.091 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 101' ' ' SER . . . . . 0.631 ' O ' ' N ' ' B' ' 103' ' ' LYS . 28.8 m -172.51 32.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.88 . . . . 63.34 110.253 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 102' ' ' ILE . . . . . 0.48 ' O ' ' N ' ' B' ' 104' ' ' ALA . 55.9 mt 49.09 -81.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.384 -0.823 . . . . 74.44 110.368 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.631 ' N ' ' O ' ' B' ' 101' ' ' SER . 44.7 mtmt -45.57 -19.97 0.06 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.242 -0.911 . . . . 71.11 108.961 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' B' ' 102' ' ' ILE . . . -55.6 -67.5 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.509 -0.744 . . . . 71.45 109.545 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 3.1 pp -60.84 -36.76 79.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.961 -1.087 . . . . 51.31 109.555 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 14.5 t -56.92 -45.69 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.74 -1.225 . . . . 65.23 108.531 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.3 -31.04 67.13 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.337 -0.986 . . . . 24.32 108.337 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -79.41 -23.72 43.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.525 -0.735 . . . . 75.31 109.822 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 83.2 mt -78.24 -39.69 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.955 -1.091 . . . . 54.24 109.11 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -73.52 -41.39 63.11 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.329 -0.949 . . . . 65.31 109.417 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.15 -53.28 59.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.192 -0.942 . . . . 72.24 109.577 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 68.3 ttt-85 -64.97 -33.85 77.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 72.04 109.47 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.521 ' O ' ' CD2' ' B' ' 115' ' ' PHE . 60.3 tp -80.54 -90.82 0.06 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.93 . . . . 75.35 109.7 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' B' ' 116' ' ' TRP . 11.6 mmt180 47.17 -170.03 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.176 -0.952 . . . . 75.5 108.881 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 115' ' ' PHE . . . . . 0.521 ' CD2' ' O ' ' B' ' 113' ' ' LEU . 1.4 m-85 66.26 -39.76 0.33 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.336 -0.853 . . . . 65.33 109.849 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 116' ' ' TRP . . . . . 0.528 ' N ' ' O ' ' B' ' 114' ' ' ARG . 17.1 t90 53.3 43.13 31.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.012 -1.055 . . . . 74.45 109.203 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.49 77.0 1.09 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.817 -1.313 . . . . 44.21 109.817 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 2.3 t -80.92 -8.35 59.72 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.207 -1.172 . . . . 71.4 109.392 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 119' ' ' ASN . . . . . 0.551 ' ND2' ' N ' ' B' ' 120' ' ' VAL . 8.8 t30 54.52 176.39 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.422 -0.798 . . . . 72.32 110.328 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 120' ' ' VAL . . . . . 0.551 ' N ' ' ND2' ' B' ' 119' ' ' ASN . 11.8 t -142.71 -36.2 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.72 -0.845 . . . . 75.02 108.72 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 121' ' ' ILE . . . . . 0.53 ' C ' HD22 ' B' ' 119' ' ' ASN . 25.6 mm -115.42 118.77 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.28 -1.008 . . . . 51.41 108.28 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -155.34 140.76 17.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.939 -1.101 . . . . 71.53 110.131 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 35.1 pt -149.02 145.23 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.998 -0.742 . . . . 72.43 108.998 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 45.8 -136.41 8.0 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.848 -1.301 . . . . 51.23 109.848 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -90.51 6.73 42.29 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.259 -1.142 . . . . 74.2 109.326 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.9 139.25 31.12 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.321 -0.862 . . . . 75.42 108.777 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 17.0 m -128.86 133.68 48.04 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.601 -0.888 . . . . 74.22 108.601 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 42.0 mt -138.95 141.31 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.147 -0.971 . . . . 60.33 110.571 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 6.1 m -136.99 117.75 10.88 Favored Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 108.915 -0.772 . . . . 72.31 108.915 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.98 -48.74 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 121.958 1.772 . . . . 75.13 112.471 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -55.53 -37.41 67.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.211 -0.93 . . . . 75.23 109.836 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -80.76 -2.15 45.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.166 -0.959 . . . . 72.43 109.374 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 49.55 57.32 6.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.256 -0.903 . . . . 75.13 108.958 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -156.66 139.7 15.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -0.908 . . . . 73.22 109.545 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 55.3 mt -124.01 132.72 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.995 -0.743 . . . . 64.14 108.995 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 136' ' ' ILE . . . . . 0.442 HG23 ' O ' ' B' ' 140' ' ' ARG . 23.7 mt -125.57 131.25 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.502 -0.749 . . . . 71.22 110.318 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -125.62 129.24 49.24 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.697 -0.627 . . . . 64.22 109.483 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm 51.46 36.34 16.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.179 -0.951 . . . . 72.02 111.095 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.76 -1.34 83.83 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 120.065 -1.064 . . . . 74.32 111.5 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 140' ' ' ARG . . . . . 0.442 ' O ' HG23 ' B' ' 136' ' ' ILE . 2.7 mpt_? -87.14 124.62 33.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.714 -1.462 . . . . 75.34 108.927 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -84.03 123.88 30.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.368 -0.832 . . . . 71.23 109.496 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 97.2 t -127.72 133.28 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.474 -0.766 . . . . 70.43 109.45 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -98.93 142.84 29.93 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.242 -0.911 . . . . 72.43 109.44 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 20.6 m -146.32 152.29 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.149 -0.969 . . . . 72.13 109.906 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.11 115.79 0.08 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.358 -0.839 . . . . 72.02 109.407 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.59 -137.86 7.03 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.788 -1.325 . . . . 42.23 109.788 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 147' ' ' LYS . . . . . 0.58 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 0.0 OUTLIER -73.53 -43.83 7.1 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.272 -1.134 . . . . 73.3 109.539 -179.58 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 148' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 24.3 Cg_exo -62.67 -49.08 5.99 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.29 1.994 . . . . 71.33 111.144 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 149' ' ' PHE . . . . . 0.44 ' CE1' HG21 ' B' ' 153' ' ' THR . 25.1 t80 -58.06 -24.39 58.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.687 -0.633 . . . . 74.23 109.608 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 150' ' ' GLU . . . . . 0.41 ' OE1' ' O ' ' B' ' 172' ' ' ILE . 24.0 tt0 -72.11 -58.6 3.29 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.299 -0.876 . . . . 72.34 110.378 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.99 -33.58 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.801 -1.187 . . . . 73.35 109.468 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 3.8 mp -58.15 -41.47 83.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.118 -0.989 . . . . 55.24 108.781 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.44 HG21 ' CE1' ' B' ' 149' ' ' PHE . 1.9 p -80.6 -18.96 46.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.967 . . . . 70.01 110.235 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -71.16 -52.13 20.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.858 -1.151 . . . . 65.32 109.576 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 155' ' ' LEU . . . . . 0.997 HD13 ' N ' ' B' ' 156' ' ' ALA . 0.0 OUTLIER -77.92 -25.01 48.11 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.313 -0.867 . . . . 71.54 110.17 -179.164 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 156' ' ' ALA . . . . . 0.997 ' N ' HD13 ' B' ' 155' ' ' LEU . . . -63.38 -53.4 53.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.906 -1.121 . . . . 75.32 109.259 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -66.06 -54.5 25.01 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.267 -0.896 . . . . 73.32 108.877 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 158' ' ' HIS . . . . . 0.448 ' ND1' ' N ' ' B' ' 158' ' ' HIS . 2.1 m-70 -84.72 38.27 0.69 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.804 -0.56 . . . . 74.14 110.263 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -73.41 45.07 0.16 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.866 -1.146 . . . . 61.41 109.408 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 160' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' B' ' 160' ' ' ASP . 15.9 p-10 -169.81 62.13 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.076 -1.015 . . . . 72.1 109.294 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 161' ' ' GLN . . . . . 0.517 ' NE2' ' OD2' ' A' ' 160' ' ' ASP . 39.7 tp60 -169.87 164.51 9.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.07 -1.019 . . . . 72.25 109.831 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 162' ' ' ILE . . . . . 0.524 HG23 ' NE ' ' B' ' 213' ' ' ARG . 45.4 mt -80.3 132.94 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.611 -0.885 . . . . 72.31 108.611 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 33.9 t -132.01 131.12 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.289 -0.882 . . . . 64.21 109.892 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 11.2 p -99.68 159.94 14.67 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.708 -0.849 . . . . 74.22 108.708 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -55.76 -39.38 71.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.028 -1.045 . . . . 65.31 109.571 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.21 -39.6 93.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.149 -0.969 . . . . 63.45 109.809 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -53.3 -47.28 69.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.176 -0.953 . . . . 72.4 109.0 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 33.5 mt -55.87 -50.53 70.37 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.448 -0.945 . . . . 72.32 108.448 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.462 ' O ' HD23 ' B' ' 169' ' ' LEU . 1.1 tt -49.9 -56.23 11.35 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.271 -0.893 . . . . 73.34 109.296 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -56.2 -39.21 72.08 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 112.833 0.679 . . . . 72.1 112.833 -178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -93.25 -18.83 22.03 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.451 -1.406 . . . . 62.13 113.408 -176.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 0.41 ' O ' ' OE1' ' B' ' 150' ' ' GLU . 1.3 mp -91.32 -53.87 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 120.375 -1.453 . . . . 71.42 111.07 -178.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 173' ' ' TRP . . . . . 0.536 ' CG ' ' O ' ' B' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.158 0 O-C-N 120.738 -1.226 . . . . 72.23 110.63 -177.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo . . . . . 0 N--CA 1.496 1.625 0 CA-C-O 121.224 0.427 . . . . 65.22 113.01 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -62.44 -33.5 74.92 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.199 -0.938 . . . . 72.31 111.072 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 183' ' ' VAL . . . . . 0.454 ' O ' HG12 ' B' ' 186' ' ' VAL . 87.2 t -66.67 -15.54 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.933 -1.104 . . . . 63.32 110.699 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 95.0 mt -60.87 -23.55 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.726 -1.234 . . . . 75.03 109.563 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 185' ' ' GLU . . . . . 0.449 ' CG ' ' N ' ' B' ' 186' ' ' VAL . 20.6 pt-20 -59.87 -43.95 94.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.283 -0.885 . . . . 64.11 109.883 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 186' ' ' VAL . . . . . 0.454 HG12 ' O ' ' B' ' 183' ' ' VAL . 2.7 p -76.98 -34.35 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.967 -1.083 . . . . 73.0 109.74 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -55.25 -52.59 62.9 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.881 -1.137 . . . . 61.12 109.588 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 8.3 tp -65.97 -37.83 80.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 120.973 -1.08 . . . . 72.43 109.603 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -58.5 -46.11 87.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.001 -1.062 . . . . 65.14 109.6 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -72.91 -47.23 47.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 63.24 110.087 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.5 mt -54.63 -40.55 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.026 -1.046 . . . . 74.03 109.463 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -62.49 -52.17 64.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.162 -0.961 . . . . 72.24 109.505 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -60.22 -38.42 83.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 73.1 109.464 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -73.25 -15.42 61.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.289 -0.882 . . . . 72.11 109.592 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 1.5 tpt -89.85 -57.13 2.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.271 -0.893 . . . . 44.33 110.098 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 196' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' B' ' 200' ' ' GLY . 95.2 m-20 -55.87 -38.35 70.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 71.21 110.998 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 197' ' ' LYS . . . . . 0.435 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 14.0 mtmm -54.96 -65.66 1.28 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.876 -1.14 . . . . 75.21 109.938 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 198' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 34.9 Cg_endo -63.11 -56.57 0.53 Allowed 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.084 1.856 . . . . 75.32 112.368 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 199' ' ' LEU . . . . . 0.496 ' N ' HD12 ' B' ' 199' ' ' LEU . 9.1 mp -62.83 -32.15 73.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.137 -0.977 . . . . 72.25 109.478 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 200' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' B' ' 196' ' ' ASP . . . 74.14 -41.9 1.13 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.486 -1.446 . . . . 64.53 109.486 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 201' ' ' ILE . . . . . 0.418 ' H ' ' C ' ' B' ' 199' ' ' LEU . 4.0 mt -92.29 129.52 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.285 -1.126 . . . . 44.23 109.231 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 26.3 p -78.12 142.35 38.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.167 -0.958 . . . . 54.01 109.07 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 10.2 p -141.45 4.88 1.8 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.314 -0.867 . . . . 74.4 109.528 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 204' ' ' VAL . 32.6 m -113.89 134.83 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.444 -0.785 . . . . 72.12 109.208 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 205' ' ' GLU . . . . . 0.531 ' N ' ' OE2' ' B' ' 205' ' ' GLU . 1.5 mp0 -106.76 136.22 46.95 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.448 -0.783 . . . . 65.41 109.508 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.36 119.21 34.42 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.209 -0.932 . . . . 71.33 109.018 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 4.8 t -131.58 130.77 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.447 -0.783 . . . . 63.5 109.59 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 208' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' B' ' 209' ' ' ARG . 65.9 ttt-85 -73.1 -28.59 62.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 74.45 109.446 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 209' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' B' ' 208' ' ' ARG . 52.4 mtp85 -55.6 -106.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 74.14 109.982 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -63.67 -66.19 0.58 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.019 . . . . 74.43 109.852 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 211' ' ' GLY . . . . . 0.78 ' H ' HH12 ' B' ' 213' ' ' ARG . . . 178.68 -119.89 0.68 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.834 -1.306 . . . . 64.45 109.834 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 212' ' ' TYR . . . . . 0.628 ' N ' ' NH2' ' B' ' 213' ' ' ARG . 78.2 m-85 -111.69 141.79 44.85 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.494 -1.004 . . . . 74.21 109.7 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 213' ' ' ARG . . . . . 0.78 HH12 ' H ' ' B' ' 211' ' ' GLY . 13.5 mmp_? -105.87 131.51 53.11 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.454 -0.779 . . . . 74.03 108.96 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 214' ' ' PHE . . . . . 0.43 ' C ' ' SG ' ' B' ' 215' ' ' CYS . 60.4 m-85 -108.45 107.27 17.74 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.348 -0.845 . . . . 74.34 108.972 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 215' ' ' CYS . . . . . 0.43 ' SG ' ' C ' ' B' ' 214' ' ' PHE . 4.2 m -148.64 169.43 20.37 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.309 -0.869 . . . . 64.33 109.53 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -79.32 150.34 73.76 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 70.04 109.117 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.77 -159.57 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.975 1.783 . . . . 65.11 111.243 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? . . . . . 0 N--CA 1.489 1.51 0 O-C-N 120.993 -1.067 . . . . 73.15 109.089 -179.814 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ptp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.469 -0.567 . . . . 65.12 109.469 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.1 ttt85 -144.24 156.47 44.3 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.277 -0.889 . . . . 72.33 109.238 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.5 t -117.04 129.21 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.59 0.709 . . . . 71.42 109.742 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 49' ' ' MET . 6.8 tp -99.86 116.76 32.68 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.902 -0.777 . . . . 65.12 108.902 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.4 tp -119.54 105.44 11.23 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.098 -0.704 . . . . 62.43 109.098 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.47 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 11.7 mt -96.36 131.9 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.071 -1.018 . . . . 71.15 109.539 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.499 ' N ' ' CD ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -163.14 131.83 3.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 75.34 109.409 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.547 ' H ' ' CD ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -76.74 -5.1 46.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -0.944 . . . . 72.44 108.898 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -74.67 -145.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.312 -0.868 . . . . 63.02 109.092 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.3 t -159.83 -69.84 0.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.107 -0.996 . . . . 72.34 109.662 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.414 HG13 ' N ' ' A' ' 12' ' ' LEU . 11.2 p -64.76 -37.46 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 74.02 109.985 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.414 ' N ' HG13 ' A' ' 11' ' ' VAL . 3.6 mm? -52.11 -41.34 62.39 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.978 -1.076 . . . . 71.43 108.756 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.25 -28.79 63.35 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.552 -1.819 . . . . 61.32 108.552 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.65 -46.43 92.15 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.696 -1.362 . . . . 71.2 109.696 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.28 -42.86 87.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.321 -1.106 . . . . 71.32 109.915 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.464 HD11 ' CE2' ' A' ' 99' ' ' TYR . 62.9 mt -69.55 -37.45 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.886 -1.134 . . . . 63.23 109.327 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -59.81 -45.94 90.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.137 -0.977 . . . . 51.11 109.488 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -86.33 -4.28 59.14 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.155 -0.966 . . . . 73.34 109.629 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.02 -57.45 2.52 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.312 -1.515 . . . . 62.15 109.312 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pp -66.31 -29.21 69.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.376 -1.073 . . . . 73.51 109.38 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -53.22 -35.1 59.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 74.25 109.35 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 82.1 t -55.52 -40.84 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.929 . . . . 70.04 109.095 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.539 ' HZ2' HG11 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -70.25 -17.33 63.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.373 -0.83 . . . . 73.23 109.015 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.95 41.6 3.5 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.197 -1.161 . . . . 75.54 110.197 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -118.15 155.85 29.73 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.404 -1.057 . . . . 73.43 108.737 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.7 mmm -103.51 139.22 39.15 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.538 -0.912 . . . . 43.24 108.538 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.69 159.81 41.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.224 -0.923 . . . . 62.11 110.066 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -140.03 146.06 38.55 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.91 -0.774 . . . . 74.42 108.91 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.93 128.15 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.647 -0.872 . . . . 72.15 108.647 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.6 p -128.48 165.05 21.44 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.584 -0.697 . . . . 71.42 109.516 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.47 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 3.5 pt-20 -94.13 -99.34 0.15 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.284 -0.885 . . . . 72.33 109.643 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.5 p -79.56 165.51 22.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.167 -0.958 . . . . 74.24 110.034 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.0 mt -57.13 -36.3 70.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.496 -0.752 . . . . 71.53 109.991 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -54.14 -41.09 68.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.111 -0.993 . . . . 74.23 110.014 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.18 -40.08 65.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.125 -0.984 . . . . 54.03 109.867 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.97 -39.46 23.96 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.91 -1.276 . . . . 61.41 109.91 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.6 -49.02 74.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -1.136 . . . . 74.34 109.872 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -66.47 -35.75 81.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.144 -0.972 . . . . 75.33 110.039 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.469 HD11 ' HE ' ' A' ' 43' ' ' ARG . 20.6 tp -73.83 -51.58 15.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 74.33 110.344 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.42 ' O ' ' O ' ' A' ' 43' ' ' ARG . 11.7 ptm -65.3 -24.79 67.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.078 -1.014 . . . . 70.32 110.094 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -54.98 -42.0 71.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.079 -1.013 . . . . 71.22 109.891 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.1 pt -88.67 -34.68 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.164 -0.96 . . . . 74.14 109.964 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.469 ' HE ' HD11 ' A' ' 39' ' ' LEU . 86.2 mtt-85 -86.59 147.35 25.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.02 -1.05 . . . . 72.24 109.684 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -88.42 151.92 22.24 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.296 -0.877 . . . . 75.42 109.237 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 12.5 p90 -156.01 171.09 20.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.149 -0.969 . . . . 74.23 109.897 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 45' ' ' TYR . 89.8 m-20 -136.3 -31.87 0.88 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.53 -0.732 . . . . 72.04 109.426 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.02 108.62 19.86 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.361 -0.837 . . . . 72.13 108.818 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.3 t -97.82 97.8 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.323 -0.861 . . . . 72.34 109.438 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.429 ' O ' ' O ' ' A' ' 4' ' ' LEU . 4.5 ttt -113.89 127.48 56.0 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.455 -0.778 . . . . 74.11 109.213 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.418 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -133.5 137.61 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.635 -0.666 . . . . 61.12 109.47 -179.082 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 t -103.92 4.07 34.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.589 -0.694 . . . . 73.11 109.647 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.418 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 78.0 m-20 -76.84 140.01 40.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.15 -0.969 . . . . 52.55 109.532 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 55' ' ' ALA . 37.9 mmtm -73.58 -42.32 61.73 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.291 -0.881 . . . . 44.22 110.104 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -70.95 13.98 0.17 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.113 -0.992 . . . . 70.44 109.682 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.01 -20.87 59.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 64.14 110.428 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.673 ' HB3' HE22 ' A' ' 89' ' ' GLN . 36.3 mt -42.06 -50.84 4.67 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.39 -0.819 . . . . 44.14 110.019 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.9 m -66.12 -33.85 76.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.074 -1.016 . . . . 55.23 108.945 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.437 ' N ' ' O ' ' A' ' 55' ' ' ALA . 52.1 t80 -64.08 -62.1 1.84 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.358 -0.839 . . . . 74.44 109.574 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.2 m -49.21 -33.25 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.671 -1.268 . . . . 74.03 109.589 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.0 m -58.2 -51.66 68.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.207 -0.933 . . . . 64.3 109.583 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -69.21 -31.22 69.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.997 -1.064 . . . . 64.44 110.014 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.9 mm -65.87 -36.11 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.726 -1.234 . . . . 63.21 109.561 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -69.75 -46.38 66.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 74.42 110.428 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.431 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 7.0 pt-20 -74.53 -42.73 58.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.831 -1.168 . . . . 70.32 110.087 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.527 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 92.8 mttt -70.13 -27.9 64.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 75.22 109.484 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.572 ' O ' HG22 ' A' ' 69' ' ' ILE . 58.6 m-70 -150.13 67.12 0.97 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.367 -0.833 . . . . 74.13 109.224 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.3 p -60.44 -28.76 68.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 73.24 109.813 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.5 t -78.58 48.54 0.8 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.158 -0.964 . . . . 61.01 109.709 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.572 HG22 ' O ' ' A' ' 66' ' ' HIS . 13.6 tt -144.81 166.72 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.094 -1.004 . . . . 71.33 109.344 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 71' ' ' VAL . 86.6 t -98.05 156.06 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.182 -0.949 . . . . 72.13 109.404 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.413 ' N ' HG12 ' A' ' 70' ' ' VAL . 4.9 t -142.63 120.86 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.286 -0.884 . . . . 54.21 108.816 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.529 ' HG ' HD11 ' A' ' 95' ' ' ILE . 2.4 mp -116.75 104.27 11.18 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.862 -0.792 . . . . 50.24 108.862 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 68.5 t -93.02 121.37 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 74.41 108.859 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.0 p -89.78 169.38 11.32 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.158 -0.964 . . . . 72.31 109.118 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.484 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 19.1 t -162.44 123.03 2.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.085 -1.01 . . . . 64.54 110.224 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 77' ' ' ASN . 54.1 p30 -78.49 -9.97 59.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.428 -0.795 . . . . 74.13 109.116 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 79' ' ' THR . 27.6 m120 -128.7 64.95 71.09 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.891 -0.781 . . . . 73.34 108.891 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -49.44 88.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.093 1.862 . . . . 63.22 111.871 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.425 ' N ' ' O ' ' A' ' 77' ' ' ASN . 24.5 m -105.83 149.24 26.68 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.706 -0.849 . . . . 62.53 108.706 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.3 -33.11 74.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 73.44 109.329 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.422 ' H ' HG22 ' A' ' 79' ' ' THR . 84.4 tt0 -61.18 -38.73 87.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 71.42 109.363 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.422 ' OE1' ' OH ' ' A' ' 94' ' ' TYR . 85.1 tt0 -75.76 -31.81 59.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 73.43 109.498 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.51 -51.44 65.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 74.22 109.741 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.469 HG23 ' N ' ' A' ' 85' ' ' HIS . 31.4 m -63.98 -42.82 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 73.2 109.605 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.469 ' N ' HG23 ' A' ' 84' ' ' VAL . 23.1 t60 -64.06 -32.54 74.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.186 -0.946 . . . . 53.33 109.509 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.37 -37.88 80.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 64.11 110.091 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -83.48 -36.93 23.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.053 -1.029 . . . . 74.34 109.294 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.85 -34.04 77.05 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.293 -0.879 . . . . 74.42 109.504 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.673 HE22 ' HB3' ' A' ' 56' ' ' LEU . 29.0 mt-30 -80.08 -60.03 2.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 74.24 109.776 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 157.36 59.12 0.01 OUTLIER Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.672 -1.252 . . . . 61.51 110.22 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.44 125.48 51.81 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.402 -1.058 . . . . 55.33 108.89 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 20.6 t70 -69.65 -35.59 75.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.002 -1.061 . . . . 73.42 109.271 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 67.9 m-20 -151.3 161.5 42.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.338 -0.851 . . . . 75.04 109.442 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.484 ' OH ' ' CB ' ' A' ' 75' ' ' SER . 86.9 t80 -134.98 119.19 17.68 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.563 -0.902 . . . . 71.33 108.563 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.699 ' H ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -125.42 148.6 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 CA-C-O 121.701 0.762 . . . . 71.13 110.7 -178.191 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.51 133.77 49.07 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.822 -1.177 . . . . 64.32 107.822 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.682 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -53.67 -55.3 36.81 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 120.907 -1.12 . . . . 62.2 111.824 -178.794 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.5 Cg_endo -41.01 -10.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 120.943 1.095 . . . . 73.11 113.19 -175.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.682 ' N ' ' O ' ' A' ' 97' ' ' LYS . 56.8 m-85 58.99 118.89 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.661 -0.649 . . . . 65.22 109.802 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 46.7 mtt-85 -62.6 -41.68 99.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.824 -1.172 . . . . 72.35 109.528 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.762 ' O ' ' N ' ' A' ' 103' ' ' LYS . 44.5 t -165.92 31.13 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.0 -1.062 . . . . 71.32 110.75 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.3 mt 50.39 -70.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 118.588 0.631 . . . . 75.43 110.208 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.762 ' N ' ' O ' ' A' ' 101' ' ' SER . 9.1 mtpm? -53.47 -32.81 51.78 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.062 -1.088 . . . . 71.41 108.062 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.29 -52.13 60.09 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.439 -0.948 . . . . 63.24 108.439 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.0 tp -58.21 -41.4 83.96 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.518 -0.919 . . . . 73.22 108.518 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.539 HG11 ' HZ2' ' A' ' 23' ' ' LYS . 84.1 t -61.99 -37.37 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.25 -0.906 . . . . 60.11 108.669 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.4 -35.49 70.1 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.345 -0.847 . . . . 70.42 108.9 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.527 ' NE ' ' OE2' ' B' ' 83' ' ' GLU . 93.8 mtt180 -79.86 -26.76 40.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.371 -0.831 . . . . 74.41 109.974 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.9 mt -80.3 -38.52 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.053 -1.029 . . . . 62.54 109.476 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -72.72 -36.88 67.89 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.236 -0.915 . . . . 74.34 109.207 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.23 -46.46 83.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.341 -0.849 . . . . 73.32 109.226 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.99 -39.36 81.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 52.41 108.793 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.439 ' C ' HD23 ' A' ' 113' ' ' LEU . 3.7 tt -142.43 80.87 1.72 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.254 -0.904 . . . . 65.24 108.781 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.526 ' O ' ' CG ' ' A' ' 115' ' ' PHE . 86.2 mtm180 -65.88 -43.42 88.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 64.45 109.927 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.526 ' CG ' ' O ' ' A' ' 114' ' ' ARG . 96.3 m-85 -158.39 -84.98 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.159 -0.963 . . . . 74.43 109.581 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 83.7 t90 -154.16 154.12 33.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 74.42 109.442 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 158.17 65.72 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.443 -1.463 . . . . 75.04 109.443 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 83.0 p -156.76 96.9 1.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.296 -1.12 . . . . 61.14 109.48 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 128' ' ' ILE . 21.8 t-20 -154.69 174.22 15.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.296 -0.877 . . . . 65.24 109.314 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.489 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 4.2 t -142.59 -35.56 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.286 -0.884 . . . . 73.11 109.139 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 20.8 mm -104.7 126.45 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.338 -0.851 . . . . 72.24 109.179 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -139.53 120.99 15.07 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.361 -0.837 . . . . 72.34 109.336 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.4 ' O ' ' C ' ' A' ' 124' ' ' GLY . 10.2 pt -150.18 135.47 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.268 -0.895 . . . . 71.44 109.373 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 123' ' ' ILE . . . 43.87 -145.34 1.58 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.991 -1.244 . . . . 73.4 109.991 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -85.44 1.04 50.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -1.165 . . . . 74.45 109.274 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.45 131.42 38.66 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.39 -0.967 . . . . 54.21 108.39 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 51.3 m -131.08 133.79 46.0 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.437 -0.789 . . . . 54.5 109.62 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.518 ' O ' ' ND2' ' A' ' 119' ' ' ASN . 72.4 mt -131.95 133.81 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.473 -0.767 . . . . 45.15 109.147 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.505 ' OG ' ' ND2' ' A' ' 119' ' ' ASN . 70.9 m -119.73 85.01 32.41 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.651 -0.655 . . . . 71.11 109.581 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.43 -44.7 47.07 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.398 2.065 . . . . 65.41 111.886 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -61.81 -41.96 98.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 63.32 109.308 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -80.67 -8.16 59.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.301 -0.874 . . . . 72.52 108.78 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 56.24 59.75 3.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.417 -0.802 . . . . 75.33 109.552 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -155.85 134.63 11.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.206 -0.934 . . . . 71.23 109.62 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 97.6 mt -107.84 140.64 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.563 -0.711 . . . . 74.02 109.33 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.6 mp -128.35 122.15 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.397 -0.814 . . . . 60.23 109.613 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -138.69 140.23 38.71 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.814 -0.809 . . . . 62.32 108.814 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.418 ' HB3' ' HZ2' ' A' ' 138' ' ' LYS . 14.8 mtpp 54.12 25.51 5.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.434 -0.791 . . . . 75.4 110.055 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.01 -7.85 58.76 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.985 -1.246 . . . . 72.24 109.985 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -88.64 128.07 35.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.087 -1.243 . . . . 71.22 109.056 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -97.97 139.0 34.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.33 -0.856 . . . . 71.42 109.636 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 13.5 p -136.76 138.75 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.461 -0.774 . . . . 53.02 109.072 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -93.86 140.92 29.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.255 -0.903 . . . . 60.45 109.543 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.02 154.01 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.303 -0.873 . . . . 74.44 109.322 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -171.08 43.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.116 -0.99 . . . . 65.15 109.899 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -164.03 -110.53 0.24 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.555 -1.418 . . . . 73.34 109.555 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.622 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 23.2 mmtp -73.29 -35.54 2.76 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.255 -1.144 . . . . 72.22 110.479 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 95.3 Cg_endo -91.4 21.96 0.74 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.464 2.109 . . . . 65.23 112.011 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -129.33 -55.54 1.17 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.56 -0.713 . . . . 60.11 109.748 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -58.61 -58.09 10.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.161 -0.962 . . . . 64.21 110.552 -178.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.6 -33.27 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.954 -1.091 . . . . 72.02 109.672 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.499 HD23 ' HA ' ' A' ' 148' ' ' PRO . 3.4 mm? -63.12 -41.68 99.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.062 -1.024 . . . . 73.31 108.676 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.6 p -74.5 -32.18 62.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.252 -0.905 . . . . 74.31 109.943 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -58.16 -50.87 72.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.172 -0.955 . . . . 74.31 109.61 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.7 pp -76.08 -26.09 56.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 75.34 109.791 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.58 -45.98 77.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 62.14 109.325 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -76.59 -44.24 35.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.195 -0.941 . . . . 61.03 108.936 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -82.41 26.43 0.56 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.514 -0.741 . . . . 74.12 109.244 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -49.66 -29.93 8.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.377 -0.827 . . . . 71.13 109.855 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 160' ' ' ASP . 42.9 p30 -123.9 74.84 1.31 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.534 -0.728 . . . . 75.45 109.198 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 162' ' ' ILE . 13.8 tm0? -171.21 152.77 3.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.9 . . . . 73.41 109.517 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.511 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 71.4 mt -83.63 122.15 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.172 -0.955 . . . . 74.41 109.439 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.5 t -112.59 137.82 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.534 -0.729 . . . . 72.31 109.761 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 29.6 t -94.78 155.79 16.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.358 -0.839 . . . . 74.12 109.453 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.467 ' NZ ' ' CB ' ' A' ' 165' ' ' LYS . 8.7 mtpm? -56.92 -43.48 81.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 70.43 109.64 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -55.24 -37.14 66.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.923 . . . . 73.52 109.446 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -59.57 -41.91 91.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -0.939 . . . . 74.52 109.444 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 26.3 mt -63.65 -33.17 75.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.2 -0.938 . . . . 72.31 109.315 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.482 ' C ' HD23 ' A' ' 169' ' ' LEU . 5.6 tt -64.71 -55.61 18.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.298 -0.876 . . . . 53.33 109.589 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -71.63 -32.6 68.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.256 -0.902 . . . . 62.44 110.295 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.414 ' C ' HD12 ' A' ' 172' ' ' ILE . . . -58.52 -47.8 82.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.049 -1.032 . . . . 60.21 110.036 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.683 HD12 ' N ' ' A' ' 172' ' ' ILE . 1.9 mp -96.96 -65.17 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.2 -0.938 . . . . 75.32 108.85 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.422 -0.799 . . . . 73.14 109.394 -179.892 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 49.2 p-10 . . . . . 0 N--CA 1.497 1.88 0 N-CA-C 109.765 -0.457 . . . . 64.54 109.765 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.46 -4.18 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.38 -0.825 . . . . 74.02 109.759 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 184' ' ' ILE . 1.9 mp -66.33 -29.35 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.949 -1.095 . . . . 72.33 109.141 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -61.7 -42.83 99.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 74.4 109.611 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 19.0 m -79.54 -28.49 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.09 -1.006 . . . . 70.42 109.379 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.51 -42.17 65.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.864 . . . . 52.11 109.795 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.5 tp -74.94 -29.95 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.986 -1.071 . . . . 71.4 109.314 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 -70.64 -43.94 68.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.845 . . . . 73.44 110.099 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -75.56 -40.9 56.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.131 -0.981 . . . . 71.42 110.135 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 74.9 mt -60.47 -36.49 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.014 -1.054 . . . . 61.55 109.561 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 18.9 mtp-105 -71.38 -40.16 70.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.035 -1.041 . . . . 63.34 108.656 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -68.05 -35.2 77.84 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.577 -0.702 . . . . 61.24 109.133 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.411 ' O ' ' CD ' ' A' ' 198' ' ' PRO . 50.7 mtpt -85.19 -8.31 58.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.349 -0.844 . . . . 75.13 109.737 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 51.1 ttm -92.84 -57.21 2.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.185 -0.947 . . . . 74.02 109.559 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -59.12 -32.48 69.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 74.02 110.011 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.437 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 54.1 mttt -57.13 -65.64 1.64 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.035 -1.041 . . . . 75.43 109.847 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 42.4 Cg_endo -64.77 -57.99 0.25 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 122.306 2.004 . . . . 72.32 112.546 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 15.3 mt -61.15 -42.75 99.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -0.958 . . . . 74.54 109.963 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 86.62 -37.63 3.15 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.78 -1.328 . . . . 61.51 109.78 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.741 HD12 ' N ' ' A' ' 201' ' ' ILE . 1.7 mp -92.41 141.53 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.132 -1.217 . . . . 61.22 109.371 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 59.5 p -85.55 145.23 27.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.888 . . . . 72.0 109.274 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.1 p -146.59 27.25 1.11 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.253 -0.904 . . . . 74.44 109.485 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 204' ' ' VAL . 29.5 m -143.97 134.21 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.169 -0.957 . . . . 64.35 109.518 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -108.58 126.16 52.64 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.536 -0.727 . . . . 71.41 109.296 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.35 119.69 32.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.116 -0.99 . . . . 73.52 109.226 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 211' ' ' GLY . 34.9 m -147.82 140.74 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.224 -0.922 . . . . 71.02 109.616 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 75.1 ttt-85 -62.62 -25.51 68.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.85 . . . . 72.12 109.373 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 211' ' ' GLY . 76.1 mtt85 -47.17 103.92 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 64.41 109.786 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 60.51 -75.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.591 -0.693 . . . . 71.54 109.844 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . -158.41 -127.77 0.96 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.838 -1.305 . . . . 72.03 109.838 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -101.53 142.21 33.24 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.407 -1.054 . . . . 75.54 109.436 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -106.43 126.57 52.41 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.478 -0.764 . . . . 75.31 109.686 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -98.04 128.36 44.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.389 -0.82 . . . . 75.41 109.034 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 34.0 m -151.78 154.94 37.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.498 -0.751 . . . . 74.14 109.137 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' TYR . . . . . 0.45 ' O ' ' O ' ' A' ' 217' ' ' PRO . 7.4 p90 -65.14 153.14 89.95 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.153 -0.967 . . . . 75.32 109.279 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 216' ' ' TYR . 84.2 Cg_exo . . . . . 0 N--CA 1.493 1.479 0 C-N-CA 122.269 1.979 . . . . 73.11 112.408 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 52.5 ttm . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.487 -0.56 . . . . 71.14 109.487 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -139.87 148.78 42.56 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.303 -0.873 . . . . 73.23 109.354 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 93.6 t -113.91 137.71 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.583 -0.698 . . . . 72.24 109.452 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.499 HD11 ' CG1' ' B' ' 6' ' ' ILE . 3.5 tp -109.89 119.66 40.04 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.555 -0.716 . . . . 54.33 109.735 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.483 ' N ' HD12 ' B' ' 4' ' ' LEU . 15.3 mt -117.23 96.33 5.38 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 108.615 -0.883 . . . . 74.35 108.615 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.689 HD12 ' HB ' ' B' ' 50' ' ' VAL . 87.2 mt -82.93 98.88 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.703 -1.248 . . . . 42.55 109.049 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.425 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 38.8 tp10 -130.78 129.72 42.8 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.506 -0.746 . . . . 74.52 109.556 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -64.96 -38.96 92.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.314 -0.866 . . . . 62.55 109.332 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -83.8 116.63 22.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 73.11 109.471 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 23.4 m -66.73 -27.01 67.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.9 . . . . 65.54 109.795 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -66.99 -51.56 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.15 -0.969 . . . . 75.55 109.844 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.538 ' N ' HD12 ' B' ' 12' ' ' LEU . 7.9 mp -62.96 -39.07 93.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.172 -0.955 . . . . 70.14 109.62 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.05 -29.34 64.9 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 108.551 -1.82 . . . . 75.4 108.551 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.91 -49.84 68.9 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.674 -1.37 . . . . 65.44 109.674 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -61.96 -46.98 86.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.309 -1.112 . . . . 60.21 109.786 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.556 HD11 ' CD1' ' B' ' 99' ' ' TYR . 5.7 mm -63.98 -40.14 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.757 -1.214 . . . . 75.15 108.632 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.505 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 73.1 tt0 -63.07 -44.27 96.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.412 -0.805 . . . . 73.01 109.554 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -85.53 1.55 48.49 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.071 -1.018 . . . . 74.3 109.588 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.93 -57.3 1.94 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.376 -1.49 . . . . 70.54 109.376 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.417 HD23 ' N ' ' B' ' 21' ' ' ASN . 1.4 pt? -71.31 -20.85 62.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.424 -1.044 . . . . 71.34 109.648 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 89.6 m-20 -57.98 -30.81 66.33 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.992 -1.067 . . . . 64.41 109.278 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 92.9 t -59.05 -37.3 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.344 -0.847 . . . . 74.23 109.142 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -65.52 -21.4 66.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.371 -0.83 . . . . 63.42 109.398 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.32 39.87 2.52 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 110.11 -1.196 . . . . 53.43 110.11 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -120.2 160.98 21.85 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.474 -1.015 . . . . 71.12 109.208 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 3.8 mtt -100.45 139.84 35.56 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.262 -1.014 . . . . 75.24 108.262 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.43 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -143.95 154.45 43.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.225 -0.922 . . . . 72.12 110.37 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 28' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 96.9 m-20 -138.87 155.01 48.44 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.173 -1.047 . . . . 72.31 108.173 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.43 139.74 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.338 -0.851 . . . . 64.43 109.985 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.5 p -130.47 171.08 13.38 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 109.144 -0.687 . . . . 65.41 109.144 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.42 ' OE2' ' OD2' ' B' ' 35' ' ' ASP . 5.4 pt-20 -91.69 -106.11 0.1 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.178 -0.951 . . . . 71.02 109.873 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 77.7 p -78.11 166.94 22.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.223 -0.923 . . . . 51.11 110.073 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 53.5 mt -51.34 -30.86 19.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.586 -0.696 . . . . 71.24 109.945 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.87 -51.01 65.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.092 -1.005 . . . . 74.32 109.885 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.42 ' OD2' ' OE2' ' B' ' 31' ' ' GLU . 2.3 m-20 -63.58 -39.44 94.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.121 -0.987 . . . . 73.03 109.264 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.81 -38.4 76.15 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.253 -1.539 . . . . 30.21 109.253 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -67.18 -38.36 85.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -1.113 . . . . 74.42 109.573 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -80.52 -36.93 32.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.155 -0.965 . . . . 74.42 109.661 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 10.5 tp -71.29 -42.67 68.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 75.41 110.091 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' MET . . . . . 0.443 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.3 ppp? -67.54 -25.26 65.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.039 -1.038 . . . . 60.41 109.977 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -60.62 -39.84 89.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.046 -1.034 . . . . 53.23 110.161 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 14.7 pt -81.21 -32.01 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.006 -1.059 . . . . 71.23 110.202 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' B' ' 40' ' ' MET . 25.2 mmt180 -130.28 141.52 50.6 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.297 -0.877 . . . . 72.22 109.548 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' ASN . . . . . 0.553 HD21 HD11 ' B' ' 69' ' ' ILE . 58.3 t30 -98.48 132.71 43.7 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.28 -0.887 . . . . 63.54 109.437 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -102.37 138.28 39.51 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.353 -0.842 . . . . 64.35 109.513 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -75.82 -34.5 60.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 62.22 109.189 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.497 HD13 ' C ' ' B' ' 47' ' ' LEU . 0.8 OUTLIER -112.38 110.59 20.89 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.645 -0.872 . . . . 73.12 108.645 179.662 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.449 ' N ' HD13 ' B' ' 47' ' ' LEU . 54.5 t -95.52 100.85 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.369 -0.832 . . . . 65.11 109.124 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.509 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 0.6 OUTLIER -114.93 129.54 56.73 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.2 -0.667 . . . . 73.44 109.2 -179.659 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.689 ' HB ' HD12 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -144.69 132.29 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.457 -0.777 . . . . 34.5 109.233 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 51' ' ' SER . . . . . 0.425 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 24.9 p -94.57 11.57 30.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.392 -0.818 . . . . 73.21 109.662 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.608 ' H ' HG22 ' B' ' 50' ' ' VAL . 35.9 m-20 -80.61 138.65 36.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.147 -0.971 . . . . 70.41 109.515 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.439 ' C ' ' H ' ' B' ' 55' ' ' ALA . 62.3 mttp -74.92 -38.53 61.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.206 -0.934 . . . . 65.0 110.029 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -71.03 9.9 0.64 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.171 -0.955 . . . . 75.21 109.619 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -66.4 -21.77 66.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 55.33 110.134 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 33.3 mt -42.82 -40.16 2.77 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.397 -0.814 . . . . 63.14 110.33 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 13.0 t -76.32 -39.97 52.64 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.946 -1.096 . . . . 63.5 109.563 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -65.1 -43.14 93.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.332 -0.855 . . . . 72.33 110.307 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.42 HG23 ' N ' ' B' ' 60' ' ' SER . 34.3 m -67.37 -37.62 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.697 -1.252 . . . . 74.54 109.509 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 60' ' ' SER . . . . . 0.42 ' N ' HG23 ' B' ' 59' ' ' VAL . 40.4 m -55.24 -48.66 73.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 71.24 109.439 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.405 HH21 ' NZ ' ' B' ' 65' ' ' LYS . 13.3 ptm180 -69.57 -34.41 74.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.115 -0.99 . . . . 74.31 110.134 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' B' ' 66' ' ' HIS . 5.4 mm -64.52 -40.33 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.785 -1.197 . . . . 72.14 109.8 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.521 ' NZ ' ' OD1' ' B' ' 92' ' ' ASP . 44.4 mmtt -65.44 -48.81 71.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.157 -0.964 . . . . 73.32 110.459 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -73.01 -37.54 66.92 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.841 -1.162 . . . . 73.12 110.035 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.47 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 46.4 mtpt -80.22 -22.04 42.22 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.11 -0.994 . . . . 72.44 109.757 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.47 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 81.6 m-70 -155.68 65.92 0.61 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.136 -0.977 . . . . 63.31 109.623 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 9.7 t -60.44 -27.78 67.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 73.1 109.793 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 84.4 p -65.27 -24.82 67.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -0.92 . . . . 71.53 110.169 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.553 HD11 HD21 ' B' ' 44' ' ' ASN . 79.9 mt -79.81 152.89 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.103 -0.998 . . . . 74.4 109.677 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.469 HG12 ' N ' ' B' ' 71' ' ' VAL . 69.4 t -92.44 159.44 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.287 -0.883 . . . . 75.12 109.468 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.469 ' N ' HG12 ' B' ' 70' ' ' VAL . 11.7 t -137.96 120.92 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.184 -0.947 . . . . 73.2 109.877 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.509 ' O ' ' SD ' ' B' ' 49' ' ' MET . 0.7 OUTLIER -111.04 105.12 13.77 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.16 -1.052 . . . . 73.34 108.16 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 94.6 t -95.68 131.9 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.107 -0.996 . . . . 73.5 109.535 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.08 162.38 13.42 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.434 -0.791 . . . . 64.34 109.103 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.495 ' CB ' ' HH ' ' B' ' 94' ' ' TYR . 25.1 p -153.92 136.64 15.24 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.96 -1.087 . . . . 74.53 110.646 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -90.43 4.42 51.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.372 -0.83 . . . . 64.5 109.119 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 77' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' B' ' 79' ' ' THR . 23.7 m120 -142.31 68.5 21.52 Favored Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 108.663 -0.865 . . . . 74.25 108.663 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -54.71 79.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.347 2.031 . . . . 74.43 111.235 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.503 ' N ' ' O ' ' B' ' 77' ' ' ASN . 37.2 p -103.28 152.49 21.46 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.053 -0.721 . . . . 73.12 109.053 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -31.4 71.42 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.262 -0.899 . . . . 71.01 109.387 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -63.34 -48.24 78.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 63.2 109.493 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -71.7 -27.11 62.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 73.22 109.372 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.527 ' OE2' ' NE ' ' A' ' 108' ' ' ARG . 86.9 tt0 -63.03 -55.6 24.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.883 . . . . 74.3 109.887 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.401 HG23 ' N ' ' B' ' 85' ' ' HIS . 22.9 m -61.93 -40.29 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.058 -1.026 . . . . 73.31 109.423 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 85' ' ' HIS . . . . . 0.401 ' N ' HG23 ' B' ' 84' ' ' VAL . 21.5 m170 -64.71 -31.69 73.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.166 -0.959 . . . . 73.24 109.483 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.48 -45.87 81.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.918 . . . . 55.33 110.256 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -79.87 -34.51 39.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.031 -1.043 . . . . 74.14 109.433 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -70.78 -40.33 72.66 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.248 -0.908 . . . . 64.04 109.57 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -65.12 -52.16 57.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -0.965 . . . . 72.35 109.412 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.24 59.43 0.02 OUTLIER Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.188 -1.165 . . . . 65.2 110.188 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.88 136.18 53.62 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.435 -1.039 . . . . 52.23 109.075 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.521 ' OD1' ' NZ ' ' B' ' 63' ' ' LYS . 24.6 m-20 -82.16 -20.8 37.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.09 -1.006 . . . . 73.32 109.525 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -153.3 164.6 37.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 72.22 109.655 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.495 ' HH ' ' CB ' ' B' ' 75' ' ' SER . 76.1 t80 -145.14 97.26 2.98 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.745 -0.835 . . . . 64.42 108.745 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 0.4 HD12 ' NH1' ' B' ' 108' ' ' ARG . 19.0 mm -104.73 142.01 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 121.163 -0.961 . . . . 72.23 109.928 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 96' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' B' ' 97' ' ' LYS . . . -60.74 124.29 19.99 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.467 -1.308 . . . . 25.24 107.467 178.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' B' ' 99' ' ' TYR . 2.1 tptt -43.35 -61.04 2.03 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.058 -1.026 . . . . 64.32 110.726 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 98' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 9.3 Cg_endo -45.02 89.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 120.566 0.844 . . . . 63.33 110.489 -176.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 99' ' ' TYR . . . . . 0.582 ' N ' ' O ' ' B' ' 97' ' ' LYS . 45.4 m-85 -39.75 97.76 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.229 0.537 . . . . 75.13 111.128 -176.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -53.27 -33.43 53.11 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.521 -1.288 . . . . 74.23 107.521 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 32.5 t -176.18 128.03 0.21 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.274 -1.01 . . . . 63.34 108.274 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 19.6 mm -51.68 -36.22 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.017 -1.052 . . . . 74.44 108.903 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.518 ' O ' ' HB2' ' B' ' 107' ' ' ALA . 11.8 mptt -67.23 -34.47 77.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.358 -0.839 . . . . 71.11 109.407 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.53 -58.72 3.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.241 -0.912 . . . . 71.45 109.771 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.702 HD13 ' C ' ' B' ' 105' ' ' LEU . 1.9 tm? -54.46 -53.33 55.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 51.31 109.275 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 106' ' ' VAL . . . . . 0.475 ' N ' HD13 ' B' ' 105' ' ' LEU . 88.3 t -61.62 -42.47 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.987 -1.071 . . . . 65.23 109.37 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 107' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' B' ' 103' ' ' LYS . . . -51.82 -38.28 55.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.137 -0.977 . . . . 24.32 108.907 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 108' ' ' ARG . . . . . 0.4 ' NH1' HD12 ' B' ' 95' ' ' ILE . 80.7 mtt180 -70.25 -34.7 73.14 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.354 -0.841 . . . . 75.31 109.441 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 86.3 mt -75.93 -26.59 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.14 -0.975 . . . . 54.24 108.788 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -76.6 -57.78 3.66 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.458 -0.776 . . . . 65.31 109.618 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.51 -44.84 73.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 72.24 109.961 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -59.83 4.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.113 -0.992 . . . . 72.04 109.646 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 30.4 tp -60.61 -35.52 76.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.11 -0.994 . . . . 75.35 109.763 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.45 ' O ' ' CB ' ' B' ' 115' ' ' PHE . 14.1 mmt180 -53.62 160.3 1.33 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.073 -1.017 . . . . 75.5 109.252 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 115' ' ' PHE . . . . . 0.45 ' CB ' ' O ' ' B' ' 114' ' ' ARG . 4.9 t80 75.6 -4.15 2.43 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.519 -0.738 . . . . 65.33 109.535 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER 54.26 -171.76 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 74.45 109.773 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -92.92 5.1 75.9 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.487 -1.445 . . . . 44.21 109.487 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 11.8 t 49.57 -174.33 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.492 -1.005 . . . . 71.4 109.854 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.73 141.74 23.0 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.424 -0.797 . . . . 72.32 109.336 -178.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 23.8 t -86.87 -44.11 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.187 -0.945 . . . . 75.02 109.854 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 3.6 mm -117.5 154.37 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.238 -0.914 . . . . 51.41 109.434 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -143.62 130.85 20.8 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.325 -0.859 . . . . 71.53 109.049 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 17.8 mt -135.47 108.33 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.18 -0.95 . . . . 72.43 109.896 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 124' ' ' GLY . . . . . 0.457 ' C ' ' H ' ' B' ' 126' ' ' LEU . . . 56.02 -155.41 12.58 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.229 -1.148 . . . . 51.23 110.229 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.99 -0.56 0.52 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.477 -1.013 . . . . 74.2 109.644 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.457 ' H ' ' C ' ' B' ' 124' ' ' GLY . 1.7 mt -94.22 148.6 22.04 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.237 -0.914 . . . . 75.42 109.405 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 7.0 m -126.33 132.33 51.64 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.109 -1.071 . . . . 74.22 108.109 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 88.8 mt -121.05 131.03 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.348 -0.845 . . . . 60.33 110.69 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 64.9 m -128.86 101.84 19.86 Favored Pre-proline 0 N--CA 1.495 1.824 0 N-CA-C 108.858 -0.793 . . . . 72.31 108.858 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -81.87 -40.32 0.15 Allowed 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.092 1.862 . . . . 75.13 111.918 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -52.97 -33.4 51.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.132 -0.98 . . . . 75.23 108.881 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -104.39 4.02 32.94 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.504 -0.747 . . . . 72.43 109.499 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 133' ' ' GLU . . . . . 0.433 ' OE1' ' CD2' ' B' ' 149' ' ' PHE . 49.0 mm-40 49.77 59.58 4.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.124 -0.985 . . . . 75.13 109.3 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 134' ' ' LYS . . . . . 0.686 ' C ' HD12 ' B' ' 135' ' ' ILE . 33.6 ttmt -151.51 145.46 25.2 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.223 -0.923 . . . . 73.22 109.726 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 135' ' ' ILE . . . . . 0.686 HD12 ' C ' ' B' ' 134' ' ' LYS . 4.5 mp -137.81 133.49 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 108.782 -0.821 . . . . 64.14 108.782 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 4.7 mm -107.18 137.1 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.533 -0.73 . . . . 71.22 109.606 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -126.04 130.97 52.2 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.181 -1.044 . . . . 64.22 108.181 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 138' ' ' LYS . . . . . 0.651 ' NZ ' ' HE ' ' B' ' 140' ' ' ARG . 23.3 ttpp 55.36 14.92 1.21 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.499 -0.751 . . . . 72.02 109.762 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.91 -0.11 66.74 Favored Glycine 0 N--CA 1.496 2.684 0 O-C-N 120.927 -1.108 . . . . 74.32 110.505 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 140' ' ' ARG . . . . . 0.651 ' HE ' ' NZ ' ' B' ' 138' ' ' LYS . 17.5 mtt-85 -89.94 137.27 32.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.208 -1.172 . . . . 75.34 108.449 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -82.94 126.98 33.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 71.23 110.419 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 39.9 t -126.81 128.81 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.912 -0.773 . . . . 70.43 108.912 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -94.2 147.28 23.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.978 -1.076 . . . . 72.43 109.228 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 144' ' ' VAL . . . . . 0.852 ' H ' ' HZ2' ' B' ' 145' ' ' LYS . 2.4 t -142.16 115.41 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.217 -0.927 . . . . 72.13 108.95 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 145' ' ' LYS . . . . . 0.852 ' HZ2' ' H ' ' B' ' 144' ' ' VAL . 0.1 OUTLIER -145.28 140.17 27.62 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.278 -0.888 . . . . 72.02 109.742 179.886 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 111.54 -114.39 3.62 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 110.666 -0.973 . . . . 42.23 110.666 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 147' ' ' LYS . . . . . 0.615 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 6.6 ttpm? -95.34 -29.82 0.27 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.57 -0.959 . . . . 73.3 112.42 -178.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 148' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 57.0 Cg_endo -80.47 -17.78 9.92 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 C-N-CA 121.482 1.455 . . . . 71.33 113.0 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 149' ' ' PHE . . . . . 0.433 ' CD2' ' OE1' ' B' ' 133' ' ' GLU . 1.1 p90 -85.54 -37.85 19.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.93 -1.107 . . . . 74.23 109.215 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 150' ' ' GLU . . . . . 0.426 ' N ' ' CG ' ' B' ' 149' ' ' PHE . 3.3 tm-20 -60.34 -46.7 88.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.533 -0.729 . . . . 72.34 109.974 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.428 HG13 ' N ' ' B' ' 152' ' ' LEU . 8.8 p -68.89 -40.65 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.864 -1.148 . . . . 73.35 110.102 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.497 ' C ' HD23 ' B' ' 152' ' ' LEU . 4.7 tt -66.65 -54.91 18.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.296 -0.877 . . . . 55.24 109.679 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 16.0 p -64.76 -32.44 74.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.004 -1.06 . . . . 70.01 110.555 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -59.2 -59.58 5.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.947 -1.095 . . . . 65.32 109.927 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 155' ' ' LEU . . . . . 0.81 HD13 ' CE2' ' B' ' 214' ' ' PHE . 1.9 pp -69.3 -21.48 63.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.028 -1.045 . . . . 71.54 109.946 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.89 -52.98 61.9 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.014 -1.054 . . . . 75.32 109.334 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 157' ' ' ARG . . . . . 0.458 ' C ' ' H ' ' B' ' 159' ' ' ARG . 16.5 mtm-85 -71.95 -51.62 21.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.18 -0.95 . . . . 73.32 109.79 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -74.79 36.19 0.11 Allowed 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.725 -0.79 . . . . 74.14 109.506 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 159' ' ' ARG . . . . . 0.458 ' H ' ' C ' ' B' ' 157' ' ' ARG . 30.2 ptt180 -59.91 166.05 2.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -0.86 . . . . 61.41 109.179 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 24.9 t70 43.66 64.24 1.32 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.253 -0.904 . . . . 72.1 109.88 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -157.3 159.21 37.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -0.965 . . . . 72.25 109.567 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 30.6 mt -93.77 114.02 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.218 -0.926 . . . . 72.31 109.139 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 4.0 m -115.13 129.78 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 121.527 0.679 . . . . 64.21 109.511 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 164' ' ' SER . . . . . 0.516 ' OG ' ' NE2' ' B' ' 167' ' ' GLN . 28.7 p -92.39 167.31 12.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -0.871 . . . . 74.22 109.125 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -51.69 -37.07 49.12 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.111 -0.993 . . . . 65.31 109.297 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -74.57 -25.46 59.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.146 -0.971 . . . . 63.45 110.559 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 167' ' ' GLN . . . . . 0.516 ' NE2' ' OG ' ' B' ' 164' ' ' SER . 0.0 OUTLIER -64.04 -56.14 17.17 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.618 -1.301 . . . . 72.4 108.792 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 47.1 mt -57.42 -57.21 13.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.102 -0.999 . . . . 72.32 108.916 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' B' ' 170' ' ' ASP . 1.9 mm? -50.55 -56.01 13.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.045 -1.034 . . . . 73.34 108.846 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 170' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' B' ' 169' ' ' LEU . 67.8 m-20 -41.69 -34.16 0.58 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.74 -0.6 . . . . 72.1 110.615 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -91.69 -37.72 12.86 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.102 -0.999 . . . . 62.13 110.729 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 0.429 ' N ' HD12 ' B' ' 172' ' ' ILE . 3.7 mp -88.09 -68.41 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.893 -1.129 . . . . 71.42 109.442 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 173' ' ' TRP . . . . . 0.476 ' C ' ' CD2' ' B' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.505 -0.747 . . . . 72.23 109.47 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo . . . . . 0 N--CA 1.491 1.371 0 CA-C-O 121.15 0.396 . . . . 65.22 111.874 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 182' ' ' ASN . . . . . 0.813 ' OD1' ' OE2' ' B' ' 185' ' ' GLU . 45.5 t-20 49.33 60.9 3.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.136 -0.978 . . . . 72.31 110.006 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 4.1 p -119.09 4.65 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 108.994 -0.743 . . . . 63.32 108.994 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.562 ' O ' HG22 ' B' ' 188' ' ' ILE . 35.2 mt -63.62 -53.53 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.058 -1.026 . . . . 75.03 109.914 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 185' ' ' GLU . . . . . 0.813 ' OE2' ' OD1' ' B' ' 182' ' ' ASN . 1.5 pm0 -61.5 -40.43 94.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 64.11 110.313 -178.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 97.2 t -73.99 -48.03 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.995 -1.066 . . . . 73.0 110.404 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -68.91 -47.27 66.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.059 -1.026 . . . . 61.12 110.704 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 188' ' ' ILE . . . . . 0.562 HG22 ' O ' ' B' ' 184' ' ' ILE . 7.5 tt -70.0 -36.6 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.741 -1.224 . . . . 72.43 110.917 -178.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -65.42 -47.61 75.65 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.945 -1.097 . . . . 65.14 109.144 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 190' ' ' GLN . . . . . 0.717 ' HB3' ' HZ3' ' B' ' 194' ' ' LYS . 35.9 mm-40 -66.58 -46.29 76.46 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.229 -0.92 . . . . 63.24 110.023 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 65.1 mt -54.45 -42.0 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.825 -1.172 . . . . 74.03 109.684 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 192' ' ' ARG . . . . . 0.413 ' CZ ' HG21 ' B' ' 206' ' ' THR . 24.1 mtp180 -59.94 -45.52 92.36 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.236 -0.915 . . . . 72.24 109.922 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -75.44 -32.86 60.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.223 -0.923 . . . . 73.1 110.159 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 194' ' ' LYS . . . . . 0.717 ' HZ3' ' HB3' ' B' ' 190' ' ' GLN . 39.1 mttp -71.84 -24.52 61.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.347 -0.846 . . . . 72.11 110.002 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 11.2 mtt -94.84 -12.14 27.53 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.036 -1.04 . . . . 44.33 109.473 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -102.03 -7.12 22.61 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.328 -0.857 . . . . 71.21 110.522 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 197' ' ' LYS . . . . . 0.457 ' N ' ' CD ' ' B' ' 198' ' ' PRO . 1.3 mmtt -95.77 -49.44 0.25 Allowed Pre-proline 0 N--CA 1.501 2.125 0 O-C-N 120.784 -1.198 . . . . 75.21 110.351 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 198' ' ' PRO . . . . . 0.509 ' CD ' ' O ' ' B' ' 194' ' ' LYS . 89.0 Cg_endo -83.97 -38.53 0.13 Allowed 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.279 1.986 . . . . 75.32 113.672 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 11.2 mt -75.73 -46.42 31.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.836 -1.165 . . . . 72.25 109.648 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 88.15 0.78 82.6 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.663 -1.775 . . . . 64.53 108.663 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 38.4 mt -125.53 125.62 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.583 -0.951 . . . . 44.23 109.296 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 27.3 p -85.78 137.16 32.99 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.836 -1.172 . . . . 54.01 107.836 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 67.7 p -137.98 11.73 2.86 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.109 -0.994 . . . . 74.4 110.125 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.46 128.37 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.304 -0.873 . . . . 72.12 109.407 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -90.85 109.41 20.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.465 -0.772 . . . . 65.41 108.922 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 206' ' ' THR . . . . . 0.413 HG21 ' CZ ' ' B' ' 192' ' ' ARG . 43.9 p -85.35 126.44 33.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.445 -0.784 . . . . 71.33 109.074 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 9.9 p -152.5 159.85 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.13 -0.982 . . . . 63.5 109.675 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -85.28 -38.97 18.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.154 -0.966 . . . . 74.45 109.914 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 209' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' B' ' 211' ' ' GLY . 80.5 mtm180 -55.85 150.69 12.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.021 -1.05 . . . . 74.14 109.512 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? 51.59 -90.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.215 -0.928 . . . . 74.43 108.805 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 211' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' B' ' 209' ' ' ARG . . . -171.79 -108.51 0.21 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.801 -1.719 . . . . 64.45 108.801 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 212' ' ' TYR . . . . . 0.474 ' CE1' HD13 ' B' ' 188' ' ' ILE . 72.0 m-85 -119.17 140.56 49.97 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.578 -0.954 . . . . 74.21 108.759 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -124.36 126.19 45.56 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.58 0.705 . . . . 74.03 110.106 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 214' ' ' PHE . . . . . 0.81 ' CE2' HD13 ' B' ' 155' ' ' LEU . 24.3 t80 -92.11 133.18 36.0 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.854 -0.795 . . . . 74.34 108.854 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 2.6 p -147.1 166.34 27.2 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.987 -1.071 . . . . 64.33 109.706 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -72.44 151.23 91.8 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.222 -0.924 . . . . 70.04 108.654 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.07 160.92 46.57 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.157 1.905 . . . . 65.11 111.718 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 22.0 mttm . . . . . 0 C--N 1.303 -1.445 0 O-C-N 121.276 -0.89 . . . . 73.15 109.335 179.955 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptp . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.451 -0.574 . . . . 65.12 109.451 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -141.68 160.18 40.7 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.299 -0.875 . . . . 72.33 109.453 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.4 t -118.34 125.35 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.169 -0.678 . . . . 71.42 109.169 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.405 ' O ' ' O ' ' A' ' 49' ' ' MET . 4.8 tp -99.31 115.1 28.39 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.497 -0.752 . . . . 65.12 109.212 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.0 tp -119.68 110.08 16.4 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.337 -0.986 . . . . 62.43 108.337 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.435 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 16.9 mt -92.73 109.18 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.899 -1.125 . . . . 71.15 109.595 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -152.54 120.09 6.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.166 -0.959 . . . . 75.34 109.673 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -65.16 -38.46 90.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 72.44 109.451 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -67.66 106.16 2.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 63.02 109.567 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 91.0 p -66.64 -26.33 67.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.316 -0.865 . . . . 72.34 109.551 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.64 -53.68 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.158 -0.964 . . . . 74.02 109.691 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.524 HD12 ' N ' ' A' ' 12' ' ' LEU . 7.9 mp -65.18 -36.45 84.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 71.43 109.552 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.92 -27.49 64.49 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.54 -1.824 . . . . 61.32 108.54 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.04 -49.72 61.09 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.441 -1.464 . . . . 71.2 109.441 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -61.59 -44.86 96.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -1.138 . . . . 71.32 109.55 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.5 mm -63.64 -39.08 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.743 -1.223 . . . . 63.23 108.281 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -64.42 -52.12 59.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.499 -0.75 . . . . 51.11 109.975 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -77.72 -2.77 37.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 73.34 109.566 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.42 -49.94 3.99 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 108.989 -1.644 . . . . 62.15 108.989 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pp -75.7 -28.96 58.83 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.433 -1.039 . . . . 73.51 109.234 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -51.65 -34.32 37.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.202 -0.936 . . . . 74.25 108.815 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.0 t -54.76 -47.38 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.523 -0.917 . . . . 70.04 108.523 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -54.35 -54.81 35.44 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.23 -1.026 . . . . 73.23 108.23 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 130.74 40.42 0.24 Allowed Glycine 0 N--CA 1.499 2.847 0 N-CA-C 110.636 -0.986 . . . . 75.54 110.636 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -118.91 159.67 23.37 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.19 -1.183 . . . . 73.43 108.694 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 11.7 mmt -97.65 138.35 35.18 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.211 -1.033 . . . . 43.24 108.211 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.95 160.12 40.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 62.11 109.784 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -142.03 151.55 42.53 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.781 -0.822 . . . . 74.42 108.781 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 t -106.03 134.7 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.706 -0.85 . . . . 72.15 108.706 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.3 p -129.7 163.46 26.09 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.517 -0.739 . . . . 71.42 109.356 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.435 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 2.8 pt-20 -92.22 -97.46 0.13 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.317 -0.865 . . . . 72.33 109.69 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.3 p -78.26 166.38 22.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 74.24 110.071 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.4 mt -55.02 -38.06 67.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.601 -0.687 . . . . 71.53 110.028 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -53.47 -43.22 67.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.168 -0.957 . . . . 74.23 110.061 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -63.92 -37.7 88.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.026 -1.046 . . . . 54.03 109.595 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.24 -45.72 11.09 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.914 -1.274 . . . . 61.41 109.914 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -61.82 -36.88 82.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -1.137 . . . . 74.34 109.88 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.443 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 64.6 t80 -80.07 -26.21 39.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.901 . . . . 75.33 110.249 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.8 tp -86.63 -32.57 20.51 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.031 -1.043 . . . . 74.33 110.223 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.485 ' SD ' ' OH ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -83.16 -34.12 26.07 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.088 -1.008 . . . . 70.32 110.79 -178.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 35.2 p-10 -57.7 -30.43 65.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.035 -1.041 . . . . 71.22 110.529 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.53 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 7.9 pt -85.03 -38.22 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.864 -1.148 . . . . 74.14 110.485 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.436 ' O ' ' O ' ' A' ' 40' ' ' MET . 97.8 mtt180 -101.52 162.58 12.79 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.105 -0.997 . . . . 72.24 110.046 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -92.39 144.51 25.3 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.336 -0.853 . . . . 75.42 108.992 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 3.5 p90 -142.13 179.94 6.61 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.151 -0.968 . . . . 74.23 109.732 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -143.16 -32.39 0.47 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.321 -0.862 . . . . 72.04 109.767 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.476 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.2 OUTLIER -108.24 113.31 26.32 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.345 -0.847 . . . . 72.13 109.086 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.476 ' N ' HD13 ' A' ' 47' ' ' LEU . 65.0 t -101.27 99.54 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.797 -0.816 . . . . 72.34 108.797 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.405 ' O ' ' O ' ' A' ' 4' ' ' LEU . 26.5 ttt -114.55 132.24 56.39 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.561 0.696 . . . . 74.11 109.567 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.466 HG21 ' HB2' ' A' ' 55' ' ' ALA . 0.8 OUTLIER -142.12 136.05 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.382 -0.824 . . . . 61.12 109.69 -179.046 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.8 t -102.06 1.25 36.2 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.478 -0.764 . . . . 73.11 109.772 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -76.07 145.99 39.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.103 -0.998 . . . . 52.55 109.713 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.409 ' C ' ' H ' ' A' ' 55' ' ' ALA . 29.2 mmtp -78.01 -46.46 20.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.25 -0.906 . . . . 44.22 110.204 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -59.98 -4.63 0.79 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.154 -0.966 . . . . 70.44 109.908 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.466 ' HB2' HG21 ' A' ' 50' ' ' VAL . . . -62.92 -23.01 67.17 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.226 -0.921 . . . . 64.14 110.139 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 55' ' ' ALA . 14.5 mt -39.98 -54.56 2.19 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.603 -0.686 . . . . 44.14 110.71 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.6 p -68.39 -31.83 71.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.734 -1.229 . . . . 55.23 109.254 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.458 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 66.5 t80 -65.74 -46.99 76.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.395 -0.816 . . . . 74.44 110.242 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.8 m -63.06 -35.09 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.706 -1.246 . . . . 74.03 109.467 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 60.8 m -57.09 -51.33 69.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.18 -0.95 . . . . 64.3 109.419 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.402 ' HG2' ' H ' ' A' ' 61' ' ' ARG . 11.7 ptm180 -67.64 -34.48 77.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.125 -0.984 . . . . 64.44 110.019 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.458 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 4.8 mm -63.32 -28.46 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.839 -1.163 . . . . 63.21 109.455 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.477 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 30.8 mmtt -75.4 -57.86 3.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.074 -1.017 . . . . 74.42 109.784 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -62.37 -33.24 74.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.897 -1.127 . . . . 70.32 109.73 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 8.3 mtpm? -85.42 -18.66 32.99 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.18 -0.95 . . . . 75.22 109.844 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.523 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 98.7 m-70 -157.61 65.97 0.48 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.027 -1.046 . . . . 74.13 109.606 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.6 m -66.12 -24.12 66.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.286 -0.884 . . . . 73.24 110.023 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.429 ' HG ' ' HZ1' ' A' ' 145' ' ' LYS . 86.8 p -68.11 -21.47 64.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.154 -0.966 . . . . 61.01 110.427 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.432 HD13 ' CE2' ' A' ' 45' ' ' TYR . 58.3 mt -88.43 153.37 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.102 -0.998 . . . . 71.33 109.635 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 71' ' ' VAL . 63.9 t -91.11 158.96 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.135 -0.978 . . . . 72.13 110.189 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.484 ' N ' HG12 ' A' ' 70' ' ' VAL . 24.8 t -132.44 125.31 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.397 -0.814 . . . . 54.21 109.759 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.492 HD23 ' C ' ' A' ' 72' ' ' LEU . 4.5 tt -118.34 101.91 8.55 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.491 -0.756 . . . . 50.24 109.125 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.0 t -91.61 137.21 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.189 -0.944 . . . . 74.41 109.707 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.8 156.55 19.51 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.492 -0.929 . . . . 72.31 108.492 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 97' ' ' LYS . 27.9 t -153.66 132.25 12.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.04 -1.037 . . . . 64.54 109.786 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -89.44 3.26 52.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.386 -0.821 . . . . 74.13 108.904 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 79' ' ' THR . 2.5 p-10 -138.52 56.48 10.05 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.528 -0.733 . . . . 73.34 109.048 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -49.92 87.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.322 2.015 . . . . 63.22 111.339 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 77' ' ' ASN . 21.2 m -110.22 152.59 25.91 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.091 -0.707 . . . . 62.53 109.091 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.39 -34.24 64.19 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.43 -0.794 . . . . 73.44 109.755 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -65.15 -52.5 54.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 71.42 110.103 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -60.71 -33.34 72.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 73.43 109.824 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -64.04 -46.0 86.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 74.22 109.721 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.8 t -57.22 -46.73 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 73.2 109.758 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -68.12 -29.37 68.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 53.33 109.65 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.42 -43.43 96.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.149 -0.969 . . . . 64.11 109.993 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -83.86 -34.52 24.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.127 -0.983 . . . . 74.34 109.579 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -65.79 -46.07 80.06 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.309 -0.869 . . . . 74.42 108.772 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -63.43 -53.11 57.4 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.678 -0.639 . . . . 74.24 109.522 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 141.07 61.33 0.03 OUTLIER Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.247 -1.141 . . . . 61.51 110.247 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -110.84 132.32 54.3 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.377 -1.073 . . . . 55.33 109.026 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.477 ' OD1' ' NZ ' ' A' ' 63' ' ' LYS . 35.9 m-20 -85.31 -19.32 31.69 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.047 -1.033 . . . . 73.42 109.01 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.448 ' OD2' ' CZ ' ' A' ' 112' ' ' ARG . 60.0 m-20 -152.14 162.66 40.78 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.82 -0.808 . . . . 75.04 108.82 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.433 ' OH ' ' CB ' ' A' ' 75' ' ' SER . 87.4 t80 -150.56 95.57 2.26 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.609 -0.886 . . . . 71.33 108.609 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 96' ' ' ALA . 8.3 mm -105.31 155.3 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.619 0 O-C-N 121.023 -1.048 . . . . 71.13 109.835 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.478 ' N ' HG22 ' A' ' 95' ' ' ILE . . . -60.33 144.57 50.31 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 106.953 -1.499 . . . . 64.32 106.953 177.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.662 ' C ' ' H ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -67.58 -57.48 10.1 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 120.645 -1.284 . . . . 62.2 112.171 -178.097 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 99' ' ' TYR . 27.7 Cg_endo -53.92 9.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.3 -1.993 0 CA-C-N 119.927 1.01 . . . . 73.11 113.477 -173.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.662 ' H ' ' C ' ' A' ' 97' ' ' LYS . 14.5 m-85 57.01 124.86 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.19 -0.459 . . . . 65.22 110.688 177.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.6 mtt85 -66.93 -35.32 79.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.696 -1.253 . . . . 72.35 108.777 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.741 ' O ' ' N ' ' A' ' 103' ' ' LYS . 29.3 t -164.92 33.18 0.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 71.32 110.404 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.4 mt 51.77 -69.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.714 -0.616 . . . . 75.43 110.296 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.741 ' N ' ' O ' ' A' ' 101' ' ' SER . 13.0 mptt -56.37 -28.81 60.29 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.633 -1.247 . . . . 71.41 107.633 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.18 87.71 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.715 -0.794 . . . . 63.24 108.881 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -61.51 -55.95 25.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.354 -0.841 . . . . 73.22 108.75 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.7 t -56.34 -41.76 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.96 -1.087 . . . . 60.11 109.278 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.02 -42.54 49.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.933 . . . . 70.42 109.309 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.515 ' O ' ' NH1' ' A' ' 112' ' ' ARG . 15.5 mmp_? -69.61 -30.08 67.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 74.41 109.521 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 93.3 mt -77.92 -29.67 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.021 -1.049 . . . . 62.54 109.117 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -73.4 -58.77 3.07 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.272 -0.893 . . . . 74.34 109.911 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.81 -46.99 87.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.123 -0.985 . . . . 73.32 109.826 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.515 ' NH1' ' O ' ' A' ' 108' ' ' ARG . 22.2 ttp-105 -59.47 -31.53 69.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.181 -0.949 . . . . 52.41 109.44 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 12.4 tp -157.63 93.06 1.25 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 65.24 109.496 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 32.5 mtm-85 -78.39 -72.73 0.36 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.227 -0.92 . . . . 64.45 108.89 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' A' ' 117' ' ' GLY . 41.4 t80 -140.11 3.18 1.97 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.31 -0.869 . . . . 74.43 109.668 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.528 ' CG ' ' O ' ' A' ' 115' ' ' PHE . 48.9 p-90 40.96 21.27 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.569 -0.707 . . . . 74.42 110.362 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 115' ' ' PHE . . . -57.12 89.77 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.615 -1.394 . . . . 75.04 109.615 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 116' ' ' TRP . 85.8 p -156.16 163.65 39.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -1.152 . . . . 61.14 109.901 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.07 125.57 3.09 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.665 -0.865 . . . . 65.24 108.665 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.2 t -83.79 -50.25 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.165 -0.96 . . . . 73.11 109.868 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 17.6 mm -100.83 126.35 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.246 -0.909 . . . . 72.24 109.351 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -129.87 124.73 33.92 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.544 -0.722 . . . . 72.34 109.143 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 123' ' ' ILE . 13.2 tt -146.71 130.21 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.284 -0.885 . . . . 71.44 109.424 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 45.94 -143.68 3.99 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.745 -1.342 . . . . 73.4 109.745 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -84.64 -3.93 58.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -1.138 . . . . 74.45 109.371 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.66 130.79 41.01 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.529 -0.915 . . . . 54.21 108.529 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.9 m -129.43 123.92 32.83 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.355 -0.84 . . . . 54.5 109.507 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 23.3 mm -110.26 140.69 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.55 -0.719 . . . . 45.15 109.103 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.9 m -128.08 78.99 74.59 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.49 -0.756 . . . . 71.11 109.33 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.85 -53.02 7.74 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.853 2.369 . . . . 65.41 112.573 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -54.08 -42.71 69.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.953 . . . . 63.32 109.451 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.492 ' OE1' ' N ' ' A' ' 132' ' ' GLU . 37.8 mp0 -88.72 -0.54 57.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.25 -0.906 . . . . 72.52 109.56 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 47.86 39.12 10.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 75.33 109.447 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -125.65 143.09 51.18 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.638 -0.663 . . . . 71.23 109.238 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.8 tt -125.17 138.87 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.537 -0.727 . . . . 74.02 109.414 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 52.4 mt -119.14 125.94 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.605 -0.684 . . . . 60.23 109.178 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.504 ' CE2' ' CD ' ' A' ' 138' ' ' LYS . 46.1 t80 -137.43 132.51 33.51 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.56 -0.713 . . . . 62.32 109.127 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.524 ' O ' ' NH1' ' A' ' 140' ' ' ARG . 15.8 mtpp 55.64 25.21 7.84 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.504 -0.748 . . . . 75.4 109.956 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.26 -0.82 89.51 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.237 -1.145 . . . . 72.24 110.237 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.524 ' NH1' ' O ' ' A' ' 138' ' ' LYS . 9.6 mpt_? -88.9 125.79 35.1 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.017 -1.284 . . . . 71.22 109.088 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -97.8 116.9 30.94 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.274 -0.891 . . . . 71.42 109.471 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 13.8 p -139.02 141.75 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.341 -0.85 . . . . 53.02 109.265 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -88.57 147.67 24.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.196 -0.94 . . . . 60.45 109.381 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.3 m -137.17 140.61 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.419 -0.801 . . . . 74.44 109.577 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.429 ' HZ1' ' HG ' ' A' ' 68' ' ' SER . 13.0 ptpt -165.83 121.99 1.34 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.883 . . . . 65.15 109.332 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 172.97 -164.45 36.48 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.579 -1.408 . . . . 73.34 109.579 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.692 ' NZ ' ' HE1' ' A' ' 173' ' ' TRP . 1.6 mtpm? -76.87 -34.76 1.31 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.235 -1.156 . . . . 72.22 111.071 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 97.0 Cg_endo -89.45 -5.4 5.51 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.166 1.91 . . . . 65.23 112.639 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -96.93 -32.71 11.9 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.214 -0.929 . . . . 60.11 109.725 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.524 ' O ' ' ND1' ' A' ' 154' ' ' HIS . 71.3 mm-40 -60.15 -40.45 89.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.113 -0.992 . . . . 64.21 109.181 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.411 HG11 ' CD1' ' A' ' 191' ' ' ILE . 7.8 p -61.03 -31.75 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.279 -0.888 . . . . 72.02 109.05 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.49 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.2 OUTLIER -65.14 -46.91 78.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.39 -0.819 . . . . 73.31 109.267 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.5 p -72.43 -30.52 64.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.091 -1.006 . . . . 74.31 109.9 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 150' ' ' GLU . 1.5 m80 -59.04 -53.38 59.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 74.31 109.728 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.68 -25.19 62.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.109 -0.995 . . . . 75.34 109.49 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.01 -54.82 40.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.204 -0.935 . . . . 62.14 109.093 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -70.45 -50.22 40.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.247 -0.908 . . . . 61.03 108.991 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.541 ' C ' ' NE2' ' A' ' 161' ' ' GLN . 40.0 m-70 -76.04 62.37 1.65 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.535 -0.728 . . . . 74.12 109.267 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.837 ' C ' HE22 ' A' ' 161' ' ' GLN . 48.0 ttp180 -98.79 139.67 34.13 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.303 -0.873 . . . . 71.13 109.33 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 214' ' ' PHE . 10.4 t0 80.02 60.92 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.662 -0.649 . . . . 75.45 110.77 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.837 HE22 ' C ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -167.27 170.61 11.47 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.933 -1.104 . . . . 73.41 109.782 178.702 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 13.6 mm -92.27 136.36 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.379 -0.826 . . . . 74.41 109.123 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.453 HG13 ' OE1' ' A' ' 167' ' ' GLN . 82.7 t -140.76 138.32 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.246 -0.909 . . . . 72.31 109.802 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 52.4 p -89.71 154.28 20.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.361 -0.837 . . . . 74.12 109.307 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.578 ' H ' ' CD ' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -60.83 -41.3 95.5 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.21 -0.931 . . . . 70.43 109.2 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.7 -35.83 66.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.237 -0.914 . . . . 73.52 109.736 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.453 ' OE1' HG13 ' A' ' 163' ' ' VAL . 34.7 tt0 -56.23 -45.72 79.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.077 -1.014 . . . . 74.52 109.26 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 21.9 mt -59.79 -37.44 79.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.08 -1.012 . . . . 72.31 108.985 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.559 ' C ' HD23 ' A' ' 169' ' ' LEU . 4.9 tt -59.53 -69.41 0.21 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.416 -0.803 . . . . 53.33 110.241 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -65.0 -33.5 76.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.157 -0.964 . . . . 62.44 111.005 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -52.65 -48.6 66.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.976 -1.077 . . . . 60.21 110.219 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.663 HD12 ' N ' ' A' ' 172' ' ' ILE . 1.8 mp -94.09 -64.28 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.971 -1.081 . . . . 75.32 108.905 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.692 ' HE1' ' NZ ' ' A' ' 147' ' ' LYS . 25.8 m-90 . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.34 -0.85 . . . . 73.14 109.534 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.771 ' N ' HD21 ' A' ' 182' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.27 0.557 . . . . 64.54 110.311 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.2 m -153.16 16.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.292 -0.88 . . . . 74.02 109.232 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 61.8 mt -58.64 -38.95 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.183 -0.948 . . . . 72.33 109.475 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -50.45 -38.77 45.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 74.4 109.324 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 49.6 t -74.67 -36.38 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.227 -0.921 . . . . 70.42 109.47 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.413 ' O ' ' CG1' ' A' ' 191' ' ' ILE . . . -64.7 -52.81 55.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 52.11 109.601 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.571 ' O ' HD13 ' A' ' 188' ' ' ILE . 0.2 OUTLIER -60.9 -34.01 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.037 -1.039 . . . . 71.4 109.191 -179.691 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -68.27 -57.68 5.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.055 -1.028 . . . . 73.44 110.394 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -64.15 -38.24 90.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.868 -1.145 . . . . 71.42 109.259 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.413 ' CG1' ' O ' ' A' ' 187' ' ' ALA . 3.4 mm -56.9 -34.19 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 61.55 108.745 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ARG . . . . . 0.642 ' HE ' ' CG2' ' A' ' 204' ' ' VAL . 3.2 tpt180 -70.17 -43.13 71.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.505 -0.747 . . . . 63.34 109.784 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -77.51 -27.87 51.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.085 -1.009 . . . . 61.24 110.187 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -84.88 -21.84 29.59 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.157 -0.965 . . . . 75.13 110.593 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' MET . . . . . 0.567 ' SD ' ' N ' ' A' ' 196' ' ' ASP . 0.0 OUTLIER -93.77 -41.04 9.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.98 -1.075 . . . . 74.02 109.718 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ASP . . . . . 0.567 ' N ' ' SD ' ' A' ' 195' ' ' MET . 31.5 p-10 -64.6 -34.41 78.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 74.02 109.696 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.498 ' N ' ' OD1' ' A' ' 196' ' ' ASP . 0.2 OUTLIER -57.2 -63.95 3.12 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.898 . . . . 75.43 109.678 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.427 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 37.2 Cg_endo -63.71 -57.26 0.38 Allowed 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.196 1.931 . . . . 72.32 112.064 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 49.0 mt -61.17 -33.09 72.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 74.54 109.556 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 73.55 -49.02 1.6 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.492 -1.443 . . . . 61.51 109.492 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 83.7 mt -92.17 138.24 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.211 -1.17 . . . . 61.22 109.278 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 34.7 m -77.83 147.43 35.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.283 -0.885 . . . . 72.0 109.52 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 8.2 p -142.54 21.13 2.03 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.325 -0.86 . . . . 74.44 109.223 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.642 ' CG2' ' HE ' ' A' ' 192' ' ' ARG . 20.3 m -135.22 147.96 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.461 -0.774 . . . . 64.35 109.25 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -123.48 133.34 54.05 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.497 -0.752 . . . . 71.41 109.392 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 29.0 p -99.24 138.08 36.84 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.381 -0.825 . . . . 73.52 109.394 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 38.6 t -144.6 136.85 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.202 -0.936 . . . . 71.02 109.391 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 70.2 ttp85 -80.82 88.26 5.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 72.12 109.393 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 47.3 ttt85 -171.0 -126.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 64.41 109.29 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -57.37 -39.72 76.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.109 -0.994 . . . . 71.54 109.418 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 167.59 -149.51 14.78 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.693 -1.363 . . . . 72.03 109.693 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -104.93 151.52 23.78 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.481 -1.011 . . . . 75.54 109.351 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -119.71 137.35 53.98 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.083 -0.71 . . . . 75.31 109.083 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.509 ' O ' ' N ' ' A' ' 160' ' ' ASP . 15.5 m-85 -106.07 126.94 52.8 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.431 -0.793 . . . . 75.41 109.377 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 52.9 t -153.11 160.27 42.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.432 -0.793 . . . . 74.14 109.06 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -63.45 151.69 87.13 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.071 -1.018 . . . . 75.32 109.072 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo . . . . . 0 N--CA 1.494 1.545 0 C-N-CA 122.381 2.054 . . . . 73.11 112.042 179.876 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 52.0 ttm . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.477 -0.564 . . . . 71.14 109.477 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 68.0 mtt85 -138.72 144.36 39.48 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.305 -0.872 . . . . 73.23 109.431 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 86.8 t -111.97 138.86 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 121.466 0.651 . . . . 72.24 109.756 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.476 HD11 ' CG1' ' B' ' 6' ' ' ILE . 2.7 tp -108.99 120.55 42.89 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.728 -0.607 . . . . 54.33 109.399 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.44 ' N ' HD12 ' B' ' 4' ' ' LEU . 20.2 mt -118.17 110.44 17.58 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.533 -0.729 . . . . 74.35 109.039 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.476 ' CG1' HD11 ' B' ' 4' ' ' LEU . 26.7 mt -100.78 114.08 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.681 -0.859 . . . . 42.55 108.681 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.486 ' OE1' ' N ' ' B' ' 9' ' ' ASN . 1.8 pp20? -151.04 164.93 35.3 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.285 -0.885 . . . . 74.52 109.58 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -95.86 -24.39 16.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.252 -0.905 . . . . 62.55 109.542 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 9' ' ' ASN . . . . . 0.486 ' N ' ' OE1' ' B' ' 7' ' ' GLU . 28.7 m120 -91.15 109.79 21.06 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.211 -0.931 . . . . 73.11 109.697 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 32.3 t -62.44 -40.78 97.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.206 -0.934 . . . . 65.54 109.633 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 86.4 t -57.72 -44.32 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 75.55 109.214 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.508 HD11 ' HZ2' ' B' ' 97' ' ' LYS . 7.6 tp -58.74 -35.47 72.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 70.14 108.841 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.04 -27.26 70.68 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 108.253 -1.939 . . . . 75.4 108.253 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.97 -52.28 49.16 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 109.536 -1.425 . . . . 65.44 109.536 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.424 ' H ' ' HG2' ' B' ' 15' ' ' GLU . 6.9 pt-20 -59.75 -47.23 86.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.372 -1.075 . . . . 60.21 109.796 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 35.5 mm -64.03 -41.48 92.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.66 -1.275 . . . . 75.15 108.951 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.474 ' CD ' ' HB3' ' B' ' 27' ' ' ALA . 39.7 tp10 -59.43 -45.22 92.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.224 -0.922 . . . . 73.01 109.156 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -84.07 0.14 49.52 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.223 -0.923 . . . . 74.3 109.557 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.5 -58.48 1.94 Allowed Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.544 -1.423 . . . . 70.54 109.544 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' B' ' 27' ' ' ALA . 1.5 pt? -71.34 -23.61 61.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.307 -1.114 . . . . 71.34 109.74 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' ASN . . . . . 0.411 ' H ' HD23 ' B' ' 20' ' ' LEU . 32.0 m-20 -51.24 -36.17 40.56 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.143 -0.973 . . . . 64.41 109.495 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 46.5 t -53.86 -32.35 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.15 -0.969 . . . . 74.23 108.442 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm -81.64 -3.88 54.65 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.746 0.784 . . . . 63.42 108.891 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.13 24.45 63.84 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.942 -1.263 . . . . 53.43 109.942 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -95.14 159.73 14.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.179 -1.189 . . . . 71.12 109.076 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 14.8 mmt -104.93 140.41 38.2 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.714 -0.847 . . . . 75.24 108.714 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.474 ' HB3' ' CD ' ' B' ' 17' ' ' GLU . . . -135.9 158.13 45.14 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.398 -0.814 . . . . 72.12 109.651 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -132.8 145.69 51.19 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.594 -0.891 . . . . 72.31 108.594 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 4.3 m -110.47 139.33 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.369 -0.832 . . . . 64.43 109.129 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.1 p -138.13 169.29 18.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.384 -0.822 . . . . 65.41 109.425 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.414 ' OE2' ' OD1' ' B' ' 35' ' ' ASP . 5.4 pt-20 -93.09 -106.99 0.12 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.342 -0.849 . . . . 71.02 109.431 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 77.3 p -79.47 168.17 19.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 51.11 109.776 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 22.7 mt -51.91 -29.81 21.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.537 -0.727 . . . . 71.24 109.856 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -52.29 -51.2 59.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.095 -1.003 . . . . 74.32 109.729 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.414 ' OD1' ' OE2' ' B' ' 31' ' ' GLU . 1.4 m-20 -63.1 -38.9 93.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -0.975 . . . . 73.03 109.261 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.97 -38.97 93.16 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.409 -1.476 . . . . 30.21 109.409 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -67.92 -42.85 80.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -1.114 . . . . 74.42 109.605 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -74.41 -34.15 63.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 74.42 109.641 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 21.0 tp -74.86 -50.0 18.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 75.41 110.078 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' MET . . . . . 0.439 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.7 ppp? -61.9 -27.69 68.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 60.41 109.907 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.81 -39.79 86.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 53.23 110.137 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 17.6 pt -87.06 -24.9 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.09 -1.006 . . . . 71.23 110.407 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.424 ' O ' ' O ' ' B' ' 40' ' ' MET . 91.3 mtt-85 -129.65 140.36 51.17 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.235 -0.916 . . . . 72.22 109.73 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -99.32 126.89 45.26 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.286 -0.884 . . . . 63.54 109.293 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -101.61 141.89 33.79 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.324 -0.86 . . . . 64.35 109.505 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -81.11 -31.71 34.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 62.22 109.021 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.522 HD13 ' C ' ' B' ' 47' ' ' LEU . 1.0 OUTLIER -114.9 110.6 19.9 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.691 -0.855 . . . . 73.12 108.691 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.462 ' N ' HD13 ' B' ' 47' ' ' LEU . 62.3 t -95.52 101.13 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.28 -0.887 . . . . 65.11 109.074 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 14.4 ttt -116.43 132.7 56.6 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.592 0.71 . . . . 73.44 109.45 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.532 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.4 OUTLIER -144.49 139.49 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.465 -0.772 . . . . 34.5 109.364 -179.49 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 31.9 p -105.58 14.71 28.1 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.668 -0.645 . . . . 73.21 109.72 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.532 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 61.9 m-20 -82.7 144.96 29.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.214 -0.929 . . . . 70.41 109.266 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' B' ' 55' ' ' ALA . 15.4 pttm -77.68 -39.41 44.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.179 -0.951 . . . . 65.0 110.118 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -73.81 10.49 1.12 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.098 -1.001 . . . . 75.21 109.559 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.415 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -65.79 -21.21 66.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.351 -0.843 . . . . 55.33 110.036 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' B' ' 55' ' ' ALA . 47.7 mt -41.94 -43.68 3.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.433 -0.792 . . . . 63.14 110.517 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.3 p -75.96 -35.79 59.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.909 -1.12 . . . . 63.5 109.451 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -66.63 -40.78 88.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.411 -0.806 . . . . 72.33 110.353 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.06 -35.49 59.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 120.757 -1.214 . . . . 74.54 109.544 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 78.8 p -57.69 -46.86 83.74 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.12 -0.988 . . . . 71.24 109.314 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -69.69 -34.41 73.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.142 -0.974 . . . . 74.31 110.018 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 4.9 mm -62.2 -34.31 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.862 -1.149 . . . . 72.14 109.779 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.421 ' O ' ' OG ' ' B' ' 67' ' ' SER . 12.0 mmtm -73.79 -52.88 11.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.099 -1.0 . . . . 73.32 110.178 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -66.24 -36.82 84.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.902 -1.123 . . . . 73.12 110.304 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.466 ' C ' ' CG ' ' B' ' 66' ' ' HIS . 29.3 mtmt -83.21 -23.56 32.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.133 -0.98 . . . . 72.44 110.258 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.466 ' CG ' ' C ' ' B' ' 65' ' ' LYS . 37.0 m-70 -153.2 67.37 0.79 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.02 -1.05 . . . . 63.31 109.837 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' B' ' 63' ' ' LYS . 10.5 m -61.9 -30.86 71.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.935 . . . . 73.1 109.724 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 90.5 p -63.24 -24.58 67.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.251 -0.905 . . . . 71.53 110.356 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.444 HD12 ' CB ' ' B' ' 66' ' ' HIS . 81.1 mt -81.5 156.36 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.988 -1.07 . . . . 74.4 109.767 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.497 HG12 ' N ' ' B' ' 71' ' ' VAL . 95.9 t -93.97 160.14 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.296 -0.877 . . . . 75.12 109.854 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.497 ' N ' HG12 ' B' ' 70' ' ' VAL . 21.7 t -136.04 127.49 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.411 -0.806 . . . . 73.2 109.366 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.417 HD21 HD11 ' B' ' 105' ' ' LEU . 0.7 OUTLIER -121.61 101.71 7.77 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.729 -0.841 . . . . 73.34 108.729 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 90.7 t -93.53 128.18 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.249 -0.907 . . . . 73.5 109.264 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 14.6 p -93.51 172.24 8.4 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.198 -0.939 . . . . 64.34 109.346 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.438 ' CB ' ' HH ' ' B' ' 94' ' ' TYR . 30.1 t -159.65 117.08 2.65 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.978 -1.077 . . . . 74.53 110.339 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -61.88 -36.34 80.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.384 -0.822 . . . . 64.5 109.84 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 77' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' B' ' 79' ' ' THR . 10.1 p-10 -118.52 82.73 19.94 Favored Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.572 -0.705 . . . . 74.25 109.227 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -47.71 84.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.235 1.957 . . . . 74.43 111.5 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.516 ' N ' ' O ' ' B' ' 77' ' ' ASN . 19.4 m -102.91 150.91 23.05 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.596 -0.69 . . . . 73.12 109.377 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.2 t -65.32 -35.41 80.9 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.344 -0.847 . . . . 71.01 109.704 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 81' ' ' GLU . . . . . 0.488 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 80.1 mm-40 -60.42 -44.75 95.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.134 -0.979 . . . . 63.2 109.565 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -75.79 -31.11 59.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 73.22 109.468 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -64.73 -54.05 37.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 74.3 109.834 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.546 HG23 ' N ' ' B' ' 85' ' ' HIS . 21.6 m -64.26 -43.37 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.098 -1.001 . . . . 73.31 109.396 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 85' ' ' HIS . . . . . 0.546 ' N ' HG23 ' B' ' 84' ' ' VAL . 23.2 m170 -63.18 -26.17 68.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.161 -0.962 . . . . 73.24 109.271 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.49 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -70.64 -46.86 62.5 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -0.878 . . . . 55.33 109.958 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -77.0 -32.09 56.96 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.01 -1.056 . . . . 74.14 109.384 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -72.67 -44.3 62.0 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.248 -0.907 . . . . 64.04 109.693 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -62.69 -52.13 64.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.191 -0.943 . . . . 72.35 109.905 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 156.45 44.74 0.02 OUTLIER Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.673 -1.251 . . . . 65.2 110.265 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 91' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -110.28 135.7 50.61 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.396 -1.061 . . . . 52.23 109.255 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -85.37 -18.43 33.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.094 -1.004 . . . . 73.32 109.201 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -152.51 162.01 41.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.298 -0.876 . . . . 72.22 109.697 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.438 ' HH ' ' CB ' ' B' ' 75' ' ' SER . 79.4 t80 -143.65 97.0 2.99 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.554 -0.906 . . . . 64.42 108.554 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 23.2 mm -108.1 156.29 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 121.255 -0.903 . . . . 72.23 110.431 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.6 152.12 45.94 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.262 -1.014 . . . . 25.24 108.262 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.694 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -74.87 -55.98 2.26 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 120.787 -1.195 . . . . 64.32 111.416 -179.562 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 98' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 2.6 Cg_endo -40.29 -10.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.034 1.156 . . . . 63.33 112.914 -175.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 99' ' ' TYR . . . . . 0.694 ' N ' ' O ' ' B' ' 97' ' ' LYS . 54.2 m-85 59.42 118.18 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.755 -0.59 . . . . 75.13 109.868 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -65.65 -33.31 75.6 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.208 -0.932 . . . . 74.23 109.452 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 101' ' ' SER . . . . . 0.766 ' O ' ' N ' ' B' ' 103' ' ' LYS . 34.2 t -171.32 27.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.961 -1.087 . . . . 63.34 110.888 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 16.2 mt 49.14 -67.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 CA-C-N 118.498 0.59 . . . . 74.44 110.336 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.766 ' N ' ' O ' ' B' ' 101' ' ' SER . 43.4 mtpt -55.4 -32.77 62.93 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.903 -1.147 . . . . 71.11 107.903 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.11 -45.87 86.72 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.666 -0.864 . . . . 71.45 108.666 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.417 HD11 HD21 ' B' ' 72' ' ' LEU . 22.5 tp -68.31 -42.43 79.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.302 -0.874 . . . . 51.31 109.123 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 78.8 t -58.92 -45.72 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.174 -0.954 . . . . 65.23 108.893 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.17 -44.02 67.55 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.422 -0.955 . . . . 24.32 108.422 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -62.41 -39.04 91.98 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.819 -0.808 . . . . 75.31 108.819 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 91.1 mt -68.95 -28.96 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 108.043 -1.095 . . . . 54.24 108.043 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -68.56 -53.76 20.89 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.651 -0.87 . . . . 65.31 108.651 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -47.36 -40.32 17.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.448 -0.783 . . . . 72.24 109.081 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -62.85 -40.33 97.13 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.299 -0.876 . . . . 72.04 109.111 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 84.6 mt -137.97 77.44 1.63 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.318 -0.864 . . . . 75.35 109.505 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -74.54 -76.02 0.15 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.218 -0.926 . . . . 75.5 108.959 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 115' ' ' PHE . . . . . 0.525 ' O ' ' CG ' ' B' ' 116' ' ' TRP . 94.1 m-85 -82.84 -65.87 0.96 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 65.33 109.563 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 116' ' ' TRP . . . . . 0.525 ' CG ' ' O ' ' B' ' 115' ' ' PHE . 7.7 m-90 -158.13 -154.39 0.44 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.36 -0.838 . . . . 74.45 109.347 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -85.65 -138.09 4.54 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.696 -1.362 . . . . 44.21 109.696 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 10.9 t -151.95 176.85 11.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.305 -1.114 . . . . 71.4 109.911 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.9 163.81 37.8 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.787 -0.819 . . . . 72.32 108.787 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 10.1 t -136.5 -38.52 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.506 -0.746 . . . . 75.02 109.726 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 27.1 mm -97.77 137.67 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.239 -0.913 . . . . 51.41 109.499 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 122' ' ' GLU . . . . . 0.95 ' OE1' ' O ' ' B' ' 122' ' ' GLU . 0.0 OUTLIER -137.74 132.61 33.04 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.476 -0.765 . . . . 71.53 109.374 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.704 ' O ' HG23 ' B' ' 123' ' ' ILE . 4.9 tt -142.76 113.08 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.285 -0.884 . . . . 72.43 109.174 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.98 -116.95 5.49 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.262 -1.535 . . . . 51.23 109.262 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -106.33 3.38 27.49 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.481 -1.011 . . . . 74.2 108.987 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.511 ' HB2' ' CG2' ' B' ' 123' ' ' ILE . 0.3 OUTLIER -97.49 139.43 33.42 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.283 -1.006 . . . . 75.42 108.283 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 18.8 m -130.33 136.42 49.09 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.229 -0.919 . . . . 74.22 110.065 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 58.8 mt -128.96 142.9 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.533 -0.729 . . . . 60.33 109.464 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 2.0 m -122.44 126.84 26.06 Favored Pre-proline 0 N--CA 1.501 2.077 0 N-CA-C 109.144 -0.687 . . . . 72.31 109.144 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.71 -60.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.793 1.662 . . . . 75.13 112.998 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -53.9 -47.51 71.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.939 -1.1 . . . . 75.23 109.956 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -82.83 -9.77 59.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.121 -0.987 . . . . 72.43 110.063 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 48.51 75.41 0.14 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.977 -1.077 . . . . 75.13 109.178 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -149.17 130.56 14.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.189 -0.945 . . . . 73.22 109.54 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 7.5 tt -110.43 132.93 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.816 -0.809 . . . . 64.14 108.816 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 20.7 mm -111.26 127.42 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.407 -0.808 . . . . 71.22 109.407 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -142.81 141.54 31.66 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.983 -1.117 . . . . 64.22 107.983 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 68.3 tttt 55.93 13.61 1.16 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.335 -0.853 . . . . 72.02 109.705 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.68 5.24 84.49 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.384 -1.086 . . . . 74.32 110.384 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -96.09 141.81 29.03 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.13 -1.218 . . . . 75.34 109.04 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -96.24 123.76 39.99 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.311 -0.868 . . . . 71.23 109.339 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 36.1 t -134.74 132.83 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.38 -0.825 . . . . 70.43 109.153 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -90.58 157.58 17.43 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.032 -1.043 . . . . 72.43 109.516 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 6.0 m -137.69 140.66 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.408 -0.808 . . . . 72.13 109.817 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 22.9 pttt -176.64 89.54 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.408 -0.807 . . . . 72.02 109.593 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -157.15 -170.15 21.76 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.587 -1.405 . . . . 42.23 109.587 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 147' ' ' LYS . . . . . 0.628 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 29.3 ttpt -78.69 -31.03 0.71 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.262 -1.14 . . . . 73.3 110.974 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 148' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 85.1 Cg_endo -89.61 -29.34 0.23 Allowed 'Trans proline' 0 N--CA 1.486 1.069 0 C-N-CA 122.03 1.82 . . . . 71.33 112.764 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -85.1 -13.31 50.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.0 -1.063 . . . . 74.23 109.964 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -53.04 -40.68 64.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.097 -1.002 . . . . 72.34 109.268 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.47 HG13 ' N ' ' B' ' 152' ' ' LEU . 12.5 p -69.24 -38.45 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 73.35 109.159 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.558 HD13 ' O ' ' B' ' 152' ' ' LEU . 0.3 OUTLIER -48.22 -44.11 32.76 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.57 -0.9 . . . . 55.24 108.57 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.14 -41.0 71.05 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.107 -0.996 . . . . 70.01 110.254 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -58.39 -63.59 1.22 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.371 -0.831 . . . . 65.32 112.362 -177.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 155' ' ' LEU . . . . . 0.609 HD12 ' N ' ' B' ' 156' ' ' ALA . 0.4 OUTLIER -70.23 -19.77 63.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.425 -1.422 . . . . 71.54 109.815 -178.628 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 156' ' ' ALA . . . . . 0.609 ' N ' HD12 ' B' ' 155' ' ' LEU . . . -58.96 -47.97 83.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.737 -1.227 . . . . 75.32 109.17 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 157' ' ' ARG . . . . . 0.421 ' HG3' ' ND1' ' B' ' 158' ' ' HIS . 23.2 ptt180 -76.86 -35.8 57.23 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.034 -1.041 . . . . 73.32 110.42 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 158' ' ' HIS . . . . . 0.421 ' ND1' ' HG3' ' B' ' 157' ' ' ARG . 1.6 m-70 -81.08 22.42 0.64 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.688 -1.257 . . . . 74.14 109.961 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 24.8 ttm-85 -59.36 163.03 4.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.125 -0.985 . . . . 61.41 109.06 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 160' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' B' ' 214' ' ' PHE . 14.8 t0 63.54 44.65 5.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.205 -0.934 . . . . 72.1 109.164 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 161' ' ' GLN . . . . . 0.908 ' NE2' ' O ' ' B' ' 162' ' ' ILE . 15.5 tm0? -158.16 155.25 28.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.353 -0.842 . . . . 72.25 109.613 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 162' ' ' ILE . . . . . 0.908 ' O ' ' NE2' ' B' ' 161' ' ' GLN . 10.3 mm -81.63 105.39 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.522 -0.918 . . . . 72.31 108.522 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 93.4 t -101.54 129.25 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.274 -0.892 . . . . 64.21 109.754 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 9.8 t -85.93 164.31 17.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.401 -0.812 . . . . 74.22 109.528 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -68.78 -46.39 68.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -0.848 . . . . 65.31 109.855 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -60.25 -24.89 65.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 63.45 109.859 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -59.26 -43.73 92.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.965 -1.085 . . . . 72.4 109.082 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 20.7 mt -71.96 -58.11 3.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.394 -0.816 . . . . 72.32 109.247 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.598 HD13 ' C ' ' B' ' 169' ' ' LEU . 2.1 tm? -50.1 -58.29 5.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.014 -1.054 . . . . 73.34 108.653 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -51.7 -32.66 31.0 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 112.183 0.438 . . . . 72.1 112.183 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.61 -30.77 14.18 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.802 -1.187 . . . . 62.13 112.952 -177.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.7 -63.13 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.458 -1.401 . . . . 71.42 109.467 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 173' ' ' TRP . . . . . 0.523 ' O ' ' CE3' ' B' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.538 0 N-CA-C 107.518 -1.29 . . . . 72.23 107.518 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_exo . . . . . 0 N--CA 1.489 1.213 0 CA-C-O 121.422 0.509 . . . . 65.22 112.019 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -164.1 122.73 1.88 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.369 -0.832 . . . . 72.31 109.061 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 10.5 m -137.71 11.87 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.244 -0.91 . . . . 63.32 108.692 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.621 HD13 ' O ' ' B' ' 184' ' ' ILE . 0.2 OUTLIER -53.52 -30.64 18.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.639 -0.874 . . . . 75.03 108.639 179.749 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -57.33 -35.49 69.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.853 . . . . 64.11 108.994 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 3.7 t -75.32 -44.41 42.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.453 -0.78 . . . . 73.0 109.372 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -61.62 -48.46 80.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.251 -0.906 . . . . 61.12 110.459 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 188' ' ' ILE . . . . . 0.47 HG23 ' N ' ' B' ' 189' ' ' ASN . 9.4 tp -63.65 -42.12 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.778 -1.201 . . . . 72.43 110.285 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 189' ' ' ASN . . . . . 0.47 ' N ' HG23 ' B' ' 188' ' ' ILE . 53.3 t30 -63.59 -34.67 78.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.898 -1.126 . . . . 65.14 109.402 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -77.14 -50.36 13.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 63.24 110.15 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 82.0 mt -50.5 -46.37 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.178 -0.951 . . . . 74.03 109.438 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -62.68 -48.81 77.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.104 -0.997 . . . . 72.24 109.914 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 193' ' ' GLN . . . . . 0.45 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 81.7 mt-30 -63.67 -21.61 66.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.051 -1.031 . . . . 73.1 109.515 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 194' ' ' LYS . . . . . 0.431 ' O ' ' CD ' ' B' ' 198' ' ' PRO . 60.3 mttm -85.74 -38.47 18.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.206 -0.933 . . . . 72.11 110.405 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 88.8 mmm -91.79 13.2 18.96 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.888 -1.133 . . . . 44.33 109.99 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 196' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 50.8 p-10 -96.56 -20.98 17.96 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.06 -1.025 . . . . 71.21 109.744 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 197' ' ' LYS . . . . . 0.554 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 1.5 tttm -93.29 -45.54 0.31 Allowed Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.116 -0.99 . . . . 75.21 109.098 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 198' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' B' ' 197' ' ' LYS . 18.8 Cg_exo -65.12 -60.47 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.163 1.909 . . . . 75.32 111.324 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 30.8 mt -63.68 -38.8 92.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 72.25 109.007 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 78.44 -17.95 6.01 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.35 -1.1 . . . . 64.53 110.35 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 29.0 mm -110.31 131.78 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.278 -1.13 . . . . 44.23 110.017 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 2.0 t -83.8 135.16 34.63 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.632 -0.877 . . . . 54.01 108.632 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 3.9 p -141.37 30.43 1.75 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.141 -0.974 . . . . 74.4 109.463 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 25.6 m -137.14 142.4 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.507 -0.745 . . . . 72.12 109.296 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -125.58 114.5 18.81 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.022 -0.732 . . . . 65.41 109.022 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.42 110.1 21.21 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.186 -0.946 . . . . 71.33 109.917 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.416 ' O ' HG13 ' B' ' 207' ' ' VAL . 10.6 p -112.45 131.09 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 107.896 -1.15 . . . . 63.5 107.896 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -47.92 -32.81 6.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.055 -1.028 . . . . 74.45 110.036 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 -66.34 148.45 51.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.093 -1.004 . . . . 74.14 109.41 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 51.37 -115.11 0.85 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.095 -1.003 . . . . 74.43 109.636 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -142.27 -92.73 0.18 Allowed Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.419 -1.473 . . . . 64.45 109.419 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -126.71 157.44 39.08 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.435 -1.038 . . . . 74.21 109.637 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -123.26 121.95 37.16 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.879 -0.785 . . . . 74.03 108.879 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 214' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' B' ' 160' ' ' ASP . 60.0 m-85 -101.49 123.92 46.32 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.369 -0.832 . . . . 74.34 110.372 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 1.9 p -147.59 164.38 33.64 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.117 -0.697 . . . . 64.33 109.117 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 216' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' B' ' 216' ' ' TYR . 0.0 OUTLIER -64.93 162.52 37.1 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.085 -1.01 . . . . 70.04 108.429 179.664 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -39.47 163.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.407 2.071 . . . . 65.11 112.267 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.121 -0.987 . . . . 73.15 109.723 -179.329 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.9 ptm . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.454 -0.573 . . . . 65.12 109.454 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -139.31 144.51 38.34 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.356 -0.84 . . . . 72.33 109.44 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 66.1 t -112.64 131.03 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.705 -0.622 . . . . 71.42 109.492 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.75 HD12 ' N ' ' A' ' 5' ' ' LEU . 0.7 OUTLIER -110.21 125.59 53.23 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.96 -0.756 . . . . 65.12 108.96 179.861 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.75 ' N ' HD12 ' A' ' 4' ' ' LEU . 59.7 tp -120.95 102.94 8.68 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.629 -0.67 . . . . 62.43 109.244 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.503 ' CG1' HD11 ' A' ' 4' ' ' LEU . 38.8 mt -88.67 113.58 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.856 -1.153 . . . . 71.15 108.692 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 13' ' ' GLY . 55.8 tt0 -154.66 121.44 5.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.198 -0.939 . . . . 75.34 109.485 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -64.36 -31.29 72.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.307 -0.871 . . . . 72.44 109.43 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -73.9 103.21 4.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.324 -0.86 . . . . 63.02 109.372 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.4 t -66.4 -25.17 66.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 72.34 109.814 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.54 -50.67 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.168 -0.958 . . . . 74.02 109.697 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.58 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.3 mm? -70.81 -41.95 70.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 71.43 109.398 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.513 ' N ' ' OE1' ' A' ' 7' ' ' GLU . . . -69.13 -24.85 75.81 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 108.475 -1.85 . . . . 61.32 108.475 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.51 -54.89 20.45 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 109.676 -1.37 . . . . 71.2 109.676 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -56.88 -45.75 82.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -1.104 . . . . 71.32 109.775 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.618 ' O ' HD23 ' A' ' 20' ' ' LEU . 35.9 mm -64.54 -48.78 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.819 -1.176 . . . . 63.23 108.878 179.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.527 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 86.5 tt0 -45.6 -56.41 5.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -0.983 . . . . 51.11 109.854 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -85.61 3.83 39.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.124 -0.985 . . . . 73.34 109.128 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.59 -70.64 1.34 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.778 -1.329 . . . . 62.15 109.778 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.618 HD23 ' O ' ' A' ' 16' ' ' ILE . 0.5 OUTLIER -58.75 -21.97 56.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.213 -1.169 . . . . 73.51 109.491 -179.826 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 93.4 m-20 -57.06 -37.84 72.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.253 -0.904 . . . . 74.25 109.634 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.7 t -53.97 -40.02 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 70.04 109.462 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -64.46 -22.13 66.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.27 -0.894 . . . . 73.23 109.233 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.46 38.28 2.65 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 110.335 -1.106 . . . . 75.54 110.335 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -117.92 159.28 23.39 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.335 -1.097 . . . . 73.43 108.905 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.7 mmt -90.8 114.51 26.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.112 -0.992 . . . . 43.24 108.574 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.531 ' HB2' HD11 ' A' ' 20' ' ' LEU . . . -99.26 147.38 25.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.397 -0.814 . . . . 62.11 110.104 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 27' ' ' ALA . 82.4 m-20 -138.52 129.03 26.16 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.619 -0.882 . . . . 74.42 108.619 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.1 m -111.82 138.86 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.449 -0.782 . . . . 72.15 109.117 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 p -135.08 176.39 8.71 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.536 -0.728 . . . . 71.42 109.354 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -95.54 -108.16 0.14 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.163 -0.961 . . . . 72.33 110.017 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.2 p -78.84 167.15 21.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.899 . . . . 74.24 110.123 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.414 HD22 ' CG ' ' A' ' 58' ' ' PHE . 57.7 mt -50.82 -33.76 24.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.629 -0.669 . . . . 71.53 109.891 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -49.5 -52.27 30.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 74.23 109.624 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -61.95 -37.76 85.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.139 -0.976 . . . . 54.03 108.952 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.79 -39.17 90.0 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.278 -1.529 . . . . 61.41 109.278 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.57 -43.59 89.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.352 -1.087 . . . . 74.34 109.445 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -73.39 -38.03 65.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.153 -0.967 . . . . 75.33 109.504 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.0 tp -68.7 -44.99 72.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 74.33 109.771 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.448 ' C ' ' SD ' ' A' ' 40' ' ' MET . 3.4 ppp? -74.39 -17.13 60.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.087 -1.008 . . . . 70.32 109.687 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -55.43 -40.68 71.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.122 -0.986 . . . . 71.22 109.441 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.8 pt -88.08 -42.56 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.304 -0.872 . . . . 74.14 109.793 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 40' ' ' MET . 3.0 mpt_? -104.41 139.19 39.71 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.195 -0.94 . . . . 72.24 109.113 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 45' ' ' TYR . 29.0 t30 -82.11 -24.36 35.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 75.42 109.782 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.485 ' O ' ' O ' ' A' ' 44' ' ' ASN . 57.2 m-85 57.4 136.65 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.684 0.754 . . . . 74.23 110.196 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -86.29 -50.45 6.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.948 -1.095 . . . . 72.04 108.945 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.508 HD13 ' C ' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -104.93 107.39 18.34 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.411 -0.959 . . . . 72.13 108.411 179.406 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.417 ' N ' HD13 ' A' ' 47' ' ' LEU . 2.4 m -106.19 104.79 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.127 -1.064 . . . . 72.34 108.127 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.8 ttt -113.69 144.51 42.81 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.545 0.688 . . . . 74.11 109.776 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.544 HG22 ' H ' ' A' ' 52' ' ' ASP . 1.4 p -139.53 136.02 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.596 0.713 . . . . 61.12 109.567 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.7 m -104.79 10.33 34.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.68 -0.638 . . . . 73.11 109.402 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.544 ' H ' HG22 ' A' ' 50' ' ' VAL . 69.8 m-20 -77.0 155.58 32.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 52.55 109.61 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.47 ' C ' ' H ' ' A' ' 55' ' ' ALA . 27.3 mtmm -76.38 -39.22 54.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.182 -0.949 . . . . 44.22 109.84 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -73.49 18.09 0.13 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.141 -0.974 . . . . 70.44 109.653 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.47 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -59.96 -35.56 75.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 64.14 110.012 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.625 ' HB3' HE22 ' A' ' 89' ' ' GLN . 23.7 mt -43.83 -52.66 6.58 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.449 -0.782 . . . . 44.14 110.251 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.2 m -65.9 -34.63 78.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.872 -1.142 . . . . 55.23 108.942 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.444 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 46.5 t80 -65.89 -62.9 1.24 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.488 -0.757 . . . . 74.44 110.079 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.5 m -48.44 -34.19 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.739 -1.226 . . . . 74.03 109.901 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.2 t -59.0 -55.24 37.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.128 -0.982 . . . . 64.3 109.692 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -65.59 -27.36 68.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.111 -0.993 . . . . 64.44 110.189 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.444 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 31.6 mm -66.25 -49.56 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.75 -1.219 . . . . 63.21 110.369 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.423 ' HZ2' ' HG3' ' A' ' 63' ' ' LYS . 26.6 mmtp -63.62 -44.69 93.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.994 -1.066 . . . . 74.42 110.921 -178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -71.02 -39.52 72.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.676 -1.265 . . . . 70.32 110.161 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.482 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 66.4 mttm -80.8 -19.49 44.64 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.116 -0.99 . . . . 75.22 109.675 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.573 ' O ' HG22 ' A' ' 69' ' ' ILE . 93.1 m-70 -155.68 68.05 0.64 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 74.13 109.391 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.4 m -59.21 -30.72 68.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.249 -0.907 . . . . 73.24 110.0 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.8 t -81.39 49.04 1.23 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.174 -0.954 . . . . 61.01 110.28 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 66' ' ' HIS . 12.3 tt -143.4 157.8 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.096 -1.002 . . . . 71.33 109.307 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.4 t -91.75 141.53 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.001 -1.062 . . . . 72.13 108.81 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.2 t -127.52 121.99 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.297 -0.877 . . . . 54.21 109.34 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.649 ' HG ' HD11 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -118.61 103.15 9.43 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.336 -0.987 . . . . 50.24 108.336 -179.544 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 73' ' ' VAL . 8.0 p -98.64 128.5 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.396 -0.815 . . . . 74.41 109.109 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.5 p -89.31 175.33 7.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.06 -1.025 . . . . 72.31 109.489 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.481 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 22.8 t -164.6 118.95 1.38 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.158 -0.964 . . . . 64.54 110.265 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -70.5 -25.94 63.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.558 -0.714 . . . . 74.13 109.599 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 79' ' ' THR . 13.2 t-20 -112.64 68.9 1.03 Allowed Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.599 -0.688 . . . . 73.34 109.614 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.78 82.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.768 1.645 . . . . 63.22 111.777 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 77' ' ' ASN . 24.1 m -103.61 151.69 22.64 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.111 -0.7 . . . . 62.53 109.111 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -36.61 83.8 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -0.907 . . . . 73.44 109.471 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.02 -42.15 84.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.158 -0.964 . . . . 71.42 109.366 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -74.14 -30.35 62.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 73.43 109.607 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.522 ' OE1' ' CD1' ' A' ' 94' ' ' TYR . 46.8 tp10 -60.59 -54.76 41.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.958 . . . . 74.22 109.587 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.6 t -62.64 -41.72 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.249 -0.907 . . . . 73.2 109.421 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.663 ' NE2' ' NE2' ' A' ' 89' ' ' GLN . 47.7 t60 -64.41 -33.33 75.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.248 -0.908 . . . . 53.33 109.589 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.57 -45.18 91.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 64.11 109.747 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.532 ' CE1' ' HB1' ' B' ' 111' ' ' ALA . 73.4 t80 -77.24 -29.94 54.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.037 -1.039 . . . . 74.34 108.572 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -60.68 -50.74 72.28 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.384 -0.822 . . . . 74.42 108.885 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.663 ' NE2' ' NE2' ' A' ' 85' ' ' HIS . 92.0 mt-30 -63.24 -61.64 2.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.583 -0.698 . . . . 74.24 109.578 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 154.79 59.01 0.01 OUTLIER Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.796 -1.192 . . . . 61.51 110.266 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.72 134.61 51.21 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.254 -1.145 . . . . 55.33 108.978 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -75.4 -32.14 60.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.005 -1.059 . . . . 73.42 109.059 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.513 ' OD2' ' NE ' ' A' ' 108' ' ' ARG . 42.2 t0 -152.34 157.45 41.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.361 -0.837 . . . . 75.04 109.44 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.522 ' CD1' ' OE1' ' A' ' 83' ' ' GLU . 62.0 t80 -131.62 113.26 13.39 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.579 -0.897 . . . . 71.33 108.579 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.872 ' H ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -117.26 152.08 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-O 121.646 0.736 . . . . 71.13 110.444 -178.192 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.93 138.72 48.3 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.27 -1.011 . . . . 64.32 108.27 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.684 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -60.71 -54.98 49.37 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.98 -1.075 . . . . 62.2 111.636 -179.192 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.4 Cg_endo -41.4 -10.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 120.749 0.966 . . . . 73.11 112.923 -175.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.684 ' N ' ' O ' ' A' ' 97' ' ' LYS . 57.4 m-85 59.42 100.31 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.752 -0.593 . . . . 65.22 110.076 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 19.1 ttm-85 -55.93 -40.23 72.83 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.082 -1.081 . . . . 72.35 108.082 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.7 t -173.79 128.82 0.4 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.796 -0.816 . . . . 71.32 108.796 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.405 ' H ' HG13 ' A' ' 102' ' ' ILE . 51.3 mt -51.81 -40.54 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.941 . . . . 75.43 109.155 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.496 ' O ' ' HB2' ' A' ' 107' ' ' ALA . 2.7 mptp? -64.42 -35.58 81.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.154 -0.966 . . . . 71.41 109.38 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.03 -60.9 2.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.228 -0.92 . . . . 63.24 109.689 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.635 ' CD1' HH22 ' A' ' 108' ' ' ARG . 17.9 tp -55.9 -51.99 65.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 73.22 109.657 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 76.0 t -60.23 -42.4 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.062 -1.023 . . . . 60.11 109.383 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 103' ' ' LYS . . . -53.3 -30.08 36.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.177 -0.952 . . . . 70.42 109.115 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.635 HH22 ' CD1' ' A' ' 105' ' ' LEU . 21.1 ttp-105 -83.14 -28.71 29.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 74.41 109.981 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 80.3 mt -74.74 -40.03 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.986 -1.071 . . . . 62.54 108.72 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 114' ' ' ARG . 24.8 pt-20 -72.26 -37.07 69.16 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.439 -0.904 . . . . 74.34 108.957 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -57.3 -45.4 84.2 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.343 -0.848 . . . . 73.32 109.15 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 68.5 ttt-85 -62.73 -41.5 99.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.27 -0.894 . . . . 52.41 109.387 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 42.6 mt -130.07 65.8 1.5 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.477 -0.764 . . . . 65.24 109.248 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' A' ' 110' ' ' GLU . 81.5 mtp180 -60.8 -29.85 69.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 64.45 109.429 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.427 ' CG ' ' O ' ' A' ' 114' ' ' ARG . 78.9 m-85 -156.64 78.88 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 74.43 109.567 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 33.4 p-90 -58.83 134.1 56.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 74.42 109.534 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 154.2 91.57 0.08 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.434 -1.466 . . . . 75.04 109.434 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.7 m -152.39 168.27 26.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.261 -1.14 . . . . 61.14 109.679 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.57 -179.61 8.14 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.823 -0.751 . . . . 65.24 109.117 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.9 t -139.69 -38.75 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.441 -0.787 . . . . 73.11 109.159 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.2 mm -106.32 131.66 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.245 -0.909 . . . . 72.24 109.208 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -128.32 99.36 5.39 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.407 -0.96 . . . . 72.34 108.407 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.918 HG13 ' NE ' ' A' ' 159' ' ' ARG . 26.9 mm -115.82 122.23 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.518 -0.739 . . . . 71.44 109.233 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.86 -160.38 0.29 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.789 -1.325 . . . . 73.4 109.789 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -66.67 -3.99 7.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -1.184 . . . . 74.45 109.666 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.16 134.99 34.77 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.091 -1.006 . . . . 54.21 109.101 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 27.0 m -119.89 131.4 55.23 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.786 -0.82 . . . . 54.5 108.786 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.4 mt -118.99 122.78 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-O 121.685 0.755 . . . . 45.15 109.125 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.7 m -107.79 109.12 62.16 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.732 -0.84 . . . . 71.11 108.732 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.589 ' CB ' ' HE ' ' A' ' 157' ' ' ARG . 94.9 Cg_endo -80.08 -29.95 2.4 Favored 'Trans proline' 0 N--CA 1.492 1.382 0 C-N-CA 121.967 1.778 . . . . 65.41 112.617 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -52.73 -69.16 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.113 -0.992 . . . . 63.32 109.258 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -82.3 4.52 23.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.361 -0.837 . . . . 72.52 109.05 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 54.19 81.25 0.1 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.491 -0.756 . . . . 75.33 109.456 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -149.43 136.0 19.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.244 -0.91 . . . . 71.23 109.553 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 11.6 tt -114.24 133.07 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.48 -0.763 . . . . 74.02 108.973 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 41.4 mt -124.74 115.43 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.847 -0.797 . . . . 60.23 108.847 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -130.61 134.66 47.17 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.456 -0.777 . . . . 62.32 109.762 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.462 ' O ' ' NH1' ' A' ' 140' ' ' ARG . 61.3 mttm 55.3 23.72 5.84 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.436 -0.79 . . . . 75.4 110.792 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 86.66 1.29 85.55 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.364 -1.094 . . . . 72.24 110.364 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.462 ' NH1' ' O ' ' A' ' 138' ' ' LYS . 11.1 mpt_? -88.94 126.55 35.45 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.06 -1.259 . . . . 71.22 108.838 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -100.01 127.36 46.23 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.398 -0.814 . . . . 71.42 109.86 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 24.0 t -137.65 136.2 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.366 -0.834 . . . . 53.02 109.491 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.438 ' O ' HG13 ' A' ' 144' ' ' VAL . 14.5 pt-20 -97.94 142.69 29.36 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.34 -0.85 . . . . 60.45 109.532 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 143' ' ' GLU . 12.2 m -155.53 154.74 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.161 -0.962 . . . . 74.44 109.76 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.0 pttt 178.27 115.28 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.282 -0.886 . . . . 65.15 109.137 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.01 176.18 37.74 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.689 -1.365 . . . . 73.34 109.689 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.583 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 0.0 OUTLIER -60.09 -44.32 96.23 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.4 -1.059 . . . . 72.22 109.254 -179.651 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 39.5 Cg_exo -59.57 -36.2 93.44 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.374 2.05 . . . . 65.23 112.268 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -92.57 -14.71 27.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.258 -0.901 . . . . 60.11 109.63 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -54.93 -40.07 69.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.885 . . . . 64.21 109.865 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.464 HG13 ' N ' ' A' ' 152' ' ' LEU . 10.6 p -61.12 -37.31 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.967 -1.083 . . . . 72.02 109.55 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.464 ' N ' HG13 ' A' ' 151' ' ' VAL . 7.2 tp -62.9 -51.32 67.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.494 -0.754 . . . . 73.31 110.405 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.3 p -74.71 -29.02 61.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.098 -1.001 . . . . 74.31 110.057 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -57.32 -56.74 17.89 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.833 -1.167 . . . . 74.31 109.672 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.8 pp -72.15 -27.28 62.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.395 -0.816 . . . . 75.34 109.732 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.57 -52.88 58.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.961 -1.087 . . . . 62.14 108.72 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.589 ' HE ' ' CB ' ' A' ' 130' ' ' PRO . 52.7 mtt85 -65.18 -43.83 90.42 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.663 -0.866 . . . . 61.03 108.663 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.64 ' N ' ' ND1' ' A' ' 158' ' ' HIS . 0.2 OUTLIER -86.55 30.84 0.69 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.53 -0.731 . . . . 74.12 110.245 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.918 ' NE ' HG13 ' A' ' 123' ' ' ILE . 57.1 ttm-85 -51.46 156.79 1.17 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.983 -1.073 . . . . 71.13 108.419 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 1.04 ' HB2' ' HE1' ' A' ' 216' ' ' TYR . 26.4 t70 57.12 79.02 0.2 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.248 -0.908 . . . . 75.45 108.773 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -171.76 154.08 3.53 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.472 -0.768 . . . . 73.41 109.714 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.7 mt -86.7 115.85 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 74.41 109.109 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 90.5 t -113.7 120.68 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.374 -0.829 . . . . 72.31 108.867 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 40.4 t -85.72 163.61 18.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.828 . . . . 74.12 109.74 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -60.44 -47.82 84.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.519 -0.738 . . . . 70.43 109.794 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -58.61 -36.53 74.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -0.928 . . . . 73.52 109.337 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 60.9 tp60 -55.15 -44.55 75.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.197 -0.939 . . . . 74.52 108.866 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.93 -37.17 81.38 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.22 -0.925 . . . . 72.31 108.563 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.574 ' C ' HD23 ' A' ' 169' ' ' LEU . 4.4 tt -66.53 -60.15 2.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.418 -0.801 . . . . 53.33 109.296 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.75 -15.49 61.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.837 -0.539 . . . . 62.44 110.857 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.1 -49.32 7.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.913 -1.117 . . . . 60.21 111.075 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.622 HD12 ' N ' ' A' ' 172' ' ' ILE . 2.3 mp -98.99 -53.55 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.023 -1.048 . . . . 75.32 110.453 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 23.1 m-90 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 120.896 -1.127 . . . . 73.14 109.683 -178.865 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 121.271 0.558 . . . . 64.54 109.913 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.0 p -141.75 -23.99 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.307 -0.871 . . . . 74.02 109.884 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.672 ' H ' HD12 ' A' ' 184' ' ' ILE . 2.4 mp -56.42 -29.65 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 72.33 109.854 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -58.85 -39.78 82.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.07 -1.019 . . . . 74.4 109.332 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.424 ' H ' HG23 ' A' ' 186' ' ' VAL . 1.5 t -73.27 -46.85 48.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.508 -0.745 . . . . 70.42 110.071 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.74 86.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 52.11 110.545 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.531 ' O ' HD13 ' A' ' 188' ' ' ILE . 0.2 OUTLIER -61.48 -42.96 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.915 -1.116 . . . . 71.4 109.95 -178.852 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -62.67 -43.1 99.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.83 -1.169 . . . . 73.44 109.443 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -66.65 -46.31 76.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.87 . . . . 71.42 109.794 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 81.9 mt -57.11 -38.17 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.179 -0.951 . . . . 61.55 109.435 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 36.6 mtp180 -61.76 -42.37 98.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.142 -0.974 . . . . 63.34 109.333 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.427 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 49.2 mt-30 -76.45 -30.13 57.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.475 -0.766 . . . . 61.24 110.455 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -86.51 -15.6 39.53 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.161 -0.962 . . . . 75.13 110.243 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 27.1 ttt -93.44 -39.16 11.05 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.014 -1.054 . . . . 74.02 110.622 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 193' ' ' GLN . 28.2 p-10 -62.65 -32.28 73.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.192 -0.942 . . . . 74.02 110.712 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.427 ' N ' ' OD1' ' A' ' 196' ' ' ASP . 51.8 mttt -65.08 -64.77 2.35 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.948 -1.095 . . . . 75.43 110.209 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 21.6 Cg_endo -60.04 -48.94 10.78 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.906 1.738 . . . . 72.32 111.738 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.511 HD13 ' O ' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -69.2 -41.48 77.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 74.54 108.748 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 85.95 -46.61 3.65 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.915 -1.274 . . . . 61.51 109.915 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 30.3 mt -93.64 133.44 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.239 -1.154 . . . . 61.22 109.642 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 70.7 m -75.87 135.98 40.15 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.364 -0.976 . . . . 72.0 108.364 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 19.6 p -144.83 45.91 1.36 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.982 -1.074 . . . . 74.44 110.463 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.8 m -148.99 128.58 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.007 -1.058 . . . . 64.35 108.925 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.493 ' N ' ' CD ' ' A' ' 205' ' ' GLU . 7.6 mp0 -91.44 120.54 32.37 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.096 -1.003 . . . . 71.41 109.475 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 5.9 p -93.15 111.97 23.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.257 -0.902 . . . . 73.52 109.291 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.79 128.61 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.241 -0.912 . . . . 71.02 108.989 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -56.08 -43.66 78.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.093 -1.004 . . . . 72.12 109.49 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.571 ' O ' ' N ' ' A' ' 211' ' ' GLY . 77.5 mtt180 -57.51 146.48 29.75 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.158 -0.964 . . . . 64.41 108.533 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 56.46 -79.08 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.087 -0.708 . . . . 71.54 109.087 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . 168.01 -112.17 0.47 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.239 -1.544 . . . . 72.03 109.239 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -116.38 123.63 48.07 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.56 -0.964 . . . . 75.54 109.18 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -107.18 130.11 54.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.696 -0.627 . . . . 75.31 109.677 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.856 ' CE1' ' HG3' ' A' ' 159' ' ' ARG . 12.2 t80 -89.8 139.53 30.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.945 -1.097 . . . . 75.41 108.812 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 99.6 m -152.66 150.67 29.72 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.999 -1.112 . . . . 74.14 107.999 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' TYR . . . . . 1.04 ' HE1' ' HB2' ' A' ' 160' ' ' ASP . 0.0 OUTLIER -59.86 151.13 65.51 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 120.902 -1.124 . . . . 75.32 108.755 -179.454 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo . . . . . 0 N--CA 1.495 1.56 0 C-N-CA 122.295 1.997 . . . . 73.11 111.907 -179.798 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ptt? . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.38 -0.6 . . . . 71.14 109.38 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.605 ' NH1' ' NE ' ' B' ' 43' ' ' ARG . 66.4 mtp180 -126.59 142.07 51.66 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.568 -0.708 . . . . 73.23 109.386 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 92.8 t -118.79 130.28 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.608 0.718 . . . . 72.24 109.77 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.46 HD11 ' CG1' ' B' ' 6' ' ' ILE . 4.1 tp -98.5 116.73 31.37 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.933 -0.766 . . . . 54.33 108.933 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.637 HD22 ' HG3' ' B' ' 49' ' ' MET . 0.2 OUTLIER -115.04 109.14 17.62 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.183 -1.043 . . . . 74.35 108.183 179.508 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.677 HD12 ' HB ' ' B' ' 50' ' ' VAL . 77.0 mt -101.31 99.41 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.926 -1.109 . . . . 42.55 109.021 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -145.18 130.38 18.53 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.36 -0.838 . . . . 74.52 109.223 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.41 -33.69 76.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.347 -0.846 . . . . 62.55 109.67 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -74.14 105.56 5.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 73.11 109.457 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 23.4 t -68.15 -25.84 65.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.882 . . . . 65.54 109.758 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 89.0 t -62.76 -48.59 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.189 -0.944 . . . . 75.55 109.84 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.415 ' CD1' ' NZ ' ' B' ' 97' ' ' LYS . 28.5 mt -68.22 -25.95 65.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 70.14 109.585 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.39 -34.58 25.5 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.919 -1.672 . . . . 75.4 108.919 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.55 -46.8 83.05 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.847 -1.301 . . . . 65.44 109.847 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -67.25 -43.83 80.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.057 -1.261 . . . . 60.21 109.271 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 91.1 mt -63.51 -38.47 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.957 -1.089 . . . . 75.15 108.57 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -60.69 -42.98 98.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.34 -0.85 . . . . 73.01 109.376 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -86.79 -0.09 55.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.147 -0.971 . . . . 74.3 109.161 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.47 -56.49 2.25 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.489 -1.444 . . . . 70.54 109.489 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.402 HD23 ' H ' ' B' ' 21' ' ' ASN . 1.5 pt? -72.13 -22.95 61.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -1.12 . . . . 71.34 109.613 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' ASN . . . . . 0.402 ' H ' HD23 ' B' ' 20' ' ' LEU . 37.9 m-20 -52.56 -35.19 53.24 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.096 -1.002 . . . . 64.41 109.205 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 59.1 t -54.94 -46.12 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 74.23 108.842 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.472 ' NZ ' HG11 ' B' ' 106' ' ' VAL . 35.1 mmtm -59.72 -53.36 58.88 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.884 -0.784 . . . . 63.42 108.884 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.27 36.77 0.23 Allowed Glycine 0 N--CA 1.5 2.901 0 N-CA-C 110.088 -1.205 . . . . 53.43 110.088 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -119.16 160.47 22.05 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.455 -1.027 . . . . 71.12 109.309 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 26.3 mtt -105.05 141.94 35.73 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.659 -0.867 . . . . 75.24 108.659 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.92 150.14 44.19 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.227 -0.921 . . . . 72.12 109.878 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' B' ' 28' ' ' ASP . 42.0 p30 -131.78 157.57 43.5 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.98 -0.748 . . . . 72.31 108.98 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.38 137.7 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.475 -0.765 . . . . 64.43 109.508 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.6 p -136.2 170.3 16.24 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.005 -0.739 . . . . 65.41 109.005 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -92.18 -107.32 0.11 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.199 -0.938 . . . . 71.02 109.935 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 60.2 p -78.54 169.67 17.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.225 -0.922 . . . . 51.11 110.189 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 56.4 mt -53.36 -33.16 52.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.601 -0.687 . . . . 71.24 109.815 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -51.26 -48.3 62.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 74.32 109.745 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -65.76 -43.79 87.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 73.03 109.409 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.02 -42.13 94.82 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.558 -1.417 . . . . 30.21 109.558 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -65.31 -41.3 94.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -1.122 . . . . 74.42 109.438 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' TYR . . . . . 0.452 ' O ' ' OD1' ' B' ' 41' ' ' ASP . 63.5 t80 -76.36 -21.3 56.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 74.42 109.892 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 12.5 tp -88.64 -36.47 16.24 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.078 -1.014 . . . . 75.41 109.875 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' MET . . . . . 0.445 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.3 ppp? -80.13 -29.09 38.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.175 -0.953 . . . . 60.41 110.474 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' B' ' 42' ' ' ILE . 30.4 p-10 -54.24 -32.27 55.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.966 -1.084 . . . . 53.23 109.758 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.547 ' N ' ' OD1' ' B' ' 41' ' ' ASP . 12.4 pt -84.39 -35.76 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.18 -0.95 . . . . 71.23 109.811 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.605 ' NE ' ' NH1' ' B' ' 2' ' ' ARG . 76.0 mtp180 -131.44 141.41 49.81 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.398 -0.813 . . . . 72.22 109.481 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -97.07 134.91 39.79 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.196 -0.94 . . . . 63.54 109.437 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -101.51 161.62 13.5 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.351 -0.843 . . . . 64.35 109.471 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -90.68 -42.51 10.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.178 -0.951 . . . . 62.22 109.236 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.507 HD13 ' C ' ' B' ' 47' ' ' LEU . 0.9 OUTLIER -104.3 109.78 21.75 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.782 -0.822 . . . . 73.12 108.782 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.452 ' N ' HD13 ' B' ' 47' ' ' LEU . 66.4 t -92.59 99.11 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.252 -0.905 . . . . 65.11 108.611 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.637 ' HG3' HD22 ' B' ' 5' ' ' LEU . 3.5 tpp -113.75 129.77 56.53 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.643 -0.66 . . . . 73.44 109.574 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.677 ' HB ' HD12 ' B' ' 6' ' ' ILE . 0.3 OUTLIER -147.8 126.51 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.506 -0.746 . . . . 34.5 109.223 179.302 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 4.0 m -91.22 14.42 14.37 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.55 -0.718 . . . . 73.21 109.58 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.538 ' H ' HG22 ' B' ' 50' ' ' VAL . 57.5 m-20 -75.92 145.36 40.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.152 -0.967 . . . . 70.41 109.485 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -77.42 -36.57 53.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 65.0 109.931 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -77.07 12.33 1.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -0.985 . . . . 75.21 109.492 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.72 -26.17 68.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.347 -0.846 . . . . 55.33 110.099 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.48 ' N ' HD12 ' B' ' 56' ' ' LEU . 11.1 mp -45.89 -37.08 5.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.159 -0.963 . . . . 63.14 109.96 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 83.9 p -74.92 -46.22 37.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.031 -1.043 . . . . 63.5 109.901 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 58' ' ' PHE . . . . . 0.6 ' CE2' HD11 ' B' ' 62' ' ' ILE . 63.8 t80 -64.83 -50.77 65.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 72.33 110.11 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.433 HG23 ' N ' ' B' ' 60' ' ' SER . 13.6 m -59.41 -36.7 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.755 -1.215 . . . . 74.54 109.764 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 60' ' ' SER . . . . . 0.433 ' N ' HG23 ' B' ' 59' ' ' VAL . 33.2 t -57.48 -49.14 77.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 71.24 109.791 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -71.35 -27.7 63.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.031 -1.043 . . . . 74.31 109.88 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.6 HD11 ' CE2' ' B' ' 58' ' ' PHE . 4.8 mm -61.42 -51.25 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.839 -1.163 . . . . 72.14 109.261 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -64.28 -40.51 96.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.015 . . . . 73.32 109.326 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -68.43 -41.69 79.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.235 -0.915 . . . . 73.12 108.54 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -81.67 -76.98 0.23 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.371 -0.831 . . . . 72.44 109.224 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.528 ' O ' HG22 ' B' ' 69' ' ' ILE . 31.7 m80 -92.94 91.62 7.48 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.211 -0.93 . . . . 63.31 108.97 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 80.6 p -77.29 -30.49 54.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 73.1 110.067 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 53.1 p -82.71 54.02 2.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.124 -0.985 . . . . 71.53 109.702 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.528 HG22 ' O ' ' B' ' 66' ' ' HIS . 16.7 tt -146.81 159.69 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.198 -0.939 . . . . 74.4 109.326 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 46.8 t -97.88 154.34 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.113 -0.992 . . . . 75.12 109.093 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 12.7 t -143.56 121.54 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.041 -1.037 . . . . 73.2 109.795 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.636 ' HG ' HD11 ' B' ' 95' ' ' ILE . 3.2 mp -121.77 99.67 6.58 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.463 -0.94 . . . . 73.34 108.463 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.511 ' O ' HG13 ' B' ' 73' ' ' VAL . 12.2 p -90.86 126.52 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 73.5 108.638 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.72 171.72 8.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.012 -1.055 . . . . 64.34 108.813 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.428 ' OG ' ' OE1' ' B' ' 82' ' ' GLU . 8.0 t -162.01 119.27 2.14 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.932 -1.105 . . . . 74.53 110.159 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.5 p30 -67.33 -1.09 4.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 64.5 109.389 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 77' ' ' ASN . . . . . 0.454 ' O ' ' N ' ' B' ' 79' ' ' THR . 11.9 p-10 -133.98 77.13 63.03 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 108.912 -0.773 . . . . 74.25 108.912 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.5 75.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.676 2.251 . . . . 74.43 112.033 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.454 ' N ' ' O ' ' B' ' 77' ' ' ASN . 75.1 p -98.74 148.28 24.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.128 -0.983 . . . . 73.12 109.197 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -32.62 74.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.91 . . . . 71.01 109.442 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.37 -33.19 74.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.008 . . . . 63.2 109.093 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 82' ' ' GLU . . . . . 0.428 ' OE1' ' OG ' ' B' ' 75' ' ' SER . 63.1 tt0 -73.12 -38.06 66.45 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.314 -0.866 . . . . 73.22 109.304 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' B' ' 83' ' ' GLU . 0.4 OUTLIER -57.62 -52.07 66.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 74.3 109.351 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 14.4 m -59.94 -38.96 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -0.969 . . . . 73.31 109.405 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -67.7 -35.42 78.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.118 -0.989 . . . . 73.24 109.303 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -65.56 -36.85 84.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 55.33 109.833 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -83.81 -38.64 21.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.045 -1.034 . . . . 74.14 109.238 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -68.22 -44.19 76.31 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.303 -0.873 . . . . 64.04 109.485 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -66.66 -48.91 67.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 72.35 109.595 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 141.65 75.45 0.04 OUTLIER Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.859 -1.296 . . . . 65.2 109.859 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 91' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -136.6 138.88 41.67 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.327 -1.102 . . . . 52.23 109.136 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.43 -44.25 52.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 73.32 109.348 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -153.81 166.1 33.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.352 -0.842 . . . . 72.22 109.531 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.527 ' O ' ' CD1' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -136.85 139.51 41.74 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.012 -0.736 . . . . 64.42 109.012 -178.743 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 0.806 HD12 ' N ' ' B' ' 95' ' ' ILE . 0.5 OUTLIER -132.45 151.43 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.512 -0.743 . . . . 72.23 110.25 -179.328 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.5 124.65 23.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.814 -1.179 . . . . 25.24 108.101 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.667 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -47.0 -55.25 15.86 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.985 -1.072 . . . . 64.32 111.103 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 98' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 4.2 Cg_endo -41.93 -10.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.124 0 C-N-CA 120.853 1.035 . . . . 63.33 112.734 -177.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 99' ' ' TYR . . . . . 0.667 ' N ' ' O ' ' B' ' 97' ' ' LYS . 51.7 m-85 61.05 128.29 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.353 -0.61 . . . . 75.13 109.353 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -72.34 -29.66 64.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.961 -1.087 . . . . 74.23 109.42 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 101' ' ' SER . . . . . 0.719 ' O ' ' N ' ' B' ' 103' ' ' LYS . 30.2 t -175.08 31.6 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.944 -1.097 . . . . 63.34 111.115 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 36.8 mm 52.34 -70.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.48 -0.763 . . . . 74.44 110.129 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' B' ' 101' ' ' SER . 67.2 mmtt -57.99 -33.0 68.45 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.18 -1.044 . . . . 71.11 108.18 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.27 -44.32 96.81 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.176 -1.046 . . . . 71.45 108.176 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 17.4 tp -64.5 -46.68 81.95 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.565 -0.902 . . . . 51.31 108.565 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 106' ' ' VAL . . . . . 0.472 HG11 ' NZ ' ' B' ' 23' ' ' LYS . 76.9 t -58.86 -41.31 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.976 . . . . 65.23 109.165 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.23 -36.63 71.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.316 -0.865 . . . . 24.32 109.131 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 54.4 ttt85 -79.44 -26.89 41.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.306 -0.871 . . . . 75.31 109.906 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 93.7 mt -76.48 -43.71 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.032 -1.043 . . . . 54.24 108.731 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 110' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' B' ' 114' ' ' ARG . 23.9 pt-20 -70.25 -28.39 65.21 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.336 -0.945 . . . . 65.31 108.714 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 111' ' ' ALA . . . . . 0.532 ' HB1' ' CE1' ' A' ' 87' ' ' PHE . . . -63.34 -49.24 74.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.409 -0.807 . . . . 72.24 109.397 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -61.5 -42.32 98.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.224 -0.922 . . . . 72.04 109.702 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 45.6 mt -120.0 49.51 1.39 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.458 -0.776 . . . . 75.35 109.569 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.529 ' N ' ' O ' ' B' ' 110' ' ' GLU . 1.2 tmt_? -65.37 -59.13 4.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -0.951 . . . . 75.5 109.232 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -69.36 -47.98 62.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 65.33 109.476 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 116' ' ' TRP . . . . . 0.526 ' O ' ' CD2' ' B' ' 116' ' ' TRP . 76.8 t90 45.83 58.59 4.24 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.313 -0.867 . . . . 74.45 109.791 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 171.13 94.69 0.1 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.414 -1.474 . . . . 44.21 109.414 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 48.7 m -144.9 170.63 15.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.295 -1.121 . . . . 71.4 109.637 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 119' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' B' ' 119' ' ' ASN . 0.0 OUTLIER -157.15 124.11 5.12 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.007 -0.738 . . . . 72.32 109.007 -178.386 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 77.7 t -77.95 -35.83 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 75.02 110.229 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 121' ' ' ILE . . . . . 0.412 HD12 ' N ' ' B' ' 121' ' ' ILE . 4.9 mp -113.54 140.86 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.334 -0.853 . . . . 51.41 109.544 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -145.48 119.22 9.21 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.194 -0.941 . . . . 71.53 109.566 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 6.8 pt -130.54 130.76 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.387 -0.821 . . . . 72.43 109.124 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 44.11 -136.27 5.48 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.797 -1.321 . . . . 51.23 109.797 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 125' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' B' ' 125' ' ' ASP . 20.3 p-10 -89.09 0.98 56.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -1.136 . . . . 74.2 109.035 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.0 134.63 40.12 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.36 -0.978 . . . . 75.42 108.36 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 8.4 m -130.17 143.72 50.94 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.393 -0.817 . . . . 74.22 109.471 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 25.2 mt -127.7 128.76 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.542 -0.724 . . . . 60.33 109.633 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 49.9 m -119.79 92.64 46.75 Favored Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 108.974 -0.75 . . . . 72.31 108.974 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.24 -22.27 9.85 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.134 1.889 . . . . 75.13 112.613 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -52.09 -46.33 65.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.033 -1.042 . . . . 75.23 108.985 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -103.13 16.47 26.52 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.385 -0.822 . . . . 72.43 109.021 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 51.77 58.3 5.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.222 -0.924 . . . . 75.13 108.866 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -137.38 124.4 21.51 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.547 -0.72 . . . . 73.22 109.204 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 135' ' ' ILE . . . . . 0.441 HG23 ' O ' ' B' ' 135' ' ' ILE . 18.5 tt -107.09 129.9 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.368 -0.832 . . . . 64.14 109.097 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 5.7 mm -108.83 126.35 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.471 -0.768 . . . . 71.22 109.281 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 137' ' ' TYR . . . . . 0.494 ' C ' ' H ' ' B' ' 139' ' ' GLY . 78.8 t80 -140.26 148.01 40.83 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.526 -0.916 . . . . 64.22 108.526 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 138' ' ' LYS . . . . . 0.486 ' O ' ' NH1' ' B' ' 140' ' ' ARG . 40.3 tttp 54.54 6.27 0.11 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.344 -0.848 . . . . 72.02 109.619 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 139' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' B' ' 137' ' ' TYR . . . 94.61 -5.14 69.88 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.072 -1.211 . . . . 74.32 110.072 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 140' ' ' ARG . . . . . 0.511 ' CD ' ' N ' ' B' ' 140' ' ' ARG . 10.7 mpt_? -88.9 142.84 27.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.151 -1.206 . . . . 75.34 109.042 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -94.17 129.13 40.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.273 -0.892 . . . . 71.23 109.552 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 39.0 t -131.23 129.03 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.45 -0.781 . . . . 70.43 109.391 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -99.14 142.79 30.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.237 -0.915 . . . . 72.43 109.318 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 144' ' ' VAL . . . . . 0.505 ' CG2' ' CG ' ' B' ' 149' ' ' PHE . 11.9 p -141.5 157.05 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.297 -0.877 . . . . 72.13 109.593 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 145' ' ' LYS . . . . . 0.444 ' N ' HG22 ' B' ' 144' ' ' VAL . 13.2 ptpt -165.85 116.36 1.03 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.886 . . . . 72.02 109.635 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 168.34 -178.95 41.69 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.779 -1.728 . . . . 42.23 108.779 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 147' ' ' LYS . . . . . 0.563 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 1.3 mptp? -79.45 -44.22 1.63 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.052 -1.263 . . . . 73.3 109.558 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 148' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 25.3 Cg_exo -62.34 -15.69 46.62 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 122.552 2.168 . . . . 71.33 112.33 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 149' ' ' PHE . . . . . 0.505 ' CG ' ' CG2' ' B' ' 144' ' ' VAL . 23.3 m-85 -100.69 -35.5 9.45 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.359 -0.838 . . . . 74.23 110.153 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -58.06 -27.77 63.93 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.229 -0.919 . . . . 72.34 108.774 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.541 HG13 ' N ' ' B' ' 152' ' ' LEU . 8.5 p -65.91 -44.89 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.207 -0.933 . . . . 73.35 108.515 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.541 ' N ' HG13 ' B' ' 151' ' ' VAL . 32.3 tp -55.47 -41.86 73.53 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.745 -0.835 . . . . 55.24 108.745 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 18.6 p -71.35 -29.45 65.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.397 -0.814 . . . . 70.01 109.665 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -59.27 -57.44 13.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.062 -1.024 . . . . 65.32 109.719 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 155' ' ' LEU . . . . . 0.421 ' H ' HD23 ' B' ' 155' ' ' LEU . 0.0 OUTLIER -68.55 -23.52 64.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.049 -1.032 . . . . 71.54 109.053 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.26 -50.48 73.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.103 -0.998 . . . . 75.32 109.79 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 45.9 mtt180 -71.1 -41.72 70.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.09 -1.006 . . . . 73.32 109.425 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -78.25 35.42 0.22 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.51 -0.744 . . . . 74.14 109.812 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 159' ' ' ARG . . . . . 0.582 ' NH1' ' CZ ' ' B' ' 214' ' ' PHE . 52.6 ttm-85 -70.24 163.14 27.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.967 . . . . 61.41 108.914 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 51.94 44.91 29.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.053 -1.03 . . . . 72.1 109.439 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -154.42 -175.82 5.59 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.279 -0.888 . . . . 72.25 109.944 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 70.1 mt -112.65 138.17 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.194 -0.669 . . . . 72.31 109.194 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.66 138.23 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.535 -0.728 . . . . 64.21 109.079 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 13.5 p -92.8 161.5 14.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.308 -0.87 . . . . 74.22 109.882 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -62.71 -49.59 74.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.476 -0.765 . . . . 65.31 109.465 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 166' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' B' ' 166' ' ' GLU . 49.9 mp0 -62.11 -35.18 77.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.346 -0.846 . . . . 63.45 109.656 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 167' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' B' ' 171' ' ' ALA . 61.2 tt0 -59.25 -35.87 74.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.161 -0.962 . . . . 72.4 109.433 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 92.1 mt -68.69 -50.34 51.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.127 -0.983 . . . . 72.32 109.492 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 9.4 mp -58.92 -43.84 91.18 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.141 -0.974 . . . . 73.34 109.264 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -75.93 -21.98 56.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.094 -1.004 . . . . 72.1 109.974 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 171' ' ' ALA . . . . . 0.444 ' C ' HD12 ' B' ' 172' ' ' ILE . . . -69.67 -46.86 65.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.9 -1.125 . . . . 62.13 109.66 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 0.736 ' N ' HD12 ' B' ' 172' ' ' ILE . 1.6 mp -94.56 -54.62 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.227 -0.92 . . . . 71.42 109.163 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 29.4 m-90 . . . . . 0 N--CA 1.494 1.758 0 O-C-N 121.213 -0.929 . . . . 72.23 109.724 -179.69 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 N--CA 1.493 1.455 0 CA-C-O 121.395 0.498 . . . . 65.22 111.259 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -148.79 -8.78 0.36 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.283 -0.886 . . . . 72.31 109.884 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 47.5 t -60.13 -24.15 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.087 -1.008 . . . . 63.32 109.618 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 41.8 mt -55.23 -48.23 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.353 -0.842 . . . . 75.03 110.625 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -63.47 -37.0 85.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 64.11 110.484 -178.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.78 -42.81 54.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.305 -0.872 . . . . 73.0 110.685 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.82 -47.32 47.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.788 -1.195 . . . . 61.12 110.491 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 188' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' B' ' 189' ' ' ASN . 9.3 tp -65.11 -41.94 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.021 -1.049 . . . . 72.43 110.48 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 189' ' ' ASN . . . . . 0.416 ' N ' ' CG2' ' B' ' 188' ' ' ILE . 61.7 t-20 -61.64 -47.47 85.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.998 -1.064 . . . . 65.14 109.959 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -65.03 -50.97 64.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.154 -0.966 . . . . 63.24 110.05 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 75.8 mt -49.31 -34.22 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.125 -0.984 . . . . 74.03 109.752 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -48.57 64.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.113 -0.992 . . . . 72.24 108.98 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -71.18 -25.3 62.47 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.244 -0.91 . . . . 73.1 110.074 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -88.35 -19.91 26.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.371 -0.83 . . . . 72.11 109.862 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 195' ' ' MET . . . . . 0.445 ' SD ' HD11 ' B' ' 152' ' ' LEU . 6.2 ttt -103.57 -45.26 4.88 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.355 -0.841 . . . . 44.33 110.575 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -59.26 -40.29 85.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.081 -1.012 . . . . 71.21 110.471 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 197' ' ' LYS . . . . . 0.439 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 0.9 OUTLIER -58.22 -65.23 2.01 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.12 -0.988 . . . . 75.21 110.545 -179.268 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 198' ' ' PRO . . . . . 0.448 ' O ' ' CZ ' ' B' ' 137' ' ' TYR . 19.4 Cg_endo -56.88 -53.98 4.32 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.568 1.512 . . . . 75.32 112.238 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 199' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' B' ' 201' ' ' ILE . 11.1 mp -63.1 -34.18 77.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.134 -0.979 . . . . 72.25 109.084 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 74.7 -37.15 1.03 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.706 -1.358 . . . . 64.53 109.706 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 201' ' ' ILE . . . . . 0.435 ' H ' ' C ' ' B' ' 199' ' ' LEU . 39.7 mm -93.15 132.5 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.285 -1.127 . . . . 44.23 109.386 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 14.4 t -77.22 135.16 38.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 54.01 108.861 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 203' ' ' THR . . . . . 0.454 ' O ' ' CE1' ' B' ' 214' ' ' PHE . 16.1 p -144.22 40.41 1.35 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.279 -0.888 . . . . 74.4 109.628 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 7.2 m -141.2 142.55 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.135 -0.978 . . . . 72.12 109.631 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -121.71 136.09 54.94 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.929 -0.767 . . . . 65.41 108.929 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.12 135.99 46.61 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.377 -0.827 . . . . 71.33 109.712 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.42 ' O ' HG13 ' B' ' 207' ' ' VAL . 13.1 p -141.7 131.83 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.295 -0.878 . . . . 63.5 109.129 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -80.27 -25.08 39.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.172 -0.955 . . . . 74.45 109.814 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 60.1 mtp85 -48.85 -27.49 3.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 74.14 109.818 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -151.92 -67.74 0.17 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.088 -1.007 . . . . 74.43 109.694 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 211' ' ' GLY . . . . . 0.424 ' C ' ' CD1' ' B' ' 212' ' ' TYR . . . -162.84 -100.8 0.15 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.859 -1.296 . . . . 64.45 109.859 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 212' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' B' ' 211' ' ' GLY . 38.6 m-85 -137.17 158.38 44.58 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.458 -1.025 . . . . 74.21 109.389 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -130.96 125.88 34.56 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.548 -0.72 . . . . 74.03 109.694 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 214' ' ' PHE . . . . . 0.582 ' CZ ' ' NH1' ' B' ' 159' ' ' ARG . 0.3 OUTLIER -85.59 119.56 26.07 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.348 -0.982 . . . . 74.34 108.348 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 48.3 t -132.66 149.5 52.29 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.189 -0.671 . . . . 64.33 109.189 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.15 164.05 3.9 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.188 -0.945 . . . . 70.04 108.631 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.03 -161.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.658 2.239 . . . . 65.11 111.586 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 43.9 mttm . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.144 -0.972 . . . . 73.15 109.037 179.852 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.55 ' SD ' ' CE2' ' A' ' 25' ' ' PHE . 12.1 ptp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.442 -0.577 . . . . 65.12 109.442 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.3 mtt85 -141.49 149.58 41.1 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.319 -0.863 . . . . 72.33 109.315 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 80.3 t -114.45 141.04 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.633 -0.667 . . . . 71.42 109.495 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.533 HD11 ' CG1' ' A' ' 6' ' ' ILE . 4.6 tp -112.35 118.81 36.25 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.532 -0.73 . . . . 65.12 109.583 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 4' ' ' LEU . 18.3 mt -115.74 101.94 9.27 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.479 -0.763 . . . . 62.43 109.18 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.533 ' CG1' HD11 ' A' ' 4' ' ' LEU . 76.6 mt -97.27 107.92 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.228 -0.92 . . . . 71.15 108.839 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.535 ' OE2' ' NZ ' ' A' ' 97' ' ' LYS . 53.5 tt0 -151.28 129.53 11.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.259 -0.901 . . . . 75.34 109.557 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -62.66 -33.04 74.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -0.895 . . . . 72.44 109.377 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -76.82 95.08 3.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.903 . . . . 63.02 109.329 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.0 t -61.11 -25.2 66.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.343 -0.848 . . . . 72.34 109.683 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.08 -53.95 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.964 . . . . 74.02 109.844 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.548 HD13 ' NZ ' ' A' ' 97' ' ' LYS . 49.5 mt -64.37 -44.07 92.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.941 . . . . 71.43 109.678 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.29 -24.63 75.96 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.123 -1.991 . . . . 61.32 108.123 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.75 -57.0 10.56 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 109.702 -1.359 . . . . 71.2 109.702 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -53.5 -45.87 69.83 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.313 -1.11 . . . . 71.32 109.651 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 78.4 mt -67.34 -45.59 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.757 -1.214 . . . . 63.23 109.041 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -51.29 -48.39 62.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.127 -0.983 . . . . 51.11 109.358 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.402 ' HB3' ' HZ2' ' A' ' 18' ' ' LYS . 15.3 ttpp -86.59 -0.09 55.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.248 -0.907 . . . . 73.34 109.19 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.6 -59.03 2.43 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.847 -1.301 . . . . 62.15 109.847 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -71.49 -20.9 62.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -1.171 . . . . 73.51 109.938 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -57.65 -31.59 66.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.119 -0.988 . . . . 74.25 109.576 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.5 t -59.34 -29.76 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.871 . . . . 70.04 109.189 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.719 ' HZ1' ' HZ1' ' A' ' 103' ' ' LYS . 32.3 mmtt -76.51 5.44 7.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.423 -0.798 . . . . 73.23 109.267 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.57 25.39 56.73 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.12 -1.192 . . . . 75.54 110.12 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CE2' ' SD ' ' A' ' 1' ' ' MET . 8.7 m-85 -102.02 156.86 17.27 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.287 -1.125 . . . . 73.43 109.119 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.3 mmt -107.07 136.61 46.64 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.461 -0.941 . . . . 43.24 108.461 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.49 165.79 26.98 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.191 -0.943 . . . . 62.11 109.949 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.413 ' OD2' ' CD2' ' A' ' 39' ' ' LEU . 25.3 t70 -139.65 150.3 44.77 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.432 -0.792 . . . . 74.42 108.995 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.33 139.48 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.483 -0.761 . . . . 72.15 109.276 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 p -137.84 176.1 9.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.381 -0.824 . . . . 71.42 109.295 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -97.73 -104.47 0.19 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.331 -0.856 . . . . 72.33 109.77 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.3 m -77.99 166.57 22.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.227 -0.92 . . . . 74.24 110.158 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.4 mt -51.0 -35.46 34.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.606 -0.684 . . . . 71.53 109.853 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -51.9 -50.31 61.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.18 -0.95 . . . . 74.23 109.947 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -63.82 -40.06 95.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.108 -0.995 . . . . 54.03 109.247 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.05 -38.48 63.81 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.344 -1.502 . . . . 61.41 109.344 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -63.63 -42.92 98.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -1.121 . . . . 74.34 109.499 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -72.55 -34.04 67.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 75.33 109.555 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.413 ' CD2' ' OD2' ' A' ' 28' ' ' ASP . 21.1 tp -71.45 -49.54 40.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.891 . . . . 74.33 109.966 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 40' ' ' MET . 3.9 ppp? -67.67 -22.96 65.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.076 -1.015 . . . . 70.32 109.849 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -59.58 -38.06 80.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.178 -0.951 . . . . 71.22 110.002 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.3 pt -85.47 -29.82 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.157 -0.964 . . . . 74.14 110.325 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 40' ' ' MET . 65.8 mtt85 -130.39 144.67 51.53 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.237 -0.915 . . . . 72.24 109.784 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -99.07 127.62 45.04 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.308 -0.87 . . . . 75.42 109.24 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -99.66 145.36 27.68 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.298 -0.876 . . . . 74.23 109.534 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -79.1 -35.72 41.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 72.04 109.282 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.549 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -110.15 116.85 32.27 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.652 -0.87 . . . . 72.13 108.652 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.549 ' N ' HD13 ' A' ' 47' ' ' LEU . 50.6 t -102.71 100.43 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.429 -0.952 . . . . 72.34 108.429 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.434 ' CE ' ' OH ' ' A' ' 99' ' ' TYR . 21.0 ttt -115.5 136.76 52.75 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.546 0.689 . . . . 74.11 110.079 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.605 HG22 ' H ' ' A' ' 52' ' ' ASP . 1.5 p -145.07 132.22 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.57 -0.706 . . . . 61.12 109.628 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.0 m -92.78 2.03 56.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.457 -0.777 . . . . 73.11 109.253 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.605 ' H ' HG22 ' A' ' 50' ' ' VAL . 51.5 m-20 -76.95 142.23 40.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 52.55 109.508 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.412 ' C ' ' H ' ' A' ' 55' ' ' ALA . 15.5 ptpt -81.15 -31.15 34.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.22 -0.925 . . . . 44.22 110.092 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -74.02 10.8 1.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.088 -1.008 . . . . 70.44 109.354 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.412 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -67.4 -21.05 65.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.427 -0.796 . . . . 64.14 110.253 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.6 mt -43.13 -48.42 6.33 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.255 -0.903 . . . . 44.14 110.067 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.2 m -68.75 -36.23 78.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.01 -1.056 . . . . 55.23 108.743 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -64.73 -64.86 0.77 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.368 -0.833 . . . . 74.44 109.579 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.1 m -48.27 -32.55 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.68 -1.263 . . . . 74.03 109.646 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.9 t -57.41 -50.53 72.71 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.227 -0.921 . . . . 64.3 109.074 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.413 ' HG2' ' H ' ' A' ' 61' ' ' ARG . 7.0 ptp180 -72.33 -34.74 68.29 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.19 -1.004 . . . . 64.44 110.128 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.8 mm -67.36 -33.48 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.599 -1.313 . . . . 63.21 109.422 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -68.25 -48.9 63.83 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.231 -0.918 . . . . 74.42 110.248 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.414 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 17.2 pt-20 -75.39 -40.68 57.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.958 -1.089 . . . . 70.32 110.308 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.521 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 54.9 mttp -73.85 -21.68 60.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.198 -0.939 . . . . 75.22 110.015 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.521 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 84.4 m-70 -156.79 64.63 0.52 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.013 -1.054 . . . . 74.13 109.677 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.3 t -61.42 -28.15 69.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.935 . . . . 73.24 109.683 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 84.6 p -64.33 -20.73 66.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.266 -0.896 . . . . 61.01 110.107 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 70' ' ' VAL . 78.3 mt -82.72 159.18 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.065 -1.022 . . . . 71.33 109.772 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.471 ' N ' HG22 ' A' ' 69' ' ' ILE . 98.4 t -95.39 149.65 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.455 -0.778 . . . . 72.13 109.213 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.0 t -130.53 126.94 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.421 -0.799 . . . . 54.21 109.71 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.0 tt -121.89 101.95 7.88 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.493 -0.755 . . . . 50.24 109.063 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 69.4 t -90.37 145.88 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 74.41 109.154 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.7 m -128.54 155.6 44.63 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.325 -0.859 . . . . 72.31 108.751 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.6 m -165.47 144.32 6.32 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.979 -1.075 . . . . 64.54 110.68 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -86.88 19.83 2.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.482 -0.761 . . . . 74.13 109.753 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 79' ' ' THR . 55.4 t30 -138.91 55.58 7.95 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.302 -0.874 . . . . 73.34 109.397 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 77' ' ' ASN . 15.1 Cg_endo -57.5 77.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.364 2.043 . . . . 63.22 111.532 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.464 HG23 ' H ' ' A' ' 82' ' ' GLU . 12.5 t -102.81 171.84 7.18 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.56 -0.904 . . . . 62.53 108.56 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 p -75.74 -20.63 58.17 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.2 -0.938 . . . . 73.44 110.081 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.511 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 77.1 tt0 -69.52 -49.91 50.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.043 -1.036 . . . . 71.42 109.533 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.464 ' H ' HG23 ' A' ' 79' ' ' THR . 98.9 mt-10 -73.82 -27.6 61.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 73.43 109.576 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -61.26 -56.68 17.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 74.22 109.85 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.524 HG23 ' N ' ' A' ' 85' ' ' HIS . 31.7 m -65.58 -43.61 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 73.2 109.812 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.524 ' N ' HG23 ' A' ' 84' ' ' VAL . 32.2 m80 -63.44 -31.23 72.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.112 -0.993 . . . . 53.33 109.701 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.32 -45.56 79.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.085 -1.01 . . . . 64.11 109.809 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -79.98 -30.35 39.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.091 -1.005 . . . . 74.34 109.207 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -71.97 -51.58 21.25 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.309 -0.869 . . . . 74.42 109.254 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -60.68 -48.58 81.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.499 -0.751 . . . . 74.24 109.622 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.16 70.82 0.02 OUTLIER Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.332 -1.107 . . . . 61.51 110.332 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.02 125.1 43.97 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.439 -1.036 . . . . 55.33 108.634 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -77.09 -27.51 54.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.999 -1.063 . . . . 73.42 109.428 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 94' ' ' TYR . 13.3 t0 -151.81 162.38 41.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 75.04 109.059 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.526 ' N ' ' OD1' ' A' ' 93' ' ' ASP . 58.3 t80 -148.3 101.82 3.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.208 -0.933 . . . . 71.33 109.484 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.1 mm -104.83 150.65 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.475 0 O-C-N 121.179 -0.951 . . . . 71.13 110.682 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.38 123.71 20.73 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.408 -1.33 . . . . 64.32 107.408 178.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.683 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -43.18 -57.68 4.98 Favored Pre-proline 0 C--N 1.3 -1.583 0 O-C-N 121.217 -0.927 . . . . 62.2 112.298 -178.364 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 6.7 Cg_endo -43.27 -7.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 120.93 1.087 . . . . 73.11 112.49 -174.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.683 ' N ' ' O ' ' A' ' 97' ' ' LYS . 58.4 m-85 57.81 120.89 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.07 0.462 . . . . 65.22 110.268 178.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.529 ' NE ' ' OH ' ' B' ' 94' ' ' TYR . 56.5 mtt-85 -62.06 -44.58 96.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.02 -1.05 . . . . 72.35 109.327 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.84 ' O ' ' N ' ' A' ' 103' ' ' LYS . 13.0 t -171.83 47.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.091 -1.006 . . . . 71.32 110.696 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.3 mt 40.21 -66.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 CA-C-N 118.324 0.511 . . . . 75.43 111.562 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.84 ' N ' ' O ' ' A' ' 101' ' ' SER . 40.9 tptt -47.03 -26.87 1.14 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.098 -1.002 . . . . 71.41 109.025 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.38 -47.02 52.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.363 -0.836 . . . . 63.24 109.884 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.4 HD13 ' C ' ' A' ' 105' ' ' LEU . 2.1 tm? -58.95 -57.23 14.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 73.22 109.324 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.46 HG13 ' N ' ' A' ' 107' ' ' ALA . 7.2 p -52.58 -40.91 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.596 -1.315 . . . . 60.11 109.222 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.46 ' N ' HG13 ' A' ' 106' ' ' VAL . . . -51.49 -44.04 62.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 70.42 109.19 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -66.22 -34.71 78.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.206 -0.934 . . . . 74.41 109.094 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.7 mt -72.09 -26.77 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.152 -0.967 . . . . 62.54 108.483 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.19 -58.28 5.74 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.689 -0.804 . . . . 74.34 109.399 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.31 -40.46 67.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.183 -0.948 . . . . 73.32 109.311 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.415 ' CA ' ' HE ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -62.05 -31.06 71.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -0.866 . . . . 52.41 109.334 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.477 HD22 ' SD ' ' A' ' 1' ' ' MET . 2.1 tt -156.14 98.21 1.85 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 65.24 109.597 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.3 mtm180 -92.04 -81.3 0.34 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.189 -0.944 . . . . 64.45 109.077 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -80.38 -81.93 0.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 74.43 109.554 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -149.67 -175.91 5.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.304 -0.873 . . . . 74.42 109.429 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.48 -155.06 4.95 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.395 -1.482 . . . . 75.04 109.395 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.6 m -134.37 164.82 26.56 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.343 -1.092 . . . . 61.14 109.569 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.67 127.15 21.55 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.083 -0.71 . . . . 65.24 109.083 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 56.4 t -89.32 -20.63 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.312 -0.867 . . . . 73.11 109.551 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.6 HG23 HH12 ' A' ' 159' ' ' ARG . 4.7 mp -117.78 119.7 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.399 -0.813 . . . . 72.24 109.004 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -140.86 122.81 15.49 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.408 -0.808 . . . . 72.34 109.748 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.442 HG23 ' O ' ' A' ' 123' ' ' ILE . 15.5 tt -138.33 130.78 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.383 -0.823 . . . . 71.44 109.143 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.62 -134.72 34.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.281 -1.528 . . . . 73.4 109.281 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.72 -9.06 45.14 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.07 -1.253 . . . . 74.45 109.462 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.35 135.73 33.77 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.971 -1.081 . . . . 54.21 108.915 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 44.2 p -129.33 139.18 51.83 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.457 -0.777 . . . . 54.5 109.122 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 81.3 mt -130.78 131.82 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.399 -0.813 . . . . 45.15 109.834 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.4 m -126.31 110.86 23.65 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.302 -0.999 . . . . 71.11 108.302 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.98 -38.47 0.82 Allowed 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.533 1.489 . . . . 65.41 112.046 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -65.35 -42.54 92.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.177 -0.952 . . . . 63.32 109.238 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 133' ' ' GLU . 44.7 mm-40 -87.82 11.48 15.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.333 -0.854 . . . . 72.52 109.708 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 132' ' ' GLU . 11.8 pt-20 33.48 61.78 0.43 Allowed 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.209 0.528 . . . . 75.33 110.846 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -152.74 148.42 27.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.081 -1.012 . . . . 71.23 110.213 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.2 tt -135.51 144.36 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.507 -0.746 . . . . 74.02 109.177 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 20.5 mt -125.49 135.37 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.63 -0.878 . . . . 60.23 108.63 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -139.38 135.68 33.94 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.086 -1.009 . . . . 62.32 110.271 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm 54.01 28.9 9.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.584 -0.698 . . . . 75.4 110.366 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.42 16.56 75.72 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 120.025 -1.083 . . . . 72.24 110.9 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -111.01 125.3 53.59 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.343 -1.093 . . . . 71.22 109.37 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -92.98 123.39 36.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.253 -0.904 . . . . 71.42 110.279 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.3 p -137.0 138.97 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.251 -1.018 . . . . 53.02 108.251 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.451 ' N ' ' CD ' ' A' ' 143' ' ' GLU . 19.3 mp0 -99.99 143.9 29.66 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.309 -0.869 . . . . 60.45 110.406 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.6 m -142.6 130.99 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.481 -0.933 . . . . 74.44 108.481 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.01 19.58 0.88 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.173 -0.954 . . . . 65.15 109.736 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.85 173.86 47.46 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.132 -1.587 . . . . 73.34 109.132 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.619 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 27.2 mttt -69.83 -37.17 7.46 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.138 -1.213 . . . . 72.22 110.162 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 19.1 Cg_exo -64.48 -18.62 63.56 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.09 1.86 . . . . 65.23 111.907 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -95.28 -30.9 13.72 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.214 -0.929 . . . . 60.11 110.009 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -50.43 -35.95 30.97 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.097 -1.002 . . . . 64.21 109.197 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.6 p -62.2 -33.37 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.138 -0.976 . . . . 72.02 109.091 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 9.5 tp -67.1 -39.3 86.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.823 . . . . 73.31 109.248 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 39.1 p -73.95 -29.7 62.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.066 -1.021 . . . . 74.31 109.388 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -61.81 -57.78 10.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.067 -1.021 . . . . 74.31 109.742 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 pp -64.43 -29.5 70.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.127 -0.983 . . . . 75.34 109.192 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.45 -45.83 69.63 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.236 -0.915 . . . . 62.14 109.046 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -73.05 -46.3 52.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.103 -0.998 . . . . 61.03 108.915 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -79.59 29.35 0.25 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.593 -0.692 . . . . 74.12 109.889 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.6 HH12 HG23 ' A' ' 121' ' ' ILE . 19.9 ttp-105 -71.29 44.7 0.09 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.162 -0.961 . . . . 71.13 109.563 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -171.26 46.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.88 -1.138 . . . . 75.45 109.915 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -168.39 178.55 4.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.023 -1.048 . . . . 73.41 109.975 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 66.7 mt -96.25 139.43 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.45 -0.781 . . . . 74.41 109.244 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 78.7 t -132.28 140.08 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.368 -0.832 . . . . 72.31 109.617 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 32.3 p -98.88 169.32 9.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.255 -0.903 . . . . 74.12 109.843 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -67.04 -46.79 73.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.52 -0.738 . . . . 70.43 109.982 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -53.73 -36.42 62.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.356 -0.84 . . . . 73.52 109.778 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -61.09 -49.32 77.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.158 -0.964 . . . . 74.52 109.525 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 38.7 mt -51.27 -40.6 59.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.077 -1.014 . . . . 72.31 109.027 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.562 ' C ' HD23 ' A' ' 169' ' ' LEU . 4.2 tt -60.65 -65.08 0.75 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.451 -0.781 . . . . 53.33 109.793 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -66.38 -10.92 48.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.214 -0.929 . . . . 62.44 110.591 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.424 ' C ' HD12 ' A' ' 172' ' ' ILE . . . -73.25 -52.93 12.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.953 -1.092 . . . . 60.21 110.033 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.771 HD12 ' N ' ' A' ' 172' ' ' ILE . 1.7 mp -95.77 -52.56 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.019 -1.051 . . . . 75.32 109.2 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 21.7 m-90 . . . . . 0 N--CA 1.495 1.807 0 O-C-N 121.333 -0.854 . . . . 73.14 109.259 -179.896 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.497 -0.556 . . . . 64.54 109.497 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 8.8 p -130.15 -13.69 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.347 -0.846 . . . . 74.02 110.556 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 58.6 mt -56.55 -27.83 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.749 -1.219 . . . . 72.33 109.235 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -53.12 -48.94 67.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.317 -0.864 . . . . 74.4 109.48 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.433 ' H ' HG23 ' A' ' 186' ' ' VAL . 2.2 t -73.79 -28.63 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.474 -0.766 . . . . 70.42 109.982 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.44 -41.13 66.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.143 -0.973 . . . . 52.11 111.071 -178.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.7 tp -76.4 -33.97 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.52 -1.363 . . . . 71.4 109.823 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -66.55 -55.72 14.16 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.272 -0.893 . . . . 73.44 110.14 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -61.85 -36.74 82.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 71.42 110.263 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 74.8 mt -69.4 -40.85 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.157 -0.965 . . . . 61.55 110.227 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 44.1 mtp85 -58.01 -39.12 77.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.88 -1.138 . . . . 63.34 108.985 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -78.06 -36.61 48.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 61.24 109.677 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -84.46 2.51 40.54 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.185 -0.947 . . . . 75.13 110.49 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' MET . . . . . 1.014 ' HE1' HG11 ' A' ' 204' ' ' VAL . 44.3 ttp -99.58 -47.16 5.21 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.088 -1.007 . . . . 74.02 109.662 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -68.82 -32.05 71.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.89 . . . . 74.02 109.869 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.434 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 1.1 mmtm -55.2 -64.49 2.05 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.23 -0.919 . . . . 75.43 109.555 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 40.0 Cg_endo -64.17 -53.66 1.1 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.128 1.885 . . . . 72.32 112.236 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.9 mp -54.71 -56.61 17.41 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.971 -1.08 . . . . 74.54 109.643 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 100.35 -17.99 56.04 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 109.842 -1.303 . . . . 61.51 109.842 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 41.2 mt -128.16 147.78 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.341 -1.094 . . . . 61.22 109.104 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 17.5 t -77.96 136.6 38.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.971 -1.08 . . . . 72.0 109.278 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.21 15.87 1.88 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.203 -0.935 . . . . 74.44 109.302 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 1.014 HG11 ' HE1' ' A' ' 195' ' ' MET . 31.2 m -127.42 152.32 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.551 -0.718 . . . . 64.35 110.089 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -126.95 130.56 50.34 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.878 -0.786 . . . . 71.41 108.878 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 4.2 t -98.84 127.23 44.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.196 -0.94 . . . . 73.52 109.06 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 209' ' ' ARG . 8.5 p -145.56 140.18 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.117 -0.989 . . . . 71.02 109.539 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -82.59 -25.28 33.4 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.263 -0.898 . . . . 72.12 109.597 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.431 ' H ' HG22 ' A' ' 207' ' ' VAL . 13.2 mmt85 -49.45 -25.08 2.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.418 -0.801 . . . . 64.41 109.866 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -152.21 -74.29 0.14 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 71.54 109.448 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -166.91 -102.01 0.16 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.206 -1.558 . . . . 72.03 109.206 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -135.49 134.08 39.15 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.443 -1.034 . . . . 75.54 109.268 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -97.92 137.55 36.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.335 -0.853 . . . . 75.31 109.54 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.423 ' O ' ' SG ' ' A' ' 215' ' ' CYS . 44.1 m-85 -105.77 119.12 38.34 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.83 -0.804 . . . . 75.41 108.83 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 214' ' ' PHE . 99.3 m -153.39 162.54 41.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.32 -0.862 . . . . 74.14 109.391 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -67.6 155.08 92.1 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 75.32 108.925 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo . . . . . 0 N--CA 1.49 1.275 0 C-N-CA 122.424 2.083 . . . . 73.11 112.033 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 54.7 ttm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.44 -0.578 . . . . 71.14 109.44 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -137.79 154.46 49.56 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.356 -0.84 . . . . 73.23 109.489 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 97.8 t -115.58 125.95 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 109.174 -0.676 . . . . 72.24 109.174 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.48 HD11 ' CG1' ' B' ' 6' ' ' ILE . 4.4 tp -99.31 119.03 37.27 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.454 -0.779 . . . . 54.33 108.975 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.418 ' CD1' ' SD ' ' B' ' 49' ' ' MET . 5.3 tp -120.45 100.29 7.06 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 108.959 -0.756 . . . . 74.35 108.959 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.48 ' CG1' HD11 ' B' ' 4' ' ' LEU . 45.7 mt -90.05 102.81 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.833 -1.167 . . . . 42.55 108.816 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.42 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 29.2 tp10 -133.2 128.87 36.91 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.501 -0.75 . . . . 74.52 109.371 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -65.49 -33.31 75.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.906 . . . . 62.55 109.168 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -88.43 111.56 21.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.346 -0.846 . . . . 73.11 109.387 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 83.1 p -69.06 -27.07 65.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.915 . . . . 65.54 109.586 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 77.7 t -61.92 -51.31 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 75.55 109.607 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 37.9 mt -64.35 -30.65 71.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 70.14 109.449 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.36 -29.91 57.57 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.623 -1.791 . . . . 75.4 108.623 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.41 -50.52 61.77 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.912 -1.275 . . . . 65.44 109.912 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -65.46 -41.53 93.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -1.165 . . . . 60.21 109.801 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 5.7 mm -67.66 -35.28 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.867 -1.145 . . . . 75.15 108.905 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -64.58 -46.39 82.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.872 . . . . 73.01 109.454 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -79.49 -9.16 59.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 74.3 109.468 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.57 -52.95 3.97 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 109.422 -1.471 . . . . 70.54 109.422 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pp -70.51 -27.83 64.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -1.089 . . . . 71.34 109.392 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 -54.19 -34.87 61.57 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.229 -0.919 . . . . 64.41 109.21 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 49.0 t -54.36 -45.37 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.345 -0.847 . . . . 74.23 108.746 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.806 ' HZ2' HG12 ' B' ' 106' ' ' VAL . 23.6 mmtp -57.09 -51.64 68.48 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.607 -0.886 . . . . 63.42 108.607 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 127.66 41.12 0.3 Allowed Glycine 0 N--CA 1.5 2.907 0 N-CA-C 110.461 -1.056 . . . . 53.43 110.461 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -119.66 159.2 24.9 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.265 -1.138 . . . . 71.12 108.862 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 15.1 mmt -98.16 138.46 35.42 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.06 -1.089 . . . . 75.24 108.06 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.24 160.71 40.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.928 . . . . 72.12 110.261 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -142.84 152.84 42.59 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.663 -0.866 . . . . 72.31 108.663 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 p -114.02 137.1 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.37 -0.831 . . . . 64.43 109.238 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.6 p -134.41 170.07 16.3 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.576 -0.703 . . . . 65.41 109.457 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.479 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 1.9 pt-20 -94.4 -98.6 0.15 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.383 -0.823 . . . . 71.02 110.055 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 70.1 m -78.59 168.8 19.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.257 -0.902 . . . . 51.11 110.363 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 16.1 mt -56.76 -31.98 65.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.61 -0.681 . . . . 71.24 110.009 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -52.76 -44.07 66.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.131 -0.981 . . . . 74.32 109.861 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.479 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 64.1 m-20 -73.76 -39.58 64.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.107 -0.995 . . . . 73.03 109.553 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.3 -44.98 57.63 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.62 -1.392 . . . . 30.21 109.62 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.66 -43.32 84.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -1.153 . . . . 74.42 109.67 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -70.55 -39.85 73.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.131 -0.98 . . . . 74.42 110.099 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 25.0 tp -70.2 -44.07 69.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -0.948 . . . . 75.41 110.373 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 40' ' ' MET . . . . . 0.448 ' SD ' ' OH ' ' B' ' 45' ' ' TYR . 0.0 OUTLIER -74.49 -28.01 60.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.025 -1.047 . . . . 60.41 110.147 -179.204 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.21 -29.89 70.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.967 -1.083 . . . . 53.23 110.383 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 19.8 pt -86.34 -18.43 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.953 -1.092 . . . . 71.23 110.905 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' B' ' 40' ' ' MET . 59.0 mmt-85 -129.63 155.19 46.25 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.082 -1.011 . . . . 72.22 110.132 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -84.62 157.03 21.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.271 -0.893 . . . . 63.54 109.551 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.513 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 3.6 p90 -149.9 -174.89 4.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.208 -0.933 . . . . 64.35 109.393 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -141.5 -33.62 0.5 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.27 -0.894 . . . . 62.22 109.569 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.502 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.3 OUTLIER -110.14 114.78 28.55 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.35 -0.844 . . . . 73.12 109.107 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.502 ' N ' HD13 ' B' ' 47' ' ' LEU . 71.5 t -101.74 97.22 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.449 -0.945 . . . . 65.11 108.449 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.434 ' O ' ' O ' ' B' ' 4' ' ' LEU . 15.4 ttt -112.91 130.53 56.08 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.571 0.7 . . . . 73.44 109.849 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.05 138.85 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.4 -0.813 . . . . 34.5 109.311 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 51' ' ' SER . . . . . 0.42 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 53.0 p -105.46 2.29 28.44 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.548 -0.72 . . . . 73.21 110.412 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -75.7 147.01 39.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.987 -1.07 . . . . 70.41 109.629 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' B' ' 55' ' ' ALA . 62.3 mttp -73.35 -58.2 3.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.287 -0.883 . . . . 65.0 110.23 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -47.43 -12.85 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.089 -1.007 . . . . 75.21 109.904 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' B' ' 53' ' ' LYS . . . -58.67 -25.15 62.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.856 . . . . 55.33 110.598 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.521 ' HB3' HE22 ' B' ' 89' ' ' GLN . 97.7 mt -45.19 -47.44 12.49 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.065 -1.022 . . . . 63.14 109.827 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 21.5 m -68.81 -33.41 73.81 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.937 -1.102 . . . . 63.5 108.751 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 58' ' ' PHE . . . . . 0.413 ' CZ ' HD11 ' B' ' 62' ' ' ILE . 61.6 t80 -65.93 -60.68 2.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.422 -0.799 . . . . 72.33 109.77 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 31.4 m -50.0 -36.14 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.527 -1.358 . . . . 74.54 109.639 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 22.5 p -56.56 -54.2 48.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.107 -0.996 . . . . 71.24 109.68 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.576 ' HE ' ' NZ ' ' B' ' 65' ' ' LYS . 5.9 ptm180 -66.02 -30.18 70.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.007 -1.058 . . . . 74.31 110.034 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.413 HD11 ' CZ ' ' B' ' 58' ' ' PHE . 34.4 mm -65.08 -37.97 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.653 -1.28 . . . . 72.14 109.723 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' B' ' 67' ' ' SER . 25.0 mmtp -68.3 -51.87 39.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.063 -1.023 . . . . 73.32 110.302 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -67.47 -37.56 83.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.847 -1.158 . . . . 73.12 109.939 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.576 ' NZ ' ' HE ' ' B' ' 61' ' ' ARG . 92.9 mttt -81.55 -20.43 39.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -0.94 . . . . 72.44 109.707 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.485 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 74.0 m-70 -155.89 64.77 0.58 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.129 -0.982 . . . . 63.31 109.701 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.404 ' N ' ' O ' ' B' ' 63' ' ' LYS . 9.4 t -63.47 -29.01 70.36 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 73.1 109.669 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 96.5 p -61.64 -25.96 67.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 71.53 110.045 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.4 HD13 ' CE2' ' B' ' 45' ' ' TYR . 65.6 mt -83.4 151.3 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.093 -1.004 . . . . 74.4 109.48 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 99.2 t -89.93 154.62 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.415 -0.803 . . . . 75.12 109.318 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 18.1 t -134.57 127.78 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.308 -0.87 . . . . 73.2 109.618 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.575 ' C ' HD23 ' B' ' 72' ' ' LEU . 4.6 tt -118.91 102.66 8.95 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.455 0.645 . . . . 73.34 109.577 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 73' ' ' VAL . . . . . 0.452 ' O ' HG13 ' B' ' 73' ' ' VAL . 10.9 p -94.07 130.58 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.947 -1.096 . . . . 73.5 109.241 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 12.7 p -85.4 174.3 9.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.086 -1.009 . . . . 64.34 108.79 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 10.4 p -153.43 110.23 3.41 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.827 -1.171 . . . . 74.53 110.679 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -71.23 -21.7 62.09 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.499 -0.926 . . . . 64.5 108.499 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -126.64 73.38 74.61 Favored Pre-proline 0 N--CA 1.494 1.764 0 N-CA-C 108.601 -0.889 . . . . 74.25 108.601 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.18 81.51 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.778 1.652 . . . . 74.43 111.843 -178.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.426 ' O ' ' OE2' ' B' ' 83' ' ' GLU . 4.3 t -110.08 152.12 26.37 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.736 -0.839 . . . . 73.12 108.736 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.6 t -50.88 -33.44 24.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 71.01 110.321 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -61.19 -37.29 82.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.999 -1.063 . . . . 63.2 110.236 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 82' ' ' GLU . . . . . 0.404 ' H ' HG23 ' B' ' 79' ' ' THR . 34.2 tp10 -78.93 -37.02 40.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.004 -1.06 . . . . 73.22 110.088 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.519 ' N ' ' OE1' ' B' ' 83' ' ' GLU . 0.3 OUTLIER -58.08 -50.51 73.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.098 -1.001 . . . . 74.3 109.615 -179.612 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.494 HG23 ' N ' ' B' ' 85' ' ' HIS . 24.3 m -67.8 -39.87 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.121 -0.987 . . . . 73.31 109.542 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 85' ' ' HIS . . . . . 0.494 ' N ' HG23 ' B' ' 84' ' ' VAL . 4.4 t-160 -66.41 -26.87 67.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.171 -0.955 . . . . 73.24 109.562 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.68 -42.72 60.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.123 -0.986 . . . . 55.33 110.115 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -82.37 -33.38 28.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.081 -1.012 . . . . 74.14 109.275 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -68.58 -34.38 75.7 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.355 -0.841 . . . . 64.04 109.572 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 89' ' ' GLN . . . . . 0.521 HE22 ' HB3' ' B' ' 56' ' ' LEU . 69.0 mt-30 -80.43 -63.61 1.37 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -0.953 . . . . 72.35 109.677 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 163.2 68.06 0.02 OUTLIER Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.401 -1.38 . . . . 65.2 110.435 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -127.18 137.29 52.9 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.455 -1.026 . . . . 52.23 108.837 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' B' ' 93' ' ' ASP . 14.2 t70 -80.89 -34.52 33.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.055 -1.028 . . . . 73.32 109.448 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 93' ' ' ASP . . . . . 0.512 ' OD1' ' NH2' ' B' ' 112' ' ' ARG . 57.9 m-20 -149.96 164.15 36.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.35 -0.844 . . . . 72.22 109.441 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.532 ' O ' ' CD1' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -140.17 112.97 8.09 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.684 -0.858 . . . . 64.42 108.684 -178.951 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 35.4 mm -114.46 147.79 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.368 -0.833 . . . . 72.23 110.124 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 96' ' ' ALA . . . . . 0.511 ' HB1' ' HD2' ' B' ' 98' ' ' PRO . . . -62.47 139.52 58.58 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.172 -0.955 . . . . 25.24 108.558 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.601 ' N ' ' CD ' ' B' ' 98' ' ' PRO . 0.0 OUTLIER -69.17 -40.95 16.68 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.185 -0.947 . . . . 64.32 110.916 -179.19 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 98' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' B' ' 97' ' ' LYS . 33.1 Cg_exo -52.25 1.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.29 -2.518 0 CA-C-N 118.4 0.464 . . . . 63.33 112.833 -174.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 99' ' ' TYR . . . . . 0.601 ' N ' ' O ' ' B' ' 97' ' ' LYS . 45.7 m-85 55.55 99.19 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.453 -0.779 . . . . 75.13 109.722 178.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 34.9 ttm-85 -59.46 -36.09 75.3 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.009 -1.057 . . . . 74.23 108.724 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 101' ' ' SER . . . . . 0.753 ' O ' ' N ' ' B' ' 103' ' ' LYS . 12.6 t -173.84 39.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.234 -0.916 . . . . 63.34 110.688 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 102' ' ' ILE . . . . . 0.425 ' C ' ' N ' ' B' ' 104' ' ' ALA . 60.3 mt 51.92 -69.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.48 -0.763 . . . . 74.44 110.062 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.753 ' N ' ' O ' ' B' ' 101' ' ' SER . 38.1 mmtm -56.65 -15.36 4.33 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.168 -1.419 . . . . 71.11 107.168 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.425 ' N ' ' C ' ' B' ' 102' ' ' ILE . . . -60.54 -78.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.349 -0.54 . . . . 71.45 110.189 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.598 ' H ' HD12 ' B' ' 105' ' ' LEU . 0.0 OUTLIER -51.9 -41.17 61.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.95 -1.094 . . . . 51.31 109.381 -179.151 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 106' ' ' VAL . . . . . 0.806 HG12 ' HZ2' ' B' ' 23' ' ' LYS . 27.6 t -57.84 -45.21 87.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.995 -1.066 . . . . 65.23 108.804 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.04 -30.86 62.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.21 -0.931 . . . . 24.32 108.787 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 108' ' ' ARG . . . . . 0.434 HH12 ' NH2' ' B' ' 112' ' ' ARG . 2.0 tpm_? -80.72 -24.77 38.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.428 -0.795 . . . . 75.31 109.649 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 93.9 mt -80.08 -38.93 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.114 -0.991 . . . . 54.24 109.391 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 110' ' ' GLU . . . . . 0.52 ' OE1' ' NZ ' ' B' ' 23' ' ' LYS . 22.7 pt-20 -72.58 -40.93 66.22 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.163 -0.961 . . . . 65.31 109.509 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.21 -44.26 95.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.929 . . . . 72.24 109.248 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 112' ' ' ARG . . . . . 0.512 ' NH2' ' OD1' ' B' ' 93' ' ' ASP . 56.2 ttm-85 -63.08 -31.73 72.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 72.04 109.443 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 13.4 tp -145.12 70.54 1.27 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.263 -0.898 . . . . 75.35 109.127 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' B' ' 110' ' ' GLU . 96.2 mtt180 -62.69 -46.22 89.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 75.5 109.709 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -81.62 -103.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 65.33 109.536 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -163.43 -28.63 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.101 -0.999 . . . . 74.45 109.759 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -167.94 -172.48 35.0 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.767 -1.333 . . . . 44.21 109.767 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 48.9 m -145.48 -172.04 3.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.369 -1.077 . . . . 71.4 109.382 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.82 160.74 43.68 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.671 -0.812 . . . . 72.32 109.406 -178.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 4.5 t -134.3 -38.1 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.484 -0.76 . . . . 75.02 109.176 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 121' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' B' ' 128' ' ' ILE . 27.6 mm -110.87 133.32 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.797 -0.816 . . . . 51.41 108.797 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -137.31 143.62 42.2 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.396 -0.815 . . . . 71.53 108.904 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.971 HD11 ' NH2' ' B' ' 159' ' ' ARG . 19.5 tt -155.02 127.1 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 72.43 109.879 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 47.49 -151.56 2.07 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.723 -1.351 . . . . 51.23 109.723 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -75.75 -3.29 34.06 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.206 -1.173 . . . . 74.2 109.065 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.41 147.02 24.92 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.112 -1.07 . . . . 75.42 108.112 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 36.1 m -126.61 134.82 50.69 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.457 -0.777 . . . . 74.22 108.978 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' B' ' 121' ' ' ILE . 96.1 mt -126.2 124.15 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.54 -0.725 . . . . 60.33 109.675 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 18.8 m -123.89 109.21 30.08 Favored Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 109.198 -0.667 . . . . 72.31 109.198 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.96 -24.72 5.63 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.665 1.577 . . . . 75.13 111.629 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 131' ' ' ASP . . . . . 0.419 ' O ' ' OE2' ' B' ' 133' ' ' GLU . 26.3 t0 -62.0 -42.9 99.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 75.23 109.183 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -91.6 4.54 52.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.368 -0.833 . . . . 72.43 108.951 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 133' ' ' GLU . . . . . 0.419 ' OE2' ' O ' ' B' ' 131' ' ' ASP . 28.8 mp0 49.32 64.29 1.8 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.098 -1.001 . . . . 75.13 109.405 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -159.43 140.3 12.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.093 -1.004 . . . . 73.22 109.997 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 63.7 mt -118.98 137.23 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.631 -0.877 . . . . 64.14 108.631 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 15.2 mt -121.59 129.78 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.606 -0.684 . . . . 71.22 109.896 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -139.94 144.59 37.16 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.445 -0.784 . . . . 64.22 109.202 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 48.9 mttp 55.19 19.65 3.0 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.932 -0.766 . . . . 72.02 108.932 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.33 2.54 90.62 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.243 -1.143 . . . . 74.32 110.243 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 140' ' ' ARG . . . . . 0.405 ' HD2' ' N ' ' B' ' 140' ' ' ARG . 10.0 mmm-85 -89.85 129.13 36.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.249 . . . . 75.34 108.931 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -91.97 121.04 33.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.269 -0.894 . . . . 71.23 109.194 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 89.2 t -135.01 132.77 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.338 -0.851 . . . . 70.43 109.786 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -97.32 154.79 17.21 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.289 -0.882 . . . . 72.43 108.724 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 4.5 m -134.01 132.76 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.298 -0.876 . . . . 72.13 109.794 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 145' ' ' LYS . . . . . 0.527 ' N ' ' CD ' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -159.77 130.21 5.65 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.365 -0.834 . . . . 72.02 109.313 179.796 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 143.63 -120.63 1.52 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 108.946 -1.662 . . . . 42.23 108.946 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 147' ' ' LYS . . . . . 0.592 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 22.3 mtmt -101.86 -35.83 0.22 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.457 -1.026 . . . . 73.3 111.072 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 148' ' ' PRO . . . . . 0.932 ' O ' HD13 ' B' ' 152' ' ' LEU . 44.6 Cg_endo -92.56 8.92 2.69 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 122.264 1.976 . . . . 71.33 113.538 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 149' ' ' PHE . . . . . 0.46 ' CG ' ' N ' ' B' ' 150' ' ' GLU . 3.5 p90 -87.28 -40.71 14.26 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.732 -1.23 . . . . 74.23 110.215 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 150' ' ' GLU . . . . . 0.46 ' N ' ' CG ' ' B' ' 149' ' ' PHE . 16.4 pt-20 -69.08 -33.4 73.48 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.391 -0.818 . . . . 72.34 110.512 -178.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.722 HG13 HD12 ' B' ' 152' ' ' LEU . 12.5 p -67.66 -39.14 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.822 -1.173 . . . . 73.35 109.039 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.932 HD13 ' O ' ' B' ' 148' ' ' PRO . 9.6 mp -59.78 -53.04 62.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.377 -0.827 . . . . 55.24 109.475 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -72.75 -30.61 64.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.318 -0.864 . . . . 70.01 111.144 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.84 -52.08 66.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.606 -1.309 . . . . 65.32 109.995 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 pp -71.97 -29.53 64.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.943 -1.098 . . . . 71.54 110.001 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.77 -50.26 72.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.017 -1.052 . . . . 75.32 110.068 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 157' ' ' ARG . . . . . 0.487 ' C ' ' H ' ' B' ' 159' ' ' ARG . 68.9 mtp180 -72.99 -57.0 4.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.177 -0.952 . . . . 73.32 109.657 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 158' ' ' HIS . . . . . 0.413 ' CE1' ' OE1' ' B' ' 161' ' ' GLN . 35.0 t-80 -61.21 1.73 0.17 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.368 -0.832 . . . . 74.14 109.704 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 159' ' ' ARG . . . . . 1.636 HH21 ' CA ' ' B' ' 216' ' ' TYR . 26.7 ttt180 -53.09 165.39 0.32 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.119 -0.988 . . . . 61.41 109.881 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 160' ' ' ASP . . . . . 0.834 ' OD1' ' HG2' ' B' ' 159' ' ' ARG . 2.7 m-20 61.25 43.33 10.98 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.71 -0.619 . . . . 72.1 110.175 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 161' ' ' GLN . . . . . 0.413 ' OE1' ' CE1' ' B' ' 158' ' ' HIS . 62.3 mt-30 -157.21 175.42 14.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.058 -1.026 . . . . 72.25 109.449 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 77.8 mt -93.6 132.19 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.656 -0.868 . . . . 72.31 108.656 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 96.8 t -128.76 138.6 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.403 -0.811 . . . . 64.21 109.86 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 37.6 t -101.04 169.08 9.19 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.454 -0.779 . . . . 74.22 109.933 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -68.63 -48.49 63.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.519 -0.738 . . . . 65.31 110.088 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.1 -41.88 79.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.295 -0.878 . . . . 63.45 110.791 -178.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 167' ' ' GLN . . . . . 0.425 ' O ' ' OD1' ' B' ' 170' ' ' ASP . 89.9 mt-30 -51.04 -38.51 51.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.048 -1.032 . . . . 72.4 110.072 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 71.9 mt -73.31 -40.53 64.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.994 -1.066 . . . . 72.32 109.635 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.598 ' O ' HD23 ' B' ' 169' ' ' LEU . 1.9 tt -61.62 -42.35 98.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.405 -0.809 . . . . 73.34 109.7 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 170' ' ' ASP . . . . . 0.534 ' O ' ' CH2' ' B' ' 173' ' ' TRP . 22.9 p30 -86.2 -13.54 46.65 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 118.769 -1.172 . . . . 72.1 110.796 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 171' ' ' ALA . . . . . 0.4 ' N ' ' OD1' ' B' ' 170' ' ' ASP . . . -94.52 -38.03 11.1 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.837 -1.164 . . . . 62.13 111.056 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 0.484 HG22 ' O ' ' B' ' 172' ' ' ILE . 60.6 mt -114.17 -9.98 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.26 -0.9 . . . . 71.42 110.589 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 173' ' ' TRP . . . . . 0.534 ' CH2' ' O ' ' B' ' 170' ' ' ASP . 10.2 m95 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.43 -0.794 . . . . 72.23 109.632 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo . . . . . 0 N--CA 1.49 1.269 0 CA-C-O 121.195 0.414 . . . . 65.22 112.413 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -149.18 120.31 7.75 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.196 -0.94 . . . . 72.31 109.14 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 3.2 p -156.14 -15.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.259 -0.901 . . . . 63.32 110.868 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.401 ' O ' HG22 ' B' ' 188' ' ' ILE . 29.0 mm -51.47 -31.11 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.738 -1.226 . . . . 75.03 109.502 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -54.59 -34.77 62.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.096 -1.003 . . . . 64.11 108.484 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 2.0 t -80.36 -57.22 5.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.491 -0.755 . . . . 73.0 109.366 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -51.78 -51.65 54.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.119 -0.988 . . . . 61.12 109.715 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 188' ' ' ILE . . . . . 0.582 HD12 ' CZ ' ' B' ' 212' ' ' TYR . 1.7 tt -57.68 -43.35 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.894 -1.129 . . . . 72.43 108.962 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 189' ' ' ASN . . . . . 0.441 ' N ' HG23 ' B' ' 188' ' ' ILE . 24.8 t-20 -62.11 -38.24 88.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.039 -1.038 . . . . 65.14 109.271 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -69.31 -50.47 46.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.922 . . . . 63.24 109.735 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 96.8 mt -53.34 -45.61 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.294 -0.879 . . . . 74.03 109.491 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -59.71 -42.75 93.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.898 . . . . 72.24 109.656 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -68.72 -38.13 79.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -0.944 . . . . 73.1 109.187 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 194' ' ' LYS . . . . . 0.49 ' O ' ' CG ' ' B' ' 198' ' ' PRO . 31.0 mttp -71.32 -13.24 61.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.371 -0.831 . . . . 72.11 109.24 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 30.0 mmm -101.47 -33.29 10.02 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.398 -0.814 . . . . 44.33 109.519 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -82.85 -12.5 57.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.097 -1.002 . . . . 71.21 110.454 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 197' ' ' LYS . . . . . 0.449 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 34.2 mttm -89.46 -65.95 0.16 Allowed Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 120.855 -1.153 . . . . 75.21 109.907 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 198' ' ' PRO . . . . . 0.49 ' CG ' ' O ' ' B' ' 194' ' ' LYS . 36.7 Cg_endo -63.56 -70.13 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.968 1.779 . . . . 75.32 112.122 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 199' ' ' LEU . . . . . 0.512 ' H ' HD12 ' B' ' 199' ' ' LEU . 7.6 mp -55.81 -38.82 70.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.116 -0.99 . . . . 72.25 108.777 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 77.69 5.63 86.39 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.792 -1.323 . . . . 64.53 109.792 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 16.1 mt -132.83 140.13 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.377 -1.072 . . . . 44.23 109.338 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 13.1 t -78.0 147.47 34.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 54.01 109.261 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 1.4 p -145.47 24.53 1.4 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.196 -0.94 . . . . 74.4 109.443 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 19.9 m -139.82 146.33 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.201 -0.937 . . . . 72.12 109.791 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -119.45 132.54 55.82 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.83 -0.804 . . . . 65.41 108.83 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 31.1 p -103.27 127.32 50.63 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.252 -0.905 . . . . 71.33 109.74 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 12.8 p -144.59 143.22 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.198 -0.939 . . . . 63.5 109.248 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 24.1 mtm105 -86.7 101.9 13.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.2 -0.938 . . . . 74.45 109.757 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -171.54 -76.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.378 -0.826 . . . . 74.14 108.82 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -107.56 -42.47 4.77 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.993 -0.743 . . . . 74.43 108.993 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 173.11 -119.8 0.78 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.408 -1.477 . . . . 64.45 109.408 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 212' ' ' TYR . . . . . 0.582 ' CZ ' HD12 ' B' ' 188' ' ' ILE . 8.1 m-85 -129.71 156.66 43.92 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.468 -1.019 . . . . 74.21 109.17 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 52.4 mmt-85 -111.32 144.71 40.07 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.539 -0.725 . . . . 74.03 109.319 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -119.63 114.27 21.95 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.611 -0.681 . . . . 74.34 109.165 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 91.3 m -148.45 170.34 18.24 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.25 -0.906 . . . . 64.33 109.614 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 216' ' ' TYR . . . . . 1.636 ' CA ' HH21 ' B' ' 159' ' ' ARG . 38.0 p90 -74.27 150.58 87.5 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 70.04 109.513 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 217' ' ' PRO . . . . . 0.939 ' HD3' HH22 ' B' ' 159' ' ' ARG . 67.1 Cg_exo -37.2 156.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.358 2.039 . . . . 65.11 112.46 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.336 -0.853 . . . . 73.15 109.806 -179.765 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.577 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.409 -0.589 . . . . 65.12 109.409 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.751 ' HE ' HH21 ' A' ' 43' ' ' ARG . 81.2 mtt85 -136.34 150.19 48.74 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.376 -0.828 . . . . 72.33 109.358 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.3 t -113.76 129.42 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 121.576 0.703 . . . . 71.42 109.982 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.507 HD11 ' CG1' ' A' ' 6' ' ' ILE . 2.6 tp -98.25 118.45 34.93 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.37 -0.974 . . . . 65.12 108.37 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.417 ' N ' HD12 ' A' ' 4' ' ' LEU . 5.8 tp -119.09 108.46 14.73 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.612 -0.68 . . . . 62.43 109.31 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.507 ' CG1' HD11 ' A' ' 4' ' ' LEU . 46.3 mt -101.2 109.72 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.514 -0.921 . . . . 71.15 108.514 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.426 ' OE1' ' CB ' ' A' ' 51' ' ' SER . 24.7 tp10 -137.96 123.69 19.89 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.437 -0.789 . . . . 75.34 109.452 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.1 tptt -68.66 -31.29 70.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.24 -0.912 . . . . 72.44 108.771 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -86.23 122.41 30.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.429 -0.794 . . . . 63.02 109.367 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.4 m -74.62 -20.7 59.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 72.34 109.728 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.2 t -71.38 -55.7 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.183 -0.948 . . . . 74.02 109.872 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.558 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.5 mm? -67.85 -35.72 79.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.219 -0.926 . . . . 71.43 109.519 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.36 -31.07 57.63 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.758 -1.737 . . . . 61.32 108.758 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.98 -48.42 76.04 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.953 -1.259 . . . . 71.2 109.953 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -64.04 -46.65 83.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -1.174 . . . . 71.32 109.882 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.3 mm -64.65 -48.54 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.778 -1.201 . . . . 63.23 109.175 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -46.28 -56.93 5.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.182 -0.949 . . . . 51.11 109.812 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -84.47 3.01 38.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.17 -0.956 . . . . 73.34 109.305 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.02 -65.95 1.71 Allowed Glycine 0 N--CA 1.483 1.786 0 N-CA-C 109.899 -1.28 . . . . 62.15 109.899 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.532 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.5 pt? -66.53 -23.39 66.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -1.173 . . . . 73.51 110.081 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -56.69 -35.95 69.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -0.991 . . . . 74.25 109.872 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 87.5 t -56.1 -39.36 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.164 -0.96 . . . . 70.04 109.579 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HZ2' HG11 ' A' ' 106' ' ' VAL . 1.7 mptm? -63.63 -12.43 33.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 73.23 109.322 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.61 37.78 4.13 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.263 -1.135 . . . . 75.54 110.263 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -119.61 160.71 21.95 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.477 -1.013 . . . . 73.43 109.263 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.4 mmt -100.86 138.97 37.2 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.257 -1.016 . . . . 43.24 108.257 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.24 159.67 41.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.25 -0.906 . . . . 62.11 109.974 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -135.94 144.88 45.69 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.512 -0.742 . . . . 74.42 109.042 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.5 131.34 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.458 -0.776 . . . . 72.15 108.911 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.8 p -134.74 169.67 16.99 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.449 -0.782 . . . . 71.42 109.379 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -93.41 -103.22 0.13 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.304 -0.872 . . . . 72.33 109.718 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 t -78.78 166.83 22.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 74.24 110.012 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.401 HD22 ' CG ' ' A' ' 58' ' ' PHE . 20.4 mt -54.37 -31.94 55.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.552 -0.718 . . . . 71.53 109.82 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.16 -48.75 44.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 74.23 109.513 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.02 -38.32 90.72 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.156 -0.965 . . . . 54.03 108.914 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.85 -37.06 92.97 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.296 -1.522 . . . . 61.41 109.296 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -68.35 -42.91 78.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 74.34 109.462 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -71.78 -37.67 70.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 75.33 109.906 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.8 tp -75.9 -46.01 32.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 74.33 110.308 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.484 ' SD ' ' OD1' ' A' ' 41' ' ' ASP . 3.5 ppp? -65.24 -32.24 73.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.045 -1.034 . . . . 70.32 110.177 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.484 ' OD1' ' SD ' ' A' ' 40' ' ' MET . 87.1 m-20 -62.68 -39.58 94.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.067 -1.021 . . . . 71.22 110.03 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.4 HG12 ' H ' ' A' ' 42' ' ' ILE . 25.8 pt -82.31 -29.44 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.066 -1.021 . . . . 74.14 110.176 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.751 HH21 ' HE ' ' A' ' 2' ' ' ARG . 73.6 mtp180 -130.07 140.51 50.82 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.342 -0.849 . . . . 72.24 109.596 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -90.25 157.66 17.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.214 -0.929 . . . . 75.42 109.488 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -138.04 150.89 47.34 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.391 -0.818 . . . . 74.23 109.345 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 2' ' ' ARG . 7.9 p-10 -95.21 -40.25 9.67 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.175 -0.953 . . . . 72.04 109.463 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.462 HD13 ' C ' ' A' ' 47' ' ' LEU . 0.5 OUTLIER -102.97 109.66 21.29 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.397 -0.814 . . . . 72.13 109.059 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.445 ' N ' HD13 ' A' ' 47' ' ' LEU . 78.7 t -95.08 97.67 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.193 -0.942 . . . . 72.34 108.616 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.1 ttm -111.44 131.51 55.15 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.481 -0.762 . . . . 74.11 109.595 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.451 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 1.3 p -141.0 133.0 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.479 -0.763 . . . . 61.12 109.818 -179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.426 ' CB ' ' OE1' ' A' ' 7' ' ' GLU . 59.9 p -100.85 7.01 43.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.608 -0.683 . . . . 73.11 109.538 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.451 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 84.7 m-20 -76.04 141.12 42.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.135 -0.978 . . . . 52.55 109.465 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.494 ' C ' ' H ' ' A' ' 55' ' ' ALA . 68.0 mttm -73.43 -44.64 57.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.29 -0.881 . . . . 44.22 110.435 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -71.02 15.47 0.11 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.107 -0.996 . . . . 70.44 109.807 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -74.97 -21.61 59.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 64.14 110.334 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.703 ' HB3' HE22 ' A' ' 89' ' ' GLN . 19.0 mt -40.49 -52.96 2.75 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.499 -0.751 . . . . 44.14 110.357 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.9 m -67.2 -32.86 74.2 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.053 -1.029 . . . . 55.23 109.141 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.523 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 63.0 t80 -66.06 -52.95 44.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.479 -0.763 . . . . 74.44 110.313 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 m -57.74 -34.57 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.701 -1.249 . . . . 74.03 109.709 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.1 m -59.02 -55.51 34.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.112 -0.993 . . . . 64.3 109.625 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -63.21 -28.08 69.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 64.44 110.142 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.523 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 5.2 mm -66.6 -31.79 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.951 -1.093 . . . . 63.21 109.898 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.525 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 23.1 mmtt -77.12 -50.23 13.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.057 -1.027 . . . . 74.42 110.267 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -67.62 -41.21 84.3 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.754 -1.217 . . . . 70.32 109.87 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.521 ' O ' ' NZ ' ' A' ' 145' ' ' LYS . 9.1 mtpm? -72.5 -26.24 61.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 75.22 109.75 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.564 ' O ' HG22 ' A' ' 69' ' ' ILE . 93.2 m-70 -153.19 65.93 0.77 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.16 -0.963 . . . . 74.13 109.301 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.476 ' N ' ' O ' ' A' ' 63' ' ' LYS . 18.0 m -56.45 -32.43 64.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 73.24 110.055 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 83.3 p -73.17 47.02 0.19 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 61.01 110.049 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 66' ' ' HIS . 13.5 tt -146.48 159.07 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.051 -1.031 . . . . 71.33 109.45 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.5 t -95.57 154.26 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.12 -0.987 . . . . 72.13 109.106 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.433 ' H ' ' HB2' ' A' ' 92' ' ' ASP . 15.4 t -142.66 118.69 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.123 -0.985 . . . . 54.21 109.823 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.572 ' HG ' HD11 ' A' ' 95' ' ' ILE . 1.6 mp -119.23 99.57 6.79 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.624 -0.88 . . . . 50.24 108.624 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.8 p -94.3 152.99 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.255 -1.017 . . . . 74.41 108.255 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.08 169.94 9.26 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.443 -0.785 . . . . 72.31 108.912 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.2 t -168.39 123.7 0.96 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.177 -0.952 . . . . 64.54 110.159 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 0.4 OUTLIER -76.12 15.84 0.51 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.466 -0.771 . . . . 74.13 110.024 -179.082 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.407 ' O ' ' N ' ' A' ' 79' ' ' THR . 30.7 m120 -139.88 58.61 11.65 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.152 -0.967 . . . . 73.34 110.115 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.44 84.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.393 2.062 . . . . 63.22 112.452 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 81' ' ' GLU . 28.7 m -106.81 149.73 27.07 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.143 -1.058 . . . . 62.53 108.143 178.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.04 -32.16 71.78 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.008 -1.057 . . . . 73.44 109.367 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.423 ' H ' HG22 ' A' ' 79' ' ' THR . 44.1 tp10 -64.44 -43.13 95.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.119 -0.988 . . . . 71.42 109.294 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -76.64 -35.74 57.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 73.43 109.602 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -57.74 -56.77 17.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.237 -0.914 . . . . 74.22 109.67 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.475 HG23 ' N ' ' A' ' 85' ' ' HIS . 25.4 m -61.55 -39.75 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.131 -0.981 . . . . 73.2 109.273 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.475 ' N ' HG23 ' A' ' 84' ' ' VAL . 72.7 t60 -60.22 -36.97 78.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.214 -0.929 . . . . 53.33 109.554 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.53 -45.83 88.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.195 -0.941 . . . . 64.11 109.829 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.615 ' CZ ' ' NH1' ' B' ' 108' ' ' ARG . 77.1 m-85 -74.96 -27.92 60.37 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.171 -0.955 . . . . 74.34 108.722 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -69.88 -50.23 44.54 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.521 -0.737 . . . . 74.42 109.297 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.703 HE22 ' HB3' ' A' ' 56' ' ' LEU . 29.6 mt-30 -58.01 -49.64 76.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.512 -0.742 . . . . 74.24 110.003 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 153.8 -10.76 0.5 Allowed Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.423 -1.37 . . . . 61.51 110.738 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.8 139.5 16.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.812 -1.405 . . . . 55.33 109.373 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.525 ' OD1' ' NZ ' ' A' ' 63' ' ' LYS . 11.4 m-20 -76.08 -40.01 54.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.103 -0.998 . . . . 73.42 109.32 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 94' ' ' TYR . 56.8 t0 -153.09 157.12 39.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.259 -0.9 . . . . 75.04 109.47 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.539 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -128.38 133.94 48.73 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.791 -0.818 . . . . 71.33 108.791 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.817 ' N ' HD12 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -122.39 138.67 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 121.717 0.77 . . . . 71.13 110.242 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.8 119.98 8.15 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.027 -1.101 . . . . 64.32 108.027 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.694 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -43.95 -54.39 11.18 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 62.2 111.501 -178.936 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -38.51 -13.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 121.198 1.266 . . . . 73.11 113.202 -176.465 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.694 ' N ' ' O ' ' A' ' 97' ' ' LYS . 57.6 m-85 56.32 100.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.632 -0.668 . . . . 65.22 110.039 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.0 mtt85 -55.7 -42.87 75.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.786 -1.197 . . . . 72.35 108.21 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.3 t -169.1 132.23 1.31 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.855 -0.794 . . . . 71.32 108.855 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 62.4 mt -51.32 -43.8 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.148 -0.97 . . . . 75.43 109.327 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.417 ' N ' ' CD ' ' A' ' 103' ' ' LYS . 3.4 mptp? -62.07 -35.07 77.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 71.41 109.611 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.24 -55.82 10.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.13 -0.982 . . . . 63.24 109.883 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.4 tp -57.84 -56.75 17.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 73.22 109.702 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.553 HG11 ' HZ2' ' A' ' 23' ' ' LYS . 74.1 t -53.15 -43.71 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.971 -1.081 . . . . 60.11 109.546 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.55 -43.1 64.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.14 -0.975 . . . . 70.42 108.913 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -66.81 -37.1 83.87 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.362 -0.836 . . . . 74.41 109.333 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 65.1 mt -66.94 -33.82 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 107.879 -1.156 . . . . 62.54 107.879 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -59.6 -42.83 93.49 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.368 -0.975 . . . . 74.34 108.368 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.417 ' HB2' ' CZ ' ' B' ' 87' ' ' PHE . . . -57.61 -50.33 73.5 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.354 -0.841 . . . . 73.32 109.497 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -59.16 -50.77 72.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.209 -0.932 . . . . 52.41 109.622 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.507 ' O ' ' CE2' ' A' ' 116' ' ' TRP . 53.2 mt -64.98 -36.61 84.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.046 -1.034 . . . . 65.24 109.646 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -56.34 -36.88 69.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -0.891 . . . . 64.45 109.595 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -78.2 54.6 1.39 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 74.43 109.431 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.507 ' CE2' ' O ' ' A' ' 113' ' ' LEU . 7.2 m-90 -59.66 148.74 32.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.928 . . . . 74.42 109.478 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -50.84 127.29 27.68 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.702 -1.359 . . . . 75.04 109.702 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.2 t -85.96 3.23 42.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -1.134 . . . . 61.14 109.424 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.487 ' CG ' ' H ' ' A' ' 120' ' ' VAL . 47.4 t30 52.53 -179.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 65.24 109.413 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.487 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 5.3 t -141.97 -45.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.304 -0.872 . . . . 73.11 109.61 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.0 mm -98.59 125.38 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.191 -0.943 . . . . 72.24 109.281 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 122' ' ' GLU . 1.3 pm0 -134.05 108.87 8.6 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.499 -0.751 . . . . 72.34 108.976 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.438 HG23 ' O ' ' A' ' 123' ' ' ILE . 18.2 tt -134.88 131.08 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.466 -0.771 . . . . 71.44 109.113 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.08 -145.83 5.47 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.576 -1.409 . . . . 73.4 109.576 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -85.75 -0.62 55.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -1.185 . . . . 74.45 109.331 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.92 130.52 44.21 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.51 -0.922 . . . . 54.21 108.51 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.474 ' CG2' ' ND2' ' A' ' 119' ' ' ASN . 32.1 m -130.45 129.37 42.9 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.353 -0.842 . . . . 54.5 109.571 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 27.1 mm -113.67 133.3 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.414 -0.804 . . . . 45.15 109.195 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.5 m -115.87 96.59 47.2 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 109.13 -0.692 . . . . 71.11 109.13 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -78.46 -37.07 0.77 Allowed 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 121.839 1.693 . . . . 65.41 111.943 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -68.18 -43.51 77.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 63.32 109.255 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -90.23 -1.87 57.98 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.375 -0.828 . . . . 72.52 109.416 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 52.97 62.41 2.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.354 -0.841 . . . . 75.33 109.972 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -150.22 140.59 22.34 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.271 -0.893 . . . . 71.23 109.085 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 7.3 tt -121.68 135.32 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 108.93 -0.767 . . . . 74.02 108.93 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 136' ' ' ILE . 14.8 mt -116.71 129.32 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.65 -0.656 . . . . 60.23 109.561 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.439 ' CE2' ' O ' ' A' ' 198' ' ' PRO . 54.8 t80 -138.46 138.05 37.76 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.589 -0.694 . . . . 62.32 109.199 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm 53.35 31.07 11.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.365 -0.834 . . . . 75.4 110.1 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 73.94 15.22 79.76 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 120.051 -1.071 . . . . 72.24 110.456 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -107.52 125.23 51.02 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.401 -1.058 . . . . 71.22 109.342 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -95.04 126.18 40.21 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.269 -0.894 . . . . 71.42 109.704 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.9 p -137.85 140.79 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.375 -0.828 . . . . 53.02 109.254 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -85.51 144.44 27.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.3 -0.875 . . . . 60.45 109.314 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.424 HG21 ' CD1' ' A' ' 149' ' ' PHE . 16.2 m -147.29 137.16 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.242 -0.911 . . . . 74.44 109.539 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.521 ' NZ ' ' O ' ' A' ' 65' ' ' LYS . 43.7 pttt -156.59 20.36 0.34 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -0.861 . . . . 65.15 109.495 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.48 -178.92 51.73 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.297 -1.521 . . . . 73.34 109.297 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 13.5 ttmt -64.76 -39.89 43.27 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.185 -1.186 . . . . 72.22 109.82 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 25.4 Cg_exo -62.18 -24.63 76.44 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.324 2.016 . . . . 65.23 112.098 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.576 ' CZ ' ' CG2' ' A' ' 153' ' ' THR . 59.0 t80 -82.27 -42.02 19.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.13 -0.981 . . . . 60.11 110.003 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.466 ' O ' ' ND1' ' A' ' 154' ' ' HIS . 80.8 mm-40 -50.11 -45.47 52.89 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.134 -0.979 . . . . 64.21 109.36 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.8 p -72.05 -35.08 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.215 -0.928 . . . . 72.02 109.099 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 15.0 tp -60.5 -38.0 82.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 73.31 109.159 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.576 ' CG2' ' CZ ' ' A' ' 149' ' ' PHE . 16.8 p -71.74 -41.89 67.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.315 -0.865 . . . . 74.31 109.8 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.818 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 34.2 m80 -53.24 -51.62 61.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.31 -0.869 . . . . 74.31 110.038 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 pp -73.27 -24.38 60.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.932 -1.105 . . . . 75.34 109.601 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.4 -53.58 56.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.135 -0.978 . . . . 62.14 109.268 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 1.09 ' HG3' ' ND1' ' A' ' 158' ' ' HIS . 13.6 ptm180 -68.43 -34.95 76.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.913 . . . . 61.03 109.069 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 1.09 ' ND1' ' HG3' ' A' ' 157' ' ' ARG . 15.9 m80 -94.95 64.75 2.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.342 -0.849 . . . . 74.12 109.083 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.52 ' NH1' ' OG1' ' A' ' 203' ' ' THR . 2.1 tpm_? -81.22 -3.01 50.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.868 . . . . 71.13 110.173 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.514 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 57.4 p30 -144.85 57.67 1.29 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.987 -1.07 . . . . 75.45 110.075 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 160' ' ' ASP . 89.1 mm-40 -148.87 179.72 7.64 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.207 -0.933 . . . . 73.41 109.211 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 68.0 mt -105.64 123.48 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.896 -0.779 . . . . 74.41 108.896 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 72.9 t -117.41 130.27 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.48 -0.762 . . . . 72.31 109.472 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 86.1 p -97.05 159.29 14.99 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.286 -0.884 . . . . 74.12 109.483 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -60.14 -44.28 95.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 70.43 109.632 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -55.72 -33.33 64.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 73.52 109.252 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.427 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 61.8 tt0 -61.49 -46.21 90.99 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.277 -0.889 . . . . 74.52 109.295 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 34.1 mt -59.54 -30.88 68.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 72.31 108.886 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.401 HD23 ' C ' ' A' ' 169' ' ' LEU . 3.4 tt -66.93 -74.38 0.11 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 53.33 109.608 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 167' ' ' GLN . 59.1 p30 -55.82 -8.45 0.42 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.504 -0.747 . . . . 62.44 111.063 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.21 -52.57 4.13 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.869 -1.144 . . . . 60.21 112.282 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.6 mp -99.31 -41.04 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 O-C-N 120.82 -1.175 . . . . 75.32 112.077 -177.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.503 ' CD2' ' C ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.8 0 O-C-N 120.39 -1.444 . . . . 73.14 109.081 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.317 0.579 . . . . 64.54 109.495 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 8.5 p -55.88 -14.27 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 74.02 109.935 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 96.0 mt -51.64 -42.4 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.942 . . . . 72.33 109.962 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.446 ' CG ' ' N ' ' A' ' 186' ' ' VAL . 19.8 pt-20 -61.63 -43.79 98.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.041 -1.037 . . . . 74.4 109.446 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' VAL . . . . . 0.446 ' N ' ' CG ' ' A' ' 185' ' ' GLU . 94.0 t -71.27 -30.41 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 70.42 109.292 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.12 -56.09 6.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.383 -0.823 . . . . 52.11 109.913 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.1 -26.29 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.809 -1.182 . . . . 71.4 109.631 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -73.45 -55.58 6.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.988 . . . . 73.44 109.962 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -68.2 -40.27 82.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.128 -0.983 . . . . 71.42 109.876 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 73.5 mt -55.68 -49.25 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.001 -1.062 . . . . 61.55 109.253 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 75.9 mtp85 -57.75 -44.69 86.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -0.977 . . . . 63.34 109.541 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -66.56 -36.85 83.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.893 . . . . 61.24 109.698 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.482 ' O ' ' CG ' ' A' ' 198' ' ' PRO . 16.4 mtpp -84.52 -2.41 57.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.913 . . . . 75.13 109.784 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 50.6 ttm -89.62 -28.41 19.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.182 -0.949 . . . . 74.02 109.555 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 197' ' ' LYS . 46.4 p30 -102.35 -10.95 19.02 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.251 -0.905 . . . . 74.02 110.303 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.576 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 14.6 tttt -77.59 -43.21 2.47 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.92 -1.113 . . . . 75.43 109.74 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 25.9 Cg_endo -88.18 -32.46 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.624 2.216 . . . . 72.32 112.304 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.644 HD22 ' N ' ' A' ' 199' ' ' LEU . 3.1 mm? -85.77 -98.31 0.07 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.913 -1.117 . . . . 74.54 109.211 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 152.2 -33.18 0.86 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.496 -1.441 . . . . 61.51 109.496 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 66.2 mt -96.4 128.93 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.291 -1.123 . . . . 61.22 109.529 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 25.0 p -79.87 132.74 36.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 72.0 108.962 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.52 ' OG1' ' NH1' ' A' ' 159' ' ' ARG . 5.2 p -141.69 40.25 1.7 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.293 -0.88 . . . . 74.44 109.666 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 17.1 m -138.96 139.03 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.325 -0.859 . . . . 64.35 109.333 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -125.41 129.17 49.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.536 -0.727 . . . . 71.41 109.174 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.08 140.85 37.19 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.349 -0.845 . . . . 73.52 109.32 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 10.5 p -139.65 141.47 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.299 -0.876 . . . . 71.02 109.332 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -92.61 52.89 1.96 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.234 -0.916 . . . . 72.12 109.542 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -146.24 -8.45 0.52 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.167 -0.958 . . . . 64.41 109.437 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -159.7 -69.0 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.186 -0.947 . . . . 71.54 109.327 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -172.31 -119.21 0.51 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.569 -1.413 . . . . 72.03 109.569 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -123.15 129.8 51.91 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.582 -0.952 . . . . 75.54 109.258 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -103.74 129.66 51.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.453 -0.78 . . . . 75.31 109.663 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -95.36 123.74 39.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.289 -0.882 . . . . 75.41 108.67 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 26.8 p -126.4 170.29 12.1 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 121.608 0.718 . . . . 74.14 110.32 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -78.43 140.55 60.34 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.899 -0.778 . . . . 75.32 108.899 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo . . . . . 0 N--CA 1.491 1.346 0 C-N-CA 122.06 1.84 . . . . 73.11 112.493 179.887 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 50.9 ttm . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.46 -0.57 . . . . 71.14 109.46 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -137.52 139.86 40.77 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.43 -0.794 . . . . 73.23 109.281 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.9 t -112.07 135.14 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.657 -0.652 . . . . 72.24 109.434 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.12 119.18 38.67 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.546 -0.721 . . . . 54.33 110.028 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 19.8 mt -118.55 97.17 5.61 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.644 -0.872 . . . . 74.35 108.644 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.416 HD12 ' HB ' ' B' ' 50' ' ' VAL . 66.8 mt -84.16 96.99 4.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.749 -1.219 . . . . 42.55 108.588 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.428 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 26.4 tp10 -134.03 132.1 39.64 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.494 -0.753 . . . . 74.52 109.375 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.7 -32.93 74.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 62.55 109.353 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 9' ' ' ASN . . . . . 0.403 ' H ' ' HG3' ' B' ' 7' ' ' GLU . 79.1 m-20 -82.92 117.24 22.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 73.11 109.399 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 19.8 m -75.98 -32.27 59.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 65.54 110.026 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' VAL . . . . . 0.552 HG13 ' N ' ' B' ' 12' ' ' LEU . 8.9 p -60.02 -45.11 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.071 -1.018 . . . . 75.55 109.908 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.552 ' N ' HG13 ' B' ' 11' ' ' VAL . 77.2 mt -66.02 -35.44 80.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.012 -1.055 . . . . 70.14 109.349 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.5 -27.34 67.81 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.63 -1.788 . . . . 75.4 108.63 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.79 -54.94 25.28 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.603 -1.399 . . . . 65.44 109.603 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' B' ' 15' ' ' GLU . 12.8 pt-20 -58.39 -44.38 88.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.351 -1.088 . . . . 60.21 109.652 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 65.8 mt -65.94 -39.26 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.956 -1.09 . . . . 75.15 108.936 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -59.69 -43.89 93.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.254 -0.904 . . . . 73.01 109.065 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -85.32 -1.6 57.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.184 -0.947 . . . . 74.3 109.109 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -85.11 -59.61 1.94 Allowed Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.695 -1.362 . . . . 70.54 109.695 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -68.55 -21.35 64.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -1.175 . . . . 71.34 109.707 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -51.79 -33.73 36.77 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.073 -1.017 . . . . 64.41 109.324 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 91.1 t -56.94 -36.82 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.179 -0.95 . . . . 74.23 108.904 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.402 ' N ' ' CD ' ' B' ' 23' ' ' LYS . 12.2 mptt -72.44 -13.12 61.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.442 -0.786 . . . . 63.42 109.212 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.52 39.25 6.35 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.045 -1.222 . . . . 53.43 110.045 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -119.23 159.94 23.12 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.515 -0.991 . . . . 71.12 109.18 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 48.4 mmm -106.03 140.65 38.69 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.721 -0.844 . . . . 75.24 108.721 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.413 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -137.83 155.54 48.88 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.392 -0.817 . . . . 72.12 109.995 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 28' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 88.5 m-20 -136.41 157.23 47.29 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.424 -0.954 . . . . 72.31 108.424 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 p -122.19 139.12 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.404 -0.81 . . . . 64.43 109.749 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 2.6 p -138.05 173.49 11.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.521 -0.737 . . . . 65.41 109.416 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -98.52 -98.67 0.22 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.362 -0.836 . . . . 71.02 109.753 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 14.0 t -78.77 164.81 24.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.223 -0.923 . . . . 51.11 110.12 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 50.6 mt -53.06 -36.99 61.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.669 -0.644 . . . . 71.24 110.086 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.58 ' H ' ' CD ' ' B' ' 34' ' ' GLU . 45.1 mp0 -53.18 -46.49 68.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 74.32 109.964 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -61.42 -38.57 87.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.117 -0.989 . . . . 73.03 109.274 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.34 -33.75 87.5 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.331 -1.508 . . . . 30.21 109.331 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -69.3 -43.95 72.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -1.13 . . . . 74.42 109.743 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 38' ' ' TYR . . . . . 0.437 ' O ' ' OD1' ' B' ' 41' ' ' ASP . 65.9 m-85 -76.27 -22.48 55.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.141 -0.974 . . . . 74.42 110.046 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 60.3 tp -90.04 -34.31 16.0 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.081 -1.012 . . . . 75.41 109.871 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 40' ' ' MET . . . . . 0.445 ' O ' ' O ' ' B' ' 43' ' ' ARG . 2.5 ppp? -79.02 -28.1 43.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.153 -0.967 . . . . 60.41 110.405 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' B' ' 42' ' ' ILE . 39.0 p-10 -62.52 -27.02 68.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.914 -1.116 . . . . 53.23 110.041 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.542 ' N ' ' OD1' ' B' ' 41' ' ' ASP . 11.8 pt -99.27 -10.87 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.184 -0.948 . . . . 71.23 110.411 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' B' ' 40' ' ' MET . 98.6 mtt180 -130.23 155.67 45.88 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.247 -0.908 . . . . 72.22 109.812 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -80.1 169.02 18.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.203 -0.935 . . . . 63.54 109.323 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 1.7 p90 -156.36 92.37 1.32 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.134 -0.979 . . . . 64.35 109.263 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -76.55 -32.27 58.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.082 -1.011 . . . . 62.22 108.909 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.508 HD13 ' C ' ' B' ' 47' ' ' LEU . 0.8 OUTLIER -112.67 108.74 17.9 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.666 -0.865 . . . . 73.12 108.666 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.433 ' N ' HD13 ' B' ' 47' ' ' LEU . 50.4 t -93.7 107.38 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.524 -0.917 . . . . 65.11 108.524 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.9 ttt -125.5 131.58 52.79 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.555 -0.715 . . . . 73.44 109.52 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.644 HG22 ' H ' ' B' ' 52' ' ' ASP . 0.4 OUTLIER -145.87 138.69 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.465 -0.772 . . . . 34.5 109.803 -179.183 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 51' ' ' SER . . . . . 0.428 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 89.4 p -99.68 12.59 36.18 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.491 -0.755 . . . . 73.21 109.828 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.644 ' H ' HG22 ' B' ' 50' ' ' VAL . 42.4 m-20 -81.77 134.37 35.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.073 -1.017 . . . . 70.41 109.561 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -71.3 -34.44 70.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.342 -0.849 . . . . 65.0 110.2 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -76.55 9.76 2.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.061 -1.024 . . . . 75.21 109.722 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' B' ' 56' ' ' LEU . . . -72.87 -21.18 60.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.19 -0.944 . . . . 55.33 110.254 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' B' ' 55' ' ' ALA . 69.5 mt -41.14 -52.7 3.25 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.496 -0.753 . . . . 63.14 110.364 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 19.8 t -65.05 -36.32 83.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.961 -1.087 . . . . 63.5 109.171 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -62.53 -61.76 2.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.327 -0.858 . . . . 72.33 109.649 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 22.4 m -49.75 -31.57 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.523 -1.36 . . . . 74.54 109.645 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 60' ' ' SER . . . . . 0.401 ' OG ' ' N ' ' B' ' 61' ' ' ARG . 5.8 p -58.61 -52.15 66.87 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.254 -0.904 . . . . 71.24 109.321 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.401 ' N ' ' OG ' ' B' ' 60' ' ' SER . 2.8 ptp180 -68.61 -31.86 71.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.075 -1.015 . . . . 74.31 110.0 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 40.6 mm -66.16 -40.08 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.723 -1.235 . . . . 72.14 109.879 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -65.83 -48.2 72.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 73.32 110.48 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -72.83 -37.19 67.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.826 -1.171 . . . . 73.12 110.12 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.484 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 66.4 mttm -81.49 -21.11 38.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.152 -0.968 . . . . 72.44 109.856 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.484 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 72.0 m-70 -155.78 66.26 0.6 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.103 -0.998 . . . . 63.31 109.691 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.5 t -62.59 -33.53 75.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.21 -0.931 . . . . 73.1 109.87 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 51.1 m -57.29 -30.34 64.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.211 -0.93 . . . . 71.53 110.073 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 73.3 mt -76.13 153.35 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.112 -0.993 . . . . 74.4 109.532 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.53 HG12 ' N ' ' B' ' 71' ' ' VAL . 72.6 t -90.33 163.47 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.324 -0.86 . . . . 75.12 109.565 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.53 ' N ' HG12 ' B' ' 70' ' ' VAL . 12.9 t -139.81 126.57 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.239 -0.913 . . . . 73.2 109.544 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.688 ' HG ' HD11 ' B' ' 95' ' ' ILE . 1.1 mp -124.94 99.93 6.36 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.727 -0.842 . . . . 73.34 108.727 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 76.0 t -91.15 145.63 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.899 . . . . 73.5 108.72 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 2.4 m -118.68 171.82 7.93 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.414 -0.804 . . . . 64.34 109.044 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.469 ' HG ' ' HH ' ' B' ' 94' ' ' TYR . 27.6 p -162.0 126.74 3.35 Favored 'General case' 0 N--CA 1.506 2.335 0 C-N-CA 118.699 -1.2 . . . . 74.53 111.284 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -65.35 -13.73 59.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.631 -0.668 . . . . 64.5 110.239 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 77' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' B' ' 79' ' ' THR . 10.1 p-10 -129.73 79.44 73.46 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 121.356 -0.84 . . . . 74.25 109.709 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.475 ' HA ' ' HH ' ' B' ' 94' ' ' TYR . 27.8 Cg_exo -57.89 80.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.428 2.085 . . . . 74.43 111.277 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.438 ' N ' ' O ' ' B' ' 77' ' ' ASN . 66.6 p -106.48 151.25 25.21 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.933 -0.766 . . . . 73.12 108.933 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -24.17 61.52 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.37 -0.831 . . . . 71.01 109.32 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -67.93 -38.96 83.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 63.2 109.8 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -76.85 -34.57 57.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.136 -0.978 . . . . 73.22 109.77 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' B' ' 83' ' ' GLU . 0.4 OUTLIER -61.38 -51.58 68.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 74.3 109.635 -179.652 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.507 HG23 ' N ' ' B' ' 85' ' ' HIS . 30.3 m -62.58 -45.81 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.975 -1.078 . . . . 73.31 109.356 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 85' ' ' HIS . . . . . 0.507 ' N ' HG23 ' B' ' 84' ' ' VAL . 18.7 m170 -61.79 -30.9 71.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.137 -0.977 . . . . 73.24 109.2 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -65.69 -39.73 91.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 55.33 109.995 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 87' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 111' ' ' ALA . 79.1 t80 -83.72 -37.89 22.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.032 -1.042 . . . . 74.14 109.315 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -67.34 -41.17 85.65 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.306 -0.871 . . . . 64.04 109.542 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -69.57 -50.64 42.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 72.35 109.556 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 145.6 70.47 0.02 OUTLIER Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.907 -1.277 . . . . 65.2 109.907 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 91' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -129.24 131.25 47.01 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.392 -1.064 . . . . 52.23 108.881 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' B' ' 71' ' ' VAL . 56.8 m-20 -75.54 -35.54 60.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.064 -1.022 . . . . 73.32 109.078 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 93' ' ' ASP . . . . . 0.521 ' OD2' ' NH2' ' B' ' 112' ' ' ARG . 7.3 m-20 -153.89 155.3 35.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.385 -0.822 . . . . 72.22 109.388 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.475 ' HH ' ' HA ' ' B' ' 78' ' ' PRO . 6.3 t80 -123.37 138.76 54.53 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.061 -0.718 . . . . 64.42 109.061 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 0.813 HD12 ' N ' ' B' ' 95' ' ' ILE . 0.3 OUTLIER -130.1 139.68 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-O 122.069 0.937 . . . . 72.23 110.622 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 96' ' ' ALA . . . . . 0.414 ' HB1' ' HD2' ' B' ' 98' ' ' PRO . . . -59.17 131.98 52.65 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.825 -1.546 . . . . 25.24 106.825 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -61.99 -41.2 74.89 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 120.833 -1.167 . . . . 64.32 110.959 -178.179 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 98' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' B' ' 97' ' ' LYS . 37.3 Cg_exo -54.73 2.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.291 -2.486 0 CA-C-N 118.827 0.617 . . . . 63.33 112.202 -175.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 99' ' ' TYR . . . . . 0.575 ' N ' ' O ' ' B' ' 97' ' ' LYS . 50.4 m-85 54.83 106.56 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.614 -0.679 . . . . 75.13 109.848 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 19.7 ttm180 -61.62 -34.83 76.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 74.23 108.976 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 101' ' ' SER . . . . . 0.762 ' O ' ' N ' ' B' ' 103' ' ' LYS . 43.9 t -174.59 38.8 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.266 -0.896 . . . . 63.34 110.508 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 59.1 mt 50.17 -70.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.656 -0.652 . . . . 74.44 110.311 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.762 ' N ' ' O ' ' B' ' 101' ' ' SER . 9.3 mtpm? -54.32 -21.03 8.28 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.953 -1.129 . . . . 71.11 107.953 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.21 -64.23 0.93 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.073 -0.651 . . . . 71.45 109.983 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 2.5 pp -62.29 -35.22 78.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.036 -1.04 . . . . 51.31 109.787 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 34.4 t -60.75 -44.21 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.876 -1.14 . . . . 65.23 108.605 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.23 -42.62 73.65 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.314 -0.995 . . . . 24.32 108.314 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 108' ' ' ARG . . . . . 0.615 ' NH1' ' CZ ' ' A' ' 87' ' ' PHE . 58.8 mtp85 -64.91 -34.07 77.51 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.412 -0.805 . . . . 75.31 108.974 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 92.4 mt -74.3 -27.69 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.488 -0.93 . . . . 54.24 108.488 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -75.31 -58.17 3.44 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.446 -0.784 . . . . 65.31 109.112 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -48.32 -42.87 32.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 72.24 109.43 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 112' ' ' ARG . . . . . 0.521 ' NH2' ' OD2' ' B' ' 93' ' ' ASP . 50.6 ttm-85 -61.36 -44.14 97.67 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.324 -0.86 . . . . 72.04 109.319 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 41.2 mt -134.8 75.78 1.59 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.43 -0.794 . . . . 75.35 109.313 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -68.1 -54.44 18.12 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.136 -0.978 . . . . 75.5 109.318 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 115' ' ' PHE . . . . . 0.521 ' O ' ' CG ' ' B' ' 116' ' ' TRP . 6.3 t80 -92.18 -76.97 0.44 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.186 -0.946 . . . . 65.33 109.436 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 116' ' ' TRP . . . . . 0.521 ' CG ' ' O ' ' B' ' 115' ' ' PHE . 4.0 m-90 -162.44 -173.22 3.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.053 -1.029 . . . . 74.45 109.294 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.17 176.22 0.93 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.455 -1.458 . . . . 44.21 109.455 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 26.9 m -128.25 178.67 6.08 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.439 -1.036 . . . . 71.4 109.599 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.51 139.63 19.27 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.941 -0.704 . . . . 72.32 109.207 -178.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 14.2 t -86.08 -40.28 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.133 -0.979 . . . . 75.02 109.619 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 18.2 mm -105.57 134.39 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.309 -0.869 . . . . 51.41 108.838 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -157.26 131.16 8.19 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.076 -1.015 . . . . 71.53 109.036 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 3.8 tt -151.77 131.3 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 72.43 108.912 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.13 -143.11 41.34 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.997 -1.641 . . . . 51.23 108.997 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -85.65 3.48 40.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -1.192 . . . . 74.2 109.043 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 mt -92.61 125.88 37.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.352 -0.842 . . . . 75.42 108.741 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 17.4 m -123.77 140.36 53.06 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.153 -1.055 . . . . 74.22 108.153 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 5.0 mt -143.01 131.25 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.023 -1.048 . . . . 60.33 109.92 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 129' ' ' SER . . . . . 0.564 ' HB3' ' OE1' ' B' ' 132' ' ' GLU . 12.4 m -116.3 92.43 36.22 Favored Pre-proline 0 N--CA 1.495 1.814 0 N-CA-C 108.573 -0.899 . . . . 72.31 108.573 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -71.67 -27.91 17.82 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.354 1.369 . . . . 75.13 111.616 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 131' ' ' ASP . . . . . 0.577 ' HB2' ' OE2' ' B' ' 132' ' ' GLU . 74.4 m-20 -66.91 -42.22 85.78 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.144 -0.972 . . . . 75.23 108.88 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 132' ' ' GLU . . . . . 0.577 ' OE2' ' HB2' ' B' ' 131' ' ' ASP . 4.7 mp0 -87.27 6.08 35.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.328 -0.857 . . . . 72.43 109.307 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 133' ' ' GLU . . . . . 0.556 ' HA ' ' CE1' ' B' ' 149' ' ' PHE . 42.9 mt-10 51.03 54.55 11.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 75.13 109.446 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -150.54 145.97 26.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.212 -0.93 . . . . 73.22 109.527 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 8.3 tt -130.45 142.06 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.502 -0.749 . . . . 64.14 109.513 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 77.3 mt -129.71 124.61 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.525 -0.734 . . . . 71.22 109.561 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 137' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' B' ' 137' ' ' TYR . 18.2 p90 -142.33 152.72 43.21 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.234 -0.916 . . . . 64.22 109.66 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 138' ' ' LYS . . . . . 0.517 ' O ' ' NH1' ' B' ' 140' ' ' ARG . 51.3 mtpt 55.57 14.54 1.24 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.513 -0.742 . . . . 72.02 110.045 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.88 -15.77 58.45 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.144 -1.027 . . . . 74.32 110.587 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 140' ' ' ARG . . . . . 0.517 ' NH1' ' O ' ' B' ' 138' ' ' LYS . 10.3 mpt_? -87.26 143.16 27.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.957 -1.319 . . . . 75.34 108.846 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 141' ' ' GLU . . . . . 0.462 ' CD ' ' N ' ' B' ' 141' ' ' GLU . 21.2 mp0 -103.2 138.63 39.74 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.235 -0.915 . . . . 71.23 109.914 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 52.8 t -138.01 133.98 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.811 -0.811 . . . . 70.43 108.811 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 143' ' ' GLU . . . . . 0.434 ' H ' ' HG3' ' B' ' 143' ' ' GLU . 3.2 pp20? -104.7 136.32 44.45 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.395 -0.816 . . . . 72.43 109.684 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 6.7 m -140.37 157.19 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.366 -0.834 . . . . 72.13 109.01 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -171.8 37.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.997 . . . . 72.02 109.839 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -133.25 -125.54 2.62 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 109.184 -1.566 . . . . 42.23 109.184 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 147' ' ' LYS . . . . . 0.611 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 33.8 tttm -76.13 -33.35 1.25 Allowed Pre-proline 0 N--CA 1.487 1.401 0 O-C-N 121.272 -1.134 . . . . 73.3 111.223 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 148' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 61.0 Cg_endo -85.22 11.77 3.27 Favored 'Trans proline' 0 N--CA 1.486 1.065 0 C-N-CA 121.854 1.702 . . . . 71.33 112.158 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 149' ' ' PHE . . . . . 0.621 ' CE1' HG21 ' B' ' 153' ' ' THR . 13.0 t80 -110.24 -50.18 2.99 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.497 -0.752 . . . . 74.23 108.988 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -60.92 -49.79 76.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.33 -0.856 . . . . 72.34 111.099 -178.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.478 HG13 ' N ' ' B' ' 152' ' ' LEU . 11.8 p -70.95 -40.23 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.91 -1.118 . . . . 73.35 110.131 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.478 ' N ' HG13 ' B' ' 151' ' ' VAL . 16.4 tp -65.65 -40.19 92.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.117 -0.989 . . . . 55.24 109.937 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.621 HG21 ' CE1' ' B' ' 149' ' ' PHE . 14.3 p -77.62 -17.79 57.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.754 -1.216 . . . . 70.01 109.69 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -71.39 -54.23 11.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.877 -1.14 . . . . 65.32 109.607 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 155' ' ' LEU . . . . . 0.885 HD13 ' N ' ' B' ' 156' ' ' ALA . 0.0 OUTLIER -74.67 -21.17 59.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.16 -0.962 . . . . 71.54 109.455 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 156' ' ' ALA . . . . . 0.885 ' N ' HD13 ' B' ' 155' ' ' LEU . . . -62.9 -55.3 27.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.793 -1.192 . . . . 75.32 108.947 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -64.23 -52.23 59.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.047 -1.033 . . . . 73.32 108.838 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -88.52 42.43 1.07 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.563 -0.71 . . . . 74.14 110.15 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 22.2 ttp-105 -55.3 -77.58 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.06 -1.025 . . . . 61.41 109.368 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -65.3 82.74 0.05 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.375 -0.828 . . . . 72.1 109.396 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -170.46 154.36 4.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.268 -0.895 . . . . 72.25 109.496 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 162' ' ' ILE . . . . . 0.753 HD12 ' N ' ' B' ' 162' ' ' ILE . 2.9 mp -76.66 109.87 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.15 -0.969 . . . . 72.31 109.062 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.65 124.79 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.309 -0.869 . . . . 64.21 109.041 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 23.3 t -100.85 178.77 4.59 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.199 -0.938 . . . . 74.22 110.167 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 165' ' ' LYS . . . . . 0.511 ' NZ ' ' CZ ' ' B' ' 212' ' ' TYR . 40.5 mttm -72.77 -56.83 4.68 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.003 0.906 . . . . 65.31 109.345 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 166' ' ' GLU . . . . . 0.723 ' O ' ' OD1' ' B' ' 170' ' ' ASP . 12.8 pt-20 -55.37 -27.99 51.03 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.368 -0.832 . . . . 63.45 109.535 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -60.28 -50.47 73.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.094 -1.004 . . . . 72.4 109.354 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 76.9 mt -59.27 -35.88 74.53 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.334 -0.854 . . . . 72.32 109.665 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' B' ' 172' ' ' ILE . 40.2 mt -65.54 -73.68 0.12 Allowed 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 117.692 -1.603 . . . . 73.34 109.303 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 170' ' ' ASP . . . . . 0.787 ' OD1' ' N ' ' B' ' 170' ' ' ASP . 0.0 OUTLIER -42.86 -21.45 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.311 0 O-C-N 120.173 -1.58 . . . . 72.1 110.233 178.578 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 171' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' B' ' 169' ' ' LEU . . . -88.12 -24.86 23.26 Favored 'General case' 0 C--N 1.283 -2.286 0 O-C-N 121.61 -0.682 . . . . 62.13 110.5 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' B' ' 169' ' ' LEU . 1.8 mp -113.93 -19.77 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.307 -0.871 . . . . 71.42 110.659 -178.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 173' ' ' TRP . . . . . 0.515 ' CZ3' ' HB3' ' B' ' 169' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.515 2.776 0 O-C-N 120.276 -1.515 . . . . 72.23 107.015 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo . . . . . 0 N--CA 1.488 1.196 0 N-CA-C 113.254 0.444 . . . . 65.22 113.254 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 12.6 m120 49.3 45.33 23.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.045 -1.034 . . . . 72.31 110.564 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.11 -23.99 16.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.259 -0.901 . . . . 63.32 109.767 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.421 HD11 HD11 ' B' ' 169' ' ' LEU . 54.2 mt -49.25 -39.78 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.114 -0.991 . . . . 75.03 110.576 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -53.61 -61.67 2.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.027 -1.045 . . . . 64.11 109.533 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 34.1 t -66.04 -40.79 88.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.486 -0.759 . . . . 73.0 110.405 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.9 -58.37 6.34 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.029 -1.044 . . . . 61.12 110.853 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 188' ' ' ILE . . . . . 0.596 HD12 ' CE2' ' B' ' 212' ' ' TYR . 1.3 tt -56.03 -33.94 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.739 -1.225 . . . . 72.43 109.977 -178.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -58.99 -57.47 12.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.098 -1.001 . . . . 65.14 109.987 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -68.76 -41.05 79.39 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.159 -0.963 . . . . 63.24 110.548 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 77.5 mt -55.26 -38.75 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.817 -1.177 . . . . 74.03 108.932 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 192' ' ' ARG . . . . . 0.409 ' CZ ' HG21 ' B' ' 206' ' ' THR . 57.0 mtp180 -64.97 -48.26 74.63 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.319 -0.863 . . . . 72.24 109.94 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -76.42 -20.06 57.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.043 -1.035 . . . . 73.1 111.12 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -90.73 -21.66 21.47 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.874 -1.141 . . . . 72.11 111.028 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 195' ' ' MET . . . . . 0.443 ' C ' ' SD ' ' B' ' 195' ' ' MET . 3.1 ppp? -88.35 -36.93 16.33 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.788 -1.195 . . . . 44.33 110.026 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -59.12 -42.85 91.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.16 -0.962 . . . . 71.21 110.348 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 197' ' ' LYS . . . . . 0.412 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 24.5 mttm -51.64 -64.45 1.44 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.974 . . . . 75.21 110.03 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 198' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 44.9 Cg_endo -65.71 -34.31 41.35 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.253 1.969 . . . . 75.32 112.613 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 199' ' ' LEU . . . . . 0.938 HD23 ' O ' ' B' ' 201' ' ' ILE . 13.3 tp -68.82 -43.75 74.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.176 -0.952 . . . . 72.25 109.69 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 92.92 -44.78 2.51 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.66 -1.376 . . . . 64.53 109.66 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 201' ' ' ILE . . . . . 0.938 ' O ' HD23 ' B' ' 199' ' ' LEU . 27.8 mm -110.31 133.81 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.397 -1.061 . . . . 44.23 109.28 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 9.0 t -77.64 135.49 38.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 54.01 109.451 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 71.2 p -143.02 44.11 1.57 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.28 -0.887 . . . . 74.4 109.24 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.594 HG12 ' CE2' ' B' ' 214' ' ' PHE . 17.5 m -139.03 140.89 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.377 -0.827 . . . . 72.12 109.871 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -124.76 114.79 19.73 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.779 -0.823 . . . . 65.41 108.779 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 206' ' ' THR . . . . . 0.409 HG21 ' CZ ' ' B' ' 192' ' ' ARG . 68.4 p -96.68 123.22 40.3 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.139 -0.975 . . . . 71.33 109.468 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 6.4 t -142.94 144.31 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.131 -0.981 . . . . 63.5 109.466 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 31.5 ttm-85 -60.14 -35.53 75.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.444 -0.785 . . . . 74.45 110.042 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 209' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' B' ' 211' ' ' GLY . 18.0 mmm180 -65.96 142.46 57.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.114 -0.991 . . . . 74.14 109.728 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 210' ' ' ARG . . . . . 0.519 ' NH1' HH21 ' B' ' 213' ' ' ARG . 90.3 mtt180 55.79 -81.5 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.668 -0.645 . . . . 74.43 109.718 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 211' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' B' ' 209' ' ' ARG . . . -179.36 -98.98 0.12 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.825 -1.31 . . . . 64.45 109.825 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 212' ' ' TYR . . . . . 0.596 ' CE2' HD12 ' B' ' 188' ' ' ILE . 6.4 m-85 -131.29 115.9 16.89 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.57 -0.959 . . . . 74.21 108.778 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 213' ' ' ARG . . . . . 0.519 HH21 ' NH1' ' B' ' 210' ' ' ARG . 35.4 ttm180 -93.1 128.11 38.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.421 -0.799 . . . . 74.03 109.976 -179.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 214' ' ' PHE . . . . . 0.604 ' CD2' HD23 ' B' ' 155' ' ' LEU . 14.2 m-85 -101.55 121.36 41.83 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.416 -0.957 . . . . 74.34 108.416 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.1 p -133.97 163.98 28.31 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.379 -0.825 . . . . 64.33 110.005 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -79.61 150.42 73.01 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.469 -0.769 . . . . 70.04 109.41 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.81 -101.5 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.282 1.988 . . . . 65.11 112.094 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 2.8 ptpp? . . . . . 0 N--CA 1.494 1.768 0 O-C-N 121.224 -0.922 . . . . 73.15 108.921 -179.937 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.546 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.427 -0.583 . . . . 65.12 109.427 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -137.61 148.97 46.26 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.445 -0.784 . . . . 72.33 109.319 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.0 t -118.06 125.09 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.66 -0.65 . . . . 71.42 109.724 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.803 HD12 ' N ' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -94.84 124.32 38.81 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.055 -1.028 . . . . 65.12 108.348 179.319 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.803 ' N ' HD12 ' A' ' 4' ' ' LEU . 4.1 tp -120.57 123.89 43.98 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.039 -0.726 . . . . 62.43 109.039 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.567 HG12 HD11 ' A' ' 4' ' ' LEU . 9.5 mt -108.63 106.1 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.271 -0.893 . . . . 71.15 108.861 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.516 ' OE2' ' ND2' ' A' ' 9' ' ' ASN . 37.0 tp10 -138.24 122.88 18.62 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.359 -0.838 . . . . 75.34 109.536 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -86.41 -13.31 46.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.28 -0.887 . . . . 72.44 109.323 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.516 ' ND2' ' OE2' ' A' ' 7' ' ' GLU . 82.3 m-20 -69.37 -136.34 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.354 -0.842 . . . . 63.02 109.454 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 11' ' ' VAL . 35.1 p -158.1 -63.86 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.071 -1.018 . . . . 72.34 109.765 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.52 HG13 ' N ' ' A' ' 12' ' ' LEU . 12.6 p -69.53 -41.22 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 74.02 109.881 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.52 ' N ' HG13 ' A' ' 11' ' ' VAL . 45.8 mt -63.98 -36.4 83.85 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.174 -0.954 . . . . 71.43 109.515 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.8 -34.87 23.58 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.696 -1.762 . . . . 61.32 108.696 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.86 -44.14 89.81 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.948 -1.261 . . . . 71.2 109.948 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -67.92 -43.59 78.84 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.069 -1.253 . . . . 71.32 109.26 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.3 mt -65.64 -49.4 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.853 -1.154 . . . . 63.23 108.655 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.525 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 86.3 tt0 -46.08 -56.46 5.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.328 -0.858 . . . . 51.11 109.817 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -85.26 3.73 38.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 73.34 109.433 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.78 -67.1 1.61 Allowed Glycine 0 N--CA 1.484 1.841 0 N-CA-C 109.921 -1.271 . . . . 62.15 109.921 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 20' ' ' LEU . 2.1 pt? -65.05 -22.77 67.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -1.205 . . . . 73.51 109.803 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 84.3 m-20 -57.35 -33.19 67.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.023 -1.048 . . . . 74.25 109.265 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 82.2 t -57.41 -33.46 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.343 -0.848 . . . . 70.04 109.384 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.418 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 11.8 mptt -70.24 2.54 3.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.879 . . . . 73.23 109.353 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.13 35.62 12.18 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.181 -1.168 . . . . 75.54 110.181 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -119.55 160.55 22.21 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.495 -1.003 . . . . 73.43 109.218 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 45.3 mmm -103.61 137.39 41.73 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.053 -1.092 . . . . 43.24 108.053 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.77 159.99 41.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.106 -0.996 . . . . 62.11 110.101 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -141.74 155.86 45.62 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.399 -0.813 . . . . 74.42 109.081 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 p -109.85 139.49 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.365 -0.834 . . . . 72.15 108.903 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.7 p -134.21 165.26 25.52 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.454 -0.779 . . . . 71.42 109.432 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.407 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 3.9 pt-20 -91.53 -103.72 0.11 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.334 -0.854 . . . . 72.33 109.602 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.5 t -79.45 165.72 22.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 74.24 109.96 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.7 mt -52.5 -32.58 40.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.535 -0.728 . . . . 71.53 109.802 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -48.47 -50.62 30.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.145 -0.972 . . . . 74.23 109.787 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.31 -39.1 85.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.118 -0.989 . . . . 54.03 109.586 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.41 -36.52 34.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.839 -1.304 . . . . 61.41 109.839 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -64.89 -40.06 94.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -1.156 . . . . 74.34 109.928 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -81.62 -40.63 22.68 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.013 -1.054 . . . . 75.33 109.503 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.5 tp -66.05 -43.04 88.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 74.33 109.729 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.441 ' O ' ' O ' ' A' ' 43' ' ' ARG . 3.6 ppp? -69.44 -26.95 64.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.167 -0.958 . . . . 70.32 109.656 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -65.51 -39.84 92.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.948 . . . . 71.22 109.751 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.519 HD12 HH12 ' A' ' 43' ' ' ARG . 24.5 pt -83.8 -26.37 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.221 -0.925 . . . . 74.14 109.989 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.519 HH12 HD12 ' A' ' 42' ' ' ILE . 80.2 mtt85 -129.13 137.94 51.5 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.404 -0.81 . . . . 72.24 109.276 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -92.27 126.84 37.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.157 -0.964 . . . . 75.42 109.588 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -104.71 141.62 36.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.465 -0.772 . . . . 74.23 109.269 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -80.63 -35.47 33.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.228 -0.92 . . . . 72.04 109.804 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.533 HD13 ' C ' ' A' ' 47' ' ' LEU . 1.1 tm? -124.55 113.82 18.58 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.795 -0.817 . . . . 72.13 108.795 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.654 ' O ' HG23 ' A' ' 48' ' ' VAL . 17.3 m -109.03 105.32 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.306 -0.871 . . . . 72.34 108.785 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.565 ' SD ' ' N ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -104.48 132.61 50.53 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.915 -1.143 . . . . 74.11 107.915 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.565 ' N ' ' SD ' ' A' ' 49' ' ' MET . 1.5 p -129.01 128.16 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.847 0.832 . . . . 61.12 110.352 -178.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.9 p -95.6 2.8 54.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.649 -0.657 . . . . 73.11 109.409 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.42 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 4.1 m-20 -76.48 150.59 36.64 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.179 -0.951 . . . . 52.55 109.552 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.458 ' C ' ' H ' ' A' ' 55' ' ' ALA . 18.7 pttp -85.88 -39.5 16.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.188 -0.945 . . . . 44.22 110.329 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -71.63 12.53 0.35 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.022 -1.049 . . . . 70.44 109.619 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.458 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.34 -21.52 58.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.849 . . . . 64.14 110.514 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.519 HD23 HE22 ' A' ' 89' ' ' GLN . 46.8 mt -39.96 -53.95 2.27 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.582 -0.699 . . . . 44.14 110.426 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 t -66.0 -35.7 81.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.984 -1.073 . . . . 55.23 109.164 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.498 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 65.9 t80 -64.02 -62.42 1.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.39 -0.819 . . . . 74.44 109.763 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.8 m -49.33 -32.2 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.655 -1.278 . . . . 74.03 109.628 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.9 t -58.93 -52.06 67.36 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.263 -0.898 . . . . 64.3 109.501 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -68.8 -30.4 68.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.025 -1.047 . . . . 64.44 109.94 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.498 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 31.7 mm -59.02 -44.41 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.868 -1.145 . . . . 63.21 110.083 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -74.29 -48.38 28.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.036 -1.04 . . . . 74.42 111.48 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.22 -36.11 82.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.611 -1.305 . . . . 70.32 109.861 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -92.18 -50.44 5.67 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.137 -0.977 . . . . 75.22 109.226 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.5 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 0.5 OUTLIER -107.9 63.03 0.61 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.466 -0.771 . . . . 74.13 109.784 -179.467 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 t -65.94 -28.38 68.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.011 -1.055 . . . . 73.24 110.043 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.4 m -63.45 -31.0 72.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.258 -0.901 . . . . 61.01 110.627 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 58.8 mt -84.74 149.08 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.973 -1.079 . . . . 71.33 110.226 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 71' ' ' VAL . 72.3 t -88.51 159.04 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.569 -0.9 . . . . 72.13 108.569 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.457 ' N ' HG12 ' A' ' 70' ' ' VAL . 17.2 t -136.58 129.67 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.282 -0.886 . . . . 54.21 109.932 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.507 ' O ' ' SD ' ' A' ' 49' ' ' MET . 1.6 mt -127.08 100.81 6.27 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.909 -1.145 . . . . 50.24 107.909 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.622 ' O ' HD12 ' A' ' 95' ' ' ILE . 15.0 p -96.37 154.65 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.368 -0.832 . . . . 74.41 109.282 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.427 ' O ' ' OG ' ' A' ' 75' ' ' SER . 0.4 OUTLIER -118.4 167.72 11.3 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.701 -0.851 . . . . 72.31 108.701 179.395 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 74' ' ' SER . 3.7 m -167.41 120.72 0.95 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.266 -0.897 . . . . 64.54 109.933 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -75.12 19.58 0.15 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.409 -0.807 . . . . 74.13 110.111 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 75' ' ' SER . 34.7 t30 -142.48 58.41 7.4 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.129 -0.982 . . . . 73.34 109.826 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.4 82.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.342 2.028 . . . . 63.22 112.471 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 77' ' ' ASN . 44.8 m -114.2 150.99 33.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.227 -1.027 . . . . 62.53 108.227 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 t -53.45 -26.49 20.39 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.074 -1.016 . . . . 73.44 109.723 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -63.41 -47.67 81.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.163 -0.961 . . . . 71.42 109.813 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -72.64 -30.61 64.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.162 -0.962 . . . . 73.43 109.917 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.464 ' OE2' ' NE ' ' B' ' 108' ' ' ARG . 35.3 tt0 -62.04 -55.75 25.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 74.22 109.965 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 85' ' ' HIS . 33.2 m -63.47 -36.49 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -0.961 . . . . 73.2 109.62 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.414 ' N ' HG23 ' A' ' 84' ' ' VAL . 21.3 m80 -73.68 -19.59 60.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 53.33 109.711 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -76.73 -44.19 34.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.158 -0.964 . . . . 64.11 110.017 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -81.42 -29.74 33.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.078 -1.013 . . . . 74.34 109.217 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -75.75 -40.54 55.24 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.326 -0.859 . . . . 74.42 110.001 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.519 HE22 HD23 ' A' ' 56' ' ' LEU . 11.1 pt20 -71.15 -46.91 60.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.042 -1.036 . . . . 74.24 109.841 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.489 ' N ' ' CG ' ' A' ' 89' ' ' GLN . . . 145.67 70.05 0.02 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.881 -1.288 . . . . 61.51 109.881 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -133.64 129.02 36.31 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.261 -1.141 . . . . 55.33 108.701 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 11.8 t70 -73.25 -40.12 64.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.912 -1.117 . . . . 73.42 108.875 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 63.6 m-20 -153.36 154.06 33.79 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.932 -0.766 . . . . 75.04 108.932 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -127.72 130.71 49.28 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.866 -0.791 . . . . 71.33 108.866 -179.597 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.922 ' H ' HD12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -118.74 142.54 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 CA-C-O 121.636 0.731 . . . . 71.13 110.14 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.12 119.89 8.69 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.982 -1.074 . . . . 64.32 108.139 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.697 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -43.22 -53.79 10.46 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.182 -0.949 . . . . 62.2 111.656 -179.168 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 1.4 Cg_endo -38.22 -11.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.27 1.314 . . . . 73.11 113.525 -176.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.697 ' N ' ' O ' ' A' ' 97' ' ' LYS . 56.4 m-85 57.88 103.27 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.454 -0.779 . . . . 65.22 109.638 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 61.2 mtm-85 -58.96 -49.93 75.98 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.071 -1.018 . . . . 72.35 109.148 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.822 ' O ' ' N ' ' A' ' 103' ' ' LYS . 3.2 t -174.5 67.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.138 -0.976 . . . . 71.32 110.631 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.76 ' H ' HD12 ' A' ' 102' ' ' ILE . 1.8 mp 35.6 -68.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 CA-C-O 121.213 0.53 . . . . 75.43 111.885 178.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.822 ' N ' ' O ' ' A' ' 101' ' ' SER . 28.3 mmtp -47.3 -15.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.867 -1.145 . . . . 71.41 109.096 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -60.79 -92.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.439 -0.788 . . . . 63.24 110.374 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.672 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.0 pt? -50.47 -33.27 20.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.053 -1.03 . . . . 73.22 110.392 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 66.2 t -65.46 -40.53 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.83 -1.168 . . . . 60.11 109.037 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 103' ' ' LYS . . . -58.89 -39.6 81.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.218 -0.926 . . . . 70.42 108.516 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -68.43 -31.21 70.37 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.917 -0.771 . . . . 74.41 108.917 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.4 mt -75.37 -34.65 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 108.294 -1.002 . . . . 62.54 108.294 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.407 ' OE2' ' NH1' ' A' ' 114' ' ' ARG . 82.5 tt0 -74.64 -57.81 3.69 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.472 -0.768 . . . . 74.34 109.184 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -49.62 -35.59 21.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.338 -0.851 . . . . 73.32 109.319 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 53.8 ttt85 -68.26 -39.47 82.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.339 -0.851 . . . . 52.41 109.865 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 34.8 mt -133.58 68.72 1.49 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.292 -0.88 . . . . 65.24 110.446 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.407 ' NH1' ' OE2' ' A' ' 110' ' ' GLU . 25.0 mtp85 -75.07 -43.09 55.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.941 -1.099 . . . . 64.45 108.341 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 115' ' ' PHE . 8.7 p90 -132.99 73.21 1.51 Allowed 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.825 -0.805 . . . . 74.43 108.825 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -56.26 -177.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.601 -0.687 . . . . 74.42 109.972 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.11 142.39 13.3 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.895 -1.282 . . . . 75.04 109.895 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.401 ' O ' ' O ' ' A' ' 119' ' ' ASN . 16.0 t -161.85 -61.16 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.346 -1.091 . . . . 61.14 109.129 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 118' ' ' SER . 36.3 t30 51.45 95.95 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.359 -0.838 . . . . 65.24 109.875 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.4 t -84.34 -19.41 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.049 -1.032 . . . . 73.11 109.158 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 22.4 mm -110.26 124.56 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.548 -0.72 . . . . 72.24 109.758 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -138.38 109.16 6.66 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.469 -0.938 . . . . 72.34 108.469 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.9 pt -142.05 122.03 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.243 -0.91 . . . . 71.44 109.338 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.03 -148.39 32.55 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.429 -1.468 . . . . 73.4 109.429 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -83.89 9.98 10.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.265 -1.138 . . . . 74.45 109.391 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.52 131.82 43.78 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.39 -0.819 . . . . 54.21 108.878 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 p -128.55 128.26 43.93 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.574 -0.899 . . . . 54.5 108.574 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 21.2 mt -133.9 135.08 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.334 -0.854 . . . . 45.15 109.752 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.3 m -119.22 91.75 44.36 Favored Pre-proline 0 N--CA 1.497 1.893 0 N-CA-C 108.845 -0.798 . . . . 71.11 108.845 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.32 -25.84 6.67 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.226 1.95 . . . . 65.41 112.538 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -59.32 -40.37 86.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.088 -1.007 . . . . 63.32 108.83 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -97.63 5.78 48.92 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.5 -0.926 . . . . 72.52 108.5 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 56.81 61.2 2.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.257 -0.902 . . . . 75.33 109.03 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -149.75 148.35 29.12 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.349 -0.844 . . . . 71.23 109.543 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 13.1 tt -119.93 139.51 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.548 -0.72 . . . . 74.02 109.212 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.85 126.34 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.581 -0.699 . . . . 60.23 109.323 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -141.46 149.95 41.63 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.395 -0.815 . . . . 62.32 109.588 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 138' ' ' LYS . 54.6 tttt 55.9 9.59 0.47 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.495 -0.753 . . . . 75.4 109.715 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.95 14.03 59.88 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.954 -1.258 . . . . 72.24 109.954 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -105.35 136.58 44.62 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.421 -1.046 . . . . 71.22 109.077 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -101.43 118.42 36.92 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.482 -0.761 . . . . 71.42 110.041 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 10.7 p -138.06 132.54 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.408 -0.808 . . . . 53.02 108.933 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.427 ' CG ' ' N ' ' A' ' 144' ' ' VAL . 29.5 tt0 -92.3 160.71 15.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -0.917 . . . . 60.45 110.357 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.455 ' CG2' ' CG ' ' A' ' 149' ' ' PHE . 13.5 p -143.41 140.81 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.182 -1.044 . . . . 74.44 108.182 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -152.26 113.25 4.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.773 -1.205 . . . . 65.15 110.399 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 176.89 -164.45 33.94 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.985 -1.646 . . . . 73.34 108.985 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.623 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 17.3 mtpp -91.19 -32.24 0.35 Allowed Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.055 -1.262 . . . . 72.22 111.499 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 85.8 Cg_endo -88.33 21.15 1.04 Allowed 'Trans proline' 0 N--CA 1.488 1.196 0 C-N-CA 122.131 1.887 . . . . 65.23 112.516 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.455 ' CG ' ' CG2' ' A' ' 144' ' ' VAL . 41.0 m-85 -125.65 -29.75 3.13 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.475 -0.766 . . . . 60.11 109.679 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -60.84 -34.05 73.98 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.909 -1.119 . . . . 64.21 108.606 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.04 -33.97 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.344 -0.984 . . . . 72.02 108.344 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 17.7 tp -62.26 -45.23 94.22 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.532 -0.914 . . . . 73.31 108.532 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.9 p -65.47 -37.61 87.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 74.31 108.957 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -53.45 -60.55 3.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.563 -0.71 . . . . 74.31 110.765 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.3 pp -65.0 -23.53 67.24 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.096 -1.002 . . . . 75.34 109.743 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.1 -40.01 84.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.976 -1.077 . . . . 62.14 108.852 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -86.1 -51.52 6.26 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.235 -0.916 . . . . 61.03 109.66 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -73.93 49.34 0.33 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 74.12 108.925 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.626 ' NH1' ' OD2' ' A' ' 160' ' ' ASP . 7.6 ptm180 -77.72 14.08 1.15 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.639 -0.663 . . . . 71.13 111.025 -178.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.626 ' OD2' ' NH1' ' A' ' 159' ' ' ARG . 64.2 m-20 -148.21 47.48 1.06 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.682 -1.262 . . . . 75.45 110.129 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -150.86 157.52 43.02 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.918 -1.114 . . . . 73.41 109.848 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.6 mt -86.05 117.85 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.527 -0.733 . . . . 74.41 109.716 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 1.279 ' HB ' ' CE1' ' A' ' 214' ' ' PHE . 44.6 t -108.17 130.02 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.941 -0.763 . . . . 72.31 108.941 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.7 t -96.11 168.05 10.84 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.164 -0.96 . . . . 74.12 110.167 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm -65.42 -55.0 20.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.401 -0.812 . . . . 70.43 109.75 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -56.32 -33.97 66.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.901 . . . . 73.52 109.651 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.6 tp60 -62.38 -42.76 99.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.314 -0.866 . . . . 74.52 108.968 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 9.1 mt -60.82 -37.51 82.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.397 -0.815 . . . . 72.31 109.12 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.563 ' C ' HD23 ' A' ' 169' ' ' LEU . 5.0 tt -57.12 -58.76 6.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.337 -0.852 . . . . 53.33 109.114 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -68.56 -29.41 67.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.614 -0.679 . . . . 62.44 110.723 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.96 -67.8 0.28 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.028 -1.045 . . . . 60.21 110.377 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.555 HD12 ' N ' ' A' ' 172' ' ' ILE . 2.1 mp -89.01 -50.44 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.003 -1.061 . . . . 75.32 109.554 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.056 -1.028 . . . . 73.14 109.156 -179.903 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.761 ' N ' HD21 ' A' ' 182' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.292 -0.633 . . . . 64.54 109.292 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.5 p -70.13 -18.8 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.444 -0.785 . . . . 74.02 109.802 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 21.7 mt -63.47 -30.68 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.156 -0.965 . . . . 72.33 109.923 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -63.0 -45.06 94.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.078 -1.014 . . . . 74.4 110.297 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 16.8 m -73.19 -25.46 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.991 -1.068 . . . . 70.42 109.401 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -78.02 -48.81 15.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.259 -0.901 . . . . 52.11 109.715 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.483 ' O ' HD13 ' A' ' 188' ' ' ILE . 0.3 OUTLIER -67.64 -32.63 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.028 -1.045 . . . . 71.4 109.108 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -67.12 -48.56 67.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.508 -0.745 . . . . 73.44 110.367 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -72.7 -32.96 66.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.791 -1.193 . . . . 71.42 109.776 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 51.7 mt -63.56 -54.7 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.779 -1.201 . . . . 61.55 110.267 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -62.78 -34.84 78.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.692 -1.255 . . . . 63.34 109.781 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.431 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 42.7 mt-30 -78.04 -18.73 55.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 61.24 111.24 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -97.24 -28.26 14.15 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.791 -1.193 . . . . 75.13 110.722 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' MET . . . . . 0.51 ' SD ' ' O ' ' A' ' 195' ' ' MET . 4.1 ppp? -93.15 9.2 36.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.753 -1.217 . . . . 74.02 110.146 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 193' ' ' GLN . 27.9 p-10 -110.31 -32.97 6.77 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.227 -0.921 . . . . 74.02 110.386 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 66.8 tttt -75.15 -36.16 2.13 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.018 -1.051 . . . . 75.43 111.184 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 89.8 Cg_endo -87.77 -52.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.974 1.783 . . . . 72.32 112.475 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.9 mp -48.88 -75.69 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.988 -1.07 . . . . 74.54 109.301 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 148.94 -47.82 0.63 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.64 -1.384 . . . . 61.51 109.64 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 24.6 mt -120.07 133.5 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.587 -0.949 . . . . 61.22 109.388 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 12.6 m -77.79 146.27 35.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.868 . . . . 72.0 108.966 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 22.0 p -132.47 27.77 4.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.461 -0.775 . . . . 74.44 109.362 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.7 m -129.45 125.57 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.485 -0.759 . . . . 64.35 109.61 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -98.54 105.05 17.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.544 -0.722 . . . . 71.41 109.379 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 24.4 p -70.57 119.68 15.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 73.52 108.816 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 12.7 m -139.93 158.54 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.219 -0.925 . . . . 71.02 110.301 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -102.64 -7.15 22.0 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.745 -0.835 . . . . 72.12 108.745 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.976 ' NH2' ' NH1' ' A' ' 213' ' ' ARG . 53.8 ttp180 -65.04 -27.55 68.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.438 -0.789 . . . . 64.41 109.677 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -151.06 -72.33 0.16 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 71.54 109.235 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.467 ' C ' ' CD1' ' A' ' 212' ' ' TYR . . . -167.89 -80.1 0.04 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.614 -1.394 . . . . 72.03 109.614 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.467 ' CD1' ' C ' ' A' ' 211' ' ' GLY . 73.5 m-85 -149.67 129.17 13.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.143 -1.21 . . . . 75.54 109.194 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.976 ' NH1' ' NH2' ' A' ' 209' ' ' ARG . 6.0 mtp180 -99.31 116.32 31.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.339 -0.851 . . . . 75.31 109.1 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 1.279 ' CE1' ' HB ' ' A' ' 163' ' ' VAL . 32.9 m-85 -92.9 104.92 17.11 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.439 -0.948 . . . . 75.41 108.439 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 15.1 p -138.96 166.17 25.19 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.965 -0.754 . . . . 74.14 108.965 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' TYR . . . . . 0.881 ' CE2' ' O ' ' A' ' 217' ' ' PRO . 2.2 p90 -70.24 157.45 89.89 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.249 -0.907 . . . . 75.32 109.383 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.881 ' O ' ' CE2' ' A' ' 216' ' ' TYR . 51.3 Cg_exo . . . . . 0 N--CA 1.494 1.505 0 C-N-CA 121.923 1.749 . . . . 73.11 111.963 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ptp . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.427 -0.582 . . . . 71.14 109.427 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -139.65 149.62 43.96 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.346 -0.847 . . . . 73.23 109.404 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 86.2 t -114.37 138.02 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.679 -0.638 . . . . 72.24 109.443 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.421 HD11 ' CG1' ' B' ' 6' ' ' ILE . 5.9 tp -113.59 119.11 36.37 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.581 -0.7 . . . . 54.33 110.159 -178.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.407 ' N ' HD12 ' B' ' 4' ' ' LEU . 12.5 mt -120.31 98.72 6.19 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 108.793 -0.817 . . . . 74.35 108.793 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.421 ' CG1' HD11 ' B' ' 4' ' ' LEU . 44.9 mt -86.27 98.27 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.716 -1.24 . . . . 42.55 108.577 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.483 ' CD ' ' HG ' ' B' ' 51' ' ' SER . 9.4 tp10 -136.0 131.32 34.87 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.414 -0.804 . . . . 74.52 109.423 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -66.03 -34.68 78.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.328 -0.858 . . . . 62.55 109.363 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -77.27 110.45 11.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.275 -0.89 . . . . 73.11 109.562 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 31.7 t -68.77 -23.01 64.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 65.54 109.682 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 93.9 t -68.21 -48.69 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.166 -0.959 . . . . 75.55 109.842 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.544 HD22 ' N ' ' B' ' 12' ' ' LEU . 3.5 mm? -67.31 -30.41 70.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.936 . . . . 70.14 109.706 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.5 -33.71 27.44 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.125 -1.59 . . . . 75.4 109.125 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.7 -45.5 75.47 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.888 -1.285 . . . . 65.44 109.888 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' B' ' 16' ' ' ILE . 11.3 pt-20 -68.38 -44.72 74.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.097 -1.237 . . . . 60.21 109.26 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.42 ' N ' ' CG ' ' B' ' 15' ' ' GLU . 6.2 mm -60.5 -35.5 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.044 -1.035 . . . . 75.15 108.336 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -62.31 -46.84 86.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.541 -0.724 . . . . 73.01 109.563 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -83.22 0.75 44.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.117 -0.989 . . . . 74.3 109.317 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.26 -55.63 2.32 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 109.684 -1.366 . . . . 70.54 109.684 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -76.45 -17.88 59.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -1.105 . . . . 71.34 109.857 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -56.7 -30.53 63.55 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.965 -1.084 . . . . 64.41 109.272 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 73.5 t -59.49 -30.68 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 74.23 109.039 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -77.43 -7.44 56.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.419 -0.801 . . . . 63.42 109.318 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.61 39.78 7.04 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.587 -1.005 . . . . 53.43 110.587 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -120.23 158.87 26.09 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.379 -1.071 . . . . 71.12 109.194 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 50.0 mmm -106.98 138.76 42.54 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.476 -0.935 . . . . 75.24 108.476 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.41 160.97 40.16 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.113 -0.992 . . . . 72.12 110.131 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -141.35 156.73 45.8 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.787 -0.82 . . . . 72.31 108.787 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 p -118.84 139.78 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.392 -0.818 . . . . 64.43 109.58 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.1 p -133.64 169.99 16.2 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.57 -0.706 . . . . 65.41 109.396 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -93.13 -99.71 0.13 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.319 -0.863 . . . . 71.02 109.884 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -78.16 167.7 21.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.195 -0.941 . . . . 51.11 110.277 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 28.1 mt -56.52 -35.51 68.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.587 -0.695 . . . . 71.24 110.008 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -54.44 -42.38 70.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.108 -0.995 . . . . 74.32 109.883 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -66.58 -39.51 88.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.097 -1.002 . . . . 73.03 109.378 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.61 -40.82 58.53 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.546 -1.422 . . . . 30.21 109.546 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.99 -38.62 91.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.281 -1.129 . . . . 74.42 109.645 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -74.96 -39.66 61.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 74.42 109.845 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 21.2 tp -72.02 -49.6 35.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.937 . . . . 75.41 110.102 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 40' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' B' ' 40' ' ' MET . 1.9 ppp? -60.72 -30.42 69.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.138 -0.976 . . . . 60.41 109.938 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.82 -37.28 70.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.16 -0.963 . . . . 53.23 110.044 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 14.2 pt -100.62 0.03 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.292 -0.88 . . . . 71.23 110.351 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' B' ' 40' ' ' MET . 59.1 mmt-85 -130.96 152.8 49.88 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.288 -0.882 . . . . 72.22 109.875 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -83.94 165.61 18.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.318 -0.864 . . . . 63.54 109.095 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 1.9 p90 -156.2 102.08 2.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.029 -1.045 . . . . 64.35 109.881 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -79.18 -32.04 44.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.177 -0.952 . . . . 62.22 108.585 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.496 HD13 ' C ' ' B' ' 47' ' ' LEU . 0.7 OUTLIER -113.75 108.41 17.07 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.612 -0.884 . . . . 73.12 108.612 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.429 ' N ' HD13 ' B' ' 47' ' ' LEU . 97.3 t -96.55 105.31 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.276 -0.89 . . . . 65.11 108.693 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 15.5 ttt -123.02 130.54 52.93 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.491 -0.756 . . . . 73.44 109.661 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.463 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.4 OUTLIER -145.28 134.03 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.594 -0.691 . . . . 34.5 109.153 -179.654 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 51' ' ' SER . . . . . 0.483 ' HG ' ' CD ' ' B' ' 7' ' ' GLU . 6.4 p -102.06 13.82 33.67 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.551 -0.718 . . . . 73.21 109.741 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.463 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 66.5 m-20 -76.75 148.1 36.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.145 -0.972 . . . . 70.41 109.712 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.406 ' C ' ' H ' ' B' ' 55' ' ' ALA . 65.5 mttp -78.05 -42.76 31.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.308 -0.87 . . . . 65.0 109.906 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -73.51 9.43 1.38 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.199 -0.938 . . . . 75.21 109.521 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -59.72 -22.89 62.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.374 -0.828 . . . . 55.33 109.826 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 56.2 mt -46.0 -34.29 3.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.331 -0.855 . . . . 63.14 109.933 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 18.5 m -77.1 -46.96 21.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.102 -0.999 . . . . 63.5 109.499 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 58' ' ' PHE . . . . . 0.41 ' CZ ' HD11 ' B' ' 62' ' ' ILE . 58.9 t80 -61.86 -53.32 57.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -0.943 . . . . 72.33 109.519 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.484 HG23 ' N ' ' B' ' 60' ' ' SER . 14.1 m -56.25 -39.99 63.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.587 -1.321 . . . . 74.54 109.17 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 60' ' ' SER . . . . . 0.484 ' N ' HG23 ' B' ' 59' ' ' VAL . 28.0 t -51.6 -46.19 63.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.143 -0.973 . . . . 71.24 109.722 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.461 ' O ' ' N ' ' B' ' 65' ' ' LYS . 13.8 ptp180 -78.32 -34.27 48.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.863 -1.148 . . . . 74.31 110.566 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' B' ' 66' ' ' HIS . 33.4 mm -63.03 -45.95 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.452 -1.405 . . . . 72.14 108.464 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 63' ' ' LYS . . . . . 0.432 ' HZ3' ' HB2' ' B' ' 89' ' ' GLN . 29.5 mttt -61.81 -40.52 95.55 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.624 -0.88 . . . . 73.32 108.624 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -75.37 -38.13 60.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.61 -0.681 . . . . 73.12 109.228 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.528 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 25.4 mtpp -83.94 -23.09 31.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.266 -0.896 . . . . 72.44 110.705 -178.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.528 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 83.4 m-70 -156.75 66.4 0.54 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.903 -1.123 . . . . 63.31 109.912 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.2 t -59.29 -29.51 67.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.328 -0.857 . . . . 73.1 109.938 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 86.4 p -65.35 -34.74 79.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.153 -0.967 . . . . 71.53 110.683 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.484 HG22 ' N ' ' B' ' 70' ' ' VAL . 78.3 mt -65.71 160.89 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.912 -1.117 . . . . 74.4 109.61 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.484 ' N ' HG22 ' B' ' 69' ' ' ILE . 97.6 t -85.0 159.23 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.21 -0.931 . . . . 75.12 110.039 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.524 ' N ' ' OD1' ' B' ' 92' ' ' ASP . 11.0 t -143.48 111.42 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.075 -1.016 . . . . 73.2 109.316 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.606 HD23 HD11 ' B' ' 95' ' ' ILE . 0.7 OUTLIER -110.06 99.62 8.68 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.544 -0.91 . . . . 73.34 108.544 -179.634 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 79.1 t -95.13 127.83 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.237 -0.915 . . . . 73.5 108.963 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.1 m -103.22 173.52 6.27 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.443 -0.786 . . . . 64.34 109.666 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.48 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 23.0 t -166.28 122.97 1.32 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.168 -0.957 . . . . 74.53 110.298 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -62.01 -17.1 56.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.435 -0.79 . . . . 64.5 109.605 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 77' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' B' ' 79' ' ' THR . 47.2 t-20 -124.43 82.23 58.59 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.516 -0.74 . . . . 74.25 109.196 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.15 71.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.566 2.177 . . . . 74.43 112.003 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.517 ' N ' ' O ' ' B' ' 77' ' ' ASN . 17.0 m -88.13 152.27 22.11 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.102 -0.999 . . . . 73.12 109.418 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -37.86 88.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.892 . . . . 71.01 109.488 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -55.64 -46.88 77.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.951 . . . . 63.2 109.63 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -71.56 -30.93 66.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.896 . . . . 73.22 109.658 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' B' ' 84' ' ' VAL . 10.6 tm-20 -70.02 -56.23 7.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 74.3 109.851 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.548 HG23 ' N ' ' B' ' 85' ' ' HIS . 13.1 m -63.27 -44.61 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.135 -0.978 . . . . 73.31 109.722 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 85' ' ' HIS . . . . . 0.548 ' N ' HG23 ' B' ' 84' ' ' VAL . 71.1 t60 -63.19 -40.26 97.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 73.24 109.456 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.04 -44.26 97.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.904 . . . . 55.33 109.588 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -74.13 -30.27 62.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.131 -0.981 . . . . 74.14 108.535 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -57.54 -50.42 73.16 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.681 -0.859 . . . . 64.04 108.681 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 89' ' ' GLN . . . . . 0.432 ' HB2' ' HZ3' ' B' ' 63' ' ' LYS . 40.7 mt-30 -64.33 -38.31 90.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.62 -0.675 . . . . 72.35 109.462 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 139.49 10.31 0.82 Allowed Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.344 -1.102 . . . . 65.2 110.344 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -48.79 122.22 5.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.878 -1.366 . . . . 52.23 109.233 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' B' ' 71' ' ' VAL . 5.8 m-20 -63.68 -37.39 87.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.116 -0.99 . . . . 73.32 109.102 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 93' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 20.3 t0 -154.79 158.44 39.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.851 . . . . 72.22 109.751 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.52 ' N ' ' OD1' ' B' ' 93' ' ' ASP . 42.4 t80 -130.26 116.97 19.13 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.158 -1.053 . . . . 64.42 108.158 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 1.026 ' H ' HD12 ' B' ' 95' ' ' ILE . 0.0 OUTLIER -119.42 156.75 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.503 0 CA-C-O 121.919 0.866 . . . . 72.23 110.797 -177.72 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.42 134.06 42.4 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.435 -1.32 . . . . 25.24 107.435 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.675 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -55.04 -55.57 37.61 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 120.773 -1.204 . . . . 64.32 111.791 -178.462 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 98' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 1.4 Cg_endo -39.44 -12.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 121.144 1.23 . . . . 63.33 113.213 -176.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 99' ' ' TYR . . . . . 0.675 ' N ' ' O ' ' B' ' 97' ' ' LYS . 53.3 m-85 56.5 104.13 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.508 -0.745 . . . . 75.13 109.728 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -55.24 -42.31 73.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.949 -1.095 . . . . 74.23 108.673 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 101' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' B' ' 104' ' ' ALA . 12.2 t -168.2 151.18 5.6 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.465 -0.772 . . . . 63.34 109.039 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 20.7 mm -55.52 -45.14 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.986 . . . . 74.44 109.362 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -68.91 -7.54 35.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 71.11 109.605 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' B' ' 101' ' ' SER . . . -71.69 -77.99 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.073 -1.017 . . . . 71.45 109.786 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.596 ' N ' HD23 ' B' ' 105' ' ' LEU . 2.2 pt? -62.32 -36.67 82.89 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.066 -1.021 . . . . 51.31 110.092 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 80.7 t -60.36 -44.97 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.9 -1.125 . . . . 65.23 109.187 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.18 -33.49 72.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.173 -0.954 . . . . 24.32 108.751 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 108' ' ' ARG . . . . . 0.521 ' NH2' ' CG2' ' B' ' 95' ' ' ILE . 78.6 mtm180 -80.27 -24.97 39.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.43 -0.793 . . . . 75.31 109.872 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 67.0 mt -79.48 -47.01 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.022 -1.049 . . . . 54.24 108.649 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.68 -39.87 94.42 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.584 -0.847 . . . . 65.31 109.146 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.91 -35.96 82.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.345 -0.847 . . . . 72.24 109.217 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -61.94 -39.19 91.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.324 -0.86 . . . . 72.04 109.765 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.65 67.57 1.25 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.157 -0.965 . . . . 75.35 109.529 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.483 ' O ' ' CG ' ' B' ' 115' ' ' PHE . 50.2 mtp180 -57.28 -32.86 67.06 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.14 -0.975 . . . . 75.5 109.341 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 115' ' ' PHE . . . . . 0.483 ' CG ' ' O ' ' B' ' 114' ' ' ARG . 87.8 m-85 -157.67 91.14 1.12 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 65.33 109.515 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 116' ' ' TRP . . . . . 0.519 ' NE1' ' OE2' ' B' ' 141' ' ' GLU . 5.3 m-90 52.21 11.25 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 74.45 109.69 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 117' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' B' ' 115' ' ' PHE . . . 70.03 -112.4 4.37 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.849 -1.3 . . . . 44.21 109.849 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 84.4 p -150.62 -172.59 4.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.286 -1.126 . . . . 71.4 109.843 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.23 130.69 13.85 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.938 -0.705 . . . . 72.32 109.195 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 5.5 t -80.65 -42.72 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 75.02 110.117 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 121' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' B' ' 128' ' ' ILE . 27.7 mm -112.67 121.41 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.442 -0.786 . . . . 51.41 109.234 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -154.65 138.84 16.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.251 -0.905 . . . . 71.53 109.392 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.778 HD13 ' H ' ' B' ' 123' ' ' ILE . 0.1 OUTLIER -147.08 157.1 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.267 -0.896 . . . . 72.43 109.492 179.721 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.85 -131.79 12.47 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.601 -1.4 . . . . 51.23 109.601 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -99.82 0.73 42.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.311 -1.111 . . . . 74.2 109.522 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.23 145.57 24.55 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.136 -0.977 . . . . 75.42 108.527 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 28.8 m -129.21 136.63 50.37 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.548 -0.72 . . . . 74.22 109.245 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' B' ' 121' ' ' ILE . 39.8 mt -136.02 136.34 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.398 -0.814 . . . . 60.33 109.645 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 7.3 m -127.58 80.27 72.15 Favored Pre-proline 0 N--CA 1.499 2.017 0 N-CA-C 109.15 -0.685 . . . . 72.31 109.15 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.41 -55.38 3.66 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.815 2.343 . . . . 75.13 112.612 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -51.82 -40.05 59.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -0.93 . . . . 75.23 109.627 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -84.6 0.17 51.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.203 -0.936 . . . . 72.43 109.461 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 52.39 60.32 3.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 75.13 109.618 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -151.34 130.43 12.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.867 . . . . 73.22 109.121 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 59.8 mt -118.1 133.81 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.547 -0.721 . . . . 64.14 109.528 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 70.5 mt -124.43 123.11 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 109.074 -0.713 . . . . 71.22 109.074 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -137.54 141.42 41.4 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.427 -0.796 . . . . 64.22 109.522 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 138' ' ' LYS . . . . . 0.498 ' NZ ' ' O ' ' B' ' 198' ' ' PRO . 50.7 mttp 54.45 26.19 6.88 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.565 -0.709 . . . . 72.02 110.085 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.88 -0.67 77.25 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.186 -1.166 . . . . 74.32 110.186 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -89.95 131.27 35.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.127 -1.219 . . . . 75.34 109.158 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 141' ' ' GLU . . . . . 0.519 ' OE2' ' NE1' ' B' ' 116' ' ' TRP . 95.5 mt-10 -97.1 125.11 41.35 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.331 -0.856 . . . . 71.23 109.472 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 96.0 t -137.49 135.1 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.387 -0.821 . . . . 70.43 109.199 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -88.93 151.07 22.54 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.325 -0.86 . . . . 72.43 109.389 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 22.2 m -90.85 137.77 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.177 -0.952 . . . . 72.13 109.792 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -171.19 56.05 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.337 -0.852 . . . . 72.02 109.511 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 178.65 176.82 46.83 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.869 -1.292 . . . . 42.23 109.869 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 147' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 15.2 mttt -70.65 -38.86 8.39 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.362 -1.081 . . . . 73.3 110.112 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 148' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 32.8 Cg_exo -57.73 -37.73 95.58 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.194 1.929 . . . . 71.33 111.83 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -87.99 -20.7 25.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.431 -0.793 . . . . 74.23 109.253 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -66.55 -41.77 88.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.302 -0.874 . . . . 72.34 109.639 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p -73.31 -32.6 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.187 -0.945 . . . . 73.35 109.58 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 23.1 tp -66.55 -43.42 85.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.209 -0.932 . . . . 55.24 109.952 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 25.8 m -72.53 -35.24 68.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.963 -1.086 . . . . 70.01 109.758 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 154' ' ' HIS . . . . . 0.551 ' CE1' ' NH2' ' B' ' 157' ' ' ARG . 1.6 m-70 -62.96 -48.84 77.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 65.32 110.259 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.0 pp -69.54 -27.09 64.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.811 -1.181 . . . . 71.54 109.294 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.62 -49.9 75.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.956 . . . . 75.32 109.499 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 157' ' ' ARG . . . . . 0.551 ' NH2' ' CE1' ' B' ' 154' ' ' HIS . 21.6 ptt180 -74.86 -36.11 62.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.242 -0.911 . . . . 73.32 109.934 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -87.98 18.2 4.39 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.08 -1.012 . . . . 74.14 109.776 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -62.04 161.25 11.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.139 -0.976 . . . . 61.41 109.266 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 37.4 t0 59.73 49.47 8.11 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.329 -0.857 . . . . 72.1 109.585 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -157.66 145.21 18.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 72.25 109.292 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 94.9 mt -85.91 128.03 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -0.943 . . . . 72.31 109.192 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 5.3 m -132.24 139.35 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.456 -0.778 . . . . 64.21 109.585 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 58.4 p -86.45 172.14 10.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.223 -0.923 . . . . 74.22 109.302 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -59.58 -39.8 85.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.945 . . . . 65.31 109.59 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -57.29 -32.46 66.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 63.45 109.798 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -60.04 -48.7 80.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.96 . . . . 72.4 109.873 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 37.6 mt -62.37 -32.96 73.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.086 -1.009 . . . . 72.32 109.101 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.547 HD23 ' C ' ' B' ' 169' ' ' LEU . 6.3 tt -57.18 -64.98 0.7 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.347 -0.846 . . . . 73.34 109.542 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -64.82 -31.81 73.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.229 -0.919 . . . . 72.1 110.143 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -48.39 -58.99 3.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.124 -0.985 . . . . 62.13 110.062 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 0.674 ' N ' HD12 ' B' ' 172' ' ' ILE . 2.1 mp -92.82 -59.14 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.056 -1.028 . . . . 71.42 109.318 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 11.2 m-90 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 72.23 109.62 -179.799 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo . . . . . 0 N--CA 1.492 1.4 0 CA-C-O 121.299 0.458 . . . . 65.22 112.392 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -69.21 -29.8 67.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 72.31 109.614 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 6.0 p -59.55 -27.61 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.287 -0.883 . . . . 63.32 110.014 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 35.2 mm -56.27 -25.87 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.179 -0.951 . . . . 75.03 109.688 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -58.69 -48.5 80.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 64.11 109.827 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 186' ' ' VAL . . . . . 0.423 ' C ' HE21 ' B' ' 190' ' ' GLN . 16.1 m -77.22 -26.42 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.102 -0.999 . . . . 73.0 109.865 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.26 -49.01 38.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.03 -1.044 . . . . 61.12 109.822 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 19.6 tt -66.87 -33.5 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.175 -0.953 . . . . 72.43 110.015 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -73.62 -40.62 63.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.112 -0.993 . . . . 65.14 111.163 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 190' ' ' GLN . . . . . 0.423 HE21 ' C ' ' B' ' 186' ' ' VAL . 7.6 pt20 -78.17 -37.94 44.63 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.784 -1.198 . . . . 63.24 111.194 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 191' ' ' ILE . . . . . 0.419 HD12 ' N ' ' B' ' 192' ' ' ARG . 2.4 pp -69.7 -41.85 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.741 -1.224 . . . . 74.03 110.138 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 192' ' ' ARG . . . . . 0.419 ' N ' HD12 ' B' ' 191' ' ' ILE . 9.4 ptm180 -69.64 -39.02 77.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.872 -1.142 . . . . 72.24 109.661 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -67.64 -40.04 84.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.246 -0.909 . . . . 73.1 110.586 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 194' ' ' LYS . . . . . 0.468 ' O ' ' CD ' ' B' ' 198' ' ' PRO . 13.1 pttp -80.22 -13.43 59.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.964 -1.085 . . . . 72.11 110.074 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 51.5 ttm -91.87 -30.26 16.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.199 -0.938 . . . . 44.33 109.771 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 196' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' B' ' 200' ' ' GLY . 95.8 m-20 -68.7 -41.6 78.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 71.21 110.266 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 197' ' ' LYS . . . . . 0.418 ' N ' ' HD2' ' B' ' 198' ' ' PRO . 12.1 tmtt? -60.66 -55.41 45.2 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.042 -1.036 . . . . 75.21 110.806 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 198' ' ' PRO . . . . . 0.498 ' O ' ' NZ ' ' B' ' 138' ' ' LYS . 29.3 Cg_endo -60.78 -54.95 1.6 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.371 1.381 . . . . 75.32 111.829 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.56 -45.67 78.6 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.084 -1.01 . . . . 72.25 108.878 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 200' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' B' ' 196' ' ' ASP . . . 87.13 -31.58 4.35 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.688 -1.365 . . . . 64.53 109.688 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 201' ' ' ILE . . . . . 0.708 ' N ' HD12 ' B' ' 201' ' ' ILE . 2.0 mp -92.21 138.34 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.245 -1.15 . . . . 44.23 109.087 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 29.2 t -87.51 139.78 30.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.284 -0.885 . . . . 54.01 109.271 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 10.2 p -144.84 22.17 1.6 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.212 -0.93 . . . . 74.4 109.687 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.424 HG12 ' CD2' ' B' ' 214' ' ' PHE . 26.8 m -138.11 143.1 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.247 -0.908 . . . . 72.12 109.663 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -126.35 135.42 51.46 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.569 -0.707 . . . . 65.41 109.124 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.6 138.0 35.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.322 -0.861 . . . . 71.33 109.304 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.42 HG22 ' H ' ' B' ' 209' ' ' ARG . 7.2 p -148.69 141.78 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -0.954 . . . . 63.5 109.442 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -66.86 -41.41 87.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.916 . . . . 74.45 109.435 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 209' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' B' ' 211' ' ' GLY . 49.2 mtp85 -60.46 147.68 40.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.914 . . . . 74.14 109.553 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 49.87 -89.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.351 -0.843 . . . . 74.43 109.841 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 211' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' B' ' 209' ' ' ARG . . . -170.95 -100.82 0.14 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.776 -1.33 . . . . 64.45 109.776 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 212' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' B' ' 212' ' ' TYR . 25.5 m-85 -130.15 153.53 48.43 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.548 -0.972 . . . . 74.21 108.855 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 5.2 ptm85 -127.43 149.93 49.87 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.383 -0.823 . . . . 74.03 109.81 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 214' ' ' PHE . . . . . 0.424 ' CD2' HG12 ' B' ' 204' ' ' VAL . 23.6 m-85 -117.97 131.13 56.53 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.908 -0.775 . . . . 74.34 108.908 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 29.0 p -160.11 164.0 33.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.064 -1.023 . . . . 64.33 109.849 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -61.83 152.5 75.96 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.381 -0.825 . . . . 70.04 108.931 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -68.16 -156.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.151 1.901 . . . . 65.11 111.482 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.262 -0.899 . . . . 73.15 109.414 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 ttm . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.38 -0.6 . . . . 65.12 109.38 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -137.78 154.95 49.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.392 -0.818 . . . . 72.33 109.394 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 83.6 t -119.79 125.96 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.547 0.689 . . . . 71.42 109.79 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.3 tp -94.42 115.94 28.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.371 -0.974 . . . . 65.12 108.371 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.576 HD22 ' CG ' ' A' ' 49' ' ' MET . 0.2 OUTLIER -117.95 110.59 17.91 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.562 -0.903 . . . . 62.43 108.562 -179.871 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.43 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 12.3 mt -94.41 105.26 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 120.791 -1.193 . . . . 71.15 109.507 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -139.52 124.72 18.92 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.241 -0.912 . . . . 75.34 109.259 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -71.83 -32.37 67.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 72.44 109.505 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -83.42 113.44 20.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.915 . . . . 63.02 109.462 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.2 p -68.07 -25.34 65.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 72.34 109.522 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.5 t -67.99 -53.59 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -0.925 . . . . 74.02 109.609 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.509 HD13 ' O ' ' A' ' 12' ' ' LEU . 0.2 OUTLIER -67.62 -38.85 84.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 71.43 108.951 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.51 -25.8 75.14 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 108.436 -1.866 . . . . 61.32 108.436 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.51 -58.05 10.13 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.477 -1.449 . . . . 71.2 109.477 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.417 ' H ' ' HG2' ' A' ' 15' ' ' GLU . 6.7 pt-20 -53.26 -46.78 69.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.411 -1.053 . . . . 71.32 109.676 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 86.0 mt -64.52 -50.93 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.866 -1.146 . . . . 63.23 108.96 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -49.2 -52.91 23.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 51.11 109.708 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.405 ' CD ' ' N ' ' A' ' 18' ' ' LYS . 0.7 OUTLIER -83.51 2.44 36.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.139 -0.976 . . . . 73.34 109.444 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.23 -60.98 1.95 Allowed Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.909 -1.276 . . . . 62.15 109.909 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.419 HD23 ' N ' ' A' ' 20' ' ' LEU . 1.7 pt? -72.66 -19.37 61.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -1.161 . . . . 73.51 110.034 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -56.87 -31.64 65.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.972 -1.08 . . . . 74.25 109.468 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.2 t -60.68 -28.92 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 70.04 109.327 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.422 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 11.5 mptt -76.55 -1.21 26.29 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.262 -0.899 . . . . 73.23 109.28 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.0 36.56 8.97 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.156 -1.177 . . . . 75.54 110.156 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -119.51 157.51 28.17 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.497 -1.002 . . . . 73.43 109.326 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.3 mmt -108.12 138.62 44.08 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.522 -0.918 . . . . 43.24 108.522 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.54 159.29 43.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.134 -0.979 . . . . 62.11 110.13 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -136.68 155.44 49.87 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.507 -0.746 . . . . 74.42 109.0 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.55 136.68 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.372 -0.83 . . . . 72.15 109.099 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.8 p -133.25 164.94 25.94 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.385 -0.822 . . . . 71.42 109.313 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.43 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 4.9 pt-20 -90.59 -105.73 0.1 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.259 -0.901 . . . . 72.33 109.853 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.5 p -78.23 170.63 16.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 74.24 109.961 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.9 mt -55.97 -30.87 62.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.564 -0.71 . . . . 71.53 109.794 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -50.41 -46.25 56.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 74.23 109.584 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.06 -39.41 90.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 54.03 109.418 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.34 -44.31 34.83 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.572 -1.411 . . . . 61.41 109.572 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -63.02 -37.29 86.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -1.139 . . . . 74.34 109.457 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -81.22 -38.09 27.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 75.33 109.655 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.4 tp -68.71 -46.65 68.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.31 -0.869 . . . . 74.33 109.937 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 41' ' ' ASP . 3.5 ppp? -63.09 -25.56 68.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.129 -0.982 . . . . 70.32 109.793 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 40' ' ' MET . 97.5 m-20 -66.51 -41.14 89.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.082 -1.011 . . . . 71.22 109.973 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.1 pt -82.82 -27.84 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.115 -0.991 . . . . 74.14 110.16 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 40' ' ' MET . 88.7 mtt-85 -129.74 144.46 51.3 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.336 -0.853 . . . . 72.24 109.449 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -91.51 154.13 19.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.239 -0.913 . . . . 75.42 109.521 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -134.76 157.6 46.32 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.491 -0.756 . . . . 74.23 109.176 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -102.7 -42.56 5.85 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.387 -0.821 . . . . 72.04 109.464 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.441 HD13 ' C ' ' A' ' 47' ' ' LEU . 0.4 OUTLIER -104.36 109.7 21.65 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.514 -0.741 . . . . 72.13 109.224 -179.82 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.418 ' N ' HD13 ' A' ' 47' ' ' LEU . 74.7 t -94.09 99.86 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.202 -0.937 . . . . 72.34 108.834 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.576 ' CG ' HD22 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -114.1 129.1 56.63 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.154 -0.684 . . . . 74.11 109.154 -179.603 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.437 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 1.3 p -134.64 133.13 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.536 -0.728 . . . . 61.12 109.89 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.5 p -96.83 1.41 50.64 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.543 -0.723 . . . . 73.11 109.435 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.437 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 55.3 m-20 -76.19 141.51 41.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.198 -0.939 . . . . 52.55 109.416 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.467 ' C ' ' H ' ' A' ' 55' ' ' ALA . 0.7 OUTLIER -79.75 -38.58 32.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 44.22 110.204 -179.479 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -71.18 10.5 0.56 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.035 -1.04 . . . . 70.44 109.364 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.467 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -72.39 -20.51 61.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -0.831 . . . . 64.14 110.298 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 55' ' ' ALA . 68.7 mt -41.18 -47.65 3.32 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.509 -0.744 . . . . 44.14 110.296 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 m -70.28 -35.21 73.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.931 -1.105 . . . . 55.23 108.97 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.659 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 67.7 t80 -66.36 -59.26 3.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.392 -0.817 . . . . 74.44 109.849 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.4 m -52.36 -34.14 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.696 -1.253 . . . . 74.03 109.345 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 p -57.79 -51.83 67.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 64.3 109.732 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -69.32 -28.92 66.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.02 . . . . 64.44 109.983 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.659 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 7.6 mm -67.08 -24.08 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.88 -1.138 . . . . 63.21 109.835 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -86.15 -53.33 5.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.034 -1.041 . . . . 74.42 110.562 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.443 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 14.9 pt-20 -63.78 -43.14 97.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.9 -1.125 . . . . 70.32 110.128 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.443 ' N ' ' CG ' ' A' ' 64' ' ' GLU . 78.2 mttt -79.02 -61.0 2.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 75.22 109.092 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.53 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 0.2 OUTLIER -97.18 80.23 2.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.326 -0.859 . . . . 74.13 108.876 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.9 m -79.02 -25.9 43.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.015 -1.053 . . . . 73.24 110.22 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.3 t -82.55 51.77 1.93 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.114 -0.991 . . . . 61.01 110.208 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 66' ' ' HIS . 15.3 tt -156.98 160.94 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.938 -1.101 . . . . 71.33 109.945 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 71' ' ' VAL . 90.6 t -95.8 160.15 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.178 -0.951 . . . . 72.13 109.135 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.467 ' N ' HG12 ' A' ' 70' ' ' VAL . 3.6 t -146.16 121.24 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.955 -1.091 . . . . 54.21 109.942 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.515 ' O ' ' SD ' ' A' ' 49' ' ' MET . 3.5 mp -119.83 103.41 9.32 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.116 -1.068 . . . . 50.24 108.116 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.9 p -95.8 146.27 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.487 -0.931 . . . . 74.41 108.487 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.453 ' O ' ' OG ' ' A' ' 75' ' ' SER . 0.5 OUTLIER -118.44 165.87 13.36 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.468 -0.77 . . . . 72.31 109.226 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 74' ' ' SER . 3.1 m -168.3 124.08 1.0 Allowed 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 119.393 -0.923 . . . . 64.54 110.242 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.52 1.45 1.19 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.552 -0.718 . . . . 74.13 109.809 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 75' ' ' SER . 33.8 m120 -120.64 62.87 10.1 Favored Pre-proline 0 N--CA 1.501 2.101 0 O-C-N 121.396 -0.815 . . . . 73.34 110.198 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -62.99 77.9 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.157 1.905 . . . . 63.22 111.789 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 77.9 p -104.36 151.72 23.13 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.566 -0.901 . . . . 62.53 108.566 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -31.9 66.8 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.243 -0.911 . . . . 73.44 109.309 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.511 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 78.0 mm-40 -66.29 -36.21 82.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.15 -0.969 . . . . 71.42 109.22 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -71.17 -35.48 71.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.331 -0.856 . . . . 73.43 109.621 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.77 -52.57 64.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 74.22 109.689 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.6 m -60.52 -36.0 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.187 -0.946 . . . . 73.2 109.258 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' A' ' 81' ' ' GLU . 27.9 m80 -71.77 -31.15 66.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.274 -0.891 . . . . 53.33 109.561 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -65.17 -40.1 93.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 64.11 110.177 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.501 ' CZ ' ' HB1' ' B' ' 111' ' ' ALA . 89.3 t80 -83.36 -37.64 23.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.954 -1.092 . . . . 74.34 109.32 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -68.21 -42.91 79.13 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.242 -0.911 . . . . 74.42 109.493 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -66.81 -49.95 64.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -0.996 . . . . 74.24 109.369 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 143.73 72.41 0.02 OUTLIER Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.017 -1.233 . . . . 61.51 110.017 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -138.25 124.16 20.04 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.242 -1.152 . . . . 55.33 109.201 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 13.9 t70 -61.13 -41.72 97.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 73.42 109.336 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 66.8 m-20 -152.05 159.34 43.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.325 -0.859 . . . . 75.04 109.337 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -124.14 131.71 53.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.605 -0.685 . . . . 71.33 109.449 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.5 mt -123.41 140.62 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-O 122.084 0.945 . . . . 71.13 110.381 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.0 121.49 13.12 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.901 -1.148 . . . . 64.32 107.901 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.694 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -45.46 -54.59 14.53 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.128 -0.983 . . . . 62.2 111.428 -178.756 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 2.5 Cg_endo -40.47 -9.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 121.08 1.187 . . . . 73.11 113.289 -176.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.694 ' N ' ' O ' ' A' ' 97' ' ' LYS . 67.5 m-85 58.6 99.39 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.514 -0.741 . . . . 65.22 109.007 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.4 ttm-85 -53.05 -41.62 64.98 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.169 -0.957 . . . . 72.35 109.37 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.822 ' O ' ' N ' ' A' ' 103' ' ' LYS . 23.1 t -172.86 36.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.982 -1.074 . . . . 71.32 110.929 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.6 mt 44.97 -68.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-N 118.693 0.679 . . . . 75.43 110.792 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.822 ' N ' ' O ' ' A' ' 101' ' ' SER . 21.3 tptm -49.22 -36.26 19.55 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.01 -1.056 . . . . 71.41 108.295 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.94 -40.91 83.22 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.189 -1.041 . . . . 63.24 108.189 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.8 -38.17 88.25 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.835 -0.802 . . . . 73.22 108.835 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.23 -42.13 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 60.11 109.353 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.44 -41.17 63.04 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.216 -0.927 . . . . 70.42 108.786 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.525 ' NE ' ' OE2' ' B' ' 83' ' ' GLU . 98.7 mtt180 -68.66 -37.84 79.96 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.35 -0.844 . . . . 74.41 109.282 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.62 -30.84 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.041 -1.037 . . . . 62.54 108.314 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -63.24 -54.81 31.55 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.777 -0.823 . . . . 74.34 108.777 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.465 ' HB2' ' CZ ' ' B' ' 87' ' ' PHE . . . -53.11 -35.87 60.13 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.402 -0.811 . . . . 73.32 109.396 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -57.76 -48.95 78.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.216 -0.927 . . . . 52.41 109.25 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 78.6 mt -144.53 97.73 3.08 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.137 -0.977 . . . . 65.24 109.496 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.403 ' O ' ' CG ' ' A' ' 115' ' ' PHE . 42.0 mtp180 -85.12 -59.02 2.45 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.205 -0.935 . . . . 64.45 108.999 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.403 ' CG ' ' O ' ' A' ' 114' ' ' ARG . 56.9 m-85 -156.55 89.27 1.1 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.256 -0.902 . . . . 74.43 109.542 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.474 ' CD1' ' N ' ' A' ' 116' ' ' TRP . 7.8 p-90 -93.17 133.5 36.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.237 -0.915 . . . . 74.42 109.078 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 178.42 98.35 0.11 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.586 -1.406 . . . . 75.04 109.586 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.83 ' HB3' ' OE2' ' A' ' 132' ' ' GLU . 31.0 t -159.61 176.97 11.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -1.113 . . . . 61.14 109.495 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -158.12 120.02 3.63 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.841 -0.8 . . . . 65.24 108.841 -178.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.8 t -83.62 -25.93 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.073 -1.017 . . . . 73.11 109.056 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.447 HG21 ' O ' ' A' ' 156' ' ' ALA . 28.2 mm -111.33 121.08 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.622 -0.881 . . . . 72.24 108.622 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -127.33 109.91 12.27 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.518 -0.738 . . . . 72.34 109.446 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.412 ' O ' ' C ' ' A' ' 124' ' ' GLY . 94.4 mt -112.67 124.64 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.63 -0.878 . . . . 71.44 108.63 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 123' ' ' ILE . . . -34.16 -44.22 0.37 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 112.109 -0.397 . . . . 73.4 112.109 -178.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.492 ' CB ' HD13 ' A' ' 126' ' ' LEU . 62.1 m-20 -63.7 -56.38 16.14 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.987 -1.302 . . . . 74.45 109.94 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.537 ' H ' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -144.12 166.44 25.01 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.113 -0.992 . . . . 54.21 110.083 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.4 m -106.49 145.07 32.27 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.229 -0.919 . . . . 54.5 109.894 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.9 mt -137.24 134.62 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.165 -0.959 . . . . 45.15 109.76 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.7 t -121.53 113.42 32.07 Favored Pre-proline 0 N--CA 1.499 1.994 0 N-CA-C 109.24 -0.652 . . . . 71.11 109.24 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -81.05 -54.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.719 1.613 . . . . 65.41 112.109 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -55.57 -42.48 74.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 63.32 109.147 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.83 ' OE2' ' HB3' ' A' ' 118' ' ' SER . 72.1 mt-10 -82.56 -4.19 57.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.288 -0.883 . . . . 72.52 109.201 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 47.51 66.35 1.04 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.334 -0.854 . . . . 75.33 109.797 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -159.58 142.76 14.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.063 -1.023 . . . . 71.23 109.783 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.0 tt -126.94 138.36 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.468 -0.77 . . . . 74.02 109.897 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.1 mm -118.03 121.77 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.728 -0.842 . . . . 60.23 108.728 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -140.29 146.01 38.0 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.102 -0.998 . . . . 62.32 110.014 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 83.0 mttt 53.87 26.72 6.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.481 -0.762 . . . . 75.4 110.215 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.18 9.08 87.24 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 120.122 -1.037 . . . . 72.24 110.857 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 43.7 mtp180 -103.11 142.89 33.35 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.194 -1.18 . . . . 71.22 109.259 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -110.74 121.96 46.63 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.899 -0.778 . . . . 71.42 108.899 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.5 143.95 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 120.924 -1.11 . . . . 53.02 110.698 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.568 ' CD ' ' H ' ' A' ' 143' ' ' GLU . 2.1 pm0 -93.65 134.63 35.75 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.398 -1.334 . . . . 60.45 107.398 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.1 136.65 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 120.936 -1.103 . . . . 74.44 110.514 -178.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.13 104.11 0.99 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.643 -0.66 . . . . 65.15 109.498 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -166.88 -147.49 5.26 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.748 -1.341 . . . . 73.34 109.748 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.455 ' H ' ' HD2' ' A' ' 148' ' ' PRO . 30.4 mttt -92.71 -59.72 0.21 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.212 -1.17 . . . . 72.22 110.691 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.762 ' HG2' ' CE1' ' A' ' 149' ' ' PHE . 21.7 Cg_endo -57.94 -15.18 21.07 Favored 'Trans proline' 0 N--CA 1.5 1.898 0 C-N-CA 121.913 1.742 . . . . 65.23 111.937 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.762 ' CE1' ' HG2' ' A' ' 148' ' ' PRO . 4.1 m-85 -98.8 -22.87 15.62 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.175 -0.953 . . . . 60.11 110.196 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -59.61 -35.63 74.71 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.77 -1.206 . . . . 64.21 108.848 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.3 p -70.45 -27.86 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.238 -0.914 . . . . 72.02 108.619 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 56.9 tp -64.48 -49.55 70.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.343 -0.848 . . . . 73.31 109.585 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.46 -33.46 74.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.816 -1.177 . . . . 74.31 108.691 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -54.24 -54.83 34.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.439 -0.788 . . . . 74.31 110.199 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.4 pp -75.26 -23.19 57.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.104 -0.998 . . . . 75.34 109.758 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.447 ' O ' HG21 ' A' ' 121' ' ' ILE . . . -55.13 -38.44 68.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.159 -0.963 . . . . 62.14 108.753 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' A' ' 159' ' ' ARG . 45.1 mtp180 -86.8 -56.08 3.56 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.285 -1.005 . . . . 61.03 108.285 178.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.437 ' N ' ' CD2' ' A' ' 158' ' ' HIS . 8.0 m170 -68.92 47.77 0.06 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.573 -0.899 . . . . 74.12 108.573 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 214' ' ' PHE . 63.9 mtm180 -53.4 -60.04 3.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.609 -0.682 . . . . 71.13 110.271 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -95.6 94.19 7.6 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.165 -0.96 . . . . 75.45 109.283 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLN . . . . . 1.362 ' NE2' ' O ' ' A' ' 162' ' ' ILE . 21.9 tm0? -170.16 142.85 2.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.025 -1.047 . . . . 73.41 109.938 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 1.362 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 2.0 mp -87.74 139.51 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.258 -1.016 . . . . 74.41 108.258 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.561 ' CG1' ' OE1' ' A' ' 161' ' ' GLN . 17.6 m -126.82 150.94 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.463 -0.773 . . . . 72.31 109.893 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 7.2 t -99.78 158.23 15.94 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.499 -0.751 . . . . 74.12 109.218 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.466 ' HB3' HD13 ' A' ' 184' ' ' ILE . 65.3 mttm -55.67 -54.07 48.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.344 -0.847 . . . . 70.43 110.01 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -63.11 -27.97 69.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 73.52 110.343 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.441 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 46.1 tt0 -62.05 -54.37 42.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.005 -1.06 . . . . 74.52 110.08 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 48.9 mt -59.33 -44.78 92.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.884 -1.135 . . . . 72.31 109.36 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 173' ' ' TRP . 4.2 mm? -62.24 -53.04 60.96 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.147 -0.971 . . . . 53.33 109.731 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 167' ' ' GLN . 14.2 p30 -71.1 -4.93 27.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.016 -1.053 . . . . 62.44 110.174 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -83.15 -59.01 2.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.06 -1.025 . . . . 60.21 109.927 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.74 HD12 ' N ' ' A' ' 172' ' ' ILE . 1.9 mp -85.59 -43.66 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.935 -1.103 . . . . 75.32 109.291 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' TRP . . . . . 0.458 ' O ' ' O ' ' A' ' 169' ' ' LEU . 23.5 m-90 . . . . . 0 N--CA 1.499 2.006 0 O-C-N 121.442 -0.786 . . . . 73.14 109.755 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 182' ' ' ASN . 25.1 p-10 . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.527 -0.545 . . . . 64.54 109.527 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 183' ' ' VAL . 11.0 m -76.88 -0.53 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 74.02 109.415 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.488 ' O ' HG22 ' A' ' 188' ' ' ILE . 50.6 mt -51.23 -46.85 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 72.33 109.546 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -56.0 -30.85 62.44 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.401 -0.812 . . . . 74.4 110.17 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 18.0 t -75.13 -53.18 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.041 -1.037 . . . . 70.42 110.735 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.8 -44.5 93.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.034 -1.041 . . . . 52.11 110.697 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 184' ' ' ILE . 8.1 tp -69.84 -37.91 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.112 -0.993 . . . . 71.4 110.418 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.412 ' N ' HG23 ' A' ' 188' ' ' ILE . 26.6 t-20 -70.73 -48.61 53.61 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.111 -0.993 . . . . 73.44 110.738 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' GLN . . . . . 0.449 ' CG ' ' N ' ' A' ' 191' ' ' ILE . 17.5 pt20 -64.44 -45.59 86.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.909 -1.119 . . . . 71.42 110.145 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.449 ' N ' ' CG ' ' A' ' 190' ' ' GLN . 89.6 mt -59.53 -46.68 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.05 -1.031 . . . . 61.55 109.711 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 19.5 mtp-105 -60.01 -45.08 93.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.025 -1.047 . . . . 63.34 109.606 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -65.85 -29.29 69.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 61.24 109.589 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -93.88 -1.46 54.77 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.244 -0.91 . . . . 75.13 109.996 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 36.5 ttm -96.84 -60.47 1.59 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.04 -1.038 . . . . 74.02 109.907 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 196' ' ' ASP . 41.8 t0 -54.94 -22.55 15.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.306 -0.871 . . . . 74.02 110.583 -178.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.432 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 1.3 mptm? -73.27 -65.81 0.63 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.917 -1.114 . . . . 75.43 110.221 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' PRO . . . . . 0.432 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 30.7 Cg_endo -62.18 -56.71 0.64 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.501 1.468 . . . . 72.32 112.355 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 18.8 mt -64.12 -40.49 96.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.176 -0.953 . . . . 74.54 109.763 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 86.3 -34.13 3.51 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.916 -1.674 . . . . 61.51 108.916 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 35.6 mm -111.58 134.82 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.614 -0.933 . . . . 61.22 108.895 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 59.5 p -95.08 166.15 12.07 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.287 -0.883 . . . . 72.0 110.345 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.9 34.41 0.26 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.348 -0.982 . . . . 74.44 108.348 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 23.7 m -135.4 137.18 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.541 -0.724 . . . . 64.35 109.329 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -120.3 135.39 55.02 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.61 -0.681 . . . . 71.41 109.408 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.5 135.13 42.42 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.317 -0.865 . . . . 73.52 109.115 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.7 145.74 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.201 -0.937 . . . . 71.02 109.465 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -77.5 76.55 4.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.94 . . . . 72.12 109.502 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -164.01 -126.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.229 -0.919 . . . . 64.41 109.432 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 18.7 tpt85 -49.39 -43.21 44.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.946 . . . . 71.54 109.733 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 160.46 -111.47 0.48 Allowed Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.686 -1.245 . . . . 72.03 110.208 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -115.45 171.26 7.83 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.503 -0.998 . . . . 75.54 109.433 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -142.2 133.0 25.64 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.246 -0.909 . . . . 75.31 109.699 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.437 ' O ' ' O ' ' A' ' 159' ' ' ARG . 7.2 m-85 -105.4 131.54 52.7 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.88 -0.785 . . . . 75.41 108.88 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 21.3 t -157.08 150.55 24.21 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.942 -0.762 . . . . 74.14 108.942 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -61.77 150.54 81.86 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.047 -1.033 . . . . 75.32 108.913 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.497 1.718 0 C-N-CA 122.412 2.075 . . . . 73.11 112.455 -179.697 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.541 ' N ' ' CZ ' ' B' ' 2' ' ' ARG . 56.1 ttm . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.485 -0.561 . . . . 71.14 109.485 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.541 ' CZ ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -128.14 147.08 50.53 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.996 -0.742 . . . . 73.23 108.996 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 96.8 t -111.11 123.64 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.642 0.734 . . . . 72.24 109.947 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.584 HD11 ' CG1' ' B' ' 6' ' ' ILE . 1.8 tp -92.79 118.65 31.32 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.477 -0.934 . . . . 54.33 108.477 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.526 HD23 ' N ' ' B' ' 6' ' ' ILE . 1.2 tt -119.08 118.05 30.38 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.318 -0.993 . . . . 74.35 108.318 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.584 ' CG1' HD11 ' B' ' 4' ' ' LEU . 24.0 mt -111.51 98.4 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.365 -0.834 . . . . 42.55 108.779 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.423 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 24.6 tp10 -128.93 137.44 51.41 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.623 -0.673 . . . . 74.52 109.365 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.3 -32.95 73.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.281 -0.887 . . . . 62.55 109.454 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -90.88 125.0 35.61 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.253 -0.904 . . . . 73.11 109.514 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 49.5 m -74.93 -32.99 61.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 65.54 109.799 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 96.0 t -60.14 -46.77 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.149 -0.97 . . . . 75.55 109.728 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.507 ' CD2' ' N ' ' B' ' 12' ' ' LEU . 3.5 mm? -63.99 -36.48 84.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 70.14 109.411 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.56 -27.31 71.41 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 108.56 -1.816 . . . . 75.4 108.56 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.59 -53.18 40.36 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 109.543 -1.423 . . . . 65.44 109.543 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -58.97 -46.31 88.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.373 -1.075 . . . . 60.21 109.789 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 36.8 mm -64.45 -40.11 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.816 -1.177 . . . . 75.15 108.826 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.462 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 83.0 tt0 -61.62 -44.92 96.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.27 -0.894 . . . . 73.01 109.317 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -84.96 1.38 47.68 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 74.3 109.196 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.48 -55.42 2.33 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.618 -1.393 . . . . 70.54 109.618 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -75.7 -20.71 58.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -1.13 . . . . 71.34 109.839 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 21' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 82.5 m-20 -52.54 -33.74 46.9 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.037 -1.039 . . . . 64.41 109.547 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 75.9 t -58.2 -29.69 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.229 -0.919 . . . . 74.23 109.278 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -80.12 -7.47 58.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.295 -0.878 . . . . 63.42 109.485 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.57 40.47 7.75 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.327 -1.109 . . . . 53.43 110.327 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -119.12 160.29 22.37 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.428 -1.042 . . . . 71.12 109.096 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.7 mmt -105.15 139.63 39.53 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.631 -0.878 . . . . 75.24 108.631 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.2 155.72 46.01 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.255 -0.903 . . . . 72.12 110.086 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' B' ' 28' ' ' ASP . 2.1 p30 -137.56 140.07 40.82 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.9 -0.778 . . . . 72.31 108.9 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 p -104.61 138.42 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.489 -0.93 . . . . 64.43 108.489 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 16.0 p -136.79 166.5 23.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.35 -0.844 . . . . 65.41 109.306 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 31' ' ' GLU . . . . . 0.476 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 3.2 pt-20 -90.92 -98.17 0.11 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.242 -0.911 . . . . 71.02 109.772 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 24.0 t -78.37 165.18 24.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 51.11 110.166 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 20.7 mt -55.52 -30.65 61.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.577 -0.702 . . . . 71.24 109.957 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -53.27 -46.15 69.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.137 -0.977 . . . . 74.32 109.964 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.476 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 75.0 m-20 -67.33 -42.27 83.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.073 -1.017 . . . . 73.03 109.444 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.59 -39.23 78.79 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.478 -1.449 . . . . 30.21 109.478 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -67.39 -38.21 84.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.322 -1.104 . . . . 74.42 109.774 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -80.2 -39.66 28.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.089 -1.007 . . . . 74.42 109.888 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 39.1 tp -68.52 -37.64 80.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.923 . . . . 75.41 110.226 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 40' ' ' MET . . . . . 0.444 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.4 ppp? -76.29 -22.68 54.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.959 -1.088 . . . . 60.41 110.211 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -64.33 -40.8 96.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.021 -1.049 . . . . 53.23 110.193 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.8 pt -82.05 -42.0 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.052 -1.03 . . . . 71.23 110.178 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' B' ' 40' ' ' MET . 2.2 mpt_? -94.86 150.71 19.89 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.029 -1.044 . . . . 72.22 109.278 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -68.68 -162.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 63.54 109.081 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -179.11 154.78 0.69 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.008 -1.057 . . . . 64.35 109.927 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -136.98 -46.87 0.58 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.455 -0.778 . . . . 62.22 108.951 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.513 HD13 ' C ' ' B' ' 47' ' ' LEU . 0.9 OUTLIER -104.08 110.66 22.92 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.43 -0.952 . . . . 73.12 108.43 179.548 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.464 ' N ' HD13 ' B' ' 47' ' ' LEU . 75.9 t -96.77 98.29 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.268 -0.895 . . . . 65.11 109.357 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.412 ' CE ' ' OG ' ' B' ' 74' ' ' SER . 3.8 ttt -113.71 130.29 56.45 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.623 0.725 . . . . 73.44 109.414 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.409 HG21 ' HB2' ' B' ' 55' ' ' ALA . 0.3 OUTLIER -144.27 130.45 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.496 -0.753 . . . . 34.5 109.132 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 51' ' ' SER . . . . . 0.423 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 95.5 p -91.92 -2.2 56.91 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.519 -0.738 . . . . 73.21 110.014 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -75.58 138.01 41.18 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.136 -0.978 . . . . 70.41 109.703 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.489 ' C ' ' H ' ' B' ' 55' ' ' ALA . 25.7 mtmm -74.5 -50.23 19.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.252 -0.905 . . . . 65.0 109.993 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -50.41 -10.57 0.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.168 -0.958 . . . . 75.21 109.545 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.489 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -64.04 -20.66 66.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.406 -0.809 . . . . 55.33 110.28 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' B' ' 55' ' ' ALA . 29.5 mt -40.89 -50.11 3.22 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.444 -0.785 . . . . 63.14 110.224 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 23.2 m -69.77 -32.68 71.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.038 -1.039 . . . . 63.5 109.124 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 58' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' B' ' 55' ' ' ALA . 66.9 t80 -65.34 -45.52 83.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.355 -0.841 . . . . 72.33 110.068 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.413 ' H ' HG22 ' B' ' 59' ' ' VAL . 12.0 m -65.57 -34.88 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.536 -1.353 . . . . 74.54 109.45 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 20.3 t -57.15 -50.2 73.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.231 -0.918 . . . . 71.24 109.569 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -66.79 -33.19 75.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 74.31 110.083 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' B' ' 62' ' ' ILE . 20.6 mm -65.93 -38.51 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.783 -1.198 . . . . 72.14 109.82 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 56.7 mmtt -67.25 -46.99 72.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.998 -1.064 . . . . 73.32 110.519 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.434 ' CG ' ' N ' ' B' ' 65' ' ' LYS . 7.7 pt-20 -74.46 -43.15 57.43 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.804 -1.185 . . . . 73.12 110.224 -179.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.448 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 66.9 mttm -71.05 -23.63 62.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 72.44 109.807 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.629 ' O ' HG22 ' B' ' 69' ' ' ILE . 97.3 m-70 -155.0 65.94 0.65 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.135 -0.978 . . . . 63.31 109.462 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.461 ' O ' ' N ' ' B' ' 69' ' ' ILE . 36.1 m -54.46 -36.44 64.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.259 -0.9 . . . . 73.1 109.95 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 29.2 m -68.13 48.11 0.05 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.056 -1.028 . . . . 71.53 109.7 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 69' ' ' ILE . . . . . 0.629 HG22 ' O ' ' B' ' 66' ' ' HIS . 16.6 tt -144.16 154.31 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.246 -0.909 . . . . 74.4 109.27 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t -95.39 155.44 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.097 -1.002 . . . . 75.12 109.106 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 42.0 t -141.86 125.61 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.155 -0.966 . . . . 73.2 109.491 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.646 ' HG ' HD11 ' B' ' 95' ' ' ILE . 0.7 OUTLIER -119.5 98.38 6.1 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.6 -0.889 . . . . 73.34 108.6 -179.653 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 70.4 t -88.7 112.75 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 73.5 108.808 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 74' ' ' SER . . . . . 0.412 ' OG ' ' CE ' ' B' ' 49' ' ' MET . 0.6 OUTLIER -89.57 174.75 7.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.038 -1.039 . . . . 64.34 108.577 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.435 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 6.6 p -166.81 121.17 1.06 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.841 -1.162 . . . . 74.53 110.542 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -57.51 -32.01 66.61 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.518 -0.919 . . . . 64.5 108.518 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -111.88 90.86 13.91 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.635 -0.876 . . . . 74.25 108.635 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.93 72.19 6.27 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.939 1.759 . . . . 74.43 112.17 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 29.5 p -87.73 162.73 16.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.539 -0.726 . . . . 73.12 109.338 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -33.17 72.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.328 -0.857 . . . . 71.01 109.459 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 81' ' ' GLU . . . . . 0.519 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 76.9 mm-40 -63.45 -41.25 98.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.144 -0.973 . . . . 63.2 109.527 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -73.14 -30.4 63.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.146 -0.971 . . . . 73.22 109.58 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.525 ' OE2' ' NE ' ' A' ' 108' ' ' ARG . 36.6 tt0 -63.9 -56.06 18.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 74.3 109.668 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 84' ' ' VAL . . . . . 0.405 HG23 ' N ' ' B' ' 85' ' ' HIS . 30.9 m -58.14 -38.54 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.132 -0.98 . . . . 73.31 108.972 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 85' ' ' HIS . . . . . 0.519 ' ND1' ' O ' ' B' ' 81' ' ' GLU . 27.2 m170 -64.44 -29.08 70.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.257 -0.902 . . . . 73.24 109.093 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.16 -45.76 79.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.302 -0.874 . . . . 55.33 109.653 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 87' ' ' PHE . . . . . 0.465 ' CZ ' ' HB2' ' A' ' 111' ' ' ALA . 40.0 t80 -80.87 -31.74 35.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.997 -1.064 . . . . 74.14 109.085 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -64.33 -52.38 58.69 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.219 -0.926 . . . . 64.04 109.387 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 89' ' ' GLN . . . . . 0.502 ' NE2' ' N ' ' B' ' 89' ' ' GLN . 0.9 OUTLIER -64.71 -52.32 57.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.451 -0.781 . . . . 72.35 109.513 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.83 72.3 0.01 OUTLIER Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.103 -1.199 . . . . 65.2 110.103 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -129.17 134.64 48.11 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.451 -1.029 . . . . 52.23 108.951 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -76.95 -30.22 55.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.098 -1.001 . . . . 73.32 109.144 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 93' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 51.2 t0 -152.49 164.22 38.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.374 -0.829 . . . . 72.22 109.34 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.449 ' N ' ' OD1' ' B' ' 93' ' ' ASP . 86.4 t80 -140.21 121.06 14.47 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.481 -0.933 . . . . 64.42 108.481 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 0.794 ' H ' HD12 ' B' ' 95' ' ' ILE . 0.0 OUTLIER -127.17 161.49 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 O-C-N 121.36 -0.838 . . . . 72.23 110.909 -178.017 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.16 129.57 35.31 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.72 -1.215 . . . . 25.24 107.72 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.688 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -50.77 -56.75 16.84 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 120.989 -1.069 . . . . 64.32 111.572 -178.544 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 98' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 4.5 Cg_endo -41.12 -8.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.116 1.211 . . . . 63.33 113.26 -175.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 99' ' ' TYR . . . . . 0.688 ' N ' ' O ' ' B' ' 97' ' ' LYS . 55.1 m-85 60.4 116.03 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.558 -0.714 . . . . 75.13 109.405 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 31.5 ttm-85 -59.94 -31.2 69.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.925 -1.109 . . . . 74.23 108.938 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 101' ' ' SER . . . . . 0.73 ' O ' ' N ' ' B' ' 103' ' ' LYS . 46.2 t -174.26 28.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.088 -1.007 . . . . 63.34 110.552 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 53.3 mt 51.23 -68.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.768 -0.583 . . . . 74.44 110.47 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.73 ' N ' ' O ' ' B' ' 101' ' ' SER . 4.3 mmmm -58.04 -33.67 69.25 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.05 -1.093 . . . . 71.11 108.05 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.07 -44.41 95.86 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.368 -0.933 . . . . 71.45 108.499 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 17.8 tp -63.53 -49.15 74.63 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.838 -0.801 . . . . 51.31 108.838 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 90.0 t -58.52 -41.16 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 65.23 109.325 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.7 -36.05 69.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.151 -0.968 . . . . 24.32 109.202 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -79.79 -28.95 40.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.403 -0.811 . . . . 75.31 109.961 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.25 -46.09 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 120.978 -1.076 . . . . 54.24 108.785 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 110' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' B' ' 114' ' ' ARG . 23.9 pt-20 -66.22 -42.15 89.08 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.06 -1.056 . . . . 65.31 108.494 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 111' ' ' ALA . . . . . 0.501 ' HB1' ' CZ ' ' A' ' 87' ' ' PHE . . . -53.69 -39.13 64.9 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.58 -0.7 . . . . 72.24 109.418 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -65.14 -44.66 87.89 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.177 -0.952 . . . . 72.04 109.953 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 113' ' ' LEU . . . . . 0.547 ' C ' ' H ' ' B' ' 115' ' ' PHE . 58.1 mt -97.78 -60.12 1.63 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.107 -0.996 . . . . 75.35 110.768 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' B' ' 110' ' ' GLU . 58.0 mtp180 57.93 -4.85 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.466 -0.772 . . . . 75.5 110.262 -178.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 115' ' ' PHE . . . . . 0.547 ' H ' ' C ' ' B' ' 113' ' ' LEU . 63.4 t80 -171.74 -104.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.993 -1.067 . . . . 65.33 109.501 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 116' ' ' TRP . . . . . 0.443 ' N ' ' CD2' ' B' ' 115' ' ' PHE . 39.9 m95 -146.75 44.88 1.19 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.334 -0.854 . . . . 74.45 108.826 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.93 -140.96 26.56 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.216 -1.554 . . . . 44.21 109.216 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 9.2 t -151.58 138.68 19.17 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.167 -1.196 . . . . 71.4 109.395 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 119' ' ' ASN . . . . . 0.489 HD21 ' C ' ' B' ' 121' ' ' ILE . 35.1 t30 -86.54 169.44 12.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.257 -0.902 . . . . 72.32 109.653 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 11.0 t -137.6 -34.32 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.981 -0.748 . . . . 75.02 108.981 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 121' ' ' ILE . . . . . 0.489 ' C ' HD21 ' B' ' 119' ' ' ASN . 26.9 mm -112.31 134.27 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.546 -0.721 . . . . 51.41 109.147 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -148.42 133.72 18.47 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.193 -0.942 . . . . 71.53 109.609 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 1.046 HD12 ' CD ' ' B' ' 159' ' ' ARG . 16.7 tt -149.49 123.96 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.792 -0.818 . . . . 72.43 108.792 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 54.87 -136.89 44.59 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.207 -1.557 . . . . 51.23 109.207 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -89.95 1.36 56.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.221 -1.164 . . . . 74.2 109.524 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.91 138.42 31.56 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.284 -0.885 . . . . 75.42 108.739 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 35.2 m -132.26 119.56 20.97 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.481 -0.762 . . . . 74.22 109.288 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 128' ' ' ILE . . . . . 0.424 ' O ' ' OD1' ' B' ' 119' ' ' ASN . 14.0 mm -117.98 147.08 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.543 -0.723 . . . . 60.33 109.304 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 129' ' ' SER . . . . . 0.414 ' C ' HH22 ' B' ' 157' ' ' ARG . 5.9 m -137.76 132.91 17.53 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.276 -0.89 . . . . 72.31 109.137 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -80.72 -49.43 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.174 1.916 . . . . 75.13 112.455 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -57.51 -49.9 74.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.912 . . . . 75.23 110.055 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -82.36 -9.33 59.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.091 -1.006 . . . . 72.43 109.749 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 47.94 69.03 0.58 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.093 -1.004 . . . . 75.13 109.274 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -139.18 141.22 37.97 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.453 -0.779 . . . . 73.22 109.353 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 2.8 tt -120.51 126.41 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.515 -0.741 . . . . 64.14 109.487 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 32.9 mm -115.2 121.82 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.653 -0.869 . . . . 71.22 108.653 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -140.79 143.85 35.11 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.206 -0.934 . . . . 64.22 109.622 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 138' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' B' ' 138' ' ' LYS . 30.3 ttpt 54.57 9.5 0.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.547 -0.721 . . . . 72.02 109.804 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 91.55 16.65 51.95 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 110.04 -1.224 . . . . 74.32 110.04 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 140' ' ' ARG . . . . . 0.4 ' HE ' ' HE3' ' B' ' 138' ' ' LYS . 41.6 mtt-85 -107.33 144.11 34.65 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.513 -0.992 . . . . 75.34 109.706 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -102.82 118.12 36.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.568 -0.707 . . . . 71.23 109.397 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 71.8 t -136.36 137.37 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.452 -0.78 . . . . 70.43 109.012 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -80.36 132.38 35.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.906 . . . . 72.43 109.531 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 5.4 p -73.1 133.27 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.159 -0.963 . . . . 72.13 109.064 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 35.3 pttt -170.4 66.3 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.9 . . . . 72.02 109.607 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 176.6 156.2 15.0 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.369 -1.492 . . . . 42.23 109.369 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 147' ' ' LYS . . . . . 0.615 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 19.3 mttt -65.23 -39.24 33.89 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.201 -1.176 . . . . 73.3 109.625 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 148' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 27.2 Cg_exo -61.54 -30.45 86.24 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.016 1.81 . . . . 71.33 111.218 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -94.94 -20.67 19.19 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.456 -0.778 . . . . 74.23 109.389 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -67.36 -39.23 85.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.273 -0.892 . . . . 72.34 109.486 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.45 -35.16 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 73.35 109.615 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.702 HD23 ' SD ' ' B' ' 195' ' ' MET . 0.2 OUTLIER -67.27 -42.43 83.84 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.125 0.964 . . . . 55.24 109.308 -179.76 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 153' ' ' THR . . . . . 0.436 ' CG2' ' NH2' ' B' ' 157' ' ' ARG . 34.7 m -74.08 -26.51 60.41 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.03 -1.043 . . . . 70.01 110.872 -179.023 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -71.98 -59.98 2.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.045 -1.035 . . . . 65.32 109.867 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 155' ' ' LEU . . . . . 1.011 HD13 ' N ' ' B' ' 156' ' ' ALA . 0.0 OUTLIER -62.29 -20.98 64.86 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.929 -1.107 . . . . 71.54 108.735 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 156' ' ' ALA . . . . . 1.011 ' N ' HD13 ' B' ' 155' ' ' LEU . . . -61.86 -48.05 82.29 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 120.901 -1.125 . . . . 75.32 108.233 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 157' ' ' ARG . . . . . 0.436 ' NH2' ' CG2' ' B' ' 153' ' ' THR . 0.0 OUTLIER -72.72 -42.45 64.14 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.42 -0.912 . . . . 73.32 109.409 179.57 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -83.28 10.83 7.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.931 . . . . 74.14 110.389 -178.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 159' ' ' ARG . . . . . 1.046 ' CD ' HD12 ' B' ' 123' ' ' ILE . 10.4 ttp-105 -48.38 164.94 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.026 -1.046 . . . . 61.41 109.019 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 61.27 53.16 3.6 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.342 -0.849 . . . . 72.1 109.716 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -161.04 156.24 24.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.34 -0.85 . . . . 72.25 109.036 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 66.6 mt -88.86 132.49 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.997 -1.065 . . . . 72.31 108.896 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 163' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' B' ' 212' ' ' TYR . 40.1 t -141.57 136.78 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.24 -0.913 . . . . 64.21 110.353 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 6.6 t -94.65 167.94 11.15 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.096 -1.002 . . . . 74.22 109.288 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 165' ' ' LYS . . . . . 1.077 ' NZ ' ' HA ' ' B' ' 185' ' ' GLU . 22.2 mttm -61.96 -38.22 87.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.028 -1.045 . . . . 65.31 109.865 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -52.96 -39.53 63.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 63.45 110.14 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -60.94 -48.14 83.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -0.951 . . . . 72.4 110.478 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 40.5 mt -57.31 -33.54 67.8 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.91 -1.119 . . . . 72.32 109.665 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.469 HD23 ' C ' ' B' ' 169' ' ' LEU . 5.7 tt -65.38 -61.83 1.88 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.161 -0.962 . . . . 73.34 109.624 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -65.19 -28.63 69.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.36 -0.837 . . . . 72.1 110.568 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.94 -59.49 5.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.119 -0.988 . . . . 62.13 110.616 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 0.724 ' N ' HD12 ' B' ' 172' ' ' ILE . 2.0 mp -86.75 -59.34 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.006 -1.059 . . . . 71.42 109.172 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 173' ' ' TRP . . . . . 0.428 ' O ' ' O ' ' B' ' 169' ' ' LEU . 23.0 m-90 . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 72.23 108.822 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo . . . . . 0 N--CA 1.496 1.665 0 CA-C-O 120.913 0.297 . . . . 65.22 112.651 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -149.57 -15.77 0.28 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.913 -1.117 . . . . 72.31 109.959 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 11.3 p -63.97 -17.86 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.19 -0.943 . . . . 63.32 109.984 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.755 HD12 ' H ' ' B' ' 184' ' ' ILE . 1.3 mp -49.74 -35.17 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.068 -1.02 . . . . 75.03 109.567 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 185' ' ' GLU . . . . . 1.077 ' HA ' ' NZ ' ' B' ' 165' ' ' LYS . 17.3 pt-20 -55.87 -36.54 67.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.994 -1.066 . . . . 64.11 109.215 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 9.2 t -75.42 -36.98 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 73.0 109.207 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.08 -55.03 28.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.36 -0.838 . . . . 61.12 109.868 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 5.4 tp -63.15 -33.93 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.098 -1.001 . . . . 72.43 109.927 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -69.04 -50.86 44.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 65.14 110.491 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -72.53 -39.08 67.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.035 -1.041 . . . . 63.24 110.157 -178.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 57.5 mt -57.22 -38.01 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.037 -1.039 . . . . 74.03 109.345 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -73.57 -44.13 58.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.037 -1.039 . . . . 72.24 109.96 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -70.5 -28.77 65.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.906 . . . . 73.1 110.601 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -82.97 -33.84 26.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.01 -1.056 . . . . 72.11 110.291 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 195' ' ' MET . . . . . 0.702 ' SD ' HD23 ' B' ' 152' ' ' LEU . 62.4 mtt -90.61 -40.8 11.71 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.053 -1.03 . . . . 44.33 110.863 -179.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 196' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 51.1 p-10 -53.32 -20.43 4.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.929 -1.107 . . . . 71.21 110.488 -178.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 197' ' ' LYS . . . . . 0.524 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 4.1 mmtp -76.19 -65.63 0.42 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.852 -1.155 . . . . 75.21 109.537 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 198' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 48.2 Cg_endo -66.12 -45.39 5.82 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.246 1.964 . . . . 75.32 111.633 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 37.1 tp -65.05 -51.09 63.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.386 -0.821 . . . . 72.25 109.342 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 85.94 -33.2 3.59 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.91 -1.276 . . . . 64.53 109.91 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 201' ' ' ILE . . . . . 0.719 ' N ' HD12 ' B' ' 201' ' ' ILE . 2.5 mp -92.19 142.15 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.131 -1.217 . . . . 44.23 109.722 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 70.3 m -119.58 133.24 55.75 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.37 -0.974 . . . . 54.01 108.37 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 24.4 p -137.22 47.42 2.11 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.312 -0.867 . . . . 74.4 109.715 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 1.6 m -143.15 122.41 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.259 -0.9 . . . . 72.12 109.219 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -107.94 129.45 55.1 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.664 -0.865 . . . . 65.41 108.664 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 206' ' ' THR . . . . . 0.43 HG22 ' H ' ' B' ' 206' ' ' THR . 0.1 OUTLIER -94.16 131.22 39.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.175 -0.953 . . . . 71.33 109.949 -179.298 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 5.0 t -129.56 122.91 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.434 -0.951 . . . . 63.5 108.434 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -61.93 -26.07 67.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 74.45 110.065 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 -68.67 -88.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.033 -1.042 . . . . 74.14 109.83 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -65.3 -63.49 1.09 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.05 -1.032 . . . . 74.43 109.668 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 157.91 -105.81 0.28 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.452 -1.459 . . . . 64.45 109.452 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 212' ' ' TYR . . . . . 0.461 ' O ' ' O ' ' B' ' 163' ' ' VAL . 39.0 m-85 -120.16 135.87 54.81 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.613 -0.933 . . . . 74.21 109.618 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -125.5 134.13 52.14 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.446 -0.784 . . . . 74.03 108.944 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 214' ' ' PHE . . . . . 0.738 ' CD1' HD23 ' B' ' 155' ' ' LEU . 80.4 m-85 -90.77 131.28 36.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.406 -0.808 . . . . 74.34 109.289 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 26.7 p -153.74 167.97 27.83 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.173 -0.954 . . . . 64.33 109.803 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -63.52 148.44 93.88 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.42 -0.8 . . . . 70.04 109.213 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.82 162.63 27.88 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.11 1.873 . . . . 65.11 111.914 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 21.8 mttm . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.246 -0.909 . . . . 73.15 109.349 -179.796 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.546 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.436 -0.579 . . . . 65.12 109.436 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.418 ' HG2' HH11 ' A' ' 2' ' ' ARG . 2.0 ttt-85 -145.06 152.9 40.84 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.213 -0.929 . . . . 72.33 109.07 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 65.7 t -115.29 128.84 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.52 -0.738 . . . . 71.42 109.652 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 5' ' ' LEU . 3.7 tp -100.39 117.08 33.85 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.516 -0.74 . . . . 65.12 109.136 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 4' ' ' LEU . 60.2 tp -115.89 111.53 20.58 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.563 -0.71 . . . . 62.43 109.475 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.443 HG12 HD11 ' A' ' 4' ' ' LEU . 9.2 mt -102.24 113.42 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.213 -0.93 . . . . 71.15 108.96 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.476 ' OE1' ' CB ' ' A' ' 51' ' ' SER . 31.0 tp10 -148.41 126.88 12.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.205 -0.934 . . . . 75.34 109.572 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -69.09 -30.76 69.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -0.869 . . . . 72.44 109.173 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -84.97 114.29 22.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.34 -0.85 . . . . 63.02 109.422 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 77.2 p -70.19 -24.84 63.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.911 . . . . 72.34 109.62 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.65 -51.49 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.209 -0.932 . . . . 74.02 109.642 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.558 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.5 mm? -66.91 -33.54 75.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 71.43 109.212 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.76 -23.3 75.36 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.674 -1.77 . . . . 61.32 108.674 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.74 -53.43 15.91 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.622 -1.391 . . . . 71.2 109.622 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -60.69 -43.37 97.83 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.35 -1.088 . . . . 71.32 109.736 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 96.2 mt -65.11 -32.5 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.891 -1.131 . . . . 63.23 109.034 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -58.01 -49.81 75.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 51.11 109.298 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -88.11 0.45 55.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.228 -0.92 . . . . 73.34 109.879 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.15 -57.82 2.58 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 110.002 -1.239 . . . . 62.15 110.002 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pp -74.58 -23.25 58.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -1.128 . . . . 73.51 110.052 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -51.47 -35.29 39.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.018 -1.052 . . . . 74.25 109.47 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.7 t -55.38 -41.3 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.97 . . . . 70.04 109.159 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.405 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 2.6 mptp? -63.17 -19.26 64.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.855 . . . . 73.23 109.026 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.85 40.64 4.88 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.553 -1.019 . . . . 75.54 110.553 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -119.04 160.43 22.04 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.421 -1.046 . . . . 73.43 108.502 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.8 mmt -90.14 124.33 34.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.051 -1.031 . . . . 43.24 108.872 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.25 138.58 37.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.417 -0.802 . . . . 62.11 110.059 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -127.82 126.89 42.54 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.508 -0.923 . . . . 74.42 108.508 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -106.11 130.78 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.729 -0.841 . . . . 72.15 108.729 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.9 p -135.67 160.58 38.07 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.5 -0.75 . . . . 71.42 109.485 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -89.0 -103.44 0.09 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.283 -0.886 . . . . 72.33 109.418 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.443 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 62.2 m -78.45 147.89 33.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.205 -0.934 . . . . 74.24 109.36 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.599 ' H ' HD12 ' A' ' 33' ' ' LEU . 1.7 mp -49.1 -15.71 0.12 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.328 -0.857 . . . . 71.53 110.189 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 32' ' ' SER . 78.8 mm-40 -62.65 -53.33 56.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.012 -1.055 . . . . 74.23 110.05 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 36' ' ' GLY . 19.8 p-10 -67.73 -30.27 69.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.0 -1.062 . . . . 54.03 109.262 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.543 ' N ' ' OD1' ' A' ' 35' ' ' ASP . . . -75.25 -36.11 46.36 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.142 -1.583 . . . . 61.41 109.142 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -70.09 -46.88 63.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.339 -1.095 . . . . 74.34 109.459 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -69.05 -34.1 74.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.969 . . . . 75.33 109.862 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.449 HD11 ' HE ' ' A' ' 43' ' ' ARG . 20.7 tp -79.23 -51.33 9.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.217 -0.927 . . . . 74.33 110.226 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.448 ' SD ' ' OH ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -58.2 -27.85 64.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.101 -1.0 . . . . 70.32 109.934 -179.27 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -61.09 -39.68 90.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.109 -0.994 . . . . 71.22 109.849 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.7 pt -91.44 1.39 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.072 -1.018 . . . . 74.14 110.076 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.449 ' HE ' HD11 ' A' ' 39' ' ' LEU . 86.2 mtt-85 -126.4 152.15 46.72 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.36 -0.838 . . . . 72.24 109.328 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -96.83 151.79 19.32 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.197 -0.94 . . . . 75.42 109.326 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.448 ' OH ' ' SD ' ' A' ' 40' ' ' MET . 10.0 p90 -154.76 175.23 13.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.243 -0.911 . . . . 74.23 109.646 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -135.76 -33.44 0.86 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.423 -0.798 . . . . 72.04 109.307 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.537 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -107.99 115.01 29.36 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.492 -0.755 . . . . 72.13 109.014 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.537 ' N ' HD13 ' A' ' 47' ' ' LEU . 58.3 t -102.41 98.84 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.852 -0.796 . . . . 72.34 108.852 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.474 ' SD ' ' O ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -109.59 122.75 48.13 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.096 -0.705 . . . . 74.11 109.096 -179.615 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.438 HG21 ' HB2' ' A' ' 55' ' ' ALA . 1.6 p -130.87 130.02 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 121.602 0.715 . . . . 61.12 109.702 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.476 ' CB ' ' OE1' ' A' ' 7' ' ' GLU . 44.9 p -99.1 0.54 43.81 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.435 -0.791 . . . . 73.11 109.281 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -76.03 141.52 42.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.141 -0.974 . . . . 52.55 109.341 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.485 ' C ' ' H ' ' A' ' 55' ' ' ALA . 21.2 pttm -79.36 -38.51 34.87 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.252 -0.905 . . . . 44.22 110.449 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -70.59 11.25 0.38 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.977 -1.077 . . . . 70.44 109.494 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.485 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.77 -21.12 57.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.406 -0.809 . . . . 64.14 110.589 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 55' ' ' ALA . 73.6 mt -38.11 -48.47 1.24 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.498 -0.751 . . . . 44.14 111.025 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.2 m -71.93 -36.76 70.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.889 -1.132 . . . . 55.23 109.59 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.441 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 72.9 t80 -66.33 -47.01 74.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.397 -0.815 . . . . 74.44 110.594 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.3 m -64.14 -34.42 68.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 120.636 -1.29 . . . . 74.03 109.561 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.0 t -57.75 -55.12 38.92 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.182 -0.949 . . . . 64.3 109.317 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.684 HH21 ' HZ2' ' A' ' 65' ' ' LYS . 5.7 ptm180 -61.42 -31.27 71.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 64.44 109.868 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.441 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 4.9 mm -63.03 -37.18 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.996 -1.065 . . . . 63.21 109.778 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -70.03 -54.24 14.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.036 -1.04 . . . . 74.42 110.315 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -64.85 -35.89 82.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.817 -1.177 . . . . 70.32 109.815 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.684 ' HZ2' HH21 ' A' ' 61' ' ' ARG . 46.4 mtpt -82.58 -23.3 34.5 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.063 -1.023 . . . . 75.22 109.818 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.477 ' CG ' ' C ' ' A' ' 65' ' ' LYS . 47.8 m-70 -154.38 65.53 0.69 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.043 -1.036 . . . . 74.13 109.64 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.8 t -64.69 -30.64 71.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.204 -0.935 . . . . 73.24 109.951 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 97.2 p -60.43 -17.87 47.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.168 -0.958 . . . . 61.01 110.014 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 53.7 mt -91.28 149.56 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.139 -0.975 . . . . 71.33 109.614 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 71' ' ' VAL . 91.9 t -88.33 159.18 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.344 -0.847 . . . . 72.13 109.135 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.46 ' N ' HG12 ' A' ' 70' ' ' VAL . 22.0 t -138.81 124.54 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.158 -0.963 . . . . 54.21 110.001 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.629 ' CD1' HH22 ' A' ' 108' ' ' ARG . 4.0 tt -113.43 99.09 7.51 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.617 -0.882 . . . . 50.24 108.617 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.6 t -96.71 123.22 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.364 -0.835 . . . . 74.41 108.816 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.82 -178.11 4.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.986 -1.071 . . . . 72.31 109.004 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.473 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 49.7 p -166.75 120.07 1.02 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.133 -0.979 . . . . 64.54 109.829 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -77.49 6.39 7.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.403 -0.811 . . . . 74.13 108.913 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 79' ' ' THR . 74.6 m-20 -142.24 64.96 17.63 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.947 -0.76 . . . . 73.34 108.947 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.6 81.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.919 1.746 . . . . 63.22 111.707 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 77' ' ' ASN . 41.1 p -100.56 161.89 13.3 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.776 -0.824 . . . . 62.53 108.776 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 p -66.52 -24.48 66.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.131 -0.981 . . . . 73.44 109.659 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -73.64 -38.98 64.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 71.42 109.769 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 96.1 mt-10 -70.92 -33.65 70.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.204 -0.935 . . . . 73.43 110.117 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.416 ' OE2' ' NE ' ' B' ' 100' ' ' ARG . 92.3 mt-10 -68.61 -55.8 10.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.005 -1.059 . . . . 74.22 109.745 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.53 HG23 ' N ' ' A' ' 85' ' ' HIS . 31.9 m -60.61 -42.52 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.191 -0.943 . . . . 73.2 109.414 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.53 ' N ' HG23 ' A' ' 84' ' ' VAL . 75.8 t60 -69.21 -31.58 70.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.32 -0.862 . . . . 53.33 109.498 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 82' ' ' GLU . . . -62.89 -36.64 84.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.298 -0.876 . . . . 64.11 109.822 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -78.32 -33.25 49.36 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.09 -1.006 . . . . 74.34 108.756 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -72.97 -34.03 66.21 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.447 -0.783 . . . . 74.42 109.378 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -69.93 -62.33 1.43 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 74.24 109.484 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 152.56 54.96 0.01 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.908 -1.277 . . . . 61.51 109.908 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.37 135.85 53.7 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.416 -1.049 . . . . 55.33 109.431 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 20.0 t70 -82.15 -31.65 30.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 73.42 109.127 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 95.6 m-20 -141.77 160.16 40.74 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.417 -0.802 . . . . 75.04 109.204 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.473 ' OH ' ' CB ' ' A' ' 75' ' ' SER . 82.6 t80 -139.49 105.66 5.24 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.395 -0.815 . . . . 71.33 109.122 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.438 HG22 ' N ' ' A' ' 96' ' ' ALA . 29.0 mm -111.62 157.82 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.221 -0.925 . . . . 71.13 110.674 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.438 ' N ' HG22 ' A' ' 95' ' ' ILE . . . -77.81 125.16 28.93 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.831 -1.174 . . . . 64.32 107.831 178.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.674 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -45.23 -53.85 16.1 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.016 -1.053 . . . . 62.2 111.467 -178.801 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.7 Cg_endo -42.11 -10.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 CA-C-N 119.729 0.939 . . . . 73.11 112.643 -177.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.674 ' N ' ' O ' ' A' ' 97' ' ' LYS . 57.7 m-85 58.7 112.39 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.667 -0.646 . . . . 65.22 109.694 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.51 ' NE ' ' OE2' ' B' ' 83' ' ' GLU . 37.8 ttm-85 -58.58 -38.19 77.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.948 -1.095 . . . . 72.35 108.511 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.806 ' O ' ' N ' ' A' ' 103' ' ' LYS . 6.3 t -173.24 31.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -0.872 . . . . 71.32 110.338 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.428 ' O ' ' N ' ' A' ' 105' ' ' LEU . 6.4 mm 46.77 -67.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 CA-C-N 118.343 0.519 . . . . 75.43 110.462 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.806 ' N ' ' O ' ' A' ' 101' ' ' SER . 16.0 mtpp -50.7 -32.72 20.26 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.749 -1.22 . . . . 71.41 107.923 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.75 -38.34 80.05 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.921 -1.14 . . . . 63.24 107.921 178.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 102' ' ' ILE . 2.0 tt -70.0 -47.85 60.49 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.275 -0.639 . . . . 73.22 109.275 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.6 t -64.74 -44.59 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 60.11 109.192 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.24 -40.0 64.23 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.205 -0.935 . . . . 70.42 109.093 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.629 HH22 ' CD1' ' A' ' 72' ' ' LEU . 14.6 ttp-105 -72.58 -25.15 61.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.361 -0.837 . . . . 74.41 109.667 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 83.0 mt -80.12 -33.24 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.439 -1.319 . . . . 62.54 107.439 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -55.62 31.43 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.557 -1.275 . . . . 74.34 107.557 178.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.76 -40.42 69.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.653 -0.654 . . . . 73.32 109.586 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 10.6 mmp_? -56.15 -33.37 65.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.182 -0.948 . . . . 52.41 109.581 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.65 72.88 0.99 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.928 -1.108 . . . . 65.24 110.23 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.482 ' O ' ' N ' ' A' ' 116' ' ' TRP . 43.7 mtm180 -73.41 101.55 3.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.002 -1.061 . . . . 64.45 108.871 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 47.87 14.55 0.05 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.314 -0.866 . . . . 74.43 109.902 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' TRP . . . . . 0.482 ' N ' ' O ' ' A' ' 114' ' ' ARG . 94.9 m95 46.99 -164.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.166 -0.959 . . . . 74.42 109.675 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 168.1 40.52 0.02 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.491 -1.444 . . . . 75.04 109.491 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.6 m -83.98 -124.68 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.263 -1.139 . . . . 61.14 109.621 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 61.44 67.21 0.8 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 65.24 109.556 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.4 t -80.5 -25.76 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 73.11 109.337 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.8 mm -98.42 132.9 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.331 -0.855 . . . . 72.24 109.278 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -144.68 117.46 8.72 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.191 -0.943 . . . . 72.34 109.551 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.43 ' N ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -138.72 128.74 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.37 -0.831 . . . . 71.44 108.829 179.706 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.3 -136.25 16.81 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.519 -1.432 . . . . 73.4 109.519 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -91.53 -6.01 53.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.249 -1.148 . . . . 74.45 109.515 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.14 135.61 33.84 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.215 -0.928 . . . . 54.21 108.788 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 26.8 p -132.1 146.33 51.98 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.474 -0.766 . . . . 54.5 109.588 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.2 mt -134.61 136.7 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.324 -0.86 . . . . 45.15 109.63 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.3 t -113.89 124.78 30.43 Favored Pre-proline 0 N--CA 1.496 1.874 0 N-CA-C 109.023 -0.732 . . . . 71.11 109.023 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -80.58 -51.67 0.05 OUTLIER 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.635 1.557 . . . . 65.41 112.044 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -65.28 -44.22 88.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 63.32 109.73 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -80.98 -15.52 55.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 72.52 109.354 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 54.5 77.07 0.21 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 75.33 109.76 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -158.04 140.36 14.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 71.23 109.461 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.5 tt -120.22 133.45 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.539 -0.726 . . . . 74.02 109.6 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 26.7 mm -110.18 121.79 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.856 -0.794 . . . . 60.23 108.856 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.501 ' C ' ' H ' ' A' ' 139' ' ' GLY . 49.8 p90 -142.68 149.17 38.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.086 -1.009 . . . . 62.32 108.967 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 46.8 tttp 53.96 5.98 0.08 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.297 -0.877 . . . . 75.4 109.536 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.501 ' H ' ' C ' ' A' ' 137' ' ' TYR . . . 94.04 -6.71 72.88 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 110.079 -1.208 . . . . 72.24 110.079 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.416 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 1.0 OUTLIER -89.78 143.57 26.69 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.056 -1.261 . . . . 71.22 109.288 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -99.51 125.91 45.36 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.369 -0.832 . . . . 71.42 109.362 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.7 t -137.1 133.48 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.422 -0.798 . . . . 53.02 109.604 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.449 ' N ' ' OE1' ' A' ' 143' ' ' GLU . 45.5 mp0 -94.95 147.1 23.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.343 -0.848 . . . . 60.45 109.046 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.09 131.61 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.251 -0.906 . . . . 74.44 109.63 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.75 121.34 8.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.36 -0.837 . . . . 65.15 109.198 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.95 -143.29 10.09 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.917 -1.273 . . . . 73.34 109.917 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -70.67 -62.82 1.85 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.424 -1.045 . . . . 72.22 110.348 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -56.0 -19.68 27.11 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.934 1.756 . . . . 65.23 111.856 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.478 ' CE1' HG21 ' A' ' 153' ' ' THR . 1.0 OUTLIER -80.61 -44.49 18.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 60.11 109.189 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -60.94 -39.65 90.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 64.21 109.995 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 152' ' ' LEU . 11.5 p -77.14 -38.61 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.135 -0.978 . . . . 72.02 110.053 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.458 ' N ' HG13 ' A' ' 151' ' ' VAL . 15.0 tp -65.04 -42.8 93.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.121 -0.987 . . . . 73.31 109.737 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.478 HG21 ' CE1' ' A' ' 149' ' ' PHE . 42.9 p -72.98 -35.54 66.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.08 -1.013 . . . . 74.31 109.851 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -57.59 -52.01 67.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 74.31 109.632 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.408 ' H ' ' HG ' ' A' ' 155' ' ' LEU . 2.6 pp -73.88 -24.4 59.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 75.34 109.846 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.41 -46.6 83.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.134 -0.979 . . . . 62.14 109.426 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.46 ' C ' ' H ' ' A' ' 159' ' ' ARG . 65.5 mtt180 -75.34 -44.07 47.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.229 -0.919 . . . . 61.03 109.335 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -75.71 22.78 0.13 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 74.12 109.406 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.46 ' H ' ' C ' ' A' ' 157' ' ' ARG . 37.2 ptt180 -56.82 165.23 1.26 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.249 -0.907 . . . . 71.13 109.49 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.582 ' OD2' ' NE2' ' B' ' 161' ' ' GLN . 50.2 t0 54.2 47.15 23.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 75.45 109.242 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -155.15 158.9 39.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.284 -0.885 . . . . 73.41 109.381 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 53.4 mt -85.03 120.05 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.209 -0.932 . . . . 74.41 109.331 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.403 ' O ' ' O ' ' A' ' 212' ' ' TYR . 40.0 t -107.76 130.36 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.419 -0.801 . . . . 72.31 109.497 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.9 m -100.9 153.04 19.83 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.361 -0.837 . . . . 74.12 109.358 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.401 ' HB3' ' HZ3' ' A' ' 165' ' ' LYS . 9.2 mtpm? -56.65 -35.47 68.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.9 . . . . 70.43 109.505 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -59.51 -37.6 78.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 73.52 109.629 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.431 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 93.4 mt-30 -62.56 -39.6 94.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 74.52 109.555 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 28.5 mt -64.95 -31.78 73.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.128 -0.982 . . . . 72.31 109.268 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.504 ' C ' HD23 ' A' ' 169' ' ' LEU . 4.2 tt -66.38 -59.11 3.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.862 . . . . 53.33 110.098 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 167' ' ' GLN . 28.9 p-10 -73.64 -30.24 62.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.04 -1.038 . . . . 62.44 110.624 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.446 ' C ' HD12 ' A' ' 172' ' ' ILE . . . -59.98 -46.35 89.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.968 -1.083 . . . . 60.21 110.173 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.693 HD12 ' N ' ' A' ' 172' ' ' ILE . 1.6 mp -94.67 -59.86 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.038 -1.039 . . . . 75.32 108.966 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 29.8 m-90 . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 73.14 109.769 -179.89 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.204 0.526 . . . . 64.54 110.286 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.42 ' O ' HG22 ' A' ' 183' ' ' VAL . 11.8 p -138.85 -4.31 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.4 -0.812 . . . . 74.02 109.569 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.673 ' H ' HD12 ' A' ' 184' ' ' ILE . 3.0 mp -53.56 -37.76 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.01 -1.056 . . . . 72.33 109.503 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -55.23 -30.53 60.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -0.947 . . . . 74.4 109.421 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 94.1 t -79.23 -57.23 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.082 -1.011 . . . . 70.42 109.495 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -54.97 -47.19 74.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.157 -0.964 . . . . 52.11 109.875 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.525 ' O ' HD13 ' A' ' 188' ' ' ILE . 0.2 OUTLIER -60.23 -44.2 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.085 -1.009 . . . . 71.4 109.061 -179.726 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.413 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 53.5 t-20 -60.35 -41.71 94.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.959 -1.088 . . . . 73.44 109.445 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -68.34 -45.13 73.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.93 . . . . 71.42 109.718 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 85.7 mt -56.41 -37.69 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.263 -0.898 . . . . 61.55 109.156 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -65.27 -40.68 94.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 63.34 109.512 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.431 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 14.8 mm100 -76.42 -26.61 55.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 61.24 110.025 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.546 ' HB3' ' HZ3' ' A' ' 194' ' ' LYS . 8.5 mtpm? -81.67 -25.26 35.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -0.946 . . . . 75.13 110.581 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 20.1 ptm -95.07 -36.32 11.57 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.033 -1.042 . . . . 74.02 110.116 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 197' ' ' LYS . 30.9 p-10 -66.04 -34.21 77.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.049 -1.032 . . . . 74.02 110.021 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.538 ' N ' ' OD1' ' A' ' 196' ' ' ASP . 11.0 ttpp -62.84 -60.87 8.64 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.013 -1.054 . . . . 75.43 109.876 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -59.04 -52.01 5.79 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.64 1.56 . . . . 72.32 111.407 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.547 HD12 ' N ' ' A' ' 199' ' ' LEU . 8.0 mp -92.53 125.15 37.04 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.345 -0.847 . . . . 74.54 109.118 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -77.79 -2.18 80.54 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.417 -1.473 . . . . 61.51 109.417 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 201' ' ' ILE . 19.6 mt -108.32 137.54 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.501 -1.0 . . . . 61.22 109.392 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 23.1 t -93.23 143.5 26.2 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.26 -0.9 . . . . 72.0 109.4 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 49.2 p -130.58 10.05 5.14 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.511 -0.743 . . . . 74.44 109.353 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 5.9 m -132.01 142.72 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.504 -0.748 . . . . 64.35 109.328 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -126.0 134.81 51.36 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.644 -0.66 . . . . 71.41 109.364 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.0 95.67 8.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.2 -0.938 . . . . 73.52 109.203 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.573 ' CG1' ' NH1' ' A' ' 213' ' ' ARG . 11.2 p -164.41 170.65 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.96 . . . . 71.02 109.347 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' ARG . . . . . 0.678 ' HE ' ' NH2' ' A' ' 210' ' ' ARG . 6.2 tpt180 76.65 146.16 0.09 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.495 -0.753 . . . . 72.12 109.547 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -61.5 -34.29 75.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.361 -0.837 . . . . 64.41 109.792 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.678 ' NH2' ' HE ' ' A' ' 208' ' ' ARG . 0.2 OUTLIER -49.94 -50.92 44.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 71.54 109.092 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 148.29 -106.06 0.33 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.051 -1.22 . . . . 72.03 110.051 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 212' ' ' TYR . 20.3 m-85 -113.43 145.38 41.25 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.568 -0.96 . . . . 75.54 109.484 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.573 ' NH1' ' CG1' ' A' ' 207' ' ' VAL . 7.8 mtm-85 -117.42 135.09 54.13 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.521 -0.737 . . . . 75.31 109.226 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -100.01 128.1 46.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.281 -0.887 . . . . 75.41 109.379 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 3.6 p -141.46 156.4 45.77 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.378 -0.826 . . . . 74.14 109.29 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -68.83 152.85 96.55 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.91 . . . . 75.32 109.108 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo . . . . . 0 C--N 1.314 -1.26 0 C-N-CA 122.299 1.999 . . . . 73.11 112.254 179.698 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 1' ' ' MET . . . . . 0.589 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.401 -0.592 . . . . 71.14 109.401 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -140.15 147.5 40.26 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.358 -0.839 . . . . 73.23 109.46 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 93.3 t -114.99 123.29 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 121.596 0.712 . . . . 72.24 109.585 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 4' ' ' LEU . . . . . 0.478 HD11 ' CG1' ' B' ' 6' ' ' ILE . 3.1 tp -91.34 118.05 30.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.898 . . . . 54.33 108.655 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 5' ' ' LEU . . . . . 0.514 HD23 ' N ' ' B' ' 6' ' ' ILE . 1.1 tt -118.08 117.0 28.02 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.49 -0.93 . . . . 74.35 108.49 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.56 HD12 ' HB ' ' B' ' 50' ' ' VAL . 78.2 mt -111.87 98.96 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.297 -0.877 . . . . 42.55 108.983 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.426 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 26.7 tp10 -129.31 135.68 49.06 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.516 -0.74 . . . . 74.52 109.434 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -67.83 -32.8 73.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 62.55 109.245 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -89.62 121.44 31.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.874 . . . . 73.11 109.47 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 23.2 m -73.7 -32.31 63.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 65.54 109.828 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 98.4 t -60.69 -47.65 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.14 -0.975 . . . . 75.55 109.829 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.552 HD12 ' NZ ' ' B' ' 97' ' ' LYS . 3.4 mm? -64.02 -33.27 75.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.155 -0.966 . . . . 70.14 109.297 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.39 -28.59 59.55 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.755 -1.738 . . . . 75.4 108.755 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.13 -50.13 62.32 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.299 -1.52 . . . . 65.44 109.299 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -62.2 -44.67 96.06 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.305 -1.114 . . . . 60.21 109.405 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.569 HD11 ' CZ ' ' B' ' 99' ' ' TYR . 5.3 mm -63.3 -35.62 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.884 -1.135 . . . . 75.15 108.399 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 17' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' B' ' 27' ' ' ALA . 43.4 tp10 -63.9 -49.11 73.95 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.329 -0.857 . . . . 73.01 109.224 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -80.53 0.56 33.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.97 . . . . 74.3 109.166 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.9 -62.35 1.52 Allowed Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.55 -1.42 . . . . 70.54 109.55 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' B' ' 27' ' ' ALA . 1.4 pt? -68.38 -23.64 64.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -1.154 . . . . 71.34 109.639 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 21' ' ' ASN . . . . . 0.422 ' H ' HD23 ' B' ' 20' ' ' LEU . 28.3 m-20 -51.56 -35.01 39.28 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.055 -1.028 . . . . 64.41 109.381 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 74.9 t -55.22 -38.93 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.162 -0.961 . . . . 74.23 108.884 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 23' ' ' LYS . . . . . 0.412 ' N ' ' CD ' ' B' ' 23' ' ' LYS . 4.7 mptp? -70.14 -25.67 63.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.441 -0.787 . . . . 63.42 109.2 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.47 20.06 10.64 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 110.293 -1.123 . . . . 53.43 110.293 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -96.72 159.99 14.62 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.071 -1.252 . . . . 71.12 109.333 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 61.3 mmm -104.65 139.89 38.83 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.674 -0.861 . . . . 75.24 108.674 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' ALA . . . . . 0.493 ' HB2' HD11 ' B' ' 20' ' ' LEU . . . -141.13 153.11 45.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.191 -0.943 . . . . 72.12 110.16 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -133.05 134.01 43.79 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.791 -0.818 . . . . 72.31 108.791 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.31 138.06 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.278 -1.008 . . . . 64.43 108.278 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.4 p -139.12 165.61 26.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.282 -0.886 . . . . 65.41 109.525 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -84.3 -99.58 0.05 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.889 . . . . 71.02 109.33 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 60.7 p -78.32 161.7 27.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 51.11 109.579 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 33' ' ' LEU . . . . . 0.501 ' H ' HD12 ' B' ' 33' ' ' LEU . 2.8 mp -56.85 -31.53 64.87 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.448 -0.783 . . . . 71.24 109.814 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -56.61 -43.67 80.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.108 -0.995 . . . . 74.32 109.637 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -63.18 -42.26 99.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.135 -0.978 . . . . 73.03 109.31 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.31 -30.88 48.61 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.45 -1.46 . . . . 30.21 109.45 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' B' ' 33' ' ' LEU . 14.8 tm-20 -63.7 -41.53 98.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -1.153 . . . . 74.42 109.462 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -74.28 -38.44 63.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 74.42 109.547 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 21.6 tp -68.65 -48.28 64.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 75.41 109.981 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 40' ' ' MET . . . . . 0.442 ' O ' ' O ' ' B' ' 43' ' ' ARG . 16.1 ptm -66.52 -23.84 66.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.116 -0.99 . . . . 60.41 109.789 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.26 -38.03 79.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.074 -1.016 . . . . 53.23 109.781 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 10.7 pt -97.61 -1.68 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.177 -0.952 . . . . 71.23 110.206 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' B' ' 40' ' ' MET . 31.1 mmt180 -125.99 155.48 41.34 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.317 -0.864 . . . . 72.22 109.593 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 44' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' B' ' 45' ' ' TYR . 53.9 t-20 -86.76 151.33 23.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.249 -0.907 . . . . 63.54 109.269 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 45' ' ' TYR . . . . . 0.559 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 1.3 p90 -142.77 115.8 8.84 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.16 -0.962 . . . . 64.35 109.518 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -90.57 -34.77 15.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.277 -0.889 . . . . 62.22 108.907 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.515 HD13 ' C ' ' B' ' 47' ' ' LEU . 0.9 OUTLIER -111.68 110.55 21.0 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.695 -0.854 . . . . 73.12 108.695 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.458 ' N ' HD13 ' B' ' 47' ' ' LEU . 68.5 t -94.56 98.77 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.217 -0.927 . . . . 65.11 109.118 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 17.2 ttt -113.24 127.13 56.07 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.631 0.729 . . . . 73.44 109.581 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.56 ' HB ' HD12 ' B' ' 6' ' ' ILE . 0.2 OUTLIER -145.0 133.91 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.394 -0.816 . . . . 34.5 109.38 -179.741 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 51' ' ' SER . . . . . 0.43 ' CB ' ' OG ' ' B' ' 74' ' ' SER . 53.0 p -100.31 17.43 21.43 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.603 -0.685 . . . . 73.21 109.908 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.519 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 82.9 m-20 -83.12 135.17 34.91 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.095 -1.003 . . . . 70.41 109.408 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -70.16 -38.03 75.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.296 -0.878 . . . . 65.0 110.118 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 54' ' ' ASN . . . . . 0.676 HD22 ' H ' ' B' ' 54' ' ' ASN . 1.0 OUTLIER -75.62 13.0 0.87 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 75.21 109.875 -179.444 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.78 -21.73 60.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 55.33 110.113 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 33.5 mt -43.44 -35.98 1.8 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.322 -0.861 . . . . 63.14 110.438 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 82.7 p -77.16 -47.59 19.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.941 -1.099 . . . . 63.5 109.825 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 58' ' ' PHE . . . . . 0.528 ' CZ ' HD11 ' B' ' 62' ' ' ILE . 76.0 t80 -63.94 -44.92 91.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 72.33 110.398 -179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.494 HG23 ' N ' ' B' ' 60' ' ' SER . 17.0 m -63.85 -40.24 88.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 120.668 -1.27 . . . . 74.54 109.685 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 60' ' ' SER . . . . . 0.494 ' N ' HG23 ' B' ' 59' ' ' VAL . 59.2 m -53.71 -50.88 64.92 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.162 -0.961 . . . . 71.24 109.676 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.454 HH21 ' NZ ' ' B' ' 65' ' ' LYS . 11.9 ptm180 -67.8 -32.34 72.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.143 -0.973 . . . . 74.31 110.279 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.528 HD11 ' CZ ' ' B' ' 58' ' ' PHE . 4.9 mm -63.6 -43.98 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.706 -1.246 . . . . 72.14 110.001 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -64.78 -50.51 66.52 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.222 -0.924 . . . . 73.32 110.571 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -68.84 -40.67 79.27 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.71 -1.244 . . . . 73.12 110.032 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.714 ' O ' ' CD2' ' B' ' 66' ' ' HIS . 45.2 mtpt -77.29 -29.69 53.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.125 -0.984 . . . . 72.44 109.724 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 66' ' ' HIS . . . . . 0.714 ' CD2' ' O ' ' B' ' 65' ' ' LYS . 31.3 m170 -144.47 67.84 1.26 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.15 -0.969 . . . . 63.31 109.913 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 81.3 p -65.62 -25.68 67.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 73.1 109.231 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 4.2 t -62.18 -24.63 67.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.864 . . . . 71.53 109.647 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 74.3 mt -86.43 152.04 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.311 -0.868 . . . . 74.4 109.401 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.499 HG12 ' N ' ' B' ' 71' ' ' VAL . 80.1 t -91.08 161.0 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.341 -0.85 . . . . 75.12 109.386 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.499 ' N ' HG12 ' B' ' 70' ' ' VAL . 14.8 t -141.15 122.39 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.169 -0.957 . . . . 73.2 109.264 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 72' ' ' LEU . . . . . 0.647 ' HG ' HD11 ' B' ' 95' ' ' ILE . 1.2 mp -117.66 103.09 9.69 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.76 -0.83 . . . . 73.34 108.76 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 70.9 t -90.12 118.69 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.314 -0.866 . . . . 73.5 108.677 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 74' ' ' SER . . . . . 0.43 ' OG ' ' CB ' ' B' ' 51' ' ' SER . 24.4 p -86.27 170.62 11.91 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.16 -0.962 . . . . 64.34 109.009 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 75' ' ' SER . . . . . 0.499 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 35.3 m -159.48 115.53 2.54 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.949 -1.095 . . . . 74.53 110.244 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -63.37 -22.93 67.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.44 -0.788 . . . . 64.5 109.69 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 77' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' B' ' 79' ' ' THR . 8.7 m-80 -125.09 79.33 65.73 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.505 -0.747 . . . . 74.25 109.623 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.13 86.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.494 2.129 . . . . 74.43 111.3 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.463 ' N ' ' O ' ' B' ' 77' ' ' ASN . 20.7 m -100.04 150.57 22.31 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.532 -0.73 . . . . 73.12 109.807 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 4.5 p -69.01 -38.01 79.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.412 -0.805 . . . . 71.01 109.661 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -63.03 -37.37 86.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.92 . . . . 63.2 109.669 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -71.76 -32.46 67.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.207 -0.933 . . . . 73.22 109.647 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 83' ' ' GLU . . . . . 0.51 ' OE2' ' NE ' ' A' ' 100' ' ' ARG . 95.0 mt-10 -64.87 -52.77 54.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.974 . . . . 74.3 109.749 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 18.6 m -60.24 -35.94 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.113 -0.992 . . . . 73.31 109.283 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -75.43 -27.43 58.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.271 -0.893 . . . . 73.24 109.464 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 86' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -66.68 -37.57 85.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.175 -0.953 . . . . 55.33 109.937 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -83.39 -36.26 24.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 74.14 109.22 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -71.9 -39.92 69.2 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.316 -0.865 . . . . 64.04 109.483 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -68.6 -50.12 53.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 72.35 109.4 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.65 69.84 0.01 OUTLIER Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.927 -1.13 . . . . 65.2 110.302 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 91' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -132.67 130.18 39.77 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.322 -1.105 . . . . 52.23 109.139 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -71.28 -33.81 70.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.918 . . . . 73.32 109.286 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 93' ' ' ASP . . . . . 0.437 ' OD2' ' NH2' ' B' ' 108' ' ' ARG . 14.1 t70 -152.25 161.8 42.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -0.843 . . . . 72.22 109.414 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 94' ' ' TYR . . . . . 0.499 ' OH ' ' CB ' ' B' ' 75' ' ' SER . 57.4 t80 -132.25 120.24 21.9 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.86 -0.792 . . . . 64.42 108.86 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 95' ' ' ILE . . . . . 0.785 ' H ' HD12 ' B' ' 95' ' ' ILE . 0.0 OUTLIER -128.08 154.63 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 CA-C-O 121.793 0.806 . . . . 72.23 110.493 -178.43 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.0 149.78 48.41 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.19 -1.041 . . . . 25.24 108.19 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 97' ' ' LYS . . . . . 0.665 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -74.24 -56.48 2.55 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.785 -1.197 . . . . 64.32 111.451 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 98' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 5.2 Cg_endo -41.95 -9.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 120.852 1.035 . . . . 63.33 112.944 -176.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 99' ' ' TYR . . . . . 0.665 ' N ' ' O ' ' B' ' 97' ' ' LYS . 34.0 m-85 61.19 125.71 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.652 -0.655 . . . . 75.13 109.438 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 100' ' ' ARG . . . . . 0.416 ' NE ' ' OE2' ' A' ' 83' ' ' GLU . 39.4 ttm-85 -66.35 -34.39 77.87 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.888 -1.133 . . . . 74.23 108.85 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 101' ' ' SER . . . . . 0.736 ' O ' ' N ' ' B' ' 103' ' ' LYS . 10.9 t -172.69 38.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.198 -0.938 . . . . 63.34 110.6 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 26.2 mm 50.91 -69.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.659 -0.651 . . . . 74.44 110.415 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 103' ' ' LYS . . . . . 0.736 ' N ' ' O ' ' B' ' 101' ' ' SER . 16.2 mtpp -57.46 -29.35 64.14 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.313 -0.995 . . . . 71.11 108.313 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.72 -46.54 81.84 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.542 -0.91 . . . . 71.45 108.542 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 13.0 tp -64.63 -54.45 31.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.478 -0.764 . . . . 51.31 109.011 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 23.4 t -57.85 -38.19 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.116 -0.99 . . . . 65.23 109.495 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.06 -48.26 70.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.25 -0.906 . . . . 24.32 109.616 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 108' ' ' ARG . . . . . 0.487 ' NH2' HD21 ' B' ' 72' ' ' LEU . 8.5 ttp-105 -68.73 -31.49 70.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 75.31 109.869 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 96.8 mt -74.33 -26.3 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.047 -1.033 . . . . 54.24 108.941 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -71.7 -54.0 11.7 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.418 -0.801 . . . . 65.31 109.53 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.3 -43.41 78.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.105 -0.997 . . . . 72.24 109.379 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 9.0 tpm_? -69.79 -41.73 74.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.258 -0.902 . . . . 72.04 109.455 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 14.0 tp -96.55 65.13 2.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.25 -0.906 . . . . 75.35 109.775 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 114' ' ' ARG . . . . . 0.553 ' HE ' ' CA ' ' B' ' 114' ' ' ARG . 0.0 OUTLIER -142.48 -62.23 0.44 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.193 -0.942 . . . . 75.5 108.695 179.647 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -89.33 22.93 2.69 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.219 -0.925 . . . . 65.33 109.511 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -62.28 -35.64 79.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.165 -0.959 . . . . 74.45 109.665 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.29 128.84 33.88 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.911 -1.275 . . . . 44.21 109.911 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 97.5 p -159.45 166.52 30.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.359 -1.083 . . . . 71.4 110.093 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.4 137.06 12.21 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.693 -0.854 . . . . 72.32 108.693 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 5.2 t -107.88 -41.37 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.323 -0.861 . . . . 75.02 110.593 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 19.1 mm -97.95 140.3 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.048 -1.033 . . . . 51.41 109.924 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -148.75 131.6 16.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.404 -0.81 . . . . 71.53 109.33 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.449 ' O ' HG23 ' B' ' 123' ' ' ILE . 10.9 tp -156.35 127.11 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 72.43 109.004 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.83 -155.31 4.29 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.1 -1.6 . . . . 51.23 109.1 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -76.86 2.18 15.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.157 -1.202 . . . . 74.2 108.938 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.577 HD11 HD12 ' B' ' 201' ' ' ILE . 0.4 OUTLIER -95.46 134.37 38.38 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.644 -0.872 . . . . 75.42 108.644 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 3.3 m -131.7 141.46 49.56 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.363 -0.836 . . . . 74.22 109.153 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 54.1 mt -132.38 130.21 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.276 -0.89 . . . . 60.33 109.998 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 129' ' ' SER . . . . . 0.459 ' O ' ' N ' ' B' ' 133' ' ' GLU . 18.9 m -115.32 98.88 51.58 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 108.786 -0.82 . . . . 72.31 108.786 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.12 -40.7 2.31 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.39 1.394 . . . . 75.13 112.041 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -56.78 -36.54 69.97 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.895 -1.128 . . . . 75.23 108.161 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -98.07 -10.0 25.0 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.715 -0.846 . . . . 72.43 108.715 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 133' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' B' ' 129' ' ' SER . 30.0 mt-10 53.84 61.33 3.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.121 -0.987 . . . . 75.13 108.393 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -137.01 112.92 9.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.503 -0.748 . . . . 73.22 109.915 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.44 137.49 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 106.456 -1.683 . . . . 64.14 106.456 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 40.2 mt -129.23 120.8 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.258 -0.901 . . . . 71.22 110.319 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -142.62 144.11 32.68 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.465 -0.772 . . . . 64.22 109.342 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt 54.6 26.37 7.3 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.43 -0.794 . . . . 72.02 110.206 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 75.22 13.68 82.55 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.334 -1.106 . . . . 74.32 110.334 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 40.8 mtp85 -104.37 123.89 48.22 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.335 -1.097 . . . . 75.34 108.99 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -95.75 137.4 34.87 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.384 -0.822 . . . . 71.23 110.162 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 1.2 p -139.51 131.33 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.206 -0.933 . . . . 70.43 109.346 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -89.03 144.32 26.23 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.834 -1.172 . . . . 72.43 107.834 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 144' ' ' VAL . . . . . 0.523 ' HB ' ' CD1' ' B' ' 149' ' ' PHE . 5.9 m -132.11 150.21 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.263 -0.898 . . . . 72.13 109.782 -179.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -174.19 109.87 0.15 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.512 -0.743 . . . . 72.02 109.51 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 146' ' ' GLY . . . . . 1.009 ' O ' ' HG3' ' B' ' 150' ' ' GLU . . . 166.71 -160.21 33.77 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.422 -1.471 . . . . 42.23 109.422 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 147' ' ' LYS . . . . . 0.565 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 26.1 ttpt -87.37 -36.9 0.48 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.149 -1.207 . . . . 73.3 110.675 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 148' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 72.2 Cg_endo -85.12 4.61 6.68 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 121.566 1.511 . . . . 71.33 110.934 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 149' ' ' PHE . . . . . 0.523 ' CD1' ' HB ' ' B' ' 144' ' ' VAL . 41.3 m-85 -108.58 -40.0 5.23 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.496 0.665 . . . . 74.23 109.259 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 150' ' ' GLU . . . . . 1.009 ' HG3' ' O ' ' B' ' 146' ' ' GLY . 41.8 mt-10 -59.65 -34.4 72.77 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.167 -0.958 . . . . 72.34 108.512 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 151' ' ' VAL . . . . . 0.746 HG13 HD22 ' B' ' 152' ' ' LEU . 12.7 p -61.05 -40.84 87.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.639 -0.824 . . . . 73.35 108.854 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.746 HD22 HG13 ' B' ' 151' ' ' VAL . 4.6 mm? -56.84 -52.39 65.3 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.711 -0.848 . . . . 55.24 108.711 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.6 p -62.36 -32.94 73.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.392 -0.818 . . . . 70.01 109.593 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -62.21 -56.15 21.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.991 -1.068 . . . . 65.32 109.463 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.64 -22.21 63.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.057 -1.027 . . . . 71.54 109.14 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.48 -49.99 74.49 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.127 -0.983 . . . . 75.32 108.653 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 51.3 mtp85 -69.64 -52.8 22.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.332 -0.855 . . . . 73.32 109.041 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -76.74 20.35 0.24 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.467 -0.771 . . . . 74.14 110.313 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 159' ' ' ARG . . . . . 1.3 HH11 ' CB ' ' B' ' 159' ' ' ARG . 0.0 OUTLIER -50.02 -38.49 37.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.104 -0.998 . . . . 61.41 109.096 179.868 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -98.15 67.6 1.89 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.25 -0.906 . . . . 72.1 109.584 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 161' ' ' GLN . . . . . 0.582 ' NE2' ' OD2' ' A' ' 160' ' ' ASP . 58.7 tp60 -171.08 161.93 6.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.142 -0.974 . . . . 72.25 109.675 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 13.6 mm -82.88 142.82 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.472 -0.768 . . . . 72.31 109.727 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.27 128.52 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.462 -0.774 . . . . 64.21 109.269 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 52.5 p -98.79 153.7 18.56 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.181 -0.949 . . . . 74.22 109.92 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -52.24 -50.99 60.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.36 -0.838 . . . . 65.31 109.494 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -51.65 -39.71 58.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.372 -0.83 . . . . 63.45 109.907 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -65.86 -41.52 91.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.116 -0.99 . . . . 72.4 109.607 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 80.6 mt -52.02 -53.79 37.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.018 -1.051 . . . . 72.32 109.162 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 169' ' ' LEU . . . . . 0.576 ' O ' ' N ' ' B' ' 171' ' ' ALA . 52.4 mt -64.9 -67.9 0.4 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.341 -0.849 . . . . 73.34 110.059 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -42.91 -15.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.693 -0.629 . . . . 72.1 110.878 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 171' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' B' ' 169' ' ' LEU . . . -93.39 -41.12 10.0 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.93 -1.106 . . . . 62.13 112.196 -178.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 172' ' ' ILE . . . . . 0.461 HD12 ' HB3' ' B' ' 171' ' ' ALA . 4.8 mp -123.47 -34.23 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.791 0 O-C-N 120.768 -1.208 . . . . 71.42 113.209 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 173' ' ' TRP . . . . . 0.476 ' CD2' ' C ' ' B' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.319 0 O-C-N 120.047 -1.658 . . . . 72.23 110.49 -177.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo . . . . . 0 N--CA 1.493 1.447 0 CA-C-O 121.198 0.416 . . . . 65.22 112.88 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 43.3 p30 -70.8 8.42 0.89 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.074 -1.017 . . . . 72.31 110.218 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 12.3 p -66.83 -22.16 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.049 -1.032 . . . . 63.32 109.594 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.426 ' O ' HG22 ' B' ' 188' ' ' ILE . 54.5 mt -54.52 -50.04 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 75.03 109.92 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -60.84 -40.98 94.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 64.11 109.887 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 3.6 t -69.35 -40.04 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.521 -0.737 . . . . 73.0 110.486 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.59 -53.68 9.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 61.12 110.031 -179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 188' ' ' ILE . . . . . 0.426 HG22 ' O ' ' B' ' 184' ' ' ILE . 11.0 tp -58.06 -25.4 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.96 . . . . 72.43 109.741 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -75.83 -56.97 4.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.256 -0.903 . . . . 65.14 110.52 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -65.32 -34.75 79.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.023 -1.048 . . . . 63.24 110.141 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 86.7 mt -63.69 -59.04 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.032 -1.042 . . . . 74.03 109.939 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 192' ' ' ARG . . . . . 0.655 HH21 HG23 ' B' ' 204' ' ' VAL . 21.0 mtp-105 -60.26 -35.86 76.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.166 -0.959 . . . . 72.24 109.622 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 193' ' ' GLN . . . . . 0.43 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 79.9 mm-40 -70.32 -33.95 72.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.183 -0.948 . . . . 73.1 109.452 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 194' ' ' LYS . . . . . 0.458 ' NZ ' ' CB ' ' B' ' 194' ' ' LYS . 7.3 mtpm? -79.58 -17.25 54.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.181 -0.949 . . . . 72.11 110.013 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 44.1 ttp -98.12 -11.52 22.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.139 -0.976 . . . . 44.33 110.372 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 196' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 57.3 p30 -107.91 -14.61 14.73 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.025 -1.047 . . . . 71.21 110.393 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 197' ' ' LYS . . . . . 0.594 ' N ' ' CD ' ' B' ' 198' ' ' PRO . 30.5 tttt -78.16 -40.8 1.95 Allowed Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 120.851 -1.156 . . . . 75.21 110.03 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 198' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' B' ' 197' ' ' LYS . 40.7 Cg_endo -89.47 -44.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.449 2.1 . . . . 75.32 112.473 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 199' ' ' LEU . . . . . 0.516 ' N ' HD12 ' B' ' 199' ' ' LEU . 9.1 mp -61.1 -54.03 49.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.862 -1.149 . . . . 72.25 109.085 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 99.74 -0.02 56.52 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.069 -1.212 . . . . 64.53 110.069 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 201' ' ' ILE . . . . . 0.577 HD12 HD11 ' B' ' 126' ' ' LEU . 38.7 mt -130.79 145.25 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.373 -1.075 . . . . 44.23 109.25 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 28.7 t -97.85 135.28 39.82 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.295 -0.878 . . . . 54.01 109.252 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 6.8 p -135.09 5.62 3.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.344 -0.848 . . . . 74.4 109.277 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.655 HG23 HH21 ' B' ' 192' ' ' ARG . 16.2 m -108.42 139.17 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.448 -0.783 . . . . 72.12 109.479 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -125.2 128.72 48.78 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.55 -0.719 . . . . 65.41 109.372 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.87 124.45 40.85 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.242 -0.911 . . . . 71.33 109.451 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 207' ' ' VAL . . . . . 0.443 ' O ' ' O ' ' B' ' 208' ' ' ARG . 6.1 m -151.42 143.11 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.274 -0.891 . . . . 63.5 109.173 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 208' ' ' ARG . . . . . 0.484 ' O ' ' N ' ' B' ' 210' ' ' ARG . 19.3 tpt180 -58.61 -109.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.089 -1.007 . . . . 74.45 109.108 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 50.63 -94.84 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.955 -1.091 . . . . 74.14 109.386 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 210' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' B' ' 208' ' ' ARG . 67.3 mtt-85 -107.62 -55.31 2.37 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.737 -0.602 . . . . 74.43 109.771 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 211' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' B' ' 207' ' ' VAL . . . -174.42 -105.92 0.19 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.558 -1.417 . . . . 64.45 109.558 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -110.77 162.41 14.8 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.382 -1.07 . . . . 74.21 109.117 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 213' ' ' ARG . . . . . 0.69 HH12 ' CB ' ' B' ' 215' ' ' CYS . 35.4 ttt-85 -130.23 122.95 29.04 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.435 -0.791 . . . . 74.03 109.164 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 214' ' ' PHE . . . . . 0.551 ' HB3' ' O ' ' B' ' 159' ' ' ARG . 17.4 m-85 -104.13 124.67 49.51 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.447 -0.783 . . . . 74.34 109.317 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 215' ' ' CYS . . . . . 0.69 ' CB ' HH12 ' B' ' 213' ' ' ARG . 1.7 m -163.51 154.64 16.56 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.112 -0.992 . . . . 64.33 109.143 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -68.58 147.87 98.06 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 120.954 -1.091 . . . . 70.04 108.167 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.89 -103.81 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.122 1.882 . . . . 65.11 113.143 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 120.96 -1.087 . . . . 73.15 109.979 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptp . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.513 -0.551 . . . . 65.12 109.513 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -140.4 152.25 45.59 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.332 -0.855 . . . . 72.33 109.182 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.9 t -116.32 138.83 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.651 -0.656 . . . . 71.42 109.708 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.546 HD11 ' CG1' ' A' ' 6' ' ' ILE . 2.3 tp -115.87 121.12 41.41 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.462 -0.774 . . . . 65.12 109.043 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 4' ' ' LEU . 16.9 mt -117.68 107.03 13.71 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.044 -0.725 . . . . 62.43 109.044 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.546 ' CG1' HD11 ' A' ' 4' ' ' LEU . 76.7 mt -98.83 112.66 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.248 -0.907 . . . . 71.15 108.829 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.429 ' OE1' ' N ' ' A' ' 13' ' ' GLY . 68.8 tt0 -149.49 127.89 12.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.169 -0.957 . . . . 75.34 109.565 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -62.94 -32.82 74.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -0.874 . . . . 72.44 109.431 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -82.05 105.26 13.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -0.892 . . . . 63.02 109.457 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.8 m -64.87 -28.19 69.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.9 . . . . 72.34 109.783 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.0 t -63.73 -49.24 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.156 -0.965 . . . . 74.02 109.795 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.573 HD13 ' OE2' ' A' ' 15' ' ' GLU . 3.5 mm? -69.85 -46.05 66.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.165 -0.959 . . . . 71.43 109.452 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.429 ' N ' ' OE1' ' A' ' 7' ' ' GLU . . . -66.13 -17.64 66.03 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.4 -1.88 . . . . 61.32 108.4 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.49 -57.59 4.98 Favored Glycine 0 N--CA 1.483 1.776 0 N-CA-C 109.589 -1.405 . . . . 71.2 109.589 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.573 ' OE2' HD13 ' A' ' 12' ' ' LEU . 13.1 pt-20 -53.0 -46.8 68.5 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.446 -1.032 . . . . 71.32 109.714 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.4 mm -61.24 -46.36 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.8 -1.187 . . . . 63.23 108.636 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.507 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 81.1 tt0 -46.54 -52.56 13.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 51.11 109.752 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -88.89 4.89 46.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.168 -0.958 . . . . 73.34 109.741 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.21 -63.54 1.79 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.958 -1.257 . . . . 62.15 109.958 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.496 ' N ' HD23 ' A' ' 20' ' ' LEU . 1.8 pt? -72.62 -19.85 61.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.18 -1.188 . . . . 73.51 110.228 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 86.4 m-20 -52.79 -33.47 49.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.883 -1.136 . . . . 74.25 109.466 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 86.7 t -58.5 -31.92 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 70.04 109.333 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.415 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 11.5 mptt -74.05 -2.8 25.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 73.23 109.25 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.84 23.17 43.02 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.074 -1.21 . . . . 75.54 110.074 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -99.4 158.2 15.89 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.214 -1.168 . . . . 73.43 109.323 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.3 mtt -101.55 139.59 36.99 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.03 -1.1 . . . . 43.24 108.03 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.64 152.7 41.69 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.045 -1.035 . . . . 62.11 110.758 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -135.1 140.92 45.87 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.565 -0.902 . . . . 74.42 108.565 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -107.6 138.28 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.839 . . . . 72.15 109.004 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.7 p -134.95 168.86 18.32 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.453 -0.779 . . . . 71.42 109.491 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.436 ' OE2' ' OD2' ' A' ' 35' ' ' ASP . 4.3 pt-20 -87.41 -102.92 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 72.33 109.559 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.0 p -77.46 163.66 26.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 74.24 109.476 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.515 HD12 ' H ' ' A' ' 33' ' ' LEU . 3.0 mp -58.42 -29.85 66.43 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.45 -0.781 . . . . 71.53 110.026 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -49.89 -43.57 49.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.036 -1.04 . . . . 74.23 109.519 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.436 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 31.9 m-20 -66.8 -42.3 86.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.207 -0.933 . . . . 54.03 109.053 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.38 -42.54 95.95 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.489 -1.444 . . . . 61.41 109.489 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -65.73 -37.85 87.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -1.154 . . . . 74.34 109.336 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.443 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 68.3 t80 -78.64 -21.38 48.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.923 . . . . 75.33 109.581 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.6 tp -90.0 -32.79 16.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.197 -0.939 . . . . 74.33 109.853 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 40' ' ' MET . 3.4 ppp? -78.93 -29.42 44.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.151 -0.968 . . . . 70.32 110.637 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 31.4 p-10 -58.8 -34.28 71.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.795 -1.191 . . . . 71.22 109.845 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.541 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 14.7 pt -90.39 -26.42 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.084 -1.01 . . . . 74.14 110.05 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 40' ' ' MET . 93.6 mtt180 -127.36 138.9 53.13 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.386 -0.821 . . . . 72.24 109.41 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -92.66 152.55 19.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.132 -0.98 . . . . 75.42 109.594 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -133.83 154.44 51.02 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.517 -0.739 . . . . 74.23 109.254 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -94.44 -43.83 8.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.139 -0.976 . . . . 72.04 108.899 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.503 ' C ' HD13 ' A' ' 47' ' ' LEU . 0.8 OUTLIER -106.34 108.91 20.65 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.743 -0.836 . . . . 72.13 108.743 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.445 ' N ' HD13 ' A' ' 47' ' ' LEU . 2.3 m -107.77 105.24 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.297 -1.001 . . . . 72.34 108.297 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.6 ttt -115.18 145.54 42.29 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.511 0.672 . . . . 74.11 109.556 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.547 HG22 ' H ' ' A' ' 52' ' ' ASP . 1.6 p -144.51 133.16 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.487 -0.758 . . . . 61.12 110.19 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 t -98.54 4.57 48.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.499 -0.751 . . . . 73.11 109.454 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.547 ' H ' HG22 ' A' ' 50' ' ' VAL . 52.6 m-20 -76.0 142.15 41.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.141 -0.974 . . . . 52.55 109.377 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 55' ' ' ALA . 67.5 mttm -77.69 -42.76 33.38 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.282 -0.886 . . . . 44.22 110.647 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -70.63 14.54 0.13 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.027 -1.045 . . . . 70.44 109.874 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.29 -19.88 59.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 64.14 110.434 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.0 mt -42.0 -49.06 4.69 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.286 -0.884 . . . . 44.14 110.606 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.9 p -68.56 -37.85 80.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.954 -1.092 . . . . 55.23 109.522 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.52 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 70.7 t80 -67.8 -63.57 1.03 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 74.44 109.914 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.7 m -49.25 -31.72 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.86 -1.15 . . . . 74.03 109.636 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.3 t -60.6 -53.33 58.77 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.149 -0.97 . . . . 64.3 109.11 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -67.87 -27.54 66.76 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.687 -1.205 . . . . 64.44 109.652 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.539 ' O ' ' N ' ' A' ' 66' ' ' HIS . 25.3 mm -56.34 -46.12 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.826 -1.172 . . . . 63.21 108.409 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -63.72 -40.47 96.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.13 -0.981 . . . . 74.42 108.354 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -67.58 -50.85 56.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.385 -0.822 . . . . 70.32 109.246 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.52 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 91.9 mttt -78.15 -12.09 59.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.603 -0.686 . . . . 75.22 110.048 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.578 ' O ' HG22 ' A' ' 69' ' ' ILE . 97.9 m-70 -157.69 70.9 0.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.93 . . . . 74.13 109.149 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.1 p -69.34 -23.9 63.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.199 -0.938 . . . . 73.24 110.015 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 82.3 p -90.83 49.87 1.72 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.141 -0.974 . . . . 61.01 110.074 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 66' ' ' HIS . 13.4 tt -143.36 163.87 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.102 -0.998 . . . . 71.33 109.343 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.417 ' HB ' HD22 ' A' ' 47' ' ' LEU . 46.5 t -93.21 142.16 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.115 -0.991 . . . . 72.13 108.768 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.462 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 9.8 t -130.55 123.44 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.311 -0.868 . . . . 54.21 109.36 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 mt -129.6 100.3 5.47 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.533 -0.914 . . . . 50.24 108.533 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.666 ' O ' HD12 ' A' ' 95' ' ' ILE . 14.9 p -96.12 154.04 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.375 -0.972 . . . . 74.41 108.375 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.4 m -122.57 171.91 8.77 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.78 -0.822 . . . . 72.31 108.78 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.414 ' C ' ' H ' ' A' ' 77' ' ' ASN . 7.6 p -171.2 121.84 0.54 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.963 -1.085 . . . . 64.54 110.431 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' NZ ' ' A' ' 53' ' ' LYS . 56.3 p30 -70.65 8.04 0.95 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.501 -0.75 . . . . 74.13 109.875 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.414 ' H ' ' C ' ' A' ' 75' ' ' SER . 89.5 m-20 -137.94 75.39 42.14 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.29 -0.881 . . . . 73.34 109.489 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -66.92 81.38 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.619 2.213 . . . . 63.22 111.237 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 81' ' ' GLU . 26.5 m -103.31 151.91 22.16 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.733 -0.84 . . . . 62.53 108.733 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 p -60.12 -28.84 68.2 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.297 -0.877 . . . . 73.44 109.773 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.402 ' H ' HG22 ' A' ' 79' ' ' THR . 86.8 tt0 -68.04 -41.54 81.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 71.42 109.865 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -74.3 -35.47 63.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.115 -0.99 . . . . 73.43 109.858 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.42 ' OE1' ' HB1' ' B' ' 104' ' ' ALA . 87.4 tt0 -60.17 -54.13 49.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.204 -0.935 . . . . 74.22 109.941 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 85' ' ' HIS . 34.3 m -61.96 -38.02 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.047 -1.033 . . . . 73.2 109.439 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.423 ' N ' HG23 ' A' ' 84' ' ' VAL . 19.4 m170 -69.0 -26.48 65.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.151 -0.968 . . . . 53.33 109.37 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -68.75 -44.33 73.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.143 -0.973 . . . . 64.11 109.647 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -79.68 -29.19 40.75 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.168 -0.958 . . . . 74.34 109.084 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -75.18 -51.3 13.72 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.436 -0.79 . . . . 74.42 109.357 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -58.57 -50.05 75.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.482 -0.761 . . . . 74.24 109.714 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 147.66 69.1 0.01 OUTLIER Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.107 -1.197 . . . . 61.51 110.107 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -134.24 135.05 42.67 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.33 -1.1 . . . . 55.33 109.017 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.462 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 70.2 m-20 -79.66 -36.8 37.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.103 -0.998 . . . . 73.42 109.031 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -153.33 150.35 28.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.391 -0.818 . . . . 75.04 109.568 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.512 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -124.25 132.54 53.59 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.722 -0.844 . . . . 71.33 108.722 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.825 HD12 ' H ' ' A' ' 95' ' ' ILE . 0.1 OUTLIER -119.29 137.06 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 CA-C-O 121.66 0.743 . . . . 71.13 110.061 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.54 120.2 8.96 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 106.922 -1.51 . . . . 64.32 106.922 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.684 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -41.72 -55.88 5.39 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.161 -0.962 . . . . 62.2 111.862 -178.134 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 1.8 Cg_endo -39.55 -12.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.14 1.226 . . . . 73.11 113.02 -175.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.684 ' N ' ' O ' ' A' ' 97' ' ' LYS . 55.4 m-85 59.86 131.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.803 -0.56 . . . . 65.22 109.835 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 29.6 ttm-85 -72.59 -40.65 66.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.754 -1.216 . . . . 72.35 108.92 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.642 ' O ' ' N ' ' A' ' 103' ' ' LYS . 19.3 m -174.42 43.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.28 -0.887 . . . . 71.32 110.045 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.447 ' O ' ' N ' ' A' ' 105' ' ' LEU . 10.7 mm 47.47 -80.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.374 -0.829 . . . . 75.43 110.414 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.642 ' N ' ' O ' ' A' ' 101' ' ' SER . 20.3 tptm -43.93 -33.37 1.36 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.238 -0.914 . . . . 71.41 109.208 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.67 -44.52 96.04 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.408 -0.96 . . . . 63.24 108.408 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 102' ' ' ILE . 17.2 tp -66.02 -49.37 67.97 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.199 -0.667 . . . . 73.22 109.199 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 70.2 t -60.18 -40.01 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.119 -0.988 . . . . 60.11 109.404 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.68 -41.19 73.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.112 -0.992 . . . . 70.42 108.869 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.525 ' O ' ' NE ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -68.22 -33.95 75.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.403 -0.81 . . . . 74.41 109.018 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 88.6 mt -75.2 -29.3 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.168 -0.958 . . . . 62.54 109.019 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -75.78 -57.43 3.88 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.45 -0.781 . . . . 74.34 109.471 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -49.65 -45.26 48.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.327 -0.858 . . . . 73.32 109.335 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 61.6 ttm-85 -64.75 -34.06 77.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.267 -0.895 . . . . 52.41 109.555 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 37.8 mt -133.52 74.68 1.57 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.393 -0.817 . . . . 65.24 110.016 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.7 mtm180 -85.64 -77.66 0.29 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.143 -0.973 . . . . 64.45 108.543 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.44 ' O ' ' O ' ' A' ' 116' ' ' TRP . 18.8 t80 -85.39 -49.73 7.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 74.43 109.465 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.44 ' O ' ' O ' ' A' ' 115' ' ' PHE . 69.7 t-105 49.85 97.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.366 -0.833 . . . . 74.42 109.663 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.59 113.06 0.28 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.617 -1.393 . . . . 75.04 109.617 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 30.8 m -156.07 164.18 38.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -1.154 . . . . 61.14 109.583 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -158.47 123.43 4.27 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.697 -0.853 . . . . 65.24 108.697 -178.45 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.414 ' HB ' HD12 ' A' ' 121' ' ' ILE . 46.5 t -79.98 -28.99 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 73.11 109.795 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.46 HD11 ' HG2' ' A' ' 157' ' ' ARG . 5.3 mp -116.76 140.94 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.345 -0.847 . . . . 72.24 109.094 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -151.81 140.36 20.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.294 -0.878 . . . . 72.34 108.946 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.446 ' O ' HG23 ' A' ' 123' ' ' ILE . 4.6 tp -160.65 121.23 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.224 -0.923 . . . . 71.44 109.174 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 60.23 -132.45 50.39 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.183 -1.567 . . . . 73.4 109.183 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -97.39 3.13 51.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.183 -1.187 . . . . 74.45 109.354 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.36 143.07 27.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.12 -0.988 . . . . 54.21 109.066 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.43 141.64 49.86 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.754 -0.832 . . . . 54.5 108.754 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.8 mt -137.85 125.09 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.409 -0.807 . . . . 45.15 109.125 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.2 m -121.56 95.94 47.84 Favored Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 109.356 -0.609 . . . . 71.11 109.356 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.15 -33.76 2.48 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.976 1.784 . . . . 65.41 112.099 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -56.43 -46.4 80.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.233 -0.917 . . . . 63.32 108.995 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -87.04 2.63 49.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.863 . . . . 72.52 109.196 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 55.0 72.71 0.46 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 75.33 109.863 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -161.65 143.51 11.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.349 -0.844 . . . . 71.23 109.367 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.5 tt -115.54 138.6 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.433 -0.951 . . . . 74.02 108.433 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.6 mt -126.99 127.13 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 109.055 -0.72 . . . . 60.23 109.055 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.418 ' CD1' ' O ' ' A' ' 137' ' ' TYR . 45.7 p90 -136.85 135.84 38.23 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.377 -0.827 . . . . 62.32 110.598 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp 55.79 31.02 16.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.515 -0.741 . . . . 75.4 110.755 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.23 16.81 79.1 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.631 -1.271 . . . . 72.24 110.911 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 65.4 mtt-85 -112.58 126.21 55.1 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.333 -1.098 . . . . 71.22 109.553 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -94.01 128.04 40.14 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.489 -0.757 . . . . 71.42 109.627 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 34.7 t -139.16 141.1 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.359 -0.838 . . . . 53.02 109.1 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.499 ' N ' ' OE1' ' A' ' 143' ' ' GLU . 48.6 mp0 -97.11 143.85 27.52 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.248 -0.907 . . . . 60.45 109.925 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.15 140.5 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.391 -0.818 . . . . 74.44 109.196 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.34 28.76 0.45 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 65.15 108.961 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.918 ' O ' ' CD1' ' A' ' 149' ' ' PHE . . . -86.93 -161.25 36.05 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.002 -1.239 . . . . 73.34 110.002 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.612 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 16.8 mttm -80.8 -38.04 1.0 Allowed Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.493 -1.004 . . . . 72.22 110.619 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 96.2 Cg_endo -89.46 19.9 1.17 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.456 2.104 . . . . 65.23 112.613 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.918 ' CD1' ' O ' ' A' ' 146' ' ' GLY . 5.3 p90 -94.81 -55.79 2.99 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.166 -0.959 . . . . 60.11 109.408 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.693 ' N ' ' CG ' ' A' ' 149' ' ' PHE . 6.1 pt-20 -53.14 -34.45 56.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.458 -0.776 . . . . 64.21 109.849 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.488 HG13 ' N ' ' A' ' 152' ' ' LEU . 8.3 p -63.03 -41.18 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.002 -1.061 . . . . 72.02 109.306 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.489 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.2 OUTLIER -63.52 -46.97 83.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.898 . . . . 73.31 108.63 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 27.2 p -67.39 -27.71 67.32 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.111 -0.993 . . . . 74.31 109.164 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -61.1 -53.96 50.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.883 . . . . 74.31 109.826 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.684 HD12 ' N ' ' A' ' 156' ' ' ALA . 3.9 pp -69.4 -21.12 63.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.025 -1.047 . . . . 75.34 109.26 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.684 ' N ' HD12 ' A' ' 155' ' ' LEU . . . -65.02 -43.38 92.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 62.14 108.96 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.501 ' C ' ' H ' ' A' ' 159' ' ' ARG . 59.0 mtm180 -77.24 -49.39 15.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 61.03 109.111 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -71.97 17.54 0.09 Allowed 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.002 -0.679 . . . . 74.12 109.422 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.501 ' H ' ' C ' ' A' ' 157' ' ' ARG . 35.4 ptt-85 -52.03 156.74 1.47 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.265 -0.897 . . . . 71.13 109.2 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.455 ' OD1' ' CD2' ' A' ' 216' ' ' TYR . 50.3 m-20 55.08 47.87 20.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.444 -0.785 . . . . 75.45 109.678 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -155.04 151.68 28.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.165 -0.959 . . . . 73.41 109.512 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.4 mt -89.51 138.37 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.224 -0.922 . . . . 74.41 109.458 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.6 t -139.43 131.01 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.345 -0.847 . . . . 72.31 109.317 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 16.2 t -78.25 164.72 24.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 74.12 109.691 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -63.63 -48.75 76.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.46 -0.775 . . . . 70.43 109.887 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -56.98 -37.03 71.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 73.52 110.102 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -53.91 -47.53 71.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.952 -1.092 . . . . 74.52 109.435 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 51.1 mt -60.27 -44.02 95.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.079 -1.013 . . . . 72.31 109.524 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 7.0 tp -54.93 -51.18 66.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.367 -0.833 . . . . 53.33 110.17 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -81.3 -11.75 59.25 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.152 -0.968 . . . . 62.44 110.685 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.52 -52.89 18.65 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.797 -1.189 . . . . 60.21 109.973 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.66 HD12 ' N ' ' A' ' 172' ' ' ILE . 1.7 mp -85.18 -36.81 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.147 -0.971 . . . . 75.32 109.072 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -108.88 74.73 0.92 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.486 -0.758 . . . . 73.14 109.359 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -86.67 -35.65 19.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.335 -0.853 . . . . 73.24 109.771 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -74.91 146.17 82.31 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.189 -0.944 . . . . 44.43 109.798 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -42.87 109.6 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.084 1.856 . . . . 72.51 112.723 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 179' ' ' VAL . 88.1 mt-10 -151.83 162.93 40.24 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.185 -0.947 . . . . 63.24 109.391 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 75.7 mtm -64.44 70.14 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 73.5 110.133 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.524 HG23 ' N ' ' A' ' 180' ' ' THR . 26.5 m -85.1 -42.4 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.151 -0.968 . . . . 65.22 109.205 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.572 ' O ' ' N ' ' A' ' 182' ' ' ASN . 82.4 m 47.73 92.22 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.172 -0.955 . . . . 71.42 109.342 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -47.37 76.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 122.446 2.097 . . . . 41.22 112.784 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.572 ' N ' ' O ' ' A' ' 180' ' ' THR . 6.8 t-20 -174.01 -20.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.327 -0.858 . . . . 64.54 108.788 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 29.4 m -74.94 -14.97 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.344 -0.847 . . . . 74.02 109.716 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.416 ' O ' HG22 ' A' ' 188' ' ' ILE . 34.5 mt -48.89 -43.17 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.153 -0.967 . . . . 72.33 109.63 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -53.08 -34.02 54.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.12 -0.988 . . . . 74.4 109.466 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.32 -49.0 21.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.482 -0.761 . . . . 70.42 110.179 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.88 96.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.006 -1.059 . . . . 52.11 110.161 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.479 HG23 ' N ' ' A' ' 189' ' ' ASN . 11.0 tp -66.3 -42.58 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 120.936 -1.103 . . . . 71.4 109.691 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.479 ' N ' HG23 ' A' ' 188' ' ' ILE . 39.2 t30 -62.87 -43.05 99.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.197 -0.94 . . . . 73.44 109.353 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -65.33 -40.16 93.33 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.37 -0.831 . . . . 71.42 109.61 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 71.8 mt -65.96 -44.86 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.247 -0.908 . . . . 61.55 109.793 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -58.7 -38.87 79.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.149 -0.969 . . . . 63.34 109.712 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -79.15 -26.04 42.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -0.991 . . . . 61.24 110.336 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -91.07 -16.98 26.97 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.962 -1.087 . . . . 75.13 110.825 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' MET . . . . . 0.568 ' SD ' ' N ' ' A' ' 196' ' ' ASP . 2.2 ppp? -91.72 -41.81 10.5 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.713 -1.242 . . . . 74.02 110.43 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ASP . . . . . 0.568 ' N ' ' SD ' ' A' ' 195' ' ' MET . 26.1 t70 -66.82 -37.04 83.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.934 -1.104 . . . . 74.02 110.103 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.412 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 0.1 OUTLIER -50.86 -63.54 1.84 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.96 -1.087 . . . . 75.43 109.156 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 40.8 Cg_endo -65.81 -58.27 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.527 1.485 . . . . 72.32 111.189 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.499 ' C ' ' H ' ' A' ' 201' ' ' ILE . 4.0 mm? -86.16 92.38 8.73 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.29 -1.004 . . . . 74.54 108.29 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -59.17 -0.22 0.69 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.968 -1.253 . . . . 61.51 109.968 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.499 ' H ' ' C ' ' A' ' 199' ' ' LEU . 26.0 mm -108.29 130.09 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.379 -1.071 . . . . 61.22 109.336 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 67.0 m -76.74 146.34 38.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 72.0 109.296 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 15.9 p -139.65 4.49 2.14 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.398 -0.813 . . . . 74.44 109.354 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 204' ' ' VAL . 7.9 m -120.54 132.05 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.606 -0.684 . . . . 64.35 109.538 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -103.8 118.33 36.44 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.378 -0.826 . . . . 71.41 108.914 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 206' ' ' THR . 0.0 OUTLIER -94.11 129.43 40.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.241 -0.912 . . . . 73.52 109.573 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.507 HG21 HH12 ' A' ' 213' ' ' ARG . 19.9 t -144.54 131.13 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 71.02 108.944 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -56.78 -31.84 65.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 72.12 109.684 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 211' ' ' GLY . 72.9 mtt85 -63.72 137.54 58.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.91 . . . . 64.41 109.808 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 57.68 -78.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.475 -0.766 . . . . 71.54 110.026 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . -177.6 -114.94 0.42 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.29 -1.524 . . . . 72.03 109.29 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -113.24 135.07 54.23 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.426 -1.044 . . . . 75.54 109.289 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.507 HH12 HG21 ' A' ' 207' ' ' VAL . 21.8 ttp-105 -109.55 139.64 44.31 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.929 -0.767 . . . . 75.31 108.929 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.442 ' O ' ' SG ' ' A' ' 215' ' ' CYS . 58.7 m-85 -107.62 134.57 50.43 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.425 -0.797 . . . . 75.41 109.935 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 214' ' ' PHE . 99.3 m -155.02 156.25 35.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.479 -0.763 . . . . 74.14 109.262 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' TYR . . . . . 0.455 ' CD2' ' OD1' ' A' ' 160' ' ' ASP . 1.9 p90 -64.74 154.34 85.59 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.193 -0.942 . . . . 75.32 109.299 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -39.45 151.94 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.232 1.955 . . . . 73.11 111.943 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.582 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 17.9 mttt -72.16 -39.0 6.14 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.103 -0.998 . . . . 75.25 110.856 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 87.9 Cg_endo -89.1 14.77 2.17 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.409 2.073 . . . . 75.1 112.466 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -57.03 -35.54 69.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.125 -0.984 . . . . 71.14 109.197 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 4.6 p -81.43 139.16 35.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.892 . . . . 71.13 109.347 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' A' ' 222' ' ' GLU . 40.8 mp0 -67.22 -26.98 66.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 75.35 109.689 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.962 -1.018 . . . . 73.41 109.47 -179.926 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.589 ' SD ' ' CE2' ' B' ' 25' ' ' PHE . 16.7 ptp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.435 -0.58 . . . . 71.14 109.435 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.532 ' NH1' ' SD ' ' B' ' 26' ' ' MET . 92.8 mtt-85 -136.62 152.97 51.03 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.387 -0.821 . . . . 73.23 109.178 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 93.5 t -110.68 133.2 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.525 -0.735 . . . . 72.24 109.582 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.431 HD11 ' CG1' ' B' ' 6' ' ' ILE . 3.6 tp -105.72 118.22 36.03 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.61 -0.681 . . . . 54.33 109.686 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.42 ' N ' HD12 ' B' ' 4' ' ' LEU . 15.3 mt -113.3 100.28 8.44 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.708 -0.849 . . . . 74.35 108.708 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.689 HD12 ' HB ' ' B' ' 50' ' ' VAL . 89.4 mt -86.97 99.66 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.04 -1.038 . . . . 42.55 109.015 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.447 ' CD ' ' HG ' ' B' ' 51' ' ' SER . 7.0 tp10 -146.69 137.61 24.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.46 -0.775 . . . . 74.52 108.913 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.524 ' CD ' ' H ' ' B' ' 8' ' ' LYS . 0.0 OUTLIER -78.39 -31.92 48.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 62.55 109.084 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ASN . . . . . 0.4 ' H ' ' HG3' ' B' ' 7' ' ' GLU . 93.3 m-20 -75.45 109.16 8.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.867 . . . . 73.11 109.552 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 29.3 m -67.43 -27.7 67.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.269 -0.895 . . . . 65.54 109.668 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 75.5 t -59.11 -52.44 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.236 -0.915 . . . . 75.55 109.668 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.535 HD13 ' NZ ' ' B' ' 97' ' ' LYS . 91.6 mt -63.28 -35.76 81.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -0.962 . . . . 70.14 109.402 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.65 -25.02 75.99 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.826 -1.71 . . . . 75.4 108.826 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.04 -53.05 24.55 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.736 -1.345 . . . . 65.44 109.736 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -58.96 -47.17 86.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.35 -1.088 . . . . 60.21 109.97 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 37.0 mm -61.82 -39.23 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.738 -1.226 . . . . 75.15 108.816 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -55.04 -42.53 72.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.35 -0.844 . . . . 73.01 109.457 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -87.76 -2.82 58.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.168 -0.957 . . . . 74.3 109.381 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.63 -53.66 3.16 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 109.91 -1.276 . . . . 70.54 109.91 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.458 HD21 ' HB2' ' B' ' 27' ' ' ALA . 1.4 pt? -74.29 -19.84 60.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -1.147 . . . . 71.34 110.016 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -52.83 -32.4 44.12 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.085 -1.009 . . . . 64.41 109.52 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 97.5 t -61.94 -33.45 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.225 -0.922 . . . . 74.23 109.159 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' B' ' 110' ' ' GLU . 16.4 mmtp -81.77 -5.4 58.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.856 . . . . 63.42 109.18 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.83 19.63 70.02 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.964 -1.254 . . . . 53.43 109.964 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.589 ' CE2' ' SD ' ' B' ' 1' ' ' MET . 7.4 m-85 -92.43 159.68 15.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.162 -1.199 . . . . 71.12 108.97 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' MET . . . . . 0.532 ' SD ' ' NH1' ' B' ' 2' ' ' ARG . 35.6 mtt -100.95 138.0 38.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.271 -0.893 . . . . 75.24 108.702 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.458 ' HB2' HD21 ' B' ' 20' ' ' LEU . . . -114.22 147.35 39.08 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.51 -0.744 . . . . 72.12 110.09 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -131.7 134.04 45.49 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.44 -0.948 . . . . 72.31 108.44 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -109.75 134.55 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.361 -0.837 . . . . 64.43 109.077 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.9 p -137.23 169.72 17.31 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.497 -0.752 . . . . 65.41 109.176 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -93.21 -107.34 0.12 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.191 -0.943 . . . . 71.02 109.679 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 68.2 p -78.75 168.45 19.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.906 . . . . 51.11 109.914 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.414 HD22 ' CG ' ' B' ' 58' ' ' PHE . 47.6 mt -51.53 -30.25 19.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.663 -0.648 . . . . 71.24 109.907 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -52.72 -51.18 61.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.097 -1.002 . . . . 74.32 109.772 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.82 -39.2 93.66 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.152 -0.968 . . . . 73.03 109.428 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.64 -39.39 78.06 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.559 -1.416 . . . . 30.21 109.559 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -69.06 -38.23 78.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -1.127 . . . . 74.42 109.874 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -80.6 -38.72 28.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.102 -0.999 . . . . 74.42 109.918 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 11.1 tp -69.23 -43.49 73.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.216 -0.927 . . . . 75.41 110.134 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.0 ppp? -66.59 -24.42 66.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.05 . . . . 60.41 109.916 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -61.28 -40.99 96.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.109 -0.995 . . . . 53.23 110.112 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.46 HD12 ' NH1' ' B' ' 43' ' ' ARG . 17.5 pt -81.25 -30.7 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.076 -1.015 . . . . 71.23 110.238 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.46 ' NH1' HD12 ' B' ' 42' ' ' ILE . 78.1 mtt85 -129.93 141.22 50.81 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.395 -0.815 . . . . 72.22 109.623 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -97.18 147.32 24.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.282 -0.886 . . . . 63.54 109.289 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -123.6 145.79 48.66 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.524 -0.735 . . . . 64.35 109.38 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ASP . . . . . 0.458 ' OD2' ' NE1' ' B' ' 116' ' ' TRP . 48.6 t0 -79.68 -42.29 25.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.232 -0.917 . . . . 62.22 109.355 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.547 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.5 OUTLIER -104.23 115.65 30.78 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.872 -0.788 . . . . 73.12 108.872 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.547 ' N ' HD13 ' B' ' 47' ' ' LEU . 72.6 t -99.62 97.24 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.967 -1.123 . . . . 65.11 107.967 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 19.9 ttt -110.31 134.09 52.62 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.608 0.718 . . . . 73.44 110.576 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.689 ' HB ' HD12 ' B' ' 6' ' ' ILE . 1.0 OUTLIER -146.98 132.71 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.543 0.687 . . . . 34.5 109.364 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 51' ' ' SER . . . . . 0.447 ' HG ' ' CD ' ' B' ' 7' ' ' GLU . 16.8 p -102.11 12.3 37.0 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.465 -0.772 . . . . 73.21 109.81 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.501 ' H ' HG22 ' B' ' 50' ' ' VAL . 55.9 m-20 -77.14 143.54 39.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.158 -0.964 . . . . 70.41 109.603 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.488 ' C ' ' H ' ' B' ' 55' ' ' ALA . 94.2 mttt -63.79 -37.44 87.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 65.0 109.822 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -71.77 16.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.935 . . . . 75.21 109.645 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.488 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -57.19 -40.05 76.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 55.33 109.818 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.517 ' N ' HD12 ' B' ' 56' ' ' LEU . 10.8 mp -46.98 -42.22 17.6 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.164 -0.96 . . . . 63.14 109.733 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' SER . . . . . 0.434 ' O ' ' NH1' ' B' ' 61' ' ' ARG . 17.5 m -72.62 -43.08 63.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 63.5 109.648 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' PHE . . . . . 0.414 ' CG ' HD22 ' B' ' 33' ' ' LEU . 50.9 t80 -64.52 -58.01 7.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.29 -0.881 . . . . 72.33 109.95 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.424 HG23 ' N ' ' B' ' 60' ' ' SER . 14.2 m -53.01 -36.96 25.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.512 -1.368 . . . . 74.54 109.609 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.424 ' N ' HG23 ' B' ' 59' ' ' VAL . 23.3 t -54.93 -52.15 63.86 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.256 -0.903 . . . . 71.24 109.6 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.434 ' NH1' ' O ' ' B' ' 57' ' ' SER . 3.9 ptp85 -69.74 -34.09 73.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.989 . . . . 74.31 110.318 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 40.4 mm -69.75 -34.52 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.759 -1.213 . . . . 72.14 109.924 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -44.36 77.29 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.15 -0.969 . . . . 73.32 110.231 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.479 ' CG ' ' N ' ' B' ' 65' ' ' LYS . 9.6 pt-20 -79.41 -45.65 19.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.934 -1.104 . . . . 73.12 110.369 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.479 ' N ' ' CG ' ' B' ' 64' ' ' GLU . 57.9 mttp -66.95 -24.87 66.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.195 -0.941 . . . . 72.44 109.852 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.584 ' O ' HG22 ' B' ' 69' ' ' ILE . 79.4 m-70 -155.28 64.5 0.63 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.138 -0.976 . . . . 63.31 109.564 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.426 ' O ' ' N ' ' B' ' 69' ' ' ILE . 8.0 t -56.09 -34.05 65.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 73.1 109.823 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 44.8 t -70.18 47.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.936 . . . . 71.53 109.924 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.584 HG22 ' O ' ' B' ' 66' ' ' HIS . 15.6 tt -145.46 156.35 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.121 -0.987 . . . . 74.4 109.176 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 31.8 t -93.92 144.95 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.08 -1.012 . . . . 75.12 109.315 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 25.3 t -131.46 125.32 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.446 -0.784 . . . . 73.2 110.002 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.549 HD23 ' C ' ' B' ' 72' ' ' LEU . 6.3 tt -121.64 98.06 5.78 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.864 -0.791 . . . . 73.34 108.864 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.408 HG22 ' N ' ' B' ' 74' ' ' SER . 10.5 p -90.26 156.35 3.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 120.901 -1.124 . . . . 73.5 108.711 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.408 ' N ' HG22 ' B' ' 73' ' ' VAL . 5.9 m -129.45 169.01 15.48 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.385 -0.968 . . . . 64.34 108.385 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.423 ' C ' ' H ' ' B' ' 77' ' ' ASN . 36.0 t -172.49 125.07 0.49 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.943 -1.098 . . . . 74.53 110.442 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -76.04 21.57 0.17 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.602 -0.686 . . . . 64.5 109.8 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' ASN . . . . . 0.423 ' H ' ' C ' ' B' ' 75' ' ' SER . 42.6 t-20 -146.75 58.77 4.62 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.137 -0.977 . . . . 74.25 109.986 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -57.96 83.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.389 2.059 . . . . 74.43 112.036 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 66.5 p -107.63 160.97 15.28 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.41 -0.959 . . . . 73.12 108.41 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.3 p -63.2 -22.68 67.02 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.22 -0.925 . . . . 71.01 109.782 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' GLU . . . . . 0.438 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 97.2 mt-10 -69.41 -46.53 66.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.099 -1.001 . . . . 63.2 109.435 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -72.86 -28.06 62.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 73.22 109.579 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 35.4 tp10 -62.15 -54.05 46.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 74.3 109.886 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.41 HG23 ' N ' ' B' ' 85' ' ' HIS . 27.2 m -65.89 -38.0 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 73.31 109.89 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' HIS . . . . . 0.438 ' ND1' ' O ' ' B' ' 81' ' ' GLU . 32.4 m80 -67.05 -35.4 79.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.075 -1.015 . . . . 73.24 109.778 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.12 -42.12 94.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.965 -1.085 . . . . 55.33 110.043 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' PHE . . . . . 0.456 ' CE1' ' NH1' ' A' ' 108' ' ' ARG . 52.9 m-85 -81.81 -35.9 28.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.065 -1.022 . . . . 74.14 109.438 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -71.05 -45.53 63.66 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.302 -0.874 . . . . 64.04 109.778 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -64.07 -50.46 68.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.087 -1.008 . . . . 72.35 109.458 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 142.44 73.29 0.03 OUTLIER Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.144 -1.182 . . . . 65.2 110.144 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -127.83 131.91 49.48 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.394 -1.062 . . . . 52.23 108.805 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -70.12 -43.07 71.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.99 -1.069 . . . . 73.32 108.848 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' B' ' 93' ' ' ASP . 13.2 p-10 -154.09 153.95 32.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.528 -0.733 . . . . 72.22 109.053 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.497 ' C ' ' CD1' ' B' ' 94' ' ' TYR . 0.5 OUTLIER -127.43 125.68 41.02 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 109.056 -0.72 . . . . 64.42 109.056 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.444 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 30.1 mm -114.16 141.18 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-O 121.878 0.847 . . . . 72.23 110.34 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.36 123.02 16.6 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.337 -1.357 . . . . 25.24 107.337 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.695 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -43.54 -55.46 8.51 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.129 -0.982 . . . . 64.32 111.879 -178.466 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 98' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 2.6 Cg_endo -40.44 -10.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.052 1.168 . . . . 63.33 113.213 -175.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 99' ' ' TYR . . . . . 0.695 ' N ' ' O ' ' B' ' 97' ' ' LYS . 44.7 m-85 59.03 118.7 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.621 -0.674 . . . . 75.13 109.539 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -65.07 -41.04 95.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.764 -1.21 . . . . 74.23 108.82 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' SER . . . . . 0.754 ' O ' ' N ' ' B' ' 103' ' ' LYS . 7.3 t -173.87 44.84 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.205 -0.934 . . . . 63.34 110.739 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 14.0 mm 49.25 -69.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-N 118.717 0.689 . . . . 74.44 110.563 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.754 ' N ' ' O ' ' B' ' 101' ' ' SER . 1.3 mptm? -53.06 -29.42 30.06 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 107.919 -1.141 . . . . 71.11 107.919 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.42 ' HB1' ' OE1' ' A' ' 83' ' ' GLU . . . -67.44 -39.84 85.42 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.177 -1.046 . . . . 71.45 108.177 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 50.7 tp -68.17 -56.53 8.41 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.075 -0.713 . . . . 51.31 109.075 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 89.0 t -60.96 -40.45 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.225 -0.922 . . . . 65.23 109.585 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.39 -44.43 65.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.155 -0.965 . . . . 24.32 108.902 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 25.5 tpt85 -64.58 -34.62 78.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.337 -0.852 . . . . 75.31 109.105 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 72.4 mt -73.63 -30.48 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.216 -0.928 . . . . 54.24 108.75 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' GLU . . . . . 0.408 ' OE1' ' NZ ' ' B' ' 23' ' ' LYS . 88.9 tt0 -67.31 -58.69 4.35 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.457 -0.777 . . . . 65.31 109.311 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.93 -31.11 62.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.279 -0.888 . . . . 72.24 109.111 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -59.39 -47.18 86.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.251 -0.905 . . . . 72.04 109.191 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.04 100.9 2.53 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.066 -1.021 . . . . 75.35 109.585 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 20.3 mtm105 -90.65 -73.25 0.54 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.274 -0.891 . . . . 75.5 108.987 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -68.74 -35.64 77.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 65.33 109.937 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' TRP . . . . . 0.458 ' NE1' ' OD2' ' B' ' 46' ' ' ASP . 58.1 t90 52.01 84.87 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 74.45 109.482 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 157.44 131.16 1.29 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.714 -1.355 . . . . 44.21 109.714 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 26.9 t -164.22 169.0 18.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.35 -1.089 . . . . 71.4 109.41 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.1 139.21 14.5 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.81 -0.756 . . . . 72.32 109.031 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 14.7 t -105.52 -45.43 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.465 -0.772 . . . . 75.02 110.146 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 9.2 mm -100.08 140.82 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.079 -1.013 . . . . 51.41 109.83 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -148.79 115.33 5.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.227 -0.921 . . . . 71.53 109.344 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.472 HD13 ' N ' ' B' ' 123' ' ' ILE . 0.0 OUTLIER -134.03 120.34 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.632 -0.877 . . . . 72.43 108.632 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.48 -139.26 48.7 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.382 -1.487 . . . . 51.23 109.382 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -88.59 4.42 46.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.197 -1.178 . . . . 74.2 109.503 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.33 135.48 35.69 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.184 -0.947 . . . . 75.42 108.591 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 5.7 m -132.8 122.88 25.15 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.452 -0.78 . . . . 74.22 109.172 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.613 HG21 ' HB1' ' B' ' 156' ' ' ALA . 31.1 mm -114.3 125.67 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.376 -0.827 . . . . 60.33 109.626 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 61.4 m -111.57 90.16 12.01 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.862 -0.792 . . . . 72.31 108.862 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.84 -29.38 8.59 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.667 1.578 . . . . 75.13 111.93 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -64.59 -43.51 93.58 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.173 -0.955 . . . . 75.23 108.873 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.3 8.18 37.26 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.356 -0.84 . . . . 72.43 109.21 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 49.82 62.14 2.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.895 . . . . 75.13 109.57 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 134' ' ' LYS . . . . . 0.589 ' C ' HD12 ' B' ' 135' ' ' ILE . 19.3 ttpp -149.77 130.05 13.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.216 -0.927 . . . . 73.22 109.392 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 135' ' ' ILE . . . . . 0.589 HD12 ' C ' ' B' ' 134' ' ' LYS . 1.8 mp -108.9 141.24 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.522 -0.736 . . . . 64.14 109.089 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 25.7 mt -131.12 132.54 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 121.359 -0.838 . . . . 71.22 110.644 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 137' ' ' TYR . . . . . 0.509 ' CE2' ' CG2' ' B' ' 135' ' ' ILE . 48.9 m-85 -134.89 133.37 39.58 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.438 -0.789 . . . . 64.22 109.442 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 138' ' ' LYS . . . . . 0.779 ' CE ' ' O ' ' B' ' 198' ' ' PRO . 23.0 mttm 55.11 25.12 6.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 72.02 110.267 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.7 13.34 80.1 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.941 -1.264 . . . . 74.32 109.941 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -99.79 124.09 44.71 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.3 -1.117 . . . . 75.34 108.85 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -88.65 131.45 34.98 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.125 -0.984 . . . . 71.23 109.913 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.5 136.85 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.462 -0.774 . . . . 70.43 109.299 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -86.16 160.76 19.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.382 -0.824 . . . . 72.43 109.154 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 144' ' ' VAL . . . . . 0.563 HG11 HD13 ' B' ' 135' ' ' ILE . 10.3 m -138.18 147.19 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.327 -0.858 . . . . 72.13 109.693 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 36.4 pttt -176.18 70.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 72.02 109.872 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 179.99 177.69 48.15 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.545 -1.312 . . . . 42.23 110.091 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 0.624 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 8.0 mtmm -70.21 -37.28 7.07 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.419 -1.047 . . . . 73.3 110.388 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 148' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 32.5 Cg_exo -58.12 -39.87 81.66 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.061 1.841 . . . . 71.33 111.898 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -87.56 -22.53 24.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.877 . . . . 74.23 109.454 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -52.68 -53.03 53.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 72.34 109.368 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.43 HG13 ' N ' ' B' ' 152' ' ' LEU . 7.6 p -61.5 -38.18 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.239 -0.913 . . . . 73.35 109.394 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.49 ' O ' ' CD1' ' B' ' 155' ' ' LEU . 33.4 tp -56.37 -36.53 68.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.19 -0.944 . . . . 55.24 108.586 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.75 -20.37 50.11 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.954 -1.091 . . . . 70.01 109.357 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 154' ' ' HIS . . . . . 0.54 ' CE1' ' CE1' ' B' ' 158' ' ' HIS . 4.8 t60 -68.21 -60.63 2.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.931 -1.106 . . . . 65.32 109.596 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.923 HD13 ' N ' ' B' ' 156' ' ' ALA . 0.0 OUTLIER -64.91 -24.81 67.64 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.218 -0.926 . . . . 71.54 108.899 179.469 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 156' ' ' ALA . . . . . 0.923 ' N ' HD13 ' B' ' 155' ' ' LEU . . . -57.42 -42.46 82.39 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.969 -1.082 . . . . 75.32 108.593 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' B' ' 159' ' ' ARG . 59.8 mtp180 -87.55 -69.23 0.7 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.228 -0.92 . . . . 73.32 110.997 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 158' ' ' HIS . . . . . 0.582 ' O ' ' CG ' ' B' ' 158' ' ' HIS . 10.6 p-80 -67.97 48.08 0.05 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.324 -0.95 . . . . 74.14 110.158 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 159' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' B' ' 157' ' ' ARG . 0.0 OUTLIER -83.78 176.98 8.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.932 -1.105 . . . . 61.41 108.84 179.276 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 53.0 t0 54.7 43.13 30.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.392 -0.817 . . . . 72.1 111.288 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -158.67 171.77 19.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.606 -1.309 . . . . 72.25 109.852 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 19.9 mm -73.18 140.47 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.327 -0.858 . . . . 72.31 109.536 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 163' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' B' ' 212' ' ' TYR . 41.0 t -133.59 111.82 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.473 -0.767 . . . . 64.21 109.343 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 8.9 t -92.22 166.08 12.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.139 -0.976 . . . . 74.22 109.001 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -59.51 -44.13 93.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.941 -1.099 . . . . 65.31 108.674 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.59 -24.72 67.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.285 -0.884 . . . . 63.45 108.956 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -61.06 -51.65 68.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.383 -0.823 . . . . 72.4 109.692 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 41.6 mt -61.46 -41.68 97.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 72.32 109.025 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.432 HD21 ' HB2' ' B' ' 174' ' ' GLU . 0.1 OUTLIER -57.4 -67.05 0.36 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.482 -0.762 . . . . 73.34 109.956 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -59.78 -17.51 36.15 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.936 -0.706 . . . . 72.1 109.829 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -93.67 -3.8 51.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.801 -1.187 . . . . 62.13 108.702 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.57 ' O ' ' CG ' ' B' ' 173' ' ' TRP . 96.5 mt -133.06 -80.91 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.495 -0.753 . . . . 71.42 109.074 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 173' ' ' TRP . . . . . 0.57 ' CG ' ' O ' ' B' ' 172' ' ' ILE . 0.0 OUTLIER 152.61 173.99 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.744 0 CA-C-O 121.73 0.776 . . . . 72.23 109.314 -179.594 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 174' ' ' GLU . . . . . 0.432 ' HB2' HD21 ' B' ' 169' ' ' LEU . 71.8 tt0 -165.28 -59.55 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.742 -0.599 . . . . 52.11 109.706 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 175' ' ' GLU . . . . . 0.429 ' N ' ' HD2' ' B' ' 176' ' ' PRO . 8.6 tt0 -69.33 -60.05 4.43 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 73.04 110.113 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' B' ' 175' ' ' GLU . 9.9 Cg_endo -51.2 -33.87 46.28 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.886 1.724 . . . . 74.13 111.871 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -84.14 4.32 30.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.16 -0.962 . . . . 72.44 109.246 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 69.3 mtp 49.35 28.64 2.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 63.43 109.227 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.45 170.72 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.198 -0.939 . . . . 71.05 108.897 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 54.8 p -74.83 129.49 83.26 Favored Pre-proline 0 C--N 1.303 -1.451 0 O-C-N 121.159 -0.963 . . . . 62.15 109.069 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -42.27 158.47 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.804 1.669 . . . . 65.22 112.466 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 4.5 m120 52.02 54.43 10.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.224 -0.923 . . . . 72.31 109.628 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 3.4 p -78.96 -28.64 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.205 -0.934 . . . . 63.32 110.12 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.449 ' O ' HG22 ' B' ' 188' ' ' ILE . 38.8 mm -57.21 -33.93 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.912 -1.117 . . . . 75.03 111.154 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -61.26 -63.23 1.35 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.924 -1.11 . . . . 64.11 111.252 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 30.4 m -70.48 -32.75 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.792 -1.193 . . . . 73.0 110.562 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 187' ' ' ALA . . . . . 0.446 ' O ' HD12 ' B' ' 191' ' ' ILE . . . -67.24 -38.03 84.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.958 -1.089 . . . . 61.12 111.725 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 188' ' ' ILE . . . . . 0.564 HG23 ' N ' ' B' ' 189' ' ' ASN . 10.6 tp -79.62 -46.07 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 119.982 -1.699 . . . . 72.43 111.222 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 189' ' ' ASN . . . . . 0.564 ' N ' HG23 ' B' ' 188' ' ' ILE . 40.1 m-20 -59.33 -34.05 71.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.745 -1.222 . . . . 65.14 109.802 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -80.79 -51.86 8.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.047 -1.033 . . . . 63.24 110.0 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 191' ' ' ILE . . . . . 0.446 HD12 ' O ' ' B' ' 187' ' ' ALA . 68.6 mt -49.76 -36.14 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.265 -0.897 . . . . 74.03 109.512 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 192' ' ' ARG . . . . . 1.49 HH12 ' CG2' ' B' ' 204' ' ' VAL . 82.6 mtt-85 -72.75 -45.73 57.15 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.756 -0.831 . . . . 72.24 108.756 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -66.54 -12.12 56.14 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.351 -0.843 . . . . 73.1 108.949 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -108.47 -13.46 14.84 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.493 -0.754 . . . . 72.11 110.617 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 35.5 ttm -96.22 -54.67 3.21 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.87 -1.144 . . . . 44.33 110.362 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -55.89 -27.62 52.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 71.21 109.701 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 197' ' ' LYS . . . . . 0.436 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 40.2 mttt -66.3 -65.75 1.59 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 75.21 110.021 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 198' ' ' PRO . . . . . 0.779 ' O ' ' CE ' ' B' ' 138' ' ' LYS . 17.8 Cg_endo -58.55 -48.21 16.1 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.139 1.893 . . . . 75.32 112.745 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 199' ' ' LEU . . . . . 0.43 ' N ' HD12 ' B' ' 199' ' ' LEU . 9.5 mp -75.86 -43.29 46.39 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.98 -1.075 . . . . 72.25 110.048 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 83.43 -9.05 62.57 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.691 -1.364 . . . . 64.53 109.691 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 31.3 mm -110.25 130.02 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.451 -1.029 . . . . 44.23 109.481 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 61.3 p -82.58 142.78 31.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.294 -0.879 . . . . 54.01 109.507 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 203' ' ' THR . . . . . 0.419 ' OG1' ' CZ ' ' B' ' 214' ' ' PHE . 57.8 p -149.89 20.8 0.89 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.459 -0.776 . . . . 74.4 109.46 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 1.49 ' CG2' HH12 ' B' ' 192' ' ' ARG . 1.2 m -135.14 137.51 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.233 -0.917 . . . . 72.12 109.664 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -125.81 133.5 51.98 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.974 -0.75 . . . . 65.41 108.974 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 206' ' ' THR . . . . . 0.474 ' O ' HG23 ' B' ' 206' ' ' THR . 9.7 t -101.96 128.66 48.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.211 -0.931 . . . . 71.33 109.273 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 27.2 m -145.11 155.44 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.124 -0.985 . . . . 63.5 109.753 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -86.24 -13.05 47.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.276 -0.89 . . . . 74.45 109.815 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 64.7 mtp85 -55.45 -38.26 68.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.125 -0.984 . . . . 74.14 109.845 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 75.8 mtt-85 -148.44 -50.55 0.16 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.127 -0.983 . . . . 74.43 109.246 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 169.28 -113.82 0.53 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.455 -1.458 . . . . 64.45 109.455 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 212' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' B' ' 163' ' ' VAL . 65.0 m-85 -109.52 127.0 54.13 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.513 -0.992 . . . . 74.21 109.563 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 43.4 ttt180 -105.06 121.79 44.52 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.379 -0.826 . . . . 74.03 109.116 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 214' ' ' PHE . . . . . 0.906 ' CE2' HD23 ' B' ' 155' ' ' LEU . 8.3 t80 -94.53 118.61 31.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.297 -0.877 . . . . 74.34 109.007 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 35.6 t -119.97 136.58 54.48 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.724 -0.61 . . . . 64.33 109.633 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -58.89 149.32 65.75 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.275 -1.009 . . . . 70.04 108.275 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.73 -169.53 0.18 Allowed 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.999 1.799 . . . . 65.11 111.742 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 6.3 pttm -47.68 153.39 1.08 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.063 -1.023 . . . . 73.15 109.242 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -38.05 102.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.444 2.096 . . . . 71.31 112.713 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -86.75 10.56 15.49 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.149 -0.969 . . . . 75.45 108.956 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 53.9 m -66.37 140.5 58.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.436 -0.79 . . . . 72.22 109.621 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -60.81 142.05 56.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.331 -0.856 . . . . 54.53 109.331 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.001 -1.0 . . . . 71.13 109.454 179.992 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 tpp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.449 -0.575 . . . . 65.12 109.449 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.517 ' NH2' ' OD2' ' A' ' 28' ' ' ASP . 33.3 ttt85 -145.43 149.58 34.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.148 -0.97 . . . . 72.33 109.383 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 82.6 t -115.91 132.56 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.403 0.62 . . . . 71.42 109.768 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 5' ' ' LEU . 4.1 tp -99.56 115.44 29.38 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.829 -0.804 . . . . 65.12 108.829 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 4' ' ' LEU . 59.8 tp -114.61 104.01 11.57 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.554 -0.716 . . . . 62.43 109.357 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.6 mt -93.23 112.16 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.854 -1.154 . . . . 71.15 109.189 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -146.86 134.18 20.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.378 -0.827 . . . . 75.34 109.153 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.564 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -73.89 -30.63 62.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.957 . . . . 72.44 109.184 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -83.63 110.58 18.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.253 -0.904 . . . . 63.02 109.347 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.6 m -65.14 -32.82 74.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 72.34 109.911 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 81.4 t -64.23 -49.49 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 74.02 109.778 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.0 tp -60.93 -37.58 82.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 71.43 109.38 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.31 -27.88 62.95 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.684 -1.767 . . . . 61.32 108.684 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.09 -48.02 79.53 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.345 -1.502 . . . . 71.2 109.345 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -64.25 -43.54 94.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.389 -1.066 . . . . 71.32 109.579 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.9 mm -65.35 -38.34 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.837 -1.165 . . . . 63.23 108.519 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.44 ' CD ' HD21 ' A' ' 21' ' ' ASN . 14.9 tm-20 -61.22 -45.18 95.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.34 -0.85 . . . . 51.11 109.518 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -86.58 -1.41 57.63 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.138 -0.976 . . . . 73.34 109.642 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.36 -61.23 1.65 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.02 -1.632 . . . . 62.15 109.02 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pp -62.3 -29.09 70.19 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.487 -1.008 . . . . 73.51 109.031 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.44 HD21 ' CD ' ' A' ' 17' ' ' GLU . 86.1 m-20 -51.64 -36.16 45.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 74.25 109.0 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.8 t -53.59 -34.19 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.611 -0.885 . . . . 70.04 108.611 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.468 ' NZ ' HG21 ' A' ' 106' ' ' VAL . 28.8 mmtm -78.74 -4.83 51.2 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.685 -0.857 . . . . 73.23 108.685 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.94 44.92 8.7 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.639 -0.984 . . . . 75.54 110.639 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -119.06 159.68 23.45 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.264 -1.139 . . . . 73.43 109.017 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.3 mmt -103.65 139.17 39.29 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.541 -0.911 . . . . 43.24 108.541 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.417 ' O ' ' OD1' ' A' ' 28' ' ' ASP . . . -143.96 160.4 40.89 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.285 -0.884 . . . . 62.11 109.841 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.517 ' OD2' ' NH2' ' A' ' 2' ' ' ARG . 79.3 m-20 -135.96 149.9 49.06 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.954 -0.758 . . . . 74.42 108.954 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.46 133.92 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.756 -0.831 . . . . 72.15 108.756 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 p -134.65 168.21 19.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.471 -0.768 . . . . 71.42 109.42 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -93.09 -106.37 0.12 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.224 -0.922 . . . . 72.33 109.612 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.8 p -79.8 168.19 19.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.123 -0.986 . . . . 74.24 109.909 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.7 mt -53.84 -29.98 43.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.465 -0.772 . . . . 71.53 109.778 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -55.27 -47.97 74.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.108 -0.995 . . . . 74.23 109.938 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.48 -44.6 70.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.096 -1.003 . . . . 54.03 109.58 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.45 -40.65 86.54 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.589 -1.404 . . . . 61.41 109.589 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -66.0 -45.42 81.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -1.115 . . . . 74.34 109.784 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.26 -40.37 74.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.101 -0.999 . . . . 75.33 109.664 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.656 ' C ' HD23 ' A' ' 39' ' ' LEU . 7.0 tt -70.5 -56.33 6.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.307 -0.871 . . . . 74.33 110.022 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.49 ' SD ' ' OH ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -55.75 -27.69 52.02 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.129 -0.982 . . . . 70.32 110.047 -179.096 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -62.36 -37.23 84.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.104 -0.998 . . . . 71.22 110.111 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.0 pt -91.6 -1.6 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.091 -1.006 . . . . 74.14 110.416 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 40' ' ' MET . 19.4 mmt85 -130.02 145.77 51.67 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.292 -0.88 . . . . 72.24 109.73 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -89.43 152.54 21.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.28 -0.888 . . . . 75.42 108.997 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.49 ' OH ' ' SD ' ' A' ' 40' ' ' MET . 6.4 p90 -153.13 176.52 11.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.072 -1.017 . . . . 74.23 109.857 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -132.34 -38.7 1.05 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.552 -0.718 . . . . 72.04 109.832 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.523 ' C ' HD13 ' A' ' 47' ' ' LEU . 1.0 OUTLIER -103.32 112.17 24.92 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.332 -0.855 . . . . 72.13 109.255 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.513 ' N ' HD13 ' A' ' 47' ' ' LEU . 75.1 t -96.53 98.06 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.89 -0.781 . . . . 72.34 108.89 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.503 ' SD ' ' N ' ' A' ' 50' ' ' VAL . 3.3 tpp -110.08 127.76 55.04 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.626 0.727 . . . . 74.11 109.143 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.503 ' N ' ' SD ' ' A' ' 49' ' ' MET . 1.6 p -138.71 128.02 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.532 -0.73 . . . . 61.12 109.64 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.1 m -96.42 5.16 51.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.338 -0.851 . . . . 73.11 109.521 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.432 ' H ' HG22 ' A' ' 50' ' ' VAL . 54.3 m-20 -76.47 141.41 41.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.129 -0.982 . . . . 52.55 109.299 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.448 ' C ' ' H ' ' A' ' 55' ' ' ALA . 18.4 pttp -77.69 -38.81 46.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.145 -0.972 . . . . 44.22 110.453 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -72.17 12.84 0.37 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.015 -1.053 . . . . 70.44 109.498 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -75.48 -21.02 58.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 64.14 110.596 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 55' ' ' ALA . 58.7 mt -40.71 -52.45 2.94 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.366 -0.834 . . . . 44.14 110.428 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -67.02 -32.72 74.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.983 -1.073 . . . . 55.23 108.908 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.634 ' CE2' HD11 ' A' ' 62' ' ' ILE . 53.4 t80 -66.46 -59.29 3.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.435 -0.791 . . . . 74.44 109.911 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.5 m -51.67 -34.14 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.561 -1.337 . . . . 74.03 109.476 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.1 t -58.07 -55.48 34.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.129 -0.982 . . . . 64.3 109.718 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -64.72 -27.72 69.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.08 -1.012 . . . . 64.44 109.782 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.634 HD11 ' CE2' ' A' ' 58' ' ' PHE . 5.7 mm -65.39 -42.29 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.894 -1.129 . . . . 63.21 109.886 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 67' ' ' SER . 1.9 mmmm -67.65 -46.99 70.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.169 -0.957 . . . . 74.42 110.402 -179.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.413 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 14.3 pt-20 -69.91 -41.46 74.63 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.594 -1.316 . . . . 70.32 109.535 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.413 ' N ' ' CG ' ' A' ' 64' ' ' GLU . 52.1 mtpt -73.85 -22.29 59.81 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.232 -0.917 . . . . 75.22 109.169 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.612 ' O ' HG22 ' A' ' 69' ' ' ILE . 67.7 m80 -152.66 64.96 0.8 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.305 -0.872 . . . . 74.13 109.148 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 63' ' ' LYS . 22.7 t -59.23 -36.21 75.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.172 -0.955 . . . . 73.24 109.967 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.7 p -74.5 50.36 0.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.136 -0.978 . . . . 61.01 109.574 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 66' ' ' HIS . 11.2 tt -145.65 168.38 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.165 -0.959 . . . . 71.33 109.472 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.6 t -104.11 152.78 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.336 -0.852 . . . . 72.13 109.154 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.439 ' H ' ' HB2' ' A' ' 92' ' ' ASP . 4.8 t -143.55 120.71 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.15 -0.969 . . . . 54.21 109.197 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.547 ' HG ' HD11 ' A' ' 95' ' ' ILE . 3.5 mp -119.33 104.64 10.56 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.708 -0.849 . . . . 50.24 108.708 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 73' ' ' VAL . 13.6 p -94.78 130.71 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.264 -0.898 . . . . 74.41 109.148 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.6 p -90.85 165.48 13.59 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.152 -0.967 . . . . 72.31 108.923 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.442 ' C ' ' H ' ' A' ' 77' ' ' ASN . 11.8 m -159.53 115.65 2.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.031 -1.043 . . . . 64.54 109.91 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 49.9 p30 -72.64 11.23 0.67 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.376 -0.827 . . . . 74.13 109.128 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 79' ' ' THR . 4.4 t-20 -142.28 64.09 16.15 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.472 -0.767 . . . . 73.34 109.455 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.97 83.83 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.027 1.818 . . . . 63.22 111.716 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.488 ' N ' ' O ' ' A' ' 77' ' ' ASN . 28.5 p -115.38 156.6 25.26 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.194 -0.669 . . . . 62.53 109.194 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.2 t -64.64 -38.87 92.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.308 -0.87 . . . . 73.44 109.596 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.403 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 85.8 tt0 -55.41 -44.79 76.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 71.42 109.386 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -74.55 -30.51 61.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.144 -0.973 . . . . 73.43 109.478 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -63.06 -57.37 10.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.299 -0.875 . . . . 74.22 109.799 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.493 HG23 ' N ' ' A' ' 85' ' ' HIS . 30.0 m -58.91 -42.85 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.109 -0.994 . . . . 73.2 109.343 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.493 ' N ' HG23 ' A' ' 84' ' ' VAL . 24.2 m170 -63.51 -21.05 66.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.932 . . . . 53.33 109.583 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -76.18 -48.74 19.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.076 -1.015 . . . . 64.11 110.024 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.57 ' CE2' ' CZ ' ' B' ' 108' ' ' ARG . 86.0 m-85 -81.0 -28.42 35.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.026 -1.046 . . . . 74.34 109.351 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -73.69 -42.73 60.88 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.223 -0.923 . . . . 74.42 109.689 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -68.61 -50.47 51.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.082 -1.011 . . . . 74.24 109.711 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.56 64.47 0.01 OUTLIER Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.138 -1.185 . . . . 61.51 110.138 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -130.33 141.15 50.6 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.393 -1.063 . . . . 55.33 109.046 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.439 ' HB2' ' H ' ' A' ' 71' ' ' VAL . 0.9 OUTLIER -79.71 -39.19 31.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.086 -1.009 . . . . 73.42 109.562 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 71.2 m-20 -152.44 164.39 37.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 75.04 109.532 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.71 129.69 24.92 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.665 -0.865 . . . . 71.33 108.665 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.809 ' N ' HD12 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -124.02 145.42 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 121.444 0.64 . . . . 71.13 110.066 -178.864 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.01 130.21 44.49 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.176 -1.046 . . . . 64.32 108.176 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.655 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -51.42 -54.03 43.27 Favored Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.056 -1.028 . . . . 62.2 111.506 -179.0 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.7 Cg_endo -42.13 -11.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.228 0 CA-C-N 119.681 0.922 . . . . 73.11 112.558 -176.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.655 ' N ' ' O ' ' A' ' 97' ' ' LYS . 57.9 m-85 59.94 135.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.859 -0.525 . . . . 65.22 110.009 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 44.1 mtt-85 -73.7 -45.06 54.54 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.083 -1.011 . . . . 72.35 109.86 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.732 ' O ' ' N ' ' A' ' 103' ' ' LYS . 42.4 t -164.41 32.56 0.07 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.838 -1.164 . . . . 71.32 111.201 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.0 mm 52.42 -70.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.494 -0.754 . . . . 75.43 110.168 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.732 ' N ' ' O ' ' A' ' 101' ' ' SER . 13.8 mptt -57.86 -26.64 62.35 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.006 -1.109 . . . . 71.41 108.006 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.53 -46.67 46.28 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.853 -0.739 . . . . 63.24 109.697 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.7 tp -63.32 -58.72 6.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.935 . . . . 73.22 109.615 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.486 HG23 ' N ' ' A' ' 107' ' ' ALA . 9.1 m -52.22 -40.94 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.966 -1.084 . . . . 60.11 109.471 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.486 ' N ' HG23 ' A' ' 106' ' ' VAL . . . -55.71 -43.09 76.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.134 -0.979 . . . . 70.42 108.557 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -64.08 -30.89 71.93 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.357 -0.839 . . . . 74.41 109.069 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 55.6 mt -71.36 -35.2 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 107.969 -1.123 . . . . 62.54 107.969 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 114' ' ' ARG . 81.6 tt0 -62.39 -34.57 76.99 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.097 -0.705 . . . . 74.34 109.097 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.523 ' HB1' ' CE1' ' B' ' 87' ' ' PHE . . . -76.36 -59.73 2.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 73.32 109.654 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.412 ' H ' ' HD2' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -57.97 -9.71 1.47 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 52.41 109.483 -179.766 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.6 tp -140.53 82.48 1.85 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.213 -0.929 . . . . 65.24 109.84 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 110' ' ' GLU . 2.1 mmt180 -152.05 -50.11 0.11 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.318 -0.864 . . . . 64.45 108.897 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -89.34 14.14 11.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.282 -0.886 . . . . 74.43 110.001 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.406 ' O ' ' CG ' ' A' ' 116' ' ' TRP . 34.9 p-90 -68.08 125.33 26.0 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.057 -1.027 . . . . 74.42 109.721 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.409 ' O ' ' OG ' ' A' ' 118' ' ' SER . . . 139.79 135.62 3.27 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.186 -1.565 . . . . 75.04 109.186 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 117' ' ' GLY . 69.1 m -166.35 171.02 12.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.071 -1.252 . . . . 61.14 110.1 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.08 103.31 2.2 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.726 -0.842 . . . . 65.24 108.726 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 97.4 t -72.04 -29.67 33.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.087 -1.008 . . . . 73.11 109.132 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.15 131.5 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.603 -0.888 . . . . 72.24 108.603 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -149.12 128.4 12.91 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.129 -0.982 . . . . 72.34 109.542 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.864 HG21 ' NH1' ' A' ' 159' ' ' ARG . 9.3 tp -161.39 136.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.309 -0.869 . . . . 71.44 109.499 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 126' ' ' LEU . . . 59.13 -167.03 7.65 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.878 -1.289 . . . . 73.4 109.878 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -70.67 12.29 0.28 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.511 -0.993 . . . . 74.45 108.83 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.534 ' H ' ' C ' ' A' ' 124' ' ' GLY . 1.9 tt -110.06 131.2 55.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.698 -0.626 . . . . 54.21 109.514 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.8 p -131.0 142.87 50.38 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.325 -0.859 . . . . 54.5 108.716 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.46 HG21 ' CB ' ' A' ' 156' ' ' ALA . 94.6 mt -136.67 135.4 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.164 -0.96 . . . . 45.15 110.661 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.1 m -127.46 104.1 22.05 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.359 -0.978 . . . . 71.11 108.359 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.33 -25.38 2.65 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.475 2.116 . . . . 65.41 112.206 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -66.06 -38.46 88.37 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.307 -0.871 . . . . 63.32 108.843 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -98.08 9.06 43.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.375 -0.828 . . . . 72.52 109.64 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.675 ' HA ' ' HZ ' ' A' ' 149' ' ' PHE . 37.7 mt-10 47.72 60.48 3.5 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.206 -0.934 . . . . 75.33 109.617 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.512 ' C ' HD12 ' A' ' 135' ' ' ILE . 36.0 ttpt -154.03 130.6 10.67 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.047 -1.033 . . . . 71.23 110.098 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.561 ' N ' HD12 ' A' ' 135' ' ' ILE . 2.2 mp -111.89 138.22 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.488 -0.93 . . . . 74.02 108.488 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 19.4 mt -125.72 131.54 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.409 -0.807 . . . . 60.23 108.9 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.417 ' CE2' ' O ' ' A' ' 198' ' ' PRO . 10.3 p90 -139.12 139.22 37.58 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.099 -1.001 . . . . 62.32 109.984 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.1 mttt 53.73 27.87 7.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.522 -0.737 . . . . 75.4 110.175 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 77.88 14.08 82.73 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.905 -1.14 . . . . 72.24 110.437 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 -105.27 133.13 50.54 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.472 -1.016 . . . . 71.22 108.78 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -90.82 129.3 36.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.322 -0.861 . . . . 71.42 110.224 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 t -128.14 108.63 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.357 -0.979 . . . . 53.02 108.357 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -92.48 102.07 14.52 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.054 -1.091 . . . . 60.45 108.054 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.514 HG23 ' CD1' ' A' ' 149' ' ' PHE . 1.3 m -115.61 139.76 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.7 0.762 . . . . 74.44 110.705 -178.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -160.53 125.39 3.77 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.856 -0.794 . . . . 65.15 108.856 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.37 -143.18 10.06 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.674 -1.37 . . . . 73.34 109.674 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -70.91 -59.27 3.64 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.346 -1.09 . . . . 72.22 110.486 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.84 4.9 1.23 Allowed 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.997 1.798 . . . . 65.23 112.785 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.675 ' HZ ' ' HA ' ' A' ' 133' ' ' GLU . 65.3 t80 -101.66 -54.82 2.65 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.234 -0.916 . . . . 60.11 110.319 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.634 ' OE2' ' OE2' ' A' ' 177' ' ' GLU . 7.9 pt-20 -46.98 -36.0 7.24 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.158 -0.964 . . . . 64.21 109.574 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.8 p -78.82 -31.26 15.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.169 -0.957 . . . . 72.02 109.137 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.532 HD11 ' SD ' ' A' ' 195' ' ' MET . 13.8 tp -63.56 -38.81 92.53 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.127 -0.983 . . . . 73.31 109.039 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.1 p -75.91 -32.75 59.76 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.08 -1.013 . . . . 74.31 108.592 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.462 ' O ' ' CD2' ' A' ' 158' ' ' HIS . 44.4 t-80 -55.13 -51.01 67.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.607 -0.683 . . . . 74.31 110.5 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.92 -33.41 65.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.988 -1.07 . . . . 75.34 109.887 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.46 ' CB ' HG21 ' A' ' 128' ' ' ILE . . . -50.45 -44.62 55.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.981 -1.074 . . . . 62.14 109.683 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 -77.66 -43.75 30.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.091 -1.006 . . . . 61.03 110.234 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.462 ' CD2' ' O ' ' A' ' 154' ' ' HIS . 34.0 m-70 -82.54 34.89 0.44 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 74.12 110.803 -178.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.864 ' NH1' HG21 ' A' ' 123' ' ' ILE . 30.8 ttp180 -64.61 169.28 5.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.807 -1.183 . . . . 71.13 107.927 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 4.4 p30 41.44 55.68 3.38 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.378 -0.826 . . . . 75.45 110.082 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -158.4 156.14 29.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 73.41 109.132 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.624 HD12 ' N ' ' A' ' 162' ' ' ILE . 2.5 mp -83.71 123.1 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.177 -0.952 . . . . 74.41 108.463 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 48.2 t -118.05 127.67 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.486 -0.759 . . . . 72.31 110.051 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.8 t -100.69 148.02 25.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.519 -0.738 . . . . 74.12 109.558 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -49.41 -49.75 43.52 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.482 -0.761 . . . . 70.43 109.816 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -51.88 -36.93 50.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.069 -1.02 . . . . 73.52 109.476 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -59.03 -43.35 91.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.976 -1.078 . . . . 74.52 109.115 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 18.5 mt -56.14 -37.22 69.2 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.245 -0.909 . . . . 72.31 108.549 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.603 HD21 ' CG1' ' A' ' 184' ' ' ILE . 92.8 mt -64.73 -74.68 0.1 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.566 -1.254 . . . . 53.33 109.019 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -45.92 -14.43 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.885 . . . . 62.44 110.516 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 169' ' ' LEU . . . -93.42 -37.54 11.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.063 -1.023 . . . . 60.21 111.428 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.416 ' N ' ' CD1' ' A' ' 172' ' ' ILE . 1.4 mp -95.42 -56.58 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 120.954 -1.091 . . . . 75.32 110.446 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -82.52 143.88 30.79 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.406 -1.434 . . . . 73.14 109.229 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -172.27 -28.46 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.716 -0.615 . . . . 73.24 109.352 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.796 ' H ' ' CD ' ' A' ' 176' ' ' PRO . 13.5 tp10 -149.3 -38.76 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.204 -0.935 . . . . 44.43 111.133 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.796 ' CD ' ' H ' ' A' ' 175' ' ' GLU . 96.1 Cg_endo -95.23 -71.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.319 -1.0 0 C-N-CA 122.652 2.235 . . . . 72.51 112.6 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.634 ' OE2' ' OE2' ' A' ' 150' ' ' GLU . 47.9 mt-10 -59.23 155.59 13.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.213 -0.93 . . . . 63.24 109.657 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.426 ' O ' ' O ' ' A' ' 179' ' ' VAL . 17.0 ptt? -123.24 -5.64 8.33 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.034 -0.728 . . . . 73.5 109.034 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 178' ' ' MET . 3.3 t 48.96 99.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.47 -0.769 . . . . 65.22 110.442 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -56.05 163.38 2.28 Favored Pre-proline 0 N--CA 1.49 1.526 0 N-CA-C 107.657 -1.238 . . . . 71.42 107.657 178.71 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -37.84 -22.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.344 2.03 . . . . 41.22 112.352 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 180' ' ' THR . 35.3 p-10 -156.42 119.39 4.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.206 -0.934 . . . . 64.54 109.292 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.3 t -145.34 -31.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.235 -0.916 . . . . 74.02 110.176 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.875 HD12 ' H ' ' A' ' 184' ' ' ILE . 2.4 mp -57.85 -34.82 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.065 -1.022 . . . . 72.33 109.898 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -52.82 -50.05 64.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.242 -0.911 . . . . 74.4 109.641 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 186' ' ' VAL . 16.7 m -77.8 -31.08 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.18 -0.95 . . . . 70.42 109.961 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.58 -51.08 68.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.926 -1.109 . . . . 52.11 109.915 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.424 HG23 ' N ' ' A' ' 189' ' ' ASN . 3.5 tp -68.03 -43.27 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.879 -1.138 . . . . 71.4 110.032 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.467 ' ND2' ' OE1' ' A' ' 193' ' ' GLN . 7.9 t-20 -60.38 -37.93 82.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.895 -1.128 . . . . 73.44 108.676 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -71.93 -50.87 25.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.551 -0.718 . . . . 71.42 110.618 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 69.5 mt -52.7 -58.5 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.053 -1.029 . . . . 61.55 109.914 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.421 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 3.3 mtp85 -51.14 -41.92 60.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.075 -1.016 . . . . 63.34 109.008 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.467 ' OE1' ' ND2' ' A' ' 189' ' ' ASN . 16.4 mt-30 -71.02 -24.05 62.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.995 -1.066 . . . . 61.24 109.932 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.447 ' O ' ' CG ' ' A' ' 198' ' ' PRO . 4.7 mtpm? -101.0 -0.27 36.81 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.289 -0.882 . . . . 75.13 110.573 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' MET . . . . . 0.532 ' SD ' HD11 ' A' ' 152' ' ' LEU . 0.6 OUTLIER -109.15 -19.11 13.46 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.2 -0.937 . . . . 74.02 110.02 -179.367 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 192' ' ' ARG . 14.0 p-10 -98.28 -5.28 33.4 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.158 -0.964 . . . . 74.02 110.164 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.485 ' H ' ' HD2' ' A' ' 198' ' ' PRO . 26.9 mttp -103.23 -64.86 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.125 0 O-C-N 121.355 -0.84 . . . . 75.43 110.575 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.485 ' HD2' ' H ' ' A' ' 197' ' ' LYS . 29.9 Cg_endo -61.42 -57.41 0.58 Allowed 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 121.966 1.777 . . . . 72.32 112.013 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.9 mp -69.55 -43.11 73.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 74.54 109.383 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 94.3 -26.97 14.8 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.254 -1.138 . . . . 61.51 110.254 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.755 ' N ' HD12 ' A' ' 201' ' ' ILE . 3.1 mp -98.68 133.54 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.97 -1.312 . . . . 61.22 110.289 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 14.6 m -106.14 139.18 41.07 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.118 -1.067 . . . . 72.0 108.118 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.4 p -141.58 42.96 1.74 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.063 -1.023 . . . . 74.44 110.128 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.529 ' CG1' ' CE2' ' A' ' 214' ' ' PHE . 1.0 OUTLIER -143.11 155.06 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.28 -0.888 . . . . 64.35 109.727 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -128.34 134.1 48.8 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.712 -0.847 . . . . 71.41 108.712 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.4 t -95.1 133.28 39.08 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.046 -1.034 . . . . 73.52 109.259 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 10.5 p -156.25 142.78 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.787 -1.196 . . . . 71.02 109.531 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -64.85 -41.06 96.01 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.379 -0.825 . . . . 72.12 109.539 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 1.077 HH21 ' NH2' ' A' ' 213' ' ' ARG . 0.8 OUTLIER -58.12 152.8 16.07 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.824 -0.806 . . . . 64.41 108.824 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 209' ' ' ARG . 9.6 mpt_? 42.9 -94.17 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.23 -0.919 . . . . 71.54 109.789 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . -171.42 -114.09 0.31 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.469 -1.452 . . . . 72.03 109.469 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -111.06 140.34 45.68 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.478 -1.013 . . . . 75.54 109.055 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 1.077 ' NH2' HH21 ' A' ' 209' ' ' ARG . 36.6 mtt180 -105.51 142.65 34.88 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.319 -0.863 . . . . 75.31 109.677 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.529 ' CE2' ' CG1' ' A' ' 204' ' ' VAL . 33.8 m-85 -115.78 112.83 22.58 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.49 -0.93 . . . . 75.41 108.49 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 8.2 p -119.35 160.6 21.96 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.628 -0.67 . . . . 74.14 109.847 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' TYR . . . . . 0.462 ' CD1' ' O ' ' A' ' 217' ' ' PRO . 36.7 p90 -68.92 151.1 97.42 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.394 -0.816 . . . . 75.32 109.229 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.462 ' O ' ' CD1' ' A' ' 216' ' ' TYR . 84.4 Cg_exo -37.07 154.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.28 1.987 . . . . 73.11 112.253 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.647 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 19.0 pttm -98.56 -19.06 0.21 Allowed Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.171 -0.956 . . . . 75.25 112.965 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 49.3 Cg_endo -87.57 -15.38 3.42 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.622 1.548 . . . . 75.1 112.346 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -51.06 -36.67 41.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.466 -0.771 . . . . 71.14 110.011 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 2.0 p -60.05 135.53 57.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.012 -1.055 . . . . 71.13 109.609 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -93.45 -160.99 0.8 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.327 -0.858 . . . . 75.35 109.671 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.983 -1.008 . . . . 73.41 109.374 -179.877 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.527 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.435 -0.58 . . . . 71.14 109.435 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.557 HH21 ' C ' ' B' ' 44' ' ' ASN . 8.1 ttp180 -139.89 150.38 44.53 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.357 -0.84 . . . . 73.23 109.067 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 92.6 t -116.03 129.93 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.537 -0.912 . . . . 72.24 108.537 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.582 HD21 HD11 ' B' ' 6' ' ' ILE . 5.5 tp -101.89 118.34 36.72 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.513 -0.742 . . . . 54.33 110.002 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 16.4 mt -114.6 111.28 21.09 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 108.412 -0.958 . . . . 74.35 108.412 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.656 HD12 ' HB ' ' B' ' 50' ' ' VAL . 66.3 mt -107.94 115.4 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.417 -0.802 . . . . 42.55 109.246 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' B' ' 7' ' ' GLU . 1.4 pm0 -160.08 140.74 12.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 74.52 109.417 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -63.68 -31.15 72.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 62.55 109.319 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -86.5 106.97 17.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.252 -0.905 . . . . 73.11 109.524 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 47.8 m -72.44 -29.14 63.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 65.54 109.847 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 90.9 t -56.79 -49.97 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.155 -0.965 . . . . 75.55 109.657 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.519 ' N ' HD22 ' B' ' 12' ' ' LEU . 3.6 mm? -63.02 -35.21 79.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 70.14 109.188 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.78 -25.47 74.89 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 108.635 -1.786 . . . . 75.4 108.635 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.79 -54.13 27.05 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.36 -1.496 . . . . 65.44 109.36 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -57.42 -46.27 83.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.4 -1.059 . . . . 60.21 109.68 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 37.5 mm -62.52 -38.88 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.866 -1.146 . . . . 75.15 108.652 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.423 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 80.0 tt0 -61.79 -43.1 99.53 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.408 -0.807 . . . . 73.01 109.508 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -87.66 2.6 50.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.186 -0.946 . . . . 74.3 109.177 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.76 -55.95 2.06 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.457 -1.457 . . . . 70.54 109.457 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -71.44 -21.99 61.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.242 -1.151 . . . . 71.34 109.633 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 88.0 m-20 -52.44 -33.91 46.24 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.215 -0.928 . . . . 64.41 109.646 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 81.8 t -59.51 -32.71 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.152 -0.968 . . . . 74.23 109.212 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -79.23 -4.79 52.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.358 -0.839 . . . . 63.42 109.193 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.17 36.35 18.21 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.264 -1.135 . . . . 53.43 110.264 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -113.76 160.01 19.14 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.463 -1.022 . . . . 71.12 108.938 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.4 mmt -107.14 140.49 39.91 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.386 -0.821 . . . . 75.24 109.09 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.02 164.74 26.95 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.491 -0.755 . . . . 72.12 109.499 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -141.24 145.58 35.75 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.372 -0.83 . . . . 72.31 108.964 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 m -113.63 137.14 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.785 . . . . 64.43 109.068 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 10.0 p -144.56 164.47 30.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.288 -0.883 . . . . 65.41 109.367 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.447 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 1.6 pt-20 -91.57 -97.24 0.12 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.242 -0.911 . . . . 71.02 109.579 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 42.4 t -79.48 166.59 21.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.192 -0.942 . . . . 51.11 109.96 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' B' ' 37' ' ' GLU . 16.7 mt -55.25 -32.0 61.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.592 -0.693 . . . . 71.24 110.134 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -54.3 -44.86 72.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.09 -1.006 . . . . 74.32 110.2 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.447 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 19.0 m-20 -66.34 -42.96 87.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.051 -1.031 . . . . 73.03 109.651 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.58 -28.48 59.38 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.629 -1.388 . . . . 30.21 109.629 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' B' ' 33' ' ' LEU . 84.7 tt0 -67.18 -46.79 72.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -1.15 . . . . 74.42 109.695 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' TYR . . . . . 0.443 ' O ' ' OD1' ' B' ' 41' ' ' ASP . 70.2 t80 -75.06 -26.59 59.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.258 -0.901 . . . . 74.42 110.036 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 9.6 tp -84.84 -30.86 24.17 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.17 -0.956 . . . . 75.41 110.031 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' MET . . . . . 0.489 ' SD ' ' OH ' ' B' ' 45' ' ' TYR . 0.0 OUTLIER -86.83 -30.61 21.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.961 . . . . 60.41 110.317 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' B' ' 42' ' ' ILE . 56.2 p-10 -71.07 -21.4 62.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.878 -1.139 . . . . 53.23 110.043 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.528 ' N ' ' OD1' ' B' ' 41' ' ' ASP . 12.5 pt -80.94 -29.95 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.03 -1.044 . . . . 71.23 110.005 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.485 ' C ' ' NH2' ' B' ' 2' ' ' ARG . 26.2 mmt180 -129.13 171.13 12.71 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.376 -0.828 . . . . 72.22 109.791 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' ASN . . . . . 0.557 ' C ' HH21 ' B' ' 2' ' ' ARG . 24.5 m120 -98.87 154.21 18.21 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.076 -1.015 . . . . 63.54 109.809 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.586 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 1.3 p90 -140.52 -177.36 5.01 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.353 -0.842 . . . . 64.35 109.09 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' ASP . . . . . 0.443 ' OD2' ' CD1' ' B' ' 116' ' ' TRP . 63.4 t0 -133.28 -43.6 0.85 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.253 -0.904 . . . . 62.22 110.256 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.533 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.5 OUTLIER -102.01 114.51 28.68 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.276 -0.89 . . . . 73.12 109.082 -179.597 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.533 ' N ' HD13 ' B' ' 47' ' ' LEU . 50.6 t -98.63 97.37 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.238 -1.023 . . . . 65.11 108.238 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.457 ' O ' ' O ' ' B' ' 4' ' ' LEU . 22.5 ttt -111.82 130.37 55.83 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.716 0.769 . . . . 73.44 109.891 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.656 ' HB ' HD12 ' B' ' 6' ' ' ILE . 0.4 OUTLIER -145.8 137.84 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.358 -0.839 . . . . 34.5 109.491 -179.579 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 42.8 p -102.53 2.94 36.92 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.579 -0.701 . . . . 73.21 109.788 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.412 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 27.4 m-20 -76.41 134.29 39.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.147 -0.97 . . . . 70.41 109.377 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' B' ' 55' ' ' ALA . 62.6 mttp -70.24 -37.79 75.05 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.275 -0.891 . . . . 65.0 110.46 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -69.96 6.71 1.13 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.969 -1.082 . . . . 75.21 109.703 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.418 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -75.35 -22.5 57.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 55.33 110.346 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 42.0 mt -44.46 -39.59 4.89 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.328 -0.857 . . . . 63.14 110.048 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 83.8 p -76.88 -37.39 55.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.041 -1.037 . . . . 63.5 109.466 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -66.08 -42.87 88.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.387 -0.821 . . . . 72.33 110.148 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.406 HG23 ' N ' ' B' ' 60' ' ' SER . 35.9 m -68.17 -37.74 78.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 120.68 -1.262 . . . . 74.54 109.121 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.406 ' N ' HG23 ' B' ' 59' ' ' VAL . 9.5 t -53.84 -49.61 68.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 71.24 109.472 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -68.32 -35.6 78.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.138 -0.976 . . . . 74.31 110.069 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 5.4 mm -63.22 -39.35 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.806 -1.184 . . . . 72.14 109.903 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' B' ' 67' ' ' SER . 6.9 mtpm? -67.13 -50.97 59.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.076 -1.015 . . . . 73.32 110.42 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -69.32 -38.19 78.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.852 -1.155 . . . . 73.12 109.765 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.503 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 25.8 mtpp -78.77 -20.52 49.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 72.44 109.346 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.55 ' O ' HG22 ' B' ' 69' ' ' ILE . 97.9 m-70 -156.88 65.73 0.52 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 63.31 109.326 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.469 ' N ' ' O ' ' B' ' 63' ' ' LYS . 86.4 p -61.22 -30.63 70.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 73.1 109.984 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 78.6 p -69.01 47.06 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.152 -0.967 . . . . 71.53 109.785 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.55 HG22 ' O ' ' B' ' 66' ' ' HIS . 16.0 tt -146.43 163.99 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.152 -0.968 . . . . 74.4 109.541 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 41.3 t -103.33 148.96 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.308 -0.87 . . . . 75.12 109.504 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 t -135.66 124.51 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.3 -0.875 . . . . 73.2 109.841 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.546 HD23 ' C ' ' B' ' 72' ' ' LEU . 4.5 tt -116.8 104.31 11.2 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.107 -0.701 . . . . 73.34 109.107 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.72 132.51 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.073 -1.017 . . . . 73.5 109.213 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 7.8 p -93.56 170.78 9.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.143 -0.973 . . . . 64.34 109.154 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.437 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 11.9 t -152.1 122.81 7.42 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.942 -1.099 . . . . 74.53 110.523 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 51.3 p30 -68.2 1.36 2.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.461 -0.775 . . . . 64.5 109.745 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' B' ' 79' ' ' THR . 38.9 t-20 -171.55 81.3 0.5 Allowed Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.248 -0.907 . . . . 74.25 109.494 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.464 ' CG ' ' HB2' ' B' ' 96' ' ' ALA . 97.4 Cg_exo -42.55 87.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.205 1.937 . . . . 74.43 111.943 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.505 ' N ' ' O ' ' B' ' 77' ' ' ASN . 3.0 p -100.5 155.83 17.62 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.177 -0.675 . . . . 73.12 109.177 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.2 -36.38 83.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.386 -0.821 . . . . 71.01 109.591 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -63.37 -40.81 98.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 63.2 109.93 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' GLU . . . . . 0.418 ' OE1' ' OG ' ' B' ' 75' ' ' SER . 78.1 tt0 -73.57 -34.37 65.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.152 -0.967 . . . . 73.22 109.998 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.407 ' OE1' ' N ' ' B' ' 84' ' ' VAL . 14.6 tm-20 -61.88 -56.68 16.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 74.3 109.711 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.445 HG23 ' N ' ' B' ' 85' ' ' HIS . 34.6 m -58.66 -39.09 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.16 -0.962 . . . . 73.31 109.299 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 85' ' ' HIS . . . . . 0.445 ' N ' HG23 ' B' ' 84' ' ' VAL . 19.7 m170 -69.38 -28.02 65.82 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 73.24 109.403 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.25 -36.39 81.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.128 -0.982 . . . . 55.33 109.732 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' PHE . . . . . 0.523 ' CE1' ' HB1' ' A' ' 111' ' ' ALA . 68.5 t80 -82.33 -38.41 24.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.058 -1.026 . . . . 74.14 108.879 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -70.47 -38.25 74.41 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.346 -0.846 . . . . 64.04 109.653 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -74.97 -57.56 3.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.933 . . . . 72.35 109.358 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 153.63 80.82 0.03 OUTLIER Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.036 -1.225 . . . . 65.2 110.036 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -139.82 115.43 10.05 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.247 -1.149 . . . . 52.23 109.256 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' B' ' 93' ' ' ASP . 18.9 t70 -73.9 -29.56 62.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.926 . . . . 73.32 108.864 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 93' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' B' ' 92' ' ' ASP . 48.2 m-20 -139.01 164.0 30.91 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.507 -0.923 . . . . 72.22 108.507 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.437 ' OH ' ' CB ' ' B' ' 75' ' ' SER . 89.1 t80 -151.14 103.32 3.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.126 -0.984 . . . . 64.42 109.26 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 28.0 mm -114.77 149.37 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 O-C-N 121.332 -0.855 . . . . 72.23 110.499 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' ALA . . . . . 0.498 ' HB1' ' HD2' ' B' ' 98' ' ' PRO . . . -62.12 143.85 56.13 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.757 -1.201 . . . . 25.24 107.757 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.593 ' N ' ' CD ' ' B' ' 98' ' ' PRO . 0.0 OUTLIER -68.33 -40.8 21.82 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.857 -1.152 . . . . 64.32 111.104 -178.701 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 98' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' B' ' 97' ' ' LYS . 39.0 Cg_exo -52.01 -2.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.289 -2.595 0 CA-C-N 118.696 0.57 . . . . 63.33 112.188 -174.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 99' ' ' TYR . . . . . 0.578 ' N ' ' O ' ' B' ' 97' ' ' LYS . 58.5 m-85 54.69 95.28 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.711 -0.618 . . . . 75.13 110.68 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 36.2 mtt85 -56.1 -38.31 70.56 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.7 -1.222 . . . . 74.23 107.7 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 10.2 t -172.68 125.97 0.48 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.644 -0.873 . . . . 63.34 108.644 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' ILE . . . . . 0.4 ' H ' HG13 ' B' ' 102' ' ' ILE . 58.3 mt -50.26 -40.06 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.06 -1.025 . . . . 74.44 109.363 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -61.79 -38.23 87.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.201 -0.937 . . . . 71.11 109.193 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.71 -49.49 65.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 71.45 109.346 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.401 HD11 HD11 ' B' ' 72' ' ' LEU . 65.1 tp -62.28 -44.45 96.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 51.31 109.149 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.98 -39.94 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.217 -0.927 . . . . 65.23 109.484 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.37 -39.09 66.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.094 -1.004 . . . . 24.32 108.961 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 0.57 ' CZ ' ' CE2' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -72.17 -34.66 68.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.421 -0.799 . . . . 75.31 109.42 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 97.3 mt -75.53 -27.36 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.208 -0.933 . . . . 54.24 109.33 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -73.51 -56.68 4.72 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.343 -0.848 . . . . 65.31 109.477 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.72 -36.11 69.31 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 72.24 109.906 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' ARG . . . . . 0.467 ' NH2' HH22 ' B' ' 108' ' ' ARG . 0.0 OUTLIER -66.28 -51.4 57.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.171 -0.956 . . . . 72.04 110.179 -179.467 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' B' ' 116' ' ' TRP . 64.2 mt -74.8 -33.07 62.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.089 -1.007 . . . . 75.35 110.277 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -48.92 -37.57 20.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.936 -1.102 . . . . 75.5 109.456 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -81.08 -2.45 48.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.911 . . . . 65.33 109.3 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' TRP . . . . . 0.443 ' CD1' ' OD2' ' B' ' 46' ' ' ASP . 88.2 t90 -55.33 -35.79 65.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 74.45 109.577 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.32 106.69 2.43 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.614 -1.394 . . . . 44.21 109.614 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 42.8 m -154.92 166.95 31.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -1.159 . . . . 71.4 109.702 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -158.0 120.78 3.83 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.875 -0.787 . . . . 72.32 108.875 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 19.3 t -87.36 -43.08 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.146 -0.971 . . . . 75.02 109.395 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 16.1 mm -99.2 137.2 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.277 -0.89 . . . . 51.41 109.431 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -135.59 100.48 4.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.446 -0.784 . . . . 71.53 109.048 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 31.2 mm -113.53 132.18 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.5 -0.75 . . . . 72.43 109.472 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 44.16 -128.22 6.67 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.034 -1.226 . . . . 51.23 110.034 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -97.38 -10.25 25.88 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.323 -1.104 . . . . 74.2 109.711 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.458 HD23 ' H ' ' B' ' 126' ' ' LEU . 0.2 OUTLIER -96.97 137.13 36.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.137 -0.977 . . . . 75.42 109.298 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 27.6 p -119.62 144.99 46.83 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.589 -0.694 . . . . 74.22 109.441 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 56.2 mt -124.46 129.26 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.514 -0.741 . . . . 60.33 109.367 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 6.3 m -109.7 118.22 50.73 Favored Pre-proline 0 N--CA 1.497 1.876 0 N-CA-C 108.858 -0.794 . . . . 72.31 108.858 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.618 ' CB ' ' HE ' ' B' ' 157' ' ' ARG . 97.3 Cg_endo -79.18 -56.88 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.751 1.634 . . . . 75.13 112.211 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -59.74 -43.15 94.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.154 -0.966 . . . . 75.23 109.545 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -81.33 -12.84 58.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 72.43 109.303 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 52.07 55.07 9.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 75.13 109.363 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 134' ' ' LYS . . . . . 0.409 ' NZ ' ' CZ3' ' B' ' 116' ' ' TRP . 35.7 ttpt -137.19 133.7 35.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.482 -0.761 . . . . 73.22 109.267 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 135' ' ' ILE . . . . . 0.403 HG23 ' O ' ' B' ' 135' ' ' ILE . 13.5 tt -117.14 132.69 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.53 -0.731 . . . . 64.14 109.441 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 14.0 mt -112.04 125.07 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.55 -0.718 . . . . 71.22 109.146 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -139.75 140.35 36.71 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.326 -0.859 . . . . 64.22 109.728 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt 53.98 19.05 1.86 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.37 -0.831 . . . . 72.02 110.011 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.38 16.42 64.41 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 120.087 -1.054 . . . . 74.32 110.614 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -112.29 127.8 56.09 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.365 -1.079 . . . . 75.34 109.493 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -93.9 127.01 39.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.249 -0.907 . . . . 71.23 109.629 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 98.7 t -137.52 136.48 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.412 -0.805 . . . . 70.43 109.254 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 143' ' ' GLU . . . . . 0.457 ' CD ' ' N ' ' B' ' 143' ' ' GLU . 42.9 mp0 -92.82 144.31 25.41 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.219 -0.926 . . . . 72.43 109.45 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 144' ' ' VAL . . . . . 0.472 HG23 ' O ' ' B' ' 144' ' ' VAL . 34.1 m -143.55 125.84 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.195 -0.941 . . . . 72.13 109.17 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.37 117.45 11.81 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.379 -0.826 . . . . 72.02 109.255 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.7 171.02 33.22 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.515 -1.434 . . . . 42.23 109.515 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 4.4 mtmm -68.67 -38.26 11.73 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.202 -1.175 . . . . 73.3 109.961 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 148' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 36.1 Cg_exo -59.61 -34.85 96.51 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.105 1.87 . . . . 71.33 111.929 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -88.47 -18.07 29.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.368 -0.832 . . . . 74.23 109.622 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -57.45 -40.02 77.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 72.34 109.644 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.46 HG13 ' N ' ' B' ' 152' ' ' LEU . 9.6 p -61.76 -39.09 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.943 . . . . 73.35 109.585 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.46 ' N ' HG13 ' B' ' 151' ' ' VAL . 41.2 tp -60.56 -41.45 94.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 55.24 109.096 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 17.7 p -76.87 -30.99 56.48 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.261 -0.899 . . . . 70.01 109.258 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -58.4 -51.24 70.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 65.32 109.585 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.478 HD13 HH22 ' B' ' 159' ' ' ARG . 1.9 pp -72.99 -28.29 62.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -0.942 . . . . 71.54 109.542 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -54.47 -46.08 73.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.957 . . . . 75.32 109.507 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.618 ' HE ' ' CB ' ' B' ' 130' ' ' PRO . 43.3 mtt85 -75.75 -43.96 44.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.203 -0.936 . . . . 73.32 109.457 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -77.04 26.37 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.349 -0.844 . . . . 74.14 109.903 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 159' ' ' ARG . . . . . 0.478 HH22 HD13 ' B' ' 155' ' ' LEU . 3.0 tpm_? -49.66 157.04 0.59 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.097 -1.002 . . . . 61.41 108.873 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 160' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' B' ' 160' ' ' ASP . 4.9 p-10 42.81 54.57 4.62 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.473 -0.767 . . . . 72.1 110.13 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -146.44 156.05 43.01 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.175 -0.953 . . . . 72.25 109.368 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 26.2 mt -98.91 138.98 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.263 -0.898 . . . . 72.31 109.379 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 9.5 m -140.73 143.52 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.33 -0.857 . . . . 64.21 109.57 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 83.7 p -94.48 161.48 14.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.285 -0.884 . . . . 74.22 109.214 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -53.78 -38.55 64.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.2 -0.938 . . . . 65.31 109.255 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -64.54 -36.85 85.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.867 . . . . 63.45 109.445 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 10.5 tm0? -56.26 -45.38 80.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.898 . . . . 72.4 109.123 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 33.1 mt -65.02 -33.83 76.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 72.32 108.919 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.562 HD23 ' C ' ' B' ' 169' ' ' LEU . 4.0 tt -53.53 -60.64 3.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.43 -0.794 . . . . 73.34 109.558 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -66.83 -27.85 67.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.371 -0.831 . . . . 72.1 110.232 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.26 -57.6 11.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.14 -0.975 . . . . 62.13 110.064 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.684 HD12 ' N ' ' B' ' 172' ' ' ILE . 2.0 mp -94.65 -59.0 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.06 -1.025 . . . . 71.42 109.291 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 23.2 m-90 -89.61 89.75 7.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.265 -0.897 . . . . 72.23 109.527 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 174' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' B' ' 175' ' ' GLU . 14.6 pt-20 -100.23 -171.15 1.98 Allowed 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.584 -0.895 . . . . 52.11 108.584 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 175' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' B' ' 174' ' ' GLU . 29.6 mt-10 56.54 152.93 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 109.734 -0.469 . . . . 73.04 109.734 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -38.91 109.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 122.172 1.915 . . . . 74.13 112.294 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -143.54 123.99 13.94 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.208 -0.932 . . . . 72.44 109.299 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 178' ' ' MET . . . . . 0.468 ' C ' ' H ' ' B' ' 180' ' ' THR . 65.4 mtt -85.5 20.35 2.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.245 -0.91 . . . . 63.43 109.449 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 179' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' B' ' 180' ' ' THR . 13.1 m -51.01 -10.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 71.05 109.641 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 180' ' ' THR . . . . . 0.468 ' H ' ' C ' ' B' ' 178' ' ' MET . 3.2 m 61.96 134.17 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 N-CA-C 109.162 -0.681 . . . . 62.15 109.162 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 181' ' ' PRO . . . . . 0.432 ' O ' ' OE1' ' B' ' 185' ' ' GLU . 67.4 Cg_endo -73.25 -10.07 23.84 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 121.826 1.684 . . . . 65.22 112.017 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 182' ' ' ASN . . . . . 0.426 ' O ' ' OE1' ' B' ' 185' ' ' GLU . 19.9 t-20 -61.65 -27.29 68.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 72.31 110.111 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 9.7 m -77.29 -17.53 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.097 -1.002 . . . . 63.32 110.114 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 87.9 mt -58.36 -52.41 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.103 -0.998 . . . . 75.03 110.034 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 185' ' ' GLU . . . . . 0.63 ' CD ' ' H ' ' B' ' 185' ' ' GLU . 1.6 pm0 -55.33 -33.93 63.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.134 -0.979 . . . . 64.11 109.318 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 91.7 t -75.26 -47.63 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 73.0 109.934 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.78 -50.18 65.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -0.999 . . . . 61.12 110.166 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 188' ' ' ILE . . . . . 0.431 HG23 ' N ' ' B' ' 189' ' ' ASN . 16.1 tt -57.79 -39.87 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.025 -1.047 . . . . 72.43 109.764 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 189' ' ' ASN . . . . . 0.431 ' N ' HG23 ' B' ' 188' ' ' ILE . 47.6 t30 -61.38 -46.37 90.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.104 -0.997 . . . . 65.14 109.545 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -68.51 -45.2 72.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 63.24 109.764 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 85.5 mt -54.98 -41.75 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.226 -0.921 . . . . 74.03 109.288 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -60.77 -47.15 87.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 72.24 109.287 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -66.21 -36.15 82.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.894 . . . . 73.1 109.533 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 194' ' ' LYS . . . . . 0.46 ' CB ' ' NZ ' ' B' ' 194' ' ' LYS . 7.8 mtpm? -81.29 -6.45 58.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.882 . . . . 72.11 109.566 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 28.1 ttt -92.92 -54.71 3.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.233 -0.917 . . . . 44.33 109.406 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 196' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' B' ' 200' ' ' GLY . 91.2 m-20 -62.6 -33.05 74.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 71.21 109.745 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 197' ' ' LYS . . . . . 0.449 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 0.0 OUTLIER -54.6 -65.15 1.43 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.17 -0.956 . . . . 75.21 109.785 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 198' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 36.9 Cg_endo -63.36 -53.44 1.45 Allowed 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.143 1.896 . . . . 75.32 112.213 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 29.7 mt -66.78 -34.28 77.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.19 -0.944 . . . . 72.25 109.679 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 200' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' B' ' 196' ' ' ASP . . . 80.41 -40.08 2.37 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.472 -1.451 . . . . 64.53 109.472 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 64.6 mt -93.67 137.49 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.273 -1.133 . . . . 44.23 109.279 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 28.6 p -81.4 134.21 35.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 54.01 109.361 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 25.9 p -131.3 -7.81 3.78 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.472 -0.767 . . . . 74.4 109.519 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 3.6 m -105.13 133.45 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.342 -0.848 . . . . 72.12 109.485 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -99.36 127.32 45.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.346 -0.846 . . . . 65.41 109.299 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.92 127.68 44.02 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.235 -0.915 . . . . 71.33 109.24 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.503 HG12 ' H ' ' B' ' 209' ' ' ARG . 9.1 t -139.78 139.46 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.262 -0.899 . . . . 63.5 109.423 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -85.33 11.68 9.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.197 -0.94 . . . . 74.45 109.466 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 209' ' ' ARG . . . . . 0.503 ' H ' HG12 ' B' ' 207' ' ' VAL . 16.5 tpt85 -74.26 -128.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.924 . . . . 74.14 109.562 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -57.58 -42.12 82.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 74.43 109.696 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 211' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' B' ' 207' ' ' VAL . . . -173.8 -118.9 0.52 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.679 -1.368 . . . . 64.45 109.679 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 212' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' B' ' 212' ' ' TYR . 29.8 m-85 -123.93 156.4 36.4 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.566 -0.961 . . . . 74.21 109.319 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -134.47 145.55 48.94 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.555 -0.716 . . . . 74.03 109.082 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -115.78 138.47 51.1 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.449 -0.782 . . . . 74.34 109.178 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.3 p -156.19 166.54 33.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.43 -0.794 . . . . 64.33 109.219 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -61.44 149.53 83.31 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.176 -0.952 . . . . 70.04 108.998 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -38.99 144.87 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 122.047 1.831 . . . . 65.11 112.152 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.512 ' NZ ' ' CB ' ' B' ' 218' ' ' LYS . 4.7 mtpm? -49.91 -64.48 1.22 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.144 -0.972 . . . . 73.15 109.152 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 219' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' B' ' 218' ' ' LYS . 38.7 Cg_endo -64.55 137.5 55.15 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.03 1.82 . . . . 71.31 111.691 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -176.84 28.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 75.45 109.351 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 10.1 p -156.53 120.26 4.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 72.22 109.38 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' B' ' 223' ' ' GLU . 22.5 pt-20 -68.1 -26.69 65.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -0.901 . . . . 54.53 109.55 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 223' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' B' ' 222' ' ' GLU . 69.6 tt0 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.033 -0.984 . . . . 71.13 109.519 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.585 ' SD ' ' CE2' ' A' ' 25' ' ' PHE . 15.4 ptp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.415 -0.587 . . . . 65.12 109.415 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.3 mtt85 -140.94 156.23 46.11 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.321 -0.862 . . . . 72.33 109.283 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.99 130.64 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.643 -0.661 . . . . 71.42 109.722 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.828 HD12 ' N ' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -100.9 125.59 47.47 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.314 -0.995 . . . . 65.12 108.314 179.27 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.828 ' N ' HD12 ' A' ' 4' ' ' LEU . 3.4 tp -120.51 118.4 30.14 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.606 -0.684 . . . . 62.43 109.496 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.588 HG12 HD11 ' A' ' 4' ' ' LEU . 8.9 mt -105.14 123.77 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.357 -0.839 . . . . 71.15 109.056 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -167.42 138.14 2.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.072 -1.018 . . . . 75.34 109.697 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.609 ' HZ3' ' C ' ' A' ' 31' ' ' GLU . 67.1 mmtt -84.32 -26.47 28.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 72.44 109.257 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -61.66 -154.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.355 -0.84 . . . . 63.02 109.5 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.1 p -148.83 -50.75 0.16 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.21 -0.932 . . . . 72.34 109.41 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.5 t -65.38 -39.8 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 74.02 109.521 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.595 ' N ' HD12 ' A' ' 12' ' ' LEU . 10.1 mp -63.18 -36.23 82.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 71.43 109.409 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.55 -35.15 26.57 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.501 -1.84 . . . . 61.32 108.501 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.94 -43.26 91.77 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 110.182 -1.167 . . . . 71.2 110.182 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -69.39 -41.17 76.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.939 -1.33 . . . . 71.32 109.306 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.7 mm -67.09 -40.28 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.825 -1.172 . . . . 63.23 108.135 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -62.75 -53.83 48.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.456 -0.777 . . . . 51.11 109.798 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -79.56 -1.0 35.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.176 -0.952 . . . . 73.34 109.771 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -85.73 -54.26 2.83 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.13 -1.588 . . . . 62.15 109.13 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pp -71.54 -28.31 63.78 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.4 -1.059 . . . . 73.51 109.315 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 58.2 m-20 -53.98 -35.82 62.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -0.929 . . . . 74.25 109.124 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.3 t -55.46 -49.1 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.306 -0.871 . . . . 70.04 109.01 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.438 ' NZ ' HG11 ' A' ' 106' ' ' VAL . 35.9 mmtm -58.54 -54.59 45.3 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.689 -0.856 . . . . 73.23 108.689 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 138.21 36.5 0.15 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.829 -1.309 . . . . 75.54 109.829 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.585 ' CE2' ' SD ' ' A' ' 1' ' ' MET . 16.9 m-85 -111.99 155.19 24.17 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.374 -1.074 . . . . 73.43 108.962 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 7.2 mtp -101.97 139.14 38.01 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.19 -1.041 . . . . 43.24 108.19 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.422 ' O ' ' OD1' ' A' ' 28' ' ' ASP . . . -143.72 158.29 43.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.199 -0.938 . . . . 62.11 110.368 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 27' ' ' ALA . 87.7 m-20 -136.09 156.5 48.63 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.054 -0.721 . . . . 74.42 109.054 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 m -104.38 139.9 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.47 -0.937 . . . . 72.15 108.47 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 p -133.94 164.26 27.69 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.489 -0.757 . . . . 71.42 109.442 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.609 ' C ' ' HZ3' ' A' ' 8' ' ' LYS . 5.6 pt-20 -97.64 -107.41 0.17 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.295 -0.878 . . . . 72.33 109.875 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.516 ' N ' ' HZ3' ' A' ' 8' ' ' LYS . 50.0 m -79.88 160.86 25.89 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.155 -0.966 . . . . 74.24 110.041 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.4 mt -48.58 -19.52 0.35 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.395 -0.816 . . . . 71.53 109.759 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -61.08 -54.47 44.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 74.23 110.58 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 36' ' ' GLY . 13.4 p-10 -68.57 -31.67 71.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.917 -1.114 . . . . 54.03 109.317 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.518 ' N ' ' OD1' ' A' ' 35' ' ' ASP . . . -68.77 -42.89 77.59 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.021 -1.632 . . . . 61.41 109.021 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.486 ' OE2' ' NH2' ' A' ' 61' ' ' ARG . 85.5 tt0 -71.22 -39.24 71.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.353 -1.086 . . . . 74.34 109.364 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -73.23 -31.81 64.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.971 . . . . 75.33 109.648 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.1 tp -70.65 -49.85 43.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.236 -0.915 . . . . 74.33 110.139 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 43' ' ' ARG . 22.8 ptm -63.45 -20.48 65.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.997 -1.064 . . . . 70.32 109.802 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -65.15 -38.49 90.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.098 -1.001 . . . . 71.22 109.956 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.8 pt -84.93 -31.33 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.059 -1.026 . . . . 74.14 110.254 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 40' ' ' MET . 79.5 mtm180 -130.31 153.5 48.59 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.304 -0.872 . . . . 72.24 109.595 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.954 ' CG ' ' OE2' ' A' ' 143' ' ' GLU . 29.4 m120 -97.93 155.89 16.87 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.251 -0.906 . . . . 75.42 109.529 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -135.84 155.32 50.51 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.463 -0.773 . . . . 74.23 109.277 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -96.08 -43.86 7.58 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.154 -0.966 . . . . 72.04 109.198 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.63 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.8 OUTLIER -110.58 122.47 47.84 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.499 -0.926 . . . . 72.13 108.499 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.63 ' N ' HD13 ' A' ' 47' ' ' LEU . 15.4 m -117.3 97.97 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.581 -0.896 . . . . 72.34 108.581 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.586 ' SD ' ' N ' ' A' ' 50' ' ' VAL . 0.3 OUTLIER -98.67 134.4 41.65 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.793 -0.818 . . . . 74.11 108.793 -179.346 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.586 ' N ' ' SD ' ' A' ' 49' ' ' MET . 1.3 p -136.43 125.51 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-O 121.774 0.797 . . . . 61.12 109.967 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.1 p -94.54 2.66 55.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.565 -0.709 . . . . 73.11 109.356 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -76.75 142.32 40.47 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.191 -0.943 . . . . 52.55 109.646 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.474 ' C ' ' H ' ' A' ' 55' ' ' ALA . 97.8 mttt -79.14 -38.52 35.84 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.312 -0.868 . . . . 44.22 110.212 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -67.93 7.99 0.46 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.051 -1.031 . . . . 70.44 109.585 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.34 -22.46 57.6 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.376 -0.827 . . . . 64.14 110.718 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 55' ' ' ALA . 55.1 mt -41.39 -51.24 3.76 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.399 -0.813 . . . . 44.14 110.361 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 t -67.86 -34.22 76.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.96 -1.088 . . . . 55.23 108.873 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.562 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 48.2 t80 -66.81 -63.62 1.03 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.505 -0.747 . . . . 74.44 109.914 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.5 m -48.16 -34.29 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.795 -1.191 . . . . 74.03 109.617 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 61' ' ' ARG . 15.0 p -57.69 -56.32 23.45 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.208 -0.932 . . . . 64.3 109.133 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.645 HH21 ' NZ ' ' A' ' 65' ' ' LYS . 13.3 ptm180 -66.4 -28.73 68.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -1.0 . . . . 64.44 110.059 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.562 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 25.1 mm -54.87 -41.42 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.666 -1.271 . . . . 63.21 107.96 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.522 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 43.4 mmtt -70.84 -40.08 72.58 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.605 -0.838 . . . . 74.42 109.056 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -67.83 -42.09 82.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 70.32 109.129 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.645 ' NZ ' HH21 ' A' ' 61' ' ' ARG . 48.6 mtpt -88.48 -14.4 37.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.614 -0.678 . . . . 75.22 110.076 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 62' ' ' ILE . 73.0 m-70 -155.22 72.17 0.81 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.146 -0.971 . . . . 74.13 109.342 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.3 p -73.69 -6.96 50.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.912 . . . . 73.24 109.765 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.2 p -100.19 42.87 1.08 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.27 -0.894 . . . . 61.01 110.072 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 66' ' ' HIS . 14.7 tt -145.07 160.09 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.011 -1.056 . . . . 71.33 109.6 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t -98.13 130.43 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.212 -0.93 . . . . 72.13 108.766 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.29 130.75 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.499 -0.751 . . . . 54.21 109.323 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.513 ' O ' ' SD ' ' A' ' 49' ' ' MET . 8.6 tt -128.0 95.88 4.32 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.599 0.714 . . . . 50.24 109.202 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.52 HG22 ' N ' ' A' ' 74' ' ' SER . 14.4 p -91.39 164.89 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.005 -1.06 . . . . 74.41 109.203 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.52 ' N ' HG22 ' A' ' 73' ' ' VAL . 72.0 m -138.87 169.7 17.31 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.204 -0.935 . . . . 72.31 109.026 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 77' ' ' ASN . 1.2 p -175.53 128.52 0.26 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.053 -1.029 . . . . 64.54 110.086 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.425 ' N ' ' HB2' ' A' ' 97' ' ' LYS . 48.7 p30 -67.33 41.6 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.509 -0.744 . . . . 74.13 109.633 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.565 ' ND2' ' O ' ' A' ' 77' ' ' ASN . 1.8 p-10 -156.32 59.45 1.99 Allowed Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.026 -1.046 . . . . 73.34 110.449 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.68 76.22 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.145 1.896 . . . . 63.22 111.148 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.458 ' N ' ' O ' ' A' ' 77' ' ' ASN . 82.3 p -103.64 152.3 21.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.575 -0.703 . . . . 62.53 109.498 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.52 -34.6 78.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.463 -0.773 . . . . 73.44 109.27 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -67.04 -44.45 80.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 71.42 109.281 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -74.51 -31.55 62.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 73.43 109.383 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.493 ' OE1' ' N ' ' A' ' 84' ' ' VAL . 14.3 tm-20 -58.66 -56.72 18.56 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.225 -0.922 . . . . 74.22 109.555 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.493 ' N ' ' OE1' ' A' ' 83' ' ' GLU . 27.4 m -62.0 -40.64 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 73.2 109.29 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.454 ' N ' HG23 ' A' ' 84' ' ' VAL . 22.8 t-80 -61.13 -38.93 88.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.24 -0.913 . . . . 53.33 109.381 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.58 86.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 64.11 109.543 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.409 ' CE1' ' HB1' ' B' ' 111' ' ' ALA . 17.3 t80 -72.83 -33.23 66.03 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.417 -0.957 . . . . 74.34 108.417 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -66.56 -36.93 83.85 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.518 -0.738 . . . . 74.42 109.143 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -64.4 -49.83 70.01 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.361 -0.837 . . . . 74.24 109.411 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 142.43 31.88 0.12 Allowed Glycine 0 N--CA 1.498 2.775 0 N-CA-C 110.024 -1.23 . . . . 61.51 110.024 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.25 131.27 38.52 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.088 -1.242 . . . . 55.33 109.43 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.522 ' OD2' ' NZ ' ' A' ' 63' ' ' LYS . 42.1 m-20 -78.03 -29.35 49.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.108 -0.995 . . . . 73.42 109.113 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.423 ' OD2' HD11 ' A' ' 95' ' ' ILE . 25.2 t70 -149.88 147.59 28.12 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.911 -0.774 . . . . 75.04 108.911 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -135.54 113.44 11.1 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.446 -0.784 . . . . 71.33 108.93 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.423 HD11 ' OD2' ' A' ' 93' ' ' ASP . 20.3 mm -107.35 150.22 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 CA-C-O 122.118 0.961 . . . . 71.13 110.918 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.95 125.54 25.75 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.51 -1.292 . . . . 64.32 107.51 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.675 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -45.12 -52.81 18.8 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.036 -1.04 . . . . 62.2 111.359 -179.061 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 1.6 Cg_endo -40.87 -12.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.112 0 CA-C-N 119.759 0.95 . . . . 73.11 112.601 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.675 ' N ' ' O ' ' A' ' 97' ' ' LYS . 49.2 m-85 56.69 104.71 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.763 -0.586 . . . . 65.22 110.383 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.8 ttm-85 -60.65 -39.08 87.0 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.02 -1.104 . . . . 72.35 108.02 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.1 t -174.45 140.08 0.61 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.916 -0.772 . . . . 71.32 108.916 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.2 mm -57.95 -37.07 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 75.43 109.157 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.428 ' H ' ' HE2' ' A' ' 103' ' ' LYS . 1.5 mppt? -64.3 -36.03 82.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 71.41 109.178 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.31 -48.91 73.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.144 -0.973 . . . . 63.24 109.406 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.453 ' C ' HD13 ' A' ' 105' ' ' LEU . 2.1 tm? -67.82 -55.05 14.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.377 -0.827 . . . . 73.22 108.906 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.438 HG11 ' NZ ' ' A' ' 23' ' ' LYS . 67.6 t -55.03 -49.02 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.932 -1.105 . . . . 60.11 109.425 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.51 -37.28 65.14 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.169 -0.957 . . . . 70.42 108.91 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.423 ' NH1' ' OE2' ' B' ' 83' ' ' GLU . 11.2 mmt85 -71.38 -30.02 65.63 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.357 -0.839 . . . . 74.41 109.389 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.67 -30.51 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 107.773 -1.195 . . . . 62.54 107.773 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -67.58 -52.48 38.1 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.837 -0.801 . . . . 74.34 108.837 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.444 ' CB ' ' CZ ' ' B' ' 87' ' ' PHE . . . -48.2 -44.09 32.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.446 -0.783 . . . . 73.32 109.477 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 75.1 mmt-85 -64.61 -32.7 74.47 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.33 -0.856 . . . . 52.41 109.702 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.1 mt -133.37 75.62 1.62 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.36 -0.837 . . . . 65.24 110.313 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -92.8 -79.51 0.39 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.089 -1.007 . . . . 64.45 108.426 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.457 ' CD2' ' O ' ' A' ' 115' ' ' PHE . 26.1 p90 -100.74 49.37 0.89 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.354 -0.841 . . . . 74.43 109.359 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 75.7 t-105 -67.05 112.58 4.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 74.42 109.424 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 159.74 111.39 0.29 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.889 -1.284 . . . . 75.04 109.889 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.2 t -164.17 157.17 17.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -1.14 . . . . 61.14 109.523 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.443 ' OD1' ' N ' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -152.92 117.12 4.88 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.854 -0.795 . . . . 65.24 108.854 -178.51 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.506 HG21 ' OD1' ' A' ' 131' ' ' ASP . 18.7 t -77.63 -39.98 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.327 -0.858 . . . . 73.11 110.466 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 11.1 mm -104.46 130.36 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.105 -0.997 . . . . 72.24 109.675 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -129.36 136.36 49.9 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.453 -0.943 . . . . 72.34 108.453 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.622 HD13 ' N ' ' A' ' 124' ' ' GLY . 0.2 OUTLIER -149.99 121.87 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.018 -1.051 . . . . 71.44 109.599 -179.229 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.622 ' N ' HD13 ' A' ' 123' ' ' ILE . . . 46.96 -129.49 12.23 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.038 -1.225 . . . . 73.4 110.038 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -93.88 -4.02 50.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.307 -1.114 . . . . 74.45 109.88 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.67 143.65 26.26 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.141 -0.974 . . . . 54.21 108.468 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.1 m -132.44 143.67 49.95 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.333 -0.854 . . . . 54.5 109.524 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.4 mt -134.84 140.38 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.457 -0.777 . . . . 45.15 109.748 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.1 m -128.31 109.05 19.46 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 108.949 -0.76 . . . . 71.11 108.949 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.52 -27.49 4.14 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.656 1.571 . . . . 65.41 111.712 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.506 ' OD1' HG21 ' A' ' 120' ' ' VAL . 1.9 m-20 -69.4 -37.15 77.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 63.32 109.093 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -88.98 -4.33 58.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.33 -0.856 . . . . 72.52 109.603 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 54.65 62.62 2.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.131 -0.981 . . . . 75.33 108.972 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -160.67 155.56 24.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.256 -0.903 . . . . 71.23 109.949 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.533 HD12 ' CD2' ' A' ' 152' ' ' LEU . 4.7 tt -124.94 137.61 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.631 -0.668 . . . . 74.02 109.349 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 24.9 mm -115.83 133.7 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.709 -0.849 . . . . 60.23 108.709 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -137.88 119.49 15.01 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.231 -0.918 . . . . 62.32 108.851 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.5 ' O ' ' CG ' ' A' ' 138' ' ' LYS . 25.4 ttpt 54.71 20.26 2.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.586 -0.696 . . . . 75.4 109.974 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.59 0.8 66.62 Favored Glycine 0 N--CA 1.499 2.877 0 O-C-N 120.862 -1.149 . . . . 72.24 110.71 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.498 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 1.9 mpt_? -89.99 124.84 35.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.963 -1.316 . . . . 71.22 108.645 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -87.9 130.39 34.93 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.245 -0.91 . . . . 71.42 109.755 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.7 t -138.45 143.13 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.433 -0.792 . . . . 53.02 109.739 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.954 ' OE2' ' CG ' ' A' ' 44' ' ' ASN . 91.1 mt-10 -95.9 142.16 28.47 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.868 -0.79 . . . . 60.45 108.868 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.2 m -138.05 137.88 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.147 -0.97 . . . . 74.44 109.758 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -168.54 41.87 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.287 -0.883 . . . . 65.15 109.856 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.25 -129.36 4.58 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 108.856 -1.697 . . . . 73.34 108.856 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.625 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 23.8 mttp -85.79 -32.29 0.45 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.273 -1.134 . . . . 72.22 110.846 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.853 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 86.9 Cg_endo -86.1 -18.14 3.59 Favored 'Trans proline' 0 N--CA 1.486 1.06 0 C-N-CA 122.06 1.84 . . . . 65.23 112.247 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -56.34 -48.83 75.97 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.828 -1.175 . . . . 60.11 107.828 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 172' ' ' ILE . 74.6 mt-10 -75.99 -42.02 49.43 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.053 -1.092 . . . . 64.21 108.053 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.853 ' HB ' ' HA ' ' A' ' 148' ' ' PRO . 1.1 t -56.27 -46.58 81.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.039 -1.097 . . . . 72.02 108.039 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.533 ' CD2' HD12 ' A' ' 135' ' ' ILE . 22.3 tp -66.66 -56.72 9.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.623 -0.673 . . . . 73.31 110.569 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.6 p -58.49 -35.84 72.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.906 -1.121 . . . . 74.31 110.03 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -58.53 -56.94 15.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.003 -1.06 . . . . 74.31 110.367 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.54 -26.42 62.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.935 -1.103 . . . . 75.34 109.525 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.05 -44.23 91.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.958 -1.089 . . . . 62.14 108.592 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -79.67 -57.99 3.41 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.984 0.897 . . . . 61.03 109.415 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -71.69 41.43 0.08 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.912 -0.586 . . . . 74.12 111.332 -177.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -82.81 166.43 19.01 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.627 -1.296 . . . . 71.13 109.027 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.441 ' OD1' ' CE2' ' A' ' 216' ' ' TYR . 14.2 m-20 53.49 47.62 23.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.157 -0.964 . . . . 75.45 109.262 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -154.89 163.58 40.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.348 -0.845 . . . . 73.41 110.12 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.3 mm -98.64 136.7 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.42 -1.326 . . . . 74.41 107.42 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.8 148.18 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.996 -1.065 . . . . 72.31 110.486 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.7 p -97.08 165.47 12.05 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.609 -0.682 . . . . 74.12 109.685 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -66.95 -44.78 79.72 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.249 -0.907 . . . . 70.43 110.121 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -56.19 -40.31 73.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 73.52 109.923 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -58.05 -43.2 86.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.05 -1.031 . . . . 74.52 109.425 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 11.7 mt -56.47 -43.72 79.88 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.973 -1.08 . . . . 72.31 108.127 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.514 HD23 ' C ' ' A' ' 169' ' ' LEU . 5.1 tt -49.16 -56.15 10.12 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.04 -1.038 . . . . 53.33 109.746 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -54.14 -37.71 64.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.559 -0.713 . . . . 62.44 112.507 -178.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.65 -32.11 13.54 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 120.531 -1.356 . . . . 60.21 113.517 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.43 ' O ' ' OE1' ' A' ' 150' ' ' GLU . 1.7 mp -77.88 -51.33 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.628 -1.295 . . . . 75.32 110.838 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.562 ' CD1' HG23 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -86.43 8.7 20.69 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.66 -1.275 . . . . 73.14 109.597 -178.899 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -46.53 -66.67 0.37 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.977 -1.077 . . . . 73.24 109.79 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.39 -61.57 0.26 Allowed Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.073 -1.017 . . . . 44.43 109.782 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.59 123.46 10.18 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.967 1.778 . . . . 72.51 111.265 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -92.36 127.64 37.91 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.872 -1.142 . . . . 63.24 110.616 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.548 ' HG3' ' CE ' ' A' ' 147' ' ' LYS . 0.0 OUTLIER -173.54 44.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.834 -1.172 . . . . 73.5 107.834 179.197 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.562 HG23 ' CD1' ' A' ' 173' ' ' TRP . 3.4 t -93.85 145.86 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.449 -0.782 . . . . 65.22 108.915 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.504 ' CG2' ' H ' ' A' ' 182' ' ' ASN . 0.4 OUTLIER -150.89 156.24 35.63 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.229 -0.92 . . . . 71.42 108.686 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -37.8 -24.23 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.362 2.042 . . . . 41.22 112.487 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.504 ' H ' ' CG2' ' A' ' 180' ' ' THR . 34.5 m120 -157.91 96.06 1.45 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.073 -1.017 . . . . 64.54 110.19 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.2 p -148.38 -32.25 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.147 -0.97 . . . . 74.02 109.325 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 6.0 mm -60.69 -43.27 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.181 -0.95 . . . . 72.33 109.211 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -64.91 -36.94 86.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 74.4 109.164 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 20.4 t -71.15 -32.33 47.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.117 -0.989 . . . . 70.42 109.139 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.39 -52.17 17.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.49 -0.757 . . . . 52.11 110.658 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.401 HG21 ' CZ ' ' A' ' 212' ' ' TYR . 9.2 tp -56.85 -39.11 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.548 -1.345 . . . . 71.4 110.112 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -63.72 -56.71 13.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.83 -1.169 . . . . 73.44 110.958 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -65.65 -42.58 91.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.848 -1.158 . . . . 71.42 110.131 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 66.6 mt -51.72 -35.72 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.808 -1.182 . . . . 61.55 109.033 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.407 ' HB2' HH11 ' A' ' 192' ' ' ARG . 16.8 mtp-105 -67.29 -54.46 20.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.115 -0.991 . . . . 63.34 109.689 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -71.21 -14.06 62.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -0.91 . . . . 61.24 110.992 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.415 ' O ' ' CD ' ' A' ' 198' ' ' PRO . 43.8 mtpt -83.37 -41.24 18.41 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.844 -1.16 . . . . 75.13 110.709 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' MET . . . . . 1.024 ' HE2' HD22 ' A' ' 199' ' ' LEU . 45.8 mtp -81.83 36.99 0.46 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.095 -1.003 . . . . 74.02 110.699 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 197' ' ' LYS . 27.4 p30 -110.61 -39.09 4.99 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.12 -0.988 . . . . 74.02 109.988 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.597 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 5.6 tmtt? -91.23 -40.15 0.39 Allowed Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 120.91 -1.119 . . . . 75.43 110.065 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 24.4 Cg_exo -63.65 -61.22 0.13 Allowed 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.256 1.971 . . . . 72.32 111.823 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 1.024 HD22 ' HE2' ' A' ' 195' ' ' MET . 10.8 mp -71.42 -28.8 64.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 74.54 108.971 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 83.46 -14.9 38.09 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.626 -1.79 . . . . 61.51 108.626 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 21.2 mt -128.52 137.13 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.841 -0.799 . . . . 61.22 109.073 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 72.8 m -89.74 144.52 25.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.211 -0.93 . . . . 72.0 109.12 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.5 p -146.07 44.68 1.25 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.164 -0.96 . . . . 74.44 110.288 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 7.9 m -148.66 129.88 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.993 -1.067 . . . . 64.35 109.23 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -112.14 140.4 46.85 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.687 -0.633 . . . . 71.41 109.532 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 206' ' ' THR . 14.9 t -126.12 131.46 52.07 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.456 -0.778 . . . . 73.52 109.942 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.7 154.25 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.47 -0.937 . . . . 71.02 108.47 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -97.03 75.22 2.62 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.103 -0.998 . . . . 72.12 110.535 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -146.52 -33.22 0.31 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.175 -0.953 . . . . 64.41 109.249 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -147.3 -60.18 0.28 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.242 -0.911 . . . . 71.54 109.217 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -163.52 -119.75 0.5 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.517 -1.433 . . . . 72.03 109.517 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.401 ' CZ ' HG21 ' A' ' 188' ' ' ILE . 43.5 m-85 -125.31 152.05 45.21 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.63 -0.923 . . . . 75.54 109.153 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.92 129.05 48.53 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.545 -0.909 . . . . 75.31 108.545 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -105.86 126.26 51.96 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.357 -0.839 . . . . 75.41 109.193 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 44.1 t -149.49 158.59 44.31 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.788 -0.819 . . . . 74.14 108.788 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' TYR . . . . . 0.441 ' CE2' ' OD1' ' A' ' 160' ' ' ASP . 8.7 p90 -58.07 150.06 53.07 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.255 -0.903 . . . . 75.32 109.238 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.36 -41.09 2.65 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.236 1.957 . . . . 73.11 111.173 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 32.0 pttt -153.56 152.27 27.0 Favored Pre-proline 0 N--CA 1.49 1.559 0 N-CA-C 108.783 -0.821 . . . . 75.25 108.783 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -35.91 105.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.608 2.205 . . . . 75.1 112.701 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -93.28 100.24 12.63 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.164 -0.96 . . . . 71.14 109.353 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 22.5 p -159.9 168.35 25.95 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.166 -0.959 . . . . 71.13 109.957 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -85.3 158.68 20.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.228 -0.92 . . . . 75.35 109.039 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.989 -1.005 . . . . 73.41 109.379 -179.895 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 54.4 ttm . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.442 -0.577 . . . . 71.14 109.442 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 57.5 ttm-85 -139.27 147.61 41.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.419 -0.8 . . . . 73.23 109.159 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 40.2 t -110.62 137.35 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.682 -0.636 . . . . 72.24 109.304 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.408 HD11 ' CG1' ' B' ' 6' ' ' ILE . 5.4 tp -113.98 117.55 31.64 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 109.366 -0.605 . . . . 54.33 109.366 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.496 HD23 ' N ' ' B' ' 5' ' ' LEU . 0.1 OUTLIER -120.39 97.67 5.68 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.171 -1.048 . . . . 74.35 108.171 178.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.471 ' CG2' ' O ' ' B' ' 31' ' ' GLU . 65.1 mt -81.97 106.14 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.775 -1.203 . . . . 42.55 109.168 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.425 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 18.3 tp10 -140.18 129.9 24.43 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.481 -0.762 . . . . 74.52 109.125 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -64.8 -32.34 73.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 62.55 109.431 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -83.86 123.59 30.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 73.11 109.503 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 87.1 p -78.8 -26.68 44.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.263 -0.898 . . . . 65.54 109.689 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 98.3 t -63.12 -49.09 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 75.55 109.564 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.566 ' N ' HD22 ' B' ' 12' ' ' LEU . 3.6 mm? -64.78 -35.2 80.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 70.14 108.949 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.25 -26.6 71.76 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.314 -1.914 . . . . 75.4 108.314 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.29 -49.99 62.61 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.652 -1.379 . . . . 65.44 109.652 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -61.97 -43.91 97.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.285 -1.126 . . . . 60.21 109.706 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 35.8 mm -67.31 -37.55 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.689 -1.257 . . . . 75.15 108.702 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -65.97 -42.39 89.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -0.891 . . . . 73.01 109.355 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -87.43 1.35 53.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.169 -0.957 . . . . 74.3 109.204 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.57 -58.06 1.99 Allowed Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.361 -1.496 . . . . 70.54 109.361 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' B' ' 27' ' ' ALA . 1.6 pt? -68.54 -24.82 64.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.308 -1.113 . . . . 71.34 109.421 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -53.8 -36.01 61.98 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.184 -0.947 . . . . 64.41 109.447 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 58.0 t -54.52 -47.64 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.268 -0.895 . . . . 74.23 108.914 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -59.91 -54.89 40.88 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.948 -0.76 . . . . 63.42 108.948 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 132.9 41.85 0.18 Allowed Glycine 0 N--CA 1.499 2.868 0 N-CA-C 109.719 -1.353 . . . . 53.43 109.719 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -118.46 160.17 22.2 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.445 -1.033 . . . . 71.12 109.308 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 8.4 mmt -98.86 138.79 35.48 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.287 -1.005 . . . . 75.24 108.287 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.468 ' HB1' HD21 ' B' ' 5' ' ' LEU . . . -125.13 149.78 47.54 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.701 0.762 . . . . 72.12 110.326 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ASP . . . . . 0.445 ' OD2' ' NH2' ' B' ' 43' ' ' ARG . 24.1 t70 -133.47 126.5 31.27 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.452 -1.314 . . . . 72.31 107.452 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 p -117.48 142.58 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.406 -0.809 . . . . 64.43 110.066 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -134.34 -153.16 0.51 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.751 -0.593 . . . . 65.41 109.413 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.471 ' O ' ' CG2' ' B' ' 6' ' ' ILE . 1.3 pt-20 -135.36 -87.56 0.36 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.422 -0.799 . . . . 71.02 109.531 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 61.8 m -79.46 152.03 30.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.963 -1.085 . . . . 51.11 109.571 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' B' ' 37' ' ' GLU . 43.8 mt -54.2 -41.71 68.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.864 . . . . 71.24 109.73 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -58.95 -40.8 85.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 74.32 109.795 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.425 ' OD2' ' OE2' ' B' ' 31' ' ' GLU . 92.7 m-20 -64.02 -40.26 95.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.147 -0.97 . . . . 73.03 109.212 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' GLY . . . . . 0.447 ' O ' ' CG ' ' B' ' 40' ' ' MET . . . -82.78 -27.89 40.37 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.642 -1.383 . . . . 30.21 109.642 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' B' ' 33' ' ' LEU . 81.7 tt0 -64.3 -41.32 96.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.188 -1.183 . . . . 74.42 109.727 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -80.54 -40.48 25.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.114 -0.992 . . . . 74.42 109.624 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 45.4 tp -68.02 -40.15 83.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 75.41 109.936 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' MET . . . . . 0.516 ' SD ' ' CE1' ' B' ' 45' ' ' TYR . 1.2 ppp? -74.05 -27.15 60.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.131 -0.981 . . . . 60.41 109.923 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -52.68 -36.07 56.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.167 -0.958 . . . . 53.23 110.041 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 9.3 pt -93.11 -20.48 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.092 -1.005 . . . . 71.23 110.314 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.445 ' NH2' ' OD2' ' B' ' 28' ' ' ASP . 34.8 mtm105 -104.71 156.81 17.66 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.192 -0.942 . . . . 72.22 109.902 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -91.29 167.72 12.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.381 -0.825 . . . . 63.54 109.035 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.516 ' CE1' ' SD ' ' B' ' 40' ' ' MET . 1.7 p90 -160.25 113.43 2.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.054 -1.029 . . . . 64.35 109.669 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -84.62 -37.73 20.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 62.22 108.859 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.504 ' C ' HD13 ' B' ' 47' ' ' LEU . 0.7 OUTLIER -109.76 109.46 20.16 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.666 -0.864 . . . . 73.12 108.666 179.524 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.444 ' N ' HD13 ' B' ' 47' ' ' LEU . 78.4 t -95.97 111.18 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.604 -0.888 . . . . 65.11 108.604 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 12.2 ttt -128.18 135.31 49.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.486 -0.759 . . . . 73.44 109.551 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.69 HG22 ' H ' ' B' ' 52' ' ' ASP . 0.8 OUTLIER -147.12 140.63 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.591 -0.693 . . . . 34.5 109.506 -179.332 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 51' ' ' SER . . . . . 0.425 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 52.8 p -103.91 13.92 31.81 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.445 -0.784 . . . . 73.21 109.626 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.69 ' H ' HG22 ' B' ' 50' ' ' VAL . 13.5 m-20 -78.34 140.7 38.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.164 -0.96 . . . . 70.41 109.502 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -72.72 -38.37 67.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.18 -0.95 . . . . 65.0 110.002 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -74.05 10.19 1.3 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.123 -0.986 . . . . 75.21 109.663 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.09 -22.72 64.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 55.33 110.148 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 39.4 mt -43.83 -48.54 8.26 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.34 -0.85 . . . . 63.14 110.174 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 88.3 p -68.9 -33.82 74.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.926 -1.109 . . . . 63.5 108.943 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' PHE . . . . . 0.468 ' CZ ' HD11 ' B' ' 62' ' ' ILE . 61.0 t80 -66.21 -61.96 1.74 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.444 -0.785 . . . . 72.33 109.779 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.9 m -49.92 -34.59 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.715 -1.24 . . . . 74.54 109.719 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.5 m -57.81 -51.79 68.14 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.285 -0.884 . . . . 71.24 109.632 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.627 ' NH2' ' HZ3' ' B' ' 65' ' ' LYS . 10.4 ptm180 -70.71 -27.4 63.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.041 -1.037 . . . . 74.31 110.132 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' B' ' 66' ' ' HIS . 29.9 mm -63.17 -53.78 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.743 -1.223 . . . . 72.14 109.181 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -59.73 -36.93 77.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.98 -1.075 . . . . 73.32 109.112 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -75.04 -38.16 61.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.365 -0.835 . . . . 73.12 109.477 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.627 ' HZ3' ' NH2' ' B' ' 61' ' ' ARG . 92.1 mttt -88.71 -18.46 27.81 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.166 -0.959 . . . . 72.44 110.722 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' B' ' 62' ' ' ILE . 77.7 m-70 -156.47 67.55 0.57 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.852 -1.155 . . . . 63.31 109.874 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 7.5 m -58.75 -29.18 66.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.277 -0.889 . . . . 73.1 109.553 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 86.4 p -66.56 -27.66 67.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.285 -0.885 . . . . 71.53 110.311 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.424 HG22 ' N ' ' B' ' 70' ' ' VAL . 72.7 mt -79.42 157.34 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.022 -1.049 . . . . 74.4 109.592 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.507 HG12 ' N ' ' B' ' 71' ' ' VAL . 87.2 t -94.62 160.68 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.284 -0.885 . . . . 75.12 109.891 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.507 ' N ' HG12 ' B' ' 70' ' ' VAL . 3.6 t -136.22 133.28 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.296 -0.877 . . . . 73.2 108.908 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.633 ' CD1' HH22 ' B' ' 108' ' ' ARG . 1.0 OUTLIER -133.52 104.67 6.5 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.752 0.787 . . . . 73.34 109.385 -179.21 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 84.3 t -92.26 130.39 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.928 . . . . 73.5 109.552 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 11.8 p -89.79 170.33 10.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.038 . . . . 64.34 108.212 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 18.8 p -157.43 110.83 2.54 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.757 -1.214 . . . . 74.53 110.329 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -64.97 -34.41 78.37 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.428 -0.953 . . . . 64.5 108.428 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -109.87 75.54 0.86 Allowed Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 108.527 -0.916 . . . . 74.25 108.527 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.2 86.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 121.889 1.726 . . . . 74.43 112.198 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.564 HG23 ' H ' ' B' ' 82' ' ' GLU . 1.6 t -105.53 150.93 24.91 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.571 -0.9 . . . . 73.12 108.571 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -32.63 74.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.112 -0.992 . . . . 71.01 109.475 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.56 -42.32 87.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 63.2 109.588 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' GLU . . . . . 0.564 ' H ' HG23 ' B' ' 79' ' ' THR . 85.6 tt0 -74.46 -26.78 60.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 73.22 109.327 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.423 ' OE2' ' NH1' ' A' ' 108' ' ' ARG . 86.7 tt0 -68.71 -51.33 42.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 74.3 109.804 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.416 HG23 ' N ' ' B' ' 85' ' ' HIS . 29.4 m -63.28 -39.1 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.103 -0.998 . . . . 73.31 109.507 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 85' ' ' HIS . . . . . 0.416 ' N ' HG23 ' B' ' 84' ' ' VAL . 22.9 m80 -77.05 -21.07 55.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 73.24 109.41 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -68.15 -48.34 65.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.22 -0.925 . . . . 55.33 109.852 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' PHE . . . . . 0.444 ' CZ ' ' CB ' ' A' ' 111' ' ' ALA . 80.7 t80 -76.28 -33.0 59.1 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.988 -1.07 . . . . 74.14 108.963 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -62.15 -51.02 69.51 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.361 -0.837 . . . . 64.04 109.195 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -58.88 -49.79 76.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.53 -0.731 . . . . 72.35 109.831 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 153.23 35.87 0.03 OUTLIER Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.775 -1.202 . . . . 65.2 110.162 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -99.47 125.49 45.22 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.245 -1.15 . . . . 52.23 109.154 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -71.08 -33.39 70.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.046 -1.034 . . . . 73.32 108.941 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 36.2 t0 -153.13 164.93 37.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.513 -0.742 . . . . 72.22 109.191 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.531 ' O ' ' CD1' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -139.59 115.47 10.2 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.108 -0.701 . . . . 64.42 109.108 -178.667 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.483 HD11 ' OD2' ' B' ' 93' ' ' ASP . 29.1 mm -113.17 144.82 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 O-C-N 121.326 -0.859 . . . . 72.23 110.013 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.64 135.18 57.53 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.042 -1.096 . . . . 25.24 108.042 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.684 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -55.67 -56.42 29.98 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 120.984 -1.072 . . . . 64.32 111.46 -178.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 98' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 6.0 Cg_endo -42.33 -7.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 120.871 1.047 . . . . 63.33 112.945 -176.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 99' ' ' TYR . . . . . 0.684 ' N ' ' O ' ' B' ' 97' ' ' LYS . 68.8 m-85 60.44 115.17 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.661 -0.649 . . . . 75.13 109.475 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -56.57 -28.18 59.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.117 -0.989 . . . . 74.23 109.422 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 101' ' ' SER . . . . . 0.742 ' O ' ' N ' ' B' ' 103' ' ' LYS . 30.2 t -174.51 30.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.003 -1.061 . . . . 63.34 110.7 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 55.1 mt 52.29 -69.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.641 -0.662 . . . . 74.44 110.283 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.742 ' N ' ' O ' ' B' ' 101' ' ' SER . 29.7 mmtp -59.62 -28.4 67.16 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.331 -0.989 . . . . 71.11 108.331 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.97 -44.8 91.64 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.462 -0.895 . . . . 71.45 108.595 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.687 ' C ' HD13 ' B' ' 105' ' ' LEU . 1.3 tm? -57.19 -55.38 35.53 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.869 -0.789 . . . . 51.31 108.869 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' VAL . . . . . 0.625 ' N ' HD13 ' B' ' 105' ' ' LEU . 21.7 t -63.28 -39.24 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.749 -1.22 . . . . 65.23 109.741 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -47.7 -44.19 27.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 24.32 110.265 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 0.633 HH22 ' CD1' ' B' ' 72' ' ' LEU . 13.9 ptt85 -79.96 -31.03 39.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.988 -1.07 . . . . 75.31 110.707 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 34.5 mt -71.77 -30.43 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.494 -1.379 . . . . 54.24 108.264 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' B' ' 113' ' ' LEU . 21.0 tt0 -72.85 -60.59 2.16 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.402 -0.919 . . . . 65.31 108.972 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' ALA . . . . . 0.409 ' HB1' ' CE1' ' A' ' 87' ' ' PHE . . . -43.33 -44.66 5.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.68 -0.638 . . . . 72.24 109.981 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 112' ' ' ARG . . . . . 0.437 HH21 HD23 ' B' ' 47' ' ' LEU . 64.9 ttp85 -66.13 -34.81 78.89 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.221 -0.925 . . . . 72.04 109.391 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' B' ' 110' ' ' GLU . 7.1 tp -97.24 -75.09 0.55 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.228 -0.92 . . . . 75.35 110.365 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' B' ' 113' ' ' LEU . 83.3 mtt180 47.14 96.55 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.278 -0.889 . . . . 75.5 109.571 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 45.46 86.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.524 -0.735 . . . . 65.33 110.076 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 81.4 t90 -59.04 146.92 36.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.872 . . . . 74.45 109.298 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 161.12 101.16 0.16 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.734 -1.346 . . . . 44.21 109.734 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 83.3 p -157.03 161.26 39.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.252 -1.146 . . . . 71.4 109.692 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.42 -177.57 5.73 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.784 -0.766 . . . . 72.32 109.151 -178.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 6.0 t -144.43 -36.92 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.31 -0.869 . . . . 75.02 109.303 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 47.5 mt -111.51 125.83 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.507 -0.745 . . . . 51.41 109.201 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.416 ' O ' HG23 ' B' ' 123' ' ' ILE . 77.0 mt-10 -138.97 120.43 14.98 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.266 -0.896 . . . . 71.53 109.2 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.416 HG23 ' O ' ' B' ' 122' ' ' GLU . 19.0 pt -154.98 142.79 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.16 -0.962 . . . . 72.43 109.778 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 124' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' B' ' 126' ' ' LEU . . . 51.12 39.22 41.29 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.444 -1.062 . . . . 51.23 110.444 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 69.06 -13.88 0.33 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.303 -1.116 . . . . 74.2 109.935 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.52 HD22 ' CD1' ' B' ' 137' ' ' TYR . 1.1 mt -82.37 144.3 30.64 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.769 -1.197 . . . . 75.42 107.769 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 92.3 m -128.65 144.18 51.1 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.375 -0.828 . . . . 74.22 109.738 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 7.6 mt -141.06 140.93 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.434 -0.791 . . . . 60.33 109.519 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 70.5 m -117.92 123.64 29.43 Favored Pre-proline 0 N--CA 1.5 2.054 0 N-CA-C 108.965 -0.754 . . . . 72.31 108.965 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.27 -40.1 0.29 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.821 1.681 . . . . 75.13 112.196 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -66.42 -44.57 82.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.175 -0.953 . . . . 75.23 109.943 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 132' ' ' GLU . . . . . 0.5 ' N ' ' OE1' ' B' ' 132' ' ' GLU . 35.6 mp0 -84.85 -5.15 59.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.197 -0.939 . . . . 72.43 109.818 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 48.53 72.03 0.31 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.206 -0.934 . . . . 75.13 109.764 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -152.39 142.53 22.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.312 -0.867 . . . . 73.22 109.369 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 135' ' ' ILE . . . . . 0.409 ' O ' HG23 ' B' ' 135' ' ' ILE . 15.8 tt -115.49 132.19 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.436 -0.79 . . . . 64.14 109.125 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 61.9 mt -117.22 130.79 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 109.069 -0.715 . . . . 71.22 109.069 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 137' ' ' TYR . . . . . 0.52 ' CD1' HD22 ' B' ' 126' ' ' LEU . 64.3 t80 -132.6 130.83 40.76 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.441 -0.787 . . . . 64.22 109.505 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 138' ' ' LYS . . . . . 0.516 ' O ' ' NH1' ' B' ' 140' ' ' ARG . 24.5 mmtm 53.55 32.82 14.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.307 -0.87 . . . . 72.02 110.49 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.25 -4.55 71.35 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 120.049 -1.072 . . . . 74.32 110.882 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 140' ' ' ARG . . . . . 0.516 ' NH1' ' O ' ' B' ' 138' ' ' LYS . 11.2 mpt_? -87.74 134.59 33.64 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.817 -1.402 . . . . 75.34 108.842 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -102.11 122.92 45.07 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.385 -0.822 . . . . 71.23 110.034 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 13.5 p -137.78 137.56 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.529 -0.915 . . . . 70.43 108.529 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -90.2 143.3 26.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.272 -0.893 . . . . 72.43 110.344 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 144' ' ' VAL . . . . . 0.535 HG23 ' O ' ' B' ' 144' ' ' VAL . 21.5 m -146.57 121.42 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.217 -1.031 . . . . 72.13 108.217 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 7.1 mtmm -139.68 126.48 20.72 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.18 -0.95 . . . . 72.02 109.484 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.16 171.39 33.17 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.473 -1.451 . . . . 42.23 109.473 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 0.87 ' HD3' ' OE1' ' B' ' 175' ' ' GLU . 11.4 mttm -67.75 -38.81 15.87 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.235 -1.156 . . . . 73.3 109.886 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 148' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 30.0 Cg_exo -60.89 -38.14 71.94 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.265 1.977 . . . . 71.33 112.211 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -88.53 -17.83 29.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.237 -0.914 . . . . 74.23 109.732 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -54.34 -38.29 65.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 72.34 109.479 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.458 HG13 ' N ' ' B' ' 152' ' ' LEU . 10.9 p -67.93 -38.68 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 73.35 109.74 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.458 ' N ' HG13 ' B' ' 151' ' ' VAL . 31.3 tp -55.38 -47.07 76.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.91 . . . . 55.24 109.542 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 60.4 p -68.27 -32.23 72.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.165 -0.96 . . . . 70.01 109.619 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -56.67 -58.99 5.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.849 . . . . 65.32 110.339 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 pp -69.18 -22.73 63.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.082 -1.012 . . . . 71.54 109.923 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.92 -39.88 86.99 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.18 -0.95 . . . . 75.32 109.198 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -85.24 -34.59 21.94 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.181 -0.95 . . . . 73.32 109.758 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -87.41 40.14 0.91 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.143 -0.973 . . . . 74.14 109.786 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -55.3 151.1 10.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 61.41 109.342 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 160' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' B' ' 214' ' ' PHE . 64.3 t0 52.28 68.18 0.86 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 72.1 109.592 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -160.1 147.32 16.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.144 -0.972 . . . . 72.25 109.797 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 12.2 mm -91.29 134.73 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.432 -0.951 . . . . 72.31 108.432 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 48.3 t -135.96 135.74 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.245 -0.909 . . . . 64.21 110.021 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 10.8 t -89.19 155.65 19.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.426 -0.796 . . . . 74.22 109.343 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -55.41 -31.68 62.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.385 -0.822 . . . . 65.31 109.794 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -57.29 -39.14 75.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 63.45 110.26 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -62.95 -43.43 98.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.012 -1.055 . . . . 72.4 109.8 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 20.0 mt -55.26 -59.09 5.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.15 -0.969 . . . . 72.32 109.102 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.566 HD13 ' C ' ' B' ' 169' ' ' LEU . 1.6 tm? -54.7 -65.33 0.6 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.078 -1.014 . . . . 73.34 109.284 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -46.4 -36.25 6.31 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 112.949 0.722 . . . . 72.1 112.949 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.05 -30.97 14.41 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.595 -1.316 . . . . 62.13 113.214 -176.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.416 ' CD1' ' N ' ' B' ' 172' ' ' ILE . 1.3 mp -84.94 -58.58 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 120.433 -1.417 . . . . 71.42 111.208 -177.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 173' ' ' TRP . . . . . 0.586 ' CE3' ' O ' ' B' ' 173' ' ' TRP . 0.0 OUTLIER -64.99 131.47 46.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.609 -1.307 . . . . 72.23 109.76 -178.463 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 174' ' ' GLU . . . . . 0.481 ' H ' ' HD2' ' B' ' 176' ' ' PRO . 87.1 tt0 -175.97 -31.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.529 -0.732 . . . . 52.11 109.734 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 175' ' ' GLU . . . . . 0.87 ' OE1' ' HD3' ' B' ' 147' ' ' LYS . 4.0 mp0 -87.44 -34.71 0.45 Allowed Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.067 -1.021 . . . . 73.04 111.613 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' B' ' 175' ' ' GLU . 96.7 Cg_endo -90.34 -44.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 122.319 2.013 . . . . 74.13 112.327 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 49.14 12.22 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 72.44 109.751 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 178' ' ' MET . . . . . 0.495 ' N ' ' O ' ' B' ' 176' ' ' PRO . 11.2 tpt -112.11 3.29 17.21 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.45 -0.945 . . . . 63.43 108.45 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 19.0 m -76.16 148.99 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.384 -0.823 . . . . 71.05 109.66 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 180' ' ' THR . . . . . 0.474 ' O ' ' N ' ' B' ' 182' ' ' ASN . 0.9 OUTLIER -60.86 155.5 52.51 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 108.604 -0.887 . . . . 62.15 108.604 179.57 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.06 43.84 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.451 2.101 . . . . 65.22 112.024 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 182' ' ' ASN . . . . . 0.5 ' C ' ' H ' ' B' ' 184' ' ' ILE . 43.4 t30 -170.4 -106.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.105 -0.997 . . . . 72.31 109.297 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 5.5 t 61.99 -3.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.454 -0.779 . . . . 63.32 109.818 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.5 ' H ' ' C ' ' B' ' 182' ' ' ASN . 28.5 mt -69.63 -38.11 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.904 -1.123 . . . . 75.03 108.425 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -55.23 -53.3 57.74 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.822 -0.549 . . . . 64.11 109.759 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 30.7 m -73.28 -31.75 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.121 -0.987 . . . . 73.0 110.02 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.44 -56.61 13.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.058 -1.027 . . . . 61.12 109.848 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 10.8 tp -63.01 -29.75 47.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.898 -1.126 . . . . 72.43 109.421 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -68.9 -56.0 9.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 65.14 110.186 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 190' ' ' GLN . . . . . 0.409 ' O ' ' CB ' ' B' ' 194' ' ' LYS . 15.7 pt20 -66.14 -39.78 90.12 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.001 -1.062 . . . . 63.24 109.35 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 55.6 mt -54.65 -37.71 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.985 -1.072 . . . . 74.03 109.528 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -68.03 -52.85 30.76 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.074 -1.016 . . . . 72.24 110.48 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 193' ' ' GLN . . . . . 0.41 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 45.8 mt-30 -76.88 -14.25 59.9 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.999 -1.063 . . . . 73.1 110.113 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 194' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' B' ' 190' ' ' GLN . 53.4 tttp -92.43 -27.42 17.49 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.388 -0.82 . . . . 72.11 110.445 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 195' ' ' MET . . . . . 0.431 ' C ' ' SD ' ' B' ' 195' ' ' MET . 1.9 ppp? -90.56 -30.93 16.93 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.068 -1.02 . . . . 44.33 109.812 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 196' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 28.0 p-10 -58.87 -32.71 69.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.981 . . . . 71.21 109.747 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 197' ' ' LYS . . . . . 0.51 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 7.6 mmtp -63.03 -64.91 2.49 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 75.21 109.935 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 198' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 33.0 Cg_endo -61.96 -53.07 2.3 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.185 1.924 . . . . 75.32 112.352 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 199' ' ' LEU . . . . . 0.49 ' N ' HD12 ' B' ' 199' ' ' LEU . 10.0 mp -65.58 -40.23 92.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.031 -1.043 . . . . 72.25 109.324 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 77.72 -40.16 1.81 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.574 -1.411 . . . . 64.53 109.574 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 19.1 mm -97.65 146.25 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.24 -1.153 . . . . 44.23 109.478 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 38.8 t -85.75 141.07 29.96 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.23 -0.919 . . . . 54.01 109.245 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 13.8 p -142.7 18.22 2.0 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.181 -0.949 . . . . 74.4 109.904 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 21.9 m -140.7 137.05 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.189 -0.944 . . . . 72.12 109.437 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -116.34 135.68 53.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.576 -0.703 . . . . 65.41 109.342 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 1.4 p -93.59 132.23 38.11 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.174 -0.954 . . . . 71.33 108.946 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 25.5 t -138.92 143.66 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.331 -0.856 . . . . 63.5 109.539 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 208' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' B' ' 209' ' ' ARG . 91.4 mtt180 -60.07 164.89 3.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 74.45 109.611 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 209' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' B' ' 211' ' ' GLY . 80.4 mtm-85 52.46 176.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.868 . . . . 74.14 109.62 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 17.0 mmt85 53.85 -85.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.466 -0.771 . . . . 74.43 109.672 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 211' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' B' ' 209' ' ' ARG . . . 164.12 -96.66 0.14 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.482 -1.447 . . . . 64.45 109.482 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 212' ' ' TYR . . . . . 0.481 ' CD1' ' C ' ' B' ' 211' ' ' GLY . 52.8 m-85 -141.28 167.77 21.37 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.362 -1.081 . . . . 74.21 109.126 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -132.58 140.37 48.22 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.411 -0.806 . . . . 74.03 109.654 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 214' ' ' PHE . . . . . 0.512 ' O ' ' N ' ' B' ' 160' ' ' ASP . 2.3 m-85 -116.41 125.38 51.96 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.942 -0.762 . . . . 74.34 108.942 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 215' ' ' CYS . . . . . 0.577 ' SG ' ' N ' ' B' ' 216' ' ' TYR . 30.5 t -147.9 167.56 24.52 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.336 -0.852 . . . . 64.33 109.314 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 216' ' ' TYR . . . . . 0.577 ' N ' ' SG ' ' B' ' 215' ' ' CYS . 3.2 p90 -60.0 152.67 59.45 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.284 -0.885 . . . . 70.04 109.116 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.18 124.1 10.59 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.357 2.038 . . . . 65.11 112.044 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.638 ' N ' ' CD ' ' B' ' 219' ' ' PRO . 8.1 tptp -74.54 -35.62 2.23 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.2 -0.937 . . . . 73.15 110.356 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 219' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' B' ' 218' ' ' LYS . 32.1 Cg_exo -58.32 -22.0 55.6 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.076 1.851 . . . . 71.31 112.144 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -72.61 121.62 20.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 75.45 109.54 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 43.1 t -88.1 134.18 33.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.315 -0.866 . . . . 72.22 109.432 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -85.13 134.76 34.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 54.53 109.385 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.055 -0.974 . . . . 71.13 109.407 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.8 ttm . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.399 -0.593 . . . . 65.12 109.399 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -137.62 146.1 43.53 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.436 -0.79 . . . . 72.33 109.305 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 79.2 t -115.81 133.32 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-O 121.451 0.643 . . . . 71.42 109.746 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.544 HD11 ' CG1' ' A' ' 6' ' ' ILE . 2.4 tp -103.48 116.95 33.35 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.417 -0.957 . . . . 65.12 108.417 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 59.0 tp -117.33 114.54 23.73 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.918 -0.771 . . . . 62.43 108.918 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.544 ' CG1' HD11 ' A' ' 4' ' ' LEU . 52.4 mt -109.41 116.29 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.851 -0.796 . . . . 71.15 108.851 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 13' ' ' GLY . 61.7 tt0 -146.7 131.11 17.62 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.334 -0.854 . . . . 75.34 109.425 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -61.98 -35.78 79.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 72.44 109.58 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -86.23 116.85 24.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 63.02 109.492 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.4 p -73.12 -27.29 61.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.917 . . . . 72.34 109.623 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.7 t -63.75 -49.57 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.184 -0.948 . . . . 74.02 109.673 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.5 mm? -67.83 -42.29 81.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.928 . . . . 71.43 109.128 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.51 ' N ' ' OE1' ' A' ' 7' ' ' GLU . . . -67.19 -19.79 70.57 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.354 -1.898 . . . . 61.32 108.354 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.38 -58.88 5.68 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.457 -1.457 . . . . 71.2 109.457 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -52.84 -42.78 65.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.399 -1.059 . . . . 71.32 109.464 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.3 mm -64.05 -38.65 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.943 -1.098 . . . . 63.23 108.807 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -62.83 -52.49 62.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.837 . . . . 51.11 109.818 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -81.63 1.96 31.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -0.949 . . . . 73.34 109.632 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.24 -68.12 1.32 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.159 -1.576 . . . . 62.15 109.159 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp -56.16 -25.93 48.5 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.417 -1.049 . . . . 73.51 109.088 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -52.09 -33.95 41.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.305 -0.872 . . . . 74.25 109.212 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.3 t -55.52 -41.4 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 70.04 109.022 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.451 ' HZ2' ' CG1' ' A' ' 106' ' ' VAL . 2.1 mptm? -67.35 -22.58 65.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.358 -0.838 . . . . 73.23 108.994 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.14 38.42 4.32 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.153 -1.179 . . . . 75.54 110.153 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -112.74 159.33 19.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.413 -1.051 . . . . 73.43 108.62 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.0 mmt -99.63 138.55 36.56 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.304 -0.998 . . . . 43.24 108.304 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.13 160.51 40.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.902 . . . . 62.11 109.995 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -134.92 141.35 46.28 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.967 -0.753 . . . . 74.42 108.967 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -110.43 130.54 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.727 -0.842 . . . . 72.15 108.727 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.1 p -135.0 167.63 20.58 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.499 -0.75 . . . . 71.42 109.251 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.459 ' CG ' ' OD2' ' A' ' 35' ' ' ASP . 3.4 pt-20 -90.68 -99.86 0.1 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.245 -0.909 . . . . 72.33 109.564 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.0 p -78.77 166.59 22.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -0.867 . . . . 74.24 109.997 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 15.5 mt -56.02 -32.04 63.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.611 -0.68 . . . . 71.53 110.032 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -50.58 -45.83 57.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.031 -1.043 . . . . 74.23 109.793 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.459 ' OD2' ' CG ' ' A' ' 31' ' ' GLU . 67.9 m-20 -68.25 -43.05 78.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.054 -1.029 . . . . 54.03 109.364 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.43 -40.47 79.46 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.386 -1.486 . . . . 61.41 109.386 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -65.11 -38.92 92.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -1.113 . . . . 74.34 109.419 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -75.61 -36.73 60.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 75.33 109.48 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.7 tp -71.42 -45.76 61.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 74.33 109.905 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.444 ' O ' ' O ' ' A' ' 43' ' ' ARG . 3.2 ppp? -69.08 -20.37 64.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.074 -1.016 . . . . 70.32 109.857 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -60.73 -36.95 80.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.022 -1.049 . . . . 71.22 109.611 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.4 pt -89.23 -27.58 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.18 -0.95 . . . . 74.14 110.317 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 40' ' ' MET . 96.9 mtt180 -127.82 146.03 50.74 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.298 -0.877 . . . . 72.24 109.771 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.491 ' OD1' HD11 ' A' ' 69' ' ' ILE . 60.8 t30 -98.61 132.05 44.32 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.231 -0.918 . . . . 75.42 109.475 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -101.9 135.16 43.93 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.36 -0.838 . . . . 74.23 109.343 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -74.75 -35.26 62.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.948 . . . . 72.04 108.969 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.555 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.7 OUTLIER -112.72 115.8 29.11 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.426 -0.953 . . . . 72.13 108.426 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.555 ' N ' HD13 ' A' ' 47' ' ' LEU . 39.2 t -99.11 97.04 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.27 -1.011 . . . . 72.34 108.27 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.2 ttt -109.22 134.07 52.22 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.536 0.684 . . . . 74.11 109.611 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.444 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 1.3 p -143.96 131.66 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.461 -0.775 . . . . 61.12 109.505 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.3 p -96.99 2.97 52.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.501 -0.749 . . . . 73.11 109.125 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.444 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 47.5 m-20 -76.26 142.23 41.45 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.269 -0.895 . . . . 52.55 109.54 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.566 ' NZ ' ' H ' ' A' ' 76' ' ' ASP . 66.0 mmtt -79.07 -39.36 34.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 44.22 110.198 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -72.17 15.0 0.18 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.082 -1.011 . . . . 70.44 109.733 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.459 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.52 -19.75 59.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 64.14 110.411 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.531 HD13 ' NE2' ' A' ' 85' ' ' HIS . 22.0 mt -40.66 -50.22 3.05 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.428 -0.795 . . . . 44.14 110.473 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.0 m -68.14 -34.69 76.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.087 . . . . 55.23 109.262 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.534 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 55.9 t80 -65.81 -56.08 13.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -0.794 . . . . 74.44 110.115 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.6 m -54.57 -35.38 31.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 120.749 -1.219 . . . . 74.03 109.662 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.6 t -57.4 -54.48 46.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.097 -1.002 . . . . 64.3 109.655 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 ptp85 -66.05 -29.26 69.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.119 -0.988 . . . . 64.44 110.092 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.534 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 5.6 mm -65.63 -38.21 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.751 -1.218 . . . . 63.21 109.898 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.521 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 33.5 mmtt -69.63 -50.51 43.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.107 -0.996 . . . . 74.42 110.117 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -67.39 -35.46 79.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.762 -1.211 . . . . 70.32 109.767 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.471 ' C ' ' CG ' ' A' ' 66' ' ' HIS . 48.7 mtpt -81.77 -23.43 36.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.196 -0.94 . . . . 75.22 109.607 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.471 ' CG ' ' C ' ' A' ' 65' ' ' LYS . 59.4 m-70 -155.26 65.03 0.63 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.168 -0.957 . . . . 74.13 109.632 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 63' ' ' LYS . 33.1 t -61.06 -30.36 70.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.25 -0.906 . . . . 73.24 110.017 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.4 t -61.9 -19.83 63.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.958 . . . . 61.01 110.198 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.491 HD11 ' OD1' ' A' ' 44' ' ' ASN . 78.8 mt -87.81 152.97 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.1 -1.0 . . . . 71.33 109.945 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 71' ' ' VAL . 48.3 t -92.95 160.63 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.351 -0.843 . . . . 72.13 109.518 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.461 ' N ' HG12 ' A' ' 70' ' ' VAL . 43.2 t -134.59 129.81 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.348 -0.845 . . . . 54.21 109.898 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.2 tt -122.39 99.05 6.21 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.884 -0.784 . . . . 50.24 108.884 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.0 t -92.22 127.45 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.167 -0.958 . . . . 74.41 108.825 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.412 ' O ' ' OG ' ' A' ' 75' ' ' SER . 0.4 OUTLIER -92.97 -176.25 4.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.019 -1.051 . . . . 72.31 108.805 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.463 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 55.7 m -166.75 119.83 1.01 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.792 -1.193 . . . . 64.54 110.502 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.566 ' H ' ' NZ ' ' A' ' 53' ' ' LYS . 50.4 t0 -61.65 -32.33 72.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.541 -0.725 . . . . 74.13 109.807 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 79' ' ' THR . 44.8 t-20 -119.78 84.06 30.5 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.583 -0.698 . . . . 73.34 109.242 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -54.19 82.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.208 1.939 . . . . 63.22 111.341 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.493 HG23 ' H ' ' A' ' 82' ' ' GLU . 3.4 t -105.22 154.74 19.81 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.519 -0.738 . . . . 62.53 109.589 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.56 -32.61 73.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.402 -0.811 . . . . 73.44 109.78 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -55.08 -55.91 25.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 71.42 110.009 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.534 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 95.4 mt-10 -64.6 -35.39 80.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -0.957 . . . . 73.43 109.796 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.52 ' OE2' ' NH2' ' B' ' 108' ' ' ARG . 66.9 tt0 -63.91 -48.98 74.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.049 -1.032 . . . . 74.22 110.068 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.5 t -57.2 -57.56 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.167 -0.958 . . . . 73.2 110.313 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.57 ' ND1' ' N ' ' A' ' 86' ' ' ALA . 1.3 p-80 -64.83 -41.11 96.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.942 -1.099 . . . . 53.33 109.515 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.57 ' N ' ' ND1' ' A' ' 85' ' ' HIS . . . -46.93 -37.69 9.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 64.11 109.833 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -78.43 -34.32 47.96 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.103 -0.998 . . . . 74.34 108.761 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -67.5 -40.47 85.18 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.414 -0.914 . . . . 74.42 109.432 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.571 ' N ' ' NE2' ' A' ' 89' ' ' GLN . 0.7 OUTLIER -65.14 -56.88 10.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 74.24 109.614 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 152.13 44.58 0.02 OUTLIER Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.724 -1.227 . . . . 61.51 110.249 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -96.2 133.28 40.7 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.083 -1.245 . . . . 55.33 109.222 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.521 ' OD1' ' NZ ' ' A' ' 63' ' ' LYS . 72.7 m-20 -90.96 -22.53 20.79 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.085 -1.009 . . . . 73.42 109.677 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 94' ' ' TYR . 18.7 t0 -149.61 154.81 39.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.22 -0.925 . . . . 75.04 109.265 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.516 ' N ' ' OD1' ' A' ' 93' ' ' ASP . 71.3 t80 -136.86 105.65 5.88 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.522 -0.736 . . . . 71.33 109.257 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.409 HG22 ' N ' ' A' ' 96' ' ' ALA . 27.0 mm -111.47 155.69 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 O-C-N 121.127 -0.983 . . . . 71.13 110.735 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.409 ' N ' HG22 ' A' ' 95' ' ' ILE . . . -74.4 128.73 36.27 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.657 -1.238 . . . . 64.32 107.657 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.687 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -50.83 -57.28 14.04 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.715 -1.241 . . . . 62.2 111.399 -178.496 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 5.2 Cg_endo -41.5 -9.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.066 1.177 . . . . 73.11 112.797 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.687 ' N ' ' O ' ' A' ' 97' ' ' LYS . 24.9 m-85 62.81 108.66 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.339 -0.615 . . . . 65.22 109.339 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.526 ' NH1' ' OE2' ' B' ' 83' ' ' GLU . 21.6 ttm105 -52.81 -33.26 48.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.848 -1.157 . . . . 72.35 108.374 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 103' ' ' LYS . 2.3 m 172.37 48.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.552 -0.717 . . . . 71.32 109.524 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 105' ' ' LEU . 13.1 mt 37.6 -77.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 121.835 -0.541 . . . . 75.43 111.982 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.692 ' N ' ' O ' ' A' ' 101' ' ' SER . 28.0 mmtp -38.03 -38.8 0.34 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.533 -0.729 . . . . 71.41 110.26 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' B' ' 80' ' ' SER . . . -70.84 -43.51 68.37 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.206 -1.035 . . . . 63.24 108.206 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 102' ' ' ILE . 1.2 tt -60.85 -44.81 96.48 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.684 -0.858 . . . . 73.22 108.684 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.451 ' CG1' ' HZ2' ' A' ' 23' ' ' LYS . 15.6 t -69.43 -43.08 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 60.11 109.619 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.61 -42.61 62.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 70.42 109.174 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.75 -35.94 77.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 74.41 109.015 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.0 mt -70.87 -30.32 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.951 -1.093 . . . . 62.54 108.677 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -62.24 -53.47 54.71 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.381 -0.825 . . . . 74.34 108.782 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.09 -39.39 69.26 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.468 -0.77 . . . . 73.32 109.148 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 20.0 tpt85 -59.25 -32.63 70.17 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.265 -0.897 . . . . 52.41 109.145 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.4 tp -157.6 102.42 1.88 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.264 -0.898 . . . . 65.24 109.638 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.519 ' O ' ' CG ' ' A' ' 115' ' ' PHE . 23.1 mtm105 -94.84 -56.3 2.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.131 -0.981 . . . . 64.45 109.007 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.519 ' CG ' ' O ' ' A' ' 114' ' ' ARG . 82.4 m-85 -157.02 -58.14 0.09 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.182 -0.949 . . . . 74.43 109.213 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 62.7 m95 48.04 -122.59 1.53 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.317 -0.865 . . . . 74.42 109.695 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.1 43.38 56.8 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.152 -1.579 . . . . 75.04 109.152 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.1 m -100.37 147.97 25.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.375 -1.074 . . . . 61.14 109.564 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.541 HD21 ' C ' ' A' ' 121' ' ' ILE . 2.4 t30 -108.91 166.72 10.61 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.61 -0.681 . . . . 65.24 109.261 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.414 ' N ' ' CG ' ' A' ' 119' ' ' ASN . 4.4 t -124.68 -39.09 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.722 -0.611 . . . . 73.11 109.379 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.541 ' C ' HD21 ' A' ' 119' ' ' ASN . 17.1 mm -100.23 140.5 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.317 -0.864 . . . . 72.24 110.005 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.743 ' H ' HH12 ' A' ' 159' ' ' ARG . 86.4 mt-10 -135.61 119.31 17.15 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.382 -0.823 . . . . 72.34 108.901 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 37.8 mt -138.62 111.84 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.228 -0.92 . . . . 71.44 109.782 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 126' ' ' LEU . . . 65.61 46.51 83.98 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.209 -1.156 . . . . 73.4 110.209 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.901 ' HA ' ' OE2' ' A' ' 223' ' ' GLU . 3.6 m-20 67.25 -14.16 0.19 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.512 -0.993 . . . . 74.45 110.308 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.49 ' H ' ' C ' ' A' ' 124' ' ' GLY . 7.1 mt -76.99 155.24 32.76 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.61 -1.256 . . . . 54.21 107.61 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.88 129.28 46.63 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.368 -0.833 . . . . 54.5 109.49 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 74.8 mt -123.58 130.86 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.071 -0.714 . . . . 45.15 109.071 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.3 m -117.16 112.99 39.48 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 121.604 -0.685 . . . . 71.11 109.304 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.09 -51.09 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.106 1.871 . . . . 65.41 112.621 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -55.19 -45.68 75.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.063 -1.023 . . . . 63.32 109.532 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -81.53 -8.43 59.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 72.52 109.169 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 52.57 57.55 6.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.401 -0.812 . . . . 75.33 109.248 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -140.79 127.8 20.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.376 -0.828 . . . . 71.23 108.942 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.666 HD13 ' N ' ' A' ' 136' ' ' ILE . 0.2 OUTLIER -107.08 126.32 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.362 -0.836 . . . . 74.02 109.147 -179.586 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.666 ' N ' HD13 ' A' ' 135' ' ' ILE . 40.9 mt -117.86 126.76 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.532 -0.73 . . . . 60.23 109.951 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -137.25 142.66 42.01 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.355 -0.841 . . . . 62.32 108.954 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp 54.83 14.04 0.83 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.575 -0.703 . . . . 75.4 110.272 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 92.33 -6.56 78.23 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.49 -1.044 . . . . 72.24 110.49 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.473 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 1.0 OUTLIER -87.99 124.87 34.16 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.858 -1.378 . . . . 71.22 108.651 179.614 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -94.3 129.23 41.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.084 -1.01 . . . . 71.42 110.049 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.6 t -135.96 133.48 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.513 -0.742 . . . . 53.02 109.046 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -88.36 131.68 34.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.415 -0.803 . . . . 60.45 109.603 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.45 150.25 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.571 -0.9 . . . . 74.44 108.571 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -162.38 113.92 1.61 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.012 -1.055 . . . . 65.15 109.653 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.608 ' O ' ' HB2' ' A' ' 150' ' ' GLU . . . 163.37 -169.07 38.32 Favored Glycine 0 N--CA 1.486 1.983 0 C-N-CA 119.511 -1.328 . . . . 73.34 109.899 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.54 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 41.7 mttp -78.06 -41.68 2.08 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.506 -0.996 . . . . 72.22 111.897 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 147' ' ' LYS . 36.7 Cg_endo -65.44 -30.38 52.93 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 CA-C-N 120.49 1.211 . . . . 65.23 111.891 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -94.38 -19.07 20.95 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.042 -1.037 . . . . 60.11 109.554 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.608 ' HB2' ' O ' ' A' ' 146' ' ' GLY . 34.9 tp10 -68.24 -43.32 78.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.356 -0.84 . . . . 64.21 108.907 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.0 p -61.66 -30.17 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.465 -0.939 . . . . 72.02 108.465 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 31.0 tp -65.61 -45.33 83.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.544 -0.723 . . . . 73.31 109.169 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.3 p -71.05 -30.1 66.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.945 . . . . 74.31 109.3 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -61.54 -53.46 56.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.168 -0.958 . . . . 74.31 109.742 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 156' ' ' ALA . 4.4 pp -69.87 -22.65 63.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 75.34 109.33 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.718 ' N ' HD12 ' A' ' 155' ' ' LEU . . . -60.67 -49.12 78.79 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.341 -0.85 . . . . 62.14 109.243 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.424 ' C ' ' H ' ' A' ' 159' ' ' ARG . 36.8 mtp180 -75.33 -44.39 45.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.025 -1.047 . . . . 61.03 109.164 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -77.71 26.43 0.18 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.255 -0.903 . . . . 74.12 109.412 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.743 HH12 ' H ' ' A' ' 122' ' ' GLU . 36.5 ptt180 -59.98 169.5 1.48 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.39 -0.819 . . . . 71.13 109.405 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.0 t0 46.47 65.49 1.19 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.316 -0.865 . . . . 75.45 109.484 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -169.94 149.67 3.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.123 -0.985 . . . . 73.41 109.792 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.402 HG21 ' HE ' ' A' ' 210' ' ' ARG . 75.5 mt -81.36 105.15 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.226 -1.027 . . . . 74.41 108.226 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 12.1 t -91.51 128.66 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.38 -0.825 . . . . 72.31 109.978 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.1 p -86.6 164.15 17.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.844 . . . . 74.12 109.052 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.482 ' NZ ' ' CB ' ' A' ' 165' ' ' LYS . 6.6 mtpm? -63.68 -48.12 78.46 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.257 -0.902 . . . . 70.43 110.185 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -56.0 -32.5 64.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.425 -0.797 . . . . 73.52 110.785 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -56.19 -56.06 25.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.973 -1.079 . . . . 74.52 110.119 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 51.2 mt -61.52 -41.69 97.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.165 -0.959 . . . . 72.31 110.372 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.547 HD13 ' C ' ' A' ' 169' ' ' LEU . 1.6 tm? -62.24 -55.63 26.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.005 -1.06 . . . . 53.33 109.868 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 49.6 t0 -71.07 -13.18 61.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.134 -0.979 . . . . 62.44 110.45 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.97 -62.97 1.53 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.025 -1.047 . . . . 60.21 110.998 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.688 HD12 ' N ' ' A' ' 172' ' ' ILE . 2.1 mp -73.23 -47.62 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 120.912 -1.117 . . . . 75.32 108.183 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 24.0 m-90 -95.18 119.4 33.62 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.559 -0.904 . . . . 73.14 108.559 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -151.66 -53.56 0.13 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.215 -0.928 . . . . 73.24 108.708 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 177' ' ' GLU . 12.4 mt-10 -60.16 154.89 48.72 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.001 -1.111 . . . . 44.43 108.001 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.421 ' C ' ' O ' ' A' ' 175' ' ' GLU . 32.2 Cg_exo -30.94 88.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.74 2.293 . . . . 72.51 112.478 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 175' ' ' GLU . 33.9 mm-40 -127.3 160.02 32.6 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 109.166 -0.679 . . . . 63.24 109.166 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 65.2 mtt -103.38 93.07 4.77 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.421 -0.8 . . . . 73.5 109.345 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 35.9 m -100.46 135.41 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.285 -0.885 . . . . 65.22 109.221 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.434 ' H ' HG23 ' A' ' 180' ' ' THR . 1.4 p -68.8 148.61 97.99 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.166 -0.959 . . . . 71.42 108.527 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.432 ' O ' ' OD1' ' A' ' 182' ' ' ASN . 99.1 Cg_exo -39.98 -30.67 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 121.974 1.783 . . . . 41.22 112.282 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 181' ' ' PRO . 69.7 m-80 -155.77 112.8 3.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.384 -0.823 . . . . 64.54 109.408 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.411 ' O ' HG22 ' A' ' 183' ' ' VAL . 3.2 p -143.71 -14.11 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.201 -0.937 . . . . 74.02 110.294 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 6.1 tt -56.1 -23.08 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.743 -1.223 . . . . 72.33 109.738 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -58.23 -49.66 76.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 74.4 109.837 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 16.4 m -76.35 -25.02 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.89 -1.132 . . . . 70.42 109.663 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.19 -46.59 49.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.058 -1.026 . . . . 52.11 110.1 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.8 tp -67.95 -30.93 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.911 -1.118 . . . . 71.4 109.093 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -70.02 -57.42 5.02 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.372 -0.83 . . . . 73.44 109.99 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.439 ' CG ' ' N ' ' A' ' 191' ' ' ILE . 7.7 pt20 -63.06 -43.85 97.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 71.42 109.983 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.439 ' N ' ' CG ' ' A' ' 190' ' ' GLN . 51.0 mt -53.69 -49.29 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.112 -0.992 . . . . 61.55 109.165 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -54.63 -40.56 69.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.003 . . . . 63.34 109.249 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -62.51 -35.97 81.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.142 -0.973 . . . . 61.24 109.538 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -93.0 -0.05 57.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.207 -0.933 . . . . 75.13 110.382 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 31.9 ttm -95.72 -63.01 1.2 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.005 -1.059 . . . . 74.02 109.389 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 200' ' ' GLY . 84.5 m-20 -60.66 -29.08 69.07 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.439 -0.788 . . . . 74.02 110.095 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.438 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 30.7 mttm -58.64 -65.75 1.78 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.053 -1.03 . . . . 75.43 110.06 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 26.7 Cg_endo -60.96 -52.83 3.11 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.915 1.743 . . . . 72.32 112.108 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' A' ' 201' ' ' ILE . 26.0 mt -66.35 -34.83 78.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.946 -1.096 . . . . 74.54 109.154 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 196' ' ' ASP . . . 77.65 -31.67 1.68 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.038 -1.625 . . . . 61.51 109.038 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.459 ' H ' ' C ' ' A' ' 199' ' ' LEU . 27.6 mm -95.89 129.45 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.41 -1.053 . . . . 61.22 109.286 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 64.9 m -78.8 139.22 38.42 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.603 -0.888 . . . . 72.0 108.603 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 38.5 p -142.57 13.77 1.95 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.216 -0.928 . . . . 74.44 109.814 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.33 131.77 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.765 -0.828 . . . . 64.35 108.765 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.41 ' OE1' ' SG ' ' A' ' 215' ' ' CYS . 30.1 mt-10 -117.01 123.45 46.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.636 -0.665 . . . . 71.41 109.509 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.99 98.93 10.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.319 -0.863 . . . . 73.52 108.715 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 208' ' ' ARG . 12.0 m -152.41 172.14 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.227 -0.921 . . . . 71.02 109.415 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 207' ' ' VAL . 70.2 mtt85 55.44 164.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.621 -0.674 . . . . 72.12 109.702 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.483 ' O ' ' N ' ' A' ' 211' ' ' GLY . 80.9 mtt85 -72.61 -126.11 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.21 -0.931 . . . . 64.41 109.398 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.402 ' HE ' HG21 ' A' ' 162' ' ' ILE . 75.6 mtp85 50.1 -91.44 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.3 -0.875 . . . . 71.54 109.928 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . -158.78 -97.7 0.13 Allowed Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.496 -1.335 . . . . 72.03 110.39 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -137.21 148.28 46.4 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.344 -1.092 . . . . 75.54 110.103 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -107.39 126.54 52.6 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.475 -0.766 . . . . 75.31 109.619 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.623 ' CE2' HD13 ' A' ' 155' ' ' LEU . 8.6 t80 -104.17 134.61 47.14 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.283 -1.006 . . . . 75.41 108.283 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' CYS . . . . . 0.41 ' SG ' ' OE1' ' A' ' 205' ' ' GLU . 31.1 p -153.51 164.43 38.24 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.173 -0.954 . . . . 74.14 109.926 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -59.33 152.82 51.78 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 75.32 109.106 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.13 -45.32 0.46 Allowed 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.237 1.958 . . . . 73.11 111.407 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 220' ' ' ALA . 0.0 OUTLIER -161.65 151.48 14.0 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.827 -0.805 . . . . 75.25 108.827 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -38.8 86.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 122.209 1.939 . . . . 75.1 112.488 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.587 ' HB1' ' OE1' ' A' ' 223' ' ' GLU . . . -70.91 -63.56 1.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.068 -1.02 . . . . 71.14 109.463 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 95.3 m 49.19 -112.13 0.51 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.145 -0.972 . . . . 71.13 109.467 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -75.38 138.08 41.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.125 -0.984 . . . . 75.35 109.688 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.901 ' OE2' ' HA ' ' A' ' 125' ' ' ASP . 11.0 pt-20 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.024 -0.989 . . . . 73.41 109.538 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.414 ' SD ' HD11 ' B' ' 113' ' ' LEU . 32.0 tpp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.492 -0.558 . . . . 71.14 109.492 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.524 ' N ' ' OD2' ' B' ' 46' ' ' ASP . 78.4 mtm-85 -140.33 151.81 45.33 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.355 -0.841 . . . . 73.23 109.286 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.8 t -112.23 129.39 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.623 -0.673 . . . . 72.24 109.274 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.509 HD12 ' N ' ' B' ' 5' ' ' LEU . 2.5 tp -104.46 121.12 42.78 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.579 -0.7 . . . . 54.33 109.566 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.509 ' N ' HD12 ' B' ' 4' ' ' LEU . 11.1 mt -118.92 98.83 6.39 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 109.031 -0.729 . . . . 74.35 109.031 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.462 ' CG1' HD11 ' B' ' 4' ' ' LEU . 55.7 mt -84.1 98.86 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.834 -1.166 . . . . 42.55 108.664 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.43 ' OE2' ' OG ' ' B' ' 51' ' ' SER . 9.3 tp10 -140.97 130.59 24.06 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.293 -0.88 . . . . 74.52 109.485 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -66.06 -35.31 80.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.346 -0.846 . . . . 62.55 109.249 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -77.02 112.26 13.46 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.376 -0.828 . . . . 73.11 109.385 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 95.4 p -74.27 -30.29 62.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 65.54 110.158 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.555 HG13 ' N ' ' B' ' 12' ' ' LEU . 9.3 p -59.1 -45.38 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.005 -1.059 . . . . 75.55 109.704 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.555 ' N ' HG13 ' B' ' 11' ' ' VAL . 80.9 mt -65.06 -31.58 72.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.06 -1.025 . . . . 70.14 109.309 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.25 -28.04 62.77 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.649 -1.781 . . . . 75.4 108.649 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.62 -56.01 19.54 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.506 -1.437 . . . . 65.44 109.506 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.52 -41.85 90.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.342 -1.093 . . . . 60.21 109.515 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.69 -43.29 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.975 -1.078 . . . . 75.15 108.846 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -58.53 -43.94 89.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.451 -0.78 . . . . 73.01 109.559 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -86.58 0.4 54.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.103 -0.998 . . . . 74.3 109.083 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.76 -58.63 1.89 Allowed Glycine 0 N--CA 1.484 1.894 0 N-CA-C 109.479 -1.448 . . . . 70.54 109.479 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -69.37 -22.31 63.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -1.144 . . . . 71.34 109.557 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 29.3 m-20 -51.67 -34.07 36.59 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.223 -0.923 . . . . 64.41 109.416 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 79.0 t -56.76 -39.91 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.093 -1.004 . . . . 74.23 108.884 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.448 ' CD ' ' N ' ' B' ' 23' ' ' LYS . 4.2 mptp? -70.59 -27.52 64.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.376 -0.828 . . . . 63.42 109.344 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.58 41.22 2.21 Favored Glycine 0 N--CA 1.499 2.893 0 N-CA-C 110.208 -1.157 . . . . 53.43 110.208 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.405 ' CZ ' HD23 ' B' ' 113' ' ' LEU . 54.0 m-85 -119.58 161.16 21.1 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.427 -1.043 . . . . 71.12 109.203 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 18.3 mmt -103.08 140.89 36.72 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.746 -0.835 . . . . 75.24 108.746 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.419 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -137.53 154.45 49.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.303 -0.873 . . . . 72.12 110.167 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 96.1 m-20 -140.63 158.11 44.46 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.535 -0.913 . . . . 72.31 108.535 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 5.0 p -122.79 140.01 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.41 -0.806 . . . . 64.43 109.947 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.2 p -131.86 171.82 13.07 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.132 -0.692 . . . . 65.41 109.132 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -91.85 -107.09 0.1 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.235 -0.915 . . . . 71.02 109.792 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 33.3 t -78.79 168.87 19.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.292 -0.88 . . . . 51.11 110.022 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 39.0 mt -52.4 -30.91 31.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.593 -0.692 . . . . 71.24 109.877 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -53.9 -49.75 67.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.113 -0.992 . . . . 74.32 109.769 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -66.03 -44.79 83.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.153 -0.967 . . . . 73.03 109.365 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.61 -40.12 94.02 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.393 -1.483 . . . . 30.21 109.393 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -64.67 -43.85 92.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.337 -1.096 . . . . 74.42 109.456 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -71.29 -37.89 71.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.179 -0.95 . . . . 74.42 109.774 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 51.8 tp -69.51 -45.27 69.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 75.41 110.068 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' MET . . . . . 0.449 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.4 ppp? -74.29 -19.68 60.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.007 -1.058 . . . . 60.41 110.005 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.39 -41.81 80.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.105 -0.997 . . . . 53.23 109.697 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 pt -86.95 -41.44 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.122 -0.986 . . . . 71.23 109.854 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' B' ' 40' ' ' MET . 2.8 mpt_? -104.54 138.48 40.84 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.279 -0.888 . . . . 72.22 109.148 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' ASN . . . . . 0.478 ' C ' ' NH2' ' B' ' 2' ' ' ARG . 55.3 t-20 -100.59 89.89 4.08 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.377 -0.827 . . . . 63.54 109.205 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -63.56 149.22 46.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 64.35 109.275 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' B' ' 2' ' ' ARG . 3.9 p30 -80.42 -44.1 19.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 62.22 109.368 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.545 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.6 OUTLIER -103.37 115.02 29.75 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.458 -0.941 . . . . 73.12 108.458 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.545 ' N ' HD13 ' B' ' 47' ' ' LEU . 74.8 t -99.01 96.43 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.38 -0.97 . . . . 65.11 108.38 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 22.8 ttt -109.26 134.2 52.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.482 -0.761 . . . . 73.44 109.908 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.22 137.11 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.008 -0.738 . . . . 34.5 109.008 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' SER . . . . . 0.43 ' OG ' ' OE2' ' B' ' 7' ' ' GLU . 41.8 p -100.22 0.03 39.58 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.468 -0.77 . . . . 73.21 109.967 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -76.35 130.42 38.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 70.41 109.521 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.429 ' C ' ' N ' ' B' ' 55' ' ' ALA . 27.5 mtmm -66.51 -48.43 69.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 65.0 109.931 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -50.04 -16.52 0.3 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.144 -0.973 . . . . 75.21 109.367 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.429 ' N ' ' C ' ' B' ' 53' ' ' LYS . . . -59.68 -21.44 60.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.422 -0.799 . . . . 55.33 110.18 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 23.1 mt -43.02 -46.44 5.52 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.305 -0.872 . . . . 63.14 110.065 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 25.2 t -70.89 -34.32 71.46 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.05 -1.031 . . . . 63.5 109.347 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' PHE . . . . . 0.495 ' CE2' HD11 ' B' ' 62' ' ' ILE . 73.4 t80 -67.45 -53.43 29.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.408 -0.808 . . . . 72.33 110.123 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.64 -33.89 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.825 -1.172 . . . . 74.54 109.73 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 9.3 t -59.74 -52.06 67.09 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.174 -0.953 . . . . 71.24 109.454 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -67.7 -27.79 67.12 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.007 -1.058 . . . . 74.31 109.876 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.495 HD11 ' CE2' ' B' ' 58' ' ' PHE . 4.7 mm -59.29 -51.63 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.932 -1.105 . . . . 72.14 109.083 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -60.41 -41.0 92.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.097 -1.002 . . . . 73.32 108.754 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -67.1 -51.73 50.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -0.862 . . . . 73.12 108.746 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -72.6 -74.76 0.16 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.599 -0.688 . . . . 72.44 109.554 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.505 ' O ' HG22 ' B' ' 69' ' ' ILE . 90.2 m-70 -90.69 92.24 8.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.144 -0.973 . . . . 63.31 109.176 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 74.8 m -79.83 -27.64 40.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 73.1 109.876 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 51.7 p -87.11 47.69 1.54 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.188 -0.945 . . . . 71.53 110.153 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.505 HG22 ' O ' ' B' ' 66' ' ' HIS . 15.9 tt -144.83 159.85 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.049 -1.032 . . . . 74.4 109.171 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.494 HG21 ' NH1' ' B' ' 112' ' ' ARG . 43.1 t -103.32 147.5 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.291 -0.881 . . . . 75.12 109.206 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 t -133.29 127.97 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.41 -0.806 . . . . 73.2 109.655 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.548 ' C ' HD23 ' B' ' 72' ' ' LEU . 5.3 tt -122.65 105.29 9.95 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.617 -0.677 . . . . 73.34 109.423 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.435 ' O ' HG13 ' B' ' 73' ' ' VAL . 14.8 p -94.25 132.44 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.012 -1.055 . . . . 73.5 109.497 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 9.5 p -89.63 171.63 9.54 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.985 -1.072 . . . . 64.34 108.723 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 27.4 p -152.54 112.05 3.91 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.817 -1.177 . . . . 74.53 110.713 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -74.28 -4.63 37.28 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.62 -0.881 . . . . 64.5 108.62 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -143.09 71.38 18.43 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 108.86 -0.793 . . . . 74.25 108.86 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.4 87.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.808 1.672 . . . . 74.43 111.701 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.43 ' OG1' ' OE2' ' B' ' 82' ' ' GLU . 44.3 p -107.43 155.77 19.67 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.683 -0.858 . . . . 73.12 108.683 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 80' ' ' SER . . . . . 0.403 ' HB2' ' HB2' ' A' ' 104' ' ' ALA . 1.1 p -61.01 -30.42 70.29 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.214 -0.929 . . . . 71.01 109.58 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.09 -43.01 88.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.921 . . . . 63.2 109.804 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' B' ' 82' ' ' GLU . 0.2 OUTLIER -66.29 -33.14 75.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 73.22 109.633 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.526 ' OE2' ' NH1' ' A' ' 100' ' ' ARG . 46.5 mt-10 -64.52 -46.51 82.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.017 -1.052 . . . . 74.3 109.535 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.06 -42.09 93.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.186 -0.946 . . . . 73.31 109.328 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' HIS . . . . . 0.438 ' O ' ' OE1' ' B' ' 89' ' ' GLN . 18.6 m170 -72.13 -20.33 61.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.215 -0.928 . . . . 73.24 109.639 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.24 -44.59 62.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.04 -1.038 . . . . 55.33 110.119 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -81.37 -35.23 31.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.002 -1.061 . . . . 74.14 109.487 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.95 -43.0 97.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.073 -1.017 . . . . 64.04 109.375 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' GLN . . . . . 0.438 ' OE1' ' O ' ' B' ' 85' ' ' HIS . 0.5 OUTLIER -67.91 -61.29 1.94 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 72.35 109.259 179.833 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 149.7 64.72 0.01 OUTLIER Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.732 -1.223 . . . . 65.2 110.154 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.51 134.44 55.22 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.493 -1.004 . . . . 52.23 108.971 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -68.22 -43.35 78.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.049 -1.032 . . . . 73.32 108.959 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' B' ' 93' ' ' ASP . 18.3 p-10 -153.81 165.14 36.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.449 -0.782 . . . . 72.22 109.253 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.537 ' O ' ' CD1' ' B' ' 94' ' ' TYR . 0.2 OUTLIER -136.19 119.09 16.29 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.364 -0.606 . . . . 64.42 109.364 -178.345 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 28.6 mm -113.67 150.66 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 O-C-N 121.379 -0.826 . . . . 72.23 110.144 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' ALA . . . . . 0.491 ' HB1' ' HD2' ' B' ' 98' ' ' PRO . . . -61.84 141.06 58.17 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.011 -1.107 . . . . 25.24 108.011 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.594 ' N ' ' CD ' ' B' ' 98' ' ' PRO . 0.0 OUTLIER -68.85 -40.26 16.4 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.944 -1.098 . . . . 64.32 110.922 -178.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 98' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' B' ' 97' ' ' LYS . 34.0 Cg_exo -53.16 -0.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.289 -2.557 0 CA-C-N 118.697 0.571 . . . . 63.33 112.135 -174.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' TYR . . . . . 0.566 ' N ' ' O ' ' B' ' 97' ' ' LYS . 60.2 m-85 53.0 102.3 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.525 -0.734 . . . . 75.13 109.935 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 38.3 mtt-85 -57.63 -35.84 71.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.925 -1.109 . . . . 74.23 108.77 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 101' ' ' SER . . . . . 0.777 ' O ' ' N ' ' B' ' 103' ' ' LYS . 27.1 t -171.27 29.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -0.934 . . . . 63.34 110.77 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 18.7 mt 48.11 -68.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-N 118.539 0.609 . . . . 74.44 110.418 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.777 ' N ' ' O ' ' B' ' 101' ' ' SER . 55.3 mttp -51.59 -31.72 25.96 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.693 -1.225 . . . . 71.11 107.693 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.84 -42.89 89.93 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.194 -1.039 . . . . 71.45 108.194 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 50.8 tp -60.79 -42.71 98.1 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.549 -0.908 . . . . 51.31 108.549 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 20.3 t -69.78 -34.23 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 65.23 109.229 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.51 -47.35 73.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.152 -0.968 . . . . 24.32 109.441 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 0.52 ' NH2' ' OE2' ' A' ' 83' ' ' GLU . 26.2 ttm105 -69.28 -37.08 77.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 75.31 109.789 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 97.7 mt -70.16 -26.66 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.04 -1.038 . . . . 54.24 108.921 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -74.98 -56.91 4.27 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.455 -0.778 . . . . 65.31 109.94 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -52.0 -35.74 47.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.071 -1.018 . . . . 72.24 109.81 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' ARG . . . . . 0.532 HH21 HD23 ' B' ' 47' ' ' LEU . 38.6 ttp85 -85.98 -57.02 3.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.113 -0.992 . . . . 72.04 110.545 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.414 HD11 ' SD ' ' B' ' 1' ' ' MET . 35.2 tp -54.7 -36.46 64.71 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.086 -1.008 . . . . 75.35 110.409 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -46.71 -33.24 4.15 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.125 -0.984 . . . . 75.5 109.611 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 115' ' ' PHE . . . . . 0.532 ' O ' ' N ' ' B' ' 117' ' ' GLY . 11.2 m-85 -54.38 -29.71 49.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.859 . . . . 65.33 108.994 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 4.3 t-105 60.47 -75.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.444 -0.785 . . . . 74.45 109.59 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 117' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' B' ' 115' ' ' PHE . . . -163.18 -171.34 29.3 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.281 -1.528 . . . . 44.21 109.281 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 118' ' ' SER . . . . . 0.642 ' CB ' ' OE2' ' B' ' 132' ' ' GLU . 7.6 t -154.85 174.48 15.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.148 -1.207 . . . . 71.4 110.011 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.29 114.37 4.44 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.983 -0.687 . . . . 72.32 109.159 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 11.9 t -78.51 -39.97 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.264 -0.897 . . . . 75.02 109.73 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 17.3 mm -101.7 127.45 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.231 -0.918 . . . . 51.41 109.365 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.464 ' CD ' ' N ' ' B' ' 122' ' ' GLU . 1.0 OUTLIER -135.2 114.64 12.52 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.529 -0.732 . . . . 71.53 109.267 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 11.2 pt -140.97 137.35 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.216 -0.928 . . . . 72.43 109.2 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.18 -149.89 3.4 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.441 -1.464 . . . . 51.23 109.441 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -83.19 -0.39 49.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -1.168 . . . . 74.2 109.332 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.31 132.82 42.68 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.288 -0.882 . . . . 75.42 108.706 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 4.4 p -129.81 120.33 24.82 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.97 -0.752 . . . . 74.22 108.97 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 18.2 mm -107.24 144.68 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.492 -0.755 . . . . 60.33 109.042 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 3.4 m -126.84 79.44 72.31 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 121.446 -0.784 . . . . 72.31 109.7 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -50.96 -40.36 58.56 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.51 2.14 . . . . 75.13 112.132 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -68.01 -50.12 57.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.87 . . . . 75.23 109.934 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 132' ' ' GLU . . . . . 0.642 ' OE2' ' CB ' ' B' ' 118' ' ' SER . 88.7 mt-10 -82.38 -1.16 49.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.119 -0.988 . . . . 72.43 109.701 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 50.39 51.97 15.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.946 . . . . 75.13 109.235 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -138.19 136.84 37.01 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.371 -0.83 . . . . 73.22 109.242 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 7.8 tt -119.23 139.2 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.565 -0.709 . . . . 64.14 109.579 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 32.0 mt -126.36 125.17 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.8 -0.815 . . . . 71.22 108.8 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -142.49 151.36 41.6 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.235 -1.024 . . . . 64.22 108.235 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 16.9 tptm 60.11 8.16 1.42 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.572 -0.851 . . . . 72.02 109.07 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.41 -8.82 79.18 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.866 -1.294 . . . . 74.32 109.866 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 140' ' ' ARG . . . . . 0.505 ' CD ' ' N ' ' B' ' 140' ' ' ARG . 0.5 OUTLIER -90.53 141.25 28.95 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.113 -1.228 . . . . 75.34 109.214 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -97.8 129.87 44.77 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.27 -0.894 . . . . 71.23 109.632 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 47.7 t -138.43 132.51 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.389 -0.819 . . . . 70.43 109.075 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -87.1 143.72 27.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.205 -0.934 . . . . 72.43 109.727 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.48 132.28 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.337 -0.852 . . . . 72.13 109.388 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 145' ' ' LYS . . . . . 0.899 ' O ' ' HE2' ' B' ' 149' ' ' PHE . 0.0 OUTLIER -148.89 124.73 10.56 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.119 -0.988 . . . . 72.02 109.23 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 146' ' ' GLY . . . . . 0.765 ' N ' ' HD2' ' B' ' 149' ' ' PHE . . . 155.63 178.27 29.68 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.532 -1.427 . . . . 42.23 109.532 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 0.62 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 26.5 mtpt -70.88 -35.85 4.67 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.208 -1.172 . . . . 73.3 110.243 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 148' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 23.3 Cg_exo -63.49 -30.05 71.39 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.942 1.761 . . . . 71.33 111.772 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 149' ' ' PHE . . . . . 0.899 ' HE2' ' O ' ' B' ' 145' ' ' LYS . 0.2 OUTLIER -92.03 -28.22 17.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.404 -0.81 . . . . 74.23 109.079 -179.61 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -51.74 -35.89 45.11 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.363 -0.835 . . . . 72.34 109.802 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.527 HG13 ' N ' ' B' ' 152' ' ' LEU . 11.4 p -63.36 -41.28 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.162 -0.961 . . . . 73.35 109.398 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.553 HD13 ' O ' ' B' ' 152' ' ' LEU . 0.3 OUTLIER -58.5 -42.56 87.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.38 -0.825 . . . . 55.24 109.088 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 16.0 p -71.13 -34.3 70.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.085 -1.01 . . . . 70.01 110.218 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -59.13 -53.73 55.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.056 -1.027 . . . . 65.32 109.628 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.82 -23.57 61.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.946 -1.096 . . . . 71.54 109.526 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.38 -50.32 71.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.197 -0.94 . . . . 75.32 109.22 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.483 ' C ' ' H ' ' B' ' 159' ' ' ARG . 13.8 mtp-105 -71.47 -47.61 54.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 73.32 108.851 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -75.84 32.76 0.12 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.507 -0.745 . . . . 74.14 109.013 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 159' ' ' ARG . . . . . 0.483 ' H ' ' C ' ' B' ' 157' ' ' ARG . 34.0 ptt180 -50.67 -33.94 24.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.423 -0.798 . . . . 61.41 110.389 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 160' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' B' ' 160' ' ' ASP . 18.4 p30 -121.49 79.25 1.52 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.33 -0.856 . . . . 72.1 109.697 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -171.72 156.5 4.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.305 -0.872 . . . . 72.25 109.644 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 162' ' ' ILE . . . . . 0.795 HD12 ' N ' ' B' ' 162' ' ' ILE . 1.9 mp -94.1 139.27 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.205 -0.935 . . . . 72.31 109.025 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 63.5 t -133.95 142.52 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.416 -0.802 . . . . 64.21 109.594 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 4.7 p -91.78 166.38 12.79 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.21 -0.931 . . . . 74.22 110.422 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -64.47 -46.09 84.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.511 -0.743 . . . . 65.31 109.987 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -57.97 -38.25 75.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 63.45 110.15 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 167' ' ' GLN . . . . . 0.423 ' O ' ' OD1' ' B' ' 170' ' ' ASP . 63.3 tp60 -58.56 -48.54 80.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 72.4 109.795 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 33.1 mt -60.17 -36.09 76.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.92 . . . . 72.32 109.551 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.546 HD23 ' C ' ' B' ' 169' ' ' LEU . 3.6 tt -55.9 -68.89 0.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.364 -0.835 . . . . 73.34 109.756 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 170' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' B' ' 167' ' ' GLN . 26.4 p30 -64.37 -11.19 30.16 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.473 -0.767 . . . . 72.1 110.802 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.57 -58.5 3.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.979 -1.076 . . . . 62.13 110.224 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.684 ' N ' HD12 ' B' ' 172' ' ' ILE . 2.0 mp -94.38 -50.4 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.018 -1.051 . . . . 71.42 109.47 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 173' ' ' TRP . . . . . 0.441 ' O ' ' O ' ' B' ' 169' ' ' LEU . 16.1 m-90 -95.72 124.32 39.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.297 -0.877 . . . . 72.23 109.452 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -154.02 -34.67 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.164 -0.96 . . . . 52.11 109.512 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 175' ' ' GLU . . . . . 0.595 ' N ' ' CD ' ' B' ' 176' ' ' PRO . 0.0 OUTLIER -72.93 -39.95 5.74 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.114 -0.992 . . . . 73.04 109.681 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' B' ' 175' ' ' GLU . 71.0 Cg_endo -92.68 68.0 0.66 Allowed 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.648 2.232 . . . . 74.13 112.19 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -63.84 -11.07 24.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.283 -0.886 . . . . 72.44 109.804 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 13.5 mmt -59.8 -27.72 66.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 63.43 110.13 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 179' ' ' VAL . . . . . 0.403 HG22 ' O ' ' B' ' 176' ' ' PRO . 25.1 m -61.95 152.57 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.109 -0.994 . . . . 71.05 109.783 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 1.2 p -78.64 154.03 78.52 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.334 -0.854 . . . . 62.15 109.362 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -75.66 -26.13 10.2 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.479 2.119 . . . . 65.22 111.989 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -72.23 -0.79 12.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 72.31 109.624 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 83.0 t -65.19 -29.01 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.257 -0.902 . . . . 63.32 109.66 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 61.7 mt -53.3 -40.71 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 75.03 110.102 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 185' ' ' GLU . . . . . 0.583 ' O ' ' ND2' ' B' ' 189' ' ' ASN . 22.6 mt-10 -56.17 -37.39 69.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.041 -1.037 . . . . 64.11 108.881 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.92 -54.63 9.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.452 -0.78 . . . . 73.0 109.765 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -54.28 -36.96 64.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.274 -0.892 . . . . 61.12 110.465 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 188' ' ' ILE . . . . . 0.439 ' CG2' ' N ' ' B' ' 189' ' ' ASN . 7.7 tp -75.38 -43.54 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.681 -1.262 . . . . 72.43 109.667 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 189' ' ' ASN . . . . . 0.583 ' ND2' ' O ' ' B' ' 185' ' ' GLU . 51.8 m-20 -61.65 -38.14 86.63 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.218 -0.926 . . . . 65.14 109.271 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -72.3 -47.72 47.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.952 . . . . 63.24 109.615 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 191' ' ' ILE . . . . . 0.441 ' O ' ' SD ' ' B' ' 195' ' ' MET . 57.4 mt -55.29 -40.52 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.155 -0.966 . . . . 74.03 109.093 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -63.06 -43.36 98.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 72.24 109.654 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -73.25 -30.83 63.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 73.1 109.87 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -82.01 -19.92 39.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.303 -0.873 . . . . 72.11 110.441 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 195' ' ' MET . . . . . 0.563 ' N ' ' SD ' ' B' ' 195' ' ' MET . 0.1 OUTLIER -99.7 -36.16 9.57 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.142 -0.974 . . . . 44.33 109.85 -179.666 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 196' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 58.2 p-10 -68.14 -19.57 64.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.086 -1.009 . . . . 71.21 110.113 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 197' ' ' LYS . . . . . 0.533 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 27.4 mttm -80.41 -64.87 0.29 Allowed Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.029 -1.045 . . . . 75.21 109.87 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 198' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 33.0 Cg_endo -61.9 -55.2 1.15 Allowed 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.314 2.009 . . . . 75.32 112.442 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 199' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' B' ' 201' ' ' ILE . 15.5 mt -64.53 -37.03 86.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.084 -1.01 . . . . 72.25 109.627 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 74.09 -31.33 0.94 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.581 -1.408 . . . . 64.53 109.581 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 201' ' ' ILE . . . . . 0.476 ' H ' ' C ' ' B' ' 199' ' ' LEU . 66.4 mt -96.78 142.51 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.226 -1.161 . . . . 44.23 109.341 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 79.8 p -94.56 146.91 23.78 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.266 -0.896 . . . . 54.01 109.595 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 22.7 p -143.36 11.9 1.73 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.252 -0.905 . . . . 74.4 109.075 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.405 ' O ' HG23 ' B' ' 204' ' ' VAL . 16.1 m -135.59 133.85 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.472 -0.767 . . . . 72.12 109.242 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -115.87 132.88 56.51 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.626 -0.671 . . . . 65.41 109.287 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.5 137.57 33.47 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.208 -0.932 . . . . 71.33 109.062 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.573 HG22 ' H ' ' B' ' 209' ' ' ARG . 7.9 p -124.55 145.7 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.584 -0.697 . . . . 63.5 109.561 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -71.0 -11.53 61.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 74.45 109.904 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 209' ' ' ARG . . . . . 0.573 ' H ' HG22 ' B' ' 207' ' ' VAL . 70.0 ttt-85 -69.1 -108.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.126 -0.984 . . . . 74.14 109.623 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -146.83 121.4 9.76 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.827 -1.171 . . . . 74.43 109.853 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 94.47 171.84 37.98 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.68 -0.968 . . . . 64.45 110.68 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -115.74 171.34 7.81 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.213 -1.032 . . . . 74.21 108.213 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -132.24 132.64 43.27 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.215 -0.928 . . . . 74.03 109.597 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -113.35 123.46 50.17 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.978 -0.749 . . . . 74.34 108.978 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 2.2 p -139.92 164.34 30.26 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.447 -0.783 . . . . 64.33 109.044 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -61.87 149.78 84.5 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 70.04 109.104 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -38.52 133.82 0.89 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.144 1.896 . . . . 65.11 112.277 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.637 ' N ' ' CD ' ' B' ' 219' ' ' PRO . 35.1 tttp -76.81 -34.38 1.27 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.167 -0.958 . . . . 73.15 110.772 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 219' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' B' ' 218' ' ' LYS . 47.4 Cg_exo -55.98 -12.87 7.9 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.928 1.752 . . . . 71.31 111.892 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -62.58 131.43 49.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.37 -0.831 . . . . 75.45 109.37 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 32.1 p -157.2 34.73 0.28 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.256 -0.903 . . . . 72.22 109.398 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -84.57 160.89 20.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 54.53 109.427 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 223' ' ' GLU . . . . . 0.449 ' H ' ' CD ' ' B' ' 223' ' ' GLU . 38.9 mp0 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.026 -0.988 . . . . 71.13 109.609 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.445 ' SD ' ' OD2' ' A' ' 46' ' ' ASP . 32.2 tpp . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.318 0.58 . . . . 65.12 109.441 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.572 ' NH2' ' CB ' ' A' ' 28' ' ' ASP . 75.5 ttt-85 -143.0 135.82 27.83 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.267 -0.895 . . . . 72.33 109.267 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.7 t -110.97 133.6 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.653 -0.654 . . . . 71.42 109.405 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.738 HD12 ' N ' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -113.88 120.29 40.21 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.752 -0.833 . . . . 65.12 108.752 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.738 ' N ' HD12 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -121.82 119.92 33.07 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.396 -0.965 . . . . 62.43 108.396 179.37 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.566 HG12 HD11 ' A' ' 4' ' ' LEU . 7.1 mt -97.31 130.38 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.25 -0.906 . . . . 71.15 109.351 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 13' ' ' GLY . 10.8 pt-20 -171.57 -22.17 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.226 -0.921 . . . . 75.34 110.719 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt 69.18 -38.38 0.4 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.278 -0.889 . . . . 72.44 109.769 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.484 ' H ' ' C ' ' A' ' 7' ' ' GLU . 26.8 m120 -64.88 103.12 0.67 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.143 -0.973 . . . . 63.02 109.419 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.1 m -61.15 -24.87 66.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.878 . . . . 72.34 109.633 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.9 t -70.03 -53.67 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.946 . . . . 74.02 109.728 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.578 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.4 mm? -69.07 -36.76 77.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 71.43 109.35 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.512 ' N ' ' OE1' ' A' ' 7' ' ' GLU . . . -73.42 -28.03 66.61 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.481 -1.848 . . . . 61.32 108.481 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.38 -50.72 60.22 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.449 -1.46 . . . . 71.2 109.449 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.414 ' H ' ' HG2' ' A' ' 15' ' ' GLU . 7.4 pt-20 -61.32 -45.99 92.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.347 -1.09 . . . . 71.32 109.76 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.7 mm -64.99 -37.11 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.751 -1.218 . . . . 63.23 108.68 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.475 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 84.1 tt0 -66.14 -47.03 75.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.368 -0.833 . . . . 51.11 109.794 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -85.24 2.98 41.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.098 -1.001 . . . . 73.34 109.324 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.85 -55.84 2.33 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.502 -1.439 . . . . 62.15 109.502 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 27' ' ' ALA . 1.4 pt? -74.24 -21.87 59.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -1.124 . . . . 73.51 109.812 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 96.2 m-20 -54.07 -33.26 57.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.119 -0.988 . . . . 74.25 109.448 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.7 t -58.33 -47.08 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 70.04 108.959 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -59.98 -53.8 53.62 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.897 -0.779 . . . . 73.23 108.897 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 135.03 22.29 0.66 Allowed Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.761 -1.336 . . . . 75.54 109.761 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -98.86 160.37 14.31 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.218 -1.166 . . . . 73.43 109.424 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.2 mmm -100.97 139.31 36.84 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.601 -0.888 . . . . 43.24 108.601 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.443 ' HB1' HD21 ' A' ' 5' ' ' LEU . . . -127.75 154.28 45.56 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.577 -0.702 . . . . 62.11 109.783 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.572 ' CB ' ' NH2' ' A' ' 2' ' ' ARG . 24.2 t70 -142.6 132.24 23.92 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.71 -0.848 . . . . 74.42 108.71 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.7 m -100.22 130.52 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.907 . . . . 72.15 108.879 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.4 p -120.62 158.19 27.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.608 -0.683 . . . . 71.42 109.223 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -89.32 -94.29 0.11 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.397 -0.814 . . . . 72.33 109.605 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.2 p -79.29 152.49 30.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.205 -0.934 . . . . 74.24 110.022 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.557 ' H ' HD12 ' A' ' 33' ' ' LEU . 2.3 mp -55.98 -37.34 68.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.49 -0.756 . . . . 71.53 109.795 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.54 -40.78 92.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 74.23 109.658 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -66.52 -40.37 89.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 54.03 109.331 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.31 -38.51 81.47 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.422 -1.471 . . . . 61.41 109.422 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -65.32 -39.93 93.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.378 -1.071 . . . . 74.34 109.523 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -78.94 -39.14 35.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.121 -0.987 . . . . 75.33 109.616 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.4 tt -67.74 -41.61 83.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.31 -0.869 . . . . 74.33 109.778 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.539 ' SD ' ' CE2' ' A' ' 45' ' ' TYR . 3.2 ppp? -74.83 -23.22 58.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.1 -1.0 . . . . 70.32 109.674 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -54.13 -37.27 64.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.117 -0.989 . . . . 71.22 109.891 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.405 HG12 ' H ' ' A' ' 42' ' ' ILE . 9.5 pt -84.94 -33.35 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.154 -0.966 . . . . 74.14 110.148 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 40' ' ' MET . 97.2 mtt180 -95.86 167.11 11.46 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.058 -1.026 . . . . 72.24 109.933 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.409 ' C ' ' CD2' ' A' ' 45' ' ' TYR . 30.4 m120 -79.8 -174.95 4.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.127 -0.983 . . . . 75.42 109.056 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.539 ' CE2' ' SD ' ' A' ' 40' ' ' MET . 1.4 p90 -173.96 134.4 0.46 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.044 -1.035 . . . . 74.23 109.861 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.445 ' OD2' ' SD ' ' A' ' 1' ' ' MET . 87.2 m-20 -120.89 -51.95 2.12 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.485 -0.932 . . . . 72.04 108.485 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.569 HD13 ' C ' ' A' ' 47' ' ' LEU . 1.7 tm? -106.32 111.1 23.54 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.049 -1.093 . . . . 72.13 108.049 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.467 ' N ' HD13 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -109.22 101.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.599 -0.889 . . . . 72.34 108.599 179.36 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 7.7 ttt -105.39 140.3 38.72 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.458 -0.942 . . . . 74.11 108.458 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -140.04 129.31 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 61.12 109.847 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.7 m -109.79 9.06 24.79 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.827 -0.805 . . . . 73.11 108.827 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -77.45 159.66 29.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.376 -0.828 . . . . 52.55 109.933 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.494 ' C ' ' H ' ' A' ' 55' ' ' ALA . 62.5 mttp -81.86 173.15 12.53 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.714 -0.847 . . . . 44.22 108.714 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 56.2 5.94 0.21 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.117 -0.989 . . . . 70.44 108.916 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -68.65 -26.92 65.56 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.41 -0.806 . . . . 64.14 109.586 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.604 HD13 HE22 ' A' ' 89' ' ' GLN . 43.7 mt -45.14 -42.79 9.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.401 -0.812 . . . . 44.14 110.19 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.3 m -70.56 -37.38 73.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.999 -1.063 . . . . 55.23 109.819 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.572 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 85.0 t80 -64.76 -46.87 80.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 74.44 110.313 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.9 m -62.97 -36.92 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.654 -1.279 . . . . 74.03 109.555 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.8 t -55.84 -52.63 63.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.252 -0.905 . . . . 64.3 109.66 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -65.63 -32.71 74.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.127 -0.983 . . . . 64.44 109.987 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.572 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 5.2 mm -64.47 -35.89 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.871 -1.143 . . . . 63.21 109.63 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.544 ' HZ2' ' C ' ' A' ' 90' ' ' GLY . 26.6 mmtp -68.97 -50.87 45.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 74.42 110.262 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.438 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 15.7 pt-20 -70.1 -42.93 72.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.927 -1.108 . . . . 70.32 110.084 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.477 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 67.3 mttm -70.12 -24.6 63.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.94 . . . . 75.22 109.593 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.542 ' O ' HG22 ' A' ' 69' ' ' ILE . 96.1 m-70 -155.85 64.2 0.59 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.921 . . . . 74.13 109.371 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.501 ' N ' ' O ' ' A' ' 63' ' ' LYS . 84.4 p -57.26 -25.48 59.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.306 -0.871 . . . . 73.24 109.763 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.5 t -75.34 45.61 0.3 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 61.01 109.89 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.542 HG22 ' O ' ' A' ' 66' ' ' HIS . 13.7 tt -145.72 158.18 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.089 -1.007 . . . . 71.33 109.645 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.5 t -94.23 149.83 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.16 -0.962 . . . . 72.13 108.687 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.526 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 11.2 t -138.09 124.96 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.205 -0.934 . . . . 54.21 109.387 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 mp -124.8 99.52 6.19 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.686 -0.857 . . . . 50.24 108.686 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.47 HG22 ' N ' ' A' ' 74' ' ' SER . 10.4 p -86.89 160.14 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.183 -0.948 . . . . 74.41 108.891 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.47 ' N ' HG22 ' A' ' 73' ' ' VAL . 19.8 m -135.5 160.36 38.71 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.371 -0.831 . . . . 72.31 109.631 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 74' ' ' SER . 70.3 m -168.57 154.74 6.95 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.275 -0.891 . . . . 64.54 110.133 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 0.4 OUTLIER -94.71 8.3 42.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.406 -0.809 . . . . 74.13 109.945 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' A' ' 79' ' ' THR . 18.3 t-20 -129.19 56.68 25.31 Favored Pre-proline 0 N--CA 1.502 2.14 0 O-C-N 121.358 -0.839 . . . . 73.34 110.109 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.6 84.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.349 2.033 . . . . 63.22 111.913 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.43 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 42.5 m -114.03 150.17 34.32 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.741 -0.837 . . . . 62.53 108.741 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.07 -32.86 23.39 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.214 -0.929 . . . . 73.44 109.432 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.434 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 97.4 mt-10 -59.45 -36.73 76.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 71.42 109.69 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 84.9 tt0 -75.84 -33.3 60.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.147 -0.971 . . . . 73.43 109.804 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.43 ' OE2' ' O ' ' A' ' 79' ' ' THR . 0.9 OUTLIER -68.69 -50.16 53.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.099 -1.001 . . . . 74.22 109.893 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.52 HG23 ' N ' ' A' ' 85' ' ' HIS . 34.6 m -63.21 -42.95 98.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.027 -1.046 . . . . 73.2 109.615 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.52 ' N ' HG23 ' A' ' 84' ' ' VAL . 56.1 m80 -74.11 -25.44 59.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 53.33 109.78 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 82' ' ' GLU . . . -65.43 -44.05 88.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.108 -0.995 . . . . 64.11 109.776 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.445 ' CZ ' ' HB1' ' B' ' 111' ' ' ALA . 66.4 t80 -81.49 -34.01 31.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.011 -1.055 . . . . 74.34 109.027 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -68.1 -51.35 47.44 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.349 -0.844 . . . . 74.42 109.261 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.604 HE22 HD13 ' A' ' 56' ' ' LEU . 95.7 mt-30 -61.2 -50.24 73.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.487 -0.758 . . . . 74.24 109.704 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.544 ' C ' ' HZ2' ' A' ' 63' ' ' LYS . . . 147.64 71.08 0.01 OUTLIER Glycine 0 N--CA 1.495 2.587 0 C-N-CA 119.851 -1.166 . . . . 61.51 110.357 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -139.81 140.01 36.52 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.186 -1.185 . . . . 55.33 109.092 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 57.3 m-20 -83.76 -39.87 19.52 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.056 -1.028 . . . . 73.42 109.492 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 73.1 m-20 -150.29 164.15 36.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -0.879 . . . . 75.04 109.223 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.438 ' CE1' ' O ' ' A' ' 95' ' ' ILE . 1.6 t80 -135.77 132.34 36.66 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.46 -0.775 . . . . 71.33 109.315 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.438 ' O ' ' CE1' ' A' ' 94' ' ' TYR . 26.1 mm -115.05 148.26 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 121.453 -0.779 . . . . 71.13 110.076 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.32 121.31 16.64 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.975 -1.491 . . . . 64.32 106.975 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.705 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.5 OUTLIER -43.66 -58.4 4.56 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.057 -1.027 . . . . 62.2 111.649 -178.272 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 7.5 Cg_endo -43.97 0.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 121.419 1.412 . . . . 73.11 113.695 -175.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.705 ' N ' ' O ' ' A' ' 97' ' ' LYS . 51.5 m-85 58.21 116.04 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.681 -0.637 . . . . 65.22 109.761 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.522 ' NE ' ' OE2' ' B' ' 83' ' ' GLU . 12.6 ttm-85 -73.63 -33.93 64.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 72.35 109.775 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.75 ' O ' ' N ' ' A' ' 103' ' ' LYS . 30.5 t -172.68 26.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.856 -1.153 . . . . 71.32 111.139 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 87.2 mt 51.13 -70.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.519 -0.738 . . . . 75.43 110.357 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.75 ' N ' ' O ' ' A' ' 101' ' ' SER . 30.5 mmtm -56.07 -30.05 61.41 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.162 -1.051 . . . . 71.41 108.162 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.4 -47.75 84.24 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.392 -0.966 . . . . 63.24 108.392 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.724 HD13 ' N ' ' A' ' 106' ' ' VAL . 0.7 OUTLIER -64.63 -56.04 16.38 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.953 -0.758 . . . . 73.22 108.953 179.602 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.724 ' N ' HD13 ' A' ' 105' ' ' LEU . 63.5 t -51.45 -40.55 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.74 -1.225 . . . . 60.11 109.018 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.21 -32.83 68.66 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.223 -0.923 . . . . 70.42 108.727 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 -77.96 -24.13 48.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -0.839 . . . . 74.41 110.333 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 81.7 mt -75.68 -38.98 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.801 -1.187 . . . . 62.54 108.869 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 114' ' ' ARG . 24.3 pt-20 -76.63 -32.5 58.06 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.298 -0.876 . . . . 74.34 109.605 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.49 -50.2 72.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.412 -0.805 . . . . 73.32 109.748 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -64.78 -46.07 83.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 52.41 109.495 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.6 mt -97.85 26.06 5.45 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.218 -0.926 . . . . 65.24 109.731 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 110' ' ' GLU . 0.8 OUTLIER -60.92 -53.13 61.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 64.45 109.383 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -86.62 50.85 2.08 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.176 -0.952 . . . . 74.43 109.412 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -88.28 132.4 34.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.247 -0.908 . . . . 74.42 109.869 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 118.99 92.3 1.44 Allowed Glycine 0 N--CA 1.501 2.972 0 N-CA-C 109.65 -1.38 . . . . 75.04 109.65 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 79.7 p -166.7 160.49 14.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.093 -1.239 . . . . 61.14 109.979 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 121' ' ' ILE . 8.2 t30 -146.06 142.82 28.95 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.51 -0.922 . . . . 65.24 108.51 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.2 t -93.54 -45.73 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.016 -1.053 . . . . 73.11 110.564 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.521 ' O ' ' ND2' ' A' ' 119' ' ' ASN . 12.4 mm -93.56 114.98 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 120.841 -1.162 . . . . 72.24 109.624 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -118.83 124.9 48.31 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.915 -0.772 . . . . 72.34 108.915 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.681 HG23 ' O ' ' A' ' 123' ' ' ILE . 5.9 tt -149.88 102.73 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.039 -1.038 . . . . 71.44 109.682 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 62.73 -135.6 44.17 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.198 -1.161 . . . . 73.4 110.198 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -87.74 -3.4 58.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.457 -1.025 . . . . 74.45 109.878 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.0 131.0 42.84 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.225 -0.922 . . . . 54.21 108.865 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.54 137.33 49.66 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.756 -0.831 . . . . 54.5 108.756 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.412 ' H ' HD21 ' A' ' 119' ' ' ASN . 56.4 mt -131.17 127.88 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.473 -0.767 . . . . 45.15 109.204 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.52 103.15 50.23 Favored Pre-proline 0 N--CA 1.494 1.766 0 N-CA-C 109.059 -0.719 . . . . 71.11 109.059 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.76 -24.95 5.65 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.795 1.663 . . . . 65.41 111.781 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -62.54 -55.8 23.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.471 -0.768 . . . . 63.32 109.863 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -94.68 12.54 27.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.29 -0.881 . . . . 72.52 109.31 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 49.61 57.91 6.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 75.33 109.18 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 26.0 ttpt -133.89 132.84 40.79 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.556 -0.715 . . . . 71.23 109.673 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.9 tt -109.74 137.17 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 109.138 -0.689 . . . . 74.02 109.138 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 70.5 mt -121.27 118.9 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.495 -0.753 . . . . 60.23 109.193 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.42 ' C ' ' H ' ' A' ' 139' ' ' GLY . 65.3 t80 -142.76 151.3 41.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.349 -0.844 . . . . 62.32 108.978 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 1.047 ' HZ3' ' HB3' ' A' ' 138' ' ' LYS . 0.0 OUTLIER 61.37 5.75 1.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.942 -1.099 . . . . 75.4 108.239 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 137' ' ' TYR . . . 86.12 13.04 69.61 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.091 -1.603 . . . . 72.24 109.091 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -103.44 142.79 33.64 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.589 -0.948 . . . . 71.22 108.782 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -107.97 116.11 31.36 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.05 -1.031 . . . . 71.42 108.823 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.14 138.48 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.437 -0.789 . . . . 53.02 109.066 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -82.29 147.86 28.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.401 -0.812 . . . . 60.45 109.931 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.4 HG23 ' CE2' ' A' ' 149' ' ' PHE . 2.1 m -146.38 125.0 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.368 -0.833 . . . . 74.44 109.489 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -158.01 134.37 9.52 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.445 -0.784 . . . . 65.15 109.184 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.13 -162.93 36.72 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.066 -1.214 . . . . 73.34 110.066 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.627 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 49.9 mtmt -82.49 -30.61 0.51 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.443 -1.034 . . . . 72.22 111.626 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 90.1 Cg_endo -86.94 -25.02 1.22 Allowed 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 121.801 1.667 . . . . 65.23 112.562 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.479 ' CE2' HG23 ' A' ' 153' ' ' THR . 85.7 t80 -89.15 -12.92 39.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.158 -0.964 . . . . 60.11 109.802 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -61.11 -38.27 85.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.1 -1.0 . . . . 64.21 109.422 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.34 -28.96 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 72.02 109.0 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.3 OUTLIER -61.18 -44.45 97.28 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.94 -0.763 . . . . 73.31 108.94 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.479 HG23 ' CE2' ' A' ' 149' ' ' PHE . 1.9 p -74.09 -37.9 64.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.206 -0.934 . . . . 74.31 110.231 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -54.76 -55.13 33.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.934 -1.104 . . . . 74.31 109.82 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.756 HD12 ' N ' ' A' ' 156' ' ' ALA . 4.6 pp -66.92 -33.47 75.67 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.207 -0.933 . . . . 75.34 109.197 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.756 ' N ' HD12 ' A' ' 155' ' ' LEU . . . -51.16 -41.24 60.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.192 -0.943 . . . . 62.14 108.949 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 159' ' ' ARG . 62.6 mtp180 -89.06 -48.95 7.06 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.143 -0.973 . . . . 61.03 108.922 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -73.09 35.03 0.08 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.389 -0.819 . . . . 74.12 109.611 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.48 ' H ' ' C ' ' A' ' 157' ' ' ARG . 27.9 ptt180 -72.16 171.1 12.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.34 -0.85 . . . . 71.13 109.347 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.6 t70 52.51 44.04 30.42 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.192 -0.942 . . . . 75.45 109.609 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -148.25 162.92 38.51 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.181 -0.949 . . . . 73.41 109.448 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.6 mt -93.37 119.34 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.218 -0.926 . . . . 74.41 108.649 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 10.8 t -99.89 122.39 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.251 -0.905 . . . . 72.31 109.675 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.2 p -84.07 164.68 19.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 74.12 108.911 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -63.27 -43.75 97.06 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.178 -0.951 . . . . 70.43 109.39 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.432 ' O ' ' OD2' ' A' ' 170' ' ' ASP . 49.0 mt-10 -72.12 -29.24 63.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 73.52 110.16 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -57.32 -57.14 13.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.961 . . . . 74.52 110.037 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 169' ' ' LEU . 2.2 pp -67.81 -36.52 80.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.974 -1.079 . . . . 72.31 110.056 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.651 HD13 ' C ' ' A' ' 169' ' ' LEU . 3.1 tm? -55.18 -52.91 61.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.927 -1.108 . . . . 53.33 108.867 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' A' ' 166' ' ' GLU . 2.6 p30 -72.38 -28.61 63.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.207 -0.933 . . . . 62.44 110.111 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -53.77 -52.16 61.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.149 -0.969 . . . . 60.21 110.358 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 12.8 mm -91.53 -28.92 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.071 -1.018 . . . . 75.32 110.015 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 16.2 m-90 -124.28 62.69 1.1 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.409 -0.807 . . . . 73.14 109.432 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -66.93 -33.76 76.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.341 -0.849 . . . . 73.24 108.869 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -82.24 150.48 64.36 Favored Pre-proline 0 N--CA 1.487 1.398 0 N-CA-C 108.684 -0.858 . . . . 44.43 108.684 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -39.87 -51.31 3.06 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 121.989 1.793 . . . . 72.51 112.315 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 44.62 -166.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.489 -0.757 . . . . 63.24 109.595 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 70.5 mtp -95.59 57.46 1.91 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.05 -1.031 . . . . 73.5 109.662 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 69.8 t -83.39 121.26 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 65.22 109.143 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.501 ' OG1' ' CG2' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -80.78 166.75 37.24 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.117 -0.989 . . . . 71.42 108.471 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -47.76 -31.81 15.6 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.36 2.04 . . . . 41.22 112.884 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.989 ' ND2' ' OE1' ' A' ' 185' ' ' GLU . 53.2 t-20 -143.76 97.02 2.99 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.123 -0.986 . . . . 64.54 110.274 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.501 ' CG2' ' OG1' ' A' ' 180' ' ' THR . 96.2 t -123.66 -13.77 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.567 -0.901 . . . . 74.02 108.567 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 96.0 mt -61.99 -42.44 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.464 -0.772 . . . . 72.33 109.832 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.989 ' OE1' ' ND2' ' A' ' 182' ' ' ASN . 11.5 pt-20 -51.48 -37.87 51.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.896 -1.128 . . . . 74.4 109.121 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 36.0 t -73.11 -32.33 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.452 -0.78 . . . . 70.42 109.372 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -79.33 -56.86 4.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.22 -0.925 . . . . 52.11 110.457 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.439 HG23 ' N ' ' A' ' 189' ' ' ASN . 3.4 tp -55.59 -39.01 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.858 -1.151 . . . . 71.4 109.776 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.449 ' ND2' ' OE1' ' A' ' 193' ' ' GLN . 4.3 t30 -67.68 -54.68 17.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.335 -0.853 . . . . 73.44 111.779 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -62.26 -31.72 72.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.835 -1.166 . . . . 71.42 111.412 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 47.1 pt -69.15 -38.14 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.201 -1.562 . . . . 61.55 109.937 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.64 -42.21 99.47 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 117.986 -1.486 . . . . 63.34 108.238 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.449 ' OE1' ' ND2' ' A' ' 189' ' ' ASN . 23.0 mt-30 -64.52 -34.26 77.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.552 -0.718 . . . . 61.24 110.167 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.489 ' O ' ' CG ' ' A' ' 198' ' ' PRO . 15.0 mtpp -75.19 -25.71 58.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.155 -0.966 . . . . 75.13 110.634 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 74.8 mtm -95.97 4.38 52.74 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.972 -1.08 . . . . 74.02 109.475 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -113.67 -12.88 12.76 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.579 -0.7 . . . . 74.02 110.636 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.577 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 20.5 tttt -98.28 -41.04 0.24 Allowed Pre-proline 0 N--CA 1.502 2.132 0 O-C-N 120.949 -1.094 . . . . 75.43 110.87 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 85.5 Cg_endo -93.3 -64.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.906 2.404 . . . . 72.32 112.999 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 45.8 mt -50.18 -35.86 28.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.1 -1.0 . . . . 74.54 109.353 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 87.17 -9.75 71.47 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.761 -1.336 . . . . 61.51 109.761 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 17.2 mt -132.9 127.57 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.482 -1.01 . . . . 61.22 109.533 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.8 t -78.67 133.1 37.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.316 -0.865 . . . . 72.0 109.199 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.6 p -118.62 34.0 5.4 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.515 -0.74 . . . . 74.44 110.503 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 6.4 m -143.27 139.39 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.976 -1.078 . . . . 64.35 110.002 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -126.01 133.44 51.76 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.109 -0.7 . . . . 71.41 109.109 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.56 133.52 34.14 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.082 -1.011 . . . . 73.52 108.962 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 10.4 p -128.54 137.23 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.52 -0.738 . . . . 71.02 109.179 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -92.79 60.37 3.4 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.205 -0.934 . . . . 72.12 109.369 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.16 -61.51 0.32 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.497 -0.927 . . . . 64.41 108.497 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -104.43 -65.39 1.03 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.592 -0.692 . . . . 71.54 109.278 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -171.75 -105.86 0.19 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.347 -1.501 . . . . 72.03 109.347 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.34 123.38 39.27 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.456 -1.026 . . . . 75.54 108.632 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -89.51 146.49 24.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.367 -0.833 . . . . 75.31 110.963 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.609 ' CE2' HD13 ' A' ' 155' ' ' LEU . 11.5 t80 -123.57 114.4 19.99 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.502 -0.925 . . . . 75.41 108.502 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 18.5 p -140.45 159.41 42.27 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.385 -0.822 . . . . 74.14 109.077 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -59.04 142.47 85.4 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.079 -1.013 . . . . 75.32 108.729 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.455 ' O ' ' HB3' ' A' ' 220' ' ' ALA . 46.8 Cg_endo -82.16 16.75 1.69 Allowed 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 122.085 1.857 . . . . 73.11 112.065 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 217' ' ' PRO . 44.8 tttt -43.74 -55.06 9.49 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.203 -0.935 . . . . 75.25 109.921 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.47 -7.6 20.56 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.568 1.512 . . . . 75.1 111.187 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 217' ' ' PRO . . . -55.75 -38.57 69.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.42 -0.8 . . . . 71.14 110.554 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 11.5 t -136.86 149.15 47.51 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.307 -0.871 . . . . 71.13 109.646 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -110.43 6.9 22.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.594 -0.691 . . . . 75.35 109.442 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.975 -1.012 . . . . 73.41 109.388 -179.935 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.413 -0.588 . . . . 71.14 109.413 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 51.4 ttt85 -139.98 155.07 47.29 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.351 -0.843 . . . . 73.23 109.279 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 83.4 t -113.23 122.13 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.59 0.709 . . . . 72.24 109.73 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.541 HD11 ' CG1' ' B' ' 6' ' ' ILE . 2.6 tp -91.71 117.64 29.94 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.367 -0.975 . . . . 54.33 108.367 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.506 HD23 ' N ' ' B' ' 6' ' ' ILE . 4.2 tt -118.95 120.15 36.42 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.437 -0.949 . . . . 74.35 108.437 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.541 ' CG1' HD11 ' B' ' 4' ' ' LEU . 19.0 mt -115.78 99.53 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.438 -0.789 . . . . 42.55 109.195 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.425 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 30.1 tp10 -125.17 139.64 53.57 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.578 -0.701 . . . . 74.52 109.295 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.443 ' NZ ' ' OD1' ' B' ' 52' ' ' ASP . 39.2 mmtm -70.39 -34.29 72.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.922 . . . . 62.55 109.374 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -90.72 118.89 30.5 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.284 -0.885 . . . . 73.11 109.576 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 18.9 t -70.37 -32.06 69.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.927 . . . . 65.54 109.56 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 82.7 t -64.27 -53.25 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.917 . . . . 75.55 109.734 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.512 HD13 ' O ' ' B' ' 12' ' ' LEU . 0.2 OUTLIER -64.21 -37.63 88.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.909 . . . . 70.14 109.003 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.05 -26.72 73.94 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.487 -1.845 . . . . 75.4 108.487 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.96 -54.2 32.25 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 109.623 -1.391 . . . . 65.44 109.623 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' B' ' 15' ' ' GLU . 7.2 pt-20 -58.3 -44.2 88.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.333 -1.098 . . . . 60.21 109.677 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.484 ' CD1' HD12 ' B' ' 102' ' ' ILE . 39.3 mm -64.33 -43.81 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.917 -1.114 . . . . 75.15 108.725 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -61.3 -43.53 98.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.411 -0.806 . . . . 73.01 109.816 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.405 ' HB3' ' HZ2' ' B' ' 18' ' ' LYS . 16.3 mtpp -87.06 2.45 49.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.098 -1.001 . . . . 74.3 109.444 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.73 -53.27 2.61 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.433 -1.467 . . . . 70.54 109.433 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -76.13 -20.09 57.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.314 -1.109 . . . . 71.34 109.704 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -58.59 -30.59 67.31 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.06 -1.025 . . . . 64.41 109.256 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 82.9 t -60.29 -34.66 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.355 -0.84 . . . . 74.23 109.114 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -68.55 -4.69 16.12 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.336 -0.852 . . . . 63.42 109.067 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.82 39.97 7.34 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.092 -1.203 . . . . 53.43 110.092 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -119.84 159.34 24.78 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.536 -0.979 . . . . 71.12 109.321 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 7.1 mmt -105.19 133.37 50.08 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.242 -1.022 . . . . 75.24 108.242 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.07 162.46 36.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.173 -0.954 . . . . 72.12 110.239 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -141.22 145.65 35.87 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.459 -0.776 . . . . 72.31 108.952 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -106.72 137.64 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.309 -0.869 . . . . 64.43 108.79 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 11.3 p -136.41 167.79 20.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.366 -0.834 . . . . 65.41 109.289 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.477 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 2.2 pt-20 -90.22 -100.05 0.1 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.153 -0.967 . . . . 71.02 109.898 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 32.8 t -78.96 166.21 22.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.958 . . . . 51.11 110.236 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 44.1 mt -53.91 -32.97 55.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.633 -0.667 . . . . 71.24 109.829 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -50.43 -48.31 56.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.121 -0.987 . . . . 74.32 109.695 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.477 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 65.9 m-20 -69.28 -41.33 76.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.169 -0.957 . . . . 73.03 109.501 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.18 -40.7 87.8 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.464 -1.454 . . . . 30.21 109.464 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -68.6 -42.69 77.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -1.151 . . . . 74.42 109.543 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' TYR . . . . . 0.448 ' O ' ' OD1' ' B' ' 41' ' ' ASP . 56.4 t80 -75.17 -21.9 58.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 74.42 110.053 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 28.5 tp -90.01 -39.16 13.13 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.14 -0.975 . . . . 75.41 110.044 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' MET . . . . . 0.449 ' SD ' ' C ' ' B' ' 40' ' ' MET . 0.0 OUTLIER -78.13 -27.69 48.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.996 . . . . 60.41 110.528 -179.102 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' B' ' 42' ' ' ILE . 41.9 p-10 -68.02 -27.51 66.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.901 -1.124 . . . . 53.23 110.225 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.533 ' N ' ' OD1' ' B' ' 41' ' ' ASP . 13.8 pt -88.8 -15.47 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.004 -1.06 . . . . 71.23 110.419 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' B' ' 40' ' ' MET . 97.2 mtt180 -129.48 149.92 51.05 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.239 -0.913 . . . . 72.22 109.77 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -82.85 163.18 21.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.202 -0.937 . . . . 63.54 109.458 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 10.4 p90 -159.3 -179.04 7.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.92 . . . . 64.35 109.706 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -138.97 -32.85 0.66 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.475 -0.766 . . . . 62.22 109.428 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.501 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.3 OUTLIER -107.08 115.1 29.59 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.357 -0.839 . . . . 73.12 109.004 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.501 ' N ' HD13 ' B' ' 47' ' ' LEU . 56.0 t -102.55 98.01 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.51 -0.922 . . . . 65.11 108.51 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -117.06 129.07 55.76 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.776 0.798 . . . . 73.44 110.141 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.624 HG22 ' H ' ' B' ' 52' ' ' ASP . 0.2 OUTLIER -141.65 135.68 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.78 0.8 . . . . 34.5 109.179 -179.622 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 51' ' ' SER . . . . . 0.425 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 53.2 p -99.3 18.29 17.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.599 -0.688 . . . . 73.21 109.599 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.624 ' H ' HG22 ' B' ' 50' ' ' VAL . 37.6 m-20 -86.09 144.16 27.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.185 -0.947 . . . . 70.41 109.534 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.449 ' C ' ' H ' ' B' ' 55' ' ' ALA . 99.1 mttt -76.52 -42.6 42.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.276 -0.89 . . . . 65.0 110.201 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -71.01 10.72 0.5 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.108 -0.995 . . . . 75.21 109.727 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -67.13 -22.22 65.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 55.33 110.106 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.42 ' HG ' ' H ' ' B' ' 56' ' ' LEU . 19.0 mt -44.68 -44.93 9.47 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.268 -0.895 . . . . 63.14 110.142 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 93.1 p -69.39 -37.96 77.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.991 -1.068 . . . . 63.5 109.284 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -65.07 -62.28 1.65 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.279 -0.888 . . . . 72.33 109.656 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 33.3 m -49.55 -33.64 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.555 -1.341 . . . . 74.54 109.661 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 10.9 p -57.6 -51.26 70.23 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.202 -0.936 . . . . 71.24 109.472 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.418 ' HG2' ' H ' ' B' ' 61' ' ' ARG . 6.7 ptp180 -70.05 -31.24 68.77 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.177 -1.009 . . . . 74.31 110.176 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' B' ' 66' ' ' HIS . 40.0 mm -66.68 -44.97 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.683 -1.261 . . . . 72.14 110.285 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -65.09 -44.94 87.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.195 -0.941 . . . . 73.32 110.818 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -73.86 -38.0 64.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.743 -1.223 . . . . 73.12 110.036 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.486 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 64.2 mttm -84.71 -17.04 39.69 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.099 -1.0 . . . . 72.44 109.711 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.486 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 76.9 m-70 -155.63 68.72 0.66 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.053 -1.03 . . . . 63.31 109.618 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 85.6 p -67.6 -27.55 67.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.312 -0.867 . . . . 73.1 109.898 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 12.5 t -63.1 -19.22 64.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.148 -0.97 . . . . 71.53 110.069 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 63.1 mt -88.25 151.94 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.182 -0.949 . . . . 74.4 109.784 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.419 HG12 ' N ' ' B' ' 71' ' ' VAL . 94.3 t -90.96 157.62 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.41 -0.806 . . . . 75.12 109.277 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.419 ' N ' HG12 ' B' ' 70' ' ' VAL . 11.0 t -135.7 126.79 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.218 -0.926 . . . . 73.2 109.864 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.555 ' C ' HD23 ' B' ' 72' ' ' LEU . 4.2 tt -116.88 105.32 12.23 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.787 -0.82 . . . . 73.34 108.787 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 71.1 t -98.06 131.23 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.033 -1.042 . . . . 73.5 109.541 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.9 p -95.23 169.26 10.21 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.239 -0.913 . . . . 64.34 109.137 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.474 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 36.2 t -157.19 117.02 3.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.007 -1.058 . . . . 74.53 110.292 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 76' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' B' ' 77' ' ' ASN . 52.8 p30 -71.28 -10.5 59.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.409 -0.807 . . . . 64.5 109.292 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' B' ' 79' ' ' THR . 84.5 m-20 -132.9 77.06 69.39 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 108.47 -0.937 . . . . 74.25 108.47 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -55.59 73.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.561 2.174 . . . . 74.43 111.894 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.542 HG23 ' H ' ' B' ' 82' ' ' GLU . 6.9 t -97.43 150.73 20.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.257 -0.902 . . . . 73.12 109.308 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -26.37 68.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.523 -0.736 . . . . 71.01 110.225 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' B' ' 81' ' ' GLU . 2.5 mp0 -64.27 -39.97 95.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.978 -1.076 . . . . 63.2 109.823 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' GLU . . . . . 0.542 ' H ' HG23 ' B' ' 79' ' ' THR . 0.1 OUTLIER -78.51 -29.11 46.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.086 -1.009 . . . . 73.22 109.627 -179.775 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.522 ' OE2' ' NE ' ' A' ' 100' ' ' ARG . 87.1 mt-10 -64.94 -48.29 74.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.034 -1.041 . . . . 74.3 109.659 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.479 HG23 ' N ' ' B' ' 85' ' ' HIS . 27.0 m -67.77 -42.65 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 73.31 109.485 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 85' ' ' HIS . . . . . 0.479 ' N ' HG23 ' B' ' 84' ' ' VAL . 42.4 m80 -69.2 -25.9 64.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.167 -0.958 . . . . 73.24 109.533 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -68.55 -45.57 71.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 55.33 109.846 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -79.35 -28.07 42.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.057 -1.027 . . . . 74.14 109.044 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 31.0 tp10 -75.98 -51.67 11.88 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.335 -0.853 . . . . 64.04 109.563 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -61.87 -50.42 72.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.414 -0.804 . . . . 72.35 109.745 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 151.75 72.81 0.01 OUTLIER Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.749 -1.215 . . . . 65.2 110.308 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -134.43 136.43 43.25 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.288 -1.125 . . . . 52.23 108.843 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -89.21 -23.15 22.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.09 -1.006 . . . . 73.32 109.56 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 11.2 t0 -152.03 163.57 39.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.277 -0.889 . . . . 72.22 109.358 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.518 ' N ' ' OD1' ' B' ' 93' ' ' ASP . 76.7 t80 -146.64 99.28 3.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.382 -0.823 . . . . 64.42 109.252 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 20.8 mm -106.37 151.01 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.388 0 O-C-N 121.227 -0.921 . . . . 72.23 109.961 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.15 139.28 57.47 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.991 -1.114 . . . . 25.24 107.991 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.656 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -58.38 -55.13 48.86 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 120.744 -1.222 . . . . 64.32 111.146 -179.067 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 98' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 3.5 Cg_endo -41.75 -12.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.188 0 CA-C-N 119.619 0.9 . . . . 63.33 112.383 -176.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 99' ' ' TYR . . . . . 0.656 ' N ' ' O ' ' B' ' 97' ' ' LYS . 51.0 m-85 57.87 104.33 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.865 -0.522 . . . . 75.13 110.256 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -55.52 -39.22 70.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.829 -1.169 . . . . 74.23 108.042 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 10.6 t -170.32 131.96 0.99 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.919 -0.771 . . . . 63.34 108.919 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' ILE . . . . . 0.484 HD12 ' CD1' ' B' ' 16' ' ' ILE . 4.1 mm -51.71 -41.61 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.951 . . . . 74.44 109.1 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -60.37 -36.34 77.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.228 -0.92 . . . . 71.11 109.264 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.41 -48.53 64.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 71.45 109.557 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 60.0 tp -60.96 -48.93 79.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 51.31 109.433 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.73 -43.83 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.167 -0.958 . . . . 65.23 110.028 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.27 -43.32 64.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.06 -1.025 . . . . 24.32 109.211 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -68.35 -33.77 74.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.337 -0.852 . . . . 75.31 109.606 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 95.3 mt -72.35 -34.51 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.054 -1.029 . . . . 54.24 108.571 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' B' ' 114' ' ' ARG . 80.6 tt0 -58.55 -56.82 17.17 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.575 -0.85 . . . . 65.31 108.987 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' ALA . . . . . 0.445 ' HB1' ' CZ ' ' A' ' 87' ' ' PHE . . . -54.85 -40.34 69.54 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.477 -0.764 . . . . 72.24 110.157 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 112' ' ' ARG . . . . . 0.401 HH12 ' HB2' ' B' ' 93' ' ' ASP . 0.0 OUTLIER -53.6 -38.28 63.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.995 -1.066 . . . . 72.04 108.896 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.86 54.22 1.05 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.987 -1.071 . . . . 75.35 109.942 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' B' ' 110' ' ' GLU . 4.9 tmt_? -72.06 -43.68 64.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.129 -0.982 . . . . 75.5 108.987 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' PHE . . . . . 0.488 ' O ' ' N ' ' B' ' 117' ' ' GLY . 96.2 m-85 -67.75 -0.84 4.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.332 -0.855 . . . . 65.33 109.502 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 66.01 -55.5 0.37 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.561 -0.712 . . . . 74.45 110.158 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 117' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' B' ' 115' ' ' PHE . . . -154.42 171.83 32.93 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.897 -1.281 . . . . 44.21 109.897 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 41.1 m -156.58 -175.51 5.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.38 -1.071 . . . . 71.4 109.662 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.15 122.95 5.73 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.822 -0.751 . . . . 72.32 109.112 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 9.9 t -85.15 -42.88 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.214 -0.929 . . . . 75.02 110.119 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 15.7 mm -97.11 132.66 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.07 -1.019 . . . . 51.41 109.819 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -114.0 121.46 43.96 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.987 -0.745 . . . . 71.53 108.987 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.551 ' CD1' HH12 ' B' ' 159' ' ' ARG . 73.4 mt -132.47 121.39 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.355 -0.841 . . . . 72.43 109.478 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 124' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' B' ' 123' ' ' ILE . . . 40.29 -122.61 2.01 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 110.518 -1.033 . . . . 51.23 110.518 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -97.1 -13.6 22.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.349 -1.089 . . . . 74.2 109.698 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' B' ' 123' ' ' ILE . 0.1 OUTLIER -95.45 143.41 26.81 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.127 -0.983 . . . . 75.42 109.406 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 20.3 p -121.27 145.79 47.49 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.101 -0.703 . . . . 74.22 109.101 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 78.0 mt -125.49 138.87 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.501 -0.749 . . . . 60.33 109.891 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 5.8 t -118.58 114.66 35.92 Favored Pre-proline 0 N--CA 1.499 1.997 0 N-CA-C 108.723 -0.843 . . . . 72.31 108.723 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.92 -53.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.651 1.567 . . . . 75.13 112.162 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -61.52 -40.82 96.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.163 -0.96 . . . . 75.23 109.459 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 132' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' B' ' 133' ' ' GLU . 23.7 tp10 -87.39 7.96 26.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.216 -0.928 . . . . 72.43 109.359 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' B' ' 132' ' ' GLU . 17.9 pt-20 34.33 54.06 0.6 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.252 0.549 . . . . 75.13 111.142 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -139.05 146.4 40.74 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.284 -0.885 . . . . 73.22 109.177 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 14.3 tt -126.11 142.39 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.543 -0.723 . . . . 64.14 109.1 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 7.2 mt -120.63 136.04 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.611 -0.681 . . . . 71.22 109.63 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -138.4 134.69 34.44 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.42 -0.955 . . . . 64.22 108.42 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 138' ' ' LYS . . . . . 0.443 ' CG ' ' O ' ' B' ' 138' ' ' LYS . 12.4 ttmt 56.41 9.34 0.52 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.465 -0.772 . . . . 72.02 109.361 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 96.7 3.62 59.44 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 110.225 -1.15 . . . . 74.32 110.225 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -89.5 126.39 35.57 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.114 -1.227 . . . . 75.34 108.803 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -91.85 120.32 32.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.248 -0.907 . . . . 71.23 109.683 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 7.9 p -134.69 140.95 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 108.777 -0.823 . . . . 70.43 108.777 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -94.01 157.84 15.91 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.188 -0.945 . . . . 72.43 110.241 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -150.28 139.05 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.455 -0.778 . . . . 72.13 108.934 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 26.3 pttt -165.89 77.94 0.26 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.184 -0.948 . . . . 72.02 109.543 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -156.99 -129.83 1.17 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.085 -1.606 . . . . 42.23 109.085 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 0.632 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 73.2 mttt -80.32 -32.4 0.69 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.108 -1.231 . . . . 73.3 110.764 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 148' ' ' PRO . . . . . 0.632 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 71.5 Cg_endo -91.12 15.45 1.76 Allowed 'Trans proline' 0 N--CA 1.486 1.082 0 C-N-CA 122.203 1.935 . . . . 71.33 112.446 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -98.79 -59.13 1.79 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.238 -0.914 . . . . 74.23 109.345 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 150' ' ' GLU . . . . . 0.475 ' CG ' ' N ' ' B' ' 151' ' ' VAL . 18.6 pt-20 -61.09 -48.79 80.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.327 -0.858 . . . . 72.34 110.47 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.525 HG13 ' N ' ' B' ' 152' ' ' LEU . 9.8 p -64.84 -43.39 96.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.811 -1.181 . . . . 73.35 110.449 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.525 ' N ' HG13 ' B' ' 151' ' ' VAL . 12.9 tp -63.74 -53.62 48.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.14 -0.975 . . . . 55.24 110.518 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 16.5 p -72.23 -37.56 69.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.799 -1.188 . . . . 70.01 110.626 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -52.01 -53.49 41.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.76 -1.212 . . . . 65.32 109.706 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' B' ' 159' ' ' ARG . 2.7 pp -71.51 -23.09 61.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.93 -1.106 . . . . 71.54 109.865 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.66 -59.25 4.48 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.816 -1.177 . . . . 75.32 110.881 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -66.03 -47.73 73.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.601 -1.312 . . . . 73.32 108.84 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 158' ' ' HIS . . . . . 0.608 ' C ' ' H ' ' B' ' 160' ' ' ASP . 44.5 t-80 -67.51 -19.17 65.28 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.718 -1.216 . . . . 74.14 107.718 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 159' ' ' ARG . . . . . 0.723 ' O ' ' N ' ' B' ' 161' ' ' GLN . 7.2 tpt180 57.79 4.49 0.27 Allowed 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 107.287 -1.375 . . . . 61.41 107.287 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 160' ' ' ASP . . . . . 0.608 ' H ' ' C ' ' B' ' 158' ' ' HIS . 2.3 m-20 50.36 -40.22 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 123.228 0.611 . . . . 72.1 112.22 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 161' ' ' GLN . . . . . 0.723 ' N ' ' O ' ' B' ' 159' ' ' ARG . 76.8 mt-30 50.48 -142.63 0.65 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.215 -1.553 . . . . 72.25 109.138 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 162' ' ' ILE . . . . . 0.741 HD12 ' N ' ' B' ' 162' ' ' ILE . 1.9 mp -77.53 106.91 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.95 -1.094 . . . . 72.31 108.724 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 163' ' ' VAL . . . . . 0.588 HG13 ' O ' ' B' ' 160' ' ' ASP . 1.3 m -135.67 144.73 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.48 -0.763 . . . . 64.21 109.166 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 41.7 p -96.66 169.76 9.66 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.327 -0.858 . . . . 74.22 109.506 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -55.57 -39.68 70.98 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.297 -0.877 . . . . 65.31 109.168 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -62.74 -39.1 93.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.867 . . . . 63.45 109.313 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -60.13 -45.92 91.38 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.137 -0.977 . . . . 72.4 109.116 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 22.6 mt -61.94 -29.59 70.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.215 -0.928 . . . . 72.32 108.576 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.52 HD23 ' C ' ' B' ' 169' ' ' LEU . 5.6 tt -66.81 -64.86 0.77 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.467 -0.771 . . . . 73.34 109.303 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -61.36 -17.44 53.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.878 . . . . 72.1 109.713 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.72 -61.0 2.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.292 -0.88 . . . . 62.13 110.123 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 8.2 mm -90.91 -54.33 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.128 -0.983 . . . . 71.42 109.401 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -90.4 111.07 22.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.311 -0.868 . . . . 72.23 109.166 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -140.01 -31.53 0.65 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.41 -0.806 . . . . 52.11 109.37 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 175' ' ' GLU . . . . . 0.515 ' C ' ' H ' ' B' ' 177' ' ' GLU . 0.7 OUTLIER -59.8 -177.53 0.11 Allowed Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 108.414 -0.958 . . . . 73.04 108.414 179.708 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' B' ' 175' ' ' GLU . 43.8 Cg_exo -57.19 8.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 122.459 2.106 . . . . 74.13 112.73 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 177' ' ' GLU . . . . . 0.515 ' H ' ' C ' ' B' ' 175' ' ' GLU . 79.0 mm-40 -50.97 -41.46 59.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.124 -0.985 . . . . 72.44 109.551 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 67.4 mtt 46.63 52.46 11.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.183 -0.948 . . . . 63.43 109.674 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 10.2 m -71.5 142.85 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.201 -0.937 . . . . 71.05 109.614 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 180' ' ' THR . . . . . 0.597 ' O ' ' N ' ' B' ' 182' ' ' ASN . 69.1 p -43.54 106.68 0.51 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.55 -0.719 . . . . 62.15 109.919 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -51.36 70.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 122.232 1.955 . . . . 65.22 112.674 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 182' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' B' ' 180' ' ' THR . 28.5 t-20 -174.86 -23.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.198 -0.939 . . . . 72.31 108.889 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 183' ' ' VAL . . . . . 0.43 ' O ' HG22 ' B' ' 186' ' ' VAL . 11.6 p -53.43 -14.47 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.397 -0.815 . . . . 63.32 109.401 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 20.9 mm -54.3 -25.74 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -0.879 . . . . 75.03 109.681 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -55.84 -45.4 78.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -0.952 . . . . 64.11 109.928 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 186' ' ' VAL . . . . . 0.435 HG22 ' H ' ' B' ' 186' ' ' VAL . 9.6 m -80.72 -30.39 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.131 -0.981 . . . . 73.0 110.105 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.97 76.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.95 -1.094 . . . . 61.12 109.938 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 188' ' ' ILE . . . . . 0.452 HG23 ' N ' ' B' ' 189' ' ' ASN . 10.4 tp -74.89 -38.9 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.554 -1.342 . . . . 72.43 109.83 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 189' ' ' ASN . . . . . 0.452 ' N ' HG23 ' B' ' 188' ' ' ILE . 21.7 t-20 -70.5 -35.99 73.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.878 . . . . 65.14 111.282 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 190' ' ' GLN . . . . . 0.458 ' CG ' ' N ' ' B' ' 191' ' ' ILE . 10.6 pt20 -76.67 -47.12 23.11 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.859 -1.151 . . . . 63.24 111.449 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 191' ' ' ILE . . . . . 0.458 ' N ' ' CG ' ' B' ' 190' ' ' GLN . 5.8 pt -65.0 -40.35 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.693 -1.255 . . . . 74.03 110.699 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -69.81 -42.97 72.98 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.026 -1.046 . . . . 72.24 111.005 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -74.21 -35.4 63.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.937 -1.102 . . . . 73.1 111.279 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 8.6 pttp -79.57 -24.35 42.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.82 -1.175 . . . . 72.11 110.54 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 195' ' ' MET . . . . . 0.483 ' SD ' ' OD1' ' B' ' 196' ' ' ASP . 3.5 ppp? -93.01 -38.2 11.78 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.0 -1.063 . . . . 44.33 110.519 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 196' ' ' ASP . . . . . 0.483 ' OD1' ' SD ' ' B' ' 195' ' ' MET . 85.3 m-20 -59.22 -38.23 79.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.035 -1.041 . . . . 71.21 110.646 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -63.28 -60.19 10.16 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.962 -1.086 . . . . 75.21 110.381 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 198' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.56 -59.58 0.24 Allowed 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 121.694 1.596 . . . . 75.32 112.402 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 199' ' ' LEU . . . . . 0.474 ' N ' HD12 ' B' ' 199' ' ' LEU . 10.6 mp -56.04 -42.45 76.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.994 -1.066 . . . . 72.25 109.203 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 82.34 -30.25 3.08 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.004 -1.239 . . . . 64.53 110.004 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 24.9 mm -91.44 129.11 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.025 -1.279 . . . . 44.23 109.435 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 42.0 t -88.13 139.76 30.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.83 . . . . 54.01 108.992 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 25.2 p -139.59 25.62 2.38 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.31 -0.869 . . . . 74.4 109.304 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.512 HG12 ' CD2' ' B' ' 214' ' ' PHE . 23.1 m -143.86 145.86 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.245 -0.909 . . . . 72.12 109.873 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -114.35 137.65 51.54 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.72 -0.613 . . . . 65.41 109.576 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.58 111.43 23.8 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.289 -0.882 . . . . 71.33 108.969 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.413 HG12 ' H ' ' B' ' 209' ' ' ARG . 3.7 t -138.36 142.38 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.286 -0.884 . . . . 63.5 109.498 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 208' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' B' ' 209' ' ' ARG . 32.7 ptt-85 -85.26 -24.65 27.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.216 -0.927 . . . . 74.45 109.642 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 209' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' B' ' 208' ' ' ARG . 96.0 mtt180 -57.5 -110.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.322 -0.861 . . . . 74.14 109.968 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 39.4 mmt-85 -51.12 -45.21 61.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.111 -0.993 . . . . 74.43 109.59 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 147.79 -130.83 3.64 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.35 -1.5 . . . . 64.45 109.35 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -104.59 131.24 52.24 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.365 -1.079 . . . . 74.21 108.779 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -105.01 146.52 28.94 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.437 -0.79 . . . . 74.03 109.902 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 214' ' ' PHE . . . . . 0.512 ' CD2' HG12 ' B' ' 204' ' ' VAL . 27.9 m-85 -128.39 104.12 7.53 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.408 -0.96 . . . . 74.34 108.408 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 215' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' B' ' 216' ' ' TYR . 50.8 t -127.66 169.01 14.26 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.2 -0.937 . . . . 64.33 110.49 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 216' ' ' TYR . . . . . 0.528 ' N ' ' SG ' ' B' ' 215' ' ' CYS . 47.6 m-85 -63.63 152.14 86.75 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.586 -0.696 . . . . 70.04 109.173 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.92 -162.08 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.212 1.941 . . . . 65.11 111.725 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -47.73 154.36 0.95 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.222 -0.924 . . . . 73.15 109.018 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -37.09 124.31 0.44 Allowed 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.364 2.043 . . . . 71.31 112.286 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 220' ' ' ALA . . . . . 0.426 ' C ' ' H ' ' B' ' 222' ' ' GLU . . . -97.34 39.29 1.2 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.281 -0.887 . . . . 75.45 109.771 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 5.5 p -77.03 32.19 0.14 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.166 -0.959 . . . . 72.22 109.647 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.426 ' H ' ' C ' ' B' ' 220' ' ' ALA . 27.6 mp0 48.5 -171.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 54.53 109.557 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 118.031 -0.985 . . . . 71.13 109.277 -179.9 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.2 ttm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.435 -0.579 . . . . 65.12 109.435 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.437 ' N ' ' OD2' ' A' ' 46' ' ' ASP . 61.2 ttm-85 -143.08 150.75 39.94 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.263 -0.898 . . . . 72.33 109.322 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 81.4 t -120.25 134.82 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-O 121.5 0.667 . . . . 71.42 110.091 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.401 ' O ' ' O ' ' A' ' 49' ' ' MET . 8.9 tp -100.25 115.97 31.14 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.645 -0.872 . . . . 65.12 108.645 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.482 HD12 ' SD ' ' A' ' 49' ' ' MET . 25.2 tp -117.39 99.55 7.08 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.582 -0.699 . . . . 62.43 109.756 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.485 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 7.8 mt -94.35 119.36 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.753 -1.217 . . . . 71.15 108.953 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -149.26 121.9 8.61 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.199 -0.938 . . . . 75.34 109.603 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -65.84 -32.97 74.79 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.265 -0.897 . . . . 72.44 108.996 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -87.27 107.34 18.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.355 -0.841 . . . . 63.02 109.363 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.2 t -65.99 -18.37 65.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 72.34 109.671 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.45 -55.82 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.16 -0.963 . . . . 74.02 109.904 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.603 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.5 mm? -69.39 -38.86 78.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.255 -0.903 . . . . 71.43 109.557 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.13 -28.67 63.84 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.693 -1.763 . . . . 61.32 108.693 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.28 -45.51 95.01 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.515 -1.434 . . . . 71.2 109.515 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.598 ' OE2' HD13 ' A' ' 12' ' ' LEU . 15.0 pt-20 -67.46 -45.91 74.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -1.129 . . . . 71.32 109.905 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 98.6 mt -64.0 -42.03 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.623 -1.298 . . . . 63.23 108.641 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -54.01 -50.81 65.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.901 . . . . 51.11 109.521 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -85.11 1.98 45.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.123 -0.986 . . . . 73.34 109.076 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.97 -60.73 2.01 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 109.737 -1.345 . . . . 62.15 109.737 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -69.46 -22.9 63.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.203 -1.175 . . . . 73.51 109.796 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 53.0 m-20 -59.05 -32.89 70.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.04 -1.037 . . . . 74.25 109.339 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.4 t -58.71 -34.04 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.445 -0.785 . . . . 70.04 109.374 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 2.4 mptp? -68.39 -1.21 5.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 73.23 109.315 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.37 35.09 11.04 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.74 -1.344 . . . . 75.54 109.74 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -115.78 159.62 21.2 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.488 -1.007 . . . . 73.43 109.143 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.7 mmt -104.09 138.13 41.05 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.45 -0.945 . . . . 43.24 108.45 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.75 164.2 31.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.913 . . . . 62.11 109.771 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -139.08 149.88 45.08 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.434 -0.791 . . . . 74.42 108.977 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.48 129.0 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.705 -0.85 . . . . 72.15 108.705 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.3 p -133.1 167.93 19.44 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.452 -0.78 . . . . 71.42 109.752 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.485 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 3.0 pt-20 -98.6 -96.14 0.23 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.398 -0.814 . . . . 72.33 109.747 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.5 p -79.96 164.25 23.64 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.015 -1.053 . . . . 74.24 110.007 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 37' ' ' GLU . 21.8 mt -54.77 -38.95 67.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.513 -0.742 . . . . 71.53 109.819 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -52.57 -44.21 65.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 74.23 109.814 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -65.3 -42.47 93.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.107 -0.996 . . . . 54.03 109.665 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.03 -30.6 50.81 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.062 -1.215 . . . . 61.41 110.062 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 33' ' ' LEU . 78.2 tt0 -66.74 -46.45 75.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.126 -1.22 . . . . 74.34 110.099 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.442 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 48.2 m-85 -78.92 -24.11 44.27 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.092 -1.005 . . . . 75.33 109.959 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.8 tp -85.49 -29.23 24.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.005 -1.06 . . . . 74.33 109.81 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.562 ' SD ' ' CE1' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -86.82 -36.81 18.29 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.069 -1.02 . . . . 70.32 110.633 -179.164 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 30.5 p-10 -58.73 -30.77 67.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.935 -1.103 . . . . 71.22 110.238 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.531 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 10.1 pt -78.17 -31.64 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.071 -1.018 . . . . 74.14 110.104 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 40' ' ' MET . 79.9 mtt85 -108.44 171.82 7.19 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.341 -0.849 . . . . 72.24 109.682 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -86.93 148.73 25.22 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.203 -0.936 . . . . 75.42 109.184 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.565 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 0.5 OUTLIER -139.0 128.65 24.63 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.282 -0.886 . . . . 74.23 109.509 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.446 ' OD1' ' CD2' ' A' ' 113' ' ' LEU . 3.7 p30 -108.08 -41.99 4.78 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.844 -0.798 . . . . 72.04 108.844 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.473 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.3 OUTLIER -103.8 112.84 25.97 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.074 -1.084 . . . . 72.13 108.074 179.335 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.473 ' N ' HD13 ' A' ' 47' ' ' LEU . 21.9 t -100.24 96.86 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.445 -0.946 . . . . 72.34 108.445 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.482 ' SD ' HD12 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -116.47 123.87 48.55 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.685 0.755 . . . . 74.11 109.857 -179.477 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.58 HG22 ' H ' ' A' ' 52' ' ' ASP . 1.1 p -131.21 131.93 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 121.632 0.729 . . . . 61.12 109.41 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.2 p -91.38 3.5 54.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.522 -0.736 . . . . 73.11 109.303 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.58 ' H ' HG22 ' A' ' 50' ' ' VAL . 1.6 m-20 -78.99 138.34 38.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.269 -0.894 . . . . 52.55 109.6 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.516 ' NZ ' ' OD1' ' A' ' 77' ' ' ASN . 14.9 mmmt -76.83 -36.18 57.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.214 -0.929 . . . . 44.22 110.11 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -70.54 12.38 0.26 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.081 -1.012 . . . . 70.44 109.537 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -69.25 -20.9 63.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.412 -0.805 . . . . 64.14 110.399 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 55' ' ' ALA . 20.3 mt -40.0 -50.46 2.55 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.468 -0.77 . . . . 44.14 110.395 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.7 t -69.08 -33.56 73.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.033 -1.042 . . . . 55.23 108.957 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.615 ' CE2' HD11 ' A' ' 62' ' ' ILE . 50.9 t80 -66.91 -59.32 3.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.468 -0.77 . . . . 74.44 109.938 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.1 m -52.22 -34.14 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.715 -1.24 . . . . 74.03 109.492 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.5 m -58.49 -54.02 51.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.2 -0.938 . . . . 64.3 109.715 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -66.85 -27.86 67.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.111 -0.993 . . . . 64.44 109.978 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.615 HD11 ' CE2' ' A' ' 58' ' ' PHE . 5.6 mm -67.05 -45.73 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.901 -1.124 . . . . 63.21 110.185 -179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 67' ' ' SER . 53.7 mmtt -65.16 -46.44 80.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 74.42 110.645 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 6.6 pt-20 -70.35 -41.83 72.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.716 -1.24 . . . . 70.32 109.953 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.491 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 25.9 mtpp -76.29 -19.12 58.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.143 -0.973 . . . . 75.22 109.313 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.532 ' O ' HG22 ' A' ' 69' ' ' ILE . 83.2 m-70 -156.29 68.1 0.6 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.888 . . . . 74.13 109.282 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 63' ' ' LYS . 82.5 p -65.49 -15.87 63.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 73.24 109.914 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 92.8 p -88.32 43.82 1.16 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.191 -0.943 . . . . 61.01 110.329 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 66' ' ' HIS . 16.9 tt -145.11 169.13 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.989 -1.069 . . . . 71.33 109.582 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.1 t -102.1 148.66 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.263 -0.898 . . . . 72.13 109.424 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.5 t -131.5 126.49 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.376 -0.828 . . . . 54.21 109.76 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.553 HD23 ' C ' ' A' ' 72' ' ' LEU . 3.8 tt -120.11 100.97 7.51 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.111 -0.7 . . . . 50.24 109.111 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 73' ' ' VAL . 8.7 p -97.09 131.32 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.982 -1.074 . . . . 74.41 109.153 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 75' ' ' SER . 4.5 p -92.86 174.98 6.97 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.086 -1.009 . . . . 72.31 109.378 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.472 ' OG ' ' CE2' ' A' ' 94' ' ' TYR . 50.9 m -164.49 116.09 1.26 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.083 -1.01 . . . . 64.54 110.371 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.8 -28.56 68.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.525 -0.734 . . . . 74.13 109.306 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.516 ' OD1' ' NZ ' ' A' ' 53' ' ' LYS . 13.0 p30 -109.6 71.13 0.52 Allowed Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.657 -0.652 . . . . 73.34 109.41 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.01 80.45 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.654 1.569 . . . . 63.22 111.769 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.63 HG23 ' H ' ' A' ' 82' ' ' GLU . 1.8 t -104.72 162.49 13.25 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.656 -0.868 . . . . 62.53 108.656 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.8 p -71.36 -29.11 64.59 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.166 -0.959 . . . . 73.44 109.864 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -62.77 -45.57 92.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 71.42 109.475 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.63 ' H ' HG23 ' A' ' 79' ' ' THR . 74.8 tt0 -76.49 -29.72 56.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.281 -0.887 . . . . 73.43 109.639 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -63.73 -57.01 11.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.954 . . . . 74.22 109.611 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.519 HG23 ' N ' ' A' ' 85' ' ' HIS . 27.2 m -60.34 -42.18 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.14 -0.975 . . . . 73.2 108.987 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.519 ' N ' HG23 ' A' ' 84' ' ' VAL . 82.4 t60 -62.95 -35.44 80.12 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.298 -0.876 . . . . 53.33 109.219 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.82 -37.38 84.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.416 -0.803 . . . . 64.11 109.861 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -77.08 -29.91 55.19 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.047 -1.033 . . . . 74.34 108.818 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.34 -36.3 68.79 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.714 -0.794 . . . . 74.42 109.229 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -66.58 -51.29 58.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.364 -0.835 . . . . 74.24 109.478 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.85 44.3 0.06 OUTLIER Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.742 -1.343 . . . . 61.51 109.742 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -99.72 135.88 40.47 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.21 -1.171 . . . . 55.33 109.416 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.524 ' OD2' ' NH1' ' A' ' 112' ' ' ARG . 45.9 t0 -82.38 -25.05 34.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 73.42 109.314 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.528 ' OD2' ' NH2' ' A' ' 112' ' ' ARG . 72.0 m-20 -149.75 155.76 40.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.349 -0.845 . . . . 75.04 109.249 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.472 ' CE2' ' OG ' ' A' ' 75' ' ' SER . 55.3 t80 -137.4 103.38 5.06 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.735 -0.839 . . . . 71.33 108.735 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.511 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -107.6 151.94 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.651 0.738 . . . . 71.13 110.001 -177.508 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.36 130.27 39.35 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.693 -1.225 . . . . 64.32 107.693 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.697 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -49.89 -55.67 22.34 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 120.988 -1.07 . . . . 62.2 111.835 -178.624 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 2.2 Cg_endo -40.21 -11.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 120.895 1.063 . . . . 73.11 113.101 -176.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.697 ' N ' ' O ' ' A' ' 97' ' ' LYS . 56.5 m-85 59.08 121.07 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.644 -0.66 . . . . 65.22 110.189 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.587 ' HE ' ' CB ' ' B' ' 80' ' ' SER . 0.0 OUTLIER -56.71 -46.63 81.15 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.047 -1.094 . . . . 72.35 108.047 179.077 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.764 ' O ' ' N ' ' A' ' 103' ' ' LYS . 22.7 t -175.11 53.69 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.236 -0.915 . . . . 71.32 110.498 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 11.4 mm 49.08 -69.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.591 -0.693 . . . . 75.43 110.796 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.764 ' N ' ' O ' ' A' ' 101' ' ' SER . 2.4 mppt? -55.29 -18.34 6.17 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.988 -1.116 . . . . 71.41 107.988 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.08 -97.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.582 -0.699 . . . . 63.24 110.405 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.632 ' N ' HD23 ' A' ' 105' ' ' LEU . 2.0 pt? -49.83 -36.18 25.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.137 -0.977 . . . . 73.22 110.226 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.48 -39.85 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.881 -1.137 . . . . 60.11 108.903 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 103' ' ' LYS . . . -64.13 -31.86 73.21 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.193 -0.942 . . . . 70.42 108.57 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.1 ttp-105 -81.91 -24.83 35.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.457 -0.777 . . . . 74.41 109.745 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 65.6 mt -75.53 -37.4 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.032 -1.043 . . . . 62.54 108.705 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.442 ' OE1' ' NZ ' ' A' ' 23' ' ' LYS . 11.8 pt-20 -76.21 -35.33 59.1 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.561 -0.856 . . . . 74.34 109.353 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.71 -45.35 94.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.431 -0.793 . . . . 73.32 109.863 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.528 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 23.3 ttm180 -66.06 -50.83 62.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.119 -0.988 . . . . 52.41 109.596 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 113' ' ' LEU . 10.1 mp -95.51 38.29 1.16 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.14 -0.975 . . . . 65.24 109.206 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.37 -55.2 5.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.262 -0.899 . . . . 64.45 109.176 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -85.07 13.53 6.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -0.869 . . . . 74.43 109.617 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 60.4 t-105 -48.98 105.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 74.42 109.537 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 157.85 -136.89 5.04 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.629 -1.388 . . . . 75.04 109.629 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.8 t 54.21 177.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.425 -1.044 . . . . 61.14 110.049 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.7 150.71 26.53 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.059 -0.719 . . . . 65.24 109.059 -178.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.0 t -90.31 -41.48 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.155 -0.966 . . . . 73.11 109.581 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 17.1 mm -100.13 135.84 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.348 -0.845 . . . . 72.24 109.586 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -148.54 127.18 12.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 72.34 109.048 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.436 ' O ' HG23 ' A' ' 123' ' ' ILE . 6.5 tp -154.42 128.09 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 71.44 108.994 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 53.47 -139.4 35.02 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.946 -1.661 . . . . 73.4 108.946 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 125' ' ' ASP . 14.3 p-10 -93.51 6.39 48.38 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.089 -1.242 . . . . 74.45 109.154 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.05 135.14 38.23 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.638 -0.875 . . . . 54.21 108.638 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.1 m -131.97 138.63 48.38 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.405 -0.809 . . . . 54.5 109.408 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.8 mt -138.85 139.92 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.332 -0.855 . . . . 45.15 109.184 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.8 m -123.36 82.33 52.65 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.604 -0.685 . . . . 71.11 109.392 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.46 -41.09 75.93 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.56 2.174 . . . . 65.41 112.115 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -56.07 -44.78 79.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 63.32 109.064 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -87.15 2.13 50.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.409 -0.807 . . . . 72.52 108.868 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 1.28 ' HB3' ' CZ ' ' A' ' 149' ' ' PHE . 21.4 mt-10 49.71 61.75 3.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.422 -0.798 . . . . 75.33 109.058 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -149.02 135.61 19.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.252 -0.905 . . . . 71.23 109.808 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 11.6 tt -107.86 136.24 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.434 -0.95 . . . . 74.02 108.434 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 47.7 mt -128.86 125.18 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.364 -0.835 . . . . 60.23 109.947 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 137' ' ' TYR . 16.5 p90 -139.3 147.25 41.38 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.454 -0.779 . . . . 62.32 109.152 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 54.9 mttp 54.33 23.87 4.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.451 -0.78 . . . . 75.4 110.05 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 79.44 -1.35 77.15 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.44 -1.064 . . . . 72.24 110.44 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -90.17 135.53 33.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.953 -1.322 . . . . 71.22 108.89 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -101.52 131.07 47.88 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.401 -0.812 . . . . 71.42 109.695 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 49.8 t -137.81 127.65 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.956 -0.757 . . . . 53.02 108.956 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -81.36 139.28 35.43 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.254 -0.904 . . . . 60.45 109.336 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.404 ' O ' ' CD1' ' A' ' 149' ' ' PHE . 12.2 m -142.6 137.09 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.252 -0.905 . . . . 74.44 109.53 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 1.136 ' HA ' ' CG ' ' A' ' 149' ' ' PHE . 49.5 pttt -171.45 28.57 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 65.15 109.214 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.19 -145.8 3.33 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.93 -1.268 . . . . 73.34 109.93 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -70.87 -38.61 7.61 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 121.357 -1.084 . . . . 72.22 110.426 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 90.5 Cg_endo -86.66 11.82 3.17 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.008 1.806 . . . . 65.23 111.853 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 1.28 ' CZ ' ' HB3' ' A' ' 133' ' ' GLU . 32.3 t80 -79.75 -34.83 39.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.418 -0.801 . . . . 60.11 109.425 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -74.41 -38.03 63.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 64.21 110.168 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.518 HG13 ' N ' ' A' ' 152' ' ' LEU . 11.5 p -74.76 -40.58 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.09 -1.006 . . . . 72.02 109.506 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.518 ' N ' HG13 ' A' ' 151' ' ' VAL . 20.4 tp -58.94 -45.63 89.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 73.31 109.216 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.7 p -65.82 -37.08 85.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 74.31 109.373 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -52.94 -54.96 27.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.374 -0.829 . . . . 74.31 109.94 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.67 HD12 ' N ' ' A' ' 156' ' ' ALA . 4.4 pp -76.33 -19.6 58.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 75.34 110.067 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.67 ' N ' HD12 ' A' ' 155' ' ' LEU . . . -61.68 -45.28 94.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.009 -1.057 . . . . 62.14 109.464 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.445 ' C ' ' H ' ' A' ' 159' ' ' ARG . 60.4 mtp180 -79.55 -51.58 9.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.185 -0.947 . . . . 61.03 109.35 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.406 ' C ' ' H ' ' A' ' 160' ' ' ASP . 62.0 m170 -73.32 43.5 0.13 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.487 -0.758 . . . . 74.12 109.172 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.445 ' H ' ' C ' ' A' ' 157' ' ' ARG . 0.2 OUTLIER -74.72 30.77 0.09 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.579 -0.7 . . . . 71.13 110.213 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 158' ' ' HIS . 63.3 t0 -165.2 66.4 0.13 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.922 -1.111 . . . . 75.45 110.131 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.562 HE22 ' CG2' ' A' ' 163' ' ' VAL . 2.1 pp0? -177.89 178.75 0.93 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.125 -0.984 . . . . 73.41 109.802 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 14.1 mm -97.44 125.67 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.309 -0.869 . . . . 74.41 109.358 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.562 ' CG2' HE22 ' A' ' 161' ' ' GLN . 18.6 t -104.5 132.82 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.376 -0.827 . . . . 72.31 109.197 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.7 t -87.31 141.59 28.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.15 -0.969 . . . . 74.12 109.321 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.439 ' O ' HD13 ' A' ' 184' ' ' ILE . 33.1 mttt -51.69 -45.63 63.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 70.43 108.77 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -56.55 -37.64 70.8 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 73.52 109.1 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.17 -40.87 71.17 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.158 -0.964 . . . . 74.52 109.296 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 74.8 mt -62.62 -49.17 76.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 72.31 109.918 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.4 tp -75.77 -65.46 0.9 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.787 -1.195 . . . . 53.33 109.84 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -39.45 -31.01 0.08 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 122.164 -0.335 . . . . 62.44 111.892 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.75 -39.88 9.64 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.774 -1.204 . . . . 60.21 112.519 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.528 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 1.3 mp -85.31 -60.16 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 120.535 -1.353 . . . . 75.32 111.709 -177.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.464 ' CD2' ' C ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -61.96 -7.14 3.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.79 -1.194 . . . . 73.14 110.049 -177.83 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.9 -24.91 59.84 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.962 -1.086 . . . . 73.24 110.133 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.451 ' CB ' ' CD ' ' A' ' 176' ' ' PRO . 1.7 mp0 -79.38 -66.17 0.28 Allowed Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 120.828 -1.17 . . . . 44.43 110.054 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' A' ' 175' ' ' GLU . 41.3 Cg_endo -64.53 -32.47 59.06 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.198 1.932 . . . . 72.51 111.579 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 52.86 22.3 2.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.495 -0.753 . . . . 63.24 110.379 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.449 ' O ' ' O ' ' A' ' 179' ' ' VAL . 26.6 ttt -77.75 -49.58 14.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.032 -1.042 . . . . 73.5 108.947 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 178' ' ' MET . 0.5 OUTLIER 60.08 128.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-O 121.675 0.75 . . . . 65.22 109.107 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.515 ' O ' HG13 ' A' ' 183' ' ' VAL . 5.3 p -151.42 153.52 32.44 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.28 -0.887 . . . . 71.42 108.796 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -35.92 -37.18 0.22 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 122.342 2.028 . . . . 41.22 112.017 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -76.01 46.17 0.38 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.395 -0.965 . . . . 64.54 108.395 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 180' ' ' THR . 26.8 m -62.05 -135.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.541 -0.724 . . . . 74.02 110.365 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 165' ' ' LYS . 57.3 mt -62.9 -31.87 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.287 -0.883 . . . . 72.33 109.636 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.406 ' H ' HG23 ' A' ' 183' ' ' VAL . 47.4 tt0 -45.64 -56.3 5.36 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.594 -0.692 . . . . 74.4 110.3 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 87.3 t -80.9 -52.69 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -0.946 . . . . 70.42 110.54 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -46.06 -47.47 17.08 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.023 -1.048 . . . . 52.11 110.387 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.509 ' O ' HD13 ' A' ' 188' ' ' ILE . 0.2 OUTLIER -71.95 -46.86 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.837 -1.164 . . . . 71.4 109.693 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.461 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 46.8 t-20 -56.13 -40.88 74.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.951 -1.093 . . . . 73.44 110.334 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 194' ' ' LYS . 25.6 mt-30 -72.9 -48.24 38.91 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.027 -1.045 . . . . 71.42 110.298 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 58.5 mt -49.12 -36.18 8.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 120.65 -1.281 . . . . 61.55 110.242 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 20.7 mtm-85 -76.04 -59.21 2.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.856 -1.153 . . . . 63.34 111.057 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.43 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 86.6 mt-30 -71.08 -14.53 62.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.13 -0.981 . . . . 61.24 110.775 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 190' ' ' GLN . 33.3 ttpt -91.17 -36.88 13.7 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.17 -0.956 . . . . 75.13 110.042 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 9.3 tpt -89.89 -4.1 57.72 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.294 -0.879 . . . . 74.02 109.701 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 197' ' ' LYS . 33.7 p-10 -68.2 -44.31 76.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.089 -1.007 . . . . 74.02 110.652 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.537 ' N ' ' OD1' ' A' ' 196' ' ' ASP . 8.9 mttm -75.84 -53.44 2.42 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.944 -1.098 . . . . 75.43 110.017 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -47.03 -61.36 0.62 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.899 1.733 . . . . 72.32 112.214 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 33.8 tp -70.61 -43.72 68.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 74.54 109.314 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 91.38 -19.45 47.06 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.985 -1.246 . . . . 61.51 109.985 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 29.9 mm -111.32 133.44 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.415 -1.05 . . . . 61.22 109.576 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 14.4 t -85.35 134.42 34.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 72.0 109.123 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 43.9 p -144.23 29.05 1.32 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.238 -0.914 . . . . 74.44 109.595 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.48 125.2 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.386 -0.821 . . . . 64.35 109.483 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -107.12 129.07 54.88 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.485 -0.759 . . . . 71.41 109.147 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 81.0 p -93.35 120.71 33.94 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.21 -0.932 . . . . 73.52 109.414 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.51 HG22 ' H ' ' A' ' 209' ' ' ARG . 7.3 p -137.49 143.1 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.366 -0.834 . . . . 71.02 109.051 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -75.69 -33.06 60.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 72.12 110.067 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 211' ' ' GLY . 44.9 mmm-85 -60.97 145.89 48.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.098 -1.001 . . . . 64.41 109.553 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 64.1 mtp85 48.64 -91.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.386 -0.821 . . . . 71.54 109.734 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . -160.27 -124.99 0.76 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.494 -1.443 . . . . 72.03 109.494 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -101.5 141.84 33.76 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.352 -1.087 . . . . 75.54 109.236 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.474 ' NH1' ' SG ' ' A' ' 215' ' ' CYS . 66.1 ttt-85 -109.03 127.28 53.96 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.514 -0.741 . . . . 75.31 109.789 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -109.66 124.02 50.47 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.646 -0.872 . . . . 75.41 108.646 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' CYS . . . . . 0.474 ' SG ' ' NH1' ' A' ' 213' ' ' ARG . 4.8 p -140.91 167.32 22.48 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.34 -0.85 . . . . 74.14 109.923 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -61.71 150.78 80.89 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.384 -0.823 . . . . 75.32 108.947 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -39.46 137.91 0.88 Allowed 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 121.852 1.701 . . . . 73.11 111.99 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.605 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 2.8 tppt? -76.96 -36.49 1.59 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.114 -0.991 . . . . 75.25 110.375 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 75.5 Cg_endo -91.48 32.43 0.3 Allowed 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 122.431 2.088 . . . . 75.1 112.419 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -53.69 134.46 41.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.154 -0.966 . . . . 71.14 109.448 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 74.8 m -83.26 -34.14 25.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.307 -0.871 . . . . 71.13 109.572 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 48.07 21.25 0.31 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 75.35 109.611 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.042 -0.98 . . . . 73.41 109.473 -179.908 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.566 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.418 -0.586 . . . . 71.14 109.418 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 1.217 ' CZ ' ' NH2' ' B' ' 43' ' ' ARG . 88.9 mtt-85 -131.21 142.34 50.17 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.507 -0.745 . . . . 73.23 109.721 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 88.2 t -107.7 123.07 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.611 -0.681 . . . . 72.24 109.709 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.58 HD11 ' CG1' ' B' ' 6' ' ' ILE . 2.4 tp -91.24 114.43 26.95 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.094 -1.076 . . . . 54.33 108.094 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 4.4 tp -117.11 111.71 19.87 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.912 -0.773 . . . . 74.35 108.912 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.58 ' CG1' HD11 ' B' ' 4' ' ' LEU . 20.0 mt -106.59 123.58 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.445 -0.785 . . . . 42.55 109.02 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -140.41 120.25 13.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.345 -0.847 . . . . 74.52 109.274 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -66.44 -30.81 71.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.158 -0.963 . . . . 62.55 109.283 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -64.24 -128.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.217 -0.927 . . . . 73.11 109.033 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 79.2 p -167.06 -66.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.11 -0.994 . . . . 65.54 109.658 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.472 HG13 ' N ' ' B' ' 12' ' ' LEU . 9.6 p -67.52 -40.96 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 75.55 109.907 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.472 ' N ' HG13 ' B' ' 11' ' ' VAL . 3.6 mm? -52.14 -43.23 63.93 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.024 -1.048 . . . . 70.14 108.725 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.94 -28.35 68.85 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 108.508 -1.837 . . . . 75.4 108.508 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.61 -51.52 53.42 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 109.72 -1.352 . . . . 65.44 109.72 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -60.82 -45.04 96.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -1.114 . . . . 60.21 109.931 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 5.6 mm -67.26 -38.73 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.828 -1.17 . . . . 75.15 108.924 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.525 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 84.0 tt0 -62.73 -42.52 99.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 73.01 109.791 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -88.58 -0.53 57.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.931 -1.106 . . . . 74.3 108.916 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.1 -53.39 3.32 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 109.551 -1.419 . . . . 70.54 109.551 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -73.83 -24.59 59.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -1.121 . . . . 71.34 109.654 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 96.2 m-20 -58.96 -34.75 72.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.158 -0.964 . . . . 64.41 109.485 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 90.9 t -55.74 -45.29 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.416 -0.802 . . . . 74.23 109.379 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 50.3 mmtt -54.2 -49.67 68.85 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.382 -0.824 . . . . 63.42 108.827 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.77 41.21 0.15 Allowed Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.1 -1.2 . . . . 53.43 110.1 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -120.38 160.13 23.69 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.395 -1.062 . . . . 71.12 109.532 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.1 mmt -100.47 139.41 36.2 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.957 -1.127 . . . . 75.24 107.957 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.28 160.43 41.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.168 -0.957 . . . . 72.12 110.314 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -135.2 141.31 45.82 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.607 -0.886 . . . . 72.31 108.607 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 1.1 m -107.59 126.96 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.332 -0.855 . . . . 64.43 109.103 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.7 p -125.13 161.85 25.9 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.616 -0.678 . . . . 65.41 109.25 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.466 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 1.7 pt-20 -88.2 -97.67 0.09 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.27 -0.894 . . . . 71.02 109.796 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.3 t -78.8 152.39 31.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.895 . . . . 51.11 110.007 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.564 ' H ' HD12 ' B' ' 33' ' ' LEU . 1.6 mp -50.59 -26.29 5.14 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.562 -0.711 . . . . 71.24 109.711 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -58.61 -48.29 81.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.96 . . . . 74.32 109.872 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.466 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 68.5 m-20 -59.88 -43.74 94.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.969 . . . . 73.03 109.258 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.06 -29.59 68.71 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.2 -1.56 . . . . 30.21 109.2 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -65.66 -43.66 88.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.358 -1.084 . . . . 74.42 109.816 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -80.28 -33.5 37.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.997 -1.064 . . . . 74.42 109.57 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 11.3 tp -72.88 -39.23 66.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.345 -0.847 . . . . 75.41 109.776 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' MET . . . . . 0.43 ' O ' ' O ' ' B' ' 43' ' ' ARG . 2.9 ppp? -75.79 -21.93 56.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.962 . . . . 60.41 109.833 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -60.73 -35.85 77.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.135 -0.978 . . . . 53.23 109.531 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 11.3 pt -92.4 -24.81 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.28 -0.888 . . . . 71.23 110.031 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 1.217 ' NH2' ' CZ ' ' B' ' 2' ' ' ARG . 54.4 mtp180 -124.9 139.47 53.8 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.335 -0.853 . . . . 72.22 109.537 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -101.35 143.38 31.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.3 -0.875 . . . . 63.54 109.62 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -114.85 143.5 45.01 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.967 -0.753 . . . . 64.35 108.967 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' B' ' 2' ' ' ARG . 8.3 p-10 -82.08 -36.92 27.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.077 -1.015 . . . . 62.22 109.276 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.508 ' C ' HD13 ' B' ' 47' ' ' LEU . 0.8 OUTLIER -109.41 109.72 20.65 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.639 -0.875 . . . . 73.12 108.639 179.608 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.446 ' N ' HD13 ' B' ' 47' ' ' LEU . 63.5 t -94.46 100.57 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.282 -0.886 . . . . 65.11 109.197 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 0.3 OUTLIER -116.93 124.98 50.76 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.669 -0.863 . . . . 73.44 108.669 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.85 130.43 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.278 -0.889 . . . . 34.5 109.342 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 75.4 p -107.21 27.92 8.58 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.691 -0.631 . . . . 73.21 109.54 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -86.86 159.02 19.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -0.927 . . . . 70.41 109.486 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' B' ' 55' ' ' ALA . 94.0 mttt -81.63 175.8 10.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.321 -0.862 . . . . 65.0 109.375 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ASN . . . . . 0.465 ' ND2' ' C ' ' B' ' 54' ' ' ASN . 0.3 OUTLIER 44.58 16.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.602 -0.686 . . . . 75.21 109.86 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' B' ' 53' ' ' LYS . . . -74.48 -20.55 59.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 55.33 109.185 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 24.6 mt -42.79 -46.73 5.3 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.631 -0.668 . . . . 63.14 110.342 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 58.7 m -65.54 -37.22 86.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.971 -1.081 . . . . 63.5 109.659 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' PHE . . . . . 0.467 ' CZ ' HD11 ' B' ' 62' ' ' ILE . 67.1 t80 -63.21 -59.99 4.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 72.33 109.898 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 15.4 m -49.59 -35.68 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.735 -1.228 . . . . 74.54 109.764 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.428 ' OG ' ' N ' ' B' ' 61' ' ' ARG . 13.0 p -58.11 -55.04 40.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.095 -1.003 . . . . 71.24 109.752 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.428 ' N ' ' OG ' ' B' ' 60' ' ' SER . 11.3 ptp180 -64.48 -27.47 69.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.064 -1.023 . . . . 74.31 110.042 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.467 HD11 ' CZ ' ' B' ' 58' ' ' PHE . 28.2 mm -64.74 -41.54 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.784 -1.197 . . . . 72.14 109.936 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.476 ' NZ ' ' O ' ' B' ' 90' ' ' GLY . 19.1 mmtp -69.65 -48.83 58.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.94 -1.1 . . . . 73.32 110.551 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -66.7 -35.93 81.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.759 -1.213 . . . . 73.12 109.807 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.421 ' C ' ' CG ' ' B' ' 66' ' ' HIS . 9.7 mtpm? -82.13 -25.29 34.53 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.166 -0.959 . . . . 72.44 109.702 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.421 ' CG ' ' C ' ' B' ' 65' ' ' LYS . 65.6 m-70 -152.73 68.01 0.83 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.164 -0.96 . . . . 63.31 109.516 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 86.6 p -64.4 -25.8 68.18 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.359 -0.838 . . . . 73.1 109.885 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 17.8 p -66.02 -9.19 28.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.179 -0.951 . . . . 71.53 109.883 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 56.9 mt -102.11 151.26 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.351 -0.843 . . . . 74.4 109.468 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.551 HG12 ' N ' ' B' ' 71' ' ' VAL . 76.6 t -87.39 165.54 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.249 -0.907 . . . . 75.12 109.486 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.551 ' N ' HG12 ' B' ' 70' ' ' VAL . 2.9 t -145.7 122.71 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.966 -1.084 . . . . 73.2 109.824 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.521 ' HG ' HD11 ' B' ' 95' ' ' ILE . 2.9 mp -120.36 105.4 10.87 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.483 -0.932 . . . . 73.34 108.483 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.463 ' O ' HG13 ' B' ' 73' ' ' VAL . 14.7 p -95.35 130.91 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.209 -0.932 . . . . 73.5 109.019 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 2.5 p -89.5 170.19 10.72 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.104 -0.997 . . . . 64.34 109.203 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 26.4 t -161.22 114.54 1.95 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.092 -1.005 . . . . 74.53 109.942 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -62.8 -36.7 84.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.173 -0.954 . . . . 64.5 108.81 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' ASN . . . . . 0.407 ' OD1' ' N ' ' B' ' 77' ' ' ASN . 13.0 p-10 -112.39 87.4 9.34 Favored Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 108.668 -0.864 . . . . 74.25 108.668 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -72.16 78.78 1.82 Allowed 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.51 1.473 . . . . 74.43 111.875 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 77.2 p -83.01 152.33 25.45 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.034 -1.098 . . . . 73.12 108.034 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' SER . . . . . 0.587 ' CB ' ' HE ' ' A' ' 100' ' ' ARG . 0.5 OUTLIER -63.96 -35.74 81.67 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.011 -1.056 . . . . 71.01 109.89 -179.239 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 81' ' ' GLU . . . . . 0.496 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 24.0 pt-20 -60.55 -36.82 79.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.129 -0.982 . . . . 63.2 109.373 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -73.63 -33.55 64.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.213 -0.929 . . . . 73.22 109.565 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -62.74 -52.36 63.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.901 . . . . 74.3 109.722 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 18.8 m -61.09 -39.3 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.111 -0.993 . . . . 73.31 109.34 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' HIS . . . . . 0.496 ' ND1' ' O ' ' B' ' 81' ' ' GLU . 25.0 m80 -66.59 -30.66 71.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 73.24 109.351 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -65.37 -43.35 91.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 55.33 109.693 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -80.22 -35.04 36.79 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.185 -0.947 . . . . 74.14 109.019 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -63.13 -50.43 70.46 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.425 -0.797 . . . . 64.04 109.074 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -60.45 -52.68 64.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.544 -0.723 . . . . 72.35 109.836 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' GLY . . . . . 0.476 ' O ' ' NZ ' ' B' ' 63' ' ' LYS . . . 155.16 -15.08 0.49 Allowed Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.649 -1.262 . . . . 65.2 110.588 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 91' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -45.02 133.05 6.65 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.973 -1.31 . . . . 52.23 109.843 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' B' ' 93' ' ' ASP . 18.1 t0 -69.39 -42.56 74.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 73.32 109.362 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 93' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' B' ' 92' ' ' ASP . 72.9 m-20 -152.25 164.91 36.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.43 -0.794 . . . . 72.22 109.175 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.522 ' O ' ' CD1' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -138.54 127.76 24.28 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.902 -0.777 . . . . 64.42 108.902 -178.784 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.786 ' N ' HD12 ' B' ' 95' ' ' ILE . 0.2 OUTLIER -123.82 151.91 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 121.451 0.643 . . . . 72.23 110.142 -178.654 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.62 138.48 58.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.186 -0.946 . . . . 25.24 108.541 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.672 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -59.73 -53.79 62.11 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 120.98 -1.075 . . . . 64.32 111.61 -179.321 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 98' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 4.0 Cg_endo -42.03 -9.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 120.648 0.899 . . . . 63.33 113.057 -176.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' TYR . . . . . 0.672 ' N ' ' O ' ' B' ' 97' ' ' LYS . 49.4 m-85 59.45 117.64 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.583 -0.698 . . . . 75.13 109.225 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -56.63 -38.21 71.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.84 -1.162 . . . . 74.23 108.882 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 101' ' ' SER . . . . . 0.731 ' O ' ' N ' ' B' ' 103' ' ' LYS . 33.3 t -174.59 41.27 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.119 -0.988 . . . . 63.34 110.728 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 63.7 mt 51.88 -69.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.546 -0.721 . . . . 74.44 110.232 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.731 ' N ' ' O ' ' B' ' 101' ' ' SER . 28.2 mtmm -57.72 -18.8 23.23 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.776 -1.194 . . . . 71.11 107.776 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.45 -83.51 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.81 -0.556 . . . . 71.45 110.578 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.732 HD23 ' H ' ' B' ' 105' ' ' LEU . 1.5 pt? -47.67 -32.75 6.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.878 -1.139 . . . . 51.31 109.858 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 99.2 t -65.33 -41.7 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.901 -1.124 . . . . 65.23 108.723 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.94 -33.56 67.13 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.317 -0.865 . . . . 24.32 108.962 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -83.41 -34.97 25.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.426 -0.796 . . . . 75.31 110.079 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 96.8 mt -72.54 -36.6 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.022 -1.048 . . . . 54.24 109.115 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' GLU . . . . . 0.435 ' CG ' ' N ' ' B' ' 111' ' ' ALA . 22.8 pt-20 -74.91 -44.79 46.78 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.444 -0.902 . . . . 65.31 109.214 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 111' ' ' ALA . . . . . 0.435 ' N ' ' CG ' ' B' ' 110' ' ' GLU . . . -50.4 -45.01 55.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.239 -0.913 . . . . 72.24 109.203 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -67.09 -38.13 85.15 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.29 -0.881 . . . . 72.04 109.689 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' B' ' 116' ' ' TRP . 24.0 mt -78.11 -26.26 47.9 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.22 -0.925 . . . . 75.35 110.496 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.465 ' O ' ' CE3' ' B' ' 116' ' ' TRP . 19.0 mmt180 -47.57 -40.54 19.38 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.88 -1.137 . . . . 75.5 109.689 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' PHE . . . . . 0.48 ' C ' ' H ' ' B' ' 117' ' ' GLY . 71.3 m-85 -68.02 -25.22 65.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.983 . . . . 65.33 109.455 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 116' ' ' TRP . . . . . 0.465 ' CE3' ' O ' ' B' ' 114' ' ' ARG . 5.4 m-90 53.34 6.36 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.384 -0.822 . . . . 74.45 109.827 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 117' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' B' ' 115' ' ' PHE . . . 68.51 175.84 10.72 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.847 -1.301 . . . . 44.21 109.847 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 58.4 m -142.06 171.59 13.84 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.347 -1.09 . . . . 71.4 109.344 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' ASN . . . . . 0.575 HD21 ' C ' ' B' ' 121' ' ' ILE . 2.7 t30 -104.11 153.67 20.63 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.42 -0.8 . . . . 72.32 109.749 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 t -104.27 -42.51 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.415 -0.803 . . . . 75.02 109.859 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 121' ' ' ILE . . . . . 0.575 ' C ' HD21 ' B' ' 119' ' ' ASN . 12.2 mm -106.66 119.22 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.204 -0.935 . . . . 51.41 109.469 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -129.49 138.67 51.51 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.516 -0.74 . . . . 71.53 109.529 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.572 HD13 ' N ' ' B' ' 124' ' ' GLY . 0.2 OUTLIER -160.28 117.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 72.43 109.192 179.821 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 124' ' ' GLY . . . . . 0.572 ' N ' HD13 ' B' ' 123' ' ' ILE . . . 53.45 -141.39 31.2 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.623 -1.391 . . . . 51.23 109.623 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -86.14 -1.9 57.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.294 -1.121 . . . . 74.2 109.471 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.52 126.7 38.81 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.118 -1.067 . . . . 75.42 108.118 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 85.6 m -129.22 135.89 49.41 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.328 -0.857 . . . . 74.22 109.952 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 12.4 mt -129.17 136.04 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.555 -0.715 . . . . 60.33 109.338 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 129' ' ' SER . . . . . 0.459 ' O ' ' N ' ' B' ' 133' ' ' GLU . 53.0 m -124.49 81.46 59.61 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.626 -0.671 . . . . 72.31 109.582 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.41 -39.61 73.25 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.454 2.103 . . . . 75.13 111.712 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.68 -43.3 97.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.406 -0.809 . . . . 75.23 109.199 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -89.54 -4.64 57.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.389 -0.819 . . . . 72.43 108.791 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' B' ' 129' ' ' SER . 87.2 mt-10 52.52 56.74 7.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.453 -0.779 . . . . 75.13 109.763 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -151.83 139.02 19.25 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.303 -0.873 . . . . 73.22 109.404 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 7.7 tt -126.64 143.05 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.403 -0.811 . . . . 64.14 109.853 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 53.1 mt -115.6 131.73 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 109.114 -0.698 . . . . 71.22 109.114 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -138.02 138.23 38.64 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.609 -0.682 . . . . 64.22 110.491 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm 50.94 25.4 2.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.391 -0.818 . . . . 72.02 111.031 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.9 14.85 71.57 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.823 -1.179 . . . . 74.32 111.05 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -115.1 126.42 54.65 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.343 -1.093 . . . . 75.34 108.987 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -93.7 126.19 38.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.355 -0.841 . . . . 71.23 109.53 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 13.8 p -135.63 133.04 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.578 -0.897 . . . . 70.43 108.578 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 143' ' ' GLU . . . . . 0.568 ' CD ' ' H ' ' B' ' 143' ' ' GLU . 1.1 pm0 -94.86 137.37 34.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.201 -0.937 . . . . 72.43 108.588 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 11.6 m -140.02 141.01 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.102 -0.999 . . . . 72.13 110.323 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.27 31.92 0.24 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.711 -1.218 . . . . 72.02 107.711 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 146' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' B' ' 150' ' ' GLU . . . -78.24 -155.82 8.41 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.605 -1.398 . . . . 42.23 109.605 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 0.62 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 0.0 OUTLIER -88.39 -35.96 0.44 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.422 -1.046 . . . . 73.3 111.046 -179.566 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 148' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 47.7 Cg_endo -84.31 -42.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 121.931 1.754 . . . . 71.33 112.533 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -56.53 -19.37 15.31 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.76 -1.212 . . . . 74.23 109.037 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 150' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' B' ' 146' ' ' GLY . 27.1 mt-10 -60.68 -36.27 78.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 72.34 109.89 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.472 HG11 HD13 ' B' ' 191' ' ' ILE . 3.8 p -67.84 -38.15 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.977 -1.077 . . . . 73.35 110.072 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 20.0 tp -60.57 -41.77 95.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.342 -0.849 . . . . 55.24 109.613 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -69.9 -39.64 76.08 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.124 -0.985 . . . . 70.01 109.209 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' HIS . . . . . 0.515 ' CD2' ' HD1' ' B' ' 158' ' ' HIS . 14.7 t60 -56.76 -52.48 64.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.484 -0.76 . . . . 65.32 110.111 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.545 HD12 ' N ' ' B' ' 156' ' ' ALA . 4.2 pp -72.0 -25.66 61.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.924 -1.11 . . . . 71.54 109.413 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 156' ' ' ALA . . . . . 0.545 ' N ' HD12 ' B' ' 155' ' ' LEU . . . -54.31 -42.47 70.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.023 -1.048 . . . . 75.32 108.346 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.426 ' C ' ' H ' ' B' ' 159' ' ' ARG . 58.0 mtp180 -77.81 -52.32 9.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.453 -0.779 . . . . 73.32 109.21 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 158' ' ' HIS . . . . . 0.607 ' HB3' HE21 ' B' ' 161' ' ' GLN . 30.9 m80 -75.27 25.66 0.1 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.549 -0.72 . . . . 74.14 109.988 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 159' ' ' ARG . . . . . 0.474 ' O ' ' N ' ' B' ' 161' ' ' GLN . 47.4 ttp180 -52.57 -78.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 61.41 109.015 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 160' ' ' ASP . . . . . 0.933 ' OD2' ' CE2' ' B' ' 216' ' ' TYR . 9.1 t70 -65.2 74.95 0.05 Allowed 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.2 -0.937 . . . . 72.1 109.27 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 161' ' ' GLN . . . . . 0.607 HE21 ' HB3' ' B' ' 158' ' ' HIS . 17.3 tt0 -175.65 160.33 2.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 72.25 109.141 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 17.1 mm -85.63 106.82 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.638 -0.875 . . . . 72.31 108.638 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 87.5 t -89.94 136.03 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.198 -0.939 . . . . 64.21 109.814 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 25.8 t -99.92 160.75 14.07 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.457 -0.777 . . . . 74.22 109.488 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -66.88 -40.01 87.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.472 -0.768 . . . . 65.31 110.047 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -66.36 -26.55 67.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 63.45 110.391 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -60.16 -57.69 11.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.99 -1.069 . . . . 72.4 109.662 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 25.9 mt -60.82 -36.72 79.8 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.127 -0.983 . . . . 72.32 108.856 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.5 HD13 ' C ' ' B' ' 169' ' ' LEU . 1.3 tm? -56.39 -66.23 0.47 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.607 -0.683 . . . . 73.34 110.162 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -54.85 -31.68 59.82 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.717 -0.615 . . . . 72.1 111.85 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -92.18 -8.82 44.46 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.706 -1.246 . . . . 62.13 112.009 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 25.6 mm -112.74 -68.4 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 120.887 -1.133 . . . . 71.42 110.82 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 173' ' ' TRP . . . . . 0.481 ' C ' ' CD2' ' B' ' 173' ' ' TRP . 0.0 OUTLIER -56.91 161.37 2.97 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 118.653 -1.219 . . . . 72.23 107.915 -179.249 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 174' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' B' ' 175' ' ' GLU . 47.4 tp10 -172.59 -30.94 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.702 -0.851 . . . . 52.11 108.702 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 175' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' B' ' 177' ' ' GLU . 9.2 pt-20 -51.13 177.01 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 107.965 -1.124 . . . . 73.04 107.965 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -61.29 49.08 0.09 OUTLIER 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.876 1.717 . . . . 74.13 112.601 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 177' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' B' ' 175' ' ' GLU . 99.6 mt-10 44.9 -122.9 0.97 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.381 -0.824 . . . . 72.44 109.939 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 64.8 mtp 52.84 20.47 1.63 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.298 -0.877 . . . . 63.43 109.641 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 179' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' B' ' 180' ' ' THR . 3.9 t -85.26 48.49 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.163 -1.051 . . . . 71.05 108.163 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 180' ' ' THR . . . . . 0.463 ' O ' ' O ' ' B' ' 179' ' ' VAL . 0.0 OUTLIER 55.11 165.95 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.532 -0.914 . . . . 62.15 108.532 -179.171 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -47.63 -69.71 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.859 1.706 . . . . 65.22 111.815 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -127.27 125.97 41.85 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.488 -0.93 . . . . 72.31 108.488 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 183' ' ' VAL . . . . . 0.442 ' O ' HG22 ' B' ' 186' ' ' VAL . 6.1 t -133.04 -13.89 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.305 -0.872 . . . . 63.32 109.701 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 4.6 tt -62.01 -25.13 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.458 -1.401 . . . . 75.03 109.164 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -61.38 -43.11 99.43 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.319 -0.863 . . . . 64.11 109.83 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 186' ' ' VAL . . . . . 0.442 HG22 ' O ' ' B' ' 183' ' ' VAL . 15.4 m -76.54 -27.39 17.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.836 -1.165 . . . . 73.0 108.254 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.28 -46.18 64.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 61.12 109.692 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 10.7 tp -71.8 -28.06 29.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 120.953 -1.092 . . . . 72.43 109.595 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 189' ' ' ASN . . . . . 0.446 ' O ' ' OE1' ' B' ' 193' ' ' GLN . 68.2 m-20 -68.2 -46.01 71.78 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.286 -0.884 . . . . 65.14 108.764 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -70.3 -47.17 62.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 63.24 109.534 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 191' ' ' ILE . . . . . 0.472 HD13 HG11 ' B' ' 151' ' ' VAL . 63.7 mt -51.23 -34.83 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -0.906 . . . . 74.03 108.846 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 192' ' ' ARG . . . . . 0.434 HH22 HG21 ' B' ' 206' ' ' THR . 68.0 mtp180 -70.33 -42.28 72.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.883 . . . . 72.24 109.39 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 193' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' B' ' 189' ' ' ASN . 1.0 OUTLIER -75.45 -17.12 60.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.262 -0.899 . . . . 73.1 109.692 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -92.3 -25.05 18.76 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.18 -0.95 . . . . 72.11 110.361 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 195' ' ' MET . . . . . 0.608 ' SD ' ' N ' ' B' ' 195' ' ' MET . 0.0 OUTLIER -96.17 -32.01 12.69 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.133 -0.979 . . . . 44.33 110.141 -179.035 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 196' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 42.2 p-10 -67.97 -31.54 71.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.029 -1.044 . . . . 71.21 110.496 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 197' ' ' LYS . . . . . 0.47 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 46.1 mttt -70.12 -65.01 1.2 Allowed Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.969 -1.082 . . . . 75.21 110.56 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 198' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 19.8 Cg_endo -58.38 -58.57 0.71 Allowed 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.22 1.947 . . . . 75.32 112.741 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 37.1 mt -60.01 -55.51 33.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.062 -1.024 . . . . 72.25 109.874 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 97.49 -24.79 29.97 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.257 -1.137 . . . . 64.53 110.257 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 201' ' ' ILE . . . . . 0.412 HG21 HD13 ' B' ' 201' ' ' ILE . 19.7 mt -106.36 127.06 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.162 -1.199 . . . . 44.23 109.706 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 53.9 p -82.48 141.05 33.0 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.458 -0.941 . . . . 54.01 108.458 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 11.9 p -142.6 19.43 2.02 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.113 -0.992 . . . . 74.4 109.585 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.429 HG22 ' CE2' ' B' ' 214' ' ' PHE . 5.3 t -125.94 141.58 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.499 -0.751 . . . . 72.12 109.78 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -119.82 107.6 13.36 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.313 -0.995 . . . . 65.41 108.313 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 206' ' ' THR . . . . . 0.443 ' H ' HG22 ' B' ' 206' ' ' THR . 0.0 OUTLIER -75.17 120.13 20.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.958 . . . . 71.33 109.796 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.49 HG12 ' H ' ' B' ' 209' ' ' ARG . 3.0 t -117.28 148.88 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 109.114 -0.698 . . . . 63.5 109.114 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -91.64 -1.63 57.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.191 -0.943 . . . . 74.45 109.44 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 209' ' ' ARG . . . . . 0.49 ' H ' HG12 ' B' ' 207' ' ' VAL . 31.4 mmt180 -76.19 -118.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.353 -0.842 . . . . 74.14 109.56 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -57.33 -47.74 80.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.197 -0.939 . . . . 74.43 109.977 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.85 -126.83 1.09 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.026 -1.229 . . . . 64.45 110.026 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -100.17 133.56 44.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.271 -1.135 . . . . 74.21 109.408 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -100.53 118.13 36.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.409 -0.807 . . . . 74.03 109.445 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 214' ' ' PHE . . . . . 0.429 ' CE2' HG22 ' B' ' 204' ' ' VAL . 26.2 m-85 -98.56 131.03 45.1 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.412 -0.805 . . . . 74.34 109.113 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 30.3 p -158.48 161.04 37.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 64.33 109.077 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 216' ' ' TYR . . . . . 0.933 ' CE2' ' OD2' ' B' ' 160' ' ' ASP . 1.6 m-85 -61.24 150.16 80.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.995 -1.065 . . . . 70.04 108.698 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.07 -55.65 0.13 Allowed 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.123 1.882 . . . . 65.11 111.561 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -151.41 151.51 29.13 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 108.385 -0.969 . . . . 73.15 108.385 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -34.61 117.7 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.536 2.157 . . . . 71.31 112.622 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -92.77 154.67 18.15 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.402 -0.811 . . . . 75.45 109.617 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 27.1 p -96.1 135.87 37.3 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.28 -0.888 . . . . 72.22 109.481 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -155.91 137.61 14.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.903 . . . . 54.53 109.368 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.001 -1.0 . . . . 71.13 109.413 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.3 ttm . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.474 -0.565 . . . . 65.12 109.474 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -144.56 141.68 29.65 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.196 -0.94 . . . . 72.33 109.182 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 80.2 t -112.55 134.86 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.562 0.696 . . . . 71.42 109.958 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.552 HD11 ' CG1' ' A' ' 6' ' ' ILE . 1.3 tp -103.2 118.58 37.12 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.101 -1.074 . . . . 65.12 108.101 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.552 HD12 ' SD ' ' A' ' 49' ' ' MET . 3.9 tp -117.82 107.23 13.88 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.66 -0.65 . . . . 62.43 109.483 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.552 ' CG1' HD11 ' A' ' 4' ' ' LEU . 37.4 mt -98.36 101.5 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.327 -0.99 . . . . 71.15 108.327 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -131.42 124.11 29.58 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.61 -0.681 . . . . 75.34 109.465 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -65.66 -34.46 78.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.277 -0.889 . . . . 72.44 109.15 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -87.07 112.2 21.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 63.02 109.227 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.6 m -65.7 -26.71 67.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 72.34 109.588 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.72 -52.75 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.193 -0.942 . . . . 74.02 109.774 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.1 mt -61.6 -34.83 76.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.977 . . . . 71.43 109.291 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.94 -26.96 71.43 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.566 -1.814 . . . . 61.32 108.566 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.13 -52.41 44.68 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 109.529 -1.428 . . . . 71.2 109.529 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -59.97 -45.09 93.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.372 -1.075 . . . . 71.32 109.824 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.4 mm -64.31 -38.55 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.795 -1.191 . . . . 63.23 108.828 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -62.89 -49.29 75.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.329 -0.857 . . . . 51.11 110.099 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -78.03 -7.34 56.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.077 -1.015 . . . . 73.34 109.815 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.77 -54.45 3.24 Favored Glycine 0 N--CA 1.483 1.824 0 N-CA-C 109.505 -1.438 . . . . 62.15 109.505 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.91 -24.13 61.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.376 -1.073 . . . . 73.51 109.489 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -56.04 -38.46 70.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.137 -0.977 . . . . 74.25 109.184 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.5 t -51.94 -47.53 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.271 -0.893 . . . . 70.04 109.05 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -53.81 -53.16 56.32 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.602 -0.888 . . . . 73.23 108.602 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.94 40.77 0.28 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.353 -1.499 . . . . 75.54 109.353 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -117.13 160.28 21.27 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.511 -0.994 . . . . 73.43 109.139 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.5 mmt -101.11 139.35 36.91 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.204 -1.036 . . . . 43.24 108.204 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.59 146.75 34.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.167 -0.958 . . . . 62.11 110.339 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -120.69 149.23 42.83 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.911 -0.774 . . . . 74.42 108.911 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 m -110.53 134.99 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.427 -0.796 . . . . 72.15 108.906 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.4 p -136.82 168.2 20.0 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.359 -0.838 . . . . 71.42 109.531 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -90.25 -105.61 0.09 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.329 -0.857 . . . . 72.33 109.662 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.5 p -81.16 169.11 17.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 74.24 110.07 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.5 mt -53.95 -32.67 54.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.579 -0.7 . . . . 71.53 109.521 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -49.81 -49.68 47.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 74.23 109.541 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -64.95 -51.83 59.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 54.03 109.31 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.36 -39.03 96.69 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.694 -1.362 . . . . 61.41 109.694 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -64.28 -47.06 80.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -1.141 . . . . 74.34 109.413 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -69.78 -35.3 74.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.067 -1.021 . . . . 75.33 109.19 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.424 ' CD1' ' C ' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -70.4 -65.53 0.72 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.84 . . . . 74.33 109.204 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 40' ' ' MET . 2.9 ppp? -48.47 -20.38 0.42 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.263 -0.898 . . . . 70.32 109.936 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -65.52 -43.24 90.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.075 -1.016 . . . . 71.22 110.091 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.3 pt -82.31 -26.71 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.172 -0.955 . . . . 74.14 110.195 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 40' ' ' MET . 99.4 mtt180 -129.96 143.7 50.94 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.35 -0.844 . . . . 72.24 109.507 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -97.59 151.09 20.42 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.214 -0.929 . . . . 75.42 109.556 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -127.51 141.08 51.75 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.529 -0.732 . . . . 74.23 109.252 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -78.05 -42.15 33.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 72.04 109.471 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.61 HD23 HD21 ' A' ' 113' ' ' LEU . 0.3 OUTLIER -104.01 112.77 25.9 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.474 -0.766 . . . . 72.13 108.941 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.461 ' N ' HD13 ' A' ' 47' ' ' LEU . 74.0 t -99.45 98.48 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.406 -0.961 . . . . 72.34 108.406 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.552 ' SD ' HD12 ' A' ' 5' ' ' LEU . 1.5 tmt? -114.99 135.94 53.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.617 -0.677 . . . . 74.11 109.834 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.6 HG22 ' H ' ' A' ' 52' ' ' ASP . 1.1 p -143.59 131.19 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.78 0.8 . . . . 61.12 109.82 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.7 p -95.26 9.64 39.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.571 -0.706 . . . . 73.11 109.744 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.6 ' H ' HG22 ' A' ' 50' ' ' VAL . 80.0 m-20 -77.04 141.48 40.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 52.55 109.514 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.48 ' C ' ' H ' ' A' ' 55' ' ' ALA . 92.2 mttt -75.1 -45.42 41.31 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.294 -0.879 . . . . 44.22 110.447 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -68.51 10.99 0.2 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.096 -1.002 . . . . 70.44 109.84 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.48 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -68.84 -22.49 64.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 64.14 110.28 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 52.4 mt -42.62 -50.34 5.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.297 -0.877 . . . . 44.14 110.401 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.1 m -68.74 -31.91 71.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.932 -1.105 . . . . 55.23 109.333 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.605 ' CE2' HD11 ' A' ' 62' ' ' ILE . 58.3 t80 -70.19 -56.57 6.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.463 -0.773 . . . . 74.44 110.2 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.4 m -55.03 -34.06 30.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.609 -1.307 . . . . 74.03 109.528 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.7 t -60.42 -54.89 40.1 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.287 -0.883 . . . . 64.3 109.499 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.667 HH21 ' NZ ' ' A' ' 65' ' ' LYS . 7.1 ptm180 -67.3 -25.52 66.07 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.045 -1.062 . . . . 64.44 109.967 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.605 HD11 ' CE2' ' A' ' 58' ' ' PHE . 4.9 mm -59.87 -48.03 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.783 -1.198 . . . . 63.21 108.968 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -64.45 -45.19 88.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.023 -1.048 . . . . 74.42 108.87 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -60.86 -51.52 68.95 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.326 -0.99 . . . . 70.32 108.326 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.667 ' NZ ' HH21 ' A' ' 61' ' ' ARG . 93.1 mttt -71.81 -69.68 0.37 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.253 -0.647 . . . . 75.22 109.253 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 62' ' ' ILE . 86.5 m-70 -98.02 90.54 4.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.319 -0.863 . . . . 74.13 109.019 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 t -79.01 -40.1 32.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 73.24 109.914 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.8 t -78.15 57.92 1.93 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 61.01 109.611 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 66' ' ' HIS . 14.6 tt -152.03 158.12 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.147 -0.97 . . . . 71.33 109.656 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.2 t -97.63 146.87 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.119 -0.988 . . . . 72.13 109.111 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.7 t -133.01 125.81 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.317 -0.864 . . . . 54.21 110.5 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.526 HD23 ' C ' ' A' ' 72' ' ' LEU . 3.7 tt -122.87 100.03 6.69 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.652 -0.87 . . . . 50.24 108.652 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.7 p -92.69 153.55 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.76 -1.212 . . . . 74.41 109.221 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.7 m -127.54 166.54 17.8 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.257 -1.016 . . . . 72.31 108.257 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 77' ' ' ASN . 23.0 t -170.8 126.41 0.72 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.967 -1.083 . . . . 64.54 110.415 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 57.3 p30 -71.69 14.67 0.18 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.569 -0.707 . . . . 74.13 110.121 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.427 ' H ' ' C ' ' A' ' 75' ' ' SER . 22.6 m120 -138.43 73.91 41.82 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.195 -0.941 . . . . 73.34 109.933 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.6 76.53 4.49 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.682 2.255 . . . . 63.22 112.358 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.415 HG23 ' H ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -104.92 154.63 19.82 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.296 -1.001 . . . . 62.53 108.296 178.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.45 -25.08 2.33 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.171 -0.956 . . . . 73.44 109.738 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -69.72 -50.61 41.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.944 . . . . 71.42 110.149 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 77' ' ' ASN . 88.9 mt-10 -71.32 -27.74 63.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.097 -1.002 . . . . 73.43 110.162 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -64.21 -56.93 11.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.091 -1.005 . . . . 74.22 109.764 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.522 HG23 ' N ' ' A' ' 85' ' ' HIS . 17.9 m -66.13 -40.96 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 73.2 109.676 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.522 ' N ' HG23 ' A' ' 84' ' ' VAL . 27.7 t-80 -64.7 -38.99 92.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.21 -0.931 . . . . 53.33 109.744 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.52 95.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 64.11 110.178 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.507 ' CE1' ' NH1' ' B' ' 108' ' ' ARG . 44.2 m-85 -72.84 -31.01 64.48 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.038 -1.039 . . . . 74.34 108.605 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -73.71 -34.73 64.95 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.412 -0.805 . . . . 74.42 109.261 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -62.86 -55.85 22.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.896 . . . . 74.24 109.441 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.63 29.0 0.08 OUTLIER Glycine 0 N--CA 1.498 2.804 0 C-N-CA 119.813 -1.184 . . . . 61.51 110.425 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.49 128.57 39.66 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.935 -1.332 . . . . 55.33 108.995 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.669 ' HB3' HH21 ' A' ' 112' ' ' ARG . 36.2 m-20 -64.68 -36.41 84.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.978 -1.076 . . . . 73.42 108.971 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 94' ' ' TYR . 62.8 t0 -152.53 145.65 24.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.373 -0.829 . . . . 75.04 108.943 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.497 ' CD1' ' C ' ' A' ' 94' ' ' TYR . 0.4 OUTLIER -123.15 121.54 36.23 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.985 -0.746 . . . . 71.33 108.985 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.496 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -108.98 141.92 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 121.789 0.804 . . . . 71.13 109.526 -178.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . -62.35 125.15 22.91 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.16 -1.422 . . . . 64.32 107.16 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.567 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -44.33 -57.13 6.86 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.004 -1.06 . . . . 62.2 111.102 -178.697 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 7.4 Cg_endo -44.2 90.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 CA-C-N 119.467 0.845 . . . . 73.11 111.17 -176.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.567 ' N ' ' O ' ' A' ' 97' ' ' LYS . 42.8 m-85 -44.18 104.26 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.625 -0.672 . . . . 65.22 109.97 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 31.2 ttm-85 -54.49 -25.6 26.38 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.595 -0.891 . . . . 72.35 108.595 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.751 ' O ' ' N ' ' A' ' 103' ' ' LYS . 15.7 t -178.07 24.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.398 -0.814 . . . . 71.32 109.866 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 87.9 mt 52.89 -70.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.66 -0.65 . . . . 75.43 109.609 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.751 ' N ' ' O ' ' A' ' 101' ' ' SER . 48.9 mttp -56.2 -23.04 32.83 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.517 -1.29 . . . . 71.41 107.517 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' A' ' 101' ' ' SER . . . -68.08 -45.47 73.7 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.929 -1.137 . . . . 63.24 107.929 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.6 tp -65.48 -51.7 58.18 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.681 -0.859 . . . . 73.22 108.681 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 38.3 t -58.36 -42.73 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.108 -0.995 . . . . 60.11 108.654 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.87 -39.55 59.15 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.304 -0.872 . . . . 70.42 108.881 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 53.8 mtp180 -66.94 -35.6 80.33 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.192 -0.942 . . . . 74.41 108.811 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.9 mt -75.56 -26.76 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.21 -0.931 . . . . 62.54 108.992 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -65.4 -52.06 56.04 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.448 -0.783 . . . . 74.34 110.137 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -74.86 -29.35 61.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.111 -0.993 . . . . 73.32 110.382 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.669 HH21 ' HB3' ' A' ' 92' ' ' ASP . 33.9 ttt85 -61.03 -44.24 97.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.041 . . . . 52.41 109.895 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.61 HD21 HD23 ' A' ' 47' ' ' LEU . 0.4 OUTLIER -150.79 82.58 1.34 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.8 -1.187 . . . . 65.24 109.745 179.277 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.401 ' HA ' ' HE ' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -95.01 -58.03 2.27 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.485 -0.932 . . . . 64.45 108.485 179.489 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -69.08 -58.04 4.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 74.43 109.662 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 46.22 85.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.232 -0.917 . . . . 74.42 109.662 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.99 99.41 0.12 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.3 -1.52 . . . . 75.04 109.3 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.7 t -152.61 162.67 40.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.197 -1.178 . . . . 61.14 109.894 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.61 129.45 6.99 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.966 -0.753 . . . . 65.24 108.966 -178.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 17.3 t -91.11 -32.77 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.185 -0.947 . . . . 73.11 109.268 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 24.9 mm -107.53 137.23 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.934 -0.765 . . . . 72.24 108.934 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -148.89 136.6 20.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.067 -1.021 . . . . 72.34 109.982 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.5 pt -151.54 134.75 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.432 -0.793 . . . . 71.44 109.112 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 45.84 -142.28 4.58 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.747 -1.341 . . . . 73.4 109.747 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -85.59 -5.96 59.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.257 -1.143 . . . . 74.45 109.393 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.429 HD22 ' CD1' ' A' ' 137' ' ' TYR . 0.7 OUTLIER -91.12 136.69 32.92 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.336 -0.987 . . . . 54.21 108.336 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.7 m -130.61 144.07 51.17 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.387 -0.82 . . . . 54.5 109.605 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 82.5 mt -133.28 137.69 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.291 -0.88 . . . . 45.15 109.475 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.4 m -121.77 85.22 44.38 Favored Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 109.069 -0.715 . . . . 71.11 109.069 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.89 -41.05 82.19 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.549 2.166 . . . . 65.41 112.237 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -59.05 -46.9 87.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 63.32 109.293 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -82.7 -7.06 59.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 72.52 109.153 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.408 ' OE2' ' O ' ' A' ' 144' ' ' VAL . 70.8 tt0 56.98 58.49 3.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.411 -0.806 . . . . 75.33 109.567 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.45 ' C ' HD12 ' A' ' 135' ' ' ILE . 32.3 ttpt -148.65 123.94 10.23 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.294 -0.879 . . . . 71.23 109.435 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.593 HD12 ' N ' ' A' ' 135' ' ' ILE . 1.6 mp -96.94 138.07 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.217 -0.927 . . . . 74.02 109.392 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.3 mm -115.11 127.89 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 109.023 -0.732 . . . . 60.23 109.023 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.429 ' CD1' HD22 ' A' ' 126' ' ' LEU . 79.5 t80 -136.43 123.71 21.88 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.356 -0.84 . . . . 62.32 109.48 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 66.3 mttm 53.52 33.85 17.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.335 -0.853 . . . . 75.4 110.032 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.11 11.09 85.71 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.292 -1.123 . . . . 72.24 110.292 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 50.3 mtp85 -94.91 124.49 38.98 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.143 -1.21 . . . . 71.22 109.073 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -94.88 119.31 33.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.259 -0.901 . . . . 71.42 109.608 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.6 p -135.61 137.7 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.469 -0.769 . . . . 53.02 109.297 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.505 ' N ' ' OE1' ' A' ' 143' ' ' GLU . 46.1 mp0 -95.98 154.46 17.22 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.323 -0.86 . . . . 60.45 109.298 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.408 ' O ' ' OE2' ' A' ' 133' ' ' GLU . 29.9 m -139.61 144.09 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.365 -0.834 . . . . 74.44 109.551 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -168.47 21.77 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.937 . . . . 65.15 109.751 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.19 -174.93 50.63 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.333 -1.507 . . . . 73.34 109.333 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.633 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 5.8 ttpm? -83.14 -32.76 0.55 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.3 -1.118 . . . . 72.22 111.048 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 91.6 Cg_endo -89.37 -16.67 2.04 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 122.149 1.899 . . . . 65.23 112.733 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -81.99 -24.87 35.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.108 -0.995 . . . . 60.11 109.818 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.525 ' O ' ' ND1' ' A' ' 154' ' ' HIS . 95.8 mt-10 -51.53 -31.94 26.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.097 -1.002 . . . . 64.21 108.862 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 148' ' ' PRO . 5.4 p -63.56 -36.76 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.438 -0.789 . . . . 72.02 109.07 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.427 ' CD1' ' SD ' ' A' ' 195' ' ' MET . 21.3 tp -62.92 -42.47 99.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 73.31 109.084 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.4 m -72.47 -36.88 68.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.403 -0.81 . . . . 74.31 109.864 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 150' ' ' GLU . 8.2 m80 -60.7 -52.71 63.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.122 -0.986 . . . . 74.31 110.182 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 159' ' ' ARG . 3.2 pp -68.89 -25.97 64.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.866 -1.146 . . . . 75.34 109.589 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.73 -52.68 64.03 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.136 -0.977 . . . . 62.14 109.241 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.0 ptm85 -68.28 -43.4 77.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.351 -0.843 . . . . 61.03 109.651 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -95.29 29.38 2.53 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.104 -0.998 . . . . 74.12 109.251 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.584 HH21 HG21 ' A' ' 203' ' ' THR . 27.8 ttt85 -60.13 -21.76 61.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.317 -0.865 . . . . 71.13 109.519 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 160' ' ' ASP . 41.8 p30 -115.6 66.65 0.7 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.009 -0.737 . . . . 75.45 109.009 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.572 ' NE2' ' O ' ' A' ' 162' ' ' ILE . 1.2 tm0? -164.3 156.8 16.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.161 -0.962 . . . . 73.41 109.378 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.572 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 9.3 mm -82.33 123.99 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.214 -0.929 . . . . 74.41 109.312 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.412 HG11 HD21 ' A' ' 168' ' ' LEU . 21.5 t -120.62 136.95 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.508 -0.745 . . . . 72.31 109.628 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.0 p -91.86 159.69 15.66 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.329 -0.857 . . . . 74.12 109.425 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.4 mtmm -59.87 -45.55 92.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 70.43 109.486 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -62.85 -31.59 72.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 73.52 109.732 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -59.99 -44.98 94.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.125 -0.984 . . . . 74.52 109.456 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.412 HD21 HG11 ' A' ' 163' ' ' VAL . 37.7 mt -64.72 -44.19 91.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 72.31 109.578 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 11.8 tp -64.58 -43.8 92.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.306 -0.871 . . . . 53.33 109.528 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -75.2 -10.0 59.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 62.44 109.705 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.02 -54.75 3.98 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -0.915 . . . . 60.21 109.804 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.699 HD12 ' N ' ' A' ' 172' ' ' ILE . 1.9 mp -88.04 -50.1 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.168 -0.957 . . . . 75.32 109.858 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 17.9 m-90 -85.67 -93.65 0.08 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.069 -1.019 . . . . 73.14 109.881 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 175' ' ' GLU . 42.8 tt0 73.01 -130.71 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.742 -0.599 . . . . 73.24 109.558 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 177' ' ' GLU . 2.9 mm-40 50.88 179.94 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.104 -0.997 . . . . 44.43 108.477 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -61.8 35.33 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.136 1.89 . . . . 72.51 112.198 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 175' ' ' GLU . 76.8 mm-40 49.38 50.23 18.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.187 -0.946 . . . . 63.24 109.657 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 66.9 mtt -56.42 -31.44 63.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 73.5 109.163 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 35.0 m -72.83 169.93 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.323 -0.861 . . . . 65.22 109.57 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.1 p -56.27 152.04 24.88 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 71.42 109.281 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -38.34 -67.15 0.11 Allowed 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 122.259 1.973 . . . . 41.22 112.126 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -93.22 147.09 23.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.36 -0.838 . . . . 64.54 109.233 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.8 p -171.52 -29.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 74.02 109.367 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.562 ' O ' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -53.57 -41.01 44.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.352 -0.843 . . . . 72.33 109.58 -179.73 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.4 ' N ' ' CG2' ' A' ' 184' ' ' ILE . 18.5 mt-10 -54.51 -38.45 66.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.849 -1.157 . . . . 74.4 109.375 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 2.3 t -75.46 -34.7 30.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.388 -0.82 . . . . 70.42 109.605 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.0 -51.04 23.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 52.11 109.869 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.2 tp -61.88 -32.62 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.984 -1.072 . . . . 71.4 109.745 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -66.31 -55.77 14.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.118 -0.989 . . . . 73.44 110.215 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -67.0 -41.53 86.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.038 -1.039 . . . . 71.42 109.665 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 71.6 mt -56.88 -44.43 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.098 -1.001 . . . . 61.55 109.136 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.4 mtp-105 -57.54 -44.14 84.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 63.34 108.947 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -67.28 -36.43 81.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.876 . . . . 61.24 109.332 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.495 ' O ' ' CG ' ' A' ' 198' ' ' PRO . 96.0 mttt -71.69 -15.8 62.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.867 . . . . 75.13 109.761 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' MET . . . . . 0.427 ' SD ' ' CD1' ' A' ' 152' ' ' LEU . 86.2 mmm -93.62 -15.45 25.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.097 -1.002 . . . . 74.02 109.968 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -102.82 -9.38 20.0 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.137 -0.977 . . . . 74.02 110.38 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.557 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 3.8 tmtp? -89.63 -42.45 0.43 Allowed Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.917 -1.114 . . . . 75.43 110.241 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 38.1 Cg_endo -90.4 -58.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.688 2.259 . . . . 72.32 112.493 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.605 HD22 ' N ' ' A' ' 199' ' ' LEU . 3.3 mm? -61.3 -33.82 74.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.911 -1.118 . . . . 74.54 108.877 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 75.22 -15.94 3.94 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.689 -1.364 . . . . 61.51 109.689 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.413 ' H ' ' C ' ' A' ' 199' ' ' LEU . 6.1 mt -115.49 129.36 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.479 -1.013 . . . . 61.22 109.011 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 12.6 t -79.94 139.09 37.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.061 -1.024 . . . . 72.0 109.242 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.584 HG21 HH21 ' A' ' 159' ' ' ARG . 3.8 p -139.88 7.72 2.28 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.295 -0.878 . . . . 74.44 109.647 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.37 133.68 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.461 -0.774 . . . . 64.35 109.413 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 39.8 tp10 -114.45 133.95 55.36 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.55 -0.719 . . . . 71.41 109.394 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.7 p -99.42 139.96 34.31 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.285 -0.885 . . . . 73.52 109.261 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 211' ' ' GLY . 18.5 m -149.86 136.75 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.231 -0.918 . . . . 71.02 109.46 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -85.66 -13.65 47.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 72.12 109.343 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -55.16 -34.13 63.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.271 -0.893 . . . . 64.41 109.485 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 64.7 mtp85 -151.18 -63.12 0.19 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.263 -0.898 . . . . 71.54 109.405 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 207' ' ' VAL . . . -161.89 -114.14 0.32 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.657 -1.377 . . . . 72.03 109.657 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -126.2 124.31 40.16 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.601 -0.941 . . . . 75.54 109.474 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 26.1 ttm105 -90.28 121.48 32.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.36 -0.837 . . . . 75.31 109.006 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -95.96 123.98 39.78 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.304 -0.872 . . . . 75.41 109.337 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 44.2 t -154.84 152.22 29.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.434 -0.792 . . . . 74.14 109.069 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.36 145.0 84.82 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.089 -1.007 . . . . 75.32 108.791 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.436 ' O ' ' CB ' ' A' ' 220' ' ' ALA . 61.7 Cg_endo -81.19 9.47 3.83 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.212 1.941 . . . . 73.11 112.334 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 217' ' ' PRO . 30.1 tptt -45.22 -54.4 14.36 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.079 -1.013 . . . . 75.25 108.943 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.18 4.46 5.82 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.594 1.529 . . . . 75.1 111.156 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 217' ' ' PRO . . . -54.09 146.79 13.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.358 -0.839 . . . . 71.14 109.893 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 32.6 t -101.77 138.75 38.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.449 -0.782 . . . . 71.13 109.446 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 49.53 72.64 0.29 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 75.35 109.53 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 118.018 -0.991 . . . . 73.41 109.47 179.921 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 53.2 ttm . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.478 -0.564 . . . . 71.14 109.478 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.609 ' NH1' ' HE ' ' B' ' 43' ' ' ARG . 39.9 ttt85 -139.8 146.73 39.79 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.375 -0.828 . . . . 73.23 109.397 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 73.2 t -118.0 137.11 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 121.583 0.706 . . . . 72.24 109.669 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.52 HD11 ' CG1' ' B' ' 6' ' ' ILE . 3.3 tp -108.8 117.65 34.73 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.576 -0.898 . . . . 54.33 108.576 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.407 ' N ' HD12 ' B' ' 4' ' ' LEU . 5.4 tp -119.4 101.42 7.94 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.071 -0.714 . . . . 74.35 109.071 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.52 ' CG1' HD11 ' B' ' 4' ' ' LEU . 53.8 mt -91.71 97.72 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.907 -1.12 . . . . 42.55 108.749 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.422 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 31.8 tp10 -123.42 136.79 54.8 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.611 0.72 . . . . 74.52 109.407 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -77.76 -32.74 52.78 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.526 -0.734 . . . . 62.55 109.308 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -90.02 115.41 27.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.364 -0.835 . . . . 73.11 109.367 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 15.6 t -65.78 -30.88 71.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.229 -0.919 . . . . 65.54 109.821 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 85.8 t -61.67 -50.29 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.133 -0.98 . . . . 75.55 109.791 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.614 HD12 ' NZ ' ' B' ' 97' ' ' LYS . 3.5 mm? -64.83 -31.34 72.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 70.14 109.439 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.26 -29.94 57.69 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.744 -1.743 . . . . 75.4 108.744 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.87 -51.64 54.17 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.584 -1.406 . . . . 65.44 109.584 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -63.17 -42.09 99.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.331 -1.099 . . . . 60.21 109.622 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 4.8 mm -65.41 -38.61 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.009 -1.057 . . . . 75.15 108.768 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -64.83 -54.37 32.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.382 -0.824 . . . . 73.01 109.986 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -72.64 -6.26 43.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.147 -0.971 . . . . 74.3 109.771 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.87 -55.35 2.83 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.657 -1.377 . . . . 70.54 109.657 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp -74.17 -23.42 59.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.38 -1.071 . . . . 71.34 109.802 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -53.74 -35.98 61.8 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.152 -0.968 . . . . 64.41 109.394 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 98.0 t -55.25 -42.31 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.205 -0.935 . . . . 74.23 109.198 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 18.7 mmtp -64.64 -13.02 51.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.309 -0.869 . . . . 63.42 108.685 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.06 32.3 23.77 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.125 -1.19 . . . . 53.43 110.125 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -102.37 159.24 15.59 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.243 -1.151 . . . . 71.12 108.48 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 15.5 mtt -100.01 137.84 37.91 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.288 -1.004 . . . . 75.24 108.288 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.57 150.86 39.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 72.12 109.984 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ASP . . . . . 0.531 ' OD2' ' NH2' ' B' ' 2' ' ' ARG . 75.2 m-20 -126.16 144.35 50.79 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.822 -0.807 . . . . 72.31 108.822 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 1.4 p -112.13 129.07 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.716 -0.846 . . . . 64.43 108.716 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 6.8 p -134.1 167.85 19.89 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.533 -0.729 . . . . 65.41 109.455 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -93.79 -97.47 0.15 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.247 -0.908 . . . . 71.02 109.808 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 51.9 p -78.15 165.16 24.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.195 -0.941 . . . . 51.11 110.25 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' B' ' 37' ' ' GLU . 46.9 mt -55.01 -35.29 64.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.567 -0.708 . . . . 71.24 110.218 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -55.98 -44.19 78.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.053 -1.029 . . . . 74.32 109.831 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -62.47 -41.26 98.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.142 -0.974 . . . . 73.03 109.311 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' GLY . . . . . 0.438 ' O ' ' CG ' ' B' ' 40' ' ' MET . . . -80.63 -23.82 59.55 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.421 -1.472 . . . . 30.21 109.421 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' B' ' 33' ' ' LEU . 84.8 tt0 -66.43 -44.72 82.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -1.152 . . . . 74.42 109.661 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -79.3 -35.07 41.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.105 -0.997 . . . . 74.42 109.706 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 8.4 tt -73.82 -37.03 65.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 75.41 110.108 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' MET . . . . . 0.442 ' SD ' ' CE1' ' B' ' 45' ' ' TYR . 2.8 ppp? -76.15 -32.28 59.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.935 -1.103 . . . . 60.41 109.902 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -51.38 -37.03 46.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.926 . . . . 53.23 110.374 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.404 HG12 ' H ' ' B' ' 42' ' ' ILE . 11.2 pt -78.94 -33.54 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.0 -1.062 . . . . 71.23 110.114 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.609 ' HE ' ' NH1' ' B' ' 2' ' ' ARG . 30.2 mmt-85 -93.96 168.6 10.86 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.906 -1.121 . . . . 72.22 110.024 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' ASN . . . . . 0.517 ' C ' ' CD1' ' B' ' 45' ' ' TYR . 30.9 p30 -92.85 -19.31 21.83 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.298 -0.876 . . . . 63.54 109.954 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.517 ' CD1' ' C ' ' B' ' 44' ' ' ASN . 11.0 p90 40.11 97.86 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.566 -0.709 . . . . 64.35 110.997 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -80.41 -38.04 31.0 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.056 -1.028 . . . . 62.22 109.1 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.464 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.3 OUTLIER -106.64 114.36 28.42 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.745 -1.206 . . . . 73.12 107.745 179.255 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.464 ' N ' HD13 ' B' ' 47' ' ' LEU . 65.4 t -99.07 97.78 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.224 -0.922 . . . . 65.11 108.846 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.404 ' SD ' ' CD1' ' B' ' 5' ' ' LEU . 25.5 ttt -113.58 131.4 56.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.554 -0.717 . . . . 73.44 109.782 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.516 HG22 ' H ' ' B' ' 52' ' ' ASP . 0.5 OUTLIER -144.89 135.46 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.535 -0.728 . . . . 34.5 109.234 -179.765 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 51' ' ' SER . . . . . 0.422 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 38.8 p -103.17 15.06 30.28 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.552 -0.718 . . . . 73.21 109.79 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.516 ' H ' HG22 ' B' ' 50' ' ' VAL . 83.0 m-20 -77.83 144.92 36.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.104 -0.998 . . . . 70.41 109.467 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' B' ' 55' ' ' ALA . 41.6 mmtm -74.37 -43.31 57.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.224 -0.923 . . . . 65.0 110.164 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -72.86 13.14 0.41 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.07 -1.019 . . . . 75.21 109.786 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.438 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -69.34 -22.35 63.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 55.33 110.136 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 19.7 mt -42.04 -52.34 4.26 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.508 -0.745 . . . . 63.14 110.083 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 24.7 m -66.44 -35.07 79.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.956 -1.09 . . . . 63.5 109.082 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' PHE . . . . . 0.431 ' CZ ' HD11 ' B' ' 62' ' ' ILE . 57.4 t80 -65.26 -62.18 1.69 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.466 -0.771 . . . . 72.33 110.0 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 32.5 m -49.33 -34.08 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.637 -1.289 . . . . 74.54 109.962 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 24.6 p -59.42 -53.66 55.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.052 -1.03 . . . . 71.24 109.739 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -66.24 -27.93 68.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.036 -1.04 . . . . 74.31 110.125 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.431 HD11 ' CZ ' ' B' ' 58' ' ' PHE . 32.9 mm -65.5 -38.82 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.767 -1.208 . . . . 72.14 109.894 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -70.72 -47.81 57.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.028 -1.045 . . . . 73.32 110.598 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -69.77 -40.41 76.09 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.873 -1.142 . . . . 73.12 110.335 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.488 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 62.7 mttm -75.84 -24.31 55.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.13 -0.981 . . . . 72.44 109.979 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.488 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 90.5 m-70 -155.71 64.48 0.6 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.116 -0.99 . . . . 63.31 109.719 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 22.8 t -57.2 -27.93 62.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -0.889 . . . . 73.1 109.606 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 92.0 p -65.17 -23.08 67.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 71.53 109.906 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.403 HG22 ' N ' ' B' ' 70' ' ' VAL . 60.5 mt -82.32 158.45 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.186 -0.946 . . . . 74.4 109.533 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.403 ' N ' HG22 ' B' ' 69' ' ' ILE . 70.3 t -98.83 150.82 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.288 -0.883 . . . . 75.12 109.608 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 16.2 t -130.38 126.51 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.386 -0.821 . . . . 73.2 109.95 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 6.5 tt -121.98 100.34 6.93 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 109.094 -0.706 . . . . 73.34 109.094 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 9.2 p -93.71 134.87 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.981 -1.075 . . . . 73.5 109.253 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 11.9 p -96.08 172.19 8.14 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.219 -0.926 . . . . 64.34 109.228 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.461 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 33.6 t -156.23 112.99 3.13 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.98 -1.075 . . . . 74.53 110.183 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' B' ' 77' ' ' ASN . 54.5 p30 -70.64 -12.13 61.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 64.5 109.217 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' ASN . . . . . 0.449 ' N ' ' OD1' ' B' ' 76' ' ' ASP . 87.2 m-20 -134.3 73.84 68.32 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.686 -0.857 . . . . 74.25 108.686 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -50.1 84.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.649 2.233 . . . . 74.43 111.781 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.449 ' N ' ' O ' ' B' ' 77' ' ' ASN . 7.1 p -100.33 151.18 21.8 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.941 -0.762 . . . . 73.12 108.941 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.99 -29.93 69.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.176 -0.953 . . . . 71.01 109.064 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -65.66 -37.01 85.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.304 -0.872 . . . . 63.2 109.251 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -74.75 -30.81 61.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.185 -0.947 . . . . 73.22 109.584 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -69.3 -50.2 48.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.95 . . . . 74.3 109.817 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.404 HG23 ' N ' ' B' ' 85' ' ' HIS . 28.3 m -62.1 -36.73 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.088 -1.008 . . . . 73.31 109.38 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 85' ' ' HIS . . . . . 0.404 ' N ' HG23 ' B' ' 84' ' ' VAL . 16.6 m80 -77.92 -20.11 53.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 73.24 109.544 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.6 -42.6 58.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.188 -0.945 . . . . 55.33 110.275 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -83.13 -29.48 28.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.956 -1.09 . . . . 74.14 109.238 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -75.86 -37.91 58.45 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.308 -0.87 . . . . 64.04 109.741 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 89' ' ' GLN . . . . . 0.482 ' CG ' ' N ' ' B' ' 90' ' ' GLY . 11.8 pt20 -73.02 -47.44 45.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.107 -0.995 . . . . 72.35 109.792 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 90' ' ' GLY . . . . . 0.482 ' N ' ' CG ' ' B' ' 89' ' ' GLN . . . 147.38 65.35 0.01 OUTLIER Glycine 0 N--CA 1.495 2.614 0 C-N-CA 119.776 -1.202 . . . . 65.2 110.395 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.24 138.15 53.6 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.363 -1.08 . . . . 52.23 108.978 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.53 ' CG ' HH21 ' B' ' 112' ' ' ARG . 46.1 t0 -86.54 -26.18 24.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.097 -1.002 . . . . 73.32 109.608 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 93' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 14.4 t0 -152.41 153.09 32.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 72.22 109.578 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.512 ' N ' ' OD1' ' B' ' 93' ' ' ASP . 61.7 t80 -134.27 101.49 5.03 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.545 -0.909 . . . . 64.42 108.545 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 23.1 mm -110.28 147.9 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.437 0 O-C-N 121.133 -0.98 . . . . 72.23 110.283 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.48 145.36 56.23 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.832 -1.173 . . . . 25.24 107.832 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.68 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -66.24 -56.53 15.93 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.671 -1.268 . . . . 64.32 111.58 -179.058 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 98' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 2.2 Cg_endo -39.88 -12.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 120.909 1.073 . . . . 63.33 112.824 -175.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 99' ' ' TYR . . . . . 0.68 ' N ' ' O ' ' B' ' 97' ' ' LYS . 53.7 m-85 59.59 137.09 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.86 -0.525 . . . . 75.13 110.315 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 50.8 mtt-85 -73.73 -40.28 63.67 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.982 -1.074 . . . . 74.23 108.808 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' SER . . . . . 0.753 ' O ' ' N ' ' B' ' 103' ' ' LYS . 34.4 t -168.1 33.8 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.162 -0.961 . . . . 63.34 110.782 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 37.3 mm 50.71 -69.62 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.567 -0.708 . . . . 74.44 110.341 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.753 ' N ' ' O ' ' B' ' 101' ' ' SER . 40.3 mmtm -55.12 -30.49 59.87 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.865 -1.161 . . . . 71.11 107.865 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.78 -55.69 13.78 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.604 -0.839 . . . . 71.45 109.011 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 19.0 tp -58.05 -43.78 87.06 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.33 -0.856 . . . . 51.31 108.762 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.21 -47.88 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -0.93 . . . . 65.23 108.853 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -49.2 -38.01 24.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.14 -0.975 . . . . 24.32 108.885 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 0.531 ' O ' ' NE ' ' B' ' 108' ' ' ARG . 0.0 OUTLIER -67.6 -35.25 78.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.476 -0.765 . . . . 75.31 108.97 179.446 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 64.3 mt -78.28 -29.94 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.066 -1.022 . . . . 54.24 109.435 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -67.9 -52.49 35.75 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.537 -0.727 . . . . 65.31 109.868 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.41 -38.04 74.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.194 -0.942 . . . . 72.24 110.035 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' ARG . . . . . 0.53 HH21 ' CG ' ' B' ' 92' ' ' ASP . 40.6 ttt85 -57.84 -35.6 71.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.993 -1.067 . . . . 72.04 109.704 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.415 HD23 ' C ' ' B' ' 113' ' ' LEU . 2.9 tt -144.07 103.01 3.96 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.097 -1.002 . . . . 75.35 109.492 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.484 ' NE ' ' H ' ' B' ' 115' ' ' PHE . 0.1 OUTLIER -142.09 -164.37 1.79 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.43 -0.952 . . . . 75.5 108.43 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 115' ' ' PHE . . . . . 0.484 ' H ' ' NE ' ' B' ' 114' ' ' ARG . 45.4 m-85 51.88 32.34 9.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.042 -1.037 . . . . 65.33 109.294 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 116' ' ' TRP . . . . . 0.757 ' CE3' ' O ' ' B' ' 117' ' ' GLY . 74.4 t90 53.66 169.01 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.499 -0.751 . . . . 74.45 110.196 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 117' ' ' GLY . . . . . 0.757 ' O ' ' CE3' ' B' ' 116' ' ' TRP . . . -47.38 145.45 4.75 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.864 -1.294 . . . . 44.21 109.864 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 43.0 t -94.22 172.87 7.94 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.425 -1.044 . . . . 71.4 109.406 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 119' ' ' ASN . . . . . 0.421 ' CG ' ' H ' ' B' ' 120' ' ' VAL . 27.4 t-20 -142.24 178.86 7.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.311 -0.868 . . . . 72.32 109.043 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 120' ' ' VAL . . . . . 0.421 ' H ' ' CG ' ' B' ' 119' ' ' ASN . 18.8 t -140.16 -45.15 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.243 -0.911 . . . . 75.02 109.233 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 9.2 mm -97.89 111.14 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.057 -1.027 . . . . 51.41 108.501 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -128.23 105.49 8.39 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.496 -0.753 . . . . 71.53 109.287 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.494 ' O ' HG23 ' B' ' 123' ' ' ILE . 10.5 tp -145.2 122.79 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.165 -0.96 . . . . 72.43 109.077 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 124' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' B' ' 126' ' ' LEU . . . 54.86 -170.98 1.3 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.464 -1.855 . . . . 51.23 108.464 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.96 2.91 0.63 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.896 -1.356 . . . . 74.2 108.877 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.489 ' H ' ' C ' ' B' ' 124' ' ' GLY . 0.6 OUTLIER -91.73 117.21 29.55 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.685 -0.857 . . . . 75.42 108.685 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 83.0 m -125.11 140.92 52.46 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.475 -0.766 . . . . 74.22 108.964 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 6.3 mt -141.22 136.21 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.271 -0.893 . . . . 60.33 110.463 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 13.4 m -114.78 114.59 44.23 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.958 -0.756 . . . . 72.31 108.958 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.453 ' HB3' ' HE ' ' B' ' 157' ' ' ARG . 86.4 Cg_endo -83.48 -40.12 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.248 1.965 . . . . 75.13 112.172 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -63.34 -49.72 72.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.392 -0.818 . . . . 75.23 109.492 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -81.83 -0.17 42.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.955 . . . . 72.43 109.278 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 50.34 74.25 0.23 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.123 -0.985 . . . . 75.13 109.605 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -159.33 129.64 5.76 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.075 -1.015 . . . . 73.22 109.351 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 12.4 tt -109.37 128.97 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.795 -0.817 . . . . 64.14 108.795 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 69.2 mt -116.39 126.48 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-O 121.535 0.683 . . . . 71.22 110.404 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -135.74 147.03 48.28 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.943 -0.762 . . . . 64.22 108.943 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm 54.03 36.11 23.77 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.554 -0.716 . . . . 72.02 110.719 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 64.5 7.75 28.64 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.985 -1.246 . . . . 74.32 109.985 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -107.04 124.48 49.71 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.478 -1.013 . . . . 75.34 108.536 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 141' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' B' ' 141' ' ' GLU . 32.2 mp0 -80.92 143.2 32.82 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.416 -0.803 . . . . 71.23 109.882 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 22.5 t -134.3 129.92 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.64 -0.874 . . . . 70.43 108.64 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -83.2 149.41 26.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.343 -0.848 . . . . 72.43 109.662 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 144' ' ' VAL . . . . . 0.547 HG21 ' CZ ' ' B' ' 149' ' ' PHE . 2.5 m -153.05 144.42 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 72.13 109.384 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 27.2 pttt -175.47 101.86 0.08 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.239 -0.913 . . . . 72.02 109.262 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 177.52 174.16 43.65 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.663 -1.256 . . . . 42.23 110.246 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 0.604 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 10.0 tttt -62.4 -42.4 79.86 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.457 -1.025 . . . . 73.3 109.706 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 148' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 23.3 Cg_exo -62.65 -32.45 79.0 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.575 2.184 . . . . 71.33 112.461 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 149' ' ' PHE . . . . . 0.547 ' CZ ' HG21 ' B' ' 144' ' ' VAL . 71.9 t80 -92.43 -15.35 27.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.129 -0.982 . . . . 74.23 109.886 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -60.88 -41.12 95.39 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.093 -1.004 . . . . 72.34 109.759 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.492 HG13 ' N ' ' B' ' 152' ' ' LEU . 8.6 p -72.92 -40.6 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.223 -0.923 . . . . 73.35 110.051 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.492 ' N ' HG13 ' B' ' 151' ' ' VAL . 21.1 tp -56.9 -31.21 64.66 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.268 -0.895 . . . . 55.24 109.119 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' B' ' 149' ' ' PHE . 0.2 OUTLIER -76.84 -46.67 23.88 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.488 -0.757 . . . . 70.01 109.183 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -50.29 -46.42 55.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.188 -0.945 . . . . 65.32 110.507 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.434 HD12 ' N ' ' B' ' 156' ' ' ALA . 1.9 pp -73.77 -34.68 64.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.648 -1.283 . . . . 71.54 109.383 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 156' ' ' ALA . . . . . 0.434 ' N ' HD12 ' B' ' 155' ' ' LEU . . . -50.19 -35.8 27.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.096 -1.002 . . . . 75.32 108.951 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.453 ' HE ' ' HB3' ' B' ' 130' ' ' PRO . 85.6 mtt180 -79.16 -46.47 17.87 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.384 -0.823 . . . . 73.32 109.175 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -85.57 49.04 1.68 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.666 -0.646 . . . . 74.14 111.068 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 159' ' ' ARG . . . . . 0.519 ' NH2' ' OG1' ' B' ' 203' ' ' THR . 5.6 tpt180 -72.83 171.57 12.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.846 -1.159 . . . . 61.41 108.097 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 51.1 t0 54.48 60.24 3.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.828 -1.17 . . . . 72.1 109.566 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -171.58 147.23 2.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.309 -0.87 . . . . 72.25 109.312 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 21.8 mm -83.63 122.31 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 72.31 108.89 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 97.1 t -119.64 139.4 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.393 -0.817 . . . . 64.21 109.553 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 5.4 t -99.69 160.46 14.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.341 -0.849 . . . . 74.22 110.047 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 165' ' ' LYS . . . . . 0.444 ' HZ2' ' CG2' ' B' ' 184' ' ' ILE . 18.0 mtpp -61.55 -44.61 96.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.528 -0.733 . . . . 65.31 109.609 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -50.54 -39.75 49.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.477 -0.764 . . . . 63.45 110.254 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -59.29 -48.89 79.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.047 -1.033 . . . . 72.4 109.51 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 27.5 mt -58.31 -30.56 66.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.212 -0.93 . . . . 72.32 109.412 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.614 HD13 ' C ' ' B' ' 169' ' ' LEU . 2.3 tm? -66.92 -66.61 0.53 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.388 -0.82 . . . . 73.34 109.872 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.01 -2.07 6.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.311 -0.868 . . . . 72.1 110.874 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.91 -57.96 2.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.838 -1.164 . . . . 62.13 110.116 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.711 ' N ' HD12 ' B' ' 172' ' ' ILE . 1.9 mp -91.73 -45.39 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.955 -1.091 . . . . 71.42 110.123 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 173' ' ' TRP . . . . . 0.525 ' O ' ' N ' ' B' ' 175' ' ' GLU . 16.5 m-90 -77.53 -5.28 49.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.909 -1.119 . . . . 72.23 108.686 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 45.18 -90.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.56 -0.712 . . . . 52.11 110.262 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 175' ' ' GLU . . . . . 0.542 ' H ' ' HD2' ' B' ' 176' ' ' PRO . 1.6 mt-10 -167.39 -52.42 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.955 -1.091 . . . . 73.04 109.997 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.542 ' HD2' ' H ' ' B' ' 175' ' ' GLU . 82.3 Cg_exo -45.34 -9.23 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.001 1.801 . . . . 74.13 112.4 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 177' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' B' ' 175' ' ' GLU . 70.8 mm-40 -82.04 161.34 22.98 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.176 -0.953 . . . . 72.44 109.468 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 178' ' ' MET . . . . . 0.437 ' O ' ' O ' ' B' ' 179' ' ' VAL . 21.6 ttt -67.24 -41.22 86.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 63.43 109.407 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 179' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' B' ' 178' ' ' MET . 48.9 t 52.59 103.24 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.502 -0.749 . . . . 71.05 109.896 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 180' ' ' THR . . . . . 0.542 ' O ' ' N ' ' B' ' 182' ' ' ASN . 1.6 p -80.17 155.6 74.6 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 108.375 -0.972 . . . . 62.15 108.375 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -39.68 -16.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.357 2.038 . . . . 65.22 112.914 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 182' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' B' ' 180' ' ' THR . 18.9 p30 -160.64 107.3 1.51 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.875 -1.14 . . . . 72.31 110.17 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 96.7 t -121.55 -36.0 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.489 -0.757 . . . . 63.32 109.477 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.444 ' CG2' ' HZ2' ' B' ' 165' ' ' LYS . 24.5 mm -60.84 -22.18 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 75.03 109.667 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.09 -42.0 99.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.123 -0.986 . . . . 64.11 110.259 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 186' ' ' VAL . . . . . 0.408 HG22 ' H ' ' B' ' 186' ' ' VAL . 5.2 m -79.42 -36.89 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.925 -1.109 . . . . 73.0 109.745 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.1 -46.84 64.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.12 -0.988 . . . . 61.12 109.714 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 188' ' ' ILE . . . . . 0.444 HG23 ' N ' ' B' ' 189' ' ' ASN . 9.1 tp -62.49 -42.51 96.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.088 -1.008 . . . . 72.43 110.028 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 189' ' ' ASN . . . . . 0.454 ' OD1' ' NH2' ' B' ' 192' ' ' ARG . 55.1 t30 -58.51 -43.69 89.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.024 . . . . 65.14 109.827 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -73.7 -38.03 65.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.176 -0.953 . . . . 63.24 110.319 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 60.9 mt -65.15 -49.14 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.136 -0.977 . . . . 74.03 110.824 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 192' ' ' ARG . . . . . 0.454 ' NH2' ' OD1' ' B' ' 189' ' ' ASN . 28.4 ptt180 -64.07 -37.33 87.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.84 -1.162 . . . . 72.24 108.131 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 193' ' ' GLN . . . . . 0.524 ' HG3' ' CE ' ' B' ' 197' ' ' LYS . 42.6 tt0 -65.18 -30.43 71.34 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.905 -1.146 . . . . 73.1 107.905 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 194' ' ' LYS . . . . . 0.648 ' O ' HD13 ' B' ' 199' ' ' LEU . 36.5 mtpt -93.44 2.74 56.37 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.084 -0.71 . . . . 72.11 109.084 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 195' ' ' MET . . . . . 0.881 ' HE2' ' OG1' ' B' ' 203' ' ' THR . 5.0 tpt -94.37 -22.31 18.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.959 -1.088 . . . . 44.33 109.703 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 196' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 5.1 m-20 -114.02 -27.35 7.74 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.107 -0.995 . . . . 71.21 111.918 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 197' ' ' LYS . . . . . 0.524 ' CE ' ' HG3' ' B' ' 193' ' ' GLN . 5.2 mtmm -79.06 -62.77 0.43 Allowed Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 120.427 -1.421 . . . . 75.21 111.288 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 198' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.66 -49.28 0.17 Allowed 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 121.787 1.658 . . . . 75.32 112.221 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 199' ' ' LEU . . . . . 0.648 HD13 ' O ' ' B' ' 194' ' ' LYS . 10.6 mp -54.35 -70.79 0.09 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.092 -1.005 . . . . 72.25 109.034 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 143.44 -59.15 0.53 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.51 -1.436 . . . . 64.53 109.51 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 29.3 mt -109.34 142.81 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.558 -0.966 . . . . 44.23 109.677 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 17.3 m -77.71 139.47 39.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.122 -0.987 . . . . 54.01 108.631 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 203' ' ' THR . . . . . 0.881 ' OG1' ' HE2' ' B' ' 195' ' ' MET . 70.7 p -129.55 5.96 5.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.439 -0.788 . . . . 74.4 109.759 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.472 HG13 ' HE2' ' B' ' 195' ' ' MET . 24.3 m -121.67 147.84 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.502 -0.749 . . . . 72.12 109.642 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -116.8 125.17 51.2 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.218 -0.66 . . . . 65.41 109.218 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 206' ' ' THR . . . . . 0.413 HG22 ' H ' ' B' ' 206' ' ' THR . 0.1 OUTLIER -84.07 112.76 20.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.394 -0.817 . . . . 71.33 109.219 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.612 HG22 ' H ' ' B' ' 209' ' ' ARG . 7.3 p -138.18 145.84 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.367 -0.833 . . . . 63.5 109.264 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 208' ' ' ARG . . . . . 0.405 ' H ' ' HG2' ' B' ' 208' ' ' ARG . 36.0 ptt180 -97.1 -15.78 20.81 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.105 -0.997 . . . . 74.45 110.11 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 209' ' ' ARG . . . . . 0.612 ' H ' HG22 ' B' ' 207' ' ' VAL . 66.5 mtt-85 -50.24 -39.83 45.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.154 -0.967 . . . . 74.14 109.859 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -140.04 -53.63 0.52 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.301 -0.875 . . . . 74.43 109.4 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 211' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' B' ' 207' ' ' VAL . . . 179.65 -102.31 0.16 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.468 -1.453 . . . . 64.45 109.468 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -136.48 135.31 38.49 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.346 -1.09 . . . . 74.21 108.948 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 43.5 mtt-85 -95.15 125.78 40.03 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.31 -0.869 . . . . 74.03 109.395 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 214' ' ' PHE . . . . . 0.416 ' CD2' HG12 ' B' ' 204' ' ' VAL . 79.8 m-85 -106.4 106.43 16.95 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.493 -0.754 . . . . 74.34 109.471 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 16.4 p -158.93 170.97 20.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.213 -0.93 . . . . 64.33 109.545 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -64.14 138.54 97.44 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 121.238 -0.914 . . . . 70.04 108.81 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 217' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' B' ' 218' ' ' LYS . 74.1 Cg_endo -73.54 77.34 2.59 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.248 1.966 . . . . 65.11 112.695 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' B' ' 220' ' ' ALA . 18.4 mttm 59.23 151.15 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.405 -0.809 . . . . 73.15 109.742 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -44.98 85.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.66 1.573 . . . . 71.31 111.325 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 220' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' B' ' 218' ' ' LYS . . . -93.14 -26.32 17.48 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.016 -1.053 . . . . 75.45 110.446 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 42.4 t -49.18 -30.89 7.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.876 -1.14 . . . . 72.22 109.674 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 49.17 44.91 23.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.128 -0.983 . . . . 54.53 109.764 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.123 -0.985 . . . . 71.13 109.751 179.594 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.638 ' CE ' ' HE1' ' A' ' 116' ' ' TRP . 64.3 ttp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.492 -0.559 . . . . 65.12 109.492 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -138.03 151.43 47.87 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.342 -0.849 . . . . 72.33 109.297 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.8 t -116.79 135.53 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.748 -0.595 . . . . 71.42 109.632 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 5' ' ' LEU . 0.7 OUTLIER -112.74 122.73 48.53 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.36 -0.837 . . . . 65.12 109.181 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.718 ' N ' HD12 ' A' ' 4' ' ' LEU . 11.0 mt -120.89 101.74 7.9 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.61 -0.681 . . . . 62.43 109.181 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.537 HG12 HD11 ' A' ' 4' ' ' LEU . 10.6 mt -79.27 104.61 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.781 -1.2 . . . . 71.15 108.753 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 9' ' ' ASN . 0.6 OUTLIER -139.16 123.19 17.86 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.306 -0.871 . . . . 75.34 109.215 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.44 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 68.3 mttm -65.35 -33.68 76.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 72.44 109.162 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.513 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 77.0 m-20 -82.41 112.36 19.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 63.02 109.485 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 45.5 m -63.83 -26.31 68.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 72.34 109.653 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.29 -53.2 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.195 -0.941 . . . . 74.02 109.863 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.6 mt -61.42 -46.84 88.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 71.43 109.585 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.32 -17.1 71.99 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.517 -1.833 . . . . 61.32 108.517 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.4 -54.41 5.57 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.483 -1.447 . . . . 71.2 109.483 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -56.51 -44.9 81.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.425 -1.044 . . . . 71.32 109.783 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.2 mm -63.41 -34.99 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.822 -1.174 . . . . 63.23 108.798 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.48 ' CD ' HD21 ' A' ' 21' ' ' ASN . 14.2 tm-20 -57.91 -49.66 75.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.922 . . . . 51.11 109.102 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -87.52 3.47 47.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.26 -0.9 . . . . 73.34 109.262 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.66 -57.96 2.48 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.68 -1.368 . . . . 62.15 109.68 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -75.05 -19.98 59.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -1.146 . . . . 73.51 109.869 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.48 HD21 ' CD ' ' A' ' 17' ' ' GLU . 80.4 m-20 -51.29 -33.88 30.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.092 -1.005 . . . . 74.25 109.282 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.2 t -58.0 -46.95 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.322 -0.861 . . . . 70.04 108.938 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -56.91 -53.18 60.95 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.903 -0.777 . . . . 73.23 108.903 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 133.63 36.41 0.26 Allowed Glycine 0 N--CA 1.5 2.929 0 N-CA-C 109.735 -1.346 . . . . 75.54 109.735 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.59 ' CE2' ' SD ' ' A' ' 1' ' ' MET . 20.1 m-85 -119.39 160.02 23.1 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.483 -1.01 . . . . 73.43 109.344 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.2 mmt -104.22 140.34 37.98 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.571 -0.9 . . . . 43.24 108.571 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.417 ' O ' ' OD1' ' A' ' 28' ' ' ASP . . . -138.52 155.48 48.36 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.337 -0.852 . . . . 62.11 110.28 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 27' ' ' ALA . 82.1 m-20 -141.57 155.6 45.75 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.592 -0.892 . . . . 74.42 108.592 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.2 t -112.11 139.35 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.379 -0.826 . . . . 72.15 109.384 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.6 p -129.99 166.69 19.57 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.523 -0.736 . . . . 71.42 109.573 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.449 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 4.4 pt-20 -93.72 -102.98 0.13 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.348 -0.845 . . . . 72.33 109.809 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.7 p -79.31 168.88 18.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.115 -0.991 . . . . 74.24 109.891 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.0 mt -57.33 -33.32 67.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.521 -0.737 . . . . 71.53 109.742 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -51.27 -43.57 61.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 74.23 109.661 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -65.91 -41.92 90.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.154 -0.966 . . . . 54.03 109.373 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.25 -38.44 46.33 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.493 -1.443 . . . . 61.41 109.493 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.71 -38.18 90.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -1.135 . . . . 74.34 109.621 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -80.84 -39.47 26.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 75.33 109.717 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.9 tp -68.16 -46.35 70.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 74.33 110.077 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 41' ' ' ASP . 3.3 ppp? -62.73 -27.62 69.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.041 -1.037 . . . . 70.32 109.83 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 40' ' ' MET . 93.5 m-20 -63.49 -40.21 96.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.135 -0.978 . . . . 71.22 109.94 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.9 pt -84.0 -25.86 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.159 -0.963 . . . . 74.14 110.167 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 40' ' ' MET . 97.4 mtt180 -130.04 138.76 50.93 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.373 -0.829 . . . . 72.24 109.584 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -93.98 126.36 39.15 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.248 -0.908 . . . . 75.42 109.472 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -106.01 145.78 30.93 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.429 -0.794 . . . . 74.23 109.524 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -85.57 -44.56 12.54 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.274 -0.891 . . . . 72.04 109.078 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.537 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -105.56 108.41 19.9 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.585 -0.894 . . . . 72.13 108.585 179.641 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.432 ' N ' HD13 ' A' ' 47' ' ' LEU . 2.0 m -104.33 101.86 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.31 -0.996 . . . . 72.34 108.31 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.6 ttt -108.37 143.02 37.83 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.688 -0.856 . . . . 74.11 108.688 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' A' ' 55' ' ' ALA . 1.3 p -144.15 132.34 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.361 -0.837 . . . . 61.12 109.933 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.0 m -98.98 2.29 46.23 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.481 -0.762 . . . . 73.11 109.472 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -76.14 139.12 41.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.192 -0.943 . . . . 52.55 109.427 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.481 ' C ' ' H ' ' A' ' 55' ' ' ALA . 61.6 mttp -73.62 -43.5 59.42 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.307 -0.871 . . . . 44.22 110.731 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -68.16 10.26 0.24 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.017 -1.052 . . . . 70.44 109.89 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.93 -22.18 56.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.893 . . . . 64.14 110.57 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' ALA . 64.0 mt -39.98 -51.59 2.51 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.511 -0.743 . . . . 44.14 110.498 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.9 m -68.75 -33.72 74.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.939 -1.1 . . . . 55.23 109.319 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.539 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 73.6 t80 -64.84 -48.42 74.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.386 -0.821 . . . . 74.44 110.088 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.61 -34.83 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.615 -1.303 . . . . 74.03 109.52 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.9 p -57.33 -49.64 75.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 64.3 109.542 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -69.41 -33.2 72.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.032 -1.043 . . . . 64.44 109.927 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.539 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 5.1 mm -63.63 -35.41 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.828 -1.17 . . . . 63.21 109.747 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 67' ' ' SER . 11.5 mtpt -72.08 -51.05 23.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.123 -0.986 . . . . 74.42 110.461 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.431 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 14.6 pt-20 -67.24 -41.69 85.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.743 -1.223 . . . . 70.32 109.708 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.448 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 93.4 mttt -73.61 -24.42 60.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.878 . . . . 75.22 109.501 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.518 ' O ' HG22 ' A' ' 69' ' ' ILE . 93.5 m-70 -154.93 65.88 0.66 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.229 -0.92 . . . . 74.13 109.293 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 63' ' ' LYS . 17.0 t -60.45 -32.56 71.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.392 -0.818 . . . . 73.24 110.038 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.1 m -67.59 46.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 61.01 109.859 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 66' ' ' HIS . 13.8 tt -145.63 162.85 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.142 -0.974 . . . . 71.33 109.726 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.537 ' HB ' HD22 ' A' ' 47' ' ' LEU . 45.0 t -97.73 148.75 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.221 -0.924 . . . . 72.13 108.942 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.51 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 11.3 t -132.38 124.08 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.282 -0.886 . . . . 54.21 109.508 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.525 HD12 HD21 ' A' ' 47' ' ' LEU . 2.1 mt -128.07 99.26 5.41 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.319 -0.993 . . . . 50.24 108.319 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.603 ' O ' HD12 ' A' ' 95' ' ' ILE . 64.3 t -93.12 149.56 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -0.869 . . . . 74.41 109.14 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.7 m -121.96 165.84 15.36 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.529 -0.915 . . . . 72.31 108.529 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.45 ' CB ' ' OE2' ' A' ' 82' ' ' GLU . 9.7 p -171.81 123.65 0.53 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.035 -1.041 . . . . 64.54 110.226 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 52.1 p30 -71.0 10.56 0.52 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.59 -0.694 . . . . 74.13 109.901 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.445 ' H ' ' C ' ' A' ' 75' ' ' SER . 5.8 p-10 -129.09 59.57 44.95 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.38 -0.825 . . . . 73.34 109.661 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -58.9 80.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.276 1.984 . . . . 63.22 112.047 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.403 ' N ' ' O ' ' A' ' 77' ' ' ASN . 72.6 p -104.28 151.56 23.27 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.621 -0.881 . . . . 62.53 108.621 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -30.8 69.53 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.228 -0.92 . . . . 73.44 109.363 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -67.15 -37.47 83.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.189 -0.945 . . . . 71.42 109.554 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.45 ' OE2' ' CB ' ' A' ' 75' ' ' SER . 79.4 tt0 -71.47 -32.62 68.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 73.43 109.722 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.476 ' OE2' ' CZ ' ' B' ' 100' ' ' ARG . 92.2 mt-10 -64.44 -50.95 65.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.918 . . . . 74.22 109.825 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.3 m -61.01 -36.32 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.157 -0.964 . . . . 73.2 109.252 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.429 ' O ' ' OE1' ' A' ' 89' ' ' GLN . 27.0 m80 -74.51 -26.65 60.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 53.33 109.599 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -66.53 -41.96 87.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.109 -0.995 . . . . 64.11 109.786 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.479 ' CZ ' ' HB1' ' B' ' 111' ' ' ALA . 89.1 t80 -82.05 -35.12 29.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.042 -1.036 . . . . 74.34 109.08 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -62.08 -51.55 67.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.379 -0.825 . . . . 74.42 109.411 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.488 ' N ' ' NE2' ' A' ' 89' ' ' GLN . 0.9 OUTLIER -66.6 -58.26 5.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.531 -0.731 . . . . 74.24 109.686 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 158.17 75.27 0.02 OUTLIER Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.613 -1.279 . . . . 61.51 110.266 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -134.84 119.61 18.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.305 -1.115 . . . . 55.33 108.947 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 71.6 m-20 -71.36 -34.79 70.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.102 -0.999 . . . . 73.42 108.923 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.517 ' CG ' HH21 ' A' ' 112' ' ' ARG . 60.7 m-20 -153.16 152.5 31.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.451 -0.781 . . . . 75.04 109.046 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.423 ' OH ' ' OG ' ' A' ' 75' ' ' SER . 9.3 t80 -126.76 132.93 50.96 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.08 -0.711 . . . . 71.33 109.08 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.798 HD12 ' H ' ' A' ' 95' ' ' ILE . 0.1 OUTLIER -121.57 142.38 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 CA-C-O 121.978 0.894 . . . . 71.13 110.442 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.52 119.86 10.61 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.599 -1.26 . . . . 64.32 107.599 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.677 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -43.9 -53.9 12.05 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 62.2 111.628 -178.683 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 2.3 Cg_endo -40.56 -10.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 120.955 1.103 . . . . 73.11 113.12 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.677 ' N ' ' O ' ' A' ' 97' ' ' LYS . 64.0 m-85 59.96 92.73 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.71 -0.619 . . . . 65.22 109.9 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.8 ttm105 -52.09 -39.03 59.14 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.354 -0.98 . . . . 72.35 108.354 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 t -172.41 134.41 0.68 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.493 -0.755 . . . . 71.32 109.025 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 81.8 mt -53.34 -40.1 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.127 -0.983 . . . . 75.43 109.26 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -66.79 -26.22 66.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 71.41 109.67 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.81 -48.58 21.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.171 -0.955 . . . . 63.24 109.856 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.7 ' C ' HD13 ' A' ' 105' ' ' LEU . 2.1 tm? -57.75 -54.05 51.24 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.207 -0.933 . . . . 73.22 109.442 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.526 HG13 ' N ' ' A' ' 107' ' ' ALA . 11.0 p -60.28 -41.9 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.099 -1.001 . . . . 60.11 109.52 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.526 ' N ' HG13 ' A' ' 106' ' ' VAL . . . -51.8 -36.63 48.47 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.17 -0.956 . . . . 70.42 108.925 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -71.87 -37.45 70.19 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.372 -0.83 . . . . 74.41 109.399 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 87.7 mt -67.11 -31.61 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 107.978 -1.119 . . . . 62.54 107.978 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 113' ' ' LEU . 78.5 tt0 -65.85 -57.55 7.66 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.637 -0.825 . . . . 74.34 108.927 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -46.21 -37.2 6.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.475 -0.766 . . . . 73.32 109.655 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.517 HH21 ' CG ' ' A' ' 93' ' ' ASP . 28.1 mmt180 -82.25 -14.46 55.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 52.41 110.103 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' ' 110' ' ' GLU . 80.4 mt -135.25 44.08 2.61 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.133 -0.979 . . . . 65.24 110.617 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -76.44 -39.19 54.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.848 -1.158 . . . . 64.45 108.846 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.529 ' CD2' ' O ' ' A' ' 116' ' ' TRP . 33.8 p90 -67.74 -10.98 57.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.424 -0.797 . . . . 74.43 109.977 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.638 ' HE1' ' CE ' ' A' ' 1' ' ' MET . 48.0 t90 50.29 -178.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.138 -0.976 . . . . 74.42 109.504 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.495 ' N ' ' CG ' ' A' ' 116' ' ' TRP . . . -50.96 143.18 15.0 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.351 -1.499 . . . . 75.04 109.351 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 87.9 p -157.6 -178.5 7.38 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -1.206 . . . . 61.14 110.068 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.38 -179.64 8.13 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.05 -0.722 . . . . 65.24 109.05 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.6 t -138.34 -36.6 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.42 -0.8 . . . . 73.11 109.125 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.55 ' N ' HD12 ' A' ' 121' ' ' ILE . 1.4 mp -90.4 136.41 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.995 . . . . 72.24 108.493 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -138.6 105.69 5.46 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.349 -0.844 . . . . 72.34 109.47 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 83.5 mt -108.94 109.78 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.962 -0.755 . . . . 71.44 108.962 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.8 -137.73 31.06 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.277 -1.529 . . . . 73.4 109.277 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -79.56 -3.83 48.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -1.191 . . . . 74.45 109.349 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.45 HD22 ' CE1' ' A' ' 137' ' ' TYR . 0.5 OUTLIER -89.06 143.25 26.98 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.356 -0.979 . . . . 54.21 108.356 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 54.9 m -129.86 141.07 50.87 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.375 -0.828 . . . . 54.5 109.231 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.74 130.81 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.42 -0.8 . . . . 45.15 109.976 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.1 m -107.4 113.45 61.89 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.633 -0.667 . . . . 71.11 109.226 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.8 -53.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.92 1.746 . . . . 65.41 111.959 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -55.3 -44.65 75.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 63.32 109.316 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -83.52 -8.54 59.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.401 -0.812 . . . . 72.52 109.153 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 51.72 57.53 6.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 75.33 109.154 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -139.37 116.03 10.73 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.411 -0.806 . . . . 71.23 109.164 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.543 ' N ' HD12 ' A' ' 135' ' ' ILE . 1.4 mp -94.22 130.24 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.185 -0.947 . . . . 74.02 108.905 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 36.8 mt -115.91 129.41 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.561 -0.712 . . . . 60.23 109.575 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.466 ' C ' ' H ' ' A' ' 139' ' ' GLY . 77.5 t80 -141.58 151.19 42.96 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.512 -0.922 . . . . 62.32 108.512 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 46.1 tttp 55.94 5.63 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.851 . . . . 75.4 109.408 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 137' ' ' TYR . . . 93.86 -4.81 72.29 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.686 -1.366 . . . . 72.24 109.686 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.404 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 0.7 OUTLIER -89.71 139.7 30.3 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.247 -1.149 . . . . 71.22 109.299 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -86.71 137.19 32.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 71.42 109.162 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.1 t -135.26 128.12 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.43 -0.794 . . . . 53.02 109.531 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -93.37 134.34 35.69 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.306 -0.871 . . . . 60.45 109.048 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.413 ' CG2' HD13 ' A' ' 135' ' ' ILE . 15.1 m -149.48 140.56 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.106 -0.996 . . . . 74.44 109.556 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -163.54 18.83 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 65.15 109.776 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.3 161.09 54.16 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.844 -1.702 . . . . 73.34 108.844 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.562 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 4.8 tttp -56.44 -44.73 99.86 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.039 -1.271 . . . . 72.22 109.091 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 24.2 Cg_exo -62.58 -28.5 77.3 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.362 2.042 . . . . 65.23 112.122 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -80.67 -20.7 42.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.232 -0.918 . . . . 60.11 110.12 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -52.75 -32.96 46.14 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.067 -1.021 . . . . 64.21 108.965 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 148' ' ' PRO . 6.4 p -64.95 -38.08 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.324 -0.86 . . . . 72.02 109.276 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 29.4 tp -60.86 -41.92 96.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.857 . . . . 73.31 109.322 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 20.0 p -74.35 -34.79 63.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.245 -0.909 . . . . 74.31 110.16 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.569 ' ND1' ' NH2' ' A' ' 157' ' ' ARG . 43.9 m-70 -60.9 -52.69 63.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.137 -0.977 . . . . 74.31 110.035 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 pp -68.52 -28.56 67.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.906 -1.121 . . . . 75.34 109.602 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.3 -47.59 78.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 62.14 109.377 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.569 ' NH2' ' ND1' ' A' ' 154' ' ' HIS . 67.9 mtm-85 -69.03 -58.69 3.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.965 . . . . 61.03 109.461 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -53.27 -47.67 68.94 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.811 -0.756 . . . . 74.12 109.457 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 161' ' ' GLN . 23.1 ttm180 44.97 -126.49 1.1 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.401 -0.812 . . . . 71.13 109.895 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 45.6 p-10 -50.08 90.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 75.45 109.561 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.844 ' OE1' ' OH ' ' B' ' 216' ' ' TYR . 1.4 tp-100 -171.53 149.54 2.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.246 -0.909 . . . . 73.41 109.325 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 65.3 mt -78.51 135.46 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.148 -0.97 . . . . 74.41 109.216 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 87.1 t -127.58 129.29 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.452 -0.78 . . . . 72.31 109.653 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.7 t -99.44 153.36 19.07 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.435 -0.791 . . . . 74.12 109.324 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.5 mtmm -56.97 -43.83 82.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.33 -0.856 . . . . 70.43 109.494 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -59.01 -34.26 71.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.341 -0.85 . . . . 73.52 109.575 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -63.91 -55.19 24.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.166 -0.959 . . . . 74.52 109.621 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 80.3 mt -47.64 -52.71 17.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.143 -0.973 . . . . 72.31 109.774 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 171' ' ' ALA . 87.2 mt -57.62 -74.6 0.05 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.591 -1.318 . . . . 53.33 109.666 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -48.86 -11.01 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.973 -1.079 . . . . 62.44 110.459 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 169' ' ' LEU . . . -95.43 -41.39 9.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.189 -0.945 . . . . 60.21 111.185 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.439 ' O ' ' OE1' ' A' ' 175' ' ' GLU . 1.7 mp -84.61 -47.18 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.917 -1.114 . . . . 75.32 109.688 -178.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.626 ' O ' ' CD1' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -81.41 0.48 37.33 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.668 -1.27 . . . . 73.14 109.188 -179.752 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.472 ' C ' ' O ' ' A' ' 173' ' ' TRP . 76.6 tt0 -36.87 -34.9 0.08 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.237 -0.914 . . . . 73.24 110.563 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.554 ' H ' ' CD ' ' A' ' 175' ' ' GLU . 0.8 OUTLIER -89.79 151.17 45.21 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 107.629 -1.249 . . . . 44.43 107.629 178.458 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.423 ' C ' ' O ' ' A' ' 175' ' ' GLU . 23.5 Cg_exo -28.48 88.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 122.943 2.429 . . . . 72.51 113.178 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.48 ' O ' ' CD1' ' A' ' 173' ' ' TRP . 48.7 tp10 -158.26 75.92 0.75 Allowed 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.04 0.924 . . . . 63.24 108.735 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 77.7 mtp -53.84 115.53 2.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.238 -0.914 . . . . 73.5 110.254 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 1.7 m -102.75 140.36 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.388 -0.967 . . . . 65.22 108.388 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 25.9 p -53.72 150.52 13.42 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.152 -0.967 . . . . 71.42 109.673 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -40.38 -29.72 0.41 Allowed 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.17 1.913 . . . . 41.22 111.958 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -141.31 134.24 29.01 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.343 -0.848 . . . . 64.54 109.345 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.0 p -166.47 -27.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.852 . . . . 74.02 109.861 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 10.9 tp -50.97 -22.38 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.068 -1.02 . . . . 72.33 109.914 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.437 ' CG ' ' N ' ' A' ' 186' ' ' VAL . 18.9 pt-20 -70.05 -48.93 55.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.055 -1.028 . . . . 74.4 109.572 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.437 ' N ' ' CG ' ' A' ' 185' ' ' GLU . 14.1 m -72.04 -28.87 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.808 -1.183 . . . . 70.42 108.969 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -77.87 -55.42 5.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 52.11 110.069 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.411 HD12 HD11 ' A' ' 191' ' ' ILE . 11.2 tp -52.6 -33.37 18.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.675 -1.266 . . . . 71.4 109.324 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -72.76 -41.27 65.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.173 -0.954 . . . . 73.44 111.214 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.452 ' CG ' ' N ' ' A' ' 191' ' ' ILE . 11.8 pt20 -77.33 -46.37 23.12 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.586 -1.321 . . . . 71.42 111.029 -178.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.452 ' N ' ' CG ' ' A' ' 190' ' ' GLN . 6.5 pt -62.22 -41.01 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.717 -1.239 . . . . 61.55 109.971 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -69.21 -34.27 74.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.849 -1.157 . . . . 63.34 108.597 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -64.86 -39.58 93.78 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.694 -0.629 . . . . 61.24 110.082 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.422 ' O ' ' CD ' ' A' ' 198' ' ' PRO . 11.4 pttp -92.09 -2.55 56.57 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.047 -1.033 . . . . 75.13 110.549 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 48.2 ttp -93.75 -45.42 7.69 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.94 -1.1 . . . . 74.02 109.974 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -60.29 -33.02 71.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.07 -1.019 . . . . 74.02 110.385 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -64.4 -61.11 7.11 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.978 -1.076 . . . . 75.43 110.335 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.422 ' CD ' ' O ' ' A' ' 194' ' ' LYS . 31.5 Cg_endo -61.11 -55.52 1.25 Allowed 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.824 1.682 . . . . 72.32 111.844 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.495 ' C ' ' H ' ' A' ' 201' ' ' ILE . 10.0 mp -63.09 -36.9 85.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -0.942 . . . . 74.54 109.282 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 73.51 -23.73 0.98 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.598 -1.401 . . . . 61.51 109.598 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.495 ' H ' ' C ' ' A' ' 199' ' ' LEU . 13.6 mt -110.66 137.12 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.483 -1.01 . . . . 61.22 109.351 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 8.6 t -84.87 143.6 28.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.164 -0.96 . . . . 72.0 109.354 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.5 p -141.19 27.94 1.91 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.278 -0.889 . . . . 74.44 109.267 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.527 ' CG1' ' CE2' ' A' ' 214' ' ' PHE . 2.7 m -143.66 128.64 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.239 -0.913 . . . . 64.35 109.692 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -102.76 121.91 43.41 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.381 -0.825 . . . . 71.41 108.808 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.425 ' H ' HG22 ' A' ' 206' ' ' THR . 0.0 OUTLIER -84.88 117.32 23.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.145 -0.972 . . . . 73.52 109.873 -179.614 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.411 ' O ' ' O ' ' A' ' 211' ' ' GLY . 12.8 p -150.25 147.58 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.345 -0.847 . . . . 71.02 109.062 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -64.34 -130.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.144 -0.973 . . . . 72.12 109.479 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? 50.17 -106.02 0.21 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.91 . . . . 64.41 109.337 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -75.9 -59.08 2.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 71.54 109.486 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 207' ' ' VAL . . . 159.26 -109.57 0.41 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.641 -1.384 . . . . 72.03 109.641 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 212' ' ' TYR . 41.9 m-85 -109.73 134.91 51.45 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.522 -0.987 . . . . 75.54 109.369 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -107.31 132.5 53.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.509 -0.744 . . . . 75.31 109.476 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.527 ' CE2' ' CG1' ' A' ' 204' ' ' VAL . 43.8 m-85 -97.45 128.69 44.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.258 -0.901 . . . . 75.41 109.107 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 49.2 m -140.18 156.55 46.47 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.439 -0.788 . . . . 74.14 109.077 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -69.52 153.98 95.25 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.916 . . . . 75.32 109.183 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -36.85 150.0 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 122.478 2.119 . . . . 73.11 112.478 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.518 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 12.4 tttt -65.05 -46.27 73.78 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 75.25 109.633 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 90.9 Cg_endo -88.78 125.64 1.68 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 122.567 2.178 . . . . 75.1 112.213 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -170.91 76.81 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 71.14 109.537 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 223' ' ' GLU . 73.8 m -57.65 -38.92 75.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 71.13 109.344 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 49.45 12.23 0.06 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.899 . . . . 75.35 109.618 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 221' ' ' CYS . 96.5 mt-10 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.972 -1.014 . . . . 73.41 109.629 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.487 ' SD ' ' OD2' ' B' ' 46' ' ' ASP . 7.4 mtt . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.364 -0.606 . . . . 71.14 109.364 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -136.09 125.04 24.19 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.463 -0.773 . . . . 73.23 109.166 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.1 t -111.83 133.79 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-O 121.359 0.6 . . . . 72.24 109.564 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.443 HD12 ' N ' ' B' ' 5' ' ' LEU . 4.9 tp -101.73 120.47 40.4 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.488 -0.757 . . . . 54.33 109.174 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.443 ' N ' HD12 ' B' ' 4' ' ' LEU . 17.3 mt -119.46 98.58 6.21 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.464 -0.772 . . . . 74.35 109.108 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.453 HD12 ' HB ' ' B' ' 50' ' ' VAL . 16.9 mt -83.48 98.8 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.872 -1.142 . . . . 42.55 108.469 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' B' ' 9' ' ' ASN . 33.8 tp10 -142.8 128.84 19.65 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.382 -0.824 . . . . 74.52 109.416 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -66.77 -31.36 71.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.9 . . . . 62.55 109.478 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' ASN . . . . . 0.404 ' H ' ' HG3' ' B' ' 7' ' ' GLU . 94.7 m-20 -79.22 112.02 16.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 73.11 109.533 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 82.2 p -71.78 -25.28 61.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 65.54 109.698 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 82.3 t -62.57 -49.85 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -0.958 . . . . 75.55 109.623 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.574 ' N ' HD22 ' B' ' 12' ' ' LEU . 3.8 mm? -67.04 -28.95 68.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 70.14 109.206 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.8 -23.18 64.82 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.745 -1.742 . . . . 75.4 108.745 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.47 -49.74 7.91 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.705 -1.358 . . . . 65.44 109.705 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.09 -42.56 99.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.1 -1.235 . . . . 60.21 109.048 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 6.0 mm -60.87 -35.59 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.259 -1.015 . . . . 75.15 108.259 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -63.1 -44.04 96.8 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.498 -0.751 . . . . 73.01 109.361 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -86.05 1.61 49.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.15 -0.969 . . . . 74.3 109.301 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.12 -53.32 2.69 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 109.446 -1.462 . . . . 70.54 109.446 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -77.41 -22.26 51.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -1.152 . . . . 71.34 109.793 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -52.5 -34.88 51.47 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.072 -1.017 . . . . 64.41 109.077 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 54.3 t -55.47 -45.93 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.351 -0.843 . . . . 74.23 108.867 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 49.3 mmtt -60.14 -53.33 59.03 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.491 -0.756 . . . . 63.42 109.035 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 133.56 35.72 0.28 Allowed Glycine 0 N--CA 1.5 2.965 0 N-CA-C 110.099 -1.201 . . . . 53.43 110.099 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -119.5 159.54 24.1 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.392 -1.064 . . . . 71.12 109.308 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 13.0 mmt -103.39 141.43 35.96 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.502 -0.925 . . . . 75.24 108.502 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.429 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -133.41 157.6 45.16 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.393 -0.817 . . . . 72.12 110.265 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ASP . . . . . 0.476 ' OD2' ' NH1' ' B' ' 43' ' ' ARG . 82.0 m-20 -142.84 160.37 40.45 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.677 -0.86 . . . . 72.31 108.677 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 5.0 p -121.43 139.76 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.364 -0.835 . . . . 64.43 109.718 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 10.2 p -133.52 165.21 25.41 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.59 -0.694 . . . . 65.41 109.213 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -91.72 -104.99 0.11 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.277 -0.889 . . . . 71.02 109.677 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 60.0 p -78.52 168.98 18.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 51.11 109.902 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' B' ' 37' ' ' GLU . 19.0 mt -53.65 -33.55 55.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.502 -0.749 . . . . 71.24 109.866 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -51.02 -48.95 61.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.099 -1.0 . . . . 74.32 109.499 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -64.37 -39.73 94.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 73.03 108.957 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.28 -36.21 63.55 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.295 -1.522 . . . . 30.21 109.295 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' B' ' 33' ' ' LEU . 83.8 tt0 -66.16 -41.54 90.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -1.122 . . . . 74.42 109.472 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -79.44 -37.77 36.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.136 -0.977 . . . . 74.42 109.408 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 41.2 tp -68.48 -41.86 79.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 75.41 109.63 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.0 ppp? -73.53 -21.74 60.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.143 -0.973 . . . . 60.41 109.535 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -53.44 -38.34 63.46 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.012 -1.055 . . . . 53.23 108.936 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 8.6 pt -95.98 -33.19 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.351 -0.843 . . . . 71.23 109.651 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.476 ' NH1' ' OD2' ' B' ' 28' ' ' ASP . 93.1 mtt180 -96.32 138.57 33.72 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.081 -1.012 . . . . 72.22 109.593 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' ASN . . . . . 0.435 ' O ' ' O ' ' B' ' 45' ' ' TYR . 84.7 m-20 -81.08 -30.63 34.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.168 -0.957 . . . . 63.54 109.966 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' B' ' 44' ' ' ASN . 38.4 m-85 52.24 100.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.302 -0.874 . . . . 64.35 109.436 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' ASP . . . . . 0.487 ' OD2' ' SD ' ' B' ' 1' ' ' MET . 73.1 m-20 -70.11 -36.99 75.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.106 -0.996 . . . . 62.22 109.016 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.522 ' C ' HD13 ' B' ' 47' ' ' LEU . 1.0 OUTLIER -107.01 111.58 24.14 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.673 -0.862 . . . . 73.12 108.673 179.567 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.475 ' N ' HD13 ' B' ' 47' ' ' LEU . 53.1 t -94.89 99.8 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.299 -0.876 . . . . 65.11 109.378 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 1.8 tpp -113.55 130.02 56.44 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.774 -0.825 . . . . 73.44 108.774 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.463 ' N ' ' SD ' ' B' ' 49' ' ' MET . 0.2 OUTLIER -146.66 135.49 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 34.5 109.312 -179.505 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 73.1 p -103.51 8.68 37.79 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.504 -0.748 . . . . 73.21 110.25 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -76.82 142.25 40.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.081 -1.012 . . . . 70.41 109.547 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -74.3 -38.36 63.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 65.0 110.293 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -72.57 8.19 1.54 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.034 -1.041 . . . . 75.21 109.716 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.55 -21.24 59.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 55.33 110.222 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 71.1 mt -43.68 -41.11 4.57 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.318 -0.864 . . . . 63.14 110.224 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 27.4 t -72.92 -38.59 66.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.999 -1.063 . . . . 63.5 109.567 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' PHE . . . . . 0.605 ' CE2' HD11 ' B' ' 62' ' ' ILE . 50.4 t80 -64.27 -49.58 71.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.343 -0.848 . . . . 72.33 110.135 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.15 -35.36 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.765 -1.209 . . . . 74.54 109.69 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 59.8 p -58.22 -45.82 86.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.237 -0.914 . . . . 71.24 109.681 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' B' ' 65' ' ' LYS . 8.8 ptp180 -75.36 -30.78 60.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.058 -1.026 . . . . 74.31 110.076 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.605 HD11 ' CE2' ' B' ' 58' ' ' PHE . 5.0 mm -60.55 -51.91 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.745 -1.222 . . . . 72.14 109.24 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -63.1 -40.78 98.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.135 -0.978 . . . . 73.32 109.183 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -68.93 -38.88 79.79 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.512 -0.921 . . . . 73.12 108.512 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' B' ' 61' ' ' ARG . 14.4 mtpp -86.24 -74.23 0.43 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.285 -0.884 . . . . 72.44 109.481 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.453 ' N ' ' O ' ' B' ' 62' ' ' ILE . 53.6 m-70 -98.08 87.43 3.95 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.226 -0.921 . . . . 63.31 109.524 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 23.2 t -78.46 -32.18 48.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 73.1 109.923 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 94.7 p -59.7 -23.51 63.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.233 -0.917 . . . . 71.53 109.643 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.407 HG21 HD13 ' B' ' 69' ' ' ILE . 57.3 mt -84.09 149.48 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.246 -0.909 . . . . 74.4 109.293 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.562 HG12 ' N ' ' B' ' 71' ' ' VAL . 75.8 t -91.08 164.49 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.247 -0.908 . . . . 75.12 109.637 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.562 ' N ' HG12 ' B' ' 70' ' ' VAL . 4.3 t -139.68 128.15 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.318 -0.864 . . . . 73.2 109.348 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.497 ' O ' ' SD ' ' B' ' 49' ' ' MET . 0.6 OUTLIER -123.69 106.52 10.6 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.608 -0.886 . . . . 73.34 108.608 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 71.0 t -91.4 129.58 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.117 -0.989 . . . . 73.5 109.008 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 6.8 p -90.36 171.25 9.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.917 -1.114 . . . . 64.34 108.987 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.424 ' C ' ' H ' ' B' ' 97' ' ' LYS . 13.6 p -155.76 112.34 3.16 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.927 -1.108 . . . . 74.53 110.261 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -67.2 -27.47 67.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.329 -0.857 . . . . 64.5 109.005 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' B' ' 79' ' ' THR . 13.5 t-20 -127.06 75.65 76.52 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.677 -0.86 . . . . 74.25 108.677 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -44.79 88.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.572 2.181 . . . . 74.43 111.777 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.471 ' N ' ' O ' ' B' ' 77' ' ' ASN . 17.1 m -104.04 148.65 25.98 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.59 0.71 . . . . 73.12 109.717 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -33.69 76.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.196 -0.94 . . . . 71.01 109.006 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' GLU . . . . . 0.434 ' H ' HG22 ' B' ' 79' ' ' THR . 84.2 tt0 -57.07 -39.42 74.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 63.2 109.036 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -71.91 -31.73 66.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.223 -0.923 . . . . 73.22 109.201 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.535 ' OE1' ' CD1' ' B' ' 94' ' ' TYR . 5.9 mm-40 -64.57 -56.55 13.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.22 -0.925 . . . . 74.3 110.027 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.437 HG23 ' N ' ' B' ' 85' ' ' HIS . 29.9 m -57.59 -41.21 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 73.31 109.832 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 85' ' ' HIS . . . . . 0.437 ' N ' HG23 ' B' ' 84' ' ' VAL . 60.5 t60 -74.05 -25.15 59.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.152 -0.968 . . . . 73.24 109.59 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.26 -36.3 79.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 55.33 110.021 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -80.17 -33.73 38.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.119 -0.988 . . . . 74.14 108.892 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -69.75 -33.52 72.55 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.338 -0.851 . . . . 64.04 109.428 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -77.55 -67.53 0.71 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 72.35 109.499 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 156.86 66.02 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.011 -1.236 . . . . 65.2 110.011 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.68 124.64 46.75 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.444 -1.033 . . . . 52.23 109.054 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -69.98 -36.85 75.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.12 -0.987 . . . . 73.32 109.438 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' ASP . . . . . 0.471 ' OD2' ' CD ' ' B' ' 112' ' ' ARG . 11.6 m-20 -151.24 166.41 30.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.304 -0.873 . . . . 72.22 109.371 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.551 ' O ' ' CD1' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -140.21 114.15 8.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.607 -0.683 . . . . 64.42 109.191 -178.697 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 27.7 mm -114.34 146.26 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 O-C-N 121.224 -0.923 . . . . 72.23 109.685 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.78 139.54 58.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.936 -1.103 . . . . 25.24 108.139 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.685 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -58.49 -56.44 35.47 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.909 -1.12 . . . . 64.32 111.381 -179.034 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 98' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 5.0 Cg_endo -41.5 -8.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.022 1.148 . . . . 63.33 113.192 -176.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 99' ' ' TYR . . . . . 0.685 ' N ' ' O ' ' B' ' 97' ' ' LYS . 13.8 m-85 66.47 117.78 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.557 -0.714 . . . . 75.13 109.674 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 100' ' ' ARG . . . . . 0.476 ' CZ ' ' OE2' ' A' ' 83' ' ' GLU . 16.0 ttm180 -67.05 -29.55 69.37 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.968 -1.083 . . . . 74.23 108.754 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 101' ' ' SER . . . . . 0.752 ' O ' ' N ' ' B' ' 103' ' ' LYS . 40.6 t -174.78 28.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.192 -0.942 . . . . 63.34 110.671 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 8.6 mm 51.66 -69.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.645 -0.659 . . . . 74.44 110.064 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.752 ' N ' ' O ' ' B' ' 101' ' ' SER . 86.3 mttt -56.64 -32.91 65.82 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.82 -1.178 . . . . 71.11 107.82 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.86 98.73 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.033 -1.099 . . . . 71.45 108.033 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 55.4 tp -64.63 -40.68 95.9 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.635 -0.876 . . . . 51.31 108.635 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 73.5 t -67.0 -41.02 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.348 -0.845 . . . . 65.23 109.527 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.02 -48.26 70.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.149 -0.97 . . . . 24.32 109.39 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -64.75 -32.24 73.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 75.31 109.732 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 93.9 mt -74.44 -34.3 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.179 -0.951 . . . . 54.24 108.903 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 110' ' ' GLU . . . . . 0.465 ' O ' ' CG ' ' B' ' 114' ' ' ARG . 88.2 tt0 -66.09 -31.02 71.63 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.492 -0.755 . . . . 65.31 109.469 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 111' ' ' ALA . . . . . 0.479 ' HB1' ' CZ ' ' A' ' 87' ' ' PHE . . . -72.56 -56.6 5.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.201 -0.937 . . . . 72.24 109.944 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 112' ' ' ARG . . . . . 0.471 ' CD ' ' OD2' ' B' ' 93' ' ' ASP . 64.3 mtm-85 -69.43 -40.61 77.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.179 -0.951 . . . . 72.04 110.358 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 41.6 tp -63.52 -34.49 77.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.121 -0.987 . . . . 75.35 109.972 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.465 ' CG ' ' O ' ' B' ' 110' ' ' GLU . 11.0 mmm180 -74.26 167.37 21.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.152 -0.968 . . . . 75.5 109.353 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 52.26 51.15 16.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.885 . . . . 65.33 109.23 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -95.7 -66.24 0.92 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.308 -0.87 . . . . 74.45 109.898 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.05 144.04 48.61 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.19 -1.164 . . . . 44.21 110.19 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 118' ' ' SER . . . . . 0.927 ' N ' ' OE2' ' B' ' 132' ' ' GLU . 33.1 t -160.44 175.26 12.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.471 -1.017 . . . . 71.4 109.355 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.88 125.8 5.9 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.652 -0.819 . . . . 72.32 109.221 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 20.5 t -99.32 -37.25 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.386 -0.822 . . . . 75.02 109.929 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 19.3 mm -101.89 128.37 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.197 -0.939 . . . . 51.41 109.584 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' B' ' 122' ' ' GLU . 17.9 pt-20 -151.06 121.99 7.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.319 -0.863 . . . . 71.53 109.473 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.797 HD13 ' H ' ' B' ' 123' ' ' ILE . 0.1 OUTLIER -146.46 133.93 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.155 -0.965 . . . . 72.43 109.335 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 63.33 -115.69 8.34 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.241 -1.543 . . . . 51.23 109.241 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 125' ' ' ASP . . . . . 0.884 ' OD2' ' HD3' ' B' ' 138' ' ' LYS . 13.3 t70 -120.59 6.31 10.55 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.596 -0.944 . . . . 74.2 109.245 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.78 128.56 42.76 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.334 -0.854 . . . . 75.42 108.769 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 61.4 m -120.4 132.11 55.1 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.5 -0.926 . . . . 74.22 108.5 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 8.0 mt -133.02 132.38 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.378 -0.826 . . . . 60.33 110.041 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 8.6 m -109.75 110.67 59.28 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.303 -0.999 . . . . 72.31 108.303 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.94 -36.98 1.26 Allowed 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.742 1.628 . . . . 75.13 113.071 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 131' ' ' ASP . . . . . 0.415 ' O ' ' OE1' ' B' ' 133' ' ' GLU . 6.8 t70 -70.33 -37.34 74.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.089 -1.007 . . . . 75.23 109.905 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 132' ' ' GLU . . . . . 0.927 ' OE2' ' N ' ' B' ' 118' ' ' SER . 81.4 mt-10 -83.21 -0.09 47.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.157 -0.964 . . . . 72.43 109.446 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.415 ' OE1' ' O ' ' B' ' 131' ' ' ASP . 35.8 mp0 47.01 59.07 4.24 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 75.13 109.254 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 15.4 ttpp -156.72 130.35 8.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 73.22 109.247 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 2.9 tt -104.23 129.47 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.433 -0.792 . . . . 64.14 109.597 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.417 HG21 HD13 ' B' ' 136' ' ' ILE . 15.3 mt -110.11 122.5 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.566 -0.902 . . . . 71.22 108.566 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 137' ' ' TYR . . . . . 0.963 ' CE1' ' CB ' ' B' ' 140' ' ' ARG . 19.0 p90 -124.97 118.18 25.69 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.249 -0.907 . . . . 64.22 110.13 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 138' ' ' LYS . . . . . 0.884 ' HD3' ' OD2' ' B' ' 125' ' ' ASP . 25.8 mmtm 55.99 28.2 12.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.591 -0.693 . . . . 72.02 110.237 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 92.4 2.56 67.88 Favored Glycine 0 N--CA 1.496 2.643 0 O-C-N 121.172 -0.955 . . . . 74.32 110.944 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 140' ' ' ARG . . . . . 0.963 ' CB ' ' CE1' ' B' ' 137' ' ' TYR . 0.2 OUTLIER -95.66 121.84 37.78 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.759 -1.436 . . . . 75.34 108.79 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -94.94 118.29 31.56 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.267 -0.895 . . . . 71.23 109.58 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 6.6 t -122.52 132.82 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.751 -0.833 . . . . 70.43 108.751 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -92.86 123.12 35.9 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.273 -0.892 . . . . 72.43 109.869 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.32 138.93 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.886 -0.783 . . . . 72.13 108.886 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -161.7 83.24 0.6 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.355 -0.84 . . . . 72.02 109.84 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' GLY . . . . . 0.666 ' N ' ' HD2' ' B' ' 149' ' ' PHE . . . -164.47 177.8 39.97 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.071 -1.612 . . . . 42.23 109.071 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 1.323 ' NZ ' ' O ' ' B' ' 172' ' ' ILE . 0.9 OUTLIER -68.21 -37.01 9.95 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.203 -1.174 . . . . 73.3 110.438 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 148' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 14.6 Cg_exo -66.23 -19.99 56.12 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.206 1.937 . . . . 71.33 112.048 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 149' ' ' PHE . . . . . 0.666 ' HD2' ' N ' ' B' ' 146' ' ' GLY . 0.5 OUTLIER -103.77 -29.76 10.82 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.493 -0.755 . . . . 74.23 109.343 -179.376 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 150' ' ' GLU . . . . . 0.428 ' O ' ' CD2' ' B' ' 154' ' ' HIS . 35.4 mt-10 -51.67 -31.5 26.01 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.199 -1.037 . . . . 72.34 108.199 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 13.2 p -67.96 -33.15 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.562 -0.711 . . . . 73.35 109.11 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 44.7 tp -65.24 -39.99 93.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.875 . . . . 55.24 109.602 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 6.0 p -76.36 -35.77 58.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.893 -1.129 . . . . 70.01 109.203 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 154' ' ' HIS . . . . . 0.428 ' CD2' ' O ' ' B' ' 150' ' ' GLU . 27.9 m170 -56.87 -48.76 77.39 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.117 -0.99 . . . . 65.32 110.174 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 pp -72.87 -27.64 62.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.7 -1.25 . . . . 71.54 108.884 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.56 -34.54 67.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 75.32 109.563 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 17.3 mtt180 -92.52 -52.2 4.76 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.897 -1.127 . . . . 73.32 109.9 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -53.42 -52.09 60.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 74.14 108.786 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 159' ' ' ARG . . . . . 0.464 ' O ' ' N ' ' B' ' 161' ' ' GLN . 89.2 mtm180 47.15 -114.81 0.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 61.41 109.259 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 160' ' ' ASP . . . . . 0.772 ' OD2' ' CE1' ' B' ' 216' ' ' TYR . 9.8 m-20 -55.36 91.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.109 -0.995 . . . . 72.1 109.083 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 161' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' B' ' 159' ' ' ARG . 50.1 tp60 -164.71 145.43 7.73 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.207 -0.933 . . . . 72.25 109.775 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 89.7 mt -109.32 126.29 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.505 -0.747 . . . . 72.31 109.178 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 19.7 m -137.03 144.42 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.965 -0.754 . . . . 64.21 108.965 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 164' ' ' SER . . . . . 0.469 ' H ' ' CD ' ' B' ' 167' ' ' GLN . 23.1 t -86.94 178.34 6.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.077 -1.015 . . . . 74.22 110.185 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -61.46 -55.42 31.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.842 . . . . 65.31 109.408 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 166' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' B' ' 166' ' ' GLU . 31.7 mp0 -51.91 -31.91 30.53 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.858 . . . . 63.45 110.116 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 167' ' ' GLN . . . . . 0.469 ' CD ' ' H ' ' B' ' 164' ' ' SER . 41.4 mt-30 -64.94 -43.32 93.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.074 -1.016 . . . . 72.4 109.607 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 51.7 mt -58.12 -37.29 74.31 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.191 -1.04 . . . . 72.32 108.191 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.25 -65.91 0.57 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.501 -0.75 . . . . 73.34 109.063 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -58.35 -28.09 64.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.561 -0.712 . . . . 72.1 109.902 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.88 -65.25 0.63 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.28 -0.888 . . . . 62.13 110.091 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 1.323 ' O ' ' NZ ' ' B' ' 147' ' ' LYS . 2.1 mp -98.82 -53.45 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.129 -0.982 . . . . 71.42 109.937 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 26.0 m-90 -77.55 61.37 2.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.031 -1.043 . . . . 72.23 109.027 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -47.07 -53.75 11.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.529 -0.732 . . . . 52.11 109.749 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 175' ' ' GLU . . . . . 0.468 ' N ' ' CD ' ' B' ' 176' ' ' PRO . 2.2 tt0 -178.89 -48.87 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 120.862 -1.149 . . . . 73.04 109.903 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' B' ' 175' ' ' GLU . 39.3 Cg_exo -57.07 -23.39 52.28 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.123 1.882 . . . . 74.13 112.24 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 177' ' ' GLU . . . . . 1.074 ' HG2' ' CD ' ' B' ' 147' ' ' LYS . 31.7 mp0 -75.58 176.99 7.1 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.093 -1.004 . . . . 72.44 109.544 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 178' ' ' MET . . . . . 0.452 ' N ' ' SD ' ' B' ' 178' ' ' MET . 0.9 OUTLIER -90.96 125.96 35.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.408 -0.808 . . . . 63.43 108.863 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 2.3 t -116.58 138.87 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.636 -0.665 . . . . 71.05 109.694 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 180' ' ' THR . . . . . 0.538 ' O ' ' N ' ' B' ' 182' ' ' ASN . 7.2 p -111.83 152.5 44.23 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 108.836 -0.801 . . . . 62.15 108.836 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -36.75 -23.71 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 122.26 1.974 . . . . 65.22 112.722 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 182' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' B' ' 180' ' ' THR . 9.1 m120 -156.57 52.0 0.52 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.033 -1.042 . . . . 72.31 109.761 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 183' ' ' VAL . . . . . 0.406 ' HB ' ' H ' ' B' ' 180' ' ' THR . 9.3 p -65.24 -21.37 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.193 -0.942 . . . . 63.32 109.634 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 36.8 mt -67.53 -40.54 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.239 -0.913 . . . . 75.03 110.621 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 185' ' ' GLU . . . . . 0.487 ' O ' ' ND2' ' B' ' 189' ' ' ASN . 64.6 mm-40 -61.9 -50.51 71.89 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.098 -1.001 . . . . 64.11 110.323 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 18.2 m -75.08 -25.51 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.151 -0.968 . . . . 73.0 110.172 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -76.04 -46.62 28.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.119 -0.988 . . . . 61.12 110.18 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 11.2 tp -69.88 -29.34 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.865 -1.147 . . . . 72.43 109.286 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 189' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' B' ' 185' ' ' GLU . 92.5 m-20 -72.79 -48.51 37.49 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.43 -0.794 . . . . 65.14 109.9 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 190' ' ' GLN . . . . . 0.46 ' CG ' ' N ' ' B' ' 191' ' ' ILE . 14.9 pt20 -72.96 -45.17 59.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.095 -1.003 . . . . 63.24 110.193 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 191' ' ' ILE . . . . . 0.46 ' N ' ' CG ' ' B' ' 190' ' ' GLN . 77.1 mt -54.28 -55.4 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.04 -1.038 . . . . 74.03 109.376 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -54.39 -48.22 71.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.122 -0.986 . . . . 72.24 110.026 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 193' ' ' GLN . . . . . 0.411 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 81.7 mt-30 -62.07 -31.62 72.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.047 -1.033 . . . . 73.1 109.575 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -91.05 -2.97 57.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.25 -0.906 . . . . 72.11 110.339 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 24.1 ttp -99.94 -5.08 28.84 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.13 -0.981 . . . . 44.33 109.876 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 196' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' B' ' 193' ' ' GLN . 5.9 p-10 -105.92 -15.24 14.97 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.364 -0.835 . . . . 71.21 109.329 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 197' ' ' LYS . . . . . 0.585 ' N ' ' CD ' ' B' ' 198' ' ' PRO . 10.3 tttm -80.13 -41.7 1.37 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.243 -0.911 . . . . 75.21 110.059 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 198' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' B' ' 197' ' ' LYS . 73.6 Cg_endo -87.39 -44.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.486 2.124 . . . . 75.32 111.988 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 17.9 mt -78.38 -35.03 47.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.047 -1.033 . . . . 72.25 109.302 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 83.13 -37.98 2.72 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.731 -1.348 . . . . 64.53 109.731 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 22.4 mm -102.07 139.19 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.263 -1.14 . . . . 44.23 109.639 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 19.9 m -86.49 137.93 32.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.283 -0.886 . . . . 54.01 108.949 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 6.7 p -134.98 29.22 3.45 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.39 -0.819 . . . . 74.4 109.307 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 16.7 m -132.28 145.95 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.549 -0.719 . . . . 72.12 109.187 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -126.25 138.11 53.58 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.487 -0.758 . . . . 65.41 109.721 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 206' ' ' THR . . . . . 0.539 HG23 HH12 ' B' ' 208' ' ' ARG . 0.1 OUTLIER -96.94 132.82 42.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.326 -0.859 . . . . 71.33 109.47 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 8.3 t -130.38 117.1 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.707 -0.849 . . . . 63.5 108.707 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 208' ' ' ARG . . . . . 0.723 ' H ' ' NE ' ' B' ' 208' ' ' ARG . 0.1 OUTLIER -68.92 -36.3 77.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.222 -0.924 . . . . 74.45 109.747 -179.486 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 62.1 mtm180 -50.77 -65.09 0.62 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.122 -0.986 . . . . 74.14 110.118 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -100.58 -77.85 0.53 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.249 -0.907 . . . . 74.43 109.932 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -164.89 -105.27 0.19 Allowed Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.619 -1.277 . . . . 64.45 110.162 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 212' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' B' ' 212' ' ' TYR . 42.2 m-85 -133.93 148.75 51.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.505 -0.997 . . . . 74.21 109.978 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -141.12 153.7 45.54 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.252 -1.018 . . . . 74.03 108.252 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 214' ' ' PHE . . . . . 0.427 ' C ' ' SG ' ' B' ' 215' ' ' CYS . 0.7 OUTLIER -117.77 148.65 41.86 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.393 -0.817 . . . . 74.34 110.557 -178.249 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 215' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' B' ' 214' ' ' PHE . 8.8 m -151.37 164.18 37.28 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.676 -0.861 . . . . 64.33 108.676 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 216' ' ' TYR . . . . . 0.844 ' OH ' ' OE1' ' A' ' 161' ' ' GLN . 0.2 OUTLIER -72.86 154.08 91.08 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 120.96 -1.088 . . . . 70.04 108.865 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.51 175.92 1.92 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.246 1.964 . . . . 65.11 111.626 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' B' ' 219' ' ' PRO . 13.8 mtmm -52.65 157.13 2.75 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 108.689 -0.856 . . . . 73.15 108.689 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 219' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' B' ' 218' ' ' LYS . 21.4 Cg_exo -30.39 100.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 122.861 2.374 . . . . 71.31 112.807 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -116.19 135.12 54.19 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.655 -0.653 . . . . 75.45 109.314 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 221' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' B' ' 222' ' ' GLU . 14.2 t -165.55 -177.85 4.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.152 -0.968 . . . . 72.22 109.378 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.423 ' N ' ' SG ' ' B' ' 221' ' ' CYS . 51.3 mt-10 -57.47 169.55 0.64 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.152 -0.967 . . . . 54.53 109.324 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 117.966 -1.016 . . . . 71.13 109.169 179.581 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.57 ' SD ' ' CE2' ' A' ' 25' ' ' PHE . 43.4 ttp . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.457 -0.571 . . . . 65.12 109.457 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -140.53 152.25 45.41 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.397 -0.814 . . . . 72.33 109.224 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.682 HG13 ' HB3' ' A' ' 47' ' ' LEU . 39.4 t -119.6 129.47 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.529 0.681 . . . . 71.42 109.574 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.572 HD11 ' CG1' ' A' ' 6' ' ' ILE . 1.4 tp -96.14 122.65 39.21 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.53 -0.731 . . . . 65.12 109.521 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.448 ' N ' HD12 ' A' ' 4' ' ' LEU . 4.2 mp -117.2 129.84 56.2 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.129 -1.063 . . . . 62.43 108.129 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.572 ' CG1' HD11 ' A' ' 4' ' ' LEU . 38.4 mt -126.03 97.18 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.062 -1.088 . . . . 71.15 108.062 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -144.11 130.97 20.32 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.243 -0.91 . . . . 75.34 109.753 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -63.12 -35.2 79.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 72.44 109.33 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -76.54 96.58 4.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 63.02 109.29 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.8 m -61.47 -29.6 70.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.88 . . . . 72.34 109.909 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.516 HG13 ' N ' ' A' ' 12' ' ' LEU . 9.5 p -67.58 -44.59 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.085 -1.009 . . . . 74.02 109.981 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.516 ' N ' HG13 ' A' ' 11' ' ' VAL . 80.9 mt -69.82 -47.72 61.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.046 -1.034 . . . . 71.43 109.242 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.6 -20.88 70.4 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 107.922 -2.071 . . . . 61.32 107.922 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.38 -58.06 6.9 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.667 -1.373 . . . . 71.2 109.667 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.402 ' H ' ' HG2' ' A' ' 15' ' ' GLU . 12.2 pt-20 -52.82 -44.31 66.6 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.342 -1.093 . . . . 71.32 109.588 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.1 mt -66.85 -38.31 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.736 -1.227 . . . . 63.23 108.329 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.507 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 88.0 tt0 -60.23 -45.94 91.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 51.11 109.213 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -86.05 -1.23 57.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -0.928 . . . . 73.34 109.715 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.62 -54.98 3.11 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 109.813 -1.315 . . . . 62.15 109.813 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -75.12 -21.32 58.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.231 -1.158 . . . . 73.51 110.0 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 96.4 m-20 -57.61 -31.65 66.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.121 -0.987 . . . . 74.25 109.636 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 85.1 t -61.13 -25.79 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.318 -0.864 . . . . 70.04 109.467 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' NZ ' ' OE1' ' A' ' 110' ' ' GLU . 17.0 mmtp -83.04 6.17 19.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.87 . . . . 73.23 109.337 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.51 37.18 21.26 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.153 -1.179 . . . . 75.54 110.153 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.57 ' CE2' ' SD ' ' A' ' 1' ' ' MET . 11.5 m-85 -116.09 159.05 22.26 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.467 -1.02 . . . . 73.43 109.017 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.4 mmt -112.75 135.21 53.75 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.833 -0.803 . . . . 43.24 108.833 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.51 161.81 38.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.194 -0.941 . . . . 62.11 109.718 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -142.76 141.16 31.67 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.357 -0.84 . . . . 74.42 109.26 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 t -104.02 130.31 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.304 -0.872 . . . . 72.15 108.877 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.2 p -118.9 170.35 9.09 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.536 -0.728 . . . . 71.42 109.361 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -88.29 -100.76 0.08 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.183 -0.948 . . . . 72.33 109.858 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.0 p -78.23 166.61 22.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 74.24 110.167 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' A' ' 37' ' ' GLU . 13.9 mt -55.61 -39.08 70.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.645 -0.659 . . . . 71.53 110.041 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -50.39 -43.81 54.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.092 -1.005 . . . . 74.23 109.652 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -65.66 -36.74 84.53 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.201 -0.937 . . . . 54.03 109.158 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.94 -34.9 29.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.558 -1.417 . . . . 61.41 109.558 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 33' ' ' LEU . 81.4 tt0 -63.37 -40.73 98.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -1.141 . . . . 74.34 109.569 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -77.9 -37.63 47.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.088 -1.008 . . . . 75.33 109.333 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.6 tp -66.91 -41.82 86.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 74.33 109.599 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.448 ' C ' ' SD ' ' A' ' 40' ' ' MET . 3.3 ppp? -77.87 -15.77 58.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.144 -0.972 . . . . 70.32 109.648 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -55.33 -39.8 70.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.052 -1.03 . . . . 71.22 109.158 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.8 pt -95.26 -32.39 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.274 -0.892 . . . . 74.14 109.885 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 40' ' ' MET . 96.6 mtt180 -91.77 153.04 19.87 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.078 -1.013 . . . . 72.24 109.676 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 45' ' ' TYR . 14.5 p30 -91.86 -34.38 14.56 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.162 -0.961 . . . . 75.42 109.765 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 44' ' ' ASN . 38.3 m-85 51.97 99.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.292 -0.88 . . . . 74.23 109.484 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -68.77 -28.97 67.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.23 -0.918 . . . . 72.04 109.42 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.682 ' HB3' HG13 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -115.5 110.58 19.48 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.747 -0.834 . . . . 72.13 108.747 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.465 ' N ' HD13 ' A' ' 47' ' ' LEU . 65.9 t -96.9 110.34 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.324 -0.86 . . . . 72.34 108.685 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.587 ' SD ' ' N ' ' A' ' 50' ' ' VAL . 1.5 tpt -122.4 130.35 53.01 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.539 -0.725 . . . . 74.11 109.549 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.587 ' N ' ' SD ' ' A' ' 49' ' ' MET . 1.1 p -138.84 130.43 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.695 0.76 . . . . 61.12 109.818 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.2 t -98.16 2.41 48.46 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.596 -0.69 . . . . 73.11 109.534 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -75.93 136.58 40.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.171 -0.956 . . . . 52.55 109.405 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.489 ' C ' ' H ' ' A' ' 55' ' ' ALA . 62.4 mttp -72.96 -42.24 63.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.306 -0.871 . . . . 44.22 110.617 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -69.19 11.23 0.23 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.039 -1.038 . . . . 70.44 109.747 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.489 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.35 -21.64 58.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 64.14 110.44 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 55' ' ' ALA . 74.5 mt -37.79 -53.21 1.29 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.7 -0.625 . . . . 44.14 110.818 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.6 t -65.65 -36.66 84.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.972 -1.08 . . . . 55.23 109.329 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.466 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 45.3 t80 -64.58 -63.03 1.23 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.327 -0.858 . . . . 74.44 109.83 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.1 m -48.36 -32.85 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.81 -1.181 . . . . 74.03 109.713 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.2 m -59.4 -52.79 64.12 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.201 -0.937 . . . . 64.3 109.348 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -68.78 -27.75 66.16 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 118.934 -1.107 . . . . 64.44 109.881 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.523 ' O ' ' N ' ' A' ' 66' ' ' HIS . 29.6 mm -59.21 -49.83 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 120.829 -1.17 . . . . 63.21 108.847 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.519 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 45.3 mmtt -59.79 -46.55 88.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.086 -1.009 . . . . 74.42 108.649 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -64.08 -42.86 96.81 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.942 -0.762 . . . . 70.32 108.942 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.472 ' C ' ' CG ' ' A' ' 66' ' ' HIS . 51.6 mtpt -76.95 -26.27 53.81 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.526 -0.734 . . . . 75.22 110.554 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 62' ' ' ILE . 56.9 m-70 -154.97 65.72 0.65 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.973 -1.079 . . . . 74.13 109.746 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 63' ' ' LYS . 33.8 t -59.28 -25.83 64.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.352 -0.842 . . . . 73.24 110.155 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.0 t -69.66 -14.77 62.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.17 -0.956 . . . . 61.01 110.493 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.473 HD12 ' CB ' ' A' ' 66' ' ' HIS . 79.0 mt -94.06 155.91 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.972 -1.08 . . . . 71.33 109.907 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 71' ' ' VAL . 90.2 t -85.02 162.76 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.364 -0.835 . . . . 72.13 109.696 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.535 ' N ' HG12 ' A' ' 70' ' ' VAL . 14.7 t -145.24 117.14 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.09 -1.006 . . . . 54.21 109.741 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.506 ' O ' ' SD ' ' A' ' 49' ' ' MET . 1.0 OUTLIER -115.46 99.92 7.71 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.219 -1.03 . . . . 50.24 108.219 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.6 p -96.48 152.6 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.127 -0.983 . . . . 74.41 108.774 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.5 m -132.42 172.33 12.6 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.215 -0.928 . . . . 72.31 109.364 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 77' ' ' ASN . 3.4 t -173.84 128.96 0.4 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.322 -0.861 . . . . 64.54 110.044 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -66.59 43.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.558 -0.714 . . . . 74.13 109.639 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 75' ' ' SER . 15.9 m120 -160.15 60.89 1.51 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 73.34 109.828 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -57.18 74.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.979 1.786 . . . . 63.22 111.469 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 77' ' ' ASN . 16.9 m -107.49 151.6 25.35 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.003 -0.74 . . . . 62.53 109.003 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -25.33 68.19 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.357 -0.839 . . . . 73.44 109.497 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -63.83 -52.39 60.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 71.42 109.489 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.29 -32.43 70.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 73.43 109.707 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -60.31 -52.62 64.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 74.22 109.603 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.64 -40.27 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.936 . . . . 73.2 109.312 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -68.65 -29.19 67.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -0.856 . . . . 53.33 109.826 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -67.28 -43.19 82.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.193 -0.942 . . . . 64.11 110.039 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -80.23 -26.39 39.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.062 -1.024 . . . . 74.34 108.946 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -75.98 -51.47 12.32 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.43 -0.794 . . . . 74.42 109.391 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.48 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 1.6 pp0? -61.57 -43.23 99.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.526 -0.734 . . . . 74.24 109.736 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.48 ' N ' ' CD ' ' A' ' 89' ' ' GLN . . . 138.45 72.82 0.05 OUTLIER Glycine 0 N--CA 1.498 2.776 0 N-CA-C 109.982 -1.247 . . . . 61.51 109.982 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.407 ' HB2' HE21 ' A' ' 89' ' ' GLN . . . -133.17 133.21 42.52 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.358 -1.083 . . . . 55.33 108.878 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 71' ' ' VAL . 2.8 m-20 -71.48 -39.66 70.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.039 -1.038 . . . . 73.42 108.999 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 61.8 m-20 -154.24 147.17 24.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.365 -0.834 . . . . 75.04 109.358 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -121.54 112.61 18.7 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.553 -0.906 . . . . 71.33 108.553 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 23.3 mm -106.56 152.4 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 CA-C-O 122.16 0.981 . . . . 71.13 111.333 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.59 123.33 21.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.849 -1.167 . . . . 64.32 107.849 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.667 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -45.99 -54.23 17.86 Favored Pre-proline 0 C--N 1.301 -1.531 0 O-C-N 121.038 -1.039 . . . . 62.2 111.525 -178.805 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.3 Cg_endo -41.46 -11.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 120.754 0.969 . . . . 73.11 112.886 -176.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.667 ' N ' ' O ' ' A' ' 97' ' ' LYS . 59.5 m-85 59.52 121.92 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.737 -0.602 . . . . 65.22 109.607 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -68.8 -32.26 71.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.059 -1.026 . . . . 72.35 109.52 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.765 ' O ' ' N ' ' A' ' 103' ' ' LYS . 41.3 t -174.21 28.41 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.989 -1.069 . . . . 71.32 110.885 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.695 HD12 ' N ' ' A' ' 102' ' ' ILE . 2.6 mp 50.4 -69.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-N 118.638 0.654 . . . . 75.43 110.194 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.765 ' N ' ' O ' ' A' ' 101' ' ' SER . 1.0 OUTLIER -55.33 -31.18 61.49 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.899 -1.148 . . . . 71.41 107.899 179.257 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.81 80.05 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.574 -0.85 . . . . 63.24 108.752 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.682 HD13 ' C ' ' A' ' 105' ' ' LEU . 1.7 tm? -69.74 -54.62 12.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.44 -0.787 . . . . 73.22 108.923 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.546 ' N ' HD13 ' A' ' 105' ' ' LEU . 53.8 t -52.77 -45.75 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.016 -1.052 . . . . 60.11 109.326 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.47 -42.25 67.03 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.13 -0.982 . . . . 70.42 108.385 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -62.58 -32.9 73.97 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.481 -0.762 . . . . 74.41 109.137 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 83.2 mt -74.35 -31.91 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.117 -0.99 . . . . 62.54 108.604 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.521 ' OE1' ' NZ ' ' A' ' 23' ' ' LYS . 75.0 tt0 -58.44 -52.11 67.02 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.492 -0.755 . . . . 74.34 109.314 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.29 -32.3 66.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.917 . . . . 73.32 109.658 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.5 ' NH2' HG22 ' A' ' 70' ' ' VAL . 24.0 tpt85 -54.52 -34.21 61.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 52.41 109.433 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.2 tp -151.74 108.87 3.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.181 -0.949 . . . . 65.24 109.504 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.4 ' HE ' ' HG3' ' A' ' 110' ' ' GLU . 4.4 mmt180 -144.46 -51.76 0.3 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.252 -0.905 . . . . 64.45 108.67 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -82.53 25.57 0.62 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.185 -0.947 . . . . 74.43 109.401 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.439 ' CG ' ' N ' ' A' ' 117' ' ' GLY . 60.4 p-90 -51.04 -40.0 57.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 74.42 109.721 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.439 ' N ' ' CG ' ' A' ' 116' ' ' TRP . . . -57.74 93.42 0.04 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.767 -1.333 . . . . 75.04 109.767 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.0 m -153.03 164.71 37.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.211 -1.17 . . . . 61.14 109.707 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -159.87 128.98 5.12 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.907 -0.775 . . . . 65.24 108.907 -178.332 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.7 t -83.86 -45.31 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.158 -0.964 . . . . 73.11 110.066 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.533 ' CG2' HH21 ' A' ' 159' ' ' ARG . 20.3 mm -102.64 130.94 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.314 -0.867 . . . . 72.24 109.812 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -121.39 128.58 52.36 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.986 -0.746 . . . . 72.34 108.986 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 126' ' ' LEU . 23.6 mt -141.03 112.65 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.181 -0.95 . . . . 71.44 109.45 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.63 -138.63 7.94 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.857 -1.297 . . . . 73.4 109.857 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -80.09 -11.47 59.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -1.165 . . . . 74.45 109.487 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 123' ' ' ILE . 0.8 OUTLIER -91.23 135.53 33.73 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.494 -0.928 . . . . 54.21 108.494 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.8 m -130.2 129.77 43.82 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.447 -0.783 . . . . 54.5 109.593 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 28.8 mm -112.87 139.71 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.902 -0.777 . . . . 45.15 108.902 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 133' ' ' GLU . 5.2 m -128.05 80.03 72.86 Favored Pre-proline 0 N--CA 1.5 2.039 0 O-C-N 121.456 -0.777 . . . . 71.11 109.697 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.46 -51.89 9.47 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.704 2.27 . . . . 65.41 112.082 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -53.68 -44.03 69.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 63.32 109.092 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -87.36 -1.98 58.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.346 -0.846 . . . . 72.52 109.163 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 129' ' ' SER . 34.6 mp0 50.05 72.51 0.32 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.91 . . . . 75.33 109.129 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -158.14 122.89 4.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.343 -0.848 . . . . 71.23 109.814 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 84.3 mt -101.56 126.76 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.422 -0.799 . . . . 74.02 108.922 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.0 mt -117.07 125.36 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.57 -0.706 . . . . 60.23 109.113 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.492 ' C ' ' H ' ' A' ' 139' ' ' GLY . 47.8 p90 -140.72 151.45 44.51 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.327 -0.858 . . . . 62.32 109.207 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.3 tptp 56.01 5.5 0.17 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.78 0.8 . . . . 75.4 109.15 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 137' ' ' TYR . . . 95.93 -2.98 64.47 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.846 -1.302 . . . . 72.24 109.846 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.529 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 1.2 mpt_? -89.71 131.64 35.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.235 -1.156 . . . . 71.22 109.14 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -93.04 127.98 38.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.241 -0.912 . . . . 71.42 109.571 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 43.2 t -137.07 136.44 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.424 -0.798 . . . . 53.02 109.493 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -91.51 143.54 26.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.268 -0.895 . . . . 60.45 109.042 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 25.9 m -139.75 153.89 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.288 -0.883 . . . . 74.44 109.699 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -167.21 24.64 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.333 -0.854 . . . . 65.15 109.163 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.52 -169.79 45.16 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.824 -1.31 . . . . 73.34 109.824 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.625 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 14.2 tmtt? -82.11 -31.14 0.54 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.343 -1.093 . . . . 72.22 111.424 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 87.0 Cg_endo -86.64 -3.58 8.32 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 C-N-CA 121.781 1.654 . . . . 65.23 112.408 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -96.85 -29.87 13.47 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.183 -0.948 . . . . 60.11 109.18 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -59.2 -40.84 87.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.271 -0.893 . . . . 64.21 109.259 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.461 HG11 HD13 ' A' ' 191' ' ' ILE . 13.9 p -61.79 -34.09 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.226 -0.921 . . . . 72.02 108.894 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.2 OUTLIER -59.94 -45.44 92.62 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.514 -0.921 . . . . 73.31 108.514 179.627 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.0 p -74.39 -24.58 59.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.197 -0.94 . . . . 74.31 109.294 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -59.36 -51.13 71.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.905 . . . . 74.31 109.685 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.7 pp -76.36 -27.22 56.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.104 -0.998 . . . . 75.34 109.618 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -54.12 -46.26 72.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.094 -1.004 . . . . 62.14 109.375 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.475 ' C ' ' H ' ' A' ' 159' ' ' ARG . 66.4 mtp180 -77.01 -49.49 15.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.928 . . . . 61.03 109.382 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -72.2 34.2 0.06 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.636 -0.665 . . . . 74.12 110.042 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.533 HH21 ' CG2' ' A' ' 121' ' ' ILE . 19.1 ttm180 -59.51 150.44 26.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.131 -0.981 . . . . 71.13 109.133 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 214' ' ' PHE . 62.2 m-20 53.05 46.93 25.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 75.45 109.544 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -149.71 150.95 32.88 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.23 -0.919 . . . . 73.41 109.312 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 58.3 mt -90.15 132.74 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.223 -0.923 . . . . 74.41 109.296 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 48.5 t -131.52 134.73 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.486 -0.759 . . . . 72.31 109.29 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.423 ' OG ' ' OE1' ' A' ' 166' ' ' GLU . 3.0 t -86.25 157.25 19.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.318 -0.863 . . . . 74.12 109.894 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -59.52 -44.08 93.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.437 -0.789 . . . . 70.43 109.627 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' A' ' 166' ' ' GLU . 34.0 mp0 -59.56 -38.01 79.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 73.52 109.526 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -59.28 -40.66 86.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.138 -0.976 . . . . 74.52 109.096 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 62.5 mt -58.02 -54.09 50.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.186 -0.947 . . . . 72.31 108.925 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 169' ' ' LEU . 10.3 mp -61.5 -55.95 25.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 53.33 109.194 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 169' ' ' LEU . 17.3 t70 -35.86 -42.8 0.28 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.04 0.447 . . . . 62.44 111.256 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.63 -30.26 13.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.078 -1.014 . . . . 60.21 110.53 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.9 mm -84.9 -72.72 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 120.986 -1.071 . . . . 75.32 109.663 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.503 ' O ' ' CE3' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -53.25 145.3 14.15 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.395 -0.965 . . . . 73.14 108.395 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -172.25 -103.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.399 -0.813 . . . . 73.24 109.129 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.438 ' CB ' ' CD ' ' A' ' 176' ' ' PRO . 8.8 mm-40 -53.5 -64.53 1.67 Allowed Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 120.926 -1.109 . . . . 44.43 109.107 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 175' ' ' GLU . 38.5 Cg_endo -64.66 77.73 0.19 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.049 1.833 . . . . 72.51 111.541 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.4 ' C ' ' N ' ' A' ' 179' ' ' VAL . 96.1 mt-10 -75.6 -128.02 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.176 -0.952 . . . . 63.24 109.686 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.435 ' C ' ' H ' ' A' ' 180' ' ' THR . 63.2 mtt 50.05 19.49 0.48 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.026 -1.046 . . . . 73.5 109.069 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 180' ' ' THR . 18.5 m -76.38 21.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.448 -0.783 . . . . 65.22 109.752 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.511 ' OG1' HG13 ' A' ' 183' ' ' VAL . 4.3 p 58.82 151.32 0.08 OUTLIER Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.574 -0.704 . . . . 71.42 109.785 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -41.17 -52.13 3.61 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.09 1.86 . . . . 41.22 112.663 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.481 ' OD1' ' CD1' ' A' ' 184' ' ' ILE . 5.9 t30 -158.14 118.09 3.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.118 -0.989 . . . . 64.54 110.04 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.511 HG13 ' OG1' ' A' ' 180' ' ' THR . 2.8 m -142.17 9.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.277 -0.89 . . . . 74.02 109.144 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.745 ' H ' HD12 ' A' ' 184' ' ' ILE . 2.1 mp -49.8 -42.22 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 72.33 109.452 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.629 ' CD ' ' H ' ' A' ' 185' ' ' GLU . 2.1 pm0 -47.05 -34.67 6.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.153 -0.967 . . . . 74.4 109.263 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 92.3 t -78.35 -51.63 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.263 -0.898 . . . . 70.42 109.395 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.97 71.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 52.11 110.069 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.529 HG23 ' N ' ' A' ' 189' ' ' ASN . 10.8 tp -58.51 -44.88 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.971 -1.08 . . . . 71.4 109.73 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.529 ' N ' HG23 ' A' ' 188' ' ' ILE . 45.7 t-20 -56.71 -45.09 82.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.932 -1.105 . . . . 73.44 109.381 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -68.88 -40.91 78.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.86 . . . . 71.42 109.64 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.461 HD13 HG11 ' A' ' 151' ' ' VAL . 68.1 mt -64.94 -34.66 71.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.175 -0.953 . . . . 61.55 109.73 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -64.01 -56.76 12.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.219 -0.925 . . . . 63.34 109.683 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -65.46 -35.69 81.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.917 . . . . 61.24 109.949 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -70.93 -17.66 62.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.071 -1.018 . . . . 75.13 109.667 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' MET . . . . . 0.444 ' SD ' ' C ' ' A' ' 195' ' ' MET . 0.2 OUTLIER -89.95 -53.52 4.45 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.253 -0.904 . . . . 74.02 109.722 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 200' ' ' GLY . 60.0 m-20 -61.18 -38.39 86.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 74.02 110.408 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.451 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 19.4 mmtt -51.76 -65.62 0.94 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 120.951 -1.093 . . . . 75.43 109.831 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 37.7 Cg_endo -64.02 -55.57 0.61 Allowed 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.242 1.961 . . . . 72.32 112.399 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 199' ' ' LEU . 10.2 mp -64.26 -38.67 91.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.091 -1.005 . . . . 74.54 109.531 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 196' ' ' ASP . . . 83.22 -40.21 2.82 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.605 -1.398 . . . . 61.51 109.605 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.71 HD12 ' N ' ' A' ' 201' ' ' ILE . 2.2 mp -92.6 139.48 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.248 -1.148 . . . . 61.22 109.319 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 34.1 t -88.06 140.37 29.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.187 -0.946 . . . . 72.0 109.235 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 11.9 p -144.25 33.41 1.21 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.177 -0.952 . . . . 74.44 109.516 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.62 143.92 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.238 -0.914 . . . . 64.35 109.649 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -122.08 137.84 54.67 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.632 -0.668 . . . . 71.41 109.284 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.1 t -114.51 141.74 47.31 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.471 -0.768 . . . . 73.52 109.357 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.457 HG22 ' H ' ' A' ' 209' ' ' ARG . 9.0 p -144.42 137.12 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.253 -0.904 . . . . 71.02 109.473 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -71.4 -34.34 70.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 72.12 109.808 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.457 ' H ' HG22 ' A' ' 207' ' ' VAL . 22.4 ttm105 -51.45 -36.77 45.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 64.41 109.699 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -140.98 -155.7 0.61 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.329 -0.857 . . . . 71.54 109.195 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -79.1 -125.13 0.44 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.739 -1.344 . . . . 72.03 109.739 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 212' ' ' TYR . 30.1 m-85 -116.78 135.0 54.1 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.577 -0.954 . . . . 75.54 109.728 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 67.4 ttt-85 -104.92 127.97 52.97 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.581 -0.7 . . . . 75.31 109.157 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 160' ' ' ASP . 18.8 m-85 -100.95 130.63 46.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.258 -0.901 . . . . 75.41 109.334 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' CYS . . . . . 0.401 ' SG ' ' OD1' ' A' ' 160' ' ' ASP . 52.0 t -154.39 155.97 35.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.36 -0.837 . . . . 74.14 109.281 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -68.07 149.93 97.96 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.164 -0.96 . . . . 75.32 108.957 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.01 -98.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.189 1.926 . . . . 73.11 111.877 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 220' ' ' ALA . 0.1 OUTLIER -68.09 153.71 94.98 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.172 -0.955 . . . . 75.25 108.846 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -37.85 -22.27 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 122.271 1.981 . . . . 75.1 112.382 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 218' ' ' LYS . . . 50.07 21.49 0.75 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 71.14 109.498 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 223' ' ' GLU . 76.7 m -151.97 -11.65 0.19 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.308 -0.87 . . . . 71.13 109.257 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 47.75 -92.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 75.35 109.629 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 221' ' ' CYS . 78.2 mm-40 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 118.015 -0.993 . . . . 73.41 109.464 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.553 ' N ' ' CD2' ' B' ' 25' ' ' PHE . 12.7 mtt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.334 -0.617 . . . . 71.14 109.334 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -97.8 121.26 39.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.324 -0.86 . . . . 73.23 109.288 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 79.9 t -115.59 136.24 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.472 0.653 . . . . 72.24 109.618 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.431 HD12 ' N ' ' B' ' 5' ' ' LEU . 5.5 tp -105.33 120.12 40.78 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.589 -0.695 . . . . 54.33 109.729 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.431 ' N ' HD12 ' B' ' 4' ' ' LEU . 18.0 mt -118.08 96.83 5.51 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.706 -0.85 . . . . 74.35 108.706 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.675 HD12 ' HB ' ' B' ' 50' ' ' VAL . 69.5 mt -84.96 97.54 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.808 -1.183 . . . . 42.55 108.377 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.431 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 35.2 tp10 -135.62 133.03 37.82 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.484 -0.76 . . . . 74.52 109.535 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -66.67 -32.51 73.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.308 -0.87 . . . . 62.55 109.32 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' ASN . . . . . 0.41 ' H ' ' HG3' ' B' ' 7' ' ' GLU . 89.7 m-20 -79.93 129.93 34.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 73.11 109.388 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 25.9 t -83.31 -32.32 26.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 65.54 109.849 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.54 HG13 ' N ' ' B' ' 12' ' ' LEU . 11.1 p -63.25 -44.3 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.141 -0.974 . . . . 75.55 109.865 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.54 ' N ' HG13 ' B' ' 11' ' ' VAL . 74.7 mt -66.58 -33.02 74.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.993 -1.067 . . . . 70.14 109.353 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.73 -23.32 64.72 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.804 -1.718 . . . . 75.4 108.804 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.7 -49.7 7.71 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.702 -1.359 . . . . 65.44 109.702 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -62.58 -43.5 98.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.113 -1.227 . . . . 60.21 109.161 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 97.3 mt -61.27 -35.67 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.075 -1.016 . . . . 75.15 108.445 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -60.83 -44.76 96.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.439 -0.788 . . . . 73.01 109.333 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -85.15 -0.14 53.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.19 -0.944 . . . . 74.3 109.097 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.6 -55.54 2.42 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.652 -1.379 . . . . 70.54 109.652 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -75.05 -19.99 59.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.152 -1.205 . . . . 71.34 109.811 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 21.1 m-20 -53.05 -32.94 49.63 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.103 -0.998 . . . . 64.41 109.328 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 79.2 t -58.02 -27.71 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 74.23 108.836 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -83.9 -4.51 58.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.445 -0.784 . . . . 63.42 109.152 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.13 33.55 32.34 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.05 -1.22 . . . . 53.43 110.05 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.553 ' CD2' ' N ' ' B' ' 1' ' ' MET . 9.0 m-85 -110.83 159.14 17.94 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.411 -1.052 . . . . 71.12 108.9 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 6.9 mmt -105.49 141.88 36.2 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.563 -0.903 . . . . 75.24 108.563 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.424 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -138.0 156.53 47.73 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.193 -0.942 . . . . 72.12 110.277 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 77.9 m-20 -138.77 159.46 42.07 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.647 -0.871 . . . . 72.31 108.647 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 p -123.04 139.98 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.327 -0.858 . . . . 64.43 109.938 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.4 p -138.16 170.78 15.44 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.532 -0.73 . . . . 65.41 109.284 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -90.62 -106.05 0.09 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.315 -0.865 . . . . 71.02 110.01 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 59.9 p -80.47 168.13 19.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.151 -0.968 . . . . 51.11 110.068 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' B' ' 37' ' ' GLU . 15.1 mt -51.85 -31.33 27.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.455 -0.778 . . . . 71.24 109.852 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -52.82 -51.49 60.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.032 -1.043 . . . . 74.32 109.647 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -62.72 -40.61 97.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.134 -0.979 . . . . 73.03 108.957 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.7 -33.27 75.59 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.964 -1.654 . . . . 30.21 108.964 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' B' ' 33' ' ' LEU . 84.3 tt0 -66.86 -44.07 81.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.363 -1.081 . . . . 74.42 109.319 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -75.83 -35.63 59.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 74.42 109.447 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 12.1 tp -72.0 -39.51 69.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.842 . . . . 75.41 110.119 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' MET . . . . . 0.449 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.7 ppp? -77.63 -18.19 57.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.999 -1.063 . . . . 60.41 109.888 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -69.5 -42.46 74.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.109 -0.995 . . . . 53.23 109.538 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 2.4 pp -87.48 -16.42 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.867 . . . . 71.23 109.737 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' B' ' 40' ' ' MET . 13.6 tpp85 -130.64 138.56 50.14 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.44 -0.787 . . . . 72.22 109.42 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -98.59 129.13 45.11 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.316 -0.865 . . . . 63.54 109.103 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -108.38 136.87 47.3 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.425 -0.797 . . . . 64.35 109.568 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' ASP . . . . . 0.449 ' OD2' ' SD ' ' B' ' 1' ' ' MET . 92.5 m-20 -76.75 -41.83 43.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 62.22 108.709 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.519 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.3 OUTLIER -103.73 115.72 31.0 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.394 -0.965 . . . . 73.12 108.394 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.519 ' N ' HD13 ' B' ' 47' ' ' LEU . 62.1 t -100.61 97.61 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.564 -0.902 . . . . 65.11 108.564 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -116.51 130.72 56.91 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.41 -0.806 . . . . 73.44 110.217 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.681 HG22 ' H ' ' B' ' 52' ' ' ASP . 0.3 OUTLIER -144.33 134.49 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.169 -0.678 . . . . 34.5 109.169 -179.605 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 51' ' ' SER . . . . . 0.431 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 19.1 p -95.43 16.4 17.02 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.385 -0.822 . . . . 73.21 109.792 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.681 ' H ' HG22 ' B' ' 50' ' ' VAL . 53.4 m-20 -80.56 144.58 32.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.956 . . . . 70.41 109.578 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -76.45 -36.01 58.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 65.0 109.986 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -74.43 10.88 1.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 75.21 109.685 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.17 -25.27 66.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 55.33 110.08 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 62.1 mt -47.34 -40.35 17.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.078 -1.014 . . . . 63.14 110.028 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 14.5 t -75.45 -41.71 55.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.944 -1.098 . . . . 63.5 109.829 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' PHE . . . . . 0.421 ' CE2' HD11 ' B' ' 62' ' ' ILE . 63.0 t80 -64.12 -47.91 78.15 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.329 -0.857 . . . . 72.33 110.232 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.43 HG23 ' N ' ' B' ' 60' ' ' SER . 19.5 m -63.95 -36.81 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.64 -1.287 . . . . 74.54 109.694 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.43 ' N ' HG23 ' B' ' 59' ' ' VAL . 80.6 p -56.59 -45.48 81.38 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.247 -0.908 . . . . 71.24 109.774 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' B' ' 65' ' ' LYS . 10.5 ptp180 -74.82 -31.82 61.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.065 -1.022 . . . . 74.31 109.971 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' B' ' 66' ' ' HIS . 5.1 mm -59.74 -53.72 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.901 -1.125 . . . . 72.14 109.493 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.498 ' HZ3' ' HB3' ' B' ' 63' ' ' LYS . 8.8 mmmm -62.28 -41.51 98.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.036 -1.04 . . . . 73.32 108.95 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -66.83 -39.64 87.72 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.305 -0.998 . . . . 73.12 108.305 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' B' ' 61' ' ' ARG . 92.6 mttt -87.3 -76.95 0.35 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.357 -0.839 . . . . 72.44 109.249 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.512 ' O ' HG22 ' B' ' 69' ' ' ILE . 97.7 m-70 -91.94 92.33 8.27 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.212 -0.93 . . . . 63.31 109.039 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.483 ' O ' ' N ' ' B' ' 69' ' ' ILE . 25.6 t -78.56 -41.47 31.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 73.1 110.058 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 46.2 t -67.76 54.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.164 -0.96 . . . . 71.53 109.81 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.512 HG22 ' O ' ' B' ' 66' ' ' HIS . 16.6 tt -151.28 153.22 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.143 -0.973 . . . . 74.4 109.395 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.415 HG13 HH12 ' B' ' 112' ' ' ARG . 76.1 t -97.48 152.14 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.15 -0.969 . . . . 75.12 109.284 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 10.0 t -136.59 129.77 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.24 -0.913 . . . . 73.2 110.108 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.559 ' C ' HD23 ' B' ' 72' ' ' LEU . 4.8 tt -121.17 106.24 11.34 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.911 -0.774 . . . . 73.34 108.911 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 77.8 t -93.09 128.21 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.154 -0.966 . . . . 73.5 109.433 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.48 157.92 16.29 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.347 -0.983 . . . . 64.34 108.347 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 40.0 m -156.02 134.38 11.54 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.841 -1.162 . . . . 74.53 110.789 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -87.18 7.63 27.42 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.499 -0.926 . . . . 64.5 108.499 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -135.91 59.83 31.43 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 108.749 -0.834 . . . . 74.25 108.749 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.468 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 19.4 Cg_endo -60.14 79.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.424 2.083 . . . . 74.43 111.736 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 68.9 p -106.98 151.87 24.73 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.852 -0.795 . . . . 73.12 108.852 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.56 -22.0 30.34 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.297 -0.877 . . . . 71.01 109.152 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -68.98 -49.26 59.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 63.2 109.31 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -74.9 -27.27 60.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 73.22 109.658 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.75 -56.03 23.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.174 -0.954 . . . . 74.3 109.657 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.514 HG23 ' N ' ' B' ' 85' ' ' HIS . 35.2 m -64.71 -42.76 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.135 -0.978 . . . . 73.31 109.279 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 85' ' ' HIS . . . . . 0.514 ' N ' HG23 ' B' ' 84' ' ' VAL . 66.2 t60 -60.76 -36.12 78.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -0.918 . . . . 73.24 109.207 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.46 -41.13 98.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.337 -0.852 . . . . 55.33 109.97 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -77.35 -39.16 48.46 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.028 -1.045 . . . . 74.14 108.852 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -65.03 -39.19 93.01 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.596 -0.842 . . . . 64.04 109.254 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -62.19 -47.1 85.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 72.35 108.935 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 144.47 -6.3 1.68 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.006 -1.237 . . . . 65.2 110.006 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.92 133.79 26.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.038 -1.272 . . . . 52.23 109.285 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.488 ' CG ' HH12 ' B' ' 112' ' ' ARG . 40.9 t0 -83.45 -18.68 37.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -0.93 . . . . 73.32 109.213 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -152.45 164.05 38.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.421 -0.799 . . . . 72.22 108.988 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.468 ' OH ' ' CB ' ' B' ' 78' ' ' PRO . 0.1 OUTLIER -150.85 107.3 3.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.189 -0.944 . . . . 64.42 108.931 -179.361 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.478 HG22 ' N ' ' B' ' 96' ' ' ALA . 30.9 mm -114.82 159.87 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 O-C-N 121.485 -0.76 . . . . 72.23 109.94 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 96' ' ' ALA . . . . . 0.478 ' N ' HG22 ' B' ' 95' ' ' ILE . . . -70.96 128.32 35.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.18 -0.95 . . . . 25.24 108.556 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.687 ' O ' ' N ' ' B' ' 99' ' ' TYR . 1.8 tptt -49.08 -59.33 6.59 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.144 -0.973 . . . . 64.32 111.443 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 98' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 8.0 Cg_endo -44.24 -3.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.569 1.513 . . . . 63.33 113.015 -175.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 99' ' ' TYR . . . . . 0.687 ' N ' ' O ' ' B' ' 97' ' ' LYS . 48.5 m-85 62.18 123.38 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.91 -0.494 . . . . 75.13 109.795 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 17.9 ttm-85 -74.41 -37.66 63.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.942 -1.099 . . . . 74.23 109.237 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' SER . . . . . 0.767 ' O ' ' N ' ' B' ' 103' ' ' LYS . 48.3 t -173.8 35.45 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.951 -1.093 . . . . 63.34 111.303 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 36.8 mm 49.67 -70.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-N 118.995 0.816 . . . . 74.44 110.52 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.767 ' N ' ' O ' ' B' ' 101' ' ' SER . 33.1 mmtm -54.08 -32.44 54.8 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.106 -1.072 . . . . 71.11 108.106 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.01 -45.75 76.59 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.342 -0.985 . . . . 71.45 108.342 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 64.2 tp -62.6 -44.18 96.94 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.72 -0.845 . . . . 51.31 108.72 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 76.5 t -66.79 -38.62 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.355 -0.841 . . . . 65.23 109.513 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.42 -46.48 69.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.225 -0.922 . . . . 24.32 109.49 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -69.56 -31.37 69.51 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.188 -0.945 . . . . 75.31 109.888 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 96.4 mt -74.06 -31.34 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.018 -1.051 . . . . 54.24 108.833 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -73.91 -58.56 3.22 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.645 -0.822 . . . . 65.31 109.367 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -50.99 -35.22 32.67 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.384 -0.823 . . . . 72.24 109.578 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' ARG . . . . . 0.488 HH12 ' CG ' ' B' ' 92' ' ' ASP . 5.6 tpt180 -65.7 -44.01 87.42 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.158 -0.964 . . . . 72.04 109.738 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 43.0 mt -134.28 64.01 1.61 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.365 -0.835 . . . . 75.35 109.963 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -60.55 -43.7 96.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.971 -1.081 . . . . 75.5 108.628 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -142.08 -109.21 0.13 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.389 -0.819 . . . . 65.33 109.357 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -148.21 162.7 38.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.272 -0.893 . . . . 74.45 109.184 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.11 153.72 52.18 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.525 -1.43 . . . . 44.21 109.525 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 118' ' ' SER . . . . . 0.427 ' O ' ' O ' ' B' ' 119' ' ' ASN . 29.5 p -82.65 30.55 0.42 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -1.182 . . . . 71.4 109.718 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 119' ' ' ASN . . . . . 0.46 ' N ' ' OD1' ' B' ' 119' ' ' ASN . 0.0 OUTLIER 55.07 170.24 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.495 -0.882 . . . . 72.32 109.629 177.602 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 11.0 t -119.88 -37.82 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.526 -0.734 . . . . 75.02 109.13 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 29.3 mm -110.94 132.79 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.437 -0.79 . . . . 51.41 109.491 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -152.98 117.14 4.87 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.196 -0.94 . . . . 71.53 109.495 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.701 HD11 ' HB3' ' B' ' 216' ' ' TYR . 11.5 tt -163.04 140.24 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.009 -1.057 . . . . 72.43 110.271 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 124' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' B' ' 126' ' ' LEU . . . 69.52 33.14 71.79 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.312 -1.115 . . . . 51.23 110.312 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 14.8 t0 69.51 -6.34 1.01 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.355 -1.086 . . . . 74.2 109.281 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.723 HD13 HD13 ' B' ' 199' ' ' LEU . 1.2 mt -91.12 144.35 25.73 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.031 -1.1 . . . . 75.42 108.031 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.46 126.31 40.27 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.357 -0.839 . . . . 74.22 109.004 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 73.6 mt -127.58 131.41 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.593 -0.692 . . . . 60.33 109.341 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 48.7 m -115.24 121.27 35.2 Favored Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 121.626 -0.671 . . . . 72.31 109.334 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -78.26 -44.25 0.16 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.572 1.515 . . . . 75.13 111.933 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 131' ' ' ASP . . . . . 0.791 ' O ' ' OE2' ' B' ' 133' ' ' GLU . 70.0 m-20 -62.91 -46.85 85.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.07 -1.019 . . . . 75.23 109.281 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 132' ' ' GLU . . . . . 0.478 ' O ' ' C ' ' B' ' 133' ' ' GLU . 41.7 mt-10 -86.84 5.72 35.31 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.252 -0.905 . . . . 72.43 109.182 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.791 ' OE2' ' O ' ' B' ' 131' ' ' ASP . 0.6 OUTLIER 29.93 59.87 0.19 Allowed 'General case' 0 N--CA 1.509 2.502 0 CA-C-O 121.596 0.712 . . . . 75.13 110.447 -179.579 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -141.99 137.56 31.26 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.973 -0.751 . . . . 73.22 108.973 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 10.9 tt -111.05 138.97 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.217 -0.927 . . . . 64.14 109.874 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 18.0 mm -115.91 132.84 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.561 -0.712 . . . . 71.22 109.534 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -140.43 125.2 18.17 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.362 -0.836 . . . . 64.22 108.964 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 81.2 mttt 55.13 33.98 21.62 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.405 -0.809 . . . . 72.02 110.311 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 76.76 14.99 81.98 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 120.182 -1.009 . . . . 74.32 110.934 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -101.05 127.8 47.4 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.179 -1.189 . . . . 75.34 109.63 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -93.74 117.83 30.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.253 -0.904 . . . . 71.23 109.621 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 5.3 t -124.74 120.99 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.389 -0.819 . . . . 70.43 108.947 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -79.22 139.8 37.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.382 -0.824 . . . . 72.43 109.62 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.99 137.21 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.285 -0.884 . . . . 72.13 109.069 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 41.8 pttt -167.24 119.11 0.91 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 72.02 109.782 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 156.96 -177.21 33.97 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.082 -1.607 . . . . 42.23 109.082 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 0.622 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 26.6 mmtm -69.05 -36.56 7.71 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.166 -1.197 . . . . 73.3 110.375 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 148' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 26.8 Cg_exo -61.3 -36.21 80.46 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.871 1.714 . . . . 71.33 111.597 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -90.6 -28.01 18.72 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.359 -0.838 . . . . 74.23 109.393 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -50.6 -49.42 56.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 72.34 109.696 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.647 HG22 HG21 ' B' ' 191' ' ' ILE . 2.8 p -64.95 -34.28 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.088 -1.008 . . . . 73.35 109.038 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 10.5 tp -64.07 -36.85 85.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.172 -0.955 . . . . 55.24 108.605 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.39 -28.65 56.8 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.441 -0.787 . . . . 70.01 109.305 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 154' ' ' HIS . . . . . 0.724 ' CD2' ' CD2' ' B' ' 158' ' ' HIS . 22.1 t-160 -63.43 -53.84 45.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.023 -1.048 . . . . 65.32 109.561 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.412 ' CD2' HD12 ' B' ' 191' ' ' ILE . 2.7 pp -66.61 -30.36 70.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.992 -1.067 . . . . 71.54 108.917 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.51 -51.22 60.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.101 -1.0 . . . . 75.32 109.016 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.559 ' NH1' ' HA ' ' B' ' 154' ' ' HIS . 51.3 mtt85 -62.37 -51.39 67.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.029 -1.044 . . . . 73.32 108.773 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 158' ' ' HIS . . . . . 0.724 ' CD2' ' CD2' ' B' ' 154' ' ' HIS . 32.7 m-70 -88.78 36.0 0.79 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.723 -0.61 . . . . 74.14 109.886 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 159' ' ' ARG . . . . . 0.419 HH12 ' CB ' ' B' ' 203' ' ' THR . 29.9 ttp85 -82.6 41.36 0.71 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.872 -1.142 . . . . 61.41 109.619 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 160' ' ' ASP . . . . . 0.764 ' HB3' ' HE1' ' B' ' 216' ' ' TYR . 3.9 p-10 -166.66 49.34 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 72.1 109.511 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -175.6 -171.54 0.48 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.346 -0.846 . . . . 72.25 109.79 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 86.9 mt -93.05 143.05 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.288 -0.883 . . . . 72.31 110.126 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 78.6 t -134.18 126.21 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.986 -0.746 . . . . 64.21 108.986 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 4.6 p -81.68 162.76 22.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.131 -0.98 . . . . 74.22 109.941 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -64.54 -51.54 62.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.422 -0.799 . . . . 65.31 110.137 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -58.38 -27.13 63.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.119 -0.988 . . . . 63.45 109.086 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -56.18 -50.95 69.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 72.4 108.906 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 79.6 mt -61.73 -36.19 80.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 72.32 108.933 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.526 HD23 ' C ' ' B' ' 169' ' ' LEU . 5.9 tt -64.9 -61.48 2.14 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.453 -0.779 . . . . 73.34 109.695 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -62.38 -25.73 68.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.91 . . . . 72.1 110.479 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.03 -47.52 58.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.943 -1.098 . . . . 62.13 110.366 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 24.3 mm -99.7 -63.06 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.149 -0.969 . . . . 71.42 110.428 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 173' ' ' TRP . . . . . 1.149 ' CD1' ' CG1' ' B' ' 179' ' ' VAL . 25.6 m-90 -77.98 65.53 3.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.081 -1.012 . . . . 72.23 109.961 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -80.37 -43.42 21.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.165 -0.959 . . . . 52.11 110.0 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 175' ' ' GLU . . . . . 0.732 ' H ' ' CD ' ' B' ' 176' ' ' PRO . 13.9 tm-20 -167.55 -35.42 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 120.916 -1.115 . . . . 73.04 111.399 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.732 ' CD ' ' H ' ' B' ' 175' ' ' GLU . 24.7 Cg_exo -64.12 -30.06 65.34 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 121.507 1.472 . . . . 74.13 111.235 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 177' ' ' GLU . . . . . 0.778 ' O ' ' HD1' ' B' ' 173' ' ' TRP . 81.0 mm-40 -119.46 92.29 3.75 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.535 -0.913 . . . . 72.44 108.535 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 26.3 ttt -68.75 135.33 51.09 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.351 -0.843 . . . . 63.43 109.515 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 179' ' ' VAL . . . . . 1.149 ' CG1' ' CD1' ' B' ' 173' ' ' TRP . 31.7 m -141.5 167.24 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.493 -0.754 . . . . 71.05 109.733 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 180' ' ' THR . . . . . 0.578 ' O ' ' N ' ' B' ' 182' ' ' ASN . 22.1 m -101.01 121.21 53.01 Favored Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 108.927 -0.768 . . . . 62.15 108.927 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -44.77 80.48 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.838 1.692 . . . . 65.22 112.441 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 182' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' B' ' 180' ' ' THR . 10.6 t-20 -179.04 -21.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.323 -0.861 . . . . 72.31 108.835 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 15.2 m -75.21 -10.13 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 63.32 109.546 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.402 ' H ' HG13 ' B' ' 184' ' ' ILE . 50.9 mt -50.4 -25.96 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.923 . . . . 75.03 109.004 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -62.18 -38.57 89.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.387 -0.82 . . . . 64.11 109.381 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 186' ' ' VAL . . . . . 0.419 ' H ' HG23 ' B' ' 186' ' ' VAL . 2.1 t -77.45 -34.94 21.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.399 -0.813 . . . . 73.0 109.986 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -68.68 -39.36 80.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.861 -1.149 . . . . 61.12 110.634 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 188' ' ' ILE . . . . . 0.525 HG23 ' N ' ' B' ' 189' ' ' ASN . 10.6 tp -76.94 -42.13 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.786 -1.196 . . . . 72.43 109.769 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 189' ' ' ASN . . . . . 0.525 ' N ' HG23 ' B' ' 188' ' ' ILE . 52.5 m-80 -70.33 -37.12 74.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 65.14 110.77 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 190' ' ' GLN . . . . . 0.429 ' CG ' ' N ' ' B' ' 191' ' ' ILE . 13.6 pt20 -71.45 -46.95 58.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.859 -1.15 . . . . 63.24 110.995 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 191' ' ' ILE . . . . . 0.647 HG21 HG22 ' B' ' 151' ' ' VAL . 6.5 pt -60.7 -38.97 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.485 -1.384 . . . . 74.03 109.379 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 192' ' ' ARG . . . . . 0.52 ' NH2' ' CD1' ' B' ' 212' ' ' TYR . 98.5 mtt180 -62.35 -35.79 80.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.029 -1.045 . . . . 72.24 109.474 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 193' ' ' GLN . . . . . 0.443 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 86.7 mt-30 -77.5 -25.91 50.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.228 -0.92 . . . . 73.1 110.384 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -78.71 -24.25 45.05 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.092 -1.005 . . . . 72.11 110.736 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 5.6 ptm -94.82 -35.7 11.97 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.921 -1.112 . . . . 44.33 110.568 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 196' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 52.9 p-10 -67.92 -24.04 65.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.985 -1.072 . . . . 71.21 110.772 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 197' ' ' LYS . . . . . 0.539 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 17.5 mttp -74.69 -62.23 0.97 Allowed Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.979 -1.076 . . . . 75.21 110.219 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 198' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -66.36 -39.51 17.04 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.082 1.855 . . . . 75.32 112.83 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 199' ' ' LEU . . . . . 0.723 HD13 HD13 ' B' ' 126' ' ' LEU . 58.1 mt -80.14 -55.77 4.7 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.881 -1.137 . . . . 72.25 110.142 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 95.91 -8.4 67.94 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.42 -1.472 . . . . 64.53 109.42 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 23.4 mm -105.36 135.93 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.325 -1.103 . . . . 44.23 109.349 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 47.7 t -90.15 133.36 34.93 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.146 -0.971 . . . . 54.01 108.723 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 203' ' ' THR . . . . . 0.419 ' CB ' HH12 ' B' ' 159' ' ' ARG . 43.7 p -146.83 50.25 1.12 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.022 -1.048 . . . . 74.4 110.226 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.475 HG23 ' O ' ' B' ' 204' ' ' VAL . 33.3 m -144.31 124.6 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 120.973 -1.08 . . . . 72.12 109.835 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -109.53 114.0 27.26 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.416 -0.957 . . . . 65.41 108.416 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 206' ' ' THR . . . . . 0.497 ' O ' HG23 ' B' ' 206' ' ' THR . 9.8 t -96.06 125.31 40.51 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.097 -1.002 . . . . 71.33 109.724 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.537 HG22 ' H ' ' B' ' 209' ' ' ARG . 7.9 p -142.22 142.62 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.303 -0.873 . . . . 63.5 109.321 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -80.6 6.97 11.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 74.45 109.611 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 209' ' ' ARG . . . . . 0.537 ' H ' HG22 ' B' ' 207' ' ' VAL . 14.2 tpt180 -58.17 -39.4 78.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.22 -0.925 . . . . 74.14 109.818 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -160.37 -37.16 0.05 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.222 -0.924 . . . . 74.43 109.397 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.9 -150.5 9.96 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.438 -1.465 . . . . 64.45 109.438 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 212' ' ' TYR . . . . . 0.52 ' CD1' ' NH2' ' B' ' 192' ' ' ARG . 54.4 m-85 -93.11 137.92 32.02 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.137 -1.213 . . . . 74.21 109.033 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -111.46 118.37 35.6 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.55 -0.719 . . . . 74.03 109.78 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -96.05 131.67 42.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.349 -0.844 . . . . 74.34 109.024 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.0 t -145.06 169.5 17.99 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.17 -0.956 . . . . 64.33 109.946 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 216' ' ' TYR . . . . . 0.764 ' HE1' ' HB3' ' B' ' 160' ' ' ASP . 0.0 OUTLIER -74.74 159.09 83.96 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.414 -0.958 . . . . 70.04 108.414 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.82 133.1 56.05 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.298 1.999 . . . . 65.11 111.943 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.628 ' N ' ' CD ' ' B' ' 219' ' ' PRO . 3.0 ttmp? -80.21 -35.2 0.88 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 73.15 110.485 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 219' ' ' PRO . . . . . 0.784 ' O ' ' N ' ' B' ' 221' ' ' CYS . 24.9 Cg_exo -61.37 -1.1 1.67 Allowed 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.531 1.488 . . . . 71.31 111.457 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 220' ' ' ALA . . . . . 0.765 ' C ' ' OE2' ' B' ' 223' ' ' GLU . . . -57.04 55.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.374 -0.829 . . . . 75.45 109.636 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 221' ' ' CYS . . . . . 0.784 ' N ' ' O ' ' B' ' 219' ' ' PRO . 31.8 p -78.65 -31.78 46.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.111 -0.993 . . . . 72.22 109.279 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -58.81 -14.79 9.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 54.53 109.091 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 223' ' ' GLU . . . . . 0.765 ' OE2' ' C ' ' B' ' 220' ' ' ALA . 1.6 pm0 . . . . . 0 N--CA 1.499 2.0 0 CA-C-O 117.967 -1.016 . . . . 71.13 109.135 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 1.176 ' CE ' ' HA ' ' A' ' 115' ' ' PHE . 28.6 tpp . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.413 -0.588 . . . . 65.12 109.413 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -140.06 140.5 36.14 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.345 -0.847 . . . . 72.33 109.203 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.6 t -119.9 142.91 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.633 0.73 . . . . 71.42 110.402 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.503 HD11 ' CG1' ' A' ' 6' ' ' ILE . 3.3 tp -113.75 116.14 28.93 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.116 -1.068 . . . . 65.12 108.116 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.561 HD12 ' SD ' ' A' ' 49' ' ' MET . 3.6 tp -118.5 103.96 10.24 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.892 -0.781 . . . . 62.43 108.892 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.503 ' CG1' HD11 ' A' ' 4' ' ' LEU . 69.9 mt -95.71 104.3 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.115 -0.991 . . . . 71.15 108.742 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.438 ' HG3' ' H ' ' A' ' 9' ' ' ASN . 28.7 tp10 -128.51 119.25 24.5 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.206 -0.664 . . . . 75.34 109.206 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.458 ' CB ' ' NZ ' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -84.19 -3.22 58.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.227 -0.921 . . . . 72.44 109.378 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.438 ' H ' ' HG3' ' A' ' 7' ' ' GLU . 70.5 m-20 -81.73 -125.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.338 -0.851 . . . . 63.02 109.279 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.3 m -165.88 -77.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.024 -1.047 . . . . 72.34 110.106 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.83 -44.09 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -0.885 . . . . 74.02 110.622 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.518 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.5 mm? -58.8 -37.24 75.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.092 -1.005 . . . . 71.43 109.668 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.92 -32.52 39.96 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.727 -1.749 . . . . 61.32 108.727 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.21 -47.84 69.13 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 110.058 -1.217 . . . . 71.2 110.058 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.67 -43.56 93.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.011 -1.288 . . . . 71.32 109.382 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.8 mm -64.86 -43.97 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.817 -1.177 . . . . 63.23 108.492 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -58.83 -50.43 74.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.86 . . . . 51.11 109.468 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -80.7 1.53 29.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.196 -0.94 . . . . 73.34 109.585 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.08 -58.41 2.0 Allowed Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.958 -1.257 . . . . 62.15 109.958 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -75.85 -18.73 59.33 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.265 -1.138 . . . . 73.51 110.032 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -57.59 -31.35 66.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.107 -0.996 . . . . 74.25 109.623 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.4 t -62.37 -38.22 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.386 -0.821 . . . . 70.04 109.876 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.497 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 12.1 mptt -67.93 -1.82 6.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.325 -0.86 . . . . 73.23 109.726 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.09 27.03 27.01 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.826 -1.31 . . . . 75.54 109.826 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.661 ' CE1' ' CE2' ' A' ' 115' ' ' PHE . 13.8 m-85 -99.49 151.25 21.34 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.33 -1.1 . . . . 73.43 109.097 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 12.0 mtt -102.06 128.44 48.52 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.572 -1.269 . . . . 43.24 107.572 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.84 140.1 38.38 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.157 -0.965 . . . . 62.11 110.507 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -112.66 139.03 48.61 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.715 -0.846 . . . . 74.42 108.715 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -104.75 124.55 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.293 -0.88 . . . . 72.15 108.722 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.4 p -128.2 166.61 18.22 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.648 -0.658 . . . . 71.42 109.495 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -83.87 -102.95 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.22 -0.925 . . . . 72.33 109.446 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.0 p -81.37 161.16 23.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 74.24 109.457 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.458 HD12 ' H ' ' A' ' 33' ' ' LEU . 2.8 mp -52.22 -28.23 17.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.375 -0.828 . . . . 71.53 109.5 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -49.25 -53.35 22.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.935 . . . . 74.23 109.5 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -60.58 -39.01 86.48 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.175 -0.953 . . . . 54.03 108.715 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.37 -34.83 80.77 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.106 -1.597 . . . . 61.41 109.106 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -66.98 -43.92 81.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -1.129 . . . . 74.34 109.351 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.447 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 36.6 t80 -76.81 -22.23 53.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.122 -0.986 . . . . 75.33 109.824 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.2 tp -87.42 -30.78 20.46 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.108 -0.995 . . . . 74.33 109.673 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.44 ' O ' ' O ' ' A' ' 43' ' ' ARG . 5.0 ppp? -86.36 -24.02 25.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.122 -0.986 . . . . 70.32 110.468 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 37.4 p-10 -59.37 -28.49 66.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.887 -1.133 . . . . 71.22 109.444 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.538 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 12.6 pt -92.24 -30.68 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.234 -0.916 . . . . 74.14 110.113 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 40' ' ' MET . 70.9 mmt-85 -130.03 148.31 51.87 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.386 -0.821 . . . . 72.24 109.645 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -98.66 160.11 14.5 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.252 -0.905 . . . . 75.42 109.483 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -131.02 160.11 35.55 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.496 -0.753 . . . . 74.23 109.241 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.745 ' OD2' ' CH2' ' A' ' 116' ' ' TRP . 5.4 m-20 -98.69 -45.21 6.13 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.267 -0.896 . . . . 72.04 109.474 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.403 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -102.18 108.84 20.36 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.45 -0.944 . . . . 72.13 108.45 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.7 t -97.25 100.78 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.339 -0.851 . . . . 72.34 109.248 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.561 ' SD ' HD12 ' A' ' 5' ' ' LEU . 2.0 tmt? -116.74 134.48 54.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.456 -0.777 . . . . 74.11 109.489 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.654 HG22 ' H ' ' A' ' 52' ' ' ASP . 1.3 p -143.43 127.69 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.499 -0.751 . . . . 61.12 109.323 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.4 p -86.69 4.95 38.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.559 -0.713 . . . . 73.11 109.408 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.654 ' H ' HG22 ' A' ' 50' ' ' VAL . 13.6 m-20 -79.92 138.9 37.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.937 . . . . 52.55 109.646 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -82.27 -32.75 29.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.269 -0.894 . . . . 44.22 109.938 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -73.21 8.93 1.42 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.195 -0.941 . . . . 70.44 109.714 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -74.93 -20.9 59.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.331 -0.856 . . . . 64.14 110.184 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 55' ' ' ALA . 31.3 mt -38.49 -45.0 0.99 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.604 -0.685 . . . . 44.14 110.706 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.3 p -74.47 -36.54 63.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.95 -1.093 . . . . 55.23 109.311 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.666 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 64.6 t80 -65.07 -46.19 82.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.417 -0.802 . . . . 74.44 109.998 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.1 m -64.29 -37.41 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.703 -1.248 . . . . 74.03 109.307 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.1 t -53.54 -49.9 66.64 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.209 -0.932 . . . . 64.3 109.228 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -70.28 -36.22 74.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 64.44 110.243 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.666 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 5.2 mm -64.67 -34.12 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.642 -1.286 . . . . 63.21 109.432 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.565 ' HZ3' ' CG ' ' A' ' 92' ' ' ASP . 44.0 mmtt -67.43 -51.58 49.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 74.42 109.868 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.443 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 17.1 pt-20 -72.38 -43.02 64.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.942 -1.099 . . . . 70.32 109.937 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.505 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 25.8 mtpp -70.14 -22.72 62.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 75.22 109.508 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.511 ' O ' HG22 ' A' ' 69' ' ' ILE . 89.9 m-70 -156.35 64.31 0.55 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.923 . . . . 74.13 109.525 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 69' ' ' ILE . 30.7 p -60.19 -31.54 70.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.871 . . . . 73.24 109.737 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 87.7 p -68.6 47.84 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -0.915 . . . . 61.01 109.705 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 66' ' ' HIS . 14.3 tt -148.61 161.92 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.083 -1.011 . . . . 71.33 109.609 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.599 HG21 HD11 ' A' ' 113' ' ' LEU . 77.4 t -95.96 154.91 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.158 -0.964 . . . . 72.13 108.754 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.725 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 6.5 t -143.32 114.52 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.11 -0.994 . . . . 54.21 109.315 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.0 mp -111.12 100.14 8.86 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.55 -0.908 . . . . 50.24 108.55 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.4 t -93.14 120.4 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.345 -0.847 . . . . 74.41 108.91 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 m -97.84 172.84 7.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.284 -0.885 . . . . 72.31 108.763 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.448 ' C ' ' H ' ' A' ' 77' ' ' ASN . 0.8 OUTLIER -173.98 120.72 0.29 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.982 -1.073 . . . . 64.54 110.203 -179.622 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -65.53 2.37 0.95 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.508 -0.745 . . . . 74.13 109.406 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 75' ' ' SER . 80.2 m-20 -120.1 64.05 9.57 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 109.123 -0.695 . . . . 73.34 109.123 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.03 74.2 0.1 OUTLIER 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.11 1.873 . . . . 63.22 111.871 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.45 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 60.1 p -104.95 149.7 25.52 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.331 -0.988 . . . . 62.53 108.331 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -28.56 69.19 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.197 -0.939 . . . . 73.44 109.813 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.459 ' OE1' ' N ' ' A' ' 81' ' ' GLU . 40.8 mp0 -63.41 -38.08 89.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.112 -0.992 . . . . 71.42 109.876 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -77.05 -33.95 57.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.044 -1.035 . . . . 73.43 109.712 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -61.05 -52.57 64.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.056 -1.028 . . . . 74.22 109.461 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.473 HG23 ' N ' ' A' ' 85' ' ' HIS . 26.9 m -62.67 -41.31 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -0.949 . . . . 73.2 109.387 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.473 ' N ' HG23 ' A' ' 84' ' ' VAL . 6.6 t-80 -65.8 -29.94 70.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.225 -0.922 . . . . 53.33 109.324 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.02 -37.05 80.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.917 . . . . 64.11 109.91 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -80.2 -34.05 37.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.106 -0.997 . . . . 74.34 108.839 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -73.64 -38.22 65.08 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.388 -0.82 . . . . 74.42 109.461 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -71.32 -60.86 2.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 74.24 109.374 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 155.71 70.88 0.01 OUTLIER Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.67 -1.252 . . . . 61.51 110.168 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -133.08 130.75 39.74 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.339 -1.095 . . . . 55.33 109.357 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.725 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 14.2 m-20 -69.51 -41.09 76.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 73.42 109.268 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.752 ' CG ' HH21 ' A' ' 112' ' ' ARG . 4.9 m-20 -146.32 163.0 36.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.834 . . . . 75.04 109.056 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.494 ' CE1' ' OE1' ' A' ' 83' ' ' GLU . 56.6 t80 -136.96 124.42 22.09 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.363 -0.977 . . . . 71.33 108.363 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.683 HD12 ' H ' ' A' ' 95' ' ' ILE . 0.1 OUTLIER -126.12 149.83 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 CA-C-O 122.045 0.926 . . . . 71.13 111.232 -178.055 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.75 121.54 16.72 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.768 -1.197 . . . . 64.32 107.768 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.659 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -44.92 -55.43 10.94 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.197 -0.939 . . . . 62.2 111.629 -178.596 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.7 Cg_endo -41.56 -12.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 120.739 0.96 . . . . 73.11 112.538 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.659 ' N ' ' O ' ' A' ' 97' ' ' LYS . 55.2 m-85 59.86 124.88 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 109.583 -0.525 . . . . 65.22 109.583 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 32.6 ttm-85 -62.08 -38.79 90.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.876 -1.14 . . . . 72.35 109.353 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.794 ' O ' ' N ' ' A' ' 103' ' ' LYS . 6.3 t -172.99 46.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.129 -0.982 . . . . 71.32 110.473 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 92.2 mt 47.11 -68.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-O 121.228 0.537 . . . . 75.43 110.825 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.794 ' N ' ' O ' ' A' ' 101' ' ' SER . 13.8 mmmt -53.25 -34.0 55.38 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.238 -0.914 . . . . 71.41 108.843 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.39 -49.73 68.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.262 -0.899 . . . . 63.24 109.204 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.695 ' C ' HD13 ' A' ' 105' ' ' LEU . 2.0 tm? -57.73 -47.9 81.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.134 -0.979 . . . . 73.22 108.726 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.96 -40.2 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.964 -1.085 . . . . 60.11 109.85 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.635 ' HB1' ' CE2' ' B' ' 87' ' ' PHE . . . -52.17 -39.23 59.78 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.252 -0.905 . . . . 70.42 108.832 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 1.27 ' HB3' ' NH1' ' A' ' 112' ' ' ARG . 93.3 mtt180 -73.55 -29.82 62.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.028 -1.045 . . . . 74.41 109.933 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 47.5 mt -73.92 -44.94 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 120.891 -1.131 . . . . 62.54 109.218 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.449 ' CG ' ' N ' ' A' ' 111' ' ' ALA . 17.7 pt-20 -70.31 -47.93 58.87 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.816 -1.154 . . . . 74.34 109.717 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.449 ' N ' ' CG ' ' A' ' 110' ' ' GLU . . . -59.49 -29.84 68.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.889 -1.132 . . . . 73.32 109.578 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 1.27 ' NH1' ' HB3' ' A' ' 108' ' ' ARG . 53.0 mtt85 -72.79 -58.34 3.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.913 . . . . 52.41 109.175 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 112' ' ' ARG . 16.7 mt -126.35 65.13 1.24 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.502 -0.925 . . . . 65.24 108.502 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.469 ' O ' ' CD2' ' A' ' 115' ' ' PHE . 29.1 mtm105 -39.94 -79.73 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.902 -0.499 . . . . 64.45 110.48 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 1.176 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 14.6 m-85 -163.18 96.48 0.88 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.029 -1.044 . . . . 74.43 108.698 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 1.01 ' CZ2' ' OE1' ' A' ' 132' ' ' GLU . 51.3 m0 -46.78 -93.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.247 -0.908 . . . . 74.42 109.861 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.15 17.85 18.42 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.078 -1.609 . . . . 75.04 109.078 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.4 p -103.56 166.76 10.22 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.366 -1.079 . . . . 61.14 109.771 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -164.18 127.89 2.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.329 -0.857 . . . . 65.24 108.98 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 18.4 t -82.98 -38.07 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.047 -1.033 . . . . 73.11 110.627 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.404 HG23 ' HE ' ' A' ' 159' ' ' ARG . 14.9 mm -95.88 133.59 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.932 -1.105 . . . . 72.24 110.038 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -149.86 127.94 11.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.151 -0.968 . . . . 72.34 108.607 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' A' ' 125' ' ' ASP . 8.7 tp -153.32 132.38 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 71.44 109.54 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 55.93 -83.49 0.01 OUTLIER Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.62 -1.392 . . . . 73.4 109.62 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 123' ' ' ILE . 15.1 t0 -149.92 -4.84 0.36 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.253 -1.146 . . . . 74.45 109.334 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.05 141.32 28.66 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.074 -1.017 . . . . 54.21 108.842 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.32 133.1 43.62 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.896 -0.779 . . . . 54.5 108.896 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 49.4 mt -130.02 134.83 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.378 -0.826 . . . . 45.15 109.554 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.0 t -108.72 111.78 60.82 Favored Pre-proline 0 N--CA 1.497 1.9 0 N-CA-C 108.524 -0.917 . . . . 71.11 108.524 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -83.18 -39.18 0.13 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.869 1.713 . . . . 65.41 112.815 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -65.86 -49.3 68.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.025 -1.047 . . . . 63.32 109.692 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 1.01 ' OE1' ' CZ2' ' A' ' 116' ' ' TRP . 5.8 mm-40 -81.48 -6.26 58.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.13 -0.981 . . . . 72.52 109.105 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 57.06 63.63 1.86 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 75.33 109.727 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -146.19 130.41 17.52 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.338 -0.851 . . . . 71.23 109.272 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 6.8 tt -106.57 140.81 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.345 -0.847 . . . . 74.02 108.87 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.4 mt -128.54 120.75 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.46 -0.775 . . . . 60.23 109.506 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -140.03 140.18 36.14 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.386 -0.821 . . . . 62.32 109.628 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 53.45 20.96 2.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.403 -0.811 . . . . 75.4 110.085 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.84 16.97 68.84 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.982 -1.104 . . . . 72.24 110.403 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 57.2 mtp85 -107.12 124.41 49.64 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.242 -1.152 . . . . 71.22 109.177 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -99.24 124.9 44.68 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.302 -0.874 . . . . 71.42 109.75 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.8 t -139.33 140.9 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.39 -0.819 . . . . 53.02 109.556 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -85.94 135.7 33.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.177 -0.952 . . . . 60.45 109.136 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.4 m -132.43 126.95 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.439 -0.788 . . . . 74.44 109.406 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.4 pttt -173.15 129.31 0.47 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.304 -0.873 . . . . 65.15 109.577 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.66 -141.19 6.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.703 -1.359 . . . . 73.34 109.703 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.547 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -85.09 -44.56 0.67 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.328 -1.101 . . . . 72.22 110.403 -179.271 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 69.6 Cg_endo -89.79 -7.85 4.5 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.73 2.287 . . . . 65.23 113.354 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -89.42 -32.84 17.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.719 -1.238 . . . . 60.11 110.035 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -50.18 -40.99 48.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.978 -1.076 . . . . 64.21 109.149 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.09 -33.59 64.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.252 -0.905 . . . . 72.02 109.246 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 7.0 tp -61.37 -40.88 95.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.91 . . . . 73.31 109.639 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.9 p -74.59 -34.89 62.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.095 -1.003 . . . . 74.31 109.041 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -52.81 -55.2 24.76 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.476 -0.765 . . . . 74.31 109.746 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 pp -72.13 -26.17 62.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.013 -1.055 . . . . 75.34 109.283 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.04 -29.39 60.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.084 -1.01 . . . . 62.14 108.716 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.461 ' C ' ' H ' ' A' ' 159' ' ' ARG . 52.4 mtt180 -97.89 -54.19 3.17 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.681 -0.859 . . . . 61.03 108.681 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.431 ' N ' ' ND1' ' A' ' 158' ' ' HIS . 5.3 m80 -69.94 43.34 0.06 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.456 -0.777 . . . . 74.12 109.141 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.548 ' O ' ' N ' ' A' ' 161' ' ' GLN . 32.2 mtm105 -53.57 -103.37 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.481 -0.762 . . . . 71.13 109.953 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -51.17 86.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.478 -0.764 . . . . 75.45 109.884 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -175.58 179.1 1.48 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.629 -0.878 . . . . 73.41 108.629 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.529 ' H ' ' CD ' ' A' ' 161' ' ' GLN . 66.6 mt -98.82 128.95 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.258 -0.901 . . . . 74.41 109.615 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 212' ' ' TYR . 77.2 t -108.99 113.94 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.509 -0.744 . . . . 72.31 109.535 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 4.4 p -90.33 138.71 31.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 74.12 108.627 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -57.75 -37.09 73.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 70.43 109.186 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -64.29 -38.19 90.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 73.52 109.617 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 62.8 tp60 -59.84 -41.12 90.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -0.968 . . . . 74.52 109.124 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 40.2 mt -61.88 -53.28 57.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.91 . . . . 72.31 109.306 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 11.8 tp -62.67 -60.83 2.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 53.33 109.635 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -40.75 -40.1 1.25 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.94 -0.475 . . . . 62.44 111.543 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.16 -31.23 14.23 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.859 -1.151 . . . . 60.21 111.784 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.3 mm -80.6 -69.3 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.72 -1.238 . . . . 75.32 109.807 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.512 ' CE3' ' O ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -59.07 145.71 41.15 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.831 -1.174 . . . . 73.14 107.831 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -172.1 -76.37 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.662 -0.866 . . . . 73.24 108.662 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.606 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 2.4 tt0 -82.6 -42.81 0.93 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.122 -0.986 . . . . 44.43 108.572 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 14.6 Cg_exo -67.95 44.23 0.27 Allowed 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.593 2.195 . . . . 72.51 111.687 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -54.66 -4.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -0.954 . . . . 63.24 110.168 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.491 ' H ' ' C ' ' A' ' 176' ' ' PRO . 23.5 ttt -53.87 -26.54 25.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.041 -1.037 . . . . 73.5 109.25 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 18.7 m -64.46 137.21 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 65.22 109.485 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.5 p -64.71 153.27 88.11 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 71.42 108.843 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -36.71 -56.16 0.76 Allowed 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.395 2.064 . . . . 41.22 112.042 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 182' ' ' ASN . 6.3 p30 -93.79 114.66 26.98 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.265 -0.897 . . . . 64.54 108.737 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.5 p -145.94 -32.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.213 -0.929 . . . . 74.02 109.3 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.576 HD13 ' O ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -51.4 -31.21 11.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.449 -0.782 . . . . 72.33 109.09 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -56.32 -53.29 58.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.253 -0.905 . . . . 74.4 110.173 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.8 m -74.06 -25.25 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.996 -1.065 . . . . 70.42 109.805 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -71.55 -52.65 17.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 52.11 110.047 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 9.9 tp -64.31 -33.97 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.91 -1.119 . . . . 71.4 109.734 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.519 ' O ' ' NE2' ' A' ' 193' ' ' GLN . 65.4 t30 -64.67 -54.85 25.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.995 . . . . 73.44 110.025 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -67.65 -39.45 84.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.002 -1.061 . . . . 71.42 109.884 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 67.2 mt -60.12 -49.35 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.016 -1.053 . . . . 61.55 109.373 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -52.85 -53.73 44.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.07 -1.019 . . . . 63.34 109.442 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 189' ' ' ASN . 0.9 OUTLIER -59.76 -36.52 76.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -0.871 . . . . 61.24 109.375 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -81.65 -3.95 54.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.175 -0.953 . . . . 75.13 110.112 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 32.5 ttp -108.82 -15.18 14.45 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.322 -0.861 . . . . 74.02 109.704 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -108.51 -16.45 14.21 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.422 -0.799 . . . . 74.02 109.869 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.628 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 31.5 tptt -78.69 -35.72 1.13 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.979 -1.076 . . . . 75.43 110.776 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 89.0 Cg_endo -90.36 -48.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.226 1.951 . . . . 72.32 112.279 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 74.1 mt -68.1 -31.95 71.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.14 -0.975 . . . . 74.54 109.19 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 73.13 0.22 50.92 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.77 -1.332 . . . . 61.51 109.77 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.8 mt -123.23 128.2 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.548 -0.972 . . . . 61.22 109.488 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 8.3 t -86.03 132.95 33.94 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.321 -0.992 . . . . 72.0 108.321 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.7 p -134.87 27.02 3.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.254 -0.904 . . . . 74.44 109.909 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 26.7 m -146.98 150.48 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.096 -1.003 . . . . 64.35 109.736 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -126.61 126.13 43.1 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.645 -0.659 . . . . 71.41 109.368 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.34 111.16 16.46 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.133 -0.979 . . . . 73.52 108.916 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.09 132.51 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.558 -0.714 . . . . 71.02 109.783 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -73.53 -30.1 62.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.839 . . . . 72.12 109.7 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -58.48 -82.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.891 . . . . 64.41 110.312 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -82.24 -47.55 12.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.891 -1.131 . . . . 71.54 109.865 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 152.42 -110.8 0.47 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.976 -1.65 . . . . 72.03 108.976 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 163' ' ' VAL . 79.6 m-85 -112.11 140.41 46.82 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.433 -1.04 . . . . 75.54 108.714 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 25.8 mtm180 -121.3 129.79 53.3 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.423 -0.798 . . . . 75.31 109.522 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -97.47 119.54 36.2 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.296 -0.878 . . . . 75.41 108.906 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 28.2 m -130.91 161.22 32.35 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.354 -0.841 . . . . 74.14 109.75 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -72.27 151.06 92.16 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 75.32 109.08 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -39.68 135.02 1.42 Allowed 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 121.974 1.783 . . . . 73.11 112.079 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 9.5 tptp -78.27 -38.26 1.55 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.114 -0.991 . . . . 75.25 110.003 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 50.7 Cg_exo -56.02 -34.63 92.93 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.191 1.927 . . . . 75.1 111.952 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -62.75 113.13 2.84 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.35 -0.843 . . . . 71.14 109.149 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' CYS . . . . . 0.562 ' O ' ' N ' ' A' ' 223' ' ' GLU . 26.3 t -160.92 144.95 13.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 71.13 109.825 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 60.85 -67.75 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.732 -0.605 . . . . 75.35 110.159 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 221' ' ' CYS . 90.3 mt-10 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.01 -0.995 . . . . 73.41 109.831 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.447 ' SD ' ' CE2' ' B' ' 25' ' ' PHE . 51.5 ttm . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.512 -0.551 . . . . 71.14 109.512 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -137.1 139.71 41.44 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.416 -0.802 . . . . 73.23 109.307 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 90.3 t -110.05 133.92 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.597 -0.689 . . . . 72.24 109.698 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.462 HD12 ' N ' ' B' ' 5' ' ' LEU . 2.6 tp -102.92 119.21 38.44 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.556 -0.715 . . . . 54.33 109.166 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.462 ' N ' HD12 ' B' ' 4' ' ' LEU . 19.5 mt -114.6 96.23 5.65 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.814 -0.81 . . . . 74.35 108.814 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.676 HD12 ' HB ' ' B' ' 50' ' ' VAL . 88.2 mt -81.43 98.19 3.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 O-C-N 120.727 -1.233 . . . . 42.55 108.494 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.434 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 28.3 tp10 -137.55 125.13 22.17 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.399 -0.813 . . . . 74.52 109.72 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -69.3 -31.17 69.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.31 -0.869 . . . . 62.55 108.896 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -85.25 112.19 20.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.379 -0.826 . . . . 73.11 109.447 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 96.9 p -68.09 -23.18 64.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.243 -0.911 . . . . 65.54 109.572 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 84.9 t -65.13 -52.62 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 75.55 109.614 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.469 HD23 ' OE2' ' B' ' 15' ' ' GLU . 62.3 mt -65.8 -37.4 86.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 70.14 109.686 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.29 -28.86 69.21 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.678 -1.769 . . . . 75.4 108.678 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.94 -53.26 41.97 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.721 -1.351 . . . . 65.44 109.721 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.469 ' OE2' HD23 ' B' ' 12' ' ' LEU . 15.0 pt-20 -58.96 -46.81 87.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.323 -1.104 . . . . 60.21 109.953 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 35.7 mm -64.52 -40.25 88.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.748 -1.22 . . . . 75.15 108.877 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -61.94 -44.65 96.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.364 -0.835 . . . . 73.01 109.446 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -85.48 1.72 47.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.187 -0.945 . . . . 74.3 108.964 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.4 -55.38 2.21 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 109.74 -1.344 . . . . 70.54 109.74 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -74.04 -19.7 60.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -1.184 . . . . 71.34 109.752 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -52.14 -32.78 37.15 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.17 -0.956 . . . . 64.41 109.521 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 79.4 t -58.7 -37.16 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.154 -0.966 . . . . 74.23 109.156 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -70.17 -13.81 62.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.362 -0.837 . . . . 63.42 109.41 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.44 38.78 6.99 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.844 -1.302 . . . . 53.43 109.844 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' PHE . . . . . 0.447 ' CE2' ' SD ' ' B' ' 1' ' ' MET . 15.6 m-85 -114.43 159.49 20.24 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.508 -0.995 . . . . 71.12 109.065 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.2 mmt -103.92 139.73 38.68 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.411 -0.959 . . . . 75.24 108.411 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.41 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -139.95 154.93 47.33 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.272 -0.892 . . . . 72.12 110.096 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 83.1 m-20 -134.65 158.03 45.12 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.482 -0.933 . . . . 72.31 108.482 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.03 139.67 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.352 -0.843 . . . . 64.43 109.866 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 6.1 p -134.48 170.08 16.29 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.586 -0.696 . . . . 65.41 109.196 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -94.08 -105.77 0.13 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.165 -0.96 . . . . 71.02 109.774 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 37.3 t -78.2 173.64 12.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.236 -0.915 . . . . 51.11 110.059 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.653 HD12 ' CG ' ' B' ' 58' ' ' PHE . 3.7 mm? -55.27 -39.26 69.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.518 -0.739 . . . . 71.24 109.681 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -46.56 -45.74 18.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 74.32 110.031 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.59 -38.73 70.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.103 -0.998 . . . . 73.03 109.249 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.18 -42.7 91.03 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.18 -1.568 . . . . 30.21 109.18 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -67.94 -40.74 83.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.294 -1.121 . . . . 74.42 109.453 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -72.17 -37.55 69.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 74.42 109.841 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 21.7 tp -72.14 -48.23 45.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -0.931 . . . . 75.41 110.12 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' MET . . . . . 0.445 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.9 ppp? -66.95 -19.75 65.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.032 -1.043 . . . . 60.41 109.923 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -61.4 -40.72 95.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.081 -1.012 . . . . 53.23 110.058 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.438 HD12 ' NH1' ' B' ' 43' ' ' ARG . 19.0 pt -82.82 -29.73 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.129 -0.982 . . . . 71.23 110.278 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.438 ' NH1' HD12 ' B' ' 42' ' ' ILE . 75.1 mtt85 -130.43 143.89 51.05 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.287 -0.883 . . . . 72.22 109.758 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -97.69 130.77 44.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.251 -0.906 . . . . 63.54 109.233 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -99.76 139.97 34.65 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.316 -0.865 . . . . 64.35 109.411 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -75.11 -37.06 61.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 62.22 109.237 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.566 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.9 OUTLIER -113.59 116.93 30.28 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.641 -0.874 . . . . 73.12 108.641 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.566 ' N ' HD13 ' B' ' 47' ' ' LEU . 72.3 t -98.43 98.22 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.354 -0.98 . . . . 65.11 108.354 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 0.5 OUTLIER -110.38 131.09 55.36 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.462 0.648 . . . . 73.44 109.288 -179.006 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.676 ' HB ' HD12 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -145.73 135.6 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.437 -0.789 . . . . 34.5 109.607 -179.626 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 51' ' ' SER . . . . . 0.434 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 14.7 p -98.8 14.03 30.26 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.541 -0.724 . . . . 73.21 109.661 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.631 ' H ' HG22 ' B' ' 50' ' ' VAL . 23.9 m-20 -82.9 140.3 32.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.184 -0.948 . . . . 70.41 109.468 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' B' ' 55' ' ' ALA . 14.4 mtpp -74.69 -39.73 61.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 65.0 110.134 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -71.41 10.98 0.52 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.108 -0.995 . . . . 75.21 109.695 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -66.27 -22.97 66.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 55.33 110.247 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 37.5 mt -45.72 -45.49 14.38 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.219 -0.926 . . . . 63.14 110.151 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 83.5 p -70.24 -38.39 75.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.892 -1.13 . . . . 63.5 109.364 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' PHE . . . . . 0.653 ' CG ' HD12 ' B' ' 33' ' ' LEU . 48.9 t80 -66.19 -61.11 2.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.339 -0.851 . . . . 72.33 109.762 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 20.7 m -50.32 -34.8 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.546 -1.346 . . . . 74.54 109.7 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 44.8 m -56.77 -51.58 68.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.115 -0.991 . . . . 71.24 109.534 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -69.38 -32.14 70.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.981 -1.074 . . . . 74.31 110.19 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' B' ' 66' ' ' HIS . 39.5 mm -65.74 -42.41 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.676 -1.265 . . . . 72.14 110.133 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -65.78 -49.6 67.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.209 -0.932 . . . . 73.32 110.695 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' B' ' 65' ' ' LYS . 7.5 pt-20 -69.17 -41.62 76.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.7 -1.25 . . . . 73.12 109.838 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.496 ' O ' ' ND1' ' B' ' 66' ' ' HIS . 85.6 mttt -79.7 -18.69 50.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.25 -0.906 . . . . 72.44 109.563 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.496 ' ND1' ' O ' ' B' ' 65' ' ' LYS . 69.1 m-70 -154.82 67.59 0.69 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.141 -0.974 . . . . 63.31 109.698 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 54.6 p -67.18 -25.0 65.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.176 -0.953 . . . . 73.1 109.553 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 24.0 m -64.08 -27.06 68.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.305 -0.872 . . . . 71.53 109.895 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 84.5 mt -81.23 152.99 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.156 -0.965 . . . . 74.4 109.687 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 67.2 t -94.81 154.18 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.356 -0.84 . . . . 75.12 109.181 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.427 ' H ' ' HB2' ' B' ' 92' ' ' ASP . 11.3 t -133.64 130.52 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.309 -0.87 . . . . 73.2 110.049 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.508 ' O ' ' SD ' ' B' ' 49' ' ' MET . 6.5 tt -122.98 104.0 8.96 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.864 -0.791 . . . . 73.34 108.864 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 9.1 p -95.45 137.07 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.977 -1.077 . . . . 73.5 108.961 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 3.9 p -96.68 170.88 8.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.297 -0.877 . . . . 64.34 109.552 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.481 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 42.9 t -157.67 114.85 2.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.169 -0.957 . . . . 74.53 110.232 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' B' ' 77' ' ' ASN . 52.1 p-10 -66.6 -21.45 66.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.221 -0.924 . . . . 64.5 109.264 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 77' ' ' ASN . . . . . 0.517 ' N ' ' OD1' ' B' ' 76' ' ' ASP . 56.6 t-20 -126.53 75.95 74.08 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 108.633 -0.877 . . . . 74.25 108.633 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -44.31 85.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.32 2.013 . . . . 74.43 111.724 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.515 ' N ' ' O ' ' B' ' 77' ' ' ASN . 7.4 m -94.67 150.24 20.42 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.635 0.731 . . . . 73.12 110.065 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.9 p -76.78 -43.16 37.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.539 -0.726 . . . . 71.01 109.655 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -56.73 -35.24 68.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.135 -0.978 . . . . 63.2 109.012 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -74.2 -34.72 63.83 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.098 -1.001 . . . . 73.22 108.97 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.522 ' OE1' ' CG ' ' B' ' 94' ' ' TYR . 42.1 tp10 -65.84 -55.95 14.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.257 -0.902 . . . . 74.3 109.609 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.459 HG23 ' N ' ' B' ' 85' ' ' HIS . 31.4 m -53.44 -41.93 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.994 -1.066 . . . . 73.31 108.968 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 85' ' ' HIS . . . . . 0.459 ' N ' HG23 ' B' ' 84' ' ' VAL . 46.6 m80 -74.26 -20.09 60.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.174 -0.954 . . . . 73.24 109.597 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -68.75 -40.87 79.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.945 -1.097 . . . . 55.33 110.428 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 87' ' ' PHE . . . . . 0.635 ' CE2' ' HB1' ' A' ' 107' ' ' ALA . 0.5 OUTLIER -83.3 -30.48 27.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.871 -1.143 . . . . 74.14 109.112 -179.777 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -77.27 -44.37 30.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.11 -0.993 . . . . 64.04 109.25 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -65.44 -54.96 21.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.425 -0.797 . . . . 72.35 109.496 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 154.72 72.81 0.01 OUTLIER Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.608 -1.282 . . . . 65.2 110.472 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -140.44 140.87 35.48 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.272 -1.134 . . . . 52.23 108.84 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.427 ' HB2' ' H ' ' B' ' 71' ' ' VAL . 54.3 m-20 -94.99 -22.99 17.58 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.06 -1.025 . . . . 73.32 109.824 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 93' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 17.4 t0 -151.78 158.32 43.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.09 -1.007 . . . . 72.22 109.609 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.522 ' CG ' ' OE1' ' B' ' 83' ' ' GLU . 55.8 t80 -142.9 104.91 4.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.478 -0.764 . . . . 64.42 108.969 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 27.2 mm -114.37 151.92 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.542 0 O-C-N 121.127 -0.983 . . . . 72.23 110.22 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.27 144.26 57.26 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.987 -1.116 . . . . 25.24 107.987 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.687 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -64.32 -54.42 38.63 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.765 -1.21 . . . . 64.32 111.516 -179.301 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 98' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 3.5 Cg_endo -41.45 -8.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 120.851 1.034 . . . . 63.33 113.341 -176.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 99' ' ' TYR . . . . . 0.687 ' N ' ' O ' ' B' ' 97' ' ' LYS . 44.7 m-85 59.06 110.22 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.366 -0.834 . . . . 75.13 109.322 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 100' ' ' ARG . . . . . 0.511 ' NH1' ' OE2' ' A' ' 83' ' ' GLU . 13.2 ttm180 -57.98 -34.2 69.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.009 -1.057 . . . . 74.23 108.88 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 101' ' ' SER . . . . . 0.778 ' O ' ' N ' ' B' ' 103' ' ' LYS . 47.9 t -174.26 32.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.148 -0.97 . . . . 63.34 110.836 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 49.9 mt 49.62 -69.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 118.745 0.702 . . . . 74.44 110.193 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.778 ' N ' ' O ' ' B' ' 101' ' ' SER . 40.6 tptt -51.77 -31.17 25.76 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.603 -1.258 . . . . 71.11 107.603 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.97 -40.72 83.09 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.608 -0.886 . . . . 71.45 108.608 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 51.9 tp -66.22 -45.86 79.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.448 -0.782 . . . . 51.31 109.022 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 42.4 t -66.89 -41.1 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.919 . . . . 65.23 109.3 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.06 -45.22 64.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.254 -0.903 . . . . 24.32 109.375 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 67.2 ttt-85 -69.07 -33.52 73.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.911 . . . . 75.31 109.671 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 96.6 mt -72.23 -29.11 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.104 -0.997 . . . . 54.24 108.767 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -67.72 -58.87 3.9 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.471 -0.891 . . . . 65.31 108.938 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -52.97 -32.11 44.34 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.305 -0.872 . . . . 72.24 109.108 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 25.6 tpt85 -58.9 -50.41 74.15 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.288 -0.883 . . . . 72.04 109.277 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 63.1 mt -146.19 103.52 3.72 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.174 -0.954 . . . . 75.35 109.995 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -98.47 107.48 19.95 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.465 -0.939 . . . . 75.5 108.465 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 78.1 t80 49.62 86.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 65.33 109.558 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 -82.39 142.79 31.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.194 -0.941 . . . . 74.45 109.45 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 163.27 86.39 0.06 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.599 -1.4 . . . . 44.21 109.599 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 8.9 t -157.61 -175.26 5.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -1.128 . . . . 71.4 109.745 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.83 137.57 16.13 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.832 -0.747 . . . . 72.32 109.114 -178.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 6.9 t -71.8 -36.75 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 75.02 109.617 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 20.8 mm -103.25 132.74 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.328 -0.858 . . . . 51.41 109.287 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -135.7 119.26 17.01 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.434 -0.791 . . . . 71.53 109.24 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.436 ' O ' HG23 ' B' ' 123' ' ' ILE . 14.5 tt -145.67 130.5 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.262 -0.898 . . . . 72.43 109.235 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.46 -153.31 1.01 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.424 -1.47 . . . . 51.23 109.424 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -79.82 2.1 24.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.152 -1.205 . . . . 74.2 109.049 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.63 135.17 37.65 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.356 -0.979 . . . . 75.42 108.356 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 1.2 p -130.9 145.18 51.93 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.361 -0.837 . . . . 74.22 109.198 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 14.0 mt -133.69 140.41 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.446 -0.784 . . . . 60.33 109.066 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 3.6 t -123.02 81.89 50.87 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.635 -0.665 . . . . 72.31 109.307 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.67 -48.09 23.79 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.169 1.912 . . . . 75.13 112.589 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -52.57 -45.76 66.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.083 -1.011 . . . . 75.23 109.232 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -86.98 2.18 50.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.261 -0.9 . . . . 72.43 109.137 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 53.12 18.07 1.09 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 75.13 109.391 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -101.46 130.92 47.8 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.432 -0.793 . . . . 73.22 109.459 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 135' ' ' ILE . . . . . 0.428 HG23 ' O ' ' B' ' 135' ' ' ILE . 16.2 tt -113.12 133.24 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.536 -0.728 . . . . 64.14 109.095 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 2.5 mp -114.56 131.63 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.504 -0.748 . . . . 71.22 109.327 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -137.76 126.68 24.09 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.333 -0.854 . . . . 64.22 109.866 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp 52.76 34.78 16.98 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.369 -0.832 . . . . 72.02 110.413 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.35 13.89 82.78 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 120.041 -1.076 . . . . 74.32 110.723 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 53.0 mtt-85 -109.3 122.81 48.15 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.311 -1.111 . . . . 75.34 109.136 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -92.08 136.59 33.06 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.189 -0.944 . . . . 71.23 109.373 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.79 135.25 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.449 -0.782 . . . . 70.43 109.158 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -88.25 125.42 34.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.202 -0.936 . . . . 72.43 109.096 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 3.2 m -143.97 124.89 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.218 -0.926 . . . . 72.13 109.471 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -156.59 16.99 0.32 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.338 -0.852 . . . . 72.02 109.271 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -66.64 164.44 42.23 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.242 -1.543 . . . . 42.23 109.242 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 0.569 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 2.8 tmtp? -58.11 -43.98 98.87 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.222 -1.163 . . . . 73.3 109.224 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 148' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 23.3 Cg_exo -63.56 -20.63 69.81 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.591 2.194 . . . . 71.33 112.331 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 149' ' ' PHE . . . . . 0.491 ' CE2' HG23 ' B' ' 153' ' ' THR . 86.1 t80 -89.24 -22.65 22.63 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.175 -0.953 . . . . 74.23 110.035 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -50.53 -41.87 54.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.078 -1.014 . . . . 72.34 109.444 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 11.0 p -66.53 -32.4 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.955 . . . . 73.35 109.084 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.522 ' O ' HD13 ' B' ' 152' ' ' LEU . 0.2 OUTLIER -56.79 -43.64 81.1 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.707 -0.849 . . . . 55.24 108.707 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.491 HG23 ' CE2' ' B' ' 149' ' ' PHE . 2.7 p -73.65 -30.73 63.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.103 -0.998 . . . . 70.01 109.193 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -55.02 -54.07 47.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.912 . . . . 65.32 109.744 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.04 -28.94 63.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.071 -1.018 . . . . 71.54 109.572 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.15 -49.84 65.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 75.32 109.583 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.427 ' C ' ' H ' ' B' ' 159' ' ' ARG . 24.3 mtp180 -71.47 -44.94 63.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 73.32 109.387 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -74.94 20.47 0.13 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.415 -0.803 . . . . 74.14 109.793 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 159' ' ' ARG . . . . . 0.427 ' H ' ' C ' ' B' ' 157' ' ' ARG . 6.6 mmt85 -54.3 173.51 0.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.042 -1.037 . . . . 61.41 108.88 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 160' ' ' ASP . . . . . 0.412 ' OD2' ' O ' ' B' ' 160' ' ' ASP . 4.6 p-10 42.37 47.47 4.25 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.544 -0.722 . . . . 72.1 110.276 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -161.32 157.76 25.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 72.25 109.459 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 162' ' ' ILE . . . . . 0.745 HD12 ' N ' ' B' ' 162' ' ' ILE . 1.8 mp -91.37 131.41 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.237 -0.915 . . . . 72.31 109.174 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 163' ' ' VAL . . . . . 0.405 HG11 HD21 ' B' ' 168' ' ' LEU . 40.3 t -123.59 136.56 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.529 -0.732 . . . . 64.21 109.335 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 11.3 p -83.39 158.35 22.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 74.22 109.568 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -62.54 -43.51 98.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.861 . . . . 65.31 109.349 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -65.53 -34.5 78.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 63.45 109.888 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -50.76 -49.38 58.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.11 -0.994 . . . . 72.4 109.39 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 168' ' ' LEU . . . . . 0.405 HD21 HG11 ' B' ' 163' ' ' VAL . 53.6 mt -66.42 -40.33 89.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.199 -0.938 . . . . 72.32 109.355 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.507 HD23 ' C ' ' B' ' 169' ' ' LEU . 3.7 tt -48.99 -59.12 3.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 73.34 109.482 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 170' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' B' ' 174' ' ' GLU . 78.0 m-20 -67.88 -41.4 82.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 72.1 110.14 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 171' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' B' ' 170' ' ' ASP . . . -43.1 -47.72 6.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.376 -0.827 . . . . 62.13 110.586 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 16.4 mm -94.96 -9.94 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.056 -1.028 . . . . 71.42 110.267 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -147.69 49.66 1.07 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.848 -1.158 . . . . 72.23 110.446 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 174' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' B' ' 170' ' ' ASP . 88.2 tt0 -76.08 -32.57 59.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.011 -1.055 . . . . 52.11 108.995 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 175' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' B' ' 177' ' ' GLU . 28.5 mt-10 -57.06 154.27 20.6 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.35 -0.844 . . . . 73.04 109.187 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -41.45 -14.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.437 2.092 . . . . 74.13 112.828 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 177' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' B' ' 175' ' ' GLU . 77.8 mm-40 -46.19 121.96 3.65 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.138 -0.976 . . . . 72.44 109.807 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 63.9 mtm -89.34 122.37 32.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.895 . . . . 63.43 109.394 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 1.2 m -103.12 143.58 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.426 -0.796 . . . . 71.05 109.19 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 180' ' ' THR . . . . . 0.443 ' O ' ' O ' ' B' ' 181' ' ' PRO . 22.7 m -63.41 135.16 96.13 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.337 -0.852 . . . . 62.15 109.484 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 181' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' B' ' 180' ' ' THR . 95.8 Cg_exo -41.11 171.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.181 1.921 . . . . 65.22 112.783 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 3.2 m120 61.32 39.52 15.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.398 -0.814 . . . . 72.31 109.411 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 25.4 t -79.33 -49.65 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.884 . . . . 63.32 109.802 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.432 ' O ' HG22 ' B' ' 188' ' ' ILE . 27.7 mm -70.0 -24.85 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 75.03 110.183 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -64.18 -44.51 91.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.831 -1.168 . . . . 64.11 109.306 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 19.4 m -77.21 -31.85 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.203 -0.936 . . . . 73.0 109.59 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.2 -50.24 20.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.06 -1.025 . . . . 61.12 110.014 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 188' ' ' ILE . . . . . 0.625 HD12 ' CZ ' ' B' ' 212' ' ' TYR . 1.8 tt -59.43 -44.78 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.154 -0.966 . . . . 72.43 110.151 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 189' ' ' ASN . . . . . 0.521 ' N ' HG23 ' B' ' 188' ' ' ILE . 58.4 t30 -60.3 -43.58 96.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.091 -1.006 . . . . 65.14 109.584 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 190' ' ' GLN . . . . . 0.414 ' O ' ' CB ' ' B' ' 194' ' ' LYS . 15.1 mm-40 -68.64 -46.51 68.99 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.258 -0.901 . . . . 63.24 109.882 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 82.3 mt -54.47 -30.26 21.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 120.654 -1.279 . . . . 74.03 109.791 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 65.8 mtp85 -73.01 -60.84 2.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.013 -1.055 . . . . 72.24 110.871 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 193' ' ' GLN . . . . . 0.429 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 76.0 mt-30 -70.94 -32.8 69.81 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.027 -1.046 . . . . 73.1 110.252 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 194' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' B' ' 190' ' ' GLN . 20.7 ttpp -72.02 -26.82 62.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.478 -0.764 . . . . 72.11 110.696 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 17.4 tpt -92.44 -44.49 8.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.889 -1.132 . . . . 44.33 110.016 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 196' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 59.3 p30 -64.17 -19.65 65.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.034 -1.041 . . . . 71.21 110.086 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 197' ' ' LYS . . . . . 0.533 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 29.7 mttm -67.96 -64.75 1.74 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.081 -1.012 . . . . 75.21 109.198 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 198' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 39.7 Cg_endo -64.88 -50.99 1.88 Allowed 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.075 1.85 . . . . 75.32 110.976 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 199' ' ' LEU . . . . . 0.903 HD21 ' O ' ' B' ' 201' ' ' ILE . 0.0 OUTLIER -95.74 134.53 38.57 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.868 -1.16 . . . . 72.25 107.868 179.303 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . -97.96 -8.52 55.4 Favored Glycine 0 N--CA 1.498 2.816 0 O-C-N 121.083 -1.011 . . . . 64.53 110.615 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 201' ' ' ILE . . . . . 0.903 ' O ' HD21 ' B' ' 199' ' ' LEU . 70.2 mt -91.74 124.84 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.023 -1.281 . . . . 44.23 109.471 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 23.3 t -77.26 135.82 38.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 54.01 109.603 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 2.0 p -145.31 28.24 1.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.261 -0.899 . . . . 74.4 109.281 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 35.8 m -135.64 138.37 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.395 -0.816 . . . . 72.12 109.466 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -126.34 136.48 52.78 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.582 -0.699 . . . . 65.41 109.281 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 10.5 p -95.05 139.37 31.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.208 -0.933 . . . . 71.33 109.422 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.462 ' N ' ' O ' ' B' ' 211' ' ' GLY . 39.0 t -131.6 124.44 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.522 -0.736 . . . . 63.5 109.197 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 208' ' ' ARG . . . . . 0.467 ' CD ' ' N ' ' B' ' 208' ' ' ARG . 1.3 mpt_? -76.5 -34.93 58.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 74.45 109.822 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 209' ' ' ARG . . . . . 0.413 ' N ' ' CD ' ' B' ' 209' ' ' ARG . 11.7 mpt_? -56.17 -62.74 1.5 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.151 -0.968 . . . . 74.14 109.68 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 62.1 mmt-85 -98.81 -76.45 0.54 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.235 -0.915 . . . . 74.43 109.529 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 211' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' B' ' 207' ' ' VAL . . . -167.26 -107.41 0.2 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.528 -1.429 . . . . 64.45 109.528 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 212' ' ' TYR . . . . . 0.625 ' CZ ' HD12 ' B' ' 188' ' ' ILE . 2.9 m-85 -120.58 133.96 55.33 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.592 -0.946 . . . . 74.21 109.346 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -104.77 126.53 51.95 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.494 -0.753 . . . . 74.03 109.083 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -101.96 125.89 48.75 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.348 -0.845 . . . . 74.34 109.276 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 20.5 p -142.76 154.26 44.08 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.336 -0.852 . . . . 64.33 109.378 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -63.96 154.24 82.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 70.04 108.865 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -38.23 147.3 0.11 Allowed 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.178 1.918 . . . . 65.11 111.902 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.588 ' N ' ' CD ' ' B' ' 219' ' ' PRO . 21.1 mttp -72.95 -36.6 3.47 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 73.15 111.355 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 219' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' B' ' 218' ' ' LYS . 86.9 Cg_endo -87.88 12.85 2.76 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.108 1.872 . . . . 71.31 112.135 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -60.81 145.71 48.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 75.45 109.321 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 36.3 t -140.36 154.3 46.69 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.324 -0.86 . . . . 72.22 109.396 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -157.54 164.6 37.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.892 . . . . 54.53 109.363 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.011 -0.995 . . . . 71.13 109.42 -179.911 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.2 ttm . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.518 -0.549 . . . . 65.12 109.518 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.485 ' N ' ' OD2' ' A' ' 46' ' ' ASP . 97.6 mtt180 -129.65 156.77 43.71 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.497 -0.752 . . . . 72.33 109.17 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.0 t -118.65 124.44 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 CA-C-O 121.792 0.806 . . . . 71.42 110.014 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.518 HD11 ' CG1' ' A' ' 6' ' ' ILE . 2.1 tp -94.07 117.35 29.97 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.398 -0.964 . . . . 65.12 108.398 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 6' ' ' ILE . 3.7 tt -119.44 119.43 33.88 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.092 -1.077 . . . . 62.43 108.092 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.539 ' N ' HD23 ' A' ' 5' ' ' LEU . 56.3 mt -110.91 99.48 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.316 -0.865 . . . . 71.15 109.259 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' A' ' 30' ' ' THR . 36.2 tp10 -122.94 133.2 54.4 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.56 -0.712 . . . . 75.34 109.423 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -66.34 -34.47 78.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.242 -0.911 . . . . 72.44 109.555 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 10' ' ' SER . 21.6 p30 -82.98 -149.72 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.24 -0.913 . . . . 63.02 109.471 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.498 ' N ' ' OD1' ' A' ' 9' ' ' ASN . 20.9 p -152.55 -39.63 0.11 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.215 -0.928 . . . . 72.34 109.67 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.556 HG13 ' N ' ' A' ' 12' ' ' LEU . 11.1 p -64.39 -44.14 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 74.02 109.725 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.556 ' N ' HG13 ' A' ' 11' ' ' VAL . 14.9 tp -65.28 -39.19 92.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 71.43 109.312 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.75 -28.03 69.78 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 108.035 -2.026 . . . . 61.32 108.035 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.12 -46.04 94.13 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 110.07 -1.212 . . . . 71.2 110.07 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -65.98 -47.15 75.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -1.203 . . . . 71.32 109.832 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.8 mm -65.51 -36.53 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.603 -1.311 . . . . 63.23 108.372 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.478 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 86.7 tt0 -65.54 -47.91 74.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.464 -0.773 . . . . 51.11 109.798 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -83.52 1.18 43.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.089 -1.007 . . . . 73.34 109.748 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.24 -55.17 2.54 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.567 -1.413 . . . . 62.15 109.567 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.402 HD23 ' N ' ' A' ' 21' ' ' ASN . 1.3 pt? -76.23 -21.79 55.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -1.15 . . . . 73.51 109.917 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 92.9 m-20 -55.22 -32.28 62.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.034 -1.041 . . . . 74.25 109.345 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.3 t -60.02 -38.31 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 70.04 109.359 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.496 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 3.4 mptp? -62.68 -26.47 68.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.354 -0.842 . . . . 73.23 109.275 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.89 24.14 5.32 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 110.215 -1.154 . . . . 75.54 110.215 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -105.33 157.51 17.27 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.227 -1.16 . . . . 73.43 109.091 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.0 mmm -104.24 136.96 42.87 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.134 -1.061 . . . . 43.24 108.134 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.26 160.25 41.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.193 -0.942 . . . . 62.11 109.851 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -140.57 145.39 36.67 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.411 -0.806 . . . . 74.42 109.526 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 t -104.13 134.92 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.462 -0.94 . . . . 72.15 108.462 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.425 ' O ' ' O ' ' A' ' 7' ' ' GLU . 6.5 p -131.04 172.44 12.08 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.39 -0.819 . . . . 71.42 109.44 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -92.26 -104.54 0.11 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.24 -0.913 . . . . 72.33 110.001 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.4 p -78.8 167.41 21.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.245 -0.909 . . . . 74.24 110.269 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 35.7 mt -54.17 -29.62 46.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.635 -0.666 . . . . 71.53 109.857 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -47.79 -49.36 28.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.049 -1.032 . . . . 74.23 109.719 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -68.12 -38.39 82.19 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.142 -0.974 . . . . 54.03 109.222 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.84 -45.05 59.69 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.377 -1.489 . . . . 61.41 109.377 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -65.75 -38.44 89.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -1.103 . . . . 74.34 109.265 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -75.41 -37.52 60.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.151 -0.968 . . . . 75.33 109.679 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.3 tp -72.7 -47.55 46.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 74.33 110.101 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.495 ' SD ' ' OD1' ' A' ' 41' ' ' ASP . 3.7 ppp? -63.73 -28.71 70.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.105 -0.997 . . . . 70.32 110.083 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.495 ' OD1' ' SD ' ' A' ' 40' ' ' MET . 99.3 m-20 -65.6 -39.9 92.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.036 -1.04 . . . . 71.22 110.016 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.0 pt -82.88 -29.63 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.148 -0.97 . . . . 74.14 110.251 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 40' ' ' MET . 93.0 mtt180 -129.89 146.89 51.61 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.323 -0.861 . . . . 72.24 109.514 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -91.28 161.7 14.93 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.206 -0.934 . . . . 75.42 109.654 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -143.11 153.67 43.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.337 -0.852 . . . . 74.23 109.142 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.485 ' OD2' ' N ' ' A' ' 2' ' ' ARG . 3.8 p30 -95.41 -41.5 8.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.192 -0.943 . . . . 72.04 109.514 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.525 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.3 OUTLIER -104.84 115.76 30.85 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.433 -0.792 . . . . 72.13 109.05 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.525 ' N ' HD13 ' A' ' 47' ' ' LEU . 74.5 t -101.49 97.8 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.389 -0.967 . . . . 72.34 108.389 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -114.27 130.66 56.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.491 -0.756 . . . . 74.11 110.303 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.561 HG22 ' H ' ' A' ' 52' ' ' ASP . 1.5 p -138.4 129.36 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 121.728 0.775 . . . . 61.12 109.652 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.8 t -92.14 3.67 54.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.49 -0.757 . . . . 73.11 109.199 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.561 ' H ' HG22 ' A' ' 50' ' ' VAL . 51.8 m-20 -76.28 138.07 40.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.305 -0.872 . . . . 52.55 109.509 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.493 ' C ' ' H ' ' A' ' 55' ' ' ALA . 28.1 mtmm -67.94 -35.25 78.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.179 -0.95 . . . . 44.22 110.049 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -71.36 17.08 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.153 -0.967 . . . . 70.44 109.734 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -60.29 -30.4 69.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 64.14 110.085 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.412 ' HG ' ' H ' ' A' ' 56' ' ' LEU . 22.3 mt -46.07 -43.85 14.96 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.087 -1.008 . . . . 44.14 110.097 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.2 p -73.21 -40.23 64.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.93 -1.106 . . . . 55.23 109.627 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.63 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 58.8 t80 -65.13 -56.9 10.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.408 -0.807 . . . . 74.44 110.127 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.459 HG23 ' N ' ' A' ' 60' ' ' SER . 17.2 m -54.05 -38.2 37.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 120.839 -1.163 . . . . 74.03 109.638 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.459 ' N ' HG23 ' A' ' 59' ' ' VAL . 46.2 p -54.83 -52.73 61.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.176 -0.952 . . . . 64.3 109.662 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -69.63 -29.81 67.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.088 -1.008 . . . . 64.44 110.342 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.63 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 6.1 mm -68.16 -47.9 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.639 -1.288 . . . . 63.21 110.357 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.466 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 41.4 mmtt -62.85 -43.7 98.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.065 -1.022 . . . . 74.42 110.691 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.403 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 7.0 pt-20 -73.55 -41.05 63.46 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.71 -1.244 . . . . 70.32 109.747 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.447 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 25.6 mtpp -78.17 -19.84 53.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.151 -0.968 . . . . 75.22 109.143 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.572 ' O ' HG22 ' A' ' 69' ' ' ILE . 91.7 m-70 -154.94 69.46 0.73 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 74.13 109.222 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.0 p -63.58 -27.2 69.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.31 -0.869 . . . . 73.24 110.085 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.6 t -79.5 48.95 0.95 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.058 -1.026 . . . . 61.01 109.856 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.572 HG22 ' O ' ' A' ' 66' ' ' HIS . 13.8 tt -146.68 156.59 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.084 -1.01 . . . . 71.33 109.456 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.9 t -92.81 154.15 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.171 -0.956 . . . . 72.13 109.51 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.518 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 21.3 t -135.96 125.99 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.299 -0.876 . . . . 54.21 110.074 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.533 HD13 ' C ' ' A' ' 72' ' ' LEU . 1.3 tm? -118.62 101.67 8.3 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.423 -0.955 . . . . 50.24 108.423 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -95.5 138.94 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.933 -1.104 . . . . 74.41 109.57 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.1 m -122.86 161.31 24.32 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.677 -0.86 . . . . 72.31 108.677 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 77' ' ' ASN . 3.0 p -172.2 121.43 0.45 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.999 -1.063 . . . . 64.54 109.971 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.415 ' N ' ' HB2' ' A' ' 97' ' ' LYS . 50.8 p30 -64.31 63.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.701 -0.624 . . . . 74.13 109.931 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 75' ' ' SER . 2.9 p30 -177.14 53.65 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.201 -0.937 . . . . 73.34 109.669 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 77' ' ' ASN . 6.9 Cg_endo -48.84 84.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.365 2.043 . . . . 63.22 111.729 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.712 HG23 ' H ' ' A' ' 82' ' ' GLU . 2.9 t -114.48 151.64 32.94 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.041 -0.725 . . . . 62.53 109.041 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -28.4 67.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 73.44 109.231 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -63.89 -41.09 97.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.279 -0.888 . . . . 71.42 109.829 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.712 ' H ' HG23 ' A' ' 79' ' ' THR . 37.8 tp10 -76.91 -26.28 53.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.085 -1.009 . . . . 73.43 109.342 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -67.89 -46.47 71.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 74.22 109.683 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 85' ' ' HIS . 29.4 m -68.89 -41.19 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.098 -1.002 . . . . 73.2 109.566 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.441 ' N ' HG23 ' A' ' 84' ' ' VAL . 73.5 t60 -72.14 -31.59 66.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -0.935 . . . . 53.33 109.637 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -65.76 -39.49 91.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 64.11 110.114 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -77.39 -36.08 53.78 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.049 -1.032 . . . . 74.34 108.769 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -68.33 -38.56 81.64 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.383 -0.823 . . . . 74.42 109.305 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 21.7 mm100 -64.39 -44.86 89.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 74.24 109.319 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.09 -15.86 1.02 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.036 -1.226 . . . . 61.51 110.036 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -51.68 132.85 31.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.047 -1.267 . . . . 55.33 109.393 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.518 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 71.0 m-20 -80.83 -33.28 34.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 73.42 109.409 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.527 ' CG ' HH21 ' A' ' 108' ' ' ARG . 65.3 m-20 -152.45 129.53 11.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.258 -0.901 . . . . 75.04 109.249 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -104.5 116.42 32.07 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.875 -0.787 . . . . 71.33 108.875 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.43 HG12 HD11 ' A' ' 72' ' ' LEU . 23.8 mm -106.53 149.92 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-O 122.194 0.997 . . . . 71.13 111.319 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.79 117.65 11.65 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.842 -1.54 . . . . 64.32 106.842 177.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.665 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -43.59 -54.0 11.08 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.173 -0.954 . . . . 62.2 111.778 -178.283 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.2 Cg_endo -41.8 -11.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.237 0 CA-C-N 119.851 0.983 . . . . 73.11 112.565 -176.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.665 ' N ' ' O ' ' A' ' 97' ' ' LYS . 61.2 m-85 57.69 116.07 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.817 -0.552 . . . . 65.22 109.701 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -56.47 -38.11 71.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.849 -1.157 . . . . 72.35 108.776 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.786 ' O ' ' N ' ' A' ' 103' ' ' LYS . 9.9 t -173.56 40.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.251 -0.906 . . . . 71.32 110.688 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.5 mt 48.09 -69.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 CA-C-N 118.68 0.673 . . . . 75.43 110.505 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.786 ' N ' ' O ' ' A' ' 101' ' ' SER . 41.4 tptt -52.07 -31.22 29.34 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.181 -1.044 . . . . 71.41 108.181 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.66 -56.04 21.43 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.622 -0.831 . . . . 63.24 108.836 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.724 HD13 ' N ' ' A' ' 106' ' ' VAL . 0.7 OUTLIER -62.69 -56.18 20.04 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.65 -0.87 . . . . 73.22 108.65 179.638 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.724 ' N ' HD13 ' A' ' 105' ' ' LEU . 87.4 t -48.44 -46.24 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.995 -1.065 . . . . 60.11 109.154 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.94 -35.73 62.05 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.212 -0.93 . . . . 70.42 108.553 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.53 ' NH1' ' CZ ' ' B' ' 87' ' ' PHE . 53.1 ttt85 -71.64 -29.43 64.63 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.435 -0.79 . . . . 74.41 109.681 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 87.0 mt -74.85 -32.92 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.978 -1.076 . . . . 62.54 108.498 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -74.47 -51.01 16.06 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.525 -0.734 . . . . 74.34 109.648 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.94 -43.3 69.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.901 . . . . 73.32 109.666 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.409 ' CB ' HD12 ' A' ' 113' ' ' LEU . 82.7 mtm180 -65.38 -39.9 92.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.193 -0.942 . . . . 52.41 109.612 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.409 HD12 ' CB ' ' A' ' 112' ' ' ARG . 5.3 mp -139.96 94.07 2.72 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.13 -0.982 . . . . 65.24 109.269 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.4 mtm-85 -84.68 -70.89 0.55 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.14 -0.975 . . . . 64.45 108.881 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' A' ' 116' ' ' TRP . 30.4 p90 -163.16 -33.83 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.124 -0.985 . . . . 74.43 109.511 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.54 ' N ' ' CD1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER 38.44 -94.66 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.707 -0.62 . . . . 74.42 110.355 179.727 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 115' ' ' PHE . . . 76.88 72.45 1.11 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.503 -1.439 . . . . 75.04 109.503 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.537 ' O ' ' OG ' ' A' ' 129' ' ' SER . 0.3 OUTLIER -147.41 172.96 13.11 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.256 -1.143 . . . . 61.14 109.688 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.542 ' HA ' ' OG ' ' A' ' 129' ' ' SER . 0.0 OUTLIER -152.25 149.86 29.16 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.552 -0.717 . . . . 65.24 109.288 -178.23 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.91 -32.73 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.177 -0.952 . . . . 73.11 110.104 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 38.4 mm -116.33 106.34 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.416 -0.802 . . . . 72.24 109.183 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -109.01 115.96 31.07 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.475 -0.766 . . . . 72.34 109.443 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.406 ' O ' ' O ' ' A' ' 126' ' ' LEU . 29.1 mm -116.17 105.29 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.567 -0.708 . . . . 71.44 109.514 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 47.21 -143.87 5.41 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.935 -1.266 . . . . 73.4 109.935 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -66.82 -21.91 66.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.359 -1.083 . . . . 74.45 108.921 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.49 ' N ' HD23 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -80.59 113.39 18.75 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.827 -1.175 . . . . 54.21 107.827 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.9 m -108.33 144.23 36.13 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.36 -0.838 . . . . 54.5 109.342 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 77.1 mt -132.7 128.98 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.457 -0.777 . . . . 45.15 109.704 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.542 ' OG ' ' HA ' ' A' ' 119' ' ' ASN . 1.8 m -117.83 94.16 45.55 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 108.551 -0.907 . . . . 71.11 108.551 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.35 -22.6 10.82 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.557 1.505 . . . . 65.41 112.277 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.883 ' OD1' ' OE2' ' A' ' 132' ' ' GLU . 11.1 t70 -59.35 -48.96 79.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.067 -1.021 . . . . 63.32 109.282 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.883 ' OE2' ' OD1' ' A' ' 131' ' ' ASP . 7.9 mm-40 -97.36 9.17 43.04 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.205 -0.934 . . . . 72.52 108.938 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 53.61 80.54 0.11 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.56 -0.712 . . . . 75.33 110.438 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 9.5 ttpt -164.37 141.42 6.53 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.81 -0.811 . . . . 71.23 108.81 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.527 HG21 ' CE2' ' A' ' 137' ' ' TYR . 88.9 mt -118.2 149.51 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.531 -0.73 . . . . 74.02 109.765 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 65.5 mt -131.72 117.69 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.527 -0.916 . . . . 60.23 108.527 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.527 ' CE2' HG21 ' A' ' 135' ' ' ILE . 44.9 m-85 -109.25 124.77 51.43 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.397 -0.815 . . . . 62.32 110.401 -178.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.1 mtpp 48.94 25.84 1.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.467 -0.77 . . . . 75.4 110.61 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 92.51 14.28 55.77 Favored Glycine 0 N--CA 1.498 2.81 0 O-C-N 121.0 -1.063 . . . . 72.24 110.999 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -105.5 124.29 49.31 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.17 -1.194 . . . . 71.22 109.267 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -82.42 122.19 27.69 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.195 -0.941 . . . . 71.42 110.852 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.08 138.0 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.055 -1.091 . . . . 53.02 108.055 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -82.18 167.14 19.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.323 -0.86 . . . . 60.45 109.627 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 1.098 ' C ' ' HD2' ' A' ' 149' ' ' PHE . 6.0 m -129.6 128.15 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.797 -0.816 . . . . 74.44 108.797 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 1.482 ' HA ' ' CE2' ' A' ' 149' ' ' PHE . 32.7 pttt -175.52 -24.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.412 -0.805 . . . . 65.15 109.698 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 1.108 ' O ' ' CD1' ' A' ' 149' ' ' PHE . . . -64.97 -172.42 3.25 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.561 -1.416 . . . . 73.34 109.561 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.593 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 6.3 ttmt -70.27 -39.4 10.11 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.365 -1.08 . . . . 72.22 110.634 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 60.6 Cg_endo -84.94 15.46 2.21 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.126 1.884 . . . . 65.23 112.757 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 1.482 ' CE2' ' HA ' ' A' ' 145' ' ' LYS . 0.1 OUTLIER -97.31 -50.36 4.58 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.073 -1.017 . . . . 60.11 109.609 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 1.443 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 97.2 mt-10 -55.35 -44.0 75.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.418 -0.801 . . . . 64.21 109.596 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.46 HG13 ' N ' ' A' ' 152' ' ' LEU . 13.1 p -63.77 -38.2 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 72.02 109.378 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.545 ' O ' HD13 ' A' ' 152' ' ' LEU . 0.2 OUTLIER -59.22 -42.82 91.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.387 -0.821 . . . . 73.31 109.016 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.4 m -72.13 -28.84 63.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 74.31 109.44 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -63.08 -55.11 28.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.405 -0.81 . . . . 74.31 110.073 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 159' ' ' ARG . 3.6 pp -67.49 -26.76 66.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.04 -1.037 . . . . 75.34 109.083 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.02 -52.21 63.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.108 -0.995 . . . . 62.14 108.904 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -66.8 -52.6 42.06 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.282 -0.886 . . . . 61.03 109.145 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -88.5 37.62 0.83 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.549 -0.719 . . . . 74.12 109.544 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' ' 155' ' ' LEU . 55.4 ttt-85 -65.46 -17.85 64.86 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.118 -0.989 . . . . 71.13 109.783 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.9 72.8 1.31 Allowed 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.517 -0.92 . . . . 75.45 108.517 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -170.57 159.18 6.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.875 . . . . 73.41 109.539 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.4 mt -81.51 136.69 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.29 -0.881 . . . . 74.41 109.002 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 14.2 t -131.48 135.73 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.341 -0.849 . . . . 72.31 109.793 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.7 p -97.59 159.36 14.97 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.4 -0.812 . . . . 74.12 109.122 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -57.9 -36.08 71.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 70.43 109.899 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -64.16 -42.23 96.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.166 -0.959 . . . . 73.52 110.075 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -53.4 -49.94 66.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.086 -1.009 . . . . 74.52 109.415 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 34.5 mt -61.9 -39.76 93.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.174 -0.954 . . . . 72.31 109.398 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.475 HD23 ' C ' ' A' ' 169' ' ' LEU . 5.3 tt -55.5 -59.21 5.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.866 . . . . 53.33 109.763 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.88 -39.66 93.89 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.423 -0.798 . . . . 62.44 111.203 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -53.0 -55.39 23.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.929 -1.107 . . . . 60.21 111.08 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.742 HD12 ' N ' ' A' ' 172' ' ' ILE . 1.9 mp -94.26 -59.69 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 120.83 -1.169 . . . . 75.32 110.237 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.458 ' O ' ' O ' ' A' ' 169' ' ' LEU . 24.3 m-90 -81.33 119.7 24.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 73.14 109.864 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.492 ' H ' ' HD2' ' A' ' 176' ' ' PRO . 74.8 tt0 -143.66 -51.69 0.33 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.97 -1.081 . . . . 73.24 110.122 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.625 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 27.6 mt-10 -86.58 -33.62 0.45 Allowed Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 120.99 -1.069 . . . . 44.43 111.654 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 58.3 Cg_exo -52.73 -48.9 19.57 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 121.97 1.78 . . . . 72.51 112.408 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 46.0 -157.45 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.263 -0.898 . . . . 63.24 109.572 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 59.7 mtt 54.71 27.44 8.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.223 -0.923 . . . . 73.5 109.666 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 9.5 m -134.25 144.38 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.493 -0.755 . . . . 65.22 109.22 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.446 ' O ' HG13 ' A' ' 183' ' ' VAL . 0.7 OUTLIER -67.86 152.6 96.23 Favored Pre-proline 0 N--CA 1.487 1.407 0 O-C-N 121.05 -1.031 . . . . 71.42 108.321 179.63 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.6 -24.67 11.69 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.348 2.032 . . . . 41.22 112.251 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 35.7 p30 -81.63 5.54 17.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.887 . . . . 64.54 110.326 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 180' ' ' THR . 26.4 m -67.68 -16.1 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.854 -1.153 . . . . 74.02 109.518 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.448 ' O ' HG22 ' A' ' 188' ' ' ILE . 32.2 mm -59.82 -30.1 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.925 . . . . 72.33 109.369 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -58.14 -35.65 71.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.236 -0.915 . . . . 74.4 109.794 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 50.4 t -82.99 -45.45 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 70.42 109.084 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -60.71 -36.35 78.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 52.11 110.255 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 189' ' ' ASN . 9.4 tp -76.33 -42.98 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.781 -1.199 . . . . 71.4 109.102 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.492 ' N ' HG23 ' A' ' 188' ' ' ILE . 69.4 m-20 -59.87 -33.89 72.41 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.198 -0.939 . . . . 73.44 109.082 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -79.68 -48.67 13.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.192 -0.942 . . . . 71.42 109.968 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.444 HD13 HG21 ' A' ' 151' ' ' VAL . 64.4 mt -55.96 -41.98 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.095 -1.003 . . . . 61.55 109.29 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -63.87 -49.64 71.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.121 -0.987 . . . . 63.34 109.269 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -62.0 -31.47 71.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 61.24 108.984 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.418 ' NZ ' ' CB ' ' A' ' 194' ' ' LYS . 7.5 mtpm? -84.79 -8.54 58.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.47 -0.769 . . . . 75.13 109.735 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 16.2 ttt -102.48 -39.56 7.07 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.45 -0.781 . . . . 74.02 110.421 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -75.02 -15.37 60.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.025 -1.047 . . . . 74.02 110.724 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.445 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 8.7 mmtm -80.58 -65.29 0.27 Allowed Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.902 -1.124 . . . . 75.43 109.964 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 24.7 Cg_endo -60.0 -49.6 9.37 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.345 2.03 . . . . 72.32 112.849 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.444 ' N ' HD12 ' A' ' 199' ' ' LEU . 10.4 mp -66.2 -100.19 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.856 -1.152 . . . . 74.54 109.239 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 156.07 -39.31 0.59 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.132 -1.587 . . . . 61.51 109.132 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 20.5 mm -104.14 127.09 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.571 -0.958 . . . . 61.22 109.12 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 11.9 p -83.6 133.07 34.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.107 -0.995 . . . . 72.0 108.682 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.03 12.91 11.24 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.447 -0.783 . . . . 74.44 109.515 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.9 148.31 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.425 -0.797 . . . . 64.35 109.532 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -124.82 115.58 20.91 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.651 -0.655 . . . . 71.41 109.329 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.37 114.01 22.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.274 -0.891 . . . . 73.52 109.011 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 209' ' ' ARG . 13.8 t -120.73 146.31 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.546 -0.721 . . . . 71.02 109.668 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -69.89 -36.44 75.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.372 -0.83 . . . . 72.12 109.547 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.412 ' H ' HG12 ' A' ' 207' ' ' VAL . 80.8 mtm180 -73.28 160.18 32.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 64.41 109.736 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.562 ' NE ' ' H ' ' A' ' 210' ' ' ARG . 0.0 OUTLIER 47.86 -102.25 0.08 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.156 -0.965 . . . . 71.54 109.002 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -158.98 -114.22 0.38 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.08 -1.608 . . . . 72.03 109.08 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -108.79 133.74 52.43 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.513 -0.992 . . . . 75.54 108.929 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -112.04 128.45 56.19 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.342 -0.849 . . . . 75.31 110.585 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -98.27 128.53 44.76 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.627 -0.879 . . . . 75.41 108.627 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 8.9 t -149.98 168.96 22.32 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.03 -1.044 . . . . 74.14 110.453 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -60.95 131.46 91.74 Favored Pre-proline 0 N--CA 1.49 1.556 0 N-CA-C 109.361 -0.607 . . . . 75.32 109.361 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -36.83 143.09 0.13 Allowed 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.291 1.994 . . . . 73.11 112.744 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 72.9 tttt -92.8 -32.36 0.32 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.439 -0.788 . . . . 75.25 111.697 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 93.0 Cg_endo -86.15 31.49 0.47 Allowed 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 121.944 1.763 . . . . 75.1 112.049 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -95.25 170.28 9.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.401 -0.812 . . . . 71.14 109.128 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 6.1 t 61.07 158.51 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.354 -0.841 . . . . 71.13 109.456 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -90.7 138.63 31.42 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.073 -1.017 . . . . 75.35 109.538 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 117.983 -1.008 . . . . 73.41 109.399 179.988 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.591 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.458 -0.571 . . . . 71.14 109.458 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.433 ' O ' ' OD1' ' B' ' 46' ' ' ASP . 88.2 mtt180 -139.28 153.43 47.78 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.261 -0.9 . . . . 73.23 109.552 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 94.2 t -111.16 135.04 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.665 -0.647 . . . . 72.24 109.297 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.448 HD11 ' CG1' ' B' ' 6' ' ' ILE . 3.6 tp -106.84 118.28 36.26 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.526 -0.734 . . . . 54.33 109.707 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.436 ' N ' HD12 ' B' ' 4' ' ' LEU . 16.9 mt -114.58 98.32 6.81 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.83 -0.804 . . . . 74.35 108.83 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.692 HD12 ' HB ' ' B' ' 50' ' ' VAL . 87.1 mt -84.79 96.98 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.743 -1.223 . . . . 42.55 108.772 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.525 ' CD ' ' HG ' ' B' ' 51' ' ' SER . 8.6 tp10 -141.91 127.86 19.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.353 -0.842 . . . . 74.52 109.46 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -66.74 -32.92 74.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 62.55 109.148 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' ASN . . . . . 0.413 ' H ' ' HG3' ' B' ' 7' ' ' GLU . 99.5 m-20 -78.24 107.41 10.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.34 -0.85 . . . . 73.11 109.431 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 85.6 p -67.94 -23.77 65.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -0.879 . . . . 65.54 109.655 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.79 -49.77 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.148 -0.97 . . . . 75.55 109.687 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 80.7 mt -65.93 -37.44 86.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.157 -0.964 . . . . 70.14 109.572 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.74 -27.94 69.97 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.627 -1.789 . . . . 75.4 108.627 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.07 -53.44 36.92 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.581 -1.408 . . . . 65.44 109.581 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -58.54 -45.48 88.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.276 -1.132 . . . . 60.21 109.819 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 36.1 mm -65.63 -41.53 90.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.845 -1.159 . . . . 75.15 108.925 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -59.84 -44.5 94.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 73.01 109.513 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.452 ' CD ' ' N ' ' B' ' 18' ' ' LYS . 1.1 mptm? -86.59 1.1 52.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.092 -1.005 . . . . 74.3 108.768 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.51 -59.39 1.83 Allowed Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.481 -1.448 . . . . 70.54 109.481 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -67.87 -22.69 65.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -1.141 . . . . 71.34 109.522 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -54.14 -34.31 60.04 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.139 -0.976 . . . . 64.41 109.238 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 56.1 t -57.48 -47.63 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.344 -0.847 . . . . 74.23 109.013 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.445 ' NZ ' HG11 ' B' ' 106' ' ' VAL . 31.9 mmtm -60.49 -53.97 51.12 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.428 -0.795 . . . . 63.42 109.005 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 136.7 38.87 0.15 Allowed Glycine 0 N--CA 1.5 2.931 0 N-CA-C 110.298 -1.121 . . . . 53.43 110.298 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -120.38 160.46 23.03 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.375 -1.073 . . . . 71.12 109.505 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.4 mmt -105.27 140.26 38.68 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.807 -0.812 . . . . 75.24 108.807 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.431 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -135.23 159.26 42.12 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.429 -0.795 . . . . 72.12 109.818 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 89.2 m-20 -138.68 159.48 42.01 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.702 -0.851 . . . . 72.31 108.702 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 p -122.63 139.12 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.381 -0.825 . . . . 64.43 109.861 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 10.9 p -134.78 169.08 17.89 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.985 -0.746 . . . . 65.41 108.985 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -90.62 -107.57 0.09 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.165 -0.959 . . . . 71.02 109.787 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 82.3 p -79.09 168.61 19.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 51.11 109.993 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 50.5 mt -50.79 -31.3 16.52 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.6 -0.687 . . . . 71.24 109.843 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -51.62 -52.19 49.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.101 -0.999 . . . . 74.32 109.717 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.73 -40.89 96.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.17 -0.956 . . . . 73.03 109.354 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.24 -43.03 81.6 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.442 -1.463 . . . . 30.21 109.442 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -66.18 -38.69 88.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.321 -1.106 . . . . 74.42 109.549 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -75.13 -39.43 60.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 74.42 109.802 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 23.3 tp -72.88 -45.95 55.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.905 . . . . 75.41 110.112 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' MET . . . . . 0.449 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.4 ppp? -64.79 -27.06 68.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.004 -1.06 . . . . 60.41 109.84 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -58.49 -45.44 88.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.145 -0.972 . . . . 53.23 109.844 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 pt -88.93 -42.06 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.175 -0.953 . . . . 71.23 109.747 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' B' ' 40' ' ' MET . 10.7 mpt_? -96.73 144.04 27.1 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.077 -1.015 . . . . 72.22 108.983 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -103.77 150.81 23.74 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.382 -0.824 . . . . 63.54 109.248 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -137.78 139.67 40.17 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.329 -0.857 . . . . 64.35 109.321 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 46' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' B' ' 2' ' ' ARG . 7.9 p-10 -79.85 -36.86 36.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 62.22 109.253 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.555 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.5 OUTLIER -108.05 116.39 31.86 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.93 -0.767 . . . . 73.12 108.93 179.899 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.555 ' N ' HD13 ' B' ' 47' ' ' LEU . 46.4 t -100.31 98.44 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.233 -1.025 . . . . 65.11 108.233 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 20.6 ttt -112.89 133.38 54.9 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.569 -0.707 . . . . 73.44 110.051 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.692 ' HB ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -145.95 134.18 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.595 -0.69 . . . . 34.5 109.351 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 51' ' ' SER . . . . . 0.525 ' HG ' ' CD ' ' B' ' 7' ' ' GLU . 9.1 p -98.19 9.94 41.75 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.415 -0.803 . . . . 73.21 109.47 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.559 ' H ' HG22 ' B' ' 50' ' ' VAL . 44.9 m-20 -76.06 138.86 41.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.203 -0.935 . . . . 70.41 109.539 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.439 ' C ' ' H ' ' B' ' 55' ' ' ALA . 60.2 mttm -73.62 -40.12 64.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 65.0 110.15 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -72.92 12.25 0.55 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.115 -0.99 . . . . 75.21 109.717 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -68.92 -21.54 64.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.903 . . . . 55.33 110.153 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' B' ' 55' ' ' ALA . 11.4 mt -41.7 -49.39 4.26 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.488 -0.757 . . . . 63.14 110.312 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 86.1 p -69.56 -34.68 74.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.986 -1.071 . . . . 63.5 109.098 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' PHE . . . . . 0.407 ' CZ ' HD11 ' B' ' 62' ' ' ILE . 59.0 t80 -66.67 -61.76 1.8 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.377 -0.827 . . . . 72.33 109.828 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 33.8 m -49.42 -35.31 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.611 -1.306 . . . . 74.54 109.716 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 22.9 p -57.55 -53.69 55.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.188 -0.945 . . . . 71.24 109.714 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -66.91 -29.1 68.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.055 -1.028 . . . . 74.31 110.108 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.407 HD11 ' CZ ' ' B' ' 58' ' ' PHE . 35.2 mm -66.06 -36.26 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.766 -1.208 . . . . 72.14 109.876 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.483 ' NZ ' ' CG2' ' B' ' 71' ' ' VAL . 29.1 mmtm -71.41 -49.4 42.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.038 -1.039 . . . . 73.32 110.278 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' B' ' 65' ' ' LYS . 13.8 pt-20 -68.85 -41.08 78.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.949 -1.094 . . . . 73.12 110.133 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.512 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 92.7 mttt -74.83 -23.52 58.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 72.44 109.825 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.512 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 92.9 m-70 -156.69 63.96 0.53 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.145 -0.972 . . . . 63.31 109.67 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.452 ' N ' ' O ' ' B' ' 63' ' ' LYS . 23.7 t -57.14 -30.01 64.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -0.88 . . . . 73.1 109.581 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 39.8 m -61.56 -27.31 68.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -0.917 . . . . 71.53 109.998 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 73.7 mt -78.64 155.77 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.142 -0.973 . . . . 74.4 109.778 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 84.7 t -95.74 152.69 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.489 -0.757 . . . . 75.12 109.137 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.483 ' CG2' ' NZ ' ' B' ' 63' ' ' LYS . 39.5 t -133.04 127.9 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.336 -0.852 . . . . 73.2 109.81 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 8.0 tt -120.41 99.48 6.59 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.716 -0.846 . . . . 73.34 108.716 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.44 135.66 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 73.5 108.876 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.24 173.75 6.18 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.315 -0.866 . . . . 64.34 108.877 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 18.7 t -165.93 119.76 1.16 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.966 -1.084 . . . . 74.53 110.236 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -67.54 -15.84 63.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.381 -0.824 . . . . 64.5 109.284 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -116.91 69.08 4.6 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.674 -0.641 . . . . 74.25 109.293 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -62.73 78.06 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.91 1.74 . . . . 74.43 111.632 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.492 HG23 ' H ' ' B' ' 82' ' ' GLU . 15.1 t -101.14 173.16 6.59 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.69 -0.856 . . . . 73.12 108.69 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.4 p -77.01 -26.25 53.6 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.164 -0.96 . . . . 71.01 110.489 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 81' ' ' GLU . . . . . 0.469 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 49.6 mp0 -66.86 -39.96 87.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.937 -1.102 . . . . 63.2 109.694 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 82' ' ' GLU . . . . . 0.492 ' H ' HG23 ' B' ' 79' ' ' THR . 97.8 mt-10 -78.01 -33.82 51.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.194 -0.941 . . . . 73.22 109.686 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -62.55 -52.91 61.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -0.964 . . . . 74.3 109.718 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.504 HG23 ' N ' ' B' ' 85' ' ' HIS . 26.4 m -63.72 -40.82 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.161 -0.962 . . . . 73.31 109.412 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 85' ' ' HIS . . . . . 0.504 ' N ' HG23 ' B' ' 84' ' ' VAL . 19.8 m80 -67.31 -31.27 71.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.905 . . . . 73.24 109.514 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.29 -41.7 93.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.922 . . . . 55.33 109.782 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 87' ' ' PHE . . . . . 0.53 ' CZ ' ' NH1' ' A' ' 108' ' ' ARG . 70.3 m-85 -80.29 -24.91 39.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.095 -1.003 . . . . 74.14 109.041 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -76.37 -51.92 10.93 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.386 -0.822 . . . . 64.04 109.437 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 89' ' ' GLN . . . . . 0.489 ' CG ' ' N ' ' B' ' 90' ' ' GLY . 11.5 pt20 -60.81 -47.19 87.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.515 -0.741 . . . . 72.35 109.774 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 90' ' ' GLY . . . . . 0.489 ' N ' ' CG ' ' B' ' 89' ' ' GLN . . . 140.15 71.55 0.04 OUTLIER Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.963 -1.255 . . . . 65.2 109.963 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.86 135.44 53.74 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.403 -1.057 . . . . 52.23 108.715 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.522 ' OD1' ' NH1' ' B' ' 112' ' ' ARG . 24.6 t0 -85.0 -23.78 28.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.061 -1.024 . . . . 73.32 109.647 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 93' ' ' ASP . . . . . 0.524 ' OD2' ' NH1' ' B' ' 112' ' ' ARG . 57.3 m-20 -152.38 156.43 39.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.184 -0.948 . . . . 72.22 109.63 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -137.9 99.83 4.01 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.463 -0.94 . . . . 64.42 108.463 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 22.7 mm -106.98 147.3 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 O-C-N 120.989 -1.07 . . . . 72.23 110.833 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.76 125.74 26.81 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.915 -1.143 . . . . 25.24 107.915 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.677 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -45.94 -54.03 18.6 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.063 -1.023 . . . . 64.32 111.486 -178.75 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 98' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 3.3 Cg_endo -41.82 -10.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 120.796 0.997 . . . . 63.33 112.743 -176.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 99' ' ' TYR . . . . . 0.677 ' N ' ' O ' ' B' ' 97' ' ' LYS . 61.0 m-85 59.41 96.71 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.728 -0.608 . . . . 75.13 110.04 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -53.41 -39.37 64.28 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.101 -1.074 . . . . 74.23 108.101 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 9.1 t -174.27 128.62 0.36 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.886 -0.783 . . . . 63.34 108.886 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 59.0 mt -52.64 -36.14 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.035 -1.04 . . . . 74.44 108.868 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' B' ' 107' ' ' ALA . 62.8 mmtt -61.87 -36.87 82.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.293 -0.88 . . . . 71.11 108.948 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.74 -53.64 14.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 71.45 109.347 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 25.0 tp -58.04 -49.75 75.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.926 . . . . 51.31 108.962 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 106' ' ' VAL . . . . . 0.445 HG11 ' NZ ' ' B' ' 23' ' ' LYS . 69.7 t -66.1 -39.88 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.063 -1.023 . . . . 65.23 109.853 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 107' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' B' ' 103' ' ' LYS . . . -56.78 -39.12 73.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.16 -0.962 . . . . 24.32 109.558 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -77.44 -25.04 50.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.875 . . . . 75.31 109.994 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 90.4 mt -80.82 -43.37 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.039 -1.038 . . . . 54.24 109.445 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -68.15 -38.92 82.66 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.18 -0.95 . . . . 65.31 109.851 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.69 -49.18 66.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 72.24 109.838 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 112' ' ' ARG . . . . . 0.524 ' NH1' ' OD2' ' B' ' 93' ' ' ASP . 38.5 ttm180 -65.6 -43.87 88.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.932 . . . . 72.04 109.976 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.491 HD23 ' C ' ' B' ' 113' ' ' LEU . 4.3 tt -64.95 -55.45 19.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.154 -0.966 . . . . 75.35 109.335 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -50.7 -30.5 13.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.969 . . . . 75.5 109.674 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -84.64 4.48 32.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.202 -0.936 . . . . 65.33 109.807 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 116' ' ' TRP . . . . . 0.524 ' CD1' ' N ' ' B' ' 117' ' ' GLY . 0.3 OUTLIER -67.84 -19.85 65.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.009 -1.057 . . . . 74.45 109.662 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 117' ' ' GLY . . . . . 0.524 ' N ' ' CD1' ' B' ' 116' ' ' TRP . . . -67.73 113.13 5.24 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.702 -1.359 . . . . 44.21 109.702 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 53.1 p -153.46 164.52 38.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.279 -1.13 . . . . 71.4 109.687 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -158.23 166.17 33.05 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.876 -0.73 . . . . 72.32 109.043 -178.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -145.59 -43.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.291 -0.881 . . . . 75.02 109.31 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 121' ' ' ILE . . . . . 0.481 HG21 ' O ' ' B' ' 156' ' ' ALA . 28.5 mm -107.83 127.48 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.449 -0.782 . . . . 51.41 109.118 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -120.47 118.31 29.95 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.538 -0.726 . . . . 71.53 109.239 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 62.2 mt -123.48 108.42 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.938 -0.764 . . . . 72.43 108.938 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.74 -133.82 11.49 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.745 -1.342 . . . . 51.23 109.745 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -83.6 -2.25 55.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.222 -1.163 . . . . 74.2 109.399 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.554 HD13 HD12 ' B' ' 199' ' ' LEU . 0.6 OUTLIER -91.18 146.04 24.16 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.473 -0.936 . . . . 75.42 108.473 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 89.3 m -130.08 134.71 47.56 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.576 -0.703 . . . . 74.22 109.212 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 21.5 mt -136.59 143.53 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.442 -0.786 . . . . 60.33 109.381 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 14.6 m -137.86 122.8 12.28 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.494 -0.754 . . . . 72.31 108.977 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -80.99 -39.95 0.19 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.994 1.796 . . . . 75.13 112.238 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -50.52 -51.31 48.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.145 -0.972 . . . . 75.23 109.428 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -86.07 -7.71 58.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.231 -0.918 . . . . 72.43 109.099 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 54.19 68.66 0.82 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.868 . . . . 75.13 109.35 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -148.6 143.38 26.53 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.228 -0.92 . . . . 73.22 109.734 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 18.1 tt -118.38 137.03 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.538 -0.726 . . . . 64.14 109.359 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 58.5 mt -126.19 123.86 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.504 -0.747 . . . . 71.22 109.144 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -140.52 144.12 35.8 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.303 -0.873 . . . . 64.22 110.113 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 31.3 mmtm 53.75 31.18 12.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.384 -0.823 . . . . 72.02 110.214 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 74.99 -6.4 27.41 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.983 -1.247 . . . . 74.32 109.983 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 12.2 mpt_? -87.96 129.43 35.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.129 -1.218 . . . . 75.34 108.838 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -98.82 130.58 45.25 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.351 -0.843 . . . . 71.23 109.675 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 66.8 t -137.12 132.12 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.444 -0.785 . . . . 70.43 109.244 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -83.15 134.92 34.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.898 . . . . 72.43 109.1 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.77 136.1 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.452 -0.78 . . . . 72.13 109.366 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.21 21.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 72.02 109.555 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.54 174.72 40.03 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.867 -1.293 . . . . 42.23 109.867 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' B' ' 148' ' ' PRO . 12.4 mtpp -65.06 -61.67 5.87 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.447 -1.031 . . . . 73.3 110.096 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 148' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' B' ' 147' ' ' LYS . 11.9 Cg_endo -54.2 -25.78 39.55 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.951 1.767 . . . . 71.33 111.87 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -87.59 -15.45 37.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.237 -0.914 . . . . 74.23 109.502 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -61.77 -45.34 94.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.162 -0.961 . . . . 72.34 109.471 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 8.8 p -56.99 -34.06 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.112 -0.992 . . . . 73.35 108.89 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.437 ' O ' HD13 ' B' ' 152' ' ' LEU . 0.2 OUTLIER -61.04 -49.71 76.27 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.535 -0.913 . . . . 55.24 108.535 179.502 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 16.3 m -70.57 -29.83 66.37 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.304 -0.873 . . . . 70.01 108.963 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -55.52 -59.89 4.2 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.193 -0.942 . . . . 65.32 109.987 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.79 -25.51 65.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.943 -1.098 . . . . 71.54 109.67 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 156' ' ' ALA . . . . . 0.481 ' O ' HG21 ' B' ' 121' ' ' ILE . . . -55.08 -43.88 74.31 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.048 -1.032 . . . . 75.32 109.931 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -83.22 -45.62 13.66 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.828 -1.17 . . . . 73.32 110.891 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 158' ' ' HIS . . . . . 0.482 ' O ' ' O ' ' B' ' 159' ' ' ARG . 51.3 m80 -50.52 -83.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.619 -1.301 . . . . 74.14 108.615 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 159' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' B' ' 158' ' ' HIS . 11.5 mmm180 56.26 153.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.596 -0.69 . . . . 61.41 110.509 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 160' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' B' ' 214' ' ' PHE . 20.4 t70 42.02 51.25 4.32 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.256 -0.903 . . . . 72.1 110.104 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -156.27 145.37 20.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.062 -1.024 . . . . 72.25 110.087 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 87.6 mt -89.19 125.66 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.747 -0.834 . . . . 72.31 108.747 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 14.7 p -135.84 136.65 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.323 -0.861 . . . . 64.21 109.248 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 11.7 t -81.54 166.45 20.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.318 -0.864 . . . . 74.22 110.524 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 18.4 mtpp -67.12 -46.1 75.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.623 -0.673 . . . . 65.31 109.896 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -58.59 -36.19 73.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.87 . . . . 63.45 110.28 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -55.14 -45.1 75.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.061 -1.024 . . . . 72.4 109.657 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 31.6 mt -66.28 -38.7 88.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.053 -1.03 . . . . 72.32 109.36 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.682 HD13 ' C ' ' B' ' 169' ' ' LEU . 3.1 tm? -55.35 -54.78 39.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.829 . . . . 73.34 108.996 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -68.94 -16.56 63.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 72.1 109.85 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.17 -57.87 3.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -0.937 . . . . 62.13 110.707 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.696 HD12 ' N ' ' B' ' 172' ' ' ILE . 1.7 mp -79.85 -44.78 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.989 -1.069 . . . . 71.42 109.239 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 19.7 m-90 -94.39 56.68 2.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.314 -0.866 . . . . 72.23 109.519 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 174' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' B' ' 175' ' ' GLU . 69.2 tt0 -65.34 -6.69 10.65 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.263 -0.898 . . . . 52.11 109.005 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 175' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' B' ' 177' ' ' GLU . 2.5 mt-10 -48.9 173.98 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.377 -0.971 . . . . 73.04 108.377 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -58.26 40.7 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.298 1.999 . . . . 74.13 112.714 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 177' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' B' ' 175' ' ' GLU . 75.1 mm-40 50.2 -131.0 2.0 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.264 -0.898 . . . . 72.44 109.747 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 83.7 mmm 49.92 15.33 0.17 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.198 -0.939 . . . . 63.43 109.422 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 179' ' ' VAL . . . . . 0.435 ' N ' ' C ' ' B' ' 177' ' ' GLU . 2.9 m -82.36 -111.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 71.05 109.344 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 180' ' ' THR . . . . . 0.403 ' H ' HG23 ' B' ' 179' ' ' VAL . 73.7 p -134.9 78.71 53.67 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.406 -0.809 . . . . 62.15 109.282 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.02 38.8 0.75 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.246 1.964 . . . . 65.22 111.735 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -148.59 -14.68 0.33 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.489 -0.757 . . . . 72.31 109.095 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.78 7.98 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.285 -0.884 . . . . 63.32 109.287 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 15.7 mm -55.75 -42.67 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.903 . . . . 75.03 109.475 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -53.84 -26.53 24.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 64.11 109.413 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 60.5 t -78.85 -54.68 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.053 -1.03 . . . . 73.0 109.149 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -51.89 -48.11 64.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 61.12 110.071 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 188' ' ' ILE . . . . . 0.525 ' O ' HD13 ' B' ' 188' ' ' ILE . 0.2 OUTLIER -61.82 -43.12 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.913 -1.117 . . . . 72.43 109.025 -179.61 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 189' ' ' ASN . . . . . 0.572 ' O ' ' NE2' ' B' ' 193' ' ' GLN . 41.4 t30 -61.48 -41.64 97.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.972 -1.08 . . . . 65.14 109.255 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -68.0 -42.52 80.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.947 . . . . 63.24 110.023 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 81.3 mt -59.85 -39.71 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.084 -1.01 . . . . 74.03 109.743 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -64.59 -40.45 95.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.116 -0.99 . . . . 72.24 109.781 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 193' ' ' GLN . . . . . 0.572 ' NE2' ' O ' ' B' ' 189' ' ' ASN . 1.2 mp0 -75.12 -37.83 61.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 73.1 110.376 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 194' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' B' ' 198' ' ' PRO . 0.0 OUTLIER -73.6 -16.87 61.23 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.75 -1.219 . . . . 72.11 109.916 -179.293 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 21.9 ttp -94.52 -24.14 17.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.156 -0.965 . . . . 44.33 110.196 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 196' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' B' ' 193' ' ' GLN . 41.3 p30 -96.0 -3.76 44.41 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.987 -1.07 . . . . 71.21 110.532 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 197' ' ' LYS . . . . . 0.568 ' N ' ' CD ' ' B' ' 198' ' ' PRO . 20.6 tttm -92.01 -42.15 0.37 Allowed Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 120.862 -1.149 . . . . 75.21 110.053 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 198' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' B' ' 197' ' ' LYS . 17.7 Cg_endo -88.68 -51.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.596 2.198 . . . . 75.32 112.22 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 199' ' ' LEU . . . . . 0.597 ' N ' HD22 ' B' ' 199' ' ' LEU . 3.7 mm? -70.9 -40.06 72.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.948 -1.095 . . . . 72.25 109.347 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 85.35 -20.39 17.78 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.915 -1.274 . . . . 64.53 109.915 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 12.1 mt -103.75 137.83 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.335 -1.097 . . . . 44.23 109.354 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 38.6 t -95.38 137.85 33.86 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.242 -0.911 . . . . 54.01 109.393 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 21.4 p -142.33 34.11 1.49 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.34 -0.85 . . . . 74.4 109.146 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.53 133.41 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.497 -0.752 . . . . 72.12 109.615 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -113.94 132.7 55.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.666 -0.865 . . . . 65.41 108.666 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.45 140.37 29.82 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.256 -0.903 . . . . 71.33 109.896 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' B' ' 211' ' ' GLY . 19.8 t -138.51 123.43 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.492 -0.755 . . . . 63.5 109.006 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 -76.85 -43.51 35.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.186 -0.946 . . . . 74.45 109.914 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -51.7 -59.85 3.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.905 . . . . 74.14 109.876 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -94.71 -71.03 0.68 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.179 -0.951 . . . . 74.43 109.58 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 211' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' B' ' 207' ' ' VAL . . . 177.76 -93.71 0.09 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.349 -1.5 . . . . 64.45 109.349 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -135.49 141.07 45.25 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.45 -1.03 . . . . 74.21 109.518 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 65.3 ttt-85 -119.64 129.06 54.4 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.438 -0.949 . . . . 74.03 108.438 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 214' ' ' PHE . . . . . 0.529 ' O ' ' N ' ' B' ' 160' ' ' ASP . 29.5 m-85 -100.58 137.84 38.44 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.384 -0.822 . . . . 74.34 109.404 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 215' ' ' CYS . . . . . 0.454 ' SG ' ' N ' ' B' ' 216' ' ' TYR . 43.7 t -152.33 168.32 25.8 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.476 -0.765 . . . . 64.33 109.613 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 216' ' ' TYR . . . . . 0.454 ' N ' ' SG ' ' B' ' 215' ' ' CYS . 81.6 m-85 -75.35 150.41 84.98 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.253 -0.904 . . . . 70.04 109.374 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 217' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' B' ' 218' ' ' LYS . 97.4 Cg_endo -76.43 119.17 5.14 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.269 1.979 . . . . 65.11 112.171 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' B' ' 220' ' ' ALA . 41.0 mttp 59.17 151.21 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.462 -0.774 . . . . 73.15 109.384 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 219' ' ' PRO . . . . . 0.421 ' C ' ' N ' ' B' ' 221' ' ' CYS . 84.0 Cg_exo -39.19 -22.05 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.936 1.757 . . . . 71.31 112.042 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 220' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' B' ' 218' ' ' LYS . . . 48.86 17.55 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.313 -0.867 . . . . 75.45 109.587 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 221' ' ' CYS . . . . . 0.421 ' N ' ' C ' ' B' ' 219' ' ' PRO . 42.1 t -136.22 152.61 50.94 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.407 -0.808 . . . . 72.22 109.317 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -155.92 158.79 38.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.258 -0.901 . . . . 54.53 109.376 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.045 -0.979 . . . . 71.13 109.462 -179.888 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.6 ptm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.446 -0.575 . . . . 65.12 109.446 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -139.58 156.41 46.89 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.305 -0.872 . . . . 72.33 109.303 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 89.3 t -114.21 125.8 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.635 -0.665 . . . . 71.42 109.607 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 5' ' ' LEU . 2.2 tp -100.03 118.74 37.05 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.832 -0.803 . . . . 65.12 108.832 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.466 ' CD1' HG21 ' A' ' 16' ' ' ILE . 7.5 tt -119.95 119.38 33.28 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.624 -0.672 . . . . 62.43 109.417 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.419 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 13.2 mt -106.45 116.89 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.352 -0.843 . . . . 71.15 108.792 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.462 ' OE1' ' CB ' ' A' ' 51' ' ' SER . 30.1 tp10 -151.37 127.63 10.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.149 -0.969 . . . . 75.34 109.491 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 9' ' ' ASN . 45.2 mtpt -77.82 -23.72 48.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 72.44 109.309 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 10' ' ' SER . 34.7 t-20 -59.68 -152.18 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.445 -0.785 . . . . 63.02 109.51 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.497 ' N ' ' OD1' ' A' ' 9' ' ' ASN . 47.6 m -156.08 -56.39 0.09 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 72.34 109.372 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.6 t -63.17 -45.49 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 74.02 109.493 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.9 mm? -66.78 -36.43 82.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.259 -0.901 . . . . 71.43 109.289 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.11 -19.07 78.96 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 108.473 -1.851 . . . . 61.32 108.473 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.32 -50.77 4.94 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.922 -1.271 . . . . 71.2 109.922 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.14 -43.66 95.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.106 -1.232 . . . . 71.32 109.296 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.559 ' O ' HD23 ' A' ' 20' ' ' LEU . 94.5 mt -61.63 -46.63 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.922 -1.111 . . . . 63.23 108.498 178.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -45.55 -52.47 10.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 51.11 109.798 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -89.48 4.41 49.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.181 -0.949 . . . . 73.34 109.596 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -85.02 -58.18 2.15 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.908 -1.277 . . . . 62.15 109.908 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.559 HD23 ' O ' ' A' ' 16' ' ' ILE . 0.6 OUTLIER -75.01 -19.06 60.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -1.165 . . . . 73.51 110.046 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 -57.08 -38.25 73.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.974 . . . . 74.25 109.676 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.5 t -52.57 -32.02 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.215 -0.928 . . . . 70.04 109.123 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -75.2 -0.36 19.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.376 -0.827 . . . . 73.23 109.043 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.91 28.55 45.6 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.267 -1.133 . . . . 75.54 110.267 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -106.09 156.89 17.96 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.278 -1.13 . . . . 73.43 109.05 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.3 mmt -94.15 118.08 31.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.194 -0.942 . . . . 43.24 108.729 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -98.47 133.1 43.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.315 -0.866 . . . . 62.11 109.918 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -123.31 131.0 53.51 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 109.035 -0.728 . . . . 74.42 109.035 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.69 132.73 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.303 -0.999 . . . . 72.15 108.303 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 p -136.08 168.98 18.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.361 -0.837 . . . . 71.42 109.524 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.419 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 4.4 pt-20 -94.04 -103.47 0.14 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.301 -0.874 . . . . 72.33 109.836 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.5 t -78.54 166.78 22.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.256 -0.902 . . . . 74.24 110.157 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.0 mt -53.42 -33.7 54.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.621 -0.674 . . . . 71.53 109.733 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -52.51 -48.03 66.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 74.23 109.791 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -61.49 -37.61 84.28 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.141 -0.974 . . . . 54.03 109.11 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.26 -37.26 48.69 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.314 -1.515 . . . . 61.41 109.314 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -63.37 -39.03 93.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -1.126 . . . . 74.34 109.407 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -77.21 -37.99 52.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 75.33 109.513 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.3 tp -66.89 -46.21 75.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -0.867 . . . . 74.33 109.983 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.436 ' C ' ' SD ' ' A' ' 40' ' ' MET . 3.9 ppp? -70.09 -24.54 63.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.101 -1.0 . . . . 70.32 109.824 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -65.84 -40.42 91.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.048 -1.033 . . . . 71.22 109.951 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.2 pt -79.12 -34.01 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.103 -0.998 . . . . 74.14 110.074 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 40' ' ' MET . 30.3 mmt180 -130.25 147.69 52.0 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.327 -0.858 . . . . 72.24 109.356 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -93.12 133.16 36.58 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.273 -0.892 . . . . 75.42 109.449 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -107.49 142.47 37.31 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.512 -0.743 . . . . 74.23 109.378 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -83.93 -42.15 16.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 72.04 109.236 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.508 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.5 OUTLIER -105.86 113.17 26.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.565 -0.71 . . . . 72.13 109.176 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.508 ' N ' HD13 ' A' ' 47' ' ' LEU . 78.7 t -99.3 97.76 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.713 -0.847 . . . . 72.34 108.713 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.485 ' SD ' ' O ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -106.17 125.04 50.51 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.988 -0.745 . . . . 74.11 108.988 -179.678 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.01 133.2 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.664 0.745 . . . . 61.12 109.623 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.462 ' CB ' ' OE1' ' A' ' 7' ' ' GLU . 52.9 m -102.95 4.88 37.98 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.656 -0.652 . . . . 73.11 109.414 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -76.27 147.51 38.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -0.966 . . . . 52.55 109.613 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.429 ' C ' ' H ' ' A' ' 55' ' ' ALA . 25.6 pttm -81.92 -39.86 23.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.287 -0.883 . . . . 44.22 110.124 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -70.26 7.32 1.03 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.039 -1.038 . . . . 70.44 109.411 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -68.68 -21.78 64.41 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.384 -0.822 . . . . 64.14 110.433 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 55' ' ' ALA . 63.2 mt -42.36 -47.73 4.95 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.196 -0.94 . . . . 44.14 110.546 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.2 m -70.96 -36.64 72.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.884 -1.135 . . . . 55.23 109.388 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.655 ' CE2' HD11 ' A' ' 62' ' ' ILE . 58.1 t80 -68.07 -61.06 2.03 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.594 -0.691 . . . . 74.44 110.158 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 60' ' ' SER . 21.6 m -51.61 -37.68 20.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.845 -1.159 . . . . 74.03 109.431 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.467 ' N ' HG23 ' A' ' 59' ' ' VAL . 61.6 m -56.3 -55.76 29.4 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.271 -0.893 . . . . 64.3 109.514 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -67.91 -26.89 66.21 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.049 -1.032 . . . . 64.44 110.24 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.655 HD11 ' CE2' ' A' ' 58' ' ' PHE . 5.9 mm -57.36 -38.58 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.668 -1.27 . . . . 63.21 107.922 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 67' ' ' SER . 61.2 mmtt -72.76 -41.95 64.52 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.389 -0.819 . . . . 74.42 109.135 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -66.55 -51.44 56.49 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.143 -0.973 . . . . 70.32 109.229 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -69.57 -24.93 63.76 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.665 -0.647 . . . . 75.22 109.874 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.586 ' O ' HG22 ' A' ' 69' ' ' ILE . 96.7 m-70 -151.39 68.52 0.92 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.184 -0.947 . . . . 74.13 109.38 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 63' ' ' LYS . 96.9 p -57.93 -28.79 64.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 73.24 109.904 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 83.2 p -82.14 49.0 1.32 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.184 -0.948 . . . . 61.01 109.782 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.586 HG22 ' O ' ' A' ' 66' ' ' HIS . 13.1 tt -142.06 155.9 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.258 -0.901 . . . . 71.33 109.571 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.8 t -95.59 149.87 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.146 -0.971 . . . . 72.13 108.773 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 t -140.17 127.33 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.163 -0.961 . . . . 54.21 109.875 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.491 HD23 ' C ' ' A' ' 72' ' ' LEU . 2.4 tt -115.43 104.56 11.89 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.984 -0.747 . . . . 50.24 108.984 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.3 t -95.9 129.5 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.24 -0.913 . . . . 74.41 108.982 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.1 p -93.76 171.91 8.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.188 -0.945 . . . . 72.31 109.796 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.473 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 42.0 t -160.93 118.39 2.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.082 -1.011 . . . . 64.54 110.45 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -64.63 -29.01 70.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.623 -0.673 . . . . 74.13 109.72 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 79' ' ' THR . 35.5 m120 -122.07 80.55 43.27 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.528 -0.733 . . . . 73.34 109.428 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.12 87.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.323 2.016 . . . . 63.22 111.431 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.456 ' N ' ' O ' ' A' ' 77' ' ' ASN . 23.8 m -98.65 150.21 22.01 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.577 -0.702 . . . . 62.53 109.593 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.475 ' CB ' ' OG ' ' B' ' 101' ' ' SER . 0.0 OUTLIER -72.77 -41.15 65.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.35 -0.844 . . . . 73.44 109.189 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -57.57 -38.63 75.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.146 -0.971 . . . . 71.42 108.844 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -75.2 -26.02 58.68 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.352 -0.842 . . . . 73.43 109.191 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.525 ' OE1' ' CD2' ' A' ' 94' ' ' TYR . 36.7 tp10 -61.29 -57.63 11.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 74.22 109.65 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.482 HG23 ' N ' ' A' ' 85' ' ' HIS . 22.0 m -63.82 -40.65 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 73.2 109.338 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.482 ' N ' HG23 ' A' ' 84' ' ' VAL . 10.5 t-80 -62.36 -34.65 77.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -0.904 . . . . 53.33 109.371 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.14 -39.81 93.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 64.11 109.969 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -78.26 -34.35 49.09 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.98 -1.075 . . . . 74.34 109.054 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -70.84 -36.84 73.08 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.299 -0.875 . . . . 74.42 109.592 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -68.39 -47.86 66.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 74.24 109.761 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.58 48.23 0.03 OUTLIER Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.949 -1.26 . . . . 61.51 109.949 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.82 133.26 54.14 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.425 -1.044 . . . . 55.33 109.382 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -84.67 -22.85 29.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.944 . . . . 73.42 109.133 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.532 ' OD2' ' NH2' ' A' ' 112' ' ' ARG . 19.6 t0 -150.61 163.3 38.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.399 -0.813 . . . . 75.04 109.325 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.525 ' CD2' ' OE1' ' A' ' 83' ' ' GLU . 67.6 t80 -146.03 101.92 3.58 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.37 -0.832 . . . . 71.33 108.936 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 96' ' ' ALA . 29.0 mm -112.19 156.04 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 O-C-N 121.29 -0.882 . . . . 71.13 110.464 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.402 ' N ' HG22 ' A' ' 95' ' ' ILE . . . -67.11 146.52 54.19 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.417 -0.957 . . . . 64.32 108.417 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.676 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -68.19 -55.79 12.1 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.869 -1.144 . . . . 62.2 111.172 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 4.3 Cg_endo -41.59 -10.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 120.87 1.047 . . . . 73.11 112.967 -176.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.676 ' N ' ' O ' ' A' ' 97' ' ' LYS . 22.6 m-85 67.12 110.3 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.789 -0.57 . . . . 65.22 109.681 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -57.41 -33.78 68.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.972 -1.08 . . . . 72.35 108.185 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.775 ' O ' ' N ' ' A' ' 103' ' ' LYS . 47.5 t -175.63 24.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 71.32 110.167 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.4 mm 50.2 -67.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.791 -0.568 . . . . 75.43 110.028 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.775 ' N ' ' O ' ' A' ' 101' ' ' SER . 3.3 mptp? -54.5 -33.06 59.19 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.343 -1.354 . . . . 71.41 107.343 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.98 -41.54 74.3 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.988 -1.116 . . . . 63.24 107.988 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.9 tt -61.7 -46.49 89.44 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.974 -0.75 . . . . 73.22 108.974 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 90.4 t -62.99 -40.75 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.302 -0.873 . . . . 60.11 109.052 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.87 -39.71 62.85 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.315 -0.866 . . . . 70.42 108.859 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.558 ' HE ' ' CD ' ' B' ' 83' ' ' GLU . 50.3 mtt85 -69.0 -35.68 76.97 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.274 -0.891 . . . . 74.41 109.412 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.4 mt -69.4 -34.92 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.058 -1.026 . . . . 62.54 108.487 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -59.58 -55.57 32.84 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.751 -0.779 . . . . 74.34 109.446 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.5 -34.58 67.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 73.32 109.959 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.532 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 64.9 mtt85 -60.74 -37.69 82.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.001 -1.062 . . . . 52.41 110.022 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -155.06 68.74 0.7 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.681 -1.262 . . . . 65.24 110.373 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -53.66 89.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.102 -0.999 . . . . 64.45 108.784 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.506 ' N ' ' O ' ' A' ' 113' ' ' LEU . 69.0 m-85 52.9 89.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 74.43 109.599 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.412 ' HE1' ' HB3' ' A' ' 132' ' ' GLU . 74.6 t-105 -87.0 141.96 28.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 74.42 109.304 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 163.36 98.39 0.13 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.683 -1.367 . . . . 75.04 109.683 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.0 t -157.26 177.58 11.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -1.179 . . . . 61.14 109.666 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -146.42 127.77 14.91 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.007 -0.677 . . . . 65.24 109.498 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 86.6 t -72.87 -30.06 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.372 -0.83 . . . . 73.11 109.824 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.747 ' CG2' HH21 ' A' ' 159' ' ' ARG . 5.1 mp -118.66 131.88 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.427 -0.796 . . . . 72.24 109.913 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -142.33 107.73 5.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.426 -0.796 . . . . 72.34 108.997 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.588 HG12 ' CZ ' ' A' ' 159' ' ' ARG . 1.2 pp -130.71 142.44 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.458 -0.776 . . . . 71.44 109.027 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.72 -152.81 2.48 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.996 -1.642 . . . . 73.4 108.996 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -84.35 11.66 8.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.339 -1.094 . . . . 74.45 108.702 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.03 136.46 43.64 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.857 -0.794 . . . . 54.21 108.857 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 18.6 p -129.56 148.71 51.49 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.5 -0.75 . . . . 54.5 109.246 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.3 mt -139.04 136.06 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.393 -0.817 . . . . 45.15 110.028 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.8 m -126.11 98.76 32.45 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 108.68 -0.859 . . . . 71.11 108.68 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.46 -34.33 0.56 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.276 1.984 . . . . 65.41 112.734 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -58.09 -43.83 87.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.004 -1.06 . . . . 63.32 109.425 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.412 ' HB3' ' HE1' ' A' ' 116' ' ' TRP . 4.5 pt-20 -97.06 14.01 27.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.463 -0.773 . . . . 72.52 109.13 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 27.4 mp0 45.84 76.25 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.375 -0.828 . . . . 75.33 109.681 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -163.56 149.99 11.89 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.058 -1.026 . . . . 71.23 110.033 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.582 ' C ' HD13 ' A' ' 136' ' ' ILE . 17.7 tt -137.68 143.96 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.318 -0.864 . . . . 74.02 109.314 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.582 HD13 ' C ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -122.46 131.78 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.477 -0.764 . . . . 60.23 109.728 -179.297 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -138.58 128.75 25.63 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.348 -0.845 . . . . 62.32 108.737 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp 54.32 29.47 10.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.519 -0.738 . . . . 75.4 109.097 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 79.56 1.19 86.2 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.774 -0.931 . . . . 72.24 110.774 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.436 ' HD2' ' N ' ' A' ' 140' ' ' ARG . 9.2 mmm180 -88.79 124.15 33.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.859 -1.377 . . . . 71.22 108.909 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.447 ' HG2' HD12 ' A' ' 136' ' ' ILE . 95.0 mt-10 -88.81 136.35 33.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.286 -0.884 . . . . 71.42 109.014 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.0 t -131.84 127.8 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.371 -0.831 . . . . 53.02 109.591 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -88.27 122.7 32.1 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.69 -0.856 . . . . 60.45 108.69 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.6 m -141.88 138.57 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.03 -1.044 . . . . 74.44 109.867 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.51 39.14 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.443 -0.785 . . . . 65.15 109.191 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -107.9 -152.52 17.11 Favored Glycine 0 N--CA 1.502 3.036 0 N-CA-C 110.009 -1.236 . . . . 73.34 110.009 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.605 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 1.1 mtmp? -88.07 -37.62 0.46 Allowed Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.222 -1.164 . . . . 72.22 110.139 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 23.3 Cg_exo -63.29 -32.08 73.2 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.175 1.917 . . . . 65.23 111.418 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.507 ' CZ ' ' CG2' ' A' ' 153' ' ' THR . 43.7 t80 -86.69 -9.98 54.75 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.435 -0.791 . . . . 60.11 109.68 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.451 ' O ' ' OG1' ' A' ' 153' ' ' THR . 15.9 tt0 -66.96 -41.74 86.39 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.076 -1.015 . . . . 64.21 109.17 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.08 -35.11 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.983 -1.073 . . . . 72.02 109.223 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.692 HD12 HD21 ' A' ' 155' ' ' LEU . 15.9 tp -65.27 -33.35 75.78 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.181 -0.949 . . . . 73.31 108.967 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.507 ' CG2' ' CZ ' ' A' ' 149' ' ' PHE . 17.0 p -70.4 -32.39 70.01 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.177 -0.952 . . . . 74.31 108.437 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -64.38 -57.7 8.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.21 -0.931 . . . . 74.31 110.23 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.692 HD21 HD12 ' A' ' 152' ' ' LEU . 2.9 pp -65.38 -25.92 67.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.951 -1.093 . . . . 75.34 109.468 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.91 -51.55 69.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.008 -1.057 . . . . 62.14 108.988 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -74.17 -51.41 15.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.406 -0.809 . . . . 61.03 109.512 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.445 ' O ' ' O ' ' A' ' 159' ' ' ARG . 39.7 m80 -86.09 33.67 0.61 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.477 -0.765 . . . . 74.12 109.98 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.747 HH21 ' CG2' ' A' ' 121' ' ' ILE . 30.4 ttm-85 -46.96 -94.1 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.302 -0.874 . . . . 71.13 109.231 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.517 ' OD2' ' NE2' ' B' ' 161' ' ' GLN . 31.6 p-10 -52.4 89.36 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.953 -1.092 . . . . 75.45 109.219 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.535 ' NE2' ' O ' ' A' ' 162' ' ' ILE . 0.0 OUTLIER -173.33 154.01 2.54 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.109 -0.994 . . . . 73.41 109.434 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.535 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 52.5 mt -87.18 126.71 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.13 -0.981 . . . . 74.41 108.613 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.492 HG11 HD21 ' A' ' 168' ' ' LEU . 51.1 t -118.89 130.66 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.409 -0.807 . . . . 72.31 110.011 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 3.9 t -94.3 163.9 13.25 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.276 -0.89 . . . . 74.12 109.063 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -64.38 -43.58 94.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.067 -1.02 . . . . 70.43 109.554 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -58.92 -38.38 78.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 73.52 109.644 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -58.47 -46.18 87.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 74.52 109.513 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.492 HD21 HG11 ' A' ' 163' ' ' VAL . 77.7 mt -62.43 -39.31 92.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.155 -0.965 . . . . 72.31 109.311 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.511 ' C ' HD23 ' A' ' 169' ' ' LEU . 4.8 tt -54.77 -68.08 0.22 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.435 -0.791 . . . . 53.33 109.949 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.42 -37.08 79.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.305 -0.872 . . . . 62.44 110.751 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -50.79 -58.08 6.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.105 -0.997 . . . . 60.21 110.402 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.697 HD12 ' N ' ' A' ' 172' ' ' ILE . 1.9 mp -93.27 -62.69 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.98 -1.075 . . . . 75.32 109.492 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.441 ' O ' ' O ' ' A' ' 169' ' ' LEU . 24.5 m-90 -81.37 118.29 22.54 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.38 -0.825 . . . . 73.14 110.06 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -144.39 -55.0 0.34 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.292 -0.88 . . . . 73.24 108.859 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.561 ' O ' ' N ' ' A' ' 177' ' ' GLU . 4.6 mp0 -55.33 155.1 10.1 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 107.989 -1.115 . . . . 44.43 107.989 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -33.66 83.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.798 2.332 . . . . 72.51 112.621 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.594 ' CD ' ' H ' ' A' ' 177' ' ' GLU . 0.0 OUTLIER -92.74 -25.65 18.1 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.661 -0.649 . . . . 63.24 110.124 -179.338 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.505 ' N ' ' CD ' ' A' ' 177' ' ' GLU . 66.5 mtm 56.14 19.92 4.12 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.268 -0.895 . . . . 73.5 110.558 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 34.9 m -87.33 154.93 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.786 -1.196 . . . . 65.22 109.116 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 38.2 p -70.13 149.72 96.13 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.168 -0.958 . . . . 71.42 109.496 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.9 32.15 0.42 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.242 1.961 . . . . 41.22 112.184 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -143.88 -9.63 0.7 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.171 -0.956 . . . . 64.54 109.531 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.433 ' O ' HG22 ' A' ' 186' ' ' VAL . 11.8 p -58.29 -12.91 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 74.02 109.382 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.57 ' N ' HD12 ' A' ' 184' ' ' ILE . 2.6 mp -59.92 -22.98 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.088 -1.007 . . . . 72.33 109.028 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -61.6 -45.35 94.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.208 -0.933 . . . . 74.4 110.027 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 183' ' ' VAL . 12.1 m -75.32 -30.14 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.001 -1.062 . . . . 70.42 109.324 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -69.5 -50.67 43.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.097 -1.002 . . . . 52.11 110.025 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.446 HG23 ' N ' ' A' ' 189' ' ' ASN . 10.3 tp -65.13 -39.26 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.84 -1.163 . . . . 71.4 110.503 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.446 ' N ' HG23 ' A' ' 188' ' ' ILE . 11.6 t-20 -58.36 -43.09 88.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.974 -1.079 . . . . 73.44 109.483 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -75.64 -47.72 25.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.347 -0.845 . . . . 71.42 110.072 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 63.6 mt -52.13 -47.91 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.13 -0.981 . . . . 61.55 109.46 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.476 ' HE ' ' CG2' ' A' ' 204' ' ' VAL . 76.0 mtp180 -60.58 -51.3 70.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.322 -0.861 . . . . 63.34 109.988 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -61.59 -33.89 74.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.24 -0.913 . . . . 61.24 110.145 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.421 ' O ' ' CD ' ' A' ' 198' ' ' PRO . 9.3 pttm -86.81 -4.31 59.16 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.92 -1.112 . . . . 75.13 109.589 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 28.2 ttt -91.46 -57.2 2.85 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.16 -0.963 . . . . 74.02 109.189 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 200' ' ' GLY . 15.0 p-10 -65.19 -31.42 72.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.364 -0.835 . . . . 74.02 109.619 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.441 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 27.5 mttm -52.86 -65.26 1.14 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.103 -0.998 . . . . 75.43 109.579 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 38.5 Cg_endo -63.89 -54.92 0.76 Allowed 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.144 1.896 . . . . 72.32 112.066 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' A' ' 201' ' ' ILE . 65.4 mt -63.79 -28.87 70.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 74.54 109.211 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 196' ' ' ASP . . . 74.92 -26.61 1.15 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.789 -1.325 . . . . 61.51 109.789 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.466 ' H ' ' C ' ' A' ' 199' ' ' LEU . 11.0 mt -101.32 129.95 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.357 -1.084 . . . . 61.22 109.356 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 15.1 t -80.6 132.2 35.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.895 . . . . 72.0 109.265 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 62.6 p -136.11 3.72 2.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.432 -0.793 . . . . 74.44 108.949 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.476 ' CG2' ' HE ' ' A' ' 192' ' ' ARG . 28.6 m -104.36 138.09 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.499 -0.75 . . . . 64.35 109.292 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -122.96 136.34 54.82 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.6 -0.688 . . . . 71.41 109.572 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.13 132.35 44.51 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.231 -0.918 . . . . 73.52 109.047 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 5.1 m -135.14 136.29 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.371 -0.831 . . . . 71.02 109.48 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -81.34 -10.05 59.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.856 . . . . 72.12 109.16 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 18.8 mtp-105 -56.04 -43.28 77.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.92 . . . . 64.41 109.812 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -148.05 -66.76 0.25 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.221 -0.924 . . . . 71.54 109.524 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -148.45 -110.89 0.59 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.636 -1.386 . . . . 72.03 109.636 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.406 ' N ' ' CD1' ' A' ' 212' ' ' TYR . 41.4 m-85 -125.81 146.34 49.84 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.643 -0.916 . . . . 75.54 109.075 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -113.09 133.39 55.02 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.539 -0.726 . . . . 75.31 109.542 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -99.36 132.01 44.99 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.689 -0.856 . . . . 75.41 108.689 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 2.0 p -141.1 166.72 24.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.278 -0.889 . . . . 74.14 109.601 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -82.11 152.44 68.2 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 75.32 109.426 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -39.13 142.17 0.36 Allowed 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 122.295 1.997 . . . . 73.11 112.266 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.604 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 53.9 mmtt -84.37 -33.68 0.53 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 75.25 111.058 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 97.7 Cg_endo -88.43 19.21 1.36 Allowed 'Trans proline' 0 N--CA 1.487 1.139 0 C-N-CA 122.029 1.819 . . . . 75.1 112.077 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.97 -41.17 74.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 71.14 109.593 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 19.4 m 53.27 50.28 17.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.165 -0.96 . . . . 71.13 109.399 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -59.87 158.72 10.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.298 -0.876 . . . . 75.35 109.531 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.015 -0.993 . . . . 73.41 109.585 -179.994 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.573 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.406 -0.59 . . . . 71.14 109.406 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -131.77 145.89 51.85 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.512 -0.743 . . . . 73.23 109.129 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.2 t -117.03 139.65 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.582 -0.699 . . . . 72.24 109.907 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.495 HD11 ' CG1' ' B' ' 6' ' ' ILE . 3.3 tp -109.01 118.7 37.47 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.568 -0.708 . . . . 54.33 109.386 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.466 ' N ' HD12 ' B' ' 4' ' ' LEU . 21.7 mt -115.62 97.8 6.34 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.597 -0.89 . . . . 74.35 108.597 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.683 HD12 ' HB ' ' B' ' 50' ' ' VAL . 90.2 mt -85.8 97.41 5.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 120.863 -1.148 . . . . 42.55 108.987 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.407 ' HG3' ' H ' ' B' ' 9' ' ' ASN . 45.8 tp10 -120.52 128.04 52.74 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.543 -0.723 . . . . 74.52 109.635 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 8' ' ' LYS . . . . . 0.491 ' CD ' ' H ' ' B' ' 8' ' ' LYS . 0.0 OUTLIER -83.43 -22.12 32.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 62.55 108.773 179.447 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 9' ' ' ASN . . . . . 0.471 ' ND2' HD23 ' B' ' 12' ' ' LEU . 37.0 t-20 -78.6 -128.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.431 -0.793 . . . . 73.11 109.232 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 10' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' B' ' 11' ' ' VAL . 22.0 p -166.83 -55.54 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -0.866 . . . . 65.54 109.32 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.418 ' N ' ' OG ' ' B' ' 10' ' ' SER . 88.0 t -67.74 -42.77 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.288 -0.883 . . . . 75.55 109.652 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.583 HD13 ' OE2' ' B' ' 15' ' ' GLU . 4.0 mm? -59.87 -42.23 93.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.338 -0.851 . . . . 70.14 109.532 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.75 -28.56 66.88 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.416 -1.874 . . . . 75.4 108.416 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.06 -47.94 80.49 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 109.828 -1.309 . . . . 65.44 109.828 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.583 ' OE2' HD13 ' B' ' 12' ' ' LEU . 15.7 pt-20 -63.76 -44.42 93.51 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.122 -1.222 . . . . 60.21 109.707 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 37.0 mm -66.7 -39.77 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.756 -1.215 . . . . 75.15 108.667 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.488 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 80.3 tt0 -63.72 -43.21 97.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.403 -0.811 . . . . 73.01 109.684 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp -86.81 0.45 54.81 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.09 -1.006 . . . . 74.3 109.366 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.49 -52.83 3.08 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.561 -1.416 . . . . 70.54 109.561 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.403 HD23 ' N ' ' B' ' 21' ' ' ASN . 1.4 pt? -76.73 -21.56 55.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -1.102 . . . . 71.34 109.914 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 90.9 m-20 -56.43 -31.47 63.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.084 -1.01 . . . . 64.41 109.451 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 87.6 t -59.87 -35.02 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.317 -0.864 . . . . 74.23 109.354 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -70.68 -8.12 49.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.343 -0.848 . . . . 63.42 109.314 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.36 43.41 6.59 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.023 -1.231 . . . . 53.43 110.023 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -116.71 159.67 21.91 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.498 -1.001 . . . . 71.12 109.054 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 14.5 mmt -100.74 138.02 38.35 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.989 -1.115 . . . . 75.24 107.989 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.23 155.57 43.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.096 -1.002 . . . . 72.12 110.257 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -132.3 160.82 35.14 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.665 -0.865 . . . . 72.31 108.665 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 p -119.49 139.0 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.45 -0.781 . . . . 64.43 109.739 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 6.8 p -134.83 170.43 15.87 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.068 -0.716 . . . . 65.41 109.068 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.402 ' OE2' ' OD2' ' B' ' 35' ' ' ASP . 5.9 pt-20 -93.31 -107.81 0.12 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.219 -0.925 . . . . 71.02 109.82 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 54.8 p -78.94 168.16 20.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.25 -0.906 . . . . 51.11 110.025 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 61.0 mt -52.83 -29.41 27.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.548 -0.72 . . . . 71.24 109.754 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -52.71 -50.38 63.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.144 -0.972 . . . . 74.32 109.636 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.402 ' OD2' ' OE2' ' B' ' 31' ' ' GLU . 1.8 m-20 -64.66 -40.89 96.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.94 . . . . 73.03 109.481 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.02 -42.0 60.03 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.573 -1.411 . . . . 30.21 109.573 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.68 -37.75 87.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.304 -1.115 . . . . 74.42 109.748 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -80.64 -41.16 24.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.088 -1.007 . . . . 74.42 109.858 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 8.6 tt -70.21 -43.86 69.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.191 -0.943 . . . . 75.41 109.972 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' MET . . . . . 0.448 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.1 ppp? -62.62 -26.34 68.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.987 -1.07 . . . . 60.41 109.88 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -63.49 -39.85 95.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.054 -1.029 . . . . 53.23 110.027 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 20.9 pt -84.38 -26.29 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.095 -1.003 . . . . 71.23 110.166 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' B' ' 40' ' ' MET . 63.6 mmt-85 -129.69 138.59 51.24 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.305 -0.872 . . . . 72.22 109.348 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -93.62 159.59 15.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.162 -0.961 . . . . 63.54 109.825 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -136.63 150.47 48.55 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.447 -0.783 . . . . 64.35 109.212 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -91.5 -35.02 14.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.147 -0.971 . . . . 62.22 109.692 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.512 HD13 ' C ' ' B' ' 47' ' ' LEU . 0.9 OUTLIER -113.37 110.6 20.6 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.421 -0.799 . . . . 73.12 109.095 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.464 ' N ' HD13 ' B' ' 47' ' ' LEU . 70.8 t -93.86 100.22 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.324 -0.86 . . . . 65.11 108.761 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.518 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 6.3 tpp -114.24 128.23 56.26 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.094 -0.706 . . . . 73.44 109.094 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.686 HG22 ' H ' ' B' ' 52' ' ' ASP . 0.7 OUTLIER -144.01 136.66 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 34.5 109.803 -179.451 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 65.2 p -101.52 16.77 24.62 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.593 -0.692 . . . . 73.21 109.658 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.686 ' H ' HG22 ' B' ' 50' ' ' VAL . 41.7 m-20 -83.59 136.22 34.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.22 -0.925 . . . . 70.41 109.331 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -71.93 -33.56 68.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.898 . . . . 65.0 110.184 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -76.91 3.7 11.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.098 -1.001 . . . . 75.21 110.097 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.403 ' O ' ' C ' ' B' ' 56' ' ' LEU . . . -71.39 -21.33 62.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 55.33 110.215 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.529 ' O ' ' NE2' ' B' ' 89' ' ' GLN . 56.2 mt -42.98 -42.91 3.94 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.424 -0.797 . . . . 63.14 110.275 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 19.7 m -72.63 -37.22 68.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.045 -1.035 . . . . 63.5 109.459 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' PHE . . . . . 0.568 ' CE2' HD11 ' B' ' 62' ' ' ILE . 69.1 t80 -67.44 -51.06 56.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.368 -0.832 . . . . 72.33 110.287 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.3 m -60.4 -35.11 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.783 -1.198 . . . . 74.54 109.542 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 66.1 p -58.41 -50.84 72.26 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.269 -0.895 . . . . 71.24 109.289 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.505 ' HE ' ' CE ' ' B' ' 65' ' ' LYS . 12.2 ptm180 -68.85 -30.94 69.57 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 118.742 -1.183 . . . . 74.31 109.815 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.568 HD11 ' CE2' ' B' ' 58' ' ' PHE . 4.8 mm -54.56 -48.44 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.842 -1.161 . . . . 72.14 108.526 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.523 ' NZ ' ' OD2' ' B' ' 92' ' ' ASP . 50.3 mmtt -61.2 -42.94 99.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.141 -0.975 . . . . 73.32 108.435 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -65.65 -43.69 88.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.415 -0.803 . . . . 73.12 108.837 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.505 ' CE ' ' HE ' ' B' ' 61' ' ' ARG . 9.5 mtmp? -82.28 -77.54 0.23 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.662 -0.649 . . . . 72.44 109.964 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.433 ' N ' ' O ' ' B' ' 62' ' ' ILE . 95.1 m-70 -97.53 87.69 4.17 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.165 -0.959 . . . . 63.31 109.727 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 71.0 p -79.34 -30.88 42.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.3 -0.875 . . . . 73.1 110.013 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 38.3 m -63.23 -28.89 70.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.19 -0.944 . . . . 71.53 110.0 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 58.3 mt -80.17 150.0 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.088 -1.008 . . . . 74.4 109.654 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.553 HG12 ' N ' ' B' ' 71' ' ' VAL . 98.8 t -88.37 165.62 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.378 -0.826 . . . . 75.12 109.387 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.553 ' N ' HG12 ' B' ' 70' ' ' VAL . 14.4 t -145.48 125.42 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.999 -1.063 . . . . 73.2 109.859 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.518 ' O ' ' SD ' ' B' ' 49' ' ' MET . 0.8 OUTLIER -120.5 103.6 9.3 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.408 -0.96 . . . . 73.34 108.408 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 13.4 p -98.4 144.98 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.179 -0.951 . . . . 73.5 108.876 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.5 m -111.07 171.25 7.58 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.318 -0.864 . . . . 64.34 109.147 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 8.0 t -171.13 122.26 0.56 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.076 -1.015 . . . . 74.53 110.065 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 46.3 p30 -78.14 29.82 0.18 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.453 -0.779 . . . . 64.5 110.189 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 77' ' ' ASN . . . . . 0.414 ' N ' ' CD ' ' B' ' 78' ' ' PRO . 12.7 t-20 -150.47 55.13 1.67 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 120.939 -1.101 . . . . 74.25 109.862 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' B' ' 77' ' ' ASN . 12.0 Cg_endo -56.26 81.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.604 2.203 . . . . 74.43 112.397 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.416 HG22 ' H ' ' B' ' 81' ' ' GLU . 29.4 m -109.35 149.69 29.12 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.317 -0.994 . . . . 73.12 108.317 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -30.66 66.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.144 -0.972 . . . . 71.01 109.213 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 81' ' ' GLU . . . . . 0.416 ' H ' HG22 ' B' ' 79' ' ' THR . 84.1 tt0 -64.53 -48.21 75.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 63.2 109.034 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -69.89 -29.49 66.7 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.138 -0.976 . . . . 73.22 109.142 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.558 ' CD ' ' HE ' ' A' ' 108' ' ' ARG . 39.8 tp10 -56.21 -56.03 25.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.871 . . . . 74.3 109.192 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 8.2 m -60.46 -38.45 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.171 -0.956 . . . . 73.31 108.917 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 69.9 t60 -63.11 -34.03 76.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.303 -0.873 . . . . 73.24 109.437 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.18 90.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.197 -0.94 . . . . 55.33 109.74 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -76.56 -31.34 57.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.195 -0.941 . . . . 74.14 108.641 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -67.32 -46.31 73.87 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.731 -0.84 . . . . 64.04 108.731 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 89' ' ' GLN . . . . . 0.529 ' NE2' ' O ' ' B' ' 56' ' ' LEU . 18.9 mm100 -59.48 -66.21 0.55 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.611 -0.681 . . . . 72.35 109.414 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 149.87 52.14 0.02 OUTLIER Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.167 -1.173 . . . . 65.2 110.167 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.6 132.23 54.08 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.31 -1.112 . . . . 52.23 109.067 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.523 ' OD2' ' NZ ' ' B' ' 63' ' ' LYS . 3.4 m-20 -67.15 -38.11 84.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.033 -1.042 . . . . 73.32 108.873 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 93' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 48.2 t0 -152.11 156.65 40.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.442 -0.786 . . . . 72.22 108.939 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.482 ' CD1' ' C ' ' B' ' 94' ' ' TYR . 0.5 OUTLIER -125.29 126.54 45.27 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.179 -0.674 . . . . 64.42 109.179 -179.586 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.435 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 25.8 mm -110.22 134.06 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 121.378 -0.826 . . . . 72.23 109.923 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 96' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' B' ' 97' ' ' LYS . . . -60.97 119.5 8.41 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.635 -1.617 . . . . 25.24 106.635 177.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.681 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -42.01 -55.36 6.3 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.032 -1.042 . . . . 64.32 111.574 -178.072 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 98' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 3.7 Cg_endo -41.64 -10.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 120.774 0.983 . . . . 63.33 112.57 -176.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 99' ' ' TYR . . . . . 0.681 ' N ' ' O ' ' B' ' 97' ' ' LYS . 58.6 m-85 58.83 104.98 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.845 -0.535 . . . . 75.13 109.719 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 33.0 ttm-85 -62.0 -34.4 76.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.071 -1.018 . . . . 74.23 109.091 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 101' ' ' SER . . . . . 0.631 ' O ' ' N ' ' B' ' 103' ' ' LYS . 28.8 m -172.51 32.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.88 . . . . 63.34 110.253 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 102' ' ' ILE . . . . . 0.48 ' O ' ' N ' ' B' ' 104' ' ' ALA . 55.9 mt 49.09 -81.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.384 -0.823 . . . . 74.44 110.368 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.631 ' N ' ' O ' ' B' ' 101' ' ' SER . 44.7 mtmt -45.57 -19.97 0.06 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.242 -0.911 . . . . 71.11 108.961 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' B' ' 102' ' ' ILE . . . -55.6 -67.5 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.509 -0.744 . . . . 71.45 109.545 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 3.1 pp -60.84 -36.76 79.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.961 -1.087 . . . . 51.31 109.555 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 14.5 t -56.92 -45.69 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.74 -1.225 . . . . 65.23 108.531 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.3 -31.04 67.13 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.337 -0.986 . . . . 24.32 108.337 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -79.41 -23.72 43.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.525 -0.735 . . . . 75.31 109.822 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 83.2 mt -78.24 -39.69 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.955 -1.091 . . . . 54.24 109.11 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -73.52 -41.39 63.11 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.329 -0.949 . . . . 65.31 109.417 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.15 -53.28 59.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.192 -0.942 . . . . 72.24 109.577 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 68.3 ttt-85 -64.97 -33.85 77.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 72.04 109.47 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.521 ' O ' ' CD2' ' B' ' 115' ' ' PHE . 60.3 tp -80.54 -90.82 0.06 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.93 . . . . 75.35 109.7 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' B' ' 116' ' ' TRP . 11.6 mmt180 47.17 -170.03 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.176 -0.952 . . . . 75.5 108.881 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 115' ' ' PHE . . . . . 0.521 ' CD2' ' O ' ' B' ' 113' ' ' LEU . 1.4 m-85 66.26 -39.76 0.33 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.336 -0.853 . . . . 65.33 109.849 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 116' ' ' TRP . . . . . 0.528 ' N ' ' O ' ' B' ' 114' ' ' ARG . 17.1 t90 53.3 43.13 31.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.012 -1.055 . . . . 74.45 109.203 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.49 77.0 1.09 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.817 -1.313 . . . . 44.21 109.817 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 2.3 t -80.92 -8.35 59.72 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.207 -1.172 . . . . 71.4 109.392 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 119' ' ' ASN . . . . . 0.551 ' ND2' ' N ' ' B' ' 120' ' ' VAL . 8.8 t30 54.52 176.39 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.422 -0.798 . . . . 72.32 110.328 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 120' ' ' VAL . . . . . 0.551 ' N ' ' ND2' ' B' ' 119' ' ' ASN . 11.8 t -142.71 -36.2 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.72 -0.845 . . . . 75.02 108.72 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 121' ' ' ILE . . . . . 0.53 ' C ' HD22 ' B' ' 119' ' ' ASN . 25.6 mm -115.42 118.77 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.28 -1.008 . . . . 51.41 108.28 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -155.34 140.76 17.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.939 -1.101 . . . . 71.53 110.131 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 35.1 pt -149.02 145.23 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.998 -0.742 . . . . 72.43 108.998 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 45.8 -136.41 8.0 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.848 -1.301 . . . . 51.23 109.848 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -90.51 6.73 42.29 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.259 -1.142 . . . . 74.2 109.326 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.9 139.25 31.12 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.321 -0.862 . . . . 75.42 108.777 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 17.0 m -128.86 133.68 48.04 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.601 -0.888 . . . . 74.22 108.601 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 42.0 mt -138.95 141.31 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.147 -0.971 . . . . 60.33 110.571 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 6.1 m -136.99 117.75 10.88 Favored Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 108.915 -0.772 . . . . 72.31 108.915 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.98 -48.74 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 121.958 1.772 . . . . 75.13 112.471 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -55.53 -37.41 67.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.211 -0.93 . . . . 75.23 109.836 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -80.76 -2.15 45.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.166 -0.959 . . . . 72.43 109.374 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 49.55 57.32 6.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.256 -0.903 . . . . 75.13 108.958 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -156.66 139.7 15.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -0.908 . . . . 73.22 109.545 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 55.3 mt -124.01 132.72 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.995 -0.743 . . . . 64.14 108.995 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 136' ' ' ILE . . . . . 0.442 HG23 ' O ' ' B' ' 140' ' ' ARG . 23.7 mt -125.57 131.25 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.502 -0.749 . . . . 71.22 110.318 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -125.62 129.24 49.24 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.697 -0.627 . . . . 64.22 109.483 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm 51.46 36.34 16.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.179 -0.951 . . . . 72.02 111.095 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.76 -1.34 83.83 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 120.065 -1.064 . . . . 74.32 111.5 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 140' ' ' ARG . . . . . 0.442 ' O ' HG23 ' B' ' 136' ' ' ILE . 2.7 mpt_? -87.14 124.62 33.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.714 -1.462 . . . . 75.34 108.927 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -84.03 123.88 30.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.368 -0.832 . . . . 71.23 109.496 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 97.2 t -127.72 133.28 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.474 -0.766 . . . . 70.43 109.45 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -98.93 142.84 29.93 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.242 -0.911 . . . . 72.43 109.44 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 20.6 m -146.32 152.29 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.149 -0.969 . . . . 72.13 109.906 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.11 115.79 0.08 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.358 -0.839 . . . . 72.02 109.407 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.59 -137.86 7.03 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.788 -1.325 . . . . 42.23 109.788 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 0.58 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 0.0 OUTLIER -73.53 -43.83 7.1 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.272 -1.134 . . . . 73.3 109.539 -179.58 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 148' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 24.3 Cg_exo -62.67 -49.08 5.99 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.29 1.994 . . . . 71.33 111.144 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 149' ' ' PHE . . . . . 0.44 ' CE1' HG21 ' B' ' 153' ' ' THR . 25.1 t80 -58.06 -24.39 58.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.687 -0.633 . . . . 74.23 109.608 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 150' ' ' GLU . . . . . 0.41 ' OE1' ' O ' ' B' ' 172' ' ' ILE . 24.0 tt0 -72.11 -58.6 3.29 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.299 -0.876 . . . . 72.34 110.378 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.99 -33.58 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.801 -1.187 . . . . 73.35 109.468 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 3.8 mp -58.15 -41.47 83.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.118 -0.989 . . . . 55.24 108.781 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.44 HG21 ' CE1' ' B' ' 149' ' ' PHE . 1.9 p -80.6 -18.96 46.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.967 . . . . 70.01 110.235 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -71.16 -52.13 20.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.858 -1.151 . . . . 65.32 109.576 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.997 HD13 ' N ' ' B' ' 156' ' ' ALA . 0.0 OUTLIER -77.92 -25.01 48.11 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.313 -0.867 . . . . 71.54 110.17 -179.164 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 156' ' ' ALA . . . . . 0.997 ' N ' HD13 ' B' ' 155' ' ' LEU . . . -63.38 -53.4 53.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.906 -1.121 . . . . 75.32 109.259 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -66.06 -54.5 25.01 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.267 -0.896 . . . . 73.32 108.877 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 158' ' ' HIS . . . . . 0.448 ' ND1' ' N ' ' B' ' 158' ' ' HIS . 2.1 m-70 -84.72 38.27 0.69 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.804 -0.56 . . . . 74.14 110.263 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -73.41 45.07 0.16 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.866 -1.146 . . . . 61.41 109.408 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 160' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' B' ' 160' ' ' ASP . 15.9 p-10 -169.81 62.13 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.076 -1.015 . . . . 72.1 109.294 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 161' ' ' GLN . . . . . 0.517 ' NE2' ' OD2' ' A' ' 160' ' ' ASP . 39.7 tp60 -169.87 164.51 9.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.07 -1.019 . . . . 72.25 109.831 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 162' ' ' ILE . . . . . 0.524 HG23 ' NE ' ' B' ' 213' ' ' ARG . 45.4 mt -80.3 132.94 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.611 -0.885 . . . . 72.31 108.611 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 33.9 t -132.01 131.12 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.289 -0.882 . . . . 64.21 109.892 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 11.2 p -99.68 159.94 14.67 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.708 -0.849 . . . . 74.22 108.708 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -55.76 -39.38 71.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.028 -1.045 . . . . 65.31 109.571 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.21 -39.6 93.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.149 -0.969 . . . . 63.45 109.809 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -53.3 -47.28 69.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.176 -0.953 . . . . 72.4 109.0 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 33.5 mt -55.87 -50.53 70.37 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.448 -0.945 . . . . 72.32 108.448 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.462 ' O ' HD23 ' B' ' 169' ' ' LEU . 1.1 tt -49.9 -56.23 11.35 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.271 -0.893 . . . . 73.34 109.296 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -56.2 -39.21 72.08 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 112.833 0.679 . . . . 72.1 112.833 -178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -93.25 -18.83 22.03 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.451 -1.406 . . . . 62.13 113.408 -176.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.41 ' O ' ' OE1' ' B' ' 150' ' ' GLU . 1.3 mp -91.32 -53.87 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 120.375 -1.453 . . . . 71.42 111.07 -178.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 173' ' ' TRP . . . . . 0.536 ' CG ' ' O ' ' B' ' 173' ' ' TRP . 0.0 OUTLIER -87.57 13.0 11.08 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.738 -1.226 . . . . 72.23 110.63 -177.542 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -48.36 -33.15 8.57 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.022 -1.049 . . . . 52.11 109.672 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 175' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' B' ' 177' ' ' GLU . 14.5 mt-10 -87.83 157.32 51.97 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 107.911 -1.144 . . . . 73.04 107.911 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' B' ' 175' ' ' GLU . 52.7 Cg_exo -34.0 86.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.581 2.187 . . . . 74.13 111.997 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 177' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' B' ' 175' ' ' GLU . 50.0 mt-10 -142.85 172.47 12.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.558 -0.714 . . . . 72.44 109.63 -178.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 3.7 tpt -142.79 70.33 1.32 Allowed 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.325 -0.991 . . . . 63.43 108.325 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 179' ' ' VAL . . . . . 0.513 ' O ' ' O ' ' B' ' 180' ' ' THR . 23.6 m -77.37 -10.97 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.522 -0.736 . . . . 71.05 110.761 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 180' ' ' THR . . . . . 0.513 ' O ' ' O ' ' B' ' 179' ' ' VAL . 0.9 OUTLIER 55.31 154.77 0.06 OUTLIER Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.773 -0.58 . . . . 62.15 109.439 -179.408 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.41 -54.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.203 1.936 . . . . 65.22 113.01 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -62.44 -33.5 74.92 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.199 -0.938 . . . . 72.31 111.072 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 183' ' ' VAL . . . . . 0.512 ' HB ' ' HG1' ' B' ' 180' ' ' THR . 87.2 t -66.67 -15.54 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.933 -1.104 . . . . 63.32 110.699 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 95.0 mt -60.87 -23.55 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.726 -1.234 . . . . 75.03 109.563 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 185' ' ' GLU . . . . . 0.449 ' CG ' ' N ' ' B' ' 186' ' ' VAL . 20.6 pt-20 -59.87 -43.95 94.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.283 -0.885 . . . . 64.11 109.883 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 186' ' ' VAL . . . . . 0.454 HG12 ' O ' ' B' ' 183' ' ' VAL . 2.7 p -76.98 -34.35 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.967 -1.083 . . . . 73.0 109.74 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -55.25 -52.59 62.9 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.881 -1.137 . . . . 61.12 109.588 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 8.3 tp -65.97 -37.83 80.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 120.973 -1.08 . . . . 72.43 109.603 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -58.5 -46.11 87.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.001 -1.062 . . . . 65.14 109.6 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -72.91 -47.23 47.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 63.24 110.087 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.5 mt -54.63 -40.55 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.026 -1.046 . . . . 74.03 109.463 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -62.49 -52.17 64.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.162 -0.961 . . . . 72.24 109.505 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -60.22 -38.42 83.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 73.1 109.464 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -73.25 -15.42 61.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.289 -0.882 . . . . 72.11 109.592 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 1.5 tpt -89.85 -57.13 2.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.271 -0.893 . . . . 44.33 110.098 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 196' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' B' ' 200' ' ' GLY . 95.2 m-20 -55.87 -38.35 70.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 71.21 110.998 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 197' ' ' LYS . . . . . 0.435 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 14.0 mtmm -54.96 -65.66 1.28 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.876 -1.14 . . . . 75.21 109.938 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 198' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 34.9 Cg_endo -63.11 -56.57 0.53 Allowed 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.084 1.856 . . . . 75.32 112.368 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 199' ' ' LEU . . . . . 0.496 ' N ' HD12 ' B' ' 199' ' ' LEU . 9.1 mp -62.83 -32.15 73.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.137 -0.977 . . . . 72.25 109.478 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 200' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' B' ' 196' ' ' ASP . . . 74.14 -41.9 1.13 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.486 -1.446 . . . . 64.53 109.486 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 201' ' ' ILE . . . . . 0.418 ' H ' ' C ' ' B' ' 199' ' ' LEU . 4.0 mt -92.29 129.52 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.285 -1.126 . . . . 44.23 109.231 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 26.3 p -78.12 142.35 38.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.167 -0.958 . . . . 54.01 109.07 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 10.2 p -141.45 4.88 1.8 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.314 -0.867 . . . . 74.4 109.528 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 204' ' ' VAL . 32.6 m -113.89 134.83 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.444 -0.785 . . . . 72.12 109.208 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 205' ' ' GLU . . . . . 0.531 ' N ' ' OE2' ' B' ' 205' ' ' GLU . 1.5 mp0 -106.76 136.22 46.95 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.448 -0.783 . . . . 65.41 109.508 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.36 119.21 34.42 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.209 -0.932 . . . . 71.33 109.018 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 4.8 t -131.58 130.77 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.447 -0.783 . . . . 63.5 109.59 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 208' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' B' ' 209' ' ' ARG . 65.9 ttt-85 -73.1 -28.59 62.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 74.45 109.446 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 209' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' B' ' 208' ' ' ARG . 52.4 mtp85 -55.6 -106.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 74.14 109.982 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -63.67 -66.19 0.58 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.019 . . . . 74.43 109.852 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 211' ' ' GLY . . . . . 0.78 ' H ' HH12 ' B' ' 213' ' ' ARG . . . 178.68 -119.89 0.68 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.834 -1.306 . . . . 64.45 109.834 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 212' ' ' TYR . . . . . 0.628 ' N ' ' NH2' ' B' ' 213' ' ' ARG . 78.2 m-85 -111.69 141.79 44.85 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.494 -1.004 . . . . 74.21 109.7 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 213' ' ' ARG . . . . . 0.78 HH12 ' H ' ' B' ' 211' ' ' GLY . 13.5 mmp_? -105.87 131.51 53.11 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.454 -0.779 . . . . 74.03 108.96 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 214' ' ' PHE . . . . . 0.43 ' C ' ' SG ' ' B' ' 215' ' ' CYS . 60.4 m-85 -108.45 107.27 17.74 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.348 -0.845 . . . . 74.34 108.972 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 215' ' ' CYS . . . . . 0.43 ' SG ' ' C ' ' B' ' 214' ' ' PHE . 4.2 m -148.64 169.43 20.37 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.309 -0.869 . . . . 64.33 109.53 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -79.32 150.34 73.76 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 70.04 109.117 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.77 -159.57 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.975 1.783 . . . . 65.11 111.243 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -56.56 151.24 31.03 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 120.993 -1.067 . . . . 73.15 109.089 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -35.41 93.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.616 2.211 . . . . 71.31 112.353 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.66 -22.1 21.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.345 -0.847 . . . . 75.45 109.904 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 221' ' ' CYS . . . . . 0.524 ' SG ' ' N ' ' B' ' 222' ' ' GLU . 24.3 t -148.3 160.73 42.68 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.086 -1.009 . . . . 72.22 109.839 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.524 ' N ' ' SG ' ' B' ' 221' ' ' CYS . 78.7 tt0 -159.29 149.28 18.96 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.879 -0.786 . . . . 54.53 108.879 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.063 -1.023 . . . . 71.13 109.375 -179.988 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ptp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.469 -0.567 . . . . 65.12 109.469 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.1 ttt85 -144.24 156.47 44.3 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.277 -0.889 . . . . 72.33 109.238 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.5 t -117.04 129.21 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.59 0.709 . . . . 71.42 109.742 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 49' ' ' MET . 6.8 tp -99.86 116.76 32.68 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.902 -0.777 . . . . 65.12 108.902 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.4 tp -119.54 105.44 11.23 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.098 -0.704 . . . . 62.43 109.098 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.47 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 11.7 mt -96.36 131.9 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.071 -1.018 . . . . 71.15 109.539 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.499 ' N ' ' CD ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -163.14 131.83 3.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 75.34 109.409 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.547 ' H ' ' CD ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -76.74 -5.1 46.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -0.944 . . . . 72.44 108.898 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -74.67 -145.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.312 -0.868 . . . . 63.02 109.092 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.3 t -159.83 -69.84 0.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.107 -0.996 . . . . 72.34 109.662 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.414 HG13 ' N ' ' A' ' 12' ' ' LEU . 11.2 p -64.76 -37.46 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 74.02 109.985 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.414 ' N ' HG13 ' A' ' 11' ' ' VAL . 3.6 mm? -52.11 -41.34 62.39 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.978 -1.076 . . . . 71.43 108.756 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.25 -28.79 63.35 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.552 -1.819 . . . . 61.32 108.552 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.65 -46.43 92.15 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.696 -1.362 . . . . 71.2 109.696 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.28 -42.86 87.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.321 -1.106 . . . . 71.32 109.915 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.464 HD11 ' CE2' ' A' ' 99' ' ' TYR . 62.9 mt -69.55 -37.45 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.886 -1.134 . . . . 63.23 109.327 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -59.81 -45.94 90.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.137 -0.977 . . . . 51.11 109.488 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -86.33 -4.28 59.14 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.155 -0.966 . . . . 73.34 109.629 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.02 -57.45 2.52 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.312 -1.515 . . . . 62.15 109.312 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pp -66.31 -29.21 69.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.376 -1.073 . . . . 73.51 109.38 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -53.22 -35.1 59.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 74.25 109.35 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 82.1 t -55.52 -40.84 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.929 . . . . 70.04 109.095 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.539 ' HZ2' HG11 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -70.25 -17.33 63.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.373 -0.83 . . . . 73.23 109.015 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.95 41.6 3.5 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.197 -1.161 . . . . 75.54 110.197 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -118.15 155.85 29.73 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.404 -1.057 . . . . 73.43 108.737 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.7 mmm -103.51 139.22 39.15 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.538 -0.912 . . . . 43.24 108.538 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.69 159.81 41.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.224 -0.923 . . . . 62.11 110.066 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -140.03 146.06 38.55 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.91 -0.774 . . . . 74.42 108.91 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.93 128.15 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.647 -0.872 . . . . 72.15 108.647 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.6 p -128.48 165.05 21.44 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.584 -0.697 . . . . 71.42 109.516 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.47 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 3.5 pt-20 -94.13 -99.34 0.15 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.284 -0.885 . . . . 72.33 109.643 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.5 p -79.56 165.51 22.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.167 -0.958 . . . . 74.24 110.034 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.0 mt -57.13 -36.3 70.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.496 -0.752 . . . . 71.53 109.991 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -54.14 -41.09 68.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.111 -0.993 . . . . 74.23 110.014 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.18 -40.08 65.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.125 -0.984 . . . . 54.03 109.867 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.97 -39.46 23.96 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.91 -1.276 . . . . 61.41 109.91 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.6 -49.02 74.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -1.136 . . . . 74.34 109.872 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -66.47 -35.75 81.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.144 -0.972 . . . . 75.33 110.039 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.469 HD11 ' HE ' ' A' ' 43' ' ' ARG . 20.6 tp -73.83 -51.58 15.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 74.33 110.344 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.42 ' O ' ' O ' ' A' ' 43' ' ' ARG . 11.7 ptm -65.3 -24.79 67.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.078 -1.014 . . . . 70.32 110.094 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -54.98 -42.0 71.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.079 -1.013 . . . . 71.22 109.891 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.1 pt -88.67 -34.68 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.164 -0.96 . . . . 74.14 109.964 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.469 ' HE ' HD11 ' A' ' 39' ' ' LEU . 86.2 mtt-85 -86.59 147.35 25.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.02 -1.05 . . . . 72.24 109.684 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -88.42 151.92 22.24 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.296 -0.877 . . . . 75.42 109.237 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 12.5 p90 -156.01 171.09 20.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.149 -0.969 . . . . 74.23 109.897 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 45' ' ' TYR . 89.8 m-20 -136.3 -31.87 0.88 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.53 -0.732 . . . . 72.04 109.426 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.02 108.62 19.86 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.361 -0.837 . . . . 72.13 108.818 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.3 t -97.82 97.8 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.323 -0.861 . . . . 72.34 109.438 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.429 ' O ' ' O ' ' A' ' 4' ' ' LEU . 4.5 ttt -113.89 127.48 56.0 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.455 -0.778 . . . . 74.11 109.213 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.418 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -133.5 137.61 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.635 -0.666 . . . . 61.12 109.47 -179.082 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 t -103.92 4.07 34.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.589 -0.694 . . . . 73.11 109.647 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.418 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 78.0 m-20 -76.84 140.01 40.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.15 -0.969 . . . . 52.55 109.532 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 55' ' ' ALA . 37.9 mmtm -73.58 -42.32 61.73 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.291 -0.881 . . . . 44.22 110.104 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -70.95 13.98 0.17 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.113 -0.992 . . . . 70.44 109.682 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.01 -20.87 59.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 64.14 110.428 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.673 ' HB3' HE22 ' A' ' 89' ' ' GLN . 36.3 mt -42.06 -50.84 4.67 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.39 -0.819 . . . . 44.14 110.019 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.9 m -66.12 -33.85 76.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.074 -1.016 . . . . 55.23 108.945 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.437 ' N ' ' O ' ' A' ' 55' ' ' ALA . 52.1 t80 -64.08 -62.1 1.84 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.358 -0.839 . . . . 74.44 109.574 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.2 m -49.21 -33.25 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.671 -1.268 . . . . 74.03 109.589 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.0 m -58.2 -51.66 68.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.207 -0.933 . . . . 64.3 109.583 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -69.21 -31.22 69.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.997 -1.064 . . . . 64.44 110.014 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.9 mm -65.87 -36.11 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.726 -1.234 . . . . 63.21 109.561 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -69.75 -46.38 66.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 74.42 110.428 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.431 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 7.0 pt-20 -74.53 -42.73 58.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.831 -1.168 . . . . 70.32 110.087 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.527 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 92.8 mttt -70.13 -27.9 64.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 75.22 109.484 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.572 ' O ' HG22 ' A' ' 69' ' ' ILE . 58.6 m-70 -150.13 67.12 0.97 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.367 -0.833 . . . . 74.13 109.224 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.3 p -60.44 -28.76 68.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 73.24 109.813 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.5 t -78.58 48.54 0.8 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.158 -0.964 . . . . 61.01 109.709 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.572 HG22 ' O ' ' A' ' 66' ' ' HIS . 13.6 tt -144.81 166.72 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.094 -1.004 . . . . 71.33 109.344 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 71' ' ' VAL . 86.6 t -98.05 156.06 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.182 -0.949 . . . . 72.13 109.404 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.413 ' N ' HG12 ' A' ' 70' ' ' VAL . 4.9 t -142.63 120.86 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.286 -0.884 . . . . 54.21 108.816 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.529 ' HG ' HD11 ' A' ' 95' ' ' ILE . 2.4 mp -116.75 104.27 11.18 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.862 -0.792 . . . . 50.24 108.862 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 68.5 t -93.02 121.37 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 74.41 108.859 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.0 p -89.78 169.38 11.32 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.158 -0.964 . . . . 72.31 109.118 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.484 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 19.1 t -162.44 123.03 2.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.085 -1.01 . . . . 64.54 110.224 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 77' ' ' ASN . 54.1 p30 -78.49 -9.97 59.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.428 -0.795 . . . . 74.13 109.116 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 79' ' ' THR . 27.6 m120 -128.7 64.95 71.09 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.891 -0.781 . . . . 73.34 108.891 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -49.44 88.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.093 1.862 . . . . 63.22 111.871 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.425 ' N ' ' O ' ' A' ' 77' ' ' ASN . 24.5 m -105.83 149.24 26.68 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.706 -0.849 . . . . 62.53 108.706 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.3 -33.11 74.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 73.44 109.329 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.422 ' H ' HG22 ' A' ' 79' ' ' THR . 84.4 tt0 -61.18 -38.73 87.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 71.42 109.363 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.422 ' OE1' ' OH ' ' A' ' 94' ' ' TYR . 85.1 tt0 -75.76 -31.81 59.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 73.43 109.498 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.51 -51.44 65.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 74.22 109.741 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.469 HG23 ' N ' ' A' ' 85' ' ' HIS . 31.4 m -63.98 -42.82 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 73.2 109.605 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.469 ' N ' HG23 ' A' ' 84' ' ' VAL . 23.1 t60 -64.06 -32.54 74.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.186 -0.946 . . . . 53.33 109.509 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.37 -37.88 80.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 64.11 110.091 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -83.48 -36.93 23.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.053 -1.029 . . . . 74.34 109.294 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.85 -34.04 77.05 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.293 -0.879 . . . . 74.42 109.504 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.673 HE22 ' HB3' ' A' ' 56' ' ' LEU . 29.0 mt-30 -80.08 -60.03 2.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 74.24 109.776 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 157.36 59.12 0.01 OUTLIER Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.672 -1.252 . . . . 61.51 110.22 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.44 125.48 51.81 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.402 -1.058 . . . . 55.33 108.89 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 20.6 t70 -69.65 -35.59 75.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.002 -1.061 . . . . 73.42 109.271 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 67.9 m-20 -151.3 161.5 42.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.338 -0.851 . . . . 75.04 109.442 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.484 ' OH ' ' CB ' ' A' ' 75' ' ' SER . 86.9 t80 -134.98 119.19 17.68 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.563 -0.902 . . . . 71.33 108.563 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.699 ' H ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -125.42 148.6 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 CA-C-O 121.701 0.762 . . . . 71.13 110.7 -178.191 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.51 133.77 49.07 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.822 -1.177 . . . . 64.32 107.822 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.682 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -53.67 -55.3 36.81 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 120.907 -1.12 . . . . 62.2 111.824 -178.794 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.5 Cg_endo -41.01 -10.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 120.943 1.095 . . . . 73.11 113.19 -175.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.682 ' N ' ' O ' ' A' ' 97' ' ' LYS . 56.8 m-85 58.99 118.89 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.661 -0.649 . . . . 65.22 109.802 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 46.7 mtt-85 -62.6 -41.68 99.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.824 -1.172 . . . . 72.35 109.528 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.762 ' O ' ' N ' ' A' ' 103' ' ' LYS . 44.5 t -165.92 31.13 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.0 -1.062 . . . . 71.32 110.75 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.3 mt 50.39 -70.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 118.588 0.631 . . . . 75.43 110.208 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.762 ' N ' ' O ' ' A' ' 101' ' ' SER . 9.1 mtpm? -53.47 -32.81 51.78 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.062 -1.088 . . . . 71.41 108.062 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.29 -52.13 60.09 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.439 -0.948 . . . . 63.24 108.439 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.0 tp -58.21 -41.4 83.96 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.518 -0.919 . . . . 73.22 108.518 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.539 HG11 ' HZ2' ' A' ' 23' ' ' LYS . 84.1 t -61.99 -37.37 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.25 -0.906 . . . . 60.11 108.669 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.4 -35.49 70.1 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.345 -0.847 . . . . 70.42 108.9 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.527 ' NE ' ' OE2' ' B' ' 83' ' ' GLU . 93.8 mtt180 -79.86 -26.76 40.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.371 -0.831 . . . . 74.41 109.974 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.9 mt -80.3 -38.52 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.053 -1.029 . . . . 62.54 109.476 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -72.72 -36.88 67.89 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.236 -0.915 . . . . 74.34 109.207 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.23 -46.46 83.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.341 -0.849 . . . . 73.32 109.226 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.99 -39.36 81.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 52.41 108.793 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.439 ' C ' HD23 ' A' ' 113' ' ' LEU . 3.7 tt -142.43 80.87 1.72 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.254 -0.904 . . . . 65.24 108.781 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.526 ' O ' ' CG ' ' A' ' 115' ' ' PHE . 86.2 mtm180 -65.88 -43.42 88.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 64.45 109.927 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.526 ' CG ' ' O ' ' A' ' 114' ' ' ARG . 96.3 m-85 -158.39 -84.98 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.159 -0.963 . . . . 74.43 109.581 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 83.7 t90 -154.16 154.12 33.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 74.42 109.442 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 158.17 65.72 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.443 -1.463 . . . . 75.04 109.443 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 83.0 p -156.76 96.9 1.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.296 -1.12 . . . . 61.14 109.48 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 128' ' ' ILE . 21.8 t-20 -154.69 174.22 15.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.296 -0.877 . . . . 65.24 109.314 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.489 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 4.2 t -142.59 -35.56 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.286 -0.884 . . . . 73.11 109.139 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 20.8 mm -104.7 126.45 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.338 -0.851 . . . . 72.24 109.179 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -139.53 120.99 15.07 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.361 -0.837 . . . . 72.34 109.336 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.4 ' O ' ' C ' ' A' ' 124' ' ' GLY . 10.2 pt -150.18 135.47 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.268 -0.895 . . . . 71.44 109.373 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 123' ' ' ILE . . . 43.87 -145.34 1.58 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.991 -1.244 . . . . 73.4 109.991 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -85.44 1.04 50.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -1.165 . . . . 74.45 109.274 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.45 131.42 38.66 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.39 -0.967 . . . . 54.21 108.39 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 51.3 m -131.08 133.79 46.0 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.437 -0.789 . . . . 54.5 109.62 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.518 ' O ' ' ND2' ' A' ' 119' ' ' ASN . 72.4 mt -131.95 133.81 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.473 -0.767 . . . . 45.15 109.147 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.505 ' OG ' ' ND2' ' A' ' 119' ' ' ASN . 70.9 m -119.73 85.01 32.41 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.651 -0.655 . . . . 71.11 109.581 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.43 -44.7 47.07 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.398 2.065 . . . . 65.41 111.886 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -61.81 -41.96 98.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 63.32 109.308 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -80.67 -8.16 59.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.301 -0.874 . . . . 72.52 108.78 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 56.24 59.75 3.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.417 -0.802 . . . . 75.33 109.552 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -155.85 134.63 11.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.206 -0.934 . . . . 71.23 109.62 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 97.6 mt -107.84 140.64 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.563 -0.711 . . . . 74.02 109.33 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.6 mp -128.35 122.15 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.397 -0.814 . . . . 60.23 109.613 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -138.69 140.23 38.71 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.814 -0.809 . . . . 62.32 108.814 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.418 ' HB3' ' HZ2' ' A' ' 138' ' ' LYS . 14.8 mtpp 54.12 25.51 5.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.434 -0.791 . . . . 75.4 110.055 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.01 -7.85 58.76 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.985 -1.246 . . . . 72.24 109.985 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -88.64 128.07 35.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.087 -1.243 . . . . 71.22 109.056 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -97.97 139.0 34.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.33 -0.856 . . . . 71.42 109.636 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 13.5 p -136.76 138.75 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.461 -0.774 . . . . 53.02 109.072 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -93.86 140.92 29.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.255 -0.903 . . . . 60.45 109.543 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.02 154.01 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.303 -0.873 . . . . 74.44 109.322 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -171.08 43.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.116 -0.99 . . . . 65.15 109.899 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -164.03 -110.53 0.24 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.555 -1.418 . . . . 73.34 109.555 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.622 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 23.2 mmtp -73.29 -35.54 2.76 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.255 -1.144 . . . . 72.22 110.479 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 95.3 Cg_endo -91.4 21.96 0.74 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.464 2.109 . . . . 65.23 112.011 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -129.33 -55.54 1.17 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.56 -0.713 . . . . 60.11 109.748 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -58.61 -58.09 10.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.161 -0.962 . . . . 64.21 110.552 -178.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.6 -33.27 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.954 -1.091 . . . . 72.02 109.672 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.499 HD23 ' HA ' ' A' ' 148' ' ' PRO . 3.4 mm? -63.12 -41.68 99.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.062 -1.024 . . . . 73.31 108.676 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.6 p -74.5 -32.18 62.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.252 -0.905 . . . . 74.31 109.943 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -58.16 -50.87 72.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.172 -0.955 . . . . 74.31 109.61 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.7 pp -76.08 -26.09 56.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 75.34 109.791 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.58 -45.98 77.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 62.14 109.325 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -76.59 -44.24 35.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.195 -0.941 . . . . 61.03 108.936 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -82.41 26.43 0.56 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.514 -0.741 . . . . 74.12 109.244 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -49.66 -29.93 8.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.377 -0.827 . . . . 71.13 109.855 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 160' ' ' ASP . 42.9 p30 -123.9 74.84 1.31 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.534 -0.728 . . . . 75.45 109.198 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 162' ' ' ILE . 13.8 tm0? -171.21 152.77 3.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.9 . . . . 73.41 109.517 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.511 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 71.4 mt -83.63 122.15 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.172 -0.955 . . . . 74.41 109.439 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.5 t -112.59 137.82 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.534 -0.729 . . . . 72.31 109.761 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 29.6 t -94.78 155.79 16.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.358 -0.839 . . . . 74.12 109.453 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.467 ' NZ ' ' CB ' ' A' ' 165' ' ' LYS . 8.7 mtpm? -56.92 -43.48 81.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 70.43 109.64 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -55.24 -37.14 66.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.923 . . . . 73.52 109.446 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -59.57 -41.91 91.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -0.939 . . . . 74.52 109.444 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 26.3 mt -63.65 -33.17 75.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.2 -0.938 . . . . 72.31 109.315 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.482 ' C ' HD23 ' A' ' 169' ' ' LEU . 5.6 tt -64.71 -55.61 18.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.298 -0.876 . . . . 53.33 109.589 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -71.63 -32.6 68.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.256 -0.902 . . . . 62.44 110.295 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.414 ' C ' HD12 ' A' ' 172' ' ' ILE . . . -58.52 -47.8 82.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.049 -1.032 . . . . 60.21 110.036 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.683 HD12 ' N ' ' A' ' 172' ' ' ILE . 1.9 mp -96.96 -65.17 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.2 -0.938 . . . . 75.32 108.85 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 -85.04 89.03 7.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.422 -0.799 . . . . 73.14 109.394 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -98.26 -74.09 0.59 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.317 -0.864 . . . . 73.24 109.758 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 177' ' ' GLU . 29.8 mt-10 -60.27 152.15 64.59 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.233 -0.917 . . . . 44.43 109.408 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -40.55 83.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.348 2.032 . . . . 72.51 112.888 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 175' ' ' GLU . 42.6 mm-40 -90.96 12.58 19.18 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.886 -1.134 . . . . 63.24 108.967 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 70.8 mtm 52.02 67.01 1.04 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.867 . . . . 73.5 109.324 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 33.5 m -131.93 150.78 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.51 -0.744 . . . . 65.22 109.372 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.529 ' O ' ' N ' ' A' ' 182' ' ' ASN . 16.3 m -91.6 113.24 58.03 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.283 -0.886 . . . . 71.42 109.14 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -44.06 -11.57 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.036 1.824 . . . . 41.22 112.814 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 180' ' ' THR . 49.2 p-10 -95.79 46.71 1.09 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.074 -1.016 . . . . 64.54 109.765 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 180' ' ' THR . 35.9 m -130.46 -4.18 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.38 -0.825 . . . . 74.02 109.759 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 184' ' ' ILE . 1.9 mp -66.33 -29.35 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.949 -1.095 . . . . 72.33 109.141 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -61.7 -42.83 99.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 74.4 109.611 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 19.0 m -79.54 -28.49 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.09 -1.006 . . . . 70.42 109.379 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.51 -42.17 65.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.864 . . . . 52.11 109.795 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.5 tp -74.94 -29.95 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.986 -1.071 . . . . 71.4 109.314 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 59.0 m-20 -70.64 -43.94 68.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.845 . . . . 73.44 110.099 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -75.56 -40.9 56.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.131 -0.981 . . . . 71.42 110.135 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 74.9 mt -60.47 -36.49 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.014 -1.054 . . . . 61.55 109.561 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 18.9 mtp-105 -71.38 -40.16 70.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.035 -1.041 . . . . 63.34 108.656 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -68.05 -35.2 77.84 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.577 -0.702 . . . . 61.24 109.133 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.411 ' O ' ' CD ' ' A' ' 198' ' ' PRO . 50.7 mtpt -85.19 -8.31 58.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.349 -0.844 . . . . 75.13 109.737 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 51.1 ttm -92.84 -57.21 2.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.185 -0.947 . . . . 74.02 109.559 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -59.12 -32.48 69.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 74.02 110.011 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.437 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 54.1 mttt -57.13 -65.64 1.64 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.035 -1.041 . . . . 75.43 109.847 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 42.4 Cg_endo -64.77 -57.99 0.25 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 122.306 2.004 . . . . 72.32 112.546 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 15.3 mt -61.15 -42.75 99.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -0.958 . . . . 74.54 109.963 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 86.62 -37.63 3.15 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.78 -1.328 . . . . 61.51 109.78 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.741 HD12 ' N ' ' A' ' 201' ' ' ILE . 1.7 mp -92.41 141.53 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.132 -1.217 . . . . 61.22 109.371 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 59.5 p -85.55 145.23 27.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.888 . . . . 72.0 109.274 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.1 p -146.59 27.25 1.11 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.253 -0.904 . . . . 74.44 109.485 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 204' ' ' VAL . 29.5 m -143.97 134.21 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.169 -0.957 . . . . 64.35 109.518 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -108.58 126.16 52.64 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.536 -0.727 . . . . 71.41 109.296 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.35 119.69 32.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.116 -0.99 . . . . 73.52 109.226 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 211' ' ' GLY . 34.9 m -147.82 140.74 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.224 -0.922 . . . . 71.02 109.616 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 75.1 ttt-85 -62.62 -25.51 68.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.85 . . . . 72.12 109.373 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 211' ' ' GLY . 76.1 mtt85 -47.17 103.92 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 64.41 109.786 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 60.51 -75.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.591 -0.693 . . . . 71.54 109.844 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . -158.41 -127.77 0.96 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.838 -1.305 . . . . 72.03 109.838 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -101.53 142.21 33.24 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.407 -1.054 . . . . 75.54 109.436 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -106.43 126.57 52.41 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.478 -0.764 . . . . 75.31 109.686 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -98.04 128.36 44.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.389 -0.82 . . . . 75.41 109.034 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 34.0 m -151.78 154.94 37.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.498 -0.751 . . . . 74.14 109.137 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' TYR . . . . . 0.45 ' O ' ' O ' ' A' ' 217' ' ' PRO . 7.4 p90 -65.14 153.14 89.95 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.153 -0.967 . . . . 75.32 109.279 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 216' ' ' TYR . 84.2 Cg_exo -42.94 176.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.269 1.979 . . . . 73.11 112.408 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 220' ' ' ALA . 10.9 ptpt -46.38 154.82 0.61 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.313 -0.867 . . . . 75.25 108.811 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -33.7 85.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.683 2.256 . . . . 75.1 112.601 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 218' ' ' LYS . . . -61.52 -30.68 70.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.472 -0.767 . . . . 71.14 109.484 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 222' ' ' GLU . 30.4 p -54.64 -37.52 65.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 71.13 109.558 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.402 ' N ' ' SG ' ' A' ' 221' ' ' CYS . 96.5 mt-10 -60.03 140.95 56.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 75.35 109.361 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.402 ' OXT' ' O ' ' A' ' 222' ' ' GLU . 96.9 mt-10 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.0 -1.0 . . . . 73.41 109.444 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 52.5 ttm . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.487 -0.56 . . . . 71.14 109.487 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -139.87 148.78 42.56 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.303 -0.873 . . . . 73.23 109.354 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 93.6 t -113.91 137.71 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.583 -0.698 . . . . 72.24 109.452 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.499 HD11 ' CG1' ' B' ' 6' ' ' ILE . 3.5 tp -109.89 119.66 40.04 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.555 -0.716 . . . . 54.33 109.735 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.483 ' N ' HD12 ' B' ' 4' ' ' LEU . 15.3 mt -117.23 96.33 5.38 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 108.615 -0.883 . . . . 74.35 108.615 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.689 HD12 ' HB ' ' B' ' 50' ' ' VAL . 87.2 mt -82.93 98.88 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.703 -1.248 . . . . 42.55 109.049 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.425 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 38.8 tp10 -130.78 129.72 42.8 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.506 -0.746 . . . . 74.52 109.556 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -64.96 -38.96 92.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.314 -0.866 . . . . 62.55 109.332 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -83.8 116.63 22.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 73.11 109.471 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 23.4 m -66.73 -27.01 67.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.9 . . . . 65.54 109.795 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -66.99 -51.56 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.15 -0.969 . . . . 75.55 109.844 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.538 ' N ' HD12 ' B' ' 12' ' ' LEU . 7.9 mp -62.96 -39.07 93.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.172 -0.955 . . . . 70.14 109.62 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.05 -29.34 64.9 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 108.551 -1.82 . . . . 75.4 108.551 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.91 -49.84 68.9 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.674 -1.37 . . . . 65.44 109.674 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -61.96 -46.98 86.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.309 -1.112 . . . . 60.21 109.786 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.556 HD11 ' CD1' ' B' ' 99' ' ' TYR . 5.7 mm -63.98 -40.14 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.757 -1.214 . . . . 75.15 108.632 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.505 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 73.1 tt0 -63.07 -44.27 96.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.412 -0.805 . . . . 73.01 109.554 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -85.53 1.55 48.49 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.071 -1.018 . . . . 74.3 109.588 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.93 -57.3 1.94 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.376 -1.49 . . . . 70.54 109.376 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.417 HD23 ' N ' ' B' ' 21' ' ' ASN . 1.4 pt? -71.31 -20.85 62.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.424 -1.044 . . . . 71.34 109.648 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 89.6 m-20 -57.98 -30.81 66.33 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.992 -1.067 . . . . 64.41 109.278 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 92.9 t -59.05 -37.3 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.344 -0.847 . . . . 74.23 109.142 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -65.52 -21.4 66.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.371 -0.83 . . . . 63.42 109.398 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.32 39.87 2.52 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 110.11 -1.196 . . . . 53.43 110.11 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -120.2 160.98 21.85 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.474 -1.015 . . . . 71.12 109.208 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 3.8 mtt -100.45 139.84 35.56 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.262 -1.014 . . . . 75.24 108.262 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.43 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -143.95 154.45 43.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.225 -0.922 . . . . 72.12 110.37 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 28' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 96.9 m-20 -138.87 155.01 48.44 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.173 -1.047 . . . . 72.31 108.173 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.43 139.74 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.338 -0.851 . . . . 64.43 109.985 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.5 p -130.47 171.08 13.38 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 109.144 -0.687 . . . . 65.41 109.144 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.42 ' OE2' ' OD2' ' B' ' 35' ' ' ASP . 5.4 pt-20 -91.69 -106.11 0.1 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.178 -0.951 . . . . 71.02 109.873 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 77.7 p -78.11 166.94 22.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.223 -0.923 . . . . 51.11 110.073 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 53.5 mt -51.34 -30.86 19.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.586 -0.696 . . . . 71.24 109.945 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.87 -51.01 65.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.092 -1.005 . . . . 74.32 109.885 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.42 ' OD2' ' OE2' ' B' ' 31' ' ' GLU . 2.3 m-20 -63.58 -39.44 94.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.121 -0.987 . . . . 73.03 109.264 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.81 -38.4 76.15 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.253 -1.539 . . . . 30.21 109.253 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -67.18 -38.36 85.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -1.113 . . . . 74.42 109.573 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -80.52 -36.93 32.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.155 -0.965 . . . . 74.42 109.661 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 10.5 tp -71.29 -42.67 68.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 75.41 110.091 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' MET . . . . . 0.443 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.3 ppp? -67.54 -25.26 65.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.039 -1.038 . . . . 60.41 109.977 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -60.62 -39.84 89.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.046 -1.034 . . . . 53.23 110.161 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 14.7 pt -81.21 -32.01 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.006 -1.059 . . . . 71.23 110.202 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' B' ' 40' ' ' MET . 25.2 mmt180 -130.28 141.52 50.6 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.297 -0.877 . . . . 72.22 109.548 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' ASN . . . . . 0.553 HD21 HD11 ' B' ' 69' ' ' ILE . 58.3 t30 -98.48 132.71 43.7 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.28 -0.887 . . . . 63.54 109.437 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -102.37 138.28 39.51 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.353 -0.842 . . . . 64.35 109.513 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -75.82 -34.5 60.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 62.22 109.189 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.497 HD13 ' C ' ' B' ' 47' ' ' LEU . 0.8 OUTLIER -112.38 110.59 20.89 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.645 -0.872 . . . . 73.12 108.645 179.662 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.449 ' N ' HD13 ' B' ' 47' ' ' LEU . 54.5 t -95.52 100.85 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.369 -0.832 . . . . 65.11 109.124 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.509 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 0.6 OUTLIER -114.93 129.54 56.73 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.2 -0.667 . . . . 73.44 109.2 -179.659 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.689 ' HB ' HD12 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -144.69 132.29 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.457 -0.777 . . . . 34.5 109.233 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 51' ' ' SER . . . . . 0.425 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 24.9 p -94.57 11.57 30.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.392 -0.818 . . . . 73.21 109.662 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.608 ' H ' HG22 ' B' ' 50' ' ' VAL . 35.9 m-20 -80.61 138.65 36.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.147 -0.971 . . . . 70.41 109.515 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.439 ' C ' ' H ' ' B' ' 55' ' ' ALA . 62.3 mttp -74.92 -38.53 61.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.206 -0.934 . . . . 65.0 110.029 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -71.03 9.9 0.64 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.171 -0.955 . . . . 75.21 109.619 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -66.4 -21.77 66.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 55.33 110.134 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 33.3 mt -42.82 -40.16 2.77 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.397 -0.814 . . . . 63.14 110.33 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 13.0 t -76.32 -39.97 52.64 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.946 -1.096 . . . . 63.5 109.563 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -65.1 -43.14 93.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.332 -0.855 . . . . 72.33 110.307 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.42 HG23 ' N ' ' B' ' 60' ' ' SER . 34.3 m -67.37 -37.62 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.697 -1.252 . . . . 74.54 109.509 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.42 ' N ' HG23 ' B' ' 59' ' ' VAL . 40.4 m -55.24 -48.66 73.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 71.24 109.439 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.405 HH21 ' NZ ' ' B' ' 65' ' ' LYS . 13.3 ptm180 -69.57 -34.41 74.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.115 -0.99 . . . . 74.31 110.134 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' B' ' 66' ' ' HIS . 5.4 mm -64.52 -40.33 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.785 -1.197 . . . . 72.14 109.8 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.521 ' NZ ' ' OD1' ' B' ' 92' ' ' ASP . 44.4 mmtt -65.44 -48.81 71.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.157 -0.964 . . . . 73.32 110.459 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -73.01 -37.54 66.92 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.841 -1.162 . . . . 73.12 110.035 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.47 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 46.4 mtpt -80.22 -22.04 42.22 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.11 -0.994 . . . . 72.44 109.757 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.47 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 81.6 m-70 -155.68 65.92 0.61 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.136 -0.977 . . . . 63.31 109.623 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 9.7 t -60.44 -27.78 67.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 73.1 109.793 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 84.4 p -65.27 -24.82 67.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -0.92 . . . . 71.53 110.169 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.553 HD11 HD21 ' B' ' 44' ' ' ASN . 79.9 mt -79.81 152.89 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.103 -0.998 . . . . 74.4 109.677 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.469 HG12 ' N ' ' B' ' 71' ' ' VAL . 69.4 t -92.44 159.44 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.287 -0.883 . . . . 75.12 109.468 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.469 ' N ' HG12 ' B' ' 70' ' ' VAL . 11.7 t -137.96 120.92 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.184 -0.947 . . . . 73.2 109.877 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.509 ' O ' ' SD ' ' B' ' 49' ' ' MET . 0.7 OUTLIER -111.04 105.12 13.77 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.16 -1.052 . . . . 73.34 108.16 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 94.6 t -95.68 131.9 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.107 -0.996 . . . . 73.5 109.535 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.08 162.38 13.42 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.434 -0.791 . . . . 64.34 109.103 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.495 ' CB ' ' HH ' ' B' ' 94' ' ' TYR . 25.1 p -153.92 136.64 15.24 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.96 -1.087 . . . . 74.53 110.646 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -90.43 4.42 51.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.372 -0.83 . . . . 64.5 109.119 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 77' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' B' ' 79' ' ' THR . 23.7 m120 -142.31 68.5 21.52 Favored Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 108.663 -0.865 . . . . 74.25 108.663 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -54.71 79.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.347 2.031 . . . . 74.43 111.235 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.503 ' N ' ' O ' ' B' ' 77' ' ' ASN . 37.2 p -103.28 152.49 21.46 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.053 -0.721 . . . . 73.12 109.053 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -31.4 71.42 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.262 -0.899 . . . . 71.01 109.387 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -63.34 -48.24 78.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 63.2 109.493 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -71.7 -27.11 62.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 73.22 109.372 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.527 ' OE2' ' NE ' ' A' ' 108' ' ' ARG . 86.9 tt0 -63.03 -55.6 24.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.883 . . . . 74.3 109.887 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.401 HG23 ' N ' ' B' ' 85' ' ' HIS . 22.9 m -61.93 -40.29 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.058 -1.026 . . . . 73.31 109.423 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 85' ' ' HIS . . . . . 0.401 ' N ' HG23 ' B' ' 84' ' ' VAL . 21.5 m170 -64.71 -31.69 73.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.166 -0.959 . . . . 73.24 109.483 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.48 -45.87 81.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.918 . . . . 55.33 110.256 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -79.87 -34.51 39.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.031 -1.043 . . . . 74.14 109.433 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -70.78 -40.33 72.66 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.248 -0.908 . . . . 64.04 109.57 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -65.12 -52.16 57.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -0.965 . . . . 72.35 109.412 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.24 59.43 0.02 OUTLIER Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.188 -1.165 . . . . 65.2 110.188 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.88 136.18 53.62 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.435 -1.039 . . . . 52.23 109.075 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.521 ' OD1' ' NZ ' ' B' ' 63' ' ' LYS . 24.6 m-20 -82.16 -20.8 37.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.09 -1.006 . . . . 73.32 109.525 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -153.3 164.6 37.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 72.22 109.655 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.495 ' HH ' ' CB ' ' B' ' 75' ' ' SER . 76.1 t80 -145.14 97.26 2.98 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.745 -0.835 . . . . 64.42 108.745 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.4 HD12 ' NH1' ' B' ' 108' ' ' ARG . 19.0 mm -104.73 142.01 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 121.163 -0.961 . . . . 72.23 109.928 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 96' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' B' ' 97' ' ' LYS . . . -60.74 124.29 19.99 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.467 -1.308 . . . . 25.24 107.467 178.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' B' ' 99' ' ' TYR . 2.1 tptt -43.35 -61.04 2.03 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.058 -1.026 . . . . 64.32 110.726 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 98' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 9.3 Cg_endo -45.02 89.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 120.566 0.844 . . . . 63.33 110.489 -176.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 99' ' ' TYR . . . . . 0.582 ' N ' ' O ' ' B' ' 97' ' ' LYS . 45.4 m-85 -39.75 97.76 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.229 0.537 . . . . 75.13 111.128 -176.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -53.27 -33.43 53.11 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.521 -1.288 . . . . 74.23 107.521 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 32.5 t -176.18 128.03 0.21 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.274 -1.01 . . . . 63.34 108.274 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 19.6 mm -51.68 -36.22 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.017 -1.052 . . . . 74.44 108.903 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.518 ' O ' ' HB2' ' B' ' 107' ' ' ALA . 11.8 mptt -67.23 -34.47 77.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.358 -0.839 . . . . 71.11 109.407 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.53 -58.72 3.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.241 -0.912 . . . . 71.45 109.771 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.702 HD13 ' C ' ' B' ' 105' ' ' LEU . 1.9 tm? -54.46 -53.33 55.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 51.31 109.275 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 106' ' ' VAL . . . . . 0.475 ' N ' HD13 ' B' ' 105' ' ' LEU . 88.3 t -61.62 -42.47 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.987 -1.071 . . . . 65.23 109.37 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 107' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' B' ' 103' ' ' LYS . . . -51.82 -38.28 55.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.137 -0.977 . . . . 24.32 108.907 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 0.4 ' NH1' HD12 ' B' ' 95' ' ' ILE . 80.7 mtt180 -70.25 -34.7 73.14 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.354 -0.841 . . . . 75.31 109.441 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 86.3 mt -75.93 -26.59 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.14 -0.975 . . . . 54.24 108.788 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -76.6 -57.78 3.66 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.458 -0.776 . . . . 65.31 109.618 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.51 -44.84 73.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 72.24 109.961 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -59.83 4.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.113 -0.992 . . . . 72.04 109.646 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 30.4 tp -60.61 -35.52 76.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.11 -0.994 . . . . 75.35 109.763 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.45 ' O ' ' CB ' ' B' ' 115' ' ' PHE . 14.1 mmt180 -53.62 160.3 1.33 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.073 -1.017 . . . . 75.5 109.252 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 115' ' ' PHE . . . . . 0.45 ' CB ' ' O ' ' B' ' 114' ' ' ARG . 4.9 t80 75.6 -4.15 2.43 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.519 -0.738 . . . . 65.33 109.535 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER 54.26 -171.76 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 74.45 109.773 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -92.92 5.1 75.9 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.487 -1.445 . . . . 44.21 109.487 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 11.8 t 49.57 -174.33 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.492 -1.005 . . . . 71.4 109.854 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.73 141.74 23.0 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.424 -0.797 . . . . 72.32 109.336 -178.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 23.8 t -86.87 -44.11 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.187 -0.945 . . . . 75.02 109.854 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 3.6 mm -117.5 154.37 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.238 -0.914 . . . . 51.41 109.434 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -143.62 130.85 20.8 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.325 -0.859 . . . . 71.53 109.049 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 17.8 mt -135.47 108.33 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.18 -0.95 . . . . 72.43 109.896 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 124' ' ' GLY . . . . . 0.457 ' C ' ' H ' ' B' ' 126' ' ' LEU . . . 56.02 -155.41 12.58 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.229 -1.148 . . . . 51.23 110.229 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.99 -0.56 0.52 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.477 -1.013 . . . . 74.2 109.644 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.457 ' H ' ' C ' ' B' ' 124' ' ' GLY . 1.7 mt -94.22 148.6 22.04 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.237 -0.914 . . . . 75.42 109.405 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 7.0 m -126.33 132.33 51.64 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.109 -1.071 . . . . 74.22 108.109 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 88.8 mt -121.05 131.03 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.348 -0.845 . . . . 60.33 110.69 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 64.9 m -128.86 101.84 19.86 Favored Pre-proline 0 N--CA 1.495 1.824 0 N-CA-C 108.858 -0.793 . . . . 72.31 108.858 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -81.87 -40.32 0.15 Allowed 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.092 1.862 . . . . 75.13 111.918 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -52.97 -33.4 51.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.132 -0.98 . . . . 75.23 108.881 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -104.39 4.02 32.94 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.504 -0.747 . . . . 72.43 109.499 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.433 ' OE1' ' CD2' ' B' ' 149' ' ' PHE . 49.0 mm-40 49.77 59.58 4.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.124 -0.985 . . . . 75.13 109.3 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 134' ' ' LYS . . . . . 0.686 ' C ' HD12 ' B' ' 135' ' ' ILE . 33.6 ttmt -151.51 145.46 25.2 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.223 -0.923 . . . . 73.22 109.726 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 135' ' ' ILE . . . . . 0.686 HD12 ' C ' ' B' ' 134' ' ' LYS . 4.5 mp -137.81 133.49 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 108.782 -0.821 . . . . 64.14 108.782 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 4.7 mm -107.18 137.1 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.533 -0.73 . . . . 71.22 109.606 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -126.04 130.97 52.2 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.181 -1.044 . . . . 64.22 108.181 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 138' ' ' LYS . . . . . 0.651 ' NZ ' ' HE ' ' B' ' 140' ' ' ARG . 23.3 ttpp 55.36 14.92 1.21 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.499 -0.751 . . . . 72.02 109.762 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.91 -0.11 66.74 Favored Glycine 0 N--CA 1.496 2.684 0 O-C-N 120.927 -1.108 . . . . 74.32 110.505 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 140' ' ' ARG . . . . . 0.651 ' HE ' ' NZ ' ' B' ' 138' ' ' LYS . 17.5 mtt-85 -89.94 137.27 32.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.208 -1.172 . . . . 75.34 108.449 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -82.94 126.98 33.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 71.23 110.419 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 39.9 t -126.81 128.81 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.912 -0.773 . . . . 70.43 108.912 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -94.2 147.28 23.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.978 -1.076 . . . . 72.43 109.228 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 144' ' ' VAL . . . . . 0.852 ' H ' ' HZ2' ' B' ' 145' ' ' LYS . 2.4 t -142.16 115.41 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.217 -0.927 . . . . 72.13 108.95 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 145' ' ' LYS . . . . . 0.852 ' HZ2' ' H ' ' B' ' 144' ' ' VAL . 0.1 OUTLIER -145.28 140.17 27.62 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.278 -0.888 . . . . 72.02 109.742 179.886 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 111.54 -114.39 3.62 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 110.666 -0.973 . . . . 42.23 110.666 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 0.615 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 6.6 ttpm? -95.34 -29.82 0.27 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.57 -0.959 . . . . 73.3 112.42 -178.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 148' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 57.0 Cg_endo -80.47 -17.78 9.92 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 C-N-CA 121.482 1.455 . . . . 71.33 113.0 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 149' ' ' PHE . . . . . 0.433 ' CD2' ' OE1' ' B' ' 133' ' ' GLU . 1.1 p90 -85.54 -37.85 19.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.93 -1.107 . . . . 74.23 109.215 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 150' ' ' GLU . . . . . 0.426 ' N ' ' CG ' ' B' ' 149' ' ' PHE . 3.3 tm-20 -60.34 -46.7 88.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.533 -0.729 . . . . 72.34 109.974 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.428 HG13 ' N ' ' B' ' 152' ' ' LEU . 8.8 p -68.89 -40.65 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.864 -1.148 . . . . 73.35 110.102 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.497 ' C ' HD23 ' B' ' 152' ' ' LEU . 4.7 tt -66.65 -54.91 18.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.296 -0.877 . . . . 55.24 109.679 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 16.0 p -64.76 -32.44 74.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.004 -1.06 . . . . 70.01 110.555 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -59.2 -59.58 5.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.947 -1.095 . . . . 65.32 109.927 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.81 HD13 ' CE2' ' B' ' 214' ' ' PHE . 1.9 pp -69.3 -21.48 63.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.028 -1.045 . . . . 71.54 109.946 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.89 -52.98 61.9 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.014 -1.054 . . . . 75.32 109.334 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.458 ' C ' ' H ' ' B' ' 159' ' ' ARG . 16.5 mtm-85 -71.95 -51.62 21.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.18 -0.95 . . . . 73.32 109.79 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -74.79 36.19 0.11 Allowed 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.725 -0.79 . . . . 74.14 109.506 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 159' ' ' ARG . . . . . 0.458 ' H ' ' C ' ' B' ' 157' ' ' ARG . 30.2 ptt180 -59.91 166.05 2.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -0.86 . . . . 61.41 109.179 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 24.9 t70 43.66 64.24 1.32 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.253 -0.904 . . . . 72.1 109.88 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -157.3 159.21 37.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -0.965 . . . . 72.25 109.567 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 30.6 mt -93.77 114.02 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.218 -0.926 . . . . 72.31 109.139 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 4.0 m -115.13 129.78 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 121.527 0.679 . . . . 64.21 109.511 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 164' ' ' SER . . . . . 0.516 ' OG ' ' NE2' ' B' ' 167' ' ' GLN . 28.7 p -92.39 167.31 12.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -0.871 . . . . 74.22 109.125 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -51.69 -37.07 49.12 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.111 -0.993 . . . . 65.31 109.297 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -74.57 -25.46 59.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.146 -0.971 . . . . 63.45 110.559 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 167' ' ' GLN . . . . . 0.516 ' NE2' ' OG ' ' B' ' 164' ' ' SER . 0.0 OUTLIER -64.04 -56.14 17.17 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.618 -1.301 . . . . 72.4 108.792 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 47.1 mt -57.42 -57.21 13.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.102 -0.999 . . . . 72.32 108.916 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' B' ' 170' ' ' ASP . 1.9 mm? -50.55 -56.01 13.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.045 -1.034 . . . . 73.34 108.846 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 170' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' B' ' 169' ' ' LEU . 67.8 m-20 -41.69 -34.16 0.58 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.74 -0.6 . . . . 72.1 110.615 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -91.69 -37.72 12.86 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.102 -0.999 . . . . 62.13 110.729 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.54 ' C ' ' H ' ' B' ' 174' ' ' GLU . 3.7 mp -88.09 -68.41 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.893 -1.129 . . . . 71.42 109.442 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 173' ' ' TRP . . . . . 0.476 ' C ' ' CD2' ' B' ' 173' ' ' TRP . 0.0 OUTLIER -54.26 -2.38 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.505 -0.747 . . . . 72.23 109.47 -179.27 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 174' ' ' GLU . . . . . 0.54 ' H ' ' C ' ' B' ' 172' ' ' ILE . 48.4 tt0 -48.43 -18.79 0.26 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.101 -0.999 . . . . 52.11 109.861 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 175' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' B' ' 177' ' ' GLU . 0.6 OUTLIER -53.04 -176.91 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.201 -0.937 . . . . 73.04 108.709 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.46 ' CD ' ' CB ' ' B' ' 175' ' ' GLU . 37.6 Cg_exo -60.37 40.39 0.06 OUTLIER 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 122.563 2.176 . . . . 74.13 112.513 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 177' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' B' ' 175' ' ' GLU . 97.6 mt-10 46.98 -161.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.185 -0.947 . . . . 72.44 109.836 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 53.8 mmm 55.72 39.01 30.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.337 -0.852 . . . . 63.43 109.504 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 179' ' ' VAL . . . . . 0.402 ' O ' ' OG1' ' B' ' 180' ' ' THR . 2.7 m -109.51 72.63 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.566 -0.709 . . . . 71.05 109.402 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 180' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' B' ' 179' ' ' VAL . 4.0 p 45.86 83.0 0.22 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.46 -0.775 . . . . 62.15 109.813 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -51.47 164.77 0.77 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.046 1.831 . . . . 65.22 111.874 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 182' ' ' ASN . . . . . 0.813 ' OD1' ' OE2' ' B' ' 185' ' ' GLU . 45.5 t-20 49.33 60.9 3.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.136 -0.978 . . . . 72.31 110.006 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 4.1 p -119.09 4.65 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 108.994 -0.743 . . . . 63.32 108.994 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.562 ' O ' HG22 ' B' ' 188' ' ' ILE . 35.2 mt -63.62 -53.53 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.058 -1.026 . . . . 75.03 109.914 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 185' ' ' GLU . . . . . 0.813 ' OE2' ' OD1' ' B' ' 182' ' ' ASN . 1.5 pm0 -61.5 -40.43 94.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 64.11 110.313 -178.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 97.2 t -73.99 -48.03 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.995 -1.066 . . . . 73.0 110.404 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -68.91 -47.27 66.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.059 -1.026 . . . . 61.12 110.704 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 188' ' ' ILE . . . . . 0.562 HG22 ' O ' ' B' ' 184' ' ' ILE . 7.5 tt -70.0 -36.6 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.741 -1.224 . . . . 72.43 110.917 -178.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -65.42 -47.61 75.65 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.945 -1.097 . . . . 65.14 109.144 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 190' ' ' GLN . . . . . 0.717 ' HB3' ' HZ3' ' B' ' 194' ' ' LYS . 35.9 mm-40 -66.58 -46.29 76.46 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.229 -0.92 . . . . 63.24 110.023 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 65.1 mt -54.45 -42.0 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.825 -1.172 . . . . 74.03 109.684 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 192' ' ' ARG . . . . . 0.413 ' CZ ' HG21 ' B' ' 206' ' ' THR . 24.1 mtp180 -59.94 -45.52 92.36 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.236 -0.915 . . . . 72.24 109.922 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -75.44 -32.86 60.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.223 -0.923 . . . . 73.1 110.159 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 194' ' ' LYS . . . . . 0.717 ' HZ3' ' HB3' ' B' ' 190' ' ' GLN . 39.1 mttp -71.84 -24.52 61.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.347 -0.846 . . . . 72.11 110.002 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 11.2 mtt -94.84 -12.14 27.53 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.036 -1.04 . . . . 44.33 109.473 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -102.03 -7.12 22.61 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.328 -0.857 . . . . 71.21 110.522 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 197' ' ' LYS . . . . . 0.457 ' N ' ' CD ' ' B' ' 198' ' ' PRO . 1.3 mmtt -95.77 -49.44 0.25 Allowed Pre-proline 0 N--CA 1.501 2.125 0 O-C-N 120.784 -1.198 . . . . 75.21 110.351 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 198' ' ' PRO . . . . . 0.509 ' CD ' ' O ' ' B' ' 194' ' ' LYS . 89.0 Cg_endo -83.97 -38.53 0.13 Allowed 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.279 1.986 . . . . 75.32 113.672 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 11.2 mt -75.73 -46.42 31.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.836 -1.165 . . . . 72.25 109.648 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 88.15 0.78 82.6 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.663 -1.775 . . . . 64.53 108.663 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 38.4 mt -125.53 125.62 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.583 -0.951 . . . . 44.23 109.296 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 27.3 p -85.78 137.16 32.99 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.836 -1.172 . . . . 54.01 107.836 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 67.7 p -137.98 11.73 2.86 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.109 -0.994 . . . . 74.4 110.125 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.46 128.37 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.304 -0.873 . . . . 72.12 109.407 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -90.85 109.41 20.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.465 -0.772 . . . . 65.41 108.922 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 206' ' ' THR . . . . . 0.413 HG21 ' CZ ' ' B' ' 192' ' ' ARG . 43.9 p -85.35 126.44 33.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.445 -0.784 . . . . 71.33 109.074 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 9.9 p -152.5 159.85 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.13 -0.982 . . . . 63.5 109.675 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -85.28 -38.97 18.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.154 -0.966 . . . . 74.45 109.914 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 209' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' B' ' 211' ' ' GLY . 80.5 mtm180 -55.85 150.69 12.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.021 -1.05 . . . . 74.14 109.512 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? 51.59 -90.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.215 -0.928 . . . . 74.43 108.805 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 211' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' B' ' 209' ' ' ARG . . . -171.79 -108.51 0.21 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.801 -1.719 . . . . 64.45 108.801 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 212' ' ' TYR . . . . . 0.474 ' CE1' HD13 ' B' ' 188' ' ' ILE . 72.0 m-85 -119.17 140.56 49.97 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.578 -0.954 . . . . 74.21 108.759 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -124.36 126.19 45.56 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.58 0.705 . . . . 74.03 110.106 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 214' ' ' PHE . . . . . 0.81 ' CE2' HD13 ' B' ' 155' ' ' LEU . 24.3 t80 -92.11 133.18 36.0 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.854 -0.795 . . . . 74.34 108.854 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 2.6 p -147.1 166.34 27.2 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.987 -1.071 . . . . 64.33 109.706 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -72.44 151.23 91.8 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.222 -0.924 . . . . 70.04 108.654 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.07 160.92 46.57 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.157 1.905 . . . . 65.11 111.718 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.429 ' CB ' ' CD ' ' B' ' 219' ' ' PRO . 22.0 mttm -49.4 -64.13 1.35 Allowed Pre-proline 0 C--N 1.303 -1.445 0 O-C-N 121.276 -0.89 . . . . 73.15 109.335 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 219' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' B' ' 218' ' ' LYS . 37.5 Cg_endo -64.48 -171.9 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.879 1.719 . . . . 71.31 111.421 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 46.23 59.44 3.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.227 -0.921 . . . . 75.45 109.806 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 221' ' ' CYS . . . . . 0.417 ' SG ' ' O ' ' B' ' 218' ' ' LYS . 16.4 p -167.16 150.18 6.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -0.922 . . . . 72.22 109.17 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 47.87 91.29 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.139 -0.975 . . . . 54.53 109.434 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.019 -0.991 . . . . 71.13 109.639 179.928 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptp . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.451 -0.574 . . . . 65.12 109.451 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -141.68 160.18 40.7 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.299 -0.875 . . . . 72.33 109.453 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.4 t -118.34 125.35 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.169 -0.678 . . . . 71.42 109.169 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.405 ' O ' ' O ' ' A' ' 49' ' ' MET . 4.8 tp -99.31 115.1 28.39 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.497 -0.752 . . . . 65.12 109.212 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.0 tp -119.68 110.08 16.4 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.337 -0.986 . . . . 62.43 108.337 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.435 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 16.9 mt -92.73 109.18 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.899 -1.125 . . . . 71.15 109.595 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -152.54 120.09 6.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.166 -0.959 . . . . 75.34 109.673 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -65.16 -38.46 90.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 72.44 109.451 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -67.66 106.16 2.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 63.02 109.567 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 91.0 p -66.64 -26.33 67.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.316 -0.865 . . . . 72.34 109.551 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.64 -53.68 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.158 -0.964 . . . . 74.02 109.691 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.524 HD12 ' N ' ' A' ' 12' ' ' LEU . 7.9 mp -65.18 -36.45 84.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 71.43 109.552 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.92 -27.49 64.49 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.54 -1.824 . . . . 61.32 108.54 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.04 -49.72 61.09 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.441 -1.464 . . . . 71.2 109.441 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -61.59 -44.86 96.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -1.138 . . . . 71.32 109.55 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.5 mm -63.64 -39.08 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.743 -1.223 . . . . 63.23 108.281 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -64.42 -52.12 59.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.499 -0.75 . . . . 51.11 109.975 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -77.72 -2.77 37.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 73.34 109.566 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.42 -49.94 3.99 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 108.989 -1.644 . . . . 62.15 108.989 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pp -75.7 -28.96 58.83 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.433 -1.039 . . . . 73.51 109.234 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -51.65 -34.32 37.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.202 -0.936 . . . . 74.25 108.815 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.0 t -54.76 -47.38 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.523 -0.917 . . . . 70.04 108.523 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -54.35 -54.81 35.44 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.23 -1.026 . . . . 73.23 108.23 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 130.74 40.42 0.24 Allowed Glycine 0 N--CA 1.499 2.847 0 N-CA-C 110.636 -0.986 . . . . 75.54 110.636 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -118.91 159.67 23.37 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.19 -1.183 . . . . 73.43 108.694 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 11.7 mmt -97.65 138.35 35.18 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.211 -1.033 . . . . 43.24 108.211 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.95 160.12 40.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 62.11 109.784 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -142.03 151.55 42.53 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.781 -0.822 . . . . 74.42 108.781 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 t -106.03 134.7 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.706 -0.85 . . . . 72.15 108.706 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.3 p -129.7 163.46 26.09 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.517 -0.739 . . . . 71.42 109.356 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.435 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 2.8 pt-20 -92.22 -97.46 0.13 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.317 -0.865 . . . . 72.33 109.69 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.3 p -78.26 166.38 22.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 74.24 110.071 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.4 mt -55.02 -38.06 67.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.601 -0.687 . . . . 71.53 110.028 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -53.47 -43.22 67.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.168 -0.957 . . . . 74.23 110.061 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -63.92 -37.7 88.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.026 -1.046 . . . . 54.03 109.595 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.24 -45.72 11.09 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.914 -1.274 . . . . 61.41 109.914 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -61.82 -36.88 82.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -1.137 . . . . 74.34 109.88 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.443 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 64.6 t80 -80.07 -26.21 39.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.901 . . . . 75.33 110.249 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.8 tp -86.63 -32.57 20.51 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.031 -1.043 . . . . 74.33 110.223 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.485 ' SD ' ' OH ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -83.16 -34.12 26.07 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.088 -1.008 . . . . 70.32 110.79 -178.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 35.2 p-10 -57.7 -30.43 65.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.035 -1.041 . . . . 71.22 110.529 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.53 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 7.9 pt -85.03 -38.22 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.864 -1.148 . . . . 74.14 110.485 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.436 ' O ' ' O ' ' A' ' 40' ' ' MET . 97.8 mtt180 -101.52 162.58 12.79 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.105 -0.997 . . . . 72.24 110.046 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -92.39 144.51 25.3 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.336 -0.853 . . . . 75.42 108.992 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.558 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 3.5 p90 -142.13 179.94 6.61 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.151 -0.968 . . . . 74.23 109.732 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -143.16 -32.39 0.47 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.321 -0.862 . . . . 72.04 109.767 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.476 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.2 OUTLIER -108.24 113.31 26.32 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.345 -0.847 . . . . 72.13 109.086 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.476 ' N ' HD13 ' A' ' 47' ' ' LEU . 65.0 t -101.27 99.54 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.797 -0.816 . . . . 72.34 108.797 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.405 ' O ' ' O ' ' A' ' 4' ' ' LEU . 26.5 ttt -114.55 132.24 56.39 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.561 0.696 . . . . 74.11 109.567 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.466 HG21 ' HB2' ' A' ' 55' ' ' ALA . 0.8 OUTLIER -142.12 136.05 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.382 -0.824 . . . . 61.12 109.69 -179.046 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.8 t -102.06 1.25 36.2 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.478 -0.764 . . . . 73.11 109.772 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -76.07 145.99 39.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.103 -0.998 . . . . 52.55 109.713 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.409 ' C ' ' H ' ' A' ' 55' ' ' ALA . 29.2 mmtp -78.01 -46.46 20.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.25 -0.906 . . . . 44.22 110.204 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -59.98 -4.63 0.79 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.154 -0.966 . . . . 70.44 109.908 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.466 ' HB2' HG21 ' A' ' 50' ' ' VAL . . . -62.92 -23.01 67.17 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.226 -0.921 . . . . 64.14 110.139 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 55' ' ' ALA . 14.5 mt -39.98 -54.56 2.19 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.603 -0.686 . . . . 44.14 110.71 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.6 p -68.39 -31.83 71.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.734 -1.229 . . . . 55.23 109.254 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.458 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 66.5 t80 -65.74 -46.99 76.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.395 -0.816 . . . . 74.44 110.242 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.8 m -63.06 -35.09 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.706 -1.246 . . . . 74.03 109.467 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 60.8 m -57.09 -51.33 69.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.18 -0.95 . . . . 64.3 109.419 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.402 ' HG2' ' H ' ' A' ' 61' ' ' ARG . 11.7 ptm180 -67.64 -34.48 77.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.125 -0.984 . . . . 64.44 110.019 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.458 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 4.8 mm -63.32 -28.46 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.839 -1.163 . . . . 63.21 109.455 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.477 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 30.8 mmtt -75.4 -57.86 3.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.074 -1.017 . . . . 74.42 109.784 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -62.37 -33.24 74.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.897 -1.127 . . . . 70.32 109.73 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 8.3 mtpm? -85.42 -18.66 32.99 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.18 -0.95 . . . . 75.22 109.844 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.523 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 98.7 m-70 -157.61 65.97 0.48 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.027 -1.046 . . . . 74.13 109.606 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.6 m -66.12 -24.12 66.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.286 -0.884 . . . . 73.24 110.023 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.429 ' HG ' ' HZ1' ' A' ' 145' ' ' LYS . 86.8 p -68.11 -21.47 64.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.154 -0.966 . . . . 61.01 110.427 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.432 HD13 ' CE2' ' A' ' 45' ' ' TYR . 58.3 mt -88.43 153.37 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.102 -0.998 . . . . 71.33 109.635 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 71' ' ' VAL . 63.9 t -91.11 158.96 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.135 -0.978 . . . . 72.13 110.189 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.484 ' N ' HG12 ' A' ' 70' ' ' VAL . 24.8 t -132.44 125.31 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.397 -0.814 . . . . 54.21 109.759 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.492 HD23 ' C ' ' A' ' 72' ' ' LEU . 4.5 tt -118.34 101.91 8.55 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.491 -0.756 . . . . 50.24 109.125 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.0 t -91.61 137.21 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.189 -0.944 . . . . 74.41 109.707 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.8 156.55 19.51 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.492 -0.929 . . . . 72.31 108.492 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 97' ' ' LYS . 27.9 t -153.66 132.25 12.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.04 -1.037 . . . . 64.54 109.786 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -89.44 3.26 52.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.386 -0.821 . . . . 74.13 108.904 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 79' ' ' THR . 2.5 p-10 -138.52 56.48 10.05 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.528 -0.733 . . . . 73.34 109.048 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -49.92 87.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.322 2.015 . . . . 63.22 111.339 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 77' ' ' ASN . 21.2 m -110.22 152.59 25.91 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.091 -0.707 . . . . 62.53 109.091 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.39 -34.24 64.19 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.43 -0.794 . . . . 73.44 109.755 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -65.15 -52.5 54.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 71.42 110.103 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -60.71 -33.34 72.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 73.43 109.824 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -64.04 -46.0 86.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 74.22 109.721 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.8 t -57.22 -46.73 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 73.2 109.758 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -68.12 -29.37 68.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 53.33 109.65 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.42 -43.43 96.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.149 -0.969 . . . . 64.11 109.993 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -83.86 -34.52 24.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.127 -0.983 . . . . 74.34 109.579 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -65.79 -46.07 80.06 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.309 -0.869 . . . . 74.42 108.772 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -63.43 -53.11 57.4 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.678 -0.639 . . . . 74.24 109.522 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 141.07 61.33 0.03 OUTLIER Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.247 -1.141 . . . . 61.51 110.247 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -110.84 132.32 54.3 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.377 -1.073 . . . . 55.33 109.026 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.477 ' OD1' ' NZ ' ' A' ' 63' ' ' LYS . 35.9 m-20 -85.31 -19.32 31.69 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.047 -1.033 . . . . 73.42 109.01 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.448 ' OD2' ' CZ ' ' A' ' 112' ' ' ARG . 60.0 m-20 -152.14 162.66 40.78 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.82 -0.808 . . . . 75.04 108.82 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.433 ' OH ' ' CB ' ' A' ' 75' ' ' SER . 87.4 t80 -150.56 95.57 2.26 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.609 -0.886 . . . . 71.33 108.609 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 96' ' ' ALA . 8.3 mm -105.31 155.3 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.619 0 O-C-N 121.023 -1.048 . . . . 71.13 109.835 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.478 ' N ' HG22 ' A' ' 95' ' ' ILE . . . -60.33 144.57 50.31 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 106.953 -1.499 . . . . 64.32 106.953 177.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.662 ' C ' ' H ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -67.58 -57.48 10.1 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 120.645 -1.284 . . . . 62.2 112.171 -178.097 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 99' ' ' TYR . 27.7 Cg_endo -53.92 9.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.3 -1.993 0 CA-C-N 119.927 1.01 . . . . 73.11 113.477 -173.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.662 ' H ' ' C ' ' A' ' 97' ' ' LYS . 14.5 m-85 57.01 124.86 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.19 -0.459 . . . . 65.22 110.688 177.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.6 mtt85 -66.93 -35.32 79.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.696 -1.253 . . . . 72.35 108.777 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.741 ' O ' ' N ' ' A' ' 103' ' ' LYS . 29.3 t -164.92 33.18 0.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 71.32 110.404 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.4 mt 51.77 -69.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.714 -0.616 . . . . 75.43 110.296 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.741 ' N ' ' O ' ' A' ' 101' ' ' SER . 13.0 mptt -56.37 -28.81 60.29 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.633 -1.247 . . . . 71.41 107.633 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.18 87.71 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.715 -0.794 . . . . 63.24 108.881 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -61.51 -55.95 25.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.354 -0.841 . . . . 73.22 108.75 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.7 t -56.34 -41.76 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.96 -1.087 . . . . 60.11 109.278 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.02 -42.54 49.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.933 . . . . 70.42 109.309 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.515 ' O ' ' NH1' ' A' ' 112' ' ' ARG . 15.5 mmp_? -69.61 -30.08 67.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 74.41 109.521 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 93.3 mt -77.92 -29.67 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.021 -1.049 . . . . 62.54 109.117 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -73.4 -58.77 3.07 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.272 -0.893 . . . . 74.34 109.911 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.81 -46.99 87.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.123 -0.985 . . . . 73.32 109.826 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.515 ' NH1' ' O ' ' A' ' 108' ' ' ARG . 22.2 ttp-105 -59.47 -31.53 69.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.181 -0.949 . . . . 52.41 109.44 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 12.4 tp -157.63 93.06 1.25 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 65.24 109.496 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 32.5 mtm-85 -78.39 -72.73 0.36 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.227 -0.92 . . . . 64.45 108.89 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' A' ' 117' ' ' GLY . 41.4 t80 -140.11 3.18 1.97 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.31 -0.869 . . . . 74.43 109.668 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.528 ' CG ' ' O ' ' A' ' 115' ' ' PHE . 48.9 p-90 40.96 21.27 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.569 -0.707 . . . . 74.42 110.362 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 115' ' ' PHE . . . -57.12 89.77 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.615 -1.394 . . . . 75.04 109.615 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 116' ' ' TRP . 85.8 p -156.16 163.65 39.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -1.152 . . . . 61.14 109.901 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.07 125.57 3.09 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.665 -0.865 . . . . 65.24 108.665 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.2 t -83.79 -50.25 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.165 -0.96 . . . . 73.11 109.868 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 17.6 mm -100.83 126.35 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.246 -0.909 . . . . 72.24 109.351 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -129.87 124.73 33.92 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.544 -0.722 . . . . 72.34 109.143 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 123' ' ' ILE . 13.2 tt -146.71 130.21 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.284 -0.885 . . . . 71.44 109.424 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 45.94 -143.68 3.99 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.745 -1.342 . . . . 73.4 109.745 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -84.64 -3.93 58.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -1.138 . . . . 74.45 109.371 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.66 130.79 41.01 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.529 -0.915 . . . . 54.21 108.529 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.9 m -129.43 123.92 32.83 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.355 -0.84 . . . . 54.5 109.507 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 23.3 mm -110.26 140.69 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.55 -0.719 . . . . 45.15 109.103 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.9 m -128.08 78.99 74.59 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.49 -0.756 . . . . 71.11 109.33 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.85 -53.02 7.74 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.853 2.369 . . . . 65.41 112.573 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -54.08 -42.71 69.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.953 . . . . 63.32 109.451 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.492 ' OE1' ' N ' ' A' ' 132' ' ' GLU . 37.8 mp0 -88.72 -0.54 57.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.25 -0.906 . . . . 72.52 109.56 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 47.86 39.12 10.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 75.33 109.447 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -125.65 143.09 51.18 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.638 -0.663 . . . . 71.23 109.238 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.8 tt -125.17 138.87 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.537 -0.727 . . . . 74.02 109.414 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 52.4 mt -119.14 125.94 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.605 -0.684 . . . . 60.23 109.178 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.504 ' CE2' ' CD ' ' A' ' 138' ' ' LYS . 46.1 t80 -137.43 132.51 33.51 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.56 -0.713 . . . . 62.32 109.127 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.524 ' O ' ' NH1' ' A' ' 140' ' ' ARG . 15.8 mtpp 55.64 25.21 7.84 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.504 -0.748 . . . . 75.4 109.956 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.26 -0.82 89.51 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.237 -1.145 . . . . 72.24 110.237 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.524 ' NH1' ' O ' ' A' ' 138' ' ' LYS . 9.6 mpt_? -88.9 125.79 35.1 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.017 -1.284 . . . . 71.22 109.088 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -97.8 116.9 30.94 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.274 -0.891 . . . . 71.42 109.471 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 13.8 p -139.02 141.75 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.341 -0.85 . . . . 53.02 109.265 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -88.57 147.67 24.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.196 -0.94 . . . . 60.45 109.381 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.3 m -137.17 140.61 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.419 -0.801 . . . . 74.44 109.577 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.429 ' HZ1' ' HG ' ' A' ' 68' ' ' SER . 13.0 ptpt -165.83 121.99 1.34 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.883 . . . . 65.15 109.332 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 172.97 -164.45 36.48 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.579 -1.408 . . . . 73.34 109.579 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.692 ' NZ ' ' HE1' ' A' ' 173' ' ' TRP . 1.6 mtpm? -76.87 -34.76 1.31 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.235 -1.156 . . . . 72.22 111.071 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 97.0 Cg_endo -89.45 -5.4 5.51 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.166 1.91 . . . . 65.23 112.639 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -96.93 -32.71 11.9 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.214 -0.929 . . . . 60.11 109.725 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.524 ' O ' ' ND1' ' A' ' 154' ' ' HIS . 71.3 mm-40 -60.15 -40.45 89.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.113 -0.992 . . . . 64.21 109.181 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.411 HG11 ' CD1' ' A' ' 191' ' ' ILE . 7.8 p -61.03 -31.75 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.279 -0.888 . . . . 72.02 109.05 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.49 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.2 OUTLIER -65.14 -46.91 78.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.39 -0.819 . . . . 73.31 109.267 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.5 p -72.43 -30.52 64.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.091 -1.006 . . . . 74.31 109.9 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 150' ' ' GLU . 1.5 m80 -59.04 -53.38 59.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 74.31 109.728 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.68 -25.19 62.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.109 -0.995 . . . . 75.34 109.49 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.01 -54.82 40.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.204 -0.935 . . . . 62.14 109.093 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -70.45 -50.22 40.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.247 -0.908 . . . . 61.03 108.991 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.541 ' C ' ' NE2' ' A' ' 161' ' ' GLN . 40.0 m-70 -76.04 62.37 1.65 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.535 -0.728 . . . . 74.12 109.267 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.837 ' C ' HE22 ' A' ' 161' ' ' GLN . 48.0 ttp180 -98.79 139.67 34.13 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.303 -0.873 . . . . 71.13 109.33 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 214' ' ' PHE . 10.4 t0 80.02 60.92 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.662 -0.649 . . . . 75.45 110.77 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.837 HE22 ' C ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -167.27 170.61 11.47 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.933 -1.104 . . . . 73.41 109.782 178.702 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 13.6 mm -92.27 136.36 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.379 -0.826 . . . . 74.41 109.123 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.453 HG13 ' OE1' ' A' ' 167' ' ' GLN . 82.7 t -140.76 138.32 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.246 -0.909 . . . . 72.31 109.802 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 52.4 p -89.71 154.28 20.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.361 -0.837 . . . . 74.12 109.307 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.578 ' H ' ' CD ' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -60.83 -41.3 95.5 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.21 -0.931 . . . . 70.43 109.2 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.7 -35.83 66.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.237 -0.914 . . . . 73.52 109.736 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.453 ' OE1' HG13 ' A' ' 163' ' ' VAL . 34.7 tt0 -56.23 -45.72 79.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.077 -1.014 . . . . 74.52 109.26 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 21.9 mt -59.79 -37.44 79.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.08 -1.012 . . . . 72.31 108.985 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.559 ' C ' HD23 ' A' ' 169' ' ' LEU . 4.9 tt -59.53 -69.41 0.21 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.416 -0.803 . . . . 53.33 110.241 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.417 ' O ' ' OE1' ' A' ' 174' ' ' GLU . 3.9 p30 -65.0 -33.5 76.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.157 -0.964 . . . . 62.44 111.005 -178.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -52.65 -48.6 66.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.976 -1.077 . . . . 60.21 110.219 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.663 HD12 ' N ' ' A' ' 172' ' ' ILE . 1.8 mp -94.09 -64.28 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.971 -1.081 . . . . 75.32 108.905 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.692 ' HE1' ' NZ ' ' A' ' 147' ' ' LYS . 25.8 m-90 -81.32 80.15 7.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.34 -0.85 . . . . 73.14 109.534 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.417 ' OE1' ' O ' ' A' ' 170' ' ' ASP . 42.5 tp10 -89.3 -58.25 2.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.239 -0.913 . . . . 73.24 109.875 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.622 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 7.3 tt0 -79.34 -37.03 1.16 Allowed Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.144 -0.973 . . . . 44.43 110.775 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 31.5 Cg_exo -58.81 62.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.402 2.068 . . . . 72.51 112.511 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 175' ' ' GLU . 97.9 mt-10 -65.57 -24.45 67.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.003 -1.061 . . . . 63.24 109.748 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 79.4 mtp -50.47 -27.19 6.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.943 . . . . 73.5 109.771 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 176' ' ' PRO . 28.1 m -52.26 149.51 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.168 -0.957 . . . . 65.22 109.531 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.4 p -49.45 152.83 2.09 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 71.42 109.046 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.14 -8.33 20.87 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.387 2.058 . . . . 41.22 112.896 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -161.18 99.08 1.18 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.872 -1.142 . . . . 64.54 110.311 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.2 m -153.16 16.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.292 -0.88 . . . . 74.02 109.232 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 61.8 mt -58.64 -38.95 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.183 -0.948 . . . . 72.33 109.475 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -50.45 -38.77 45.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 74.4 109.324 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 49.6 t -74.67 -36.38 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.227 -0.921 . . . . 70.42 109.47 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.413 ' O ' ' CG1' ' A' ' 191' ' ' ILE . . . -64.7 -52.81 55.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 52.11 109.601 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.571 ' O ' HD13 ' A' ' 188' ' ' ILE . 0.2 OUTLIER -60.9 -34.01 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.037 -1.039 . . . . 71.4 109.191 -179.691 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -68.27 -57.68 5.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.055 -1.028 . . . . 73.44 110.394 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -64.15 -38.24 90.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.868 -1.145 . . . . 71.42 109.259 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.413 ' CG1' ' O ' ' A' ' 187' ' ' ALA . 3.4 mm -56.9 -34.19 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 61.55 108.745 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.642 ' HE ' ' CG2' ' A' ' 204' ' ' VAL . 3.2 tpt180 -70.17 -43.13 71.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.505 -0.747 . . . . 63.34 109.784 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -77.51 -27.87 51.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.085 -1.009 . . . . 61.24 110.187 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -84.88 -21.84 29.59 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.157 -0.965 . . . . 75.13 110.593 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' MET . . . . . 0.567 ' SD ' ' N ' ' A' ' 196' ' ' ASP . 0.0 OUTLIER -93.77 -41.04 9.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.98 -1.075 . . . . 74.02 109.718 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ASP . . . . . 0.567 ' N ' ' SD ' ' A' ' 195' ' ' MET . 31.5 p-10 -64.6 -34.41 78.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 74.02 109.696 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.498 ' N ' ' OD1' ' A' ' 196' ' ' ASP . 0.2 OUTLIER -57.2 -63.95 3.12 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.898 . . . . 75.43 109.678 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.427 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 37.2 Cg_endo -63.71 -57.26 0.38 Allowed 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.196 1.931 . . . . 72.32 112.064 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 49.0 mt -61.17 -33.09 72.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 74.54 109.556 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 73.55 -49.02 1.6 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.492 -1.443 . . . . 61.51 109.492 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 83.7 mt -92.17 138.24 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.211 -1.17 . . . . 61.22 109.278 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 34.7 m -77.83 147.43 35.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.283 -0.885 . . . . 72.0 109.52 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 8.2 p -142.54 21.13 2.03 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.325 -0.86 . . . . 74.44 109.223 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.642 ' CG2' ' HE ' ' A' ' 192' ' ' ARG . 20.3 m -135.22 147.96 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.461 -0.774 . . . . 64.35 109.25 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -123.48 133.34 54.05 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.497 -0.752 . . . . 71.41 109.392 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 29.0 p -99.24 138.08 36.84 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.381 -0.825 . . . . 73.52 109.394 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 38.6 t -144.6 136.85 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.202 -0.936 . . . . 71.02 109.391 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 70.2 ttp85 -80.82 88.26 5.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 72.12 109.393 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 47.3 ttt85 -171.0 -126.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 64.41 109.29 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -57.37 -39.72 76.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.109 -0.994 . . . . 71.54 109.418 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 167.59 -149.51 14.78 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.693 -1.363 . . . . 72.03 109.693 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -104.93 151.52 23.78 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.481 -1.011 . . . . 75.54 109.351 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -119.71 137.35 53.98 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.083 -0.71 . . . . 75.31 109.083 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.509 ' O ' ' N ' ' A' ' 160' ' ' ASP . 15.5 m-85 -106.07 126.94 52.8 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.431 -0.793 . . . . 75.41 109.377 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 52.9 t -153.11 160.27 42.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.432 -0.793 . . . . 74.14 109.06 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -63.45 151.69 87.13 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.071 -1.018 . . . . 75.32 109.072 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.481 ' O ' ' O ' ' A' ' 218' ' ' LYS . 84.1 Cg_endo -75.72 122.62 6.97 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.381 2.054 . . . . 73.11 112.042 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 217' ' ' PRO . 32.7 mttp 56.64 155.31 0.07 OUTLIER Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.662 -0.649 . . . . 75.25 109.445 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.72 -15.59 26.85 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.259 1.973 . . . . 75.1 111.681 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . 46.94 -170.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 71.14 109.801 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 28.3 p -81.45 145.82 30.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 71.13 109.657 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.43 -31.76 72.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.306 -0.871 . . . . 75.35 109.493 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.033 -0.984 . . . . 73.41 109.455 -179.985 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 52.0 ttm . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.477 -0.564 . . . . 71.14 109.477 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 68.0 mtt85 -138.72 144.36 39.48 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.305 -0.872 . . . . 73.23 109.431 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 86.8 t -111.97 138.86 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 121.466 0.651 . . . . 72.24 109.756 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.476 HD11 ' CG1' ' B' ' 6' ' ' ILE . 2.7 tp -108.99 120.55 42.89 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.728 -0.607 . . . . 54.33 109.399 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.44 ' N ' HD12 ' B' ' 4' ' ' LEU . 20.2 mt -118.17 110.44 17.58 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.533 -0.729 . . . . 74.35 109.039 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.476 ' CG1' HD11 ' B' ' 4' ' ' LEU . 26.7 mt -100.78 114.08 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.681 -0.859 . . . . 42.55 108.681 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.486 ' OE1' ' N ' ' B' ' 9' ' ' ASN . 1.8 pp20? -151.04 164.93 35.3 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.285 -0.885 . . . . 74.52 109.58 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -95.86 -24.39 16.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.252 -0.905 . . . . 62.55 109.542 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' ASN . . . . . 0.486 ' N ' ' OE1' ' B' ' 7' ' ' GLU . 28.7 m120 -91.15 109.79 21.06 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.211 -0.931 . . . . 73.11 109.697 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 32.3 t -62.44 -40.78 97.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.206 -0.934 . . . . 65.54 109.633 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 86.4 t -57.72 -44.32 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 75.55 109.214 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.508 HD11 ' HZ2' ' B' ' 97' ' ' LYS . 7.6 tp -58.74 -35.47 72.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 70.14 108.841 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.04 -27.26 70.68 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 108.253 -1.939 . . . . 75.4 108.253 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.97 -52.28 49.16 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 109.536 -1.425 . . . . 65.44 109.536 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.424 ' H ' ' HG2' ' B' ' 15' ' ' GLU . 6.9 pt-20 -59.75 -47.23 86.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.372 -1.075 . . . . 60.21 109.796 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 35.5 mm -64.03 -41.48 92.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.66 -1.275 . . . . 75.15 108.951 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.474 ' CD ' ' HB3' ' B' ' 27' ' ' ALA . 39.7 tp10 -59.43 -45.22 92.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.224 -0.922 . . . . 73.01 109.156 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -84.07 0.14 49.52 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.223 -0.923 . . . . 74.3 109.557 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.5 -58.48 1.94 Allowed Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.544 -1.423 . . . . 70.54 109.544 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' B' ' 27' ' ' ALA . 1.5 pt? -71.34 -23.61 61.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.307 -1.114 . . . . 71.34 109.74 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' ASN . . . . . 0.411 ' H ' HD23 ' B' ' 20' ' ' LEU . 32.0 m-20 -51.24 -36.17 40.56 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.143 -0.973 . . . . 64.41 109.495 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 46.5 t -53.86 -32.35 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.15 -0.969 . . . . 74.23 108.442 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm -81.64 -3.88 54.65 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.746 0.784 . . . . 63.42 108.891 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.13 24.45 63.84 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.942 -1.263 . . . . 53.43 109.942 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -95.14 159.73 14.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.179 -1.189 . . . . 71.12 109.076 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 14.8 mmt -104.93 140.41 38.2 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.714 -0.847 . . . . 75.24 108.714 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.474 ' HB3' ' CD ' ' B' ' 17' ' ' GLU . . . -135.9 158.13 45.14 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.398 -0.814 . . . . 72.12 109.651 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -132.8 145.69 51.19 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.594 -0.891 . . . . 72.31 108.594 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 4.3 m -110.47 139.33 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.369 -0.832 . . . . 64.43 109.129 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.1 p -138.13 169.29 18.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.384 -0.822 . . . . 65.41 109.425 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.414 ' OE2' ' OD1' ' B' ' 35' ' ' ASP . 5.4 pt-20 -93.09 -106.99 0.12 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.342 -0.849 . . . . 71.02 109.431 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 77.3 p -79.47 168.17 19.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 51.11 109.776 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 22.7 mt -51.91 -29.81 21.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.537 -0.727 . . . . 71.24 109.856 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -52.29 -51.2 59.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.095 -1.003 . . . . 74.32 109.729 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.414 ' OD1' ' OE2' ' B' ' 31' ' ' GLU . 1.4 m-20 -63.1 -38.9 93.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -0.975 . . . . 73.03 109.261 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.97 -38.97 93.16 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.409 -1.476 . . . . 30.21 109.409 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -67.92 -42.85 80.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -1.114 . . . . 74.42 109.605 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -74.41 -34.15 63.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 74.42 109.641 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 21.0 tp -74.86 -50.0 18.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 75.41 110.078 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' MET . . . . . 0.439 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.7 ppp? -61.9 -27.69 68.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 60.41 109.907 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.81 -39.79 86.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 53.23 110.137 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 17.6 pt -87.06 -24.9 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.09 -1.006 . . . . 71.23 110.407 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.424 ' O ' ' O ' ' B' ' 40' ' ' MET . 91.3 mtt-85 -129.65 140.36 51.17 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.235 -0.916 . . . . 72.22 109.73 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -99.32 126.89 45.26 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.286 -0.884 . . . . 63.54 109.293 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -101.61 141.89 33.79 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.324 -0.86 . . . . 64.35 109.505 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -81.11 -31.71 34.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 62.22 109.021 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.522 HD13 ' C ' ' B' ' 47' ' ' LEU . 1.0 OUTLIER -114.9 110.6 19.9 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.691 -0.855 . . . . 73.12 108.691 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.462 ' N ' HD13 ' B' ' 47' ' ' LEU . 62.3 t -95.52 101.13 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.28 -0.887 . . . . 65.11 109.074 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 14.4 ttt -116.43 132.7 56.6 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.592 0.71 . . . . 73.44 109.45 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.532 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.4 OUTLIER -144.49 139.49 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.465 -0.772 . . . . 34.5 109.364 -179.49 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 31.9 p -105.58 14.71 28.1 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.668 -0.645 . . . . 73.21 109.72 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.532 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 61.9 m-20 -82.7 144.96 29.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.214 -0.929 . . . . 70.41 109.266 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' B' ' 55' ' ' ALA . 15.4 pttm -77.68 -39.41 44.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.179 -0.951 . . . . 65.0 110.118 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -73.81 10.49 1.12 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.098 -1.001 . . . . 75.21 109.559 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.415 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -65.79 -21.21 66.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.351 -0.843 . . . . 55.33 110.036 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' B' ' 55' ' ' ALA . 47.7 mt -41.94 -43.68 3.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.433 -0.792 . . . . 63.14 110.517 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.3 p -75.96 -35.79 59.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.909 -1.12 . . . . 63.5 109.451 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -66.63 -40.78 88.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.411 -0.806 . . . . 72.33 110.353 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.06 -35.49 59.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 120.757 -1.214 . . . . 74.54 109.544 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 78.8 p -57.69 -46.86 83.74 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.12 -0.988 . . . . 71.24 109.314 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -69.69 -34.41 73.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.142 -0.974 . . . . 74.31 110.018 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 4.9 mm -62.2 -34.31 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.862 -1.149 . . . . 72.14 109.779 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.421 ' O ' ' OG ' ' B' ' 67' ' ' SER . 12.0 mmtm -73.79 -52.88 11.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.099 -1.0 . . . . 73.32 110.178 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -66.24 -36.82 84.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.902 -1.123 . . . . 73.12 110.304 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.466 ' C ' ' CG ' ' B' ' 66' ' ' HIS . 29.3 mtmt -83.21 -23.56 32.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.133 -0.98 . . . . 72.44 110.258 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.466 ' CG ' ' C ' ' B' ' 65' ' ' LYS . 37.0 m-70 -153.2 67.37 0.79 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.02 -1.05 . . . . 63.31 109.837 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' B' ' 63' ' ' LYS . 10.5 m -61.9 -30.86 71.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.935 . . . . 73.1 109.724 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 90.5 p -63.24 -24.58 67.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.251 -0.905 . . . . 71.53 110.356 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.444 HD12 ' CB ' ' B' ' 66' ' ' HIS . 81.1 mt -81.5 156.36 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.988 -1.07 . . . . 74.4 109.767 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.497 HG12 ' N ' ' B' ' 71' ' ' VAL . 95.9 t -93.97 160.14 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.296 -0.877 . . . . 75.12 109.854 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.497 ' N ' HG12 ' B' ' 70' ' ' VAL . 21.7 t -136.04 127.49 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.411 -0.806 . . . . 73.2 109.366 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.417 HD21 HD11 ' B' ' 105' ' ' LEU . 0.7 OUTLIER -121.61 101.71 7.77 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.729 -0.841 . . . . 73.34 108.729 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 90.7 t -93.53 128.18 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.249 -0.907 . . . . 73.5 109.264 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 14.6 p -93.51 172.24 8.4 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.198 -0.939 . . . . 64.34 109.346 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.438 ' CB ' ' HH ' ' B' ' 94' ' ' TYR . 30.1 t -159.65 117.08 2.65 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.978 -1.077 . . . . 74.53 110.339 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -61.88 -36.34 80.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.384 -0.822 . . . . 64.5 109.84 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 77' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' B' ' 79' ' ' THR . 10.1 p-10 -118.52 82.73 19.94 Favored Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.572 -0.705 . . . . 74.25 109.227 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -47.71 84.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.235 1.957 . . . . 74.43 111.5 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.516 ' N ' ' O ' ' B' ' 77' ' ' ASN . 19.4 m -102.91 150.91 23.05 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.596 -0.69 . . . . 73.12 109.377 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.2 t -65.32 -35.41 80.9 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.344 -0.847 . . . . 71.01 109.704 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 81' ' ' GLU . . . . . 0.488 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 80.1 mm-40 -60.42 -44.75 95.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.134 -0.979 . . . . 63.2 109.565 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -75.79 -31.11 59.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 73.22 109.468 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -64.73 -54.05 37.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 74.3 109.834 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.546 HG23 ' N ' ' B' ' 85' ' ' HIS . 21.6 m -64.26 -43.37 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.098 -1.001 . . . . 73.31 109.396 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 85' ' ' HIS . . . . . 0.546 ' N ' HG23 ' B' ' 84' ' ' VAL . 23.2 m170 -63.18 -26.17 68.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.161 -0.962 . . . . 73.24 109.271 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.49 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -70.64 -46.86 62.5 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -0.878 . . . . 55.33 109.958 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -77.0 -32.09 56.96 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.01 -1.056 . . . . 74.14 109.384 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -72.67 -44.3 62.0 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.248 -0.907 . . . . 64.04 109.693 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -62.69 -52.13 64.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.191 -0.943 . . . . 72.35 109.905 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 156.45 44.74 0.02 OUTLIER Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.673 -1.251 . . . . 65.2 110.265 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 91' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -110.28 135.7 50.61 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.396 -1.061 . . . . 52.23 109.255 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -85.37 -18.43 33.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.094 -1.004 . . . . 73.32 109.201 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -152.51 162.01 41.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.298 -0.876 . . . . 72.22 109.697 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.438 ' HH ' ' CB ' ' B' ' 75' ' ' SER . 79.4 t80 -143.65 97.0 2.99 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.554 -0.906 . . . . 64.42 108.554 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 23.2 mm -108.1 156.29 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 121.255 -0.903 . . . . 72.23 110.431 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.6 152.12 45.94 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.262 -1.014 . . . . 25.24 108.262 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.694 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -74.87 -55.98 2.26 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 120.787 -1.195 . . . . 64.32 111.416 -179.562 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 98' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 2.6 Cg_endo -40.29 -10.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.034 1.156 . . . . 63.33 112.914 -175.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 99' ' ' TYR . . . . . 0.694 ' N ' ' O ' ' B' ' 97' ' ' LYS . 54.2 m-85 59.42 118.18 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.755 -0.59 . . . . 75.13 109.868 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -65.65 -33.31 75.6 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.208 -0.932 . . . . 74.23 109.452 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 101' ' ' SER . . . . . 0.766 ' O ' ' N ' ' B' ' 103' ' ' LYS . 34.2 t -171.32 27.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.961 -1.087 . . . . 63.34 110.888 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 16.2 mt 49.14 -67.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 CA-C-N 118.498 0.59 . . . . 74.44 110.336 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.766 ' N ' ' O ' ' B' ' 101' ' ' SER . 43.4 mtpt -55.4 -32.77 62.93 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.903 -1.147 . . . . 71.11 107.903 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.11 -45.87 86.72 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.666 -0.864 . . . . 71.45 108.666 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.417 HD11 HD21 ' B' ' 72' ' ' LEU . 22.5 tp -68.31 -42.43 79.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.302 -0.874 . . . . 51.31 109.123 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 78.8 t -58.92 -45.72 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.174 -0.954 . . . . 65.23 108.893 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.17 -44.02 67.55 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.422 -0.955 . . . . 24.32 108.422 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -62.41 -39.04 91.98 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.819 -0.808 . . . . 75.31 108.819 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 91.1 mt -68.95 -28.96 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 108.043 -1.095 . . . . 54.24 108.043 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -68.56 -53.76 20.89 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.651 -0.87 . . . . 65.31 108.651 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -47.36 -40.32 17.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.448 -0.783 . . . . 72.24 109.081 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -62.85 -40.33 97.13 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.299 -0.876 . . . . 72.04 109.111 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 84.6 mt -137.97 77.44 1.63 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.318 -0.864 . . . . 75.35 109.505 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -74.54 -76.02 0.15 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.218 -0.926 . . . . 75.5 108.959 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 115' ' ' PHE . . . . . 0.525 ' O ' ' CG ' ' B' ' 116' ' ' TRP . 94.1 m-85 -82.84 -65.87 0.96 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 65.33 109.563 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 116' ' ' TRP . . . . . 0.525 ' CG ' ' O ' ' B' ' 115' ' ' PHE . 7.7 m-90 -158.13 -154.39 0.44 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.36 -0.838 . . . . 74.45 109.347 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -85.65 -138.09 4.54 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.696 -1.362 . . . . 44.21 109.696 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 10.9 t -151.95 176.85 11.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.305 -1.114 . . . . 71.4 109.911 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.9 163.81 37.8 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.787 -0.819 . . . . 72.32 108.787 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 10.1 t -136.5 -38.52 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.506 -0.746 . . . . 75.02 109.726 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 27.1 mm -97.77 137.67 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.239 -0.913 . . . . 51.41 109.499 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 122' ' ' GLU . . . . . 0.95 ' OE1' ' O ' ' B' ' 122' ' ' GLU . 0.0 OUTLIER -137.74 132.61 33.04 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.476 -0.765 . . . . 71.53 109.374 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.704 ' O ' HG23 ' B' ' 123' ' ' ILE . 4.9 tt -142.76 113.08 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.285 -0.884 . . . . 72.43 109.174 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.98 -116.95 5.49 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.262 -1.535 . . . . 51.23 109.262 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -106.33 3.38 27.49 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.481 -1.011 . . . . 74.2 108.987 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.511 ' HB2' ' CG2' ' B' ' 123' ' ' ILE . 0.3 OUTLIER -97.49 139.43 33.42 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.283 -1.006 . . . . 75.42 108.283 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 18.8 m -130.33 136.42 49.09 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.229 -0.919 . . . . 74.22 110.065 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 58.8 mt -128.96 142.9 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.533 -0.729 . . . . 60.33 109.464 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 2.0 m -122.44 126.84 26.06 Favored Pre-proline 0 N--CA 1.501 2.077 0 N-CA-C 109.144 -0.687 . . . . 72.31 109.144 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.71 -60.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.793 1.662 . . . . 75.13 112.998 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -53.9 -47.51 71.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.939 -1.1 . . . . 75.23 109.956 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -82.83 -9.77 59.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.121 -0.987 . . . . 72.43 110.063 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 48.51 75.41 0.14 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.977 -1.077 . . . . 75.13 109.178 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -149.17 130.56 14.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.189 -0.945 . . . . 73.22 109.54 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 7.5 tt -110.43 132.93 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.816 -0.809 . . . . 64.14 108.816 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 20.7 mm -111.26 127.42 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.407 -0.808 . . . . 71.22 109.407 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -142.81 141.54 31.66 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.983 -1.117 . . . . 64.22 107.983 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 68.3 tttt 55.93 13.61 1.16 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.335 -0.853 . . . . 72.02 109.705 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.68 5.24 84.49 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.384 -1.086 . . . . 74.32 110.384 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -96.09 141.81 29.03 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.13 -1.218 . . . . 75.34 109.04 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -96.24 123.76 39.99 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.311 -0.868 . . . . 71.23 109.339 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 36.1 t -134.74 132.83 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.38 -0.825 . . . . 70.43 109.153 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -90.58 157.58 17.43 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.032 -1.043 . . . . 72.43 109.516 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 6.0 m -137.69 140.66 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.408 -0.808 . . . . 72.13 109.817 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 22.9 pttt -176.64 89.54 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.408 -0.807 . . . . 72.02 109.593 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -157.15 -170.15 21.76 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.587 -1.405 . . . . 42.23 109.587 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 0.628 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 29.3 ttpt -78.69 -31.03 0.71 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.262 -1.14 . . . . 73.3 110.974 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 148' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 85.1 Cg_endo -89.61 -29.34 0.23 Allowed 'Trans proline' 0 N--CA 1.486 1.069 0 C-N-CA 122.03 1.82 . . . . 71.33 112.764 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -85.1 -13.31 50.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.0 -1.063 . . . . 74.23 109.964 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -53.04 -40.68 64.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.097 -1.002 . . . . 72.34 109.268 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.47 HG13 ' N ' ' B' ' 152' ' ' LEU . 12.5 p -69.24 -38.45 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 73.35 109.159 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.558 HD13 ' O ' ' B' ' 152' ' ' LEU . 0.3 OUTLIER -48.22 -44.11 32.76 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.57 -0.9 . . . . 55.24 108.57 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.14 -41.0 71.05 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.107 -0.996 . . . . 70.01 110.254 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -58.39 -63.59 1.22 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.371 -0.831 . . . . 65.32 112.362 -177.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.609 HD12 ' N ' ' B' ' 156' ' ' ALA . 0.4 OUTLIER -70.23 -19.77 63.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.425 -1.422 . . . . 71.54 109.815 -178.628 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 156' ' ' ALA . . . . . 0.609 ' N ' HD12 ' B' ' 155' ' ' LEU . . . -58.96 -47.97 83.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.737 -1.227 . . . . 75.32 109.17 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.421 ' HG3' ' ND1' ' B' ' 158' ' ' HIS . 23.2 ptt180 -76.86 -35.8 57.23 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.034 -1.041 . . . . 73.32 110.42 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 158' ' ' HIS . . . . . 0.421 ' ND1' ' HG3' ' B' ' 157' ' ' ARG . 1.6 m-70 -81.08 22.42 0.64 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.688 -1.257 . . . . 74.14 109.961 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 24.8 ttm-85 -59.36 163.03 4.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.125 -0.985 . . . . 61.41 109.06 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 160' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' B' ' 214' ' ' PHE . 14.8 t0 63.54 44.65 5.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.205 -0.934 . . . . 72.1 109.164 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 161' ' ' GLN . . . . . 0.908 ' NE2' ' O ' ' B' ' 162' ' ' ILE . 15.5 tm0? -158.16 155.25 28.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.353 -0.842 . . . . 72.25 109.613 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 162' ' ' ILE . . . . . 0.908 ' O ' ' NE2' ' B' ' 161' ' ' GLN . 10.3 mm -81.63 105.39 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.522 -0.918 . . . . 72.31 108.522 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 93.4 t -101.54 129.25 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.274 -0.892 . . . . 64.21 109.754 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 9.8 t -85.93 164.31 17.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.401 -0.812 . . . . 74.22 109.528 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -68.78 -46.39 68.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -0.848 . . . . 65.31 109.855 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -60.25 -24.89 65.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 63.45 109.859 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -59.26 -43.73 92.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.965 -1.085 . . . . 72.4 109.082 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 20.7 mt -71.96 -58.11 3.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.394 -0.816 . . . . 72.32 109.247 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.598 HD13 ' C ' ' B' ' 169' ' ' LEU . 2.1 tm? -50.1 -58.29 5.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.014 -1.054 . . . . 73.34 108.653 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -51.7 -32.66 31.0 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 112.183 0.438 . . . . 72.1 112.183 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.61 -30.77 14.18 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.802 -1.187 . . . . 62.13 112.952 -177.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.7 -63.13 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.458 -1.401 . . . . 71.42 109.467 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 173' ' ' TRP . . . . . 0.523 ' O ' ' CE3' ' B' ' 173' ' ' TRP . 0.0 OUTLIER -66.47 143.22 57.22 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.518 -1.29 . . . . 72.23 107.518 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -170.7 -75.63 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.748 -1.22 . . . . 52.11 109.635 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -66.59 -53.4 29.4 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.226 -0.921 . . . . 73.04 109.33 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -81.95 85.45 1.7 Allowed 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.86 1.707 . . . . 74.13 111.876 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -83.51 -130.68 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.919 . . . . 72.44 109.854 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 4.4 ttt 54.78 16.15 1.33 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.083 -1.011 . . . . 63.43 108.764 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 14.1 m -81.62 152.67 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.83 . . . . 71.05 109.918 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -50.2 157.33 1.18 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 62.15 109.223 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_exo -39.02 -57.46 0.96 Allowed 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 122.167 1.912 . . . . 65.22 112.019 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -164.1 122.73 1.88 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.369 -0.832 . . . . 72.31 109.061 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 10.5 m -137.71 11.87 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.244 -0.91 . . . . 63.32 108.692 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.621 HD13 ' O ' ' B' ' 184' ' ' ILE . 0.2 OUTLIER -53.52 -30.64 18.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.639 -0.874 . . . . 75.03 108.639 179.749 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -57.33 -35.49 69.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.853 . . . . 64.11 108.994 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 3.7 t -75.32 -44.41 42.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.453 -0.78 . . . . 73.0 109.372 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -61.62 -48.46 80.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.251 -0.906 . . . . 61.12 110.459 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 188' ' ' ILE . . . . . 0.47 HG23 ' N ' ' B' ' 189' ' ' ASN . 9.4 tp -63.65 -42.12 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.778 -1.201 . . . . 72.43 110.285 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 189' ' ' ASN . . . . . 0.47 ' N ' HG23 ' B' ' 188' ' ' ILE . 53.3 t30 -63.59 -34.67 78.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.898 -1.126 . . . . 65.14 109.402 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -77.14 -50.36 13.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 63.24 110.15 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 82.0 mt -50.5 -46.37 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.178 -0.951 . . . . 74.03 109.438 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -62.68 -48.81 77.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.104 -0.997 . . . . 72.24 109.914 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 193' ' ' GLN . . . . . 0.45 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 81.7 mt-30 -63.67 -21.61 66.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.051 -1.031 . . . . 73.1 109.515 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 194' ' ' LYS . . . . . 0.431 ' O ' ' CD ' ' B' ' 198' ' ' PRO . 60.3 mttm -85.74 -38.47 18.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.206 -0.933 . . . . 72.11 110.405 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 88.8 mmm -91.79 13.2 18.96 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.888 -1.133 . . . . 44.33 109.99 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 196' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 50.8 p-10 -96.56 -20.98 17.96 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.06 -1.025 . . . . 71.21 109.744 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 197' ' ' LYS . . . . . 0.554 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 1.5 tttm -93.29 -45.54 0.31 Allowed Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.116 -0.99 . . . . 75.21 109.098 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 198' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' B' ' 197' ' ' LYS . 18.8 Cg_exo -65.12 -60.47 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.163 1.909 . . . . 75.32 111.324 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 30.8 mt -63.68 -38.8 92.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 72.25 109.007 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 78.44 -17.95 6.01 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.35 -1.1 . . . . 64.53 110.35 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 29.0 mm -110.31 131.78 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.278 -1.13 . . . . 44.23 110.017 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 2.0 t -83.8 135.16 34.63 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.632 -0.877 . . . . 54.01 108.632 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 3.9 p -141.37 30.43 1.75 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.141 -0.974 . . . . 74.4 109.463 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 25.6 m -137.14 142.4 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.507 -0.745 . . . . 72.12 109.296 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -125.58 114.5 18.81 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.022 -0.732 . . . . 65.41 109.022 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.42 110.1 21.21 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.186 -0.946 . . . . 71.33 109.917 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.416 ' O ' HG13 ' B' ' 207' ' ' VAL . 10.6 p -112.45 131.09 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 107.896 -1.15 . . . . 63.5 107.896 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -47.92 -32.81 6.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.055 -1.028 . . . . 74.45 110.036 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 -66.34 148.45 51.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.093 -1.004 . . . . 74.14 109.41 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 51.37 -115.11 0.85 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.095 -1.003 . . . . 74.43 109.636 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -142.27 -92.73 0.18 Allowed Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.419 -1.473 . . . . 64.45 109.419 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -126.71 157.44 39.08 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.435 -1.038 . . . . 74.21 109.637 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -123.26 121.95 37.16 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.879 -0.785 . . . . 74.03 108.879 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 214' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' B' ' 160' ' ' ASP . 60.0 m-85 -101.49 123.92 46.32 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.369 -0.832 . . . . 74.34 110.372 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 1.9 p -147.59 164.38 33.64 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.117 -0.697 . . . . 64.33 109.117 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 216' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' B' ' 216' ' ' TYR . 0.0 OUTLIER -64.93 162.52 37.1 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.085 -1.01 . . . . 70.04 108.429 179.664 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -39.47 163.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.407 2.071 . . . . 65.11 112.267 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.426 ' C ' ' H ' ' B' ' 220' ' ' ALA . 19.4 mtmt -84.55 -63.7 0.24 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.121 -0.987 . . . . 73.15 109.723 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 219' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' B' ' 218' ' ' LYS . 67.3 Cg_endo -70.41 34.38 0.23 Allowed 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.167 1.912 . . . . 71.31 111.443 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 220' ' ' ALA . . . . . 0.426 ' H ' ' C ' ' B' ' 218' ' ' LYS . . . -47.77 142.77 4.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.375 -0.828 . . . . 75.45 109.87 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 93.8 m -86.25 127.72 34.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.455 -0.778 . . . . 72.22 109.114 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -64.51 136.02 56.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 54.53 109.786 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.022 -0.99 . . . . 71.13 109.379 179.545 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.9 ptm . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.454 -0.573 . . . . 65.12 109.454 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -139.31 144.51 38.34 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.356 -0.84 . . . . 72.33 109.44 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 66.1 t -112.64 131.03 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.705 -0.622 . . . . 71.42 109.492 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.75 HD12 ' N ' ' A' ' 5' ' ' LEU . 0.7 OUTLIER -110.21 125.59 53.23 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.96 -0.756 . . . . 65.12 108.96 179.861 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.75 ' N ' HD12 ' A' ' 4' ' ' LEU . 59.7 tp -120.95 102.94 8.68 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.629 -0.67 . . . . 62.43 109.244 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.503 ' CG1' HD11 ' A' ' 4' ' ' LEU . 38.8 mt -88.67 113.58 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.856 -1.153 . . . . 71.15 108.692 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 13' ' ' GLY . 55.8 tt0 -154.66 121.44 5.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.198 -0.939 . . . . 75.34 109.485 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -64.36 -31.29 72.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.307 -0.871 . . . . 72.44 109.43 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -73.9 103.21 4.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.324 -0.86 . . . . 63.02 109.372 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.4 t -66.4 -25.17 66.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 72.34 109.814 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.54 -50.67 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.168 -0.958 . . . . 74.02 109.697 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.58 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.3 mm? -70.81 -41.95 70.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 71.43 109.398 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.513 ' N ' ' OE1' ' A' ' 7' ' ' GLU . . . -69.13 -24.85 75.81 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 108.475 -1.85 . . . . 61.32 108.475 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.51 -54.89 20.45 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 109.676 -1.37 . . . . 71.2 109.676 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -56.88 -45.75 82.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -1.104 . . . . 71.32 109.775 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.618 ' O ' HD23 ' A' ' 20' ' ' LEU . 35.9 mm -64.54 -48.78 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.819 -1.176 . . . . 63.23 108.878 179.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.527 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 86.5 tt0 -45.6 -56.41 5.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -0.983 . . . . 51.11 109.854 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -85.61 3.83 39.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.124 -0.985 . . . . 73.34 109.128 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.59 -70.64 1.34 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.778 -1.329 . . . . 62.15 109.778 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.618 HD23 ' O ' ' A' ' 16' ' ' ILE . 0.5 OUTLIER -58.75 -21.97 56.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.213 -1.169 . . . . 73.51 109.491 -179.826 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 93.4 m-20 -57.06 -37.84 72.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.253 -0.904 . . . . 74.25 109.634 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.7 t -53.97 -40.02 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 70.04 109.462 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -64.46 -22.13 66.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.27 -0.894 . . . . 73.23 109.233 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.46 38.28 2.65 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 110.335 -1.106 . . . . 75.54 110.335 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -117.92 159.28 23.39 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.335 -1.097 . . . . 73.43 108.905 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.7 mmt -90.8 114.51 26.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.112 -0.992 . . . . 43.24 108.574 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.531 ' HB2' HD11 ' A' ' 20' ' ' LEU . . . -99.26 147.38 25.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.397 -0.814 . . . . 62.11 110.104 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 27' ' ' ALA . 82.4 m-20 -138.52 129.03 26.16 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.619 -0.882 . . . . 74.42 108.619 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.1 m -111.82 138.86 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.449 -0.782 . . . . 72.15 109.117 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 p -135.08 176.39 8.71 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.536 -0.728 . . . . 71.42 109.354 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -95.54 -108.16 0.14 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.163 -0.961 . . . . 72.33 110.017 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.2 p -78.84 167.15 21.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.899 . . . . 74.24 110.123 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.414 HD22 ' CG ' ' A' ' 58' ' ' PHE . 57.7 mt -50.82 -33.76 24.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.629 -0.669 . . . . 71.53 109.891 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -49.5 -52.27 30.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 74.23 109.624 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -61.95 -37.76 85.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.139 -0.976 . . . . 54.03 108.952 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.79 -39.17 90.0 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.278 -1.529 . . . . 61.41 109.278 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.57 -43.59 89.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.352 -1.087 . . . . 74.34 109.445 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -73.39 -38.03 65.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.153 -0.967 . . . . 75.33 109.504 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.0 tp -68.7 -44.99 72.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 74.33 109.771 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.448 ' C ' ' SD ' ' A' ' 40' ' ' MET . 3.4 ppp? -74.39 -17.13 60.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.087 -1.008 . . . . 70.32 109.687 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -55.43 -40.68 71.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.122 -0.986 . . . . 71.22 109.441 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.8 pt -88.08 -42.56 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.304 -0.872 . . . . 74.14 109.793 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 40' ' ' MET . 3.0 mpt_? -104.41 139.19 39.71 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.195 -0.94 . . . . 72.24 109.113 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 45' ' ' TYR . 29.0 t30 -82.11 -24.36 35.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 75.42 109.782 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.485 ' O ' ' O ' ' A' ' 44' ' ' ASN . 57.2 m-85 57.4 136.65 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.684 0.754 . . . . 74.23 110.196 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -86.29 -50.45 6.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.948 -1.095 . . . . 72.04 108.945 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.508 HD13 ' C ' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -104.93 107.39 18.34 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.411 -0.959 . . . . 72.13 108.411 179.406 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.417 ' N ' HD13 ' A' ' 47' ' ' LEU . 2.4 m -106.19 104.79 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.127 -1.064 . . . . 72.34 108.127 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.8 ttt -113.69 144.51 42.81 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.545 0.688 . . . . 74.11 109.776 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.544 HG22 ' H ' ' A' ' 52' ' ' ASP . 1.4 p -139.53 136.02 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.596 0.713 . . . . 61.12 109.567 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.7 m -104.79 10.33 34.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.68 -0.638 . . . . 73.11 109.402 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.544 ' H ' HG22 ' A' ' 50' ' ' VAL . 69.8 m-20 -77.0 155.58 32.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 52.55 109.61 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.47 ' C ' ' H ' ' A' ' 55' ' ' ALA . 27.3 mtmm -76.38 -39.22 54.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.182 -0.949 . . . . 44.22 109.84 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -73.49 18.09 0.13 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.141 -0.974 . . . . 70.44 109.653 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.47 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -59.96 -35.56 75.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 64.14 110.012 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.625 ' HB3' HE22 ' A' ' 89' ' ' GLN . 23.7 mt -43.83 -52.66 6.58 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.449 -0.782 . . . . 44.14 110.251 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.2 m -65.9 -34.63 78.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.872 -1.142 . . . . 55.23 108.942 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.444 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 46.5 t80 -65.89 -62.9 1.24 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.488 -0.757 . . . . 74.44 110.079 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.5 m -48.44 -34.19 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.739 -1.226 . . . . 74.03 109.901 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.2 t -59.0 -55.24 37.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.128 -0.982 . . . . 64.3 109.692 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -65.59 -27.36 68.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.111 -0.993 . . . . 64.44 110.189 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.444 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 31.6 mm -66.25 -49.56 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.75 -1.219 . . . . 63.21 110.369 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.423 ' HZ2' ' HG3' ' A' ' 63' ' ' LYS . 26.6 mmtp -63.62 -44.69 93.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.994 -1.066 . . . . 74.42 110.921 -178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -71.02 -39.52 72.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.676 -1.265 . . . . 70.32 110.161 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.482 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 66.4 mttm -80.8 -19.49 44.64 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.116 -0.99 . . . . 75.22 109.675 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.573 ' O ' HG22 ' A' ' 69' ' ' ILE . 93.1 m-70 -155.68 68.05 0.64 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 74.13 109.391 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.4 m -59.21 -30.72 68.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.249 -0.907 . . . . 73.24 110.0 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.8 t -81.39 49.04 1.23 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.174 -0.954 . . . . 61.01 110.28 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 66' ' ' HIS . 12.3 tt -143.4 157.8 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.096 -1.002 . . . . 71.33 109.307 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.4 t -91.75 141.53 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.001 -1.062 . . . . 72.13 108.81 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.2 t -127.52 121.99 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.297 -0.877 . . . . 54.21 109.34 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.649 ' HG ' HD11 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -118.61 103.15 9.43 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.336 -0.987 . . . . 50.24 108.336 -179.544 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 73' ' ' VAL . 8.0 p -98.64 128.5 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.396 -0.815 . . . . 74.41 109.109 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.5 p -89.31 175.33 7.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.06 -1.025 . . . . 72.31 109.489 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.481 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 22.8 t -164.6 118.95 1.38 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.158 -0.964 . . . . 64.54 110.265 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -70.5 -25.94 63.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.558 -0.714 . . . . 74.13 109.599 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 79' ' ' THR . 13.2 t-20 -112.64 68.9 1.03 Allowed Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.599 -0.688 . . . . 73.34 109.614 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.78 82.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.768 1.645 . . . . 63.22 111.777 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 77' ' ' ASN . 24.1 m -103.61 151.69 22.64 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.111 -0.7 . . . . 62.53 109.111 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -36.61 83.8 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -0.907 . . . . 73.44 109.471 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.02 -42.15 84.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.158 -0.964 . . . . 71.42 109.366 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -74.14 -30.35 62.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 73.43 109.607 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.522 ' OE1' ' CD1' ' A' ' 94' ' ' TYR . 46.8 tp10 -60.59 -54.76 41.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.958 . . . . 74.22 109.587 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.6 t -62.64 -41.72 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.249 -0.907 . . . . 73.2 109.421 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.663 ' NE2' ' NE2' ' A' ' 89' ' ' GLN . 47.7 t60 -64.41 -33.33 75.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.248 -0.908 . . . . 53.33 109.589 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.57 -45.18 91.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 64.11 109.747 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.532 ' CE1' ' HB1' ' B' ' 111' ' ' ALA . 73.4 t80 -77.24 -29.94 54.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.037 -1.039 . . . . 74.34 108.572 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -60.68 -50.74 72.28 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.384 -0.822 . . . . 74.42 108.885 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.663 ' NE2' ' NE2' ' A' ' 85' ' ' HIS . 92.0 mt-30 -63.24 -61.64 2.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.583 -0.698 . . . . 74.24 109.578 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 154.79 59.01 0.01 OUTLIER Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.796 -1.192 . . . . 61.51 110.266 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.72 134.61 51.21 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.254 -1.145 . . . . 55.33 108.978 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -75.4 -32.14 60.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.005 -1.059 . . . . 73.42 109.059 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.513 ' OD2' ' NE ' ' A' ' 108' ' ' ARG . 42.2 t0 -152.34 157.45 41.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.361 -0.837 . . . . 75.04 109.44 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.522 ' CD1' ' OE1' ' A' ' 83' ' ' GLU . 62.0 t80 -131.62 113.26 13.39 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.579 -0.897 . . . . 71.33 108.579 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.872 ' H ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -117.26 152.08 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-O 121.646 0.736 . . . . 71.13 110.444 -178.192 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.93 138.72 48.3 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.27 -1.011 . . . . 64.32 108.27 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.684 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -60.71 -54.98 49.37 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.98 -1.075 . . . . 62.2 111.636 -179.192 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.4 Cg_endo -41.4 -10.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 120.749 0.966 . . . . 73.11 112.923 -175.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.684 ' N ' ' O ' ' A' ' 97' ' ' LYS . 57.4 m-85 59.42 100.31 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.752 -0.593 . . . . 65.22 110.076 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 19.1 ttm-85 -55.93 -40.23 72.83 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.082 -1.081 . . . . 72.35 108.082 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.7 t -173.79 128.82 0.4 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.796 -0.816 . . . . 71.32 108.796 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.405 ' H ' HG13 ' A' ' 102' ' ' ILE . 51.3 mt -51.81 -40.54 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.941 . . . . 75.43 109.155 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.496 ' O ' ' HB2' ' A' ' 107' ' ' ALA . 2.7 mptp? -64.42 -35.58 81.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.154 -0.966 . . . . 71.41 109.38 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.03 -60.9 2.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.228 -0.92 . . . . 63.24 109.689 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.635 ' CD1' HH22 ' A' ' 108' ' ' ARG . 17.9 tp -55.9 -51.99 65.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 73.22 109.657 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 76.0 t -60.23 -42.4 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.062 -1.023 . . . . 60.11 109.383 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 103' ' ' LYS . . . -53.3 -30.08 36.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.177 -0.952 . . . . 70.42 109.115 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.635 HH22 ' CD1' ' A' ' 105' ' ' LEU . 21.1 ttp-105 -83.14 -28.71 29.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 74.41 109.981 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 80.3 mt -74.74 -40.03 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.986 -1.071 . . . . 62.54 108.72 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 114' ' ' ARG . 24.8 pt-20 -72.26 -37.07 69.16 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.439 -0.904 . . . . 74.34 108.957 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -57.3 -45.4 84.2 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.343 -0.848 . . . . 73.32 109.15 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 68.5 ttt-85 -62.73 -41.5 99.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.27 -0.894 . . . . 52.41 109.387 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 42.6 mt -130.07 65.8 1.5 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.477 -0.764 . . . . 65.24 109.248 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' A' ' 110' ' ' GLU . 81.5 mtp180 -60.8 -29.85 69.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 64.45 109.429 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.427 ' CG ' ' O ' ' A' ' 114' ' ' ARG . 78.9 m-85 -156.64 78.88 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 74.43 109.567 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 33.4 p-90 -58.83 134.1 56.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 74.42 109.534 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 154.2 91.57 0.08 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.434 -1.466 . . . . 75.04 109.434 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.7 m -152.39 168.27 26.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.261 -1.14 . . . . 61.14 109.679 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.57 -179.61 8.14 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.823 -0.751 . . . . 65.24 109.117 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.9 t -139.69 -38.75 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.441 -0.787 . . . . 73.11 109.159 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.2 mm -106.32 131.66 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.245 -0.909 . . . . 72.24 109.208 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -128.32 99.36 5.39 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.407 -0.96 . . . . 72.34 108.407 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.918 HG13 ' NE ' ' A' ' 159' ' ' ARG . 26.9 mm -115.82 122.23 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.518 -0.739 . . . . 71.44 109.233 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.86 -160.38 0.29 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.789 -1.325 . . . . 73.4 109.789 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -66.67 -3.99 7.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -1.184 . . . . 74.45 109.666 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.16 134.99 34.77 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.091 -1.006 . . . . 54.21 109.101 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 27.0 m -119.89 131.4 55.23 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.786 -0.82 . . . . 54.5 108.786 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.4 mt -118.99 122.78 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-O 121.685 0.755 . . . . 45.15 109.125 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.7 m -107.79 109.12 62.16 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.732 -0.84 . . . . 71.11 108.732 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.589 ' CB ' ' HE ' ' A' ' 157' ' ' ARG . 94.9 Cg_endo -80.08 -29.95 2.4 Favored 'Trans proline' 0 N--CA 1.492 1.382 0 C-N-CA 121.967 1.778 . . . . 65.41 112.617 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -52.73 -69.16 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.113 -0.992 . . . . 63.32 109.258 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -82.3 4.52 23.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.361 -0.837 . . . . 72.52 109.05 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 54.19 81.25 0.1 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.491 -0.756 . . . . 75.33 109.456 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -149.43 136.0 19.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.244 -0.91 . . . . 71.23 109.553 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 11.6 tt -114.24 133.07 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.48 -0.763 . . . . 74.02 108.973 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 41.4 mt -124.74 115.43 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.847 -0.797 . . . . 60.23 108.847 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -130.61 134.66 47.17 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.456 -0.777 . . . . 62.32 109.762 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.462 ' O ' ' NH1' ' A' ' 140' ' ' ARG . 61.3 mttm 55.3 23.72 5.84 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.436 -0.79 . . . . 75.4 110.792 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 86.66 1.29 85.55 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.364 -1.094 . . . . 72.24 110.364 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.462 ' NH1' ' O ' ' A' ' 138' ' ' LYS . 11.1 mpt_? -88.94 126.55 35.45 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.06 -1.259 . . . . 71.22 108.838 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -100.01 127.36 46.23 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.398 -0.814 . . . . 71.42 109.86 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 24.0 t -137.65 136.2 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.366 -0.834 . . . . 53.02 109.491 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.438 ' O ' HG13 ' A' ' 144' ' ' VAL . 14.5 pt-20 -97.94 142.69 29.36 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.34 -0.85 . . . . 60.45 109.532 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 143' ' ' GLU . 12.2 m -155.53 154.74 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.161 -0.962 . . . . 74.44 109.76 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.0 pttt 178.27 115.28 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.282 -0.886 . . . . 65.15 109.137 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.01 176.18 37.74 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.689 -1.365 . . . . 73.34 109.689 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.583 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 0.0 OUTLIER -60.09 -44.32 96.23 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.4 -1.059 . . . . 72.22 109.254 -179.651 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 39.5 Cg_exo -59.57 -36.2 93.44 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.374 2.05 . . . . 65.23 112.268 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -92.57 -14.71 27.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.258 -0.901 . . . . 60.11 109.63 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -54.93 -40.07 69.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.885 . . . . 64.21 109.865 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.464 HG13 ' N ' ' A' ' 152' ' ' LEU . 10.6 p -61.12 -37.31 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.967 -1.083 . . . . 72.02 109.55 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.464 ' N ' HG13 ' A' ' 151' ' ' VAL . 7.2 tp -62.9 -51.32 67.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.494 -0.754 . . . . 73.31 110.405 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.3 p -74.71 -29.02 61.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.098 -1.001 . . . . 74.31 110.057 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -57.32 -56.74 17.89 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.833 -1.167 . . . . 74.31 109.672 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.8 pp -72.15 -27.28 62.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.395 -0.816 . . . . 75.34 109.732 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.57 -52.88 58.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.961 -1.087 . . . . 62.14 108.72 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.589 ' HE ' ' CB ' ' A' ' 130' ' ' PRO . 52.7 mtt85 -65.18 -43.83 90.42 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.663 -0.866 . . . . 61.03 108.663 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.64 ' N ' ' ND1' ' A' ' 158' ' ' HIS . 0.2 OUTLIER -86.55 30.84 0.69 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.53 -0.731 . . . . 74.12 110.245 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.918 ' NE ' HG13 ' A' ' 123' ' ' ILE . 57.1 ttm-85 -51.46 156.79 1.17 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.983 -1.073 . . . . 71.13 108.419 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 1.04 ' HB2' ' HE1' ' A' ' 216' ' ' TYR . 26.4 t70 57.12 79.02 0.2 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.248 -0.908 . . . . 75.45 108.773 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -171.76 154.08 3.53 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.472 -0.768 . . . . 73.41 109.714 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.7 mt -86.7 115.85 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 74.41 109.109 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 90.5 t -113.7 120.68 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.374 -0.829 . . . . 72.31 108.867 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 40.4 t -85.72 163.61 18.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.828 . . . . 74.12 109.74 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -60.44 -47.82 84.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.519 -0.738 . . . . 70.43 109.794 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -58.61 -36.53 74.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -0.928 . . . . 73.52 109.337 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 60.9 tp60 -55.15 -44.55 75.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.197 -0.939 . . . . 74.52 108.866 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.93 -37.17 81.38 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.22 -0.925 . . . . 72.31 108.563 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.574 ' C ' HD23 ' A' ' 169' ' ' LEU . 4.4 tt -66.53 -60.15 2.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.418 -0.801 . . . . 53.33 109.296 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.75 -15.49 61.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.837 -0.539 . . . . 62.44 110.857 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.1 -49.32 7.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.913 -1.117 . . . . 60.21 111.075 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.622 HD12 ' N ' ' A' ' 172' ' ' ILE . 2.3 mp -98.99 -53.55 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.023 -1.048 . . . . 75.32 110.453 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 23.1 m-90 -89.02 35.54 0.79 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.896 -1.127 . . . . 73.14 109.683 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -50.11 -34.39 21.86 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.351 -0.843 . . . . 73.24 108.818 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' A' ' 175' ' ' GLU . 14.6 mp0 -83.1 154.11 66.88 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 108.672 -0.862 . . . . 44.43 108.672 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.508 ' O ' ' N ' ' A' ' 178' ' ' MET . 89.5 Cg_exo -38.5 -57.37 0.89 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.075 1.85 . . . . 72.51 111.995 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 45.34 16.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 63.24 109.839 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.508 ' N ' ' O ' ' A' ' 176' ' ' PRO . 12.6 ttt 47.91 71.67 0.32 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.334 -0.854 . . . . 73.5 109.868 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 28.4 m -123.06 140.09 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.487 -0.758 . . . . 65.22 108.969 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 49.8 p -85.43 146.31 44.26 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.188 -0.945 . . . . 71.42 109.419 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -41.88 -56.58 1.87 Allowed 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.06 1.84 . . . . 41.22 112.486 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -88.98 86.1 6.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.243 -0.91 . . . . 64.54 109.913 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.0 p -141.75 -23.99 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.307 -0.871 . . . . 74.02 109.884 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.672 ' H ' HD12 ' A' ' 184' ' ' ILE . 2.4 mp -56.42 -29.65 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 72.33 109.854 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -58.85 -39.78 82.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.07 -1.019 . . . . 74.4 109.332 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.424 ' H ' HG23 ' A' ' 186' ' ' VAL . 1.5 t -73.27 -46.85 48.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.508 -0.745 . . . . 70.42 110.071 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.74 86.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 52.11 110.545 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.531 ' O ' HD13 ' A' ' 188' ' ' ILE . 0.2 OUTLIER -61.48 -42.96 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.915 -1.116 . . . . 71.4 109.95 -178.852 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -62.67 -43.1 99.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.83 -1.169 . . . . 73.44 109.443 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -66.65 -46.31 76.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.87 . . . . 71.42 109.794 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 81.9 mt -57.11 -38.17 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.179 -0.951 . . . . 61.55 109.435 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 36.6 mtp180 -61.76 -42.37 98.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.142 -0.974 . . . . 63.34 109.333 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.427 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 49.2 mt-30 -76.45 -30.13 57.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.475 -0.766 . . . . 61.24 110.455 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -86.51 -15.6 39.53 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.161 -0.962 . . . . 75.13 110.243 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 27.1 ttt -93.44 -39.16 11.05 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.014 -1.054 . . . . 74.02 110.622 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 193' ' ' GLN . 28.2 p-10 -62.65 -32.28 73.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.192 -0.942 . . . . 74.02 110.712 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.427 ' N ' ' OD1' ' A' ' 196' ' ' ASP . 51.8 mttt -65.08 -64.77 2.35 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.948 -1.095 . . . . 75.43 110.209 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 21.6 Cg_endo -60.04 -48.94 10.78 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.906 1.738 . . . . 72.32 111.738 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.511 HD13 ' O ' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -69.2 -41.48 77.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 74.54 108.748 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 85.95 -46.61 3.65 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.915 -1.274 . . . . 61.51 109.915 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 30.3 mt -93.64 133.44 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.239 -1.154 . . . . 61.22 109.642 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 70.7 m -75.87 135.98 40.15 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.364 -0.976 . . . . 72.0 108.364 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 19.6 p -144.83 45.91 1.36 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.982 -1.074 . . . . 74.44 110.463 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.8 m -148.99 128.58 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.007 -1.058 . . . . 64.35 108.925 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.493 ' N ' ' CD ' ' A' ' 205' ' ' GLU . 7.6 mp0 -91.44 120.54 32.37 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.096 -1.003 . . . . 71.41 109.475 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 5.9 p -93.15 111.97 23.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.257 -0.902 . . . . 73.52 109.291 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.79 128.61 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.241 -0.912 . . . . 71.02 108.989 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -56.08 -43.66 78.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.093 -1.004 . . . . 72.12 109.49 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.571 ' O ' ' N ' ' A' ' 211' ' ' GLY . 77.5 mtt180 -57.51 146.48 29.75 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.158 -0.964 . . . . 64.41 108.533 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 56.46 -79.08 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.087 -0.708 . . . . 71.54 109.087 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . 168.01 -112.17 0.47 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.239 -1.544 . . . . 72.03 109.239 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -116.38 123.63 48.07 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.56 -0.964 . . . . 75.54 109.18 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -107.18 130.11 54.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.696 -0.627 . . . . 75.31 109.677 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.856 ' CE1' ' HG3' ' A' ' 159' ' ' ARG . 12.2 t80 -89.8 139.53 30.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.945 -1.097 . . . . 75.41 108.812 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 99.6 m -152.66 150.67 29.72 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.999 -1.112 . . . . 74.14 107.999 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' TYR . . . . . 1.04 ' HE1' ' HB2' ' A' ' 160' ' ' ASP . 0.0 OUTLIER -59.86 151.13 65.51 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 120.902 -1.124 . . . . 75.32 108.755 -179.454 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.3 -81.7 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.295 1.997 . . . . 73.11 111.907 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.568 ' H ' ' CD ' ' A' ' 219' ' ' PRO . 4.7 tmtm? -170.34 -44.92 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.982 -1.074 . . . . 75.25 109.728 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.568 ' CD ' ' H ' ' A' ' 218' ' ' LYS . 18.9 Cg_exo -66.36 -9.86 25.46 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.212 1.941 . . . . 75.1 111.794 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -54.54 100.44 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.243 -0.911 . . . . 71.14 108.936 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 25.6 m -64.21 126.1 26.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.451 -0.781 . . . . 71.13 109.807 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.428 ' O ' ' OXT' ' A' ' 223' ' ' GLU . 74.0 tt0 -90.7 124.65 35.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.314 -0.866 . . . . 75.35 108.672 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.428 ' OXT' ' O ' ' A' ' 222' ' ' GLU . 38.6 tp10 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.092 -0.956 . . . . 73.41 109.499 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ptt? . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.38 -0.6 . . . . 71.14 109.38 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.605 ' NH1' ' NE ' ' B' ' 43' ' ' ARG . 66.4 mtp180 -126.59 142.07 51.66 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.568 -0.708 . . . . 73.23 109.386 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 92.8 t -118.79 130.28 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.608 0.718 . . . . 72.24 109.77 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.46 HD11 ' CG1' ' B' ' 6' ' ' ILE . 4.1 tp -98.5 116.73 31.37 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.933 -0.766 . . . . 54.33 108.933 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.637 HD22 ' HG3' ' B' ' 49' ' ' MET . 0.2 OUTLIER -115.04 109.14 17.62 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.183 -1.043 . . . . 74.35 108.183 179.508 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.677 HD12 ' HB ' ' B' ' 50' ' ' VAL . 77.0 mt -101.31 99.41 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.926 -1.109 . . . . 42.55 109.021 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -145.18 130.38 18.53 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.36 -0.838 . . . . 74.52 109.223 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.41 -33.69 76.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.347 -0.846 . . . . 62.55 109.67 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -74.14 105.56 5.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 73.11 109.457 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 23.4 t -68.15 -25.84 65.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.882 . . . . 65.54 109.758 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 89.0 t -62.76 -48.59 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.189 -0.944 . . . . 75.55 109.84 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.415 ' CD1' ' NZ ' ' B' ' 97' ' ' LYS . 28.5 mt -68.22 -25.95 65.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 70.14 109.585 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.39 -34.58 25.5 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.919 -1.672 . . . . 75.4 108.919 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.55 -46.8 83.05 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.847 -1.301 . . . . 65.44 109.847 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -67.25 -43.83 80.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.057 -1.261 . . . . 60.21 109.271 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 91.1 mt -63.51 -38.47 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.957 -1.089 . . . . 75.15 108.57 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -60.69 -42.98 98.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.34 -0.85 . . . . 73.01 109.376 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -86.79 -0.09 55.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.147 -0.971 . . . . 74.3 109.161 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.47 -56.49 2.25 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.489 -1.444 . . . . 70.54 109.489 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.402 HD23 ' H ' ' B' ' 21' ' ' ASN . 1.5 pt? -72.13 -22.95 61.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -1.12 . . . . 71.34 109.613 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' ASN . . . . . 0.402 ' H ' HD23 ' B' ' 20' ' ' LEU . 37.9 m-20 -52.56 -35.19 53.24 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.096 -1.002 . . . . 64.41 109.205 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 59.1 t -54.94 -46.12 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 74.23 108.842 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.472 ' NZ ' HG11 ' B' ' 106' ' ' VAL . 35.1 mmtm -59.72 -53.36 58.88 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.884 -0.784 . . . . 63.42 108.884 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.27 36.77 0.23 Allowed Glycine 0 N--CA 1.5 2.901 0 N-CA-C 110.088 -1.205 . . . . 53.43 110.088 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -119.16 160.47 22.05 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.455 -1.027 . . . . 71.12 109.309 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 26.3 mtt -105.05 141.94 35.73 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.659 -0.867 . . . . 75.24 108.659 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.92 150.14 44.19 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.227 -0.921 . . . . 72.12 109.878 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' B' ' 28' ' ' ASP . 42.0 p30 -131.78 157.57 43.5 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.98 -0.748 . . . . 72.31 108.98 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.38 137.7 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.475 -0.765 . . . . 64.43 109.508 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.6 p -136.2 170.3 16.24 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.005 -0.739 . . . . 65.41 109.005 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -92.18 -107.32 0.11 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.199 -0.938 . . . . 71.02 109.935 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 60.2 p -78.54 169.67 17.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.225 -0.922 . . . . 51.11 110.189 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 56.4 mt -53.36 -33.16 52.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.601 -0.687 . . . . 71.24 109.815 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -51.26 -48.3 62.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 74.32 109.745 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -65.76 -43.79 87.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 73.03 109.409 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.02 -42.13 94.82 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.558 -1.417 . . . . 30.21 109.558 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -65.31 -41.3 94.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -1.122 . . . . 74.42 109.438 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' TYR . . . . . 0.452 ' O ' ' OD1' ' B' ' 41' ' ' ASP . 63.5 t80 -76.36 -21.3 56.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 74.42 109.892 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 12.5 tp -88.64 -36.47 16.24 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.078 -1.014 . . . . 75.41 109.875 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' MET . . . . . 0.445 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.3 ppp? -80.13 -29.09 38.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.175 -0.953 . . . . 60.41 110.474 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' B' ' 42' ' ' ILE . 30.4 p-10 -54.24 -32.27 55.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.966 -1.084 . . . . 53.23 109.758 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.547 ' N ' ' OD1' ' B' ' 41' ' ' ASP . 12.4 pt -84.39 -35.76 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.18 -0.95 . . . . 71.23 109.811 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.605 ' NE ' ' NH1' ' B' ' 2' ' ' ARG . 76.0 mtp180 -131.44 141.41 49.81 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.398 -0.813 . . . . 72.22 109.481 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -97.07 134.91 39.79 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.196 -0.94 . . . . 63.54 109.437 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -101.51 161.62 13.5 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.351 -0.843 . . . . 64.35 109.471 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -90.68 -42.51 10.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.178 -0.951 . . . . 62.22 109.236 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.507 HD13 ' C ' ' B' ' 47' ' ' LEU . 0.9 OUTLIER -104.3 109.78 21.75 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.782 -0.822 . . . . 73.12 108.782 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.452 ' N ' HD13 ' B' ' 47' ' ' LEU . 66.4 t -92.59 99.11 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.252 -0.905 . . . . 65.11 108.611 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.637 ' HG3' HD22 ' B' ' 5' ' ' LEU . 3.5 tpp -113.75 129.77 56.53 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.643 -0.66 . . . . 73.44 109.574 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.677 ' HB ' HD12 ' B' ' 6' ' ' ILE . 0.3 OUTLIER -147.8 126.51 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.506 -0.746 . . . . 34.5 109.223 179.302 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 4.0 m -91.22 14.42 14.37 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.55 -0.718 . . . . 73.21 109.58 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.538 ' H ' HG22 ' B' ' 50' ' ' VAL . 57.5 m-20 -75.92 145.36 40.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.152 -0.967 . . . . 70.41 109.485 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -77.42 -36.57 53.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 65.0 109.931 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -77.07 12.33 1.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -0.985 . . . . 75.21 109.492 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.72 -26.17 68.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.347 -0.846 . . . . 55.33 110.099 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.48 ' N ' HD12 ' B' ' 56' ' ' LEU . 11.1 mp -45.89 -37.08 5.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.159 -0.963 . . . . 63.14 109.96 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 83.9 p -74.92 -46.22 37.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.031 -1.043 . . . . 63.5 109.901 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 58' ' ' PHE . . . . . 0.6 ' CE2' HD11 ' B' ' 62' ' ' ILE . 63.8 t80 -64.83 -50.77 65.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 72.33 110.11 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.433 HG23 ' N ' ' B' ' 60' ' ' SER . 13.6 m -59.41 -36.7 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.755 -1.215 . . . . 74.54 109.764 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.433 ' N ' HG23 ' B' ' 59' ' ' VAL . 33.2 t -57.48 -49.14 77.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 71.24 109.791 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -71.35 -27.7 63.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.031 -1.043 . . . . 74.31 109.88 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.6 HD11 ' CE2' ' B' ' 58' ' ' PHE . 4.8 mm -61.42 -51.25 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.839 -1.163 . . . . 72.14 109.261 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -64.28 -40.51 96.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.015 . . . . 73.32 109.326 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -68.43 -41.69 79.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.235 -0.915 . . . . 73.12 108.54 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -81.67 -76.98 0.23 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.371 -0.831 . . . . 72.44 109.224 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.528 ' O ' HG22 ' B' ' 69' ' ' ILE . 31.7 m80 -92.94 91.62 7.48 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.211 -0.93 . . . . 63.31 108.97 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 80.6 p -77.29 -30.49 54.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 73.1 110.067 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 53.1 p -82.71 54.02 2.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.124 -0.985 . . . . 71.53 109.702 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.528 HG22 ' O ' ' B' ' 66' ' ' HIS . 16.7 tt -146.81 159.69 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.198 -0.939 . . . . 74.4 109.326 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 46.8 t -97.88 154.34 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.113 -0.992 . . . . 75.12 109.093 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 12.7 t -143.56 121.54 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.041 -1.037 . . . . 73.2 109.795 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.636 ' HG ' HD11 ' B' ' 95' ' ' ILE . 3.2 mp -121.77 99.67 6.58 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.463 -0.94 . . . . 73.34 108.463 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.511 ' O ' HG13 ' B' ' 73' ' ' VAL . 12.2 p -90.86 126.52 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 73.5 108.638 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.72 171.72 8.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.012 -1.055 . . . . 64.34 108.813 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.428 ' OG ' ' OE1' ' B' ' 82' ' ' GLU . 8.0 t -162.01 119.27 2.14 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.932 -1.105 . . . . 74.53 110.159 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.5 p30 -67.33 -1.09 4.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 64.5 109.389 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 77' ' ' ASN . . . . . 0.454 ' O ' ' N ' ' B' ' 79' ' ' THR . 11.9 p-10 -133.98 77.13 63.03 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 108.912 -0.773 . . . . 74.25 108.912 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.5 75.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.676 2.251 . . . . 74.43 112.033 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.454 ' N ' ' O ' ' B' ' 77' ' ' ASN . 75.1 p -98.74 148.28 24.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.128 -0.983 . . . . 73.12 109.197 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -32.62 74.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.91 . . . . 71.01 109.442 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.37 -33.19 74.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.008 . . . . 63.2 109.093 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 82' ' ' GLU . . . . . 0.428 ' OE1' ' OG ' ' B' ' 75' ' ' SER . 63.1 tt0 -73.12 -38.06 66.45 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.314 -0.866 . . . . 73.22 109.304 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' B' ' 83' ' ' GLU . 0.4 OUTLIER -57.62 -52.07 66.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 74.3 109.351 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 14.4 m -59.94 -38.96 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -0.969 . . . . 73.31 109.405 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -67.7 -35.42 78.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.118 -0.989 . . . . 73.24 109.303 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -65.56 -36.85 84.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 55.33 109.833 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -83.81 -38.64 21.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.045 -1.034 . . . . 74.14 109.238 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -68.22 -44.19 76.31 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.303 -0.873 . . . . 64.04 109.485 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -66.66 -48.91 67.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 72.35 109.595 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 141.65 75.45 0.04 OUTLIER Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.859 -1.296 . . . . 65.2 109.859 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 91' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -136.6 138.88 41.67 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.327 -1.102 . . . . 52.23 109.136 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.43 -44.25 52.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 73.32 109.348 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -153.81 166.1 33.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.352 -0.842 . . . . 72.22 109.531 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.527 ' O ' ' CD1' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -136.85 139.51 41.74 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.012 -0.736 . . . . 64.42 109.012 -178.743 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.806 HD12 ' N ' ' B' ' 95' ' ' ILE . 0.5 OUTLIER -132.45 151.43 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.512 -0.743 . . . . 72.23 110.25 -179.328 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.5 124.65 23.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.814 -1.179 . . . . 25.24 108.101 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.667 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -47.0 -55.25 15.86 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.985 -1.072 . . . . 64.32 111.103 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 98' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 4.2 Cg_endo -41.93 -10.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.124 0 C-N-CA 120.853 1.035 . . . . 63.33 112.734 -177.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 99' ' ' TYR . . . . . 0.667 ' N ' ' O ' ' B' ' 97' ' ' LYS . 51.7 m-85 61.05 128.29 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.353 -0.61 . . . . 75.13 109.353 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -72.34 -29.66 64.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.961 -1.087 . . . . 74.23 109.42 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 101' ' ' SER . . . . . 0.719 ' O ' ' N ' ' B' ' 103' ' ' LYS . 30.2 t -175.08 31.6 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.944 -1.097 . . . . 63.34 111.115 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 36.8 mm 52.34 -70.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.48 -0.763 . . . . 74.44 110.129 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' B' ' 101' ' ' SER . 67.2 mmtt -57.99 -33.0 68.45 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.18 -1.044 . . . . 71.11 108.18 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.27 -44.32 96.81 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.176 -1.046 . . . . 71.45 108.176 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 17.4 tp -64.5 -46.68 81.95 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.565 -0.902 . . . . 51.31 108.565 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 106' ' ' VAL . . . . . 0.472 HG11 ' NZ ' ' B' ' 23' ' ' LYS . 76.9 t -58.86 -41.31 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.976 . . . . 65.23 109.165 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.23 -36.63 71.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.316 -0.865 . . . . 24.32 109.131 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 54.4 ttt85 -79.44 -26.89 41.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.306 -0.871 . . . . 75.31 109.906 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 93.7 mt -76.48 -43.71 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.032 -1.043 . . . . 54.24 108.731 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 110' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' B' ' 114' ' ' ARG . 23.9 pt-20 -70.25 -28.39 65.21 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.336 -0.945 . . . . 65.31 108.714 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 111' ' ' ALA . . . . . 0.532 ' HB1' ' CE1' ' A' ' 87' ' ' PHE . . . -63.34 -49.24 74.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.409 -0.807 . . . . 72.24 109.397 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -61.5 -42.32 98.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.224 -0.922 . . . . 72.04 109.702 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 45.6 mt -120.0 49.51 1.39 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.458 -0.776 . . . . 75.35 109.569 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.529 ' N ' ' O ' ' B' ' 110' ' ' GLU . 1.2 tmt_? -65.37 -59.13 4.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -0.951 . . . . 75.5 109.232 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -69.36 -47.98 62.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 65.33 109.476 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 116' ' ' TRP . . . . . 0.526 ' O ' ' CD2' ' B' ' 116' ' ' TRP . 76.8 t90 45.83 58.59 4.24 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.313 -0.867 . . . . 74.45 109.791 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 171.13 94.69 0.1 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.414 -1.474 . . . . 44.21 109.414 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 48.7 m -144.9 170.63 15.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.295 -1.121 . . . . 71.4 109.637 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 119' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' B' ' 119' ' ' ASN . 0.0 OUTLIER -157.15 124.11 5.12 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.007 -0.738 . . . . 72.32 109.007 -178.386 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 77.7 t -77.95 -35.83 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 75.02 110.229 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 121' ' ' ILE . . . . . 0.412 HD12 ' N ' ' B' ' 121' ' ' ILE . 4.9 mp -113.54 140.86 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.334 -0.853 . . . . 51.41 109.544 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -145.48 119.22 9.21 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.194 -0.941 . . . . 71.53 109.566 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 6.8 pt -130.54 130.76 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.387 -0.821 . . . . 72.43 109.124 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 44.11 -136.27 5.48 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.797 -1.321 . . . . 51.23 109.797 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 125' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' B' ' 125' ' ' ASP . 20.3 p-10 -89.09 0.98 56.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -1.136 . . . . 74.2 109.035 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.0 134.63 40.12 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.36 -0.978 . . . . 75.42 108.36 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 8.4 m -130.17 143.72 50.94 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.393 -0.817 . . . . 74.22 109.471 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 25.2 mt -127.7 128.76 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.542 -0.724 . . . . 60.33 109.633 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 49.9 m -119.79 92.64 46.75 Favored Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 108.974 -0.75 . . . . 72.31 108.974 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.24 -22.27 9.85 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.134 1.889 . . . . 75.13 112.613 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -52.09 -46.33 65.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.033 -1.042 . . . . 75.23 108.985 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -103.13 16.47 26.52 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.385 -0.822 . . . . 72.43 109.021 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 51.77 58.3 5.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.222 -0.924 . . . . 75.13 108.866 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -137.38 124.4 21.51 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.547 -0.72 . . . . 73.22 109.204 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 135' ' ' ILE . . . . . 0.441 HG23 ' O ' ' B' ' 135' ' ' ILE . 18.5 tt -107.09 129.9 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.368 -0.832 . . . . 64.14 109.097 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 5.7 mm -108.83 126.35 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.471 -0.768 . . . . 71.22 109.281 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 137' ' ' TYR . . . . . 0.494 ' C ' ' H ' ' B' ' 139' ' ' GLY . 78.8 t80 -140.26 148.01 40.83 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.526 -0.916 . . . . 64.22 108.526 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 138' ' ' LYS . . . . . 0.486 ' O ' ' NH1' ' B' ' 140' ' ' ARG . 40.3 tttp 54.54 6.27 0.11 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.344 -0.848 . . . . 72.02 109.619 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 139' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' B' ' 137' ' ' TYR . . . 94.61 -5.14 69.88 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.072 -1.211 . . . . 74.32 110.072 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 140' ' ' ARG . . . . . 0.511 ' CD ' ' N ' ' B' ' 140' ' ' ARG . 10.7 mpt_? -88.9 142.84 27.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.151 -1.206 . . . . 75.34 109.042 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -94.17 129.13 40.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.273 -0.892 . . . . 71.23 109.552 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 39.0 t -131.23 129.03 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.45 -0.781 . . . . 70.43 109.391 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -99.14 142.79 30.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.237 -0.915 . . . . 72.43 109.318 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 144' ' ' VAL . . . . . 0.505 ' CG2' ' CG ' ' B' ' 149' ' ' PHE . 11.9 p -141.5 157.05 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.297 -0.877 . . . . 72.13 109.593 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 145' ' ' LYS . . . . . 0.444 ' N ' HG22 ' B' ' 144' ' ' VAL . 13.2 ptpt -165.85 116.36 1.03 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.886 . . . . 72.02 109.635 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 168.34 -178.95 41.69 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.779 -1.728 . . . . 42.23 108.779 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 0.563 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 1.3 mptp? -79.45 -44.22 1.63 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.052 -1.263 . . . . 73.3 109.558 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 148' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 25.3 Cg_exo -62.34 -15.69 46.62 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 122.552 2.168 . . . . 71.33 112.33 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 149' ' ' PHE . . . . . 0.505 ' CG ' ' CG2' ' B' ' 144' ' ' VAL . 23.3 m-85 -100.69 -35.5 9.45 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.359 -0.838 . . . . 74.23 110.153 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -58.06 -27.77 63.93 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.229 -0.919 . . . . 72.34 108.774 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.541 HG13 ' N ' ' B' ' 152' ' ' LEU . 8.5 p -65.91 -44.89 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.207 -0.933 . . . . 73.35 108.515 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.541 ' N ' HG13 ' B' ' 151' ' ' VAL . 32.3 tp -55.47 -41.86 73.53 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.745 -0.835 . . . . 55.24 108.745 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 18.6 p -71.35 -29.45 65.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.397 -0.814 . . . . 70.01 109.665 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -59.27 -57.44 13.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.062 -1.024 . . . . 65.32 109.719 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.421 ' H ' HD23 ' B' ' 155' ' ' LEU . 0.0 OUTLIER -68.55 -23.52 64.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.049 -1.032 . . . . 71.54 109.053 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.26 -50.48 73.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.103 -0.998 . . . . 75.32 109.79 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 45.9 mtt180 -71.1 -41.72 70.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.09 -1.006 . . . . 73.32 109.425 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -78.25 35.42 0.22 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.51 -0.744 . . . . 74.14 109.812 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 159' ' ' ARG . . . . . 0.582 ' NH1' ' CZ ' ' B' ' 214' ' ' PHE . 52.6 ttm-85 -70.24 163.14 27.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.967 . . . . 61.41 108.914 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 51.94 44.91 29.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.053 -1.03 . . . . 72.1 109.439 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -154.42 -175.82 5.59 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.279 -0.888 . . . . 72.25 109.944 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 70.1 mt -112.65 138.17 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.194 -0.669 . . . . 72.31 109.194 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.66 138.23 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.535 -0.728 . . . . 64.21 109.079 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 13.5 p -92.8 161.5 14.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.308 -0.87 . . . . 74.22 109.882 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -62.71 -49.59 74.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.476 -0.765 . . . . 65.31 109.465 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 166' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' B' ' 166' ' ' GLU . 49.9 mp0 -62.11 -35.18 77.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.346 -0.846 . . . . 63.45 109.656 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 167' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' B' ' 171' ' ' ALA . 61.2 tt0 -59.25 -35.87 74.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.161 -0.962 . . . . 72.4 109.433 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 92.1 mt -68.69 -50.34 51.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.127 -0.983 . . . . 72.32 109.492 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 9.4 mp -58.92 -43.84 91.18 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.141 -0.974 . . . . 73.34 109.264 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -75.93 -21.98 56.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.094 -1.004 . . . . 72.1 109.974 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 171' ' ' ALA . . . . . 0.444 ' C ' HD12 ' B' ' 172' ' ' ILE . . . -69.67 -46.86 65.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.9 -1.125 . . . . 62.13 109.66 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.736 ' N ' HD12 ' B' ' 172' ' ' ILE . 1.6 mp -94.56 -54.62 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.227 -0.92 . . . . 71.42 109.163 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 29.4 m-90 -93.79 68.56 3.93 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.213 -0.929 . . . . 72.23 109.724 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 174' ' ' GLU . . . . . 0.638 ' CD ' ' H ' ' B' ' 174' ' ' GLU . 1.5 pm0 -76.83 -31.89 57.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.265 -0.897 . . . . 52.11 108.924 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.14 154.21 83.14 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.319 -0.863 . . . . 73.04 108.699 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.48 65.16 2.23 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.039 1.826 . . . . 74.13 111.098 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -81.98 -166.62 1.28 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.402 -0.811 . . . . 72.44 109.655 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 17.9 ttt -99.49 63.59 1.27 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.311 -0.868 . . . . 63.43 109.593 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 68.9 t -87.9 124.27 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.141 -0.974 . . . . 71.05 109.468 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 180' ' ' THR . . . . . 0.426 ' C ' ' H ' ' B' ' 182' ' ' ASN . 2.9 p -85.39 151.76 56.8 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 62.15 108.734 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.66 38.04 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.084 1.856 . . . . 65.22 111.259 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 182' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' B' ' 180' ' ' THR . 51.5 p-10 -148.79 -8.78 0.36 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.283 -0.886 . . . . 72.31 109.884 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 47.5 t -60.13 -24.15 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.087 -1.008 . . . . 63.32 109.618 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 41.8 mt -55.23 -48.23 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.353 -0.842 . . . . 75.03 110.625 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -63.47 -37.0 85.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 64.11 110.484 -178.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.78 -42.81 54.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.305 -0.872 . . . . 73.0 110.685 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.82 -47.32 47.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.788 -1.195 . . . . 61.12 110.491 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 188' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' B' ' 189' ' ' ASN . 9.3 tp -65.11 -41.94 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.021 -1.049 . . . . 72.43 110.48 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 189' ' ' ASN . . . . . 0.416 ' N ' ' CG2' ' B' ' 188' ' ' ILE . 61.7 t-20 -61.64 -47.47 85.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.998 -1.064 . . . . 65.14 109.959 -179.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -65.03 -50.97 64.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.154 -0.966 . . . . 63.24 110.05 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 75.8 mt -49.31 -34.22 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.125 -0.984 . . . . 74.03 109.752 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -48.57 64.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.113 -0.992 . . . . 72.24 108.98 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -71.18 -25.3 62.47 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.244 -0.91 . . . . 73.1 110.074 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -88.35 -19.91 26.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.371 -0.83 . . . . 72.11 109.862 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 195' ' ' MET . . . . . 0.445 ' SD ' HD11 ' B' ' 152' ' ' LEU . 6.2 ttt -103.57 -45.26 4.88 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.355 -0.841 . . . . 44.33 110.575 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -59.26 -40.29 85.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.081 -1.012 . . . . 71.21 110.471 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 197' ' ' LYS . . . . . 0.439 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 0.9 OUTLIER -58.22 -65.23 2.01 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.12 -0.988 . . . . 75.21 110.545 -179.268 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 198' ' ' PRO . . . . . 0.448 ' O ' ' CZ ' ' B' ' 137' ' ' TYR . 19.4 Cg_endo -56.88 -53.98 4.32 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.568 1.512 . . . . 75.32 112.238 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 199' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' B' ' 201' ' ' ILE . 11.1 mp -63.1 -34.18 77.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.134 -0.979 . . . . 72.25 109.084 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 74.7 -37.15 1.03 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.706 -1.358 . . . . 64.53 109.706 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 201' ' ' ILE . . . . . 0.435 ' H ' ' C ' ' B' ' 199' ' ' LEU . 39.7 mm -93.15 132.5 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.285 -1.127 . . . . 44.23 109.386 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 14.4 t -77.22 135.16 38.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 54.01 108.861 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 203' ' ' THR . . . . . 0.454 ' O ' ' CE1' ' B' ' 214' ' ' PHE . 16.1 p -144.22 40.41 1.35 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.279 -0.888 . . . . 74.4 109.628 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 7.2 m -141.2 142.55 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.135 -0.978 . . . . 72.12 109.631 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -121.71 136.09 54.94 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.929 -0.767 . . . . 65.41 108.929 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.12 135.99 46.61 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.377 -0.827 . . . . 71.33 109.712 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.42 ' O ' HG13 ' B' ' 207' ' ' VAL . 13.1 p -141.7 131.83 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.295 -0.878 . . . . 63.5 109.129 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -80.27 -25.08 39.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.172 -0.955 . . . . 74.45 109.814 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 60.1 mtp85 -48.85 -27.49 3.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 74.14 109.818 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -151.92 -67.74 0.17 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.088 -1.007 . . . . 74.43 109.694 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 211' ' ' GLY . . . . . 0.424 ' C ' ' CD1' ' B' ' 212' ' ' TYR . . . -162.84 -100.8 0.15 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.859 -1.296 . . . . 64.45 109.859 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 212' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' B' ' 211' ' ' GLY . 38.6 m-85 -137.17 158.38 44.58 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.458 -1.025 . . . . 74.21 109.389 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -130.96 125.88 34.56 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.548 -0.72 . . . . 74.03 109.694 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 214' ' ' PHE . . . . . 0.582 ' CZ ' ' NH1' ' B' ' 159' ' ' ARG . 0.3 OUTLIER -85.59 119.56 26.07 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.348 -0.982 . . . . 74.34 108.348 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 48.3 t -132.66 149.5 52.29 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.189 -0.671 . . . . 64.33 109.189 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.15 164.05 3.9 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.188 -0.945 . . . . 70.04 108.631 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.03 -161.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.658 2.239 . . . . 65.11 111.586 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' B' ' 220' ' ' ALA . 43.9 mttm -57.9 152.74 36.7 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.144 -0.972 . . . . 73.15 109.037 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -35.5 87.36 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 122.513 2.142 . . . . 71.31 112.592 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 220' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' B' ' 218' ' ' LYS . . . -64.86 -33.13 75.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.313 -0.867 . . . . 75.45 109.733 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 71.7 m -80.11 123.84 28.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.171 -0.956 . . . . 72.22 109.486 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -60.89 140.23 57.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 54.53 109.473 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.983 -1.008 . . . . 71.13 109.785 -179.923 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.55 ' SD ' ' CE2' ' A' ' 25' ' ' PHE . 12.1 ptp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.442 -0.577 . . . . 65.12 109.442 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.3 mtt85 -141.49 149.58 41.1 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.319 -0.863 . . . . 72.33 109.315 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 80.3 t -114.45 141.04 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.633 -0.667 . . . . 71.42 109.495 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.533 HD11 ' CG1' ' A' ' 6' ' ' ILE . 4.6 tp -112.35 118.81 36.25 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.532 -0.73 . . . . 65.12 109.583 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 4' ' ' LEU . 18.3 mt -115.74 101.94 9.27 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.479 -0.763 . . . . 62.43 109.18 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.533 ' CG1' HD11 ' A' ' 4' ' ' LEU . 76.6 mt -97.27 107.92 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.228 -0.92 . . . . 71.15 108.839 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.535 ' OE2' ' NZ ' ' A' ' 97' ' ' LYS . 53.5 tt0 -151.28 129.53 11.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.259 -0.901 . . . . 75.34 109.557 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -62.66 -33.04 74.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -0.895 . . . . 72.44 109.377 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -76.82 95.08 3.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.903 . . . . 63.02 109.329 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.0 t -61.11 -25.2 66.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.343 -0.848 . . . . 72.34 109.683 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.08 -53.95 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.964 . . . . 74.02 109.844 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.548 HD13 ' NZ ' ' A' ' 97' ' ' LYS . 49.5 mt -64.37 -44.07 92.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.941 . . . . 71.43 109.678 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.29 -24.63 75.96 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.123 -1.991 . . . . 61.32 108.123 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.75 -57.0 10.56 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 109.702 -1.359 . . . . 71.2 109.702 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -53.5 -45.87 69.83 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.313 -1.11 . . . . 71.32 109.651 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 78.4 mt -67.34 -45.59 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.757 -1.214 . . . . 63.23 109.041 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -51.29 -48.39 62.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.127 -0.983 . . . . 51.11 109.358 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.402 ' HB3' ' HZ2' ' A' ' 18' ' ' LYS . 15.3 ttpp -86.59 -0.09 55.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.248 -0.907 . . . . 73.34 109.19 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.6 -59.03 2.43 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.847 -1.301 . . . . 62.15 109.847 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -71.49 -20.9 62.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -1.171 . . . . 73.51 109.938 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -57.65 -31.59 66.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.119 -0.988 . . . . 74.25 109.576 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.5 t -59.34 -29.76 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.871 . . . . 70.04 109.189 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.719 ' HZ1' ' HZ1' ' A' ' 103' ' ' LYS . 32.3 mmtt -76.51 5.44 7.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.423 -0.798 . . . . 73.23 109.267 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.57 25.39 56.73 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.12 -1.192 . . . . 75.54 110.12 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CE2' ' SD ' ' A' ' 1' ' ' MET . 8.7 m-85 -102.02 156.86 17.27 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.287 -1.125 . . . . 73.43 109.119 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.3 mmt -107.07 136.61 46.64 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.461 -0.941 . . . . 43.24 108.461 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.49 165.79 26.98 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.191 -0.943 . . . . 62.11 109.949 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.413 ' OD2' ' CD2' ' A' ' 39' ' ' LEU . 25.3 t70 -139.65 150.3 44.77 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.432 -0.792 . . . . 74.42 108.995 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.33 139.48 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.483 -0.761 . . . . 72.15 109.276 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 p -137.84 176.1 9.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.381 -0.824 . . . . 71.42 109.295 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -97.73 -104.47 0.19 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.331 -0.856 . . . . 72.33 109.77 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.3 m -77.99 166.57 22.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.227 -0.92 . . . . 74.24 110.158 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.4 mt -51.0 -35.46 34.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.606 -0.684 . . . . 71.53 109.853 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -51.9 -50.31 61.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.18 -0.95 . . . . 74.23 109.947 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -63.82 -40.06 95.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.108 -0.995 . . . . 54.03 109.247 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.05 -38.48 63.81 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.344 -1.502 . . . . 61.41 109.344 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -63.63 -42.92 98.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -1.121 . . . . 74.34 109.499 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -72.55 -34.04 67.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 75.33 109.555 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.413 ' CD2' ' OD2' ' A' ' 28' ' ' ASP . 21.1 tp -71.45 -49.54 40.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.891 . . . . 74.33 109.966 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 40' ' ' MET . 3.9 ppp? -67.67 -22.96 65.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.076 -1.015 . . . . 70.32 109.849 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -59.58 -38.06 80.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.178 -0.951 . . . . 71.22 110.002 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.3 pt -85.47 -29.82 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.157 -0.964 . . . . 74.14 110.325 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 40' ' ' MET . 65.8 mtt85 -130.39 144.67 51.53 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.237 -0.915 . . . . 72.24 109.784 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -99.07 127.62 45.04 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.308 -0.87 . . . . 75.42 109.24 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -99.66 145.36 27.68 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.298 -0.876 . . . . 74.23 109.534 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -79.1 -35.72 41.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 72.04 109.282 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.549 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -110.15 116.85 32.27 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.652 -0.87 . . . . 72.13 108.652 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.549 ' N ' HD13 ' A' ' 47' ' ' LEU . 50.6 t -102.71 100.43 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.429 -0.952 . . . . 72.34 108.429 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.434 ' CE ' ' OH ' ' A' ' 99' ' ' TYR . 21.0 ttt -115.5 136.76 52.75 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.546 0.689 . . . . 74.11 110.079 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.605 HG22 ' H ' ' A' ' 52' ' ' ASP . 1.5 p -145.07 132.22 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.57 -0.706 . . . . 61.12 109.628 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.0 m -92.78 2.03 56.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.457 -0.777 . . . . 73.11 109.253 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.605 ' H ' HG22 ' A' ' 50' ' ' VAL . 51.5 m-20 -76.95 142.23 40.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 52.55 109.508 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.412 ' C ' ' H ' ' A' ' 55' ' ' ALA . 15.5 ptpt -81.15 -31.15 34.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.22 -0.925 . . . . 44.22 110.092 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -74.02 10.8 1.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.088 -1.008 . . . . 70.44 109.354 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.412 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -67.4 -21.05 65.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.427 -0.796 . . . . 64.14 110.253 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.6 mt -43.13 -48.42 6.33 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.255 -0.903 . . . . 44.14 110.067 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.2 m -68.75 -36.23 78.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.01 -1.056 . . . . 55.23 108.743 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -64.73 -64.86 0.77 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.368 -0.833 . . . . 74.44 109.579 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.1 m -48.27 -32.55 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.68 -1.263 . . . . 74.03 109.646 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.9 t -57.41 -50.53 72.71 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.227 -0.921 . . . . 64.3 109.074 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.413 ' HG2' ' H ' ' A' ' 61' ' ' ARG . 7.0 ptp180 -72.33 -34.74 68.29 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.19 -1.004 . . . . 64.44 110.128 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.8 mm -67.36 -33.48 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.599 -1.313 . . . . 63.21 109.422 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -68.25 -48.9 63.83 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.231 -0.918 . . . . 74.42 110.248 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.414 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 17.2 pt-20 -75.39 -40.68 57.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.958 -1.089 . . . . 70.32 110.308 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.521 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 54.9 mttp -73.85 -21.68 60.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.198 -0.939 . . . . 75.22 110.015 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.521 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 84.4 m-70 -156.79 64.63 0.52 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.013 -1.054 . . . . 74.13 109.677 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.3 t -61.42 -28.15 69.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.935 . . . . 73.24 109.683 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 84.6 p -64.33 -20.73 66.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.266 -0.896 . . . . 61.01 110.107 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 70' ' ' VAL . 78.3 mt -82.72 159.18 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.065 -1.022 . . . . 71.33 109.772 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.471 ' N ' HG22 ' A' ' 69' ' ' ILE . 98.4 t -95.39 149.65 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.455 -0.778 . . . . 72.13 109.213 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.0 t -130.53 126.94 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.421 -0.799 . . . . 54.21 109.71 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.0 tt -121.89 101.95 7.88 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.493 -0.755 . . . . 50.24 109.063 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 69.4 t -90.37 145.88 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 74.41 109.154 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.7 m -128.54 155.6 44.63 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.325 -0.859 . . . . 72.31 108.751 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.6 m -165.47 144.32 6.32 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.979 -1.075 . . . . 64.54 110.68 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -86.88 19.83 2.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.482 -0.761 . . . . 74.13 109.753 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 79' ' ' THR . 55.4 t30 -138.91 55.58 7.95 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.302 -0.874 . . . . 73.34 109.397 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 77' ' ' ASN . 15.1 Cg_endo -57.5 77.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.364 2.043 . . . . 63.22 111.532 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.464 HG23 ' H ' ' A' ' 82' ' ' GLU . 12.5 t -102.81 171.84 7.18 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.56 -0.904 . . . . 62.53 108.56 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 p -75.74 -20.63 58.17 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.2 -0.938 . . . . 73.44 110.081 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.511 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 77.1 tt0 -69.52 -49.91 50.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.043 -1.036 . . . . 71.42 109.533 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.464 ' H ' HG23 ' A' ' 79' ' ' THR . 98.9 mt-10 -73.82 -27.6 61.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 73.43 109.576 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -61.26 -56.68 17.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 74.22 109.85 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.524 HG23 ' N ' ' A' ' 85' ' ' HIS . 31.7 m -65.58 -43.61 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 73.2 109.812 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.524 ' N ' HG23 ' A' ' 84' ' ' VAL . 32.2 m80 -63.44 -31.23 72.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.112 -0.993 . . . . 53.33 109.701 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.32 -45.56 79.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.085 -1.01 . . . . 64.11 109.809 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -79.98 -30.35 39.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.091 -1.005 . . . . 74.34 109.207 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -71.97 -51.58 21.25 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.309 -0.869 . . . . 74.42 109.254 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -60.68 -48.58 81.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.499 -0.751 . . . . 74.24 109.622 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.16 70.82 0.02 OUTLIER Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.332 -1.107 . . . . 61.51 110.332 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.02 125.1 43.97 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.439 -1.036 . . . . 55.33 108.634 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -77.09 -27.51 54.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.999 -1.063 . . . . 73.42 109.428 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 94' ' ' TYR . 13.3 t0 -151.81 162.38 41.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 75.04 109.059 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.526 ' N ' ' OD1' ' A' ' 93' ' ' ASP . 58.3 t80 -148.3 101.82 3.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.208 -0.933 . . . . 71.33 109.484 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.1 mm -104.83 150.65 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.475 0 O-C-N 121.179 -0.951 . . . . 71.13 110.682 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.38 123.71 20.73 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.408 -1.33 . . . . 64.32 107.408 178.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.683 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -43.18 -57.68 4.98 Favored Pre-proline 0 C--N 1.3 -1.583 0 O-C-N 121.217 -0.927 . . . . 62.2 112.298 -178.364 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 6.7 Cg_endo -43.27 -7.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 120.93 1.087 . . . . 73.11 112.49 -174.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.683 ' N ' ' O ' ' A' ' 97' ' ' LYS . 58.4 m-85 57.81 120.89 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.07 0.462 . . . . 65.22 110.268 178.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.529 ' NE ' ' OH ' ' B' ' 94' ' ' TYR . 56.5 mtt-85 -62.06 -44.58 96.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.02 -1.05 . . . . 72.35 109.327 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.84 ' O ' ' N ' ' A' ' 103' ' ' LYS . 13.0 t -171.83 47.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.091 -1.006 . . . . 71.32 110.696 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.3 mt 40.21 -66.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 CA-C-N 118.324 0.511 . . . . 75.43 111.562 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.84 ' N ' ' O ' ' A' ' 101' ' ' SER . 40.9 tptt -47.03 -26.87 1.14 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.098 -1.002 . . . . 71.41 109.025 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.38 -47.02 52.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.363 -0.836 . . . . 63.24 109.884 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.4 HD13 ' C ' ' A' ' 105' ' ' LEU . 2.1 tm? -58.95 -57.23 14.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 73.22 109.324 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.46 HG13 ' N ' ' A' ' 107' ' ' ALA . 7.2 p -52.58 -40.91 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.596 -1.315 . . . . 60.11 109.222 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.46 ' N ' HG13 ' A' ' 106' ' ' VAL . . . -51.49 -44.04 62.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 70.42 109.19 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -66.22 -34.71 78.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.206 -0.934 . . . . 74.41 109.094 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.7 mt -72.09 -26.77 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.152 -0.967 . . . . 62.54 108.483 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.19 -58.28 5.74 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.689 -0.804 . . . . 74.34 109.399 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.31 -40.46 67.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.183 -0.948 . . . . 73.32 109.311 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.415 ' CA ' ' HE ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -62.05 -31.06 71.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -0.866 . . . . 52.41 109.334 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.477 HD22 ' SD ' ' A' ' 1' ' ' MET . 2.1 tt -156.14 98.21 1.85 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 65.24 109.597 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.3 mtm180 -92.04 -81.3 0.34 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.189 -0.944 . . . . 64.45 109.077 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -80.38 -81.93 0.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 74.43 109.554 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -149.67 -175.91 5.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.304 -0.873 . . . . 74.42 109.429 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.48 -155.06 4.95 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.395 -1.482 . . . . 75.04 109.395 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.6 m -134.37 164.82 26.56 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.343 -1.092 . . . . 61.14 109.569 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.67 127.15 21.55 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.083 -0.71 . . . . 65.24 109.083 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 56.4 t -89.32 -20.63 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.312 -0.867 . . . . 73.11 109.551 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.6 HG23 HH12 ' A' ' 159' ' ' ARG . 4.7 mp -117.78 119.7 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.399 -0.813 . . . . 72.24 109.004 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -140.86 122.81 15.49 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.408 -0.808 . . . . 72.34 109.748 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.442 HG23 ' O ' ' A' ' 123' ' ' ILE . 15.5 tt -138.33 130.78 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.383 -0.823 . . . . 71.44 109.143 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.62 -134.72 34.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.281 -1.528 . . . . 73.4 109.281 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.72 -9.06 45.14 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.07 -1.253 . . . . 74.45 109.462 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.35 135.73 33.77 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.971 -1.081 . . . . 54.21 108.915 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 44.2 p -129.33 139.18 51.83 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.457 -0.777 . . . . 54.5 109.122 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 81.3 mt -130.78 131.82 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.399 -0.813 . . . . 45.15 109.834 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.4 m -126.31 110.86 23.65 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.302 -0.999 . . . . 71.11 108.302 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.98 -38.47 0.82 Allowed 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.533 1.489 . . . . 65.41 112.046 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -65.35 -42.54 92.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.177 -0.952 . . . . 63.32 109.238 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 133' ' ' GLU . 44.7 mm-40 -87.82 11.48 15.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.333 -0.854 . . . . 72.52 109.708 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 132' ' ' GLU . 11.8 pt-20 33.48 61.78 0.43 Allowed 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.209 0.528 . . . . 75.33 110.846 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -152.74 148.42 27.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.081 -1.012 . . . . 71.23 110.213 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.2 tt -135.51 144.36 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.507 -0.746 . . . . 74.02 109.177 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 20.5 mt -125.49 135.37 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.63 -0.878 . . . . 60.23 108.63 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -139.38 135.68 33.94 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.086 -1.009 . . . . 62.32 110.271 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm 54.01 28.9 9.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.584 -0.698 . . . . 75.4 110.366 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.42 16.56 75.72 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 120.025 -1.083 . . . . 72.24 110.9 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -111.01 125.3 53.59 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.343 -1.093 . . . . 71.22 109.37 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -92.98 123.39 36.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.253 -0.904 . . . . 71.42 110.279 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.3 p -137.0 138.97 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.251 -1.018 . . . . 53.02 108.251 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.451 ' N ' ' CD ' ' A' ' 143' ' ' GLU . 19.3 mp0 -99.99 143.9 29.66 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.309 -0.869 . . . . 60.45 110.406 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.6 m -142.6 130.99 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.481 -0.933 . . . . 74.44 108.481 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.01 19.58 0.88 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.173 -0.954 . . . . 65.15 109.736 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.85 173.86 47.46 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.132 -1.587 . . . . 73.34 109.132 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.619 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 27.2 mttt -69.83 -37.17 7.46 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.138 -1.213 . . . . 72.22 110.162 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 19.1 Cg_exo -64.48 -18.62 63.56 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.09 1.86 . . . . 65.23 111.907 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -95.28 -30.9 13.72 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.214 -0.929 . . . . 60.11 110.009 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -50.43 -35.95 30.97 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.097 -1.002 . . . . 64.21 109.197 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.6 p -62.2 -33.37 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.138 -0.976 . . . . 72.02 109.091 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 9.5 tp -67.1 -39.3 86.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.823 . . . . 73.31 109.248 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 39.1 p -73.95 -29.7 62.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.066 -1.021 . . . . 74.31 109.388 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -61.81 -57.78 10.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.067 -1.021 . . . . 74.31 109.742 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 pp -64.43 -29.5 70.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.127 -0.983 . . . . 75.34 109.192 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.45 -45.83 69.63 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.236 -0.915 . . . . 62.14 109.046 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -73.05 -46.3 52.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.103 -0.998 . . . . 61.03 108.915 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -79.59 29.35 0.25 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.593 -0.692 . . . . 74.12 109.889 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.6 HH12 HG23 ' A' ' 121' ' ' ILE . 19.9 ttp-105 -71.29 44.7 0.09 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.162 -0.961 . . . . 71.13 109.563 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -171.26 46.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.88 -1.138 . . . . 75.45 109.915 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -168.39 178.55 4.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.023 -1.048 . . . . 73.41 109.975 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 66.7 mt -96.25 139.43 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.45 -0.781 . . . . 74.41 109.244 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 78.7 t -132.28 140.08 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.368 -0.832 . . . . 72.31 109.617 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 32.3 p -98.88 169.32 9.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.255 -0.903 . . . . 74.12 109.843 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -67.04 -46.79 73.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.52 -0.738 . . . . 70.43 109.982 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -53.73 -36.42 62.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.356 -0.84 . . . . 73.52 109.778 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -61.09 -49.32 77.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.158 -0.964 . . . . 74.52 109.525 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 38.7 mt -51.27 -40.6 59.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.077 -1.014 . . . . 72.31 109.027 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.562 ' C ' HD23 ' A' ' 169' ' ' LEU . 4.2 tt -60.65 -65.08 0.75 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.451 -0.781 . . . . 53.33 109.793 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -66.38 -10.92 48.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.214 -0.929 . . . . 62.44 110.591 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.424 ' C ' HD12 ' A' ' 172' ' ' ILE . . . -73.25 -52.93 12.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.953 -1.092 . . . . 60.21 110.033 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.771 HD12 ' N ' ' A' ' 172' ' ' ILE . 1.7 mp -95.77 -52.56 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.019 -1.051 . . . . 75.32 109.2 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 21.7 m-90 -96.4 113.07 24.62 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.333 -0.854 . . . . 73.14 109.259 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.486 ' N ' ' CD ' ' A' ' 174' ' ' GLU . 2.3 pm0 -147.01 8.17 0.94 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.162 -0.961 . . . . 73.24 109.491 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.445 ' H ' ' HD2' ' A' ' 176' ' ' PRO . 0.5 OUTLIER 177.69 -50.47 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.287 -0.883 . . . . 44.43 109.471 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.445 ' HD2' ' H ' ' A' ' 175' ' ' GLU . 91.0 Cg_exo -45.43 -38.47 15.78 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.004 1.803 . . . . 72.51 112.401 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -147.92 145.13 28.5 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.175 -0.953 . . . . 63.24 109.689 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 71.3 mtm -89.96 126.77 35.86 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.439 -0.788 . . . . 73.5 109.104 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 28.5 m -133.9 139.86 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.401 -0.812 . . . . 65.22 109.776 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.475 ' O ' HG12 ' A' ' 183' ' ' VAL . 26.0 m -73.5 135.74 78.5 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.334 -0.987 . . . . 71.42 108.334 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.2 -12.63 35.7 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 121.685 1.59 . . . . 41.22 112.391 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.436 ' H ' HG22 ' A' ' 180' ' ' THR . 72.9 m-20 -81.28 34.32 0.36 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.188 -0.945 . . . . 64.54 109.497 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 180' ' ' THR . 8.8 p -130.15 -13.69 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.347 -0.846 . . . . 74.02 110.556 -179.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 58.6 mt -56.55 -27.83 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.749 -1.219 . . . . 72.33 109.235 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -53.12 -48.94 67.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.317 -0.864 . . . . 74.4 109.48 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.433 ' H ' HG23 ' A' ' 186' ' ' VAL . 2.2 t -73.79 -28.63 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.474 -0.766 . . . . 70.42 109.982 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.44 -41.13 66.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.143 -0.973 . . . . 52.11 111.071 -178.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.7 tp -76.4 -33.97 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.52 -1.363 . . . . 71.4 109.823 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -66.55 -55.72 14.16 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.272 -0.893 . . . . 73.44 110.14 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -61.85 -36.74 82.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 71.42 110.263 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 74.8 mt -69.4 -40.85 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.157 -0.965 . . . . 61.55 110.227 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 44.1 mtp85 -58.01 -39.12 77.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.88 -1.138 . . . . 63.34 108.985 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -78.06 -36.61 48.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 61.24 109.677 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -84.46 2.51 40.54 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.185 -0.947 . . . . 75.13 110.49 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' MET . . . . . 1.014 ' HE1' HG11 ' A' ' 204' ' ' VAL . 44.3 ttp -99.58 -47.16 5.21 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.088 -1.007 . . . . 74.02 109.662 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -68.82 -32.05 71.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.89 . . . . 74.02 109.869 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.434 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 1.1 mmtm -55.2 -64.49 2.05 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.23 -0.919 . . . . 75.43 109.555 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 40.0 Cg_endo -64.17 -53.66 1.1 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.128 1.885 . . . . 72.32 112.236 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.9 mp -54.71 -56.61 17.41 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.971 -1.08 . . . . 74.54 109.643 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 100.35 -17.99 56.04 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 109.842 -1.303 . . . . 61.51 109.842 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 41.2 mt -128.16 147.78 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.341 -1.094 . . . . 61.22 109.104 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 17.5 t -77.96 136.6 38.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.971 -1.08 . . . . 72.0 109.278 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.21 15.87 1.88 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.203 -0.935 . . . . 74.44 109.302 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 1.014 HG11 ' HE1' ' A' ' 195' ' ' MET . 31.2 m -127.42 152.32 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.551 -0.718 . . . . 64.35 110.089 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -126.95 130.56 50.34 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.878 -0.786 . . . . 71.41 108.878 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 4.2 t -98.84 127.23 44.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.196 -0.94 . . . . 73.52 109.06 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 209' ' ' ARG . 8.5 p -145.56 140.18 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.117 -0.989 . . . . 71.02 109.539 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -82.59 -25.28 33.4 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.263 -0.898 . . . . 72.12 109.597 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.431 ' H ' HG22 ' A' ' 207' ' ' VAL . 13.2 mmt85 -49.45 -25.08 2.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.418 -0.801 . . . . 64.41 109.866 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -152.21 -74.29 0.14 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 71.54 109.448 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -166.91 -102.01 0.16 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.206 -1.558 . . . . 72.03 109.206 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -135.49 134.08 39.15 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.443 -1.034 . . . . 75.54 109.268 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -97.92 137.55 36.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.335 -0.853 . . . . 75.31 109.54 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.423 ' O ' ' SG ' ' A' ' 215' ' ' CYS . 44.1 m-85 -105.77 119.12 38.34 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.83 -0.804 . . . . 75.41 108.83 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 214' ' ' PHE . 99.3 m -153.39 162.54 41.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.32 -0.862 . . . . 74.14 109.391 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -67.6 155.08 92.1 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 75.32 108.925 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -36.14 138.91 0.17 Allowed 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 122.424 2.083 . . . . 73.11 112.033 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.582 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 34.7 tttt -68.5 -39.28 14.91 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.156 -0.965 . . . . 75.25 110.647 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 52.3 Cg_exo -54.44 -7.38 0.78 Allowed 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.98 1.787 . . . . 75.1 111.829 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -65.47 -54.19 31.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.345 -0.847 . . . . 71.14 109.826 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 46.3 m 47.5 -139.08 0.66 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.123 -0.986 . . . . 71.13 109.293 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -59.62 -39.8 85.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.099 -1.0 . . . . 75.35 109.219 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.982 -1.009 . . . . 73.41 109.537 -179.93 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 54.7 ttm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.44 -0.578 . . . . 71.14 109.44 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -137.79 154.46 49.56 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.356 -0.84 . . . . 73.23 109.489 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 97.8 t -115.58 125.95 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 109.174 -0.676 . . . . 72.24 109.174 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.48 HD11 ' CG1' ' B' ' 6' ' ' ILE . 4.4 tp -99.31 119.03 37.27 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.454 -0.779 . . . . 54.33 108.975 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.418 ' CD1' ' SD ' ' B' ' 49' ' ' MET . 5.3 tp -120.45 100.29 7.06 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 108.959 -0.756 . . . . 74.35 108.959 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.48 ' CG1' HD11 ' B' ' 4' ' ' LEU . 45.7 mt -90.05 102.81 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.833 -1.167 . . . . 42.55 108.816 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.42 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 29.2 tp10 -133.2 128.87 36.91 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.501 -0.75 . . . . 74.52 109.371 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -65.49 -33.31 75.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.906 . . . . 62.55 109.168 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -88.43 111.56 21.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.346 -0.846 . . . . 73.11 109.387 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 83.1 p -69.06 -27.07 65.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.915 . . . . 65.54 109.586 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 77.7 t -61.92 -51.31 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 75.55 109.607 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 37.9 mt -64.35 -30.65 71.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 70.14 109.449 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.36 -29.91 57.57 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.623 -1.791 . . . . 75.4 108.623 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.41 -50.52 61.77 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.912 -1.275 . . . . 65.44 109.912 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -65.46 -41.53 93.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -1.165 . . . . 60.21 109.801 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 5.7 mm -67.66 -35.28 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.867 -1.145 . . . . 75.15 108.905 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -64.58 -46.39 82.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.872 . . . . 73.01 109.454 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -79.49 -9.16 59.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 74.3 109.468 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.57 -52.95 3.97 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 109.422 -1.471 . . . . 70.54 109.422 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pp -70.51 -27.83 64.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -1.089 . . . . 71.34 109.392 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 -54.19 -34.87 61.57 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.229 -0.919 . . . . 64.41 109.21 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 49.0 t -54.36 -45.37 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.345 -0.847 . . . . 74.23 108.746 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.806 ' HZ2' HG12 ' B' ' 106' ' ' VAL . 23.6 mmtp -57.09 -51.64 68.48 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.607 -0.886 . . . . 63.42 108.607 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 127.66 41.12 0.3 Allowed Glycine 0 N--CA 1.5 2.907 0 N-CA-C 110.461 -1.056 . . . . 53.43 110.461 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -119.66 159.2 24.9 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.265 -1.138 . . . . 71.12 108.862 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 15.1 mmt -98.16 138.46 35.42 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.06 -1.089 . . . . 75.24 108.06 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.24 160.71 40.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.928 . . . . 72.12 110.261 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -142.84 152.84 42.59 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.663 -0.866 . . . . 72.31 108.663 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 p -114.02 137.1 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.37 -0.831 . . . . 64.43 109.238 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.6 p -134.41 170.07 16.3 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.576 -0.703 . . . . 65.41 109.457 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.479 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 1.9 pt-20 -94.4 -98.6 0.15 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.383 -0.823 . . . . 71.02 110.055 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 70.1 m -78.59 168.8 19.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.257 -0.902 . . . . 51.11 110.363 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 16.1 mt -56.76 -31.98 65.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.61 -0.681 . . . . 71.24 110.009 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -52.76 -44.07 66.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.131 -0.981 . . . . 74.32 109.861 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.479 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 64.1 m-20 -73.76 -39.58 64.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.107 -0.995 . . . . 73.03 109.553 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.3 -44.98 57.63 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.62 -1.392 . . . . 30.21 109.62 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.66 -43.32 84.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -1.153 . . . . 74.42 109.67 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -70.55 -39.85 73.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.131 -0.98 . . . . 74.42 110.099 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 25.0 tp -70.2 -44.07 69.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -0.948 . . . . 75.41 110.373 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' MET . . . . . 0.448 ' SD ' ' OH ' ' B' ' 45' ' ' TYR . 0.0 OUTLIER -74.49 -28.01 60.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.025 -1.047 . . . . 60.41 110.147 -179.204 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.21 -29.89 70.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.967 -1.083 . . . . 53.23 110.383 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 19.8 pt -86.34 -18.43 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.953 -1.092 . . . . 71.23 110.905 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' B' ' 40' ' ' MET . 59.0 mmt-85 -129.63 155.19 46.25 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.082 -1.011 . . . . 72.22 110.132 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -84.62 157.03 21.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.271 -0.893 . . . . 63.54 109.551 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.513 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 3.6 p90 -149.9 -174.89 4.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.208 -0.933 . . . . 64.35 109.393 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -141.5 -33.62 0.5 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.27 -0.894 . . . . 62.22 109.569 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.502 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.3 OUTLIER -110.14 114.78 28.55 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.35 -0.844 . . . . 73.12 109.107 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.502 ' N ' HD13 ' B' ' 47' ' ' LEU . 71.5 t -101.74 97.22 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.449 -0.945 . . . . 65.11 108.449 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.434 ' O ' ' O ' ' B' ' 4' ' ' LEU . 15.4 ttt -112.91 130.53 56.08 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.571 0.7 . . . . 73.44 109.849 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.05 138.85 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.4 -0.813 . . . . 34.5 109.311 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 51' ' ' SER . . . . . 0.42 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 53.0 p -105.46 2.29 28.44 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.548 -0.72 . . . . 73.21 110.412 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -75.7 147.01 39.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.987 -1.07 . . . . 70.41 109.629 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' B' ' 55' ' ' ALA . 62.3 mttp -73.35 -58.2 3.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.287 -0.883 . . . . 65.0 110.23 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -47.43 -12.85 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.089 -1.007 . . . . 75.21 109.904 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' B' ' 53' ' ' LYS . . . -58.67 -25.15 62.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.856 . . . . 55.33 110.598 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.521 ' HB3' HE22 ' B' ' 89' ' ' GLN . 97.7 mt -45.19 -47.44 12.49 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.065 -1.022 . . . . 63.14 109.827 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 21.5 m -68.81 -33.41 73.81 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.937 -1.102 . . . . 63.5 108.751 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 58' ' ' PHE . . . . . 0.413 ' CZ ' HD11 ' B' ' 62' ' ' ILE . 61.6 t80 -65.93 -60.68 2.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.422 -0.799 . . . . 72.33 109.77 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 31.4 m -50.0 -36.14 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.527 -1.358 . . . . 74.54 109.639 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 22.5 p -56.56 -54.2 48.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.107 -0.996 . . . . 71.24 109.68 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.576 ' HE ' ' NZ ' ' B' ' 65' ' ' LYS . 5.9 ptm180 -66.02 -30.18 70.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.007 -1.058 . . . . 74.31 110.034 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.413 HD11 ' CZ ' ' B' ' 58' ' ' PHE . 34.4 mm -65.08 -37.97 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.653 -1.28 . . . . 72.14 109.723 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' B' ' 67' ' ' SER . 25.0 mmtp -68.3 -51.87 39.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.063 -1.023 . . . . 73.32 110.302 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -67.47 -37.56 83.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.847 -1.158 . . . . 73.12 109.939 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.576 ' NZ ' ' HE ' ' B' ' 61' ' ' ARG . 92.9 mttt -81.55 -20.43 39.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -0.94 . . . . 72.44 109.707 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.485 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 74.0 m-70 -155.89 64.77 0.58 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.129 -0.982 . . . . 63.31 109.701 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.404 ' N ' ' O ' ' B' ' 63' ' ' LYS . 9.4 t -63.47 -29.01 70.36 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 73.1 109.669 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 96.5 p -61.64 -25.96 67.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 71.53 110.045 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.4 HD13 ' CE2' ' B' ' 45' ' ' TYR . 65.6 mt -83.4 151.3 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.093 -1.004 . . . . 74.4 109.48 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 99.2 t -89.93 154.62 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.415 -0.803 . . . . 75.12 109.318 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 18.1 t -134.57 127.78 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.308 -0.87 . . . . 73.2 109.618 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.575 ' C ' HD23 ' B' ' 72' ' ' LEU . 4.6 tt -118.91 102.66 8.95 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.455 0.645 . . . . 73.34 109.577 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 73' ' ' VAL . . . . . 0.452 ' O ' HG13 ' B' ' 73' ' ' VAL . 10.9 p -94.07 130.58 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.947 -1.096 . . . . 73.5 109.241 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 12.7 p -85.4 174.3 9.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.086 -1.009 . . . . 64.34 108.79 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 10.4 p -153.43 110.23 3.41 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.827 -1.171 . . . . 74.53 110.679 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -71.23 -21.7 62.09 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.499 -0.926 . . . . 64.5 108.499 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -126.64 73.38 74.61 Favored Pre-proline 0 N--CA 1.494 1.764 0 N-CA-C 108.601 -0.889 . . . . 74.25 108.601 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.18 81.51 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.778 1.652 . . . . 74.43 111.843 -178.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.426 ' O ' ' OE2' ' B' ' 83' ' ' GLU . 4.3 t -110.08 152.12 26.37 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.736 -0.839 . . . . 73.12 108.736 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.6 t -50.88 -33.44 24.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 71.01 110.321 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -61.19 -37.29 82.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.999 -1.063 . . . . 63.2 110.236 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 82' ' ' GLU . . . . . 0.404 ' H ' HG23 ' B' ' 79' ' ' THR . 34.2 tp10 -78.93 -37.02 40.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.004 -1.06 . . . . 73.22 110.088 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.519 ' N ' ' OE1' ' B' ' 83' ' ' GLU . 0.3 OUTLIER -58.08 -50.51 73.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.098 -1.001 . . . . 74.3 109.615 -179.612 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.494 HG23 ' N ' ' B' ' 85' ' ' HIS . 24.3 m -67.8 -39.87 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.121 -0.987 . . . . 73.31 109.542 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 85' ' ' HIS . . . . . 0.494 ' N ' HG23 ' B' ' 84' ' ' VAL . 4.4 t-160 -66.41 -26.87 67.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.171 -0.955 . . . . 73.24 109.562 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.68 -42.72 60.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.123 -0.986 . . . . 55.33 110.115 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -82.37 -33.38 28.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.081 -1.012 . . . . 74.14 109.275 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -68.58 -34.38 75.7 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.355 -0.841 . . . . 64.04 109.572 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 89' ' ' GLN . . . . . 0.521 HE22 ' HB3' ' B' ' 56' ' ' LEU . 69.0 mt-30 -80.43 -63.61 1.37 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -0.953 . . . . 72.35 109.677 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 163.2 68.06 0.02 OUTLIER Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.401 -1.38 . . . . 65.2 110.435 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -127.18 137.29 52.9 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.455 -1.026 . . . . 52.23 108.837 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' B' ' 93' ' ' ASP . 14.2 t70 -80.89 -34.52 33.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.055 -1.028 . . . . 73.32 109.448 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 93' ' ' ASP . . . . . 0.512 ' OD1' ' NH2' ' B' ' 112' ' ' ARG . 57.9 m-20 -149.96 164.15 36.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.35 -0.844 . . . . 72.22 109.441 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.532 ' O ' ' CD1' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -140.17 112.97 8.09 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.684 -0.858 . . . . 64.42 108.684 -178.951 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 35.4 mm -114.46 147.79 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.368 -0.833 . . . . 72.23 110.124 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 96' ' ' ALA . . . . . 0.511 ' HB1' ' HD2' ' B' ' 98' ' ' PRO . . . -62.47 139.52 58.58 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.172 -0.955 . . . . 25.24 108.558 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.601 ' N ' ' CD ' ' B' ' 98' ' ' PRO . 0.0 OUTLIER -69.17 -40.95 16.68 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.185 -0.947 . . . . 64.32 110.916 -179.19 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 98' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' B' ' 97' ' ' LYS . 33.1 Cg_exo -52.25 1.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.29 -2.518 0 CA-C-N 118.4 0.464 . . . . 63.33 112.833 -174.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 99' ' ' TYR . . . . . 0.601 ' N ' ' O ' ' B' ' 97' ' ' LYS . 45.7 m-85 55.55 99.19 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.453 -0.779 . . . . 75.13 109.722 178.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 34.9 ttm-85 -59.46 -36.09 75.3 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.009 -1.057 . . . . 74.23 108.724 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 101' ' ' SER . . . . . 0.753 ' O ' ' N ' ' B' ' 103' ' ' LYS . 12.6 t -173.84 39.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.234 -0.916 . . . . 63.34 110.688 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 102' ' ' ILE . . . . . 0.425 ' C ' ' N ' ' B' ' 104' ' ' ALA . 60.3 mt 51.92 -69.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.48 -0.763 . . . . 74.44 110.062 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.753 ' N ' ' O ' ' B' ' 101' ' ' SER . 38.1 mmtm -56.65 -15.36 4.33 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.168 -1.419 . . . . 71.11 107.168 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.425 ' N ' ' C ' ' B' ' 102' ' ' ILE . . . -60.54 -78.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.349 -0.54 . . . . 71.45 110.189 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.598 ' H ' HD12 ' B' ' 105' ' ' LEU . 0.0 OUTLIER -51.9 -41.17 61.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.95 -1.094 . . . . 51.31 109.381 -179.151 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 106' ' ' VAL . . . . . 0.806 HG12 ' HZ2' ' B' ' 23' ' ' LYS . 27.6 t -57.84 -45.21 87.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.995 -1.066 . . . . 65.23 108.804 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.04 -30.86 62.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.21 -0.931 . . . . 24.32 108.787 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 0.434 HH12 ' NH2' ' B' ' 112' ' ' ARG . 2.0 tpm_? -80.72 -24.77 38.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.428 -0.795 . . . . 75.31 109.649 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 93.9 mt -80.08 -38.93 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.114 -0.991 . . . . 54.24 109.391 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 110' ' ' GLU . . . . . 0.52 ' OE1' ' NZ ' ' B' ' 23' ' ' LYS . 22.7 pt-20 -72.58 -40.93 66.22 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.163 -0.961 . . . . 65.31 109.509 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.21 -44.26 95.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.929 . . . . 72.24 109.248 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 112' ' ' ARG . . . . . 0.512 ' NH2' ' OD1' ' B' ' 93' ' ' ASP . 56.2 ttm-85 -63.08 -31.73 72.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 72.04 109.443 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 13.4 tp -145.12 70.54 1.27 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.263 -0.898 . . . . 75.35 109.127 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' B' ' 110' ' ' GLU . 96.2 mtt180 -62.69 -46.22 89.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 75.5 109.709 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -81.62 -103.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 65.33 109.536 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -163.43 -28.63 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.101 -0.999 . . . . 74.45 109.759 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -167.94 -172.48 35.0 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.767 -1.333 . . . . 44.21 109.767 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 48.9 m -145.48 -172.04 3.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.369 -1.077 . . . . 71.4 109.382 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.82 160.74 43.68 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.671 -0.812 . . . . 72.32 109.406 -178.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 4.5 t -134.3 -38.1 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.484 -0.76 . . . . 75.02 109.176 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 121' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' B' ' 128' ' ' ILE . 27.6 mm -110.87 133.32 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.797 -0.816 . . . . 51.41 108.797 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -137.31 143.62 42.2 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.396 -0.815 . . . . 71.53 108.904 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.971 HD11 ' NH2' ' B' ' 159' ' ' ARG . 19.5 tt -155.02 127.1 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 72.43 109.879 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 47.49 -151.56 2.07 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.723 -1.351 . . . . 51.23 109.723 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -75.75 -3.29 34.06 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.206 -1.173 . . . . 74.2 109.065 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.41 147.02 24.92 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.112 -1.07 . . . . 75.42 108.112 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 36.1 m -126.61 134.82 50.69 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.457 -0.777 . . . . 74.22 108.978 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' B' ' 121' ' ' ILE . 96.1 mt -126.2 124.15 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.54 -0.725 . . . . 60.33 109.675 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 18.8 m -123.89 109.21 30.08 Favored Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 109.198 -0.667 . . . . 72.31 109.198 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.96 -24.72 5.63 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.665 1.577 . . . . 75.13 111.629 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 131' ' ' ASP . . . . . 0.419 ' O ' ' OE2' ' B' ' 133' ' ' GLU . 26.3 t0 -62.0 -42.9 99.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 75.23 109.183 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -91.6 4.54 52.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.368 -0.833 . . . . 72.43 108.951 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.419 ' OE2' ' O ' ' B' ' 131' ' ' ASP . 28.8 mp0 49.32 64.29 1.8 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.098 -1.001 . . . . 75.13 109.405 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -159.43 140.3 12.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.093 -1.004 . . . . 73.22 109.997 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 63.7 mt -118.98 137.23 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.631 -0.877 . . . . 64.14 108.631 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 15.2 mt -121.59 129.78 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.606 -0.684 . . . . 71.22 109.896 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -139.94 144.59 37.16 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.445 -0.784 . . . . 64.22 109.202 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 48.9 mttp 55.19 19.65 3.0 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.932 -0.766 . . . . 72.02 108.932 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.33 2.54 90.62 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.243 -1.143 . . . . 74.32 110.243 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 140' ' ' ARG . . . . . 0.405 ' HD2' ' N ' ' B' ' 140' ' ' ARG . 10.0 mmm-85 -89.85 129.13 36.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.249 . . . . 75.34 108.931 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -91.97 121.04 33.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.269 -0.894 . . . . 71.23 109.194 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 89.2 t -135.01 132.77 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.338 -0.851 . . . . 70.43 109.786 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -97.32 154.79 17.21 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.289 -0.882 . . . . 72.43 108.724 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 4.5 m -134.01 132.76 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.298 -0.876 . . . . 72.13 109.794 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 145' ' ' LYS . . . . . 0.527 ' N ' ' CD ' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -159.77 130.21 5.65 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.365 -0.834 . . . . 72.02 109.313 179.796 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 143.63 -120.63 1.52 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 108.946 -1.662 . . . . 42.23 108.946 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 0.592 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 22.3 mtmt -101.86 -35.83 0.22 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.457 -1.026 . . . . 73.3 111.072 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 148' ' ' PRO . . . . . 0.932 ' O ' HD13 ' B' ' 152' ' ' LEU . 44.6 Cg_endo -92.56 8.92 2.69 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 122.264 1.976 . . . . 71.33 113.538 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 149' ' ' PHE . . . . . 0.46 ' CG ' ' N ' ' B' ' 150' ' ' GLU . 3.5 p90 -87.28 -40.71 14.26 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.732 -1.23 . . . . 74.23 110.215 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 150' ' ' GLU . . . . . 0.46 ' N ' ' CG ' ' B' ' 149' ' ' PHE . 16.4 pt-20 -69.08 -33.4 73.48 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.391 -0.818 . . . . 72.34 110.512 -178.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.722 HG13 HD12 ' B' ' 152' ' ' LEU . 12.5 p -67.66 -39.14 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.822 -1.173 . . . . 73.35 109.039 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.932 HD13 ' O ' ' B' ' 148' ' ' PRO . 9.6 mp -59.78 -53.04 62.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.377 -0.827 . . . . 55.24 109.475 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -72.75 -30.61 64.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.318 -0.864 . . . . 70.01 111.144 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -59.84 -52.08 66.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.606 -1.309 . . . . 65.32 109.995 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 pp -71.97 -29.53 64.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.943 -1.098 . . . . 71.54 110.001 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.77 -50.26 72.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.017 -1.052 . . . . 75.32 110.068 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.487 ' C ' ' H ' ' B' ' 159' ' ' ARG . 68.9 mtp180 -72.99 -57.0 4.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.177 -0.952 . . . . 73.32 109.657 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 158' ' ' HIS . . . . . 0.413 ' CE1' ' OE1' ' B' ' 161' ' ' GLN . 35.0 t-80 -61.21 1.73 0.17 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.368 -0.832 . . . . 74.14 109.704 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 159' ' ' ARG . . . . . 1.636 HH21 ' CA ' ' B' ' 216' ' ' TYR . 26.7 ttt180 -53.09 165.39 0.32 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.119 -0.988 . . . . 61.41 109.881 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 160' ' ' ASP . . . . . 0.834 ' OD1' ' HG2' ' B' ' 159' ' ' ARG . 2.7 m-20 61.25 43.33 10.98 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.71 -0.619 . . . . 72.1 110.175 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 161' ' ' GLN . . . . . 0.413 ' OE1' ' CE1' ' B' ' 158' ' ' HIS . 62.3 mt-30 -157.21 175.42 14.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.058 -1.026 . . . . 72.25 109.449 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 77.8 mt -93.6 132.19 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.656 -0.868 . . . . 72.31 108.656 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 96.8 t -128.76 138.6 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.403 -0.811 . . . . 64.21 109.86 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 37.6 t -101.04 169.08 9.19 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.454 -0.779 . . . . 74.22 109.933 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -68.63 -48.49 63.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.519 -0.738 . . . . 65.31 110.088 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.1 -41.88 79.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.295 -0.878 . . . . 63.45 110.791 -178.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 167' ' ' GLN . . . . . 0.425 ' O ' ' OD1' ' B' ' 170' ' ' ASP . 89.9 mt-30 -51.04 -38.51 51.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.048 -1.032 . . . . 72.4 110.072 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 71.9 mt -73.31 -40.53 64.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.994 -1.066 . . . . 72.32 109.635 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.598 ' O ' HD23 ' B' ' 169' ' ' LEU . 1.9 tt -61.62 -42.35 98.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.405 -0.809 . . . . 73.34 109.7 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 170' ' ' ASP . . . . . 0.534 ' O ' ' CH2' ' B' ' 173' ' ' TRP . 22.9 p30 -86.2 -13.54 46.65 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 118.769 -1.172 . . . . 72.1 110.796 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 171' ' ' ALA . . . . . 0.4 ' N ' ' OD1' ' B' ' 170' ' ' ASP . . . -94.52 -38.03 11.1 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.837 -1.164 . . . . 62.13 111.056 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.484 HG22 ' O ' ' B' ' 172' ' ' ILE . 60.6 mt -114.17 -9.98 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.26 -0.9 . . . . 71.42 110.589 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 173' ' ' TRP . . . . . 0.569 ' O ' ' N ' ' B' ' 175' ' ' GLU . 10.2 m95 71.72 -1.8 2.69 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.43 -0.794 . . . . 72.23 109.632 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 63.72 -59.79 0.18 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.947 -0.701 . . . . 52.11 110.662 177.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 175' ' ' GLU . . . . . 0.569 ' N ' ' O ' ' B' ' 173' ' ' TRP . 7.0 mt-10 -149.81 162.78 27.14 Favored Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 107.533 -1.284 . . . . 73.04 107.533 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' B' ' 175' ' ' GLU . 54.5 Cg_exo -34.94 -73.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.231 1.954 . . . . 74.13 111.459 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 177' ' ' GLU . . . . . 0.484 ' C ' ' H ' ' B' ' 179' ' ' VAL . 78.5 mt-10 -157.35 -1.69 0.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -0.926 . . . . 72.44 108.84 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 7.2 tpt -69.37 5.97 1.17 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.529 -0.915 . . . . 63.43 108.529 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 179' ' ' VAL . . . . . 0.484 ' H ' ' C ' ' B' ' 177' ' ' GLU . 7.6 p -46.06 152.52 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.56 -0.713 . . . . 71.05 109.986 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 180' ' ' THR . . . . . 0.536 ' O ' ' N ' ' B' ' 182' ' ' ASN . 3.0 p -135.66 154.49 78.17 Favored Pre-proline 0 N--CA 1.497 1.893 0 N-CA-C 108.687 -0.857 . . . . 62.15 108.687 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -37.18 -23.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 122.31 2.007 . . . . 65.22 112.413 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 182' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' B' ' 180' ' ' THR . 5.7 p30 -149.18 120.31 7.75 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.196 -0.94 . . . . 72.31 109.14 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 3.2 p -156.14 -15.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.259 -0.901 . . . . 63.32 110.868 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.401 ' O ' HG22 ' B' ' 188' ' ' ILE . 29.0 mm -51.47 -31.11 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.738 -1.226 . . . . 75.03 109.502 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -54.59 -34.77 62.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.096 -1.003 . . . . 64.11 108.484 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 2.0 t -80.36 -57.22 5.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.491 -0.755 . . . . 73.0 109.366 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -51.78 -51.65 54.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.119 -0.988 . . . . 61.12 109.715 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 188' ' ' ILE . . . . . 0.582 HD12 ' CZ ' ' B' ' 212' ' ' TYR . 1.7 tt -57.68 -43.35 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.894 -1.129 . . . . 72.43 108.962 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 189' ' ' ASN . . . . . 0.441 ' N ' HG23 ' B' ' 188' ' ' ILE . 24.8 t-20 -62.11 -38.24 88.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.039 -1.038 . . . . 65.14 109.271 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -69.31 -50.47 46.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.922 . . . . 63.24 109.735 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 96.8 mt -53.34 -45.61 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.294 -0.879 . . . . 74.03 109.491 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -59.71 -42.75 93.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.898 . . . . 72.24 109.656 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -68.72 -38.13 79.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -0.944 . . . . 73.1 109.187 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 194' ' ' LYS . . . . . 0.49 ' O ' ' CG ' ' B' ' 198' ' ' PRO . 31.0 mttp -71.32 -13.24 61.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.371 -0.831 . . . . 72.11 109.24 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 30.0 mmm -101.47 -33.29 10.02 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.398 -0.814 . . . . 44.33 109.519 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -82.85 -12.5 57.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.097 -1.002 . . . . 71.21 110.454 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 197' ' ' LYS . . . . . 0.449 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 34.2 mttm -89.46 -65.95 0.16 Allowed Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 120.855 -1.153 . . . . 75.21 109.907 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 198' ' ' PRO . . . . . 0.49 ' CG ' ' O ' ' B' ' 194' ' ' LYS . 36.7 Cg_endo -63.56 -70.13 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.968 1.779 . . . . 75.32 112.122 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 199' ' ' LEU . . . . . 0.512 ' H ' HD12 ' B' ' 199' ' ' LEU . 7.6 mp -55.81 -38.82 70.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.116 -0.99 . . . . 72.25 108.777 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 77.69 5.63 86.39 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.792 -1.323 . . . . 64.53 109.792 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 16.1 mt -132.83 140.13 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.377 -1.072 . . . . 44.23 109.338 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 13.1 t -78.0 147.47 34.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 54.01 109.261 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 1.4 p -145.47 24.53 1.4 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.196 -0.94 . . . . 74.4 109.443 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 19.9 m -139.82 146.33 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.201 -0.937 . . . . 72.12 109.791 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -119.45 132.54 55.82 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.83 -0.804 . . . . 65.41 108.83 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 31.1 p -103.27 127.32 50.63 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.252 -0.905 . . . . 71.33 109.74 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 12.8 p -144.59 143.22 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.198 -0.939 . . . . 63.5 109.248 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 24.1 mtm105 -86.7 101.9 13.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.2 -0.938 . . . . 74.45 109.757 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -171.54 -76.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.378 -0.826 . . . . 74.14 108.82 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -107.56 -42.47 4.77 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.993 -0.743 . . . . 74.43 108.993 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 173.11 -119.8 0.78 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.408 -1.477 . . . . 64.45 109.408 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 212' ' ' TYR . . . . . 0.582 ' CZ ' HD12 ' B' ' 188' ' ' ILE . 8.1 m-85 -129.71 156.66 43.92 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.468 -1.019 . . . . 74.21 109.17 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 52.4 mmt-85 -111.32 144.71 40.07 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.539 -0.725 . . . . 74.03 109.319 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -119.63 114.27 21.95 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.611 -0.681 . . . . 74.34 109.165 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 91.3 m -148.45 170.34 18.24 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.25 -0.906 . . . . 64.33 109.614 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 216' ' ' TYR . . . . . 1.636 ' CA ' HH21 ' B' ' 159' ' ' ARG . 38.0 p90 -74.27 150.58 87.5 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 70.04 109.513 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 217' ' ' PRO . . . . . 0.939 ' HD3' HH22 ' B' ' 159' ' ' ARG . 67.1 Cg_exo -37.2 156.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.358 2.039 . . . . 65.11 112.46 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.449 ' CB ' ' CD ' ' B' ' 219' ' ' PRO . 2.7 mptm? -65.18 -64.95 2.17 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.336 -0.853 . . . . 73.15 109.806 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 219' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' B' ' 218' ' ' LYS . 30.1 Cg_endo -60.94 -33.35 92.54 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.257 1.971 . . . . 71.31 112.295 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 54.94 26.51 7.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.108 -0.995 . . . . 75.45 109.391 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 4.5 t 62.8 40.73 9.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 72.22 109.349 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -81.56 149.8 28.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 54.53 109.657 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.951 -1.024 . . . . 71.13 109.337 179.664 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.577 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.409 -0.589 . . . . 65.12 109.409 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.751 ' HE ' HH21 ' A' ' 43' ' ' ARG . 81.2 mtt85 -136.34 150.19 48.74 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.376 -0.828 . . . . 72.33 109.358 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.3 t -113.76 129.42 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 121.576 0.703 . . . . 71.42 109.982 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.507 HD11 ' CG1' ' A' ' 6' ' ' ILE . 2.6 tp -98.25 118.45 34.93 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.37 -0.974 . . . . 65.12 108.37 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.417 ' N ' HD12 ' A' ' 4' ' ' LEU . 5.8 tp -119.09 108.46 14.73 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.612 -0.68 . . . . 62.43 109.31 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.507 ' CG1' HD11 ' A' ' 4' ' ' LEU . 46.3 mt -101.2 109.72 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.514 -0.921 . . . . 71.15 108.514 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.426 ' OE1' ' CB ' ' A' ' 51' ' ' SER . 24.7 tp10 -137.96 123.69 19.89 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.437 -0.789 . . . . 75.34 109.452 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.1 tptt -68.66 -31.29 70.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.24 -0.912 . . . . 72.44 108.771 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -86.23 122.41 30.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.429 -0.794 . . . . 63.02 109.367 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.4 m -74.62 -20.7 59.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 72.34 109.728 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.2 t -71.38 -55.7 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.183 -0.948 . . . . 74.02 109.872 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.558 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.5 mm? -67.85 -35.72 79.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.219 -0.926 . . . . 71.43 109.519 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.36 -31.07 57.63 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.758 -1.737 . . . . 61.32 108.758 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.98 -48.42 76.04 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.953 -1.259 . . . . 71.2 109.953 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -64.04 -46.65 83.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -1.174 . . . . 71.32 109.882 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.3 mm -64.65 -48.54 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.778 -1.201 . . . . 63.23 109.175 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -46.28 -56.93 5.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.182 -0.949 . . . . 51.11 109.812 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -84.47 3.01 38.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.17 -0.956 . . . . 73.34 109.305 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.02 -65.95 1.71 Allowed Glycine 0 N--CA 1.483 1.786 0 N-CA-C 109.899 -1.28 . . . . 62.15 109.899 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.532 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.5 pt? -66.53 -23.39 66.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -1.173 . . . . 73.51 110.081 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -56.69 -35.95 69.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -0.991 . . . . 74.25 109.872 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 87.5 t -56.1 -39.36 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.164 -0.96 . . . . 70.04 109.579 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HZ2' HG11 ' A' ' 106' ' ' VAL . 1.7 mptm? -63.63 -12.43 33.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 73.23 109.322 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.61 37.78 4.13 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.263 -1.135 . . . . 75.54 110.263 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -119.61 160.71 21.95 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.477 -1.013 . . . . 73.43 109.263 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.4 mmt -100.86 138.97 37.2 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.257 -1.016 . . . . 43.24 108.257 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.24 159.67 41.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.25 -0.906 . . . . 62.11 109.974 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -135.94 144.88 45.69 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.512 -0.742 . . . . 74.42 109.042 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.5 131.34 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.458 -0.776 . . . . 72.15 108.911 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.8 p -134.74 169.67 16.99 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.449 -0.782 . . . . 71.42 109.379 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -93.41 -103.22 0.13 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.304 -0.872 . . . . 72.33 109.718 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 t -78.78 166.83 22.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 74.24 110.012 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.401 HD22 ' CG ' ' A' ' 58' ' ' PHE . 20.4 mt -54.37 -31.94 55.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.552 -0.718 . . . . 71.53 109.82 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.16 -48.75 44.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 74.23 109.513 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.02 -38.32 90.72 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.156 -0.965 . . . . 54.03 108.914 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.85 -37.06 92.97 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.296 -1.522 . . . . 61.41 109.296 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -68.35 -42.91 78.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 74.34 109.462 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -71.78 -37.67 70.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 75.33 109.906 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.8 tp -75.9 -46.01 32.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 74.33 110.308 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.484 ' SD ' ' OD1' ' A' ' 41' ' ' ASP . 3.5 ppp? -65.24 -32.24 73.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.045 -1.034 . . . . 70.32 110.177 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.484 ' OD1' ' SD ' ' A' ' 40' ' ' MET . 87.1 m-20 -62.68 -39.58 94.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.067 -1.021 . . . . 71.22 110.03 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.4 HG12 ' H ' ' A' ' 42' ' ' ILE . 25.8 pt -82.31 -29.44 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.066 -1.021 . . . . 74.14 110.176 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.751 HH21 ' HE ' ' A' ' 2' ' ' ARG . 73.6 mtp180 -130.07 140.51 50.82 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.342 -0.849 . . . . 72.24 109.596 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -90.25 157.66 17.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.214 -0.929 . . . . 75.42 109.488 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -138.04 150.89 47.34 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.391 -0.818 . . . . 74.23 109.345 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 2' ' ' ARG . 7.9 p-10 -95.21 -40.25 9.67 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.175 -0.953 . . . . 72.04 109.463 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.462 ' C ' HD13 ' A' ' 47' ' ' LEU . 0.5 OUTLIER -102.97 109.66 21.29 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.397 -0.814 . . . . 72.13 109.059 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.445 ' N ' HD13 ' A' ' 47' ' ' LEU . 78.7 t -95.08 97.67 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.193 -0.942 . . . . 72.34 108.616 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.1 ttm -111.44 131.51 55.15 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.481 -0.762 . . . . 74.11 109.595 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.451 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 1.3 p -141.0 133.0 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.479 -0.763 . . . . 61.12 109.818 -179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.426 ' CB ' ' OE1' ' A' ' 7' ' ' GLU . 59.9 p -100.85 7.01 43.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.608 -0.683 . . . . 73.11 109.538 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 84.7 m-20 -76.04 141.12 42.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.135 -0.978 . . . . 52.55 109.465 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.494 ' C ' ' H ' ' A' ' 55' ' ' ALA . 68.0 mttm -73.43 -44.64 57.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.29 -0.881 . . . . 44.22 110.435 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -71.02 15.47 0.11 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.107 -0.996 . . . . 70.44 109.807 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -74.97 -21.61 59.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 64.14 110.334 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.703 ' HB3' HE22 ' A' ' 89' ' ' GLN . 19.0 mt -40.49 -52.96 2.75 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.499 -0.751 . . . . 44.14 110.357 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.9 m -67.2 -32.86 74.2 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.053 -1.029 . . . . 55.23 109.141 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.523 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 63.0 t80 -66.06 -52.95 44.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.479 -0.763 . . . . 74.44 110.313 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 m -57.74 -34.57 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.701 -1.249 . . . . 74.03 109.709 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.1 m -59.02 -55.51 34.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.112 -0.993 . . . . 64.3 109.625 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -63.21 -28.08 69.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 64.44 110.142 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.523 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 5.2 mm -66.6 -31.79 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.951 -1.093 . . . . 63.21 109.898 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.525 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 23.1 mmtt -77.12 -50.23 13.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.057 -1.027 . . . . 74.42 110.267 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -67.62 -41.21 84.3 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.754 -1.217 . . . . 70.32 109.87 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.521 ' O ' ' NZ ' ' A' ' 145' ' ' LYS . 9.1 mtpm? -72.5 -26.24 61.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 75.22 109.75 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.564 ' O ' HG22 ' A' ' 69' ' ' ILE . 93.2 m-70 -153.19 65.93 0.77 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.16 -0.963 . . . . 74.13 109.301 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.476 ' N ' ' O ' ' A' ' 63' ' ' LYS . 18.0 m -56.45 -32.43 64.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 73.24 110.055 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 83.3 p -73.17 47.02 0.19 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 61.01 110.049 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 66' ' ' HIS . 13.5 tt -146.48 159.07 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.051 -1.031 . . . . 71.33 109.45 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.5 t -95.57 154.26 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.12 -0.987 . . . . 72.13 109.106 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.433 ' H ' ' HB2' ' A' ' 92' ' ' ASP . 15.4 t -142.66 118.69 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.123 -0.985 . . . . 54.21 109.823 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.572 ' HG ' HD11 ' A' ' 95' ' ' ILE . 1.6 mp -119.23 99.57 6.79 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.624 -0.88 . . . . 50.24 108.624 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.8 p -94.3 152.99 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.255 -1.017 . . . . 74.41 108.255 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.08 169.94 9.26 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.443 -0.785 . . . . 72.31 108.912 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.2 t -168.39 123.7 0.96 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.177 -0.952 . . . . 64.54 110.159 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 0.4 OUTLIER -76.12 15.84 0.51 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.466 -0.771 . . . . 74.13 110.024 -179.082 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.407 ' O ' ' N ' ' A' ' 79' ' ' THR . 30.7 m120 -139.88 58.61 11.65 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.152 -0.967 . . . . 73.34 110.115 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.44 84.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.393 2.062 . . . . 63.22 112.452 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 81' ' ' GLU . 28.7 m -106.81 149.73 27.07 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.143 -1.058 . . . . 62.53 108.143 178.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.04 -32.16 71.78 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.008 -1.057 . . . . 73.44 109.367 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.423 ' H ' HG22 ' A' ' 79' ' ' THR . 44.1 tp10 -64.44 -43.13 95.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.119 -0.988 . . . . 71.42 109.294 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -76.64 -35.74 57.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 73.43 109.602 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -57.74 -56.77 17.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.237 -0.914 . . . . 74.22 109.67 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.475 HG23 ' N ' ' A' ' 85' ' ' HIS . 25.4 m -61.55 -39.75 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.131 -0.981 . . . . 73.2 109.273 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.475 ' N ' HG23 ' A' ' 84' ' ' VAL . 72.7 t60 -60.22 -36.97 78.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.214 -0.929 . . . . 53.33 109.554 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.53 -45.83 88.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.195 -0.941 . . . . 64.11 109.829 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.615 ' CZ ' ' NH1' ' B' ' 108' ' ' ARG . 77.1 m-85 -74.96 -27.92 60.37 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.171 -0.955 . . . . 74.34 108.722 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -69.88 -50.23 44.54 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.521 -0.737 . . . . 74.42 109.297 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.703 HE22 ' HB3' ' A' ' 56' ' ' LEU . 29.6 mt-30 -58.01 -49.64 76.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.512 -0.742 . . . . 74.24 110.003 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 153.8 -10.76 0.5 Allowed Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.423 -1.37 . . . . 61.51 110.738 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.8 139.5 16.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.812 -1.405 . . . . 55.33 109.373 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.525 ' OD1' ' NZ ' ' A' ' 63' ' ' LYS . 11.4 m-20 -76.08 -40.01 54.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.103 -0.998 . . . . 73.42 109.32 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 94' ' ' TYR . 56.8 t0 -153.09 157.12 39.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.259 -0.9 . . . . 75.04 109.47 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.539 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -128.38 133.94 48.73 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.791 -0.818 . . . . 71.33 108.791 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.817 ' N ' HD12 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -122.39 138.67 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 121.717 0.77 . . . . 71.13 110.242 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.8 119.98 8.15 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.027 -1.101 . . . . 64.32 108.027 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.694 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -43.95 -54.39 11.18 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 62.2 111.501 -178.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -38.51 -13.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 121.198 1.266 . . . . 73.11 113.202 -176.465 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.694 ' N ' ' O ' ' A' ' 97' ' ' LYS . 57.6 m-85 56.32 100.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.632 -0.668 . . . . 65.22 110.039 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.0 mtt85 -55.7 -42.87 75.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.786 -1.197 . . . . 72.35 108.21 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.3 t -169.1 132.23 1.31 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.855 -0.794 . . . . 71.32 108.855 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 62.4 mt -51.32 -43.8 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.148 -0.97 . . . . 75.43 109.327 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.417 ' CD ' ' N ' ' A' ' 103' ' ' LYS . 3.4 mptp? -62.07 -35.07 77.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 71.41 109.611 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.24 -55.82 10.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.13 -0.982 . . . . 63.24 109.883 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.4 tp -57.84 -56.75 17.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 73.22 109.702 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.553 HG11 ' HZ2' ' A' ' 23' ' ' LYS . 74.1 t -53.15 -43.71 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.971 -1.081 . . . . 60.11 109.546 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.55 -43.1 64.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.14 -0.975 . . . . 70.42 108.913 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -66.81 -37.1 83.87 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.362 -0.836 . . . . 74.41 109.333 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 65.1 mt -66.94 -33.82 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 107.879 -1.156 . . . . 62.54 107.879 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -59.6 -42.83 93.49 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.368 -0.975 . . . . 74.34 108.368 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.417 ' HB2' ' CZ ' ' B' ' 87' ' ' PHE . . . -57.61 -50.33 73.5 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.354 -0.841 . . . . 73.32 109.497 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -59.16 -50.77 72.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.209 -0.932 . . . . 52.41 109.622 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.507 ' O ' ' CE2' ' A' ' 116' ' ' TRP . 53.2 mt -64.98 -36.61 84.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.046 -1.034 . . . . 65.24 109.646 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -56.34 -36.88 69.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -0.891 . . . . 64.45 109.595 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -78.2 54.6 1.39 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 74.43 109.431 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.507 ' CE2' ' O ' ' A' ' 113' ' ' LEU . 7.2 m-90 -59.66 148.74 32.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.928 . . . . 74.42 109.478 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -50.84 127.29 27.68 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.702 -1.359 . . . . 75.04 109.702 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.2 t -85.96 3.23 42.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -1.134 . . . . 61.14 109.424 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.487 ' CG ' ' H ' ' A' ' 120' ' ' VAL . 47.4 t30 52.53 -179.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 65.24 109.413 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.487 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 5.3 t -141.97 -45.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.304 -0.872 . . . . 73.11 109.61 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.0 mm -98.59 125.38 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.191 -0.943 . . . . 72.24 109.281 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.474 ' CD ' ' N ' ' A' ' 122' ' ' GLU . 1.3 pm0 -134.05 108.87 8.6 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.499 -0.751 . . . . 72.34 108.976 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.438 ' O ' HG23 ' A' ' 123' ' ' ILE . 18.2 tt -134.88 131.08 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.466 -0.771 . . . . 71.44 109.113 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.08 -145.83 5.47 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.576 -1.409 . . . . 73.4 109.576 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -85.75 -0.62 55.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -1.185 . . . . 74.45 109.331 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.92 130.52 44.21 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.51 -0.922 . . . . 54.21 108.51 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.474 ' CG2' ' ND2' ' A' ' 119' ' ' ASN . 32.1 m -130.45 129.37 42.9 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.353 -0.842 . . . . 54.5 109.571 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 27.1 mm -113.67 133.3 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.414 -0.804 . . . . 45.15 109.195 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.5 m -115.87 96.59 47.2 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 109.13 -0.692 . . . . 71.11 109.13 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -78.46 -37.07 0.77 Allowed 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 121.839 1.693 . . . . 65.41 111.943 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -68.18 -43.51 77.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 63.32 109.255 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -90.23 -1.87 57.98 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.375 -0.828 . . . . 72.52 109.416 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 52.97 62.41 2.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.354 -0.841 . . . . 75.33 109.972 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -150.22 140.59 22.34 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.271 -0.893 . . . . 71.23 109.085 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 7.3 tt -121.68 135.32 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 108.93 -0.767 . . . . 74.02 108.93 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 136' ' ' ILE . 14.8 mt -116.71 129.32 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.65 -0.656 . . . . 60.23 109.561 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.439 ' CE2' ' O ' ' A' ' 198' ' ' PRO . 54.8 t80 -138.46 138.05 37.76 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.589 -0.694 . . . . 62.32 109.199 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm 53.35 31.07 11.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.365 -0.834 . . . . 75.4 110.1 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 73.94 15.22 79.76 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 120.051 -1.071 . . . . 72.24 110.456 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -107.52 125.23 51.02 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.401 -1.058 . . . . 71.22 109.342 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -95.04 126.18 40.21 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.269 -0.894 . . . . 71.42 109.704 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.9 p -137.85 140.79 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.375 -0.828 . . . . 53.02 109.254 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -85.51 144.44 27.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.3 -0.875 . . . . 60.45 109.314 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.424 HG21 ' CD1' ' A' ' 149' ' ' PHE . 16.2 m -147.29 137.16 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.242 -0.911 . . . . 74.44 109.539 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.521 ' NZ ' ' O ' ' A' ' 65' ' ' LYS . 43.7 pttt -156.59 20.36 0.34 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -0.861 . . . . 65.15 109.495 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.48 -178.92 51.73 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.297 -1.521 . . . . 73.34 109.297 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 13.5 ttmt -64.76 -39.89 43.27 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.185 -1.186 . . . . 72.22 109.82 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 25.4 Cg_exo -62.18 -24.63 76.44 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.324 2.016 . . . . 65.23 112.098 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.576 ' CZ ' ' CG2' ' A' ' 153' ' ' THR . 59.0 t80 -82.27 -42.02 19.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.13 -0.981 . . . . 60.11 110.003 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.466 ' O ' ' ND1' ' A' ' 154' ' ' HIS . 80.8 mm-40 -50.11 -45.47 52.89 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.134 -0.979 . . . . 64.21 109.36 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.8 p -72.05 -35.08 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.215 -0.928 . . . . 72.02 109.099 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 15.0 tp -60.5 -38.0 82.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 73.31 109.159 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.576 ' CG2' ' CZ ' ' A' ' 149' ' ' PHE . 16.8 p -71.74 -41.89 67.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.315 -0.865 . . . . 74.31 109.8 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.818 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 34.2 m80 -53.24 -51.62 61.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.31 -0.869 . . . . 74.31 110.038 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 pp -73.27 -24.38 60.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.932 -1.105 . . . . 75.34 109.601 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.4 -53.58 56.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.135 -0.978 . . . . 62.14 109.268 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 1.09 ' HG3' ' ND1' ' A' ' 158' ' ' HIS . 13.6 ptm180 -68.43 -34.95 76.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.913 . . . . 61.03 109.069 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 1.09 ' ND1' ' HG3' ' A' ' 157' ' ' ARG . 15.9 m80 -94.95 64.75 2.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.342 -0.849 . . . . 74.12 109.083 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.52 ' NH1' ' OG1' ' A' ' 203' ' ' THR . 2.1 tpm_? -81.22 -3.01 50.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.868 . . . . 71.13 110.173 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.514 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 57.4 p30 -144.85 57.67 1.29 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.987 -1.07 . . . . 75.45 110.075 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 160' ' ' ASP . 89.1 mm-40 -148.87 179.72 7.64 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.207 -0.933 . . . . 73.41 109.211 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 68.0 mt -105.64 123.48 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.896 -0.779 . . . . 74.41 108.896 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 72.9 t -117.41 130.27 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.48 -0.762 . . . . 72.31 109.472 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 86.1 p -97.05 159.29 14.99 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.286 -0.884 . . . . 74.12 109.483 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -60.14 -44.28 95.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 70.43 109.632 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -55.72 -33.33 64.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 73.52 109.252 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.427 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 61.8 tt0 -61.49 -46.21 90.99 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.277 -0.889 . . . . 74.52 109.295 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 34.1 mt -59.54 -30.88 68.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 72.31 108.886 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.401 HD23 ' C ' ' A' ' 169' ' ' LEU . 3.4 tt -66.93 -74.38 0.11 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 53.33 109.608 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 167' ' ' GLN . 59.1 p30 -55.82 -8.45 0.42 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.504 -0.747 . . . . 62.44 111.063 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.21 -52.57 4.13 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.869 -1.144 . . . . 60.21 112.282 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.492 ' C ' ' H ' ' A' ' 174' ' ' GLU . 4.6 mp -99.31 -41.04 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 O-C-N 120.82 -1.175 . . . . 75.32 112.077 -177.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.503 ' CD2' ' C ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -63.02 2.64 0.31 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.39 -1.444 . . . . 73.14 109.081 -178.852 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.492 ' H ' ' C ' ' A' ' 172' ' ' ILE . 2.9 pp20? -50.01 -15.96 0.25 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.081 -1.012 . . . . 73.24 109.506 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 177' ' ' GLU . 0.7 OUTLIER -53.74 -176.5 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 108.2 -1.037 . . . . 44.43 108.2 179.583 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 175' ' ' GLU . 31.4 Cg_exo -59.4 35.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 122.549 2.166 . . . . 72.51 112.664 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 175' ' ' GLU . 96.0 mt-10 48.17 -160.18 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.118 -0.989 . . . . 63.24 109.783 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.493 ' O ' ' SD ' ' A' ' 178' ' ' MET . 0.5 OUTLIER 60.49 52.58 4.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.328 -0.858 . . . . 73.5 108.903 -179.748 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.417 ' O ' ' OG1' ' A' ' 180' ' ' THR . 4.4 m -137.43 36.18 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.361 -0.837 . . . . 65.22 109.281 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.462 ' O ' HG12 ' A' ' 183' ' ' VAL . 3.0 p 47.27 78.38 0.4 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 71.42 109.46 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -46.54 -32.68 11.83 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.554 2.169 . . . . 41.22 112.545 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -74.54 -12.25 60.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.072 -1.018 . . . . 64.54 109.495 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 180' ' ' THR . 8.5 p -55.88 -14.27 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 74.02 109.935 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 96.0 mt -51.64 -42.4 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.942 . . . . 72.33 109.962 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.446 ' CG ' ' N ' ' A' ' 186' ' ' VAL . 19.8 pt-20 -61.63 -43.79 98.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.041 -1.037 . . . . 74.4 109.446 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' VAL . . . . . 0.446 ' N ' ' CG ' ' A' ' 185' ' ' GLU . 94.0 t -71.27 -30.41 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 70.42 109.292 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.12 -56.09 6.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.383 -0.823 . . . . 52.11 109.913 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.1 -26.29 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.809 -1.182 . . . . 71.4 109.631 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -73.45 -55.58 6.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.988 . . . . 73.44 109.962 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -68.2 -40.27 82.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.128 -0.983 . . . . 71.42 109.876 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 73.5 mt -55.68 -49.25 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.001 -1.062 . . . . 61.55 109.253 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 75.9 mtp85 -57.75 -44.69 86.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -0.977 . . . . 63.34 109.541 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -66.56 -36.85 83.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.893 . . . . 61.24 109.698 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.482 ' O ' ' CG ' ' A' ' 198' ' ' PRO . 16.4 mtpp -84.52 -2.41 57.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.913 . . . . 75.13 109.784 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 50.6 ttm -89.62 -28.41 19.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.182 -0.949 . . . . 74.02 109.555 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 197' ' ' LYS . 46.4 p30 -102.35 -10.95 19.02 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.251 -0.905 . . . . 74.02 110.303 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.576 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 14.6 tttt -77.59 -43.21 2.47 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.92 -1.113 . . . . 75.43 109.74 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 25.9 Cg_endo -88.18 -32.46 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.624 2.216 . . . . 72.32 112.304 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.644 HD22 ' N ' ' A' ' 199' ' ' LEU . 3.1 mm? -85.77 -98.31 0.07 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.913 -1.117 . . . . 74.54 109.211 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 152.2 -33.18 0.86 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.496 -1.441 . . . . 61.51 109.496 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 66.2 mt -96.4 128.93 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.291 -1.123 . . . . 61.22 109.529 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 25.0 p -79.87 132.74 36.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 72.0 108.962 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.52 ' OG1' ' NH1' ' A' ' 159' ' ' ARG . 5.2 p -141.69 40.25 1.7 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.293 -0.88 . . . . 74.44 109.666 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 17.1 m -138.96 139.03 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.325 -0.859 . . . . 64.35 109.333 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -125.41 129.17 49.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.536 -0.727 . . . . 71.41 109.174 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.08 140.85 37.19 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.349 -0.845 . . . . 73.52 109.32 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 10.5 p -139.65 141.47 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.299 -0.876 . . . . 71.02 109.332 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -92.61 52.89 1.96 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.234 -0.916 . . . . 72.12 109.542 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -146.24 -8.45 0.52 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.167 -0.958 . . . . 64.41 109.437 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -159.7 -69.0 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.186 -0.947 . . . . 71.54 109.327 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -172.31 -119.21 0.51 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.569 -1.413 . . . . 72.03 109.569 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -123.15 129.8 51.91 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.582 -0.952 . . . . 75.54 109.258 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -103.74 129.66 51.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.453 -0.78 . . . . 75.31 109.663 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -95.36 123.74 39.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.289 -0.882 . . . . 75.41 108.67 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 26.8 p -126.4 170.29 12.1 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 121.608 0.718 . . . . 74.14 110.32 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -78.43 140.55 60.34 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.899 -0.778 . . . . 75.32 108.899 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -37.7 136.02 0.48 Allowed 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.06 1.84 . . . . 73.11 112.493 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.622 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 22.4 mttp -78.15 -36.54 1.34 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 75.25 110.489 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 47.4 Cg_exo -56.08 -19.09 25.32 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.086 1.857 . . . . 75.1 112.052 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -63.0 146.87 52.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.322 -0.861 . . . . 71.14 109.346 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 16.7 t -155.56 -53.12 0.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.189 -0.945 . . . . 71.13 109.478 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 38.4 mp0 46.47 -111.12 0.31 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 75.35 109.68 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 118.015 -0.993 . . . . 73.41 109.495 -179.998 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 50.9 ttm . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.46 -0.57 . . . . 71.14 109.46 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -137.52 139.86 40.77 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.43 -0.794 . . . . 73.23 109.281 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.9 t -112.07 135.14 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.657 -0.652 . . . . 72.24 109.434 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.12 119.18 38.67 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.546 -0.721 . . . . 54.33 110.028 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 19.8 mt -118.55 97.17 5.61 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.644 -0.872 . . . . 74.35 108.644 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.416 HD12 ' HB ' ' B' ' 50' ' ' VAL . 66.8 mt -84.16 96.99 4.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.749 -1.219 . . . . 42.55 108.588 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.428 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 26.4 tp10 -134.03 132.1 39.64 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.494 -0.753 . . . . 74.52 109.375 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.7 -32.93 74.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 62.55 109.353 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' ASN . . . . . 0.403 ' H ' ' HG3' ' B' ' 7' ' ' GLU . 79.1 m-20 -82.92 117.24 22.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 73.11 109.399 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 19.8 m -75.98 -32.27 59.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 65.54 110.026 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' VAL . . . . . 0.552 HG13 ' N ' ' B' ' 12' ' ' LEU . 8.9 p -60.02 -45.11 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.071 -1.018 . . . . 75.55 109.908 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.552 ' N ' HG13 ' B' ' 11' ' ' VAL . 77.2 mt -66.02 -35.44 80.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.012 -1.055 . . . . 70.14 109.349 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.5 -27.34 67.81 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.63 -1.788 . . . . 75.4 108.63 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.79 -54.94 25.28 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.603 -1.399 . . . . 65.44 109.603 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' B' ' 15' ' ' GLU . 12.8 pt-20 -58.39 -44.38 88.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.351 -1.088 . . . . 60.21 109.652 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 65.8 mt -65.94 -39.26 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.956 -1.09 . . . . 75.15 108.936 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -59.69 -43.89 93.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.254 -0.904 . . . . 73.01 109.065 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -85.32 -1.6 57.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.184 -0.947 . . . . 74.3 109.109 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -85.11 -59.61 1.94 Allowed Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.695 -1.362 . . . . 70.54 109.695 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -68.55 -21.35 64.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -1.175 . . . . 71.34 109.707 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 38.2 m-20 -51.79 -33.73 36.77 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.073 -1.017 . . . . 64.41 109.324 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 91.1 t -56.94 -36.82 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.179 -0.95 . . . . 74.23 108.904 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.402 ' N ' ' CD ' ' B' ' 23' ' ' LYS . 12.2 mptt -72.44 -13.12 61.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.442 -0.786 . . . . 63.42 109.212 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.52 39.25 6.35 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.045 -1.222 . . . . 53.43 110.045 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -119.23 159.94 23.12 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.515 -0.991 . . . . 71.12 109.18 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 48.4 mmm -106.03 140.65 38.69 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.721 -0.844 . . . . 75.24 108.721 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.413 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -137.83 155.54 48.88 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.392 -0.817 . . . . 72.12 109.995 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 88.5 m-20 -136.41 157.23 47.29 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.424 -0.954 . . . . 72.31 108.424 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 p -122.19 139.12 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.404 -0.81 . . . . 64.43 109.749 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 2.6 p -138.05 173.49 11.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.521 -0.737 . . . . 65.41 109.416 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -98.52 -98.67 0.22 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.362 -0.836 . . . . 71.02 109.753 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 14.0 t -78.77 164.81 24.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.223 -0.923 . . . . 51.11 110.12 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 50.6 mt -53.06 -36.99 61.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.669 -0.644 . . . . 71.24 110.086 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.58 ' H ' ' CD ' ' B' ' 34' ' ' GLU . 45.1 mp0 -53.18 -46.49 68.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 74.32 109.964 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -61.42 -38.57 87.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.117 -0.989 . . . . 73.03 109.274 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.34 -33.75 87.5 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.331 -1.508 . . . . 30.21 109.331 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -69.3 -43.95 72.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -1.13 . . . . 74.42 109.743 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 38' ' ' TYR . . . . . 0.437 ' O ' ' OD1' ' B' ' 41' ' ' ASP . 65.9 m-85 -76.27 -22.48 55.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.141 -0.974 . . . . 74.42 110.046 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 60.3 tp -90.04 -34.31 16.0 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.081 -1.012 . . . . 75.41 109.871 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' MET . . . . . 0.445 ' O ' ' O ' ' B' ' 43' ' ' ARG . 2.5 ppp? -79.02 -28.1 43.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.153 -0.967 . . . . 60.41 110.405 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' B' ' 42' ' ' ILE . 39.0 p-10 -62.52 -27.02 68.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.914 -1.116 . . . . 53.23 110.041 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.542 ' N ' ' OD1' ' B' ' 41' ' ' ASP . 11.8 pt -99.27 -10.87 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.184 -0.948 . . . . 71.23 110.411 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' B' ' 40' ' ' MET . 98.6 mtt180 -130.23 155.67 45.88 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.247 -0.908 . . . . 72.22 109.812 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -80.1 169.02 18.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.203 -0.935 . . . . 63.54 109.323 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 1.7 p90 -156.36 92.37 1.32 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.134 -0.979 . . . . 64.35 109.263 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -76.55 -32.27 58.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.082 -1.011 . . . . 62.22 108.909 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.508 ' C ' HD13 ' B' ' 47' ' ' LEU . 0.8 OUTLIER -112.67 108.74 17.9 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.666 -0.865 . . . . 73.12 108.666 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.433 ' N ' HD13 ' B' ' 47' ' ' LEU . 50.4 t -93.7 107.38 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.524 -0.917 . . . . 65.11 108.524 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.9 ttt -125.5 131.58 52.79 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.555 -0.715 . . . . 73.44 109.52 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.644 HG22 ' H ' ' B' ' 52' ' ' ASP . 0.4 OUTLIER -145.87 138.69 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.465 -0.772 . . . . 34.5 109.803 -179.183 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 51' ' ' SER . . . . . 0.428 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 89.4 p -99.68 12.59 36.18 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.491 -0.755 . . . . 73.21 109.828 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.644 ' H ' HG22 ' B' ' 50' ' ' VAL . 42.4 m-20 -81.77 134.37 35.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.073 -1.017 . . . . 70.41 109.561 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -71.3 -34.44 70.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.342 -0.849 . . . . 65.0 110.2 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -76.55 9.76 2.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.061 -1.024 . . . . 75.21 109.722 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' B' ' 56' ' ' LEU . . . -72.87 -21.18 60.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.19 -0.944 . . . . 55.33 110.254 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' B' ' 55' ' ' ALA . 69.5 mt -41.14 -52.7 3.25 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.496 -0.753 . . . . 63.14 110.364 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 19.8 t -65.05 -36.32 83.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.961 -1.087 . . . . 63.5 109.171 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -62.53 -61.76 2.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.327 -0.858 . . . . 72.33 109.649 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 22.4 m -49.75 -31.57 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.523 -1.36 . . . . 74.54 109.645 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.401 ' OG ' ' N ' ' B' ' 61' ' ' ARG . 5.8 p -58.61 -52.15 66.87 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.254 -0.904 . . . . 71.24 109.321 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.401 ' N ' ' OG ' ' B' ' 60' ' ' SER . 2.8 ptp180 -68.61 -31.86 71.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.075 -1.015 . . . . 74.31 110.0 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 40.6 mm -66.16 -40.08 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.723 -1.235 . . . . 72.14 109.879 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -65.83 -48.2 72.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 73.32 110.48 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -72.83 -37.19 67.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.826 -1.171 . . . . 73.12 110.12 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.484 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 66.4 mttm -81.49 -21.11 38.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.152 -0.968 . . . . 72.44 109.856 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.484 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 72.0 m-70 -155.78 66.26 0.6 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.103 -0.998 . . . . 63.31 109.691 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.5 t -62.59 -33.53 75.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.21 -0.931 . . . . 73.1 109.87 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 51.1 m -57.29 -30.34 64.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.211 -0.93 . . . . 71.53 110.073 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 73.3 mt -76.13 153.35 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.112 -0.993 . . . . 74.4 109.532 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.53 HG12 ' N ' ' B' ' 71' ' ' VAL . 72.6 t -90.33 163.47 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.324 -0.86 . . . . 75.12 109.565 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.53 ' N ' HG12 ' B' ' 70' ' ' VAL . 12.9 t -139.81 126.57 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.239 -0.913 . . . . 73.2 109.544 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.688 ' HG ' HD11 ' B' ' 95' ' ' ILE . 1.1 mp -124.94 99.93 6.36 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.727 -0.842 . . . . 73.34 108.727 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 76.0 t -91.15 145.63 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.899 . . . . 73.5 108.72 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 2.4 m -118.68 171.82 7.93 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.414 -0.804 . . . . 64.34 109.044 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.469 ' HG ' ' HH ' ' B' ' 94' ' ' TYR . 27.6 p -162.0 126.74 3.35 Favored 'General case' 0 N--CA 1.506 2.335 0 C-N-CA 118.699 -1.2 . . . . 74.53 111.284 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -65.35 -13.73 59.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.631 -0.668 . . . . 64.5 110.239 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 77' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' B' ' 79' ' ' THR . 10.1 p-10 -129.73 79.44 73.46 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 121.356 -0.84 . . . . 74.25 109.709 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.475 ' HA ' ' HH ' ' B' ' 94' ' ' TYR . 27.8 Cg_exo -57.89 80.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.428 2.085 . . . . 74.43 111.277 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.438 ' N ' ' O ' ' B' ' 77' ' ' ASN . 66.6 p -106.48 151.25 25.21 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.933 -0.766 . . . . 73.12 108.933 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -24.17 61.52 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.37 -0.831 . . . . 71.01 109.32 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -67.93 -38.96 83.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 63.2 109.8 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -76.85 -34.57 57.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.136 -0.978 . . . . 73.22 109.77 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' B' ' 83' ' ' GLU . 0.4 OUTLIER -61.38 -51.58 68.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 74.3 109.635 -179.652 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.507 HG23 ' N ' ' B' ' 85' ' ' HIS . 30.3 m -62.58 -45.81 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.975 -1.078 . . . . 73.31 109.356 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 85' ' ' HIS . . . . . 0.507 ' N ' HG23 ' B' ' 84' ' ' VAL . 18.7 m170 -61.79 -30.9 71.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.137 -0.977 . . . . 73.24 109.2 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -65.69 -39.73 91.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 55.33 109.995 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 87' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 111' ' ' ALA . 79.1 t80 -83.72 -37.89 22.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.032 -1.042 . . . . 74.14 109.315 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -67.34 -41.17 85.65 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.306 -0.871 . . . . 64.04 109.542 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -69.57 -50.64 42.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 72.35 109.556 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 145.6 70.47 0.02 OUTLIER Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.907 -1.277 . . . . 65.2 109.907 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 91' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -129.24 131.25 47.01 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.392 -1.064 . . . . 52.23 108.881 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' B' ' 71' ' ' VAL . 56.8 m-20 -75.54 -35.54 60.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.064 -1.022 . . . . 73.32 109.078 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 93' ' ' ASP . . . . . 0.521 ' OD2' ' NH2' ' B' ' 112' ' ' ARG . 7.3 m-20 -153.89 155.3 35.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.385 -0.822 . . . . 72.22 109.388 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.475 ' HH ' ' HA ' ' B' ' 78' ' ' PRO . 6.3 t80 -123.37 138.76 54.53 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.061 -0.718 . . . . 64.42 109.061 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.813 ' N ' HD12 ' B' ' 95' ' ' ILE . 0.3 OUTLIER -130.1 139.68 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-O 122.069 0.937 . . . . 72.23 110.622 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 96' ' ' ALA . . . . . 0.414 ' HB1' ' HD2' ' B' ' 98' ' ' PRO . . . -59.17 131.98 52.65 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.825 -1.546 . . . . 25.24 106.825 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -61.99 -41.2 74.89 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 120.833 -1.167 . . . . 64.32 110.959 -178.179 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 98' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' B' ' 97' ' ' LYS . 37.3 Cg_exo -54.73 2.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.291 -2.486 0 CA-C-N 118.827 0.617 . . . . 63.33 112.202 -175.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 99' ' ' TYR . . . . . 0.575 ' N ' ' O ' ' B' ' 97' ' ' LYS . 50.4 m-85 54.83 106.56 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.614 -0.679 . . . . 75.13 109.848 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 19.7 ttm180 -61.62 -34.83 76.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 74.23 108.976 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 101' ' ' SER . . . . . 0.762 ' O ' ' N ' ' B' ' 103' ' ' LYS . 43.9 t -174.59 38.8 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.266 -0.896 . . . . 63.34 110.508 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 59.1 mt 50.17 -70.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.656 -0.652 . . . . 74.44 110.311 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.762 ' N ' ' O ' ' B' ' 101' ' ' SER . 9.3 mtpm? -54.32 -21.03 8.28 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.953 -1.129 . . . . 71.11 107.953 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.21 -64.23 0.93 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.073 -0.651 . . . . 71.45 109.983 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 2.5 pp -62.29 -35.22 78.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.036 -1.04 . . . . 51.31 109.787 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 34.4 t -60.75 -44.21 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.876 -1.14 . . . . 65.23 108.605 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.23 -42.62 73.65 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.314 -0.995 . . . . 24.32 108.314 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 0.615 ' NH1' ' CZ ' ' A' ' 87' ' ' PHE . 58.8 mtp85 -64.91 -34.07 77.51 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.412 -0.805 . . . . 75.31 108.974 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 92.4 mt -74.3 -27.69 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.488 -0.93 . . . . 54.24 108.488 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -75.31 -58.17 3.44 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.446 -0.784 . . . . 65.31 109.112 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -48.32 -42.87 32.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 72.24 109.43 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 112' ' ' ARG . . . . . 0.521 ' NH2' ' OD2' ' B' ' 93' ' ' ASP . 50.6 ttm-85 -61.36 -44.14 97.67 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.324 -0.86 . . . . 72.04 109.319 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 41.2 mt -134.8 75.78 1.59 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.43 -0.794 . . . . 75.35 109.313 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -68.1 -54.44 18.12 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.136 -0.978 . . . . 75.5 109.318 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 115' ' ' PHE . . . . . 0.521 ' O ' ' CG ' ' B' ' 116' ' ' TRP . 6.3 t80 -92.18 -76.97 0.44 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.186 -0.946 . . . . 65.33 109.436 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 116' ' ' TRP . . . . . 0.521 ' CG ' ' O ' ' B' ' 115' ' ' PHE . 4.0 m-90 -162.44 -173.22 3.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.053 -1.029 . . . . 74.45 109.294 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.17 176.22 0.93 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.455 -1.458 . . . . 44.21 109.455 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 26.9 m -128.25 178.67 6.08 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.439 -1.036 . . . . 71.4 109.599 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.51 139.63 19.27 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.941 -0.704 . . . . 72.32 109.207 -178.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 14.2 t -86.08 -40.28 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.133 -0.979 . . . . 75.02 109.619 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 18.2 mm -105.57 134.39 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.309 -0.869 . . . . 51.41 108.838 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -157.26 131.16 8.19 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.076 -1.015 . . . . 71.53 109.036 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 3.8 tt -151.77 131.3 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 72.43 108.912 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.13 -143.11 41.34 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.997 -1.641 . . . . 51.23 108.997 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -85.65 3.48 40.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -1.192 . . . . 74.2 109.043 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 mt -92.61 125.88 37.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.352 -0.842 . . . . 75.42 108.741 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 17.4 m -123.77 140.36 53.06 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.153 -1.055 . . . . 74.22 108.153 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 5.0 mt -143.01 131.25 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.023 -1.048 . . . . 60.33 109.92 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 129' ' ' SER . . . . . 0.564 ' HB3' ' OE1' ' B' ' 132' ' ' GLU . 12.4 m -116.3 92.43 36.22 Favored Pre-proline 0 N--CA 1.495 1.814 0 N-CA-C 108.573 -0.899 . . . . 72.31 108.573 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -71.67 -27.91 17.82 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.354 1.369 . . . . 75.13 111.616 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 131' ' ' ASP . . . . . 0.577 ' HB2' ' OE2' ' B' ' 132' ' ' GLU . 74.4 m-20 -66.91 -42.22 85.78 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.144 -0.972 . . . . 75.23 108.88 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 132' ' ' GLU . . . . . 0.577 ' OE2' ' HB2' ' B' ' 131' ' ' ASP . 4.7 mp0 -87.27 6.08 35.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.328 -0.857 . . . . 72.43 109.307 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.556 ' HA ' ' CE1' ' B' ' 149' ' ' PHE . 42.9 mt-10 51.03 54.55 11.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 75.13 109.446 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -150.54 145.97 26.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.212 -0.93 . . . . 73.22 109.527 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 8.3 tt -130.45 142.06 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.502 -0.749 . . . . 64.14 109.513 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 77.3 mt -129.71 124.61 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.525 -0.734 . . . . 71.22 109.561 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 137' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' B' ' 137' ' ' TYR . 18.2 p90 -142.33 152.72 43.21 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.234 -0.916 . . . . 64.22 109.66 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 138' ' ' LYS . . . . . 0.517 ' O ' ' NH1' ' B' ' 140' ' ' ARG . 51.3 mtpt 55.57 14.54 1.24 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.513 -0.742 . . . . 72.02 110.045 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.88 -15.77 58.45 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.144 -1.027 . . . . 74.32 110.587 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 140' ' ' ARG . . . . . 0.517 ' NH1' ' O ' ' B' ' 138' ' ' LYS . 10.3 mpt_? -87.26 143.16 27.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.957 -1.319 . . . . 75.34 108.846 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 141' ' ' GLU . . . . . 0.462 ' N ' ' CD ' ' B' ' 141' ' ' GLU . 21.2 mp0 -103.2 138.63 39.74 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.235 -0.915 . . . . 71.23 109.914 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 52.8 t -138.01 133.98 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.811 -0.811 . . . . 70.43 108.811 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 143' ' ' GLU . . . . . 0.434 ' H ' ' HG3' ' B' ' 143' ' ' GLU . 3.2 pp20? -104.7 136.32 44.45 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.395 -0.816 . . . . 72.43 109.684 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 6.7 m -140.37 157.19 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.366 -0.834 . . . . 72.13 109.01 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -171.8 37.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.997 . . . . 72.02 109.839 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -133.25 -125.54 2.62 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 109.184 -1.566 . . . . 42.23 109.184 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 0.662 ' HB2' ' HE2' ' B' ' 178' ' ' MET . 33.8 tttm -76.13 -33.35 1.25 Allowed Pre-proline 0 N--CA 1.487 1.401 0 O-C-N 121.272 -1.134 . . . . 73.3 111.223 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 148' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 61.0 Cg_endo -85.22 11.77 3.27 Favored 'Trans proline' 0 N--CA 1.486 1.065 0 C-N-CA 121.854 1.702 . . . . 71.33 112.158 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 149' ' ' PHE . . . . . 0.621 ' CE1' HG21 ' B' ' 153' ' ' THR . 13.0 t80 -110.24 -50.18 2.99 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.497 -0.752 . . . . 74.23 108.988 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -60.92 -49.79 76.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.33 -0.856 . . . . 72.34 111.099 -178.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.478 HG13 ' N ' ' B' ' 152' ' ' LEU . 11.8 p -70.95 -40.23 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.91 -1.118 . . . . 73.35 110.131 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.478 ' N ' HG13 ' B' ' 151' ' ' VAL . 16.4 tp -65.65 -40.19 92.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.117 -0.989 . . . . 55.24 109.937 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.621 HG21 ' CE1' ' B' ' 149' ' ' PHE . 14.3 p -77.62 -17.79 57.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.754 -1.216 . . . . 70.01 109.69 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -71.39 -54.23 11.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.877 -1.14 . . . . 65.32 109.607 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 0.885 HD13 ' N ' ' B' ' 156' ' ' ALA . 0.0 OUTLIER -74.67 -21.17 59.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.16 -0.962 . . . . 71.54 109.455 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 156' ' ' ALA . . . . . 0.885 ' N ' HD13 ' B' ' 155' ' ' LEU . . . -62.9 -55.3 27.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.793 -1.192 . . . . 75.32 108.947 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -64.23 -52.23 59.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.047 -1.033 . . . . 73.32 108.838 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -88.52 42.43 1.07 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.563 -0.71 . . . . 74.14 110.15 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 22.2 ttp-105 -55.3 -77.58 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.06 -1.025 . . . . 61.41 109.368 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -65.3 82.74 0.05 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.375 -0.828 . . . . 72.1 109.396 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -170.46 154.36 4.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.268 -0.895 . . . . 72.25 109.496 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 162' ' ' ILE . . . . . 0.753 HD12 ' N ' ' B' ' 162' ' ' ILE . 2.9 mp -76.66 109.87 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.15 -0.969 . . . . 72.31 109.062 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.65 124.79 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.309 -0.869 . . . . 64.21 109.041 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 23.3 t -100.85 178.77 4.59 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.199 -0.938 . . . . 74.22 110.167 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 165' ' ' LYS . . . . . 0.511 ' NZ ' ' CZ ' ' B' ' 212' ' ' TYR . 40.5 mttm -72.77 -56.83 4.68 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.003 0.906 . . . . 65.31 109.345 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 166' ' ' GLU . . . . . 0.723 ' O ' ' OD1' ' B' ' 170' ' ' ASP . 12.8 pt-20 -55.37 -27.99 51.03 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.368 -0.832 . . . . 63.45 109.535 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -60.28 -50.47 73.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.094 -1.004 . . . . 72.4 109.354 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 76.9 mt -59.27 -35.88 74.53 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.334 -0.854 . . . . 72.32 109.665 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' B' ' 172' ' ' ILE . 40.2 mt -65.54 -73.68 0.12 Allowed 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 117.692 -1.603 . . . . 73.34 109.303 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 170' ' ' ASP . . . . . 0.787 ' OD1' ' N ' ' B' ' 170' ' ' ASP . 0.0 OUTLIER -42.86 -21.45 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.311 0 O-C-N 120.173 -1.58 . . . . 72.1 110.233 178.578 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 171' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' B' ' 169' ' ' LEU . . . -88.12 -24.86 23.26 Favored 'General case' 0 C--N 1.283 -2.286 0 O-C-N 121.61 -0.682 . . . . 62.13 110.5 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' B' ' 174' ' ' GLU . 1.8 mp -113.93 -19.77 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.307 -0.871 . . . . 71.42 110.659 -178.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 173' ' ' TRP . . . . . 0.515 ' CZ3' ' HB3' ' B' ' 169' ' ' LEU . 0.1 OUTLIER -52.05 94.97 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.776 0 O-C-N 120.276 -1.515 . . . . 72.23 107.015 178.132 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 174' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' B' ' 172' ' ' ILE . 35.2 tt0 -176.94 167.43 2.5 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.476 -1.675 . . . . 52.11 106.476 -178.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 175' ' ' GLU . . . . . 0.619 ' O ' ' N ' ' B' ' 177' ' ' GLU . 59.4 mt-10 62.55 153.47 0.11 Allowed Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 106.597 -1.631 . . . . 73.04 106.597 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.517 ' O ' ' C ' ' B' ' 177' ' ' GLU . 26.6 Cg_exo -33.72 80.18 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.603 2.202 . . . . 74.13 113.474 -177.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 177' ' ' GLU . . . . . 0.619 ' N ' ' O ' ' B' ' 175' ' ' GLU . 2.2 mm-40 15.63 98.34 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 CA-C-O 121.359 0.6 . . . . 72.44 112.136 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 178' ' ' MET . . . . . 0.662 ' HE2' ' HB2' ' B' ' 147' ' ' LYS . 0.1 OUTLIER -108.61 21.32 17.44 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.757 -0.831 . . . . 63.43 108.757 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.6 132.89 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 O-C-N 121.653 -0.654 . . . . 71.05 109.365 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.8 159.67 52.44 Favored Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 108.873 -0.788 . . . . 62.15 108.873 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -37.84 110.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 123.037 2.492 . . . . 65.22 113.254 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 12.6 m120 49.3 45.33 23.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.045 -1.034 . . . . 72.31 110.564 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.11 -23.99 16.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.259 -0.901 . . . . 63.32 109.767 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.421 HD11 HD11 ' B' ' 169' ' ' LEU . 54.2 mt -49.25 -39.78 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.114 -0.991 . . . . 75.03 110.576 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -53.61 -61.67 2.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.027 -1.045 . . . . 64.11 109.533 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 34.1 t -66.04 -40.79 88.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.486 -0.759 . . . . 73.0 110.405 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.9 -58.37 6.34 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.029 -1.044 . . . . 61.12 110.853 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 188' ' ' ILE . . . . . 0.596 HD12 ' CE2' ' B' ' 212' ' ' TYR . 1.3 tt -56.03 -33.94 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.739 -1.225 . . . . 72.43 109.977 -178.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -58.99 -57.47 12.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.098 -1.001 . . . . 65.14 109.987 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -68.76 -41.05 79.39 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.159 -0.963 . . . . 63.24 110.548 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 77.5 mt -55.26 -38.75 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.817 -1.177 . . . . 74.03 108.932 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 192' ' ' ARG . . . . . 0.409 ' CZ ' HG21 ' B' ' 206' ' ' THR . 57.0 mtp180 -64.97 -48.26 74.63 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.319 -0.863 . . . . 72.24 109.94 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -76.42 -20.06 57.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.043 -1.035 . . . . 73.1 111.12 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -90.73 -21.66 21.47 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.874 -1.141 . . . . 72.11 111.028 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 195' ' ' MET . . . . . 0.443 ' C ' ' SD ' ' B' ' 195' ' ' MET . 3.1 ppp? -88.35 -36.93 16.33 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.788 -1.195 . . . . 44.33 110.026 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -59.12 -42.85 91.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.16 -0.962 . . . . 71.21 110.348 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 197' ' ' LYS . . . . . 0.412 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 24.5 mttm -51.64 -64.45 1.44 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.974 . . . . 75.21 110.03 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 198' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 44.9 Cg_endo -65.71 -34.31 41.35 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.253 1.969 . . . . 75.32 112.613 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 199' ' ' LEU . . . . . 0.938 HD23 ' O ' ' B' ' 201' ' ' ILE . 13.3 tp -68.82 -43.75 74.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.176 -0.952 . . . . 72.25 109.69 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 92.92 -44.78 2.51 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.66 -1.376 . . . . 64.53 109.66 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 201' ' ' ILE . . . . . 0.938 ' O ' HD23 ' B' ' 199' ' ' LEU . 27.8 mm -110.31 133.81 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.397 -1.061 . . . . 44.23 109.28 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 9.0 t -77.64 135.49 38.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 54.01 109.451 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 71.2 p -143.02 44.11 1.57 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.28 -0.887 . . . . 74.4 109.24 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.594 HG12 ' CE2' ' B' ' 214' ' ' PHE . 17.5 m -139.03 140.89 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.377 -0.827 . . . . 72.12 109.871 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -124.76 114.79 19.73 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.779 -0.823 . . . . 65.41 108.779 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 206' ' ' THR . . . . . 0.409 HG21 ' CZ ' ' B' ' 192' ' ' ARG . 68.4 p -96.68 123.22 40.3 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.139 -0.975 . . . . 71.33 109.468 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 6.4 t -142.94 144.31 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.131 -0.981 . . . . 63.5 109.466 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 31.5 ttm-85 -60.14 -35.53 75.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.444 -0.785 . . . . 74.45 110.042 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 209' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' B' ' 211' ' ' GLY . 18.0 mmm180 -65.96 142.46 57.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.114 -0.991 . . . . 74.14 109.728 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 210' ' ' ARG . . . . . 0.519 ' NH1' HH21 ' B' ' 213' ' ' ARG . 90.3 mtt180 55.79 -81.5 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.668 -0.645 . . . . 74.43 109.718 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 211' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' B' ' 209' ' ' ARG . . . -179.36 -98.98 0.12 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.825 -1.31 . . . . 64.45 109.825 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 212' ' ' TYR . . . . . 0.596 ' CE2' HD12 ' B' ' 188' ' ' ILE . 6.4 m-85 -131.29 115.9 16.89 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.57 -0.959 . . . . 74.21 108.778 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 213' ' ' ARG . . . . . 0.519 HH21 ' NH1' ' B' ' 210' ' ' ARG . 35.4 ttm180 -93.1 128.11 38.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.421 -0.799 . . . . 74.03 109.976 -179.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 214' ' ' PHE . . . . . 0.604 ' CD2' HD23 ' B' ' 155' ' ' LEU . 14.2 m-85 -101.55 121.36 41.83 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.416 -0.957 . . . . 74.34 108.416 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.1 p -133.97 163.98 28.31 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.379 -0.825 . . . . 64.33 110.005 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -79.61 150.42 73.01 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.469 -0.769 . . . . 70.04 109.41 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.81 -101.5 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.282 1.988 . . . . 65.11 112.094 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' B' ' 220' ' ' ALA . 2.8 ptpp? -92.02 153.93 43.38 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.224 -0.922 . . . . 73.15 108.921 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -36.95 -25.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.602 2.201 . . . . 71.31 112.757 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 220' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' B' ' 218' ' ' LYS . . . 52.08 35.76 17.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 75.45 109.602 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 26.0 p -84.16 136.29 34.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.254 -0.904 . . . . 72.22 109.543 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -59.69 137.91 57.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 54.53 109.567 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.996 -1.002 . . . . 71.13 109.574 179.977 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.546 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.427 -0.583 . . . . 65.12 109.427 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -137.61 148.97 46.26 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.445 -0.784 . . . . 72.33 109.319 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.0 t -118.06 125.09 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.66 -0.65 . . . . 71.42 109.724 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.803 HD12 ' N ' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -94.84 124.32 38.81 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.055 -1.028 . . . . 65.12 108.348 179.319 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.803 ' N ' HD12 ' A' ' 4' ' ' LEU . 4.1 tp -120.57 123.89 43.98 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.039 -0.726 . . . . 62.43 109.039 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.567 HG12 HD11 ' A' ' 4' ' ' LEU . 9.5 mt -108.63 106.1 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.271 -0.893 . . . . 71.15 108.861 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.516 ' OE2' ' ND2' ' A' ' 9' ' ' ASN . 37.0 tp10 -138.24 122.88 18.62 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.359 -0.838 . . . . 75.34 109.536 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -86.41 -13.31 46.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.28 -0.887 . . . . 72.44 109.323 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.516 ' ND2' ' OE2' ' A' ' 7' ' ' GLU . 82.3 m-20 -69.37 -136.34 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.354 -0.842 . . . . 63.02 109.454 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 11' ' ' VAL . 35.1 p -158.1 -63.86 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.071 -1.018 . . . . 72.34 109.765 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.52 HG13 ' N ' ' A' ' 12' ' ' LEU . 12.6 p -69.53 -41.22 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 74.02 109.881 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.52 ' N ' HG13 ' A' ' 11' ' ' VAL . 45.8 mt -63.98 -36.4 83.85 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.174 -0.954 . . . . 71.43 109.515 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.8 -34.87 23.58 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.696 -1.762 . . . . 61.32 108.696 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.86 -44.14 89.81 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.948 -1.261 . . . . 71.2 109.948 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -67.92 -43.59 78.84 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.069 -1.253 . . . . 71.32 109.26 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.3 mt -65.64 -49.4 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.853 -1.154 . . . . 63.23 108.655 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.525 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 86.3 tt0 -46.08 -56.46 5.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.328 -0.858 . . . . 51.11 109.817 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -85.26 3.73 38.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 73.34 109.433 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.78 -67.1 1.61 Allowed Glycine 0 N--CA 1.484 1.841 0 N-CA-C 109.921 -1.271 . . . . 62.15 109.921 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 20' ' ' LEU . 2.1 pt? -65.05 -22.77 67.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -1.205 . . . . 73.51 109.803 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 84.3 m-20 -57.35 -33.19 67.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.023 -1.048 . . . . 74.25 109.265 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 82.2 t -57.41 -33.46 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.343 -0.848 . . . . 70.04 109.384 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.418 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 11.8 mptt -70.24 2.54 3.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.879 . . . . 73.23 109.353 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.13 35.62 12.18 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.181 -1.168 . . . . 75.54 110.181 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -119.55 160.55 22.21 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.495 -1.003 . . . . 73.43 109.218 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 45.3 mmm -103.61 137.39 41.73 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.053 -1.092 . . . . 43.24 108.053 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.77 159.99 41.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.106 -0.996 . . . . 62.11 110.101 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -141.74 155.86 45.62 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.399 -0.813 . . . . 74.42 109.081 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 p -109.85 139.49 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.365 -0.834 . . . . 72.15 108.903 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.7 p -134.21 165.26 25.52 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.454 -0.779 . . . . 71.42 109.432 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.407 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 3.9 pt-20 -91.53 -103.72 0.11 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.334 -0.854 . . . . 72.33 109.602 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.5 t -79.45 165.72 22.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 74.24 109.96 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.7 mt -52.5 -32.58 40.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.535 -0.728 . . . . 71.53 109.802 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -48.47 -50.62 30.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.145 -0.972 . . . . 74.23 109.787 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.31 -39.1 85.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.118 -0.989 . . . . 54.03 109.586 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.41 -36.52 34.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.839 -1.304 . . . . 61.41 109.839 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -64.89 -40.06 94.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -1.156 . . . . 74.34 109.928 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -81.62 -40.63 22.68 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.013 -1.054 . . . . 75.33 109.503 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.5 tp -66.05 -43.04 88.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 74.33 109.729 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.441 ' O ' ' O ' ' A' ' 43' ' ' ARG . 3.6 ppp? -69.44 -26.95 64.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.167 -0.958 . . . . 70.32 109.656 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -65.51 -39.84 92.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.948 . . . . 71.22 109.751 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.519 HD12 HH12 ' A' ' 43' ' ' ARG . 24.5 pt -83.8 -26.37 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.221 -0.925 . . . . 74.14 109.989 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.519 HH12 HD12 ' A' ' 42' ' ' ILE . 80.2 mtt85 -129.13 137.94 51.5 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.404 -0.81 . . . . 72.24 109.276 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -92.27 126.84 37.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.157 -0.964 . . . . 75.42 109.588 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -104.71 141.62 36.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.465 -0.772 . . . . 74.23 109.269 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -80.63 -35.47 33.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.228 -0.92 . . . . 72.04 109.804 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.533 HD13 ' C ' ' A' ' 47' ' ' LEU . 1.1 tm? -124.55 113.82 18.58 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.795 -0.817 . . . . 72.13 108.795 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.654 ' O ' HG23 ' A' ' 48' ' ' VAL . 17.3 m -109.03 105.32 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.306 -0.871 . . . . 72.34 108.785 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.565 ' SD ' ' N ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -104.48 132.61 50.53 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.915 -1.143 . . . . 74.11 107.915 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.565 ' N ' ' SD ' ' A' ' 49' ' ' MET . 1.5 p -129.01 128.16 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.847 0.832 . . . . 61.12 110.352 -178.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.9 p -95.6 2.8 54.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.649 -0.657 . . . . 73.11 109.409 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.42 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 4.1 m-20 -76.48 150.59 36.64 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.179 -0.951 . . . . 52.55 109.552 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.458 ' C ' ' H ' ' A' ' 55' ' ' ALA . 18.7 pttp -85.88 -39.5 16.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.188 -0.945 . . . . 44.22 110.329 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -71.63 12.53 0.35 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.022 -1.049 . . . . 70.44 109.619 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.458 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.34 -21.52 58.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.849 . . . . 64.14 110.514 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.519 HD23 HE22 ' A' ' 89' ' ' GLN . 46.8 mt -39.96 -53.95 2.27 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.582 -0.699 . . . . 44.14 110.426 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 t -66.0 -35.7 81.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.984 -1.073 . . . . 55.23 109.164 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.498 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 65.9 t80 -64.02 -62.42 1.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.39 -0.819 . . . . 74.44 109.763 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.8 m -49.33 -32.2 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.655 -1.278 . . . . 74.03 109.628 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.9 t -58.93 -52.06 67.36 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.263 -0.898 . . . . 64.3 109.501 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -68.8 -30.4 68.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.025 -1.047 . . . . 64.44 109.94 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.498 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 31.7 mm -59.02 -44.41 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.868 -1.145 . . . . 63.21 110.083 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -74.29 -48.38 28.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.036 -1.04 . . . . 74.42 111.48 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.22 -36.11 82.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.611 -1.305 . . . . 70.32 109.861 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -92.18 -50.44 5.67 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.137 -0.977 . . . . 75.22 109.226 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.5 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 0.5 OUTLIER -107.9 63.03 0.61 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.466 -0.771 . . . . 74.13 109.784 -179.467 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 t -65.94 -28.38 68.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.011 -1.055 . . . . 73.24 110.043 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.4 m -63.45 -31.0 72.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.258 -0.901 . . . . 61.01 110.627 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 58.8 mt -84.74 149.08 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.973 -1.079 . . . . 71.33 110.226 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 71' ' ' VAL . 72.3 t -88.51 159.04 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.569 -0.9 . . . . 72.13 108.569 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.457 ' N ' HG12 ' A' ' 70' ' ' VAL . 17.2 t -136.58 129.67 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.282 -0.886 . . . . 54.21 109.932 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.507 ' O ' ' SD ' ' A' ' 49' ' ' MET . 1.6 mt -127.08 100.81 6.27 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.909 -1.145 . . . . 50.24 107.909 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.622 ' O ' HD12 ' A' ' 95' ' ' ILE . 15.0 p -96.37 154.65 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.368 -0.832 . . . . 74.41 109.282 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.427 ' O ' ' OG ' ' A' ' 75' ' ' SER . 0.4 OUTLIER -118.4 167.72 11.3 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.701 -0.851 . . . . 72.31 108.701 179.395 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 74' ' ' SER . 3.7 m -167.41 120.72 0.95 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.266 -0.897 . . . . 64.54 109.933 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -75.12 19.58 0.15 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.409 -0.807 . . . . 74.13 110.111 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 75' ' ' SER . 34.7 t30 -142.48 58.41 7.4 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.129 -0.982 . . . . 73.34 109.826 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.4 82.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.342 2.028 . . . . 63.22 112.471 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 77' ' ' ASN . 44.8 m -114.2 150.99 33.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.227 -1.027 . . . . 62.53 108.227 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 t -53.45 -26.49 20.39 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.074 -1.016 . . . . 73.44 109.723 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -63.41 -47.67 81.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.163 -0.961 . . . . 71.42 109.813 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -72.64 -30.61 64.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.162 -0.962 . . . . 73.43 109.917 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.464 ' OE2' ' NE ' ' B' ' 108' ' ' ARG . 35.3 tt0 -62.04 -55.75 25.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 74.22 109.965 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 85' ' ' HIS . 33.2 m -63.47 -36.49 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -0.961 . . . . 73.2 109.62 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.414 ' N ' HG23 ' A' ' 84' ' ' VAL . 21.3 m80 -73.68 -19.59 60.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 53.33 109.711 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -76.73 -44.19 34.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.158 -0.964 . . . . 64.11 110.017 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -81.42 -29.74 33.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.078 -1.013 . . . . 74.34 109.217 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -75.75 -40.54 55.24 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.326 -0.859 . . . . 74.42 110.001 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.519 HE22 HD23 ' A' ' 56' ' ' LEU . 11.1 pt20 -71.15 -46.91 60.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.042 -1.036 . . . . 74.24 109.841 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.489 ' N ' ' CG ' ' A' ' 89' ' ' GLN . . . 145.67 70.05 0.02 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.881 -1.288 . . . . 61.51 109.881 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -133.64 129.02 36.31 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.261 -1.141 . . . . 55.33 108.701 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 11.8 t70 -73.25 -40.12 64.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.912 -1.117 . . . . 73.42 108.875 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 63.6 m-20 -153.36 154.06 33.79 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.932 -0.766 . . . . 75.04 108.932 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -127.72 130.71 49.28 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.866 -0.791 . . . . 71.33 108.866 -179.597 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.922 ' H ' HD12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -118.74 142.54 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 CA-C-O 121.636 0.731 . . . . 71.13 110.14 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.12 119.89 8.69 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.982 -1.074 . . . . 64.32 108.139 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.697 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -43.22 -53.79 10.46 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.182 -0.949 . . . . 62.2 111.656 -179.168 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 1.4 Cg_endo -38.22 -11.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.27 1.314 . . . . 73.11 113.525 -176.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.697 ' N ' ' O ' ' A' ' 97' ' ' LYS . 56.4 m-85 57.88 103.27 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.454 -0.779 . . . . 65.22 109.638 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 61.2 mtm-85 -58.96 -49.93 75.98 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.071 -1.018 . . . . 72.35 109.148 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.822 ' O ' ' N ' ' A' ' 103' ' ' LYS . 3.2 t -174.5 67.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.138 -0.976 . . . . 71.32 110.631 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.76 ' H ' HD12 ' A' ' 102' ' ' ILE . 1.8 mp 35.6 -68.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 CA-C-O 121.213 0.53 . . . . 75.43 111.885 178.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.822 ' N ' ' O ' ' A' ' 101' ' ' SER . 28.3 mmtp -47.3 -15.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.867 -1.145 . . . . 71.41 109.096 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -60.79 -92.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.439 -0.788 . . . . 63.24 110.374 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.672 ' H ' HD23 ' A' ' 105' ' ' LEU . 2.0 pt? -50.47 -33.27 20.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.053 -1.03 . . . . 73.22 110.392 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 66.2 t -65.46 -40.53 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.83 -1.168 . . . . 60.11 109.037 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 103' ' ' LYS . . . -58.89 -39.6 81.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.218 -0.926 . . . . 70.42 108.516 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -68.43 -31.21 70.37 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.917 -0.771 . . . . 74.41 108.917 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.4 mt -75.37 -34.65 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 108.294 -1.002 . . . . 62.54 108.294 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.407 ' OE2' ' NH1' ' A' ' 114' ' ' ARG . 82.5 tt0 -74.64 -57.81 3.69 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.472 -0.768 . . . . 74.34 109.184 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -49.62 -35.59 21.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.338 -0.851 . . . . 73.32 109.319 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 53.8 ttt85 -68.26 -39.47 82.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.339 -0.851 . . . . 52.41 109.865 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 34.8 mt -133.58 68.72 1.49 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.292 -0.88 . . . . 65.24 110.446 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.407 ' NH1' ' OE2' ' A' ' 110' ' ' GLU . 25.0 mtp85 -75.07 -43.09 55.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.941 -1.099 . . . . 64.45 108.341 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 115' ' ' PHE . 8.7 p90 -132.99 73.21 1.51 Allowed 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.825 -0.805 . . . . 74.43 108.825 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -56.26 -177.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.601 -0.687 . . . . 74.42 109.972 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.11 142.39 13.3 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.895 -1.282 . . . . 75.04 109.895 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.401 ' O ' ' O ' ' A' ' 119' ' ' ASN . 16.0 t -161.85 -61.16 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.346 -1.091 . . . . 61.14 109.129 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 118' ' ' SER . 36.3 t30 51.45 95.95 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.359 -0.838 . . . . 65.24 109.875 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.4 t -84.34 -19.41 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.049 -1.032 . . . . 73.11 109.158 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 22.4 mm -110.26 124.56 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.548 -0.72 . . . . 72.24 109.758 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -138.38 109.16 6.66 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.469 -0.938 . . . . 72.34 108.469 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.9 pt -142.05 122.03 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.243 -0.91 . . . . 71.44 109.338 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.03 -148.39 32.55 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.429 -1.468 . . . . 73.4 109.429 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -83.89 9.98 10.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.265 -1.138 . . . . 74.45 109.391 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.52 131.82 43.78 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.39 -0.819 . . . . 54.21 108.878 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 p -128.55 128.26 43.93 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.574 -0.899 . . . . 54.5 108.574 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 21.2 mt -133.9 135.08 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.334 -0.854 . . . . 45.15 109.752 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.3 m -119.22 91.75 44.36 Favored Pre-proline 0 N--CA 1.497 1.893 0 N-CA-C 108.845 -0.798 . . . . 71.11 108.845 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.32 -25.84 6.67 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.226 1.95 . . . . 65.41 112.538 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -59.32 -40.37 86.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.088 -1.007 . . . . 63.32 108.83 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -97.63 5.78 48.92 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.5 -0.926 . . . . 72.52 108.5 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 56.81 61.2 2.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.257 -0.902 . . . . 75.33 109.03 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -149.75 148.35 29.12 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.349 -0.844 . . . . 71.23 109.543 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 13.1 tt -119.93 139.51 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.548 -0.72 . . . . 74.02 109.212 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.85 126.34 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.581 -0.699 . . . . 60.23 109.323 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -141.46 149.95 41.63 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.395 -0.815 . . . . 62.32 109.588 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 138' ' ' LYS . 54.6 tttt 55.9 9.59 0.47 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.495 -0.753 . . . . 75.4 109.715 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.95 14.03 59.88 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.954 -1.258 . . . . 72.24 109.954 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -105.35 136.58 44.62 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.421 -1.046 . . . . 71.22 109.077 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -101.43 118.42 36.92 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.482 -0.761 . . . . 71.42 110.041 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 10.7 p -138.06 132.54 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.408 -0.808 . . . . 53.02 108.933 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.427 ' CG ' ' N ' ' A' ' 144' ' ' VAL . 29.5 tt0 -92.3 160.71 15.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -0.917 . . . . 60.45 110.357 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.455 ' CG2' ' CG ' ' A' ' 149' ' ' PHE . 13.5 p -143.41 140.81 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.182 -1.044 . . . . 74.44 108.182 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -152.26 113.25 4.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.773 -1.205 . . . . 65.15 110.399 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 176.89 -164.45 33.94 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.985 -1.646 . . . . 73.34 108.985 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.623 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 17.3 mtpp -91.19 -32.24 0.35 Allowed Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.055 -1.262 . . . . 72.22 111.499 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 85.8 Cg_endo -88.33 21.15 1.04 Allowed 'Trans proline' 0 N--CA 1.488 1.196 0 C-N-CA 122.131 1.887 . . . . 65.23 112.516 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.455 ' CG ' ' CG2' ' A' ' 144' ' ' VAL . 41.0 m-85 -125.65 -29.75 3.13 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.475 -0.766 . . . . 60.11 109.679 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -60.84 -34.05 73.98 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.909 -1.119 . . . . 64.21 108.606 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.04 -33.97 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.344 -0.984 . . . . 72.02 108.344 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 17.7 tp -62.26 -45.23 94.22 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.532 -0.914 . . . . 73.31 108.532 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.9 p -65.47 -37.61 87.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 74.31 108.957 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -53.45 -60.55 3.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.563 -0.71 . . . . 74.31 110.765 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.3 pp -65.0 -23.53 67.24 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.096 -1.002 . . . . 75.34 109.743 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.1 -40.01 84.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.976 -1.077 . . . . 62.14 108.852 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -86.1 -51.52 6.26 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.235 -0.916 . . . . 61.03 109.66 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -73.93 49.34 0.33 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 74.12 108.925 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.626 ' NH1' ' OD2' ' A' ' 160' ' ' ASP . 7.6 ptm180 -77.72 14.08 1.15 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.639 -0.663 . . . . 71.13 111.025 -178.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.626 ' OD2' ' NH1' ' A' ' 159' ' ' ARG . 64.2 m-20 -148.21 47.48 1.06 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.682 -1.262 . . . . 75.45 110.129 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -150.86 157.52 43.02 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.918 -1.114 . . . . 73.41 109.848 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.6 mt -86.05 117.85 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.527 -0.733 . . . . 74.41 109.716 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 1.279 ' HB ' ' CE1' ' A' ' 214' ' ' PHE . 44.6 t -108.17 130.02 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.941 -0.763 . . . . 72.31 108.941 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.7 t -96.11 168.05 10.84 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.164 -0.96 . . . . 74.12 110.167 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm -65.42 -55.0 20.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.401 -0.812 . . . . 70.43 109.75 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -56.32 -33.97 66.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.901 . . . . 73.52 109.651 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.6 tp60 -62.38 -42.76 99.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.314 -0.866 . . . . 74.52 108.968 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 9.1 mt -60.82 -37.51 82.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.397 -0.815 . . . . 72.31 109.12 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.563 ' C ' HD23 ' A' ' 169' ' ' LEU . 5.0 tt -57.12 -58.76 6.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.337 -0.852 . . . . 53.33 109.114 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -68.56 -29.41 67.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.614 -0.679 . . . . 62.44 110.723 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.96 -67.8 0.28 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.028 -1.045 . . . . 60.21 110.377 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.555 HD12 ' N ' ' A' ' 172' ' ' ILE . 2.1 mp -89.01 -50.44 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.003 -1.061 . . . . 75.32 109.554 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -87.94 73.64 9.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.056 -1.028 . . . . 73.14 109.156 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -83.23 23.93 0.84 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.296 -0.877 . . . . 73.24 110.14 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' A' ' 177' ' ' GLU . 7.9 mt-10 -78.34 173.88 6.92 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.104 -0.998 . . . . 44.43 108.421 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -65.91 43.49 0.17 Allowed 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.919 1.746 . . . . 72.51 112.311 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.46 ' C ' ' H ' ' A' ' 179' ' ' VAL . 95.3 mt-10 48.63 -141.3 0.61 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.087 -1.008 . . . . 63.24 109.383 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 14.9 ttt 57.03 6.84 0.36 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 73.5 109.032 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.46 ' H ' ' C ' ' A' ' 177' ' ' GLU . 3.7 m -108.72 74.5 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.494 -0.754 . . . . 65.22 109.753 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 179' ' ' VAL . 41.8 p 46.38 93.59 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 71.42 109.455 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -75.93 -38.07 1.36 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.83 1.687 . . . . 41.22 113.065 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -76.7 8.11 3.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.832 -1.167 . . . . 64.54 109.292 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.5 p -70.13 -18.8 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.444 -0.785 . . . . 74.02 109.802 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 21.7 mt -63.47 -30.68 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.156 -0.965 . . . . 72.33 109.923 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -63.0 -45.06 94.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.078 -1.014 . . . . 74.4 110.297 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 16.8 m -73.19 -25.46 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.991 -1.068 . . . . 70.42 109.401 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -78.02 -48.81 15.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.259 -0.901 . . . . 52.11 109.715 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.483 ' O ' HD13 ' A' ' 188' ' ' ILE . 0.3 OUTLIER -67.64 -32.63 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.028 -1.045 . . . . 71.4 109.108 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -67.12 -48.56 67.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.508 -0.745 . . . . 73.44 110.367 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -72.7 -32.96 66.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.791 -1.193 . . . . 71.42 109.776 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 51.7 mt -63.56 -54.7 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.779 -1.201 . . . . 61.55 110.267 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -62.78 -34.84 78.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.692 -1.255 . . . . 63.34 109.781 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.431 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 42.7 mt-30 -78.04 -18.73 55.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 61.24 111.24 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -97.24 -28.26 14.15 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.791 -1.193 . . . . 75.13 110.722 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' MET . . . . . 0.51 ' SD ' ' O ' ' A' ' 195' ' ' MET . 4.1 ppp? -93.15 9.2 36.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.753 -1.217 . . . . 74.02 110.146 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 193' ' ' GLN . 27.9 p-10 -110.31 -32.97 6.77 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.227 -0.921 . . . . 74.02 110.386 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 66.8 tttt -75.15 -36.16 2.13 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.018 -1.051 . . . . 75.43 111.184 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 89.8 Cg_endo -87.77 -52.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.974 1.783 . . . . 72.32 112.475 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.9 mp -48.88 -75.69 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.988 -1.07 . . . . 74.54 109.301 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 148.94 -47.82 0.63 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.64 -1.384 . . . . 61.51 109.64 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 24.6 mt -120.07 133.5 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.587 -0.949 . . . . 61.22 109.388 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 12.6 m -77.79 146.27 35.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.868 . . . . 72.0 108.966 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 22.0 p -132.47 27.77 4.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.461 -0.775 . . . . 74.44 109.362 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.7 m -129.45 125.57 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.485 -0.759 . . . . 64.35 109.61 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -98.54 105.05 17.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.544 -0.722 . . . . 71.41 109.379 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 24.4 p -70.57 119.68 15.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 73.52 108.816 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 12.7 m -139.93 158.54 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.219 -0.925 . . . . 71.02 110.301 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -102.64 -7.15 22.0 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.745 -0.835 . . . . 72.12 108.745 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.976 ' NH2' ' NH1' ' A' ' 213' ' ' ARG . 53.8 ttp180 -65.04 -27.55 68.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.438 -0.789 . . . . 64.41 109.677 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -151.06 -72.33 0.16 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 71.54 109.235 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.467 ' C ' ' CD1' ' A' ' 212' ' ' TYR . . . -167.89 -80.1 0.04 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.614 -1.394 . . . . 72.03 109.614 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.467 ' CD1' ' C ' ' A' ' 211' ' ' GLY . 73.5 m-85 -149.67 129.17 13.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.143 -1.21 . . . . 75.54 109.194 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.976 ' NH1' ' NH2' ' A' ' 209' ' ' ARG . 6.0 mtp180 -99.31 116.32 31.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.339 -0.851 . . . . 75.31 109.1 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 1.279 ' CE1' ' HB ' ' A' ' 163' ' ' VAL . 32.9 m-85 -92.9 104.92 17.11 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.439 -0.948 . . . . 75.41 108.439 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 15.1 p -138.96 166.17 25.19 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.965 -0.754 . . . . 74.14 108.965 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' TYR . . . . . 0.881 ' CE2' ' O ' ' A' ' 217' ' ' PRO . 2.2 p90 -70.24 157.45 89.89 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.249 -0.907 . . . . 75.32 109.383 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.881 ' O ' ' CE2' ' A' ' 216' ' ' TYR . 51.3 Cg_exo -49.9 161.13 1.02 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.923 1.749 . . . . 73.11 111.963 178.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.414 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 13.8 mtpt -80.82 -61.39 0.41 Allowed Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.153 -0.967 . . . . 75.25 109.757 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 218' ' ' LYS . 31.0 Cg_endo -61.91 -51.08 4.17 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.872 1.715 . . . . 75.1 112.006 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . 51.26 68.13 0.84 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.088 -1.007 . . . . 71.14 108.992 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' CYS . . . . . 0.435 ' SG ' ' N ' ' A' ' 222' ' ' GLU . 51.0 t -170.4 -108.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 71.13 109.133 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.435 ' N ' ' SG ' ' A' ' 221' ' ' CYS . 74.6 tt0 47.91 88.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.058 -1.026 . . . . 75.35 109.666 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.484 ' CD ' ' H ' ' A' ' 223' ' ' GLU . 1.2 pm0 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.039 -1.038 . . . . 73.41 109.768 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ptp . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.427 -0.582 . . . . 71.14 109.427 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -139.65 149.62 43.96 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.346 -0.847 . . . . 73.23 109.404 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 86.2 t -114.37 138.02 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.679 -0.638 . . . . 72.24 109.443 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.421 HD11 ' CG1' ' B' ' 6' ' ' ILE . 5.9 tp -113.59 119.11 36.37 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.581 -0.7 . . . . 54.33 110.159 -178.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.407 ' N ' HD12 ' B' ' 4' ' ' LEU . 12.5 mt -120.31 98.72 6.19 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 108.793 -0.817 . . . . 74.35 108.793 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.421 ' CG1' HD11 ' B' ' 4' ' ' LEU . 44.9 mt -86.27 98.27 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.716 -1.24 . . . . 42.55 108.577 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.483 ' CD ' ' HG ' ' B' ' 51' ' ' SER . 9.4 tp10 -136.0 131.32 34.87 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.414 -0.804 . . . . 74.52 109.423 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -66.03 -34.68 78.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.328 -0.858 . . . . 62.55 109.363 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -77.27 110.45 11.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.275 -0.89 . . . . 73.11 109.562 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 31.7 t -68.77 -23.01 64.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 65.54 109.682 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 93.9 t -68.21 -48.69 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.166 -0.959 . . . . 75.55 109.842 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.544 HD22 ' N ' ' B' ' 12' ' ' LEU . 3.5 mm? -67.31 -30.41 70.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.936 . . . . 70.14 109.706 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.5 -33.71 27.44 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.125 -1.59 . . . . 75.4 109.125 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.7 -45.5 75.47 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.888 -1.285 . . . . 65.44 109.888 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' B' ' 16' ' ' ILE . 11.3 pt-20 -68.38 -44.72 74.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.097 -1.237 . . . . 60.21 109.26 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.42 ' N ' ' CG ' ' B' ' 15' ' ' GLU . 6.2 mm -60.5 -35.5 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.044 -1.035 . . . . 75.15 108.336 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -62.31 -46.84 86.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.541 -0.724 . . . . 73.01 109.563 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -83.22 0.75 44.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.117 -0.989 . . . . 74.3 109.317 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.26 -55.63 2.32 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 109.684 -1.366 . . . . 70.54 109.684 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -76.45 -17.88 59.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -1.105 . . . . 71.34 109.857 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -56.7 -30.53 63.55 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.965 -1.084 . . . . 64.41 109.272 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 73.5 t -59.49 -30.68 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 74.23 109.039 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -77.43 -7.44 56.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.419 -0.801 . . . . 63.42 109.318 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.61 39.78 7.04 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.587 -1.005 . . . . 53.43 110.587 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -120.23 158.87 26.09 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.379 -1.071 . . . . 71.12 109.194 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 50.0 mmm -106.98 138.76 42.54 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.476 -0.935 . . . . 75.24 108.476 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.41 160.97 40.16 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.113 -0.992 . . . . 72.12 110.131 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -141.35 156.73 45.8 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.787 -0.82 . . . . 72.31 108.787 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 p -118.84 139.78 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.392 -0.818 . . . . 64.43 109.58 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.1 p -133.64 169.99 16.2 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.57 -0.706 . . . . 65.41 109.396 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -93.13 -99.71 0.13 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.319 -0.863 . . . . 71.02 109.884 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -78.16 167.7 21.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.195 -0.941 . . . . 51.11 110.277 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 28.1 mt -56.52 -35.51 68.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.587 -0.695 . . . . 71.24 110.008 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -54.44 -42.38 70.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.108 -0.995 . . . . 74.32 109.883 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -66.58 -39.51 88.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.097 -1.002 . . . . 73.03 109.378 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.61 -40.82 58.53 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.546 -1.422 . . . . 30.21 109.546 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.99 -38.62 91.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.281 -1.129 . . . . 74.42 109.645 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -74.96 -39.66 61.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 74.42 109.845 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 21.2 tp -72.02 -49.6 35.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.937 . . . . 75.41 110.102 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' B' ' 40' ' ' MET . 1.9 ppp? -60.72 -30.42 69.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.138 -0.976 . . . . 60.41 109.938 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.82 -37.28 70.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.16 -0.963 . . . . 53.23 110.044 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 14.2 pt -100.62 0.03 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.292 -0.88 . . . . 71.23 110.351 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' B' ' 40' ' ' MET . 59.1 mmt-85 -130.96 152.8 49.88 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.288 -0.882 . . . . 72.22 109.875 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -83.94 165.61 18.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.318 -0.864 . . . . 63.54 109.095 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 1.9 p90 -156.2 102.08 2.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.029 -1.045 . . . . 64.35 109.881 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -79.18 -32.04 44.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.177 -0.952 . . . . 62.22 108.585 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.496 HD13 ' C ' ' B' ' 47' ' ' LEU . 0.7 OUTLIER -113.75 108.41 17.07 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.612 -0.884 . . . . 73.12 108.612 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.429 ' N ' HD13 ' B' ' 47' ' ' LEU . 97.3 t -96.55 105.31 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.276 -0.89 . . . . 65.11 108.693 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 15.5 ttt -123.02 130.54 52.93 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.491 -0.756 . . . . 73.44 109.661 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.463 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.4 OUTLIER -145.28 134.03 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.594 -0.691 . . . . 34.5 109.153 -179.654 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 51' ' ' SER . . . . . 0.483 ' HG ' ' CD ' ' B' ' 7' ' ' GLU . 6.4 p -102.06 13.82 33.67 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.551 -0.718 . . . . 73.21 109.741 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.463 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 66.5 m-20 -76.75 148.1 36.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.145 -0.972 . . . . 70.41 109.712 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.406 ' C ' ' H ' ' B' ' 55' ' ' ALA . 65.5 mttp -78.05 -42.76 31.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.308 -0.87 . . . . 65.0 109.906 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -73.51 9.43 1.38 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.199 -0.938 . . . . 75.21 109.521 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -59.72 -22.89 62.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.374 -0.828 . . . . 55.33 109.826 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 56.2 mt -46.0 -34.29 3.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.331 -0.855 . . . . 63.14 109.933 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 18.5 m -77.1 -46.96 21.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.102 -0.999 . . . . 63.5 109.499 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 58' ' ' PHE . . . . . 0.41 ' CZ ' HD11 ' B' ' 62' ' ' ILE . 58.9 t80 -61.86 -53.32 57.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -0.943 . . . . 72.33 109.519 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.484 HG23 ' N ' ' B' ' 60' ' ' SER . 14.1 m -56.25 -39.99 63.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.587 -1.321 . . . . 74.54 109.17 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.484 ' N ' HG23 ' B' ' 59' ' ' VAL . 28.0 t -51.6 -46.19 63.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.143 -0.973 . . . . 71.24 109.722 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.461 ' O ' ' N ' ' B' ' 65' ' ' LYS . 13.8 ptp180 -78.32 -34.27 48.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.863 -1.148 . . . . 74.31 110.566 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' B' ' 66' ' ' HIS . 33.4 mm -63.03 -45.95 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.452 -1.405 . . . . 72.14 108.464 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.432 ' HZ3' ' HB2' ' B' ' 89' ' ' GLN . 29.5 mttt -61.81 -40.52 95.55 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.624 -0.88 . . . . 73.32 108.624 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -75.37 -38.13 60.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.61 -0.681 . . . . 73.12 109.228 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.528 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 25.4 mtpp -83.94 -23.09 31.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.266 -0.896 . . . . 72.44 110.705 -178.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.528 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 83.4 m-70 -156.75 66.4 0.54 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.903 -1.123 . . . . 63.31 109.912 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.2 t -59.29 -29.51 67.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.328 -0.857 . . . . 73.1 109.938 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 86.4 p -65.35 -34.74 79.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.153 -0.967 . . . . 71.53 110.683 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.484 HG22 ' N ' ' B' ' 70' ' ' VAL . 78.3 mt -65.71 160.89 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.912 -1.117 . . . . 74.4 109.61 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.484 ' N ' HG22 ' B' ' 69' ' ' ILE . 97.6 t -85.0 159.23 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.21 -0.931 . . . . 75.12 110.039 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.524 ' N ' ' OD1' ' B' ' 92' ' ' ASP . 11.0 t -143.48 111.42 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.075 -1.016 . . . . 73.2 109.316 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.606 HD23 HD11 ' B' ' 95' ' ' ILE . 0.7 OUTLIER -110.06 99.62 8.68 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.544 -0.91 . . . . 73.34 108.544 -179.634 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 79.1 t -95.13 127.83 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.237 -0.915 . . . . 73.5 108.963 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.1 m -103.22 173.52 6.27 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.443 -0.786 . . . . 64.34 109.666 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.48 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 23.0 t -166.28 122.97 1.32 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.168 -0.957 . . . . 74.53 110.298 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -62.01 -17.1 56.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.435 -0.79 . . . . 64.5 109.605 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 77' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' B' ' 79' ' ' THR . 47.2 t-20 -124.43 82.23 58.59 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.516 -0.74 . . . . 74.25 109.196 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.15 71.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.566 2.177 . . . . 74.43 112.003 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.517 ' N ' ' O ' ' B' ' 77' ' ' ASN . 17.0 m -88.13 152.27 22.11 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.102 -0.999 . . . . 73.12 109.418 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -37.86 88.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.892 . . . . 71.01 109.488 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -55.64 -46.88 77.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.951 . . . . 63.2 109.63 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -71.56 -30.93 66.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.896 . . . . 73.22 109.658 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' B' ' 84' ' ' VAL . 10.6 tm-20 -70.02 -56.23 7.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 74.3 109.851 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.548 HG23 ' N ' ' B' ' 85' ' ' HIS . 13.1 m -63.27 -44.61 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.135 -0.978 . . . . 73.31 109.722 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 85' ' ' HIS . . . . . 0.548 ' N ' HG23 ' B' ' 84' ' ' VAL . 71.1 t60 -63.19 -40.26 97.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 73.24 109.456 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.04 -44.26 97.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.904 . . . . 55.33 109.588 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -74.13 -30.27 62.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.131 -0.981 . . . . 74.14 108.535 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -57.54 -50.42 73.16 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.681 -0.859 . . . . 64.04 108.681 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 89' ' ' GLN . . . . . 0.432 ' HB2' ' HZ3' ' B' ' 63' ' ' LYS . 40.7 mt-30 -64.33 -38.31 90.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.62 -0.675 . . . . 72.35 109.462 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 139.49 10.31 0.82 Allowed Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.344 -1.102 . . . . 65.2 110.344 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -48.79 122.22 5.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.878 -1.366 . . . . 52.23 109.233 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' B' ' 71' ' ' VAL . 5.8 m-20 -63.68 -37.39 87.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.116 -0.99 . . . . 73.32 109.102 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 93' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 20.3 t0 -154.79 158.44 39.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.851 . . . . 72.22 109.751 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.52 ' N ' ' OD1' ' B' ' 93' ' ' ASP . 42.4 t80 -130.26 116.97 19.13 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.158 -1.053 . . . . 64.42 108.158 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 1.026 ' H ' HD12 ' B' ' 95' ' ' ILE . 0.0 OUTLIER -119.42 156.75 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.503 0 CA-C-O 121.919 0.866 . . . . 72.23 110.797 -177.72 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.42 134.06 42.4 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.435 -1.32 . . . . 25.24 107.435 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.675 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -55.04 -55.57 37.61 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 120.773 -1.204 . . . . 64.32 111.791 -178.462 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 98' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 1.4 Cg_endo -39.44 -12.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 121.144 1.23 . . . . 63.33 113.213 -176.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 99' ' ' TYR . . . . . 0.675 ' N ' ' O ' ' B' ' 97' ' ' LYS . 53.3 m-85 56.5 104.13 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.508 -0.745 . . . . 75.13 109.728 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -55.24 -42.31 73.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.949 -1.095 . . . . 74.23 108.673 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 101' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' B' ' 104' ' ' ALA . 12.2 t -168.2 151.18 5.6 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.465 -0.772 . . . . 63.34 109.039 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 20.7 mm -55.52 -45.14 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.986 . . . . 74.44 109.362 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -68.91 -7.54 35.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 71.11 109.605 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' B' ' 101' ' ' SER . . . -71.69 -77.99 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.073 -1.017 . . . . 71.45 109.786 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.596 ' N ' HD23 ' B' ' 105' ' ' LEU . 2.2 pt? -62.32 -36.67 82.89 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.066 -1.021 . . . . 51.31 110.092 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 80.7 t -60.36 -44.97 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.9 -1.125 . . . . 65.23 109.187 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.18 -33.49 72.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.173 -0.954 . . . . 24.32 108.751 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 0.521 ' NH2' ' CG2' ' B' ' 95' ' ' ILE . 78.6 mtm180 -80.27 -24.97 39.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.43 -0.793 . . . . 75.31 109.872 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 67.0 mt -79.48 -47.01 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.022 -1.049 . . . . 54.24 108.649 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.68 -39.87 94.42 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.584 -0.847 . . . . 65.31 109.146 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.91 -35.96 82.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.345 -0.847 . . . . 72.24 109.217 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -61.94 -39.19 91.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.324 -0.86 . . . . 72.04 109.765 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.65 67.57 1.25 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.157 -0.965 . . . . 75.35 109.529 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.483 ' O ' ' CG ' ' B' ' 115' ' ' PHE . 50.2 mtp180 -57.28 -32.86 67.06 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.14 -0.975 . . . . 75.5 109.341 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 115' ' ' PHE . . . . . 0.483 ' CG ' ' O ' ' B' ' 114' ' ' ARG . 87.8 m-85 -157.67 91.14 1.12 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 65.33 109.515 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 116' ' ' TRP . . . . . 0.519 ' NE1' ' OE2' ' B' ' 141' ' ' GLU . 5.3 m-90 52.21 11.25 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 74.45 109.69 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 117' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' B' ' 115' ' ' PHE . . . 70.03 -112.4 4.37 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.849 -1.3 . . . . 44.21 109.849 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 84.4 p -150.62 -172.59 4.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.286 -1.126 . . . . 71.4 109.843 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.23 130.69 13.85 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.938 -0.705 . . . . 72.32 109.195 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 5.5 t -80.65 -42.72 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 75.02 110.117 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 121' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' B' ' 128' ' ' ILE . 27.7 mm -112.67 121.41 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.442 -0.786 . . . . 51.41 109.234 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -154.65 138.84 16.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.251 -0.905 . . . . 71.53 109.392 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.778 HD13 ' H ' ' B' ' 123' ' ' ILE . 0.1 OUTLIER -147.08 157.1 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.267 -0.896 . . . . 72.43 109.492 179.721 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.85 -131.79 12.47 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.601 -1.4 . . . . 51.23 109.601 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -99.82 0.73 42.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.311 -1.111 . . . . 74.2 109.522 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.23 145.57 24.55 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.136 -0.977 . . . . 75.42 108.527 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 28.8 m -129.21 136.63 50.37 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.548 -0.72 . . . . 74.22 109.245 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' B' ' 121' ' ' ILE . 39.8 mt -136.02 136.34 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.398 -0.814 . . . . 60.33 109.645 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 7.3 m -127.58 80.27 72.15 Favored Pre-proline 0 N--CA 1.499 2.017 0 N-CA-C 109.15 -0.685 . . . . 72.31 109.15 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.41 -55.38 3.66 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.815 2.343 . . . . 75.13 112.612 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -51.82 -40.05 59.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -0.93 . . . . 75.23 109.627 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -84.6 0.17 51.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.203 -0.936 . . . . 72.43 109.461 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 52.39 60.32 3.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 75.13 109.618 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -151.34 130.43 12.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.867 . . . . 73.22 109.121 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 59.8 mt -118.1 133.81 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.547 -0.721 . . . . 64.14 109.528 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 70.5 mt -124.43 123.11 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 109.074 -0.713 . . . . 71.22 109.074 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -137.54 141.42 41.4 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.427 -0.796 . . . . 64.22 109.522 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 138' ' ' LYS . . . . . 0.498 ' NZ ' ' O ' ' B' ' 198' ' ' PRO . 50.7 mttp 54.45 26.19 6.88 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.565 -0.709 . . . . 72.02 110.085 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.88 -0.67 77.25 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.186 -1.166 . . . . 74.32 110.186 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -89.95 131.27 35.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.127 -1.219 . . . . 75.34 109.158 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 141' ' ' GLU . . . . . 0.519 ' OE2' ' NE1' ' B' ' 116' ' ' TRP . 95.5 mt-10 -97.1 125.11 41.35 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.331 -0.856 . . . . 71.23 109.472 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 96.0 t -137.49 135.1 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.387 -0.821 . . . . 70.43 109.199 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -88.93 151.07 22.54 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.325 -0.86 . . . . 72.43 109.389 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 22.2 m -90.85 137.77 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.177 -0.952 . . . . 72.13 109.792 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -171.19 56.05 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.337 -0.852 . . . . 72.02 109.511 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 178.65 176.82 46.83 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.869 -1.292 . . . . 42.23 109.869 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 15.2 mttt -70.65 -38.86 8.39 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.362 -1.081 . . . . 73.3 110.112 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 148' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 32.8 Cg_exo -57.73 -37.73 95.58 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.194 1.929 . . . . 71.33 111.83 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -87.99 -20.7 25.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.431 -0.793 . . . . 74.23 109.253 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -66.55 -41.77 88.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.302 -0.874 . . . . 72.34 109.639 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p -73.31 -32.6 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.187 -0.945 . . . . 73.35 109.58 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 23.1 tp -66.55 -43.42 85.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.209 -0.932 . . . . 55.24 109.952 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 25.8 m -72.53 -35.24 68.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.963 -1.086 . . . . 70.01 109.758 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 154' ' ' HIS . . . . . 0.551 ' CE1' ' NH2' ' B' ' 157' ' ' ARG . 1.6 m-70 -62.96 -48.84 77.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 65.32 110.259 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.0 pp -69.54 -27.09 64.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.811 -1.181 . . . . 71.54 109.294 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.62 -49.9 75.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.956 . . . . 75.32 109.499 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.551 ' NH2' ' CE1' ' B' ' 154' ' ' HIS . 21.6 ptt180 -74.86 -36.11 62.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.242 -0.911 . . . . 73.32 109.934 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -87.98 18.2 4.39 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.08 -1.012 . . . . 74.14 109.776 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -62.04 161.25 11.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.139 -0.976 . . . . 61.41 109.266 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 37.4 t0 59.73 49.47 8.11 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.329 -0.857 . . . . 72.1 109.585 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -157.66 145.21 18.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 72.25 109.292 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 94.9 mt -85.91 128.03 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -0.943 . . . . 72.31 109.192 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 5.3 m -132.24 139.35 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.456 -0.778 . . . . 64.21 109.585 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 58.4 p -86.45 172.14 10.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.223 -0.923 . . . . 74.22 109.302 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -59.58 -39.8 85.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.945 . . . . 65.31 109.59 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -57.29 -32.46 66.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 63.45 109.798 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -60.04 -48.7 80.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.96 . . . . 72.4 109.873 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 37.6 mt -62.37 -32.96 73.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.086 -1.009 . . . . 72.32 109.101 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.547 HD23 ' C ' ' B' ' 169' ' ' LEU . 6.3 tt -57.18 -64.98 0.7 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.347 -0.846 . . . . 73.34 109.542 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -64.82 -31.81 73.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.229 -0.919 . . . . 72.1 110.143 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -48.39 -58.99 3.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.124 -0.985 . . . . 62.13 110.062 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.674 ' N ' HD12 ' B' ' 172' ' ' ILE . 2.1 mp -92.82 -59.14 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.056 -1.028 . . . . 71.42 109.318 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 11.2 m-90 -78.5 66.4 4.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 72.23 109.62 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -83.61 -33.85 25.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.21 -0.931 . . . . 52.11 109.966 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -76.15 149.92 82.63 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.031 -1.043 . . . . 73.04 109.743 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -42.7 120.17 1.7 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.11 1.874 . . . . 74.13 112.364 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -145.23 -5.26 0.68 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.125 -0.984 . . . . 72.44 109.392 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 66.0 mtt 49.93 57.14 6.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.159 -0.963 . . . . 63.43 109.576 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 3.7 m -92.72 144.42 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.228 -0.92 . . . . 71.05 109.711 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 180' ' ' THR . . . . . 0.447 ' O ' ' N ' ' B' ' 182' ' ' ASN . 75.0 p -86.23 117.75 69.23 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.367 -0.833 . . . . 62.15 108.828 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -41.08 -22.93 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.778 1.652 . . . . 65.22 112.392 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 182' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' B' ' 180' ' ' THR . 43.5 t-20 -69.21 -29.8 67.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 72.31 109.614 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 183' ' ' VAL . . . . . 0.41 HG12 ' O ' ' B' ' 180' ' ' THR . 6.0 p -59.55 -27.61 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.287 -0.883 . . . . 63.32 110.014 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 35.2 mm -56.27 -25.87 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.179 -0.951 . . . . 75.03 109.688 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -58.69 -48.5 80.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 64.11 109.827 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 186' ' ' VAL . . . . . 0.423 ' C ' HE21 ' B' ' 190' ' ' GLN . 16.1 m -77.22 -26.42 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.102 -0.999 . . . . 73.0 109.865 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.26 -49.01 38.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.03 -1.044 . . . . 61.12 109.822 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 19.6 tt -66.87 -33.5 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.175 -0.953 . . . . 72.43 110.015 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -73.62 -40.62 63.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.112 -0.993 . . . . 65.14 111.163 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 190' ' ' GLN . . . . . 0.423 HE21 ' C ' ' B' ' 186' ' ' VAL . 7.6 pt20 -78.17 -37.94 44.63 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.784 -1.198 . . . . 63.24 111.194 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 191' ' ' ILE . . . . . 0.419 HD12 ' N ' ' B' ' 192' ' ' ARG . 2.4 pp -69.7 -41.85 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.741 -1.224 . . . . 74.03 110.138 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 192' ' ' ARG . . . . . 0.419 ' N ' HD12 ' B' ' 191' ' ' ILE . 9.4 ptm180 -69.64 -39.02 77.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.872 -1.142 . . . . 72.24 109.661 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -67.64 -40.04 84.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.246 -0.909 . . . . 73.1 110.586 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 194' ' ' LYS . . . . . 0.468 ' O ' ' CD ' ' B' ' 198' ' ' PRO . 13.1 pttp -80.22 -13.43 59.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.964 -1.085 . . . . 72.11 110.074 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 51.5 ttm -91.87 -30.26 16.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.199 -0.938 . . . . 44.33 109.771 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 196' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' B' ' 200' ' ' GLY . 95.8 m-20 -68.7 -41.6 78.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 71.21 110.266 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 197' ' ' LYS . . . . . 0.418 ' N ' ' HD2' ' B' ' 198' ' ' PRO . 12.1 tmtt? -60.66 -55.41 45.2 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.042 -1.036 . . . . 75.21 110.806 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 198' ' ' PRO . . . . . 0.498 ' O ' ' NZ ' ' B' ' 138' ' ' LYS . 29.3 Cg_endo -60.78 -54.95 1.6 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.371 1.381 . . . . 75.32 111.829 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.56 -45.67 78.6 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.084 -1.01 . . . . 72.25 108.878 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 200' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' B' ' 196' ' ' ASP . . . 87.13 -31.58 4.35 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.688 -1.365 . . . . 64.53 109.688 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 201' ' ' ILE . . . . . 0.708 ' N ' HD12 ' B' ' 201' ' ' ILE . 2.0 mp -92.21 138.34 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.245 -1.15 . . . . 44.23 109.087 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 29.2 t -87.51 139.78 30.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.284 -0.885 . . . . 54.01 109.271 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 10.2 p -144.84 22.17 1.6 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.212 -0.93 . . . . 74.4 109.687 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.424 HG12 ' CD2' ' B' ' 214' ' ' PHE . 26.8 m -138.11 143.1 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.247 -0.908 . . . . 72.12 109.663 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -126.35 135.42 51.46 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.569 -0.707 . . . . 65.41 109.124 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.6 138.0 35.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.322 -0.861 . . . . 71.33 109.304 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.42 HG22 ' H ' ' B' ' 209' ' ' ARG . 7.2 p -148.69 141.78 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -0.954 . . . . 63.5 109.442 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -66.86 -41.41 87.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.916 . . . . 74.45 109.435 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 209' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' B' ' 211' ' ' GLY . 49.2 mtp85 -60.46 147.68 40.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.914 . . . . 74.14 109.553 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 49.87 -89.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.351 -0.843 . . . . 74.43 109.841 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 211' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' B' ' 209' ' ' ARG . . . -170.95 -100.82 0.14 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.776 -1.33 . . . . 64.45 109.776 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 212' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' B' ' 212' ' ' TYR . 25.5 m-85 -130.15 153.53 48.43 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.548 -0.972 . . . . 74.21 108.855 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 5.2 ptm85 -127.43 149.93 49.87 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.383 -0.823 . . . . 74.03 109.81 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 214' ' ' PHE . . . . . 0.424 ' CD2' HG12 ' B' ' 204' ' ' VAL . 23.6 m-85 -117.97 131.13 56.53 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.908 -0.775 . . . . 74.34 108.908 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 29.0 p -160.11 164.0 33.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.064 -1.023 . . . . 64.33 109.849 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -61.83 152.5 75.96 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.381 -0.825 . . . . 70.04 108.931 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -68.16 -156.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.151 1.901 . . . . 65.11 111.482 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' B' ' 220' ' ' ALA . 51.2 mtpt -44.94 153.05 0.52 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.262 -0.899 . . . . 73.15 109.414 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -34.03 -26.45 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.831 2.354 . . . . 71.31 113.04 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 220' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' B' ' 218' ' ' LYS . . . 50.98 -165.18 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.057 -1.027 . . . . 75.45 109.456 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 23.9 p -71.96 8.75 1.12 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 72.22 109.565 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 47.41 39.11 8.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.165 -0.959 . . . . 54.53 109.572 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.051 -0.976 . . . . 71.13 109.541 -179.873 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 ttm . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.38 -0.6 . . . . 65.12 109.38 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -137.78 154.95 49.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.392 -0.818 . . . . 72.33 109.394 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 83.6 t -119.79 125.96 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.547 0.689 . . . . 71.42 109.79 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.3 tp -94.42 115.94 28.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.371 -0.974 . . . . 65.12 108.371 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.576 HD22 ' CG ' ' A' ' 49' ' ' MET . 0.2 OUTLIER -117.95 110.59 17.91 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.562 -0.903 . . . . 62.43 108.562 -179.871 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.43 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 12.3 mt -94.41 105.26 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 120.791 -1.193 . . . . 71.15 109.507 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -139.52 124.72 18.92 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.241 -0.912 . . . . 75.34 109.259 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -71.83 -32.37 67.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 72.44 109.505 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -83.42 113.44 20.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.915 . . . . 63.02 109.462 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.2 p -68.07 -25.34 65.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 72.34 109.522 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.5 t -67.99 -53.59 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -0.925 . . . . 74.02 109.609 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.509 HD13 ' O ' ' A' ' 12' ' ' LEU . 0.2 OUTLIER -67.62 -38.85 84.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 71.43 108.951 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.51 -25.8 75.14 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 108.436 -1.866 . . . . 61.32 108.436 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.51 -58.05 10.13 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.477 -1.449 . . . . 71.2 109.477 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.417 ' H ' ' HG2' ' A' ' 15' ' ' GLU . 6.7 pt-20 -53.26 -46.78 69.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.411 -1.053 . . . . 71.32 109.676 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 86.0 mt -64.52 -50.93 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.866 -1.146 . . . . 63.23 108.96 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -49.2 -52.91 23.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 51.11 109.708 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.405 ' CD ' ' N ' ' A' ' 18' ' ' LYS . 0.7 OUTLIER -83.51 2.44 36.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.139 -0.976 . . . . 73.34 109.444 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.23 -60.98 1.95 Allowed Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.909 -1.276 . . . . 62.15 109.909 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.419 HD23 ' N ' ' A' ' 20' ' ' LEU . 1.7 pt? -72.66 -19.37 61.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -1.161 . . . . 73.51 110.034 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -56.87 -31.64 65.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.972 -1.08 . . . . 74.25 109.468 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.2 t -60.68 -28.92 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 70.04 109.327 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.422 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 11.5 mptt -76.55 -1.21 26.29 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.262 -0.899 . . . . 73.23 109.28 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.0 36.56 8.97 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.156 -1.177 . . . . 75.54 110.156 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -119.51 157.51 28.17 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.497 -1.002 . . . . 73.43 109.326 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.3 mmt -108.12 138.62 44.08 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.522 -0.918 . . . . 43.24 108.522 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.54 159.29 43.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.134 -0.979 . . . . 62.11 110.13 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -136.68 155.44 49.87 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.507 -0.746 . . . . 74.42 109.0 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.55 136.68 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.372 -0.83 . . . . 72.15 109.099 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.8 p -133.25 164.94 25.94 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.385 -0.822 . . . . 71.42 109.313 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.43 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 4.9 pt-20 -90.59 -105.73 0.1 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.259 -0.901 . . . . 72.33 109.853 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.5 p -78.23 170.63 16.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 74.24 109.961 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.9 mt -55.97 -30.87 62.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.564 -0.71 . . . . 71.53 109.794 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -50.41 -46.25 56.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 74.23 109.584 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.06 -39.41 90.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 54.03 109.418 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.34 -44.31 34.83 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.572 -1.411 . . . . 61.41 109.572 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -63.02 -37.29 86.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -1.139 . . . . 74.34 109.457 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -81.22 -38.09 27.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 75.33 109.655 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.4 tp -68.71 -46.65 68.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.31 -0.869 . . . . 74.33 109.937 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 41' ' ' ASP . 3.5 ppp? -63.09 -25.56 68.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.129 -0.982 . . . . 70.32 109.793 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 40' ' ' MET . 97.5 m-20 -66.51 -41.14 89.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.082 -1.011 . . . . 71.22 109.973 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.1 pt -82.82 -27.84 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.115 -0.991 . . . . 74.14 110.16 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 40' ' ' MET . 88.7 mtt-85 -129.74 144.46 51.3 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.336 -0.853 . . . . 72.24 109.449 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -91.51 154.13 19.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.239 -0.913 . . . . 75.42 109.521 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -134.76 157.6 46.32 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.491 -0.756 . . . . 74.23 109.176 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -102.7 -42.56 5.85 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.387 -0.821 . . . . 72.04 109.464 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.441 HD13 ' C ' ' A' ' 47' ' ' LEU . 0.4 OUTLIER -104.36 109.7 21.65 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.514 -0.741 . . . . 72.13 109.224 -179.82 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.418 ' N ' HD13 ' A' ' 47' ' ' LEU . 74.7 t -94.09 99.86 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.202 -0.937 . . . . 72.34 108.834 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.576 ' CG ' HD22 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -114.1 129.1 56.63 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.154 -0.684 . . . . 74.11 109.154 -179.603 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.437 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 1.3 p -134.64 133.13 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.536 -0.728 . . . . 61.12 109.89 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.5 p -96.83 1.41 50.64 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.543 -0.723 . . . . 73.11 109.435 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.437 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 55.3 m-20 -76.19 141.51 41.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.198 -0.939 . . . . 52.55 109.416 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.467 ' C ' ' H ' ' A' ' 55' ' ' ALA . 0.7 OUTLIER -79.75 -38.58 32.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 44.22 110.204 -179.479 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -71.18 10.5 0.56 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.035 -1.04 . . . . 70.44 109.364 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.467 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -72.39 -20.51 61.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -0.831 . . . . 64.14 110.298 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 55' ' ' ALA . 68.7 mt -41.18 -47.65 3.32 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.509 -0.744 . . . . 44.14 110.296 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 m -70.28 -35.21 73.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.931 -1.105 . . . . 55.23 108.97 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.659 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 67.7 t80 -66.36 -59.26 3.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.392 -0.817 . . . . 74.44 109.849 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.4 m -52.36 -34.14 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.696 -1.253 . . . . 74.03 109.345 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 p -57.79 -51.83 67.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 64.3 109.732 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -69.32 -28.92 66.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.02 . . . . 64.44 109.983 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.659 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 7.6 mm -67.08 -24.08 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.88 -1.138 . . . . 63.21 109.835 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -86.15 -53.33 5.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.034 -1.041 . . . . 74.42 110.562 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.443 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 14.9 pt-20 -63.78 -43.14 97.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.9 -1.125 . . . . 70.32 110.128 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.443 ' N ' ' CG ' ' A' ' 64' ' ' GLU . 78.2 mttt -79.02 -61.0 2.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 75.22 109.092 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.53 ' N ' ' ND1' ' A' ' 66' ' ' HIS . 0.2 OUTLIER -97.18 80.23 2.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.326 -0.859 . . . . 74.13 108.876 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.9 m -79.02 -25.9 43.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.015 -1.053 . . . . 73.24 110.22 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.3 t -82.55 51.77 1.93 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.114 -0.991 . . . . 61.01 110.208 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 66' ' ' HIS . 15.3 tt -156.98 160.94 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.938 -1.101 . . . . 71.33 109.945 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 71' ' ' VAL . 90.6 t -95.8 160.15 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.178 -0.951 . . . . 72.13 109.135 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.467 ' N ' HG12 ' A' ' 70' ' ' VAL . 3.6 t -146.16 121.24 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.955 -1.091 . . . . 54.21 109.942 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.515 ' O ' ' SD ' ' A' ' 49' ' ' MET . 3.5 mp -119.83 103.41 9.32 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.116 -1.068 . . . . 50.24 108.116 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.9 p -95.8 146.27 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.487 -0.931 . . . . 74.41 108.487 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.453 ' O ' ' OG ' ' A' ' 75' ' ' SER . 0.5 OUTLIER -118.44 165.87 13.36 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.468 -0.77 . . . . 72.31 109.226 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 74' ' ' SER . 3.1 m -168.3 124.08 1.0 Allowed 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 119.393 -0.923 . . . . 64.54 110.242 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.52 1.45 1.19 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.552 -0.718 . . . . 74.13 109.809 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 75' ' ' SER . 33.8 m120 -120.64 62.87 10.1 Favored Pre-proline 0 N--CA 1.501 2.101 0 O-C-N 121.396 -0.815 . . . . 73.34 110.198 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -62.99 77.9 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.157 1.905 . . . . 63.22 111.789 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 77.9 p -104.36 151.72 23.13 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.566 -0.901 . . . . 62.53 108.566 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -31.9 66.8 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.243 -0.911 . . . . 73.44 109.309 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.511 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 78.0 mm-40 -66.29 -36.21 82.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.15 -0.969 . . . . 71.42 109.22 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -71.17 -35.48 71.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.331 -0.856 . . . . 73.43 109.621 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.77 -52.57 64.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 74.22 109.689 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.6 m -60.52 -36.0 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.187 -0.946 . . . . 73.2 109.258 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' A' ' 81' ' ' GLU . 27.9 m80 -71.77 -31.15 66.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.274 -0.891 . . . . 53.33 109.561 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -65.17 -40.1 93.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 64.11 110.177 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.501 ' CZ ' ' HB1' ' B' ' 111' ' ' ALA . 89.3 t80 -83.36 -37.64 23.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.954 -1.092 . . . . 74.34 109.32 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -68.21 -42.91 79.13 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.242 -0.911 . . . . 74.42 109.493 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -66.81 -49.95 64.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -0.996 . . . . 74.24 109.369 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 143.73 72.41 0.02 OUTLIER Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.017 -1.233 . . . . 61.51 110.017 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -138.25 124.16 20.04 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.242 -1.152 . . . . 55.33 109.201 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 13.9 t70 -61.13 -41.72 97.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 73.42 109.336 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 66.8 m-20 -152.05 159.34 43.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.325 -0.859 . . . . 75.04 109.337 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -124.14 131.71 53.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.605 -0.685 . . . . 71.33 109.449 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.5 mt -123.41 140.62 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-O 122.084 0.945 . . . . 71.13 110.381 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.0 121.49 13.12 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.901 -1.148 . . . . 64.32 107.901 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.694 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -45.46 -54.59 14.53 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.128 -0.983 . . . . 62.2 111.428 -178.756 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 2.5 Cg_endo -40.47 -9.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 121.08 1.187 . . . . 73.11 113.289 -176.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.694 ' N ' ' O ' ' A' ' 97' ' ' LYS . 67.5 m-85 58.6 99.39 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.514 -0.741 . . . . 65.22 109.007 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.4 ttm-85 -53.05 -41.62 64.98 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.169 -0.957 . . . . 72.35 109.37 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.822 ' O ' ' N ' ' A' ' 103' ' ' LYS . 23.1 t -172.86 36.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.982 -1.074 . . . . 71.32 110.929 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.6 mt 44.97 -68.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-N 118.693 0.679 . . . . 75.43 110.792 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.822 ' N ' ' O ' ' A' ' 101' ' ' SER . 21.3 tptm -49.22 -36.26 19.55 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.01 -1.056 . . . . 71.41 108.295 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.94 -40.91 83.22 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.189 -1.041 . . . . 63.24 108.189 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.8 -38.17 88.25 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.835 -0.802 . . . . 73.22 108.835 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.23 -42.13 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 60.11 109.353 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.44 -41.17 63.04 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.216 -0.927 . . . . 70.42 108.786 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.525 ' NE ' ' OE2' ' B' ' 83' ' ' GLU . 98.7 mtt180 -68.66 -37.84 79.96 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.35 -0.844 . . . . 74.41 109.282 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.62 -30.84 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.041 -1.037 . . . . 62.54 108.314 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -63.24 -54.81 31.55 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.777 -0.823 . . . . 74.34 108.777 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.465 ' HB2' ' CZ ' ' B' ' 87' ' ' PHE . . . -53.11 -35.87 60.13 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.402 -0.811 . . . . 73.32 109.396 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -57.76 -48.95 78.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.216 -0.927 . . . . 52.41 109.25 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 78.6 mt -144.53 97.73 3.08 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.137 -0.977 . . . . 65.24 109.496 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.403 ' O ' ' CG ' ' A' ' 115' ' ' PHE . 42.0 mtp180 -85.12 -59.02 2.45 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.205 -0.935 . . . . 64.45 108.999 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.403 ' CG ' ' O ' ' A' ' 114' ' ' ARG . 56.9 m-85 -156.55 89.27 1.1 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.256 -0.902 . . . . 74.43 109.542 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.474 ' CD1' ' N ' ' A' ' 116' ' ' TRP . 7.8 p-90 -93.17 133.5 36.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.237 -0.915 . . . . 74.42 109.078 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 178.42 98.35 0.11 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.586 -1.406 . . . . 75.04 109.586 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.83 ' HB3' ' OE2' ' A' ' 132' ' ' GLU . 31.0 t -159.61 176.97 11.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -1.113 . . . . 61.14 109.495 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -158.12 120.02 3.63 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.841 -0.8 . . . . 65.24 108.841 -178.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.8 t -83.62 -25.93 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.073 -1.017 . . . . 73.11 109.056 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.447 HG21 ' O ' ' A' ' 156' ' ' ALA . 28.2 mm -111.33 121.08 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.622 -0.881 . . . . 72.24 108.622 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -127.33 109.91 12.27 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.518 -0.738 . . . . 72.34 109.446 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.412 ' O ' ' C ' ' A' ' 124' ' ' GLY . 94.4 mt -112.67 124.64 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.63 -0.878 . . . . 71.44 108.63 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 123' ' ' ILE . . . -34.16 -44.22 0.37 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 112.109 -0.397 . . . . 73.4 112.109 -178.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.492 ' CB ' HD13 ' A' ' 126' ' ' LEU . 62.1 m-20 -63.7 -56.38 16.14 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.987 -1.302 . . . . 74.45 109.94 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.537 ' H ' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -144.12 166.44 25.01 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.113 -0.992 . . . . 54.21 110.083 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.4 m -106.49 145.07 32.27 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.229 -0.919 . . . . 54.5 109.894 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.9 mt -137.24 134.62 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.165 -0.959 . . . . 45.15 109.76 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.7 t -121.53 113.42 32.07 Favored Pre-proline 0 N--CA 1.499 1.994 0 N-CA-C 109.24 -0.652 . . . . 71.11 109.24 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -81.05 -54.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.719 1.613 . . . . 65.41 112.109 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -55.57 -42.48 74.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 63.32 109.147 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.83 ' OE2' ' HB3' ' A' ' 118' ' ' SER . 72.1 mt-10 -82.56 -4.19 57.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.288 -0.883 . . . . 72.52 109.201 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 47.51 66.35 1.04 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.334 -0.854 . . . . 75.33 109.797 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -159.58 142.76 14.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.063 -1.023 . . . . 71.23 109.783 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.0 tt -126.94 138.36 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.468 -0.77 . . . . 74.02 109.897 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.1 mm -118.03 121.77 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.728 -0.842 . . . . 60.23 108.728 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -140.29 146.01 38.0 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.102 -0.998 . . . . 62.32 110.014 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 83.0 mttt 53.87 26.72 6.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.481 -0.762 . . . . 75.4 110.215 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.18 9.08 87.24 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 120.122 -1.037 . . . . 72.24 110.857 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 43.7 mtp180 -103.11 142.89 33.35 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.194 -1.18 . . . . 71.22 109.259 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -110.74 121.96 46.63 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.899 -0.778 . . . . 71.42 108.899 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.5 143.95 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 120.924 -1.11 . . . . 53.02 110.698 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.568 ' CD ' ' H ' ' A' ' 143' ' ' GLU . 2.1 pm0 -93.65 134.63 35.75 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.398 -1.334 . . . . 60.45 107.398 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.1 136.65 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 120.936 -1.103 . . . . 74.44 110.514 -178.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.13 104.11 0.99 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.643 -0.66 . . . . 65.15 109.498 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -166.88 -147.49 5.26 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.748 -1.341 . . . . 73.34 109.748 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.455 ' H ' ' HD2' ' A' ' 148' ' ' PRO . 30.4 mttt -92.71 -59.72 0.21 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.212 -1.17 . . . . 72.22 110.691 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.762 ' HG2' ' CE1' ' A' ' 149' ' ' PHE . 21.7 Cg_endo -57.94 -15.18 21.07 Favored 'Trans proline' 0 N--CA 1.5 1.898 0 C-N-CA 121.913 1.742 . . . . 65.23 111.937 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.762 ' CE1' ' HG2' ' A' ' 148' ' ' PRO . 4.1 m-85 -98.8 -22.87 15.62 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.175 -0.953 . . . . 60.11 110.196 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -59.61 -35.63 74.71 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.77 -1.206 . . . . 64.21 108.848 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.3 p -70.45 -27.86 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.238 -0.914 . . . . 72.02 108.619 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 56.9 tp -64.48 -49.55 70.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.343 -0.848 . . . . 73.31 109.585 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.46 -33.46 74.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.816 -1.177 . . . . 74.31 108.691 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -54.24 -54.83 34.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.439 -0.788 . . . . 74.31 110.199 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.4 pp -75.26 -23.19 57.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.104 -0.998 . . . . 75.34 109.758 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.447 ' O ' HG21 ' A' ' 121' ' ' ILE . . . -55.13 -38.44 68.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.159 -0.963 . . . . 62.14 108.753 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' A' ' 159' ' ' ARG . 45.1 mtp180 -86.8 -56.08 3.56 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.285 -1.005 . . . . 61.03 108.285 178.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.437 ' N ' ' CD2' ' A' ' 158' ' ' HIS . 8.0 m170 -68.92 47.77 0.06 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.573 -0.899 . . . . 74.12 108.573 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 214' ' ' PHE . 63.9 mtm180 -53.4 -60.04 3.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.609 -0.682 . . . . 71.13 110.271 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -95.6 94.19 7.6 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.165 -0.96 . . . . 75.45 109.283 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLN . . . . . 1.362 ' NE2' ' O ' ' A' ' 162' ' ' ILE . 21.9 tm0? -170.16 142.85 2.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.025 -1.047 . . . . 73.41 109.938 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 1.362 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 2.0 mp -87.74 139.51 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.258 -1.016 . . . . 74.41 108.258 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.561 ' CG1' ' OE1' ' A' ' 161' ' ' GLN . 17.6 m -126.82 150.94 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.463 -0.773 . . . . 72.31 109.893 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 7.2 t -99.78 158.23 15.94 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.499 -0.751 . . . . 74.12 109.218 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.466 ' HB3' HD13 ' A' ' 184' ' ' ILE . 65.3 mttm -55.67 -54.07 48.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.344 -0.847 . . . . 70.43 110.01 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -63.11 -27.97 69.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 73.52 110.343 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.441 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 46.1 tt0 -62.05 -54.37 42.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.005 -1.06 . . . . 74.52 110.08 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 48.9 mt -59.33 -44.78 92.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.884 -1.135 . . . . 72.31 109.36 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 173' ' ' TRP . 4.2 mm? -62.24 -53.04 60.96 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.147 -0.971 . . . . 53.33 109.731 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 167' ' ' GLN . 14.2 p30 -71.1 -4.93 27.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.016 -1.053 . . . . 62.44 110.174 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -83.15 -59.01 2.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.06 -1.025 . . . . 60.21 109.927 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.74 HD12 ' N ' ' A' ' 172' ' ' ILE . 1.9 mp -85.59 -43.66 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.935 -1.103 . . . . 75.32 109.291 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' TRP . . . . . 0.458 ' O ' ' O ' ' A' ' 169' ' ' LEU . 23.5 m-90 -106.49 115.46 30.24 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.442 -0.786 . . . . 73.14 109.755 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -144.23 19.65 1.74 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.882 -1.137 . . . . 73.24 109.209 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.579 ' H ' ' CD ' ' A' ' 176' ' ' PRO . 0.9 OUTLIER -172.74 -44.63 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 44.43 109.623 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.579 ' CD ' ' H ' ' A' ' 175' ' ' GLU . 37.0 Cg_exo -60.66 -60.72 0.23 Allowed 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.091 1.861 . . . . 72.51 111.747 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.511 ' C ' ' H ' ' A' ' 179' ' ' VAL . 61.0 mm-40 -86.24 152.95 22.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.203 -0.936 . . . . 63.24 109.281 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.539 ' O ' ' N ' ' A' ' 180' ' ' THR . 32.0 ttm -60.81 -1.24 0.38 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.936 . . . . 73.5 108.922 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.572 ' O ' HG13 ' A' ' 179' ' ' VAL . 0.3 OUTLIER 38.17 23.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.412 0.625 . . . . 65.22 110.763 179.616 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 178' ' ' MET . 60.0 m -47.59 135.63 10.15 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.01 -1.056 . . . . 71.42 108.843 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.01 72.54 1.56 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.637 1.558 . . . . 41.22 111.723 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 182' ' ' ASN . 25.1 p-10 -168.36 -26.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.312 -0.868 . . . . 64.54 109.527 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 183' ' ' VAL . 11.0 m -76.88 -0.53 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 74.02 109.415 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.488 ' O ' HG22 ' A' ' 188' ' ' ILE . 50.6 mt -51.23 -46.85 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 72.33 109.546 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -56.0 -30.85 62.44 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.401 -0.812 . . . . 74.4 110.17 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 18.0 t -75.13 -53.18 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.041 -1.037 . . . . 70.42 110.735 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.8 -44.5 93.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.034 -1.041 . . . . 52.11 110.697 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 184' ' ' ILE . 8.1 tp -69.84 -37.91 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.112 -0.993 . . . . 71.4 110.418 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.412 ' N ' HG23 ' A' ' 188' ' ' ILE . 26.6 t-20 -70.73 -48.61 53.61 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.111 -0.993 . . . . 73.44 110.738 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.449 ' CG ' ' N ' ' A' ' 191' ' ' ILE . 17.5 pt20 -64.44 -45.59 86.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.909 -1.119 . . . . 71.42 110.145 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.449 ' N ' ' CG ' ' A' ' 190' ' ' GLN . 89.6 mt -59.53 -46.68 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.05 -1.031 . . . . 61.55 109.711 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 19.5 mtp-105 -60.01 -45.08 93.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.025 -1.047 . . . . 63.34 109.606 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -65.85 -29.29 69.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 61.24 109.589 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -93.88 -1.46 54.77 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.244 -0.91 . . . . 75.13 109.996 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 36.5 ttm -96.84 -60.47 1.59 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.04 -1.038 . . . . 74.02 109.907 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 196' ' ' ASP . 41.8 t0 -54.94 -22.55 15.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.306 -0.871 . . . . 74.02 110.583 -178.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.432 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 1.3 mptm? -73.27 -65.81 0.63 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.917 -1.114 . . . . 75.43 110.221 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' PRO . . . . . 0.432 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 30.7 Cg_endo -62.18 -56.71 0.64 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.501 1.468 . . . . 72.32 112.355 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 18.8 mt -64.12 -40.49 96.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.176 -0.953 . . . . 74.54 109.763 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 86.3 -34.13 3.51 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.916 -1.674 . . . . 61.51 108.916 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 35.6 mm -111.58 134.82 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.614 -0.933 . . . . 61.22 108.895 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 59.5 p -95.08 166.15 12.07 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.287 -0.883 . . . . 72.0 110.345 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.9 34.41 0.26 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.348 -0.982 . . . . 74.44 108.348 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 23.7 m -135.4 137.18 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.541 -0.724 . . . . 64.35 109.329 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -120.3 135.39 55.02 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.61 -0.681 . . . . 71.41 109.408 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.5 135.13 42.42 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.317 -0.865 . . . . 73.52 109.115 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.7 145.74 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.201 -0.937 . . . . 71.02 109.465 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -77.5 76.55 4.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.94 . . . . 72.12 109.502 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -164.01 -126.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.229 -0.919 . . . . 64.41 109.432 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 18.7 tpt85 -49.39 -43.21 44.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.946 . . . . 71.54 109.733 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 160.46 -111.47 0.48 Allowed Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.686 -1.245 . . . . 72.03 110.208 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -115.45 171.26 7.83 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.503 -0.998 . . . . 75.54 109.433 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -142.2 133.0 25.64 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.246 -0.909 . . . . 75.31 109.699 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.437 ' O ' ' O ' ' A' ' 159' ' ' ARG . 7.2 m-85 -105.4 131.54 52.7 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.88 -0.785 . . . . 75.41 108.88 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 21.3 t -157.08 150.55 24.21 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.942 -0.762 . . . . 74.14 108.942 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -61.77 150.54 81.86 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.047 -1.033 . . . . 75.32 108.913 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.5 -159.89 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.412 2.075 . . . . 73.11 112.455 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.88 162.14 0.2 Allowed Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.542 -0.724 . . . . 75.25 109.315 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -41.44 111.73 0.18 Allowed 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.875 1.717 . . . . 75.1 111.83 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -57.34 -37.52 72.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.293 -0.879 . . . . 71.14 110.035 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 18.2 p -157.18 177.6 11.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.038 -1.039 . . . . 71.13 109.93 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -143.43 -47.1 0.29 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.401 -0.812 . . . . 75.35 109.093 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.009 -0.996 . . . . 73.41 109.416 179.889 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.541 ' N ' ' CZ ' ' B' ' 2' ' ' ARG . 56.1 ttm . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.485 -0.561 . . . . 71.14 109.485 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.541 ' CZ ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -128.14 147.08 50.53 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.996 -0.742 . . . . 73.23 108.996 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 96.8 t -111.11 123.64 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.642 0.734 . . . . 72.24 109.947 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.584 HD11 ' CG1' ' B' ' 6' ' ' ILE . 1.8 tp -92.79 118.65 31.32 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.477 -0.934 . . . . 54.33 108.477 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.526 HD23 ' N ' ' B' ' 6' ' ' ILE . 1.2 tt -119.08 118.05 30.38 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.318 -0.993 . . . . 74.35 108.318 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.584 ' CG1' HD11 ' B' ' 4' ' ' LEU . 24.0 mt -111.51 98.4 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.365 -0.834 . . . . 42.55 108.779 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.423 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 24.6 tp10 -128.93 137.44 51.41 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.623 -0.673 . . . . 74.52 109.365 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.3 -32.95 73.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.281 -0.887 . . . . 62.55 109.454 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -90.88 125.0 35.61 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.253 -0.904 . . . . 73.11 109.514 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 49.5 m -74.93 -32.99 61.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 65.54 109.799 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 96.0 t -60.14 -46.77 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.149 -0.97 . . . . 75.55 109.728 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.507 ' CD2' ' N ' ' B' ' 12' ' ' LEU . 3.5 mm? -63.99 -36.48 84.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 70.14 109.411 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.56 -27.31 71.41 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 108.56 -1.816 . . . . 75.4 108.56 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.59 -53.18 40.36 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 109.543 -1.423 . . . . 65.44 109.543 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -58.97 -46.31 88.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.373 -1.075 . . . . 60.21 109.789 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 36.8 mm -64.45 -40.11 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.816 -1.177 . . . . 75.15 108.826 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.462 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 83.0 tt0 -61.62 -44.92 96.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.27 -0.894 . . . . 73.01 109.317 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -84.96 1.38 47.68 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 74.3 109.196 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.48 -55.42 2.33 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.618 -1.393 . . . . 70.54 109.618 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -75.7 -20.71 58.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -1.13 . . . . 71.34 109.839 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 82.5 m-20 -52.54 -33.74 46.9 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.037 -1.039 . . . . 64.41 109.547 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 75.9 t -58.2 -29.69 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.229 -0.919 . . . . 74.23 109.278 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -80.12 -7.47 58.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.295 -0.878 . . . . 63.42 109.485 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.57 40.47 7.75 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.327 -1.109 . . . . 53.43 110.327 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -119.12 160.29 22.37 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.428 -1.042 . . . . 71.12 109.096 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.7 mmt -105.15 139.63 39.53 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.631 -0.878 . . . . 75.24 108.631 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.2 155.72 46.01 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.255 -0.903 . . . . 72.12 110.086 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' B' ' 28' ' ' ASP . 2.1 p30 -137.56 140.07 40.82 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.9 -0.778 . . . . 72.31 108.9 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 p -104.61 138.42 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.489 -0.93 . . . . 64.43 108.489 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 16.0 p -136.79 166.5 23.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.35 -0.844 . . . . 65.41 109.306 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.476 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 3.2 pt-20 -90.92 -98.17 0.11 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.242 -0.911 . . . . 71.02 109.772 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 24.0 t -78.37 165.18 24.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 51.11 110.166 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 20.7 mt -55.52 -30.65 61.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.577 -0.702 . . . . 71.24 109.957 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -53.27 -46.15 69.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.137 -0.977 . . . . 74.32 109.964 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.476 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 75.0 m-20 -67.33 -42.27 83.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.073 -1.017 . . . . 73.03 109.444 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.59 -39.23 78.79 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.478 -1.449 . . . . 30.21 109.478 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -67.39 -38.21 84.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.322 -1.104 . . . . 74.42 109.774 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -80.2 -39.66 28.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.089 -1.007 . . . . 74.42 109.888 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 39.1 tp -68.52 -37.64 80.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.923 . . . . 75.41 110.226 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 40' ' ' MET . . . . . 0.444 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.4 ppp? -76.29 -22.68 54.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.959 -1.088 . . . . 60.41 110.211 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -64.33 -40.8 96.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.021 -1.049 . . . . 53.23 110.193 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.8 pt -82.05 -42.0 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.052 -1.03 . . . . 71.23 110.178 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' B' ' 40' ' ' MET . 2.2 mpt_? -94.86 150.71 19.89 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.029 -1.044 . . . . 72.22 109.278 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -68.68 -162.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 63.54 109.081 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -179.11 154.78 0.69 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.008 -1.057 . . . . 64.35 109.927 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -136.98 -46.87 0.58 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.455 -0.778 . . . . 62.22 108.951 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.513 HD13 ' C ' ' B' ' 47' ' ' LEU . 0.9 OUTLIER -104.08 110.66 22.92 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.43 -0.952 . . . . 73.12 108.43 179.548 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.464 ' N ' HD13 ' B' ' 47' ' ' LEU . 75.9 t -96.77 98.29 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.268 -0.895 . . . . 65.11 109.357 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.412 ' CE ' ' OG ' ' B' ' 74' ' ' SER . 3.8 ttt -113.71 130.29 56.45 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.623 0.725 . . . . 73.44 109.414 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.409 HG21 ' HB2' ' B' ' 55' ' ' ALA . 0.3 OUTLIER -144.27 130.45 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.496 -0.753 . . . . 34.5 109.132 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 51' ' ' SER . . . . . 0.423 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 95.5 p -91.92 -2.2 56.91 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.519 -0.738 . . . . 73.21 110.014 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -75.58 138.01 41.18 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.136 -0.978 . . . . 70.41 109.703 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.489 ' C ' ' H ' ' B' ' 55' ' ' ALA . 25.7 mtmm -74.5 -50.23 19.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.252 -0.905 . . . . 65.0 109.993 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -50.41 -10.57 0.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.168 -0.958 . . . . 75.21 109.545 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.489 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -64.04 -20.66 66.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.406 -0.809 . . . . 55.33 110.28 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' B' ' 55' ' ' ALA . 29.5 mt -40.89 -50.11 3.22 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.444 -0.785 . . . . 63.14 110.224 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 23.2 m -69.77 -32.68 71.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.038 -1.039 . . . . 63.5 109.124 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 58' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' B' ' 55' ' ' ALA . 66.9 t80 -65.34 -45.52 83.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.355 -0.841 . . . . 72.33 110.068 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.413 ' H ' HG22 ' B' ' 59' ' ' VAL . 12.0 m -65.57 -34.88 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.536 -1.353 . . . . 74.54 109.45 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 20.3 t -57.15 -50.2 73.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.231 -0.918 . . . . 71.24 109.569 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -66.79 -33.19 75.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 74.31 110.083 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' B' ' 62' ' ' ILE . 20.6 mm -65.93 -38.51 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.783 -1.198 . . . . 72.14 109.82 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 56.7 mmtt -67.25 -46.99 72.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.998 -1.064 . . . . 73.32 110.519 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.434 ' CG ' ' N ' ' B' ' 65' ' ' LYS . 7.7 pt-20 -74.46 -43.15 57.43 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.804 -1.185 . . . . 73.12 110.224 -179.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.448 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 66.9 mttm -71.05 -23.63 62.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 72.44 109.807 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.629 ' O ' HG22 ' B' ' 69' ' ' ILE . 97.3 m-70 -155.0 65.94 0.65 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.135 -0.978 . . . . 63.31 109.462 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.461 ' O ' ' N ' ' B' ' 69' ' ' ILE . 36.1 m -54.46 -36.44 64.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.259 -0.9 . . . . 73.1 109.95 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 29.2 m -68.13 48.11 0.05 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.056 -1.028 . . . . 71.53 109.7 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 69' ' ' ILE . . . . . 0.629 HG22 ' O ' ' B' ' 66' ' ' HIS . 16.6 tt -144.16 154.31 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.246 -0.909 . . . . 74.4 109.27 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t -95.39 155.44 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.097 -1.002 . . . . 75.12 109.106 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 42.0 t -141.86 125.61 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.155 -0.966 . . . . 73.2 109.491 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.646 ' HG ' HD11 ' B' ' 95' ' ' ILE . 0.7 OUTLIER -119.5 98.38 6.1 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.6 -0.889 . . . . 73.34 108.6 -179.653 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 70.4 t -88.7 112.75 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 73.5 108.808 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.412 ' OG ' ' CE ' ' B' ' 49' ' ' MET . 0.6 OUTLIER -89.57 174.75 7.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.038 -1.039 . . . . 64.34 108.577 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.435 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 6.6 p -166.81 121.17 1.06 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.841 -1.162 . . . . 74.53 110.542 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -57.51 -32.01 66.61 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.518 -0.919 . . . . 64.5 108.518 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -111.88 90.86 13.91 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.635 -0.876 . . . . 74.25 108.635 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.93 72.19 6.27 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.939 1.759 . . . . 74.43 112.17 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 29.5 p -87.73 162.73 16.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.539 -0.726 . . . . 73.12 109.338 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -33.17 72.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.328 -0.857 . . . . 71.01 109.459 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 81' ' ' GLU . . . . . 0.519 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 76.9 mm-40 -63.45 -41.25 98.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.144 -0.973 . . . . 63.2 109.527 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -73.14 -30.4 63.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.146 -0.971 . . . . 73.22 109.58 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.525 ' OE2' ' NE ' ' A' ' 108' ' ' ARG . 36.6 tt0 -63.9 -56.06 18.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 74.3 109.668 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 84' ' ' VAL . . . . . 0.405 HG23 ' N ' ' B' ' 85' ' ' HIS . 30.9 m -58.14 -38.54 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.132 -0.98 . . . . 73.31 108.972 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 85' ' ' HIS . . . . . 0.519 ' ND1' ' O ' ' B' ' 81' ' ' GLU . 27.2 m170 -64.44 -29.08 70.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.257 -0.902 . . . . 73.24 109.093 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.16 -45.76 79.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.302 -0.874 . . . . 55.33 109.653 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 87' ' ' PHE . . . . . 0.465 ' CZ ' ' HB2' ' A' ' 111' ' ' ALA . 40.0 t80 -80.87 -31.74 35.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.997 -1.064 . . . . 74.14 109.085 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -64.33 -52.38 58.69 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.219 -0.926 . . . . 64.04 109.387 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 89' ' ' GLN . . . . . 0.502 ' NE2' ' N ' ' B' ' 89' ' ' GLN . 0.9 OUTLIER -64.71 -52.32 57.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.451 -0.781 . . . . 72.35 109.513 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.83 72.3 0.01 OUTLIER Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.103 -1.199 . . . . 65.2 110.103 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -129.17 134.64 48.11 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.451 -1.029 . . . . 52.23 108.951 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -76.95 -30.22 55.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.098 -1.001 . . . . 73.32 109.144 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 93' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 51.2 t0 -152.49 164.22 38.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.374 -0.829 . . . . 72.22 109.34 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.449 ' N ' ' OD1' ' B' ' 93' ' ' ASP . 86.4 t80 -140.21 121.06 14.47 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.481 -0.933 . . . . 64.42 108.481 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.794 ' H ' HD12 ' B' ' 95' ' ' ILE . 0.0 OUTLIER -127.17 161.49 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 O-C-N 121.36 -0.838 . . . . 72.23 110.909 -178.017 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.16 129.57 35.31 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.72 -1.215 . . . . 25.24 107.72 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.688 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -50.77 -56.75 16.84 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 120.989 -1.069 . . . . 64.32 111.572 -178.544 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 98' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 4.5 Cg_endo -41.12 -8.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.116 1.211 . . . . 63.33 113.26 -175.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 99' ' ' TYR . . . . . 0.688 ' N ' ' O ' ' B' ' 97' ' ' LYS . 55.1 m-85 60.4 116.03 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.558 -0.714 . . . . 75.13 109.405 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 31.5 ttm-85 -59.94 -31.2 69.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.925 -1.109 . . . . 74.23 108.938 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 101' ' ' SER . . . . . 0.73 ' O ' ' N ' ' B' ' 103' ' ' LYS . 46.2 t -174.26 28.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.088 -1.007 . . . . 63.34 110.552 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 53.3 mt 51.23 -68.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.768 -0.583 . . . . 74.44 110.47 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.73 ' N ' ' O ' ' B' ' 101' ' ' SER . 4.3 mmmm -58.04 -33.67 69.25 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.05 -1.093 . . . . 71.11 108.05 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.07 -44.41 95.86 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.368 -0.933 . . . . 71.45 108.499 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 17.8 tp -63.53 -49.15 74.63 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.838 -0.801 . . . . 51.31 108.838 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 90.0 t -58.52 -41.16 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 65.23 109.325 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.7 -36.05 69.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.151 -0.968 . . . . 24.32 109.202 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -79.79 -28.95 40.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.403 -0.811 . . . . 75.31 109.961 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.25 -46.09 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 120.978 -1.076 . . . . 54.24 108.785 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 110' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' B' ' 114' ' ' ARG . 23.9 pt-20 -66.22 -42.15 89.08 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.06 -1.056 . . . . 65.31 108.494 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 111' ' ' ALA . . . . . 0.501 ' HB1' ' CZ ' ' A' ' 87' ' ' PHE . . . -53.69 -39.13 64.9 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.58 -0.7 . . . . 72.24 109.418 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -65.14 -44.66 87.89 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.177 -0.952 . . . . 72.04 109.953 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 113' ' ' LEU . . . . . 0.547 ' C ' ' H ' ' B' ' 115' ' ' PHE . 58.1 mt -97.78 -60.12 1.63 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.107 -0.996 . . . . 75.35 110.768 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' B' ' 110' ' ' GLU . 58.0 mtp180 57.93 -4.85 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.466 -0.772 . . . . 75.5 110.262 -178.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 115' ' ' PHE . . . . . 0.547 ' H ' ' C ' ' B' ' 113' ' ' LEU . 63.4 t80 -171.74 -104.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.993 -1.067 . . . . 65.33 109.501 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 116' ' ' TRP . . . . . 0.443 ' N ' ' CD2' ' B' ' 115' ' ' PHE . 39.9 m95 -146.75 44.88 1.19 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.334 -0.854 . . . . 74.45 108.826 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.93 -140.96 26.56 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.216 -1.554 . . . . 44.21 109.216 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 9.2 t -151.58 138.68 19.17 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.167 -1.196 . . . . 71.4 109.395 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 119' ' ' ASN . . . . . 0.489 HD21 ' C ' ' B' ' 121' ' ' ILE . 35.1 t30 -86.54 169.44 12.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.257 -0.902 . . . . 72.32 109.653 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 11.0 t -137.6 -34.32 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.981 -0.748 . . . . 75.02 108.981 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 121' ' ' ILE . . . . . 0.489 ' C ' HD21 ' B' ' 119' ' ' ASN . 26.9 mm -112.31 134.27 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.546 -0.721 . . . . 51.41 109.147 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -148.42 133.72 18.47 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.193 -0.942 . . . . 71.53 109.609 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 1.046 HD12 ' CD ' ' B' ' 159' ' ' ARG . 16.7 tt -149.49 123.96 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.792 -0.818 . . . . 72.43 108.792 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 54.87 -136.89 44.59 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.207 -1.557 . . . . 51.23 109.207 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -89.95 1.36 56.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.221 -1.164 . . . . 74.2 109.524 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.91 138.42 31.56 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.284 -0.885 . . . . 75.42 108.739 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 35.2 m -132.26 119.56 20.97 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.481 -0.762 . . . . 74.22 109.288 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 128' ' ' ILE . . . . . 0.424 ' O ' ' OD1' ' B' ' 119' ' ' ASN . 14.0 mm -117.98 147.08 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.543 -0.723 . . . . 60.33 109.304 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 129' ' ' SER . . . . . 0.414 ' C ' HH22 ' B' ' 157' ' ' ARG . 5.9 m -137.76 132.91 17.53 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.276 -0.89 . . . . 72.31 109.137 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -80.72 -49.43 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.174 1.916 . . . . 75.13 112.455 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -57.51 -49.9 74.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.912 . . . . 75.23 110.055 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -82.36 -9.33 59.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.091 -1.006 . . . . 72.43 109.749 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 47.94 69.03 0.58 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.093 -1.004 . . . . 75.13 109.274 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -139.18 141.22 37.97 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.453 -0.779 . . . . 73.22 109.353 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 2.8 tt -120.51 126.41 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.515 -0.741 . . . . 64.14 109.487 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 32.9 mm -115.2 121.82 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.653 -0.869 . . . . 71.22 108.653 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -140.79 143.85 35.11 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.206 -0.934 . . . . 64.22 109.622 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 138' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' B' ' 138' ' ' LYS . 30.3 ttpt 54.57 9.5 0.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.547 -0.721 . . . . 72.02 109.804 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 91.55 16.65 51.95 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 110.04 -1.224 . . . . 74.32 110.04 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 140' ' ' ARG . . . . . 0.4 ' HE ' ' HE3' ' B' ' 138' ' ' LYS . 41.6 mtt-85 -107.33 144.11 34.65 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.513 -0.992 . . . . 75.34 109.706 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -102.82 118.12 36.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.568 -0.707 . . . . 71.23 109.397 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 71.8 t -136.36 137.37 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.452 -0.78 . . . . 70.43 109.012 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -80.36 132.38 35.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.906 . . . . 72.43 109.531 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 5.4 p -73.1 133.27 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.159 -0.963 . . . . 72.13 109.064 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 35.3 pttt -170.4 66.3 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.9 . . . . 72.02 109.607 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 176.6 156.2 15.0 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.369 -1.492 . . . . 42.23 109.369 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 0.615 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 19.3 mttt -65.23 -39.24 33.89 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.201 -1.176 . . . . 73.3 109.625 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 148' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 27.2 Cg_exo -61.54 -30.45 86.24 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.016 1.81 . . . . 71.33 111.218 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -94.94 -20.67 19.19 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.456 -0.778 . . . . 74.23 109.389 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -67.36 -39.23 85.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.273 -0.892 . . . . 72.34 109.486 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.45 -35.16 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 73.35 109.615 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.702 HD23 ' SD ' ' B' ' 195' ' ' MET . 0.2 OUTLIER -67.27 -42.43 83.84 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.125 0.964 . . . . 55.24 109.308 -179.76 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 153' ' ' THR . . . . . 0.436 ' CG2' ' NH2' ' B' ' 157' ' ' ARG . 34.7 m -74.08 -26.51 60.41 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.03 -1.043 . . . . 70.01 110.872 -179.023 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -71.98 -59.98 2.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.045 -1.035 . . . . 65.32 109.867 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 155' ' ' LEU . . . . . 1.011 HD13 ' N ' ' B' ' 156' ' ' ALA . 0.0 OUTLIER -62.29 -20.98 64.86 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.929 -1.107 . . . . 71.54 108.735 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 156' ' ' ALA . . . . . 1.011 ' N ' HD13 ' B' ' 155' ' ' LEU . . . -61.86 -48.05 82.29 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 120.901 -1.125 . . . . 75.32 108.233 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.436 ' NH2' ' CG2' ' B' ' 153' ' ' THR . 0.0 OUTLIER -72.72 -42.45 64.14 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.42 -0.912 . . . . 73.32 109.409 179.57 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -83.28 10.83 7.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.931 . . . . 74.14 110.389 -178.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 159' ' ' ARG . . . . . 1.046 ' CD ' HD12 ' B' ' 123' ' ' ILE . 10.4 ttp-105 -48.38 164.94 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.026 -1.046 . . . . 61.41 109.019 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 61.27 53.16 3.6 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.342 -0.849 . . . . 72.1 109.716 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -161.04 156.24 24.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.34 -0.85 . . . . 72.25 109.036 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 66.6 mt -88.86 132.49 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.997 -1.065 . . . . 72.31 108.896 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 163' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' B' ' 212' ' ' TYR . 40.1 t -141.57 136.78 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.24 -0.913 . . . . 64.21 110.353 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 6.6 t -94.65 167.94 11.15 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.096 -1.002 . . . . 74.22 109.288 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 165' ' ' LYS . . . . . 1.077 ' NZ ' ' HA ' ' B' ' 185' ' ' GLU . 22.2 mttm -61.96 -38.22 87.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.028 -1.045 . . . . 65.31 109.865 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -52.96 -39.53 63.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 63.45 110.14 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -60.94 -48.14 83.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -0.951 . . . . 72.4 110.478 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 40.5 mt -57.31 -33.54 67.8 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.91 -1.119 . . . . 72.32 109.665 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.469 HD23 ' C ' ' B' ' 169' ' ' LEU . 5.7 tt -65.38 -61.83 1.88 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.161 -0.962 . . . . 73.34 109.624 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -65.19 -28.63 69.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.36 -0.837 . . . . 72.1 110.568 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.94 -59.49 5.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.119 -0.988 . . . . 62.13 110.616 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.724 ' N ' HD12 ' B' ' 172' ' ' ILE . 2.0 mp -86.75 -59.34 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.006 -1.059 . . . . 71.42 109.172 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 173' ' ' TRP . . . . . 0.428 ' O ' ' O ' ' B' ' 169' ' ' LEU . 23.0 m-90 -80.72 133.72 35.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 72.23 108.822 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -163.19 -35.01 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.976 -1.078 . . . . 52.11 110.426 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 175' ' ' GLU . . . . . 0.613 ' N ' ' CD ' ' B' ' 176' ' ' PRO . 8.8 tt0 -80.37 -35.81 0.91 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.001 -1.062 . . . . 73.04 111.049 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' B' ' 175' ' ' GLU . 95.8 Cg_endo -90.94 -41.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 122.432 2.088 . . . . 74.13 112.795 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 49.45 14.49 0.11 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.096 -1.002 . . . . 72.44 109.5 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 178' ' ' MET . . . . . 0.447 ' N ' ' O ' ' B' ' 176' ' ' PRO . 54.8 mtp -74.55 -26.77 60.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.221 -0.924 . . . . 63.43 110.027 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 29.1 m -61.32 143.02 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.994 -1.066 . . . . 71.05 109.445 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 25.2 p -66.84 150.34 97.79 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.142 -0.974 . . . . 62.15 109.263 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -76.58 31.73 0.41 Allowed 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.324 2.016 . . . . 65.22 112.651 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -149.57 -15.77 0.28 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.913 -1.117 . . . . 72.31 109.959 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 11.3 p -63.97 -17.86 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.19 -0.943 . . . . 63.32 109.984 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.755 HD12 ' H ' ' B' ' 184' ' ' ILE . 1.3 mp -49.74 -35.17 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.068 -1.02 . . . . 75.03 109.567 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 185' ' ' GLU . . . . . 1.077 ' HA ' ' NZ ' ' B' ' 165' ' ' LYS . 17.3 pt-20 -55.87 -36.54 67.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.994 -1.066 . . . . 64.11 109.215 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 9.2 t -75.42 -36.98 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 73.0 109.207 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.08 -55.03 28.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.36 -0.838 . . . . 61.12 109.868 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 5.4 tp -63.15 -33.93 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.098 -1.001 . . . . 72.43 109.927 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -69.04 -50.86 44.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 65.14 110.491 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -72.53 -39.08 67.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.035 -1.041 . . . . 63.24 110.157 -178.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 57.5 mt -57.22 -38.01 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.037 -1.039 . . . . 74.03 109.345 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -73.57 -44.13 58.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.037 -1.039 . . . . 72.24 109.96 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -70.5 -28.77 65.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.906 . . . . 73.1 110.601 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -82.97 -33.84 26.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.01 -1.056 . . . . 72.11 110.291 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 195' ' ' MET . . . . . 0.702 ' SD ' HD23 ' B' ' 152' ' ' LEU . 62.4 mtt -90.61 -40.8 11.71 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.053 -1.03 . . . . 44.33 110.863 -179.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 196' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 51.1 p-10 -53.32 -20.43 4.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.929 -1.107 . . . . 71.21 110.488 -178.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 197' ' ' LYS . . . . . 0.524 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 4.1 mmtp -76.19 -65.63 0.42 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.852 -1.155 . . . . 75.21 109.537 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 198' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 48.2 Cg_endo -66.12 -45.39 5.82 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.246 1.964 . . . . 75.32 111.633 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 37.1 tp -65.05 -51.09 63.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.386 -0.821 . . . . 72.25 109.342 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 85.94 -33.2 3.59 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.91 -1.276 . . . . 64.53 109.91 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 201' ' ' ILE . . . . . 0.719 ' N ' HD12 ' B' ' 201' ' ' ILE . 2.5 mp -92.19 142.15 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.131 -1.217 . . . . 44.23 109.722 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 70.3 m -119.58 133.24 55.75 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.37 -0.974 . . . . 54.01 108.37 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 24.4 p -137.22 47.42 2.11 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.312 -0.867 . . . . 74.4 109.715 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 1.6 m -143.15 122.41 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.259 -0.9 . . . . 72.12 109.219 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -107.94 129.45 55.1 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.664 -0.865 . . . . 65.41 108.664 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 206' ' ' THR . . . . . 0.43 HG22 ' H ' ' B' ' 206' ' ' THR . 0.1 OUTLIER -94.16 131.22 39.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.175 -0.953 . . . . 71.33 109.949 -179.298 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 5.0 t -129.56 122.91 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.434 -0.951 . . . . 63.5 108.434 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -61.93 -26.07 67.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 74.45 110.065 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 -68.67 -88.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.033 -1.042 . . . . 74.14 109.83 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -65.3 -63.49 1.09 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.05 -1.032 . . . . 74.43 109.668 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 157.91 -105.81 0.28 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.452 -1.459 . . . . 64.45 109.452 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 212' ' ' TYR . . . . . 0.461 ' O ' ' O ' ' B' ' 163' ' ' VAL . 39.0 m-85 -120.16 135.87 54.81 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.613 -0.933 . . . . 74.21 109.618 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -125.5 134.13 52.14 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.446 -0.784 . . . . 74.03 108.944 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 214' ' ' PHE . . . . . 0.738 ' CD1' HD23 ' B' ' 155' ' ' LEU . 80.4 m-85 -90.77 131.28 36.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.406 -0.808 . . . . 74.34 109.289 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 26.7 p -153.74 167.97 27.83 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.173 -0.954 . . . . 64.33 109.803 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 216' ' ' TYR . . . . . 0.664 ' HD2' ' HB2' ' B' ' 220' ' ' ALA . 27.5 p90 -63.52 148.44 93.88 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.42 -0.8 . . . . 70.04 109.213 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.82 162.63 27.88 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.11 1.873 . . . . 65.11 111.914 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.44 ' CB ' ' CD ' ' B' ' 219' ' ' PRO . 21.8 mttm -51.22 -64.67 1.25 Allowed Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.246 -0.909 . . . . 73.15 109.349 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 219' ' ' PRO . . . . . 0.44 ' CD ' ' CB ' ' B' ' 218' ' ' LYS . 49.0 Cg_endo -66.5 83.67 0.29 Allowed 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.195 1.93 . . . . 71.31 111.782 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 220' ' ' ALA . . . . . 0.664 ' HB2' ' HD2' ' B' ' 216' ' ' TYR . . . -122.19 129.08 51.95 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.519 -0.738 . . . . 75.45 109.274 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 65.4 m -145.25 133.96 22.23 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.31 -0.869 . . . . 72.22 109.236 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.25 -31.12 68.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.303 -0.873 . . . . 54.53 109.504 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.038 -0.982 . . . . 71.13 109.409 -179.968 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.546 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.436 -0.579 . . . . 65.12 109.436 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.418 HH11 ' HG2' ' A' ' 2' ' ' ARG . 2.0 ttt-85 -145.06 152.9 40.84 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.213 -0.929 . . . . 72.33 109.07 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 65.7 t -115.29 128.84 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.52 -0.738 . . . . 71.42 109.652 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 5' ' ' LEU . 3.7 tp -100.39 117.08 33.85 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.516 -0.74 . . . . 65.12 109.136 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 4' ' ' LEU . 60.2 tp -115.89 111.53 20.58 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.563 -0.71 . . . . 62.43 109.475 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.443 HG12 HD11 ' A' ' 4' ' ' LEU . 9.2 mt -102.24 113.42 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.213 -0.93 . . . . 71.15 108.96 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.476 ' OE1' ' CB ' ' A' ' 51' ' ' SER . 31.0 tp10 -148.41 126.88 12.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.205 -0.934 . . . . 75.34 109.572 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -69.09 -30.76 69.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -0.869 . . . . 72.44 109.173 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -84.97 114.29 22.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.34 -0.85 . . . . 63.02 109.422 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 77.2 p -70.19 -24.84 63.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.911 . . . . 72.34 109.62 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.65 -51.49 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.209 -0.932 . . . . 74.02 109.642 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.558 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.5 mm? -66.91 -33.54 75.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 71.43 109.212 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.76 -23.3 75.36 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.674 -1.77 . . . . 61.32 108.674 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.74 -53.43 15.91 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.622 -1.391 . . . . 71.2 109.622 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -60.69 -43.37 97.83 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.35 -1.088 . . . . 71.32 109.736 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 96.2 mt -65.11 -32.5 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.891 -1.131 . . . . 63.23 109.034 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -58.01 -49.81 75.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 51.11 109.298 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -88.11 0.45 55.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.228 -0.92 . . . . 73.34 109.879 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.15 -57.82 2.58 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 110.002 -1.239 . . . . 62.15 110.002 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pp -74.58 -23.25 58.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -1.128 . . . . 73.51 110.052 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.3 m-20 -51.47 -35.29 39.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.018 -1.052 . . . . 74.25 109.47 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.7 t -55.38 -41.3 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.97 . . . . 70.04 109.159 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.405 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 2.6 mptp? -63.17 -19.26 64.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.855 . . . . 73.23 109.026 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.85 40.64 4.88 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.553 -1.019 . . . . 75.54 110.553 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -119.04 160.43 22.04 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.421 -1.046 . . . . 73.43 108.502 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.8 mmt -90.14 124.33 34.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.051 -1.031 . . . . 43.24 108.872 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.25 138.58 37.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.417 -0.802 . . . . 62.11 110.059 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -127.82 126.89 42.54 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.508 -0.923 . . . . 74.42 108.508 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -106.11 130.78 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.729 -0.841 . . . . 72.15 108.729 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.9 p -135.67 160.58 38.07 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.5 -0.75 . . . . 71.42 109.485 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -89.0 -103.44 0.09 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.283 -0.886 . . . . 72.33 109.418 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.443 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 62.2 m -78.45 147.89 33.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.205 -0.934 . . . . 74.24 109.36 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.599 HD12 ' H ' ' A' ' 33' ' ' LEU . 1.7 mp -49.1 -15.71 0.12 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.328 -0.857 . . . . 71.53 110.189 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 32' ' ' SER . 78.8 mm-40 -62.65 -53.33 56.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.012 -1.055 . . . . 74.23 110.05 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 36' ' ' GLY . 19.8 p-10 -67.73 -30.27 69.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.0 -1.062 . . . . 54.03 109.262 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.543 ' N ' ' OD1' ' A' ' 35' ' ' ASP . . . -75.25 -36.11 46.36 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.142 -1.583 . . . . 61.41 109.142 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -70.09 -46.88 63.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.339 -1.095 . . . . 74.34 109.459 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -69.05 -34.1 74.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.969 . . . . 75.33 109.862 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.449 HD11 ' HE ' ' A' ' 43' ' ' ARG . 20.7 tp -79.23 -51.33 9.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.217 -0.927 . . . . 74.33 110.226 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.448 ' SD ' ' OH ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -58.2 -27.85 64.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.101 -1.0 . . . . 70.32 109.934 -179.27 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -61.09 -39.68 90.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.109 -0.994 . . . . 71.22 109.849 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.7 pt -91.44 1.39 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.072 -1.018 . . . . 74.14 110.076 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.449 ' HE ' HD11 ' A' ' 39' ' ' LEU . 86.2 mtt-85 -126.4 152.15 46.72 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.36 -0.838 . . . . 72.24 109.328 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -96.83 151.79 19.32 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.197 -0.94 . . . . 75.42 109.326 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.448 ' OH ' ' SD ' ' A' ' 40' ' ' MET . 10.0 p90 -154.76 175.23 13.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.243 -0.911 . . . . 74.23 109.646 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -135.76 -33.44 0.86 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.423 -0.798 . . . . 72.04 109.307 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.537 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -107.99 115.01 29.36 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.492 -0.755 . . . . 72.13 109.014 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.537 ' N ' HD13 ' A' ' 47' ' ' LEU . 58.3 t -102.41 98.84 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.852 -0.796 . . . . 72.34 108.852 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.474 ' SD ' ' O ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -109.59 122.75 48.13 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.096 -0.705 . . . . 74.11 109.096 -179.615 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.438 HG21 ' HB2' ' A' ' 55' ' ' ALA . 1.6 p -130.87 130.02 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 121.602 0.715 . . . . 61.12 109.702 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.476 ' CB ' ' OE1' ' A' ' 7' ' ' GLU . 44.9 p -99.1 0.54 43.81 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.435 -0.791 . . . . 73.11 109.281 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -76.03 141.52 42.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.141 -0.974 . . . . 52.55 109.341 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.485 ' C ' ' H ' ' A' ' 55' ' ' ALA . 21.2 pttm -79.36 -38.51 34.87 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.252 -0.905 . . . . 44.22 110.449 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -70.59 11.25 0.38 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.977 -1.077 . . . . 70.44 109.494 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.485 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.77 -21.12 57.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.406 -0.809 . . . . 64.14 110.589 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 55' ' ' ALA . 73.6 mt -38.11 -48.47 1.24 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.498 -0.751 . . . . 44.14 111.025 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.2 m -71.93 -36.76 70.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.889 -1.132 . . . . 55.23 109.59 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.441 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 72.9 t80 -66.33 -47.01 74.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.397 -0.815 . . . . 74.44 110.594 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.3 m -64.14 -34.42 68.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 120.636 -1.29 . . . . 74.03 109.561 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.0 t -57.75 -55.12 38.92 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.182 -0.949 . . . . 64.3 109.317 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.684 HH21 ' HZ2' ' A' ' 65' ' ' LYS . 5.7 ptm180 -61.42 -31.27 71.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 64.44 109.868 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.441 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 4.9 mm -63.03 -37.18 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.996 -1.065 . . . . 63.21 109.778 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -70.03 -54.24 14.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.036 -1.04 . . . . 74.42 110.315 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -64.85 -35.89 82.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.817 -1.177 . . . . 70.32 109.815 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.684 ' HZ2' HH21 ' A' ' 61' ' ' ARG . 46.4 mtpt -82.58 -23.3 34.5 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.063 -1.023 . . . . 75.22 109.818 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.477 ' CG ' ' C ' ' A' ' 65' ' ' LYS . 47.8 m-70 -154.38 65.53 0.69 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.043 -1.036 . . . . 74.13 109.64 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.8 t -64.69 -30.64 71.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.204 -0.935 . . . . 73.24 109.951 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 97.2 p -60.43 -17.87 47.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.168 -0.958 . . . . 61.01 110.014 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 53.7 mt -91.28 149.56 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.139 -0.975 . . . . 71.33 109.614 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 71' ' ' VAL . 91.9 t -88.33 159.18 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.344 -0.847 . . . . 72.13 109.135 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.46 ' N ' HG12 ' A' ' 70' ' ' VAL . 22.0 t -138.81 124.54 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.158 -0.963 . . . . 54.21 110.001 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.629 ' CD1' HH22 ' A' ' 108' ' ' ARG . 4.0 tt -113.43 99.09 7.51 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.617 -0.882 . . . . 50.24 108.617 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.6 t -96.71 123.22 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.364 -0.835 . . . . 74.41 108.816 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.82 -178.11 4.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.986 -1.071 . . . . 72.31 109.004 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.473 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 49.7 p -166.75 120.07 1.02 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.133 -0.979 . . . . 64.54 109.829 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -77.49 6.39 7.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.403 -0.811 . . . . 74.13 108.913 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 79' ' ' THR . 74.6 m-20 -142.24 64.96 17.63 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.947 -0.76 . . . . 73.34 108.947 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.6 81.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.919 1.746 . . . . 63.22 111.707 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 77' ' ' ASN . 41.1 p -100.56 161.89 13.3 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.776 -0.824 . . . . 62.53 108.776 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 p -66.52 -24.48 66.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.131 -0.981 . . . . 73.44 109.659 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -73.64 -38.98 64.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 71.42 109.769 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 96.1 mt-10 -70.92 -33.65 70.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.204 -0.935 . . . . 73.43 110.117 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.416 ' OE2' ' NE ' ' B' ' 100' ' ' ARG . 92.3 mt-10 -68.61 -55.8 10.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.005 -1.059 . . . . 74.22 109.745 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.53 HG23 ' N ' ' A' ' 85' ' ' HIS . 31.9 m -60.61 -42.52 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.191 -0.943 . . . . 73.2 109.414 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.53 ' N ' HG23 ' A' ' 84' ' ' VAL . 75.8 t60 -69.21 -31.58 70.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.32 -0.862 . . . . 53.33 109.498 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 82' ' ' GLU . . . -62.89 -36.64 84.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.298 -0.876 . . . . 64.11 109.822 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -78.32 -33.25 49.36 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.09 -1.006 . . . . 74.34 108.756 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -72.97 -34.03 66.21 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.447 -0.783 . . . . 74.42 109.378 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -69.93 -62.33 1.43 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 74.24 109.484 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 152.56 54.96 0.01 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.908 -1.277 . . . . 61.51 109.908 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.37 135.85 53.7 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.416 -1.049 . . . . 55.33 109.431 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 20.0 t70 -82.15 -31.65 30.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 73.42 109.127 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 95.6 m-20 -141.77 160.16 40.74 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.417 -0.802 . . . . 75.04 109.204 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.473 ' OH ' ' CB ' ' A' ' 75' ' ' SER . 82.6 t80 -139.49 105.66 5.24 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.395 -0.815 . . . . 71.33 109.122 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.438 HG22 ' N ' ' A' ' 96' ' ' ALA . 29.0 mm -111.62 157.82 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.221 -0.925 . . . . 71.13 110.674 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.438 ' N ' HG22 ' A' ' 95' ' ' ILE . . . -77.81 125.16 28.93 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.831 -1.174 . . . . 64.32 107.831 178.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.674 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -45.23 -53.85 16.1 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.016 -1.053 . . . . 62.2 111.467 -178.801 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.7 Cg_endo -42.11 -10.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 CA-C-N 119.729 0.939 . . . . 73.11 112.643 -177.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.674 ' N ' ' O ' ' A' ' 97' ' ' LYS . 57.7 m-85 58.7 112.39 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.667 -0.646 . . . . 65.22 109.694 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.51 ' NE ' ' OE2' ' B' ' 83' ' ' GLU . 37.8 ttm-85 -58.58 -38.19 77.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.948 -1.095 . . . . 72.35 108.511 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.806 ' O ' ' N ' ' A' ' 103' ' ' LYS . 6.3 t -173.24 31.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -0.872 . . . . 71.32 110.338 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.428 ' O ' ' N ' ' A' ' 105' ' ' LEU . 6.4 mm 46.77 -67.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 CA-C-N 118.343 0.519 . . . . 75.43 110.462 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.806 ' N ' ' O ' ' A' ' 101' ' ' SER . 16.0 mtpp -50.7 -32.72 20.26 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.749 -1.22 . . . . 71.41 107.923 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.75 -38.34 80.05 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.921 -1.14 . . . . 63.24 107.921 178.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 102' ' ' ILE . 2.0 tt -70.0 -47.85 60.49 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.275 -0.639 . . . . 73.22 109.275 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.6 t -64.74 -44.59 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 60.11 109.192 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.24 -40.0 64.23 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.205 -0.935 . . . . 70.42 109.093 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.629 HH22 ' CD1' ' A' ' 72' ' ' LEU . 14.6 ttp-105 -72.58 -25.15 61.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.361 -0.837 . . . . 74.41 109.667 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 83.0 mt -80.12 -33.24 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.439 -1.319 . . . . 62.54 107.439 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -55.62 31.43 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.557 -1.275 . . . . 74.34 107.557 178.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.76 -40.42 69.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.653 -0.654 . . . . 73.32 109.586 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 10.6 mmp_? -56.15 -33.37 65.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.182 -0.948 . . . . 52.41 109.581 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.65 72.88 0.99 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.928 -1.108 . . . . 65.24 110.23 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.482 ' O ' ' N ' ' A' ' 116' ' ' TRP . 43.7 mtm180 -73.41 101.55 3.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.002 -1.061 . . . . 64.45 108.871 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 47.87 14.55 0.05 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.314 -0.866 . . . . 74.43 109.902 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.482 ' N ' ' O ' ' A' ' 114' ' ' ARG . 94.9 m95 46.99 -164.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.166 -0.959 . . . . 74.42 109.675 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 168.1 40.52 0.02 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.491 -1.444 . . . . 75.04 109.491 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.6 m -83.98 -124.68 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.263 -1.139 . . . . 61.14 109.621 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 61.44 67.21 0.8 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 65.24 109.556 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.4 t -80.5 -25.76 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 73.11 109.337 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.8 mm -98.42 132.9 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.331 -0.855 . . . . 72.24 109.278 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -144.68 117.46 8.72 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.191 -0.943 . . . . 72.34 109.551 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.43 ' N ' HD13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -138.72 128.74 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.37 -0.831 . . . . 71.44 108.829 179.706 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.3 -136.25 16.81 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.519 -1.432 . . . . 73.4 109.519 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -91.53 -6.01 53.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.249 -1.148 . . . . 74.45 109.515 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.14 135.61 33.84 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.215 -0.928 . . . . 54.21 108.788 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 26.8 p -132.1 146.33 51.98 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.474 -0.766 . . . . 54.5 109.588 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.2 mt -134.61 136.7 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.324 -0.86 . . . . 45.15 109.63 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.3 t -113.89 124.78 30.43 Favored Pre-proline 0 N--CA 1.496 1.874 0 N-CA-C 109.023 -0.732 . . . . 71.11 109.023 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -80.58 -51.67 0.05 OUTLIER 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.635 1.557 . . . . 65.41 112.044 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -65.28 -44.22 88.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 63.32 109.73 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -80.98 -15.52 55.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 72.52 109.354 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 54.5 77.07 0.21 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 75.33 109.76 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -158.04 140.36 14.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 71.23 109.461 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.5 tt -120.22 133.45 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.539 -0.726 . . . . 74.02 109.6 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 26.7 mm -110.18 121.79 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.856 -0.794 . . . . 60.23 108.856 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.501 ' C ' ' H ' ' A' ' 139' ' ' GLY . 49.8 p90 -142.68 149.17 38.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.086 -1.009 . . . . 62.32 108.967 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 46.8 tttp 53.96 5.98 0.08 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.297 -0.877 . . . . 75.4 109.536 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.501 ' H ' ' C ' ' A' ' 137' ' ' TYR . . . 94.04 -6.71 72.88 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 110.079 -1.208 . . . . 72.24 110.079 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.416 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 1.0 OUTLIER -89.78 143.57 26.69 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.056 -1.261 . . . . 71.22 109.288 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -99.51 125.91 45.36 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.369 -0.832 . . . . 71.42 109.362 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.7 t -137.1 133.48 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.422 -0.798 . . . . 53.02 109.604 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.449 ' N ' ' OE1' ' A' ' 143' ' ' GLU . 45.5 mp0 -94.95 147.1 23.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.343 -0.848 . . . . 60.45 109.046 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.09 131.61 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.251 -0.906 . . . . 74.44 109.63 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.75 121.34 8.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.36 -0.837 . . . . 65.15 109.198 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.95 -143.29 10.09 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.917 -1.273 . . . . 73.34 109.917 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -70.67 -62.82 1.85 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.424 -1.045 . . . . 72.22 110.348 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -56.0 -19.68 27.11 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.934 1.756 . . . . 65.23 111.856 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.478 ' CE1' HG21 ' A' ' 153' ' ' THR . 1.0 OUTLIER -80.61 -44.49 18.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 60.11 109.189 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -60.94 -39.65 90.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 64.21 109.995 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 152' ' ' LEU . 11.5 p -77.14 -38.61 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.135 -0.978 . . . . 72.02 110.053 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.458 ' N ' HG13 ' A' ' 151' ' ' VAL . 15.0 tp -65.04 -42.8 93.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.121 -0.987 . . . . 73.31 109.737 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.478 HG21 ' CE1' ' A' ' 149' ' ' PHE . 42.9 p -72.98 -35.54 66.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.08 -1.013 . . . . 74.31 109.851 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -57.59 -52.01 67.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 74.31 109.632 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.408 ' H ' ' HG ' ' A' ' 155' ' ' LEU . 2.6 pp -73.88 -24.4 59.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 75.34 109.846 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.41 -46.6 83.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.134 -0.979 . . . . 62.14 109.426 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.46 ' C ' ' H ' ' A' ' 159' ' ' ARG . 65.5 mtt180 -75.34 -44.07 47.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.229 -0.919 . . . . 61.03 109.335 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -75.71 22.78 0.13 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 74.12 109.406 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.46 ' H ' ' C ' ' A' ' 157' ' ' ARG . 37.2 ptt180 -56.82 165.23 1.26 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.249 -0.907 . . . . 71.13 109.49 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.582 ' OD2' ' NE2' ' B' ' 161' ' ' GLN . 50.2 t0 54.2 47.15 23.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 75.45 109.242 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -155.15 158.9 39.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.284 -0.885 . . . . 73.41 109.381 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 53.4 mt -85.03 120.05 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.209 -0.932 . . . . 74.41 109.331 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.403 ' O ' ' O ' ' A' ' 212' ' ' TYR . 40.0 t -107.76 130.36 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.419 -0.801 . . . . 72.31 109.497 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.9 m -100.9 153.04 19.83 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.361 -0.837 . . . . 74.12 109.358 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.401 ' HB3' ' HZ3' ' A' ' 165' ' ' LYS . 9.2 mtpm? -56.65 -35.47 68.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.9 . . . . 70.43 109.505 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -59.51 -37.6 78.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 73.52 109.629 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.431 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 93.4 mt-30 -62.56 -39.6 94.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 74.52 109.555 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 28.5 mt -64.95 -31.78 73.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.128 -0.982 . . . . 72.31 109.268 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.504 HD23 ' C ' ' A' ' 169' ' ' LEU . 4.2 tt -66.38 -59.11 3.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.862 . . . . 53.33 110.098 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 167' ' ' GLN . 28.9 p-10 -73.64 -30.24 62.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.04 -1.038 . . . . 62.44 110.624 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.446 ' C ' HD12 ' A' ' 172' ' ' ILE . . . -59.98 -46.35 89.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.968 -1.083 . . . . 60.21 110.173 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.693 HD12 ' N ' ' A' ' 172' ' ' ILE . 1.6 mp -94.67 -59.86 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.038 -1.039 . . . . 75.32 108.966 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 29.8 m-90 -91.54 104.07 16.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 73.14 109.769 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -116.9 159.38 22.51 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.64 -0.874 . . . . 73.24 108.64 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 64.2 150.27 0.11 Allowed Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 108.762 -0.829 . . . . 44.43 108.762 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -33.36 138.01 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.677 2.251 . . . . 72.51 112.679 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.76 179.11 9.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.379 -0.826 . . . . 63.24 109.527 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 17.4 ttt -104.5 42.09 1.24 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.892 -0.781 . . . . 73.5 108.892 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.06 138.7 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 65.22 109.623 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.6 m -69.56 135.01 88.38 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 71.42 108.759 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 182' ' ' ASN . 69.4 Cg_exo -37.72 109.34 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 121.992 1.795 . . . . 41.22 112.648 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 181' ' ' PRO . 86.9 m-20 52.0 101.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.4 -0.812 . . . . 64.54 110.286 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 183' ' ' VAL . 11.8 p -138.85 -4.31 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.4 -0.812 . . . . 74.02 109.569 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.673 HD12 ' H ' ' A' ' 184' ' ' ILE . 3.0 mp -53.56 -37.76 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.01 -1.056 . . . . 72.33 109.503 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -55.23 -30.53 60.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -0.947 . . . . 74.4 109.421 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 94.1 t -79.23 -57.23 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.082 -1.011 . . . . 70.42 109.495 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -54.97 -47.19 74.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.157 -0.964 . . . . 52.11 109.875 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.525 ' O ' HD13 ' A' ' 188' ' ' ILE . 0.2 OUTLIER -60.23 -44.2 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.085 -1.009 . . . . 71.4 109.061 -179.726 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.413 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 53.5 t-20 -60.35 -41.71 94.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.959 -1.088 . . . . 73.44 109.445 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -68.34 -45.13 73.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.93 . . . . 71.42 109.718 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 85.7 mt -56.41 -37.69 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.263 -0.898 . . . . 61.55 109.156 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -65.27 -40.68 94.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 63.34 109.512 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.431 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 14.8 mm100 -76.42 -26.61 55.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 61.24 110.025 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.546 ' HB3' ' HZ3' ' A' ' 194' ' ' LYS . 8.5 mtpm? -81.67 -25.26 35.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -0.946 . . . . 75.13 110.581 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 20.1 ptm -95.07 -36.32 11.57 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.033 -1.042 . . . . 74.02 110.116 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 197' ' ' LYS . 30.9 p-10 -66.04 -34.21 77.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.049 -1.032 . . . . 74.02 110.021 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.538 ' N ' ' OD1' ' A' ' 196' ' ' ASP . 11.0 ttpp -62.84 -60.87 8.64 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.013 -1.054 . . . . 75.43 109.876 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -59.04 -52.01 5.79 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.64 1.56 . . . . 72.32 111.407 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.547 ' N ' HD12 ' A' ' 199' ' ' LEU . 8.0 mp -92.53 125.15 37.04 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.345 -0.847 . . . . 74.54 109.118 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -77.79 -2.18 80.54 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.417 -1.473 . . . . 61.51 109.417 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 201' ' ' ILE . 19.6 mt -108.32 137.54 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.501 -1.0 . . . . 61.22 109.392 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 23.1 t -93.23 143.5 26.2 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.26 -0.9 . . . . 72.0 109.4 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 49.2 p -130.58 10.05 5.14 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.511 -0.743 . . . . 74.44 109.353 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 5.9 m -132.01 142.72 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.504 -0.748 . . . . 64.35 109.328 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -126.0 134.81 51.36 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.644 -0.66 . . . . 71.41 109.364 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.0 95.67 8.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.2 -0.938 . . . . 73.52 109.203 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.573 ' CG1' ' NH1' ' A' ' 213' ' ' ARG . 11.2 p -164.41 170.65 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.96 . . . . 71.02 109.347 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' ARG . . . . . 0.678 ' HE ' ' NH2' ' A' ' 210' ' ' ARG . 6.2 tpt180 76.65 146.16 0.09 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.495 -0.753 . . . . 72.12 109.547 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -61.5 -34.29 75.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.361 -0.837 . . . . 64.41 109.792 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.678 ' NH2' ' HE ' ' A' ' 208' ' ' ARG . 0.2 OUTLIER -49.94 -50.92 44.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 71.54 109.092 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 148.29 -106.06 0.33 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.051 -1.22 . . . . 72.03 110.051 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 212' ' ' TYR . 20.3 m-85 -113.43 145.38 41.25 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.568 -0.96 . . . . 75.54 109.484 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.573 ' NH1' ' CG1' ' A' ' 207' ' ' VAL . 7.8 mtm-85 -117.42 135.09 54.13 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.521 -0.737 . . . . 75.31 109.226 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -100.01 128.1 46.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.281 -0.887 . . . . 75.41 109.379 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 3.6 p -141.46 156.4 45.77 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.378 -0.826 . . . . 74.14 109.29 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -68.83 152.85 96.55 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.91 . . . . 75.32 109.108 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -38.03 146.67 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.299 1.999 . . . . 73.11 112.254 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.435 ' CB ' ' CD ' ' A' ' 219' ' ' PRO . 26.7 mtpt -55.94 -64.61 2.12 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 75.25 109.489 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' A' ' 218' ' ' LYS . 33.7 Cg_endo -62.63 -31.5 79.45 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.078 1.852 . . . . 75.1 111.904 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . 48.03 -144.96 0.35 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 71.14 109.575 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' CYS . . . . . 0.405 ' O ' ' O ' ' A' ' 222' ' ' GLU . 20.9 p -59.68 -31.3 69.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.258 -0.901 . . . . 71.13 109.407 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 221' ' ' CYS . 86.4 tt0 49.04 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 75.35 109.511 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.056 -0.974 . . . . 73.41 109.457 179.95 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.589 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.401 -0.592 . . . . 71.14 109.401 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -140.15 147.5 40.26 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.358 -0.839 . . . . 73.23 109.46 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 93.3 t -114.99 123.29 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 121.596 0.712 . . . . 72.24 109.585 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' LEU . . . . . 0.478 HD11 ' CG1' ' B' ' 6' ' ' ILE . 3.1 tp -91.34 118.05 30.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.898 . . . . 54.33 108.655 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.514 HD23 ' N ' ' B' ' 6' ' ' ILE . 1.1 tt -118.08 117.0 28.02 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.49 -0.93 . . . . 74.35 108.49 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.56 HD12 ' HB ' ' B' ' 50' ' ' VAL . 78.2 mt -111.87 98.96 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.297 -0.877 . . . . 42.55 108.983 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.426 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 26.7 tp10 -129.31 135.68 49.06 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.516 -0.74 . . . . 74.52 109.434 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -67.83 -32.8 73.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 62.55 109.245 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -89.62 121.44 31.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.874 . . . . 73.11 109.47 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 23.2 m -73.7 -32.31 63.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 65.54 109.828 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 98.4 t -60.69 -47.65 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.14 -0.975 . . . . 75.55 109.829 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.552 HD12 ' NZ ' ' B' ' 97' ' ' LYS . 3.4 mm? -64.02 -33.27 75.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.155 -0.966 . . . . 70.14 109.297 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.39 -28.59 59.55 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.755 -1.738 . . . . 75.4 108.755 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.13 -50.13 62.32 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.299 -1.52 . . . . 65.44 109.299 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -62.2 -44.67 96.06 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.305 -1.114 . . . . 60.21 109.405 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.569 HD11 ' CZ ' ' B' ' 99' ' ' TYR . 5.3 mm -63.3 -35.62 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.884 -1.135 . . . . 75.15 108.399 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' B' ' 27' ' ' ALA . 43.4 tp10 -63.9 -49.11 73.95 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.329 -0.857 . . . . 73.01 109.224 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -80.53 0.56 33.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.97 . . . . 74.3 109.166 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.9 -62.35 1.52 Allowed Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.55 -1.42 . . . . 70.54 109.55 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' B' ' 27' ' ' ALA . 1.4 pt? -68.38 -23.64 64.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -1.154 . . . . 71.34 109.639 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' ASN . . . . . 0.422 ' H ' HD23 ' B' ' 20' ' ' LEU . 28.3 m-20 -51.56 -35.01 39.28 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.055 -1.028 . . . . 64.41 109.381 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 74.9 t -55.22 -38.93 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.162 -0.961 . . . . 74.23 108.884 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 23' ' ' LYS . . . . . 0.412 ' N ' ' CD ' ' B' ' 23' ' ' LYS . 4.7 mptp? -70.14 -25.67 63.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.441 -0.787 . . . . 63.42 109.2 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.47 20.06 10.64 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 110.293 -1.123 . . . . 53.43 110.293 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -96.72 159.99 14.62 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.071 -1.252 . . . . 71.12 109.333 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 61.3 mmm -104.65 139.89 38.83 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.674 -0.861 . . . . 75.24 108.674 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' ALA . . . . . 0.493 ' HB2' HD11 ' B' ' 20' ' ' LEU . . . -141.13 153.11 45.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.191 -0.943 . . . . 72.12 110.16 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -133.05 134.01 43.79 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.791 -0.818 . . . . 72.31 108.791 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.31 138.06 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.278 -1.008 . . . . 64.43 108.278 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.4 p -139.12 165.61 26.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.282 -0.886 . . . . 65.41 109.525 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -84.3 -99.58 0.05 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.889 . . . . 71.02 109.33 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 60.7 p -78.32 161.7 27.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 51.11 109.579 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 33' ' ' LEU . . . . . 0.501 ' H ' HD12 ' B' ' 33' ' ' LEU . 2.8 mp -56.85 -31.53 64.87 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.448 -0.783 . . . . 71.24 109.814 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -56.61 -43.67 80.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.108 -0.995 . . . . 74.32 109.637 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -63.18 -42.26 99.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.135 -0.978 . . . . 73.03 109.31 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.31 -30.88 48.61 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.45 -1.46 . . . . 30.21 109.45 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' B' ' 33' ' ' LEU . 14.8 tm-20 -63.7 -41.53 98.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -1.153 . . . . 74.42 109.462 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -74.28 -38.44 63.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 74.42 109.547 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 21.6 tp -68.65 -48.28 64.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 75.41 109.981 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' MET . . . . . 0.442 ' O ' ' O ' ' B' ' 43' ' ' ARG . 16.1 ptm -66.52 -23.84 66.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.116 -0.99 . . . . 60.41 109.789 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.26 -38.03 79.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.074 -1.016 . . . . 53.23 109.781 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 10.7 pt -97.61 -1.68 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.177 -0.952 . . . . 71.23 110.206 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' B' ' 40' ' ' MET . 31.1 mmt180 -125.99 155.48 41.34 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.317 -0.864 . . . . 72.22 109.593 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 44' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' B' ' 45' ' ' TYR . 53.9 t-20 -86.76 151.33 23.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.249 -0.907 . . . . 63.54 109.269 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 45' ' ' TYR . . . . . 0.559 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 1.3 p90 -142.77 115.8 8.84 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.16 -0.962 . . . . 64.35 109.518 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -90.57 -34.77 15.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.277 -0.889 . . . . 62.22 108.907 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.515 ' C ' HD13 ' B' ' 47' ' ' LEU . 0.9 OUTLIER -111.68 110.55 21.0 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.695 -0.854 . . . . 73.12 108.695 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.458 ' N ' HD13 ' B' ' 47' ' ' LEU . 68.5 t -94.56 98.77 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.217 -0.927 . . . . 65.11 109.118 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 17.2 ttt -113.24 127.13 56.07 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.631 0.729 . . . . 73.44 109.581 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.56 ' HB ' HD12 ' B' ' 6' ' ' ILE . 0.2 OUTLIER -145.0 133.91 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.394 -0.816 . . . . 34.5 109.38 -179.741 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 51' ' ' SER . . . . . 0.43 ' CB ' ' OG ' ' B' ' 74' ' ' SER . 53.0 p -100.31 17.43 21.43 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.603 -0.685 . . . . 73.21 109.908 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.519 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 82.9 m-20 -83.12 135.17 34.91 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.095 -1.003 . . . . 70.41 109.408 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -70.16 -38.03 75.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.296 -0.878 . . . . 65.0 110.118 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 54' ' ' ASN . . . . . 0.676 ' H ' HD22 ' B' ' 54' ' ' ASN . 1.0 OUTLIER -75.62 13.0 0.87 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 75.21 109.875 -179.444 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.78 -21.73 60.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 55.33 110.113 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 33.5 mt -43.44 -35.98 1.8 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.322 -0.861 . . . . 63.14 110.438 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 82.7 p -77.16 -47.59 19.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.941 -1.099 . . . . 63.5 109.825 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 58' ' ' PHE . . . . . 0.528 ' CZ ' HD11 ' B' ' 62' ' ' ILE . 76.0 t80 -63.94 -44.92 91.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 72.33 110.398 -179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.494 HG23 ' N ' ' B' ' 60' ' ' SER . 17.0 m -63.85 -40.24 88.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 120.668 -1.27 . . . . 74.54 109.685 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 60' ' ' SER . . . . . 0.494 ' N ' HG23 ' B' ' 59' ' ' VAL . 59.2 m -53.71 -50.88 64.92 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.162 -0.961 . . . . 71.24 109.676 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.454 HH21 ' NZ ' ' B' ' 65' ' ' LYS . 11.9 ptm180 -67.8 -32.34 72.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.143 -0.973 . . . . 74.31 110.279 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.528 HD11 ' CZ ' ' B' ' 58' ' ' PHE . 4.9 mm -63.6 -43.98 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.706 -1.246 . . . . 72.14 110.001 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -64.78 -50.51 66.52 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.222 -0.924 . . . . 73.32 110.571 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -68.84 -40.67 79.27 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.71 -1.244 . . . . 73.12 110.032 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.714 ' O ' ' CD2' ' B' ' 66' ' ' HIS . 45.2 mtpt -77.29 -29.69 53.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.125 -0.984 . . . . 72.44 109.724 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.714 ' CD2' ' O ' ' B' ' 65' ' ' LYS . 31.3 m170 -144.47 67.84 1.26 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.15 -0.969 . . . . 63.31 109.913 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 81.3 p -65.62 -25.68 67.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 73.1 109.231 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 4.2 t -62.18 -24.63 67.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.864 . . . . 71.53 109.647 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 74.3 mt -86.43 152.04 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.311 -0.868 . . . . 74.4 109.401 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.499 HG12 ' N ' ' B' ' 71' ' ' VAL . 80.1 t -91.08 161.0 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.341 -0.85 . . . . 75.12 109.386 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.499 ' N ' HG12 ' B' ' 70' ' ' VAL . 14.8 t -141.15 122.39 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.169 -0.957 . . . . 73.2 109.264 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 72' ' ' LEU . . . . . 0.647 ' HG ' HD11 ' B' ' 95' ' ' ILE . 1.2 mp -117.66 103.09 9.69 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.76 -0.83 . . . . 73.34 108.76 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 70.9 t -90.12 118.69 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.314 -0.866 . . . . 73.5 108.677 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 74' ' ' SER . . . . . 0.43 ' OG ' ' CB ' ' B' ' 51' ' ' SER . 24.4 p -86.27 170.62 11.91 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.16 -0.962 . . . . 64.34 109.009 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 75' ' ' SER . . . . . 0.499 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 35.3 m -159.48 115.53 2.54 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.949 -1.095 . . . . 74.53 110.244 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -63.37 -22.93 67.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.44 -0.788 . . . . 64.5 109.69 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 77' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' B' ' 79' ' ' THR . 8.7 m-80 -125.09 79.33 65.73 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.505 -0.747 . . . . 74.25 109.623 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.13 86.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.494 2.129 . . . . 74.43 111.3 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.463 ' N ' ' O ' ' B' ' 77' ' ' ASN . 20.7 m -100.04 150.57 22.31 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.532 -0.73 . . . . 73.12 109.807 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 4.5 p -69.01 -38.01 79.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.412 -0.805 . . . . 71.01 109.661 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -63.03 -37.37 86.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.92 . . . . 63.2 109.669 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -71.76 -32.46 67.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.207 -0.933 . . . . 73.22 109.647 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.51 ' OE2' ' NE ' ' A' ' 100' ' ' ARG . 95.0 mt-10 -64.87 -52.77 54.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.974 . . . . 74.3 109.749 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 18.6 m -60.24 -35.94 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.113 -0.992 . . . . 73.31 109.283 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -75.43 -27.43 58.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.271 -0.893 . . . . 73.24 109.464 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 86' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -66.68 -37.57 85.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.175 -0.953 . . . . 55.33 109.937 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -83.39 -36.26 24.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 74.14 109.22 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -71.9 -39.92 69.2 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.316 -0.865 . . . . 64.04 109.483 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -68.6 -50.12 53.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 72.35 109.4 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.65 69.84 0.01 OUTLIER Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.927 -1.13 . . . . 65.2 110.302 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 91' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -132.67 130.18 39.77 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.322 -1.105 . . . . 52.23 109.139 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -71.28 -33.81 70.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.918 . . . . 73.32 109.286 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 93' ' ' ASP . . . . . 0.437 ' OD2' ' NH2' ' B' ' 108' ' ' ARG . 14.1 t70 -152.25 161.8 42.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -0.843 . . . . 72.22 109.414 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 94' ' ' TYR . . . . . 0.499 ' OH ' ' CB ' ' B' ' 75' ' ' SER . 57.4 t80 -132.25 120.24 21.9 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.86 -0.792 . . . . 64.42 108.86 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 0.785 ' H ' HD12 ' B' ' 95' ' ' ILE . 0.0 OUTLIER -128.08 154.63 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 CA-C-O 121.793 0.806 . . . . 72.23 110.493 -178.43 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.0 149.78 48.41 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.19 -1.041 . . . . 25.24 108.19 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 97' ' ' LYS . . . . . 0.665 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -74.24 -56.48 2.55 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.785 -1.197 . . . . 64.32 111.451 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 98' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 5.2 Cg_endo -41.95 -9.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 120.852 1.035 . . . . 63.33 112.944 -176.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 99' ' ' TYR . . . . . 0.665 ' N ' ' O ' ' B' ' 97' ' ' LYS . 34.0 m-85 61.19 125.71 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.652 -0.655 . . . . 75.13 109.438 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 100' ' ' ARG . . . . . 0.416 ' NE ' ' OE2' ' A' ' 83' ' ' GLU . 39.4 ttm-85 -66.35 -34.39 77.87 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.888 -1.133 . . . . 74.23 108.85 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 101' ' ' SER . . . . . 0.736 ' O ' ' N ' ' B' ' 103' ' ' LYS . 10.9 t -172.69 38.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.198 -0.938 . . . . 63.34 110.6 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 26.2 mm 50.91 -69.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.659 -0.651 . . . . 74.44 110.415 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 103' ' ' LYS . . . . . 0.736 ' N ' ' O ' ' B' ' 101' ' ' SER . 16.2 mtpp -57.46 -29.35 64.14 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.313 -0.995 . . . . 71.11 108.313 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.72 -46.54 81.84 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.542 -0.91 . . . . 71.45 108.542 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 13.0 tp -64.63 -54.45 31.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.478 -0.764 . . . . 51.31 109.011 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 23.4 t -57.85 -38.19 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.116 -0.99 . . . . 65.23 109.495 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.06 -48.26 70.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.25 -0.906 . . . . 24.32 109.616 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 108' ' ' ARG . . . . . 0.487 ' NH2' HD21 ' B' ' 72' ' ' LEU . 8.5 ttp-105 -68.73 -31.49 70.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 75.31 109.869 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 96.8 mt -74.33 -26.3 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.047 -1.033 . . . . 54.24 108.941 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -71.7 -54.0 11.7 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.418 -0.801 . . . . 65.31 109.53 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.3 -43.41 78.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.105 -0.997 . . . . 72.24 109.379 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 9.0 tpm_? -69.79 -41.73 74.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.258 -0.902 . . . . 72.04 109.455 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 14.0 tp -96.55 65.13 2.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.25 -0.906 . . . . 75.35 109.775 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 114' ' ' ARG . . . . . 0.553 ' HE ' ' CA ' ' B' ' 114' ' ' ARG . 0.0 OUTLIER -142.48 -62.23 0.44 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.193 -0.942 . . . . 75.5 108.695 179.647 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -89.33 22.93 2.69 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.219 -0.925 . . . . 65.33 109.511 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -62.28 -35.64 79.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.165 -0.959 . . . . 74.45 109.665 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.29 128.84 33.88 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.911 -1.275 . . . . 44.21 109.911 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 97.5 p -159.45 166.52 30.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.359 -1.083 . . . . 71.4 110.093 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.4 137.06 12.21 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.693 -0.854 . . . . 72.32 108.693 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 5.2 t -107.88 -41.37 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.323 -0.861 . . . . 75.02 110.593 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 19.1 mm -97.95 140.3 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.048 -1.033 . . . . 51.41 109.924 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -148.75 131.6 16.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.404 -0.81 . . . . 71.53 109.33 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.449 ' O ' HG23 ' B' ' 123' ' ' ILE . 10.9 tp -156.35 127.11 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 72.43 109.004 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.83 -155.31 4.29 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.1 -1.6 . . . . 51.23 109.1 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -76.86 2.18 15.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.157 -1.202 . . . . 74.2 108.938 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.577 HD11 HD12 ' B' ' 201' ' ' ILE . 0.4 OUTLIER -95.46 134.37 38.38 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.644 -0.872 . . . . 75.42 108.644 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 3.3 m -131.7 141.46 49.56 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.363 -0.836 . . . . 74.22 109.153 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 54.1 mt -132.38 130.21 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.276 -0.89 . . . . 60.33 109.998 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 129' ' ' SER . . . . . 0.459 ' O ' ' N ' ' B' ' 133' ' ' GLU . 18.9 m -115.32 98.88 51.58 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 108.786 -0.82 . . . . 72.31 108.786 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.12 -40.7 2.31 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.39 1.394 . . . . 75.13 112.041 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -56.78 -36.54 69.97 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.895 -1.128 . . . . 75.23 108.161 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -98.07 -10.0 25.0 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.715 -0.846 . . . . 72.43 108.715 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' B' ' 129' ' ' SER . 30.0 mt-10 53.84 61.33 3.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.121 -0.987 . . . . 75.13 108.393 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -137.01 112.92 9.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.503 -0.748 . . . . 73.22 109.915 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.44 137.49 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 106.456 -1.683 . . . . 64.14 106.456 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 40.2 mt -129.23 120.8 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.258 -0.901 . . . . 71.22 110.319 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -142.62 144.11 32.68 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.465 -0.772 . . . . 64.22 109.342 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt 54.6 26.37 7.3 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.43 -0.794 . . . . 72.02 110.206 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 75.22 13.68 82.55 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.334 -1.106 . . . . 74.32 110.334 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 40.8 mtp85 -104.37 123.89 48.22 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.335 -1.097 . . . . 75.34 108.99 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -95.75 137.4 34.87 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.384 -0.822 . . . . 71.23 110.162 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 1.2 p -139.51 131.33 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.206 -0.933 . . . . 70.43 109.346 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -89.03 144.32 26.23 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.834 -1.172 . . . . 72.43 107.834 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 144' ' ' VAL . . . . . 0.523 ' HB ' ' CD1' ' B' ' 149' ' ' PHE . 5.9 m -132.11 150.21 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.263 -0.898 . . . . 72.13 109.782 -179.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -174.19 109.87 0.15 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.512 -0.743 . . . . 72.02 109.51 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 146' ' ' GLY . . . . . 1.009 ' O ' ' HG3' ' B' ' 150' ' ' GLU . . . 166.71 -160.21 33.77 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.422 -1.471 . . . . 42.23 109.422 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 147' ' ' LYS . . . . . 1.267 ' NZ ' ' HG3' ' B' ' 176' ' ' PRO . 26.1 ttpt -87.37 -36.9 0.48 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.149 -1.207 . . . . 73.3 110.675 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 148' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 72.2 Cg_endo -85.12 4.61 6.68 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 121.566 1.511 . . . . 71.33 110.934 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 149' ' ' PHE . . . . . 0.523 ' CD1' ' HB ' ' B' ' 144' ' ' VAL . 41.3 m-85 -108.58 -40.0 5.23 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.496 0.665 . . . . 74.23 109.259 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 150' ' ' GLU . . . . . 1.009 ' HG3' ' O ' ' B' ' 146' ' ' GLY . 41.8 mt-10 -59.65 -34.4 72.77 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.167 -0.958 . . . . 72.34 108.512 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 151' ' ' VAL . . . . . 0.746 HG13 HD22 ' B' ' 152' ' ' LEU . 12.7 p -61.05 -40.84 87.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.639 -0.824 . . . . 73.35 108.854 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.746 HD22 HG13 ' B' ' 151' ' ' VAL . 4.6 mm? -56.84 -52.39 65.3 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.711 -0.848 . . . . 55.24 108.711 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.6 p -62.36 -32.94 73.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.392 -0.818 . . . . 70.01 109.593 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -62.21 -56.15 21.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.991 -1.068 . . . . 65.32 109.463 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.64 -22.21 63.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.057 -1.027 . . . . 71.54 109.14 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.48 -49.99 74.49 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.127 -0.983 . . . . 75.32 108.653 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 51.3 mtp85 -69.64 -52.8 22.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.332 -0.855 . . . . 73.32 109.041 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -76.74 20.35 0.24 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.467 -0.771 . . . . 74.14 110.313 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 159' ' ' ARG . . . . . 1.3 HH11 ' CB ' ' B' ' 159' ' ' ARG . 0.0 OUTLIER -50.02 -38.49 37.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.104 -0.998 . . . . 61.41 109.096 179.868 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -98.15 67.6 1.89 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.25 -0.906 . . . . 72.1 109.584 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 161' ' ' GLN . . . . . 0.582 ' NE2' ' OD2' ' A' ' 160' ' ' ASP . 58.7 tp60 -171.08 161.93 6.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.142 -0.974 . . . . 72.25 109.675 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 13.6 mm -82.88 142.82 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.472 -0.768 . . . . 72.31 109.727 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.27 128.52 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.462 -0.774 . . . . 64.21 109.269 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 52.5 p -98.79 153.7 18.56 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.181 -0.949 . . . . 74.22 109.92 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -52.24 -50.99 60.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.36 -0.838 . . . . 65.31 109.494 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -51.65 -39.71 58.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.372 -0.83 . . . . 63.45 109.907 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -65.86 -41.52 91.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.116 -0.99 . . . . 72.4 109.607 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 80.6 mt -52.02 -53.79 37.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.018 -1.051 . . . . 72.32 109.162 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 169' ' ' LEU . . . . . 0.576 ' O ' ' N ' ' B' ' 171' ' ' ALA . 52.4 mt -64.9 -67.9 0.4 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.341 -0.849 . . . . 73.34 110.059 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -42.91 -15.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.693 -0.629 . . . . 72.1 110.878 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 171' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' B' ' 169' ' ' LEU . . . -93.39 -41.12 10.0 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.93 -1.106 . . . . 62.13 112.196 -178.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 172' ' ' ILE . . . . . 0.531 ' C ' ' H ' ' B' ' 174' ' ' GLU . 4.8 mp -123.47 -34.23 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.791 0 O-C-N 120.768 -1.208 . . . . 71.42 113.209 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 173' ' ' TRP . . . . . 0.476 ' CD2' ' C ' ' B' ' 173' ' ' TRP . 0.0 OUTLIER -61.48 7.2 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.319 0 O-C-N 120.047 -1.658 . . . . 72.23 110.49 -177.984 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 174' ' ' GLU . . . . . 0.531 ' H ' ' C ' ' B' ' 172' ' ' ILE . 56.9 tt0 -72.01 -16.24 62.06 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.006 -1.059 . . . . 52.11 109.578 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 175' ' ' GLU . . . . . 0.405 ' CB ' ' CD ' ' B' ' 176' ' ' PRO . 5.6 mt-10 -83.44 -65.65 0.22 Allowed Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.039 -1.038 . . . . 73.04 109.887 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 176' ' ' PRO . . . . . 1.267 ' HG3' ' NZ ' ' B' ' 147' ' ' LYS . 59.2 Cg_endo -69.89 -62.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.763 1.642 . . . . 74.13 112.235 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 177' ' ' GLU . . . . . 0.415 ' CB ' ' O ' ' B' ' 176' ' ' PRO . 7.2 tt0 71.43 -30.34 0.21 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.363 -0.836 . . . . 72.44 109.319 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 178' ' ' MET . . . . . 0.513 ' H ' ' C ' ' B' ' 176' ' ' PRO . 22.0 mtt -66.17 -22.67 66.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.144 -0.973 . . . . 63.43 109.01 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 4.7 m -47.66 156.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.612 -0.68 . . . . 71.05 109.727 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 73.4 p -92.71 144.98 29.48 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.196 -0.94 . . . . 62.15 109.191 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -39.81 -42.52 3.08 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.122 1.881 . . . . 65.22 112.88 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 43.3 p30 -70.8 8.42 0.89 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.074 -1.017 . . . . 72.31 110.218 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 12.3 p -66.83 -22.16 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.049 -1.032 . . . . 63.32 109.594 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.426 ' O ' HG22 ' B' ' 188' ' ' ILE . 54.5 mt -54.52 -50.04 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 75.03 109.92 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -60.84 -40.98 94.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 64.11 109.887 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 3.6 t -69.35 -40.04 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.521 -0.737 . . . . 73.0 110.486 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.59 -53.68 9.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 61.12 110.031 -179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 188' ' ' ILE . . . . . 0.426 HG22 ' O ' ' B' ' 184' ' ' ILE . 11.0 tp -58.06 -25.4 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.96 . . . . 72.43 109.741 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -75.83 -56.97 4.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.256 -0.903 . . . . 65.14 110.52 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -65.32 -34.75 79.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.023 -1.048 . . . . 63.24 110.141 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 86.7 mt -63.69 -59.04 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.032 -1.042 . . . . 74.03 109.939 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 192' ' ' ARG . . . . . 0.655 HH21 HG23 ' B' ' 204' ' ' VAL . 21.0 mtp-105 -60.26 -35.86 76.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.166 -0.959 . . . . 72.24 109.622 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 193' ' ' GLN . . . . . 0.43 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 79.9 mm-40 -70.32 -33.95 72.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.183 -0.948 . . . . 73.1 109.452 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 194' ' ' LYS . . . . . 0.458 ' CB ' ' NZ ' ' B' ' 194' ' ' LYS . 7.3 mtpm? -79.58 -17.25 54.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.181 -0.949 . . . . 72.11 110.013 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 44.1 ttp -98.12 -11.52 22.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.139 -0.976 . . . . 44.33 110.372 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 196' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 57.3 p30 -107.91 -14.61 14.73 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.025 -1.047 . . . . 71.21 110.393 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 197' ' ' LYS . . . . . 0.594 ' N ' ' CD ' ' B' ' 198' ' ' PRO . 30.5 tttt -78.16 -40.8 1.95 Allowed Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 120.851 -1.156 . . . . 75.21 110.03 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 198' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' B' ' 197' ' ' LYS . 40.7 Cg_endo -89.47 -44.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.449 2.1 . . . . 75.32 112.473 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 199' ' ' LEU . . . . . 0.516 ' N ' HD12 ' B' ' 199' ' ' LEU . 9.1 mp -61.1 -54.03 49.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.862 -1.149 . . . . 72.25 109.085 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 99.74 -0.02 56.52 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.069 -1.212 . . . . 64.53 110.069 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 201' ' ' ILE . . . . . 0.577 HD12 HD11 ' B' ' 126' ' ' LEU . 38.7 mt -130.79 145.25 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.373 -1.075 . . . . 44.23 109.25 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 28.7 t -97.85 135.28 39.82 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.295 -0.878 . . . . 54.01 109.252 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 6.8 p -135.09 5.62 3.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.344 -0.848 . . . . 74.4 109.277 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.655 HG23 HH21 ' B' ' 192' ' ' ARG . 16.2 m -108.42 139.17 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.448 -0.783 . . . . 72.12 109.479 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -125.2 128.72 48.78 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.55 -0.719 . . . . 65.41 109.372 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.87 124.45 40.85 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.242 -0.911 . . . . 71.33 109.451 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.443 ' O ' ' O ' ' B' ' 208' ' ' ARG . 6.1 m -151.42 143.11 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.274 -0.891 . . . . 63.5 109.173 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 208' ' ' ARG . . . . . 0.484 ' O ' ' N ' ' B' ' 210' ' ' ARG . 19.3 tpt180 -58.61 -109.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.089 -1.007 . . . . 74.45 109.108 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 50.63 -94.84 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.955 -1.091 . . . . 74.14 109.386 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 210' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' B' ' 208' ' ' ARG . 67.3 mtt-85 -107.62 -55.31 2.37 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.737 -0.602 . . . . 74.43 109.771 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 211' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' B' ' 207' ' ' VAL . . . -174.42 -105.92 0.19 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.558 -1.417 . . . . 64.45 109.558 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -110.77 162.41 14.8 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.382 -1.07 . . . . 74.21 109.117 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 213' ' ' ARG . . . . . 0.69 HH12 ' CB ' ' B' ' 215' ' ' CYS . 35.4 ttt-85 -130.23 122.95 29.04 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.435 -0.791 . . . . 74.03 109.164 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 214' ' ' PHE . . . . . 0.551 ' HB3' ' O ' ' B' ' 159' ' ' ARG . 17.4 m-85 -104.13 124.67 49.51 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.447 -0.783 . . . . 74.34 109.317 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 215' ' ' CYS . . . . . 0.69 ' CB ' HH12 ' B' ' 213' ' ' ARG . 1.7 m -163.51 154.64 16.56 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.112 -0.992 . . . . 64.33 109.143 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -68.58 147.87 98.06 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 120.954 -1.091 . . . . 70.04 108.167 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.89 -103.81 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.122 1.882 . . . . 65.11 113.143 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.78 148.02 81.77 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.96 -1.087 . . . . 73.15 109.979 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -38.84 101.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.352 2.035 . . . . 71.31 112.529 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -76.47 -170.03 1.39 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.127 -0.983 . . . . 75.45 109.276 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 32.9 m 52.89 -173.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.291 -0.881 . . . . 72.22 109.614 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.463 ' CD ' ' N ' ' B' ' 223' ' ' GLU . 3.4 tm-20 -87.88 140.59 29.35 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.233 -0.917 . . . . 54.53 109.426 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 223' ' ' GLU . . . . . 0.463 ' N ' ' CD ' ' B' ' 222' ' ' GLU . 3.9 pt-20 . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 117.966 -1.016 . . . . 71.13 109.4 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptp . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.513 -0.551 . . . . 65.120000000000005 109.513 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -140.4 152.25 45.59 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.332 -0.855 . . . . 72.329999999999998 109.182 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.9 t -116.32 138.83 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.651 -0.656 . . . . 71.420000000000002 109.708 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.546 HD11 ' CG1' ' A' ' 6' ' ' ILE . 2.3 tp -115.87 121.12 41.41 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.462 -0.774 . . . . 65.120000000000005 109.043 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 4' ' ' LEU . 16.9 mt -117.68 107.03 13.71 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.044 -0.725 . . . . 62.43 109.044 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.546 ' CG1' HD11 ' A' ' 4' ' ' LEU . 76.7 mt -98.83 112.66 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.248 -0.907 . . . . 71.150000000000006 108.829 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.429 ' OE1' ' N ' ' A' ' 13' ' ' GLY . 68.8 tt0 -149.49 127.89 12.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.169 -0.957 . . . . 75.340000000000003 109.565 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -62.94 -32.82 74.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -0.874 . . . . 72.439999999999998 109.431 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -82.05 105.26 13.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -0.892 . . . . 63.020000000000003 109.457 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.8 m -64.87 -28.19 69.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.9 . . . . 72.340000000000003 109.783 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.0 t -63.73 -49.24 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.156 -0.965 . . . . 74.019999999999996 109.795 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.573 HD13 ' OE2' ' A' ' 15' ' ' GLU . 3.5 mm? -69.85 -46.05 66.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.165 -0.959 . . . . 71.430000000000007 109.452 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.429 ' N ' ' OE1' ' A' ' 7' ' ' GLU . . . -66.13 -17.64 66.03 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.4 -1.88 . . . . 61.32 108.4 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.49 -57.59 4.98 Favored Glycine 0 N--CA 1.483 1.776 0 N-CA-C 109.589 -1.405 . . . . 71.200000000000003 109.589 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.573 ' OE2' HD13 ' A' ' 12' ' ' LEU . 13.1 pt-20 -53.0 -46.8 68.5 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.446 -1.032 . . . . 71.319999999999993 109.714 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.4 mm -61.24 -46.36 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.8 -1.187 . . . . 63.229999999999997 108.636 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.507 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 81.1 tt0 -46.54 -52.56 13.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 51.109999999999999 109.752 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -88.89 4.89 46.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.168 -0.958 . . . . 73.340000000000003 109.741 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.21 -63.54 1.79 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.958 -1.257 . . . . 62.149999999999999 109.958 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.496 HD23 ' N ' ' A' ' 20' ' ' LEU . 1.8 pt? -72.62 -19.85 61.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.18 -1.188 . . . . 73.510000000000005 110.228 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 86.4 m-20 -52.79 -33.47 49.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.883 -1.136 . . . . 74.25 109.466 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 86.7 t -58.5 -31.92 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 70.040000000000006 109.333 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.415 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 11.5 mptt -74.05 -2.8 25.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 73.230000000000004 109.25 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.84 23.17 43.02 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.074 -1.21 . . . . 75.540000000000006 110.074 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -99.4 158.2 15.89 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.214 -1.168 . . . . 73.430000000000007 109.323 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.3 mtt -101.55 139.59 36.99 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.03 -1.1 . . . . 43.240000000000002 108.03 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.64 152.7 41.69 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.045 -1.035 . . . . 62.109999999999999 110.758 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -135.1 140.92 45.87 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.565 -0.902 . . . . 74.420000000000002 108.565 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -107.6 138.28 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.839 . . . . 72.150000000000006 109.004 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.7 p -134.95 168.86 18.32 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.453 -0.779 . . . . 71.420000000000002 109.491 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.436 ' OE2' ' OD2' ' A' ' 35' ' ' ASP . 4.3 pt-20 -87.41 -102.92 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 72.329999999999998 109.559 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.0 p -77.46 163.66 26.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 74.239999999999995 109.476 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.515 ' H ' HD12 ' A' ' 33' ' ' LEU . 3.0 mp -58.42 -29.85 66.43 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.45 -0.781 . . . . 71.530000000000001 110.026 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -49.89 -43.57 49.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.036 -1.04 . . . . 74.230000000000004 109.519 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.436 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 31.9 m-20 -66.8 -42.3 86.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.207 -0.933 . . . . 54.030000000000001 109.053 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.38 -42.54 95.95 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.489 -1.444 . . . . 61.409999999999997 109.489 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -65.73 -37.85 87.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -1.154 . . . . 74.340000000000003 109.336 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.443 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 68.3 t80 -78.64 -21.38 48.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.923 . . . . 75.329999999999998 109.581 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.6 tp -90.0 -32.79 16.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.197 -0.939 . . . . 74.329999999999998 109.853 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 40' ' ' MET . 3.4 ppp? -78.93 -29.42 44.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.151 -0.968 . . . . 70.319999999999993 110.637 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 31.4 p-10 -58.8 -34.28 71.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.795 -1.191 . . . . 71.219999999999999 109.845 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.541 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 14.7 pt -90.39 -26.42 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.084 -1.01 . . . . 74.140000000000001 110.05 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 40' ' ' MET . 93.6 mtt180 -127.36 138.9 53.13 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.386 -0.821 . . . . 72.239999999999995 109.41 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -92.66 152.55 19.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.132 -0.98 . . . . 75.420000000000002 109.594 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -133.83 154.44 51.02 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.517 -0.739 . . . . 74.230000000000004 109.254 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -94.44 -43.83 8.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.139 -0.976 . . . . 72.040000000000006 108.899 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.503 HD13 ' C ' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -106.34 108.91 20.65 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.743 -0.836 . . . . 72.129999999999995 108.743 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.445 ' N ' HD13 ' A' ' 47' ' ' LEU . 2.3 m -107.77 105.24 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.297 -1.001 . . . . 72.340000000000003 108.297 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.6 ttt -115.18 145.54 42.29 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.511 0.672 . . . . 74.109999999999999 109.556 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.547 HG22 ' H ' ' A' ' 52' ' ' ASP . 1.6 p -144.51 133.16 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.487 -0.758 . . . . 61.119999999999997 110.19 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 t -98.54 4.57 48.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.499 -0.751 . . . . 73.109999999999999 109.454 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.547 ' H ' HG22 ' A' ' 50' ' ' VAL . 52.6 m-20 -76.0 142.15 41.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.141 -0.974 . . . . 52.549999999999997 109.377 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 55' ' ' ALA . 67.5 mttm -77.69 -42.76 33.38 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.282 -0.886 . . . . 44.219999999999999 110.647 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -70.63 14.54 0.13 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.027 -1.045 . . . . 70.439999999999998 109.874 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.29 -19.88 59.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 64.140000000000001 110.434 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.0 mt -42.0 -49.06 4.69 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.286 -0.884 . . . . 44.140000000000001 110.606 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.9 p -68.56 -37.85 80.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.954 -1.092 . . . . 55.229999999999997 109.522 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.52 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 70.7 t80 -67.8 -63.57 1.03 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 74.439999999999998 109.914 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.7 m -49.25 -31.72 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.86 -1.15 . . . . 74.030000000000001 109.636 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.3 t -60.6 -53.33 58.77 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.149 -0.97 . . . . 64.299999999999997 109.11 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -67.87 -27.54 66.76 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.687 -1.205 . . . . 64.439999999999998 109.652 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.539 ' O ' ' N ' ' A' ' 66' ' ' HIS . 25.3 mm -56.34 -46.12 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.826 -1.172 . . . . 63.210000000000001 108.409 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -63.72 -40.47 96.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.13 -0.981 . . . . 74.420000000000002 108.354 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -67.58 -50.85 56.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.385 -0.822 . . . . 70.319999999999993 109.246 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.52 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 91.9 mttt -78.15 -12.09 59.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.603 -0.686 . . . . 75.219999999999999 110.048 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.578 ' O ' HG22 ' A' ' 69' ' ' ILE . 97.9 m-70 -157.69 70.9 0.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.93 . . . . 74.129999999999995 109.149 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.1 p -69.34 -23.9 63.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.199 -0.938 . . . . 73.239999999999995 110.015 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 82.3 p -90.83 49.87 1.72 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.141 -0.974 . . . . 61.009999999999998 110.074 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 66' ' ' HIS . 13.4 tt -143.36 163.87 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.102 -0.998 . . . . 71.329999999999998 109.343 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.417 ' HB ' HD22 ' A' ' 47' ' ' LEU . 46.5 t -93.21 142.16 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.115 -0.991 . . . . 72.129999999999995 108.768 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.462 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 9.8 t -130.55 123.44 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.311 -0.868 . . . . 54.210000000000001 109.36 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 mt -129.6 100.3 5.47 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.533 -0.914 . . . . 50.240000000000002 108.533 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.666 ' O ' HD12 ' A' ' 95' ' ' ILE . 14.9 p -96.12 154.04 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.375 -0.972 . . . . 74.409999999999997 108.375 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.4 m -122.57 171.91 8.77 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.78 -0.822 . . . . 72.310000000000002 108.78 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.414 ' C ' ' H ' ' A' ' 77' ' ' ASN . 7.6 p -171.2 121.84 0.54 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.963 -1.085 . . . . 64.540000000000006 110.431 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' NZ ' ' A' ' 53' ' ' LYS . 56.3 p30 -70.65 8.04 0.95 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.501 -0.75 . . . . 74.129999999999995 109.875 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.414 ' H ' ' C ' ' A' ' 75' ' ' SER . 18.7 m120 -137.94 75.39 42.14 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.29 -0.881 . . . . 73.340000000000003 109.489 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -66.92 81.38 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.619 2.213 . . . . 63.219999999999999 111.237 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 81' ' ' GLU . 26.5 m -103.31 151.91 22.16 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.733 -0.84 . . . . 62.530000000000001 108.733 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 p -60.12 -28.84 68.2 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.297 -0.877 . . . . 73.439999999999998 109.773 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.402 ' H ' HG22 ' A' ' 79' ' ' THR . 86.8 tt0 -68.04 -41.54 81.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 71.420000000000002 109.865 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -74.3 -35.47 63.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.115 -0.99 . . . . 73.430000000000007 109.858 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.42 ' OE1' ' HB1' ' B' ' 104' ' ' ALA . 87.4 tt0 -60.17 -54.13 49.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.204 -0.935 . . . . 74.219999999999999 109.941 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 85' ' ' HIS . 34.3 m -61.96 -38.02 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.047 -1.033 . . . . 73.200000000000003 109.439 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.423 ' N ' HG23 ' A' ' 84' ' ' VAL . 19.4 m170 -69.0 -26.48 65.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.151 -0.968 . . . . 53.329999999999998 109.37 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -68.75 -44.33 73.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.143 -0.973 . . . . 64.109999999999999 109.647 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -79.68 -29.19 40.75 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.168 -0.958 . . . . 74.340000000000003 109.084 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -75.18 -51.3 13.72 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.436 -0.79 . . . . 74.420000000000002 109.357 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -58.57 -50.05 75.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.482 -0.761 . . . . 74.239999999999995 109.714 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 147.66 69.1 0.01 OUTLIER Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.107 -1.197 . . . . 61.509999999999998 110.107 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -134.24 135.05 42.67 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.33 -1.1 . . . . 55.329999999999998 109.017 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.462 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 70.2 m-20 -79.66 -36.8 37.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.103 -0.998 . . . . 73.420000000000002 109.031 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -153.33 150.35 28.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.391 -0.818 . . . . 75.040000000000006 109.568 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.512 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -124.25 132.54 53.59 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.722 -0.844 . . . . 71.329999999999998 108.722 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.825 ' H ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -119.29 137.06 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 CA-C-O 121.66 0.743 . . . . 71.129999999999995 110.061 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.54 120.2 8.96 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 106.922 -1.51 . . . . 64.319999999999993 106.922 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.684 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -41.72 -55.88 5.39 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.161 -0.962 . . . . 62.200000000000003 111.862 -178.134 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 1.8 Cg_endo -39.55 -12.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.14 1.226 . . . . 73.109999999999999 113.02 -175.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.684 ' N ' ' O ' ' A' ' 97' ' ' LYS . 55.4 m-85 59.86 131.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.803 -0.56 . . . . 65.219999999999999 109.835 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 29.6 ttm-85 -72.59 -40.65 66.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.754 -1.216 . . . . 72.349999999999994 108.92 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.642 ' O ' ' N ' ' A' ' 103' ' ' LYS . 19.3 m -174.42 43.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.28 -0.887 . . . . 71.319999999999993 110.045 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.447 ' O ' ' N ' ' A' ' 105' ' ' LEU . 10.7 mm 47.47 -80.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.374 -0.829 . . . . 75.430000000000007 110.414 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.642 ' N ' ' O ' ' A' ' 101' ' ' SER . 20.3 tptm -43.93 -33.37 1.36 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.238 -0.914 . . . . 71.409999999999997 109.208 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.67 -44.52 96.04 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.408 -0.96 . . . . 63.240000000000002 108.408 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 102' ' ' ILE . 17.2 tp -66.02 -49.37 67.97 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.199 -0.667 . . . . 73.219999999999999 109.199 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 70.2 t -60.18 -40.01 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.119 -0.988 . . . . 60.109999999999999 109.404 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.68 -41.19 73.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.112 -0.992 . . . . 70.420000000000002 108.869 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.525 ' O ' ' NE ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -68.22 -33.95 75.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.403 -0.81 . . . . 74.409999999999997 109.018 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 88.6 mt -75.2 -29.3 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.168 -0.958 . . . . 62.539999999999999 109.019 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -75.78 -57.43 3.88 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.45 -0.781 . . . . 74.340000000000003 109.471 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -49.65 -45.26 48.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.327 -0.858 . . . . 73.319999999999993 109.335 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 61.6 ttm-85 -64.75 -34.06 77.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.267 -0.895 . . . . 52.409999999999997 109.555 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 37.8 mt -133.52 74.68 1.57 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.393 -0.817 . . . . 65.239999999999995 110.016 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.7 mtm180 -85.64 -77.66 0.29 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.143 -0.973 . . . . 64.450000000000003 108.543 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.44 ' O ' ' O ' ' A' ' 116' ' ' TRP . 18.8 t80 -85.39 -49.73 7.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 74.430000000000007 109.465 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.44 ' O ' ' O ' ' A' ' 115' ' ' PHE . 69.7 t-105 49.85 97.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.366 -0.833 . . . . 74.420000000000002 109.663 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.59 113.06 0.28 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.617 -1.393 . . . . 75.040000000000006 109.617 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 30.8 m -156.07 164.18 38.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -1.154 . . . . 61.140000000000001 109.583 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.476 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -158.47 123.43 4.27 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.697 -0.853 . . . . 65.239999999999995 108.697 -178.45 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.414 ' HB ' HD12 ' A' ' 121' ' ' ILE . 46.5 t -79.98 -28.99 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 73.109999999999999 109.795 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.46 HD11 ' HG2' ' A' ' 157' ' ' ARG . 5.3 mp -116.76 140.94 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.345 -0.847 . . . . 72.239999999999995 109.094 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -151.81 140.36 20.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.294 -0.878 . . . . 72.340000000000003 108.946 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.446 ' O ' HG23 ' A' ' 123' ' ' ILE . 4.6 tp -160.65 121.23 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.224 -0.923 . . . . 71.439999999999998 109.174 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 60.23 -132.45 50.39 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.183 -1.567 . . . . 73.400000000000006 109.183 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -97.39 3.13 51.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.183 -1.187 . . . . 74.450000000000003 109.354 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.36 143.07 27.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.12 -0.988 . . . . 54.210000000000001 109.066 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.43 141.64 49.86 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.754 -0.832 . . . . 54.5 108.754 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.8 mt -137.85 125.09 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.409 -0.807 . . . . 45.149999999999999 109.125 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.2 m -121.56 95.94 47.84 Favored Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 109.356 -0.609 . . . . 71.109999999999999 109.356 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.15 -33.76 2.48 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.976 1.784 . . . . 65.409999999999997 112.099 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -56.43 -46.4 80.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.233 -0.917 . . . . 63.32 108.995 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -87.04 2.63 49.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.863 . . . . 72.519999999999996 109.196 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 55.0 72.71 0.46 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 75.329999999999998 109.863 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -161.65 143.51 11.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.349 -0.844 . . . . 71.230000000000004 109.367 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.5 tt -115.54 138.6 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.433 -0.951 . . . . 74.019999999999996 108.433 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.6 mt -126.99 127.13 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 109.055 -0.72 . . . . 60.229999999999997 109.055 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.418 ' O ' ' CD1' ' A' ' 137' ' ' TYR . 45.7 p90 -136.85 135.84 38.23 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.377 -0.827 . . . . 62.32 110.598 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp 55.79 31.02 16.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.515 -0.741 . . . . 75.400000000000006 110.755 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.23 16.81 79.1 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.631 -1.271 . . . . 72.239999999999995 110.911 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 65.4 mtt-85 -112.58 126.21 55.1 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.333 -1.098 . . . . 71.219999999999999 109.553 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -94.01 128.04 40.14 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.489 -0.757 . . . . 71.420000000000002 109.627 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 34.7 t -139.16 141.1 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.359 -0.838 . . . . 53.020000000000003 109.1 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.499 ' N ' ' OE1' ' A' ' 143' ' ' GLU . 48.6 mp0 -97.11 143.85 27.52 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.248 -0.907 . . . . 60.450000000000003 109.925 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.15 140.5 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.391 -0.818 . . . . 74.439999999999998 109.196 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.34 28.76 0.45 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 65.150000000000006 108.961 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.918 ' O ' ' CD1' ' A' ' 149' ' ' PHE . . . -86.93 -161.25 36.05 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.002 -1.239 . . . . 73.340000000000003 110.002 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.612 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 16.8 mttm -80.8 -38.04 1.0 Allowed Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.493 -1.004 . . . . 72.219999999999999 110.619 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 96.2 Cg_endo -89.46 19.9 1.17 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.456 2.104 . . . . 65.230000000000004 112.613 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.918 ' CD1' ' O ' ' A' ' 146' ' ' GLY . 5.3 p90 -94.81 -55.79 2.99 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.166 -0.959 . . . . 60.109999999999999 109.408 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.693 ' N ' ' CG ' ' A' ' 149' ' ' PHE . 6.1 pt-20 -53.14 -34.45 56.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.458 -0.776 . . . . 64.209999999999994 109.849 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.488 HG13 ' N ' ' A' ' 152' ' ' LEU . 8.3 p -63.03 -41.18 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.002 -1.061 . . . . 72.019999999999996 109.306 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.489 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.2 OUTLIER -63.52 -46.97 83.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.898 . . . . 73.310000000000002 108.63 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 27.2 p -67.39 -27.71 67.32 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.111 -0.993 . . . . 74.310000000000002 109.164 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -61.1 -53.96 50.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.883 . . . . 74.310000000000002 109.826 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.684 HD12 ' N ' ' A' ' 156' ' ' ALA . 3.9 pp -69.4 -21.12 63.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.025 -1.047 . . . . 75.340000000000003 109.26 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.684 ' N ' HD12 ' A' ' 155' ' ' LEU . . . -65.02 -43.38 92.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 62.140000000000001 108.96 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.501 ' C ' ' H ' ' A' ' 159' ' ' ARG . 59.0 mtm180 -77.24 -49.39 15.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 61.030000000000001 109.111 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -71.97 17.54 0.09 Allowed 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.002 -0.679 . . . . 74.120000000000005 109.422 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.501 ' H ' ' C ' ' A' ' 157' ' ' ARG . 35.4 ptt-85 -52.03 156.74 1.47 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.265 -0.897 . . . . 71.129999999999995 109.2 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.455 ' OD1' ' CD2' ' A' ' 216' ' ' TYR . 50.3 m-20 55.08 47.87 20.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.444 -0.785 . . . . 75.450000000000003 109.678 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -155.04 151.68 28.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.165 -0.959 . . . . 73.409999999999997 109.512 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.4 mt -89.51 138.37 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.224 -0.922 . . . . 74.409999999999997 109.458 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.6 t -139.43 131.01 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.345 -0.847 . . . . 72.310000000000002 109.317 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 16.2 t -78.25 164.72 24.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 74.120000000000005 109.691 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -63.63 -48.75 76.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.46 -0.775 . . . . 70.430000000000007 109.887 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -56.98 -37.03 71.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 73.519999999999996 110.102 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -53.91 -47.53 71.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.952 -1.092 . . . . 74.519999999999996 109.435 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 51.1 mt -60.27 -44.02 95.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.079 -1.013 . . . . 72.310000000000002 109.524 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 7.0 tp -54.93 -51.18 66.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.367 -0.833 . . . . 53.329999999999998 110.17 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -81.3 -11.75 59.25 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.152 -0.968 . . . . 62.439999999999998 110.685 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.52 -52.89 18.65 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.797 -1.189 . . . . 60.210000000000001 109.973 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.66 ' N ' HD12 ' A' ' 172' ' ' ILE . 1.7 mp -85.18 -36.81 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.147 -0.971 . . . . 75.319999999999993 109.072 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.486 -0.758 . . . . 73.140000000000001 109.359 179.993 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 108.788 -0.819 . . . . 64.540000000000006 108.788 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 29.4 m -74.94 -14.97 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.344 -0.847 . . . . 74.019999999999996 109.716 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.416 ' O ' HG22 ' A' ' 188' ' ' ILE . 34.5 mt -48.89 -43.17 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.153 -0.967 . . . . 72.329999999999998 109.63 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -53.08 -34.02 54.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.12 -0.988 . . . . 74.400000000000006 109.466 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.32 -49.0 21.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.482 -0.761 . . . . 70.420000000000002 110.179 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.88 96.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.006 -1.059 . . . . 52.109999999999999 110.161 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.479 HG23 ' N ' ' A' ' 189' ' ' ASN . 11.0 tp -66.3 -42.58 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 120.936 -1.103 . . . . 71.400000000000006 109.691 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.479 ' N ' HG23 ' A' ' 188' ' ' ILE . 39.2 t30 -62.87 -43.05 99.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.197 -0.94 . . . . 73.439999999999998 109.353 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -65.33 -40.16 93.33 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.37 -0.831 . . . . 71.420000000000002 109.61 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 71.8 mt -65.96 -44.86 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.247 -0.908 . . . . 61.549999999999997 109.793 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -58.7 -38.87 79.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.149 -0.969 . . . . 63.340000000000003 109.712 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -79.15 -26.04 42.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -0.991 . . . . 61.240000000000002 110.336 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -91.07 -16.98 26.97 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.962 -1.087 . . . . 75.129999999999995 110.825 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . 0.568 ' SD ' ' N ' ' A' ' 196' ' ' ASP . 2.2 ppp? -91.72 -41.81 10.5 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.713 -1.242 . . . . 74.019999999999996 110.43 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . 0.568 ' N ' ' SD ' ' A' ' 195' ' ' MET . 26.1 t70 -66.82 -37.04 83.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.934 -1.104 . . . . 74.019999999999996 110.103 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.412 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 0.1 OUTLIER -50.86 -63.54 1.84 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.96 -1.087 . . . . 75.430000000000007 109.156 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 40.8 Cg_endo -65.81 -58.27 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.527 1.485 . . . . 72.319999999999993 111.189 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.499 ' C ' ' H ' ' A' ' 201' ' ' ILE . 4.0 mm? -86.16 92.38 8.73 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.29 -1.004 . . . . 74.540000000000006 108.29 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -59.17 -0.22 0.69 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.968 -1.253 . . . . 61.509999999999998 109.968 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.499 ' H ' ' C ' ' A' ' 199' ' ' LEU . 26.0 mm -108.29 130.09 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.379 -1.071 . . . . 61.219999999999999 109.336 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 67.0 m -76.74 146.34 38.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 72.0 109.296 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 15.9 p -139.65 4.49 2.14 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.398 -0.813 . . . . 74.439999999999998 109.354 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 204' ' ' VAL . 7.9 m -120.54 132.05 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.606 -0.684 . . . . 64.349999999999994 109.538 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -103.8 118.33 36.44 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.378 -0.826 . . . . 71.409999999999997 108.914 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 206' ' ' THR . 0.0 OUTLIER -94.11 129.43 40.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.241 -0.912 . . . . 73.519999999999996 109.573 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.507 HG21 HH12 ' A' ' 213' ' ' ARG . 19.9 t -144.54 131.13 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 71.019999999999996 108.944 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -56.78 -31.84 65.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 72.120000000000005 109.684 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 211' ' ' GLY . 72.9 mtt85 -63.72 137.54 58.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.91 . . . . 64.409999999999997 109.808 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 57.68 -78.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.475 -0.766 . . . . 71.540000000000006 110.026 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . -177.6 -114.94 0.42 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.29 -1.524 . . . . 72.030000000000001 109.29 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -113.24 135.07 54.23 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.426 -1.044 . . . . 75.540000000000006 109.289 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.507 HH12 HG21 ' A' ' 207' ' ' VAL . 21.8 ttp-105 -109.55 139.64 44.31 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.929 -0.767 . . . . 75.310000000000002 108.929 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.442 ' O ' ' SG ' ' A' ' 215' ' ' CYS . 58.7 m-85 -107.62 134.57 50.43 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.425 -0.797 . . . . 75.409999999999997 109.935 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 214' ' ' PHE . 99.3 m -155.02 156.25 35.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.479 -0.763 . . . . 74.140000000000001 109.262 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . 0.455 ' CD2' ' OD1' ' A' ' 160' ' ' ASP . 1.9 p90 -64.74 154.34 85.59 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.193 -0.942 . . . . 75.319999999999993 109.299 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo . . . . . 0 N--CA 1.492 1.392 0 C-N-CA 122.232 1.955 . . . . 73.109999999999999 111.943 179.827 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.589 ' SD ' ' CE2' ' B' ' 25' ' ' PHE . 16.7 ptp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.435 -0.58 . . . . 71.140000000000001 109.435 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.532 ' NH1' ' SD ' ' B' ' 26' ' ' MET . 92.8 mtt-85 -136.62 152.97 51.03 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.387 -0.821 . . . . 73.230000000000004 109.178 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 93.5 t -110.68 133.2 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.525 -0.735 . . . . 72.239999999999995 109.582 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.431 HD11 ' CG1' ' B' ' 6' ' ' ILE . 3.6 tp -105.72 118.22 36.03 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.61 -0.681 . . . . 54.329999999999998 109.686 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.42 ' N ' HD12 ' B' ' 4' ' ' LEU . 15.3 mt -113.3 100.28 8.44 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.708 -0.849 . . . . 74.349999999999994 108.708 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.689 HD12 ' HB ' ' B' ' 50' ' ' VAL . 89.4 mt -86.97 99.66 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.04 -1.038 . . . . 42.549999999999997 109.015 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.447 ' CD ' ' HG ' ' B' ' 51' ' ' SER . 7.0 tp10 -146.69 137.61 24.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.46 -0.775 . . . . 74.519999999999996 108.913 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.524 ' H ' ' CD ' ' B' ' 8' ' ' LYS . 0.0 OUTLIER -78.39 -31.92 48.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 62.549999999999997 109.084 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . 0.4 ' H ' ' HG3' ' B' ' 7' ' ' GLU . 93.3 m-20 -75.45 109.16 8.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.867 . . . . 73.109999999999999 109.552 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 29.3 m -67.43 -27.7 67.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.269 -0.895 . . . . 65.540000000000006 109.668 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 75.5 t -59.11 -52.44 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.236 -0.915 . . . . 75.549999999999997 109.668 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.535 HD13 ' NZ ' ' B' ' 97' ' ' LYS . 91.6 mt -63.28 -35.76 81.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -0.962 . . . . 70.140000000000001 109.402 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.65 -25.02 75.99 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.826 -1.71 . . . . 75.400000000000006 108.826 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.04 -53.05 24.55 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.736 -1.345 . . . . 65.439999999999998 109.736 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -58.96 -47.17 86.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.35 -1.088 . . . . 60.210000000000001 109.97 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 37.0 mm -61.82 -39.23 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.738 -1.226 . . . . 75.150000000000006 108.816 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -55.04 -42.53 72.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.35 -0.844 . . . . 73.010000000000005 109.457 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -87.76 -2.82 58.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.168 -0.957 . . . . 74.299999999999997 109.381 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.63 -53.66 3.16 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 109.91 -1.276 . . . . 70.540000000000006 109.91 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.458 HD21 ' HB2' ' B' ' 27' ' ' ALA . 1.4 pt? -74.29 -19.84 60.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -1.147 . . . . 71.340000000000003 110.016 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -52.83 -32.4 44.12 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.085 -1.009 . . . . 64.409999999999997 109.52 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 97.5 t -61.94 -33.45 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.225 -0.922 . . . . 74.230000000000004 109.159 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' B' ' 110' ' ' GLU . 16.4 mmtp -81.77 -5.4 58.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.856 . . . . 63.420000000000002 109.18 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.83 19.63 70.02 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.964 -1.254 . . . . 53.43 109.964 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.589 ' CE2' ' SD ' ' B' ' 1' ' ' MET . 7.4 m-85 -92.43 159.68 15.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.162 -1.199 . . . . 71.120000000000005 108.97 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . 0.532 ' SD ' ' NH1' ' B' ' 2' ' ' ARG . 35.6 mtt -100.95 138.0 38.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.271 -0.893 . . . . 75.239999999999995 108.702 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.458 ' HB2' HD21 ' B' ' 20' ' ' LEU . . . -114.22 147.35 39.08 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.51 -0.744 . . . . 72.120000000000005 110.09 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -131.7 134.04 45.49 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.44 -0.948 . . . . 72.310000000000002 108.44 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -109.75 134.55 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.361 -0.837 . . . . 64.430000000000007 109.077 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.9 p -137.23 169.72 17.31 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.497 -0.752 . . . . 65.409999999999997 109.176 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -93.21 -107.34 0.12 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.191 -0.943 . . . . 71.019999999999996 109.679 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 68.2 p -78.75 168.45 19.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.906 . . . . 51.109999999999999 109.914 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.414 HD22 ' CG ' ' B' ' 58' ' ' PHE . 47.6 mt -51.53 -30.25 19.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.663 -0.648 . . . . 71.239999999999995 109.907 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -52.72 -51.18 61.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.097 -1.002 . . . . 74.319999999999993 109.772 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.82 -39.2 93.66 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.152 -0.968 . . . . 73.030000000000001 109.428 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.64 -39.39 78.06 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.559 -1.416 . . . . 30.210000000000001 109.559 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -69.06 -38.23 78.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -1.127 . . . . 74.420000000000002 109.874 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -80.6 -38.72 28.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.102 -0.999 . . . . 74.420000000000002 109.918 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 11.1 tp -69.23 -43.49 73.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.216 -0.927 . . . . 75.409999999999997 110.134 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.0 ppp? -66.59 -24.42 66.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.05 . . . . 60.409999999999997 109.916 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -61.28 -40.99 96.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.109 -0.995 . . . . 53.229999999999997 110.112 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.46 HD12 ' NH1' ' B' ' 43' ' ' ARG . 17.5 pt -81.25 -30.7 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.076 -1.015 . . . . 71.230000000000004 110.238 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.46 ' NH1' HD12 ' B' ' 42' ' ' ILE . 78.1 mtt85 -129.93 141.22 50.81 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.395 -0.815 . . . . 72.219999999999999 109.623 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -97.18 147.32 24.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.282 -0.886 . . . . 63.539999999999999 109.289 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -123.6 145.79 48.66 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.524 -0.735 . . . . 64.349999999999994 109.38 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . 0.458 ' OD2' ' NE1' ' B' ' 116' ' ' TRP . 48.6 t0 -79.68 -42.29 25.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.232 -0.917 . . . . 62.219999999999999 109.355 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.547 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.5 OUTLIER -104.23 115.65 30.78 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.872 -0.788 . . . . 73.120000000000005 108.872 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.547 ' N ' HD13 ' B' ' 47' ' ' LEU . 72.6 t -99.62 97.24 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.967 -1.123 . . . . 65.109999999999999 107.967 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 19.9 ttt -110.31 134.09 52.62 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.608 0.718 . . . . 73.439999999999998 110.576 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.689 ' HB ' HD12 ' B' ' 6' ' ' ILE . 1.0 OUTLIER -146.98 132.71 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.543 0.687 . . . . 34.5 109.364 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . 0.447 ' HG ' ' CD ' ' B' ' 7' ' ' GLU . 16.8 p -102.11 12.3 37.0 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.465 -0.772 . . . . 73.209999999999994 109.81 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.501 ' H ' HG22 ' B' ' 50' ' ' VAL . 55.9 m-20 -77.14 143.54 39.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.158 -0.964 . . . . 70.409999999999997 109.603 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.488 ' C ' ' H ' ' B' ' 55' ' ' ALA . 94.2 mttt -63.79 -37.44 87.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 65.0 109.822 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -71.77 16.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.935 . . . . 75.209999999999994 109.645 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.488 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -57.19 -40.05 76.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 55.329999999999998 109.818 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.517 ' N ' HD12 ' B' ' 56' ' ' LEU . 10.8 mp -46.98 -42.22 17.6 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.164 -0.96 . . . . 63.140000000000001 109.733 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . 0.434 ' O ' ' NH1' ' B' ' 61' ' ' ARG . 17.5 m -72.62 -43.08 63.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 63.5 109.648 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . 0.414 ' CG ' HD22 ' B' ' 33' ' ' LEU . 50.9 t80 -64.52 -58.01 7.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.29 -0.881 . . . . 72.329999999999998 109.95 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.424 HG23 ' N ' ' B' ' 60' ' ' SER . 14.2 m -53.01 -36.96 25.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.512 -1.368 . . . . 74.540000000000006 109.609 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . 0.424 ' N ' HG23 ' B' ' 59' ' ' VAL . 23.3 t -54.93 -52.15 63.86 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.256 -0.903 . . . . 71.239999999999995 109.6 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.434 ' NH1' ' O ' ' B' ' 57' ' ' SER . 3.9 ptp85 -69.74 -34.09 73.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.989 . . . . 74.310000000000002 110.318 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 40.4 mm -69.75 -34.52 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.759 -1.213 . . . . 72.140000000000001 109.924 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -44.36 77.29 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.15 -0.969 . . . . 73.319999999999993 110.231 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.479 ' CG ' ' N ' ' B' ' 65' ' ' LYS . 9.6 pt-20 -79.41 -45.65 19.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.934 -1.104 . . . . 73.120000000000005 110.369 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.479 ' N ' ' CG ' ' B' ' 64' ' ' GLU . 57.9 mttp -66.95 -24.87 66.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.195 -0.941 . . . . 72.439999999999998 109.852 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.584 ' O ' HG22 ' B' ' 69' ' ' ILE . 79.4 m-70 -155.28 64.5 0.63 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.138 -0.976 . . . . 63.310000000000002 109.564 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.426 ' O ' ' N ' ' B' ' 69' ' ' ILE . 8.0 t -56.09 -34.05 65.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 73.099999999999994 109.823 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 44.8 t -70.18 47.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.936 . . . . 71.530000000000001 109.924 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.584 HG22 ' O ' ' B' ' 66' ' ' HIS . 15.6 tt -145.46 156.35 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.121 -0.987 . . . . 74.400000000000006 109.176 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 31.8 t -93.92 144.95 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.08 -1.012 . . . . 75.120000000000005 109.315 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 25.3 t -131.46 125.32 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.446 -0.784 . . . . 73.200000000000003 110.002 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.549 HD23 ' C ' ' B' ' 72' ' ' LEU . 6.3 tt -121.64 98.06 5.78 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.864 -0.791 . . . . 73.340000000000003 108.864 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.408 HG22 ' N ' ' B' ' 74' ' ' SER . 10.5 p -90.26 156.35 3.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 120.901 -1.124 . . . . 73.5 108.711 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . 0.408 ' N ' HG22 ' B' ' 73' ' ' VAL . 5.9 m -129.45 169.01 15.48 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.385 -0.968 . . . . 64.340000000000003 108.385 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.423 ' C ' ' H ' ' B' ' 77' ' ' ASN . 36.0 t -172.49 125.07 0.49 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.943 -1.098 . . . . 74.530000000000001 110.442 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -76.04 21.57 0.17 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.602 -0.686 . . . . 64.5 109.8 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . 0.423 ' H ' ' C ' ' B' ' 75' ' ' SER . 42.6 t-20 -146.75 58.77 4.62 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.137 -0.977 . . . . 74.25 109.986 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -57.96 83.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.389 2.059 . . . . 74.430000000000007 112.036 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 66.5 p -107.63 160.97 15.28 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.41 -0.959 . . . . 73.120000000000005 108.41 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.3 p -63.2 -22.68 67.02 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.22 -0.925 . . . . 71.010000000000005 109.782 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . 0.438 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 97.2 mt-10 -69.41 -46.53 66.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.099 -1.001 . . . . 63.200000000000003 109.435 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -72.86 -28.06 62.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 73.219999999999999 109.579 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 35.4 tp10 -62.15 -54.05 46.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 74.299999999999997 109.886 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.41 HG23 ' N ' ' B' ' 85' ' ' HIS . 27.2 m -65.89 -38.0 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 73.310000000000002 109.89 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' HIS . . . . . 0.438 ' ND1' ' O ' ' B' ' 81' ' ' GLU . 32.4 m80 -67.05 -35.4 79.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.075 -1.015 . . . . 73.239999999999995 109.778 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.12 -42.12 94.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.965 -1.085 . . . . 55.329999999999998 110.043 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' PHE . . . . . 0.456 ' CE1' ' NH1' ' A' ' 108' ' ' ARG . 52.9 m-85 -81.81 -35.9 28.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.065 -1.022 . . . . 74.140000000000001 109.438 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -71.05 -45.53 63.66 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.302 -0.874 . . . . 64.040000000000006 109.778 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -64.07 -50.46 68.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.087 -1.008 . . . . 72.349999999999994 109.458 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 142.44 73.29 0.03 OUTLIER Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.144 -1.182 . . . . 65.200000000000003 110.144 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -127.83 131.91 49.48 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.394 -1.062 . . . . 52.229999999999997 108.805 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -70.12 -43.07 71.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.99 -1.069 . . . . 73.319999999999993 108.848 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' ASP . . . . . 0.533 ' N ' ' OD1' ' B' ' 93' ' ' ASP . 13.2 p-10 -154.09 153.95 32.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.528 -0.733 . . . . 72.219999999999999 109.053 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.497 ' C ' ' CD1' ' B' ' 94' ' ' TYR . 0.5 OUTLIER -127.43 125.68 41.02 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 109.056 -0.72 . . . . 64.420000000000002 109.056 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 0.444 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 30.1 mm -114.16 141.18 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-O 121.878 0.847 . . . . 72.230000000000004 110.34 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.36 123.02 16.6 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.337 -1.357 . . . . 25.239999999999998 107.337 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.695 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -43.54 -55.46 8.51 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.129 -0.982 . . . . 64.319999999999993 111.879 -178.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 2.6 Cg_endo -40.44 -10.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.052 1.168 . . . . 63.329999999999998 113.213 -175.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . 0.695 ' N ' ' O ' ' B' ' 97' ' ' LYS . 44.7 m-85 59.03 118.7 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.621 -0.674 . . . . 75.129999999999995 109.539 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -65.07 -41.04 95.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.764 -1.21 . . . . 74.230000000000004 108.82 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . 0.754 ' O ' ' N ' ' B' ' 103' ' ' LYS . 7.3 t -173.87 44.84 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.205 -0.934 . . . . 63.340000000000003 110.739 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 14.0 mm 49.25 -69.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-N 118.717 0.689 . . . . 74.439999999999998 110.563 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.754 ' N ' ' O ' ' B' ' 101' ' ' SER . 1.3 mptm? -53.06 -29.42 30.06 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 107.919 -1.141 . . . . 71.109999999999999 107.919 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.42 ' HB1' ' OE1' ' A' ' 83' ' ' GLU . . . -67.44 -39.84 85.42 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.177 -1.046 . . . . 71.450000000000003 108.177 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 50.7 tp -68.17 -56.53 8.41 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.075 -0.713 . . . . 51.310000000000002 109.075 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 89.0 t -60.96 -40.45 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.225 -0.922 . . . . 65.230000000000004 109.585 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.39 -44.43 65.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.155 -0.965 . . . . 24.32 108.902 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 25.5 tpt85 -64.58 -34.62 78.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.337 -0.852 . . . . 75.310000000000002 109.105 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 72.4 mt -73.63 -30.48 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.216 -0.928 . . . . 54.240000000000002 108.75 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . 0.408 ' OE1' ' NZ ' ' B' ' 23' ' ' LYS . 88.9 tt0 -67.31 -58.69 4.35 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.457 -0.777 . . . . 65.310000000000002 109.311 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.93 -31.11 62.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.279 -0.888 . . . . 72.239999999999995 109.111 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -59.39 -47.18 86.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.251 -0.905 . . . . 72.040000000000006 109.191 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.04 100.9 2.53 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.066 -1.021 . . . . 75.349999999999994 109.585 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 20.3 mtm105 -90.65 -73.25 0.54 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.274 -0.891 . . . . 75.5 108.987 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -68.74 -35.64 77.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 65.329999999999998 109.937 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' TRP . . . . . 0.458 ' NE1' ' OD2' ' B' ' 46' ' ' ASP . 58.1 t90 52.01 84.87 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 74.450000000000003 109.482 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 157.44 131.16 1.29 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.714 -1.355 . . . . 44.210000000000001 109.714 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 26.9 t -164.22 169.0 18.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.35 -1.089 . . . . 71.400000000000006 109.41 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.1 139.21 14.5 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.81 -0.756 . . . . 72.319999999999993 109.031 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 14.7 t -105.52 -45.43 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.465 -0.772 . . . . 75.019999999999996 110.146 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 9.2 mm -100.08 140.82 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.079 -1.013 . . . . 51.409999999999997 109.83 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -148.79 115.33 5.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.227 -0.921 . . . . 71.530000000000001 109.344 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.472 ' N ' HD13 ' B' ' 123' ' ' ILE . 0.0 OUTLIER -134.03 120.34 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.632 -0.877 . . . . 72.430000000000007 108.632 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.48 -139.26 48.7 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.382 -1.487 . . . . 51.229999999999997 109.382 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -88.59 4.42 46.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.197 -1.178 . . . . 74.200000000000003 109.503 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.33 135.48 35.69 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.184 -0.947 . . . . 75.420000000000002 108.591 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 5.7 m -132.8 122.88 25.15 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.452 -0.78 . . . . 74.219999999999999 109.172 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.613 HG21 ' HB1' ' B' ' 156' ' ' ALA . 31.1 mm -114.3 125.67 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.376 -0.827 . . . . 60.329999999999998 109.626 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 61.4 m -111.57 90.16 12.01 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.862 -0.792 . . . . 72.310000000000002 108.862 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.84 -29.38 8.59 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.667 1.578 . . . . 75.129999999999995 111.93 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -64.59 -43.51 93.58 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.173 -0.955 . . . . 75.230000000000004 108.873 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.3 8.18 37.26 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.356 -0.84 . . . . 72.430000000000007 109.21 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 49.82 62.14 2.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.895 . . . . 75.129999999999995 109.57 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . 0.589 ' C ' HD12 ' B' ' 135' ' ' ILE . 19.3 ttpp -149.77 130.05 13.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.216 -0.927 . . . . 73.219999999999999 109.392 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . 0.589 HD12 ' C ' ' B' ' 134' ' ' LYS . 1.8 mp -108.9 141.24 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.522 -0.736 . . . . 64.140000000000001 109.089 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 25.7 mt -131.12 132.54 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 121.359 -0.838 . . . . 71.219999999999999 110.644 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . 0.509 ' CE2' ' CG2' ' B' ' 135' ' ' ILE . 48.9 m-85 -134.89 133.37 39.58 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.438 -0.789 . . . . 64.219999999999999 109.442 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . 0.779 ' CE ' ' O ' ' B' ' 198' ' ' PRO . 23.0 mttm 55.11 25.12 6.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 72.019999999999996 110.267 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.7 13.34 80.1 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.941 -1.264 . . . . 74.319999999999993 109.941 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -99.79 124.09 44.71 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.3 -1.117 . . . . 75.340000000000003 108.85 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -88.65 131.45 34.98 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.125 -0.984 . . . . 71.230000000000004 109.913 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.5 136.85 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.462 -0.774 . . . . 70.430000000000007 109.299 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -86.16 160.76 19.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.382 -0.824 . . . . 72.430000000000007 109.154 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 144' ' ' VAL . . . . . 0.563 HG11 HD13 ' B' ' 135' ' ' ILE . 10.3 m -138.18 147.19 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.327 -0.858 . . . . 72.129999999999995 109.693 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 36.4 pttt -176.18 70.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 72.019999999999996 109.872 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 179.99 177.69 48.15 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.545 -1.312 . . . . 42.229999999999997 110.091 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . 0.624 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 8.0 mtmm -70.21 -37.28 7.07 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.419 -1.047 . . . . 73.299999999999997 110.388 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 32.5 Cg_exo -58.12 -39.87 81.66 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.061 1.841 . . . . 71.329999999999998 111.898 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -87.56 -22.53 24.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.877 . . . . 74.230000000000004 109.454 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -52.68 -53.03 53.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 72.340000000000003 109.368 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.43 HG13 ' N ' ' B' ' 152' ' ' LEU . 7.6 p -61.5 -38.18 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.239 -0.913 . . . . 73.349999999999994 109.394 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.49 ' O ' ' CD1' ' B' ' 155' ' ' LEU . 33.4 tp -56.37 -36.53 68.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.19 -0.944 . . . . 55.240000000000002 108.586 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.75 -20.37 50.11 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.954 -1.091 . . . . 70.010000000000005 109.357 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 154' ' ' HIS . . . . . 0.625 ' CE1' ' CE1' ' B' ' 158' ' ' HIS . 16.6 t-160 -68.21 -60.63 2.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.931 -1.106 . . . . 65.319999999999993 109.596 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . 0.923 HD13 ' N ' ' B' ' 156' ' ' ALA . 0.0 OUTLIER -64.91 -24.81 67.64 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.218 -0.926 . . . . 71.540000000000006 108.899 179.469 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . 0.923 ' N ' HD13 ' B' ' 155' ' ' LEU . . . -57.42 -42.46 82.39 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.969 -1.082 . . . . 75.319999999999993 108.593 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' B' ' 159' ' ' ARG . 59.8 mtp180 -87.55 -69.23 0.7 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.228 -0.92 . . . . 73.319999999999993 110.997 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 158' ' ' HIS . . . . . 0.625 ' CE1' ' CE1' ' B' ' 154' ' ' HIS . 10.6 p-80 -67.97 48.08 0.05 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.324 -0.95 . . . . 74.140000000000001 110.158 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' B' ' 157' ' ' ARG . 0.0 OUTLIER -83.78 176.98 8.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.932 -1.105 . . . . 61.409999999999997 108.84 179.276 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 53.0 t0 54.7 43.13 30.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.392 -0.817 . . . . 72.099999999999994 111.288 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -158.67 171.77 19.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.606 -1.309 . . . . 72.25 109.852 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 19.9 mm -73.18 140.47 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.327 -0.858 . . . . 72.310000000000002 109.536 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' B' ' 212' ' ' TYR . 41.0 t -133.59 111.82 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.473 -0.767 . . . . 64.209999999999994 109.343 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 8.9 t -92.22 166.08 12.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.139 -0.976 . . . . 74.219999999999999 109.001 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -59.51 -44.13 93.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.941 -1.099 . . . . 65.310000000000002 108.674 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.59 -24.72 67.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.285 -0.884 . . . . 63.450000000000003 108.956 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -61.06 -51.65 68.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.383 -0.823 . . . . 72.400000000000006 109.692 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 41.6 mt -61.46 -41.68 97.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 72.319999999999993 109.025 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -67.05 0.36 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.482 -0.762 . . . . 73.340000000000003 109.956 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -59.78 -17.51 36.15 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.936 -0.706 . . . . 72.099999999999994 109.829 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . 0.59 ' CB ' ' CE1' ' B' ' 154' ' ' HIS . . . -93.67 -3.8 51.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.801 -1.187 . . . . 62.130000000000003 108.702 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 0.57 ' O ' ' CG ' ' B' ' 173' ' ' TRP . 96.5 mt -133.06 -80.91 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.495 -0.753 . . . . 71.420000000000002 109.074 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 173' ' ' TRP . . . . . 0.57 ' CG ' ' O ' ' B' ' 172' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.514 2.744 0 CA-C-O 121.73 0.776 . . . . 72.230000000000004 109.314 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo . . . . . 0 N--CA 1.494 1.51 0 CA-C-O 121.212 0.422 . . . . 65.219999999999999 112.466 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 52.02 54.43 10.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.224 -0.923 . . . . 72.310000000000002 109.628 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 3.4 p -78.96 -28.64 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.205 -0.934 . . . . 63.32 110.12 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.449 ' O ' HG22 ' B' ' 188' ' ' ILE . 38.8 mm -57.21 -33.93 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.912 -1.117 . . . . 75.030000000000001 111.154 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -61.26 -63.23 1.35 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.924 -1.11 . . . . 64.109999999999999 111.252 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 30.4 m -70.48 -32.75 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.792 -1.193 . . . . 73.0 110.562 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 187' ' ' ALA . . . . . 0.446 ' O ' HD12 ' B' ' 191' ' ' ILE . . . -67.24 -38.03 84.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.958 -1.089 . . . . 61.119999999999997 111.725 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 188' ' ' ILE . . . . . 0.564 HG23 ' N ' ' B' ' 189' ' ' ASN . 10.6 tp -79.62 -46.07 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 119.982 -1.699 . . . . 72.430000000000007 111.222 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 189' ' ' ASN . . . . . 0.564 ' N ' HG23 ' B' ' 188' ' ' ILE . 40.1 m-20 -59.33 -34.05 71.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.745 -1.222 . . . . 65.140000000000001 109.802 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -80.79 -51.86 8.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.047 -1.033 . . . . 63.240000000000002 110.0 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . 0.446 HD12 ' O ' ' B' ' 187' ' ' ALA . 68.6 mt -49.76 -36.14 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.265 -0.897 . . . . 74.030000000000001 109.512 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 192' ' ' ARG . . . . . 1.49 HH12 ' CG2' ' B' ' 204' ' ' VAL . 82.6 mtt-85 -72.75 -45.73 57.15 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.756 -0.831 . . . . 72.239999999999995 108.756 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -66.54 -12.12 56.14 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.351 -0.843 . . . . 73.099999999999994 108.949 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -108.47 -13.46 14.84 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.493 -0.754 . . . . 72.109999999999999 110.617 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 35.5 ttm -96.22 -54.67 3.21 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.87 -1.144 . . . . 44.329999999999998 110.362 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -55.89 -27.62 52.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 71.209999999999994 109.701 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . 0.436 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 40.2 mttt -66.3 -65.75 1.59 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 75.209999999999994 110.021 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 198' ' ' PRO . . . . . 0.779 ' O ' ' CE ' ' B' ' 138' ' ' LYS . 17.8 Cg_endo -58.55 -48.21 16.1 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.139 1.893 . . . . 75.319999999999993 112.745 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . 0.43 ' N ' HD12 ' B' ' 199' ' ' LEU . 9.5 mp -75.86 -43.29 46.39 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.98 -1.075 . . . . 72.25 110.048 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 83.43 -9.05 62.57 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.691 -1.364 . . . . 64.530000000000001 109.691 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 31.3 mm -110.25 130.02 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.451 -1.029 . . . . 44.229999999999997 109.481 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 61.3 p -82.58 142.78 31.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.294 -0.879 . . . . 54.009999999999998 109.507 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . 0.419 ' OG1' ' CZ ' ' B' ' 214' ' ' PHE . 57.8 p -149.89 20.8 0.89 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.459 -0.776 . . . . 74.400000000000006 109.46 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 1.49 ' CG2' HH12 ' B' ' 192' ' ' ARG . 1.2 m -135.14 137.51 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.233 -0.917 . . . . 72.120000000000005 109.664 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -125.81 133.5 51.98 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.974 -0.75 . . . . 65.409999999999997 108.974 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 206' ' ' THR . . . . . 0.474 HG23 ' O ' ' B' ' 206' ' ' THR . 9.7 t -101.96 128.66 48.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.211 -0.931 . . . . 71.329999999999998 109.273 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 27.2 m -145.11 155.44 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.124 -0.985 . . . . 63.5 109.753 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -86.24 -13.05 47.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.276 -0.89 . . . . 74.450000000000003 109.815 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 64.7 mtp85 -55.45 -38.26 68.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.125 -0.984 . . . . 74.140000000000001 109.845 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 75.8 mtt-85 -148.44 -50.55 0.16 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.127 -0.983 . . . . 74.430000000000007 109.246 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 169.28 -113.82 0.53 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.455 -1.458 . . . . 64.450000000000003 109.455 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 212' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' B' ' 163' ' ' VAL . 65.0 m-85 -109.52 127.0 54.13 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.513 -0.992 . . . . 74.209999999999994 109.563 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 43.4 ttt180 -105.06 121.79 44.52 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.379 -0.826 . . . . 74.030000000000001 109.116 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . 0.906 ' CE2' HD23 ' B' ' 155' ' ' LEU . 8.3 t80 -94.53 118.61 31.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.297 -0.877 . . . . 74.340000000000003 109.007 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 35.6 t -119.97 136.58 54.48 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.724 -0.61 . . . . 64.329999999999998 109.633 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -58.89 149.32 65.75 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.275 -1.009 . . . . 70.040000000000006 108.275 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.73 -169.53 0.18 Allowed 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.999 1.799 . . . . 65.109999999999999 111.742 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 6.3 pttm . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.063 -1.023 . . . . 73.150000000000006 109.242 -179.851 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 tpp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.449 -0.575 . . . . 65.120000000000005 109.449 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.517 ' NH2' ' OD2' ' A' ' 28' ' ' ASP . 33.3 ttt85 -145.43 149.58 34.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.148 -0.97 . . . . 72.329999999999998 109.383 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 82.6 t -115.91 132.56 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.403 0.62 . . . . 71.420000000000002 109.768 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 5' ' ' LEU . 4.1 tp -99.56 115.44 29.38 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.829 -0.804 . . . . 65.120000000000005 108.829 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 4' ' ' LEU . 59.8 tp -114.61 104.01 11.57 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.554 -0.716 . . . . 62.43 109.357 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.6 mt -93.23 112.16 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.854 -1.154 . . . . 71.150000000000006 109.189 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -146.86 134.18 20.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.378 -0.827 . . . . 75.340000000000003 109.153 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.564 ' H ' ' CD ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -73.89 -30.63 62.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.957 . . . . 72.439999999999998 109.184 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -83.63 110.58 18.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.253 -0.904 . . . . 63.020000000000003 109.347 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.6 m -65.14 -32.82 74.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 72.340000000000003 109.911 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 81.4 t -64.23 -49.49 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 74.019999999999996 109.778 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.0 tp -60.93 -37.58 82.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 71.430000000000007 109.38 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.31 -27.88 62.95 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.684 -1.767 . . . . 61.32 108.684 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.09 -48.02 79.53 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.345 -1.502 . . . . 71.200000000000003 109.345 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -64.25 -43.54 94.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.389 -1.066 . . . . 71.319999999999993 109.579 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.9 mm -65.35 -38.34 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.837 -1.165 . . . . 63.229999999999997 108.519 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.44 ' CD ' HD21 ' A' ' 21' ' ' ASN . 14.9 tm-20 -61.22 -45.18 95.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.34 -0.85 . . . . 51.109999999999999 109.518 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -86.58 -1.41 57.63 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.138 -0.976 . . . . 73.340000000000003 109.642 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.36 -61.23 1.65 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.02 -1.632 . . . . 62.149999999999999 109.02 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pp -62.3 -29.09 70.19 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.487 -1.008 . . . . 73.510000000000005 109.031 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.44 HD21 ' CD ' ' A' ' 17' ' ' GLU . 86.1 m-20 -51.64 -36.16 45.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 74.25 109.0 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.8 t -53.59 -34.19 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.611 -0.885 . . . . 70.040000000000006 108.611 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.468 ' NZ ' HG21 ' A' ' 106' ' ' VAL . 28.8 mmtm -78.74 -4.83 51.2 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.685 -0.857 . . . . 73.230000000000004 108.685 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.94 44.92 8.7 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.639 -0.984 . . . . 75.540000000000006 110.639 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -119.06 159.68 23.45 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.264 -1.139 . . . . 73.430000000000007 109.017 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.3 mmt -103.65 139.17 39.29 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.541 -0.911 . . . . 43.240000000000002 108.541 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.417 ' O ' ' OD1' ' A' ' 28' ' ' ASP . . . -143.96 160.4 40.89 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.285 -0.884 . . . . 62.109999999999999 109.841 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.517 ' OD2' ' NH2' ' A' ' 2' ' ' ARG . 79.3 m-20 -135.96 149.9 49.06 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.954 -0.758 . . . . 74.420000000000002 108.954 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.46 133.92 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.756 -0.831 . . . . 72.150000000000006 108.756 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 p -134.65 168.21 19.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.471 -0.768 . . . . 71.420000000000002 109.42 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -93.09 -106.37 0.12 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.224 -0.922 . . . . 72.329999999999998 109.612 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.8 p -79.8 168.19 19.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.123 -0.986 . . . . 74.239999999999995 109.909 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.7 mt -53.84 -29.98 43.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.465 -0.772 . . . . 71.530000000000001 109.778 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -55.27 -47.97 74.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.108 -0.995 . . . . 74.230000000000004 109.938 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.48 -44.6 70.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.096 -1.003 . . . . 54.030000000000001 109.58 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.45 -40.65 86.54 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.589 -1.404 . . . . 61.409999999999997 109.589 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -66.0 -45.42 81.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -1.115 . . . . 74.340000000000003 109.784 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.26 -40.37 74.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.101 -0.999 . . . . 75.329999999999998 109.664 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.656 HD23 ' C ' ' A' ' 39' ' ' LEU . 7.0 tt -70.5 -56.33 6.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.307 -0.871 . . . . 74.329999999999998 110.022 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.49 ' SD ' ' OH ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -55.75 -27.69 52.02 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.129 -0.982 . . . . 70.319999999999993 110.047 -179.096 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -62.36 -37.23 84.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.104 -0.998 . . . . 71.219999999999999 110.111 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.0 pt -91.6 -1.6 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.091 -1.006 . . . . 74.140000000000001 110.416 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 40' ' ' MET . 19.4 mmt85 -130.02 145.77 51.67 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.292 -0.88 . . . . 72.239999999999995 109.73 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -89.43 152.54 21.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.28 -0.888 . . . . 75.420000000000002 108.997 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.49 ' OH ' ' SD ' ' A' ' 40' ' ' MET . 6.4 p90 -153.13 176.52 11.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.072 -1.017 . . . . 74.230000000000004 109.857 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -132.34 -38.7 1.05 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.552 -0.718 . . . . 72.040000000000006 109.832 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.523 HD13 ' C ' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -103.32 112.17 24.92 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.332 -0.855 . . . . 72.129999999999995 109.255 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.513 ' N ' HD13 ' A' ' 47' ' ' LEU . 75.1 t -96.53 98.06 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.89 -0.781 . . . . 72.340000000000003 108.89 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.503 ' SD ' ' N ' ' A' ' 50' ' ' VAL . 3.3 tpp -110.08 127.76 55.04 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.626 0.727 . . . . 74.109999999999999 109.143 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.503 ' N ' ' SD ' ' A' ' 49' ' ' MET . 1.6 p -138.71 128.02 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.532 -0.73 . . . . 61.119999999999997 109.64 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.1 m -96.42 5.16 51.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.338 -0.851 . . . . 73.109999999999999 109.521 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.432 ' H ' HG22 ' A' ' 50' ' ' VAL . 54.3 m-20 -76.47 141.41 41.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.129 -0.982 . . . . 52.549999999999997 109.299 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.448 ' C ' ' H ' ' A' ' 55' ' ' ALA . 18.4 pttp -77.69 -38.81 46.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.145 -0.972 . . . . 44.219999999999999 110.453 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -72.17 12.84 0.37 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.015 -1.053 . . . . 70.439999999999998 109.498 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -75.48 -21.02 58.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 64.140000000000001 110.596 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 55' ' ' ALA . 58.7 mt -40.71 -52.45 2.94 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.366 -0.834 . . . . 44.140000000000001 110.428 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -67.02 -32.72 74.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.983 -1.073 . . . . 55.229999999999997 108.908 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.634 ' CE2' HD11 ' A' ' 62' ' ' ILE . 53.4 t80 -66.46 -59.29 3.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.435 -0.791 . . . . 74.439999999999998 109.911 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.5 m -51.67 -34.14 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.561 -1.337 . . . . 74.030000000000001 109.476 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.1 t -58.07 -55.48 34.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.129 -0.982 . . . . 64.299999999999997 109.718 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -64.72 -27.72 69.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.08 -1.012 . . . . 64.439999999999998 109.782 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.634 HD11 ' CE2' ' A' ' 58' ' ' PHE . 5.7 mm -65.39 -42.29 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.894 -1.129 . . . . 63.210000000000001 109.886 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 67' ' ' SER . 1.9 mmmm -67.65 -46.99 70.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.169 -0.957 . . . . 74.420000000000002 110.402 -179.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.413 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 14.3 pt-20 -69.91 -41.46 74.63 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.594 -1.316 . . . . 70.319999999999993 109.535 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.413 ' N ' ' CG ' ' A' ' 64' ' ' GLU . 52.1 mtpt -73.85 -22.29 59.81 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.232 -0.917 . . . . 75.219999999999999 109.169 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.612 ' O ' HG22 ' A' ' 69' ' ' ILE . 78.7 m-70 -152.66 64.96 0.8 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.305 -0.872 . . . . 74.129999999999995 109.148 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 63' ' ' LYS . 22.7 t -59.23 -36.21 75.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.172 -0.955 . . . . 73.239999999999995 109.967 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.7 p -74.5 50.36 0.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.136 -0.978 . . . . 61.009999999999998 109.574 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 66' ' ' HIS . 11.2 tt -145.65 168.38 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.165 -0.959 . . . . 71.329999999999998 109.472 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.6 t -104.11 152.78 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.336 -0.852 . . . . 72.129999999999995 109.154 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.439 ' H ' ' HB2' ' A' ' 92' ' ' ASP . 4.8 t -143.55 120.71 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.15 -0.969 . . . . 54.210000000000001 109.197 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.547 ' HG ' HD11 ' A' ' 95' ' ' ILE . 3.5 mp -119.33 104.64 10.56 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.708 -0.849 . . . . 50.240000000000002 108.708 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 73' ' ' VAL . 13.6 p -94.78 130.71 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.264 -0.898 . . . . 74.409999999999997 109.148 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.6 p -90.85 165.48 13.59 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.152 -0.967 . . . . 72.310000000000002 108.923 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.442 ' C ' ' H ' ' A' ' 77' ' ' ASN . 11.8 m -159.53 115.65 2.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.031 -1.043 . . . . 64.540000000000006 109.91 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 49.9 p30 -72.64 11.23 0.67 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.376 -0.827 . . . . 74.129999999999995 109.128 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 79' ' ' THR . 4.4 t-20 -142.28 64.09 16.15 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.472 -0.767 . . . . 73.340000000000003 109.455 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.97 83.83 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.027 1.818 . . . . 63.219999999999999 111.716 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.488 ' N ' ' O ' ' A' ' 77' ' ' ASN . 28.5 p -115.38 156.6 25.26 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.194 -0.669 . . . . 62.530000000000001 109.194 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.2 t -64.64 -38.87 92.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.308 -0.87 . . . . 73.439999999999998 109.596 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.403 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 85.8 tt0 -55.41 -44.79 76.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 71.420000000000002 109.386 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -74.55 -30.51 61.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.144 -0.973 . . . . 73.430000000000007 109.478 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -63.06 -57.37 10.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.299 -0.875 . . . . 74.219999999999999 109.799 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.493 HG23 ' N ' ' A' ' 85' ' ' HIS . 30.0 m -58.91 -42.85 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.109 -0.994 . . . . 73.200000000000003 109.343 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.493 ' N ' HG23 ' A' ' 84' ' ' VAL . 24.2 m170 -63.51 -21.05 66.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.932 . . . . 53.329999999999998 109.583 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -76.18 -48.74 19.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.076 -1.015 . . . . 64.109999999999999 110.024 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.57 ' CE2' ' CZ ' ' B' ' 108' ' ' ARG . 86.0 m-85 -81.0 -28.42 35.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.026 -1.046 . . . . 74.340000000000003 109.351 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -73.69 -42.73 60.88 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.223 -0.923 . . . . 74.420000000000002 109.689 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -68.61 -50.47 51.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.082 -1.011 . . . . 74.239999999999995 109.711 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.56 64.47 0.01 OUTLIER Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.138 -1.185 . . . . 61.509999999999998 110.138 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -130.33 141.15 50.6 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.393 -1.063 . . . . 55.329999999999998 109.046 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.439 ' HB2' ' H ' ' A' ' 71' ' ' VAL . 0.9 OUTLIER -79.71 -39.19 31.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.086 -1.009 . . . . 73.420000000000002 109.562 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 71.2 m-20 -152.44 164.39 37.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 75.040000000000006 109.532 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.71 129.69 24.92 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.665 -0.865 . . . . 71.329999999999998 108.665 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.809 ' N ' HD12 ' A' ' 95' ' ' ILE . 0.3 OUTLIER -124.02 145.42 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 121.444 0.64 . . . . 71.129999999999995 110.066 -178.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.01 130.21 44.49 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.176 -1.046 . . . . 64.319999999999993 108.176 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.655 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -51.42 -54.03 43.27 Favored Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.056 -1.028 . . . . 62.200000000000003 111.506 -179.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.7 Cg_endo -42.13 -11.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.228 0 CA-C-N 119.681 0.922 . . . . 73.109999999999999 112.558 -176.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.655 ' N ' ' O ' ' A' ' 97' ' ' LYS . 57.9 m-85 59.94 135.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.859 -0.525 . . . . 65.219999999999999 110.009 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 44.1 mtt-85 -73.7 -45.06 54.54 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.083 -1.011 . . . . 72.349999999999994 109.86 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.732 ' O ' ' N ' ' A' ' 103' ' ' LYS . 42.4 t -164.41 32.56 0.07 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.838 -1.164 . . . . 71.319999999999993 111.201 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.0 mm 52.42 -70.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.494 -0.754 . . . . 75.430000000000007 110.168 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.732 ' N ' ' O ' ' A' ' 101' ' ' SER . 13.8 mptt -57.86 -26.64 62.35 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.006 -1.109 . . . . 71.409999999999997 108.006 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.53 -46.67 46.28 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.853 -0.739 . . . . 63.240000000000002 109.697 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.7 tp -63.32 -58.72 6.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.935 . . . . 73.219999999999999 109.615 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.486 HG23 ' N ' ' A' ' 107' ' ' ALA . 9.1 m -52.22 -40.94 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.966 -1.084 . . . . 60.109999999999999 109.471 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.486 ' N ' HG23 ' A' ' 106' ' ' VAL . . . -55.71 -43.09 76.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.134 -0.979 . . . . 70.420000000000002 108.557 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -64.08 -30.89 71.93 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.357 -0.839 . . . . 74.409999999999997 109.069 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 55.6 mt -71.36 -35.2 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 107.969 -1.123 . . . . 62.539999999999999 107.969 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 114' ' ' ARG . 81.6 tt0 -62.39 -34.57 76.99 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.097 -0.705 . . . . 74.340000000000003 109.097 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.523 ' HB1' ' CE1' ' B' ' 87' ' ' PHE . . . -76.36 -59.73 2.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 73.319999999999993 109.654 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.412 ' H ' ' HD2' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -57.97 -9.71 1.47 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 52.409999999999997 109.483 -179.766 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.6 tp -140.53 82.48 1.85 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.213 -0.929 . . . . 65.239999999999995 109.84 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 110' ' ' GLU . 2.1 mmt180 -152.05 -50.11 0.11 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.318 -0.864 . . . . 64.450000000000003 108.897 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -89.34 14.14 11.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.282 -0.886 . . . . 74.430000000000007 110.001 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.406 ' O ' ' CG ' ' A' ' 116' ' ' TRP . 34.9 p-90 -68.08 125.33 26.0 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.057 -1.027 . . . . 74.420000000000002 109.721 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.409 ' O ' ' OG ' ' A' ' 118' ' ' SER . . . 139.79 135.62 3.27 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.186 -1.565 . . . . 75.040000000000006 109.186 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 117' ' ' GLY . 69.1 m -166.35 171.02 12.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.071 -1.252 . . . . 61.140000000000001 110.1 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.08 103.31 2.2 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.726 -0.842 . . . . 65.239999999999995 108.726 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 97.4 t -72.04 -29.67 33.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.087 -1.008 . . . . 73.109999999999999 109.132 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.15 131.5 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.603 -0.888 . . . . 72.239999999999995 108.603 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -149.12 128.4 12.91 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.129 -0.982 . . . . 72.340000000000003 109.542 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.864 HG21 ' NH1' ' A' ' 159' ' ' ARG . 9.3 tp -161.39 136.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.309 -0.869 . . . . 71.439999999999998 109.499 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 126' ' ' LEU . . . 59.13 -167.03 7.65 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.878 -1.289 . . . . 73.400000000000006 109.878 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -70.67 12.29 0.28 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.511 -0.993 . . . . 74.450000000000003 108.83 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.534 ' H ' ' C ' ' A' ' 124' ' ' GLY . 1.9 tt -110.06 131.2 55.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.698 -0.626 . . . . 54.210000000000001 109.514 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.8 p -131.0 142.87 50.38 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.325 -0.859 . . . . 54.5 108.716 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.46 HG21 ' CB ' ' A' ' 156' ' ' ALA . 94.6 mt -136.67 135.4 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.164 -0.96 . . . . 45.149999999999999 110.661 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.1 m -127.46 104.1 22.05 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.359 -0.978 . . . . 71.109999999999999 108.359 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.33 -25.38 2.65 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.475 2.116 . . . . 65.409999999999997 112.206 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -66.06 -38.46 88.37 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.307 -0.871 . . . . 63.32 108.843 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -98.08 9.06 43.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.375 -0.828 . . . . 72.519999999999996 109.64 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.675 ' HA ' ' HZ ' ' A' ' 149' ' ' PHE . 37.7 mt-10 47.72 60.48 3.5 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.206 -0.934 . . . . 75.329999999999998 109.617 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.512 ' C ' HD12 ' A' ' 135' ' ' ILE . 36.0 ttpt -154.03 130.6 10.67 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.047 -1.033 . . . . 71.230000000000004 110.098 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.561 ' N ' HD12 ' A' ' 135' ' ' ILE . 2.2 mp -111.89 138.22 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.488 -0.93 . . . . 74.019999999999996 108.488 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 19.4 mt -125.72 131.54 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.409 -0.807 . . . . 60.229999999999997 108.9 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.417 ' CE2' ' O ' ' A' ' 198' ' ' PRO . 10.3 p90 -139.12 139.22 37.58 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.099 -1.001 . . . . 62.32 109.984 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.1 mttt 53.73 27.87 7.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.522 -0.737 . . . . 75.400000000000006 110.175 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 77.88 14.08 82.73 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.905 -1.14 . . . . 72.239999999999995 110.437 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 -105.27 133.13 50.54 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.472 -1.016 . . . . 71.219999999999999 108.78 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -90.82 129.3 36.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.322 -0.861 . . . . 71.420000000000002 110.224 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 t -128.14 108.63 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.357 -0.979 . . . . 53.020000000000003 108.357 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -92.48 102.07 14.52 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.054 -1.091 . . . . 60.450000000000003 108.054 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.514 HG23 ' CD1' ' A' ' 149' ' ' PHE . 1.3 m -115.61 139.76 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.7 0.762 . . . . 74.439999999999998 110.705 -178.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -160.53 125.39 3.77 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.856 -0.794 . . . . 65.150000000000006 108.856 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.37 -143.18 10.06 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.674 -1.37 . . . . 73.340000000000003 109.674 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -70.91 -59.27 3.64 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.346 -1.09 . . . . 72.219999999999999 110.486 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.84 4.9 1.23 Allowed 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.997 1.798 . . . . 65.230000000000004 112.785 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.675 ' HZ ' ' HA ' ' A' ' 133' ' ' GLU . 65.3 t80 -101.66 -54.82 2.65 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.234 -0.916 . . . . 60.109999999999999 110.319 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.4 ' CD ' HG23 ' A' ' 172' ' ' ILE . 7.9 pt-20 -46.98 -36.0 7.24 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.158 -0.964 . . . . 64.209999999999994 109.574 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.8 p -78.82 -31.26 15.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.169 -0.957 . . . . 72.019999999999996 109.137 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.532 HD11 ' SD ' ' A' ' 195' ' ' MET . 13.8 tp -63.56 -38.81 92.53 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.127 -0.983 . . . . 73.310000000000002 109.039 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.1 p -75.91 -32.75 59.76 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.08 -1.013 . . . . 74.310000000000002 108.592 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.487 ' CD2' ' HE1' ' A' ' 158' ' ' HIS . 44.4 t-80 -55.13 -51.01 67.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.607 -0.683 . . . . 74.310000000000002 110.5 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.92 -33.41 65.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.988 -1.07 . . . . 75.340000000000003 109.887 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.46 ' CB ' HG21 ' A' ' 128' ' ' ILE . . . -50.45 -44.62 55.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.981 -1.074 . . . . 62.140000000000001 109.683 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 -77.66 -43.75 30.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.091 -1.006 . . . . 61.030000000000001 110.234 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.487 ' HE1' ' CD2' ' A' ' 154' ' ' HIS . 22.1 m170 -82.54 34.89 0.44 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 74.120000000000005 110.803 -178.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.864 ' NH1' HG21 ' A' ' 123' ' ' ILE . 30.8 ttp180 -64.61 169.28 5.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.807 -1.183 . . . . 71.129999999999995 107.927 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 4.4 p30 41.44 55.68 3.38 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.378 -0.826 . . . . 75.450000000000003 110.082 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -158.4 156.14 29.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 73.409999999999997 109.132 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.624 ' N ' HD12 ' A' ' 162' ' ' ILE . 2.5 mp -83.71 123.1 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.177 -0.952 . . . . 74.409999999999997 108.463 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 48.2 t -118.05 127.67 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.486 -0.759 . . . . 72.310000000000002 110.051 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.8 t -100.69 148.02 25.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.519 -0.738 . . . . 74.120000000000005 109.558 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -49.41 -49.75 43.52 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.482 -0.761 . . . . 70.430000000000007 109.816 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -51.88 -36.93 50.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.069 -1.02 . . . . 73.519999999999996 109.476 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -59.03 -43.35 91.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.976 -1.078 . . . . 74.519999999999996 109.115 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 18.5 mt -56.14 -37.22 69.2 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.245 -0.909 . . . . 72.310000000000002 108.549 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.603 HD21 ' CG1' ' A' ' 184' ' ' ILE . 92.8 mt -64.73 -74.68 0.1 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.566 -1.254 . . . . 53.329999999999998 109.019 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -45.92 -14.43 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.885 . . . . 62.439999999999998 110.516 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 169' ' ' LEU . . . -93.42 -37.54 11.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.063 -1.023 . . . . 60.210000000000001 111.428 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.416 ' N ' ' CD1' ' A' ' 172' ' ' ILE . 1.4 mp -95.42 -56.58 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 120.954 -1.091 . . . . 75.319999999999993 110.446 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.506 2.363 0 O-C-N 120.406 -1.434 . . . . 73.140000000000001 109.229 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 109.292 -0.633 . . . . 64.540000000000006 109.292 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.3 t -145.34 -31.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.235 -0.916 . . . . 74.019999999999996 110.176 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.875 ' H ' HD12 ' A' ' 184' ' ' ILE . 2.4 mp -57.85 -34.82 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.065 -1.022 . . . . 72.329999999999998 109.898 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -52.82 -50.05 64.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.242 -0.911 . . . . 74.400000000000006 109.641 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 186' ' ' VAL . 16.7 m -77.8 -31.08 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.18 -0.95 . . . . 70.420000000000002 109.961 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.58 -51.08 68.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.926 -1.109 . . . . 52.109999999999999 109.915 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.424 HG23 ' N ' ' A' ' 189' ' ' ASN . 3.5 tp -68.03 -43.27 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.879 -1.138 . . . . 71.400000000000006 110.032 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.467 ' ND2' ' OE1' ' A' ' 193' ' ' GLN . 7.9 t-20 -60.38 -37.93 82.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.895 -1.128 . . . . 73.439999999999998 108.676 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -71.93 -50.87 25.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.551 -0.718 . . . . 71.420000000000002 110.618 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 69.5 mt -52.7 -58.5 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.053 -1.029 . . . . 61.549999999999997 109.914 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . 0.421 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 3.3 mtp85 -51.14 -41.92 60.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.075 -1.016 . . . . 63.340000000000003 109.008 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.467 ' OE1' ' ND2' ' A' ' 189' ' ' ASN . 16.4 mt-30 -71.02 -24.05 62.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.995 -1.066 . . . . 61.240000000000002 109.932 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.447 ' O ' ' CG ' ' A' ' 198' ' ' PRO . 4.7 mtpm? -101.0 -0.27 36.81 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.289 -0.882 . . . . 75.129999999999995 110.573 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . 0.532 ' SD ' HD11 ' A' ' 152' ' ' LEU . 0.6 OUTLIER -109.15 -19.11 13.46 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.2 -0.937 . . . . 74.019999999999996 110.02 -179.367 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 192' ' ' ARG . 14.0 p-10 -98.28 -5.28 33.4 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.158 -0.964 . . . . 74.019999999999996 110.164 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.485 ' H ' ' HD2' ' A' ' 198' ' ' PRO . 26.9 mttp -103.23 -64.86 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.125 0 O-C-N 121.355 -0.84 . . . . 75.430000000000007 110.575 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.485 ' HD2' ' H ' ' A' ' 197' ' ' LYS . 29.9 Cg_endo -61.42 -57.41 0.58 Allowed 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 121.966 1.777 . . . . 72.319999999999993 112.013 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.9 mp -69.55 -43.11 73.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 74.540000000000006 109.383 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 94.3 -26.97 14.8 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.254 -1.138 . . . . 61.509999999999998 110.254 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.755 ' N ' HD12 ' A' ' 201' ' ' ILE . 3.1 mp -98.68 133.54 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.97 -1.312 . . . . 61.219999999999999 110.289 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 14.6 m -106.14 139.18 41.07 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.118 -1.067 . . . . 72.0 108.118 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.4 p -141.58 42.96 1.74 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.063 -1.023 . . . . 74.439999999999998 110.128 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.529 ' CG1' ' CE2' ' A' ' 214' ' ' PHE . 1.0 OUTLIER -143.11 155.06 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.28 -0.888 . . . . 64.349999999999994 109.727 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -128.34 134.1 48.8 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.712 -0.847 . . . . 71.409999999999997 108.712 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.4 t -95.1 133.28 39.08 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.046 -1.034 . . . . 73.519999999999996 109.259 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 10.5 p -156.25 142.78 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.787 -1.196 . . . . 71.019999999999996 109.531 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -64.85 -41.06 96.01 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.379 -0.825 . . . . 72.120000000000005 109.539 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 1.077 HH21 ' NH2' ' A' ' 213' ' ' ARG . 0.8 OUTLIER -58.12 152.8 16.07 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.824 -0.806 . . . . 64.409999999999997 108.824 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 209' ' ' ARG . 9.6 mpt_? 42.9 -94.17 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.23 -0.919 . . . . 71.540000000000006 109.789 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . -171.42 -114.09 0.31 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.469 -1.452 . . . . 72.030000000000001 109.469 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -111.06 140.34 45.68 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.478 -1.013 . . . . 75.540000000000006 109.055 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 1.077 ' NH2' HH21 ' A' ' 209' ' ' ARG . 36.6 mtt180 -105.51 142.65 34.88 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.319 -0.863 . . . . 75.310000000000002 109.677 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.529 ' CE2' ' CG1' ' A' ' 204' ' ' VAL . 33.8 m-85 -115.78 112.83 22.58 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.49 -0.93 . . . . 75.409999999999997 108.49 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 8.2 p -119.35 160.6 21.96 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.628 -0.67 . . . . 74.140000000000001 109.847 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . 0.462 ' CD1' ' O ' ' A' ' 217' ' ' PRO . 36.7 p90 -68.92 151.1 97.42 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.394 -0.816 . . . . 75.319999999999993 109.229 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.462 ' O ' ' CD1' ' A' ' 216' ' ' TYR . 84.4 Cg_exo . . . . . 0 N--CA 1.493 1.488 0 C-N-CA 122.28 1.987 . . . . 73.109999999999999 112.253 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.527 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.435 -0.58 . . . . 71.140000000000001 109.435 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.557 HH21 ' C ' ' B' ' 44' ' ' ASN . 8.1 ttp180 -139.89 150.38 44.53 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.357 -0.84 . . . . 73.230000000000004 109.067 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 92.6 t -116.03 129.93 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.537 -0.912 . . . . 72.239999999999995 108.537 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.582 HD21 HD11 ' B' ' 6' ' ' ILE . 5.5 tp -101.89 118.34 36.72 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.513 -0.742 . . . . 54.329999999999998 110.002 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 16.4 mt -114.6 111.28 21.09 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 108.412 -0.958 . . . . 74.349999999999994 108.412 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.656 HD12 ' HB ' ' B' ' 50' ' ' VAL . 66.3 mt -107.94 115.4 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.417 -0.802 . . . . 42.549999999999997 109.246 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' B' ' 7' ' ' GLU . 1.4 pm0 -160.08 140.74 12.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 74.519999999999996 109.417 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -63.68 -31.15 72.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 62.549999999999997 109.319 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -86.5 106.97 17.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.252 -0.905 . . . . 73.109999999999999 109.524 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 47.8 m -72.44 -29.14 63.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 65.540000000000006 109.847 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 90.9 t -56.79 -49.97 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.155 -0.965 . . . . 75.549999999999997 109.657 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.519 ' N ' HD22 ' B' ' 12' ' ' LEU . 3.6 mm? -63.02 -35.21 79.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 70.140000000000001 109.188 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.78 -25.47 74.89 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 108.635 -1.786 . . . . 75.400000000000006 108.635 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.79 -54.13 27.05 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.36 -1.496 . . . . 65.439999999999998 109.36 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -57.42 -46.27 83.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.4 -1.059 . . . . 60.210000000000001 109.68 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 37.5 mm -62.52 -38.88 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.866 -1.146 . . . . 75.150000000000006 108.652 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.423 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 80.0 tt0 -61.79 -43.1 99.53 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.408 -0.807 . . . . 73.010000000000005 109.508 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -87.66 2.6 50.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.186 -0.946 . . . . 74.299999999999997 109.177 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.76 -55.95 2.06 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.457 -1.457 . . . . 70.540000000000006 109.457 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -71.44 -21.99 61.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.242 -1.151 . . . . 71.340000000000003 109.633 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 88.0 m-20 -52.44 -33.91 46.24 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.215 -0.928 . . . . 64.409999999999997 109.646 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 81.8 t -59.51 -32.71 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.152 -0.968 . . . . 74.230000000000004 109.212 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -79.23 -4.79 52.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.358 -0.839 . . . . 63.420000000000002 109.193 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.17 36.35 18.21 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.264 -1.135 . . . . 53.43 110.264 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -113.76 160.01 19.14 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.463 -1.022 . . . . 71.120000000000005 108.938 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.4 mmt -107.14 140.49 39.91 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.386 -0.821 . . . . 75.239999999999995 109.09 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.02 164.74 26.95 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.491 -0.755 . . . . 72.120000000000005 109.499 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -141.24 145.58 35.75 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.372 -0.83 . . . . 72.310000000000002 108.964 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 m -113.63 137.14 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.785 . . . . 64.430000000000007 109.068 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 10.0 p -144.56 164.47 30.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.288 -0.883 . . . . 65.409999999999997 109.367 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.447 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 1.6 pt-20 -91.57 -97.24 0.12 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.242 -0.911 . . . . 71.019999999999996 109.579 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 42.4 t -79.48 166.59 21.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.192 -0.942 . . . . 51.109999999999999 109.96 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' B' ' 37' ' ' GLU . 16.7 mt -55.25 -32.0 61.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.592 -0.693 . . . . 71.239999999999995 110.134 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -54.3 -44.86 72.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.09 -1.006 . . . . 74.319999999999993 110.2 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.447 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 19.0 m-20 -66.34 -42.96 87.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.051 -1.031 . . . . 73.030000000000001 109.651 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.58 -28.48 59.38 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.629 -1.388 . . . . 30.210000000000001 109.629 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' B' ' 33' ' ' LEU . 84.7 tt0 -67.18 -46.79 72.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -1.15 . . . . 74.420000000000002 109.695 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . 0.443 ' O ' ' OD1' ' B' ' 41' ' ' ASP . 70.2 t80 -75.06 -26.59 59.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.258 -0.901 . . . . 74.420000000000002 110.036 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 9.6 tp -84.84 -30.86 24.17 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.17 -0.956 . . . . 75.409999999999997 110.031 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . 0.489 ' SD ' ' OH ' ' B' ' 45' ' ' TYR . 0.0 OUTLIER -86.83 -30.61 21.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.961 . . . . 60.409999999999997 110.317 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' B' ' 42' ' ' ILE . 56.2 p-10 -71.07 -21.4 62.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.878 -1.139 . . . . 53.229999999999997 110.043 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.528 ' N ' ' OD1' ' B' ' 41' ' ' ASP . 12.5 pt -80.94 -29.95 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.03 -1.044 . . . . 71.230000000000004 110.005 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.485 ' C ' ' NH2' ' B' ' 2' ' ' ARG . 26.2 mmt180 -129.13 171.13 12.71 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.376 -0.828 . . . . 72.219999999999999 109.791 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' ASN . . . . . 0.557 ' C ' HH21 ' B' ' 2' ' ' ARG . 24.5 m120 -98.87 154.21 18.21 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.076 -1.015 . . . . 63.539999999999999 109.809 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.586 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 1.3 p90 -140.52 -177.36 5.01 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.353 -0.842 . . . . 64.349999999999994 109.09 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . 0.443 ' OD2' ' CD1' ' B' ' 116' ' ' TRP . 63.4 t0 -133.28 -43.6 0.85 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.253 -0.904 . . . . 62.219999999999999 110.256 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.533 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.5 OUTLIER -102.01 114.51 28.68 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.276 -0.89 . . . . 73.120000000000005 109.082 -179.597 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.533 ' N ' HD13 ' B' ' 47' ' ' LEU . 50.6 t -98.63 97.37 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.238 -1.023 . . . . 65.109999999999999 108.238 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.457 ' O ' ' O ' ' B' ' 4' ' ' LEU . 22.5 ttt -111.82 130.37 55.83 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.716 0.769 . . . . 73.439999999999998 109.891 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.656 ' HB ' HD12 ' B' ' 6' ' ' ILE . 0.4 OUTLIER -145.8 137.84 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.358 -0.839 . . . . 34.5 109.491 -179.579 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 42.8 p -102.53 2.94 36.92 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.579 -0.701 . . . . 73.209999999999994 109.788 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.412 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 27.4 m-20 -76.41 134.29 39.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.147 -0.97 . . . . 70.409999999999997 109.377 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' B' ' 55' ' ' ALA . 62.6 mttp -70.24 -37.79 75.05 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.275 -0.891 . . . . 65.0 110.46 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -69.96 6.71 1.13 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.969 -1.082 . . . . 75.209999999999994 109.703 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.418 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -75.35 -22.5 57.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 55.329999999999998 110.346 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 42.0 mt -44.46 -39.59 4.89 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.328 -0.857 . . . . 63.140000000000001 110.048 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 83.8 p -76.88 -37.39 55.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.041 -1.037 . . . . 63.5 109.466 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -66.08 -42.87 88.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.387 -0.821 . . . . 72.329999999999998 110.148 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.406 HG23 ' N ' ' B' ' 60' ' ' SER . 35.9 m -68.17 -37.74 78.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 120.68 -1.262 . . . . 74.540000000000006 109.121 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . 0.406 ' N ' HG23 ' B' ' 59' ' ' VAL . 9.5 t -53.84 -49.61 68.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 71.239999999999995 109.472 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -68.32 -35.6 78.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.138 -0.976 . . . . 74.310000000000002 110.069 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 5.4 mm -63.22 -39.35 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.806 -1.184 . . . . 72.140000000000001 109.903 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' B' ' 67' ' ' SER . 6.9 mtpm? -67.13 -50.97 59.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.076 -1.015 . . . . 73.319999999999993 110.42 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -69.32 -38.19 78.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.852 -1.155 . . . . 73.120000000000005 109.765 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.503 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 25.8 mtpp -78.77 -20.52 49.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 72.439999999999998 109.346 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.55 ' O ' HG22 ' B' ' 69' ' ' ILE . 97.9 m-70 -156.88 65.73 0.52 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 63.310000000000002 109.326 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.469 ' N ' ' O ' ' B' ' 63' ' ' LYS . 86.4 p -61.22 -30.63 70.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 73.099999999999994 109.984 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 78.6 p -69.01 47.06 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.152 -0.967 . . . . 71.530000000000001 109.785 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.55 HG22 ' O ' ' B' ' 66' ' ' HIS . 16.0 tt -146.43 163.99 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.152 -0.968 . . . . 74.400000000000006 109.541 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 41.3 t -103.33 148.96 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.308 -0.87 . . . . 75.120000000000005 109.504 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 t -135.66 124.51 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.3 -0.875 . . . . 73.200000000000003 109.841 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.546 HD23 ' C ' ' B' ' 72' ' ' LEU . 4.5 tt -116.8 104.31 11.2 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.107 -0.701 . . . . 73.340000000000003 109.107 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.72 132.51 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.073 -1.017 . . . . 73.5 109.213 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 7.8 p -93.56 170.78 9.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.143 -0.973 . . . . 64.340000000000003 109.154 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.437 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 11.9 t -152.1 122.81 7.42 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.942 -1.099 . . . . 74.530000000000001 110.523 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 51.3 p30 -68.2 1.36 2.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.461 -0.775 . . . . 64.5 109.745 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' B' ' 79' ' ' THR . 38.9 t-20 -171.55 81.3 0.5 Allowed Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.248 -0.907 . . . . 74.25 109.494 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.464 ' CG ' ' HB2' ' B' ' 96' ' ' ALA . 97.4 Cg_exo -42.55 87.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.205 1.937 . . . . 74.430000000000007 111.943 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.505 ' N ' ' O ' ' B' ' 77' ' ' ASN . 3.0 p -100.5 155.83 17.62 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.177 -0.675 . . . . 73.120000000000005 109.177 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.2 -36.38 83.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.386 -0.821 . . . . 71.010000000000005 109.591 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -63.37 -40.81 98.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 63.200000000000003 109.93 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . 0.418 ' OE1' ' OG ' ' B' ' 75' ' ' SER . 78.1 tt0 -73.57 -34.37 65.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.152 -0.967 . . . . 73.219999999999999 109.998 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.407 ' OE1' ' N ' ' B' ' 84' ' ' VAL . 14.6 tm-20 -61.88 -56.68 16.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 74.299999999999997 109.711 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.445 HG23 ' N ' ' B' ' 85' ' ' HIS . 34.6 m -58.66 -39.09 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.16 -0.962 . . . . 73.310000000000002 109.299 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' HIS . . . . . 0.445 ' N ' HG23 ' B' ' 84' ' ' VAL . 19.7 m170 -69.38 -28.02 65.82 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 73.239999999999995 109.403 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.25 -36.39 81.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.128 -0.982 . . . . 55.329999999999998 109.732 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' PHE . . . . . 0.523 ' CE1' ' HB1' ' A' ' 111' ' ' ALA . 68.5 t80 -82.33 -38.41 24.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.058 -1.026 . . . . 74.140000000000001 108.879 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -70.47 -38.25 74.41 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.346 -0.846 . . . . 64.040000000000006 109.653 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -74.97 -57.56 3.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.933 . . . . 72.349999999999994 109.358 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 153.63 80.82 0.03 OUTLIER Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.036 -1.225 . . . . 65.200000000000003 110.036 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -139.82 115.43 10.05 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.247 -1.149 . . . . 52.229999999999997 109.256 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' B' ' 93' ' ' ASP . 18.9 t70 -73.9 -29.56 62.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.926 . . . . 73.319999999999993 108.864 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' B' ' 92' ' ' ASP . 48.2 m-20 -139.01 164.0 30.91 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.507 -0.923 . . . . 72.219999999999999 108.507 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.437 ' OH ' ' CB ' ' B' ' 75' ' ' SER . 89.1 t80 -151.14 103.32 3.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.126 -0.984 . . . . 64.420000000000002 109.26 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 28.0 mm -114.77 149.37 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 O-C-N 121.332 -0.855 . . . . 72.230000000000004 110.499 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . 0.498 ' HB1' ' HD2' ' B' ' 98' ' ' PRO . . . -62.12 143.85 56.13 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.757 -1.201 . . . . 25.239999999999998 107.757 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.593 ' N ' ' CD ' ' B' ' 98' ' ' PRO . 0.0 OUTLIER -68.33 -40.8 21.82 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.857 -1.152 . . . . 64.319999999999993 111.104 -178.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' B' ' 97' ' ' LYS . 39.0 Cg_exo -52.01 -2.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.289 -2.595 0 CA-C-N 118.696 0.57 . . . . 63.329999999999998 112.188 -174.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . 0.578 ' N ' ' O ' ' B' ' 97' ' ' LYS . 58.5 m-85 54.69 95.28 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.711 -0.618 . . . . 75.129999999999995 110.68 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 36.2 mtt85 -56.1 -38.31 70.56 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.7 -1.222 . . . . 74.230000000000004 107.7 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 10.2 t -172.68 125.97 0.48 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.644 -0.873 . . . . 63.340000000000003 108.644 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . 0.4 ' H ' HG13 ' B' ' 102' ' ' ILE . 58.3 mt -50.26 -40.06 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.06 -1.025 . . . . 74.439999999999998 109.363 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -61.79 -38.23 87.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.201 -0.937 . . . . 71.109999999999999 109.193 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.71 -49.49 65.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 71.450000000000003 109.346 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.401 HD11 HD11 ' B' ' 72' ' ' LEU . 65.1 tp -62.28 -44.45 96.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 51.310000000000002 109.149 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.98 -39.94 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.217 -0.927 . . . . 65.230000000000004 109.484 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.37 -39.09 66.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.094 -1.004 . . . . 24.32 108.961 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . 0.57 ' CZ ' ' CE2' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -72.17 -34.66 68.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.421 -0.799 . . . . 75.310000000000002 109.42 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 97.3 mt -75.53 -27.36 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.208 -0.933 . . . . 54.240000000000002 109.33 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -73.51 -56.68 4.72 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.343 -0.848 . . . . 65.310000000000002 109.477 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.72 -36.11 69.31 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 72.239999999999995 109.906 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . 0.467 ' NH2' HH22 ' B' ' 108' ' ' ARG . 0.0 OUTLIER -66.28 -51.4 57.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.171 -0.956 . . . . 72.040000000000006 110.179 -179.467 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' B' ' 116' ' ' TRP . 64.2 mt -74.8 -33.07 62.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.089 -1.007 . . . . 75.349999999999994 110.277 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -48.92 -37.57 20.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.936 -1.102 . . . . 75.5 109.456 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -81.08 -2.45 48.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.911 . . . . 65.329999999999998 109.3 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' TRP . . . . . 0.443 ' CD1' ' OD2' ' B' ' 46' ' ' ASP . 88.2 t90 -55.33 -35.79 65.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 74.450000000000003 109.577 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.32 106.69 2.43 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.614 -1.394 . . . . 44.210000000000001 109.614 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . 0.462 ' C ' ' ND2' ' B' ' 119' ' ' ASN . 42.8 m -154.92 166.95 31.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -1.159 . . . . 71.400000000000006 109.702 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . 0.462 ' ND2' ' C ' ' B' ' 118' ' ' SER . 0.0 OUTLIER -158.0 120.78 3.83 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.875 -0.787 . . . . 72.319999999999993 108.875 -178.37 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 19.3 t -87.36 -43.08 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.146 -0.971 . . . . 75.019999999999996 109.395 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 16.1 mm -99.2 137.2 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.277 -0.89 . . . . 51.409999999999997 109.431 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -135.59 100.48 4.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.446 -0.784 . . . . 71.530000000000001 109.048 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 31.2 mm -113.53 132.18 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.5 -0.75 . . . . 72.430000000000007 109.472 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 44.16 -128.22 6.67 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.034 -1.226 . . . . 51.229999999999997 110.034 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -97.38 -10.25 25.88 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.323 -1.104 . . . . 74.200000000000003 109.711 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.458 HD23 ' H ' ' B' ' 126' ' ' LEU . 0.2 OUTLIER -96.97 137.13 36.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.137 -0.977 . . . . 75.420000000000002 109.298 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 27.6 p -119.62 144.99 46.83 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.589 -0.694 . . . . 74.219999999999999 109.441 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 56.2 mt -124.46 129.26 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.514 -0.741 . . . . 60.329999999999998 109.367 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 6.3 m -109.7 118.22 50.73 Favored Pre-proline 0 N--CA 1.497 1.876 0 N-CA-C 108.858 -0.794 . . . . 72.310000000000002 108.858 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.618 ' CB ' ' HE ' ' B' ' 157' ' ' ARG . 97.3 Cg_endo -79.18 -56.88 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.751 1.634 . . . . 75.129999999999995 112.211 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -59.74 -43.15 94.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.154 -0.966 . . . . 75.230000000000004 109.545 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -81.33 -12.84 58.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 72.430000000000007 109.303 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 52.07 55.07 9.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 75.129999999999995 109.363 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . 0.409 ' NZ ' ' CZ3' ' B' ' 116' ' ' TRP . 35.7 ttpt -137.19 133.7 35.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.482 -0.761 . . . . 73.219999999999999 109.267 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . 0.403 HG23 ' O ' ' B' ' 135' ' ' ILE . 13.5 tt -117.14 132.69 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.53 -0.731 . . . . 64.140000000000001 109.441 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 14.0 mt -112.04 125.07 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.55 -0.718 . . . . 71.219999999999999 109.146 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -139.75 140.35 36.71 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.326 -0.859 . . . . 64.219999999999999 109.728 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt 53.98 19.05 1.86 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.37 -0.831 . . . . 72.019999999999996 110.011 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.38 16.42 64.41 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 120.087 -1.054 . . . . 74.319999999999993 110.614 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -112.29 127.8 56.09 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.365 -1.079 . . . . 75.340000000000003 109.493 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -93.9 127.01 39.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.249 -0.907 . . . . 71.230000000000004 109.629 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 98.7 t -137.52 136.48 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.412 -0.805 . . . . 70.430000000000007 109.254 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . 0.457 ' CD ' ' N ' ' B' ' 143' ' ' GLU . 42.9 mp0 -92.82 144.31 25.41 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.219 -0.926 . . . . 72.430000000000007 109.45 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 144' ' ' VAL . . . . . 0.472 HG23 ' O ' ' B' ' 144' ' ' VAL . 34.1 m -143.55 125.84 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.195 -0.941 . . . . 72.129999999999995 109.17 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.37 117.45 11.81 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.379 -0.826 . . . . 72.019999999999996 109.255 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.7 171.02 33.22 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.515 -1.434 . . . . 42.229999999999997 109.515 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 4.4 mtmm -68.67 -38.26 11.73 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.202 -1.175 . . . . 73.299999999999997 109.961 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 36.1 Cg_exo -59.61 -34.85 96.51 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.105 1.87 . . . . 71.329999999999998 111.929 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -88.47 -18.07 29.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.368 -0.832 . . . . 74.230000000000004 109.622 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -57.45 -40.02 77.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 72.340000000000003 109.644 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.46 HG13 ' N ' ' B' ' 152' ' ' LEU . 9.6 p -61.76 -39.09 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.943 . . . . 73.349999999999994 109.585 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.46 ' N ' HG13 ' B' ' 151' ' ' VAL . 41.2 tp -60.56 -41.45 94.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 55.240000000000002 109.096 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 17.7 p -76.87 -30.99 56.48 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.261 -0.899 . . . . 70.010000000000005 109.258 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -58.4 -51.24 70.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 65.319999999999993 109.585 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . 0.478 HD13 HH22 ' B' ' 159' ' ' ARG . 1.9 pp -72.99 -28.29 62.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -0.942 . . . . 71.540000000000006 109.542 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -54.47 -46.08 73.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.957 . . . . 75.319999999999993 109.507 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . 0.618 ' HE ' ' CB ' ' B' ' 130' ' ' PRO . 43.3 mtt85 -75.75 -43.96 44.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.203 -0.936 . . . . 73.319999999999993 109.457 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -77.04 26.37 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.349 -0.844 . . . . 74.140000000000001 109.903 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . 0.478 HH22 HD13 ' B' ' 155' ' ' LEU . 3.0 tpm_? -49.66 157.04 0.59 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.097 -1.002 . . . . 61.409999999999997 108.873 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' B' ' 160' ' ' ASP . 4.9 p-10 42.81 54.57 4.62 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.473 -0.767 . . . . 72.099999999999994 110.13 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -146.44 156.05 43.01 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.175 -0.953 . . . . 72.25 109.368 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 26.2 mt -98.91 138.98 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.263 -0.898 . . . . 72.310000000000002 109.379 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 9.5 m -140.73 143.52 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.33 -0.857 . . . . 64.209999999999994 109.57 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 83.7 p -94.48 161.48 14.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.285 -0.884 . . . . 74.219999999999999 109.214 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -53.78 -38.55 64.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.2 -0.938 . . . . 65.310000000000002 109.255 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -64.54 -36.85 85.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.867 . . . . 63.450000000000003 109.445 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 10.5 tm0? -56.26 -45.38 80.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.898 . . . . 72.400000000000006 109.123 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 33.1 mt -65.02 -33.83 76.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 72.319999999999993 108.919 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.562 HD23 ' C ' ' B' ' 169' ' ' LEU . 4.0 tt -53.53 -60.64 3.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.43 -0.794 . . . . 73.340000000000003 109.558 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -66.83 -27.85 67.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.371 -0.831 . . . . 72.099999999999994 110.232 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.26 -57.6 11.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.14 -0.975 . . . . 62.130000000000003 110.064 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 0.684 ' N ' HD12 ' B' ' 172' ' ' ILE . 2.0 mp -94.65 -59.0 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.06 -1.025 . . . . 71.420000000000002 109.291 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 23.2 m-90 . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.265 -0.897 . . . . 72.230000000000004 109.527 -179.843 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . 0.432 ' O ' ' OE1' ' B' ' 185' ' ' GLU . 67.4 Cg_endo . . . . . 0 N--CA 1.495 1.564 0 CA-C-O 121.294 0.456 . . . . 65.219999999999999 112.017 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 182' ' ' ASN . . . . . 0.426 ' O ' ' OE1' ' B' ' 185' ' ' GLU . 19.9 t-20 -61.65 -27.29 68.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 72.310000000000002 110.111 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 9.7 m -77.29 -17.53 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.097 -1.002 . . . . 63.32 110.114 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 87.9 mt -58.36 -52.41 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.103 -0.998 . . . . 75.030000000000001 110.034 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . 0.63 ' CD ' ' H ' ' B' ' 185' ' ' GLU . 1.6 pm0 -55.33 -33.93 63.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.134 -0.979 . . . . 64.109999999999999 109.318 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 91.7 t -75.26 -47.63 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 73.0 109.934 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.78 -50.18 65.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -0.999 . . . . 61.119999999999997 110.166 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 188' ' ' ILE . . . . . 0.431 HG23 ' N ' ' B' ' 189' ' ' ASN . 16.1 tt -57.79 -39.87 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.025 -1.047 . . . . 72.430000000000007 109.764 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 189' ' ' ASN . . . . . 0.431 ' N ' HG23 ' B' ' 188' ' ' ILE . 47.6 t30 -61.38 -46.37 90.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.104 -0.997 . . . . 65.140000000000001 109.545 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -68.51 -45.2 72.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 63.240000000000002 109.764 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 85.5 mt -54.98 -41.75 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.226 -0.921 . . . . 74.030000000000001 109.288 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -60.77 -47.15 87.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 72.239999999999995 109.287 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -66.21 -36.15 82.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.894 . . . . 73.099999999999994 109.533 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . 0.46 ' CB ' ' NZ ' ' B' ' 194' ' ' LYS . 7.8 mtpm? -81.29 -6.45 58.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.882 . . . . 72.109999999999999 109.566 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 28.1 ttt -92.92 -54.71 3.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.233 -0.917 . . . . 44.329999999999998 109.406 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 196' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' B' ' 200' ' ' GLY . 91.2 m-20 -62.6 -33.05 74.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 71.209999999999994 109.745 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . 0.449 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 0.0 OUTLIER -54.6 -65.15 1.43 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.17 -0.956 . . . . 75.209999999999994 109.785 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 198' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 36.9 Cg_endo -63.36 -53.44 1.45 Allowed 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.143 1.896 . . . . 75.319999999999993 112.213 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 29.7 mt -66.78 -34.28 77.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.19 -0.944 . . . . 72.25 109.679 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' B' ' 196' ' ' ASP . . . 80.41 -40.08 2.37 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.472 -1.451 . . . . 64.530000000000001 109.472 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 64.6 mt -93.67 137.49 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.273 -1.133 . . . . 44.229999999999997 109.279 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 28.6 p -81.4 134.21 35.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 54.009999999999998 109.361 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 25.9 p -131.3 -7.81 3.78 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.472 -0.767 . . . . 74.400000000000006 109.519 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 3.6 m -105.13 133.45 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.342 -0.848 . . . . 72.120000000000005 109.485 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -99.36 127.32 45.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.346 -0.846 . . . . 65.409999999999997 109.299 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.92 127.68 44.02 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.235 -0.915 . . . . 71.329999999999998 109.24 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.503 HG12 ' H ' ' B' ' 209' ' ' ARG . 9.1 t -139.78 139.46 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.262 -0.899 . . . . 63.5 109.423 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -85.33 11.68 9.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.197 -0.94 . . . . 74.450000000000003 109.466 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 209' ' ' ARG . . . . . 0.503 ' H ' HG12 ' B' ' 207' ' ' VAL . 16.5 tpt85 -74.26 -128.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.924 . . . . 74.140000000000001 109.562 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -57.58 -42.12 82.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 74.430000000000007 109.696 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 211' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' B' ' 207' ' ' VAL . . . -173.8 -118.9 0.52 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.679 -1.368 . . . . 64.450000000000003 109.679 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 212' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' B' ' 212' ' ' TYR . 29.8 m-85 -123.93 156.4 36.4 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.566 -0.961 . . . . 74.209999999999994 109.319 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -134.47 145.55 48.94 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.555 -0.716 . . . . 74.030000000000001 109.082 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -115.78 138.47 51.1 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.449 -0.782 . . . . 74.340000000000003 109.178 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.3 p -156.19 166.54 33.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.43 -0.794 . . . . 64.329999999999998 109.219 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -61.44 149.53 83.31 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.176 -0.952 . . . . 70.040000000000006 108.998 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -38.99 144.87 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 122.047 1.831 . . . . 65.109999999999999 112.152 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . 0.512 ' CB ' ' NZ ' ' B' ' 218' ' ' LYS . 4.7 mtpm? . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.144 -0.972 . . . . 73.150000000000006 109.152 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.585 ' SD ' ' CE2' ' A' ' 25' ' ' PHE . 15.4 ptp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.415 -0.587 . . . . 65.120000000000005 109.415 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.3 mtt85 -140.94 156.23 46.11 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.321 -0.862 . . . . 72.329999999999998 109.283 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.99 130.64 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.643 -0.661 . . . . 71.420000000000002 109.722 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.828 HD12 ' N ' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -100.9 125.59 47.47 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.314 -0.995 . . . . 65.120000000000005 108.314 179.27 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.828 ' N ' HD12 ' A' ' 4' ' ' LEU . 3.4 tp -120.51 118.4 30.14 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.606 -0.684 . . . . 62.43 109.496 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.588 HG12 HD11 ' A' ' 4' ' ' LEU . 8.9 mt -105.14 123.77 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.357 -0.839 . . . . 71.150000000000006 109.056 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -167.42 138.14 2.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.072 -1.018 . . . . 75.340000000000003 109.697 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.609 ' HZ3' ' C ' ' A' ' 31' ' ' GLU . 67.1 mmtt -84.32 -26.47 28.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 72.439999999999998 109.257 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -61.66 -154.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.355 -0.84 . . . . 63.020000000000003 109.5 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.1 p -148.83 -50.75 0.16 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.21 -0.932 . . . . 72.340000000000003 109.41 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.5 t -65.38 -39.8 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 74.019999999999996 109.521 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 12' ' ' LEU . 10.1 mp -63.18 -36.23 82.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 71.430000000000007 109.409 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.55 -35.15 26.57 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.501 -1.84 . . . . 61.32 108.501 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.94 -43.26 91.77 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 110.182 -1.167 . . . . 71.200000000000003 110.182 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -69.39 -41.17 76.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.939 -1.33 . . . . 71.319999999999993 109.306 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.7 mm -67.09 -40.28 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.825 -1.172 . . . . 63.229999999999997 108.135 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -62.75 -53.83 48.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.456 -0.777 . . . . 51.109999999999999 109.798 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -79.56 -1.0 35.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.176 -0.952 . . . . 73.340000000000003 109.771 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -85.73 -54.26 2.83 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.13 -1.588 . . . . 62.149999999999999 109.13 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pp -71.54 -28.31 63.78 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.4 -1.059 . . . . 73.510000000000005 109.315 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -53.98 -35.82 62.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -0.929 . . . . 74.25 109.124 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.3 t -55.46 -49.1 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.306 -0.871 . . . . 70.040000000000006 109.01 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.438 ' NZ ' HG11 ' A' ' 106' ' ' VAL . 35.9 mmtm -58.54 -54.59 45.3 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.689 -0.856 . . . . 73.230000000000004 108.689 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 138.21 36.5 0.15 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.829 -1.309 . . . . 75.540000000000006 109.829 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.585 ' CE2' ' SD ' ' A' ' 1' ' ' MET . 16.9 m-85 -111.99 155.19 24.17 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.374 -1.074 . . . . 73.430000000000007 108.962 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 7.2 mtp -101.97 139.14 38.01 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.19 -1.041 . . . . 43.240000000000002 108.19 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.422 ' O ' ' OD1' ' A' ' 28' ' ' ASP . . . -143.72 158.29 43.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.199 -0.938 . . . . 62.109999999999999 110.368 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 27' ' ' ALA . 87.7 m-20 -136.09 156.5 48.63 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.054 -0.721 . . . . 74.420000000000002 109.054 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 m -104.38 139.9 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.47 -0.937 . . . . 72.150000000000006 108.47 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 p -133.94 164.26 27.69 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.489 -0.757 . . . . 71.420000000000002 109.442 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.609 ' C ' ' HZ3' ' A' ' 8' ' ' LYS . 5.6 pt-20 -97.64 -107.41 0.17 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.295 -0.878 . . . . 72.329999999999998 109.875 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.516 ' N ' ' HZ3' ' A' ' 8' ' ' LYS . 50.0 m -79.88 160.86 25.89 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.155 -0.966 . . . . 74.239999999999995 110.041 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.4 mt -48.58 -19.52 0.35 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.395 -0.816 . . . . 71.530000000000001 109.759 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -61.08 -54.47 44.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 74.230000000000004 110.58 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 36' ' ' GLY . 13.4 p-10 -68.57 -31.67 71.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.917 -1.114 . . . . 54.030000000000001 109.317 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.518 ' N ' ' OD1' ' A' ' 35' ' ' ASP . . . -68.77 -42.89 77.59 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.021 -1.632 . . . . 61.409999999999997 109.021 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.486 ' OE2' ' NH2' ' A' ' 61' ' ' ARG . 85.5 tt0 -71.22 -39.24 71.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.353 -1.086 . . . . 74.340000000000003 109.364 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -73.23 -31.81 64.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.971 . . . . 75.329999999999998 109.648 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.1 tp -70.65 -49.85 43.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.236 -0.915 . . . . 74.329999999999998 110.139 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 43' ' ' ARG . 22.8 ptm -63.45 -20.48 65.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.997 -1.064 . . . . 70.319999999999993 109.802 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -65.15 -38.49 90.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.098 -1.001 . . . . 71.219999999999999 109.956 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.8 pt -84.93 -31.33 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.059 -1.026 . . . . 74.140000000000001 110.254 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 40' ' ' MET . 79.5 mtm180 -130.31 153.5 48.59 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.304 -0.872 . . . . 72.239999999999995 109.595 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.954 ' CG ' ' OE2' ' A' ' 143' ' ' GLU . 29.4 m120 -97.93 155.89 16.87 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.251 -0.906 . . . . 75.420000000000002 109.529 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -135.84 155.32 50.51 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.463 -0.773 . . . . 74.230000000000004 109.277 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -96.08 -43.86 7.58 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.154 -0.966 . . . . 72.040000000000006 109.198 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.63 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.8 OUTLIER -110.58 122.47 47.84 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.499 -0.926 . . . . 72.129999999999995 108.499 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.63 ' N ' HD13 ' A' ' 47' ' ' LEU . 15.4 m -117.3 97.97 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.581 -0.896 . . . . 72.340000000000003 108.581 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.586 ' SD ' ' N ' ' A' ' 50' ' ' VAL . 0.3 OUTLIER -98.67 134.4 41.65 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.793 -0.818 . . . . 74.109999999999999 108.793 -179.346 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.586 ' N ' ' SD ' ' A' ' 49' ' ' MET . 1.3 p -136.43 125.51 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-O 121.774 0.797 . . . . 61.119999999999997 109.967 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.1 p -94.54 2.66 55.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.565 -0.709 . . . . 73.109999999999999 109.356 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -76.75 142.32 40.47 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.191 -0.943 . . . . 52.549999999999997 109.646 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.474 ' C ' ' H ' ' A' ' 55' ' ' ALA . 97.8 mttt -79.14 -38.52 35.84 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.312 -0.868 . . . . 44.219999999999999 110.212 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -67.93 7.99 0.46 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.051 -1.031 . . . . 70.439999999999998 109.585 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.34 -22.46 57.6 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.376 -0.827 . . . . 64.140000000000001 110.718 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 55' ' ' ALA . 55.1 mt -41.39 -51.24 3.76 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.399 -0.813 . . . . 44.140000000000001 110.361 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 t -67.86 -34.22 76.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.96 -1.088 . . . . 55.229999999999997 108.873 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.562 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 48.2 t80 -66.81 -63.62 1.03 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.505 -0.747 . . . . 74.439999999999998 109.914 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.5 m -48.16 -34.29 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.795 -1.191 . . . . 74.030000000000001 109.617 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 61' ' ' ARG . 15.0 p -57.69 -56.32 23.45 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.208 -0.932 . . . . 64.299999999999997 109.133 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.645 HH21 ' NZ ' ' A' ' 65' ' ' LYS . 13.3 ptm180 -66.4 -28.73 68.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -1.0 . . . . 64.439999999999998 110.059 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.562 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 25.1 mm -54.87 -41.42 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.666 -1.271 . . . . 63.210000000000001 107.96 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.522 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 43.4 mmtt -70.84 -40.08 72.58 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.605 -0.838 . . . . 74.420000000000002 109.056 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -67.83 -42.09 82.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 70.319999999999993 109.129 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.645 ' NZ ' HH21 ' A' ' 61' ' ' ARG . 48.6 mtpt -88.48 -14.4 37.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.614 -0.678 . . . . 75.219999999999999 110.076 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 62' ' ' ILE . 73.0 m-70 -155.22 72.17 0.81 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.146 -0.971 . . . . 74.129999999999995 109.342 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.3 p -73.69 -6.96 50.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.912 . . . . 73.239999999999995 109.765 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.2 p -100.19 42.87 1.08 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.27 -0.894 . . . . 61.009999999999998 110.072 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 66' ' ' HIS . 14.7 tt -145.07 160.09 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.011 -1.056 . . . . 71.329999999999998 109.6 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t -98.13 130.43 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.212 -0.93 . . . . 72.129999999999995 108.766 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.29 130.75 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.499 -0.751 . . . . 54.210000000000001 109.323 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.513 ' O ' ' SD ' ' A' ' 49' ' ' MET . 8.6 tt -128.0 95.88 4.32 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.599 0.714 . . . . 50.240000000000002 109.202 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.52 HG22 ' N ' ' A' ' 74' ' ' SER . 14.4 p -91.39 164.89 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.005 -1.06 . . . . 74.409999999999997 109.203 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.52 ' N ' HG22 ' A' ' 73' ' ' VAL . 72.0 m -138.87 169.7 17.31 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.204 -0.935 . . . . 72.310000000000002 109.026 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 77' ' ' ASN . 1.2 p -175.53 128.52 0.26 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.053 -1.029 . . . . 64.540000000000006 110.086 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.425 ' N ' ' HB2' ' A' ' 97' ' ' LYS . 48.7 p30 -67.33 41.6 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.509 -0.744 . . . . 74.129999999999995 109.633 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 75' ' ' SER . 9.9 p30 -156.32 59.45 1.99 Allowed Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.026 -1.046 . . . . 73.340000000000003 110.449 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.68 76.22 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.145 1.896 . . . . 63.219999999999999 111.148 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.458 ' N ' ' O ' ' A' ' 77' ' ' ASN . 82.3 p -103.64 152.3 21.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.575 -0.703 . . . . 62.530000000000001 109.498 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.52 -34.6 78.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.463 -0.773 . . . . 73.439999999999998 109.27 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -67.04 -44.45 80.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 71.420000000000002 109.281 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -74.51 -31.55 62.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 73.430000000000007 109.383 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.493 ' OE1' ' N ' ' A' ' 84' ' ' VAL . 14.3 tm-20 -58.66 -56.72 18.56 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.225 -0.922 . . . . 74.219999999999999 109.555 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.493 ' N ' ' OE1' ' A' ' 83' ' ' GLU . 27.4 m -62.0 -40.64 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 73.200000000000003 109.29 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.454 ' N ' HG23 ' A' ' 84' ' ' VAL . 22.8 t-80 -61.13 -38.93 88.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.24 -0.913 . . . . 53.329999999999998 109.381 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.58 86.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 64.109999999999999 109.543 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.409 ' CE1' ' HB1' ' B' ' 111' ' ' ALA . 17.3 t80 -72.83 -33.23 66.03 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.417 -0.957 . . . . 74.340000000000003 108.417 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -66.56 -36.93 83.85 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.518 -0.738 . . . . 74.420000000000002 109.143 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -64.4 -49.83 70.01 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.361 -0.837 . . . . 74.239999999999995 109.411 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 142.43 31.88 0.12 Allowed Glycine 0 N--CA 1.498 2.775 0 N-CA-C 110.024 -1.23 . . . . 61.509999999999998 110.024 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.25 131.27 38.52 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.088 -1.242 . . . . 55.329999999999998 109.43 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.522 ' OD2' ' NZ ' ' A' ' 63' ' ' LYS . 42.1 m-20 -78.03 -29.35 49.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.108 -0.995 . . . . 73.420000000000002 109.113 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.423 ' OD2' HD11 ' A' ' 95' ' ' ILE . 25.2 t70 -149.88 147.59 28.12 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.911 -0.774 . . . . 75.040000000000006 108.911 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -135.54 113.44 11.1 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.446 -0.784 . . . . 71.329999999999998 108.93 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.423 HD11 ' OD2' ' A' ' 93' ' ' ASP . 20.3 mm -107.35 150.22 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 CA-C-O 122.118 0.961 . . . . 71.129999999999995 110.918 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.95 125.54 25.75 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.51 -1.292 . . . . 64.319999999999993 107.51 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.675 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -45.12 -52.81 18.8 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.036 -1.04 . . . . 62.200000000000003 111.359 -179.061 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 1.6 Cg_endo -40.87 -12.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.112 0 CA-C-N 119.759 0.95 . . . . 73.109999999999999 112.601 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.675 ' N ' ' O ' ' A' ' 97' ' ' LYS . 49.2 m-85 56.69 104.71 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.763 -0.586 . . . . 65.219999999999999 110.383 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.8 ttm-85 -60.65 -39.08 87.0 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.02 -1.104 . . . . 72.349999999999994 108.02 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.1 t -174.45 140.08 0.61 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.916 -0.772 . . . . 71.319999999999993 108.916 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.2 mm -57.95 -37.07 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 75.430000000000007 109.157 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.428 ' HE2' ' H ' ' A' ' 103' ' ' LYS . 1.5 mppt? -64.3 -36.03 82.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 71.409999999999997 109.178 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.31 -48.91 73.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.144 -0.973 . . . . 63.240000000000002 109.406 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.453 ' C ' HD13 ' A' ' 105' ' ' LEU . 2.1 tm? -67.82 -55.05 14.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.377 -0.827 . . . . 73.219999999999999 108.906 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.438 HG11 ' NZ ' ' A' ' 23' ' ' LYS . 67.6 t -55.03 -49.02 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.932 -1.105 . . . . 60.109999999999999 109.425 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.51 -37.28 65.14 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.169 -0.957 . . . . 70.420000000000002 108.91 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.423 ' NH1' ' OE2' ' B' ' 83' ' ' GLU . 11.2 mmt85 -71.38 -30.02 65.63 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.357 -0.839 . . . . 74.409999999999997 109.389 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.67 -30.51 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 107.773 -1.195 . . . . 62.539999999999999 107.773 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -67.58 -52.48 38.1 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.837 -0.801 . . . . 74.340000000000003 108.837 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.444 ' CB ' ' CZ ' ' B' ' 87' ' ' PHE . . . -48.2 -44.09 32.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.446 -0.783 . . . . 73.319999999999993 109.477 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 75.1 mmt-85 -64.61 -32.7 74.47 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.33 -0.856 . . . . 52.409999999999997 109.702 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.1 mt -133.37 75.62 1.62 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.36 -0.837 . . . . 65.239999999999995 110.313 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -92.8 -79.51 0.39 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.089 -1.007 . . . . 64.450000000000003 108.426 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.457 ' O ' ' CD2' ' A' ' 115' ' ' PHE . 26.1 p90 -100.74 49.37 0.89 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.354 -0.841 . . . . 74.430000000000007 109.359 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 75.7 t-105 -67.05 112.58 4.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 74.420000000000002 109.424 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 159.74 111.39 0.29 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.889 -1.284 . . . . 75.040000000000006 109.889 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.2 t -164.17 157.17 17.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -1.14 . . . . 61.140000000000001 109.523 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.595 ' N ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -152.92 117.12 4.88 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.854 -0.795 . . . . 65.239999999999995 108.854 -178.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.506 HG21 ' OD1' ' A' ' 131' ' ' ASP . 18.7 t -77.63 -39.98 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.327 -0.858 . . . . 73.109999999999999 110.466 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 11.1 mm -104.46 130.36 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.105 -0.997 . . . . 72.239999999999995 109.675 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -129.36 136.36 49.9 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.453 -0.943 . . . . 72.340000000000003 108.453 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.622 HD13 ' N ' ' A' ' 124' ' ' GLY . 0.2 OUTLIER -149.99 121.87 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.018 -1.051 . . . . 71.439999999999998 109.599 -179.229 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.622 ' N ' HD13 ' A' ' 123' ' ' ILE . . . 46.96 -129.49 12.23 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.038 -1.225 . . . . 73.400000000000006 110.038 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -93.88 -4.02 50.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.307 -1.114 . . . . 74.450000000000003 109.88 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.67 143.65 26.26 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.141 -0.974 . . . . 54.210000000000001 108.468 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.1 m -132.44 143.67 49.95 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.333 -0.854 . . . . 54.5 109.524 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.4 mt -134.84 140.38 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.457 -0.777 . . . . 45.149999999999999 109.748 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.1 m -128.31 109.05 19.46 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 108.949 -0.76 . . . . 71.109999999999999 108.949 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.52 -27.49 4.14 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.656 1.571 . . . . 65.409999999999997 111.712 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.506 ' OD1' HG21 ' A' ' 120' ' ' VAL . 1.9 m-20 -69.4 -37.15 77.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 63.32 109.093 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -88.98 -4.33 58.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.33 -0.856 . . . . 72.519999999999996 109.603 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 54.65 62.62 2.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.131 -0.981 . . . . 75.329999999999998 108.972 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -160.67 155.56 24.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.256 -0.903 . . . . 71.230000000000004 109.949 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.533 HD12 ' CD2' ' A' ' 152' ' ' LEU . 4.7 tt -124.94 137.61 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.631 -0.668 . . . . 74.019999999999996 109.349 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 24.9 mm -115.83 133.7 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.709 -0.849 . . . . 60.229999999999997 108.709 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -137.88 119.49 15.01 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.231 -0.918 . . . . 62.32 108.851 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.5 ' O ' ' CG ' ' A' ' 138' ' ' LYS . 25.4 ttpt 54.71 20.26 2.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.586 -0.696 . . . . 75.400000000000006 109.974 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.59 0.8 66.62 Favored Glycine 0 N--CA 1.499 2.877 0 O-C-N 120.862 -1.149 . . . . 72.239999999999995 110.71 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.498 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 1.9 mpt_? -89.99 124.84 35.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.963 -1.316 . . . . 71.219999999999999 108.645 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -87.9 130.39 34.93 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.245 -0.91 . . . . 71.420000000000002 109.755 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.7 t -138.45 143.13 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.433 -0.792 . . . . 53.020000000000003 109.739 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.954 ' OE2' ' CG ' ' A' ' 44' ' ' ASN . 91.1 mt-10 -95.9 142.16 28.47 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.868 -0.79 . . . . 60.450000000000003 108.868 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.2 m -138.05 137.88 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.147 -0.97 . . . . 74.439999999999998 109.758 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -168.54 41.87 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.287 -0.883 . . . . 65.150000000000006 109.856 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.25 -129.36 4.58 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 108.856 -1.697 . . . . 73.340000000000003 108.856 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.625 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 23.8 mttp -85.79 -32.29 0.45 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.273 -1.134 . . . . 72.219999999999999 110.846 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.853 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 86.9 Cg_endo -86.1 -18.14 3.59 Favored 'Trans proline' 0 N--CA 1.486 1.06 0 C-N-CA 122.06 1.84 . . . . 65.230000000000004 112.247 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -56.34 -48.83 75.97 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.828 -1.175 . . . . 60.109999999999999 107.828 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 172' ' ' ILE . 74.6 mt-10 -75.99 -42.02 49.43 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.053 -1.092 . . . . 64.209999999999994 108.053 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.853 ' HB ' ' HA ' ' A' ' 148' ' ' PRO . 1.1 t -56.27 -46.58 81.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.039 -1.097 . . . . 72.019999999999996 108.039 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.533 ' CD2' HD12 ' A' ' 135' ' ' ILE . 22.3 tp -66.66 -56.72 9.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.623 -0.673 . . . . 73.310000000000002 110.569 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.6 p -58.49 -35.84 72.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.906 -1.121 . . . . 74.310000000000002 110.03 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.412 ' CD2' ' HD2' ' A' ' 158' ' ' HIS . 22.4 t-80 -58.53 -56.94 15.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.003 -1.06 . . . . 74.310000000000002 110.367 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.54 -26.42 62.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.935 -1.103 . . . . 75.340000000000003 109.525 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.05 -44.23 91.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.958 -1.089 . . . . 62.140000000000001 108.592 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -79.67 -57.99 3.41 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.984 0.897 . . . . 61.030000000000001 109.415 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.412 ' HD2' ' CD2' ' A' ' 154' ' ' HIS . 98.0 m-70 -71.69 41.43 0.08 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.912 -0.586 . . . . 74.120000000000005 111.332 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -82.81 166.43 19.01 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.627 -1.296 . . . . 71.129999999999995 109.027 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.441 ' OD1' ' CE2' ' A' ' 216' ' ' TYR . 14.2 m-20 53.49 47.62 23.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.157 -0.964 . . . . 75.450000000000003 109.262 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -154.89 163.58 40.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.348 -0.845 . . . . 73.409999999999997 110.12 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.3 mm -98.64 136.7 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.42 -1.326 . . . . 74.409999999999997 107.42 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.8 148.18 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.996 -1.065 . . . . 72.310000000000002 110.486 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.7 p -97.08 165.47 12.05 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.609 -0.682 . . . . 74.120000000000005 109.685 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -66.95 -44.78 79.72 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.249 -0.907 . . . . 70.430000000000007 110.121 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -56.19 -40.31 73.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 73.519999999999996 109.923 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -58.05 -43.2 86.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.05 -1.031 . . . . 74.519999999999996 109.425 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 11.7 mt -56.47 -43.72 79.88 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.973 -1.08 . . . . 72.310000000000002 108.127 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.514 HD23 ' C ' ' A' ' 169' ' ' LEU . 5.1 tt -49.16 -56.15 10.12 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.04 -1.038 . . . . 53.329999999999998 109.746 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -54.14 -37.71 64.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.559 -0.713 . . . . 62.439999999999998 112.507 -178.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.65 -32.11 13.54 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 120.531 -1.356 . . . . 60.210000000000001 113.517 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.43 ' O ' ' OE1' ' A' ' 150' ' ' GLU . 1.7 mp -77.88 -51.33 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.628 -1.295 . . . . 75.319999999999993 110.838 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.541 ' O ' ' CG ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.98 0 O-C-N 120.66 -1.275 . . . . 73.140000000000001 109.597 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 34.5 m120 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.187 0.518 . . . . 64.540000000000006 110.19 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.2 p -148.38 -32.25 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.147 -0.97 . . . . 74.019999999999996 109.325 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 6.0 mm -60.69 -43.27 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.181 -0.95 . . . . 72.329999999999998 109.211 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -64.91 -36.94 86.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 74.400000000000006 109.164 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 20.4 t -71.15 -32.33 47.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.117 -0.989 . . . . 70.420000000000002 109.139 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.39 -52.17 17.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.49 -0.757 . . . . 52.109999999999999 110.658 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.401 HG21 ' CZ ' ' A' ' 212' ' ' TYR . 9.2 tp -56.85 -39.11 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.548 -1.345 . . . . 71.400000000000006 110.112 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -63.72 -56.71 13.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.83 -1.169 . . . . 73.439999999999998 110.958 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -65.65 -42.58 91.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.848 -1.158 . . . . 71.420000000000002 110.131 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 66.6 mt -51.72 -35.72 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.808 -1.182 . . . . 61.549999999999997 109.033 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . 0.407 ' HB2' HH11 ' A' ' 192' ' ' ARG . 16.8 mtp-105 -67.29 -54.46 20.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.115 -0.991 . . . . 63.340000000000003 109.689 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -71.21 -14.06 62.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -0.91 . . . . 61.240000000000002 110.992 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.415 ' O ' ' CD ' ' A' ' 198' ' ' PRO . 43.8 mtpt -83.37 -41.24 18.41 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.844 -1.16 . . . . 75.129999999999995 110.709 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . 1.024 ' HE2' HD22 ' A' ' 199' ' ' LEU . 45.8 mtp -81.83 36.99 0.46 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.095 -1.003 . . . . 74.019999999999996 110.699 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 197' ' ' LYS . 27.4 p30 -110.61 -39.09 4.99 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.12 -0.988 . . . . 74.019999999999996 109.988 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.597 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 5.6 tmtt? -91.23 -40.15 0.39 Allowed Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 120.91 -1.119 . . . . 75.430000000000007 110.065 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 24.4 Cg_exo -63.65 -61.22 0.13 Allowed 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.256 1.971 . . . . 72.319999999999993 111.823 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 1.024 HD22 ' HE2' ' A' ' 195' ' ' MET . 10.8 mp -71.42 -28.8 64.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 74.540000000000006 108.971 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 83.46 -14.9 38.09 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.626 -1.79 . . . . 61.509999999999998 108.626 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 21.2 mt -128.52 137.13 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.841 -0.799 . . . . 61.219999999999999 109.073 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 72.8 m -89.74 144.52 25.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.211 -0.93 . . . . 72.0 109.12 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.5 p -146.07 44.68 1.25 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.164 -0.96 . . . . 74.439999999999998 110.288 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 7.9 m -148.66 129.88 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.993 -1.067 . . . . 64.349999999999994 109.23 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -112.14 140.4 46.85 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.687 -0.633 . . . . 71.409999999999997 109.532 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 206' ' ' THR . 14.9 t -126.12 131.46 52.07 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.456 -0.778 . . . . 73.519999999999996 109.942 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.7 154.25 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.47 -0.937 . . . . 71.019999999999996 108.47 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -97.03 75.22 2.62 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.103 -0.998 . . . . 72.120000000000005 110.535 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -146.52 -33.22 0.31 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.175 -0.953 . . . . 64.409999999999997 109.249 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -147.3 -60.18 0.28 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.242 -0.911 . . . . 71.540000000000006 109.217 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -163.52 -119.75 0.5 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.517 -1.433 . . . . 72.030000000000001 109.517 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.401 ' CZ ' HG21 ' A' ' 188' ' ' ILE . 43.5 m-85 -125.31 152.05 45.21 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.63 -0.923 . . . . 75.540000000000006 109.153 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.92 129.05 48.53 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.545 -0.909 . . . . 75.310000000000002 108.545 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -105.86 126.26 51.96 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.357 -0.839 . . . . 75.409999999999997 109.193 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 44.1 t -149.49 158.59 44.31 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.788 -0.819 . . . . 74.140000000000001 108.788 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . 0.441 ' CE2' ' OD1' ' A' ' 160' ' ' ASP . 8.7 p90 -58.07 150.06 53.07 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.255 -0.903 . . . . 75.319999999999993 109.238 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 N--CA 1.494 1.545 0 C-N-CA 122.236 1.957 . . . . 73.109999999999999 111.173 179.52 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 54.4 ttm . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.442 -0.577 . . . . 71.140000000000001 109.442 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 57.5 ttm-85 -139.27 147.61 41.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.419 -0.8 . . . . 73.230000000000004 109.159 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 40.2 t -110.62 137.35 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.682 -0.636 . . . . 72.239999999999995 109.304 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.408 HD11 ' CG1' ' B' ' 6' ' ' ILE . 5.4 tp -113.98 117.55 31.64 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 109.366 -0.605 . . . . 54.329999999999998 109.366 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.496 ' N ' HD23 ' B' ' 5' ' ' LEU . 0.1 OUTLIER -120.39 97.67 5.68 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.171 -1.048 . . . . 74.349999999999994 108.171 178.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.471 ' CG2' ' O ' ' B' ' 31' ' ' GLU . 65.1 mt -81.97 106.14 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.775 -1.203 . . . . 42.549999999999997 109.168 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.425 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 18.3 tp10 -140.18 129.9 24.43 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.481 -0.762 . . . . 74.519999999999996 109.125 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -64.8 -32.34 73.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 62.549999999999997 109.431 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -83.86 123.59 30.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 73.109999999999999 109.503 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 87.1 p -78.8 -26.68 44.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.263 -0.898 . . . . 65.540000000000006 109.689 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 98.3 t -63.12 -49.09 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 75.549999999999997 109.564 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.566 ' N ' HD22 ' B' ' 12' ' ' LEU . 3.6 mm? -64.78 -35.2 80.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 70.140000000000001 108.949 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.25 -26.6 71.76 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.314 -1.914 . . . . 75.400000000000006 108.314 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.29 -49.99 62.61 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.652 -1.379 . . . . 65.439999999999998 109.652 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -61.97 -43.91 97.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.285 -1.126 . . . . 60.210000000000001 109.706 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 35.8 mm -67.31 -37.55 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.689 -1.257 . . . . 75.150000000000006 108.702 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -65.97 -42.39 89.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -0.891 . . . . 73.010000000000005 109.355 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -87.43 1.35 53.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.169 -0.957 . . . . 74.299999999999997 109.204 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.57 -58.06 1.99 Allowed Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.361 -1.496 . . . . 70.540000000000006 109.361 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' B' ' 27' ' ' ALA . 1.6 pt? -68.54 -24.82 64.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.308 -1.113 . . . . 71.340000000000003 109.421 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -53.8 -36.01 61.98 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.184 -0.947 . . . . 64.409999999999997 109.447 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 58.0 t -54.52 -47.64 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.268 -0.895 . . . . 74.230000000000004 108.914 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -59.91 -54.89 40.88 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.948 -0.76 . . . . 63.420000000000002 108.948 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 132.9 41.85 0.18 Allowed Glycine 0 N--CA 1.499 2.868 0 N-CA-C 109.719 -1.353 . . . . 53.43 109.719 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -118.46 160.17 22.2 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.445 -1.033 . . . . 71.120000000000005 109.308 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 8.4 mmt -98.86 138.79 35.48 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.287 -1.005 . . . . 75.239999999999995 108.287 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.468 ' HB1' HD21 ' B' ' 5' ' ' LEU . . . -125.13 149.78 47.54 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.701 0.762 . . . . 72.120000000000005 110.326 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . 0.445 ' OD2' ' NH2' ' B' ' 43' ' ' ARG . 24.1 t70 -133.47 126.5 31.27 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.452 -1.314 . . . . 72.310000000000002 107.452 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 p -117.48 142.58 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.406 -0.809 . . . . 64.430000000000007 110.066 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -134.34 -153.16 0.51 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.751 -0.593 . . . . 65.409999999999997 109.413 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.471 ' O ' ' CG2' ' B' ' 6' ' ' ILE . 1.3 pt-20 -135.36 -87.56 0.36 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.422 -0.799 . . . . 71.019999999999996 109.531 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 61.8 m -79.46 152.03 30.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.963 -1.085 . . . . 51.109999999999999 109.571 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' B' ' 37' ' ' GLU . 43.8 mt -54.2 -41.71 68.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.864 . . . . 71.239999999999995 109.73 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -58.95 -40.8 85.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 74.319999999999993 109.795 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.425 ' OD2' ' OE2' ' B' ' 31' ' ' GLU . 92.7 m-20 -64.02 -40.26 95.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.147 -0.97 . . . . 73.030000000000001 109.212 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . 0.447 ' O ' ' CG ' ' B' ' 40' ' ' MET . . . -82.78 -27.89 40.37 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.642 -1.383 . . . . 30.210000000000001 109.642 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' B' ' 33' ' ' LEU . 81.7 tt0 -64.3 -41.32 96.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.188 -1.183 . . . . 74.420000000000002 109.727 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -80.54 -40.48 25.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.114 -0.992 . . . . 74.420000000000002 109.624 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 45.4 tp -68.02 -40.15 83.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 75.409999999999997 109.936 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . 0.516 ' SD ' ' CE1' ' B' ' 45' ' ' TYR . 1.2 ppp? -74.05 -27.15 60.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.131 -0.981 . . . . 60.409999999999997 109.923 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -52.68 -36.07 56.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.167 -0.958 . . . . 53.229999999999997 110.041 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 9.3 pt -93.11 -20.48 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.092 -1.005 . . . . 71.230000000000004 110.314 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.445 ' NH2' ' OD2' ' B' ' 28' ' ' ASP . 34.8 mtm105 -104.71 156.81 17.66 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.192 -0.942 . . . . 72.219999999999999 109.902 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -91.29 167.72 12.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.381 -0.825 . . . . 63.539999999999999 109.035 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.516 ' CE1' ' SD ' ' B' ' 40' ' ' MET . 1.7 p90 -160.25 113.43 2.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.054 -1.029 . . . . 64.349999999999994 109.669 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -84.62 -37.73 20.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 62.219999999999999 108.859 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.504 HD13 ' C ' ' B' ' 47' ' ' LEU . 0.7 OUTLIER -109.76 109.46 20.16 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.666 -0.864 . . . . 73.120000000000005 108.666 179.524 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.444 ' N ' HD13 ' B' ' 47' ' ' LEU . 78.4 t -95.97 111.18 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.604 -0.888 . . . . 65.109999999999999 108.604 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 12.2 ttt -128.18 135.31 49.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.486 -0.759 . . . . 73.439999999999998 109.551 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.69 HG22 ' H ' ' B' ' 52' ' ' ASP . 0.8 OUTLIER -147.12 140.63 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.591 -0.693 . . . . 34.5 109.506 -179.332 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . 0.425 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 52.8 p -103.91 13.92 31.81 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.445 -0.784 . . . . 73.209999999999994 109.626 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.69 ' H ' HG22 ' B' ' 50' ' ' VAL . 13.5 m-20 -78.34 140.7 38.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.164 -0.96 . . . . 70.409999999999997 109.502 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -72.72 -38.37 67.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.18 -0.95 . . . . 65.0 110.002 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -74.05 10.19 1.3 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.123 -0.986 . . . . 75.209999999999994 109.663 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.09 -22.72 64.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 55.329999999999998 110.148 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 39.4 mt -43.83 -48.54 8.26 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.34 -0.85 . . . . 63.140000000000001 110.174 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 88.3 p -68.9 -33.82 74.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.926 -1.109 . . . . 63.5 108.943 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . 0.468 ' CZ ' HD11 ' B' ' 62' ' ' ILE . 61.0 t80 -66.21 -61.96 1.74 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.444 -0.785 . . . . 72.329999999999998 109.779 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.9 m -49.92 -34.59 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.715 -1.24 . . . . 74.540000000000006 109.719 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.5 m -57.81 -51.79 68.14 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.285 -0.884 . . . . 71.239999999999995 109.632 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.627 ' NH2' ' HZ3' ' B' ' 65' ' ' LYS . 10.4 ptm180 -70.71 -27.4 63.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.041 -1.037 . . . . 74.310000000000002 110.132 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' B' ' 66' ' ' HIS . 29.9 mm -63.17 -53.78 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.743 -1.223 . . . . 72.140000000000001 109.181 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -59.73 -36.93 77.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.98 -1.075 . . . . 73.319999999999993 109.112 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -75.04 -38.16 61.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.365 -0.835 . . . . 73.120000000000005 109.477 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.627 ' HZ3' ' NH2' ' B' ' 61' ' ' ARG . 92.1 mttt -88.71 -18.46 27.81 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.166 -0.959 . . . . 72.439999999999998 110.722 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' B' ' 62' ' ' ILE . 77.7 m-70 -156.47 67.55 0.57 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.852 -1.155 . . . . 63.310000000000002 109.874 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 7.5 m -58.75 -29.18 66.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.277 -0.889 . . . . 73.099999999999994 109.553 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 86.4 p -66.56 -27.66 67.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.285 -0.885 . . . . 71.530000000000001 110.311 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.424 HG22 ' N ' ' B' ' 70' ' ' VAL . 72.7 mt -79.42 157.34 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.022 -1.049 . . . . 74.400000000000006 109.592 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.507 HG12 ' N ' ' B' ' 71' ' ' VAL . 87.2 t -94.62 160.68 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.284 -0.885 . . . . 75.120000000000005 109.891 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.507 ' N ' HG12 ' B' ' 70' ' ' VAL . 3.6 t -136.22 133.28 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.296 -0.877 . . . . 73.200000000000003 108.908 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.633 ' CD1' HH22 ' B' ' 108' ' ' ARG . 1.0 OUTLIER -133.52 104.67 6.5 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.752 0.787 . . . . 73.340000000000003 109.385 -179.21 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 84.3 t -92.26 130.39 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.928 . . . . 73.5 109.552 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 11.8 p -89.79 170.33 10.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.038 . . . . 64.340000000000003 108.212 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 18.8 p -157.43 110.83 2.54 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.757 -1.214 . . . . 74.530000000000001 110.329 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -64.97 -34.41 78.37 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.428 -0.953 . . . . 64.5 108.428 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -109.87 75.54 0.86 Allowed Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 108.527 -0.916 . . . . 74.25 108.527 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.2 86.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 121.889 1.726 . . . . 74.430000000000007 112.198 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.564 HG23 ' H ' ' B' ' 82' ' ' GLU . 1.6 t -105.53 150.93 24.91 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.571 -0.9 . . . . 73.120000000000005 108.571 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -32.63 74.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.112 -0.992 . . . . 71.010000000000005 109.475 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.56 -42.32 87.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 63.200000000000003 109.588 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . 0.564 ' H ' HG23 ' B' ' 79' ' ' THR . 85.6 tt0 -74.46 -26.78 60.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 73.219999999999999 109.327 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.423 ' OE2' ' NH1' ' A' ' 108' ' ' ARG . 86.7 tt0 -68.71 -51.33 42.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 74.299999999999997 109.804 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.416 HG23 ' N ' ' B' ' 85' ' ' HIS . 29.4 m -63.28 -39.1 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.103 -0.998 . . . . 73.310000000000002 109.507 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' HIS . . . . . 0.416 ' N ' HG23 ' B' ' 84' ' ' VAL . 22.9 m80 -77.05 -21.07 55.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 73.239999999999995 109.41 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -68.15 -48.34 65.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.22 -0.925 . . . . 55.329999999999998 109.852 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' PHE . . . . . 0.444 ' CZ ' ' CB ' ' A' ' 111' ' ' ALA . 80.7 t80 -76.28 -33.0 59.1 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.988 -1.07 . . . . 74.140000000000001 108.963 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -62.15 -51.02 69.51 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.361 -0.837 . . . . 64.040000000000006 109.195 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -58.88 -49.79 76.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.53 -0.731 . . . . 72.349999999999994 109.831 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 153.23 35.87 0.03 OUTLIER Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.775 -1.202 . . . . 65.200000000000003 110.162 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -99.47 125.49 45.22 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.245 -1.15 . . . . 52.229999999999997 109.154 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -71.08 -33.39 70.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.046 -1.034 . . . . 73.319999999999993 108.941 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 36.2 t0 -153.13 164.93 37.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.513 -0.742 . . . . 72.219999999999999 109.191 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.531 ' O ' ' CD1' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -139.59 115.47 10.2 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.108 -0.701 . . . . 64.420000000000002 109.108 -178.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 0.483 HD11 ' OD2' ' B' ' 93' ' ' ASP . 29.1 mm -113.17 144.82 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 O-C-N 121.326 -0.859 . . . . 72.230000000000004 110.013 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.64 135.18 57.53 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.042 -1.096 . . . . 25.239999999999998 108.042 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.684 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -55.67 -56.42 29.98 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 120.984 -1.072 . . . . 64.319999999999993 111.46 -178.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 6.0 Cg_endo -42.33 -7.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 120.871 1.047 . . . . 63.329999999999998 112.945 -176.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . 0.684 ' N ' ' O ' ' B' ' 97' ' ' LYS . 68.8 m-85 60.44 115.17 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.661 -0.649 . . . . 75.129999999999995 109.475 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -56.57 -28.18 59.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.117 -0.989 . . . . 74.230000000000004 109.422 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . 0.742 ' O ' ' N ' ' B' ' 103' ' ' LYS . 30.2 t -174.51 30.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.003 -1.061 . . . . 63.340000000000003 110.7 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 55.1 mt 52.29 -69.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.641 -0.662 . . . . 74.439999999999998 110.283 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.742 ' N ' ' O ' ' B' ' 101' ' ' SER . 29.7 mmtp -59.62 -28.4 67.16 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.331 -0.989 . . . . 71.109999999999999 108.331 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.97 -44.8 91.64 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.462 -0.895 . . . . 71.450000000000003 108.595 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.687 HD13 ' C ' ' B' ' 105' ' ' LEU . 1.3 tm? -57.19 -55.38 35.53 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.869 -0.789 . . . . 51.310000000000002 108.869 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . 0.625 ' N ' HD13 ' B' ' 105' ' ' LEU . 21.7 t -63.28 -39.24 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.749 -1.22 . . . . 65.230000000000004 109.741 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -47.7 -44.19 27.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 24.32 110.265 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . 0.633 HH22 ' CD1' ' B' ' 72' ' ' LEU . 13.9 ptt85 -79.96 -31.03 39.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.988 -1.07 . . . . 75.310000000000002 110.707 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 34.5 mt -71.77 -30.43 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.494 -1.379 . . . . 54.240000000000002 108.264 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' B' ' 113' ' ' LEU . 21.0 tt0 -72.85 -60.59 2.16 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.402 -0.919 . . . . 65.310000000000002 108.972 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . 0.409 ' HB1' ' CE1' ' A' ' 87' ' ' PHE . . . -43.33 -44.66 5.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.68 -0.638 . . . . 72.239999999999995 109.981 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . 0.437 HH21 HD23 ' B' ' 47' ' ' LEU . 64.9 ttp85 -66.13 -34.81 78.89 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.221 -0.925 . . . . 72.040000000000006 109.391 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' B' ' 110' ' ' GLU . 7.1 tp -97.24 -75.09 0.55 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.228 -0.92 . . . . 75.349999999999994 110.365 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' B' ' 113' ' ' LEU . 83.3 mtt180 47.14 96.55 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.278 -0.889 . . . . 75.5 109.571 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 45.46 86.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.524 -0.735 . . . . 65.329999999999998 110.076 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 81.4 t90 -59.04 146.92 36.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.872 . . . . 74.450000000000003 109.298 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 161.12 101.16 0.16 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.734 -1.346 . . . . 44.210000000000001 109.734 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 83.3 p -157.03 161.26 39.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.252 -1.146 . . . . 71.400000000000006 109.692 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.42 -177.57 5.73 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.784 -0.766 . . . . 72.319999999999993 109.151 -178.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 6.0 t -144.43 -36.92 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.31 -0.869 . . . . 75.019999999999996 109.303 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 47.5 mt -111.51 125.83 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.507 -0.745 . . . . 51.409999999999997 109.201 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.416 ' O ' HG23 ' B' ' 123' ' ' ILE . 77.0 mt-10 -138.97 120.43 14.98 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.266 -0.896 . . . . 71.530000000000001 109.2 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.416 HG23 ' O ' ' B' ' 122' ' ' GLU . 19.0 pt -154.98 142.79 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.16 -0.962 . . . . 72.430000000000007 109.778 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' B' ' 126' ' ' LEU . . . 51.12 39.22 41.29 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.444 -1.062 . . . . 51.229999999999997 110.444 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 69.06 -13.88 0.33 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.303 -1.116 . . . . 74.200000000000003 109.935 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.52 HD22 ' CD1' ' B' ' 137' ' ' TYR . 1.1 mt -82.37 144.3 30.64 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.769 -1.197 . . . . 75.420000000000002 107.769 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 92.3 m -128.65 144.18 51.1 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.375 -0.828 . . . . 74.219999999999999 109.738 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 7.6 mt -141.06 140.93 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.434 -0.791 . . . . 60.329999999999998 109.519 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 70.5 m -117.92 123.64 29.43 Favored Pre-proline 0 N--CA 1.5 2.054 0 N-CA-C 108.965 -0.754 . . . . 72.310000000000002 108.965 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.27 -40.1 0.29 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.821 1.681 . . . . 75.129999999999995 112.196 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -66.42 -44.57 82.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.175 -0.953 . . . . 75.230000000000004 109.943 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' B' ' 132' ' ' GLU . 35.6 mp0 -84.85 -5.15 59.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.197 -0.939 . . . . 72.430000000000007 109.818 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 48.53 72.03 0.31 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.206 -0.934 . . . . 75.129999999999995 109.764 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -152.39 142.53 22.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.312 -0.867 . . . . 73.219999999999999 109.369 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . 0.409 ' O ' HG23 ' B' ' 135' ' ' ILE . 15.8 tt -115.49 132.19 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.436 -0.79 . . . . 64.140000000000001 109.125 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 61.9 mt -117.22 130.79 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 109.069 -0.715 . . . . 71.219999999999999 109.069 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . 0.52 ' CD1' HD22 ' B' ' 126' ' ' LEU . 64.3 t80 -132.6 130.83 40.76 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.441 -0.787 . . . . 64.219999999999999 109.505 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . 0.516 ' O ' ' NH1' ' B' ' 140' ' ' ARG . 24.5 mmtm 53.55 32.82 14.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.307 -0.87 . . . . 72.019999999999996 110.49 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.25 -4.55 71.35 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 120.049 -1.072 . . . . 74.319999999999993 110.882 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . 0.516 ' NH1' ' O ' ' B' ' 138' ' ' LYS . 11.2 mpt_? -87.74 134.59 33.64 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.817 -1.402 . . . . 75.340000000000003 108.842 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -102.11 122.92 45.07 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.385 -0.822 . . . . 71.230000000000004 110.034 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 13.5 p -137.78 137.56 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.529 -0.915 . . . . 70.430000000000007 108.529 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -90.2 143.3 26.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.272 -0.893 . . . . 72.430000000000007 110.344 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 144' ' ' VAL . . . . . 0.535 HG23 ' O ' ' B' ' 144' ' ' VAL . 21.5 m -146.57 121.42 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.217 -1.031 . . . . 72.129999999999995 108.217 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 7.1 mtmm -139.68 126.48 20.72 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.18 -0.95 . . . . 72.019999999999996 109.484 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.16 171.39 33.17 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.473 -1.451 . . . . 42.229999999999997 109.473 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . 0.627 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 11.4 mttm -67.75 -38.81 15.87 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.235 -1.156 . . . . 73.299999999999997 109.886 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 30.0 Cg_exo -60.89 -38.14 71.94 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.265 1.977 . . . . 71.329999999999998 112.211 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -88.53 -17.83 29.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.237 -0.914 . . . . 74.230000000000004 109.732 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -54.34 -38.29 65.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 72.340000000000003 109.479 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.458 HG13 ' N ' ' B' ' 152' ' ' LEU . 10.9 p -67.93 -38.68 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 73.349999999999994 109.74 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.458 ' N ' HG13 ' B' ' 151' ' ' VAL . 31.3 tp -55.38 -47.07 76.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.91 . . . . 55.240000000000002 109.542 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 60.4 p -68.27 -32.23 72.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.165 -0.96 . . . . 70.010000000000005 109.619 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 154' ' ' HIS . . . . . 0.582 ' CE1' ' HD1' ' B' ' 158' ' ' HIS . 56.9 t-80 -56.67 -58.99 5.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.849 . . . . 65.319999999999993 110.339 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 pp -69.18 -22.73 63.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.082 -1.012 . . . . 71.540000000000006 109.923 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.92 -39.88 86.99 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.18 -0.95 . . . . 75.319999999999993 109.198 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -85.24 -34.59 21.94 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.181 -0.95 . . . . 73.319999999999993 109.758 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 158' ' ' HIS . . . . . 0.582 ' HD1' ' CE1' ' B' ' 154' ' ' HIS . 36.5 m80 -87.41 40.14 0.91 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.143 -0.973 . . . . 74.140000000000001 109.786 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -55.3 151.1 10.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 61.409999999999997 109.342 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' B' ' 214' ' ' PHE . 64.3 t0 52.28 68.18 0.86 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 72.099999999999994 109.592 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -160.1 147.32 16.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.144 -0.972 . . . . 72.25 109.797 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 12.2 mm -91.29 134.73 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.432 -0.951 . . . . 72.310000000000002 108.432 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 48.3 t -135.96 135.74 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.245 -0.909 . . . . 64.209999999999994 110.021 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 10.8 t -89.19 155.65 19.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.426 -0.796 . . . . 74.219999999999999 109.343 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -55.41 -31.68 62.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.385 -0.822 . . . . 65.310000000000002 109.794 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -57.29 -39.14 75.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 63.450000000000003 110.26 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -62.95 -43.43 98.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.012 -1.055 . . . . 72.400000000000006 109.8 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 20.0 mt -55.26 -59.09 5.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.15 -0.969 . . . . 72.319999999999993 109.102 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.566 ' C ' HD13 ' B' ' 169' ' ' LEU . 1.6 tm? -54.7 -65.33 0.6 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.078 -1.014 . . . . 73.340000000000003 109.284 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -46.4 -36.25 6.31 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 112.949 0.722 . . . . 72.099999999999994 112.949 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.05 -30.97 14.41 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.595 -1.316 . . . . 62.130000000000003 113.214 -176.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 0.416 ' CD1' ' N ' ' B' ' 172' ' ' ILE . 1.3 mp -84.94 -58.58 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 120.433 -1.417 . . . . 71.420000000000002 111.208 -177.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 173' ' ' TRP . . . . . 0.586 ' O ' ' CE3' ' B' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.834 0 O-C-N 120.609 -1.307 . . . . 72.230000000000004 109.76 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo . . . . . 0 N--CA 1.497 1.702 0 CA-C-O 121.601 0.584 . . . . 65.219999999999999 112.024 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 182' ' ' ASN . . . . . 0.5 ' C ' ' H ' ' B' ' 184' ' ' ILE . 43.4 t30 -170.4 -106.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.105 -0.997 . . . . 72.310000000000002 109.297 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 5.5 t 61.99 -3.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.454 -0.779 . . . . 63.32 109.818 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.5 ' H ' ' C ' ' B' ' 182' ' ' ASN . 28.5 mt -69.63 -38.11 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.904 -1.123 . . . . 75.030000000000001 108.425 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -55.23 -53.3 57.74 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.822 -0.549 . . . . 64.109999999999999 109.759 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 30.7 m -73.28 -31.75 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.121 -0.987 . . . . 73.0 110.02 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.44 -56.61 13.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.058 -1.027 . . . . 61.119999999999997 109.848 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 10.8 tp -63.01 -29.75 47.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.898 -1.126 . . . . 72.430000000000007 109.421 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -68.9 -56.0 9.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 65.140000000000001 110.186 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 190' ' ' GLN . . . . . 0.409 ' O ' ' CB ' ' B' ' 194' ' ' LYS . 15.7 pt20 -66.14 -39.78 90.12 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.001 -1.062 . . . . 63.240000000000002 109.35 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 55.6 mt -54.65 -37.71 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.985 -1.072 . . . . 74.030000000000001 109.528 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -68.03 -52.85 30.76 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.074 -1.016 . . . . 72.239999999999995 110.48 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 193' ' ' GLN . . . . . 0.41 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 45.8 mt-30 -76.88 -14.25 59.9 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.999 -1.063 . . . . 73.099999999999994 110.113 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' B' ' 190' ' ' GLN . 53.4 tttp -92.43 -27.42 17.49 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.388 -0.82 . . . . 72.109999999999999 110.445 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 195' ' ' MET . . . . . 0.431 ' SD ' ' C ' ' B' ' 195' ' ' MET . 1.9 ppp? -90.56 -30.93 16.93 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.068 -1.02 . . . . 44.329999999999998 109.812 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 196' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 28.0 p-10 -58.87 -32.71 69.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.981 . . . . 71.209999999999994 109.747 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . 0.51 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 7.6 mmtp -63.03 -64.91 2.49 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 75.209999999999994 109.935 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 198' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 33.0 Cg_endo -61.96 -53.07 2.3 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.185 1.924 . . . . 75.319999999999993 112.352 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . 0.49 HD12 ' N ' ' B' ' 199' ' ' LEU . 10.0 mp -65.58 -40.23 92.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.031 -1.043 . . . . 72.25 109.324 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 77.72 -40.16 1.81 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.574 -1.411 . . . . 64.530000000000001 109.574 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 19.1 mm -97.65 146.25 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.24 -1.153 . . . . 44.229999999999997 109.478 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 38.8 t -85.75 141.07 29.96 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.23 -0.919 . . . . 54.009999999999998 109.245 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 13.8 p -142.7 18.22 2.0 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.181 -0.949 . . . . 74.400000000000006 109.904 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 21.9 m -140.7 137.05 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.189 -0.944 . . . . 72.120000000000005 109.437 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -116.34 135.68 53.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.576 -0.703 . . . . 65.409999999999997 109.342 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 1.4 p -93.59 132.23 38.11 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.174 -0.954 . . . . 71.329999999999998 108.946 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 25.5 t -138.92 143.66 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.331 -0.856 . . . . 63.5 109.539 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 208' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' B' ' 209' ' ' ARG . 91.4 mtt180 -60.07 164.89 3.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 74.450000000000003 109.611 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 209' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' B' ' 211' ' ' GLY . 80.4 mtm-85 52.46 176.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.868 . . . . 74.140000000000001 109.62 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 17.0 mmt85 53.85 -85.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.466 -0.771 . . . . 74.430000000000007 109.672 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 211' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' B' ' 209' ' ' ARG . . . 164.12 -96.66 0.14 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.482 -1.447 . . . . 64.450000000000003 109.482 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 212' ' ' TYR . . . . . 0.481 ' CD1' ' C ' ' B' ' 211' ' ' GLY . 52.8 m-85 -141.28 167.77 21.37 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.362 -1.081 . . . . 74.209999999999994 109.126 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -132.58 140.37 48.22 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.411 -0.806 . . . . 74.030000000000001 109.654 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . 0.512 ' O ' ' N ' ' B' ' 160' ' ' ASP . 2.3 m-85 -116.41 125.38 51.96 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.942 -0.762 . . . . 74.340000000000003 108.942 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . 0.577 ' SG ' ' N ' ' B' ' 216' ' ' TYR . 30.5 t -147.9 167.56 24.52 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.336 -0.852 . . . . 64.329999999999998 109.314 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . 0.577 ' N ' ' SG ' ' B' ' 215' ' ' CYS . 3.2 p90 -60.0 152.67 59.45 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.284 -0.885 . . . . 70.040000000000006 109.116 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.18 124.1 10.59 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.357 2.038 . . . . 65.109999999999999 112.044 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 8.1 tptp . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.2 -0.937 . . . . 73.150000000000006 110.356 179.744 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.8 ttm . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.399 -0.593 . . . . 65.120000000000005 109.399 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -137.62 146.1 43.53 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.436 -0.79 . . . . 72.329999999999998 109.305 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 79.2 t -115.81 133.32 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-O 121.451 0.643 . . . . 71.420000000000002 109.746 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.544 HD11 ' CG1' ' A' ' 6' ' ' ILE . 2.4 tp -103.48 116.95 33.35 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.417 -0.957 . . . . 65.120000000000005 108.417 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 59.0 tp -117.33 114.54 23.73 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.918 -0.771 . . . . 62.43 108.918 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.544 ' CG1' HD11 ' A' ' 4' ' ' LEU . 52.4 mt -109.41 116.29 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.851 -0.796 . . . . 71.150000000000006 108.851 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 13' ' ' GLY . 61.7 tt0 -146.7 131.11 17.62 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.334 -0.854 . . . . 75.340000000000003 109.425 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -61.98 -35.78 79.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 72.439999999999998 109.58 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -86.23 116.85 24.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 63.020000000000003 109.492 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.4 p -73.12 -27.29 61.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.917 . . . . 72.340000000000003 109.623 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.7 t -63.75 -49.57 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.184 -0.948 . . . . 74.019999999999996 109.673 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.5 mm? -67.83 -42.29 81.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.928 . . . . 71.430000000000007 109.128 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.51 ' N ' ' OE1' ' A' ' 7' ' ' GLU . . . -67.19 -19.79 70.57 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.354 -1.898 . . . . 61.32 108.354 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.38 -58.88 5.68 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.457 -1.457 . . . . 71.200000000000003 109.457 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -52.84 -42.78 65.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.399 -1.059 . . . . 71.319999999999993 109.464 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.3 mm -64.05 -38.65 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.943 -1.098 . . . . 63.229999999999997 108.807 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.42 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 72.6 tt0 -62.83 -52.49 62.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.837 . . . . 51.109999999999999 109.818 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -81.63 1.96 31.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -0.949 . . . . 73.340000000000003 109.632 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.24 -68.12 1.32 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.159 -1.576 . . . . 62.149999999999999 109.159 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp -56.16 -25.93 48.5 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.417 -1.049 . . . . 73.510000000000005 109.088 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 2.6 m120 -52.09 -33.95 41.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.305 -0.872 . . . . 74.25 109.212 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.3 t -55.52 -41.4 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 70.040000000000006 109.022 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.451 ' HZ2' ' CG1' ' A' ' 106' ' ' VAL . 2.1 mptm? -67.35 -22.58 65.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.358 -0.838 . . . . 73.230000000000004 108.994 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.14 38.42 4.32 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.153 -1.179 . . . . 75.540000000000006 110.153 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -112.74 159.33 19.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.413 -1.051 . . . . 73.430000000000007 108.62 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.0 mmt -99.63 138.55 36.56 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.304 -0.998 . . . . 43.240000000000002 108.304 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.13 160.51 40.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.902 . . . . 62.109999999999999 109.995 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -134.92 141.35 46.28 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.967 -0.753 . . . . 74.420000000000002 108.967 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -110.43 130.54 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.727 -0.842 . . . . 72.150000000000006 108.727 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.1 p -135.0 167.63 20.58 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.499 -0.75 . . . . 71.420000000000002 109.251 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.459 ' CG ' ' OD2' ' A' ' 35' ' ' ASP . 3.4 pt-20 -90.68 -99.86 0.1 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.245 -0.909 . . . . 72.329999999999998 109.564 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.0 p -78.77 166.59 22.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -0.867 . . . . 74.239999999999995 109.997 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 15.5 mt -56.02 -32.04 63.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.611 -0.68 . . . . 71.530000000000001 110.032 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -50.58 -45.83 57.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.031 -1.043 . . . . 74.230000000000004 109.793 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.459 ' OD2' ' CG ' ' A' ' 31' ' ' GLU . 67.9 m-20 -68.25 -43.05 78.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.054 -1.029 . . . . 54.030000000000001 109.364 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.43 -40.47 79.46 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.386 -1.486 . . . . 61.409999999999997 109.386 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -65.11 -38.92 92.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -1.113 . . . . 74.340000000000003 109.419 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -75.61 -36.73 60.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 75.329999999999998 109.48 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.7 tp -71.42 -45.76 61.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 74.329999999999998 109.905 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.444 ' O ' ' O ' ' A' ' 43' ' ' ARG . 3.2 ppp? -69.08 -20.37 64.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.074 -1.016 . . . . 70.319999999999993 109.857 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -60.73 -36.95 80.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.022 -1.049 . . . . 71.219999999999999 109.611 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.4 pt -89.23 -27.58 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.18 -0.95 . . . . 74.140000000000001 110.317 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 40' ' ' MET . 96.9 mtt180 -127.82 146.03 50.74 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.298 -0.877 . . . . 72.239999999999995 109.771 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.491 ' OD1' HD11 ' A' ' 69' ' ' ILE . 60.8 t30 -98.61 132.05 44.32 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.231 -0.918 . . . . 75.420000000000002 109.475 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -101.9 135.16 43.93 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.36 -0.838 . . . . 74.230000000000004 109.343 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -74.75 -35.26 62.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.948 . . . . 72.040000000000006 108.969 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.555 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.7 OUTLIER -112.72 115.8 29.11 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.426 -0.953 . . . . 72.129999999999995 108.426 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.555 ' N ' HD13 ' A' ' 47' ' ' LEU . 39.2 t -99.11 97.04 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.27 -1.011 . . . . 72.340000000000003 108.27 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.2 ttt -109.22 134.07 52.22 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.536 0.684 . . . . 74.109999999999999 109.611 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.444 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 1.3 p -143.96 131.66 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.461 -0.775 . . . . 61.119999999999997 109.505 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.3 p -96.99 2.97 52.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.501 -0.749 . . . . 73.109999999999999 109.125 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.444 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 47.5 m-20 -76.26 142.23 41.45 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.269 -0.895 . . . . 52.549999999999997 109.54 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.566 ' NZ ' ' H ' ' A' ' 76' ' ' ASP . 66.0 mmtt -79.07 -39.36 34.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 44.219999999999999 110.198 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -72.17 15.0 0.18 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.082 -1.011 . . . . 70.439999999999998 109.733 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.459 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.52 -19.75 59.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 64.140000000000001 110.411 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.531 HD13 ' NE2' ' A' ' 85' ' ' HIS . 22.0 mt -40.66 -50.22 3.05 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.428 -0.795 . . . . 44.140000000000001 110.473 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.0 m -68.14 -34.69 76.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.087 . . . . 55.229999999999997 109.262 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.534 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 55.9 t80 -65.81 -56.08 13.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -0.794 . . . . 74.439999999999998 110.115 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.6 m -54.57 -35.38 31.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 120.749 -1.219 . . . . 74.030000000000001 109.662 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.6 t -57.4 -54.48 46.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.097 -1.002 . . . . 64.299999999999997 109.655 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 ptp85 -66.05 -29.26 69.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.119 -0.988 . . . . 64.439999999999998 110.092 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.534 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 5.6 mm -65.63 -38.21 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.751 -1.218 . . . . 63.210000000000001 109.898 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.521 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 33.5 mmtt -69.63 -50.51 43.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.107 -0.996 . . . . 74.420000000000002 110.117 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -67.39 -35.46 79.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.762 -1.211 . . . . 70.319999999999993 109.767 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.471 ' C ' ' CG ' ' A' ' 66' ' ' HIS . 48.7 mtpt -81.77 -23.43 36.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.196 -0.94 . . . . 75.219999999999999 109.607 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.471 ' CG ' ' C ' ' A' ' 65' ' ' LYS . 59.4 m-70 -155.26 65.03 0.63 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.168 -0.957 . . . . 74.129999999999995 109.632 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 63' ' ' LYS . 33.1 t -61.06 -30.36 70.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.25 -0.906 . . . . 73.239999999999995 110.017 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.4 t -61.9 -19.83 63.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.958 . . . . 61.009999999999998 110.198 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.491 HD11 ' OD1' ' A' ' 44' ' ' ASN . 78.8 mt -87.81 152.97 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.1 -1.0 . . . . 71.329999999999998 109.945 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 71' ' ' VAL . 48.3 t -92.95 160.63 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.351 -0.843 . . . . 72.129999999999995 109.518 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.461 ' N ' HG12 ' A' ' 70' ' ' VAL . 43.2 t -134.59 129.81 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.348 -0.845 . . . . 54.210000000000001 109.898 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.2 tt -122.39 99.05 6.21 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.884 -0.784 . . . . 50.240000000000002 108.884 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.0 t -92.22 127.45 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.167 -0.958 . . . . 74.409999999999997 108.825 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.412 ' O ' ' OG ' ' A' ' 75' ' ' SER . 0.4 OUTLIER -92.97 -176.25 4.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.019 -1.051 . . . . 72.310000000000002 108.805 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.463 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 55.7 m -166.75 119.83 1.01 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.792 -1.193 . . . . 64.540000000000006 110.502 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.566 ' H ' ' NZ ' ' A' ' 53' ' ' LYS . 50.4 t0 -61.65 -32.33 72.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.541 -0.725 . . . . 74.129999999999995 109.807 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 79' ' ' THR . 44.8 t-20 -119.78 84.06 30.5 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.583 -0.698 . . . . 73.340000000000003 109.242 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -54.19 82.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.208 1.939 . . . . 63.219999999999999 111.341 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.493 HG23 ' H ' ' A' ' 82' ' ' GLU . 3.4 t -105.22 154.74 19.81 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.519 -0.738 . . . . 62.530000000000001 109.589 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.56 -32.61 73.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.402 -0.811 . . . . 73.439999999999998 109.78 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -55.08 -55.91 25.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 71.420000000000002 110.009 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.534 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 95.4 mt-10 -64.6 -35.39 80.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -0.957 . . . . 73.430000000000007 109.796 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.52 ' OE2' ' NH2' ' B' ' 108' ' ' ARG . 66.9 tt0 -63.91 -48.98 74.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.049 -1.032 . . . . 74.219999999999999 110.068 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.5 t -57.2 -57.56 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.167 -0.958 . . . . 73.200000000000003 110.313 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.57 ' ND1' ' N ' ' A' ' 86' ' ' ALA . 1.3 p-80 -64.83 -41.11 96.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.942 -1.099 . . . . 53.329999999999998 109.515 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.57 ' N ' ' ND1' ' A' ' 85' ' ' HIS . . . -46.93 -37.69 9.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 64.109999999999999 109.833 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -78.43 -34.32 47.96 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.103 -0.998 . . . . 74.340000000000003 108.761 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -67.5 -40.47 85.18 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.414 -0.914 . . . . 74.420000000000002 109.432 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.571 ' NE2' ' N ' ' A' ' 89' ' ' GLN . 0.7 OUTLIER -65.14 -56.88 10.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 74.239999999999995 109.614 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 152.13 44.58 0.02 OUTLIER Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.724 -1.227 . . . . 61.509999999999998 110.249 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -96.2 133.28 40.7 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.083 -1.245 . . . . 55.329999999999998 109.222 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.521 ' OD1' ' NZ ' ' A' ' 63' ' ' LYS . 72.7 m-20 -90.96 -22.53 20.79 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.085 -1.009 . . . . 73.420000000000002 109.677 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 94' ' ' TYR . 18.7 t0 -149.61 154.81 39.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.22 -0.925 . . . . 75.040000000000006 109.265 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.516 ' N ' ' OD1' ' A' ' 93' ' ' ASP . 71.3 t80 -136.86 105.65 5.88 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.522 -0.736 . . . . 71.329999999999998 109.257 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.409 HG22 ' N ' ' A' ' 96' ' ' ALA . 27.0 mm -111.47 155.69 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 O-C-N 121.127 -0.983 . . . . 71.129999999999995 110.735 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.409 ' N ' HG22 ' A' ' 95' ' ' ILE . . . -74.4 128.73 36.27 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.657 -1.238 . . . . 64.319999999999993 107.657 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.687 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -50.83 -57.28 14.04 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.715 -1.241 . . . . 62.200000000000003 111.399 -178.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 5.2 Cg_endo -41.5 -9.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.066 1.177 . . . . 73.109999999999999 112.797 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.687 ' N ' ' O ' ' A' ' 97' ' ' LYS . 24.9 m-85 62.81 108.66 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.339 -0.615 . . . . 65.219999999999999 109.339 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.526 ' NH1' ' OE2' ' B' ' 83' ' ' GLU . 21.6 ttm105 -52.81 -33.26 48.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.848 -1.157 . . . . 72.349999999999994 108.374 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 103' ' ' LYS . 2.3 m 172.37 48.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.552 -0.717 . . . . 71.319999999999993 109.524 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 105' ' ' LEU . 13.1 mt 37.6 -77.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 121.835 -0.541 . . . . 75.430000000000007 111.982 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.692 ' N ' ' O ' ' A' ' 101' ' ' SER . 28.0 mmtp -38.03 -38.8 0.34 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.533 -0.729 . . . . 71.409999999999997 110.26 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' B' ' 80' ' ' SER . . . -70.84 -43.51 68.37 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.206 -1.035 . . . . 63.240000000000002 108.206 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 102' ' ' ILE . 1.2 tt -60.85 -44.81 96.48 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.684 -0.858 . . . . 73.219999999999999 108.684 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.451 ' CG1' ' HZ2' ' A' ' 23' ' ' LYS . 15.6 t -69.43 -43.08 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 60.109999999999999 109.619 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.61 -42.61 62.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 70.420000000000002 109.174 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.75 -35.94 77.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 74.409999999999997 109.015 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.0 mt -70.87 -30.32 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.951 -1.093 . . . . 62.539999999999999 108.677 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -62.24 -53.47 54.71 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.381 -0.825 . . . . 74.340000000000003 108.782 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.09 -39.39 69.26 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.468 -0.77 . . . . 73.319999999999993 109.148 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 20.0 tpt85 -59.25 -32.63 70.17 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.265 -0.897 . . . . 52.409999999999997 109.145 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.4 tp -157.6 102.42 1.88 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.264 -0.898 . . . . 65.239999999999995 109.638 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.519 ' O ' ' CG ' ' A' ' 115' ' ' PHE . 23.1 mtm105 -94.84 -56.3 2.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.131 -0.981 . . . . 64.450000000000003 109.007 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.519 ' CG ' ' O ' ' A' ' 114' ' ' ARG . 82.4 m-85 -157.02 -58.14 0.09 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.182 -0.949 . . . . 74.430000000000007 109.213 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 62.7 m95 48.04 -122.59 1.53 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.317 -0.865 . . . . 74.420000000000002 109.695 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.1 43.38 56.8 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.152 -1.579 . . . . 75.040000000000006 109.152 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.1 m -100.37 147.97 25.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.375 -1.074 . . . . 61.140000000000001 109.564 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.541 HD21 ' C ' ' A' ' 121' ' ' ILE . 2.4 t30 -108.91 166.72 10.61 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.61 -0.681 . . . . 65.239999999999995 109.261 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.414 ' N ' ' CG ' ' A' ' 119' ' ' ASN . 4.4 t -124.68 -39.09 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.722 -0.611 . . . . 73.109999999999999 109.379 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.541 ' C ' HD21 ' A' ' 119' ' ' ASN . 17.1 mm -100.23 140.5 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.317 -0.864 . . . . 72.239999999999995 110.005 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.743 ' H ' HH12 ' A' ' 159' ' ' ARG . 86.4 mt-10 -135.61 119.31 17.15 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.382 -0.823 . . . . 72.340000000000003 108.901 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 37.8 mt -138.62 111.84 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.228 -0.92 . . . . 71.439999999999998 109.782 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 126' ' ' LEU . . . 65.61 46.51 83.98 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.209 -1.156 . . . . 73.400000000000006 110.209 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 67.25 -14.16 0.19 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.512 -0.993 . . . . 74.450000000000003 110.308 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.49 ' H ' ' C ' ' A' ' 124' ' ' GLY . 7.1 mt -76.99 155.24 32.76 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.61 -1.256 . . . . 54.210000000000001 107.61 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.88 129.28 46.63 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.368 -0.833 . . . . 54.5 109.49 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 74.8 mt -123.58 130.86 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.071 -0.714 . . . . 45.149999999999999 109.071 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.3 m -117.16 112.99 39.48 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 121.604 -0.685 . . . . 71.109999999999999 109.304 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.09 -51.09 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.106 1.871 . . . . 65.409999999999997 112.621 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -55.19 -45.68 75.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.063 -1.023 . . . . 63.32 109.532 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -81.53 -8.43 59.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 72.519999999999996 109.169 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 52.57 57.55 6.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.401 -0.812 . . . . 75.329999999999998 109.248 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -140.79 127.8 20.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.376 -0.828 . . . . 71.230000000000004 108.942 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.666 HD13 ' N ' ' A' ' 136' ' ' ILE . 0.2 OUTLIER -107.08 126.32 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.362 -0.836 . . . . 74.019999999999996 109.147 -179.586 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.666 ' N ' HD13 ' A' ' 135' ' ' ILE . 40.9 mt -117.86 126.76 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.532 -0.73 . . . . 60.229999999999997 109.951 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -137.25 142.66 42.01 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.355 -0.841 . . . . 62.32 108.954 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp 54.83 14.04 0.83 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.575 -0.703 . . . . 75.400000000000006 110.272 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 92.33 -6.56 78.23 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.49 -1.044 . . . . 72.239999999999995 110.49 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.473 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 1.0 OUTLIER -87.99 124.87 34.16 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.858 -1.378 . . . . 71.219999999999999 108.651 179.614 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -94.3 129.23 41.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.084 -1.01 . . . . 71.420000000000002 110.049 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.6 t -135.96 133.48 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.513 -0.742 . . . . 53.020000000000003 109.046 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -88.36 131.68 34.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.415 -0.803 . . . . 60.450000000000003 109.603 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.45 150.25 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.571 -0.9 . . . . 74.439999999999998 108.571 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -162.38 113.92 1.61 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.012 -1.055 . . . . 65.150000000000006 109.653 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.608 ' O ' ' HB2' ' A' ' 150' ' ' GLU . . . 163.37 -169.07 38.32 Favored Glycine 0 N--CA 1.486 1.983 0 C-N-CA 119.511 -1.328 . . . . 73.340000000000003 109.899 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.54 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 41.7 mttp -78.06 -41.68 2.08 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.506 -0.996 . . . . 72.219999999999999 111.897 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 147' ' ' LYS . 36.7 Cg_endo -65.44 -30.38 52.93 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 CA-C-N 120.49 1.211 . . . . 65.230000000000004 111.891 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -94.38 -19.07 20.95 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.042 -1.037 . . . . 60.109999999999999 109.554 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.608 ' HB2' ' O ' ' A' ' 146' ' ' GLY . 34.9 tp10 -68.24 -43.32 78.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.356 -0.84 . . . . 64.209999999999994 108.907 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.0 p -61.66 -30.17 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.465 -0.939 . . . . 72.019999999999996 108.465 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 31.0 tp -65.61 -45.33 83.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.544 -0.723 . . . . 73.310000000000002 109.169 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.3 p -71.05 -30.1 66.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.945 . . . . 74.310000000000002 109.3 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -61.54 -53.46 56.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.168 -0.958 . . . . 74.310000000000002 109.742 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 156' ' ' ALA . 4.4 pp -69.87 -22.65 63.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 75.340000000000003 109.33 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.718 ' N ' HD12 ' A' ' 155' ' ' LEU . . . -60.67 -49.12 78.79 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.341 -0.85 . . . . 62.140000000000001 109.243 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.424 ' C ' ' H ' ' A' ' 159' ' ' ARG . 36.8 mtp180 -75.33 -44.39 45.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.025 -1.047 . . . . 61.030000000000001 109.164 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -77.71 26.43 0.18 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.255 -0.903 . . . . 74.120000000000005 109.412 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.743 HH12 ' H ' ' A' ' 122' ' ' GLU . 36.5 ptt180 -59.98 169.5 1.48 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.39 -0.819 . . . . 71.129999999999995 109.405 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.0 t0 46.47 65.49 1.19 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.316 -0.865 . . . . 75.450000000000003 109.484 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -169.94 149.67 3.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.123 -0.985 . . . . 73.409999999999997 109.792 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.402 HG21 ' HE ' ' A' ' 210' ' ' ARG . 75.5 mt -81.36 105.15 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.226 -1.027 . . . . 74.409999999999997 108.226 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 12.1 t -91.51 128.66 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.38 -0.825 . . . . 72.310000000000002 109.978 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.1 p -86.6 164.15 17.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.844 . . . . 74.120000000000005 109.052 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.482 ' CB ' ' NZ ' ' A' ' 165' ' ' LYS . 6.6 mtpm? -63.68 -48.12 78.46 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.257 -0.902 . . . . 70.430000000000007 110.185 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -56.0 -32.5 64.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.425 -0.797 . . . . 73.519999999999996 110.785 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -56.19 -56.06 25.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.973 -1.079 . . . . 74.519999999999996 110.119 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 51.2 mt -61.52 -41.69 97.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.165 -0.959 . . . . 72.310000000000002 110.372 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.547 ' C ' HD13 ' A' ' 169' ' ' LEU . 1.6 tm? -62.24 -55.63 26.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.005 -1.06 . . . . 53.329999999999998 109.868 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 49.6 t0 -71.07 -13.18 61.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.134 -0.979 . . . . 62.439999999999998 110.45 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.97 -62.97 1.53 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.025 -1.047 . . . . 60.210000000000001 110.998 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.688 ' N ' HD12 ' A' ' 172' ' ' ILE . 2.1 mp -73.23 -47.62 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 120.912 -1.117 . . . . 75.319999999999993 108.183 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 24.0 m-90 . . . . . 0 C--N 1.303 -1.436 0 N-CA-C 108.559 -0.904 . . . . 73.140000000000001 108.559 178.864 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.408 -0.59 . . . . 64.540000000000006 109.408 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.411 ' O ' HG22 ' A' ' 183' ' ' VAL . 3.2 p -143.71 -14.11 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.201 -0.937 . . . . 74.019999999999996 110.294 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 6.1 tt -56.1 -23.08 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.743 -1.223 . . . . 72.329999999999998 109.738 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -58.23 -49.66 76.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 74.400000000000006 109.837 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 16.4 m -76.35 -25.02 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.89 -1.132 . . . . 70.420000000000002 109.663 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.19 -46.59 49.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.058 -1.026 . . . . 52.109999999999999 110.1 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.8 tp -67.95 -30.93 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.911 -1.118 . . . . 71.400000000000006 109.093 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -70.02 -57.42 5.02 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.372 -0.83 . . . . 73.439999999999998 109.99 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.439 ' CG ' ' N ' ' A' ' 191' ' ' ILE . 7.7 pt20 -63.06 -43.85 97.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 71.420000000000002 109.983 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.439 ' N ' ' CG ' ' A' ' 190' ' ' GLN . 51.0 mt -53.69 -49.29 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.112 -0.992 . . . . 61.549999999999997 109.165 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -54.63 -40.56 69.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.003 . . . . 63.340000000000003 109.249 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -62.51 -35.97 81.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.142 -0.973 . . . . 61.240000000000002 109.538 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -93.0 -0.05 57.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.207 -0.933 . . . . 75.129999999999995 110.382 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 31.9 ttm -95.72 -63.01 1.2 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.005 -1.059 . . . . 74.019999999999996 109.389 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 200' ' ' GLY . 84.5 m-20 -60.66 -29.08 69.07 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.439 -0.788 . . . . 74.019999999999996 110.095 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.438 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 30.7 mttm -58.64 -65.75 1.78 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.053 -1.03 . . . . 75.430000000000007 110.06 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 26.7 Cg_endo -60.96 -52.83 3.11 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.915 1.743 . . . . 72.319999999999993 112.108 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' A' ' 201' ' ' ILE . 26.0 mt -66.35 -34.83 78.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.946 -1.096 . . . . 74.540000000000006 109.154 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 196' ' ' ASP . . . 77.65 -31.67 1.68 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.038 -1.625 . . . . 61.509999999999998 109.038 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.459 ' H ' ' C ' ' A' ' 199' ' ' LEU . 27.6 mm -95.89 129.45 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.41 -1.053 . . . . 61.219999999999999 109.286 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 64.9 m -78.8 139.22 38.42 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.603 -0.888 . . . . 72.0 108.603 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 38.5 p -142.57 13.77 1.95 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.216 -0.928 . . . . 74.439999999999998 109.814 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.33 131.77 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.765 -0.828 . . . . 64.349999999999994 108.765 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.41 ' OE1' ' SG ' ' A' ' 215' ' ' CYS . 30.1 mt-10 -117.01 123.45 46.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.636 -0.665 . . . . 71.409999999999997 109.509 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.99 98.93 10.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.319 -0.863 . . . . 73.519999999999996 108.715 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 208' ' ' ARG . 12.0 m -152.41 172.14 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.227 -0.921 . . . . 71.019999999999996 109.415 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 207' ' ' VAL . 70.2 mtt85 55.44 164.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.621 -0.674 . . . . 72.120000000000005 109.702 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.483 ' O ' ' N ' ' A' ' 211' ' ' GLY . 80.9 mtt85 -72.61 -126.11 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.21 -0.931 . . . . 64.409999999999997 109.398 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.402 ' HE ' HG21 ' A' ' 162' ' ' ILE . 75.6 mtp85 50.1 -91.44 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.3 -0.875 . . . . 71.540000000000006 109.928 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . -158.78 -97.7 0.13 Allowed Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.496 -1.335 . . . . 72.030000000000001 110.39 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -137.21 148.28 46.4 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.344 -1.092 . . . . 75.540000000000006 110.103 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -107.39 126.54 52.6 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.475 -0.766 . . . . 75.310000000000002 109.619 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.623 ' CE2' HD13 ' A' ' 155' ' ' LEU . 8.6 t80 -104.17 134.61 47.14 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.283 -1.006 . . . . 75.409999999999997 108.283 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . 0.41 ' SG ' ' OE1' ' A' ' 205' ' ' GLU . 31.1 p -153.51 164.43 38.24 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.173 -0.954 . . . . 74.140000000000001 109.926 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -59.33 152.82 51.78 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 75.319999999999993 109.106 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 N--CA 1.493 1.485 0 C-N-CA 122.237 1.958 . . . . 73.109999999999999 111.407 179.219 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.414 ' SD ' HD11 ' B' ' 113' ' ' LEU . 32.0 tpp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.492 -0.558 . . . . 71.140000000000001 109.492 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.524 ' N ' ' OD2' ' B' ' 46' ' ' ASP . 78.4 mtm-85 -140.33 151.81 45.33 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.355 -0.841 . . . . 73.230000000000004 109.286 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.8 t -112.23 129.39 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.623 -0.673 . . . . 72.239999999999995 109.274 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.509 HD12 ' N ' ' B' ' 5' ' ' LEU . 2.5 tp -104.46 121.12 42.78 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.579 -0.7 . . . . 54.329999999999998 109.566 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.509 ' N ' HD12 ' B' ' 4' ' ' LEU . 11.1 mt -118.92 98.83 6.39 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 109.031 -0.729 . . . . 74.349999999999994 109.031 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.462 ' CG1' HD11 ' B' ' 4' ' ' LEU . 55.7 mt -84.1 98.86 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.834 -1.166 . . . . 42.549999999999997 108.664 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.43 ' OE2' ' OG ' ' B' ' 51' ' ' SER . 9.3 tp10 -140.97 130.59 24.06 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.293 -0.88 . . . . 74.519999999999996 109.485 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -66.06 -35.31 80.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.346 -0.846 . . . . 62.549999999999997 109.249 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -77.02 112.26 13.46 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.376 -0.828 . . . . 73.109999999999999 109.385 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 95.4 p -74.27 -30.29 62.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 65.540000000000006 110.158 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.555 HG13 ' N ' ' B' ' 12' ' ' LEU . 9.3 p -59.1 -45.38 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.005 -1.059 . . . . 75.549999999999997 109.704 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.555 ' N ' HG13 ' B' ' 11' ' ' VAL . 80.9 mt -65.06 -31.58 72.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.06 -1.025 . . . . 70.140000000000001 109.309 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.25 -28.04 62.77 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.649 -1.781 . . . . 75.400000000000006 108.649 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.62 -56.01 19.54 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.506 -1.437 . . . . 65.439999999999998 109.506 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.52 -41.85 90.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.342 -1.093 . . . . 60.210000000000001 109.515 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.69 -43.29 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.975 -1.078 . . . . 75.150000000000006 108.846 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.413 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 80.2 tt0 -58.53 -43.94 89.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.451 -0.78 . . . . 73.010000000000005 109.559 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -86.58 0.4 54.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.103 -0.998 . . . . 74.299999999999997 109.083 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.76 -58.63 1.89 Allowed Glycine 0 N--CA 1.484 1.894 0 N-CA-C 109.479 -1.448 . . . . 70.540000000000006 109.479 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -69.37 -22.31 63.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -1.144 . . . . 71.340000000000003 109.557 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . 0.413 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 2.0 m120 -51.67 -34.07 36.59 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.223 -0.923 . . . . 64.409999999999997 109.416 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 79.0 t -56.76 -39.91 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.093 -1.004 . . . . 74.230000000000004 108.884 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.448 ' CD ' ' N ' ' B' ' 23' ' ' LYS . 4.2 mptp? -70.59 -27.52 64.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.376 -0.828 . . . . 63.420000000000002 109.344 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.58 41.22 2.21 Favored Glycine 0 N--CA 1.499 2.893 0 N-CA-C 110.208 -1.157 . . . . 53.43 110.208 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.405 ' CZ ' HD23 ' B' ' 113' ' ' LEU . 54.0 m-85 -119.58 161.16 21.1 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.427 -1.043 . . . . 71.120000000000005 109.203 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 18.3 mmt -103.08 140.89 36.72 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.746 -0.835 . . . . 75.239999999999995 108.746 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.419 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -137.53 154.45 49.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.303 -0.873 . . . . 72.120000000000005 110.167 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 96.1 m-20 -140.63 158.11 44.46 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.535 -0.913 . . . . 72.310000000000002 108.535 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 5.0 p -122.79 140.01 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.41 -0.806 . . . . 64.430000000000007 109.947 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.2 p -131.86 171.82 13.07 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.132 -0.692 . . . . 65.409999999999997 109.132 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -91.85 -107.09 0.1 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.235 -0.915 . . . . 71.019999999999996 109.792 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 33.3 t -78.79 168.87 19.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.292 -0.88 . . . . 51.109999999999999 110.022 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 39.0 mt -52.4 -30.91 31.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.593 -0.692 . . . . 71.239999999999995 109.877 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -53.9 -49.75 67.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.113 -0.992 . . . . 74.319999999999993 109.769 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -66.03 -44.79 83.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.153 -0.967 . . . . 73.030000000000001 109.365 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.61 -40.12 94.02 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.393 -1.483 . . . . 30.210000000000001 109.393 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -64.67 -43.85 92.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.337 -1.096 . . . . 74.420000000000002 109.456 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -71.29 -37.89 71.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.179 -0.95 . . . . 74.420000000000002 109.774 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 51.8 tp -69.51 -45.27 69.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 75.409999999999997 110.068 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.4 ppp? -74.29 -19.68 60.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.007 -1.058 . . . . 60.409999999999997 110.005 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.39 -41.81 80.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.105 -0.997 . . . . 53.229999999999997 109.697 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 pt -86.95 -41.44 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.122 -0.986 . . . . 71.230000000000004 109.854 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' B' ' 40' ' ' MET . 2.8 mpt_? -104.54 138.48 40.84 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.279 -0.888 . . . . 72.219999999999999 109.148 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' ASN . . . . . 0.478 ' C ' ' NH2' ' B' ' 2' ' ' ARG . 55.3 t-20 -100.59 89.89 4.08 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.377 -0.827 . . . . 63.539999999999999 109.205 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -63.56 149.22 46.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 64.349999999999994 109.275 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' B' ' 2' ' ' ARG . 3.9 p30 -80.42 -44.1 19.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 62.219999999999999 109.368 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.545 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.6 OUTLIER -103.37 115.02 29.75 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.458 -0.941 . . . . 73.120000000000005 108.458 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.545 ' N ' HD13 ' B' ' 47' ' ' LEU . 74.8 t -99.01 96.43 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.38 -0.97 . . . . 65.109999999999999 108.38 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 22.8 ttt -109.26 134.2 52.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.482 -0.761 . . . . 73.439999999999998 109.908 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.22 137.11 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.008 -0.738 . . . . 34.5 109.008 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . 0.43 ' OG ' ' OE2' ' B' ' 7' ' ' GLU . 41.8 p -100.22 0.03 39.58 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.468 -0.77 . . . . 73.209999999999994 109.967 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -76.35 130.42 38.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 70.409999999999997 109.521 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.429 ' C ' ' N ' ' B' ' 55' ' ' ALA . 27.5 mtmm -66.51 -48.43 69.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 65.0 109.931 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -50.04 -16.52 0.3 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.144 -0.973 . . . . 75.209999999999994 109.367 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.429 ' N ' ' C ' ' B' ' 53' ' ' LYS . . . -59.68 -21.44 60.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.422 -0.799 . . . . 55.329999999999998 110.18 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 23.1 mt -43.02 -46.44 5.52 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.305 -0.872 . . . . 63.140000000000001 110.065 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 25.2 t -70.89 -34.32 71.46 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.05 -1.031 . . . . 63.5 109.347 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . 0.495 ' CE2' HD11 ' B' ' 62' ' ' ILE . 73.4 t80 -67.45 -53.43 29.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.408 -0.808 . . . . 72.329999999999998 110.123 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.64 -33.89 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.825 -1.172 . . . . 74.540000000000006 109.73 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 9.3 t -59.74 -52.06 67.09 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.174 -0.953 . . . . 71.239999999999995 109.454 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -67.7 -27.79 67.12 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.007 -1.058 . . . . 74.310000000000002 109.876 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.495 HD11 ' CE2' ' B' ' 58' ' ' PHE . 4.7 mm -59.29 -51.63 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.932 -1.105 . . . . 72.140000000000001 109.083 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -60.41 -41.0 92.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.097 -1.002 . . . . 73.319999999999993 108.754 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -67.1 -51.73 50.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -0.862 . . . . 73.120000000000005 108.746 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -72.6 -74.76 0.16 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.599 -0.688 . . . . 72.439999999999998 109.554 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.505 ' O ' HG22 ' B' ' 69' ' ' ILE . 90.2 m-70 -90.69 92.24 8.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.144 -0.973 . . . . 63.310000000000002 109.176 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 74.8 m -79.83 -27.64 40.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 73.099999999999994 109.876 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 51.7 p -87.11 47.69 1.54 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.188 -0.945 . . . . 71.530000000000001 110.153 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.505 HG22 ' O ' ' B' ' 66' ' ' HIS . 15.9 tt -144.83 159.85 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.049 -1.032 . . . . 74.400000000000006 109.171 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.494 HG21 ' NH1' ' B' ' 112' ' ' ARG . 43.1 t -103.32 147.5 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.291 -0.881 . . . . 75.120000000000005 109.206 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 t -133.29 127.97 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.41 -0.806 . . . . 73.200000000000003 109.655 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.548 HD23 ' C ' ' B' ' 72' ' ' LEU . 5.3 tt -122.65 105.29 9.95 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.617 -0.677 . . . . 73.340000000000003 109.423 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.435 ' O ' HG13 ' B' ' 73' ' ' VAL . 14.8 p -94.25 132.44 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.012 -1.055 . . . . 73.5 109.497 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 9.5 p -89.63 171.63 9.54 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.985 -1.072 . . . . 64.340000000000003 108.723 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 27.4 p -152.54 112.05 3.91 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.817 -1.177 . . . . 74.530000000000001 110.713 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -74.28 -4.63 37.28 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.62 -0.881 . . . . 64.5 108.62 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -143.09 71.38 18.43 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 108.86 -0.793 . . . . 74.25 108.86 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.4 87.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.808 1.672 . . . . 74.430000000000007 111.701 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.43 ' OG1' ' OE2' ' B' ' 82' ' ' GLU . 44.3 p -107.43 155.77 19.67 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.683 -0.858 . . . . 73.120000000000005 108.683 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . 0.403 ' HB2' ' HB2' ' A' ' 104' ' ' ALA . 1.1 p -61.01 -30.42 70.29 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.214 -0.929 . . . . 71.010000000000005 109.58 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.09 -43.01 88.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.921 . . . . 63.200000000000003 109.804 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' B' ' 82' ' ' GLU . 0.2 OUTLIER -66.29 -33.14 75.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 73.219999999999999 109.633 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.526 ' OE2' ' NH1' ' A' ' 100' ' ' ARG . 46.5 mt-10 -64.52 -46.51 82.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.017 -1.052 . . . . 74.299999999999997 109.535 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.06 -42.09 93.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.186 -0.946 . . . . 73.310000000000002 109.328 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' HIS . . . . . 0.438 ' O ' ' OE1' ' B' ' 89' ' ' GLN . 18.6 m170 -72.13 -20.33 61.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.215 -0.928 . . . . 73.239999999999995 109.639 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.24 -44.59 62.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.04 -1.038 . . . . 55.329999999999998 110.119 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -81.37 -35.23 31.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.002 -1.061 . . . . 74.140000000000001 109.487 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.95 -43.0 97.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.073 -1.017 . . . . 64.040000000000006 109.375 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . 0.438 ' OE1' ' O ' ' B' ' 85' ' ' HIS . 0.5 OUTLIER -67.91 -61.29 1.94 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 72.349999999999994 109.259 179.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 149.7 64.72 0.01 OUTLIER Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.732 -1.223 . . . . 65.200000000000003 110.154 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.51 134.44 55.22 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.493 -1.004 . . . . 52.229999999999997 108.971 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -68.22 -43.35 78.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.049 -1.032 . . . . 73.319999999999993 108.959 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' ASP . . . . . 0.502 ' N ' ' OD1' ' B' ' 93' ' ' ASP . 18.3 p-10 -153.81 165.14 36.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.449 -0.782 . . . . 72.219999999999999 109.253 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' B' ' 94' ' ' TYR . 0.2 OUTLIER -136.19 119.09 16.29 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.364 -0.606 . . . . 64.420000000000002 109.364 -178.345 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 28.6 mm -113.67 150.66 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 O-C-N 121.379 -0.826 . . . . 72.230000000000004 110.144 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . 0.491 ' HB1' ' HD2' ' B' ' 98' ' ' PRO . . . -61.84 141.06 58.17 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.011 -1.107 . . . . 25.239999999999998 108.011 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.594 ' N ' ' CD ' ' B' ' 98' ' ' PRO . 0.0 OUTLIER -68.85 -40.26 16.4 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.944 -1.098 . . . . 64.319999999999993 110.922 -178.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' B' ' 97' ' ' LYS . 34.0 Cg_exo -53.16 -0.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.289 -2.557 0 CA-C-N 118.697 0.571 . . . . 63.329999999999998 112.135 -174.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . 0.566 ' N ' ' O ' ' B' ' 97' ' ' LYS . 60.2 m-85 53.0 102.3 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.525 -0.734 . . . . 75.129999999999995 109.935 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 38.3 mtt-85 -57.63 -35.84 71.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.925 -1.109 . . . . 74.230000000000004 108.77 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . 0.777 ' O ' ' N ' ' B' ' 103' ' ' LYS . 27.1 t -171.27 29.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -0.934 . . . . 63.340000000000003 110.77 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 18.7 mt 48.11 -68.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-N 118.539 0.609 . . . . 74.439999999999998 110.418 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.777 ' N ' ' O ' ' B' ' 101' ' ' SER . 55.3 mttp -51.59 -31.72 25.96 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.693 -1.225 . . . . 71.109999999999999 107.693 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.84 -42.89 89.93 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.194 -1.039 . . . . 71.450000000000003 108.194 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 50.8 tp -60.79 -42.71 98.1 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.549 -0.908 . . . . 51.310000000000002 108.549 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 20.3 t -69.78 -34.23 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 65.230000000000004 109.229 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.51 -47.35 73.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.152 -0.968 . . . . 24.32 109.441 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . 0.52 ' NH2' ' OE2' ' A' ' 83' ' ' GLU . 26.2 ttm105 -69.28 -37.08 77.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 75.310000000000002 109.789 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 97.7 mt -70.16 -26.66 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.04 -1.038 . . . . 54.240000000000002 108.921 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -74.98 -56.91 4.27 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.455 -0.778 . . . . 65.310000000000002 109.94 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -52.0 -35.74 47.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.071 -1.018 . . . . 72.239999999999995 109.81 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . 0.532 HH21 HD23 ' B' ' 47' ' ' LEU . 38.6 ttp85 -85.98 -57.02 3.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.113 -0.992 . . . . 72.040000000000006 110.545 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.414 HD11 ' SD ' ' B' ' 1' ' ' MET . 35.2 tp -54.7 -36.46 64.71 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.086 -1.008 . . . . 75.349999999999994 110.409 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -46.71 -33.24 4.15 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.125 -0.984 . . . . 75.5 109.611 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' PHE . . . . . 0.532 ' O ' ' N ' ' B' ' 117' ' ' GLY . 11.2 m-85 -54.38 -29.71 49.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.859 . . . . 65.329999999999998 108.994 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 4.3 t-105 60.47 -75.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.444 -0.785 . . . . 74.450000000000003 109.59 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' B' ' 115' ' ' PHE . . . -163.18 -171.34 29.3 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.281 -1.528 . . . . 44.210000000000001 109.281 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . 0.642 ' CB ' ' OE2' ' B' ' 132' ' ' GLU . 7.6 t -154.85 174.48 15.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.148 -1.207 . . . . 71.400000000000006 110.011 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.29 114.37 4.44 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.983 -0.687 . . . . 72.319999999999993 109.159 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 11.9 t -78.51 -39.97 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.264 -0.897 . . . . 75.019999999999996 109.73 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 17.3 mm -101.7 127.45 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.231 -0.918 . . . . 51.409999999999997 109.365 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.464 ' CD ' ' N ' ' B' ' 122' ' ' GLU . 1.0 OUTLIER -135.2 114.64 12.52 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.529 -0.732 . . . . 71.530000000000001 109.267 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 11.2 pt -140.97 137.35 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.216 -0.928 . . . . 72.430000000000007 109.2 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.18 -149.89 3.4 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.441 -1.464 . . . . 51.229999999999997 109.441 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -83.19 -0.39 49.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -1.168 . . . . 74.200000000000003 109.332 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.31 132.82 42.68 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.288 -0.882 . . . . 75.420000000000002 108.706 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 4.4 p -129.81 120.33 24.82 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.97 -0.752 . . . . 74.219999999999999 108.97 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 18.2 mm -107.24 144.68 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.492 -0.755 . . . . 60.329999999999998 109.042 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 3.4 m -126.84 79.44 72.31 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 121.446 -0.784 . . . . 72.310000000000002 109.7 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -50.96 -40.36 58.56 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.51 2.14 . . . . 75.129999999999995 112.132 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -68.01 -50.12 57.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.87 . . . . 75.230000000000004 109.934 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . 0.642 ' OE2' ' CB ' ' B' ' 118' ' ' SER . 88.7 mt-10 -82.38 -1.16 49.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.119 -0.988 . . . . 72.430000000000007 109.701 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 50.39 51.97 15.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.946 . . . . 75.129999999999995 109.235 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -138.19 136.84 37.01 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.371 -0.83 . . . . 73.219999999999999 109.242 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 7.8 tt -119.23 139.2 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.565 -0.709 . . . . 64.140000000000001 109.579 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 32.0 mt -126.36 125.17 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.8 -0.815 . . . . 71.219999999999999 108.8 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -142.49 151.36 41.6 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.235 -1.024 . . . . 64.219999999999999 108.235 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 16.9 tptm 60.11 8.16 1.42 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.572 -0.851 . . . . 72.019999999999996 109.07 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.41 -8.82 79.18 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.866 -1.294 . . . . 74.319999999999993 109.866 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . 0.505 ' N ' ' CD ' ' B' ' 140' ' ' ARG . 0.5 OUTLIER -90.53 141.25 28.95 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.113 -1.228 . . . . 75.340000000000003 109.214 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -97.8 129.87 44.77 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.27 -0.894 . . . . 71.230000000000004 109.632 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 47.7 t -138.43 132.51 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.389 -0.819 . . . . 70.430000000000007 109.075 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -87.1 143.72 27.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.205 -0.934 . . . . 72.430000000000007 109.727 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.48 132.28 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.337 -0.852 . . . . 72.129999999999995 109.388 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . 0.899 ' O ' ' HE2' ' B' ' 149' ' ' PHE . 0.0 OUTLIER -148.89 124.73 10.56 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.119 -0.988 . . . . 72.019999999999996 109.23 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . 0.765 ' N ' ' HD2' ' B' ' 149' ' ' PHE . . . 155.63 178.27 29.68 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.532 -1.427 . . . . 42.229999999999997 109.532 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . 0.62 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 26.5 mtpt -70.88 -35.85 4.67 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.208 -1.172 . . . . 73.299999999999997 110.243 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 23.3 Cg_exo -63.49 -30.05 71.39 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.942 1.761 . . . . 71.329999999999998 111.772 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . 0.899 ' HE2' ' O ' ' B' ' 145' ' ' LYS . 0.2 OUTLIER -92.03 -28.22 17.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.404 -0.81 . . . . 74.230000000000004 109.079 -179.61 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -51.74 -35.89 45.11 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.363 -0.835 . . . . 72.340000000000003 109.802 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.527 HG13 ' N ' ' B' ' 152' ' ' LEU . 11.4 p -63.36 -41.28 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.162 -0.961 . . . . 73.349999999999994 109.398 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.553 ' O ' HD13 ' B' ' 152' ' ' LEU . 0.3 OUTLIER -58.5 -42.56 87.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.38 -0.825 . . . . 55.240000000000002 109.088 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 16.0 p -71.13 -34.3 70.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.085 -1.01 . . . . 70.010000000000005 110.218 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -59.13 -53.73 55.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.056 -1.027 . . . . 65.319999999999993 109.628 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.82 -23.57 61.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.946 -1.096 . . . . 71.540000000000006 109.526 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.38 -50.32 71.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.197 -0.94 . . . . 75.319999999999993 109.22 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . 0.483 ' C ' ' H ' ' B' ' 159' ' ' ARG . 13.8 mtp-105 -71.47 -47.61 54.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 73.319999999999993 108.851 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -75.84 32.76 0.12 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.507 -0.745 . . . . 74.140000000000001 109.013 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . 0.483 ' H ' ' C ' ' B' ' 157' ' ' ARG . 34.0 ptt180 -50.67 -33.94 24.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.423 -0.798 . . . . 61.409999999999997 110.389 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' B' ' 160' ' ' ASP . 18.4 p30 -121.49 79.25 1.52 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.33 -0.856 . . . . 72.099999999999994 109.697 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -171.72 156.5 4.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.305 -0.872 . . . . 72.25 109.644 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 162' ' ' ILE . . . . . 0.795 HD12 ' N ' ' B' ' 162' ' ' ILE . 1.9 mp -94.1 139.27 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.205 -0.935 . . . . 72.310000000000002 109.025 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 63.5 t -133.95 142.52 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.416 -0.802 . . . . 64.209999999999994 109.594 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 4.7 p -91.78 166.38 12.79 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.21 -0.931 . . . . 74.219999999999999 110.422 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -64.47 -46.09 84.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.511 -0.743 . . . . 65.310000000000002 109.987 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -57.97 -38.25 75.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 63.450000000000003 110.15 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 167' ' ' GLN . . . . . 0.423 ' O ' ' OD1' ' B' ' 170' ' ' ASP . 63.3 tp60 -58.56 -48.54 80.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 72.400000000000006 109.795 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 33.1 mt -60.17 -36.09 76.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.92 . . . . 72.319999999999993 109.551 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.546 HD23 ' C ' ' B' ' 169' ' ' LEU . 3.6 tt -55.9 -68.89 0.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.364 -0.835 . . . . 73.340000000000003 109.756 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' B' ' 167' ' ' GLN . 26.4 p30 -64.37 -11.19 30.16 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.473 -0.767 . . . . 72.099999999999994 110.802 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.57 -58.5 3.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.979 -1.076 . . . . 62.130000000000003 110.224 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 0.684 ' N ' HD12 ' B' ' 172' ' ' ILE . 2.0 mp -94.38 -50.4 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.018 -1.051 . . . . 71.420000000000002 109.47 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 173' ' ' TRP . . . . . 0.441 ' O ' ' O ' ' B' ' 169' ' ' LEU . 16.1 m-90 . . . . . 0 N--CA 1.493 1.718 0 O-C-N 121.297 -0.877 . . . . 72.230000000000004 109.452 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo . . . . . 0 N--CA 1.495 1.606 0 CA-C-O 121.33 0.471 . . . . 65.219999999999999 111.989 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 182' ' ' ASN . . . . . 0.511 HD21 ' CD ' ' B' ' 185' ' ' GLU . 16.2 t-20 -72.23 -0.79 12.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 72.310000000000002 109.624 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 83.0 t -65.19 -29.01 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.257 -0.902 . . . . 63.32 109.66 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 61.7 mt -53.3 -40.71 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 75.030000000000001 110.102 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . 0.511 ' CD ' HD21 ' B' ' 182' ' ' ASN . 22.6 mt-10 -56.17 -37.39 69.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.041 -1.037 . . . . 64.109999999999999 108.881 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.92 -54.63 9.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.452 -0.78 . . . . 73.0 109.765 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -54.28 -36.96 64.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.274 -0.892 . . . . 61.119999999999997 110.465 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 188' ' ' ILE . . . . . 0.439 ' CG2' ' N ' ' B' ' 189' ' ' ASN . 7.7 tp -75.38 -43.54 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.681 -1.262 . . . . 72.430000000000007 109.667 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 189' ' ' ASN . . . . . 0.439 ' N ' ' CG2' ' B' ' 188' ' ' ILE . 11.3 m120 -61.65 -38.14 86.63 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.218 -0.926 . . . . 65.140000000000001 109.271 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -72.3 -47.72 47.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.952 . . . . 63.240000000000002 109.615 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . 0.441 ' O ' ' SD ' ' B' ' 195' ' ' MET . 57.4 mt -55.29 -40.52 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.155 -0.966 . . . . 74.030000000000001 109.093 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -63.06 -43.36 98.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 72.239999999999995 109.654 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -73.25 -30.83 63.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 73.099999999999994 109.87 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -82.01 -19.92 39.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.303 -0.873 . . . . 72.109999999999999 110.441 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 195' ' ' MET . . . . . 0.563 ' N ' ' SD ' ' B' ' 195' ' ' MET . 0.1 OUTLIER -99.7 -36.16 9.57 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.142 -0.974 . . . . 44.329999999999998 109.85 -179.666 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 196' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 58.2 p-10 -68.14 -19.57 64.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.086 -1.009 . . . . 71.209999999999994 110.113 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . 0.533 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 27.4 mttm -80.41 -64.87 0.29 Allowed Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.029 -1.045 . . . . 75.209999999999994 109.87 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 198' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 33.0 Cg_endo -61.9 -55.2 1.15 Allowed 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.314 2.009 . . . . 75.319999999999993 112.442 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' B' ' 201' ' ' ILE . 15.5 mt -64.53 -37.03 86.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.084 -1.01 . . . . 72.25 109.627 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 74.09 -31.33 0.94 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.581 -1.408 . . . . 64.530000000000001 109.581 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . 0.476 ' H ' ' C ' ' B' ' 199' ' ' LEU . 66.4 mt -96.78 142.51 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.226 -1.161 . . . . 44.229999999999997 109.341 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 79.8 p -94.56 146.91 23.78 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.266 -0.896 . . . . 54.009999999999998 109.595 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 22.7 p -143.36 11.9 1.73 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.252 -0.905 . . . . 74.400000000000006 109.075 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.405 ' O ' HG23 ' B' ' 204' ' ' VAL . 16.1 m -135.59 133.85 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.472 -0.767 . . . . 72.120000000000005 109.242 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -115.87 132.88 56.51 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.626 -0.671 . . . . 65.409999999999997 109.287 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.5 137.57 33.47 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.208 -0.932 . . . . 71.329999999999998 109.062 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.573 HG22 ' H ' ' B' ' 209' ' ' ARG . 7.9 p -124.55 145.7 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.584 -0.697 . . . . 63.5 109.561 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -71.0 -11.53 61.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 74.450000000000003 109.904 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 209' ' ' ARG . . . . . 0.573 ' H ' HG22 ' B' ' 207' ' ' VAL . 70.0 ttt-85 -69.1 -108.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.126 -0.984 . . . . 74.140000000000001 109.623 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -146.83 121.4 9.76 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.827 -1.171 . . . . 74.430000000000007 109.853 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 94.47 171.84 37.98 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.68 -0.968 . . . . 64.450000000000003 110.68 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -115.74 171.34 7.81 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.213 -1.032 . . . . 74.209999999999994 108.213 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -132.24 132.64 43.27 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.215 -0.928 . . . . 74.030000000000001 109.597 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -113.35 123.46 50.17 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.978 -0.749 . . . . 74.340000000000003 108.978 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 2.2 p -139.92 164.34 30.26 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.447 -0.783 . . . . 64.329999999999998 109.044 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -61.87 149.78 84.5 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 70.040000000000006 109.104 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -38.52 133.82 0.89 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.144 1.896 . . . . 65.109999999999999 112.277 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 35.1 tttp . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.167 -0.958 . . . . 73.150000000000006 110.772 179.893 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.445 ' SD ' ' OD2' ' A' ' 46' ' ' ASP . 32.2 tpp . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.318 0.58 . . . . 65.120000000000005 109.441 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.572 ' NH2' ' CB ' ' A' ' 28' ' ' ASP . 75.5 ttt-85 -143.0 135.82 27.83 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.267 -0.895 . . . . 72.329999999999998 109.267 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.7 t -110.97 133.6 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.653 -0.654 . . . . 71.420000000000002 109.405 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.738 HD12 ' N ' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -113.88 120.29 40.21 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.752 -0.833 . . . . 65.120000000000005 108.752 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.738 ' N ' HD12 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -121.82 119.92 33.07 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.396 -0.965 . . . . 62.43 108.396 179.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.566 HG12 HD11 ' A' ' 4' ' ' LEU . 7.1 mt -97.31 130.38 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.25 -0.906 . . . . 71.150000000000006 109.351 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 13' ' ' GLY . 10.8 pt-20 -171.57 -22.17 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.226 -0.921 . . . . 75.340000000000003 110.719 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt 69.18 -38.38 0.4 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.278 -0.889 . . . . 72.439999999999998 109.769 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.484 ' H ' ' C ' ' A' ' 7' ' ' GLU . 26.8 m120 -64.88 103.12 0.67 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.143 -0.973 . . . . 63.020000000000003 109.419 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.1 m -61.15 -24.87 66.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.878 . . . . 72.340000000000003 109.633 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.9 t -70.03 -53.67 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.946 . . . . 74.019999999999996 109.728 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.578 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.4 mm? -69.07 -36.76 77.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 71.430000000000007 109.35 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.512 ' N ' ' OE1' ' A' ' 7' ' ' GLU . . . -73.42 -28.03 66.61 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.481 -1.848 . . . . 61.32 108.481 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.38 -50.72 60.22 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.449 -1.46 . . . . 71.200000000000003 109.449 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.414 ' H ' ' HG2' ' A' ' 15' ' ' GLU . 7.4 pt-20 -61.32 -45.99 92.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.347 -1.09 . . . . 71.319999999999993 109.76 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.7 mm -64.99 -37.11 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.751 -1.218 . . . . 63.229999999999997 108.68 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.475 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 84.1 tt0 -66.14 -47.03 75.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.368 -0.833 . . . . 51.109999999999999 109.794 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -85.24 2.98 41.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.098 -1.001 . . . . 73.340000000000003 109.324 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.85 -55.84 2.33 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.502 -1.439 . . . . 62.149999999999999 109.502 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 27' ' ' ALA . 1.4 pt? -74.24 -21.87 59.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -1.124 . . . . 73.510000000000005 109.812 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 96.2 m-20 -54.07 -33.26 57.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.119 -0.988 . . . . 74.25 109.448 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.7 t -58.33 -47.08 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 70.040000000000006 108.959 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -59.98 -53.8 53.62 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.897 -0.779 . . . . 73.230000000000004 108.897 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 135.03 22.29 0.66 Allowed Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.761 -1.336 . . . . 75.540000000000006 109.761 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -98.86 160.37 14.31 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.218 -1.166 . . . . 73.430000000000007 109.424 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.2 mmm -100.97 139.31 36.84 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.601 -0.888 . . . . 43.240000000000002 108.601 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.443 ' HB1' HD21 ' A' ' 5' ' ' LEU . . . -127.75 154.28 45.56 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.577 -0.702 . . . . 62.109999999999999 109.783 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.572 ' CB ' ' NH2' ' A' ' 2' ' ' ARG . 24.2 t70 -142.6 132.24 23.92 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.71 -0.848 . . . . 74.420000000000002 108.71 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.7 m -100.22 130.52 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.907 . . . . 72.150000000000006 108.879 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.4 p -120.62 158.19 27.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.608 -0.683 . . . . 71.420000000000002 109.223 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -89.32 -94.29 0.11 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.397 -0.814 . . . . 72.329999999999998 109.605 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.2 p -79.29 152.49 30.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.205 -0.934 . . . . 74.239999999999995 110.022 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.557 ' H ' HD12 ' A' ' 33' ' ' LEU . 2.3 mp -55.98 -37.34 68.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.49 -0.756 . . . . 71.530000000000001 109.795 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.54 -40.78 92.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 74.230000000000004 109.658 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -66.52 -40.37 89.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 54.030000000000001 109.331 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.31 -38.51 81.47 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.422 -1.471 . . . . 61.409999999999997 109.422 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -65.32 -39.93 93.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.378 -1.071 . . . . 74.340000000000003 109.523 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -78.94 -39.14 35.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.121 -0.987 . . . . 75.329999999999998 109.616 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.4 tt -67.74 -41.61 83.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.31 -0.869 . . . . 74.329999999999998 109.778 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.539 ' SD ' ' CE2' ' A' ' 45' ' ' TYR . 3.2 ppp? -74.83 -23.22 58.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.1 -1.0 . . . . 70.319999999999993 109.674 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -54.13 -37.27 64.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.117 -0.989 . . . . 71.219999999999999 109.891 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.405 HG12 ' H ' ' A' ' 42' ' ' ILE . 9.5 pt -84.94 -33.35 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.154 -0.966 . . . . 74.140000000000001 110.148 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 40' ' ' MET . 97.2 mtt180 -95.86 167.11 11.46 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.058 -1.026 . . . . 72.239999999999995 109.933 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.409 ' C ' ' CD2' ' A' ' 45' ' ' TYR . 30.4 m120 -79.8 -174.95 4.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.127 -0.983 . . . . 75.420000000000002 109.056 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.539 ' CE2' ' SD ' ' A' ' 40' ' ' MET . 1.4 p90 -173.96 134.4 0.46 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.044 -1.035 . . . . 74.230000000000004 109.861 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.445 ' OD2' ' SD ' ' A' ' 1' ' ' MET . 87.2 m-20 -120.89 -51.95 2.12 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.485 -0.932 . . . . 72.040000000000006 108.485 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.569 HD13 ' C ' ' A' ' 47' ' ' LEU . 1.7 tm? -106.32 111.1 23.54 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.049 -1.093 . . . . 72.129999999999995 108.049 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.467 ' N ' HD13 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -109.22 101.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.599 -0.889 . . . . 72.340000000000003 108.599 179.36 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 7.7 ttt -105.39 140.3 38.72 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.458 -0.942 . . . . 74.109999999999999 108.458 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -140.04 129.31 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 61.119999999999997 109.847 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.7 m -109.79 9.06 24.79 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.827 -0.805 . . . . 73.109999999999999 108.827 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -77.45 159.66 29.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.376 -0.828 . . . . 52.549999999999997 109.933 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.494 ' C ' ' H ' ' A' ' 55' ' ' ALA . 62.5 mttp -81.86 173.15 12.53 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.714 -0.847 . . . . 44.219999999999999 108.714 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 56.2 5.94 0.21 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.117 -0.989 . . . . 70.439999999999998 108.916 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -68.65 -26.92 65.56 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.41 -0.806 . . . . 64.140000000000001 109.586 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.604 HD13 HE22 ' A' ' 89' ' ' GLN . 43.7 mt -45.14 -42.79 9.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.401 -0.812 . . . . 44.140000000000001 110.19 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.3 m -70.56 -37.38 73.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.999 -1.063 . . . . 55.229999999999997 109.819 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.572 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 85.0 t80 -64.76 -46.87 80.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 74.439999999999998 110.313 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.9 m -62.97 -36.92 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.654 -1.279 . . . . 74.030000000000001 109.555 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.8 t -55.84 -52.63 63.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.252 -0.905 . . . . 64.299999999999997 109.66 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -65.63 -32.71 74.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.127 -0.983 . . . . 64.439999999999998 109.987 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.572 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 5.2 mm -64.47 -35.89 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.871 -1.143 . . . . 63.210000000000001 109.63 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.544 ' HZ2' ' C ' ' A' ' 90' ' ' GLY . 26.6 mmtp -68.97 -50.87 45.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 74.420000000000002 110.262 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.438 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 15.7 pt-20 -70.1 -42.93 72.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.927 -1.108 . . . . 70.319999999999993 110.084 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.477 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 67.3 mttm -70.12 -24.6 63.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.94 . . . . 75.219999999999999 109.593 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.542 ' O ' HG22 ' A' ' 69' ' ' ILE . 96.1 m-70 -155.85 64.2 0.59 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.921 . . . . 74.129999999999995 109.371 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.501 ' N ' ' O ' ' A' ' 63' ' ' LYS . 84.4 p -57.26 -25.48 59.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.306 -0.871 . . . . 73.239999999999995 109.763 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.5 t -75.34 45.61 0.3 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 61.009999999999998 109.89 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.542 HG22 ' O ' ' A' ' 66' ' ' HIS . 13.7 tt -145.72 158.18 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.089 -1.007 . . . . 71.329999999999998 109.645 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.5 t -94.23 149.83 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.16 -0.962 . . . . 72.129999999999995 108.687 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.526 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 11.2 t -138.09 124.96 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.205 -0.934 . . . . 54.210000000000001 109.387 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 mp -124.8 99.52 6.19 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.686 -0.857 . . . . 50.240000000000002 108.686 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.47 HG22 ' N ' ' A' ' 74' ' ' SER . 10.4 p -86.89 160.14 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.183 -0.948 . . . . 74.409999999999997 108.891 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.47 ' N ' HG22 ' A' ' 73' ' ' VAL . 19.8 m -135.5 160.36 38.71 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.371 -0.831 . . . . 72.310000000000002 109.631 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 74' ' ' SER . 70.3 m -168.57 154.74 6.95 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.275 -0.891 . . . . 64.540000000000006 110.133 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 0.4 OUTLIER -94.71 8.3 42.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.406 -0.809 . . . . 74.129999999999995 109.945 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' A' ' 79' ' ' THR . 37.6 t30 -129.19 56.68 25.31 Favored Pre-proline 0 N--CA 1.502 2.14 0 O-C-N 121.358 -0.839 . . . . 73.340000000000003 110.109 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.6 84.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.349 2.033 . . . . 63.219999999999999 111.913 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.43 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 42.5 m -114.03 150.17 34.32 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.741 -0.837 . . . . 62.530000000000001 108.741 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.07 -32.86 23.39 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.214 -0.929 . . . . 73.439999999999998 109.432 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.434 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 97.4 mt-10 -59.45 -36.73 76.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 71.420000000000002 109.69 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 84.9 tt0 -75.84 -33.3 60.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.147 -0.971 . . . . 73.430000000000007 109.804 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.43 ' OE2' ' O ' ' A' ' 79' ' ' THR . 0.9 OUTLIER -68.69 -50.16 53.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.099 -1.001 . . . . 74.219999999999999 109.893 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.52 HG23 ' N ' ' A' ' 85' ' ' HIS . 34.6 m -63.21 -42.95 98.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.027 -1.046 . . . . 73.200000000000003 109.615 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.52 ' N ' HG23 ' A' ' 84' ' ' VAL . 56.1 m80 -74.11 -25.44 59.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 53.329999999999998 109.78 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 82' ' ' GLU . . . -65.43 -44.05 88.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.108 -0.995 . . . . 64.109999999999999 109.776 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.445 ' CZ ' ' HB1' ' B' ' 111' ' ' ALA . 66.4 t80 -81.49 -34.01 31.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.011 -1.055 . . . . 74.340000000000003 109.027 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -68.1 -51.35 47.44 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.349 -0.844 . . . . 74.420000000000002 109.261 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.604 HE22 HD13 ' A' ' 56' ' ' LEU . 95.7 mt-30 -61.2 -50.24 73.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.487 -0.758 . . . . 74.239999999999995 109.704 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.544 ' C ' ' HZ2' ' A' ' 63' ' ' LYS . . . 147.64 71.08 0.01 OUTLIER Glycine 0 N--CA 1.495 2.587 0 C-N-CA 119.851 -1.166 . . . . 61.509999999999998 110.357 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -139.81 140.01 36.52 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.186 -1.185 . . . . 55.329999999999998 109.092 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 57.3 m-20 -83.76 -39.87 19.52 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.056 -1.028 . . . . 73.420000000000002 109.492 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 73.1 m-20 -150.29 164.15 36.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -0.879 . . . . 75.040000000000006 109.223 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.438 ' CE1' ' O ' ' A' ' 95' ' ' ILE . 1.6 t80 -135.77 132.34 36.66 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.46 -0.775 . . . . 71.329999999999998 109.315 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.438 ' O ' ' CE1' ' A' ' 94' ' ' TYR . 26.1 mm -115.05 148.26 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 121.453 -0.779 . . . . 71.129999999999995 110.076 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.32 121.31 16.64 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.975 -1.491 . . . . 64.319999999999993 106.975 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.705 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.5 OUTLIER -43.66 -58.4 4.56 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.057 -1.027 . . . . 62.200000000000003 111.649 -178.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 7.5 Cg_endo -43.97 0.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 121.419 1.412 . . . . 73.109999999999999 113.695 -175.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.705 ' N ' ' O ' ' A' ' 97' ' ' LYS . 51.5 m-85 58.21 116.04 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.681 -0.637 . . . . 65.219999999999999 109.761 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.522 ' NE ' ' OE2' ' B' ' 83' ' ' GLU . 12.6 ttm-85 -73.63 -33.93 64.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 72.349999999999994 109.775 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.75 ' O ' ' N ' ' A' ' 103' ' ' LYS . 30.5 t -172.68 26.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.856 -1.153 . . . . 71.319999999999993 111.139 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 87.2 mt 51.13 -70.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.519 -0.738 . . . . 75.430000000000007 110.357 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.75 ' N ' ' O ' ' A' ' 101' ' ' SER . 30.5 mmtm -56.07 -30.05 61.41 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.162 -1.051 . . . . 71.409999999999997 108.162 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.4 -47.75 84.24 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.392 -0.966 . . . . 63.240000000000002 108.392 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.724 HD13 ' N ' ' A' ' 106' ' ' VAL . 0.7 OUTLIER -64.63 -56.04 16.38 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.953 -0.758 . . . . 73.219999999999999 108.953 179.602 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.724 ' N ' HD13 ' A' ' 105' ' ' LEU . 63.5 t -51.45 -40.55 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.74 -1.225 . . . . 60.109999999999999 109.018 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.21 -32.83 68.66 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.223 -0.923 . . . . 70.420000000000002 108.727 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 -77.96 -24.13 48.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -0.839 . . . . 74.409999999999997 110.333 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 81.7 mt -75.68 -38.98 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.801 -1.187 . . . . 62.539999999999999 108.869 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 114' ' ' ARG . 24.3 pt-20 -76.63 -32.5 58.06 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.298 -0.876 . . . . 74.340000000000003 109.605 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.49 -50.2 72.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.412 -0.805 . . . . 73.319999999999993 109.748 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -64.78 -46.07 83.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 52.409999999999997 109.495 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.6 mt -97.85 26.06 5.45 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.218 -0.926 . . . . 65.239999999999995 109.731 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 110' ' ' GLU . 0.8 OUTLIER -60.92 -53.13 61.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 64.450000000000003 109.383 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -86.62 50.85 2.08 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.176 -0.952 . . . . 74.430000000000007 109.412 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -88.28 132.4 34.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.247 -0.908 . . . . 74.420000000000002 109.869 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 118.99 92.3 1.44 Allowed Glycine 0 N--CA 1.501 2.972 0 N-CA-C 109.65 -1.38 . . . . 75.040000000000006 109.65 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 79.7 p -166.7 160.49 14.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.093 -1.239 . . . . 61.140000000000001 109.979 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 121' ' ' ILE . 8.2 t30 -146.06 142.82 28.95 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.51 -0.922 . . . . 65.239999999999995 108.51 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.2 t -93.54 -45.73 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.016 -1.053 . . . . 73.109999999999999 110.564 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.521 ' O ' ' ND2' ' A' ' 119' ' ' ASN . 12.4 mm -93.56 114.98 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 120.841 -1.162 . . . . 72.239999999999995 109.624 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -118.83 124.9 48.31 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.915 -0.772 . . . . 72.340000000000003 108.915 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.681 ' O ' HG23 ' A' ' 123' ' ' ILE . 5.9 tt -149.88 102.73 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.039 -1.038 . . . . 71.439999999999998 109.682 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 62.73 -135.6 44.17 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.198 -1.161 . . . . 73.400000000000006 110.198 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -87.74 -3.4 58.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.457 -1.025 . . . . 74.450000000000003 109.878 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.0 131.0 42.84 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.225 -0.922 . . . . 54.210000000000001 108.865 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.54 137.33 49.66 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.756 -0.831 . . . . 54.5 108.756 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.412 ' H ' HD21 ' A' ' 119' ' ' ASN . 56.4 mt -131.17 127.88 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.473 -0.767 . . . . 45.149999999999999 109.204 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.52 103.15 50.23 Favored Pre-proline 0 N--CA 1.494 1.766 0 N-CA-C 109.059 -0.719 . . . . 71.109999999999999 109.059 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.76 -24.95 5.65 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.795 1.663 . . . . 65.409999999999997 111.781 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -62.54 -55.8 23.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.471 -0.768 . . . . 63.32 109.863 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -94.68 12.54 27.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.29 -0.881 . . . . 72.519999999999996 109.31 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 49.61 57.91 6.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 75.329999999999998 109.18 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 26.0 ttpt -133.89 132.84 40.79 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.556 -0.715 . . . . 71.230000000000004 109.673 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.9 tt -109.74 137.17 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 109.138 -0.689 . . . . 74.019999999999996 109.138 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 70.5 mt -121.27 118.9 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.495 -0.753 . . . . 60.229999999999997 109.193 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.42 ' C ' ' H ' ' A' ' 139' ' ' GLY . 65.3 t80 -142.76 151.3 41.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.349 -0.844 . . . . 62.32 108.978 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 1.047 ' HZ3' ' HB3' ' A' ' 138' ' ' LYS . 0.0 OUTLIER 61.37 5.75 1.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.942 -1.099 . . . . 75.400000000000006 108.239 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 137' ' ' TYR . . . 86.12 13.04 69.61 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.091 -1.603 . . . . 72.239999999999995 109.091 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -103.44 142.79 33.64 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.589 -0.948 . . . . 71.219999999999999 108.782 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -107.97 116.11 31.36 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.05 -1.031 . . . . 71.420000000000002 108.823 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.14 138.48 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.437 -0.789 . . . . 53.020000000000003 109.066 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -82.29 147.86 28.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.401 -0.812 . . . . 60.450000000000003 109.931 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.4 HG23 ' CE2' ' A' ' 149' ' ' PHE . 2.1 m -146.38 125.0 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.368 -0.833 . . . . 74.439999999999998 109.489 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -158.01 134.37 9.52 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.445 -0.784 . . . . 65.150000000000006 109.184 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.13 -162.93 36.72 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.066 -1.214 . . . . 73.340000000000003 110.066 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.627 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 49.9 mtmt -82.49 -30.61 0.51 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.443 -1.034 . . . . 72.219999999999999 111.626 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 90.1 Cg_endo -86.94 -25.02 1.22 Allowed 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 121.801 1.667 . . . . 65.230000000000004 112.562 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.479 ' CE2' HG23 ' A' ' 153' ' ' THR . 85.7 t80 -89.15 -12.92 39.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.158 -0.964 . . . . 60.109999999999999 109.802 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -61.11 -38.27 85.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.1 -1.0 . . . . 64.209999999999994 109.422 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.34 -28.96 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 72.019999999999996 109.0 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.3 OUTLIER -61.18 -44.45 97.28 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.94 -0.763 . . . . 73.310000000000002 108.94 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.479 HG23 ' CE2' ' A' ' 149' ' ' PHE . 1.9 p -74.09 -37.9 64.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.206 -0.934 . . . . 74.310000000000002 110.231 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -54.76 -55.13 33.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.934 -1.104 . . . . 74.310000000000002 109.82 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.756 HD12 ' N ' ' A' ' 156' ' ' ALA . 4.6 pp -66.92 -33.47 75.67 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.207 -0.933 . . . . 75.340000000000003 109.197 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.756 ' N ' HD12 ' A' ' 155' ' ' LEU . . . -51.16 -41.24 60.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.192 -0.943 . . . . 62.140000000000001 108.949 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 159' ' ' ARG . 62.6 mtp180 -89.06 -48.95 7.06 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.143 -0.973 . . . . 61.030000000000001 108.922 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -73.09 35.03 0.08 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.389 -0.819 . . . . 74.120000000000005 109.611 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.48 ' H ' ' C ' ' A' ' 157' ' ' ARG . 27.9 ptt180 -72.16 171.1 12.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.34 -0.85 . . . . 71.129999999999995 109.347 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.6 t70 52.51 44.04 30.42 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.192 -0.942 . . . . 75.450000000000003 109.609 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -148.25 162.92 38.51 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.181 -0.949 . . . . 73.409999999999997 109.448 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.6 mt -93.37 119.34 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.218 -0.926 . . . . 74.409999999999997 108.649 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 10.8 t -99.89 122.39 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.251 -0.905 . . . . 72.310000000000002 109.675 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.2 p -84.07 164.68 19.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 74.120000000000005 108.911 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -63.27 -43.75 97.06 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.178 -0.951 . . . . 70.430000000000007 109.39 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.432 ' O ' ' OD2' ' A' ' 170' ' ' ASP . 49.0 mt-10 -72.12 -29.24 63.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 73.519999999999996 110.16 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -57.32 -57.14 13.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.961 . . . . 74.519999999999996 110.037 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 169' ' ' LEU . 2.2 pp -67.81 -36.52 80.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.974 -1.079 . . . . 72.310000000000002 110.056 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.651 ' C ' HD13 ' A' ' 169' ' ' LEU . 3.1 tm? -55.18 -52.91 61.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.927 -1.108 . . . . 53.329999999999998 108.867 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' A' ' 166' ' ' GLU . 2.6 p30 -72.38 -28.61 63.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.207 -0.933 . . . . 62.439999999999998 110.111 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -53.77 -52.16 61.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.149 -0.969 . . . . 60.210000000000001 110.358 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 12.8 mm -91.53 -28.92 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.071 -1.018 . . . . 75.319999999999993 110.015 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 16.2 m-90 . . . . . 0 N--CA 1.498 1.957 0 O-C-N 121.409 -0.807 . . . . 73.140000000000001 109.432 179.931 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.989 ' ND2' ' OE1' ' A' ' 185' ' ' GLU . 53.2 t-20 . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 121.321 0.581 . . . . 64.540000000000006 110.274 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 183' ' ' VAL . 96.2 t -123.66 -13.77 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.567 -0.901 . . . . 74.019999999999996 108.567 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 96.0 mt -61.99 -42.44 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.464 -0.772 . . . . 72.329999999999998 109.832 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.989 ' OE1' ' ND2' ' A' ' 182' ' ' ASN . 11.5 pt-20 -51.48 -37.87 51.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.896 -1.128 . . . . 74.400000000000006 109.121 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 36.0 t -73.11 -32.33 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.452 -0.78 . . . . 70.420000000000002 109.372 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -79.33 -56.86 4.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.22 -0.925 . . . . 52.109999999999999 110.457 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.439 HG23 ' N ' ' A' ' 189' ' ' ASN . 3.4 tp -55.59 -39.01 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.858 -1.151 . . . . 71.400000000000006 109.776 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.45 ' OD1' ' NE2' ' A' ' 193' ' ' GLN . 25.8 t-20 -67.68 -54.68 17.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.335 -0.853 . . . . 73.439999999999998 111.779 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -62.26 -31.72 72.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.835 -1.166 . . . . 71.420000000000002 111.412 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 47.1 pt -69.15 -38.14 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.201 -1.562 . . . . 61.549999999999997 109.937 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.64 -42.21 99.47 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 117.986 -1.486 . . . . 63.340000000000003 108.238 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.45 ' NE2' ' OD1' ' A' ' 189' ' ' ASN . 79.5 mt-30 -64.52 -34.26 77.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.552 -0.718 . . . . 61.240000000000002 110.167 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.489 ' O ' ' CG ' ' A' ' 198' ' ' PRO . 15.0 mtpp -75.19 -25.71 58.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.155 -0.966 . . . . 75.129999999999995 110.634 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 74.8 mtm -95.97 4.38 52.74 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.972 -1.08 . . . . 74.019999999999996 109.475 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -113.67 -12.88 12.76 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.579 -0.7 . . . . 74.019999999999996 110.636 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.577 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 20.5 tttt -98.28 -41.04 0.24 Allowed Pre-proline 0 N--CA 1.502 2.132 0 O-C-N 120.949 -1.094 . . . . 75.430000000000007 110.87 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 85.5 Cg_endo -93.3 -64.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.906 2.404 . . . . 72.319999999999993 112.999 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 45.8 mt -50.18 -35.86 28.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.1 -1.0 . . . . 74.540000000000006 109.353 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 87.17 -9.75 71.47 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.761 -1.336 . . . . 61.509999999999998 109.761 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 17.2 mt -132.9 127.57 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.482 -1.01 . . . . 61.219999999999999 109.533 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.8 t -78.67 133.1 37.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.316 -0.865 . . . . 72.0 109.199 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.6 p -118.62 34.0 5.4 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.515 -0.74 . . . . 74.439999999999998 110.503 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 6.4 m -143.27 139.39 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.976 -1.078 . . . . 64.349999999999994 110.002 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -126.01 133.44 51.76 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.109 -0.7 . . . . 71.409999999999997 109.109 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.56 133.52 34.14 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.082 -1.011 . . . . 73.519999999999996 108.962 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 10.4 p -128.54 137.23 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.52 -0.738 . . . . 71.019999999999996 109.179 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -92.79 60.37 3.4 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.205 -0.934 . . . . 72.120000000000005 109.369 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.16 -61.51 0.32 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.497 -0.927 . . . . 64.409999999999997 108.497 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -104.43 -65.39 1.03 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.592 -0.692 . . . . 71.540000000000006 109.278 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -171.75 -105.86 0.19 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.347 -1.501 . . . . 72.030000000000001 109.347 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.34 123.38 39.27 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.456 -1.026 . . . . 75.540000000000006 108.632 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -89.51 146.49 24.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.367 -0.833 . . . . 75.310000000000002 110.963 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.609 ' CE2' HD13 ' A' ' 155' ' ' LEU . 11.5 t80 -123.57 114.4 19.99 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.502 -0.925 . . . . 75.409999999999997 108.502 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 18.5 p -140.45 159.41 42.27 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.385 -0.822 . . . . 74.140000000000001 109.077 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -59.04 142.47 85.4 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.079 -1.013 . . . . 75.319999999999993 108.729 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 C--N 1.313 -1.304 0 C-N-CA 122.085 1.857 . . . . 73.109999999999999 112.065 179.678 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.413 -0.588 . . . . 71.140000000000001 109.413 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 51.4 ttt85 -139.98 155.07 47.29 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.351 -0.843 . . . . 73.230000000000004 109.279 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 83.4 t -113.23 122.13 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.59 0.709 . . . . 72.239999999999995 109.73 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.541 HD11 ' CG1' ' B' ' 6' ' ' ILE . 2.6 tp -91.71 117.64 29.94 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.367 -0.975 . . . . 54.329999999999998 108.367 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.506 HD23 ' N ' ' B' ' 6' ' ' ILE . 4.2 tt -118.95 120.15 36.42 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.437 -0.949 . . . . 74.349999999999994 108.437 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.541 ' CG1' HD11 ' B' ' 4' ' ' LEU . 19.0 mt -115.78 99.53 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.438 -0.789 . . . . 42.549999999999997 109.195 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.425 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 30.1 tp10 -125.17 139.64 53.57 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.578 -0.701 . . . . 74.519999999999996 109.295 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.443 ' NZ ' ' OD1' ' B' ' 52' ' ' ASP . 39.2 mmtm -70.39 -34.29 72.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.922 . . . . 62.549999999999997 109.374 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -90.72 118.89 30.5 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.284 -0.885 . . . . 73.109999999999999 109.576 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 18.9 t -70.37 -32.06 69.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.927 . . . . 65.540000000000006 109.56 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 82.7 t -64.27 -53.25 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.917 . . . . 75.549999999999997 109.734 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.512 ' O ' HD13 ' B' ' 12' ' ' LEU . 0.2 OUTLIER -64.21 -37.63 88.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.909 . . . . 70.140000000000001 109.003 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.05 -26.72 73.94 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.487 -1.845 . . . . 75.400000000000006 108.487 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.96 -54.2 32.25 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 109.623 -1.391 . . . . 65.439999999999998 109.623 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' B' ' 15' ' ' GLU . 7.2 pt-20 -58.3 -44.2 88.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.333 -1.098 . . . . 60.210000000000001 109.677 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.484 ' CD1' HD12 ' B' ' 102' ' ' ILE . 39.3 mm -64.33 -43.81 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.917 -1.114 . . . . 75.150000000000006 108.725 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -61.3 -43.53 98.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.411 -0.806 . . . . 73.010000000000005 109.816 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.405 ' HZ2' ' HB3' ' B' ' 18' ' ' LYS . 16.3 mtpp -87.06 2.45 49.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.098 -1.001 . . . . 74.299999999999997 109.444 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.73 -53.27 2.61 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.433 -1.467 . . . . 70.540000000000006 109.433 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -76.13 -20.09 57.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.314 -1.109 . . . . 71.340000000000003 109.704 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -58.59 -30.59 67.31 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.06 -1.025 . . . . 64.409999999999997 109.256 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 82.9 t -60.29 -34.66 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.355 -0.84 . . . . 74.230000000000004 109.114 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -68.55 -4.69 16.12 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.336 -0.852 . . . . 63.420000000000002 109.067 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.82 39.97 7.34 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.092 -1.203 . . . . 53.43 110.092 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -119.84 159.34 24.78 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.536 -0.979 . . . . 71.120000000000005 109.321 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 7.1 mmt -105.19 133.37 50.08 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.242 -1.022 . . . . 75.239999999999995 108.242 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.07 162.46 36.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.173 -0.954 . . . . 72.120000000000005 110.239 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -141.22 145.65 35.87 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.459 -0.776 . . . . 72.310000000000002 108.952 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -106.72 137.64 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.309 -0.869 . . . . 64.430000000000007 108.79 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 11.3 p -136.41 167.79 20.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.366 -0.834 . . . . 65.409999999999997 109.289 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.477 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 2.2 pt-20 -90.22 -100.05 0.1 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.153 -0.967 . . . . 71.019999999999996 109.898 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 32.8 t -78.96 166.21 22.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.958 . . . . 51.109999999999999 110.236 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 44.1 mt -53.91 -32.97 55.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.633 -0.667 . . . . 71.239999999999995 109.829 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -50.43 -48.31 56.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.121 -0.987 . . . . 74.319999999999993 109.695 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.477 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 65.9 m-20 -69.28 -41.33 76.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.169 -0.957 . . . . 73.030000000000001 109.501 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.18 -40.7 87.8 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.464 -1.454 . . . . 30.210000000000001 109.464 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -68.6 -42.69 77.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -1.151 . . . . 74.420000000000002 109.543 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . 0.448 ' O ' ' OD1' ' B' ' 41' ' ' ASP . 56.4 t80 -75.17 -21.9 58.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 74.420000000000002 110.053 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 28.5 tp -90.01 -39.16 13.13 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.14 -0.975 . . . . 75.409999999999997 110.044 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' B' ' 40' ' ' MET . 0.0 OUTLIER -78.13 -27.69 48.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.996 . . . . 60.409999999999997 110.528 -179.102 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' B' ' 42' ' ' ILE . 41.9 p-10 -68.02 -27.51 66.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.901 -1.124 . . . . 53.229999999999997 110.225 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.533 ' N ' ' OD1' ' B' ' 41' ' ' ASP . 13.8 pt -88.8 -15.47 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.004 -1.06 . . . . 71.230000000000004 110.419 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' B' ' 40' ' ' MET . 97.2 mtt180 -129.48 149.92 51.05 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.239 -0.913 . . . . 72.219999999999999 109.77 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -82.85 163.18 21.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.202 -0.937 . . . . 63.539999999999999 109.458 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 10.4 p90 -159.3 -179.04 7.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.92 . . . . 64.349999999999994 109.706 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -138.97 -32.85 0.66 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.475 -0.766 . . . . 62.219999999999999 109.428 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.501 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.3 OUTLIER -107.08 115.1 29.59 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.357 -0.839 . . . . 73.120000000000005 109.004 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.501 ' N ' HD13 ' B' ' 47' ' ' LEU . 56.0 t -102.55 98.01 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.51 -0.922 . . . . 65.109999999999999 108.51 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -117.06 129.07 55.76 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.776 0.798 . . . . 73.439999999999998 110.141 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.624 HG22 ' H ' ' B' ' 52' ' ' ASP . 0.2 OUTLIER -141.65 135.68 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.78 0.8 . . . . 34.5 109.179 -179.622 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . 0.425 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 53.2 p -99.3 18.29 17.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.599 -0.688 . . . . 73.209999999999994 109.599 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.624 ' H ' HG22 ' B' ' 50' ' ' VAL . 37.6 m-20 -86.09 144.16 27.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.185 -0.947 . . . . 70.409999999999997 109.534 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.449 ' C ' ' H ' ' B' ' 55' ' ' ALA . 99.1 mttt -76.52 -42.6 42.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.276 -0.89 . . . . 65.0 110.201 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -71.01 10.72 0.5 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.108 -0.995 . . . . 75.209999999999994 109.727 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -67.13 -22.22 65.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 55.329999999999998 110.106 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.42 ' HG ' ' H ' ' B' ' 56' ' ' LEU . 19.0 mt -44.68 -44.93 9.47 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.268 -0.895 . . . . 63.140000000000001 110.142 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 93.1 p -69.39 -37.96 77.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.991 -1.068 . . . . 63.5 109.284 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -65.07 -62.28 1.65 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.279 -0.888 . . . . 72.329999999999998 109.656 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 33.3 m -49.55 -33.64 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.555 -1.341 . . . . 74.540000000000006 109.661 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 10.9 p -57.6 -51.26 70.23 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.202 -0.936 . . . . 71.239999999999995 109.472 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.418 ' HG2' ' H ' ' B' ' 61' ' ' ARG . 6.7 ptp180 -70.05 -31.24 68.77 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.177 -1.009 . . . . 74.310000000000002 110.176 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' B' ' 66' ' ' HIS . 40.0 mm -66.68 -44.97 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.683 -1.261 . . . . 72.140000000000001 110.285 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -65.09 -44.94 87.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.195 -0.941 . . . . 73.319999999999993 110.818 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -73.86 -38.0 64.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.743 -1.223 . . . . 73.120000000000005 110.036 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.486 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 64.2 mttm -84.71 -17.04 39.69 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.099 -1.0 . . . . 72.439999999999998 109.711 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.486 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 76.9 m-70 -155.63 68.72 0.66 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.053 -1.03 . . . . 63.310000000000002 109.618 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 85.6 p -67.6 -27.55 67.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.312 -0.867 . . . . 73.099999999999994 109.898 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 12.5 t -63.1 -19.22 64.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.148 -0.97 . . . . 71.530000000000001 110.069 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 63.1 mt -88.25 151.94 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.182 -0.949 . . . . 74.400000000000006 109.784 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.419 HG12 ' N ' ' B' ' 71' ' ' VAL . 94.3 t -90.96 157.62 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.41 -0.806 . . . . 75.120000000000005 109.277 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.419 ' N ' HG12 ' B' ' 70' ' ' VAL . 11.0 t -135.7 126.79 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.218 -0.926 . . . . 73.200000000000003 109.864 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.555 HD23 ' C ' ' B' ' 72' ' ' LEU . 4.2 tt -116.88 105.32 12.23 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.787 -0.82 . . . . 73.340000000000003 108.787 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 71.1 t -98.06 131.23 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.033 -1.042 . . . . 73.5 109.541 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.9 p -95.23 169.26 10.21 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.239 -0.913 . . . . 64.340000000000003 109.137 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.474 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 36.2 t -157.19 117.02 3.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.007 -1.058 . . . . 74.530000000000001 110.292 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' B' ' 77' ' ' ASN . 52.8 p30 -71.28 -10.5 59.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.409 -0.807 . . . . 64.5 109.292 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' B' ' 79' ' ' THR . 84.5 m-20 -132.9 77.06 69.39 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 108.47 -0.937 . . . . 74.25 108.47 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -55.59 73.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.561 2.174 . . . . 74.430000000000007 111.894 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.542 HG23 ' H ' ' B' ' 82' ' ' GLU . 6.9 t -97.43 150.73 20.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.257 -0.902 . . . . 73.120000000000005 109.308 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -26.37 68.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.523 -0.736 . . . . 71.010000000000005 110.225 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' B' ' 81' ' ' GLU . 2.5 mp0 -64.27 -39.97 95.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.978 -1.076 . . . . 63.200000000000003 109.823 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . 0.542 ' H ' HG23 ' B' ' 79' ' ' THR . 0.1 OUTLIER -78.51 -29.11 46.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.086 -1.009 . . . . 73.219999999999999 109.627 -179.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.522 ' OE2' ' NE ' ' A' ' 100' ' ' ARG . 87.1 mt-10 -64.94 -48.29 74.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.034 -1.041 . . . . 74.299999999999997 109.659 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.479 HG23 ' N ' ' B' ' 85' ' ' HIS . 27.0 m -67.77 -42.65 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 73.310000000000002 109.485 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' HIS . . . . . 0.479 ' N ' HG23 ' B' ' 84' ' ' VAL . 42.4 m80 -69.2 -25.9 64.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.167 -0.958 . . . . 73.239999999999995 109.533 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -68.55 -45.57 71.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 55.329999999999998 109.846 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -79.35 -28.07 42.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.057 -1.027 . . . . 74.140000000000001 109.044 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 31.0 tp10 -75.98 -51.67 11.88 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.335 -0.853 . . . . 64.040000000000006 109.563 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -61.87 -50.42 72.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.414 -0.804 . . . . 72.349999999999994 109.745 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 151.75 72.81 0.01 OUTLIER Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.749 -1.215 . . . . 65.200000000000003 110.308 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -134.43 136.43 43.25 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.288 -1.125 . . . . 52.229999999999997 108.843 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -89.21 -23.15 22.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.09 -1.006 . . . . 73.319999999999993 109.56 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 11.2 t0 -152.03 163.57 39.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.277 -0.889 . . . . 72.219999999999999 109.358 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.518 ' N ' ' OD1' ' B' ' 93' ' ' ASP . 76.7 t80 -146.64 99.28 3.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.382 -0.823 . . . . 64.420000000000002 109.252 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 20.8 mm -106.37 151.01 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.388 0 O-C-N 121.227 -0.921 . . . . 72.230000000000004 109.961 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.15 139.28 57.47 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.991 -1.114 . . . . 25.239999999999998 107.991 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.656 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -58.38 -55.13 48.86 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 120.744 -1.222 . . . . 64.319999999999993 111.146 -179.067 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 3.5 Cg_endo -41.75 -12.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.188 0 CA-C-N 119.619 0.9 . . . . 63.329999999999998 112.383 -176.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . 0.656 ' N ' ' O ' ' B' ' 97' ' ' LYS . 51.0 m-85 57.87 104.33 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.865 -0.522 . . . . 75.129999999999995 110.256 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -55.52 -39.22 70.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.829 -1.169 . . . . 74.230000000000004 108.042 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 10.6 t -170.32 131.96 0.99 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.919 -0.771 . . . . 63.340000000000003 108.919 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . 0.484 HD12 ' CD1' ' B' ' 16' ' ' ILE . 4.1 mm -51.71 -41.61 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.951 . . . . 74.439999999999998 109.1 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -60.37 -36.34 77.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.228 -0.92 . . . . 71.109999999999999 109.264 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.41 -48.53 64.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 71.450000000000003 109.557 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 60.0 tp -60.96 -48.93 79.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 51.310000000000002 109.433 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.73 -43.83 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.167 -0.958 . . . . 65.230000000000004 110.028 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.27 -43.32 64.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.06 -1.025 . . . . 24.32 109.211 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -68.35 -33.77 74.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.337 -0.852 . . . . 75.310000000000002 109.606 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 95.3 mt -72.35 -34.51 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.054 -1.029 . . . . 54.240000000000002 108.571 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' B' ' 114' ' ' ARG . 80.6 tt0 -58.55 -56.82 17.17 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.575 -0.85 . . . . 65.310000000000002 108.987 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . 0.445 ' HB1' ' CZ ' ' A' ' 87' ' ' PHE . . . -54.85 -40.34 69.54 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.477 -0.764 . . . . 72.239999999999995 110.157 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . 0.401 HH12 ' HB2' ' B' ' 93' ' ' ASP . 0.0 OUTLIER -53.6 -38.28 63.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.995 -1.066 . . . . 72.040000000000006 108.896 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.86 54.22 1.05 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.987 -1.071 . . . . 75.349999999999994 109.942 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' B' ' 110' ' ' GLU . 4.9 tmt_? -72.06 -43.68 64.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.129 -0.982 . . . . 75.5 108.987 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' PHE . . . . . 0.488 ' O ' ' N ' ' B' ' 117' ' ' GLY . 96.2 m-85 -67.75 -0.84 4.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.332 -0.855 . . . . 65.329999999999998 109.502 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 66.01 -55.5 0.37 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.561 -0.712 . . . . 74.450000000000003 110.158 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' B' ' 115' ' ' PHE . . . -154.42 171.83 32.93 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.897 -1.281 . . . . 44.210000000000001 109.897 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 41.1 m -156.58 -175.51 5.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.38 -1.071 . . . . 71.400000000000006 109.662 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.15 122.95 5.73 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.822 -0.751 . . . . 72.319999999999993 109.112 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 9.9 t -85.15 -42.88 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.214 -0.929 . . . . 75.019999999999996 110.119 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 15.7 mm -97.11 132.66 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.07 -1.019 . . . . 51.409999999999997 109.819 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -114.0 121.46 43.96 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.987 -0.745 . . . . 71.530000000000001 108.987 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.551 ' CD1' HH12 ' B' ' 159' ' ' ARG . 73.4 mt -132.47 121.39 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.355 -0.841 . . . . 72.430000000000007 109.478 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' B' ' 123' ' ' ILE . . . 40.29 -122.61 2.01 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 110.518 -1.033 . . . . 51.229999999999997 110.518 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -97.1 -13.6 22.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.349 -1.089 . . . . 74.200000000000003 109.698 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' B' ' 123' ' ' ILE . 0.1 OUTLIER -95.45 143.41 26.81 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.127 -0.983 . . . . 75.420000000000002 109.406 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 20.3 p -121.27 145.79 47.49 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.101 -0.703 . . . . 74.219999999999999 109.101 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 78.0 mt -125.49 138.87 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.501 -0.749 . . . . 60.329999999999998 109.891 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 5.8 t -118.58 114.66 35.92 Favored Pre-proline 0 N--CA 1.499 1.997 0 N-CA-C 108.723 -0.843 . . . . 72.310000000000002 108.723 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.92 -53.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.651 1.567 . . . . 75.129999999999995 112.162 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -61.52 -40.82 96.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.163 -0.96 . . . . 75.230000000000004 109.459 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' B' ' 133' ' ' GLU . 23.7 tp10 -87.39 7.96 26.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.216 -0.928 . . . . 72.430000000000007 109.359 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' B' ' 132' ' ' GLU . 17.9 pt-20 34.33 54.06 0.6 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.252 0.549 . . . . 75.129999999999995 111.142 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -139.05 146.4 40.74 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.284 -0.885 . . . . 73.219999999999999 109.177 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 14.3 tt -126.11 142.39 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.543 -0.723 . . . . 64.140000000000001 109.1 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 7.2 mt -120.63 136.04 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.611 -0.681 . . . . 71.219999999999999 109.63 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -138.4 134.69 34.44 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.42 -0.955 . . . . 64.219999999999999 108.42 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . 0.443 ' CG ' ' O ' ' B' ' 138' ' ' LYS . 12.4 ttmt 56.41 9.34 0.52 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.465 -0.772 . . . . 72.019999999999996 109.361 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 96.7 3.62 59.44 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 110.225 -1.15 . . . . 74.319999999999993 110.225 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -89.5 126.39 35.57 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.114 -1.227 . . . . 75.340000000000003 108.803 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -91.85 120.32 32.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.248 -0.907 . . . . 71.230000000000004 109.683 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 7.9 p -134.69 140.95 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 108.777 -0.823 . . . . 70.430000000000007 108.777 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -94.01 157.84 15.91 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.188 -0.945 . . . . 72.430000000000007 110.241 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -150.28 139.05 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.455 -0.778 . . . . 72.129999999999995 108.934 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 26.3 pttt -165.89 77.94 0.26 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.184 -0.948 . . . . 72.019999999999996 109.543 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -156.99 -129.83 1.17 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.085 -1.606 . . . . 42.229999999999997 109.085 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . 0.632 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 73.2 mttt -80.32 -32.4 0.69 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.108 -1.231 . . . . 73.299999999999997 110.764 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . 0.632 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 71.5 Cg_endo -91.12 15.45 1.76 Allowed 'Trans proline' 0 N--CA 1.486 1.082 0 C-N-CA 122.203 1.935 . . . . 71.329999999999998 112.446 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -98.79 -59.13 1.79 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.238 -0.914 . . . . 74.230000000000004 109.345 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . 0.475 ' CG ' ' N ' ' B' ' 151' ' ' VAL . 18.6 pt-20 -61.09 -48.79 80.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.327 -0.858 . . . . 72.340000000000003 110.47 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.525 HG13 ' N ' ' B' ' 152' ' ' LEU . 9.8 p -64.84 -43.39 96.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.811 -1.181 . . . . 73.349999999999994 110.449 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.525 ' N ' HG13 ' B' ' 151' ' ' VAL . 12.9 tp -63.74 -53.62 48.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.14 -0.975 . . . . 55.240000000000002 110.518 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 16.5 p -72.23 -37.56 69.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.799 -1.188 . . . . 70.010000000000005 110.626 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -52.01 -53.49 41.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.76 -1.212 . . . . 65.319999999999993 109.706 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' B' ' 159' ' ' ARG . 2.7 pp -71.51 -23.09 61.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.93 -1.106 . . . . 71.540000000000006 109.865 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.66 -59.25 4.48 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.816 -1.177 . . . . 75.319999999999993 110.881 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -66.03 -47.73 73.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.601 -1.312 . . . . 73.319999999999993 108.84 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 158' ' ' HIS . . . . . 0.608 ' C ' ' H ' ' B' ' 160' ' ' ASP . 44.5 t-80 -67.51 -19.17 65.28 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.718 -1.216 . . . . 74.140000000000001 107.718 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . 0.723 ' O ' ' N ' ' B' ' 161' ' ' GLN . 7.2 tpt180 57.79 4.49 0.27 Allowed 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 107.287 -1.375 . . . . 61.409999999999997 107.287 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . 0.608 ' H ' ' C ' ' B' ' 158' ' ' HIS . 2.3 m-20 50.36 -40.22 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 123.228 0.611 . . . . 72.099999999999994 112.22 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . 0.723 ' N ' ' O ' ' B' ' 159' ' ' ARG . 24.1 mt-30 50.48 -142.63 0.65 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.215 -1.553 . . . . 72.25 109.138 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 162' ' ' ILE . . . . . 0.741 HD12 ' N ' ' B' ' 162' ' ' ILE . 1.9 mp -77.53 106.91 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.95 -1.094 . . . . 72.310000000000002 108.724 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . 0.588 HG13 ' O ' ' B' ' 160' ' ' ASP . 1.3 m -135.67 144.73 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.48 -0.763 . . . . 64.209999999999994 109.166 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 41.7 p -96.66 169.76 9.66 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.327 -0.858 . . . . 74.219999999999999 109.506 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -55.57 -39.68 70.98 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.297 -0.877 . . . . 65.310000000000002 109.168 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -62.74 -39.1 93.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.867 . . . . 63.450000000000003 109.313 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -60.13 -45.92 91.38 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.137 -0.977 . . . . 72.400000000000006 109.116 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 22.6 mt -61.94 -29.59 70.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.215 -0.928 . . . . 72.319999999999993 108.576 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.52 HD23 ' C ' ' B' ' 169' ' ' LEU . 5.6 tt -66.81 -64.86 0.77 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.467 -0.771 . . . . 73.340000000000003 109.303 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -61.36 -17.44 53.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.878 . . . . 72.099999999999994 109.713 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.72 -61.0 2.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.292 -0.88 . . . . 62.130000000000003 110.123 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 8.2 mm -90.91 -54.33 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.128 -0.983 . . . . 71.420000000000002 109.401 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.311 -0.868 . . . . 72.230000000000004 109.166 179.901 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo . . . . . 0 N--CA 1.501 1.918 0 CA-C-O 121.422 0.509 . . . . 65.219999999999999 112.674 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -174.86 -23.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.198 -0.939 . . . . 72.310000000000002 108.889 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . 0.43 ' O ' HG22 ' B' ' 186' ' ' VAL . 11.6 p -53.43 -14.47 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.397 -0.815 . . . . 63.32 109.401 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 20.9 mm -54.3 -25.74 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -0.879 . . . . 75.030000000000001 109.681 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -55.84 -45.4 78.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -0.952 . . . . 64.109999999999999 109.928 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . 0.435 HG22 ' H ' ' B' ' 186' ' ' VAL . 9.6 m -80.72 -30.39 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.131 -0.981 . . . . 73.0 110.105 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.97 76.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.95 -1.094 . . . . 61.119999999999997 109.938 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 188' ' ' ILE . . . . . 0.452 HG23 ' N ' ' B' ' 189' ' ' ASN . 10.4 tp -74.89 -38.9 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.554 -1.342 . . . . 72.430000000000007 109.83 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 189' ' ' ASN . . . . . 0.452 ' N ' HG23 ' B' ' 188' ' ' ILE . 21.7 t-20 -70.5 -35.99 73.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.878 . . . . 65.140000000000001 111.282 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 190' ' ' GLN . . . . . 0.458 ' CG ' ' N ' ' B' ' 191' ' ' ILE . 10.6 pt20 -76.67 -47.12 23.11 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.859 -1.151 . . . . 63.240000000000002 111.449 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . 0.458 ' N ' ' CG ' ' B' ' 190' ' ' GLN . 5.8 pt -65.0 -40.35 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.693 -1.255 . . . . 74.030000000000001 110.699 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -69.81 -42.97 72.98 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.026 -1.046 . . . . 72.239999999999995 111.005 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -74.21 -35.4 63.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.937 -1.102 . . . . 73.099999999999994 111.279 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 8.6 pttp -79.57 -24.35 42.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.82 -1.175 . . . . 72.109999999999999 110.54 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 195' ' ' MET . . . . . 0.483 ' SD ' ' OD1' ' B' ' 196' ' ' ASP . 3.5 ppp? -93.01 -38.2 11.78 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.0 -1.063 . . . . 44.329999999999998 110.519 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 196' ' ' ASP . . . . . 0.483 ' OD1' ' SD ' ' B' ' 195' ' ' MET . 85.3 m-20 -59.22 -38.23 79.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.035 -1.041 . . . . 71.209999999999994 110.646 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -63.28 -60.19 10.16 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.962 -1.086 . . . . 75.209999999999994 110.381 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 198' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.56 -59.58 0.24 Allowed 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 121.694 1.596 . . . . 75.319999999999993 112.402 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . 0.474 ' N ' HD12 ' B' ' 199' ' ' LEU . 10.6 mp -56.04 -42.45 76.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.994 -1.066 . . . . 72.25 109.203 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 82.34 -30.25 3.08 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.004 -1.239 . . . . 64.530000000000001 110.004 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 24.9 mm -91.44 129.11 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.025 -1.279 . . . . 44.229999999999997 109.435 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 42.0 t -88.13 139.76 30.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.83 . . . . 54.009999999999998 108.992 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 25.2 p -139.59 25.62 2.38 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.31 -0.869 . . . . 74.400000000000006 109.304 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.512 HG12 ' CD2' ' B' ' 214' ' ' PHE . 23.1 m -143.86 145.86 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.245 -0.909 . . . . 72.120000000000005 109.873 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -114.35 137.65 51.54 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.72 -0.613 . . . . 65.409999999999997 109.576 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.58 111.43 23.8 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.289 -0.882 . . . . 71.329999999999998 108.969 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.413 HG12 ' H ' ' B' ' 209' ' ' ARG . 3.7 t -138.36 142.38 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.286 -0.884 . . . . 63.5 109.498 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 208' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' B' ' 209' ' ' ARG . 32.7 ptt-85 -85.26 -24.65 27.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.216 -0.927 . . . . 74.450000000000003 109.642 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 209' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' B' ' 208' ' ' ARG . 96.0 mtt180 -57.5 -110.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.322 -0.861 . . . . 74.140000000000001 109.968 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 39.4 mmt-85 -51.12 -45.21 61.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.111 -0.993 . . . . 74.430000000000007 109.59 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 147.79 -130.83 3.64 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.35 -1.5 . . . . 64.450000000000003 109.35 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -104.59 131.24 52.24 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.365 -1.079 . . . . 74.209999999999994 108.779 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -105.01 146.52 28.94 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.437 -0.79 . . . . 74.030000000000001 109.902 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . 0.512 ' CD2' HG12 ' B' ' 204' ' ' VAL . 27.9 m-85 -128.39 104.12 7.53 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.408 -0.96 . . . . 74.340000000000003 108.408 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' B' ' 216' ' ' TYR . 50.8 t -127.66 169.01 14.26 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.2 -0.937 . . . . 64.329999999999998 110.49 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . 0.528 ' N ' ' SG ' ' B' ' 215' ' ' CYS . 47.6 m-85 -63.63 152.14 86.75 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.586 -0.696 . . . . 70.040000000000006 109.173 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.92 -162.08 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.212 1.941 . . . . 65.109999999999999 111.725 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 42.4 mttp . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.222 -0.924 . . . . 73.150000000000006 109.018 179.746 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.2 ttm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.435 -0.579 . . . . 65.120000000000005 109.435 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.437 ' N ' ' OD2' ' A' ' 46' ' ' ASP . 61.2 ttm-85 -143.08 150.75 39.94 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.263 -0.898 . . . . 72.329999999999998 109.322 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 81.4 t -120.25 134.82 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-O 121.5 0.667 . . . . 71.420000000000002 110.091 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.401 ' O ' ' O ' ' A' ' 49' ' ' MET . 8.9 tp -100.25 115.97 31.14 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.645 -0.872 . . . . 65.120000000000005 108.645 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.482 HD12 ' SD ' ' A' ' 49' ' ' MET . 25.2 tp -117.39 99.55 7.08 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.582 -0.699 . . . . 62.43 109.756 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.485 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 7.8 mt -94.35 119.36 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.753 -1.217 . . . . 71.150000000000006 108.953 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -149.26 121.9 8.61 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.199 -0.938 . . . . 75.340000000000003 109.603 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -65.84 -32.97 74.79 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.265 -0.897 . . . . 72.439999999999998 108.996 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -87.27 107.34 18.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.355 -0.841 . . . . 63.020000000000003 109.363 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.2 t -65.99 -18.37 65.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 72.340000000000003 109.671 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.45 -55.82 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.16 -0.963 . . . . 74.019999999999996 109.904 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.603 ' N ' HD22 ' A' ' 12' ' ' LEU . 3.5 mm? -69.39 -38.86 78.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.255 -0.903 . . . . 71.430000000000007 109.557 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.13 -28.67 63.84 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.693 -1.763 . . . . 61.32 108.693 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.28 -45.51 95.01 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.515 -1.434 . . . . 71.200000000000003 109.515 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.598 ' OE2' HD13 ' A' ' 12' ' ' LEU . 15.0 pt-20 -67.46 -45.91 74.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -1.129 . . . . 71.319999999999993 109.905 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 98.6 mt -64.0 -42.03 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.623 -1.298 . . . . 63.229999999999997 108.641 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -54.01 -50.81 65.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.901 . . . . 51.109999999999999 109.521 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -85.11 1.98 45.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.123 -0.986 . . . . 73.340000000000003 109.076 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.97 -60.73 2.01 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 109.737 -1.345 . . . . 62.149999999999999 109.737 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -69.46 -22.9 63.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.203 -1.175 . . . . 73.510000000000005 109.796 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.402 HD21 ' HB3' ' A' ' 27' ' ' ALA . 3.3 m120 -59.05 -32.89 70.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.04 -1.037 . . . . 74.25 109.339 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.4 t -58.71 -34.04 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.445 -0.785 . . . . 70.040000000000006 109.374 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.521 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 2.4 mptp? -68.39 -1.21 5.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 73.230000000000004 109.315 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.37 35.09 11.04 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.74 -1.344 . . . . 75.540000000000006 109.74 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -115.78 159.62 21.2 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.488 -1.007 . . . . 73.430000000000007 109.143 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.7 mmt -104.09 138.13 41.05 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.45 -0.945 . . . . 43.240000000000002 108.45 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.402 ' HB3' HD21 ' A' ' 21' ' ' ASN . . . -143.75 164.2 31.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.913 . . . . 62.109999999999999 109.771 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -139.08 149.88 45.08 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.434 -0.791 . . . . 74.420000000000002 108.977 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.48 129.0 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.705 -0.85 . . . . 72.150000000000006 108.705 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.3 p -133.1 167.93 19.44 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.452 -0.78 . . . . 71.420000000000002 109.752 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.485 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 3.0 pt-20 -98.6 -96.14 0.23 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.398 -0.814 . . . . 72.329999999999998 109.747 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.5 p -79.96 164.25 23.64 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.015 -1.053 . . . . 74.239999999999995 110.007 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 37' ' ' GLU . 21.8 mt -54.77 -38.95 67.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.513 -0.742 . . . . 71.530000000000001 109.819 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -52.57 -44.21 65.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 74.230000000000004 109.814 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -65.3 -42.47 93.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.107 -0.996 . . . . 54.030000000000001 109.665 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.03 -30.6 50.81 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.062 -1.215 . . . . 61.409999999999997 110.062 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 33' ' ' LEU . 78.2 tt0 -66.74 -46.45 75.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.126 -1.22 . . . . 74.340000000000003 110.099 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.442 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 48.2 m-85 -78.92 -24.11 44.27 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.092 -1.005 . . . . 75.329999999999998 109.959 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.8 tp -85.49 -29.23 24.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.005 -1.06 . . . . 74.329999999999998 109.81 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.562 ' SD ' ' CE1' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -86.82 -36.81 18.29 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.069 -1.02 . . . . 70.319999999999993 110.633 -179.164 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 30.5 p-10 -58.73 -30.77 67.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.935 -1.103 . . . . 71.219999999999999 110.238 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.531 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 10.1 pt -78.17 -31.64 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.071 -1.018 . . . . 74.140000000000001 110.104 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 40' ' ' MET . 79.9 mtt85 -108.44 171.82 7.19 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.341 -0.849 . . . . 72.239999999999995 109.682 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.494 ' ND2' ' H ' ' A' ' 45' ' ' TYR . 1.8 t-20 -86.93 148.73 25.22 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.203 -0.936 . . . . 75.420000000000002 109.184 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.565 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 0.5 OUTLIER -139.0 128.65 24.63 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.282 -0.886 . . . . 74.230000000000004 109.509 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.446 ' OD1' ' CD2' ' A' ' 113' ' ' LEU . 3.7 p30 -108.08 -41.99 4.78 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.844 -0.798 . . . . 72.040000000000006 108.844 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.473 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.3 OUTLIER -103.8 112.84 25.97 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.074 -1.084 . . . . 72.129999999999995 108.074 179.335 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.473 ' N ' HD13 ' A' ' 47' ' ' LEU . 21.9 t -100.24 96.86 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.445 -0.946 . . . . 72.340000000000003 108.445 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.482 ' SD ' HD12 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -116.47 123.87 48.55 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.685 0.755 . . . . 74.109999999999999 109.857 -179.477 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.58 HG22 ' H ' ' A' ' 52' ' ' ASP . 1.1 p -131.21 131.93 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 121.632 0.729 . . . . 61.119999999999997 109.41 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.2 p -91.38 3.5 54.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.522 -0.736 . . . . 73.109999999999999 109.303 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.58 ' H ' HG22 ' A' ' 50' ' ' VAL . 1.6 m-20 -78.99 138.34 38.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.269 -0.894 . . . . 52.549999999999997 109.6 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.516 ' NZ ' ' OD1' ' A' ' 77' ' ' ASN . 14.9 mmmt -76.83 -36.18 57.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.214 -0.929 . . . . 44.219999999999999 110.11 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -70.54 12.38 0.26 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.081 -1.012 . . . . 70.439999999999998 109.537 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -69.25 -20.9 63.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.412 -0.805 . . . . 64.140000000000001 110.399 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 55' ' ' ALA . 20.3 mt -40.0 -50.46 2.55 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.468 -0.77 . . . . 44.140000000000001 110.395 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.7 t -69.08 -33.56 73.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.033 -1.042 . . . . 55.229999999999997 108.957 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.615 ' CE2' HD11 ' A' ' 62' ' ' ILE . 50.9 t80 -66.91 -59.32 3.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.468 -0.77 . . . . 74.439999999999998 109.938 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.1 m -52.22 -34.14 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.715 -1.24 . . . . 74.030000000000001 109.492 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.5 m -58.49 -54.02 51.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.2 -0.938 . . . . 64.299999999999997 109.715 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -66.85 -27.86 67.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.111 -0.993 . . . . 64.439999999999998 109.978 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.615 HD11 ' CE2' ' A' ' 58' ' ' PHE . 5.6 mm -67.05 -45.73 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.901 -1.124 . . . . 63.210000000000001 110.185 -179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 67' ' ' SER . 53.7 mmtt -65.16 -46.44 80.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 74.420000000000002 110.645 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 6.6 pt-20 -70.35 -41.83 72.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.716 -1.24 . . . . 70.319999999999993 109.953 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.491 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 25.9 mtpp -76.29 -19.12 58.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.143 -0.973 . . . . 75.219999999999999 109.313 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.532 ' O ' HG22 ' A' ' 69' ' ' ILE . 83.2 m-70 -156.29 68.1 0.6 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.888 . . . . 74.129999999999995 109.282 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 63' ' ' LYS . 82.5 p -65.49 -15.87 63.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 73.239999999999995 109.914 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 92.8 p -88.32 43.82 1.16 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.191 -0.943 . . . . 61.009999999999998 110.329 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 66' ' ' HIS . 16.9 tt -145.11 169.13 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.989 -1.069 . . . . 71.329999999999998 109.582 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.1 t -102.1 148.66 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.263 -0.898 . . . . 72.129999999999995 109.424 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.5 t -131.5 126.49 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.376 -0.828 . . . . 54.210000000000001 109.76 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 72' ' ' LEU . 3.8 tt -120.11 100.97 7.51 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.111 -0.7 . . . . 50.240000000000002 109.111 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 73' ' ' VAL . 8.7 p -97.09 131.32 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.982 -1.074 . . . . 74.409999999999997 109.153 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 75' ' ' SER . 4.5 p -92.86 174.98 6.97 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.086 -1.009 . . . . 72.310000000000002 109.378 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.472 ' OG ' ' CE2' ' A' ' 94' ' ' TYR . 50.9 m -164.49 116.09 1.26 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.083 -1.01 . . . . 64.540000000000006 110.371 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.8 -28.56 68.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.525 -0.734 . . . . 74.129999999999995 109.306 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.516 ' OD1' ' NZ ' ' A' ' 53' ' ' LYS . 13.0 p30 -109.6 71.13 0.52 Allowed Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.657 -0.652 . . . . 73.340000000000003 109.41 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.01 80.45 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.654 1.569 . . . . 63.219999999999999 111.769 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.63 HG23 ' H ' ' A' ' 82' ' ' GLU . 1.8 t -104.72 162.49 13.25 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.656 -0.868 . . . . 62.530000000000001 108.656 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.8 p -71.36 -29.11 64.59 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.166 -0.959 . . . . 73.439999999999998 109.864 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -62.77 -45.57 92.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 71.420000000000002 109.475 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.63 ' H ' HG23 ' A' ' 79' ' ' THR . 74.8 tt0 -76.49 -29.72 56.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.281 -0.887 . . . . 73.430000000000007 109.639 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -63.73 -57.01 11.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.954 . . . . 74.219999999999999 109.611 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.519 HG23 ' N ' ' A' ' 85' ' ' HIS . 27.2 m -60.34 -42.18 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.14 -0.975 . . . . 73.200000000000003 108.987 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.527 ' CE1' HE21 ' A' ' 89' ' ' GLN . 82.4 t60 -62.95 -35.44 80.12 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.298 -0.876 . . . . 53.329999999999998 109.219 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.82 -37.38 84.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.416 -0.803 . . . . 64.109999999999999 109.861 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -77.08 -29.91 55.19 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.047 -1.033 . . . . 74.340000000000003 108.818 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.34 -36.3 68.79 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.714 -0.794 . . . . 74.420000000000002 109.229 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.527 HE21 ' CE1' ' A' ' 85' ' ' HIS . 90.2 mm-40 -66.58 -51.29 58.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.364 -0.835 . . . . 74.239999999999995 109.478 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.85 44.3 0.06 OUTLIER Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.742 -1.343 . . . . 61.509999999999998 109.742 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -99.72 135.88 40.47 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.21 -1.171 . . . . 55.329999999999998 109.416 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.524 ' OD2' ' NH1' ' A' ' 112' ' ' ARG . 45.9 t0 -82.38 -25.05 34.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 73.420000000000002 109.314 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.528 ' OD2' ' NH2' ' A' ' 112' ' ' ARG . 72.0 m-20 -149.75 155.76 40.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.349 -0.845 . . . . 75.040000000000006 109.249 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.472 ' CE2' ' OG ' ' A' ' 75' ' ' SER . 55.3 t80 -137.4 103.38 5.06 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.735 -0.839 . . . . 71.329999999999998 108.735 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.511 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -107.6 151.94 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.651 0.738 . . . . 71.129999999999995 110.001 -177.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.36 130.27 39.35 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.693 -1.225 . . . . 64.319999999999993 107.693 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.697 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -49.89 -55.67 22.34 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 120.988 -1.07 . . . . 62.200000000000003 111.835 -178.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 2.2 Cg_endo -40.21 -11.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 120.895 1.063 . . . . 73.109999999999999 113.101 -176.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.697 ' N ' ' O ' ' A' ' 97' ' ' LYS . 56.5 m-85 59.08 121.07 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.644 -0.66 . . . . 65.219999999999999 110.189 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.587 ' HE ' ' CB ' ' B' ' 80' ' ' SER . 0.0 OUTLIER -56.71 -46.63 81.15 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.047 -1.094 . . . . 72.349999999999994 108.047 179.077 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.764 ' O ' ' N ' ' A' ' 103' ' ' LYS . 22.7 t -175.11 53.69 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.236 -0.915 . . . . 71.319999999999993 110.498 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 11.4 mm 49.08 -69.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.591 -0.693 . . . . 75.430000000000007 110.796 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.764 ' N ' ' O ' ' A' ' 101' ' ' SER . 2.4 mppt? -55.29 -18.34 6.17 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.988 -1.116 . . . . 71.409999999999997 107.988 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.08 -97.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.582 -0.699 . . . . 63.240000000000002 110.405 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.632 ' N ' HD23 ' A' ' 105' ' ' LEU . 2.0 pt? -49.83 -36.18 25.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.137 -0.977 . . . . 73.219999999999999 110.226 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.48 -39.85 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.881 -1.137 . . . . 60.109999999999999 108.903 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 103' ' ' LYS . . . -64.13 -31.86 73.21 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.193 -0.942 . . . . 70.420000000000002 108.57 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.1 ttp-105 -81.91 -24.83 35.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.457 -0.777 . . . . 74.409999999999997 109.745 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 65.6 mt -75.53 -37.4 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.032 -1.043 . . . . 62.539999999999999 108.705 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.442 ' OE1' ' NZ ' ' A' ' 23' ' ' LYS . 11.8 pt-20 -76.21 -35.33 59.1 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.561 -0.856 . . . . 74.340000000000003 109.353 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.71 -45.35 94.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.431 -0.793 . . . . 73.319999999999993 109.863 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.528 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 23.3 ttm180 -66.06 -50.83 62.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.119 -0.988 . . . . 52.409999999999997 109.596 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 113' ' ' LEU . 10.1 mp -95.51 38.29 1.16 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.14 -0.975 . . . . 65.239999999999995 109.206 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.37 -55.2 5.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.262 -0.899 . . . . 64.450000000000003 109.176 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -85.07 13.53 6.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -0.869 . . . . 74.430000000000007 109.617 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 60.4 t-105 -48.98 105.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 74.420000000000002 109.537 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 157.85 -136.89 5.04 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.629 -1.388 . . . . 75.040000000000006 109.629 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.8 t 54.21 177.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.425 -1.044 . . . . 61.140000000000001 110.049 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.7 150.71 26.53 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.059 -0.719 . . . . 65.239999999999995 109.059 -178.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.0 t -90.31 -41.48 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.155 -0.966 . . . . 73.109999999999999 109.581 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 17.1 mm -100.13 135.84 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.348 -0.845 . . . . 72.239999999999995 109.586 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -148.54 127.18 12.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 72.340000000000003 109.048 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.436 ' O ' HG23 ' A' ' 123' ' ' ILE . 6.5 tp -154.42 128.09 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 71.439999999999998 108.994 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 53.47 -139.4 35.02 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.946 -1.661 . . . . 73.400000000000006 108.946 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 125' ' ' ASP . 14.3 p-10 -93.51 6.39 48.38 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.089 -1.242 . . . . 74.450000000000003 109.154 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.05 135.14 38.23 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.638 -0.875 . . . . 54.210000000000001 108.638 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.1 m -131.97 138.63 48.38 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.405 -0.809 . . . . 54.5 109.408 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.8 mt -138.85 139.92 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.332 -0.855 . . . . 45.149999999999999 109.184 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.8 m -123.36 82.33 52.65 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.604 -0.685 . . . . 71.109999999999999 109.392 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.46 -41.09 75.93 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.56 2.174 . . . . 65.409999999999997 112.115 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -56.07 -44.78 79.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 63.32 109.064 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -87.15 2.13 50.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.409 -0.807 . . . . 72.519999999999996 108.868 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 1.28 ' HB3' ' CZ ' ' A' ' 149' ' ' PHE . 21.4 mt-10 49.71 61.75 3.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.422 -0.798 . . . . 75.329999999999998 109.058 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -149.02 135.61 19.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.252 -0.905 . . . . 71.230000000000004 109.808 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 11.6 tt -107.86 136.24 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.434 -0.95 . . . . 74.019999999999996 108.434 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 47.7 mt -128.86 125.18 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.364 -0.835 . . . . 60.229999999999997 109.947 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.431 ' N ' ' CD1' ' A' ' 137' ' ' TYR . 16.5 p90 -139.3 147.25 41.38 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.454 -0.779 . . . . 62.32 109.152 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 54.9 mttp 54.33 23.87 4.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.451 -0.78 . . . . 75.400000000000006 110.05 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 79.44 -1.35 77.15 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.44 -1.064 . . . . 72.239999999999995 110.44 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -90.17 135.53 33.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.953 -1.322 . . . . 71.219999999999999 108.89 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -101.52 131.07 47.88 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.401 -0.812 . . . . 71.420000000000002 109.695 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 49.8 t -137.81 127.65 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.956 -0.757 . . . . 53.020000000000003 108.956 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -81.36 139.28 35.43 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.254 -0.904 . . . . 60.450000000000003 109.336 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.404 ' O ' ' CD1' ' A' ' 149' ' ' PHE . 12.2 m -142.6 137.09 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.252 -0.905 . . . . 74.439999999999998 109.53 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 1.136 ' HA ' ' CG ' ' A' ' 149' ' ' PHE . 49.5 pttt -171.45 28.57 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 65.150000000000006 109.214 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.19 -145.8 3.33 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.93 -1.268 . . . . 73.340000000000003 109.93 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -70.87 -38.61 7.61 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 121.357 -1.084 . . . . 72.219999999999999 110.426 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 90.5 Cg_endo -86.66 11.82 3.17 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.008 1.806 . . . . 65.230000000000004 111.853 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 1.28 ' CZ ' ' HB3' ' A' ' 133' ' ' GLU . 32.3 t80 -79.75 -34.83 39.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.418 -0.801 . . . . 60.109999999999999 109.425 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -74.41 -38.03 63.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 64.209999999999994 110.168 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.518 HG13 ' N ' ' A' ' 152' ' ' LEU . 11.5 p -74.76 -40.58 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.09 -1.006 . . . . 72.019999999999996 109.506 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.518 ' N ' HG13 ' A' ' 151' ' ' VAL . 20.4 tp -58.94 -45.63 89.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 73.310000000000002 109.216 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.7 p -65.82 -37.08 85.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 74.310000000000002 109.373 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -52.94 -54.96 27.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.374 -0.829 . . . . 74.310000000000002 109.94 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.67 HD12 ' N ' ' A' ' 156' ' ' ALA . 4.4 pp -76.33 -19.6 58.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 75.340000000000003 110.067 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.67 ' N ' HD12 ' A' ' 155' ' ' LEU . . . -61.68 -45.28 94.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.009 -1.057 . . . . 62.140000000000001 109.464 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.445 ' C ' ' H ' ' A' ' 159' ' ' ARG . 60.4 mtp180 -79.55 -51.58 9.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.185 -0.947 . . . . 61.030000000000001 109.35 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.406 ' C ' ' H ' ' A' ' 160' ' ' ASP . 62.0 m170 -73.32 43.5 0.13 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.487 -0.758 . . . . 74.120000000000005 109.172 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.765 HH12 ' NE2' ' B' ' 161' ' ' GLN . 0.2 OUTLIER -74.72 30.77 0.09 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.579 -0.7 . . . . 71.129999999999995 110.213 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 158' ' ' HIS . 63.3 t0 -165.2 66.4 0.13 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.922 -1.111 . . . . 75.450000000000003 110.131 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.562 HE22 ' CG2' ' A' ' 163' ' ' VAL . 2.1 pp0? -177.89 178.75 0.93 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.125 -0.984 . . . . 73.409999999999997 109.802 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 14.1 mm -97.44 125.67 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.309 -0.869 . . . . 74.409999999999997 109.358 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.562 ' CG2' HE22 ' A' ' 161' ' ' GLN . 18.6 t -104.5 132.82 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.376 -0.827 . . . . 72.310000000000002 109.197 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.7 t -87.31 141.59 28.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.15 -0.969 . . . . 74.120000000000005 109.321 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.439 ' O ' HD13 ' A' ' 184' ' ' ILE . 33.1 mttt -51.69 -45.63 63.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 70.430000000000007 108.77 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -56.55 -37.64 70.8 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 73.519999999999996 109.1 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.17 -40.87 71.17 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.158 -0.964 . . . . 74.519999999999996 109.296 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 74.8 mt -62.62 -49.17 76.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 72.310000000000002 109.918 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.4 tp -75.77 -65.46 0.9 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.787 -1.195 . . . . 53.329999999999998 109.84 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -39.45 -31.01 0.08 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 122.164 -0.335 . . . . 62.439999999999998 111.892 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.75 -39.88 9.64 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.774 -1.204 . . . . 60.210000000000001 112.519 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.528 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 1.3 mp -85.31 -60.16 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 120.535 -1.353 . . . . 75.319999999999993 111.709 -177.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.464 ' C ' ' CD2' ' A' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 O-C-N 120.79 -1.194 . . . . 73.140000000000001 110.049 -177.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 108.395 -0.965 . . . . 64.540000000000006 108.395 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.406 HG23 ' H ' ' A' ' 185' ' ' GLU . 26.8 m -62.05 -135.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.541 -0.724 . . . . 74.019999999999996 110.365 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 165' ' ' LYS . 57.3 mt -62.9 -31.87 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.287 -0.883 . . . . 72.329999999999998 109.636 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.406 ' H ' HG23 ' A' ' 183' ' ' VAL . 47.4 tt0 -45.64 -56.3 5.36 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.594 -0.692 . . . . 74.400000000000006 110.3 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 87.3 t -80.9 -52.69 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -0.946 . . . . 70.420000000000002 110.54 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -46.06 -47.47 17.08 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.023 -1.048 . . . . 52.109999999999999 110.387 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.509 HD13 ' O ' ' A' ' 188' ' ' ILE . 0.2 OUTLIER -71.95 -46.86 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.837 -1.164 . . . . 71.400000000000006 109.693 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.461 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 46.8 t-20 -56.13 -40.88 74.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.951 -1.093 . . . . 73.439999999999998 110.334 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 194' ' ' LYS . 25.6 mt-30 -72.9 -48.24 38.91 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.027 -1.045 . . . . 71.420000000000002 110.298 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 58.5 mt -49.12 -36.18 8.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 120.65 -1.281 . . . . 61.549999999999997 110.242 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 20.7 mtm-85 -76.04 -59.21 2.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.856 -1.153 . . . . 63.340000000000003 111.057 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.43 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 86.6 mt-30 -71.08 -14.53 62.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.13 -0.981 . . . . 61.240000000000002 110.775 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 190' ' ' GLN . 33.3 ttpt -91.17 -36.88 13.7 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.17 -0.956 . . . . 75.129999999999995 110.042 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 9.3 tpt -89.89 -4.1 57.72 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.294 -0.879 . . . . 74.019999999999996 109.701 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 197' ' ' LYS . 33.7 p-10 -68.2 -44.31 76.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.089 -1.007 . . . . 74.019999999999996 110.652 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.537 ' N ' ' OD1' ' A' ' 196' ' ' ASP . 8.9 mttm -75.84 -53.44 2.42 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.944 -1.098 . . . . 75.430000000000007 110.017 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -47.03 -61.36 0.62 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.899 1.733 . . . . 72.319999999999993 112.214 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 33.8 tp -70.61 -43.72 68.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 74.540000000000006 109.314 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 91.38 -19.45 47.06 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.985 -1.246 . . . . 61.509999999999998 109.985 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 29.9 mm -111.32 133.44 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.415 -1.05 . . . . 61.219999999999999 109.576 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 14.4 t -85.35 134.42 34.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 72.0 109.123 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 43.9 p -144.23 29.05 1.32 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.238 -0.914 . . . . 74.439999999999998 109.595 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.48 125.2 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.386 -0.821 . . . . 64.349999999999994 109.483 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -107.12 129.07 54.88 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.485 -0.759 . . . . 71.409999999999997 109.147 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 81.0 p -93.35 120.71 33.94 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.21 -0.932 . . . . 73.519999999999996 109.414 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.51 HG22 ' H ' ' A' ' 209' ' ' ARG . 7.3 p -137.49 143.1 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.366 -0.834 . . . . 71.019999999999996 109.051 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -75.69 -33.06 60.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 72.120000000000005 110.067 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 211' ' ' GLY . 44.9 mmm-85 -60.97 145.89 48.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.098 -1.001 . . . . 64.409999999999997 109.553 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 64.1 mtp85 48.64 -91.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.386 -0.821 . . . . 71.540000000000006 109.734 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . -160.27 -124.99 0.76 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.494 -1.443 . . . . 72.030000000000001 109.494 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -101.5 141.84 33.76 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.352 -1.087 . . . . 75.540000000000006 109.236 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.474 ' NH1' ' SG ' ' A' ' 215' ' ' CYS . 66.1 ttt-85 -109.03 127.28 53.96 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.514 -0.741 . . . . 75.310000000000002 109.789 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -109.66 124.02 50.47 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.646 -0.872 . . . . 75.409999999999997 108.646 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . 0.474 ' SG ' ' NH1' ' A' ' 213' ' ' ARG . 4.8 p -140.91 167.32 22.48 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.34 -0.85 . . . . 74.140000000000001 109.923 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -61.71 150.78 80.89 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.384 -0.823 . . . . 75.319999999999993 108.947 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo . . . . . 0 C--N 1.315 -1.189 0 C-N-CA 121.852 1.701 . . . . 73.109999999999999 111.99 179.804 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.566 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.418 -0.586 . . . . 71.140000000000001 109.418 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 1.217 ' CZ ' ' NH2' ' B' ' 43' ' ' ARG . 88.9 mtt-85 -131.21 142.34 50.17 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.507 -0.745 . . . . 73.230000000000004 109.721 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 88.2 t -107.7 123.07 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.611 -0.681 . . . . 72.239999999999995 109.709 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.58 HD11 ' CG1' ' B' ' 6' ' ' ILE . 2.4 tp -91.24 114.43 26.95 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.094 -1.076 . . . . 54.329999999999998 108.094 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 4.4 tp -117.11 111.71 19.87 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.912 -0.773 . . . . 74.349999999999994 108.912 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.58 ' CG1' HD11 ' B' ' 4' ' ' LEU . 20.0 mt -106.59 123.58 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.445 -0.785 . . . . 42.549999999999997 109.02 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -140.41 120.25 13.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.345 -0.847 . . . . 74.519999999999996 109.274 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -66.44 -30.81 71.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.158 -0.963 . . . . 62.549999999999997 109.283 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -64.24 -128.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.217 -0.927 . . . . 73.109999999999999 109.033 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 79.2 p -167.06 -66.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.11 -0.994 . . . . 65.540000000000006 109.658 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.472 HG13 ' N ' ' B' ' 12' ' ' LEU . 9.6 p -67.52 -40.96 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 75.549999999999997 109.907 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.472 ' N ' HG13 ' B' ' 11' ' ' VAL . 3.6 mm? -52.14 -43.23 63.93 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.024 -1.048 . . . . 70.140000000000001 108.725 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.94 -28.35 68.85 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 108.508 -1.837 . . . . 75.400000000000006 108.508 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.61 -51.52 53.42 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 109.72 -1.352 . . . . 65.439999999999998 109.72 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -60.82 -45.04 96.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -1.114 . . . . 60.210000000000001 109.931 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 5.6 mm -67.26 -38.73 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.828 -1.17 . . . . 75.150000000000006 108.924 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.525 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 84.0 tt0 -62.73 -42.52 99.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 73.010000000000005 109.791 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -88.58 -0.53 57.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.931 -1.106 . . . . 74.299999999999997 108.916 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.1 -53.39 3.32 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 109.551 -1.419 . . . . 70.540000000000006 109.551 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -73.83 -24.59 59.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -1.121 . . . . 71.340000000000003 109.654 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 96.2 m-20 -58.96 -34.75 72.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.158 -0.964 . . . . 64.409999999999997 109.485 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 90.9 t -55.74 -45.29 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.416 -0.802 . . . . 74.230000000000004 109.379 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 50.3 mmtt -54.2 -49.67 68.85 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.382 -0.824 . . . . 63.420000000000002 108.827 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.77 41.21 0.15 Allowed Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.1 -1.2 . . . . 53.43 110.1 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -120.38 160.13 23.69 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.395 -1.062 . . . . 71.120000000000005 109.532 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.1 mmt -100.47 139.41 36.2 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.957 -1.127 . . . . 75.239999999999995 107.957 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.28 160.43 41.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.168 -0.957 . . . . 72.120000000000005 110.314 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -135.2 141.31 45.82 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.607 -0.886 . . . . 72.310000000000002 108.607 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 1.1 m -107.59 126.96 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.332 -0.855 . . . . 64.430000000000007 109.103 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.7 p -125.13 161.85 25.9 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.616 -0.678 . . . . 65.409999999999997 109.25 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.466 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 1.7 pt-20 -88.2 -97.67 0.09 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.27 -0.894 . . . . 71.019999999999996 109.796 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.3 t -78.8 152.39 31.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.895 . . . . 51.109999999999999 110.007 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.564 ' H ' HD12 ' B' ' 33' ' ' LEU . 1.6 mp -50.59 -26.29 5.14 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.562 -0.711 . . . . 71.239999999999995 109.711 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -58.61 -48.29 81.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.96 . . . . 74.319999999999993 109.872 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.466 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 68.5 m-20 -59.88 -43.74 94.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.969 . . . . 73.030000000000001 109.258 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.06 -29.59 68.71 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.2 -1.56 . . . . 30.210000000000001 109.2 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -65.66 -43.66 88.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.358 -1.084 . . . . 74.420000000000002 109.816 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -80.28 -33.5 37.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.997 -1.064 . . . . 74.420000000000002 109.57 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 11.3 tp -72.88 -39.23 66.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.345 -0.847 . . . . 75.409999999999997 109.776 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . 0.43 ' O ' ' O ' ' B' ' 43' ' ' ARG . 2.9 ppp? -75.79 -21.93 56.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.962 . . . . 60.409999999999997 109.833 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -60.73 -35.85 77.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.135 -0.978 . . . . 53.229999999999997 109.531 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 11.3 pt -92.4 -24.81 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.28 -0.888 . . . . 71.230000000000004 110.031 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 1.217 ' NH2' ' CZ ' ' B' ' 2' ' ' ARG . 54.4 mtp180 -124.9 139.47 53.8 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.335 -0.853 . . . . 72.219999999999999 109.537 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -101.35 143.38 31.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.3 -0.875 . . . . 63.539999999999999 109.62 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -114.85 143.5 45.01 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.967 -0.753 . . . . 64.349999999999994 108.967 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' B' ' 2' ' ' ARG . 8.3 p-10 -82.08 -36.92 27.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.077 -1.015 . . . . 62.219999999999999 109.276 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.508 HD13 ' C ' ' B' ' 47' ' ' LEU . 0.8 OUTLIER -109.41 109.72 20.65 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.639 -0.875 . . . . 73.120000000000005 108.639 179.608 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.446 ' N ' HD13 ' B' ' 47' ' ' LEU . 63.5 t -94.46 100.57 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.282 -0.886 . . . . 65.109999999999999 109.197 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 0.3 OUTLIER -116.93 124.98 50.76 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.669 -0.863 . . . . 73.439999999999998 108.669 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.85 130.43 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.278 -0.889 . . . . 34.5 109.342 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 75.4 p -107.21 27.92 8.58 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.691 -0.631 . . . . 73.209999999999994 109.54 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -86.86 159.02 19.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -0.927 . . . . 70.409999999999997 109.486 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' B' ' 55' ' ' ALA . 94.0 mttt -81.63 175.8 10.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.321 -0.862 . . . . 65.0 109.375 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . 0.465 ' C ' ' ND2' ' B' ' 54' ' ' ASN . 0.3 OUTLIER 44.58 16.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.602 -0.686 . . . . 75.209999999999994 109.86 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' B' ' 53' ' ' LYS . . . -74.48 -20.55 59.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 55.329999999999998 109.185 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 24.6 mt -42.79 -46.73 5.3 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.631 -0.668 . . . . 63.140000000000001 110.342 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 58.7 m -65.54 -37.22 86.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.971 -1.081 . . . . 63.5 109.659 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . 0.467 ' CZ ' HD11 ' B' ' 62' ' ' ILE . 67.1 t80 -63.21 -59.99 4.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 72.329999999999998 109.898 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 15.4 m -49.59 -35.68 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.735 -1.228 . . . . 74.540000000000006 109.764 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . 0.428 ' OG ' ' N ' ' B' ' 61' ' ' ARG . 13.0 p -58.11 -55.04 40.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.095 -1.003 . . . . 71.239999999999995 109.752 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.428 ' N ' ' OG ' ' B' ' 60' ' ' SER . 11.3 ptp180 -64.48 -27.47 69.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.064 -1.023 . . . . 74.310000000000002 110.042 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.467 HD11 ' CZ ' ' B' ' 58' ' ' PHE . 28.2 mm -64.74 -41.54 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.784 -1.197 . . . . 72.140000000000001 109.936 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.476 ' NZ ' ' O ' ' B' ' 90' ' ' GLY . 19.1 mmtp -69.65 -48.83 58.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.94 -1.1 . . . . 73.319999999999993 110.551 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -66.7 -35.93 81.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.759 -1.213 . . . . 73.120000000000005 109.807 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.421 ' C ' ' CG ' ' B' ' 66' ' ' HIS . 9.7 mtpm? -82.13 -25.29 34.53 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.166 -0.959 . . . . 72.439999999999998 109.702 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.421 ' CG ' ' C ' ' B' ' 65' ' ' LYS . 65.6 m-70 -152.73 68.01 0.83 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.164 -0.96 . . . . 63.310000000000002 109.516 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 86.6 p -64.4 -25.8 68.18 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.359 -0.838 . . . . 73.099999999999994 109.885 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 17.8 p -66.02 -9.19 28.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.179 -0.951 . . . . 71.530000000000001 109.883 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 56.9 mt -102.11 151.26 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.351 -0.843 . . . . 74.400000000000006 109.468 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.551 HG12 ' N ' ' B' ' 71' ' ' VAL . 76.6 t -87.39 165.54 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.249 -0.907 . . . . 75.120000000000005 109.486 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.551 ' N ' HG12 ' B' ' 70' ' ' VAL . 2.9 t -145.7 122.71 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.966 -1.084 . . . . 73.200000000000003 109.824 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.521 ' HG ' HD11 ' B' ' 95' ' ' ILE . 2.9 mp -120.36 105.4 10.87 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.483 -0.932 . . . . 73.340000000000003 108.483 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.463 ' O ' HG13 ' B' ' 73' ' ' VAL . 14.7 p -95.35 130.91 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.209 -0.932 . . . . 73.5 109.019 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 2.5 p -89.5 170.19 10.72 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.104 -0.997 . . . . 64.340000000000003 109.203 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 26.4 t -161.22 114.54 1.95 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.092 -1.005 . . . . 74.530000000000001 109.942 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -62.8 -36.7 84.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.173 -0.954 . . . . 64.5 108.81 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . 0.407 ' OD1' ' N ' ' B' ' 77' ' ' ASN . 13.0 p-10 -112.39 87.4 9.34 Favored Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 108.668 -0.864 . . . . 74.25 108.668 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -72.16 78.78 1.82 Allowed 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.51 1.473 . . . . 74.430000000000007 111.875 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 77.2 p -83.01 152.33 25.45 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.034 -1.098 . . . . 73.120000000000005 108.034 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . 0.587 ' CB ' ' HE ' ' A' ' 100' ' ' ARG . 0.5 OUTLIER -63.96 -35.74 81.67 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.011 -1.056 . . . . 71.010000000000005 109.89 -179.239 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . 0.496 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 24.0 pt-20 -60.55 -36.82 79.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.129 -0.982 . . . . 63.200000000000003 109.373 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -73.63 -33.55 64.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.213 -0.929 . . . . 73.219999999999999 109.565 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -62.74 -52.36 63.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.901 . . . . 74.299999999999997 109.722 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 18.8 m -61.09 -39.3 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.111 -0.993 . . . . 73.310000000000002 109.34 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' HIS . . . . . 0.496 ' ND1' ' O ' ' B' ' 81' ' ' GLU . 25.0 m80 -66.59 -30.66 71.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 73.239999999999995 109.351 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -65.37 -43.35 91.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 55.329999999999998 109.693 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -80.22 -35.04 36.79 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.185 -0.947 . . . . 74.140000000000001 109.019 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -63.13 -50.43 70.46 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.425 -0.797 . . . . 64.040000000000006 109.074 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -60.45 -52.68 64.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.544 -0.723 . . . . 72.349999999999994 109.836 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . 0.476 ' O ' ' NZ ' ' B' ' 63' ' ' LYS . . . 155.16 -15.08 0.49 Allowed Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.649 -1.262 . . . . 65.200000000000003 110.588 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -45.02 133.05 6.65 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.973 -1.31 . . . . 52.229999999999997 109.843 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' B' ' 93' ' ' ASP . 18.1 t0 -69.39 -42.56 74.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 73.319999999999993 109.362 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' B' ' 92' ' ' ASP . 72.9 m-20 -152.25 164.91 36.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.43 -0.794 . . . . 72.219999999999999 109.175 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.522 ' O ' ' CD1' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -138.54 127.76 24.28 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.902 -0.777 . . . . 64.420000000000002 108.902 -178.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 0.786 HD12 ' N ' ' B' ' 95' ' ' ILE . 0.2 OUTLIER -123.82 151.91 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 121.451 0.643 . . . . 72.230000000000004 110.142 -178.654 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.62 138.48 58.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.186 -0.946 . . . . 25.239999999999998 108.541 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.672 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -59.73 -53.79 62.11 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 120.98 -1.075 . . . . 64.319999999999993 111.61 -179.321 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 4.0 Cg_endo -42.03 -9.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 120.648 0.899 . . . . 63.329999999999998 113.057 -176.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . 0.672 ' N ' ' O ' ' B' ' 97' ' ' LYS . 49.4 m-85 59.45 117.64 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.583 -0.698 . . . . 75.129999999999995 109.225 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -56.63 -38.21 71.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.84 -1.162 . . . . 74.230000000000004 108.882 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . 0.731 ' O ' ' N ' ' B' ' 103' ' ' LYS . 33.3 t -174.59 41.27 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.119 -0.988 . . . . 63.340000000000003 110.728 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 63.7 mt 51.88 -69.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.546 -0.721 . . . . 74.439999999999998 110.232 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.731 ' N ' ' O ' ' B' ' 101' ' ' SER . 28.2 mtmm -57.72 -18.8 23.23 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.776 -1.194 . . . . 71.109999999999999 107.776 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.45 -83.51 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.81 -0.556 . . . . 71.450000000000003 110.578 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.732 ' H ' HD23 ' B' ' 105' ' ' LEU . 1.5 pt? -47.67 -32.75 6.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.878 -1.139 . . . . 51.310000000000002 109.858 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 99.2 t -65.33 -41.7 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.901 -1.124 . . . . 65.230000000000004 108.723 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.94 -33.56 67.13 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.317 -0.865 . . . . 24.32 108.962 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -83.41 -34.97 25.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.426 -0.796 . . . . 75.310000000000002 110.079 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 96.8 mt -72.54 -36.6 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.022 -1.048 . . . . 54.240000000000002 109.115 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . 0.435 ' CG ' ' N ' ' B' ' 111' ' ' ALA . 22.8 pt-20 -74.91 -44.79 46.78 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.444 -0.902 . . . . 65.310000000000002 109.214 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . 0.435 ' N ' ' CG ' ' B' ' 110' ' ' GLU . . . -50.4 -45.01 55.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.239 -0.913 . . . . 72.239999999999995 109.203 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -67.09 -38.13 85.15 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.29 -0.881 . . . . 72.040000000000006 109.689 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' B' ' 116' ' ' TRP . 24.0 mt -78.11 -26.26 47.9 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.22 -0.925 . . . . 75.349999999999994 110.496 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.465 ' O ' ' CE3' ' B' ' 116' ' ' TRP . 19.0 mmt180 -47.57 -40.54 19.38 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.88 -1.137 . . . . 75.5 109.689 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' PHE . . . . . 0.48 ' C ' ' H ' ' B' ' 117' ' ' GLY . 71.3 m-85 -68.02 -25.22 65.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.983 . . . . 65.329999999999998 109.455 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' TRP . . . . . 0.465 ' CE3' ' O ' ' B' ' 114' ' ' ARG . 5.4 m-90 53.34 6.36 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.384 -0.822 . . . . 74.450000000000003 109.827 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' B' ' 115' ' ' PHE . . . 68.51 175.84 10.72 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.847 -1.301 . . . . 44.210000000000001 109.847 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 58.4 m -142.06 171.59 13.84 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.347 -1.09 . . . . 71.400000000000006 109.344 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . 0.575 HD21 ' C ' ' B' ' 121' ' ' ILE . 2.7 t30 -104.11 153.67 20.63 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.42 -0.8 . . . . 72.319999999999993 109.749 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 t -104.27 -42.51 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.415 -0.803 . . . . 75.019999999999996 109.859 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . 0.575 ' C ' HD21 ' B' ' 119' ' ' ASN . 12.2 mm -106.66 119.22 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.204 -0.935 . . . . 51.409999999999997 109.469 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -129.49 138.67 51.51 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.516 -0.74 . . . . 71.530000000000001 109.529 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.572 HD13 ' N ' ' B' ' 124' ' ' GLY . 0.2 OUTLIER -160.28 117.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 72.430000000000007 109.192 179.821 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . 0.572 ' N ' HD13 ' B' ' 123' ' ' ILE . . . 53.45 -141.39 31.2 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.623 -1.391 . . . . 51.229999999999997 109.623 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -86.14 -1.9 57.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.294 -1.121 . . . . 74.200000000000003 109.471 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.52 126.7 38.81 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.118 -1.067 . . . . 75.420000000000002 108.118 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 85.6 m -129.22 135.89 49.41 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.328 -0.857 . . . . 74.219999999999999 109.952 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 12.4 mt -129.17 136.04 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.555 -0.715 . . . . 60.329999999999998 109.338 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . 0.459 ' O ' ' N ' ' B' ' 133' ' ' GLU . 53.0 m -124.49 81.46 59.61 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.626 -0.671 . . . . 72.310000000000002 109.582 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.41 -39.61 73.25 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.454 2.103 . . . . 75.129999999999995 111.712 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.68 -43.3 97.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.406 -0.809 . . . . 75.230000000000004 109.199 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -89.54 -4.64 57.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.389 -0.819 . . . . 72.430000000000007 108.791 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' B' ' 129' ' ' SER . 87.2 mt-10 52.52 56.74 7.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.453 -0.779 . . . . 75.129999999999995 109.763 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -151.83 139.02 19.25 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.303 -0.873 . . . . 73.219999999999999 109.404 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 7.7 tt -126.64 143.05 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.403 -0.811 . . . . 64.140000000000001 109.853 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 53.1 mt -115.6 131.73 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 109.114 -0.698 . . . . 71.219999999999999 109.114 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -138.02 138.23 38.64 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.609 -0.682 . . . . 64.219999999999999 110.491 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm 50.94 25.4 2.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.391 -0.818 . . . . 72.019999999999996 111.031 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.9 14.85 71.57 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.823 -1.179 . . . . 74.319999999999993 111.05 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -115.1 126.42 54.65 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.343 -1.093 . . . . 75.340000000000003 108.987 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -93.7 126.19 38.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.355 -0.841 . . . . 71.230000000000004 109.53 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 13.8 p -135.63 133.04 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.578 -0.897 . . . . 70.430000000000007 108.578 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . 0.568 ' H ' ' CD ' ' B' ' 143' ' ' GLU . 1.1 pm0 -94.86 137.37 34.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.201 -0.937 . . . . 72.430000000000007 108.588 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 11.6 m -140.02 141.01 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.102 -0.999 . . . . 72.129999999999995 110.323 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.27 31.92 0.24 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.711 -1.218 . . . . 72.019999999999996 107.711 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' B' ' 150' ' ' GLU . . . -78.24 -155.82 8.41 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.605 -1.398 . . . . 42.229999999999997 109.605 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . 0.62 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 0.0 OUTLIER -88.39 -35.96 0.44 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.422 -1.046 . . . . 73.299999999999997 111.046 -179.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 47.7 Cg_endo -84.31 -42.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 121.931 1.754 . . . . 71.329999999999998 112.533 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -56.53 -19.37 15.31 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.76 -1.212 . . . . 74.230000000000004 109.037 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' B' ' 146' ' ' GLY . 27.1 mt-10 -60.68 -36.27 78.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 72.340000000000003 109.89 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.472 HG11 HD13 ' B' ' 191' ' ' ILE . 3.8 p -67.84 -38.15 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.977 -1.077 . . . . 73.349999999999994 110.072 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 20.0 tp -60.57 -41.77 95.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.342 -0.849 . . . . 55.240000000000002 109.613 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -69.9 -39.64 76.08 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.124 -0.985 . . . . 70.010000000000005 109.209 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 154' ' ' HIS . . . . . 0.515 ' CD2' ' HD1' ' B' ' 158' ' ' HIS . 14.7 t60 -56.76 -52.48 64.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.484 -0.76 . . . . 65.319999999999993 110.111 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . 0.545 HD12 ' N ' ' B' ' 156' ' ' ALA . 4.2 pp -72.0 -25.66 61.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.924 -1.11 . . . . 71.540000000000006 109.413 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . 0.545 ' N ' HD12 ' B' ' 155' ' ' LEU . . . -54.31 -42.47 70.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.023 -1.048 . . . . 75.319999999999993 108.346 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . 0.426 ' C ' ' H ' ' B' ' 159' ' ' ARG . 58.0 mtp180 -77.81 -52.32 9.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.453 -0.779 . . . . 73.319999999999993 109.21 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 158' ' ' HIS . . . . . 0.515 ' HD1' ' CD2' ' B' ' 154' ' ' HIS . 30.9 m80 -75.27 25.66 0.1 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.549 -0.72 . . . . 74.140000000000001 109.988 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . 0.474 ' O ' ' N ' ' B' ' 161' ' ' GLN . 47.4 ttp180 -52.57 -78.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 61.409999999999997 109.015 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . 0.933 ' OD2' ' CE2' ' B' ' 216' ' ' TYR . 9.1 t70 -65.2 74.95 0.05 Allowed 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.2 -0.937 . . . . 72.099999999999994 109.27 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . 0.765 ' NE2' HH12 ' A' ' 159' ' ' ARG . 38.2 tt0 -175.65 160.33 2.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 72.25 109.141 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 17.1 mm -85.63 106.82 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.638 -0.875 . . . . 72.310000000000002 108.638 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 87.5 t -89.94 136.03 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.198 -0.939 . . . . 64.209999999999994 109.814 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 25.8 t -99.92 160.75 14.07 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.457 -0.777 . . . . 74.219999999999999 109.488 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -66.88 -40.01 87.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.472 -0.768 . . . . 65.310000000000002 110.047 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -66.36 -26.55 67.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 63.450000000000003 110.391 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -60.16 -57.69 11.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.99 -1.069 . . . . 72.400000000000006 109.662 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 25.9 mt -60.82 -36.72 79.8 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.127 -0.983 . . . . 72.319999999999993 108.856 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.5 ' C ' HD13 ' B' ' 169' ' ' LEU . 1.3 tm? -56.39 -66.23 0.47 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.607 -0.683 . . . . 73.340000000000003 110.162 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -54.85 -31.68 59.82 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.717 -0.615 . . . . 72.099999999999994 111.85 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -92.18 -8.82 44.46 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.706 -1.246 . . . . 62.130000000000003 112.009 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 25.6 mm -112.74 -68.4 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 120.887 -1.133 . . . . 71.420000000000002 110.82 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 173' ' ' TRP . . . . . 0.481 ' CD2' ' C ' ' B' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.431 0 C-N-CA 118.653 -1.219 . . . . 72.230000000000004 107.915 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo . . . . . 0 N--CA 1.494 1.521 0 CA-C-O 121.284 0.452 . . . . 65.219999999999999 111.815 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -127.27 125.97 41.85 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.488 -0.93 . . . . 72.310000000000002 108.488 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . 0.442 ' O ' HG22 ' B' ' 186' ' ' VAL . 6.1 t -133.04 -13.89 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.305 -0.872 . . . . 63.32 109.701 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 4.6 tt -62.01 -25.13 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.458 -1.401 . . . . 75.030000000000001 109.164 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -61.38 -43.11 99.43 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.319 -0.863 . . . . 64.109999999999999 109.83 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . 0.442 HG22 ' O ' ' B' ' 183' ' ' VAL . 15.4 m -76.54 -27.39 17.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.836 -1.165 . . . . 73.0 108.254 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.28 -46.18 64.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 61.119999999999997 109.692 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 10.7 tp -71.8 -28.06 29.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 120.953 -1.092 . . . . 72.430000000000007 109.595 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 189' ' ' ASN . . . . . 0.446 ' O ' ' OE1' ' B' ' 193' ' ' GLN . 68.2 m-20 -68.2 -46.01 71.78 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.286 -0.884 . . . . 65.140000000000001 108.764 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -70.3 -47.17 62.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 63.240000000000002 109.534 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . 0.472 HD13 HG11 ' B' ' 151' ' ' VAL . 63.7 mt -51.23 -34.83 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -0.906 . . . . 74.030000000000001 108.846 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 192' ' ' ARG . . . . . 0.434 HH22 HG21 ' B' ' 206' ' ' THR . 68.0 mtp180 -70.33 -42.28 72.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.883 . . . . 72.239999999999995 109.39 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 193' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' B' ' 189' ' ' ASN . 1.0 OUTLIER -75.45 -17.12 60.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.262 -0.899 . . . . 73.099999999999994 109.692 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -92.3 -25.05 18.76 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.18 -0.95 . . . . 72.109999999999999 110.361 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 195' ' ' MET . . . . . 0.608 ' N ' ' SD ' ' B' ' 195' ' ' MET . 0.0 OUTLIER -96.17 -32.01 12.69 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.133 -0.979 . . . . 44.329999999999998 110.141 -179.035 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 196' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 42.2 p-10 -67.97 -31.54 71.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.029 -1.044 . . . . 71.209999999999994 110.496 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . 0.47 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 46.1 mttt -70.12 -65.01 1.2 Allowed Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.969 -1.082 . . . . 75.209999999999994 110.56 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 198' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 19.8 Cg_endo -58.38 -58.57 0.71 Allowed 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.22 1.947 . . . . 75.319999999999993 112.741 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 37.1 mt -60.01 -55.51 33.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.062 -1.024 . . . . 72.25 109.874 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 97.49 -24.79 29.97 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.257 -1.137 . . . . 64.530000000000001 110.257 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . 0.412 HG21 HD13 ' B' ' 201' ' ' ILE . 19.7 mt -106.36 127.06 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.162 -1.199 . . . . 44.229999999999997 109.706 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 53.9 p -82.48 141.05 33.0 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.458 -0.941 . . . . 54.009999999999998 108.458 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 11.9 p -142.6 19.43 2.02 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.113 -0.992 . . . . 74.400000000000006 109.585 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.429 HG22 ' CE2' ' B' ' 214' ' ' PHE . 5.3 t -125.94 141.58 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.499 -0.751 . . . . 72.120000000000005 109.78 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -119.82 107.6 13.36 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.313 -0.995 . . . . 65.409999999999997 108.313 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 206' ' ' THR . . . . . 0.443 ' H ' HG22 ' B' ' 206' ' ' THR . 0.0 OUTLIER -75.17 120.13 20.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.958 . . . . 71.329999999999998 109.796 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.49 HG12 ' H ' ' B' ' 209' ' ' ARG . 3.0 t -117.28 148.88 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 109.114 -0.698 . . . . 63.5 109.114 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -91.64 -1.63 57.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.191 -0.943 . . . . 74.450000000000003 109.44 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 209' ' ' ARG . . . . . 0.49 ' H ' HG12 ' B' ' 207' ' ' VAL . 31.4 mmt180 -76.19 -118.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.353 -0.842 . . . . 74.140000000000001 109.56 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -57.33 -47.74 80.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.197 -0.939 . . . . 74.430000000000007 109.977 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.85 -126.83 1.09 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.026 -1.229 . . . . 64.450000000000003 110.026 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -100.17 133.56 44.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.271 -1.135 . . . . 74.209999999999994 109.408 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -100.53 118.13 36.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.409 -0.807 . . . . 74.030000000000001 109.445 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . 0.429 ' CE2' HG22 ' B' ' 204' ' ' VAL . 26.2 m-85 -98.56 131.03 45.1 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.412 -0.805 . . . . 74.340000000000003 109.113 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 30.3 p -158.48 161.04 37.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 64.329999999999998 109.077 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . 0.933 ' CE2' ' OD2' ' B' ' 160' ' ' ASP . 1.6 m-85 -61.24 150.16 80.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.995 -1.065 . . . . 70.040000000000006 108.698 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.07 -55.65 0.13 Allowed 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.123 1.882 . . . . 65.109999999999999 111.561 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 62.8 mttm . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 108.385 -0.969 . . . . 73.150000000000006 108.385 179.817 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.3 ttm . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.474 -0.565 . . . . 65.120000000000005 109.474 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -144.56 141.68 29.65 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.196 -0.94 . . . . 72.329999999999998 109.182 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 80.2 t -112.55 134.86 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.562 0.696 . . . . 71.420000000000002 109.958 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.552 HD11 ' CG1' ' A' ' 6' ' ' ILE . 1.3 tp -103.2 118.58 37.12 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.101 -1.074 . . . . 65.120000000000005 108.101 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.552 HD12 ' SD ' ' A' ' 49' ' ' MET . 3.9 tp -117.82 107.23 13.88 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.66 -0.65 . . . . 62.43 109.483 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.552 ' CG1' HD11 ' A' ' 4' ' ' LEU . 37.4 mt -98.36 101.5 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.327 -0.99 . . . . 71.150000000000006 108.327 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -131.42 124.11 29.58 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.61 -0.681 . . . . 75.340000000000003 109.465 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -65.66 -34.46 78.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.277 -0.889 . . . . 72.439999999999998 109.15 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -87.07 112.2 21.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 63.020000000000003 109.227 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.6 m -65.7 -26.71 67.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 72.340000000000003 109.588 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.72 -52.75 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.193 -0.942 . . . . 74.019999999999996 109.774 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.1 mt -61.6 -34.83 76.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.977 . . . . 71.430000000000007 109.291 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.94 -26.96 71.43 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.566 -1.814 . . . . 61.32 108.566 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.13 -52.41 44.68 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 109.529 -1.428 . . . . 71.200000000000003 109.529 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -59.97 -45.09 93.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.372 -1.075 . . . . 71.319999999999993 109.824 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.4 mm -64.31 -38.55 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.795 -1.191 . . . . 63.229999999999997 108.828 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -62.89 -49.29 75.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.329 -0.857 . . . . 51.109999999999999 110.099 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -78.03 -7.34 56.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.077 -1.015 . . . . 73.340000000000003 109.815 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.77 -54.45 3.24 Favored Glycine 0 N--CA 1.483 1.824 0 N-CA-C 109.505 -1.438 . . . . 62.149999999999999 109.505 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.91 -24.13 61.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.376 -1.073 . . . . 73.510000000000005 109.489 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -56.04 -38.46 70.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.137 -0.977 . . . . 74.25 109.184 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.5 t -51.94 -47.53 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.271 -0.893 . . . . 70.040000000000006 109.05 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -53.81 -53.16 56.32 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.602 -0.888 . . . . 73.230000000000004 108.602 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.94 40.77 0.28 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.353 -1.499 . . . . 75.540000000000006 109.353 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -117.13 160.28 21.27 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.511 -0.994 . . . . 73.430000000000007 109.139 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.5 mmt -101.11 139.35 36.91 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.204 -1.036 . . . . 43.240000000000002 108.204 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.59 146.75 34.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.167 -0.958 . . . . 62.109999999999999 110.339 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -120.69 149.23 42.83 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.911 -0.774 . . . . 74.420000000000002 108.911 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 m -110.53 134.99 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.427 -0.796 . . . . 72.150000000000006 108.906 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.4 p -136.82 168.2 20.0 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.359 -0.838 . . . . 71.420000000000002 109.531 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -90.25 -105.61 0.09 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.329 -0.857 . . . . 72.329999999999998 109.662 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.5 p -81.16 169.11 17.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 74.239999999999995 110.07 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.5 mt -53.95 -32.67 54.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.579 -0.7 . . . . 71.530000000000001 109.521 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -49.81 -49.68 47.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 74.230000000000004 109.541 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -64.95 -51.83 59.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 54.030000000000001 109.31 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.36 -39.03 96.69 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.694 -1.362 . . . . 61.409999999999997 109.694 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -64.28 -47.06 80.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -1.141 . . . . 74.340000000000003 109.413 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -69.78 -35.3 74.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.067 -1.021 . . . . 75.329999999999998 109.19 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.424 ' C ' ' CD1' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -70.4 -65.53 0.72 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.84 . . . . 74.329999999999998 109.204 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 40' ' ' MET . 2.9 ppp? -48.47 -20.38 0.42 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.263 -0.898 . . . . 70.319999999999993 109.936 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -65.52 -43.24 90.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.075 -1.016 . . . . 71.219999999999999 110.091 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.3 pt -82.31 -26.71 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.172 -0.955 . . . . 74.140000000000001 110.195 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 40' ' ' MET . 99.4 mtt180 -129.96 143.7 50.94 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.35 -0.844 . . . . 72.239999999999995 109.507 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -97.59 151.09 20.42 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.214 -0.929 . . . . 75.420000000000002 109.556 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -127.51 141.08 51.75 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.529 -0.732 . . . . 74.230000000000004 109.252 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -78.05 -42.15 33.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 72.040000000000006 109.471 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.61 HD23 HD21 ' A' ' 113' ' ' LEU . 0.3 OUTLIER -104.01 112.77 25.9 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.474 -0.766 . . . . 72.129999999999995 108.941 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.461 ' N ' HD13 ' A' ' 47' ' ' LEU . 74.0 t -99.45 98.48 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.406 -0.961 . . . . 72.340000000000003 108.406 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.552 ' SD ' HD12 ' A' ' 5' ' ' LEU . 1.5 tmt? -114.99 135.94 53.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.617 -0.677 . . . . 74.109999999999999 109.834 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.6 HG22 ' H ' ' A' ' 52' ' ' ASP . 1.1 p -143.59 131.19 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.78 0.8 . . . . 61.119999999999997 109.82 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.7 p -95.26 9.64 39.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.571 -0.706 . . . . 73.109999999999999 109.744 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.6 ' H ' HG22 ' A' ' 50' ' ' VAL . 80.0 m-20 -77.04 141.48 40.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 52.549999999999997 109.514 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.48 ' C ' ' H ' ' A' ' 55' ' ' ALA . 92.2 mttt -75.1 -45.42 41.31 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.294 -0.879 . . . . 44.219999999999999 110.447 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -68.51 10.99 0.2 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.096 -1.002 . . . . 70.439999999999998 109.84 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.48 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -68.84 -22.49 64.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 64.140000000000001 110.28 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 52.4 mt -42.62 -50.34 5.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.297 -0.877 . . . . 44.140000000000001 110.401 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.1 m -68.74 -31.91 71.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.932 -1.105 . . . . 55.229999999999997 109.333 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.605 ' CE2' HD11 ' A' ' 62' ' ' ILE . 58.3 t80 -70.19 -56.57 6.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.463 -0.773 . . . . 74.439999999999998 110.2 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.4 m -55.03 -34.06 30.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.609 -1.307 . . . . 74.030000000000001 109.528 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.7 t -60.42 -54.89 40.1 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.287 -0.883 . . . . 64.299999999999997 109.499 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.667 HH21 ' NZ ' ' A' ' 65' ' ' LYS . 7.1 ptm180 -67.3 -25.52 66.07 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.045 -1.062 . . . . 64.439999999999998 109.967 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.605 HD11 ' CE2' ' A' ' 58' ' ' PHE . 4.9 mm -59.87 -48.03 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.783 -1.198 . . . . 63.210000000000001 108.968 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -64.45 -45.19 88.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.023 -1.048 . . . . 74.420000000000002 108.87 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -60.86 -51.52 68.95 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.326 -0.99 . . . . 70.319999999999993 108.326 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.667 ' NZ ' HH21 ' A' ' 61' ' ' ARG . 93.1 mttt -71.81 -69.68 0.37 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.253 -0.647 . . . . 75.219999999999999 109.253 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 62' ' ' ILE . 86.5 m-70 -98.02 90.54 4.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.319 -0.863 . . . . 74.129999999999995 109.019 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 t -79.01 -40.1 32.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 73.239999999999995 109.914 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.8 t -78.15 57.92 1.93 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 61.009999999999998 109.611 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 66' ' ' HIS . 14.6 tt -152.03 158.12 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.147 -0.97 . . . . 71.329999999999998 109.656 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.2 t -97.63 146.87 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.119 -0.988 . . . . 72.129999999999995 109.111 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.7 t -133.01 125.81 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.317 -0.864 . . . . 54.210000000000001 110.5 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.526 ' C ' HD23 ' A' ' 72' ' ' LEU . 3.7 tt -122.87 100.03 6.69 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.652 -0.87 . . . . 50.240000000000002 108.652 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.7 p -92.69 153.55 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.76 -1.212 . . . . 74.409999999999997 109.221 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.7 m -127.54 166.54 17.8 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.257 -1.016 . . . . 72.310000000000002 108.257 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 77' ' ' ASN . 23.0 t -170.8 126.41 0.72 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.967 -1.083 . . . . 64.540000000000006 110.415 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 57.3 p30 -71.69 14.67 0.18 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.569 -0.707 . . . . 74.129999999999995 110.121 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.427 ' H ' ' C ' ' A' ' 75' ' ' SER . 22.6 m120 -138.43 73.91 41.82 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.195 -0.941 . . . . 73.340000000000003 109.933 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.6 76.53 4.49 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.682 2.255 . . . . 63.219999999999999 112.358 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.415 HG23 ' H ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -104.92 154.63 19.82 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.296 -1.001 . . . . 62.530000000000001 108.296 178.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.45 -25.08 2.33 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.171 -0.956 . . . . 73.439999999999998 109.738 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -69.72 -50.61 41.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.944 . . . . 71.420000000000002 110.149 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 77' ' ' ASN . 88.9 mt-10 -71.32 -27.74 63.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.097 -1.002 . . . . 73.430000000000007 110.162 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -64.21 -56.93 11.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.091 -1.005 . . . . 74.219999999999999 109.764 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.522 HG23 ' N ' ' A' ' 85' ' ' HIS . 17.9 m -66.13 -40.96 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 73.200000000000003 109.676 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.522 ' N ' HG23 ' A' ' 84' ' ' VAL . 27.7 t-80 -64.7 -38.99 92.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.21 -0.931 . . . . 53.329999999999998 109.744 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.52 95.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 64.109999999999999 110.178 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.507 ' CE1' ' NH1' ' B' ' 108' ' ' ARG . 44.2 m-85 -72.84 -31.01 64.48 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.038 -1.039 . . . . 74.340000000000003 108.605 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -73.71 -34.73 64.95 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.412 -0.805 . . . . 74.420000000000002 109.261 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -62.86 -55.85 22.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.896 . . . . 74.239999999999995 109.441 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.63 29.0 0.08 OUTLIER Glycine 0 N--CA 1.498 2.804 0 C-N-CA 119.813 -1.184 . . . . 61.509999999999998 110.425 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.49 128.57 39.66 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.935 -1.332 . . . . 55.329999999999998 108.995 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.669 ' HB3' HH21 ' A' ' 112' ' ' ARG . 36.2 m-20 -64.68 -36.41 84.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.978 -1.076 . . . . 73.420000000000002 108.971 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 94' ' ' TYR . 62.8 t0 -152.53 145.65 24.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.373 -0.829 . . . . 75.040000000000006 108.943 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.497 ' CD1' ' C ' ' A' ' 94' ' ' TYR . 0.4 OUTLIER -123.15 121.54 36.23 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.985 -0.746 . . . . 71.329999999999998 108.985 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.496 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -108.98 141.92 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 121.789 0.804 . . . . 71.129999999999995 109.526 -178.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . -62.35 125.15 22.91 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.16 -1.422 . . . . 64.319999999999993 107.16 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.567 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -44.33 -57.13 6.86 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.004 -1.06 . . . . 62.200000000000003 111.102 -178.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 7.4 Cg_endo -44.2 90.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 CA-C-N 119.467 0.845 . . . . 73.109999999999999 111.17 -176.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.567 ' N ' ' O ' ' A' ' 97' ' ' LYS . 42.8 m-85 -44.18 104.26 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.625 -0.672 . . . . 65.219999999999999 109.97 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 31.2 ttm-85 -54.49 -25.6 26.38 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.595 -0.891 . . . . 72.349999999999994 108.595 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.751 ' O ' ' N ' ' A' ' 103' ' ' LYS . 15.7 t -178.07 24.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.398 -0.814 . . . . 71.319999999999993 109.866 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 87.9 mt 52.89 -70.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.66 -0.65 . . . . 75.430000000000007 109.609 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.751 ' N ' ' O ' ' A' ' 101' ' ' SER . 48.9 mttp -56.2 -23.04 32.83 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.517 -1.29 . . . . 71.409999999999997 107.517 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' A' ' 101' ' ' SER . . . -68.08 -45.47 73.7 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.929 -1.137 . . . . 63.240000000000002 107.929 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.6 tp -65.48 -51.7 58.18 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.681 -0.859 . . . . 73.219999999999999 108.681 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 38.3 t -58.36 -42.73 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.108 -0.995 . . . . 60.109999999999999 108.654 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.87 -39.55 59.15 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.304 -0.872 . . . . 70.420000000000002 108.881 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 53.8 mtp180 -66.94 -35.6 80.33 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.192 -0.942 . . . . 74.409999999999997 108.811 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.9 mt -75.56 -26.76 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.21 -0.931 . . . . 62.539999999999999 108.992 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -65.4 -52.06 56.04 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.448 -0.783 . . . . 74.340000000000003 110.137 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -74.86 -29.35 61.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.111 -0.993 . . . . 73.319999999999993 110.382 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.669 HH21 ' HB3' ' A' ' 92' ' ' ASP . 33.9 ttt85 -61.03 -44.24 97.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.041 . . . . 52.409999999999997 109.895 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.61 HD21 HD23 ' A' ' 47' ' ' LEU . 0.4 OUTLIER -150.79 82.58 1.34 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.8 -1.187 . . . . 65.239999999999995 109.745 179.277 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.401 ' HA ' ' HE ' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -95.01 -58.03 2.27 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.485 -0.932 . . . . 64.450000000000003 108.485 179.489 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -69.08 -58.04 4.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 74.430000000000007 109.662 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 46.22 85.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.232 -0.917 . . . . 74.420000000000002 109.662 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.99 99.41 0.12 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.3 -1.52 . . . . 75.040000000000006 109.3 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.7 t -152.61 162.67 40.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.197 -1.178 . . . . 61.140000000000001 109.894 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.545 ' ND2' ' N ' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -157.61 129.45 6.99 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.966 -0.753 . . . . 65.239999999999995 108.966 -178.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 17.3 t -91.11 -32.77 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.185 -0.947 . . . . 73.109999999999999 109.268 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 24.9 mm -107.53 137.23 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.934 -0.765 . . . . 72.239999999999995 108.934 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -148.89 136.6 20.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.067 -1.021 . . . . 72.340000000000003 109.982 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.5 pt -151.54 134.75 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.432 -0.793 . . . . 71.439999999999998 109.112 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 45.84 -142.28 4.58 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.747 -1.341 . . . . 73.400000000000006 109.747 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -85.59 -5.96 59.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.257 -1.143 . . . . 74.450000000000003 109.393 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.429 HD22 ' CD1' ' A' ' 137' ' ' TYR . 0.7 OUTLIER -91.12 136.69 32.92 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.336 -0.987 . . . . 54.210000000000001 108.336 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.7 m -130.61 144.07 51.17 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.387 -0.82 . . . . 54.5 109.605 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 82.5 mt -133.28 137.69 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.291 -0.88 . . . . 45.149999999999999 109.475 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.4 m -121.77 85.22 44.38 Favored Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 109.069 -0.715 . . . . 71.109999999999999 109.069 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.89 -41.05 82.19 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.549 2.166 . . . . 65.409999999999997 112.237 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -59.05 -46.9 87.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 63.32 109.293 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -82.7 -7.06 59.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 72.519999999999996 109.153 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.408 ' OE2' ' O ' ' A' ' 144' ' ' VAL . 70.8 tt0 56.98 58.49 3.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.411 -0.806 . . . . 75.329999999999998 109.567 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.45 ' C ' HD12 ' A' ' 135' ' ' ILE . 32.3 ttpt -148.65 123.94 10.23 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.294 -0.879 . . . . 71.230000000000004 109.435 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.593 ' N ' HD12 ' A' ' 135' ' ' ILE . 1.6 mp -96.94 138.07 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.217 -0.927 . . . . 74.019999999999996 109.392 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.3 mm -115.11 127.89 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 109.023 -0.732 . . . . 60.229999999999997 109.023 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.429 ' CD1' HD22 ' A' ' 126' ' ' LEU . 79.5 t80 -136.43 123.71 21.88 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.356 -0.84 . . . . 62.32 109.48 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 66.3 mttm 53.52 33.85 17.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.335 -0.853 . . . . 75.400000000000006 110.032 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.11 11.09 85.71 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.292 -1.123 . . . . 72.239999999999995 110.292 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 50.3 mtp85 -94.91 124.49 38.98 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.143 -1.21 . . . . 71.219999999999999 109.073 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -94.88 119.31 33.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.259 -0.901 . . . . 71.420000000000002 109.608 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.6 p -135.61 137.7 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.469 -0.769 . . . . 53.020000000000003 109.297 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.505 ' N ' ' OE1' ' A' ' 143' ' ' GLU . 46.1 mp0 -95.98 154.46 17.22 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.323 -0.86 . . . . 60.450000000000003 109.298 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.408 ' O ' ' OE2' ' A' ' 133' ' ' GLU . 29.9 m -139.61 144.09 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.365 -0.834 . . . . 74.439999999999998 109.551 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -168.47 21.77 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.937 . . . . 65.150000000000006 109.751 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.19 -174.93 50.63 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.333 -1.507 . . . . 73.340000000000003 109.333 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.633 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 5.8 ttpm? -83.14 -32.76 0.55 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.3 -1.118 . . . . 72.219999999999999 111.048 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 91.6 Cg_endo -89.37 -16.67 2.04 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 122.149 1.899 . . . . 65.230000000000004 112.733 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -81.99 -24.87 35.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.108 -0.995 . . . . 60.109999999999999 109.818 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.525 ' O ' ' ND1' ' A' ' 154' ' ' HIS . 95.8 mt-10 -51.53 -31.94 26.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.097 -1.002 . . . . 64.209999999999994 108.862 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 148' ' ' PRO . 5.4 p -63.56 -36.76 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.438 -0.789 . . . . 72.019999999999996 109.07 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.427 ' CD1' ' SD ' ' A' ' 195' ' ' MET . 21.3 tp -62.92 -42.47 99.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 73.310000000000002 109.084 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.4 m -72.47 -36.88 68.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.403 -0.81 . . . . 74.310000000000002 109.864 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 150' ' ' GLU . 8.2 m80 -60.7 -52.71 63.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.122 -0.986 . . . . 74.310000000000002 110.182 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 159' ' ' ARG . 3.2 pp -68.89 -25.97 64.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.866 -1.146 . . . . 75.340000000000003 109.589 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.73 -52.68 64.03 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.136 -0.977 . . . . 62.140000000000001 109.241 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.563 ' HE ' ' CE1' ' A' ' 158' ' ' HIS . 5.0 ptm85 -68.28 -43.4 77.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.351 -0.843 . . . . 61.030000000000001 109.651 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.563 ' CE1' ' HE ' ' A' ' 157' ' ' ARG . 35.8 m80 -95.29 29.38 2.53 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.104 -0.998 . . . . 74.120000000000005 109.251 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.584 HH21 HG21 ' A' ' 203' ' ' THR . 27.8 ttt85 -60.13 -21.76 61.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.317 -0.865 . . . . 71.129999999999995 109.519 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 41.8 p30 -115.6 66.65 0.7 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.009 -0.737 . . . . 75.450000000000003 109.009 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 162' ' ' ILE . 10.3 tm0? -164.3 156.8 16.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.161 -0.962 . . . . 73.409999999999997 109.378 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.528 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 9.3 mm -82.33 123.99 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.214 -0.929 . . . . 74.409999999999997 109.312 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.412 HG11 HD21 ' A' ' 168' ' ' LEU . 21.5 t -120.62 136.95 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.508 -0.745 . . . . 72.310000000000002 109.628 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.0 p -91.86 159.69 15.66 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.329 -0.857 . . . . 74.120000000000005 109.425 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.4 mtmm -59.87 -45.55 92.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 70.430000000000007 109.486 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -62.85 -31.59 72.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 73.519999999999996 109.732 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -59.99 -44.98 94.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.125 -0.984 . . . . 74.519999999999996 109.456 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.412 HD21 HG11 ' A' ' 163' ' ' VAL . 37.7 mt -64.72 -44.19 91.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 72.310000000000002 109.578 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 11.8 tp -64.58 -43.8 92.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.306 -0.871 . . . . 53.329999999999998 109.528 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -75.2 -10.0 59.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 62.439999999999998 109.705 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.02 -54.75 3.98 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -0.915 . . . . 60.210000000000001 109.804 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.699 ' N ' HD12 ' A' ' 172' ' ' ILE . 1.9 mp -88.04 -50.1 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.168 -0.957 . . . . 75.319999999999993 109.858 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 17.9 m-90 . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.069 -1.019 . . . . 73.140000000000001 109.881 -179.413 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 21.0 p30 . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.233 -0.655 . . . . 64.540000000000006 109.233 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.8 p -171.52 -29.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 74.019999999999996 109.367 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.562 ' O ' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -53.57 -41.01 44.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.352 -0.843 . . . . 72.329999999999998 109.58 -179.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.4 ' N ' ' CG2' ' A' ' 184' ' ' ILE . 18.5 mt-10 -54.51 -38.45 66.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.849 -1.157 . . . . 74.400000000000006 109.375 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 2.3 t -75.46 -34.7 30.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.388 -0.82 . . . . 70.420000000000002 109.605 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.0 -51.04 23.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 52.109999999999999 109.869 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.2 tp -61.88 -32.62 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.984 -1.072 . . . . 71.400000000000006 109.745 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -66.31 -55.77 14.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.118 -0.989 . . . . 73.439999999999998 110.215 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -67.0 -41.53 86.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.038 -1.039 . . . . 71.420000000000002 109.665 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 71.6 mt -56.88 -44.43 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.098 -1.001 . . . . 61.549999999999997 109.136 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.4 mtp-105 -57.54 -44.14 84.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 63.340000000000003 108.947 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -67.28 -36.43 81.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.876 . . . . 61.240000000000002 109.332 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.495 ' O ' ' CG ' ' A' ' 198' ' ' PRO . 96.0 mttt -71.69 -15.8 62.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.867 . . . . 75.129999999999995 109.761 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . 0.427 ' SD ' ' CD1' ' A' ' 152' ' ' LEU . 86.2 mmm -93.62 -15.45 25.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.097 -1.002 . . . . 74.019999999999996 109.968 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -102.82 -9.38 20.0 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.137 -0.977 . . . . 74.019999999999996 110.38 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.557 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 3.8 tmtp? -89.63 -42.45 0.43 Allowed Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.917 -1.114 . . . . 75.430000000000007 110.241 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 38.1 Cg_endo -90.4 -58.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.688 2.259 . . . . 72.319999999999993 112.493 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.605 ' N ' HD22 ' A' ' 199' ' ' LEU . 3.3 mm? -61.3 -33.82 74.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.911 -1.118 . . . . 74.540000000000006 108.877 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 75.22 -15.94 3.94 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.689 -1.364 . . . . 61.509999999999998 109.689 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.413 ' H ' ' C ' ' A' ' 199' ' ' LEU . 6.1 mt -115.49 129.36 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.479 -1.013 . . . . 61.219999999999999 109.011 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 12.6 t -79.94 139.09 37.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.061 -1.024 . . . . 72.0 109.242 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.584 HG21 HH21 ' A' ' 159' ' ' ARG . 3.8 p -139.88 7.72 2.28 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.295 -0.878 . . . . 74.439999999999998 109.647 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.37 133.68 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.461 -0.774 . . . . 64.349999999999994 109.413 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 39.8 tp10 -114.45 133.95 55.36 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.55 -0.719 . . . . 71.409999999999997 109.394 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.7 p -99.42 139.96 34.31 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.285 -0.885 . . . . 73.519999999999996 109.261 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 211' ' ' GLY . 18.5 m -149.86 136.75 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.231 -0.918 . . . . 71.019999999999996 109.46 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -85.66 -13.65 47.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 72.120000000000005 109.343 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -55.16 -34.13 63.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.271 -0.893 . . . . 64.409999999999997 109.485 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 64.7 mtp85 -151.18 -63.12 0.19 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.263 -0.898 . . . . 71.540000000000006 109.405 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 207' ' ' VAL . . . -161.89 -114.14 0.32 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.657 -1.377 . . . . 72.030000000000001 109.657 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -126.2 124.31 40.16 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.601 -0.941 . . . . 75.540000000000006 109.474 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 26.1 ttm105 -90.28 121.48 32.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.36 -0.837 . . . . 75.310000000000002 109.006 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -95.96 123.98 39.78 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.304 -0.872 . . . . 75.409999999999997 109.337 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 44.2 t -154.84 152.22 29.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.434 -0.792 . . . . 74.140000000000001 109.069 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.36 145.0 84.82 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.089 -1.007 . . . . 75.319999999999993 108.791 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo . . . . . 0 N--CA 1.49 1.291 0 C-N-CA 122.212 1.941 . . . . 73.109999999999999 112.334 -179.926 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 53.2 ttm . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.478 -0.564 . . . . 71.140000000000001 109.478 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.609 ' NH1' ' HE ' ' B' ' 43' ' ' ARG . 39.9 ttt85 -139.8 146.73 39.79 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.375 -0.828 . . . . 73.230000000000004 109.397 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 73.2 t -118.0 137.11 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 121.583 0.706 . . . . 72.239999999999995 109.669 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.52 HD11 ' CG1' ' B' ' 6' ' ' ILE . 3.3 tp -108.8 117.65 34.73 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.576 -0.898 . . . . 54.329999999999998 108.576 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.407 ' N ' HD12 ' B' ' 4' ' ' LEU . 5.4 tp -119.4 101.42 7.94 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.071 -0.714 . . . . 74.349999999999994 109.071 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.52 ' CG1' HD11 ' B' ' 4' ' ' LEU . 53.8 mt -91.71 97.72 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.907 -1.12 . . . . 42.549999999999997 108.749 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.422 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 31.8 tp10 -123.42 136.79 54.8 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.611 0.72 . . . . 74.519999999999996 109.407 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -77.76 -32.74 52.78 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.526 -0.734 . . . . 62.549999999999997 109.308 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -90.02 115.41 27.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.364 -0.835 . . . . 73.109999999999999 109.367 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 15.6 t -65.78 -30.88 71.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.229 -0.919 . . . . 65.540000000000006 109.821 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 85.8 t -61.67 -50.29 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.133 -0.98 . . . . 75.549999999999997 109.791 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.614 HD12 ' NZ ' ' B' ' 97' ' ' LYS . 3.5 mm? -64.83 -31.34 72.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 70.140000000000001 109.439 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.26 -29.94 57.69 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.744 -1.743 . . . . 75.400000000000006 108.744 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.87 -51.64 54.17 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.584 -1.406 . . . . 65.439999999999998 109.584 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -63.17 -42.09 99.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.331 -1.099 . . . . 60.210000000000001 109.622 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 4.8 mm -65.41 -38.61 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.009 -1.057 . . . . 75.150000000000006 108.768 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -64.83 -54.37 32.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.382 -0.824 . . . . 73.010000000000005 109.986 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -72.64 -6.26 43.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.147 -0.971 . . . . 74.299999999999997 109.771 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.87 -55.35 2.83 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.657 -1.377 . . . . 70.540000000000006 109.657 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp -74.17 -23.42 59.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.38 -1.071 . . . . 71.340000000000003 109.802 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -53.74 -35.98 61.8 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.152 -0.968 . . . . 64.409999999999997 109.394 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 98.0 t -55.25 -42.31 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.205 -0.935 . . . . 74.230000000000004 109.198 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 18.7 mmtp -64.64 -13.02 51.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.309 -0.869 . . . . 63.420000000000002 108.685 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.06 32.3 23.77 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.125 -1.19 . . . . 53.43 110.125 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -102.37 159.24 15.59 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.243 -1.151 . . . . 71.120000000000005 108.48 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 15.5 mtt -100.01 137.84 37.91 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.288 -1.004 . . . . 75.239999999999995 108.288 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.57 150.86 39.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 72.120000000000005 109.984 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . 0.531 ' OD2' ' NH2' ' B' ' 2' ' ' ARG . 75.2 m-20 -126.16 144.35 50.79 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.822 -0.807 . . . . 72.310000000000002 108.822 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 1.4 p -112.13 129.07 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.716 -0.846 . . . . 64.430000000000007 108.716 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 6.8 p -134.1 167.85 19.89 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.533 -0.729 . . . . 65.409999999999997 109.455 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -93.79 -97.47 0.15 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.247 -0.908 . . . . 71.019999999999996 109.808 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 51.9 p -78.15 165.16 24.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.195 -0.941 . . . . 51.109999999999999 110.25 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' B' ' 37' ' ' GLU . 46.9 mt -55.01 -35.29 64.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.567 -0.708 . . . . 71.239999999999995 110.218 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -55.98 -44.19 78.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.053 -1.029 . . . . 74.319999999999993 109.831 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -62.47 -41.26 98.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.142 -0.974 . . . . 73.030000000000001 109.311 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . 0.438 ' O ' ' CG ' ' B' ' 40' ' ' MET . . . -80.63 -23.82 59.55 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.421 -1.472 . . . . 30.210000000000001 109.421 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' B' ' 33' ' ' LEU . 84.8 tt0 -66.43 -44.72 82.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -1.152 . . . . 74.420000000000002 109.661 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -79.3 -35.07 41.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.105 -0.997 . . . . 74.420000000000002 109.706 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 8.4 tt -73.82 -37.03 65.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 75.409999999999997 110.108 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . 0.442 ' SD ' ' CE1' ' B' ' 45' ' ' TYR . 2.8 ppp? -76.15 -32.28 59.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.935 -1.103 . . . . 60.409999999999997 109.902 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -51.38 -37.03 46.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.926 . . . . 53.229999999999997 110.374 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.404 HG12 ' H ' ' B' ' 42' ' ' ILE . 11.2 pt -78.94 -33.54 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.0 -1.062 . . . . 71.230000000000004 110.114 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.609 ' HE ' ' NH1' ' B' ' 2' ' ' ARG . 30.2 mmt-85 -93.96 168.6 10.86 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.906 -1.121 . . . . 72.219999999999999 110.024 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' ASN . . . . . 0.517 ' C ' ' CD1' ' B' ' 45' ' ' TYR . 30.9 p30 -92.85 -19.31 21.83 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.298 -0.876 . . . . 63.539999999999999 109.954 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.517 ' CD1' ' C ' ' B' ' 44' ' ' ASN . 11.0 p90 40.11 97.86 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.566 -0.709 . . . . 64.349999999999994 110.997 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -80.41 -38.04 31.0 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.056 -1.028 . . . . 62.219999999999999 109.1 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.464 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.3 OUTLIER -106.64 114.36 28.42 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.745 -1.206 . . . . 73.120000000000005 107.745 179.255 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.464 ' N ' HD13 ' B' ' 47' ' ' LEU . 65.4 t -99.07 97.78 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.224 -0.922 . . . . 65.109999999999999 108.846 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.404 ' SD ' ' CD1' ' B' ' 5' ' ' LEU . 25.5 ttt -113.58 131.4 56.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.554 -0.717 . . . . 73.439999999999998 109.782 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.516 HG22 ' H ' ' B' ' 52' ' ' ASP . 0.5 OUTLIER -144.89 135.46 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.535 -0.728 . . . . 34.5 109.234 -179.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . 0.422 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 38.8 p -103.17 15.06 30.28 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.552 -0.718 . . . . 73.209999999999994 109.79 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.516 ' H ' HG22 ' B' ' 50' ' ' VAL . 83.0 m-20 -77.83 144.92 36.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.104 -0.998 . . . . 70.409999999999997 109.467 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' B' ' 55' ' ' ALA . 41.6 mmtm -74.37 -43.31 57.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.224 -0.923 . . . . 65.0 110.164 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -72.86 13.14 0.41 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.07 -1.019 . . . . 75.209999999999994 109.786 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.438 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -69.34 -22.35 63.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 55.329999999999998 110.136 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 19.7 mt -42.04 -52.34 4.26 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.508 -0.745 . . . . 63.140000000000001 110.083 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 24.7 m -66.44 -35.07 79.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.956 -1.09 . . . . 63.5 109.082 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . 0.431 ' CZ ' HD11 ' B' ' 62' ' ' ILE . 57.4 t80 -65.26 -62.18 1.69 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.466 -0.771 . . . . 72.329999999999998 110.0 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 32.5 m -49.33 -34.08 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.637 -1.289 . . . . 74.540000000000006 109.962 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 24.6 p -59.42 -53.66 55.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.052 -1.03 . . . . 71.239999999999995 109.739 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -66.24 -27.93 68.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.036 -1.04 . . . . 74.310000000000002 110.125 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.431 HD11 ' CZ ' ' B' ' 58' ' ' PHE . 32.9 mm -65.5 -38.82 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.767 -1.208 . . . . 72.140000000000001 109.894 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -70.72 -47.81 57.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.028 -1.045 . . . . 73.319999999999993 110.598 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -69.77 -40.41 76.09 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.873 -1.142 . . . . 73.120000000000005 110.335 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.488 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 62.7 mttm -75.84 -24.31 55.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.13 -0.981 . . . . 72.439999999999998 109.979 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.488 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 90.5 m-70 -155.71 64.48 0.6 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.116 -0.99 . . . . 63.310000000000002 109.719 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 22.8 t -57.2 -27.93 62.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -0.889 . . . . 73.099999999999994 109.606 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 92.0 p -65.17 -23.08 67.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 71.530000000000001 109.906 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.403 HG22 ' N ' ' B' ' 70' ' ' VAL . 60.5 mt -82.32 158.45 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.186 -0.946 . . . . 74.400000000000006 109.533 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.403 ' N ' HG22 ' B' ' 69' ' ' ILE . 70.3 t -98.83 150.82 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.288 -0.883 . . . . 75.120000000000005 109.608 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 16.2 t -130.38 126.51 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.386 -0.821 . . . . 73.200000000000003 109.95 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 6.5 tt -121.98 100.34 6.93 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 109.094 -0.706 . . . . 73.340000000000003 109.094 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 9.2 p -93.71 134.87 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.981 -1.075 . . . . 73.5 109.253 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 11.9 p -96.08 172.19 8.14 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.219 -0.926 . . . . 64.340000000000003 109.228 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.461 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 33.6 t -156.23 112.99 3.13 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.98 -1.075 . . . . 74.530000000000001 110.183 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' B' ' 77' ' ' ASN . 54.5 p30 -70.64 -12.13 61.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 64.5 109.217 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . 0.449 ' N ' ' OD1' ' B' ' 76' ' ' ASP . 87.2 m-20 -134.3 73.84 68.32 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.686 -0.857 . . . . 74.25 108.686 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -50.1 84.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.649 2.233 . . . . 74.430000000000007 111.781 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.449 ' N ' ' O ' ' B' ' 77' ' ' ASN . 7.1 p -100.33 151.18 21.8 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.941 -0.762 . . . . 73.120000000000005 108.941 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.99 -29.93 69.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.176 -0.953 . . . . 71.010000000000005 109.064 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -65.66 -37.01 85.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.304 -0.872 . . . . 63.200000000000003 109.251 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -74.75 -30.81 61.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.185 -0.947 . . . . 73.219999999999999 109.584 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -69.3 -50.2 48.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.95 . . . . 74.299999999999997 109.817 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.404 HG23 ' N ' ' B' ' 85' ' ' HIS . 28.3 m -62.1 -36.73 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.088 -1.008 . . . . 73.310000000000002 109.38 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' HIS . . . . . 0.404 ' N ' HG23 ' B' ' 84' ' ' VAL . 16.6 m80 -77.92 -20.11 53.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 73.239999999999995 109.544 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.6 -42.6 58.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.188 -0.945 . . . . 55.329999999999998 110.275 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -83.13 -29.48 28.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.956 -1.09 . . . . 74.140000000000001 109.238 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -75.86 -37.91 58.45 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.308 -0.87 . . . . 64.040000000000006 109.741 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . 0.482 ' CG ' ' N ' ' B' ' 90' ' ' GLY . 11.8 pt20 -73.02 -47.44 45.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.107 -0.995 . . . . 72.349999999999994 109.792 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . 0.482 ' N ' ' CG ' ' B' ' 89' ' ' GLN . . . 147.38 65.35 0.01 OUTLIER Glycine 0 N--CA 1.495 2.614 0 C-N-CA 119.776 -1.202 . . . . 65.200000000000003 110.395 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.24 138.15 53.6 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.363 -1.08 . . . . 52.229999999999997 108.978 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.53 ' CG ' HH21 ' B' ' 112' ' ' ARG . 46.1 t0 -86.54 -26.18 24.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.097 -1.002 . . . . 73.319999999999993 109.608 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 14.4 t0 -152.41 153.09 32.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 72.219999999999999 109.578 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.512 ' N ' ' OD1' ' B' ' 93' ' ' ASP . 61.7 t80 -134.27 101.49 5.03 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.545 -0.909 . . . . 64.420000000000002 108.545 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 23.1 mm -110.28 147.9 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.437 0 O-C-N 121.133 -0.98 . . . . 72.230000000000004 110.283 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.48 145.36 56.23 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.832 -1.173 . . . . 25.239999999999998 107.832 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.68 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -66.24 -56.53 15.93 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.671 -1.268 . . . . 64.319999999999993 111.58 -179.058 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 2.2 Cg_endo -39.88 -12.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 120.909 1.073 . . . . 63.329999999999998 112.824 -175.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . 0.68 ' N ' ' O ' ' B' ' 97' ' ' LYS . 53.7 m-85 59.59 137.09 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.86 -0.525 . . . . 75.129999999999995 110.315 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 50.8 mtt-85 -73.73 -40.28 63.67 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.982 -1.074 . . . . 74.230000000000004 108.808 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . 0.753 ' O ' ' N ' ' B' ' 103' ' ' LYS . 34.4 t -168.1 33.8 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.162 -0.961 . . . . 63.340000000000003 110.782 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 37.3 mm 50.71 -69.62 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.567 -0.708 . . . . 74.439999999999998 110.341 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.753 ' N ' ' O ' ' B' ' 101' ' ' SER . 40.3 mmtm -55.12 -30.49 59.87 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.865 -1.161 . . . . 71.109999999999999 107.865 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.78 -55.69 13.78 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.604 -0.839 . . . . 71.450000000000003 109.011 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 19.0 tp -58.05 -43.78 87.06 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.33 -0.856 . . . . 51.310000000000002 108.762 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.21 -47.88 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -0.93 . . . . 65.230000000000004 108.853 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -49.2 -38.01 24.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.14 -0.975 . . . . 24.32 108.885 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . 0.531 ' O ' ' NE ' ' B' ' 108' ' ' ARG . 0.0 OUTLIER -67.6 -35.25 78.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.476 -0.765 . . . . 75.310000000000002 108.97 179.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 64.3 mt -78.28 -29.94 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.066 -1.022 . . . . 54.240000000000002 109.435 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -67.9 -52.49 35.75 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.537 -0.727 . . . . 65.310000000000002 109.868 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.41 -38.04 74.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.194 -0.942 . . . . 72.239999999999995 110.035 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . 0.53 HH21 ' CG ' ' B' ' 92' ' ' ASP . 40.6 ttt85 -57.84 -35.6 71.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.993 -1.067 . . . . 72.040000000000006 109.704 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.415 ' C ' HD23 ' B' ' 113' ' ' LEU . 2.9 tt -144.07 103.01 3.96 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.097 -1.002 . . . . 75.349999999999994 109.492 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.484 ' NE ' ' H ' ' B' ' 115' ' ' PHE . 0.1 OUTLIER -142.09 -164.37 1.79 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.43 -0.952 . . . . 75.5 108.43 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' PHE . . . . . 0.484 ' H ' ' NE ' ' B' ' 114' ' ' ARG . 45.4 m-85 51.88 32.34 9.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.042 -1.037 . . . . 65.329999999999998 109.294 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' TRP . . . . . 0.757 ' CE3' ' O ' ' B' ' 117' ' ' GLY . 74.4 t90 53.66 169.01 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.499 -0.751 . . . . 74.450000000000003 110.196 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . 0.757 ' O ' ' CE3' ' B' ' 116' ' ' TRP . . . -47.38 145.45 4.75 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.864 -1.294 . . . . 44.210000000000001 109.864 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 43.0 t -94.22 172.87 7.94 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.425 -1.044 . . . . 71.400000000000006 109.406 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . 0.421 ' CG ' ' H ' ' B' ' 120' ' ' VAL . 27.4 t-20 -142.24 178.86 7.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.311 -0.868 . . . . 72.319999999999993 109.043 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . 0.421 ' H ' ' CG ' ' B' ' 119' ' ' ASN . 18.8 t -140.16 -45.15 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.243 -0.911 . . . . 75.019999999999996 109.233 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 9.2 mm -97.89 111.14 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.057 -1.027 . . . . 51.409999999999997 108.501 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -128.23 105.49 8.39 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.496 -0.753 . . . . 71.530000000000001 109.287 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.494 HG23 ' O ' ' B' ' 123' ' ' ILE . 10.5 tp -145.2 122.79 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.165 -0.96 . . . . 72.430000000000007 109.077 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' B' ' 126' ' ' LEU . . . 54.86 -170.98 1.3 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.464 -1.855 . . . . 51.229999999999997 108.464 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.96 2.91 0.63 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.896 -1.356 . . . . 74.200000000000003 108.877 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.489 ' H ' ' C ' ' B' ' 124' ' ' GLY . 0.6 OUTLIER -91.73 117.21 29.55 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.685 -0.857 . . . . 75.420000000000002 108.685 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 83.0 m -125.11 140.92 52.46 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.475 -0.766 . . . . 74.219999999999999 108.964 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 6.3 mt -141.22 136.21 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.271 -0.893 . . . . 60.329999999999998 110.463 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 13.4 m -114.78 114.59 44.23 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.958 -0.756 . . . . 72.310000000000002 108.958 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.453 ' HB3' ' HE ' ' B' ' 157' ' ' ARG . 86.4 Cg_endo -83.48 -40.12 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.248 1.965 . . . . 75.129999999999995 112.172 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -63.34 -49.72 72.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.392 -0.818 . . . . 75.230000000000004 109.492 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -81.83 -0.17 42.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.955 . . . . 72.430000000000007 109.278 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 50.34 74.25 0.23 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.123 -0.985 . . . . 75.129999999999995 109.605 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -159.33 129.64 5.76 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.075 -1.015 . . . . 73.219999999999999 109.351 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 12.4 tt -109.37 128.97 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.795 -0.817 . . . . 64.140000000000001 108.795 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 69.2 mt -116.39 126.48 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-O 121.535 0.683 . . . . 71.219999999999999 110.404 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -135.74 147.03 48.28 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.943 -0.762 . . . . 64.219999999999999 108.943 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm 54.03 36.11 23.77 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.554 -0.716 . . . . 72.019999999999996 110.719 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 64.5 7.75 28.64 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.985 -1.246 . . . . 74.319999999999993 109.985 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -107.04 124.48 49.71 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.478 -1.013 . . . . 75.340000000000003 108.536 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 141' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' B' ' 141' ' ' GLU . 32.2 mp0 -80.92 143.2 32.82 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.416 -0.803 . . . . 71.230000000000004 109.882 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 22.5 t -134.3 129.92 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.64 -0.874 . . . . 70.430000000000007 108.64 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -83.2 149.41 26.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.343 -0.848 . . . . 72.430000000000007 109.662 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 144' ' ' VAL . . . . . 0.547 HG21 ' CZ ' ' B' ' 149' ' ' PHE . 2.5 m -153.05 144.42 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 72.129999999999995 109.384 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 27.2 pttt -175.47 101.86 0.08 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.239 -0.913 . . . . 72.019999999999996 109.262 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 177.52 174.16 43.65 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.663 -1.256 . . . . 42.229999999999997 110.246 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . 0.604 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 10.0 tttt -62.4 -42.4 79.86 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.457 -1.025 . . . . 73.299999999999997 109.706 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 23.3 Cg_exo -62.65 -32.45 79.0 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.575 2.184 . . . . 71.329999999999998 112.461 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . 0.547 ' CZ ' HG21 ' B' ' 144' ' ' VAL . 71.9 t80 -92.43 -15.35 27.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.129 -0.982 . . . . 74.230000000000004 109.886 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -60.88 -41.12 95.39 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.093 -1.004 . . . . 72.340000000000003 109.759 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.492 HG13 ' N ' ' B' ' 152' ' ' LEU . 8.6 p -72.92 -40.6 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.223 -0.923 . . . . 73.349999999999994 110.051 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.492 ' N ' HG13 ' B' ' 151' ' ' VAL . 21.1 tp -56.9 -31.21 64.66 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.268 -0.895 . . . . 55.240000000000002 109.119 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' B' ' 149' ' ' PHE . 0.2 OUTLIER -76.84 -46.67 23.88 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.488 -0.757 . . . . 70.010000000000005 109.183 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -50.29 -46.42 55.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.188 -0.945 . . . . 65.319999999999993 110.507 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . 0.434 HD12 ' N ' ' B' ' 156' ' ' ALA . 1.9 pp -73.77 -34.68 64.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.648 -1.283 . . . . 71.540000000000006 109.383 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . 0.434 ' N ' HD12 ' B' ' 155' ' ' LEU . . . -50.19 -35.8 27.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.096 -1.002 . . . . 75.319999999999993 108.951 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . 0.453 ' HE ' ' HB3' ' B' ' 130' ' ' PRO . 85.6 mtt180 -79.16 -46.47 17.87 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.384 -0.823 . . . . 73.319999999999993 109.175 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -85.57 49.04 1.68 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.666 -0.646 . . . . 74.140000000000001 111.068 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . 0.519 ' NH2' ' OG1' ' B' ' 203' ' ' THR . 5.6 tpt180 -72.83 171.57 12.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.846 -1.159 . . . . 61.409999999999997 108.097 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 51.1 t0 54.48 60.24 3.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.828 -1.17 . . . . 72.099999999999994 109.566 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -171.58 147.23 2.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.309 -0.87 . . . . 72.25 109.312 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 21.8 mm -83.63 122.31 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 72.310000000000002 108.89 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 97.1 t -119.64 139.4 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.393 -0.817 . . . . 64.209999999999994 109.553 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 5.4 t -99.69 160.46 14.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.341 -0.849 . . . . 74.219999999999999 110.047 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . 0.444 ' HZ2' ' CG2' ' B' ' 184' ' ' ILE . 18.0 mtpp -61.55 -44.61 96.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.528 -0.733 . . . . 65.310000000000002 109.609 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -50.54 -39.75 49.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.477 -0.764 . . . . 63.450000000000003 110.254 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -59.29 -48.89 79.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.047 -1.033 . . . . 72.400000000000006 109.51 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 27.5 mt -58.31 -30.56 66.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.212 -0.93 . . . . 72.319999999999993 109.412 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.614 ' C ' HD13 ' B' ' 169' ' ' LEU . 2.3 tm? -66.92 -66.61 0.53 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.388 -0.82 . . . . 73.340000000000003 109.872 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.01 -2.07 6.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.311 -0.868 . . . . 72.099999999999994 110.874 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.91 -57.96 2.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.838 -1.164 . . . . 62.130000000000003 110.116 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 0.711 ' N ' HD12 ' B' ' 172' ' ' ILE . 1.9 mp -91.73 -45.39 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.955 -1.091 . . . . 71.420000000000002 110.123 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 16.5 m-90 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 120.909 -1.119 . . . . 72.230000000000004 108.686 179.796 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo . . . . . 0 N--CA 1.492 1.395 0 N-CA-C 112.914 0.313 . . . . 65.219999999999999 112.914 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 18.9 p30 -160.64 107.3 1.51 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.875 -1.14 . . . . 72.310000000000002 110.17 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 96.7 t -121.55 -36.0 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.489 -0.757 . . . . 63.32 109.477 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.444 ' CG2' ' HZ2' ' B' ' 165' ' ' LYS . 24.5 mm -60.84 -22.18 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 75.030000000000001 109.667 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.09 -42.0 99.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.123 -0.986 . . . . 64.109999999999999 110.259 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . 0.408 HG22 ' H ' ' B' ' 186' ' ' VAL . 5.2 m -79.42 -36.89 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.925 -1.109 . . . . 73.0 109.745 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.1 -46.84 64.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.12 -0.988 . . . . 61.119999999999997 109.714 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 188' ' ' ILE . . . . . 0.444 HG23 ' N ' ' B' ' 189' ' ' ASN . 9.1 tp -62.49 -42.51 96.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.088 -1.008 . . . . 72.430000000000007 110.028 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 189' ' ' ASN . . . . . 0.454 ' OD1' ' NH2' ' B' ' 192' ' ' ARG . 55.1 t30 -58.51 -43.69 89.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.024 . . . . 65.140000000000001 109.827 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -73.7 -38.03 65.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.176 -0.953 . . . . 63.240000000000002 110.319 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 60.9 mt -65.15 -49.14 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.136 -0.977 . . . . 74.030000000000001 110.824 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 192' ' ' ARG . . . . . 0.454 ' NH2' ' OD1' ' B' ' 189' ' ' ASN . 28.4 ptt180 -64.07 -37.33 87.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.84 -1.162 . . . . 72.239999999999995 108.131 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 193' ' ' GLN . . . . . 0.524 ' HG3' ' CE ' ' B' ' 197' ' ' LYS . 42.6 tt0 -65.18 -30.43 71.34 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.905 -1.146 . . . . 73.099999999999994 107.905 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . 0.648 ' O ' HD13 ' B' ' 199' ' ' LEU . 36.5 mtpt -93.44 2.74 56.37 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.084 -0.71 . . . . 72.109999999999999 109.084 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 195' ' ' MET . . . . . 0.881 ' HE2' ' OG1' ' B' ' 203' ' ' THR . 5.0 tpt -94.37 -22.31 18.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.959 -1.088 . . . . 44.329999999999998 109.703 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 196' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 5.1 m-20 -114.02 -27.35 7.74 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.107 -0.995 . . . . 71.209999999999994 111.918 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . 0.524 ' CE ' ' HG3' ' B' ' 193' ' ' GLN . 5.2 mtmm -79.06 -62.77 0.43 Allowed Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 120.427 -1.421 . . . . 75.209999999999994 111.288 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 198' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.66 -49.28 0.17 Allowed 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 121.787 1.658 . . . . 75.319999999999993 112.221 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . 0.648 HD13 ' O ' ' B' ' 194' ' ' LYS . 10.6 mp -54.35 -70.79 0.09 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.092 -1.005 . . . . 72.25 109.034 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 143.44 -59.15 0.53 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.51 -1.436 . . . . 64.530000000000001 109.51 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 29.3 mt -109.34 142.81 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.558 -0.966 . . . . 44.229999999999997 109.677 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 17.3 m -77.71 139.47 39.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.122 -0.987 . . . . 54.009999999999998 108.631 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . 0.881 ' OG1' ' HE2' ' B' ' 195' ' ' MET . 70.7 p -129.55 5.96 5.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.439 -0.788 . . . . 74.400000000000006 109.759 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.472 HG13 ' HE2' ' B' ' 195' ' ' MET . 24.3 m -121.67 147.84 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.502 -0.749 . . . . 72.120000000000005 109.642 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -116.8 125.17 51.2 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.218 -0.66 . . . . 65.409999999999997 109.218 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 206' ' ' THR . . . . . 0.413 HG22 ' H ' ' B' ' 206' ' ' THR . 0.1 OUTLIER -84.07 112.76 20.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.394 -0.817 . . . . 71.329999999999998 109.219 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.612 HG22 ' H ' ' B' ' 209' ' ' ARG . 7.3 p -138.18 145.84 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.367 -0.833 . . . . 63.5 109.264 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 208' ' ' ARG . . . . . 0.405 ' H ' ' HG2' ' B' ' 208' ' ' ARG . 36.0 ptt180 -97.1 -15.78 20.81 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.105 -0.997 . . . . 74.450000000000003 110.11 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 209' ' ' ARG . . . . . 0.612 ' H ' HG22 ' B' ' 207' ' ' VAL . 66.5 mtt-85 -50.24 -39.83 45.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.154 -0.967 . . . . 74.140000000000001 109.859 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -140.04 -53.63 0.52 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.301 -0.875 . . . . 74.430000000000007 109.4 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 211' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' B' ' 207' ' ' VAL . . . 179.65 -102.31 0.16 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.468 -1.453 . . . . 64.450000000000003 109.468 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -136.48 135.31 38.49 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.346 -1.09 . . . . 74.209999999999994 108.948 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 43.5 mtt-85 -95.15 125.78 40.03 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.31 -0.869 . . . . 74.030000000000001 109.395 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . 0.416 ' CD2' HG12 ' B' ' 204' ' ' VAL . 79.8 m-85 -106.4 106.43 16.95 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.493 -0.754 . . . . 74.340000000000003 109.471 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 16.4 p -158.93 170.97 20.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.213 -0.93 . . . . 64.329999999999998 109.545 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -64.14 138.54 97.44 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 121.238 -0.914 . . . . 70.040000000000006 108.81 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 217' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' B' ' 218' ' ' LYS . 74.1 Cg_endo -73.54 77.34 2.59 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.248 1.966 . . . . 65.109999999999999 112.695 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' B' ' 217' ' ' PRO . 18.4 mttm . . . . . 0 N--CA 1.494 1.726 0 O-C-N 121.405 -0.809 . . . . 73.150000000000006 109.742 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.638 ' CE ' ' HE1' ' A' ' 116' ' ' TRP . 64.3 ttp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.492 -0.559 . . . . 65.120000000000005 109.492 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -138.03 151.43 47.87 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.342 -0.849 . . . . 72.329999999999998 109.297 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.8 t -116.79 135.53 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.748 -0.595 . . . . 71.420000000000002 109.632 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 5' ' ' LEU . 0.7 OUTLIER -112.74 122.73 48.53 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.36 -0.837 . . . . 65.120000000000005 109.181 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.718 ' N ' HD12 ' A' ' 4' ' ' LEU . 11.0 mt -120.89 101.74 7.9 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.61 -0.681 . . . . 62.43 109.181 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.537 HG12 HD11 ' A' ' 4' ' ' LEU . 10.6 mt -79.27 104.61 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.781 -1.2 . . . . 71.150000000000006 108.753 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 9' ' ' ASN . 0.6 OUTLIER -139.16 123.19 17.86 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.306 -0.871 . . . . 75.340000000000003 109.215 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.44 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 68.3 mttm -65.35 -33.68 76.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 72.439999999999998 109.162 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.513 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 18.2 m120 -82.41 112.36 19.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 63.020000000000003 109.485 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 45.5 m -63.83 -26.31 68.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 72.340000000000003 109.653 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.29 -53.2 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.195 -0.941 . . . . 74.019999999999996 109.863 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.6 mt -61.42 -46.84 88.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 71.430000000000007 109.585 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.32 -17.1 71.99 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.517 -1.833 . . . . 61.32 108.517 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.4 -54.41 5.57 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.483 -1.447 . . . . 71.200000000000003 109.483 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -56.51 -44.9 81.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.425 -1.044 . . . . 71.319999999999993 109.783 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.2 mm -63.41 -34.99 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.822 -1.174 . . . . 63.229999999999997 108.798 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.48 ' CD ' HD21 ' A' ' 21' ' ' ASN . 14.2 tm-20 -57.91 -49.66 75.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.922 . . . . 51.109999999999999 109.102 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -87.52 3.47 47.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.26 -0.9 . . . . 73.340000000000003 109.262 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.66 -57.96 2.48 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.68 -1.368 . . . . 62.149999999999999 109.68 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -75.05 -19.98 59.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -1.146 . . . . 73.510000000000005 109.869 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.48 HD21 ' CD ' ' A' ' 17' ' ' GLU . 80.4 m-20 -51.29 -33.88 30.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.092 -1.005 . . . . 74.25 109.282 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.2 t -58.0 -46.95 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.322 -0.861 . . . . 70.040000000000006 108.938 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -56.91 -53.18 60.95 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.903 -0.777 . . . . 73.230000000000004 108.903 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 133.63 36.41 0.26 Allowed Glycine 0 N--CA 1.5 2.929 0 N-CA-C 109.735 -1.346 . . . . 75.540000000000006 109.735 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.59 ' CE2' ' SD ' ' A' ' 1' ' ' MET . 20.1 m-85 -119.39 160.02 23.1 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.483 -1.01 . . . . 73.430000000000007 109.344 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.2 mmt -104.22 140.34 37.98 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.571 -0.9 . . . . 43.240000000000002 108.571 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.417 ' O ' ' OD1' ' A' ' 28' ' ' ASP . . . -138.52 155.48 48.36 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.337 -0.852 . . . . 62.109999999999999 110.28 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 27' ' ' ALA . 82.1 m-20 -141.57 155.6 45.75 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.592 -0.892 . . . . 74.420000000000002 108.592 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.2 t -112.11 139.35 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.379 -0.826 . . . . 72.150000000000006 109.384 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.6 p -129.99 166.69 19.57 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.523 -0.736 . . . . 71.420000000000002 109.573 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.449 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 4.4 pt-20 -93.72 -102.98 0.13 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.348 -0.845 . . . . 72.329999999999998 109.809 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.7 p -79.31 168.88 18.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.115 -0.991 . . . . 74.239999999999995 109.891 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.0 mt -57.33 -33.32 67.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.521 -0.737 . . . . 71.530000000000001 109.742 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -51.27 -43.57 61.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 74.230000000000004 109.661 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -65.91 -41.92 90.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.154 -0.966 . . . . 54.030000000000001 109.373 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.25 -38.44 46.33 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.493 -1.443 . . . . 61.409999999999997 109.493 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.71 -38.18 90.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -1.135 . . . . 74.340000000000003 109.621 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -80.84 -39.47 26.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 75.329999999999998 109.717 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.9 tp -68.16 -46.35 70.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 74.329999999999998 110.077 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 41' ' ' ASP . 3.3 ppp? -62.73 -27.62 69.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.041 -1.037 . . . . 70.319999999999993 109.83 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 40' ' ' MET . 93.5 m-20 -63.49 -40.21 96.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.135 -0.978 . . . . 71.219999999999999 109.94 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.9 pt -84.0 -25.86 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.159 -0.963 . . . . 74.140000000000001 110.167 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 40' ' ' MET . 97.4 mtt180 -130.04 138.76 50.93 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.373 -0.829 . . . . 72.239999999999995 109.584 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -93.98 126.36 39.15 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.248 -0.908 . . . . 75.420000000000002 109.472 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -106.01 145.78 30.93 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.429 -0.794 . . . . 74.230000000000004 109.524 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -85.57 -44.56 12.54 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.274 -0.891 . . . . 72.040000000000006 109.078 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.537 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -105.56 108.41 19.9 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.585 -0.894 . . . . 72.129999999999995 108.585 179.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.432 ' N ' HD13 ' A' ' 47' ' ' LEU . 2.0 m -104.33 101.86 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.31 -0.996 . . . . 72.340000000000003 108.31 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.6 ttt -108.37 143.02 37.83 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.688 -0.856 . . . . 74.109999999999999 108.688 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' A' ' 55' ' ' ALA . 1.3 p -144.15 132.34 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.361 -0.837 . . . . 61.119999999999997 109.933 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.0 m -98.98 2.29 46.23 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.481 -0.762 . . . . 73.109999999999999 109.472 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -76.14 139.12 41.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.192 -0.943 . . . . 52.549999999999997 109.427 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.481 ' C ' ' H ' ' A' ' 55' ' ' ALA . 61.6 mttp -73.62 -43.5 59.42 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.307 -0.871 . . . . 44.219999999999999 110.731 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -68.16 10.26 0.24 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.017 -1.052 . . . . 70.439999999999998 109.89 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.93 -22.18 56.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.893 . . . . 64.140000000000001 110.57 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' ALA . 64.0 mt -39.98 -51.59 2.51 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.511 -0.743 . . . . 44.140000000000001 110.498 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.9 m -68.75 -33.72 74.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.939 -1.1 . . . . 55.229999999999997 109.319 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.539 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 73.6 t80 -64.84 -48.42 74.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.386 -0.821 . . . . 74.439999999999998 110.088 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.61 -34.83 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.615 -1.303 . . . . 74.030000000000001 109.52 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.9 p -57.33 -49.64 75.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 64.299999999999997 109.542 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -69.41 -33.2 72.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.032 -1.043 . . . . 64.439999999999998 109.927 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.539 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 5.1 mm -63.63 -35.41 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.828 -1.17 . . . . 63.210000000000001 109.747 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 67' ' ' SER . 11.5 mtpt -72.08 -51.05 23.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.123 -0.986 . . . . 74.420000000000002 110.461 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.431 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 14.6 pt-20 -67.24 -41.69 85.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.743 -1.223 . . . . 70.319999999999993 109.708 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.448 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 93.4 mttt -73.61 -24.42 60.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.878 . . . . 75.219999999999999 109.501 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.518 ' O ' HG22 ' A' ' 69' ' ' ILE . 93.5 m-70 -154.93 65.88 0.66 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.229 -0.92 . . . . 74.129999999999995 109.293 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 63' ' ' LYS . 17.0 t -60.45 -32.56 71.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.392 -0.818 . . . . 73.239999999999995 110.038 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.1 m -67.59 46.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 61.009999999999998 109.859 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 66' ' ' HIS . 13.8 tt -145.63 162.85 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.142 -0.974 . . . . 71.329999999999998 109.726 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.537 ' HB ' HD22 ' A' ' 47' ' ' LEU . 45.0 t -97.73 148.75 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.221 -0.924 . . . . 72.129999999999995 108.942 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.51 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 11.3 t -132.38 124.08 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.282 -0.886 . . . . 54.210000000000001 109.508 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.525 HD12 HD21 ' A' ' 47' ' ' LEU . 2.1 mt -128.07 99.26 5.41 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.319 -0.993 . . . . 50.240000000000002 108.319 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.603 ' O ' HD12 ' A' ' 95' ' ' ILE . 64.3 t -93.12 149.56 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -0.869 . . . . 74.409999999999997 109.14 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.7 m -121.96 165.84 15.36 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.529 -0.915 . . . . 72.310000000000002 108.529 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.45 ' CB ' ' OE2' ' A' ' 82' ' ' GLU . 9.7 p -171.81 123.65 0.53 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.035 -1.041 . . . . 64.540000000000006 110.226 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 52.1 p30 -71.0 10.56 0.52 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.59 -0.694 . . . . 74.129999999999995 109.901 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.445 ' H ' ' C ' ' A' ' 75' ' ' SER . 5.8 p-10 -129.09 59.57 44.95 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.38 -0.825 . . . . 73.340000000000003 109.661 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -58.9 80.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.276 1.984 . . . . 63.219999999999999 112.047 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.403 ' N ' ' O ' ' A' ' 77' ' ' ASN . 72.6 p -104.28 151.56 23.27 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.621 -0.881 . . . . 62.530000000000001 108.621 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -30.8 69.53 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.228 -0.92 . . . . 73.439999999999998 109.363 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -67.15 -37.47 83.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.189 -0.945 . . . . 71.420000000000002 109.554 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.45 ' OE2' ' CB ' ' A' ' 75' ' ' SER . 79.4 tt0 -71.47 -32.62 68.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 73.430000000000007 109.722 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.476 ' OE2' ' CZ ' ' B' ' 100' ' ' ARG . 92.2 mt-10 -64.44 -50.95 65.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.918 . . . . 74.219999999999999 109.825 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.3 m -61.01 -36.32 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.157 -0.964 . . . . 73.200000000000003 109.252 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.429 ' O ' ' OE1' ' A' ' 89' ' ' GLN . 27.0 m80 -74.51 -26.65 60.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 53.329999999999998 109.599 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -66.53 -41.96 87.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.109 -0.995 . . . . 64.109999999999999 109.786 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.479 ' CZ ' ' HB1' ' B' ' 111' ' ' ALA . 89.1 t80 -82.05 -35.12 29.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.042 -1.036 . . . . 74.340000000000003 109.08 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -62.08 -51.55 67.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.379 -0.825 . . . . 74.420000000000002 109.411 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.488 ' NE2' ' N ' ' A' ' 89' ' ' GLN . 0.9 OUTLIER -66.6 -58.26 5.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.531 -0.731 . . . . 74.239999999999995 109.686 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 158.17 75.27 0.02 OUTLIER Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.613 -1.279 . . . . 61.509999999999998 110.266 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -134.84 119.61 18.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.305 -1.115 . . . . 55.329999999999998 108.947 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 71.6 m-20 -71.36 -34.79 70.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.102 -0.999 . . . . 73.420000000000002 108.923 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.517 ' CG ' HH21 ' A' ' 112' ' ' ARG . 60.7 m-20 -153.16 152.5 31.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.451 -0.781 . . . . 75.040000000000006 109.046 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.423 ' OH ' ' OG ' ' A' ' 75' ' ' SER . 9.3 t80 -126.76 132.93 50.96 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.08 -0.711 . . . . 71.329999999999998 109.08 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.798 ' H ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -121.57 142.38 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 CA-C-O 121.978 0.894 . . . . 71.129999999999995 110.442 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.52 119.86 10.61 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.599 -1.26 . . . . 64.319999999999993 107.599 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.677 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -43.9 -53.9 12.05 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 62.200000000000003 111.628 -178.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 2.3 Cg_endo -40.56 -10.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 120.955 1.103 . . . . 73.109999999999999 113.12 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.677 ' N ' ' O ' ' A' ' 97' ' ' LYS . 64.0 m-85 59.96 92.73 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.71 -0.619 . . . . 65.219999999999999 109.9 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.8 ttm105 -52.09 -39.03 59.14 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.354 -0.98 . . . . 72.349999999999994 108.354 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 t -172.41 134.41 0.68 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.493 -0.755 . . . . 71.319999999999993 109.025 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 81.8 mt -53.34 -40.1 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.127 -0.983 . . . . 75.430000000000007 109.26 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -66.79 -26.22 66.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 71.409999999999997 109.67 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.81 -48.58 21.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.171 -0.955 . . . . 63.240000000000002 109.856 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.7 ' C ' HD13 ' A' ' 105' ' ' LEU . 2.1 tm? -57.75 -54.05 51.24 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.207 -0.933 . . . . 73.219999999999999 109.442 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.526 HG13 ' N ' ' A' ' 107' ' ' ALA . 11.0 p -60.28 -41.9 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.099 -1.001 . . . . 60.109999999999999 109.52 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.526 ' N ' HG13 ' A' ' 106' ' ' VAL . . . -51.8 -36.63 48.47 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.17 -0.956 . . . . 70.420000000000002 108.925 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -71.87 -37.45 70.19 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.372 -0.83 . . . . 74.409999999999997 109.399 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 87.7 mt -67.11 -31.61 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 107.978 -1.119 . . . . 62.539999999999999 107.978 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 113' ' ' LEU . 78.5 tt0 -65.85 -57.55 7.66 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.637 -0.825 . . . . 74.340000000000003 108.927 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -46.21 -37.2 6.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.475 -0.766 . . . . 73.319999999999993 109.655 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.517 HH21 ' CG ' ' A' ' 93' ' ' ASP . 28.1 mmt180 -82.25 -14.46 55.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 52.409999999999997 110.103 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' ' 110' ' ' GLU . 80.4 mt -135.25 44.08 2.61 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.133 -0.979 . . . . 65.239999999999995 110.617 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -76.44 -39.19 54.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.848 -1.158 . . . . 64.450000000000003 108.846 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.529 ' CD2' ' O ' ' A' ' 116' ' ' TRP . 33.8 p90 -67.74 -10.98 57.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.424 -0.797 . . . . 74.430000000000007 109.977 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.638 ' HE1' ' CE ' ' A' ' 1' ' ' MET . 48.0 t90 50.29 -178.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.138 -0.976 . . . . 74.420000000000002 109.504 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.495 ' N ' ' CG ' ' A' ' 116' ' ' TRP . . . -50.96 143.18 15.0 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.351 -1.499 . . . . 75.040000000000006 109.351 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 87.9 p -157.6 -178.5 7.38 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -1.206 . . . . 61.140000000000001 110.068 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.38 -179.64 8.13 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.05 -0.722 . . . . 65.239999999999995 109.05 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.6 t -138.34 -36.6 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.42 -0.8 . . . . 73.109999999999999 109.125 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.55 HD12 ' N ' ' A' ' 121' ' ' ILE . 1.4 mp -90.4 136.41 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.995 . . . . 72.239999999999995 108.493 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -138.6 105.69 5.46 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.349 -0.844 . . . . 72.340000000000003 109.47 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 83.5 mt -108.94 109.78 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.962 -0.755 . . . . 71.439999999999998 108.962 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.8 -137.73 31.06 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.277 -1.529 . . . . 73.400000000000006 109.277 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -79.56 -3.83 48.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -1.191 . . . . 74.450000000000003 109.349 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.45 HD22 ' CE1' ' A' ' 137' ' ' TYR . 0.5 OUTLIER -89.06 143.25 26.98 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.356 -0.979 . . . . 54.210000000000001 108.356 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 54.9 m -129.86 141.07 50.87 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.375 -0.828 . . . . 54.5 109.231 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.74 130.81 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.42 -0.8 . . . . 45.149999999999999 109.976 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.1 m -107.4 113.45 61.89 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.633 -0.667 . . . . 71.109999999999999 109.226 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.8 -53.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.92 1.746 . . . . 65.409999999999997 111.959 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -55.3 -44.65 75.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 63.32 109.316 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -83.52 -8.54 59.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.401 -0.812 . . . . 72.519999999999996 109.153 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 51.72 57.53 6.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 75.329999999999998 109.154 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -139.37 116.03 10.73 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.411 -0.806 . . . . 71.230000000000004 109.164 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.543 HD12 ' N ' ' A' ' 135' ' ' ILE . 1.4 mp -94.22 130.24 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.185 -0.947 . . . . 74.019999999999996 108.905 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 36.8 mt -115.91 129.41 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.561 -0.712 . . . . 60.229999999999997 109.575 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.466 ' C ' ' H ' ' A' ' 139' ' ' GLY . 77.5 t80 -141.58 151.19 42.96 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.512 -0.922 . . . . 62.32 108.512 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 46.1 tttp 55.94 5.63 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.851 . . . . 75.400000000000006 109.408 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 137' ' ' TYR . . . 93.86 -4.81 72.29 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.686 -1.366 . . . . 72.239999999999995 109.686 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.404 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 0.7 OUTLIER -89.71 139.7 30.3 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.247 -1.149 . . . . 71.219999999999999 109.299 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -86.71 137.19 32.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 71.420000000000002 109.162 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.1 t -135.26 128.12 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.43 -0.794 . . . . 53.020000000000003 109.531 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -93.37 134.34 35.69 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.306 -0.871 . . . . 60.450000000000003 109.048 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.413 ' CG2' HD13 ' A' ' 135' ' ' ILE . 15.1 m -149.48 140.56 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.106 -0.996 . . . . 74.439999999999998 109.556 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -163.54 18.83 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 65.150000000000006 109.776 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.3 161.09 54.16 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.844 -1.702 . . . . 73.340000000000003 108.844 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.562 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 4.8 tttp -56.44 -44.73 99.86 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.039 -1.271 . . . . 72.219999999999999 109.091 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 24.2 Cg_exo -62.58 -28.5 77.3 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.362 2.042 . . . . 65.230000000000004 112.122 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -80.67 -20.7 42.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.232 -0.918 . . . . 60.109999999999999 110.12 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -52.75 -32.96 46.14 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.067 -1.021 . . . . 64.209999999999994 108.965 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 148' ' ' PRO . 6.4 p -64.95 -38.08 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.324 -0.86 . . . . 72.019999999999996 109.276 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 29.4 tp -60.86 -41.92 96.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.857 . . . . 73.310000000000002 109.322 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 20.0 p -74.35 -34.79 63.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.245 -0.909 . . . . 74.310000000000002 110.16 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.569 ' ND1' ' NH2' ' A' ' 157' ' ' ARG . 43.9 m-70 -60.9 -52.69 63.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.137 -0.977 . . . . 74.310000000000002 110.035 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 pp -68.52 -28.56 67.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.906 -1.121 . . . . 75.340000000000003 109.602 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.3 -47.59 78.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 62.140000000000001 109.377 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.569 ' NH2' ' ND1' ' A' ' 154' ' ' HIS . 67.9 mtm-85 -69.03 -58.69 3.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.965 . . . . 61.030000000000001 109.461 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -53.27 -47.67 68.94 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.811 -0.756 . . . . 74.120000000000005 109.457 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 161' ' ' GLN . 23.1 ttm180 44.97 -126.49 1.1 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.401 -0.812 . . . . 71.129999999999995 109.895 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 45.6 p-10 -50.08 90.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 75.450000000000003 109.561 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.844 ' OE1' ' OH ' ' B' ' 216' ' ' TYR . 1.4 tp-100 -171.53 149.54 2.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.246 -0.909 . . . . 73.409999999999997 109.325 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 65.3 mt -78.51 135.46 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.148 -0.97 . . . . 74.409999999999997 109.216 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 87.1 t -127.58 129.29 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.452 -0.78 . . . . 72.310000000000002 109.653 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.7 t -99.44 153.36 19.07 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.435 -0.791 . . . . 74.120000000000005 109.324 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.5 mtmm -56.97 -43.83 82.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.33 -0.856 . . . . 70.430000000000007 109.494 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -59.01 -34.26 71.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.341 -0.85 . . . . 73.519999999999996 109.575 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -63.91 -55.19 24.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.166 -0.959 . . . . 74.519999999999996 109.621 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 80.3 mt -47.64 -52.71 17.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.143 -0.973 . . . . 72.310000000000002 109.774 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 171' ' ' ALA . 87.2 mt -57.62 -74.6 0.05 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.591 -1.318 . . . . 53.329999999999998 109.666 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -48.86 -11.01 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.973 -1.079 . . . . 62.439999999999998 110.459 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 169' ' ' LEU . . . -95.43 -41.39 9.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.189 -0.945 . . . . 60.210000000000001 111.185 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.61 -47.18 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.917 -1.114 . . . . 75.319999999999993 109.688 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.626 ' O ' ' CD1' ' A' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.251 0 O-C-N 120.668 -1.27 . . . . 73.140000000000001 109.188 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 14.9 p30 . . . . . 0 N--CA 1.494 1.754 0 N-CA-C 109.345 -0.613 . . . . 64.540000000000006 109.345 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.0 p -166.47 -27.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.852 . . . . 74.019999999999996 109.861 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 10.9 tp -50.97 -22.38 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.068 -1.02 . . . . 72.329999999999998 109.914 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.437 ' CG ' ' N ' ' A' ' 186' ' ' VAL . 18.9 pt-20 -70.05 -48.93 55.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.055 -1.028 . . . . 74.400000000000006 109.572 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.437 ' N ' ' CG ' ' A' ' 185' ' ' GLU . 14.1 m -72.04 -28.87 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.808 -1.183 . . . . 70.420000000000002 108.969 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -77.87 -55.42 5.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 52.109999999999999 110.069 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.411 HD12 HD11 ' A' ' 191' ' ' ILE . 11.2 tp -52.6 -33.37 18.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.675 -1.266 . . . . 71.400000000000006 109.324 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -72.76 -41.27 65.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.173 -0.954 . . . . 73.439999999999998 111.214 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.452 ' CG ' ' N ' ' A' ' 191' ' ' ILE . 1.0 OUTLIER -77.33 -46.37 23.12 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.586 -1.321 . . . . 71.420000000000002 111.029 -178.431 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.452 ' N ' ' CG ' ' A' ' 190' ' ' GLN . 6.5 pt -62.22 -41.01 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.717 -1.239 . . . . 61.549999999999997 109.971 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -69.21 -34.27 74.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.849 -1.157 . . . . 63.340000000000003 108.597 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -64.86 -39.58 93.78 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.694 -0.629 . . . . 61.240000000000002 110.082 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.422 ' O ' ' CD ' ' A' ' 198' ' ' PRO . 11.4 pttp -92.09 -2.55 56.57 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.047 -1.033 . . . . 75.129999999999995 110.549 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 48.2 ttp -93.75 -45.42 7.69 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.94 -1.1 . . . . 74.019999999999996 109.974 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -60.29 -33.02 71.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.07 -1.019 . . . . 74.019999999999996 110.385 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -64.4 -61.11 7.11 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.978 -1.076 . . . . 75.430000000000007 110.335 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.422 ' CD ' ' O ' ' A' ' 194' ' ' LYS . 31.5 Cg_endo -61.11 -55.52 1.25 Allowed 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.824 1.682 . . . . 72.319999999999993 111.844 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.495 ' C ' ' H ' ' A' ' 201' ' ' ILE . 10.0 mp -63.09 -36.9 85.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -0.942 . . . . 74.540000000000006 109.282 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 73.51 -23.73 0.98 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.598 -1.401 . . . . 61.509999999999998 109.598 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.495 ' H ' ' C ' ' A' ' 199' ' ' LEU . 13.6 mt -110.66 137.12 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.483 -1.01 . . . . 61.219999999999999 109.351 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 8.6 t -84.87 143.6 28.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.164 -0.96 . . . . 72.0 109.354 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.5 p -141.19 27.94 1.91 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.278 -0.889 . . . . 74.439999999999998 109.267 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.527 ' CG1' ' CE2' ' A' ' 214' ' ' PHE . 2.7 m -143.66 128.64 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.239 -0.913 . . . . 64.349999999999994 109.692 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -102.76 121.91 43.41 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.381 -0.825 . . . . 71.409999999999997 108.808 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.425 ' H ' HG22 ' A' ' 206' ' ' THR . 0.0 OUTLIER -84.88 117.32 23.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.145 -0.972 . . . . 73.519999999999996 109.873 -179.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.411 ' O ' ' O ' ' A' ' 211' ' ' GLY . 12.8 p -150.25 147.58 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.345 -0.847 . . . . 71.019999999999996 109.062 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -64.34 -130.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.144 -0.973 . . . . 72.120000000000005 109.479 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? 50.17 -106.02 0.21 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.91 . . . . 64.409999999999997 109.337 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -75.9 -59.08 2.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 71.540000000000006 109.486 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 207' ' ' VAL . . . 159.26 -109.57 0.41 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.641 -1.384 . . . . 72.030000000000001 109.641 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 212' ' ' TYR . 41.9 m-85 -109.73 134.91 51.45 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.522 -0.987 . . . . 75.540000000000006 109.369 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -107.31 132.5 53.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.509 -0.744 . . . . 75.310000000000002 109.476 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.527 ' CE2' ' CG1' ' A' ' 204' ' ' VAL . 43.8 m-85 -97.45 128.69 44.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.258 -0.901 . . . . 75.409999999999997 109.107 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 49.2 m -140.18 156.55 46.47 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.439 -0.788 . . . . 74.140000000000001 109.077 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -69.52 153.98 95.25 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.916 . . . . 75.319999999999993 109.183 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo . . . . . 0 N--CA 1.49 1.288 0 C-N-CA 122.478 2.119 . . . . 73.109999999999999 112.478 179.946 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.487 ' SD ' ' OD2' ' B' ' 46' ' ' ASP . 7.4 mtt . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.364 -0.606 . . . . 71.140000000000001 109.364 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -136.09 125.04 24.19 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.463 -0.773 . . . . 73.230000000000004 109.166 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.1 t -111.83 133.79 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-O 121.359 0.6 . . . . 72.239999999999995 109.564 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.443 HD12 ' N ' ' B' ' 5' ' ' LEU . 4.9 tp -101.73 120.47 40.4 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.488 -0.757 . . . . 54.329999999999998 109.174 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.443 ' N ' HD12 ' B' ' 4' ' ' LEU . 17.3 mt -119.46 98.58 6.21 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.464 -0.772 . . . . 74.349999999999994 109.108 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.453 HD12 ' HB ' ' B' ' 50' ' ' VAL . 16.9 mt -83.48 98.8 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.872 -1.142 . . . . 42.549999999999997 108.469 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' B' ' 9' ' ' ASN . 33.8 tp10 -142.8 128.84 19.65 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.382 -0.824 . . . . 74.519999999999996 109.416 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -66.77 -31.36 71.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.9 . . . . 62.549999999999997 109.478 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . 0.404 ' H ' ' HG3' ' B' ' 7' ' ' GLU . 94.7 m-20 -79.22 112.02 16.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 73.109999999999999 109.533 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 82.2 p -71.78 -25.28 61.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 65.540000000000006 109.698 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 82.3 t -62.57 -49.85 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -0.958 . . . . 75.549999999999997 109.623 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.574 ' N ' HD22 ' B' ' 12' ' ' LEU . 3.8 mm? -67.04 -28.95 68.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 70.140000000000001 109.206 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.8 -23.18 64.82 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.745 -1.742 . . . . 75.400000000000006 108.745 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.47 -49.74 7.91 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.705 -1.358 . . . . 65.439999999999998 109.705 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.09 -42.56 99.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.1 -1.235 . . . . 60.210000000000001 109.048 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 6.0 mm -60.87 -35.59 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.259 -1.015 . . . . 75.150000000000006 108.259 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -63.1 -44.04 96.8 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.498 -0.751 . . . . 73.010000000000005 109.361 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -86.05 1.61 49.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.15 -0.969 . . . . 74.299999999999997 109.301 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.12 -53.32 2.69 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 109.446 -1.462 . . . . 70.540000000000006 109.446 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -77.41 -22.26 51.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -1.152 . . . . 71.340000000000003 109.793 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -52.5 -34.88 51.47 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.072 -1.017 . . . . 64.409999999999997 109.077 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 54.3 t -55.47 -45.93 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.351 -0.843 . . . . 74.230000000000004 108.867 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 49.3 mmtt -60.14 -53.33 59.03 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.491 -0.756 . . . . 63.420000000000002 109.035 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 133.56 35.72 0.28 Allowed Glycine 0 N--CA 1.5 2.965 0 N-CA-C 110.099 -1.201 . . . . 53.43 110.099 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -119.5 159.54 24.1 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.392 -1.064 . . . . 71.120000000000005 109.308 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 13.0 mmt -103.39 141.43 35.96 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.502 -0.925 . . . . 75.239999999999995 108.502 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.429 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -133.41 157.6 45.16 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.393 -0.817 . . . . 72.120000000000005 110.265 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . 0.476 ' OD2' ' NH1' ' B' ' 43' ' ' ARG . 82.0 m-20 -142.84 160.37 40.45 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.677 -0.86 . . . . 72.310000000000002 108.677 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 5.0 p -121.43 139.76 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.364 -0.835 . . . . 64.430000000000007 109.718 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 10.2 p -133.52 165.21 25.41 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.59 -0.694 . . . . 65.409999999999997 109.213 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -91.72 -104.99 0.11 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.277 -0.889 . . . . 71.019999999999996 109.677 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 60.0 p -78.52 168.98 18.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 51.109999999999999 109.902 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' B' ' 37' ' ' GLU . 19.0 mt -53.65 -33.55 55.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.502 -0.749 . . . . 71.239999999999995 109.866 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -51.02 -48.95 61.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.099 -1.0 . . . . 74.319999999999993 109.499 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -64.37 -39.73 94.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 73.030000000000001 108.957 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.28 -36.21 63.55 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.295 -1.522 . . . . 30.210000000000001 109.295 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' B' ' 33' ' ' LEU . 83.8 tt0 -66.16 -41.54 90.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -1.122 . . . . 74.420000000000002 109.472 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -79.44 -37.77 36.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.136 -0.977 . . . . 74.420000000000002 109.408 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 41.2 tp -68.48 -41.86 79.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 75.409999999999997 109.63 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.0 ppp? -73.53 -21.74 60.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.143 -0.973 . . . . 60.409999999999997 109.535 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -53.44 -38.34 63.46 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.012 -1.055 . . . . 53.229999999999997 108.936 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 8.6 pt -95.98 -33.19 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.351 -0.843 . . . . 71.230000000000004 109.651 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.476 ' NH1' ' OD2' ' B' ' 28' ' ' ASP . 93.1 mtt180 -96.32 138.57 33.72 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.081 -1.012 . . . . 72.219999999999999 109.593 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' ASN . . . . . 0.435 ' O ' ' O ' ' B' ' 45' ' ' TYR . 84.7 m-20 -81.08 -30.63 34.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.168 -0.957 . . . . 63.539999999999999 109.966 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' B' ' 44' ' ' ASN . 38.4 m-85 52.24 100.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.302 -0.874 . . . . 64.349999999999994 109.436 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . 0.487 ' OD2' ' SD ' ' B' ' 1' ' ' MET . 73.1 m-20 -70.11 -36.99 75.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.106 -0.996 . . . . 62.219999999999999 109.016 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.522 HD13 ' C ' ' B' ' 47' ' ' LEU . 1.0 OUTLIER -107.01 111.58 24.14 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.673 -0.862 . . . . 73.120000000000005 108.673 179.567 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.475 ' N ' HD13 ' B' ' 47' ' ' LEU . 53.1 t -94.89 99.8 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.299 -0.876 . . . . 65.109999999999999 109.378 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 1.8 tpp -113.55 130.02 56.44 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.774 -0.825 . . . . 73.439999999999998 108.774 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.463 ' N ' ' SD ' ' B' ' 49' ' ' MET . 0.2 OUTLIER -146.66 135.49 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 34.5 109.312 -179.505 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 73.1 p -103.51 8.68 37.79 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.504 -0.748 . . . . 73.209999999999994 110.25 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -76.82 142.25 40.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.081 -1.012 . . . . 70.409999999999997 109.547 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -74.3 -38.36 63.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 65.0 110.293 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -72.57 8.19 1.54 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.034 -1.041 . . . . 75.209999999999994 109.716 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.55 -21.24 59.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 55.329999999999998 110.222 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 71.1 mt -43.68 -41.11 4.57 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.318 -0.864 . . . . 63.140000000000001 110.224 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 27.4 t -72.92 -38.59 66.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.999 -1.063 . . . . 63.5 109.567 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . 0.605 ' CE2' HD11 ' B' ' 62' ' ' ILE . 50.4 t80 -64.27 -49.58 71.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.343 -0.848 . . . . 72.329999999999998 110.135 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.15 -35.36 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.765 -1.209 . . . . 74.540000000000006 109.69 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 59.8 p -58.22 -45.82 86.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.237 -0.914 . . . . 71.239999999999995 109.681 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' B' ' 65' ' ' LYS . 8.8 ptp180 -75.36 -30.78 60.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.058 -1.026 . . . . 74.310000000000002 110.076 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.605 HD11 ' CE2' ' B' ' 58' ' ' PHE . 5.0 mm -60.55 -51.91 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.745 -1.222 . . . . 72.140000000000001 109.24 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -63.1 -40.78 98.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.135 -0.978 . . . . 73.319999999999993 109.183 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -68.93 -38.88 79.79 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.512 -0.921 . . . . 73.120000000000005 108.512 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' B' ' 61' ' ' ARG . 14.4 mtpp -86.24 -74.23 0.43 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.285 -0.884 . . . . 72.439999999999998 109.481 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.453 ' N ' ' O ' ' B' ' 62' ' ' ILE . 53.6 m-70 -98.08 87.43 3.95 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.226 -0.921 . . . . 63.310000000000002 109.524 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 23.2 t -78.46 -32.18 48.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 73.099999999999994 109.923 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 94.7 p -59.7 -23.51 63.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.233 -0.917 . . . . 71.530000000000001 109.643 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.407 HG21 HD13 ' B' ' 69' ' ' ILE . 57.3 mt -84.09 149.48 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.246 -0.909 . . . . 74.400000000000006 109.293 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.562 HG12 ' N ' ' B' ' 71' ' ' VAL . 75.8 t -91.08 164.49 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.247 -0.908 . . . . 75.120000000000005 109.637 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.562 ' N ' HG12 ' B' ' 70' ' ' VAL . 4.3 t -139.68 128.15 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.318 -0.864 . . . . 73.200000000000003 109.348 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.497 ' O ' ' SD ' ' B' ' 49' ' ' MET . 0.6 OUTLIER -123.69 106.52 10.6 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.608 -0.886 . . . . 73.340000000000003 108.608 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 71.0 t -91.4 129.58 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.117 -0.989 . . . . 73.5 109.008 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 6.8 p -90.36 171.25 9.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.917 -1.114 . . . . 64.340000000000003 108.987 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.424 ' C ' ' H ' ' B' ' 97' ' ' LYS . 13.6 p -155.76 112.34 3.16 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.927 -1.108 . . . . 74.530000000000001 110.261 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -67.2 -27.47 67.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.329 -0.857 . . . . 64.5 109.005 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' B' ' 79' ' ' THR . 13.5 t-20 -127.06 75.65 76.52 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.677 -0.86 . . . . 74.25 108.677 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -44.79 88.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.572 2.181 . . . . 74.430000000000007 111.777 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.471 ' N ' ' O ' ' B' ' 77' ' ' ASN . 17.1 m -104.04 148.65 25.98 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.59 0.71 . . . . 73.120000000000005 109.717 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -33.69 76.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.196 -0.94 . . . . 71.010000000000005 109.006 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . 0.434 ' H ' HG22 ' B' ' 79' ' ' THR . 84.2 tt0 -57.07 -39.42 74.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 63.200000000000003 109.036 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -71.91 -31.73 66.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.223 -0.923 . . . . 73.219999999999999 109.201 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.535 ' OE1' ' CD1' ' B' ' 94' ' ' TYR . 5.9 mm-40 -64.57 -56.55 13.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.22 -0.925 . . . . 74.299999999999997 110.027 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.437 HG23 ' N ' ' B' ' 85' ' ' HIS . 29.9 m -57.59 -41.21 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 73.310000000000002 109.832 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' HIS . . . . . 0.437 ' N ' HG23 ' B' ' 84' ' ' VAL . 60.5 t60 -74.05 -25.15 59.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.152 -0.968 . . . . 73.239999999999995 109.59 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.26 -36.3 79.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 55.329999999999998 110.021 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -80.17 -33.73 38.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.119 -0.988 . . . . 74.140000000000001 108.892 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -69.75 -33.52 72.55 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.338 -0.851 . . . . 64.040000000000006 109.428 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -77.55 -67.53 0.71 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 72.349999999999994 109.499 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 156.86 66.02 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.011 -1.236 . . . . 65.200000000000003 110.011 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.68 124.64 46.75 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.444 -1.033 . . . . 52.229999999999997 109.054 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -69.98 -36.85 75.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.12 -0.987 . . . . 73.319999999999993 109.438 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' ASP . . . . . 0.471 ' OD2' ' CD ' ' B' ' 112' ' ' ARG . 11.6 m-20 -151.24 166.41 30.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.304 -0.873 . . . . 72.219999999999999 109.371 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.551 ' O ' ' CD1' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -140.21 114.15 8.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.607 -0.683 . . . . 64.420000000000002 109.191 -178.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 27.7 mm -114.34 146.26 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 O-C-N 121.224 -0.923 . . . . 72.230000000000004 109.685 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.78 139.54 58.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.936 -1.103 . . . . 25.239999999999998 108.139 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.685 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -58.49 -56.44 35.47 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.909 -1.12 . . . . 64.319999999999993 111.381 -179.034 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 5.0 Cg_endo -41.5 -8.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.022 1.148 . . . . 63.329999999999998 113.192 -176.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . 0.685 ' N ' ' O ' ' B' ' 97' ' ' LYS . 13.8 m-85 66.47 117.78 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.557 -0.714 . . . . 75.129999999999995 109.674 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . 0.476 ' CZ ' ' OE2' ' A' ' 83' ' ' GLU . 16.0 ttm180 -67.05 -29.55 69.37 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.968 -1.083 . . . . 74.230000000000004 108.754 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . 0.752 ' O ' ' N ' ' B' ' 103' ' ' LYS . 40.6 t -174.78 28.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.192 -0.942 . . . . 63.340000000000003 110.671 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 8.6 mm 51.66 -69.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.645 -0.659 . . . . 74.439999999999998 110.064 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.752 ' N ' ' O ' ' B' ' 101' ' ' SER . 86.3 mttt -56.64 -32.91 65.82 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.82 -1.178 . . . . 71.109999999999999 107.82 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.86 98.73 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.033 -1.099 . . . . 71.450000000000003 108.033 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 55.4 tp -64.63 -40.68 95.9 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.635 -0.876 . . . . 51.310000000000002 108.635 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 73.5 t -67.0 -41.02 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.348 -0.845 . . . . 65.230000000000004 109.527 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.02 -48.26 70.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.149 -0.97 . . . . 24.32 109.39 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -64.75 -32.24 73.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 75.310000000000002 109.732 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 93.9 mt -74.44 -34.3 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.179 -0.951 . . . . 54.240000000000002 108.903 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . 0.465 ' O ' ' CG ' ' B' ' 114' ' ' ARG . 88.2 tt0 -66.09 -31.02 71.63 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.492 -0.755 . . . . 65.310000000000002 109.469 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . 0.479 ' HB1' ' CZ ' ' A' ' 87' ' ' PHE . . . -72.56 -56.6 5.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.201 -0.937 . . . . 72.239999999999995 109.944 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . 0.471 ' CD ' ' OD2' ' B' ' 93' ' ' ASP . 64.3 mtm-85 -69.43 -40.61 77.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.179 -0.951 . . . . 72.040000000000006 110.358 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 41.6 tp -63.52 -34.49 77.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.121 -0.987 . . . . 75.349999999999994 109.972 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.465 ' CG ' ' O ' ' B' ' 110' ' ' GLU . 11.0 mmm180 -74.26 167.37 21.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.152 -0.968 . . . . 75.5 109.353 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 52.26 51.15 16.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.885 . . . . 65.329999999999998 109.23 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -95.7 -66.24 0.92 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.308 -0.87 . . . . 74.450000000000003 109.898 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.05 144.04 48.61 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.19 -1.164 . . . . 44.210000000000001 110.19 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . 0.927 ' N ' ' OE2' ' B' ' 132' ' ' GLU . 33.1 t -160.44 175.26 12.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.471 -1.017 . . . . 71.400000000000006 109.355 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.88 125.8 5.9 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.652 -0.819 . . . . 72.319999999999993 109.221 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 20.5 t -99.32 -37.25 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.386 -0.822 . . . . 75.019999999999996 109.929 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 19.3 mm -101.89 128.37 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.197 -0.939 . . . . 51.409999999999997 109.584 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' B' ' 122' ' ' GLU . 17.9 pt-20 -151.06 121.99 7.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.319 -0.863 . . . . 71.530000000000001 109.473 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.797 ' H ' HD13 ' B' ' 123' ' ' ILE . 0.1 OUTLIER -146.46 133.93 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.155 -0.965 . . . . 72.430000000000007 109.335 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 63.33 -115.69 8.34 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.241 -1.543 . . . . 51.229999999999997 109.241 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . 0.884 ' OD2' ' HD3' ' B' ' 138' ' ' LYS . 13.3 t70 -120.59 6.31 10.55 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.596 -0.944 . . . . 74.200000000000003 109.245 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.78 128.56 42.76 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.334 -0.854 . . . . 75.420000000000002 108.769 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 61.4 m -120.4 132.11 55.1 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.5 -0.926 . . . . 74.219999999999999 108.5 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 8.0 mt -133.02 132.38 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.378 -0.826 . . . . 60.329999999999998 110.041 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 8.6 m -109.75 110.67 59.28 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.303 -0.999 . . . . 72.310000000000002 108.303 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.94 -36.98 1.26 Allowed 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.742 1.628 . . . . 75.129999999999995 113.071 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . 0.415 ' O ' ' OE1' ' B' ' 133' ' ' GLU . 6.8 t70 -70.33 -37.34 74.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.089 -1.007 . . . . 75.230000000000004 109.905 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . 0.927 ' OE2' ' N ' ' B' ' 118' ' ' SER . 81.4 mt-10 -83.21 -0.09 47.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.157 -0.964 . . . . 72.430000000000007 109.446 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . 0.415 ' OE1' ' O ' ' B' ' 131' ' ' ASP . 35.8 mp0 47.01 59.07 4.24 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 75.129999999999995 109.254 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 15.4 ttpp -156.72 130.35 8.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 73.219999999999999 109.247 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 2.9 tt -104.23 129.47 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.433 -0.792 . . . . 64.140000000000001 109.597 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.417 HG21 HD13 ' B' ' 136' ' ' ILE . 15.3 mt -110.11 122.5 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.566 -0.902 . . . . 71.219999999999999 108.566 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . 0.963 ' CE1' ' CB ' ' B' ' 140' ' ' ARG . 19.0 p90 -124.97 118.18 25.69 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.249 -0.907 . . . . 64.219999999999999 110.13 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . 0.884 ' HD3' ' OD2' ' B' ' 125' ' ' ASP . 25.8 mmtm 55.99 28.2 12.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.591 -0.693 . . . . 72.019999999999996 110.237 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 92.4 2.56 67.88 Favored Glycine 0 N--CA 1.496 2.643 0 O-C-N 121.172 -0.955 . . . . 74.319999999999993 110.944 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . 0.963 ' CB ' ' CE1' ' B' ' 137' ' ' TYR . 0.2 OUTLIER -95.66 121.84 37.78 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.759 -1.436 . . . . 75.340000000000003 108.79 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -94.94 118.29 31.56 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.267 -0.895 . . . . 71.230000000000004 109.58 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 6.6 t -122.52 132.82 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.751 -0.833 . . . . 70.430000000000007 108.751 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -92.86 123.12 35.9 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.273 -0.892 . . . . 72.430000000000007 109.869 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.32 138.93 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.886 -0.783 . . . . 72.129999999999995 108.886 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -161.7 83.24 0.6 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.355 -0.84 . . . . 72.019999999999996 109.84 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . 0.666 ' N ' ' HD2' ' B' ' 149' ' ' PHE . . . -164.47 177.8 39.97 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.071 -1.612 . . . . 42.229999999999997 109.071 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . 1.323 ' NZ ' ' O ' ' B' ' 172' ' ' ILE . 0.9 OUTLIER -68.21 -37.01 9.95 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.203 -1.174 . . . . 73.299999999999997 110.438 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 14.6 Cg_exo -66.23 -19.99 56.12 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.206 1.937 . . . . 71.329999999999998 112.048 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . 0.666 ' HD2' ' N ' ' B' ' 146' ' ' GLY . 0.5 OUTLIER -103.77 -29.76 10.82 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.493 -0.755 . . . . 74.230000000000004 109.343 -179.376 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . 0.428 ' O ' ' CD2' ' B' ' 154' ' ' HIS . 35.4 mt-10 -51.67 -31.5 26.01 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.199 -1.037 . . . . 72.340000000000003 108.199 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 13.2 p -67.96 -33.15 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.562 -0.711 . . . . 73.349999999999994 109.11 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 44.7 tp -65.24 -39.99 93.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.875 . . . . 55.240000000000002 109.602 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 6.0 p -76.36 -35.77 58.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.893 -1.129 . . . . 70.010000000000005 109.203 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 154' ' ' HIS . . . . . 0.428 ' CD2' ' O ' ' B' ' 150' ' ' GLU . 27.9 m170 -56.87 -48.76 77.39 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.117 -0.99 . . . . 65.319999999999993 110.174 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 pp -72.87 -27.64 62.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.7 -1.25 . . . . 71.540000000000006 108.884 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.56 -34.54 67.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 75.319999999999993 109.563 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 17.3 mtt180 -92.52 -52.2 4.76 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.897 -1.127 . . . . 73.319999999999993 109.9 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -53.42 -52.09 60.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 74.140000000000001 108.786 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . 0.464 ' O ' ' N ' ' B' ' 161' ' ' GLN . 89.2 mtm180 47.15 -114.81 0.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 61.409999999999997 109.259 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . 0.772 ' OD2' ' CE1' ' B' ' 216' ' ' TYR . 9.8 m-20 -55.36 91.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.109 -0.995 . . . . 72.099999999999994 109.083 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' B' ' 159' ' ' ARG . 50.1 tp60 -164.71 145.43 7.73 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.207 -0.933 . . . . 72.25 109.775 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 89.7 mt -109.32 126.29 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.505 -0.747 . . . . 72.310000000000002 109.178 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 19.7 m -137.03 144.42 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.965 -0.754 . . . . 64.209999999999994 108.965 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 164' ' ' SER . . . . . 0.469 ' H ' ' CD ' ' B' ' 167' ' ' GLN . 23.1 t -86.94 178.34 6.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.077 -1.015 . . . . 74.219999999999999 110.185 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -61.46 -55.42 31.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.842 . . . . 65.310000000000002 109.408 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' B' ' 166' ' ' GLU . 31.7 mp0 -51.91 -31.91 30.53 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.858 . . . . 63.450000000000003 110.116 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 167' ' ' GLN . . . . . 0.469 ' CD ' ' H ' ' B' ' 164' ' ' SER . 41.4 mt-30 -64.94 -43.32 93.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.074 -1.016 . . . . 72.400000000000006 109.607 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 51.7 mt -58.12 -37.29 74.31 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.191 -1.04 . . . . 72.319999999999993 108.191 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.25 -65.91 0.57 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.501 -0.75 . . . . 73.340000000000003 109.063 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -58.35 -28.09 64.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.561 -0.712 . . . . 72.099999999999994 109.902 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.88 -65.25 0.63 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.28 -0.888 . . . . 62.130000000000003 110.091 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 1.323 ' O ' ' NZ ' ' B' ' 147' ' ' LYS . 2.1 mp -98.82 -53.45 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.129 -0.982 . . . . 71.420000000000002 109.937 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 26.0 m-90 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.031 -1.043 . . . . 72.230000000000004 109.027 -179.584 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo . . . . . 0 N--CA 1.49 1.271 0 CA-C-O 121.128 0.387 . . . . 65.219999999999999 112.722 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -156.57 52.0 0.52 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.033 -1.042 . . . . 72.310000000000002 109.761 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 9.3 p -65.24 -21.37 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.193 -0.942 . . . . 63.32 109.634 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 36.8 mt -67.53 -40.54 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.239 -0.913 . . . . 75.030000000000001 110.621 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . 0.487 ' O ' ' ND2' ' B' ' 189' ' ' ASN . 64.6 mm-40 -61.9 -50.51 71.89 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.098 -1.001 . . . . 64.109999999999999 110.323 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 18.2 m -75.08 -25.51 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.151 -0.968 . . . . 73.0 110.172 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -76.04 -46.62 28.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.119 -0.988 . . . . 61.119999999999997 110.18 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 11.2 tp -69.88 -29.34 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.865 -1.147 . . . . 72.430000000000007 109.286 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 189' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' B' ' 185' ' ' GLU . 92.5 m-20 -72.79 -48.51 37.49 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.43 -0.794 . . . . 65.140000000000001 109.9 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 190' ' ' GLN . . . . . 0.46 ' CG ' ' N ' ' B' ' 191' ' ' ILE . 1.9 pt20 -72.96 -45.17 59.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.095 -1.003 . . . . 63.240000000000002 110.193 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . 0.46 ' N ' ' CG ' ' B' ' 190' ' ' GLN . 77.1 mt -54.28 -55.4 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.04 -1.038 . . . . 74.030000000000001 109.376 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -54.39 -48.22 71.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.122 -0.986 . . . . 72.239999999999995 110.026 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 193' ' ' GLN . . . . . 0.411 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 81.7 mt-30 -62.07 -31.62 72.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.047 -1.033 . . . . 73.099999999999994 109.575 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -91.05 -2.97 57.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.25 -0.906 . . . . 72.109999999999999 110.339 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 24.1 ttp -99.94 -5.08 28.84 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.13 -0.981 . . . . 44.329999999999998 109.876 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 196' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' B' ' 193' ' ' GLN . 5.9 p-10 -105.92 -15.24 14.97 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.364 -0.835 . . . . 71.209999999999994 109.329 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . 0.585 ' N ' ' CD ' ' B' ' 198' ' ' PRO . 10.3 tttm -80.13 -41.7 1.37 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.243 -0.911 . . . . 75.209999999999994 110.059 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 198' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' B' ' 197' ' ' LYS . 73.6 Cg_endo -87.39 -44.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.486 2.124 . . . . 75.319999999999993 111.988 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 17.9 mt -78.38 -35.03 47.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.047 -1.033 . . . . 72.25 109.302 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 83.13 -37.98 2.72 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.731 -1.348 . . . . 64.530000000000001 109.731 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 22.4 mm -102.07 139.19 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.263 -1.14 . . . . 44.229999999999997 109.639 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 19.9 m -86.49 137.93 32.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.283 -0.886 . . . . 54.009999999999998 108.949 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 6.7 p -134.98 29.22 3.45 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.39 -0.819 . . . . 74.400000000000006 109.307 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 16.7 m -132.28 145.95 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.549 -0.719 . . . . 72.120000000000005 109.187 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -126.25 138.11 53.58 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.487 -0.758 . . . . 65.409999999999997 109.721 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 206' ' ' THR . . . . . 0.539 HG23 HH12 ' B' ' 208' ' ' ARG . 0.1 OUTLIER -96.94 132.82 42.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.326 -0.859 . . . . 71.329999999999998 109.47 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 8.3 t -130.38 117.1 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.707 -0.849 . . . . 63.5 108.707 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 208' ' ' ARG . . . . . 0.723 ' NE ' ' H ' ' B' ' 208' ' ' ARG . 0.1 OUTLIER -68.92 -36.3 77.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.222 -0.924 . . . . 74.450000000000003 109.747 -179.486 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 62.1 mtm180 -50.77 -65.09 0.62 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.122 -0.986 . . . . 74.140000000000001 110.118 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -100.58 -77.85 0.53 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.249 -0.907 . . . . 74.430000000000007 109.932 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -164.89 -105.27 0.19 Allowed Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.619 -1.277 . . . . 64.450000000000003 110.162 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 212' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' B' ' 212' ' ' TYR . 42.2 m-85 -133.93 148.75 51.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.505 -0.997 . . . . 74.209999999999994 109.978 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -141.12 153.7 45.54 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.252 -1.018 . . . . 74.030000000000001 108.252 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . 0.427 ' C ' ' SG ' ' B' ' 215' ' ' CYS . 0.7 OUTLIER -117.77 148.65 41.86 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.393 -0.817 . . . . 74.340000000000003 110.557 -178.249 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' B' ' 214' ' ' PHE . 8.8 m -151.37 164.18 37.28 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.676 -0.861 . . . . 64.329999999999998 108.676 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . 0.844 ' OH ' ' OE1' ' A' ' 161' ' ' GLN . 0.2 OUTLIER -72.86 154.08 91.08 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 120.96 -1.088 . . . . 70.040000000000006 108.865 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.51 175.92 1.92 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.246 1.964 . . . . 65.109999999999999 111.626 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 13.8 mtmm . . . . . 0 C--N 1.301 -1.534 0 N-CA-C 108.689 -0.856 . . . . 73.150000000000006 108.689 -179.931 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.57 ' SD ' ' CE2' ' A' ' 25' ' ' PHE . 43.4 ttp . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.457 -0.571 . . . . 65.120000000000005 109.457 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -140.53 152.25 45.41 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.397 -0.814 . . . . 72.329999999999998 109.224 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.682 HG13 ' HB3' ' A' ' 47' ' ' LEU . 39.4 t -119.6 129.47 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.529 0.681 . . . . 71.420000000000002 109.574 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.572 HD11 ' CG1' ' A' ' 6' ' ' ILE . 1.4 tp -96.14 122.65 39.21 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.53 -0.731 . . . . 65.120000000000005 109.521 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.448 ' N ' HD12 ' A' ' 4' ' ' LEU . 4.2 mp -117.2 129.84 56.2 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.129 -1.063 . . . . 62.43 108.129 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.572 ' CG1' HD11 ' A' ' 4' ' ' LEU . 38.4 mt -126.03 97.18 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.062 -1.088 . . . . 71.150000000000006 108.062 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -144.11 130.97 20.32 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.243 -0.91 . . . . 75.340000000000003 109.753 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -63.12 -35.2 79.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 72.439999999999998 109.33 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -76.54 96.58 4.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 63.020000000000003 109.29 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.8 m -61.47 -29.6 70.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.88 . . . . 72.340000000000003 109.909 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.516 HG13 ' N ' ' A' ' 12' ' ' LEU . 9.5 p -67.58 -44.59 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.085 -1.009 . . . . 74.019999999999996 109.981 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.516 ' N ' HG13 ' A' ' 11' ' ' VAL . 80.9 mt -69.82 -47.72 61.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.046 -1.034 . . . . 71.430000000000007 109.242 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.6 -20.88 70.4 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 107.922 -2.071 . . . . 61.32 107.922 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.38 -58.06 6.9 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.667 -1.373 . . . . 71.200000000000003 109.667 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.402 ' H ' ' HG2' ' A' ' 15' ' ' GLU . 12.2 pt-20 -52.82 -44.31 66.6 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.342 -1.093 . . . . 71.319999999999993 109.588 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.1 mt -66.85 -38.31 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.736 -1.227 . . . . 63.229999999999997 108.329 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.507 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 88.0 tt0 -60.23 -45.94 91.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 51.109999999999999 109.213 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -86.05 -1.23 57.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -0.928 . . . . 73.340000000000003 109.715 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.62 -54.98 3.11 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 109.813 -1.315 . . . . 62.149999999999999 109.813 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -75.12 -21.32 58.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.231 -1.158 . . . . 73.510000000000005 110.0 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 96.4 m-20 -57.61 -31.65 66.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.121 -0.987 . . . . 74.25 109.636 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 85.1 t -61.13 -25.79 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.318 -0.864 . . . . 70.040000000000006 109.467 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.521 ' NZ ' ' OE1' ' A' ' 110' ' ' GLU . 17.0 mmtp -83.04 6.17 19.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.87 . . . . 73.230000000000004 109.337 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.51 37.18 21.26 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.153 -1.179 . . . . 75.540000000000006 110.153 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.57 ' CE2' ' SD ' ' A' ' 1' ' ' MET . 11.5 m-85 -116.09 159.05 22.26 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.467 -1.02 . . . . 73.430000000000007 109.017 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.4 mmt -112.75 135.21 53.75 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.833 -0.803 . . . . 43.240000000000002 108.833 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.51 161.81 38.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.194 -0.941 . . . . 62.109999999999999 109.718 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -142.76 141.16 31.67 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.357 -0.84 . . . . 74.420000000000002 109.26 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 t -104.02 130.31 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.304 -0.872 . . . . 72.150000000000006 108.877 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.2 p -118.9 170.35 9.09 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.536 -0.728 . . . . 71.420000000000002 109.361 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -88.29 -100.76 0.08 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.183 -0.948 . . . . 72.329999999999998 109.858 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.0 p -78.23 166.61 22.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 74.239999999999995 110.167 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' A' ' 37' ' ' GLU . 13.9 mt -55.61 -39.08 70.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.645 -0.659 . . . . 71.530000000000001 110.041 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -50.39 -43.81 54.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.092 -1.005 . . . . 74.230000000000004 109.652 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -65.66 -36.74 84.53 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.201 -0.937 . . . . 54.030000000000001 109.158 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.94 -34.9 29.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.558 -1.417 . . . . 61.409999999999997 109.558 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 33' ' ' LEU . 81.4 tt0 -63.37 -40.73 98.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -1.141 . . . . 74.340000000000003 109.569 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -77.9 -37.63 47.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.088 -1.008 . . . . 75.329999999999998 109.333 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.6 tp -66.91 -41.82 86.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 74.329999999999998 109.599 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.448 ' C ' ' SD ' ' A' ' 40' ' ' MET . 3.3 ppp? -77.87 -15.77 58.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.144 -0.972 . . . . 70.319999999999993 109.648 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -55.33 -39.8 70.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.052 -1.03 . . . . 71.219999999999999 109.158 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.8 pt -95.26 -32.39 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.274 -0.892 . . . . 74.140000000000001 109.885 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 40' ' ' MET . 96.6 mtt180 -91.77 153.04 19.87 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.078 -1.013 . . . . 72.239999999999995 109.676 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 45' ' ' TYR . 14.5 p30 -91.86 -34.38 14.56 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.162 -0.961 . . . . 75.420000000000002 109.765 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 44' ' ' ASN . 38.3 m-85 51.97 99.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.292 -0.88 . . . . 74.230000000000004 109.484 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -68.77 -28.97 67.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.23 -0.918 . . . . 72.040000000000006 109.42 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.682 ' HB3' HG13 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -115.5 110.58 19.48 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.747 -0.834 . . . . 72.129999999999995 108.747 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.465 ' N ' HD13 ' A' ' 47' ' ' LEU . 65.9 t -96.9 110.34 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.324 -0.86 . . . . 72.340000000000003 108.685 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.587 ' SD ' ' N ' ' A' ' 50' ' ' VAL . 1.5 tpt -122.4 130.35 53.01 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.539 -0.725 . . . . 74.109999999999999 109.549 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.587 ' N ' ' SD ' ' A' ' 49' ' ' MET . 1.1 p -138.84 130.43 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.695 0.76 . . . . 61.119999999999997 109.818 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.2 t -98.16 2.41 48.46 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.596 -0.69 . . . . 73.109999999999999 109.534 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -75.93 136.58 40.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.171 -0.956 . . . . 52.549999999999997 109.405 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.489 ' C ' ' H ' ' A' ' 55' ' ' ALA . 62.4 mttp -72.96 -42.24 63.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.306 -0.871 . . . . 44.219999999999999 110.617 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -69.19 11.23 0.23 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.039 -1.038 . . . . 70.439999999999998 109.747 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.489 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.35 -21.64 58.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 64.140000000000001 110.44 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 55' ' ' ALA . 74.5 mt -37.79 -53.21 1.29 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.7 -0.625 . . . . 44.140000000000001 110.818 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.6 t -65.65 -36.66 84.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.972 -1.08 . . . . 55.229999999999997 109.329 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.466 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 45.3 t80 -64.58 -63.03 1.23 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.327 -0.858 . . . . 74.439999999999998 109.83 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.1 m -48.36 -32.85 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.81 -1.181 . . . . 74.030000000000001 109.713 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.2 m -59.4 -52.79 64.12 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.201 -0.937 . . . . 64.299999999999997 109.348 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -68.78 -27.75 66.16 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 118.934 -1.107 . . . . 64.439999999999998 109.881 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.523 ' O ' ' N ' ' A' ' 66' ' ' HIS . 29.6 mm -59.21 -49.83 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 120.829 -1.17 . . . . 63.210000000000001 108.847 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.519 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 45.3 mmtt -59.79 -46.55 88.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.086 -1.009 . . . . 74.420000000000002 108.649 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -64.08 -42.86 96.81 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.942 -0.762 . . . . 70.319999999999993 108.942 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.472 ' C ' ' CG ' ' A' ' 66' ' ' HIS . 51.6 mtpt -76.95 -26.27 53.81 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.526 -0.734 . . . . 75.219999999999999 110.554 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 62' ' ' ILE . 56.9 m-70 -154.97 65.72 0.65 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.973 -1.079 . . . . 74.129999999999995 109.746 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 63' ' ' LYS . 33.8 t -59.28 -25.83 64.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.352 -0.842 . . . . 73.239999999999995 110.155 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.0 t -69.66 -14.77 62.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.17 -0.956 . . . . 61.009999999999998 110.493 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.473 HD12 ' CB ' ' A' ' 66' ' ' HIS . 79.0 mt -94.06 155.91 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.972 -1.08 . . . . 71.329999999999998 109.907 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 71' ' ' VAL . 90.2 t -85.02 162.76 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.364 -0.835 . . . . 72.129999999999995 109.696 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.535 ' N ' HG12 ' A' ' 70' ' ' VAL . 14.7 t -145.24 117.14 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.09 -1.006 . . . . 54.210000000000001 109.741 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.506 ' O ' ' SD ' ' A' ' 49' ' ' MET . 1.0 OUTLIER -115.46 99.92 7.71 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.219 -1.03 . . . . 50.240000000000002 108.219 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.6 p -96.48 152.6 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.127 -0.983 . . . . 74.409999999999997 108.774 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.5 m -132.42 172.33 12.6 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.215 -0.928 . . . . 72.310000000000002 109.364 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 77' ' ' ASN . 3.4 t -173.84 128.96 0.4 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.322 -0.861 . . . . 64.540000000000006 110.044 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -66.59 43.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.558 -0.714 . . . . 74.129999999999995 109.639 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 75' ' ' SER . 15.9 m120 -160.15 60.89 1.51 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 73.340000000000003 109.828 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -57.18 74.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.979 1.786 . . . . 63.219999999999999 111.469 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 77' ' ' ASN . 16.9 m -107.49 151.6 25.35 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.003 -0.74 . . . . 62.530000000000001 109.003 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -25.33 68.19 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.357 -0.839 . . . . 73.439999999999998 109.497 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -63.83 -52.39 60.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 71.420000000000002 109.489 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.29 -32.43 70.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 73.430000000000007 109.707 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -60.31 -52.62 64.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 74.219999999999999 109.603 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.64 -40.27 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.936 . . . . 73.200000000000003 109.312 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -68.65 -29.19 67.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -0.856 . . . . 53.329999999999998 109.826 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -67.28 -43.19 82.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.193 -0.942 . . . . 64.109999999999999 110.039 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -80.23 -26.39 39.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.062 -1.024 . . . . 74.340000000000003 108.946 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -75.98 -51.47 12.32 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.43 -0.794 . . . . 74.420000000000002 109.391 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.48 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 1.6 pp0? -61.57 -43.23 99.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.526 -0.734 . . . . 74.239999999999995 109.736 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.48 ' N ' ' CD ' ' A' ' 89' ' ' GLN . . . 138.45 72.82 0.05 OUTLIER Glycine 0 N--CA 1.498 2.776 0 N-CA-C 109.982 -1.247 . . . . 61.509999999999998 109.982 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.407 ' HB2' HE21 ' A' ' 89' ' ' GLN . . . -133.17 133.21 42.52 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.358 -1.083 . . . . 55.329999999999998 108.878 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 71' ' ' VAL . 2.8 m-20 -71.48 -39.66 70.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.039 -1.038 . . . . 73.420000000000002 108.999 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 61.8 m-20 -154.24 147.17 24.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.365 -0.834 . . . . 75.040000000000006 109.358 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -121.54 112.61 18.7 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.553 -0.906 . . . . 71.329999999999998 108.553 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 23.3 mm -106.56 152.4 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 CA-C-O 122.16 0.981 . . . . 71.129999999999995 111.333 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.59 123.33 21.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.849 -1.167 . . . . 64.319999999999993 107.849 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.667 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -45.99 -54.23 17.86 Favored Pre-proline 0 C--N 1.301 -1.531 0 O-C-N 121.038 -1.039 . . . . 62.200000000000003 111.525 -178.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.3 Cg_endo -41.46 -11.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 120.754 0.969 . . . . 73.109999999999999 112.886 -176.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.667 ' N ' ' O ' ' A' ' 97' ' ' LYS . 59.5 m-85 59.52 121.92 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.737 -0.602 . . . . 65.219999999999999 109.607 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -68.8 -32.26 71.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.059 -1.026 . . . . 72.349999999999994 109.52 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.765 ' O ' ' N ' ' A' ' 103' ' ' LYS . 41.3 t -174.21 28.41 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.989 -1.069 . . . . 71.319999999999993 110.885 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.695 ' N ' HD12 ' A' ' 102' ' ' ILE . 2.6 mp 50.4 -69.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-N 118.638 0.654 . . . . 75.430000000000007 110.194 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.765 ' N ' ' O ' ' A' ' 101' ' ' SER . 1.0 OUTLIER -55.33 -31.18 61.49 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.899 -1.148 . . . . 71.409999999999997 107.899 179.257 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.81 80.05 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.574 -0.85 . . . . 63.240000000000002 108.752 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.682 ' C ' HD13 ' A' ' 105' ' ' LEU . 1.7 tm? -69.74 -54.62 12.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.44 -0.787 . . . . 73.219999999999999 108.923 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.546 ' N ' HD13 ' A' ' 105' ' ' LEU . 53.8 t -52.77 -45.75 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.016 -1.052 . . . . 60.109999999999999 109.326 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.47 -42.25 67.03 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.13 -0.982 . . . . 70.420000000000002 108.385 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -62.58 -32.9 73.97 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.481 -0.762 . . . . 74.409999999999997 109.137 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 83.2 mt -74.35 -31.91 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.117 -0.99 . . . . 62.539999999999999 108.604 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.521 ' OE1' ' NZ ' ' A' ' 23' ' ' LYS . 75.0 tt0 -58.44 -52.11 67.02 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.492 -0.755 . . . . 74.340000000000003 109.314 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.29 -32.3 66.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.917 . . . . 73.319999999999993 109.658 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.5 ' NH2' HG22 ' A' ' 70' ' ' VAL . 24.0 tpt85 -54.52 -34.21 61.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 52.409999999999997 109.433 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.2 tp -151.74 108.87 3.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.181 -0.949 . . . . 65.239999999999995 109.504 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.4 ' HE ' ' HG3' ' A' ' 110' ' ' GLU . 4.4 mmt180 -144.46 -51.76 0.3 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.252 -0.905 . . . . 64.450000000000003 108.67 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -82.53 25.57 0.62 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.185 -0.947 . . . . 74.430000000000007 109.401 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.439 ' CG ' ' N ' ' A' ' 117' ' ' GLY . 60.4 p-90 -51.04 -40.0 57.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 74.420000000000002 109.721 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.439 ' N ' ' CG ' ' A' ' 116' ' ' TRP . . . -57.74 93.42 0.04 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.767 -1.333 . . . . 75.040000000000006 109.767 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.0 m -153.03 164.71 37.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.211 -1.17 . . . . 61.140000000000001 109.707 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -159.87 128.98 5.12 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.907 -0.775 . . . . 65.239999999999995 108.907 -178.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.7 t -83.86 -45.31 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.158 -0.964 . . . . 73.109999999999999 110.066 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.533 ' CG2' HH21 ' A' ' 159' ' ' ARG . 20.3 mm -102.64 130.94 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.314 -0.867 . . . . 72.239999999999995 109.812 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -121.39 128.58 52.36 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.986 -0.746 . . . . 72.340000000000003 108.986 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 126' ' ' LEU . 23.6 mt -141.03 112.65 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.181 -0.95 . . . . 71.439999999999998 109.45 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.63 -138.63 7.94 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.857 -1.297 . . . . 73.400000000000006 109.857 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -80.09 -11.47 59.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -1.165 . . . . 74.450000000000003 109.487 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 123' ' ' ILE . 0.8 OUTLIER -91.23 135.53 33.73 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.494 -0.928 . . . . 54.210000000000001 108.494 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.8 m -130.2 129.77 43.82 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.447 -0.783 . . . . 54.5 109.593 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 28.8 mm -112.87 139.71 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.902 -0.777 . . . . 45.149999999999999 108.902 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 133' ' ' GLU . 5.2 m -128.05 80.03 72.86 Favored Pre-proline 0 N--CA 1.5 2.039 0 O-C-N 121.456 -0.777 . . . . 71.109999999999999 109.697 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.46 -51.89 9.47 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.704 2.27 . . . . 65.409999999999997 112.082 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -53.68 -44.03 69.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 63.32 109.092 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -87.36 -1.98 58.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.346 -0.846 . . . . 72.519999999999996 109.163 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 129' ' ' SER . 34.6 mp0 50.05 72.51 0.32 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.91 . . . . 75.329999999999998 109.129 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -158.14 122.89 4.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.343 -0.848 . . . . 71.230000000000004 109.814 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 84.3 mt -101.56 126.76 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.422 -0.799 . . . . 74.019999999999996 108.922 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.0 mt -117.07 125.36 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.57 -0.706 . . . . 60.229999999999997 109.113 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.492 ' C ' ' H ' ' A' ' 139' ' ' GLY . 47.8 p90 -140.72 151.45 44.51 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.327 -0.858 . . . . 62.32 109.207 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.3 tptp 56.01 5.5 0.17 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.78 0.8 . . . . 75.400000000000006 109.15 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 137' ' ' TYR . . . 95.93 -2.98 64.47 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.846 -1.302 . . . . 72.239999999999995 109.846 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.529 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 1.2 mpt_? -89.71 131.64 35.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.235 -1.156 . . . . 71.219999999999999 109.14 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -93.04 127.98 38.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.241 -0.912 . . . . 71.420000000000002 109.571 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 43.2 t -137.07 136.44 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.424 -0.798 . . . . 53.020000000000003 109.493 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -91.51 143.54 26.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.268 -0.895 . . . . 60.450000000000003 109.042 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 25.9 m -139.75 153.89 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.288 -0.883 . . . . 74.439999999999998 109.699 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -167.21 24.64 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.333 -0.854 . . . . 65.150000000000006 109.163 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.52 -169.79 45.16 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.824 -1.31 . . . . 73.340000000000003 109.824 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.625 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 14.2 tmtt? -82.11 -31.14 0.54 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.343 -1.093 . . . . 72.219999999999999 111.424 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 87.0 Cg_endo -86.64 -3.58 8.32 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 C-N-CA 121.781 1.654 . . . . 65.230000000000004 112.408 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -96.85 -29.87 13.47 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.183 -0.948 . . . . 60.109999999999999 109.18 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -59.2 -40.84 87.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.271 -0.893 . . . . 64.209999999999994 109.259 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.461 HG11 HD13 ' A' ' 191' ' ' ILE . 13.9 p -61.79 -34.09 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.226 -0.921 . . . . 72.019999999999996 108.894 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.2 OUTLIER -59.94 -45.44 92.62 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.514 -0.921 . . . . 73.310000000000002 108.514 179.627 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.0 p -74.39 -24.58 59.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.197 -0.94 . . . . 74.310000000000002 109.294 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -59.36 -51.13 71.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.905 . . . . 74.310000000000002 109.685 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.7 pp -76.36 -27.22 56.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.104 -0.998 . . . . 75.340000000000003 109.618 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -54.12 -46.26 72.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.094 -1.004 . . . . 62.140000000000001 109.375 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.475 ' C ' ' H ' ' A' ' 159' ' ' ARG . 66.4 mtp180 -77.01 -49.49 15.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.928 . . . . 61.030000000000001 109.382 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -72.2 34.2 0.06 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.636 -0.665 . . . . 74.120000000000005 110.042 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.533 HH21 ' CG2' ' A' ' 121' ' ' ILE . 19.1 ttm180 -59.51 150.44 26.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.131 -0.981 . . . . 71.129999999999995 109.133 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 214' ' ' PHE . 62.2 m-20 53.05 46.93 25.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 75.450000000000003 109.544 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -149.71 150.95 32.88 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.23 -0.919 . . . . 73.409999999999997 109.312 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 58.3 mt -90.15 132.74 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.223 -0.923 . . . . 74.409999999999997 109.296 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 48.5 t -131.52 134.73 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.486 -0.759 . . . . 72.310000000000002 109.29 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.423 ' OG ' ' OE1' ' A' ' 166' ' ' GLU . 3.0 t -86.25 157.25 19.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.318 -0.863 . . . . 74.120000000000005 109.894 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -59.52 -44.08 93.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.437 -0.789 . . . . 70.430000000000007 109.627 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.483 ' H ' ' CD ' ' A' ' 166' ' ' GLU . 34.0 mp0 -59.56 -38.01 79.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 73.519999999999996 109.526 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -59.28 -40.66 86.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.138 -0.976 . . . . 74.519999999999996 109.096 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 62.5 mt -58.02 -54.09 50.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.186 -0.947 . . . . 72.310000000000002 108.925 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 169' ' ' LEU . 10.3 mp -61.5 -55.95 25.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 53.329999999999998 109.194 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 169' ' ' LEU . 17.3 t70 -35.86 -42.8 0.28 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.04 0.447 . . . . 62.439999999999998 111.256 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.63 -30.26 13.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.078 -1.014 . . . . 60.210000000000001 110.53 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.9 mm -84.9 -72.72 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 120.986 -1.071 . . . . 75.319999999999993 109.663 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.503 ' O ' ' CE3' ' A' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 108.395 -0.965 . . . . 73.140000000000001 108.395 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.481 ' OD1' ' CD1' ' A' ' 184' ' ' ILE . 5.9 t30 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.215 0.531 . . . . 64.540000000000006 110.04 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.8 m -142.17 9.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.277 -0.89 . . . . 74.019999999999996 109.144 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.745 ' H ' HD12 ' A' ' 184' ' ' ILE . 2.1 mp -49.8 -42.22 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 72.329999999999998 109.452 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.629 ' H ' ' CD ' ' A' ' 185' ' ' GLU . 2.1 pm0 -47.05 -34.67 6.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.153 -0.967 . . . . 74.400000000000006 109.263 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 92.3 t -78.35 -51.63 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.263 -0.898 . . . . 70.420000000000002 109.395 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.97 71.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 52.109999999999999 110.069 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.529 HG23 ' N ' ' A' ' 189' ' ' ASN . 10.8 tp -58.51 -44.88 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.971 -1.08 . . . . 71.400000000000006 109.73 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.529 ' N ' HG23 ' A' ' 188' ' ' ILE . 45.7 t-20 -56.71 -45.09 82.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.932 -1.105 . . . . 73.439999999999998 109.381 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -68.88 -40.91 78.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.86 . . . . 71.420000000000002 109.64 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.461 HD13 HG11 ' A' ' 151' ' ' VAL . 68.1 mt -64.94 -34.66 71.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.175 -0.953 . . . . 61.549999999999997 109.73 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -64.01 -56.76 12.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.219 -0.925 . . . . 63.340000000000003 109.683 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -65.46 -35.69 81.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.917 . . . . 61.240000000000002 109.949 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -70.93 -17.66 62.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.071 -1.018 . . . . 75.129999999999995 109.667 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 195' ' ' MET . 0.2 OUTLIER -89.95 -53.52 4.45 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.253 -0.904 . . . . 74.019999999999996 109.722 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 200' ' ' GLY . 60.0 m-20 -61.18 -38.39 86.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 74.019999999999996 110.408 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.451 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 19.4 mmtt -51.76 -65.62 0.94 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 120.951 -1.093 . . . . 75.430000000000007 109.831 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 37.7 Cg_endo -64.02 -55.57 0.61 Allowed 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.242 1.961 . . . . 72.319999999999993 112.399 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 199' ' ' LEU . 10.2 mp -64.26 -38.67 91.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.091 -1.005 . . . . 74.540000000000006 109.531 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 196' ' ' ASP . . . 83.22 -40.21 2.82 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.605 -1.398 . . . . 61.509999999999998 109.605 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.71 ' N ' HD12 ' A' ' 201' ' ' ILE . 2.2 mp -92.6 139.48 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.248 -1.148 . . . . 61.219999999999999 109.319 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 34.1 t -88.06 140.37 29.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.187 -0.946 . . . . 72.0 109.235 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 11.9 p -144.25 33.41 1.21 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.177 -0.952 . . . . 74.439999999999998 109.516 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.62 143.92 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.238 -0.914 . . . . 64.349999999999994 109.649 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -122.08 137.84 54.67 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.632 -0.668 . . . . 71.409999999999997 109.284 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.1 t -114.51 141.74 47.31 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.471 -0.768 . . . . 73.519999999999996 109.357 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.457 HG22 ' H ' ' A' ' 209' ' ' ARG . 9.0 p -144.42 137.12 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.253 -0.904 . . . . 71.019999999999996 109.473 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -71.4 -34.34 70.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 72.120000000000005 109.808 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.457 ' H ' HG22 ' A' ' 207' ' ' VAL . 22.4 ttm105 -51.45 -36.77 45.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 64.409999999999997 109.699 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -140.98 -155.7 0.61 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.329 -0.857 . . . . 71.540000000000006 109.195 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -79.1 -125.13 0.44 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.739 -1.344 . . . . 72.030000000000001 109.739 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 212' ' ' TYR . 30.1 m-85 -116.78 135.0 54.1 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.577 -0.954 . . . . 75.540000000000006 109.728 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 67.4 ttt-85 -104.92 127.97 52.97 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.581 -0.7 . . . . 75.310000000000002 109.157 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 160' ' ' ASP . 18.8 m-85 -100.95 130.63 46.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.258 -0.901 . . . . 75.409999999999997 109.334 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . 0.401 ' SG ' ' OD1' ' A' ' 160' ' ' ASP . 52.0 t -154.39 155.97 35.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.36 -0.837 . . . . 74.140000000000001 109.281 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -68.07 149.93 97.96 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.164 -0.96 . . . . 75.319999999999993 108.957 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.495 1.577 0 C-N-CA 122.189 1.926 . . . . 73.109999999999999 111.877 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.553 ' N ' ' CD2' ' B' ' 25' ' ' PHE . 12.7 mtt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.334 -0.617 . . . . 71.140000000000001 109.334 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -97.8 121.26 39.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.324 -0.86 . . . . 73.230000000000004 109.288 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 79.9 t -115.59 136.24 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.472 0.653 . . . . 72.239999999999995 109.618 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.431 HD12 ' N ' ' B' ' 5' ' ' LEU . 5.5 tp -105.33 120.12 40.78 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.589 -0.695 . . . . 54.329999999999998 109.729 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.431 ' N ' HD12 ' B' ' 4' ' ' LEU . 18.0 mt -118.08 96.83 5.51 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.706 -0.85 . . . . 74.349999999999994 108.706 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.675 HD12 ' HB ' ' B' ' 50' ' ' VAL . 69.5 mt -84.96 97.54 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.808 -1.183 . . . . 42.549999999999997 108.377 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.431 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 35.2 tp10 -135.62 133.03 37.82 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.484 -0.76 . . . . 74.519999999999996 109.535 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -66.67 -32.51 73.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.308 -0.87 . . . . 62.549999999999997 109.32 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . 0.41 ' H ' ' HG3' ' B' ' 7' ' ' GLU . 89.7 m-20 -79.93 129.93 34.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 73.109999999999999 109.388 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 25.9 t -83.31 -32.32 26.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 65.540000000000006 109.849 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.54 HG13 ' N ' ' B' ' 12' ' ' LEU . 11.1 p -63.25 -44.3 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.141 -0.974 . . . . 75.549999999999997 109.865 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.54 ' N ' HG13 ' B' ' 11' ' ' VAL . 74.7 mt -66.58 -33.02 74.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.993 -1.067 . . . . 70.140000000000001 109.353 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.73 -23.32 64.72 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.804 -1.718 . . . . 75.400000000000006 108.804 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.7 -49.7 7.71 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.702 -1.359 . . . . 65.439999999999998 109.702 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -62.58 -43.5 98.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.113 -1.227 . . . . 60.210000000000001 109.161 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 97.3 mt -61.27 -35.67 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.075 -1.016 . . . . 75.150000000000006 108.445 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.476 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 78.7 tt0 -60.83 -44.76 96.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.439 -0.788 . . . . 73.010000000000005 109.333 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -85.15 -0.14 53.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.19 -0.944 . . . . 74.299999999999997 109.097 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.6 -55.54 2.42 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.652 -1.379 . . . . 70.540000000000006 109.652 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -75.05 -19.99 59.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.152 -1.205 . . . . 71.340000000000003 109.811 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 1.7 m120 -53.05 -32.94 49.63 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.103 -0.998 . . . . 64.409999999999997 109.328 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 79.2 t -58.02 -27.71 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 74.230000000000004 108.836 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -83.9 -4.51 58.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.445 -0.784 . . . . 63.420000000000002 109.152 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.13 33.55 32.34 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.05 -1.22 . . . . 53.43 110.05 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.553 ' CD2' ' N ' ' B' ' 1' ' ' MET . 9.0 m-85 -110.83 159.14 17.94 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.411 -1.052 . . . . 71.120000000000005 108.9 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 6.9 mmt -105.49 141.88 36.2 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.563 -0.903 . . . . 75.239999999999995 108.563 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.424 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -138.0 156.53 47.73 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.193 -0.942 . . . . 72.120000000000005 110.277 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 77.9 m-20 -138.77 159.46 42.07 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.647 -0.871 . . . . 72.310000000000002 108.647 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 p -123.04 139.98 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.327 -0.858 . . . . 64.430000000000007 109.938 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.4 p -138.16 170.78 15.44 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.532 -0.73 . . . . 65.409999999999997 109.284 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -90.62 -106.05 0.09 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.315 -0.865 . . . . 71.019999999999996 110.01 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 59.9 p -80.47 168.13 19.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.151 -0.968 . . . . 51.109999999999999 110.068 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' B' ' 37' ' ' GLU . 15.1 mt -51.85 -31.33 27.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.455 -0.778 . . . . 71.239999999999995 109.852 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -52.82 -51.49 60.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.032 -1.043 . . . . 74.319999999999993 109.647 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -62.72 -40.61 97.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.134 -0.979 . . . . 73.030000000000001 108.957 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.7 -33.27 75.59 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.964 -1.654 . . . . 30.210000000000001 108.964 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' B' ' 33' ' ' LEU . 84.3 tt0 -66.86 -44.07 81.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.363 -1.081 . . . . 74.420000000000002 109.319 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -75.83 -35.63 59.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 74.420000000000002 109.447 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 12.1 tp -72.0 -39.51 69.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.842 . . . . 75.409999999999997 110.119 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.7 ppp? -77.63 -18.19 57.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.999 -1.063 . . . . 60.409999999999997 109.888 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -69.5 -42.46 74.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.109 -0.995 . . . . 53.229999999999997 109.538 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 2.4 pp -87.48 -16.42 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.867 . . . . 71.230000000000004 109.737 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' B' ' 40' ' ' MET . 13.6 tpp85 -130.64 138.56 50.14 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.44 -0.787 . . . . 72.219999999999999 109.42 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -98.59 129.13 45.11 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.316 -0.865 . . . . 63.539999999999999 109.103 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -108.38 136.87 47.3 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.425 -0.797 . . . . 64.349999999999994 109.568 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . 0.449 ' OD2' ' SD ' ' B' ' 1' ' ' MET . 92.5 m-20 -76.75 -41.83 43.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 62.219999999999999 108.709 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.519 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.3 OUTLIER -103.73 115.72 31.0 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.394 -0.965 . . . . 73.120000000000005 108.394 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.519 ' N ' HD13 ' B' ' 47' ' ' LEU . 62.1 t -100.61 97.61 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.564 -0.902 . . . . 65.109999999999999 108.564 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -116.51 130.72 56.91 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.41 -0.806 . . . . 73.439999999999998 110.217 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.681 HG22 ' H ' ' B' ' 52' ' ' ASP . 0.3 OUTLIER -144.33 134.49 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.169 -0.678 . . . . 34.5 109.169 -179.605 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . 0.431 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 19.1 p -95.43 16.4 17.02 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.385 -0.822 . . . . 73.209999999999994 109.792 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.681 ' H ' HG22 ' B' ' 50' ' ' VAL . 53.4 m-20 -80.56 144.58 32.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.956 . . . . 70.409999999999997 109.578 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.509 ' NZ ' HD21 ' B' ' 54' ' ' ASN . 18.4 pttp -76.45 -36.01 58.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 65.0 109.986 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . 0.509 HD21 ' NZ ' ' B' ' 53' ' ' LYS . 22.5 m120 -74.43 10.88 1.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 75.209999999999994 109.685 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.17 -25.27 66.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 55.329999999999998 110.08 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 62.1 mt -47.34 -40.35 17.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.078 -1.014 . . . . 63.140000000000001 110.028 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 14.5 t -75.45 -41.71 55.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.944 -1.098 . . . . 63.5 109.829 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . 0.421 ' CE2' HD11 ' B' ' 62' ' ' ILE . 63.0 t80 -64.12 -47.91 78.15 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.329 -0.857 . . . . 72.329999999999998 110.232 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.43 HG23 ' N ' ' B' ' 60' ' ' SER . 19.5 m -63.95 -36.81 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.64 -1.287 . . . . 74.540000000000006 109.694 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . 0.43 ' N ' HG23 ' B' ' 59' ' ' VAL . 80.6 p -56.59 -45.48 81.38 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.247 -0.908 . . . . 71.239999999999995 109.774 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' B' ' 65' ' ' LYS . 10.5 ptp180 -74.82 -31.82 61.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.065 -1.022 . . . . 74.310000000000002 109.971 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' B' ' 66' ' ' HIS . 5.1 mm -59.74 -53.72 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.901 -1.125 . . . . 72.140000000000001 109.493 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.498 ' HB3' ' HZ3' ' B' ' 63' ' ' LYS . 8.8 mmmm -62.28 -41.51 98.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.036 -1.04 . . . . 73.319999999999993 108.95 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -66.83 -39.64 87.72 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.305 -0.998 . . . . 73.120000000000005 108.305 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' B' ' 61' ' ' ARG . 92.6 mttt -87.3 -76.95 0.35 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.357 -0.839 . . . . 72.439999999999998 109.249 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.512 ' O ' HG22 ' B' ' 69' ' ' ILE . 97.7 m-70 -91.94 92.33 8.27 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.212 -0.93 . . . . 63.310000000000002 109.039 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.483 ' O ' ' N ' ' B' ' 69' ' ' ILE . 25.6 t -78.56 -41.47 31.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 73.099999999999994 110.058 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 46.2 t -67.76 54.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.164 -0.96 . . . . 71.530000000000001 109.81 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.512 HG22 ' O ' ' B' ' 66' ' ' HIS . 16.6 tt -151.28 153.22 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.143 -0.973 . . . . 74.400000000000006 109.395 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.415 HG13 HH12 ' B' ' 112' ' ' ARG . 76.1 t -97.48 152.14 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.15 -0.969 . . . . 75.120000000000005 109.284 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 10.0 t -136.59 129.77 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.24 -0.913 . . . . 73.200000000000003 110.108 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.559 HD23 ' C ' ' B' ' 72' ' ' LEU . 4.8 tt -121.17 106.24 11.34 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.911 -0.774 . . . . 73.340000000000003 108.911 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 77.8 t -93.09 128.21 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.154 -0.966 . . . . 73.5 109.433 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.48 157.92 16.29 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.347 -0.983 . . . . 64.340000000000003 108.347 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 40.0 m -156.02 134.38 11.54 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.841 -1.162 . . . . 74.530000000000001 110.789 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -87.18 7.63 27.42 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.499 -0.926 . . . . 64.5 108.499 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -135.91 59.83 31.43 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 108.749 -0.834 . . . . 74.25 108.749 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.468 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 19.4 Cg_endo -60.14 79.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.424 2.083 . . . . 74.430000000000007 111.736 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 68.9 p -106.98 151.87 24.73 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.852 -0.795 . . . . 73.120000000000005 108.852 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.56 -22.0 30.34 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.297 -0.877 . . . . 71.010000000000005 109.152 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -68.98 -49.26 59.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 63.200000000000003 109.31 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -74.9 -27.27 60.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 73.219999999999999 109.658 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.75 -56.03 23.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.174 -0.954 . . . . 74.299999999999997 109.657 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.514 HG23 ' N ' ' B' ' 85' ' ' HIS . 35.2 m -64.71 -42.76 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.135 -0.978 . . . . 73.310000000000002 109.279 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' HIS . . . . . 0.665 ' CE1' HE21 ' B' ' 89' ' ' GLN . 66.2 t60 -60.76 -36.12 78.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -0.918 . . . . 73.239999999999995 109.207 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.46 -41.13 98.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.337 -0.852 . . . . 55.329999999999998 109.97 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -77.35 -39.16 48.46 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.028 -1.045 . . . . 74.140000000000001 108.852 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -65.03 -39.19 93.01 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.596 -0.842 . . . . 64.040000000000006 109.254 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . 0.665 HE21 ' CE1' ' B' ' 85' ' ' HIS . 68.9 mm-40 -62.19 -47.1 85.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 72.349999999999994 108.935 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 144.47 -6.3 1.68 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.006 -1.237 . . . . 65.200000000000003 110.006 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.92 133.79 26.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.038 -1.272 . . . . 52.229999999999997 109.285 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.488 ' CG ' HH12 ' B' ' 112' ' ' ARG . 40.9 t0 -83.45 -18.68 37.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -0.93 . . . . 73.319999999999993 109.213 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -152.45 164.05 38.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.421 -0.799 . . . . 72.219999999999999 108.988 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.468 ' OH ' ' CB ' ' B' ' 78' ' ' PRO . 0.1 OUTLIER -150.85 107.3 3.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.189 -0.944 . . . . 64.420000000000002 108.931 -179.361 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 0.478 HG22 ' N ' ' B' ' 96' ' ' ALA . 30.9 mm -114.82 159.87 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 O-C-N 121.485 -0.76 . . . . 72.230000000000004 109.94 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . 0.478 ' N ' HG22 ' B' ' 95' ' ' ILE . . . -70.96 128.32 35.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.18 -0.95 . . . . 25.239999999999998 108.556 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.687 ' O ' ' N ' ' B' ' 99' ' ' TYR . 1.8 tptt -49.08 -59.33 6.59 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.144 -0.973 . . . . 64.319999999999993 111.443 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 8.0 Cg_endo -44.24 -3.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.569 1.513 . . . . 63.329999999999998 113.015 -175.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . 0.687 ' N ' ' O ' ' B' ' 97' ' ' LYS . 48.5 m-85 62.18 123.38 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.91 -0.494 . . . . 75.129999999999995 109.795 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 17.9 ttm-85 -74.41 -37.66 63.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.942 -1.099 . . . . 74.230000000000004 109.237 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . 0.767 ' O ' ' N ' ' B' ' 103' ' ' LYS . 48.3 t -173.8 35.45 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.951 -1.093 . . . . 63.340000000000003 111.303 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 36.8 mm 49.67 -70.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-N 118.995 0.816 . . . . 74.439999999999998 110.52 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.767 ' N ' ' O ' ' B' ' 101' ' ' SER . 33.1 mmtm -54.08 -32.44 54.8 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.106 -1.072 . . . . 71.109999999999999 108.106 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.01 -45.75 76.59 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.342 -0.985 . . . . 71.450000000000003 108.342 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 64.2 tp -62.6 -44.18 96.94 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.72 -0.845 . . . . 51.310000000000002 108.72 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 76.5 t -66.79 -38.62 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.355 -0.841 . . . . 65.230000000000004 109.513 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.42 -46.48 69.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.225 -0.922 . . . . 24.32 109.49 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -69.56 -31.37 69.51 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.188 -0.945 . . . . 75.310000000000002 109.888 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 96.4 mt -74.06 -31.34 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.018 -1.051 . . . . 54.240000000000002 108.833 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -73.91 -58.56 3.22 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.645 -0.822 . . . . 65.310000000000002 109.367 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -50.99 -35.22 32.67 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.384 -0.823 . . . . 72.239999999999995 109.578 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . 0.488 HH12 ' CG ' ' B' ' 92' ' ' ASP . 5.6 tpt180 -65.7 -44.01 87.42 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.158 -0.964 . . . . 72.040000000000006 109.738 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 43.0 mt -134.28 64.01 1.61 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.365 -0.835 . . . . 75.349999999999994 109.963 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -60.55 -43.7 96.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.971 -1.081 . . . . 75.5 108.628 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -142.08 -109.21 0.13 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.389 -0.819 . . . . 65.329999999999998 109.357 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -148.21 162.7 38.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.272 -0.893 . . . . 74.450000000000003 109.184 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.11 153.72 52.18 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.525 -1.43 . . . . 44.210000000000001 109.525 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . 0.427 ' O ' ' O ' ' B' ' 119' ' ' ASN . 29.5 p -82.65 30.55 0.42 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -1.182 . . . . 71.400000000000006 109.718 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . 0.609 ' N ' ' ND2' ' B' ' 119' ' ' ASN . 0.0 OUTLIER 55.07 170.24 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.495 -0.882 . . . . 72.319999999999993 109.629 177.602 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 11.0 t -119.88 -37.82 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.526 -0.734 . . . . 75.019999999999996 109.13 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 29.3 mm -110.94 132.79 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.437 -0.79 . . . . 51.409999999999997 109.491 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -152.98 117.14 4.87 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.196 -0.94 . . . . 71.530000000000001 109.495 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.701 HD11 ' HB3' ' B' ' 216' ' ' TYR . 11.5 tt -163.04 140.24 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.009 -1.057 . . . . 72.430000000000007 110.271 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' B' ' 126' ' ' LEU . . . 69.52 33.14 71.79 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.312 -1.115 . . . . 51.229999999999997 110.312 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 14.8 t0 69.51 -6.34 1.01 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.355 -1.086 . . . . 74.200000000000003 109.281 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.723 HD13 HD13 ' B' ' 199' ' ' LEU . 1.2 mt -91.12 144.35 25.73 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.031 -1.1 . . . . 75.420000000000002 108.031 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.46 126.31 40.27 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.357 -0.839 . . . . 74.219999999999999 109.004 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 73.6 mt -127.58 131.41 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.593 -0.692 . . . . 60.329999999999998 109.341 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 48.7 m -115.24 121.27 35.2 Favored Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 121.626 -0.671 . . . . 72.310000000000002 109.334 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -78.26 -44.25 0.16 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.572 1.515 . . . . 75.129999999999995 111.933 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . 0.791 ' O ' ' OE2' ' B' ' 133' ' ' GLU . 70.0 m-20 -62.91 -46.85 85.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.07 -1.019 . . . . 75.230000000000004 109.281 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . 0.478 ' O ' ' C ' ' B' ' 133' ' ' GLU . 41.7 mt-10 -86.84 5.72 35.31 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.252 -0.905 . . . . 72.430000000000007 109.182 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . 0.791 ' OE2' ' O ' ' B' ' 131' ' ' ASP . 0.6 OUTLIER 29.93 59.87 0.19 Allowed 'General case' 0 N--CA 1.509 2.502 0 CA-C-O 121.596 0.712 . . . . 75.129999999999995 110.447 -179.579 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -141.99 137.56 31.26 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.973 -0.751 . . . . 73.219999999999999 108.973 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 10.9 tt -111.05 138.97 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.217 -0.927 . . . . 64.140000000000001 109.874 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 18.0 mm -115.91 132.84 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.561 -0.712 . . . . 71.219999999999999 109.534 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -140.43 125.2 18.17 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.362 -0.836 . . . . 64.219999999999999 108.964 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 81.2 mttt 55.13 33.98 21.62 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.405 -0.809 . . . . 72.019999999999996 110.311 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 76.76 14.99 81.98 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 120.182 -1.009 . . . . 74.319999999999993 110.934 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -101.05 127.8 47.4 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.179 -1.189 . . . . 75.340000000000003 109.63 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -93.74 117.83 30.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.253 -0.904 . . . . 71.230000000000004 109.621 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 5.3 t -124.74 120.99 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.389 -0.819 . . . . 70.430000000000007 108.947 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -79.22 139.8 37.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.382 -0.824 . . . . 72.430000000000007 109.62 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.99 137.21 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.285 -0.884 . . . . 72.129999999999995 109.069 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 41.8 pttt -167.24 119.11 0.91 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 72.019999999999996 109.782 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 156.96 -177.21 33.97 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.082 -1.607 . . . . 42.229999999999997 109.082 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . 0.622 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 26.6 mmtm -69.05 -36.56 7.71 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.166 -1.197 . . . . 73.299999999999997 110.375 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 26.8 Cg_exo -61.3 -36.21 80.46 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.871 1.714 . . . . 71.329999999999998 111.597 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -90.6 -28.01 18.72 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.359 -0.838 . . . . 74.230000000000004 109.393 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -50.6 -49.42 56.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 72.340000000000003 109.696 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.647 HG22 HG21 ' B' ' 191' ' ' ILE . 2.8 p -64.95 -34.28 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.088 -1.008 . . . . 73.349999999999994 109.038 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 10.5 tp -64.07 -36.85 85.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.172 -0.955 . . . . 55.240000000000002 108.605 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.39 -28.65 56.8 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.441 -0.787 . . . . 70.010000000000005 109.305 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 154' ' ' HIS . . . . . 1.029 ' CE1' ' CE1' ' B' ' 158' ' ' HIS . 1.3 t60 -63.43 -53.84 45.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.023 -1.048 . . . . 65.319999999999993 109.561 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . 0.412 ' CD2' HD12 ' B' ' 191' ' ' ILE . 2.7 pp -66.61 -30.36 70.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.992 -1.067 . . . . 71.540000000000006 108.917 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.51 -51.22 60.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.101 -1.0 . . . . 75.319999999999993 109.016 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . 0.559 ' NH1' ' HA ' ' B' ' 154' ' ' HIS . 51.3 mtt85 -62.37 -51.39 67.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.029 -1.044 . . . . 73.319999999999993 108.773 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 158' ' ' HIS . . . . . 1.029 ' CE1' ' CE1' ' B' ' 154' ' ' HIS . 11.8 m80 -88.78 36.0 0.79 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.723 -0.61 . . . . 74.140000000000001 109.886 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . 0.419 HH12 ' CB ' ' B' ' 203' ' ' THR . 29.9 ttp85 -82.6 41.36 0.71 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.872 -1.142 . . . . 61.409999999999997 109.619 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . 0.764 ' HB3' ' HE1' ' B' ' 216' ' ' TYR . 3.9 p-10 -166.66 49.34 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 72.099999999999994 109.511 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -175.6 -171.54 0.48 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.346 -0.846 . . . . 72.25 109.79 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 86.9 mt -93.05 143.05 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.288 -0.883 . . . . 72.310000000000002 110.126 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 78.6 t -134.18 126.21 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.986 -0.746 . . . . 64.209999999999994 108.986 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 4.6 p -81.68 162.76 22.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.131 -0.98 . . . . 74.219999999999999 109.941 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -64.54 -51.54 62.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.422 -0.799 . . . . 65.310000000000002 110.137 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -58.38 -27.13 63.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.119 -0.988 . . . . 63.450000000000003 109.086 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -56.18 -50.95 69.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 72.400000000000006 108.906 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 79.6 mt -61.73 -36.19 80.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 72.319999999999993 108.933 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.526 HD23 ' C ' ' B' ' 169' ' ' LEU . 5.9 tt -64.9 -61.48 2.14 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.453 -0.779 . . . . 73.340000000000003 109.695 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -62.38 -25.73 68.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.91 . . . . 72.099999999999994 110.479 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.03 -47.52 58.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.943 -1.098 . . . . 62.130000000000003 110.366 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 24.3 mm -99.7 -63.06 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.149 -0.969 . . . . 71.420000000000002 110.428 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 25.6 m-90 . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.081 -1.012 . . . . 72.230000000000004 109.961 -179.29 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo . . . . . 0 N--CA 1.498 1.736 0 CA-C-O 121.348 0.478 . . . . 65.219999999999999 112.441 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -179.04 -21.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.323 -0.861 . . . . 72.310000000000002 108.835 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 15.2 m -75.21 -10.13 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 63.32 109.546 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.402 ' H ' HG13 ' B' ' 184' ' ' ILE . 50.9 mt -50.4 -25.96 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.923 . . . . 75.030000000000001 109.004 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . 0.413 ' O ' ' OD1' ' B' ' 189' ' ' ASN . 25.1 mm-40 -62.18 -38.57 89.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.387 -0.82 . . . . 64.109999999999999 109.381 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . 0.419 ' H ' HG23 ' B' ' 186' ' ' VAL . 2.1 t -77.45 -34.94 21.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.399 -0.813 . . . . 73.0 109.986 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -68.68 -39.36 80.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.861 -1.149 . . . . 61.119999999999997 110.634 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 188' ' ' ILE . . . . . 0.525 HG23 ' N ' ' B' ' 189' ' ' ASN . 10.6 tp -76.94 -42.13 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.786 -1.196 . . . . 72.430000000000007 109.769 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 189' ' ' ASN . . . . . 0.525 ' N ' HG23 ' B' ' 188' ' ' ILE . 18.6 m120 -70.33 -37.12 74.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 65.140000000000001 110.77 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 190' ' ' GLN . . . . . 0.429 ' CG ' ' N ' ' B' ' 191' ' ' ILE . 13.6 pt20 -71.45 -46.95 58.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.859 -1.15 . . . . 63.240000000000002 110.995 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . 0.647 HG21 HG22 ' B' ' 151' ' ' VAL . 6.5 pt -60.7 -38.97 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.485 -1.384 . . . . 74.030000000000001 109.379 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 192' ' ' ARG . . . . . 0.52 ' NH2' ' CD1' ' B' ' 212' ' ' TYR . 98.5 mtt180 -62.35 -35.79 80.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.029 -1.045 . . . . 72.239999999999995 109.474 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 193' ' ' GLN . . . . . 0.443 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 86.7 mt-30 -77.5 -25.91 50.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.228 -0.92 . . . . 73.099999999999994 110.384 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -78.71 -24.25 45.05 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.092 -1.005 . . . . 72.109999999999999 110.736 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 5.6 ptm -94.82 -35.7 11.97 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.921 -1.112 . . . . 44.329999999999998 110.568 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 196' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 52.9 p-10 -67.92 -24.04 65.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.985 -1.072 . . . . 71.209999999999994 110.772 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . 0.539 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 17.5 mttp -74.69 -62.23 0.97 Allowed Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.979 -1.076 . . . . 75.209999999999994 110.219 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 198' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -66.36 -39.51 17.04 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.082 1.855 . . . . 75.319999999999993 112.83 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . 0.723 HD13 HD13 ' B' ' 126' ' ' LEU . 58.1 mt -80.14 -55.77 4.7 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.881 -1.137 . . . . 72.25 110.142 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 95.91 -8.4 67.94 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.42 -1.472 . . . . 64.530000000000001 109.42 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 23.4 mm -105.36 135.93 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.325 -1.103 . . . . 44.229999999999997 109.349 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 47.7 t -90.15 133.36 34.93 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.146 -0.971 . . . . 54.009999999999998 108.723 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . 0.419 ' CB ' HH12 ' B' ' 159' ' ' ARG . 43.7 p -146.83 50.25 1.12 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.022 -1.048 . . . . 74.400000000000006 110.226 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.475 HG23 ' O ' ' B' ' 204' ' ' VAL . 33.3 m -144.31 124.6 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 120.973 -1.08 . . . . 72.120000000000005 109.835 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -109.53 114.0 27.26 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.416 -0.957 . . . . 65.409999999999997 108.416 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 206' ' ' THR . . . . . 0.497 HG23 ' O ' ' B' ' 206' ' ' THR . 9.8 t -96.06 125.31 40.51 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.097 -1.002 . . . . 71.329999999999998 109.724 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.537 HG22 ' H ' ' B' ' 209' ' ' ARG . 7.9 p -142.22 142.62 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.303 -0.873 . . . . 63.5 109.321 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -80.6 6.97 11.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 74.450000000000003 109.611 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 209' ' ' ARG . . . . . 0.537 ' H ' HG22 ' B' ' 207' ' ' VAL . 14.2 tpt180 -58.17 -39.4 78.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.22 -0.925 . . . . 74.140000000000001 109.818 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -160.37 -37.16 0.05 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.222 -0.924 . . . . 74.430000000000007 109.397 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.9 -150.5 9.96 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.438 -1.465 . . . . 64.450000000000003 109.438 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 212' ' ' TYR . . . . . 0.52 ' CD1' ' NH2' ' B' ' 192' ' ' ARG . 54.4 m-85 -93.11 137.92 32.02 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.137 -1.213 . . . . 74.209999999999994 109.033 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -111.46 118.37 35.6 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.55 -0.719 . . . . 74.030000000000001 109.78 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -96.05 131.67 42.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.349 -0.844 . . . . 74.340000000000003 109.024 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.0 t -145.06 169.5 17.99 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.17 -0.956 . . . . 64.329999999999998 109.946 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . 0.764 ' HE1' ' HB3' ' B' ' 160' ' ' ASP . 0.0 OUTLIER -74.74 159.09 83.96 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.414 -0.958 . . . . 70.040000000000006 108.414 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.82 133.1 56.05 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.298 1.999 . . . . 65.109999999999999 111.943 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 73.150000000000006 110.485 -179.871 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 1.176 ' CE ' ' HA ' ' A' ' 115' ' ' PHE . 28.6 tpp . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.413 -0.588 . . . . 65.120000000000005 109.413 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -140.06 140.5 36.14 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.345 -0.847 . . . . 72.329999999999998 109.203 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.6 t -119.9 142.91 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.633 0.73 . . . . 71.420000000000002 110.402 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.503 HD11 ' CG1' ' A' ' 6' ' ' ILE . 3.3 tp -113.75 116.14 28.93 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.116 -1.068 . . . . 65.120000000000005 108.116 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.561 HD12 ' SD ' ' A' ' 49' ' ' MET . 3.6 tp -118.5 103.96 10.24 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.892 -0.781 . . . . 62.43 108.892 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.503 ' CG1' HD11 ' A' ' 4' ' ' LEU . 69.9 mt -95.71 104.3 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.115 -0.991 . . . . 71.150000000000006 108.742 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.438 ' HG3' ' H ' ' A' ' 9' ' ' ASN . 28.7 tp10 -128.51 119.25 24.5 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.206 -0.664 . . . . 75.340000000000003 109.206 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.458 ' CB ' ' NZ ' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -84.19 -3.22 58.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.227 -0.921 . . . . 72.439999999999998 109.378 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.438 ' H ' ' HG3' ' A' ' 7' ' ' GLU . 70.5 m-20 -81.73 -125.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.338 -0.851 . . . . 63.020000000000003 109.279 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.3 m -165.88 -77.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.024 -1.047 . . . . 72.340000000000003 110.106 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.83 -44.09 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -0.885 . . . . 74.019999999999996 110.622 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.518 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.5 mm? -58.8 -37.24 75.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.092 -1.005 . . . . 71.430000000000007 109.668 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.92 -32.52 39.96 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.727 -1.749 . . . . 61.32 108.727 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.21 -47.84 69.13 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 110.058 -1.217 . . . . 71.200000000000003 110.058 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.67 -43.56 93.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.011 -1.288 . . . . 71.319999999999993 109.382 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.8 mm -64.86 -43.97 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.817 -1.177 . . . . 63.229999999999997 108.492 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -58.83 -50.43 74.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.86 . . . . 51.109999999999999 109.468 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -80.7 1.53 29.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.196 -0.94 . . . . 73.340000000000003 109.585 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.08 -58.41 2.0 Allowed Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.958 -1.257 . . . . 62.149999999999999 109.958 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -75.85 -18.73 59.33 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.265 -1.138 . . . . 73.510000000000005 110.032 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -57.59 -31.35 66.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.107 -0.996 . . . . 74.25 109.623 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.4 t -62.37 -38.22 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.386 -0.821 . . . . 70.040000000000006 109.876 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.497 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 12.1 mptt -67.93 -1.82 6.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.325 -0.86 . . . . 73.230000000000004 109.726 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.09 27.03 27.01 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.826 -1.31 . . . . 75.540000000000006 109.826 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.661 ' CE1' ' CE2' ' A' ' 115' ' ' PHE . 13.8 m-85 -99.49 151.25 21.34 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.33 -1.1 . . . . 73.430000000000007 109.097 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 12.0 mtt -102.06 128.44 48.52 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.572 -1.269 . . . . 43.240000000000002 107.572 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.84 140.1 38.38 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.157 -0.965 . . . . 62.109999999999999 110.507 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -112.66 139.03 48.61 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.715 -0.846 . . . . 74.420000000000002 108.715 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -104.75 124.55 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.293 -0.88 . . . . 72.150000000000006 108.722 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.4 p -128.2 166.61 18.22 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.648 -0.658 . . . . 71.420000000000002 109.495 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -83.87 -102.95 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.22 -0.925 . . . . 72.329999999999998 109.446 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.0 p -81.37 161.16 23.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 74.239999999999995 109.457 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.458 ' H ' HD12 ' A' ' 33' ' ' LEU . 2.8 mp -52.22 -28.23 17.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.375 -0.828 . . . . 71.530000000000001 109.5 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -49.25 -53.35 22.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.935 . . . . 74.230000000000004 109.5 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -60.58 -39.01 86.48 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.175 -0.953 . . . . 54.030000000000001 108.715 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.37 -34.83 80.77 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.106 -1.597 . . . . 61.409999999999997 109.106 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -66.98 -43.92 81.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -1.129 . . . . 74.340000000000003 109.351 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.447 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 36.6 t80 -76.81 -22.23 53.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.122 -0.986 . . . . 75.329999999999998 109.824 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.2 tp -87.42 -30.78 20.46 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.108 -0.995 . . . . 74.329999999999998 109.673 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.44 ' O ' ' O ' ' A' ' 43' ' ' ARG . 5.0 ppp? -86.36 -24.02 25.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.122 -0.986 . . . . 70.319999999999993 110.468 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 37.4 p-10 -59.37 -28.49 66.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.887 -1.133 . . . . 71.219999999999999 109.444 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.538 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 12.6 pt -92.24 -30.68 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.234 -0.916 . . . . 74.140000000000001 110.113 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 40' ' ' MET . 70.9 mmt-85 -130.03 148.31 51.87 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.386 -0.821 . . . . 72.239999999999995 109.645 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -98.66 160.11 14.5 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.252 -0.905 . . . . 75.420000000000002 109.483 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -131.02 160.11 35.55 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.496 -0.753 . . . . 74.230000000000004 109.241 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.745 ' OD2' ' CH2' ' A' ' 116' ' ' TRP . 5.4 m-20 -98.69 -45.21 6.13 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.267 -0.896 . . . . 72.040000000000006 109.474 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.403 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -102.18 108.84 20.36 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.45 -0.944 . . . . 72.129999999999995 108.45 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.7 t -97.25 100.78 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.339 -0.851 . . . . 72.340000000000003 109.248 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.561 ' SD ' HD12 ' A' ' 5' ' ' LEU . 2.0 tmt? -116.74 134.48 54.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.456 -0.777 . . . . 74.109999999999999 109.489 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.654 HG22 ' H ' ' A' ' 52' ' ' ASP . 1.3 p -143.43 127.69 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.499 -0.751 . . . . 61.119999999999997 109.323 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.4 p -86.69 4.95 38.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.559 -0.713 . . . . 73.109999999999999 109.408 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.654 ' H ' HG22 ' A' ' 50' ' ' VAL . 13.6 m-20 -79.92 138.9 37.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.937 . . . . 52.549999999999997 109.646 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -82.27 -32.75 29.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.269 -0.894 . . . . 44.219999999999999 109.938 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -73.21 8.93 1.42 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.195 -0.941 . . . . 70.439999999999998 109.714 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -74.93 -20.9 59.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.331 -0.856 . . . . 64.140000000000001 110.184 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 55' ' ' ALA . 31.3 mt -38.49 -45.0 0.99 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.604 -0.685 . . . . 44.140000000000001 110.706 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.3 p -74.47 -36.54 63.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.95 -1.093 . . . . 55.229999999999997 109.311 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.666 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 64.6 t80 -65.07 -46.19 82.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.417 -0.802 . . . . 74.439999999999998 109.998 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.1 m -64.29 -37.41 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.703 -1.248 . . . . 74.030000000000001 109.307 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.1 t -53.54 -49.9 66.64 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.209 -0.932 . . . . 64.299999999999997 109.228 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -70.28 -36.22 74.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 64.439999999999998 110.243 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.666 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 5.2 mm -64.67 -34.12 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.642 -1.286 . . . . 63.210000000000001 109.432 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.565 ' HZ3' ' CG ' ' A' ' 92' ' ' ASP . 44.0 mmtt -67.43 -51.58 49.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 74.420000000000002 109.868 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.443 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 17.1 pt-20 -72.38 -43.02 64.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.942 -1.099 . . . . 70.319999999999993 109.937 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.505 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 25.8 mtpp -70.14 -22.72 62.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 75.219999999999999 109.508 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.511 ' O ' HG22 ' A' ' 69' ' ' ILE . 89.9 m-70 -156.35 64.31 0.55 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.923 . . . . 74.129999999999995 109.525 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 69' ' ' ILE . 30.7 p -60.19 -31.54 70.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.871 . . . . 73.239999999999995 109.737 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 87.7 p -68.6 47.84 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -0.915 . . . . 61.009999999999998 109.705 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 66' ' ' HIS . 14.3 tt -148.61 161.92 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.083 -1.011 . . . . 71.329999999999998 109.609 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.599 HG21 HD11 ' A' ' 113' ' ' LEU . 77.4 t -95.96 154.91 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.158 -0.964 . . . . 72.129999999999995 108.754 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.725 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 6.5 t -143.32 114.52 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.11 -0.994 . . . . 54.210000000000001 109.315 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.0 mp -111.12 100.14 8.86 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.55 -0.908 . . . . 50.240000000000002 108.55 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.4 t -93.14 120.4 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.345 -0.847 . . . . 74.409999999999997 108.91 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 m -97.84 172.84 7.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.284 -0.885 . . . . 72.310000000000002 108.763 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.448 ' C ' ' H ' ' A' ' 77' ' ' ASN . 0.8 OUTLIER -173.98 120.72 0.29 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.982 -1.073 . . . . 64.540000000000006 110.203 -179.622 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -65.53 2.37 0.95 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.508 -0.745 . . . . 74.129999999999995 109.406 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 75' ' ' SER . 80.2 m-20 -120.1 64.05 9.57 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 109.123 -0.695 . . . . 73.340000000000003 109.123 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.03 74.2 0.1 OUTLIER 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.11 1.873 . . . . 63.219999999999999 111.871 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.45 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 60.1 p -104.95 149.7 25.52 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.331 -0.988 . . . . 62.530000000000001 108.331 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -28.56 69.19 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.197 -0.939 . . . . 73.439999999999998 109.813 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.459 ' OE1' ' N ' ' A' ' 81' ' ' GLU . 40.8 mp0 -63.41 -38.08 89.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.112 -0.992 . . . . 71.420000000000002 109.876 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -77.05 -33.95 57.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.044 -1.035 . . . . 73.430000000000007 109.712 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -61.05 -52.57 64.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.056 -1.028 . . . . 74.219999999999999 109.461 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.473 HG23 ' N ' ' A' ' 85' ' ' HIS . 26.9 m -62.67 -41.31 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -0.949 . . . . 73.200000000000003 109.387 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.473 ' N ' HG23 ' A' ' 84' ' ' VAL . 6.6 t-80 -65.8 -29.94 70.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.225 -0.922 . . . . 53.329999999999998 109.324 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.02 -37.05 80.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.917 . . . . 64.109999999999999 109.91 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -80.2 -34.05 37.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.106 -0.997 . . . . 74.340000000000003 108.839 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -73.64 -38.22 65.08 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.388 -0.82 . . . . 74.420000000000002 109.461 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -71.32 -60.86 2.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 74.239999999999995 109.374 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 155.71 70.88 0.01 OUTLIER Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.67 -1.252 . . . . 61.509999999999998 110.168 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -133.08 130.75 39.74 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.339 -1.095 . . . . 55.329999999999998 109.357 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.725 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 14.2 m-20 -69.51 -41.09 76.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 73.420000000000002 109.268 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.752 ' CG ' HH21 ' A' ' 112' ' ' ARG . 4.9 m-20 -146.32 163.0 36.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.834 . . . . 75.040000000000006 109.056 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.494 ' CE1' ' OE1' ' A' ' 83' ' ' GLU . 56.6 t80 -136.96 124.42 22.09 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.363 -0.977 . . . . 71.329999999999998 108.363 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.683 ' H ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -126.12 149.83 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 CA-C-O 122.045 0.926 . . . . 71.129999999999995 111.232 -178.055 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.75 121.54 16.72 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.768 -1.197 . . . . 64.319999999999993 107.768 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.659 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -44.92 -55.43 10.94 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.197 -0.939 . . . . 62.200000000000003 111.629 -178.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.7 Cg_endo -41.56 -12.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 120.739 0.96 . . . . 73.109999999999999 112.538 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.659 ' N ' ' O ' ' A' ' 97' ' ' LYS . 55.2 m-85 59.86 124.88 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 109.583 -0.525 . . . . 65.219999999999999 109.583 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 32.6 ttm-85 -62.08 -38.79 90.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.876 -1.14 . . . . 72.349999999999994 109.353 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.794 ' O ' ' N ' ' A' ' 103' ' ' LYS . 6.3 t -172.99 46.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.129 -0.982 . . . . 71.319999999999993 110.473 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 92.2 mt 47.11 -68.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-O 121.228 0.537 . . . . 75.430000000000007 110.825 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.794 ' N ' ' O ' ' A' ' 101' ' ' SER . 13.8 mmmt -53.25 -34.0 55.38 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.238 -0.914 . . . . 71.409999999999997 108.843 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.39 -49.73 68.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.262 -0.899 . . . . 63.240000000000002 109.204 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.695 ' C ' HD13 ' A' ' 105' ' ' LEU . 2.0 tm? -57.73 -47.9 81.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.134 -0.979 . . . . 73.219999999999999 108.726 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.96 -40.2 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.964 -1.085 . . . . 60.109999999999999 109.85 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.635 ' HB1' ' CE2' ' B' ' 87' ' ' PHE . . . -52.17 -39.23 59.78 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.252 -0.905 . . . . 70.420000000000002 108.832 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 1.27 ' HB3' ' NH1' ' A' ' 112' ' ' ARG . 93.3 mtt180 -73.55 -29.82 62.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.028 -1.045 . . . . 74.409999999999997 109.933 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 47.5 mt -73.92 -44.94 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 120.891 -1.131 . . . . 62.539999999999999 109.218 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.449 ' CG ' ' N ' ' A' ' 111' ' ' ALA . 17.7 pt-20 -70.31 -47.93 58.87 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.816 -1.154 . . . . 74.340000000000003 109.717 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.449 ' N ' ' CG ' ' A' ' 110' ' ' GLU . . . -59.49 -29.84 68.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.889 -1.132 . . . . 73.319999999999993 109.578 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 1.27 ' NH1' ' HB3' ' A' ' 108' ' ' ARG . 53.0 mtt85 -72.79 -58.34 3.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.913 . . . . 52.409999999999997 109.175 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 112' ' ' ARG . 16.7 mt -126.35 65.13 1.24 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.502 -0.925 . . . . 65.239999999999995 108.502 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.469 ' O ' ' CD2' ' A' ' 115' ' ' PHE . 29.1 mtm105 -39.94 -79.73 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.902 -0.499 . . . . 64.450000000000003 110.48 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 1.176 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 14.6 m-85 -163.18 96.48 0.88 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.029 -1.044 . . . . 74.430000000000007 108.698 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 1.01 ' CZ2' ' OE1' ' A' ' 132' ' ' GLU . 51.3 m0 -46.78 -93.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.247 -0.908 . . . . 74.420000000000002 109.861 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.15 17.85 18.42 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.078 -1.609 . . . . 75.040000000000006 109.078 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.4 p -103.56 166.76 10.22 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.366 -1.079 . . . . 61.140000000000001 109.771 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.692 HD21 ' N ' ' A' ' 128' ' ' ILE . 1.0 OUTLIER -164.18 127.89 2.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.329 -0.857 . . . . 65.239999999999995 108.98 179.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 18.4 t -82.98 -38.07 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.047 -1.033 . . . . 73.109999999999999 110.627 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.547 ' O ' ' ND2' ' A' ' 119' ' ' ASN . 14.9 mm -95.88 133.59 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.932 -1.105 . . . . 72.239999999999995 110.038 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -149.86 127.94 11.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.151 -0.968 . . . . 72.340000000000003 108.607 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' A' ' 125' ' ' ASP . 8.7 tp -153.32 132.38 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 71.439999999999998 109.54 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 55.93 -83.49 0.01 OUTLIER Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.62 -1.392 . . . . 73.400000000000006 109.62 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 123' ' ' ILE . 15.1 t0 -149.92 -4.84 0.36 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.253 -1.146 . . . . 74.450000000000003 109.334 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.05 141.32 28.66 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.074 -1.017 . . . . 54.210000000000001 108.842 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.32 133.1 43.62 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.896 -0.779 . . . . 54.5 108.896 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.692 ' N ' HD21 ' A' ' 119' ' ' ASN . 49.4 mt -130.02 134.83 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.378 -0.826 . . . . 45.149999999999999 109.554 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.0 t -108.72 111.78 60.82 Favored Pre-proline 0 N--CA 1.497 1.9 0 N-CA-C 108.524 -0.917 . . . . 71.109999999999999 108.524 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -83.18 -39.18 0.13 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.869 1.713 . . . . 65.409999999999997 112.815 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -65.86 -49.3 68.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.025 -1.047 . . . . 63.32 109.692 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 1.01 ' OE1' ' CZ2' ' A' ' 116' ' ' TRP . 5.8 mm-40 -81.48 -6.26 58.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.13 -0.981 . . . . 72.519999999999996 109.105 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 57.06 63.63 1.86 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 75.329999999999998 109.727 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -146.19 130.41 17.52 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.338 -0.851 . . . . 71.230000000000004 109.272 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 6.8 tt -106.57 140.81 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.345 -0.847 . . . . 74.019999999999996 108.87 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.4 mt -128.54 120.75 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.46 -0.775 . . . . 60.229999999999997 109.506 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -140.03 140.18 36.14 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.386 -0.821 . . . . 62.32 109.628 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 53.45 20.96 2.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.403 -0.811 . . . . 75.400000000000006 110.085 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.84 16.97 68.84 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.982 -1.104 . . . . 72.239999999999995 110.403 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 57.2 mtp85 -107.12 124.41 49.64 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.242 -1.152 . . . . 71.219999999999999 109.177 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -99.24 124.9 44.68 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.302 -0.874 . . . . 71.420000000000002 109.75 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.8 t -139.33 140.9 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.39 -0.819 . . . . 53.020000000000003 109.556 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -85.94 135.7 33.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.177 -0.952 . . . . 60.450000000000003 109.136 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.4 m -132.43 126.95 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.439 -0.788 . . . . 74.439999999999998 109.406 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.4 pttt -173.15 129.31 0.47 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.304 -0.873 . . . . 65.150000000000006 109.577 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.66 -141.19 6.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.703 -1.359 . . . . 73.340000000000003 109.703 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.547 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -85.09 -44.56 0.67 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.328 -1.101 . . . . 72.219999999999999 110.403 -179.271 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 69.6 Cg_endo -89.79 -7.85 4.5 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.73 2.287 . . . . 65.230000000000004 113.354 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -89.42 -32.84 17.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.719 -1.238 . . . . 60.109999999999999 110.035 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -50.18 -40.99 48.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.978 -1.076 . . . . 64.209999999999994 109.149 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.09 -33.59 64.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.252 -0.905 . . . . 72.019999999999996 109.246 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 7.0 tp -61.37 -40.88 95.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.91 . . . . 73.310000000000002 109.639 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.9 p -74.59 -34.89 62.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.095 -1.003 . . . . 74.310000000000002 109.041 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -52.81 -55.2 24.76 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.476 -0.765 . . . . 74.310000000000002 109.746 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 pp -72.13 -26.17 62.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.013 -1.055 . . . . 75.340000000000003 109.283 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.04 -29.39 60.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.084 -1.01 . . . . 62.140000000000001 108.716 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.461 ' C ' ' H ' ' A' ' 159' ' ' ARG . 52.4 mtt180 -97.89 -54.19 3.17 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.681 -0.859 . . . . 61.030000000000001 108.681 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.431 ' ND1' ' N ' ' A' ' 158' ' ' HIS . 5.3 m80 -69.94 43.34 0.06 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.456 -0.777 . . . . 74.120000000000005 109.141 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.548 ' O ' ' N ' ' A' ' 161' ' ' GLN . 32.2 mtm105 -53.57 -103.37 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.481 -0.762 . . . . 71.129999999999995 109.953 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -51.17 86.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.478 -0.764 . . . . 75.450000000000003 109.884 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -175.58 179.1 1.48 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.629 -0.878 . . . . 73.409999999999997 108.629 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.529 ' H ' ' CD ' ' A' ' 161' ' ' GLN . 66.6 mt -98.82 128.95 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.258 -0.901 . . . . 74.409999999999997 109.615 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 212' ' ' TYR . 77.2 t -108.99 113.94 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.509 -0.744 . . . . 72.310000000000002 109.535 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 4.4 p -90.33 138.71 31.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 74.120000000000005 108.627 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -57.75 -37.09 73.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 70.430000000000007 109.186 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -64.29 -38.19 90.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 73.519999999999996 109.617 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -59.84 -41.12 90.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -0.968 . . . . 74.519999999999996 109.124 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 40.2 mt -61.88 -53.28 57.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.91 . . . . 72.310000000000002 109.306 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 11.8 tp -62.67 -60.83 2.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 53.329999999999998 109.635 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -40.75 -40.1 1.25 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.94 -0.475 . . . . 62.439999999999998 111.543 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.16 -31.23 14.23 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.859 -1.151 . . . . 60.210000000000001 111.784 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.3 mm -80.6 -69.3 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.72 -1.238 . . . . 75.319999999999993 109.807 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.512 ' O ' ' CE3' ' A' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 107.831 -1.174 . . . . 73.140000000000001 107.831 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.487 ' N ' ' OD1' ' A' ' 182' ' ' ASN . 6.3 p30 . . . . . 0 N--CA 1.493 1.724 0 N-CA-C 108.737 -0.838 . . . . 64.540000000000006 108.737 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.5 p -145.94 -32.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.213 -0.929 . . . . 74.019999999999996 109.3 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.576 ' O ' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -51.4 -31.21 11.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.449 -0.782 . . . . 72.329999999999998 109.09 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -56.32 -53.29 58.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.253 -0.905 . . . . 74.400000000000006 110.173 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.8 m -74.06 -25.25 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.996 -1.065 . . . . 70.420000000000002 109.805 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -71.55 -52.65 17.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 52.109999999999999 110.047 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 9.9 tp -64.31 -33.97 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.91 -1.119 . . . . 71.400000000000006 109.734 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -64.67 -54.85 25.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.995 . . . . 73.439999999999998 110.025 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -67.65 -39.45 84.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.002 -1.061 . . . . 71.420000000000002 109.884 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 67.2 mt -60.12 -49.35 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.016 -1.053 . . . . 61.549999999999997 109.373 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -52.85 -53.73 44.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.07 -1.019 . . . . 63.340000000000003 109.442 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.629 ' NE2' ' N ' ' A' ' 193' ' ' GLN . 0.1 OUTLIER -59.76 -36.52 76.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -0.871 . . . . 61.240000000000002 109.375 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -81.65 -3.95 54.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.175 -0.953 . . . . 75.129999999999995 110.112 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 32.5 ttp -108.82 -15.18 14.45 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.322 -0.861 . . . . 74.019999999999996 109.704 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -108.51 -16.45 14.21 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.422 -0.799 . . . . 74.019999999999996 109.869 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.628 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 31.5 tptt -78.69 -35.72 1.13 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.979 -1.076 . . . . 75.430000000000007 110.776 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 89.0 Cg_endo -90.36 -48.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.226 1.951 . . . . 72.319999999999993 112.279 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 74.1 mt -68.1 -31.95 71.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.14 -0.975 . . . . 74.540000000000006 109.19 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 73.13 0.22 50.92 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.77 -1.332 . . . . 61.509999999999998 109.77 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.8 mt -123.23 128.2 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.548 -0.972 . . . . 61.219999999999999 109.488 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 8.3 t -86.03 132.95 33.94 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.321 -0.992 . . . . 72.0 108.321 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.7 p -134.87 27.02 3.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.254 -0.904 . . . . 74.439999999999998 109.909 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 26.7 m -146.98 150.48 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.096 -1.003 . . . . 64.349999999999994 109.736 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -126.61 126.13 43.1 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.645 -0.659 . . . . 71.409999999999997 109.368 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.34 111.16 16.46 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.133 -0.979 . . . . 73.519999999999996 108.916 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.09 132.51 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.558 -0.714 . . . . 71.019999999999996 109.783 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -73.53 -30.1 62.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.839 . . . . 72.120000000000005 109.7 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -58.48 -82.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.891 . . . . 64.409999999999997 110.312 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -82.24 -47.55 12.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.891 -1.131 . . . . 71.540000000000006 109.865 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 152.42 -110.8 0.47 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.976 -1.65 . . . . 72.030000000000001 108.976 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 163' ' ' VAL . 79.6 m-85 -112.11 140.41 46.82 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.433 -1.04 . . . . 75.540000000000006 108.714 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 25.8 mtm180 -121.3 129.79 53.3 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.423 -0.798 . . . . 75.310000000000002 109.522 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -97.47 119.54 36.2 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.296 -0.878 . . . . 75.409999999999997 108.906 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 28.2 m -130.91 161.22 32.35 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.354 -0.841 . . . . 74.140000000000001 109.75 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -72.27 151.06 92.16 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 75.319999999999993 109.08 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo . . . . . 0 N--CA 1.488 1.19 0 C-N-CA 121.974 1.783 . . . . 73.109999999999999 112.079 179.711 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.447 ' SD ' ' CE2' ' B' ' 25' ' ' PHE . 51.5 ttm . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.512 -0.551 . . . . 71.140000000000001 109.512 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -137.1 139.71 41.44 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.416 -0.802 . . . . 73.230000000000004 109.307 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 90.3 t -110.05 133.92 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.597 -0.689 . . . . 72.239999999999995 109.698 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.462 HD12 ' N ' ' B' ' 5' ' ' LEU . 2.6 tp -102.92 119.21 38.44 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.556 -0.715 . . . . 54.329999999999998 109.166 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.462 ' N ' HD12 ' B' ' 4' ' ' LEU . 19.5 mt -114.6 96.23 5.65 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.814 -0.81 . . . . 74.349999999999994 108.814 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.676 HD12 ' HB ' ' B' ' 50' ' ' VAL . 88.2 mt -81.43 98.19 3.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 O-C-N 120.727 -1.233 . . . . 42.549999999999997 108.494 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.434 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 28.3 tp10 -137.55 125.13 22.17 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.399 -0.813 . . . . 74.519999999999996 109.72 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -69.3 -31.17 69.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.31 -0.869 . . . . 62.549999999999997 108.896 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -85.25 112.19 20.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.379 -0.826 . . . . 73.109999999999999 109.447 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 96.9 p -68.09 -23.18 64.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.243 -0.911 . . . . 65.540000000000006 109.572 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 84.9 t -65.13 -52.62 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 75.549999999999997 109.614 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.469 HD23 ' OE2' ' B' ' 15' ' ' GLU . 62.3 mt -65.8 -37.4 86.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 70.140000000000001 109.686 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.29 -28.86 69.21 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.678 -1.769 . . . . 75.400000000000006 108.678 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.94 -53.26 41.97 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.721 -1.351 . . . . 65.439999999999998 109.721 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.469 ' OE2' HD23 ' B' ' 12' ' ' LEU . 15.0 pt-20 -58.96 -46.81 87.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.323 -1.104 . . . . 60.210000000000001 109.953 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 35.7 mm -64.52 -40.25 88.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.748 -1.22 . . . . 75.150000000000006 108.877 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -61.94 -44.65 96.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.364 -0.835 . . . . 73.010000000000005 109.446 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -85.48 1.72 47.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.187 -0.945 . . . . 74.299999999999997 108.964 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.4 -55.38 2.21 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 109.74 -1.344 . . . . 70.540000000000006 109.74 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -74.04 -19.7 60.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -1.184 . . . . 71.340000000000003 109.752 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -52.14 -32.78 37.15 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.17 -0.956 . . . . 64.409999999999997 109.521 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 79.4 t -58.7 -37.16 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.154 -0.966 . . . . 74.230000000000004 109.156 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -70.17 -13.81 62.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.362 -0.837 . . . . 63.420000000000002 109.41 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.44 38.78 6.99 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.844 -1.302 . . . . 53.43 109.844 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . 0.447 ' CE2' ' SD ' ' B' ' 1' ' ' MET . 15.6 m-85 -114.43 159.49 20.24 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.508 -0.995 . . . . 71.120000000000005 109.065 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.2 mmt -103.92 139.73 38.68 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.411 -0.959 . . . . 75.239999999999995 108.411 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.41 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -139.95 154.93 47.33 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.272 -0.892 . . . . 72.120000000000005 110.096 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 83.1 m-20 -134.65 158.03 45.12 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.482 -0.933 . . . . 72.310000000000002 108.482 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.03 139.67 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.352 -0.843 . . . . 64.430000000000007 109.866 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 6.1 p -134.48 170.08 16.29 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.586 -0.696 . . . . 65.409999999999997 109.196 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -94.08 -105.77 0.13 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.165 -0.96 . . . . 71.019999999999996 109.774 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 37.3 t -78.2 173.64 12.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.236 -0.915 . . . . 51.109999999999999 110.059 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.653 HD12 ' CG ' ' B' ' 58' ' ' PHE . 3.7 mm? -55.27 -39.26 69.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.518 -0.739 . . . . 71.239999999999995 109.681 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -46.56 -45.74 18.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 74.319999999999993 110.031 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.59 -38.73 70.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.103 -0.998 . . . . 73.030000000000001 109.249 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.18 -42.7 91.03 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.18 -1.568 . . . . 30.210000000000001 109.18 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -67.94 -40.74 83.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.294 -1.121 . . . . 74.420000000000002 109.453 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -72.17 -37.55 69.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 74.420000000000002 109.841 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 21.7 tp -72.14 -48.23 45.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -0.931 . . . . 75.409999999999997 110.12 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.9 ppp? -66.95 -19.75 65.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.032 -1.043 . . . . 60.409999999999997 109.923 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -61.4 -40.72 95.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.081 -1.012 . . . . 53.229999999999997 110.058 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.438 HD12 ' NH1' ' B' ' 43' ' ' ARG . 19.0 pt -82.82 -29.73 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.129 -0.982 . . . . 71.230000000000004 110.278 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.438 ' NH1' HD12 ' B' ' 42' ' ' ILE . 75.1 mtt85 -130.43 143.89 51.05 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.287 -0.883 . . . . 72.219999999999999 109.758 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -97.69 130.77 44.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.251 -0.906 . . . . 63.539999999999999 109.233 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -99.76 139.97 34.65 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.316 -0.865 . . . . 64.349999999999994 109.411 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -75.11 -37.06 61.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 62.219999999999999 109.237 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.566 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.9 OUTLIER -113.59 116.93 30.28 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.641 -0.874 . . . . 73.120000000000005 108.641 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.566 ' N ' HD13 ' B' ' 47' ' ' LEU . 72.3 t -98.43 98.22 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.354 -0.98 . . . . 65.109999999999999 108.354 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 0.5 OUTLIER -110.38 131.09 55.36 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.462 0.648 . . . . 73.439999999999998 109.288 -179.006 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.676 ' HB ' HD12 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -145.73 135.6 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.437 -0.789 . . . . 34.5 109.607 -179.626 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . 0.434 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 14.7 p -98.8 14.03 30.26 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.541 -0.724 . . . . 73.209999999999994 109.661 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.631 ' H ' HG22 ' B' ' 50' ' ' VAL . 23.9 m-20 -82.9 140.3 32.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.184 -0.948 . . . . 70.409999999999997 109.468 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' B' ' 55' ' ' ALA . 14.4 mtpp -74.69 -39.73 61.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 65.0 110.134 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -71.41 10.98 0.52 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.108 -0.995 . . . . 75.209999999999994 109.695 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -66.27 -22.97 66.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 55.329999999999998 110.247 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 37.5 mt -45.72 -45.49 14.38 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.219 -0.926 . . . . 63.140000000000001 110.151 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 83.5 p -70.24 -38.39 75.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.892 -1.13 . . . . 63.5 109.364 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . 0.653 ' CG ' HD12 ' B' ' 33' ' ' LEU . 48.9 t80 -66.19 -61.11 2.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.339 -0.851 . . . . 72.329999999999998 109.762 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 20.7 m -50.32 -34.8 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.546 -1.346 . . . . 74.540000000000006 109.7 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 44.8 m -56.77 -51.58 68.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.115 -0.991 . . . . 71.239999999999995 109.534 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -69.38 -32.14 70.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.981 -1.074 . . . . 74.310000000000002 110.19 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' B' ' 66' ' ' HIS . 39.5 mm -65.74 -42.41 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.676 -1.265 . . . . 72.140000000000001 110.133 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -65.78 -49.6 67.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.209 -0.932 . . . . 73.319999999999993 110.695 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' B' ' 65' ' ' LYS . 7.5 pt-20 -69.17 -41.62 76.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.7 -1.25 . . . . 73.120000000000005 109.838 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.496 ' O ' ' ND1' ' B' ' 66' ' ' HIS . 85.6 mttt -79.7 -18.69 50.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.25 -0.906 . . . . 72.439999999999998 109.563 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.496 ' ND1' ' O ' ' B' ' 65' ' ' LYS . 69.1 m-70 -154.82 67.59 0.69 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.141 -0.974 . . . . 63.310000000000002 109.698 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 54.6 p -67.18 -25.0 65.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.176 -0.953 . . . . 73.099999999999994 109.553 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 24.0 m -64.08 -27.06 68.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.305 -0.872 . . . . 71.530000000000001 109.895 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 84.5 mt -81.23 152.99 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.156 -0.965 . . . . 74.400000000000006 109.687 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 67.2 t -94.81 154.18 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.356 -0.84 . . . . 75.120000000000005 109.181 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.427 ' H ' ' HB2' ' B' ' 92' ' ' ASP . 11.3 t -133.64 130.52 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.309 -0.87 . . . . 73.200000000000003 110.049 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.508 ' O ' ' SD ' ' B' ' 49' ' ' MET . 6.5 tt -122.98 104.0 8.96 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.864 -0.791 . . . . 73.340000000000003 108.864 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 9.1 p -95.45 137.07 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.977 -1.077 . . . . 73.5 108.961 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 3.9 p -96.68 170.88 8.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.297 -0.877 . . . . 64.340000000000003 109.552 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.481 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 42.9 t -157.67 114.85 2.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.169 -0.957 . . . . 74.530000000000001 110.232 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' B' ' 77' ' ' ASN . 52.1 p-10 -66.6 -21.45 66.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.221 -0.924 . . . . 64.5 109.264 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . 0.517 ' N ' ' OD1' ' B' ' 76' ' ' ASP . 56.6 t-20 -126.53 75.95 74.08 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 108.633 -0.877 . . . . 74.25 108.633 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -44.31 85.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.32 2.013 . . . . 74.430000000000007 111.724 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.515 ' N ' ' O ' ' B' ' 77' ' ' ASN . 7.4 m -94.67 150.24 20.42 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.635 0.731 . . . . 73.120000000000005 110.065 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.9 p -76.78 -43.16 37.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.539 -0.726 . . . . 71.010000000000005 109.655 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -56.73 -35.24 68.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.135 -0.978 . . . . 63.200000000000003 109.012 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -74.2 -34.72 63.83 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.098 -1.001 . . . . 73.219999999999999 108.97 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.522 ' OE1' ' CG ' ' B' ' 94' ' ' TYR . 42.1 tp10 -65.84 -55.95 14.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.257 -0.902 . . . . 74.299999999999997 109.609 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.459 HG23 ' N ' ' B' ' 85' ' ' HIS . 31.4 m -53.44 -41.93 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.994 -1.066 . . . . 73.310000000000002 108.968 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' HIS . . . . . 0.459 ' N ' HG23 ' B' ' 84' ' ' VAL . 46.6 m80 -74.26 -20.09 60.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.174 -0.954 . . . . 73.239999999999995 109.597 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -68.75 -40.87 79.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.945 -1.097 . . . . 55.329999999999998 110.428 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' PHE . . . . . 0.635 ' CE2' ' HB1' ' A' ' 107' ' ' ALA . 0.5 OUTLIER -83.3 -30.48 27.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.871 -1.143 . . . . 74.140000000000001 109.112 -179.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -77.27 -44.37 30.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.11 -0.993 . . . . 64.040000000000006 109.25 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -65.44 -54.96 21.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.425 -0.797 . . . . 72.349999999999994 109.496 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 154.72 72.81 0.01 OUTLIER Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.608 -1.282 . . . . 65.200000000000003 110.472 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -140.44 140.87 35.48 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.272 -1.134 . . . . 52.229999999999997 108.84 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.427 ' HB2' ' H ' ' B' ' 71' ' ' VAL . 54.3 m-20 -94.99 -22.99 17.58 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.06 -1.025 . . . . 73.319999999999993 109.824 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 17.4 t0 -151.78 158.32 43.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.09 -1.007 . . . . 72.219999999999999 109.609 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.522 ' CG ' ' OE1' ' B' ' 83' ' ' GLU . 55.8 t80 -142.9 104.91 4.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.478 -0.764 . . . . 64.420000000000002 108.969 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 27.2 mm -114.37 151.92 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.542 0 O-C-N 121.127 -0.983 . . . . 72.230000000000004 110.22 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.27 144.26 57.26 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.987 -1.116 . . . . 25.239999999999998 107.987 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.687 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -64.32 -54.42 38.63 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.765 -1.21 . . . . 64.319999999999993 111.516 -179.301 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 3.5 Cg_endo -41.45 -8.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 120.851 1.034 . . . . 63.329999999999998 113.341 -176.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . 0.687 ' N ' ' O ' ' B' ' 97' ' ' LYS . 44.7 m-85 59.06 110.22 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.366 -0.834 . . . . 75.129999999999995 109.322 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . 0.511 ' NH1' ' OE2' ' A' ' 83' ' ' GLU . 13.2 ttm180 -57.98 -34.2 69.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.009 -1.057 . . . . 74.230000000000004 108.88 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . 0.778 ' O ' ' N ' ' B' ' 103' ' ' LYS . 47.9 t -174.26 32.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.148 -0.97 . . . . 63.340000000000003 110.836 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 49.9 mt 49.62 -69.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 118.745 0.702 . . . . 74.439999999999998 110.193 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.778 ' N ' ' O ' ' B' ' 101' ' ' SER . 40.6 tptt -51.77 -31.17 25.76 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.603 -1.258 . . . . 71.109999999999999 107.603 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.97 -40.72 83.09 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.608 -0.886 . . . . 71.450000000000003 108.608 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 51.9 tp -66.22 -45.86 79.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.448 -0.782 . . . . 51.310000000000002 109.022 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 42.4 t -66.89 -41.1 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.919 . . . . 65.230000000000004 109.3 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.06 -45.22 64.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.254 -0.903 . . . . 24.32 109.375 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 67.2 ttt-85 -69.07 -33.52 73.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.911 . . . . 75.310000000000002 109.671 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 96.6 mt -72.23 -29.11 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.104 -0.997 . . . . 54.240000000000002 108.767 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -67.72 -58.87 3.9 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.471 -0.891 . . . . 65.310000000000002 108.938 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -52.97 -32.11 44.34 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.305 -0.872 . . . . 72.239999999999995 109.108 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 25.6 tpt85 -58.9 -50.41 74.15 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.288 -0.883 . . . . 72.040000000000006 109.277 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 63.1 mt -146.19 103.52 3.72 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.174 -0.954 . . . . 75.349999999999994 109.995 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -98.47 107.48 19.95 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.465 -0.939 . . . . 75.5 108.465 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 78.1 t80 49.62 86.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 65.329999999999998 109.558 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 -82.39 142.79 31.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.194 -0.941 . . . . 74.450000000000003 109.45 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 163.27 86.39 0.06 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.599 -1.4 . . . . 44.210000000000001 109.599 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . 0.451 ' O ' ' ND2' ' B' ' 119' ' ' ASN . 8.9 t -157.61 -175.26 5.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -1.128 . . . . 71.400000000000006 109.745 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' B' ' 118' ' ' SER . 0.0 OUTLIER -153.83 137.57 16.13 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.832 -0.747 . . . . 72.319999999999993 109.114 -178.205 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 6.9 t -71.8 -36.75 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 75.019999999999996 109.617 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 20.8 mm -103.25 132.74 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.328 -0.858 . . . . 51.409999999999997 109.287 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -135.7 119.26 17.01 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.434 -0.791 . . . . 71.530000000000001 109.24 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.436 HG23 ' O ' ' B' ' 123' ' ' ILE . 14.5 tt -145.67 130.5 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.262 -0.898 . . . . 72.430000000000007 109.235 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.46 -153.31 1.01 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.424 -1.47 . . . . 51.229999999999997 109.424 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -79.82 2.1 24.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.152 -1.205 . . . . 74.200000000000003 109.049 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.63 135.17 37.65 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.356 -0.979 . . . . 75.420000000000002 108.356 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 1.2 p -130.9 145.18 51.93 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.361 -0.837 . . . . 74.219999999999999 109.198 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 14.0 mt -133.69 140.41 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.446 -0.784 . . . . 60.329999999999998 109.066 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 3.6 t -123.02 81.89 50.87 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.635 -0.665 . . . . 72.310000000000002 109.307 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.67 -48.09 23.79 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.169 1.912 . . . . 75.129999999999995 112.589 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -52.57 -45.76 66.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.083 -1.011 . . . . 75.230000000000004 109.232 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -86.98 2.18 50.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.261 -0.9 . . . . 72.430000000000007 109.137 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 53.12 18.07 1.09 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 75.129999999999995 109.391 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -101.46 130.92 47.8 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.432 -0.793 . . . . 73.219999999999999 109.459 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . 0.428 HG23 ' O ' ' B' ' 135' ' ' ILE . 16.2 tt -113.12 133.24 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.536 -0.728 . . . . 64.140000000000001 109.095 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 2.5 mp -114.56 131.63 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.504 -0.748 . . . . 71.219999999999999 109.327 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -137.76 126.68 24.09 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.333 -0.854 . . . . 64.219999999999999 109.866 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp 52.76 34.78 16.98 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.369 -0.832 . . . . 72.019999999999996 110.413 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.35 13.89 82.78 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 120.041 -1.076 . . . . 74.319999999999993 110.723 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 53.0 mtt-85 -109.3 122.81 48.15 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.311 -1.111 . . . . 75.340000000000003 109.136 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -92.08 136.59 33.06 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.189 -0.944 . . . . 71.230000000000004 109.373 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.79 135.25 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.449 -0.782 . . . . 70.430000000000007 109.158 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -88.25 125.42 34.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.202 -0.936 . . . . 72.430000000000007 109.096 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 3.2 m -143.97 124.89 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.218 -0.926 . . . . 72.129999999999995 109.471 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -156.59 16.99 0.32 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.338 -0.852 . . . . 72.019999999999996 109.271 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -66.64 164.44 42.23 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.242 -1.543 . . . . 42.229999999999997 109.242 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . 0.569 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 2.8 tmtp? -58.11 -43.98 98.87 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.222 -1.163 . . . . 73.299999999999997 109.224 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 23.3 Cg_exo -63.56 -20.63 69.81 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.591 2.194 . . . . 71.329999999999998 112.331 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . 0.491 ' CE2' HG23 ' B' ' 153' ' ' THR . 86.1 t80 -89.24 -22.65 22.63 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.175 -0.953 . . . . 74.230000000000004 110.035 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -50.53 -41.87 54.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.078 -1.014 . . . . 72.340000000000003 109.444 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 11.0 p -66.53 -32.4 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.955 . . . . 73.349999999999994 109.084 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.522 ' O ' HD13 ' B' ' 152' ' ' LEU . 0.2 OUTLIER -56.79 -43.64 81.1 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.707 -0.849 . . . . 55.240000000000002 108.707 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.491 HG23 ' CE2' ' B' ' 149' ' ' PHE . 2.7 p -73.65 -30.73 63.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.103 -0.998 . . . . 70.010000000000005 109.193 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -55.02 -54.07 47.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.912 . . . . 65.319999999999993 109.744 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.04 -28.94 63.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.071 -1.018 . . . . 71.540000000000006 109.572 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.15 -49.84 65.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 75.319999999999993 109.583 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . 0.427 ' C ' ' H ' ' B' ' 159' ' ' ARG . 24.3 mtp180 -71.47 -44.94 63.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 73.319999999999993 109.387 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -74.94 20.47 0.13 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.415 -0.803 . . . . 74.140000000000001 109.793 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . 0.427 ' H ' ' C ' ' B' ' 157' ' ' ARG . 6.6 mmt85 -54.3 173.51 0.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.042 -1.037 . . . . 61.409999999999997 108.88 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . 0.412 ' OD2' ' O ' ' B' ' 160' ' ' ASP . 4.6 p-10 42.37 47.47 4.25 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.544 -0.722 . . . . 72.099999999999994 110.276 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -161.32 157.76 25.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 72.25 109.459 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 162' ' ' ILE . . . . . 0.745 HD12 ' N ' ' B' ' 162' ' ' ILE . 1.8 mp -91.37 131.41 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.237 -0.915 . . . . 72.310000000000002 109.174 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . 0.405 HG11 HD21 ' B' ' 168' ' ' LEU . 40.3 t -123.59 136.56 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.529 -0.732 . . . . 64.209999999999994 109.335 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 11.3 p -83.39 158.35 22.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 74.219999999999999 109.568 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -62.54 -43.51 98.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.861 . . . . 65.310000000000002 109.349 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -65.53 -34.5 78.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 63.450000000000003 109.888 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -50.76 -49.38 58.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.11 -0.994 . . . . 72.400000000000006 109.39 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . 0.405 HD21 HG11 ' B' ' 163' ' ' VAL . 53.6 mt -66.42 -40.33 89.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.199 -0.938 . . . . 72.319999999999993 109.355 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.507 HD23 ' C ' ' B' ' 169' ' ' LEU . 3.7 tt -48.99 -59.12 3.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 73.340000000000003 109.482 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' B' ' 171' ' ' ALA . 78.0 m-20 -67.88 -41.4 82.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 72.099999999999994 110.14 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' B' ' 170' ' ' ASP . . . -43.1 -47.72 6.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.376 -0.827 . . . . 62.130000000000003 110.586 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 16.4 mm -94.96 -9.94 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.056 -1.028 . . . . 71.420000000000002 110.267 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 . . . . . 0 N--CA 1.498 1.939 0 O-C-N 120.848 -1.158 . . . . 72.230000000000004 110.446 -179.796 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo . . . . . 0 N--CA 1.495 1.602 0 CA-C-O 121.36 0.483 . . . . 65.219999999999999 112.783 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 3.2 m120 61.32 39.52 15.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.398 -0.814 . . . . 72.310000000000002 109.411 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 25.4 t -79.33 -49.65 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.884 . . . . 63.32 109.802 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.432 ' O ' HG22 ' B' ' 188' ' ' ILE . 27.7 mm -70.0 -24.85 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 75.030000000000001 110.183 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -64.18 -44.51 91.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.831 -1.168 . . . . 64.109999999999999 109.306 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 19.4 m -77.21 -31.85 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.203 -0.936 . . . . 73.0 109.59 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.2 -50.24 20.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.06 -1.025 . . . . 61.119999999999997 110.014 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 188' ' ' ILE . . . . . 0.625 HD12 ' CZ ' ' B' ' 212' ' ' TYR . 1.8 tt -59.43 -44.78 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.154 -0.966 . . . . 72.430000000000007 110.151 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 189' ' ' ASN . . . . . 0.521 ' N ' HG23 ' B' ' 188' ' ' ILE . 58.4 t30 -60.3 -43.58 96.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.091 -1.006 . . . . 65.140000000000001 109.584 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 190' ' ' GLN . . . . . 0.414 ' O ' ' CB ' ' B' ' 194' ' ' LYS . 15.1 mm-40 -68.64 -46.51 68.99 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.258 -0.901 . . . . 63.240000000000002 109.882 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 82.3 mt -54.47 -30.26 21.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 120.654 -1.279 . . . . 74.030000000000001 109.791 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 65.8 mtp85 -73.01 -60.84 2.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.013 -1.055 . . . . 72.239999999999995 110.871 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 193' ' ' GLN . . . . . 0.429 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 76.0 mt-30 -70.94 -32.8 69.81 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.027 -1.046 . . . . 73.099999999999994 110.252 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' B' ' 190' ' ' GLN . 20.7 ttpp -72.02 -26.82 62.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.478 -0.764 . . . . 72.109999999999999 110.696 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 17.4 tpt -92.44 -44.49 8.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.889 -1.132 . . . . 44.329999999999998 110.016 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 196' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 59.3 p30 -64.17 -19.65 65.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.034 -1.041 . . . . 71.209999999999994 110.086 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . 0.533 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 29.7 mttm -67.96 -64.75 1.74 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.081 -1.012 . . . . 75.209999999999994 109.198 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 198' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 39.7 Cg_endo -64.88 -50.99 1.88 Allowed 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.075 1.85 . . . . 75.319999999999993 110.976 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . 0.903 HD21 ' O ' ' B' ' 201' ' ' ILE . 0.0 OUTLIER -95.74 134.53 38.57 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.868 -1.16 . . . . 72.25 107.868 179.303 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . -97.96 -8.52 55.4 Favored Glycine 0 N--CA 1.498 2.816 0 O-C-N 121.083 -1.011 . . . . 64.530000000000001 110.615 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . 0.903 ' O ' HD21 ' B' ' 199' ' ' LEU . 70.2 mt -91.74 124.84 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.023 -1.281 . . . . 44.229999999999997 109.471 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 23.3 t -77.26 135.82 38.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 54.009999999999998 109.603 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 2.0 p -145.31 28.24 1.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.261 -0.899 . . . . 74.400000000000006 109.281 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 35.8 m -135.64 138.37 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.395 -0.816 . . . . 72.120000000000005 109.466 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -126.34 136.48 52.78 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.582 -0.699 . . . . 65.409999999999997 109.281 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 10.5 p -95.05 139.37 31.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.208 -0.933 . . . . 71.329999999999998 109.422 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.462 ' N ' ' O ' ' B' ' 211' ' ' GLY . 39.0 t -131.6 124.44 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.522 -0.736 . . . . 63.5 109.197 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 208' ' ' ARG . . . . . 0.467 ' CD ' ' N ' ' B' ' 208' ' ' ARG . 1.3 mpt_? -76.5 -34.93 58.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 74.450000000000003 109.822 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 209' ' ' ARG . . . . . 0.413 ' CD ' ' N ' ' B' ' 209' ' ' ARG . 11.7 mpt_? -56.17 -62.74 1.5 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.151 -0.968 . . . . 74.140000000000001 109.68 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 62.1 mmt-85 -98.81 -76.45 0.54 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.235 -0.915 . . . . 74.430000000000007 109.529 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 211' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' B' ' 207' ' ' VAL . . . -167.26 -107.41 0.2 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.528 -1.429 . . . . 64.450000000000003 109.528 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 212' ' ' TYR . . . . . 0.625 ' CZ ' HD12 ' B' ' 188' ' ' ILE . 2.9 m-85 -120.58 133.96 55.33 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.592 -0.946 . . . . 74.209999999999994 109.346 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -104.77 126.53 51.95 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.494 -0.753 . . . . 74.030000000000001 109.083 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -101.96 125.89 48.75 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.348 -0.845 . . . . 74.340000000000003 109.276 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 20.5 p -142.76 154.26 44.08 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.336 -0.852 . . . . 64.329999999999998 109.378 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -63.96 154.24 82.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 70.040000000000006 108.865 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -38.23 147.3 0.11 Allowed 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.178 1.918 . . . . 65.109999999999999 111.902 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 21.1 mttp . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 73.150000000000006 111.355 -179.14 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.2 ttm . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.518 -0.549 . . . . 65.120000000000005 109.518 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.485 ' N ' ' OD2' ' A' ' 46' ' ' ASP . 97.6 mtt180 -129.65 156.77 43.71 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.497 -0.752 . . . . 72.329999999999998 109.17 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.0 t -118.65 124.44 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 CA-C-O 121.792 0.806 . . . . 71.420000000000002 110.014 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.518 HD11 ' CG1' ' A' ' 6' ' ' ILE . 2.1 tp -94.07 117.35 29.97 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.398 -0.964 . . . . 65.120000000000005 108.398 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 6' ' ' ILE . 3.7 tt -119.44 119.43 33.88 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.092 -1.077 . . . . 62.43 108.092 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.539 ' N ' HD23 ' A' ' 5' ' ' LEU . 56.3 mt -110.91 99.48 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.316 -0.865 . . . . 71.150000000000006 109.259 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' A' ' 30' ' ' THR . 36.2 tp10 -122.94 133.2 54.4 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.56 -0.712 . . . . 75.340000000000003 109.423 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -66.34 -34.47 78.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.242 -0.911 . . . . 72.439999999999998 109.555 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 10' ' ' SER . 21.6 p30 -82.98 -149.72 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.24 -0.913 . . . . 63.020000000000003 109.471 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.498 ' N ' ' OD1' ' A' ' 9' ' ' ASN . 20.9 p -152.55 -39.63 0.11 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.215 -0.928 . . . . 72.340000000000003 109.67 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.556 HG13 ' N ' ' A' ' 12' ' ' LEU . 11.1 p -64.39 -44.14 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 74.019999999999996 109.725 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.556 ' N ' HG13 ' A' ' 11' ' ' VAL . 14.9 tp -65.28 -39.19 92.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 71.430000000000007 109.312 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.75 -28.03 69.78 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 108.035 -2.026 . . . . 61.32 108.035 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.12 -46.04 94.13 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 110.07 -1.212 . . . . 71.200000000000003 110.07 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -65.98 -47.15 75.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -1.203 . . . . 71.319999999999993 109.832 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.8 mm -65.51 -36.53 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.603 -1.311 . . . . 63.229999999999997 108.372 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.478 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 86.7 tt0 -65.54 -47.91 74.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.464 -0.773 . . . . 51.109999999999999 109.798 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -83.52 1.18 43.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.089 -1.007 . . . . 73.340000000000003 109.748 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.24 -55.17 2.54 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.567 -1.413 . . . . 62.149999999999999 109.567 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.402 HD23 ' N ' ' A' ' 21' ' ' ASN . 1.3 pt? -76.23 -21.79 55.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -1.15 . . . . 73.510000000000005 109.917 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 92.9 m-20 -55.22 -32.28 62.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.034 -1.041 . . . . 74.25 109.345 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.3 t -60.02 -38.31 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 70.040000000000006 109.359 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.496 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 3.4 mptp? -62.68 -26.47 68.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.354 -0.842 . . . . 73.230000000000004 109.275 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.89 24.14 5.32 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 110.215 -1.154 . . . . 75.540000000000006 110.215 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -105.33 157.51 17.27 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.227 -1.16 . . . . 73.430000000000007 109.091 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.0 mmm -104.24 136.96 42.87 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.134 -1.061 . . . . 43.240000000000002 108.134 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.26 160.25 41.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.193 -0.942 . . . . 62.109999999999999 109.851 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -140.57 145.39 36.67 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.411 -0.806 . . . . 74.420000000000002 109.526 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 t -104.13 134.92 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.462 -0.94 . . . . 72.150000000000006 108.462 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.425 ' O ' ' O ' ' A' ' 7' ' ' GLU . 6.5 p -131.04 172.44 12.08 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.39 -0.819 . . . . 71.420000000000002 109.44 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -92.26 -104.54 0.11 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.24 -0.913 . . . . 72.329999999999998 110.001 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.4 p -78.8 167.41 21.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.245 -0.909 . . . . 74.239999999999995 110.269 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 35.7 mt -54.17 -29.62 46.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.635 -0.666 . . . . 71.530000000000001 109.857 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -47.79 -49.36 28.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.049 -1.032 . . . . 74.230000000000004 109.719 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -68.12 -38.39 82.19 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.142 -0.974 . . . . 54.030000000000001 109.222 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.84 -45.05 59.69 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.377 -1.489 . . . . 61.409999999999997 109.377 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -65.75 -38.44 89.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -1.103 . . . . 74.340000000000003 109.265 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -75.41 -37.52 60.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.151 -0.968 . . . . 75.329999999999998 109.679 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.3 tp -72.7 -47.55 46.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 74.329999999999998 110.101 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.495 ' SD ' ' OD1' ' A' ' 41' ' ' ASP . 3.7 ppp? -63.73 -28.71 70.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.105 -0.997 . . . . 70.319999999999993 110.083 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.495 ' OD1' ' SD ' ' A' ' 40' ' ' MET . 99.3 m-20 -65.6 -39.9 92.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.036 -1.04 . . . . 71.219999999999999 110.016 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.0 pt -82.88 -29.63 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.148 -0.97 . . . . 74.140000000000001 110.251 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 40' ' ' MET . 93.0 mtt180 -129.89 146.89 51.61 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.323 -0.861 . . . . 72.239999999999995 109.514 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -91.28 161.7 14.93 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.206 -0.934 . . . . 75.420000000000002 109.654 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -143.11 153.67 43.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.337 -0.852 . . . . 74.230000000000004 109.142 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.485 ' OD2' ' N ' ' A' ' 2' ' ' ARG . 3.8 p30 -95.41 -41.5 8.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.192 -0.943 . . . . 72.040000000000006 109.514 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.525 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.3 OUTLIER -104.84 115.76 30.85 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.433 -0.792 . . . . 72.129999999999995 109.05 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.525 ' N ' HD13 ' A' ' 47' ' ' LEU . 74.5 t -101.49 97.8 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.389 -0.967 . . . . 72.340000000000003 108.389 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -114.27 130.66 56.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.491 -0.756 . . . . 74.109999999999999 110.303 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.561 HG22 ' H ' ' A' ' 52' ' ' ASP . 1.5 p -138.4 129.36 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 121.728 0.775 . . . . 61.119999999999997 109.652 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.8 t -92.14 3.67 54.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.49 -0.757 . . . . 73.109999999999999 109.199 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.561 ' H ' HG22 ' A' ' 50' ' ' VAL . 51.8 m-20 -76.28 138.07 40.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.305 -0.872 . . . . 52.549999999999997 109.509 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.493 ' C ' ' H ' ' A' ' 55' ' ' ALA . 28.1 mtmm -67.94 -35.25 78.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.179 -0.95 . . . . 44.219999999999999 110.049 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -71.36 17.08 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.153 -0.967 . . . . 70.439999999999998 109.734 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -60.29 -30.4 69.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 64.140000000000001 110.085 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.412 ' HG ' ' H ' ' A' ' 56' ' ' LEU . 22.3 mt -46.07 -43.85 14.96 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.087 -1.008 . . . . 44.140000000000001 110.097 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.2 p -73.21 -40.23 64.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.93 -1.106 . . . . 55.229999999999997 109.627 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.63 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 58.8 t80 -65.13 -56.9 10.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.408 -0.807 . . . . 74.439999999999998 110.127 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.459 HG23 ' N ' ' A' ' 60' ' ' SER . 17.2 m -54.05 -38.2 37.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 120.839 -1.163 . . . . 74.030000000000001 109.638 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.459 ' N ' HG23 ' A' ' 59' ' ' VAL . 46.2 p -54.83 -52.73 61.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.176 -0.952 . . . . 64.299999999999997 109.662 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -69.63 -29.81 67.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.088 -1.008 . . . . 64.439999999999998 110.342 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.63 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 6.1 mm -68.16 -47.9 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.639 -1.288 . . . . 63.210000000000001 110.357 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.466 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 41.4 mmtt -62.85 -43.7 98.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.065 -1.022 . . . . 74.420000000000002 110.691 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.403 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 7.0 pt-20 -73.55 -41.05 63.46 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.71 -1.244 . . . . 70.319999999999993 109.747 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.447 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 25.6 mtpp -78.17 -19.84 53.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.151 -0.968 . . . . 75.219999999999999 109.143 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.572 ' O ' HG22 ' A' ' 69' ' ' ILE . 91.7 m-70 -154.94 69.46 0.73 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 74.129999999999995 109.222 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.0 p -63.58 -27.2 69.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.31 -0.869 . . . . 73.239999999999995 110.085 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.6 t -79.5 48.95 0.95 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.058 -1.026 . . . . 61.009999999999998 109.856 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.572 HG22 ' O ' ' A' ' 66' ' ' HIS . 13.8 tt -146.68 156.59 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.084 -1.01 . . . . 71.329999999999998 109.456 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.9 t -92.81 154.15 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.171 -0.956 . . . . 72.129999999999995 109.51 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.518 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 21.3 t -135.96 125.99 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.299 -0.876 . . . . 54.210000000000001 110.074 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.533 HD13 ' C ' ' A' ' 72' ' ' LEU . 1.3 tm? -118.62 101.67 8.3 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.423 -0.955 . . . . 50.240000000000002 108.423 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -95.5 138.94 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.933 -1.104 . . . . 74.409999999999997 109.57 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.1 m -122.86 161.31 24.32 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.677 -0.86 . . . . 72.310000000000002 108.677 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 77' ' ' ASN . 3.0 p -172.2 121.43 0.45 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.999 -1.063 . . . . 64.540000000000006 109.971 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.415 ' N ' ' HB2' ' A' ' 97' ' ' LYS . 50.8 p30 -64.31 63.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.701 -0.624 . . . . 74.129999999999995 109.931 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 75' ' ' SER . 2.9 p30 -177.14 53.65 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.201 -0.937 . . . . 73.340000000000003 109.669 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 77' ' ' ASN . 6.9 Cg_endo -48.84 84.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.365 2.043 . . . . 63.219999999999999 111.729 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.712 HG23 ' H ' ' A' ' 82' ' ' GLU . 2.9 t -114.48 151.64 32.94 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.041 -0.725 . . . . 62.530000000000001 109.041 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -28.4 67.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 73.439999999999998 109.231 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -63.89 -41.09 97.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.279 -0.888 . . . . 71.420000000000002 109.829 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.712 ' H ' HG23 ' A' ' 79' ' ' THR . 37.8 tp10 -76.91 -26.28 53.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.085 -1.009 . . . . 73.430000000000007 109.342 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -67.89 -46.47 71.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 74.219999999999999 109.683 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 85' ' ' HIS . 29.4 m -68.89 -41.19 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.098 -1.002 . . . . 73.200000000000003 109.566 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.441 ' N ' HG23 ' A' ' 84' ' ' VAL . 73.5 t60 -72.14 -31.59 66.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -0.935 . . . . 53.329999999999998 109.637 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -65.76 -39.49 91.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 64.109999999999999 110.114 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -77.39 -36.08 53.78 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.049 -1.032 . . . . 74.340000000000003 108.769 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -68.33 -38.56 81.64 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.383 -0.823 . . . . 74.420000000000002 109.305 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -64.39 -44.86 89.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 74.239999999999995 109.319 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.09 -15.86 1.02 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.036 -1.226 . . . . 61.509999999999998 110.036 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -51.68 132.85 31.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.047 -1.267 . . . . 55.329999999999998 109.393 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.518 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 71.0 m-20 -80.83 -33.28 34.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 73.420000000000002 109.409 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.527 ' CG ' HH21 ' A' ' 108' ' ' ARG . 65.3 m-20 -152.45 129.53 11.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.258 -0.901 . . . . 75.040000000000006 109.249 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -104.5 116.42 32.07 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.875 -0.787 . . . . 71.329999999999998 108.875 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.43 HG12 HD11 ' A' ' 72' ' ' LEU . 23.8 mm -106.53 149.92 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-O 122.194 0.997 . . . . 71.129999999999995 111.319 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.79 117.65 11.65 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.842 -1.54 . . . . 64.319999999999993 106.842 177.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.665 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -43.59 -54.0 11.08 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.173 -0.954 . . . . 62.200000000000003 111.778 -178.283 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.2 Cg_endo -41.8 -11.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.237 0 CA-C-N 119.851 0.983 . . . . 73.109999999999999 112.565 -176.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.665 ' N ' ' O ' ' A' ' 97' ' ' LYS . 61.2 m-85 57.69 116.07 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.817 -0.552 . . . . 65.219999999999999 109.701 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -56.47 -38.11 71.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.849 -1.157 . . . . 72.349999999999994 108.776 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.786 ' O ' ' N ' ' A' ' 103' ' ' LYS . 9.9 t -173.56 40.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.251 -0.906 . . . . 71.319999999999993 110.688 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.5 mt 48.09 -69.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 CA-C-N 118.68 0.673 . . . . 75.430000000000007 110.505 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.786 ' N ' ' O ' ' A' ' 101' ' ' SER . 41.4 tptt -52.07 -31.22 29.34 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.181 -1.044 . . . . 71.409999999999997 108.181 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.66 -56.04 21.43 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.622 -0.831 . . . . 63.240000000000002 108.836 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.724 HD13 ' N ' ' A' ' 106' ' ' VAL . 0.7 OUTLIER -62.69 -56.18 20.04 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.65 -0.87 . . . . 73.219999999999999 108.65 179.638 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.724 ' N ' HD13 ' A' ' 105' ' ' LEU . 87.4 t -48.44 -46.24 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.995 -1.065 . . . . 60.109999999999999 109.154 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.94 -35.73 62.05 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.212 -0.93 . . . . 70.420000000000002 108.553 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.53 ' NH1' ' CZ ' ' B' ' 87' ' ' PHE . 53.1 ttt85 -71.64 -29.43 64.63 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.435 -0.79 . . . . 74.409999999999997 109.681 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 87.0 mt -74.85 -32.92 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.978 -1.076 . . . . 62.539999999999999 108.498 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -74.47 -51.01 16.06 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.525 -0.734 . . . . 74.340000000000003 109.648 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.94 -43.3 69.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.901 . . . . 73.319999999999993 109.666 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.409 ' CB ' HD12 ' A' ' 113' ' ' LEU . 82.7 mtm180 -65.38 -39.9 92.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.193 -0.942 . . . . 52.409999999999997 109.612 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.409 HD12 ' CB ' ' A' ' 112' ' ' ARG . 5.3 mp -139.96 94.07 2.72 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.13 -0.982 . . . . 65.239999999999995 109.269 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.4 mtm-85 -84.68 -70.89 0.55 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.14 -0.975 . . . . 64.450000000000003 108.881 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' A' ' 116' ' ' TRP . 30.4 p90 -163.16 -33.83 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.124 -0.985 . . . . 74.430000000000007 109.511 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.54 ' N ' ' CD1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER 38.44 -94.66 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.707 -0.62 . . . . 74.420000000000002 110.355 179.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 115' ' ' PHE . . . 76.88 72.45 1.11 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.503 -1.439 . . . . 75.040000000000006 109.503 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.537 ' O ' ' OG ' ' A' ' 129' ' ' SER . 0.3 OUTLIER -147.41 172.96 13.11 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.256 -1.143 . . . . 61.140000000000001 109.688 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.542 ' HA ' ' OG ' ' A' ' 129' ' ' SER . 0.0 OUTLIER -152.25 149.86 29.16 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.552 -0.717 . . . . 65.239999999999995 109.288 -178.23 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.91 -32.73 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.177 -0.952 . . . . 73.109999999999999 110.104 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 38.4 mm -116.33 106.34 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.416 -0.802 . . . . 72.239999999999995 109.183 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -109.01 115.96 31.07 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.475 -0.766 . . . . 72.340000000000003 109.443 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.406 ' O ' ' O ' ' A' ' 126' ' ' LEU . 29.1 mm -116.17 105.29 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.567 -0.708 . . . . 71.439999999999998 109.514 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 47.21 -143.87 5.41 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.935 -1.266 . . . . 73.400000000000006 109.935 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -66.82 -21.91 66.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.359 -1.083 . . . . 74.450000000000003 108.921 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.49 HD23 ' N ' ' A' ' 126' ' ' LEU . 0.2 OUTLIER -80.59 113.39 18.75 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.827 -1.175 . . . . 54.210000000000001 107.827 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.9 m -108.33 144.23 36.13 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.36 -0.838 . . . . 54.5 109.342 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 77.1 mt -132.7 128.98 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.457 -0.777 . . . . 45.149999999999999 109.704 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.542 ' OG ' ' HA ' ' A' ' 119' ' ' ASN . 1.8 m -117.83 94.16 45.55 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 108.551 -0.907 . . . . 71.109999999999999 108.551 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.35 -22.6 10.82 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.557 1.505 . . . . 65.409999999999997 112.277 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.883 ' OD1' ' OE2' ' A' ' 132' ' ' GLU . 11.1 t70 -59.35 -48.96 79.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.067 -1.021 . . . . 63.32 109.282 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.883 ' OE2' ' OD1' ' A' ' 131' ' ' ASP . 7.9 mm-40 -97.36 9.17 43.04 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.205 -0.934 . . . . 72.519999999999996 108.938 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 53.61 80.54 0.11 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.56 -0.712 . . . . 75.329999999999998 110.438 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 9.5 ttpt -164.37 141.42 6.53 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.81 -0.811 . . . . 71.230000000000004 108.81 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.527 HG21 ' CE2' ' A' ' 137' ' ' TYR . 88.9 mt -118.2 149.51 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.531 -0.73 . . . . 74.019999999999996 109.765 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 65.5 mt -131.72 117.69 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.527 -0.916 . . . . 60.229999999999997 108.527 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.527 ' CE2' HG21 ' A' ' 135' ' ' ILE . 44.9 m-85 -109.25 124.77 51.43 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.397 -0.815 . . . . 62.32 110.401 -178.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.1 mtpp 48.94 25.84 1.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.467 -0.77 . . . . 75.400000000000006 110.61 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 92.51 14.28 55.77 Favored Glycine 0 N--CA 1.498 2.81 0 O-C-N 121.0 -1.063 . . . . 72.239999999999995 110.999 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -105.5 124.29 49.31 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.17 -1.194 . . . . 71.219999999999999 109.267 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -82.42 122.19 27.69 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.195 -0.941 . . . . 71.420000000000002 110.852 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.08 138.0 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.055 -1.091 . . . . 53.020000000000003 108.055 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -82.18 167.14 19.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.323 -0.86 . . . . 60.450000000000003 109.627 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 1.098 ' C ' ' HD2' ' A' ' 149' ' ' PHE . 6.0 m -129.6 128.15 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.797 -0.816 . . . . 74.439999999999998 108.797 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 1.482 ' HA ' ' CE2' ' A' ' 149' ' ' PHE . 32.7 pttt -175.52 -24.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.412 -0.805 . . . . 65.150000000000006 109.698 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 1.108 ' O ' ' CD1' ' A' ' 149' ' ' PHE . . . -64.97 -172.42 3.25 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.561 -1.416 . . . . 73.340000000000003 109.561 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.593 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 6.3 ttmt -70.27 -39.4 10.11 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.365 -1.08 . . . . 72.219999999999999 110.634 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 60.6 Cg_endo -84.94 15.46 2.21 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.126 1.884 . . . . 65.230000000000004 112.757 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 1.482 ' CE2' ' HA ' ' A' ' 145' ' ' LYS . 0.1 OUTLIER -97.31 -50.36 4.58 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.073 -1.017 . . . . 60.109999999999999 109.609 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 1.443 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 97.2 mt-10 -55.35 -44.0 75.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.418 -0.801 . . . . 64.209999999999994 109.596 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.46 HG13 ' N ' ' A' ' 152' ' ' LEU . 13.1 p -63.77 -38.2 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 72.019999999999996 109.378 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.2 OUTLIER -59.22 -42.82 91.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.387 -0.821 . . . . 73.310000000000002 109.016 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.4 m -72.13 -28.84 63.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 74.310000000000002 109.44 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -63.08 -55.11 28.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.405 -0.81 . . . . 74.310000000000002 110.073 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 159' ' ' ARG . 3.6 pp -67.49 -26.76 66.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.04 -1.037 . . . . 75.340000000000003 109.083 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.02 -52.21 63.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.108 -0.995 . . . . 62.140000000000001 108.904 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -66.8 -52.6 42.06 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.282 -0.886 . . . . 61.030000000000001 109.145 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -88.5 37.62 0.83 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.549 -0.719 . . . . 74.120000000000005 109.544 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' ' 155' ' ' LEU . 55.4 ttt-85 -65.46 -17.85 64.86 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.118 -0.989 . . . . 71.129999999999995 109.783 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.9 72.8 1.31 Allowed 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.517 -0.92 . . . . 75.450000000000003 108.517 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -170.57 159.18 6.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.875 . . . . 73.409999999999997 109.539 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.4 mt -81.51 136.69 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.29 -0.881 . . . . 74.409999999999997 109.002 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 14.2 t -131.48 135.73 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.341 -0.849 . . . . 72.310000000000002 109.793 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.7 p -97.59 159.36 14.97 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.4 -0.812 . . . . 74.120000000000005 109.122 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -57.9 -36.08 71.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 70.430000000000007 109.899 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -64.16 -42.23 96.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.166 -0.959 . . . . 73.519999999999996 110.075 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -53.4 -49.94 66.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.086 -1.009 . . . . 74.519999999999996 109.415 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 34.5 mt -61.9 -39.76 93.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.174 -0.954 . . . . 72.310000000000002 109.398 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.475 HD23 ' C ' ' A' ' 169' ' ' LEU . 5.3 tt -55.5 -59.21 5.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.866 . . . . 53.329999999999998 109.763 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.88 -39.66 93.89 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.423 -0.798 . . . . 62.439999999999998 111.203 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -53.0 -55.39 23.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.929 -1.107 . . . . 60.210000000000001 111.08 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.742 ' N ' HD12 ' A' ' 172' ' ' ILE . 1.9 mp -94.26 -59.69 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 120.83 -1.169 . . . . 75.319999999999993 110.237 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.458 ' O ' ' O ' ' A' ' 169' ' ' LEU . 24.3 m-90 . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 73.140000000000001 109.864 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 35.7 p30 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 120.856 0.36 . . . . 64.540000000000006 110.326 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 26.4 m -67.68 -16.1 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.854 -1.153 . . . . 74.019999999999996 109.518 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.448 ' O ' HG22 ' A' ' 188' ' ' ILE . 32.2 mm -59.82 -30.1 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.925 . . . . 72.329999999999998 109.369 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -58.14 -35.65 71.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.236 -0.915 . . . . 74.400000000000006 109.794 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 50.4 t -82.99 -45.45 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 70.420000000000002 109.084 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -60.71 -36.35 78.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 52.109999999999999 110.255 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 189' ' ' ASN . 9.4 tp -76.33 -42.98 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.781 -1.199 . . . . 71.400000000000006 109.102 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.492 ' N ' HG23 ' A' ' 188' ' ' ILE . 69.4 m-20 -59.87 -33.89 72.41 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.198 -0.939 . . . . 73.439999999999998 109.082 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -79.68 -48.67 13.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.192 -0.942 . . . . 71.420000000000002 109.968 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.444 HD13 HG21 ' A' ' 151' ' ' VAL . 64.4 mt -55.96 -41.98 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.095 -1.003 . . . . 61.549999999999997 109.29 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -63.87 -49.64 71.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.121 -0.987 . . . . 63.340000000000003 109.269 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -62.0 -31.47 71.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 61.240000000000002 108.984 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.418 ' CB ' ' NZ ' ' A' ' 194' ' ' LYS . 7.5 mtpm? -84.79 -8.54 58.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.47 -0.769 . . . . 75.129999999999995 109.735 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 16.2 ttt -102.48 -39.56 7.07 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.45 -0.781 . . . . 74.019999999999996 110.421 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -75.02 -15.37 60.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.025 -1.047 . . . . 74.019999999999996 110.724 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.445 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 8.7 mmtm -80.58 -65.29 0.27 Allowed Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.902 -1.124 . . . . 75.430000000000007 109.964 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 24.7 Cg_endo -60.0 -49.6 9.37 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.345 2.03 . . . . 72.319999999999993 112.849 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 199' ' ' LEU . 10.4 mp -66.2 -100.19 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.856 -1.152 . . . . 74.540000000000006 109.239 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 156.07 -39.31 0.59 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.132 -1.587 . . . . 61.509999999999998 109.132 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 20.5 mm -104.14 127.09 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.571 -0.958 . . . . 61.219999999999999 109.12 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 11.9 p -83.6 133.07 34.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.107 -0.995 . . . . 72.0 108.682 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.03 12.91 11.24 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.447 -0.783 . . . . 74.439999999999998 109.515 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.9 148.31 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.425 -0.797 . . . . 64.349999999999994 109.532 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -124.82 115.58 20.91 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.651 -0.655 . . . . 71.409999999999997 109.329 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.37 114.01 22.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.274 -0.891 . . . . 73.519999999999996 109.011 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 209' ' ' ARG . 13.8 t -120.73 146.31 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.546 -0.721 . . . . 71.019999999999996 109.668 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -69.89 -36.44 75.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.372 -0.83 . . . . 72.120000000000005 109.547 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.412 ' H ' HG12 ' A' ' 207' ' ' VAL . 80.8 mtm180 -73.28 160.18 32.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 64.409999999999997 109.736 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.562 ' NE ' ' H ' ' A' ' 210' ' ' ARG . 0.0 OUTLIER 47.86 -102.25 0.08 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.156 -0.965 . . . . 71.540000000000006 109.002 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -158.98 -114.22 0.38 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.08 -1.608 . . . . 72.030000000000001 109.08 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -108.79 133.74 52.43 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.513 -0.992 . . . . 75.540000000000006 108.929 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -112.04 128.45 56.19 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.342 -0.849 . . . . 75.310000000000002 110.585 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -98.27 128.53 44.76 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.627 -0.879 . . . . 75.409999999999997 108.627 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 8.9 t -149.98 168.96 22.32 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.03 -1.044 . . . . 74.140000000000001 110.453 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -60.95 131.46 91.74 Favored Pre-proline 0 N--CA 1.49 1.556 0 N-CA-C 109.361 -0.607 . . . . 75.319999999999993 109.361 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo . . . . . 0 N--CA 1.491 1.346 0 C-N-CA 122.291 1.994 . . . . 73.109999999999999 112.744 -179.852 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.591 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.458 -0.571 . . . . 71.140000000000001 109.458 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.433 ' O ' ' OD1' ' B' ' 46' ' ' ASP . 88.2 mtt180 -139.28 153.43 47.78 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.261 -0.9 . . . . 73.230000000000004 109.552 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 94.2 t -111.16 135.04 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.665 -0.647 . . . . 72.239999999999995 109.297 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.448 HD11 ' CG1' ' B' ' 6' ' ' ILE . 3.6 tp -106.84 118.28 36.26 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.526 -0.734 . . . . 54.329999999999998 109.707 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.436 ' N ' HD12 ' B' ' 4' ' ' LEU . 16.9 mt -114.58 98.32 6.81 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.83 -0.804 . . . . 74.349999999999994 108.83 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.692 HD12 ' HB ' ' B' ' 50' ' ' VAL . 87.1 mt -84.79 96.98 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.743 -1.223 . . . . 42.549999999999997 108.772 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.525 ' CD ' ' HG ' ' B' ' 51' ' ' SER . 8.6 tp10 -141.91 127.86 19.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.353 -0.842 . . . . 74.519999999999996 109.46 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -66.74 -32.92 74.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 62.549999999999997 109.148 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . 0.413 ' H ' ' HG3' ' B' ' 7' ' ' GLU . 99.5 m-20 -78.24 107.41 10.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.34 -0.85 . . . . 73.109999999999999 109.431 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 85.6 p -67.94 -23.77 65.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -0.879 . . . . 65.540000000000006 109.655 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.79 -49.77 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.148 -0.97 . . . . 75.549999999999997 109.687 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 80.7 mt -65.93 -37.44 86.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.157 -0.964 . . . . 70.140000000000001 109.572 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.74 -27.94 69.97 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.627 -1.789 . . . . 75.400000000000006 108.627 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.07 -53.44 36.92 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.581 -1.408 . . . . 65.439999999999998 109.581 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -58.54 -45.48 88.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.276 -1.132 . . . . 60.210000000000001 109.819 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 36.1 mm -65.63 -41.53 90.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.845 -1.159 . . . . 75.150000000000006 108.925 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -59.84 -44.5 94.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 73.010000000000005 109.513 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.452 ' CD ' ' N ' ' B' ' 18' ' ' LYS . 1.1 mptm? -86.59 1.1 52.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.092 -1.005 . . . . 74.299999999999997 108.768 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.51 -59.39 1.83 Allowed Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.481 -1.448 . . . . 70.540000000000006 109.481 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -67.87 -22.69 65.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -1.141 . . . . 71.340000000000003 109.522 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -54.14 -34.31 60.04 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.139 -0.976 . . . . 64.409999999999997 109.238 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 56.1 t -57.48 -47.63 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.344 -0.847 . . . . 74.230000000000004 109.013 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.445 ' NZ ' HG11 ' B' ' 106' ' ' VAL . 31.9 mmtm -60.49 -53.97 51.12 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.428 -0.795 . . . . 63.420000000000002 109.005 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 136.7 38.87 0.15 Allowed Glycine 0 N--CA 1.5 2.931 0 N-CA-C 110.298 -1.121 . . . . 53.43 110.298 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -120.38 160.46 23.03 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.375 -1.073 . . . . 71.120000000000005 109.505 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.4 mmt -105.27 140.26 38.68 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.807 -0.812 . . . . 75.239999999999995 108.807 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.431 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -135.23 159.26 42.12 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.429 -0.795 . . . . 72.120000000000005 109.818 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 89.2 m-20 -138.68 159.48 42.01 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.702 -0.851 . . . . 72.310000000000002 108.702 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 p -122.63 139.12 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.381 -0.825 . . . . 64.430000000000007 109.861 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 10.9 p -134.78 169.08 17.89 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.985 -0.746 . . . . 65.409999999999997 108.985 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -90.62 -107.57 0.09 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.165 -0.959 . . . . 71.019999999999996 109.787 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 82.3 p -79.09 168.61 19.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 51.109999999999999 109.993 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 50.5 mt -50.79 -31.3 16.52 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.6 -0.687 . . . . 71.239999999999995 109.843 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -51.62 -52.19 49.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.101 -0.999 . . . . 74.319999999999993 109.717 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.73 -40.89 96.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.17 -0.956 . . . . 73.030000000000001 109.354 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.24 -43.03 81.6 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.442 -1.463 . . . . 30.210000000000001 109.442 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -66.18 -38.69 88.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.321 -1.106 . . . . 74.420000000000002 109.549 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -75.13 -39.43 60.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 74.420000000000002 109.802 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 23.3 tp -72.88 -45.95 55.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.905 . . . . 75.409999999999997 110.112 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.4 ppp? -64.79 -27.06 68.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.004 -1.06 . . . . 60.409999999999997 109.84 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -58.49 -45.44 88.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.145 -0.972 . . . . 53.229999999999997 109.844 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 pt -88.93 -42.06 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.175 -0.953 . . . . 71.230000000000004 109.747 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' B' ' 40' ' ' MET . 10.7 mpt_? -96.73 144.04 27.1 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.077 -1.015 . . . . 72.219999999999999 108.983 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -103.77 150.81 23.74 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.382 -0.824 . . . . 63.539999999999999 109.248 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -137.78 139.67 40.17 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.329 -0.857 . . . . 64.349999999999994 109.321 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' B' ' 2' ' ' ARG . 7.9 p-10 -79.85 -36.86 36.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 62.219999999999999 109.253 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.555 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.5 OUTLIER -108.05 116.39 31.86 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.93 -0.767 . . . . 73.120000000000005 108.93 179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.555 ' N ' HD13 ' B' ' 47' ' ' LEU . 46.4 t -100.31 98.44 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.233 -1.025 . . . . 65.109999999999999 108.233 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 20.6 ttt -112.89 133.38 54.9 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.569 -0.707 . . . . 73.439999999999998 110.051 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.692 ' HB ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -145.95 134.18 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.595 -0.69 . . . . 34.5 109.351 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . 0.525 ' HG ' ' CD ' ' B' ' 7' ' ' GLU . 9.1 p -98.19 9.94 41.75 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.415 -0.803 . . . . 73.209999999999994 109.47 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.559 ' H ' HG22 ' B' ' 50' ' ' VAL . 44.9 m-20 -76.06 138.86 41.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.203 -0.935 . . . . 70.409999999999997 109.539 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.439 ' C ' ' H ' ' B' ' 55' ' ' ALA . 60.2 mttm -73.62 -40.12 64.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 65.0 110.15 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -72.92 12.25 0.55 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.115 -0.99 . . . . 75.209999999999994 109.717 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -68.92 -21.54 64.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.903 . . . . 55.329999999999998 110.153 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' B' ' 55' ' ' ALA . 11.4 mt -41.7 -49.39 4.26 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.488 -0.757 . . . . 63.140000000000001 110.312 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 86.1 p -69.56 -34.68 74.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.986 -1.071 . . . . 63.5 109.098 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . 0.407 ' CZ ' HD11 ' B' ' 62' ' ' ILE . 59.0 t80 -66.67 -61.76 1.8 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.377 -0.827 . . . . 72.329999999999998 109.828 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 33.8 m -49.42 -35.31 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.611 -1.306 . . . . 74.540000000000006 109.716 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 22.9 p -57.55 -53.69 55.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.188 -0.945 . . . . 71.239999999999995 109.714 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -66.91 -29.1 68.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.055 -1.028 . . . . 74.310000000000002 110.108 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.407 HD11 ' CZ ' ' B' ' 58' ' ' PHE . 35.2 mm -66.06 -36.26 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.766 -1.208 . . . . 72.140000000000001 109.876 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.483 ' NZ ' ' CG2' ' B' ' 71' ' ' VAL . 29.1 mmtm -71.41 -49.4 42.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.038 -1.039 . . . . 73.319999999999993 110.278 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' B' ' 65' ' ' LYS . 13.8 pt-20 -68.85 -41.08 78.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.949 -1.094 . . . . 73.120000000000005 110.133 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.512 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 92.7 mttt -74.83 -23.52 58.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 72.439999999999998 109.825 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.512 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 92.9 m-70 -156.69 63.96 0.53 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.145 -0.972 . . . . 63.310000000000002 109.67 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.452 ' N ' ' O ' ' B' ' 63' ' ' LYS . 23.7 t -57.14 -30.01 64.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -0.88 . . . . 73.099999999999994 109.581 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 39.8 m -61.56 -27.31 68.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -0.917 . . . . 71.530000000000001 109.998 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 73.7 mt -78.64 155.77 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.142 -0.973 . . . . 74.400000000000006 109.778 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 84.7 t -95.74 152.69 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.489 -0.757 . . . . 75.120000000000005 109.137 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.483 ' CG2' ' NZ ' ' B' ' 63' ' ' LYS . 39.5 t -133.04 127.9 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.336 -0.852 . . . . 73.200000000000003 109.81 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 8.0 tt -120.41 99.48 6.59 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.716 -0.846 . . . . 73.340000000000003 108.716 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.44 135.66 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 73.5 108.876 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.24 173.75 6.18 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.315 -0.866 . . . . 64.340000000000003 108.877 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 18.7 t -165.93 119.76 1.16 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.966 -1.084 . . . . 74.530000000000001 110.236 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -67.54 -15.84 63.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.381 -0.824 . . . . 64.5 109.284 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -116.91 69.08 4.6 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.674 -0.641 . . . . 74.25 109.293 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -62.73 78.06 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.91 1.74 . . . . 74.430000000000007 111.632 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.492 HG23 ' H ' ' B' ' 82' ' ' GLU . 15.1 t -101.14 173.16 6.59 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.69 -0.856 . . . . 73.120000000000005 108.69 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.4 p -77.01 -26.25 53.6 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.164 -0.96 . . . . 71.010000000000005 110.489 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . 0.469 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 49.6 mp0 -66.86 -39.96 87.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.937 -1.102 . . . . 63.200000000000003 109.694 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . 0.492 ' H ' HG23 ' B' ' 79' ' ' THR . 97.8 mt-10 -78.01 -33.82 51.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.194 -0.941 . . . . 73.219999999999999 109.686 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -62.55 -52.91 61.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -0.964 . . . . 74.299999999999997 109.718 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.504 HG23 ' N ' ' B' ' 85' ' ' HIS . 26.4 m -63.72 -40.82 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.161 -0.962 . . . . 73.310000000000002 109.412 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' HIS . . . . . 0.504 ' N ' HG23 ' B' ' 84' ' ' VAL . 19.8 m80 -67.31 -31.27 71.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.905 . . . . 73.239999999999995 109.514 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.29 -41.7 93.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.922 . . . . 55.329999999999998 109.782 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' PHE . . . . . 0.53 ' CZ ' ' NH1' ' A' ' 108' ' ' ARG . 70.3 m-85 -80.29 -24.91 39.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.095 -1.003 . . . . 74.140000000000001 109.041 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -76.37 -51.92 10.93 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.386 -0.822 . . . . 64.040000000000006 109.437 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . 0.489 ' CG ' ' N ' ' B' ' 90' ' ' GLY . 11.5 pt20 -60.81 -47.19 87.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.515 -0.741 . . . . 72.349999999999994 109.774 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . 0.489 ' N ' ' CG ' ' B' ' 89' ' ' GLN . . . 140.15 71.55 0.04 OUTLIER Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.963 -1.255 . . . . 65.200000000000003 109.963 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.86 135.44 53.74 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.403 -1.057 . . . . 52.229999999999997 108.715 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.522 ' OD1' ' NH1' ' B' ' 112' ' ' ARG . 24.6 t0 -85.0 -23.78 28.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.061 -1.024 . . . . 73.319999999999993 109.647 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' ASP . . . . . 0.524 ' OD2' ' NH1' ' B' ' 112' ' ' ARG . 57.3 m-20 -152.38 156.43 39.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.184 -0.948 . . . . 72.219999999999999 109.63 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -137.9 99.83 4.01 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.463 -0.94 . . . . 64.420000000000002 108.463 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 22.7 mm -106.98 147.3 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 O-C-N 120.989 -1.07 . . . . 72.230000000000004 110.833 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.76 125.74 26.81 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.915 -1.143 . . . . 25.239999999999998 107.915 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.677 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -45.94 -54.03 18.6 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.063 -1.023 . . . . 64.319999999999993 111.486 -178.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 3.3 Cg_endo -41.82 -10.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 120.796 0.997 . . . . 63.329999999999998 112.743 -176.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . 0.677 ' N ' ' O ' ' B' ' 97' ' ' LYS . 61.0 m-85 59.41 96.71 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.728 -0.608 . . . . 75.129999999999995 110.04 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -53.41 -39.37 64.28 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.101 -1.074 . . . . 74.230000000000004 108.101 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 9.1 t -174.27 128.62 0.36 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.886 -0.783 . . . . 63.340000000000003 108.886 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 59.0 mt -52.64 -36.14 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.035 -1.04 . . . . 74.439999999999998 108.868 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' B' ' 107' ' ' ALA . 62.8 mmtt -61.87 -36.87 82.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.293 -0.88 . . . . 71.109999999999999 108.948 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.74 -53.64 14.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 71.450000000000003 109.347 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 25.0 tp -58.04 -49.75 75.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.926 . . . . 51.310000000000002 108.962 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . 0.445 HG11 ' NZ ' ' B' ' 23' ' ' LYS . 69.7 t -66.1 -39.88 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.063 -1.023 . . . . 65.230000000000004 109.853 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' B' ' 103' ' ' LYS . . . -56.78 -39.12 73.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.16 -0.962 . . . . 24.32 109.558 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -77.44 -25.04 50.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.875 . . . . 75.310000000000002 109.994 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 90.4 mt -80.82 -43.37 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.039 -1.038 . . . . 54.240000000000002 109.445 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -68.15 -38.92 82.66 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.18 -0.95 . . . . 65.310000000000002 109.851 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.69 -49.18 66.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 72.239999999999995 109.838 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . 0.524 ' NH1' ' OD2' ' B' ' 93' ' ' ASP . 38.5 ttm180 -65.6 -43.87 88.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.932 . . . . 72.040000000000006 109.976 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.491 ' C ' HD23 ' B' ' 113' ' ' LEU . 4.3 tt -64.95 -55.45 19.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.154 -0.966 . . . . 75.349999999999994 109.335 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -50.7 -30.5 13.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.969 . . . . 75.5 109.674 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -84.64 4.48 32.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.202 -0.936 . . . . 65.329999999999998 109.807 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 116' ' ' TRP . . . . . 0.524 ' CD1' ' N ' ' B' ' 117' ' ' GLY . 0.3 OUTLIER -67.84 -19.85 65.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.009 -1.057 . . . . 74.450000000000003 109.662 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . 0.524 ' N ' ' CD1' ' B' ' 116' ' ' TRP . . . -67.73 113.13 5.24 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.702 -1.359 . . . . 44.210000000000001 109.702 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 53.1 p -153.46 164.52 38.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.279 -1.13 . . . . 71.400000000000006 109.687 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -158.23 166.17 33.05 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.876 -0.73 . . . . 72.319999999999993 109.043 -178.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -145.59 -43.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.291 -0.881 . . . . 75.019999999999996 109.31 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . 0.481 HG21 ' O ' ' B' ' 156' ' ' ALA . 28.5 mm -107.83 127.48 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.449 -0.782 . . . . 51.409999999999997 109.118 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -120.47 118.31 29.95 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.538 -0.726 . . . . 71.530000000000001 109.239 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 62.2 mt -123.48 108.42 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.938 -0.764 . . . . 72.430000000000007 108.938 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.74 -133.82 11.49 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.745 -1.342 . . . . 51.229999999999997 109.745 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -83.6 -2.25 55.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.222 -1.163 . . . . 74.200000000000003 109.399 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.554 HD13 HD12 ' B' ' 199' ' ' LEU . 0.6 OUTLIER -91.18 146.04 24.16 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.473 -0.936 . . . . 75.420000000000002 108.473 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 89.3 m -130.08 134.71 47.56 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.576 -0.703 . . . . 74.219999999999999 109.212 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 21.5 mt -136.59 143.53 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.442 -0.786 . . . . 60.329999999999998 109.381 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 14.6 m -137.86 122.8 12.28 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.494 -0.754 . . . . 72.310000000000002 108.977 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -80.99 -39.95 0.19 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.994 1.796 . . . . 75.129999999999995 112.238 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -50.52 -51.31 48.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.145 -0.972 . . . . 75.230000000000004 109.428 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -86.07 -7.71 58.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.231 -0.918 . . . . 72.430000000000007 109.099 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 54.19 68.66 0.82 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.868 . . . . 75.129999999999995 109.35 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -148.6 143.38 26.53 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.228 -0.92 . . . . 73.219999999999999 109.734 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 18.1 tt -118.38 137.03 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.538 -0.726 . . . . 64.140000000000001 109.359 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 58.5 mt -126.19 123.86 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.504 -0.747 . . . . 71.219999999999999 109.144 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -140.52 144.12 35.8 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.303 -0.873 . . . . 64.219999999999999 110.113 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 31.3 mmtm 53.75 31.18 12.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.384 -0.823 . . . . 72.019999999999996 110.214 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 74.99 -6.4 27.41 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.983 -1.247 . . . . 74.319999999999993 109.983 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 12.2 mpt_? -87.96 129.43 35.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.129 -1.218 . . . . 75.340000000000003 108.838 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -98.82 130.58 45.25 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.351 -0.843 . . . . 71.230000000000004 109.675 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 66.8 t -137.12 132.12 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.444 -0.785 . . . . 70.430000000000007 109.244 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -83.15 134.92 34.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.898 . . . . 72.430000000000007 109.1 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.77 136.1 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.452 -0.78 . . . . 72.129999999999995 109.366 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.21 21.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 72.019999999999996 109.555 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.54 174.72 40.03 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.867 -1.293 . . . . 42.229999999999997 109.867 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' B' ' 148' ' ' PRO . 12.4 mtpp -65.06 -61.67 5.87 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.447 -1.031 . . . . 73.299999999999997 110.096 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' B' ' 147' ' ' LYS . 11.9 Cg_endo -54.2 -25.78 39.55 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.951 1.767 . . . . 71.329999999999998 111.87 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -87.59 -15.45 37.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.237 -0.914 . . . . 74.230000000000004 109.502 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -61.77 -45.34 94.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.162 -0.961 . . . . 72.340000000000003 109.471 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 8.8 p -56.99 -34.06 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.112 -0.992 . . . . 73.349999999999994 108.89 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.437 ' O ' HD13 ' B' ' 152' ' ' LEU . 0.2 OUTLIER -61.04 -49.71 76.27 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.535 -0.913 . . . . 55.240000000000002 108.535 179.502 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 16.3 m -70.57 -29.83 66.37 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.304 -0.873 . . . . 70.010000000000005 108.963 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -55.52 -59.89 4.2 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.193 -0.942 . . . . 65.319999999999993 109.987 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.79 -25.51 65.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.943 -1.098 . . . . 71.540000000000006 109.67 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . 0.481 ' O ' HG21 ' B' ' 121' ' ' ILE . . . -55.08 -43.88 74.31 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.048 -1.032 . . . . 75.319999999999993 109.931 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -83.22 -45.62 13.66 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.828 -1.17 . . . . 73.319999999999993 110.891 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 158' ' ' HIS . . . . . 0.482 ' O ' ' O ' ' B' ' 159' ' ' ARG . 51.3 m80 -50.52 -83.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.619 -1.301 . . . . 74.140000000000001 108.615 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' B' ' 158' ' ' HIS . 11.5 mmm180 56.26 153.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.596 -0.69 . . . . 61.409999999999997 110.509 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' B' ' 214' ' ' PHE . 20.4 t70 42.02 51.25 4.32 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.256 -0.903 . . . . 72.099999999999994 110.104 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -156.27 145.37 20.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.062 -1.024 . . . . 72.25 110.087 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 87.6 mt -89.19 125.66 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.747 -0.834 . . . . 72.310000000000002 108.747 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 14.7 p -135.84 136.65 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.323 -0.861 . . . . 64.209999999999994 109.248 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 11.7 t -81.54 166.45 20.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.318 -0.864 . . . . 74.219999999999999 110.524 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 18.4 mtpp -67.12 -46.1 75.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.623 -0.673 . . . . 65.310000000000002 109.896 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -58.59 -36.19 73.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.87 . . . . 63.450000000000003 110.28 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -55.14 -45.1 75.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.061 -1.024 . . . . 72.400000000000006 109.657 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 31.6 mt -66.28 -38.7 88.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.053 -1.03 . . . . 72.319999999999993 109.36 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.682 ' C ' HD13 ' B' ' 169' ' ' LEU . 3.1 tm? -55.35 -54.78 39.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.829 . . . . 73.340000000000003 108.996 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -68.94 -16.56 63.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 72.099999999999994 109.85 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.17 -57.87 3.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -0.937 . . . . 62.130000000000003 110.707 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 0.696 ' N ' HD12 ' B' ' 172' ' ' ILE . 1.7 mp -79.85 -44.78 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.989 -1.069 . . . . 71.420000000000002 109.239 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 19.7 m-90 . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.314 -0.866 . . . . 72.230000000000004 109.519 -179.861 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.488 1.203 0 CA-C-O 121.511 0.546 . . . . 65.219999999999999 111.735 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -148.59 -14.68 0.33 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.489 -0.757 . . . . 72.310000000000002 109.095 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.78 7.98 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.285 -0.884 . . . . 63.32 109.287 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 15.7 mm -55.75 -42.67 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.903 . . . . 75.030000000000001 109.475 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -53.84 -26.53 24.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 64.109999999999999 109.413 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 60.5 t -78.85 -54.68 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.053 -1.03 . . . . 73.0 109.149 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -51.89 -48.11 64.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 61.119999999999997 110.071 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 188' ' ' ILE . . . . . 0.525 ' O ' HD13 ' B' ' 188' ' ' ILE . 0.2 OUTLIER -61.82 -43.12 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.913 -1.117 . . . . 72.430000000000007 109.025 -179.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 189' ' ' ASN . . . . . 0.434 ' O ' ' OE1' ' B' ' 193' ' ' GLN . 41.4 t30 -61.48 -41.64 97.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.972 -1.08 . . . . 65.140000000000001 109.255 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -68.0 -42.52 80.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.947 . . . . 63.240000000000002 110.023 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 81.3 mt -59.85 -39.71 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.084 -1.01 . . . . 74.030000000000001 109.743 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -64.59 -40.45 95.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.116 -0.99 . . . . 72.239999999999995 109.781 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 193' ' ' GLN . . . . . 0.617 ' NE2' ' N ' ' B' ' 193' ' ' GLN . 0.2 OUTLIER -75.12 -37.83 61.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 73.099999999999994 110.376 -179.311 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' B' ' 198' ' ' PRO . 0.0 OUTLIER -73.6 -16.87 61.23 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.75 -1.219 . . . . 72.109999999999999 109.916 -179.293 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 21.9 ttp -94.52 -24.14 17.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.156 -0.965 . . . . 44.329999999999998 110.196 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 196' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' B' ' 193' ' ' GLN . 41.3 p30 -96.0 -3.76 44.41 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.987 -1.07 . . . . 71.209999999999994 110.532 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . 0.568 ' N ' ' CD ' ' B' ' 198' ' ' PRO . 20.6 tttm -92.01 -42.15 0.37 Allowed Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 120.862 -1.149 . . . . 75.209999999999994 110.053 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 198' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' B' ' 197' ' ' LYS . 17.7 Cg_endo -88.68 -51.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.596 2.198 . . . . 75.319999999999993 112.22 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . 0.597 HD22 ' N ' ' B' ' 199' ' ' LEU . 3.7 mm? -70.9 -40.06 72.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.948 -1.095 . . . . 72.25 109.347 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 85.35 -20.39 17.78 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.915 -1.274 . . . . 64.530000000000001 109.915 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 12.1 mt -103.75 137.83 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.335 -1.097 . . . . 44.229999999999997 109.354 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 38.6 t -95.38 137.85 33.86 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.242 -0.911 . . . . 54.009999999999998 109.393 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 21.4 p -142.33 34.11 1.49 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.34 -0.85 . . . . 74.400000000000006 109.146 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.53 133.41 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.497 -0.752 . . . . 72.120000000000005 109.615 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -113.94 132.7 55.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.666 -0.865 . . . . 65.409999999999997 108.666 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.45 140.37 29.82 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.256 -0.903 . . . . 71.329999999999998 109.896 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' B' ' 211' ' ' GLY . 19.8 t -138.51 123.43 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.492 -0.755 . . . . 63.5 109.006 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 -76.85 -43.51 35.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.186 -0.946 . . . . 74.450000000000003 109.914 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -51.7 -59.85 3.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.905 . . . . 74.140000000000001 109.876 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -94.71 -71.03 0.68 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.179 -0.951 . . . . 74.430000000000007 109.58 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 211' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' B' ' 207' ' ' VAL . . . 177.76 -93.71 0.09 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.349 -1.5 . . . . 64.450000000000003 109.349 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -135.49 141.07 45.25 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.45 -1.03 . . . . 74.209999999999994 109.518 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 65.3 ttt-85 -119.64 129.06 54.4 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.438 -0.949 . . . . 74.030000000000001 108.438 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . 0.529 ' O ' ' N ' ' B' ' 160' ' ' ASP . 29.5 m-85 -100.58 137.84 38.44 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.384 -0.822 . . . . 74.340000000000003 109.404 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . 0.454 ' SG ' ' N ' ' B' ' 216' ' ' TYR . 43.7 t -152.33 168.32 25.8 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.476 -0.765 . . . . 64.329999999999998 109.613 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . 0.454 ' N ' ' SG ' ' B' ' 215' ' ' CYS . 81.6 m-85 -75.35 150.41 84.98 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.253 -0.904 . . . . 70.040000000000006 109.374 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 217' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' B' ' 218' ' ' LYS . 97.4 Cg_endo -76.43 119.17 5.14 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.269 1.979 . . . . 65.109999999999999 112.171 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' B' ' 217' ' ' PRO . 41.0 mttp . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.462 -0.774 . . . . 73.150000000000006 109.384 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.6 ptm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.446 -0.575 . . . . 65.120000000000005 109.446 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -139.58 156.41 46.89 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.305 -0.872 . . . . 72.329999999999998 109.303 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 89.3 t -114.21 125.8 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.635 -0.665 . . . . 71.420000000000002 109.607 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 5' ' ' LEU . 2.2 tp -100.03 118.74 37.05 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.832 -0.803 . . . . 65.120000000000005 108.832 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.466 ' CD1' HG21 ' A' ' 16' ' ' ILE . 7.5 tt -119.95 119.38 33.28 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.624 -0.672 . . . . 62.43 109.417 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.419 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 13.2 mt -106.45 116.89 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.352 -0.843 . . . . 71.150000000000006 108.792 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.462 ' OE1' ' CB ' ' A' ' 51' ' ' SER . 30.1 tp10 -151.37 127.63 10.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.149 -0.969 . . . . 75.340000000000003 109.491 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 9' ' ' ASN . 45.2 mtpt -77.82 -23.72 48.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 72.439999999999998 109.309 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 10' ' ' SER . 34.7 t-20 -59.68 -152.18 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.445 -0.785 . . . . 63.020000000000003 109.51 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.497 ' N ' ' OD1' ' A' ' 9' ' ' ASN . 47.6 m -156.08 -56.39 0.09 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 72.340000000000003 109.372 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.6 t -63.17 -45.49 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 74.019999999999996 109.493 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.9 mm? -66.78 -36.43 82.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.259 -0.901 . . . . 71.430000000000007 109.289 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.11 -19.07 78.96 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 108.473 -1.851 . . . . 61.32 108.473 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.32 -50.77 4.94 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.922 -1.271 . . . . 71.200000000000003 109.922 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.14 -43.66 95.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.106 -1.232 . . . . 71.319999999999993 109.296 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.559 ' O ' HD23 ' A' ' 20' ' ' LEU . 94.5 mt -61.63 -46.63 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.922 -1.111 . . . . 63.229999999999997 108.498 178.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -45.55 -52.47 10.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 51.109999999999999 109.798 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -89.48 4.41 49.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.181 -0.949 . . . . 73.340000000000003 109.596 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -85.02 -58.18 2.15 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.908 -1.277 . . . . 62.149999999999999 109.908 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.559 HD23 ' O ' ' A' ' 16' ' ' ILE . 0.6 OUTLIER -75.01 -19.06 60.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -1.165 . . . . 73.510000000000005 110.046 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -57.08 -38.25 73.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.974 . . . . 74.25 109.676 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.5 t -52.57 -32.02 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.215 -0.928 . . . . 70.040000000000006 109.123 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -75.2 -0.36 19.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.376 -0.827 . . . . 73.230000000000004 109.043 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.91 28.55 45.6 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.267 -1.133 . . . . 75.540000000000006 110.267 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -106.09 156.89 17.96 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.278 -1.13 . . . . 73.430000000000007 109.05 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.3 mmt -94.15 118.08 31.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.194 -0.942 . . . . 43.240000000000002 108.729 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -98.47 133.1 43.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.315 -0.866 . . . . 62.109999999999999 109.918 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -123.31 131.0 53.51 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 109.035 -0.728 . . . . 74.420000000000002 109.035 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.69 132.73 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.303 -0.999 . . . . 72.150000000000006 108.303 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 p -136.08 168.98 18.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.361 -0.837 . . . . 71.420000000000002 109.524 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.419 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 4.4 pt-20 -94.04 -103.47 0.14 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.301 -0.874 . . . . 72.329999999999998 109.836 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.5 t -78.54 166.78 22.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.256 -0.902 . . . . 74.239999999999995 110.157 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.0 mt -53.42 -33.7 54.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.621 -0.674 . . . . 71.530000000000001 109.733 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -52.51 -48.03 66.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 74.230000000000004 109.791 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -61.49 -37.61 84.28 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.141 -0.974 . . . . 54.030000000000001 109.11 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.26 -37.26 48.69 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.314 -1.515 . . . . 61.409999999999997 109.314 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -63.37 -39.03 93.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -1.126 . . . . 74.340000000000003 109.407 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -77.21 -37.99 52.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 75.329999999999998 109.513 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.3 tp -66.89 -46.21 75.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -0.867 . . . . 74.329999999999998 109.983 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.436 ' C ' ' SD ' ' A' ' 40' ' ' MET . 3.9 ppp? -70.09 -24.54 63.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.101 -1.0 . . . . 70.319999999999993 109.824 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -65.84 -40.42 91.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.048 -1.033 . . . . 71.219999999999999 109.951 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.2 pt -79.12 -34.01 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.103 -0.998 . . . . 74.140000000000001 110.074 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 40' ' ' MET . 30.3 mmt180 -130.25 147.69 52.0 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.327 -0.858 . . . . 72.239999999999995 109.356 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.626 HD22 ' N ' ' A' ' 44' ' ' ASN . 1.2 m120 -93.12 133.16 36.58 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.273 -0.892 . . . . 75.420000000000002 109.449 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -107.49 142.47 37.31 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.512 -0.743 . . . . 74.230000000000004 109.378 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -83.93 -42.15 16.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 72.040000000000006 109.236 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.508 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.5 OUTLIER -105.86 113.17 26.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.565 -0.71 . . . . 72.129999999999995 109.176 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.508 ' N ' HD13 ' A' ' 47' ' ' LEU . 78.7 t -99.3 97.76 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.713 -0.847 . . . . 72.340000000000003 108.713 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.485 ' SD ' ' O ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -106.17 125.04 50.51 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.988 -0.745 . . . . 74.109999999999999 108.988 -179.678 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.01 133.2 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.664 0.745 . . . . 61.119999999999997 109.623 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.462 ' CB ' ' OE1' ' A' ' 7' ' ' GLU . 52.9 m -102.95 4.88 37.98 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.656 -0.652 . . . . 73.109999999999999 109.414 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -76.27 147.51 38.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -0.966 . . . . 52.549999999999997 109.613 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.429 ' C ' ' H ' ' A' ' 55' ' ' ALA . 25.6 pttm -81.92 -39.86 23.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.287 -0.883 . . . . 44.219999999999999 110.124 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -70.26 7.32 1.03 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.039 -1.038 . . . . 70.439999999999998 109.411 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -68.68 -21.78 64.41 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.384 -0.822 . . . . 64.140000000000001 110.433 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 55' ' ' ALA . 63.2 mt -42.36 -47.73 4.95 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.196 -0.94 . . . . 44.140000000000001 110.546 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.2 m -70.96 -36.64 72.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.884 -1.135 . . . . 55.229999999999997 109.388 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.655 ' CE2' HD11 ' A' ' 62' ' ' ILE . 58.1 t80 -68.07 -61.06 2.03 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.594 -0.691 . . . . 74.439999999999998 110.158 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 60' ' ' SER . 21.6 m -51.61 -37.68 20.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.845 -1.159 . . . . 74.030000000000001 109.431 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.467 ' N ' HG23 ' A' ' 59' ' ' VAL . 61.6 m -56.3 -55.76 29.4 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.271 -0.893 . . . . 64.299999999999997 109.514 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -67.91 -26.89 66.21 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.049 -1.032 . . . . 64.439999999999998 110.24 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.655 HD11 ' CE2' ' A' ' 58' ' ' PHE . 5.9 mm -57.36 -38.58 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.668 -1.27 . . . . 63.210000000000001 107.922 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 67' ' ' SER . 61.2 mmtt -72.76 -41.95 64.52 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.389 -0.819 . . . . 74.420000000000002 109.135 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -66.55 -51.44 56.49 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.143 -0.973 . . . . 70.319999999999993 109.229 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -69.57 -24.93 63.76 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.665 -0.647 . . . . 75.219999999999999 109.874 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.586 ' O ' HG22 ' A' ' 69' ' ' ILE . 96.7 m-70 -151.39 68.52 0.92 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.184 -0.947 . . . . 74.129999999999995 109.38 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 63' ' ' LYS . 96.9 p -57.93 -28.79 64.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 73.239999999999995 109.904 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 83.2 p -82.14 49.0 1.32 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.184 -0.948 . . . . 61.009999999999998 109.782 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.586 HG22 ' O ' ' A' ' 66' ' ' HIS . 13.1 tt -142.06 155.9 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.258 -0.901 . . . . 71.329999999999998 109.571 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.8 t -95.59 149.87 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.146 -0.971 . . . . 72.129999999999995 108.773 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 t -140.17 127.33 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.163 -0.961 . . . . 54.210000000000001 109.875 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.491 ' C ' HD23 ' A' ' 72' ' ' LEU . 2.4 tt -115.43 104.56 11.89 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.984 -0.747 . . . . 50.240000000000002 108.984 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.3 t -95.9 129.5 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.24 -0.913 . . . . 74.409999999999997 108.982 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.1 p -93.76 171.91 8.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.188 -0.945 . . . . 72.310000000000002 109.796 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.473 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 42.0 t -160.93 118.39 2.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.082 -1.011 . . . . 64.540000000000006 110.45 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -64.63 -29.01 70.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.623 -0.673 . . . . 74.129999999999995 109.72 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 79' ' ' THR . 35.5 m120 -122.07 80.55 43.27 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.528 -0.733 . . . . 73.340000000000003 109.428 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.12 87.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.323 2.016 . . . . 63.219999999999999 111.431 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.456 ' N ' ' O ' ' A' ' 77' ' ' ASN . 23.8 m -98.65 150.21 22.01 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.577 -0.702 . . . . 62.530000000000001 109.593 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.475 ' CB ' ' OG ' ' B' ' 101' ' ' SER . 0.0 OUTLIER -72.77 -41.15 65.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.35 -0.844 . . . . 73.439999999999998 109.189 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -57.57 -38.63 75.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.146 -0.971 . . . . 71.420000000000002 108.844 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -75.2 -26.02 58.68 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.352 -0.842 . . . . 73.430000000000007 109.191 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.525 ' OE1' ' CD2' ' A' ' 94' ' ' TYR . 36.7 tp10 -61.29 -57.63 11.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 74.219999999999999 109.65 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.482 HG23 ' N ' ' A' ' 85' ' ' HIS . 22.0 m -63.82 -40.65 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 73.200000000000003 109.338 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.482 ' N ' HG23 ' A' ' 84' ' ' VAL . 10.5 t-80 -62.36 -34.65 77.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -0.904 . . . . 53.329999999999998 109.371 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.14 -39.81 93.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 64.109999999999999 109.969 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -78.26 -34.35 49.09 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.98 -1.075 . . . . 74.340000000000003 109.054 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -70.84 -36.84 73.08 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.299 -0.875 . . . . 74.420000000000002 109.592 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -68.39 -47.86 66.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 74.239999999999995 109.761 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.58 48.23 0.03 OUTLIER Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.949 -1.26 . . . . 61.509999999999998 109.949 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.82 133.26 54.14 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.425 -1.044 . . . . 55.329999999999998 109.382 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -84.67 -22.85 29.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.944 . . . . 73.420000000000002 109.133 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.532 ' OD2' ' NH2' ' A' ' 112' ' ' ARG . 19.6 t0 -150.61 163.3 38.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.399 -0.813 . . . . 75.040000000000006 109.325 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.525 ' CD2' ' OE1' ' A' ' 83' ' ' GLU . 67.6 t80 -146.03 101.92 3.58 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.37 -0.832 . . . . 71.329999999999998 108.936 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 96' ' ' ALA . 29.0 mm -112.19 156.04 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 O-C-N 121.29 -0.882 . . . . 71.129999999999995 110.464 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.402 ' N ' HG22 ' A' ' 95' ' ' ILE . . . -67.11 146.52 54.19 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.417 -0.957 . . . . 64.319999999999993 108.417 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.676 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -68.19 -55.79 12.1 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.869 -1.144 . . . . 62.200000000000003 111.172 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 4.3 Cg_endo -41.59 -10.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 120.87 1.047 . . . . 73.109999999999999 112.967 -176.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.676 ' N ' ' O ' ' A' ' 97' ' ' LYS . 22.6 m-85 67.12 110.3 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.789 -0.57 . . . . 65.219999999999999 109.681 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -57.41 -33.78 68.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.972 -1.08 . . . . 72.349999999999994 108.185 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.775 ' O ' ' N ' ' A' ' 103' ' ' LYS . 47.5 t -175.63 24.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 71.319999999999993 110.167 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.4 mm 50.2 -67.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.791 -0.568 . . . . 75.430000000000007 110.028 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.775 ' N ' ' O ' ' A' ' 101' ' ' SER . 3.3 mptp? -54.5 -33.06 59.19 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.343 -1.354 . . . . 71.409999999999997 107.343 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.98 -41.54 74.3 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.988 -1.116 . . . . 63.240000000000002 107.988 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.9 tt -61.7 -46.49 89.44 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.974 -0.75 . . . . 73.219999999999999 108.974 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 90.4 t -62.99 -40.75 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.302 -0.873 . . . . 60.109999999999999 109.052 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.87 -39.71 62.85 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.315 -0.866 . . . . 70.420000000000002 108.859 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.558 ' HE ' ' CD ' ' B' ' 83' ' ' GLU . 50.3 mtt85 -69.0 -35.68 76.97 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.274 -0.891 . . . . 74.409999999999997 109.412 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.4 mt -69.4 -34.92 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.058 -1.026 . . . . 62.539999999999999 108.487 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -59.58 -55.57 32.84 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.751 -0.779 . . . . 74.340000000000003 109.446 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.5 -34.58 67.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 73.319999999999993 109.959 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.532 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 64.9 mtt85 -60.74 -37.69 82.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.001 -1.062 . . . . 52.409999999999997 110.022 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -155.06 68.74 0.7 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.681 -1.262 . . . . 65.239999999999995 110.373 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -53.66 89.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.102 -0.999 . . . . 64.450000000000003 108.784 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.506 ' N ' ' O ' ' A' ' 113' ' ' LEU . 69.0 m-85 52.9 89.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 74.430000000000007 109.599 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.412 ' HE1' ' HB3' ' A' ' 132' ' ' GLU . 74.6 t-105 -87.0 141.96 28.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 74.420000000000002 109.304 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 163.36 98.39 0.13 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.683 -1.367 . . . . 75.040000000000006 109.683 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.477 ' O ' ' ND2' ' A' ' 119' ' ' ASN . 9.0 t -157.26 177.58 11.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -1.179 . . . . 61.140000000000001 109.666 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.477 ' ND2' ' O ' ' A' ' 118' ' ' SER . 0.4 OUTLIER -146.42 127.77 14.91 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.007 -0.677 . . . . 65.239999999999995 109.498 -177.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 86.6 t -72.87 -30.06 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.372 -0.83 . . . . 73.109999999999999 109.824 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.747 ' CG2' HH21 ' A' ' 159' ' ' ARG . 5.1 mp -118.66 131.88 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.427 -0.796 . . . . 72.239999999999995 109.913 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -142.33 107.73 5.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.426 -0.796 . . . . 72.340000000000003 108.997 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.588 HG12 ' CZ ' ' A' ' 159' ' ' ARG . 1.2 pp -130.71 142.44 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.458 -0.776 . . . . 71.439999999999998 109.027 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.72 -152.81 2.48 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.996 -1.642 . . . . 73.400000000000006 108.996 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -84.35 11.66 8.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.339 -1.094 . . . . 74.450000000000003 108.702 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.03 136.46 43.64 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.857 -0.794 . . . . 54.210000000000001 108.857 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 18.6 p -129.56 148.71 51.49 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.5 -0.75 . . . . 54.5 109.246 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.3 mt -139.04 136.06 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.393 -0.817 . . . . 45.149999999999999 110.028 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.8 m -126.11 98.76 32.45 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 108.68 -0.859 . . . . 71.109999999999999 108.68 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.46 -34.33 0.56 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.276 1.984 . . . . 65.409999999999997 112.734 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -58.09 -43.83 87.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.004 -1.06 . . . . 63.32 109.425 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.412 ' HB3' ' HE1' ' A' ' 116' ' ' TRP . 4.5 pt-20 -97.06 14.01 27.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.463 -0.773 . . . . 72.519999999999996 109.13 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 27.4 mp0 45.84 76.25 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.375 -0.828 . . . . 75.329999999999998 109.681 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -163.56 149.99 11.89 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.058 -1.026 . . . . 71.230000000000004 110.033 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.582 ' C ' HD13 ' A' ' 136' ' ' ILE . 17.7 tt -137.68 143.96 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.318 -0.864 . . . . 74.019999999999996 109.314 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.582 HD13 ' C ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -122.46 131.78 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.477 -0.764 . . . . 60.229999999999997 109.728 -179.297 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -138.58 128.75 25.63 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.348 -0.845 . . . . 62.32 108.737 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp 54.32 29.47 10.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.519 -0.738 . . . . 75.400000000000006 109.097 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 79.56 1.19 86.2 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.774 -0.931 . . . . 72.239999999999995 110.774 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.436 ' HD2' ' N ' ' A' ' 140' ' ' ARG . 9.2 mmm180 -88.79 124.15 33.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.859 -1.377 . . . . 71.219999999999999 108.909 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.447 ' HG2' HD12 ' A' ' 136' ' ' ILE . 95.0 mt-10 -88.81 136.35 33.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.286 -0.884 . . . . 71.420000000000002 109.014 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.0 t -131.84 127.8 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.371 -0.831 . . . . 53.020000000000003 109.591 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -88.27 122.7 32.1 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.69 -0.856 . . . . 60.450000000000003 108.69 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.6 m -141.88 138.57 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.03 -1.044 . . . . 74.439999999999998 109.867 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.51 39.14 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.443 -0.785 . . . . 65.150000000000006 109.191 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -107.9 -152.52 17.11 Favored Glycine 0 N--CA 1.502 3.036 0 N-CA-C 110.009 -1.236 . . . . 73.340000000000003 110.009 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.605 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 1.1 mtmp? -88.07 -37.62 0.46 Allowed Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.222 -1.164 . . . . 72.219999999999999 110.139 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 23.3 Cg_exo -63.29 -32.08 73.2 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.175 1.917 . . . . 65.230000000000004 111.418 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.507 ' CZ ' ' CG2' ' A' ' 153' ' ' THR . 43.7 t80 -86.69 -9.98 54.75 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.435 -0.791 . . . . 60.109999999999999 109.68 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.451 ' O ' ' OG1' ' A' ' 153' ' ' THR . 15.9 tt0 -66.96 -41.74 86.39 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.076 -1.015 . . . . 64.209999999999994 109.17 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.08 -35.11 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.983 -1.073 . . . . 72.019999999999996 109.223 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.692 HD12 HD21 ' A' ' 155' ' ' LEU . 15.9 tp -65.27 -33.35 75.78 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.181 -0.949 . . . . 73.310000000000002 108.967 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.507 ' CG2' ' CZ ' ' A' ' 149' ' ' PHE . 17.0 p -70.4 -32.39 70.01 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.177 -0.952 . . . . 74.310000000000002 108.437 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -64.38 -57.7 8.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.21 -0.931 . . . . 74.310000000000002 110.23 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.692 HD21 HD12 ' A' ' 152' ' ' LEU . 2.9 pp -65.38 -25.92 67.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.951 -1.093 . . . . 75.340000000000003 109.468 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.91 -51.55 69.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.008 -1.057 . . . . 62.140000000000001 108.988 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -74.17 -51.41 15.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.406 -0.809 . . . . 61.030000000000001 109.512 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.445 ' O ' ' O ' ' A' ' 159' ' ' ARG . 39.7 m80 -86.09 33.67 0.61 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.477 -0.765 . . . . 74.120000000000005 109.98 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.747 HH21 ' CG2' ' A' ' 121' ' ' ILE . 30.4 ttm-85 -46.96 -94.1 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.302 -0.874 . . . . 71.129999999999995 109.231 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.517 ' OD2' ' NE2' ' B' ' 161' ' ' GLN . 31.6 p-10 -52.4 89.36 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.953 -1.092 . . . . 75.450000000000003 109.219 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.535 ' NE2' ' O ' ' A' ' 162' ' ' ILE . 0.0 OUTLIER -173.33 154.01 2.54 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.109 -0.994 . . . . 73.409999999999997 109.434 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.535 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 52.5 mt -87.18 126.71 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.13 -0.981 . . . . 74.409999999999997 108.613 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.492 HG11 HD21 ' A' ' 168' ' ' LEU . 51.1 t -118.89 130.66 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.409 -0.807 . . . . 72.310000000000002 110.011 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 3.9 t -94.3 163.9 13.25 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.276 -0.89 . . . . 74.120000000000005 109.063 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -64.38 -43.58 94.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.067 -1.02 . . . . 70.430000000000007 109.554 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -58.92 -38.38 78.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 73.519999999999996 109.644 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -58.47 -46.18 87.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 74.519999999999996 109.513 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.492 HD21 HG11 ' A' ' 163' ' ' VAL . 77.7 mt -62.43 -39.31 92.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.155 -0.965 . . . . 72.310000000000002 109.311 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.511 HD23 ' C ' ' A' ' 169' ' ' LEU . 4.8 tt -54.77 -68.08 0.22 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.435 -0.791 . . . . 53.329999999999998 109.949 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.42 -37.08 79.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.305 -0.872 . . . . 62.439999999999998 110.751 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -50.79 -58.08 6.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.105 -0.997 . . . . 60.210000000000001 110.402 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.697 ' N ' HD12 ' A' ' 172' ' ' ILE . 1.9 mp -93.27 -62.69 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.98 -1.075 . . . . 75.319999999999993 109.492 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.441 ' O ' ' O ' ' A' ' 169' ' ' LEU . 24.5 m-90 . . . . . 0 N--CA 1.488 1.454 0 O-C-N 121.38 -0.825 . . . . 73.140000000000001 110.06 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 109.531 -0.544 . . . . 64.540000000000006 109.531 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.433 ' O ' HG22 ' A' ' 186' ' ' VAL . 11.8 p -58.29 -12.91 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 74.019999999999996 109.382 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.57 ' N ' HD12 ' A' ' 184' ' ' ILE . 2.6 mp -59.92 -22.98 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.088 -1.007 . . . . 72.329999999999998 109.028 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -61.6 -45.35 94.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.208 -0.933 . . . . 74.400000000000006 110.027 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 183' ' ' VAL . 12.1 m -75.32 -30.14 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.001 -1.062 . . . . 70.420000000000002 109.324 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -69.5 -50.67 43.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.097 -1.002 . . . . 52.109999999999999 110.025 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.446 HG23 ' N ' ' A' ' 189' ' ' ASN . 10.3 tp -65.13 -39.26 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.84 -1.163 . . . . 71.400000000000006 110.503 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.446 ' N ' HG23 ' A' ' 188' ' ' ILE . 11.6 t-20 -58.36 -43.09 88.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.974 -1.079 . . . . 73.439999999999998 109.483 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -75.64 -47.72 25.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.347 -0.845 . . . . 71.420000000000002 110.072 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 63.6 mt -52.13 -47.91 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.13 -0.981 . . . . 61.549999999999997 109.46 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . 0.476 ' HE ' ' CG2' ' A' ' 204' ' ' VAL . 76.0 mtp180 -60.58 -51.3 70.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.322 -0.861 . . . . 63.340000000000003 109.988 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -61.59 -33.89 74.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.24 -0.913 . . . . 61.240000000000002 110.145 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.421 ' O ' ' CD ' ' A' ' 198' ' ' PRO . 9.3 pttm -86.81 -4.31 59.16 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.92 -1.112 . . . . 75.129999999999995 109.589 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 28.2 ttt -91.46 -57.2 2.85 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.16 -0.963 . . . . 74.019999999999996 109.189 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 200' ' ' GLY . 15.0 p-10 -65.19 -31.42 72.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.364 -0.835 . . . . 74.019999999999996 109.619 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.441 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 27.5 mttm -52.86 -65.26 1.14 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.103 -0.998 . . . . 75.430000000000007 109.579 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 38.5 Cg_endo -63.89 -54.92 0.76 Allowed 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.144 1.896 . . . . 72.319999999999993 112.066 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' A' ' 201' ' ' ILE . 65.4 mt -63.79 -28.87 70.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 74.540000000000006 109.211 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 196' ' ' ASP . . . 74.92 -26.61 1.15 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.789 -1.325 . . . . 61.509999999999998 109.789 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.466 ' H ' ' C ' ' A' ' 199' ' ' LEU . 11.0 mt -101.32 129.95 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.357 -1.084 . . . . 61.219999999999999 109.356 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 15.1 t -80.6 132.2 35.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.895 . . . . 72.0 109.265 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 62.6 p -136.11 3.72 2.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.432 -0.793 . . . . 74.439999999999998 108.949 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.476 ' CG2' ' HE ' ' A' ' 192' ' ' ARG . 28.6 m -104.36 138.09 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.499 -0.75 . . . . 64.349999999999994 109.292 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -122.96 136.34 54.82 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.6 -0.688 . . . . 71.409999999999997 109.572 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.13 132.35 44.51 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.231 -0.918 . . . . 73.519999999999996 109.047 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 5.1 m -135.14 136.29 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.371 -0.831 . . . . 71.019999999999996 109.48 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -81.34 -10.05 59.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.856 . . . . 72.120000000000005 109.16 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 18.8 mtp-105 -56.04 -43.28 77.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.92 . . . . 64.409999999999997 109.812 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -148.05 -66.76 0.25 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.221 -0.924 . . . . 71.540000000000006 109.524 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -148.45 -110.89 0.59 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.636 -1.386 . . . . 72.030000000000001 109.636 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.406 ' N ' ' CD1' ' A' ' 212' ' ' TYR . 41.4 m-85 -125.81 146.34 49.84 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.643 -0.916 . . . . 75.540000000000006 109.075 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -113.09 133.39 55.02 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.539 -0.726 . . . . 75.310000000000002 109.542 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -99.36 132.01 44.99 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.689 -0.856 . . . . 75.409999999999997 108.689 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 2.0 p -141.1 166.72 24.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.278 -0.889 . . . . 74.140000000000001 109.601 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -82.11 152.44 68.2 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 75.319999999999993 109.426 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo . . . . . 0 N--CA 1.49 1.308 0 C-N-CA 122.295 1.997 . . . . 73.109999999999999 112.266 179.491 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.573 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.406 -0.59 . . . . 71.140000000000001 109.406 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -131.77 145.89 51.85 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.512 -0.743 . . . . 73.230000000000004 109.129 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.2 t -117.03 139.65 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.582 -0.699 . . . . 72.239999999999995 109.907 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.495 HD11 ' CG1' ' B' ' 6' ' ' ILE . 3.3 tp -109.01 118.7 37.47 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.568 -0.708 . . . . 54.329999999999998 109.386 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.466 ' N ' HD12 ' B' ' 4' ' ' LEU . 21.7 mt -115.62 97.8 6.34 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.597 -0.89 . . . . 74.349999999999994 108.597 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.683 HD12 ' HB ' ' B' ' 50' ' ' VAL . 90.2 mt -85.8 97.41 5.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 120.863 -1.148 . . . . 42.549999999999997 108.987 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.407 ' HG3' ' H ' ' B' ' 9' ' ' ASN . 45.8 tp10 -120.52 128.04 52.74 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.543 -0.723 . . . . 74.519999999999996 109.635 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . 0.491 ' H ' ' CD ' ' B' ' 8' ' ' LYS . 0.0 OUTLIER -83.43 -22.12 32.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 62.549999999999997 108.773 179.447 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . 0.471 ' ND2' HD23 ' B' ' 12' ' ' LEU . 37.0 t-20 -78.6 -128.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.431 -0.793 . . . . 73.109999999999999 109.232 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' B' ' 11' ' ' VAL . 22.0 p -166.83 -55.54 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -0.866 . . . . 65.540000000000006 109.32 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.418 ' N ' ' OG ' ' B' ' 10' ' ' SER . 88.0 t -67.74 -42.77 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.288 -0.883 . . . . 75.549999999999997 109.652 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.583 HD13 ' OE2' ' B' ' 15' ' ' GLU . 4.0 mm? -59.87 -42.23 93.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.338 -0.851 . . . . 70.140000000000001 109.532 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.75 -28.56 66.88 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.416 -1.874 . . . . 75.400000000000006 108.416 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.06 -47.94 80.49 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 109.828 -1.309 . . . . 65.439999999999998 109.828 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.583 ' OE2' HD13 ' B' ' 12' ' ' LEU . 15.7 pt-20 -63.76 -44.42 93.51 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.122 -1.222 . . . . 60.210000000000001 109.707 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 37.0 mm -66.7 -39.77 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.756 -1.215 . . . . 75.150000000000006 108.667 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.488 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 80.3 tt0 -63.72 -43.21 97.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.403 -0.811 . . . . 73.010000000000005 109.684 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp -86.81 0.45 54.81 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.09 -1.006 . . . . 74.299999999999997 109.366 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.49 -52.83 3.08 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.561 -1.416 . . . . 70.540000000000006 109.561 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.403 HD23 ' N ' ' B' ' 21' ' ' ASN . 1.4 pt? -76.73 -21.56 55.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -1.102 . . . . 71.340000000000003 109.914 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 90.9 m-20 -56.43 -31.47 63.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.084 -1.01 . . . . 64.409999999999997 109.451 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 87.6 t -59.87 -35.02 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.317 -0.864 . . . . 74.230000000000004 109.354 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -70.68 -8.12 49.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.343 -0.848 . . . . 63.420000000000002 109.314 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.36 43.41 6.59 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.023 -1.231 . . . . 53.43 110.023 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -116.71 159.67 21.91 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.498 -1.001 . . . . 71.120000000000005 109.054 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 14.5 mmt -100.74 138.02 38.35 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.989 -1.115 . . . . 75.239999999999995 107.989 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.23 155.57 43.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.096 -1.002 . . . . 72.120000000000005 110.257 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -132.3 160.82 35.14 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.665 -0.865 . . . . 72.310000000000002 108.665 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 p -119.49 139.0 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.45 -0.781 . . . . 64.430000000000007 109.739 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 6.8 p -134.83 170.43 15.87 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.068 -0.716 . . . . 65.409999999999997 109.068 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.402 ' OE2' ' OD2' ' B' ' 35' ' ' ASP . 5.9 pt-20 -93.31 -107.81 0.12 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.219 -0.925 . . . . 71.019999999999996 109.82 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 54.8 p -78.94 168.16 20.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.25 -0.906 . . . . 51.109999999999999 110.025 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 61.0 mt -52.83 -29.41 27.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.548 -0.72 . . . . 71.239999999999995 109.754 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -52.71 -50.38 63.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.144 -0.972 . . . . 74.319999999999993 109.636 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.402 ' OD2' ' OE2' ' B' ' 31' ' ' GLU . 1.8 m-20 -64.66 -40.89 96.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.94 . . . . 73.030000000000001 109.481 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.02 -42.0 60.03 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.573 -1.411 . . . . 30.210000000000001 109.573 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.68 -37.75 87.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.304 -1.115 . . . . 74.420000000000002 109.748 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -80.64 -41.16 24.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.088 -1.007 . . . . 74.420000000000002 109.858 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 8.6 tt -70.21 -43.86 69.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.191 -0.943 . . . . 75.409999999999997 109.972 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . 0.448 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.1 ppp? -62.62 -26.34 68.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.987 -1.07 . . . . 60.409999999999997 109.88 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -63.49 -39.85 95.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.054 -1.029 . . . . 53.229999999999997 110.027 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 20.9 pt -84.38 -26.29 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.095 -1.003 . . . . 71.230000000000004 110.166 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' B' ' 40' ' ' MET . 63.6 mmt-85 -129.69 138.59 51.24 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.305 -0.872 . . . . 72.219999999999999 109.348 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -93.62 159.59 15.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.162 -0.961 . . . . 63.539999999999999 109.825 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -136.63 150.47 48.55 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.447 -0.783 . . . . 64.349999999999994 109.212 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -91.5 -35.02 14.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.147 -0.971 . . . . 62.219999999999999 109.692 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.512 ' C ' HD13 ' B' ' 47' ' ' LEU . 0.9 OUTLIER -113.37 110.6 20.6 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.421 -0.799 . . . . 73.120000000000005 109.095 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.464 ' N ' HD13 ' B' ' 47' ' ' LEU . 70.8 t -93.86 100.22 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.324 -0.86 . . . . 65.109999999999999 108.761 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.518 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 6.3 tpp -114.24 128.23 56.26 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.094 -0.706 . . . . 73.439999999999998 109.094 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.686 HG22 ' H ' ' B' ' 52' ' ' ASP . 0.7 OUTLIER -144.01 136.66 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 34.5 109.803 -179.451 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 65.2 p -101.52 16.77 24.62 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.593 -0.692 . . . . 73.209999999999994 109.658 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.686 ' H ' HG22 ' B' ' 50' ' ' VAL . 41.7 m-20 -83.59 136.22 34.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.22 -0.925 . . . . 70.409999999999997 109.331 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -71.93 -33.56 68.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.898 . . . . 65.0 110.184 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -76.91 3.7 11.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.098 -1.001 . . . . 75.209999999999994 110.097 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.403 ' O ' ' C ' ' B' ' 56' ' ' LEU . . . -71.39 -21.33 62.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 55.329999999999998 110.215 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' B' ' 55' ' ' ALA . 56.2 mt -42.98 -42.91 3.94 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.424 -0.797 . . . . 63.140000000000001 110.275 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 19.7 m -72.63 -37.22 68.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.045 -1.035 . . . . 63.5 109.459 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . 0.568 ' CE2' HD11 ' B' ' 62' ' ' ILE . 69.1 t80 -67.44 -51.06 56.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.368 -0.832 . . . . 72.329999999999998 110.287 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.3 m -60.4 -35.11 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.783 -1.198 . . . . 74.540000000000006 109.542 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 66.1 p -58.41 -50.84 72.26 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.269 -0.895 . . . . 71.239999999999995 109.289 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.505 ' HE ' ' CE ' ' B' ' 65' ' ' LYS . 12.2 ptm180 -68.85 -30.94 69.57 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 118.742 -1.183 . . . . 74.310000000000002 109.815 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.568 HD11 ' CE2' ' B' ' 58' ' ' PHE . 4.8 mm -54.56 -48.44 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.842 -1.161 . . . . 72.140000000000001 108.526 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.523 ' NZ ' ' OD2' ' B' ' 92' ' ' ASP . 50.3 mmtt -61.2 -42.94 99.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.141 -0.975 . . . . 73.319999999999993 108.435 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -65.65 -43.69 88.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.415 -0.803 . . . . 73.120000000000005 108.837 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.505 ' CE ' ' HE ' ' B' ' 61' ' ' ARG . 9.5 mtmp? -82.28 -77.54 0.23 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.662 -0.649 . . . . 72.439999999999998 109.964 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.433 ' N ' ' O ' ' B' ' 62' ' ' ILE . 95.1 m-70 -97.53 87.69 4.17 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.165 -0.959 . . . . 63.310000000000002 109.727 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 71.0 p -79.34 -30.88 42.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.3 -0.875 . . . . 73.099999999999994 110.013 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 38.3 m -63.23 -28.89 70.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.19 -0.944 . . . . 71.530000000000001 110.0 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 58.3 mt -80.17 150.0 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.088 -1.008 . . . . 74.400000000000006 109.654 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.553 HG12 ' N ' ' B' ' 71' ' ' VAL . 98.8 t -88.37 165.62 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.378 -0.826 . . . . 75.120000000000005 109.387 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.553 ' N ' HG12 ' B' ' 70' ' ' VAL . 14.4 t -145.48 125.42 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.999 -1.063 . . . . 73.200000000000003 109.859 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.518 ' O ' ' SD ' ' B' ' 49' ' ' MET . 0.8 OUTLIER -120.5 103.6 9.3 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.408 -0.96 . . . . 73.340000000000003 108.408 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 13.4 p -98.4 144.98 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.179 -0.951 . . . . 73.5 108.876 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.5 m -111.07 171.25 7.58 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.318 -0.864 . . . . 64.340000000000003 109.147 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 8.0 t -171.13 122.26 0.56 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.076 -1.015 . . . . 74.530000000000001 110.065 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 46.3 p30 -78.14 29.82 0.18 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.453 -0.779 . . . . 64.5 110.189 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . 0.414 ' N ' ' CD ' ' B' ' 78' ' ' PRO . 12.7 t-20 -150.47 55.13 1.67 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 120.939 -1.101 . . . . 74.25 109.862 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' B' ' 77' ' ' ASN . 12.0 Cg_endo -56.26 81.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.604 2.203 . . . . 74.430000000000007 112.397 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.416 HG22 ' H ' ' B' ' 81' ' ' GLU . 29.4 m -109.35 149.69 29.12 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.317 -0.994 . . . . 73.120000000000005 108.317 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -30.66 66.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.144 -0.972 . . . . 71.010000000000005 109.213 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . 0.416 ' H ' HG22 ' B' ' 79' ' ' THR . 84.1 tt0 -64.53 -48.21 75.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 63.200000000000003 109.034 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -69.89 -29.49 66.7 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.138 -0.976 . . . . 73.219999999999999 109.142 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.558 ' CD ' ' HE ' ' A' ' 108' ' ' ARG . 39.8 tp10 -56.21 -56.03 25.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.871 . . . . 74.299999999999997 109.192 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 8.2 m -60.46 -38.45 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.171 -0.956 . . . . 73.310000000000002 108.917 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 69.9 t60 -63.11 -34.03 76.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.303 -0.873 . . . . 73.239999999999995 109.437 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.18 90.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.197 -0.94 . . . . 55.329999999999998 109.74 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -76.56 -31.34 57.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.195 -0.941 . . . . 74.140000000000001 108.641 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -67.32 -46.31 73.87 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.731 -0.84 . . . . 64.040000000000006 108.731 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -59.48 -66.21 0.55 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.611 -0.681 . . . . 72.349999999999994 109.414 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 149.87 52.14 0.02 OUTLIER Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.167 -1.173 . . . . 65.200000000000003 110.167 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.6 132.23 54.08 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.31 -1.112 . . . . 52.229999999999997 109.067 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.523 ' OD2' ' NZ ' ' B' ' 63' ' ' LYS . 3.4 m-20 -67.15 -38.11 84.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.033 -1.042 . . . . 73.319999999999993 108.873 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 48.2 t0 -152.11 156.65 40.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.442 -0.786 . . . . 72.219999999999999 108.939 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.482 ' C ' ' CD1' ' B' ' 94' ' ' TYR . 0.5 OUTLIER -125.29 126.54 45.27 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.179 -0.674 . . . . 64.420000000000002 109.179 -179.586 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 0.435 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 25.8 mm -110.22 134.06 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 121.378 -0.826 . . . . 72.230000000000004 109.923 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' B' ' 97' ' ' LYS . . . -60.97 119.5 8.41 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.635 -1.617 . . . . 25.239999999999998 106.635 177.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.681 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -42.01 -55.36 6.3 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.032 -1.042 . . . . 64.319999999999993 111.574 -178.072 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 3.7 Cg_endo -41.64 -10.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 120.774 0.983 . . . . 63.329999999999998 112.57 -176.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . 0.681 ' N ' ' O ' ' B' ' 97' ' ' LYS . 58.6 m-85 58.83 104.98 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.845 -0.535 . . . . 75.129999999999995 109.719 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 33.0 ttm-85 -62.0 -34.4 76.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.071 -1.018 . . . . 74.230000000000004 109.091 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . 0.631 ' O ' ' N ' ' B' ' 103' ' ' LYS . 28.8 m -172.51 32.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.88 . . . . 63.340000000000003 110.253 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . 0.48 ' O ' ' N ' ' B' ' 104' ' ' ALA . 55.9 mt 49.09 -81.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.384 -0.823 . . . . 74.439999999999998 110.368 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.631 ' N ' ' O ' ' B' ' 101' ' ' SER . 44.7 mtmt -45.57 -19.97 0.06 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.242 -0.911 . . . . 71.109999999999999 108.961 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' B' ' 102' ' ' ILE . . . -55.6 -67.5 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.509 -0.744 . . . . 71.450000000000003 109.545 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 3.1 pp -60.84 -36.76 79.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.961 -1.087 . . . . 51.310000000000002 109.555 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 14.5 t -56.92 -45.69 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.74 -1.225 . . . . 65.230000000000004 108.531 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.3 -31.04 67.13 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.337 -0.986 . . . . 24.32 108.337 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -79.41 -23.72 43.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.525 -0.735 . . . . 75.310000000000002 109.822 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 83.2 mt -78.24 -39.69 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.955 -1.091 . . . . 54.240000000000002 109.11 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -73.52 -41.39 63.11 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.329 -0.949 . . . . 65.310000000000002 109.417 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.15 -53.28 59.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.192 -0.942 . . . . 72.239999999999995 109.577 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 68.3 ttt-85 -64.97 -33.85 77.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 72.040000000000006 109.47 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.521 ' O ' ' CD2' ' B' ' 115' ' ' PHE . 60.3 tp -80.54 -90.82 0.06 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.93 . . . . 75.349999999999994 109.7 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' B' ' 116' ' ' TRP . 11.6 mmt180 47.17 -170.03 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.176 -0.952 . . . . 75.5 108.881 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 115' ' ' PHE . . . . . 0.521 ' CD2' ' O ' ' B' ' 113' ' ' LEU . 1.4 m-85 66.26 -39.76 0.33 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.336 -0.853 . . . . 65.329999999999998 109.849 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 116' ' ' TRP . . . . . 0.528 ' N ' ' O ' ' B' ' 114' ' ' ARG . 17.1 t90 53.3 43.13 31.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.012 -1.055 . . . . 74.450000000000003 109.203 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.49 77.0 1.09 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.817 -1.313 . . . . 44.210000000000001 109.817 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 2.3 t -80.92 -8.35 59.72 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.207 -1.172 . . . . 71.400000000000006 109.392 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . 0.54 HD21 ' C ' ' B' ' 128' ' ' ILE . 24.4 t-20 54.52 176.39 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.422 -0.798 . . . . 72.319999999999993 110.328 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . 0.437 ' H ' ' CG ' ' B' ' 119' ' ' ASN . 11.8 t -142.71 -36.2 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.72 -0.845 . . . . 75.019999999999996 108.72 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 25.6 mm -115.42 118.77 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.28 -1.008 . . . . 51.409999999999997 108.28 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -155.34 140.76 17.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.939 -1.101 . . . . 71.530000000000001 110.131 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 35.1 pt -149.02 145.23 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.998 -0.742 . . . . 72.430000000000007 108.998 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 45.8 -136.41 8.0 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.848 -1.301 . . . . 51.229999999999997 109.848 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -90.51 6.73 42.29 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.259 -1.142 . . . . 74.200000000000003 109.326 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.9 139.25 31.12 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.321 -0.862 . . . . 75.420000000000002 108.777 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 17.0 m -128.86 133.68 48.04 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.601 -0.888 . . . . 74.219999999999999 108.601 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.54 ' C ' HD21 ' B' ' 119' ' ' ASN . 42.0 mt -138.95 141.31 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.147 -0.971 . . . . 60.329999999999998 110.571 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . 0.49 ' OG ' ' ND2' ' B' ' 119' ' ' ASN . 6.1 m -136.99 117.75 10.88 Favored Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 108.915 -0.772 . . . . 72.310000000000002 108.915 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.98 -48.74 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 121.958 1.772 . . . . 75.129999999999995 112.471 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -55.53 -37.41 67.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.211 -0.93 . . . . 75.230000000000004 109.836 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -80.76 -2.15 45.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.166 -0.959 . . . . 72.430000000000007 109.374 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 49.55 57.32 6.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.256 -0.903 . . . . 75.129999999999995 108.958 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -156.66 139.7 15.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -0.908 . . . . 73.219999999999999 109.545 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 55.3 mt -124.01 132.72 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.995 -0.743 . . . . 64.140000000000001 108.995 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . 0.442 HG23 ' O ' ' B' ' 140' ' ' ARG . 23.7 mt -125.57 131.25 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.502 -0.749 . . . . 71.219999999999999 110.318 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -125.62 129.24 49.24 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.697 -0.627 . . . . 64.219999999999999 109.483 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm 51.46 36.34 16.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.179 -0.951 . . . . 72.019999999999996 111.095 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.76 -1.34 83.83 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 120.065 -1.064 . . . . 74.319999999999993 111.5 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . 0.442 ' O ' HG23 ' B' ' 136' ' ' ILE . 2.7 mpt_? -87.14 124.62 33.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.714 -1.462 . . . . 75.340000000000003 108.927 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -84.03 123.88 30.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.368 -0.832 . . . . 71.230000000000004 109.496 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 97.2 t -127.72 133.28 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.474 -0.766 . . . . 70.430000000000007 109.45 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -98.93 142.84 29.93 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.242 -0.911 . . . . 72.430000000000007 109.44 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 20.6 m -146.32 152.29 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.149 -0.969 . . . . 72.129999999999995 109.906 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.11 115.79 0.08 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.358 -0.839 . . . . 72.019999999999996 109.407 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.59 -137.86 7.03 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.788 -1.325 . . . . 42.229999999999997 109.788 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . 0.58 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 0.0 OUTLIER -73.53 -43.83 7.1 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.272 -1.134 . . . . 73.299999999999997 109.539 -179.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 24.3 Cg_exo -62.67 -49.08 5.99 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.29 1.994 . . . . 71.329999999999998 111.144 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . 0.44 ' CE1' HG21 ' B' ' 153' ' ' THR . 25.1 t80 -58.06 -24.39 58.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.687 -0.633 . . . . 74.230000000000004 109.608 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . 0.41 ' OE1' ' O ' ' B' ' 172' ' ' ILE . 24.0 tt0 -72.11 -58.6 3.29 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.299 -0.876 . . . . 72.340000000000003 110.378 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.99 -33.58 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.801 -1.187 . . . . 73.349999999999994 109.468 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 3.8 mp -58.15 -41.47 83.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.118 -0.989 . . . . 55.240000000000002 108.781 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.44 HG21 ' CE1' ' B' ' 149' ' ' PHE . 1.9 p -80.6 -18.96 46.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.967 . . . . 70.010000000000005 110.235 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -71.16 -52.13 20.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.858 -1.151 . . . . 65.319999999999993 109.576 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . 0.997 HD13 ' N ' ' B' ' 156' ' ' ALA . 0.0 OUTLIER -77.92 -25.01 48.11 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.313 -0.867 . . . . 71.540000000000006 110.17 -179.164 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . 0.997 ' N ' HD13 ' B' ' 155' ' ' LEU . . . -63.38 -53.4 53.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.906 -1.121 . . . . 75.319999999999993 109.259 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -66.06 -54.5 25.01 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.267 -0.896 . . . . 73.319999999999993 108.877 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 158' ' ' HIS . . . . . 0.448 ' ND1' ' N ' ' B' ' 158' ' ' HIS . 2.1 m-70 -84.72 38.27 0.69 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.804 -0.56 . . . . 74.140000000000001 110.263 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -73.41 45.07 0.16 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.866 -1.146 . . . . 61.409999999999997 109.408 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' B' ' 160' ' ' ASP . 15.9 p-10 -169.81 62.13 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.076 -1.015 . . . . 72.099999999999994 109.294 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . 0.517 ' NE2' ' OD2' ' A' ' 160' ' ' ASP . 39.7 tp60 -169.87 164.51 9.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.07 -1.019 . . . . 72.25 109.831 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 162' ' ' ILE . . . . . 0.524 HG23 ' NE ' ' B' ' 213' ' ' ARG . 45.4 mt -80.3 132.94 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.611 -0.885 . . . . 72.310000000000002 108.611 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 33.9 t -132.01 131.12 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.289 -0.882 . . . . 64.209999999999994 109.892 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 11.2 p -99.68 159.94 14.67 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.708 -0.849 . . . . 74.219999999999999 108.708 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -55.76 -39.38 71.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.028 -1.045 . . . . 65.310000000000002 109.571 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.21 -39.6 93.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.149 -0.969 . . . . 63.450000000000003 109.809 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -53.3 -47.28 69.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.176 -0.953 . . . . 72.400000000000006 109.0 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 33.5 mt -55.87 -50.53 70.37 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.448 -0.945 . . . . 72.319999999999993 108.448 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.462 HD23 ' O ' ' B' ' 169' ' ' LEU . 1.1 tt -49.9 -56.23 11.35 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.271 -0.893 . . . . 73.340000000000003 109.296 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -56.2 -39.21 72.08 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 112.833 0.679 . . . . 72.099999999999994 112.833 -178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -93.25 -18.83 22.03 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.451 -1.406 . . . . 62.130000000000003 113.408 -176.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 0.41 ' O ' ' OE1' ' B' ' 150' ' ' GLU . 1.3 mp -91.32 -53.87 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 120.375 -1.453 . . . . 71.420000000000002 111.07 -178.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 173' ' ' TRP . . . . . 0.536 ' O ' ' CG ' ' B' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.158 0 O-C-N 120.738 -1.226 . . . . 72.230000000000004 110.63 -177.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo . . . . . 0 N--CA 1.496 1.625 0 CA-C-O 121.224 0.427 . . . . 65.219999999999999 113.01 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -62.44 -33.5 74.92 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.199 -0.938 . . . . 72.310000000000002 111.072 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . 0.454 ' O ' HG12 ' B' ' 186' ' ' VAL . 87.2 t -66.67 -15.54 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.933 -1.104 . . . . 63.32 110.699 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 95.0 mt -60.87 -23.55 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.726 -1.234 . . . . 75.030000000000001 109.563 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . 0.449 ' CG ' ' N ' ' B' ' 186' ' ' VAL . 20.6 pt-20 -59.87 -43.95 94.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.283 -0.885 . . . . 64.109999999999999 109.883 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . 0.454 HG12 ' O ' ' B' ' 183' ' ' VAL . 2.7 p -76.98 -34.35 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.967 -1.083 . . . . 73.0 109.74 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -55.25 -52.59 62.9 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.881 -1.137 . . . . 61.119999999999997 109.588 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 8.3 tp -65.97 -37.83 80.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 120.973 -1.08 . . . . 72.430000000000007 109.603 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -58.5 -46.11 87.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.001 -1.062 . . . . 65.140000000000001 109.6 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -72.91 -47.23 47.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 63.240000000000002 110.087 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.5 mt -54.63 -40.55 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.026 -1.046 . . . . 74.030000000000001 109.463 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -62.49 -52.17 64.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.162 -0.961 . . . . 72.239999999999995 109.505 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -60.22 -38.42 83.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 73.099999999999994 109.464 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -73.25 -15.42 61.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.289 -0.882 . . . . 72.109999999999999 109.592 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 1.5 tpt -89.85 -57.13 2.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.271 -0.893 . . . . 44.329999999999998 110.098 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 196' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' B' ' 200' ' ' GLY . 95.2 m-20 -55.87 -38.35 70.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 71.209999999999994 110.998 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . 0.435 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 14.0 mtmm -54.96 -65.66 1.28 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.876 -1.14 . . . . 75.209999999999994 109.938 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 198' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 34.9 Cg_endo -63.11 -56.57 0.53 Allowed 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.084 1.856 . . . . 75.319999999999993 112.368 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . 0.496 ' N ' HD12 ' B' ' 199' ' ' LEU . 9.1 mp -62.83 -32.15 73.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.137 -0.977 . . . . 72.25 109.478 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' B' ' 196' ' ' ASP . . . 74.14 -41.9 1.13 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.486 -1.446 . . . . 64.530000000000001 109.486 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . 0.418 ' H ' ' C ' ' B' ' 199' ' ' LEU . 4.0 mt -92.29 129.52 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.285 -1.126 . . . . 44.229999999999997 109.231 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 26.3 p -78.12 142.35 38.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.167 -0.958 . . . . 54.009999999999998 109.07 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 10.2 p -141.45 4.88 1.8 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.314 -0.867 . . . . 74.400000000000006 109.528 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 204' ' ' VAL . 32.6 m -113.89 134.83 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.444 -0.785 . . . . 72.120000000000005 109.208 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . 0.531 ' OE2' ' N ' ' B' ' 205' ' ' GLU . 1.5 mp0 -106.76 136.22 46.95 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.448 -0.783 . . . . 65.409999999999997 109.508 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.36 119.21 34.42 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.209 -0.932 . . . . 71.329999999999998 109.018 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 4.8 t -131.58 130.77 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.447 -0.783 . . . . 63.5 109.59 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 208' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' B' ' 209' ' ' ARG . 65.9 ttt-85 -73.1 -28.59 62.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 74.450000000000003 109.446 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 209' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' B' ' 208' ' ' ARG . 52.4 mtp85 -55.6 -106.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 74.140000000000001 109.982 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -63.67 -66.19 0.58 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.019 . . . . 74.430000000000007 109.852 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 211' ' ' GLY . . . . . 0.78 ' H ' HH12 ' B' ' 213' ' ' ARG . . . 178.68 -119.89 0.68 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.834 -1.306 . . . . 64.450000000000003 109.834 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 212' ' ' TYR . . . . . 0.628 ' N ' ' NH2' ' B' ' 213' ' ' ARG . 78.2 m-85 -111.69 141.79 44.85 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.494 -1.004 . . . . 74.209999999999994 109.7 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . 0.78 HH12 ' H ' ' B' ' 211' ' ' GLY . 13.5 mmp_? -105.87 131.51 53.11 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.454 -0.779 . . . . 74.030000000000001 108.96 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . 0.43 ' C ' ' SG ' ' B' ' 215' ' ' CYS . 60.4 m-85 -108.45 107.27 17.74 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.348 -0.845 . . . . 74.340000000000003 108.972 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . 0.43 ' SG ' ' C ' ' B' ' 214' ' ' PHE . 4.2 m -148.64 169.43 20.37 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.309 -0.869 . . . . 64.329999999999998 109.53 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -79.32 150.34 73.76 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 70.040000000000006 109.117 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.77 -159.57 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.975 1.783 . . . . 65.109999999999999 111.243 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? . . . . . 0 N--CA 1.489 1.51 0 O-C-N 120.993 -1.067 . . . . 73.150000000000006 109.089 -179.814 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ptp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.469 -0.567 . . . . 65.120000000000005 109.469 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.1 ttt85 -144.24 156.47 44.3 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.277 -0.889 . . . . 72.329999999999998 109.238 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.5 t -117.04 129.21 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.59 0.709 . . . . 71.420000000000002 109.742 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 49' ' ' MET . 6.8 tp -99.86 116.76 32.68 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.902 -0.777 . . . . 65.120000000000005 108.902 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.4 tp -119.54 105.44 11.23 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.098 -0.704 . . . . 62.43 109.098 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.47 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 11.7 mt -96.36 131.9 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.071 -1.018 . . . . 71.150000000000006 109.539 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.499 ' CD ' ' N ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -163.14 131.83 3.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 75.340000000000003 109.409 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.547 ' H ' ' CD ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -76.74 -5.1 46.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -0.944 . . . . 72.439999999999998 108.898 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -74.67 -145.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.312 -0.868 . . . . 63.020000000000003 109.092 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.3 t -159.83 -69.84 0.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.107 -0.996 . . . . 72.340000000000003 109.662 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.414 HG13 ' N ' ' A' ' 12' ' ' LEU . 11.2 p -64.76 -37.46 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 74.019999999999996 109.985 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.414 ' N ' HG13 ' A' ' 11' ' ' VAL . 3.6 mm? -52.11 -41.34 62.39 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.978 -1.076 . . . . 71.430000000000007 108.756 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.25 -28.79 63.35 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.552 -1.819 . . . . 61.32 108.552 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.65 -46.43 92.15 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.696 -1.362 . . . . 71.200000000000003 109.696 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.28 -42.86 87.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.321 -1.106 . . . . 71.319999999999993 109.915 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.464 HD11 ' CE2' ' A' ' 99' ' ' TYR . 62.9 mt -69.55 -37.45 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.886 -1.134 . . . . 63.229999999999997 109.327 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -59.81 -45.94 90.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.137 -0.977 . . . . 51.109999999999999 109.488 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -86.33 -4.28 59.14 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.155 -0.966 . . . . 73.340000000000003 109.629 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.02 -57.45 2.52 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.312 -1.515 . . . . 62.149999999999999 109.312 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pp -66.31 -29.21 69.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.376 -1.073 . . . . 73.510000000000005 109.38 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -53.22 -35.1 59.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 74.25 109.35 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 82.1 t -55.52 -40.84 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.929 . . . . 70.040000000000006 109.095 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.539 ' HZ2' HG11 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -70.25 -17.33 63.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.373 -0.83 . . . . 73.230000000000004 109.015 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.95 41.6 3.5 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.197 -1.161 . . . . 75.540000000000006 110.197 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -118.15 155.85 29.73 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.404 -1.057 . . . . 73.430000000000007 108.737 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.7 mmm -103.51 139.22 39.15 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.538 -0.912 . . . . 43.240000000000002 108.538 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.69 159.81 41.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.224 -0.923 . . . . 62.109999999999999 110.066 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -140.03 146.06 38.55 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.91 -0.774 . . . . 74.420000000000002 108.91 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.93 128.15 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.647 -0.872 . . . . 72.150000000000006 108.647 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.6 p -128.48 165.05 21.44 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.584 -0.697 . . . . 71.420000000000002 109.516 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.47 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 3.5 pt-20 -94.13 -99.34 0.15 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.284 -0.885 . . . . 72.329999999999998 109.643 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.5 p -79.56 165.51 22.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.167 -0.958 . . . . 74.239999999999995 110.034 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.0 mt -57.13 -36.3 70.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.496 -0.752 . . . . 71.530000000000001 109.991 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -54.14 -41.09 68.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.111 -0.993 . . . . 74.230000000000004 110.014 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.18 -40.08 65.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.125 -0.984 . . . . 54.030000000000001 109.867 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.97 -39.46 23.96 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.91 -1.276 . . . . 61.409999999999997 109.91 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.6 -49.02 74.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -1.136 . . . . 74.340000000000003 109.872 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -66.47 -35.75 81.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.144 -0.972 . . . . 75.329999999999998 110.039 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.469 HD11 ' HE ' ' A' ' 43' ' ' ARG . 20.6 tp -73.83 -51.58 15.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 74.329999999999998 110.344 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.42 ' O ' ' O ' ' A' ' 43' ' ' ARG . 11.7 ptm -65.3 -24.79 67.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.078 -1.014 . . . . 70.319999999999993 110.094 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -54.98 -42.0 71.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.079 -1.013 . . . . 71.219999999999999 109.891 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.1 pt -88.67 -34.68 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.164 -0.96 . . . . 74.140000000000001 109.964 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.469 ' HE ' HD11 ' A' ' 39' ' ' LEU . 86.2 mtt-85 -86.59 147.35 25.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.02 -1.05 . . . . 72.239999999999995 109.684 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -88.42 151.92 22.24 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.296 -0.877 . . . . 75.420000000000002 109.237 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 12.5 p90 -156.01 171.09 20.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.149 -0.969 . . . . 74.230000000000004 109.897 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 45' ' ' TYR . 89.8 m-20 -136.3 -31.87 0.88 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.53 -0.732 . . . . 72.040000000000006 109.426 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.02 108.62 19.86 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.361 -0.837 . . . . 72.129999999999995 108.818 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.3 t -97.82 97.8 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.323 -0.861 . . . . 72.340000000000003 109.438 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.429 ' O ' ' O ' ' A' ' 4' ' ' LEU . 4.5 ttt -113.89 127.48 56.0 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.455 -0.778 . . . . 74.109999999999999 109.213 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.418 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -133.5 137.61 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.635 -0.666 . . . . 61.119999999999997 109.47 -179.082 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 t -103.92 4.07 34.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.589 -0.694 . . . . 73.109999999999999 109.647 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.418 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 78.0 m-20 -76.84 140.01 40.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.15 -0.969 . . . . 52.549999999999997 109.532 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 55' ' ' ALA . 37.9 mmtm -73.58 -42.32 61.73 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.291 -0.881 . . . . 44.219999999999999 110.104 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -70.95 13.98 0.17 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.113 -0.992 . . . . 70.439999999999998 109.682 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.01 -20.87 59.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 64.140000000000001 110.428 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 55' ' ' ALA . 36.3 mt -42.06 -50.84 4.67 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.39 -0.819 . . . . 44.140000000000001 110.019 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.9 m -66.12 -33.85 76.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.074 -1.016 . . . . 55.229999999999997 108.945 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.437 ' N ' ' O ' ' A' ' 55' ' ' ALA . 52.1 t80 -64.08 -62.1 1.84 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.358 -0.839 . . . . 74.439999999999998 109.574 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.2 m -49.21 -33.25 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.671 -1.268 . . . . 74.030000000000001 109.589 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.0 m -58.2 -51.66 68.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.207 -0.933 . . . . 64.299999999999997 109.583 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -69.21 -31.22 69.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.997 -1.064 . . . . 64.439999999999998 110.014 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.9 mm -65.87 -36.11 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.726 -1.234 . . . . 63.210000000000001 109.561 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -69.75 -46.38 66.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 74.420000000000002 110.428 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.431 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 7.0 pt-20 -74.53 -42.73 58.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.831 -1.168 . . . . 70.319999999999993 110.087 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.527 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 92.8 mttt -70.13 -27.9 64.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 75.219999999999999 109.484 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.572 ' O ' HG22 ' A' ' 69' ' ' ILE . 58.6 m-70 -150.13 67.12 0.97 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.367 -0.833 . . . . 74.129999999999995 109.224 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.3 p -60.44 -28.76 68.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 73.239999999999995 109.813 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.5 t -78.58 48.54 0.8 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.158 -0.964 . . . . 61.009999999999998 109.709 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.572 HG22 ' O ' ' A' ' 66' ' ' HIS . 13.6 tt -144.81 166.72 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.094 -1.004 . . . . 71.329999999999998 109.344 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 71' ' ' VAL . 86.6 t -98.05 156.06 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.182 -0.949 . . . . 72.129999999999995 109.404 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.413 ' N ' HG12 ' A' ' 70' ' ' VAL . 4.9 t -142.63 120.86 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.286 -0.884 . . . . 54.210000000000001 108.816 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.529 ' HG ' HD11 ' A' ' 95' ' ' ILE . 2.4 mp -116.75 104.27 11.18 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.862 -0.792 . . . . 50.240000000000002 108.862 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 68.5 t -93.02 121.37 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 74.409999999999997 108.859 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.0 p -89.78 169.38 11.32 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.158 -0.964 . . . . 72.310000000000002 109.118 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.484 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 19.1 t -162.44 123.03 2.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.085 -1.01 . . . . 64.540000000000006 110.224 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 77' ' ' ASN . 54.1 p30 -78.49 -9.97 59.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.428 -0.795 . . . . 74.129999999999995 109.116 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 79' ' ' THR . 27.6 m120 -128.7 64.95 71.09 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.891 -0.781 . . . . 73.340000000000003 108.891 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -49.44 88.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.093 1.862 . . . . 63.219999999999999 111.871 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.425 ' N ' ' O ' ' A' ' 77' ' ' ASN . 24.5 m -105.83 149.24 26.68 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.706 -0.849 . . . . 62.530000000000001 108.706 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.3 -33.11 74.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 73.439999999999998 109.329 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.422 ' H ' HG22 ' A' ' 79' ' ' THR . 84.4 tt0 -61.18 -38.73 87.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 71.420000000000002 109.363 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.422 ' OE1' ' OH ' ' A' ' 94' ' ' TYR . 85.1 tt0 -75.76 -31.81 59.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 73.430000000000007 109.498 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.51 -51.44 65.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 74.219999999999999 109.741 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.469 HG23 ' N ' ' A' ' 85' ' ' HIS . 31.4 m -63.98 -42.82 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 73.200000000000003 109.605 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.622 ' CE1' ' NE2' ' A' ' 89' ' ' GLN . 7.0 t-80 -64.06 -32.54 74.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.186 -0.946 . . . . 53.329999999999998 109.509 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.37 -37.88 80.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 64.109999999999999 110.091 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -83.48 -36.93 23.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.053 -1.029 . . . . 74.340000000000003 109.294 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.85 -34.04 77.05 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.293 -0.879 . . . . 74.420000000000002 109.504 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.622 ' NE2' ' CE1' ' A' ' 85' ' ' HIS . 87.8 mt-30 -80.08 -60.03 2.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 74.239999999999995 109.776 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 157.36 59.12 0.01 OUTLIER Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.672 -1.252 . . . . 61.509999999999998 110.22 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.44 125.48 51.81 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.402 -1.058 . . . . 55.329999999999998 108.89 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 20.6 t70 -69.65 -35.59 75.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.002 -1.061 . . . . 73.420000000000002 109.271 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 67.9 m-20 -151.3 161.5 42.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.338 -0.851 . . . . 75.040000000000006 109.442 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.484 ' OH ' ' CB ' ' A' ' 75' ' ' SER . 86.9 t80 -134.98 119.19 17.68 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.563 -0.902 . . . . 71.329999999999998 108.563 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.699 ' H ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -125.42 148.6 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 CA-C-O 121.701 0.762 . . . . 71.129999999999995 110.7 -178.191 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.51 133.77 49.07 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.822 -1.177 . . . . 64.319999999999993 107.822 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.682 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -53.67 -55.3 36.81 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 120.907 -1.12 . . . . 62.200000000000003 111.824 -178.794 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.5 Cg_endo -41.01 -10.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 120.943 1.095 . . . . 73.109999999999999 113.19 -175.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.682 ' N ' ' O ' ' A' ' 97' ' ' LYS . 56.8 m-85 58.99 118.89 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.661 -0.649 . . . . 65.219999999999999 109.802 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 46.7 mtt-85 -62.6 -41.68 99.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.824 -1.172 . . . . 72.349999999999994 109.528 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.762 ' O ' ' N ' ' A' ' 103' ' ' LYS . 44.5 t -165.92 31.13 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.0 -1.062 . . . . 71.319999999999993 110.75 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.3 mt 50.39 -70.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 118.588 0.631 . . . . 75.430000000000007 110.208 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.762 ' N ' ' O ' ' A' ' 101' ' ' SER . 9.1 mtpm? -53.47 -32.81 51.78 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.062 -1.088 . . . . 71.409999999999997 108.062 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.29 -52.13 60.09 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.439 -0.948 . . . . 63.240000000000002 108.439 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.0 tp -58.21 -41.4 83.96 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.518 -0.919 . . . . 73.219999999999999 108.518 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.539 HG11 ' HZ2' ' A' ' 23' ' ' LYS . 84.1 t -61.99 -37.37 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.25 -0.906 . . . . 60.109999999999999 108.669 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.4 -35.49 70.1 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.345 -0.847 . . . . 70.420000000000002 108.9 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.527 ' NE ' ' OE2' ' B' ' 83' ' ' GLU . 93.8 mtt180 -79.86 -26.76 40.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.371 -0.831 . . . . 74.409999999999997 109.974 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.9 mt -80.3 -38.52 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.053 -1.029 . . . . 62.539999999999999 109.476 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -72.72 -36.88 67.89 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.236 -0.915 . . . . 74.340000000000003 109.207 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.23 -46.46 83.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.341 -0.849 . . . . 73.319999999999993 109.226 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.99 -39.36 81.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 52.409999999999997 108.793 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.439 HD23 ' C ' ' A' ' 113' ' ' LEU . 3.7 tt -142.43 80.87 1.72 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.254 -0.904 . . . . 65.239999999999995 108.781 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.526 ' O ' ' CG ' ' A' ' 115' ' ' PHE . 86.2 mtm180 -65.88 -43.42 88.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 64.450000000000003 109.927 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.526 ' CG ' ' O ' ' A' ' 114' ' ' ARG . 96.3 m-85 -158.39 -84.98 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.159 -0.963 . . . . 74.430000000000007 109.581 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 83.7 t90 -154.16 154.12 33.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 74.420000000000002 109.442 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 158.17 65.72 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.443 -1.463 . . . . 75.040000000000006 109.443 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 83.0 p -156.76 96.9 1.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.296 -1.12 . . . . 61.140000000000001 109.48 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 128' ' ' ILE . 21.8 t-20 -154.69 174.22 15.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.296 -0.877 . . . . 65.239999999999995 109.314 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.489 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 4.2 t -142.59 -35.56 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.286 -0.884 . . . . 73.109999999999999 109.139 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 20.8 mm -104.7 126.45 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.338 -0.851 . . . . 72.239999999999995 109.179 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -139.53 120.99 15.07 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.361 -0.837 . . . . 72.340000000000003 109.336 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.4 ' O ' ' C ' ' A' ' 124' ' ' GLY . 10.2 pt -150.18 135.47 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.268 -0.895 . . . . 71.439999999999998 109.373 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 123' ' ' ILE . . . 43.87 -145.34 1.58 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.991 -1.244 . . . . 73.400000000000006 109.991 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -85.44 1.04 50.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -1.165 . . . . 74.450000000000003 109.274 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.45 131.42 38.66 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.39 -0.967 . . . . 54.210000000000001 108.39 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 51.3 m -131.08 133.79 46.0 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.437 -0.789 . . . . 54.5 109.62 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.518 ' O ' ' ND2' ' A' ' 119' ' ' ASN . 72.4 mt -131.95 133.81 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.473 -0.767 . . . . 45.149999999999999 109.147 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.505 ' OG ' ' ND2' ' A' ' 119' ' ' ASN . 70.9 m -119.73 85.01 32.41 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.651 -0.655 . . . . 71.109999999999999 109.581 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.43 -44.7 47.07 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.398 2.065 . . . . 65.409999999999997 111.886 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -61.81 -41.96 98.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 63.32 109.308 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -80.67 -8.16 59.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.301 -0.874 . . . . 72.519999999999996 108.78 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 56.24 59.75 3.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.417 -0.802 . . . . 75.329999999999998 109.552 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -155.85 134.63 11.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.206 -0.934 . . . . 71.230000000000004 109.62 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 97.6 mt -107.84 140.64 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.563 -0.711 . . . . 74.019999999999996 109.33 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.6 mp -128.35 122.15 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.397 -0.814 . . . . 60.229999999999997 109.613 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -138.69 140.23 38.71 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.814 -0.809 . . . . 62.32 108.814 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.418 ' HZ2' ' HB3' ' A' ' 138' ' ' LYS . 14.8 mtpp 54.12 25.51 5.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.434 -0.791 . . . . 75.400000000000006 110.055 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.01 -7.85 58.76 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.985 -1.246 . . . . 72.239999999999995 109.985 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -88.64 128.07 35.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.087 -1.243 . . . . 71.219999999999999 109.056 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -97.97 139.0 34.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.33 -0.856 . . . . 71.420000000000002 109.636 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 13.5 p -136.76 138.75 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.461 -0.774 . . . . 53.020000000000003 109.072 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -93.86 140.92 29.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.255 -0.903 . . . . 60.450000000000003 109.543 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.02 154.01 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.303 -0.873 . . . . 74.439999999999998 109.322 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -171.08 43.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.116 -0.99 . . . . 65.150000000000006 109.899 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -164.03 -110.53 0.24 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.555 -1.418 . . . . 73.340000000000003 109.555 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.622 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 23.2 mmtp -73.29 -35.54 2.76 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.255 -1.144 . . . . 72.219999999999999 110.479 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 95.3 Cg_endo -91.4 21.96 0.74 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.464 2.109 . . . . 65.230000000000004 112.011 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -129.33 -55.54 1.17 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.56 -0.713 . . . . 60.109999999999999 109.748 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -58.61 -58.09 10.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.161 -0.962 . . . . 64.209999999999994 110.552 -178.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.6 -33.27 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.954 -1.091 . . . . 72.019999999999996 109.672 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.499 HD23 ' HA ' ' A' ' 148' ' ' PRO . 3.4 mm? -63.12 -41.68 99.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.062 -1.024 . . . . 73.310000000000002 108.676 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.6 p -74.5 -32.18 62.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.252 -0.905 . . . . 74.310000000000002 109.943 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -58.16 -50.87 72.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.172 -0.955 . . . . 74.310000000000002 109.61 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.7 pp -76.08 -26.09 56.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 75.340000000000003 109.791 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.58 -45.98 77.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 62.140000000000001 109.325 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -76.59 -44.24 35.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.195 -0.941 . . . . 61.030000000000001 108.936 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -82.41 26.43 0.56 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.514 -0.741 . . . . 74.120000000000005 109.244 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -49.66 -29.93 8.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.377 -0.827 . . . . 71.129999999999995 109.855 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 42.9 p30 -123.9 74.84 1.31 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.534 -0.728 . . . . 75.450000000000003 109.198 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 162' ' ' ILE . 13.8 tm0? -171.21 152.77 3.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.9 . . . . 73.409999999999997 109.517 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.511 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 71.4 mt -83.63 122.15 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.172 -0.955 . . . . 74.409999999999997 109.439 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.5 t -112.59 137.82 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.534 -0.729 . . . . 72.310000000000002 109.761 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 29.6 t -94.78 155.79 16.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.358 -0.839 . . . . 74.120000000000005 109.453 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.467 ' CB ' ' NZ ' ' A' ' 165' ' ' LYS . 8.7 mtpm? -56.92 -43.48 81.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 70.430000000000007 109.64 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -55.24 -37.14 66.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.923 . . . . 73.519999999999996 109.446 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -59.57 -41.91 91.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -0.939 . . . . 74.519999999999996 109.444 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 26.3 mt -63.65 -33.17 75.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.2 -0.938 . . . . 72.310000000000002 109.315 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.482 HD23 ' C ' ' A' ' 169' ' ' LEU . 5.6 tt -64.71 -55.61 18.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.298 -0.876 . . . . 53.329999999999998 109.589 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -71.63 -32.6 68.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.256 -0.902 . . . . 62.439999999999998 110.295 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.414 ' C ' HD12 ' A' ' 172' ' ' ILE . . . -58.52 -47.8 82.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.049 -1.032 . . . . 60.210000000000001 110.036 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.683 ' N ' HD12 ' A' ' 172' ' ' ILE . 1.9 mp -96.96 -65.17 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.2 -0.938 . . . . 75.319999999999993 108.85 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.422 -0.799 . . . . 73.140000000000001 109.394 -179.892 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 49.2 p-10 . . . . . 0 N--CA 1.497 1.88 0 N-CA-C 109.765 -0.457 . . . . 64.540000000000006 109.765 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 35.9 m -130.46 -4.18 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.38 -0.825 . . . . 74.019999999999996 109.759 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 184' ' ' ILE . 1.9 mp -66.33 -29.35 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.949 -1.095 . . . . 72.329999999999998 109.141 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -61.7 -42.83 99.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 74.400000000000006 109.611 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 19.0 m -79.54 -28.49 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.09 -1.006 . . . . 70.420000000000002 109.379 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.51 -42.17 65.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.864 . . . . 52.109999999999999 109.795 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.418 HG23 HD22 ' A' ' 189' ' ' ASN . 10.5 tp -74.94 -29.95 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.986 -1.071 . . . . 71.400000000000006 109.314 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.418 HD22 HG23 ' A' ' 188' ' ' ILE . 3.5 m120 -70.64 -43.94 68.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.845 . . . . 73.439999999999998 110.099 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -75.56 -40.9 56.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.131 -0.981 . . . . 71.420000000000002 110.135 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 74.9 mt -60.47 -36.49 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.014 -1.054 . . . . 61.549999999999997 109.561 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 18.9 mtp-105 -71.38 -40.16 70.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.035 -1.041 . . . . 63.340000000000003 108.656 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -68.05 -35.2 77.84 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.577 -0.702 . . . . 61.240000000000002 109.133 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.411 ' O ' ' CD ' ' A' ' 198' ' ' PRO . 50.7 mtpt -85.19 -8.31 58.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.349 -0.844 . . . . 75.129999999999995 109.737 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 51.1 ttm -92.84 -57.21 2.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.185 -0.947 . . . . 74.019999999999996 109.559 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -59.12 -32.48 69.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 74.019999999999996 110.011 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.437 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 54.1 mttt -57.13 -65.64 1.64 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.035 -1.041 . . . . 75.430000000000007 109.847 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 42.4 Cg_endo -64.77 -57.99 0.25 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 122.306 2.004 . . . . 72.319999999999993 112.546 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 15.3 mt -61.15 -42.75 99.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -0.958 . . . . 74.540000000000006 109.963 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 86.62 -37.63 3.15 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.78 -1.328 . . . . 61.509999999999998 109.78 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.741 ' N ' HD12 ' A' ' 201' ' ' ILE . 1.7 mp -92.41 141.53 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.132 -1.217 . . . . 61.219999999999999 109.371 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 59.5 p -85.55 145.23 27.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.888 . . . . 72.0 109.274 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.1 p -146.59 27.25 1.11 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.253 -0.904 . . . . 74.439999999999998 109.485 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 204' ' ' VAL . 29.5 m -143.97 134.21 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.169 -0.957 . . . . 64.349999999999994 109.518 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -108.58 126.16 52.64 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.536 -0.727 . . . . 71.409999999999997 109.296 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.35 119.69 32.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.116 -0.99 . . . . 73.519999999999996 109.226 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 211' ' ' GLY . 34.9 m -147.82 140.74 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.224 -0.922 . . . . 71.019999999999996 109.616 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 75.1 ttt-85 -62.62 -25.51 68.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.85 . . . . 72.120000000000005 109.373 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 211' ' ' GLY . 76.1 mtt85 -47.17 103.92 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 64.409999999999997 109.786 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 60.51 -75.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.591 -0.693 . . . . 71.540000000000006 109.844 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . -158.41 -127.77 0.96 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.838 -1.305 . . . . 72.030000000000001 109.838 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -101.53 142.21 33.24 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.407 -1.054 . . . . 75.540000000000006 109.436 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -106.43 126.57 52.41 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.478 -0.764 . . . . 75.310000000000002 109.686 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -98.04 128.36 44.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.389 -0.82 . . . . 75.409999999999997 109.034 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 34.0 m -151.78 154.94 37.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.498 -0.751 . . . . 74.140000000000001 109.137 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . 0.45 ' O ' ' O ' ' A' ' 217' ' ' PRO . 7.4 p90 -65.14 153.14 89.95 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.153 -0.967 . . . . 75.319999999999993 109.279 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 216' ' ' TYR . 84.2 Cg_exo . . . . . 0 N--CA 1.493 1.479 0 C-N-CA 122.269 1.979 . . . . 73.109999999999999 112.408 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 52.5 ttm . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.487 -0.56 . . . . 71.140000000000001 109.487 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -139.87 148.78 42.56 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.303 -0.873 . . . . 73.230000000000004 109.354 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 93.6 t -113.91 137.71 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.583 -0.698 . . . . 72.239999999999995 109.452 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.499 HD11 ' CG1' ' B' ' 6' ' ' ILE . 3.5 tp -109.89 119.66 40.04 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.555 -0.716 . . . . 54.329999999999998 109.735 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.483 ' N ' HD12 ' B' ' 4' ' ' LEU . 15.3 mt -117.23 96.33 5.38 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 108.615 -0.883 . . . . 74.349999999999994 108.615 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.689 HD12 ' HB ' ' B' ' 50' ' ' VAL . 87.2 mt -82.93 98.88 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.703 -1.248 . . . . 42.549999999999997 109.049 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.425 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 38.8 tp10 -130.78 129.72 42.8 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.506 -0.746 . . . . 74.519999999999996 109.556 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -64.96 -38.96 92.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.314 -0.866 . . . . 62.549999999999997 109.332 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -83.8 116.63 22.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 73.109999999999999 109.471 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 23.4 m -66.73 -27.01 67.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.9 . . . . 65.540000000000006 109.795 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -66.99 -51.56 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.15 -0.969 . . . . 75.549999999999997 109.844 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.538 ' N ' HD12 ' B' ' 12' ' ' LEU . 7.9 mp -62.96 -39.07 93.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.172 -0.955 . . . . 70.140000000000001 109.62 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.05 -29.34 64.9 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 108.551 -1.82 . . . . 75.400000000000006 108.551 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.91 -49.84 68.9 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.674 -1.37 . . . . 65.439999999999998 109.674 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -61.96 -46.98 86.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.309 -1.112 . . . . 60.210000000000001 109.786 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.556 HD11 ' CD1' ' B' ' 99' ' ' TYR . 5.7 mm -63.98 -40.14 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.757 -1.214 . . . . 75.150000000000006 108.632 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.505 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 73.1 tt0 -63.07 -44.27 96.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.412 -0.805 . . . . 73.010000000000005 109.554 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -85.53 1.55 48.49 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.071 -1.018 . . . . 74.299999999999997 109.588 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.93 -57.3 1.94 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.376 -1.49 . . . . 70.540000000000006 109.376 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.417 HD23 ' N ' ' B' ' 21' ' ' ASN . 1.4 pt? -71.31 -20.85 62.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.424 -1.044 . . . . 71.340000000000003 109.648 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 89.6 m-20 -57.98 -30.81 66.33 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.992 -1.067 . . . . 64.409999999999997 109.278 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 92.9 t -59.05 -37.3 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.344 -0.847 . . . . 74.230000000000004 109.142 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -65.52 -21.4 66.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.371 -0.83 . . . . 63.420000000000002 109.398 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.32 39.87 2.52 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 110.11 -1.196 . . . . 53.43 110.11 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -120.2 160.98 21.85 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.474 -1.015 . . . . 71.120000000000005 109.208 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 3.8 mtt -100.45 139.84 35.56 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.262 -1.014 . . . . 75.239999999999995 108.262 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.43 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -143.95 154.45 43.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.225 -0.922 . . . . 72.120000000000005 110.37 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 96.9 m-20 -138.87 155.01 48.44 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.173 -1.047 . . . . 72.310000000000002 108.173 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.43 139.74 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.338 -0.851 . . . . 64.430000000000007 109.985 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.5 p -130.47 171.08 13.38 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 109.144 -0.687 . . . . 65.409999999999997 109.144 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.42 ' OE2' ' OD2' ' B' ' 35' ' ' ASP . 5.4 pt-20 -91.69 -106.11 0.1 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.178 -0.951 . . . . 71.019999999999996 109.873 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 77.7 p -78.11 166.94 22.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.223 -0.923 . . . . 51.109999999999999 110.073 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 53.5 mt -51.34 -30.86 19.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.586 -0.696 . . . . 71.239999999999995 109.945 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.87 -51.01 65.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.092 -1.005 . . . . 74.319999999999993 109.885 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.42 ' OD2' ' OE2' ' B' ' 31' ' ' GLU . 2.3 m-20 -63.58 -39.44 94.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.121 -0.987 . . . . 73.030000000000001 109.264 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.81 -38.4 76.15 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.253 -1.539 . . . . 30.210000000000001 109.253 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -67.18 -38.36 85.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -1.113 . . . . 74.420000000000002 109.573 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -80.52 -36.93 32.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.155 -0.965 . . . . 74.420000000000002 109.661 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 10.5 tp -71.29 -42.67 68.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 75.409999999999997 110.091 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . 0.443 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.3 ppp? -67.54 -25.26 65.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.039 -1.038 . . . . 60.409999999999997 109.977 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -60.62 -39.84 89.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.046 -1.034 . . . . 53.229999999999997 110.161 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 14.7 pt -81.21 -32.01 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.006 -1.059 . . . . 71.230000000000004 110.202 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' B' ' 40' ' ' MET . 25.2 mmt180 -130.28 141.52 50.6 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.297 -0.877 . . . . 72.219999999999999 109.548 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' ASN . . . . . 0.553 HD21 HD11 ' B' ' 69' ' ' ILE . 58.3 t30 -98.48 132.71 43.7 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.28 -0.887 . . . . 63.539999999999999 109.437 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -102.37 138.28 39.51 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.353 -0.842 . . . . 64.349999999999994 109.513 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -75.82 -34.5 60.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 62.219999999999999 109.189 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.497 ' C ' HD13 ' B' ' 47' ' ' LEU . 0.8 OUTLIER -112.38 110.59 20.89 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.645 -0.872 . . . . 73.120000000000005 108.645 179.662 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.449 ' N ' HD13 ' B' ' 47' ' ' LEU . 54.5 t -95.52 100.85 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.369 -0.832 . . . . 65.109999999999999 109.124 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.509 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 0.6 OUTLIER -114.93 129.54 56.73 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.2 -0.667 . . . . 73.439999999999998 109.2 -179.659 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.689 ' HB ' HD12 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -144.69 132.29 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.457 -0.777 . . . . 34.5 109.233 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . 0.425 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 24.9 p -94.57 11.57 30.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.392 -0.818 . . . . 73.209999999999994 109.662 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.608 ' H ' HG22 ' B' ' 50' ' ' VAL . 35.9 m-20 -80.61 138.65 36.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.147 -0.971 . . . . 70.409999999999997 109.515 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.439 ' C ' ' H ' ' B' ' 55' ' ' ALA . 62.3 mttp -74.92 -38.53 61.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.206 -0.934 . . . . 65.0 110.029 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -71.03 9.9 0.64 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.171 -0.955 . . . . 75.209999999999994 109.619 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -66.4 -21.77 66.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 55.329999999999998 110.134 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 33.3 mt -42.82 -40.16 2.77 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.397 -0.814 . . . . 63.140000000000001 110.33 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 13.0 t -76.32 -39.97 52.64 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.946 -1.096 . . . . 63.5 109.563 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -65.1 -43.14 93.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.332 -0.855 . . . . 72.329999999999998 110.307 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.42 HG23 ' N ' ' B' ' 60' ' ' SER . 34.3 m -67.37 -37.62 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.697 -1.252 . . . . 74.540000000000006 109.509 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . 0.42 ' N ' HG23 ' B' ' 59' ' ' VAL . 40.4 m -55.24 -48.66 73.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 71.239999999999995 109.439 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.405 HH21 ' NZ ' ' B' ' 65' ' ' LYS . 13.3 ptm180 -69.57 -34.41 74.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.115 -0.99 . . . . 74.310000000000002 110.134 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' B' ' 66' ' ' HIS . 5.4 mm -64.52 -40.33 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.785 -1.197 . . . . 72.140000000000001 109.8 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.521 ' NZ ' ' OD1' ' B' ' 92' ' ' ASP . 44.4 mmtt -65.44 -48.81 71.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.157 -0.964 . . . . 73.319999999999993 110.459 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -73.01 -37.54 66.92 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.841 -1.162 . . . . 73.120000000000005 110.035 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.47 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 46.4 mtpt -80.22 -22.04 42.22 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.11 -0.994 . . . . 72.439999999999998 109.757 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.47 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 81.6 m-70 -155.68 65.92 0.61 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.136 -0.977 . . . . 63.310000000000002 109.623 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 9.7 t -60.44 -27.78 67.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 73.099999999999994 109.793 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 84.4 p -65.27 -24.82 67.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -0.92 . . . . 71.530000000000001 110.169 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.553 HD11 HD21 ' B' ' 44' ' ' ASN . 79.9 mt -79.81 152.89 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.103 -0.998 . . . . 74.400000000000006 109.677 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.469 HG12 ' N ' ' B' ' 71' ' ' VAL . 69.4 t -92.44 159.44 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.287 -0.883 . . . . 75.120000000000005 109.468 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.469 ' N ' HG12 ' B' ' 70' ' ' VAL . 11.7 t -137.96 120.92 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.184 -0.947 . . . . 73.200000000000003 109.877 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.509 ' O ' ' SD ' ' B' ' 49' ' ' MET . 0.7 OUTLIER -111.04 105.12 13.77 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.16 -1.052 . . . . 73.340000000000003 108.16 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 94.6 t -95.68 131.9 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.107 -0.996 . . . . 73.5 109.535 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.08 162.38 13.42 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.434 -0.791 . . . . 64.340000000000003 109.103 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.495 ' CB ' ' HH ' ' B' ' 94' ' ' TYR . 25.1 p -153.92 136.64 15.24 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.96 -1.087 . . . . 74.530000000000001 110.646 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -90.43 4.42 51.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.372 -0.83 . . . . 64.5 109.119 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' B' ' 79' ' ' THR . 65.5 m-80 -142.31 68.5 21.52 Favored Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 108.663 -0.865 . . . . 74.25 108.663 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -54.71 79.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.347 2.031 . . . . 74.430000000000007 111.235 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.503 ' N ' ' O ' ' B' ' 77' ' ' ASN . 37.2 p -103.28 152.49 21.46 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.053 -0.721 . . . . 73.120000000000005 109.053 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -31.4 71.42 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.262 -0.899 . . . . 71.010000000000005 109.387 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -63.34 -48.24 78.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 63.200000000000003 109.493 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -71.7 -27.11 62.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 73.219999999999999 109.372 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.527 ' OE2' ' NE ' ' A' ' 108' ' ' ARG . 86.9 tt0 -63.03 -55.6 24.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.883 . . . . 74.299999999999997 109.887 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.401 HG23 ' N ' ' B' ' 85' ' ' HIS . 22.9 m -61.93 -40.29 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.058 -1.026 . . . . 73.310000000000002 109.423 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' HIS . . . . . 0.401 ' N ' HG23 ' B' ' 84' ' ' VAL . 21.5 m170 -64.71 -31.69 73.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.166 -0.959 . . . . 73.239999999999995 109.483 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.48 -45.87 81.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.918 . . . . 55.329999999999998 110.256 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -79.87 -34.51 39.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.031 -1.043 . . . . 74.140000000000001 109.433 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -70.78 -40.33 72.66 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.248 -0.908 . . . . 64.040000000000006 109.57 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -65.12 -52.16 57.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -0.965 . . . . 72.349999999999994 109.412 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.24 59.43 0.02 OUTLIER Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.188 -1.165 . . . . 65.200000000000003 110.188 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.88 136.18 53.62 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.435 -1.039 . . . . 52.229999999999997 109.075 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.521 ' OD1' ' NZ ' ' B' ' 63' ' ' LYS . 24.6 m-20 -82.16 -20.8 37.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.09 -1.006 . . . . 73.319999999999993 109.525 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -153.3 164.6 37.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 72.219999999999999 109.655 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.495 ' HH ' ' CB ' ' B' ' 75' ' ' SER . 76.1 t80 -145.14 97.26 2.98 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.745 -0.835 . . . . 64.420000000000002 108.745 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 0.4 HD12 ' NH1' ' B' ' 108' ' ' ARG . 19.0 mm -104.73 142.01 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 121.163 -0.961 . . . . 72.230000000000004 109.928 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' B' ' 97' ' ' LYS . . . -60.74 124.29 19.99 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.467 -1.308 . . . . 25.239999999999998 107.467 178.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' B' ' 99' ' ' TYR . 2.1 tptt -43.35 -61.04 2.03 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.058 -1.026 . . . . 64.319999999999993 110.726 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 9.3 Cg_endo -45.02 89.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 120.566 0.844 . . . . 63.329999999999998 110.489 -176.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . 0.582 ' N ' ' O ' ' B' ' 97' ' ' LYS . 45.4 m-85 -39.75 97.76 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.229 0.537 . . . . 75.129999999999995 111.128 -176.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -53.27 -33.43 53.11 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.521 -1.288 . . . . 74.230000000000004 107.521 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 32.5 t -176.18 128.03 0.21 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.274 -1.01 . . . . 63.340000000000003 108.274 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 19.6 mm -51.68 -36.22 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.017 -1.052 . . . . 74.439999999999998 108.903 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.518 ' O ' ' HB2' ' B' ' 107' ' ' ALA . 11.8 mptt -67.23 -34.47 77.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.358 -0.839 . . . . 71.109999999999999 109.407 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.53 -58.72 3.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.241 -0.912 . . . . 71.450000000000003 109.771 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.702 HD13 ' C ' ' B' ' 105' ' ' LEU . 1.9 tm? -54.46 -53.33 55.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 51.310000000000002 109.275 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . 0.475 ' N ' HD13 ' B' ' 105' ' ' LEU . 88.3 t -61.62 -42.47 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.987 -1.071 . . . . 65.230000000000004 109.37 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' B' ' 103' ' ' LYS . . . -51.82 -38.28 55.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.137 -0.977 . . . . 24.32 108.907 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . 0.4 ' NH1' HD12 ' B' ' 95' ' ' ILE . 80.7 mtt180 -70.25 -34.7 73.14 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.354 -0.841 . . . . 75.310000000000002 109.441 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 86.3 mt -75.93 -26.59 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.14 -0.975 . . . . 54.240000000000002 108.788 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -76.6 -57.78 3.66 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.458 -0.776 . . . . 65.310000000000002 109.618 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.51 -44.84 73.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 72.239999999999995 109.961 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -59.83 4.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.113 -0.992 . . . . 72.040000000000006 109.646 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 30.4 tp -60.61 -35.52 76.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.11 -0.994 . . . . 75.349999999999994 109.763 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.45 ' O ' ' CB ' ' B' ' 115' ' ' PHE . 14.1 mmt180 -53.62 160.3 1.33 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.073 -1.017 . . . . 75.5 109.252 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 115' ' ' PHE . . . . . 0.45 ' CB ' ' O ' ' B' ' 114' ' ' ARG . 4.9 t80 75.6 -4.15 2.43 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.519 -0.738 . . . . 65.329999999999998 109.535 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER 54.26 -171.76 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 74.450000000000003 109.773 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -92.92 5.1 75.9 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.487 -1.445 . . . . 44.210000000000001 109.487 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 11.8 t 49.57 -174.33 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.492 -1.005 . . . . 71.400000000000006 109.854 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.73 141.74 23.0 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.424 -0.797 . . . . 72.319999999999993 109.336 -178.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 23.8 t -86.87 -44.11 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.187 -0.945 . . . . 75.019999999999996 109.854 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 3.6 mm -117.5 154.37 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.238 -0.914 . . . . 51.409999999999997 109.434 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -143.62 130.85 20.8 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.325 -0.859 . . . . 71.530000000000001 109.049 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 17.8 mt -135.47 108.33 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.18 -0.95 . . . . 72.430000000000007 109.896 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . 0.457 ' C ' ' H ' ' B' ' 126' ' ' LEU . . . 56.02 -155.41 12.58 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.229 -1.148 . . . . 51.229999999999997 110.229 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.99 -0.56 0.52 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.477 -1.013 . . . . 74.200000000000003 109.644 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.457 ' H ' ' C ' ' B' ' 124' ' ' GLY . 1.7 mt -94.22 148.6 22.04 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.237 -0.914 . . . . 75.420000000000002 109.405 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 7.0 m -126.33 132.33 51.64 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.109 -1.071 . . . . 74.219999999999999 108.109 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 88.8 mt -121.05 131.03 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.348 -0.845 . . . . 60.329999999999998 110.69 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 64.9 m -128.86 101.84 19.86 Favored Pre-proline 0 N--CA 1.495 1.824 0 N-CA-C 108.858 -0.793 . . . . 72.310000000000002 108.858 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -81.87 -40.32 0.15 Allowed 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.092 1.862 . . . . 75.129999999999995 111.918 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -52.97 -33.4 51.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.132 -0.98 . . . . 75.230000000000004 108.881 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -104.39 4.02 32.94 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.504 -0.747 . . . . 72.430000000000007 109.499 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . 0.433 ' OE1' ' CD2' ' B' ' 149' ' ' PHE . 49.0 mm-40 49.77 59.58 4.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.124 -0.985 . . . . 75.129999999999995 109.3 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . 0.686 ' C ' HD12 ' B' ' 135' ' ' ILE . 33.6 ttmt -151.51 145.46 25.2 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.223 -0.923 . . . . 73.219999999999999 109.726 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . 0.686 HD12 ' C ' ' B' ' 134' ' ' LYS . 4.5 mp -137.81 133.49 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 108.782 -0.821 . . . . 64.140000000000001 108.782 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 4.7 mm -107.18 137.1 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.533 -0.73 . . . . 71.219999999999999 109.606 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -126.04 130.97 52.2 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.181 -1.044 . . . . 64.219999999999999 108.181 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . 0.651 ' NZ ' ' HE ' ' B' ' 140' ' ' ARG . 23.3 ttpp 55.36 14.92 1.21 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.499 -0.751 . . . . 72.019999999999996 109.762 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.91 -0.11 66.74 Favored Glycine 0 N--CA 1.496 2.684 0 O-C-N 120.927 -1.108 . . . . 74.319999999999993 110.505 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . 0.651 ' HE ' ' NZ ' ' B' ' 138' ' ' LYS . 17.5 mtt-85 -89.94 137.27 32.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.208 -1.172 . . . . 75.340000000000003 108.449 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -82.94 126.98 33.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 71.230000000000004 110.419 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 39.9 t -126.81 128.81 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.912 -0.773 . . . . 70.430000000000007 108.912 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -94.2 147.28 23.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.978 -1.076 . . . . 72.430000000000007 109.228 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 144' ' ' VAL . . . . . 0.852 ' H ' ' HZ2' ' B' ' 145' ' ' LYS . 2.4 t -142.16 115.41 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.217 -0.927 . . . . 72.129999999999995 108.95 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . 0.852 ' HZ2' ' H ' ' B' ' 144' ' ' VAL . 0.1 OUTLIER -145.28 140.17 27.62 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.278 -0.888 . . . . 72.019999999999996 109.742 179.886 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 111.54 -114.39 3.62 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 110.666 -0.973 . . . . 42.229999999999997 110.666 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . 0.615 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 6.6 ttpm? -95.34 -29.82 0.27 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.57 -0.959 . . . . 73.299999999999997 112.42 -178.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 57.0 Cg_endo -80.47 -17.78 9.92 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 C-N-CA 121.482 1.455 . . . . 71.329999999999998 113.0 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . 0.433 ' CD2' ' OE1' ' B' ' 133' ' ' GLU . 1.1 p90 -85.54 -37.85 19.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.93 -1.107 . . . . 74.230000000000004 109.215 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . 0.426 ' N ' ' CG ' ' B' ' 149' ' ' PHE . 3.3 tm-20 -60.34 -46.7 88.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.533 -0.729 . . . . 72.340000000000003 109.974 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.428 HG13 ' N ' ' B' ' 152' ' ' LEU . 8.8 p -68.89 -40.65 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.864 -1.148 . . . . 73.349999999999994 110.102 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.497 ' C ' HD23 ' B' ' 152' ' ' LEU . 4.7 tt -66.65 -54.91 18.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.296 -0.877 . . . . 55.240000000000002 109.679 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 16.0 p -64.76 -32.44 74.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.004 -1.06 . . . . 70.010000000000005 110.555 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -59.2 -59.58 5.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.947 -1.095 . . . . 65.319999999999993 109.927 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . 0.81 HD13 ' CE2' ' B' ' 214' ' ' PHE . 1.9 pp -69.3 -21.48 63.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.028 -1.045 . . . . 71.540000000000006 109.946 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.89 -52.98 61.9 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.014 -1.054 . . . . 75.319999999999993 109.334 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . 0.458 ' C ' ' H ' ' B' ' 159' ' ' ARG . 16.5 mtm-85 -71.95 -51.62 21.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.18 -0.95 . . . . 73.319999999999993 109.79 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -74.79 36.19 0.11 Allowed 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.725 -0.79 . . . . 74.140000000000001 109.506 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . 0.458 ' H ' ' C ' ' B' ' 157' ' ' ARG . 30.2 ptt180 -59.91 166.05 2.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -0.86 . . . . 61.409999999999997 109.179 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 24.9 t70 43.66 64.24 1.32 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.253 -0.904 . . . . 72.099999999999994 109.88 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -157.3 159.21 37.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -0.965 . . . . 72.25 109.567 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 30.6 mt -93.77 114.02 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.218 -0.926 . . . . 72.310000000000002 109.139 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 4.0 m -115.13 129.78 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 121.527 0.679 . . . . 64.209999999999994 109.511 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 164' ' ' SER . . . . . 0.516 ' OG ' ' NE2' ' B' ' 167' ' ' GLN . 28.7 p -92.39 167.31 12.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -0.871 . . . . 74.219999999999999 109.125 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -51.69 -37.07 49.12 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.111 -0.993 . . . . 65.310000000000002 109.297 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -74.57 -25.46 59.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.146 -0.971 . . . . 63.450000000000003 110.559 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 167' ' ' GLN . . . . . 0.516 ' NE2' ' OG ' ' B' ' 164' ' ' SER . 0.0 OUTLIER -64.04 -56.14 17.17 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.618 -1.301 . . . . 72.400000000000006 108.792 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 47.1 mt -57.42 -57.21 13.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.102 -0.999 . . . . 72.319999999999993 108.916 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' B' ' 170' ' ' ASP . 1.9 mm? -50.55 -56.01 13.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.045 -1.034 . . . . 73.340000000000003 108.846 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' B' ' 169' ' ' LEU . 67.8 m-20 -41.69 -34.16 0.58 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.74 -0.6 . . . . 72.099999999999994 110.615 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -91.69 -37.72 12.86 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.102 -0.999 . . . . 62.130000000000003 110.729 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 0.429 ' N ' HD12 ' B' ' 172' ' ' ILE . 3.7 mp -88.09 -68.41 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.893 -1.129 . . . . 71.420000000000002 109.442 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 173' ' ' TRP . . . . . 0.476 ' C ' ' CD2' ' B' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.505 -0.747 . . . . 72.230000000000004 109.47 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo . . . . . 0 N--CA 1.491 1.371 0 CA-C-O 121.15 0.396 . . . . 65.219999999999999 111.874 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 182' ' ' ASN . . . . . 0.813 ' OD1' ' OE2' ' B' ' 185' ' ' GLU . 45.5 t-20 49.33 60.9 3.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.136 -0.978 . . . . 72.310000000000002 110.006 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 4.1 p -119.09 4.65 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 108.994 -0.743 . . . . 63.32 108.994 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.562 ' O ' HG22 ' B' ' 188' ' ' ILE . 35.2 mt -63.62 -53.53 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.058 -1.026 . . . . 75.030000000000001 109.914 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . 0.813 ' OE2' ' OD1' ' B' ' 182' ' ' ASN . 1.5 pm0 -61.5 -40.43 94.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 64.109999999999999 110.313 -178.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 97.2 t -73.99 -48.03 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.995 -1.066 . . . . 73.0 110.404 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -68.91 -47.27 66.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.059 -1.026 . . . . 61.119999999999997 110.704 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 188' ' ' ILE . . . . . 0.562 HG22 ' O ' ' B' ' 184' ' ' ILE . 7.5 tt -70.0 -36.6 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.741 -1.224 . . . . 72.430000000000007 110.917 -178.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -65.42 -47.61 75.65 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.945 -1.097 . . . . 65.140000000000001 109.144 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 190' ' ' GLN . . . . . 0.717 ' HB3' ' HZ3' ' B' ' 194' ' ' LYS . 35.9 mm-40 -66.58 -46.29 76.46 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.229 -0.92 . . . . 63.240000000000002 110.023 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 65.1 mt -54.45 -42.0 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.825 -1.172 . . . . 74.030000000000001 109.684 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 192' ' ' ARG . . . . . 0.413 ' CZ ' HG21 ' B' ' 206' ' ' THR . 24.1 mtp180 -59.94 -45.52 92.36 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.236 -0.915 . . . . 72.239999999999995 109.922 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -75.44 -32.86 60.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.223 -0.923 . . . . 73.099999999999994 110.159 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . 0.717 ' HZ3' ' HB3' ' B' ' 190' ' ' GLN . 39.1 mttp -71.84 -24.52 61.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.347 -0.846 . . . . 72.109999999999999 110.002 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 11.2 mtt -94.84 -12.14 27.53 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.036 -1.04 . . . . 44.329999999999998 109.473 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -102.03 -7.12 22.61 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.328 -0.857 . . . . 71.209999999999994 110.522 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . 0.457 ' N ' ' CD ' ' B' ' 198' ' ' PRO . 1.3 mmtt -95.77 -49.44 0.25 Allowed Pre-proline 0 N--CA 1.501 2.125 0 O-C-N 120.784 -1.198 . . . . 75.209999999999994 110.351 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 198' ' ' PRO . . . . . 0.509 ' CD ' ' O ' ' B' ' 194' ' ' LYS . 89.0 Cg_endo -83.97 -38.53 0.13 Allowed 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.279 1.986 . . . . 75.319999999999993 113.672 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 11.2 mt -75.73 -46.42 31.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.836 -1.165 . . . . 72.25 109.648 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 88.15 0.78 82.6 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.663 -1.775 . . . . 64.530000000000001 108.663 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 38.4 mt -125.53 125.62 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.583 -0.951 . . . . 44.229999999999997 109.296 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 27.3 p -85.78 137.16 32.99 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.836 -1.172 . . . . 54.009999999999998 107.836 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 67.7 p -137.98 11.73 2.86 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.109 -0.994 . . . . 74.400000000000006 110.125 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.46 128.37 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.304 -0.873 . . . . 72.120000000000005 109.407 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -90.85 109.41 20.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.465 -0.772 . . . . 65.409999999999997 108.922 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 206' ' ' THR . . . . . 0.413 HG21 ' CZ ' ' B' ' 192' ' ' ARG . 43.9 p -85.35 126.44 33.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.445 -0.784 . . . . 71.329999999999998 109.074 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 9.9 p -152.5 159.85 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.13 -0.982 . . . . 63.5 109.675 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -85.28 -38.97 18.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.154 -0.966 . . . . 74.450000000000003 109.914 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 209' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' B' ' 211' ' ' GLY . 80.5 mtm180 -55.85 150.69 12.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.021 -1.05 . . . . 74.140000000000001 109.512 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? 51.59 -90.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.215 -0.928 . . . . 74.430000000000007 108.805 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 211' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' B' ' 209' ' ' ARG . . . -171.79 -108.51 0.21 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.801 -1.719 . . . . 64.450000000000003 108.801 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 212' ' ' TYR . . . . . 0.474 ' CE1' HD13 ' B' ' 188' ' ' ILE . 72.0 m-85 -119.17 140.56 49.97 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.578 -0.954 . . . . 74.209999999999994 108.759 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -124.36 126.19 45.56 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.58 0.705 . . . . 74.030000000000001 110.106 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . 0.81 ' CE2' HD13 ' B' ' 155' ' ' LEU . 24.3 t80 -92.11 133.18 36.0 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.854 -0.795 . . . . 74.340000000000003 108.854 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 2.6 p -147.1 166.34 27.2 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.987 -1.071 . . . . 64.329999999999998 109.706 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -72.44 151.23 91.8 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.222 -0.924 . . . . 70.040000000000006 108.654 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.07 160.92 46.57 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.157 1.905 . . . . 65.109999999999999 111.718 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 22.0 mttm . . . . . 0 C--N 1.303 -1.445 0 O-C-N 121.276 -0.89 . . . . 73.150000000000006 109.335 179.955 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptp . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.451 -0.574 . . . . 65.120000000000005 109.451 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -141.68 160.18 40.7 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.299 -0.875 . . . . 72.329999999999998 109.453 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.4 t -118.34 125.35 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.169 -0.678 . . . . 71.420000000000002 109.169 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.405 ' O ' ' O ' ' A' ' 49' ' ' MET . 4.8 tp -99.31 115.1 28.39 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.497 -0.752 . . . . 65.120000000000005 109.212 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.0 tp -119.68 110.08 16.4 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.337 -0.986 . . . . 62.43 108.337 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.435 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 16.9 mt -92.73 109.18 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.899 -1.125 . . . . 71.150000000000006 109.595 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -152.54 120.09 6.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.166 -0.959 . . . . 75.340000000000003 109.673 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -65.16 -38.46 90.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 72.439999999999998 109.451 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -67.66 106.16 2.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 63.020000000000003 109.567 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 91.0 p -66.64 -26.33 67.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.316 -0.865 . . . . 72.340000000000003 109.551 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.64 -53.68 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.158 -0.964 . . . . 74.019999999999996 109.691 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.524 ' N ' HD12 ' A' ' 12' ' ' LEU . 7.9 mp -65.18 -36.45 84.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 71.430000000000007 109.552 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.92 -27.49 64.49 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.54 -1.824 . . . . 61.32 108.54 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.04 -49.72 61.09 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.441 -1.464 . . . . 71.200000000000003 109.441 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -61.59 -44.86 96.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -1.138 . . . . 71.319999999999993 109.55 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.5 mm -63.64 -39.08 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.743 -1.223 . . . . 63.229999999999997 108.281 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -64.42 -52.12 59.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.499 -0.75 . . . . 51.109999999999999 109.975 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -77.72 -2.77 37.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 73.340000000000003 109.566 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.42 -49.94 3.99 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 108.989 -1.644 . . . . 62.149999999999999 108.989 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pp -75.7 -28.96 58.83 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.433 -1.039 . . . . 73.510000000000005 109.234 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -51.65 -34.32 37.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.202 -0.936 . . . . 74.25 108.815 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.0 t -54.76 -47.38 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.523 -0.917 . . . . 70.040000000000006 108.523 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -54.35 -54.81 35.44 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.23 -1.026 . . . . 73.230000000000004 108.23 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 130.74 40.42 0.24 Allowed Glycine 0 N--CA 1.499 2.847 0 N-CA-C 110.636 -0.986 . . . . 75.540000000000006 110.636 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -118.91 159.67 23.37 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.19 -1.183 . . . . 73.430000000000007 108.694 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 11.7 mmt -97.65 138.35 35.18 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.211 -1.033 . . . . 43.240000000000002 108.211 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.95 160.12 40.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 62.109999999999999 109.784 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -142.03 151.55 42.53 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.781 -0.822 . . . . 74.420000000000002 108.781 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 t -106.03 134.7 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.706 -0.85 . . . . 72.150000000000006 108.706 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.3 p -129.7 163.46 26.09 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.517 -0.739 . . . . 71.420000000000002 109.356 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.435 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 2.8 pt-20 -92.22 -97.46 0.13 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.317 -0.865 . . . . 72.329999999999998 109.69 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.3 p -78.26 166.38 22.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 74.239999999999995 110.071 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.4 mt -55.02 -38.06 67.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.601 -0.687 . . . . 71.530000000000001 110.028 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -53.47 -43.22 67.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.168 -0.957 . . . . 74.230000000000004 110.061 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -63.92 -37.7 88.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.026 -1.046 . . . . 54.030000000000001 109.595 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.24 -45.72 11.09 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.914 -1.274 . . . . 61.409999999999997 109.914 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -61.82 -36.88 82.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -1.137 . . . . 74.340000000000003 109.88 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.443 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 64.6 t80 -80.07 -26.21 39.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.901 . . . . 75.329999999999998 110.249 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.8 tp -86.63 -32.57 20.51 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.031 -1.043 . . . . 74.329999999999998 110.223 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.485 ' SD ' ' OH ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -83.16 -34.12 26.07 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.088 -1.008 . . . . 70.319999999999993 110.79 -178.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 35.2 p-10 -57.7 -30.43 65.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.035 -1.041 . . . . 71.219999999999999 110.529 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.53 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 7.9 pt -85.03 -38.22 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.864 -1.148 . . . . 74.140000000000001 110.485 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.436 ' O ' ' O ' ' A' ' 40' ' ' MET . 97.8 mtt180 -101.52 162.58 12.79 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.105 -0.997 . . . . 72.239999999999995 110.046 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -92.39 144.51 25.3 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.336 -0.853 . . . . 75.420000000000002 108.992 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.558 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 3.5 p90 -142.13 179.94 6.61 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.151 -0.968 . . . . 74.230000000000004 109.732 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -143.16 -32.39 0.47 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.321 -0.862 . . . . 72.040000000000006 109.767 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.476 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.2 OUTLIER -108.24 113.31 26.32 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.345 -0.847 . . . . 72.129999999999995 109.086 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.476 ' N ' HD13 ' A' ' 47' ' ' LEU . 65.0 t -101.27 99.54 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.797 -0.816 . . . . 72.340000000000003 108.797 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.405 ' O ' ' O ' ' A' ' 4' ' ' LEU . 26.5 ttt -114.55 132.24 56.39 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.561 0.696 . . . . 74.109999999999999 109.567 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.466 HG21 ' HB2' ' A' ' 55' ' ' ALA . 0.8 OUTLIER -142.12 136.05 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.382 -0.824 . . . . 61.119999999999997 109.69 -179.046 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.8 t -102.06 1.25 36.2 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.478 -0.764 . . . . 73.109999999999999 109.772 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -76.07 145.99 39.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.103 -0.998 . . . . 52.549999999999997 109.713 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.409 ' C ' ' H ' ' A' ' 55' ' ' ALA . 29.2 mmtp -78.01 -46.46 20.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.25 -0.906 . . . . 44.219999999999999 110.204 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -59.98 -4.63 0.79 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.154 -0.966 . . . . 70.439999999999998 109.908 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.466 ' HB2' HG21 ' A' ' 50' ' ' VAL . . . -62.92 -23.01 67.17 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.226 -0.921 . . . . 64.140000000000001 110.139 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 55' ' ' ALA . 14.5 mt -39.98 -54.56 2.19 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.603 -0.686 . . . . 44.140000000000001 110.71 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.6 p -68.39 -31.83 71.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.734 -1.229 . . . . 55.229999999999997 109.254 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.458 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 66.5 t80 -65.74 -46.99 76.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.395 -0.816 . . . . 74.439999999999998 110.242 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.8 m -63.06 -35.09 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.706 -1.246 . . . . 74.030000000000001 109.467 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 60.8 m -57.09 -51.33 69.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.18 -0.95 . . . . 64.299999999999997 109.419 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.402 ' HG2' ' H ' ' A' ' 61' ' ' ARG . 11.7 ptm180 -67.64 -34.48 77.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.125 -0.984 . . . . 64.439999999999998 110.019 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.458 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 4.8 mm -63.32 -28.46 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.839 -1.163 . . . . 63.210000000000001 109.455 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.477 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 30.8 mmtt -75.4 -57.86 3.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.074 -1.017 . . . . 74.420000000000002 109.784 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -62.37 -33.24 74.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.897 -1.127 . . . . 70.319999999999993 109.73 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 8.3 mtpm? -85.42 -18.66 32.99 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.18 -0.95 . . . . 75.219999999999999 109.844 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.523 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 98.7 m-70 -157.61 65.97 0.48 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.027 -1.046 . . . . 74.129999999999995 109.606 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.6 m -66.12 -24.12 66.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.286 -0.884 . . . . 73.239999999999995 110.023 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.429 ' HG ' ' HZ1' ' A' ' 145' ' ' LYS . 86.8 p -68.11 -21.47 64.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.154 -0.966 . . . . 61.009999999999998 110.427 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.432 HD13 ' CE2' ' A' ' 45' ' ' TYR . 58.3 mt -88.43 153.37 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.102 -0.998 . . . . 71.329999999999998 109.635 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 71' ' ' VAL . 63.9 t -91.11 158.96 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.135 -0.978 . . . . 72.129999999999995 110.189 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.484 ' N ' HG12 ' A' ' 70' ' ' VAL . 24.8 t -132.44 125.31 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.397 -0.814 . . . . 54.210000000000001 109.759 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.492 ' C ' HD23 ' A' ' 72' ' ' LEU . 4.5 tt -118.34 101.91 8.55 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.491 -0.756 . . . . 50.240000000000002 109.125 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.0 t -91.61 137.21 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.189 -0.944 . . . . 74.409999999999997 109.707 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.8 156.55 19.51 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.492 -0.929 . . . . 72.310000000000002 108.492 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 97' ' ' LYS . 27.9 t -153.66 132.25 12.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.04 -1.037 . . . . 64.540000000000006 109.786 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -89.44 3.26 52.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.386 -0.821 . . . . 74.129999999999995 108.904 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 79' ' ' THR . 2.5 p-10 -138.52 56.48 10.05 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.528 -0.733 . . . . 73.340000000000003 109.048 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -49.92 87.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.322 2.015 . . . . 63.219999999999999 111.339 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 77' ' ' ASN . 21.2 m -110.22 152.59 25.91 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.091 -0.707 . . . . 62.530000000000001 109.091 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.39 -34.24 64.19 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.43 -0.794 . . . . 73.439999999999998 109.755 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -65.15 -52.5 54.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 71.420000000000002 110.103 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -60.71 -33.34 72.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 73.430000000000007 109.824 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -64.04 -46.0 86.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 74.219999999999999 109.721 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.8 t -57.22 -46.73 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 73.200000000000003 109.758 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -68.12 -29.37 68.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 53.329999999999998 109.65 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.42 -43.43 96.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.149 -0.969 . . . . 64.109999999999999 109.993 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -83.86 -34.52 24.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.127 -0.983 . . . . 74.340000000000003 109.579 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -65.79 -46.07 80.06 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.309 -0.869 . . . . 74.420000000000002 108.772 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -63.43 -53.11 57.4 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.678 -0.639 . . . . 74.239999999999995 109.522 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 141.07 61.33 0.03 OUTLIER Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.247 -1.141 . . . . 61.509999999999998 110.247 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -110.84 132.32 54.3 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.377 -1.073 . . . . 55.329999999999998 109.026 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.477 ' OD1' ' NZ ' ' A' ' 63' ' ' LYS . 35.9 m-20 -85.31 -19.32 31.69 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.047 -1.033 . . . . 73.420000000000002 109.01 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.448 ' OD2' ' CZ ' ' A' ' 112' ' ' ARG . 60.0 m-20 -152.14 162.66 40.78 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.82 -0.808 . . . . 75.040000000000006 108.82 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.433 ' OH ' ' CB ' ' A' ' 75' ' ' SER . 87.4 t80 -150.56 95.57 2.26 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.609 -0.886 . . . . 71.329999999999998 108.609 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 96' ' ' ALA . 8.3 mm -105.31 155.3 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.619 0 O-C-N 121.023 -1.048 . . . . 71.129999999999995 109.835 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.478 ' N ' HG22 ' A' ' 95' ' ' ILE . . . -60.33 144.57 50.31 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 106.953 -1.499 . . . . 64.319999999999993 106.953 177.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.662 ' C ' ' H ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -67.58 -57.48 10.1 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 120.645 -1.284 . . . . 62.200000000000003 112.171 -178.097 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 99' ' ' TYR . 27.7 Cg_endo -53.92 9.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.3 -1.993 0 CA-C-N 119.927 1.01 . . . . 73.109999999999999 113.477 -173.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.662 ' H ' ' C ' ' A' ' 97' ' ' LYS . 14.5 m-85 57.01 124.86 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.19 -0.459 . . . . 65.219999999999999 110.688 177.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.6 mtt85 -66.93 -35.32 79.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.696 -1.253 . . . . 72.349999999999994 108.777 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.741 ' O ' ' N ' ' A' ' 103' ' ' LYS . 29.3 t -164.92 33.18 0.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 71.319999999999993 110.404 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.4 mt 51.77 -69.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.714 -0.616 . . . . 75.430000000000007 110.296 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.741 ' N ' ' O ' ' A' ' 101' ' ' SER . 13.0 mptt -56.37 -28.81 60.29 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.633 -1.247 . . . . 71.409999999999997 107.633 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.18 87.71 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.715 -0.794 . . . . 63.240000000000002 108.881 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -61.51 -55.95 25.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.354 -0.841 . . . . 73.219999999999999 108.75 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.7 t -56.34 -41.76 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.96 -1.087 . . . . 60.109999999999999 109.278 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.02 -42.54 49.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.933 . . . . 70.420000000000002 109.309 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.515 ' O ' ' NH1' ' A' ' 112' ' ' ARG . 15.5 mmp_? -69.61 -30.08 67.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 74.409999999999997 109.521 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 93.3 mt -77.92 -29.67 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.021 -1.049 . . . . 62.539999999999999 109.117 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -73.4 -58.77 3.07 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.272 -0.893 . . . . 74.340000000000003 109.911 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.81 -46.99 87.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.123 -0.985 . . . . 73.319999999999993 109.826 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.515 ' NH1' ' O ' ' A' ' 108' ' ' ARG . 22.2 ttp-105 -59.47 -31.53 69.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.181 -0.949 . . . . 52.409999999999997 109.44 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 12.4 tp -157.63 93.06 1.25 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 65.239999999999995 109.496 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 32.5 mtm-85 -78.39 -72.73 0.36 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.227 -0.92 . . . . 64.450000000000003 108.89 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' A' ' 117' ' ' GLY . 41.4 t80 -140.11 3.18 1.97 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.31 -0.869 . . . . 74.430000000000007 109.668 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.528 ' CG ' ' O ' ' A' ' 115' ' ' PHE . 48.9 p-90 40.96 21.27 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.569 -0.707 . . . . 74.420000000000002 110.362 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 115' ' ' PHE . . . -57.12 89.77 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.615 -1.394 . . . . 75.040000000000006 109.615 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 116' ' ' TRP . 85.8 p -156.16 163.65 39.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -1.152 . . . . 61.140000000000001 109.901 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.07 125.57 3.09 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.665 -0.865 . . . . 65.239999999999995 108.665 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.2 t -83.79 -50.25 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.165 -0.96 . . . . 73.109999999999999 109.868 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 17.6 mm -100.83 126.35 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.246 -0.909 . . . . 72.239999999999995 109.351 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -129.87 124.73 33.92 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.544 -0.722 . . . . 72.340000000000003 109.143 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 123' ' ' ILE . 13.2 tt -146.71 130.21 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.284 -0.885 . . . . 71.439999999999998 109.424 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 45.94 -143.68 3.99 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.745 -1.342 . . . . 73.400000000000006 109.745 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -84.64 -3.93 58.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -1.138 . . . . 74.450000000000003 109.371 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.66 130.79 41.01 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.529 -0.915 . . . . 54.210000000000001 108.529 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.9 m -129.43 123.92 32.83 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.355 -0.84 . . . . 54.5 109.507 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 23.3 mm -110.26 140.69 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.55 -0.719 . . . . 45.149999999999999 109.103 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.9 m -128.08 78.99 74.59 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.49 -0.756 . . . . 71.109999999999999 109.33 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.85 -53.02 7.74 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.853 2.369 . . . . 65.409999999999997 112.573 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -54.08 -42.71 69.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.953 . . . . 63.32 109.451 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.492 ' OE1' ' N ' ' A' ' 132' ' ' GLU . 37.8 mp0 -88.72 -0.54 57.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.25 -0.906 . . . . 72.519999999999996 109.56 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 47.86 39.12 10.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 75.329999999999998 109.447 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -125.65 143.09 51.18 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.638 -0.663 . . . . 71.230000000000004 109.238 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.8 tt -125.17 138.87 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.537 -0.727 . . . . 74.019999999999996 109.414 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 52.4 mt -119.14 125.94 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.605 -0.684 . . . . 60.229999999999997 109.178 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.504 ' CE2' ' CD ' ' A' ' 138' ' ' LYS . 46.1 t80 -137.43 132.51 33.51 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.56 -0.713 . . . . 62.32 109.127 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.524 ' O ' ' NH1' ' A' ' 140' ' ' ARG . 15.8 mtpp 55.64 25.21 7.84 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.504 -0.748 . . . . 75.400000000000006 109.956 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.26 -0.82 89.51 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.237 -1.145 . . . . 72.239999999999995 110.237 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.524 ' NH1' ' O ' ' A' ' 138' ' ' LYS . 9.6 mpt_? -88.9 125.79 35.1 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.017 -1.284 . . . . 71.219999999999999 109.088 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -97.8 116.9 30.94 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.274 -0.891 . . . . 71.420000000000002 109.471 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 13.8 p -139.02 141.75 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.341 -0.85 . . . . 53.020000000000003 109.265 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -88.57 147.67 24.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.196 -0.94 . . . . 60.450000000000003 109.381 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.3 m -137.17 140.61 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.419 -0.801 . . . . 74.439999999999998 109.577 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.429 ' HZ1' ' HG ' ' A' ' 68' ' ' SER . 13.0 ptpt -165.83 121.99 1.34 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.883 . . . . 65.150000000000006 109.332 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 172.97 -164.45 36.48 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.579 -1.408 . . . . 73.340000000000003 109.579 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.692 ' NZ ' ' HE1' ' A' ' 173' ' ' TRP . 1.6 mtpm? -76.87 -34.76 1.31 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.235 -1.156 . . . . 72.219999999999999 111.071 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 97.0 Cg_endo -89.45 -5.4 5.51 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.166 1.91 . . . . 65.230000000000004 112.639 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -96.93 -32.71 11.9 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.214 -0.929 . . . . 60.109999999999999 109.725 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.524 ' O ' ' ND1' ' A' ' 154' ' ' HIS . 71.3 mm-40 -60.15 -40.45 89.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.113 -0.992 . . . . 64.209999999999994 109.181 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.411 HG11 ' CD1' ' A' ' 191' ' ' ILE . 7.8 p -61.03 -31.75 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.279 -0.888 . . . . 72.019999999999996 109.05 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.49 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.2 OUTLIER -65.14 -46.91 78.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.39 -0.819 . . . . 73.310000000000002 109.267 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.5 p -72.43 -30.52 64.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.091 -1.006 . . . . 74.310000000000002 109.9 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 150' ' ' GLU . 1.5 m80 -59.04 -53.38 59.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 74.310000000000002 109.728 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.68 -25.19 62.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.109 -0.995 . . . . 75.340000000000003 109.49 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.01 -54.82 40.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.204 -0.935 . . . . 62.140000000000001 109.093 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -70.45 -50.22 40.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.247 -0.908 . . . . 61.030000000000001 108.991 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.526 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 40.0 m-70 -76.04 62.37 1.65 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.535 -0.728 . . . . 74.120000000000005 109.267 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.552 ' C ' HE22 ' A' ' 161' ' ' GLN . 48.0 ttp180 -98.79 139.67 34.13 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.303 -0.873 . . . . 71.129999999999995 109.33 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.676 ' N ' HE22 ' A' ' 161' ' ' GLN . 10.4 t0 80.02 60.92 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.662 -0.649 . . . . 75.450000000000003 110.77 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.676 HE22 ' N ' ' A' ' 160' ' ' ASP . 2.0 pm0 -167.27 170.61 11.47 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.933 -1.104 . . . . 73.409999999999997 109.782 178.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 13.6 mm -92.27 136.36 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.379 -0.826 . . . . 74.409999999999997 109.123 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.453 HG13 ' OE1' ' A' ' 167' ' ' GLN . 82.7 t -140.76 138.32 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.246 -0.909 . . . . 72.310000000000002 109.802 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 52.4 p -89.71 154.28 20.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.361 -0.837 . . . . 74.120000000000005 109.307 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.578 ' CD ' ' H ' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -60.83 -41.3 95.5 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.21 -0.931 . . . . 70.430000000000007 109.2 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.7 -35.83 66.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.237 -0.914 . . . . 73.519999999999996 109.736 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.453 ' OE1' HG13 ' A' ' 163' ' ' VAL . 34.7 tt0 -56.23 -45.72 79.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.077 -1.014 . . . . 74.519999999999996 109.26 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 21.9 mt -59.79 -37.44 79.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.08 -1.012 . . . . 72.310000000000002 108.985 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.559 HD23 ' C ' ' A' ' 169' ' ' LEU . 4.9 tt -59.53 -69.41 0.21 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.416 -0.803 . . . . 53.329999999999998 110.241 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -65.0 -33.5 76.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.157 -0.964 . . . . 62.439999999999998 111.005 -178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -52.65 -48.6 66.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.976 -1.077 . . . . 60.210000000000001 110.219 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.663 ' N ' HD12 ' A' ' 172' ' ' ILE . 1.8 mp -94.09 -64.28 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.971 -1.081 . . . . 75.319999999999993 108.905 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.692 ' HE1' ' NZ ' ' A' ' 147' ' ' LYS . 25.8 m-90 . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.34 -0.85 . . . . 73.140000000000001 109.534 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.27 0.557 . . . . 64.540000000000006 110.311 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.2 m -153.16 16.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.292 -0.88 . . . . 74.019999999999996 109.232 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 61.8 mt -58.64 -38.95 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.183 -0.948 . . . . 72.329999999999998 109.475 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -50.45 -38.77 45.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 74.400000000000006 109.324 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 49.6 t -74.67 -36.38 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.227 -0.921 . . . . 70.420000000000002 109.47 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.413 ' O ' ' CG1' ' A' ' 191' ' ' ILE . . . -64.7 -52.81 55.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 52.109999999999999 109.601 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.571 ' O ' HD13 ' A' ' 188' ' ' ILE . 0.2 OUTLIER -60.9 -34.01 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.037 -1.039 . . . . 71.400000000000006 109.191 -179.691 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -68.27 -57.68 5.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.055 -1.028 . . . . 73.439999999999998 110.394 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -64.15 -38.24 90.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.868 -1.145 . . . . 71.420000000000002 109.259 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.413 ' CG1' ' O ' ' A' ' 187' ' ' ALA . 3.4 mm -56.9 -34.19 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 61.549999999999997 108.745 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . 0.642 ' HE ' ' CG2' ' A' ' 204' ' ' VAL . 3.2 tpt180 -70.17 -43.13 71.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.505 -0.747 . . . . 63.340000000000003 109.784 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -77.51 -27.87 51.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.085 -1.009 . . . . 61.240000000000002 110.187 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -84.88 -21.84 29.59 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.157 -0.965 . . . . 75.129999999999995 110.593 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . 0.567 ' SD ' ' N ' ' A' ' 196' ' ' ASP . 0.0 OUTLIER -93.77 -41.04 9.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.98 -1.075 . . . . 74.019999999999996 109.718 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . 0.567 ' N ' ' SD ' ' A' ' 195' ' ' MET . 31.5 p-10 -64.6 -34.41 78.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 74.019999999999996 109.696 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.498 ' N ' ' OD1' ' A' ' 196' ' ' ASP . 0.2 OUTLIER -57.2 -63.95 3.12 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.898 . . . . 75.430000000000007 109.678 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.427 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 37.2 Cg_endo -63.71 -57.26 0.38 Allowed 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.196 1.931 . . . . 72.319999999999993 112.064 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 49.0 mt -61.17 -33.09 72.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 74.540000000000006 109.556 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 73.55 -49.02 1.6 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.492 -1.443 . . . . 61.509999999999998 109.492 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 83.7 mt -92.17 138.24 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.211 -1.17 . . . . 61.219999999999999 109.278 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 34.7 m -77.83 147.43 35.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.283 -0.885 . . . . 72.0 109.52 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 8.2 p -142.54 21.13 2.03 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.325 -0.86 . . . . 74.439999999999998 109.223 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.642 ' CG2' ' HE ' ' A' ' 192' ' ' ARG . 20.3 m -135.22 147.96 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.461 -0.774 . . . . 64.349999999999994 109.25 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -123.48 133.34 54.05 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.497 -0.752 . . . . 71.409999999999997 109.392 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 29.0 p -99.24 138.08 36.84 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.381 -0.825 . . . . 73.519999999999996 109.394 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 38.6 t -144.6 136.85 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.202 -0.936 . . . . 71.019999999999996 109.391 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 70.2 ttp85 -80.82 88.26 5.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 72.120000000000005 109.393 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 47.3 ttt85 -171.0 -126.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 64.409999999999997 109.29 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -57.37 -39.72 76.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.109 -0.994 . . . . 71.540000000000006 109.418 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 167.59 -149.51 14.78 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.693 -1.363 . . . . 72.030000000000001 109.693 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -104.93 151.52 23.78 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.481 -1.011 . . . . 75.540000000000006 109.351 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -119.71 137.35 53.98 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.083 -0.71 . . . . 75.310000000000002 109.083 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.509 ' O ' ' N ' ' A' ' 160' ' ' ASP . 15.5 m-85 -106.07 126.94 52.8 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.431 -0.793 . . . . 75.409999999999997 109.377 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 52.9 t -153.11 160.27 42.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.432 -0.793 . . . . 74.140000000000001 109.06 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -63.45 151.69 87.13 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.071 -1.018 . . . . 75.319999999999993 109.072 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo . . . . . 0 N--CA 1.494 1.545 0 C-N-CA 122.381 2.054 . . . . 73.109999999999999 112.042 179.876 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 52.0 ttm . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.477 -0.564 . . . . 71.140000000000001 109.477 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 68.0 mtt85 -138.72 144.36 39.48 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.305 -0.872 . . . . 73.230000000000004 109.431 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 86.8 t -111.97 138.86 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 121.466 0.651 . . . . 72.239999999999995 109.756 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.476 HD11 ' CG1' ' B' ' 6' ' ' ILE . 2.7 tp -108.99 120.55 42.89 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.728 -0.607 . . . . 54.329999999999998 109.399 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.44 ' N ' HD12 ' B' ' 4' ' ' LEU . 20.2 mt -118.17 110.44 17.58 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.533 -0.729 . . . . 74.349999999999994 109.039 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.476 ' CG1' HD11 ' B' ' 4' ' ' LEU . 26.7 mt -100.78 114.08 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.681 -0.859 . . . . 42.549999999999997 108.681 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.486 ' OE1' ' N ' ' B' ' 9' ' ' ASN . 1.8 pp20? -151.04 164.93 35.3 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.285 -0.885 . . . . 74.519999999999996 109.58 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -95.86 -24.39 16.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.252 -0.905 . . . . 62.549999999999997 109.542 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . 0.486 ' N ' ' OE1' ' B' ' 7' ' ' GLU . 28.7 m120 -91.15 109.79 21.06 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.211 -0.931 . . . . 73.109999999999999 109.697 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 32.3 t -62.44 -40.78 97.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.206 -0.934 . . . . 65.540000000000006 109.633 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 86.4 t -57.72 -44.32 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 75.549999999999997 109.214 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.508 HD11 ' HZ2' ' B' ' 97' ' ' LYS . 7.6 tp -58.74 -35.47 72.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 70.140000000000001 108.841 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.04 -27.26 70.68 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 108.253 -1.939 . . . . 75.400000000000006 108.253 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.97 -52.28 49.16 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 109.536 -1.425 . . . . 65.439999999999998 109.536 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.424 ' H ' ' HG2' ' B' ' 15' ' ' GLU . 6.9 pt-20 -59.75 -47.23 86.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.372 -1.075 . . . . 60.210000000000001 109.796 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 35.5 mm -64.03 -41.48 92.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.66 -1.275 . . . . 75.150000000000006 108.951 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.474 ' CD ' ' HB3' ' B' ' 27' ' ' ALA . 39.7 tp10 -59.43 -45.22 92.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.224 -0.922 . . . . 73.010000000000005 109.156 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -84.07 0.14 49.52 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.223 -0.923 . . . . 74.299999999999997 109.557 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.5 -58.48 1.94 Allowed Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.544 -1.423 . . . . 70.540000000000006 109.544 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' B' ' 27' ' ' ALA . 1.5 pt? -71.34 -23.61 61.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.307 -1.114 . . . . 71.340000000000003 109.74 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . 0.411 ' H ' HD23 ' B' ' 20' ' ' LEU . 2.1 m120 -51.24 -36.17 40.56 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.143 -0.973 . . . . 64.409999999999997 109.495 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 46.5 t -53.86 -32.35 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.15 -0.969 . . . . 74.230000000000004 108.442 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm -81.64 -3.88 54.65 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.746 0.784 . . . . 63.420000000000002 108.891 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.13 24.45 63.84 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.942 -1.263 . . . . 53.43 109.942 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -95.14 159.73 14.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.179 -1.189 . . . . 71.120000000000005 109.076 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 14.8 mmt -104.93 140.41 38.2 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.714 -0.847 . . . . 75.239999999999995 108.714 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.474 ' HB3' ' CD ' ' B' ' 17' ' ' GLU . . . -135.9 158.13 45.14 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.398 -0.814 . . . . 72.120000000000005 109.651 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -132.8 145.69 51.19 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.594 -0.891 . . . . 72.310000000000002 108.594 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 4.3 m -110.47 139.33 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.369 -0.832 . . . . 64.430000000000007 109.129 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.1 p -138.13 169.29 18.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.384 -0.822 . . . . 65.409999999999997 109.425 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.414 ' OE2' ' OD1' ' B' ' 35' ' ' ASP . 5.4 pt-20 -93.09 -106.99 0.12 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.342 -0.849 . . . . 71.019999999999996 109.431 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 77.3 p -79.47 168.17 19.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 51.109999999999999 109.776 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 22.7 mt -51.91 -29.81 21.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.537 -0.727 . . . . 71.239999999999995 109.856 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -52.29 -51.2 59.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.095 -1.003 . . . . 74.319999999999993 109.729 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.414 ' OD1' ' OE2' ' B' ' 31' ' ' GLU . 1.4 m-20 -63.1 -38.9 93.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -0.975 . . . . 73.030000000000001 109.261 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.97 -38.97 93.16 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.409 -1.476 . . . . 30.210000000000001 109.409 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -67.92 -42.85 80.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -1.114 . . . . 74.420000000000002 109.605 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -74.41 -34.15 63.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 74.420000000000002 109.641 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 21.0 tp -74.86 -50.0 18.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 75.409999999999997 110.078 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . 0.439 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.7 ppp? -61.9 -27.69 68.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 60.409999999999997 109.907 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.81 -39.79 86.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 53.229999999999997 110.137 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 17.6 pt -87.06 -24.9 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.09 -1.006 . . . . 71.230000000000004 110.407 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.424 ' O ' ' O ' ' B' ' 40' ' ' MET . 91.3 mtt-85 -129.65 140.36 51.17 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.235 -0.916 . . . . 72.219999999999999 109.73 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -99.32 126.89 45.26 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.286 -0.884 . . . . 63.539999999999999 109.293 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -101.61 141.89 33.79 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.324 -0.86 . . . . 64.349999999999994 109.505 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -81.11 -31.71 34.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 62.219999999999999 109.021 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.522 ' C ' HD13 ' B' ' 47' ' ' LEU . 1.0 OUTLIER -114.9 110.6 19.9 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.691 -0.855 . . . . 73.120000000000005 108.691 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.462 ' N ' HD13 ' B' ' 47' ' ' LEU . 62.3 t -95.52 101.13 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.28 -0.887 . . . . 65.109999999999999 109.074 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 14.4 ttt -116.43 132.7 56.6 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.592 0.71 . . . . 73.439999999999998 109.45 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.532 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.4 OUTLIER -144.49 139.49 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.465 -0.772 . . . . 34.5 109.364 -179.49 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 31.9 p -105.58 14.71 28.1 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.668 -0.645 . . . . 73.209999999999994 109.72 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.532 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 61.9 m-20 -82.7 144.96 29.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.214 -0.929 . . . . 70.409999999999997 109.266 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' B' ' 55' ' ' ALA . 15.4 pttm -77.68 -39.41 44.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.179 -0.951 . . . . 65.0 110.118 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -73.81 10.49 1.12 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.098 -1.001 . . . . 75.209999999999994 109.559 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.415 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -65.79 -21.21 66.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.351 -0.843 . . . . 55.329999999999998 110.036 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' B' ' 55' ' ' ALA . 47.7 mt -41.94 -43.68 3.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.433 -0.792 . . . . 63.140000000000001 110.517 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.3 p -75.96 -35.79 59.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.909 -1.12 . . . . 63.5 109.451 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -66.63 -40.78 88.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.411 -0.806 . . . . 72.329999999999998 110.353 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.06 -35.49 59.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 120.757 -1.214 . . . . 74.540000000000006 109.544 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 78.8 p -57.69 -46.86 83.74 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.12 -0.988 . . . . 71.239999999999995 109.314 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -69.69 -34.41 73.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.142 -0.974 . . . . 74.310000000000002 110.018 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 4.9 mm -62.2 -34.31 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.862 -1.149 . . . . 72.140000000000001 109.779 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.421 ' O ' ' OG ' ' B' ' 67' ' ' SER . 12.0 mmtm -73.79 -52.88 11.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.099 -1.0 . . . . 73.319999999999993 110.178 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -66.24 -36.82 84.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.902 -1.123 . . . . 73.120000000000005 110.304 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.466 ' C ' ' CG ' ' B' ' 66' ' ' HIS . 29.3 mtmt -83.21 -23.56 32.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.133 -0.98 . . . . 72.439999999999998 110.258 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.466 ' CG ' ' C ' ' B' ' 65' ' ' LYS . 37.0 m-70 -153.2 67.37 0.79 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.02 -1.05 . . . . 63.310000000000002 109.837 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' B' ' 63' ' ' LYS . 10.5 m -61.9 -30.86 71.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.935 . . . . 73.099999999999994 109.724 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 90.5 p -63.24 -24.58 67.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.251 -0.905 . . . . 71.530000000000001 110.356 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.444 HD12 ' CB ' ' B' ' 66' ' ' HIS . 81.1 mt -81.5 156.36 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.988 -1.07 . . . . 74.400000000000006 109.767 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.497 HG12 ' N ' ' B' ' 71' ' ' VAL . 95.9 t -93.97 160.14 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.296 -0.877 . . . . 75.120000000000005 109.854 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.497 ' N ' HG12 ' B' ' 70' ' ' VAL . 21.7 t -136.04 127.49 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.411 -0.806 . . . . 73.200000000000003 109.366 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.417 HD21 HD11 ' B' ' 105' ' ' LEU . 0.7 OUTLIER -121.61 101.71 7.77 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.729 -0.841 . . . . 73.340000000000003 108.729 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 90.7 t -93.53 128.18 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.249 -0.907 . . . . 73.5 109.264 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 14.6 p -93.51 172.24 8.4 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.198 -0.939 . . . . 64.340000000000003 109.346 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.438 ' CB ' ' HH ' ' B' ' 94' ' ' TYR . 30.1 t -159.65 117.08 2.65 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.978 -1.077 . . . . 74.530000000000001 110.339 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -61.88 -36.34 80.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.384 -0.822 . . . . 64.5 109.84 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . 0.524 ' ND2' ' H ' ' B' ' 77' ' ' ASN . 0.5 OUTLIER -118.52 82.73 19.94 Favored Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.572 -0.705 . . . . 74.25 109.227 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -47.71 84.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.235 1.957 . . . . 74.430000000000007 111.5 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.516 ' N ' ' O ' ' B' ' 77' ' ' ASN . 19.4 m -102.91 150.91 23.05 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.596 -0.69 . . . . 73.120000000000005 109.377 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.2 t -65.32 -35.41 80.9 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.344 -0.847 . . . . 71.010000000000005 109.704 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . 0.488 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 80.1 mm-40 -60.42 -44.75 95.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.134 -0.979 . . . . 63.200000000000003 109.565 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -75.79 -31.11 59.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 73.219999999999999 109.468 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -64.73 -54.05 37.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 74.299999999999997 109.834 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.546 HG23 ' N ' ' B' ' 85' ' ' HIS . 21.6 m -64.26 -43.37 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.098 -1.001 . . . . 73.310000000000002 109.396 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' HIS . . . . . 0.546 ' N ' HG23 ' B' ' 84' ' ' VAL . 23.2 m170 -63.18 -26.17 68.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.161 -0.962 . . . . 73.239999999999995 109.271 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.49 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -70.64 -46.86 62.5 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -0.878 . . . . 55.329999999999998 109.958 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -77.0 -32.09 56.96 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.01 -1.056 . . . . 74.140000000000001 109.384 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -72.67 -44.3 62.0 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.248 -0.907 . . . . 64.040000000000006 109.693 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -62.69 -52.13 64.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.191 -0.943 . . . . 72.349999999999994 109.905 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 156.45 44.74 0.02 OUTLIER Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.673 -1.251 . . . . 65.200000000000003 110.265 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -110.28 135.7 50.61 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.396 -1.061 . . . . 52.229999999999997 109.255 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -85.37 -18.43 33.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.094 -1.004 . . . . 73.319999999999993 109.201 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -152.51 162.01 41.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.298 -0.876 . . . . 72.219999999999999 109.697 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.438 ' HH ' ' CB ' ' B' ' 75' ' ' SER . 79.4 t80 -143.65 97.0 2.99 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.554 -0.906 . . . . 64.420000000000002 108.554 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 23.2 mm -108.1 156.29 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 121.255 -0.903 . . . . 72.230000000000004 110.431 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.6 152.12 45.94 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.262 -1.014 . . . . 25.239999999999998 108.262 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.694 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -74.87 -55.98 2.26 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 120.787 -1.195 . . . . 64.319999999999993 111.416 -179.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 2.6 Cg_endo -40.29 -10.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.034 1.156 . . . . 63.329999999999998 112.914 -175.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . 0.694 ' N ' ' O ' ' B' ' 97' ' ' LYS . 54.2 m-85 59.42 118.18 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.755 -0.59 . . . . 75.129999999999995 109.868 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -65.65 -33.31 75.6 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.208 -0.932 . . . . 74.230000000000004 109.452 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . 0.766 ' O ' ' N ' ' B' ' 103' ' ' LYS . 34.2 t -171.32 27.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.961 -1.087 . . . . 63.340000000000003 110.888 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 16.2 mt 49.14 -67.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 CA-C-N 118.498 0.59 . . . . 74.439999999999998 110.336 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.766 ' N ' ' O ' ' B' ' 101' ' ' SER . 43.4 mtpt -55.4 -32.77 62.93 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.903 -1.147 . . . . 71.109999999999999 107.903 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.11 -45.87 86.72 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.666 -0.864 . . . . 71.450000000000003 108.666 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.417 HD11 HD21 ' B' ' 72' ' ' LEU . 22.5 tp -68.31 -42.43 79.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.302 -0.874 . . . . 51.310000000000002 109.123 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 78.8 t -58.92 -45.72 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.174 -0.954 . . . . 65.230000000000004 108.893 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.17 -44.02 67.55 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.422 -0.955 . . . . 24.32 108.422 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -62.41 -39.04 91.98 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.819 -0.808 . . . . 75.310000000000002 108.819 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 91.1 mt -68.95 -28.96 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 108.043 -1.095 . . . . 54.240000000000002 108.043 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -68.56 -53.76 20.89 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.651 -0.87 . . . . 65.310000000000002 108.651 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -47.36 -40.32 17.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.448 -0.783 . . . . 72.239999999999995 109.081 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -62.85 -40.33 97.13 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.299 -0.876 . . . . 72.040000000000006 109.111 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 84.6 mt -137.97 77.44 1.63 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.318 -0.864 . . . . 75.349999999999994 109.505 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -74.54 -76.02 0.15 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.218 -0.926 . . . . 75.5 108.959 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 115' ' ' PHE . . . . . 0.525 ' O ' ' CG ' ' B' ' 116' ' ' TRP . 94.1 m-85 -82.84 -65.87 0.96 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 65.329999999999998 109.563 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 116' ' ' TRP . . . . . 0.525 ' CG ' ' O ' ' B' ' 115' ' ' PHE . 7.7 m-90 -158.13 -154.39 0.44 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.36 -0.838 . . . . 74.450000000000003 109.347 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -85.65 -138.09 4.54 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.696 -1.362 . . . . 44.210000000000001 109.696 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 10.9 t -151.95 176.85 11.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.305 -1.114 . . . . 71.400000000000006 109.911 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.9 163.81 37.8 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.787 -0.819 . . . . 72.319999999999993 108.787 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 10.1 t -136.5 -38.52 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.506 -0.746 . . . . 75.019999999999996 109.726 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 27.1 mm -97.77 137.67 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.239 -0.913 . . . . 51.409999999999997 109.499 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . 0.95 ' OE1' ' O ' ' B' ' 122' ' ' GLU . 0.0 OUTLIER -137.74 132.61 33.04 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.476 -0.765 . . . . 71.530000000000001 109.374 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.704 HG23 ' O ' ' B' ' 123' ' ' ILE . 4.9 tt -142.76 113.08 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.285 -0.884 . . . . 72.430000000000007 109.174 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.98 -116.95 5.49 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.262 -1.535 . . . . 51.229999999999997 109.262 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -106.33 3.38 27.49 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.481 -1.011 . . . . 74.200000000000003 108.987 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.511 ' HB2' ' CG2' ' B' ' 123' ' ' ILE . 0.3 OUTLIER -97.49 139.43 33.42 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.283 -1.006 . . . . 75.420000000000002 108.283 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 18.8 m -130.33 136.42 49.09 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.229 -0.919 . . . . 74.219999999999999 110.065 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 58.8 mt -128.96 142.9 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.533 -0.729 . . . . 60.329999999999998 109.464 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 2.0 m -122.44 126.84 26.06 Favored Pre-proline 0 N--CA 1.501 2.077 0 N-CA-C 109.144 -0.687 . . . . 72.310000000000002 109.144 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.71 -60.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.793 1.662 . . . . 75.129999999999995 112.998 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -53.9 -47.51 71.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.939 -1.1 . . . . 75.230000000000004 109.956 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -82.83 -9.77 59.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.121 -0.987 . . . . 72.430000000000007 110.063 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 48.51 75.41 0.14 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.977 -1.077 . . . . 75.129999999999995 109.178 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -149.17 130.56 14.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.189 -0.945 . . . . 73.219999999999999 109.54 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 7.5 tt -110.43 132.93 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.816 -0.809 . . . . 64.140000000000001 108.816 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 20.7 mm -111.26 127.42 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.407 -0.808 . . . . 71.219999999999999 109.407 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -142.81 141.54 31.66 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.983 -1.117 . . . . 64.219999999999999 107.983 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 68.3 tttt 55.93 13.61 1.16 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.335 -0.853 . . . . 72.019999999999996 109.705 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.68 5.24 84.49 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.384 -1.086 . . . . 74.319999999999993 110.384 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -96.09 141.81 29.03 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.13 -1.218 . . . . 75.340000000000003 109.04 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -96.24 123.76 39.99 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.311 -0.868 . . . . 71.230000000000004 109.339 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 36.1 t -134.74 132.83 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.38 -0.825 . . . . 70.430000000000007 109.153 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -90.58 157.58 17.43 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.032 -1.043 . . . . 72.430000000000007 109.516 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 6.0 m -137.69 140.66 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.408 -0.808 . . . . 72.129999999999995 109.817 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 22.9 pttt -176.64 89.54 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.408 -0.807 . . . . 72.019999999999996 109.593 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -157.15 -170.15 21.76 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.587 -1.405 . . . . 42.229999999999997 109.587 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . 0.628 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 29.3 ttpt -78.69 -31.03 0.71 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.262 -1.14 . . . . 73.299999999999997 110.974 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 85.1 Cg_endo -89.61 -29.34 0.23 Allowed 'Trans proline' 0 N--CA 1.486 1.069 0 C-N-CA 122.03 1.82 . . . . 71.329999999999998 112.764 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -85.1 -13.31 50.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.0 -1.063 . . . . 74.230000000000004 109.964 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -53.04 -40.68 64.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.097 -1.002 . . . . 72.340000000000003 109.268 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.47 HG13 ' N ' ' B' ' 152' ' ' LEU . 12.5 p -69.24 -38.45 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 73.349999999999994 109.159 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.558 ' O ' HD13 ' B' ' 152' ' ' LEU . 0.3 OUTLIER -48.22 -44.11 32.76 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.57 -0.9 . . . . 55.240000000000002 108.57 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.14 -41.0 71.05 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.107 -0.996 . . . . 70.010000000000005 110.254 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -58.39 -63.59 1.22 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.371 -0.831 . . . . 65.319999999999993 112.362 -177.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . 0.609 HD12 ' N ' ' B' ' 156' ' ' ALA . 0.4 OUTLIER -70.23 -19.77 63.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.425 -1.422 . . . . 71.540000000000006 109.815 -178.628 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . 0.609 ' N ' HD12 ' B' ' 155' ' ' LEU . . . -58.96 -47.97 83.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.737 -1.227 . . . . 75.319999999999993 109.17 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . 0.421 ' HG3' ' ND1' ' B' ' 158' ' ' HIS . 23.2 ptt180 -76.86 -35.8 57.23 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.034 -1.041 . . . . 73.319999999999993 110.42 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 158' ' ' HIS . . . . . 0.421 ' ND1' ' HG3' ' B' ' 157' ' ' ARG . 1.6 m-70 -81.08 22.42 0.64 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.688 -1.257 . . . . 74.140000000000001 109.961 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 24.8 ttm-85 -59.36 163.03 4.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.125 -0.985 . . . . 61.409999999999997 109.06 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' B' ' 214' ' ' PHE . 14.8 t0 63.54 44.65 5.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.205 -0.934 . . . . 72.099999999999994 109.164 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . 0.908 ' NE2' ' O ' ' B' ' 162' ' ' ILE . 15.5 tm0? -158.16 155.25 28.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.353 -0.842 . . . . 72.25 109.613 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 162' ' ' ILE . . . . . 0.908 ' O ' ' NE2' ' B' ' 161' ' ' GLN . 10.3 mm -81.63 105.39 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.522 -0.918 . . . . 72.310000000000002 108.522 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 93.4 t -101.54 129.25 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.274 -0.892 . . . . 64.209999999999994 109.754 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 9.8 t -85.93 164.31 17.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.401 -0.812 . . . . 74.219999999999999 109.528 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -68.78 -46.39 68.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -0.848 . . . . 65.310000000000002 109.855 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -60.25 -24.89 65.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 63.450000000000003 109.859 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -59.26 -43.73 92.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.965 -1.085 . . . . 72.400000000000006 109.082 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 20.7 mt -71.96 -58.11 3.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.394 -0.816 . . . . 72.319999999999993 109.247 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.598 ' C ' HD13 ' B' ' 169' ' ' LEU . 2.1 tm? -50.1 -58.29 5.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.014 -1.054 . . . . 73.340000000000003 108.653 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -51.7 -32.66 31.0 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 112.183 0.438 . . . . 72.099999999999994 112.183 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.61 -30.77 14.18 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.802 -1.187 . . . . 62.130000000000003 112.952 -177.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.7 -63.13 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.458 -1.401 . . . . 71.420000000000002 109.467 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 173' ' ' TRP . . . . . 0.523 ' O ' ' CE3' ' B' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.538 0 N-CA-C 107.518 -1.29 . . . . 72.230000000000004 107.518 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_exo . . . . . 0 N--CA 1.489 1.213 0 CA-C-O 121.422 0.509 . . . . 65.219999999999999 112.019 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -164.1 122.73 1.88 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.369 -0.832 . . . . 72.310000000000002 109.061 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 10.5 m -137.71 11.87 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.244 -0.91 . . . . 63.32 108.692 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.621 HD13 ' O ' ' B' ' 184' ' ' ILE . 0.2 OUTLIER -53.52 -30.64 18.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.639 -0.874 . . . . 75.030000000000001 108.639 179.749 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -57.33 -35.49 69.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.853 . . . . 64.109999999999999 108.994 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 3.7 t -75.32 -44.41 42.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.453 -0.78 . . . . 73.0 109.372 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -61.62 -48.46 80.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.251 -0.906 . . . . 61.119999999999997 110.459 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 188' ' ' ILE . . . . . 0.47 HG23 ' N ' ' B' ' 189' ' ' ASN . 9.4 tp -63.65 -42.12 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.778 -1.201 . . . . 72.430000000000007 110.285 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 189' ' ' ASN . . . . . 0.47 ' N ' HG23 ' B' ' 188' ' ' ILE . 53.3 t30 -63.59 -34.67 78.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.898 -1.126 . . . . 65.140000000000001 109.402 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -77.14 -50.36 13.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 63.240000000000002 110.15 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 82.0 mt -50.5 -46.37 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.178 -0.951 . . . . 74.030000000000001 109.438 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -62.68 -48.81 77.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.104 -0.997 . . . . 72.239999999999995 109.914 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 193' ' ' GLN . . . . . 0.45 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 25.6 mt-30 -63.67 -21.61 66.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.051 -1.031 . . . . 73.099999999999994 109.515 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . 0.431 ' O ' ' CD ' ' B' ' 198' ' ' PRO . 60.3 mttm -85.74 -38.47 18.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.206 -0.933 . . . . 72.109999999999999 110.405 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 88.8 mmm -91.79 13.2 18.96 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.888 -1.133 . . . . 44.329999999999998 109.99 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 196' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 50.8 p-10 -96.56 -20.98 17.96 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.06 -1.025 . . . . 71.209999999999994 109.744 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . 0.554 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 1.5 tttm -93.29 -45.54 0.31 Allowed Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.116 -0.99 . . . . 75.209999999999994 109.098 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 198' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' B' ' 197' ' ' LYS . 18.8 Cg_exo -65.12 -60.47 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.163 1.909 . . . . 75.319999999999993 111.324 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 30.8 mt -63.68 -38.8 92.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 72.25 109.007 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 78.44 -17.95 6.01 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.35 -1.1 . . . . 64.530000000000001 110.35 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 29.0 mm -110.31 131.78 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.278 -1.13 . . . . 44.229999999999997 110.017 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 2.0 t -83.8 135.16 34.63 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.632 -0.877 . . . . 54.009999999999998 108.632 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 3.9 p -141.37 30.43 1.75 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.141 -0.974 . . . . 74.400000000000006 109.463 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 25.6 m -137.14 142.4 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.507 -0.745 . . . . 72.120000000000005 109.296 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -125.58 114.5 18.81 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.022 -0.732 . . . . 65.409999999999997 109.022 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.42 110.1 21.21 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.186 -0.946 . . . . 71.329999999999998 109.917 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.416 ' O ' HG13 ' B' ' 207' ' ' VAL . 10.6 p -112.45 131.09 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 107.896 -1.15 . . . . 63.5 107.896 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -47.92 -32.81 6.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.055 -1.028 . . . . 74.450000000000003 110.036 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 -66.34 148.45 51.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.093 -1.004 . . . . 74.140000000000001 109.41 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 51.37 -115.11 0.85 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.095 -1.003 . . . . 74.430000000000007 109.636 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -142.27 -92.73 0.18 Allowed Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.419 -1.473 . . . . 64.450000000000003 109.419 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -126.71 157.44 39.08 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.435 -1.038 . . . . 74.209999999999994 109.637 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -123.26 121.95 37.16 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.879 -0.785 . . . . 74.030000000000001 108.879 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' B' ' 160' ' ' ASP . 60.0 m-85 -101.49 123.92 46.32 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.369 -0.832 . . . . 74.340000000000003 110.372 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 1.9 p -147.59 164.38 33.64 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.117 -0.697 . . . . 64.329999999999998 109.117 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' B' ' 216' ' ' TYR . 0.0 OUTLIER -64.93 162.52 37.1 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.085 -1.01 . . . . 70.040000000000006 108.429 179.664 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -39.47 163.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.407 2.071 . . . . 65.109999999999999 112.267 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 19.4 mtmt . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.121 -0.987 . . . . 73.150000000000006 109.723 -179.329 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.9 ptm . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.454 -0.573 . . . . 65.120000000000005 109.454 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -139.31 144.51 38.34 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.356 -0.84 . . . . 72.329999999999998 109.44 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 66.1 t -112.64 131.03 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.705 -0.622 . . . . 71.420000000000002 109.492 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.75 HD12 ' N ' ' A' ' 5' ' ' LEU . 0.7 OUTLIER -110.21 125.59 53.23 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.96 -0.756 . . . . 65.120000000000005 108.96 179.861 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.75 ' N ' HD12 ' A' ' 4' ' ' LEU . 59.7 tp -120.95 102.94 8.68 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.629 -0.67 . . . . 62.43 109.244 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.503 ' CG1' HD11 ' A' ' 4' ' ' LEU . 38.8 mt -88.67 113.58 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.856 -1.153 . . . . 71.150000000000006 108.692 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 13' ' ' GLY . 55.8 tt0 -154.66 121.44 5.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.198 -0.939 . . . . 75.340000000000003 109.485 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -64.36 -31.29 72.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.307 -0.871 . . . . 72.439999999999998 109.43 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -73.9 103.21 4.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.324 -0.86 . . . . 63.020000000000003 109.372 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.4 t -66.4 -25.17 66.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 72.340000000000003 109.814 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.54 -50.67 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.168 -0.958 . . . . 74.019999999999996 109.697 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.58 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.3 mm? -70.81 -41.95 70.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 71.430000000000007 109.398 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.513 ' N ' ' OE1' ' A' ' 7' ' ' GLU . . . -69.13 -24.85 75.81 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 108.475 -1.85 . . . . 61.32 108.475 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.51 -54.89 20.45 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 109.676 -1.37 . . . . 71.200000000000003 109.676 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -56.88 -45.75 82.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -1.104 . . . . 71.319999999999993 109.775 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.618 ' O ' HD23 ' A' ' 20' ' ' LEU . 35.9 mm -64.54 -48.78 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.819 -1.176 . . . . 63.229999999999997 108.878 179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.527 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 86.5 tt0 -45.6 -56.41 5.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -0.983 . . . . 51.109999999999999 109.854 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -85.61 3.83 39.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.124 -0.985 . . . . 73.340000000000003 109.128 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.59 -70.64 1.34 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.778 -1.329 . . . . 62.149999999999999 109.778 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.618 HD23 ' O ' ' A' ' 16' ' ' ILE . 0.5 OUTLIER -58.75 -21.97 56.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.213 -1.169 . . . . 73.510000000000005 109.491 -179.826 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 93.4 m-20 -57.06 -37.84 72.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.253 -0.904 . . . . 74.25 109.634 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.7 t -53.97 -40.02 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 70.040000000000006 109.462 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -64.46 -22.13 66.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.27 -0.894 . . . . 73.230000000000004 109.233 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.46 38.28 2.65 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 110.335 -1.106 . . . . 75.540000000000006 110.335 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -117.92 159.28 23.39 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.335 -1.097 . . . . 73.430000000000007 108.905 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.7 mmt -90.8 114.51 26.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.112 -0.992 . . . . 43.240000000000002 108.574 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.531 ' HB2' HD11 ' A' ' 20' ' ' LEU . . . -99.26 147.38 25.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.397 -0.814 . . . . 62.109999999999999 110.104 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 27' ' ' ALA . 82.4 m-20 -138.52 129.03 26.16 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.619 -0.882 . . . . 74.420000000000002 108.619 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.1 m -111.82 138.86 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.449 -0.782 . . . . 72.150000000000006 109.117 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 p -135.08 176.39 8.71 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.536 -0.728 . . . . 71.420000000000002 109.354 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -95.54 -108.16 0.14 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.163 -0.961 . . . . 72.329999999999998 110.017 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.2 p -78.84 167.15 21.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.899 . . . . 74.239999999999995 110.123 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.414 HD22 ' CG ' ' A' ' 58' ' ' PHE . 57.7 mt -50.82 -33.76 24.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.629 -0.669 . . . . 71.530000000000001 109.891 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -49.5 -52.27 30.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 74.230000000000004 109.624 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -61.95 -37.76 85.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.139 -0.976 . . . . 54.030000000000001 108.952 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.79 -39.17 90.0 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.278 -1.529 . . . . 61.409999999999997 109.278 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.57 -43.59 89.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.352 -1.087 . . . . 74.340000000000003 109.445 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -73.39 -38.03 65.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.153 -0.967 . . . . 75.329999999999998 109.504 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.0 tp -68.7 -44.99 72.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 74.329999999999998 109.771 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.448 ' C ' ' SD ' ' A' ' 40' ' ' MET . 3.4 ppp? -74.39 -17.13 60.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.087 -1.008 . . . . 70.319999999999993 109.687 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -55.43 -40.68 71.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.122 -0.986 . . . . 71.219999999999999 109.441 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.8 pt -88.08 -42.56 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.304 -0.872 . . . . 74.140000000000001 109.793 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 40' ' ' MET . 3.0 mpt_? -104.41 139.19 39.71 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.195 -0.94 . . . . 72.239999999999995 109.113 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.539 ' ND2' ' HZ1' ' A' ' 145' ' ' LYS . 16.8 t-20 -82.11 -24.36 35.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 75.420000000000002 109.782 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.485 ' O ' ' O ' ' A' ' 44' ' ' ASN . 57.2 m-85 57.4 136.65 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.684 0.754 . . . . 74.230000000000004 110.196 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -86.29 -50.45 6.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.948 -1.095 . . . . 72.040000000000006 108.945 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.508 HD13 ' C ' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -104.93 107.39 18.34 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.411 -0.959 . . . . 72.129999999999995 108.411 179.406 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.417 ' N ' HD13 ' A' ' 47' ' ' LEU . 2.4 m -106.19 104.79 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.127 -1.064 . . . . 72.340000000000003 108.127 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.8 ttt -113.69 144.51 42.81 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.545 0.688 . . . . 74.109999999999999 109.776 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.544 HG22 ' H ' ' A' ' 52' ' ' ASP . 1.4 p -139.53 136.02 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.596 0.713 . . . . 61.119999999999997 109.567 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.7 m -104.79 10.33 34.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.68 -0.638 . . . . 73.109999999999999 109.402 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.544 ' H ' HG22 ' A' ' 50' ' ' VAL . 69.8 m-20 -77.0 155.58 32.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 52.549999999999997 109.61 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.47 ' C ' ' H ' ' A' ' 55' ' ' ALA . 27.3 mtmm -76.38 -39.22 54.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.182 -0.949 . . . . 44.219999999999999 109.84 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -73.49 18.09 0.13 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.141 -0.974 . . . . 70.439999999999998 109.653 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.47 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -59.96 -35.56 75.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 64.140000000000001 110.012 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.4 ' HA ' HE22 ' A' ' 89' ' ' GLN . 23.7 mt -43.83 -52.66 6.58 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.449 -0.782 . . . . 44.140000000000001 110.251 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.2 m -65.9 -34.63 78.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.872 -1.142 . . . . 55.229999999999997 108.942 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.444 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 46.5 t80 -65.89 -62.9 1.24 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.488 -0.757 . . . . 74.439999999999998 110.079 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.5 m -48.44 -34.19 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.739 -1.226 . . . . 74.030000000000001 109.901 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.2 t -59.0 -55.24 37.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.128 -0.982 . . . . 64.299999999999997 109.692 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -65.59 -27.36 68.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.111 -0.993 . . . . 64.439999999999998 110.189 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.444 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 31.6 mm -66.25 -49.56 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.75 -1.219 . . . . 63.210000000000001 110.369 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.423 ' HG3' ' HZ2' ' A' ' 63' ' ' LYS . 26.6 mmtp -63.62 -44.69 93.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.994 -1.066 . . . . 74.420000000000002 110.921 -178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -71.02 -39.52 72.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.676 -1.265 . . . . 70.319999999999993 110.161 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.482 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 66.4 mttm -80.8 -19.49 44.64 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.116 -0.99 . . . . 75.219999999999999 109.675 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.573 ' O ' HG22 ' A' ' 69' ' ' ILE . 93.1 m-70 -155.68 68.05 0.64 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 74.129999999999995 109.391 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.4 m -59.21 -30.72 68.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.249 -0.907 . . . . 73.239999999999995 110.0 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.8 t -81.39 49.04 1.23 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.174 -0.954 . . . . 61.009999999999998 110.28 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 66' ' ' HIS . 12.3 tt -143.4 157.8 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.096 -1.002 . . . . 71.329999999999998 109.307 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.4 t -91.75 141.53 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.001 -1.062 . . . . 72.129999999999995 108.81 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.2 t -127.52 121.99 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.297 -0.877 . . . . 54.210000000000001 109.34 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.649 ' HG ' HD11 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -118.61 103.15 9.43 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.336 -0.987 . . . . 50.240000000000002 108.336 -179.544 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.48 ' O ' HG13 ' A' ' 73' ' ' VAL . 8.0 p -98.64 128.5 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.396 -0.815 . . . . 74.409999999999997 109.109 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.5 p -89.31 175.33 7.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.06 -1.025 . . . . 72.310000000000002 109.489 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.481 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 22.8 t -164.6 118.95 1.38 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.158 -0.964 . . . . 64.540000000000006 110.265 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -70.5 -25.94 63.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.558 -0.714 . . . . 74.129999999999995 109.599 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 79' ' ' THR . 13.2 t-20 -112.64 68.9 1.03 Allowed Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.599 -0.688 . . . . 73.340000000000003 109.614 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.78 82.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.768 1.645 . . . . 63.219999999999999 111.777 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 77' ' ' ASN . 24.1 m -103.61 151.69 22.64 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.111 -0.7 . . . . 62.530000000000001 109.111 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -36.61 83.8 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -0.907 . . . . 73.439999999999998 109.471 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.02 -42.15 84.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.158 -0.964 . . . . 71.420000000000002 109.366 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -74.14 -30.35 62.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 73.430000000000007 109.607 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.522 ' OE1' ' CD1' ' A' ' 94' ' ' TYR . 46.8 tp10 -60.59 -54.76 41.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.958 . . . . 74.219999999999999 109.587 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.6 t -62.64 -41.72 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.249 -0.907 . . . . 73.200000000000003 109.421 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.518 ' NE2' ' OE1' ' A' ' 89' ' ' GLN . 47.7 t60 -64.41 -33.33 75.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.248 -0.908 . . . . 53.329999999999998 109.589 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.57 -45.18 91.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 64.109999999999999 109.747 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.532 ' CE1' ' HB1' ' B' ' 111' ' ' ALA . 73.4 t80 -77.24 -29.94 54.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.037 -1.039 . . . . 74.340000000000003 108.572 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -60.68 -50.74 72.28 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.384 -0.822 . . . . 74.420000000000002 108.885 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.518 ' OE1' ' NE2' ' A' ' 85' ' ' HIS . 28.2 mt-30 -63.24 -61.64 2.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.583 -0.698 . . . . 74.239999999999995 109.578 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 154.79 59.01 0.01 OUTLIER Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.796 -1.192 . . . . 61.509999999999998 110.266 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.72 134.61 51.21 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.254 -1.145 . . . . 55.329999999999998 108.978 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -75.4 -32.14 60.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.005 -1.059 . . . . 73.420000000000002 109.059 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.513 ' OD2' ' NE ' ' A' ' 108' ' ' ARG . 42.2 t0 -152.34 157.45 41.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.361 -0.837 . . . . 75.040000000000006 109.44 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.522 ' CD1' ' OE1' ' A' ' 83' ' ' GLU . 62.0 t80 -131.62 113.26 13.39 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.579 -0.897 . . . . 71.329999999999998 108.579 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.872 ' H ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -117.26 152.08 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-O 121.646 0.736 . . . . 71.129999999999995 110.444 -178.192 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.93 138.72 48.3 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.27 -1.011 . . . . 64.319999999999993 108.27 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.684 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -60.71 -54.98 49.37 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.98 -1.075 . . . . 62.200000000000003 111.636 -179.192 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.4 Cg_endo -41.4 -10.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 120.749 0.966 . . . . 73.109999999999999 112.923 -175.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.684 ' N ' ' O ' ' A' ' 97' ' ' LYS . 57.4 m-85 59.42 100.31 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.752 -0.593 . . . . 65.219999999999999 110.076 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 19.1 ttm-85 -55.93 -40.23 72.83 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.082 -1.081 . . . . 72.349999999999994 108.082 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.7 t -173.79 128.82 0.4 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.796 -0.816 . . . . 71.319999999999993 108.796 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.405 ' H ' HG13 ' A' ' 102' ' ' ILE . 51.3 mt -51.81 -40.54 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.941 . . . . 75.430000000000007 109.155 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.496 ' O ' ' HB2' ' A' ' 107' ' ' ALA . 2.7 mptp? -64.42 -35.58 81.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.154 -0.966 . . . . 71.409999999999997 109.38 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.03 -60.9 2.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.228 -0.92 . . . . 63.240000000000002 109.689 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.635 ' CD1' HH22 ' A' ' 108' ' ' ARG . 17.9 tp -55.9 -51.99 65.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 73.219999999999999 109.657 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 76.0 t -60.23 -42.4 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.062 -1.023 . . . . 60.109999999999999 109.383 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 103' ' ' LYS . . . -53.3 -30.08 36.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.177 -0.952 . . . . 70.420000000000002 109.115 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.635 HH22 ' CD1' ' A' ' 105' ' ' LEU . 21.1 ttp-105 -83.14 -28.71 29.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 74.409999999999997 109.981 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 80.3 mt -74.74 -40.03 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.986 -1.071 . . . . 62.539999999999999 108.72 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 114' ' ' ARG . 24.8 pt-20 -72.26 -37.07 69.16 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.439 -0.904 . . . . 74.340000000000003 108.957 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -57.3 -45.4 84.2 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.343 -0.848 . . . . 73.319999999999993 109.15 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 68.5 ttt-85 -62.73 -41.5 99.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.27 -0.894 . . . . 52.409999999999997 109.387 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 42.6 mt -130.07 65.8 1.5 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.477 -0.764 . . . . 65.239999999999995 109.248 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' A' ' 110' ' ' GLU . 81.5 mtp180 -60.8 -29.85 69.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 64.450000000000003 109.429 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.427 ' CG ' ' O ' ' A' ' 114' ' ' ARG . 78.9 m-85 -156.64 78.88 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 74.430000000000007 109.567 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 33.4 p-90 -58.83 134.1 56.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 74.420000000000002 109.534 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 154.2 91.57 0.08 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.434 -1.466 . . . . 75.040000000000006 109.434 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.7 m -152.39 168.27 26.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.261 -1.14 . . . . 61.140000000000001 109.679 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.57 -179.61 8.14 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.823 -0.751 . . . . 65.239999999999995 109.117 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.9 t -139.69 -38.75 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.441 -0.787 . . . . 73.109999999999999 109.159 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.2 mm -106.32 131.66 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.245 -0.909 . . . . 72.239999999999995 109.208 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -128.32 99.36 5.39 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.407 -0.96 . . . . 72.340000000000003 108.407 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.918 HG13 ' NE ' ' A' ' 159' ' ' ARG . 26.9 mm -115.82 122.23 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.518 -0.739 . . . . 71.439999999999998 109.233 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.86 -160.38 0.29 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.789 -1.325 . . . . 73.400000000000006 109.789 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -66.67 -3.99 7.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -1.184 . . . . 74.450000000000003 109.666 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.16 134.99 34.77 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.091 -1.006 . . . . 54.210000000000001 109.101 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 27.0 m -119.89 131.4 55.23 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.786 -0.82 . . . . 54.5 108.786 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.4 mt -118.99 122.78 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-O 121.685 0.755 . . . . 45.149999999999999 109.125 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.7 m -107.79 109.12 62.16 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.732 -0.84 . . . . 71.109999999999999 108.732 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.589 ' CB ' ' HE ' ' A' ' 157' ' ' ARG . 94.9 Cg_endo -80.08 -29.95 2.4 Favored 'Trans proline' 0 N--CA 1.492 1.382 0 C-N-CA 121.967 1.778 . . . . 65.409999999999997 112.617 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -52.73 -69.16 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.113 -0.992 . . . . 63.32 109.258 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -82.3 4.52 23.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.361 -0.837 . . . . 72.519999999999996 109.05 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 54.19 81.25 0.1 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.491 -0.756 . . . . 75.329999999999998 109.456 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -149.43 136.0 19.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.244 -0.91 . . . . 71.230000000000004 109.553 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 11.6 tt -114.24 133.07 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.48 -0.763 . . . . 74.019999999999996 108.973 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 41.4 mt -124.74 115.43 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.847 -0.797 . . . . 60.229999999999997 108.847 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -130.61 134.66 47.17 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.456 -0.777 . . . . 62.32 109.762 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.462 ' O ' ' NH1' ' A' ' 140' ' ' ARG . 61.3 mttm 55.3 23.72 5.84 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.436 -0.79 . . . . 75.400000000000006 110.792 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 86.66 1.29 85.55 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.364 -1.094 . . . . 72.239999999999995 110.364 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.462 ' NH1' ' O ' ' A' ' 138' ' ' LYS . 11.1 mpt_? -88.94 126.55 35.45 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.06 -1.259 . . . . 71.219999999999999 108.838 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -100.01 127.36 46.23 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.398 -0.814 . . . . 71.420000000000002 109.86 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 24.0 t -137.65 136.2 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.366 -0.834 . . . . 53.020000000000003 109.491 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.438 ' O ' HG13 ' A' ' 144' ' ' VAL . 14.5 pt-20 -97.94 142.69 29.36 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.34 -0.85 . . . . 60.450000000000003 109.532 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 143' ' ' GLU . 12.2 m -155.53 154.74 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.161 -0.962 . . . . 74.439999999999998 109.76 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.539 ' HZ1' ' ND2' ' A' ' 44' ' ' ASN . 20.0 pttt 178.27 115.28 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.282 -0.886 . . . . 65.150000000000006 109.137 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.01 176.18 37.74 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.689 -1.365 . . . . 73.340000000000003 109.689 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.583 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 0.0 OUTLIER -60.09 -44.32 96.23 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.4 -1.059 . . . . 72.219999999999999 109.254 -179.651 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 39.5 Cg_exo -59.57 -36.2 93.44 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.374 2.05 . . . . 65.230000000000004 112.268 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -92.57 -14.71 27.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.258 -0.901 . . . . 60.109999999999999 109.63 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -54.93 -40.07 69.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.885 . . . . 64.209999999999994 109.865 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.464 HG13 ' N ' ' A' ' 152' ' ' LEU . 10.6 p -61.12 -37.31 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.967 -1.083 . . . . 72.019999999999996 109.55 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.464 ' N ' HG13 ' A' ' 151' ' ' VAL . 7.2 tp -62.9 -51.32 67.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.494 -0.754 . . . . 73.310000000000002 110.405 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.3 p -74.71 -29.02 61.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.098 -1.001 . . . . 74.310000000000002 110.057 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -57.32 -56.74 17.89 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.833 -1.167 . . . . 74.310000000000002 109.672 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.8 pp -72.15 -27.28 62.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.395 -0.816 . . . . 75.340000000000003 109.732 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.57 -52.88 58.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.961 -1.087 . . . . 62.140000000000001 108.72 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.589 ' HE ' ' CB ' ' A' ' 130' ' ' PRO . 52.7 mtt85 -65.18 -43.83 90.42 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.663 -0.866 . . . . 61.030000000000001 108.663 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.64 ' ND1' ' N ' ' A' ' 158' ' ' HIS . 0.2 OUTLIER -86.55 30.84 0.69 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.53 -0.731 . . . . 74.120000000000005 110.245 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.918 ' NE ' HG13 ' A' ' 123' ' ' ILE . 57.1 ttm-85 -51.46 156.79 1.17 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.983 -1.073 . . . . 71.129999999999995 108.419 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 1.04 ' HB2' ' HE1' ' A' ' 216' ' ' TYR . 26.4 t70 57.12 79.02 0.2 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.248 -0.908 . . . . 75.450000000000003 108.773 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -171.76 154.08 3.53 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.472 -0.768 . . . . 73.409999999999997 109.714 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.7 mt -86.7 115.85 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 74.409999999999997 109.109 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 90.5 t -113.7 120.68 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.374 -0.829 . . . . 72.310000000000002 108.867 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 40.4 t -85.72 163.61 18.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.828 . . . . 74.120000000000005 109.74 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -60.44 -47.82 84.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.519 -0.738 . . . . 70.430000000000007 109.794 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -58.61 -36.53 74.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -0.928 . . . . 73.519999999999996 109.337 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 60.9 tp60 -55.15 -44.55 75.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.197 -0.939 . . . . 74.519999999999996 108.866 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.93 -37.17 81.38 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.22 -0.925 . . . . 72.310000000000002 108.563 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.574 HD23 ' C ' ' A' ' 169' ' ' LEU . 4.4 tt -66.53 -60.15 2.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.418 -0.801 . . . . 53.329999999999998 109.296 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.75 -15.49 61.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.837 -0.539 . . . . 62.439999999999998 110.857 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.1 -49.32 7.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.913 -1.117 . . . . 60.210000000000001 111.075 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.622 ' N ' HD12 ' A' ' 172' ' ' ILE . 2.3 mp -98.99 -53.55 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.023 -1.048 . . . . 75.319999999999993 110.453 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 23.1 m-90 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 120.896 -1.127 . . . . 73.140000000000001 109.683 -178.865 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 121.271 0.558 . . . . 64.540000000000006 109.913 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.0 p -141.75 -23.99 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.307 -0.871 . . . . 74.019999999999996 109.884 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.672 ' H ' HD12 ' A' ' 184' ' ' ILE . 2.4 mp -56.42 -29.65 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 72.329999999999998 109.854 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -58.85 -39.78 82.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.07 -1.019 . . . . 74.400000000000006 109.332 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.424 ' H ' HG23 ' A' ' 186' ' ' VAL . 1.5 t -73.27 -46.85 48.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.508 -0.745 . . . . 70.420000000000002 110.071 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.74 86.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 52.109999999999999 110.545 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.531 ' O ' HD13 ' A' ' 188' ' ' ILE . 0.2 OUTLIER -61.48 -42.96 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.915 -1.116 . . . . 71.400000000000006 109.95 -178.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -62.67 -43.1 99.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.83 -1.169 . . . . 73.439999999999998 109.443 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -66.65 -46.31 76.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.87 . . . . 71.420000000000002 109.794 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 81.9 mt -57.11 -38.17 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.179 -0.951 . . . . 61.549999999999997 109.435 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 36.6 mtp180 -61.76 -42.37 98.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.142 -0.974 . . . . 63.340000000000003 109.333 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.427 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 49.2 mt-30 -76.45 -30.13 57.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.475 -0.766 . . . . 61.240000000000002 110.455 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -86.51 -15.6 39.53 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.161 -0.962 . . . . 75.129999999999995 110.243 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 27.1 ttt -93.44 -39.16 11.05 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.014 -1.054 . . . . 74.019999999999996 110.622 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 193' ' ' GLN . 28.2 p-10 -62.65 -32.28 73.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.192 -0.942 . . . . 74.019999999999996 110.712 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.427 ' N ' ' OD1' ' A' ' 196' ' ' ASP . 51.8 mttt -65.08 -64.77 2.35 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.948 -1.095 . . . . 75.430000000000007 110.209 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 21.6 Cg_endo -60.04 -48.94 10.78 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.906 1.738 . . . . 72.319999999999993 111.738 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.511 HD13 ' O ' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -69.2 -41.48 77.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 74.540000000000006 108.748 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 85.95 -46.61 3.65 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.915 -1.274 . . . . 61.509999999999998 109.915 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 30.3 mt -93.64 133.44 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.239 -1.154 . . . . 61.219999999999999 109.642 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 70.7 m -75.87 135.98 40.15 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.364 -0.976 . . . . 72.0 108.364 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 19.6 p -144.83 45.91 1.36 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.982 -1.074 . . . . 74.439999999999998 110.463 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.8 m -148.99 128.58 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.007 -1.058 . . . . 64.349999999999994 108.925 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.493 ' N ' ' CD ' ' A' ' 205' ' ' GLU . 7.6 mp0 -91.44 120.54 32.37 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.096 -1.003 . . . . 71.409999999999997 109.475 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 5.9 p -93.15 111.97 23.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.257 -0.902 . . . . 73.519999999999996 109.291 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.79 128.61 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.241 -0.912 . . . . 71.019999999999996 108.989 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -56.08 -43.66 78.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.093 -1.004 . . . . 72.120000000000005 109.49 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.571 ' O ' ' N ' ' A' ' 211' ' ' GLY . 77.5 mtt180 -57.51 146.48 29.75 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.158 -0.964 . . . . 64.409999999999997 108.533 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 56.46 -79.08 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.087 -0.708 . . . . 71.540000000000006 109.087 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . 168.01 -112.17 0.47 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.239 -1.544 . . . . 72.030000000000001 109.239 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -116.38 123.63 48.07 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.56 -0.964 . . . . 75.540000000000006 109.18 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -107.18 130.11 54.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.696 -0.627 . . . . 75.310000000000002 109.677 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.856 ' CE1' ' HG3' ' A' ' 159' ' ' ARG . 12.2 t80 -89.8 139.53 30.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.945 -1.097 . . . . 75.409999999999997 108.812 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 99.6 m -152.66 150.67 29.72 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.999 -1.112 . . . . 74.140000000000001 107.999 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . 1.04 ' HE1' ' HB2' ' A' ' 160' ' ' ASP . 0.0 OUTLIER -59.86 151.13 65.51 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 120.902 -1.124 . . . . 75.319999999999993 108.755 -179.454 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo . . . . . 0 N--CA 1.495 1.56 0 C-N-CA 122.295 1.997 . . . . 73.109999999999999 111.907 -179.798 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ptt? . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.38 -0.6 . . . . 71.140000000000001 109.38 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.605 ' NH1' ' NE ' ' B' ' 43' ' ' ARG . 66.4 mtp180 -126.59 142.07 51.66 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.568 -0.708 . . . . 73.230000000000004 109.386 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 92.8 t -118.79 130.28 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.608 0.718 . . . . 72.239999999999995 109.77 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.46 HD11 ' CG1' ' B' ' 6' ' ' ILE . 4.1 tp -98.5 116.73 31.37 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.933 -0.766 . . . . 54.329999999999998 108.933 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.637 HD22 ' HG3' ' B' ' 49' ' ' MET . 0.2 OUTLIER -115.04 109.14 17.62 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.183 -1.043 . . . . 74.349999999999994 108.183 179.508 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.677 HD12 ' HB ' ' B' ' 50' ' ' VAL . 77.0 mt -101.31 99.41 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.926 -1.109 . . . . 42.549999999999997 109.021 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -145.18 130.38 18.53 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.36 -0.838 . . . . 74.519999999999996 109.223 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.41 -33.69 76.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.347 -0.846 . . . . 62.549999999999997 109.67 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -74.14 105.56 5.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 73.109999999999999 109.457 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 23.4 t -68.15 -25.84 65.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.882 . . . . 65.540000000000006 109.758 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 89.0 t -62.76 -48.59 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.189 -0.944 . . . . 75.549999999999997 109.84 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.415 ' CD1' ' NZ ' ' B' ' 97' ' ' LYS . 28.5 mt -68.22 -25.95 65.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 70.140000000000001 109.585 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.39 -34.58 25.5 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.919 -1.672 . . . . 75.400000000000006 108.919 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.55 -46.8 83.05 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.847 -1.301 . . . . 65.439999999999998 109.847 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -67.25 -43.83 80.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.057 -1.261 . . . . 60.210000000000001 109.271 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 91.1 mt -63.51 -38.47 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.957 -1.089 . . . . 75.150000000000006 108.57 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -60.69 -42.98 98.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.34 -0.85 . . . . 73.010000000000005 109.376 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -86.79 -0.09 55.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.147 -0.971 . . . . 74.299999999999997 109.161 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.47 -56.49 2.25 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.489 -1.444 . . . . 70.540000000000006 109.489 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.402 HD23 ' H ' ' B' ' 21' ' ' ASN . 1.5 pt? -72.13 -22.95 61.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -1.12 . . . . 71.340000000000003 109.613 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . 0.402 ' H ' HD23 ' B' ' 20' ' ' LEU . 2.3 m120 -52.56 -35.19 53.24 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.096 -1.002 . . . . 64.409999999999997 109.205 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 59.1 t -54.94 -46.12 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 74.230000000000004 108.842 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.472 ' NZ ' HG11 ' B' ' 106' ' ' VAL . 35.1 mmtm -59.72 -53.36 58.88 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.884 -0.784 . . . . 63.420000000000002 108.884 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.27 36.77 0.23 Allowed Glycine 0 N--CA 1.5 2.901 0 N-CA-C 110.088 -1.205 . . . . 53.43 110.088 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -119.16 160.47 22.05 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.455 -1.027 . . . . 71.120000000000005 109.309 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 26.3 mtt -105.05 141.94 35.73 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.659 -0.867 . . . . 75.239999999999995 108.659 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.92 150.14 44.19 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.227 -0.921 . . . . 72.120000000000005 109.878 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' B' ' 28' ' ' ASP . 42.0 p30 -131.78 157.57 43.5 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.98 -0.748 . . . . 72.310000000000002 108.98 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.38 137.7 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.475 -0.765 . . . . 64.430000000000007 109.508 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.6 p -136.2 170.3 16.24 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.005 -0.739 . . . . 65.409999999999997 109.005 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -92.18 -107.32 0.11 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.199 -0.938 . . . . 71.019999999999996 109.935 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 60.2 p -78.54 169.67 17.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.225 -0.922 . . . . 51.109999999999999 110.189 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 56.4 mt -53.36 -33.16 52.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.601 -0.687 . . . . 71.239999999999995 109.815 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -51.26 -48.3 62.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 74.319999999999993 109.745 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -65.76 -43.79 87.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 73.030000000000001 109.409 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.02 -42.13 94.82 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.558 -1.417 . . . . 30.210000000000001 109.558 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -65.31 -41.3 94.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -1.122 . . . . 74.420000000000002 109.438 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . 0.452 ' O ' ' OD1' ' B' ' 41' ' ' ASP . 63.5 t80 -76.36 -21.3 56.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 74.420000000000002 109.892 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 12.5 tp -88.64 -36.47 16.24 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.078 -1.014 . . . . 75.409999999999997 109.875 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.3 ppp? -80.13 -29.09 38.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.175 -0.953 . . . . 60.409999999999997 110.474 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' B' ' 42' ' ' ILE . 30.4 p-10 -54.24 -32.27 55.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.966 -1.084 . . . . 53.229999999999997 109.758 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.547 ' N ' ' OD1' ' B' ' 41' ' ' ASP . 12.4 pt -84.39 -35.76 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.18 -0.95 . . . . 71.230000000000004 109.811 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.605 ' NE ' ' NH1' ' B' ' 2' ' ' ARG . 76.0 mtp180 -131.44 141.41 49.81 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.398 -0.813 . . . . 72.219999999999999 109.481 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -97.07 134.91 39.79 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.196 -0.94 . . . . 63.539999999999999 109.437 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -101.51 161.62 13.5 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.351 -0.843 . . . . 64.349999999999994 109.471 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -90.68 -42.51 10.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.178 -0.951 . . . . 62.219999999999999 109.236 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.507 ' C ' HD13 ' B' ' 47' ' ' LEU . 0.9 OUTLIER -104.3 109.78 21.75 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.782 -0.822 . . . . 73.120000000000005 108.782 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.452 ' N ' HD13 ' B' ' 47' ' ' LEU . 66.4 t -92.59 99.11 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.252 -0.905 . . . . 65.109999999999999 108.611 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.637 ' HG3' HD22 ' B' ' 5' ' ' LEU . 3.5 tpp -113.75 129.77 56.53 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.643 -0.66 . . . . 73.439999999999998 109.574 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.677 ' HB ' HD12 ' B' ' 6' ' ' ILE . 0.3 OUTLIER -147.8 126.51 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.506 -0.746 . . . . 34.5 109.223 179.302 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 4.0 m -91.22 14.42 14.37 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.55 -0.718 . . . . 73.209999999999994 109.58 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.538 ' H ' HG22 ' B' ' 50' ' ' VAL . 57.5 m-20 -75.92 145.36 40.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.152 -0.967 . . . . 70.409999999999997 109.485 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -77.42 -36.57 53.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 65.0 109.931 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -77.07 12.33 1.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -0.985 . . . . 75.209999999999994 109.492 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.72 -26.17 68.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.347 -0.846 . . . . 55.329999999999998 110.099 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.48 ' N ' HD12 ' B' ' 56' ' ' LEU . 11.1 mp -45.89 -37.08 5.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.159 -0.963 . . . . 63.140000000000001 109.96 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 83.9 p -74.92 -46.22 37.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.031 -1.043 . . . . 63.5 109.901 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . 0.6 ' CE2' HD11 ' B' ' 62' ' ' ILE . 63.8 t80 -64.83 -50.77 65.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 72.329999999999998 110.11 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.433 HG23 ' N ' ' B' ' 60' ' ' SER . 13.6 m -59.41 -36.7 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.755 -1.215 . . . . 74.540000000000006 109.764 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . 0.433 ' N ' HG23 ' B' ' 59' ' ' VAL . 33.2 t -57.48 -49.14 77.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 71.239999999999995 109.791 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -71.35 -27.7 63.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.031 -1.043 . . . . 74.310000000000002 109.88 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.6 HD11 ' CE2' ' B' ' 58' ' ' PHE . 4.8 mm -61.42 -51.25 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.839 -1.163 . . . . 72.140000000000001 109.261 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -64.28 -40.51 96.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.015 . . . . 73.319999999999993 109.326 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -68.43 -41.69 79.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.235 -0.915 . . . . 73.120000000000005 108.54 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -81.67 -76.98 0.23 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.371 -0.831 . . . . 72.439999999999998 109.224 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.528 ' O ' HG22 ' B' ' 69' ' ' ILE . 73.1 m-70 -92.94 91.62 7.48 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.211 -0.93 . . . . 63.310000000000002 108.97 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 80.6 p -77.29 -30.49 54.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 73.099999999999994 110.067 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 53.1 p -82.71 54.02 2.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.124 -0.985 . . . . 71.530000000000001 109.702 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.528 HG22 ' O ' ' B' ' 66' ' ' HIS . 16.7 tt -146.81 159.69 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.198 -0.939 . . . . 74.400000000000006 109.326 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 46.8 t -97.88 154.34 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.113 -0.992 . . . . 75.120000000000005 109.093 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 12.7 t -143.56 121.54 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.041 -1.037 . . . . 73.200000000000003 109.795 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.636 ' HG ' HD11 ' B' ' 95' ' ' ILE . 3.2 mp -121.77 99.67 6.58 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.463 -0.94 . . . . 73.340000000000003 108.463 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.511 ' O ' HG13 ' B' ' 73' ' ' VAL . 12.2 p -90.86 126.52 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 73.5 108.638 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.72 171.72 8.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.012 -1.055 . . . . 64.340000000000003 108.813 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.428 ' OG ' ' OE1' ' B' ' 82' ' ' GLU . 8.0 t -162.01 119.27 2.14 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.932 -1.105 . . . . 74.530000000000001 110.159 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.5 p30 -67.33 -1.09 4.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 64.5 109.389 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . 0.454 ' O ' ' N ' ' B' ' 79' ' ' THR . 11.9 p-10 -133.98 77.13 63.03 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 108.912 -0.773 . . . . 74.25 108.912 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.5 75.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.676 2.251 . . . . 74.430000000000007 112.033 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.454 ' N ' ' O ' ' B' ' 77' ' ' ASN . 75.1 p -98.74 148.28 24.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.128 -0.983 . . . . 73.120000000000005 109.197 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -32.62 74.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.91 . . . . 71.010000000000005 109.442 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.37 -33.19 74.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.008 . . . . 63.200000000000003 109.093 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . 0.428 ' OE1' ' OG ' ' B' ' 75' ' ' SER . 63.1 tt0 -73.12 -38.06 66.45 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.314 -0.866 . . . . 73.219999999999999 109.304 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' B' ' 83' ' ' GLU . 0.4 OUTLIER -57.62 -52.07 66.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 74.299999999999997 109.351 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 14.4 m -59.94 -38.96 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -0.969 . . . . 73.310000000000002 109.405 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -67.7 -35.42 78.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.118 -0.989 . . . . 73.239999999999995 109.303 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -65.56 -36.85 84.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 55.329999999999998 109.833 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -83.81 -38.64 21.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.045 -1.034 . . . . 74.140000000000001 109.238 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -68.22 -44.19 76.31 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.303 -0.873 . . . . 64.040000000000006 109.485 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -66.66 -48.91 67.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 72.349999999999994 109.595 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 141.65 75.45 0.04 OUTLIER Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.859 -1.296 . . . . 65.200000000000003 109.859 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -136.6 138.88 41.67 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.327 -1.102 . . . . 52.229999999999997 109.136 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.43 -44.25 52.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 73.319999999999993 109.348 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -153.81 166.1 33.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.352 -0.842 . . . . 72.219999999999999 109.531 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.527 ' CD1' ' O ' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -136.85 139.51 41.74 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.012 -0.736 . . . . 64.420000000000002 109.012 -178.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 0.806 ' N ' HD12 ' B' ' 95' ' ' ILE . 0.5 OUTLIER -132.45 151.43 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.512 -0.743 . . . . 72.230000000000004 110.25 -179.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.5 124.65 23.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.814 -1.179 . . . . 25.239999999999998 108.101 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.667 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -47.0 -55.25 15.86 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.985 -1.072 . . . . 64.319999999999993 111.103 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 4.2 Cg_endo -41.93 -10.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.124 0 C-N-CA 120.853 1.035 . . . . 63.329999999999998 112.734 -177.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . 0.667 ' N ' ' O ' ' B' ' 97' ' ' LYS . 51.7 m-85 61.05 128.29 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.353 -0.61 . . . . 75.129999999999995 109.353 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -72.34 -29.66 64.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.961 -1.087 . . . . 74.230000000000004 109.42 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . 0.719 ' O ' ' N ' ' B' ' 103' ' ' LYS . 30.2 t -175.08 31.6 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.944 -1.097 . . . . 63.340000000000003 111.115 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 36.8 mm 52.34 -70.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.48 -0.763 . . . . 74.439999999999998 110.129 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' B' ' 101' ' ' SER . 67.2 mmtt -57.99 -33.0 68.45 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.18 -1.044 . . . . 71.109999999999999 108.18 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.27 -44.32 96.81 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.176 -1.046 . . . . 71.450000000000003 108.176 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 17.4 tp -64.5 -46.68 81.95 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.565 -0.902 . . . . 51.310000000000002 108.565 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . 0.472 HG11 ' NZ ' ' B' ' 23' ' ' LYS . 76.9 t -58.86 -41.31 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.976 . . . . 65.230000000000004 109.165 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.23 -36.63 71.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.316 -0.865 . . . . 24.32 109.131 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 54.4 ttt85 -79.44 -26.89 41.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.306 -0.871 . . . . 75.310000000000002 109.906 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 93.7 mt -76.48 -43.71 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.032 -1.043 . . . . 54.240000000000002 108.731 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' B' ' 114' ' ' ARG . 23.9 pt-20 -70.25 -28.39 65.21 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.336 -0.945 . . . . 65.310000000000002 108.714 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . 0.532 ' HB1' ' CE1' ' A' ' 87' ' ' PHE . . . -63.34 -49.24 74.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.409 -0.807 . . . . 72.239999999999995 109.397 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -61.5 -42.32 98.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.224 -0.922 . . . . 72.040000000000006 109.702 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 45.6 mt -120.0 49.51 1.39 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.458 -0.776 . . . . 75.349999999999994 109.569 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.529 ' N ' ' O ' ' B' ' 110' ' ' GLU . 1.2 tmt_? -65.37 -59.13 4.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -0.951 . . . . 75.5 109.232 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -69.36 -47.98 62.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 65.329999999999998 109.476 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 116' ' ' TRP . . . . . 0.526 ' O ' ' CD2' ' B' ' 116' ' ' TRP . 76.8 t90 45.83 58.59 4.24 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.313 -0.867 . . . . 74.450000000000003 109.791 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 171.13 94.69 0.1 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.414 -1.474 . . . . 44.210000000000001 109.414 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 48.7 m -144.9 170.63 15.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.295 -1.121 . . . . 71.400000000000006 109.637 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' B' ' 119' ' ' ASN . 0.0 OUTLIER -157.15 124.11 5.12 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.007 -0.738 . . . . 72.319999999999993 109.007 -178.386 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 77.7 t -77.95 -35.83 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 75.019999999999996 110.229 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . 0.412 HD12 ' N ' ' B' ' 121' ' ' ILE . 4.9 mp -113.54 140.86 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.334 -0.853 . . . . 51.409999999999997 109.544 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -145.48 119.22 9.21 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.194 -0.941 . . . . 71.530000000000001 109.566 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 6.8 pt -130.54 130.76 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.387 -0.821 . . . . 72.430000000000007 109.124 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 44.11 -136.27 5.48 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.797 -1.321 . . . . 51.229999999999997 109.797 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' B' ' 125' ' ' ASP . 20.3 p-10 -89.09 0.98 56.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -1.136 . . . . 74.200000000000003 109.035 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.0 134.63 40.12 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.36 -0.978 . . . . 75.420000000000002 108.36 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 8.4 m -130.17 143.72 50.94 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.393 -0.817 . . . . 74.219999999999999 109.471 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 25.2 mt -127.7 128.76 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.542 -0.724 . . . . 60.329999999999998 109.633 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 49.9 m -119.79 92.64 46.75 Favored Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 108.974 -0.75 . . . . 72.310000000000002 108.974 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.24 -22.27 9.85 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.134 1.889 . . . . 75.129999999999995 112.613 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -52.09 -46.33 65.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.033 -1.042 . . . . 75.230000000000004 108.985 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -103.13 16.47 26.52 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.385 -0.822 . . . . 72.430000000000007 109.021 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 51.77 58.3 5.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.222 -0.924 . . . . 75.129999999999995 108.866 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -137.38 124.4 21.51 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.547 -0.72 . . . . 73.219999999999999 109.204 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . 0.441 HG23 ' O ' ' B' ' 135' ' ' ILE . 18.5 tt -107.09 129.9 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.368 -0.832 . . . . 64.140000000000001 109.097 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 5.7 mm -108.83 126.35 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.471 -0.768 . . . . 71.219999999999999 109.281 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . 0.494 ' C ' ' H ' ' B' ' 139' ' ' GLY . 78.8 t80 -140.26 148.01 40.83 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.526 -0.916 . . . . 64.219999999999999 108.526 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . 0.486 ' O ' ' NH1' ' B' ' 140' ' ' ARG . 40.3 tttp 54.54 6.27 0.11 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.344 -0.848 . . . . 72.019999999999996 109.619 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' B' ' 137' ' ' TYR . . . 94.61 -5.14 69.88 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.072 -1.211 . . . . 74.319999999999993 110.072 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . 0.511 ' N ' ' CD ' ' B' ' 140' ' ' ARG . 10.7 mpt_? -88.9 142.84 27.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.151 -1.206 . . . . 75.340000000000003 109.042 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -94.17 129.13 40.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.273 -0.892 . . . . 71.230000000000004 109.552 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 39.0 t -131.23 129.03 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.45 -0.781 . . . . 70.430000000000007 109.391 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -99.14 142.79 30.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.237 -0.915 . . . . 72.430000000000007 109.318 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 144' ' ' VAL . . . . . 0.505 ' CG2' ' CG ' ' B' ' 149' ' ' PHE . 11.9 p -141.5 157.05 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.297 -0.877 . . . . 72.129999999999995 109.593 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . 0.444 ' N ' HG22 ' B' ' 144' ' ' VAL . 13.2 ptpt -165.85 116.36 1.03 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.886 . . . . 72.019999999999996 109.635 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 168.34 -178.95 41.69 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.779 -1.728 . . . . 42.229999999999997 108.779 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . 0.563 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 1.3 mptp? -79.45 -44.22 1.63 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.052 -1.263 . . . . 73.299999999999997 109.558 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 25.3 Cg_exo -62.34 -15.69 46.62 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 122.552 2.168 . . . . 71.329999999999998 112.33 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . 0.505 ' CG ' ' CG2' ' B' ' 144' ' ' VAL . 23.3 m-85 -100.69 -35.5 9.45 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.359 -0.838 . . . . 74.230000000000004 110.153 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -58.06 -27.77 63.93 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.229 -0.919 . . . . 72.340000000000003 108.774 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.541 HG13 ' N ' ' B' ' 152' ' ' LEU . 8.5 p -65.91 -44.89 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.207 -0.933 . . . . 73.349999999999994 108.515 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.541 ' N ' HG13 ' B' ' 151' ' ' VAL . 32.3 tp -55.47 -41.86 73.53 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.745 -0.835 . . . . 55.240000000000002 108.745 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 18.6 p -71.35 -29.45 65.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.397 -0.814 . . . . 70.010000000000005 109.665 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -59.27 -57.44 13.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.062 -1.024 . . . . 65.319999999999993 109.719 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . 0.421 ' H ' HD23 ' B' ' 155' ' ' LEU . 0.0 OUTLIER -68.55 -23.52 64.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.049 -1.032 . . . . 71.540000000000006 109.053 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.26 -50.48 73.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.103 -0.998 . . . . 75.319999999999993 109.79 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 45.9 mtt180 -71.1 -41.72 70.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.09 -1.006 . . . . 73.319999999999993 109.425 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -78.25 35.42 0.22 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.51 -0.744 . . . . 74.140000000000001 109.812 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . 0.582 ' NH1' ' CZ ' ' B' ' 214' ' ' PHE . 52.6 ttm-85 -70.24 163.14 27.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.967 . . . . 61.409999999999997 108.914 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 51.94 44.91 29.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.053 -1.03 . . . . 72.099999999999994 109.439 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -154.42 -175.82 5.59 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.279 -0.888 . . . . 72.25 109.944 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 70.1 mt -112.65 138.17 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.194 -0.669 . . . . 72.310000000000002 109.194 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.66 138.23 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.535 -0.728 . . . . 64.209999999999994 109.079 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 164' ' ' SER . . . . . 0.542 ' H ' HE21 ' B' ' 167' ' ' GLN . 13.5 p -92.8 161.5 14.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.308 -0.87 . . . . 74.219999999999999 109.882 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -62.71 -49.59 74.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.476 -0.765 . . . . 65.310000000000002 109.465 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . 0.587 ' H ' ' CD ' ' B' ' 166' ' ' GLU . 49.9 mp0 -62.11 -35.18 77.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.346 -0.846 . . . . 63.450000000000003 109.656 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 167' ' ' GLN . . . . . 0.542 HE21 ' H ' ' B' ' 164' ' ' SER . 9.5 tt0 -59.25 -35.87 74.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.161 -0.962 . . . . 72.400000000000006 109.433 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 92.1 mt -68.69 -50.34 51.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.127 -0.983 . . . . 72.319999999999993 109.492 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 9.4 mp -58.92 -43.84 91.18 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.141 -0.974 . . . . 73.340000000000003 109.264 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -75.93 -21.98 56.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.094 -1.004 . . . . 72.099999999999994 109.974 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . 0.444 ' C ' HD12 ' B' ' 172' ' ' ILE . . . -69.67 -46.86 65.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.9 -1.125 . . . . 62.130000000000003 109.66 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 0.736 ' N ' HD12 ' B' ' 172' ' ' ILE . 1.6 mp -94.56 -54.62 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.227 -0.92 . . . . 71.420000000000002 109.163 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 29.4 m-90 . . . . . 0 N--CA 1.494 1.758 0 O-C-N 121.213 -0.929 . . . . 72.230000000000004 109.724 -179.69 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 N--CA 1.493 1.455 0 CA-C-O 121.395 0.498 . . . . 65.219999999999999 111.259 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -148.79 -8.78 0.36 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.283 -0.886 . . . . 72.310000000000002 109.884 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 47.5 t -60.13 -24.15 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.087 -1.008 . . . . 63.32 109.618 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 41.8 mt -55.23 -48.23 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.353 -0.842 . . . . 75.030000000000001 110.625 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -63.47 -37.0 85.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 64.109999999999999 110.484 -178.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.78 -42.81 54.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.305 -0.872 . . . . 73.0 110.685 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.82 -47.32 47.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.788 -1.195 . . . . 61.119999999999997 110.491 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 188' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' B' ' 189' ' ' ASN . 9.3 tp -65.11 -41.94 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.021 -1.049 . . . . 72.430000000000007 110.48 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 189' ' ' ASN . . . . . 0.456 ' C ' HD22 ' B' ' 189' ' ' ASN . 0.5 OUTLIER -61.64 -47.47 85.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.998 -1.064 . . . . 65.140000000000001 109.959 -179.614 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -65.03 -50.97 64.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.154 -0.966 . . . . 63.240000000000002 110.05 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 75.8 mt -49.31 -34.22 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.125 -0.984 . . . . 74.030000000000001 109.752 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -48.57 64.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.113 -0.992 . . . . 72.239999999999995 108.98 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -71.18 -25.3 62.47 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.244 -0.91 . . . . 73.099999999999994 110.074 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -88.35 -19.91 26.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.371 -0.83 . . . . 72.109999999999999 109.862 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 195' ' ' MET . . . . . 0.445 ' SD ' HD11 ' B' ' 152' ' ' LEU . 6.2 ttt -103.57 -45.26 4.88 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.355 -0.841 . . . . 44.329999999999998 110.575 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -59.26 -40.29 85.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.081 -1.012 . . . . 71.209999999999994 110.471 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . 0.439 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 0.9 OUTLIER -58.22 -65.23 2.01 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.12 -0.988 . . . . 75.209999999999994 110.545 -179.268 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 198' ' ' PRO . . . . . 0.448 ' O ' ' CZ ' ' B' ' 137' ' ' TYR . 19.4 Cg_endo -56.88 -53.98 4.32 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.568 1.512 . . . . 75.319999999999993 112.238 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' B' ' 201' ' ' ILE . 11.1 mp -63.1 -34.18 77.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.134 -0.979 . . . . 72.25 109.084 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 74.7 -37.15 1.03 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.706 -1.358 . . . . 64.530000000000001 109.706 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . 0.435 ' H ' ' C ' ' B' ' 199' ' ' LEU . 39.7 mm -93.15 132.5 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.285 -1.127 . . . . 44.229999999999997 109.386 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 14.4 t -77.22 135.16 38.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 54.009999999999998 108.861 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . 0.454 ' O ' ' CE1' ' B' ' 214' ' ' PHE . 16.1 p -144.22 40.41 1.35 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.279 -0.888 . . . . 74.400000000000006 109.628 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 7.2 m -141.2 142.55 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.135 -0.978 . . . . 72.120000000000005 109.631 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -121.71 136.09 54.94 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.929 -0.767 . . . . 65.409999999999997 108.929 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.12 135.99 46.61 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.377 -0.827 . . . . 71.329999999999998 109.712 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.42 ' O ' HG13 ' B' ' 207' ' ' VAL . 13.1 p -141.7 131.83 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.295 -0.878 . . . . 63.5 109.129 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -80.27 -25.08 39.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.172 -0.955 . . . . 74.450000000000003 109.814 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 60.1 mtp85 -48.85 -27.49 3.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 74.140000000000001 109.818 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -151.92 -67.74 0.17 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.088 -1.007 . . . . 74.430000000000007 109.694 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 211' ' ' GLY . . . . . 0.424 ' C ' ' CD1' ' B' ' 212' ' ' TYR . . . -162.84 -100.8 0.15 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.859 -1.296 . . . . 64.450000000000003 109.859 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 212' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' B' ' 211' ' ' GLY . 38.6 m-85 -137.17 158.38 44.58 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.458 -1.025 . . . . 74.209999999999994 109.389 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -130.96 125.88 34.56 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.548 -0.72 . . . . 74.030000000000001 109.694 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . 0.582 ' CZ ' ' NH1' ' B' ' 159' ' ' ARG . 0.3 OUTLIER -85.59 119.56 26.07 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.348 -0.982 . . . . 74.340000000000003 108.348 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 48.3 t -132.66 149.5 52.29 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.189 -0.671 . . . . 64.329999999999998 109.189 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.15 164.05 3.9 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.188 -0.945 . . . . 70.040000000000006 108.631 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.03 -161.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.658 2.239 . . . . 65.109999999999999 111.586 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 43.9 mttm . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.144 -0.972 . . . . 73.150000000000006 109.037 179.852 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.55 ' SD ' ' CE2' ' A' ' 25' ' ' PHE . 12.1 ptp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.442 -0.577 . . . . 65.120000000000005 109.442 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.3 mtt85 -141.49 149.58 41.1 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.319 -0.863 . . . . 72.329999999999998 109.315 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 80.3 t -114.45 141.04 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.633 -0.667 . . . . 71.420000000000002 109.495 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.533 HD11 ' CG1' ' A' ' 6' ' ' ILE . 4.6 tp -112.35 118.81 36.25 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.532 -0.73 . . . . 65.120000000000005 109.583 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 4' ' ' LEU . 18.3 mt -115.74 101.94 9.27 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.479 -0.763 . . . . 62.43 109.18 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.533 ' CG1' HD11 ' A' ' 4' ' ' LEU . 76.6 mt -97.27 107.92 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.228 -0.92 . . . . 71.150000000000006 108.839 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.535 ' OE2' ' NZ ' ' A' ' 97' ' ' LYS . 53.5 tt0 -151.28 129.53 11.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.259 -0.901 . . . . 75.340000000000003 109.557 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -62.66 -33.04 74.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -0.895 . . . . 72.439999999999998 109.377 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -76.82 95.08 3.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.903 . . . . 63.020000000000003 109.329 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.0 t -61.11 -25.2 66.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.343 -0.848 . . . . 72.340000000000003 109.683 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.08 -53.95 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.964 . . . . 74.019999999999996 109.844 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.548 HD13 ' NZ ' ' A' ' 97' ' ' LYS . 49.5 mt -64.37 -44.07 92.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.941 . . . . 71.430000000000007 109.678 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.29 -24.63 75.96 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.123 -1.991 . . . . 61.32 108.123 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.75 -57.0 10.56 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 109.702 -1.359 . . . . 71.200000000000003 109.702 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -53.5 -45.87 69.83 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.313 -1.11 . . . . 71.319999999999993 109.651 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 78.4 mt -67.34 -45.59 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.757 -1.214 . . . . 63.229999999999997 109.041 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -51.29 -48.39 62.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.127 -0.983 . . . . 51.109999999999999 109.358 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.402 ' HB3' ' HZ2' ' A' ' 18' ' ' LYS . 15.3 ttpp -86.59 -0.09 55.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.248 -0.907 . . . . 73.340000000000003 109.19 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.6 -59.03 2.43 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.847 -1.301 . . . . 62.149999999999999 109.847 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -71.49 -20.9 62.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -1.171 . . . . 73.510000000000005 109.938 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -57.65 -31.59 66.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.119 -0.988 . . . . 74.25 109.576 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.5 t -59.34 -29.76 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.871 . . . . 70.040000000000006 109.189 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.719 ' HZ1' ' HZ1' ' A' ' 103' ' ' LYS . 32.3 mmtt -76.51 5.44 7.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.423 -0.798 . . . . 73.230000000000004 109.267 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.57 25.39 56.73 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.12 -1.192 . . . . 75.540000000000006 110.12 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CE2' ' SD ' ' A' ' 1' ' ' MET . 8.7 m-85 -102.02 156.86 17.27 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.287 -1.125 . . . . 73.430000000000007 109.119 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.3 mmt -107.07 136.61 46.64 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.461 -0.941 . . . . 43.240000000000002 108.461 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.49 165.79 26.98 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.191 -0.943 . . . . 62.109999999999999 109.949 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.413 ' OD2' ' CD2' ' A' ' 39' ' ' LEU . 25.3 t70 -139.65 150.3 44.77 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.432 -0.792 . . . . 74.420000000000002 108.995 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.33 139.48 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.483 -0.761 . . . . 72.150000000000006 109.276 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 p -137.84 176.1 9.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.381 -0.824 . . . . 71.420000000000002 109.295 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -97.73 -104.47 0.19 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.331 -0.856 . . . . 72.329999999999998 109.77 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.3 m -77.99 166.57 22.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.227 -0.92 . . . . 74.239999999999995 110.158 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.4 mt -51.0 -35.46 34.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.606 -0.684 . . . . 71.530000000000001 109.853 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -51.9 -50.31 61.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.18 -0.95 . . . . 74.230000000000004 109.947 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -63.82 -40.06 95.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.108 -0.995 . . . . 54.030000000000001 109.247 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.05 -38.48 63.81 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.344 -1.502 . . . . 61.409999999999997 109.344 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -63.63 -42.92 98.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -1.121 . . . . 74.340000000000003 109.499 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -72.55 -34.04 67.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 75.329999999999998 109.555 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.413 ' CD2' ' OD2' ' A' ' 28' ' ' ASP . 21.1 tp -71.45 -49.54 40.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.891 . . . . 74.329999999999998 109.966 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 40' ' ' MET . 3.9 ppp? -67.67 -22.96 65.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.076 -1.015 . . . . 70.319999999999993 109.849 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -59.58 -38.06 80.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.178 -0.951 . . . . 71.219999999999999 110.002 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.3 pt -85.47 -29.82 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.157 -0.964 . . . . 74.140000000000001 110.325 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 40' ' ' MET . 65.8 mtt85 -130.39 144.67 51.53 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.237 -0.915 . . . . 72.239999999999995 109.784 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -99.07 127.62 45.04 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.308 -0.87 . . . . 75.420000000000002 109.24 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -99.66 145.36 27.68 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.298 -0.876 . . . . 74.230000000000004 109.534 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -79.1 -35.72 41.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 72.040000000000006 109.282 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.549 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -110.15 116.85 32.27 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.652 -0.87 . . . . 72.129999999999995 108.652 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.549 ' N ' HD13 ' A' ' 47' ' ' LEU . 50.6 t -102.71 100.43 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.429 -0.952 . . . . 72.340000000000003 108.429 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.434 ' CE ' ' OH ' ' A' ' 99' ' ' TYR . 21.0 ttt -115.5 136.76 52.75 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.546 0.689 . . . . 74.109999999999999 110.079 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.605 HG22 ' H ' ' A' ' 52' ' ' ASP . 1.5 p -145.07 132.22 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.57 -0.706 . . . . 61.119999999999997 109.628 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.0 m -92.78 2.03 56.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.457 -0.777 . . . . 73.109999999999999 109.253 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.605 ' H ' HG22 ' A' ' 50' ' ' VAL . 51.5 m-20 -76.95 142.23 40.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 52.549999999999997 109.508 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.412 ' C ' ' H ' ' A' ' 55' ' ' ALA . 15.5 ptpt -81.15 -31.15 34.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.22 -0.925 . . . . 44.219999999999999 110.092 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -74.02 10.8 1.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.088 -1.008 . . . . 70.439999999999998 109.354 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.412 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -67.4 -21.05 65.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.427 -0.796 . . . . 64.140000000000001 110.253 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.6 mt -43.13 -48.42 6.33 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.255 -0.903 . . . . 44.140000000000001 110.067 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.2 m -68.75 -36.23 78.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.01 -1.056 . . . . 55.229999999999997 108.743 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -64.73 -64.86 0.77 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.368 -0.833 . . . . 74.439999999999998 109.579 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.1 m -48.27 -32.55 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.68 -1.263 . . . . 74.030000000000001 109.646 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.9 t -57.41 -50.53 72.71 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.227 -0.921 . . . . 64.299999999999997 109.074 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.413 ' HG2' ' H ' ' A' ' 61' ' ' ARG . 7.0 ptp180 -72.33 -34.74 68.29 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.19 -1.004 . . . . 64.439999999999998 110.128 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.8 mm -67.36 -33.48 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.599 -1.313 . . . . 63.210000000000001 109.422 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -68.25 -48.9 63.83 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.231 -0.918 . . . . 74.420000000000002 110.248 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.414 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 17.2 pt-20 -75.39 -40.68 57.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.958 -1.089 . . . . 70.319999999999993 110.308 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.521 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 54.9 mttp -73.85 -21.68 60.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.198 -0.939 . . . . 75.219999999999999 110.015 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.521 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 84.4 m-70 -156.79 64.63 0.52 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.013 -1.054 . . . . 74.129999999999995 109.677 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.3 t -61.42 -28.15 69.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.935 . . . . 73.239999999999995 109.683 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 84.6 p -64.33 -20.73 66.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.266 -0.896 . . . . 61.009999999999998 110.107 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 70' ' ' VAL . 78.3 mt -82.72 159.18 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.065 -1.022 . . . . 71.329999999999998 109.772 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.471 ' N ' HG22 ' A' ' 69' ' ' ILE . 98.4 t -95.39 149.65 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.455 -0.778 . . . . 72.129999999999995 109.213 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.0 t -130.53 126.94 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.421 -0.799 . . . . 54.210000000000001 109.71 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.0 tt -121.89 101.95 7.88 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.493 -0.755 . . . . 50.240000000000002 109.063 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 69.4 t -90.37 145.88 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 74.409999999999997 109.154 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.7 m -128.54 155.6 44.63 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.325 -0.859 . . . . 72.310000000000002 108.751 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.6 m -165.47 144.32 6.32 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.979 -1.075 . . . . 64.540000000000006 110.68 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -86.88 19.83 2.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.482 -0.761 . . . . 74.129999999999995 109.753 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 79' ' ' THR . 55.4 t30 -138.91 55.58 7.95 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.302 -0.874 . . . . 73.340000000000003 109.397 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 77' ' ' ASN . 15.1 Cg_endo -57.5 77.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.364 2.043 . . . . 63.219999999999999 111.532 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.464 HG23 ' H ' ' A' ' 82' ' ' GLU . 12.5 t -102.81 171.84 7.18 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.56 -0.904 . . . . 62.530000000000001 108.56 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 p -75.74 -20.63 58.17 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.2 -0.938 . . . . 73.439999999999998 110.081 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.511 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 77.1 tt0 -69.52 -49.91 50.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.043 -1.036 . . . . 71.420000000000002 109.533 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.464 ' H ' HG23 ' A' ' 79' ' ' THR . 98.9 mt-10 -73.82 -27.6 61.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 73.430000000000007 109.576 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -61.26 -56.68 17.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 74.219999999999999 109.85 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.524 HG23 ' N ' ' A' ' 85' ' ' HIS . 31.7 m -65.58 -43.61 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 73.200000000000003 109.812 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.524 ' N ' HG23 ' A' ' 84' ' ' VAL . 32.2 m80 -63.44 -31.23 72.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.112 -0.993 . . . . 53.329999999999998 109.701 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.32 -45.56 79.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.085 -1.01 . . . . 64.109999999999999 109.809 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -79.98 -30.35 39.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.091 -1.005 . . . . 74.340000000000003 109.207 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -71.97 -51.58 21.25 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.309 -0.869 . . . . 74.420000000000002 109.254 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -60.68 -48.58 81.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.499 -0.751 . . . . 74.239999999999995 109.622 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.16 70.82 0.02 OUTLIER Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.332 -1.107 . . . . 61.509999999999998 110.332 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.02 125.1 43.97 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.439 -1.036 . . . . 55.329999999999998 108.634 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -77.09 -27.51 54.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.999 -1.063 . . . . 73.420000000000002 109.428 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 94' ' ' TYR . 13.3 t0 -151.81 162.38 41.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 75.040000000000006 109.059 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.526 ' N ' ' OD1' ' A' ' 93' ' ' ASP . 58.3 t80 -148.3 101.82 3.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.208 -0.933 . . . . 71.329999999999998 109.484 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.1 mm -104.83 150.65 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.475 0 O-C-N 121.179 -0.951 . . . . 71.129999999999995 110.682 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.38 123.71 20.73 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.408 -1.33 . . . . 64.319999999999993 107.408 178.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.683 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -43.18 -57.68 4.98 Favored Pre-proline 0 C--N 1.3 -1.583 0 O-C-N 121.217 -0.927 . . . . 62.200000000000003 112.298 -178.364 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 6.7 Cg_endo -43.27 -7.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 120.93 1.087 . . . . 73.109999999999999 112.49 -174.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.683 ' N ' ' O ' ' A' ' 97' ' ' LYS . 58.4 m-85 57.81 120.89 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.07 0.462 . . . . 65.219999999999999 110.268 178.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.529 ' NE ' ' OH ' ' B' ' 94' ' ' TYR . 56.5 mtt-85 -62.06 -44.58 96.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.02 -1.05 . . . . 72.349999999999994 109.327 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.84 ' O ' ' N ' ' A' ' 103' ' ' LYS . 13.0 t -171.83 47.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.091 -1.006 . . . . 71.319999999999993 110.696 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.3 mt 40.21 -66.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 CA-C-N 118.324 0.511 . . . . 75.430000000000007 111.562 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.84 ' N ' ' O ' ' A' ' 101' ' ' SER . 40.9 tptt -47.03 -26.87 1.14 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.098 -1.002 . . . . 71.409999999999997 109.025 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.38 -47.02 52.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.363 -0.836 . . . . 63.240000000000002 109.884 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.4 HD13 ' C ' ' A' ' 105' ' ' LEU . 2.1 tm? -58.95 -57.23 14.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 73.219999999999999 109.324 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.46 HG13 ' N ' ' A' ' 107' ' ' ALA . 7.2 p -52.58 -40.91 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.596 -1.315 . . . . 60.109999999999999 109.222 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.46 ' N ' HG13 ' A' ' 106' ' ' VAL . . . -51.49 -44.04 62.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 70.420000000000002 109.19 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -66.22 -34.71 78.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.206 -0.934 . . . . 74.409999999999997 109.094 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.7 mt -72.09 -26.77 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.152 -0.967 . . . . 62.539999999999999 108.483 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.19 -58.28 5.74 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.689 -0.804 . . . . 74.340000000000003 109.399 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.31 -40.46 67.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.183 -0.948 . . . . 73.319999999999993 109.311 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.415 ' CA ' ' HE ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -62.05 -31.06 71.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -0.866 . . . . 52.409999999999997 109.334 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.477 HD22 ' SD ' ' A' ' 1' ' ' MET . 2.1 tt -156.14 98.21 1.85 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 65.239999999999995 109.597 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.3 mtm180 -92.04 -81.3 0.34 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.189 -0.944 . . . . 64.450000000000003 109.077 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -80.38 -81.93 0.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 74.430000000000007 109.554 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -149.67 -175.91 5.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.304 -0.873 . . . . 74.420000000000002 109.429 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.48 -155.06 4.95 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.395 -1.482 . . . . 75.040000000000006 109.395 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.452 ' C ' ' ND2' ' A' ' 119' ' ' ASN . 68.6 m -134.37 164.82 26.56 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.343 -1.092 . . . . 61.140000000000001 109.569 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.452 ' ND2' ' C ' ' A' ' 118' ' ' SER . 0.0 OUTLIER -139.67 127.15 21.55 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.083 -0.71 . . . . 65.239999999999995 109.083 -178.178 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 56.4 t -89.32 -20.63 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.312 -0.867 . . . . 73.109999999999999 109.551 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.6 HG23 HH12 ' A' ' 159' ' ' ARG . 4.7 mp -117.78 119.7 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.399 -0.813 . . . . 72.239999999999995 109.004 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -140.86 122.81 15.49 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.408 -0.808 . . . . 72.340000000000003 109.748 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.442 ' O ' HG23 ' A' ' 123' ' ' ILE . 15.5 tt -138.33 130.78 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.383 -0.823 . . . . 71.439999999999998 109.143 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.62 -134.72 34.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.281 -1.528 . . . . 73.400000000000006 109.281 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.72 -9.06 45.14 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.07 -1.253 . . . . 74.450000000000003 109.462 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.35 135.73 33.77 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.971 -1.081 . . . . 54.210000000000001 108.915 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 44.2 p -129.33 139.18 51.83 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.457 -0.777 . . . . 54.5 109.122 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 81.3 mt -130.78 131.82 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.399 -0.813 . . . . 45.149999999999999 109.834 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.4 m -126.31 110.86 23.65 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.302 -0.999 . . . . 71.109999999999999 108.302 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.98 -38.47 0.82 Allowed 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.533 1.489 . . . . 65.409999999999997 112.046 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -65.35 -42.54 92.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.177 -0.952 . . . . 63.32 109.238 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 133' ' ' GLU . 44.7 mm-40 -87.82 11.48 15.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.333 -0.854 . . . . 72.519999999999996 109.708 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 132' ' ' GLU . 11.8 pt-20 33.48 61.78 0.43 Allowed 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.209 0.528 . . . . 75.329999999999998 110.846 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -152.74 148.42 27.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.081 -1.012 . . . . 71.230000000000004 110.213 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.2 tt -135.51 144.36 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.507 -0.746 . . . . 74.019999999999996 109.177 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 20.5 mt -125.49 135.37 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.63 -0.878 . . . . 60.229999999999997 108.63 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -139.38 135.68 33.94 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.086 -1.009 . . . . 62.32 110.271 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm 54.01 28.9 9.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.584 -0.698 . . . . 75.400000000000006 110.366 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.42 16.56 75.72 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 120.025 -1.083 . . . . 72.239999999999995 110.9 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -111.01 125.3 53.59 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.343 -1.093 . . . . 71.219999999999999 109.37 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -92.98 123.39 36.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.253 -0.904 . . . . 71.420000000000002 110.279 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.3 p -137.0 138.97 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.251 -1.018 . . . . 53.020000000000003 108.251 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.451 ' N ' ' CD ' ' A' ' 143' ' ' GLU . 19.3 mp0 -99.99 143.9 29.66 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.309 -0.869 . . . . 60.450000000000003 110.406 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.6 m -142.6 130.99 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.481 -0.933 . . . . 74.439999999999998 108.481 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.01 19.58 0.88 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.173 -0.954 . . . . 65.150000000000006 109.736 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.85 173.86 47.46 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.132 -1.587 . . . . 73.340000000000003 109.132 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.619 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 27.2 mttt -69.83 -37.17 7.46 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.138 -1.213 . . . . 72.219999999999999 110.162 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 19.1 Cg_exo -64.48 -18.62 63.56 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.09 1.86 . . . . 65.230000000000004 111.907 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -95.28 -30.9 13.72 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.214 -0.929 . . . . 60.109999999999999 110.009 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -50.43 -35.95 30.97 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.097 -1.002 . . . . 64.209999999999994 109.197 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.6 p -62.2 -33.37 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.138 -0.976 . . . . 72.019999999999996 109.091 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 9.5 tp -67.1 -39.3 86.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.823 . . . . 73.310000000000002 109.248 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 39.1 p -73.95 -29.7 62.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.066 -1.021 . . . . 74.310000000000002 109.388 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -61.81 -57.78 10.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.067 -1.021 . . . . 74.310000000000002 109.742 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 pp -64.43 -29.5 70.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.127 -0.983 . . . . 75.340000000000003 109.192 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.45 -45.83 69.63 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.236 -0.915 . . . . 62.140000000000001 109.046 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -73.05 -46.3 52.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.103 -0.998 . . . . 61.030000000000001 108.915 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -79.59 29.35 0.25 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.593 -0.692 . . . . 74.120000000000005 109.889 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.6 HH12 HG23 ' A' ' 121' ' ' ILE . 19.9 ttp-105 -71.29 44.7 0.09 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.162 -0.961 . . . . 71.129999999999995 109.563 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -171.26 46.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.88 -1.138 . . . . 75.450000000000003 109.915 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -168.39 178.55 4.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.023 -1.048 . . . . 73.409999999999997 109.975 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 66.7 mt -96.25 139.43 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.45 -0.781 . . . . 74.409999999999997 109.244 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 78.7 t -132.28 140.08 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.368 -0.832 . . . . 72.310000000000002 109.617 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 32.3 p -98.88 169.32 9.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.255 -0.903 . . . . 74.120000000000005 109.843 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -67.04 -46.79 73.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.52 -0.738 . . . . 70.430000000000007 109.982 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -53.73 -36.42 62.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.356 -0.84 . . . . 73.519999999999996 109.778 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -61.09 -49.32 77.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.158 -0.964 . . . . 74.519999999999996 109.525 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 38.7 mt -51.27 -40.6 59.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.077 -1.014 . . . . 72.310000000000002 109.027 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.562 HD23 ' C ' ' A' ' 169' ' ' LEU . 4.2 tt -60.65 -65.08 0.75 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.451 -0.781 . . . . 53.329999999999998 109.793 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -66.38 -10.92 48.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.214 -0.929 . . . . 62.439999999999998 110.591 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.424 ' C ' HD12 ' A' ' 172' ' ' ILE . . . -73.25 -52.93 12.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.953 -1.092 . . . . 60.210000000000001 110.033 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.771 ' N ' HD12 ' A' ' 172' ' ' ILE . 1.7 mp -95.77 -52.56 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.019 -1.051 . . . . 75.319999999999993 109.2 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 21.7 m-90 . . . . . 0 N--CA 1.495 1.807 0 O-C-N 121.333 -0.854 . . . . 73.140000000000001 109.259 -179.896 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.497 -0.556 . . . . 64.540000000000006 109.497 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 8.8 p -130.15 -13.69 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.347 -0.846 . . . . 74.019999999999996 110.556 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 58.6 mt -56.55 -27.83 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.749 -1.219 . . . . 72.329999999999998 109.235 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -53.12 -48.94 67.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.317 -0.864 . . . . 74.400000000000006 109.48 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.433 ' H ' HG23 ' A' ' 186' ' ' VAL . 2.2 t -73.79 -28.63 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.474 -0.766 . . . . 70.420000000000002 109.982 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.44 -41.13 66.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.143 -0.973 . . . . 52.109999999999999 111.071 -178.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.7 tp -76.4 -33.97 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.52 -1.363 . . . . 71.400000000000006 109.823 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -66.55 -55.72 14.16 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.272 -0.893 . . . . 73.439999999999998 110.14 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -61.85 -36.74 82.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 71.420000000000002 110.263 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 74.8 mt -69.4 -40.85 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.157 -0.965 . . . . 61.549999999999997 110.227 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 44.1 mtp85 -58.01 -39.12 77.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.88 -1.138 . . . . 63.340000000000003 108.985 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -78.06 -36.61 48.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 61.240000000000002 109.677 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -84.46 2.51 40.54 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.185 -0.947 . . . . 75.129999999999995 110.49 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . 1.014 ' HE1' HG11 ' A' ' 204' ' ' VAL . 44.3 ttp -99.58 -47.16 5.21 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.088 -1.007 . . . . 74.019999999999996 109.662 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -68.82 -32.05 71.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.89 . . . . 74.019999999999996 109.869 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.434 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 1.1 mmtm -55.2 -64.49 2.05 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.23 -0.919 . . . . 75.430000000000007 109.555 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 40.0 Cg_endo -64.17 -53.66 1.1 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.128 1.885 . . . . 72.319999999999993 112.236 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.9 mp -54.71 -56.61 17.41 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.971 -1.08 . . . . 74.540000000000006 109.643 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 100.35 -17.99 56.04 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 109.842 -1.303 . . . . 61.509999999999998 109.842 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 41.2 mt -128.16 147.78 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.341 -1.094 . . . . 61.219999999999999 109.104 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 17.5 t -77.96 136.6 38.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.971 -1.08 . . . . 72.0 109.278 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.21 15.87 1.88 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.203 -0.935 . . . . 74.439999999999998 109.302 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 1.014 HG11 ' HE1' ' A' ' 195' ' ' MET . 31.2 m -127.42 152.32 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.551 -0.718 . . . . 64.349999999999994 110.089 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -126.95 130.56 50.34 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.878 -0.786 . . . . 71.409999999999997 108.878 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 4.2 t -98.84 127.23 44.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.196 -0.94 . . . . 73.519999999999996 109.06 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 209' ' ' ARG . 8.5 p -145.56 140.18 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.117 -0.989 . . . . 71.019999999999996 109.539 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -82.59 -25.28 33.4 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.263 -0.898 . . . . 72.120000000000005 109.597 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.431 ' H ' HG22 ' A' ' 207' ' ' VAL . 13.2 mmt85 -49.45 -25.08 2.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.418 -0.801 . . . . 64.409999999999997 109.866 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -152.21 -74.29 0.14 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 71.540000000000006 109.448 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -166.91 -102.01 0.16 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.206 -1.558 . . . . 72.030000000000001 109.206 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -135.49 134.08 39.15 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.443 -1.034 . . . . 75.540000000000006 109.268 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -97.92 137.55 36.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.335 -0.853 . . . . 75.310000000000002 109.54 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.423 ' O ' ' SG ' ' A' ' 215' ' ' CYS . 44.1 m-85 -105.77 119.12 38.34 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.83 -0.804 . . . . 75.409999999999997 108.83 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 214' ' ' PHE . 99.3 m -153.39 162.54 41.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.32 -0.862 . . . . 74.140000000000001 109.391 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -67.6 155.08 92.1 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 75.319999999999993 108.925 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo . . . . . 0 N--CA 1.49 1.275 0 C-N-CA 122.424 2.083 . . . . 73.109999999999999 112.033 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 54.7 ttm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.44 -0.578 . . . . 71.140000000000001 109.44 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -137.79 154.46 49.56 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.356 -0.84 . . . . 73.230000000000004 109.489 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 97.8 t -115.58 125.95 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 109.174 -0.676 . . . . 72.239999999999995 109.174 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.48 HD11 ' CG1' ' B' ' 6' ' ' ILE . 4.4 tp -99.31 119.03 37.27 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.454 -0.779 . . . . 54.329999999999998 108.975 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.418 ' CD1' ' SD ' ' B' ' 49' ' ' MET . 5.3 tp -120.45 100.29 7.06 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 108.959 -0.756 . . . . 74.349999999999994 108.959 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.48 ' CG1' HD11 ' B' ' 4' ' ' LEU . 45.7 mt -90.05 102.81 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.833 -1.167 . . . . 42.549999999999997 108.816 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.42 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 29.2 tp10 -133.2 128.87 36.91 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.501 -0.75 . . . . 74.519999999999996 109.371 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -65.49 -33.31 75.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.906 . . . . 62.549999999999997 109.168 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -88.43 111.56 21.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.346 -0.846 . . . . 73.109999999999999 109.387 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 83.1 p -69.06 -27.07 65.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.915 . . . . 65.540000000000006 109.586 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 77.7 t -61.92 -51.31 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 75.549999999999997 109.607 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 37.9 mt -64.35 -30.65 71.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 70.140000000000001 109.449 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.36 -29.91 57.57 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.623 -1.791 . . . . 75.400000000000006 108.623 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.41 -50.52 61.77 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.912 -1.275 . . . . 65.439999999999998 109.912 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -65.46 -41.53 93.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -1.165 . . . . 60.210000000000001 109.801 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 5.7 mm -67.66 -35.28 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.867 -1.145 . . . . 75.150000000000006 108.905 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -64.58 -46.39 82.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.872 . . . . 73.010000000000005 109.454 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -79.49 -9.16 59.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 74.299999999999997 109.468 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.57 -52.95 3.97 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 109.422 -1.471 . . . . 70.540000000000006 109.422 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pp -70.51 -27.83 64.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -1.089 . . . . 71.340000000000003 109.392 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.19 -34.87 61.57 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.229 -0.919 . . . . 64.409999999999997 109.21 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 49.0 t -54.36 -45.37 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.345 -0.847 . . . . 74.230000000000004 108.746 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.806 ' HZ2' HG12 ' B' ' 106' ' ' VAL . 23.6 mmtp -57.09 -51.64 68.48 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.607 -0.886 . . . . 63.420000000000002 108.607 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 127.66 41.12 0.3 Allowed Glycine 0 N--CA 1.5 2.907 0 N-CA-C 110.461 -1.056 . . . . 53.43 110.461 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -119.66 159.2 24.9 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.265 -1.138 . . . . 71.120000000000005 108.862 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 15.1 mmt -98.16 138.46 35.42 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.06 -1.089 . . . . 75.239999999999995 108.06 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.24 160.71 40.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.928 . . . . 72.120000000000005 110.261 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -142.84 152.84 42.59 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.663 -0.866 . . . . 72.310000000000002 108.663 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 p -114.02 137.1 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.37 -0.831 . . . . 64.430000000000007 109.238 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.6 p -134.41 170.07 16.3 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.576 -0.703 . . . . 65.409999999999997 109.457 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.479 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 1.9 pt-20 -94.4 -98.6 0.15 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.383 -0.823 . . . . 71.019999999999996 110.055 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 70.1 m -78.59 168.8 19.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.257 -0.902 . . . . 51.109999999999999 110.363 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 16.1 mt -56.76 -31.98 65.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.61 -0.681 . . . . 71.239999999999995 110.009 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -52.76 -44.07 66.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.131 -0.981 . . . . 74.319999999999993 109.861 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.479 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 64.1 m-20 -73.76 -39.58 64.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.107 -0.995 . . . . 73.030000000000001 109.553 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.3 -44.98 57.63 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.62 -1.392 . . . . 30.210000000000001 109.62 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.66 -43.32 84.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -1.153 . . . . 74.420000000000002 109.67 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -70.55 -39.85 73.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.131 -0.98 . . . . 74.420000000000002 110.099 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 25.0 tp -70.2 -44.07 69.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -0.948 . . . . 75.409999999999997 110.373 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . 0.448 ' SD ' ' OH ' ' B' ' 45' ' ' TYR . 0.0 OUTLIER -74.49 -28.01 60.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.025 -1.047 . . . . 60.409999999999997 110.147 -179.204 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.21 -29.89 70.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.967 -1.083 . . . . 53.229999999999997 110.383 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 19.8 pt -86.34 -18.43 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.953 -1.092 . . . . 71.230000000000004 110.905 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' B' ' 40' ' ' MET . 59.0 mmt-85 -129.63 155.19 46.25 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.082 -1.011 . . . . 72.219999999999999 110.132 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -84.62 157.03 21.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.271 -0.893 . . . . 63.539999999999999 109.551 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.513 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 3.6 p90 -149.9 -174.89 4.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.208 -0.933 . . . . 64.349999999999994 109.393 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -141.5 -33.62 0.5 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.27 -0.894 . . . . 62.219999999999999 109.569 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.502 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.3 OUTLIER -110.14 114.78 28.55 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.35 -0.844 . . . . 73.120000000000005 109.107 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.502 ' N ' HD13 ' B' ' 47' ' ' LEU . 71.5 t -101.74 97.22 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.449 -0.945 . . . . 65.109999999999999 108.449 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.434 ' O ' ' O ' ' B' ' 4' ' ' LEU . 15.4 ttt -112.91 130.53 56.08 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.571 0.7 . . . . 73.439999999999998 109.849 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.05 138.85 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.4 -0.813 . . . . 34.5 109.311 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . 0.42 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 53.0 p -105.46 2.29 28.44 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.548 -0.72 . . . . 73.209999999999994 110.412 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -75.7 147.01 39.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.987 -1.07 . . . . 70.409999999999997 109.629 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' B' ' 55' ' ' ALA . 62.3 mttp -73.35 -58.2 3.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.287 -0.883 . . . . 65.0 110.23 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -47.43 -12.85 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.089 -1.007 . . . . 75.209999999999994 109.904 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' B' ' 53' ' ' LYS . . . -58.67 -25.15 62.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.856 . . . . 55.329999999999998 110.598 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.427 HD22 ' NE2' ' B' ' 89' ' ' GLN . 97.7 mt -45.19 -47.44 12.49 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.065 -1.022 . . . . 63.140000000000001 109.827 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 21.5 m -68.81 -33.41 73.81 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.937 -1.102 . . . . 63.5 108.751 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . 0.413 ' CZ ' HD11 ' B' ' 62' ' ' ILE . 61.6 t80 -65.93 -60.68 2.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.422 -0.799 . . . . 72.329999999999998 109.77 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 31.4 m -50.0 -36.14 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.527 -1.358 . . . . 74.540000000000006 109.639 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 22.5 p -56.56 -54.2 48.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.107 -0.996 . . . . 71.239999999999995 109.68 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.576 ' HE ' ' NZ ' ' B' ' 65' ' ' LYS . 5.9 ptm180 -66.02 -30.18 70.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.007 -1.058 . . . . 74.310000000000002 110.034 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.413 HD11 ' CZ ' ' B' ' 58' ' ' PHE . 34.4 mm -65.08 -37.97 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.653 -1.28 . . . . 72.140000000000001 109.723 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' B' ' 67' ' ' SER . 25.0 mmtp -68.3 -51.87 39.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.063 -1.023 . . . . 73.319999999999993 110.302 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -67.47 -37.56 83.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.847 -1.158 . . . . 73.120000000000005 109.939 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.576 ' NZ ' ' HE ' ' B' ' 61' ' ' ARG . 92.9 mttt -81.55 -20.43 39.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -0.94 . . . . 72.439999999999998 109.707 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.485 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 74.0 m-70 -155.89 64.77 0.58 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.129 -0.982 . . . . 63.310000000000002 109.701 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.404 ' N ' ' O ' ' B' ' 63' ' ' LYS . 9.4 t -63.47 -29.01 70.36 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 73.099999999999994 109.669 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 96.5 p -61.64 -25.96 67.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 71.530000000000001 110.045 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.4 HD13 ' CE2' ' B' ' 45' ' ' TYR . 65.6 mt -83.4 151.3 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.093 -1.004 . . . . 74.400000000000006 109.48 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 99.2 t -89.93 154.62 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.415 -0.803 . . . . 75.120000000000005 109.318 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 18.1 t -134.57 127.78 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.308 -0.87 . . . . 73.200000000000003 109.618 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.575 HD23 ' C ' ' B' ' 72' ' ' LEU . 4.6 tt -118.91 102.66 8.95 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.455 0.645 . . . . 73.340000000000003 109.577 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . 0.452 ' O ' HG13 ' B' ' 73' ' ' VAL . 10.9 p -94.07 130.58 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.947 -1.096 . . . . 73.5 109.241 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 12.7 p -85.4 174.3 9.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.086 -1.009 . . . . 64.340000000000003 108.79 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 10.4 p -153.43 110.23 3.41 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.827 -1.171 . . . . 74.530000000000001 110.679 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -71.23 -21.7 62.09 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.499 -0.926 . . . . 64.5 108.499 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -126.64 73.38 74.61 Favored Pre-proline 0 N--CA 1.494 1.764 0 N-CA-C 108.601 -0.889 . . . . 74.25 108.601 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.18 81.51 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.778 1.652 . . . . 74.430000000000007 111.843 -178.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.426 ' O ' ' OE2' ' B' ' 83' ' ' GLU . 4.3 t -110.08 152.12 26.37 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.736 -0.839 . . . . 73.120000000000005 108.736 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.6 t -50.88 -33.44 24.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 71.010000000000005 110.321 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -61.19 -37.29 82.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.999 -1.063 . . . . 63.200000000000003 110.236 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . 0.404 ' H ' HG23 ' B' ' 79' ' ' THR . 34.2 tp10 -78.93 -37.02 40.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.004 -1.06 . . . . 73.219999999999999 110.088 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.519 ' N ' ' OE1' ' B' ' 83' ' ' GLU . 0.3 OUTLIER -58.08 -50.51 73.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.098 -1.001 . . . . 74.299999999999997 109.615 -179.612 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.494 HG23 ' N ' ' B' ' 85' ' ' HIS . 24.3 m -67.8 -39.87 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.121 -0.987 . . . . 73.310000000000002 109.542 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' HIS . . . . . 0.625 ' CE1' ' NE2' ' B' ' 89' ' ' GLN . 4.4 t-160 -66.41 -26.87 67.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.171 -0.955 . . . . 73.239999999999995 109.562 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.68 -42.72 60.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.123 -0.986 . . . . 55.329999999999998 110.115 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -82.37 -33.38 28.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.081 -1.012 . . . . 74.140000000000001 109.275 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -68.58 -34.38 75.7 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.355 -0.841 . . . . 64.040000000000006 109.572 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . 0.625 ' NE2' ' CE1' ' B' ' 85' ' ' HIS . 36.5 mt-30 -80.43 -63.61 1.37 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -0.953 . . . . 72.349999999999994 109.677 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 163.2 68.06 0.02 OUTLIER Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.401 -1.38 . . . . 65.200000000000003 110.435 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -127.18 137.29 52.9 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.455 -1.026 . . . . 52.229999999999997 108.837 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' B' ' 93' ' ' ASP . 14.2 t70 -80.89 -34.52 33.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.055 -1.028 . . . . 73.319999999999993 109.448 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' ASP . . . . . 0.512 ' OD1' ' NH2' ' B' ' 112' ' ' ARG . 57.9 m-20 -149.96 164.15 36.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.35 -0.844 . . . . 72.219999999999999 109.441 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.532 ' CD1' ' O ' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -140.17 112.97 8.09 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.684 -0.858 . . . . 64.420000000000002 108.684 -178.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 35.4 mm -114.46 147.79 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.368 -0.833 . . . . 72.230000000000004 110.124 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . 0.511 ' HB1' ' HD2' ' B' ' 98' ' ' PRO . . . -62.47 139.52 58.58 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.172 -0.955 . . . . 25.239999999999998 108.558 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.601 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -69.17 -40.95 16.68 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.185 -0.947 . . . . 64.319999999999993 110.916 -179.19 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' B' ' 97' ' ' LYS . 33.1 Cg_exo -52.25 1.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.29 -2.518 0 CA-C-N 118.4 0.464 . . . . 63.329999999999998 112.833 -174.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . 0.601 ' N ' ' O ' ' B' ' 97' ' ' LYS . 45.7 m-85 55.55 99.19 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.453 -0.779 . . . . 75.129999999999995 109.722 178.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 34.9 ttm-85 -59.46 -36.09 75.3 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.009 -1.057 . . . . 74.230000000000004 108.724 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . 0.753 ' O ' ' N ' ' B' ' 103' ' ' LYS . 12.6 t -173.84 39.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.234 -0.916 . . . . 63.340000000000003 110.688 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . 0.425 ' C ' ' N ' ' B' ' 104' ' ' ALA . 60.3 mt 51.92 -69.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.48 -0.763 . . . . 74.439999999999998 110.062 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.753 ' N ' ' O ' ' B' ' 101' ' ' SER . 38.1 mmtm -56.65 -15.36 4.33 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.168 -1.419 . . . . 71.109999999999999 107.168 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.425 ' N ' ' C ' ' B' ' 102' ' ' ILE . . . -60.54 -78.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.349 -0.54 . . . . 71.450000000000003 110.189 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.598 ' H ' HD12 ' B' ' 105' ' ' LEU . 0.0 OUTLIER -51.9 -41.17 61.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.95 -1.094 . . . . 51.310000000000002 109.381 -179.151 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . 0.806 HG12 ' HZ2' ' B' ' 23' ' ' LYS . 27.6 t -57.84 -45.21 87.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.995 -1.066 . . . . 65.230000000000004 108.804 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.04 -30.86 62.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.21 -0.931 . . . . 24.32 108.787 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . 0.434 HH12 ' NH2' ' B' ' 112' ' ' ARG . 2.0 tpm_? -80.72 -24.77 38.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.428 -0.795 . . . . 75.310000000000002 109.649 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 93.9 mt -80.08 -38.93 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.114 -0.991 . . . . 54.240000000000002 109.391 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . 0.52 ' OE1' ' NZ ' ' B' ' 23' ' ' LYS . 22.7 pt-20 -72.58 -40.93 66.22 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.163 -0.961 . . . . 65.310000000000002 109.509 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.21 -44.26 95.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.929 . . . . 72.239999999999995 109.248 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . 0.512 ' NH2' ' OD1' ' B' ' 93' ' ' ASP . 56.2 ttm-85 -63.08 -31.73 72.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 72.040000000000006 109.443 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 13.4 tp -145.12 70.54 1.27 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.263 -0.898 . . . . 75.349999999999994 109.127 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' B' ' 110' ' ' GLU . 96.2 mtt180 -62.69 -46.22 89.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 75.5 109.709 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -81.62 -103.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 65.329999999999998 109.536 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -163.43 -28.63 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.101 -0.999 . . . . 74.450000000000003 109.759 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -167.94 -172.48 35.0 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.767 -1.333 . . . . 44.210000000000001 109.767 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 48.9 m -145.48 -172.04 3.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.369 -1.077 . . . . 71.400000000000006 109.382 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.82 160.74 43.68 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.671 -0.812 . . . . 72.319999999999993 109.406 -178.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 4.5 t -134.3 -38.1 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.484 -0.76 . . . . 75.019999999999996 109.176 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' B' ' 128' ' ' ILE . 27.6 mm -110.87 133.32 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.797 -0.816 . . . . 51.409999999999997 108.797 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -137.31 143.62 42.2 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.396 -0.815 . . . . 71.530000000000001 108.904 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.971 HD11 ' NH2' ' B' ' 159' ' ' ARG . 19.5 tt -155.02 127.1 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 72.430000000000007 109.879 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 47.49 -151.56 2.07 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.723 -1.351 . . . . 51.229999999999997 109.723 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -75.75 -3.29 34.06 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.206 -1.173 . . . . 74.200000000000003 109.065 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.41 147.02 24.92 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.112 -1.07 . . . . 75.420000000000002 108.112 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 36.1 m -126.61 134.82 50.69 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.457 -0.777 . . . . 74.219999999999999 108.978 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' B' ' 121' ' ' ILE . 96.1 mt -126.2 124.15 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.54 -0.725 . . . . 60.329999999999998 109.675 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 18.8 m -123.89 109.21 30.08 Favored Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 109.198 -0.667 . . . . 72.310000000000002 109.198 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.96 -24.72 5.63 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.665 1.577 . . . . 75.129999999999995 111.629 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . 0.419 ' O ' ' OE2' ' B' ' 133' ' ' GLU . 26.3 t0 -62.0 -42.9 99.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 75.230000000000004 109.183 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -91.6 4.54 52.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.368 -0.833 . . . . 72.430000000000007 108.951 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . 0.419 ' OE2' ' O ' ' B' ' 131' ' ' ASP . 28.8 mp0 49.32 64.29 1.8 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.098 -1.001 . . . . 75.129999999999995 109.405 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -159.43 140.3 12.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.093 -1.004 . . . . 73.219999999999999 109.997 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 63.7 mt -118.98 137.23 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.631 -0.877 . . . . 64.140000000000001 108.631 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 15.2 mt -121.59 129.78 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.606 -0.684 . . . . 71.219999999999999 109.896 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -139.94 144.59 37.16 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.445 -0.784 . . . . 64.219999999999999 109.202 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 48.9 mttp 55.19 19.65 3.0 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.932 -0.766 . . . . 72.019999999999996 108.932 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.33 2.54 90.62 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.243 -1.143 . . . . 74.319999999999993 110.243 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . 0.405 ' N ' ' HD2' ' B' ' 140' ' ' ARG . 10.0 mmm-85 -89.85 129.13 36.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.249 . . . . 75.340000000000003 108.931 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -91.97 121.04 33.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.269 -0.894 . . . . 71.230000000000004 109.194 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 89.2 t -135.01 132.77 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.338 -0.851 . . . . 70.430000000000007 109.786 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -97.32 154.79 17.21 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.289 -0.882 . . . . 72.430000000000007 108.724 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 4.5 m -134.01 132.76 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.298 -0.876 . . . . 72.129999999999995 109.794 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . 0.527 ' N ' ' CD ' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -159.77 130.21 5.65 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.365 -0.834 . . . . 72.019999999999996 109.313 179.796 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 143.63 -120.63 1.52 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 108.946 -1.662 . . . . 42.229999999999997 108.946 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . 0.592 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 22.3 mtmt -101.86 -35.83 0.22 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.457 -1.026 . . . . 73.299999999999997 111.072 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . 0.932 ' O ' HD13 ' B' ' 152' ' ' LEU . 44.6 Cg_endo -92.56 8.92 2.69 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 122.264 1.976 . . . . 71.329999999999998 113.538 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . 0.46 ' CG ' ' N ' ' B' ' 150' ' ' GLU . 3.5 p90 -87.28 -40.71 14.26 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.732 -1.23 . . . . 74.230000000000004 110.215 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . 0.46 ' N ' ' CG ' ' B' ' 149' ' ' PHE . 16.4 pt-20 -69.08 -33.4 73.48 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.391 -0.818 . . . . 72.340000000000003 110.512 -178.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.722 HG13 HD12 ' B' ' 152' ' ' LEU . 12.5 p -67.66 -39.14 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.822 -1.173 . . . . 73.349999999999994 109.039 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.932 HD13 ' O ' ' B' ' 148' ' ' PRO . 9.6 mp -59.78 -53.04 62.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.377 -0.827 . . . . 55.240000000000002 109.475 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -72.75 -30.61 64.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.318 -0.864 . . . . 70.010000000000005 111.144 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -59.84 -52.08 66.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.606 -1.309 . . . . 65.319999999999993 109.995 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 pp -71.97 -29.53 64.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.943 -1.098 . . . . 71.540000000000006 110.001 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.77 -50.26 72.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.017 -1.052 . . . . 75.319999999999993 110.068 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . 0.487 ' C ' ' H ' ' B' ' 159' ' ' ARG . 68.9 mtp180 -72.99 -57.0 4.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.177 -0.952 . . . . 73.319999999999993 109.657 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -61.21 1.73 0.17 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.368 -0.832 . . . . 74.140000000000001 109.704 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . 1.636 HH21 ' CA ' ' B' ' 216' ' ' TYR . 26.7 ttt180 -53.09 165.39 0.32 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.119 -0.988 . . . . 61.409999999999997 109.881 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . 0.834 ' OD1' ' HG2' ' B' ' 159' ' ' ARG . 2.7 m-20 61.25 43.33 10.98 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.71 -0.619 . . . . 72.099999999999994 110.175 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -157.21 175.42 14.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.058 -1.026 . . . . 72.25 109.449 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 77.8 mt -93.6 132.19 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.656 -0.868 . . . . 72.310000000000002 108.656 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 96.8 t -128.76 138.6 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.403 -0.811 . . . . 64.209999999999994 109.86 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 37.6 t -101.04 169.08 9.19 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.454 -0.779 . . . . 74.219999999999999 109.933 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -68.63 -48.49 63.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.519 -0.738 . . . . 65.310000000000002 110.088 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.1 -41.88 79.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.295 -0.878 . . . . 63.450000000000003 110.791 -178.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 167' ' ' GLN . . . . . 0.425 ' O ' ' OD1' ' B' ' 170' ' ' ASP . 89.9 mt-30 -51.04 -38.51 51.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.048 -1.032 . . . . 72.400000000000006 110.072 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 71.9 mt -73.31 -40.53 64.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.994 -1.066 . . . . 72.319999999999993 109.635 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.598 HD23 ' O ' ' B' ' 169' ' ' LEU . 1.9 tt -61.62 -42.35 98.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.405 -0.809 . . . . 73.340000000000003 109.7 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . 0.534 ' O ' ' CH2' ' B' ' 173' ' ' TRP . 22.9 p30 -86.2 -13.54 46.65 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 118.769 -1.172 . . . . 72.099999999999994 110.796 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . 0.4 ' N ' ' OD1' ' B' ' 170' ' ' ASP . . . -94.52 -38.03 11.1 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.837 -1.164 . . . . 62.130000000000003 111.056 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 0.484 HG22 ' O ' ' B' ' 172' ' ' ILE . 60.6 mt -114.17 -9.98 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.26 -0.9 . . . . 71.420000000000002 110.589 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 173' ' ' TRP . . . . . 0.534 ' CH2' ' O ' ' B' ' 170' ' ' ASP . 10.2 m95 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.43 -0.794 . . . . 72.230000000000004 109.632 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo . . . . . 0 N--CA 1.49 1.269 0 CA-C-O 121.195 0.414 . . . . 65.219999999999999 112.413 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -149.18 120.31 7.75 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.196 -0.94 . . . . 72.310000000000002 109.14 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 3.2 p -156.14 -15.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.259 -0.901 . . . . 63.32 110.868 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.401 ' O ' HG22 ' B' ' 188' ' ' ILE . 29.0 mm -51.47 -31.11 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.738 -1.226 . . . . 75.030000000000001 109.502 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -54.59 -34.77 62.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.096 -1.003 . . . . 64.109999999999999 108.484 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 2.0 t -80.36 -57.22 5.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.491 -0.755 . . . . 73.0 109.366 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -51.78 -51.65 54.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.119 -0.988 . . . . 61.119999999999997 109.715 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 188' ' ' ILE . . . . . 0.582 HD12 ' CZ ' ' B' ' 212' ' ' TYR . 1.7 tt -57.68 -43.35 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.894 -1.129 . . . . 72.430000000000007 108.962 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 189' ' ' ASN . . . . . 0.441 ' N ' HG23 ' B' ' 188' ' ' ILE . 24.8 t-20 -62.11 -38.24 88.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.039 -1.038 . . . . 65.140000000000001 109.271 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -69.31 -50.47 46.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.922 . . . . 63.240000000000002 109.735 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 96.8 mt -53.34 -45.61 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.294 -0.879 . . . . 74.030000000000001 109.491 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -59.71 -42.75 93.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.898 . . . . 72.239999999999995 109.656 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -68.72 -38.13 79.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -0.944 . . . . 73.099999999999994 109.187 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . 0.49 ' O ' ' CG ' ' B' ' 198' ' ' PRO . 31.0 mttp -71.32 -13.24 61.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.371 -0.831 . . . . 72.109999999999999 109.24 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 30.0 mmm -101.47 -33.29 10.02 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.398 -0.814 . . . . 44.329999999999998 109.519 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -82.85 -12.5 57.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.097 -1.002 . . . . 71.209999999999994 110.454 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . 0.449 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 34.2 mttm -89.46 -65.95 0.16 Allowed Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 120.855 -1.153 . . . . 75.209999999999994 109.907 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 198' ' ' PRO . . . . . 0.49 ' CG ' ' O ' ' B' ' 194' ' ' LYS . 36.7 Cg_endo -63.56 -70.13 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.968 1.779 . . . . 75.319999999999993 112.122 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . 0.512 ' H ' HD12 ' B' ' 199' ' ' LEU . 7.6 mp -55.81 -38.82 70.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.116 -0.99 . . . . 72.25 108.777 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 77.69 5.63 86.39 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.792 -1.323 . . . . 64.530000000000001 109.792 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 16.1 mt -132.83 140.13 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.377 -1.072 . . . . 44.229999999999997 109.338 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 13.1 t -78.0 147.47 34.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 54.009999999999998 109.261 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 1.4 p -145.47 24.53 1.4 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.196 -0.94 . . . . 74.400000000000006 109.443 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 19.9 m -139.82 146.33 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.201 -0.937 . . . . 72.120000000000005 109.791 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -119.45 132.54 55.82 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.83 -0.804 . . . . 65.409999999999997 108.83 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 31.1 p -103.27 127.32 50.63 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.252 -0.905 . . . . 71.329999999999998 109.74 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 12.8 p -144.59 143.22 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.198 -0.939 . . . . 63.5 109.248 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 24.1 mtm105 -86.7 101.9 13.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.2 -0.938 . . . . 74.450000000000003 109.757 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -171.54 -76.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.378 -0.826 . . . . 74.140000000000001 108.82 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -107.56 -42.47 4.77 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.993 -0.743 . . . . 74.430000000000007 108.993 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 173.11 -119.8 0.78 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.408 -1.477 . . . . 64.450000000000003 109.408 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 212' ' ' TYR . . . . . 0.582 ' CZ ' HD12 ' B' ' 188' ' ' ILE . 8.1 m-85 -129.71 156.66 43.92 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.468 -1.019 . . . . 74.209999999999994 109.17 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 52.4 mmt-85 -111.32 144.71 40.07 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.539 -0.725 . . . . 74.030000000000001 109.319 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -119.63 114.27 21.95 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.611 -0.681 . . . . 74.340000000000003 109.165 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 91.3 m -148.45 170.34 18.24 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.25 -0.906 . . . . 64.329999999999998 109.614 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . 1.636 ' CA ' HH21 ' B' ' 159' ' ' ARG . 38.0 p90 -74.27 150.58 87.5 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 70.040000000000006 109.513 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 217' ' ' PRO . . . . . 0.939 ' HD3' HH22 ' B' ' 159' ' ' ARG . 67.1 Cg_exo -37.2 156.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.358 2.039 . . . . 65.109999999999999 112.46 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 2.7 mptm? . . . . . 0 N--CA 1.493 1.685 0 O-C-N 121.336 -0.853 . . . . 73.150000000000006 109.806 -179.765 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.577 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.409 -0.589 . . . . 65.120000000000005 109.409 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.751 ' HE ' HH21 ' A' ' 43' ' ' ARG . 81.2 mtt85 -136.34 150.19 48.74 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.376 -0.828 . . . . 72.329999999999998 109.358 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.3 t -113.76 129.42 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 121.576 0.703 . . . . 71.420000000000002 109.982 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.507 HD11 ' CG1' ' A' ' 6' ' ' ILE . 2.6 tp -98.25 118.45 34.93 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.37 -0.974 . . . . 65.120000000000005 108.37 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.417 ' N ' HD12 ' A' ' 4' ' ' LEU . 5.8 tp -119.09 108.46 14.73 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.612 -0.68 . . . . 62.43 109.31 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.507 ' CG1' HD11 ' A' ' 4' ' ' LEU . 46.3 mt -101.2 109.72 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.514 -0.921 . . . . 71.150000000000006 108.514 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.426 ' OE1' ' CB ' ' A' ' 51' ' ' SER . 24.7 tp10 -137.96 123.69 19.89 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.437 -0.789 . . . . 75.340000000000003 109.452 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.1 tptt -68.66 -31.29 70.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.24 -0.912 . . . . 72.439999999999998 108.771 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -86.23 122.41 30.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.429 -0.794 . . . . 63.020000000000003 109.367 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.4 m -74.62 -20.7 59.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 72.340000000000003 109.728 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.2 t -71.38 -55.7 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.183 -0.948 . . . . 74.019999999999996 109.872 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.558 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.5 mm? -67.85 -35.72 79.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.219 -0.926 . . . . 71.430000000000007 109.519 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.36 -31.07 57.63 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.758 -1.737 . . . . 61.32 108.758 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.98 -48.42 76.04 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.953 -1.259 . . . . 71.200000000000003 109.953 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -64.04 -46.65 83.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -1.174 . . . . 71.319999999999993 109.882 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.3 mm -64.65 -48.54 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.778 -1.201 . . . . 63.229999999999997 109.175 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -46.28 -56.93 5.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.182 -0.949 . . . . 51.109999999999999 109.812 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -84.47 3.01 38.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.17 -0.956 . . . . 73.340000000000003 109.305 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.02 -65.95 1.71 Allowed Glycine 0 N--CA 1.483 1.786 0 N-CA-C 109.899 -1.28 . . . . 62.149999999999999 109.899 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.532 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.5 pt? -66.53 -23.39 66.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -1.173 . . . . 73.510000000000005 110.081 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.435 HD21 ' HB3' ' A' ' 27' ' ' ALA . 3.9 m120 -56.69 -35.95 69.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -0.991 . . . . 74.25 109.872 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 87.5 t -56.1 -39.36 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.164 -0.96 . . . . 70.040000000000006 109.579 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HZ2' HG11 ' A' ' 106' ' ' VAL . 1.7 mptm? -63.63 -12.43 33.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 73.230000000000004 109.322 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.61 37.78 4.13 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.263 -1.135 . . . . 75.540000000000006 110.263 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -119.61 160.71 21.95 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.477 -1.013 . . . . 73.430000000000007 109.263 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.4 mmt -100.86 138.97 37.2 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.257 -1.016 . . . . 43.240000000000002 108.257 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.435 ' HB3' HD21 ' A' ' 21' ' ' ASN . . . -141.24 159.67 41.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.25 -0.906 . . . . 62.109999999999999 109.974 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -135.94 144.88 45.69 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.512 -0.742 . . . . 74.420000000000002 109.042 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.5 131.34 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.458 -0.776 . . . . 72.150000000000006 108.911 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.8 p -134.74 169.67 16.99 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.449 -0.782 . . . . 71.420000000000002 109.379 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -93.41 -103.22 0.13 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.304 -0.872 . . . . 72.329999999999998 109.718 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 t -78.78 166.83 22.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 74.239999999999995 110.012 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.401 HD22 ' CG ' ' A' ' 58' ' ' PHE . 20.4 mt -54.37 -31.94 55.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.552 -0.718 . . . . 71.530000000000001 109.82 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.16 -48.75 44.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 74.230000000000004 109.513 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.02 -38.32 90.72 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.156 -0.965 . . . . 54.030000000000001 108.914 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.85 -37.06 92.97 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.296 -1.522 . . . . 61.409999999999997 109.296 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -68.35 -42.91 78.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 74.340000000000003 109.462 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -71.78 -37.67 70.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 75.329999999999998 109.906 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.8 tp -75.9 -46.01 32.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 74.329999999999998 110.308 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.484 ' SD ' ' OD1' ' A' ' 41' ' ' ASP . 3.5 ppp? -65.24 -32.24 73.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.045 -1.034 . . . . 70.319999999999993 110.177 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.484 ' OD1' ' SD ' ' A' ' 40' ' ' MET . 87.1 m-20 -62.68 -39.58 94.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.067 -1.021 . . . . 71.219999999999999 110.03 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.4 HG12 ' H ' ' A' ' 42' ' ' ILE . 25.8 pt -82.31 -29.44 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.066 -1.021 . . . . 74.140000000000001 110.176 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.751 HH21 ' HE ' ' A' ' 2' ' ' ARG . 73.6 mtp180 -130.07 140.51 50.82 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.342 -0.849 . . . . 72.239999999999995 109.596 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -90.25 157.66 17.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.214 -0.929 . . . . 75.420000000000002 109.488 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -138.04 150.89 47.34 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.391 -0.818 . . . . 74.230000000000004 109.345 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 2' ' ' ARG . 7.9 p-10 -95.21 -40.25 9.67 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.175 -0.953 . . . . 72.040000000000006 109.463 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.462 HD13 ' C ' ' A' ' 47' ' ' LEU . 0.5 OUTLIER -102.97 109.66 21.29 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.397 -0.814 . . . . 72.129999999999995 109.059 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.445 ' N ' HD13 ' A' ' 47' ' ' LEU . 78.7 t -95.08 97.67 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.193 -0.942 . . . . 72.340000000000003 108.616 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.1 ttm -111.44 131.51 55.15 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.481 -0.762 . . . . 74.109999999999999 109.595 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.451 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 1.3 p -141.0 133.0 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.479 -0.763 . . . . 61.119999999999997 109.818 -179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.426 ' CB ' ' OE1' ' A' ' 7' ' ' GLU . 59.9 p -100.85 7.01 43.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.608 -0.683 . . . . 73.109999999999999 109.538 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.451 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 84.7 m-20 -76.04 141.12 42.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.135 -0.978 . . . . 52.549999999999997 109.465 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.494 ' C ' ' H ' ' A' ' 55' ' ' ALA . 68.0 mttm -73.43 -44.64 57.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.29 -0.881 . . . . 44.219999999999999 110.435 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -71.02 15.47 0.11 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.107 -0.996 . . . . 70.439999999999998 109.807 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -74.97 -21.61 59.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 64.140000000000001 110.334 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.41 ' HB3' HE22 ' A' ' 89' ' ' GLN . 19.0 mt -40.49 -52.96 2.75 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.499 -0.751 . . . . 44.140000000000001 110.357 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.9 m -67.2 -32.86 74.2 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.053 -1.029 . . . . 55.229999999999997 109.141 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.523 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 63.0 t80 -66.06 -52.95 44.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.479 -0.763 . . . . 74.439999999999998 110.313 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 m -57.74 -34.57 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.701 -1.249 . . . . 74.030000000000001 109.709 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.1 m -59.02 -55.51 34.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.112 -0.993 . . . . 64.299999999999997 109.625 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -63.21 -28.08 69.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 64.439999999999998 110.142 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.523 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 5.2 mm -66.6 -31.79 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.951 -1.093 . . . . 63.210000000000001 109.898 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.525 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 23.1 mmtt -77.12 -50.23 13.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.057 -1.027 . . . . 74.420000000000002 110.267 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -67.62 -41.21 84.3 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.754 -1.217 . . . . 70.319999999999993 109.87 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.521 ' O ' ' NZ ' ' A' ' 145' ' ' LYS . 9.1 mtpm? -72.5 -26.24 61.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 75.219999999999999 109.75 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.564 ' O ' HG22 ' A' ' 69' ' ' ILE . 93.2 m-70 -153.19 65.93 0.77 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.16 -0.963 . . . . 74.129999999999995 109.301 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.476 ' N ' ' O ' ' A' ' 63' ' ' LYS . 18.0 m -56.45 -32.43 64.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 73.239999999999995 110.055 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 83.3 p -73.17 47.02 0.19 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 61.009999999999998 110.049 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 66' ' ' HIS . 13.5 tt -146.48 159.07 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.051 -1.031 . . . . 71.329999999999998 109.45 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.5 t -95.57 154.26 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.12 -0.987 . . . . 72.129999999999995 109.106 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.433 ' H ' ' HB2' ' A' ' 92' ' ' ASP . 15.4 t -142.66 118.69 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.123 -0.985 . . . . 54.210000000000001 109.823 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.572 ' HG ' HD11 ' A' ' 95' ' ' ILE . 1.6 mp -119.23 99.57 6.79 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.624 -0.88 . . . . 50.240000000000002 108.624 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.8 p -94.3 152.99 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.255 -1.017 . . . . 74.409999999999997 108.255 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.08 169.94 9.26 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.443 -0.785 . . . . 72.310000000000002 108.912 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.2 t -168.39 123.7 0.96 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.177 -0.952 . . . . 64.540000000000006 110.159 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.513 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 0.4 OUTLIER -76.12 15.84 0.51 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.466 -0.771 . . . . 74.129999999999995 110.024 -179.082 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.407 ' O ' ' N ' ' A' ' 79' ' ' THR . 30.7 m120 -139.88 58.61 11.65 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.152 -0.967 . . . . 73.340000000000003 110.115 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.44 84.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.393 2.062 . . . . 63.219999999999999 112.452 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 81' ' ' GLU . 28.7 m -106.81 149.73 27.07 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.143 -1.058 . . . . 62.530000000000001 108.143 178.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.04 -32.16 71.78 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.008 -1.057 . . . . 73.439999999999998 109.367 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.423 ' H ' HG22 ' A' ' 79' ' ' THR . 44.1 tp10 -64.44 -43.13 95.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.119 -0.988 . . . . 71.420000000000002 109.294 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -76.64 -35.74 57.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 73.430000000000007 109.602 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -57.74 -56.77 17.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.237 -0.914 . . . . 74.219999999999999 109.67 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.475 HG23 ' N ' ' A' ' 85' ' ' HIS . 25.4 m -61.55 -39.75 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.131 -0.981 . . . . 73.200000000000003 109.273 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.475 ' N ' HG23 ' A' ' 84' ' ' VAL . 72.7 t60 -60.22 -36.97 78.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.214 -0.929 . . . . 53.329999999999998 109.554 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.53 -45.83 88.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.195 -0.941 . . . . 64.109999999999999 109.829 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.615 ' CZ ' ' NH1' ' B' ' 108' ' ' ARG . 77.1 m-85 -74.96 -27.92 60.37 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.171 -0.955 . . . . 74.340000000000003 108.722 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -69.88 -50.23 44.54 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.521 -0.737 . . . . 74.420000000000002 109.297 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.474 ' NE2' ' NE2' ' A' ' 85' ' ' HIS . 84.8 mt-30 -58.01 -49.64 76.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.512 -0.742 . . . . 74.239999999999995 110.003 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 153.8 -10.76 0.5 Allowed Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.423 -1.37 . . . . 61.509999999999998 110.738 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.8 139.5 16.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.812 -1.405 . . . . 55.329999999999998 109.373 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.525 ' OD1' ' NZ ' ' A' ' 63' ' ' LYS . 11.4 m-20 -76.08 -40.01 54.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.103 -0.998 . . . . 73.420000000000002 109.32 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 94' ' ' TYR . 56.8 t0 -153.09 157.12 39.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.259 -0.9 . . . . 75.040000000000006 109.47 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.539 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -128.38 133.94 48.73 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.791 -0.818 . . . . 71.329999999999998 108.791 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.817 ' N ' HD12 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -122.39 138.67 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 121.717 0.77 . . . . 71.129999999999995 110.242 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.8 119.98 8.15 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.027 -1.101 . . . . 64.319999999999993 108.027 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.694 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -43.95 -54.39 11.18 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 62.200000000000003 111.501 -178.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -38.51 -13.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 121.198 1.266 . . . . 73.109999999999999 113.202 -176.465 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.694 ' N ' ' O ' ' A' ' 97' ' ' LYS . 57.6 m-85 56.32 100.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.632 -0.668 . . . . 65.219999999999999 110.039 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.0 mtt85 -55.7 -42.87 75.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.786 -1.197 . . . . 72.349999999999994 108.21 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.3 t -169.1 132.23 1.31 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.855 -0.794 . . . . 71.319999999999993 108.855 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 62.4 mt -51.32 -43.8 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.148 -0.97 . . . . 75.430000000000007 109.327 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.417 ' CD ' ' N ' ' A' ' 103' ' ' LYS . 3.4 mptp? -62.07 -35.07 77.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 71.409999999999997 109.611 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.24 -55.82 10.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.13 -0.982 . . . . 63.240000000000002 109.883 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.4 tp -57.84 -56.75 17.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 73.219999999999999 109.702 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.553 HG11 ' HZ2' ' A' ' 23' ' ' LYS . 74.1 t -53.15 -43.71 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.971 -1.081 . . . . 60.109999999999999 109.546 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.55 -43.1 64.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.14 -0.975 . . . . 70.420000000000002 108.913 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -66.81 -37.1 83.87 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.362 -0.836 . . . . 74.409999999999997 109.333 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 65.1 mt -66.94 -33.82 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 107.879 -1.156 . . . . 62.539999999999999 107.879 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -59.6 -42.83 93.49 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.368 -0.975 . . . . 74.340000000000003 108.368 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.417 ' HB2' ' CZ ' ' B' ' 87' ' ' PHE . . . -57.61 -50.33 73.5 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.354 -0.841 . . . . 73.319999999999993 109.497 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -59.16 -50.77 72.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.209 -0.932 . . . . 52.409999999999997 109.622 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.507 ' O ' ' CE2' ' A' ' 116' ' ' TRP . 53.2 mt -64.98 -36.61 84.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.046 -1.034 . . . . 65.239999999999995 109.646 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -56.34 -36.88 69.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -0.891 . . . . 64.450000000000003 109.595 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -78.2 54.6 1.39 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 74.430000000000007 109.431 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.507 ' CE2' ' O ' ' A' ' 113' ' ' LEU . 7.2 m-90 -59.66 148.74 32.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.928 . . . . 74.420000000000002 109.478 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -50.84 127.29 27.68 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.702 -1.359 . . . . 75.040000000000006 109.702 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.2 t -85.96 3.23 42.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -1.134 . . . . 61.140000000000001 109.424 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.487 ' CG ' ' H ' ' A' ' 120' ' ' VAL . 47.4 t30 52.53 -179.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 65.239999999999995 109.413 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.487 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 5.3 t -141.97 -45.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.304 -0.872 . . . . 73.109999999999999 109.61 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.0 mm -98.59 125.38 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.191 -0.943 . . . . 72.239999999999995 109.281 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 122' ' ' GLU . 1.3 pm0 -134.05 108.87 8.6 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.499 -0.751 . . . . 72.340000000000003 108.976 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.438 ' O ' HG23 ' A' ' 123' ' ' ILE . 18.2 tt -134.88 131.08 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.466 -0.771 . . . . 71.439999999999998 109.113 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.08 -145.83 5.47 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.576 -1.409 . . . . 73.400000000000006 109.576 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -85.75 -0.62 55.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -1.185 . . . . 74.450000000000003 109.331 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.92 130.52 44.21 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.51 -0.922 . . . . 54.210000000000001 108.51 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.474 ' CG2' ' ND2' ' A' ' 119' ' ' ASN . 32.1 m -130.45 129.37 42.9 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.353 -0.842 . . . . 54.5 109.571 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 27.1 mm -113.67 133.3 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.414 -0.804 . . . . 45.149999999999999 109.195 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.5 m -115.87 96.59 47.2 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 109.13 -0.692 . . . . 71.109999999999999 109.13 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -78.46 -37.07 0.77 Allowed 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 121.839 1.693 . . . . 65.409999999999997 111.943 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -68.18 -43.51 77.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 63.32 109.255 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -90.23 -1.87 57.98 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.375 -0.828 . . . . 72.519999999999996 109.416 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 52.97 62.41 2.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.354 -0.841 . . . . 75.329999999999998 109.972 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -150.22 140.59 22.34 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.271 -0.893 . . . . 71.230000000000004 109.085 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 7.3 tt -121.68 135.32 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 108.93 -0.767 . . . . 74.019999999999996 108.93 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 136' ' ' ILE . 14.8 mt -116.71 129.32 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.65 -0.656 . . . . 60.229999999999997 109.561 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.439 ' CE2' ' O ' ' A' ' 198' ' ' PRO . 54.8 t80 -138.46 138.05 37.76 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.589 -0.694 . . . . 62.32 109.199 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm 53.35 31.07 11.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.365 -0.834 . . . . 75.400000000000006 110.1 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 73.94 15.22 79.76 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 120.051 -1.071 . . . . 72.239999999999995 110.456 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -107.52 125.23 51.02 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.401 -1.058 . . . . 71.219999999999999 109.342 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -95.04 126.18 40.21 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.269 -0.894 . . . . 71.420000000000002 109.704 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.9 p -137.85 140.79 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.375 -0.828 . . . . 53.020000000000003 109.254 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -85.51 144.44 27.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.3 -0.875 . . . . 60.450000000000003 109.314 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.424 HG21 ' CD1' ' A' ' 149' ' ' PHE . 16.2 m -147.29 137.16 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.242 -0.911 . . . . 74.439999999999998 109.539 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.521 ' NZ ' ' O ' ' A' ' 65' ' ' LYS . 43.7 pttt -156.59 20.36 0.34 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -0.861 . . . . 65.150000000000006 109.495 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.48 -178.92 51.73 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.297 -1.521 . . . . 73.340000000000003 109.297 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 13.5 ttmt -64.76 -39.89 43.27 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.185 -1.186 . . . . 72.219999999999999 109.82 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 25.4 Cg_exo -62.18 -24.63 76.44 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.324 2.016 . . . . 65.230000000000004 112.098 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.576 ' CZ ' ' CG2' ' A' ' 153' ' ' THR . 59.0 t80 -82.27 -42.02 19.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.13 -0.981 . . . . 60.109999999999999 110.003 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.466 ' O ' ' ND1' ' A' ' 154' ' ' HIS . 80.8 mm-40 -50.11 -45.47 52.89 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.134 -0.979 . . . . 64.209999999999994 109.36 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.8 p -72.05 -35.08 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.215 -0.928 . . . . 72.019999999999996 109.099 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 15.0 tp -60.5 -38.0 82.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 73.310000000000002 109.159 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.576 ' CG2' ' CZ ' ' A' ' 149' ' ' PHE . 16.8 p -71.74 -41.89 67.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.315 -0.865 . . . . 74.310000000000002 109.8 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.818 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 34.2 m80 -53.24 -51.62 61.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.31 -0.869 . . . . 74.310000000000002 110.038 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 pp -73.27 -24.38 60.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.932 -1.105 . . . . 75.340000000000003 109.601 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.4 -53.58 56.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.135 -0.978 . . . . 62.140000000000001 109.268 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 1.09 ' HG3' ' ND1' ' A' ' 158' ' ' HIS . 13.6 ptm180 -68.43 -34.95 76.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.913 . . . . 61.030000000000001 109.069 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 1.09 ' ND1' ' HG3' ' A' ' 157' ' ' ARG . 15.9 m80 -94.95 64.75 2.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.342 -0.849 . . . . 74.120000000000005 109.083 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.52 ' NH1' ' OG1' ' A' ' 203' ' ' THR . 2.1 tpm_? -81.22 -3.01 50.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.868 . . . . 71.129999999999995 110.173 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.514 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 57.4 p30 -144.85 57.67 1.29 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.987 -1.07 . . . . 75.450000000000003 110.075 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 160' ' ' ASP . 89.1 mm-40 -148.87 179.72 7.64 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.207 -0.933 . . . . 73.409999999999997 109.211 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 68.0 mt -105.64 123.48 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.896 -0.779 . . . . 74.409999999999997 108.896 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 72.9 t -117.41 130.27 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.48 -0.762 . . . . 72.310000000000002 109.472 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 86.1 p -97.05 159.29 14.99 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.286 -0.884 . . . . 74.120000000000005 109.483 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -60.14 -44.28 95.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 70.430000000000007 109.632 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -55.72 -33.33 64.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 73.519999999999996 109.252 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.427 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 61.8 tt0 -61.49 -46.21 90.99 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.277 -0.889 . . . . 74.519999999999996 109.295 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 34.1 mt -59.54 -30.88 68.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 72.310000000000002 108.886 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.401 HD23 ' C ' ' A' ' 169' ' ' LEU . 3.4 tt -66.93 -74.38 0.11 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 53.329999999999998 109.608 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 167' ' ' GLN . 59.1 p30 -55.82 -8.45 0.42 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.504 -0.747 . . . . 62.439999999999998 111.063 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.21 -52.57 4.13 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.869 -1.144 . . . . 60.210000000000001 112.282 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.6 mp -99.31 -41.04 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 O-C-N 120.82 -1.175 . . . . 75.319999999999993 112.077 -177.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.503 ' CD2' ' C ' ' A' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.8 0 O-C-N 120.39 -1.444 . . . . 73.140000000000001 109.081 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.317 0.579 . . . . 64.540000000000006 109.495 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 8.5 p -55.88 -14.27 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 74.019999999999996 109.935 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 96.0 mt -51.64 -42.4 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.942 . . . . 72.329999999999998 109.962 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.446 ' CG ' ' N ' ' A' ' 186' ' ' VAL . 19.8 pt-20 -61.63 -43.79 98.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.041 -1.037 . . . . 74.400000000000006 109.446 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . 0.446 ' N ' ' CG ' ' A' ' 185' ' ' GLU . 94.0 t -71.27 -30.41 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 70.420000000000002 109.292 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.12 -56.09 6.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.383 -0.823 . . . . 52.109999999999999 109.913 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.1 -26.29 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.809 -1.182 . . . . 71.400000000000006 109.631 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -73.45 -55.58 6.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.988 . . . . 73.439999999999998 109.962 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -68.2 -40.27 82.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.128 -0.983 . . . . 71.420000000000002 109.876 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 73.5 mt -55.68 -49.25 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.001 -1.062 . . . . 61.549999999999997 109.253 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 75.9 mtp85 -57.75 -44.69 86.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -0.977 . . . . 63.340000000000003 109.541 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -66.56 -36.85 83.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.893 . . . . 61.240000000000002 109.698 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.482 ' O ' ' CG ' ' A' ' 198' ' ' PRO . 16.4 mtpp -84.52 -2.41 57.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.913 . . . . 75.129999999999995 109.784 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 50.6 ttm -89.62 -28.41 19.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.182 -0.949 . . . . 74.019999999999996 109.555 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 197' ' ' LYS . 46.4 p30 -102.35 -10.95 19.02 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.251 -0.905 . . . . 74.019999999999996 110.303 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.576 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 14.6 tttt -77.59 -43.21 2.47 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.92 -1.113 . . . . 75.430000000000007 109.74 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 25.9 Cg_endo -88.18 -32.46 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.624 2.216 . . . . 72.319999999999993 112.304 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.644 ' N ' HD22 ' A' ' 199' ' ' LEU . 3.1 mm? -85.77 -98.31 0.07 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.913 -1.117 . . . . 74.540000000000006 109.211 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 152.2 -33.18 0.86 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.496 -1.441 . . . . 61.509999999999998 109.496 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 66.2 mt -96.4 128.93 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.291 -1.123 . . . . 61.219999999999999 109.529 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 25.0 p -79.87 132.74 36.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 72.0 108.962 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.52 ' OG1' ' NH1' ' A' ' 159' ' ' ARG . 5.2 p -141.69 40.25 1.7 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.293 -0.88 . . . . 74.439999999999998 109.666 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 17.1 m -138.96 139.03 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.325 -0.859 . . . . 64.349999999999994 109.333 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -125.41 129.17 49.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.536 -0.727 . . . . 71.409999999999997 109.174 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.08 140.85 37.19 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.349 -0.845 . . . . 73.519999999999996 109.32 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 10.5 p -139.65 141.47 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.299 -0.876 . . . . 71.019999999999996 109.332 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -92.61 52.89 1.96 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.234 -0.916 . . . . 72.120000000000005 109.542 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -146.24 -8.45 0.52 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.167 -0.958 . . . . 64.409999999999997 109.437 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -159.7 -69.0 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.186 -0.947 . . . . 71.540000000000006 109.327 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -172.31 -119.21 0.51 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.569 -1.413 . . . . 72.030000000000001 109.569 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -123.15 129.8 51.91 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.582 -0.952 . . . . 75.540000000000006 109.258 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -103.74 129.66 51.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.453 -0.78 . . . . 75.310000000000002 109.663 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -95.36 123.74 39.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.289 -0.882 . . . . 75.409999999999997 108.67 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 26.8 p -126.4 170.29 12.1 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 121.608 0.718 . . . . 74.140000000000001 110.32 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -78.43 140.55 60.34 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.899 -0.778 . . . . 75.319999999999993 108.899 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo . . . . . 0 N--CA 1.491 1.346 0 C-N-CA 122.06 1.84 . . . . 73.109999999999999 112.493 179.887 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 50.9 ttm . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.46 -0.57 . . . . 71.140000000000001 109.46 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -137.52 139.86 40.77 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.43 -0.794 . . . . 73.230000000000004 109.281 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.9 t -112.07 135.14 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.657 -0.652 . . . . 72.239999999999995 109.434 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.12 119.18 38.67 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.546 -0.721 . . . . 54.329999999999998 110.028 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 19.8 mt -118.55 97.17 5.61 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.644 -0.872 . . . . 74.349999999999994 108.644 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.416 HD12 ' HB ' ' B' ' 50' ' ' VAL . 66.8 mt -84.16 96.99 4.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.749 -1.219 . . . . 42.549999999999997 108.588 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.428 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 26.4 tp10 -134.03 132.1 39.64 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.494 -0.753 . . . . 74.519999999999996 109.375 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.7 -32.93 74.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 62.549999999999997 109.353 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . 0.403 ' H ' ' HG3' ' B' ' 7' ' ' GLU . 79.1 m-20 -82.92 117.24 22.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 73.109999999999999 109.399 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 19.8 m -75.98 -32.27 59.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 65.540000000000006 110.026 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . 0.552 HG13 ' N ' ' B' ' 12' ' ' LEU . 8.9 p -60.02 -45.11 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.071 -1.018 . . . . 75.549999999999997 109.908 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.552 ' N ' HG13 ' B' ' 11' ' ' VAL . 77.2 mt -66.02 -35.44 80.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.012 -1.055 . . . . 70.140000000000001 109.349 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.5 -27.34 67.81 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.63 -1.788 . . . . 75.400000000000006 108.63 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.79 -54.94 25.28 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.603 -1.399 . . . . 65.439999999999998 109.603 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' B' ' 15' ' ' GLU . 12.8 pt-20 -58.39 -44.38 88.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.351 -1.088 . . . . 60.210000000000001 109.652 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 65.8 mt -65.94 -39.26 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.956 -1.09 . . . . 75.150000000000006 108.936 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.407 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 86.2 tt0 -59.69 -43.89 93.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.254 -0.904 . . . . 73.010000000000005 109.065 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -85.32 -1.6 57.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.184 -0.947 . . . . 74.299999999999997 109.109 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -85.11 -59.61 1.94 Allowed Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.695 -1.362 . . . . 70.540000000000006 109.695 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -68.55 -21.35 64.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -1.175 . . . . 71.340000000000003 109.707 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 2.3 m120 -51.79 -33.73 36.77 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.073 -1.017 . . . . 64.409999999999997 109.324 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 91.1 t -56.94 -36.82 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.179 -0.95 . . . . 74.230000000000004 108.904 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.402 ' N ' ' CD ' ' B' ' 23' ' ' LYS . 12.2 mptt -72.44 -13.12 61.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.442 -0.786 . . . . 63.420000000000002 109.212 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.52 39.25 6.35 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.045 -1.222 . . . . 53.43 110.045 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -119.23 159.94 23.12 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.515 -0.991 . . . . 71.120000000000005 109.18 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 48.4 mmm -106.03 140.65 38.69 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.721 -0.844 . . . . 75.239999999999995 108.721 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.413 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -137.83 155.54 48.88 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.392 -0.817 . . . . 72.120000000000005 109.995 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 88.5 m-20 -136.41 157.23 47.29 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.424 -0.954 . . . . 72.310000000000002 108.424 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 p -122.19 139.12 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.404 -0.81 . . . . 64.430000000000007 109.749 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 2.6 p -138.05 173.49 11.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.521 -0.737 . . . . 65.409999999999997 109.416 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -98.52 -98.67 0.22 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.362 -0.836 . . . . 71.019999999999996 109.753 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 14.0 t -78.77 164.81 24.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.223 -0.923 . . . . 51.109999999999999 110.12 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 50.6 mt -53.06 -36.99 61.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.669 -0.644 . . . . 71.239999999999995 110.086 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.58 ' H ' ' CD ' ' B' ' 34' ' ' GLU . 45.1 mp0 -53.18 -46.49 68.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 74.319999999999993 109.964 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -61.42 -38.57 87.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.117 -0.989 . . . . 73.030000000000001 109.274 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.34 -33.75 87.5 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.331 -1.508 . . . . 30.210000000000001 109.331 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -69.3 -43.95 72.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -1.13 . . . . 74.420000000000002 109.743 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . 0.437 ' O ' ' OD1' ' B' ' 41' ' ' ASP . 65.9 m-85 -76.27 -22.48 55.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.141 -0.974 . . . . 74.420000000000002 110.046 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 60.3 tp -90.04 -34.31 16.0 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.081 -1.012 . . . . 75.409999999999997 109.871 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . 0.445 ' O ' ' O ' ' B' ' 43' ' ' ARG . 2.5 ppp? -79.02 -28.1 43.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.153 -0.967 . . . . 60.409999999999997 110.405 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' B' ' 42' ' ' ILE . 39.0 p-10 -62.52 -27.02 68.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.914 -1.116 . . . . 53.229999999999997 110.041 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.542 ' N ' ' OD1' ' B' ' 41' ' ' ASP . 11.8 pt -99.27 -10.87 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.184 -0.948 . . . . 71.230000000000004 110.411 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' B' ' 40' ' ' MET . 98.6 mtt180 -130.23 155.67 45.88 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.247 -0.908 . . . . 72.219999999999999 109.812 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -80.1 169.02 18.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.203 -0.935 . . . . 63.539999999999999 109.323 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 1.7 p90 -156.36 92.37 1.32 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.134 -0.979 . . . . 64.349999999999994 109.263 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -76.55 -32.27 58.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.082 -1.011 . . . . 62.219999999999999 108.909 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.508 ' C ' HD13 ' B' ' 47' ' ' LEU . 0.8 OUTLIER -112.67 108.74 17.9 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.666 -0.865 . . . . 73.120000000000005 108.666 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.433 ' N ' HD13 ' B' ' 47' ' ' LEU . 50.4 t -93.7 107.38 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.524 -0.917 . . . . 65.109999999999999 108.524 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.9 ttt -125.5 131.58 52.79 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.555 -0.715 . . . . 73.439999999999998 109.52 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.644 HG22 ' H ' ' B' ' 52' ' ' ASP . 0.4 OUTLIER -145.87 138.69 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.465 -0.772 . . . . 34.5 109.803 -179.183 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . 0.428 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 89.4 p -99.68 12.59 36.18 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.491 -0.755 . . . . 73.209999999999994 109.828 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.644 ' H ' HG22 ' B' ' 50' ' ' VAL . 42.4 m-20 -81.77 134.37 35.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.073 -1.017 . . . . 70.409999999999997 109.561 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -71.3 -34.44 70.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.342 -0.849 . . . . 65.0 110.2 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -76.55 9.76 2.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.061 -1.024 . . . . 75.209999999999994 109.722 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' B' ' 56' ' ' LEU . . . -72.87 -21.18 60.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.19 -0.944 . . . . 55.329999999999998 110.254 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' B' ' 55' ' ' ALA . 69.5 mt -41.14 -52.7 3.25 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.496 -0.753 . . . . 63.140000000000001 110.364 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 19.8 t -65.05 -36.32 83.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.961 -1.087 . . . . 63.5 109.171 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -62.53 -61.76 2.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.327 -0.858 . . . . 72.329999999999998 109.649 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 22.4 m -49.75 -31.57 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.523 -1.36 . . . . 74.540000000000006 109.645 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . 0.401 ' OG ' ' N ' ' B' ' 61' ' ' ARG . 5.8 p -58.61 -52.15 66.87 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.254 -0.904 . . . . 71.239999999999995 109.321 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.401 ' N ' ' OG ' ' B' ' 60' ' ' SER . 2.8 ptp180 -68.61 -31.86 71.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.075 -1.015 . . . . 74.310000000000002 110.0 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 40.6 mm -66.16 -40.08 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.723 -1.235 . . . . 72.140000000000001 109.879 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -65.83 -48.2 72.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 73.319999999999993 110.48 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -72.83 -37.19 67.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.826 -1.171 . . . . 73.120000000000005 110.12 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.484 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 66.4 mttm -81.49 -21.11 38.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.152 -0.968 . . . . 72.439999999999998 109.856 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.484 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 72.0 m-70 -155.78 66.26 0.6 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.103 -0.998 . . . . 63.310000000000002 109.691 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.5 t -62.59 -33.53 75.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.21 -0.931 . . . . 73.099999999999994 109.87 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 51.1 m -57.29 -30.34 64.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.211 -0.93 . . . . 71.530000000000001 110.073 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 73.3 mt -76.13 153.35 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.112 -0.993 . . . . 74.400000000000006 109.532 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.53 HG12 ' N ' ' B' ' 71' ' ' VAL . 72.6 t -90.33 163.47 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.324 -0.86 . . . . 75.120000000000005 109.565 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.53 ' N ' HG12 ' B' ' 70' ' ' VAL . 12.9 t -139.81 126.57 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.239 -0.913 . . . . 73.200000000000003 109.544 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.688 ' HG ' HD11 ' B' ' 95' ' ' ILE . 1.1 mp -124.94 99.93 6.36 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.727 -0.842 . . . . 73.340000000000003 108.727 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 76.0 t -91.15 145.63 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.899 . . . . 73.5 108.72 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 2.4 m -118.68 171.82 7.93 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.414 -0.804 . . . . 64.340000000000003 109.044 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.469 ' HG ' ' HH ' ' B' ' 94' ' ' TYR . 27.6 p -162.0 126.74 3.35 Favored 'General case' 0 N--CA 1.506 2.335 0 C-N-CA 118.699 -1.2 . . . . 74.530000000000001 111.284 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -65.35 -13.73 59.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.631 -0.668 . . . . 64.5 110.239 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' B' ' 79' ' ' THR . 10.1 p-10 -129.73 79.44 73.46 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 121.356 -0.84 . . . . 74.25 109.709 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.475 ' HA ' ' HH ' ' B' ' 94' ' ' TYR . 27.8 Cg_exo -57.89 80.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.428 2.085 . . . . 74.430000000000007 111.277 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.438 ' N ' ' O ' ' B' ' 77' ' ' ASN . 66.6 p -106.48 151.25 25.21 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.933 -0.766 . . . . 73.120000000000005 108.933 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -24.17 61.52 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.37 -0.831 . . . . 71.010000000000005 109.32 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -67.93 -38.96 83.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 63.200000000000003 109.8 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -76.85 -34.57 57.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.136 -0.978 . . . . 73.219999999999999 109.77 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' B' ' 83' ' ' GLU . 0.4 OUTLIER -61.38 -51.58 68.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 74.299999999999997 109.635 -179.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.507 HG23 ' N ' ' B' ' 85' ' ' HIS . 30.3 m -62.58 -45.81 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.975 -1.078 . . . . 73.310000000000002 109.356 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' HIS . . . . . 0.507 ' N ' HG23 ' B' ' 84' ' ' VAL . 18.7 m170 -61.79 -30.9 71.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.137 -0.977 . . . . 73.239999999999995 109.2 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -65.69 -39.73 91.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 55.329999999999998 109.995 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 111' ' ' ALA . 79.1 t80 -83.72 -37.89 22.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.032 -1.042 . . . . 74.140000000000001 109.315 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -67.34 -41.17 85.65 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.306 -0.871 . . . . 64.040000000000006 109.542 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -69.57 -50.64 42.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 72.349999999999994 109.556 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 145.6 70.47 0.02 OUTLIER Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.907 -1.277 . . . . 65.200000000000003 109.907 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -129.24 131.25 47.01 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.392 -1.064 . . . . 52.229999999999997 108.881 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' B' ' 71' ' ' VAL . 56.8 m-20 -75.54 -35.54 60.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.064 -1.022 . . . . 73.319999999999993 109.078 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' ASP . . . . . 0.521 ' OD2' ' NH2' ' B' ' 112' ' ' ARG . 7.3 m-20 -153.89 155.3 35.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.385 -0.822 . . . . 72.219999999999999 109.388 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.475 ' HH ' ' HA ' ' B' ' 78' ' ' PRO . 6.3 t80 -123.37 138.76 54.53 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.061 -0.718 . . . . 64.420000000000002 109.061 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 0.813 ' N ' HD12 ' B' ' 95' ' ' ILE . 0.3 OUTLIER -130.1 139.68 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-O 122.069 0.937 . . . . 72.230000000000004 110.622 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . 0.414 ' HB1' ' HD2' ' B' ' 98' ' ' PRO . . . -59.17 131.98 52.65 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.825 -1.546 . . . . 25.239999999999998 106.825 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -61.99 -41.2 74.89 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 120.833 -1.167 . . . . 64.319999999999993 110.959 -178.179 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' B' ' 97' ' ' LYS . 37.3 Cg_exo -54.73 2.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.291 -2.486 0 CA-C-N 118.827 0.617 . . . . 63.329999999999998 112.202 -175.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . 0.575 ' N ' ' O ' ' B' ' 97' ' ' LYS . 50.4 m-85 54.83 106.56 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.614 -0.679 . . . . 75.129999999999995 109.848 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 19.7 ttm180 -61.62 -34.83 76.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 74.230000000000004 108.976 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . 0.762 ' O ' ' N ' ' B' ' 103' ' ' LYS . 43.9 t -174.59 38.8 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.266 -0.896 . . . . 63.340000000000003 110.508 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 59.1 mt 50.17 -70.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.656 -0.652 . . . . 74.439999999999998 110.311 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.762 ' N ' ' O ' ' B' ' 101' ' ' SER . 9.3 mtpm? -54.32 -21.03 8.28 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.953 -1.129 . . . . 71.109999999999999 107.953 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.21 -64.23 0.93 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.073 -0.651 . . . . 71.450000000000003 109.983 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 2.5 pp -62.29 -35.22 78.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.036 -1.04 . . . . 51.310000000000002 109.787 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 34.4 t -60.75 -44.21 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.876 -1.14 . . . . 65.230000000000004 108.605 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.23 -42.62 73.65 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.314 -0.995 . . . . 24.32 108.314 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . 0.615 ' NH1' ' CZ ' ' A' ' 87' ' ' PHE . 58.8 mtp85 -64.91 -34.07 77.51 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.412 -0.805 . . . . 75.310000000000002 108.974 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 92.4 mt -74.3 -27.69 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.488 -0.93 . . . . 54.240000000000002 108.488 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -75.31 -58.17 3.44 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.446 -0.784 . . . . 65.310000000000002 109.112 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -48.32 -42.87 32.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 72.239999999999995 109.43 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . 0.521 ' NH2' ' OD2' ' B' ' 93' ' ' ASP . 50.6 ttm-85 -61.36 -44.14 97.67 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.324 -0.86 . . . . 72.040000000000006 109.319 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 41.2 mt -134.8 75.78 1.59 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.43 -0.794 . . . . 75.349999999999994 109.313 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -68.1 -54.44 18.12 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.136 -0.978 . . . . 75.5 109.318 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 115' ' ' PHE . . . . . 0.521 ' O ' ' CG ' ' B' ' 116' ' ' TRP . 6.3 t80 -92.18 -76.97 0.44 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.186 -0.946 . . . . 65.329999999999998 109.436 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 116' ' ' TRP . . . . . 0.521 ' CG ' ' O ' ' B' ' 115' ' ' PHE . 4.0 m-90 -162.44 -173.22 3.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.053 -1.029 . . . . 74.450000000000003 109.294 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.17 176.22 0.93 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.455 -1.458 . . . . 44.210000000000001 109.455 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . 0.471 ' C ' ' ND2' ' B' ' 119' ' ' ASN . 26.9 m -128.25 178.67 6.08 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.439 -1.036 . . . . 71.400000000000006 109.599 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . 0.471 ' ND2' ' C ' ' B' ' 118' ' ' SER . 0.0 OUTLIER -152.51 139.63 19.27 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.941 -0.704 . . . . 72.319999999999993 109.207 -178.023 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 14.2 t -86.08 -40.28 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.133 -0.979 . . . . 75.019999999999996 109.619 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 18.2 mm -105.57 134.39 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.309 -0.869 . . . . 51.409999999999997 108.838 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -157.26 131.16 8.19 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.076 -1.015 . . . . 71.530000000000001 109.036 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 3.8 tt -151.77 131.3 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 72.430000000000007 108.912 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.13 -143.11 41.34 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.997 -1.641 . . . . 51.229999999999997 108.997 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -85.65 3.48 40.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -1.192 . . . . 74.200000000000003 109.043 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 mt -92.61 125.88 37.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.352 -0.842 . . . . 75.420000000000002 108.741 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 17.4 m -123.77 140.36 53.06 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.153 -1.055 . . . . 74.219999999999999 108.153 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 5.0 mt -143.01 131.25 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.023 -1.048 . . . . 60.329999999999998 109.92 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . 0.564 ' HB3' ' OE1' ' B' ' 132' ' ' GLU . 12.4 m -116.3 92.43 36.22 Favored Pre-proline 0 N--CA 1.495 1.814 0 N-CA-C 108.573 -0.899 . . . . 72.310000000000002 108.573 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -71.67 -27.91 17.82 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.354 1.369 . . . . 75.129999999999995 111.616 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . 0.577 ' HB2' ' OE2' ' B' ' 132' ' ' GLU . 74.4 m-20 -66.91 -42.22 85.78 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.144 -0.972 . . . . 75.230000000000004 108.88 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . 0.577 ' OE2' ' HB2' ' B' ' 131' ' ' ASP . 4.7 mp0 -87.27 6.08 35.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.328 -0.857 . . . . 72.430000000000007 109.307 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . 0.556 ' HA ' ' CE1' ' B' ' 149' ' ' PHE . 42.9 mt-10 51.03 54.55 11.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 75.129999999999995 109.446 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -150.54 145.97 26.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.212 -0.93 . . . . 73.219999999999999 109.527 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 8.3 tt -130.45 142.06 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.502 -0.749 . . . . 64.140000000000001 109.513 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 77.3 mt -129.71 124.61 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.525 -0.734 . . . . 71.219999999999999 109.561 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' B' ' 137' ' ' TYR . 18.2 p90 -142.33 152.72 43.21 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.234 -0.916 . . . . 64.219999999999999 109.66 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . 0.517 ' O ' ' NH1' ' B' ' 140' ' ' ARG . 51.3 mtpt 55.57 14.54 1.24 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.513 -0.742 . . . . 72.019999999999996 110.045 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.88 -15.77 58.45 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.144 -1.027 . . . . 74.319999999999993 110.587 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . 0.517 ' NH1' ' O ' ' B' ' 138' ' ' LYS . 10.3 mpt_? -87.26 143.16 27.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.957 -1.319 . . . . 75.340000000000003 108.846 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 141' ' ' GLU . . . . . 0.462 ' N ' ' CD ' ' B' ' 141' ' ' GLU . 21.2 mp0 -103.2 138.63 39.74 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.235 -0.915 . . . . 71.230000000000004 109.914 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 52.8 t -138.01 133.98 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.811 -0.811 . . . . 70.430000000000007 108.811 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . 0.434 ' H ' ' HG3' ' B' ' 143' ' ' GLU . 3.2 pp20? -104.7 136.32 44.45 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.395 -0.816 . . . . 72.430000000000007 109.684 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 6.7 m -140.37 157.19 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.366 -0.834 . . . . 72.129999999999995 109.01 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -171.8 37.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.997 . . . . 72.019999999999996 109.839 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -133.25 -125.54 2.62 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 109.184 -1.566 . . . . 42.229999999999997 109.184 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . 0.611 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 33.8 tttm -76.13 -33.35 1.25 Allowed Pre-proline 0 N--CA 1.487 1.401 0 O-C-N 121.272 -1.134 . . . . 73.299999999999997 111.223 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 61.0 Cg_endo -85.22 11.77 3.27 Favored 'Trans proline' 0 N--CA 1.486 1.065 0 C-N-CA 121.854 1.702 . . . . 71.329999999999998 112.158 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . 0.621 ' CE1' HG21 ' B' ' 153' ' ' THR . 13.0 t80 -110.24 -50.18 2.99 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.497 -0.752 . . . . 74.230000000000004 108.988 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -60.92 -49.79 76.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.33 -0.856 . . . . 72.340000000000003 111.099 -178.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.478 HG13 ' N ' ' B' ' 152' ' ' LEU . 11.8 p -70.95 -40.23 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.91 -1.118 . . . . 73.349999999999994 110.131 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.478 ' N ' HG13 ' B' ' 151' ' ' VAL . 16.4 tp -65.65 -40.19 92.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.117 -0.989 . . . . 55.240000000000002 109.937 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.621 HG21 ' CE1' ' B' ' 149' ' ' PHE . 14.3 p -77.62 -17.79 57.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.754 -1.216 . . . . 70.010000000000005 109.69 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -71.39 -54.23 11.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.877 -1.14 . . . . 65.319999999999993 109.607 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . 0.885 HD13 ' N ' ' B' ' 156' ' ' ALA . 0.0 OUTLIER -74.67 -21.17 59.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.16 -0.962 . . . . 71.540000000000006 109.455 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . 0.885 ' N ' HD13 ' B' ' 155' ' ' LEU . . . -62.9 -55.3 27.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.793 -1.192 . . . . 75.319999999999993 108.947 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -64.23 -52.23 59.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.047 -1.033 . . . . 73.319999999999993 108.838 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 158' ' ' HIS . . . . . 0.5 ' CG ' ' NE2' ' B' ' 161' ' ' GLN . 17.0 m-70 -88.52 42.43 1.07 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.563 -0.71 . . . . 74.140000000000001 110.15 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 22.2 ttp-105 -55.3 -77.58 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.06 -1.025 . . . . 61.409999999999997 109.368 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -65.3 82.74 0.05 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.375 -0.828 . . . . 72.099999999999994 109.396 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . 0.5 ' NE2' ' CG ' ' B' ' 158' ' ' HIS . 8.8 tt0 -170.46 154.36 4.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.268 -0.895 . . . . 72.25 109.496 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 162' ' ' ILE . . . . . 0.753 HD12 ' N ' ' B' ' 162' ' ' ILE . 2.9 mp -76.66 109.87 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.15 -0.969 . . . . 72.310000000000002 109.062 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.65 124.79 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.309 -0.869 . . . . 64.209999999999994 109.041 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 23.3 t -100.85 178.77 4.59 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.199 -0.938 . . . . 74.219999999999999 110.167 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . 0.511 ' NZ ' ' CZ ' ' B' ' 212' ' ' TYR . 40.5 mttm -72.77 -56.83 4.68 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.003 0.906 . . . . 65.310000000000002 109.345 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . 0.723 ' O ' ' OD1' ' B' ' 170' ' ' ASP . 12.8 pt-20 -55.37 -27.99 51.03 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.368 -0.832 . . . . 63.450000000000003 109.535 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -60.28 -50.47 73.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.094 -1.004 . . . . 72.400000000000006 109.354 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 76.9 mt -59.27 -35.88 74.53 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.334 -0.854 . . . . 72.319999999999993 109.665 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' B' ' 172' ' ' ILE . 40.2 mt -65.54 -73.68 0.12 Allowed 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 117.692 -1.603 . . . . 73.340000000000003 109.303 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . 0.787 ' OD1' ' N ' ' B' ' 170' ' ' ASP . 0.0 OUTLIER -42.86 -21.45 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.311 0 O-C-N 120.173 -1.58 . . . . 72.099999999999994 110.233 178.578 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' B' ' 169' ' ' LEU . . . -88.12 -24.86 23.26 Favored 'General case' 0 C--N 1.283 -2.286 0 O-C-N 121.61 -0.682 . . . . 62.130000000000003 110.5 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 0.532 ' N ' ' O ' ' B' ' 169' ' ' LEU . 1.8 mp -113.93 -19.77 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.307 -0.871 . . . . 71.420000000000002 110.659 -178.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 173' ' ' TRP . . . . . 0.515 ' CZ3' ' HB3' ' B' ' 169' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.515 2.776 0 O-C-N 120.276 -1.515 . . . . 72.230000000000004 107.015 178.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo . . . . . 0 N--CA 1.488 1.196 0 N-CA-C 113.254 0.444 . . . . 65.219999999999999 113.254 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 12.6 m120 49.3 45.33 23.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.045 -1.034 . . . . 72.310000000000002 110.564 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.11 -23.99 16.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.259 -0.901 . . . . 63.32 109.767 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.421 HD11 HD11 ' B' ' 169' ' ' LEU . 54.2 mt -49.25 -39.78 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.114 -0.991 . . . . 75.030000000000001 110.576 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -53.61 -61.67 2.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.027 -1.045 . . . . 64.109999999999999 109.533 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 34.1 t -66.04 -40.79 88.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.486 -0.759 . . . . 73.0 110.405 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.9 -58.37 6.34 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.029 -1.044 . . . . 61.119999999999997 110.853 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 188' ' ' ILE . . . . . 0.596 HD12 ' CE2' ' B' ' 212' ' ' TYR . 1.3 tt -56.03 -33.94 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.739 -1.225 . . . . 72.430000000000007 109.977 -178.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.99 -57.47 12.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.098 -1.001 . . . . 65.140000000000001 109.987 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -68.76 -41.05 79.39 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.159 -0.963 . . . . 63.240000000000002 110.548 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 77.5 mt -55.26 -38.75 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.817 -1.177 . . . . 74.030000000000001 108.932 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 192' ' ' ARG . . . . . 0.409 ' CZ ' HG21 ' B' ' 206' ' ' THR . 57.0 mtp180 -64.97 -48.26 74.63 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.319 -0.863 . . . . 72.239999999999995 109.94 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -76.42 -20.06 57.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.043 -1.035 . . . . 73.099999999999994 111.12 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -90.73 -21.66 21.47 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.874 -1.141 . . . . 72.109999999999999 111.028 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 195' ' ' MET . . . . . 0.443 ' C ' ' SD ' ' B' ' 195' ' ' MET . 3.1 ppp? -88.35 -36.93 16.33 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.788 -1.195 . . . . 44.329999999999998 110.026 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -59.12 -42.85 91.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.16 -0.962 . . . . 71.209999999999994 110.348 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . 0.412 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 24.5 mttm -51.64 -64.45 1.44 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.974 . . . . 75.209999999999994 110.03 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 198' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 44.9 Cg_endo -65.71 -34.31 41.35 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.253 1.969 . . . . 75.319999999999993 112.613 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . 0.938 HD23 ' O ' ' B' ' 201' ' ' ILE . 13.3 tp -68.82 -43.75 74.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.176 -0.952 . . . . 72.25 109.69 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 92.92 -44.78 2.51 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.66 -1.376 . . . . 64.530000000000001 109.66 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . 0.938 ' O ' HD23 ' B' ' 199' ' ' LEU . 27.8 mm -110.31 133.81 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.397 -1.061 . . . . 44.229999999999997 109.28 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 9.0 t -77.64 135.49 38.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 54.009999999999998 109.451 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 71.2 p -143.02 44.11 1.57 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.28 -0.887 . . . . 74.400000000000006 109.24 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.594 HG12 ' CE2' ' B' ' 214' ' ' PHE . 17.5 m -139.03 140.89 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.377 -0.827 . . . . 72.120000000000005 109.871 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -124.76 114.79 19.73 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.779 -0.823 . . . . 65.409999999999997 108.779 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 206' ' ' THR . . . . . 0.409 HG21 ' CZ ' ' B' ' 192' ' ' ARG . 68.4 p -96.68 123.22 40.3 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.139 -0.975 . . . . 71.329999999999998 109.468 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 6.4 t -142.94 144.31 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.131 -0.981 . . . . 63.5 109.466 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 31.5 ttm-85 -60.14 -35.53 75.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.444 -0.785 . . . . 74.450000000000003 110.042 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 209' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' B' ' 211' ' ' GLY . 18.0 mmm180 -65.96 142.46 57.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.114 -0.991 . . . . 74.140000000000001 109.728 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . 0.519 ' NH1' HH21 ' B' ' 213' ' ' ARG . 90.3 mtt180 55.79 -81.5 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.668 -0.645 . . . . 74.430000000000007 109.718 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 211' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' B' ' 209' ' ' ARG . . . -179.36 -98.98 0.12 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.825 -1.31 . . . . 64.450000000000003 109.825 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 212' ' ' TYR . . . . . 0.596 ' CE2' HD12 ' B' ' 188' ' ' ILE . 6.4 m-85 -131.29 115.9 16.89 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.57 -0.959 . . . . 74.209999999999994 108.778 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . 0.519 HH21 ' NH1' ' B' ' 210' ' ' ARG . 35.4 ttm180 -93.1 128.11 38.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.421 -0.799 . . . . 74.030000000000001 109.976 -179.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . 0.604 ' CD2' HD23 ' B' ' 155' ' ' LEU . 14.2 m-85 -101.55 121.36 41.83 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.416 -0.957 . . . . 74.340000000000003 108.416 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.1 p -133.97 163.98 28.31 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.379 -0.825 . . . . 64.329999999999998 110.005 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -79.61 150.42 73.01 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.469 -0.769 . . . . 70.040000000000006 109.41 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.81 -101.5 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.282 1.988 . . . . 65.109999999999999 112.094 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 2.8 ptpp? . . . . . 0 N--CA 1.494 1.768 0 O-C-N 121.224 -0.922 . . . . 73.150000000000006 108.921 -179.937 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.546 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.427 -0.583 . . . . 65.120000000000005 109.427 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -137.61 148.97 46.26 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.445 -0.784 . . . . 72.329999999999998 109.319 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.0 t -118.06 125.09 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.66 -0.65 . . . . 71.420000000000002 109.724 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.803 HD12 ' N ' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -94.84 124.32 38.81 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.055 -1.028 . . . . 65.120000000000005 108.348 179.319 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.803 ' N ' HD12 ' A' ' 4' ' ' LEU . 4.1 tp -120.57 123.89 43.98 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.039 -0.726 . . . . 62.43 109.039 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.567 HG12 HD11 ' A' ' 4' ' ' LEU . 9.5 mt -108.63 106.1 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.271 -0.893 . . . . 71.150000000000006 108.861 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.516 ' OE2' ' ND2' ' A' ' 9' ' ' ASN . 37.0 tp10 -138.24 122.88 18.62 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.359 -0.838 . . . . 75.340000000000003 109.536 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -86.41 -13.31 46.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.28 -0.887 . . . . 72.439999999999998 109.323 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.516 ' ND2' ' OE2' ' A' ' 7' ' ' GLU . 82.3 m-20 -69.37 -136.34 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.354 -0.842 . . . . 63.020000000000003 109.454 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 11' ' ' VAL . 35.1 p -158.1 -63.86 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.071 -1.018 . . . . 72.340000000000003 109.765 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.52 HG13 ' N ' ' A' ' 12' ' ' LEU . 12.6 p -69.53 -41.22 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 74.019999999999996 109.881 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.52 ' N ' HG13 ' A' ' 11' ' ' VAL . 45.8 mt -63.98 -36.4 83.85 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.174 -0.954 . . . . 71.430000000000007 109.515 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.8 -34.87 23.58 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.696 -1.762 . . . . 61.32 108.696 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.86 -44.14 89.81 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.948 -1.261 . . . . 71.200000000000003 109.948 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -67.92 -43.59 78.84 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.069 -1.253 . . . . 71.319999999999993 109.26 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.3 mt -65.64 -49.4 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.853 -1.154 . . . . 63.229999999999997 108.655 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.525 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 86.3 tt0 -46.08 -56.46 5.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.328 -0.858 . . . . 51.109999999999999 109.817 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -85.26 3.73 38.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 73.340000000000003 109.433 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.78 -67.1 1.61 Allowed Glycine 0 N--CA 1.484 1.841 0 N-CA-C 109.921 -1.271 . . . . 62.149999999999999 109.921 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 20' ' ' LEU . 2.1 pt? -65.05 -22.77 67.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -1.205 . . . . 73.510000000000005 109.803 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 84.3 m-20 -57.35 -33.19 67.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.023 -1.048 . . . . 74.25 109.265 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 82.2 t -57.41 -33.46 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.343 -0.848 . . . . 70.040000000000006 109.384 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.418 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 11.8 mptt -70.24 2.54 3.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.879 . . . . 73.230000000000004 109.353 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.13 35.62 12.18 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.181 -1.168 . . . . 75.540000000000006 110.181 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -119.55 160.55 22.21 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.495 -1.003 . . . . 73.430000000000007 109.218 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 45.3 mmm -103.61 137.39 41.73 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.053 -1.092 . . . . 43.240000000000002 108.053 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.77 159.99 41.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.106 -0.996 . . . . 62.109999999999999 110.101 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -141.74 155.86 45.62 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.399 -0.813 . . . . 74.420000000000002 109.081 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 p -109.85 139.49 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.365 -0.834 . . . . 72.150000000000006 108.903 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.7 p -134.21 165.26 25.52 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.454 -0.779 . . . . 71.420000000000002 109.432 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.407 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 3.9 pt-20 -91.53 -103.72 0.11 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.334 -0.854 . . . . 72.329999999999998 109.602 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.5 t -79.45 165.72 22.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 74.239999999999995 109.96 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.7 mt -52.5 -32.58 40.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.535 -0.728 . . . . 71.530000000000001 109.802 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -48.47 -50.62 30.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.145 -0.972 . . . . 74.230000000000004 109.787 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.31 -39.1 85.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.118 -0.989 . . . . 54.030000000000001 109.586 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.41 -36.52 34.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.839 -1.304 . . . . 61.409999999999997 109.839 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -64.89 -40.06 94.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -1.156 . . . . 74.340000000000003 109.928 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -81.62 -40.63 22.68 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.013 -1.054 . . . . 75.329999999999998 109.503 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.5 tp -66.05 -43.04 88.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 74.329999999999998 109.729 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.441 ' O ' ' O ' ' A' ' 43' ' ' ARG . 3.6 ppp? -69.44 -26.95 64.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.167 -0.958 . . . . 70.319999999999993 109.656 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -65.51 -39.84 92.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.948 . . . . 71.219999999999999 109.751 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.519 HD12 HH12 ' A' ' 43' ' ' ARG . 24.5 pt -83.8 -26.37 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.221 -0.925 . . . . 74.140000000000001 109.989 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.519 HH12 HD12 ' A' ' 42' ' ' ILE . 80.2 mtt85 -129.13 137.94 51.5 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.404 -0.81 . . . . 72.239999999999995 109.276 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -92.27 126.84 37.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.157 -0.964 . . . . 75.420000000000002 109.588 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -104.71 141.62 36.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.465 -0.772 . . . . 74.230000000000004 109.269 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -80.63 -35.47 33.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.228 -0.92 . . . . 72.040000000000006 109.804 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.533 HD13 ' C ' ' A' ' 47' ' ' LEU . 1.1 tm? -124.55 113.82 18.58 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.795 -0.817 . . . . 72.129999999999995 108.795 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 48' ' ' VAL . 17.3 m -109.03 105.32 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.306 -0.871 . . . . 72.340000000000003 108.785 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.565 ' SD ' ' N ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -104.48 132.61 50.53 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.915 -1.143 . . . . 74.109999999999999 107.915 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.565 ' N ' ' SD ' ' A' ' 49' ' ' MET . 1.5 p -129.01 128.16 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.847 0.832 . . . . 61.119999999999997 110.352 -178.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.9 p -95.6 2.8 54.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.649 -0.657 . . . . 73.109999999999999 109.409 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.42 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 4.1 m-20 -76.48 150.59 36.64 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.179 -0.951 . . . . 52.549999999999997 109.552 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.458 ' C ' ' H ' ' A' ' 55' ' ' ALA . 18.7 pttp -85.88 -39.5 16.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.188 -0.945 . . . . 44.219999999999999 110.329 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -71.63 12.53 0.35 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.022 -1.049 . . . . 70.439999999999998 109.619 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.458 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.34 -21.52 58.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.849 . . . . 64.140000000000001 110.514 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.519 HD23 HE22 ' A' ' 89' ' ' GLN . 46.8 mt -39.96 -53.95 2.27 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.582 -0.699 . . . . 44.140000000000001 110.426 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 t -66.0 -35.7 81.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.984 -1.073 . . . . 55.229999999999997 109.164 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.498 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 65.9 t80 -64.02 -62.42 1.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.39 -0.819 . . . . 74.439999999999998 109.763 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.8 m -49.33 -32.2 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.655 -1.278 . . . . 74.030000000000001 109.628 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.9 t -58.93 -52.06 67.36 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.263 -0.898 . . . . 64.299999999999997 109.501 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -68.8 -30.4 68.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.025 -1.047 . . . . 64.439999999999998 109.94 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.498 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 31.7 mm -59.02 -44.41 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.868 -1.145 . . . . 63.210000000000001 110.083 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -74.29 -48.38 28.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.036 -1.04 . . . . 74.420000000000002 111.48 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.22 -36.11 82.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.611 -1.305 . . . . 70.319999999999993 109.861 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -92.18 -50.44 5.67 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.137 -0.977 . . . . 75.219999999999999 109.226 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.5 ' ND1' ' N ' ' A' ' 66' ' ' HIS . 0.5 OUTLIER -107.9 63.03 0.61 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.466 -0.771 . . . . 74.129999999999995 109.784 -179.467 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 t -65.94 -28.38 68.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.011 -1.055 . . . . 73.239999999999995 110.043 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.4 m -63.45 -31.0 72.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.258 -0.901 . . . . 61.009999999999998 110.627 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 58.8 mt -84.74 149.08 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.973 -1.079 . . . . 71.329999999999998 110.226 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 71' ' ' VAL . 72.3 t -88.51 159.04 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.569 -0.9 . . . . 72.129999999999995 108.569 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.457 ' N ' HG12 ' A' ' 70' ' ' VAL . 17.2 t -136.58 129.67 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.282 -0.886 . . . . 54.210000000000001 109.932 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.507 ' O ' ' SD ' ' A' ' 49' ' ' MET . 1.6 mt -127.08 100.81 6.27 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.909 -1.145 . . . . 50.240000000000002 107.909 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.622 ' O ' HD12 ' A' ' 95' ' ' ILE . 15.0 p -96.37 154.65 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.368 -0.832 . . . . 74.409999999999997 109.282 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.427 ' O ' ' OG ' ' A' ' 75' ' ' SER . 0.4 OUTLIER -118.4 167.72 11.3 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.701 -0.851 . . . . 72.310000000000002 108.701 179.395 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 74' ' ' SER . 3.7 m -167.41 120.72 0.95 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.266 -0.897 . . . . 64.540000000000006 109.933 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -75.12 19.58 0.15 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.409 -0.807 . . . . 74.129999999999995 110.111 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 75' ' ' SER . 34.7 t30 -142.48 58.41 7.4 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.129 -0.982 . . . . 73.340000000000003 109.826 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.4 82.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.342 2.028 . . . . 63.219999999999999 112.471 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 77' ' ' ASN . 44.8 m -114.2 150.99 33.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.227 -1.027 . . . . 62.530000000000001 108.227 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 t -53.45 -26.49 20.39 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.074 -1.016 . . . . 73.439999999999998 109.723 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -63.41 -47.67 81.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.163 -0.961 . . . . 71.420000000000002 109.813 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -72.64 -30.61 64.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.162 -0.962 . . . . 73.430000000000007 109.917 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.464 ' OE2' ' NE ' ' B' ' 108' ' ' ARG . 35.3 tt0 -62.04 -55.75 25.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 74.219999999999999 109.965 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 85' ' ' HIS . 33.2 m -63.47 -36.49 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -0.961 . . . . 73.200000000000003 109.62 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.414 ' N ' HG23 ' A' ' 84' ' ' VAL . 21.3 m80 -73.68 -19.59 60.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 53.329999999999998 109.711 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -76.73 -44.19 34.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.158 -0.964 . . . . 64.109999999999999 110.017 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -81.42 -29.74 33.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.078 -1.013 . . . . 74.340000000000003 109.217 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -75.75 -40.54 55.24 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.326 -0.859 . . . . 74.420000000000002 110.001 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.519 HE22 HD23 ' A' ' 56' ' ' LEU . 11.1 pt20 -71.15 -46.91 60.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.042 -1.036 . . . . 74.239999999999995 109.841 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.489 ' N ' ' CG ' ' A' ' 89' ' ' GLN . . . 145.67 70.05 0.02 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.881 -1.288 . . . . 61.509999999999998 109.881 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -133.64 129.02 36.31 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.261 -1.141 . . . . 55.329999999999998 108.701 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 11.8 t70 -73.25 -40.12 64.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.912 -1.117 . . . . 73.420000000000002 108.875 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 63.6 m-20 -153.36 154.06 33.79 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.932 -0.766 . . . . 75.040000000000006 108.932 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -127.72 130.71 49.28 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.866 -0.791 . . . . 71.329999999999998 108.866 -179.597 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.922 ' H ' HD12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -118.74 142.54 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 CA-C-O 121.636 0.731 . . . . 71.129999999999995 110.14 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.12 119.89 8.69 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.982 -1.074 . . . . 64.319999999999993 108.139 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.697 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -43.22 -53.79 10.46 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.182 -0.949 . . . . 62.200000000000003 111.656 -179.168 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 1.4 Cg_endo -38.22 -11.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.27 1.314 . . . . 73.109999999999999 113.525 -176.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.697 ' N ' ' O ' ' A' ' 97' ' ' LYS . 56.4 m-85 57.88 103.27 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.454 -0.779 . . . . 65.219999999999999 109.638 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 61.2 mtm-85 -58.96 -49.93 75.98 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.071 -1.018 . . . . 72.349999999999994 109.148 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.822 ' O ' ' N ' ' A' ' 103' ' ' LYS . 3.2 t -174.5 67.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.138 -0.976 . . . . 71.319999999999993 110.631 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.76 ' H ' HD12 ' A' ' 102' ' ' ILE . 1.8 mp 35.6 -68.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 CA-C-O 121.213 0.53 . . . . 75.430000000000007 111.885 178.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.822 ' N ' ' O ' ' A' ' 101' ' ' SER . 28.3 mmtp -47.3 -15.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.867 -1.145 . . . . 71.409999999999997 109.096 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -60.79 -92.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.439 -0.788 . . . . 63.240000000000002 110.374 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.672 HD23 ' H ' ' A' ' 105' ' ' LEU . 2.0 pt? -50.47 -33.27 20.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.053 -1.03 . . . . 73.219999999999999 110.392 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 66.2 t -65.46 -40.53 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.83 -1.168 . . . . 60.109999999999999 109.037 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 103' ' ' LYS . . . -58.89 -39.6 81.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.218 -0.926 . . . . 70.420000000000002 108.516 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -68.43 -31.21 70.37 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.917 -0.771 . . . . 74.409999999999997 108.917 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.4 mt -75.37 -34.65 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 108.294 -1.002 . . . . 62.539999999999999 108.294 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.407 ' OE2' ' NH1' ' A' ' 114' ' ' ARG . 82.5 tt0 -74.64 -57.81 3.69 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.472 -0.768 . . . . 74.340000000000003 109.184 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -49.62 -35.59 21.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.338 -0.851 . . . . 73.319999999999993 109.319 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 53.8 ttt85 -68.26 -39.47 82.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.339 -0.851 . . . . 52.409999999999997 109.865 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 34.8 mt -133.58 68.72 1.49 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.292 -0.88 . . . . 65.239999999999995 110.446 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.407 ' NH1' ' OE2' ' A' ' 110' ' ' GLU . 25.0 mtp85 -75.07 -43.09 55.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.941 -1.099 . . . . 64.450000000000003 108.341 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.478 ' N ' ' CD1' ' A' ' 115' ' ' PHE . 8.7 p90 -132.99 73.21 1.51 Allowed 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.825 -0.805 . . . . 74.430000000000007 108.825 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -56.26 -177.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.601 -0.687 . . . . 74.420000000000002 109.972 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.11 142.39 13.3 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.895 -1.282 . . . . 75.040000000000006 109.895 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.401 ' O ' ' O ' ' A' ' 119' ' ' ASN . 16.0 t -161.85 -61.16 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.346 -1.091 . . . . 61.140000000000001 109.129 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.454 HD21 ' N ' ' A' ' 128' ' ' ILE . 20.7 t-20 51.45 95.95 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.359 -0.838 . . . . 65.239999999999995 109.875 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.4 t -84.34 -19.41 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.049 -1.032 . . . . 73.109999999999999 109.158 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 22.4 mm -110.26 124.56 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.548 -0.72 . . . . 72.239999999999995 109.758 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -138.38 109.16 6.66 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.469 -0.938 . . . . 72.340000000000003 108.469 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.9 pt -142.05 122.03 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.243 -0.91 . . . . 71.439999999999998 109.338 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.03 -148.39 32.55 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.429 -1.468 . . . . 73.400000000000006 109.429 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -83.89 9.98 10.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.265 -1.138 . . . . 74.450000000000003 109.391 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.52 131.82 43.78 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.39 -0.819 . . . . 54.210000000000001 108.878 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 p -128.55 128.26 43.93 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.574 -0.899 . . . . 54.5 108.574 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.454 ' N ' HD21 ' A' ' 119' ' ' ASN . 21.2 mt -133.9 135.08 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.334 -0.854 . . . . 45.149999999999999 109.752 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.3 m -119.22 91.75 44.36 Favored Pre-proline 0 N--CA 1.497 1.893 0 N-CA-C 108.845 -0.798 . . . . 71.109999999999999 108.845 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.32 -25.84 6.67 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.226 1.95 . . . . 65.409999999999997 112.538 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -59.32 -40.37 86.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.088 -1.007 . . . . 63.32 108.83 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -97.63 5.78 48.92 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.5 -0.926 . . . . 72.519999999999996 108.5 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 56.81 61.2 2.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.257 -0.902 . . . . 75.329999999999998 109.03 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -149.75 148.35 29.12 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.349 -0.844 . . . . 71.230000000000004 109.543 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 13.1 tt -119.93 139.51 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.548 -0.72 . . . . 74.019999999999996 109.212 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.85 126.34 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.581 -0.699 . . . . 60.229999999999997 109.323 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -141.46 149.95 41.63 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.395 -0.815 . . . . 62.32 109.588 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 138' ' ' LYS . 54.6 tttt 55.9 9.59 0.47 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.495 -0.753 . . . . 75.400000000000006 109.715 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.95 14.03 59.88 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.954 -1.258 . . . . 72.239999999999995 109.954 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -105.35 136.58 44.62 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.421 -1.046 . . . . 71.219999999999999 109.077 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -101.43 118.42 36.92 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.482 -0.761 . . . . 71.420000000000002 110.041 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 10.7 p -138.06 132.54 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.408 -0.808 . . . . 53.020000000000003 108.933 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.427 ' CG ' ' N ' ' A' ' 144' ' ' VAL . 29.5 tt0 -92.3 160.71 15.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -0.917 . . . . 60.450000000000003 110.357 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.455 ' CG2' ' CG ' ' A' ' 149' ' ' PHE . 13.5 p -143.41 140.81 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.182 -1.044 . . . . 74.439999999999998 108.182 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -152.26 113.25 4.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.773 -1.205 . . . . 65.150000000000006 110.399 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 176.89 -164.45 33.94 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.985 -1.646 . . . . 73.340000000000003 108.985 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.623 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 17.3 mtpp -91.19 -32.24 0.35 Allowed Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.055 -1.262 . . . . 72.219999999999999 111.499 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 85.8 Cg_endo -88.33 21.15 1.04 Allowed 'Trans proline' 0 N--CA 1.488 1.196 0 C-N-CA 122.131 1.887 . . . . 65.230000000000004 112.516 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.455 ' CG ' ' CG2' ' A' ' 144' ' ' VAL . 41.0 m-85 -125.65 -29.75 3.13 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.475 -0.766 . . . . 60.109999999999999 109.679 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -60.84 -34.05 73.98 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.909 -1.119 . . . . 64.209999999999994 108.606 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.04 -33.97 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.344 -0.984 . . . . 72.019999999999996 108.344 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 17.7 tp -62.26 -45.23 94.22 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.532 -0.914 . . . . 73.310000000000002 108.532 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.9 p -65.47 -37.61 87.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 74.310000000000002 108.957 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -53.45 -60.55 3.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.563 -0.71 . . . . 74.310000000000002 110.765 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.3 pp -65.0 -23.53 67.24 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.096 -1.002 . . . . 75.340000000000003 109.743 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.1 -40.01 84.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.976 -1.077 . . . . 62.140000000000001 108.852 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -86.1 -51.52 6.26 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.235 -0.916 . . . . 61.030000000000001 109.66 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -73.93 49.34 0.33 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 74.120000000000005 108.925 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.626 ' NH1' ' OD2' ' A' ' 160' ' ' ASP . 7.6 ptm180 -77.72 14.08 1.15 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.639 -0.663 . . . . 71.129999999999995 111.025 -178.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.626 ' OD2' ' NH1' ' A' ' 159' ' ' ARG . 64.2 m-20 -148.21 47.48 1.06 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.682 -1.262 . . . . 75.450000000000003 110.129 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 0.473 ' NE2' ' OD2' ' B' ' 160' ' ' ASP . 63.9 mt-30 -150.86 157.52 43.02 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.918 -1.114 . . . . 73.409999999999997 109.848 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.6 mt -86.05 117.85 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.527 -0.733 . . . . 74.409999999999997 109.716 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 1.279 ' HB ' ' CE1' ' A' ' 214' ' ' PHE . 44.6 t -108.17 130.02 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.941 -0.763 . . . . 72.310000000000002 108.941 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.7 t -96.11 168.05 10.84 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.164 -0.96 . . . . 74.120000000000005 110.167 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm -65.42 -55.0 20.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.401 -0.812 . . . . 70.430000000000007 109.75 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -56.32 -33.97 66.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.901 . . . . 73.519999999999996 109.651 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.6 tp60 -62.38 -42.76 99.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.314 -0.866 . . . . 74.519999999999996 108.968 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 9.1 mt -60.82 -37.51 82.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.397 -0.815 . . . . 72.310000000000002 109.12 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.563 HD23 ' C ' ' A' ' 169' ' ' LEU . 5.0 tt -57.12 -58.76 6.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.337 -0.852 . . . . 53.329999999999998 109.114 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -68.56 -29.41 67.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.614 -0.679 . . . . 62.439999999999998 110.723 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.96 -67.8 0.28 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.028 -1.045 . . . . 60.210000000000001 110.377 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.555 ' N ' HD12 ' A' ' 172' ' ' ILE . 2.1 mp -89.01 -50.44 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.003 -1.061 . . . . 75.319999999999993 109.554 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.056 -1.028 . . . . 73.140000000000001 109.156 -179.903 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.292 -0.633 . . . . 64.540000000000006 109.292 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.5 p -70.13 -18.8 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.444 -0.785 . . . . 74.019999999999996 109.802 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 21.7 mt -63.47 -30.68 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.156 -0.965 . . . . 72.329999999999998 109.923 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -63.0 -45.06 94.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.078 -1.014 . . . . 74.400000000000006 110.297 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 16.8 m -73.19 -25.46 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.991 -1.068 . . . . 70.420000000000002 109.401 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -78.02 -48.81 15.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.259 -0.901 . . . . 52.109999999999999 109.715 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.483 ' O ' HD13 ' A' ' 188' ' ' ILE . 0.3 OUTLIER -67.64 -32.63 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.028 -1.045 . . . . 71.400000000000006 109.108 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.4 ' OD1' ' NE2' ' A' ' 193' ' ' GLN . 40.5 t30 -67.12 -48.56 67.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.508 -0.745 . . . . 73.439999999999998 110.367 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -72.7 -32.96 66.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.791 -1.193 . . . . 71.420000000000002 109.776 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 51.7 mt -63.56 -54.7 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.779 -1.201 . . . . 61.549999999999997 110.267 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -62.78 -34.84 78.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.692 -1.255 . . . . 63.340000000000003 109.781 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.431 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 45.1 mt-30 -78.04 -18.73 55.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 61.240000000000002 111.24 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -97.24 -28.26 14.15 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.791 -1.193 . . . . 75.129999999999995 110.722 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . 0.51 ' SD ' ' O ' ' A' ' 195' ' ' MET . 4.1 ppp? -93.15 9.2 36.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.753 -1.217 . . . . 74.019999999999996 110.146 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 193' ' ' GLN . 27.9 p-10 -110.31 -32.97 6.77 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.227 -0.921 . . . . 74.019999999999996 110.386 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 66.8 tttt -75.15 -36.16 2.13 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.018 -1.051 . . . . 75.430000000000007 111.184 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 89.8 Cg_endo -87.77 -52.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.974 1.783 . . . . 72.319999999999993 112.475 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.9 mp -48.88 -75.69 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.988 -1.07 . . . . 74.540000000000006 109.301 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 148.94 -47.82 0.63 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.64 -1.384 . . . . 61.509999999999998 109.64 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 24.6 mt -120.07 133.5 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.587 -0.949 . . . . 61.219999999999999 109.388 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 12.6 m -77.79 146.27 35.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.868 . . . . 72.0 108.966 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 22.0 p -132.47 27.77 4.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.461 -0.775 . . . . 74.439999999999998 109.362 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.7 m -129.45 125.57 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.485 -0.759 . . . . 64.349999999999994 109.61 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -98.54 105.05 17.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.544 -0.722 . . . . 71.409999999999997 109.379 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 24.4 p -70.57 119.68 15.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 73.519999999999996 108.816 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 12.7 m -139.93 158.54 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.219 -0.925 . . . . 71.019999999999996 110.301 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -102.64 -7.15 22.0 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.745 -0.835 . . . . 72.120000000000005 108.745 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.976 ' NH2' ' NH1' ' A' ' 213' ' ' ARG . 53.8 ttp180 -65.04 -27.55 68.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.438 -0.789 . . . . 64.409999999999997 109.677 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -151.06 -72.33 0.16 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 71.540000000000006 109.235 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.467 ' C ' ' CD1' ' A' ' 212' ' ' TYR . . . -167.89 -80.1 0.04 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.614 -1.394 . . . . 72.030000000000001 109.614 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.467 ' CD1' ' C ' ' A' ' 211' ' ' GLY . 73.5 m-85 -149.67 129.17 13.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.143 -1.21 . . . . 75.540000000000006 109.194 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.976 ' NH1' ' NH2' ' A' ' 209' ' ' ARG . 6.0 mtp180 -99.31 116.32 31.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.339 -0.851 . . . . 75.310000000000002 109.1 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 1.279 ' CE1' ' HB ' ' A' ' 163' ' ' VAL . 32.9 m-85 -92.9 104.92 17.11 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.439 -0.948 . . . . 75.409999999999997 108.439 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 15.1 p -138.96 166.17 25.19 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.965 -0.754 . . . . 74.140000000000001 108.965 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . 0.881 ' CE2' ' O ' ' A' ' 217' ' ' PRO . 2.2 p90 -70.24 157.45 89.89 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.249 -0.907 . . . . 75.319999999999993 109.383 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.881 ' O ' ' CE2' ' A' ' 216' ' ' TYR . 51.3 Cg_exo . . . . . 0 N--CA 1.494 1.505 0 C-N-CA 121.923 1.749 . . . . 73.109999999999999 111.963 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ptp . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.427 -0.582 . . . . 71.140000000000001 109.427 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -139.65 149.62 43.96 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.346 -0.847 . . . . 73.230000000000004 109.404 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 86.2 t -114.37 138.02 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.679 -0.638 . . . . 72.239999999999995 109.443 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.421 HD11 ' CG1' ' B' ' 6' ' ' ILE . 5.9 tp -113.59 119.11 36.37 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.581 -0.7 . . . . 54.329999999999998 110.159 -178.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.407 ' N ' HD12 ' B' ' 4' ' ' LEU . 12.5 mt -120.31 98.72 6.19 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 108.793 -0.817 . . . . 74.349999999999994 108.793 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.421 ' CG1' HD11 ' B' ' 4' ' ' LEU . 44.9 mt -86.27 98.27 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.716 -1.24 . . . . 42.549999999999997 108.577 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.483 ' CD ' ' HG ' ' B' ' 51' ' ' SER . 9.4 tp10 -136.0 131.32 34.87 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.414 -0.804 . . . . 74.519999999999996 109.423 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -66.03 -34.68 78.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.328 -0.858 . . . . 62.549999999999997 109.363 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -77.27 110.45 11.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.275 -0.89 . . . . 73.109999999999999 109.562 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 31.7 t -68.77 -23.01 64.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 65.540000000000006 109.682 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 93.9 t -68.21 -48.69 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.166 -0.959 . . . . 75.549999999999997 109.842 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.544 ' N ' HD22 ' B' ' 12' ' ' LEU . 3.5 mm? -67.31 -30.41 70.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.936 . . . . 70.140000000000001 109.706 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.5 -33.71 27.44 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.125 -1.59 . . . . 75.400000000000006 109.125 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.7 -45.5 75.47 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.888 -1.285 . . . . 65.439999999999998 109.888 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' B' ' 16' ' ' ILE . 11.3 pt-20 -68.38 -44.72 74.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.097 -1.237 . . . . 60.210000000000001 109.26 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.42 ' N ' ' CG ' ' B' ' 15' ' ' GLU . 6.2 mm -60.5 -35.5 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.044 -1.035 . . . . 75.150000000000006 108.336 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -62.31 -46.84 86.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.541 -0.724 . . . . 73.010000000000005 109.563 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -83.22 0.75 44.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.117 -0.989 . . . . 74.299999999999997 109.317 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.26 -55.63 2.32 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 109.684 -1.366 . . . . 70.540000000000006 109.684 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -76.45 -17.88 59.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -1.105 . . . . 71.340000000000003 109.857 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -56.7 -30.53 63.55 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.965 -1.084 . . . . 64.409999999999997 109.272 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 73.5 t -59.49 -30.68 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 74.230000000000004 109.039 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -77.43 -7.44 56.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.419 -0.801 . . . . 63.420000000000002 109.318 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.61 39.78 7.04 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.587 -1.005 . . . . 53.43 110.587 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -120.23 158.87 26.09 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.379 -1.071 . . . . 71.120000000000005 109.194 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 50.0 mmm -106.98 138.76 42.54 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.476 -0.935 . . . . 75.239999999999995 108.476 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.41 160.97 40.16 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.113 -0.992 . . . . 72.120000000000005 110.131 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -141.35 156.73 45.8 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.787 -0.82 . . . . 72.310000000000002 108.787 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 p -118.84 139.78 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.392 -0.818 . . . . 64.430000000000007 109.58 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.1 p -133.64 169.99 16.2 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.57 -0.706 . . . . 65.409999999999997 109.396 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -93.13 -99.71 0.13 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.319 -0.863 . . . . 71.019999999999996 109.884 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -78.16 167.7 21.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.195 -0.941 . . . . 51.109999999999999 110.277 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 28.1 mt -56.52 -35.51 68.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.587 -0.695 . . . . 71.239999999999995 110.008 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -54.44 -42.38 70.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.108 -0.995 . . . . 74.319999999999993 109.883 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -66.58 -39.51 88.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.097 -1.002 . . . . 73.030000000000001 109.378 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.61 -40.82 58.53 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.546 -1.422 . . . . 30.210000000000001 109.546 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.99 -38.62 91.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.281 -1.129 . . . . 74.420000000000002 109.645 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -74.96 -39.66 61.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 74.420000000000002 109.845 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 21.2 tp -72.02 -49.6 35.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.937 . . . . 75.409999999999997 110.102 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' B' ' 40' ' ' MET . 1.9 ppp? -60.72 -30.42 69.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.138 -0.976 . . . . 60.409999999999997 109.938 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.82 -37.28 70.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.16 -0.963 . . . . 53.229999999999997 110.044 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 14.2 pt -100.62 0.03 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.292 -0.88 . . . . 71.230000000000004 110.351 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' B' ' 40' ' ' MET . 59.1 mmt-85 -130.96 152.8 49.88 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.288 -0.882 . . . . 72.219999999999999 109.875 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -83.94 165.61 18.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.318 -0.864 . . . . 63.539999999999999 109.095 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 1.9 p90 -156.2 102.08 2.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.029 -1.045 . . . . 64.349999999999994 109.881 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -79.18 -32.04 44.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.177 -0.952 . . . . 62.219999999999999 108.585 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.496 ' C ' HD13 ' B' ' 47' ' ' LEU . 0.7 OUTLIER -113.75 108.41 17.07 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.612 -0.884 . . . . 73.120000000000005 108.612 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.429 ' N ' HD13 ' B' ' 47' ' ' LEU . 97.3 t -96.55 105.31 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.276 -0.89 . . . . 65.109999999999999 108.693 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 15.5 ttt -123.02 130.54 52.93 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.491 -0.756 . . . . 73.439999999999998 109.661 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.463 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.4 OUTLIER -145.28 134.03 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.594 -0.691 . . . . 34.5 109.153 -179.654 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . 0.483 ' HG ' ' CD ' ' B' ' 7' ' ' GLU . 6.4 p -102.06 13.82 33.67 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.551 -0.718 . . . . 73.209999999999994 109.741 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.463 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 66.5 m-20 -76.75 148.1 36.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.145 -0.972 . . . . 70.409999999999997 109.712 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.406 ' C ' ' H ' ' B' ' 55' ' ' ALA . 65.5 mttp -78.05 -42.76 31.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.308 -0.87 . . . . 65.0 109.906 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -73.51 9.43 1.38 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.199 -0.938 . . . . 75.209999999999994 109.521 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -59.72 -22.89 62.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.374 -0.828 . . . . 55.329999999999998 109.826 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 56.2 mt -46.0 -34.29 3.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.331 -0.855 . . . . 63.140000000000001 109.933 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 18.5 m -77.1 -46.96 21.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.102 -0.999 . . . . 63.5 109.499 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . 0.41 ' CZ ' HD11 ' B' ' 62' ' ' ILE . 58.9 t80 -61.86 -53.32 57.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -0.943 . . . . 72.329999999999998 109.519 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.484 HG23 ' N ' ' B' ' 60' ' ' SER . 14.1 m -56.25 -39.99 63.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.587 -1.321 . . . . 74.540000000000006 109.17 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . 0.484 ' N ' HG23 ' B' ' 59' ' ' VAL . 28.0 t -51.6 -46.19 63.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.143 -0.973 . . . . 71.239999999999995 109.722 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.461 ' O ' ' N ' ' B' ' 65' ' ' LYS . 13.8 ptp180 -78.32 -34.27 48.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.863 -1.148 . . . . 74.310000000000002 110.566 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' B' ' 66' ' ' HIS . 33.4 mm -63.03 -45.95 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.452 -1.405 . . . . 72.140000000000001 108.464 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . 0.432 ' HZ3' ' HB2' ' B' ' 89' ' ' GLN . 29.5 mttt -61.81 -40.52 95.55 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.624 -0.88 . . . . 73.319999999999993 108.624 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -75.37 -38.13 60.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.61 -0.681 . . . . 73.120000000000005 109.228 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.528 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 25.4 mtpp -83.94 -23.09 31.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.266 -0.896 . . . . 72.439999999999998 110.705 -178.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.528 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 83.4 m-70 -156.75 66.4 0.54 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.903 -1.123 . . . . 63.310000000000002 109.912 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.2 t -59.29 -29.51 67.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.328 -0.857 . . . . 73.099999999999994 109.938 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 86.4 p -65.35 -34.74 79.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.153 -0.967 . . . . 71.530000000000001 110.683 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.484 HG22 ' N ' ' B' ' 70' ' ' VAL . 78.3 mt -65.71 160.89 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.912 -1.117 . . . . 74.400000000000006 109.61 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.484 ' N ' HG22 ' B' ' 69' ' ' ILE . 97.6 t -85.0 159.23 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.21 -0.931 . . . . 75.120000000000005 110.039 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.524 ' N ' ' OD1' ' B' ' 92' ' ' ASP . 11.0 t -143.48 111.42 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.075 -1.016 . . . . 73.200000000000003 109.316 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.606 HD23 HD11 ' B' ' 95' ' ' ILE . 0.7 OUTLIER -110.06 99.62 8.68 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.544 -0.91 . . . . 73.340000000000003 108.544 -179.634 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 79.1 t -95.13 127.83 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.237 -0.915 . . . . 73.5 108.963 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.1 m -103.22 173.52 6.27 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.443 -0.786 . . . . 64.340000000000003 109.666 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.48 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 23.0 t -166.28 122.97 1.32 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.168 -0.957 . . . . 74.530000000000001 110.298 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -62.01 -17.1 56.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.435 -0.79 . . . . 64.5 109.605 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' B' ' 79' ' ' THR . 47.2 t-20 -124.43 82.23 58.59 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.516 -0.74 . . . . 74.25 109.196 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.15 71.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.566 2.177 . . . . 74.430000000000007 112.003 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.517 ' N ' ' O ' ' B' ' 77' ' ' ASN . 17.0 m -88.13 152.27 22.11 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.102 -0.999 . . . . 73.120000000000005 109.418 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -37.86 88.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.892 . . . . 71.010000000000005 109.488 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -55.64 -46.88 77.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.951 . . . . 63.200000000000003 109.63 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -71.56 -30.93 66.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.896 . . . . 73.219999999999999 109.658 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' B' ' 84' ' ' VAL . 10.6 tm-20 -70.02 -56.23 7.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 74.299999999999997 109.851 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.548 HG23 ' N ' ' B' ' 85' ' ' HIS . 13.1 m -63.27 -44.61 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.135 -0.978 . . . . 73.310000000000002 109.722 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' HIS . . . . . 0.548 ' N ' HG23 ' B' ' 84' ' ' VAL . 71.1 t60 -63.19 -40.26 97.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 73.239999999999995 109.456 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.04 -44.26 97.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.904 . . . . 55.329999999999998 109.588 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -74.13 -30.27 62.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.131 -0.981 . . . . 74.140000000000001 108.535 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -57.54 -50.42 73.16 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.681 -0.859 . . . . 64.040000000000006 108.681 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . 0.432 ' HB2' ' HZ3' ' B' ' 63' ' ' LYS . 50.8 mt-30 -64.33 -38.31 90.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.62 -0.675 . . . . 72.349999999999994 109.462 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 139.49 10.31 0.82 Allowed Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.344 -1.102 . . . . 65.200000000000003 110.344 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -48.79 122.22 5.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.878 -1.366 . . . . 52.229999999999997 109.233 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' B' ' 71' ' ' VAL . 5.8 m-20 -63.68 -37.39 87.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.116 -0.99 . . . . 73.319999999999993 109.102 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 20.3 t0 -154.79 158.44 39.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.851 . . . . 72.219999999999999 109.751 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.52 ' N ' ' OD1' ' B' ' 93' ' ' ASP . 42.4 t80 -130.26 116.97 19.13 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.158 -1.053 . . . . 64.420000000000002 108.158 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 1.026 ' H ' HD12 ' B' ' 95' ' ' ILE . 0.0 OUTLIER -119.42 156.75 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.503 0 CA-C-O 121.919 0.866 . . . . 72.230000000000004 110.797 -177.72 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.42 134.06 42.4 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.435 -1.32 . . . . 25.239999999999998 107.435 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.675 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -55.04 -55.57 37.61 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 120.773 -1.204 . . . . 64.319999999999993 111.791 -178.462 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 1.4 Cg_endo -39.44 -12.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 121.144 1.23 . . . . 63.329999999999998 113.213 -176.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . 0.675 ' N ' ' O ' ' B' ' 97' ' ' LYS . 53.3 m-85 56.5 104.13 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.508 -0.745 . . . . 75.129999999999995 109.728 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -55.24 -42.31 73.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.949 -1.095 . . . . 74.230000000000004 108.673 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' B' ' 104' ' ' ALA . 12.2 t -168.2 151.18 5.6 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.465 -0.772 . . . . 63.340000000000003 109.039 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 20.7 mm -55.52 -45.14 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.986 . . . . 74.439999999999998 109.362 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -68.91 -7.54 35.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 71.109999999999999 109.605 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' B' ' 101' ' ' SER . . . -71.69 -77.99 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.073 -1.017 . . . . 71.450000000000003 109.786 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.596 HD23 ' N ' ' B' ' 105' ' ' LEU . 2.2 pt? -62.32 -36.67 82.89 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.066 -1.021 . . . . 51.310000000000002 110.092 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 80.7 t -60.36 -44.97 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.9 -1.125 . . . . 65.230000000000004 109.187 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.18 -33.49 72.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.173 -0.954 . . . . 24.32 108.751 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . 0.521 ' NH2' ' CG2' ' B' ' 95' ' ' ILE . 78.6 mtm180 -80.27 -24.97 39.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.43 -0.793 . . . . 75.310000000000002 109.872 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 67.0 mt -79.48 -47.01 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.022 -1.049 . . . . 54.240000000000002 108.649 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.68 -39.87 94.42 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.584 -0.847 . . . . 65.310000000000002 109.146 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.91 -35.96 82.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.345 -0.847 . . . . 72.239999999999995 109.217 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -61.94 -39.19 91.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.324 -0.86 . . . . 72.040000000000006 109.765 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.65 67.57 1.25 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.157 -0.965 . . . . 75.349999999999994 109.529 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.483 ' O ' ' CG ' ' B' ' 115' ' ' PHE . 50.2 mtp180 -57.28 -32.86 67.06 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.14 -0.975 . . . . 75.5 109.341 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 115' ' ' PHE . . . . . 0.483 ' CG ' ' O ' ' B' ' 114' ' ' ARG . 87.8 m-85 -157.67 91.14 1.12 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 65.329999999999998 109.515 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 116' ' ' TRP . . . . . 0.519 ' NE1' ' OE2' ' B' ' 141' ' ' GLU . 5.3 m-90 52.21 11.25 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 74.450000000000003 109.69 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' B' ' 115' ' ' PHE . . . 70.03 -112.4 4.37 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.849 -1.3 . . . . 44.210000000000001 109.849 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 84.4 p -150.62 -172.59 4.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.286 -1.126 . . . . 71.400000000000006 109.843 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.23 130.69 13.85 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.938 -0.705 . . . . 72.319999999999993 109.195 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 5.5 t -80.65 -42.72 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 75.019999999999996 110.117 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' B' ' 128' ' ' ILE . 27.7 mm -112.67 121.41 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.442 -0.786 . . . . 51.409999999999997 109.234 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -154.65 138.84 16.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.251 -0.905 . . . . 71.530000000000001 109.392 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.778 ' H ' HD13 ' B' ' 123' ' ' ILE . 0.1 OUTLIER -147.08 157.1 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.267 -0.896 . . . . 72.430000000000007 109.492 179.721 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.85 -131.79 12.47 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.601 -1.4 . . . . 51.229999999999997 109.601 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -99.82 0.73 42.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.311 -1.111 . . . . 74.200000000000003 109.522 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.23 145.57 24.55 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.136 -0.977 . . . . 75.420000000000002 108.527 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 28.8 m -129.21 136.63 50.37 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.548 -0.72 . . . . 74.219999999999999 109.245 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' B' ' 121' ' ' ILE . 39.8 mt -136.02 136.34 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.398 -0.814 . . . . 60.329999999999998 109.645 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 7.3 m -127.58 80.27 72.15 Favored Pre-proline 0 N--CA 1.499 2.017 0 N-CA-C 109.15 -0.685 . . . . 72.310000000000002 109.15 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.41 -55.38 3.66 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.815 2.343 . . . . 75.129999999999995 112.612 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -51.82 -40.05 59.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -0.93 . . . . 75.230000000000004 109.627 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -84.6 0.17 51.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.203 -0.936 . . . . 72.430000000000007 109.461 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 52.39 60.32 3.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 75.129999999999995 109.618 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -151.34 130.43 12.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.867 . . . . 73.219999999999999 109.121 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 59.8 mt -118.1 133.81 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.547 -0.721 . . . . 64.140000000000001 109.528 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 70.5 mt -124.43 123.11 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 109.074 -0.713 . . . . 71.219999999999999 109.074 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -137.54 141.42 41.4 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.427 -0.796 . . . . 64.219999999999999 109.522 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . 0.498 ' NZ ' ' O ' ' B' ' 198' ' ' PRO . 50.7 mttp 54.45 26.19 6.88 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.565 -0.709 . . . . 72.019999999999996 110.085 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.88 -0.67 77.25 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.186 -1.166 . . . . 74.319999999999993 110.186 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -89.95 131.27 35.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.127 -1.219 . . . . 75.340000000000003 109.158 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 141' ' ' GLU . . . . . 0.519 ' OE2' ' NE1' ' B' ' 116' ' ' TRP . 95.5 mt-10 -97.1 125.11 41.35 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.331 -0.856 . . . . 71.230000000000004 109.472 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 96.0 t -137.49 135.1 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.387 -0.821 . . . . 70.430000000000007 109.199 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -88.93 151.07 22.54 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.325 -0.86 . . . . 72.430000000000007 109.389 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 22.2 m -90.85 137.77 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.177 -0.952 . . . . 72.129999999999995 109.792 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -171.19 56.05 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.337 -0.852 . . . . 72.019999999999996 109.511 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 178.65 176.82 46.83 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.869 -1.292 . . . . 42.229999999999997 109.869 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 15.2 mttt -70.65 -38.86 8.39 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.362 -1.081 . . . . 73.299999999999997 110.112 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 32.8 Cg_exo -57.73 -37.73 95.58 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.194 1.929 . . . . 71.329999999999998 111.83 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -87.99 -20.7 25.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.431 -0.793 . . . . 74.230000000000004 109.253 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -66.55 -41.77 88.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.302 -0.874 . . . . 72.340000000000003 109.639 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p -73.31 -32.6 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.187 -0.945 . . . . 73.349999999999994 109.58 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 23.1 tp -66.55 -43.42 85.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.209 -0.932 . . . . 55.240000000000002 109.952 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 25.8 m -72.53 -35.24 68.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.963 -1.086 . . . . 70.010000000000005 109.758 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 154' ' ' HIS . . . . . 0.551 ' CE1' ' NH2' ' B' ' 157' ' ' ARG . 1.6 m-70 -62.96 -48.84 77.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 65.319999999999993 110.259 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.0 pp -69.54 -27.09 64.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.811 -1.181 . . . . 71.540000000000006 109.294 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.62 -49.9 75.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.956 . . . . 75.319999999999993 109.499 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . 0.551 ' NH2' ' CE1' ' B' ' 154' ' ' HIS . 21.6 ptt180 -74.86 -36.11 62.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.242 -0.911 . . . . 73.319999999999993 109.934 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -87.98 18.2 4.39 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.08 -1.012 . . . . 74.140000000000001 109.776 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -62.04 161.25 11.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.139 -0.976 . . . . 61.409999999999997 109.266 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . 0.473 ' OD2' ' NE2' ' A' ' 161' ' ' GLN . 37.4 t0 59.73 49.47 8.11 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.329 -0.857 . . . . 72.099999999999994 109.585 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -157.66 145.21 18.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 72.25 109.292 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 94.9 mt -85.91 128.03 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -0.943 . . . . 72.310000000000002 109.192 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 5.3 m -132.24 139.35 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.456 -0.778 . . . . 64.209999999999994 109.585 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 58.4 p -86.45 172.14 10.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.223 -0.923 . . . . 74.219999999999999 109.302 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -59.58 -39.8 85.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.945 . . . . 65.310000000000002 109.59 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -57.29 -32.46 66.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 63.450000000000003 109.798 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -60.04 -48.7 80.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.96 . . . . 72.400000000000006 109.873 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 37.6 mt -62.37 -32.96 73.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.086 -1.009 . . . . 72.319999999999993 109.101 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.547 HD23 ' C ' ' B' ' 169' ' ' LEU . 6.3 tt -57.18 -64.98 0.7 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.347 -0.846 . . . . 73.340000000000003 109.542 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -64.82 -31.81 73.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.229 -0.919 . . . . 72.099999999999994 110.143 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -48.39 -58.99 3.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.124 -0.985 . . . . 62.130000000000003 110.062 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 0.674 ' N ' HD12 ' B' ' 172' ' ' ILE . 2.1 mp -92.82 -59.14 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.056 -1.028 . . . . 71.420000000000002 109.318 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 11.2 m-90 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 72.230000000000004 109.62 -179.799 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo . . . . . 0 N--CA 1.492 1.4 0 CA-C-O 121.299 0.458 . . . . 65.219999999999999 112.392 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -69.21 -29.8 67.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 72.310000000000002 109.614 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 6.0 p -59.55 -27.61 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.287 -0.883 . . . . 63.32 110.014 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 35.2 mm -56.27 -25.87 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.179 -0.951 . . . . 75.030000000000001 109.688 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -58.69 -48.5 80.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 64.109999999999999 109.827 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . 0.423 ' C ' HE21 ' B' ' 190' ' ' GLN . 16.1 m -77.22 -26.42 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.102 -0.999 . . . . 73.0 109.865 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.26 -49.01 38.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.03 -1.044 . . . . 61.119999999999997 109.822 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 19.6 tt -66.87 -33.5 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.175 -0.953 . . . . 72.430000000000007 110.015 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -73.62 -40.62 63.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.112 -0.993 . . . . 65.140000000000001 111.163 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 190' ' ' GLN . . . . . 0.423 HE21 ' C ' ' B' ' 186' ' ' VAL . 7.6 pt20 -78.17 -37.94 44.63 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.784 -1.198 . . . . 63.240000000000002 111.194 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . 0.419 HD12 ' N ' ' B' ' 192' ' ' ARG . 2.4 pp -69.7 -41.85 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.741 -1.224 . . . . 74.030000000000001 110.138 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 192' ' ' ARG . . . . . 0.419 ' N ' HD12 ' B' ' 191' ' ' ILE . 9.4 ptm180 -69.64 -39.02 77.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.872 -1.142 . . . . 72.239999999999995 109.661 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 193' ' ' GLN . . . . . 0.411 HE21 ' NH1' ' B' ' 192' ' ' ARG . 81.0 mm-40 -67.64 -40.04 84.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.246 -0.909 . . . . 73.099999999999994 110.586 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . 0.468 ' O ' ' CD ' ' B' ' 198' ' ' PRO . 13.1 pttp -80.22 -13.43 59.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.964 -1.085 . . . . 72.109999999999999 110.074 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 51.5 ttm -91.87 -30.26 16.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.199 -0.938 . . . . 44.329999999999998 109.771 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 196' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' B' ' 200' ' ' GLY . 95.8 m-20 -68.7 -41.6 78.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 71.209999999999994 110.266 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . 0.418 ' N ' ' HD2' ' B' ' 198' ' ' PRO . 12.1 tmtt? -60.66 -55.41 45.2 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.042 -1.036 . . . . 75.209999999999994 110.806 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 198' ' ' PRO . . . . . 0.498 ' O ' ' NZ ' ' B' ' 138' ' ' LYS . 29.3 Cg_endo -60.78 -54.95 1.6 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.371 1.381 . . . . 75.319999999999993 111.829 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.56 -45.67 78.6 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.084 -1.01 . . . . 72.25 108.878 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' B' ' 196' ' ' ASP . . . 87.13 -31.58 4.35 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.688 -1.365 . . . . 64.530000000000001 109.688 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . 0.708 ' N ' HD12 ' B' ' 201' ' ' ILE . 2.0 mp -92.21 138.34 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.245 -1.15 . . . . 44.229999999999997 109.087 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 29.2 t -87.51 139.78 30.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.284 -0.885 . . . . 54.009999999999998 109.271 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 10.2 p -144.84 22.17 1.6 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.212 -0.93 . . . . 74.400000000000006 109.687 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.424 HG12 ' CD2' ' B' ' 214' ' ' PHE . 26.8 m -138.11 143.1 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.247 -0.908 . . . . 72.120000000000005 109.663 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -126.35 135.42 51.46 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.569 -0.707 . . . . 65.409999999999997 109.124 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.6 138.0 35.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.322 -0.861 . . . . 71.329999999999998 109.304 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.42 HG22 ' H ' ' B' ' 209' ' ' ARG . 7.2 p -148.69 141.78 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -0.954 . . . . 63.5 109.442 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -66.86 -41.41 87.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.916 . . . . 74.450000000000003 109.435 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 209' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' B' ' 211' ' ' GLY . 49.2 mtp85 -60.46 147.68 40.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.914 . . . . 74.140000000000001 109.553 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 49.87 -89.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.351 -0.843 . . . . 74.430000000000007 109.841 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 211' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' B' ' 209' ' ' ARG . . . -170.95 -100.82 0.14 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.776 -1.33 . . . . 64.450000000000003 109.776 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 212' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' B' ' 212' ' ' TYR . 25.5 m-85 -130.15 153.53 48.43 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.548 -0.972 . . . . 74.209999999999994 108.855 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 5.2 ptm85 -127.43 149.93 49.87 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.383 -0.823 . . . . 74.030000000000001 109.81 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . 0.424 ' CD2' HG12 ' B' ' 204' ' ' VAL . 23.6 m-85 -117.97 131.13 56.53 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.908 -0.775 . . . . 74.340000000000003 108.908 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 29.0 p -160.11 164.0 33.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.064 -1.023 . . . . 64.329999999999998 109.849 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -61.83 152.5 75.96 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.381 -0.825 . . . . 70.040000000000006 108.931 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -68.16 -156.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.151 1.901 . . . . 65.109999999999999 111.482 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.262 -0.899 . . . . 73.150000000000006 109.414 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 ttm . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.38 -0.6 . . . . 65.120000000000005 109.38 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -137.78 154.95 49.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.392 -0.818 . . . . 72.329999999999998 109.394 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 83.6 t -119.79 125.96 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.547 0.689 . . . . 71.420000000000002 109.79 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.3 tp -94.42 115.94 28.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.371 -0.974 . . . . 65.120000000000005 108.371 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.576 HD22 ' CG ' ' A' ' 49' ' ' MET . 0.2 OUTLIER -117.95 110.59 17.91 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.562 -0.903 . . . . 62.43 108.562 -179.871 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.43 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 12.3 mt -94.41 105.26 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 120.791 -1.193 . . . . 71.150000000000006 109.507 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -139.52 124.72 18.92 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.241 -0.912 . . . . 75.340000000000003 109.259 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -71.83 -32.37 67.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 72.439999999999998 109.505 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -83.42 113.44 20.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.915 . . . . 63.020000000000003 109.462 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.2 p -68.07 -25.34 65.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 72.340000000000003 109.522 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.5 t -67.99 -53.59 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -0.925 . . . . 74.019999999999996 109.609 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.509 ' O ' HD13 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -67.62 -38.85 84.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 71.430000000000007 108.951 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.51 -25.8 75.14 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 108.436 -1.866 . . . . 61.32 108.436 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.51 -58.05 10.13 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.477 -1.449 . . . . 71.200000000000003 109.477 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.417 ' H ' ' HG2' ' A' ' 15' ' ' GLU . 6.7 pt-20 -53.26 -46.78 69.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.411 -1.053 . . . . 71.319999999999993 109.676 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 86.0 mt -64.52 -50.93 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.866 -1.146 . . . . 63.229999999999997 108.96 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -49.2 -52.91 23.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 51.109999999999999 109.708 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.405 ' CD ' ' N ' ' A' ' 18' ' ' LYS . 0.7 OUTLIER -83.51 2.44 36.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.139 -0.976 . . . . 73.340000000000003 109.444 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.23 -60.98 1.95 Allowed Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.909 -1.276 . . . . 62.149999999999999 109.909 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.419 HD23 ' N ' ' A' ' 20' ' ' LEU . 1.7 pt? -72.66 -19.37 61.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -1.161 . . . . 73.510000000000005 110.034 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -56.87 -31.64 65.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.972 -1.08 . . . . 74.25 109.468 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.2 t -60.68 -28.92 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 70.040000000000006 109.327 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.422 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 11.5 mptt -76.55 -1.21 26.29 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.262 -0.899 . . . . 73.230000000000004 109.28 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.0 36.56 8.97 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.156 -1.177 . . . . 75.540000000000006 110.156 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -119.51 157.51 28.17 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.497 -1.002 . . . . 73.430000000000007 109.326 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.3 mmt -108.12 138.62 44.08 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.522 -0.918 . . . . 43.240000000000002 108.522 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.54 159.29 43.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.134 -0.979 . . . . 62.109999999999999 110.13 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -136.68 155.44 49.87 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.507 -0.746 . . . . 74.420000000000002 109.0 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.55 136.68 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.372 -0.83 . . . . 72.150000000000006 109.099 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.8 p -133.25 164.94 25.94 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.385 -0.822 . . . . 71.420000000000002 109.313 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.43 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 4.9 pt-20 -90.59 -105.73 0.1 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.259 -0.901 . . . . 72.329999999999998 109.853 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.5 p -78.23 170.63 16.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 74.239999999999995 109.961 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.9 mt -55.97 -30.87 62.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.564 -0.71 . . . . 71.530000000000001 109.794 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -50.41 -46.25 56.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 74.230000000000004 109.584 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.06 -39.41 90.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 54.030000000000001 109.418 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.34 -44.31 34.83 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.572 -1.411 . . . . 61.409999999999997 109.572 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -63.02 -37.29 86.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -1.139 . . . . 74.340000000000003 109.457 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -81.22 -38.09 27.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 75.329999999999998 109.655 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.4 tp -68.71 -46.65 68.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.31 -0.869 . . . . 74.329999999999998 109.937 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 41' ' ' ASP . 3.5 ppp? -63.09 -25.56 68.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.129 -0.982 . . . . 70.319999999999993 109.793 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 40' ' ' MET . 97.5 m-20 -66.51 -41.14 89.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.082 -1.011 . . . . 71.219999999999999 109.973 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.1 pt -82.82 -27.84 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.115 -0.991 . . . . 74.140000000000001 110.16 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 40' ' ' MET . 88.7 mtt-85 -129.74 144.46 51.3 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.336 -0.853 . . . . 72.239999999999995 109.449 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -91.51 154.13 19.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.239 -0.913 . . . . 75.420000000000002 109.521 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -134.76 157.6 46.32 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.491 -0.756 . . . . 74.230000000000004 109.176 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -102.7 -42.56 5.85 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.387 -0.821 . . . . 72.040000000000006 109.464 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.441 HD13 ' C ' ' A' ' 47' ' ' LEU . 0.4 OUTLIER -104.36 109.7 21.65 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.514 -0.741 . . . . 72.129999999999995 109.224 -179.82 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.418 ' N ' HD13 ' A' ' 47' ' ' LEU . 74.7 t -94.09 99.86 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.202 -0.937 . . . . 72.340000000000003 108.834 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.576 ' CG ' HD22 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -114.1 129.1 56.63 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.154 -0.684 . . . . 74.109999999999999 109.154 -179.603 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.437 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 1.3 p -134.64 133.13 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.536 -0.728 . . . . 61.119999999999997 109.89 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.5 p -96.83 1.41 50.64 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.543 -0.723 . . . . 73.109999999999999 109.435 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.437 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 55.3 m-20 -76.19 141.51 41.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.198 -0.939 . . . . 52.549999999999997 109.416 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.467 ' C ' ' H ' ' A' ' 55' ' ' ALA . 0.7 OUTLIER -79.75 -38.58 32.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 44.219999999999999 110.204 -179.479 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -71.18 10.5 0.56 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.035 -1.04 . . . . 70.439999999999998 109.364 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.467 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -72.39 -20.51 61.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -0.831 . . . . 64.140000000000001 110.298 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 55' ' ' ALA . 68.7 mt -41.18 -47.65 3.32 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.509 -0.744 . . . . 44.140000000000001 110.296 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 m -70.28 -35.21 73.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.931 -1.105 . . . . 55.229999999999997 108.97 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.659 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 67.7 t80 -66.36 -59.26 3.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.392 -0.817 . . . . 74.439999999999998 109.849 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.4 m -52.36 -34.14 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.696 -1.253 . . . . 74.030000000000001 109.345 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 p -57.79 -51.83 67.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 64.299999999999997 109.732 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -69.32 -28.92 66.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.02 . . . . 64.439999999999998 109.983 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.659 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 7.6 mm -67.08 -24.08 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.88 -1.138 . . . . 63.210000000000001 109.835 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -86.15 -53.33 5.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.034 -1.041 . . . . 74.420000000000002 110.562 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.443 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 14.9 pt-20 -63.78 -43.14 97.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.9 -1.125 . . . . 70.319999999999993 110.128 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.443 ' N ' ' CG ' ' A' ' 64' ' ' GLU . 78.2 mttt -79.02 -61.0 2.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 75.219999999999999 109.092 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.53 ' ND1' ' N ' ' A' ' 66' ' ' HIS . 0.2 OUTLIER -97.18 80.23 2.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.326 -0.859 . . . . 74.129999999999995 108.876 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.9 m -79.02 -25.9 43.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.015 -1.053 . . . . 73.239999999999995 110.22 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.3 t -82.55 51.77 1.93 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.114 -0.991 . . . . 61.009999999999998 110.208 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 66' ' ' HIS . 15.3 tt -156.98 160.94 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.938 -1.101 . . . . 71.329999999999998 109.945 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 71' ' ' VAL . 90.6 t -95.8 160.15 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.178 -0.951 . . . . 72.129999999999995 109.135 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.467 ' N ' HG12 ' A' ' 70' ' ' VAL . 3.6 t -146.16 121.24 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.955 -1.091 . . . . 54.210000000000001 109.942 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.515 ' O ' ' SD ' ' A' ' 49' ' ' MET . 3.5 mp -119.83 103.41 9.32 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.116 -1.068 . . . . 50.240000000000002 108.116 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.9 p -95.8 146.27 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.487 -0.931 . . . . 74.409999999999997 108.487 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.453 ' O ' ' OG ' ' A' ' 75' ' ' SER . 0.5 OUTLIER -118.44 165.87 13.36 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.468 -0.77 . . . . 72.310000000000002 109.226 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 74' ' ' SER . 3.1 m -168.3 124.08 1.0 Allowed 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 119.393 -0.923 . . . . 64.540000000000006 110.242 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.52 1.45 1.19 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.552 -0.718 . . . . 74.129999999999995 109.809 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 75' ' ' SER . 33.8 m120 -120.64 62.87 10.1 Favored Pre-proline 0 N--CA 1.501 2.101 0 O-C-N 121.396 -0.815 . . . . 73.340000000000003 110.198 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -62.99 77.9 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.157 1.905 . . . . 63.219999999999999 111.789 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 77.9 p -104.36 151.72 23.13 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.566 -0.901 . . . . 62.530000000000001 108.566 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -31.9 66.8 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.243 -0.911 . . . . 73.439999999999998 109.309 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.511 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 78.0 mm-40 -66.29 -36.21 82.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.15 -0.969 . . . . 71.420000000000002 109.22 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -71.17 -35.48 71.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.331 -0.856 . . . . 73.430000000000007 109.621 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.77 -52.57 64.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 74.219999999999999 109.689 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.6 m -60.52 -36.0 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.187 -0.946 . . . . 73.200000000000003 109.258 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' A' ' 81' ' ' GLU . 27.9 m80 -71.77 -31.15 66.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.274 -0.891 . . . . 53.329999999999998 109.561 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -65.17 -40.1 93.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 64.109999999999999 110.177 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.501 ' CZ ' ' HB1' ' B' ' 111' ' ' ALA . 89.3 t80 -83.36 -37.64 23.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.954 -1.092 . . . . 74.340000000000003 109.32 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -68.21 -42.91 79.13 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.242 -0.911 . . . . 74.420000000000002 109.493 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -66.81 -49.95 64.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -0.996 . . . . 74.239999999999995 109.369 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 143.73 72.41 0.02 OUTLIER Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.017 -1.233 . . . . 61.509999999999998 110.017 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -138.25 124.16 20.04 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.242 -1.152 . . . . 55.329999999999998 109.201 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 13.9 t70 -61.13 -41.72 97.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 73.420000000000002 109.336 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 66.8 m-20 -152.05 159.34 43.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.325 -0.859 . . . . 75.040000000000006 109.337 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -124.14 131.71 53.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.605 -0.685 . . . . 71.329999999999998 109.449 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.5 mt -123.41 140.62 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-O 122.084 0.945 . . . . 71.129999999999995 110.381 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.0 121.49 13.12 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.901 -1.148 . . . . 64.319999999999993 107.901 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.694 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -45.46 -54.59 14.53 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.128 -0.983 . . . . 62.200000000000003 111.428 -178.756 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 2.5 Cg_endo -40.47 -9.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 121.08 1.187 . . . . 73.109999999999999 113.289 -176.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.694 ' N ' ' O ' ' A' ' 97' ' ' LYS . 67.5 m-85 58.6 99.39 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.514 -0.741 . . . . 65.219999999999999 109.007 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.4 ttm-85 -53.05 -41.62 64.98 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.169 -0.957 . . . . 72.349999999999994 109.37 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.822 ' O ' ' N ' ' A' ' 103' ' ' LYS . 23.1 t -172.86 36.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.982 -1.074 . . . . 71.319999999999993 110.929 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.6 mt 44.97 -68.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-N 118.693 0.679 . . . . 75.430000000000007 110.792 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.822 ' N ' ' O ' ' A' ' 101' ' ' SER . 21.3 tptm -49.22 -36.26 19.55 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.01 -1.056 . . . . 71.409999999999997 108.295 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.94 -40.91 83.22 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.189 -1.041 . . . . 63.240000000000002 108.189 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.8 -38.17 88.25 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.835 -0.802 . . . . 73.219999999999999 108.835 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.23 -42.13 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 60.109999999999999 109.353 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.44 -41.17 63.04 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.216 -0.927 . . . . 70.420000000000002 108.786 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.525 ' NE ' ' OE2' ' B' ' 83' ' ' GLU . 98.7 mtt180 -68.66 -37.84 79.96 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.35 -0.844 . . . . 74.409999999999997 109.282 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.62 -30.84 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.041 -1.037 . . . . 62.539999999999999 108.314 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -63.24 -54.81 31.55 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.777 -0.823 . . . . 74.340000000000003 108.777 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.465 ' HB2' ' CZ ' ' B' ' 87' ' ' PHE . . . -53.11 -35.87 60.13 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.402 -0.811 . . . . 73.319999999999993 109.396 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -57.76 -48.95 78.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.216 -0.927 . . . . 52.409999999999997 109.25 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 78.6 mt -144.53 97.73 3.08 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.137 -0.977 . . . . 65.239999999999995 109.496 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.403 ' O ' ' CG ' ' A' ' 115' ' ' PHE . 42.0 mtp180 -85.12 -59.02 2.45 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.205 -0.935 . . . . 64.450000000000003 108.999 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.403 ' CG ' ' O ' ' A' ' 114' ' ' ARG . 56.9 m-85 -156.55 89.27 1.1 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.256 -0.902 . . . . 74.430000000000007 109.542 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.474 ' CD1' ' N ' ' A' ' 116' ' ' TRP . 7.8 p-90 -93.17 133.5 36.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.237 -0.915 . . . . 74.420000000000002 109.078 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 178.42 98.35 0.11 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.586 -1.406 . . . . 75.040000000000006 109.586 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.83 ' HB3' ' OE2' ' A' ' 132' ' ' GLU . 31.0 t -159.61 176.97 11.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -1.113 . . . . 61.140000000000001 109.495 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -158.12 120.02 3.63 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.841 -0.8 . . . . 65.239999999999995 108.841 -178.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.8 t -83.62 -25.93 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.073 -1.017 . . . . 73.109999999999999 109.056 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.447 HG21 ' O ' ' A' ' 156' ' ' ALA . 28.2 mm -111.33 121.08 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.622 -0.881 . . . . 72.239999999999995 108.622 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -127.33 109.91 12.27 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.518 -0.738 . . . . 72.340000000000003 109.446 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.412 ' O ' ' C ' ' A' ' 124' ' ' GLY . 94.4 mt -112.67 124.64 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.63 -0.878 . . . . 71.439999999999998 108.63 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 123' ' ' ILE . . . -34.16 -44.22 0.37 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 112.109 -0.397 . . . . 73.400000000000006 112.109 -178.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.492 ' CB ' HD13 ' A' ' 126' ' ' LEU . 62.1 m-20 -63.7 -56.38 16.14 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.987 -1.302 . . . . 74.450000000000003 109.94 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.537 ' H ' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -144.12 166.44 25.01 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.113 -0.992 . . . . 54.210000000000001 110.083 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.4 m -106.49 145.07 32.27 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.229 -0.919 . . . . 54.5 109.894 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.9 mt -137.24 134.62 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.165 -0.959 . . . . 45.149999999999999 109.76 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.7 t -121.53 113.42 32.07 Favored Pre-proline 0 N--CA 1.499 1.994 0 N-CA-C 109.24 -0.652 . . . . 71.109999999999999 109.24 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -81.05 -54.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.719 1.613 . . . . 65.409999999999997 112.109 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -55.57 -42.48 74.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 63.32 109.147 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.83 ' OE2' ' HB3' ' A' ' 118' ' ' SER . 72.1 mt-10 -82.56 -4.19 57.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.288 -0.883 . . . . 72.519999999999996 109.201 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 47.51 66.35 1.04 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.334 -0.854 . . . . 75.329999999999998 109.797 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -159.58 142.76 14.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.063 -1.023 . . . . 71.230000000000004 109.783 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.0 tt -126.94 138.36 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.468 -0.77 . . . . 74.019999999999996 109.897 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.1 mm -118.03 121.77 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.728 -0.842 . . . . 60.229999999999997 108.728 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -140.29 146.01 38.0 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.102 -0.998 . . . . 62.32 110.014 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 83.0 mttt 53.87 26.72 6.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.481 -0.762 . . . . 75.400000000000006 110.215 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.18 9.08 87.24 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 120.122 -1.037 . . . . 72.239999999999995 110.857 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 43.7 mtp180 -103.11 142.89 33.35 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.194 -1.18 . . . . 71.219999999999999 109.259 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -110.74 121.96 46.63 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.899 -0.778 . . . . 71.420000000000002 108.899 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.5 143.95 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 120.924 -1.11 . . . . 53.020000000000003 110.698 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.568 ' H ' ' CD ' ' A' ' 143' ' ' GLU . 2.1 pm0 -93.65 134.63 35.75 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.398 -1.334 . . . . 60.450000000000003 107.398 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.1 136.65 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 120.936 -1.103 . . . . 74.439999999999998 110.514 -178.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.13 104.11 0.99 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.643 -0.66 . . . . 65.150000000000006 109.498 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -166.88 -147.49 5.26 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.748 -1.341 . . . . 73.340000000000003 109.748 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.455 ' H ' ' HD2' ' A' ' 148' ' ' PRO . 30.4 mttt -92.71 -59.72 0.21 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.212 -1.17 . . . . 72.219999999999999 110.691 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.762 ' HG2' ' CE1' ' A' ' 149' ' ' PHE . 21.7 Cg_endo -57.94 -15.18 21.07 Favored 'Trans proline' 0 N--CA 1.5 1.898 0 C-N-CA 121.913 1.742 . . . . 65.230000000000004 111.937 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.762 ' CE1' ' HG2' ' A' ' 148' ' ' PRO . 4.1 m-85 -98.8 -22.87 15.62 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.175 -0.953 . . . . 60.109999999999999 110.196 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -59.61 -35.63 74.71 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.77 -1.206 . . . . 64.209999999999994 108.848 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.3 p -70.45 -27.86 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.238 -0.914 . . . . 72.019999999999996 108.619 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 56.9 tp -64.48 -49.55 70.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.343 -0.848 . . . . 73.310000000000002 109.585 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.46 -33.46 74.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.816 -1.177 . . . . 74.310000000000002 108.691 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -54.24 -54.83 34.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.439 -0.788 . . . . 74.310000000000002 110.199 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.4 pp -75.26 -23.19 57.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.104 -0.998 . . . . 75.340000000000003 109.758 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.447 ' O ' HG21 ' A' ' 121' ' ' ILE . . . -55.13 -38.44 68.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.159 -0.963 . . . . 62.140000000000001 108.753 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' A' ' 159' ' ' ARG . 45.1 mtp180 -86.8 -56.08 3.56 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.285 -1.005 . . . . 61.030000000000001 108.285 178.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.437 ' N ' ' CD2' ' A' ' 158' ' ' HIS . 8.0 m170 -68.92 47.77 0.06 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.573 -0.899 . . . . 74.120000000000005 108.573 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 214' ' ' PHE . 63.9 mtm180 -53.4 -60.04 3.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.609 -0.682 . . . . 71.129999999999995 110.271 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -95.6 94.19 7.6 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.165 -0.96 . . . . 75.450000000000003 109.283 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . 1.362 ' NE2' ' O ' ' A' ' 162' ' ' ILE . 21.9 tm0? -170.16 142.85 2.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.025 -1.047 . . . . 73.409999999999997 109.938 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 1.362 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 2.0 mp -87.74 139.51 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.258 -1.016 . . . . 74.409999999999997 108.258 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.561 ' CG1' ' OE1' ' A' ' 161' ' ' GLN . 17.6 m -126.82 150.94 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.463 -0.773 . . . . 72.310000000000002 109.893 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 7.2 t -99.78 158.23 15.94 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.499 -0.751 . . . . 74.120000000000005 109.218 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.466 ' HB3' HD13 ' A' ' 184' ' ' ILE . 65.3 mttm -55.67 -54.07 48.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.344 -0.847 . . . . 70.430000000000007 110.01 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -63.11 -27.97 69.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 73.519999999999996 110.343 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.441 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 46.1 tt0 -62.05 -54.37 42.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.005 -1.06 . . . . 74.519999999999996 110.08 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 48.9 mt -59.33 -44.78 92.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.884 -1.135 . . . . 72.310000000000002 109.36 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 173' ' ' TRP . 4.2 mm? -62.24 -53.04 60.96 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.147 -0.971 . . . . 53.329999999999998 109.731 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 167' ' ' GLN . 14.2 p30 -71.1 -4.93 27.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.016 -1.053 . . . . 62.439999999999998 110.174 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -83.15 -59.01 2.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.06 -1.025 . . . . 60.210000000000001 109.927 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.74 ' N ' HD12 ' A' ' 172' ' ' ILE . 1.9 mp -85.59 -43.66 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.935 -1.103 . . . . 75.319999999999993 109.291 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . 0.458 ' O ' ' O ' ' A' ' 169' ' ' LEU . 23.5 m-90 . . . . . 0 N--CA 1.499 2.006 0 O-C-N 121.442 -0.786 . . . . 73.140000000000001 109.755 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.428 ' N ' ' OD1' ' A' ' 182' ' ' ASN . 25.1 p-10 . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.527 -0.545 . . . . 64.540000000000006 109.527 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 183' ' ' VAL . 11.0 m -76.88 -0.53 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 74.019999999999996 109.415 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.488 ' O ' HG22 ' A' ' 188' ' ' ILE . 50.6 mt -51.23 -46.85 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 72.329999999999998 109.546 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -56.0 -30.85 62.44 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.401 -0.812 . . . . 74.400000000000006 110.17 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 18.0 t -75.13 -53.18 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.041 -1.037 . . . . 70.420000000000002 110.735 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.8 -44.5 93.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.034 -1.041 . . . . 52.109999999999999 110.697 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 184' ' ' ILE . 8.1 tp -69.84 -37.91 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.112 -0.993 . . . . 71.400000000000006 110.418 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.412 ' N ' HG23 ' A' ' 188' ' ' ILE . 26.6 t-20 -70.73 -48.61 53.61 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.111 -0.993 . . . . 73.439999999999998 110.738 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . 0.449 ' CG ' ' N ' ' A' ' 191' ' ' ILE . 7.1 pt20 -64.44 -45.59 86.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.909 -1.119 . . . . 71.420000000000002 110.145 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.449 ' N ' ' CG ' ' A' ' 190' ' ' GLN . 89.6 mt -59.53 -46.68 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.05 -1.031 . . . . 61.549999999999997 109.711 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 19.5 mtp-105 -60.01 -45.08 93.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.025 -1.047 . . . . 63.340000000000003 109.606 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -65.85 -29.29 69.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 61.240000000000002 109.589 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -93.88 -1.46 54.77 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.244 -0.91 . . . . 75.129999999999995 109.996 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 36.5 ttm -96.84 -60.47 1.59 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.04 -1.038 . . . . 74.019999999999996 109.907 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 41.8 t0 -54.94 -22.55 15.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.306 -0.871 . . . . 74.019999999999996 110.583 -178.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.432 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 1.3 mptm? -73.27 -65.81 0.63 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.917 -1.114 . . . . 75.430000000000007 110.221 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . 0.432 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 30.7 Cg_endo -62.18 -56.71 0.64 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.501 1.468 . . . . 72.319999999999993 112.355 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 18.8 mt -64.12 -40.49 96.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.176 -0.953 . . . . 74.540000000000006 109.763 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 86.3 -34.13 3.51 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.916 -1.674 . . . . 61.509999999999998 108.916 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 35.6 mm -111.58 134.82 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.614 -0.933 . . . . 61.219999999999999 108.895 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 59.5 p -95.08 166.15 12.07 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.287 -0.883 . . . . 72.0 110.345 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.9 34.41 0.26 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.348 -0.982 . . . . 74.439999999999998 108.348 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 23.7 m -135.4 137.18 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.541 -0.724 . . . . 64.349999999999994 109.329 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -120.3 135.39 55.02 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.61 -0.681 . . . . 71.409999999999997 109.408 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.5 135.13 42.42 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.317 -0.865 . . . . 73.519999999999996 109.115 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.7 145.74 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.201 -0.937 . . . . 71.019999999999996 109.465 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -77.5 76.55 4.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.94 . . . . 72.120000000000005 109.502 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -164.01 -126.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.229 -0.919 . . . . 64.409999999999997 109.432 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 18.7 tpt85 -49.39 -43.21 44.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.946 . . . . 71.540000000000006 109.733 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 160.46 -111.47 0.48 Allowed Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.686 -1.245 . . . . 72.030000000000001 110.208 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -115.45 171.26 7.83 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.503 -0.998 . . . . 75.540000000000006 109.433 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -142.2 133.0 25.64 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.246 -0.909 . . . . 75.310000000000002 109.699 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.437 ' O ' ' O ' ' A' ' 159' ' ' ARG . 7.2 m-85 -105.4 131.54 52.7 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.88 -0.785 . . . . 75.409999999999997 108.88 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 21.3 t -157.08 150.55 24.21 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.942 -0.762 . . . . 74.140000000000001 108.942 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -61.77 150.54 81.86 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.047 -1.033 . . . . 75.319999999999993 108.913 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.497 1.718 0 C-N-CA 122.412 2.075 . . . . 73.109999999999999 112.455 -179.697 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.541 ' N ' ' CZ ' ' B' ' 2' ' ' ARG . 56.1 ttm . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.485 -0.561 . . . . 71.140000000000001 109.485 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.541 ' CZ ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -128.14 147.08 50.53 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.996 -0.742 . . . . 73.230000000000004 108.996 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 96.8 t -111.11 123.64 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.642 0.734 . . . . 72.239999999999995 109.947 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.584 HD11 ' CG1' ' B' ' 6' ' ' ILE . 1.8 tp -92.79 118.65 31.32 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.477 -0.934 . . . . 54.329999999999998 108.477 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.526 HD23 ' N ' ' B' ' 6' ' ' ILE . 1.2 tt -119.08 118.05 30.38 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.318 -0.993 . . . . 74.349999999999994 108.318 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.584 ' CG1' HD11 ' B' ' 4' ' ' LEU . 24.0 mt -111.51 98.4 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.365 -0.834 . . . . 42.549999999999997 108.779 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.423 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 24.6 tp10 -128.93 137.44 51.41 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.623 -0.673 . . . . 74.519999999999996 109.365 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.3 -32.95 73.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.281 -0.887 . . . . 62.549999999999997 109.454 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -90.88 125.0 35.61 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.253 -0.904 . . . . 73.109999999999999 109.514 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 49.5 m -74.93 -32.99 61.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 65.540000000000006 109.799 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 96.0 t -60.14 -46.77 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.149 -0.97 . . . . 75.549999999999997 109.728 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.507 ' CD2' ' N ' ' B' ' 12' ' ' LEU . 3.5 mm? -63.99 -36.48 84.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 70.140000000000001 109.411 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.56 -27.31 71.41 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 108.56 -1.816 . . . . 75.400000000000006 108.56 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.59 -53.18 40.36 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 109.543 -1.423 . . . . 65.439999999999998 109.543 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -58.97 -46.31 88.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.373 -1.075 . . . . 60.210000000000001 109.789 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 36.8 mm -64.45 -40.11 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.816 -1.177 . . . . 75.150000000000006 108.826 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.462 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 83.0 tt0 -61.62 -44.92 96.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.27 -0.894 . . . . 73.010000000000005 109.317 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -84.96 1.38 47.68 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 74.299999999999997 109.196 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.48 -55.42 2.33 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.618 -1.393 . . . . 70.540000000000006 109.618 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -75.7 -20.71 58.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -1.13 . . . . 71.340000000000003 109.839 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 82.5 m-20 -52.54 -33.74 46.9 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.037 -1.039 . . . . 64.409999999999997 109.547 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 75.9 t -58.2 -29.69 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.229 -0.919 . . . . 74.230000000000004 109.278 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -80.12 -7.47 58.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.295 -0.878 . . . . 63.420000000000002 109.485 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.57 40.47 7.75 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.327 -1.109 . . . . 53.43 110.327 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -119.12 160.29 22.37 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.428 -1.042 . . . . 71.120000000000005 109.096 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.7 mmt -105.15 139.63 39.53 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.631 -0.878 . . . . 75.239999999999995 108.631 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.2 155.72 46.01 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.255 -0.903 . . . . 72.120000000000005 110.086 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' B' ' 28' ' ' ASP . 2.1 p30 -137.56 140.07 40.82 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.9 -0.778 . . . . 72.310000000000002 108.9 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 p -104.61 138.42 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.489 -0.93 . . . . 64.430000000000007 108.489 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 16.0 p -136.79 166.5 23.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.35 -0.844 . . . . 65.409999999999997 109.306 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . 0.476 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 3.2 pt-20 -90.92 -98.17 0.11 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.242 -0.911 . . . . 71.019999999999996 109.772 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 24.0 t -78.37 165.18 24.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 51.109999999999999 110.166 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 20.7 mt -55.52 -30.65 61.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.577 -0.702 . . . . 71.239999999999995 109.957 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -53.27 -46.15 69.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.137 -0.977 . . . . 74.319999999999993 109.964 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.476 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 75.0 m-20 -67.33 -42.27 83.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.073 -1.017 . . . . 73.030000000000001 109.444 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.59 -39.23 78.79 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.478 -1.449 . . . . 30.210000000000001 109.478 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -67.39 -38.21 84.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.322 -1.104 . . . . 74.420000000000002 109.774 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -80.2 -39.66 28.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.089 -1.007 . . . . 74.420000000000002 109.888 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 39.1 tp -68.52 -37.64 80.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.923 . . . . 75.409999999999997 110.226 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.4 ppp? -76.29 -22.68 54.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.959 -1.088 . . . . 60.409999999999997 110.211 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -64.33 -40.8 96.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.021 -1.049 . . . . 53.229999999999997 110.193 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.8 pt -82.05 -42.0 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.052 -1.03 . . . . 71.230000000000004 110.178 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' B' ' 40' ' ' MET . 2.2 mpt_? -94.86 150.71 19.89 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.029 -1.044 . . . . 72.219999999999999 109.278 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -68.68 -162.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 63.539999999999999 109.081 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -179.11 154.78 0.69 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.008 -1.057 . . . . 64.349999999999994 109.927 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -136.98 -46.87 0.58 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.455 -0.778 . . . . 62.219999999999999 108.951 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.513 ' C ' HD13 ' B' ' 47' ' ' LEU . 0.9 OUTLIER -104.08 110.66 22.92 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.43 -0.952 . . . . 73.120000000000005 108.43 179.548 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.464 ' N ' HD13 ' B' ' 47' ' ' LEU . 75.9 t -96.77 98.29 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.268 -0.895 . . . . 65.109999999999999 109.357 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.412 ' CE ' ' OG ' ' B' ' 74' ' ' SER . 3.8 ttt -113.71 130.29 56.45 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.623 0.725 . . . . 73.439999999999998 109.414 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.409 HG21 ' HB2' ' B' ' 55' ' ' ALA . 0.3 OUTLIER -144.27 130.45 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.496 -0.753 . . . . 34.5 109.132 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . 0.423 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 95.5 p -91.92 -2.2 56.91 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.519 -0.738 . . . . 73.209999999999994 110.014 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -75.58 138.01 41.18 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.136 -0.978 . . . . 70.409999999999997 109.703 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.489 ' C ' ' H ' ' B' ' 55' ' ' ALA . 25.7 mtmm -74.5 -50.23 19.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.252 -0.905 . . . . 65.0 109.993 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -50.41 -10.57 0.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.168 -0.958 . . . . 75.209999999999994 109.545 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.489 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -64.04 -20.66 66.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.406 -0.809 . . . . 55.329999999999998 110.28 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' B' ' 55' ' ' ALA . 29.5 mt -40.89 -50.11 3.22 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.444 -0.785 . . . . 63.140000000000001 110.224 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 23.2 m -69.77 -32.68 71.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.038 -1.039 . . . . 63.5 109.124 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' B' ' 55' ' ' ALA . 66.9 t80 -65.34 -45.52 83.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.355 -0.841 . . . . 72.329999999999998 110.068 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.413 ' H ' HG22 ' B' ' 59' ' ' VAL . 12.0 m -65.57 -34.88 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.536 -1.353 . . . . 74.540000000000006 109.45 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 20.3 t -57.15 -50.2 73.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.231 -0.918 . . . . 71.239999999999995 109.569 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -66.79 -33.19 75.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 74.310000000000002 110.083 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' B' ' 62' ' ' ILE . 20.6 mm -65.93 -38.51 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.783 -1.198 . . . . 72.140000000000001 109.82 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 56.7 mmtt -67.25 -46.99 72.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.998 -1.064 . . . . 73.319999999999993 110.519 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.434 ' CG ' ' N ' ' B' ' 65' ' ' LYS . 7.7 pt-20 -74.46 -43.15 57.43 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.804 -1.185 . . . . 73.120000000000005 110.224 -179.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.448 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 66.9 mttm -71.05 -23.63 62.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 72.439999999999998 109.807 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.629 ' O ' HG22 ' B' ' 69' ' ' ILE . 97.3 m-70 -155.0 65.94 0.65 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.135 -0.978 . . . . 63.310000000000002 109.462 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.461 ' O ' ' N ' ' B' ' 69' ' ' ILE . 36.1 m -54.46 -36.44 64.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.259 -0.9 . . . . 73.099999999999994 109.95 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 29.2 m -68.13 48.11 0.05 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.056 -1.028 . . . . 71.530000000000001 109.7 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . 0.629 HG22 ' O ' ' B' ' 66' ' ' HIS . 16.6 tt -144.16 154.31 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.246 -0.909 . . . . 74.400000000000006 109.27 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t -95.39 155.44 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.097 -1.002 . . . . 75.120000000000005 109.106 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 42.0 t -141.86 125.61 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.155 -0.966 . . . . 73.200000000000003 109.491 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.646 ' HG ' HD11 ' B' ' 95' ' ' ILE . 0.7 OUTLIER -119.5 98.38 6.1 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.6 -0.889 . . . . 73.340000000000003 108.6 -179.653 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 70.4 t -88.7 112.75 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 73.5 108.808 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . 0.412 ' OG ' ' CE ' ' B' ' 49' ' ' MET . 0.6 OUTLIER -89.57 174.75 7.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.038 -1.039 . . . . 64.340000000000003 108.577 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.435 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 6.6 p -166.81 121.17 1.06 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.841 -1.162 . . . . 74.530000000000001 110.542 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -57.51 -32.01 66.61 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.518 -0.919 . . . . 64.5 108.518 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -111.88 90.86 13.91 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.635 -0.876 . . . . 74.25 108.635 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.93 72.19 6.27 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.939 1.759 . . . . 74.430000000000007 112.17 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 29.5 p -87.73 162.73 16.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.539 -0.726 . . . . 73.120000000000005 109.338 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -33.17 72.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.328 -0.857 . . . . 71.010000000000005 109.459 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . 0.519 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 76.9 mm-40 -63.45 -41.25 98.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.144 -0.973 . . . . 63.200000000000003 109.527 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -73.14 -30.4 63.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.146 -0.971 . . . . 73.219999999999999 109.58 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.525 ' OE2' ' NE ' ' A' ' 108' ' ' ARG . 36.6 tt0 -63.9 -56.06 18.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 74.299999999999997 109.668 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . 0.405 HG23 ' N ' ' B' ' 85' ' ' HIS . 30.9 m -58.14 -38.54 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.132 -0.98 . . . . 73.310000000000002 108.972 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' HIS . . . . . 0.519 ' ND1' ' O ' ' B' ' 81' ' ' GLU . 27.2 m170 -64.44 -29.08 70.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.257 -0.902 . . . . 73.239999999999995 109.093 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.16 -45.76 79.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.302 -0.874 . . . . 55.329999999999998 109.653 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' PHE . . . . . 0.465 ' CZ ' ' HB2' ' A' ' 111' ' ' ALA . 40.0 t80 -80.87 -31.74 35.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.997 -1.064 . . . . 74.140000000000001 109.085 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -64.33 -52.38 58.69 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.219 -0.926 . . . . 64.040000000000006 109.387 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . 0.502 ' NE2' ' N ' ' B' ' 89' ' ' GLN . 0.9 OUTLIER -64.71 -52.32 57.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.451 -0.781 . . . . 72.349999999999994 109.513 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.83 72.3 0.01 OUTLIER Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.103 -1.199 . . . . 65.200000000000003 110.103 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -129.17 134.64 48.11 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.451 -1.029 . . . . 52.229999999999997 108.951 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -76.95 -30.22 55.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.098 -1.001 . . . . 73.319999999999993 109.144 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 93' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 51.2 t0 -152.49 164.22 38.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.374 -0.829 . . . . 72.219999999999999 109.34 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.449 ' N ' ' OD1' ' B' ' 93' ' ' ASP . 86.4 t80 -140.21 121.06 14.47 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.481 -0.933 . . . . 64.420000000000002 108.481 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 0.794 ' H ' HD12 ' B' ' 95' ' ' ILE . 0.0 OUTLIER -127.17 161.49 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 O-C-N 121.36 -0.838 . . . . 72.230000000000004 110.909 -178.017 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.16 129.57 35.31 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.72 -1.215 . . . . 25.239999999999998 107.72 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.688 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -50.77 -56.75 16.84 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 120.989 -1.069 . . . . 64.319999999999993 111.572 -178.544 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 4.5 Cg_endo -41.12 -8.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.116 1.211 . . . . 63.329999999999998 113.26 -175.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . 0.688 ' N ' ' O ' ' B' ' 97' ' ' LYS . 55.1 m-85 60.4 116.03 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.558 -0.714 . . . . 75.129999999999995 109.405 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 31.5 ttm-85 -59.94 -31.2 69.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.925 -1.109 . . . . 74.230000000000004 108.938 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . 0.73 ' O ' ' N ' ' B' ' 103' ' ' LYS . 46.2 t -174.26 28.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.088 -1.007 . . . . 63.340000000000003 110.552 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 53.3 mt 51.23 -68.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.768 -0.583 . . . . 74.439999999999998 110.47 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.73 ' N ' ' O ' ' B' ' 101' ' ' SER . 4.3 mmmm -58.04 -33.67 69.25 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.05 -1.093 . . . . 71.109999999999999 108.05 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.07 -44.41 95.86 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.368 -0.933 . . . . 71.450000000000003 108.499 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 17.8 tp -63.53 -49.15 74.63 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.838 -0.801 . . . . 51.310000000000002 108.838 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 90.0 t -58.52 -41.16 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 65.230000000000004 109.325 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.7 -36.05 69.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.151 -0.968 . . . . 24.32 109.202 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -79.79 -28.95 40.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.403 -0.811 . . . . 75.310000000000002 109.961 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.25 -46.09 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 120.978 -1.076 . . . . 54.240000000000002 108.785 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' B' ' 114' ' ' ARG . 23.9 pt-20 -66.22 -42.15 89.08 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.06 -1.056 . . . . 65.310000000000002 108.494 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . 0.501 ' HB1' ' CZ ' ' A' ' 87' ' ' PHE . . . -53.69 -39.13 64.9 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.58 -0.7 . . . . 72.239999999999995 109.418 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -65.14 -44.66 87.89 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.177 -0.952 . . . . 72.040000000000006 109.953 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . 0.547 ' C ' ' H ' ' B' ' 115' ' ' PHE . 58.1 mt -97.78 -60.12 1.63 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.107 -0.996 . . . . 75.349999999999994 110.768 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' B' ' 110' ' ' GLU . 58.0 mtp180 57.93 -4.85 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.466 -0.772 . . . . 75.5 110.262 -178.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 115' ' ' PHE . . . . . 0.547 ' H ' ' C ' ' B' ' 113' ' ' LEU . 63.4 t80 -171.74 -104.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.993 -1.067 . . . . 65.329999999999998 109.501 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 116' ' ' TRP . . . . . 0.443 ' N ' ' CD2' ' B' ' 115' ' ' PHE . 39.9 m95 -146.75 44.88 1.19 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.334 -0.854 . . . . 74.450000000000003 108.826 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.93 -140.96 26.56 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.216 -1.554 . . . . 44.210000000000001 109.216 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 9.2 t -151.58 138.68 19.17 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.167 -1.196 . . . . 71.400000000000006 109.395 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . 0.489 HD21 ' C ' ' B' ' 121' ' ' ILE . 35.1 t30 -86.54 169.44 12.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.257 -0.902 . . . . 72.319999999999993 109.653 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 11.0 t -137.6 -34.32 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.981 -0.748 . . . . 75.019999999999996 108.981 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . 0.489 ' C ' HD21 ' B' ' 119' ' ' ASN . 26.9 mm -112.31 134.27 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.546 -0.721 . . . . 51.409999999999997 109.147 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -148.42 133.72 18.47 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.193 -0.942 . . . . 71.530000000000001 109.609 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 1.046 HD12 ' CD ' ' B' ' 159' ' ' ARG . 16.7 tt -149.49 123.96 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.792 -0.818 . . . . 72.430000000000007 108.792 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 54.87 -136.89 44.59 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.207 -1.557 . . . . 51.229999999999997 109.207 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -89.95 1.36 56.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.221 -1.164 . . . . 74.200000000000003 109.524 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.91 138.42 31.56 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.284 -0.885 . . . . 75.420000000000002 108.739 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 35.2 m -132.26 119.56 20.97 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.481 -0.762 . . . . 74.219999999999999 109.288 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . 0.424 ' O ' ' OD1' ' B' ' 119' ' ' ASN . 14.0 mm -117.98 147.08 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.543 -0.723 . . . . 60.329999999999998 109.304 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . 0.414 ' C ' HH22 ' B' ' 157' ' ' ARG . 5.9 m -137.76 132.91 17.53 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.276 -0.89 . . . . 72.310000000000002 109.137 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -80.72 -49.43 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.174 1.916 . . . . 75.129999999999995 112.455 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -57.51 -49.9 74.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.912 . . . . 75.230000000000004 110.055 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -82.36 -9.33 59.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.091 -1.006 . . . . 72.430000000000007 109.749 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 47.94 69.03 0.58 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.093 -1.004 . . . . 75.129999999999995 109.274 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -139.18 141.22 37.97 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.453 -0.779 . . . . 73.219999999999999 109.353 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 2.8 tt -120.51 126.41 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.515 -0.741 . . . . 64.140000000000001 109.487 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 32.9 mm -115.2 121.82 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.653 -0.869 . . . . 71.219999999999999 108.653 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -140.79 143.85 35.11 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.206 -0.934 . . . . 64.219999999999999 109.622 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' B' ' 138' ' ' LYS . 30.3 ttpt 54.57 9.5 0.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.547 -0.721 . . . . 72.019999999999996 109.804 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 91.55 16.65 51.95 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 110.04 -1.224 . . . . 74.319999999999993 110.04 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . 0.4 ' HE ' ' HE3' ' B' ' 138' ' ' LYS . 41.6 mtt-85 -107.33 144.11 34.65 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.513 -0.992 . . . . 75.340000000000003 109.706 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -102.82 118.12 36.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.568 -0.707 . . . . 71.230000000000004 109.397 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 71.8 t -136.36 137.37 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.452 -0.78 . . . . 70.430000000000007 109.012 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -80.36 132.38 35.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.906 . . . . 72.430000000000007 109.531 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 5.4 p -73.1 133.27 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.159 -0.963 . . . . 72.129999999999995 109.064 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 35.3 pttt -170.4 66.3 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.9 . . . . 72.019999999999996 109.607 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 176.6 156.2 15.0 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.369 -1.492 . . . . 42.229999999999997 109.369 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . 0.615 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 19.3 mttt -65.23 -39.24 33.89 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.201 -1.176 . . . . 73.299999999999997 109.625 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 27.2 Cg_exo -61.54 -30.45 86.24 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.016 1.81 . . . . 71.329999999999998 111.218 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -94.94 -20.67 19.19 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.456 -0.778 . . . . 74.230000000000004 109.389 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -67.36 -39.23 85.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.273 -0.892 . . . . 72.340000000000003 109.486 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.45 -35.16 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 73.349999999999994 109.615 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.702 HD23 ' SD ' ' B' ' 195' ' ' MET . 0.2 OUTLIER -67.27 -42.43 83.84 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.125 0.964 . . . . 55.240000000000002 109.308 -179.76 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . 0.436 ' CG2' ' NH2' ' B' ' 157' ' ' ARG . 34.7 m -74.08 -26.51 60.41 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.03 -1.043 . . . . 70.010000000000005 110.872 -179.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -71.98 -59.98 2.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.045 -1.035 . . . . 65.319999999999993 109.867 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . 1.011 HD13 ' N ' ' B' ' 156' ' ' ALA . 0.0 OUTLIER -62.29 -20.98 64.86 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.929 -1.107 . . . . 71.540000000000006 108.735 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . 1.011 ' N ' HD13 ' B' ' 155' ' ' LEU . . . -61.86 -48.05 82.29 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 120.901 -1.125 . . . . 75.319999999999993 108.233 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . 0.436 ' NH2' ' CG2' ' B' ' 153' ' ' THR . 0.0 OUTLIER -72.72 -42.45 64.14 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.42 -0.912 . . . . 73.319999999999993 109.409 179.57 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -83.28 10.83 7.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.931 . . . . 74.140000000000001 110.389 -178.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . 1.046 ' CD ' HD12 ' B' ' 123' ' ' ILE . 10.4 ttp-105 -48.38 164.94 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.026 -1.046 . . . . 61.409999999999997 109.019 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 61.27 53.16 3.6 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.342 -0.849 . . . . 72.099999999999994 109.716 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -161.04 156.24 24.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.34 -0.85 . . . . 72.25 109.036 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 66.6 mt -88.86 132.49 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.997 -1.065 . . . . 72.310000000000002 108.896 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' B' ' 212' ' ' TYR . 40.1 t -141.57 136.78 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.24 -0.913 . . . . 64.209999999999994 110.353 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 6.6 t -94.65 167.94 11.15 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.096 -1.002 . . . . 74.219999999999999 109.288 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . 1.077 ' NZ ' ' HA ' ' B' ' 185' ' ' GLU . 22.2 mttm -61.96 -38.22 87.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.028 -1.045 . . . . 65.310000000000002 109.865 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -52.96 -39.53 63.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 63.450000000000003 110.14 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -60.94 -48.14 83.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -0.951 . . . . 72.400000000000006 110.478 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 40.5 mt -57.31 -33.54 67.8 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.91 -1.119 . . . . 72.319999999999993 109.665 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.469 HD23 ' C ' ' B' ' 169' ' ' LEU . 5.7 tt -65.38 -61.83 1.88 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.161 -0.962 . . . . 73.340000000000003 109.624 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -65.19 -28.63 69.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.36 -0.837 . . . . 72.099999999999994 110.568 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.94 -59.49 5.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.119 -0.988 . . . . 62.130000000000003 110.616 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 0.724 ' N ' HD12 ' B' ' 172' ' ' ILE . 2.0 mp -86.75 -59.34 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.006 -1.059 . . . . 71.420000000000002 109.172 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 173' ' ' TRP . . . . . 0.428 ' O ' ' O ' ' B' ' 169' ' ' LEU . 23.0 m-90 . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 72.230000000000004 108.822 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo . . . . . 0 N--CA 1.496 1.665 0 CA-C-O 120.913 0.297 . . . . 65.219999999999999 112.651 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -149.57 -15.77 0.28 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.913 -1.117 . . . . 72.310000000000002 109.959 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 11.3 p -63.97 -17.86 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.19 -0.943 . . . . 63.32 109.984 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.755 ' H ' HD12 ' B' ' 184' ' ' ILE . 1.3 mp -49.74 -35.17 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.068 -1.02 . . . . 75.030000000000001 109.567 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . 1.077 ' HA ' ' NZ ' ' B' ' 165' ' ' LYS . 17.3 pt-20 -55.87 -36.54 67.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.994 -1.066 . . . . 64.109999999999999 109.215 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 9.2 t -75.42 -36.98 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 73.0 109.207 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.08 -55.03 28.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.36 -0.838 . . . . 61.119999999999997 109.868 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 5.4 tp -63.15 -33.93 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.098 -1.001 . . . . 72.430000000000007 109.927 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -69.04 -50.86 44.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 65.140000000000001 110.491 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -72.53 -39.08 67.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.035 -1.041 . . . . 63.240000000000002 110.157 -178.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 57.5 mt -57.22 -38.01 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.037 -1.039 . . . . 74.030000000000001 109.345 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -73.57 -44.13 58.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.037 -1.039 . . . . 72.239999999999995 109.96 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -70.5 -28.77 65.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.906 . . . . 73.099999999999994 110.601 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -82.97 -33.84 26.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.01 -1.056 . . . . 72.109999999999999 110.291 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 195' ' ' MET . . . . . 0.702 ' SD ' HD23 ' B' ' 152' ' ' LEU . 62.4 mtt -90.61 -40.8 11.71 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.053 -1.03 . . . . 44.329999999999998 110.863 -179.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 196' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 51.1 p-10 -53.32 -20.43 4.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.929 -1.107 . . . . 71.209999999999994 110.488 -178.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . 0.524 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 4.1 mmtp -76.19 -65.63 0.42 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.852 -1.155 . . . . 75.209999999999994 109.537 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 198' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 48.2 Cg_endo -66.12 -45.39 5.82 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.246 1.964 . . . . 75.319999999999993 111.633 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 37.1 tp -65.05 -51.09 63.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.386 -0.821 . . . . 72.25 109.342 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 85.94 -33.2 3.59 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.91 -1.276 . . . . 64.530000000000001 109.91 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . 0.719 ' N ' HD12 ' B' ' 201' ' ' ILE . 2.5 mp -92.19 142.15 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.131 -1.217 . . . . 44.229999999999997 109.722 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 70.3 m -119.58 133.24 55.75 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.37 -0.974 . . . . 54.009999999999998 108.37 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 24.4 p -137.22 47.42 2.11 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.312 -0.867 . . . . 74.400000000000006 109.715 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 1.6 m -143.15 122.41 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.259 -0.9 . . . . 72.120000000000005 109.219 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -107.94 129.45 55.1 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.664 -0.865 . . . . 65.409999999999997 108.664 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 206' ' ' THR . . . . . 0.43 HG22 ' H ' ' B' ' 206' ' ' THR . 0.1 OUTLIER -94.16 131.22 39.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.175 -0.953 . . . . 71.329999999999998 109.949 -179.298 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 5.0 t -129.56 122.91 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.434 -0.951 . . . . 63.5 108.434 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -61.93 -26.07 67.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 74.450000000000003 110.065 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 -68.67 -88.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.033 -1.042 . . . . 74.140000000000001 109.83 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -65.3 -63.49 1.09 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.05 -1.032 . . . . 74.430000000000007 109.668 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 157.91 -105.81 0.28 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.452 -1.459 . . . . 64.450000000000003 109.452 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 212' ' ' TYR . . . . . 0.461 ' O ' ' O ' ' B' ' 163' ' ' VAL . 39.0 m-85 -120.16 135.87 54.81 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.613 -0.933 . . . . 74.209999999999994 109.618 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -125.5 134.13 52.14 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.446 -0.784 . . . . 74.030000000000001 108.944 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . 0.738 ' CD1' HD23 ' B' ' 155' ' ' LEU . 80.4 m-85 -90.77 131.28 36.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.406 -0.808 . . . . 74.340000000000003 109.289 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 26.7 p -153.74 167.97 27.83 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.173 -0.954 . . . . 64.329999999999998 109.803 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -63.52 148.44 93.88 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.42 -0.8 . . . . 70.040000000000006 109.213 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.82 162.63 27.88 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.11 1.873 . . . . 65.109999999999999 111.914 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 21.8 mttm . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.246 -0.909 . . . . 73.150000000000006 109.349 -179.796 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.546 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.436 -0.579 . . . . 65.120000000000005 109.436 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.418 ' HG2' HH11 ' A' ' 2' ' ' ARG . 2.0 ttt-85 -145.06 152.9 40.84 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.213 -0.929 . . . . 72.329999999999998 109.07 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 65.7 t -115.29 128.84 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.52 -0.738 . . . . 71.420000000000002 109.652 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 5' ' ' LEU . 3.7 tp -100.39 117.08 33.85 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.516 -0.74 . . . . 65.120000000000005 109.136 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 4' ' ' LEU . 60.2 tp -115.89 111.53 20.58 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.563 -0.71 . . . . 62.43 109.475 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.443 HG12 HD11 ' A' ' 4' ' ' LEU . 9.2 mt -102.24 113.42 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.213 -0.93 . . . . 71.150000000000006 108.96 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.476 ' OE1' ' CB ' ' A' ' 51' ' ' SER . 31.0 tp10 -148.41 126.88 12.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.205 -0.934 . . . . 75.340000000000003 109.572 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -69.09 -30.76 69.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -0.869 . . . . 72.439999999999998 109.173 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -84.97 114.29 22.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.34 -0.85 . . . . 63.020000000000003 109.422 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 77.2 p -70.19 -24.84 63.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.911 . . . . 72.340000000000003 109.62 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.65 -51.49 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.209 -0.932 . . . . 74.019999999999996 109.642 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.558 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.5 mm? -66.91 -33.54 75.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 71.430000000000007 109.212 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.76 -23.3 75.36 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.674 -1.77 . . . . 61.32 108.674 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.74 -53.43 15.91 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.622 -1.391 . . . . 71.200000000000003 109.622 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -60.69 -43.37 97.83 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.35 -1.088 . . . . 71.319999999999993 109.736 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 96.2 mt -65.11 -32.5 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.891 -1.131 . . . . 63.229999999999997 109.034 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -58.01 -49.81 75.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 51.109999999999999 109.298 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -88.11 0.45 55.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.228 -0.92 . . . . 73.340000000000003 109.879 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.15 -57.82 2.58 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 110.002 -1.239 . . . . 62.149999999999999 110.002 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pp -74.58 -23.25 58.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -1.128 . . . . 73.510000000000005 110.052 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -51.47 -35.29 39.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.018 -1.052 . . . . 74.25 109.47 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.7 t -55.38 -41.3 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.97 . . . . 70.040000000000006 109.159 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.405 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 2.6 mptp? -63.17 -19.26 64.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.855 . . . . 73.230000000000004 109.026 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.85 40.64 4.88 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.553 -1.019 . . . . 75.540000000000006 110.553 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -119.04 160.43 22.04 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.421 -1.046 . . . . 73.430000000000007 108.502 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.8 mmt -90.14 124.33 34.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.051 -1.031 . . . . 43.240000000000002 108.872 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.25 138.58 37.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.417 -0.802 . . . . 62.109999999999999 110.059 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -127.82 126.89 42.54 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.508 -0.923 . . . . 74.420000000000002 108.508 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -106.11 130.78 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.729 -0.841 . . . . 72.150000000000006 108.729 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.9 p -135.67 160.58 38.07 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.5 -0.75 . . . . 71.420000000000002 109.485 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -89.0 -103.44 0.09 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.283 -0.886 . . . . 72.329999999999998 109.418 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.443 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 62.2 m -78.45 147.89 33.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.205 -0.934 . . . . 74.239999999999995 109.36 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.599 ' H ' HD12 ' A' ' 33' ' ' LEU . 1.7 mp -49.1 -15.71 0.12 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.328 -0.857 . . . . 71.530000000000001 110.189 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 32' ' ' SER . 78.8 mm-40 -62.65 -53.33 56.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.012 -1.055 . . . . 74.230000000000004 110.05 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 36' ' ' GLY . 19.8 p-10 -67.73 -30.27 69.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.0 -1.062 . . . . 54.030000000000001 109.262 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.543 ' N ' ' OD1' ' A' ' 35' ' ' ASP . . . -75.25 -36.11 46.36 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.142 -1.583 . . . . 61.409999999999997 109.142 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -70.09 -46.88 63.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.339 -1.095 . . . . 74.340000000000003 109.459 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -69.05 -34.1 74.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.969 . . . . 75.329999999999998 109.862 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.449 HD11 ' HE ' ' A' ' 43' ' ' ARG . 20.7 tp -79.23 -51.33 9.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.217 -0.927 . . . . 74.329999999999998 110.226 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.448 ' SD ' ' OH ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -58.2 -27.85 64.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.101 -1.0 . . . . 70.319999999999993 109.934 -179.27 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -61.09 -39.68 90.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.109 -0.994 . . . . 71.219999999999999 109.849 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.7 pt -91.44 1.39 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.072 -1.018 . . . . 74.140000000000001 110.076 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.449 ' HE ' HD11 ' A' ' 39' ' ' LEU . 86.2 mtt-85 -126.4 152.15 46.72 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.36 -0.838 . . . . 72.239999999999995 109.328 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -96.83 151.79 19.32 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.197 -0.94 . . . . 75.420000000000002 109.326 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.448 ' OH ' ' SD ' ' A' ' 40' ' ' MET . 10.0 p90 -154.76 175.23 13.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.243 -0.911 . . . . 74.230000000000004 109.646 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -135.76 -33.44 0.86 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.423 -0.798 . . . . 72.040000000000006 109.307 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.537 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -107.99 115.01 29.36 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.492 -0.755 . . . . 72.129999999999995 109.014 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.537 ' N ' HD13 ' A' ' 47' ' ' LEU . 58.3 t -102.41 98.84 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.852 -0.796 . . . . 72.340000000000003 108.852 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.474 ' SD ' ' O ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -109.59 122.75 48.13 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.096 -0.705 . . . . 74.109999999999999 109.096 -179.615 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.438 HG21 ' HB2' ' A' ' 55' ' ' ALA . 1.6 p -130.87 130.02 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 121.602 0.715 . . . . 61.119999999999997 109.702 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.476 ' CB ' ' OE1' ' A' ' 7' ' ' GLU . 44.9 p -99.1 0.54 43.81 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.435 -0.791 . . . . 73.109999999999999 109.281 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -76.03 141.52 42.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.141 -0.974 . . . . 52.549999999999997 109.341 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.485 ' C ' ' H ' ' A' ' 55' ' ' ALA . 21.2 pttm -79.36 -38.51 34.87 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.252 -0.905 . . . . 44.219999999999999 110.449 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -70.59 11.25 0.38 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.977 -1.077 . . . . 70.439999999999998 109.494 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.485 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.77 -21.12 57.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.406 -0.809 . . . . 64.140000000000001 110.589 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 55' ' ' ALA . 73.6 mt -38.11 -48.47 1.24 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.498 -0.751 . . . . 44.140000000000001 111.025 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.2 m -71.93 -36.76 70.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.889 -1.132 . . . . 55.229999999999997 109.59 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.441 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 72.9 t80 -66.33 -47.01 74.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.397 -0.815 . . . . 74.439999999999998 110.594 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.3 m -64.14 -34.42 68.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 120.636 -1.29 . . . . 74.030000000000001 109.561 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.0 t -57.75 -55.12 38.92 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.182 -0.949 . . . . 64.299999999999997 109.317 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.684 HH21 ' HZ2' ' A' ' 65' ' ' LYS . 5.7 ptm180 -61.42 -31.27 71.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 64.439999999999998 109.868 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.441 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 4.9 mm -63.03 -37.18 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.996 -1.065 . . . . 63.210000000000001 109.778 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -70.03 -54.24 14.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.036 -1.04 . . . . 74.420000000000002 110.315 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -64.85 -35.89 82.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.817 -1.177 . . . . 70.319999999999993 109.815 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.684 ' HZ2' HH21 ' A' ' 61' ' ' ARG . 46.4 mtpt -82.58 -23.3 34.5 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.063 -1.023 . . . . 75.219999999999999 109.818 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.477 ' CG ' ' C ' ' A' ' 65' ' ' LYS . 47.8 m-70 -154.38 65.53 0.69 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.043 -1.036 . . . . 74.129999999999995 109.64 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.8 t -64.69 -30.64 71.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.204 -0.935 . . . . 73.239999999999995 109.951 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 97.2 p -60.43 -17.87 47.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.168 -0.958 . . . . 61.009999999999998 110.014 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 53.7 mt -91.28 149.56 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.139 -0.975 . . . . 71.329999999999998 109.614 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 71' ' ' VAL . 91.9 t -88.33 159.18 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.344 -0.847 . . . . 72.129999999999995 109.135 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.46 ' N ' HG12 ' A' ' 70' ' ' VAL . 22.0 t -138.81 124.54 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.158 -0.963 . . . . 54.210000000000001 110.001 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.629 ' CD1' HH22 ' A' ' 108' ' ' ARG . 4.0 tt -113.43 99.09 7.51 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.617 -0.882 . . . . 50.240000000000002 108.617 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.6 t -96.71 123.22 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.364 -0.835 . . . . 74.409999999999997 108.816 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.82 -178.11 4.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.986 -1.071 . . . . 72.310000000000002 109.004 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.473 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 49.7 p -166.75 120.07 1.02 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.133 -0.979 . . . . 64.540000000000006 109.829 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -77.49 6.39 7.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.403 -0.811 . . . . 74.129999999999995 108.913 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 79' ' ' THR . 74.6 m-20 -142.24 64.96 17.63 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.947 -0.76 . . . . 73.340000000000003 108.947 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.6 81.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.919 1.746 . . . . 63.219999999999999 111.707 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 77' ' ' ASN . 41.1 p -100.56 161.89 13.3 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.776 -0.824 . . . . 62.530000000000001 108.776 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 p -66.52 -24.48 66.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.131 -0.981 . . . . 73.439999999999998 109.659 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -73.64 -38.98 64.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 71.420000000000002 109.769 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 96.1 mt-10 -70.92 -33.65 70.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.204 -0.935 . . . . 73.430000000000007 110.117 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.416 ' OE2' ' NE ' ' B' ' 100' ' ' ARG . 92.3 mt-10 -68.61 -55.8 10.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.005 -1.059 . . . . 74.219999999999999 109.745 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.53 HG23 ' N ' ' A' ' 85' ' ' HIS . 31.9 m -60.61 -42.52 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.191 -0.943 . . . . 73.200000000000003 109.414 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.575 ' CE1' HE21 ' A' ' 89' ' ' GLN . 75.8 t60 -69.21 -31.58 70.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.32 -0.862 . . . . 53.329999999999998 109.498 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 82' ' ' GLU . . . -62.89 -36.64 84.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.298 -0.876 . . . . 64.109999999999999 109.822 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -78.32 -33.25 49.36 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.09 -1.006 . . . . 74.340000000000003 108.756 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -72.97 -34.03 66.21 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.447 -0.783 . . . . 74.420000000000002 109.378 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.575 HE21 ' CE1' ' A' ' 85' ' ' HIS . 83.9 mm-40 -69.93 -62.33 1.43 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 74.239999999999995 109.484 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 152.56 54.96 0.01 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.908 -1.277 . . . . 61.509999999999998 109.908 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.37 135.85 53.7 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.416 -1.049 . . . . 55.329999999999998 109.431 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 20.0 t70 -82.15 -31.65 30.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 73.420000000000002 109.127 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 95.6 m-20 -141.77 160.16 40.74 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.417 -0.802 . . . . 75.040000000000006 109.204 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.473 ' OH ' ' CB ' ' A' ' 75' ' ' SER . 82.6 t80 -139.49 105.66 5.24 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.395 -0.815 . . . . 71.329999999999998 109.122 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.438 HG22 ' N ' ' A' ' 96' ' ' ALA . 29.0 mm -111.62 157.82 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.221 -0.925 . . . . 71.129999999999995 110.674 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.438 ' N ' HG22 ' A' ' 95' ' ' ILE . . . -77.81 125.16 28.93 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.831 -1.174 . . . . 64.319999999999993 107.831 178.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.674 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -45.23 -53.85 16.1 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.016 -1.053 . . . . 62.200000000000003 111.467 -178.801 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.7 Cg_endo -42.11 -10.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 CA-C-N 119.729 0.939 . . . . 73.109999999999999 112.643 -177.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.674 ' N ' ' O ' ' A' ' 97' ' ' LYS . 57.7 m-85 58.7 112.39 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.667 -0.646 . . . . 65.219999999999999 109.694 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.51 ' NE ' ' OE2' ' B' ' 83' ' ' GLU . 37.8 ttm-85 -58.58 -38.19 77.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.948 -1.095 . . . . 72.349999999999994 108.511 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.806 ' O ' ' N ' ' A' ' 103' ' ' LYS . 6.3 t -173.24 31.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -0.872 . . . . 71.319999999999993 110.338 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.428 ' O ' ' N ' ' A' ' 105' ' ' LEU . 6.4 mm 46.77 -67.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 CA-C-N 118.343 0.519 . . . . 75.430000000000007 110.462 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.806 ' N ' ' O ' ' A' ' 101' ' ' SER . 16.0 mtpp -50.7 -32.72 20.26 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.749 -1.22 . . . . 71.409999999999997 107.923 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.75 -38.34 80.05 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.921 -1.14 . . . . 63.240000000000002 107.921 178.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 102' ' ' ILE . 2.0 tt -70.0 -47.85 60.49 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.275 -0.639 . . . . 73.219999999999999 109.275 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.6 t -64.74 -44.59 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 60.109999999999999 109.192 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.24 -40.0 64.23 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.205 -0.935 . . . . 70.420000000000002 109.093 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.629 HH22 ' CD1' ' A' ' 72' ' ' LEU . 14.6 ttp-105 -72.58 -25.15 61.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.361 -0.837 . . . . 74.409999999999997 109.667 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 83.0 mt -80.12 -33.24 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.439 -1.319 . . . . 62.539999999999999 107.439 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -55.62 31.43 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.557 -1.275 . . . . 74.340000000000003 107.557 178.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.76 -40.42 69.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.653 -0.654 . . . . 73.319999999999993 109.586 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 10.6 mmp_? -56.15 -33.37 65.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.182 -0.948 . . . . 52.409999999999997 109.581 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.65 72.88 0.99 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.928 -1.108 . . . . 65.239999999999995 110.23 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.482 ' O ' ' N ' ' A' ' 116' ' ' TRP . 43.7 mtm180 -73.41 101.55 3.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.002 -1.061 . . . . 64.450000000000003 108.871 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 47.87 14.55 0.05 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.314 -0.866 . . . . 74.430000000000007 109.902 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' TRP . . . . . 0.482 ' N ' ' O ' ' A' ' 114' ' ' ARG . 94.9 m95 46.99 -164.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.166 -0.959 . . . . 74.420000000000002 109.675 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 168.1 40.52 0.02 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.491 -1.444 . . . . 75.040000000000006 109.491 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.6 m -83.98 -124.68 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.263 -1.139 . . . . 61.140000000000001 109.621 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 61.44 67.21 0.8 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 65.239999999999995 109.556 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.4 t -80.5 -25.76 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 73.109999999999999 109.337 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.8 mm -98.42 132.9 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.331 -0.855 . . . . 72.239999999999995 109.278 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -144.68 117.46 8.72 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.191 -0.943 . . . . 72.340000000000003 109.551 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.43 HD13 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -138.72 128.74 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.37 -0.831 . . . . 71.439999999999998 108.829 179.706 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.3 -136.25 16.81 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.519 -1.432 . . . . 73.400000000000006 109.519 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -91.53 -6.01 53.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.249 -1.148 . . . . 74.450000000000003 109.515 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.14 135.61 33.84 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.215 -0.928 . . . . 54.210000000000001 108.788 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 26.8 p -132.1 146.33 51.98 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.474 -0.766 . . . . 54.5 109.588 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.2 mt -134.61 136.7 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.324 -0.86 . . . . 45.149999999999999 109.63 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.3 t -113.89 124.78 30.43 Favored Pre-proline 0 N--CA 1.496 1.874 0 N-CA-C 109.023 -0.732 . . . . 71.109999999999999 109.023 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -80.58 -51.67 0.05 OUTLIER 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.635 1.557 . . . . 65.409999999999997 112.044 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -65.28 -44.22 88.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 63.32 109.73 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -80.98 -15.52 55.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 72.519999999999996 109.354 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 54.5 77.07 0.21 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 75.329999999999998 109.76 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -158.04 140.36 14.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 71.230000000000004 109.461 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.5 tt -120.22 133.45 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.539 -0.726 . . . . 74.019999999999996 109.6 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 26.7 mm -110.18 121.79 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.856 -0.794 . . . . 60.229999999999997 108.856 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.501 ' C ' ' H ' ' A' ' 139' ' ' GLY . 49.8 p90 -142.68 149.17 38.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.086 -1.009 . . . . 62.32 108.967 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 46.8 tttp 53.96 5.98 0.08 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.297 -0.877 . . . . 75.400000000000006 109.536 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.501 ' H ' ' C ' ' A' ' 137' ' ' TYR . . . 94.04 -6.71 72.88 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 110.079 -1.208 . . . . 72.239999999999995 110.079 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.416 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 1.0 OUTLIER -89.78 143.57 26.69 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.056 -1.261 . . . . 71.219999999999999 109.288 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -99.51 125.91 45.36 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.369 -0.832 . . . . 71.420000000000002 109.362 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.7 t -137.1 133.48 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.422 -0.798 . . . . 53.020000000000003 109.604 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.449 ' N ' ' OE1' ' A' ' 143' ' ' GLU . 45.5 mp0 -94.95 147.1 23.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.343 -0.848 . . . . 60.450000000000003 109.046 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.09 131.61 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.251 -0.906 . . . . 74.439999999999998 109.63 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.75 121.34 8.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.36 -0.837 . . . . 65.150000000000006 109.198 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.95 -143.29 10.09 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.917 -1.273 . . . . 73.340000000000003 109.917 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -70.67 -62.82 1.85 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.424 -1.045 . . . . 72.219999999999999 110.348 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -56.0 -19.68 27.11 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.934 1.756 . . . . 65.230000000000004 111.856 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.478 ' CE1' HG21 ' A' ' 153' ' ' THR . 1.0 OUTLIER -80.61 -44.49 18.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 60.109999999999999 109.189 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -60.94 -39.65 90.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 64.209999999999994 109.995 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 152' ' ' LEU . 11.5 p -77.14 -38.61 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.135 -0.978 . . . . 72.019999999999996 110.053 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.458 ' N ' HG13 ' A' ' 151' ' ' VAL . 15.0 tp -65.04 -42.8 93.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.121 -0.987 . . . . 73.310000000000002 109.737 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.478 HG21 ' CE1' ' A' ' 149' ' ' PHE . 42.9 p -72.98 -35.54 66.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.08 -1.013 . . . . 74.310000000000002 109.851 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -57.59 -52.01 67.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 74.310000000000002 109.632 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.408 ' H ' ' HG ' ' A' ' 155' ' ' LEU . 2.6 pp -73.88 -24.4 59.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 75.340000000000003 109.846 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.41 -46.6 83.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.134 -0.979 . . . . 62.140000000000001 109.426 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.46 ' C ' ' H ' ' A' ' 159' ' ' ARG . 65.5 mtt180 -75.34 -44.07 47.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.229 -0.919 . . . . 61.030000000000001 109.335 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -75.71 22.78 0.13 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 74.120000000000005 109.406 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.46 ' H ' ' C ' ' A' ' 157' ' ' ARG . 37.2 ptt180 -56.82 165.23 1.26 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.249 -0.907 . . . . 71.129999999999995 109.49 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.432 ' OD2' ' OE1' ' B' ' 161' ' ' GLN . 50.2 t0 54.2 47.15 23.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 75.450000000000003 109.242 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -155.15 158.9 39.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.284 -0.885 . . . . 73.409999999999997 109.381 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 53.4 mt -85.03 120.05 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.209 -0.932 . . . . 74.409999999999997 109.331 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.403 ' O ' ' O ' ' A' ' 212' ' ' TYR . 40.0 t -107.76 130.36 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.419 -0.801 . . . . 72.310000000000002 109.497 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.9 m -100.9 153.04 19.83 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.361 -0.837 . . . . 74.120000000000005 109.358 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.401 ' HB3' ' HZ3' ' A' ' 165' ' ' LYS . 9.2 mtpm? -56.65 -35.47 68.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.9 . . . . 70.430000000000007 109.505 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -59.51 -37.6 78.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 73.519999999999996 109.629 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.431 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 93.4 mt-30 -62.56 -39.6 94.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 74.519999999999996 109.555 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 28.5 mt -64.95 -31.78 73.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.128 -0.982 . . . . 72.310000000000002 109.268 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.504 HD23 ' C ' ' A' ' 169' ' ' LEU . 4.2 tt -66.38 -59.11 3.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.862 . . . . 53.329999999999998 110.098 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 167' ' ' GLN . 28.9 p-10 -73.64 -30.24 62.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.04 -1.038 . . . . 62.439999999999998 110.624 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.446 ' C ' HD12 ' A' ' 172' ' ' ILE . . . -59.98 -46.35 89.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.968 -1.083 . . . . 60.210000000000001 110.173 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.693 ' N ' HD12 ' A' ' 172' ' ' ILE . 1.6 mp -94.67 -59.86 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.038 -1.039 . . . . 75.319999999999993 108.966 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 29.8 m-90 . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 73.140000000000001 109.769 -179.89 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 23.5 m120 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.204 0.526 . . . . 64.540000000000006 110.286 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.42 ' O ' HG22 ' A' ' 183' ' ' VAL . 11.8 p -138.85 -4.31 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.4 -0.812 . . . . 74.019999999999996 109.569 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.673 ' H ' HD12 ' A' ' 184' ' ' ILE . 3.0 mp -53.56 -37.76 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.01 -1.056 . . . . 72.329999999999998 109.503 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -55.23 -30.53 60.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -0.947 . . . . 74.400000000000006 109.421 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 94.1 t -79.23 -57.23 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.082 -1.011 . . . . 70.420000000000002 109.495 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -54.97 -47.19 74.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.157 -0.964 . . . . 52.109999999999999 109.875 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.525 ' O ' HD13 ' A' ' 188' ' ' ILE . 0.2 OUTLIER -60.23 -44.2 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.085 -1.009 . . . . 71.400000000000006 109.061 -179.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.413 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 0.5 OUTLIER -60.35 -41.71 94.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.959 -1.088 . . . . 73.439999999999998 109.445 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -68.34 -45.13 73.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.93 . . . . 71.420000000000002 109.718 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 85.7 mt -56.41 -37.69 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.263 -0.898 . . . . 61.549999999999997 109.156 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -65.27 -40.68 94.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 63.340000000000003 109.512 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.431 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 14.8 mm100 -76.42 -26.61 55.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 61.240000000000002 110.025 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.546 ' HB3' ' HZ3' ' A' ' 194' ' ' LYS . 8.5 mtpm? -81.67 -25.26 35.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -0.946 . . . . 75.129999999999995 110.581 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 20.1 ptm -95.07 -36.32 11.57 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.033 -1.042 . . . . 74.019999999999996 110.116 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 197' ' ' LYS . 30.9 p-10 -66.04 -34.21 77.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.049 -1.032 . . . . 74.019999999999996 110.021 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.538 ' N ' ' OD1' ' A' ' 196' ' ' ASP . 11.0 ttpp -62.84 -60.87 8.64 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.013 -1.054 . . . . 75.430000000000007 109.876 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -59.04 -52.01 5.79 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.64 1.56 . . . . 72.319999999999993 111.407 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.547 HD12 ' N ' ' A' ' 199' ' ' LEU . 8.0 mp -92.53 125.15 37.04 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.345 -0.847 . . . . 74.540000000000006 109.118 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -77.79 -2.18 80.54 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.417 -1.473 . . . . 61.509999999999998 109.417 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 201' ' ' ILE . 19.6 mt -108.32 137.54 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.501 -1.0 . . . . 61.219999999999999 109.392 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 23.1 t -93.23 143.5 26.2 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.26 -0.9 . . . . 72.0 109.4 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 49.2 p -130.58 10.05 5.14 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.511 -0.743 . . . . 74.439999999999998 109.353 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 5.9 m -132.01 142.72 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.504 -0.748 . . . . 64.349999999999994 109.328 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -126.0 134.81 51.36 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.644 -0.66 . . . . 71.409999999999997 109.364 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.0 95.67 8.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.2 -0.938 . . . . 73.519999999999996 109.203 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.573 ' CG1' ' NH1' ' A' ' 213' ' ' ARG . 11.2 p -164.41 170.65 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.96 . . . . 71.019999999999996 109.347 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' ARG . . . . . 0.678 ' HE ' ' NH2' ' A' ' 210' ' ' ARG . 6.2 tpt180 76.65 146.16 0.09 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.495 -0.753 . . . . 72.120000000000005 109.547 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -61.5 -34.29 75.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.361 -0.837 . . . . 64.409999999999997 109.792 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.678 ' NH2' ' HE ' ' A' ' 208' ' ' ARG . 0.2 OUTLIER -49.94 -50.92 44.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 71.540000000000006 109.092 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 148.29 -106.06 0.33 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.051 -1.22 . . . . 72.030000000000001 110.051 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 212' ' ' TYR . 20.3 m-85 -113.43 145.38 41.25 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.568 -0.96 . . . . 75.540000000000006 109.484 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.573 ' NH1' ' CG1' ' A' ' 207' ' ' VAL . 7.8 mtm-85 -117.42 135.09 54.13 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.521 -0.737 . . . . 75.310000000000002 109.226 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -100.01 128.1 46.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.281 -0.887 . . . . 75.409999999999997 109.379 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 3.6 p -141.46 156.4 45.77 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.378 -0.826 . . . . 74.140000000000001 109.29 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -68.83 152.85 96.55 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.91 . . . . 75.319999999999993 109.108 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo . . . . . 0 C--N 1.314 -1.26 0 C-N-CA 122.299 1.999 . . . . 73.109999999999999 112.254 179.698 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 1' ' ' MET . . . . . 0.589 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.401 -0.592 . . . . 71.140000000000001 109.401 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -140.15 147.5 40.26 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.358 -0.839 . . . . 73.230000000000004 109.46 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 93.3 t -114.99 123.29 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 121.596 0.712 . . . . 72.239999999999995 109.585 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . 0.478 HD11 ' CG1' ' B' ' 6' ' ' ILE . 3.1 tp -91.34 118.05 30.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.898 . . . . 54.329999999999998 108.655 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' LEU . . . . . 0.514 HD23 ' N ' ' B' ' 6' ' ' ILE . 1.1 tt -118.08 117.0 28.02 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.49 -0.93 . . . . 74.349999999999994 108.49 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.56 HD12 ' HB ' ' B' ' 50' ' ' VAL . 78.2 mt -111.87 98.96 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.297 -0.877 . . . . 42.549999999999997 108.983 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.426 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 26.7 tp10 -129.31 135.68 49.06 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.516 -0.74 . . . . 74.519999999999996 109.434 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -67.83 -32.8 73.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 62.549999999999997 109.245 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -89.62 121.44 31.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.874 . . . . 73.109999999999999 109.47 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 23.2 m -73.7 -32.31 63.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 65.540000000000006 109.828 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 98.4 t -60.69 -47.65 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.14 -0.975 . . . . 75.549999999999997 109.829 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.552 HD12 ' NZ ' ' B' ' 97' ' ' LYS . 3.4 mm? -64.02 -33.27 75.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.155 -0.966 . . . . 70.140000000000001 109.297 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.39 -28.59 59.55 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.755 -1.738 . . . . 75.400000000000006 108.755 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.13 -50.13 62.32 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.299 -1.52 . . . . 65.439999999999998 109.299 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -62.2 -44.67 96.06 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.305 -1.114 . . . . 60.210000000000001 109.405 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.569 HD11 ' CZ ' ' B' ' 99' ' ' TYR . 5.3 mm -63.3 -35.62 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.884 -1.135 . . . . 75.150000000000006 108.399 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' B' ' 27' ' ' ALA . 43.4 tp10 -63.9 -49.11 73.95 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.329 -0.857 . . . . 73.010000000000005 109.224 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -80.53 0.56 33.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.97 . . . . 74.299999999999997 109.166 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.9 -62.35 1.52 Allowed Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.55 -1.42 . . . . 70.540000000000006 109.55 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' B' ' 27' ' ' ALA . 1.4 pt? -68.38 -23.64 64.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -1.154 . . . . 71.340000000000003 109.639 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' ASN . . . . . 0.422 ' H ' HD23 ' B' ' 20' ' ' LEU . 1.9 m120 -51.56 -35.01 39.28 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.055 -1.028 . . . . 64.409999999999997 109.381 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 74.9 t -55.22 -38.93 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.162 -0.961 . . . . 74.230000000000004 108.884 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' LYS . . . . . 0.412 ' N ' ' CD ' ' B' ' 23' ' ' LYS . 4.7 mptp? -70.14 -25.67 63.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.441 -0.787 . . . . 63.420000000000002 109.2 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.47 20.06 10.64 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 110.293 -1.123 . . . . 53.43 110.293 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -96.72 159.99 14.62 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.071 -1.252 . . . . 71.120000000000005 109.333 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 61.3 mmm -104.65 139.89 38.83 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.674 -0.861 . . . . 75.239999999999995 108.674 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . 0.493 ' HB2' HD11 ' B' ' 20' ' ' LEU . . . -141.13 153.11 45.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.191 -0.943 . . . . 72.120000000000005 110.16 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -133.05 134.01 43.79 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.791 -0.818 . . . . 72.310000000000002 108.791 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.31 138.06 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.278 -1.008 . . . . 64.430000000000007 108.278 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.4 p -139.12 165.61 26.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.282 -0.886 . . . . 65.409999999999997 109.525 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -84.3 -99.58 0.05 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.889 . . . . 71.019999999999996 109.33 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 60.7 p -78.32 161.7 27.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 51.109999999999999 109.579 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' LEU . . . . . 0.501 ' H ' HD12 ' B' ' 33' ' ' LEU . 2.8 mp -56.85 -31.53 64.87 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.448 -0.783 . . . . 71.239999999999995 109.814 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -56.61 -43.67 80.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.108 -0.995 . . . . 74.319999999999993 109.637 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -63.18 -42.26 99.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.135 -0.978 . . . . 73.030000000000001 109.31 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.31 -30.88 48.61 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.45 -1.46 . . . . 30.210000000000001 109.45 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' B' ' 33' ' ' LEU . 14.8 tm-20 -63.7 -41.53 98.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -1.153 . . . . 74.420000000000002 109.462 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -74.28 -38.44 63.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 74.420000000000002 109.547 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 21.6 tp -68.65 -48.28 64.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 75.409999999999997 109.981 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' MET . . . . . 0.442 ' O ' ' O ' ' B' ' 43' ' ' ARG . 16.1 ptm -66.52 -23.84 66.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.116 -0.99 . . . . 60.409999999999997 109.789 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.26 -38.03 79.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.074 -1.016 . . . . 53.229999999999997 109.781 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 10.7 pt -97.61 -1.68 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.177 -0.952 . . . . 71.230000000000004 110.206 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' B' ' 40' ' ' MET . 31.1 mmt180 -125.99 155.48 41.34 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.317 -0.864 . . . . 72.219999999999999 109.593 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' B' ' 45' ' ' TYR . 53.9 t-20 -86.76 151.33 23.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.249 -0.907 . . . . 63.539999999999999 109.269 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' TYR . . . . . 0.559 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 1.3 p90 -142.77 115.8 8.84 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.16 -0.962 . . . . 64.349999999999994 109.518 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -90.57 -34.77 15.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.277 -0.889 . . . . 62.219999999999999 108.907 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.515 ' C ' HD13 ' B' ' 47' ' ' LEU . 0.9 OUTLIER -111.68 110.55 21.0 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.695 -0.854 . . . . 73.120000000000005 108.695 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.458 ' N ' HD13 ' B' ' 47' ' ' LEU . 68.5 t -94.56 98.77 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.217 -0.927 . . . . 65.109999999999999 109.118 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 17.2 ttt -113.24 127.13 56.07 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.631 0.729 . . . . 73.439999999999998 109.581 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.56 ' HB ' HD12 ' B' ' 6' ' ' ILE . 0.2 OUTLIER -145.0 133.91 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.394 -0.816 . . . . 34.5 109.38 -179.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' SER . . . . . 0.43 ' CB ' ' OG ' ' B' ' 74' ' ' SER . 53.0 p -100.31 17.43 21.43 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.603 -0.685 . . . . 73.209999999999994 109.908 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.519 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 82.9 m-20 -83.12 135.17 34.91 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.095 -1.003 . . . . 70.409999999999997 109.408 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -70.16 -38.03 75.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.296 -0.878 . . . . 65.0 110.118 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' ASN . . . . . 0.676 HD22 ' H ' ' B' ' 54' ' ' ASN . 1.0 OUTLIER -75.62 13.0 0.87 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 75.209999999999994 109.875 -179.444 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.78 -21.73 60.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 55.329999999999998 110.113 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 33.5 mt -43.44 -35.98 1.8 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.322 -0.861 . . . . 63.140000000000001 110.438 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 82.7 p -77.16 -47.59 19.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.941 -1.099 . . . . 63.5 109.825 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' PHE . . . . . 0.528 ' CZ ' HD11 ' B' ' 62' ' ' ILE . 76.0 t80 -63.94 -44.92 91.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 72.329999999999998 110.398 -179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.494 HG23 ' N ' ' B' ' 60' ' ' SER . 17.0 m -63.85 -40.24 88.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 120.668 -1.27 . . . . 74.540000000000006 109.685 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' SER . . . . . 0.494 ' N ' HG23 ' B' ' 59' ' ' VAL . 59.2 m -53.71 -50.88 64.92 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.162 -0.961 . . . . 71.239999999999995 109.676 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.454 HH21 ' NZ ' ' B' ' 65' ' ' LYS . 11.9 ptm180 -67.8 -32.34 72.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.143 -0.973 . . . . 74.310000000000002 110.279 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.528 HD11 ' CZ ' ' B' ' 58' ' ' PHE . 4.9 mm -63.6 -43.98 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.706 -1.246 . . . . 72.140000000000001 110.001 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -64.78 -50.51 66.52 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.222 -0.924 . . . . 73.319999999999993 110.571 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -68.84 -40.67 79.27 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.71 -1.244 . . . . 73.120000000000005 110.032 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.513 ' O ' ' ND1' ' B' ' 66' ' ' HIS . 45.2 mtpt -77.29 -29.69 53.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.125 -0.984 . . . . 72.439999999999998 109.724 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' HIS . . . . . 0.544 ' CE1' ' NZ ' ' B' ' 145' ' ' LYS . 42.3 m-70 -144.47 67.84 1.26 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.15 -0.969 . . . . 63.310000000000002 109.913 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 81.3 p -65.62 -25.68 67.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 73.099999999999994 109.231 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 4.2 t -62.18 -24.63 67.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.864 . . . . 71.530000000000001 109.647 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 74.3 mt -86.43 152.04 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.311 -0.868 . . . . 74.400000000000006 109.401 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.499 HG12 ' N ' ' B' ' 71' ' ' VAL . 80.1 t -91.08 161.0 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.341 -0.85 . . . . 75.120000000000005 109.386 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.499 ' N ' HG12 ' B' ' 70' ' ' VAL . 14.8 t -141.15 122.39 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.169 -0.957 . . . . 73.200000000000003 109.264 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' LEU . . . . . 0.647 ' HG ' HD11 ' B' ' 95' ' ' ILE . 1.2 mp -117.66 103.09 9.69 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.76 -0.83 . . . . 73.340000000000003 108.76 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 70.9 t -90.12 118.69 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.314 -0.866 . . . . 73.5 108.677 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' SER . . . . . 0.43 ' OG ' ' CB ' ' B' ' 51' ' ' SER . 24.4 p -86.27 170.62 11.91 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.16 -0.962 . . . . 64.340000000000003 109.009 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' SER . . . . . 0.499 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 35.3 m -159.48 115.53 2.54 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.949 -1.095 . . . . 74.530000000000001 110.244 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -63.37 -22.93 67.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.44 -0.788 . . . . 64.5 109.69 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' B' ' 79' ' ' THR . 8.7 m-80 -125.09 79.33 65.73 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.505 -0.747 . . . . 74.25 109.623 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.13 86.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.494 2.129 . . . . 74.430000000000007 111.3 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.463 ' N ' ' O ' ' B' ' 77' ' ' ASN . 20.7 m -100.04 150.57 22.31 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.532 -0.73 . . . . 73.120000000000005 109.807 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 4.5 p -69.01 -38.01 79.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.412 -0.805 . . . . 71.010000000000005 109.661 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -63.03 -37.37 86.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.92 . . . . 63.200000000000003 109.669 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -71.76 -32.46 67.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.207 -0.933 . . . . 73.219999999999999 109.647 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' GLU . . . . . 0.51 ' OE2' ' NE ' ' A' ' 100' ' ' ARG . 95.0 mt-10 -64.87 -52.77 54.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.974 . . . . 74.299999999999997 109.749 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 18.6 m -60.24 -35.94 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.113 -0.992 . . . . 73.310000000000002 109.283 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -75.43 -27.43 58.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.271 -0.893 . . . . 73.239999999999995 109.464 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -66.68 -37.57 85.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.175 -0.953 . . . . 55.329999999999998 109.937 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -83.39 -36.26 24.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 74.140000000000001 109.22 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -71.9 -39.92 69.2 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.316 -0.865 . . . . 64.040000000000006 109.483 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -68.6 -50.12 53.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 72.349999999999994 109.4 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.65 69.84 0.01 OUTLIER Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.927 -1.13 . . . . 65.200000000000003 110.302 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -132.67 130.18 39.77 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.322 -1.105 . . . . 52.229999999999997 109.139 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -71.28 -33.81 70.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.918 . . . . 73.319999999999993 109.286 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 93' ' ' ASP . . . . . 0.437 ' OD2' ' NH2' ' B' ' 108' ' ' ARG . 14.1 t70 -152.25 161.8 42.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -0.843 . . . . 72.219999999999999 109.414 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 94' ' ' TYR . . . . . 0.499 ' OH ' ' CB ' ' B' ' 75' ' ' SER . 57.4 t80 -132.25 120.24 21.9 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.86 -0.792 . . . . 64.420000000000002 108.86 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . 0.785 ' H ' HD12 ' B' ' 95' ' ' ILE . 0.0 OUTLIER -128.08 154.63 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 CA-C-O 121.793 0.806 . . . . 72.230000000000004 110.493 -178.43 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.0 149.78 48.41 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.19 -1.041 . . . . 25.239999999999998 108.19 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . 0.665 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -74.24 -56.48 2.55 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.785 -1.197 . . . . 64.319999999999993 111.451 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 98' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 5.2 Cg_endo -41.95 -9.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 120.852 1.035 . . . . 63.329999999999998 112.944 -176.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 99' ' ' TYR . . . . . 0.665 ' N ' ' O ' ' B' ' 97' ' ' LYS . 34.0 m-85 61.19 125.71 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.652 -0.655 . . . . 75.129999999999995 109.438 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . 0.416 ' NE ' ' OE2' ' A' ' 83' ' ' GLU . 39.4 ttm-85 -66.35 -34.39 77.87 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.888 -1.133 . . . . 74.230000000000004 108.85 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . 0.736 ' O ' ' N ' ' B' ' 103' ' ' LYS . 10.9 t -172.69 38.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.198 -0.938 . . . . 63.340000000000003 110.6 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 26.2 mm 50.91 -69.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.659 -0.651 . . . . 74.439999999999998 110.415 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 103' ' ' LYS . . . . . 0.736 ' N ' ' O ' ' B' ' 101' ' ' SER . 16.2 mtpp -57.46 -29.35 64.14 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.313 -0.995 . . . . 71.109999999999999 108.313 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.72 -46.54 81.84 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.542 -0.91 . . . . 71.450000000000003 108.542 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 13.0 tp -64.63 -54.45 31.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.478 -0.764 . . . . 51.310000000000002 109.011 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 23.4 t -57.85 -38.19 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.116 -0.99 . . . . 65.230000000000004 109.495 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.06 -48.26 70.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.25 -0.906 . . . . 24.32 109.616 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 108' ' ' ARG . . . . . 0.487 ' NH2' HD21 ' B' ' 72' ' ' LEU . 8.5 ttp-105 -68.73 -31.49 70.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 75.310000000000002 109.869 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 96.8 mt -74.33 -26.3 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.047 -1.033 . . . . 54.240000000000002 108.941 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -71.7 -54.0 11.7 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.418 -0.801 . . . . 65.310000000000002 109.53 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.3 -43.41 78.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.105 -0.997 . . . . 72.239999999999995 109.379 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 9.0 tpm_? -69.79 -41.73 74.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.258 -0.902 . . . . 72.040000000000006 109.455 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 14.0 tp -96.55 65.13 2.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.25 -0.906 . . . . 75.349999999999994 109.775 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 114' ' ' ARG . . . . . 0.553 ' CA ' ' HE ' ' B' ' 114' ' ' ARG . 0.0 OUTLIER -142.48 -62.23 0.44 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.193 -0.942 . . . . 75.5 108.695 179.647 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -89.33 22.93 2.69 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.219 -0.925 . . . . 65.329999999999998 109.511 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -62.28 -35.64 79.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.165 -0.959 . . . . 74.450000000000003 109.665 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.29 128.84 33.88 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.911 -1.275 . . . . 44.210000000000001 109.911 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 97.5 p -159.45 166.52 30.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.359 -1.083 . . . . 71.400000000000006 110.093 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.4 137.06 12.21 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.693 -0.854 . . . . 72.319999999999993 108.693 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 5.2 t -107.88 -41.37 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.323 -0.861 . . . . 75.019999999999996 110.593 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 19.1 mm -97.95 140.3 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.048 -1.033 . . . . 51.409999999999997 109.924 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -148.75 131.6 16.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.404 -0.81 . . . . 71.530000000000001 109.33 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.449 HG23 ' O ' ' B' ' 123' ' ' ILE . 10.9 tp -156.35 127.11 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 72.430000000000007 109.004 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.83 -155.31 4.29 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.1 -1.6 . . . . 51.229999999999997 109.1 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -76.86 2.18 15.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.157 -1.202 . . . . 74.200000000000003 108.938 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.577 HD11 HD12 ' B' ' 201' ' ' ILE . 0.4 OUTLIER -95.46 134.37 38.38 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.644 -0.872 . . . . 75.420000000000002 108.644 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 3.3 m -131.7 141.46 49.56 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.363 -0.836 . . . . 74.219999999999999 109.153 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 54.1 mt -132.38 130.21 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.276 -0.89 . . . . 60.329999999999998 109.998 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 129' ' ' SER . . . . . 0.459 ' O ' ' N ' ' B' ' 133' ' ' GLU . 18.9 m -115.32 98.88 51.58 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 108.786 -0.82 . . . . 72.310000000000002 108.786 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.12 -40.7 2.31 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.39 1.394 . . . . 75.129999999999995 112.041 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -56.78 -36.54 69.97 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.895 -1.128 . . . . 75.230000000000004 108.161 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -98.07 -10.0 25.0 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.715 -0.846 . . . . 72.430000000000007 108.715 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' B' ' 129' ' ' SER . 30.0 mt-10 53.84 61.33 3.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.121 -0.987 . . . . 75.129999999999995 108.393 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -137.01 112.92 9.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.503 -0.748 . . . . 73.219999999999999 109.915 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.44 137.49 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 106.456 -1.683 . . . . 64.140000000000001 106.456 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 40.2 mt -129.23 120.8 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.258 -0.901 . . . . 71.219999999999999 110.319 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -142.62 144.11 32.68 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.465 -0.772 . . . . 64.219999999999999 109.342 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt 54.6 26.37 7.3 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.43 -0.794 . . . . 72.019999999999996 110.206 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 75.22 13.68 82.55 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.334 -1.106 . . . . 74.319999999999993 110.334 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 40.8 mtp85 -104.37 123.89 48.22 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.335 -1.097 . . . . 75.340000000000003 108.99 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -95.75 137.4 34.87 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.384 -0.822 . . . . 71.230000000000004 110.162 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 1.2 p -139.51 131.33 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.206 -0.933 . . . . 70.430000000000007 109.346 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -89.03 144.32 26.23 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.834 -1.172 . . . . 72.430000000000007 107.834 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 144' ' ' VAL . . . . . 0.523 ' HB ' ' CD1' ' B' ' 149' ' ' PHE . 5.9 m -132.11 150.21 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.263 -0.898 . . . . 72.129999999999995 109.782 -179.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 145' ' ' LYS . . . . . 0.544 ' NZ ' ' CE1' ' B' ' 66' ' ' HIS . 25.2 pttt -174.19 109.87 0.15 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.512 -0.743 . . . . 72.019999999999996 109.51 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . 1.009 ' O ' ' HG3' ' B' ' 150' ' ' GLU . . . 166.71 -160.21 33.77 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.422 -1.471 . . . . 42.229999999999997 109.422 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . 0.565 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 26.1 ttpt -87.37 -36.9 0.48 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.149 -1.207 . . . . 73.299999999999997 110.675 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 148' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 72.2 Cg_endo -85.12 4.61 6.68 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 121.566 1.511 . . . . 71.329999999999998 110.934 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 149' ' ' PHE . . . . . 0.523 ' CD1' ' HB ' ' B' ' 144' ' ' VAL . 41.3 m-85 -108.58 -40.0 5.23 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.496 0.665 . . . . 74.230000000000004 109.259 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 150' ' ' GLU . . . . . 1.009 ' HG3' ' O ' ' B' ' 146' ' ' GLY . 41.8 mt-10 -59.65 -34.4 72.77 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.167 -0.958 . . . . 72.340000000000003 108.512 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . 0.746 HG13 HD22 ' B' ' 152' ' ' LEU . 12.7 p -61.05 -40.84 87.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.639 -0.824 . . . . 73.349999999999994 108.854 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.746 HD22 HG13 ' B' ' 151' ' ' VAL . 4.6 mm? -56.84 -52.39 65.3 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.711 -0.848 . . . . 55.240000000000002 108.711 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.6 p -62.36 -32.94 73.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.392 -0.818 . . . . 70.010000000000005 109.593 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -62.21 -56.15 21.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.991 -1.068 . . . . 65.319999999999993 109.463 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.64 -22.21 63.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.057 -1.027 . . . . 71.540000000000006 109.14 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.48 -49.99 74.49 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.127 -0.983 . . . . 75.319999999999993 108.653 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 51.3 mtp85 -69.64 -52.8 22.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.332 -0.855 . . . . 73.319999999999993 109.041 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -76.74 20.35 0.24 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.467 -0.771 . . . . 74.140000000000001 110.313 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . 1.3 HH11 ' CB ' ' B' ' 159' ' ' ARG . 0.0 OUTLIER -50.02 -38.49 37.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.104 -0.998 . . . . 61.409999999999997 109.096 179.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -98.15 67.6 1.89 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.25 -0.906 . . . . 72.099999999999994 109.584 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 161' ' ' GLN . . . . . 0.432 ' OE1' ' OD2' ' A' ' 160' ' ' ASP . 9.6 tp-100 -171.08 161.93 6.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.142 -0.974 . . . . 72.25 109.675 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 13.6 mm -82.88 142.82 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.472 -0.768 . . . . 72.310000000000002 109.727 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.27 128.52 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.462 -0.774 . . . . 64.209999999999994 109.269 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 52.5 p -98.79 153.7 18.56 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.181 -0.949 . . . . 74.219999999999999 109.92 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -52.24 -50.99 60.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.36 -0.838 . . . . 65.310000000000002 109.494 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -51.65 -39.71 58.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.372 -0.83 . . . . 63.450000000000003 109.907 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -65.86 -41.52 91.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.116 -0.99 . . . . 72.400000000000006 109.607 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 80.6 mt -52.02 -53.79 37.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.018 -1.051 . . . . 72.319999999999993 109.162 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 169' ' ' LEU . . . . . 0.576 ' O ' ' N ' ' B' ' 171' ' ' ALA . 52.4 mt -64.9 -67.9 0.4 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.341 -0.849 . . . . 73.340000000000003 110.059 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -42.91 -15.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.693 -0.629 . . . . 72.099999999999994 110.878 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 171' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' B' ' 169' ' ' LEU . . . -93.39 -41.12 10.0 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.93 -1.106 . . . . 62.130000000000003 112.196 -178.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 172' ' ' ILE . . . . . 0.461 HD12 ' HB3' ' B' ' 171' ' ' ALA . 4.8 mp -123.47 -34.23 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.791 0 O-C-N 120.768 -1.208 . . . . 71.420000000000002 113.209 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 173' ' ' TRP . . . . . 0.476 ' CD2' ' C ' ' B' ' 173' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.505 2.319 0 O-C-N 120.047 -1.658 . . . . 72.230000000000004 110.49 -177.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo . . . . . 0 N--CA 1.493 1.447 0 CA-C-O 121.198 0.416 . . . . 65.219999999999999 112.88 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 43.3 p30 -70.8 8.42 0.89 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.074 -1.017 . . . . 72.310000000000002 110.218 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 12.3 p -66.83 -22.16 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.049 -1.032 . . . . 63.32 109.594 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.426 ' O ' HG22 ' B' ' 188' ' ' ILE . 54.5 mt -54.52 -50.04 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 75.030000000000001 109.92 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -60.84 -40.98 94.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 64.109999999999999 109.887 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 3.6 t -69.35 -40.04 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.521 -0.737 . . . . 73.0 110.486 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.59 -53.68 9.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 61.119999999999997 110.031 -179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 188' ' ' ILE . . . . . 0.426 HG22 ' O ' ' B' ' 184' ' ' ILE . 11.0 tp -58.06 -25.4 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.96 . . . . 72.430000000000007 109.741 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -75.83 -56.97 4.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.256 -0.903 . . . . 65.140000000000001 110.52 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -65.32 -34.75 79.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.023 -1.048 . . . . 63.240000000000002 110.141 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 86.7 mt -63.69 -59.04 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.032 -1.042 . . . . 74.030000000000001 109.939 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 192' ' ' ARG . . . . . 0.655 HH21 HG23 ' B' ' 204' ' ' VAL . 21.0 mtp-105 -60.26 -35.86 76.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.166 -0.959 . . . . 72.239999999999995 109.622 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 193' ' ' GLN . . . . . 0.43 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 79.9 mm-40 -70.32 -33.95 72.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.183 -0.948 . . . . 73.099999999999994 109.452 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 194' ' ' LYS . . . . . 0.458 ' CB ' ' NZ ' ' B' ' 194' ' ' LYS . 7.3 mtpm? -79.58 -17.25 54.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.181 -0.949 . . . . 72.109999999999999 110.013 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 44.1 ttp -98.12 -11.52 22.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.139 -0.976 . . . . 44.329999999999998 110.372 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 196' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 57.3 p30 -107.91 -14.61 14.73 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.025 -1.047 . . . . 71.209999999999994 110.393 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . 0.594 ' N ' ' CD ' ' B' ' 198' ' ' PRO . 30.5 tttt -78.16 -40.8 1.95 Allowed Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 120.851 -1.156 . . . . 75.209999999999994 110.03 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 198' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' B' ' 197' ' ' LYS . 40.7 Cg_endo -89.47 -44.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.449 2.1 . . . . 75.319999999999993 112.473 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . 0.516 ' N ' HD12 ' B' ' 199' ' ' LEU . 9.1 mp -61.1 -54.03 49.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.862 -1.149 . . . . 72.25 109.085 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 99.74 -0.02 56.52 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.069 -1.212 . . . . 64.530000000000001 110.069 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 201' ' ' ILE . . . . . 0.577 HD12 HD11 ' B' ' 126' ' ' LEU . 38.7 mt -130.79 145.25 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.373 -1.075 . . . . 44.229999999999997 109.25 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 28.7 t -97.85 135.28 39.82 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.295 -0.878 . . . . 54.009999999999998 109.252 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 6.8 p -135.09 5.62 3.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.344 -0.848 . . . . 74.400000000000006 109.277 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.655 HG23 HH21 ' B' ' 192' ' ' ARG . 16.2 m -108.42 139.17 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.448 -0.783 . . . . 72.120000000000005 109.479 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -125.2 128.72 48.78 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.55 -0.719 . . . . 65.409999999999997 109.372 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.87 124.45 40.85 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.242 -0.911 . . . . 71.329999999999998 109.451 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 207' ' ' VAL . . . . . 0.443 ' O ' ' O ' ' B' ' 208' ' ' ARG . 6.1 m -151.42 143.11 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.274 -0.891 . . . . 63.5 109.173 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 208' ' ' ARG . . . . . 0.484 ' O ' ' N ' ' B' ' 210' ' ' ARG . 19.3 tpt180 -58.61 -109.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.089 -1.007 . . . . 74.450000000000003 109.108 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 50.63 -94.84 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.955 -1.091 . . . . 74.140000000000001 109.386 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 210' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' B' ' 208' ' ' ARG . 67.3 mtt-85 -107.62 -55.31 2.37 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.737 -0.602 . . . . 74.430000000000007 109.771 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 211' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' B' ' 207' ' ' VAL . . . -174.42 -105.92 0.19 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.558 -1.417 . . . . 64.450000000000003 109.558 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -110.77 162.41 14.8 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.382 -1.07 . . . . 74.209999999999994 109.117 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 213' ' ' ARG . . . . . 0.69 HH12 ' CB ' ' B' ' 215' ' ' CYS . 35.4 ttt-85 -130.23 122.95 29.04 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.435 -0.791 . . . . 74.030000000000001 109.164 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 214' ' ' PHE . . . . . 0.551 ' HB3' ' O ' ' B' ' 159' ' ' ARG . 17.4 m-85 -104.13 124.67 49.51 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.447 -0.783 . . . . 74.340000000000003 109.317 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 215' ' ' CYS . . . . . 0.69 ' CB ' HH12 ' B' ' 213' ' ' ARG . 1.7 m -163.51 154.64 16.56 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.112 -0.992 . . . . 64.329999999999998 109.143 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -68.58 147.87 98.06 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 120.954 -1.091 . . . . 70.040000000000006 108.167 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.89 -103.81 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.122 1.882 . . . . 65.109999999999999 113.143 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 120.96 -1.087 . . . . 73.150000000000006 109.979 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptp . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.513 -0.551 . . . . 65.120000000000005 109.513 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -140.4 152.25 45.59 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.332 -0.855 . . . . 72.329999999999998 109.182 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.9 t -116.32 138.83 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.651 -0.656 . . . . 71.420000000000002 109.708 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.546 HD11 ' CG1' ' A' ' 6' ' ' ILE . 2.3 tp -115.87 121.12 41.41 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.462 -0.774 . . . . 65.120000000000005 109.043 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 4' ' ' LEU . 16.9 mt -117.68 107.03 13.71 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.044 -0.725 . . . . 62.43 109.044 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.546 ' CG1' HD11 ' A' ' 4' ' ' LEU . 76.7 mt -98.83 112.66 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.248 -0.907 . . . . 71.150000000000006 108.829 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.429 ' OE1' ' N ' ' A' ' 13' ' ' GLY . 68.8 tt0 -149.49 127.89 12.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.169 -0.957 . . . . 75.340000000000003 109.565 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -62.94 -32.82 74.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.301 -0.874 . . . . 72.439999999999998 109.431 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -82.05 105.26 13.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.274 -0.892 . . . . 63.020000000000003 109.457 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 49.8 m -64.87 -28.19 69.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.9 . . . . 72.340000000000003 109.783 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 66.0 t -63.73 -49.24 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.156 -0.965 . . . . 74.019999999999996 109.795 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.573 HD13 ' OE2' ' A' ' 15' ' ' GLU . 3.5 mm? -69.85 -46.05 66.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.165 -0.959 . . . . 71.430000000000007 109.452 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.429 ' N ' ' OE1' ' A' ' 7' ' ' GLU . . . -66.13 -17.64 66.03 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.4 -1.88 . . . . 61.32 108.4 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.49 -57.59 4.98 Favored Glycine 0 N--CA 1.483 1.776 0 N-CA-C 109.589 -1.405 . . . . 71.200000000000003 109.589 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.573 ' OE2' HD13 ' A' ' 12' ' ' LEU . 13.1 pt-20 -53.0 -46.8 68.5 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.446 -1.032 . . . . 71.319999999999993 109.714 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.4 mm -61.24 -46.36 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.8 -1.187 . . . . 63.229999999999997 108.636 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.507 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 81.1 tt0 -46.54 -52.56 13.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 51.109999999999999 109.752 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -88.89 4.89 46.35 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.168 -0.958 . . . . 73.340000000000003 109.741 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.21 -63.54 1.79 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.958 -1.257 . . . . 62.149999999999999 109.958 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.496 HD23 ' N ' ' A' ' 20' ' ' LEU . 1.8 pt? -72.62 -19.85 61.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.18 -1.188 . . . . 73.510000000000005 110.228 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 86.4 m-20 -52.79 -33.47 49.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.883 -1.136 . . . . 74.25 109.466 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 86.7 t -58.5 -31.92 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 70.040000000000006 109.333 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.415 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 11.5 mptt -74.05 -2.8 25.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 73.230000000000004 109.25 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.84 23.17 43.02 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.074 -1.21 . . . . 75.540000000000006 110.074 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -99.4 158.2 15.89 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.214 -1.168 . . . . 73.430000000000007 109.323 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.3 mtt -101.55 139.59 36.99 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.03 -1.1 . . . . 43.240000000000002 108.03 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.64 152.7 41.69 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.045 -1.035 . . . . 62.109999999999999 110.758 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -135.1 140.92 45.87 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.565 -0.902 . . . . 74.420000000000002 108.565 179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -107.6 138.28 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.357 -0.839 . . . . 72.150000000000006 109.004 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.7 p -134.95 168.86 18.32 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.453 -0.779 . . . . 71.420000000000002 109.491 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.436 ' OE2' ' OD2' ' A' ' 35' ' ' ASP . 4.3 pt-20 -87.41 -102.92 0.07 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.297 -0.877 . . . . 72.329999999999998 109.559 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.0 p -77.46 163.66 26.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.198 -0.939 . . . . 74.239999999999995 109.476 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.515 ' H ' HD12 ' A' ' 33' ' ' LEU . 3.0 mp -58.42 -29.85 66.43 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.45 -0.781 . . . . 71.530000000000001 110.026 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -49.89 -43.57 49.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.036 -1.04 . . . . 74.230000000000004 109.519 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.436 ' OD2' ' OE2' ' A' ' 31' ' ' GLU . 31.9 m-20 -66.8 -42.3 86.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.207 -0.933 . . . . 54.030000000000001 109.053 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.38 -42.54 95.95 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.489 -1.444 . . . . 61.409999999999997 109.489 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -65.73 -37.85 87.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -1.154 . . . . 74.340000000000003 109.336 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.443 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 68.3 t80 -78.64 -21.38 48.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.923 . . . . 75.329999999999998 109.581 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 32.6 tp -90.0 -32.79 16.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.197 -0.939 . . . . 74.329999999999998 109.853 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.445 ' SD ' ' C ' ' A' ' 40' ' ' MET . 3.4 ppp? -78.93 -29.42 44.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.151 -0.968 . . . . 70.319999999999993 110.637 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 31.4 p-10 -58.8 -34.28 71.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.795 -1.191 . . . . 71.219999999999999 109.845 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.541 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 14.7 pt -90.39 -26.42 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.084 -1.01 . . . . 74.140000000000001 110.05 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.434 ' O ' ' O ' ' A' ' 40' ' ' MET . 93.6 mtt180 -127.36 138.9 53.13 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.386 -0.821 . . . . 72.239999999999995 109.41 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -92.66 152.55 19.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.132 -0.98 . . . . 75.420000000000002 109.594 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -133.83 154.44 51.02 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.517 -0.739 . . . . 74.230000000000004 109.254 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -94.44 -43.83 8.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.139 -0.976 . . . . 72.040000000000006 108.899 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.503 HD13 ' C ' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -106.34 108.91 20.65 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.743 -0.836 . . . . 72.129999999999995 108.743 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.445 ' N ' HD13 ' A' ' 47' ' ' LEU . 2.3 m -107.77 105.24 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.297 -1.001 . . . . 72.340000000000003 108.297 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 8.6 ttt -115.18 145.54 42.29 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.511 0.672 . . . . 74.109999999999999 109.556 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.547 HG22 ' H ' ' A' ' 52' ' ' ASP . 1.6 p -144.51 133.16 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.487 -0.758 . . . . 61.119999999999997 110.19 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 t -98.54 4.57 48.2 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.499 -0.751 . . . . 73.109999999999999 109.454 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.547 ' H ' HG22 ' A' ' 50' ' ' VAL . 52.6 m-20 -76.0 142.15 41.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.141 -0.974 . . . . 52.549999999999997 109.377 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 55' ' ' ALA . 67.5 mttm -77.69 -42.76 33.38 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.282 -0.886 . . . . 44.219999999999999 110.647 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -70.63 14.54 0.13 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.027 -1.045 . . . . 70.439999999999998 109.874 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.29 -19.88 59.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 64.140000000000001 110.434 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.0 mt -42.0 -49.06 4.69 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.286 -0.884 . . . . 44.140000000000001 110.606 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.9 p -68.56 -37.85 80.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.954 -1.092 . . . . 55.229999999999997 109.522 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.52 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 70.7 t80 -67.8 -63.57 1.03 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.347 -0.846 . . . . 74.439999999999998 109.914 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.7 m -49.25 -31.72 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.86 -1.15 . . . . 74.030000000000001 109.636 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.3 t -60.6 -53.33 58.77 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.149 -0.97 . . . . 64.299999999999997 109.11 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -67.87 -27.54 66.76 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.687 -1.205 . . . . 64.439999999999998 109.652 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.539 ' O ' ' N ' ' A' ' 66' ' ' HIS . 25.3 mm -56.34 -46.12 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.826 -1.172 . . . . 63.210000000000001 108.409 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -63.72 -40.47 96.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.13 -0.981 . . . . 74.420000000000002 108.354 179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -67.58 -50.85 56.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.385 -0.822 . . . . 70.319999999999993 109.246 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.52 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 91.9 mttt -78.15 -12.09 59.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.603 -0.686 . . . . 75.219999999999999 110.048 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.578 ' O ' HG22 ' A' ' 69' ' ' ILE . 97.9 m-70 -157.69 70.9 0.6 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.211 -0.93 . . . . 74.129999999999995 109.149 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 73.1 p -69.34 -23.9 63.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.199 -0.938 . . . . 73.239999999999995 110.015 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 82.3 p -90.83 49.87 1.72 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.141 -0.974 . . . . 61.009999999999998 110.074 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 66' ' ' HIS . 13.4 tt -143.36 163.87 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.102 -0.998 . . . . 71.329999999999998 109.343 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.417 ' HB ' HD22 ' A' ' 47' ' ' LEU . 46.5 t -93.21 142.16 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.115 -0.991 . . . . 72.129999999999995 108.768 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.462 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 9.8 t -130.55 123.44 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.311 -0.868 . . . . 54.210000000000001 109.36 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 mt -129.6 100.3 5.47 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.533 -0.914 . . . . 50.240000000000002 108.533 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.666 ' O ' HD12 ' A' ' 95' ' ' ILE . 14.9 p -96.12 154.04 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.375 -0.972 . . . . 74.409999999999997 108.375 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.4 m -122.57 171.91 8.77 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 108.78 -0.822 . . . . 72.310000000000002 108.78 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.414 ' C ' ' H ' ' A' ' 77' ' ' ASN . 7.6 p -171.2 121.84 0.54 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.963 -1.085 . . . . 64.540000000000006 110.431 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' NZ ' ' A' ' 53' ' ' LYS . 56.3 p30 -70.65 8.04 0.95 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.501 -0.75 . . . . 74.129999999999995 109.875 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.414 ' H ' ' C ' ' A' ' 75' ' ' SER . 18.7 m120 -137.94 75.39 42.14 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.29 -0.881 . . . . 73.340000000000003 109.489 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -66.92 81.38 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.619 2.213 . . . . 63.219999999999999 111.237 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 81' ' ' GLU . 26.5 m -103.31 151.91 22.16 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.733 -0.84 . . . . 62.530000000000001 108.733 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 p -60.12 -28.84 68.2 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.297 -0.877 . . . . 73.439999999999998 109.773 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.402 ' H ' HG22 ' A' ' 79' ' ' THR . 86.8 tt0 -68.04 -41.54 81.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 71.420000000000002 109.865 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -74.3 -35.47 63.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.115 -0.99 . . . . 73.430000000000007 109.858 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.42 ' OE1' ' HB1' ' B' ' 104' ' ' ALA . 87.4 tt0 -60.17 -54.13 49.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.204 -0.935 . . . . 74.219999999999999 109.941 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 85' ' ' HIS . 34.3 m -61.96 -38.02 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.047 -1.033 . . . . 73.200000000000003 109.439 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.423 ' N ' HG23 ' A' ' 84' ' ' VAL . 19.4 m170 -69.0 -26.48 65.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.151 -0.968 . . . . 53.329999999999998 109.37 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -68.75 -44.33 73.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.143 -0.973 . . . . 64.109999999999999 109.647 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -79.68 -29.19 40.75 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.168 -0.958 . . . . 74.340000000000003 109.084 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 31.4 tp10 -75.18 -51.3 13.72 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.436 -0.79 . . . . 74.420000000000002 109.357 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -58.57 -50.05 75.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.482 -0.761 . . . . 74.239999999999995 109.714 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 147.66 69.1 0.01 OUTLIER Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.107 -1.197 . . . . 61.509999999999998 110.107 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -134.24 135.05 42.67 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.33 -1.1 . . . . 55.329999999999998 109.017 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.462 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 70.2 m-20 -79.66 -36.8 37.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.103 -0.998 . . . . 73.420000000000002 109.031 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -153.33 150.35 28.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.391 -0.818 . . . . 75.040000000000006 109.568 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.512 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -124.25 132.54 53.59 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.722 -0.844 . . . . 71.329999999999998 108.722 179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.825 ' H ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -119.29 137.06 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 CA-C-O 121.66 0.743 . . . . 71.129999999999995 110.061 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.54 120.2 8.96 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 106.922 -1.51 . . . . 64.319999999999993 106.922 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.684 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -41.72 -55.88 5.39 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.161 -0.962 . . . . 62.200000000000003 111.862 -178.134 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 1.8 Cg_endo -39.55 -12.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.14 1.226 . . . . 73.109999999999999 113.02 -175.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.684 ' N ' ' O ' ' A' ' 97' ' ' LYS . 55.4 m-85 59.86 131.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.803 -0.56 . . . . 65.219999999999999 109.835 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 29.6 ttm-85 -72.59 -40.65 66.4 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.754 -1.216 . . . . 72.349999999999994 108.92 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.642 ' O ' ' N ' ' A' ' 103' ' ' LYS . 19.3 m -174.42 43.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.28 -0.887 . . . . 71.319999999999993 110.045 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.447 ' O ' ' N ' ' A' ' 105' ' ' LEU . 10.7 mm 47.47 -80.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 121.374 -0.829 . . . . 75.430000000000007 110.414 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.642 ' N ' ' O ' ' A' ' 101' ' ' SER . 20.3 tptm -43.93 -33.37 1.36 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.238 -0.914 . . . . 71.409999999999997 109.208 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.67 -44.52 96.04 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.408 -0.96 . . . . 63.240000000000002 108.408 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 102' ' ' ILE . 17.2 tp -66.02 -49.37 67.97 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.199 -0.667 . . . . 73.219999999999999 109.199 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 70.2 t -60.18 -40.01 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.119 -0.988 . . . . 60.109999999999999 109.404 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.68 -41.19 73.35 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.112 -0.992 . . . . 70.420000000000002 108.869 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.525 ' O ' ' NE ' ' A' ' 108' ' ' ARG . 0.0 OUTLIER -68.22 -33.95 75.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.403 -0.81 . . . . 74.409999999999997 109.018 179.572 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 88.6 mt -75.2 -29.3 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.168 -0.958 . . . . 62.539999999999999 109.019 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -75.78 -57.43 3.88 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.45 -0.781 . . . . 74.340000000000003 109.471 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -49.65 -45.26 48.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.327 -0.858 . . . . 73.319999999999993 109.335 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 61.6 ttm-85 -64.75 -34.06 77.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.267 -0.895 . . . . 52.409999999999997 109.555 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 37.8 mt -133.52 74.68 1.57 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.393 -0.817 . . . . 65.239999999999995 110.016 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.7 mtm180 -85.64 -77.66 0.29 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.143 -0.973 . . . . 64.450000000000003 108.543 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.44 ' O ' ' O ' ' A' ' 116' ' ' TRP . 18.8 t80 -85.39 -49.73 7.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 74.430000000000007 109.465 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.44 ' O ' ' O ' ' A' ' 115' ' ' PHE . 69.7 t-105 49.85 97.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.366 -0.833 . . . . 74.420000000000002 109.663 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.59 113.06 0.28 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.617 -1.393 . . . . 75.040000000000006 109.617 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 30.8 m -156.07 164.18 38.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -1.154 . . . . 61.140000000000001 109.583 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -158.47 123.43 4.27 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.697 -0.853 . . . . 65.239999999999995 108.697 -178.45 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.414 ' HB ' HD12 ' A' ' 121' ' ' ILE . 46.5 t -79.98 -28.99 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 73.109999999999999 109.795 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.46 HD11 ' HG2' ' A' ' 157' ' ' ARG . 5.3 mp -116.76 140.94 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.345 -0.847 . . . . 72.239999999999995 109.094 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -151.81 140.36 20.66 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.294 -0.878 . . . . 72.340000000000003 108.946 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.446 ' O ' HG23 ' A' ' 123' ' ' ILE . 4.6 tp -160.65 121.23 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.224 -0.923 . . . . 71.439999999999998 109.174 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 60.23 -132.45 50.39 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.183 -1.567 . . . . 73.400000000000006 109.183 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -97.39 3.13 51.09 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.183 -1.187 . . . . 74.450000000000003 109.354 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -91.36 143.07 27.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.12 -0.988 . . . . 54.210000000000001 109.066 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.43 141.64 49.86 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.754 -0.832 . . . . 54.5 108.754 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 65.8 mt -137.85 125.09 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.409 -0.807 . . . . 45.149999999999999 109.125 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 6.2 m -121.56 95.94 47.84 Favored Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 109.356 -0.609 . . . . 71.109999999999999 109.356 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.15 -33.76 2.48 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.976 1.784 . . . . 65.409999999999997 112.099 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -56.43 -46.4 80.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.233 -0.917 . . . . 63.32 108.995 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -87.04 2.63 49.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.32 -0.863 . . . . 72.519999999999996 109.196 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 55.0 72.71 0.46 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 75.329999999999998 109.863 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -161.65 143.51 11.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.349 -0.844 . . . . 71.230000000000004 109.367 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.5 tt -115.54 138.6 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.433 -0.951 . . . . 74.019999999999996 108.433 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.6 mt -126.99 127.13 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 109.055 -0.72 . . . . 60.229999999999997 109.055 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.418 ' O ' ' CD1' ' A' ' 137' ' ' TYR . 45.7 p90 -136.85 135.84 38.23 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.377 -0.827 . . . . 62.32 110.598 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp 55.79 31.02 16.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.515 -0.741 . . . . 75.400000000000006 110.755 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.23 16.81 79.1 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.631 -1.271 . . . . 72.239999999999995 110.911 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 65.4 mtt-85 -112.58 126.21 55.1 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.333 -1.098 . . . . 71.219999999999999 109.553 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -94.01 128.04 40.14 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.489 -0.757 . . . . 71.420000000000002 109.627 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 34.7 t -139.16 141.1 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.359 -0.838 . . . . 53.020000000000003 109.1 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 143' ' ' GLU . 48.6 mp0 -97.11 143.85 27.52 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.248 -0.907 . . . . 60.450000000000003 109.925 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.15 140.5 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.391 -0.818 . . . . 74.439999999999998 109.196 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.34 28.76 0.45 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 65.150000000000006 108.961 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.918 ' O ' ' CD1' ' A' ' 149' ' ' PHE . . . -86.93 -161.25 36.05 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.002 -1.239 . . . . 73.340000000000003 110.002 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.612 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 16.8 mttm -80.8 -38.04 1.0 Allowed Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.493 -1.004 . . . . 72.219999999999999 110.619 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 96.2 Cg_endo -89.46 19.9 1.17 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.456 2.104 . . . . 65.230000000000004 112.613 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.918 ' CD1' ' O ' ' A' ' 146' ' ' GLY . 5.3 p90 -94.81 -55.79 2.99 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.166 -0.959 . . . . 60.109999999999999 109.408 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.693 ' N ' ' CG ' ' A' ' 149' ' ' PHE . 6.1 pt-20 -53.14 -34.45 56.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.458 -0.776 . . . . 64.209999999999994 109.849 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.488 HG13 ' N ' ' A' ' 152' ' ' LEU . 8.3 p -63.03 -41.18 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.002 -1.061 . . . . 72.019999999999996 109.306 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.489 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.2 OUTLIER -63.52 -46.97 83.6 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.898 . . . . 73.310000000000002 108.63 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 27.2 p -67.39 -27.71 67.32 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.111 -0.993 . . . . 74.310000000000002 109.164 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -61.1 -53.96 50.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.883 . . . . 74.310000000000002 109.826 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.684 HD12 ' N ' ' A' ' 156' ' ' ALA . 3.9 pp -69.4 -21.12 63.79 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.025 -1.047 . . . . 75.340000000000003 109.26 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.684 ' N ' HD12 ' A' ' 155' ' ' LEU . . . -65.02 -43.38 92.64 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 62.140000000000001 108.96 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.501 ' C ' ' H ' ' A' ' 159' ' ' ARG . 59.0 mtm180 -77.24 -49.39 15.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 61.030000000000001 109.111 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -71.97 17.54 0.09 Allowed 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.002 -0.679 . . . . 74.120000000000005 109.422 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.501 ' H ' ' C ' ' A' ' 157' ' ' ARG . 35.4 ptt-85 -52.03 156.74 1.47 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.265 -0.897 . . . . 71.129999999999995 109.2 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.455 ' OD1' ' CD2' ' A' ' 216' ' ' TYR . 50.3 m-20 55.08 47.87 20.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.444 -0.785 . . . . 75.450000000000003 109.678 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -155.04 151.68 28.7 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.165 -0.959 . . . . 73.409999999999997 109.512 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.4 mt -89.51 138.37 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.224 -0.922 . . . . 74.409999999999997 109.458 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.6 t -139.43 131.01 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.345 -0.847 . . . . 72.310000000000002 109.317 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 16.2 t -78.25 164.72 24.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 74.120000000000005 109.691 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -63.63 -48.75 76.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.46 -0.775 . . . . 70.430000000000007 109.887 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -56.98 -37.03 71.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 73.519999999999996 110.102 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -53.91 -47.53 71.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.952 -1.092 . . . . 74.519999999999996 109.435 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 51.1 mt -60.27 -44.02 95.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.079 -1.013 . . . . 72.310000000000002 109.524 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 7.0 tp -54.93 -51.18 66.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.367 -0.833 . . . . 53.329999999999998 110.17 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -81.3 -11.75 59.25 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.152 -0.968 . . . . 62.439999999999998 110.685 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.52 -52.89 18.65 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.797 -1.189 . . . . 60.210000000000001 109.973 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.66 HD12 ' N ' ' A' ' 172' ' ' ILE . 1.7 mp -85.18 -36.81 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.147 -0.971 . . . . 75.319999999999993 109.072 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -108.88 74.73 0.92 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.486 -0.758 . . . . 73.140000000000001 109.359 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -86.67 -35.65 19.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.335 -0.853 . . . . 73.239999999999995 109.771 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -74.91 146.17 82.31 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.189 -0.944 . . . . 44.43 109.798 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -42.87 109.6 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.084 1.856 . . . . 72.510000000000005 112.723 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.508 ' O ' ' N ' ' A' ' 179' ' ' VAL . 88.1 mt-10 -151.83 162.93 40.24 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.185 -0.947 . . . . 63.240000000000002 109.391 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 75.7 mtm -64.44 70.14 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 73.5 110.133 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.524 HG23 ' N ' ' A' ' 180' ' ' THR . 26.5 m -85.1 -42.4 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.151 -0.968 . . . . 65.219999999999999 109.205 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.572 ' O ' ' N ' ' A' ' 182' ' ' ASN . 82.4 m 47.73 92.22 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.172 -0.955 . . . . 71.420000000000002 109.342 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -47.37 76.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 122.446 2.097 . . . . 41.219999999999999 112.784 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.572 ' N ' ' O ' ' A' ' 180' ' ' THR . 6.8 t-20 -174.01 -20.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.327 -0.858 . . . . 64.540000000000006 108.788 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 29.4 m -74.94 -14.97 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.344 -0.847 . . . . 74.019999999999996 109.716 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.416 ' O ' HG22 ' A' ' 188' ' ' ILE . 34.5 mt -48.89 -43.17 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.153 -0.967 . . . . 72.329999999999998 109.63 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -53.08 -34.02 54.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.12 -0.988 . . . . 74.400000000000006 109.466 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.32 -49.0 21.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.482 -0.761 . . . . 70.420000000000002 110.179 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.88 96.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.006 -1.059 . . . . 52.109999999999999 110.161 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.479 HG23 ' N ' ' A' ' 189' ' ' ASN . 11.0 tp -66.3 -42.58 91.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 120.936 -1.103 . . . . 71.400000000000006 109.691 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.479 ' N ' HG23 ' A' ' 188' ' ' ILE . 39.2 t30 -62.87 -43.05 99.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.197 -0.94 . . . . 73.439999999999998 109.353 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -65.33 -40.16 93.33 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.37 -0.831 . . . . 71.420000000000002 109.61 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 71.8 mt -65.96 -44.86 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.247 -0.908 . . . . 61.549999999999997 109.793 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -58.7 -38.87 79.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.149 -0.969 . . . . 63.340000000000003 109.712 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -79.15 -26.04 42.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -0.991 . . . . 61.240000000000002 110.336 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -91.07 -16.98 26.97 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.962 -1.087 . . . . 75.129999999999995 110.825 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . 0.568 ' SD ' ' N ' ' A' ' 196' ' ' ASP . 2.2 ppp? -91.72 -41.81 10.5 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.713 -1.242 . . . . 74.019999999999996 110.43 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . 0.568 ' N ' ' SD ' ' A' ' 195' ' ' MET . 26.1 t70 -66.82 -37.04 83.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.934 -1.104 . . . . 74.019999999999996 110.103 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.412 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 0.1 OUTLIER -50.86 -63.54 1.84 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.96 -1.087 . . . . 75.430000000000007 109.156 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 40.8 Cg_endo -65.81 -58.27 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 121.527 1.485 . . . . 72.319999999999993 111.189 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.499 ' C ' ' H ' ' A' ' 201' ' ' ILE . 4.0 mm? -86.16 92.38 8.73 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.29 -1.004 . . . . 74.540000000000006 108.29 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -59.17 -0.22 0.69 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.968 -1.253 . . . . 61.509999999999998 109.968 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.499 ' H ' ' C ' ' A' ' 199' ' ' LEU . 26.0 mm -108.29 130.09 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.379 -1.071 . . . . 61.219999999999999 109.336 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 67.0 m -76.74 146.34 38.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 72.0 109.296 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 15.9 p -139.65 4.49 2.14 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.398 -0.813 . . . . 74.439999999999998 109.354 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 204' ' ' VAL . 7.9 m -120.54 132.05 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.606 -0.684 . . . . 64.349999999999994 109.538 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -103.8 118.33 36.44 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.378 -0.826 . . . . 71.409999999999997 108.914 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 206' ' ' THR . 0.0 OUTLIER -94.11 129.43 40.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.241 -0.912 . . . . 73.519999999999996 109.573 -179.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.507 HG21 HH12 ' A' ' 213' ' ' ARG . 19.9 t -144.54 131.13 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 71.019999999999996 108.944 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -56.78 -31.84 65.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.217 -0.927 . . . . 72.120000000000005 109.684 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.532 ' O ' ' N ' ' A' ' 211' ' ' GLY . 72.9 mtt85 -63.72 137.54 58.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.91 . . . . 64.409999999999997 109.808 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 57.68 -78.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.475 -0.766 . . . . 71.540000000000006 110.026 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . -177.6 -114.94 0.42 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.29 -1.524 . . . . 72.030000000000001 109.29 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -113.24 135.07 54.23 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.426 -1.044 . . . . 75.540000000000006 109.289 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.507 HH12 HG21 ' A' ' 207' ' ' VAL . 21.8 ttp-105 -109.55 139.64 44.31 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.929 -0.767 . . . . 75.310000000000002 108.929 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.442 ' O ' ' SG ' ' A' ' 215' ' ' CYS . 58.7 m-85 -107.62 134.57 50.43 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.425 -0.797 . . . . 75.409999999999997 109.935 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 214' ' ' PHE . 99.3 m -155.02 156.25 35.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.479 -0.763 . . . . 74.140000000000001 109.262 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . 0.455 ' CD2' ' OD1' ' A' ' 160' ' ' ASP . 1.9 p90 -64.74 154.34 85.59 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.193 -0.942 . . . . 75.319999999999993 109.299 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -39.45 151.94 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.232 1.955 . . . . 73.109999999999999 111.943 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.582 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 17.9 mttt -72.16 -39.0 6.14 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.103 -0.998 . . . . 75.25 110.856 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 87.9 Cg_endo -89.1 14.77 2.17 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.409 2.073 . . . . 75.099999999999994 112.466 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -57.03 -35.54 69.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.125 -0.984 . . . . 71.140000000000001 109.197 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 4.6 p -81.43 139.16 35.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.892 . . . . 71.129999999999995 109.347 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' A' ' 222' ' ' GLU . 40.8 mp0 -67.22 -26.98 66.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 75.349999999999994 109.689 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.962 -1.018 . . . . 73.409999999999997 109.47 -179.926 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.589 ' SD ' ' CE2' ' B' ' 25' ' ' PHE . 16.7 ptp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.435 -0.58 . . . . 71.140000000000001 109.435 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.532 ' NH1' ' SD ' ' B' ' 26' ' ' MET . 92.8 mtt-85 -136.62 152.97 51.03 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.387 -0.821 . . . . 73.230000000000004 109.178 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 93.5 t -110.68 133.2 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.525 -0.735 . . . . 72.239999999999995 109.582 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.431 HD11 ' CG1' ' B' ' 6' ' ' ILE . 3.6 tp -105.72 118.22 36.03 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.61 -0.681 . . . . 54.329999999999998 109.686 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.42 ' N ' HD12 ' B' ' 4' ' ' LEU . 15.3 mt -113.3 100.28 8.44 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.708 -0.849 . . . . 74.349999999999994 108.708 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.689 HD12 ' HB ' ' B' ' 50' ' ' VAL . 89.4 mt -86.97 99.66 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.04 -1.038 . . . . 42.549999999999997 109.015 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.447 ' CD ' ' HG ' ' B' ' 51' ' ' SER . 7.0 tp10 -146.69 137.61 24.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.46 -0.775 . . . . 74.519999999999996 108.913 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.524 ' CD ' ' H ' ' B' ' 8' ' ' LYS . 0.0 OUTLIER -78.39 -31.92 48.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 62.549999999999997 109.084 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . 0.4 ' H ' ' HG3' ' B' ' 7' ' ' GLU . 93.3 m-20 -75.45 109.16 8.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.867 . . . . 73.109999999999999 109.552 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 29.3 m -67.43 -27.7 67.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.269 -0.895 . . . . 65.540000000000006 109.668 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 75.5 t -59.11 -52.44 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.236 -0.915 . . . . 75.549999999999997 109.668 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.535 HD13 ' NZ ' ' B' ' 97' ' ' LYS . 91.6 mt -63.28 -35.76 81.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.161 -0.962 . . . . 70.140000000000001 109.402 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.65 -25.02 75.99 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.826 -1.71 . . . . 75.400000000000006 108.826 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.04 -53.05 24.55 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.736 -1.345 . . . . 65.439999999999998 109.736 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -58.96 -47.17 86.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.35 -1.088 . . . . 60.210000000000001 109.97 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 37.0 mm -61.82 -39.23 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.738 -1.226 . . . . 75.150000000000006 108.816 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -55.04 -42.53 72.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.35 -0.844 . . . . 73.010000000000005 109.457 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -87.76 -2.82 58.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.168 -0.957 . . . . 74.299999999999997 109.381 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.63 -53.66 3.16 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 109.91 -1.276 . . . . 70.540000000000006 109.91 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.458 HD21 ' HB2' ' B' ' 27' ' ' ALA . 1.4 pt? -74.29 -19.84 60.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -1.147 . . . . 71.340000000000003 110.016 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -52.83 -32.4 44.12 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.085 -1.009 . . . . 64.409999999999997 109.52 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 97.5 t -61.94 -33.45 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.225 -0.922 . . . . 74.230000000000004 109.159 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' B' ' 110' ' ' GLU . 16.4 mmtp -81.77 -5.4 58.13 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.33 -0.856 . . . . 63.420000000000002 109.18 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.83 19.63 70.02 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.964 -1.254 . . . . 53.43 109.964 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.589 ' CE2' ' SD ' ' B' ' 1' ' ' MET . 7.4 m-85 -92.43 159.68 15.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.162 -1.199 . . . . 71.120000000000005 108.97 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . 0.532 ' SD ' ' NH1' ' B' ' 2' ' ' ARG . 35.6 mtt -100.95 138.0 38.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.271 -0.893 . . . . 75.239999999999995 108.702 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.458 ' HB2' HD21 ' B' ' 20' ' ' LEU . . . -114.22 147.35 39.08 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.51 -0.744 . . . . 72.120000000000005 110.09 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -131.7 134.04 45.49 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.44 -0.948 . . . . 72.310000000000002 108.44 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -109.75 134.55 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.361 -0.837 . . . . 64.430000000000007 109.077 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.9 p -137.23 169.72 17.31 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.497 -0.752 . . . . 65.409999999999997 109.176 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -93.21 -107.34 0.12 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.191 -0.943 . . . . 71.019999999999996 109.679 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 68.2 p -78.75 168.45 19.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.251 -0.906 . . . . 51.109999999999999 109.914 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.414 HD22 ' CG ' ' B' ' 58' ' ' PHE . 47.6 mt -51.53 -30.25 19.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.663 -0.648 . . . . 71.239999999999995 109.907 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -52.72 -51.18 61.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.097 -1.002 . . . . 74.319999999999993 109.772 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.82 -39.2 93.66 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.152 -0.968 . . . . 73.030000000000001 109.428 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.64 -39.39 78.06 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.559 -1.416 . . . . 30.210000000000001 109.559 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -69.06 -38.23 78.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -1.127 . . . . 74.420000000000002 109.874 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -80.6 -38.72 28.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.102 -0.999 . . . . 74.420000000000002 109.918 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 11.1 tp -69.23 -43.49 73.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.216 -0.927 . . . . 75.409999999999997 110.134 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.0 ppp? -66.59 -24.42 66.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.02 -1.05 . . . . 60.409999999999997 109.916 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -61.28 -40.99 96.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.109 -0.995 . . . . 53.229999999999997 110.112 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.46 HD12 ' NH1' ' B' ' 43' ' ' ARG . 17.5 pt -81.25 -30.7 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.076 -1.015 . . . . 71.230000000000004 110.238 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.46 ' NH1' HD12 ' B' ' 42' ' ' ILE . 78.1 mtt85 -129.93 141.22 50.81 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.395 -0.815 . . . . 72.219999999999999 109.623 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -97.18 147.32 24.2 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.282 -0.886 . . . . 63.539999999999999 109.289 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -123.6 145.79 48.66 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.524 -0.735 . . . . 64.349999999999994 109.38 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . 0.458 ' OD2' ' NE1' ' B' ' 116' ' ' TRP . 48.6 t0 -79.68 -42.29 25.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.232 -0.917 . . . . 62.219999999999999 109.355 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.547 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.5 OUTLIER -104.23 115.65 30.78 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.872 -0.788 . . . . 73.120000000000005 108.872 179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.547 ' N ' HD13 ' B' ' 47' ' ' LEU . 72.6 t -99.62 97.24 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.967 -1.123 . . . . 65.109999999999999 107.967 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 19.9 ttt -110.31 134.09 52.62 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.608 0.718 . . . . 73.439999999999998 110.576 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.689 ' HB ' HD12 ' B' ' 6' ' ' ILE . 1.0 OUTLIER -146.98 132.71 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 CA-C-O 121.543 0.687 . . . . 34.5 109.364 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . 0.447 ' HG ' ' CD ' ' B' ' 7' ' ' GLU . 16.8 p -102.11 12.3 37.0 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.465 -0.772 . . . . 73.209999999999994 109.81 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.501 ' H ' HG22 ' B' ' 50' ' ' VAL . 55.9 m-20 -77.14 143.54 39.06 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.158 -0.964 . . . . 70.409999999999997 109.603 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.488 ' C ' ' H ' ' B' ' 55' ' ' ALA . 94.2 mttt -63.79 -37.44 87.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 65.0 109.822 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -71.77 16.07 0.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.935 . . . . 75.209999999999994 109.645 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.488 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -57.19 -40.05 76.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 55.329999999999998 109.818 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.517 HD12 ' N ' ' B' ' 56' ' ' LEU . 10.8 mp -46.98 -42.22 17.6 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.164 -0.96 . . . . 63.140000000000001 109.733 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . 0.434 ' O ' ' NH1' ' B' ' 61' ' ' ARG . 17.5 m -72.62 -43.08 63.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 63.5 109.648 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . 0.414 ' CG ' HD22 ' B' ' 33' ' ' LEU . 50.9 t80 -64.52 -58.01 7.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.29 -0.881 . . . . 72.329999999999998 109.95 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.424 HG23 ' N ' ' B' ' 60' ' ' SER . 14.2 m -53.01 -36.96 25.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.512 -1.368 . . . . 74.540000000000006 109.609 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.424 ' N ' HG23 ' B' ' 59' ' ' VAL . 23.3 t -54.93 -52.15 63.86 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.256 -0.903 . . . . 71.239999999999995 109.6 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.434 ' NH1' ' O ' ' B' ' 57' ' ' SER . 3.9 ptp85 -69.74 -34.09 73.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.117 -0.989 . . . . 74.310000000000002 110.318 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 40.4 mm -69.75 -34.52 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.759 -1.213 . . . . 72.140000000000001 109.924 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -44.36 77.29 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.15 -0.969 . . . . 73.319999999999993 110.231 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.479 ' CG ' ' N ' ' B' ' 65' ' ' LYS . 9.6 pt-20 -79.41 -45.65 19.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.934 -1.104 . . . . 73.120000000000005 110.369 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.479 ' N ' ' CG ' ' B' ' 64' ' ' GLU . 57.9 mttp -66.95 -24.87 66.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.195 -0.941 . . . . 72.439999999999998 109.852 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.584 ' O ' HG22 ' B' ' 69' ' ' ILE . 79.4 m-70 -155.28 64.5 0.63 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.138 -0.976 . . . . 63.310000000000002 109.564 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.426 ' O ' ' N ' ' B' ' 69' ' ' ILE . 8.0 t -56.09 -34.05 65.64 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 73.099999999999994 109.823 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 44.8 t -70.18 47.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.202 -0.936 . . . . 71.530000000000001 109.924 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.584 HG22 ' O ' ' B' ' 66' ' ' HIS . 15.6 tt -145.46 156.35 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.121 -0.987 . . . . 74.400000000000006 109.176 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 31.8 t -93.92 144.95 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.08 -1.012 . . . . 75.120000000000005 109.315 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 25.3 t -131.46 125.32 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.446 -0.784 . . . . 73.200000000000003 110.002 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.549 ' C ' HD23 ' B' ' 72' ' ' LEU . 6.3 tt -121.64 98.06 5.78 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.864 -0.791 . . . . 73.340000000000003 108.864 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.408 HG22 ' N ' ' B' ' 74' ' ' SER . 10.5 p -90.26 156.35 3.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 120.901 -1.124 . . . . 73.5 108.711 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.408 ' N ' HG22 ' B' ' 73' ' ' VAL . 5.9 m -129.45 169.01 15.48 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.385 -0.968 . . . . 64.340000000000003 108.385 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.423 ' C ' ' H ' ' B' ' 77' ' ' ASN . 36.0 t -172.49 125.07 0.49 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.943 -1.098 . . . . 74.530000000000001 110.442 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -76.04 21.57 0.17 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.602 -0.686 . . . . 64.5 109.8 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . 0.423 ' H ' ' C ' ' B' ' 75' ' ' SER . 42.6 t-20 -146.75 58.77 4.62 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.137 -0.977 . . . . 74.25 109.986 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -57.96 83.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.389 2.059 . . . . 74.430000000000007 112.036 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 66.5 p -107.63 160.97 15.28 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.41 -0.959 . . . . 73.120000000000005 108.41 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.3 p -63.2 -22.68 67.02 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.22 -0.925 . . . . 71.010000000000005 109.782 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . 0.438 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 97.2 mt-10 -69.41 -46.53 66.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.099 -1.001 . . . . 63.200000000000003 109.435 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -72.86 -28.06 62.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 73.219999999999999 109.579 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 35.4 tp10 -62.15 -54.05 46.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 74.299999999999997 109.886 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.41 HG23 ' N ' ' B' ' 85' ' ' HIS . 27.2 m -65.89 -38.0 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 73.310000000000002 109.89 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' HIS . . . . . 0.438 ' ND1' ' O ' ' B' ' 81' ' ' GLU . 32.4 m80 -67.05 -35.4 79.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.075 -1.015 . . . . 73.239999999999995 109.778 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.12 -42.12 94.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.965 -1.085 . . . . 55.329999999999998 110.043 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' PHE . . . . . 0.456 ' CE1' ' NH1' ' A' ' 108' ' ' ARG . 52.9 m-85 -81.81 -35.9 28.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.065 -1.022 . . . . 74.140000000000001 109.438 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -71.05 -45.53 63.66 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.302 -0.874 . . . . 64.040000000000006 109.778 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -64.07 -50.46 68.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.087 -1.008 . . . . 72.349999999999994 109.458 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 142.44 73.29 0.03 OUTLIER Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.144 -1.182 . . . . 65.200000000000003 110.144 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -127.83 131.91 49.48 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.394 -1.062 . . . . 52.229999999999997 108.805 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -70.12 -43.07 71.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.99 -1.069 . . . . 73.319999999999993 108.848 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' B' ' 93' ' ' ASP . 13.2 p-10 -154.09 153.95 32.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.528 -0.733 . . . . 72.219999999999999 109.053 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.497 ' CD1' ' C ' ' B' ' 94' ' ' TYR . 0.5 OUTLIER -127.43 125.68 41.02 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 109.056 -0.72 . . . . 64.420000000000002 109.056 -179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.444 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 30.1 mm -114.16 141.18 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-O 121.878 0.847 . . . . 72.230000000000004 110.34 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.36 123.02 16.6 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.337 -1.357 . . . . 25.239999999999998 107.337 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.695 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -43.54 -55.46 8.51 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.129 -0.982 . . . . 64.319999999999993 111.879 -178.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 2.6 Cg_endo -40.44 -10.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.052 1.168 . . . . 63.329999999999998 113.213 -175.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . 0.695 ' N ' ' O ' ' B' ' 97' ' ' LYS . 44.7 m-85 59.03 118.7 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.621 -0.674 . . . . 75.129999999999995 109.539 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -65.07 -41.04 95.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.764 -1.21 . . . . 74.230000000000004 108.82 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . 0.754 ' O ' ' N ' ' B' ' 103' ' ' LYS . 7.3 t -173.87 44.84 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.205 -0.934 . . . . 63.340000000000003 110.739 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 14.0 mm 49.25 -69.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-N 118.717 0.689 . . . . 74.439999999999998 110.563 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.754 ' N ' ' O ' ' B' ' 101' ' ' SER . 1.3 mptm? -53.06 -29.42 30.06 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 107.919 -1.141 . . . . 71.109999999999999 107.919 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.42 ' HB1' ' OE1' ' A' ' 83' ' ' GLU . . . -67.44 -39.84 85.42 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.177 -1.046 . . . . 71.450000000000003 108.177 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 50.7 tp -68.17 -56.53 8.41 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.075 -0.713 . . . . 51.310000000000002 109.075 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 89.0 t -60.96 -40.45 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.225 -0.922 . . . . 65.230000000000004 109.585 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.39 -44.43 65.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.155 -0.965 . . . . 24.32 108.902 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 25.5 tpt85 -64.58 -34.62 78.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.337 -0.852 . . . . 75.310000000000002 109.105 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 72.4 mt -73.63 -30.48 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.216 -0.928 . . . . 54.240000000000002 108.75 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . 0.408 ' OE1' ' NZ ' ' B' ' 23' ' ' LYS . 88.9 tt0 -67.31 -58.69 4.35 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.457 -0.777 . . . . 65.310000000000002 109.311 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.93 -31.11 62.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.279 -0.888 . . . . 72.239999999999995 109.111 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -59.39 -47.18 86.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.251 -0.905 . . . . 72.040000000000006 109.191 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.04 100.9 2.53 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.066 -1.021 . . . . 75.349999999999994 109.585 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 20.3 mtm105 -90.65 -73.25 0.54 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.274 -0.891 . . . . 75.5 108.987 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -68.74 -35.64 77.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.268 -0.895 . . . . 65.329999999999998 109.937 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' TRP . . . . . 0.458 ' NE1' ' OD2' ' B' ' 46' ' ' ASP . 58.1 t90 52.01 84.87 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 74.450000000000003 109.482 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 157.44 131.16 1.29 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.714 -1.355 . . . . 44.210000000000001 109.714 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 26.9 t -164.22 169.0 18.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.35 -1.089 . . . . 71.400000000000006 109.41 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.1 139.21 14.5 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.81 -0.756 . . . . 72.319999999999993 109.031 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 14.7 t -105.52 -45.43 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.465 -0.772 . . . . 75.019999999999996 110.146 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 9.2 mm -100.08 140.82 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.079 -1.013 . . . . 51.409999999999997 109.83 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -148.79 115.33 5.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.227 -0.921 . . . . 71.530000000000001 109.344 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.472 HD13 ' N ' ' B' ' 123' ' ' ILE . 0.0 OUTLIER -134.03 120.34 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.632 -0.877 . . . . 72.430000000000007 108.632 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.48 -139.26 48.7 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.382 -1.487 . . . . 51.229999999999997 109.382 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -88.59 4.42 46.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.197 -1.178 . . . . 74.200000000000003 109.503 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.33 135.48 35.69 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.184 -0.947 . . . . 75.420000000000002 108.591 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 5.7 m -132.8 122.88 25.15 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.452 -0.78 . . . . 74.219999999999999 109.172 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.613 HG21 ' HB1' ' B' ' 156' ' ' ALA . 31.1 mm -114.3 125.67 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.376 -0.827 . . . . 60.329999999999998 109.626 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 61.4 m -111.57 90.16 12.01 Favored Pre-proline 0 N--CA 1.495 1.803 0 N-CA-C 108.862 -0.792 . . . . 72.310000000000002 108.862 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.84 -29.38 8.59 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.667 1.578 . . . . 75.129999999999995 111.93 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -64.59 -43.51 93.58 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.173 -0.955 . . . . 75.230000000000004 108.873 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.3 8.18 37.26 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.356 -0.84 . . . . 72.430000000000007 109.21 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 49.82 62.14 2.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.895 . . . . 75.129999999999995 109.57 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . 0.589 ' C ' HD12 ' B' ' 135' ' ' ILE . 19.3 ttpp -149.77 130.05 13.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.216 -0.927 . . . . 73.219999999999999 109.392 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . 0.589 HD12 ' C ' ' B' ' 134' ' ' LYS . 1.8 mp -108.9 141.24 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.522 -0.736 . . . . 64.140000000000001 109.089 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 25.7 mt -131.12 132.54 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 121.359 -0.838 . . . . 71.219999999999999 110.644 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . 0.509 ' CE2' ' CG2' ' B' ' 135' ' ' ILE . 48.9 m-85 -134.89 133.37 39.58 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.438 -0.789 . . . . 64.219999999999999 109.442 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . 0.779 ' CE ' ' O ' ' B' ' 198' ' ' PRO . 23.0 mttm 55.11 25.12 6.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 72.019999999999996 110.267 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.7 13.34 80.1 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.941 -1.264 . . . . 74.319999999999993 109.941 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -99.79 124.09 44.71 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.3 -1.117 . . . . 75.340000000000003 108.85 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -88.65 131.45 34.98 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.125 -0.984 . . . . 71.230000000000004 109.913 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.5 136.85 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.462 -0.774 . . . . 70.430000000000007 109.299 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -86.16 160.76 19.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.382 -0.824 . . . . 72.430000000000007 109.154 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . 0.563 HG11 HD13 ' B' ' 135' ' ' ILE . 10.3 m -138.18 147.19 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.327 -0.858 . . . . 72.129999999999995 109.693 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 36.4 pttt -176.18 70.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.271 -0.893 . . . . 72.019999999999996 109.872 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 179.99 177.69 48.15 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.545 -1.312 . . . . 42.229999999999997 110.091 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 0.624 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 8.0 mtmm -70.21 -37.28 7.07 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.419 -1.047 . . . . 73.299999999999997 110.388 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 32.5 Cg_exo -58.12 -39.87 81.66 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.061 1.841 . . . . 71.329999999999998 111.898 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -87.56 -22.53 24.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.877 . . . . 74.230000000000004 109.454 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -52.68 -53.03 53.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 72.340000000000003 109.368 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.43 HG13 ' N ' ' B' ' 152' ' ' LEU . 7.6 p -61.5 -38.18 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.239 -0.913 . . . . 73.349999999999994 109.394 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.49 ' O ' ' CD1' ' B' ' 155' ' ' LEU . 33.4 tp -56.37 -36.53 68.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.19 -0.944 . . . . 55.240000000000002 108.586 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.75 -20.37 50.11 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.954 -1.091 . . . . 70.010000000000005 109.357 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . 0.625 ' CE1' ' CE1' ' B' ' 158' ' ' HIS . 16.6 t-160 -68.21 -60.63 2.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.931 -1.106 . . . . 65.319999999999993 109.596 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.923 HD13 ' N ' ' B' ' 156' ' ' ALA . 0.0 OUTLIER -64.91 -24.81 67.64 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.218 -0.926 . . . . 71.540000000000006 108.899 179.469 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . 0.923 ' N ' HD13 ' B' ' 155' ' ' LEU . . . -57.42 -42.46 82.39 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 120.969 -1.082 . . . . 75.319999999999993 108.593 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' B' ' 159' ' ' ARG . 59.8 mtp180 -87.55 -69.23 0.7 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.228 -0.92 . . . . 73.319999999999993 110.997 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . 0.625 ' CE1' ' CE1' ' B' ' 154' ' ' HIS . 10.6 p-80 -67.97 48.08 0.05 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.324 -0.95 . . . . 74.140000000000001 110.158 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' B' ' 157' ' ' ARG . 0.0 OUTLIER -83.78 176.98 8.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.932 -1.105 . . . . 61.409999999999997 108.84 179.276 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 53.0 t0 54.7 43.13 30.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.392 -0.817 . . . . 72.099999999999994 111.288 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -158.67 171.77 19.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.606 -1.309 . . . . 72.25 109.852 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 19.9 mm -73.18 140.47 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.327 -0.858 . . . . 72.310000000000002 109.536 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' B' ' 212' ' ' TYR . 41.0 t -133.59 111.82 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.473 -0.767 . . . . 64.209999999999994 109.343 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 8.9 t -92.22 166.08 12.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.139 -0.976 . . . . 74.219999999999999 109.001 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -59.51 -44.13 93.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.941 -1.099 . . . . 65.310000000000002 108.674 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.59 -24.72 67.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.285 -0.884 . . . . 63.450000000000003 108.956 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -61.06 -51.65 68.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.383 -0.823 . . . . 72.400000000000006 109.692 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 41.6 mt -61.46 -41.68 97.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 72.319999999999993 109.025 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.432 HD21 ' HB2' ' B' ' 174' ' ' GLU . 0.1 OUTLIER -57.4 -67.05 0.36 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.482 -0.762 . . . . 73.340000000000003 109.956 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -59.78 -17.51 36.15 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.936 -0.706 . . . . 72.099999999999994 109.829 -179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . 0.59 ' CB ' ' CE1' ' B' ' 154' ' ' HIS . . . -93.67 -3.8 51.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.801 -1.187 . . . . 62.130000000000003 108.702 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.57 ' O ' ' CG ' ' B' ' 173' ' ' TRP . 96.5 mt -133.06 -80.91 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.495 -0.753 . . . . 71.420000000000002 109.074 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' TRP . . . . . 0.57 ' CG ' ' O ' ' B' ' 172' ' ' ILE . 0.0 OUTLIER 152.61 173.99 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.744 0 CA-C-O 121.73 0.776 . . . . 72.230000000000004 109.314 -179.594 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . 0.432 ' HB2' HD21 ' B' ' 169' ' ' LEU . 71.8 tt0 -165.28 -59.55 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.742 -0.599 . . . . 52.109999999999999 109.706 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . 0.429 ' N ' ' HD2' ' B' ' 176' ' ' PRO . 8.6 tt0 -69.33 -60.05 4.43 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.207 -0.933 . . . . 73.040000000000006 110.113 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' B' ' 175' ' ' GLU . 9.9 Cg_endo -51.2 -33.87 46.28 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.886 1.724 . . . . 74.129999999999995 111.871 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -84.14 4.32 30.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.16 -0.962 . . . . 72.439999999999998 109.246 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 69.3 mtp 49.35 28.64 2.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 63.43 109.227 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -69.45 170.72 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.198 -0.939 . . . . 71.049999999999997 108.897 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 54.8 p -74.83 129.49 83.26 Favored Pre-proline 0 C--N 1.303 -1.451 0 O-C-N 121.159 -0.963 . . . . 62.149999999999999 109.069 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -42.27 158.47 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.804 1.669 . . . . 65.219999999999999 112.466 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 52.02 54.43 10.85 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.224 -0.923 . . . . 72.310000000000002 109.628 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 3.4 p -78.96 -28.64 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.205 -0.934 . . . . 63.32 110.12 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.449 ' O ' HG22 ' B' ' 188' ' ' ILE . 38.8 mm -57.21 -33.93 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.912 -1.117 . . . . 75.030000000000001 111.154 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -61.26 -63.23 1.35 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.924 -1.11 . . . . 64.109999999999999 111.252 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 30.4 m -70.48 -32.75 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.792 -1.193 . . . . 73.0 110.562 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 187' ' ' ALA . . . . . 0.446 ' O ' HD12 ' B' ' 191' ' ' ILE . . . -67.24 -38.03 84.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.958 -1.089 . . . . 61.119999999999997 111.725 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 188' ' ' ILE . . . . . 0.564 HG23 ' N ' ' B' ' 189' ' ' ASN . 10.6 tp -79.62 -46.07 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 119.982 -1.699 . . . . 72.430000000000007 111.222 -178.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 189' ' ' ASN . . . . . 0.564 ' N ' HG23 ' B' ' 188' ' ' ILE . 40.1 m-20 -59.33 -34.05 71.88 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.745 -1.222 . . . . 65.140000000000001 109.802 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -80.79 -51.86 8.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.047 -1.033 . . . . 63.240000000000002 110.0 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . 0.446 HD12 ' O ' ' B' ' 187' ' ' ALA . 68.6 mt -49.76 -36.14 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.265 -0.897 . . . . 74.030000000000001 109.512 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 192' ' ' ARG . . . . . 1.49 HH12 ' CG2' ' B' ' 204' ' ' VAL . 82.6 mtt-85 -72.75 -45.73 57.15 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.756 -0.831 . . . . 72.239999999999995 108.756 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -66.54 -12.12 56.14 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.351 -0.843 . . . . 73.099999999999994 108.949 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -108.47 -13.46 14.84 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.493 -0.754 . . . . 72.109999999999999 110.617 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 35.5 ttm -96.22 -54.67 3.21 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.87 -1.144 . . . . 44.329999999999998 110.362 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -55.89 -27.62 52.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 71.209999999999994 109.701 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . 0.436 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 40.2 mttt -66.3 -65.75 1.59 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.156 -0.965 . . . . 75.209999999999994 110.021 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 198' ' ' PRO . . . . . 0.779 ' O ' ' CE ' ' B' ' 138' ' ' LYS . 17.8 Cg_endo -58.55 -48.21 16.1 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.139 1.893 . . . . 75.319999999999993 112.745 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . 0.43 ' N ' HD12 ' B' ' 199' ' ' LEU . 9.5 mp -75.86 -43.29 46.39 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.98 -1.075 . . . . 72.25 110.048 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 83.43 -9.05 62.57 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.691 -1.364 . . . . 64.530000000000001 109.691 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 31.3 mm -110.25 130.02 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.451 -1.029 . . . . 44.229999999999997 109.481 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 61.3 p -82.58 142.78 31.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.294 -0.879 . . . . 54.009999999999998 109.507 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . 0.419 ' OG1' ' CZ ' ' B' ' 214' ' ' PHE . 57.8 p -149.89 20.8 0.89 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.459 -0.776 . . . . 74.400000000000006 109.46 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 1.49 ' CG2' HH12 ' B' ' 192' ' ' ARG . 1.2 m -135.14 137.51 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.233 -0.917 . . . . 72.120000000000005 109.664 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -125.81 133.5 51.98 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.974 -0.75 . . . . 65.409999999999997 108.974 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' THR . . . . . 0.474 HG23 ' O ' ' B' ' 206' ' ' THR . 9.7 t -101.96 128.66 48.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.211 -0.931 . . . . 71.329999999999998 109.273 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 27.2 m -145.11 155.44 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.124 -0.985 . . . . 63.5 109.753 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -86.24 -13.05 47.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.276 -0.89 . . . . 74.450000000000003 109.815 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 64.7 mtp85 -55.45 -38.26 68.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.125 -0.984 . . . . 74.140000000000001 109.845 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 75.8 mtt-85 -148.44 -50.55 0.16 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.127 -0.983 . . . . 74.430000000000007 109.246 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 169.28 -113.82 0.53 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.455 -1.458 . . . . 64.450000000000003 109.455 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' B' ' 163' ' ' VAL . 65.0 m-85 -109.52 127.0 54.13 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.513 -0.992 . . . . 74.209999999999994 109.563 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 43.4 ttt180 -105.06 121.79 44.52 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.379 -0.826 . . . . 74.030000000000001 109.116 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . 0.906 ' CE2' HD23 ' B' ' 155' ' ' LEU . 8.3 t80 -94.53 118.61 31.94 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.297 -0.877 . . . . 74.340000000000003 109.007 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 35.6 t -119.97 136.58 54.48 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.724 -0.61 . . . . 64.329999999999998 109.633 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -58.89 149.32 65.75 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.275 -1.009 . . . . 70.040000000000006 108.275 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.73 -169.53 0.18 Allowed 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.999 1.799 . . . . 65.109999999999999 111.742 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 6.3 pttm -47.68 153.39 1.08 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.063 -1.023 . . . . 73.150000000000006 109.242 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -38.05 102.1 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 122.444 2.096 . . . . 71.310000000000002 112.713 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -86.75 10.56 15.49 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.149 -0.969 . . . . 75.450000000000003 108.956 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 53.9 m -66.37 140.5 58.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.436 -0.79 . . . . 72.219999999999999 109.621 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -60.81 142.05 56.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.331 -0.856 . . . . 54.530000000000001 109.331 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.001 -1.0 . . . . 71.129999999999995 109.454 179.992 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 tpp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.449 -0.575 . . . . 65.120000000000005 109.449 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.517 ' NH2' ' OD2' ' A' ' 28' ' ' ASP . 33.3 ttt85 -145.43 149.58 34.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.148 -0.97 . . . . 72.329999999999998 109.383 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 82.6 t -115.91 132.56 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 CA-C-O 121.403 0.62 . . . . 71.420000000000002 109.768 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 5' ' ' LEU . 4.1 tp -99.56 115.44 29.38 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.829 -0.804 . . . . 65.120000000000005 108.829 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 4' ' ' LEU . 59.8 tp -114.61 104.01 11.57 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.554 -0.716 . . . . 62.43 109.357 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.6 mt -93.23 112.16 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.854 -1.154 . . . . 71.150000000000006 109.189 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -146.86 134.18 20.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.378 -0.827 . . . . 75.340000000000003 109.153 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.564 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -73.89 -30.63 62.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.957 . . . . 72.439999999999998 109.184 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -83.63 110.58 18.37 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.253 -0.904 . . . . 63.020000000000003 109.347 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.6 m -65.14 -32.82 74.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 72.340000000000003 109.911 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 81.4 t -64.23 -49.49 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 74.019999999999996 109.778 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 41.0 tp -60.93 -37.58 82.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 71.430000000000007 109.38 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.31 -27.88 62.95 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 108.684 -1.767 . . . . 61.32 108.684 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.09 -48.02 79.53 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.345 -1.502 . . . . 71.200000000000003 109.345 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -64.25 -43.54 94.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.389 -1.066 . . . . 71.319999999999993 109.579 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.9 mm -65.35 -38.34 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.837 -1.165 . . . . 63.229999999999997 108.519 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.44 ' CD ' HD21 ' A' ' 21' ' ' ASN . 14.9 tm-20 -61.22 -45.18 95.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.34 -0.85 . . . . 51.109999999999999 109.518 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -86.58 -1.41 57.63 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.138 -0.976 . . . . 73.340000000000003 109.642 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.36 -61.23 1.65 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.02 -1.632 . . . . 62.149999999999999 109.02 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pp -62.3 -29.09 70.19 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.487 -1.008 . . . . 73.510000000000005 109.031 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.44 HD21 ' CD ' ' A' ' 17' ' ' GLU . 86.1 m-20 -51.64 -36.16 45.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 74.25 109.0 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.8 t -53.59 -34.19 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.611 -0.885 . . . . 70.040000000000006 108.611 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.468 ' NZ ' HG21 ' A' ' 106' ' ' VAL . 28.8 mmtm -78.74 -4.83 51.2 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.685 -0.857 . . . . 73.230000000000004 108.685 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.94 44.92 8.7 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.639 -0.984 . . . . 75.540000000000006 110.639 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -119.06 159.68 23.45 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.264 -1.139 . . . . 73.430000000000007 109.017 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.3 mmt -103.65 139.17 39.29 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.541 -0.911 . . . . 43.240000000000002 108.541 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.417 ' O ' ' OD1' ' A' ' 28' ' ' ASP . . . -143.96 160.4 40.89 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.285 -0.884 . . . . 62.109999999999999 109.841 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.517 ' OD2' ' NH2' ' A' ' 2' ' ' ARG . 79.3 m-20 -135.96 149.9 49.06 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.954 -0.758 . . . . 74.420000000000002 108.954 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -110.46 133.92 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.756 -0.831 . . . . 72.150000000000006 108.756 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 p -134.65 168.21 19.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.471 -0.768 . . . . 71.420000000000002 109.42 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -93.09 -106.37 0.12 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.224 -0.922 . . . . 72.329999999999998 109.612 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.8 p -79.8 168.19 19.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.123 -0.986 . . . . 74.239999999999995 109.909 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.7 mt -53.84 -29.98 43.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.465 -0.772 . . . . 71.530000000000001 109.778 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -55.27 -47.97 74.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.108 -0.995 . . . . 74.230000000000004 109.938 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.48 -44.6 70.8 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.096 -1.003 . . . . 54.030000000000001 109.58 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.45 -40.65 86.54 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.589 -1.404 . . . . 61.409999999999997 109.589 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -66.0 -45.42 81.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.304 -1.115 . . . . 74.340000000000003 109.784 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.26 -40.37 74.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.101 -0.999 . . . . 75.329999999999998 109.664 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.656 ' C ' HD23 ' A' ' 39' ' ' LEU . 7.0 tt -70.5 -56.33 6.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.307 -0.871 . . . . 74.329999999999998 110.022 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.49 ' SD ' ' OH ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -55.75 -27.69 52.02 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.129 -0.982 . . . . 70.319999999999993 110.047 -179.096 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -62.36 -37.23 84.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.104 -0.998 . . . . 71.219999999999999 110.111 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.0 pt -91.6 -1.6 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.091 -1.006 . . . . 74.140000000000001 110.416 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 40' ' ' MET . 19.4 mmt85 -130.02 145.77 51.67 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.292 -0.88 . . . . 72.239999999999995 109.73 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -89.43 152.54 21.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.28 -0.888 . . . . 75.420000000000002 108.997 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.49 ' OH ' ' SD ' ' A' ' 40' ' ' MET . 6.4 p90 -153.13 176.52 11.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.072 -1.017 . . . . 74.230000000000004 109.857 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -132.34 -38.7 1.05 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.552 -0.718 . . . . 72.040000000000006 109.832 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.523 HD13 ' C ' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -103.32 112.17 24.92 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.332 -0.855 . . . . 72.129999999999995 109.255 -179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.513 ' N ' HD13 ' A' ' 47' ' ' LEU . 75.1 t -96.53 98.06 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.89 -0.781 . . . . 72.340000000000003 108.89 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.503 ' SD ' ' N ' ' A' ' 50' ' ' VAL . 3.3 tpp -110.08 127.76 55.04 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.626 0.727 . . . . 74.109999999999999 109.143 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.503 ' N ' ' SD ' ' A' ' 49' ' ' MET . 1.6 p -138.71 128.02 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.532 -0.73 . . . . 61.119999999999997 109.64 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.1 m -96.42 5.16 51.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.338 -0.851 . . . . 73.109999999999999 109.521 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.432 ' H ' HG22 ' A' ' 50' ' ' VAL . 54.3 m-20 -76.47 141.41 41.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.129 -0.982 . . . . 52.549999999999997 109.299 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.448 ' C ' ' H ' ' A' ' 55' ' ' ALA . 18.4 pttp -77.69 -38.81 46.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.145 -0.972 . . . . 44.219999999999999 110.453 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -72.17 12.84 0.37 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.015 -1.053 . . . . 70.439999999999998 109.498 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -75.48 -21.02 58.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 64.140000000000001 110.596 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 55' ' ' ALA . 58.7 mt -40.71 -52.45 2.94 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.366 -0.834 . . . . 44.140000000000001 110.428 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -67.02 -32.72 74.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.983 -1.073 . . . . 55.229999999999997 108.908 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.634 ' CE2' HD11 ' A' ' 62' ' ' ILE . 53.4 t80 -66.46 -59.29 3.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.435 -0.791 . . . . 74.439999999999998 109.911 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.5 m -51.67 -34.14 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.561 -1.337 . . . . 74.030000000000001 109.476 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.1 t -58.07 -55.48 34.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.129 -0.982 . . . . 64.299999999999997 109.718 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -64.72 -27.72 69.1 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.08 -1.012 . . . . 64.439999999999998 109.782 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.634 HD11 ' CE2' ' A' ' 58' ' ' PHE . 5.7 mm -65.39 -42.29 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.894 -1.129 . . . . 63.210000000000001 109.886 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 67' ' ' SER . 1.9 mmmm -67.65 -46.99 70.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.169 -0.957 . . . . 74.420000000000002 110.402 -179.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.413 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 14.3 pt-20 -69.91 -41.46 74.63 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.594 -1.316 . . . . 70.319999999999993 109.535 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.413 ' N ' ' CG ' ' A' ' 64' ' ' GLU . 52.1 mtpt -73.85 -22.29 59.81 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.232 -0.917 . . . . 75.219999999999999 109.169 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.612 ' O ' HG22 ' A' ' 69' ' ' ILE . 78.7 m-70 -152.66 64.96 0.8 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.305 -0.872 . . . . 74.129999999999995 109.148 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 63' ' ' LYS . 22.7 t -59.23 -36.21 75.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.172 -0.955 . . . . 73.239999999999995 109.967 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 67.7 p -74.5 50.36 0.41 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.136 -0.978 . . . . 61.009999999999998 109.574 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 66' ' ' HIS . 11.2 tt -145.65 168.38 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.165 -0.959 . . . . 71.329999999999998 109.472 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.6 t -104.11 152.78 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.336 -0.852 . . . . 72.129999999999995 109.154 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.439 ' H ' ' HB2' ' A' ' 92' ' ' ASP . 4.8 t -143.55 120.71 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.15 -0.969 . . . . 54.210000000000001 109.197 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.547 ' HG ' HD11 ' A' ' 95' ' ' ILE . 3.5 mp -119.33 104.64 10.56 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.708 -0.849 . . . . 50.240000000000002 108.708 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 73' ' ' VAL . 13.6 p -94.78 130.71 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.264 -0.898 . . . . 74.409999999999997 109.148 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.6 p -90.85 165.48 13.59 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.152 -0.967 . . . . 72.310000000000002 108.923 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.442 ' C ' ' H ' ' A' ' 77' ' ' ASN . 11.8 m -159.53 115.65 2.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.031 -1.043 . . . . 64.540000000000006 109.91 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 49.9 p30 -72.64 11.23 0.67 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.376 -0.827 . . . . 74.129999999999995 109.128 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 79' ' ' THR . 4.4 t-20 -142.28 64.09 16.15 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.472 -0.767 . . . . 73.340000000000003 109.455 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.97 83.83 0.02 OUTLIER 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.027 1.818 . . . . 63.219999999999999 111.716 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.488 ' N ' ' O ' ' A' ' 77' ' ' ASN . 28.5 p -115.38 156.6 25.26 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.194 -0.669 . . . . 62.530000000000001 109.194 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.2 t -64.64 -38.87 92.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.308 -0.87 . . . . 73.439999999999998 109.596 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.403 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 85.8 tt0 -55.41 -44.79 76.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 71.420000000000002 109.386 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.6 tt0 -74.55 -30.51 61.78 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.144 -0.973 . . . . 73.430000000000007 109.478 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -63.06 -57.37 10.86 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.299 -0.875 . . . . 74.219999999999999 109.799 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.493 HG23 ' N ' ' A' ' 85' ' ' HIS . 30.0 m -58.91 -42.85 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.109 -0.994 . . . . 73.200000000000003 109.343 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.493 ' N ' HG23 ' A' ' 84' ' ' VAL . 24.2 m170 -63.51 -21.05 66.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.21 -0.932 . . . . 53.329999999999998 109.583 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -76.18 -48.74 19.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.076 -1.015 . . . . 64.109999999999999 110.024 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.57 ' CE2' ' CZ ' ' B' ' 108' ' ' ARG . 86.0 m-85 -81.0 -28.42 35.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.026 -1.046 . . . . 74.340000000000003 109.351 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -73.69 -42.73 60.88 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.223 -0.923 . . . . 74.420000000000002 109.689 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -68.61 -50.47 51.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.082 -1.011 . . . . 74.239999999999995 109.711 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.56 64.47 0.01 OUTLIER Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.138 -1.185 . . . . 61.509999999999998 110.138 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -130.33 141.15 50.6 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.393 -1.063 . . . . 55.329999999999998 109.046 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.439 ' HB2' ' H ' ' A' ' 71' ' ' VAL . 0.9 OUTLIER -79.71 -39.19 31.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.086 -1.009 . . . . 73.420000000000002 109.562 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 71.2 m-20 -152.44 164.39 37.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.263 -0.898 . . . . 75.040000000000006 109.532 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.71 129.69 24.92 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.665 -0.865 . . . . 71.329999999999998 108.665 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.809 HD12 ' N ' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -124.02 145.42 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 121.444 0.64 . . . . 71.129999999999995 110.066 -178.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.01 130.21 44.49 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.176 -1.046 . . . . 64.319999999999993 108.176 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.655 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -51.42 -54.03 43.27 Favored Pre-proline 0 C--N 1.302 -1.465 0 O-C-N 121.056 -1.028 . . . . 62.200000000000003 111.506 -179.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.7 Cg_endo -42.13 -11.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.228 0 CA-C-N 119.681 0.922 . . . . 73.109999999999999 112.558 -176.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.655 ' N ' ' O ' ' A' ' 97' ' ' LYS . 57.9 m-85 59.94 135.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.859 -0.525 . . . . 65.219999999999999 110.009 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 44.1 mtt-85 -73.7 -45.06 54.54 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.083 -1.011 . . . . 72.349999999999994 109.86 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.732 ' O ' ' N ' ' A' ' 103' ' ' LYS . 42.4 t -164.41 32.56 0.07 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.838 -1.164 . . . . 71.319999999999993 111.201 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.0 mm 52.42 -70.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.494 -0.754 . . . . 75.430000000000007 110.168 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.732 ' N ' ' O ' ' A' ' 101' ' ' SER . 13.8 mptt -57.86 -26.64 62.35 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.006 -1.109 . . . . 71.409999999999997 108.006 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.53 -46.67 46.28 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.853 -0.739 . . . . 63.240000000000002 109.697 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.7 tp -63.32 -58.72 6.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.935 . . . . 73.219999999999999 109.615 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.486 HG23 ' N ' ' A' ' 107' ' ' ALA . 9.1 m -52.22 -40.94 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.966 -1.084 . . . . 60.109999999999999 109.471 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.486 ' N ' HG23 ' A' ' 106' ' ' VAL . . . -55.71 -43.09 76.18 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.134 -0.979 . . . . 70.420000000000002 108.557 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -64.08 -30.89 71.93 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.357 -0.839 . . . . 74.409999999999997 109.069 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 55.6 mt -71.36 -35.2 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 107.969 -1.123 . . . . 62.539999999999999 107.969 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 114' ' ' ARG . 81.6 tt0 -62.39 -34.57 76.99 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.097 -0.705 . . . . 74.340000000000003 109.097 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.523 ' HB1' ' CE1' ' B' ' 87' ' ' PHE . . . -76.36 -59.73 2.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 73.319999999999993 109.654 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.412 ' H ' ' HD2' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -57.97 -9.71 1.47 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.286 -0.884 . . . . 52.409999999999997 109.483 -179.766 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 16.6 tp -140.53 82.48 1.85 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.213 -0.929 . . . . 65.239999999999995 109.84 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.424 ' CG ' ' O ' ' A' ' 110' ' ' GLU . 2.1 mmt180 -152.05 -50.11 0.11 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.318 -0.864 . . . . 64.450000000000003 108.897 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -89.34 14.14 11.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.282 -0.886 . . . . 74.430000000000007 110.001 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.406 ' O ' ' CG ' ' A' ' 116' ' ' TRP . 34.9 p-90 -68.08 125.33 26.0 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.057 -1.027 . . . . 74.420000000000002 109.721 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.409 ' O ' ' OG ' ' A' ' 118' ' ' SER . . . 139.79 135.62 3.27 Favored Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.186 -1.565 . . . . 75.040000000000006 109.186 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 117' ' ' GLY . 69.1 m -166.35 171.02 12.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.071 -1.252 . . . . 61.140000000000001 110.1 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.08 103.31 2.2 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.726 -0.842 . . . . 65.239999999999995 108.726 -178.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 97.4 t -72.04 -29.67 33.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.087 -1.008 . . . . 73.109999999999999 109.132 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.0 mp -128.15 131.5 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.603 -0.888 . . . . 72.239999999999995 108.603 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -149.12 128.4 12.91 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.129 -0.982 . . . . 72.340000000000003 109.542 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.864 HG21 ' NH1' ' A' ' 159' ' ' ARG . 9.3 tp -161.39 136.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.309 -0.869 . . . . 71.439999999999998 109.499 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 126' ' ' LEU . . . 59.13 -167.03 7.65 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.878 -1.289 . . . . 73.400000000000006 109.878 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -70.67 12.29 0.28 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.511 -0.993 . . . . 74.450000000000003 108.83 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.534 ' H ' ' C ' ' A' ' 124' ' ' GLY . 1.9 tt -110.06 131.2 55.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.698 -0.626 . . . . 54.210000000000001 109.514 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.8 p -131.0 142.87 50.38 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.325 -0.859 . . . . 54.5 108.716 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.46 HG21 ' CB ' ' A' ' 156' ' ' ALA . 94.6 mt -136.67 135.4 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.164 -0.96 . . . . 45.149999999999999 110.661 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.1 m -127.46 104.1 22.05 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.359 -0.978 . . . . 71.109999999999999 108.359 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.33 -25.38 2.65 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.475 2.116 . . . . 65.409999999999997 112.206 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -66.06 -38.46 88.37 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.307 -0.871 . . . . 63.32 108.843 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -98.08 9.06 43.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.375 -0.828 . . . . 72.519999999999996 109.64 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.675 ' HA ' ' HZ ' ' A' ' 149' ' ' PHE . 37.7 mt-10 47.72 60.48 3.5 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.206 -0.934 . . . . 75.329999999999998 109.617 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.512 ' C ' HD12 ' A' ' 135' ' ' ILE . 36.0 ttpt -154.03 130.6 10.67 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.047 -1.033 . . . . 71.230000000000004 110.098 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.561 HD12 ' N ' ' A' ' 135' ' ' ILE . 2.2 mp -111.89 138.22 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 108.488 -0.93 . . . . 74.019999999999996 108.488 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 19.4 mt -125.72 131.54 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.409 -0.807 . . . . 60.229999999999997 108.9 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.417 ' CE2' ' O ' ' A' ' 198' ' ' PRO . 10.3 p90 -139.12 139.22 37.58 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.099 -1.001 . . . . 62.32 109.984 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 87.1 mttt 53.73 27.87 7.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.522 -0.737 . . . . 75.400000000000006 110.175 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 77.88 14.08 82.73 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.905 -1.14 . . . . 72.239999999999995 110.437 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 -105.27 133.13 50.54 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.472 -1.016 . . . . 71.219999999999999 108.78 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -90.82 129.3 36.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.322 -0.861 . . . . 71.420000000000002 110.224 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 1.9 t -128.14 108.63 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.357 -0.979 . . . . 53.020000000000003 108.357 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -92.48 102.07 14.52 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.054 -1.091 . . . . 60.450000000000003 108.054 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.514 HG23 ' CD1' ' A' ' 149' ' ' PHE . 1.3 m -115.61 139.76 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.7 0.762 . . . . 74.439999999999998 110.705 -178.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -160.53 125.39 3.77 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.856 -0.794 . . . . 65.150000000000006 108.856 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.37 -143.18 10.06 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.674 -1.37 . . . . 73.340000000000003 109.674 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -70.91 -59.27 3.64 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.346 -1.09 . . . . 72.219999999999999 110.486 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.84 4.9 1.23 Allowed 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.997 1.798 . . . . 65.230000000000004 112.785 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.675 ' HZ ' ' HA ' ' A' ' 133' ' ' GLU . 65.3 t80 -101.66 -54.82 2.65 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.234 -0.916 . . . . 60.109999999999999 110.319 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.634 ' OE2' ' OE2' ' A' ' 177' ' ' GLU . 7.9 pt-20 -46.98 -36.0 7.24 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.158 -0.964 . . . . 64.209999999999994 109.574 -178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.8 p -78.82 -31.26 15.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.169 -0.957 . . . . 72.019999999999996 109.137 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.532 HD11 ' SD ' ' A' ' 195' ' ' MET . 13.8 tp -63.56 -38.81 92.53 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.127 -0.983 . . . . 73.310000000000002 109.039 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 14.1 p -75.91 -32.75 59.76 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.08 -1.013 . . . . 74.310000000000002 108.592 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.487 ' CD2' ' HE1' ' A' ' 158' ' ' HIS . 44.4 t-80 -55.13 -51.01 67.81 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.607 -0.683 . . . . 74.310000000000002 110.5 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.92 -33.41 65.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.988 -1.07 . . . . 75.340000000000003 109.887 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.46 ' CB ' HG21 ' A' ' 128' ' ' ILE . . . -50.45 -44.62 55.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.981 -1.074 . . . . 62.140000000000001 109.683 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 -77.66 -43.75 30.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.091 -1.006 . . . . 61.030000000000001 110.234 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.487 ' HE1' ' CD2' ' A' ' 154' ' ' HIS . 22.1 m170 -82.54 34.89 0.44 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 74.120000000000005 110.803 -178.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.864 ' NH1' HG21 ' A' ' 123' ' ' ILE . 30.8 ttp180 -64.61 169.28 5.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.807 -1.183 . . . . 71.129999999999995 107.927 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.408 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 4.4 p30 41.44 55.68 3.38 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.378 -0.826 . . . . 75.450000000000003 110.082 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -158.4 156.14 29.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 73.409999999999997 109.132 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.624 HD12 ' N ' ' A' ' 162' ' ' ILE . 2.5 mp -83.71 123.1 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.177 -0.952 . . . . 74.409999999999997 108.463 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 48.2 t -118.05 127.67 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.486 -0.759 . . . . 72.310000000000002 110.051 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.8 t -100.69 148.02 25.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.519 -0.738 . . . . 74.120000000000005 109.558 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -49.41 -49.75 43.52 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.482 -0.761 . . . . 70.430000000000007 109.816 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -51.88 -36.93 50.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.069 -1.02 . . . . 73.519999999999996 109.476 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -59.03 -43.35 91.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.976 -1.078 . . . . 74.519999999999996 109.115 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 18.5 mt -56.14 -37.22 69.2 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.245 -0.909 . . . . 72.310000000000002 108.549 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.603 HD21 ' CG1' ' A' ' 184' ' ' ILE . 92.8 mt -64.73 -74.68 0.1 Allowed 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 118.566 -1.254 . . . . 53.329999999999998 109.019 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -45.92 -14.43 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.885 . . . . 62.439999999999998 110.516 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 169' ' ' LEU . . . -93.42 -37.54 11.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.063 -1.023 . . . . 60.210000000000001 111.428 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.416 ' N ' ' CD1' ' A' ' 172' ' ' ILE . 1.4 mp -95.42 -56.58 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 120.954 -1.091 . . . . 75.319999999999993 110.446 -178.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -82.52 143.88 30.79 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.406 -1.434 . . . . 73.140000000000001 109.229 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -172.27 -28.46 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.716 -0.615 . . . . 73.239999999999995 109.352 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.796 ' H ' ' CD ' ' A' ' 176' ' ' PRO . 13.5 tp10 -149.3 -38.76 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.204 -0.935 . . . . 44.43 111.133 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.796 ' CD ' ' H ' ' A' ' 175' ' ' GLU . 96.1 Cg_endo -95.23 -71.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.319 -1.0 0 C-N-CA 122.652 2.235 . . . . 72.510000000000005 112.6 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.634 ' OE2' ' OE2' ' A' ' 150' ' ' GLU . 47.9 mt-10 -59.23 155.59 13.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.213 -0.93 . . . . 63.240000000000002 109.657 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.426 ' O ' ' O ' ' A' ' 179' ' ' VAL . 17.0 ptt? -123.24 -5.64 8.33 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.034 -0.728 . . . . 73.5 109.034 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 178' ' ' MET . 3.3 t 48.96 99.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.47 -0.769 . . . . 65.219999999999999 110.442 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -56.05 163.38 2.28 Favored Pre-proline 0 N--CA 1.49 1.526 0 N-CA-C 107.657 -1.238 . . . . 71.420000000000002 107.657 178.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -37.84 -22.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.344 2.03 . . . . 41.219999999999999 112.352 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' A' ' 180' ' ' THR . 35.3 p-10 -156.42 119.39 4.15 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.206 -0.934 . . . . 64.540000000000006 109.292 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.3 t -145.34 -31.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.235 -0.916 . . . . 74.019999999999996 110.176 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.875 HD12 ' H ' ' A' ' 184' ' ' ILE . 2.4 mp -57.85 -34.82 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.065 -1.022 . . . . 72.329999999999998 109.898 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -52.82 -50.05 64.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.242 -0.911 . . . . 74.400000000000006 109.641 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 186' ' ' VAL . 16.7 m -77.8 -31.08 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.18 -0.95 . . . . 70.420000000000002 109.961 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.58 -51.08 68.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.926 -1.109 . . . . 52.109999999999999 109.915 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.424 HG23 ' N ' ' A' ' 189' ' ' ASN . 3.5 tp -68.03 -43.27 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.879 -1.138 . . . . 71.400000000000006 110.032 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.467 ' ND2' ' OE1' ' A' ' 193' ' ' GLN . 7.9 t-20 -60.38 -37.93 82.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.895 -1.128 . . . . 73.439999999999998 108.676 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -71.93 -50.87 25.37 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.551 -0.718 . . . . 71.420000000000002 110.618 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 69.5 mt -52.7 -58.5 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.053 -1.029 . . . . 61.549999999999997 109.914 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.421 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 3.3 mtp85 -51.14 -41.92 60.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.075 -1.016 . . . . 63.340000000000003 109.008 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.467 ' OE1' ' ND2' ' A' ' 189' ' ' ASN . 16.4 mt-30 -71.02 -24.05 62.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.995 -1.066 . . . . 61.240000000000002 109.932 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.447 ' O ' ' CG ' ' A' ' 198' ' ' PRO . 4.7 mtpm? -101.0 -0.27 36.81 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.289 -0.882 . . . . 75.129999999999995 110.573 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . 0.532 ' SD ' HD11 ' A' ' 152' ' ' LEU . 0.6 OUTLIER -109.15 -19.11 13.46 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.2 -0.937 . . . . 74.019999999999996 110.02 -179.367 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 192' ' ' ARG . 14.0 p-10 -98.28 -5.28 33.4 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.158 -0.964 . . . . 74.019999999999996 110.164 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.485 ' H ' ' HD2' ' A' ' 198' ' ' PRO . 26.9 mttp -103.23 -64.86 0.05 OUTLIER Pre-proline 0 N--CA 1.502 2.125 0 O-C-N 121.355 -0.84 . . . . 75.430000000000007 110.575 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.485 ' HD2' ' H ' ' A' ' 197' ' ' LYS . 29.9 Cg_endo -61.42 -57.41 0.58 Allowed 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 121.966 1.777 . . . . 72.319999999999993 112.013 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.9 mp -69.55 -43.11 73.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.257 -0.902 . . . . 74.540000000000006 109.383 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 94.3 -26.97 14.8 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.254 -1.138 . . . . 61.509999999999998 110.254 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.755 ' N ' HD12 ' A' ' 201' ' ' ILE . 3.1 mp -98.68 133.54 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.97 -1.312 . . . . 61.219999999999999 110.289 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 14.6 m -106.14 139.18 41.07 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.118 -1.067 . . . . 72.0 108.118 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.4 p -141.58 42.96 1.74 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.063 -1.023 . . . . 74.439999999999998 110.128 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.529 ' CG1' ' CE2' ' A' ' 214' ' ' PHE . 1.0 OUTLIER -143.11 155.06 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.28 -0.888 . . . . 64.349999999999994 109.727 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -128.34 134.1 48.8 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.712 -0.847 . . . . 71.409999999999997 108.712 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.4 t -95.1 133.28 39.08 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.046 -1.034 . . . . 73.519999999999996 109.259 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 10.5 p -156.25 142.78 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.787 -1.196 . . . . 71.019999999999996 109.531 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -64.85 -41.06 96.01 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.379 -0.825 . . . . 72.120000000000005 109.539 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 1.077 HH21 ' NH2' ' A' ' 213' ' ' ARG . 0.8 OUTLIER -58.12 152.8 16.07 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.824 -0.806 . . . . 64.409999999999997 108.824 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 209' ' ' ARG . 9.6 mpt_? 42.9 -94.17 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.23 -0.919 . . . . 71.540000000000006 109.789 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . -171.42 -114.09 0.31 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.469 -1.452 . . . . 72.030000000000001 109.469 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -111.06 140.34 45.68 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.478 -1.013 . . . . 75.540000000000006 109.055 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 1.077 ' NH2' HH21 ' A' ' 209' ' ' ARG . 36.6 mtt180 -105.51 142.65 34.88 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.319 -0.863 . . . . 75.310000000000002 109.677 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.529 ' CE2' ' CG1' ' A' ' 204' ' ' VAL . 33.8 m-85 -115.78 112.83 22.58 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.49 -0.93 . . . . 75.409999999999997 108.49 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 8.2 p -119.35 160.6 21.96 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.628 -0.67 . . . . 74.140000000000001 109.847 -179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . 0.462 ' CD1' ' O ' ' A' ' 217' ' ' PRO . 36.7 p90 -68.92 151.1 97.42 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.394 -0.816 . . . . 75.319999999999993 109.229 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.462 ' O ' ' CD1' ' A' ' 216' ' ' TYR . 84.4 Cg_exo -37.07 154.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.28 1.987 . . . . 73.109999999999999 112.253 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.647 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 19.0 pttm -98.56 -19.06 0.21 Allowed Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.171 -0.956 . . . . 75.25 112.965 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 49.3 Cg_endo -87.57 -15.38 3.42 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 121.622 1.548 . . . . 75.099999999999994 112.346 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -51.06 -36.67 41.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.466 -0.771 . . . . 71.140000000000001 110.011 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 2.0 p -60.05 135.53 57.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.012 -1.055 . . . . 71.129999999999995 109.609 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -93.45 -160.99 0.8 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.327 -0.858 . . . . 75.349999999999994 109.671 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.983 -1.008 . . . . 73.409999999999997 109.374 -179.877 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.527 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.435 -0.58 . . . . 71.140000000000001 109.435 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.557 HH21 ' C ' ' B' ' 44' ' ' ASN . 8.1 ttp180 -139.89 150.38 44.53 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.357 -0.84 . . . . 73.230000000000004 109.067 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 92.6 t -116.03 129.93 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.537 -0.912 . . . . 72.239999999999995 108.537 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.582 HD21 HD11 ' B' ' 6' ' ' ILE . 5.5 tp -101.89 118.34 36.72 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.513 -0.742 . . . . 54.329999999999998 110.002 -178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 16.4 mt -114.6 111.28 21.09 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 108.412 -0.958 . . . . 74.349999999999994 108.412 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.656 HD12 ' HB ' ' B' ' 50' ' ' VAL . 66.3 mt -107.94 115.4 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.417 -0.802 . . . . 42.549999999999997 109.246 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' B' ' 7' ' ' GLU . 1.4 pm0 -160.08 140.74 12.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.897 . . . . 74.519999999999996 109.417 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -63.68 -31.15 72.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -0.937 . . . . 62.549999999999997 109.319 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -86.5 106.97 17.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.252 -0.905 . . . . 73.109999999999999 109.524 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 47.8 m -72.44 -29.14 63.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.914 . . . . 65.540000000000006 109.847 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 90.9 t -56.79 -49.97 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.155 -0.965 . . . . 75.549999999999997 109.657 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.519 ' N ' HD22 ' B' ' 12' ' ' LEU . 3.6 mm? -63.02 -35.21 79.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 70.140000000000001 109.188 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.78 -25.47 74.89 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 108.635 -1.786 . . . . 75.400000000000006 108.635 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.79 -54.13 27.05 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.36 -1.496 . . . . 65.439999999999998 109.36 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -57.42 -46.27 83.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.4 -1.059 . . . . 60.210000000000001 109.68 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 37.5 mm -62.52 -38.88 82.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.866 -1.146 . . . . 75.150000000000006 108.652 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.423 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 80.0 tt0 -61.79 -43.1 99.53 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.408 -0.807 . . . . 73.010000000000005 109.508 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -87.66 2.6 50.57 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.186 -0.946 . . . . 74.299999999999997 109.177 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.76 -55.95 2.06 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.457 -1.457 . . . . 70.540000000000006 109.457 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -71.44 -21.99 61.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.242 -1.151 . . . . 71.340000000000003 109.633 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 88.0 m-20 -52.44 -33.91 46.24 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.215 -0.928 . . . . 64.409999999999997 109.646 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 81.8 t -59.51 -32.71 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.152 -0.968 . . . . 74.230000000000004 109.212 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 31.3 mmtt -79.23 -4.79 52.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.358 -0.839 . . . . 63.420000000000002 109.193 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.17 36.35 18.21 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.264 -1.135 . . . . 53.43 110.264 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -113.76 160.01 19.14 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.463 -1.022 . . . . 71.120000000000005 108.938 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.4 mmt -107.14 140.49 39.91 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.386 -0.821 . . . . 75.239999999999995 109.09 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.02 164.74 26.95 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.491 -0.755 . . . . 72.120000000000005 109.499 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -141.24 145.58 35.75 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.372 -0.83 . . . . 72.310000000000002 108.964 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 m -113.63 137.14 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.785 . . . . 64.430000000000007 109.068 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 10.0 p -144.56 164.47 30.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.288 -0.883 . . . . 65.409999999999997 109.367 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.447 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 1.6 pt-20 -91.57 -97.24 0.12 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.242 -0.911 . . . . 71.019999999999996 109.579 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 42.4 t -79.48 166.59 21.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.192 -0.942 . . . . 51.109999999999999 109.96 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' B' ' 37' ' ' GLU . 16.7 mt -55.25 -32.0 61.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.592 -0.693 . . . . 71.239999999999995 110.134 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -54.3 -44.86 72.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.09 -1.006 . . . . 74.319999999999993 110.2 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.447 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 19.0 m-20 -66.34 -42.96 87.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.051 -1.031 . . . . 73.030000000000001 109.651 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.58 -28.48 59.38 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.629 -1.388 . . . . 30.210000000000001 109.629 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' B' ' 33' ' ' LEU . 84.7 tt0 -67.18 -46.79 72.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -1.15 . . . . 74.420000000000002 109.695 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . 0.443 ' O ' ' OD1' ' B' ' 41' ' ' ASP . 70.2 t80 -75.06 -26.59 59.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.258 -0.901 . . . . 74.420000000000002 110.036 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 9.6 tp -84.84 -30.86 24.17 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.17 -0.956 . . . . 75.409999999999997 110.031 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . 0.489 ' SD ' ' OH ' ' B' ' 45' ' ' TYR . 0.0 OUTLIER -86.83 -30.61 21.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.163 -0.961 . . . . 60.409999999999997 110.317 -179.13 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' B' ' 42' ' ' ILE . 56.2 p-10 -71.07 -21.4 62.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.878 -1.139 . . . . 53.229999999999997 110.043 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.528 ' N ' ' OD1' ' B' ' 41' ' ' ASP . 12.5 pt -80.94 -29.95 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.03 -1.044 . . . . 71.230000000000004 110.005 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.485 ' C ' ' NH2' ' B' ' 2' ' ' ARG . 26.2 mmt180 -129.13 171.13 12.71 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.376 -0.828 . . . . 72.219999999999999 109.791 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . 0.557 ' C ' HH21 ' B' ' 2' ' ' ARG . 24.5 m120 -98.87 154.21 18.21 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.076 -1.015 . . . . 63.539999999999999 109.809 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.586 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 1.3 p90 -140.52 -177.36 5.01 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.353 -0.842 . . . . 64.349999999999994 109.09 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . 0.443 ' OD2' ' CD1' ' B' ' 116' ' ' TRP . 63.4 t0 -133.28 -43.6 0.85 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.253 -0.904 . . . . 62.219999999999999 110.256 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.533 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.5 OUTLIER -102.01 114.51 28.68 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.276 -0.89 . . . . 73.120000000000005 109.082 -179.597 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.533 ' N ' HD13 ' B' ' 47' ' ' LEU . 50.6 t -98.63 97.37 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.238 -1.023 . . . . 65.109999999999999 108.238 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.457 ' O ' ' O ' ' B' ' 4' ' ' LEU . 22.5 ttt -111.82 130.37 55.83 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.716 0.769 . . . . 73.439999999999998 109.891 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.656 ' HB ' HD12 ' B' ' 6' ' ' ILE . 0.4 OUTLIER -145.8 137.84 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.358 -0.839 . . . . 34.5 109.491 -179.579 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 42.8 p -102.53 2.94 36.92 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.579 -0.701 . . . . 73.209999999999994 109.788 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.412 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 27.4 m-20 -76.41 134.29 39.65 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.147 -0.97 . . . . 70.409999999999997 109.377 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' B' ' 55' ' ' ALA . 62.6 mttp -70.24 -37.79 75.05 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.275 -0.891 . . . . 65.0 110.46 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -69.96 6.71 1.13 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.969 -1.082 . . . . 75.209999999999994 109.703 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.418 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -75.35 -22.5 57.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 55.329999999999998 110.346 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 42.0 mt -44.46 -39.59 4.89 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.328 -0.857 . . . . 63.140000000000001 110.048 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 83.8 p -76.88 -37.39 55.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.041 -1.037 . . . . 63.5 109.466 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -66.08 -42.87 88.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.387 -0.821 . . . . 72.329999999999998 110.148 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.406 HG23 ' N ' ' B' ' 60' ' ' SER . 35.9 m -68.17 -37.74 78.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 120.68 -1.262 . . . . 74.540000000000006 109.121 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.406 ' N ' HG23 ' B' ' 59' ' ' VAL . 9.5 t -53.84 -49.61 68.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 71.239999999999995 109.472 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -68.32 -35.6 78.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.138 -0.976 . . . . 74.310000000000002 110.069 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 5.4 mm -63.22 -39.35 84.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.806 -1.184 . . . . 72.140000000000001 109.903 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' B' ' 67' ' ' SER . 6.9 mtpm? -67.13 -50.97 59.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.076 -1.015 . . . . 73.319999999999993 110.42 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -69.32 -38.19 78.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.852 -1.155 . . . . 73.120000000000005 109.765 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.503 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 25.8 mtpp -78.77 -20.52 49.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.223 -0.923 . . . . 72.439999999999998 109.346 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.55 ' O ' HG22 ' B' ' 69' ' ' ILE . 97.9 m-70 -156.88 65.73 0.52 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.243 -0.911 . . . . 63.310000000000002 109.326 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.469 ' N ' ' O ' ' B' ' 63' ' ' LYS . 86.4 p -61.22 -30.63 70.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 73.099999999999994 109.984 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 78.6 p -69.01 47.06 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.152 -0.967 . . . . 71.530000000000001 109.785 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.55 HG22 ' O ' ' B' ' 66' ' ' HIS . 16.0 tt -146.43 163.99 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.152 -0.968 . . . . 74.400000000000006 109.541 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 41.3 t -103.33 148.96 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.308 -0.87 . . . . 75.120000000000005 109.504 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 t -135.66 124.51 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.3 -0.875 . . . . 73.200000000000003 109.841 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.546 ' C ' HD23 ' B' ' 72' ' ' LEU . 4.5 tt -116.8 104.31 11.2 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.107 -0.701 . . . . 73.340000000000003 109.107 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.72 132.51 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.073 -1.017 . . . . 73.5 109.213 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 7.8 p -93.56 170.78 9.33 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.143 -0.973 . . . . 64.340000000000003 109.154 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.437 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 11.9 t -152.1 122.81 7.42 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 120.942 -1.099 . . . . 74.530000000000001 110.523 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 51.3 p30 -68.2 1.36 2.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.461 -0.775 . . . . 64.5 109.745 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' B' ' 79' ' ' THR . 38.9 t-20 -171.55 81.3 0.5 Allowed Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.248 -0.907 . . . . 74.25 109.494 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.464 ' CG ' ' HB2' ' B' ' 96' ' ' ALA . 97.4 Cg_exo -42.55 87.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.205 1.937 . . . . 74.430000000000007 111.943 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.505 ' N ' ' O ' ' B' ' 77' ' ' ASN . 3.0 p -100.5 155.83 17.62 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.177 -0.675 . . . . 73.120000000000005 109.177 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.2 -36.38 83.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.386 -0.821 . . . . 71.010000000000005 109.591 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -63.37 -40.81 98.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 63.200000000000003 109.93 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . 0.418 ' OE1' ' OG ' ' B' ' 75' ' ' SER . 78.1 tt0 -73.57 -34.37 65.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.152 -0.967 . . . . 73.219999999999999 109.998 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.407 ' OE1' ' N ' ' B' ' 84' ' ' VAL . 14.6 tm-20 -61.88 -56.68 16.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.116 -0.99 . . . . 74.299999999999997 109.711 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.445 HG23 ' N ' ' B' ' 85' ' ' HIS . 34.6 m -58.66 -39.09 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.16 -0.962 . . . . 73.310000000000002 109.299 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' HIS . . . . . 0.445 ' N ' HG23 ' B' ' 84' ' ' VAL . 19.7 m170 -69.38 -28.02 65.82 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 73.239999999999995 109.403 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -67.25 -36.39 81.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.128 -0.982 . . . . 55.329999999999998 109.732 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' PHE . . . . . 0.523 ' CE1' ' HB1' ' A' ' 111' ' ' ALA . 68.5 t80 -82.33 -38.41 24.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.058 -1.026 . . . . 74.140000000000001 108.879 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -70.47 -38.25 74.41 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.346 -0.846 . . . . 64.040000000000006 109.653 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -74.97 -57.56 3.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.933 . . . . 72.349999999999994 109.358 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 153.63 80.82 0.03 OUTLIER Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.036 -1.225 . . . . 65.200000000000003 110.036 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -139.82 115.43 10.05 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.247 -1.149 . . . . 52.229999999999997 109.256 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' B' ' 93' ' ' ASP . 18.9 t70 -73.9 -29.56 62.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.219 -0.926 . . . . 73.319999999999993 108.864 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' B' ' 92' ' ' ASP . 48.2 m-20 -139.01 164.0 30.91 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.507 -0.923 . . . . 72.219999999999999 108.507 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.437 ' OH ' ' CB ' ' B' ' 75' ' ' SER . 89.1 t80 -151.14 103.32 3.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.126 -0.984 . . . . 64.420000000000002 109.26 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 28.0 mm -114.77 149.37 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 O-C-N 121.332 -0.855 . . . . 72.230000000000004 110.499 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . 0.498 ' HB1' ' HD2' ' B' ' 98' ' ' PRO . . . -62.12 143.85 56.13 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.757 -1.201 . . . . 25.239999999999998 107.757 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.593 ' N ' ' CD ' ' B' ' 98' ' ' PRO . 0.0 OUTLIER -68.33 -40.8 21.82 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.857 -1.152 . . . . 64.319999999999993 111.104 -178.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' B' ' 97' ' ' LYS . 39.0 Cg_exo -52.01 -2.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.289 -2.595 0 CA-C-N 118.696 0.57 . . . . 63.329999999999998 112.188 -174.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . 0.578 ' N ' ' O ' ' B' ' 97' ' ' LYS . 58.5 m-85 54.69 95.28 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.711 -0.618 . . . . 75.129999999999995 110.68 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 36.2 mtt85 -56.1 -38.31 70.56 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.7 -1.222 . . . . 74.230000000000004 107.7 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 10.2 t -172.68 125.97 0.48 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.644 -0.873 . . . . 63.340000000000003 108.644 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . 0.4 ' H ' HG13 ' B' ' 102' ' ' ILE . 58.3 mt -50.26 -40.06 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.06 -1.025 . . . . 74.439999999999998 109.363 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -61.79 -38.23 87.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.201 -0.937 . . . . 71.109999999999999 109.193 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.71 -49.49 65.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 71.450000000000003 109.346 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.401 HD11 HD11 ' B' ' 72' ' ' LEU . 65.1 tp -62.28 -44.45 96.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 51.310000000000002 109.149 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.98 -39.94 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.217 -0.927 . . . . 65.230000000000004 109.484 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.37 -39.09 66.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.094 -1.004 . . . . 24.32 108.961 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 0.57 ' CZ ' ' CE2' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -72.17 -34.66 68.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.421 -0.799 . . . . 75.310000000000002 109.42 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 97.3 mt -75.53 -27.36 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.208 -0.933 . . . . 54.240000000000002 109.33 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -73.51 -56.68 4.72 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.343 -0.848 . . . . 65.310000000000002 109.477 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.72 -36.11 69.31 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.201 -0.937 . . . . 72.239999999999995 109.906 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . 0.467 ' NH2' HH22 ' B' ' 108' ' ' ARG . 0.0 OUTLIER -66.28 -51.4 57.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.171 -0.956 . . . . 72.040000000000006 110.179 -179.467 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' B' ' 116' ' ' TRP . 64.2 mt -74.8 -33.07 62.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.089 -1.007 . . . . 75.349999999999994 110.277 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -48.92 -37.57 20.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.936 -1.102 . . . . 75.5 109.456 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -81.08 -2.45 48.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.911 . . . . 65.329999999999998 109.3 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' TRP . . . . . 0.443 ' CD1' ' OD2' ' B' ' 46' ' ' ASP . 88.2 t90 -55.33 -35.79 65.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 74.450000000000003 109.577 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.32 106.69 2.43 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.614 -1.394 . . . . 44.210000000000001 109.614 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . 0.462 ' C ' ' ND2' ' B' ' 119' ' ' ASN . 42.8 m -154.92 166.95 31.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.23 -1.159 . . . . 71.400000000000006 109.702 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . 0.462 ' ND2' ' C ' ' B' ' 118' ' ' SER . 0.0 OUTLIER -158.0 120.78 3.83 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.875 -0.787 . . . . 72.319999999999993 108.875 -178.37 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 19.3 t -87.36 -43.08 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.146 -0.971 . . . . 75.019999999999996 109.395 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 16.1 mm -99.2 137.2 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.277 -0.89 . . . . 51.409999999999997 109.431 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -135.59 100.48 4.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.446 -0.784 . . . . 71.530000000000001 109.048 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 31.2 mm -113.53 132.18 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.5 -0.75 . . . . 72.430000000000007 109.472 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 44.16 -128.22 6.67 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.034 -1.226 . . . . 51.229999999999997 110.034 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -97.38 -10.25 25.88 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.323 -1.104 . . . . 74.200000000000003 109.711 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.458 HD23 ' H ' ' B' ' 126' ' ' LEU . 0.2 OUTLIER -96.97 137.13 36.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.137 -0.977 . . . . 75.420000000000002 109.298 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 27.6 p -119.62 144.99 46.83 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.589 -0.694 . . . . 74.219999999999999 109.441 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 56.2 mt -124.46 129.26 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.514 -0.741 . . . . 60.329999999999998 109.367 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 6.3 m -109.7 118.22 50.73 Favored Pre-proline 0 N--CA 1.497 1.876 0 N-CA-C 108.858 -0.794 . . . . 72.310000000000002 108.858 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.618 ' CB ' ' HE ' ' B' ' 157' ' ' ARG . 97.3 Cg_endo -79.18 -56.88 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.751 1.634 . . . . 75.129999999999995 112.211 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -59.74 -43.15 94.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.154 -0.966 . . . . 75.230000000000004 109.545 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -81.33 -12.84 58.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 72.430000000000007 109.303 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 52.07 55.07 9.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 75.129999999999995 109.363 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . 0.409 ' NZ ' ' CZ3' ' B' ' 116' ' ' TRP . 35.7 ttpt -137.19 133.7 35.48 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.482 -0.761 . . . . 73.219999999999999 109.267 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . 0.403 HG23 ' O ' ' B' ' 135' ' ' ILE . 13.5 tt -117.14 132.69 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.53 -0.731 . . . . 64.140000000000001 109.441 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 14.0 mt -112.04 125.07 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.55 -0.718 . . . . 71.219999999999999 109.146 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -139.75 140.35 36.71 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.326 -0.859 . . . . 64.219999999999999 109.728 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt 53.98 19.05 1.86 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.37 -0.831 . . . . 72.019999999999996 110.011 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.38 16.42 64.41 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 120.087 -1.054 . . . . 74.319999999999993 110.614 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -112.29 127.8 56.09 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.365 -1.079 . . . . 75.340000000000003 109.493 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -93.9 127.01 39.43 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.249 -0.907 . . . . 71.230000000000004 109.629 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 98.7 t -137.52 136.48 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.412 -0.805 . . . . 70.430000000000007 109.254 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . 0.457 ' N ' ' CD ' ' B' ' 143' ' ' GLU . 42.9 mp0 -92.82 144.31 25.41 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.219 -0.926 . . . . 72.430000000000007 109.45 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . 0.472 HG23 ' O ' ' B' ' 144' ' ' VAL . 34.1 m -143.55 125.84 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.195 -0.941 . . . . 72.129999999999995 109.17 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.37 117.45 11.81 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.379 -0.826 . . . . 72.019999999999996 109.255 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.7 171.02 33.22 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.515 -1.434 . . . . 42.229999999999997 109.515 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 4.4 mtmm -68.67 -38.26 11.73 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.202 -1.175 . . . . 73.299999999999997 109.961 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 36.1 Cg_exo -59.61 -34.85 96.51 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.105 1.87 . . . . 71.329999999999998 111.929 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -88.47 -18.07 29.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.368 -0.832 . . . . 74.230000000000004 109.622 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -57.45 -40.02 77.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 72.340000000000003 109.644 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.46 HG13 ' N ' ' B' ' 152' ' ' LEU . 9.6 p -61.76 -39.09 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -0.943 . . . . 73.349999999999994 109.585 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.46 ' N ' HG13 ' B' ' 151' ' ' VAL . 41.2 tp -60.56 -41.45 94.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 55.240000000000002 109.096 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 17.7 p -76.87 -30.99 56.48 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.261 -0.899 . . . . 70.010000000000005 109.258 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -58.4 -51.24 70.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 65.319999999999993 109.585 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.478 HD13 HH22 ' B' ' 159' ' ' ARG . 1.9 pp -72.99 -28.29 62.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.194 -0.942 . . . . 71.540000000000006 109.542 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -54.47 -46.08 73.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.957 . . . . 75.319999999999993 109.507 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.618 ' HE ' ' CB ' ' B' ' 130' ' ' PRO . 43.3 mtt85 -75.75 -43.96 44.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.203 -0.936 . . . . 73.319999999999993 109.457 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 53.8 m80 -77.04 26.37 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.349 -0.844 . . . . 74.140000000000001 109.903 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . 0.478 HH22 HD13 ' B' ' 155' ' ' LEU . 3.0 tpm_? -49.66 157.04 0.59 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.097 -1.002 . . . . 61.409999999999997 108.873 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . 0.431 ' O ' ' OD2' ' B' ' 160' ' ' ASP . 4.9 p-10 42.81 54.57 4.62 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.473 -0.767 . . . . 72.099999999999994 110.13 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -146.44 156.05 43.01 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.175 -0.953 . . . . 72.25 109.368 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 26.2 mt -98.91 138.98 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.263 -0.898 . . . . 72.310000000000002 109.379 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 9.5 m -140.73 143.52 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.33 -0.857 . . . . 64.209999999999994 109.57 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 83.7 p -94.48 161.48 14.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.285 -0.884 . . . . 74.219999999999999 109.214 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -53.78 -38.55 64.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.2 -0.938 . . . . 65.310000000000002 109.255 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -64.54 -36.85 85.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.867 . . . . 63.450000000000003 109.445 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 10.5 tm0? -56.26 -45.38 80.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.264 -0.898 . . . . 72.400000000000006 109.123 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 33.1 mt -65.02 -33.83 76.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 72.319999999999993 108.919 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.562 HD23 ' C ' ' B' ' 169' ' ' LEU . 4.0 tt -53.53 -60.64 3.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.43 -0.794 . . . . 73.340000000000003 109.558 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -66.83 -27.85 67.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.371 -0.831 . . . . 72.099999999999994 110.232 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.26 -57.6 11.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.14 -0.975 . . . . 62.130000000000003 110.064 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.684 HD12 ' N ' ' B' ' 172' ' ' ILE . 2.0 mp -94.65 -59.0 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.06 -1.025 . . . . 71.420000000000002 109.291 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 23.2 m-90 -89.61 89.75 7.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.265 -0.897 . . . . 72.230000000000004 109.527 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' B' ' 175' ' ' GLU . 14.6 pt-20 -100.23 -171.15 1.98 Allowed 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.584 -0.895 . . . . 52.109999999999999 108.584 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' B' ' 174' ' ' GLU . 29.6 mt-10 56.54 152.93 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 109.734 -0.469 . . . . 73.040000000000006 109.734 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -38.91 109.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 122.172 1.915 . . . . 74.129999999999995 112.294 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -143.54 123.99 13.94 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.208 -0.932 . . . . 72.439999999999998 109.299 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . 0.468 ' C ' ' H ' ' B' ' 180' ' ' THR . 65.4 mtt -85.5 20.35 2.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.245 -0.91 . . . . 63.43 109.449 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 179' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' B' ' 180' ' ' THR . 13.1 m -51.01 -10.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 71.049999999999997 109.641 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . 0.468 ' H ' ' C ' ' B' ' 178' ' ' MET . 3.2 m 61.96 134.17 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.711 0 N-CA-C 109.162 -0.681 . . . . 62.149999999999999 109.162 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . 0.432 ' O ' ' OE1' ' B' ' 185' ' ' GLU . 67.4 Cg_endo -73.25 -10.07 23.84 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 121.826 1.684 . . . . 65.219999999999999 112.017 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 182' ' ' ASN . . . . . 0.426 ' O ' ' OE1' ' B' ' 185' ' ' GLU . 19.9 t-20 -61.65 -27.29 68.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 72.310000000000002 110.111 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 9.7 m -77.29 -17.53 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.097 -1.002 . . . . 63.32 110.114 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 87.9 mt -58.36 -52.41 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.103 -0.998 . . . . 75.030000000000001 110.034 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . 0.63 ' H ' ' CD ' ' B' ' 185' ' ' GLU . 1.6 pm0 -55.33 -33.93 63.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.134 -0.979 . . . . 64.109999999999999 109.318 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 91.7 t -75.26 -47.63 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 73.0 109.934 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.78 -50.18 65.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.101 -0.999 . . . . 61.119999999999997 110.166 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 188' ' ' ILE . . . . . 0.431 HG23 ' N ' ' B' ' 189' ' ' ASN . 16.1 tt -57.79 -39.87 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.025 -1.047 . . . . 72.430000000000007 109.764 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 189' ' ' ASN . . . . . 0.431 ' N ' HG23 ' B' ' 188' ' ' ILE . 47.6 t30 -61.38 -46.37 90.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.104 -0.997 . . . . 65.140000000000001 109.545 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -68.51 -45.2 72.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 63.240000000000002 109.764 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 85.5 mt -54.98 -41.75 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.226 -0.921 . . . . 74.030000000000001 109.288 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -60.77 -47.15 87.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 72.239999999999995 109.287 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -66.21 -36.15 82.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.894 . . . . 73.099999999999994 109.533 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . 0.46 ' CB ' ' NZ ' ' B' ' 194' ' ' LYS . 7.8 mtpm? -81.29 -6.45 58.9 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.882 . . . . 72.109999999999999 109.566 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 28.1 ttt -92.92 -54.71 3.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.233 -0.917 . . . . 44.329999999999998 109.406 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 196' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' B' ' 200' ' ' GLY . 91.2 m-20 -62.6 -33.05 74.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 71.209999999999994 109.745 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . 0.449 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 0.0 OUTLIER -54.6 -65.15 1.43 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.17 -0.956 . . . . 75.209999999999994 109.785 -179.605 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 198' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 36.9 Cg_endo -63.36 -53.44 1.45 Allowed 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.143 1.896 . . . . 75.319999999999993 112.213 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 29.7 mt -66.78 -34.28 77.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.19 -0.944 . . . . 72.25 109.679 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' B' ' 196' ' ' ASP . . . 80.41 -40.08 2.37 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.472 -1.451 . . . . 64.530000000000001 109.472 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 64.6 mt -93.67 137.49 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.273 -1.133 . . . . 44.229999999999997 109.279 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 28.6 p -81.4 134.21 35.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 54.009999999999998 109.361 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 25.9 p -131.3 -7.81 3.78 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.472 -0.767 . . . . 74.400000000000006 109.519 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 3.6 m -105.13 133.45 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.342 -0.848 . . . . 72.120000000000005 109.485 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -99.36 127.32 45.37 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.346 -0.846 . . . . 65.409999999999997 109.299 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.92 127.68 44.02 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.235 -0.915 . . . . 71.329999999999998 109.24 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.503 HG12 ' H ' ' B' ' 209' ' ' ARG . 9.1 t -139.78 139.46 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.262 -0.899 . . . . 63.5 109.423 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -85.33 11.68 9.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.197 -0.94 . . . . 74.450000000000003 109.466 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . 0.503 ' H ' HG12 ' B' ' 207' ' ' VAL . 16.5 tpt85 -74.26 -128.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.924 . . . . 74.140000000000001 109.562 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 14.9 tpp180 -57.58 -42.12 82.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 74.430000000000007 109.696 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' B' ' 207' ' ' VAL . . . -173.8 -118.9 0.52 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.679 -1.368 . . . . 64.450000000000003 109.679 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' B' ' 212' ' ' TYR . 29.8 m-85 -123.93 156.4 36.4 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.566 -0.961 . . . . 74.209999999999994 109.319 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -134.47 145.55 48.94 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.555 -0.716 . . . . 74.030000000000001 109.082 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -115.78 138.47 51.1 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.449 -0.782 . . . . 74.340000000000003 109.178 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.3 p -156.19 166.54 33.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.43 -0.794 . . . . 64.329999999999998 109.219 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -61.44 149.53 83.31 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.176 -0.952 . . . . 70.040000000000006 108.998 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -38.99 144.87 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.203 0 C-N-CA 122.047 1.831 . . . . 65.109999999999999 112.152 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.512 ' CB ' ' NZ ' ' B' ' 218' ' ' LYS . 4.7 mtpm? -49.91 -64.48 1.22 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.144 -0.972 . . . . 73.150000000000006 109.152 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' B' ' 218' ' ' LYS . 38.7 Cg_endo -64.55 137.5 55.15 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.03 1.82 . . . . 71.310000000000002 111.691 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -176.84 28.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 75.450000000000003 109.351 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 10.1 p -156.53 120.26 4.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.285 -0.884 . . . . 72.219999999999999 109.38 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' B' ' 223' ' ' GLU . 22.5 pt-20 -68.1 -26.69 65.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -0.901 . . . . 54.530000000000001 109.55 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' B' ' 222' ' ' GLU . 69.6 tt0 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.033 -0.984 . . . . 71.129999999999995 109.519 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.585 ' SD ' ' CE2' ' A' ' 25' ' ' PHE . 15.4 ptp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.415 -0.587 . . . . 65.120000000000005 109.415 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.3 mtt85 -140.94 156.23 46.11 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.321 -0.862 . . . . 72.329999999999998 109.283 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.99 130.64 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.643 -0.661 . . . . 71.420000000000002 109.722 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.828 HD12 ' N ' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -100.9 125.59 47.47 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.314 -0.995 . . . . 65.120000000000005 108.314 179.27 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.828 ' N ' HD12 ' A' ' 4' ' ' LEU . 3.4 tp -120.51 118.4 30.14 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.606 -0.684 . . . . 62.43 109.496 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.588 HG12 HD11 ' A' ' 4' ' ' LEU . 8.9 mt -105.14 123.77 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.357 -0.839 . . . . 71.150000000000006 109.056 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -167.42 138.14 2.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.072 -1.018 . . . . 75.340000000000003 109.697 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.609 ' HZ3' ' C ' ' A' ' 31' ' ' GLU . 67.1 mmtt -84.32 -26.47 28.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.234 -0.916 . . . . 72.439999999999998 109.257 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -61.66 -154.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.355 -0.84 . . . . 63.020000000000003 109.5 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.1 p -148.83 -50.75 0.16 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.21 -0.932 . . . . 72.340000000000003 109.41 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 86.5 t -65.38 -39.8 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 74.019999999999996 109.521 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 12' ' ' LEU . 10.1 mp -63.18 -36.23 82.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 71.430000000000007 109.409 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.55 -35.15 26.57 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.501 -1.84 . . . . 61.32 108.501 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.94 -43.26 91.77 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 110.182 -1.167 . . . . 71.200000000000003 110.182 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -69.39 -41.17 76.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.939 -1.33 . . . . 71.319999999999993 109.306 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.7 mm -67.09 -40.28 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.825 -1.172 . . . . 63.229999999999997 108.135 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -62.75 -53.83 48.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.456 -0.777 . . . . 51.109999999999999 109.798 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -79.56 -1.0 35.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.176 -0.952 . . . . 73.340000000000003 109.771 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -85.73 -54.26 2.83 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.13 -1.588 . . . . 62.149999999999999 109.13 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 pp -71.54 -28.31 63.78 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.4 -1.059 . . . . 73.510000000000005 109.315 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -53.98 -35.82 62.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -0.929 . . . . 74.25 109.124 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.3 t -55.46 -49.1 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.306 -0.871 . . . . 70.040000000000006 109.01 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.438 ' NZ ' HG11 ' A' ' 106' ' ' VAL . 35.9 mmtm -58.54 -54.59 45.3 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.689 -0.856 . . . . 73.230000000000004 108.689 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 138.21 36.5 0.15 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.829 -1.309 . . . . 75.540000000000006 109.829 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.585 ' CE2' ' SD ' ' A' ' 1' ' ' MET . 16.9 m-85 -111.99 155.19 24.17 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.374 -1.074 . . . . 73.430000000000007 108.962 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 7.2 mtp -101.97 139.14 38.01 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.19 -1.041 . . . . 43.240000000000002 108.19 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.422 ' O ' ' OD1' ' A' ' 28' ' ' ASP . . . -143.72 158.29 43.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.199 -0.938 . . . . 62.109999999999999 110.368 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 27' ' ' ALA . 87.7 m-20 -136.09 156.5 48.63 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.054 -0.721 . . . . 74.420000000000002 109.054 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 m -104.38 139.9 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.47 -0.937 . . . . 72.150000000000006 108.47 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 p -133.94 164.26 27.69 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.489 -0.757 . . . . 71.420000000000002 109.442 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.609 ' C ' ' HZ3' ' A' ' 8' ' ' LYS . 5.6 pt-20 -97.64 -107.41 0.17 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.295 -0.878 . . . . 72.329999999999998 109.875 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.516 ' N ' ' HZ3' ' A' ' 8' ' ' LYS . 50.0 m -79.88 160.86 25.89 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.155 -0.966 . . . . 74.239999999999995 110.041 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.4 mt -48.58 -19.52 0.35 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.395 -0.816 . . . . 71.530000000000001 109.759 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -61.08 -54.47 44.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.195 -0.941 . . . . 74.230000000000004 110.58 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 36' ' ' GLY . 13.4 p-10 -68.57 -31.67 71.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.917 -1.114 . . . . 54.030000000000001 109.317 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.518 ' N ' ' OD1' ' A' ' 35' ' ' ASP . . . -68.77 -42.89 77.59 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.021 -1.632 . . . . 61.409999999999997 109.021 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.486 ' OE2' ' NH2' ' A' ' 61' ' ' ARG . 85.5 tt0 -71.22 -39.24 71.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.353 -1.086 . . . . 74.340000000000003 109.364 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -73.23 -31.81 64.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.971 . . . . 75.329999999999998 109.648 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.1 tp -70.65 -49.85 43.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.236 -0.915 . . . . 74.329999999999998 110.139 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.437 ' O ' ' O ' ' A' ' 43' ' ' ARG . 22.8 ptm -63.45 -20.48 65.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.997 -1.064 . . . . 70.319999999999993 109.802 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -65.15 -38.49 90.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.098 -1.001 . . . . 71.219999999999999 109.956 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.8 pt -84.93 -31.33 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.059 -1.026 . . . . 74.140000000000001 110.254 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 40' ' ' MET . 79.5 mtm180 -130.31 153.5 48.59 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.304 -0.872 . . . . 72.239999999999995 109.595 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.954 ' CG ' ' OE2' ' A' ' 143' ' ' GLU . 29.4 m120 -97.93 155.89 16.87 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.251 -0.906 . . . . 75.420000000000002 109.529 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -135.84 155.32 50.51 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.463 -0.773 . . . . 74.230000000000004 109.277 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -96.08 -43.86 7.58 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.154 -0.966 . . . . 72.040000000000006 109.198 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.63 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.8 OUTLIER -110.58 122.47 47.84 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.499 -0.926 . . . . 72.129999999999995 108.499 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.63 ' N ' HD13 ' A' ' 47' ' ' LEU . 15.4 m -117.3 97.97 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.581 -0.896 . . . . 72.340000000000003 108.581 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.586 ' SD ' ' N ' ' A' ' 50' ' ' VAL . 0.3 OUTLIER -98.67 134.4 41.65 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.793 -0.818 . . . . 74.109999999999999 108.793 -179.346 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.586 ' N ' ' SD ' ' A' ' 49' ' ' MET . 1.3 p -136.43 125.51 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-O 121.774 0.797 . . . . 61.119999999999997 109.967 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.1 p -94.54 2.66 55.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.565 -0.709 . . . . 73.109999999999999 109.356 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -76.75 142.32 40.47 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.191 -0.943 . . . . 52.549999999999997 109.646 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.474 ' C ' ' H ' ' A' ' 55' ' ' ALA . 97.8 mttt -79.14 -38.52 35.84 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.312 -0.868 . . . . 44.219999999999999 110.212 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -67.93 7.99 0.46 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.051 -1.031 . . . . 70.439999999999998 109.585 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.34 -22.46 57.6 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.376 -0.827 . . . . 64.140000000000001 110.718 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 55' ' ' ALA . 55.1 mt -41.39 -51.24 3.76 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.399 -0.813 . . . . 44.140000000000001 110.361 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.1 t -67.86 -34.22 76.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.96 -1.088 . . . . 55.229999999999997 108.873 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.562 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 48.2 t80 -66.81 -63.62 1.03 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.505 -0.747 . . . . 74.439999999999998 109.914 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.5 m -48.16 -34.29 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.795 -1.191 . . . . 74.030000000000001 109.617 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 61' ' ' ARG . 15.0 p -57.69 -56.32 23.45 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.208 -0.932 . . . . 64.299999999999997 109.133 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.645 HH21 ' NZ ' ' A' ' 65' ' ' LYS . 13.3 ptm180 -66.4 -28.73 68.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -1.0 . . . . 64.439999999999998 110.059 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.562 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 25.1 mm -54.87 -41.42 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.666 -1.271 . . . . 63.210000000000001 107.96 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.522 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 43.4 mmtt -70.84 -40.08 72.58 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.605 -0.838 . . . . 74.420000000000002 109.056 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -67.83 -42.09 82.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.138 -0.976 . . . . 70.319999999999993 109.129 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.645 ' NZ ' HH21 ' A' ' 61' ' ' ARG . 48.6 mtpt -88.48 -14.4 37.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.614 -0.678 . . . . 75.219999999999999 110.076 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 62' ' ' ILE . 73.0 m-70 -155.22 72.17 0.81 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.146 -0.971 . . . . 74.129999999999995 109.342 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.3 p -73.69 -6.96 50.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.24 -0.912 . . . . 73.239999999999995 109.765 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.2 p -100.19 42.87 1.08 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.27 -0.894 . . . . 61.009999999999998 110.072 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 66' ' ' HIS . 14.7 tt -145.07 160.09 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.011 -1.056 . . . . 71.329999999999998 109.6 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.0 t -98.13 130.43 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.212 -0.93 . . . . 72.129999999999995 108.766 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.5 t -115.29 130.75 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.499 -0.751 . . . . 54.210000000000001 109.323 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.513 ' O ' ' SD ' ' A' ' 49' ' ' MET . 8.6 tt -128.0 95.88 4.32 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.599 0.714 . . . . 50.240000000000002 109.202 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.52 HG22 ' N ' ' A' ' 74' ' ' SER . 14.4 p -91.39 164.89 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.005 -1.06 . . . . 74.409999999999997 109.203 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.52 ' N ' HG22 ' A' ' 73' ' ' VAL . 72.0 m -138.87 169.7 17.31 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.204 -0.935 . . . . 72.310000000000002 109.026 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 77' ' ' ASN . 1.2 p -175.53 128.52 0.26 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.053 -1.029 . . . . 64.540000000000006 110.086 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.425 ' N ' ' HB2' ' A' ' 97' ' ' LYS . 48.7 p30 -67.33 41.6 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.509 -0.744 . . . . 74.129999999999995 109.633 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 75' ' ' SER . 9.9 p30 -156.32 59.45 1.99 Allowed Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.026 -1.046 . . . . 73.340000000000003 110.449 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.68 76.22 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.145 1.896 . . . . 63.219999999999999 111.148 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.458 ' N ' ' O ' ' A' ' 77' ' ' ASN . 82.3 p -103.64 152.3 21.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.575 -0.703 . . . . 62.530000000000001 109.498 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.52 -34.6 78.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.463 -0.773 . . . . 73.439999999999998 109.27 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -67.04 -44.45 80.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 71.420000000000002 109.281 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -74.51 -31.55 62.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 73.430000000000007 109.383 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.493 ' OE1' ' N ' ' A' ' 84' ' ' VAL . 14.3 tm-20 -58.66 -56.72 18.56 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.225 -0.922 . . . . 74.219999999999999 109.555 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.493 ' N ' ' OE1' ' A' ' 83' ' ' GLU . 27.4 m -62.0 -40.64 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 73.200000000000003 109.29 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.454 ' N ' HG23 ' A' ' 84' ' ' VAL . 22.8 t-80 -61.13 -38.93 88.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.24 -0.913 . . . . 53.329999999999998 109.381 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.58 86.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 64.109999999999999 109.543 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.409 ' CE1' ' HB1' ' B' ' 111' ' ' ALA . 17.3 t80 -72.83 -33.23 66.03 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.417 -0.957 . . . . 74.340000000000003 108.417 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -66.56 -36.93 83.85 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.518 -0.738 . . . . 74.420000000000002 109.143 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -64.4 -49.83 70.01 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.361 -0.837 . . . . 74.239999999999995 109.411 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 142.43 31.88 0.12 Allowed Glycine 0 N--CA 1.498 2.775 0 N-CA-C 110.024 -1.23 . . . . 61.509999999999998 110.024 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.25 131.27 38.52 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.088 -1.242 . . . . 55.329999999999998 109.43 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.522 ' OD2' ' NZ ' ' A' ' 63' ' ' LYS . 42.1 m-20 -78.03 -29.35 49.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.108 -0.995 . . . . 73.420000000000002 109.113 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.423 ' OD2' HD11 ' A' ' 95' ' ' ILE . 25.2 t70 -149.88 147.59 28.12 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.911 -0.774 . . . . 75.040000000000006 108.911 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -135.54 113.44 11.1 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.446 -0.784 . . . . 71.329999999999998 108.93 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.423 HD11 ' OD2' ' A' ' 93' ' ' ASP . 20.3 mm -107.35 150.22 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 CA-C-O 122.118 0.961 . . . . 71.129999999999995 110.918 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.95 125.54 25.75 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.51 -1.292 . . . . 64.319999999999993 107.51 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.675 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -45.12 -52.81 18.8 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.036 -1.04 . . . . 62.200000000000003 111.359 -179.061 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 1.6 Cg_endo -40.87 -12.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.112 0 CA-C-N 119.759 0.95 . . . . 73.109999999999999 112.601 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.675 ' N ' ' O ' ' A' ' 97' ' ' LYS . 49.2 m-85 56.69 104.71 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.763 -0.586 . . . . 65.219999999999999 110.383 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.8 ttm-85 -60.65 -39.08 87.0 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.02 -1.104 . . . . 72.349999999999994 108.02 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.1 t -174.45 140.08 0.61 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.916 -0.772 . . . . 71.319999999999993 108.916 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 19.2 mm -57.95 -37.07 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 75.430000000000007 109.157 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.428 ' HE2' ' H ' ' A' ' 103' ' ' LYS . 1.5 mppt? -64.3 -36.03 82.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.266 -0.896 . . . . 71.409999999999997 109.178 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.31 -48.91 73.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.144 -0.973 . . . . 63.240000000000002 109.406 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.453 ' C ' HD13 ' A' ' 105' ' ' LEU . 2.1 tm? -67.82 -55.05 14.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.377 -0.827 . . . . 73.219999999999999 108.906 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.438 HG11 ' NZ ' ' A' ' 23' ' ' LYS . 67.6 t -55.03 -49.02 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.932 -1.105 . . . . 60.109999999999999 109.425 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.51 -37.28 65.14 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.169 -0.957 . . . . 70.420000000000002 108.91 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.423 ' NH1' ' OE2' ' B' ' 83' ' ' GLU . 11.2 mmt85 -71.38 -30.02 65.63 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.357 -0.839 . . . . 74.409999999999997 109.389 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 61.6 mt -68.67 -30.51 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 107.773 -1.195 . . . . 62.539999999999999 107.773 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -67.58 -52.48 38.1 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.837 -0.801 . . . . 74.340000000000003 108.837 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.444 ' CB ' ' CZ ' ' B' ' 87' ' ' PHE . . . -48.2 -44.09 32.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.446 -0.783 . . . . 73.319999999999993 109.477 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 75.1 mmt-85 -64.61 -32.7 74.47 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.33 -0.856 . . . . 52.409999999999997 109.702 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 45.1 mt -133.37 75.62 1.62 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.36 -0.837 . . . . 65.239999999999995 110.313 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -92.8 -79.51 0.39 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.089 -1.007 . . . . 64.450000000000003 108.426 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.457 ' O ' ' CD2' ' A' ' 115' ' ' PHE . 26.1 p90 -100.74 49.37 0.89 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.354 -0.841 . . . . 74.430000000000007 109.359 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 75.7 t-105 -67.05 112.58 4.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 74.420000000000002 109.424 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 159.74 111.39 0.29 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.889 -1.284 . . . . 75.040000000000006 109.889 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 23.2 t -164.17 157.17 17.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -1.14 . . . . 61.140000000000001 109.523 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.595 ' N ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -152.92 117.12 4.88 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.854 -0.795 . . . . 65.239999999999995 108.854 -178.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.506 HG21 ' OD1' ' A' ' 131' ' ' ASP . 18.7 t -77.63 -39.98 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.327 -0.858 . . . . 73.109999999999999 110.466 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 11.1 mm -104.46 130.36 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.105 -0.997 . . . . 72.239999999999995 109.675 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -129.36 136.36 49.9 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.453 -0.943 . . . . 72.340000000000003 108.453 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.622 HD13 ' N ' ' A' ' 124' ' ' GLY . 0.2 OUTLIER -149.99 121.87 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.018 -1.051 . . . . 71.439999999999998 109.599 -179.229 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.622 ' N ' HD13 ' A' ' 123' ' ' ILE . . . 46.96 -129.49 12.23 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.038 -1.225 . . . . 73.400000000000006 110.038 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -93.88 -4.02 50.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.307 -1.114 . . . . 74.450000000000003 109.88 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.67 143.65 26.26 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.141 -0.974 . . . . 54.210000000000001 108.468 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.1 m -132.44 143.67 49.95 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.333 -0.854 . . . . 54.5 109.524 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.4 mt -134.84 140.38 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.457 -0.777 . . . . 45.149999999999999 109.748 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.1 m -128.31 109.05 19.46 Favored Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 108.949 -0.76 . . . . 71.109999999999999 108.949 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.52 -27.49 4.14 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.656 1.571 . . . . 65.409999999999997 111.712 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.506 ' OD1' HG21 ' A' ' 120' ' ' VAL . 1.9 m-20 -69.4 -37.15 77.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 63.32 109.093 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -88.98 -4.33 58.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.33 -0.856 . . . . 72.519999999999996 109.603 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 54.65 62.62 2.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.131 -0.981 . . . . 75.329999999999998 108.972 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -160.67 155.56 24.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.256 -0.903 . . . . 71.230000000000004 109.949 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.533 HD12 ' CD2' ' A' ' 152' ' ' LEU . 4.7 tt -124.94 137.61 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.631 -0.668 . . . . 74.019999999999996 109.349 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 24.9 mm -115.83 133.7 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.709 -0.849 . . . . 60.229999999999997 108.709 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -137.88 119.49 15.01 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.231 -0.918 . . . . 62.32 108.851 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.5 ' O ' ' CG ' ' A' ' 138' ' ' LYS . 25.4 ttpt 54.71 20.26 2.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.586 -0.696 . . . . 75.400000000000006 109.974 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.59 0.8 66.62 Favored Glycine 0 N--CA 1.499 2.877 0 O-C-N 120.862 -1.149 . . . . 72.239999999999995 110.71 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.498 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 1.9 mpt_? -89.99 124.84 35.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.963 -1.316 . . . . 71.219999999999999 108.645 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -87.9 130.39 34.93 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.245 -0.91 . . . . 71.420000000000002 109.755 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.7 t -138.45 143.13 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.433 -0.792 . . . . 53.020000000000003 109.739 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.954 ' OE2' ' CG ' ' A' ' 44' ' ' ASN . 91.1 mt-10 -95.9 142.16 28.47 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.868 -0.79 . . . . 60.450000000000003 108.868 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.2 m -138.05 137.88 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.147 -0.97 . . . . 74.439999999999998 109.758 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -168.54 41.87 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.287 -0.883 . . . . 65.150000000000006 109.856 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -115.25 -129.36 4.58 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 108.856 -1.697 . . . . 73.340000000000003 108.856 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.625 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 23.8 mttp -85.79 -32.29 0.45 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.273 -1.134 . . . . 72.219999999999999 110.846 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.853 ' HA ' ' HB ' ' A' ' 151' ' ' VAL . 86.9 Cg_endo -86.1 -18.14 3.59 Favored 'Trans proline' 0 N--CA 1.486 1.06 0 C-N-CA 122.06 1.84 . . . . 65.230000000000004 112.247 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -56.34 -48.83 75.97 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.828 -1.175 . . . . 60.109999999999999 107.828 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 172' ' ' ILE . 74.6 mt-10 -75.99 -42.02 49.43 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.053 -1.092 . . . . 64.209999999999994 108.053 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.853 ' HB ' ' HA ' ' A' ' 148' ' ' PRO . 1.1 t -56.27 -46.58 81.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.039 -1.097 . . . . 72.019999999999996 108.039 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.533 ' CD2' HD12 ' A' ' 135' ' ' ILE . 22.3 tp -66.66 -56.72 9.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.623 -0.673 . . . . 73.310000000000002 110.569 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.6 p -58.49 -35.84 72.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.906 -1.121 . . . . 74.310000000000002 110.03 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.412 ' CD2' ' HD2' ' A' ' 158' ' ' HIS . 22.4 t-80 -58.53 -56.94 15.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.003 -1.06 . . . . 74.310000000000002 110.367 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.54 -26.42 62.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.935 -1.103 . . . . 75.340000000000003 109.525 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.05 -44.23 91.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.958 -1.089 . . . . 62.140000000000001 108.592 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -79.67 -57.99 3.41 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.984 0.897 . . . . 61.030000000000001 109.415 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.412 ' HD2' ' CD2' ' A' ' 154' ' ' HIS . 98.0 m-70 -71.69 41.43 0.08 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.912 -0.586 . . . . 74.120000000000005 111.332 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -82.81 166.43 19.01 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.627 -1.296 . . . . 71.129999999999995 109.027 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.441 ' OD1' ' CE2' ' A' ' 216' ' ' TYR . 14.2 m-20 53.49 47.62 23.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.157 -0.964 . . . . 75.450000000000003 109.262 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -154.89 163.58 40.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.348 -0.845 . . . . 73.409999999999997 110.12 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.3 mm -98.64 136.7 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.42 -1.326 . . . . 74.409999999999997 107.42 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.8 148.18 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.996 -1.065 . . . . 72.310000000000002 110.486 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.7 p -97.08 165.47 12.05 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.609 -0.682 . . . . 74.120000000000005 109.685 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -66.95 -44.78 79.72 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.249 -0.907 . . . . 70.430000000000007 110.121 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -56.19 -40.31 73.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 73.519999999999996 109.923 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -58.05 -43.2 86.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.05 -1.031 . . . . 74.519999999999996 109.425 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 11.7 mt -56.47 -43.72 79.88 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.973 -1.08 . . . . 72.310000000000002 108.127 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.514 HD23 ' C ' ' A' ' 169' ' ' LEU . 5.1 tt -49.16 -56.15 10.12 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.04 -1.038 . . . . 53.329999999999998 109.746 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -54.14 -37.71 64.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.559 -0.713 . . . . 62.439999999999998 112.507 -178.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.65 -32.11 13.54 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 120.531 -1.356 . . . . 60.210000000000001 113.517 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.43 ' O ' ' OE1' ' A' ' 150' ' ' GLU . 1.7 mp -77.88 -51.33 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.628 -1.295 . . . . 75.319999999999993 110.838 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.562 ' CD1' HG23 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -86.43 8.7 20.69 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.66 -1.275 . . . . 73.140000000000001 109.597 -178.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -46.53 -66.67 0.37 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.977 -1.077 . . . . 73.239999999999995 109.79 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.39 -61.57 0.26 Allowed Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.073 -1.017 . . . . 44.43 109.782 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.59 123.46 10.18 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.967 1.778 . . . . 72.510000000000005 111.265 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -92.36 127.64 37.91 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.872 -1.142 . . . . 63.240000000000002 110.616 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.548 ' HG3' ' CE ' ' A' ' 147' ' ' LYS . 0.0 OUTLIER -173.54 44.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.834 -1.172 . . . . 73.5 107.834 179.197 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.562 HG23 ' CD1' ' A' ' 173' ' ' TRP . 3.4 t -93.85 145.86 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.449 -0.782 . . . . 65.219999999999999 108.915 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.504 ' CG2' ' H ' ' A' ' 182' ' ' ASN . 0.4 OUTLIER -150.89 156.24 35.63 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.229 -0.92 . . . . 71.420000000000002 108.686 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -37.8 -24.23 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.362 2.042 . . . . 41.219999999999999 112.487 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.504 ' H ' ' CG2' ' A' ' 180' ' ' THR . 34.5 m120 -157.91 96.06 1.45 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.073 -1.017 . . . . 64.540000000000006 110.19 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.2 p -148.38 -32.25 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.147 -0.97 . . . . 74.019999999999996 109.325 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 6.0 mm -60.69 -43.27 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.181 -0.95 . . . . 72.329999999999998 109.211 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -64.91 -36.94 86.0 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 74.400000000000006 109.164 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 20.4 t -71.15 -32.33 47.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.117 -0.989 . . . . 70.420000000000002 109.139 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.39 -52.17 17.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.49 -0.757 . . . . 52.109999999999999 110.658 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.401 HG21 ' CZ ' ' A' ' 212' ' ' TYR . 9.2 tp -56.85 -39.11 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.548 -1.345 . . . . 71.400000000000006 110.112 -178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -63.72 -56.71 13.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.83 -1.169 . . . . 73.439999999999998 110.958 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -65.65 -42.58 91.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.848 -1.158 . . . . 71.420000000000002 110.131 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 66.6 mt -51.72 -35.72 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.808 -1.182 . . . . 61.549999999999997 109.033 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.407 ' HB2' HH11 ' A' ' 192' ' ' ARG . 16.8 mtp-105 -67.29 -54.46 20.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.115 -0.991 . . . . 63.340000000000003 109.689 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -71.21 -14.06 62.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -0.91 . . . . 61.240000000000002 110.992 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.415 ' O ' ' CD ' ' A' ' 198' ' ' PRO . 43.8 mtpt -83.37 -41.24 18.41 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.844 -1.16 . . . . 75.129999999999995 110.709 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . 1.024 ' HE2' HD22 ' A' ' 199' ' ' LEU . 45.8 mtp -81.83 36.99 0.46 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.095 -1.003 . . . . 74.019999999999996 110.699 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 197' ' ' LYS . 27.4 p30 -110.61 -39.09 4.99 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.12 -0.988 . . . . 74.019999999999996 109.988 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.597 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 5.6 tmtt? -91.23 -40.15 0.39 Allowed Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 120.91 -1.119 . . . . 75.430000000000007 110.065 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 24.4 Cg_exo -63.65 -61.22 0.13 Allowed 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.256 1.971 . . . . 72.319999999999993 111.823 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 1.024 HD22 ' HE2' ' A' ' 195' ' ' MET . 10.8 mp -71.42 -28.8 64.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 74.540000000000006 108.971 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 83.46 -14.9 38.09 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.626 -1.79 . . . . 61.509999999999998 108.626 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 21.2 mt -128.52 137.13 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.841 -0.799 . . . . 61.219999999999999 109.073 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 72.8 m -89.74 144.52 25.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.211 -0.93 . . . . 72.0 109.12 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.5 p -146.07 44.68 1.25 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.164 -0.96 . . . . 74.439999999999998 110.288 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 7.9 m -148.66 129.88 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.993 -1.067 . . . . 64.349999999999994 109.23 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -112.14 140.4 46.85 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.687 -0.633 . . . . 71.409999999999997 109.532 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 206' ' ' THR . 14.9 t -126.12 131.46 52.07 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.456 -0.778 . . . . 73.519999999999996 109.942 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 7.5 p -135.7 154.25 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.47 -0.937 . . . . 71.019999999999996 108.47 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -97.03 75.22 2.62 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.103 -0.998 . . . . 72.120000000000005 110.535 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -146.52 -33.22 0.31 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.175 -0.953 . . . . 64.409999999999997 109.249 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.6 tpp180 -147.3 -60.18 0.28 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.242 -0.911 . . . . 71.540000000000006 109.217 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -163.52 -119.75 0.5 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.517 -1.433 . . . . 72.030000000000001 109.517 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.401 ' CZ ' HG21 ' A' ' 188' ' ' ILE . 43.5 m-85 -125.31 152.05 45.21 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.63 -0.923 . . . . 75.540000000000006 109.153 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.92 129.05 48.53 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.545 -0.909 . . . . 75.310000000000002 108.545 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -105.86 126.26 51.96 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.357 -0.839 . . . . 75.409999999999997 109.193 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 44.1 t -149.49 158.59 44.31 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.788 -0.819 . . . . 74.140000000000001 108.788 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . 0.441 ' CE2' ' OD1' ' A' ' 160' ' ' ASP . 8.7 p90 -58.07 150.06 53.07 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.255 -0.903 . . . . 75.319999999999993 109.238 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.36 -41.09 2.65 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.236 1.957 . . . . 73.109999999999999 111.173 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 32.0 pttt -153.56 152.27 27.0 Favored Pre-proline 0 N--CA 1.49 1.559 0 N-CA-C 108.783 -0.821 . . . . 75.25 108.783 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -35.91 105.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 122.608 2.205 . . . . 75.099999999999994 112.701 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -93.28 100.24 12.63 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.164 -0.96 . . . . 71.140000000000001 109.353 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 22.5 p -159.9 168.35 25.95 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.166 -0.959 . . . . 71.129999999999995 109.957 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -85.3 158.68 20.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.228 -0.92 . . . . 75.349999999999994 109.039 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.989 -1.005 . . . . 73.409999999999997 109.379 -179.895 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 54.4 ttm . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.442 -0.577 . . . . 71.140000000000001 109.442 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 57.5 ttm-85 -139.27 147.61 41.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.419 -0.8 . . . . 73.230000000000004 109.159 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 40.2 t -110.62 137.35 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.682 -0.636 . . . . 72.239999999999995 109.304 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.408 HD11 ' CG1' ' B' ' 6' ' ' ILE . 5.4 tp -113.98 117.55 31.64 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 109.366 -0.605 . . . . 54.329999999999998 109.366 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.496 ' N ' HD23 ' B' ' 5' ' ' LEU . 0.1 OUTLIER -120.39 97.67 5.68 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.171 -1.048 . . . . 74.349999999999994 108.171 178.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.471 ' CG2' ' O ' ' B' ' 31' ' ' GLU . 65.1 mt -81.97 106.14 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.775 -1.203 . . . . 42.549999999999997 109.168 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.425 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 18.3 tp10 -140.18 129.9 24.43 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.481 -0.762 . . . . 74.519999999999996 109.125 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -64.8 -32.34 73.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.17 -0.956 . . . . 62.549999999999997 109.431 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -83.86 123.59 30.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 73.109999999999999 109.503 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 87.1 p -78.8 -26.68 44.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.263 -0.898 . . . . 65.540000000000006 109.689 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 98.3 t -63.12 -49.09 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.241 -0.912 . . . . 75.549999999999997 109.564 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.566 ' N ' HD22 ' B' ' 12' ' ' LEU . 3.6 mm? -64.78 -35.2 80.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 70.140000000000001 108.949 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.25 -26.6 71.76 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.314 -1.914 . . . . 75.400000000000006 108.314 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.29 -49.99 62.61 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.652 -1.379 . . . . 65.439999999999998 109.652 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -61.97 -43.91 97.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.285 -1.126 . . . . 60.210000000000001 109.706 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 35.8 mm -67.31 -37.55 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.689 -1.257 . . . . 75.150000000000006 108.702 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -65.97 -42.39 89.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -0.891 . . . . 73.010000000000005 109.355 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -87.43 1.35 53.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.169 -0.957 . . . . 74.299999999999997 109.204 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.57 -58.06 1.99 Allowed Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.361 -1.496 . . . . 70.540000000000006 109.361 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' B' ' 27' ' ' ALA . 1.6 pt? -68.54 -24.82 64.68 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.308 -1.113 . . . . 71.340000000000003 109.421 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -53.8 -36.01 61.98 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.184 -0.947 . . . . 64.409999999999997 109.447 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 58.0 t -54.52 -47.64 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.268 -0.895 . . . . 74.230000000000004 108.914 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 52.8 mmtt -59.91 -54.89 40.88 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.948 -0.76 . . . . 63.420000000000002 108.948 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 132.9 41.85 0.18 Allowed Glycine 0 N--CA 1.499 2.868 0 N-CA-C 109.719 -1.353 . . . . 53.43 109.719 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -118.46 160.17 22.2 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.445 -1.033 . . . . 71.120000000000005 109.308 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 8.4 mmt -98.86 138.79 35.48 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.287 -1.005 . . . . 75.239999999999995 108.287 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.468 ' HB1' HD21 ' B' ' 5' ' ' LEU . . . -125.13 149.78 47.54 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.701 0.762 . . . . 72.120000000000005 110.326 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . 0.445 ' OD2' ' NH2' ' B' ' 43' ' ' ARG . 24.1 t70 -133.47 126.5 31.27 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.452 -1.314 . . . . 72.310000000000002 107.452 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 p -117.48 142.58 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.406 -0.809 . . . . 64.430000000000007 110.066 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -134.34 -153.16 0.51 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.751 -0.593 . . . . 65.409999999999997 109.413 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.471 ' O ' ' CG2' ' B' ' 6' ' ' ILE . 1.3 pt-20 -135.36 -87.56 0.36 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.422 -0.799 . . . . 71.019999999999996 109.531 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 61.8 m -79.46 152.03 30.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.963 -1.085 . . . . 51.109999999999999 109.571 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.446 ' O ' ' N ' ' B' ' 37' ' ' GLU . 43.8 mt -54.2 -41.71 68.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.864 . . . . 71.239999999999995 109.73 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -58.95 -40.8 85.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.924 . . . . 74.319999999999993 109.795 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.425 ' OD2' ' OE2' ' B' ' 31' ' ' GLU . 92.7 m-20 -64.02 -40.26 95.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.147 -0.97 . . . . 73.030000000000001 109.212 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . 0.447 ' O ' ' CG ' ' B' ' 40' ' ' MET . . . -82.78 -27.89 40.37 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.642 -1.383 . . . . 30.210000000000001 109.642 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' B' ' 33' ' ' LEU . 81.7 tt0 -64.3 -41.32 96.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.188 -1.183 . . . . 74.420000000000002 109.727 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -80.54 -40.48 25.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.114 -0.992 . . . . 74.420000000000002 109.624 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 45.4 tp -68.02 -40.15 83.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 75.409999999999997 109.936 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . 0.516 ' SD ' ' CE1' ' B' ' 45' ' ' TYR . 1.2 ppp? -74.05 -27.15 60.78 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.131 -0.981 . . . . 60.409999999999997 109.923 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -52.68 -36.07 56.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.167 -0.958 . . . . 53.229999999999997 110.041 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 9.3 pt -93.11 -20.48 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.092 -1.005 . . . . 71.230000000000004 110.314 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.445 ' NH2' ' OD2' ' B' ' 28' ' ' ASP . 34.8 mtm105 -104.71 156.81 17.66 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.192 -0.942 . . . . 72.219999999999999 109.902 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -91.29 167.72 12.1 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.381 -0.825 . . . . 63.539999999999999 109.035 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.516 ' CE1' ' SD ' ' B' ' 40' ' ' MET . 1.7 p90 -160.25 113.43 2.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.054 -1.029 . . . . 64.349999999999994 109.669 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -84.62 -37.73 20.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -0.903 . . . . 62.219999999999999 108.859 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.504 HD13 ' C ' ' B' ' 47' ' ' LEU . 0.7 OUTLIER -109.76 109.46 20.16 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.666 -0.864 . . . . 73.120000000000005 108.666 179.524 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.444 ' N ' HD13 ' B' ' 47' ' ' LEU . 78.4 t -95.97 111.18 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.604 -0.888 . . . . 65.109999999999999 108.604 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 12.2 ttt -128.18 135.31 49.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.486 -0.759 . . . . 73.439999999999998 109.551 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.69 HG22 ' H ' ' B' ' 52' ' ' ASP . 0.8 OUTLIER -147.12 140.63 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.591 -0.693 . . . . 34.5 109.506 -179.332 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . 0.425 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 52.8 p -103.91 13.92 31.81 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.445 -0.784 . . . . 73.209999999999994 109.626 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.69 ' H ' HG22 ' B' ' 50' ' ' VAL . 13.5 m-20 -78.34 140.7 38.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.164 -0.96 . . . . 70.409999999999997 109.502 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -72.72 -38.37 67.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.18 -0.95 . . . . 65.0 110.002 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -74.05 10.19 1.3 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.123 -0.986 . . . . 75.209999999999994 109.663 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.09 -22.72 64.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 55.329999999999998 110.148 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 39.4 mt -43.83 -48.54 8.26 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.34 -0.85 . . . . 63.140000000000001 110.174 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 88.3 p -68.9 -33.82 74.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.926 -1.109 . . . . 63.5 108.943 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . 0.468 ' CZ ' HD11 ' B' ' 62' ' ' ILE . 61.0 t80 -66.21 -61.96 1.74 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.444 -0.785 . . . . 72.329999999999998 109.779 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.9 m -49.92 -34.59 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.715 -1.24 . . . . 74.540000000000006 109.719 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 15.5 m -57.81 -51.79 68.14 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.285 -0.884 . . . . 71.239999999999995 109.632 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.627 ' NH2' ' HZ3' ' B' ' 65' ' ' LYS . 10.4 ptm180 -70.71 -27.4 63.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.041 -1.037 . . . . 74.310000000000002 110.132 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' B' ' 66' ' ' HIS . 29.9 mm -63.17 -53.78 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.743 -1.223 . . . . 72.140000000000001 109.181 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -59.73 -36.93 77.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.98 -1.075 . . . . 73.319999999999993 109.112 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -75.04 -38.16 61.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.365 -0.835 . . . . 73.120000000000005 109.477 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.627 ' HZ3' ' NH2' ' B' ' 61' ' ' ARG . 92.1 mttt -88.71 -18.46 27.81 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.166 -0.959 . . . . 72.439999999999998 110.722 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' B' ' 62' ' ' ILE . 77.7 m-70 -156.47 67.55 0.57 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.852 -1.155 . . . . 63.310000000000002 109.874 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 7.5 m -58.75 -29.18 66.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.277 -0.889 . . . . 73.099999999999994 109.553 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 86.4 p -66.56 -27.66 67.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.285 -0.885 . . . . 71.530000000000001 110.311 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.424 HG22 ' N ' ' B' ' 70' ' ' VAL . 72.7 mt -79.42 157.34 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.022 -1.049 . . . . 74.400000000000006 109.592 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.507 HG12 ' N ' ' B' ' 71' ' ' VAL . 87.2 t -94.62 160.68 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.284 -0.885 . . . . 75.120000000000005 109.891 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.507 ' N ' HG12 ' B' ' 70' ' ' VAL . 3.6 t -136.22 133.28 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.296 -0.877 . . . . 73.200000000000003 108.908 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.633 ' CD1' HH22 ' B' ' 108' ' ' ARG . 1.0 OUTLIER -133.52 104.67 6.5 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.752 0.787 . . . . 73.340000000000003 109.385 -179.21 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 84.3 t -92.26 130.39 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.928 . . . . 73.5 109.552 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 11.8 p -89.79 170.33 10.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.04 -1.038 . . . . 64.340000000000003 108.212 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 18.8 p -157.43 110.83 2.54 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.757 -1.214 . . . . 74.530000000000001 110.329 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -64.97 -34.41 78.37 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.428 -0.953 . . . . 64.5 108.428 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -109.87 75.54 0.86 Allowed Pre-proline 0 N--CA 1.494 1.744 0 N-CA-C 108.527 -0.916 . . . . 74.25 108.527 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.2 86.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 121.889 1.726 . . . . 74.430000000000007 112.198 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.564 HG23 ' H ' ' B' ' 82' ' ' GLU . 1.6 t -105.53 150.93 24.91 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.571 -0.9 . . . . 73.120000000000005 108.571 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.94 -32.63 74.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.112 -0.992 . . . . 71.010000000000005 109.475 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.56 -42.32 87.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.175 -0.953 . . . . 63.200000000000003 109.588 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . 0.564 ' H ' HG23 ' B' ' 79' ' ' THR . 85.6 tt0 -74.46 -26.78 60.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 73.219999999999999 109.327 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.423 ' OE2' ' NH1' ' A' ' 108' ' ' ARG . 86.7 tt0 -68.71 -51.33 42.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 74.299999999999997 109.804 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.416 HG23 ' N ' ' B' ' 85' ' ' HIS . 29.4 m -63.28 -39.1 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.103 -0.998 . . . . 73.310000000000002 109.507 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' HIS . . . . . 0.416 ' N ' HG23 ' B' ' 84' ' ' VAL . 22.9 m80 -77.05 -21.07 55.04 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 73.239999999999995 109.41 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -68.15 -48.34 65.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.22 -0.925 . . . . 55.329999999999998 109.852 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' PHE . . . . . 0.444 ' CZ ' ' CB ' ' A' ' 111' ' ' ALA . 80.7 t80 -76.28 -33.0 59.1 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.988 -1.07 . . . . 74.140000000000001 108.963 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -62.15 -51.02 69.51 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.361 -0.837 . . . . 64.040000000000006 109.195 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -58.88 -49.79 76.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.53 -0.731 . . . . 72.349999999999994 109.831 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 153.23 35.87 0.03 OUTLIER Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.775 -1.202 . . . . 65.200000000000003 110.162 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -99.47 125.49 45.22 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.245 -1.15 . . . . 52.229999999999997 109.154 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -71.08 -33.39 70.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.046 -1.034 . . . . 73.319999999999993 108.941 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 36.2 t0 -153.13 164.93 37.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.513 -0.742 . . . . 72.219999999999999 109.191 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.531 ' O ' ' CD1' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -139.59 115.47 10.2 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.108 -0.701 . . . . 64.420000000000002 109.108 -178.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.483 HD11 ' OD2' ' B' ' 93' ' ' ASP . 29.1 mm -113.17 144.82 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.356 0 O-C-N 121.326 -0.859 . . . . 72.230000000000004 110.013 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.64 135.18 57.53 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.042 -1.096 . . . . 25.239999999999998 108.042 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.684 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -55.67 -56.42 29.98 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 120.984 -1.072 . . . . 64.319999999999993 111.46 -178.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 6.0 Cg_endo -42.33 -7.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 120.871 1.047 . . . . 63.329999999999998 112.945 -176.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . 0.684 ' N ' ' O ' ' B' ' 97' ' ' LYS . 68.8 m-85 60.44 115.17 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.661 -0.649 . . . . 75.129999999999995 109.475 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -56.57 -28.18 59.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.117 -0.989 . . . . 74.230000000000004 109.422 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . 0.742 ' O ' ' N ' ' B' ' 103' ' ' LYS . 30.2 t -174.51 30.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.003 -1.061 . . . . 63.340000000000003 110.7 179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 55.1 mt 52.29 -69.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.641 -0.662 . . . . 74.439999999999998 110.283 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.742 ' N ' ' O ' ' B' ' 101' ' ' SER . 29.7 mmtp -59.62 -28.4 67.16 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.331 -0.989 . . . . 71.109999999999999 108.331 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.97 -44.8 91.64 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.462 -0.895 . . . . 71.450000000000003 108.595 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.687 HD13 ' C ' ' B' ' 105' ' ' LEU . 1.3 tm? -57.19 -55.38 35.53 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.869 -0.789 . . . . 51.310000000000002 108.869 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . 0.625 ' N ' HD13 ' B' ' 105' ' ' LEU . 21.7 t -63.28 -39.24 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.749 -1.22 . . . . 65.230000000000004 109.741 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -47.7 -44.19 27.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 24.32 110.265 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 0.633 HH22 ' CD1' ' B' ' 72' ' ' LEU . 13.9 ptt85 -79.96 -31.03 39.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.988 -1.07 . . . . 75.310000000000002 110.707 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 34.5 mt -71.77 -30.43 37.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.494 -1.379 . . . . 54.240000000000002 108.264 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' B' ' 113' ' ' LEU . 21.0 tt0 -72.85 -60.59 2.16 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.402 -0.919 . . . . 65.310000000000002 108.972 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . 0.409 ' HB1' ' CE1' ' A' ' 87' ' ' PHE . . . -43.33 -44.66 5.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.68 -0.638 . . . . 72.239999999999995 109.981 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . 0.437 HH21 HD23 ' B' ' 47' ' ' LEU . 64.9 ttp85 -66.13 -34.81 78.89 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.221 -0.925 . . . . 72.040000000000006 109.391 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.439 ' N ' ' O ' ' B' ' 110' ' ' GLU . 7.1 tp -97.24 -75.09 0.55 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.228 -0.92 . . . . 75.349999999999994 110.365 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' B' ' 113' ' ' LEU . 83.3 mtt180 47.14 96.55 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.278 -0.889 . . . . 75.5 109.571 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 45.46 86.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.524 -0.735 . . . . 65.329999999999998 110.076 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 81.4 t90 -59.04 146.92 36.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.872 . . . . 74.450000000000003 109.298 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 161.12 101.16 0.16 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.734 -1.346 . . . . 44.210000000000001 109.734 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 83.3 p -157.03 161.26 39.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.252 -1.146 . . . . 71.400000000000006 109.692 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.42 -177.57 5.73 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.784 -0.766 . . . . 72.319999999999993 109.151 -178.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 6.0 t -144.43 -36.92 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.31 -0.869 . . . . 75.019999999999996 109.303 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 47.5 mt -111.51 125.83 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.507 -0.745 . . . . 51.409999999999997 109.201 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.416 ' O ' HG23 ' B' ' 123' ' ' ILE . 77.0 mt-10 -138.97 120.43 14.98 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.266 -0.896 . . . . 71.530000000000001 109.2 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.416 HG23 ' O ' ' B' ' 122' ' ' GLU . 19.0 pt -154.98 142.79 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.16 -0.962 . . . . 72.430000000000007 109.778 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' B' ' 126' ' ' LEU . . . 51.12 39.22 41.29 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.444 -1.062 . . . . 51.229999999999997 110.444 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 69.06 -13.88 0.33 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.303 -1.116 . . . . 74.200000000000003 109.935 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.52 HD22 ' CD1' ' B' ' 137' ' ' TYR . 1.1 mt -82.37 144.3 30.64 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.769 -1.197 . . . . 75.420000000000002 107.769 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 92.3 m -128.65 144.18 51.1 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.375 -0.828 . . . . 74.219999999999999 109.738 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 7.6 mt -141.06 140.93 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.434 -0.791 . . . . 60.329999999999998 109.519 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 70.5 m -117.92 123.64 29.43 Favored Pre-proline 0 N--CA 1.5 2.054 0 N-CA-C 108.965 -0.754 . . . . 72.310000000000002 108.965 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.27 -40.1 0.29 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.821 1.681 . . . . 75.129999999999995 112.196 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -66.42 -44.57 82.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.175 -0.953 . . . . 75.230000000000004 109.943 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' B' ' 132' ' ' GLU . 35.6 mp0 -84.85 -5.15 59.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.197 -0.939 . . . . 72.430000000000007 109.818 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 48.53 72.03 0.31 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.206 -0.934 . . . . 75.129999999999995 109.764 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -152.39 142.53 22.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.312 -0.867 . . . . 73.219999999999999 109.369 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . 0.409 ' O ' HG23 ' B' ' 135' ' ' ILE . 15.8 tt -115.49 132.19 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.436 -0.79 . . . . 64.140000000000001 109.125 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 61.9 mt -117.22 130.79 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 109.069 -0.715 . . . . 71.219999999999999 109.069 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . 0.52 ' CD1' HD22 ' B' ' 126' ' ' LEU . 64.3 t80 -132.6 130.83 40.76 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.441 -0.787 . . . . 64.219999999999999 109.505 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . 0.516 ' O ' ' NH1' ' B' ' 140' ' ' ARG . 24.5 mmtm 53.55 32.82 14.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.307 -0.87 . . . . 72.019999999999996 110.49 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.25 -4.55 71.35 Favored Glycine 0 N--CA 1.494 2.549 0 C-N-CA 120.049 -1.072 . . . . 74.319999999999993 110.882 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . 0.516 ' NH1' ' O ' ' B' ' 138' ' ' LYS . 11.2 mpt_? -87.74 134.59 33.64 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.817 -1.402 . . . . 75.340000000000003 108.842 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -102.11 122.92 45.07 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.385 -0.822 . . . . 71.230000000000004 110.034 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 13.5 p -137.78 137.56 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.529 -0.915 . . . . 70.430000000000007 108.529 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -90.2 143.3 26.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.272 -0.893 . . . . 72.430000000000007 110.344 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . 0.535 HG23 ' O ' ' B' ' 144' ' ' VAL . 21.5 m -146.57 121.42 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.217 -1.031 . . . . 72.129999999999995 108.217 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 7.1 mtmm -139.68 126.48 20.72 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.18 -0.95 . . . . 72.019999999999996 109.484 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.16 171.39 33.17 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.473 -1.451 . . . . 42.229999999999997 109.473 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 0.87 ' HD3' ' OE1' ' B' ' 175' ' ' GLU . 11.4 mttm -67.75 -38.81 15.87 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.235 -1.156 . . . . 73.299999999999997 109.886 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 30.0 Cg_exo -60.89 -38.14 71.94 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.265 1.977 . . . . 71.329999999999998 112.211 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -88.53 -17.83 29.42 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.237 -0.914 . . . . 74.230000000000004 109.732 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -54.34 -38.29 65.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 72.340000000000003 109.479 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.458 HG13 ' N ' ' B' ' 152' ' ' LEU . 10.9 p -67.93 -38.68 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.364 -0.835 . . . . 73.349999999999994 109.74 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.458 ' N ' HG13 ' B' ' 151' ' ' VAL . 31.3 tp -55.38 -47.07 76.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.91 . . . . 55.240000000000002 109.542 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 60.4 p -68.27 -32.23 72.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.165 -0.96 . . . . 70.010000000000005 109.619 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . 0.582 ' CE1' ' HD1' ' B' ' 158' ' ' HIS . 56.9 t-80 -56.67 -58.99 5.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.849 . . . . 65.319999999999993 110.339 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 pp -69.18 -22.73 63.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.082 -1.012 . . . . 71.540000000000006 109.923 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.92 -39.88 86.99 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.18 -0.95 . . . . 75.319999999999993 109.198 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -85.24 -34.59 21.94 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.181 -0.95 . . . . 73.319999999999993 109.758 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . 0.582 ' HD1' ' CE1' ' B' ' 154' ' ' HIS . 36.5 m80 -87.41 40.14 0.91 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.143 -0.973 . . . . 74.140000000000001 109.786 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -55.3 151.1 10.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 61.409999999999997 109.342 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' B' ' 214' ' ' PHE . 64.3 t0 52.28 68.18 0.86 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 72.099999999999994 109.592 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -160.1 147.32 16.28 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.144 -0.972 . . . . 72.25 109.797 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 12.2 mm -91.29 134.73 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.432 -0.951 . . . . 72.310000000000002 108.432 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 48.3 t -135.96 135.74 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.245 -0.909 . . . . 64.209999999999994 110.021 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 10.8 t -89.19 155.65 19.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.426 -0.796 . . . . 74.219999999999999 109.343 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -55.41 -31.68 62.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.385 -0.822 . . . . 65.310000000000002 109.794 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -57.29 -39.14 75.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 63.450000000000003 110.26 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -62.95 -43.43 98.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.012 -1.055 . . . . 72.400000000000006 109.8 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 20.0 mt -55.26 -59.09 5.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.15 -0.969 . . . . 72.319999999999993 109.102 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.566 ' C ' HD13 ' B' ' 169' ' ' LEU . 1.6 tm? -54.7 -65.33 0.6 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.078 -1.014 . . . . 73.340000000000003 109.284 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -46.4 -36.25 6.31 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 112.949 0.722 . . . . 72.099999999999994 112.949 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.05 -30.97 14.41 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.595 -1.316 . . . . 62.130000000000003 113.214 -176.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.416 ' CD1' ' N ' ' B' ' 172' ' ' ILE . 1.3 mp -84.94 -58.58 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 120.433 -1.417 . . . . 71.420000000000002 111.208 -177.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' TRP . . . . . 0.586 ' O ' ' CE3' ' B' ' 173' ' ' TRP . 0.0 OUTLIER -64.99 131.47 46.68 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.609 -1.307 . . . . 72.230000000000004 109.76 -178.463 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . 0.481 ' H ' ' HD2' ' B' ' 176' ' ' PRO . 87.1 tt0 -175.97 -31.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.529 -0.732 . . . . 52.109999999999999 109.734 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . 0.87 ' OE1' ' HD3' ' B' ' 147' ' ' LYS . 4.0 mp0 -87.44 -34.71 0.45 Allowed Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.067 -1.021 . . . . 73.040000000000006 111.613 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' B' ' 175' ' ' GLU . 96.7 Cg_endo -90.34 -44.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 122.319 2.013 . . . . 74.129999999999995 112.327 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 49.14 12.22 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 72.439999999999998 109.751 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . 0.495 ' N ' ' O ' ' B' ' 176' ' ' PRO . 11.2 tpt -112.11 3.29 17.21 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.45 -0.945 . . . . 63.43 108.45 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 19.0 m -76.16 148.99 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.384 -0.823 . . . . 71.049999999999997 109.66 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . 0.474 ' O ' ' N ' ' B' ' 182' ' ' ASN . 0.9 OUTLIER -60.86 155.5 52.51 Favored Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 108.604 -0.887 . . . . 62.149999999999999 108.604 179.57 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.06 43.84 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.451 2.101 . . . . 65.219999999999999 112.024 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 182' ' ' ASN . . . . . 0.5 ' C ' ' H ' ' B' ' 184' ' ' ILE . 43.4 t30 -170.4 -106.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.105 -0.997 . . . . 72.310000000000002 109.297 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 5.5 t 61.99 -3.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.454 -0.779 . . . . 63.32 109.818 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.5 ' H ' ' C ' ' B' ' 182' ' ' ASN . 28.5 mt -69.63 -38.11 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.904 -1.123 . . . . 75.030000000000001 108.425 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -55.23 -53.3 57.74 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.822 -0.549 . . . . 64.109999999999999 109.759 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 30.7 m -73.28 -31.75 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.121 -0.987 . . . . 73.0 110.02 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.44 -56.61 13.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.058 -1.027 . . . . 61.119999999999997 109.848 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 10.8 tp -63.01 -29.75 47.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 120.898 -1.126 . . . . 72.430000000000007 109.421 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -68.9 -56.0 9.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 65.140000000000001 110.186 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . 0.409 ' O ' ' CB ' ' B' ' 194' ' ' LYS . 15.7 pt20 -66.14 -39.78 90.12 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.001 -1.062 . . . . 63.240000000000002 109.35 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 55.6 mt -54.65 -37.71 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.985 -1.072 . . . . 74.030000000000001 109.528 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -68.03 -52.85 30.76 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.074 -1.016 . . . . 72.239999999999995 110.48 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 193' ' ' GLN . . . . . 0.41 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 45.8 mt-30 -76.88 -14.25 59.9 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.999 -1.063 . . . . 73.099999999999994 110.113 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' B' ' 190' ' ' GLN . 53.4 tttp -92.43 -27.42 17.49 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.388 -0.82 . . . . 72.109999999999999 110.445 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 195' ' ' MET . . . . . 0.431 ' SD ' ' C ' ' B' ' 195' ' ' MET . 1.9 ppp? -90.56 -30.93 16.93 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.068 -1.02 . . . . 44.329999999999998 109.812 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 196' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 28.0 p-10 -58.87 -32.71 69.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.981 . . . . 71.209999999999994 109.747 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . 0.51 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 7.6 mmtp -63.03 -64.91 2.49 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 75.209999999999994 109.935 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 198' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 33.0 Cg_endo -61.96 -53.07 2.3 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 122.185 1.924 . . . . 75.319999999999993 112.352 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . 0.49 HD12 ' N ' ' B' ' 199' ' ' LEU . 10.0 mp -65.58 -40.23 92.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.031 -1.043 . . . . 72.25 109.324 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 77.72 -40.16 1.81 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.574 -1.411 . . . . 64.530000000000001 109.574 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 19.1 mm -97.65 146.25 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.24 -1.153 . . . . 44.229999999999997 109.478 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 38.8 t -85.75 141.07 29.96 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.23 -0.919 . . . . 54.009999999999998 109.245 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 13.8 p -142.7 18.22 2.0 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.181 -0.949 . . . . 74.400000000000006 109.904 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 21.9 m -140.7 137.05 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.189 -0.944 . . . . 72.120000000000005 109.437 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -116.34 135.68 53.66 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.576 -0.703 . . . . 65.409999999999997 109.342 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 1.4 p -93.59 132.23 38.11 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.174 -0.954 . . . . 71.329999999999998 108.946 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 25.5 t -138.92 143.66 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.331 -0.856 . . . . 63.5 109.539 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 208' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' B' ' 209' ' ' ARG . 91.4 mtt180 -60.07 164.89 3.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -0.856 . . . . 74.450000000000003 109.611 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' B' ' 211' ' ' GLY . 80.4 mtm-85 52.46 176.41 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.312 -0.868 . . . . 74.140000000000001 109.62 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 17.0 mmt85 53.85 -85.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.466 -0.771 . . . . 74.430000000000007 109.672 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' B' ' 209' ' ' ARG . . . 164.12 -96.66 0.14 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.482 -1.447 . . . . 64.450000000000003 109.482 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' TYR . . . . . 0.481 ' CD1' ' C ' ' B' ' 211' ' ' GLY . 52.8 m-85 -141.28 167.77 21.37 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.362 -1.081 . . . . 74.209999999999994 109.126 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -132.58 140.37 48.22 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.411 -0.806 . . . . 74.030000000000001 109.654 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . 0.512 ' O ' ' N ' ' B' ' 160' ' ' ASP . 2.3 m-85 -116.41 125.38 51.96 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.942 -0.762 . . . . 74.340000000000003 108.942 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . 0.577 ' SG ' ' N ' ' B' ' 216' ' ' TYR . 30.5 t -147.9 167.56 24.52 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.336 -0.852 . . . . 64.329999999999998 109.314 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . 0.577 ' N ' ' SG ' ' B' ' 215' ' ' CYS . 3.2 p90 -60.0 152.67 59.45 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.284 -0.885 . . . . 70.040000000000006 109.116 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.18 124.1 10.59 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.357 2.038 . . . . 65.109999999999999 112.044 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.638 ' N ' ' CD ' ' B' ' 219' ' ' PRO . 8.1 tptp -74.54 -35.62 2.23 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.2 -0.937 . . . . 73.150000000000006 110.356 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' B' ' 218' ' ' LYS . 32.1 Cg_exo -58.32 -22.0 55.6 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.076 1.851 . . . . 71.310000000000002 112.144 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -72.61 121.62 20.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 75.450000000000003 109.54 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 43.1 t -88.1 134.18 33.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.315 -0.866 . . . . 72.219999999999999 109.432 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -85.13 134.76 34.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 54.530000000000001 109.385 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.055 -0.974 . . . . 71.129999999999995 109.407 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.8 ttm . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.399 -0.593 . . . . 65.120000000000005 109.399 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -137.62 146.1 43.53 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.436 -0.79 . . . . 72.329999999999998 109.305 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 79.2 t -115.81 133.32 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-O 121.451 0.643 . . . . 71.420000000000002 109.746 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.544 HD11 ' CG1' ' A' ' 6' ' ' ILE . 2.4 tp -103.48 116.95 33.35 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.417 -0.957 . . . . 65.120000000000005 108.417 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 59.0 tp -117.33 114.54 23.73 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.918 -0.771 . . . . 62.43 108.918 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.544 ' CG1' HD11 ' A' ' 4' ' ' LEU . 52.4 mt -109.41 116.29 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.851 -0.796 . . . . 71.150000000000006 108.851 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 13' ' ' GLY . 61.7 tt0 -146.7 131.11 17.62 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.334 -0.854 . . . . 75.340000000000003 109.425 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -61.98 -35.78 79.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 72.439999999999998 109.58 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -86.23 116.85 24.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 63.020000000000003 109.492 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.4 p -73.12 -27.29 61.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.917 . . . . 72.340000000000003 109.623 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.7 t -63.75 -49.57 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.184 -0.948 . . . . 74.019999999999996 109.673 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.575 ' N ' HD22 ' A' ' 12' ' ' LEU . 3.5 mm? -67.83 -42.29 81.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.928 . . . . 71.430000000000007 109.128 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.51 ' N ' ' OE1' ' A' ' 7' ' ' GLU . . . -67.19 -19.79 70.57 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 108.354 -1.898 . . . . 61.32 108.354 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -70.38 -58.88 5.68 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.457 -1.457 . . . . 71.200000000000003 109.457 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -52.84 -42.78 65.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.399 -1.059 . . . . 71.319999999999993 109.464 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.3 mm -64.05 -38.65 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.943 -1.098 . . . . 63.229999999999997 108.807 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.42 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 72.6 tt0 -62.83 -52.49 62.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.837 . . . . 51.109999999999999 109.818 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.2 mttp -81.63 1.96 31.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -0.949 . . . . 73.340000000000003 109.632 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.24 -68.12 1.32 Allowed Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.159 -1.576 . . . . 62.149999999999999 109.159 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp -56.16 -25.93 48.5 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.417 -1.049 . . . . 73.510000000000005 109.088 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 2.6 m120 -52.09 -33.95 41.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.305 -0.872 . . . . 74.25 109.212 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.3 t -55.52 -41.4 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.881 . . . . 70.040000000000006 109.022 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.451 ' HZ2' ' CG1' ' A' ' 106' ' ' VAL . 2.1 mptm? -67.35 -22.58 65.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.358 -0.838 . . . . 73.230000000000004 108.994 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.14 38.42 4.32 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.153 -1.179 . . . . 75.540000000000006 110.153 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -112.74 159.33 19.06 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.413 -1.051 . . . . 73.430000000000007 108.62 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.0 mmt -99.63 138.55 36.56 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.304 -0.998 . . . . 43.240000000000002 108.304 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.13 160.51 40.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.902 . . . . 62.109999999999999 109.995 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -134.92 141.35 46.28 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.967 -0.753 . . . . 74.420000000000002 108.967 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -110.43 130.54 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.727 -0.842 . . . . 72.150000000000006 108.727 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.1 p -135.0 167.63 20.58 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.499 -0.75 . . . . 71.420000000000002 109.251 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.459 ' CG ' ' OD2' ' A' ' 35' ' ' ASP . 3.4 pt-20 -90.68 -99.86 0.1 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.245 -0.909 . . . . 72.329999999999998 109.564 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.0 p -78.77 166.59 22.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -0.867 . . . . 74.239999999999995 109.997 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 15.5 mt -56.02 -32.04 63.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.611 -0.68 . . . . 71.530000000000001 110.032 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -50.58 -45.83 57.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.031 -1.043 . . . . 74.230000000000004 109.793 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.459 ' OD2' ' CG ' ' A' ' 31' ' ' GLU . 67.9 m-20 -68.25 -43.05 78.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.054 -1.029 . . . . 54.030000000000001 109.364 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.43 -40.47 79.46 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.386 -1.486 . . . . 61.409999999999997 109.386 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -65.11 -38.92 92.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.308 -1.113 . . . . 74.340000000000003 109.419 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -75.61 -36.73 60.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 75.329999999999998 109.48 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.7 tp -71.42 -45.76 61.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 74.329999999999998 109.905 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.444 ' O ' ' O ' ' A' ' 43' ' ' ARG . 3.2 ppp? -69.08 -20.37 64.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.074 -1.016 . . . . 70.319999999999993 109.857 -179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -60.73 -36.95 80.14 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.022 -1.049 . . . . 71.219999999999999 109.611 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.4 pt -89.23 -27.58 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.18 -0.95 . . . . 74.140000000000001 110.317 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 40' ' ' MET . 96.9 mtt180 -127.82 146.03 50.74 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.298 -0.877 . . . . 72.239999999999995 109.771 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.491 ' OD1' HD11 ' A' ' 69' ' ' ILE . 60.8 t30 -98.61 132.05 44.32 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.231 -0.918 . . . . 75.420000000000002 109.475 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -101.9 135.16 43.93 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.36 -0.838 . . . . 74.230000000000004 109.343 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -74.75 -35.26 62.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.948 . . . . 72.040000000000006 108.969 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.555 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.7 OUTLIER -112.72 115.8 29.11 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.426 -0.953 . . . . 72.129999999999995 108.426 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.555 ' N ' HD13 ' A' ' 47' ' ' LEU . 39.2 t -99.11 97.04 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.27 -1.011 . . . . 72.340000000000003 108.27 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.2 ttt -109.22 134.07 52.22 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.536 0.684 . . . . 74.109999999999999 109.611 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.444 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 1.3 p -143.96 131.66 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.461 -0.775 . . . . 61.119999999999997 109.505 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.3 p -96.99 2.97 52.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.501 -0.749 . . . . 73.109999999999999 109.125 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.444 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 47.5 m-20 -76.26 142.23 41.45 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.269 -0.895 . . . . 52.549999999999997 109.54 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.566 ' NZ ' ' H ' ' A' ' 76' ' ' ASP . 66.0 mmtt -79.07 -39.36 34.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 44.219999999999999 110.198 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -72.17 15.0 0.18 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.082 -1.011 . . . . 70.439999999999998 109.733 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.459 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.52 -19.75 59.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 64.140000000000001 110.411 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.531 HD13 ' NE2' ' A' ' 85' ' ' HIS . 22.0 mt -40.66 -50.22 3.05 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.428 -0.795 . . . . 44.140000000000001 110.473 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.0 m -68.14 -34.69 76.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.96 -1.087 . . . . 55.229999999999997 109.262 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.534 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 55.9 t80 -65.81 -56.08 13.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -0.794 . . . . 74.439999999999998 110.115 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.6 m -54.57 -35.38 31.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 120.749 -1.219 . . . . 74.030000000000001 109.662 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.6 t -57.4 -54.48 46.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.097 -1.002 . . . . 64.299999999999997 109.655 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 ptp85 -66.05 -29.26 69.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.119 -0.988 . . . . 64.439999999999998 110.092 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.534 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 5.6 mm -65.63 -38.21 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.751 -1.218 . . . . 63.210000000000001 109.898 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.521 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 33.5 mmtt -69.63 -50.51 43.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.107 -0.996 . . . . 74.420000000000002 110.117 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -67.39 -35.46 79.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.762 -1.211 . . . . 70.319999999999993 109.767 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.471 ' C ' ' CG ' ' A' ' 66' ' ' HIS . 48.7 mtpt -81.77 -23.43 36.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.196 -0.94 . . . . 75.219999999999999 109.607 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.471 ' CG ' ' C ' ' A' ' 65' ' ' LYS . 59.4 m-70 -155.26 65.03 0.63 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.168 -0.957 . . . . 74.129999999999995 109.632 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 63' ' ' LYS . 33.1 t -61.06 -30.36 70.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.25 -0.906 . . . . 73.239999999999995 110.017 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.4 t -61.9 -19.83 63.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.168 -0.958 . . . . 61.009999999999998 110.198 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.491 HD11 ' OD1' ' A' ' 44' ' ' ASN . 78.8 mt -87.81 152.97 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.1 -1.0 . . . . 71.329999999999998 109.945 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 71' ' ' VAL . 48.3 t -92.95 160.63 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.351 -0.843 . . . . 72.129999999999995 109.518 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.461 ' N ' HG12 ' A' ' 70' ' ' VAL . 43.2 t -134.59 129.81 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.348 -0.845 . . . . 54.210000000000001 109.898 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.2 tt -122.39 99.05 6.21 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.884 -0.784 . . . . 50.240000000000002 108.884 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.0 t -92.22 127.45 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.167 -0.958 . . . . 74.409999999999997 108.825 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.412 ' O ' ' OG ' ' A' ' 75' ' ' SER . 0.4 OUTLIER -92.97 -176.25 4.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.019 -1.051 . . . . 72.310000000000002 108.805 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.463 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 55.7 m -166.75 119.83 1.01 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.792 -1.193 . . . . 64.540000000000006 110.502 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.566 ' H ' ' NZ ' ' A' ' 53' ' ' LYS . 50.4 t0 -61.65 -32.33 72.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.541 -0.725 . . . . 74.129999999999995 109.807 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 79' ' ' THR . 44.8 t-20 -119.78 84.06 30.5 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.583 -0.698 . . . . 73.340000000000003 109.242 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -54.19 82.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.208 1.939 . . . . 63.219999999999999 111.341 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.493 HG23 ' H ' ' A' ' 82' ' ' GLU . 3.4 t -105.22 154.74 19.81 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.519 -0.738 . . . . 62.530000000000001 109.589 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.56 -32.61 73.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.402 -0.811 . . . . 73.439999999999998 109.78 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -55.08 -55.91 25.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 71.420000000000002 110.009 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.534 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 95.4 mt-10 -64.6 -35.39 80.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -0.957 . . . . 73.430000000000007 109.796 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.52 ' OE2' ' NH2' ' B' ' 108' ' ' ARG . 66.9 tt0 -63.91 -48.98 74.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.049 -1.032 . . . . 74.219999999999999 110.068 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.5 t -57.2 -57.56 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.167 -0.958 . . . . 73.200000000000003 110.313 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.57 ' ND1' ' N ' ' A' ' 86' ' ' ALA . 1.3 p-80 -64.83 -41.11 96.01 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.942 -1.099 . . . . 53.329999999999998 109.515 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.57 ' N ' ' ND1' ' A' ' 85' ' ' HIS . . . -46.93 -37.69 9.36 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 64.109999999999999 109.833 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -78.43 -34.32 47.96 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.103 -0.998 . . . . 74.340000000000003 108.761 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -67.5 -40.47 85.18 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.414 -0.914 . . . . 74.420000000000002 109.432 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.571 ' NE2' ' N ' ' A' ' 89' ' ' GLN . 0.7 OUTLIER -65.14 -56.88 10.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 74.239999999999995 109.614 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 152.13 44.58 0.02 OUTLIER Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.724 -1.227 . . . . 61.509999999999998 110.249 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -96.2 133.28 40.7 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.083 -1.245 . . . . 55.329999999999998 109.222 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.521 ' OD1' ' NZ ' ' A' ' 63' ' ' LYS . 72.7 m-20 -90.96 -22.53 20.79 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.085 -1.009 . . . . 73.420000000000002 109.677 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 94' ' ' TYR . 18.7 t0 -149.61 154.81 39.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.22 -0.925 . . . . 75.040000000000006 109.265 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.516 ' N ' ' OD1' ' A' ' 93' ' ' ASP . 71.3 t80 -136.86 105.65 5.88 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.522 -0.736 . . . . 71.329999999999998 109.257 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.409 HG22 ' N ' ' A' ' 96' ' ' ALA . 27.0 mm -111.47 155.69 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 O-C-N 121.127 -0.983 . . . . 71.129999999999995 110.735 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.409 ' N ' HG22 ' A' ' 95' ' ' ILE . . . -74.4 128.73 36.27 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.657 -1.238 . . . . 64.319999999999993 107.657 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.687 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -50.83 -57.28 14.04 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.715 -1.241 . . . . 62.200000000000003 111.399 -178.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 5.2 Cg_endo -41.5 -9.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.066 1.177 . . . . 73.109999999999999 112.797 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.687 ' N ' ' O ' ' A' ' 97' ' ' LYS . 24.9 m-85 62.81 108.66 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.339 -0.615 . . . . 65.219999999999999 109.339 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.526 ' NH1' ' OE2' ' B' ' 83' ' ' GLU . 21.6 ttm105 -52.81 -33.26 48.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.848 -1.157 . . . . 72.349999999999994 108.374 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 103' ' ' LYS . 2.3 m 172.37 48.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.552 -0.717 . . . . 71.319999999999993 109.524 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.516 ' O ' ' N ' ' A' ' 105' ' ' LEU . 13.1 mt 37.6 -77.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 121.835 -0.541 . . . . 75.430000000000007 111.982 178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.692 ' N ' ' O ' ' A' ' 101' ' ' SER . 28.0 mmtp -38.03 -38.8 0.34 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.533 -0.729 . . . . 71.409999999999997 110.26 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' B' ' 80' ' ' SER . . . -70.84 -43.51 68.37 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.206 -1.035 . . . . 63.240000000000002 108.206 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 102' ' ' ILE . 1.2 tt -60.85 -44.81 96.48 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.684 -0.858 . . . . 73.219999999999999 108.684 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.451 ' CG1' ' HZ2' ' A' ' 23' ' ' LYS . 15.6 t -69.43 -43.08 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 60.109999999999999 109.619 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.61 -42.61 62.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 70.420000000000002 109.174 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.75 -35.94 77.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 74.409999999999997 109.015 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.0 mt -70.87 -30.32 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.951 -1.093 . . . . 62.539999999999999 108.677 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -62.24 -53.47 54.71 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.381 -0.825 . . . . 74.340000000000003 108.782 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.09 -39.39 69.26 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.468 -0.77 . . . . 73.319999999999993 109.148 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 20.0 tpt85 -59.25 -32.63 70.17 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.265 -0.897 . . . . 52.409999999999997 109.145 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.4 tp -157.6 102.42 1.88 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.264 -0.898 . . . . 65.239999999999995 109.638 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.519 ' O ' ' CG ' ' A' ' 115' ' ' PHE . 23.1 mtm105 -94.84 -56.3 2.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.131 -0.981 . . . . 64.450000000000003 109.007 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.519 ' CG ' ' O ' ' A' ' 114' ' ' ARG . 82.4 m-85 -157.02 -58.14 0.09 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.182 -0.949 . . . . 74.430000000000007 109.213 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 62.7 m95 48.04 -122.59 1.53 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.317 -0.865 . . . . 74.420000000000002 109.695 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.1 43.38 56.8 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.152 -1.579 . . . . 75.040000000000006 109.152 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.1 m -100.37 147.97 25.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.375 -1.074 . . . . 61.140000000000001 109.564 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.541 HD21 ' C ' ' A' ' 121' ' ' ILE . 2.4 t30 -108.91 166.72 10.61 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.61 -0.681 . . . . 65.239999999999995 109.261 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.414 ' N ' ' CG ' ' A' ' 119' ' ' ASN . 4.4 t -124.68 -39.09 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.722 -0.611 . . . . 73.109999999999999 109.379 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.541 ' C ' HD21 ' A' ' 119' ' ' ASN . 17.1 mm -100.23 140.5 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.317 -0.864 . . . . 72.239999999999995 110.005 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.743 ' H ' HH12 ' A' ' 159' ' ' ARG . 86.4 mt-10 -135.61 119.31 17.15 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.382 -0.823 . . . . 72.340000000000003 108.901 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 37.8 mt -138.62 111.84 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.228 -0.92 . . . . 71.439999999999998 109.782 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 126' ' ' LEU . . . 65.61 46.51 83.98 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.209 -1.156 . . . . 73.400000000000006 110.209 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.901 ' HA ' ' OE2' ' A' ' 223' ' ' GLU . 3.6 m-20 67.25 -14.16 0.19 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.512 -0.993 . . . . 74.450000000000003 110.308 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.49 ' H ' ' C ' ' A' ' 124' ' ' GLY . 7.1 mt -76.99 155.24 32.76 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.61 -1.256 . . . . 54.210000000000001 107.61 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.88 129.28 46.63 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.368 -0.833 . . . . 54.5 109.49 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 74.8 mt -123.58 130.86 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.071 -0.714 . . . . 45.149999999999999 109.071 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 22.3 m -117.16 112.99 39.48 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 121.604 -0.685 . . . . 71.109999999999999 109.304 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -81.09 -51.09 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.106 1.871 . . . . 65.409999999999997 112.621 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -55.19 -45.68 75.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.063 -1.023 . . . . 63.32 109.532 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -81.53 -8.43 59.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 72.519999999999996 109.169 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 52.57 57.55 6.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.401 -0.812 . . . . 75.329999999999998 109.248 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -140.79 127.8 20.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.376 -0.828 . . . . 71.230000000000004 108.942 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.666 HD13 ' N ' ' A' ' 136' ' ' ILE . 0.2 OUTLIER -107.08 126.32 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.362 -0.836 . . . . 74.019999999999996 109.147 -179.586 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.666 ' N ' HD13 ' A' ' 135' ' ' ILE . 40.9 mt -117.86 126.76 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.532 -0.73 . . . . 60.229999999999997 109.951 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -137.25 142.66 42.01 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.355 -0.841 . . . . 62.32 108.954 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp 54.83 14.04 0.83 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.575 -0.703 . . . . 75.400000000000006 110.272 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 92.33 -6.56 78.23 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.49 -1.044 . . . . 72.239999999999995 110.49 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.473 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 1.0 OUTLIER -87.99 124.87 34.16 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.858 -1.378 . . . . 71.219999999999999 108.651 179.614 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -94.3 129.23 41.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.084 -1.01 . . . . 71.420000000000002 110.049 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.6 t -135.96 133.48 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.513 -0.742 . . . . 53.020000000000003 109.046 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -88.36 131.68 34.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.415 -0.803 . . . . 60.450000000000003 109.603 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.45 150.25 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.571 -0.9 . . . . 74.439999999999998 108.571 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -162.38 113.92 1.61 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.012 -1.055 . . . . 65.150000000000006 109.653 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.608 ' O ' ' HB2' ' A' ' 150' ' ' GLU . . . 163.37 -169.07 38.32 Favored Glycine 0 N--CA 1.486 1.983 0 C-N-CA 119.511 -1.328 . . . . 73.340000000000003 109.899 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.54 ' N ' ' HD2' ' A' ' 148' ' ' PRO . 41.7 mttp -78.06 -41.68 2.08 Favored Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.506 -0.996 . . . . 72.219999999999999 111.897 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 147' ' ' LYS . 36.7 Cg_endo -65.44 -30.38 52.93 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 CA-C-N 120.49 1.211 . . . . 65.230000000000004 111.891 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -94.38 -19.07 20.95 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.042 -1.037 . . . . 60.109999999999999 109.554 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.608 ' HB2' ' O ' ' A' ' 146' ' ' GLY . 34.9 tp10 -68.24 -43.32 78.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.356 -0.84 . . . . 64.209999999999994 108.907 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 12.0 p -61.66 -30.17 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.465 -0.939 . . . . 72.019999999999996 108.465 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 31.0 tp -65.61 -45.33 83.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.544 -0.723 . . . . 73.310000000000002 109.169 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.3 p -71.05 -30.1 66.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.945 . . . . 74.310000000000002 109.3 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -61.54 -53.46 56.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.168 -0.958 . . . . 74.310000000000002 109.742 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 156' ' ' ALA . 4.4 pp -69.87 -22.65 63.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 75.340000000000003 109.33 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.718 ' N ' HD12 ' A' ' 155' ' ' LEU . . . -60.67 -49.12 78.79 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.341 -0.85 . . . . 62.140000000000001 109.243 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.424 ' C ' ' H ' ' A' ' 159' ' ' ARG . 36.8 mtp180 -75.33 -44.39 45.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.025 -1.047 . . . . 61.030000000000001 109.164 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -77.71 26.43 0.18 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.255 -0.903 . . . . 74.120000000000005 109.412 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.743 HH12 ' H ' ' A' ' 122' ' ' GLU . 36.5 ptt180 -59.98 169.5 1.48 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.39 -0.819 . . . . 71.129999999999995 109.405 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.0 t0 46.47 65.49 1.19 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.316 -0.865 . . . . 75.450000000000003 109.484 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -169.94 149.67 3.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.123 -0.985 . . . . 73.409999999999997 109.792 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.402 HG21 ' HE ' ' A' ' 210' ' ' ARG . 75.5 mt -81.36 105.15 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.226 -1.027 . . . . 74.409999999999997 108.226 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 12.1 t -91.51 128.66 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.38 -0.825 . . . . 72.310000000000002 109.978 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.1 p -86.6 164.15 17.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.844 . . . . 74.120000000000005 109.052 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.482 ' CB ' ' NZ ' ' A' ' 165' ' ' LYS . 6.6 mtpm? -63.68 -48.12 78.46 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.257 -0.902 . . . . 70.430000000000007 110.185 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -56.0 -32.5 64.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.425 -0.797 . . . . 73.519999999999996 110.785 -178.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -56.19 -56.06 25.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.973 -1.079 . . . . 74.519999999999996 110.119 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 51.2 mt -61.52 -41.69 97.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.165 -0.959 . . . . 72.310000000000002 110.372 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.547 ' C ' HD13 ' A' ' 169' ' ' LEU . 1.6 tm? -62.24 -55.63 26.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.005 -1.06 . . . . 53.329999999999998 109.868 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 49.6 t0 -71.07 -13.18 61.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.134 -0.979 . . . . 62.439999999999998 110.45 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.97 -62.97 1.53 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.025 -1.047 . . . . 60.210000000000001 110.998 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.688 HD12 ' N ' ' A' ' 172' ' ' ILE . 2.1 mp -73.23 -47.62 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 120.912 -1.117 . . . . 75.319999999999993 108.183 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 24.0 m-90 -95.18 119.4 33.62 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.559 -0.904 . . . . 73.140000000000001 108.559 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -151.66 -53.56 0.13 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.215 -0.928 . . . . 73.239999999999995 108.708 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 177' ' ' GLU . 12.4 mt-10 -60.16 154.89 48.72 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 108.001 -1.111 . . . . 44.43 108.001 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.421 ' C ' ' O ' ' A' ' 175' ' ' GLU . 32.2 Cg_exo -30.94 88.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.74 2.293 . . . . 72.510000000000005 112.478 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 175' ' ' GLU . 33.9 mm-40 -127.3 160.02 32.6 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 109.166 -0.679 . . . . 63.240000000000002 109.166 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 65.2 mtt -103.38 93.07 4.77 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.421 -0.8 . . . . 73.5 109.345 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 35.9 m -100.46 135.41 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.285 -0.885 . . . . 65.219999999999999 109.221 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.434 HG23 ' H ' ' A' ' 180' ' ' THR . 1.4 p -68.8 148.61 97.99 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.166 -0.959 . . . . 71.420000000000002 108.527 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.432 ' O ' ' OD1' ' A' ' 182' ' ' ASN . 99.1 Cg_exo -39.98 -30.67 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 121.974 1.783 . . . . 41.219999999999999 112.282 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 181' ' ' PRO . 69.7 m-80 -155.77 112.8 3.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.384 -0.823 . . . . 64.540000000000006 109.408 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.411 ' O ' HG22 ' A' ' 183' ' ' VAL . 3.2 p -143.71 -14.11 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.201 -0.937 . . . . 74.019999999999996 110.294 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 6.1 tt -56.1 -23.08 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.743 -1.223 . . . . 72.329999999999998 109.738 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -58.23 -49.66 76.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 74.400000000000006 109.837 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 16.4 m -76.35 -25.02 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.89 -1.132 . . . . 70.420000000000002 109.663 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.19 -46.59 49.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.058 -1.026 . . . . 52.109999999999999 110.1 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.8 tp -67.95 -30.93 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.911 -1.118 . . . . 71.400000000000006 109.093 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -70.02 -57.42 5.02 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.372 -0.83 . . . . 73.439999999999998 109.99 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.439 ' CG ' ' N ' ' A' ' 191' ' ' ILE . 7.7 pt20 -63.06 -43.85 97.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 71.420000000000002 109.983 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.439 ' N ' ' CG ' ' A' ' 190' ' ' GLN . 51.0 mt -53.69 -49.29 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.112 -0.992 . . . . 61.549999999999997 109.165 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -54.63 -40.56 69.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.096 -1.003 . . . . 63.340000000000003 109.249 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -62.51 -35.97 81.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.142 -0.973 . . . . 61.240000000000002 109.538 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -93.0 -0.05 57.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.207 -0.933 . . . . 75.129999999999995 110.382 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 31.9 ttm -95.72 -63.01 1.2 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.005 -1.059 . . . . 74.019999999999996 109.389 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 200' ' ' GLY . 84.5 m-20 -60.66 -29.08 69.07 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.439 -0.788 . . . . 74.019999999999996 110.095 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.438 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 30.7 mttm -58.64 -65.75 1.78 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.053 -1.03 . . . . 75.430000000000007 110.06 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 26.7 Cg_endo -60.96 -52.83 3.11 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.915 1.743 . . . . 72.319999999999993 112.108 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' A' ' 201' ' ' ILE . 26.0 mt -66.35 -34.83 78.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.946 -1.096 . . . . 74.540000000000006 109.154 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 196' ' ' ASP . . . 77.65 -31.67 1.68 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.038 -1.625 . . . . 61.509999999999998 109.038 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.459 ' H ' ' C ' ' A' ' 199' ' ' LEU . 27.6 mm -95.89 129.45 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.41 -1.053 . . . . 61.219999999999999 109.286 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 64.9 m -78.8 139.22 38.42 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.603 -0.888 . . . . 72.0 108.603 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 38.5 p -142.57 13.77 1.95 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.216 -0.928 . . . . 74.439999999999998 109.814 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.33 131.77 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 N-CA-C 108.765 -0.828 . . . . 64.349999999999994 108.765 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.41 ' OE1' ' SG ' ' A' ' 215' ' ' CYS . 30.1 mt-10 -117.01 123.45 46.92 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.636 -0.665 . . . . 71.409999999999997 109.509 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.99 98.93 10.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.319 -0.863 . . . . 73.519999999999996 108.715 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 208' ' ' ARG . 12.0 m -152.41 172.14 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.227 -0.921 . . . . 71.019999999999996 109.415 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 207' ' ' VAL . 70.2 mtt85 55.44 164.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.621 -0.674 . . . . 72.120000000000005 109.702 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.483 ' O ' ' N ' ' A' ' 211' ' ' GLY . 80.9 mtt85 -72.61 -126.11 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.21 -0.931 . . . . 64.409999999999997 109.398 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.402 ' HE ' HG21 ' A' ' 162' ' ' ILE . 75.6 mtp85 50.1 -91.44 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.3 -0.875 . . . . 71.540000000000006 109.928 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . -158.78 -97.7 0.13 Allowed Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.496 -1.335 . . . . 72.030000000000001 110.39 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -137.21 148.28 46.4 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.344 -1.092 . . . . 75.540000000000006 110.103 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -107.39 126.54 52.6 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.475 -0.766 . . . . 75.310000000000002 109.619 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.623 ' CE2' HD13 ' A' ' 155' ' ' LEU . 8.6 t80 -104.17 134.61 47.14 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.283 -1.006 . . . . 75.409999999999997 108.283 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . 0.41 ' SG ' ' OE1' ' A' ' 205' ' ' GLU . 31.1 p -153.51 164.43 38.24 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.173 -0.954 . . . . 74.140000000000001 109.926 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -59.33 152.82 51.78 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 75.319999999999993 109.106 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.13 -45.32 0.46 Allowed 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.237 1.958 . . . . 73.109999999999999 111.407 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.509 ' O ' ' N ' ' A' ' 220' ' ' ALA . 0.0 OUTLIER -161.65 151.48 14.0 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.827 -0.805 . . . . 75.25 108.827 179.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -38.8 86.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.332 0 C-N-CA 122.209 1.939 . . . . 75.099999999999994 112.488 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.587 ' HB1' ' OE1' ' A' ' 223' ' ' GLU . . . -70.91 -63.56 1.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.068 -1.02 . . . . 71.140000000000001 109.463 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 95.3 m 49.19 -112.13 0.51 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.145 -0.972 . . . . 71.129999999999995 109.467 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -75.38 138.08 41.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.125 -0.984 . . . . 75.349999999999994 109.688 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.901 ' OE2' ' HA ' ' A' ' 125' ' ' ASP . 11.0 pt-20 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.024 -0.989 . . . . 73.409999999999997 109.538 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.414 ' SD ' HD11 ' B' ' 113' ' ' LEU . 32.0 tpp . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.492 -0.558 . . . . 71.140000000000001 109.492 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.524 ' N ' ' OD2' ' B' ' 46' ' ' ASP . 78.4 mtm-85 -140.33 151.81 45.33 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.355 -0.841 . . . . 73.230000000000004 109.286 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.8 t -112.23 129.39 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.623 -0.673 . . . . 72.239999999999995 109.274 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.509 HD12 ' N ' ' B' ' 5' ' ' LEU . 2.5 tp -104.46 121.12 42.78 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.579 -0.7 . . . . 54.329999999999998 109.566 -179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.509 ' N ' HD12 ' B' ' 4' ' ' LEU . 11.1 mt -118.92 98.83 6.39 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 109.031 -0.729 . . . . 74.349999999999994 109.031 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.462 ' CG1' HD11 ' B' ' 4' ' ' LEU . 55.7 mt -84.1 98.86 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.834 -1.166 . . . . 42.549999999999997 108.664 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.43 ' OE2' ' OG ' ' B' ' 51' ' ' SER . 9.3 tp10 -140.97 130.59 24.06 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.293 -0.88 . . . . 74.519999999999996 109.485 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -66.06 -35.31 80.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.346 -0.846 . . . . 62.549999999999997 109.249 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -77.02 112.26 13.46 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.376 -0.828 . . . . 73.109999999999999 109.385 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 95.4 p -74.27 -30.29 62.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 65.540000000000006 110.158 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.555 HG13 ' N ' ' B' ' 12' ' ' LEU . 9.3 p -59.1 -45.38 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.005 -1.059 . . . . 75.549999999999997 109.704 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.555 ' N ' HG13 ' B' ' 11' ' ' VAL . 80.9 mt -65.06 -31.58 72.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.06 -1.025 . . . . 70.140000000000001 109.309 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.25 -28.04 62.77 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.649 -1.781 . . . . 75.400000000000006 108.649 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.62 -56.01 19.54 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.506 -1.437 . . . . 65.439999999999998 109.506 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.52 -41.85 90.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.342 -1.093 . . . . 60.210000000000001 109.515 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.69 -43.29 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.975 -1.078 . . . . 75.150000000000006 108.846 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.413 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 80.2 tt0 -58.53 -43.94 89.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.451 -0.78 . . . . 73.010000000000005 109.559 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -86.58 0.4 54.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.103 -0.998 . . . . 74.299999999999997 109.083 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.76 -58.63 1.89 Allowed Glycine 0 N--CA 1.484 1.894 0 N-CA-C 109.479 -1.448 . . . . 70.540000000000006 109.479 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -69.37 -22.31 63.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -1.144 . . . . 71.340000000000003 109.557 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . 0.413 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 2.0 m120 -51.67 -34.07 36.59 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.223 -0.923 . . . . 64.409999999999997 109.416 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 79.0 t -56.76 -39.91 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.093 -1.004 . . . . 74.230000000000004 108.884 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.448 ' N ' ' CD ' ' B' ' 23' ' ' LYS . 4.2 mptp? -70.59 -27.52 64.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.376 -0.828 . . . . 63.420000000000002 109.344 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.58 41.22 2.21 Favored Glycine 0 N--CA 1.499 2.893 0 N-CA-C 110.208 -1.157 . . . . 53.43 110.208 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.405 ' CZ ' HD23 ' B' ' 113' ' ' LEU . 54.0 m-85 -119.58 161.16 21.1 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.427 -1.043 . . . . 71.120000000000005 109.203 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 18.3 mmt -103.08 140.89 36.72 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.746 -0.835 . . . . 75.239999999999995 108.746 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.419 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -137.53 154.45 49.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.303 -0.873 . . . . 72.120000000000005 110.167 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 96.1 m-20 -140.63 158.11 44.46 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.535 -0.913 . . . . 72.310000000000002 108.535 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 5.0 p -122.79 140.01 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.41 -0.806 . . . . 64.430000000000007 109.947 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 3.2 p -131.86 171.82 13.07 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.132 -0.692 . . . . 65.409999999999997 109.132 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -91.85 -107.09 0.1 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.235 -0.915 . . . . 71.019999999999996 109.792 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 33.3 t -78.79 168.87 19.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.292 -0.88 . . . . 51.109999999999999 110.022 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 39.0 mt -52.4 -30.91 31.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.593 -0.692 . . . . 71.239999999999995 109.877 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -53.9 -49.75 67.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.113 -0.992 . . . . 74.319999999999993 109.769 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -66.03 -44.79 83.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.153 -0.967 . . . . 73.030000000000001 109.365 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.61 -40.12 94.02 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.393 -1.483 . . . . 30.210000000000001 109.393 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -64.67 -43.85 92.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.337 -1.096 . . . . 74.420000000000002 109.456 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -71.29 -37.89 71.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.179 -0.95 . . . . 74.420000000000002 109.774 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 51.8 tp -69.51 -45.27 69.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 75.409999999999997 110.068 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . 0.449 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.4 ppp? -74.29 -19.68 60.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.007 -1.058 . . . . 60.409999999999997 110.005 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.39 -41.81 80.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.105 -0.997 . . . . 53.229999999999997 109.697 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.6 pt -86.95 -41.44 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.122 -0.986 . . . . 71.230000000000004 109.854 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' B' ' 40' ' ' MET . 2.8 mpt_? -104.54 138.48 40.84 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.279 -0.888 . . . . 72.219999999999999 109.148 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . 0.478 ' C ' ' NH2' ' B' ' 2' ' ' ARG . 55.3 t-20 -100.59 89.89 4.08 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.377 -0.827 . . . . 63.539999999999999 109.205 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -63.56 149.22 46.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.165 -0.959 . . . . 64.349999999999994 109.275 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' B' ' 2' ' ' ARG . 3.9 p30 -80.42 -44.1 19.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 62.219999999999999 109.368 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.545 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.6 OUTLIER -103.37 115.02 29.75 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.458 -0.941 . . . . 73.120000000000005 108.458 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.545 ' N ' HD13 ' B' ' 47' ' ' LEU . 74.8 t -99.01 96.43 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.38 -0.97 . . . . 65.109999999999999 108.38 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 22.8 ttt -109.26 134.2 52.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.482 -0.761 . . . . 73.439999999999998 109.908 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -145.22 137.11 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.008 -0.738 . . . . 34.5 109.008 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . 0.43 ' OG ' ' OE2' ' B' ' 7' ' ' GLU . 41.8 p -100.22 0.03 39.58 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.468 -0.77 . . . . 73.209999999999994 109.967 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -76.35 130.42 38.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 70.409999999999997 109.521 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.429 ' C ' ' N ' ' B' ' 55' ' ' ALA . 27.5 mtmm -66.51 -48.43 69.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 65.0 109.931 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -50.04 -16.52 0.3 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.144 -0.973 . . . . 75.209999999999994 109.367 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.429 ' N ' ' C ' ' B' ' 53' ' ' LYS . . . -59.68 -21.44 60.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.422 -0.799 . . . . 55.329999999999998 110.18 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 23.1 mt -43.02 -46.44 5.52 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.305 -0.872 . . . . 63.140000000000001 110.065 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 25.2 t -70.89 -34.32 71.46 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.05 -1.031 . . . . 63.5 109.347 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . 0.495 ' CE2' HD11 ' B' ' 62' ' ' ILE . 73.4 t80 -67.45 -53.43 29.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.408 -0.808 . . . . 72.329999999999998 110.123 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.64 -33.89 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.825 -1.172 . . . . 74.540000000000006 109.73 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 9.3 t -59.74 -52.06 67.09 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.174 -0.953 . . . . 71.239999999999995 109.454 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -67.7 -27.79 67.12 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.007 -1.058 . . . . 74.310000000000002 109.876 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.495 HD11 ' CE2' ' B' ' 58' ' ' PHE . 4.7 mm -59.29 -51.63 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.932 -1.105 . . . . 72.140000000000001 109.083 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -60.41 -41.0 92.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.097 -1.002 . . . . 73.319999999999993 108.754 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -67.1 -51.73 50.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -0.862 . . . . 73.120000000000005 108.746 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -72.6 -74.76 0.16 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.599 -0.688 . . . . 72.439999999999998 109.554 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.505 ' O ' HG22 ' B' ' 69' ' ' ILE . 90.2 m-70 -90.69 92.24 8.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.144 -0.973 . . . . 63.310000000000002 109.176 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 74.8 m -79.83 -27.64 40.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.167 -0.958 . . . . 73.099999999999994 109.876 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 51.7 p -87.11 47.69 1.54 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.188 -0.945 . . . . 71.530000000000001 110.153 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.505 HG22 ' O ' ' B' ' 66' ' ' HIS . 15.9 tt -144.83 159.85 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.049 -1.032 . . . . 74.400000000000006 109.171 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.494 HG21 ' NH1' ' B' ' 112' ' ' ARG . 43.1 t -103.32 147.5 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.291 -0.881 . . . . 75.120000000000005 109.206 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 t -133.29 127.97 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.41 -0.806 . . . . 73.200000000000003 109.655 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.548 ' C ' HD23 ' B' ' 72' ' ' LEU . 5.3 tt -122.65 105.29 9.95 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.617 -0.677 . . . . 73.340000000000003 109.423 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.435 ' O ' HG13 ' B' ' 73' ' ' VAL . 14.8 p -94.25 132.44 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.012 -1.055 . . . . 73.5 109.497 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 9.5 p -89.63 171.63 9.54 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.985 -1.072 . . . . 64.340000000000003 108.723 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 27.4 p -152.54 112.05 3.91 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.817 -1.177 . . . . 74.530000000000001 110.713 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -74.28 -4.63 37.28 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.62 -0.881 . . . . 64.5 108.62 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -143.09 71.38 18.43 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 108.86 -0.793 . . . . 74.25 108.86 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.4 87.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.808 1.672 . . . . 74.430000000000007 111.701 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.43 ' OG1' ' OE2' ' B' ' 82' ' ' GLU . 44.3 p -107.43 155.77 19.67 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.683 -0.858 . . . . 73.120000000000005 108.683 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . 0.403 ' HB2' ' HB2' ' A' ' 104' ' ' ALA . 1.1 p -61.01 -30.42 70.29 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.214 -0.929 . . . . 71.010000000000005 109.58 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.09 -43.01 88.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.921 . . . . 63.200000000000003 109.804 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' B' ' 82' ' ' GLU . 0.2 OUTLIER -66.29 -33.14 75.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.172 -0.955 . . . . 73.219999999999999 109.633 -179.682 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.526 ' OE2' ' NH1' ' A' ' 100' ' ' ARG . 46.5 mt-10 -64.52 -46.51 82.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.017 -1.052 . . . . 74.299999999999997 109.535 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.06 -42.09 93.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.186 -0.946 . . . . 73.310000000000002 109.328 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' HIS . . . . . 0.438 ' O ' ' OE1' ' B' ' 89' ' ' GLN . 18.6 m170 -72.13 -20.33 61.64 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.215 -0.928 . . . . 73.239999999999995 109.639 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.24 -44.59 62.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.04 -1.038 . . . . 55.329999999999998 110.119 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -81.37 -35.23 31.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.002 -1.061 . . . . 74.140000000000001 109.487 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.95 -43.0 97.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.073 -1.017 . . . . 64.040000000000006 109.375 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . 0.438 ' OE1' ' O ' ' B' ' 85' ' ' HIS . 0.5 OUTLIER -67.91 -61.29 1.94 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 72.349999999999994 109.259 179.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 149.7 64.72 0.01 OUTLIER Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.732 -1.223 . . . . 65.200000000000003 110.154 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.51 134.44 55.22 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.493 -1.004 . . . . 52.229999999999997 108.971 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -68.22 -43.35 78.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.049 -1.032 . . . . 73.319999999999993 108.959 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' B' ' 93' ' ' ASP . 18.3 p-10 -153.81 165.14 36.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.449 -0.782 . . . . 72.219999999999999 109.253 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.537 ' O ' ' CD1' ' B' ' 94' ' ' TYR . 0.2 OUTLIER -136.19 119.09 16.29 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.364 -0.606 . . . . 64.420000000000002 109.364 -178.345 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 28.6 mm -113.67 150.66 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 O-C-N 121.379 -0.826 . . . . 72.230000000000004 110.144 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . 0.491 ' HB1' ' HD2' ' B' ' 98' ' ' PRO . . . -61.84 141.06 58.17 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.011 -1.107 . . . . 25.239999999999998 108.011 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.594 ' N ' ' CD ' ' B' ' 98' ' ' PRO . 0.0 OUTLIER -68.85 -40.26 16.4 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.944 -1.098 . . . . 64.319999999999993 110.922 -178.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' B' ' 97' ' ' LYS . 34.0 Cg_exo -53.16 -0.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.289 -2.557 0 CA-C-N 118.697 0.571 . . . . 63.329999999999998 112.135 -174.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . 0.566 ' N ' ' O ' ' B' ' 97' ' ' LYS . 60.2 m-85 53.0 102.3 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.525 -0.734 . . . . 75.129999999999995 109.935 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 38.3 mtt-85 -57.63 -35.84 71.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.925 -1.109 . . . . 74.230000000000004 108.77 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . 0.777 ' O ' ' N ' ' B' ' 103' ' ' LYS . 27.1 t -171.27 29.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -0.934 . . . . 63.340000000000003 110.77 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 18.7 mt 48.11 -68.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-N 118.539 0.609 . . . . 74.439999999999998 110.418 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.777 ' N ' ' O ' ' B' ' 101' ' ' SER . 55.3 mttp -51.59 -31.72 25.96 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.693 -1.225 . . . . 71.109999999999999 107.693 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.84 -42.89 89.93 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.194 -1.039 . . . . 71.450000000000003 108.194 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 50.8 tp -60.79 -42.71 98.1 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.549 -0.908 . . . . 51.310000000000002 108.549 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 20.3 t -69.78 -34.23 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -0.871 . . . . 65.230000000000004 109.229 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.51 -47.35 73.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.152 -0.968 . . . . 24.32 109.441 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 0.52 ' NH2' ' OE2' ' A' ' 83' ' ' GLU . 26.2 ttm105 -69.28 -37.08 77.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 75.310000000000002 109.789 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 97.7 mt -70.16 -26.66 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.04 -1.038 . . . . 54.240000000000002 108.921 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -74.98 -56.91 4.27 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.455 -0.778 . . . . 65.310000000000002 109.94 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -52.0 -35.74 47.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.071 -1.018 . . . . 72.239999999999995 109.81 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . 0.532 HH21 HD23 ' B' ' 47' ' ' LEU . 38.6 ttp85 -85.98 -57.02 3.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.113 -0.992 . . . . 72.040000000000006 110.545 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.414 HD11 ' SD ' ' B' ' 1' ' ' MET . 35.2 tp -54.7 -36.46 64.71 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.086 -1.008 . . . . 75.349999999999994 110.409 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -46.71 -33.24 4.15 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.125 -0.984 . . . . 75.5 109.611 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' PHE . . . . . 0.532 ' O ' ' N ' ' B' ' 117' ' ' GLY . 11.2 m-85 -54.38 -29.71 49.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.859 . . . . 65.329999999999998 108.994 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 4.3 t-105 60.47 -75.89 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.444 -0.785 . . . . 74.450000000000003 109.59 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' B' ' 115' ' ' PHE . . . -163.18 -171.34 29.3 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.281 -1.528 . . . . 44.210000000000001 109.281 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . 0.642 ' CB ' ' OE2' ' B' ' 132' ' ' GLU . 7.6 t -154.85 174.48 15.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.148 -1.207 . . . . 71.400000000000006 110.011 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.29 114.37 4.44 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.983 -0.687 . . . . 72.319999999999993 109.159 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 11.9 t -78.51 -39.97 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.264 -0.897 . . . . 75.019999999999996 109.73 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 17.3 mm -101.7 127.45 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.231 -0.918 . . . . 51.409999999999997 109.365 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.464 ' N ' ' CD ' ' B' ' 122' ' ' GLU . 1.0 OUTLIER -135.2 114.64 12.52 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.529 -0.732 . . . . 71.530000000000001 109.267 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 11.2 pt -140.97 137.35 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.216 -0.928 . . . . 72.430000000000007 109.2 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.18 -149.89 3.4 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.441 -1.464 . . . . 51.229999999999997 109.441 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -83.19 -0.39 49.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -1.168 . . . . 74.200000000000003 109.332 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.31 132.82 42.68 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.288 -0.882 . . . . 75.420000000000002 108.706 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 4.4 p -129.81 120.33 24.82 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.97 -0.752 . . . . 74.219999999999999 108.97 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 18.2 mm -107.24 144.68 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.492 -0.755 . . . . 60.329999999999998 109.042 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 3.4 m -126.84 79.44 72.31 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 121.446 -0.784 . . . . 72.310000000000002 109.7 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -50.96 -40.36 58.56 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.51 2.14 . . . . 75.129999999999995 112.132 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -68.01 -50.12 57.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.307 -0.87 . . . . 75.230000000000004 109.934 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . 0.642 ' OE2' ' CB ' ' B' ' 118' ' ' SER . 88.7 mt-10 -82.38 -1.16 49.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.119 -0.988 . . . . 72.430000000000007 109.701 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 50.39 51.97 15.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.946 . . . . 75.129999999999995 109.235 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -138.19 136.84 37.01 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.371 -0.83 . . . . 73.219999999999999 109.242 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 7.8 tt -119.23 139.2 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.565 -0.709 . . . . 64.140000000000001 109.579 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 32.0 mt -126.36 125.17 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 N-CA-C 108.8 -0.815 . . . . 71.219999999999999 108.8 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -142.49 151.36 41.6 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.235 -1.024 . . . . 64.219999999999999 108.235 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 16.9 tptm 60.11 8.16 1.42 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.572 -0.851 . . . . 72.019999999999996 109.07 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 90.41 -8.82 79.18 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.866 -1.294 . . . . 74.319999999999993 109.866 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . 0.505 ' N ' ' CD ' ' B' ' 140' ' ' ARG . 0.5 OUTLIER -90.53 141.25 28.95 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.113 -1.228 . . . . 75.340000000000003 109.214 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -97.8 129.87 44.77 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.27 -0.894 . . . . 71.230000000000004 109.632 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 47.7 t -138.43 132.51 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.389 -0.819 . . . . 70.430000000000007 109.075 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -87.1 143.72 27.19 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.205 -0.934 . . . . 72.430000000000007 109.727 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.48 132.28 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.337 -0.852 . . . . 72.129999999999995 109.388 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . 0.899 ' O ' ' HE2' ' B' ' 149' ' ' PHE . 0.0 OUTLIER -148.89 124.73 10.56 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.119 -0.988 . . . . 72.019999999999996 109.23 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . 0.765 ' N ' ' HD2' ' B' ' 149' ' ' PHE . . . 155.63 178.27 29.68 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.532 -1.427 . . . . 42.229999999999997 109.532 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 0.62 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 26.5 mtpt -70.88 -35.85 4.67 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.208 -1.172 . . . . 73.299999999999997 110.243 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 23.3 Cg_exo -63.49 -30.05 71.39 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.942 1.761 . . . . 71.329999999999998 111.772 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . 0.899 ' HE2' ' O ' ' B' ' 145' ' ' LYS . 0.2 OUTLIER -92.03 -28.22 17.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.404 -0.81 . . . . 74.230000000000004 109.079 -179.61 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -51.74 -35.89 45.11 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.363 -0.835 . . . . 72.340000000000003 109.802 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.527 HG13 ' N ' ' B' ' 152' ' ' LEU . 11.4 p -63.36 -41.28 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.162 -0.961 . . . . 73.349999999999994 109.398 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.553 ' O ' HD13 ' B' ' 152' ' ' LEU . 0.3 OUTLIER -58.5 -42.56 87.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.38 -0.825 . . . . 55.240000000000002 109.088 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 16.0 p -71.13 -34.3 70.91 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.085 -1.01 . . . . 70.010000000000005 110.218 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -59.13 -53.73 55.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.056 -1.027 . . . . 65.319999999999993 109.628 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.82 -23.57 61.57 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.946 -1.096 . . . . 71.540000000000006 109.526 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.38 -50.32 71.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.197 -0.94 . . . . 75.319999999999993 109.22 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.483 ' C ' ' H ' ' B' ' 159' ' ' ARG . 13.8 mtp-105 -71.47 -47.61 54.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 73.319999999999993 108.851 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 21.7 m-70 -75.84 32.76 0.12 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.507 -0.745 . . . . 74.140000000000001 109.013 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . 0.483 ' H ' ' C ' ' B' ' 157' ' ' ARG . 34.0 ptt180 -50.67 -33.94 24.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.423 -0.798 . . . . 61.409999999999997 110.389 -179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' B' ' 160' ' ' ASP . 18.4 p30 -121.49 79.25 1.52 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.33 -0.856 . . . . 72.099999999999994 109.697 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -171.72 156.5 4.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.305 -0.872 . . . . 72.25 109.644 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' ILE . . . . . 0.795 HD12 ' N ' ' B' ' 162' ' ' ILE . 1.9 mp -94.1 139.27 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.205 -0.935 . . . . 72.310000000000002 109.025 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 63.5 t -133.95 142.52 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.416 -0.802 . . . . 64.209999999999994 109.594 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 4.7 p -91.78 166.38 12.79 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.21 -0.931 . . . . 74.219999999999999 110.422 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -64.47 -46.09 84.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.511 -0.743 . . . . 65.310000000000002 109.987 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -57.97 -38.25 75.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 63.450000000000003 110.15 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' GLN . . . . . 0.423 ' O ' ' OD1' ' B' ' 170' ' ' ASP . 63.3 tp60 -58.56 -48.54 80.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 72.400000000000006 109.795 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 33.1 mt -60.17 -36.09 76.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.92 . . . . 72.319999999999993 109.551 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.546 HD23 ' C ' ' B' ' 169' ' ' LEU . 3.6 tt -55.9 -68.89 0.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.364 -0.835 . . . . 73.340000000000003 109.756 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' B' ' 167' ' ' GLN . 26.4 p30 -64.37 -11.19 30.16 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.473 -0.767 . . . . 72.099999999999994 110.802 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.57 -58.5 3.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.979 -1.076 . . . . 62.130000000000003 110.224 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.684 HD12 ' N ' ' B' ' 172' ' ' ILE . 2.0 mp -94.38 -50.4 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.018 -1.051 . . . . 71.420000000000002 109.47 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' TRP . . . . . 0.441 ' O ' ' O ' ' B' ' 169' ' ' LEU . 16.1 m-90 -95.72 124.32 39.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.297 -0.877 . . . . 72.230000000000004 109.452 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -154.02 -34.67 0.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.164 -0.96 . . . . 52.109999999999999 109.512 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . 0.595 ' N ' ' CD ' ' B' ' 176' ' ' PRO . 0.0 OUTLIER -72.93 -39.95 5.74 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.114 -0.992 . . . . 73.040000000000006 109.681 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' B' ' 175' ' ' GLU . 71.0 Cg_endo -92.68 68.0 0.66 Allowed 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.648 2.232 . . . . 74.129999999999995 112.19 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -63.84 -11.07 24.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.283 -0.886 . . . . 72.439999999999998 109.804 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 13.5 mmt -59.8 -27.72 66.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 63.43 110.13 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 179' ' ' VAL . . . . . 0.403 HG22 ' O ' ' B' ' 176' ' ' PRO . 25.1 m -61.95 152.57 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.109 -0.994 . . . . 71.049999999999997 109.783 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 1.2 p -78.64 154.03 78.52 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.334 -0.854 . . . . 62.149999999999999 109.362 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -75.66 -26.13 10.2 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.479 2.119 . . . . 65.219999999999999 111.989 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 182' ' ' ASN . . . . . 0.511 HD21 ' CD ' ' B' ' 185' ' ' GLU . 16.2 t-20 -72.23 -0.79 12.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 72.310000000000002 109.624 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 83.0 t -65.19 -29.01 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.257 -0.902 . . . . 63.32 109.66 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 61.7 mt -53.3 -40.71 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.921 . . . . 75.030000000000001 110.102 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . 0.511 ' CD ' HD21 ' B' ' 182' ' ' ASN . 22.6 mt-10 -56.17 -37.39 69.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.041 -1.037 . . . . 64.109999999999999 108.881 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 2.6 t -81.92 -54.63 9.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.452 -0.78 . . . . 73.0 109.765 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -54.28 -36.96 64.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.274 -0.892 . . . . 61.119999999999997 110.465 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 188' ' ' ILE . . . . . 0.439 ' CG2' ' N ' ' B' ' 189' ' ' ASN . 7.7 tp -75.38 -43.54 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.681 -1.262 . . . . 72.430000000000007 109.667 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 189' ' ' ASN . . . . . 0.439 ' N ' ' CG2' ' B' ' 188' ' ' ILE . 11.3 m120 -61.65 -38.14 86.63 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.218 -0.926 . . . . 65.140000000000001 109.271 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -72.3 -47.72 47.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.952 . . . . 63.240000000000002 109.615 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . 0.441 ' O ' ' SD ' ' B' ' 195' ' ' MET . 57.4 mt -55.29 -40.52 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.155 -0.966 . . . . 74.030000000000001 109.093 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -63.06 -43.36 98.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 72.239999999999995 109.654 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -73.25 -30.83 63.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 73.099999999999994 109.87 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -82.01 -19.92 39.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.303 -0.873 . . . . 72.109999999999999 110.441 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 195' ' ' MET . . . . . 0.563 ' N ' ' SD ' ' B' ' 195' ' ' MET . 0.1 OUTLIER -99.7 -36.16 9.57 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.142 -0.974 . . . . 44.329999999999998 109.85 -179.666 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 196' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 58.2 p-10 -68.14 -19.57 64.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.086 -1.009 . . . . 71.209999999999994 110.113 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . 0.533 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 27.4 mttm -80.41 -64.87 0.29 Allowed Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.029 -1.045 . . . . 75.209999999999994 109.87 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 198' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 33.0 Cg_endo -61.9 -55.2 1.15 Allowed 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.314 2.009 . . . . 75.319999999999993 112.442 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' B' ' 201' ' ' ILE . 15.5 mt -64.53 -37.03 86.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.084 -1.01 . . . . 72.25 109.627 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 74.09 -31.33 0.94 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.581 -1.408 . . . . 64.530000000000001 109.581 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . 0.476 ' H ' ' C ' ' B' ' 199' ' ' LEU . 66.4 mt -96.78 142.51 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.226 -1.161 . . . . 44.229999999999997 109.341 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 79.8 p -94.56 146.91 23.78 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.266 -0.896 . . . . 54.009999999999998 109.595 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 22.7 p -143.36 11.9 1.73 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.252 -0.905 . . . . 74.400000000000006 109.075 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.405 ' O ' HG23 ' B' ' 204' ' ' VAL . 16.1 m -135.59 133.85 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.472 -0.767 . . . . 72.120000000000005 109.242 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -115.87 132.88 56.51 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.626 -0.671 . . . . 65.409999999999997 109.287 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.5 137.57 33.47 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.208 -0.932 . . . . 71.329999999999998 109.062 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.573 HG22 ' H ' ' B' ' 209' ' ' ARG . 7.9 p -124.55 145.7 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.584 -0.697 . . . . 63.5 109.561 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -71.0 -11.53 61.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 74.450000000000003 109.904 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . 0.573 ' H ' HG22 ' B' ' 207' ' ' VAL . 70.0 ttt-85 -69.1 -108.04 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.126 -0.984 . . . . 74.140000000000001 109.623 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -146.83 121.4 9.76 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.827 -1.171 . . . . 74.430000000000007 109.853 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 94.47 171.84 37.98 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.68 -0.968 . . . . 64.450000000000003 110.68 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -115.74 171.34 7.81 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.213 -1.032 . . . . 74.209999999999994 108.213 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -132.24 132.64 43.27 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.215 -0.928 . . . . 74.030000000000001 109.597 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -113.35 123.46 50.17 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.978 -0.749 . . . . 74.340000000000003 108.978 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 2.2 p -139.92 164.34 30.26 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.447 -0.783 . . . . 64.329999999999998 109.044 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -61.87 149.78 84.5 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.185 -0.947 . . . . 70.040000000000006 109.104 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_exo -38.52 133.82 0.89 Allowed 'Trans proline' 0 N--CA 1.49 1.319 0 C-N-CA 122.144 1.896 . . . . 65.109999999999999 112.277 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.637 ' N ' ' CD ' ' B' ' 219' ' ' PRO . 35.1 tttp -76.81 -34.38 1.27 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.167 -0.958 . . . . 73.150000000000006 110.772 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' B' ' 218' ' ' LYS . 47.4 Cg_exo -55.98 -12.87 7.9 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.928 1.752 . . . . 71.310000000000002 111.892 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -62.58 131.43 49.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.37 -0.831 . . . . 75.450000000000003 109.37 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 32.1 p -157.2 34.73 0.28 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.256 -0.903 . . . . 72.219999999999999 109.398 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -84.57 160.89 20.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 54.530000000000001 109.427 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . 0.449 ' H ' ' CD ' ' B' ' 223' ' ' GLU . 38.9 mp0 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.026 -0.988 . . . . 71.129999999999995 109.609 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.445 ' SD ' ' OD2' ' A' ' 46' ' ' ASP . 32.2 tpp . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.318 0.58 . . . . 65.120000000000005 109.441 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.572 ' NH2' ' CB ' ' A' ' 28' ' ' ASP . 75.5 ttt-85 -143.0 135.82 27.83 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.267 -0.895 . . . . 72.329999999999998 109.267 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.7 t -110.97 133.6 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.653 -0.654 . . . . 71.420000000000002 109.405 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.738 HD12 ' N ' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -113.88 120.29 40.21 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.752 -0.833 . . . . 65.120000000000005 108.752 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.738 ' N ' HD12 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -121.82 119.92 33.07 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.396 -0.965 . . . . 62.43 108.396 179.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.566 HG12 HD11 ' A' ' 4' ' ' LEU . 7.1 mt -97.31 130.38 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.25 -0.906 . . . . 71.150000000000006 109.351 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 13' ' ' GLY . 10.8 pt-20 -171.57 -22.17 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.226 -0.921 . . . . 75.340000000000003 110.719 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt 69.18 -38.38 0.4 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.278 -0.889 . . . . 72.439999999999998 109.769 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.484 ' H ' ' C ' ' A' ' 7' ' ' GLU . 26.8 m120 -64.88 103.12 0.67 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.143 -0.973 . . . . 63.020000000000003 109.419 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.1 m -61.15 -24.87 66.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.296 -0.878 . . . . 72.340000000000003 109.633 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.9 t -70.03 -53.67 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.946 . . . . 74.019999999999996 109.728 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.578 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.4 mm? -69.07 -36.76 77.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 71.430000000000007 109.35 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.512 ' N ' ' OE1' ' A' ' 7' ' ' GLU . . . -73.42 -28.03 66.61 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.481 -1.848 . . . . 61.32 108.481 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.38 -50.72 60.22 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.449 -1.46 . . . . 71.200000000000003 109.449 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.414 ' H ' ' HG2' ' A' ' 15' ' ' GLU . 7.4 pt-20 -61.32 -45.99 92.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.347 -1.09 . . . . 71.319999999999993 109.76 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.7 mm -64.99 -37.11 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.751 -1.218 . . . . 63.229999999999997 108.68 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.475 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 84.1 tt0 -66.14 -47.03 75.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.368 -0.833 . . . . 51.109999999999999 109.794 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -85.24 2.98 41.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.098 -1.001 . . . . 73.340000000000003 109.324 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.85 -55.84 2.33 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.502 -1.439 . . . . 62.149999999999999 109.502 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 27' ' ' ALA . 1.4 pt? -74.24 -21.87 59.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -1.124 . . . . 73.510000000000005 109.812 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 96.2 m-20 -54.07 -33.26 57.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.119 -0.988 . . . . 74.25 109.448 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.7 t -58.33 -47.08 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 70.040000000000006 108.959 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -59.98 -53.8 53.62 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.897 -0.779 . . . . 73.230000000000004 108.897 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 135.03 22.29 0.66 Allowed Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.761 -1.336 . . . . 75.540000000000006 109.761 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -98.86 160.37 14.31 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.218 -1.166 . . . . 73.430000000000007 109.424 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.2 mmm -100.97 139.31 36.84 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.601 -0.888 . . . . 43.240000000000002 108.601 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.443 ' HB1' HD21 ' A' ' 5' ' ' LEU . . . -127.75 154.28 45.56 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.577 -0.702 . . . . 62.109999999999999 109.783 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.572 ' CB ' ' NH2' ' A' ' 2' ' ' ARG . 24.2 t70 -142.6 132.24 23.92 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.71 -0.848 . . . . 74.420000000000002 108.71 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.7 m -100.22 130.52 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.907 . . . . 72.150000000000006 108.879 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.4 p -120.62 158.19 27.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.608 -0.683 . . . . 71.420000000000002 109.223 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -89.32 -94.29 0.11 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.397 -0.814 . . . . 72.329999999999998 109.605 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 56.2 p -79.29 152.49 30.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.205 -0.934 . . . . 74.239999999999995 110.022 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.557 ' H ' HD12 ' A' ' 33' ' ' LEU . 2.3 mp -55.98 -37.34 68.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.49 -0.756 . . . . 71.530000000000001 109.795 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -60.54 -40.78 92.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.168 -0.957 . . . . 74.230000000000004 109.658 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -66.52 -40.37 89.14 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.201 -0.937 . . . . 54.030000000000001 109.331 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.31 -38.51 81.47 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.422 -1.471 . . . . 61.409999999999997 109.422 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -65.32 -39.93 93.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.378 -1.071 . . . . 74.340000000000003 109.523 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -78.94 -39.14 35.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.121 -0.987 . . . . 75.329999999999998 109.616 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.4 tt -67.74 -41.61 83.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.31 -0.869 . . . . 74.329999999999998 109.778 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.539 ' SD ' ' CE2' ' A' ' 45' ' ' TYR . 3.2 ppp? -74.83 -23.22 58.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.1 -1.0 . . . . 70.319999999999993 109.674 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -54.13 -37.27 64.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.117 -0.989 . . . . 71.219999999999999 109.891 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.405 HG12 ' H ' ' A' ' 42' ' ' ILE . 9.5 pt -84.94 -33.35 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.154 -0.966 . . . . 74.140000000000001 110.148 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 40' ' ' MET . 97.2 mtt180 -95.86 167.11 11.46 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.058 -1.026 . . . . 72.239999999999995 109.933 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.409 ' C ' ' CD2' ' A' ' 45' ' ' TYR . 30.4 m120 -79.8 -174.95 4.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.127 -0.983 . . . . 75.420000000000002 109.056 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.539 ' CE2' ' SD ' ' A' ' 40' ' ' MET . 1.4 p90 -173.96 134.4 0.46 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.044 -1.035 . . . . 74.230000000000004 109.861 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.445 ' OD2' ' SD ' ' A' ' 1' ' ' MET . 87.2 m-20 -120.89 -51.95 2.12 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.485 -0.932 . . . . 72.040000000000006 108.485 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.569 HD13 ' C ' ' A' ' 47' ' ' LEU . 1.7 tm? -106.32 111.1 23.54 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.049 -1.093 . . . . 72.129999999999995 108.049 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.467 ' N ' HD13 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -109.22 101.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 108.599 -0.889 . . . . 72.340000000000003 108.599 179.36 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 7.7 ttt -105.39 140.3 38.72 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.458 -0.942 . . . . 74.109999999999999 108.458 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -140.04 129.31 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.862 . . . . 61.119999999999997 109.847 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.7 m -109.79 9.06 24.79 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.827 -0.805 . . . . 73.109999999999999 108.827 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -77.45 159.66 29.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.376 -0.828 . . . . 52.549999999999997 109.933 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.494 ' C ' ' H ' ' A' ' 55' ' ' ALA . 62.5 mttp -81.86 173.15 12.53 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.714 -0.847 . . . . 44.219999999999999 108.714 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 56.2 5.94 0.21 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.117 -0.989 . . . . 70.439999999999998 108.916 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -68.65 -26.92 65.56 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.41 -0.806 . . . . 64.140000000000001 109.586 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.604 HD13 HE22 ' A' ' 89' ' ' GLN . 43.7 mt -45.14 -42.79 9.28 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.401 -0.812 . . . . 44.140000000000001 110.19 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.3 m -70.56 -37.38 73.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.999 -1.063 . . . . 55.229999999999997 109.819 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.572 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 85.0 t80 -64.76 -46.87 80.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 74.439999999999998 110.313 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.9 m -62.97 -36.92 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 120.654 -1.279 . . . . 74.030000000000001 109.555 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.8 t -55.84 -52.63 63.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.252 -0.905 . . . . 64.299999999999997 109.66 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -65.63 -32.71 74.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.127 -0.983 . . . . 64.439999999999998 109.987 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.572 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 5.2 mm -64.47 -35.89 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.871 -1.143 . . . . 63.210000000000001 109.63 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.544 ' HZ2' ' C ' ' A' ' 90' ' ' GLY . 26.6 mmtp -68.97 -50.87 45.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.182 -0.949 . . . . 74.420000000000002 110.262 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.438 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 15.7 pt-20 -70.1 -42.93 72.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.927 -1.108 . . . . 70.319999999999993 110.084 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.477 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 67.3 mttm -70.12 -24.6 63.21 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.94 . . . . 75.219999999999999 109.593 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.542 ' O ' HG22 ' A' ' 69' ' ' ILE . 96.1 m-70 -155.85 64.2 0.59 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.921 . . . . 74.129999999999995 109.371 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.501 ' N ' ' O ' ' A' ' 63' ' ' LYS . 84.4 p -57.26 -25.48 59.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.306 -0.871 . . . . 73.239999999999995 109.763 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.5 t -75.34 45.61 0.3 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 61.009999999999998 109.89 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.542 HG22 ' O ' ' A' ' 66' ' ' HIS . 13.7 tt -145.72 158.18 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.089 -1.007 . . . . 71.329999999999998 109.645 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.5 t -94.23 149.83 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.16 -0.962 . . . . 72.129999999999995 108.687 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.526 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 11.2 t -138.09 124.96 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.205 -0.934 . . . . 54.210000000000001 109.387 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 mp -124.8 99.52 6.19 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.686 -0.857 . . . . 50.240000000000002 108.686 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.47 HG22 ' N ' ' A' ' 74' ' ' SER . 10.4 p -86.89 160.14 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.183 -0.948 . . . . 74.409999999999997 108.891 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.47 ' N ' HG22 ' A' ' 73' ' ' VAL . 19.8 m -135.5 160.36 38.71 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.371 -0.831 . . . . 72.310000000000002 109.631 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 74' ' ' SER . 70.3 m -168.57 154.74 6.95 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.275 -0.891 . . . . 64.540000000000006 110.133 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 0.4 OUTLIER -94.71 8.3 42.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.406 -0.809 . . . . 74.129999999999995 109.945 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' A' ' 79' ' ' THR . 37.6 t30 -129.19 56.68 25.31 Favored Pre-proline 0 N--CA 1.502 2.14 0 O-C-N 121.358 -0.839 . . . . 73.340000000000003 110.109 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -53.6 84.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.349 2.033 . . . . 63.219999999999999 111.913 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.43 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 42.5 m -114.03 150.17 34.32 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.741 -0.837 . . . . 62.530000000000001 108.741 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.07 -32.86 23.39 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.214 -0.929 . . . . 73.439999999999998 109.432 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.434 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 97.4 mt-10 -59.45 -36.73 76.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 71.420000000000002 109.69 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 84.9 tt0 -75.84 -33.3 60.04 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.147 -0.971 . . . . 73.430000000000007 109.804 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.43 ' OE2' ' O ' ' A' ' 79' ' ' THR . 0.9 OUTLIER -68.69 -50.16 53.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.099 -1.001 . . . . 74.219999999999999 109.893 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.52 HG23 ' N ' ' A' ' 85' ' ' HIS . 34.6 m -63.21 -42.95 98.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.027 -1.046 . . . . 73.200000000000003 109.615 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.52 ' N ' HG23 ' A' ' 84' ' ' VAL . 56.1 m80 -74.11 -25.44 59.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 53.329999999999998 109.78 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 82' ' ' GLU . . . -65.43 -44.05 88.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.108 -0.995 . . . . 64.109999999999999 109.776 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.445 ' CZ ' ' HB1' ' B' ' 111' ' ' ALA . 66.4 t80 -81.49 -34.01 31.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.011 -1.055 . . . . 74.340000000000003 109.027 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -68.1 -51.35 47.44 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.349 -0.844 . . . . 74.420000000000002 109.261 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.604 HE22 HD13 ' A' ' 56' ' ' LEU . 95.7 mt-30 -61.2 -50.24 73.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.487 -0.758 . . . . 74.239999999999995 109.704 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.544 ' C ' ' HZ2' ' A' ' 63' ' ' LYS . . . 147.64 71.08 0.01 OUTLIER Glycine 0 N--CA 1.495 2.587 0 C-N-CA 119.851 -1.166 . . . . 61.509999999999998 110.357 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -139.81 140.01 36.52 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.186 -1.185 . . . . 55.329999999999998 109.092 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 57.3 m-20 -83.76 -39.87 19.52 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.056 -1.028 . . . . 73.420000000000002 109.492 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 73.1 m-20 -150.29 164.15 36.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.294 -0.879 . . . . 75.040000000000006 109.223 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.438 ' CE1' ' O ' ' A' ' 95' ' ' ILE . 1.6 t80 -135.77 132.34 36.66 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.46 -0.775 . . . . 71.329999999999998 109.315 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.438 ' O ' ' CE1' ' A' ' 94' ' ' TYR . 26.1 mm -115.05 148.26 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 121.453 -0.779 . . . . 71.129999999999995 110.076 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.32 121.31 16.64 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.975 -1.491 . . . . 64.319999999999993 106.975 177.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.705 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.5 OUTLIER -43.66 -58.4 4.56 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.057 -1.027 . . . . 62.200000000000003 111.649 -178.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 7.5 Cg_endo -43.97 0.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 121.419 1.412 . . . . 73.109999999999999 113.695 -175.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.705 ' N ' ' O ' ' A' ' 97' ' ' LYS . 51.5 m-85 58.21 116.04 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.681 -0.637 . . . . 65.219999999999999 109.761 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.522 ' NE ' ' OE2' ' B' ' 83' ' ' GLU . 12.6 ttm-85 -73.63 -33.93 64.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 72.349999999999994 109.775 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.75 ' O ' ' N ' ' A' ' 103' ' ' LYS . 30.5 t -172.68 26.78 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.856 -1.153 . . . . 71.319999999999993 111.139 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 87.2 mt 51.13 -70.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.519 -0.738 . . . . 75.430000000000007 110.357 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.75 ' N ' ' O ' ' A' ' 101' ' ' SER . 30.5 mmtm -56.07 -30.05 61.41 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.162 -1.051 . . . . 71.409999999999997 108.162 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.4 -47.75 84.24 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.392 -0.966 . . . . 63.240000000000002 108.392 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.724 HD13 ' N ' ' A' ' 106' ' ' VAL . 0.7 OUTLIER -64.63 -56.04 16.38 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.953 -0.758 . . . . 73.219999999999999 108.953 179.602 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.724 ' N ' HD13 ' A' ' 105' ' ' LEU . 63.5 t -51.45 -40.55 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.74 -1.225 . . . . 60.109999999999999 109.018 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.21 -32.83 68.66 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.223 -0.923 . . . . 70.420000000000002 108.727 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 89.0 mtm-85 -77.96 -24.13 48.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -0.839 . . . . 74.409999999999997 110.333 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 81.7 mt -75.68 -38.98 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.801 -1.187 . . . . 62.539999999999999 108.869 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 114' ' ' ARG . 24.3 pt-20 -76.63 -32.5 58.06 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.298 -0.876 . . . . 74.340000000000003 109.605 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.49 -50.2 72.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.412 -0.805 . . . . 73.319999999999993 109.748 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -64.78 -46.07 83.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 52.409999999999997 109.495 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 23.6 mt -97.85 26.06 5.45 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.218 -0.926 . . . . 65.239999999999995 109.731 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 110' ' ' GLU . 0.8 OUTLIER -60.92 -53.13 61.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 64.450000000000003 109.383 -179.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -86.62 50.85 2.08 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.176 -0.952 . . . . 74.430000000000007 109.412 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -88.28 132.4 34.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.247 -0.908 . . . . 74.420000000000002 109.869 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 118.99 92.3 1.44 Allowed Glycine 0 N--CA 1.501 2.972 0 N-CA-C 109.65 -1.38 . . . . 75.040000000000006 109.65 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 79.7 p -166.7 160.49 14.93 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.093 -1.239 . . . . 61.140000000000001 109.979 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 121' ' ' ILE . 8.2 t30 -146.06 142.82 28.95 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.51 -0.922 . . . . 65.239999999999995 108.51 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.2 t -93.54 -45.73 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.016 -1.053 . . . . 73.109999999999999 110.564 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.521 ' O ' ' ND2' ' A' ' 119' ' ' ASN . 12.4 mm -93.56 114.98 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 120.841 -1.162 . . . . 72.239999999999995 109.624 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -118.83 124.9 48.31 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.915 -0.772 . . . . 72.340000000000003 108.915 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.681 ' O ' HG23 ' A' ' 123' ' ' ILE . 5.9 tt -149.88 102.73 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.039 -1.038 . . . . 71.439999999999998 109.682 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 62.73 -135.6 44.17 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.198 -1.161 . . . . 73.400000000000006 110.198 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -87.74 -3.4 58.96 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.457 -1.025 . . . . 74.450000000000003 109.878 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.0 131.0 42.84 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.225 -0.922 . . . . 54.210000000000001 108.865 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.54 137.33 49.66 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.756 -0.831 . . . . 54.5 108.756 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.412 ' H ' HD21 ' A' ' 119' ' ' ASN . 56.4 mt -131.17 127.88 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.473 -0.767 . . . . 45.149999999999999 109.204 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.52 103.15 50.23 Favored Pre-proline 0 N--CA 1.494 1.766 0 N-CA-C 109.059 -0.719 . . . . 71.109999999999999 109.059 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.76 -24.95 5.65 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.795 1.663 . . . . 65.409999999999997 111.781 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -62.54 -55.8 23.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.471 -0.768 . . . . 63.32 109.863 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -94.68 12.54 27.38 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.29 -0.881 . . . . 72.519999999999996 109.31 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 49.61 57.91 6.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 75.329999999999998 109.18 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 26.0 ttpt -133.89 132.84 40.79 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.556 -0.715 . . . . 71.230000000000004 109.673 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 15.9 tt -109.74 137.17 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 109.138 -0.689 . . . . 74.019999999999996 109.138 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 70.5 mt -121.27 118.9 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.495 -0.753 . . . . 60.229999999999997 109.193 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.42 ' C ' ' H ' ' A' ' 139' ' ' GLY . 65.3 t80 -142.76 151.3 41.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.349 -0.844 . . . . 62.32 108.978 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 1.047 ' HZ3' ' HB3' ' A' ' 138' ' ' LYS . 0.0 OUTLIER 61.37 5.75 1.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.942 -1.099 . . . . 75.400000000000006 108.239 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 137' ' ' TYR . . . 86.12 13.04 69.61 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 109.091 -1.603 . . . . 72.239999999999995 109.091 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -103.44 142.79 33.64 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.589 -0.948 . . . . 71.219999999999999 108.782 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -107.97 116.11 31.36 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.05 -1.031 . . . . 71.420000000000002 108.823 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.14 138.48 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.437 -0.789 . . . . 53.020000000000003 109.066 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -82.29 147.86 28.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.401 -0.812 . . . . 60.450000000000003 109.931 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.4 HG23 ' CE2' ' A' ' 149' ' ' PHE . 2.1 m -146.38 125.0 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.368 -0.833 . . . . 74.439999999999998 109.489 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -158.01 134.37 9.52 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.445 -0.784 . . . . 65.150000000000006 109.184 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.13 -162.93 36.72 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.066 -1.214 . . . . 73.340000000000003 110.066 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.627 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 49.9 mtmt -82.49 -30.61 0.51 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.443 -1.034 . . . . 72.219999999999999 111.626 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 90.1 Cg_endo -86.94 -25.02 1.22 Allowed 'Trans proline' 0 N--CA 1.488 1.173 0 C-N-CA 121.801 1.667 . . . . 65.230000000000004 112.562 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.479 ' CE2' HG23 ' A' ' 153' ' ' THR . 85.7 t80 -89.15 -12.92 39.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.158 -0.964 . . . . 60.109999999999999 109.802 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -61.11 -38.27 85.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.1 -1.0 . . . . 64.209999999999994 109.422 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.34 -28.96 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.898 . . . . 72.019999999999996 109.0 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.3 OUTLIER -61.18 -44.45 97.28 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.94 -0.763 . . . . 73.310000000000002 108.94 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.479 HG23 ' CE2' ' A' ' 149' ' ' PHE . 1.9 p -74.09 -37.9 64.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.206 -0.934 . . . . 74.310000000000002 110.231 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 17.4 m170 -54.76 -55.13 33.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.934 -1.104 . . . . 74.310000000000002 109.82 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.756 HD12 ' N ' ' A' ' 156' ' ' ALA . 4.6 pp -66.92 -33.47 75.67 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.207 -0.933 . . . . 75.340000000000003 109.197 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.756 ' N ' HD12 ' A' ' 155' ' ' LEU . . . -51.16 -41.24 60.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.192 -0.943 . . . . 62.140000000000001 108.949 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 159' ' ' ARG . 62.6 mtp180 -89.06 -48.95 7.06 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.143 -0.973 . . . . 61.030000000000001 108.922 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -73.09 35.03 0.08 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.389 -0.819 . . . . 74.120000000000005 109.611 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.48 ' H ' ' C ' ' A' ' 157' ' ' ARG . 27.9 ptt180 -72.16 171.1 12.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.34 -0.85 . . . . 71.129999999999995 109.347 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.6 t70 52.51 44.04 30.42 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.192 -0.942 . . . . 75.450000000000003 109.609 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -148.25 162.92 38.51 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.181 -0.949 . . . . 73.409999999999997 109.448 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.6 mt -93.37 119.34 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.218 -0.926 . . . . 74.409999999999997 108.649 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 10.8 t -99.89 122.39 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.251 -0.905 . . . . 72.310000000000002 109.675 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.2 p -84.07 164.68 19.09 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 74.120000000000005 108.911 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -63.27 -43.75 97.06 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.178 -0.951 . . . . 70.430000000000007 109.39 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.432 ' O ' ' OD2' ' A' ' 170' ' ' ASP . 49.0 mt-10 -72.12 -29.24 63.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.359 -0.838 . . . . 73.519999999999996 110.16 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -57.32 -57.14 13.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.961 . . . . 74.519999999999996 110.037 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 169' ' ' LEU . 2.2 pp -67.81 -36.52 80.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.974 -1.079 . . . . 72.310000000000002 110.056 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.651 ' C ' HD13 ' A' ' 169' ' ' LEU . 3.1 tm? -55.18 -52.91 61.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.927 -1.108 . . . . 53.329999999999998 108.867 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' A' ' 166' ' ' GLU . 2.6 p30 -72.38 -28.61 63.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.207 -0.933 . . . . 62.439999999999998 110.111 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -53.77 -52.16 61.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.149 -0.969 . . . . 60.210000000000001 110.358 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 12.8 mm -91.53 -28.92 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.071 -1.018 . . . . 75.319999999999993 110.015 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 16.2 m-90 -124.28 62.69 1.1 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.409 -0.807 . . . . 73.140000000000001 109.432 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -66.93 -33.76 76.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.341 -0.849 . . . . 73.239999999999995 108.869 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -82.24 150.48 64.36 Favored Pre-proline 0 N--CA 1.487 1.398 0 N-CA-C 108.684 -0.858 . . . . 44.43 108.684 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -39.87 -51.31 3.06 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 121.989 1.793 . . . . 72.510000000000005 112.315 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 44.62 -166.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.489 -0.757 . . . . 63.240000000000002 109.595 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 70.5 mtp -95.59 57.46 1.91 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.05 -1.031 . . . . 73.5 109.662 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 69.8 t -83.39 121.26 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 65.219999999999999 109.143 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.501 ' OG1' ' CG2' ' A' ' 183' ' ' VAL . 0.0 OUTLIER -80.78 166.75 37.24 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.117 -0.989 . . . . 71.420000000000002 108.471 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -47.76 -31.81 15.6 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 122.36 2.04 . . . . 41.219999999999999 112.884 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.989 ' ND2' ' OE1' ' A' ' 185' ' ' GLU . 53.2 t-20 -143.76 97.02 2.99 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.123 -0.986 . . . . 64.540000000000006 110.274 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.501 ' CG2' ' OG1' ' A' ' 180' ' ' THR . 96.2 t -123.66 -13.77 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.567 -0.901 . . . . 74.019999999999996 108.567 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 96.0 mt -61.99 -42.44 94.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.464 -0.772 . . . . 72.329999999999998 109.832 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.989 ' OE1' ' ND2' ' A' ' 182' ' ' ASN . 11.5 pt-20 -51.48 -37.87 51.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.896 -1.128 . . . . 74.400000000000006 109.121 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 36.0 t -73.11 -32.33 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.452 -0.78 . . . . 70.420000000000002 109.372 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -79.33 -56.86 4.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.22 -0.925 . . . . 52.109999999999999 110.457 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.439 HG23 ' N ' ' A' ' 189' ' ' ASN . 3.4 tp -55.59 -39.01 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.858 -1.151 . . . . 71.400000000000006 109.776 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.45 ' OD1' ' NE2' ' A' ' 193' ' ' GLN . 25.8 t-20 -67.68 -54.68 17.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.335 -0.853 . . . . 73.439999999999998 111.779 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -62.26 -31.72 72.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.835 -1.166 . . . . 71.420000000000002 111.412 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 47.1 pt -69.15 -38.14 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.201 -1.562 . . . . 61.549999999999997 109.937 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.64 -42.21 99.47 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 117.986 -1.486 . . . . 63.340000000000003 108.238 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.45 ' NE2' ' OD1' ' A' ' 189' ' ' ASN . 79.5 mt-30 -64.52 -34.26 77.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.552 -0.718 . . . . 61.240000000000002 110.167 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.489 ' O ' ' CG ' ' A' ' 198' ' ' PRO . 15.0 mtpp -75.19 -25.71 58.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.155 -0.966 . . . . 75.129999999999995 110.634 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 74.8 mtm -95.97 4.38 52.74 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.972 -1.08 . . . . 74.019999999999996 109.475 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -113.67 -12.88 12.76 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.579 -0.7 . . . . 74.019999999999996 110.636 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.577 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 20.5 tttt -98.28 -41.04 0.24 Allowed Pre-proline 0 N--CA 1.502 2.132 0 O-C-N 120.949 -1.094 . . . . 75.430000000000007 110.87 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 85.5 Cg_endo -93.3 -64.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.906 2.404 . . . . 72.319999999999993 112.999 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 45.8 mt -50.18 -35.86 28.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.1 -1.0 . . . . 74.540000000000006 109.353 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 87.17 -9.75 71.47 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.761 -1.336 . . . . 61.509999999999998 109.761 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 17.2 mt -132.9 127.57 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.482 -1.01 . . . . 61.219999999999999 109.533 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 39.8 t -78.67 133.1 37.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.316 -0.865 . . . . 72.0 109.199 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.6 p -118.62 34.0 5.4 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.515 -0.74 . . . . 74.439999999999998 110.503 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 6.4 m -143.27 139.39 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.976 -1.078 . . . . 64.349999999999994 110.002 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -126.01 133.44 51.76 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.109 -0.7 . . . . 71.409999999999997 109.109 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.56 133.52 34.14 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.082 -1.011 . . . . 73.519999999999996 108.962 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 10.4 p -128.54 137.23 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.52 -0.738 . . . . 71.019999999999996 109.179 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -92.79 60.37 3.4 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.205 -0.934 . . . . 72.120000000000005 109.369 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.16 -61.51 0.32 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.497 -0.927 . . . . 64.409999999999997 108.497 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -104.43 -65.39 1.03 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.592 -0.692 . . . . 71.540000000000006 109.278 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -171.75 -105.86 0.19 Allowed Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.347 -1.501 . . . . 72.030000000000001 109.347 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.34 123.38 39.27 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.456 -1.026 . . . . 75.540000000000006 108.632 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -89.51 146.49 24.57 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.367 -0.833 . . . . 75.310000000000002 110.963 -178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.609 ' CE2' HD13 ' A' ' 155' ' ' LEU . 11.5 t80 -123.57 114.4 19.99 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.502 -0.925 . . . . 75.409999999999997 108.502 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 18.5 p -140.45 159.41 42.27 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.385 -0.822 . . . . 74.140000000000001 109.077 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -59.04 142.47 85.4 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.079 -1.013 . . . . 75.319999999999993 108.729 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.455 ' O ' ' HB3' ' A' ' 220' ' ' ALA . 46.8 Cg_endo -82.16 16.75 1.69 Allowed 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 122.085 1.857 . . . . 73.109999999999999 112.065 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 217' ' ' PRO . 44.8 tttt -43.74 -55.06 9.49 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.203 -0.935 . . . . 75.25 109.921 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.47 -7.6 20.56 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.568 1.512 . . . . 75.099999999999994 111.187 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 217' ' ' PRO . . . -55.75 -38.57 69.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.42 -0.8 . . . . 71.140000000000001 110.554 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 11.5 t -136.86 149.15 47.51 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.307 -0.871 . . . . 71.129999999999995 109.646 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -110.43 6.9 22.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.594 -0.691 . . . . 75.349999999999994 109.442 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.975 -1.012 . . . . 73.409999999999997 109.388 -179.935 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.413 -0.588 . . . . 71.140000000000001 109.413 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 51.4 ttt85 -139.98 155.07 47.29 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.351 -0.843 . . . . 73.230000000000004 109.279 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 83.4 t -113.23 122.13 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-O 121.59 0.709 . . . . 72.239999999999995 109.73 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.541 HD11 ' CG1' ' B' ' 6' ' ' ILE . 2.6 tp -91.71 117.64 29.94 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.367 -0.975 . . . . 54.329999999999998 108.367 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.506 HD23 ' N ' ' B' ' 6' ' ' ILE . 4.2 tt -118.95 120.15 36.42 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.437 -0.949 . . . . 74.349999999999994 108.437 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.541 ' CG1' HD11 ' B' ' 4' ' ' LEU . 19.0 mt -115.78 99.53 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.438 -0.789 . . . . 42.549999999999997 109.195 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.425 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 30.1 tp10 -125.17 139.64 53.57 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.578 -0.701 . . . . 74.519999999999996 109.295 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.443 ' NZ ' ' OD1' ' B' ' 52' ' ' ASP . 39.2 mmtm -70.39 -34.29 72.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.922 . . . . 62.549999999999997 109.374 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -90.72 118.89 30.5 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.284 -0.885 . . . . 73.109999999999999 109.576 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 18.9 t -70.37 -32.06 69.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.216 -0.927 . . . . 65.540000000000006 109.56 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 82.7 t -64.27 -53.25 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.917 . . . . 75.549999999999997 109.734 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.512 ' O ' HD13 ' B' ' 12' ' ' LEU . 0.2 OUTLIER -64.21 -37.63 88.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.909 . . . . 70.140000000000001 109.003 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.05 -26.72 73.94 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.487 -1.845 . . . . 75.400000000000006 108.487 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.96 -54.2 32.25 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 109.623 -1.391 . . . . 65.439999999999998 109.623 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' B' ' 15' ' ' GLU . 7.2 pt-20 -58.3 -44.2 88.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.333 -1.098 . . . . 60.210000000000001 109.677 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.484 ' CD1' HD12 ' B' ' 102' ' ' ILE . 39.3 mm -64.33 -43.81 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.917 -1.114 . . . . 75.150000000000006 108.725 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -61.3 -43.53 98.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.411 -0.806 . . . . 73.010000000000005 109.816 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.405 ' HZ2' ' HB3' ' B' ' 18' ' ' LYS . 16.3 mtpp -87.06 2.45 49.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.098 -1.001 . . . . 74.299999999999997 109.444 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.73 -53.27 2.61 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.433 -1.467 . . . . 70.540000000000006 109.433 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -76.13 -20.09 57.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.314 -1.109 . . . . 71.340000000000003 109.704 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -58.59 -30.59 67.31 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.06 -1.025 . . . . 64.409999999999997 109.256 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 82.9 t -60.29 -34.66 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.355 -0.84 . . . . 74.230000000000004 109.114 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -68.55 -4.69 16.12 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.336 -0.852 . . . . 63.420000000000002 109.067 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.82 39.97 7.34 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.092 -1.203 . . . . 53.43 110.092 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -119.84 159.34 24.78 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.536 -0.979 . . . . 71.120000000000005 109.321 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 7.1 mmt -105.19 133.37 50.08 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.242 -1.022 . . . . 75.239999999999995 108.242 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.07 162.46 36.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.173 -0.954 . . . . 72.120000000000005 110.239 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -141.22 145.65 35.87 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.459 -0.776 . . . . 72.310000000000002 108.952 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -106.72 137.64 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.309 -0.869 . . . . 64.430000000000007 108.79 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 11.3 p -136.41 167.79 20.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.366 -0.834 . . . . 65.409999999999997 109.289 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.477 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 2.2 pt-20 -90.22 -100.05 0.1 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.153 -0.967 . . . . 71.019999999999996 109.898 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 32.8 t -78.96 166.21 22.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.168 -0.958 . . . . 51.109999999999999 110.236 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 44.1 mt -53.91 -32.97 55.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.633 -0.667 . . . . 71.239999999999995 109.829 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -50.43 -48.31 56.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.121 -0.987 . . . . 74.319999999999993 109.695 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.477 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 65.9 m-20 -69.28 -41.33 76.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.169 -0.957 . . . . 73.030000000000001 109.501 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.18 -40.7 87.8 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.464 -1.454 . . . . 30.210000000000001 109.464 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -68.6 -42.69 77.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -1.151 . . . . 74.420000000000002 109.543 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . 0.448 ' O ' ' OD1' ' B' ' 41' ' ' ASP . 56.4 t80 -75.17 -21.9 58.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 74.420000000000002 110.053 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 28.5 tp -90.01 -39.16 13.13 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.14 -0.975 . . . . 75.409999999999997 110.044 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' B' ' 40' ' ' MET . 0.0 OUTLIER -78.13 -27.69 48.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.996 . . . . 60.409999999999997 110.528 -179.102 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' B' ' 42' ' ' ILE . 41.9 p-10 -68.02 -27.51 66.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.901 -1.124 . . . . 53.229999999999997 110.225 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.533 ' N ' ' OD1' ' B' ' 41' ' ' ASP . 13.8 pt -88.8 -15.47 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.004 -1.06 . . . . 71.230000000000004 110.419 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' B' ' 40' ' ' MET . 97.2 mtt180 -129.48 149.92 51.05 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.239 -0.913 . . . . 72.219999999999999 109.77 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -82.85 163.18 21.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.202 -0.937 . . . . 63.539999999999999 109.458 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 10.4 p90 -159.3 -179.04 7.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.92 . . . . 64.349999999999994 109.706 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -138.97 -32.85 0.66 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.475 -0.766 . . . . 62.219999999999999 109.428 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.501 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.3 OUTLIER -107.08 115.1 29.59 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.357 -0.839 . . . . 73.120000000000005 109.004 179.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.501 ' N ' HD13 ' B' ' 47' ' ' LEU . 56.0 t -102.55 98.01 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.51 -0.922 . . . . 65.109999999999999 108.51 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -117.06 129.07 55.76 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.776 0.798 . . . . 73.439999999999998 110.141 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.624 HG22 ' H ' ' B' ' 52' ' ' ASP . 0.2 OUTLIER -141.65 135.68 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.78 0.8 . . . . 34.5 109.179 -179.622 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . 0.425 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 53.2 p -99.3 18.29 17.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.599 -0.688 . . . . 73.209999999999994 109.599 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.624 ' H ' HG22 ' B' ' 50' ' ' VAL . 37.6 m-20 -86.09 144.16 27.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.185 -0.947 . . . . 70.409999999999997 109.534 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.449 ' C ' ' H ' ' B' ' 55' ' ' ALA . 99.1 mttt -76.52 -42.6 42.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.276 -0.89 . . . . 65.0 110.201 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -71.01 10.72 0.5 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.108 -0.995 . . . . 75.209999999999994 109.727 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -67.13 -22.22 65.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.327 -0.858 . . . . 55.329999999999998 110.106 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.42 ' HG ' ' H ' ' B' ' 56' ' ' LEU . 19.0 mt -44.68 -44.93 9.47 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.268 -0.895 . . . . 63.140000000000001 110.142 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 93.1 p -69.39 -37.96 77.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.991 -1.068 . . . . 63.5 109.284 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -65.07 -62.28 1.65 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.279 -0.888 . . . . 72.329999999999998 109.656 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 33.3 m -49.55 -33.64 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.555 -1.341 . . . . 74.540000000000006 109.661 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 10.9 p -57.6 -51.26 70.23 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.202 -0.936 . . . . 71.239999999999995 109.472 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.418 ' HG2' ' H ' ' B' ' 61' ' ' ARG . 6.7 ptp180 -70.05 -31.24 68.77 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.177 -1.009 . . . . 74.310000000000002 110.176 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' B' ' 66' ' ' HIS . 40.0 mm -66.68 -44.97 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.683 -1.261 . . . . 72.140000000000001 110.285 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -65.09 -44.94 87.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.195 -0.941 . . . . 73.319999999999993 110.818 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -73.86 -38.0 64.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.743 -1.223 . . . . 73.120000000000005 110.036 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.486 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 64.2 mttm -84.71 -17.04 39.69 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.099 -1.0 . . . . 72.439999999999998 109.711 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.486 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 76.9 m-70 -155.63 68.72 0.66 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.053 -1.03 . . . . 63.310000000000002 109.618 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 85.6 p -67.6 -27.55 67.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.312 -0.867 . . . . 73.099999999999994 109.898 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 12.5 t -63.1 -19.22 64.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.148 -0.97 . . . . 71.530000000000001 110.069 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 63.1 mt -88.25 151.94 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.182 -0.949 . . . . 74.400000000000006 109.784 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.419 HG12 ' N ' ' B' ' 71' ' ' VAL . 94.3 t -90.96 157.62 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.41 -0.806 . . . . 75.120000000000005 109.277 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.419 ' N ' HG12 ' B' ' 70' ' ' VAL . 11.0 t -135.7 126.79 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.218 -0.926 . . . . 73.200000000000003 109.864 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.555 HD23 ' C ' ' B' ' 72' ' ' LEU . 4.2 tt -116.88 105.32 12.23 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.787 -0.82 . . . . 73.340000000000003 108.787 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 71.1 t -98.06 131.23 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.033 -1.042 . . . . 73.5 109.541 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.9 p -95.23 169.26 10.21 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.239 -0.913 . . . . 64.340000000000003 109.137 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.474 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 36.2 t -157.19 117.02 3.44 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.007 -1.058 . . . . 74.530000000000001 110.292 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' B' ' 77' ' ' ASN . 52.8 p30 -71.28 -10.5 59.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.409 -0.807 . . . . 64.5 109.292 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' B' ' 79' ' ' THR . 84.5 m-20 -132.9 77.06 69.39 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 108.47 -0.937 . . . . 74.25 108.47 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -55.59 73.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.561 2.174 . . . . 74.430000000000007 111.894 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.542 HG23 ' H ' ' B' ' 82' ' ' GLU . 6.9 t -97.43 150.73 20.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.257 -0.902 . . . . 73.120000000000005 109.308 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -26.37 68.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.523 -0.736 . . . . 71.010000000000005 110.225 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' B' ' 81' ' ' GLU . 2.5 mp0 -64.27 -39.97 95.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.978 -1.076 . . . . 63.200000000000003 109.823 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . 0.542 ' H ' HG23 ' B' ' 79' ' ' THR . 0.1 OUTLIER -78.51 -29.11 46.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.086 -1.009 . . . . 73.219999999999999 109.627 -179.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.522 ' OE2' ' NE ' ' A' ' 100' ' ' ARG . 87.1 mt-10 -64.94 -48.29 74.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.034 -1.041 . . . . 74.299999999999997 109.659 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.479 HG23 ' N ' ' B' ' 85' ' ' HIS . 27.0 m -67.77 -42.65 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 73.310000000000002 109.485 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' HIS . . . . . 0.479 ' N ' HG23 ' B' ' 84' ' ' VAL . 42.4 m80 -69.2 -25.9 64.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.167 -0.958 . . . . 73.239999999999995 109.533 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -68.55 -45.57 71.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 55.329999999999998 109.846 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -79.35 -28.07 42.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.057 -1.027 . . . . 74.140000000000001 109.044 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 31.0 tp10 -75.98 -51.67 11.88 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.335 -0.853 . . . . 64.040000000000006 109.563 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -61.87 -50.42 72.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.414 -0.804 . . . . 72.349999999999994 109.745 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 151.75 72.81 0.01 OUTLIER Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.749 -1.215 . . . . 65.200000000000003 110.308 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -134.43 136.43 43.25 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.288 -1.125 . . . . 52.229999999999997 108.843 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -89.21 -23.15 22.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.09 -1.006 . . . . 73.319999999999993 109.56 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 11.2 t0 -152.03 163.57 39.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.277 -0.889 . . . . 72.219999999999999 109.358 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.518 ' N ' ' OD1' ' B' ' 93' ' ' ASP . 76.7 t80 -146.64 99.28 3.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.382 -0.823 . . . . 64.420000000000002 109.252 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 20.8 mm -106.37 151.01 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.388 0 O-C-N 121.227 -0.921 . . . . 72.230000000000004 109.961 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.15 139.28 57.47 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.991 -1.114 . . . . 25.239999999999998 107.991 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.656 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -58.38 -55.13 48.86 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 120.744 -1.222 . . . . 64.319999999999993 111.146 -179.067 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 3.5 Cg_endo -41.75 -12.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.188 0 CA-C-N 119.619 0.9 . . . . 63.329999999999998 112.383 -176.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . 0.656 ' N ' ' O ' ' B' ' 97' ' ' LYS . 51.0 m-85 57.87 104.33 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.865 -0.522 . . . . 75.129999999999995 110.256 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -55.52 -39.22 70.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.829 -1.169 . . . . 74.230000000000004 108.042 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 10.6 t -170.32 131.96 0.99 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.919 -0.771 . . . . 63.340000000000003 108.919 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . 0.484 HD12 ' CD1' ' B' ' 16' ' ' ILE . 4.1 mm -51.71 -41.61 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.951 . . . . 74.439999999999998 109.1 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -60.37 -36.34 77.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.228 -0.92 . . . . 71.109999999999999 109.264 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.41 -48.53 64.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 71.450000000000003 109.557 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 60.0 tp -60.96 -48.93 79.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 51.310000000000002 109.433 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 85.7 t -67.73 -43.83 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.167 -0.958 . . . . 65.230000000000004 110.028 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.27 -43.32 64.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.06 -1.025 . . . . 24.32 109.211 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -68.35 -33.77 74.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.337 -0.852 . . . . 75.310000000000002 109.606 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 95.3 mt -72.35 -34.51 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.054 -1.029 . . . . 54.240000000000002 108.571 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' B' ' 114' ' ' ARG . 80.6 tt0 -58.55 -56.82 17.17 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.575 -0.85 . . . . 65.310000000000002 108.987 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . 0.445 ' HB1' ' CZ ' ' A' ' 87' ' ' PHE . . . -54.85 -40.34 69.54 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.477 -0.764 . . . . 72.239999999999995 110.157 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . 0.401 HH12 ' HB2' ' B' ' 93' ' ' ASP . 0.0 OUTLIER -53.6 -38.28 63.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.995 -1.066 . . . . 72.040000000000006 108.896 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.86 54.22 1.05 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.987 -1.071 . . . . 75.349999999999994 109.942 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' B' ' 110' ' ' GLU . 4.9 tmt_? -72.06 -43.68 64.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.129 -0.982 . . . . 75.5 108.987 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' PHE . . . . . 0.488 ' O ' ' N ' ' B' ' 117' ' ' GLY . 96.2 m-85 -67.75 -0.84 4.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.332 -0.855 . . . . 65.329999999999998 109.502 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 66.01 -55.5 0.37 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.561 -0.712 . . . . 74.450000000000003 110.158 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' B' ' 115' ' ' PHE . . . -154.42 171.83 32.93 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.897 -1.281 . . . . 44.210000000000001 109.897 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 41.1 m -156.58 -175.51 5.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.38 -1.071 . . . . 71.400000000000006 109.662 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.15 122.95 5.73 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.822 -0.751 . . . . 72.319999999999993 109.112 -178.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 9.9 t -85.15 -42.88 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.214 -0.929 . . . . 75.019999999999996 110.119 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 15.7 mm -97.11 132.66 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.07 -1.019 . . . . 51.409999999999997 109.819 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -114.0 121.46 43.96 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.987 -0.745 . . . . 71.530000000000001 108.987 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.551 ' CD1' HH12 ' B' ' 159' ' ' ARG . 73.4 mt -132.47 121.39 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.355 -0.841 . . . . 72.430000000000007 109.478 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' B' ' 123' ' ' ILE . . . 40.29 -122.61 2.01 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 110.518 -1.033 . . . . 51.229999999999997 110.518 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -97.1 -13.6 22.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.349 -1.089 . . . . 74.200000000000003 109.698 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' B' ' 123' ' ' ILE . 0.1 OUTLIER -95.45 143.41 26.81 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.127 -0.983 . . . . 75.420000000000002 109.406 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 20.3 p -121.27 145.79 47.49 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.101 -0.703 . . . . 74.219999999999999 109.101 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 78.0 mt -125.49 138.87 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.501 -0.749 . . . . 60.329999999999998 109.891 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 5.8 t -118.58 114.66 35.92 Favored Pre-proline 0 N--CA 1.499 1.997 0 N-CA-C 108.723 -0.843 . . . . 72.310000000000002 108.723 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.92 -53.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.651 1.567 . . . . 75.129999999999995 112.162 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -61.52 -40.82 96.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.163 -0.96 . . . . 75.230000000000004 109.459 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' B' ' 133' ' ' GLU . 23.7 tp10 -87.39 7.96 26.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.216 -0.928 . . . . 72.430000000000007 109.359 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' B' ' 132' ' ' GLU . 17.9 pt-20 34.33 54.06 0.6 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.252 0.549 . . . . 75.129999999999995 111.142 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -139.05 146.4 40.74 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.284 -0.885 . . . . 73.219999999999999 109.177 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 14.3 tt -126.11 142.39 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.543 -0.723 . . . . 64.140000000000001 109.1 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 7.2 mt -120.63 136.04 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.611 -0.681 . . . . 71.219999999999999 109.63 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -138.4 134.69 34.44 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.42 -0.955 . . . . 64.219999999999999 108.42 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . 0.443 ' CG ' ' O ' ' B' ' 138' ' ' LYS . 12.4 ttmt 56.41 9.34 0.52 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.465 -0.772 . . . . 72.019999999999996 109.361 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 96.7 3.62 59.44 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 110.225 -1.15 . . . . 74.319999999999993 110.225 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -89.5 126.39 35.57 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.114 -1.227 . . . . 75.340000000000003 108.803 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -91.85 120.32 32.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.248 -0.907 . . . . 71.230000000000004 109.683 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 7.9 p -134.69 140.95 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 108.777 -0.823 . . . . 70.430000000000007 108.777 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -94.01 157.84 15.91 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.188 -0.945 . . . . 72.430000000000007 110.241 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -150.28 139.05 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.455 -0.778 . . . . 72.129999999999995 108.934 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 26.3 pttt -165.89 77.94 0.26 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.184 -0.948 . . . . 72.019999999999996 109.543 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -156.99 -129.83 1.17 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.085 -1.606 . . . . 42.229999999999997 109.085 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 0.632 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 73.2 mttt -80.32 -32.4 0.69 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.108 -1.231 . . . . 73.299999999999997 110.764 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . 0.632 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 71.5 Cg_endo -91.12 15.45 1.76 Allowed 'Trans proline' 0 N--CA 1.486 1.082 0 C-N-CA 122.203 1.935 . . . . 71.329999999999998 112.446 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -98.79 -59.13 1.79 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.238 -0.914 . . . . 74.230000000000004 109.345 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . 0.475 ' CG ' ' N ' ' B' ' 151' ' ' VAL . 18.6 pt-20 -61.09 -48.79 80.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.327 -0.858 . . . . 72.340000000000003 110.47 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.525 HG13 ' N ' ' B' ' 152' ' ' LEU . 9.8 p -64.84 -43.39 96.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.811 -1.181 . . . . 73.349999999999994 110.449 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.525 ' N ' HG13 ' B' ' 151' ' ' VAL . 12.9 tp -63.74 -53.62 48.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.14 -0.975 . . . . 55.240000000000002 110.518 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 16.5 p -72.23 -37.56 69.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.799 -1.188 . . . . 70.010000000000005 110.626 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -52.01 -53.49 41.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.76 -1.212 . . . . 65.319999999999993 109.706 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' B' ' 159' ' ' ARG . 2.7 pp -71.51 -23.09 61.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.93 -1.106 . . . . 71.540000000000006 109.865 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.66 -59.25 4.48 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.816 -1.177 . . . . 75.319999999999993 110.881 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -66.03 -47.73 73.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.601 -1.312 . . . . 73.319999999999993 108.84 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . 0.608 ' C ' ' H ' ' B' ' 160' ' ' ASP . 44.5 t-80 -67.51 -19.17 65.28 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.718 -1.216 . . . . 74.140000000000001 107.718 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . 0.723 ' O ' ' N ' ' B' ' 161' ' ' GLN . 7.2 tpt180 57.79 4.49 0.27 Allowed 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 107.287 -1.375 . . . . 61.409999999999997 107.287 -178.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . 0.608 ' H ' ' C ' ' B' ' 158' ' ' HIS . 2.3 m-20 50.36 -40.22 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 123.228 0.611 . . . . 72.099999999999994 112.22 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . 0.723 ' N ' ' O ' ' B' ' 159' ' ' ARG . 24.1 mt-30 50.48 -142.63 0.65 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.215 -1.553 . . . . 72.25 109.138 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' ILE . . . . . 0.741 HD12 ' N ' ' B' ' 162' ' ' ILE . 1.9 mp -77.53 106.91 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.95 -1.094 . . . . 72.310000000000002 108.724 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . 0.588 HG13 ' O ' ' B' ' 160' ' ' ASP . 1.3 m -135.67 144.73 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.48 -0.763 . . . . 64.209999999999994 109.166 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 41.7 p -96.66 169.76 9.66 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.327 -0.858 . . . . 74.219999999999999 109.506 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -55.57 -39.68 70.98 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.297 -0.877 . . . . 65.310000000000002 109.168 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -62.74 -39.1 93.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.867 . . . . 63.450000000000003 109.313 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -60.13 -45.92 91.38 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.137 -0.977 . . . . 72.400000000000006 109.116 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 22.6 mt -61.94 -29.59 70.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.215 -0.928 . . . . 72.319999999999993 108.576 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.52 HD23 ' C ' ' B' ' 169' ' ' LEU . 5.6 tt -66.81 -64.86 0.77 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.467 -0.771 . . . . 73.340000000000003 109.303 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -61.36 -17.44 53.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -0.878 . . . . 72.099999999999994 109.713 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.72 -61.0 2.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.292 -0.88 . . . . 62.130000000000003 110.123 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 8.2 mm -90.91 -54.33 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.128 -0.983 . . . . 71.420000000000002 109.401 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -90.4 111.07 22.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.311 -0.868 . . . . 72.230000000000004 109.166 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -140.01 -31.53 0.65 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.41 -0.806 . . . . 52.109999999999999 109.37 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . 0.515 ' C ' ' H ' ' B' ' 177' ' ' GLU . 0.7 OUTLIER -59.8 -177.53 0.11 Allowed Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 108.414 -0.958 . . . . 73.040000000000006 108.414 179.708 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' B' ' 175' ' ' GLU . 43.8 Cg_exo -57.19 8.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 122.459 2.106 . . . . 74.129999999999995 112.73 -179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . 0.515 ' H ' ' C ' ' B' ' 175' ' ' GLU . 79.0 mm-40 -50.97 -41.46 59.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.124 -0.985 . . . . 72.439999999999998 109.551 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 67.4 mtt 46.63 52.46 11.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.183 -0.948 . . . . 63.43 109.674 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 10.2 m -71.5 142.85 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.201 -0.937 . . . . 71.049999999999997 109.614 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . 0.597 ' O ' ' N ' ' B' ' 182' ' ' ASN . 69.1 p -43.54 106.68 0.51 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.55 -0.719 . . . . 62.149999999999999 109.919 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -51.36 70.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 122.232 1.955 . . . . 65.219999999999999 112.674 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 182' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' B' ' 180' ' ' THR . 28.5 t-20 -174.86 -23.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.198 -0.939 . . . . 72.310000000000002 108.889 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . 0.43 ' O ' HG22 ' B' ' 186' ' ' VAL . 11.6 p -53.43 -14.47 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.397 -0.815 . . . . 63.32 109.401 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 20.9 mm -54.3 -25.74 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -0.879 . . . . 75.030000000000001 109.681 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -55.84 -45.4 78.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -0.952 . . . . 64.109999999999999 109.928 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . 0.435 HG22 ' H ' ' B' ' 186' ' ' VAL . 9.6 m -80.72 -30.39 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.131 -0.981 . . . . 73.0 110.105 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -68.31 -43.97 76.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.95 -1.094 . . . . 61.119999999999997 109.938 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 188' ' ' ILE . . . . . 0.452 HG23 ' N ' ' B' ' 189' ' ' ASN . 10.4 tp -74.89 -38.9 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.554 -1.342 . . . . 72.430000000000007 109.83 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 189' ' ' ASN . . . . . 0.452 ' N ' HG23 ' B' ' 188' ' ' ILE . 21.7 t-20 -70.5 -35.99 73.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.296 -0.878 . . . . 65.140000000000001 111.282 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . 0.458 ' CG ' ' N ' ' B' ' 191' ' ' ILE . 10.6 pt20 -76.67 -47.12 23.11 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.859 -1.151 . . . . 63.240000000000002 111.449 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . 0.458 ' N ' ' CG ' ' B' ' 190' ' ' GLN . 5.8 pt -65.0 -40.35 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.693 -1.255 . . . . 74.030000000000001 110.699 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -69.81 -42.97 72.98 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.026 -1.046 . . . . 72.239999999999995 111.005 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -74.21 -35.4 63.91 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.937 -1.102 . . . . 73.099999999999994 111.279 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 8.6 pttp -79.57 -24.35 42.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.82 -1.175 . . . . 72.109999999999999 110.54 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 195' ' ' MET . . . . . 0.483 ' SD ' ' OD1' ' B' ' 196' ' ' ASP . 3.5 ppp? -93.01 -38.2 11.78 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.0 -1.063 . . . . 44.329999999999998 110.519 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 196' ' ' ASP . . . . . 0.483 ' OD1' ' SD ' ' B' ' 195' ' ' MET . 85.3 m-20 -59.22 -38.23 79.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.035 -1.041 . . . . 71.209999999999994 110.646 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -63.28 -60.19 10.16 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.962 -1.086 . . . . 75.209999999999994 110.381 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 198' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.56 -59.58 0.24 Allowed 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 121.694 1.596 . . . . 75.319999999999993 112.402 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . 0.474 ' N ' HD12 ' B' ' 199' ' ' LEU . 10.6 mp -56.04 -42.45 76.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.994 -1.066 . . . . 72.25 109.203 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 82.34 -30.25 3.08 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.004 -1.239 . . . . 64.530000000000001 110.004 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 24.9 mm -91.44 129.11 42.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.025 -1.279 . . . . 44.229999999999997 109.435 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 42.0 t -88.13 139.76 30.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.83 . . . . 54.009999999999998 108.992 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 25.2 p -139.59 25.62 2.38 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.31 -0.869 . . . . 74.400000000000006 109.304 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.512 HG12 ' CD2' ' B' ' 214' ' ' PHE . 23.1 m -143.86 145.86 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.245 -0.909 . . . . 72.120000000000005 109.873 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -114.35 137.65 51.54 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.72 -0.613 . . . . 65.409999999999997 109.576 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.58 111.43 23.8 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.289 -0.882 . . . . 71.329999999999998 108.969 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.413 HG12 ' H ' ' B' ' 209' ' ' ARG . 3.7 t -138.36 142.38 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.286 -0.884 . . . . 63.5 109.498 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 208' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' B' ' 209' ' ' ARG . 32.7 ptt-85 -85.26 -24.65 27.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.216 -0.927 . . . . 74.450000000000003 109.642 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . 0.423 ' O ' ' O ' ' B' ' 208' ' ' ARG . 96.0 mtt180 -57.5 -110.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.322 -0.861 . . . . 74.140000000000001 109.968 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 39.4 mmt-85 -51.12 -45.21 61.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.111 -0.993 . . . . 74.430000000000007 109.59 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 147.79 -130.83 3.64 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.35 -1.5 . . . . 64.450000000000003 109.35 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -104.59 131.24 52.24 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.365 -1.079 . . . . 74.209999999999994 108.779 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -105.01 146.52 28.94 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.437 -0.79 . . . . 74.030000000000001 109.902 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . 0.512 ' CD2' HG12 ' B' ' 204' ' ' VAL . 27.9 m-85 -128.39 104.12 7.53 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.408 -0.96 . . . . 74.340000000000003 108.408 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . 0.528 ' SG ' ' N ' ' B' ' 216' ' ' TYR . 50.8 t -127.66 169.01 14.26 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.2 -0.937 . . . . 64.329999999999998 110.49 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . 0.528 ' N ' ' SG ' ' B' ' 215' ' ' CYS . 47.6 m-85 -63.63 152.14 86.75 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.586 -0.696 . . . . 70.040000000000006 109.173 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.92 -162.08 0.1 OUTLIER 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.212 1.941 . . . . 65.109999999999999 111.725 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -47.73 154.36 0.95 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.222 -0.924 . . . . 73.150000000000006 109.018 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -37.09 124.31 0.44 Allowed 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.364 2.043 . . . . 71.310000000000002 112.286 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . 0.426 ' C ' ' H ' ' B' ' 222' ' ' GLU . . . -97.34 39.29 1.2 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.281 -0.887 . . . . 75.450000000000003 109.771 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 5.5 p -77.03 32.19 0.14 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.166 -0.959 . . . . 72.219999999999999 109.647 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.426 ' H ' ' C ' ' B' ' 220' ' ' ALA . 27.6 mp0 48.5 -171.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.218 -0.926 . . . . 54.530000000000001 109.557 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 118.031 -0.985 . . . . 71.129999999999995 109.277 -179.9 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.2 ttm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.435 -0.579 . . . . 65.120000000000005 109.435 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.437 ' N ' ' OD2' ' A' ' 46' ' ' ASP . 61.2 ttm-85 -143.08 150.75 39.94 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.263 -0.898 . . . . 72.329999999999998 109.322 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 81.4 t -120.25 134.82 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-O 121.5 0.667 . . . . 71.420000000000002 110.091 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.401 ' O ' ' O ' ' A' ' 49' ' ' MET . 8.9 tp -100.25 115.97 31.14 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.645 -0.872 . . . . 65.120000000000005 108.645 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.482 HD12 ' SD ' ' A' ' 49' ' ' MET . 25.2 tp -117.39 99.55 7.08 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.582 -0.699 . . . . 62.43 109.756 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.485 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 7.8 mt -94.35 119.36 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.753 -1.217 . . . . 71.150000000000006 108.953 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.8 tp10 -149.26 121.9 8.61 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.199 -0.938 . . . . 75.340000000000003 109.603 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -65.84 -32.97 74.79 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.265 -0.897 . . . . 72.439999999999998 108.996 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -87.27 107.34 18.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.355 -0.841 . . . . 63.020000000000003 109.363 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.2 t -65.99 -18.37 65.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 72.340000000000003 109.671 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.45 -55.82 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.16 -0.963 . . . . 74.019999999999996 109.904 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.603 ' N ' HD22 ' A' ' 12' ' ' LEU . 3.5 mm? -69.39 -38.86 78.18 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.255 -0.903 . . . . 71.430000000000007 109.557 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.13 -28.67 63.84 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.693 -1.763 . . . . 61.32 108.693 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.28 -45.51 95.01 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 109.515 -1.434 . . . . 71.200000000000003 109.515 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.598 ' OE2' HD13 ' A' ' 12' ' ' LEU . 15.0 pt-20 -67.46 -45.91 74.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -1.129 . . . . 71.319999999999993 109.905 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 98.6 mt -64.0 -42.03 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.623 -1.298 . . . . 63.229999999999997 108.641 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -54.01 -50.81 65.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.901 . . . . 51.109999999999999 109.521 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -85.11 1.98 45.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.123 -0.986 . . . . 73.340000000000003 109.076 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.97 -60.73 2.01 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 109.737 -1.345 . . . . 62.149999999999999 109.737 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -69.46 -22.9 63.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.203 -1.175 . . . . 73.510000000000005 109.796 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.402 HD21 ' HB3' ' A' ' 27' ' ' ALA . 3.3 m120 -59.05 -32.89 70.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.04 -1.037 . . . . 74.25 109.339 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 81.4 t -58.71 -34.04 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.445 -0.785 . . . . 70.040000000000006 109.374 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 2.4 mptp? -68.39 -1.21 5.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 73.230000000000004 109.315 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.37 35.09 11.04 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.74 -1.344 . . . . 75.540000000000006 109.74 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -115.78 159.62 21.2 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.488 -1.007 . . . . 73.430000000000007 109.143 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.7 mmt -104.09 138.13 41.05 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.45 -0.945 . . . . 43.240000000000002 108.45 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.402 ' HB3' HD21 ' A' ' 21' ' ' ASN . . . -143.75 164.2 31.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.24 -0.913 . . . . 62.109999999999999 109.771 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -139.08 149.88 45.08 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.434 -0.791 . . . . 74.420000000000002 108.977 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.48 129.0 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.705 -0.85 . . . . 72.150000000000006 108.705 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.3 p -133.1 167.93 19.44 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.452 -0.78 . . . . 71.420000000000002 109.752 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.485 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 3.0 pt-20 -98.6 -96.14 0.23 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.398 -0.814 . . . . 72.329999999999998 109.747 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.5 p -79.96 164.25 23.64 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.015 -1.053 . . . . 74.239999999999995 110.007 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 37' ' ' GLU . 21.8 mt -54.77 -38.95 67.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.513 -0.742 . . . . 71.530000000000001 109.819 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -52.57 -44.21 65.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 74.230000000000004 109.814 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -65.3 -42.47 93.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.107 -0.996 . . . . 54.030000000000001 109.665 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.03 -30.6 50.81 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.062 -1.215 . . . . 61.409999999999997 110.062 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 33' ' ' LEU . 78.2 tt0 -66.74 -46.45 75.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.126 -1.22 . . . . 74.340000000000003 110.099 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.442 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 48.2 m-85 -78.92 -24.11 44.27 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.092 -1.005 . . . . 75.329999999999998 109.959 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.8 tp -85.49 -29.23 24.44 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.005 -1.06 . . . . 74.329999999999998 109.81 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.562 ' SD ' ' CE1' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -86.82 -36.81 18.29 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.069 -1.02 . . . . 70.319999999999993 110.633 -179.164 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 30.5 p-10 -58.73 -30.77 67.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.935 -1.103 . . . . 71.219999999999999 110.238 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.531 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 10.1 pt -78.17 -31.64 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.071 -1.018 . . . . 74.140000000000001 110.104 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 40' ' ' MET . 79.9 mtt85 -108.44 171.82 7.19 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.341 -0.849 . . . . 72.239999999999995 109.682 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.494 ' ND2' ' H ' ' A' ' 45' ' ' TYR . 1.8 t-20 -86.93 148.73 25.22 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.203 -0.936 . . . . 75.420000000000002 109.184 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.565 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 0.5 OUTLIER -139.0 128.65 24.63 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.282 -0.886 . . . . 74.230000000000004 109.509 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.446 ' OD1' ' CD2' ' A' ' 113' ' ' LEU . 3.7 p30 -108.08 -41.99 4.78 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.844 -0.798 . . . . 72.040000000000006 108.844 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.473 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.3 OUTLIER -103.8 112.84 25.97 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.074 -1.084 . . . . 72.129999999999995 108.074 179.335 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.473 ' N ' HD13 ' A' ' 47' ' ' LEU . 21.9 t -100.24 96.86 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.445 -0.946 . . . . 72.340000000000003 108.445 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.482 ' SD ' HD12 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -116.47 123.87 48.55 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.685 0.755 . . . . 74.109999999999999 109.857 -179.477 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.58 HG22 ' H ' ' A' ' 52' ' ' ASP . 1.1 p -131.21 131.93 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 121.632 0.729 . . . . 61.119999999999997 109.41 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.2 p -91.38 3.5 54.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.522 -0.736 . . . . 73.109999999999999 109.303 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.58 ' H ' HG22 ' A' ' 50' ' ' VAL . 1.6 m-20 -78.99 138.34 38.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.269 -0.894 . . . . 52.549999999999997 109.6 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.516 ' NZ ' ' OD1' ' A' ' 77' ' ' ASN . 14.9 mmmt -76.83 -36.18 57.03 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.214 -0.929 . . . . 44.219999999999999 110.11 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -70.54 12.38 0.26 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.081 -1.012 . . . . 70.439999999999998 109.537 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -69.25 -20.9 63.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.412 -0.805 . . . . 64.140000000000001 110.399 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 55' ' ' ALA . 20.3 mt -40.0 -50.46 2.55 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.468 -0.77 . . . . 44.140000000000001 110.395 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.7 t -69.08 -33.56 73.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.033 -1.042 . . . . 55.229999999999997 108.957 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.615 ' CE2' HD11 ' A' ' 62' ' ' ILE . 50.9 t80 -66.91 -59.32 3.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.468 -0.77 . . . . 74.439999999999998 109.938 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.1 m -52.22 -34.14 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.715 -1.24 . . . . 74.030000000000001 109.492 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.5 m -58.49 -54.02 51.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.2 -0.938 . . . . 64.299999999999997 109.715 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -66.85 -27.86 67.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.111 -0.993 . . . . 64.439999999999998 109.978 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.615 HD11 ' CE2' ' A' ' 58' ' ' PHE . 5.6 mm -67.05 -45.73 86.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.901 -1.124 . . . . 63.210000000000001 110.185 -179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 67' ' ' SER . 53.7 mmtt -65.16 -46.44 80.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 74.420000000000002 110.645 -179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 6.6 pt-20 -70.35 -41.83 72.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.716 -1.24 . . . . 70.319999999999993 109.953 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.491 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 25.9 mtpp -76.29 -19.12 58.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.143 -0.973 . . . . 75.219999999999999 109.313 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.532 ' O ' HG22 ' A' ' 69' ' ' ILE . 83.2 m-70 -156.29 68.1 0.6 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.888 . . . . 74.129999999999995 109.282 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 63' ' ' LYS . 82.5 p -65.49 -15.87 63.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 73.239999999999995 109.914 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 92.8 p -88.32 43.82 1.16 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.191 -0.943 . . . . 61.009999999999998 110.329 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 66' ' ' HIS . 16.9 tt -145.11 169.13 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.989 -1.069 . . . . 71.329999999999998 109.582 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.1 t -102.1 148.66 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.263 -0.898 . . . . 72.129999999999995 109.424 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.5 t -131.5 126.49 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.376 -0.828 . . . . 54.210000000000001 109.76 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.553 ' C ' HD23 ' A' ' 72' ' ' LEU . 3.8 tt -120.11 100.97 7.51 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.111 -0.7 . . . . 50.240000000000002 109.111 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 73' ' ' VAL . 8.7 p -97.09 131.32 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.982 -1.074 . . . . 74.409999999999997 109.153 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 75' ' ' SER . 4.5 p -92.86 174.98 6.97 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.086 -1.009 . . . . 72.310000000000002 109.378 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.472 ' OG ' ' CE2' ' A' ' 94' ' ' TYR . 50.9 m -164.49 116.09 1.26 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.083 -1.01 . . . . 64.540000000000006 110.371 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.8 -28.56 68.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.525 -0.734 . . . . 74.129999999999995 109.306 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.516 ' OD1' ' NZ ' ' A' ' 53' ' ' LYS . 13.0 p30 -109.6 71.13 0.52 Allowed Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.657 -0.652 . . . . 73.340000000000003 109.41 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.01 80.45 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 121.654 1.569 . . . . 63.219999999999999 111.769 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.63 HG23 ' H ' ' A' ' 82' ' ' GLU . 1.8 t -104.72 162.49 13.25 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.656 -0.868 . . . . 62.530000000000001 108.656 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.8 p -71.36 -29.11 64.59 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.166 -0.959 . . . . 73.439999999999998 109.864 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -62.77 -45.57 92.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 71.420000000000002 109.475 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.63 ' H ' HG23 ' A' ' 79' ' ' THR . 74.8 tt0 -76.49 -29.72 56.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.281 -0.887 . . . . 73.430000000000007 109.639 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -63.73 -57.01 11.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.954 . . . . 74.219999999999999 109.611 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.519 HG23 ' N ' ' A' ' 85' ' ' HIS . 27.2 m -60.34 -42.18 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.14 -0.975 . . . . 73.200000000000003 108.987 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.527 ' CE1' HE21 ' A' ' 89' ' ' GLN . 82.4 t60 -62.95 -35.44 80.12 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.298 -0.876 . . . . 53.329999999999998 109.219 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.82 -37.38 84.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.416 -0.803 . . . . 64.109999999999999 109.861 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -77.08 -29.91 55.19 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.047 -1.033 . . . . 74.340000000000003 108.818 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.34 -36.3 68.79 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.714 -0.794 . . . . 74.420000000000002 109.229 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.527 HE21 ' CE1' ' A' ' 85' ' ' HIS . 90.2 mm-40 -66.58 -51.29 58.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.364 -0.835 . . . . 74.239999999999995 109.478 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.85 44.3 0.06 OUTLIER Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.742 -1.343 . . . . 61.509999999999998 109.742 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -99.72 135.88 40.47 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.21 -1.171 . . . . 55.329999999999998 109.416 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.524 ' OD2' ' NH1' ' A' ' 112' ' ' ARG . 45.9 t0 -82.38 -25.05 34.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 73.420000000000002 109.314 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.528 ' OD2' ' NH2' ' A' ' 112' ' ' ARG . 72.0 m-20 -149.75 155.76 40.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.349 -0.845 . . . . 75.040000000000006 109.249 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.472 ' CE2' ' OG ' ' A' ' 75' ' ' SER . 55.3 t80 -137.4 103.38 5.06 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.735 -0.839 . . . . 71.329999999999998 108.735 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.511 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 0.3 OUTLIER -107.6 151.94 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 121.651 0.738 . . . . 71.129999999999995 110.001 -177.508 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.36 130.27 39.35 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.693 -1.225 . . . . 64.319999999999993 107.693 178.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.697 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -49.89 -55.67 22.34 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 120.988 -1.07 . . . . 62.200000000000003 111.835 -178.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 2.2 Cg_endo -40.21 -11.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 120.895 1.063 . . . . 73.109999999999999 113.101 -176.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.697 ' N ' ' O ' ' A' ' 97' ' ' LYS . 56.5 m-85 59.08 121.07 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.644 -0.66 . . . . 65.219999999999999 110.189 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.587 ' HE ' ' CB ' ' B' ' 80' ' ' SER . 0.0 OUTLIER -56.71 -46.63 81.15 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.047 -1.094 . . . . 72.349999999999994 108.047 179.077 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.764 ' O ' ' N ' ' A' ' 103' ' ' LYS . 22.7 t -175.11 53.69 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.236 -0.915 . . . . 71.319999999999993 110.498 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 11.4 mm 49.08 -69.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.591 -0.693 . . . . 75.430000000000007 110.796 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.764 ' N ' ' O ' ' A' ' 101' ' ' SER . 2.4 mppt? -55.29 -18.34 6.17 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.988 -1.116 . . . . 71.409999999999997 107.988 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.08 -97.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.582 -0.699 . . . . 63.240000000000002 110.405 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.632 ' N ' HD23 ' A' ' 105' ' ' LEU . 2.0 pt? -49.83 -36.18 25.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.137 -0.977 . . . . 73.219999999999999 110.226 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 67.3 t -59.48 -39.85 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.881 -1.137 . . . . 60.109999999999999 108.903 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 103' ' ' LYS . . . -64.13 -31.86 73.21 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.193 -0.942 . . . . 70.420000000000002 108.57 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.1 ttp-105 -81.91 -24.83 35.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.457 -0.777 . . . . 74.409999999999997 109.745 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 65.6 mt -75.53 -37.4 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.032 -1.043 . . . . 62.539999999999999 108.705 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.442 ' OE1' ' NZ ' ' A' ' 23' ' ' LYS . 11.8 pt-20 -76.21 -35.33 59.1 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.561 -0.856 . . . . 74.340000000000003 109.353 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.71 -45.35 94.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.431 -0.793 . . . . 73.319999999999993 109.863 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.528 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 23.3 ttm180 -66.06 -50.83 62.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.119 -0.988 . . . . 52.409999999999997 109.596 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 113' ' ' LEU . 10.1 mp -95.51 38.29 1.16 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.14 -0.975 . . . . 65.239999999999995 109.206 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.37 -55.2 5.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.262 -0.899 . . . . 64.450000000000003 109.176 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -85.07 13.53 6.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -0.869 . . . . 74.430000000000007 109.617 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 60.4 t-105 -48.98 105.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 74.420000000000002 109.537 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 157.85 -136.89 5.04 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.629 -1.388 . . . . 75.040000000000006 109.629 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.8 t 54.21 177.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.425 -1.044 . . . . 61.140000000000001 110.049 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.7 150.71 26.53 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.059 -0.719 . . . . 65.239999999999995 109.059 -178.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.0 t -90.31 -41.48 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.155 -0.966 . . . . 73.109999999999999 109.581 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 17.1 mm -100.13 135.84 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.348 -0.845 . . . . 72.239999999999995 109.586 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -148.54 127.18 12.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.27 -0.894 . . . . 72.340000000000003 109.048 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.436 ' O ' HG23 ' A' ' 123' ' ' ILE . 6.5 tp -154.42 128.09 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 71.439999999999998 108.994 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 53.47 -139.4 35.02 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.946 -1.661 . . . . 73.400000000000006 108.946 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 125' ' ' ASP . 14.3 p-10 -93.51 6.39 48.38 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.089 -1.242 . . . . 74.450000000000003 109.154 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.05 135.14 38.23 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.638 -0.875 . . . . 54.210000000000001 108.638 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.1 m -131.97 138.63 48.38 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.405 -0.809 . . . . 54.5 109.408 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.8 mt -138.85 139.92 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.332 -0.855 . . . . 45.149999999999999 109.184 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.8 m -123.36 82.33 52.65 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 121.604 -0.685 . . . . 71.109999999999999 109.392 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.46 -41.09 75.93 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.56 2.174 . . . . 65.409999999999997 112.115 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -56.07 -44.78 79.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 63.32 109.064 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -87.15 2.13 50.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.409 -0.807 . . . . 72.519999999999996 108.868 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 1.28 ' HB3' ' CZ ' ' A' ' 149' ' ' PHE . 21.4 mt-10 49.71 61.75 3.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.422 -0.798 . . . . 75.329999999999998 109.058 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -149.02 135.61 19.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.252 -0.905 . . . . 71.230000000000004 109.808 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 11.6 tt -107.86 136.24 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.434 -0.95 . . . . 74.019999999999996 108.434 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 47.7 mt -128.86 125.18 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.364 -0.835 . . . . 60.229999999999997 109.947 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.431 ' N ' ' CD1' ' A' ' 137' ' ' TYR . 16.5 p90 -139.3 147.25 41.38 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.454 -0.779 . . . . 62.32 109.152 179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 54.9 mttp 54.33 23.87 4.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.451 -0.78 . . . . 75.400000000000006 110.05 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 79.44 -1.35 77.15 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.44 -1.064 . . . . 72.239999999999995 110.44 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -90.17 135.53 33.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.953 -1.322 . . . . 71.219999999999999 108.89 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -101.52 131.07 47.88 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.401 -0.812 . . . . 71.420000000000002 109.695 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 49.8 t -137.81 127.65 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.956 -0.757 . . . . 53.020000000000003 108.956 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -81.36 139.28 35.43 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.254 -0.904 . . . . 60.450000000000003 109.336 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.404 ' O ' ' CD1' ' A' ' 149' ' ' PHE . 12.2 m -142.6 137.09 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.252 -0.905 . . . . 74.439999999999998 109.53 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 1.136 ' HA ' ' CG ' ' A' ' 149' ' ' PHE . 49.5 pttt -171.45 28.57 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 65.150000000000006 109.214 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.19 -145.8 3.33 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.93 -1.268 . . . . 73.340000000000003 109.93 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -70.87 -38.61 7.61 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 121.357 -1.084 . . . . 72.219999999999999 110.426 -179.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 90.5 Cg_endo -86.66 11.82 3.17 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 122.008 1.806 . . . . 65.230000000000004 111.853 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 1.28 ' CZ ' ' HB3' ' A' ' 133' ' ' GLU . 32.3 t80 -79.75 -34.83 39.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.418 -0.801 . . . . 60.109999999999999 109.425 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -74.41 -38.03 63.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 64.209999999999994 110.168 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.518 HG13 ' N ' ' A' ' 152' ' ' LEU . 11.5 p -74.76 -40.58 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.09 -1.006 . . . . 72.019999999999996 109.506 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.518 ' N ' HG13 ' A' ' 151' ' ' VAL . 20.4 tp -58.94 -45.63 89.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 73.310000000000002 109.216 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 4.7 p -65.82 -37.08 85.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.896 . . . . 74.310000000000002 109.373 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -52.94 -54.96 27.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.374 -0.829 . . . . 74.310000000000002 109.94 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.67 HD12 ' N ' ' A' ' 156' ' ' ALA . 4.4 pp -76.33 -19.6 58.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 75.340000000000003 110.067 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.67 ' N ' HD12 ' A' ' 155' ' ' LEU . . . -61.68 -45.28 94.68 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.009 -1.057 . . . . 62.140000000000001 109.464 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.445 ' C ' ' H ' ' A' ' 159' ' ' ARG . 60.4 mtp180 -79.55 -51.58 9.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.185 -0.947 . . . . 61.030000000000001 109.35 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.406 ' C ' ' H ' ' A' ' 160' ' ' ASP . 62.0 m170 -73.32 43.5 0.13 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.487 -0.758 . . . . 74.120000000000005 109.172 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.765 HH12 ' NE2' ' B' ' 161' ' ' GLN . 0.2 OUTLIER -74.72 30.77 0.09 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.579 -0.7 . . . . 71.129999999999995 110.213 -179.623 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.406 ' H ' ' C ' ' A' ' 158' ' ' HIS . 63.3 t0 -165.2 66.4 0.13 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.922 -1.111 . . . . 75.450000000000003 110.131 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.562 HE22 ' CG2' ' A' ' 163' ' ' VAL . 2.1 pp0? -177.89 178.75 0.93 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.125 -0.984 . . . . 73.409999999999997 109.802 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 14.1 mm -97.44 125.67 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.309 -0.869 . . . . 74.409999999999997 109.358 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.562 ' CG2' HE22 ' A' ' 161' ' ' GLN . 18.6 t -104.5 132.82 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.376 -0.827 . . . . 72.310000000000002 109.197 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.7 t -87.31 141.59 28.53 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.15 -0.969 . . . . 74.120000000000005 109.321 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.439 ' O ' HD13 ' A' ' 184' ' ' ILE . 33.1 mttt -51.69 -45.63 63.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 70.430000000000007 108.77 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -56.55 -37.64 70.8 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 73.519999999999996 109.1 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.17 -40.87 71.17 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.158 -0.964 . . . . 74.519999999999996 109.296 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 74.8 mt -62.62 -49.17 76.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 72.310000000000002 109.918 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.4 tp -75.77 -65.46 0.9 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.787 -1.195 . . . . 53.329999999999998 109.84 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -39.45 -31.01 0.08 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 122.164 -0.335 . . . . 62.439999999999998 111.892 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.75 -39.88 9.64 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.774 -1.204 . . . . 60.210000000000001 112.519 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.528 ' CD1' ' N ' ' A' ' 172' ' ' ILE . 1.3 mp -85.31 -60.16 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 120.535 -1.353 . . . . 75.319999999999993 111.709 -177.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.464 ' C ' ' CD2' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -61.96 -7.14 3.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.79 -1.194 . . . . 73.140000000000001 110.049 -177.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.9 -24.91 59.84 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.962 -1.086 . . . . 73.239999999999995 110.133 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.451 ' CB ' ' CD ' ' A' ' 176' ' ' PRO . 1.7 mp0 -79.38 -66.17 0.28 Allowed Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 120.828 -1.17 . . . . 44.43 110.054 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' A' ' 175' ' ' GLU . 41.3 Cg_endo -64.53 -32.47 59.06 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.198 1.932 . . . . 72.510000000000005 111.579 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 52.86 22.3 2.31 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.495 -0.753 . . . . 63.240000000000002 110.379 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.449 ' O ' ' O ' ' A' ' 179' ' ' VAL . 26.6 ttt -77.75 -49.58 14.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.032 -1.042 . . . . 73.5 108.947 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.449 ' O ' ' O ' ' A' ' 178' ' ' MET . 0.5 OUTLIER 60.08 128.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-O 121.675 0.75 . . . . 65.219999999999999 109.107 179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.515 ' O ' HG13 ' A' ' 183' ' ' VAL . 5.3 p -151.42 153.52 32.44 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.28 -0.887 . . . . 71.420000000000002 108.796 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -35.92 -37.18 0.22 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 122.342 2.028 . . . . 41.219999999999999 112.017 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -76.01 46.17 0.38 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.395 -0.965 . . . . 64.540000000000006 108.395 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 180' ' ' THR . 26.8 m -62.05 -135.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.541 -0.724 . . . . 74.019999999999996 110.365 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 165' ' ' LYS . 57.3 mt -62.9 -31.87 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.287 -0.883 . . . . 72.329999999999998 109.636 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.406 ' H ' HG23 ' A' ' 183' ' ' VAL . 47.4 tt0 -45.64 -56.3 5.36 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.594 -0.692 . . . . 74.400000000000006 110.3 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 87.3 t -80.9 -52.69 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.186 -0.946 . . . . 70.420000000000002 110.54 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -46.06 -47.47 17.08 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.023 -1.048 . . . . 52.109999999999999 110.387 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.509 HD13 ' O ' ' A' ' 188' ' ' ILE . 0.2 OUTLIER -71.95 -46.86 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.837 -1.164 . . . . 71.400000000000006 109.693 -179.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.461 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 46.8 t-20 -56.13 -40.88 74.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.951 -1.093 . . . . 73.439999999999998 110.334 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 194' ' ' LYS . 25.6 mt-30 -72.9 -48.24 38.91 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.027 -1.045 . . . . 71.420000000000002 110.298 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 58.5 mt -49.12 -36.18 8.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 O-C-N 120.65 -1.281 . . . . 61.549999999999997 110.242 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 20.7 mtm-85 -76.04 -59.21 2.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.856 -1.153 . . . . 63.340000000000003 111.057 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.43 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 86.6 mt-30 -71.08 -14.53 62.34 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.13 -0.981 . . . . 61.240000000000002 110.775 -178.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 190' ' ' GLN . 33.3 ttpt -91.17 -36.88 13.7 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.17 -0.956 . . . . 75.129999999999995 110.042 -179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 9.3 tpt -89.89 -4.1 57.72 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.294 -0.879 . . . . 74.019999999999996 109.701 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 197' ' ' LYS . 33.7 p-10 -68.2 -44.31 76.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.089 -1.007 . . . . 74.019999999999996 110.652 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.537 ' N ' ' OD1' ' A' ' 196' ' ' ASP . 8.9 mttm -75.84 -53.44 2.42 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.944 -1.098 . . . . 75.430000000000007 110.017 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -47.03 -61.36 0.62 Allowed 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.899 1.733 . . . . 72.319999999999993 112.214 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 33.8 tp -70.61 -43.72 68.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 74.540000000000006 109.314 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 91.38 -19.45 47.06 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.985 -1.246 . . . . 61.509999999999998 109.985 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 29.9 mm -111.32 133.44 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.415 -1.05 . . . . 61.219999999999999 109.576 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 14.4 t -85.35 134.42 34.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 72.0 109.123 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 43.9 p -144.23 29.05 1.32 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.238 -0.914 . . . . 74.439999999999998 109.595 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 3.2 m -135.48 125.2 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.386 -0.821 . . . . 64.349999999999994 109.483 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -107.12 129.07 54.88 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.485 -0.759 . . . . 71.409999999999997 109.147 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 81.0 p -93.35 120.71 33.94 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.21 -0.932 . . . . 73.519999999999996 109.414 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.51 HG22 ' H ' ' A' ' 209' ' ' ARG . 7.3 p -137.49 143.1 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.366 -0.834 . . . . 71.019999999999996 109.051 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -75.69 -33.06 60.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 72.120000000000005 110.067 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 211' ' ' GLY . 44.9 mmm-85 -60.97 145.89 48.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.098 -1.001 . . . . 64.409999999999997 109.553 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 64.1 mtp85 48.64 -91.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.386 -0.821 . . . . 71.540000000000006 109.734 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . -160.27 -124.99 0.76 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.494 -1.443 . . . . 72.030000000000001 109.494 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -101.5 141.84 33.76 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.352 -1.087 . . . . 75.540000000000006 109.236 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.474 ' NH1' ' SG ' ' A' ' 215' ' ' CYS . 66.1 ttt-85 -109.03 127.28 53.96 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.514 -0.741 . . . . 75.310000000000002 109.789 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -109.66 124.02 50.47 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.646 -0.872 . . . . 75.409999999999997 108.646 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . 0.474 ' SG ' ' NH1' ' A' ' 213' ' ' ARG . 4.8 p -140.91 167.32 22.48 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.34 -0.85 . . . . 74.140000000000001 109.923 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -61.71 150.78 80.89 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.384 -0.823 . . . . 75.319999999999993 108.947 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -39.46 137.91 0.88 Allowed 'Trans proline' 0 C--N 1.315 -1.189 0 C-N-CA 121.852 1.701 . . . . 73.109999999999999 111.99 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.605 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 2.8 tppt? -76.96 -36.49 1.59 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.114 -0.991 . . . . 75.25 110.375 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 75.5 Cg_endo -91.48 32.43 0.3 Allowed 'Trans proline' 0 C--N 1.317 -1.108 0 C-N-CA 122.431 2.088 . . . . 75.099999999999994 112.419 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -53.69 134.46 41.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.154 -0.966 . . . . 71.140000000000001 109.448 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 74.8 m -83.26 -34.14 25.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.307 -0.871 . . . . 71.129999999999995 109.572 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 48.07 21.25 0.31 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 75.349999999999994 109.611 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.042 -0.98 . . . . 73.409999999999997 109.473 -179.908 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.566 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.418 -0.586 . . . . 71.140000000000001 109.418 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 1.217 ' CZ ' ' NH2' ' B' ' 43' ' ' ARG . 88.9 mtt-85 -131.21 142.34 50.17 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.507 -0.745 . . . . 73.230000000000004 109.721 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 88.2 t -107.7 123.07 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.611 -0.681 . . . . 72.239999999999995 109.709 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.58 HD11 ' CG1' ' B' ' 6' ' ' ILE . 2.4 tp -91.24 114.43 26.95 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.094 -1.076 . . . . 54.329999999999998 108.094 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 4.4 tp -117.11 111.71 19.87 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.912 -0.773 . . . . 74.349999999999994 108.912 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.58 ' CG1' HD11 ' B' ' 4' ' ' LEU . 20.0 mt -106.59 123.58 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.445 -0.785 . . . . 42.549999999999997 109.02 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -140.41 120.25 13.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.345 -0.847 . . . . 74.519999999999996 109.274 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -66.44 -30.81 71.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.158 -0.963 . . . . 62.549999999999997 109.283 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -64.24 -128.53 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.217 -0.927 . . . . 73.109999999999999 109.033 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 79.2 p -167.06 -66.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.11 -0.994 . . . . 65.540000000000006 109.658 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.472 HG13 ' N ' ' B' ' 12' ' ' LEU . 9.6 p -67.52 -40.96 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 75.549999999999997 109.907 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.472 ' N ' HG13 ' B' ' 11' ' ' VAL . 3.6 mm? -52.14 -43.23 63.93 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.024 -1.048 . . . . 70.140000000000001 108.725 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.94 -28.35 68.85 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 108.508 -1.837 . . . . 75.400000000000006 108.508 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.61 -51.52 53.42 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 109.72 -1.352 . . . . 65.439999999999998 109.72 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -60.82 -45.04 96.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.306 -1.114 . . . . 60.210000000000001 109.931 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 5.6 mm -67.26 -38.73 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.828 -1.17 . . . . 75.150000000000006 108.924 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.525 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 84.0 tt0 -62.73 -42.52 99.7 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 73.010000000000005 109.791 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -88.58 -0.53 57.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.931 -1.106 . . . . 74.299999999999997 108.916 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.1 -53.39 3.32 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 109.551 -1.419 . . . . 70.540000000000006 109.551 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -73.83 -24.59 59.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -1.121 . . . . 71.340000000000003 109.654 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 96.2 m-20 -58.96 -34.75 72.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.158 -0.964 . . . . 64.409999999999997 109.485 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 90.9 t -55.74 -45.29 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.416 -0.802 . . . . 74.230000000000004 109.379 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 50.3 mmtt -54.2 -49.67 68.85 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.382 -0.824 . . . . 63.420000000000002 108.827 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.77 41.21 0.15 Allowed Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.1 -1.2 . . . . 53.43 110.1 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -120.38 160.13 23.69 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.395 -1.062 . . . . 71.120000000000005 109.532 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.1 mmt -100.47 139.41 36.2 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.957 -1.127 . . . . 75.239999999999995 107.957 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.28 160.43 41.01 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.168 -0.957 . . . . 72.120000000000005 110.314 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -135.2 141.31 45.82 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.607 -0.886 . . . . 72.310000000000002 108.607 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 1.1 m -107.59 126.96 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.332 -0.855 . . . . 64.430000000000007 109.103 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.7 p -125.13 161.85 25.9 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.616 -0.678 . . . . 65.409999999999997 109.25 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.466 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 1.7 pt-20 -88.2 -97.67 0.09 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.27 -0.894 . . . . 71.019999999999996 109.796 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 9.3 t -78.8 152.39 31.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.895 . . . . 51.109999999999999 110.007 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.564 ' H ' HD12 ' B' ' 33' ' ' LEU . 1.6 mp -50.59 -26.29 5.14 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.562 -0.711 . . . . 71.239999999999995 109.711 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -58.61 -48.29 81.49 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.163 -0.96 . . . . 74.319999999999993 109.872 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.466 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 68.5 m-20 -59.88 -43.74 94.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.969 . . . . 73.030000000000001 109.258 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.06 -29.59 68.71 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.2 -1.56 . . . . 30.210000000000001 109.2 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -65.66 -43.66 88.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.358 -1.084 . . . . 74.420000000000002 109.816 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -80.28 -33.5 37.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.997 -1.064 . . . . 74.420000000000002 109.57 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 11.3 tp -72.88 -39.23 66.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.345 -0.847 . . . . 75.409999999999997 109.776 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . 0.43 ' O ' ' O ' ' B' ' 43' ' ' ARG . 2.9 ppp? -75.79 -21.93 56.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.962 . . . . 60.409999999999997 109.833 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -60.73 -35.85 77.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.135 -0.978 . . . . 53.229999999999997 109.531 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 11.3 pt -92.4 -24.81 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.28 -0.888 . . . . 71.230000000000004 110.031 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 1.217 ' NH2' ' CZ ' ' B' ' 2' ' ' ARG . 54.4 mtp180 -124.9 139.47 53.8 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.335 -0.853 . . . . 72.219999999999999 109.537 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -101.35 143.38 31.46 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.3 -0.875 . . . . 63.539999999999999 109.62 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -114.85 143.5 45.01 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.967 -0.753 . . . . 64.349999999999994 108.967 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' B' ' 2' ' ' ARG . 8.3 p-10 -82.08 -36.92 27.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.077 -1.015 . . . . 62.219999999999999 109.276 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.508 HD13 ' C ' ' B' ' 47' ' ' LEU . 0.8 OUTLIER -109.41 109.72 20.65 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.639 -0.875 . . . . 73.120000000000005 108.639 179.608 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.446 ' N ' HD13 ' B' ' 47' ' ' LEU . 63.5 t -94.46 100.57 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.282 -0.886 . . . . 65.109999999999999 109.197 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 0.3 OUTLIER -116.93 124.98 50.76 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.669 -0.863 . . . . 73.439999999999998 108.669 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.85 130.43 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.278 -0.889 . . . . 34.5 109.342 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 75.4 p -107.21 27.92 8.58 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.691 -0.631 . . . . 73.209999999999994 109.54 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -86.86 159.02 19.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -0.927 . . . . 70.409999999999997 109.486 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' B' ' 55' ' ' ALA . 94.0 mttt -81.63 175.8 10.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.321 -0.862 . . . . 65.0 109.375 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . 0.465 ' C ' ' ND2' ' B' ' 54' ' ' ASN . 0.3 OUTLIER 44.58 16.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.602 -0.686 . . . . 75.209999999999994 109.86 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' B' ' 53' ' ' LYS . . . -74.48 -20.55 59.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 55.329999999999998 109.185 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 24.6 mt -42.79 -46.73 5.3 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.631 -0.668 . . . . 63.140000000000001 110.342 -179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 58.7 m -65.54 -37.22 86.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.971 -1.081 . . . . 63.5 109.659 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . 0.467 ' CZ ' HD11 ' B' ' 62' ' ' ILE . 67.1 t80 -63.21 -59.99 4.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 72.329999999999998 109.898 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 15.4 m -49.59 -35.68 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.735 -1.228 . . . . 74.540000000000006 109.764 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.428 ' OG ' ' N ' ' B' ' 61' ' ' ARG . 13.0 p -58.11 -55.04 40.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.095 -1.003 . . . . 71.239999999999995 109.752 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.428 ' N ' ' OG ' ' B' ' 60' ' ' SER . 11.3 ptp180 -64.48 -27.47 69.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.064 -1.023 . . . . 74.310000000000002 110.042 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.467 HD11 ' CZ ' ' B' ' 58' ' ' PHE . 28.2 mm -64.74 -41.54 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.784 -1.197 . . . . 72.140000000000001 109.936 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.476 ' NZ ' ' O ' ' B' ' 90' ' ' GLY . 19.1 mmtp -69.65 -48.83 58.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.94 -1.1 . . . . 73.319999999999993 110.551 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -66.7 -35.93 81.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.759 -1.213 . . . . 73.120000000000005 109.807 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.421 ' C ' ' CG ' ' B' ' 66' ' ' HIS . 9.7 mtpm? -82.13 -25.29 34.53 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.166 -0.959 . . . . 72.439999999999998 109.702 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.421 ' CG ' ' C ' ' B' ' 65' ' ' LYS . 65.6 m-70 -152.73 68.01 0.83 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.164 -0.96 . . . . 63.310000000000002 109.516 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 86.6 p -64.4 -25.8 68.18 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.359 -0.838 . . . . 73.099999999999994 109.885 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 17.8 p -66.02 -9.19 28.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.179 -0.951 . . . . 71.530000000000001 109.883 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 56.9 mt -102.11 151.26 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.351 -0.843 . . . . 74.400000000000006 109.468 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.551 HG12 ' N ' ' B' ' 71' ' ' VAL . 76.6 t -87.39 165.54 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.249 -0.907 . . . . 75.120000000000005 109.486 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.551 ' N ' HG12 ' B' ' 70' ' ' VAL . 2.9 t -145.7 122.71 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.966 -1.084 . . . . 73.200000000000003 109.824 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.521 ' HG ' HD11 ' B' ' 95' ' ' ILE . 2.9 mp -120.36 105.4 10.87 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.483 -0.932 . . . . 73.340000000000003 108.483 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.463 ' O ' HG13 ' B' ' 73' ' ' VAL . 14.7 p -95.35 130.91 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.209 -0.932 . . . . 73.5 109.019 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 2.5 p -89.5 170.19 10.72 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.104 -0.997 . . . . 64.340000000000003 109.203 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 26.4 t -161.22 114.54 1.95 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.092 -1.005 . . . . 74.530000000000001 109.942 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -62.8 -36.7 84.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.173 -0.954 . . . . 64.5 108.81 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . 0.407 ' OD1' ' N ' ' B' ' 77' ' ' ASN . 13.0 p-10 -112.39 87.4 9.34 Favored Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 108.668 -0.864 . . . . 74.25 108.668 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -72.16 78.78 1.82 Allowed 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.51 1.473 . . . . 74.430000000000007 111.875 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 77.2 p -83.01 152.33 25.45 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.034 -1.098 . . . . 73.120000000000005 108.034 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . 0.587 ' CB ' ' HE ' ' A' ' 100' ' ' ARG . 0.5 OUTLIER -63.96 -35.74 81.67 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.011 -1.056 . . . . 71.010000000000005 109.89 -179.239 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . 0.496 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 24.0 pt-20 -60.55 -36.82 79.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.129 -0.982 . . . . 63.200000000000003 109.373 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -73.63 -33.55 64.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.213 -0.929 . . . . 73.219999999999999 109.565 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -62.74 -52.36 63.54 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.259 -0.901 . . . . 74.299999999999997 109.722 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 18.8 m -61.09 -39.3 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.111 -0.993 . . . . 73.310000000000002 109.34 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' HIS . . . . . 0.496 ' ND1' ' O ' ' B' ' 81' ' ' GLU . 25.0 m80 -66.59 -30.66 71.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.246 -0.909 . . . . 73.239999999999995 109.351 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -65.37 -43.35 91.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 55.329999999999998 109.693 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -80.22 -35.04 36.79 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.185 -0.947 . . . . 74.140000000000001 109.019 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -63.13 -50.43 70.46 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.425 -0.797 . . . . 64.040000000000006 109.074 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -60.45 -52.68 64.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.544 -0.723 . . . . 72.349999999999994 109.836 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . 0.476 ' O ' ' NZ ' ' B' ' 63' ' ' LYS . . . 155.16 -15.08 0.49 Allowed Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.649 -1.262 . . . . 65.200000000000003 110.588 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -45.02 133.05 6.65 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.973 -1.31 . . . . 52.229999999999997 109.843 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.42 ' O ' ' OD1' ' B' ' 93' ' ' ASP . 18.1 t0 -69.39 -42.56 74.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 73.319999999999993 109.362 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' B' ' 92' ' ' ASP . 72.9 m-20 -152.25 164.91 36.43 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.43 -0.794 . . . . 72.219999999999999 109.175 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.522 ' O ' ' CD1' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -138.54 127.76 24.28 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.902 -0.777 . . . . 64.420000000000002 108.902 -178.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.786 HD12 ' N ' ' B' ' 95' ' ' ILE . 0.2 OUTLIER -123.82 151.91 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 121.451 0.643 . . . . 72.230000000000004 110.142 -178.654 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.62 138.48 58.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.186 -0.946 . . . . 25.239999999999998 108.541 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.672 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -59.73 -53.79 62.11 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 120.98 -1.075 . . . . 64.319999999999993 111.61 -179.321 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 4.0 Cg_endo -42.03 -9.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 120.648 0.899 . . . . 63.329999999999998 113.057 -176.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . 0.672 ' N ' ' O ' ' B' ' 97' ' ' LYS . 49.4 m-85 59.45 117.64 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.583 -0.698 . . . . 75.129999999999995 109.225 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -56.63 -38.21 71.8 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.84 -1.162 . . . . 74.230000000000004 108.882 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . 0.731 ' O ' ' N ' ' B' ' 103' ' ' LYS . 33.3 t -174.59 41.27 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.119 -0.988 . . . . 63.340000000000003 110.728 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 63.7 mt 51.88 -69.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.546 -0.721 . . . . 74.439999999999998 110.232 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.731 ' N ' ' O ' ' B' ' 101' ' ' SER . 28.2 mtmm -57.72 -18.8 23.23 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.776 -1.194 . . . . 71.109999999999999 107.776 179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.45 -83.51 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.81 -0.556 . . . . 71.450000000000003 110.578 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.732 ' H ' HD23 ' B' ' 105' ' ' LEU . 1.5 pt? -47.67 -32.75 6.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.878 -1.139 . . . . 51.310000000000002 109.858 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 99.2 t -65.33 -41.7 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.901 -1.124 . . . . 65.230000000000004 108.723 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.94 -33.56 67.13 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.317 -0.865 . . . . 24.32 108.962 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -83.41 -34.97 25.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.426 -0.796 . . . . 75.310000000000002 110.079 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 96.8 mt -72.54 -36.6 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.022 -1.048 . . . . 54.240000000000002 109.115 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . 0.435 ' CG ' ' N ' ' B' ' 111' ' ' ALA . 22.8 pt-20 -74.91 -44.79 46.78 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.444 -0.902 . . . . 65.310000000000002 109.214 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . 0.435 ' N ' ' CG ' ' B' ' 110' ' ' GLU . . . -50.4 -45.01 55.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.239 -0.913 . . . . 72.239999999999995 109.203 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -67.09 -38.13 85.15 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.29 -0.881 . . . . 72.040000000000006 109.689 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' B' ' 116' ' ' TRP . 24.0 mt -78.11 -26.26 47.9 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.22 -0.925 . . . . 75.349999999999994 110.496 -179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.465 ' O ' ' CE3' ' B' ' 116' ' ' TRP . 19.0 mmt180 -47.57 -40.54 19.38 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.88 -1.137 . . . . 75.5 109.689 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' PHE . . . . . 0.48 ' C ' ' H ' ' B' ' 117' ' ' GLY . 71.3 m-85 -68.02 -25.22 65.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.128 -0.983 . . . . 65.329999999999998 109.455 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' TRP . . . . . 0.465 ' CE3' ' O ' ' B' ' 114' ' ' ARG . 5.4 m-90 53.34 6.36 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.384 -0.822 . . . . 74.450000000000003 109.827 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' B' ' 115' ' ' PHE . . . 68.51 175.84 10.72 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.847 -1.301 . . . . 44.210000000000001 109.847 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 58.4 m -142.06 171.59 13.84 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.347 -1.09 . . . . 71.400000000000006 109.344 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . 0.575 HD21 ' C ' ' B' ' 121' ' ' ILE . 2.7 t30 -104.11 153.67 20.63 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.42 -0.8 . . . . 72.319999999999993 109.749 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 t -104.27 -42.51 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.415 -0.803 . . . . 75.019999999999996 109.859 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . 0.575 ' C ' HD21 ' B' ' 119' ' ' ASN . 12.2 mm -106.66 119.22 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.204 -0.935 . . . . 51.409999999999997 109.469 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -129.49 138.67 51.51 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.516 -0.74 . . . . 71.530000000000001 109.529 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.572 HD13 ' N ' ' B' ' 124' ' ' GLY . 0.2 OUTLIER -160.28 117.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 72.430000000000007 109.192 179.821 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . 0.572 ' N ' HD13 ' B' ' 123' ' ' ILE . . . 53.45 -141.39 31.2 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.623 -1.391 . . . . 51.229999999999997 109.623 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -86.14 -1.9 57.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.294 -1.121 . . . . 74.200000000000003 109.471 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.52 126.7 38.81 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.118 -1.067 . . . . 75.420000000000002 108.118 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 85.6 m -129.22 135.89 49.41 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.328 -0.857 . . . . 74.219999999999999 109.952 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 12.4 mt -129.17 136.04 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.555 -0.715 . . . . 60.329999999999998 109.338 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . 0.459 ' O ' ' N ' ' B' ' 133' ' ' GLU . 53.0 m -124.49 81.46 59.61 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.626 -0.671 . . . . 72.310000000000002 109.582 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.41 -39.61 73.25 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.454 2.103 . . . . 75.129999999999995 111.712 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.68 -43.3 97.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.406 -0.809 . . . . 75.230000000000004 109.199 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -89.54 -4.64 57.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.389 -0.819 . . . . 72.430000000000007 108.791 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' B' ' 129' ' ' SER . 87.2 mt-10 52.52 56.74 7.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.453 -0.779 . . . . 75.129999999999995 109.763 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -151.83 139.02 19.25 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.303 -0.873 . . . . 73.219999999999999 109.404 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 7.7 tt -126.64 143.05 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.403 -0.811 . . . . 64.140000000000001 109.853 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 53.1 mt -115.6 131.73 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 109.114 -0.698 . . . . 71.219999999999999 109.114 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -138.02 138.23 38.64 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.609 -0.682 . . . . 64.219999999999999 110.491 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm 50.94 25.4 2.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.391 -0.818 . . . . 72.019999999999996 111.031 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.9 14.85 71.57 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.823 -1.179 . . . . 74.319999999999993 111.05 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -115.1 126.42 54.65 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.343 -1.093 . . . . 75.340000000000003 108.987 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -93.7 126.19 38.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.355 -0.841 . . . . 71.230000000000004 109.53 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 13.8 p -135.63 133.04 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.578 -0.897 . . . . 70.430000000000007 108.578 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . 0.568 ' H ' ' CD ' ' B' ' 143' ' ' GLU . 1.1 pm0 -94.86 137.37 34.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.201 -0.937 . . . . 72.430000000000007 108.588 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 11.6 m -140.02 141.01 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.102 -0.999 . . . . 72.129999999999995 110.323 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.27 31.92 0.24 Allowed 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.711 -1.218 . . . . 72.019999999999996 107.711 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' B' ' 150' ' ' GLU . . . -78.24 -155.82 8.41 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.605 -1.398 . . . . 42.229999999999997 109.605 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 0.62 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 0.0 OUTLIER -88.39 -35.96 0.44 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.422 -1.046 . . . . 73.299999999999997 111.046 -179.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 47.7 Cg_endo -84.31 -42.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 121.931 1.754 . . . . 71.329999999999998 112.533 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -56.53 -19.37 15.31 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.76 -1.212 . . . . 74.230000000000004 109.037 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' B' ' 146' ' ' GLY . 27.1 mt-10 -60.68 -36.27 78.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -0.883 . . . . 72.340000000000003 109.89 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.472 HG11 HD13 ' B' ' 191' ' ' ILE . 3.8 p -67.84 -38.15 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.977 -1.077 . . . . 73.349999999999994 110.072 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 20.0 tp -60.57 -41.77 95.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.342 -0.849 . . . . 55.240000000000002 109.613 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -69.9 -39.64 76.08 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.124 -0.985 . . . . 70.010000000000005 109.209 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . 0.515 ' CD2' ' HD1' ' B' ' 158' ' ' HIS . 14.7 t60 -56.76 -52.48 64.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.484 -0.76 . . . . 65.319999999999993 110.111 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.545 HD12 ' N ' ' B' ' 156' ' ' ALA . 4.2 pp -72.0 -25.66 61.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.924 -1.11 . . . . 71.540000000000006 109.413 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . 0.545 ' N ' HD12 ' B' ' 155' ' ' LEU . . . -54.31 -42.47 70.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.023 -1.048 . . . . 75.319999999999993 108.346 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.426 ' C ' ' H ' ' B' ' 159' ' ' ARG . 58.0 mtp180 -77.81 -52.32 9.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.453 -0.779 . . . . 73.319999999999993 109.21 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . 0.515 ' HD1' ' CD2' ' B' ' 154' ' ' HIS . 30.9 m80 -75.27 25.66 0.1 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.549 -0.72 . . . . 74.140000000000001 109.988 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . 0.474 ' O ' ' N ' ' B' ' 161' ' ' GLN . 47.4 ttp180 -52.57 -78.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 61.409999999999997 109.015 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . 0.933 ' OD2' ' CE2' ' B' ' 216' ' ' TYR . 9.1 t70 -65.2 74.95 0.05 Allowed 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.2 -0.937 . . . . 72.099999999999994 109.27 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . 0.765 ' NE2' HH12 ' A' ' 159' ' ' ARG . 38.2 tt0 -175.65 160.33 2.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 72.25 109.141 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 17.1 mm -85.63 106.82 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.638 -0.875 . . . . 72.310000000000002 108.638 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 87.5 t -89.94 136.03 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.198 -0.939 . . . . 64.209999999999994 109.814 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 25.8 t -99.92 160.75 14.07 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.457 -0.777 . . . . 74.219999999999999 109.488 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -66.88 -40.01 87.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.472 -0.768 . . . . 65.310000000000002 110.047 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -66.36 -26.55 67.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 63.450000000000003 110.391 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -60.16 -57.69 11.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.99 -1.069 . . . . 72.400000000000006 109.662 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 25.9 mt -60.82 -36.72 79.8 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.127 -0.983 . . . . 72.319999999999993 108.856 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.5 ' C ' HD13 ' B' ' 169' ' ' LEU . 1.3 tm? -56.39 -66.23 0.47 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.607 -0.683 . . . . 73.340000000000003 110.162 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -54.85 -31.68 59.82 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.717 -0.615 . . . . 72.099999999999994 111.85 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -92.18 -8.82 44.46 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.706 -1.246 . . . . 62.130000000000003 112.009 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 25.6 mm -112.74 -68.4 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 120.887 -1.133 . . . . 71.420000000000002 110.82 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' TRP . . . . . 0.481 ' CD2' ' C ' ' B' ' 173' ' ' TRP . 0.0 OUTLIER -56.91 161.37 2.97 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 118.653 -1.219 . . . . 72.230000000000004 107.915 -179.249 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' B' ' 175' ' ' GLU . 47.4 tp10 -172.59 -30.94 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.702 -0.851 . . . . 52.109999999999999 108.702 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' B' ' 177' ' ' GLU . 9.2 pt-20 -51.13 177.01 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 107.965 -1.124 . . . . 73.040000000000006 107.965 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -61.29 49.08 0.09 OUTLIER 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.876 1.717 . . . . 74.129999999999995 112.601 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' B' ' 175' ' ' GLU . 99.6 mt-10 44.9 -122.9 0.97 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.381 -0.824 . . . . 72.439999999999998 109.939 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 64.8 mtp 52.84 20.47 1.63 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.298 -0.877 . . . . 63.43 109.641 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 179' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' B' ' 180' ' ' THR . 3.9 t -85.26 48.49 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.163 -1.051 . . . . 71.049999999999997 108.163 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . 0.463 ' O ' ' O ' ' B' ' 179' ' ' VAL . 0.0 OUTLIER 55.11 165.95 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.532 -0.914 . . . . 62.149999999999999 108.532 -179.171 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -47.63 -69.71 0.07 OUTLIER 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.859 1.706 . . . . 65.219999999999999 111.815 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -127.27 125.97 41.85 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.488 -0.93 . . . . 72.310000000000002 108.488 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . 0.442 ' O ' HG22 ' B' ' 186' ' ' VAL . 6.1 t -133.04 -13.89 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.305 -0.872 . . . . 63.32 109.701 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 4.6 tt -62.01 -25.13 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.458 -1.401 . . . . 75.030000000000001 109.164 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -61.38 -43.11 99.43 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.319 -0.863 . . . . 64.109999999999999 109.83 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . 0.442 HG22 ' O ' ' B' ' 183' ' ' VAL . 15.4 m -76.54 -27.39 17.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.836 -1.165 . . . . 73.0 108.254 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.28 -46.18 64.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.152 -0.968 . . . . 61.119999999999997 109.692 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 10.7 tp -71.8 -28.06 29.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 120.953 -1.092 . . . . 72.430000000000007 109.595 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 189' ' ' ASN . . . . . 0.446 ' O ' ' OE1' ' B' ' 193' ' ' GLN . 68.2 m-20 -68.2 -46.01 71.78 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.286 -0.884 . . . . 65.140000000000001 108.764 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -70.3 -47.17 62.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -0.871 . . . . 63.240000000000002 109.534 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . 0.472 HD13 HG11 ' B' ' 151' ' ' VAL . 63.7 mt -51.23 -34.83 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -0.906 . . . . 74.030000000000001 108.846 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 192' ' ' ARG . . . . . 0.434 HH22 HG21 ' B' ' 206' ' ' THR . 68.0 mtp180 -70.33 -42.28 72.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.883 . . . . 72.239999999999995 109.39 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 193' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' B' ' 189' ' ' ASN . 1.0 OUTLIER -75.45 -17.12 60.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.262 -0.899 . . . . 73.099999999999994 109.692 179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -92.3 -25.05 18.76 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.18 -0.95 . . . . 72.109999999999999 110.361 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 195' ' ' MET . . . . . 0.608 ' N ' ' SD ' ' B' ' 195' ' ' MET . 0.0 OUTLIER -96.17 -32.01 12.69 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.133 -0.979 . . . . 44.329999999999998 110.141 -179.035 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 196' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 42.2 p-10 -67.97 -31.54 71.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.029 -1.044 . . . . 71.209999999999994 110.496 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . 0.47 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 46.1 mttt -70.12 -65.01 1.2 Allowed Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.969 -1.082 . . . . 75.209999999999994 110.56 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 198' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 19.8 Cg_endo -58.38 -58.57 0.71 Allowed 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.22 1.947 . . . . 75.319999999999993 112.741 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 37.1 mt -60.01 -55.51 33.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.062 -1.024 . . . . 72.25 109.874 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 97.49 -24.79 29.97 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.257 -1.137 . . . . 64.530000000000001 110.257 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . 0.412 HG21 HD13 ' B' ' 201' ' ' ILE . 19.7 mt -106.36 127.06 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.162 -1.199 . . . . 44.229999999999997 109.706 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 53.9 p -82.48 141.05 33.0 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.458 -0.941 . . . . 54.009999999999998 108.458 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 11.9 p -142.6 19.43 2.02 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.113 -0.992 . . . . 74.400000000000006 109.585 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.429 HG22 ' CE2' ' B' ' 214' ' ' PHE . 5.3 t -125.94 141.58 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.499 -0.751 . . . . 72.120000000000005 109.78 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -119.82 107.6 13.36 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.313 -0.995 . . . . 65.409999999999997 108.313 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 206' ' ' THR . . . . . 0.443 ' H ' HG22 ' B' ' 206' ' ' THR . 0.0 OUTLIER -75.17 120.13 20.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.958 . . . . 71.329999999999998 109.796 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.49 HG12 ' H ' ' B' ' 209' ' ' ARG . 3.0 t -117.28 148.88 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 109.114 -0.698 . . . . 63.5 109.114 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -91.64 -1.63 57.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.191 -0.943 . . . . 74.450000000000003 109.44 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . 0.49 ' H ' HG12 ' B' ' 207' ' ' VAL . 31.4 mmt180 -76.19 -118.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.353 -0.842 . . . . 74.140000000000001 109.56 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -57.33 -47.74 80.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.197 -0.939 . . . . 74.430000000000007 109.977 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 178.85 -126.83 1.09 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.026 -1.229 . . . . 64.450000000000003 110.026 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -100.17 133.56 44.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.271 -1.135 . . . . 74.209999999999994 109.408 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -100.53 118.13 36.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.409 -0.807 . . . . 74.030000000000001 109.445 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . 0.429 ' CE2' HG22 ' B' ' 204' ' ' VAL . 26.2 m-85 -98.56 131.03 45.1 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.412 -0.805 . . . . 74.340000000000003 109.113 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 30.3 p -158.48 161.04 37.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 64.329999999999998 109.077 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . 0.933 ' CE2' ' OD2' ' B' ' 160' ' ' ASP . 1.6 m-85 -61.24 150.16 80.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.995 -1.065 . . . . 70.040000000000006 108.698 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.07 -55.65 0.13 Allowed 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.123 1.882 . . . . 65.109999999999999 111.561 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -151.41 151.51 29.13 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 108.385 -0.969 . . . . 73.150000000000006 108.385 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -34.61 117.7 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.246 0 C-N-CA 122.536 2.157 . . . . 71.310000000000002 112.622 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -92.77 154.67 18.15 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.402 -0.811 . . . . 75.450000000000003 109.617 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 27.1 p -96.1 135.87 37.3 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.28 -0.888 . . . . 72.219999999999999 109.481 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -155.91 137.61 14.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.903 . . . . 54.530000000000001 109.368 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.001 -1.0 . . . . 71.129999999999995 109.413 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.3 ttm . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.474 -0.565 . . . . 65.120000000000005 109.474 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -144.56 141.68 29.65 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.196 -0.94 . . . . 72.329999999999998 109.182 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 80.2 t -112.55 134.86 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.562 0.696 . . . . 71.420000000000002 109.958 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.552 HD11 ' CG1' ' A' ' 6' ' ' ILE . 1.3 tp -103.2 118.58 37.12 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.101 -1.074 . . . . 65.120000000000005 108.101 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.552 HD12 ' SD ' ' A' ' 49' ' ' MET . 3.9 tp -117.82 107.23 13.88 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.66 -0.65 . . . . 62.43 109.483 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.552 ' CG1' HD11 ' A' ' 4' ' ' LEU . 37.4 mt -98.36 101.5 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.327 -0.99 . . . . 71.150000000000006 108.327 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.7 tp10 -131.42 124.11 29.58 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.61 -0.681 . . . . 75.340000000000003 109.465 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -65.66 -34.46 78.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.277 -0.889 . . . . 72.439999999999998 109.15 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -87.07 112.2 21.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.308 -0.87 . . . . 63.020000000000003 109.227 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.6 m -65.7 -26.71 67.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 72.340000000000003 109.588 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.72 -52.75 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.193 -0.942 . . . . 74.019999999999996 109.774 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.1 mt -61.6 -34.83 76.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.977 . . . . 71.430000000000007 109.291 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.94 -26.96 71.43 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.566 -1.814 . . . . 61.32 108.566 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.13 -52.41 44.68 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 109.529 -1.428 . . . . 71.200000000000003 109.529 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -59.97 -45.09 93.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.372 -1.075 . . . . 71.319999999999993 109.824 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.4 mm -64.31 -38.55 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.795 -1.191 . . . . 63.229999999999997 108.828 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -62.89 -49.29 75.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.329 -0.857 . . . . 51.109999999999999 110.099 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -78.03 -7.34 56.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.077 -1.015 . . . . 73.340000000000003 109.815 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.77 -54.45 3.24 Favored Glycine 0 N--CA 1.483 1.824 0 N-CA-C 109.505 -1.438 . . . . 62.149999999999999 109.505 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.91 -24.13 61.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.376 -1.073 . . . . 73.510000000000005 109.489 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -56.04 -38.46 70.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.137 -0.977 . . . . 74.25 109.184 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.5 t -51.94 -47.53 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.271 -0.893 . . . . 70.040000000000006 109.05 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -53.81 -53.16 56.32 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.602 -0.888 . . . . 73.230000000000004 108.602 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 128.94 40.77 0.28 Allowed Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.353 -1.499 . . . . 75.540000000000006 109.353 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -117.13 160.28 21.27 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.511 -0.994 . . . . 73.430000000000007 109.139 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.5 mmt -101.11 139.35 36.91 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.204 -1.036 . . . . 43.240000000000002 108.204 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.59 146.75 34.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.167 -0.958 . . . . 62.109999999999999 110.339 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -120.69 149.23 42.83 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.911 -0.774 . . . . 74.420000000000002 108.911 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 m -110.53 134.99 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.427 -0.796 . . . . 72.150000000000006 108.906 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.4 p -136.82 168.2 20.0 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.359 -0.838 . . . . 71.420000000000002 109.531 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -90.25 -105.61 0.09 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.329 -0.857 . . . . 72.329999999999998 109.662 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.5 p -81.16 169.11 17.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 74.239999999999995 110.07 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.5 mt -53.95 -32.67 54.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.579 -0.7 . . . . 71.530000000000001 109.521 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -49.81 -49.68 47.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.143 -0.973 . . . . 74.230000000000004 109.541 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -64.95 -51.83 59.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 54.030000000000001 109.31 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.36 -39.03 96.69 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.694 -1.362 . . . . 61.409999999999997 109.694 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -64.28 -47.06 80.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -1.141 . . . . 74.340000000000003 109.413 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -69.78 -35.3 74.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.067 -1.021 . . . . 75.329999999999998 109.19 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.424 ' C ' ' CD1' ' A' ' 39' ' ' LEU . 0.2 OUTLIER -70.4 -65.53 0.72 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.355 -0.84 . . . . 74.329999999999998 109.204 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.442 ' C ' ' SD ' ' A' ' 40' ' ' MET . 2.9 ppp? -48.47 -20.38 0.42 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.263 -0.898 . . . . 70.319999999999993 109.936 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -65.52 -43.24 90.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.075 -1.016 . . . . 71.219999999999999 110.091 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.3 pt -82.31 -26.71 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.172 -0.955 . . . . 74.140000000000001 110.195 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.441 ' O ' ' O ' ' A' ' 40' ' ' MET . 99.4 mtt180 -129.96 143.7 50.94 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.35 -0.844 . . . . 72.239999999999995 109.507 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -97.59 151.09 20.42 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.214 -0.929 . . . . 75.420000000000002 109.556 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -127.51 141.08 51.75 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.529 -0.732 . . . . 74.230000000000004 109.252 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -78.05 -42.15 33.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 72.040000000000006 109.471 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.61 HD23 HD21 ' A' ' 113' ' ' LEU . 0.3 OUTLIER -104.01 112.77 25.9 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.474 -0.766 . . . . 72.129999999999995 108.941 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.461 ' N ' HD13 ' A' ' 47' ' ' LEU . 74.0 t -99.45 98.48 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.406 -0.961 . . . . 72.340000000000003 108.406 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.552 ' SD ' HD12 ' A' ' 5' ' ' LEU . 1.5 tmt? -114.99 135.94 53.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.617 -0.677 . . . . 74.109999999999999 109.834 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.6 HG22 ' H ' ' A' ' 52' ' ' ASP . 1.1 p -143.59 131.19 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.78 0.8 . . . . 61.119999999999997 109.82 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.7 p -95.26 9.64 39.04 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.571 -0.706 . . . . 73.109999999999999 109.744 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.6 ' H ' HG22 ' A' ' 50' ' ' VAL . 80.0 m-20 -77.04 141.48 40.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 52.549999999999997 109.514 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.48 ' C ' ' H ' ' A' ' 55' ' ' ALA . 92.2 mttt -75.1 -45.42 41.31 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.294 -0.879 . . . . 44.219999999999999 110.447 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -68.51 10.99 0.2 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.096 -1.002 . . . . 70.439999999999998 109.84 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.48 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -68.84 -22.49 64.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 64.140000000000001 110.28 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 52.4 mt -42.62 -50.34 5.41 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.297 -0.877 . . . . 44.140000000000001 110.401 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.1 m -68.74 -31.91 71.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.932 -1.105 . . . . 55.229999999999997 109.333 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.605 ' CE2' HD11 ' A' ' 62' ' ' ILE . 58.3 t80 -70.19 -56.57 6.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.463 -0.773 . . . . 74.439999999999998 110.2 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.4 m -55.03 -34.06 30.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 120.609 -1.307 . . . . 74.030000000000001 109.528 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.7 t -60.42 -54.89 40.1 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.287 -0.883 . . . . 64.299999999999997 109.499 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.667 HH21 ' NZ ' ' A' ' 65' ' ' LYS . 7.1 ptm180 -67.3 -25.52 66.07 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.045 -1.062 . . . . 64.439999999999998 109.967 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.605 HD11 ' CE2' ' A' ' 58' ' ' PHE . 4.9 mm -59.87 -48.03 89.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.783 -1.198 . . . . 63.210000000000001 108.968 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -64.45 -45.19 88.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.023 -1.048 . . . . 74.420000000000002 108.87 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -60.86 -51.52 68.95 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.326 -0.99 . . . . 70.319999999999993 108.326 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.667 ' NZ ' HH21 ' A' ' 61' ' ' ARG . 93.1 mttt -71.81 -69.68 0.37 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.253 -0.647 . . . . 75.219999999999999 109.253 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 62' ' ' ILE . 86.5 m-70 -98.02 90.54 4.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.319 -0.863 . . . . 74.129999999999995 109.019 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 t -79.01 -40.1 32.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 73.239999999999995 109.914 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.8 t -78.15 57.92 1.93 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.23 -0.919 . . . . 61.009999999999998 109.611 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 66' ' ' HIS . 14.6 tt -152.03 158.12 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.147 -0.97 . . . . 71.329999999999998 109.656 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.2 t -97.63 146.87 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.119 -0.988 . . . . 72.129999999999995 109.111 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.7 t -133.01 125.81 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.317 -0.864 . . . . 54.210000000000001 110.5 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.526 ' C ' HD23 ' A' ' 72' ' ' LEU . 3.7 tt -122.87 100.03 6.69 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.652 -0.87 . . . . 50.240000000000002 108.652 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.7 p -92.69 153.55 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.76 -1.212 . . . . 74.409999999999997 109.221 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.7 m -127.54 166.54 17.8 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.257 -1.016 . . . . 72.310000000000002 108.257 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 77' ' ' ASN . 23.0 t -170.8 126.41 0.72 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.967 -1.083 . . . . 64.540000000000006 110.415 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 57.3 p30 -71.69 14.67 0.18 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.569 -0.707 . . . . 74.129999999999995 110.121 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.427 ' H ' ' C ' ' A' ' 75' ' ' SER . 22.6 m120 -138.43 73.91 41.82 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.195 -0.941 . . . . 73.340000000000003 109.933 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.6 76.53 4.49 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.682 2.255 . . . . 63.219999999999999 112.358 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.415 HG23 ' H ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -104.92 154.63 19.82 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.296 -1.001 . . . . 62.530000000000001 108.296 178.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.45 -25.08 2.33 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.171 -0.956 . . . . 73.439999999999998 109.738 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -69.72 -50.61 41.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.944 . . . . 71.420000000000002 110.149 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.423 ' OE1' ' O ' ' A' ' 77' ' ' ASN . 88.9 mt-10 -71.32 -27.74 63.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.097 -1.002 . . . . 73.430000000000007 110.162 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -64.21 -56.93 11.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.091 -1.005 . . . . 74.219999999999999 109.764 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.522 HG23 ' N ' ' A' ' 85' ' ' HIS . 17.9 m -66.13 -40.96 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 73.200000000000003 109.676 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.522 ' N ' HG23 ' A' ' 84' ' ' VAL . 27.7 t-80 -64.7 -38.99 92.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.21 -0.931 . . . . 53.329999999999998 109.744 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.52 95.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 64.109999999999999 110.178 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.507 ' CE1' ' NH1' ' B' ' 108' ' ' ARG . 44.2 m-85 -72.84 -31.01 64.48 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.038 -1.039 . . . . 74.340000000000003 108.605 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -73.71 -34.73 64.95 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.412 -0.805 . . . . 74.420000000000002 109.261 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 76.9 mm-40 -62.86 -55.85 22.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.896 . . . . 74.239999999999995 109.441 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.63 29.0 0.08 OUTLIER Glycine 0 N--CA 1.498 2.804 0 C-N-CA 119.813 -1.184 . . . . 61.509999999999998 110.425 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.49 128.57 39.66 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.935 -1.332 . . . . 55.329999999999998 108.995 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.669 ' HB3' HH21 ' A' ' 112' ' ' ARG . 36.2 m-20 -64.68 -36.41 84.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.978 -1.076 . . . . 73.420000000000002 108.971 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 94' ' ' TYR . 62.8 t0 -152.53 145.65 24.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.373 -0.829 . . . . 75.040000000000006 108.943 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.497 ' CD1' ' C ' ' A' ' 94' ' ' TYR . 0.4 OUTLIER -123.15 121.54 36.23 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.985 -0.746 . . . . 71.329999999999998 108.985 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.496 ' N ' ' CD1' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -108.98 141.92 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 121.789 0.804 . . . . 71.129999999999995 109.526 -178.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 97' ' ' LYS . . . -62.35 125.15 22.91 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.16 -1.422 . . . . 64.319999999999993 107.16 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.567 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -44.33 -57.13 6.86 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.004 -1.06 . . . . 62.200000000000003 111.102 -178.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 7.4 Cg_endo -44.2 90.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 CA-C-N 119.467 0.845 . . . . 73.109999999999999 111.17 -176.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.567 ' N ' ' O ' ' A' ' 97' ' ' LYS . 42.8 m-85 -44.18 104.26 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.625 -0.672 . . . . 65.219999999999999 109.97 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 31.2 ttm-85 -54.49 -25.6 26.38 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.595 -0.891 . . . . 72.349999999999994 108.595 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.751 ' O ' ' N ' ' A' ' 103' ' ' LYS . 15.7 t -178.07 24.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.398 -0.814 . . . . 71.319999999999993 109.866 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 87.9 mt 52.89 -70.01 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.66 -0.65 . . . . 75.430000000000007 109.609 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.751 ' N ' ' O ' ' A' ' 101' ' ' SER . 48.9 mttp -56.2 -23.04 32.83 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.517 -1.29 . . . . 71.409999999999997 107.517 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.457 ' HB2' ' HB3' ' A' ' 101' ' ' SER . . . -68.08 -45.47 73.7 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.929 -1.137 . . . . 63.240000000000002 107.929 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 12.6 tp -65.48 -51.7 58.18 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.681 -0.859 . . . . 73.219999999999999 108.681 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 38.3 t -58.36 -42.73 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.108 -0.995 . . . . 60.109999999999999 108.654 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.87 -39.55 59.15 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.304 -0.872 . . . . 70.420000000000002 108.881 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 53.8 mtp180 -66.94 -35.6 80.33 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.192 -0.942 . . . . 74.409999999999997 108.811 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.9 mt -75.56 -26.76 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.21 -0.931 . . . . 62.539999999999999 108.992 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -65.4 -52.06 56.04 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.448 -0.783 . . . . 74.340000000000003 110.137 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -74.86 -29.35 61.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.111 -0.993 . . . . 73.319999999999993 110.382 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.669 HH21 ' HB3' ' A' ' 92' ' ' ASP . 33.9 ttt85 -61.03 -44.24 97.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.035 -1.041 . . . . 52.409999999999997 109.895 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.61 HD21 HD23 ' A' ' 47' ' ' LEU . 0.4 OUTLIER -150.79 82.58 1.34 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.8 -1.187 . . . . 65.239999999999995 109.745 179.277 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.401 ' HA ' ' HE ' ' A' ' 114' ' ' ARG . 0.0 OUTLIER -95.01 -58.03 2.27 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.485 -0.932 . . . . 64.450000000000003 108.485 179.489 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -69.08 -58.04 4.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 74.430000000000007 109.662 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 46.22 85.86 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.232 -0.917 . . . . 74.420000000000002 109.662 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.99 99.41 0.12 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.3 -1.52 . . . . 75.040000000000006 109.3 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.7 t -152.61 162.67 40.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.197 -1.178 . . . . 61.140000000000001 109.894 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.545 ' ND2' ' N ' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -157.61 129.45 6.99 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.966 -0.753 . . . . 65.239999999999995 108.966 -178.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 17.3 t -91.11 -32.77 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.185 -0.947 . . . . 73.109999999999999 109.268 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 24.9 mm -107.53 137.23 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.934 -0.765 . . . . 72.239999999999995 108.934 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -148.89 136.6 20.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.067 -1.021 . . . . 72.340000000000003 109.982 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 11.5 pt -151.54 134.75 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.432 -0.793 . . . . 71.439999999999998 109.112 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 45.84 -142.28 4.58 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.747 -1.341 . . . . 73.400000000000006 109.747 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -85.59 -5.96 59.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.257 -1.143 . . . . 74.450000000000003 109.393 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.429 HD22 ' CD1' ' A' ' 137' ' ' TYR . 0.7 OUTLIER -91.12 136.69 32.92 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.336 -0.987 . . . . 54.210000000000001 108.336 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.7 m -130.61 144.07 51.17 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.387 -0.82 . . . . 54.5 109.605 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 82.5 mt -133.28 137.69 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.291 -0.88 . . . . 45.149999999999999 109.475 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 4.4 m -121.77 85.22 44.38 Favored Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 109.069 -0.715 . . . . 71.109999999999999 109.069 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.89 -41.05 82.19 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.549 2.166 . . . . 65.409999999999997 112.237 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -59.05 -46.9 87.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 63.32 109.293 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -82.7 -7.06 59.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 72.519999999999996 109.153 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.408 ' OE2' ' O ' ' A' ' 144' ' ' VAL . 70.8 tt0 56.98 58.49 3.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.411 -0.806 . . . . 75.329999999999998 109.567 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.45 ' C ' HD12 ' A' ' 135' ' ' ILE . 32.3 ttpt -148.65 123.94 10.23 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.294 -0.879 . . . . 71.230000000000004 109.435 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.593 ' N ' HD12 ' A' ' 135' ' ' ILE . 1.6 mp -96.94 138.07 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.217 -0.927 . . . . 74.019999999999996 109.392 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.3 mm -115.11 127.89 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 N-CA-C 109.023 -0.732 . . . . 60.229999999999997 109.023 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.429 ' CD1' HD22 ' A' ' 126' ' ' LEU . 79.5 t80 -136.43 123.71 21.88 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.356 -0.84 . . . . 62.32 109.48 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 66.3 mttm 53.52 33.85 17.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.335 -0.853 . . . . 75.400000000000006 110.032 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.11 11.09 85.71 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.292 -1.123 . . . . 72.239999999999995 110.292 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 50.3 mtp85 -94.91 124.49 38.98 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.143 -1.21 . . . . 71.219999999999999 109.073 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -94.88 119.31 33.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.259 -0.901 . . . . 71.420000000000002 109.608 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.6 p -135.61 137.7 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.469 -0.769 . . . . 53.020000000000003 109.297 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.505 ' N ' ' OE1' ' A' ' 143' ' ' GLU . 46.1 mp0 -95.98 154.46 17.22 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.323 -0.86 . . . . 60.450000000000003 109.298 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.408 ' O ' ' OE2' ' A' ' 133' ' ' GLU . 29.9 m -139.61 144.09 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.365 -0.834 . . . . 74.439999999999998 109.551 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -168.47 21.77 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.937 . . . . 65.150000000000006 109.751 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.19 -174.93 50.63 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.333 -1.507 . . . . 73.340000000000003 109.333 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.633 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 5.8 ttpm? -83.14 -32.76 0.55 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.3 -1.118 . . . . 72.219999999999999 111.048 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 91.6 Cg_endo -89.37 -16.67 2.04 Favored 'Trans proline' 0 C--N 1.318 -1.07 0 C-N-CA 122.149 1.899 . . . . 65.230000000000004 112.733 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -81.99 -24.87 35.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.108 -0.995 . . . . 60.109999999999999 109.818 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.525 ' O ' ' ND1' ' A' ' 154' ' ' HIS . 95.8 mt-10 -51.53 -31.94 26.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.097 -1.002 . . . . 64.209999999999994 108.862 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 148' ' ' PRO . 5.4 p -63.56 -36.76 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.438 -0.789 . . . . 72.019999999999996 109.07 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.427 ' CD1' ' SD ' ' A' ' 195' ' ' MET . 21.3 tp -62.92 -42.47 99.81 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 73.310000000000002 109.084 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.4 m -72.47 -36.88 68.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.403 -0.81 . . . . 74.310000000000002 109.864 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 150' ' ' GLU . 8.2 m80 -60.7 -52.71 63.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.122 -0.986 . . . . 74.310000000000002 110.182 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.53 ' O ' ' N ' ' A' ' 159' ' ' ARG . 3.2 pp -68.89 -25.97 64.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.866 -1.146 . . . . 75.340000000000003 109.589 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.73 -52.68 64.03 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.136 -0.977 . . . . 62.140000000000001 109.241 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.563 ' HE ' ' CE1' ' A' ' 158' ' ' HIS . 5.0 ptm85 -68.28 -43.4 77.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.351 -0.843 . . . . 61.030000000000001 109.651 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.563 ' CE1' ' HE ' ' A' ' 157' ' ' ARG . 35.8 m80 -95.29 29.38 2.53 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.104 -0.998 . . . . 74.120000000000005 109.251 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.584 HH21 HG21 ' A' ' 203' ' ' THR . 27.8 ttt85 -60.13 -21.76 61.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.317 -0.865 . . . . 71.129999999999995 109.519 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 41.8 p30 -115.6 66.65 0.7 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 109.009 -0.737 . . . . 75.450000000000003 109.009 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 162' ' ' ILE . 10.3 tm0? -164.3 156.8 16.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.161 -0.962 . . . . 73.409999999999997 109.378 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.528 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 9.3 mm -82.33 123.99 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.214 -0.929 . . . . 74.409999999999997 109.312 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.412 HG11 HD21 ' A' ' 168' ' ' LEU . 21.5 t -120.62 136.95 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.508 -0.745 . . . . 72.310000000000002 109.628 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.0 p -91.86 159.69 15.66 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.329 -0.857 . . . . 74.120000000000005 109.425 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.4 mtmm -59.87 -45.55 92.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 70.430000000000007 109.486 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -62.85 -31.59 72.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 73.519999999999996 109.732 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -59.99 -44.98 94.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.125 -0.984 . . . . 74.519999999999996 109.456 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.412 HD21 HG11 ' A' ' 163' ' ' VAL . 37.7 mt -64.72 -44.19 91.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 72.310000000000002 109.578 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 11.8 tp -64.58 -43.8 92.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.306 -0.871 . . . . 53.329999999999998 109.528 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -75.2 -10.0 59.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 62.439999999999998 109.705 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -89.02 -54.75 3.98 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -0.915 . . . . 60.210000000000001 109.804 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.699 ' N ' HD12 ' A' ' 172' ' ' ILE . 1.9 mp -88.04 -50.1 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.168 -0.957 . . . . 75.319999999999993 109.858 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 17.9 m-90 -85.67 -93.65 0.08 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.069 -1.019 . . . . 73.140000000000001 109.881 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 175' ' ' GLU . 42.8 tt0 73.01 -130.71 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.742 -0.599 . . . . 73.239999999999995 109.558 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 177' ' ' GLU . 2.9 mm-40 50.88 179.94 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.104 -0.997 . . . . 44.43 108.477 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -61.8 35.33 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.136 1.89 . . . . 72.510000000000005 112.198 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 175' ' ' GLU . 76.8 mm-40 49.38 50.23 18.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.187 -0.946 . . . . 63.240000000000002 109.657 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 66.9 mtt -56.42 -31.44 63.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 73.5 109.163 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 35.0 m -72.83 169.93 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.323 -0.861 . . . . 65.219999999999999 109.57 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.1 p -56.27 152.04 24.88 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 71.420000000000002 109.281 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -38.34 -67.15 0.11 Allowed 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 122.259 1.973 . . . . 41.219999999999999 112.126 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -93.22 147.09 23.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.36 -0.838 . . . . 64.540000000000006 109.233 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 14.8 p -171.52 -29.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 74.019999999999996 109.367 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.562 ' O ' HD13 ' A' ' 184' ' ' ILE . 0.2 OUTLIER -53.57 -41.01 44.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.352 -0.843 . . . . 72.329999999999998 109.58 -179.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.4 ' N ' ' CG2' ' A' ' 184' ' ' ILE . 18.5 mt-10 -54.51 -38.45 66.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.849 -1.157 . . . . 74.400000000000006 109.375 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 2.3 t -75.46 -34.7 30.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.388 -0.82 . . . . 70.420000000000002 109.605 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.0 -51.04 23.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 52.109999999999999 109.869 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.2 tp -61.88 -32.62 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.984 -1.072 . . . . 71.400000000000006 109.745 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -66.31 -55.77 14.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.118 -0.989 . . . . 73.439999999999998 110.215 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -67.0 -41.53 86.54 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.038 -1.039 . . . . 71.420000000000002 109.665 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 71.6 mt -56.88 -44.43 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.098 -1.001 . . . . 61.549999999999997 109.136 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.4 mtp-105 -57.54 -44.14 84.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 63.340000000000003 108.947 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -67.28 -36.43 81.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.876 . . . . 61.240000000000002 109.332 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.495 ' O ' ' CG ' ' A' ' 198' ' ' PRO . 96.0 mttt -71.69 -15.8 62.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.867 . . . . 75.129999999999995 109.761 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . 0.427 ' SD ' ' CD1' ' A' ' 152' ' ' LEU . 86.2 mmm -93.62 -15.45 25.34 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.097 -1.002 . . . . 74.019999999999996 109.968 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -102.82 -9.38 20.0 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.137 -0.977 . . . . 74.019999999999996 110.38 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.557 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 3.8 tmtp? -89.63 -42.45 0.43 Allowed Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.917 -1.114 . . . . 75.430000000000007 110.241 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 38.1 Cg_endo -90.4 -58.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.688 2.259 . . . . 72.319999999999993 112.493 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.605 ' N ' HD22 ' A' ' 199' ' ' LEU . 3.3 mm? -61.3 -33.82 74.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.911 -1.118 . . . . 74.540000000000006 108.877 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 75.22 -15.94 3.94 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.689 -1.364 . . . . 61.509999999999998 109.689 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.413 ' H ' ' C ' ' A' ' 199' ' ' LEU . 6.1 mt -115.49 129.36 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.479 -1.013 . . . . 61.219999999999999 109.011 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 12.6 t -79.94 139.09 37.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.061 -1.024 . . . . 72.0 109.242 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.584 HG21 HH21 ' A' ' 159' ' ' ARG . 3.8 p -139.88 7.72 2.28 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.295 -0.878 . . . . 74.439999999999998 109.647 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.37 133.68 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.461 -0.774 . . . . 64.349999999999994 109.413 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 39.8 tp10 -114.45 133.95 55.36 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.55 -0.719 . . . . 71.409999999999997 109.394 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.7 p -99.42 139.96 34.31 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.285 -0.885 . . . . 73.519999999999996 109.261 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 211' ' ' GLY . 18.5 m -149.86 136.75 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.231 -0.918 . . . . 71.019999999999996 109.46 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 69.3 mtm180 -85.66 -13.65 47.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 72.120000000000005 109.343 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -55.16 -34.13 63.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.271 -0.893 . . . . 64.409999999999997 109.485 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 64.7 mtp85 -151.18 -63.12 0.19 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.263 -0.898 . . . . 71.540000000000006 109.405 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 207' ' ' VAL . . . -161.89 -114.14 0.32 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.657 -1.377 . . . . 72.030000000000001 109.657 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -126.2 124.31 40.16 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.601 -0.941 . . . . 75.540000000000006 109.474 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 26.1 ttm105 -90.28 121.48 32.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.36 -0.837 . . . . 75.310000000000002 109.006 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -95.96 123.98 39.78 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.304 -0.872 . . . . 75.409999999999997 109.337 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 44.2 t -154.84 152.22 29.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.434 -0.792 . . . . 74.140000000000001 109.069 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -73.36 145.0 84.82 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.089 -1.007 . . . . 75.319999999999993 108.791 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.436 ' O ' ' CB ' ' A' ' 220' ' ' ALA . 61.7 Cg_endo -81.19 9.47 3.83 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 C-N-CA 122.212 1.941 . . . . 73.109999999999999 112.334 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 217' ' ' PRO . 30.1 tptt -45.22 -54.4 14.36 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.079 -1.013 . . . . 75.25 108.943 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.18 4.46 5.82 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.594 1.529 . . . . 75.099999999999994 111.156 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 217' ' ' PRO . . . -54.09 146.79 13.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.358 -0.839 . . . . 71.140000000000001 109.893 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 32.6 t -101.77 138.75 38.33 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.449 -0.782 . . . . 71.129999999999995 109.446 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 49.53 72.64 0.29 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 75.349999999999994 109.53 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 118.018 -0.991 . . . . 73.409999999999997 109.47 179.921 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 53.2 ttm . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.478 -0.564 . . . . 71.140000000000001 109.478 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.609 ' NH1' ' HE ' ' B' ' 43' ' ' ARG . 39.9 ttt85 -139.8 146.73 39.79 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.375 -0.828 . . . . 73.230000000000004 109.397 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 73.2 t -118.0 137.11 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 121.583 0.706 . . . . 72.239999999999995 109.669 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.52 HD11 ' CG1' ' B' ' 6' ' ' ILE . 3.3 tp -108.8 117.65 34.73 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.576 -0.898 . . . . 54.329999999999998 108.576 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.407 ' N ' HD12 ' B' ' 4' ' ' LEU . 5.4 tp -119.4 101.42 7.94 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.071 -0.714 . . . . 74.349999999999994 109.071 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.52 ' CG1' HD11 ' B' ' 4' ' ' LEU . 53.8 mt -91.71 97.72 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.907 -1.12 . . . . 42.549999999999997 108.749 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.422 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 31.8 tp10 -123.42 136.79 54.8 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.611 0.72 . . . . 74.519999999999996 109.407 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -77.76 -32.74 52.78 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.526 -0.734 . . . . 62.549999999999997 109.308 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -90.02 115.41 27.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.364 -0.835 . . . . 73.109999999999999 109.367 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 15.6 t -65.78 -30.88 71.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.229 -0.919 . . . . 65.540000000000006 109.821 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 85.8 t -61.67 -50.29 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.133 -0.98 . . . . 75.549999999999997 109.791 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.614 HD12 ' NZ ' ' B' ' 97' ' ' LYS . 3.5 mm? -64.83 -31.34 72.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 70.140000000000001 109.439 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.26 -29.94 57.69 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.744 -1.743 . . . . 75.400000000000006 108.744 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.87 -51.64 54.17 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.584 -1.406 . . . . 65.439999999999998 109.584 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -63.17 -42.09 99.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.331 -1.099 . . . . 60.210000000000001 109.622 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 4.8 mm -65.41 -38.61 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.009 -1.057 . . . . 75.150000000000006 108.768 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -64.83 -54.37 32.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.382 -0.824 . . . . 73.010000000000005 109.986 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 39.7 tttm -72.64 -6.26 43.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.147 -0.971 . . . . 74.299999999999997 109.771 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.87 -55.35 2.83 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.657 -1.377 . . . . 70.540000000000006 109.657 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pp -74.17 -23.42 59.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.38 -1.071 . . . . 71.340000000000003 109.802 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -53.74 -35.98 61.8 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.152 -0.968 . . . . 64.409999999999997 109.394 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 98.0 t -55.25 -42.31 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.205 -0.935 . . . . 74.230000000000004 109.198 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 18.7 mmtp -64.64 -13.02 51.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.309 -0.869 . . . . 63.420000000000002 108.685 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.06 32.3 23.77 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.125 -1.19 . . . . 53.43 110.125 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -102.37 159.24 15.59 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.243 -1.151 . . . . 71.120000000000005 108.48 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 15.5 mtt -100.01 137.84 37.91 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.288 -1.004 . . . . 75.239999999999995 108.288 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.57 150.86 39.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 72.120000000000005 109.984 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . 0.531 ' OD2' ' NH2' ' B' ' 2' ' ' ARG . 75.2 m-20 -126.16 144.35 50.79 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.822 -0.807 . . . . 72.310000000000002 108.822 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 1.4 p -112.13 129.07 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.716 -0.846 . . . . 64.430000000000007 108.716 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 6.8 p -134.1 167.85 19.89 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.533 -0.729 . . . . 65.409999999999997 109.455 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -93.79 -97.47 0.15 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.247 -0.908 . . . . 71.019999999999996 109.808 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 51.9 p -78.15 165.16 24.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.195 -0.941 . . . . 51.109999999999999 110.25 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' B' ' 37' ' ' GLU . 46.9 mt -55.01 -35.29 64.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.567 -0.708 . . . . 71.239999999999995 110.218 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -55.98 -44.19 78.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.053 -1.029 . . . . 74.319999999999993 109.831 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -62.47 -41.26 98.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.142 -0.974 . . . . 73.030000000000001 109.311 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . 0.438 ' O ' ' CG ' ' B' ' 40' ' ' MET . . . -80.63 -23.82 59.55 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.421 -1.472 . . . . 30.210000000000001 109.421 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' B' ' 33' ' ' LEU . 84.8 tt0 -66.43 -44.72 82.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -1.152 . . . . 74.420000000000002 109.661 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -79.3 -35.07 41.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.105 -0.997 . . . . 74.420000000000002 109.706 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 8.4 tt -73.82 -37.03 65.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 75.409999999999997 110.108 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . 0.442 ' SD ' ' CE1' ' B' ' 45' ' ' TYR . 2.8 ppp? -76.15 -32.28 59.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.935 -1.103 . . . . 60.409999999999997 109.902 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -51.38 -37.03 46.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.926 . . . . 53.229999999999997 110.374 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.404 HG12 ' H ' ' B' ' 42' ' ' ILE . 11.2 pt -78.94 -33.54 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.0 -1.062 . . . . 71.230000000000004 110.114 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.609 ' HE ' ' NH1' ' B' ' 2' ' ' ARG . 30.2 mmt-85 -93.96 168.6 10.86 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.906 -1.121 . . . . 72.219999999999999 110.024 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . 0.517 ' C ' ' CD1' ' B' ' 45' ' ' TYR . 30.9 p30 -92.85 -19.31 21.83 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.298 -0.876 . . . . 63.539999999999999 109.954 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.517 ' CD1' ' C ' ' B' ' 44' ' ' ASN . 11.0 p90 40.11 97.86 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.566 -0.709 . . . . 64.349999999999994 110.997 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -80.41 -38.04 31.0 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.056 -1.028 . . . . 62.219999999999999 109.1 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.464 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.3 OUTLIER -106.64 114.36 28.42 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.745 -1.206 . . . . 73.120000000000005 107.745 179.255 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.464 ' N ' HD13 ' B' ' 47' ' ' LEU . 65.4 t -99.07 97.78 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.224 -0.922 . . . . 65.109999999999999 108.846 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.404 ' SD ' ' CD1' ' B' ' 5' ' ' LEU . 25.5 ttt -113.58 131.4 56.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.554 -0.717 . . . . 73.439999999999998 109.782 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.516 HG22 ' H ' ' B' ' 52' ' ' ASP . 0.5 OUTLIER -144.89 135.46 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.535 -0.728 . . . . 34.5 109.234 -179.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . 0.422 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 38.8 p -103.17 15.06 30.28 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.552 -0.718 . . . . 73.209999999999994 109.79 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.516 ' H ' HG22 ' B' ' 50' ' ' VAL . 83.0 m-20 -77.83 144.92 36.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.104 -0.998 . . . . 70.409999999999997 109.467 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' B' ' 55' ' ' ALA . 41.6 mmtm -74.37 -43.31 57.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.224 -0.923 . . . . 65.0 110.164 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -72.86 13.14 0.41 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.07 -1.019 . . . . 75.209999999999994 109.786 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.438 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -69.34 -22.35 63.76 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 55.329999999999998 110.136 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 19.7 mt -42.04 -52.34 4.26 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.508 -0.745 . . . . 63.140000000000001 110.083 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 24.7 m -66.44 -35.07 79.38 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.956 -1.09 . . . . 63.5 109.082 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . 0.431 ' CZ ' HD11 ' B' ' 62' ' ' ILE . 57.4 t80 -65.26 -62.18 1.69 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.466 -0.771 . . . . 72.329999999999998 110.0 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 32.5 m -49.33 -34.08 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.637 -1.289 . . . . 74.540000000000006 109.962 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 24.6 p -59.42 -53.66 55.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.052 -1.03 . . . . 71.239999999999995 109.739 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -66.24 -27.93 68.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.036 -1.04 . . . . 74.310000000000002 110.125 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.431 HD11 ' CZ ' ' B' ' 58' ' ' PHE . 32.9 mm -65.5 -38.82 83.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.767 -1.208 . . . . 72.140000000000001 109.894 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -70.72 -47.81 57.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.028 -1.045 . . . . 73.319999999999993 110.598 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -69.77 -40.41 76.09 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.873 -1.142 . . . . 73.120000000000005 110.335 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.488 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 62.7 mttm -75.84 -24.31 55.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.13 -0.981 . . . . 72.439999999999998 109.979 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.488 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 90.5 m-70 -155.71 64.48 0.6 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.116 -0.99 . . . . 63.310000000000002 109.719 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 22.8 t -57.2 -27.93 62.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -0.889 . . . . 73.099999999999994 109.606 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 92.0 p -65.17 -23.08 67.01 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.26 -0.9 . . . . 71.530000000000001 109.906 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.403 HG22 ' N ' ' B' ' 70' ' ' VAL . 60.5 mt -82.32 158.45 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.186 -0.946 . . . . 74.400000000000006 109.533 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.403 ' N ' HG22 ' B' ' 69' ' ' ILE . 70.3 t -98.83 150.82 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.288 -0.883 . . . . 75.120000000000005 109.608 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 16.2 t -130.38 126.51 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.386 -0.821 . . . . 73.200000000000003 109.95 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 6.5 tt -121.98 100.34 6.93 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 109.094 -0.706 . . . . 73.340000000000003 109.094 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 9.2 p -93.71 134.87 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.981 -1.075 . . . . 73.5 109.253 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 11.9 p -96.08 172.19 8.14 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.219 -0.926 . . . . 64.340000000000003 109.228 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.461 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 33.6 t -156.23 112.99 3.13 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.98 -1.075 . . . . 74.530000000000001 110.183 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' B' ' 77' ' ' ASN . 54.5 p30 -70.64 -12.13 61.37 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.273 -0.892 . . . . 64.5 109.217 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . 0.449 ' N ' ' OD1' ' B' ' 76' ' ' ASP . 87.2 m-20 -134.3 73.84 68.32 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.686 -0.857 . . . . 74.25 108.686 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -50.1 84.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.649 2.233 . . . . 74.430000000000007 111.781 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.449 ' N ' ' O ' ' B' ' 77' ' ' ASN . 7.1 p -100.33 151.18 21.8 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.941 -0.762 . . . . 73.120000000000005 108.941 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.99 -29.93 69.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.176 -0.953 . . . . 71.010000000000005 109.064 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -65.66 -37.01 85.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.304 -0.872 . . . . 63.200000000000003 109.251 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -74.75 -30.81 61.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.185 -0.947 . . . . 73.219999999999999 109.584 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -69.3 -50.2 48.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.95 . . . . 74.299999999999997 109.817 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.404 HG23 ' N ' ' B' ' 85' ' ' HIS . 28.3 m -62.1 -36.73 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.088 -1.008 . . . . 73.310000000000002 109.38 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' HIS . . . . . 0.404 ' N ' HG23 ' B' ' 84' ' ' VAL . 16.6 m80 -77.92 -20.11 53.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.214 -0.929 . . . . 73.239999999999995 109.544 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -74.6 -42.6 58.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.188 -0.945 . . . . 55.329999999999998 110.275 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -83.13 -29.48 28.64 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.956 -1.09 . . . . 74.140000000000001 109.238 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -75.86 -37.91 58.45 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.308 -0.87 . . . . 64.040000000000006 109.741 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . 0.482 ' CG ' ' N ' ' B' ' 90' ' ' GLY . 11.8 pt20 -73.02 -47.44 45.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.107 -0.995 . . . . 72.349999999999994 109.792 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . 0.482 ' N ' ' CG ' ' B' ' 89' ' ' GLN . . . 147.38 65.35 0.01 OUTLIER Glycine 0 N--CA 1.495 2.614 0 C-N-CA 119.776 -1.202 . . . . 65.200000000000003 110.395 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -126.24 138.15 53.6 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.363 -1.08 . . . . 52.229999999999997 108.978 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.53 ' CG ' HH21 ' B' ' 112' ' ' ARG . 46.1 t0 -86.54 -26.18 24.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.097 -1.002 . . . . 73.319999999999993 109.608 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 14.4 t0 -152.41 153.09 32.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.19 -0.944 . . . . 72.219999999999999 109.578 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.512 ' N ' ' OD1' ' B' ' 93' ' ' ASP . 61.7 t80 -134.27 101.49 5.03 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.545 -0.909 . . . . 64.420000000000002 108.545 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 23.1 mm -110.28 147.9 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.437 0 O-C-N 121.133 -0.98 . . . . 72.230000000000004 110.283 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.48 145.36 56.23 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.832 -1.173 . . . . 25.239999999999998 107.832 178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.68 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -66.24 -56.53 15.93 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.671 -1.268 . . . . 64.319999999999993 111.58 -179.058 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 2.2 Cg_endo -39.88 -12.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 120.909 1.073 . . . . 63.329999999999998 112.824 -175.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . 0.68 ' N ' ' O ' ' B' ' 97' ' ' LYS . 53.7 m-85 59.59 137.09 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.86 -0.525 . . . . 75.129999999999995 110.315 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 50.8 mtt-85 -73.73 -40.28 63.67 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.982 -1.074 . . . . 74.230000000000004 108.808 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . 0.753 ' O ' ' N ' ' B' ' 103' ' ' LYS . 34.4 t -168.1 33.8 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.162 -0.961 . . . . 63.340000000000003 110.782 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 37.3 mm 50.71 -69.62 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.567 -0.708 . . . . 74.439999999999998 110.341 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.753 ' N ' ' O ' ' B' ' 101' ' ' SER . 40.3 mmtm -55.12 -30.49 59.87 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.865 -1.161 . . . . 71.109999999999999 107.865 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.78 -55.69 13.78 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.604 -0.839 . . . . 71.450000000000003 109.011 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 19.0 tp -58.05 -43.78 87.06 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.33 -0.856 . . . . 51.310000000000002 108.762 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.21 -47.88 86.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -0.93 . . . . 65.230000000000004 108.853 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -49.2 -38.01 24.7 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.14 -0.975 . . . . 24.32 108.885 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 0.531 ' O ' ' NE ' ' B' ' 108' ' ' ARG . 0.0 OUTLIER -67.6 -35.25 78.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.476 -0.765 . . . . 75.310000000000002 108.97 179.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 64.3 mt -78.28 -29.94 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.066 -1.022 . . . . 54.240000000000002 109.435 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -67.9 -52.49 35.75 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.537 -0.727 . . . . 65.310000000000002 109.868 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.41 -38.04 74.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.194 -0.942 . . . . 72.239999999999995 110.035 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . 0.53 HH21 ' CG ' ' B' ' 92' ' ' ASP . 40.6 ttt85 -57.84 -35.6 71.14 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.993 -1.067 . . . . 72.040000000000006 109.704 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.415 ' C ' HD23 ' B' ' 113' ' ' LEU . 2.9 tt -144.07 103.01 3.96 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.097 -1.002 . . . . 75.349999999999994 109.492 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.484 ' NE ' ' H ' ' B' ' 115' ' ' PHE . 0.1 OUTLIER -142.09 -164.37 1.79 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.43 -0.952 . . . . 75.5 108.43 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' PHE . . . . . 0.484 ' H ' ' NE ' ' B' ' 114' ' ' ARG . 45.4 m-85 51.88 32.34 9.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.042 -1.037 . . . . 65.329999999999998 109.294 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' TRP . . . . . 0.757 ' CE3' ' O ' ' B' ' 117' ' ' GLY . 74.4 t90 53.66 169.01 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.499 -0.751 . . . . 74.450000000000003 110.196 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . 0.757 ' O ' ' CE3' ' B' ' 116' ' ' TRP . . . -47.38 145.45 4.75 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.864 -1.294 . . . . 44.210000000000001 109.864 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 43.0 t -94.22 172.87 7.94 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.425 -1.044 . . . . 71.400000000000006 109.406 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . 0.421 ' CG ' ' H ' ' B' ' 120' ' ' VAL . 27.4 t-20 -142.24 178.86 7.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.311 -0.868 . . . . 72.319999999999993 109.043 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . 0.421 ' H ' ' CG ' ' B' ' 119' ' ' ASN . 18.8 t -140.16 -45.15 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.243 -0.911 . . . . 75.019999999999996 109.233 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 9.2 mm -97.89 111.14 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.057 -1.027 . . . . 51.409999999999997 108.501 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -128.23 105.49 8.39 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.496 -0.753 . . . . 71.530000000000001 109.287 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.494 HG23 ' O ' ' B' ' 123' ' ' ILE . 10.5 tp -145.2 122.79 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.165 -0.96 . . . . 72.430000000000007 109.077 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' B' ' 126' ' ' LEU . . . 54.86 -170.98 1.3 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.464 -1.855 . . . . 51.229999999999997 108.464 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -64.96 2.91 0.63 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.896 -1.356 . . . . 74.200000000000003 108.877 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.489 ' H ' ' C ' ' B' ' 124' ' ' GLY . 0.6 OUTLIER -91.73 117.21 29.55 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.685 -0.857 . . . . 75.420000000000002 108.685 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 83.0 m -125.11 140.92 52.46 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.475 -0.766 . . . . 74.219999999999999 108.964 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 6.3 mt -141.22 136.21 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.271 -0.893 . . . . 60.329999999999998 110.463 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 13.4 m -114.78 114.59 44.23 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.958 -0.756 . . . . 72.310000000000002 108.958 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.453 ' HB3' ' HE ' ' B' ' 157' ' ' ARG . 86.4 Cg_endo -83.48 -40.12 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.248 1.965 . . . . 75.129999999999995 112.172 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -63.34 -49.72 72.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.392 -0.818 . . . . 75.230000000000004 109.492 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 15.8 mp0 -81.83 -0.17 42.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.955 . . . . 72.430000000000007 109.278 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 50.34 74.25 0.23 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.123 -0.985 . . . . 75.129999999999995 109.605 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -159.33 129.64 5.76 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.075 -1.015 . . . . 73.219999999999999 109.351 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 12.4 tt -109.37 128.97 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.795 -0.817 . . . . 64.140000000000001 108.795 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 69.2 mt -116.39 126.48 73.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 CA-C-O 121.535 0.683 . . . . 71.219999999999999 110.404 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -135.74 147.03 48.28 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.943 -0.762 . . . . 64.219999999999999 108.943 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm 54.03 36.11 23.77 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.554 -0.716 . . . . 72.019999999999996 110.719 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 64.5 7.75 28.64 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.985 -1.246 . . . . 74.319999999999993 109.985 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -107.04 124.48 49.71 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.478 -1.013 . . . . 75.340000000000003 108.536 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' B' ' 141' ' ' GLU . 32.2 mp0 -80.92 143.2 32.82 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.416 -0.803 . . . . 71.230000000000004 109.882 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 22.5 t -134.3 129.92 53.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.64 -0.874 . . . . 70.430000000000007 108.64 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -83.2 149.41 26.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.343 -0.848 . . . . 72.430000000000007 109.662 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . 0.547 HG21 ' CZ ' ' B' ' 149' ' ' PHE . 2.5 m -153.05 144.42 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 72.129999999999995 109.384 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 27.2 pttt -175.47 101.86 0.08 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.239 -0.913 . . . . 72.019999999999996 109.262 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 177.52 174.16 43.65 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.663 -1.256 . . . . 42.229999999999997 110.246 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 0.604 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 10.0 tttt -62.4 -42.4 79.86 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.457 -1.025 . . . . 73.299999999999997 109.706 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 23.3 Cg_exo -62.65 -32.45 79.0 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.575 2.184 . . . . 71.329999999999998 112.461 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . 0.547 ' CZ ' HG21 ' B' ' 144' ' ' VAL . 71.9 t80 -92.43 -15.35 27.28 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.129 -0.982 . . . . 74.230000000000004 109.886 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -60.88 -41.12 95.39 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.093 -1.004 . . . . 72.340000000000003 109.759 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.492 HG13 ' N ' ' B' ' 152' ' ' LEU . 8.6 p -72.92 -40.6 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.223 -0.923 . . . . 73.349999999999994 110.051 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.492 ' N ' HG13 ' B' ' 151' ' ' VAL . 21.1 tp -56.9 -31.21 64.66 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.268 -0.895 . . . . 55.240000000000002 109.119 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' B' ' 149' ' ' PHE . 0.2 OUTLIER -76.84 -46.67 23.88 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.488 -0.757 . . . . 70.010000000000005 109.183 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -50.29 -46.42 55.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.188 -0.945 . . . . 65.319999999999993 110.507 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.434 HD12 ' N ' ' B' ' 156' ' ' ALA . 1.9 pp -73.77 -34.68 64.79 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.648 -1.283 . . . . 71.540000000000006 109.383 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . 0.434 ' N ' HD12 ' B' ' 155' ' ' LEU . . . -50.19 -35.8 27.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.096 -1.002 . . . . 75.319999999999993 108.951 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.453 ' HE ' ' HB3' ' B' ' 130' ' ' PRO . 85.6 mtt180 -79.16 -46.47 17.87 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.384 -0.823 . . . . 73.319999999999993 109.175 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -85.57 49.04 1.68 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.666 -0.646 . . . . 74.140000000000001 111.068 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . 0.519 ' NH2' ' OG1' ' B' ' 203' ' ' THR . 5.6 tpt180 -72.83 171.57 12.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.846 -1.159 . . . . 61.409999999999997 108.097 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 51.1 t0 54.48 60.24 3.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.828 -1.17 . . . . 72.099999999999994 109.566 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -171.58 147.23 2.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.309 -0.87 . . . . 72.25 109.312 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 21.8 mm -83.63 122.31 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.221 -0.924 . . . . 72.310000000000002 108.89 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 97.1 t -119.64 139.4 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.393 -0.817 . . . . 64.209999999999994 109.553 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 5.4 t -99.69 160.46 14.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.341 -0.849 . . . . 74.219999999999999 110.047 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . 0.444 ' HZ2' ' CG2' ' B' ' 184' ' ' ILE . 18.0 mtpp -61.55 -44.61 96.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.528 -0.733 . . . . 65.310000000000002 109.609 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -50.54 -39.75 49.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.477 -0.764 . . . . 63.450000000000003 110.254 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -59.29 -48.89 79.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.047 -1.033 . . . . 72.400000000000006 109.51 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 27.5 mt -58.31 -30.56 66.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.212 -0.93 . . . . 72.319999999999993 109.412 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.614 ' C ' HD13 ' B' ' 169' ' ' LEU . 2.3 tm? -66.92 -66.61 0.53 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.388 -0.82 . . . . 73.340000000000003 109.872 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -68.01 -2.07 6.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.311 -0.868 . . . . 72.099999999999994 110.874 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.91 -57.96 2.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.838 -1.164 . . . . 62.130000000000003 110.116 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.711 ' N ' HD12 ' B' ' 172' ' ' ILE . 1.9 mp -91.73 -45.39 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 120.955 -1.091 . . . . 71.420000000000002 110.123 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' TRP . . . . . 0.525 ' O ' ' N ' ' B' ' 175' ' ' GLU . 16.5 m-90 -77.53 -5.28 49.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.909 -1.119 . . . . 72.230000000000004 108.686 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 45.18 -90.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.56 -0.712 . . . . 52.109999999999999 110.262 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . 0.542 ' H ' ' HD2' ' B' ' 176' ' ' PRO . 1.6 mt-10 -167.39 -52.42 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.955 -1.091 . . . . 73.040000000000006 109.997 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.542 ' HD2' ' H ' ' B' ' 175' ' ' GLU . 82.3 Cg_exo -45.34 -9.23 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.001 1.801 . . . . 74.129999999999995 112.4 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . 0.539 ' N ' ' O ' ' B' ' 175' ' ' GLU . 70.8 mm-40 -82.04 161.34 22.98 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.176 -0.953 . . . . 72.439999999999998 109.468 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . 0.437 ' O ' ' O ' ' B' ' 179' ' ' VAL . 21.6 ttt -67.24 -41.22 86.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 63.43 109.407 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 179' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' B' ' 178' ' ' MET . 48.9 t 52.59 103.24 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.502 -0.749 . . . . 71.049999999999997 109.896 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . 0.542 ' O ' ' N ' ' B' ' 182' ' ' ASN . 1.6 p -80.17 155.6 74.6 Favored Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 108.375 -0.972 . . . . 62.149999999999999 108.375 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -39.68 -16.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.357 2.038 . . . . 65.219999999999999 112.914 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 182' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' B' ' 180' ' ' THR . 18.9 p30 -160.64 107.3 1.51 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.875 -1.14 . . . . 72.310000000000002 110.17 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 96.7 t -121.55 -36.0 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.489 -0.757 . . . . 63.32 109.477 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.444 ' CG2' ' HZ2' ' B' ' 165' ' ' LYS . 24.5 mm -60.84 -22.18 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 75.030000000000001 109.667 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.09 -42.0 99.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.123 -0.986 . . . . 64.109999999999999 110.259 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . 0.408 HG22 ' H ' ' B' ' 186' ' ' VAL . 5.2 m -79.42 -36.89 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.925 -1.109 . . . . 73.0 109.745 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -70.1 -46.84 64.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.12 -0.988 . . . . 61.119999999999997 109.714 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 188' ' ' ILE . . . . . 0.444 HG23 ' N ' ' B' ' 189' ' ' ASN . 9.1 tp -62.49 -42.51 96.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.088 -1.008 . . . . 72.430000000000007 110.028 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 189' ' ' ASN . . . . . 0.454 ' OD1' ' NH2' ' B' ' 192' ' ' ARG . 55.1 t30 -58.51 -43.69 89.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.061 -1.024 . . . . 65.140000000000001 109.827 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -73.7 -38.03 65.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.176 -0.953 . . . . 63.240000000000002 110.319 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 60.9 mt -65.15 -49.14 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.136 -0.977 . . . . 74.030000000000001 110.824 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 192' ' ' ARG . . . . . 0.454 ' NH2' ' OD1' ' B' ' 189' ' ' ASN . 28.4 ptt180 -64.07 -37.33 87.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.84 -1.162 . . . . 72.239999999999995 108.131 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 193' ' ' GLN . . . . . 0.524 ' HG3' ' CE ' ' B' ' 197' ' ' LYS . 42.6 tt0 -65.18 -30.43 71.34 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.905 -1.146 . . . . 73.099999999999994 107.905 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . 0.648 ' O ' HD13 ' B' ' 199' ' ' LEU . 36.5 mtpt -93.44 2.74 56.37 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.084 -0.71 . . . . 72.109999999999999 109.084 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 195' ' ' MET . . . . . 0.881 ' HE2' ' OG1' ' B' ' 203' ' ' THR . 5.0 tpt -94.37 -22.31 18.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.959 -1.088 . . . . 44.329999999999998 109.703 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 196' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 5.1 m-20 -114.02 -27.35 7.74 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.107 -0.995 . . . . 71.209999999999994 111.918 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . 0.524 ' CE ' ' HG3' ' B' ' 193' ' ' GLN . 5.2 mtmm -79.06 -62.77 0.43 Allowed Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 120.427 -1.421 . . . . 75.209999999999994 111.288 -177.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 198' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.66 -49.28 0.17 Allowed 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 121.787 1.658 . . . . 75.319999999999993 112.221 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . 0.648 HD13 ' O ' ' B' ' 194' ' ' LYS . 10.6 mp -54.35 -70.79 0.09 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.092 -1.005 . . . . 72.25 109.034 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 143.44 -59.15 0.53 Allowed Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.51 -1.436 . . . . 64.530000000000001 109.51 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 29.3 mt -109.34 142.81 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.558 -0.966 . . . . 44.229999999999997 109.677 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 17.3 m -77.71 139.47 39.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.122 -0.987 . . . . 54.009999999999998 108.631 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . 0.881 ' OG1' ' HE2' ' B' ' 195' ' ' MET . 70.7 p -129.55 5.96 5.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.439 -0.788 . . . . 74.400000000000006 109.759 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.472 HG13 ' HE2' ' B' ' 195' ' ' MET . 24.3 m -121.67 147.84 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.502 -0.749 . . . . 72.120000000000005 109.642 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 42.2 tp10 -116.8 125.17 51.2 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.218 -0.66 . . . . 65.409999999999997 109.218 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 206' ' ' THR . . . . . 0.413 HG22 ' H ' ' B' ' 206' ' ' THR . 0.1 OUTLIER -84.07 112.76 20.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.394 -0.817 . . . . 71.329999999999998 109.219 179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.612 HG22 ' H ' ' B' ' 209' ' ' ARG . 7.3 p -138.18 145.84 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.367 -0.833 . . . . 63.5 109.264 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 208' ' ' ARG . . . . . 0.405 ' H ' ' HG2' ' B' ' 208' ' ' ARG . 36.0 ptt180 -97.1 -15.78 20.81 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.105 -0.997 . . . . 74.450000000000003 110.11 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . 0.612 ' H ' HG22 ' B' ' 207' ' ' VAL . 66.5 mtt-85 -50.24 -39.83 45.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.154 -0.967 . . . . 74.140000000000001 109.859 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -140.04 -53.63 0.52 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.301 -0.875 . . . . 74.430000000000007 109.4 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' B' ' 207' ' ' VAL . . . 179.65 -102.31 0.16 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.468 -1.453 . . . . 64.450000000000003 109.468 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 -136.48 135.31 38.49 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.346 -1.09 . . . . 74.209999999999994 108.948 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 43.5 mtt-85 -95.15 125.78 40.03 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.31 -0.869 . . . . 74.030000000000001 109.395 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . 0.416 ' CD2' HG12 ' B' ' 204' ' ' VAL . 79.8 m-85 -106.4 106.43 16.95 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.493 -0.754 . . . . 74.340000000000003 109.471 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 16.4 p -158.93 170.97 20.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.213 -0.93 . . . . 64.329999999999998 109.545 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -64.14 138.54 97.44 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 121.238 -0.914 . . . . 70.040000000000006 108.81 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' B' ' 218' ' ' LYS . 74.1 Cg_endo -73.54 77.34 2.59 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.248 1.966 . . . . 65.109999999999999 112.695 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' B' ' 220' ' ' ALA . 18.4 mttm 59.23 151.15 0.08 OUTLIER Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.405 -0.809 . . . . 73.150000000000006 109.742 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -44.98 85.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 121.66 1.573 . . . . 71.310000000000002 111.325 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . 0.534 ' N ' ' O ' ' B' ' 218' ' ' LYS . . . -93.14 -26.32 17.48 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.016 -1.053 . . . . 75.450000000000003 110.446 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 42.4 t -49.18 -30.89 7.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.876 -1.14 . . . . 72.219999999999999 109.674 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 49.17 44.91 23.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.128 -0.983 . . . . 54.530000000000001 109.764 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.123 -0.985 . . . . 71.129999999999995 109.751 179.594 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.638 ' CE ' ' HE1' ' A' ' 116' ' ' TRP . 64.3 ttp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.492 -0.559 . . . . 65.120000000000005 109.492 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -138.03 151.43 47.87 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.342 -0.849 . . . . 72.329999999999998 109.297 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.8 t -116.79 135.53 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.748 -0.595 . . . . 71.420000000000002 109.632 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 5' ' ' LEU . 0.7 OUTLIER -112.74 122.73 48.53 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.36 -0.837 . . . . 65.120000000000005 109.181 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.718 ' N ' HD12 ' A' ' 4' ' ' LEU . 11.0 mt -120.89 101.74 7.9 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.61 -0.681 . . . . 62.43 109.181 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.537 HG12 HD11 ' A' ' 4' ' ' LEU . 10.6 mt -79.27 104.61 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.781 -1.2 . . . . 71.150000000000006 108.753 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 9' ' ' ASN . 0.6 OUTLIER -139.16 123.19 17.86 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.306 -0.871 . . . . 75.340000000000003 109.215 -179.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.44 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 68.3 mttm -65.35 -33.68 76.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 72.439999999999998 109.162 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.513 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 18.2 m120 -82.41 112.36 19.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.337 -0.852 . . . . 63.020000000000003 109.485 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 45.5 m -63.83 -26.31 68.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 72.340000000000003 109.653 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.29 -53.2 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.195 -0.941 . . . . 74.019999999999996 109.863 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 38.6 mt -61.42 -46.84 88.43 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.234 -0.916 . . . . 71.430000000000007 109.585 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.32 -17.1 71.99 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.517 -1.833 . . . . 61.32 108.517 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.4 -54.41 5.57 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 109.483 -1.447 . . . . 71.200000000000003 109.483 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -56.51 -44.9 81.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.425 -1.044 . . . . 71.319999999999993 109.783 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.2 mm -63.41 -34.99 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.822 -1.174 . . . . 63.229999999999997 108.798 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.48 ' CD ' HD21 ' A' ' 21' ' ' ASN . 14.2 tm-20 -57.91 -49.66 75.97 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.922 . . . . 51.109999999999999 109.102 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -87.52 3.47 47.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.26 -0.9 . . . . 73.340000000000003 109.262 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.66 -57.96 2.48 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.68 -1.368 . . . . 62.149999999999999 109.68 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -75.05 -19.98 59.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -1.146 . . . . 73.510000000000005 109.869 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.48 HD21 ' CD ' ' A' ' 17' ' ' GLU . 80.4 m-20 -51.29 -33.88 30.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.092 -1.005 . . . . 74.25 109.282 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 65.2 t -58.0 -46.95 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.322 -0.861 . . . . 70.040000000000006 108.938 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -56.91 -53.18 60.95 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.903 -0.777 . . . . 73.230000000000004 108.903 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 133.63 36.41 0.26 Allowed Glycine 0 N--CA 1.5 2.929 0 N-CA-C 109.735 -1.346 . . . . 75.540000000000006 109.735 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.59 ' CE2' ' SD ' ' A' ' 1' ' ' MET . 20.1 m-85 -119.39 160.02 23.1 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.483 -1.01 . . . . 73.430000000000007 109.344 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.2 mmt -104.22 140.34 37.98 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.571 -0.9 . . . . 43.240000000000002 108.571 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.417 ' O ' ' OD1' ' A' ' 28' ' ' ASP . . . -138.52 155.48 48.36 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.337 -0.852 . . . . 62.109999999999999 110.28 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 27' ' ' ALA . 82.1 m-20 -141.57 155.6 45.75 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.592 -0.892 . . . . 74.420000000000002 108.592 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.2 t -112.11 139.35 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.379 -0.826 . . . . 72.150000000000006 109.384 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.6 p -129.99 166.69 19.57 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.523 -0.736 . . . . 71.420000000000002 109.573 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.449 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 4.4 pt-20 -93.72 -102.98 0.13 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.348 -0.845 . . . . 72.329999999999998 109.809 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.7 p -79.31 168.88 18.93 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.115 -0.991 . . . . 74.239999999999995 109.891 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.0 mt -57.33 -33.32 67.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.521 -0.737 . . . . 71.530000000000001 109.742 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -51.27 -43.57 61.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 74.230000000000004 109.661 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -65.91 -41.92 90.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.154 -0.966 . . . . 54.030000000000001 109.373 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.25 -38.44 46.33 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.493 -1.443 . . . . 61.409999999999997 109.493 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.71 -38.18 90.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -1.135 . . . . 74.340000000000003 109.621 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -80.84 -39.47 26.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 75.329999999999998 109.717 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.9 tp -68.16 -46.35 70.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 74.329999999999998 110.077 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 41' ' ' ASP . 3.3 ppp? -62.73 -27.62 69.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.041 -1.037 . . . . 70.319999999999993 109.83 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 40' ' ' MET . 93.5 m-20 -63.49 -40.21 96.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.135 -0.978 . . . . 71.219999999999999 109.94 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.9 pt -84.0 -25.86 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.159 -0.963 . . . . 74.140000000000001 110.167 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 40' ' ' MET . 97.4 mtt180 -130.04 138.76 50.93 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.373 -0.829 . . . . 72.239999999999995 109.584 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -93.98 126.36 39.15 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.248 -0.908 . . . . 75.420000000000002 109.472 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -106.01 145.78 30.93 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.429 -0.794 . . . . 74.230000000000004 109.524 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -85.57 -44.56 12.54 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.274 -0.891 . . . . 72.040000000000006 109.078 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.537 HD22 ' HB ' ' A' ' 70' ' ' VAL . 0.8 OUTLIER -105.56 108.41 19.9 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.585 -0.894 . . . . 72.129999999999995 108.585 179.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.432 ' N ' HD13 ' A' ' 47' ' ' LEU . 2.0 m -104.33 101.86 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.31 -0.996 . . . . 72.340000000000003 108.31 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 9.6 ttt -108.37 143.02 37.83 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.688 -0.856 . . . . 74.109999999999999 108.688 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' A' ' 55' ' ' ALA . 1.3 p -144.15 132.34 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.361 -0.837 . . . . 61.119999999999997 109.933 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.0 m -98.98 2.29 46.23 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.481 -0.762 . . . . 73.109999999999999 109.472 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -76.14 139.12 41.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.192 -0.943 . . . . 52.549999999999997 109.427 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.481 ' C ' ' H ' ' A' ' 55' ' ' ALA . 61.6 mttp -73.62 -43.5 59.42 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.307 -0.871 . . . . 44.219999999999999 110.731 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -68.16 10.26 0.24 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.017 -1.052 . . . . 70.439999999999998 109.89 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.93 -22.18 56.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.893 . . . . 64.140000000000001 110.57 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' ALA . 64.0 mt -39.98 -51.59 2.51 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.511 -0.743 . . . . 44.140000000000001 110.498 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.9 m -68.75 -33.72 74.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.939 -1.1 . . . . 55.229999999999997 109.319 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.539 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 73.6 t80 -64.84 -48.42 74.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.386 -0.821 . . . . 74.439999999999998 110.088 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.61 -34.83 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.615 -1.303 . . . . 74.030000000000001 109.52 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.9 p -57.33 -49.64 75.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.189 -0.944 . . . . 64.299999999999997 109.542 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -69.41 -33.2 72.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.032 -1.043 . . . . 64.439999999999998 109.927 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.539 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 5.1 mm -63.63 -35.41 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.828 -1.17 . . . . 63.210000000000001 109.747 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 67' ' ' SER . 11.5 mtpt -72.08 -51.05 23.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.123 -0.986 . . . . 74.420000000000002 110.461 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.431 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 14.6 pt-20 -67.24 -41.69 85.22 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.743 -1.223 . . . . 70.319999999999993 109.708 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.448 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 93.4 mttt -73.61 -24.42 60.04 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.878 . . . . 75.219999999999999 109.501 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.518 ' O ' HG22 ' A' ' 69' ' ' ILE . 93.5 m-70 -154.93 65.88 0.66 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.229 -0.92 . . . . 74.129999999999995 109.293 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 63' ' ' LYS . 17.0 t -60.45 -32.56 71.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.392 -0.818 . . . . 73.239999999999995 110.038 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.1 m -67.59 46.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 61.009999999999998 109.859 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 66' ' ' HIS . 13.8 tt -145.63 162.85 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.142 -0.974 . . . . 71.329999999999998 109.726 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.537 ' HB ' HD22 ' A' ' 47' ' ' LEU . 45.0 t -97.73 148.75 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.221 -0.924 . . . . 72.129999999999995 108.942 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.51 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 11.3 t -132.38 124.08 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.282 -0.886 . . . . 54.210000000000001 109.508 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.525 HD12 HD21 ' A' ' 47' ' ' LEU . 2.1 mt -128.07 99.26 5.41 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.319 -0.993 . . . . 50.240000000000002 108.319 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.603 ' O ' HD12 ' A' ' 95' ' ' ILE . 64.3 t -93.12 149.56 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -0.869 . . . . 74.409999999999997 109.14 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.7 m -121.96 165.84 15.36 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.529 -0.915 . . . . 72.310000000000002 108.529 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.45 ' CB ' ' OE2' ' A' ' 82' ' ' GLU . 9.7 p -171.81 123.65 0.53 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.035 -1.041 . . . . 64.540000000000006 110.226 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 52.1 p30 -71.0 10.56 0.52 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.59 -0.694 . . . . 74.129999999999995 109.901 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.445 ' H ' ' C ' ' A' ' 75' ' ' SER . 5.8 p-10 -129.09 59.57 44.95 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.38 -0.825 . . . . 73.340000000000003 109.661 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -58.9 80.2 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.276 1.984 . . . . 63.219999999999999 112.047 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.403 ' N ' ' O ' ' A' ' 77' ' ' ASN . 72.6 p -104.28 151.56 23.27 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.621 -0.881 . . . . 62.530000000000001 108.621 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -30.8 69.53 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.228 -0.92 . . . . 73.439999999999998 109.363 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -67.15 -37.47 83.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.189 -0.945 . . . . 71.420000000000002 109.554 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.45 ' OE2' ' CB ' ' A' ' 75' ' ' SER . 79.4 tt0 -71.47 -32.62 68.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 73.430000000000007 109.722 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.476 ' OE2' ' CZ ' ' B' ' 100' ' ' ARG . 92.2 mt-10 -64.44 -50.95 65.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.918 . . . . 74.219999999999999 109.825 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.3 m -61.01 -36.32 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.157 -0.964 . . . . 73.200000000000003 109.252 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.429 ' O ' ' OE1' ' A' ' 89' ' ' GLN . 27.0 m80 -74.51 -26.65 60.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 53.329999999999998 109.599 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -66.53 -41.96 87.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.109 -0.995 . . . . 64.109999999999999 109.786 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.479 ' CZ ' ' HB1' ' B' ' 111' ' ' ALA . 89.1 t80 -82.05 -35.12 29.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.042 -1.036 . . . . 74.340000000000003 109.08 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 68.3 tt0 -62.08 -51.55 67.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.379 -0.825 . . . . 74.420000000000002 109.411 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.488 ' NE2' ' N ' ' A' ' 89' ' ' GLN . 0.9 OUTLIER -66.6 -58.26 5.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.531 -0.731 . . . . 74.239999999999995 109.686 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 158.17 75.27 0.02 OUTLIER Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.613 -1.279 . . . . 61.509999999999998 110.266 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -134.84 119.61 18.33 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.305 -1.115 . . . . 55.329999999999998 108.947 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 71.6 m-20 -71.36 -34.79 70.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.102 -0.999 . . . . 73.420000000000002 108.923 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.517 ' CG ' HH21 ' A' ' 112' ' ' ARG . 60.7 m-20 -153.16 152.5 31.32 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.451 -0.781 . . . . 75.040000000000006 109.046 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.423 ' OH ' ' OG ' ' A' ' 75' ' ' SER . 9.3 t80 -126.76 132.93 50.96 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.08 -0.711 . . . . 71.329999999999998 109.08 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.798 ' H ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -121.57 142.38 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 CA-C-O 121.978 0.894 . . . . 71.129999999999995 110.442 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.52 119.86 10.61 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.599 -1.26 . . . . 64.319999999999993 107.599 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.677 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -43.9 -53.9 12.05 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 62.200000000000003 111.628 -178.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 2.3 Cg_endo -40.56 -10.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 120.955 1.103 . . . . 73.109999999999999 113.12 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.677 ' N ' ' O ' ' A' ' 97' ' ' LYS . 64.0 m-85 59.96 92.73 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.71 -0.619 . . . . 65.219999999999999 109.9 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.8 ttm105 -52.09 -39.03 59.14 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.354 -0.98 . . . . 72.349999999999994 108.354 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 t -172.41 134.41 0.68 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.493 -0.755 . . . . 71.319999999999993 109.025 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 81.8 mt -53.34 -40.1 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.127 -0.983 . . . . 75.430000000000007 109.26 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -66.79 -26.22 66.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 71.409999999999997 109.67 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.81 -48.58 21.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.171 -0.955 . . . . 63.240000000000002 109.856 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.7 ' C ' HD13 ' A' ' 105' ' ' LEU . 2.1 tm? -57.75 -54.05 51.24 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.207 -0.933 . . . . 73.219999999999999 109.442 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.526 HG13 ' N ' ' A' ' 107' ' ' ALA . 11.0 p -60.28 -41.9 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.099 -1.001 . . . . 60.109999999999999 109.52 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.526 ' N ' HG13 ' A' ' 106' ' ' VAL . . . -51.8 -36.63 48.47 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.17 -0.956 . . . . 70.420000000000002 108.925 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -71.87 -37.45 70.19 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.372 -0.83 . . . . 74.409999999999997 109.399 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 87.7 mt -67.11 -31.61 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 107.978 -1.119 . . . . 62.539999999999999 107.978 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 113' ' ' LEU . 78.5 tt0 -65.85 -57.55 7.66 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.637 -0.825 . . . . 74.340000000000003 108.927 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -46.21 -37.2 6.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.475 -0.766 . . . . 73.319999999999993 109.655 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.517 HH21 ' CG ' ' A' ' 93' ' ' ASP . 28.1 mmt180 -82.25 -14.46 55.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.236 -0.915 . . . . 52.409999999999997 110.103 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' ' 110' ' ' GLU . 80.4 mt -135.25 44.08 2.61 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.133 -0.979 . . . . 65.239999999999995 110.617 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -76.44 -39.19 54.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.848 -1.158 . . . . 64.450000000000003 108.846 178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.529 ' CD2' ' O ' ' A' ' 116' ' ' TRP . 33.8 p90 -67.74 -10.98 57.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.424 -0.797 . . . . 74.430000000000007 109.977 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.638 ' HE1' ' CE ' ' A' ' 1' ' ' MET . 48.0 t90 50.29 -178.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.138 -0.976 . . . . 74.420000000000002 109.504 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.495 ' N ' ' CG ' ' A' ' 116' ' ' TRP . . . -50.96 143.18 15.0 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.351 -1.499 . . . . 75.040000000000006 109.351 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 87.9 p -157.6 -178.5 7.38 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -1.206 . . . . 61.140000000000001 110.068 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.38 -179.64 8.13 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.05 -0.722 . . . . 65.239999999999995 109.05 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 30.6 t -138.34 -36.6 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.42 -0.8 . . . . 73.109999999999999 109.125 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.55 HD12 ' N ' ' A' ' 121' ' ' ILE . 1.4 mp -90.4 136.41 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.107 -0.995 . . . . 72.239999999999995 108.493 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -138.6 105.69 5.46 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.349 -0.844 . . . . 72.340000000000003 109.47 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 83.5 mt -108.94 109.78 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.962 -0.755 . . . . 71.439999999999998 108.962 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.8 -137.73 31.06 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.277 -1.529 . . . . 73.400000000000006 109.277 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -79.56 -3.83 48.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -1.191 . . . . 74.450000000000003 109.349 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.45 HD22 ' CE1' ' A' ' 137' ' ' TYR . 0.5 OUTLIER -89.06 143.25 26.98 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.356 -0.979 . . . . 54.210000000000001 108.356 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 54.9 m -129.86 141.07 50.87 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.375 -0.828 . . . . 54.5 109.231 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.74 130.81 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.42 -0.8 . . . . 45.149999999999999 109.976 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.1 m -107.4 113.45 61.89 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.633 -0.667 . . . . 71.109999999999999 109.226 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.8 -53.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 121.92 1.746 . . . . 65.409999999999997 111.959 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -55.3 -44.65 75.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 63.32 109.316 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -83.52 -8.54 59.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.401 -0.812 . . . . 72.519999999999996 109.153 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 51.72 57.53 6.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 75.329999999999998 109.154 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -139.37 116.03 10.73 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.411 -0.806 . . . . 71.230000000000004 109.164 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.543 HD12 ' N ' ' A' ' 135' ' ' ILE . 1.4 mp -94.22 130.24 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.185 -0.947 . . . . 74.019999999999996 108.905 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 36.8 mt -115.91 129.41 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.561 -0.712 . . . . 60.229999999999997 109.575 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.466 ' C ' ' H ' ' A' ' 139' ' ' GLY . 77.5 t80 -141.58 151.19 42.96 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.512 -0.922 . . . . 62.32 108.512 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 46.1 tttp 55.94 5.63 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.851 . . . . 75.400000000000006 109.408 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 137' ' ' TYR . . . 93.86 -4.81 72.29 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 109.686 -1.366 . . . . 72.239999999999995 109.686 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.404 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 0.7 OUTLIER -89.71 139.7 30.3 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.247 -1.149 . . . . 71.219999999999999 109.299 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -86.71 137.19 32.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.279 -0.888 . . . . 71.420000000000002 109.162 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.1 t -135.26 128.12 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.43 -0.794 . . . . 53.020000000000003 109.531 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -93.37 134.34 35.69 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.306 -0.871 . . . . 60.450000000000003 109.048 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.413 ' CG2' HD13 ' A' ' 135' ' ' ILE . 15.1 m -149.48 140.56 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.106 -0.996 . . . . 74.439999999999998 109.556 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 5.0 ptpp? -163.54 18.83 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 65.150000000000006 109.776 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.3 161.09 54.16 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 108.844 -1.702 . . . . 73.340000000000003 108.844 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.562 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 4.8 tttp -56.44 -44.73 99.86 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.039 -1.271 . . . . 72.219999999999999 109.091 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 24.2 Cg_exo -62.58 -28.5 77.3 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.362 2.042 . . . . 65.230000000000004 112.122 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -80.67 -20.7 42.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.232 -0.918 . . . . 60.109999999999999 110.12 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -52.75 -32.96 46.14 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.067 -1.021 . . . . 64.209999999999994 108.965 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.454 HG12 ' O ' ' A' ' 148' ' ' PRO . 6.4 p -64.95 -38.08 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.324 -0.86 . . . . 72.019999999999996 109.276 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 29.4 tp -60.86 -41.92 96.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.857 . . . . 73.310000000000002 109.322 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 20.0 p -74.35 -34.79 63.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.245 -0.909 . . . . 74.310000000000002 110.16 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.569 ' ND1' ' NH2' ' A' ' 157' ' ' ARG . 43.9 m-70 -60.9 -52.69 63.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.137 -0.977 . . . . 74.310000000000002 110.035 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 pp -68.52 -28.56 67.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.906 -1.121 . . . . 75.340000000000003 109.602 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.3 -47.59 78.38 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.169 -0.957 . . . . 62.140000000000001 109.377 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.569 ' NH2' ' ND1' ' A' ' 154' ' ' HIS . 67.9 mtm-85 -69.03 -58.69 3.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.965 . . . . 61.030000000000001 109.461 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -53.27 -47.67 68.94 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.811 -0.756 . . . . 74.120000000000005 109.457 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 161' ' ' GLN . 23.1 ttm180 44.97 -126.49 1.1 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.401 -0.812 . . . . 71.129999999999995 109.895 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.423 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 45.6 p-10 -50.08 90.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 75.450000000000003 109.561 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.844 ' OE1' ' OH ' ' B' ' 216' ' ' TYR . 1.4 tp-100 -171.53 149.54 2.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.246 -0.909 . . . . 73.409999999999997 109.325 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 65.3 mt -78.51 135.46 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.148 -0.97 . . . . 74.409999999999997 109.216 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 87.1 t -127.58 129.29 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.452 -0.78 . . . . 72.310000000000002 109.653 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.7 t -99.44 153.36 19.07 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.435 -0.791 . . . . 74.120000000000005 109.324 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.5 mtmm -56.97 -43.83 82.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.33 -0.856 . . . . 70.430000000000007 109.494 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -59.01 -34.26 71.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.341 -0.85 . . . . 73.519999999999996 109.575 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -63.91 -55.19 24.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.166 -0.959 . . . . 74.519999999999996 109.621 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 80.3 mt -47.64 -52.71 17.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.143 -0.973 . . . . 72.310000000000002 109.774 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 171' ' ' ALA . 87.2 mt -57.62 -74.6 0.05 Allowed 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.591 -1.318 . . . . 53.329999999999998 109.666 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -48.86 -11.01 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.973 -1.079 . . . . 62.439999999999998 110.459 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 169' ' ' LEU . . . -95.43 -41.39 9.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.189 -0.945 . . . . 60.210000000000001 111.185 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.439 ' O ' ' OE1' ' A' ' 175' ' ' GLU . 1.7 mp -84.61 -47.18 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.917 -1.114 . . . . 75.319999999999993 109.688 -178.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.626 ' O ' ' CD1' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -81.41 0.48 37.33 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.668 -1.27 . . . . 73.140000000000001 109.188 -179.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.472 ' C ' ' O ' ' A' ' 173' ' ' TRP . 76.6 tt0 -36.87 -34.9 0.08 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.237 -0.914 . . . . 73.239999999999995 110.563 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.554 ' H ' ' CD ' ' A' ' 175' ' ' GLU . 0.8 OUTLIER -89.79 151.17 45.21 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 107.629 -1.249 . . . . 44.43 107.629 178.458 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.423 ' C ' ' O ' ' A' ' 175' ' ' GLU . 23.5 Cg_exo -28.48 88.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 122.943 2.429 . . . . 72.510000000000005 113.178 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.48 ' O ' ' CD1' ' A' ' 173' ' ' TRP . 48.7 tp10 -158.26 75.92 0.75 Allowed 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 122.04 0.924 . . . . 63.240000000000002 108.735 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 77.7 mtp -53.84 115.53 2.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.238 -0.914 . . . . 73.5 110.254 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 1.7 m -102.75 140.36 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.388 -0.967 . . . . 65.219999999999999 108.388 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 25.9 p -53.72 150.52 13.42 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.152 -0.967 . . . . 71.420000000000002 109.673 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -40.38 -29.72 0.41 Allowed 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.17 1.913 . . . . 41.219999999999999 111.958 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 14.9 p30 -141.31 134.24 29.01 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.343 -0.848 . . . . 64.540000000000006 109.345 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.0 p -166.47 -27.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.852 . . . . 74.019999999999996 109.861 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 10.9 tp -50.97 -22.38 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.068 -1.02 . . . . 72.329999999999998 109.914 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.437 ' CG ' ' N ' ' A' ' 186' ' ' VAL . 18.9 pt-20 -70.05 -48.93 55.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.055 -1.028 . . . . 74.400000000000006 109.572 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.437 ' N ' ' CG ' ' A' ' 185' ' ' GLU . 14.1 m -72.04 -28.87 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.808 -1.183 . . . . 70.420000000000002 108.969 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -77.87 -55.42 5.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 52.109999999999999 110.069 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.411 HD12 HD11 ' A' ' 191' ' ' ILE . 11.2 tp -52.6 -33.37 18.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 120.675 -1.266 . . . . 71.400000000000006 109.324 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -72.76 -41.27 65.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.173 -0.954 . . . . 73.439999999999998 111.214 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.452 ' CG ' ' N ' ' A' ' 191' ' ' ILE . 1.0 OUTLIER -77.33 -46.37 23.12 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.586 -1.321 . . . . 71.420000000000002 111.029 -178.431 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.452 ' N ' ' CG ' ' A' ' 190' ' ' GLN . 6.5 pt -62.22 -41.01 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.717 -1.239 . . . . 61.549999999999997 109.971 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -69.21 -34.27 74.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.849 -1.157 . . . . 63.340000000000003 108.597 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -64.86 -39.58 93.78 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.694 -0.629 . . . . 61.240000000000002 110.082 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.422 ' O ' ' CD ' ' A' ' 198' ' ' PRO . 11.4 pttp -92.09 -2.55 56.57 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.047 -1.033 . . . . 75.129999999999995 110.549 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 48.2 ttp -93.75 -45.42 7.69 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.94 -1.1 . . . . 74.019999999999996 109.974 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -60.29 -33.02 71.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.07 -1.019 . . . . 74.019999999999996 110.385 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -64.4 -61.11 7.11 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.978 -1.076 . . . . 75.430000000000007 110.335 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.422 ' CD ' ' O ' ' A' ' 194' ' ' LYS . 31.5 Cg_endo -61.11 -55.52 1.25 Allowed 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 121.824 1.682 . . . . 72.319999999999993 111.844 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.495 ' C ' ' H ' ' A' ' 201' ' ' ILE . 10.0 mp -63.09 -36.9 85.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -0.942 . . . . 74.540000000000006 109.282 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 73.51 -23.73 0.98 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.598 -1.401 . . . . 61.509999999999998 109.598 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.495 ' H ' ' C ' ' A' ' 199' ' ' LEU . 13.6 mt -110.66 137.12 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.483 -1.01 . . . . 61.219999999999999 109.351 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 8.6 t -84.87 143.6 28.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.164 -0.96 . . . . 72.0 109.354 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.5 p -141.19 27.94 1.91 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.278 -0.889 . . . . 74.439999999999998 109.267 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.527 ' CG1' ' CE2' ' A' ' 214' ' ' PHE . 2.7 m -143.66 128.64 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.239 -0.913 . . . . 64.349999999999994 109.692 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -102.76 121.91 43.41 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.381 -0.825 . . . . 71.409999999999997 108.808 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.425 ' H ' HG22 ' A' ' 206' ' ' THR . 0.0 OUTLIER -84.88 117.32 23.83 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.145 -0.972 . . . . 73.519999999999996 109.873 -179.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.411 ' O ' ' O ' ' A' ' 211' ' ' GLY . 12.8 p -150.25 147.58 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.345 -0.847 . . . . 71.019999999999996 109.062 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -64.34 -130.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.144 -0.973 . . . . 72.120000000000005 109.479 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? 50.17 -106.02 0.21 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.91 . . . . 64.409999999999997 109.337 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -75.9 -59.08 2.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 71.540000000000006 109.486 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 207' ' ' VAL . . . 159.26 -109.57 0.41 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.641 -1.384 . . . . 72.030000000000001 109.641 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 212' ' ' TYR . 41.9 m-85 -109.73 134.91 51.45 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.522 -0.987 . . . . 75.540000000000006 109.369 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 52.4 mtp180 -107.31 132.5 53.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.509 -0.744 . . . . 75.310000000000002 109.476 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.527 ' CE2' ' CG1' ' A' ' 204' ' ' VAL . 43.8 m-85 -97.45 128.69 44.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.258 -0.901 . . . . 75.409999999999997 109.107 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 49.2 m -140.18 156.55 46.47 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.439 -0.788 . . . . 74.140000000000001 109.077 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -69.52 153.98 95.25 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.235 -0.916 . . . . 75.319999999999993 109.183 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -36.85 150.0 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 122.478 2.119 . . . . 73.109999999999999 112.478 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.518 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 12.4 tttt -65.05 -46.27 73.78 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 75.25 109.633 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 90.9 Cg_endo -88.78 125.64 1.68 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 122.567 2.178 . . . . 75.099999999999994 112.213 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -170.91 76.81 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 71.140000000000001 109.537 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . 0.488 ' O ' ' N ' ' A' ' 223' ' ' GLU . 73.8 m -57.65 -38.92 75.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 71.129999999999995 109.344 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 49.45 12.23 0.06 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.899 . . . . 75.349999999999994 109.618 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 221' ' ' CYS . 96.5 mt-10 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.972 -1.014 . . . . 73.409999999999997 109.629 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.487 ' SD ' ' OD2' ' B' ' 46' ' ' ASP . 7.4 mtt . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.364 -0.606 . . . . 71.140000000000001 109.364 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -136.09 125.04 24.19 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.463 -0.773 . . . . 73.230000000000004 109.166 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.1 t -111.83 133.79 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-O 121.359 0.6 . . . . 72.239999999999995 109.564 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.443 HD12 ' N ' ' B' ' 5' ' ' LEU . 4.9 tp -101.73 120.47 40.4 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.488 -0.757 . . . . 54.329999999999998 109.174 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.443 ' N ' HD12 ' B' ' 4' ' ' LEU . 17.3 mt -119.46 98.58 6.21 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.464 -0.772 . . . . 74.349999999999994 109.108 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.453 HD12 ' HB ' ' B' ' 50' ' ' VAL . 16.9 mt -83.48 98.8 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.872 -1.142 . . . . 42.549999999999997 108.469 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' B' ' 9' ' ' ASN . 33.8 tp10 -142.8 128.84 19.65 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.382 -0.824 . . . . 74.519999999999996 109.416 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -66.77 -31.36 71.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.259 -0.9 . . . . 62.549999999999997 109.478 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . 0.404 ' H ' ' HG3' ' B' ' 7' ' ' GLU . 94.7 m-20 -79.22 112.02 16.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.902 . . . . 73.109999999999999 109.533 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 82.2 p -71.78 -25.28 61.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 65.540000000000006 109.698 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 82.3 t -62.57 -49.85 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -0.958 . . . . 75.549999999999997 109.623 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.574 ' N ' HD22 ' B' ' 12' ' ' LEU . 3.8 mm? -67.04 -28.95 68.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 70.140000000000001 109.206 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.8 -23.18 64.82 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.745 -1.742 . . . . 75.400000000000006 108.745 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.47 -49.74 7.91 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.705 -1.358 . . . . 65.439999999999998 109.705 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -63.09 -42.56 99.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.1 -1.235 . . . . 60.210000000000001 109.048 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 6.0 mm -60.87 -35.59 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.259 -1.015 . . . . 75.150000000000006 108.259 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -63.1 -44.04 96.8 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.498 -0.751 . . . . 73.010000000000005 109.361 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -86.05 1.61 49.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.15 -0.969 . . . . 74.299999999999997 109.301 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.12 -53.32 2.69 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 109.446 -1.462 . . . . 70.540000000000006 109.446 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -77.41 -22.26 51.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -1.152 . . . . 71.340000000000003 109.793 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -52.5 -34.88 51.47 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.072 -1.017 . . . . 64.409999999999997 109.077 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 54.3 t -55.47 -45.93 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.351 -0.843 . . . . 74.230000000000004 108.867 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 49.3 mmtt -60.14 -53.33 59.03 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.491 -0.756 . . . . 63.420000000000002 109.035 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 133.56 35.72 0.28 Allowed Glycine 0 N--CA 1.5 2.965 0 N-CA-C 110.099 -1.201 . . . . 53.43 110.099 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -119.5 159.54 24.1 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.392 -1.064 . . . . 71.120000000000005 109.308 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 13.0 mmt -103.39 141.43 35.96 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.502 -0.925 . . . . 75.239999999999995 108.502 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.429 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -133.41 157.6 45.16 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.393 -0.817 . . . . 72.120000000000005 110.265 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . 0.476 ' OD2' ' NH1' ' B' ' 43' ' ' ARG . 82.0 m-20 -142.84 160.37 40.45 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.677 -0.86 . . . . 72.310000000000002 108.677 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 5.0 p -121.43 139.76 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 O-C-N 121.364 -0.835 . . . . 64.430000000000007 109.718 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 10.2 p -133.52 165.21 25.41 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.59 -0.694 . . . . 65.409999999999997 109.213 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -91.72 -104.99 0.11 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.277 -0.889 . . . . 71.019999999999996 109.677 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 60.0 p -78.52 168.98 18.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 51.109999999999999 109.902 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' B' ' 37' ' ' GLU . 19.0 mt -53.65 -33.55 55.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.502 -0.749 . . . . 71.239999999999995 109.866 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -51.02 -48.95 61.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.099 -1.0 . . . . 74.319999999999993 109.499 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -64.37 -39.73 94.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 73.030000000000001 108.957 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.28 -36.21 63.55 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.295 -1.522 . . . . 30.210000000000001 109.295 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' B' ' 33' ' ' LEU . 83.8 tt0 -66.16 -41.54 90.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -1.122 . . . . 74.420000000000002 109.472 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -79.44 -37.77 36.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.136 -0.977 . . . . 74.420000000000002 109.408 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 41.2 tp -68.48 -41.86 79.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 75.409999999999997 109.63 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.0 ppp? -73.53 -21.74 60.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.143 -0.973 . . . . 60.409999999999997 109.535 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -53.44 -38.34 63.46 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.012 -1.055 . . . . 53.229999999999997 108.936 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 8.6 pt -95.98 -33.19 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.351 -0.843 . . . . 71.230000000000004 109.651 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.476 ' NH1' ' OD2' ' B' ' 28' ' ' ASP . 93.1 mtt180 -96.32 138.57 33.72 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.081 -1.012 . . . . 72.219999999999999 109.593 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . 0.435 ' O ' ' O ' ' B' ' 45' ' ' TYR . 84.7 m-20 -81.08 -30.63 34.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.168 -0.957 . . . . 63.539999999999999 109.966 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.435 ' O ' ' O ' ' B' ' 44' ' ' ASN . 38.4 m-85 52.24 100.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.302 -0.874 . . . . 64.349999999999994 109.436 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . 0.487 ' OD2' ' SD ' ' B' ' 1' ' ' MET . 73.1 m-20 -70.11 -36.99 75.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.106 -0.996 . . . . 62.219999999999999 109.016 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.522 HD13 ' C ' ' B' ' 47' ' ' LEU . 1.0 OUTLIER -107.01 111.58 24.14 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.673 -0.862 . . . . 73.120000000000005 108.673 179.567 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.475 ' N ' HD13 ' B' ' 47' ' ' LEU . 53.1 t -94.89 99.8 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.299 -0.876 . . . . 65.109999999999999 109.378 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.497 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 1.8 tpp -113.55 130.02 56.44 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.774 -0.825 . . . . 73.439999999999998 108.774 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.463 ' N ' ' SD ' ' B' ' 49' ' ' MET . 0.2 OUTLIER -146.66 135.49 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 34.5 109.312 -179.505 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 73.1 p -103.51 8.68 37.79 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.504 -0.748 . . . . 73.209999999999994 110.25 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -76.82 142.25 40.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.081 -1.012 . . . . 70.409999999999997 109.547 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -74.3 -38.36 63.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 65.0 110.293 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -72.57 8.19 1.54 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.034 -1.041 . . . . 75.209999999999994 109.716 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -74.55 -21.24 59.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.251 -0.906 . . . . 55.329999999999998 110.222 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 71.1 mt -43.68 -41.11 4.57 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.318 -0.864 . . . . 63.140000000000001 110.224 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 27.4 t -72.92 -38.59 66.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.999 -1.063 . . . . 63.5 109.567 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . 0.605 ' CE2' HD11 ' B' ' 62' ' ' ILE . 50.4 t80 -64.27 -49.58 71.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.343 -0.848 . . . . 72.329999999999998 110.135 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.15 -35.36 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 120.765 -1.209 . . . . 74.540000000000006 109.69 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 59.8 p -58.22 -45.82 86.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.237 -0.914 . . . . 71.239999999999995 109.681 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' B' ' 65' ' ' LYS . 8.8 ptp180 -75.36 -30.78 60.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.058 -1.026 . . . . 74.310000000000002 110.076 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.605 HD11 ' CE2' ' B' ' 58' ' ' PHE . 5.0 mm -60.55 -51.91 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.745 -1.222 . . . . 72.140000000000001 109.24 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 8.0 mtpt -63.1 -40.78 98.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.135 -0.978 . . . . 73.319999999999993 109.183 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -68.93 -38.88 79.79 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.512 -0.921 . . . . 73.120000000000005 108.512 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' B' ' 61' ' ' ARG . 14.4 mtpp -86.24 -74.23 0.43 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.285 -0.884 . . . . 72.439999999999998 109.481 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.453 ' N ' ' O ' ' B' ' 62' ' ' ILE . 53.6 m-70 -98.08 87.43 3.95 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.226 -0.921 . . . . 63.310000000000002 109.524 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 23.2 t -78.46 -32.18 48.26 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 73.099999999999994 109.923 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 94.7 p -59.7 -23.51 63.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.233 -0.917 . . . . 71.530000000000001 109.643 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.407 HG21 HD13 ' B' ' 69' ' ' ILE . 57.3 mt -84.09 149.48 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.246 -0.909 . . . . 74.400000000000006 109.293 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.562 HG12 ' N ' ' B' ' 71' ' ' VAL . 75.8 t -91.08 164.49 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.247 -0.908 . . . . 75.120000000000005 109.637 -179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.562 ' N ' HG12 ' B' ' 70' ' ' VAL . 4.3 t -139.68 128.15 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.318 -0.864 . . . . 73.200000000000003 109.348 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.497 ' O ' ' SD ' ' B' ' 49' ' ' MET . 0.6 OUTLIER -123.69 106.52 10.6 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.608 -0.886 . . . . 73.340000000000003 108.608 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 71.0 t -91.4 129.58 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.117 -0.989 . . . . 73.5 109.008 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 6.8 p -90.36 171.25 9.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.917 -1.114 . . . . 64.340000000000003 108.987 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.424 ' C ' ' H ' ' B' ' 97' ' ' LYS . 13.6 p -155.76 112.34 3.16 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.927 -1.108 . . . . 74.530000000000001 110.261 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -67.2 -27.47 67.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.329 -0.857 . . . . 64.5 109.005 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' B' ' 79' ' ' THR . 13.5 t-20 -127.06 75.65 76.52 Favored Pre-proline 0 N--CA 1.497 1.921 0 N-CA-C 108.677 -0.86 . . . . 74.25 108.677 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -44.79 88.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.572 2.181 . . . . 74.430000000000007 111.777 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.471 ' N ' ' O ' ' B' ' 77' ' ' ASN . 17.1 m -104.04 148.65 25.98 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.59 0.71 . . . . 73.120000000000005 109.717 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -33.69 76.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.196 -0.94 . . . . 71.010000000000005 109.006 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . 0.434 ' H ' HG22 ' B' ' 79' ' ' THR . 84.2 tt0 -57.07 -39.42 74.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 63.200000000000003 109.036 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -71.91 -31.73 66.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.223 -0.923 . . . . 73.219999999999999 109.201 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.535 ' OE1' ' CD1' ' B' ' 94' ' ' TYR . 5.9 mm-40 -64.57 -56.55 13.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.22 -0.925 . . . . 74.299999999999997 110.027 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.437 HG23 ' N ' ' B' ' 85' ' ' HIS . 29.9 m -57.59 -41.21 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 73.310000000000002 109.832 -179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' HIS . . . . . 0.437 ' N ' HG23 ' B' ' 84' ' ' VAL . 60.5 t60 -74.05 -25.15 59.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.152 -0.968 . . . . 73.239999999999995 109.59 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.26 -36.3 79.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 55.329999999999998 110.021 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -80.17 -33.73 38.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.119 -0.988 . . . . 74.140000000000001 108.892 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -69.75 -33.52 72.55 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.338 -0.851 . . . . 64.040000000000006 109.428 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 -77.55 -67.53 0.71 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 72.349999999999994 109.499 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 156.86 66.02 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.011 -1.236 . . . . 65.200000000000003 110.011 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -119.68 124.64 46.75 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.444 -1.033 . . . . 52.229999999999997 109.054 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -69.98 -36.85 75.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.12 -0.987 . . . . 73.319999999999993 109.438 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . 0.471 ' OD2' ' CD ' ' B' ' 112' ' ' ARG . 11.6 m-20 -151.24 166.41 30.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.304 -0.873 . . . . 72.219999999999999 109.371 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.551 ' O ' ' CD1' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -140.21 114.15 8.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.607 -0.683 . . . . 64.420000000000002 109.191 -178.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 27.7 mm -114.34 146.26 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 O-C-N 121.224 -0.923 . . . . 72.230000000000004 109.685 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.78 139.54 58.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.936 -1.103 . . . . 25.239999999999998 108.139 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.685 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -58.49 -56.44 35.47 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.909 -1.12 . . . . 64.319999999999993 111.381 -179.034 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 5.0 Cg_endo -41.5 -8.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.022 1.148 . . . . 63.329999999999998 113.192 -176.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . 0.685 ' N ' ' O ' ' B' ' 97' ' ' LYS . 13.8 m-85 66.47 117.78 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.557 -0.714 . . . . 75.129999999999995 109.674 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . 0.476 ' CZ ' ' OE2' ' A' ' 83' ' ' GLU . 16.0 ttm180 -67.05 -29.55 69.37 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.968 -1.083 . . . . 74.230000000000004 108.754 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . 0.752 ' O ' ' N ' ' B' ' 103' ' ' LYS . 40.6 t -174.78 28.04 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.192 -0.942 . . . . 63.340000000000003 110.671 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 8.6 mm 51.66 -69.4 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.645 -0.659 . . . . 74.439999999999998 110.064 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.752 ' N ' ' O ' ' B' ' 101' ' ' SER . 86.3 mttt -56.64 -32.91 65.82 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.82 -1.178 . . . . 71.109999999999999 107.82 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.86 98.73 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.033 -1.099 . . . . 71.450000000000003 108.033 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 55.4 tp -64.63 -40.68 95.9 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.635 -0.876 . . . . 51.310000000000002 108.635 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 73.5 t -67.0 -41.02 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.348 -0.845 . . . . 65.230000000000004 109.527 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.02 -48.26 70.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.149 -0.97 . . . . 24.32 109.39 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -64.75 -32.24 73.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -0.878 . . . . 75.310000000000002 109.732 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 93.9 mt -74.44 -34.3 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.179 -0.951 . . . . 54.240000000000002 108.903 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . 0.465 ' O ' ' CG ' ' B' ' 114' ' ' ARG . 88.2 tt0 -66.09 -31.02 71.63 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.492 -0.755 . . . . 65.310000000000002 109.469 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . 0.479 ' HB1' ' CZ ' ' A' ' 87' ' ' PHE . . . -72.56 -56.6 5.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.201 -0.937 . . . . 72.239999999999995 109.944 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . 0.471 ' CD ' ' OD2' ' B' ' 93' ' ' ASP . 64.3 mtm-85 -69.43 -40.61 77.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.179 -0.951 . . . . 72.040000000000006 110.358 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 41.6 tp -63.52 -34.49 77.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.121 -0.987 . . . . 75.349999999999994 109.972 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.465 ' CG ' ' O ' ' B' ' 110' ' ' GLU . 11.0 mmm180 -74.26 167.37 21.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.152 -0.968 . . . . 75.5 109.353 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 52.26 51.15 16.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.885 . . . . 65.329999999999998 109.23 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -95.7 -66.24 0.92 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.308 -0.87 . . . . 74.450000000000003 109.898 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.05 144.04 48.61 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.19 -1.164 . . . . 44.210000000000001 110.19 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . 0.927 ' N ' ' OE2' ' B' ' 132' ' ' GLU . 33.1 t -160.44 175.26 12.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.471 -1.017 . . . . 71.400000000000006 109.355 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.88 125.8 5.9 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.652 -0.819 . . . . 72.319999999999993 109.221 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 20.5 t -99.32 -37.25 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.386 -0.822 . . . . 75.019999999999996 109.929 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 19.3 mm -101.89 128.37 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.197 -0.939 . . . . 51.409999999999997 109.584 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.407 ' O ' ' CG ' ' B' ' 122' ' ' GLU . 17.9 pt-20 -151.06 121.99 7.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.319 -0.863 . . . . 71.530000000000001 109.473 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.797 ' H ' HD13 ' B' ' 123' ' ' ILE . 0.1 OUTLIER -146.46 133.93 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.155 -0.965 . . . . 72.430000000000007 109.335 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 63.33 -115.69 8.34 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.241 -1.543 . . . . 51.229999999999997 109.241 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . 0.884 ' OD2' ' HD3' ' B' ' 138' ' ' LYS . 13.3 t70 -120.59 6.31 10.55 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.596 -0.944 . . . . 74.200000000000003 109.245 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.78 128.56 42.76 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.334 -0.854 . . . . 75.420000000000002 108.769 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 61.4 m -120.4 132.11 55.1 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.5 -0.926 . . . . 74.219999999999999 108.5 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 8.0 mt -133.02 132.38 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.378 -0.826 . . . . 60.329999999999998 110.041 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 8.6 m -109.75 110.67 59.28 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.303 -0.999 . . . . 72.310000000000002 108.303 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.94 -36.98 1.26 Allowed 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.742 1.628 . . . . 75.129999999999995 113.071 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . 0.415 ' O ' ' OE1' ' B' ' 133' ' ' GLU . 6.8 t70 -70.33 -37.34 74.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.089 -1.007 . . . . 75.230000000000004 109.905 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . 0.927 ' OE2' ' N ' ' B' ' 118' ' ' SER . 81.4 mt-10 -83.21 -0.09 47.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.157 -0.964 . . . . 72.430000000000007 109.446 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.415 ' OE1' ' O ' ' B' ' 131' ' ' ASP . 35.8 mp0 47.01 59.07 4.24 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 75.129999999999995 109.254 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 15.4 ttpp -156.72 130.35 8.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -0.862 . . . . 73.219999999999999 109.247 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 2.9 tt -104.23 129.47 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.433 -0.792 . . . . 64.140000000000001 109.597 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.417 HG21 HD13 ' B' ' 136' ' ' ILE . 15.3 mt -110.11 122.5 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.566 -0.902 . . . . 71.219999999999999 108.566 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . 0.963 ' CE1' ' CB ' ' B' ' 140' ' ' ARG . 19.0 p90 -124.97 118.18 25.69 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.249 -0.907 . . . . 64.219999999999999 110.13 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . 0.884 ' HD3' ' OD2' ' B' ' 125' ' ' ASP . 25.8 mmtm 55.99 28.2 12.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.591 -0.693 . . . . 72.019999999999996 110.237 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 92.4 2.56 67.88 Favored Glycine 0 N--CA 1.496 2.643 0 O-C-N 121.172 -0.955 . . . . 74.319999999999993 110.944 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . 0.963 ' CB ' ' CE1' ' B' ' 137' ' ' TYR . 0.2 OUTLIER -95.66 121.84 37.78 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.759 -1.436 . . . . 75.340000000000003 108.79 179.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -94.94 118.29 31.56 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.267 -0.895 . . . . 71.230000000000004 109.58 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 6.6 t -122.52 132.82 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 108.751 -0.833 . . . . 70.430000000000007 108.751 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -92.86 123.12 35.9 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.273 -0.892 . . . . 72.430000000000007 109.869 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.32 138.93 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.886 -0.783 . . . . 72.129999999999995 108.886 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -161.7 83.24 0.6 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.355 -0.84 . . . . 72.019999999999996 109.84 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . 0.666 ' N ' ' HD2' ' B' ' 149' ' ' PHE . . . -164.47 177.8 39.97 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.071 -1.612 . . . . 42.229999999999997 109.071 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 1.323 ' NZ ' ' O ' ' B' ' 172' ' ' ILE . 0.9 OUTLIER -68.21 -37.01 9.95 Favored Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.203 -1.174 . . . . 73.299999999999997 110.438 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 14.6 Cg_exo -66.23 -19.99 56.12 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 122.206 1.937 . . . . 71.329999999999998 112.048 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . 0.666 ' HD2' ' N ' ' B' ' 146' ' ' GLY . 0.5 OUTLIER -103.77 -29.76 10.82 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.493 -0.755 . . . . 74.230000000000004 109.343 -179.376 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . 0.428 ' O ' ' CD2' ' B' ' 154' ' ' HIS . 35.4 mt-10 -51.67 -31.5 26.01 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.199 -1.037 . . . . 72.340000000000003 108.199 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 13.2 p -67.96 -33.15 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.562 -0.711 . . . . 73.349999999999994 109.11 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 44.7 tp -65.24 -39.99 93.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.875 . . . . 55.240000000000002 109.602 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 6.0 p -76.36 -35.77 58.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.893 -1.129 . . . . 70.010000000000005 109.203 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . 0.428 ' CD2' ' O ' ' B' ' 150' ' ' GLU . 27.9 m170 -56.87 -48.76 77.39 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.117 -0.99 . . . . 65.319999999999993 110.174 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 pp -72.87 -27.64 62.03 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.7 -1.25 . . . . 71.540000000000006 108.884 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.56 -34.54 67.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 75.319999999999993 109.563 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 17.3 mtt180 -92.52 -52.2 4.76 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.897 -1.127 . . . . 73.319999999999993 109.9 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -53.42 -52.09 60.49 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 74.140000000000001 108.786 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . 0.464 ' O ' ' N ' ' B' ' 161' ' ' GLN . 89.2 mtm180 47.15 -114.81 0.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 61.409999999999997 109.259 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . 0.772 ' OD2' ' CE1' ' B' ' 216' ' ' TYR . 9.8 m-20 -55.36 91.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.109 -0.995 . . . . 72.099999999999994 109.083 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' B' ' 159' ' ' ARG . 50.1 tp60 -164.71 145.43 7.73 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.207 -0.933 . . . . 72.25 109.775 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 89.7 mt -109.32 126.29 66.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.505 -0.747 . . . . 72.310000000000002 109.178 178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 19.7 m -137.03 144.42 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.965 -0.754 . . . . 64.209999999999994 108.965 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . 0.469 ' H ' ' CD ' ' B' ' 167' ' ' GLN . 23.1 t -86.94 178.34 6.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.077 -1.015 . . . . 74.219999999999999 110.185 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -61.46 -55.42 31.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.842 . . . . 65.310000000000002 109.408 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' B' ' 166' ' ' GLU . 31.7 mp0 -51.91 -31.91 30.53 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.858 . . . . 63.450000000000003 110.116 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' GLN . . . . . 0.469 ' CD ' ' H ' ' B' ' 164' ' ' SER . 41.4 mt-30 -64.94 -43.32 93.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.074 -1.016 . . . . 72.400000000000006 109.607 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 51.7 mt -58.12 -37.29 74.31 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.191 -1.04 . . . . 72.319999999999993 108.191 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 7.5 tt -58.25 -65.91 0.57 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.501 -0.75 . . . . 73.340000000000003 109.063 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -58.35 -28.09 64.77 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.561 -0.712 . . . . 72.099999999999994 109.902 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -55.88 -65.25 0.63 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.28 -0.888 . . . . 62.130000000000003 110.091 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 1.323 ' O ' ' NZ ' ' B' ' 147' ' ' LYS . 2.1 mp -98.82 -53.45 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.129 -0.982 . . . . 71.420000000000002 109.937 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 26.0 m-90 -77.55 61.37 2.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.031 -1.043 . . . . 72.230000000000004 109.027 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -47.07 -53.75 11.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.529 -0.732 . . . . 52.109999999999999 109.749 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . 0.468 ' N ' ' CD ' ' B' ' 176' ' ' PRO . 2.2 tt0 -178.89 -48.87 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 120.862 -1.149 . . . . 73.040000000000006 109.903 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.468 ' CD ' ' N ' ' B' ' 175' ' ' GLU . 39.3 Cg_exo -57.07 -23.39 52.28 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.123 1.882 . . . . 74.129999999999995 112.24 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . 1.074 ' HG2' ' CD ' ' B' ' 147' ' ' LYS . 31.7 mp0 -75.58 176.99 7.1 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.093 -1.004 . . . . 72.439999999999998 109.544 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . 0.452 ' N ' ' SD ' ' B' ' 178' ' ' MET . 0.9 OUTLIER -90.96 125.96 35.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.408 -0.808 . . . . 63.43 108.863 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 2.3 t -116.58 138.87 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.636 -0.665 . . . . 71.049999999999997 109.694 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . 0.538 ' O ' ' N ' ' B' ' 182' ' ' ASN . 7.2 p -111.83 152.5 44.23 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 108.836 -0.801 . . . . 62.149999999999999 108.836 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -36.75 -23.71 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 122.26 1.974 . . . . 65.219999999999999 112.722 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 182' ' ' ASN . . . . . 0.538 ' N ' ' O ' ' B' ' 180' ' ' THR . 11.2 m-80 -156.57 52.0 0.52 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.033 -1.042 . . . . 72.310000000000002 109.761 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . 0.406 ' HB ' ' H ' ' B' ' 180' ' ' THR . 9.3 p -65.24 -21.37 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.193 -0.942 . . . . 63.32 109.634 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 36.8 mt -67.53 -40.54 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.239 -0.913 . . . . 75.030000000000001 110.621 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . 0.487 ' O ' ' ND2' ' B' ' 189' ' ' ASN . 64.6 mm-40 -61.9 -50.51 71.89 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.098 -1.001 . . . . 64.109999999999999 110.323 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 18.2 m -75.08 -25.51 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.151 -0.968 . . . . 73.0 110.172 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -76.04 -46.62 28.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.119 -0.988 . . . . 61.119999999999997 110.18 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 11.2 tp -69.88 -29.34 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.865 -1.147 . . . . 72.430000000000007 109.286 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 189' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' B' ' 185' ' ' GLU . 92.5 m-20 -72.79 -48.51 37.49 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.43 -0.794 . . . . 65.140000000000001 109.9 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . 0.46 ' CG ' ' N ' ' B' ' 191' ' ' ILE . 1.9 pt20 -72.96 -45.17 59.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.095 -1.003 . . . . 63.240000000000002 110.193 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . 0.46 ' N ' ' CG ' ' B' ' 190' ' ' GLN . 77.1 mt -54.28 -55.4 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.04 -1.038 . . . . 74.030000000000001 109.376 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -54.39 -48.22 71.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.122 -0.986 . . . . 72.239999999999995 110.026 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 193' ' ' GLN . . . . . 0.411 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 81.7 mt-30 -62.07 -31.62 72.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.047 -1.033 . . . . 73.099999999999994 109.575 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -91.05 -2.97 57.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.25 -0.906 . . . . 72.109999999999999 110.339 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 24.1 ttp -99.94 -5.08 28.84 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.13 -0.981 . . . . 44.329999999999998 109.876 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 196' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' B' ' 193' ' ' GLN . 5.9 p-10 -105.92 -15.24 14.97 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.364 -0.835 . . . . 71.209999999999994 109.329 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . 0.585 ' N ' ' CD ' ' B' ' 198' ' ' PRO . 10.3 tttm -80.13 -41.7 1.37 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.243 -0.911 . . . . 75.209999999999994 110.059 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 198' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' B' ' 197' ' ' LYS . 73.6 Cg_endo -87.39 -44.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.486 2.124 . . . . 75.319999999999993 111.988 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 17.9 mt -78.38 -35.03 47.81 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.047 -1.033 . . . . 72.25 109.302 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 83.13 -37.98 2.72 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.731 -1.348 . . . . 64.530000000000001 109.731 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 22.4 mm -102.07 139.19 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.263 -1.14 . . . . 44.229999999999997 109.639 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 19.9 m -86.49 137.93 32.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.283 -0.886 . . . . 54.009999999999998 108.949 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 6.7 p -134.98 29.22 3.45 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.39 -0.819 . . . . 74.400000000000006 109.307 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 16.7 m -132.28 145.95 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.549 -0.719 . . . . 72.120000000000005 109.187 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -126.25 138.11 53.58 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.487 -0.758 . . . . 65.409999999999997 109.721 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 206' ' ' THR . . . . . 0.539 HG23 HH12 ' B' ' 208' ' ' ARG . 0.1 OUTLIER -96.94 132.82 42.34 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.326 -0.859 . . . . 71.329999999999998 109.47 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 8.3 t -130.38 117.1 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.707 -0.849 . . . . 63.5 108.707 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 208' ' ' ARG . . . . . 0.723 ' NE ' ' H ' ' B' ' 208' ' ' ARG . 0.1 OUTLIER -68.92 -36.3 77.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.222 -0.924 . . . . 74.450000000000003 109.747 -179.486 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 62.1 mtm180 -50.77 -65.09 0.62 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.122 -0.986 . . . . 74.140000000000001 110.118 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -100.58 -77.85 0.53 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.249 -0.907 . . . . 74.430000000000007 109.932 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -164.89 -105.27 0.19 Allowed Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.619 -1.277 . . . . 64.450000000000003 110.162 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' B' ' 212' ' ' TYR . 42.2 m-85 -133.93 148.75 51.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.505 -0.997 . . . . 74.209999999999994 109.978 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -141.12 153.7 45.54 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.252 -1.018 . . . . 74.030000000000001 108.252 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . 0.427 ' C ' ' SG ' ' B' ' 215' ' ' CYS . 0.7 OUTLIER -117.77 148.65 41.86 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.393 -0.817 . . . . 74.340000000000003 110.557 -178.249 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . 0.427 ' SG ' ' C ' ' B' ' 214' ' ' PHE . 8.8 m -151.37 164.18 37.28 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.676 -0.861 . . . . 64.329999999999998 108.676 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . 0.844 ' OH ' ' OE1' ' A' ' 161' ' ' GLN . 0.2 OUTLIER -72.86 154.08 91.08 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 120.96 -1.088 . . . . 70.040000000000006 108.865 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.51 175.92 1.92 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.246 1.964 . . . . 65.109999999999999 111.626 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' B' ' 219' ' ' PRO . 13.8 mtmm -52.65 157.13 2.75 Favored Pre-proline 0 C--N 1.301 -1.534 0 N-CA-C 108.689 -0.856 . . . . 73.150000000000006 108.689 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . 0.415 ' C ' ' O ' ' B' ' 218' ' ' LYS . 21.4 Cg_exo -30.39 100.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 122.861 2.374 . . . . 71.310000000000002 112.807 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -116.19 135.12 54.19 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.655 -0.653 . . . . 75.450000000000003 109.314 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' B' ' 222' ' ' GLU . 14.2 t -165.55 -177.85 4.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.152 -0.968 . . . . 72.219999999999999 109.378 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.423 ' N ' ' SG ' ' B' ' 221' ' ' CYS . 51.3 mt-10 -57.47 169.55 0.64 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.152 -0.967 . . . . 54.530000000000001 109.324 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 117.966 -1.016 . . . . 71.129999999999995 109.169 179.581 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.57 ' SD ' ' CE2' ' A' ' 25' ' ' PHE . 43.4 ttp . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.457 -0.571 . . . . 65.120000000000005 109.457 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -140.53 152.25 45.41 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.397 -0.814 . . . . 72.329999999999998 109.224 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.682 HG13 ' HB3' ' A' ' 47' ' ' LEU . 39.4 t -119.6 129.47 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 121.529 0.681 . . . . 71.420000000000002 109.574 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.572 HD11 ' CG1' ' A' ' 6' ' ' ILE . 1.4 tp -96.14 122.65 39.21 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.53 -0.731 . . . . 65.120000000000005 109.521 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.448 ' N ' HD12 ' A' ' 4' ' ' LEU . 4.2 mp -117.2 129.84 56.2 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.129 -1.063 . . . . 62.43 108.129 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.572 ' CG1' HD11 ' A' ' 4' ' ' LEU . 38.4 mt -126.03 97.18 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.062 -1.088 . . . . 71.150000000000006 108.062 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -144.11 130.97 20.32 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.243 -0.91 . . . . 75.340000000000003 109.753 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -63.12 -35.2 79.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 72.439999999999998 109.33 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -76.54 96.58 4.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 63.020000000000003 109.29 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.8 m -61.47 -29.6 70.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.88 . . . . 72.340000000000003 109.909 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.516 HG13 ' N ' ' A' ' 12' ' ' LEU . 9.5 p -67.58 -44.59 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.085 -1.009 . . . . 74.019999999999996 109.981 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.516 ' N ' HG13 ' A' ' 11' ' ' VAL . 80.9 mt -69.82 -47.72 61.71 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.046 -1.034 . . . . 71.430000000000007 109.242 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.6 -20.88 70.4 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 107.922 -2.071 . . . . 61.32 107.922 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.38 -58.06 6.9 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.667 -1.373 . . . . 71.200000000000003 109.667 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.402 ' H ' ' HG2' ' A' ' 15' ' ' GLU . 12.2 pt-20 -52.82 -44.31 66.6 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.342 -1.093 . . . . 71.319999999999993 109.588 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 12.1 mt -66.85 -38.31 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.736 -1.227 . . . . 63.229999999999997 108.329 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.507 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 88.0 tt0 -60.23 -45.94 91.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 51.109999999999999 109.213 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -86.05 -1.23 57.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.215 -0.928 . . . . 73.340000000000003 109.715 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.62 -54.98 3.11 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 109.813 -1.315 . . . . 62.149999999999999 109.813 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -75.12 -21.32 58.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.231 -1.158 . . . . 73.510000000000005 110.0 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 96.4 m-20 -57.61 -31.65 66.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.121 -0.987 . . . . 74.25 109.636 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 85.1 t -61.13 -25.79 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.318 -0.864 . . . . 70.040000000000006 109.467 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' NZ ' ' OE1' ' A' ' 110' ' ' GLU . 17.0 mmtp -83.04 6.17 19.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.87 . . . . 73.230000000000004 109.337 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.51 37.18 21.26 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.153 -1.179 . . . . 75.540000000000006 110.153 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.57 ' CE2' ' SD ' ' A' ' 1' ' ' MET . 11.5 m-85 -116.09 159.05 22.26 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.467 -1.02 . . . . 73.430000000000007 109.017 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.4 mmt -112.75 135.21 53.75 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.833 -0.803 . . . . 43.240000000000002 108.833 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.51 161.81 38.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.194 -0.941 . . . . 62.109999999999999 109.718 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -142.76 141.16 31.67 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.357 -0.84 . . . . 74.420000000000002 109.26 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 t -104.02 130.31 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.304 -0.872 . . . . 72.150000000000006 108.877 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.2 p -118.9 170.35 9.09 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.536 -0.728 . . . . 71.420000000000002 109.361 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -88.29 -100.76 0.08 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.183 -0.948 . . . . 72.329999999999998 109.858 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.0 p -78.23 166.61 22.52 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 74.239999999999995 110.167 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' A' ' 37' ' ' GLU . 13.9 mt -55.61 -39.08 70.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.645 -0.659 . . . . 71.530000000000001 110.041 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -50.39 -43.81 54.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.092 -1.005 . . . . 74.230000000000004 109.652 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -65.66 -36.74 84.53 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.201 -0.937 . . . . 54.030000000000001 109.158 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -79.94 -34.9 29.24 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.558 -1.417 . . . . 61.409999999999997 109.558 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 33' ' ' LEU . 81.4 tt0 -63.37 -40.73 98.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -1.141 . . . . 74.340000000000003 109.569 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -77.9 -37.63 47.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.088 -1.008 . . . . 75.329999999999998 109.333 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.6 tp -66.91 -41.82 86.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.268 -0.895 . . . . 74.329999999999998 109.599 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.448 ' SD ' ' C ' ' A' ' 40' ' ' MET . 3.3 ppp? -77.87 -15.77 58.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.144 -0.972 . . . . 70.319999999999993 109.648 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -55.33 -39.8 70.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.052 -1.03 . . . . 71.219999999999999 109.158 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.8 pt -95.26 -32.39 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.274 -0.892 . . . . 74.140000000000001 109.885 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 40' ' ' MET . 96.6 mtt180 -91.77 153.04 19.87 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.078 -1.013 . . . . 72.239999999999995 109.676 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' ' 45' ' ' TYR . 14.5 p30 -91.86 -34.38 14.56 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.162 -0.961 . . . . 75.420000000000002 109.765 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' A' ' 44' ' ' ASN . 38.3 m-85 51.97 99.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.292 -0.88 . . . . 74.230000000000004 109.484 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -68.77 -28.97 67.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.23 -0.918 . . . . 72.040000000000006 109.42 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.682 ' HB3' HG13 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -115.5 110.58 19.48 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.747 -0.834 . . . . 72.129999999999995 108.747 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.465 ' N ' HD13 ' A' ' 47' ' ' LEU . 65.9 t -96.9 110.34 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.324 -0.86 . . . . 72.340000000000003 108.685 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.587 ' SD ' ' N ' ' A' ' 50' ' ' VAL . 1.5 tpt -122.4 130.35 53.01 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.539 -0.725 . . . . 74.109999999999999 109.549 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.587 ' N ' ' SD ' ' A' ' 49' ' ' MET . 1.1 p -138.84 130.43 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.695 0.76 . . . . 61.119999999999997 109.818 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.2 t -98.16 2.41 48.46 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.596 -0.69 . . . . 73.109999999999999 109.534 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -75.93 136.58 40.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.171 -0.956 . . . . 52.549999999999997 109.405 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.489 ' C ' ' H ' ' A' ' 55' ' ' ALA . 62.4 mttp -72.96 -42.24 63.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.306 -0.871 . . . . 44.219999999999999 110.617 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -69.19 11.23 0.23 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.039 -1.038 . . . . 70.439999999999998 109.747 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.489 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.35 -21.64 58.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 64.140000000000001 110.44 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 55' ' ' ALA . 74.5 mt -37.79 -53.21 1.29 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.7 -0.625 . . . . 44.140000000000001 110.818 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.6 t -65.65 -36.66 84.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.972 -1.08 . . . . 55.229999999999997 109.329 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.466 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 45.3 t80 -64.58 -63.03 1.23 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.327 -0.858 . . . . 74.439999999999998 109.83 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.1 m -48.36 -32.85 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.81 -1.181 . . . . 74.030000000000001 109.713 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.2 m -59.4 -52.79 64.12 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.201 -0.937 . . . . 64.299999999999997 109.348 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -68.78 -27.75 66.16 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 118.934 -1.107 . . . . 64.439999999999998 109.881 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.523 ' O ' ' N ' ' A' ' 66' ' ' HIS . 29.6 mm -59.21 -49.83 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 120.829 -1.17 . . . . 63.210000000000001 108.847 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.519 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 45.3 mmtt -59.79 -46.55 88.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.086 -1.009 . . . . 74.420000000000002 108.649 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -64.08 -42.86 96.81 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.942 -0.762 . . . . 70.319999999999993 108.942 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.472 ' C ' ' CG ' ' A' ' 66' ' ' HIS . 51.6 mtpt -76.95 -26.27 53.81 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.526 -0.734 . . . . 75.219999999999999 110.554 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.523 ' N ' ' O ' ' A' ' 62' ' ' ILE . 56.9 m-70 -154.97 65.72 0.65 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.973 -1.079 . . . . 74.129999999999995 109.746 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 63' ' ' LYS . 33.8 t -59.28 -25.83 64.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.352 -0.842 . . . . 73.239999999999995 110.155 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.0 t -69.66 -14.77 62.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.17 -0.956 . . . . 61.009999999999998 110.493 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.473 HD12 ' CB ' ' A' ' 66' ' ' HIS . 79.0 mt -94.06 155.91 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.972 -1.08 . . . . 71.329999999999998 109.907 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 71' ' ' VAL . 90.2 t -85.02 162.76 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.364 -0.835 . . . . 72.129999999999995 109.696 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.535 ' N ' HG12 ' A' ' 70' ' ' VAL . 14.7 t -145.24 117.14 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.09 -1.006 . . . . 54.210000000000001 109.741 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.506 ' O ' ' SD ' ' A' ' 49' ' ' MET . 1.0 OUTLIER -115.46 99.92 7.71 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.219 -1.03 . . . . 50.240000000000002 108.219 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.6 p -96.48 152.6 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.127 -0.983 . . . . 74.409999999999997 108.774 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.5 m -132.42 172.33 12.6 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.215 -0.928 . . . . 72.310000000000002 109.364 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 77' ' ' ASN . 3.4 t -173.84 128.96 0.4 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.322 -0.861 . . . . 64.540000000000006 110.044 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -66.59 43.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.558 -0.714 . . . . 74.129999999999995 109.639 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 75' ' ' SER . 15.9 m120 -160.15 60.89 1.51 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 73.340000000000003 109.828 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -57.18 74.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.979 1.786 . . . . 63.219999999999999 111.469 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 77' ' ' ASN . 16.9 m -107.49 151.6 25.35 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.003 -0.74 . . . . 62.530000000000001 109.003 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -25.33 68.19 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.357 -0.839 . . . . 73.439999999999998 109.497 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -63.83 -52.39 60.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 71.420000000000002 109.489 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.29 -32.43 70.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 73.430000000000007 109.707 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -60.31 -52.62 64.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 74.219999999999999 109.603 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.64 -40.27 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.936 . . . . 73.200000000000003 109.312 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -68.65 -29.19 67.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.331 -0.856 . . . . 53.329999999999998 109.826 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -67.28 -43.19 82.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.193 -0.942 . . . . 64.109999999999999 110.039 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -80.23 -26.39 39.13 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.062 -1.024 . . . . 74.340000000000003 108.946 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -75.98 -51.47 12.32 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.43 -0.794 . . . . 74.420000000000002 109.391 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.48 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 1.6 pp0? -61.57 -43.23 99.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.526 -0.734 . . . . 74.239999999999995 109.736 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.48 ' N ' ' CD ' ' A' ' 89' ' ' GLN . . . 138.45 72.82 0.05 OUTLIER Glycine 0 N--CA 1.498 2.776 0 N-CA-C 109.982 -1.247 . . . . 61.509999999999998 109.982 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.407 ' HB2' HE21 ' A' ' 89' ' ' GLN . . . -133.17 133.21 42.52 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.358 -1.083 . . . . 55.329999999999998 108.878 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 71' ' ' VAL . 2.8 m-20 -71.48 -39.66 70.76 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.039 -1.038 . . . . 73.420000000000002 108.999 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 61.8 m-20 -154.24 147.17 24.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.365 -0.834 . . . . 75.040000000000006 109.358 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -121.54 112.61 18.7 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.553 -0.906 . . . . 71.329999999999998 108.553 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 23.3 mm -106.56 152.4 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 CA-C-O 122.16 0.981 . . . . 71.129999999999995 111.333 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.59 123.33 21.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.849 -1.167 . . . . 64.319999999999993 107.849 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.667 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -45.99 -54.23 17.86 Favored Pre-proline 0 C--N 1.301 -1.531 0 O-C-N 121.038 -1.039 . . . . 62.200000000000003 111.525 -178.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.3 Cg_endo -41.46 -11.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 120.754 0.969 . . . . 73.109999999999999 112.886 -176.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.667 ' N ' ' O ' ' A' ' 97' ' ' LYS . 59.5 m-85 59.52 121.92 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.737 -0.602 . . . . 65.219999999999999 109.607 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -68.8 -32.26 71.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.059 -1.026 . . . . 72.349999999999994 109.52 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.765 ' O ' ' N ' ' A' ' 103' ' ' LYS . 41.3 t -174.21 28.41 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.989 -1.069 . . . . 71.319999999999993 110.885 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.695 HD12 ' N ' ' A' ' 102' ' ' ILE . 2.6 mp 50.4 -69.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-N 118.638 0.654 . . . . 75.430000000000007 110.194 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.765 ' N ' ' O ' ' A' ' 101' ' ' SER . 1.0 OUTLIER -55.33 -31.18 61.49 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.899 -1.148 . . . . 71.409999999999997 107.899 179.257 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.81 80.05 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.574 -0.85 . . . . 63.240000000000002 108.752 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.682 ' C ' HD13 ' A' ' 105' ' ' LEU . 1.7 tm? -69.74 -54.62 12.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.44 -0.787 . . . . 73.219999999999999 108.923 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.546 ' N ' HD13 ' A' ' 105' ' ' LEU . 53.8 t -52.77 -45.75 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.016 -1.052 . . . . 60.109999999999999 109.326 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.47 -42.25 67.03 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.13 -0.982 . . . . 70.420000000000002 108.385 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -62.58 -32.9 73.97 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.481 -0.762 . . . . 74.409999999999997 109.137 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 83.2 mt -74.35 -31.91 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.117 -0.99 . . . . 62.539999999999999 108.604 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.521 ' OE1' ' NZ ' ' A' ' 23' ' ' LYS . 75.0 tt0 -58.44 -52.11 67.02 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.492 -0.755 . . . . 74.340000000000003 109.314 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.29 -32.3 66.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.234 -0.917 . . . . 73.319999999999993 109.658 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.5 ' NH2' HG22 ' A' ' 70' ' ' VAL . 24.0 tpt85 -54.52 -34.21 61.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.206 -0.934 . . . . 52.409999999999997 109.433 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 30.2 tp -151.74 108.87 3.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.181 -0.949 . . . . 65.239999999999995 109.504 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.4 ' HE ' ' HG3' ' A' ' 110' ' ' GLU . 4.4 mmt180 -144.46 -51.76 0.3 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.252 -0.905 . . . . 64.450000000000003 108.67 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -82.53 25.57 0.62 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.185 -0.947 . . . . 74.430000000000007 109.401 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.439 ' CG ' ' N ' ' A' ' 117' ' ' GLY . 60.4 p-90 -51.04 -40.0 57.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 74.420000000000002 109.721 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.439 ' N ' ' CG ' ' A' ' 116' ' ' TRP . . . -57.74 93.42 0.04 OUTLIER Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.767 -1.333 . . . . 75.040000000000006 109.767 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 67.0 m -153.03 164.71 37.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.211 -1.17 . . . . 61.140000000000001 109.707 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 119' ' ' ASN . 0.0 OUTLIER -159.87 128.98 5.12 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.907 -0.775 . . . . 65.239999999999995 108.907 -178.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.7 t -83.86 -45.31 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.158 -0.964 . . . . 73.109999999999999 110.066 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.533 ' CG2' HH21 ' A' ' 159' ' ' ARG . 20.3 mm -102.64 130.94 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.314 -0.867 . . . . 72.239999999999995 109.812 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -121.39 128.58 52.36 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.986 -0.746 . . . . 72.340000000000003 108.986 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 126' ' ' LEU . 23.6 mt -141.03 112.65 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.181 -0.95 . . . . 71.439999999999998 109.45 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.63 -138.63 7.94 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.857 -1.297 . . . . 73.400000000000006 109.857 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -80.09 -11.47 59.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -1.165 . . . . 74.450000000000003 109.487 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 123' ' ' ILE . 0.8 OUTLIER -91.23 135.53 33.73 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.494 -0.928 . . . . 54.210000000000001 108.494 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.8 m -130.2 129.77 43.82 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.447 -0.783 . . . . 54.5 109.593 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 28.8 mm -112.87 139.71 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 108.902 -0.777 . . . . 45.149999999999999 108.902 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 133' ' ' GLU . 5.2 m -128.05 80.03 72.86 Favored Pre-proline 0 N--CA 1.5 2.039 0 O-C-N 121.456 -0.777 . . . . 71.109999999999999 109.697 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.46 -51.89 9.47 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.704 2.27 . . . . 65.409999999999997 112.082 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -53.68 -44.03 69.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 63.32 109.092 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -87.36 -1.98 58.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.346 -0.846 . . . . 72.519999999999996 109.163 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 129' ' ' SER . 34.6 mp0 50.05 72.51 0.32 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.91 . . . . 75.329999999999998 109.129 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -158.14 122.89 4.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.343 -0.848 . . . . 71.230000000000004 109.814 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 84.3 mt -101.56 126.76 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.422 -0.799 . . . . 74.019999999999996 108.922 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.0 mt -117.07 125.36 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.57 -0.706 . . . . 60.229999999999997 109.113 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.492 ' C ' ' H ' ' A' ' 139' ' ' GLY . 47.8 p90 -140.72 151.45 44.51 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.327 -0.858 . . . . 62.32 109.207 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.3 tptp 56.01 5.5 0.17 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.78 0.8 . . . . 75.400000000000006 109.15 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 137' ' ' TYR . . . 95.93 -2.98 64.47 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.846 -1.302 . . . . 72.239999999999995 109.846 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.529 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 1.2 mpt_? -89.71 131.64 35.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.235 -1.156 . . . . 71.219999999999999 109.14 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -93.04 127.98 38.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.241 -0.912 . . . . 71.420000000000002 109.571 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 43.2 t -137.07 136.44 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.424 -0.798 . . . . 53.020000000000003 109.493 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -91.51 143.54 26.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.268 -0.895 . . . . 60.450000000000003 109.042 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 25.9 m -139.75 153.89 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.288 -0.883 . . . . 74.439999999999998 109.699 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -167.21 24.64 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.333 -0.854 . . . . 65.150000000000006 109.163 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.52 -169.79 45.16 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.824 -1.31 . . . . 73.340000000000003 109.824 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.625 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 14.2 tmtt? -82.11 -31.14 0.54 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.343 -1.093 . . . . 72.219999999999999 111.424 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 87.0 Cg_endo -86.64 -3.58 8.32 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 C-N-CA 121.781 1.654 . . . . 65.230000000000004 112.408 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -96.85 -29.87 13.47 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.183 -0.948 . . . . 60.109999999999999 109.18 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -59.2 -40.84 87.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.271 -0.893 . . . . 64.209999999999994 109.259 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.461 HG11 HD13 ' A' ' 191' ' ' ILE . 13.9 p -61.79 -34.09 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.226 -0.921 . . . . 72.019999999999996 108.894 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.2 OUTLIER -59.94 -45.44 92.62 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.514 -0.921 . . . . 73.310000000000002 108.514 179.627 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.0 p -74.39 -24.58 59.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.197 -0.94 . . . . 74.310000000000002 109.294 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -59.36 -51.13 71.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.905 . . . . 74.310000000000002 109.685 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.7 pp -76.36 -27.22 56.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.104 -0.998 . . . . 75.340000000000003 109.618 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -54.12 -46.26 72.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.094 -1.004 . . . . 62.140000000000001 109.375 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.475 ' C ' ' H ' ' A' ' 159' ' ' ARG . 66.4 mtp180 -77.01 -49.49 15.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.928 . . . . 61.030000000000001 109.382 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -72.2 34.2 0.06 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.636 -0.665 . . . . 74.120000000000005 110.042 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.533 HH21 ' CG2' ' A' ' 121' ' ' ILE . 19.1 ttm180 -59.51 150.44 26.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.131 -0.981 . . . . 71.129999999999995 109.133 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 214' ' ' PHE . 62.2 m-20 53.05 46.93 25.72 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 75.450000000000003 109.544 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -149.71 150.95 32.88 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.23 -0.919 . . . . 73.409999999999997 109.312 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 58.3 mt -90.15 132.74 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.223 -0.923 . . . . 74.409999999999997 109.296 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 48.5 t -131.52 134.73 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.486 -0.759 . . . . 72.310000000000002 109.29 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.423 ' OG ' ' OE1' ' A' ' 166' ' ' GLU . 3.0 t -86.25 157.25 19.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.318 -0.863 . . . . 74.120000000000005 109.894 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -59.52 -44.08 93.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.437 -0.789 . . . . 70.430000000000007 109.627 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' A' ' 166' ' ' GLU . 34.0 mp0 -59.56 -38.01 79.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 73.519999999999996 109.526 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -59.28 -40.66 86.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.138 -0.976 . . . . 74.519999999999996 109.096 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 62.5 mt -58.02 -54.09 50.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.186 -0.947 . . . . 72.310000000000002 108.925 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 169' ' ' LEU . 10.3 mp -61.5 -55.95 25.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.308 -0.87 . . . . 53.329999999999998 109.194 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 169' ' ' LEU . 17.3 t70 -35.86 -42.8 0.28 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.04 0.447 . . . . 62.439999999999998 111.256 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.63 -30.26 13.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.078 -1.014 . . . . 60.210000000000001 110.53 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 4.9 mm -84.9 -72.72 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 120.986 -1.071 . . . . 75.319999999999993 109.663 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.503 ' O ' ' CE3' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -53.25 145.3 14.15 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.395 -0.965 . . . . 73.140000000000001 108.395 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -172.25 -103.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.399 -0.813 . . . . 73.239999999999995 109.129 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.438 ' CB ' ' CD ' ' A' ' 176' ' ' PRO . 8.8 mm-40 -53.5 -64.53 1.67 Allowed Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 120.926 -1.109 . . . . 44.43 109.107 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.438 ' CD ' ' CB ' ' A' ' 175' ' ' GLU . 38.5 Cg_endo -64.66 77.73 0.19 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.049 1.833 . . . . 72.510000000000005 111.541 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.4 ' C ' ' N ' ' A' ' 179' ' ' VAL . 96.1 mt-10 -75.6 -128.02 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.176 -0.952 . . . . 63.240000000000002 109.686 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.435 ' C ' ' H ' ' A' ' 180' ' ' THR . 63.2 mtt 50.05 19.49 0.48 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.026 -1.046 . . . . 73.5 109.069 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.453 ' O ' ' O ' ' A' ' 180' ' ' THR . 18.5 m -76.38 21.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.448 -0.783 . . . . 65.219999999999999 109.752 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.511 ' OG1' HG13 ' A' ' 183' ' ' VAL . 4.3 p 58.82 151.32 0.08 OUTLIER Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.574 -0.704 . . . . 71.420000000000002 109.785 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -41.17 -52.13 3.61 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.09 1.86 . . . . 41.219999999999999 112.663 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.481 ' OD1' ' CD1' ' A' ' 184' ' ' ILE . 5.9 t30 -158.14 118.09 3.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.118 -0.989 . . . . 64.540000000000006 110.04 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.511 HG13 ' OG1' ' A' ' 180' ' ' THR . 2.8 m -142.17 9.76 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.277 -0.89 . . . . 74.019999999999996 109.144 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.745 HD12 ' H ' ' A' ' 184' ' ' ILE . 2.1 mp -49.8 -42.22 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.183 -0.948 . . . . 72.329999999999998 109.452 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.629 ' H ' ' CD ' ' A' ' 185' ' ' GLU . 2.1 pm0 -47.05 -34.67 6.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.153 -0.967 . . . . 74.400000000000006 109.263 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 92.3 t -78.35 -51.63 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.263 -0.898 . . . . 70.420000000000002 109.395 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.97 71.27 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 52.109999999999999 110.069 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.529 HG23 ' N ' ' A' ' 189' ' ' ASN . 10.8 tp -58.51 -44.88 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.971 -1.08 . . . . 71.400000000000006 109.73 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.529 ' N ' HG23 ' A' ' 188' ' ' ILE . 45.7 t-20 -56.71 -45.09 82.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.932 -1.105 . . . . 73.439999999999998 109.381 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -68.88 -40.91 78.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.86 . . . . 71.420000000000002 109.64 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.461 HD13 HG11 ' A' ' 151' ' ' VAL . 68.1 mt -64.94 -34.66 71.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.175 -0.953 . . . . 61.549999999999997 109.73 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -64.01 -56.76 12.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.219 -0.925 . . . . 63.340000000000003 109.683 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -65.46 -35.69 81.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.917 . . . . 61.240000000000002 109.949 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -70.93 -17.66 62.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.071 -1.018 . . . . 75.129999999999995 109.667 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . 0.444 ' SD ' ' C ' ' A' ' 195' ' ' MET . 0.2 OUTLIER -89.95 -53.52 4.45 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.253 -0.904 . . . . 74.019999999999996 109.722 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . 0.517 ' O ' ' N ' ' A' ' 200' ' ' GLY . 60.0 m-20 -61.18 -38.39 86.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 74.019999999999996 110.408 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.451 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 19.4 mmtt -51.76 -65.62 0.94 Allowed Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 120.951 -1.093 . . . . 75.430000000000007 109.831 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 37.7 Cg_endo -64.02 -55.57 0.61 Allowed 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.242 1.961 . . . . 72.319999999999993 112.399 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.483 HD12 ' N ' ' A' ' 199' ' ' LEU . 10.2 mp -64.26 -38.67 91.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.091 -1.005 . . . . 74.540000000000006 109.531 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 196' ' ' ASP . . . 83.22 -40.21 2.82 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.605 -1.398 . . . . 61.509999999999998 109.605 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.71 ' N ' HD12 ' A' ' 201' ' ' ILE . 2.2 mp -92.6 139.48 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.248 -1.148 . . . . 61.219999999999999 109.319 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 34.1 t -88.06 140.37 29.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.187 -0.946 . . . . 72.0 109.235 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 11.9 p -144.25 33.41 1.21 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.177 -0.952 . . . . 74.439999999999998 109.516 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.62 143.92 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.238 -0.914 . . . . 64.349999999999994 109.649 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -122.08 137.84 54.67 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.632 -0.668 . . . . 71.409999999999997 109.284 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.1 t -114.51 141.74 47.31 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.471 -0.768 . . . . 73.519999999999996 109.357 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.457 HG22 ' H ' ' A' ' 209' ' ' ARG . 9.0 p -144.42 137.12 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.253 -0.904 . . . . 71.019999999999996 109.473 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -71.4 -34.34 70.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 72.120000000000005 109.808 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.457 ' H ' HG22 ' A' ' 207' ' ' VAL . 22.4 ttm105 -51.45 -36.77 45.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 64.409999999999997 109.699 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -140.98 -155.7 0.61 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.329 -0.857 . . . . 71.540000000000006 109.195 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -79.1 -125.13 0.44 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.739 -1.344 . . . . 72.030000000000001 109.739 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 212' ' ' TYR . 30.1 m-85 -116.78 135.0 54.1 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.577 -0.954 . . . . 75.540000000000006 109.728 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 67.4 ttt-85 -104.92 127.97 52.97 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.581 -0.7 . . . . 75.310000000000002 109.157 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 160' ' ' ASP . 18.8 m-85 -100.95 130.63 46.97 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.258 -0.901 . . . . 75.409999999999997 109.334 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . 0.401 ' SG ' ' OD1' ' A' ' 160' ' ' ASP . 52.0 t -154.39 155.97 35.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.36 -0.837 . . . . 74.140000000000001 109.281 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -68.07 149.93 97.96 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.164 -0.96 . . . . 75.319999999999993 108.957 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.01 -98.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.189 1.926 . . . . 73.109999999999999 111.877 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 220' ' ' ALA . 0.1 OUTLIER -68.09 153.71 94.98 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.172 -0.955 . . . . 75.25 108.846 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -37.85 -22.27 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.257 0 C-N-CA 122.271 1.981 . . . . 75.099999999999994 112.382 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 218' ' ' LYS . . . 50.07 21.49 0.75 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 71.140000000000001 109.498 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . 0.515 ' O ' ' N ' ' A' ' 223' ' ' GLU . 76.7 m -151.97 -11.65 0.19 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.308 -0.87 . . . . 71.129999999999995 109.257 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 47.75 -92.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 75.349999999999994 109.629 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' A' ' 221' ' ' CYS . 78.2 mm-40 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 118.015 -0.993 . . . . 73.409999999999997 109.464 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.553 ' N ' ' CD2' ' B' ' 25' ' ' PHE . 12.7 mtt . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.334 -0.617 . . . . 71.140000000000001 109.334 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -97.8 121.26 39.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.324 -0.86 . . . . 73.230000000000004 109.288 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 79.9 t -115.59 136.24 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.472 0.653 . . . . 72.239999999999995 109.618 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.431 HD12 ' N ' ' B' ' 5' ' ' LEU . 5.5 tp -105.33 120.12 40.78 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.589 -0.695 . . . . 54.329999999999998 109.729 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.431 ' N ' HD12 ' B' ' 4' ' ' LEU . 18.0 mt -118.08 96.83 5.51 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.706 -0.85 . . . . 74.349999999999994 108.706 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.675 HD12 ' HB ' ' B' ' 50' ' ' VAL . 69.5 mt -84.96 97.54 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 120.808 -1.183 . . . . 42.549999999999997 108.377 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.431 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 35.2 tp10 -135.62 133.03 37.82 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.484 -0.76 . . . . 74.519999999999996 109.535 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -66.67 -32.51 73.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.308 -0.87 . . . . 62.549999999999997 109.32 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . 0.41 ' H ' ' HG3' ' B' ' 7' ' ' GLU . 89.7 m-20 -79.93 129.93 34.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 73.109999999999999 109.388 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 25.9 t -83.31 -32.32 26.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 65.540000000000006 109.849 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.54 HG13 ' N ' ' B' ' 12' ' ' LEU . 11.1 p -63.25 -44.3 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.141 -0.974 . . . . 75.549999999999997 109.865 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.54 ' N ' HG13 ' B' ' 11' ' ' VAL . 74.7 mt -66.58 -33.02 74.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.993 -1.067 . . . . 70.140000000000001 109.353 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.73 -23.32 64.72 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.804 -1.718 . . . . 75.400000000000006 108.804 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.7 -49.7 7.71 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.702 -1.359 . . . . 65.439999999999998 109.702 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -62.58 -43.5 98.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.113 -1.227 . . . . 60.210000000000001 109.161 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 97.3 mt -61.27 -35.67 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.075 -1.016 . . . . 75.150000000000006 108.445 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.476 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 78.7 tt0 -60.83 -44.76 96.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.439 -0.788 . . . . 73.010000000000005 109.333 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -85.15 -0.14 53.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.19 -0.944 . . . . 74.299999999999997 109.097 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.6 -55.54 2.42 Favored Glycine 0 N--CA 1.485 1.904 0 N-CA-C 109.652 -1.379 . . . . 70.540000000000006 109.652 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -75.05 -19.99 59.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.152 -1.205 . . . . 71.340000000000003 109.811 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 1.7 m120 -53.05 -32.94 49.63 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.103 -0.998 . . . . 64.409999999999997 109.328 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 79.2 t -58.02 -27.71 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.214 -0.929 . . . . 74.230000000000004 108.836 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 34.0 mmtt -83.9 -4.51 58.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.445 -0.784 . . . . 63.420000000000002 109.152 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.13 33.55 32.34 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.05 -1.22 . . . . 53.43 110.05 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.553 ' CD2' ' N ' ' B' ' 1' ' ' MET . 9.0 m-85 -110.83 159.14 17.94 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.411 -1.052 . . . . 71.120000000000005 108.9 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 6.9 mmt -105.49 141.88 36.2 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.563 -0.903 . . . . 75.239999999999995 108.563 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.424 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -138.0 156.53 47.73 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.193 -0.942 . . . . 72.120000000000005 110.277 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 77.9 m-20 -138.77 159.46 42.07 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.647 -0.871 . . . . 72.310000000000002 108.647 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 p -123.04 139.98 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.327 -0.858 . . . . 64.430000000000007 109.938 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.4 p -138.16 170.78 15.44 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.532 -0.73 . . . . 65.409999999999997 109.284 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -90.62 -106.05 0.09 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.315 -0.865 . . . . 71.019999999999996 110.01 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 59.9 p -80.47 168.13 19.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.151 -0.968 . . . . 51.109999999999999 110.068 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' B' ' 37' ' ' GLU . 15.1 mt -51.85 -31.33 27.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.455 -0.778 . . . . 71.239999999999995 109.852 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -52.82 -51.49 60.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.032 -1.043 . . . . 74.319999999999993 109.647 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -62.72 -40.61 97.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.134 -0.979 . . . . 73.030000000000001 108.957 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.7 -33.27 75.59 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.964 -1.654 . . . . 30.210000000000001 108.964 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' B' ' 33' ' ' LEU . 84.3 tt0 -66.86 -44.07 81.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.363 -1.081 . . . . 74.420000000000002 109.319 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -75.83 -35.63 59.93 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 74.420000000000002 109.447 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 12.1 tp -72.0 -39.51 69.19 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.352 -0.842 . . . . 75.409999999999997 110.119 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . 0.449 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.7 ppp? -77.63 -18.19 57.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.999 -1.063 . . . . 60.409999999999997 109.888 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -69.5 -42.46 74.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.109 -0.995 . . . . 53.229999999999997 109.538 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 2.4 pp -87.48 -16.42 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.314 -0.867 . . . . 71.230000000000004 109.737 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' B' ' 40' ' ' MET . 13.6 tpp85 -130.64 138.56 50.14 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.44 -0.787 . . . . 72.219999999999999 109.42 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -98.59 129.13 45.11 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.316 -0.865 . . . . 63.539999999999999 109.103 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -108.38 136.87 47.3 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.425 -0.797 . . . . 64.349999999999994 109.568 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . 0.449 ' OD2' ' SD ' ' B' ' 1' ' ' MET . 92.5 m-20 -76.75 -41.83 43.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 62.219999999999999 108.709 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.519 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.3 OUTLIER -103.73 115.72 31.0 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.394 -0.965 . . . . 73.120000000000005 108.394 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.519 ' N ' HD13 ' B' ' 47' ' ' LEU . 62.1 t -100.61 97.61 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.564 -0.902 . . . . 65.109999999999999 108.564 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -116.51 130.72 56.91 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.41 -0.806 . . . . 73.439999999999998 110.217 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.681 HG22 ' H ' ' B' ' 52' ' ' ASP . 0.3 OUTLIER -144.33 134.49 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 109.169 -0.678 . . . . 34.5 109.169 -179.605 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . 0.431 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 19.1 p -95.43 16.4 17.02 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.385 -0.822 . . . . 73.209999999999994 109.792 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.681 ' H ' HG22 ' B' ' 50' ' ' VAL . 53.4 m-20 -80.56 144.58 32.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.171 -0.956 . . . . 70.409999999999997 109.578 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.509 ' NZ ' HD21 ' B' ' 54' ' ' ASN . 18.4 pttp -76.45 -36.01 58.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.879 . . . . 65.0 109.986 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . 0.509 HD21 ' NZ ' ' B' ' 53' ' ' LYS . 22.5 m120 -74.43 10.88 1.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 75.209999999999994 109.685 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.17 -25.27 66.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 55.329999999999998 110.08 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 62.1 mt -47.34 -40.35 17.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.078 -1.014 . . . . 63.140000000000001 110.028 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 14.5 t -75.45 -41.71 55.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.944 -1.098 . . . . 63.5 109.829 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . 0.421 ' CE2' HD11 ' B' ' 62' ' ' ILE . 63.0 t80 -64.12 -47.91 78.15 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.329 -0.857 . . . . 72.329999999999998 110.232 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.43 HG23 ' N ' ' B' ' 60' ' ' SER . 19.5 m -63.95 -36.81 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.64 -1.287 . . . . 74.540000000000006 109.694 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.43 ' N ' HG23 ' B' ' 59' ' ' VAL . 80.6 p -56.59 -45.48 81.38 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.247 -0.908 . . . . 71.239999999999995 109.774 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' B' ' 65' ' ' LYS . 10.5 ptp180 -74.82 -31.82 61.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.065 -1.022 . . . . 74.310000000000002 109.971 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' B' ' 66' ' ' HIS . 5.1 mm -59.74 -53.72 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.901 -1.125 . . . . 72.140000000000001 109.493 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.498 ' HZ3' ' HB3' ' B' ' 63' ' ' LYS . 8.8 mmmm -62.28 -41.51 98.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.036 -1.04 . . . . 73.319999999999993 108.95 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -66.83 -39.64 87.72 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.305 -0.998 . . . . 73.120000000000005 108.305 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.427 ' N ' ' O ' ' B' ' 61' ' ' ARG . 92.6 mttt -87.3 -76.95 0.35 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.357 -0.839 . . . . 72.439999999999998 109.249 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.512 ' O ' HG22 ' B' ' 69' ' ' ILE . 97.7 m-70 -91.94 92.33 8.27 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.212 -0.93 . . . . 63.310000000000002 109.039 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.483 ' O ' ' N ' ' B' ' 69' ' ' ILE . 25.6 t -78.56 -41.47 31.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 73.099999999999994 110.058 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 46.2 t -67.76 54.75 0.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.164 -0.96 . . . . 71.530000000000001 109.81 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.512 HG22 ' O ' ' B' ' 66' ' ' HIS . 16.6 tt -151.28 153.22 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.143 -0.973 . . . . 74.400000000000006 109.395 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.415 HG13 HH12 ' B' ' 112' ' ' ARG . 76.1 t -97.48 152.14 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.15 -0.969 . . . . 75.120000000000005 109.284 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 10.0 t -136.59 129.77 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.24 -0.913 . . . . 73.200000000000003 110.108 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.559 ' C ' HD23 ' B' ' 72' ' ' LEU . 4.8 tt -121.17 106.24 11.34 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.911 -0.774 . . . . 73.340000000000003 108.911 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 77.8 t -93.09 128.21 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.154 -0.966 . . . . 73.5 109.433 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.48 157.92 16.29 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.347 -0.983 . . . . 64.340000000000003 108.347 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 40.0 m -156.02 134.38 11.54 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.841 -1.162 . . . . 74.530000000000001 110.789 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -87.18 7.63 27.42 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.499 -0.926 . . . . 64.5 108.499 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -135.91 59.83 31.43 Favored Pre-proline 0 N--CA 1.493 1.692 0 N-CA-C 108.749 -0.834 . . . . 74.25 108.749 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.468 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 19.4 Cg_endo -60.14 79.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.424 2.083 . . . . 74.430000000000007 111.736 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 68.9 p -106.98 151.87 24.73 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.852 -0.795 . . . . 73.120000000000005 108.852 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.56 -22.0 30.34 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.297 -0.877 . . . . 71.010000000000005 109.152 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -68.98 -49.26 59.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 63.200000000000003 109.31 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -74.9 -27.27 60.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 73.219999999999999 109.658 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.75 -56.03 23.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.174 -0.954 . . . . 74.299999999999997 109.657 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.514 HG23 ' N ' ' B' ' 85' ' ' HIS . 35.2 m -64.71 -42.76 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.135 -0.978 . . . . 73.310000000000002 109.279 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' HIS . . . . . 0.665 ' CE1' HE21 ' B' ' 89' ' ' GLN . 66.2 t60 -60.76 -36.12 78.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -0.918 . . . . 73.239999999999995 109.207 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.46 -41.13 98.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.337 -0.852 . . . . 55.329999999999998 109.97 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -77.35 -39.16 48.46 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.028 -1.045 . . . . 74.140000000000001 108.852 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -65.03 -39.19 93.01 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.596 -0.842 . . . . 64.040000000000006 109.254 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . 0.665 HE21 ' CE1' ' B' ' 85' ' ' HIS . 68.9 mm-40 -62.19 -47.1 85.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 72.349999999999994 108.935 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 144.47 -6.3 1.68 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.006 -1.237 . . . . 65.200000000000003 110.006 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.92 133.79 26.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.038 -1.272 . . . . 52.229999999999997 109.285 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.488 ' CG ' HH12 ' B' ' 112' ' ' ARG . 40.9 t0 -83.45 -18.68 37.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.212 -0.93 . . . . 73.319999999999993 109.213 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -152.45 164.05 38.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.421 -0.799 . . . . 72.219999999999999 108.988 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.468 ' OH ' ' CB ' ' B' ' 78' ' ' PRO . 0.1 OUTLIER -150.85 107.3 3.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.189 -0.944 . . . . 64.420000000000002 108.931 -179.361 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.478 HG22 ' N ' ' B' ' 96' ' ' ALA . 30.9 mm -114.82 159.87 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 O-C-N 121.485 -0.76 . . . . 72.230000000000004 109.94 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . 0.478 ' N ' HG22 ' B' ' 95' ' ' ILE . . . -70.96 128.32 35.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.18 -0.95 . . . . 25.239999999999998 108.556 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.687 ' O ' ' N ' ' B' ' 99' ' ' TYR . 1.8 tptt -49.08 -59.33 6.59 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.144 -0.973 . . . . 64.319999999999993 111.443 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 8.0 Cg_endo -44.24 -3.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.569 1.513 . . . . 63.329999999999998 113.015 -175.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . 0.687 ' N ' ' O ' ' B' ' 97' ' ' LYS . 48.5 m-85 62.18 123.38 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.91 -0.494 . . . . 75.129999999999995 109.795 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 17.9 ttm-85 -74.41 -37.66 63.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.942 -1.099 . . . . 74.230000000000004 109.237 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . 0.767 ' O ' ' N ' ' B' ' 103' ' ' LYS . 48.3 t -173.8 35.45 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.951 -1.093 . . . . 63.340000000000003 111.303 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 36.8 mm 49.67 -70.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-N 118.995 0.816 . . . . 74.439999999999998 110.52 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.767 ' N ' ' O ' ' B' ' 101' ' ' SER . 33.1 mmtm -54.08 -32.44 54.8 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.106 -1.072 . . . . 71.109999999999999 108.106 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.01 -45.75 76.59 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.342 -0.985 . . . . 71.450000000000003 108.342 179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 64.2 tp -62.6 -44.18 96.94 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.72 -0.845 . . . . 51.310000000000002 108.72 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 76.5 t -66.79 -38.62 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.355 -0.841 . . . . 65.230000000000004 109.513 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.42 -46.48 69.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.225 -0.922 . . . . 24.32 109.49 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 57.5 ttt85 -69.56 -31.37 69.51 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.188 -0.945 . . . . 75.310000000000002 109.888 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 96.4 mt -74.06 -31.34 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.018 -1.051 . . . . 54.240000000000002 108.833 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -73.91 -58.56 3.22 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.645 -0.822 . . . . 65.310000000000002 109.367 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -50.99 -35.22 32.67 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.384 -0.823 . . . . 72.239999999999995 109.578 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . 0.488 HH12 ' CG ' ' B' ' 92' ' ' ASP . 5.6 tpt180 -65.7 -44.01 87.42 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.158 -0.964 . . . . 72.040000000000006 109.738 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 43.0 mt -134.28 64.01 1.61 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.365 -0.835 . . . . 75.349999999999994 109.963 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -60.55 -43.7 96.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.971 -1.081 . . . . 75.5 108.628 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -142.08 -109.21 0.13 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.389 -0.819 . . . . 65.329999999999998 109.357 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -148.21 162.7 38.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.272 -0.893 . . . . 74.450000000000003 109.184 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.11 153.72 52.18 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.525 -1.43 . . . . 44.210000000000001 109.525 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . 0.427 ' O ' ' O ' ' B' ' 119' ' ' ASN . 29.5 p -82.65 30.55 0.42 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -1.182 . . . . 71.400000000000006 109.718 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . 0.609 ' ND2' ' N ' ' B' ' 119' ' ' ASN . 0.0 OUTLIER 55.07 170.24 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.495 -0.882 . . . . 72.319999999999993 109.629 177.602 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 11.0 t -119.88 -37.82 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.526 -0.734 . . . . 75.019999999999996 109.13 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 29.3 mm -110.94 132.79 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.437 -0.79 . . . . 51.409999999999997 109.491 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -152.98 117.14 4.87 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.196 -0.94 . . . . 71.530000000000001 109.495 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.701 HD11 ' HB3' ' B' ' 216' ' ' TYR . 11.5 tt -163.04 140.24 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.009 -1.057 . . . . 72.430000000000007 110.271 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' B' ' 126' ' ' LEU . . . 69.52 33.14 71.79 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.312 -1.115 . . . . 51.229999999999997 110.312 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 14.8 t0 69.51 -6.34 1.01 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.355 -1.086 . . . . 74.200000000000003 109.281 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.723 HD13 HD13 ' B' ' 199' ' ' LEU . 1.2 mt -91.12 144.35 25.73 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.031 -1.1 . . . . 75.420000000000002 108.031 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.46 126.31 40.27 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.357 -0.839 . . . . 74.219999999999999 109.004 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 73.6 mt -127.58 131.41 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.593 -0.692 . . . . 60.329999999999998 109.341 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 48.7 m -115.24 121.27 35.2 Favored Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 121.626 -0.671 . . . . 72.310000000000002 109.334 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -78.26 -44.25 0.16 Allowed 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 121.572 1.515 . . . . 75.129999999999995 111.933 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . 0.791 ' O ' ' OE2' ' B' ' 133' ' ' GLU . 70.0 m-20 -62.91 -46.85 85.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.07 -1.019 . . . . 75.230000000000004 109.281 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . 0.478 ' O ' ' C ' ' B' ' 133' ' ' GLU . 41.7 mt-10 -86.84 5.72 35.31 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.252 -0.905 . . . . 72.430000000000007 109.182 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.791 ' OE2' ' O ' ' B' ' 131' ' ' ASP . 0.6 OUTLIER 29.93 59.87 0.19 Allowed 'General case' 0 N--CA 1.509 2.502 0 CA-C-O 121.596 0.712 . . . . 75.129999999999995 110.447 -179.579 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -141.99 137.56 31.26 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.973 -0.751 . . . . 73.219999999999999 108.973 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 10.9 tt -111.05 138.97 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.217 -0.927 . . . . 64.140000000000001 109.874 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 18.0 mm -115.91 132.84 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.561 -0.712 . . . . 71.219999999999999 109.534 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -140.43 125.2 18.17 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.362 -0.836 . . . . 64.219999999999999 108.964 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 81.2 mttt 55.13 33.98 21.62 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.405 -0.809 . . . . 72.019999999999996 110.311 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 76.76 14.99 81.98 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 120.182 -1.009 . . . . 74.319999999999993 110.934 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -101.05 127.8 47.4 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.179 -1.189 . . . . 75.340000000000003 109.63 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -93.74 117.83 30.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.253 -0.904 . . . . 71.230000000000004 109.621 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 5.3 t -124.74 120.99 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.389 -0.819 . . . . 70.430000000000007 108.947 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -79.22 139.8 37.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.382 -0.824 . . . . 72.430000000000007 109.62 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.99 137.21 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.285 -0.884 . . . . 72.129999999999995 109.069 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 41.8 pttt -167.24 119.11 0.91 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 72.019999999999996 109.782 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 156.96 -177.21 33.97 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.082 -1.607 . . . . 42.229999999999997 109.082 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 0.622 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 26.6 mmtm -69.05 -36.56 7.71 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.166 -1.197 . . . . 73.299999999999997 110.375 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 26.8 Cg_exo -61.3 -36.21 80.46 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.871 1.714 . . . . 71.329999999999998 111.597 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -90.6 -28.01 18.72 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.359 -0.838 . . . . 74.230000000000004 109.393 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -50.6 -49.42 56.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.215 -0.928 . . . . 72.340000000000003 109.696 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.647 HG22 HG21 ' B' ' 191' ' ' ILE . 2.8 p -64.95 -34.28 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.088 -1.008 . . . . 73.349999999999994 109.038 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 10.5 tp -64.07 -36.85 85.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.172 -0.955 . . . . 55.240000000000002 108.605 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.39 -28.65 56.8 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.441 -0.787 . . . . 70.010000000000005 109.305 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . 1.029 ' CE1' ' CE1' ' B' ' 158' ' ' HIS . 1.3 t60 -63.43 -53.84 45.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.023 -1.048 . . . . 65.319999999999993 109.561 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.412 ' CD2' HD12 ' B' ' 191' ' ' ILE . 2.7 pp -66.61 -30.36 70.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.992 -1.067 . . . . 71.540000000000006 108.917 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -52.51 -51.22 60.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.101 -1.0 . . . . 75.319999999999993 109.016 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.559 ' NH1' ' HA ' ' B' ' 154' ' ' HIS . 51.3 mtt85 -62.37 -51.39 67.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.029 -1.044 . . . . 73.319999999999993 108.773 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . 1.029 ' CE1' ' CE1' ' B' ' 154' ' ' HIS . 11.8 m80 -88.78 36.0 0.79 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.723 -0.61 . . . . 74.140000000000001 109.886 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . 0.419 HH12 ' CB ' ' B' ' 203' ' ' THR . 29.9 ttp85 -82.6 41.36 0.71 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.872 -1.142 . . . . 61.409999999999997 109.619 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . 0.764 ' HB3' ' HE1' ' B' ' 216' ' ' TYR . 3.9 p-10 -166.66 49.34 0.07 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 72.099999999999994 109.511 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -175.6 -171.54 0.48 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.346 -0.846 . . . . 72.25 109.79 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 86.9 mt -93.05 143.05 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.288 -0.883 . . . . 72.310000000000002 110.126 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 78.6 t -134.18 126.21 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.986 -0.746 . . . . 64.209999999999994 108.986 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 4.6 p -81.68 162.76 22.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.131 -0.98 . . . . 74.219999999999999 109.941 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -64.54 -51.54 62.36 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.422 -0.799 . . . . 65.310000000000002 110.137 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -58.38 -27.13 63.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.119 -0.988 . . . . 63.450000000000003 109.086 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -56.18 -50.95 69.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 72.400000000000006 108.906 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 79.6 mt -61.73 -36.19 80.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 72.319999999999993 108.933 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.526 HD23 ' C ' ' B' ' 169' ' ' LEU . 5.9 tt -64.9 -61.48 2.14 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.453 -0.779 . . . . 73.340000000000003 109.695 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -62.38 -25.73 68.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.91 . . . . 72.099999999999994 110.479 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.03 -47.52 58.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.943 -1.098 . . . . 62.130000000000003 110.366 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 24.3 mm -99.7 -63.06 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.149 -0.969 . . . . 71.420000000000002 110.428 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' TRP . . . . . 1.149 ' CD1' ' CG1' ' B' ' 179' ' ' VAL . 25.6 m-90 -77.98 65.53 3.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.081 -1.012 . . . . 72.230000000000004 109.961 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -80.37 -43.42 21.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.165 -0.959 . . . . 52.109999999999999 110.0 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . 0.732 ' H ' ' CD ' ' B' ' 176' ' ' PRO . 13.9 tm-20 -167.55 -35.42 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 120.916 -1.115 . . . . 73.040000000000006 111.399 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.732 ' CD ' ' H ' ' B' ' 175' ' ' GLU . 24.7 Cg_exo -64.12 -30.06 65.34 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 121.507 1.472 . . . . 74.129999999999995 111.235 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . 0.778 ' O ' ' HD1' ' B' ' 173' ' ' TRP . 81.0 mm-40 -119.46 92.29 3.75 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.535 -0.913 . . . . 72.439999999999998 108.535 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 26.3 ttt -68.75 135.33 51.09 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.351 -0.843 . . . . 63.43 109.515 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 179' ' ' VAL . . . . . 1.149 ' CG1' ' CD1' ' B' ' 173' ' ' TRP . 31.7 m -141.5 167.24 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.493 -0.754 . . . . 71.049999999999997 109.733 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . 0.578 ' O ' ' N ' ' B' ' 182' ' ' ASN . 22.1 m -101.01 121.21 53.01 Favored Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 108.927 -0.768 . . . . 62.149999999999999 108.927 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -44.77 80.48 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.838 1.692 . . . . 65.219999999999999 112.441 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 182' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' B' ' 180' ' ' THR . 10.6 t-20 -179.04 -21.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.323 -0.861 . . . . 72.310000000000002 108.835 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 15.2 m -75.21 -10.13 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 63.32 109.546 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.402 ' H ' HG13 ' B' ' 184' ' ' ILE . 50.9 mt -50.4 -25.96 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.923 . . . . 75.030000000000001 109.004 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . 0.413 ' O ' ' OD1' ' B' ' 189' ' ' ASN . 25.1 mm-40 -62.18 -38.57 89.59 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.387 -0.82 . . . . 64.109999999999999 109.381 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . 0.419 ' H ' HG23 ' B' ' 186' ' ' VAL . 2.1 t -77.45 -34.94 21.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.399 -0.813 . . . . 73.0 109.986 -179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -68.68 -39.36 80.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.861 -1.149 . . . . 61.119999999999997 110.634 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 188' ' ' ILE . . . . . 0.525 HG23 ' N ' ' B' ' 189' ' ' ASN . 10.6 tp -76.94 -42.13 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.786 -1.196 . . . . 72.430000000000007 109.769 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 189' ' ' ASN . . . . . 0.525 ' N ' HG23 ' B' ' 188' ' ' ILE . 18.6 m120 -70.33 -37.12 74.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -0.823 . . . . 65.140000000000001 110.77 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . 0.429 ' CG ' ' N ' ' B' ' 191' ' ' ILE . 13.6 pt20 -71.45 -46.95 58.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.859 -1.15 . . . . 63.240000000000002 110.995 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . 0.647 HG21 HG22 ' B' ' 151' ' ' VAL . 6.5 pt -60.7 -38.97 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.485 -1.384 . . . . 74.030000000000001 109.379 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 192' ' ' ARG . . . . . 0.52 ' NH2' ' CD1' ' B' ' 212' ' ' TYR . 98.5 mtt180 -62.35 -35.79 80.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.029 -1.045 . . . . 72.239999999999995 109.474 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 193' ' ' GLN . . . . . 0.443 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 86.7 mt-30 -77.5 -25.91 50.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.228 -0.92 . . . . 73.099999999999994 110.384 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -78.71 -24.25 45.05 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.092 -1.005 . . . . 72.109999999999999 110.736 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 5.6 ptm -94.82 -35.7 11.97 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.921 -1.112 . . . . 44.329999999999998 110.568 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 196' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 52.9 p-10 -67.92 -24.04 65.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.985 -1.072 . . . . 71.209999999999994 110.772 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . 0.539 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 17.5 mttp -74.69 -62.23 0.97 Allowed Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.979 -1.076 . . . . 75.209999999999994 110.219 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 198' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -66.36 -39.51 17.04 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.082 1.855 . . . . 75.319999999999993 112.83 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . 0.723 HD13 HD13 ' B' ' 126' ' ' LEU . 58.1 mt -80.14 -55.77 4.7 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.881 -1.137 . . . . 72.25 110.142 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 95.91 -8.4 67.94 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.42 -1.472 . . . . 64.530000000000001 109.42 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 23.4 mm -105.36 135.93 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.325 -1.103 . . . . 44.229999999999997 109.349 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 47.7 t -90.15 133.36 34.93 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.146 -0.971 . . . . 54.009999999999998 108.723 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . 0.419 ' CB ' HH12 ' B' ' 159' ' ' ARG . 43.7 p -146.83 50.25 1.12 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.022 -1.048 . . . . 74.400000000000006 110.226 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.475 ' O ' HG23 ' B' ' 204' ' ' VAL . 33.3 m -144.31 124.6 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 120.973 -1.08 . . . . 72.120000000000005 109.835 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -109.53 114.0 27.26 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.416 -0.957 . . . . 65.409999999999997 108.416 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 206' ' ' THR . . . . . 0.497 HG23 ' O ' ' B' ' 206' ' ' THR . 9.8 t -96.06 125.31 40.51 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.097 -1.002 . . . . 71.329999999999998 109.724 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.537 HG22 ' H ' ' B' ' 209' ' ' ARG . 7.9 p -142.22 142.62 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.303 -0.873 . . . . 63.5 109.321 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -80.6 6.97 11.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 74.450000000000003 109.611 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . 0.537 ' H ' HG22 ' B' ' 207' ' ' VAL . 14.2 tpt180 -58.17 -39.4 78.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.22 -0.925 . . . . 74.140000000000001 109.818 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -160.37 -37.16 0.05 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.222 -0.924 . . . . 74.430000000000007 109.397 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 177.9 -150.5 9.96 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.438 -1.465 . . . . 64.450000000000003 109.438 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' TYR . . . . . 0.52 ' CD1' ' NH2' ' B' ' 192' ' ' ARG . 54.4 m-85 -93.11 137.92 32.02 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.137 -1.213 . . . . 74.209999999999994 109.033 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -111.46 118.37 35.6 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.55 -0.719 . . . . 74.030000000000001 109.78 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -96.05 131.67 42.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.349 -0.844 . . . . 74.340000000000003 109.024 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.0 t -145.06 169.5 17.99 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.17 -0.956 . . . . 64.329999999999998 109.946 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . 0.764 ' HE1' ' HB3' ' B' ' 160' ' ' ASP . 0.0 OUTLIER -74.74 159.09 83.96 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.414 -0.958 . . . . 70.040000000000006 108.414 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.82 133.1 56.05 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.298 1.999 . . . . 65.109999999999999 111.943 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.628 ' N ' ' CD ' ' B' ' 219' ' ' PRO . 3.0 ttmp? -80.21 -35.2 0.88 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.338 -0.851 . . . . 73.150000000000006 110.485 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . 0.784 ' O ' ' N ' ' B' ' 221' ' ' CYS . 24.9 Cg_exo -61.37 -1.1 1.67 Allowed 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.531 1.488 . . . . 71.310000000000002 111.457 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . 0.765 ' C ' ' OE2' ' B' ' 223' ' ' GLU . . . -57.04 55.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.374 -0.829 . . . . 75.450000000000003 109.636 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' CYS . . . . . 0.784 ' N ' ' O ' ' B' ' 219' ' ' PRO . 31.8 p -78.65 -31.78 46.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.111 -0.993 . . . . 72.219999999999999 109.279 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -58.81 -14.79 9.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 54.530000000000001 109.091 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . 0.765 ' OE2' ' C ' ' B' ' 220' ' ' ALA . 1.6 pm0 . . . . . 0 N--CA 1.499 2.0 0 CA-C-O 117.967 -1.016 . . . . 71.129999999999995 109.135 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 1.176 ' CE ' ' HA ' ' A' ' 115' ' ' PHE . 28.6 tpp . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.413 -0.588 . . . . 65.120000000000005 109.413 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -140.06 140.5 36.14 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.345 -0.847 . . . . 72.329999999999998 109.203 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.6 t -119.9 142.91 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 121.633 0.73 . . . . 71.420000000000002 110.402 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.503 HD11 ' CG1' ' A' ' 6' ' ' ILE . 3.3 tp -113.75 116.14 28.93 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.116 -1.068 . . . . 65.120000000000005 108.116 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.561 HD12 ' SD ' ' A' ' 49' ' ' MET . 3.6 tp -118.5 103.96 10.24 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.892 -0.781 . . . . 62.43 108.892 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.503 ' CG1' HD11 ' A' ' 4' ' ' LEU . 69.9 mt -95.71 104.3 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.115 -0.991 . . . . 71.150000000000006 108.742 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.438 ' HG3' ' H ' ' A' ' 9' ' ' ASN . 28.7 tp10 -128.51 119.25 24.5 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 109.206 -0.664 . . . . 75.340000000000003 109.206 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.458 ' NZ ' ' CB ' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -84.19 -3.22 58.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.227 -0.921 . . . . 72.439999999999998 109.378 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.438 ' H ' ' HG3' ' A' ' 7' ' ' GLU . 70.5 m-20 -81.73 -125.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.338 -0.851 . . . . 63.020000000000003 109.279 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.3 m -165.88 -77.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.024 -1.047 . . . . 72.340000000000003 110.106 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.83 -44.09 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.283 -0.885 . . . . 74.019999999999996 110.622 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.518 ' N ' HD22 ' A' ' 12' ' ' LEU . 3.5 mm? -58.8 -37.24 75.93 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.092 -1.005 . . . . 71.430000000000007 109.668 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.92 -32.52 39.96 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.727 -1.749 . . . . 61.32 108.727 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.21 -47.84 69.13 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 110.058 -1.217 . . . . 71.200000000000003 110.058 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.67 -43.56 93.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.011 -1.288 . . . . 71.319999999999993 109.382 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 6.8 mm -64.86 -43.97 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.817 -1.177 . . . . 63.229999999999997 108.492 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -58.83 -50.43 74.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.86 . . . . 51.109999999999999 109.468 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -80.7 1.53 29.76 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.196 -0.94 . . . . 73.340000000000003 109.585 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.08 -58.41 2.0 Allowed Glycine 0 N--CA 1.484 1.89 0 N-CA-C 109.958 -1.257 . . . . 62.149999999999999 109.958 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -75.85 -18.73 59.33 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.265 -1.138 . . . . 73.510000000000005 110.032 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -57.59 -31.35 66.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.107 -0.996 . . . . 74.25 109.623 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.4 t -62.37 -38.22 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.386 -0.821 . . . . 70.040000000000006 109.876 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.497 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 12.1 mptt -67.93 -1.82 6.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.325 -0.86 . . . . 73.230000000000004 109.726 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.09 27.03 27.01 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.826 -1.31 . . . . 75.540000000000006 109.826 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.661 ' CE1' ' CE2' ' A' ' 115' ' ' PHE . 13.8 m-85 -99.49 151.25 21.34 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.33 -1.1 . . . . 73.430000000000007 109.097 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 12.0 mtt -102.06 128.44 48.52 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.572 -1.269 . . . . 43.240000000000002 107.572 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.84 140.1 38.38 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.157 -0.965 . . . . 62.109999999999999 110.507 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -112.66 139.03 48.61 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.715 -0.846 . . . . 74.420000000000002 108.715 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -104.75 124.55 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.293 -0.88 . . . . 72.150000000000006 108.722 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.4 p -128.2 166.61 18.22 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.648 -0.658 . . . . 71.420000000000002 109.495 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -83.87 -102.95 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.22 -0.925 . . . . 72.329999999999998 109.446 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.0 p -81.37 161.16 23.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 74.239999999999995 109.457 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.458 ' H ' HD12 ' A' ' 33' ' ' LEU . 2.8 mp -52.22 -28.23 17.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.375 -0.828 . . . . 71.530000000000001 109.5 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -49.25 -53.35 22.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.935 . . . . 74.230000000000004 109.5 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -60.58 -39.01 86.48 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.175 -0.953 . . . . 54.030000000000001 108.715 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.37 -34.83 80.77 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.106 -1.597 . . . . 61.409999999999997 109.106 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -66.98 -43.92 81.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -1.129 . . . . 74.340000000000003 109.351 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.447 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 36.6 t80 -76.81 -22.23 53.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.122 -0.986 . . . . 75.329999999999998 109.824 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.2 tp -87.42 -30.78 20.46 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.108 -0.995 . . . . 74.329999999999998 109.673 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.44 ' O ' ' O ' ' A' ' 43' ' ' ARG . 5.0 ppp? -86.36 -24.02 25.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.122 -0.986 . . . . 70.319999999999993 110.468 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 37.4 p-10 -59.37 -28.49 66.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.887 -1.133 . . . . 71.219999999999999 109.444 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.538 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 12.6 pt -92.24 -30.68 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.234 -0.916 . . . . 74.140000000000001 110.113 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 40' ' ' MET . 70.9 mmt-85 -130.03 148.31 51.87 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.386 -0.821 . . . . 72.239999999999995 109.645 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -98.66 160.11 14.5 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.252 -0.905 . . . . 75.420000000000002 109.483 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -131.02 160.11 35.55 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.496 -0.753 . . . . 74.230000000000004 109.241 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.745 ' OD2' ' CH2' ' A' ' 116' ' ' TRP . 5.4 m-20 -98.69 -45.21 6.13 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.267 -0.896 . . . . 72.040000000000006 109.474 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.403 ' C ' ' CD1' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -102.18 108.84 20.36 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.45 -0.944 . . . . 72.129999999999995 108.45 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.7 t -97.25 100.78 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.339 -0.851 . . . . 72.340000000000003 109.248 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.561 ' SD ' HD12 ' A' ' 5' ' ' LEU . 2.0 tmt? -116.74 134.48 54.75 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.456 -0.777 . . . . 74.109999999999999 109.489 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.654 HG22 ' H ' ' A' ' 52' ' ' ASP . 1.3 p -143.43 127.69 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.499 -0.751 . . . . 61.119999999999997 109.323 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.4 p -86.69 4.95 38.46 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.559 -0.713 . . . . 73.109999999999999 109.408 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.654 ' H ' HG22 ' A' ' 50' ' ' VAL . 13.6 m-20 -79.92 138.9 37.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.937 . . . . 52.549999999999997 109.646 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -82.27 -32.75 29.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.269 -0.894 . . . . 44.219999999999999 109.938 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -73.21 8.93 1.42 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.195 -0.941 . . . . 70.439999999999998 109.714 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 58' ' ' PHE . . . -74.93 -20.9 59.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.331 -0.856 . . . . 64.140000000000001 110.184 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 55' ' ' ALA . 31.3 mt -38.49 -45.0 0.99 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.604 -0.685 . . . . 44.140000000000001 110.706 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.3 p -74.47 -36.54 63.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.95 -1.093 . . . . 55.229999999999997 109.311 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.666 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 64.6 t80 -65.07 -46.19 82.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.417 -0.802 . . . . 74.439999999999998 109.998 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.1 m -64.29 -37.41 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.703 -1.248 . . . . 74.030000000000001 109.307 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.1 t -53.54 -49.9 66.64 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.209 -0.932 . . . . 64.299999999999997 109.228 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -70.28 -36.22 74.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 64.439999999999998 110.243 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.666 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 5.2 mm -64.67 -34.12 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.642 -1.286 . . . . 63.210000000000001 109.432 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.565 ' HZ3' ' CG ' ' A' ' 92' ' ' ASP . 44.0 mmtt -67.43 -51.58 49.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.204 -0.935 . . . . 74.420000000000002 109.868 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.443 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 17.1 pt-20 -72.38 -43.02 64.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.942 -1.099 . . . . 70.319999999999993 109.937 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.505 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 25.8 mtpp -70.14 -22.72 62.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 75.219999999999999 109.508 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.511 ' O ' HG22 ' A' ' 69' ' ' ILE . 89.9 m-70 -156.35 64.31 0.55 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.923 . . . . 74.129999999999995 109.525 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.486 ' O ' ' N ' ' A' ' 69' ' ' ILE . 30.7 p -60.19 -31.54 70.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.306 -0.871 . . . . 73.239999999999995 109.737 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 87.7 p -68.6 47.84 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -0.915 . . . . 61.009999999999998 109.705 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 66' ' ' HIS . 14.3 tt -148.61 161.92 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.083 -1.011 . . . . 71.329999999999998 109.609 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.599 HG21 HD11 ' A' ' 113' ' ' LEU . 77.4 t -95.96 154.91 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.158 -0.964 . . . . 72.129999999999995 108.754 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.725 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 6.5 t -143.32 114.52 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.11 -0.994 . . . . 54.210000000000001 109.315 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.0 mp -111.12 100.14 8.86 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.55 -0.908 . . . . 50.240000000000002 108.55 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.4 t -93.14 120.4 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.345 -0.847 . . . . 74.409999999999997 108.91 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.8 m -97.84 172.84 7.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.284 -0.885 . . . . 72.310000000000002 108.763 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.448 ' C ' ' H ' ' A' ' 77' ' ' ASN . 0.8 OUTLIER -173.98 120.72 0.29 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.982 -1.073 . . . . 64.540000000000006 110.203 -179.622 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -65.53 2.37 0.95 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.508 -0.745 . . . . 74.129999999999995 109.406 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 75' ' ' SER . 80.2 m-20 -120.1 64.05 9.57 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 109.123 -0.695 . . . . 73.340000000000003 109.123 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.03 74.2 0.1 OUTLIER 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.11 1.873 . . . . 63.219999999999999 111.871 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.45 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 60.1 p -104.95 149.7 25.52 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.331 -0.988 . . . . 62.530000000000001 108.331 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -28.56 69.19 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.197 -0.939 . . . . 73.439999999999998 109.813 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.459 ' OE1' ' N ' ' A' ' 81' ' ' GLU . 40.8 mp0 -63.41 -38.08 89.76 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.112 -0.992 . . . . 71.420000000000002 109.876 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 82' ' ' GLU . 0.2 OUTLIER -77.05 -33.95 57.19 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.044 -1.035 . . . . 73.430000000000007 109.712 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -61.05 -52.57 64.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.056 -1.028 . . . . 74.219999999999999 109.461 -179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.473 HG23 ' N ' ' A' ' 85' ' ' HIS . 26.9 m -62.67 -41.31 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.182 -0.949 . . . . 73.200000000000003 109.387 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.473 ' N ' HG23 ' A' ' 84' ' ' VAL . 6.6 t-80 -65.8 -29.94 70.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.225 -0.922 . . . . 53.329999999999998 109.324 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.02 -37.05 80.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.917 . . . . 64.109999999999999 109.91 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -80.2 -34.05 37.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.106 -0.997 . . . . 74.340000000000003 108.839 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -73.64 -38.22 65.08 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.388 -0.82 . . . . 74.420000000000002 109.461 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -71.32 -60.86 2.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 74.239999999999995 109.374 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 155.71 70.88 0.01 OUTLIER Glycine 0 N--CA 1.492 2.413 0 C-N-CA 119.67 -1.252 . . . . 61.509999999999998 110.168 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -133.08 130.75 39.74 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.339 -1.095 . . . . 55.329999999999998 109.357 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.725 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 14.2 m-20 -69.51 -41.09 76.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 73.420000000000002 109.268 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.752 ' CG ' HH21 ' A' ' 112' ' ' ARG . 4.9 m-20 -146.32 163.0 36.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.366 -0.834 . . . . 75.040000000000006 109.056 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.494 ' CE1' ' OE1' ' A' ' 83' ' ' GLU . 56.6 t80 -136.96 124.42 22.09 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.363 -0.977 . . . . 71.329999999999998 108.363 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.683 ' H ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -126.12 149.83 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 CA-C-O 122.045 0.926 . . . . 71.129999999999995 111.232 -178.055 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.75 121.54 16.72 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.768 -1.197 . . . . 64.319999999999993 107.768 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.659 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -44.92 -55.43 10.94 Favored Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.197 -0.939 . . . . 62.200000000000003 111.629 -178.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.7 Cg_endo -41.56 -12.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 120.739 0.96 . . . . 73.109999999999999 112.538 -175.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.659 ' N ' ' O ' ' A' ' 97' ' ' LYS . 55.2 m-85 59.86 124.88 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 109.583 -0.525 . . . . 65.219999999999999 109.583 179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 32.6 ttm-85 -62.08 -38.79 90.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.876 -1.14 . . . . 72.349999999999994 109.353 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.794 ' O ' ' N ' ' A' ' 103' ' ' LYS . 6.3 t -172.99 46.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.129 -0.982 . . . . 71.319999999999993 110.473 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 92.2 mt 47.11 -68.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 CA-C-O 121.228 0.537 . . . . 75.430000000000007 110.825 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.794 ' N ' ' O ' ' A' ' 101' ' ' SER . 13.8 mmmt -53.25 -34.0 55.38 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.238 -0.914 . . . . 71.409999999999997 108.843 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.39 -49.73 68.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.262 -0.899 . . . . 63.240000000000002 109.204 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.695 ' C ' HD13 ' A' ' 105' ' ' LEU . 2.0 tm? -57.73 -47.9 81.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.134 -0.979 . . . . 73.219999999999999 108.726 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 61.1 t -60.96 -40.2 84.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 120.964 -1.085 . . . . 60.109999999999999 109.85 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.635 ' HB1' ' CE2' ' B' ' 87' ' ' PHE . . . -52.17 -39.23 59.78 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.252 -0.905 . . . . 70.420000000000002 108.832 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 1.27 ' HB3' ' NH1' ' A' ' 112' ' ' ARG . 93.3 mtt180 -73.55 -29.82 62.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.028 -1.045 . . . . 74.409999999999997 109.933 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 47.5 mt -73.92 -44.94 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 120.891 -1.131 . . . . 62.539999999999999 109.218 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.449 ' CG ' ' N ' ' A' ' 111' ' ' ALA . 17.7 pt-20 -70.31 -47.93 58.87 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.816 -1.154 . . . . 74.340000000000003 109.717 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.449 ' N ' ' CG ' ' A' ' 110' ' ' GLU . . . -59.49 -29.84 68.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.889 -1.132 . . . . 73.319999999999993 109.578 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 1.27 ' NH1' ' HB3' ' A' ' 108' ' ' ARG . 53.0 mtt85 -72.79 -58.34 3.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.913 . . . . 52.409999999999997 109.175 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 112' ' ' ARG . 16.7 mt -126.35 65.13 1.24 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.502 -0.925 . . . . 65.239999999999995 108.502 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.469 ' O ' ' CD2' ' A' ' 115' ' ' PHE . 29.1 mtm105 -39.94 -79.73 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.902 -0.499 . . . . 64.450000000000003 110.48 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 1.176 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 14.6 m-85 -163.18 96.48 0.88 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.029 -1.044 . . . . 74.430000000000007 108.698 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 1.01 ' CZ2' ' OE1' ' A' ' 132' ' ' GLU . 51.3 m0 -46.78 -93.75 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.247 -0.908 . . . . 74.420000000000002 109.861 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.15 17.85 18.42 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.078 -1.609 . . . . 75.040000000000006 109.078 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 24.4 p -103.56 166.76 10.22 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.366 -1.079 . . . . 61.140000000000001 109.771 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.692 HD21 ' N ' ' A' ' 128' ' ' ILE . 1.0 OUTLIER -164.18 127.89 2.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.329 -0.857 . . . . 65.239999999999995 108.98 179.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 18.4 t -82.98 -38.07 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.047 -1.033 . . . . 73.109999999999999 110.627 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.547 ' O ' ' ND2' ' A' ' 119' ' ' ASN . 14.9 mm -95.88 133.59 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 120.932 -1.105 . . . . 72.239999999999995 110.038 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -149.86 127.94 11.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.151 -0.968 . . . . 72.340000000000003 108.607 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' A' ' 125' ' ' ASP . 8.7 tp -153.32 132.38 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.878 . . . . 71.439999999999998 109.54 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 55.93 -83.49 0.01 OUTLIER Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.62 -1.392 . . . . 73.400000000000006 109.62 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 123' ' ' ILE . 15.1 t0 -149.92 -4.84 0.36 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.253 -1.146 . . . . 74.450000000000003 109.334 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.05 141.32 28.66 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.074 -1.017 . . . . 54.210000000000001 108.842 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.32 133.1 43.62 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.896 -0.779 . . . . 54.5 108.896 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.692 ' N ' HD21 ' A' ' 119' ' ' ASN . 49.4 mt -130.02 134.83 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.378 -0.826 . . . . 45.149999999999999 109.554 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.0 t -108.72 111.78 60.82 Favored Pre-proline 0 N--CA 1.497 1.9 0 N-CA-C 108.524 -0.917 . . . . 71.109999999999999 108.524 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -83.18 -39.18 0.13 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.869 1.713 . . . . 65.409999999999997 112.815 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -65.86 -49.3 68.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.025 -1.047 . . . . 63.32 109.692 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 1.01 ' OE1' ' CZ2' ' A' ' 116' ' ' TRP . 5.8 mm-40 -81.48 -6.26 58.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.13 -0.981 . . . . 72.519999999999996 109.105 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 57.06 63.63 1.86 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.33 -0.856 . . . . 75.329999999999998 109.727 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -146.19 130.41 17.52 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.338 -0.851 . . . . 71.230000000000004 109.272 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 6.8 tt -106.57 140.81 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.345 -0.847 . . . . 74.019999999999996 108.87 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.4 mt -128.54 120.75 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.46 -0.775 . . . . 60.229999999999997 109.506 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -140.03 140.18 36.14 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.386 -0.821 . . . . 62.32 109.628 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 53.45 20.96 2.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.403 -0.811 . . . . 75.400000000000006 110.085 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.84 16.97 68.84 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.982 -1.104 . . . . 72.239999999999995 110.403 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 57.2 mtp85 -107.12 124.41 49.64 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.242 -1.152 . . . . 71.219999999999999 109.177 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -99.24 124.9 44.68 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.302 -0.874 . . . . 71.420000000000002 109.75 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.8 t -139.33 140.9 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.39 -0.819 . . . . 53.020000000000003 109.556 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -85.94 135.7 33.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.177 -0.952 . . . . 60.450000000000003 109.136 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.4 m -132.43 126.95 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.439 -0.788 . . . . 74.439999999999998 109.406 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 29.4 pttt -173.15 129.31 0.47 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.304 -0.873 . . . . 65.150000000000006 109.577 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.66 -141.19 6.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.703 -1.359 . . . . 73.340000000000003 109.703 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.547 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -85.09 -44.56 0.67 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.328 -1.101 . . . . 72.219999999999999 110.403 -179.271 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 69.6 Cg_endo -89.79 -7.85 4.5 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.73 2.287 . . . . 65.230000000000004 113.354 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -89.42 -32.84 17.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.719 -1.238 . . . . 60.109999999999999 110.035 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -50.18 -40.99 48.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.978 -1.076 . . . . 64.209999999999994 109.149 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.3 p -65.09 -33.59 64.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.252 -0.905 . . . . 72.019999999999996 109.246 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 7.0 tp -61.37 -40.88 95.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.243 -0.91 . . . . 73.310000000000002 109.639 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 7.9 p -74.59 -34.89 62.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.095 -1.003 . . . . 74.310000000000002 109.041 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -52.81 -55.2 24.76 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.476 -0.765 . . . . 74.310000000000002 109.746 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 pp -72.13 -26.17 62.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.013 -1.055 . . . . 75.340000000000003 109.283 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.04 -29.39 60.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.084 -1.01 . . . . 62.140000000000001 108.716 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.461 ' C ' ' H ' ' A' ' 159' ' ' ARG . 52.4 mtt180 -97.89 -54.19 3.17 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.681 -0.859 . . . . 61.030000000000001 108.681 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.431 ' ND1' ' N ' ' A' ' 158' ' ' HIS . 5.3 m80 -69.94 43.34 0.06 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.456 -0.777 . . . . 74.120000000000005 109.141 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.548 ' O ' ' N ' ' A' ' 161' ' ' GLN . 32.2 mtm105 -53.57 -103.37 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.481 -0.762 . . . . 71.129999999999995 109.953 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -51.17 86.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.478 -0.764 . . . . 75.450000000000003 109.884 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 159' ' ' ARG . 0.0 OUTLIER -175.58 179.1 1.48 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.629 -0.878 . . . . 73.409999999999997 108.629 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.529 ' H ' ' CD ' ' A' ' 161' ' ' GLN . 66.6 mt -98.82 128.95 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.258 -0.901 . . . . 74.409999999999997 109.615 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 212' ' ' TYR . 77.2 t -108.99 113.94 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.509 -0.744 . . . . 72.310000000000002 109.535 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 4.4 p -90.33 138.71 31.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 74.120000000000005 108.627 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 5.8 ptpt -57.75 -37.09 73.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 70.430000000000007 109.186 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -64.29 -38.19 90.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 73.519999999999996 109.617 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -59.84 -41.12 90.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -0.968 . . . . 74.519999999999996 109.124 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 40.2 mt -61.88 -53.28 57.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.91 . . . . 72.310000000000002 109.306 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 11.8 tp -62.67 -60.83 2.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 53.329999999999998 109.635 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -40.75 -40.1 1.25 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.94 -0.475 . . . . 62.439999999999998 111.543 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.16 -31.23 14.23 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.859 -1.151 . . . . 60.210000000000001 111.784 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 5.3 mm -80.6 -69.3 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 120.72 -1.238 . . . . 75.319999999999993 109.807 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.512 ' O ' ' CE3' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -59.07 145.71 41.15 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.831 -1.174 . . . . 73.140000000000001 107.831 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -172.1 -76.37 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.662 -0.866 . . . . 73.239999999999995 108.662 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.606 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 2.4 tt0 -82.6 -42.81 0.93 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.122 -0.986 . . . . 44.43 108.572 178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 14.6 Cg_exo -67.95 44.23 0.27 Allowed 'Trans proline' 0 N--CA 1.495 1.613 0 C-N-CA 122.593 2.195 . . . . 72.510000000000005 111.687 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -54.66 -4.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -0.954 . . . . 63.240000000000002 110.168 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.491 ' H ' ' C ' ' A' ' 176' ' ' PRO . 23.5 ttt -53.87 -26.54 25.25 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.041 -1.037 . . . . 73.5 109.25 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 18.7 m -64.46 137.21 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 65.219999999999999 109.485 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.5 p -64.71 153.27 88.11 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.245 -0.91 . . . . 71.420000000000002 108.843 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -36.71 -56.16 0.76 Allowed 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 122.395 2.064 . . . . 41.219999999999999 112.042 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 182' ' ' ASN . 6.3 p30 -93.79 114.66 26.98 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.265 -0.897 . . . . 64.540000000000006 108.737 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 10.5 p -145.94 -32.6 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.213 -0.929 . . . . 74.019999999999996 109.3 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.576 HD13 ' O ' ' A' ' 184' ' ' ILE . 0.2 OUTLIER -51.4 -31.21 11.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.449 -0.782 . . . . 72.329999999999998 109.09 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -56.32 -53.29 58.99 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.253 -0.905 . . . . 74.400000000000006 110.173 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 15.8 m -74.06 -25.25 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.996 -1.065 . . . . 70.420000000000002 109.805 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -71.55 -52.65 17.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 52.109999999999999 110.047 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 9.9 tp -64.31 -33.97 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.91 -1.119 . . . . 71.400000000000006 109.734 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -64.67 -54.85 25.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.995 . . . . 73.439999999999998 110.025 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -67.65 -39.45 84.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.002 -1.061 . . . . 71.420000000000002 109.884 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 67.2 mt -60.12 -49.35 84.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.016 -1.053 . . . . 61.549999999999997 109.373 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -52.85 -53.73 44.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.07 -1.019 . . . . 63.340000000000003 109.442 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.629 ' NE2' ' N ' ' A' ' 193' ' ' GLN . 0.1 OUTLIER -59.76 -36.52 76.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -0.871 . . . . 61.240000000000002 109.375 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -81.65 -3.95 54.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.175 -0.953 . . . . 75.129999999999995 110.112 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 32.5 ttp -108.82 -15.18 14.45 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.322 -0.861 . . . . 74.019999999999996 109.704 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -108.51 -16.45 14.21 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.422 -0.799 . . . . 74.019999999999996 109.869 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.628 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 31.5 tptt -78.69 -35.72 1.13 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.979 -1.076 . . . . 75.430000000000007 110.776 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 89.0 Cg_endo -90.36 -48.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.226 1.951 . . . . 72.319999999999993 112.279 -179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 74.1 mt -68.1 -31.95 71.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.14 -0.975 . . . . 74.540000000000006 109.19 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 73.13 0.22 50.92 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.77 -1.332 . . . . 61.509999999999998 109.77 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.8 mt -123.23 128.2 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.548 -0.972 . . . . 61.219999999999999 109.488 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 8.3 t -86.03 132.95 33.94 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.321 -0.992 . . . . 72.0 108.321 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.7 p -134.87 27.02 3.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.254 -0.904 . . . . 74.439999999999998 109.909 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 26.7 m -146.98 150.48 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.096 -1.003 . . . . 64.349999999999994 109.736 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -126.61 126.13 43.1 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.645 -0.659 . . . . 71.409999999999997 109.368 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.34 111.16 16.46 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.133 -0.979 . . . . 73.519999999999996 108.916 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.09 132.51 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.558 -0.714 . . . . 71.019999999999996 109.783 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -73.53 -30.1 62.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.839 . . . . 72.120000000000005 109.7 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -58.48 -82.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.891 . . . . 64.409999999999997 110.312 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -82.24 -47.55 12.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.891 -1.131 . . . . 71.540000000000006 109.865 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 152.42 -110.8 0.47 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.976 -1.65 . . . . 72.030000000000001 108.976 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 163' ' ' VAL . 79.6 m-85 -112.11 140.41 46.82 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.433 -1.04 . . . . 75.540000000000006 108.714 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 25.8 mtm180 -121.3 129.79 53.3 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.423 -0.798 . . . . 75.310000000000002 109.522 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -97.47 119.54 36.2 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.296 -0.878 . . . . 75.409999999999997 108.906 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 28.2 m -130.91 161.22 32.35 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.354 -0.841 . . . . 74.140000000000001 109.75 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -72.27 151.06 92.16 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 75.319999999999993 109.08 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_exo -39.68 135.02 1.42 Allowed 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 121.974 1.783 . . . . 73.109999999999999 112.079 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 9.5 tptp -78.27 -38.26 1.55 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.114 -0.991 . . . . 75.25 110.003 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 50.7 Cg_exo -56.02 -34.63 92.93 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 122.191 1.927 . . . . 75.099999999999994 111.952 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -62.75 113.13 2.84 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.35 -0.843 . . . . 71.140000000000001 109.149 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . 0.562 ' O ' ' N ' ' A' ' 223' ' ' GLU . 26.3 t -160.92 144.95 13.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 71.129999999999995 109.825 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 60.85 -67.75 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.732 -0.605 . . . . 75.349999999999994 110.159 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.562 ' N ' ' O ' ' A' ' 221' ' ' CYS . 90.3 mt-10 . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.01 -0.995 . . . . 73.409999999999997 109.831 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.447 ' SD ' ' CE2' ' B' ' 25' ' ' PHE . 51.5 ttm . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.512 -0.551 . . . . 71.140000000000001 109.512 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -137.1 139.71 41.44 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.416 -0.802 . . . . 73.230000000000004 109.307 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 90.3 t -110.05 133.92 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.597 -0.689 . . . . 72.239999999999995 109.698 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.462 HD12 ' N ' ' B' ' 5' ' ' LEU . 2.6 tp -102.92 119.21 38.44 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.556 -0.715 . . . . 54.329999999999998 109.166 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.462 ' N ' HD12 ' B' ' 4' ' ' LEU . 19.5 mt -114.6 96.23 5.65 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.814 -0.81 . . . . 74.349999999999994 108.814 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.676 HD12 ' HB ' ' B' ' 50' ' ' VAL . 88.2 mt -81.43 98.19 3.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 O-C-N 120.727 -1.233 . . . . 42.549999999999997 108.494 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.434 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 28.3 tp10 -137.55 125.13 22.17 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.399 -0.813 . . . . 74.519999999999996 109.72 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 19.5 tptp -69.3 -31.17 69.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.31 -0.869 . . . . 62.549999999999997 108.896 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -85.25 112.19 20.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.379 -0.826 . . . . 73.109999999999999 109.447 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 96.9 p -68.09 -23.18 64.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.243 -0.911 . . . . 65.540000000000006 109.572 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 84.9 t -65.13 -52.62 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 75.549999999999997 109.614 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.469 HD23 ' OE2' ' B' ' 15' ' ' GLU . 62.3 mt -65.8 -37.4 86.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 70.140000000000001 109.686 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.29 -28.86 69.21 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.678 -1.769 . . . . 75.400000000000006 108.678 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.94 -53.26 41.97 Favored Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.721 -1.351 . . . . 65.439999999999998 109.721 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.469 ' OE2' HD23 ' B' ' 12' ' ' LEU . 15.0 pt-20 -58.96 -46.81 87.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.323 -1.104 . . . . 60.210000000000001 109.953 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 35.7 mm -64.52 -40.25 88.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.748 -1.22 . . . . 75.150000000000006 108.877 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -61.94 -44.65 96.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.364 -0.835 . . . . 73.010000000000005 109.446 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 15.5 tptm -85.48 1.72 47.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.187 -0.945 . . . . 74.299999999999997 108.964 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.4 -55.38 2.21 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 109.74 -1.344 . . . . 70.540000000000006 109.74 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -74.04 -19.7 60.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -1.184 . . . . 71.340000000000003 109.752 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -52.14 -32.78 37.15 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.17 -0.956 . . . . 64.409999999999997 109.521 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 79.4 t -58.7 -37.16 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.154 -0.966 . . . . 74.230000000000004 109.156 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -70.17 -13.81 62.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.362 -0.837 . . . . 63.420000000000002 109.41 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.44 38.78 6.99 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.844 -1.302 . . . . 53.43 109.844 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . 0.447 ' CE2' ' SD ' ' B' ' 1' ' ' MET . 15.6 m-85 -114.43 159.49 20.24 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.508 -0.995 . . . . 71.120000000000005 109.065 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.2 mmt -103.92 139.73 38.68 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.411 -0.959 . . . . 75.239999999999995 108.411 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.41 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -139.95 154.93 47.33 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.272 -0.892 . . . . 72.120000000000005 110.096 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 83.1 m-20 -134.65 158.03 45.12 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.482 -0.933 . . . . 72.310000000000002 108.482 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.03 139.67 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.352 -0.843 . . . . 64.430000000000007 109.866 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 6.1 p -134.48 170.08 16.29 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.586 -0.696 . . . . 65.409999999999997 109.196 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -94.08 -105.77 0.13 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.165 -0.96 . . . . 71.019999999999996 109.774 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 37.3 t -78.2 173.64 12.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.236 -0.915 . . . . 51.109999999999999 110.059 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.653 HD12 ' CG ' ' B' ' 58' ' ' PHE . 3.7 mm? -55.27 -39.26 69.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.518 -0.739 . . . . 71.239999999999995 109.681 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -46.56 -45.74 18.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 74.319999999999993 110.031 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -71.59 -38.73 70.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.103 -0.998 . . . . 73.030000000000001 109.249 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.18 -42.7 91.03 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.18 -1.568 . . . . 30.210000000000001 109.18 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -67.94 -40.74 83.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.294 -1.121 . . . . 74.420000000000002 109.453 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -72.17 -37.55 69.31 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.196 -0.94 . . . . 74.420000000000002 109.841 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 21.7 tp -72.14 -48.23 45.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -0.931 . . . . 75.409999999999997 110.12 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . 0.445 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.9 ppp? -66.95 -19.75 65.78 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.032 -1.043 . . . . 60.409999999999997 109.923 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -61.4 -40.72 95.39 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.081 -1.012 . . . . 53.229999999999997 110.058 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.438 HD12 ' NH1' ' B' ' 43' ' ' ARG . 19.0 pt -82.82 -29.73 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.129 -0.982 . . . . 71.230000000000004 110.278 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.438 ' NH1' HD12 ' B' ' 42' ' ' ILE . 75.1 mtt85 -130.43 143.89 51.05 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.287 -0.883 . . . . 72.219999999999999 109.758 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -97.69 130.77 44.65 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.251 -0.906 . . . . 63.539999999999999 109.233 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -99.76 139.97 34.65 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.316 -0.865 . . . . 64.349999999999994 109.411 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -75.11 -37.06 61.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 62.219999999999999 109.237 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.566 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.9 OUTLIER -113.59 116.93 30.28 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.641 -0.874 . . . . 73.120000000000005 108.641 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.566 ' N ' HD13 ' B' ' 47' ' ' LEU . 72.3 t -98.43 98.22 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.354 -0.98 . . . . 65.109999999999999 108.354 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 0.5 OUTLIER -110.38 131.09 55.36 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.462 0.648 . . . . 73.439999999999998 109.288 -179.006 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.676 ' HB ' HD12 ' B' ' 6' ' ' ILE . 0.5 OUTLIER -145.73 135.6 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.437 -0.789 . . . . 34.5 109.607 -179.626 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . 0.434 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 14.7 p -98.8 14.03 30.26 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.541 -0.724 . . . . 73.209999999999994 109.661 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.631 ' H ' HG22 ' B' ' 50' ' ' VAL . 23.9 m-20 -82.9 140.3 32.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.184 -0.948 . . . . 70.409999999999997 109.468 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' B' ' 55' ' ' ALA . 14.4 mtpp -74.69 -39.73 61.8 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.254 -0.904 . . . . 65.0 110.134 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -71.41 10.98 0.52 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.108 -0.995 . . . . 75.209999999999994 109.695 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -66.27 -22.97 66.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 55.329999999999998 110.247 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 37.5 mt -45.72 -45.49 14.38 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.219 -0.926 . . . . 63.140000000000001 110.151 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 83.5 p -70.24 -38.39 75.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.892 -1.13 . . . . 63.5 109.364 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . 0.653 ' CG ' HD12 ' B' ' 33' ' ' LEU . 48.9 t80 -66.19 -61.11 2.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.339 -0.851 . . . . 72.329999999999998 109.762 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 20.7 m -50.32 -34.8 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.546 -1.346 . . . . 74.540000000000006 109.7 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 44.8 m -56.77 -51.58 68.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.115 -0.991 . . . . 71.239999999999995 109.534 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -69.38 -32.14 70.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.981 -1.074 . . . . 74.310000000000002 110.19 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' B' ' 66' ' ' HIS . 39.5 mm -65.74 -42.41 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.676 -1.265 . . . . 72.140000000000001 110.133 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -65.78 -49.6 67.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.209 -0.932 . . . . 73.319999999999993 110.695 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.422 ' CG ' ' N ' ' B' ' 65' ' ' LYS . 7.5 pt-20 -69.17 -41.62 76.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.7 -1.25 . . . . 73.120000000000005 109.838 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.496 ' O ' ' ND1' ' B' ' 66' ' ' HIS . 85.6 mttt -79.7 -18.69 50.7 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.25 -0.906 . . . . 72.439999999999998 109.563 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.496 ' ND1' ' O ' ' B' ' 65' ' ' LYS . 69.1 m-70 -154.82 67.59 0.69 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.141 -0.974 . . . . 63.310000000000002 109.698 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 54.6 p -67.18 -25.0 65.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.176 -0.953 . . . . 73.099999999999994 109.553 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 24.0 m -64.08 -27.06 68.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.305 -0.872 . . . . 71.530000000000001 109.895 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 84.5 mt -81.23 152.99 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.156 -0.965 . . . . 74.400000000000006 109.687 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 67.2 t -94.81 154.18 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.356 -0.84 . . . . 75.120000000000005 109.181 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.427 ' H ' ' HB2' ' B' ' 92' ' ' ASP . 11.3 t -133.64 130.52 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.309 -0.87 . . . . 73.200000000000003 110.049 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.508 ' O ' ' SD ' ' B' ' 49' ' ' MET . 6.5 tt -122.98 104.0 8.96 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.864 -0.791 . . . . 73.340000000000003 108.864 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 9.1 p -95.45 137.07 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.977 -1.077 . . . . 73.5 108.961 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 3.9 p -96.68 170.88 8.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.297 -0.877 . . . . 64.340000000000003 109.552 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.481 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 42.9 t -157.67 114.85 2.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.169 -0.957 . . . . 74.530000000000001 110.232 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' B' ' 77' ' ' ASN . 52.1 p-10 -66.6 -21.45 66.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.221 -0.924 . . . . 64.5 109.264 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . 0.517 ' N ' ' OD1' ' B' ' 76' ' ' ASP . 56.6 t-20 -126.53 75.95 74.08 Favored Pre-proline 0 N--CA 1.497 1.909 0 N-CA-C 108.633 -0.877 . . . . 74.25 108.633 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -44.31 85.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.32 2.013 . . . . 74.430000000000007 111.724 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.515 ' N ' ' O ' ' B' ' 77' ' ' ASN . 7.4 m -94.67 150.24 20.42 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.635 0.731 . . . . 73.120000000000005 110.065 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.9 p -76.78 -43.16 37.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.539 -0.726 . . . . 71.010000000000005 109.655 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -56.73 -35.24 68.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.135 -0.978 . . . . 63.200000000000003 109.012 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -74.2 -34.72 63.83 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.098 -1.001 . . . . 73.219999999999999 108.97 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.522 ' OE1' ' CG ' ' B' ' 94' ' ' TYR . 42.1 tp10 -65.84 -55.95 14.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.257 -0.902 . . . . 74.299999999999997 109.609 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.459 HG23 ' N ' ' B' ' 85' ' ' HIS . 31.4 m -53.44 -41.93 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.994 -1.066 . . . . 73.310000000000002 108.968 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' HIS . . . . . 0.459 ' N ' HG23 ' B' ' 84' ' ' VAL . 46.6 m80 -74.26 -20.09 60.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.174 -0.954 . . . . 73.239999999999995 109.597 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -68.75 -40.87 79.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.945 -1.097 . . . . 55.329999999999998 110.428 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' PHE . . . . . 0.635 ' CE2' ' HB1' ' A' ' 107' ' ' ALA . 0.5 OUTLIER -83.3 -30.48 27.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.871 -1.143 . . . . 74.140000000000001 109.112 -179.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -77.27 -44.37 30.03 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.11 -0.993 . . . . 64.040000000000006 109.25 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -65.44 -54.96 21.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.425 -0.797 . . . . 72.349999999999994 109.496 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 154.72 72.81 0.01 OUTLIER Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.608 -1.282 . . . . 65.200000000000003 110.472 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -140.44 140.87 35.48 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.272 -1.134 . . . . 52.229999999999997 108.84 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.427 ' HB2' ' H ' ' B' ' 71' ' ' VAL . 54.3 m-20 -94.99 -22.99 17.58 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.06 -1.025 . . . . 73.319999999999993 109.824 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 17.4 t0 -151.78 158.32 43.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.09 -1.007 . . . . 72.219999999999999 109.609 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.522 ' CG ' ' OE1' ' B' ' 83' ' ' GLU . 55.8 t80 -142.9 104.91 4.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.478 -0.764 . . . . 64.420000000000002 108.969 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 27.2 mm -114.37 151.92 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.542 0 O-C-N 121.127 -0.983 . . . . 72.230000000000004 110.22 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.27 144.26 57.26 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.987 -1.116 . . . . 25.239999999999998 107.987 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.687 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -64.32 -54.42 38.63 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.765 -1.21 . . . . 64.319999999999993 111.516 -179.301 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 3.5 Cg_endo -41.45 -8.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 120.851 1.034 . . . . 63.329999999999998 113.341 -176.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . 0.687 ' N ' ' O ' ' B' ' 97' ' ' LYS . 44.7 m-85 59.06 110.22 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.366 -0.834 . . . . 75.129999999999995 109.322 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . 0.511 ' NH1' ' OE2' ' A' ' 83' ' ' GLU . 13.2 ttm180 -57.98 -34.2 69.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.009 -1.057 . . . . 74.230000000000004 108.88 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . 0.778 ' O ' ' N ' ' B' ' 103' ' ' LYS . 47.9 t -174.26 32.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.148 -0.97 . . . . 63.340000000000003 110.836 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 49.9 mt 49.62 -69.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 118.745 0.702 . . . . 74.439999999999998 110.193 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.778 ' N ' ' O ' ' B' ' 101' ' ' SER . 40.6 tptt -51.77 -31.17 25.76 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.603 -1.258 . . . . 71.109999999999999 107.603 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.97 -40.72 83.09 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.608 -0.886 . . . . 71.450000000000003 108.608 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 51.9 tp -66.22 -45.86 79.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.448 -0.782 . . . . 51.310000000000002 109.022 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 42.4 t -66.89 -41.1 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.919 . . . . 65.230000000000004 109.3 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.06 -45.22 64.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.254 -0.903 . . . . 24.32 109.375 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 67.2 ttt-85 -69.07 -33.52 73.69 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.911 . . . . 75.310000000000002 109.671 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 96.6 mt -72.23 -29.11 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.104 -0.997 . . . . 54.240000000000002 108.767 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -67.72 -58.87 3.9 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.471 -0.891 . . . . 65.310000000000002 108.938 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -52.97 -32.11 44.34 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.305 -0.872 . . . . 72.239999999999995 109.108 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 25.6 tpt85 -58.9 -50.41 74.15 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.288 -0.883 . . . . 72.040000000000006 109.277 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 63.1 mt -146.19 103.52 3.72 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.174 -0.954 . . . . 75.349999999999994 109.995 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -98.47 107.48 19.95 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.465 -0.939 . . . . 75.5 108.465 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 78.1 t80 49.62 86.5 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 65.329999999999998 109.558 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 -82.39 142.79 31.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.194 -0.941 . . . . 74.450000000000003 109.45 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 163.27 86.39 0.06 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.599 -1.4 . . . . 44.210000000000001 109.599 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . 0.451 ' O ' ' ND2' ' B' ' 119' ' ' ASN . 8.9 t -157.61 -175.26 5.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -1.128 . . . . 71.400000000000006 109.745 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' B' ' 118' ' ' SER . 0.0 OUTLIER -153.83 137.57 16.13 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.832 -0.747 . . . . 72.319999999999993 109.114 -178.205 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 6.9 t -71.8 -36.75 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 75.019999999999996 109.617 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 20.8 mm -103.25 132.74 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.328 -0.858 . . . . 51.409999999999997 109.287 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -135.7 119.26 17.01 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.434 -0.791 . . . . 71.530000000000001 109.24 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.436 ' O ' HG23 ' B' ' 123' ' ' ILE . 14.5 tt -145.67 130.5 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.262 -0.898 . . . . 72.430000000000007 109.235 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.46 -153.31 1.01 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.424 -1.47 . . . . 51.229999999999997 109.424 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -79.82 2.1 24.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.152 -1.205 . . . . 74.200000000000003 109.049 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.63 135.17 37.65 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.356 -0.979 . . . . 75.420000000000002 108.356 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 1.2 p -130.9 145.18 51.93 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.361 -0.837 . . . . 74.219999999999999 109.198 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 14.0 mt -133.69 140.41 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.446 -0.784 . . . . 60.329999999999998 109.066 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 3.6 t -123.02 81.89 50.87 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.635 -0.665 . . . . 72.310000000000002 109.307 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.67 -48.09 23.79 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.169 1.912 . . . . 75.129999999999995 112.589 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -52.57 -45.76 66.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.083 -1.011 . . . . 75.230000000000004 109.232 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -86.98 2.18 50.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.261 -0.9 . . . . 72.430000000000007 109.137 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 53.12 18.07 1.09 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 75.129999999999995 109.391 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -101.46 130.92 47.8 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.432 -0.793 . . . . 73.219999999999999 109.459 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . 0.428 HG23 ' O ' ' B' ' 135' ' ' ILE . 16.2 tt -113.12 133.24 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.536 -0.728 . . . . 64.140000000000001 109.095 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 2.5 mp -114.56 131.63 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.504 -0.748 . . . . 71.219999999999999 109.327 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -137.76 126.68 24.09 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.333 -0.854 . . . . 64.219999999999999 109.866 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp 52.76 34.78 16.98 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.369 -0.832 . . . . 72.019999999999996 110.413 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.35 13.89 82.78 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 120.041 -1.076 . . . . 74.319999999999993 110.723 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 53.0 mtt-85 -109.3 122.81 48.15 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.311 -1.111 . . . . 75.340000000000003 109.136 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -92.08 136.59 33.06 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.189 -0.944 . . . . 71.230000000000004 109.373 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.79 135.25 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.449 -0.782 . . . . 70.430000000000007 109.158 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -88.25 125.42 34.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.202 -0.936 . . . . 72.430000000000007 109.096 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 3.2 m -143.97 124.89 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.218 -0.926 . . . . 72.129999999999995 109.471 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -156.59 16.99 0.32 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.338 -0.852 . . . . 72.019999999999996 109.271 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -66.64 164.44 42.23 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.242 -1.543 . . . . 42.229999999999997 109.242 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 0.569 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 2.8 tmtp? -58.11 -43.98 98.87 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.222 -1.163 . . . . 73.299999999999997 109.224 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 23.3 Cg_exo -63.56 -20.63 69.81 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.591 2.194 . . . . 71.329999999999998 112.331 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . 0.491 ' CE2' HG23 ' B' ' 153' ' ' THR . 86.1 t80 -89.24 -22.65 22.63 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.175 -0.953 . . . . 74.230000000000004 110.035 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -50.53 -41.87 54.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.078 -1.014 . . . . 72.340000000000003 109.444 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 11.0 p -66.53 -32.4 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.173 -0.955 . . . . 73.349999999999994 109.084 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.522 ' O ' HD13 ' B' ' 152' ' ' LEU . 0.2 OUTLIER -56.79 -43.64 81.1 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.707 -0.849 . . . . 55.240000000000002 108.707 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.491 HG23 ' CE2' ' B' ' 149' ' ' PHE . 2.7 p -73.65 -30.73 63.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.103 -0.998 . . . . 70.010000000000005 109.193 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -55.02 -54.07 47.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.912 . . . . 65.319999999999993 109.744 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.04 -28.94 63.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.071 -1.018 . . . . 71.540000000000006 109.572 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.15 -49.84 65.77 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.233 -0.917 . . . . 75.319999999999993 109.583 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.427 ' C ' ' H ' ' B' ' 159' ' ' ARG . 24.3 mtp180 -71.47 -44.94 63.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 73.319999999999993 109.387 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -74.94 20.47 0.13 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.415 -0.803 . . . . 74.140000000000001 109.793 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . 0.427 ' H ' ' C ' ' B' ' 157' ' ' ARG . 6.6 mmt85 -54.3 173.51 0.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.042 -1.037 . . . . 61.409999999999997 108.88 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . 0.412 ' OD2' ' O ' ' B' ' 160' ' ' ASP . 4.6 p-10 42.37 47.47 4.25 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.544 -0.722 . . . . 72.099999999999994 110.276 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -161.32 157.76 25.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.261 -0.9 . . . . 72.25 109.459 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' ILE . . . . . 0.745 HD12 ' N ' ' B' ' 162' ' ' ILE . 1.8 mp -91.37 131.41 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.237 -0.915 . . . . 72.310000000000002 109.174 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . 0.405 HG11 HD21 ' B' ' 168' ' ' LEU . 40.3 t -123.59 136.56 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.529 -0.732 . . . . 64.209999999999994 109.335 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 11.3 p -83.39 158.35 22.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 74.219999999999999 109.568 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -62.54 -43.51 98.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.861 . . . . 65.310000000000002 109.349 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -65.53 -34.5 78.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 63.450000000000003 109.888 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 56.8 tp60 -50.76 -49.38 58.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.11 -0.994 . . . . 72.400000000000006 109.39 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . 0.405 HD21 HG11 ' B' ' 163' ' ' VAL . 53.6 mt -66.42 -40.33 89.47 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.199 -0.938 . . . . 72.319999999999993 109.355 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.507 HD23 ' C ' ' B' ' 169' ' ' LEU . 3.7 tt -48.99 -59.12 3.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 73.340000000000003 109.482 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' B' ' 174' ' ' GLU . 78.0 m-20 -67.88 -41.4 82.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.25 -0.906 . . . . 72.099999999999994 110.14 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' B' ' 170' ' ' ASP . . . -43.1 -47.72 6.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.376 -0.827 . . . . 62.130000000000003 110.586 -179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 16.4 mm -94.96 -9.94 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.056 -1.028 . . . . 71.420000000000002 110.267 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -147.69 49.66 1.07 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.848 -1.158 . . . . 72.230000000000004 110.446 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . 0.515 ' N ' ' O ' ' B' ' 170' ' ' ASP . 88.2 tt0 -76.08 -32.57 59.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.011 -1.055 . . . . 52.109999999999999 108.995 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . 0.547 ' O ' ' N ' ' B' ' 177' ' ' GLU . 28.5 mt-10 -57.06 154.27 20.6 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.35 -0.844 . . . . 73.040000000000006 109.187 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -41.45 -14.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 122.437 2.092 . . . . 74.129999999999995 112.828 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' B' ' 175' ' ' GLU . 77.8 mm-40 -46.19 121.96 3.65 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.138 -0.976 . . . . 72.439999999999998 109.807 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 63.9 mtm -89.34 122.37 32.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.895 . . . . 63.43 109.394 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 1.2 m -103.12 143.58 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.426 -0.796 . . . . 71.049999999999997 109.19 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . 0.443 ' O ' ' O ' ' B' ' 181' ' ' PRO . 22.7 m -63.41 135.16 96.13 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.337 -0.852 . . . . 62.149999999999999 109.484 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' B' ' 180' ' ' THR . 95.8 Cg_exo -41.11 171.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.181 1.921 . . . . 65.219999999999999 112.783 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 3.2 m120 61.32 39.52 15.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.398 -0.814 . . . . 72.310000000000002 109.411 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 25.4 t -79.33 -49.65 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.884 . . . . 63.32 109.802 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.432 ' O ' HG22 ' B' ' 188' ' ' ILE . 27.7 mm -70.0 -24.85 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 75.030000000000001 110.183 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -64.18 -44.51 91.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.831 -1.168 . . . . 64.109999999999999 109.306 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 19.4 m -77.21 -31.85 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.203 -0.936 . . . . 73.0 109.59 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.2 -50.24 20.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.06 -1.025 . . . . 61.119999999999997 110.014 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 188' ' ' ILE . . . . . 0.625 HD12 ' CZ ' ' B' ' 212' ' ' TYR . 1.8 tt -59.43 -44.78 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.154 -0.966 . . . . 72.430000000000007 110.151 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 189' ' ' ASN . . . . . 0.521 ' N ' HG23 ' B' ' 188' ' ' ILE . 58.4 t30 -60.3 -43.58 96.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.091 -1.006 . . . . 65.140000000000001 109.584 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . 0.414 ' O ' ' CB ' ' B' ' 194' ' ' LYS . 15.1 mm-40 -68.64 -46.51 68.99 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.258 -0.901 . . . . 63.240000000000002 109.882 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 82.3 mt -54.47 -30.26 21.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 120.654 -1.279 . . . . 74.030000000000001 109.791 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 65.8 mtp85 -73.01 -60.84 2.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.013 -1.055 . . . . 72.239999999999995 110.871 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 193' ' ' GLN . . . . . 0.429 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 76.0 mt-30 -70.94 -32.8 69.81 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.027 -1.046 . . . . 73.099999999999994 110.252 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' B' ' 190' ' ' GLN . 20.7 ttpp -72.02 -26.82 62.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.478 -0.764 . . . . 72.109999999999999 110.696 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 17.4 tpt -92.44 -44.49 8.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.889 -1.132 . . . . 44.329999999999998 110.016 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 196' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 59.3 p30 -64.17 -19.65 65.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.034 -1.041 . . . . 71.209999999999994 110.086 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . 0.533 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 29.7 mttm -67.96 -64.75 1.74 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.081 -1.012 . . . . 75.209999999999994 109.198 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 198' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 39.7 Cg_endo -64.88 -50.99 1.88 Allowed 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.075 1.85 . . . . 75.319999999999993 110.976 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . 0.903 HD21 ' O ' ' B' ' 201' ' ' ILE . 0.0 OUTLIER -95.74 134.53 38.57 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.868 -1.16 . . . . 72.25 107.868 179.303 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . -97.96 -8.52 55.4 Favored Glycine 0 N--CA 1.498 2.816 0 O-C-N 121.083 -1.011 . . . . 64.530000000000001 110.615 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . 0.903 ' O ' HD21 ' B' ' 199' ' ' LEU . 70.2 mt -91.74 124.84 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.023 -1.281 . . . . 44.229999999999997 109.471 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 23.3 t -77.26 135.82 38.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 54.009999999999998 109.603 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 2.0 p -145.31 28.24 1.22 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.261 -0.899 . . . . 74.400000000000006 109.281 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 35.8 m -135.64 138.37 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.395 -0.816 . . . . 72.120000000000005 109.466 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -126.34 136.48 52.78 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.582 -0.699 . . . . 65.409999999999997 109.281 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 10.5 p -95.05 139.37 31.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.208 -0.933 . . . . 71.329999999999998 109.422 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.462 ' N ' ' O ' ' B' ' 211' ' ' GLY . 39.0 t -131.6 124.44 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.522 -0.736 . . . . 63.5 109.197 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 208' ' ' ARG . . . . . 0.467 ' N ' ' CD ' ' B' ' 208' ' ' ARG . 1.3 mpt_? -76.5 -34.93 58.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.297 -0.877 . . . . 74.450000000000003 109.822 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . 0.413 ' CD ' ' N ' ' B' ' 209' ' ' ARG . 11.7 mpt_? -56.17 -62.74 1.5 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.151 -0.968 . . . . 74.140000000000001 109.68 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 62.1 mmt-85 -98.81 -76.45 0.54 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.235 -0.915 . . . . 74.430000000000007 109.529 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' B' ' 207' ' ' VAL . . . -167.26 -107.41 0.2 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.528 -1.429 . . . . 64.450000000000003 109.528 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' TYR . . . . . 0.625 ' CZ ' HD12 ' B' ' 188' ' ' ILE . 2.9 m-85 -120.58 133.96 55.33 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.592 -0.946 . . . . 74.209999999999994 109.346 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -104.77 126.53 51.95 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.494 -0.753 . . . . 74.030000000000001 109.083 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -101.96 125.89 48.75 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.348 -0.845 . . . . 74.340000000000003 109.276 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 20.5 p -142.76 154.26 44.08 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.336 -0.852 . . . . 64.329999999999998 109.378 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -63.96 154.24 82.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 70.040000000000006 108.865 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -38.23 147.3 0.11 Allowed 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.178 1.918 . . . . 65.109999999999999 111.902 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.588 ' N ' ' CD ' ' B' ' 219' ' ' PRO . 21.1 mttp -72.95 -36.6 3.47 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 73.150000000000006 111.355 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' B' ' 218' ' ' LYS . 86.9 Cg_endo -87.88 12.85 2.76 Favored 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.108 1.872 . . . . 71.310000000000002 112.135 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -60.81 145.71 48.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 75.450000000000003 109.321 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 36.3 t -140.36 154.3 46.69 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.324 -0.86 . . . . 72.219999999999999 109.396 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -157.54 164.6 37.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.892 . . . . 54.530000000000001 109.363 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.011 -0.995 . . . . 71.129999999999995 109.42 -179.911 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.2 ttm . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.518 -0.549 . . . . 65.120000000000005 109.518 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.485 ' N ' ' OD2' ' A' ' 46' ' ' ASP . 97.6 mtt180 -129.65 156.77 43.71 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.497 -0.752 . . . . 72.329999999999998 109.17 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.0 t -118.65 124.44 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 CA-C-O 121.792 0.806 . . . . 71.420000000000002 110.014 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.518 HD11 ' CG1' ' A' ' 6' ' ' ILE . 2.1 tp -94.07 117.35 29.97 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.398 -0.964 . . . . 65.120000000000005 108.398 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 6' ' ' ILE . 3.7 tt -119.44 119.43 33.88 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.092 -1.077 . . . . 62.43 108.092 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.539 ' N ' HD23 ' A' ' 5' ' ' LEU . 56.3 mt -110.91 99.48 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.316 -0.865 . . . . 71.150000000000006 109.259 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.425 ' O ' ' O ' ' A' ' 30' ' ' THR . 36.2 tp10 -122.94 133.2 54.4 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.56 -0.712 . . . . 75.340000000000003 109.423 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -66.34 -34.47 78.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.242 -0.911 . . . . 72.439999999999998 109.555 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 10' ' ' SER . 21.6 p30 -82.98 -149.72 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.24 -0.913 . . . . 63.020000000000003 109.471 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.498 ' N ' ' OD1' ' A' ' 9' ' ' ASN . 20.9 p -152.55 -39.63 0.11 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.215 -0.928 . . . . 72.340000000000003 109.67 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.556 HG13 ' N ' ' A' ' 12' ' ' LEU . 11.1 p -64.39 -44.14 97.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 74.019999999999996 109.725 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.556 ' N ' HG13 ' A' ' 11' ' ' VAL . 14.9 tp -65.28 -39.19 92.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 71.430000000000007 109.312 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.75 -28.03 69.78 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 108.035 -2.026 . . . . 61.32 108.035 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.12 -46.04 94.13 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 110.07 -1.212 . . . . 71.200000000000003 110.07 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -65.98 -47.15 75.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -1.203 . . . . 71.319999999999993 109.832 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.8 mm -65.51 -36.53 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.603 -1.311 . . . . 63.229999999999997 108.372 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.478 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 86.7 tt0 -65.54 -47.91 74.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.464 -0.773 . . . . 51.109999999999999 109.798 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -83.52 1.18 43.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.089 -1.007 . . . . 73.340000000000003 109.748 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.24 -55.17 2.54 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.567 -1.413 . . . . 62.149999999999999 109.567 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.402 HD23 ' N ' ' A' ' 21' ' ' ASN . 1.3 pt? -76.23 -21.79 55.98 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.246 -1.15 . . . . 73.510000000000005 109.917 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 92.9 m-20 -55.22 -32.28 62.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.034 -1.041 . . . . 74.25 109.345 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.3 t -60.02 -38.31 76.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.321 -0.862 . . . . 70.040000000000006 109.359 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.496 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 3.4 mptp? -62.68 -26.47 68.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.354 -0.842 . . . . 73.230000000000004 109.275 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.89 24.14 5.32 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 110.215 -1.154 . . . . 75.540000000000006 110.215 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -105.33 157.51 17.27 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.227 -1.16 . . . . 73.430000000000007 109.091 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.0 mmm -104.24 136.96 42.87 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.134 -1.061 . . . . 43.240000000000002 108.134 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.26 160.25 41.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.193 -0.942 . . . . 62.109999999999999 109.851 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -140.57 145.39 36.67 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.411 -0.806 . . . . 74.420000000000002 109.526 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 t -104.13 134.92 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.462 -0.94 . . . . 72.150000000000006 108.462 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.425 ' O ' ' O ' ' A' ' 7' ' ' GLU . 6.5 p -131.04 172.44 12.08 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.39 -0.819 . . . . 71.420000000000002 109.44 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -92.26 -104.54 0.11 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.24 -0.913 . . . . 72.329999999999998 110.001 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.4 p -78.8 167.41 21.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.245 -0.909 . . . . 74.239999999999995 110.269 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 35.7 mt -54.17 -29.62 46.33 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.635 -0.666 . . . . 71.530000000000001 109.857 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -47.79 -49.36 28.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.049 -1.032 . . . . 74.230000000000004 109.719 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -68.12 -38.39 82.19 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.142 -0.974 . . . . 54.030000000000001 109.222 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.84 -45.05 59.69 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.377 -1.489 . . . . 61.409999999999997 109.377 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -65.75 -38.44 89.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -1.103 . . . . 74.340000000000003 109.265 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -75.41 -37.52 60.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.151 -0.968 . . . . 75.329999999999998 109.679 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.3 tp -72.7 -47.55 46.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 74.329999999999998 110.101 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.495 ' SD ' ' OD1' ' A' ' 41' ' ' ASP . 3.7 ppp? -63.73 -28.71 70.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.105 -0.997 . . . . 70.319999999999993 110.083 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.495 ' OD1' ' SD ' ' A' ' 40' ' ' MET . 99.3 m-20 -65.6 -39.9 92.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.036 -1.04 . . . . 71.219999999999999 110.016 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.0 pt -82.88 -29.63 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.148 -0.97 . . . . 74.140000000000001 110.251 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 40' ' ' MET . 93.0 mtt180 -129.89 146.89 51.61 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.323 -0.861 . . . . 72.239999999999995 109.514 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -91.28 161.7 14.93 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.206 -0.934 . . . . 75.420000000000002 109.654 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -143.11 153.67 43.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.337 -0.852 . . . . 74.230000000000004 109.142 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.485 ' OD2' ' N ' ' A' ' 2' ' ' ARG . 3.8 p30 -95.41 -41.5 8.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.192 -0.943 . . . . 72.040000000000006 109.514 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.525 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.3 OUTLIER -104.84 115.76 30.85 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.433 -0.792 . . . . 72.129999999999995 109.05 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.525 ' N ' HD13 ' A' ' 47' ' ' LEU . 74.5 t -101.49 97.8 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.389 -0.967 . . . . 72.340000000000003 108.389 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -114.27 130.66 56.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.491 -0.756 . . . . 74.109999999999999 110.303 -178.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.561 HG22 ' H ' ' A' ' 52' ' ' ASP . 1.5 p -138.4 129.36 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 121.728 0.775 . . . . 61.119999999999997 109.652 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.8 t -92.14 3.67 54.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.49 -0.757 . . . . 73.109999999999999 109.199 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.561 ' H ' HG22 ' A' ' 50' ' ' VAL . 51.8 m-20 -76.28 138.07 40.31 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.305 -0.872 . . . . 52.549999999999997 109.509 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.493 ' C ' ' H ' ' A' ' 55' ' ' ALA . 28.1 mtmm -67.94 -35.25 78.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.179 -0.95 . . . . 44.219999999999999 110.049 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -71.36 17.08 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.153 -0.967 . . . . 70.439999999999998 109.734 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.493 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -60.29 -30.4 69.45 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.934 . . . . 64.140000000000001 110.085 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.412 ' HG ' ' H ' ' A' ' 56' ' ' LEU . 22.3 mt -46.07 -43.85 14.96 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.087 -1.008 . . . . 44.140000000000001 110.097 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.2 p -73.21 -40.23 64.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.93 -1.106 . . . . 55.229999999999997 109.627 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.63 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 58.8 t80 -65.13 -56.9 10.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.408 -0.807 . . . . 74.439999999999998 110.127 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.459 HG23 ' N ' ' A' ' 60' ' ' SER . 17.2 m -54.05 -38.2 37.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 120.839 -1.163 . . . . 74.030000000000001 109.638 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.459 ' N ' HG23 ' A' ' 59' ' ' VAL . 46.2 p -54.83 -52.73 61.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.176 -0.952 . . . . 64.299999999999997 109.662 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -69.63 -29.81 67.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.088 -1.008 . . . . 64.439999999999998 110.342 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.63 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 6.1 mm -68.16 -47.9 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.639 -1.288 . . . . 63.210000000000001 110.357 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.466 ' NZ ' ' OD2' ' A' ' 92' ' ' ASP . 41.4 mmtt -62.85 -43.7 98.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.065 -1.022 . . . . 74.420000000000002 110.691 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.403 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 7.0 pt-20 -73.55 -41.05 63.46 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.71 -1.244 . . . . 70.319999999999993 109.747 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.447 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 25.6 mtpp -78.17 -19.84 53.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.151 -0.968 . . . . 75.219999999999999 109.143 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.572 ' O ' HG22 ' A' ' 69' ' ' ILE . 91.7 m-70 -154.94 69.46 0.73 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 74.129999999999995 109.222 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 84.0 p -63.58 -27.2 69.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.31 -0.869 . . . . 73.239999999999995 110.085 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.6 t -79.5 48.95 0.95 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.058 -1.026 . . . . 61.009999999999998 109.856 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.572 HG22 ' O ' ' A' ' 66' ' ' HIS . 13.8 tt -146.68 156.59 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.084 -1.01 . . . . 71.329999999999998 109.456 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.9 t -92.81 154.15 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.171 -0.956 . . . . 72.129999999999995 109.51 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.518 ' N ' ' OD2' ' A' ' 92' ' ' ASP . 21.3 t -135.96 125.99 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.075 0 O-C-N 121.299 -0.876 . . . . 54.210000000000001 110.074 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.533 HD13 ' C ' ' A' ' 72' ' ' LEU . 1.3 tm? -118.62 101.67 8.3 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.423 -0.955 . . . . 50.240000000000002 108.423 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -95.5 138.94 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.933 -1.104 . . . . 74.409999999999997 109.57 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.1 m -122.86 161.31 24.32 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.677 -0.86 . . . . 72.310000000000002 108.677 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.514 ' O ' ' N ' ' A' ' 77' ' ' ASN . 3.0 p -172.2 121.43 0.45 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.999 -1.063 . . . . 64.540000000000006 109.971 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.415 ' N ' ' HB2' ' A' ' 97' ' ' LYS . 50.8 p30 -64.31 63.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.701 -0.624 . . . . 74.129999999999995 109.931 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 75' ' ' SER . 2.9 p30 -177.14 53.65 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.201 -0.937 . . . . 73.340000000000003 109.669 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 77' ' ' ASN . 6.9 Cg_endo -48.84 84.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.365 2.043 . . . . 63.219999999999999 111.729 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.712 HG23 ' H ' ' A' ' 82' ' ' GLU . 2.9 t -114.48 151.64 32.94 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.041 -0.725 . . . . 62.530000000000001 109.041 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -28.4 67.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 73.439999999999998 109.231 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -63.89 -41.09 97.81 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.279 -0.888 . . . . 71.420000000000002 109.829 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.712 ' H ' HG23 ' A' ' 79' ' ' THR . 37.8 tp10 -76.91 -26.28 53.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.085 -1.009 . . . . 73.430000000000007 109.342 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -67.89 -46.47 71.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.316 -0.865 . . . . 74.219999999999999 109.683 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 85' ' ' HIS . 29.4 m -68.89 -41.19 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.098 -1.002 . . . . 73.200000000000003 109.566 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.441 ' N ' HG23 ' A' ' 84' ' ' VAL . 73.5 t60 -72.14 -31.59 66.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -0.935 . . . . 53.329999999999998 109.637 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -65.76 -39.49 91.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 64.109999999999999 110.114 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -77.39 -36.08 53.78 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.049 -1.032 . . . . 74.340000000000003 108.769 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -68.33 -38.56 81.64 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.383 -0.823 . . . . 74.420000000000002 109.305 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -64.39 -44.86 89.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 74.239999999999995 109.319 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.09 -15.86 1.02 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.036 -1.226 . . . . 61.509999999999998 110.036 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -51.68 132.85 31.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.047 -1.267 . . . . 55.329999999999998 109.393 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.518 ' OD2' ' N ' ' A' ' 71' ' ' VAL . 71.0 m-20 -80.83 -33.28 34.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 73.420000000000002 109.409 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.527 ' CG ' HH21 ' A' ' 108' ' ' ARG . 65.3 m-20 -152.45 129.53 11.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.258 -0.901 . . . . 75.040000000000006 109.249 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -104.5 116.42 32.07 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.875 -0.787 . . . . 71.329999999999998 108.875 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.43 HG12 HD11 ' A' ' 72' ' ' LEU . 23.8 mm -106.53 149.92 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-O 122.194 0.997 . . . . 71.129999999999995 111.319 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.79 117.65 11.65 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.842 -1.54 . . . . 64.319999999999993 106.842 177.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.665 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -43.59 -54.0 11.08 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.173 -0.954 . . . . 62.200000000000003 111.778 -178.283 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.2 Cg_endo -41.8 -11.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.237 0 CA-C-N 119.851 0.983 . . . . 73.109999999999999 112.565 -176.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.665 ' N ' ' O ' ' A' ' 97' ' ' LYS . 61.2 m-85 57.69 116.07 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.817 -0.552 . . . . 65.219999999999999 109.701 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -56.47 -38.11 71.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.849 -1.157 . . . . 72.349999999999994 108.776 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.786 ' O ' ' N ' ' A' ' 103' ' ' LYS . 9.9 t -173.56 40.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.251 -0.906 . . . . 71.319999999999993 110.688 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.5 mt 48.09 -69.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 CA-C-N 118.68 0.673 . . . . 75.430000000000007 110.505 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.786 ' N ' ' O ' ' A' ' 101' ' ' SER . 41.4 tptt -52.07 -31.22 29.34 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.181 -1.044 . . . . 71.409999999999997 108.181 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.66 -56.04 21.43 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.622 -0.831 . . . . 63.240000000000002 108.836 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.724 HD13 ' N ' ' A' ' 106' ' ' VAL . 0.7 OUTLIER -62.69 -56.18 20.04 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.65 -0.87 . . . . 73.219999999999999 108.65 179.638 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.724 ' N ' HD13 ' A' ' 105' ' ' LEU . 87.4 t -48.44 -46.24 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.995 -1.065 . . . . 60.109999999999999 109.154 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.94 -35.73 62.05 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.212 -0.93 . . . . 70.420000000000002 108.553 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.53 ' NH1' ' CZ ' ' B' ' 87' ' ' PHE . 53.1 ttt85 -71.64 -29.43 64.63 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.435 -0.79 . . . . 74.409999999999997 109.681 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 87.0 mt -74.85 -32.92 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 120.978 -1.076 . . . . 62.539999999999999 108.498 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -74.47 -51.01 16.06 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.525 -0.734 . . . . 74.340000000000003 109.648 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.94 -43.3 69.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.901 . . . . 73.319999999999993 109.666 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.409 ' CB ' HD12 ' A' ' 113' ' ' LEU . 82.7 mtm180 -65.38 -39.9 92.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.193 -0.942 . . . . 52.409999999999997 109.612 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.409 HD12 ' CB ' ' A' ' 112' ' ' ARG . 5.3 mp -139.96 94.07 2.72 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.13 -0.982 . . . . 65.239999999999995 109.269 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 16.4 mtm-85 -84.68 -70.89 0.55 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.14 -0.975 . . . . 64.450000000000003 108.881 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.54 ' CD1' ' N ' ' A' ' 116' ' ' TRP . 30.4 p90 -163.16 -33.83 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.124 -0.985 . . . . 74.430000000000007 109.511 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.54 ' N ' ' CD1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER 38.44 -94.66 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.707 -0.62 . . . . 74.420000000000002 110.355 179.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 115' ' ' PHE . . . 76.88 72.45 1.11 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.503 -1.439 . . . . 75.040000000000006 109.503 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.537 ' O ' ' OG ' ' A' ' 129' ' ' SER . 0.3 OUTLIER -147.41 172.96 13.11 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.256 -1.143 . . . . 61.140000000000001 109.688 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.542 ' HA ' ' OG ' ' A' ' 129' ' ' SER . 0.0 OUTLIER -152.25 149.86 29.16 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.552 -0.717 . . . . 65.239999999999995 109.288 -178.23 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.91 -32.73 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.177 -0.952 . . . . 73.109999999999999 110.104 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 38.4 mm -116.33 106.34 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.416 -0.802 . . . . 72.239999999999995 109.183 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -109.01 115.96 31.07 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.475 -0.766 . . . . 72.340000000000003 109.443 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.406 ' O ' ' O ' ' A' ' 126' ' ' LEU . 29.1 mm -116.17 105.29 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.567 -0.708 . . . . 71.439999999999998 109.514 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 47.21 -143.87 5.41 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.935 -1.266 . . . . 73.400000000000006 109.935 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -66.82 -21.91 66.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.359 -1.083 . . . . 74.450000000000003 108.921 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.49 ' N ' HD23 ' A' ' 126' ' ' LEU . 0.2 OUTLIER -80.59 113.39 18.75 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.827 -1.175 . . . . 54.210000000000001 107.827 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.9 m -108.33 144.23 36.13 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.36 -0.838 . . . . 54.5 109.342 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 77.1 mt -132.7 128.98 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.457 -0.777 . . . . 45.149999999999999 109.704 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.542 ' OG ' ' HA ' ' A' ' 119' ' ' ASN . 1.8 m -117.83 94.16 45.55 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 108.551 -0.907 . . . . 71.109999999999999 108.551 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.35 -22.6 10.82 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.557 1.505 . . . . 65.409999999999997 112.277 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.883 ' OD1' ' OE2' ' A' ' 132' ' ' GLU . 11.1 t70 -59.35 -48.96 79.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.067 -1.021 . . . . 63.32 109.282 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.883 ' OE2' ' OD1' ' A' ' 131' ' ' ASP . 7.9 mm-40 -97.36 9.17 43.04 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.205 -0.934 . . . . 72.519999999999996 108.938 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 53.61 80.54 0.11 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.56 -0.712 . . . . 75.329999999999998 110.438 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 9.5 ttpt -164.37 141.42 6.53 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.81 -0.811 . . . . 71.230000000000004 108.81 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.527 HG21 ' CE2' ' A' ' 137' ' ' TYR . 88.9 mt -118.2 149.51 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.531 -0.73 . . . . 74.019999999999996 109.765 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 65.5 mt -131.72 117.69 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.527 -0.916 . . . . 60.229999999999997 108.527 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.527 ' CE2' HG21 ' A' ' 135' ' ' ILE . 44.9 m-85 -109.25 124.77 51.43 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.397 -0.815 . . . . 62.32 110.401 -178.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 4.1 mtpp 48.94 25.84 1.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.467 -0.77 . . . . 75.400000000000006 110.61 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 92.51 14.28 55.77 Favored Glycine 0 N--CA 1.498 2.81 0 O-C-N 121.0 -1.063 . . . . 72.239999999999995 110.999 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -105.5 124.29 49.31 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.17 -1.194 . . . . 71.219999999999999 109.267 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -82.42 122.19 27.69 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.195 -0.941 . . . . 71.420000000000002 110.852 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.08 138.0 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.055 -1.091 . . . . 53.020000000000003 108.055 178.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -82.18 167.14 19.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.323 -0.86 . . . . 60.450000000000003 109.627 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 1.098 ' C ' ' HD2' ' A' ' 149' ' ' PHE . 6.0 m -129.6 128.15 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 108.797 -0.816 . . . . 74.439999999999998 108.797 178.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 1.482 ' HA ' ' CE2' ' A' ' 149' ' ' PHE . 32.7 pttt -175.52 -24.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.412 -0.805 . . . . 65.150000000000006 109.698 -179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 1.108 ' O ' ' CD1' ' A' ' 149' ' ' PHE . . . -64.97 -172.42 3.25 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.561 -1.416 . . . . 73.340000000000003 109.561 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.593 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 6.3 ttmt -70.27 -39.4 10.11 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.365 -1.08 . . . . 72.219999999999999 110.634 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 60.6 Cg_endo -84.94 15.46 2.21 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.126 1.884 . . . . 65.230000000000004 112.757 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 1.482 ' CE2' ' HA ' ' A' ' 145' ' ' LYS . 0.1 OUTLIER -97.31 -50.36 4.58 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.073 -1.017 . . . . 60.109999999999999 109.609 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 1.443 ' HG3' ' CE1' ' A' ' 149' ' ' PHE . 97.2 mt-10 -55.35 -44.0 75.56 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.418 -0.801 . . . . 64.209999999999994 109.596 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.46 HG13 ' N ' ' A' ' 152' ' ' LEU . 13.1 p -63.77 -38.2 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 72.019999999999996 109.378 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.2 OUTLIER -59.22 -42.82 91.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.387 -0.821 . . . . 73.310000000000002 109.016 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.4 m -72.13 -28.84 63.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 74.310000000000002 109.44 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -63.08 -55.11 28.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.405 -0.81 . . . . 74.310000000000002 110.073 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 159' ' ' ARG . 3.6 pp -67.49 -26.76 66.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.04 -1.037 . . . . 75.340000000000003 109.083 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.02 -52.21 63.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.108 -0.995 . . . . 62.140000000000001 108.904 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 85.2 mtt180 -66.8 -52.6 42.06 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.282 -0.886 . . . . 61.030000000000001 109.145 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -88.5 37.62 0.83 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.549 -0.719 . . . . 74.120000000000005 109.544 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' ' 155' ' ' LEU . 55.4 ttt-85 -65.46 -17.85 64.86 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.118 -0.989 . . . . 71.129999999999995 109.783 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.9 72.8 1.31 Allowed 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.517 -0.92 . . . . 75.450000000000003 108.517 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -170.57 159.18 6.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.875 . . . . 73.409999999999997 109.539 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.4 mt -81.51 136.69 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.29 -0.881 . . . . 74.409999999999997 109.002 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 14.2 t -131.48 135.73 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.341 -0.849 . . . . 72.310000000000002 109.793 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.7 p -97.59 159.36 14.97 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.4 -0.812 . . . . 74.120000000000005 109.122 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -57.9 -36.08 71.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 70.430000000000007 109.899 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -64.16 -42.23 96.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.166 -0.959 . . . . 73.519999999999996 110.075 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -53.4 -49.94 66.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.086 -1.009 . . . . 74.519999999999996 109.415 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 34.5 mt -61.9 -39.76 93.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.174 -0.954 . . . . 72.310000000000002 109.398 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.475 HD23 ' C ' ' A' ' 169' ' ' LEU . 5.3 tt -55.5 -59.21 5.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.866 . . . . 53.329999999999998 109.763 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.88 -39.66 93.89 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.423 -0.798 . . . . 62.439999999999998 111.203 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -53.0 -55.39 23.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.929 -1.107 . . . . 60.210000000000001 111.08 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.742 HD12 ' N ' ' A' ' 172' ' ' ILE . 1.9 mp -94.26 -59.69 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 120.83 -1.169 . . . . 75.319999999999993 110.237 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.458 ' O ' ' O ' ' A' ' 169' ' ' LEU . 24.3 m-90 -81.33 119.7 24.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 73.140000000000001 109.864 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.492 ' H ' ' HD2' ' A' ' 176' ' ' PRO . 74.8 tt0 -143.66 -51.69 0.33 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.97 -1.081 . . . . 73.239999999999995 110.122 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.625 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 27.6 mt-10 -86.58 -33.62 0.45 Allowed Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 120.99 -1.069 . . . . 44.43 111.654 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 58.3 Cg_exo -52.73 -48.9 19.57 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 121.97 1.78 . . . . 72.510000000000005 112.408 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 46.0 -157.45 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.263 -0.898 . . . . 63.240000000000002 109.572 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 59.7 mtt 54.71 27.44 8.75 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.223 -0.923 . . . . 73.5 109.666 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 9.5 m -134.25 144.38 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.493 -0.755 . . . . 65.219999999999999 109.22 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.446 ' O ' HG13 ' A' ' 183' ' ' VAL . 0.7 OUTLIER -67.86 152.6 96.23 Favored Pre-proline 0 N--CA 1.487 1.407 0 O-C-N 121.05 -1.031 . . . . 71.420000000000002 108.321 179.63 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.6 -24.67 11.69 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.348 2.032 . . . . 41.219999999999999 112.251 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 35.7 p30 -81.63 5.54 17.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.887 . . . . 64.540000000000006 110.326 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 180' ' ' THR . 26.4 m -67.68 -16.1 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.854 -1.153 . . . . 74.019999999999996 109.518 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.448 ' O ' HG22 ' A' ' 188' ' ' ILE . 32.2 mm -59.82 -30.1 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.221 -0.925 . . . . 72.329999999999998 109.369 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -58.14 -35.65 71.82 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.236 -0.915 . . . . 74.400000000000006 109.794 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 50.4 t -82.99 -45.45 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.1 -1.0 . . . . 70.420000000000002 109.084 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -60.71 -36.35 78.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 52.109999999999999 110.255 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.492 HG23 ' N ' ' A' ' 189' ' ' ASN . 9.4 tp -76.33 -42.98 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.781 -1.199 . . . . 71.400000000000006 109.102 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.492 ' N ' HG23 ' A' ' 188' ' ' ILE . 69.4 m-20 -59.87 -33.89 72.41 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.198 -0.939 . . . . 73.439999999999998 109.082 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -79.68 -48.67 13.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.192 -0.942 . . . . 71.420000000000002 109.968 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.444 HD13 HG21 ' A' ' 151' ' ' VAL . 64.4 mt -55.96 -41.98 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.095 -1.003 . . . . 61.549999999999997 109.29 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -63.87 -49.64 71.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.121 -0.987 . . . . 63.340000000000003 109.269 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -62.0 -31.47 71.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.214 -0.929 . . . . 61.240000000000002 108.984 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.418 ' NZ ' ' CB ' ' A' ' 194' ' ' LYS . 7.5 mtpm? -84.79 -8.54 58.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.47 -0.769 . . . . 75.129999999999995 109.735 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 16.2 ttt -102.48 -39.56 7.07 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.45 -0.781 . . . . 74.019999999999996 110.421 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 7.9 p30 -75.02 -15.37 60.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.025 -1.047 . . . . 74.019999999999996 110.724 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.445 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 8.7 mmtm -80.58 -65.29 0.27 Allowed Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.902 -1.124 . . . . 75.430000000000007 109.964 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 24.7 Cg_endo -60.0 -49.6 9.37 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.345 2.03 . . . . 72.319999999999993 112.849 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 199' ' ' LEU . 10.4 mp -66.2 -100.19 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.856 -1.152 . . . . 74.540000000000006 109.239 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 156.07 -39.31 0.59 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.132 -1.587 . . . . 61.509999999999998 109.132 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 20.5 mm -104.14 127.09 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.571 -0.958 . . . . 61.219999999999999 109.12 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 11.9 p -83.6 133.07 34.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.107 -0.995 . . . . 72.0 108.682 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -121.03 12.91 11.24 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.447 -0.783 . . . . 74.439999999999998 109.515 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.9 148.31 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.425 -0.797 . . . . 64.349999999999994 109.532 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -124.82 115.58 20.91 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.651 -0.655 . . . . 71.409999999999997 109.329 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.37 114.01 22.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.274 -0.891 . . . . 73.519999999999996 109.011 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.412 HG12 ' H ' ' A' ' 209' ' ' ARG . 13.8 t -120.73 146.31 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.546 -0.721 . . . . 71.019999999999996 109.668 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -69.89 -36.44 75.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.372 -0.83 . . . . 72.120000000000005 109.547 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.412 ' H ' HG12 ' A' ' 207' ' ' VAL . 80.8 mtm180 -73.28 160.18 32.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.288 -0.882 . . . . 64.409999999999997 109.736 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.562 ' NE ' ' H ' ' A' ' 210' ' ' ARG . 0.0 OUTLIER 47.86 -102.25 0.08 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.156 -0.965 . . . . 71.540000000000006 109.002 -179.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -158.98 -114.22 0.38 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.08 -1.608 . . . . 72.030000000000001 109.08 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -108.79 133.74 52.43 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.513 -0.992 . . . . 75.540000000000006 108.929 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -112.04 128.45 56.19 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.342 -0.849 . . . . 75.310000000000002 110.585 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -98.27 128.53 44.76 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.627 -0.879 . . . . 75.409999999999997 108.627 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 8.9 t -149.98 168.96 22.32 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.03 -1.044 . . . . 74.140000000000001 110.453 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -60.95 131.46 91.74 Favored Pre-proline 0 N--CA 1.49 1.556 0 N-CA-C 109.361 -0.607 . . . . 75.319999999999993 109.361 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -36.83 143.09 0.13 Allowed 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.291 1.994 . . . . 73.109999999999999 112.744 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 72.9 tttt -92.8 -32.36 0.32 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.439 -0.788 . . . . 75.25 111.697 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 93.0 Cg_endo -86.15 31.49 0.47 Allowed 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 121.944 1.763 . . . . 75.099999999999994 112.049 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -95.25 170.28 9.49 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.401 -0.812 . . . . 71.140000000000001 109.128 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 6.1 t 61.07 158.51 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.354 -0.841 . . . . 71.129999999999995 109.456 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -90.7 138.63 31.42 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.073 -1.017 . . . . 75.349999999999994 109.538 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 117.983 -1.008 . . . . 73.409999999999997 109.399 179.988 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.591 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.458 -0.571 . . . . 71.140000000000001 109.458 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.433 ' O ' ' OD1' ' B' ' 46' ' ' ASP . 88.2 mtt180 -139.28 153.43 47.78 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.261 -0.9 . . . . 73.230000000000004 109.552 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 94.2 t -111.16 135.04 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.665 -0.647 . . . . 72.239999999999995 109.297 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.448 HD11 ' CG1' ' B' ' 6' ' ' ILE . 3.6 tp -106.84 118.28 36.26 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.526 -0.734 . . . . 54.329999999999998 109.707 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.436 ' N ' HD12 ' B' ' 4' ' ' LEU . 16.9 mt -114.58 98.32 6.81 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.83 -0.804 . . . . 74.349999999999994 108.83 178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.692 HD12 ' HB ' ' B' ' 50' ' ' VAL . 87.1 mt -84.79 96.98 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.743 -1.223 . . . . 42.549999999999997 108.772 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.525 ' CD ' ' HG ' ' B' ' 51' ' ' SER . 8.6 tp10 -141.91 127.86 19.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.353 -0.842 . . . . 74.519999999999996 109.46 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -66.74 -32.92 74.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 62.549999999999997 109.148 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . 0.413 ' H ' ' HG3' ' B' ' 7' ' ' GLU . 99.5 m-20 -78.24 107.41 10.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.34 -0.85 . . . . 73.109999999999999 109.431 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 85.6 p -67.94 -23.77 65.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -0.879 . . . . 65.540000000000006 109.655 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 97.1 t -63.79 -49.77 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.148 -0.97 . . . . 75.549999999999997 109.687 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 80.7 mt -65.93 -37.44 86.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.157 -0.964 . . . . 70.140000000000001 109.572 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.74 -27.94 69.97 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.627 -1.789 . . . . 75.400000000000006 108.627 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.07 -53.44 36.92 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.581 -1.408 . . . . 65.439999999999998 109.581 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -58.54 -45.48 88.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.276 -1.132 . . . . 60.210000000000001 109.819 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 36.1 mm -65.63 -41.53 90.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.845 -1.159 . . . . 75.150000000000006 108.925 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -59.84 -44.5 94.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 73.010000000000005 109.513 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.452 ' N ' ' CD ' ' B' ' 18' ' ' LYS . 1.1 mptm? -86.59 1.1 52.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.092 -1.005 . . . . 74.299999999999997 108.768 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.51 -59.39 1.83 Allowed Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.481 -1.448 . . . . 70.540000000000006 109.481 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -67.87 -22.69 65.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -1.141 . . . . 71.340000000000003 109.522 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -54.14 -34.31 60.04 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.139 -0.976 . . . . 64.409999999999997 109.238 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 56.1 t -57.48 -47.63 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.344 -0.847 . . . . 74.230000000000004 109.013 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.445 ' NZ ' HG11 ' B' ' 106' ' ' VAL . 31.9 mmtm -60.49 -53.97 51.12 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.428 -0.795 . . . . 63.420000000000002 109.005 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 136.7 38.87 0.15 Allowed Glycine 0 N--CA 1.5 2.931 0 N-CA-C 110.298 -1.121 . . . . 53.43 110.298 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -120.38 160.46 23.03 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.375 -1.073 . . . . 71.120000000000005 109.505 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.4 mmt -105.27 140.26 38.68 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.807 -0.812 . . . . 75.239999999999995 108.807 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.431 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -135.23 159.26 42.12 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.429 -0.795 . . . . 72.120000000000005 109.818 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 89.2 m-20 -138.68 159.48 42.01 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.702 -0.851 . . . . 72.310000000000002 108.702 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 p -122.63 139.12 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.381 -0.825 . . . . 64.430000000000007 109.861 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 10.9 p -134.78 169.08 17.89 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.985 -0.746 . . . . 65.409999999999997 108.985 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -90.62 -107.57 0.09 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.165 -0.959 . . . . 71.019999999999996 109.787 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 82.3 p -79.09 168.61 19.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 51.109999999999999 109.993 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 50.5 mt -50.79 -31.3 16.52 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.6 -0.687 . . . . 71.239999999999995 109.843 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -51.62 -52.19 49.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.101 -0.999 . . . . 74.319999999999993 109.717 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.73 -40.89 96.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.17 -0.956 . . . . 73.030000000000001 109.354 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -68.24 -43.03 81.6 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.442 -1.463 . . . . 30.210000000000001 109.442 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -66.18 -38.69 88.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.321 -1.106 . . . . 74.420000000000002 109.549 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -75.13 -39.43 60.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.933 . . . . 74.420000000000002 109.802 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 23.3 tp -72.88 -45.95 55.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.905 . . . . 75.409999999999997 110.112 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . 0.449 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.4 ppp? -64.79 -27.06 68.63 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.004 -1.06 . . . . 60.409999999999997 109.84 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -58.49 -45.44 88.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.145 -0.972 . . . . 53.229999999999997 109.844 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 5.2 pt -88.93 -42.06 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.175 -0.953 . . . . 71.230000000000004 109.747 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' B' ' 40' ' ' MET . 10.7 mpt_? -96.73 144.04 27.1 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.077 -1.015 . . . . 72.219999999999999 108.983 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -103.77 150.81 23.74 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.382 -0.824 . . . . 63.539999999999999 109.248 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -137.78 139.67 40.17 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.329 -0.857 . . . . 64.349999999999994 109.321 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' B' ' 2' ' ' ARG . 7.9 p-10 -79.85 -36.86 36.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 62.219999999999999 109.253 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.555 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.5 OUTLIER -108.05 116.39 31.86 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.93 -0.767 . . . . 73.120000000000005 108.93 179.899 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.555 ' N ' HD13 ' B' ' 47' ' ' LEU . 46.4 t -100.31 98.44 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.233 -1.025 . . . . 65.109999999999999 108.233 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 20.6 ttt -112.89 133.38 54.9 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.569 -0.707 . . . . 73.439999999999998 110.051 -179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.692 ' HB ' HD12 ' B' ' 6' ' ' ILE . 0.7 OUTLIER -145.95 134.18 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.595 -0.69 . . . . 34.5 109.351 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . 0.525 ' HG ' ' CD ' ' B' ' 7' ' ' GLU . 9.1 p -98.19 9.94 41.75 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.415 -0.803 . . . . 73.209999999999994 109.47 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.559 ' H ' HG22 ' B' ' 50' ' ' VAL . 44.9 m-20 -76.06 138.86 41.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.203 -0.935 . . . . 70.409999999999997 109.539 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.439 ' C ' ' H ' ' B' ' 55' ' ' ALA . 60.2 mttm -73.62 -40.12 64.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 65.0 110.15 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -72.92 12.25 0.55 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.115 -0.99 . . . . 75.209999999999994 109.717 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -68.92 -21.54 64.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.903 . . . . 55.329999999999998 110.153 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' B' ' 55' ' ' ALA . 11.4 mt -41.7 -49.39 4.26 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.488 -0.757 . . . . 63.140000000000001 110.312 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 86.1 p -69.56 -34.68 74.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.986 -1.071 . . . . 63.5 109.098 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . 0.407 ' CZ ' HD11 ' B' ' 62' ' ' ILE . 59.0 t80 -66.67 -61.76 1.8 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.377 -0.827 . . . . 72.329999999999998 109.828 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 33.8 m -49.42 -35.31 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.611 -1.306 . . . . 74.540000000000006 109.716 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 22.9 p -57.55 -53.69 55.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.188 -0.945 . . . . 71.239999999999995 109.714 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -66.91 -29.1 68.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.055 -1.028 . . . . 74.310000000000002 110.108 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.407 HD11 ' CZ ' ' B' ' 58' ' ' PHE . 35.2 mm -66.06 -36.26 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.766 -1.208 . . . . 72.140000000000001 109.876 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.483 ' NZ ' ' CG2' ' B' ' 71' ' ' VAL . 29.1 mmtm -71.41 -49.4 42.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.038 -1.039 . . . . 73.319999999999993 110.278 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' B' ' 65' ' ' LYS . 13.8 pt-20 -68.85 -41.08 78.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.949 -1.094 . . . . 73.120000000000005 110.133 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.512 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 92.7 mttt -74.83 -23.52 58.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 72.439999999999998 109.825 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.512 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 92.9 m-70 -156.69 63.96 0.53 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.145 -0.972 . . . . 63.310000000000002 109.67 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.452 ' N ' ' O ' ' B' ' 63' ' ' LYS . 23.7 t -57.14 -30.01 64.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -0.88 . . . . 73.099999999999994 109.581 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 39.8 m -61.56 -27.31 68.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.233 -0.917 . . . . 71.530000000000001 109.998 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 73.7 mt -78.64 155.77 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.142 -0.973 . . . . 74.400000000000006 109.778 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 84.7 t -95.74 152.69 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.489 -0.757 . . . . 75.120000000000005 109.137 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.483 ' CG2' ' NZ ' ' B' ' 63' ' ' LYS . 39.5 t -133.04 127.9 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.336 -0.852 . . . . 73.200000000000003 109.81 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 8.0 tt -120.41 99.48 6.59 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.716 -0.846 . . . . 73.340000000000003 108.716 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 7.6 p -94.44 135.66 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.186 -0.946 . . . . 73.5 108.876 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.24 173.75 6.18 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.315 -0.866 . . . . 64.340000000000003 108.877 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 18.7 t -165.93 119.76 1.16 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.966 -1.084 . . . . 74.530000000000001 110.236 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -67.54 -15.84 63.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.381 -0.824 . . . . 64.5 109.284 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -116.91 69.08 4.6 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.674 -0.641 . . . . 74.25 109.293 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -62.73 78.06 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.91 1.74 . . . . 74.430000000000007 111.632 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.492 HG23 ' H ' ' B' ' 82' ' ' GLU . 15.1 t -101.14 173.16 6.59 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.69 -0.856 . . . . 73.120000000000005 108.69 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.4 p -77.01 -26.25 53.6 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.164 -0.96 . . . . 71.010000000000005 110.489 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . 0.469 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 49.6 mp0 -66.86 -39.96 87.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.937 -1.102 . . . . 63.200000000000003 109.694 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . 0.492 ' H ' HG23 ' B' ' 79' ' ' THR . 97.8 mt-10 -78.01 -33.82 51.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.194 -0.941 . . . . 73.219999999999999 109.686 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -62.55 -52.91 61.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -0.964 . . . . 74.299999999999997 109.718 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.504 HG23 ' N ' ' B' ' 85' ' ' HIS . 26.4 m -63.72 -40.82 90.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.161 -0.962 . . . . 73.310000000000002 109.412 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' HIS . . . . . 0.504 ' N ' HG23 ' B' ' 84' ' ' VAL . 19.8 m80 -67.31 -31.27 71.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.905 . . . . 73.239999999999995 109.514 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.29 -41.7 93.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.922 . . . . 55.329999999999998 109.782 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' PHE . . . . . 0.53 ' CZ ' ' NH1' ' A' ' 108' ' ' ARG . 70.3 m-85 -80.29 -24.91 39.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.095 -1.003 . . . . 74.140000000000001 109.041 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -76.37 -51.92 10.93 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.386 -0.822 . . . . 64.040000000000006 109.437 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . 0.489 ' CG ' ' N ' ' B' ' 90' ' ' GLY . 11.5 pt20 -60.81 -47.19 87.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.515 -0.741 . . . . 72.349999999999994 109.774 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . 0.489 ' N ' ' CG ' ' B' ' 89' ' ' GLN . . . 140.15 71.55 0.04 OUTLIER Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.963 -1.255 . . . . 65.200000000000003 109.963 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -123.86 135.44 53.74 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.403 -1.057 . . . . 52.229999999999997 108.715 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.522 ' OD1' ' NH1' ' B' ' 112' ' ' ARG . 24.6 t0 -85.0 -23.78 28.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.061 -1.024 . . . . 73.319999999999993 109.647 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . 0.524 ' OD2' ' NH1' ' B' ' 112' ' ' ARG . 57.3 m-20 -152.38 156.43 39.53 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.184 -0.948 . . . . 72.219999999999999 109.63 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -137.9 99.83 4.01 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.463 -0.94 . . . . 64.420000000000002 108.463 -179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 22.7 mm -106.98 147.3 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.531 0 O-C-N 120.989 -1.07 . . . . 72.230000000000004 110.833 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.76 125.74 26.81 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.915 -1.143 . . . . 25.239999999999998 107.915 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.677 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -45.94 -54.03 18.6 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.063 -1.023 . . . . 64.319999999999993 111.486 -178.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 3.3 Cg_endo -41.82 -10.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.211 0 C-N-CA 120.796 0.997 . . . . 63.329999999999998 112.743 -176.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . 0.677 ' N ' ' O ' ' B' ' 97' ' ' LYS . 61.0 m-85 59.41 96.71 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.728 -0.608 . . . . 75.129999999999995 110.04 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -53.41 -39.37 64.28 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.101 -1.074 . . . . 74.230000000000004 108.101 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 9.1 t -174.27 128.62 0.36 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.886 -0.783 . . . . 63.340000000000003 108.886 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 59.0 mt -52.64 -36.14 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.035 -1.04 . . . . 74.439999999999998 108.868 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' B' ' 107' ' ' ALA . 62.8 mmtt -61.87 -36.87 82.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.293 -0.88 . . . . 71.109999999999999 108.948 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.74 -53.64 14.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 71.450000000000003 109.347 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 25.0 tp -58.04 -49.75 75.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.219 -0.926 . . . . 51.310000000000002 108.962 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . 0.445 HG11 ' NZ ' ' B' ' 23' ' ' LYS . 69.7 t -66.1 -39.88 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.063 -1.023 . . . . 65.230000000000004 109.853 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' B' ' 103' ' ' LYS . . . -56.78 -39.12 73.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.16 -0.962 . . . . 24.32 109.558 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -77.44 -25.04 50.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.875 . . . . 75.310000000000002 109.994 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 90.4 mt -80.82 -43.37 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.039 -1.038 . . . . 54.240000000000002 109.445 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -68.15 -38.92 82.66 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.18 -0.95 . . . . 65.310000000000002 109.851 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.69 -49.18 66.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.21 -0.931 . . . . 72.239999999999995 109.838 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . 0.524 ' NH1' ' OD2' ' B' ' 93' ' ' ASP . 38.5 ttm180 -65.6 -43.87 88.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.932 . . . . 72.040000000000006 109.976 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.491 HD23 ' C ' ' B' ' 113' ' ' LEU . 4.3 tt -64.95 -55.45 19.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.154 -0.966 . . . . 75.349999999999994 109.335 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -50.7 -30.5 13.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.149 -0.969 . . . . 75.5 109.674 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -84.64 4.48 32.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.202 -0.936 . . . . 65.329999999999998 109.807 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' TRP . . . . . 0.524 ' CD1' ' N ' ' B' ' 117' ' ' GLY . 0.3 OUTLIER -67.84 -19.85 65.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.009 -1.057 . . . . 74.450000000000003 109.662 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . 0.524 ' N ' ' CD1' ' B' ' 116' ' ' TRP . . . -67.73 113.13 5.24 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.702 -1.359 . . . . 44.210000000000001 109.702 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 53.1 p -153.46 164.52 38.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.279 -1.13 . . . . 71.400000000000006 109.687 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -158.23 166.17 33.05 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.876 -0.73 . . . . 72.319999999999993 109.043 -178.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t -145.59 -43.68 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.291 -0.881 . . . . 75.019999999999996 109.31 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . 0.481 HG21 ' O ' ' B' ' 156' ' ' ALA . 28.5 mm -107.83 127.48 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.449 -0.782 . . . . 51.409999999999997 109.118 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -120.47 118.31 29.95 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.538 -0.726 . . . . 71.530000000000001 109.239 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 62.2 mt -123.48 108.42 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.938 -0.764 . . . . 72.430000000000007 108.938 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.74 -133.82 11.49 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.745 -1.342 . . . . 51.229999999999997 109.745 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -83.6 -2.25 55.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.222 -1.163 . . . . 74.200000000000003 109.399 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.554 HD13 HD12 ' B' ' 199' ' ' LEU . 0.6 OUTLIER -91.18 146.04 24.16 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.473 -0.936 . . . . 75.420000000000002 108.473 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 89.3 m -130.08 134.71 47.56 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.576 -0.703 . . . . 74.219999999999999 109.212 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 21.5 mt -136.59 143.53 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.442 -0.786 . . . . 60.329999999999998 109.381 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 14.6 m -137.86 122.8 12.28 Favored Pre-proline 0 N--CA 1.497 1.915 0 O-C-N 121.494 -0.754 . . . . 72.310000000000002 108.977 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -80.99 -39.95 0.19 Allowed 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.994 1.796 . . . . 75.129999999999995 112.238 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -50.52 -51.31 48.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.145 -0.972 . . . . 75.230000000000004 109.428 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -86.07 -7.71 58.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.231 -0.918 . . . . 72.430000000000007 109.099 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 54.19 68.66 0.82 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.868 . . . . 75.129999999999995 109.35 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -148.6 143.38 26.53 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.228 -0.92 . . . . 73.219999999999999 109.734 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 18.1 tt -118.38 137.03 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.538 -0.726 . . . . 64.140000000000001 109.359 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 58.5 mt -126.19 123.86 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.504 -0.747 . . . . 71.219999999999999 109.144 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -140.52 144.12 35.8 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.303 -0.873 . . . . 64.219999999999999 110.113 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 31.3 mmtm 53.75 31.18 12.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.384 -0.823 . . . . 72.019999999999996 110.214 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 74.99 -6.4 27.41 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.983 -1.247 . . . . 74.319999999999993 109.983 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 12.2 mpt_? -87.96 129.43 35.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.129 -1.218 . . . . 75.340000000000003 108.838 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -98.82 130.58 45.25 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.351 -0.843 . . . . 71.230000000000004 109.675 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 66.8 t -137.12 132.12 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.444 -0.785 . . . . 70.430000000000007 109.244 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -83.15 134.92 34.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.898 . . . . 72.430000000000007 109.1 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.77 136.1 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.452 -0.78 . . . . 72.129999999999995 109.366 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.21 21.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 72.019999999999996 109.555 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.54 174.72 40.03 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.867 -1.293 . . . . 42.229999999999997 109.867 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' B' ' 148' ' ' PRO . 12.4 mtpp -65.06 -61.67 5.87 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.447 -1.031 . . . . 73.299999999999997 110.096 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' B' ' 147' ' ' LYS . 11.9 Cg_endo -54.2 -25.78 39.55 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.951 1.767 . . . . 71.329999999999998 111.87 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -87.59 -15.45 37.32 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.237 -0.914 . . . . 74.230000000000004 109.502 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 10.8 tm-20 -61.77 -45.34 94.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.162 -0.961 . . . . 72.340000000000003 109.471 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 8.8 p -56.99 -34.06 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.112 -0.992 . . . . 73.349999999999994 108.89 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.437 ' O ' HD13 ' B' ' 152' ' ' LEU . 0.2 OUTLIER -61.04 -49.71 76.27 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.535 -0.913 . . . . 55.240000000000002 108.535 179.502 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 16.3 m -70.57 -29.83 66.37 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.304 -0.873 . . . . 70.010000000000005 108.963 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -55.52 -59.89 4.2 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.193 -0.942 . . . . 65.319999999999993 109.987 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.79 -25.51 65.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.943 -1.098 . . . . 71.540000000000006 109.67 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . 0.481 ' O ' HG21 ' B' ' 121' ' ' ILE . . . -55.08 -43.88 74.31 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.048 -1.032 . . . . 75.319999999999993 109.931 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -83.22 -45.62 13.66 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.828 -1.17 . . . . 73.319999999999993 110.891 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . 0.482 ' O ' ' O ' ' B' ' 159' ' ' ARG . 51.3 m80 -50.52 -83.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.619 -1.301 . . . . 74.140000000000001 108.615 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . 0.482 ' O ' ' O ' ' B' ' 158' ' ' HIS . 11.5 mmm180 56.26 153.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.596 -0.69 . . . . 61.409999999999997 110.509 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' B' ' 214' ' ' PHE . 20.4 t70 42.02 51.25 4.32 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.256 -0.903 . . . . 72.099999999999994 110.104 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -156.27 145.37 20.48 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.062 -1.024 . . . . 72.25 110.087 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 87.6 mt -89.19 125.66 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 108.747 -0.834 . . . . 72.310000000000002 108.747 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 14.7 p -135.84 136.65 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.323 -0.861 . . . . 64.209999999999994 109.248 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 11.7 t -81.54 166.45 20.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.318 -0.864 . . . . 74.219999999999999 110.524 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 18.4 mtpp -67.12 -46.1 75.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.623 -0.673 . . . . 65.310000000000002 109.896 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -58.59 -36.19 73.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.87 . . . . 63.450000000000003 110.28 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -55.14 -45.1 75.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.061 -1.024 . . . . 72.400000000000006 109.657 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 31.6 mt -66.28 -38.7 88.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.053 -1.03 . . . . 72.319999999999993 109.36 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.682 ' C ' HD13 ' B' ' 169' ' ' LEU . 3.1 tm? -55.35 -54.78 39.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.829 . . . . 73.340000000000003 108.996 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -68.94 -16.56 63.77 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 72.099999999999994 109.85 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.17 -57.87 3.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.201 -0.937 . . . . 62.130000000000003 110.707 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.696 HD12 ' N ' ' B' ' 172' ' ' ILE . 1.7 mp -79.85 -44.78 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.989 -1.069 . . . . 71.420000000000002 109.239 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 19.7 m-90 -94.39 56.68 2.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.314 -0.866 . . . . 72.230000000000004 109.519 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' B' ' 175' ' ' GLU . 69.2 tt0 -65.34 -6.69 10.65 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.263 -0.898 . . . . 52.109999999999999 109.005 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' B' ' 177' ' ' GLU . 2.5 mt-10 -48.9 173.98 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.377 -0.971 . . . . 73.040000000000006 108.377 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -58.26 40.7 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.298 1.999 . . . . 74.129999999999995 112.714 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' B' ' 175' ' ' GLU . 75.1 mm-40 50.2 -131.0 2.0 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.264 -0.898 . . . . 72.439999999999998 109.747 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 83.7 mmm 49.92 15.33 0.17 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.198 -0.939 . . . . 63.43 109.422 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 179' ' ' VAL . . . . . 0.435 ' N ' ' C ' ' B' ' 177' ' ' GLU . 2.9 m -82.36 -111.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 71.049999999999997 109.344 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . 0.403 ' H ' HG23 ' B' ' 179' ' ' VAL . 73.7 p -134.9 78.71 53.67 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.406 -0.809 . . . . 62.149999999999999 109.282 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.02 38.8 0.75 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.246 1.964 . . . . 65.219999999999999 111.735 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -148.59 -14.68 0.33 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.489 -0.757 . . . . 72.310000000000002 109.095 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 11.1 m -97.78 7.98 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.285 -0.884 . . . . 63.32 109.287 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 15.7 mm -55.75 -42.67 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.903 . . . . 75.030000000000001 109.475 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -53.84 -26.53 24.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 64.109999999999999 109.413 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 60.5 t -78.85 -54.68 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.053 -1.03 . . . . 73.0 109.149 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -51.89 -48.11 64.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.257 -0.902 . . . . 61.119999999999997 110.071 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 188' ' ' ILE . . . . . 0.525 HD13 ' O ' ' B' ' 188' ' ' ILE . 0.2 OUTLIER -61.82 -43.12 96.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.913 -1.117 . . . . 72.430000000000007 109.025 -179.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 189' ' ' ASN . . . . . 0.434 ' O ' ' OE1' ' B' ' 193' ' ' GLN . 41.4 t30 -61.48 -41.64 97.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.972 -1.08 . . . . 65.140000000000001 109.255 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -68.0 -42.52 80.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.947 . . . . 63.240000000000002 110.023 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 81.3 mt -59.85 -39.71 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.084 -1.01 . . . . 74.030000000000001 109.743 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 73.7 mtp85 -64.59 -40.45 95.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.116 -0.99 . . . . 72.239999999999995 109.781 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 193' ' ' GLN . . . . . 0.617 ' NE2' ' N ' ' B' ' 193' ' ' GLN . 0.2 OUTLIER -75.12 -37.83 61.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 73.099999999999994 110.376 -179.311 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . 0.411 ' O ' ' CG ' ' B' ' 198' ' ' PRO . 0.0 OUTLIER -73.6 -16.87 61.23 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.75 -1.219 . . . . 72.109999999999999 109.916 -179.293 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 21.9 ttp -94.52 -24.14 17.39 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.156 -0.965 . . . . 44.329999999999998 110.196 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 196' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' B' ' 193' ' ' GLN . 41.3 p30 -96.0 -3.76 44.41 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.987 -1.07 . . . . 71.209999999999994 110.532 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . 0.568 ' N ' ' CD ' ' B' ' 198' ' ' PRO . 20.6 tttm -92.01 -42.15 0.37 Allowed Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 120.862 -1.149 . . . . 75.209999999999994 110.053 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 198' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' B' ' 197' ' ' LYS . 17.7 Cg_endo -88.68 -51.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.596 2.198 . . . . 75.319999999999993 112.22 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . 0.597 HD22 ' N ' ' B' ' 199' ' ' LEU . 3.7 mm? -70.9 -40.06 72.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.948 -1.095 . . . . 72.25 109.347 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 85.35 -20.39 17.78 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.915 -1.274 . . . . 64.530000000000001 109.915 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 12.1 mt -103.75 137.83 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.335 -1.097 . . . . 44.229999999999997 109.354 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 38.6 t -95.38 137.85 33.86 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.242 -0.911 . . . . 54.009999999999998 109.393 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 21.4 p -142.33 34.11 1.49 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.34 -0.85 . . . . 74.400000000000006 109.146 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.53 133.41 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.497 -0.752 . . . . 72.120000000000005 109.615 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -113.94 132.7 55.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.666 -0.865 . . . . 65.409999999999997 108.666 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.45 140.37 29.82 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.256 -0.903 . . . . 71.329999999999998 109.896 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' B' ' 211' ' ' GLY . 19.8 t -138.51 123.43 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.492 -0.755 . . . . 63.5 109.006 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 -76.85 -43.51 35.85 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.186 -0.946 . . . . 74.450000000000003 109.914 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -51.7 -59.85 3.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.905 . . . . 74.140000000000001 109.876 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -94.71 -71.03 0.68 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.179 -0.951 . . . . 74.430000000000007 109.58 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' B' ' 207' ' ' VAL . . . 177.76 -93.71 0.09 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.349 -1.5 . . . . 64.450000000000003 109.349 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -135.49 141.07 45.25 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.45 -1.03 . . . . 74.209999999999994 109.518 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 65.3 ttt-85 -119.64 129.06 54.4 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.438 -0.949 . . . . 74.030000000000001 108.438 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . 0.529 ' O ' ' N ' ' B' ' 160' ' ' ASP . 29.5 m-85 -100.58 137.84 38.44 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.384 -0.822 . . . . 74.340000000000003 109.404 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . 0.454 ' SG ' ' N ' ' B' ' 216' ' ' TYR . 43.7 t -152.33 168.32 25.8 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.476 -0.765 . . . . 64.329999999999998 109.613 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . 0.454 ' N ' ' SG ' ' B' ' 215' ' ' CYS . 81.6 m-85 -75.35 150.41 84.98 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.253 -0.904 . . . . 70.040000000000006 109.374 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 217' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' B' ' 218' ' ' LYS . 97.4 Cg_endo -76.43 119.17 5.14 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 122.269 1.979 . . . . 65.109999999999999 112.171 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.529 ' O ' ' N ' ' B' ' 220' ' ' ALA . 41.0 mttp 59.17 151.21 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.462 -0.774 . . . . 73.150000000000006 109.384 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . 0.421 ' C ' ' N ' ' B' ' 221' ' ' CYS . 84.0 Cg_exo -39.19 -22.05 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.936 1.757 . . . . 71.310000000000002 112.042 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' B' ' 218' ' ' LYS . . . 48.86 17.55 0.16 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.313 -0.867 . . . . 75.450000000000003 109.587 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 221' ' ' CYS . . . . . 0.421 ' N ' ' C ' ' B' ' 219' ' ' PRO . 42.1 t -136.22 152.61 50.94 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.407 -0.808 . . . . 72.219999999999999 109.317 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -155.92 158.79 38.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.258 -0.901 . . . . 54.530000000000001 109.376 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.045 -0.979 . . . . 71.129999999999995 109.462 -179.888 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.6 ptm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.446 -0.575 . . . . 65.120000000000005 109.446 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -139.58 156.41 46.89 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.305 -0.872 . . . . 72.329999999999998 109.303 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 89.3 t -114.21 125.8 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.635 -0.665 . . . . 71.420000000000002 109.607 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 5' ' ' LEU . 2.2 tp -100.03 118.74 37.05 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.832 -0.803 . . . . 65.120000000000005 108.832 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.466 ' CD1' HG21 ' A' ' 16' ' ' ILE . 7.5 tt -119.95 119.38 33.28 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.624 -0.672 . . . . 62.43 109.417 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.419 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 13.2 mt -106.45 116.89 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.352 -0.843 . . . . 71.150000000000006 108.792 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.462 ' OE1' ' CB ' ' A' ' 51' ' ' SER . 30.1 tp10 -151.37 127.63 10.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.149 -0.969 . . . . 75.340000000000003 109.491 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 9' ' ' ASN . 45.2 mtpt -77.82 -23.72 48.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.28 -0.888 . . . . 72.439999999999998 109.309 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 10' ' ' SER . 34.7 t-20 -59.68 -152.18 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.445 -0.785 . . . . 63.020000000000003 109.51 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.497 ' N ' ' OD1' ' A' ' 9' ' ' ASN . 47.6 m -156.08 -56.39 0.09 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 72.340000000000003 109.372 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.6 t -63.17 -45.49 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 74.019999999999996 109.493 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.593 ' N ' HD22 ' A' ' 12' ' ' LEU . 3.9 mm? -66.78 -36.43 82.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.259 -0.901 . . . . 71.430000000000007 109.289 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.11 -19.07 78.96 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 108.473 -1.851 . . . . 61.32 108.473 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.32 -50.77 4.94 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.922 -1.271 . . . . 71.200000000000003 109.922 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.14 -43.66 95.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.106 -1.232 . . . . 71.319999999999993 109.296 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.559 ' O ' HD23 ' A' ' 20' ' ' LEU . 94.5 mt -61.63 -46.63 96.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.922 -1.111 . . . . 63.229999999999997 108.498 178.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -45.55 -52.47 10.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.295 -0.878 . . . . 51.109999999999999 109.798 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -89.48 4.41 49.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.181 -0.949 . . . . 73.340000000000003 109.596 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -85.02 -58.18 2.15 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.908 -1.277 . . . . 62.149999999999999 109.908 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.559 HD23 ' O ' ' A' ' 16' ' ' ILE . 0.6 OUTLIER -75.01 -19.06 60.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -1.165 . . . . 73.510000000000005 110.046 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -57.08 -38.25 73.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.974 . . . . 74.25 109.676 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.5 t -52.57 -32.02 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.215 -0.928 . . . . 70.040000000000006 109.123 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -75.2 -0.36 19.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.376 -0.827 . . . . 73.230000000000004 109.043 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.91 28.55 45.6 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.267 -1.133 . . . . 75.540000000000006 110.267 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -106.09 156.89 17.96 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.278 -1.13 . . . . 73.430000000000007 109.05 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.3 mmt -94.15 118.08 31.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.194 -0.942 . . . . 43.240000000000002 108.729 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -98.47 133.1 43.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.315 -0.866 . . . . 62.109999999999999 109.918 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -123.31 131.0 53.51 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 109.035 -0.728 . . . . 74.420000000000002 109.035 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.69 132.73 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 108.303 -0.999 . . . . 72.150000000000006 108.303 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 p -136.08 168.98 18.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.361 -0.837 . . . . 71.420000000000002 109.524 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.419 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 4.4 pt-20 -94.04 -103.47 0.14 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.301 -0.874 . . . . 72.329999999999998 109.836 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.5 t -78.54 166.78 22.18 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.256 -0.902 . . . . 74.239999999999995 110.157 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.0 mt -53.42 -33.7 54.99 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.621 -0.674 . . . . 71.530000000000001 109.733 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -52.51 -48.03 66.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.148 -0.97 . . . . 74.230000000000004 109.791 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -61.49 -37.61 84.28 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.141 -0.974 . . . . 54.030000000000001 109.11 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.26 -37.26 48.69 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.314 -1.515 . . . . 61.409999999999997 109.314 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -63.37 -39.03 93.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -1.126 . . . . 74.340000000000003 109.407 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -77.21 -37.99 52.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 75.329999999999998 109.513 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.3 tp -66.89 -46.21 75.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -0.867 . . . . 74.329999999999998 109.983 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.436 ' SD ' ' C ' ' A' ' 40' ' ' MET . 3.9 ppp? -70.09 -24.54 63.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.101 -1.0 . . . . 70.319999999999993 109.824 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -65.84 -40.42 91.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.048 -1.033 . . . . 71.219999999999999 109.951 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.2 pt -79.12 -34.01 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.103 -0.998 . . . . 74.140000000000001 110.074 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 40' ' ' MET . 30.3 mmt180 -130.25 147.69 52.0 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.327 -0.858 . . . . 72.239999999999995 109.356 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.626 ' N ' HD22 ' A' ' 44' ' ' ASN . 1.2 m120 -93.12 133.16 36.58 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.273 -0.892 . . . . 75.420000000000002 109.449 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -107.49 142.47 37.31 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.512 -0.743 . . . . 74.230000000000004 109.378 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -83.93 -42.15 16.61 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.939 . . . . 72.040000000000006 109.236 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.508 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.5 OUTLIER -105.86 113.17 26.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.565 -0.71 . . . . 72.129999999999995 109.176 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.508 ' N ' HD13 ' A' ' 47' ' ' LEU . 78.7 t -99.3 97.76 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.713 -0.847 . . . . 72.340000000000003 108.713 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.485 ' SD ' ' O ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -106.17 125.04 50.51 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.988 -0.745 . . . . 74.109999999999999 108.988 -179.678 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.01 133.2 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 121.664 0.745 . . . . 61.119999999999997 109.623 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.462 ' CB ' ' OE1' ' A' ' 7' ' ' GLU . 52.9 m -102.95 4.88 37.98 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.656 -0.652 . . . . 73.109999999999999 109.414 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -76.27 147.51 38.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -0.966 . . . . 52.549999999999997 109.613 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.429 ' C ' ' H ' ' A' ' 55' ' ' ALA . 25.6 pttm -81.92 -39.86 23.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.287 -0.883 . . . . 44.219999999999999 110.124 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -70.26 7.32 1.03 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.039 -1.038 . . . . 70.439999999999998 109.411 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.429 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -68.68 -21.78 64.41 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.384 -0.822 . . . . 64.140000000000001 110.433 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 55' ' ' ALA . 63.2 mt -42.36 -47.73 4.95 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.196 -0.94 . . . . 44.140000000000001 110.546 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.2 m -70.96 -36.64 72.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.884 -1.135 . . . . 55.229999999999997 109.388 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.655 ' CE2' HD11 ' A' ' 62' ' ' ILE . 58.1 t80 -68.07 -61.06 2.03 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.594 -0.691 . . . . 74.439999999999998 110.158 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 60' ' ' SER . 21.6 m -51.61 -37.68 20.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.845 -1.159 . . . . 74.030000000000001 109.431 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.467 ' N ' HG23 ' A' ' 59' ' ' VAL . 61.6 m -56.3 -55.76 29.4 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.271 -0.893 . . . . 64.299999999999997 109.514 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -67.91 -26.89 66.21 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.049 -1.032 . . . . 64.439999999999998 110.24 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.655 HD11 ' CE2' ' A' ' 58' ' ' PHE . 5.9 mm -57.36 -38.58 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.668 -1.27 . . . . 63.210000000000001 107.922 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 67' ' ' SER . 61.2 mmtt -72.76 -41.95 64.52 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.389 -0.819 . . . . 74.420000000000002 109.135 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -66.55 -51.44 56.49 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.143 -0.973 . . . . 70.319999999999993 109.229 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -69.57 -24.93 63.76 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.665 -0.647 . . . . 75.219999999999999 109.874 -179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.586 ' O ' HG22 ' A' ' 69' ' ' ILE . 96.7 m-70 -151.39 68.52 0.92 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.184 -0.947 . . . . 74.129999999999995 109.38 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 63' ' ' LYS . 96.9 p -57.93 -28.79 64.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 73.239999999999995 109.904 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 83.2 p -82.14 49.0 1.32 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.184 -0.948 . . . . 61.009999999999998 109.782 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.586 HG22 ' O ' ' A' ' 66' ' ' HIS . 13.1 tt -142.06 155.9 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.258 -0.901 . . . . 71.329999999999998 109.571 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.8 t -95.59 149.87 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.146 -0.971 . . . . 72.129999999999995 108.773 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 t -140.17 127.33 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.163 -0.961 . . . . 54.210000000000001 109.875 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.491 ' C ' HD23 ' A' ' 72' ' ' LEU . 2.4 tt -115.43 104.56 11.89 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.984 -0.747 . . . . 50.240000000000002 108.984 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.3 t -95.9 129.5 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.24 -0.913 . . . . 74.409999999999997 108.982 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.1 p -93.76 171.91 8.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.188 -0.945 . . . . 72.310000000000002 109.796 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.473 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 42.0 t -160.93 118.39 2.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.082 -1.011 . . . . 64.540000000000006 110.45 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -64.63 -29.01 70.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.623 -0.673 . . . . 74.129999999999995 109.72 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 79' ' ' THR . 35.5 m120 -122.07 80.55 43.27 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.528 -0.733 . . . . 73.340000000000003 109.428 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.12 87.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.323 2.016 . . . . 63.219999999999999 111.431 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.456 ' N ' ' O ' ' A' ' 77' ' ' ASN . 23.8 m -98.65 150.21 22.01 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.577 -0.702 . . . . 62.530000000000001 109.593 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.475 ' CB ' ' OG ' ' B' ' 101' ' ' SER . 0.0 OUTLIER -72.77 -41.15 65.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.35 -0.844 . . . . 73.439999999999998 109.189 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -57.57 -38.63 75.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.146 -0.971 . . . . 71.420000000000002 108.844 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -75.2 -26.02 58.68 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.352 -0.842 . . . . 73.430000000000007 109.191 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.525 ' OE1' ' CD2' ' A' ' 94' ' ' TYR . 36.7 tp10 -61.29 -57.63 11.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 74.219999999999999 109.65 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.482 HG23 ' N ' ' A' ' 85' ' ' HIS . 22.0 m -63.82 -40.65 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 73.200000000000003 109.338 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.482 ' N ' HG23 ' A' ' 84' ' ' VAL . 10.5 t-80 -62.36 -34.65 77.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.253 -0.904 . . . . 53.329999999999998 109.371 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.14 -39.81 93.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 64.109999999999999 109.969 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -78.26 -34.35 49.09 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.98 -1.075 . . . . 74.340000000000003 109.054 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -70.84 -36.84 73.08 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.299 -0.875 . . . . 74.420000000000002 109.592 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -68.39 -47.86 66.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 74.239999999999995 109.761 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.58 48.23 0.03 OUTLIER Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.949 -1.26 . . . . 61.509999999999998 109.949 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -111.82 133.26 54.14 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.425 -1.044 . . . . 55.329999999999998 109.382 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -84.67 -22.85 29.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.944 . . . . 73.420000000000002 109.133 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.532 ' OD2' ' NH2' ' A' ' 112' ' ' ARG . 19.6 t0 -150.61 163.3 38.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.399 -0.813 . . . . 75.040000000000006 109.325 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.525 ' CD2' ' OE1' ' A' ' 83' ' ' GLU . 67.6 t80 -146.03 101.92 3.58 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.37 -0.832 . . . . 71.329999999999998 108.936 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 96' ' ' ALA . 29.0 mm -112.19 156.04 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 O-C-N 121.29 -0.882 . . . . 71.129999999999995 110.464 -179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.402 ' N ' HG22 ' A' ' 95' ' ' ILE . . . -67.11 146.52 54.19 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.417 -0.957 . . . . 64.319999999999993 108.417 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.676 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -68.19 -55.79 12.1 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 120.869 -1.144 . . . . 62.200000000000003 111.172 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 4.3 Cg_endo -41.59 -10.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 120.87 1.047 . . . . 73.109999999999999 112.967 -176.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.676 ' N ' ' O ' ' A' ' 97' ' ' LYS . 22.6 m-85 67.12 110.3 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.789 -0.57 . . . . 65.219999999999999 109.681 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -57.41 -33.78 68.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.972 -1.08 . . . . 72.349999999999994 108.185 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.775 ' O ' ' N ' ' A' ' 103' ' ' LYS . 47.5 t -175.63 24.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 71.319999999999993 110.167 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.4 mm 50.2 -67.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 121.791 -0.568 . . . . 75.430000000000007 110.028 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.775 ' N ' ' O ' ' A' ' 101' ' ' SER . 3.3 mptp? -54.5 -33.06 59.19 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.343 -1.354 . . . . 71.409999999999997 107.343 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.98 -41.54 74.3 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.988 -1.116 . . . . 63.240000000000002 107.988 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.9 tt -61.7 -46.49 89.44 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.974 -0.75 . . . . 73.219999999999999 108.974 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 90.4 t -62.99 -40.75 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.302 -0.873 . . . . 60.109999999999999 109.052 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.87 -39.71 62.85 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.315 -0.866 . . . . 70.420000000000002 108.859 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.558 ' HE ' ' CD ' ' B' ' 83' ' ' GLU . 50.3 mtt85 -69.0 -35.68 76.97 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.274 -0.891 . . . . 74.409999999999997 109.412 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.4 mt -69.4 -34.92 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.058 -1.026 . . . . 62.539999999999999 108.487 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -59.58 -55.57 32.84 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.751 -0.779 . . . . 74.340000000000003 109.446 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.5 -34.58 67.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 73.319999999999993 109.959 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.532 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 64.9 mtt85 -60.74 -37.69 82.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.001 -1.062 . . . . 52.409999999999997 110.022 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -155.06 68.74 0.7 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.681 -1.262 . . . . 65.239999999999995 110.373 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -53.66 89.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.102 -0.999 . . . . 64.450000000000003 108.784 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.506 ' N ' ' O ' ' A' ' 113' ' ' LEU . 69.0 m-85 52.9 89.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.186 -0.946 . . . . 74.430000000000007 109.599 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.412 ' HE1' ' HB3' ' A' ' 132' ' ' GLU . 74.6 t-105 -87.0 141.96 28.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -0.918 . . . . 74.420000000000002 109.304 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 163.36 98.39 0.13 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.683 -1.367 . . . . 75.040000000000006 109.683 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.477 ' O ' ' ND2' ' A' ' 119' ' ' ASN . 9.0 t -157.26 177.58 11.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -1.179 . . . . 61.140000000000001 109.666 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.477 ' ND2' ' O ' ' A' ' 118' ' ' SER . 0.4 OUTLIER -146.42 127.77 14.91 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.007 -0.677 . . . . 65.239999999999995 109.498 -177.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 86.6 t -72.87 -30.06 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.372 -0.83 . . . . 73.109999999999999 109.824 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.747 ' CG2' HH21 ' A' ' 159' ' ' ARG . 5.1 mp -118.66 131.88 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.427 -0.796 . . . . 72.239999999999995 109.913 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -142.33 107.73 5.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.426 -0.796 . . . . 72.340000000000003 108.997 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.588 HG12 ' CZ ' ' A' ' 159' ' ' ARG . 1.2 pp -130.71 142.44 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.458 -0.776 . . . . 71.439999999999998 109.027 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.72 -152.81 2.48 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.996 -1.642 . . . . 73.400000000000006 108.996 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -84.35 11.66 8.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.339 -1.094 . . . . 74.450000000000003 108.702 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.03 136.46 43.64 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.857 -0.794 . . . . 54.210000000000001 108.857 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 18.6 p -129.56 148.71 51.49 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.5 -0.75 . . . . 54.5 109.246 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.3 mt -139.04 136.06 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.393 -0.817 . . . . 45.149999999999999 110.028 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 12.8 m -126.11 98.76 32.45 Favored Pre-proline 0 N--CA 1.5 2.068 0 N-CA-C 108.68 -0.859 . . . . 71.109999999999999 108.68 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.46 -34.33 0.56 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.276 1.984 . . . . 65.409999999999997 112.734 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -58.09 -43.83 87.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.004 -1.06 . . . . 63.32 109.425 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.412 ' HB3' ' HE1' ' A' ' 116' ' ' TRP . 4.5 pt-20 -97.06 14.01 27.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.463 -0.773 . . . . 72.519999999999996 109.13 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 27.4 mp0 45.84 76.25 0.1 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.375 -0.828 . . . . 75.329999999999998 109.681 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -163.56 149.99 11.89 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.058 -1.026 . . . . 71.230000000000004 110.033 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.582 ' C ' HD13 ' A' ' 136' ' ' ILE . 17.7 tt -137.68 143.96 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.318 -0.864 . . . . 74.019999999999996 109.314 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.582 HD13 ' C ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -122.46 131.78 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.477 -0.764 . . . . 60.229999999999997 109.728 -179.297 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -138.58 128.75 25.63 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.348 -0.845 . . . . 62.32 108.737 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp 54.32 29.47 10.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.519 -0.738 . . . . 75.400000000000006 109.097 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 79.56 1.19 86.2 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.774 -0.931 . . . . 72.239999999999995 110.774 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.436 ' HD2' ' N ' ' A' ' 140' ' ' ARG . 9.2 mmm180 -88.79 124.15 33.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.859 -1.377 . . . . 71.219999999999999 108.909 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.447 ' HG2' HD12 ' A' ' 136' ' ' ILE . 95.0 mt-10 -88.81 136.35 33.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.286 -0.884 . . . . 71.420000000000002 109.014 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.0 t -131.84 127.8 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.371 -0.831 . . . . 53.020000000000003 109.591 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -88.27 122.7 32.1 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.69 -0.856 . . . . 60.450000000000003 108.69 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.6 m -141.88 138.57 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.03 -1.044 . . . . 74.439999999999998 109.867 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.51 39.14 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.443 -0.785 . . . . 65.150000000000006 109.191 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -107.9 -152.52 17.11 Favored Glycine 0 N--CA 1.502 3.036 0 N-CA-C 110.009 -1.236 . . . . 73.340000000000003 110.009 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.605 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 1.1 mtmp? -88.07 -37.62 0.46 Allowed Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.222 -1.164 . . . . 72.219999999999999 110.139 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 23.3 Cg_exo -63.29 -32.08 73.2 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.175 1.917 . . . . 65.230000000000004 111.418 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.507 ' CZ ' ' CG2' ' A' ' 153' ' ' THR . 43.7 t80 -86.69 -9.98 54.75 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.435 -0.791 . . . . 60.109999999999999 109.68 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.451 ' O ' ' OG1' ' A' ' 153' ' ' THR . 15.9 tt0 -66.96 -41.74 86.39 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.076 -1.015 . . . . 64.209999999999994 109.17 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.08 -35.11 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.983 -1.073 . . . . 72.019999999999996 109.223 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.692 HD12 HD21 ' A' ' 155' ' ' LEU . 15.9 tp -65.27 -33.35 75.78 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.181 -0.949 . . . . 73.310000000000002 108.967 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.507 ' CG2' ' CZ ' ' A' ' 149' ' ' PHE . 17.0 p -70.4 -32.39 70.01 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.177 -0.952 . . . . 74.310000000000002 108.437 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -64.38 -57.7 8.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.21 -0.931 . . . . 74.310000000000002 110.23 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.692 HD21 HD12 ' A' ' 152' ' ' LEU . 2.9 pp -65.38 -25.92 67.78 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.951 -1.093 . . . . 75.340000000000003 109.468 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.91 -51.55 69.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.008 -1.057 . . . . 62.140000000000001 108.988 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.1 mtt180 -74.17 -51.41 15.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.406 -0.809 . . . . 61.030000000000001 109.512 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.445 ' O ' ' O ' ' A' ' 159' ' ' ARG . 39.7 m80 -86.09 33.67 0.61 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.477 -0.765 . . . . 74.120000000000005 109.98 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.747 HH21 ' CG2' ' A' ' 121' ' ' ILE . 30.4 ttm-85 -46.96 -94.1 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.302 -0.874 . . . . 71.129999999999995 109.231 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.517 ' OD2' ' NE2' ' B' ' 161' ' ' GLN . 31.6 p-10 -52.4 89.36 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.953 -1.092 . . . . 75.450000000000003 109.219 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.535 ' NE2' ' O ' ' A' ' 162' ' ' ILE . 0.0 OUTLIER -173.33 154.01 2.54 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.109 -0.994 . . . . 73.409999999999997 109.434 -179.705 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.535 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 52.5 mt -87.18 126.71 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.13 -0.981 . . . . 74.409999999999997 108.613 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.492 HG11 HD21 ' A' ' 168' ' ' LEU . 51.1 t -118.89 130.66 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.409 -0.807 . . . . 72.310000000000002 110.011 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 3.9 t -94.3 163.9 13.25 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.276 -0.89 . . . . 74.120000000000005 109.063 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -64.38 -43.58 94.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.067 -1.02 . . . . 70.430000000000007 109.554 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -58.92 -38.38 78.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 73.519999999999996 109.644 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -58.47 -46.18 87.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 74.519999999999996 109.513 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.492 HD21 HG11 ' A' ' 163' ' ' VAL . 77.7 mt -62.43 -39.31 92.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.155 -0.965 . . . . 72.310000000000002 109.311 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.511 HD23 ' C ' ' A' ' 169' ' ' LEU . 4.8 tt -54.77 -68.08 0.22 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.435 -0.791 . . . . 53.329999999999998 109.949 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.42 -37.08 79.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.305 -0.872 . . . . 62.439999999999998 110.751 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -50.79 -58.08 6.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.105 -0.997 . . . . 60.210000000000001 110.402 -178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.697 HD12 ' N ' ' A' ' 172' ' ' ILE . 1.9 mp -93.27 -62.69 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.98 -1.075 . . . . 75.319999999999993 109.492 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.441 ' O ' ' O ' ' A' ' 169' ' ' LEU . 24.5 m-90 -81.37 118.29 22.54 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.38 -0.825 . . . . 73.140000000000001 110.06 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -144.39 -55.0 0.34 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.292 -0.88 . . . . 73.239999999999995 108.859 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.561 ' O ' ' N ' ' A' ' 177' ' ' GLU . 4.6 mp0 -55.33 155.1 10.1 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 107.989 -1.115 . . . . 44.43 107.989 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -33.66 83.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.798 2.332 . . . . 72.510000000000005 112.621 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.594 ' CD ' ' H ' ' A' ' 177' ' ' GLU . 0.0 OUTLIER -92.74 -25.65 18.1 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.661 -0.649 . . . . 63.240000000000002 110.124 -179.338 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.505 ' N ' ' CD ' ' A' ' 177' ' ' GLU . 66.5 mtm 56.14 19.92 4.12 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.268 -0.895 . . . . 73.5 110.558 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 34.9 m -87.33 154.93 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.786 -1.196 . . . . 65.219999999999999 109.116 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 38.2 p -70.13 149.72 96.13 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.168 -0.958 . . . . 71.420000000000002 109.496 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -76.9 32.15 0.42 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.242 1.961 . . . . 41.219999999999999 112.184 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -143.88 -9.63 0.7 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.171 -0.956 . . . . 64.540000000000006 109.531 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.433 ' O ' HG22 ' A' ' 186' ' ' VAL . 11.8 p -58.29 -12.91 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 74.019999999999996 109.382 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.57 ' N ' HD12 ' A' ' 184' ' ' ILE . 2.6 mp -59.92 -22.98 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.088 -1.007 . . . . 72.329999999999998 109.028 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -61.6 -45.35 94.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.208 -0.933 . . . . 74.400000000000006 110.027 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 183' ' ' VAL . 12.1 m -75.32 -30.14 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.001 -1.062 . . . . 70.420000000000002 109.324 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -69.5 -50.67 43.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.097 -1.002 . . . . 52.109999999999999 110.025 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.446 HG23 ' N ' ' A' ' 189' ' ' ASN . 10.3 tp -65.13 -39.26 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.84 -1.163 . . . . 71.400000000000006 110.503 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.446 ' N ' HG23 ' A' ' 188' ' ' ILE . 11.6 t-20 -58.36 -43.09 88.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.974 -1.079 . . . . 73.439999999999998 109.483 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -75.64 -47.72 25.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.347 -0.845 . . . . 71.420000000000002 110.072 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 63.6 mt -52.13 -47.91 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.13 -0.981 . . . . 61.549999999999997 109.46 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.476 ' HE ' ' CG2' ' A' ' 204' ' ' VAL . 76.0 mtp180 -60.58 -51.3 70.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.322 -0.861 . . . . 63.340000000000003 109.988 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -61.59 -33.89 74.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.24 -0.913 . . . . 61.240000000000002 110.145 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.421 ' O ' ' CD ' ' A' ' 198' ' ' PRO . 9.3 pttm -86.81 -4.31 59.16 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.92 -1.112 . . . . 75.129999999999995 109.589 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 28.2 ttt -91.46 -57.2 2.85 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.16 -0.963 . . . . 74.019999999999996 109.189 179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 200' ' ' GLY . 15.0 p-10 -65.19 -31.42 72.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.364 -0.835 . . . . 74.019999999999996 109.619 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.441 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 27.5 mttm -52.86 -65.26 1.14 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.103 -0.998 . . . . 75.430000000000007 109.579 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.441 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 38.5 Cg_endo -63.89 -54.92 0.76 Allowed 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 122.144 1.896 . . . . 72.319999999999993 112.066 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' A' ' 201' ' ' ILE . 65.4 mt -63.79 -28.87 70.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 74.540000000000006 109.211 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 196' ' ' ASP . . . 74.92 -26.61 1.15 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.789 -1.325 . . . . 61.509999999999998 109.789 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.466 ' H ' ' C ' ' A' ' 199' ' ' LEU . 11.0 mt -101.32 129.95 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.357 -1.084 . . . . 61.219999999999999 109.356 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 15.1 t -80.6 132.2 35.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.895 . . . . 72.0 109.265 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 62.6 p -136.11 3.72 2.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.432 -0.793 . . . . 74.439999999999998 108.949 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.476 ' CG2' ' HE ' ' A' ' 192' ' ' ARG . 28.6 m -104.36 138.09 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.499 -0.75 . . . . 64.349999999999994 109.292 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -122.96 136.34 54.82 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.6 -0.688 . . . . 71.409999999999997 109.572 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.13 132.35 44.51 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.231 -0.918 . . . . 73.519999999999996 109.047 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 5.1 m -135.14 136.29 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.371 -0.831 . . . . 71.019999999999996 109.48 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 23.6 ttp180 -81.34 -10.05 59.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.856 . . . . 72.120000000000005 109.16 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 18.8 mtp-105 -56.04 -43.28 77.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.92 . . . . 64.409999999999997 109.812 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -148.05 -66.76 0.25 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.221 -0.924 . . . . 71.540000000000006 109.524 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -148.45 -110.89 0.59 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.636 -1.386 . . . . 72.030000000000001 109.636 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.406 ' N ' ' CD1' ' A' ' 212' ' ' TYR . 41.4 m-85 -125.81 146.34 49.84 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.643 -0.916 . . . . 75.540000000000006 109.075 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -113.09 133.39 55.02 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.539 -0.726 . . . . 75.310000000000002 109.542 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -99.36 132.01 44.99 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.689 -0.856 . . . . 75.409999999999997 108.689 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 2.0 p -141.1 166.72 24.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.278 -0.889 . . . . 74.140000000000001 109.601 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -82.11 152.44 68.2 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.298 -0.876 . . . . 75.319999999999993 109.426 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -39.13 142.17 0.36 Allowed 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 122.295 1.997 . . . . 73.109999999999999 112.266 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.604 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 53.9 mmtt -84.37 -33.68 0.53 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 75.25 111.058 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 97.7 Cg_endo -88.43 19.21 1.36 Allowed 'Trans proline' 0 N--CA 1.487 1.139 0 C-N-CA 122.029 1.819 . . . . 75.099999999999994 112.077 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.97 -41.17 74.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.277 -0.889 . . . . 71.140000000000001 109.593 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 19.4 m 53.27 50.28 17.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.165 -0.96 . . . . 71.129999999999995 109.399 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -59.87 158.72 10.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.298 -0.876 . . . . 75.349999999999994 109.531 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.015 -0.993 . . . . 73.409999999999997 109.585 -179.994 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.573 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.406 -0.59 . . . . 71.140000000000001 109.406 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 75.9 mtp180 -131.77 145.89 51.85 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.512 -0.743 . . . . 73.230000000000004 109.129 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.2 t -117.03 139.65 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.582 -0.699 . . . . 72.239999999999995 109.907 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.495 HD11 ' CG1' ' B' ' 6' ' ' ILE . 3.3 tp -109.01 118.7 37.47 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.568 -0.708 . . . . 54.329999999999998 109.386 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.466 ' N ' HD12 ' B' ' 4' ' ' LEU . 21.7 mt -115.62 97.8 6.34 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.597 -0.89 . . . . 74.349999999999994 108.597 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.683 HD12 ' HB ' ' B' ' 50' ' ' VAL . 90.2 mt -85.8 97.41 5.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 120.863 -1.148 . . . . 42.549999999999997 108.987 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.407 ' HG3' ' H ' ' B' ' 9' ' ' ASN . 45.8 tp10 -120.52 128.04 52.74 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.543 -0.723 . . . . 74.519999999999996 109.635 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . 0.491 ' CD ' ' H ' ' B' ' 8' ' ' LYS . 0.0 OUTLIER -83.43 -22.12 32.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.269 -0.894 . . . . 62.549999999999997 108.773 179.447 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . 0.471 ' ND2' HD23 ' B' ' 12' ' ' LEU . 37.0 t-20 -78.6 -128.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.431 -0.793 . . . . 73.109999999999999 109.232 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . 0.418 ' OG ' ' N ' ' B' ' 11' ' ' VAL . 22.0 p -166.83 -55.54 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -0.866 . . . . 65.540000000000006 109.32 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.418 ' N ' ' OG ' ' B' ' 10' ' ' SER . 88.0 t -67.74 -42.77 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.288 -0.883 . . . . 75.549999999999997 109.652 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.583 HD13 ' OE2' ' B' ' 15' ' ' GLU . 4.0 mm? -59.87 -42.23 93.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.338 -0.851 . . . . 70.140000000000001 109.532 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.75 -28.56 66.88 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 108.416 -1.874 . . . . 75.400000000000006 108.416 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.06 -47.94 80.49 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 109.828 -1.309 . . . . 65.439999999999998 109.828 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.583 ' OE2' HD13 ' B' ' 12' ' ' LEU . 15.7 pt-20 -63.76 -44.42 93.51 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.122 -1.222 . . . . 60.210000000000001 109.707 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 37.0 mm -66.7 -39.77 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.756 -1.215 . . . . 75.150000000000006 108.667 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.488 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 80.3 tt0 -63.72 -43.21 97.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.403 -0.811 . . . . 73.010000000000005 109.684 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp -86.81 0.45 54.81 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.09 -1.006 . . . . 74.299999999999997 109.366 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.49 -52.83 3.08 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.561 -1.416 . . . . 70.540000000000006 109.561 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.403 HD23 ' N ' ' B' ' 21' ' ' ASN . 1.4 pt? -76.73 -21.56 55.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -1.102 . . . . 71.340000000000003 109.914 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 90.9 m-20 -56.43 -31.47 63.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.084 -1.01 . . . . 64.409999999999997 109.451 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 87.6 t -59.87 -35.02 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.317 -0.864 . . . . 74.230000000000004 109.354 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -70.68 -8.12 49.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.343 -0.848 . . . . 63.420000000000002 109.314 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.36 43.41 6.59 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.023 -1.231 . . . . 53.43 110.023 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -116.71 159.67 21.91 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.498 -1.001 . . . . 71.120000000000005 109.054 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 14.5 mmt -100.74 138.02 38.35 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.989 -1.115 . . . . 75.239999999999995 107.989 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.23 155.57 43.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.096 -1.002 . . . . 72.120000000000005 110.257 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -132.3 160.82 35.14 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.665 -0.865 . . . . 72.310000000000002 108.665 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.2 p -119.49 139.0 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.45 -0.781 . . . . 64.430000000000007 109.739 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 6.8 p -134.83 170.43 15.87 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.068 -0.716 . . . . 65.409999999999997 109.068 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.402 ' OE2' ' OD2' ' B' ' 35' ' ' ASP . 5.9 pt-20 -93.31 -107.81 0.12 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.219 -0.925 . . . . 71.019999999999996 109.82 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 54.8 p -78.94 168.16 20.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.25 -0.906 . . . . 51.109999999999999 110.025 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 61.0 mt -52.83 -29.41 27.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.548 -0.72 . . . . 71.239999999999995 109.754 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -52.71 -50.38 63.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.144 -0.972 . . . . 74.319999999999993 109.636 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.402 ' OD2' ' OE2' ' B' ' 31' ' ' GLU . 1.8 m-20 -64.66 -40.89 96.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.94 . . . . 73.030000000000001 109.481 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.02 -42.0 60.03 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.573 -1.411 . . . . 30.210000000000001 109.573 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.68 -37.75 87.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.304 -1.115 . . . . 74.420000000000002 109.748 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -80.64 -41.16 24.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.088 -1.007 . . . . 74.420000000000002 109.858 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 8.6 tt -70.21 -43.86 69.83 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.191 -0.943 . . . . 75.409999999999997 109.972 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . 0.448 ' SD ' ' C ' ' B' ' 40' ' ' MET . 3.1 ppp? -62.62 -26.34 68.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.987 -1.07 . . . . 60.409999999999997 109.88 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -63.49 -39.85 95.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.054 -1.029 . . . . 53.229999999999997 110.027 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 20.9 pt -84.38 -26.29 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.095 -1.003 . . . . 71.230000000000004 110.166 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' B' ' 40' ' ' MET . 63.6 mmt-85 -129.69 138.59 51.24 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.305 -0.872 . . . . 72.219999999999999 109.348 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -93.62 159.59 15.15 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.162 -0.961 . . . . 63.539999999999999 109.825 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -136.63 150.47 48.55 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.447 -0.783 . . . . 64.349999999999994 109.212 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -91.5 -35.02 14.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.147 -0.971 . . . . 62.219999999999999 109.692 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.512 HD13 ' C ' ' B' ' 47' ' ' LEU . 0.9 OUTLIER -113.37 110.6 20.6 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.421 -0.799 . . . . 73.120000000000005 109.095 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.464 ' N ' HD13 ' B' ' 47' ' ' LEU . 70.8 t -93.86 100.22 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.324 -0.86 . . . . 65.109999999999999 108.761 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.518 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 6.3 tpp -114.24 128.23 56.26 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.094 -0.706 . . . . 73.439999999999998 109.094 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.686 HG22 ' H ' ' B' ' 52' ' ' ASP . 0.7 OUTLIER -144.01 136.66 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 34.5 109.803 -179.451 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 65.2 p -101.52 16.77 24.62 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.593 -0.692 . . . . 73.209999999999994 109.658 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.686 ' H ' HG22 ' B' ' 50' ' ' VAL . 41.7 m-20 -83.59 136.22 34.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.22 -0.925 . . . . 70.409999999999997 109.331 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -71.93 -33.56 68.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.898 . . . . 65.0 110.184 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -76.91 3.7 11.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.098 -1.001 . . . . 75.209999999999994 110.097 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.403 ' O ' ' C ' ' B' ' 56' ' ' LEU . . . -71.39 -21.33 62.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 55.329999999999998 110.215 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' B' ' 55' ' ' ALA . 56.2 mt -42.98 -42.91 3.94 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.424 -0.797 . . . . 63.140000000000001 110.275 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 19.7 m -72.63 -37.22 68.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.045 -1.035 . . . . 63.5 109.459 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . 0.568 ' CE2' HD11 ' B' ' 62' ' ' ILE . 69.1 t80 -67.44 -51.06 56.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.368 -0.832 . . . . 72.329999999999998 110.287 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.3 m -60.4 -35.11 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.783 -1.198 . . . . 74.540000000000006 109.542 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 66.1 p -58.41 -50.84 72.26 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.269 -0.895 . . . . 71.239999999999995 109.289 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.505 ' HE ' ' CE ' ' B' ' 65' ' ' LYS . 12.2 ptm180 -68.85 -30.94 69.57 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 118.742 -1.183 . . . . 74.310000000000002 109.815 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.568 HD11 ' CE2' ' B' ' 58' ' ' PHE . 4.8 mm -54.56 -48.44 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.842 -1.161 . . . . 72.140000000000001 108.526 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.523 ' NZ ' ' OD2' ' B' ' 92' ' ' ASP . 50.3 mmtt -61.2 -42.94 99.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.141 -0.975 . . . . 73.319999999999993 108.435 179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 35.1 tp10 -65.65 -43.69 88.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.415 -0.803 . . . . 73.120000000000005 108.837 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.505 ' CE ' ' HE ' ' B' ' 61' ' ' ARG . 9.5 mtmp? -82.28 -77.54 0.23 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.662 -0.649 . . . . 72.439999999999998 109.964 -179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.433 ' N ' ' O ' ' B' ' 62' ' ' ILE . 95.1 m-70 -97.53 87.69 4.17 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.165 -0.959 . . . . 63.310000000000002 109.727 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 71.0 p -79.34 -30.88 42.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.3 -0.875 . . . . 73.099999999999994 110.013 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 38.3 m -63.23 -28.89 70.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.19 -0.944 . . . . 71.530000000000001 110.0 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 58.3 mt -80.17 150.0 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.088 -1.008 . . . . 74.400000000000006 109.654 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.553 HG12 ' N ' ' B' ' 71' ' ' VAL . 98.8 t -88.37 165.62 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.378 -0.826 . . . . 75.120000000000005 109.387 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.553 ' N ' HG12 ' B' ' 70' ' ' VAL . 14.4 t -145.48 125.42 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.999 -1.063 . . . . 73.200000000000003 109.859 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.518 ' O ' ' SD ' ' B' ' 49' ' ' MET . 0.8 OUTLIER -120.5 103.6 9.3 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.408 -0.96 . . . . 73.340000000000003 108.408 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 13.4 p -98.4 144.98 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.179 -0.951 . . . . 73.5 108.876 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.5 m -111.07 171.25 7.58 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.318 -0.864 . . . . 64.340000000000003 109.147 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 8.0 t -171.13 122.26 0.56 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.076 -1.015 . . . . 74.530000000000001 110.065 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 46.3 p30 -78.14 29.82 0.18 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.453 -0.779 . . . . 64.5 110.189 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . 0.414 ' N ' ' CD ' ' B' ' 78' ' ' PRO . 12.7 t-20 -150.47 55.13 1.67 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 120.939 -1.101 . . . . 74.25 109.862 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' B' ' 77' ' ' ASN . 12.0 Cg_endo -56.26 81.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.604 2.203 . . . . 74.430000000000007 112.397 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.416 HG22 ' H ' ' B' ' 81' ' ' GLU . 29.4 m -109.35 149.69 29.12 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.317 -0.994 . . . . 73.120000000000005 108.317 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.06 -30.66 66.38 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.144 -0.972 . . . . 71.010000000000005 109.213 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . 0.416 ' H ' HG22 ' B' ' 79' ' ' THR . 84.1 tt0 -64.53 -48.21 75.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.204 -0.935 . . . . 63.200000000000003 109.034 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -69.89 -29.49 66.7 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.138 -0.976 . . . . 73.219999999999999 109.142 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.558 ' CD ' ' HE ' ' A' ' 108' ' ' ARG . 39.8 tp10 -56.21 -56.03 25.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.871 . . . . 74.299999999999997 109.192 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 8.2 m -60.46 -38.45 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.171 -0.956 . . . . 73.310000000000002 108.917 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 69.9 t60 -63.11 -34.03 76.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.303 -0.873 . . . . 73.239999999999995 109.437 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.18 90.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.197 -0.94 . . . . 55.329999999999998 109.74 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -76.56 -31.34 57.51 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.195 -0.941 . . . . 74.140000000000001 108.641 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -67.32 -46.31 73.87 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.731 -0.84 . . . . 64.040000000000006 108.731 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -59.48 -66.21 0.55 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.611 -0.681 . . . . 72.349999999999994 109.414 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 149.87 52.14 0.02 OUTLIER Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.167 -1.173 . . . . 65.200000000000003 110.167 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.6 132.23 54.08 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.31 -1.112 . . . . 52.229999999999997 109.067 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.523 ' OD2' ' NZ ' ' B' ' 63' ' ' LYS . 3.4 m-20 -67.15 -38.11 84.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.033 -1.042 . . . . 73.319999999999993 108.873 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 48.2 t0 -152.11 156.65 40.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.442 -0.786 . . . . 72.219999999999999 108.939 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.482 ' CD1' ' C ' ' B' ' 94' ' ' TYR . 0.5 OUTLIER -125.29 126.54 45.27 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.179 -0.674 . . . . 64.420000000000002 109.179 -179.586 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.435 ' N ' ' CD1' ' B' ' 94' ' ' TYR . 25.8 mm -110.22 134.06 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 121.378 -0.826 . . . . 72.230000000000004 109.923 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' B' ' 97' ' ' LYS . . . -60.97 119.5 8.41 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 106.635 -1.617 . . . . 25.239999999999998 106.635 177.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.681 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -42.01 -55.36 6.3 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.032 -1.042 . . . . 64.319999999999993 111.574 -178.072 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 3.7 Cg_endo -41.64 -10.76 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 120.774 0.983 . . . . 63.329999999999998 112.57 -176.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . 0.681 ' N ' ' O ' ' B' ' 97' ' ' LYS . 58.6 m-85 58.83 104.98 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.845 -0.535 . . . . 75.129999999999995 109.719 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 33.0 ttm-85 -62.0 -34.4 76.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.071 -1.018 . . . . 74.230000000000004 109.091 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . 0.631 ' O ' ' N ' ' B' ' 103' ' ' LYS . 28.8 m -172.51 32.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.88 . . . . 63.340000000000003 110.253 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . 0.48 ' O ' ' N ' ' B' ' 104' ' ' ALA . 55.9 mt 49.09 -81.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.384 -0.823 . . . . 74.439999999999998 110.368 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.631 ' N ' ' O ' ' B' ' 101' ' ' SER . 44.7 mtmt -45.57 -19.97 0.06 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.242 -0.911 . . . . 71.109999999999999 108.961 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' B' ' 102' ' ' ILE . . . -55.6 -67.5 0.28 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.509 -0.744 . . . . 71.450000000000003 109.545 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 3.1 pp -60.84 -36.76 79.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.961 -1.087 . . . . 51.310000000000002 109.555 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 14.5 t -56.92 -45.69 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.74 -1.225 . . . . 65.230000000000004 108.531 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.3 -31.04 67.13 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.337 -0.986 . . . . 24.32 108.337 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -79.41 -23.72 43.05 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.525 -0.735 . . . . 75.310000000000002 109.822 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 83.2 mt -78.24 -39.69 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.955 -1.091 . . . . 54.240000000000002 109.11 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -73.52 -41.39 63.11 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.329 -0.949 . . . . 65.310000000000002 109.417 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.15 -53.28 59.58 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.192 -0.942 . . . . 72.239999999999995 109.577 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 68.3 ttt-85 -64.97 -33.85 77.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 72.040000000000006 109.47 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.521 ' O ' ' CD2' ' B' ' 115' ' ' PHE . 60.3 tp -80.54 -90.82 0.06 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.211 -0.93 . . . . 75.349999999999994 109.7 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' B' ' 116' ' ' TRP . 11.6 mmt180 47.17 -170.03 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.176 -0.952 . . . . 75.5 108.881 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' PHE . . . . . 0.521 ' CD2' ' O ' ' B' ' 113' ' ' LEU . 1.4 m-85 66.26 -39.76 0.33 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.336 -0.853 . . . . 65.329999999999998 109.849 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' TRP . . . . . 0.528 ' N ' ' O ' ' B' ' 114' ' ' ARG . 17.1 t90 53.3 43.13 31.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.012 -1.055 . . . . 74.450000000000003 109.203 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.49 77.0 1.09 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.817 -1.313 . . . . 44.210000000000001 109.817 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 2.3 t -80.92 -8.35 59.72 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.207 -1.172 . . . . 71.400000000000006 109.392 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . 0.54 HD21 ' C ' ' B' ' 128' ' ' ILE . 24.4 t-20 54.52 176.39 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.422 -0.798 . . . . 72.319999999999993 110.328 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . 0.437 ' H ' ' CG ' ' B' ' 119' ' ' ASN . 11.8 t -142.71 -36.2 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.72 -0.845 . . . . 75.019999999999996 108.72 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 25.6 mm -115.42 118.77 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.28 -1.008 . . . . 51.409999999999997 108.28 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -155.34 140.76 17.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.939 -1.101 . . . . 71.530000000000001 110.131 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 35.1 pt -149.02 145.23 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 108.998 -0.742 . . . . 72.430000000000007 108.998 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 45.8 -136.41 8.0 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.848 -1.301 . . . . 51.229999999999997 109.848 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -90.51 6.73 42.29 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.259 -1.142 . . . . 74.200000000000003 109.326 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.9 139.25 31.12 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.321 -0.862 . . . . 75.420000000000002 108.777 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 17.0 m -128.86 133.68 48.04 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.601 -0.888 . . . . 74.219999999999999 108.601 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.54 ' C ' HD21 ' B' ' 119' ' ' ASN . 42.0 mt -138.95 141.31 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.147 -0.971 . . . . 60.329999999999998 110.571 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . 0.49 ' OG ' ' ND2' ' B' ' 119' ' ' ASN . 6.1 m -136.99 117.75 10.88 Favored Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 108.915 -0.772 . . . . 72.310000000000002 108.915 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.98 -48.74 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 121.958 1.772 . . . . 75.129999999999995 112.471 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -55.53 -37.41 67.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.211 -0.93 . . . . 75.230000000000004 109.836 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -80.76 -2.15 45.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.166 -0.959 . . . . 72.430000000000007 109.374 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 49.55 57.32 6.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.256 -0.903 . . . . 75.129999999999995 108.958 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -156.66 139.7 15.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.248 -0.908 . . . . 73.219999999999999 109.545 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 55.3 mt -124.01 132.72 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.995 -0.743 . . . . 64.140000000000001 108.995 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . 0.442 HG23 ' O ' ' B' ' 140' ' ' ARG . 23.7 mt -125.57 131.25 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.502 -0.749 . . . . 71.219999999999999 110.318 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -125.62 129.24 49.24 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.697 -0.627 . . . . 64.219999999999999 109.483 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm 51.46 36.34 16.52 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.179 -0.951 . . . . 72.019999999999996 111.095 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.76 -1.34 83.83 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 120.065 -1.064 . . . . 74.319999999999993 111.5 177.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . 0.442 ' O ' HG23 ' B' ' 136' ' ' ILE . 2.7 mpt_? -87.14 124.62 33.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.714 -1.462 . . . . 75.340000000000003 108.927 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -84.03 123.88 30.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.368 -0.832 . . . . 71.230000000000004 109.496 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 97.2 t -127.72 133.28 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.474 -0.766 . . . . 70.430000000000007 109.45 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -98.93 142.84 29.93 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.242 -0.911 . . . . 72.430000000000007 109.44 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 20.6 m -146.32 152.29 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.149 -0.969 . . . . 72.129999999999995 109.906 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.11 115.79 0.08 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.358 -0.839 . . . . 72.019999999999996 109.407 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.59 -137.86 7.03 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.788 -1.325 . . . . 42.229999999999997 109.788 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 0.58 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 0.0 OUTLIER -73.53 -43.83 7.1 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.272 -1.134 . . . . 73.299999999999997 109.539 -179.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 24.3 Cg_exo -62.67 -49.08 5.99 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 122.29 1.994 . . . . 71.329999999999998 111.144 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . 0.44 ' CE1' HG21 ' B' ' 153' ' ' THR . 25.1 t80 -58.06 -24.39 58.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.687 -0.633 . . . . 74.230000000000004 109.608 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . 0.41 ' OE1' ' O ' ' B' ' 172' ' ' ILE . 24.0 tt0 -72.11 -58.6 3.29 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.299 -0.876 . . . . 72.340000000000003 110.378 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.99 -33.58 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.801 -1.187 . . . . 73.349999999999994 109.468 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 3.8 mp -58.15 -41.47 83.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.118 -0.989 . . . . 55.240000000000002 108.781 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.44 HG21 ' CE1' ' B' ' 149' ' ' PHE . 1.9 p -80.6 -18.96 46.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.967 . . . . 70.010000000000005 110.235 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -71.16 -52.13 20.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.858 -1.151 . . . . 65.319999999999993 109.576 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.997 HD13 ' N ' ' B' ' 156' ' ' ALA . 0.0 OUTLIER -77.92 -25.01 48.11 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.313 -0.867 . . . . 71.540000000000006 110.17 -179.164 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . 0.997 ' N ' HD13 ' B' ' 155' ' ' LEU . . . -63.38 -53.4 53.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.906 -1.121 . . . . 75.319999999999993 109.259 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -66.06 -54.5 25.01 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.267 -0.896 . . . . 73.319999999999993 108.877 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . 0.448 ' ND1' ' N ' ' B' ' 158' ' ' HIS . 2.1 m-70 -84.72 38.27 0.69 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.804 -0.56 . . . . 74.140000000000001 110.263 -178.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -73.41 45.07 0.16 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.866 -1.146 . . . . 61.409999999999997 109.408 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' B' ' 160' ' ' ASP . 15.9 p-10 -169.81 62.13 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.076 -1.015 . . . . 72.099999999999994 109.294 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . 0.517 ' NE2' ' OD2' ' A' ' 160' ' ' ASP . 39.7 tp60 -169.87 164.51 9.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.07 -1.019 . . . . 72.25 109.831 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 162' ' ' ILE . . . . . 0.524 HG23 ' NE ' ' B' ' 213' ' ' ARG . 45.4 mt -80.3 132.94 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.611 -0.885 . . . . 72.310000000000002 108.611 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 33.9 t -132.01 131.12 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.289 -0.882 . . . . 64.209999999999994 109.892 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 11.2 p -99.68 159.94 14.67 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.708 -0.849 . . . . 74.219999999999999 108.708 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -55.76 -39.38 71.12 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.028 -1.045 . . . . 65.310000000000002 109.571 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.21 -39.6 93.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.149 -0.969 . . . . 63.450000000000003 109.809 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -53.3 -47.28 69.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.176 -0.953 . . . . 72.400000000000006 109.0 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 33.5 mt -55.87 -50.53 70.37 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.448 -0.945 . . . . 72.319999999999993 108.448 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.462 HD23 ' O ' ' B' ' 169' ' ' LEU . 1.1 tt -49.9 -56.23 11.35 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.271 -0.893 . . . . 73.340000000000003 109.296 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -56.2 -39.21 72.08 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 112.833 0.679 . . . . 72.099999999999994 112.833 -178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -93.25 -18.83 22.03 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.451 -1.406 . . . . 62.130000000000003 113.408 -176.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.41 ' O ' ' OE1' ' B' ' 150' ' ' GLU . 1.3 mp -91.32 -53.87 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 120.375 -1.453 . . . . 71.420000000000002 111.07 -178.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 173' ' ' TRP . . . . . 0.536 ' O ' ' CG ' ' B' ' 173' ' ' TRP . 0.0 OUTLIER -87.57 13.0 11.08 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.738 -1.226 . . . . 72.230000000000004 110.63 -177.542 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -48.36 -33.15 8.57 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.022 -1.049 . . . . 52.109999999999999 109.672 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' B' ' 177' ' ' GLU . 14.5 mt-10 -87.83 157.32 51.97 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 107.911 -1.144 . . . . 73.040000000000006 107.911 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.412 ' C ' ' O ' ' B' ' 175' ' ' GLU . 52.7 Cg_exo -34.0 86.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.581 2.187 . . . . 74.129999999999995 111.997 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' B' ' 175' ' ' GLU . 50.0 mt-10 -142.85 172.47 12.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.558 -0.714 . . . . 72.439999999999998 109.63 -178.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 3.7 tpt -142.79 70.33 1.32 Allowed 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.325 -0.991 . . . . 63.43 108.325 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 179' ' ' VAL . . . . . 0.513 ' O ' ' O ' ' B' ' 180' ' ' THR . 23.6 m -77.37 -10.97 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.522 -0.736 . . . . 71.049999999999997 110.761 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . 0.513 ' O ' ' O ' ' B' ' 179' ' ' VAL . 0.9 OUTLIER 55.31 154.77 0.06 OUTLIER Pre-proline 0 N--CA 1.497 1.902 0 O-C-N 121.773 -0.58 . . . . 62.149999999999999 109.439 -179.408 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.41 -54.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.203 1.936 . . . . 65.219999999999999 113.01 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -62.44 -33.5 74.92 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.199 -0.938 . . . . 72.310000000000002 111.072 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . 0.512 ' HB ' ' HG1' ' B' ' 180' ' ' THR . 87.2 t -66.67 -15.54 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.933 -1.104 . . . . 63.32 110.699 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 95.0 mt -60.87 -23.55 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.726 -1.234 . . . . 75.030000000000001 109.563 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . 0.449 ' CG ' ' N ' ' B' ' 186' ' ' VAL . 20.6 pt-20 -59.87 -43.95 94.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.283 -0.885 . . . . 64.109999999999999 109.883 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . 0.454 HG12 ' O ' ' B' ' 183' ' ' VAL . 2.7 p -76.98 -34.35 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.967 -1.083 . . . . 73.0 109.74 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -55.25 -52.59 62.9 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.881 -1.137 . . . . 61.119999999999997 109.588 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 8.3 tp -65.97 -37.83 80.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 120.973 -1.08 . . . . 72.430000000000007 109.603 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -58.5 -46.11 87.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.001 -1.062 . . . . 65.140000000000001 109.6 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -72.91 -47.23 47.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -0.904 . . . . 63.240000000000002 110.087 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.5 mt -54.63 -40.55 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.026 -1.046 . . . . 74.030000000000001 109.463 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -62.49 -52.17 64.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.162 -0.961 . . . . 72.239999999999995 109.505 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -60.22 -38.42 83.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 73.099999999999994 109.464 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -73.25 -15.42 61.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.289 -0.882 . . . . 72.109999999999999 109.592 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 1.5 tpt -89.85 -57.13 2.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.271 -0.893 . . . . 44.329999999999998 110.098 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 196' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' B' ' 200' ' ' GLY . 95.2 m-20 -55.87 -38.35 70.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 71.209999999999994 110.998 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . 0.435 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 14.0 mtmm -54.96 -65.66 1.28 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.876 -1.14 . . . . 75.209999999999994 109.938 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 198' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 34.9 Cg_endo -63.11 -56.57 0.53 Allowed 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 122.084 1.856 . . . . 75.319999999999993 112.368 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . 0.496 HD12 ' N ' ' B' ' 199' ' ' LEU . 9.1 mp -62.83 -32.15 73.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.137 -0.977 . . . . 72.25 109.478 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' B' ' 196' ' ' ASP . . . 74.14 -41.9 1.13 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.486 -1.446 . . . . 64.530000000000001 109.486 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . 0.418 ' H ' ' C ' ' B' ' 199' ' ' LEU . 4.0 mt -92.29 129.52 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.285 -1.126 . . . . 44.229999999999997 109.231 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 26.3 p -78.12 142.35 38.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.167 -0.958 . . . . 54.009999999999998 109.07 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 10.2 p -141.45 4.88 1.8 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.314 -0.867 . . . . 74.400000000000006 109.528 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.402 HG23 ' O ' ' B' ' 204' ' ' VAL . 32.6 m -113.89 134.83 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.444 -0.785 . . . . 72.120000000000005 109.208 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . 0.531 ' OE2' ' N ' ' B' ' 205' ' ' GLU . 1.5 mp0 -106.76 136.22 46.95 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.448 -0.783 . . . . 65.409999999999997 109.508 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.36 119.21 34.42 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.209 -0.932 . . . . 71.329999999999998 109.018 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 4.8 t -131.58 130.77 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.447 -0.783 . . . . 63.5 109.59 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 208' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' B' ' 209' ' ' ARG . 65.9 ttt-85 -73.1 -28.59 62.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 74.450000000000003 109.446 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' B' ' 208' ' ' ARG . 52.4 mtp85 -55.6 -106.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 74.140000000000001 109.982 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -63.67 -66.19 0.58 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.019 . . . . 74.430000000000007 109.852 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . 0.78 ' H ' HH12 ' B' ' 213' ' ' ARG . . . 178.68 -119.89 0.68 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.834 -1.306 . . . . 64.450000000000003 109.834 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 212' ' ' TYR . . . . . 0.628 ' N ' ' NH2' ' B' ' 213' ' ' ARG . 78.2 m-85 -111.69 141.79 44.85 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.494 -1.004 . . . . 74.209999999999994 109.7 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . 0.78 HH12 ' H ' ' B' ' 211' ' ' GLY . 13.5 mmp_? -105.87 131.51 53.11 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.454 -0.779 . . . . 74.030000000000001 108.96 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . 0.43 ' C ' ' SG ' ' B' ' 215' ' ' CYS . 60.4 m-85 -108.45 107.27 17.74 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.348 -0.845 . . . . 74.340000000000003 108.972 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . 0.43 ' SG ' ' C ' ' B' ' 214' ' ' PHE . 4.2 m -148.64 169.43 20.37 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.309 -0.869 . . . . 64.329999999999998 109.53 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -79.32 150.34 73.76 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 70.040000000000006 109.117 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.77 -159.57 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.975 1.783 . . . . 65.109999999999999 111.243 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -56.56 151.24 31.03 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 120.993 -1.067 . . . . 73.150000000000006 109.089 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -35.41 93.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.616 2.211 . . . . 71.310000000000002 112.353 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.66 -22.1 21.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.345 -0.847 . . . . 75.450000000000003 109.904 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 221' ' ' CYS . . . . . 0.524 ' SG ' ' N ' ' B' ' 222' ' ' GLU . 24.3 t -148.3 160.73 42.68 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.086 -1.009 . . . . 72.219999999999999 109.839 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.524 ' N ' ' SG ' ' B' ' 221' ' ' CYS . 78.7 tt0 -159.29 149.28 18.96 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.879 -0.786 . . . . 54.530000000000001 108.879 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.063 -1.023 . . . . 71.129999999999995 109.375 -179.988 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ptp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.469 -0.567 . . . . 65.120000000000005 109.469 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 43.1 ttt85 -144.24 156.47 44.3 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.277 -0.889 . . . . 72.329999999999998 109.238 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.5 t -117.04 129.21 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.59 0.709 . . . . 71.420000000000002 109.742 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' A' ' 49' ' ' MET . 6.8 tp -99.86 116.76 32.68 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.902 -0.777 . . . . 65.120000000000005 108.902 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.4 tp -119.54 105.44 11.23 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.098 -0.704 . . . . 62.43 109.098 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.47 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 11.7 mt -96.36 131.9 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.071 -1.018 . . . . 71.150000000000006 109.539 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.499 ' CD ' ' N ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -163.14 131.83 3.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.343 -0.848 . . . . 75.340000000000003 109.409 179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.547 ' H ' ' CD ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -76.74 -5.1 46.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -0.944 . . . . 72.439999999999998 108.898 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -74.67 -145.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.312 -0.868 . . . . 63.020000000000003 109.092 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.3 t -159.83 -69.84 0.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.107 -0.996 . . . . 72.340000000000003 109.662 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.414 HG13 ' N ' ' A' ' 12' ' ' LEU . 11.2 p -64.76 -37.46 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 74.019999999999996 109.985 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.414 ' N ' HG13 ' A' ' 11' ' ' VAL . 3.6 mm? -52.11 -41.34 62.39 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.978 -1.076 . . . . 71.430000000000007 108.756 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.25 -28.79 63.35 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.552 -1.819 . . . . 61.32 108.552 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.65 -46.43 92.15 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.696 -1.362 . . . . 71.200000000000003 109.696 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -66.28 -42.86 87.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.321 -1.106 . . . . 71.319999999999993 109.915 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.464 HD11 ' CE2' ' A' ' 99' ' ' TYR . 62.9 mt -69.55 -37.45 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.886 -1.134 . . . . 63.229999999999997 109.327 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -59.81 -45.94 90.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.137 -0.977 . . . . 51.109999999999999 109.488 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -86.33 -4.28 59.14 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.155 -0.966 . . . . 73.340000000000003 109.629 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.02 -57.45 2.52 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.312 -1.515 . . . . 62.149999999999999 109.312 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pp -66.31 -29.21 69.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.376 -1.073 . . . . 73.510000000000005 109.38 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -53.22 -35.1 59.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 74.25 109.35 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 82.1 t -55.52 -40.84 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.929 . . . . 70.040000000000006 109.095 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.539 ' HZ2' HG11 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -70.25 -17.33 63.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.373 -0.83 . . . . 73.230000000000004 109.015 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.95 41.6 3.5 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.197 -1.161 . . . . 75.540000000000006 110.197 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -118.15 155.85 29.73 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.404 -1.057 . . . . 73.430000000000007 108.737 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 53.7 mmm -103.51 139.22 39.15 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.538 -0.912 . . . . 43.240000000000002 108.538 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.69 159.81 41.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.224 -0.923 . . . . 62.109999999999999 110.066 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -140.03 146.06 38.55 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.91 -0.774 . . . . 74.420000000000002 108.91 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -105.93 128.15 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.647 -0.872 . . . . 72.150000000000006 108.647 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.6 p -128.48 165.05 21.44 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.584 -0.697 . . . . 71.420000000000002 109.516 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.47 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 3.5 pt-20 -94.13 -99.34 0.15 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.284 -0.885 . . . . 72.329999999999998 109.643 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.5 p -79.56 165.51 22.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.167 -0.958 . . . . 74.239999999999995 110.034 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.0 mt -57.13 -36.3 70.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.496 -0.752 . . . . 71.530000000000001 109.991 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -54.14 -41.09 68.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.111 -0.993 . . . . 74.230000000000004 110.014 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.18 -40.08 65.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.125 -0.984 . . . . 54.030000000000001 109.867 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.97 -39.46 23.96 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.91 -1.276 . . . . 61.409999999999997 109.91 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.6 -49.02 74.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -1.136 . . . . 74.340000000000003 109.872 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -66.47 -35.75 81.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.144 -0.972 . . . . 75.329999999999998 110.039 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.469 HD11 ' HE ' ' A' ' 43' ' ' ARG . 20.6 tp -73.83 -51.58 15.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.161 -0.962 . . . . 74.329999999999998 110.344 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.42 ' O ' ' O ' ' A' ' 43' ' ' ARG . 11.7 ptm -65.3 -24.79 67.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.078 -1.014 . . . . 70.319999999999993 110.094 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -54.98 -42.0 71.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.079 -1.013 . . . . 71.219999999999999 109.891 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.1 pt -88.67 -34.68 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.164 -0.96 . . . . 74.140000000000001 109.964 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.469 ' HE ' HD11 ' A' ' 39' ' ' LEU . 86.2 mtt-85 -86.59 147.35 25.97 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.02 -1.05 . . . . 72.239999999999995 109.684 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -88.42 151.92 22.24 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.296 -0.877 . . . . 75.420000000000002 109.237 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.459 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 12.5 p90 -156.01 171.09 20.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.149 -0.969 . . . . 74.230000000000004 109.897 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 45' ' ' TYR . 89.8 m-20 -136.3 -31.87 0.88 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.53 -0.732 . . . . 72.040000000000006 109.426 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.02 108.62 19.86 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.361 -0.837 . . . . 72.129999999999995 108.818 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.3 t -97.82 97.8 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.323 -0.861 . . . . 72.340000000000003 109.438 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.429 ' O ' ' O ' ' A' ' 4' ' ' LEU . 4.5 ttt -113.89 127.48 56.0 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.455 -0.778 . . . . 74.109999999999999 109.213 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.418 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -133.5 137.61 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.635 -0.666 . . . . 61.119999999999997 109.47 -179.082 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 t -103.92 4.07 34.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.589 -0.694 . . . . 73.109999999999999 109.647 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.418 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 78.0 m-20 -76.84 140.01 40.5 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.15 -0.969 . . . . 52.549999999999997 109.532 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 55' ' ' ALA . 37.9 mmtm -73.58 -42.32 61.73 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.291 -0.881 . . . . 44.219999999999999 110.104 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -70.95 13.98 0.17 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.113 -0.992 . . . . 70.439999999999998 109.682 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.01 -20.87 59.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 64.140000000000001 110.428 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.406 ' C ' ' O ' ' A' ' 55' ' ' ALA . 36.3 mt -42.06 -50.84 4.67 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.39 -0.819 . . . . 44.140000000000001 110.019 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.9 m -66.12 -33.85 76.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.074 -1.016 . . . . 55.229999999999997 108.945 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.437 ' N ' ' O ' ' A' ' 55' ' ' ALA . 52.1 t80 -64.08 -62.1 1.84 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.358 -0.839 . . . . 74.439999999999998 109.574 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.2 m -49.21 -33.25 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.671 -1.268 . . . . 74.030000000000001 109.589 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.0 m -58.2 -51.66 68.81 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.207 -0.933 . . . . 64.299999999999997 109.583 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -69.21 -31.22 69.66 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.997 -1.064 . . . . 64.439999999999998 110.014 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.9 mm -65.87 -36.11 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.726 -1.234 . . . . 63.210000000000001 109.561 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -69.75 -46.38 66.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 74.420000000000002 110.428 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.431 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 7.0 pt-20 -74.53 -42.73 58.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.831 -1.168 . . . . 70.319999999999993 110.087 -179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.527 ' O ' ' ND1' ' A' ' 66' ' ' HIS . 92.8 mttt -70.13 -27.9 64.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 75.219999999999999 109.484 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.572 ' O ' HG22 ' A' ' 69' ' ' ILE . 58.6 m-70 -150.13 67.12 0.97 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.367 -0.833 . . . . 74.129999999999995 109.224 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.3 p -60.44 -28.76 68.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 73.239999999999995 109.813 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.5 t -78.58 48.54 0.8 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.158 -0.964 . . . . 61.009999999999998 109.709 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.572 HG22 ' O ' ' A' ' 66' ' ' HIS . 13.6 tt -144.81 166.72 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.094 -1.004 . . . . 71.329999999999998 109.344 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 71' ' ' VAL . 86.6 t -98.05 156.06 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.182 -0.949 . . . . 72.129999999999995 109.404 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.413 ' N ' HG12 ' A' ' 70' ' ' VAL . 4.9 t -142.63 120.86 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.286 -0.884 . . . . 54.210000000000001 108.816 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.529 ' HG ' HD11 ' A' ' 95' ' ' ILE . 2.4 mp -116.75 104.27 11.18 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.862 -0.792 . . . . 50.240000000000002 108.862 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 68.5 t -93.02 121.37 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 74.409999999999997 108.859 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.0 p -89.78 169.38 11.32 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.158 -0.964 . . . . 72.310000000000002 109.118 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.484 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 19.1 t -162.44 123.03 2.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.085 -1.01 . . . . 64.540000000000006 110.224 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 77' ' ' ASN . 54.1 p30 -78.49 -9.97 59.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.428 -0.795 . . . . 74.129999999999995 109.116 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 79' ' ' THR . 27.6 m120 -128.7 64.95 71.09 Favored Pre-proline 0 N--CA 1.495 1.817 0 N-CA-C 108.891 -0.781 . . . . 73.340000000000003 108.891 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -49.44 88.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.093 1.862 . . . . 63.219999999999999 111.871 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.425 ' N ' ' O ' ' A' ' 77' ' ' ASN . 24.5 m -105.83 149.24 26.68 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.706 -0.849 . . . . 62.530000000000001 108.706 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.3 -33.11 74.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 73.439999999999998 109.329 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.422 ' H ' HG22 ' A' ' 79' ' ' THR . 84.4 tt0 -61.18 -38.73 87.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 71.420000000000002 109.363 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.422 ' OE1' ' OH ' ' A' ' 94' ' ' TYR . 85.1 tt0 -75.76 -31.81 59.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 73.430000000000007 109.498 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.51 -51.44 65.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 74.219999999999999 109.741 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.469 HG23 ' N ' ' A' ' 85' ' ' HIS . 31.4 m -63.98 -42.82 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 73.200000000000003 109.605 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.622 ' CE1' ' NE2' ' A' ' 89' ' ' GLN . 7.0 t-80 -64.06 -32.54 74.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.186 -0.946 . . . . 53.329999999999998 109.509 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -68.37 -37.88 80.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 64.109999999999999 110.091 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -83.48 -36.93 23.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.053 -1.029 . . . . 74.340000000000003 109.294 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.85 -34.04 77.05 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.293 -0.879 . . . . 74.420000000000002 109.504 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.622 ' NE2' ' CE1' ' A' ' 85' ' ' HIS . 87.8 mt-30 -80.08 -60.03 2.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 74.239999999999995 109.776 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 157.36 59.12 0.01 OUTLIER Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.672 -1.252 . . . . 61.509999999999998 110.22 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.44 125.48 51.81 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.402 -1.058 . . . . 55.329999999999998 108.89 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 20.6 t70 -69.65 -35.59 75.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.002 -1.061 . . . . 73.420000000000002 109.271 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 67.9 m-20 -151.3 161.5 42.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.338 -0.851 . . . . 75.040000000000006 109.442 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.484 ' OH ' ' CB ' ' A' ' 75' ' ' SER . 86.9 t80 -134.98 119.19 17.68 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.563 -0.902 . . . . 71.329999999999998 108.563 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.699 ' H ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -125.42 148.6 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 CA-C-O 121.701 0.762 . . . . 71.129999999999995 110.7 -178.191 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.51 133.77 49.07 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.822 -1.177 . . . . 64.319999999999993 107.822 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.682 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -53.67 -55.3 36.81 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 120.907 -1.12 . . . . 62.200000000000003 111.824 -178.794 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.5 Cg_endo -41.01 -10.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 120.943 1.095 . . . . 73.109999999999999 113.19 -175.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.682 ' N ' ' O ' ' A' ' 97' ' ' LYS . 56.8 m-85 58.99 118.89 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.661 -0.649 . . . . 65.219999999999999 109.802 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 46.7 mtt-85 -62.6 -41.68 99.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.824 -1.172 . . . . 72.349999999999994 109.528 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.762 ' O ' ' N ' ' A' ' 103' ' ' LYS . 44.5 t -165.92 31.13 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.0 -1.062 . . . . 71.319999999999993 110.75 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.3 mt 50.39 -70.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 118.588 0.631 . . . . 75.430000000000007 110.208 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.762 ' N ' ' O ' ' A' ' 101' ' ' SER . 9.1 mtpm? -53.47 -32.81 51.78 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.062 -1.088 . . . . 71.409999999999997 108.062 179.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.29 -52.13 60.09 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.439 -0.948 . . . . 63.240000000000002 108.439 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.0 tp -58.21 -41.4 83.96 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.518 -0.919 . . . . 73.219999999999999 108.518 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.539 HG11 ' HZ2' ' A' ' 23' ' ' LYS . 84.1 t -61.99 -37.37 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.25 -0.906 . . . . 60.109999999999999 108.669 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.4 -35.49 70.1 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.345 -0.847 . . . . 70.420000000000002 108.9 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.527 ' NE ' ' OE2' ' B' ' 83' ' ' GLU . 93.8 mtt180 -79.86 -26.76 40.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.371 -0.831 . . . . 74.409999999999997 109.974 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.9 mt -80.3 -38.52 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.053 -1.029 . . . . 62.539999999999999 109.476 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -72.72 -36.88 67.89 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.236 -0.915 . . . . 74.340000000000003 109.207 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.23 -46.46 83.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.341 -0.849 . . . . 73.319999999999993 109.226 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.99 -39.36 81.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.22 -0.925 . . . . 52.409999999999997 108.793 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.439 HD23 ' C ' ' A' ' 113' ' ' LEU . 3.7 tt -142.43 80.87 1.72 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.254 -0.904 . . . . 65.239999999999995 108.781 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.526 ' O ' ' CG ' ' A' ' 115' ' ' PHE . 86.2 mtm180 -65.88 -43.42 88.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 64.450000000000003 109.927 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.526 ' CG ' ' O ' ' A' ' 114' ' ' ARG . 96.3 m-85 -158.39 -84.98 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.159 -0.963 . . . . 74.430000000000007 109.581 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 83.7 t90 -154.16 154.12 33.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.255 -0.903 . . . . 74.420000000000002 109.442 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 158.17 65.72 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.443 -1.463 . . . . 75.040000000000006 109.443 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 83.0 p -156.76 96.9 1.67 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.296 -1.12 . . . . 61.140000000000001 109.48 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 128' ' ' ILE . 21.8 t-20 -154.69 174.22 15.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.296 -0.877 . . . . 65.239999999999995 109.314 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.489 ' N ' ' OD1' ' A' ' 119' ' ' ASN . 4.2 t -142.59 -35.56 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.286 -0.884 . . . . 73.109999999999999 109.139 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 20.8 mm -104.7 126.45 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.338 -0.851 . . . . 72.239999999999995 109.179 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -139.53 120.99 15.07 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.361 -0.837 . . . . 72.340000000000003 109.336 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.4 ' O ' ' C ' ' A' ' 124' ' ' GLY . 10.2 pt -150.18 135.47 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.268 -0.895 . . . . 71.439999999999998 109.373 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 123' ' ' ILE . . . 43.87 -145.34 1.58 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.991 -1.244 . . . . 73.400000000000006 109.991 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -85.44 1.04 50.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -1.165 . . . . 74.450000000000003 109.274 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.45 131.42 38.66 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.39 -0.967 . . . . 54.210000000000001 108.39 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 51.3 m -131.08 133.79 46.0 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.437 -0.789 . . . . 54.5 109.62 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.518 ' O ' ' ND2' ' A' ' 119' ' ' ASN . 72.4 mt -131.95 133.81 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.473 -0.767 . . . . 45.149999999999999 109.147 179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.505 ' OG ' ' ND2' ' A' ' 119' ' ' ASN . 70.9 m -119.73 85.01 32.41 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.651 -0.655 . . . . 71.109999999999999 109.581 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.43 -44.7 47.07 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.398 2.065 . . . . 65.409999999999997 111.886 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -61.81 -41.96 98.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 63.32 109.308 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -80.67 -8.16 59.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.301 -0.874 . . . . 72.519999999999996 108.78 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 56.24 59.75 3.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.417 -0.802 . . . . 75.329999999999998 109.552 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -155.85 134.63 11.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.206 -0.934 . . . . 71.230000000000004 109.62 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 97.6 mt -107.84 140.64 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.563 -0.711 . . . . 74.019999999999996 109.33 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.6 mp -128.35 122.15 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.397 -0.814 . . . . 60.229999999999997 109.613 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -138.69 140.23 38.71 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.814 -0.809 . . . . 62.32 108.814 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.418 ' HZ2' ' HB3' ' A' ' 138' ' ' LYS . 14.8 mtpp 54.12 25.51 5.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.434 -0.791 . . . . 75.400000000000006 110.055 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 81.01 -7.85 58.76 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.985 -1.246 . . . . 72.239999999999995 109.985 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -88.64 128.07 35.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.087 -1.243 . . . . 71.219999999999999 109.056 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -97.97 139.0 34.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.33 -0.856 . . . . 71.420000000000002 109.636 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 13.5 p -136.76 138.75 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.461 -0.774 . . . . 53.020000000000003 109.072 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -93.86 140.92 29.1 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.255 -0.903 . . . . 60.450000000000003 109.543 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.8 m -140.02 154.01 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.303 -0.873 . . . . 74.439999999999998 109.322 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -171.08 43.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.116 -0.99 . . . . 65.150000000000006 109.899 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -164.03 -110.53 0.24 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.555 -1.418 . . . . 73.340000000000003 109.555 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.622 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 23.2 mmtp -73.29 -35.54 2.76 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.255 -1.144 . . . . 72.219999999999999 110.479 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 95.3 Cg_endo -91.4 21.96 0.74 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 122.464 2.109 . . . . 65.230000000000004 112.011 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -129.33 -55.54 1.17 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.56 -0.713 . . . . 60.109999999999999 109.748 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -58.61 -58.09 10.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.161 -0.962 . . . . 64.209999999999994 110.552 -178.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.6 -33.27 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.954 -1.091 . . . . 72.019999999999996 109.672 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.499 HD23 ' HA ' ' A' ' 148' ' ' PRO . 3.4 mm? -63.12 -41.68 99.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.062 -1.024 . . . . 73.310000000000002 108.676 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.6 p -74.5 -32.18 62.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.252 -0.905 . . . . 74.310000000000002 109.943 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -58.16 -50.87 72.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.172 -0.955 . . . . 74.310000000000002 109.61 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.7 pp -76.08 -26.09 56.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 75.340000000000003 109.791 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -55.58 -45.98 77.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 62.140000000000001 109.325 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -76.59 -44.24 35.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.195 -0.941 . . . . 61.030000000000001 108.936 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -82.41 26.43 0.56 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.514 -0.741 . . . . 74.120000000000005 109.244 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -49.66 -29.93 8.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.377 -0.827 . . . . 71.129999999999995 109.855 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 160' ' ' ASP . 42.9 p30 -123.9 74.84 1.31 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.534 -0.728 . . . . 75.450000000000003 109.198 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.511 ' NE2' ' O ' ' A' ' 162' ' ' ILE . 13.8 tm0? -171.21 152.77 3.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.9 . . . . 73.409999999999997 109.517 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.511 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 71.4 mt -83.63 122.15 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.172 -0.955 . . . . 74.409999999999997 109.439 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 53.5 t -112.59 137.82 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.534 -0.729 . . . . 72.310000000000002 109.761 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 29.6 t -94.78 155.79 16.66 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.358 -0.839 . . . . 74.120000000000005 109.453 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.467 ' CB ' ' NZ ' ' A' ' 165' ' ' LYS . 8.7 mtpm? -56.92 -43.48 81.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 70.430000000000007 109.64 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -55.24 -37.14 66.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.923 . . . . 73.519999999999996 109.446 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -59.57 -41.91 91.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -0.939 . . . . 74.519999999999996 109.444 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 26.3 mt -63.65 -33.17 75.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.2 -0.938 . . . . 72.310000000000002 109.315 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.482 HD23 ' C ' ' A' ' 169' ' ' LEU . 5.6 tt -64.71 -55.61 18.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.298 -0.876 . . . . 53.329999999999998 109.589 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -71.63 -32.6 68.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.256 -0.902 . . . . 62.439999999999998 110.295 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.414 ' C ' HD12 ' A' ' 172' ' ' ILE . . . -58.52 -47.8 82.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.049 -1.032 . . . . 60.210000000000001 110.036 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.683 ' N ' HD12 ' A' ' 172' ' ' ILE . 1.9 mp -96.96 -65.17 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.2 -0.938 . . . . 75.319999999999993 108.85 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 -85.04 89.03 7.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.422 -0.799 . . . . 73.140000000000001 109.394 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -98.26 -74.09 0.59 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.317 -0.864 . . . . 73.239999999999995 109.758 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 177' ' ' GLU . 29.8 mt-10 -60.27 152.15 64.59 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.233 -0.917 . . . . 44.43 109.408 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -40.55 83.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 122.348 2.032 . . . . 72.510000000000005 112.888 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 175' ' ' GLU . 42.6 mm-40 -90.96 12.58 19.18 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.886 -1.134 . . . . 63.240000000000002 108.967 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 70.8 mtm 52.02 67.01 1.04 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.867 . . . . 73.5 109.324 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 33.5 m -131.93 150.78 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.51 -0.744 . . . . 65.219999999999999 109.372 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.529 ' O ' ' N ' ' A' ' 182' ' ' ASN . 16.3 m -91.6 113.24 58.03 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.283 -0.886 . . . . 71.420000000000002 109.14 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -44.06 -11.57 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.036 1.824 . . . . 41.219999999999999 112.814 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 180' ' ' THR . 49.2 p-10 -95.79 46.71 1.09 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.074 -1.016 . . . . 64.540000000000006 109.765 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 180' ' ' THR . 35.9 m -130.46 -4.18 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.38 -0.825 . . . . 74.019999999999996 109.759 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 184' ' ' ILE . 1.9 mp -66.33 -29.35 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.949 -1.095 . . . . 72.329999999999998 109.141 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -61.7 -42.83 99.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 74.400000000000006 109.611 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 19.0 m -79.54 -28.49 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.09 -1.006 . . . . 70.420000000000002 109.379 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.51 -42.17 65.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.864 . . . . 52.109999999999999 109.795 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.418 HG23 HD22 ' A' ' 189' ' ' ASN . 10.5 tp -74.94 -29.95 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.986 -1.071 . . . . 71.400000000000006 109.314 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.418 HD22 HG23 ' A' ' 188' ' ' ILE . 3.5 m120 -70.64 -43.94 68.16 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.845 . . . . 73.439999999999998 110.099 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -75.56 -40.9 56.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.131 -0.981 . . . . 71.420000000000002 110.135 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 74.9 mt -60.47 -36.49 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.014 -1.054 . . . . 61.549999999999997 109.561 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 18.9 mtp-105 -71.38 -40.16 70.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.035 -1.041 . . . . 63.340000000000003 108.656 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -68.05 -35.2 77.84 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.577 -0.702 . . . . 61.240000000000002 109.133 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.411 ' O ' ' CD ' ' A' ' 198' ' ' PRO . 50.7 mtpt -85.19 -8.31 58.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.349 -0.844 . . . . 75.129999999999995 109.737 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 51.1 ttm -92.84 -57.21 2.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.185 -0.947 . . . . 74.019999999999996 109.559 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -59.12 -32.48 69.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 74.019999999999996 110.011 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.437 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 54.1 mttt -57.13 -65.64 1.64 Allowed Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.035 -1.041 . . . . 75.430000000000007 109.847 -179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 42.4 Cg_endo -64.77 -57.99 0.25 Allowed 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 122.306 2.004 . . . . 72.319999999999993 112.546 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 15.3 mt -61.15 -42.75 99.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -0.958 . . . . 74.540000000000006 109.963 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 86.62 -37.63 3.15 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.78 -1.328 . . . . 61.509999999999998 109.78 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.741 ' N ' HD12 ' A' ' 201' ' ' ILE . 1.7 mp -92.41 141.53 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.132 -1.217 . . . . 61.219999999999999 109.371 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 59.5 p -85.55 145.23 27.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.888 . . . . 72.0 109.274 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 3.1 p -146.59 27.25 1.11 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.253 -0.904 . . . . 74.439999999999998 109.485 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 204' ' ' VAL . 29.5 m -143.97 134.21 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.169 -0.957 . . . . 64.349999999999994 109.518 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -108.58 126.16 52.64 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.536 -0.727 . . . . 71.409999999999997 109.296 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.35 119.69 32.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.116 -0.99 . . . . 73.519999999999996 109.226 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.421 ' O ' ' O ' ' A' ' 211' ' ' GLY . 34.9 m -147.82 140.74 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.224 -0.922 . . . . 71.019999999999996 109.616 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 75.1 ttt-85 -62.62 -25.51 68.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.85 . . . . 72.120000000000005 109.373 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.529 ' O ' ' N ' ' A' ' 211' ' ' GLY . 76.1 mtt85 -47.17 103.92 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 64.409999999999997 109.786 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 60.51 -75.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.591 -0.693 . . . . 71.540000000000006 109.844 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . -158.41 -127.77 0.96 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.838 -1.305 . . . . 72.030000000000001 109.838 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -101.53 142.21 33.24 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.407 -1.054 . . . . 75.540000000000006 109.436 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 38.8 ttp180 -106.43 126.57 52.41 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.478 -0.764 . . . . 75.310000000000002 109.686 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -98.04 128.36 44.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.389 -0.82 . . . . 75.409999999999997 109.034 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 34.0 m -151.78 154.94 37.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.498 -0.751 . . . . 74.140000000000001 109.137 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . 0.45 ' O ' ' O ' ' A' ' 217' ' ' PRO . 7.4 p90 -65.14 153.14 89.95 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.153 -0.967 . . . . 75.319999999999993 109.279 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.45 ' O ' ' O ' ' A' ' 216' ' ' TYR . 84.2 Cg_exo -42.94 176.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.269 1.979 . . . . 73.109999999999999 112.408 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 220' ' ' ALA . 10.9 ptpt -46.38 154.82 0.61 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.313 -0.867 . . . . 75.25 108.811 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -33.7 85.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.683 2.256 . . . . 75.099999999999994 112.601 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 218' ' ' LYS . . . -61.52 -30.68 70.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.472 -0.767 . . . . 71.140000000000001 109.484 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 222' ' ' GLU . 30.4 p -54.64 -37.52 65.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 71.129999999999995 109.558 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.402 ' N ' ' SG ' ' A' ' 221' ' ' CYS . 96.5 mt-10 -60.03 140.95 56.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.231 -0.918 . . . . 75.349999999999994 109.361 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.402 ' OXT' ' O ' ' A' ' 222' ' ' GLU . 96.9 mt-10 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.0 -1.0 . . . . 73.409999999999997 109.444 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 52.5 ttm . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.487 -0.56 . . . . 71.140000000000001 109.487 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -139.87 148.78 42.56 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.303 -0.873 . . . . 73.230000000000004 109.354 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 93.6 t -113.91 137.71 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.583 -0.698 . . . . 72.239999999999995 109.452 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.499 HD11 ' CG1' ' B' ' 6' ' ' ILE . 3.5 tp -109.89 119.66 40.04 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.555 -0.716 . . . . 54.329999999999998 109.735 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.483 ' N ' HD12 ' B' ' 4' ' ' LEU . 15.3 mt -117.23 96.33 5.38 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 108.615 -0.883 . . . . 74.349999999999994 108.615 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.689 HD12 ' HB ' ' B' ' 50' ' ' VAL . 87.2 mt -82.93 98.88 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.703 -1.248 . . . . 42.549999999999997 109.049 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.425 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 38.8 tp10 -130.78 129.72 42.8 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.506 -0.746 . . . . 74.519999999999996 109.556 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -64.96 -38.96 92.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.314 -0.866 . . . . 62.549999999999997 109.332 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -83.8 116.63 22.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 73.109999999999999 109.471 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 23.4 m -66.73 -27.01 67.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.9 . . . . 65.540000000000006 109.795 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 97.7 t -66.99 -51.56 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.15 -0.969 . . . . 75.549999999999997 109.844 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.538 ' N ' HD12 ' B' ' 12' ' ' LEU . 7.9 mp -62.96 -39.07 93.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.172 -0.955 . . . . 70.140000000000001 109.62 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.05 -29.34 64.9 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 108.551 -1.82 . . . . 75.400000000000006 108.551 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.91 -49.84 68.9 Favored Glycine 0 N--CA 1.485 1.928 0 N-CA-C 109.674 -1.37 . . . . 65.439999999999998 109.674 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -61.96 -46.98 86.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.309 -1.112 . . . . 60.210000000000001 109.786 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.556 HD11 ' CD1' ' B' ' 99' ' ' TYR . 5.7 mm -63.98 -40.14 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.757 -1.214 . . . . 75.150000000000006 108.632 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.505 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 73.1 tt0 -63.07 -44.27 96.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.412 -0.805 . . . . 73.010000000000005 109.554 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -85.53 1.55 48.49 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.071 -1.018 . . . . 74.299999999999997 109.588 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.93 -57.3 1.94 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.376 -1.49 . . . . 70.540000000000006 109.376 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.417 HD23 ' N ' ' B' ' 21' ' ' ASN . 1.4 pt? -71.31 -20.85 62.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.424 -1.044 . . . . 71.340000000000003 109.648 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 89.6 m-20 -57.98 -30.81 66.33 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.992 -1.067 . . . . 64.409999999999997 109.278 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 92.9 t -59.05 -37.3 67.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.344 -0.847 . . . . 74.230000000000004 109.142 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -65.52 -21.4 66.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.371 -0.83 . . . . 63.420000000000002 109.398 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.32 39.87 2.52 Favored Glycine 0 N--CA 1.5 2.961 0 N-CA-C 110.11 -1.196 . . . . 53.43 110.11 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -120.2 160.98 21.85 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.474 -1.015 . . . . 71.120000000000005 109.208 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 3.8 mtt -100.45 139.84 35.56 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.262 -1.014 . . . . 75.239999999999995 108.262 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.43 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -143.95 154.45 43.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.225 -0.922 . . . . 72.120000000000005 110.37 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 96.9 m-20 -138.87 155.01 48.44 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.173 -1.047 . . . . 72.310000000000002 108.173 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.43 139.74 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.338 -0.851 . . . . 64.430000000000007 109.985 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.5 p -130.47 171.08 13.38 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 109.144 -0.687 . . . . 65.409999999999997 109.144 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.42 ' OE2' ' OD2' ' B' ' 35' ' ' ASP . 5.4 pt-20 -91.69 -106.11 0.1 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.178 -0.951 . . . . 71.019999999999996 109.873 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 77.7 p -78.11 166.94 22.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.223 -0.923 . . . . 51.109999999999999 110.073 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 53.5 mt -51.34 -30.86 19.89 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.586 -0.696 . . . . 71.239999999999995 109.945 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -53.87 -51.01 65.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.092 -1.005 . . . . 74.319999999999993 109.885 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.42 ' OD2' ' OE2' ' B' ' 31' ' ' GLU . 2.3 m-20 -63.58 -39.44 94.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.121 -0.987 . . . . 73.030000000000001 109.264 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.81 -38.4 76.15 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.253 -1.539 . . . . 30.210000000000001 109.253 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -67.18 -38.36 85.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -1.113 . . . . 74.420000000000002 109.573 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -80.52 -36.93 32.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.155 -0.965 . . . . 74.420000000000002 109.661 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 10.5 tp -71.29 -42.67 68.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 75.409999999999997 110.091 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . 0.443 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.3 ppp? -67.54 -25.26 65.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.039 -1.038 . . . . 60.409999999999997 109.977 -179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -60.62 -39.84 89.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.046 -1.034 . . . . 53.229999999999997 110.161 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 14.7 pt -81.21 -32.01 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.006 -1.059 . . . . 71.230000000000004 110.202 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' B' ' 40' ' ' MET . 25.2 mmt180 -130.28 141.52 50.6 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.297 -0.877 . . . . 72.219999999999999 109.548 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . 0.553 HD21 HD11 ' B' ' 69' ' ' ILE . 58.3 t30 -98.48 132.71 43.7 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.28 -0.887 . . . . 63.539999999999999 109.437 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -102.37 138.28 39.51 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.353 -0.842 . . . . 64.349999999999994 109.513 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -75.82 -34.5 60.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 62.219999999999999 109.189 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.497 ' C ' HD13 ' B' ' 47' ' ' LEU . 0.8 OUTLIER -112.38 110.59 20.89 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.645 -0.872 . . . . 73.120000000000005 108.645 179.662 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.449 ' N ' HD13 ' B' ' 47' ' ' LEU . 54.5 t -95.52 100.85 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.369 -0.832 . . . . 65.109999999999999 109.124 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.509 ' SD ' ' O ' ' B' ' 72' ' ' LEU . 0.6 OUTLIER -114.93 129.54 56.73 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.2 -0.667 . . . . 73.439999999999998 109.2 -179.659 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.689 ' HB ' HD12 ' B' ' 6' ' ' ILE . 0.6 OUTLIER -144.69 132.29 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.457 -0.777 . . . . 34.5 109.233 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . 0.425 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 24.9 p -94.57 11.57 30.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.392 -0.818 . . . . 73.209999999999994 109.662 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.608 ' H ' HG22 ' B' ' 50' ' ' VAL . 35.9 m-20 -80.61 138.65 36.45 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.147 -0.971 . . . . 70.409999999999997 109.515 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.439 ' C ' ' H ' ' B' ' 55' ' ' ALA . 62.3 mttp -74.92 -38.53 61.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.206 -0.934 . . . . 65.0 110.029 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -71.03 9.9 0.64 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.171 -0.955 . . . . 75.209999999999994 109.619 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -66.4 -21.77 66.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 55.329999999999998 110.134 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 33.3 mt -42.82 -40.16 2.77 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.397 -0.814 . . . . 63.140000000000001 110.33 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 13.0 t -76.32 -39.97 52.64 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.946 -1.096 . . . . 63.5 109.563 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -65.1 -43.14 93.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.332 -0.855 . . . . 72.329999999999998 110.307 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.42 HG23 ' N ' ' B' ' 60' ' ' SER . 34.3 m -67.37 -37.62 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.697 -1.252 . . . . 74.540000000000006 109.509 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.42 ' N ' HG23 ' B' ' 59' ' ' VAL . 40.4 m -55.24 -48.66 73.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 71.239999999999995 109.439 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.405 HH21 ' NZ ' ' B' ' 65' ' ' LYS . 13.3 ptm180 -69.57 -34.41 74.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.115 -0.99 . . . . 74.310000000000002 110.134 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' B' ' 66' ' ' HIS . 5.4 mm -64.52 -40.33 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.785 -1.197 . . . . 72.140000000000001 109.8 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.521 ' NZ ' ' OD1' ' B' ' 92' ' ' ASP . 44.4 mmtt -65.44 -48.81 71.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.157 -0.964 . . . . 73.319999999999993 110.459 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -73.01 -37.54 66.92 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.841 -1.162 . . . . 73.120000000000005 110.035 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.47 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 46.4 mtpt -80.22 -22.04 42.22 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.11 -0.994 . . . . 72.439999999999998 109.757 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.47 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 81.6 m-70 -155.68 65.92 0.61 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.136 -0.977 . . . . 63.310000000000002 109.623 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 9.7 t -60.44 -27.78 67.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -0.918 . . . . 73.099999999999994 109.793 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 84.4 p -65.27 -24.82 67.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -0.92 . . . . 71.530000000000001 110.169 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.553 HD11 HD21 ' B' ' 44' ' ' ASN . 79.9 mt -79.81 152.89 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.103 -0.998 . . . . 74.400000000000006 109.677 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.469 HG12 ' N ' ' B' ' 71' ' ' VAL . 69.4 t -92.44 159.44 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.287 -0.883 . . . . 75.120000000000005 109.468 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.469 ' N ' HG12 ' B' ' 70' ' ' VAL . 11.7 t -137.96 120.92 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.184 -0.947 . . . . 73.200000000000003 109.877 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.509 ' O ' ' SD ' ' B' ' 49' ' ' MET . 0.7 OUTLIER -111.04 105.12 13.77 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.16 -1.052 . . . . 73.340000000000003 108.16 179.666 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 94.6 t -95.68 131.9 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.107 -0.996 . . . . 73.5 109.535 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.08 162.38 13.42 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.434 -0.791 . . . . 64.340000000000003 109.103 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.495 ' CB ' ' HH ' ' B' ' 94' ' ' TYR . 25.1 p -153.92 136.64 15.24 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.96 -1.087 . . . . 74.530000000000001 110.646 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 40.2 p-10 -90.43 4.42 51.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.372 -0.83 . . . . 64.5 109.119 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' B' ' 79' ' ' THR . 65.5 m-80 -142.31 68.5 21.52 Favored Pre-proline 0 N--CA 1.491 1.623 0 N-CA-C 108.663 -0.865 . . . . 74.25 108.663 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -54.71 79.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.347 2.031 . . . . 74.430000000000007 111.235 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.503 ' N ' ' O ' ' B' ' 77' ' ' ASN . 37.2 p -103.28 152.49 21.46 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.053 -0.721 . . . . 73.120000000000005 109.053 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -31.4 71.42 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.262 -0.899 . . . . 71.010000000000005 109.387 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -63.34 -48.24 78.82 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.198 -0.939 . . . . 63.200000000000003 109.493 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -71.7 -27.11 62.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 73.219999999999999 109.372 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.527 ' OE2' ' NE ' ' A' ' 108' ' ' ARG . 86.9 tt0 -63.03 -55.6 24.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.883 . . . . 74.299999999999997 109.887 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.401 HG23 ' N ' ' B' ' 85' ' ' HIS . 22.9 m -61.93 -40.29 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.058 -1.026 . . . . 73.310000000000002 109.423 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' HIS . . . . . 0.401 ' N ' HG23 ' B' ' 84' ' ' VAL . 21.5 m170 -64.71 -31.69 73.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.166 -0.959 . . . . 73.239999999999995 109.483 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.48 -45.87 81.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.232 -0.918 . . . . 55.329999999999998 110.256 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -79.87 -34.51 39.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.031 -1.043 . . . . 74.140000000000001 109.433 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -70.78 -40.33 72.66 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.248 -0.908 . . . . 64.040000000000006 109.57 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -65.12 -52.16 57.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -0.965 . . . . 72.349999999999994 109.412 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.24 59.43 0.02 OUTLIER Glycine 0 N--CA 1.495 2.622 0 N-CA-C 110.188 -1.165 . . . . 65.200000000000003 110.188 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -117.88 136.18 53.62 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.435 -1.039 . . . . 52.229999999999997 109.075 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.521 ' OD1' ' NZ ' ' B' ' 63' ' ' LYS . 24.6 m-20 -82.16 -20.8 37.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.09 -1.006 . . . . 73.319999999999993 109.525 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -153.3 164.6 37.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.154 -0.966 . . . . 72.219999999999999 109.655 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.495 ' HH ' ' CB ' ' B' ' 75' ' ' SER . 76.1 t80 -145.14 97.26 2.98 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.745 -0.835 . . . . 64.420000000000002 108.745 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.4 HD12 ' NH1' ' B' ' 108' ' ' ARG . 19.0 mm -104.73 142.01 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 121.163 -0.961 . . . . 72.230000000000004 109.928 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . 0.409 ' O ' ' C ' ' B' ' 97' ' ' LYS . . . -60.74 124.29 19.99 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.467 -1.308 . . . . 25.239999999999998 107.467 178.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' B' ' 99' ' ' TYR . 2.1 tptt -43.35 -61.04 2.03 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.058 -1.026 . . . . 64.319999999999993 110.726 -179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 9.3 Cg_endo -45.02 89.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 120.566 0.844 . . . . 63.329999999999998 110.489 -176.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . 0.582 ' N ' ' O ' ' B' ' 97' ' ' LYS . 45.4 m-85 -39.75 97.76 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.229 0.537 . . . . 75.129999999999995 111.128 -176.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 41.9 ttm-85 -53.27 -33.43 53.11 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.521 -1.288 . . . . 74.230000000000004 107.521 178.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 32.5 t -176.18 128.03 0.21 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.274 -1.01 . . . . 63.340000000000003 108.274 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 19.6 mm -51.68 -36.22 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.017 -1.052 . . . . 74.439999999999998 108.903 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.518 ' O ' ' HB2' ' B' ' 107' ' ' ALA . 11.8 mptt -67.23 -34.47 77.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.358 -0.839 . . . . 71.109999999999999 109.407 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.53 -58.72 3.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.241 -0.912 . . . . 71.450000000000003 109.771 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.702 HD13 ' C ' ' B' ' 105' ' ' LEU . 1.9 tm? -54.46 -53.33 55.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.886 . . . . 51.310000000000002 109.275 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . 0.475 ' N ' HD13 ' B' ' 105' ' ' LEU . 88.3 t -61.62 -42.47 94.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.987 -1.071 . . . . 65.230000000000004 109.37 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' B' ' 103' ' ' LYS . . . -51.82 -38.28 55.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.137 -0.977 . . . . 24.32 108.907 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 0.4 ' NH1' HD12 ' B' ' 95' ' ' ILE . 80.7 mtt180 -70.25 -34.7 73.14 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.354 -0.841 . . . . 75.310000000000002 109.441 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 86.3 mt -75.93 -26.59 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.14 -0.975 . . . . 54.240000000000002 108.788 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -76.6 -57.78 3.66 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.458 -0.776 . . . . 65.310000000000002 109.618 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.51 -44.84 73.09 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 72.239999999999995 109.961 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.12 -59.83 4.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.113 -0.992 . . . . 72.040000000000006 109.646 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 30.4 tp -60.61 -35.52 76.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.11 -0.994 . . . . 75.349999999999994 109.763 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.45 ' O ' ' CB ' ' B' ' 115' ' ' PHE . 14.1 mmt180 -53.62 160.3 1.33 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.073 -1.017 . . . . 75.5 109.252 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' PHE . . . . . 0.45 ' CB ' ' O ' ' B' ' 114' ' ' ARG . 4.9 t80 75.6 -4.15 2.43 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.519 -0.738 . . . . 65.329999999999998 109.535 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER 54.26 -171.76 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 74.450000000000003 109.773 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -92.92 5.1 75.9 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.487 -1.445 . . . . 44.210000000000001 109.487 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 11.8 t 49.57 -174.33 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.492 -1.005 . . . . 71.400000000000006 109.854 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.73 141.74 23.0 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.424 -0.797 . . . . 72.319999999999993 109.336 -178.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 23.8 t -86.87 -44.11 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.187 -0.945 . . . . 75.019999999999996 109.854 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 3.6 mm -117.5 154.37 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.238 -0.914 . . . . 51.409999999999997 109.434 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -143.62 130.85 20.8 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.325 -0.859 . . . . 71.530000000000001 109.049 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 17.8 mt -135.47 108.33 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.18 -0.95 . . . . 72.430000000000007 109.896 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . 0.457 ' C ' ' H ' ' B' ' 126' ' ' LEU . . . 56.02 -155.41 12.58 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 110.229 -1.148 . . . . 51.229999999999997 110.229 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.99 -0.56 0.52 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.477 -1.013 . . . . 74.200000000000003 109.644 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.457 ' H ' ' C ' ' B' ' 124' ' ' GLY . 1.7 mt -94.22 148.6 22.04 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.237 -0.914 . . . . 75.420000000000002 109.405 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 7.0 m -126.33 132.33 51.64 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.109 -1.071 . . . . 74.219999999999999 108.109 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 88.8 mt -121.05 131.03 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.348 -0.845 . . . . 60.329999999999998 110.69 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 64.9 m -128.86 101.84 19.86 Favored Pre-proline 0 N--CA 1.495 1.824 0 N-CA-C 108.858 -0.793 . . . . 72.310000000000002 108.858 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -81.87 -40.32 0.15 Allowed 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.092 1.862 . . . . 75.129999999999995 111.918 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -52.97 -33.4 51.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.132 -0.98 . . . . 75.230000000000004 108.881 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -104.39 4.02 32.94 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.504 -0.747 . . . . 72.430000000000007 109.499 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.433 ' OE1' ' CD2' ' B' ' 149' ' ' PHE . 49.0 mm-40 49.77 59.58 4.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.124 -0.985 . . . . 75.129999999999995 109.3 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . 0.686 ' C ' HD12 ' B' ' 135' ' ' ILE . 33.6 ttmt -151.51 145.46 25.2 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.223 -0.923 . . . . 73.219999999999999 109.726 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . 0.686 HD12 ' C ' ' B' ' 134' ' ' LYS . 4.5 mp -137.81 133.49 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 108.782 -0.821 . . . . 64.140000000000001 108.782 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 4.7 mm -107.18 137.1 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.533 -0.73 . . . . 71.219999999999999 109.606 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -126.04 130.97 52.2 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.181 -1.044 . . . . 64.219999999999999 108.181 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . 0.651 ' NZ ' ' HE ' ' B' ' 140' ' ' ARG . 23.3 ttpp 55.36 14.92 1.21 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.499 -0.751 . . . . 72.019999999999996 109.762 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.91 -0.11 66.74 Favored Glycine 0 N--CA 1.496 2.684 0 O-C-N 120.927 -1.108 . . . . 74.319999999999993 110.505 178.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . 0.651 ' HE ' ' NZ ' ' B' ' 138' ' ' LYS . 17.5 mtt-85 -89.94 137.27 32.48 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.208 -1.172 . . . . 75.340000000000003 108.449 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -82.94 126.98 33.11 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.233 -0.917 . . . . 71.230000000000004 110.419 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 39.9 t -126.81 128.81 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.912 -0.773 . . . . 70.430000000000007 108.912 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -94.2 147.28 23.33 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.978 -1.076 . . . . 72.430000000000007 109.228 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . 0.852 ' H ' ' HZ2' ' B' ' 145' ' ' LYS . 2.4 t -142.16 115.41 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.217 -0.927 . . . . 72.129999999999995 108.95 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . 0.852 ' HZ2' ' H ' ' B' ' 144' ' ' VAL . 0.1 OUTLIER -145.28 140.17 27.62 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.278 -0.888 . . . . 72.019999999999996 109.742 179.886 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 111.54 -114.39 3.62 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 110.666 -0.973 . . . . 42.229999999999997 110.666 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 0.615 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 6.6 ttpm? -95.34 -29.82 0.27 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.57 -0.959 . . . . 73.299999999999997 112.42 -178.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 57.0 Cg_endo -80.47 -17.78 9.92 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 C-N-CA 121.482 1.455 . . . . 71.329999999999998 113.0 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . 0.433 ' CD2' ' OE1' ' B' ' 133' ' ' GLU . 1.1 p90 -85.54 -37.85 19.18 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.93 -1.107 . . . . 74.230000000000004 109.215 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . 0.426 ' N ' ' CG ' ' B' ' 149' ' ' PHE . 3.3 tm-20 -60.34 -46.7 88.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.533 -0.729 . . . . 72.340000000000003 109.974 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.428 HG13 ' N ' ' B' ' 152' ' ' LEU . 8.8 p -68.89 -40.65 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.864 -1.148 . . . . 73.349999999999994 110.102 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.497 ' C ' HD23 ' B' ' 152' ' ' LEU . 4.7 tt -66.65 -54.91 18.19 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.296 -0.877 . . . . 55.240000000000002 109.679 -179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 16.0 p -64.76 -32.44 74.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.004 -1.06 . . . . 70.010000000000005 110.555 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -59.2 -59.58 5.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.947 -1.095 . . . . 65.319999999999993 109.927 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.81 HD13 ' CE2' ' B' ' 214' ' ' PHE . 1.9 pp -69.3 -21.48 63.86 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.028 -1.045 . . . . 71.540000000000006 109.946 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.89 -52.98 61.9 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.014 -1.054 . . . . 75.319999999999993 109.334 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.458 ' C ' ' H ' ' B' ' 159' ' ' ARG . 16.5 mtm-85 -71.95 -51.62 21.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.18 -0.95 . . . . 73.319999999999993 109.79 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -74.79 36.19 0.11 Allowed 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.725 -0.79 . . . . 74.140000000000001 109.506 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . 0.458 ' H ' ' C ' ' B' ' 157' ' ' ARG . 30.2 ptt180 -59.91 166.05 2.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -0.86 . . . . 61.409999999999997 109.179 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 24.9 t70 43.66 64.24 1.32 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.253 -0.904 . . . . 72.099999999999994 109.88 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -157.3 159.21 37.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -0.965 . . . . 72.25 109.567 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 30.6 mt -93.77 114.02 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.218 -0.926 . . . . 72.310000000000002 109.139 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 4.0 m -115.13 129.78 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 121.527 0.679 . . . . 64.209999999999994 109.511 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . 0.516 ' OG ' ' NE2' ' B' ' 167' ' ' GLN . 28.7 p -92.39 167.31 12.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -0.871 . . . . 74.219999999999999 109.125 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -51.69 -37.07 49.12 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.111 -0.993 . . . . 65.310000000000002 109.297 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -74.57 -25.46 59.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.146 -0.971 . . . . 63.450000000000003 110.559 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 167' ' ' GLN . . . . . 0.516 ' NE2' ' OG ' ' B' ' 164' ' ' SER . 0.0 OUTLIER -64.04 -56.14 17.17 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.618 -1.301 . . . . 72.400000000000006 108.792 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 47.1 mt -57.42 -57.21 13.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.102 -0.999 . . . . 72.319999999999993 108.916 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' B' ' 170' ' ' ASP . 1.9 mm? -50.55 -56.01 13.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.045 -1.034 . . . . 73.340000000000003 108.846 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' B' ' 169' ' ' LEU . 67.8 m-20 -41.69 -34.16 0.58 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.74 -0.6 . . . . 72.099999999999994 110.615 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -91.69 -37.72 12.86 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.102 -0.999 . . . . 62.130000000000003 110.729 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.54 ' C ' ' H ' ' B' ' 174' ' ' GLU . 3.7 mp -88.09 -68.41 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.893 -1.129 . . . . 71.420000000000002 109.442 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 173' ' ' TRP . . . . . 0.476 ' C ' ' CD2' ' B' ' 173' ' ' TRP . 0.0 OUTLIER -54.26 -2.38 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.505 -0.747 . . . . 72.230000000000004 109.47 -179.27 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . 0.54 ' H ' ' C ' ' B' ' 172' ' ' ILE . 48.4 tt0 -48.43 -18.79 0.26 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.101 -0.999 . . . . 52.109999999999999 109.861 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' B' ' 177' ' ' GLU . 0.6 OUTLIER -53.04 -176.91 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.201 -0.937 . . . . 73.040000000000006 108.709 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.46 ' CD ' ' CB ' ' B' ' 175' ' ' GLU . 37.6 Cg_exo -60.37 40.39 0.06 OUTLIER 'Trans proline' 0 N--CA 1.499 1.821 0 C-N-CA 122.563 2.176 . . . . 74.129999999999995 112.513 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' B' ' 175' ' ' GLU . 97.6 mt-10 46.98 -161.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.185 -0.947 . . . . 72.439999999999998 109.836 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 53.8 mmm 55.72 39.01 30.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.337 -0.852 . . . . 63.43 109.504 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 179' ' ' VAL . . . . . 0.402 ' O ' ' OG1' ' B' ' 180' ' ' THR . 2.7 m -109.51 72.63 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.566 -0.709 . . . . 71.049999999999997 109.402 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' B' ' 179' ' ' VAL . 4.0 p 45.86 83.0 0.22 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.46 -0.775 . . . . 62.149999999999999 109.813 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -51.47 164.77 0.77 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.046 1.831 . . . . 65.219999999999999 111.874 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 182' ' ' ASN . . . . . 0.813 ' OD1' ' OE2' ' B' ' 185' ' ' GLU . 45.5 t-20 49.33 60.9 3.44 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.136 -0.978 . . . . 72.310000000000002 110.006 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 4.1 p -119.09 4.65 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 N-CA-C 108.994 -0.743 . . . . 63.32 108.994 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.562 ' O ' HG22 ' B' ' 188' ' ' ILE . 35.2 mt -63.62 -53.53 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.058 -1.026 . . . . 75.030000000000001 109.914 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . 0.813 ' OE2' ' OD1' ' B' ' 182' ' ' ASN . 1.5 pm0 -61.5 -40.43 94.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 64.109999999999999 110.313 -178.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 97.2 t -73.99 -48.03 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.995 -1.066 . . . . 73.0 110.404 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -68.91 -47.27 66.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.059 -1.026 . . . . 61.119999999999997 110.704 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 188' ' ' ILE . . . . . 0.562 HG22 ' O ' ' B' ' 184' ' ' ILE . 7.5 tt -70.0 -36.6 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.741 -1.224 . . . . 72.430000000000007 110.917 -178.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -65.42 -47.61 75.65 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.945 -1.097 . . . . 65.140000000000001 109.144 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . 0.717 ' HB3' ' HZ3' ' B' ' 194' ' ' LYS . 35.9 mm-40 -66.58 -46.29 76.46 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.229 -0.92 . . . . 63.240000000000002 110.023 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 65.1 mt -54.45 -42.0 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.825 -1.172 . . . . 74.030000000000001 109.684 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 192' ' ' ARG . . . . . 0.413 ' CZ ' HG21 ' B' ' 206' ' ' THR . 24.1 mtp180 -59.94 -45.52 92.36 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.236 -0.915 . . . . 72.239999999999995 109.922 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -75.44 -32.86 60.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.223 -0.923 . . . . 73.099999999999994 110.159 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . 0.717 ' HZ3' ' HB3' ' B' ' 190' ' ' GLN . 39.1 mttp -71.84 -24.52 61.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.347 -0.846 . . . . 72.109999999999999 110.002 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 11.2 mtt -94.84 -12.14 27.53 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.036 -1.04 . . . . 44.329999999999998 109.473 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -102.03 -7.12 22.61 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.328 -0.857 . . . . 71.209999999999994 110.522 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . 0.457 ' N ' ' CD ' ' B' ' 198' ' ' PRO . 1.3 mmtt -95.77 -49.44 0.25 Allowed Pre-proline 0 N--CA 1.501 2.125 0 O-C-N 120.784 -1.198 . . . . 75.209999999999994 110.351 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 198' ' ' PRO . . . . . 0.509 ' CD ' ' O ' ' B' ' 194' ' ' LYS . 89.0 Cg_endo -83.97 -38.53 0.13 Allowed 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.279 1.986 . . . . 75.319999999999993 113.672 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 11.2 mt -75.73 -46.42 31.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.836 -1.165 . . . . 72.25 109.648 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 88.15 0.78 82.6 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 108.663 -1.775 . . . . 64.530000000000001 108.663 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 38.4 mt -125.53 125.62 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.583 -0.951 . . . . 44.229999999999997 109.296 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 27.3 p -85.78 137.16 32.99 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.836 -1.172 . . . . 54.009999999999998 107.836 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 67.7 p -137.98 11.73 2.86 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.109 -0.994 . . . . 74.400000000000006 110.125 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -125.46 128.37 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.304 -0.873 . . . . 72.120000000000005 109.407 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -90.85 109.41 20.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.465 -0.772 . . . . 65.409999999999997 108.922 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 206' ' ' THR . . . . . 0.413 HG21 ' CZ ' ' B' ' 192' ' ' ARG . 43.9 p -85.35 126.44 33.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.445 -0.784 . . . . 71.329999999999998 109.074 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 9.9 p -152.5 159.85 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.13 -0.982 . . . . 63.5 109.675 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -85.28 -38.97 18.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.154 -0.966 . . . . 74.450000000000003 109.914 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . 0.523 ' O ' ' N ' ' B' ' 211' ' ' GLY . 80.5 mtm180 -55.85 150.69 12.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.021 -1.05 . . . . 74.140000000000001 109.512 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? 51.59 -90.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.215 -0.928 . . . . 74.430000000000007 108.805 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' B' ' 209' ' ' ARG . . . -171.79 -108.51 0.21 Allowed Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.801 -1.719 . . . . 64.450000000000003 108.801 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 212' ' ' TYR . . . . . 0.474 ' CE1' HD13 ' B' ' 188' ' ' ILE . 72.0 m-85 -119.17 140.56 49.97 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.578 -0.954 . . . . 74.209999999999994 108.759 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 65.5 ttt180 -124.36 126.19 45.56 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.58 0.705 . . . . 74.030000000000001 110.106 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . 0.81 ' CE2' HD13 ' B' ' 155' ' ' LEU . 24.3 t80 -92.11 133.18 36.0 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.854 -0.795 . . . . 74.340000000000003 108.854 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 2.6 p -147.1 166.34 27.2 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.987 -1.071 . . . . 64.329999999999998 109.706 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -72.44 151.23 91.8 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.222 -0.924 . . . . 70.040000000000006 108.654 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -68.07 160.92 46.57 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.157 1.905 . . . . 65.109999999999999 111.718 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.429 ' CB ' ' CD ' ' B' ' 219' ' ' PRO . 22.0 mttm -49.4 -64.13 1.35 Allowed Pre-proline 0 C--N 1.303 -1.445 0 O-C-N 121.276 -0.89 . . . . 73.150000000000006 109.335 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' B' ' 218' ' ' LYS . 37.5 Cg_endo -64.48 -171.9 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 121.879 1.719 . . . . 71.310000000000002 111.421 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 46.23 59.44 3.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.227 -0.921 . . . . 75.450000000000003 109.806 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 221' ' ' CYS . . . . . 0.417 ' SG ' ' O ' ' B' ' 218' ' ' LYS . 16.4 p -167.16 150.18 6.35 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -0.922 . . . . 72.219999999999999 109.17 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 47.87 91.29 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.139 -0.975 . . . . 54.530000000000001 109.434 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.019 -0.991 . . . . 71.129999999999995 109.639 179.928 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptp . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.451 -0.574 . . . . 65.120000000000005 109.451 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -141.68 160.18 40.7 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.299 -0.875 . . . . 72.329999999999998 109.453 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.4 t -118.34 125.35 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.169 -0.678 . . . . 71.420000000000002 109.169 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.405 ' O ' ' O ' ' A' ' 49' ' ' MET . 4.8 tp -99.31 115.1 28.39 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.497 -0.752 . . . . 65.120000000000005 109.212 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.0 tp -119.68 110.08 16.4 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.337 -0.986 . . . . 62.43 108.337 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.435 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 16.9 mt -92.73 109.18 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.899 -1.125 . . . . 71.150000000000006 109.595 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -152.54 120.09 6.02 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.166 -0.959 . . . . 75.340000000000003 109.673 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -65.16 -38.46 90.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 72.439999999999998 109.451 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -67.66 106.16 2.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 63.020000000000003 109.567 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 91.0 p -66.64 -26.33 67.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.316 -0.865 . . . . 72.340000000000003 109.551 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.64 -53.68 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.158 -0.964 . . . . 74.019999999999996 109.691 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.524 ' N ' HD12 ' A' ' 12' ' ' LEU . 7.9 mp -65.18 -36.45 84.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 71.430000000000007 109.552 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.92 -27.49 64.49 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.54 -1.824 . . . . 61.32 108.54 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.04 -49.72 61.09 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.441 -1.464 . . . . 71.200000000000003 109.441 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -61.59 -44.86 96.24 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -1.138 . . . . 71.319999999999993 109.55 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.5 mm -63.64 -39.08 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.743 -1.223 . . . . 63.229999999999997 108.281 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -64.42 -52.12 59.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.499 -0.75 . . . . 51.109999999999999 109.975 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -77.72 -2.77 37.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 73.340000000000003 109.566 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.42 -49.94 3.99 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 108.989 -1.644 . . . . 62.149999999999999 108.989 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pp -75.7 -28.96 58.83 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.433 -1.039 . . . . 73.510000000000005 109.234 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -51.65 -34.32 37.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.202 -0.936 . . . . 74.25 108.815 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.0 t -54.76 -47.38 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.523 -0.917 . . . . 70.040000000000006 108.523 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -54.35 -54.81 35.44 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.23 -1.026 . . . . 73.230000000000004 108.23 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 130.74 40.42 0.24 Allowed Glycine 0 N--CA 1.499 2.847 0 N-CA-C 110.636 -0.986 . . . . 75.540000000000006 110.636 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -118.91 159.67 23.37 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.19 -1.183 . . . . 73.430000000000007 108.694 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 11.7 mmt -97.65 138.35 35.18 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.211 -1.033 . . . . 43.240000000000002 108.211 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -142.95 160.12 40.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 62.109999999999999 109.784 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -142.03 151.55 42.53 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.781 -0.822 . . . . 74.420000000000002 108.781 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 t -106.03 134.7 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.706 -0.85 . . . . 72.150000000000006 108.706 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.3 p -129.7 163.46 26.09 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.517 -0.739 . . . . 71.420000000000002 109.356 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.435 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 2.8 pt-20 -92.22 -97.46 0.13 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.317 -0.865 . . . . 72.329999999999998 109.69 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.3 p -78.26 166.38 22.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 74.239999999999995 110.071 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.4 mt -55.02 -38.06 67.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.601 -0.687 . . . . 71.530000000000001 110.028 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -53.47 -43.22 67.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.168 -0.957 . . . . 74.230000000000004 110.061 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -63.92 -37.7 88.38 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.026 -1.046 . . . . 54.030000000000001 109.595 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.24 -45.72 11.09 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.914 -1.274 . . . . 61.409999999999997 109.914 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -61.82 -36.88 82.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -1.137 . . . . 74.340000000000003 109.88 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.443 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 64.6 t80 -80.07 -26.21 39.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.259 -0.901 . . . . 75.329999999999998 110.249 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 33.8 tp -86.63 -32.57 20.51 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.031 -1.043 . . . . 74.329999999999998 110.223 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.485 ' SD ' ' OH ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -83.16 -34.12 26.07 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.088 -1.008 . . . . 70.319999999999993 110.79 -178.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 42' ' ' ILE . 35.2 p-10 -57.7 -30.43 65.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.035 -1.041 . . . . 71.219999999999999 110.529 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.53 ' N ' ' OD1' ' A' ' 41' ' ' ASP . 7.9 pt -85.03 -38.22 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.864 -1.148 . . . . 74.140000000000001 110.485 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.436 ' O ' ' O ' ' A' ' 40' ' ' MET . 97.8 mtt180 -101.52 162.58 12.79 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.105 -0.997 . . . . 72.239999999999995 110.046 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -92.39 144.51 25.3 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.336 -0.853 . . . . 75.420000000000002 108.992 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.558 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 3.5 p90 -142.13 179.94 6.61 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.151 -0.968 . . . . 74.230000000000004 109.732 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -143.16 -32.39 0.47 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.321 -0.862 . . . . 72.040000000000006 109.767 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.476 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.2 OUTLIER -108.24 113.31 26.32 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.345 -0.847 . . . . 72.129999999999995 109.086 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.476 ' N ' HD13 ' A' ' 47' ' ' LEU . 65.0 t -101.27 99.54 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.797 -0.816 . . . . 72.340000000000003 108.797 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.405 ' O ' ' O ' ' A' ' 4' ' ' LEU . 26.5 ttt -114.55 132.24 56.39 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.561 0.696 . . . . 74.109999999999999 109.567 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.466 HG21 ' HB2' ' A' ' 55' ' ' ALA . 0.8 OUTLIER -142.12 136.05 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.382 -0.824 . . . . 61.119999999999997 109.69 -179.046 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.8 t -102.06 1.25 36.2 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.478 -0.764 . . . . 73.109999999999999 109.772 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -76.07 145.99 39.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.103 -0.998 . . . . 52.549999999999997 109.713 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.409 ' C ' ' H ' ' A' ' 55' ' ' ALA . 29.2 mmtp -78.01 -46.46 20.93 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.25 -0.906 . . . . 44.219999999999999 110.204 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -59.98 -4.63 0.79 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.154 -0.966 . . . . 70.439999999999998 109.908 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.466 ' HB2' HG21 ' A' ' 50' ' ' VAL . . . -62.92 -23.01 67.17 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.226 -0.921 . . . . 64.140000000000001 110.139 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 55' ' ' ALA . 14.5 mt -39.98 -54.56 2.19 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.603 -0.686 . . . . 44.140000000000001 110.71 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.6 p -68.39 -31.83 71.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.734 -1.229 . . . . 55.229999999999997 109.254 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.458 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 66.5 t80 -65.74 -46.99 76.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.395 -0.816 . . . . 74.439999999999998 110.242 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.8 m -63.06 -35.09 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.706 -1.246 . . . . 74.030000000000001 109.467 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 60.8 m -57.09 -51.33 69.7 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.18 -0.95 . . . . 64.299999999999997 109.419 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.402 ' HG2' ' H ' ' A' ' 61' ' ' ARG . 11.7 ptm180 -67.64 -34.48 77.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.125 -0.984 . . . . 64.439999999999998 110.019 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.458 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 4.8 mm -63.32 -28.46 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.839 -1.163 . . . . 63.210000000000001 109.455 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.477 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 30.8 mmtt -75.4 -57.86 3.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.074 -1.017 . . . . 74.420000000000002 109.784 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -62.37 -33.24 74.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.897 -1.127 . . . . 70.319999999999993 109.73 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 8.3 mtpm? -85.42 -18.66 32.99 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.18 -0.95 . . . . 75.219999999999999 109.844 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.523 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 98.7 m-70 -157.61 65.97 0.48 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.027 -1.046 . . . . 74.129999999999995 109.606 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.6 m -66.12 -24.12 66.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.286 -0.884 . . . . 73.239999999999995 110.023 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.429 ' HG ' ' HZ1' ' A' ' 145' ' ' LYS . 86.8 p -68.11 -21.47 64.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.154 -0.966 . . . . 61.009999999999998 110.427 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.432 HD13 ' CE2' ' A' ' 45' ' ' TYR . 58.3 mt -88.43 153.37 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.102 -0.998 . . . . 71.329999999999998 109.635 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 71' ' ' VAL . 63.9 t -91.11 158.96 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.135 -0.978 . . . . 72.129999999999995 110.189 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.484 ' N ' HG12 ' A' ' 70' ' ' VAL . 24.8 t -132.44 125.31 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.397 -0.814 . . . . 54.210000000000001 109.759 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.492 ' C ' HD23 ' A' ' 72' ' ' LEU . 4.5 tt -118.34 101.91 8.55 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.491 -0.756 . . . . 50.240000000000002 109.125 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.0 t -91.61 137.21 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.189 -0.944 . . . . 74.409999999999997 109.707 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.8 156.55 19.51 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.492 -0.929 . . . . 72.310000000000002 108.492 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 97' ' ' LYS . 27.9 t -153.66 132.25 12.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.04 -1.037 . . . . 64.540000000000006 109.786 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -89.44 3.26 52.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.386 -0.821 . . . . 74.129999999999995 108.904 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 79' ' ' THR . 2.5 p-10 -138.52 56.48 10.05 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.528 -0.733 . . . . 73.340000000000003 109.048 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -49.92 87.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.322 2.015 . . . . 63.219999999999999 111.339 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.444 ' N ' ' O ' ' A' ' 77' ' ' ASN . 21.2 m -110.22 152.59 25.91 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.091 -0.707 . . . . 62.530000000000001 109.091 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.39 -34.24 64.19 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.43 -0.794 . . . . 73.439999999999998 109.755 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -65.15 -52.5 54.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.087 -1.008 . . . . 71.420000000000002 110.103 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -60.71 -33.34 72.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.268 -0.895 . . . . 73.430000000000007 109.824 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -64.04 -46.0 86.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 74.219999999999999 109.721 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 98.8 t -57.22 -46.73 84.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 73.200000000000003 109.758 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -68.12 -29.37 68.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 53.329999999999998 109.65 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.42 -43.43 96.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.149 -0.969 . . . . 64.109999999999999 109.993 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -83.86 -34.52 24.6 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.127 -0.983 . . . . 74.340000000000003 109.579 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -65.79 -46.07 80.06 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.309 -0.869 . . . . 74.420000000000002 108.772 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -63.43 -53.11 57.4 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.678 -0.639 . . . . 74.239999999999995 109.522 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 141.07 61.33 0.03 OUTLIER Glycine 0 N--CA 1.495 2.61 0 N-CA-C 110.247 -1.141 . . . . 61.509999999999998 110.247 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -110.84 132.32 54.3 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.377 -1.073 . . . . 55.329999999999998 109.026 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.477 ' OD1' ' NZ ' ' A' ' 63' ' ' LYS . 35.9 m-20 -85.31 -19.32 31.69 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.047 -1.033 . . . . 73.420000000000002 109.01 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.448 ' OD2' ' CZ ' ' A' ' 112' ' ' ARG . 60.0 m-20 -152.14 162.66 40.78 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.82 -0.808 . . . . 75.040000000000006 108.82 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.433 ' OH ' ' CB ' ' A' ' 75' ' ' SER . 87.4 t80 -150.56 95.57 2.26 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.609 -0.886 . . . . 71.329999999999998 108.609 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 96' ' ' ALA . 8.3 mm -105.31 155.3 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.619 0 O-C-N 121.023 -1.048 . . . . 71.129999999999995 109.835 -179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.478 ' N ' HG22 ' A' ' 95' ' ' ILE . . . -60.33 144.57 50.31 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 106.953 -1.499 . . . . 64.319999999999993 106.953 177.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.662 ' C ' ' H ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -67.58 -57.48 10.1 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 120.645 -1.284 . . . . 62.200000000000003 112.171 -178.097 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 99' ' ' TYR . 27.7 Cg_endo -53.92 9.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.3 -1.993 0 CA-C-N 119.927 1.01 . . . . 73.109999999999999 113.477 -173.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.662 ' H ' ' C ' ' A' ' 97' ' ' LYS . 14.5 m-85 57.01 124.86 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.19 -0.459 . . . . 65.219999999999999 110.688 177.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 40.6 mtt85 -66.93 -35.32 79.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.696 -1.253 . . . . 72.349999999999994 108.777 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.741 ' O ' ' N ' ' A' ' 103' ' ' LYS . 29.3 t -164.92 33.18 0.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 71.319999999999993 110.404 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.4 mt 51.77 -69.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.714 -0.616 . . . . 75.430000000000007 110.296 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.741 ' N ' ' O ' ' A' ' 101' ' ' SER . 13.0 mptt -56.37 -28.81 60.29 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 107.633 -1.247 . . . . 71.409999999999997 107.633 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.18 87.71 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.715 -0.794 . . . . 63.240000000000002 108.881 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -61.51 -55.95 25.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.354 -0.841 . . . . 73.219999999999999 108.75 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.7 t -56.34 -41.76 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.96 -1.087 . . . . 60.109999999999999 109.278 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -50.02 -42.54 49.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.933 . . . . 70.420000000000002 109.309 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.515 ' O ' ' NH1' ' A' ' 112' ' ' ARG . 15.5 mmp_? -69.61 -30.08 67.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 74.409999999999997 109.521 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 93.3 mt -77.92 -29.67 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.021 -1.049 . . . . 62.539999999999999 109.117 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -73.4 -58.77 3.07 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.272 -0.893 . . . . 74.340000000000003 109.911 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.81 -46.99 87.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.123 -0.985 . . . . 73.319999999999993 109.826 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.515 ' NH1' ' O ' ' A' ' 108' ' ' ARG . 22.2 ttp-105 -59.47 -31.53 69.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.181 -0.949 . . . . 52.409999999999997 109.44 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 12.4 tp -157.63 93.06 1.25 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 65.239999999999995 109.496 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 32.5 mtm-85 -78.39 -72.73 0.36 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.227 -0.92 . . . . 64.450000000000003 108.89 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' A' ' 117' ' ' GLY . 41.4 t80 -140.11 3.18 1.97 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.31 -0.869 . . . . 74.430000000000007 109.668 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.528 ' CG ' ' O ' ' A' ' 115' ' ' PHE . 48.9 p-90 40.96 21.27 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.569 -0.707 . . . . 74.420000000000002 110.362 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 115' ' ' PHE . . . -57.12 89.77 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.615 -1.394 . . . . 75.040000000000006 109.615 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.434 ' N ' ' O ' ' A' ' 116' ' ' TRP . 85.8 p -156.16 163.65 39.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -1.152 . . . . 61.140000000000001 109.901 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.07 125.57 3.09 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.665 -0.865 . . . . 65.239999999999995 108.665 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.2 t -83.79 -50.25 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.165 -0.96 . . . . 73.109999999999999 109.868 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 17.6 mm -100.83 126.35 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.246 -0.909 . . . . 72.239999999999995 109.351 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -129.87 124.73 33.92 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.544 -0.722 . . . . 72.340000000000003 109.143 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 123' ' ' ILE . 13.2 tt -146.71 130.21 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.284 -0.885 . . . . 71.439999999999998 109.424 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 45.94 -143.68 3.99 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.745 -1.342 . . . . 73.400000000000006 109.745 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -84.64 -3.93 58.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -1.138 . . . . 74.450000000000003 109.371 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.66 130.79 41.01 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.529 -0.915 . . . . 54.210000000000001 108.529 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.9 m -129.43 123.92 32.83 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.355 -0.84 . . . . 54.5 109.507 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 23.3 mm -110.26 140.69 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.55 -0.719 . . . . 45.149999999999999 109.103 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.9 m -128.08 78.99 74.59 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.49 -0.756 . . . . 71.109999999999999 109.33 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -49.85 -53.02 7.74 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.853 2.369 . . . . 65.409999999999997 112.573 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -54.08 -42.71 69.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.953 . . . . 63.32 109.451 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.492 ' OE1' ' N ' ' A' ' 132' ' ' GLU . 37.8 mp0 -88.72 -0.54 57.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.25 -0.906 . . . . 72.519999999999996 109.56 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 47.86 39.12 10.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 75.329999999999998 109.447 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -125.65 143.09 51.18 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.638 -0.663 . . . . 71.230000000000004 109.238 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 8.8 tt -125.17 138.87 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.537 -0.727 . . . . 74.019999999999996 109.414 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 52.4 mt -119.14 125.94 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.605 -0.684 . . . . 60.229999999999997 109.178 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.504 ' CE2' ' CD ' ' A' ' 138' ' ' LYS . 46.1 t80 -137.43 132.51 33.51 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.56 -0.713 . . . . 62.32 109.127 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.524 ' O ' ' NH1' ' A' ' 140' ' ' ARG . 15.8 mtpp 55.64 25.21 7.84 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.504 -0.748 . . . . 75.400000000000006 109.956 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 83.26 -0.82 89.51 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.237 -1.145 . . . . 72.239999999999995 110.237 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.524 ' NH1' ' O ' ' A' ' 138' ' ' LYS . 9.6 mpt_? -88.9 125.79 35.1 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.017 -1.284 . . . . 71.219999999999999 109.088 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -97.8 116.9 30.94 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.274 -0.891 . . . . 71.420000000000002 109.471 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 13.8 p -139.02 141.75 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.341 -0.85 . . . . 53.020000000000003 109.265 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -88.57 147.67 24.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.196 -0.94 . . . . 60.450000000000003 109.381 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.3 m -137.17 140.61 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.419 -0.801 . . . . 74.439999999999998 109.577 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.429 ' HZ1' ' HG ' ' A' ' 68' ' ' SER . 13.0 ptpt -165.83 121.99 1.34 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.883 . . . . 65.150000000000006 109.332 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 172.97 -164.45 36.48 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.579 -1.408 . . . . 73.340000000000003 109.579 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.692 ' NZ ' ' HE1' ' A' ' 173' ' ' TRP . 1.6 mtpm? -76.87 -34.76 1.31 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.235 -1.156 . . . . 72.219999999999999 111.071 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.607 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 97.0 Cg_endo -89.45 -5.4 5.51 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 C-N-CA 122.166 1.91 . . . . 65.230000000000004 112.639 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -96.93 -32.71 11.9 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.214 -0.929 . . . . 60.109999999999999 109.725 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.524 ' O ' ' ND1' ' A' ' 154' ' ' HIS . 71.3 mm-40 -60.15 -40.45 89.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.113 -0.992 . . . . 64.209999999999994 109.181 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.411 HG11 ' CD1' ' A' ' 191' ' ' ILE . 7.8 p -61.03 -31.75 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.279 -0.888 . . . . 72.019999999999996 109.05 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.49 HD13 ' O ' ' A' ' 152' ' ' LEU . 0.2 OUTLIER -65.14 -46.91 78.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.39 -0.819 . . . . 73.310000000000002 109.267 -179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.5 p -72.43 -30.52 64.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.091 -1.006 . . . . 74.310000000000002 109.9 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.524 ' ND1' ' O ' ' A' ' 150' ' ' GLU . 1.5 m80 -59.04 -53.38 59.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 74.310000000000002 109.728 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.68 -25.19 62.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.109 -0.995 . . . . 75.340000000000003 109.49 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.01 -54.82 40.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.204 -0.935 . . . . 62.140000000000001 109.093 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 62.7 mtp180 -70.45 -50.22 40.58 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.247 -0.908 . . . . 61.030000000000001 108.991 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.526 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 40.0 m-70 -76.04 62.37 1.65 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.535 -0.728 . . . . 74.120000000000005 109.267 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.552 ' C ' HE22 ' A' ' 161' ' ' GLN . 48.0 ttp180 -98.79 139.67 34.13 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.303 -0.873 . . . . 71.129999999999995 109.33 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.676 ' N ' HE22 ' A' ' 161' ' ' GLN . 10.4 t0 80.02 60.92 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.662 -0.649 . . . . 75.450000000000003 110.77 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.676 HE22 ' N ' ' A' ' 160' ' ' ASP . 2.0 pm0 -167.27 170.61 11.47 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.933 -1.104 . . . . 73.409999999999997 109.782 178.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 13.6 mm -92.27 136.36 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.379 -0.826 . . . . 74.409999999999997 109.123 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.453 HG13 ' OE1' ' A' ' 167' ' ' GLN . 82.7 t -140.76 138.32 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.246 -0.909 . . . . 72.310000000000002 109.802 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 52.4 p -89.71 154.28 20.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.361 -0.837 . . . . 74.120000000000005 109.307 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.578 ' CD ' ' H ' ' A' ' 165' ' ' LYS . 0.0 OUTLIER -60.83 -41.3 95.5 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.21 -0.931 . . . . 70.430000000000007 109.2 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.7 -35.83 66.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.237 -0.914 . . . . 73.519999999999996 109.736 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.453 ' OE1' HG13 ' A' ' 163' ' ' VAL . 34.7 tt0 -56.23 -45.72 79.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.077 -1.014 . . . . 74.519999999999996 109.26 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 21.9 mt -59.79 -37.44 79.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.08 -1.012 . . . . 72.310000000000002 108.985 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.559 HD23 ' C ' ' A' ' 169' ' ' LEU . 4.9 tt -59.53 -69.41 0.21 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.416 -0.803 . . . . 53.329999999999998 110.241 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.417 ' O ' ' OE1' ' A' ' 174' ' ' GLU . 3.9 p30 -65.0 -33.5 76.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.157 -0.964 . . . . 62.439999999999998 111.005 -178.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -52.65 -48.6 66.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.976 -1.077 . . . . 60.210000000000001 110.219 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.663 ' N ' HD12 ' A' ' 172' ' ' ILE . 1.8 mp -94.09 -64.28 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.971 -1.081 . . . . 75.319999999999993 108.905 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.692 ' HE1' ' NZ ' ' A' ' 147' ' ' LYS . 25.8 m-90 -81.32 80.15 7.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.34 -0.85 . . . . 73.140000000000001 109.534 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.417 ' OE1' ' O ' ' A' ' 170' ' ' ASP . 42.5 tp10 -89.3 -58.25 2.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.239 -0.913 . . . . 73.239999999999995 109.875 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.622 ' N ' ' CD ' ' A' ' 176' ' ' PRO . 7.3 tt0 -79.34 -37.03 1.16 Allowed Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.144 -0.973 . . . . 44.43 110.775 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 175' ' ' GLU . 31.5 Cg_exo -58.81 62.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.402 2.068 . . . . 72.510000000000005 112.511 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 175' ' ' GLU . 97.9 mt-10 -65.57 -24.45 67.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.003 -1.061 . . . . 63.240000000000002 109.748 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 79.4 mtp -50.47 -27.19 6.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.943 . . . . 73.5 109.771 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 176' ' ' PRO . 28.1 m -52.26 149.51 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.168 -0.957 . . . . 65.219999999999999 109.531 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 2.4 p -49.45 152.83 2.09 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 71.420000000000002 109.046 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.14 -8.33 20.87 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.387 2.058 . . . . 41.219999999999999 112.896 -179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -161.18 99.08 1.18 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.872 -1.142 . . . . 64.540000000000006 110.311 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.2 m -153.16 16.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.292 -0.88 . . . . 74.019999999999996 109.232 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 61.8 mt -58.64 -38.95 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.183 -0.948 . . . . 72.329999999999998 109.475 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -50.45 -38.77 45.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 74.400000000000006 109.324 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 49.6 t -74.67 -36.38 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.227 -0.921 . . . . 70.420000000000002 109.47 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.413 ' O ' ' CG1' ' A' ' 191' ' ' ILE . . . -64.7 -52.81 55.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -0.918 . . . . 52.109999999999999 109.601 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.571 ' O ' HD13 ' A' ' 188' ' ' ILE . 0.2 OUTLIER -60.9 -34.01 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.037 -1.039 . . . . 71.400000000000006 109.191 -179.691 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -68.27 -57.68 5.6 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.055 -1.028 . . . . 73.439999999999998 110.394 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -64.15 -38.24 90.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.868 -1.145 . . . . 71.420000000000002 109.259 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.413 ' CG1' ' O ' ' A' ' 187' ' ' ALA . 3.4 mm -56.9 -34.19 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 61.549999999999997 108.745 179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.642 ' HE ' ' CG2' ' A' ' 204' ' ' VAL . 3.2 tpt180 -70.17 -43.13 71.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.505 -0.747 . . . . 63.340000000000003 109.784 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -77.51 -27.87 51.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.085 -1.009 . . . . 61.240000000000002 110.187 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -84.88 -21.84 29.59 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.157 -0.965 . . . . 75.129999999999995 110.593 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . 0.567 ' SD ' ' N ' ' A' ' 196' ' ' ASP . 0.0 OUTLIER -93.77 -41.04 9.88 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.98 -1.075 . . . . 74.019999999999996 109.718 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . 0.567 ' N ' ' SD ' ' A' ' 195' ' ' MET . 31.5 p-10 -64.6 -34.41 78.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.175 -0.953 . . . . 74.019999999999996 109.696 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.498 ' N ' ' OD1' ' A' ' 196' ' ' ASP . 0.2 OUTLIER -57.2 -63.95 3.12 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.898 . . . . 75.430000000000007 109.678 -179.851 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.427 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 37.2 Cg_endo -63.71 -57.26 0.38 Allowed 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.196 1.931 . . . . 72.319999999999993 112.064 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 49.0 mt -61.17 -33.09 72.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 74.540000000000006 109.556 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 73.55 -49.02 1.6 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.492 -1.443 . . . . 61.509999999999998 109.492 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 83.7 mt -92.17 138.24 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.211 -1.17 . . . . 61.219999999999999 109.278 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 34.7 m -77.83 147.43 35.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.283 -0.885 . . . . 72.0 109.52 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 8.2 p -142.54 21.13 2.03 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.325 -0.86 . . . . 74.439999999999998 109.223 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.642 ' CG2' ' HE ' ' A' ' 192' ' ' ARG . 20.3 m -135.22 147.96 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.461 -0.774 . . . . 64.349999999999994 109.25 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -123.48 133.34 54.05 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.497 -0.752 . . . . 71.409999999999997 109.392 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 29.0 p -99.24 138.08 36.84 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.381 -0.825 . . . . 73.519999999999996 109.394 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 38.6 t -144.6 136.85 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.202 -0.936 . . . . 71.019999999999996 109.391 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 70.2 ttp85 -80.82 88.26 5.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 72.120000000000005 109.393 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 47.3 ttt85 -171.0 -126.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 64.409999999999997 109.29 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -57.37 -39.72 76.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.109 -0.994 . . . . 71.540000000000006 109.418 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 167.59 -149.51 14.78 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.693 -1.363 . . . . 72.030000000000001 109.693 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -104.93 151.52 23.78 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.481 -1.011 . . . . 75.540000000000006 109.351 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -119.71 137.35 53.98 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.083 -0.71 . . . . 75.310000000000002 109.083 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.509 ' O ' ' N ' ' A' ' 160' ' ' ASP . 15.5 m-85 -106.07 126.94 52.8 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.431 -0.793 . . . . 75.409999999999997 109.377 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 52.9 t -153.11 160.27 42.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.432 -0.793 . . . . 74.140000000000001 109.06 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -63.45 151.69 87.13 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.071 -1.018 . . . . 75.319999999999993 109.072 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.481 ' O ' ' O ' ' A' ' 218' ' ' LYS . 84.1 Cg_endo -75.72 122.62 6.97 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.381 2.054 . . . . 73.109999999999999 112.042 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 217' ' ' PRO . 32.7 mttp 56.64 155.31 0.07 OUTLIER Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.662 -0.649 . . . . 75.25 109.445 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.72 -15.59 26.85 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.259 1.973 . . . . 75.099999999999994 111.681 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . 46.94 -170.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 71.140000000000001 109.801 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 28.3 p -81.45 145.82 30.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 71.129999999999995 109.657 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.43 -31.76 72.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.306 -0.871 . . . . 75.349999999999994 109.493 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.033 -0.984 . . . . 73.409999999999997 109.455 -179.985 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 52.0 ttm . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.477 -0.564 . . . . 71.140000000000001 109.477 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 68.0 mtt85 -138.72 144.36 39.48 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.305 -0.872 . . . . 73.230000000000004 109.431 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 86.8 t -111.97 138.86 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 CA-C-O 121.466 0.651 . . . . 72.239999999999995 109.756 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.476 HD11 ' CG1' ' B' ' 6' ' ' ILE . 2.7 tp -108.99 120.55 42.89 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.728 -0.607 . . . . 54.329999999999998 109.399 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.44 ' N ' HD12 ' B' ' 4' ' ' LEU . 20.2 mt -118.17 110.44 17.58 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.533 -0.729 . . . . 74.349999999999994 109.039 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.476 ' CG1' HD11 ' B' ' 4' ' ' LEU . 26.7 mt -100.78 114.08 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.681 -0.859 . . . . 42.549999999999997 108.681 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.486 ' OE1' ' N ' ' B' ' 9' ' ' ASN . 1.8 pp20? -151.04 164.93 35.3 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.285 -0.885 . . . . 74.519999999999996 109.58 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 20.0 tptp -95.86 -24.39 16.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.252 -0.905 . . . . 62.549999999999997 109.542 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . 0.486 ' N ' ' OE1' ' B' ' 7' ' ' GLU . 28.7 m120 -91.15 109.79 21.06 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.211 -0.931 . . . . 73.109999999999999 109.697 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 32.3 t -62.44 -40.78 97.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.206 -0.934 . . . . 65.540000000000006 109.633 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 86.4 t -57.72 -44.32 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 75.549999999999997 109.214 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.508 HD11 ' HZ2' ' B' ' 97' ' ' LYS . 7.6 tp -58.74 -35.47 72.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 70.140000000000001 108.841 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.04 -27.26 70.68 Favored Glycine 0 N--CA 1.484 1.87 0 N-CA-C 108.253 -1.939 . . . . 75.400000000000006 108.253 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.97 -52.28 49.16 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 109.536 -1.425 . . . . 65.439999999999998 109.536 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.424 ' H ' ' HG2' ' B' ' 15' ' ' GLU . 6.9 pt-20 -59.75 -47.23 86.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.372 -1.075 . . . . 60.210000000000001 109.796 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 35.5 mm -64.03 -41.48 92.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.66 -1.275 . . . . 75.150000000000006 108.951 179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.474 ' CD ' ' HB3' ' B' ' 27' ' ' ALA . 39.7 tp10 -59.43 -45.22 92.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.224 -0.922 . . . . 73.010000000000005 109.156 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -84.07 0.14 49.52 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.223 -0.923 . . . . 74.299999999999997 109.557 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.5 -58.48 1.94 Allowed Glycine 0 N--CA 1.485 1.95 0 N-CA-C 109.544 -1.423 . . . . 70.540000000000006 109.544 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' B' ' 27' ' ' ALA . 1.5 pt? -71.34 -23.61 61.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.307 -1.114 . . . . 71.340000000000003 109.74 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . 0.411 ' H ' HD23 ' B' ' 20' ' ' LEU . 2.1 m120 -51.24 -36.17 40.56 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.143 -0.973 . . . . 64.409999999999997 109.495 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 46.5 t -53.86 -32.35 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.15 -0.969 . . . . 74.230000000000004 108.442 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 27.5 mmtm -81.64 -3.88 54.65 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.746 0.784 . . . . 63.420000000000002 108.891 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.13 24.45 63.84 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.942 -1.263 . . . . 53.43 109.942 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -95.14 159.73 14.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.179 -1.189 . . . . 71.120000000000005 109.076 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 14.8 mmt -104.93 140.41 38.2 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.714 -0.847 . . . . 75.239999999999995 108.714 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.474 ' HB3' ' CD ' ' B' ' 17' ' ' GLU . . . -135.9 158.13 45.14 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.398 -0.814 . . . . 72.120000000000005 109.651 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -132.8 145.69 51.19 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.594 -0.891 . . . . 72.310000000000002 108.594 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 4.3 m -110.47 139.33 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.369 -0.832 . . . . 64.430000000000007 109.129 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.1 p -138.13 169.29 18.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.384 -0.822 . . . . 65.409999999999997 109.425 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.414 ' OE2' ' OD1' ' B' ' 35' ' ' ASP . 5.4 pt-20 -93.09 -106.99 0.12 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.342 -0.849 . . . . 71.019999999999996 109.431 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 77.3 p -79.47 168.17 19.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 51.109999999999999 109.776 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 22.7 mt -51.91 -29.81 21.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.537 -0.727 . . . . 71.239999999999995 109.856 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -52.29 -51.2 59.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.095 -1.003 . . . . 74.319999999999993 109.729 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.414 ' OD1' ' OE2' ' B' ' 31' ' ' GLU . 1.4 m-20 -63.1 -38.9 93.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -0.975 . . . . 73.030000000000001 109.261 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.97 -38.97 93.16 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.409 -1.476 . . . . 30.210000000000001 109.409 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -67.92 -42.85 80.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -1.114 . . . . 74.420000000000002 109.605 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -74.41 -34.15 63.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 74.420000000000002 109.641 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 21.0 tp -74.86 -50.0 18.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.29 -0.881 . . . . 75.409999999999997 110.078 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . 0.439 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.7 ppp? -61.9 -27.69 68.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 60.409999999999997 109.907 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.81 -39.79 86.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 53.229999999999997 110.137 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 17.6 pt -87.06 -24.9 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.09 -1.006 . . . . 71.230000000000004 110.407 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.424 ' O ' ' O ' ' B' ' 40' ' ' MET . 91.3 mtt-85 -129.65 140.36 51.17 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.235 -0.916 . . . . 72.219999999999999 109.73 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -99.32 126.89 45.26 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.286 -0.884 . . . . 63.539999999999999 109.293 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -101.61 141.89 33.79 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.324 -0.86 . . . . 64.349999999999994 109.505 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -81.11 -31.71 34.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 62.219999999999999 109.021 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.522 ' C ' HD13 ' B' ' 47' ' ' LEU . 1.0 OUTLIER -114.9 110.6 19.9 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.691 -0.855 . . . . 73.120000000000005 108.691 179.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.462 ' N ' HD13 ' B' ' 47' ' ' LEU . 62.3 t -95.52 101.13 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.28 -0.887 . . . . 65.109999999999999 109.074 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 14.4 ttt -116.43 132.7 56.6 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.592 0.71 . . . . 73.439999999999998 109.45 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.532 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.4 OUTLIER -144.49 139.49 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.465 -0.772 . . . . 34.5 109.364 -179.49 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 31.9 p -105.58 14.71 28.1 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.668 -0.645 . . . . 73.209999999999994 109.72 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.532 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 61.9 m-20 -82.7 144.96 29.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.214 -0.929 . . . . 70.409999999999997 109.266 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.415 ' C ' ' H ' ' B' ' 55' ' ' ALA . 15.4 pttm -77.68 -39.41 44.94 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.179 -0.951 . . . . 65.0 110.118 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -73.81 10.49 1.12 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.098 -1.001 . . . . 75.209999999999994 109.559 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.415 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -65.79 -21.21 66.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.351 -0.843 . . . . 55.329999999999998 110.036 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' B' ' 55' ' ' ALA . 47.7 mt -41.94 -43.68 3.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.433 -0.792 . . . . 63.140000000000001 110.517 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 91.3 p -75.96 -35.79 59.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.909 -1.12 . . . . 63.5 109.451 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -66.63 -40.78 88.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.411 -0.806 . . . . 72.329999999999998 110.353 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.06 -35.49 59.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 120.757 -1.214 . . . . 74.540000000000006 109.544 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 78.8 p -57.69 -46.86 83.74 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.12 -0.988 . . . . 71.239999999999995 109.314 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -69.69 -34.41 73.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.142 -0.974 . . . . 74.310000000000002 110.018 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 4.9 mm -62.2 -34.31 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.862 -1.149 . . . . 72.140000000000001 109.779 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.421 ' O ' ' OG ' ' B' ' 67' ' ' SER . 12.0 mmtm -73.79 -52.88 11.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.099 -1.0 . . . . 73.319999999999993 110.178 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -66.24 -36.82 84.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.902 -1.123 . . . . 73.120000000000005 110.304 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.466 ' C ' ' CG ' ' B' ' 66' ' ' HIS . 29.3 mtmt -83.21 -23.56 32.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.133 -0.98 . . . . 72.439999999999998 110.258 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.466 ' CG ' ' C ' ' B' ' 65' ' ' LYS . 37.0 m-70 -153.2 67.37 0.79 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.02 -1.05 . . . . 63.310000000000002 109.837 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' B' ' 63' ' ' LYS . 10.5 m -61.9 -30.86 71.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.935 . . . . 73.099999999999994 109.724 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 90.5 p -63.24 -24.58 67.93 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.251 -0.905 . . . . 71.530000000000001 110.356 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.444 HD12 ' CB ' ' B' ' 66' ' ' HIS . 81.1 mt -81.5 156.36 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.988 -1.07 . . . . 74.400000000000006 109.767 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.497 HG12 ' N ' ' B' ' 71' ' ' VAL . 95.9 t -93.97 160.14 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.296 -0.877 . . . . 75.120000000000005 109.854 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.497 ' N ' HG12 ' B' ' 70' ' ' VAL . 21.7 t -136.04 127.49 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.411 -0.806 . . . . 73.200000000000003 109.366 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.417 HD21 HD11 ' B' ' 105' ' ' LEU . 0.7 OUTLIER -121.61 101.71 7.77 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.729 -0.841 . . . . 73.340000000000003 108.729 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 90.7 t -93.53 128.18 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.249 -0.907 . . . . 73.5 109.264 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 14.6 p -93.51 172.24 8.4 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.198 -0.939 . . . . 64.340000000000003 109.346 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.438 ' CB ' ' HH ' ' B' ' 94' ' ' TYR . 30.1 t -159.65 117.08 2.65 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.978 -1.077 . . . . 74.530000000000001 110.339 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -61.88 -36.34 80.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.384 -0.822 . . . . 64.5 109.84 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . 0.524 ' ND2' ' H ' ' B' ' 77' ' ' ASN . 0.5 OUTLIER -118.52 82.73 19.94 Favored Pre-proline 0 N--CA 1.499 2.0 0 O-C-N 121.572 -0.705 . . . . 74.25 109.227 -179.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -47.71 84.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.235 1.957 . . . . 74.430000000000007 111.5 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.516 ' N ' ' O ' ' B' ' 77' ' ' ASN . 19.4 m -102.91 150.91 23.05 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.596 -0.69 . . . . 73.120000000000005 109.377 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.2 t -65.32 -35.41 80.9 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.344 -0.847 . . . . 71.010000000000005 109.704 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . 0.488 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 80.1 mm-40 -60.42 -44.75 95.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.134 -0.979 . . . . 63.200000000000003 109.565 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -75.79 -31.11 59.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 73.219999999999999 109.468 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -64.73 -54.05 37.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 74.299999999999997 109.834 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.546 HG23 ' N ' ' B' ' 85' ' ' HIS . 21.6 m -64.26 -43.37 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.098 -1.001 . . . . 73.310000000000002 109.396 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' HIS . . . . . 0.546 ' N ' HG23 ' B' ' 84' ' ' VAL . 23.2 m170 -63.18 -26.17 68.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.161 -0.962 . . . . 73.239999999999995 109.271 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.49 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -70.64 -46.86 62.5 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -0.878 . . . . 55.329999999999998 109.958 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -77.0 -32.09 56.96 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.01 -1.056 . . . . 74.140000000000001 109.384 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -72.67 -44.3 62.0 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.248 -0.907 . . . . 64.040000000000006 109.693 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -62.69 -52.13 64.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.191 -0.943 . . . . 72.349999999999994 109.905 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 156.45 44.74 0.02 OUTLIER Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.673 -1.251 . . . . 65.200000000000003 110.265 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -110.28 135.7 50.61 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.396 -1.061 . . . . 52.229999999999997 109.255 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -85.37 -18.43 33.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.094 -1.004 . . . . 73.319999999999993 109.201 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -152.51 162.01 41.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.298 -0.876 . . . . 72.219999999999999 109.697 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.438 ' HH ' ' CB ' ' B' ' 75' ' ' SER . 79.4 t80 -143.65 97.0 2.99 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.554 -0.906 . . . . 64.420000000000002 108.554 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 23.2 mm -108.1 156.29 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 121.255 -0.903 . . . . 72.230000000000004 110.431 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.6 152.12 45.94 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.262 -1.014 . . . . 25.239999999999998 108.262 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.694 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -74.87 -55.98 2.26 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 120.787 -1.195 . . . . 64.319999999999993 111.416 -179.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 2.6 Cg_endo -40.29 -10.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.034 1.156 . . . . 63.329999999999998 112.914 -175.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . 0.694 ' N ' ' O ' ' B' ' 97' ' ' LYS . 54.2 m-85 59.42 118.18 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.755 -0.59 . . . . 75.129999999999995 109.868 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 47.9 mtt85 -65.65 -33.31 75.6 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.208 -0.932 . . . . 74.230000000000004 109.452 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . 0.766 ' O ' ' N ' ' B' ' 103' ' ' LYS . 34.2 t -171.32 27.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.961 -1.087 . . . . 63.340000000000003 110.888 179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 16.2 mt 49.14 -67.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 CA-C-N 118.498 0.59 . . . . 74.439999999999998 110.336 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.766 ' N ' ' O ' ' B' ' 101' ' ' SER . 43.4 mtpt -55.4 -32.77 62.93 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.903 -1.147 . . . . 71.109999999999999 107.903 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.11 -45.87 86.72 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.666 -0.864 . . . . 71.450000000000003 108.666 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.417 HD11 HD21 ' B' ' 72' ' ' LEU . 22.5 tp -68.31 -42.43 79.41 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.302 -0.874 . . . . 51.310000000000002 109.123 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 78.8 t -58.92 -45.72 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.174 -0.954 . . . . 65.230000000000004 108.893 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.17 -44.02 67.55 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.422 -0.955 . . . . 24.32 108.422 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -62.41 -39.04 91.98 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.819 -0.808 . . . . 75.310000000000002 108.819 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 91.1 mt -68.95 -28.96 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 108.043 -1.095 . . . . 54.240000000000002 108.043 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -68.56 -53.76 20.89 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.651 -0.87 . . . . 65.310000000000002 108.651 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -47.36 -40.32 17.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.448 -0.783 . . . . 72.239999999999995 109.081 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -62.85 -40.33 97.13 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.299 -0.876 . . . . 72.040000000000006 109.111 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 84.6 mt -137.97 77.44 1.63 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.318 -0.864 . . . . 75.349999999999994 109.505 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -74.54 -76.02 0.15 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.218 -0.926 . . . . 75.5 108.959 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' PHE . . . . . 0.525 ' O ' ' CG ' ' B' ' 116' ' ' TRP . 94.1 m-85 -82.84 -65.87 0.96 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.198 -0.939 . . . . 65.329999999999998 109.563 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' TRP . . . . . 0.525 ' CG ' ' O ' ' B' ' 115' ' ' PHE . 7.7 m-90 -158.13 -154.39 0.44 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.36 -0.838 . . . . 74.450000000000003 109.347 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -85.65 -138.09 4.54 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.696 -1.362 . . . . 44.210000000000001 109.696 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 10.9 t -151.95 176.85 11.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.305 -1.114 . . . . 71.400000000000006 109.911 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.9 163.81 37.8 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.787 -0.819 . . . . 72.319999999999993 108.787 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 10.1 t -136.5 -38.52 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.506 -0.746 . . . . 75.019999999999996 109.726 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 27.1 mm -97.77 137.67 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.239 -0.913 . . . . 51.409999999999997 109.499 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . 0.95 ' OE1' ' O ' ' B' ' 122' ' ' GLU . 0.0 OUTLIER -137.74 132.61 33.04 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.476 -0.765 . . . . 71.530000000000001 109.374 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.704 HG23 ' O ' ' B' ' 123' ' ' ILE . 4.9 tt -142.76 113.08 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.285 -0.884 . . . . 72.430000000000007 109.174 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.98 -116.95 5.49 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.262 -1.535 . . . . 51.229999999999997 109.262 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -106.33 3.38 27.49 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.481 -1.011 . . . . 74.200000000000003 108.987 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.511 ' HB2' ' CG2' ' B' ' 123' ' ' ILE . 0.3 OUTLIER -97.49 139.43 33.42 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.283 -1.006 . . . . 75.420000000000002 108.283 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 18.8 m -130.33 136.42 49.09 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.229 -0.919 . . . . 74.219999999999999 110.065 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 58.8 mt -128.96 142.9 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.533 -0.729 . . . . 60.329999999999998 109.464 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 2.0 m -122.44 126.84 26.06 Favored Pre-proline 0 N--CA 1.501 2.077 0 N-CA-C 109.144 -0.687 . . . . 72.310000000000002 109.144 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.71 -60.69 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.793 1.662 . . . . 75.129999999999995 112.998 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -53.9 -47.51 71.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.939 -1.1 . . . . 75.230000000000004 109.956 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -82.83 -9.77 59.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.121 -0.987 . . . . 72.430000000000007 110.063 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 48.51 75.41 0.14 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.977 -1.077 . . . . 75.129999999999995 109.178 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -149.17 130.56 14.73 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.189 -0.945 . . . . 73.219999999999999 109.54 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 7.5 tt -110.43 132.93 57.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.816 -0.809 . . . . 64.140000000000001 108.816 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 20.7 mm -111.26 127.42 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.407 -0.808 . . . . 71.219999999999999 109.407 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -142.81 141.54 31.66 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.983 -1.117 . . . . 64.219999999999999 107.983 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 68.3 tttt 55.93 13.61 1.16 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.335 -0.853 . . . . 72.019999999999996 109.705 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 85.68 5.24 84.49 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.384 -1.086 . . . . 74.319999999999993 110.384 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -96.09 141.81 29.03 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.13 -1.218 . . . . 75.340000000000003 109.04 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -96.24 123.76 39.99 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.311 -0.868 . . . . 71.230000000000004 109.339 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 36.1 t -134.74 132.83 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.38 -0.825 . . . . 70.430000000000007 109.153 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -90.58 157.58 17.43 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.032 -1.043 . . . . 72.430000000000007 109.516 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 6.0 m -137.69 140.66 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.408 -0.808 . . . . 72.129999999999995 109.817 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 22.9 pttt -176.64 89.54 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.408 -0.807 . . . . 72.019999999999996 109.593 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -157.15 -170.15 21.76 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.587 -1.405 . . . . 42.229999999999997 109.587 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 0.628 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 29.3 ttpt -78.69 -31.03 0.71 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.262 -1.14 . . . . 73.299999999999997 110.974 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 85.1 Cg_endo -89.61 -29.34 0.23 Allowed 'Trans proline' 0 N--CA 1.486 1.069 0 C-N-CA 122.03 1.82 . . . . 71.329999999999998 112.764 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -85.1 -13.31 50.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.0 -1.063 . . . . 74.230000000000004 109.964 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -53.04 -40.68 64.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.097 -1.002 . . . . 72.340000000000003 109.268 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.47 HG13 ' N ' ' B' ' 152' ' ' LEU . 12.5 p -69.24 -38.45 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 73.349999999999994 109.159 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.558 ' O ' HD13 ' B' ' 152' ' ' LEU . 0.3 OUTLIER -48.22 -44.11 32.76 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.57 -0.9 . . . . 55.240000000000002 108.57 179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.14 -41.0 71.05 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.107 -0.996 . . . . 70.010000000000005 110.254 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -58.39 -63.59 1.22 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.371 -0.831 . . . . 65.319999999999993 112.362 -177.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.609 HD12 ' N ' ' B' ' 156' ' ' ALA . 0.4 OUTLIER -70.23 -19.77 63.12 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.425 -1.422 . . . . 71.540000000000006 109.815 -178.628 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . 0.609 ' N ' HD12 ' B' ' 155' ' ' LEU . . . -58.96 -47.97 83.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.737 -1.227 . . . . 75.319999999999993 109.17 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.421 ' HG3' ' ND1' ' B' ' 158' ' ' HIS . 23.2 ptt180 -76.86 -35.8 57.23 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.034 -1.041 . . . . 73.319999999999993 110.42 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . 0.421 ' ND1' ' HG3' ' B' ' 157' ' ' ARG . 1.6 m-70 -81.08 22.42 0.64 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.688 -1.257 . . . . 74.140000000000001 109.961 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 24.8 ttm-85 -59.36 163.03 4.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.125 -0.985 . . . . 61.409999999999997 109.06 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' B' ' 214' ' ' PHE . 14.8 t0 63.54 44.65 5.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.205 -0.934 . . . . 72.099999999999994 109.164 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . 0.908 ' NE2' ' O ' ' B' ' 162' ' ' ILE . 15.5 tm0? -158.16 155.25 28.76 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.353 -0.842 . . . . 72.25 109.613 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 162' ' ' ILE . . . . . 0.908 ' O ' ' NE2' ' B' ' 161' ' ' GLN . 10.3 mm -81.63 105.39 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.522 -0.918 . . . . 72.310000000000002 108.522 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 93.4 t -101.54 129.25 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.274 -0.892 . . . . 64.209999999999994 109.754 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 9.8 t -85.93 164.31 17.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.401 -0.812 . . . . 74.219999999999999 109.528 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -68.78 -46.39 68.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -0.848 . . . . 65.310000000000002 109.855 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -60.25 -24.89 65.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 63.450000000000003 109.859 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -59.26 -43.73 92.45 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.965 -1.085 . . . . 72.400000000000006 109.082 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 20.7 mt -71.96 -58.11 3.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.394 -0.816 . . . . 72.319999999999993 109.247 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.598 ' C ' HD13 ' B' ' 169' ' ' LEU . 2.1 tm? -50.1 -58.29 5.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.014 -1.054 . . . . 73.340000000000003 108.653 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -51.7 -32.66 31.0 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 112.183 0.438 . . . . 72.099999999999994 112.183 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -94.61 -30.77 14.18 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.802 -1.187 . . . . 62.130000000000003 112.952 -177.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.7 -63.13 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.458 -1.401 . . . . 71.420000000000002 109.467 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 173' ' ' TRP . . . . . 0.523 ' O ' ' CE3' ' B' ' 173' ' ' TRP . 0.0 OUTLIER -66.47 143.22 57.22 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.518 -1.29 . . . . 72.230000000000004 107.518 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -170.7 -75.63 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.748 -1.22 . . . . 52.109999999999999 109.635 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -66.59 -53.4 29.4 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.226 -0.921 . . . . 73.040000000000006 109.33 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -81.95 85.45 1.7 Allowed 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 121.86 1.707 . . . . 74.129999999999995 111.876 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -83.51 -130.68 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.23 -0.919 . . . . 72.439999999999998 109.854 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 4.4 ttt 54.78 16.15 1.33 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.083 -1.011 . . . . 63.43 108.764 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 14.1 m -81.62 152.67 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.371 -0.83 . . . . 71.049999999999997 109.918 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -50.2 157.33 1.18 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 62.149999999999999 109.223 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_exo -39.02 -57.46 0.96 Allowed 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 122.167 1.912 . . . . 65.219999999999999 112.019 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -164.1 122.73 1.88 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.369 -0.832 . . . . 72.310000000000002 109.061 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 10.5 m -137.71 11.87 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.244 -0.91 . . . . 63.32 108.692 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.621 HD13 ' O ' ' B' ' 184' ' ' ILE . 0.2 OUTLIER -53.52 -30.64 18.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.639 -0.874 . . . . 75.030000000000001 108.639 179.749 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -57.33 -35.49 69.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.853 . . . . 64.109999999999999 108.994 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 3.7 t -75.32 -44.41 42.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.453 -0.78 . . . . 73.0 109.372 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -61.62 -48.46 80.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.251 -0.906 . . . . 61.119999999999997 110.459 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 188' ' ' ILE . . . . . 0.47 HG23 ' N ' ' B' ' 189' ' ' ASN . 9.4 tp -63.65 -42.12 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.778 -1.201 . . . . 72.430000000000007 110.285 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 189' ' ' ASN . . . . . 0.47 ' N ' HG23 ' B' ' 188' ' ' ILE . 53.3 t30 -63.59 -34.67 78.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.898 -1.126 . . . . 65.140000000000001 109.402 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -77.14 -50.36 13.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 63.240000000000002 110.15 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 82.0 mt -50.5 -46.37 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.178 -0.951 . . . . 74.030000000000001 109.438 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -62.68 -48.81 77.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.104 -0.997 . . . . 72.239999999999995 109.914 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 193' ' ' GLN . . . . . 0.45 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 25.6 mt-30 -63.67 -21.61 66.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.051 -1.031 . . . . 73.099999999999994 109.515 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . 0.431 ' O ' ' CD ' ' B' ' 198' ' ' PRO . 60.3 mttm -85.74 -38.47 18.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.206 -0.933 . . . . 72.109999999999999 110.405 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 88.8 mmm -91.79 13.2 18.96 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.888 -1.133 . . . . 44.329999999999998 109.99 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 196' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 50.8 p-10 -96.56 -20.98 17.96 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.06 -1.025 . . . . 71.209999999999994 109.744 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . 0.554 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 1.5 tttm -93.29 -45.54 0.31 Allowed Pre-proline 0 N--CA 1.496 1.86 0 O-C-N 121.116 -0.99 . . . . 75.209999999999994 109.098 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 198' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' B' ' 197' ' ' LYS . 18.8 Cg_exo -65.12 -60.47 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.163 1.909 . . . . 75.319999999999993 111.324 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 30.8 mt -63.68 -38.8 92.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 72.25 109.007 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 78.44 -17.95 6.01 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.35 -1.1 . . . . 64.530000000000001 110.35 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 29.0 mm -110.31 131.78 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.278 -1.13 . . . . 44.229999999999997 110.017 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 2.0 t -83.8 135.16 34.63 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.632 -0.877 . . . . 54.009999999999998 108.632 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 3.9 p -141.37 30.43 1.75 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.141 -0.974 . . . . 74.400000000000006 109.463 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 25.6 m -137.14 142.4 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.507 -0.745 . . . . 72.120000000000005 109.296 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -125.58 114.5 18.81 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.022 -0.732 . . . . 65.409999999999997 109.022 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.42 110.1 21.21 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.186 -0.946 . . . . 71.329999999999998 109.917 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.416 ' O ' HG13 ' B' ' 207' ' ' VAL . 10.6 p -112.45 131.09 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 107.896 -1.15 . . . . 63.5 107.896 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -47.92 -32.81 6.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.055 -1.028 . . . . 74.450000000000003 110.036 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 66.0 mtp180 -66.34 148.45 51.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.093 -1.004 . . . . 74.140000000000001 109.41 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 51.37 -115.11 0.85 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.095 -1.003 . . . . 74.430000000000007 109.636 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . -142.27 -92.73 0.18 Allowed Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.419 -1.473 . . . . 64.450000000000003 109.419 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -126.71 157.44 39.08 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.435 -1.038 . . . . 74.209999999999994 109.637 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -123.26 121.95 37.16 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.879 -0.785 . . . . 74.030000000000001 108.879 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' B' ' 160' ' ' ASP . 60.0 m-85 -101.49 123.92 46.32 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.369 -0.832 . . . . 74.340000000000003 110.372 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 1.9 p -147.59 164.38 33.64 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.117 -0.697 . . . . 64.329999999999998 109.117 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' B' ' 216' ' ' TYR . 0.0 OUTLIER -64.93 162.52 37.1 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.085 -1.01 . . . . 70.040000000000006 108.429 179.664 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -39.47 163.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.407 2.071 . . . . 65.109999999999999 112.267 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.426 ' C ' ' H ' ' B' ' 220' ' ' ALA . 19.4 mtmt -84.55 -63.7 0.24 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.121 -0.987 . . . . 73.150000000000006 109.723 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' B' ' 218' ' ' LYS . 67.3 Cg_endo -70.41 34.38 0.23 Allowed 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.167 1.912 . . . . 71.310000000000002 111.443 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . 0.426 ' H ' ' C ' ' B' ' 218' ' ' LYS . . . -47.77 142.77 4.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.375 -0.828 . . . . 75.450000000000003 109.87 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 93.8 m -86.25 127.72 34.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.455 -0.778 . . . . 72.219999999999999 109.114 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -64.51 136.02 56.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.268 -0.895 . . . . 54.530000000000001 109.786 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.022 -0.99 . . . . 71.129999999999995 109.379 179.545 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.9 ptm . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.454 -0.573 . . . . 65.120000000000005 109.454 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -139.31 144.51 38.34 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.356 -0.84 . . . . 72.329999999999998 109.44 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 66.1 t -112.64 131.03 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.705 -0.622 . . . . 71.420000000000002 109.492 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.75 HD12 ' N ' ' A' ' 5' ' ' LEU . 0.7 OUTLIER -110.21 125.59 53.23 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.96 -0.756 . . . . 65.120000000000005 108.96 179.861 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.75 ' N ' HD12 ' A' ' 4' ' ' LEU . 59.7 tp -120.95 102.94 8.68 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.629 -0.67 . . . . 62.43 109.244 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.503 ' CG1' HD11 ' A' ' 4' ' ' LEU . 38.8 mt -88.67 113.58 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.856 -1.153 . . . . 71.150000000000006 108.692 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' A' ' 13' ' ' GLY . 55.8 tt0 -154.66 121.44 5.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.198 -0.939 . . . . 75.340000000000003 109.485 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -64.36 -31.29 72.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.307 -0.871 . . . . 72.439999999999998 109.43 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -73.9 103.21 4.34 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.324 -0.86 . . . . 63.020000000000003 109.372 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.4 t -66.4 -25.17 66.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 72.340000000000003 109.814 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.54 -50.67 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.168 -0.958 . . . . 74.019999999999996 109.697 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.58 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.3 mm? -70.81 -41.95 70.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 71.430000000000007 109.398 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.513 ' N ' ' OE1' ' A' ' 7' ' ' GLU . . . -69.13 -24.85 75.81 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 108.475 -1.85 . . . . 61.32 108.475 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.51 -54.89 20.45 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 109.676 -1.37 . . . . 71.200000000000003 109.676 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -56.88 -45.75 82.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -1.104 . . . . 71.319999999999993 109.775 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.618 ' O ' HD23 ' A' ' 20' ' ' LEU . 35.9 mm -64.54 -48.78 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.819 -1.176 . . . . 63.229999999999997 108.878 179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.527 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 86.5 tt0 -45.6 -56.41 5.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -0.983 . . . . 51.109999999999999 109.854 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -85.61 3.83 39.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.124 -0.985 . . . . 73.340000000000003 109.128 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.59 -70.64 1.34 Allowed Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.778 -1.329 . . . . 62.149999999999999 109.778 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.618 HD23 ' O ' ' A' ' 16' ' ' ILE . 0.5 OUTLIER -58.75 -21.97 56.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.213 -1.169 . . . . 73.510000000000005 109.491 -179.826 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 93.4 m-20 -57.06 -37.84 72.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.253 -0.904 . . . . 74.25 109.634 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 88.7 t -53.97 -40.02 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.917 . . . . 70.040000000000006 109.462 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -64.46 -22.13 66.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.27 -0.894 . . . . 73.230000000000004 109.233 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.46 38.28 2.65 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 110.335 -1.106 . . . . 75.540000000000006 110.335 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -117.92 159.28 23.39 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.335 -1.097 . . . . 73.430000000000007 108.905 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.7 mmt -90.8 114.51 26.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.112 -0.992 . . . . 43.240000000000002 108.574 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.531 ' HB2' HD11 ' A' ' 20' ' ' LEU . . . -99.26 147.38 25.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.397 -0.814 . . . . 62.109999999999999 110.104 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 27' ' ' ALA . 82.4 m-20 -138.52 129.03 26.16 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.619 -0.882 . . . . 74.420000000000002 108.619 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.1 m -111.82 138.86 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.449 -0.782 . . . . 72.150000000000006 109.117 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 p -135.08 176.39 8.71 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.536 -0.728 . . . . 71.420000000000002 109.354 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -95.54 -108.16 0.14 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.163 -0.961 . . . . 72.329999999999998 110.017 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.2 p -78.84 167.15 21.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.899 . . . . 74.239999999999995 110.123 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.414 HD22 ' CG ' ' A' ' 58' ' ' PHE . 57.7 mt -50.82 -33.76 24.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.629 -0.669 . . . . 71.530000000000001 109.891 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -49.5 -52.27 30.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 74.230000000000004 109.624 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -61.95 -37.76 85.95 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.139 -0.976 . . . . 54.030000000000001 108.952 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.79 -39.17 90.0 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.278 -1.529 . . . . 61.409999999999997 109.278 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.57 -43.59 89.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.352 -1.087 . . . . 74.340000000000003 109.445 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -73.39 -38.03 65.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.153 -0.967 . . . . 75.329999999999998 109.504 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.0 tp -68.7 -44.99 72.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.267 -0.896 . . . . 74.329999999999998 109.771 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.448 ' C ' ' SD ' ' A' ' 40' ' ' MET . 3.4 ppp? -74.39 -17.13 60.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.087 -1.008 . . . . 70.319999999999993 109.687 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -55.43 -40.68 71.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.122 -0.986 . . . . 71.219999999999999 109.441 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.8 pt -88.08 -42.56 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.304 -0.872 . . . . 74.140000000000001 109.793 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 40' ' ' MET . 3.0 mpt_? -104.41 139.19 39.71 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.195 -0.94 . . . . 72.239999999999995 109.113 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.539 ' ND2' ' HZ1' ' A' ' 145' ' ' LYS . 16.8 t-20 -82.11 -24.36 35.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 75.420000000000002 109.782 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.485 ' O ' ' O ' ' A' ' 44' ' ' ASN . 57.2 m-85 57.4 136.65 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.684 0.754 . . . . 74.230000000000004 110.196 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -86.29 -50.45 6.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.948 -1.095 . . . . 72.040000000000006 108.945 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.508 HD13 ' C ' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -104.93 107.39 18.34 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.411 -0.959 . . . . 72.129999999999995 108.411 179.406 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.417 ' N ' HD13 ' A' ' 47' ' ' LEU . 2.4 m -106.19 104.79 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.127 -1.064 . . . . 72.340000000000003 108.127 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 10.8 ttt -113.69 144.51 42.81 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.545 0.688 . . . . 74.109999999999999 109.776 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.544 HG22 ' H ' ' A' ' 52' ' ' ASP . 1.4 p -139.53 136.02 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.596 0.713 . . . . 61.119999999999997 109.567 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.7 m -104.79 10.33 34.59 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.68 -0.638 . . . . 73.109999999999999 109.402 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.544 ' H ' HG22 ' A' ' 50' ' ' VAL . 69.8 m-20 -77.0 155.58 32.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 52.549999999999997 109.61 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.47 ' C ' ' H ' ' A' ' 55' ' ' ALA . 27.3 mtmm -76.38 -39.22 54.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.182 -0.949 . . . . 44.219999999999999 109.84 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -73.49 18.09 0.13 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.141 -0.974 . . . . 70.439999999999998 109.653 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.47 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -59.96 -35.56 75.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 64.140000000000001 110.012 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.4 ' HA ' HE22 ' A' ' 89' ' ' GLN . 23.7 mt -43.83 -52.66 6.58 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.449 -0.782 . . . . 44.140000000000001 110.251 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.2 m -65.9 -34.63 78.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.872 -1.142 . . . . 55.229999999999997 108.942 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.444 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 46.5 t80 -65.89 -62.9 1.24 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.488 -0.757 . . . . 74.439999999999998 110.079 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.5 m -48.44 -34.19 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.739 -1.226 . . . . 74.030000000000001 109.901 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.2 t -59.0 -55.24 37.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.128 -0.982 . . . . 64.299999999999997 109.692 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -65.59 -27.36 68.36 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.111 -0.993 . . . . 64.439999999999998 110.189 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.444 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 31.6 mm -66.25 -49.56 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.75 -1.219 . . . . 63.210000000000001 110.369 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.423 ' HG3' ' HZ2' ' A' ' 63' ' ' LYS . 26.6 mmtp -63.62 -44.69 93.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.994 -1.066 . . . . 74.420000000000002 110.921 -178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -71.02 -39.52 72.29 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.676 -1.265 . . . . 70.319999999999993 110.161 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.482 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 66.4 mttm -80.8 -19.49 44.64 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.116 -0.99 . . . . 75.219999999999999 109.675 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.573 ' O ' HG22 ' A' ' 69' ' ' ILE . 93.1 m-70 -155.68 68.05 0.64 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 74.129999999999995 109.391 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.4 m -59.21 -30.72 68.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.249 -0.907 . . . . 73.239999999999995 110.0 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.8 t -81.39 49.04 1.23 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.174 -0.954 . . . . 61.009999999999998 110.28 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 66' ' ' HIS . 12.3 tt -143.4 157.8 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.096 -1.002 . . . . 71.329999999999998 109.307 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.4 t -91.75 141.53 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.001 -1.062 . . . . 72.129999999999995 108.81 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.2 t -127.52 121.99 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.297 -0.877 . . . . 54.210000000000001 109.34 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.649 ' HG ' HD11 ' A' ' 95' ' ' ILE . 0.5 OUTLIER -118.61 103.15 9.43 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.336 -0.987 . . . . 50.240000000000002 108.336 -179.544 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.48 ' O ' HG13 ' A' ' 73' ' ' VAL . 8.0 p -98.64 128.5 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.396 -0.815 . . . . 74.409999999999997 109.109 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.5 p -89.31 175.33 7.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.06 -1.025 . . . . 72.310000000000002 109.489 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.481 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 22.8 t -164.6 118.95 1.38 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.158 -0.964 . . . . 64.540000000000006 110.265 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -70.5 -25.94 63.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.558 -0.714 . . . . 74.129999999999995 109.599 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 79' ' ' THR . 13.2 t-20 -112.64 68.9 1.03 Allowed Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.599 -0.688 . . . . 73.340000000000003 109.614 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.78 82.24 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.768 1.645 . . . . 63.219999999999999 111.777 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 77' ' ' ASN . 24.1 m -103.61 151.69 22.64 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.111 -0.7 . . . . 62.530000000000001 109.111 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -36.61 83.8 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.249 -0.907 . . . . 73.439999999999998 109.471 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.02 -42.15 84.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.158 -0.964 . . . . 71.420000000000002 109.366 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -74.14 -30.35 62.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 73.430000000000007 109.607 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.522 ' OE1' ' CD1' ' A' ' 94' ' ' TYR . 46.8 tp10 -60.59 -54.76 41.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.958 . . . . 74.219999999999999 109.587 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.6 t -62.64 -41.72 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.249 -0.907 . . . . 73.200000000000003 109.421 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.518 ' NE2' ' OE1' ' A' ' 89' ' ' GLN . 47.7 t60 -64.41 -33.33 75.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.248 -0.908 . . . . 53.329999999999998 109.589 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.57 -45.18 91.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.217 -0.927 . . . . 64.109999999999999 109.747 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.532 ' CE1' ' HB1' ' B' ' 111' ' ' ALA . 73.4 t80 -77.24 -29.94 54.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.037 -1.039 . . . . 74.340000000000003 108.572 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -60.68 -50.74 72.28 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.384 -0.822 . . . . 74.420000000000002 108.885 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.518 ' OE1' ' NE2' ' A' ' 85' ' ' HIS . 28.2 mt-30 -63.24 -61.64 2.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.583 -0.698 . . . . 74.239999999999995 109.578 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 154.79 59.01 0.01 OUTLIER Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.796 -1.192 . . . . 61.509999999999998 110.266 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -108.72 134.61 51.21 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.254 -1.145 . . . . 55.329999999999998 108.978 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -75.4 -32.14 60.66 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.005 -1.059 . . . . 73.420000000000002 109.059 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.513 ' OD2' ' NE ' ' A' ' 108' ' ' ARG . 42.2 t0 -152.34 157.45 41.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.361 -0.837 . . . . 75.040000000000006 109.44 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.522 ' CD1' ' OE1' ' A' ' 83' ' ' GLU . 62.0 t80 -131.62 113.26 13.39 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.579 -0.897 . . . . 71.329999999999998 108.579 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.872 ' H ' HD12 ' A' ' 95' ' ' ILE . 0.1 OUTLIER -117.26 152.08 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-O 121.646 0.736 . . . . 71.129999999999995 110.444 -178.192 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.93 138.72 48.3 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.27 -1.011 . . . . 64.319999999999993 108.27 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.684 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -60.71 -54.98 49.37 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.98 -1.075 . . . . 62.200000000000003 111.636 -179.192 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.4 Cg_endo -41.4 -10.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 120.749 0.966 . . . . 73.109999999999999 112.923 -175.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.684 ' N ' ' O ' ' A' ' 97' ' ' LYS . 57.4 m-85 59.42 100.31 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.752 -0.593 . . . . 65.219999999999999 110.076 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 19.1 ttm-85 -55.93 -40.23 72.83 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.082 -1.081 . . . . 72.349999999999994 108.082 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.7 t -173.79 128.82 0.4 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.796 -0.816 . . . . 71.319999999999993 108.796 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.405 ' H ' HG13 ' A' ' 102' ' ' ILE . 51.3 mt -51.81 -40.54 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -0.941 . . . . 75.430000000000007 109.155 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.496 ' O ' ' HB2' ' A' ' 107' ' ' ALA . 2.7 mptp? -64.42 -35.58 81.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.154 -0.966 . . . . 71.409999999999997 109.38 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.03 -60.9 2.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.228 -0.92 . . . . 63.240000000000002 109.689 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.635 ' CD1' HH22 ' A' ' 108' ' ' ARG . 17.9 tp -55.9 -51.99 65.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 73.219999999999999 109.657 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 76.0 t -60.23 -42.4 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.062 -1.023 . . . . 60.109999999999999 109.383 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 103' ' ' LYS . . . -53.3 -30.08 36.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.177 -0.952 . . . . 70.420000000000002 109.115 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.635 HH22 ' CD1' ' A' ' 105' ' ' LEU . 21.1 ttp-105 -83.14 -28.71 29.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 74.409999999999997 109.981 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 80.3 mt -74.74 -40.03 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.986 -1.071 . . . . 62.539999999999999 108.72 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 114' ' ' ARG . 24.8 pt-20 -72.26 -37.07 69.16 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.439 -0.904 . . . . 74.340000000000003 108.957 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -57.3 -45.4 84.2 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.343 -0.848 . . . . 73.319999999999993 109.15 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 68.5 ttt-85 -62.73 -41.5 99.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.27 -0.894 . . . . 52.409999999999997 109.387 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 42.6 mt -130.07 65.8 1.5 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.477 -0.764 . . . . 65.239999999999995 109.248 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' A' ' 110' ' ' GLU . 81.5 mtp180 -60.8 -29.85 69.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 64.450000000000003 109.429 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.427 ' CG ' ' O ' ' A' ' 114' ' ' ARG . 78.9 m-85 -156.64 78.88 0.93 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 74.430000000000007 109.567 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 33.4 p-90 -58.83 134.1 56.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.143 -0.973 . . . . 74.420000000000002 109.534 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 154.2 91.57 0.08 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.434 -1.466 . . . . 75.040000000000006 109.434 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.7 m -152.39 168.27 26.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.261 -1.14 . . . . 61.140000000000001 109.679 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -154.57 -179.61 8.14 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 119.823 -0.751 . . . . 65.239999999999995 109.117 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.9 t -139.69 -38.75 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.441 -0.787 . . . . 73.109999999999999 109.159 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.2 mm -106.32 131.66 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.245 -0.909 . . . . 72.239999999999995 109.208 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -128.32 99.36 5.39 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.407 -0.96 . . . . 72.340000000000003 108.407 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.918 HG13 ' NE ' ' A' ' 159' ' ' ARG . 26.9 mm -115.82 122.23 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.518 -0.739 . . . . 71.439999999999998 109.233 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.86 -160.38 0.29 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.789 -1.325 . . . . 73.400000000000006 109.789 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -66.67 -3.99 7.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -1.184 . . . . 74.450000000000003 109.666 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.16 134.99 34.77 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.091 -1.006 . . . . 54.210000000000001 109.101 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 27.0 m -119.89 131.4 55.23 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.786 -0.82 . . . . 54.5 108.786 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 96.4 mt -118.99 122.78 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-O 121.685 0.755 . . . . 45.149999999999999 109.125 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 17.7 m -107.79 109.12 62.16 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.732 -0.84 . . . . 71.109999999999999 108.732 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.589 ' CB ' ' HE ' ' A' ' 157' ' ' ARG . 94.9 Cg_endo -80.08 -29.95 2.4 Favored 'Trans proline' 0 N--CA 1.492 1.382 0 C-N-CA 121.967 1.778 . . . . 65.409999999999997 112.617 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -52.73 -69.16 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.113 -0.992 . . . . 63.32 109.258 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -82.3 4.52 23.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.361 -0.837 . . . . 72.519999999999996 109.05 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 54.19 81.25 0.1 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.491 -0.756 . . . . 75.329999999999998 109.456 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -149.43 136.0 19.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.244 -0.91 . . . . 71.230000000000004 109.553 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 11.6 tt -114.24 133.07 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.48 -0.763 . . . . 74.019999999999996 108.973 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 41.4 mt -124.74 115.43 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.847 -0.797 . . . . 60.229999999999997 108.847 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -130.61 134.66 47.17 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.456 -0.777 . . . . 62.32 109.762 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.462 ' O ' ' NH1' ' A' ' 140' ' ' ARG . 61.3 mttm 55.3 23.72 5.84 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.436 -0.79 . . . . 75.400000000000006 110.792 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 86.66 1.29 85.55 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.364 -1.094 . . . . 72.239999999999995 110.364 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.462 ' NH1' ' O ' ' A' ' 138' ' ' LYS . 11.1 mpt_? -88.94 126.55 35.45 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.06 -1.259 . . . . 71.219999999999999 108.838 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -100.01 127.36 46.23 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.398 -0.814 . . . . 71.420000000000002 109.86 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 24.0 t -137.65 136.2 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.366 -0.834 . . . . 53.020000000000003 109.491 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.438 ' O ' HG13 ' A' ' 144' ' ' VAL . 14.5 pt-20 -97.94 142.69 29.36 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.34 -0.85 . . . . 60.450000000000003 109.532 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 143' ' ' GLU . 12.2 m -155.53 154.74 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.161 -0.962 . . . . 74.439999999999998 109.76 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.539 ' HZ1' ' ND2' ' A' ' 44' ' ' ASN . 20.0 pttt 178.27 115.28 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.282 -0.886 . . . . 65.150000000000006 109.137 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.01 176.18 37.74 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.689 -1.365 . . . . 73.340000000000003 109.689 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.583 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 0.0 OUTLIER -60.09 -44.32 96.23 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.4 -1.059 . . . . 72.219999999999999 109.254 -179.651 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 39.5 Cg_exo -59.57 -36.2 93.44 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 122.374 2.05 . . . . 65.230000000000004 112.268 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -92.57 -14.71 27.89 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.258 -0.901 . . . . 60.109999999999999 109.63 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -54.93 -40.07 69.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.885 . . . . 64.209999999999994 109.865 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.464 HG13 ' N ' ' A' ' 152' ' ' LEU . 10.6 p -61.12 -37.31 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.967 -1.083 . . . . 72.019999999999996 109.55 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.464 ' N ' HG13 ' A' ' 151' ' ' VAL . 7.2 tp -62.9 -51.32 67.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.494 -0.754 . . . . 73.310000000000002 110.405 -179.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.3 p -74.71 -29.02 61.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.098 -1.001 . . . . 74.310000000000002 110.057 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -57.32 -56.74 17.89 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.833 -1.167 . . . . 74.310000000000002 109.672 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.8 pp -72.15 -27.28 62.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.395 -0.816 . . . . 75.340000000000003 109.732 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.57 -52.88 58.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.961 -1.087 . . . . 62.140000000000001 108.72 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.589 ' HE ' ' CB ' ' A' ' 130' ' ' PRO . 52.7 mtt85 -65.18 -43.83 90.42 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.663 -0.866 . . . . 61.030000000000001 108.663 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.64 ' ND1' ' N ' ' A' ' 158' ' ' HIS . 0.2 OUTLIER -86.55 30.84 0.69 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.53 -0.731 . . . . 74.120000000000005 110.245 -179.158 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.918 ' NE ' HG13 ' A' ' 123' ' ' ILE . 57.1 ttm-85 -51.46 156.79 1.17 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.983 -1.073 . . . . 71.129999999999995 108.419 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 1.04 ' HB2' ' HE1' ' A' ' 216' ' ' TYR . 26.4 t70 57.12 79.02 0.2 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.248 -0.908 . . . . 75.450000000000003 108.773 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -171.76 154.08 3.53 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.472 -0.768 . . . . 73.409999999999997 109.714 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 15.7 mt -86.7 115.85 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 74.409999999999997 109.109 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 90.5 t -113.7 120.68 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.374 -0.829 . . . . 72.310000000000002 108.867 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 40.4 t -85.72 163.61 18.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.828 . . . . 74.120000000000005 109.74 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -60.44 -47.82 84.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.519 -0.738 . . . . 70.430000000000007 109.794 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -58.61 -36.53 74.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -0.928 . . . . 73.519999999999996 109.337 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 60.9 tp60 -55.15 -44.55 75.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.197 -0.939 . . . . 74.519999999999996 108.866 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.93 -37.17 81.38 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.22 -0.925 . . . . 72.310000000000002 108.563 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.574 HD23 ' C ' ' A' ' 169' ' ' LEU . 4.4 tt -66.53 -60.15 2.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.418 -0.801 . . . . 53.329999999999998 109.296 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.75 -15.49 61.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.837 -0.539 . . . . 62.439999999999998 110.857 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -87.1 -49.32 7.39 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.913 -1.117 . . . . 60.210000000000001 111.075 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.622 ' N ' HD12 ' A' ' 172' ' ' ILE . 2.3 mp -98.99 -53.55 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.023 -1.048 . . . . 75.319999999999993 110.453 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 23.1 m-90 -89.02 35.54 0.79 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.896 -1.127 . . . . 73.140000000000001 109.683 -178.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -50.11 -34.39 21.86 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.351 -0.843 . . . . 73.239999999999995 108.818 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' A' ' 175' ' ' GLU . 14.6 mp0 -83.1 154.11 66.88 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 108.672 -0.862 . . . . 44.43 108.672 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.508 ' O ' ' N ' ' A' ' 178' ' ' MET . 89.5 Cg_exo -38.5 -57.37 0.89 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.075 1.85 . . . . 72.510000000000005 111.995 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 45.34 16.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.305 -0.872 . . . . 63.240000000000002 109.839 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.508 ' N ' ' O ' ' A' ' 176' ' ' PRO . 12.6 ttt 47.91 71.67 0.32 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.334 -0.854 . . . . 73.5 109.868 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 28.4 m -123.06 140.09 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.487 -0.758 . . . . 65.219999999999999 108.969 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 49.8 p -85.43 146.31 44.26 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.188 -0.945 . . . . 71.420000000000002 109.419 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -41.88 -56.58 1.87 Allowed 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 122.06 1.84 . . . . 41.219999999999999 112.486 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -88.98 86.1 6.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.243 -0.91 . . . . 64.540000000000006 109.913 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 12.0 p -141.75 -23.99 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.307 -0.871 . . . . 74.019999999999996 109.884 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.672 ' H ' HD12 ' A' ' 184' ' ' ILE . 2.4 mp -56.42 -29.65 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 72.329999999999998 109.854 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -58.85 -39.78 82.33 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.07 -1.019 . . . . 74.400000000000006 109.332 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.424 ' H ' HG23 ' A' ' 186' ' ' VAL . 1.5 t -73.27 -46.85 48.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.508 -0.745 . . . . 70.420000000000002 110.071 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.74 86.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 52.109999999999999 110.545 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.531 ' O ' HD13 ' A' ' 188' ' ' ILE . 0.2 OUTLIER -61.48 -42.96 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.915 -1.116 . . . . 71.400000000000006 109.95 -178.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -62.67 -43.1 99.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.83 -1.169 . . . . 73.439999999999998 109.443 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -66.65 -46.31 76.16 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.87 . . . . 71.420000000000002 109.794 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 81.9 mt -57.11 -38.17 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.179 -0.951 . . . . 61.549999999999997 109.435 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 36.6 mtp180 -61.76 -42.37 98.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.142 -0.974 . . . . 63.340000000000003 109.333 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.427 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 49.2 mt-30 -76.45 -30.13 57.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.475 -0.766 . . . . 61.240000000000002 110.455 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -86.51 -15.6 39.53 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.161 -0.962 . . . . 75.129999999999995 110.243 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 27.1 ttt -93.44 -39.16 11.05 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.014 -1.054 . . . . 74.019999999999996 110.622 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 193' ' ' GLN . 28.2 p-10 -62.65 -32.28 73.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.192 -0.942 . . . . 74.019999999999996 110.712 -178.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.427 ' N ' ' OD1' ' A' ' 196' ' ' ASP . 51.8 mttt -65.08 -64.77 2.35 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.948 -1.095 . . . . 75.430000000000007 110.209 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.418 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 21.6 Cg_endo -60.04 -48.94 10.78 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 121.906 1.738 . . . . 72.319999999999993 111.738 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.511 HD13 ' O ' ' A' ' 199' ' ' LEU . 0.2 OUTLIER -69.2 -41.48 77.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 74.540000000000006 108.748 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 85.95 -46.61 3.65 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.915 -1.274 . . . . 61.509999999999998 109.915 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 30.3 mt -93.64 133.44 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.239 -1.154 . . . . 61.219999999999999 109.642 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 70.7 m -75.87 135.98 40.15 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.364 -0.976 . . . . 72.0 108.364 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 19.6 p -144.83 45.91 1.36 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.982 -1.074 . . . . 74.439999999999998 110.463 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.8 m -148.99 128.58 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.007 -1.058 . . . . 64.349999999999994 108.925 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.493 ' N ' ' CD ' ' A' ' 205' ' ' GLU . 7.6 mp0 -91.44 120.54 32.37 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.096 -1.003 . . . . 71.409999999999997 109.475 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 5.9 p -93.15 111.97 23.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.257 -0.902 . . . . 73.519999999999996 109.291 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.79 128.61 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.241 -0.912 . . . . 71.019999999999996 108.989 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -56.08 -43.66 78.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.093 -1.004 . . . . 72.120000000000005 109.49 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.571 ' O ' ' N ' ' A' ' 211' ' ' GLY . 77.5 mtt180 -57.51 146.48 29.75 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.158 -0.964 . . . . 64.409999999999997 108.533 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 56.46 -79.08 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 109.087 -0.708 . . . . 71.540000000000006 109.087 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 209' ' ' ARG . . . 168.01 -112.17 0.47 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.239 -1.544 . . . . 72.030000000000001 109.239 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -116.38 123.63 48.07 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.56 -0.964 . . . . 75.540000000000006 109.18 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -107.18 130.11 54.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.696 -0.627 . . . . 75.310000000000002 109.677 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.856 ' CE1' ' HG3' ' A' ' 159' ' ' ARG . 12.2 t80 -89.8 139.53 30.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.945 -1.097 . . . . 75.409999999999997 108.812 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 99.6 m -152.66 150.67 29.72 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.999 -1.112 . . . . 74.140000000000001 107.999 179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . 1.04 ' HE1' ' HB2' ' A' ' 160' ' ' ASP . 0.0 OUTLIER -59.86 151.13 65.51 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 120.902 -1.124 . . . . 75.319999999999993 108.755 -179.454 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -58.3 -81.7 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.295 1.997 . . . . 73.109999999999999 111.907 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.568 ' H ' ' CD ' ' A' ' 219' ' ' PRO . 4.7 tmtm? -170.34 -44.92 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.982 -1.074 . . . . 75.25 109.728 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.568 ' CD ' ' H ' ' A' ' 218' ' ' LYS . 18.9 Cg_exo -66.36 -9.86 25.46 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.212 1.941 . . . . 75.099999999999994 111.794 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -54.54 100.44 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.243 -0.911 . . . . 71.140000000000001 108.936 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 25.6 m -64.21 126.1 26.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.451 -0.781 . . . . 71.129999999999995 109.807 -179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.428 ' O ' ' OXT' ' A' ' 223' ' ' GLU . 74.0 tt0 -90.7 124.65 35.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.314 -0.866 . . . . 75.349999999999994 108.672 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.428 ' OXT' ' O ' ' A' ' 222' ' ' GLU . 38.6 tp10 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.092 -0.956 . . . . 73.409999999999997 109.499 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ptt? . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.38 -0.6 . . . . 71.140000000000001 109.38 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.605 ' NH1' ' NE ' ' B' ' 43' ' ' ARG . 66.4 mtp180 -126.59 142.07 51.66 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.568 -0.708 . . . . 73.230000000000004 109.386 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 92.8 t -118.79 130.28 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 CA-C-O 121.608 0.718 . . . . 72.239999999999995 109.77 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.46 HD11 ' CG1' ' B' ' 6' ' ' ILE . 4.1 tp -98.5 116.73 31.37 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.933 -0.766 . . . . 54.329999999999998 108.933 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.637 HD22 ' HG3' ' B' ' 49' ' ' MET . 0.2 OUTLIER -115.04 109.14 17.62 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.183 -1.043 . . . . 74.349999999999994 108.183 179.508 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.677 HD12 ' HB ' ' B' ' 50' ' ' VAL . 77.0 mt -101.31 99.41 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.926 -1.109 . . . . 42.549999999999997 109.021 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -145.18 130.38 18.53 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.36 -0.838 . . . . 74.519999999999996 109.223 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.41 -33.69 76.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.347 -0.846 . . . . 62.549999999999997 109.67 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -74.14 105.56 5.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 73.109999999999999 109.457 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 23.4 t -68.15 -25.84 65.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.882 . . . . 65.540000000000006 109.758 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 89.0 t -62.76 -48.59 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.189 -0.944 . . . . 75.549999999999997 109.84 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.415 ' CD1' ' NZ ' ' B' ' 97' ' ' LYS . 28.5 mt -68.22 -25.95 65.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 70.140000000000001 109.585 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.39 -34.58 25.5 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.919 -1.672 . . . . 75.400000000000006 108.919 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.55 -46.8 83.05 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.847 -1.301 . . . . 65.439999999999998 109.847 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -67.25 -43.83 80.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.057 -1.261 . . . . 60.210000000000001 109.271 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 91.1 mt -63.51 -38.47 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.957 -1.089 . . . . 75.150000000000006 108.57 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -60.69 -42.98 98.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.34 -0.85 . . . . 73.010000000000005 109.376 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -86.79 -0.09 55.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.147 -0.971 . . . . 74.299999999999997 109.161 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.47 -56.49 2.25 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.489 -1.444 . . . . 70.540000000000006 109.489 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.402 HD23 ' H ' ' B' ' 21' ' ' ASN . 1.5 pt? -72.13 -22.95 61.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -1.12 . . . . 71.340000000000003 109.613 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . 0.402 ' H ' HD23 ' B' ' 20' ' ' LEU . 2.3 m120 -52.56 -35.19 53.24 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.096 -1.002 . . . . 64.409999999999997 109.205 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 59.1 t -54.94 -46.12 76.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.244 -0.91 . . . . 74.230000000000004 108.842 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.472 ' NZ ' HG11 ' B' ' 106' ' ' VAL . 35.1 mmtm -59.72 -53.36 58.88 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.884 -0.784 . . . . 63.420000000000002 108.884 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.27 36.77 0.23 Allowed Glycine 0 N--CA 1.5 2.901 0 N-CA-C 110.088 -1.205 . . . . 53.43 110.088 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -119.16 160.47 22.05 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.455 -1.027 . . . . 71.120000000000005 109.309 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 26.3 mtt -105.05 141.94 35.73 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.659 -0.867 . . . . 75.239999999999995 108.659 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.92 150.14 44.19 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.227 -0.921 . . . . 72.120000000000005 109.878 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' B' ' 28' ' ' ASP . 42.0 p30 -131.78 157.57 43.5 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.98 -0.748 . . . . 72.310000000000002 108.98 179.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.38 137.7 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.475 -0.765 . . . . 64.430000000000007 109.508 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 5.6 p -136.2 170.3 16.24 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.005 -0.739 . . . . 65.409999999999997 109.005 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -92.18 -107.32 0.11 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.199 -0.938 . . . . 71.019999999999996 109.935 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 60.2 p -78.54 169.67 17.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.225 -0.922 . . . . 51.109999999999999 110.189 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 56.4 mt -53.36 -33.16 52.55 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.601 -0.687 . . . . 71.239999999999995 109.815 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -51.26 -48.3 62.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.151 -0.968 . . . . 74.319999999999993 109.745 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -65.76 -43.79 87.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 73.030000000000001 109.409 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.02 -42.13 94.82 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.558 -1.417 . . . . 30.210000000000001 109.558 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -65.31 -41.3 94.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -1.122 . . . . 74.420000000000002 109.438 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . 0.452 ' O ' ' OD1' ' B' ' 41' ' ' ASP . 63.5 t80 -76.36 -21.3 56.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 74.420000000000002 109.892 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 12.5 tp -88.64 -36.47 16.24 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.078 -1.014 . . . . 75.409999999999997 109.875 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.3 ppp? -80.13 -29.09 38.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.175 -0.953 . . . . 60.409999999999997 110.474 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' B' ' 42' ' ' ILE . 30.4 p-10 -54.24 -32.27 55.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.966 -1.084 . . . . 53.229999999999997 109.758 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.547 ' N ' ' OD1' ' B' ' 41' ' ' ASP . 12.4 pt -84.39 -35.76 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.18 -0.95 . . . . 71.230000000000004 109.811 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.605 ' NE ' ' NH1' ' B' ' 2' ' ' ARG . 76.0 mtp180 -131.44 141.41 49.81 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.398 -0.813 . . . . 72.219999999999999 109.481 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -97.07 134.91 39.79 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.196 -0.94 . . . . 63.539999999999999 109.437 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -101.51 161.62 13.5 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.351 -0.843 . . . . 64.349999999999994 109.471 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -90.68 -42.51 10.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.178 -0.951 . . . . 62.219999999999999 109.236 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.507 ' C ' HD13 ' B' ' 47' ' ' LEU . 0.9 OUTLIER -104.3 109.78 21.75 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.782 -0.822 . . . . 73.120000000000005 108.782 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.452 ' N ' HD13 ' B' ' 47' ' ' LEU . 66.4 t -92.59 99.11 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.252 -0.905 . . . . 65.109999999999999 108.611 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.637 ' HG3' HD22 ' B' ' 5' ' ' LEU . 3.5 tpp -113.75 129.77 56.53 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.643 -0.66 . . . . 73.439999999999998 109.574 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.677 ' HB ' HD12 ' B' ' 6' ' ' ILE . 0.3 OUTLIER -147.8 126.51 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.506 -0.746 . . . . 34.5 109.223 179.302 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . . . . . . . . . 4.0 m -91.22 14.42 14.37 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.55 -0.718 . . . . 73.209999999999994 109.58 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.538 ' H ' HG22 ' B' ' 50' ' ' VAL . 57.5 m-20 -75.92 145.36 40.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.152 -0.967 . . . . 70.409999999999997 109.485 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -77.42 -36.57 53.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 65.0 109.931 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -77.07 12.33 1.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -0.985 . . . . 75.209999999999994 109.492 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.72 -26.17 68.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.347 -0.846 . . . . 55.329999999999998 110.099 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.48 ' N ' HD12 ' B' ' 56' ' ' LEU . 11.1 mp -45.89 -37.08 5.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.159 -0.963 . . . . 63.140000000000001 109.96 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 83.9 p -74.92 -46.22 37.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.031 -1.043 . . . . 63.5 109.901 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . 0.6 ' CE2' HD11 ' B' ' 62' ' ' ILE . 63.8 t80 -64.83 -50.77 65.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 72.329999999999998 110.11 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.433 HG23 ' N ' ' B' ' 60' ' ' SER . 13.6 m -59.41 -36.7 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.755 -1.215 . . . . 74.540000000000006 109.764 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.433 ' N ' HG23 ' B' ' 59' ' ' VAL . 33.2 t -57.48 -49.14 77.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 71.239999999999995 109.791 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -71.35 -27.7 63.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.031 -1.043 . . . . 74.310000000000002 109.88 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.6 HD11 ' CE2' ' B' ' 58' ' ' PHE . 4.8 mm -61.42 -51.25 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.839 -1.163 . . . . 72.140000000000001 109.261 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt -64.28 -40.51 96.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.015 . . . . 73.319999999999993 109.326 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -68.43 -41.69 79.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.235 -0.915 . . . . 73.120000000000005 108.54 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -81.67 -76.98 0.23 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.371 -0.831 . . . . 72.439999999999998 109.224 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.528 ' O ' HG22 ' B' ' 69' ' ' ILE . 73.1 m-70 -92.94 91.62 7.48 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.211 -0.93 . . . . 63.310000000000002 108.97 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 80.6 p -77.29 -30.49 54.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.218 -0.926 . . . . 73.099999999999994 110.067 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 53.1 p -82.71 54.02 2.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.124 -0.985 . . . . 71.530000000000001 109.702 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.528 HG22 ' O ' ' B' ' 66' ' ' HIS . 16.7 tt -146.81 159.69 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.198 -0.939 . . . . 74.400000000000006 109.326 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 46.8 t -97.88 154.34 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.113 -0.992 . . . . 75.120000000000005 109.093 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 12.7 t -143.56 121.54 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.041 -1.037 . . . . 73.200000000000003 109.795 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.636 ' HG ' HD11 ' B' ' 95' ' ' ILE . 3.2 mp -121.77 99.67 6.58 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.463 -0.94 . . . . 73.340000000000003 108.463 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.511 ' O ' HG13 ' B' ' 73' ' ' VAL . 12.2 p -90.86 126.52 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 73.5 108.638 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.72 171.72 8.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.012 -1.055 . . . . 64.340000000000003 108.813 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.428 ' OG ' ' OE1' ' B' ' 82' ' ' GLU . 8.0 t -162.01 119.27 2.14 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.932 -1.105 . . . . 74.530000000000001 110.159 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.5 p30 -67.33 -1.09 4.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 64.5 109.389 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . 0.454 ' O ' ' N ' ' B' ' 79' ' ' THR . 11.9 p-10 -133.98 77.13 63.03 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 108.912 -0.773 . . . . 74.25 108.912 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.5 75.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.676 2.251 . . . . 74.430000000000007 112.033 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.454 ' N ' ' O ' ' B' ' 77' ' ' ASN . 75.1 p -98.74 148.28 24.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.128 -0.983 . . . . 73.120000000000005 109.197 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -32.62 74.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.91 . . . . 71.010000000000005 109.442 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.37 -33.19 74.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.008 . . . . 63.200000000000003 109.093 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . 0.428 ' OE1' ' OG ' ' B' ' 75' ' ' SER . 63.1 tt0 -73.12 -38.06 66.45 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.314 -0.866 . . . . 73.219999999999999 109.304 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' B' ' 83' ' ' GLU . 0.4 OUTLIER -57.62 -52.07 66.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.265 -0.897 . . . . 74.299999999999997 109.351 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 14.4 m -59.94 -38.96 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -0.969 . . . . 73.310000000000002 109.405 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -67.7 -35.42 78.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.118 -0.989 . . . . 73.239999999999995 109.303 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -65.56 -36.85 84.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 55.329999999999998 109.833 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -83.81 -38.64 21.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.045 -1.034 . . . . 74.140000000000001 109.238 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -68.22 -44.19 76.31 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.303 -0.873 . . . . 64.040000000000006 109.485 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -66.66 -48.91 67.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 72.349999999999994 109.595 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 141.65 75.45 0.04 OUTLIER Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.859 -1.296 . . . . 65.200000000000003 109.859 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -136.6 138.88 41.67 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.327 -1.102 . . . . 52.229999999999997 109.136 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.43 -44.25 52.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.21 -0.931 . . . . 73.319999999999993 109.348 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -153.81 166.1 33.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.352 -0.842 . . . . 72.219999999999999 109.531 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.527 ' CD1' ' O ' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -136.85 139.51 41.74 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.012 -0.736 . . . . 64.420000000000002 109.012 -178.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.806 ' N ' HD12 ' B' ' 95' ' ' ILE . 0.5 OUTLIER -132.45 151.43 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.512 -0.743 . . . . 72.230000000000004 110.25 -179.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.5 124.65 23.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.814 -1.179 . . . . 25.239999999999998 108.101 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.667 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -47.0 -55.25 15.86 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.985 -1.072 . . . . 64.319999999999993 111.103 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 4.2 Cg_endo -41.93 -10.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.124 0 C-N-CA 120.853 1.035 . . . . 63.329999999999998 112.734 -177.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . 0.667 ' N ' ' O ' ' B' ' 97' ' ' LYS . 51.7 m-85 61.05 128.29 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.353 -0.61 . . . . 75.129999999999995 109.353 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -72.34 -29.66 64.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.961 -1.087 . . . . 74.230000000000004 109.42 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . 0.719 ' O ' ' N ' ' B' ' 103' ' ' LYS . 30.2 t -175.08 31.6 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.944 -1.097 . . . . 63.340000000000003 111.115 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 36.8 mm 52.34 -70.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.48 -0.763 . . . . 74.439999999999998 110.129 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' B' ' 101' ' ' SER . 67.2 mmtt -57.99 -33.0 68.45 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.18 -1.044 . . . . 71.109999999999999 108.18 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.27 -44.32 96.81 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.176 -1.046 . . . . 71.450000000000003 108.176 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 17.4 tp -64.5 -46.68 81.95 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.565 -0.902 . . . . 51.310000000000002 108.565 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . 0.472 HG11 ' NZ ' ' B' ' 23' ' ' LYS . 76.9 t -58.86 -41.31 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.976 . . . . 65.230000000000004 109.165 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.23 -36.63 71.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.316 -0.865 . . . . 24.32 109.131 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 54.4 ttt85 -79.44 -26.89 41.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.306 -0.871 . . . . 75.310000000000002 109.906 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 93.7 mt -76.48 -43.71 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.032 -1.043 . . . . 54.240000000000002 108.731 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' B' ' 114' ' ' ARG . 23.9 pt-20 -70.25 -28.39 65.21 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.336 -0.945 . . . . 65.310000000000002 108.714 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . 0.532 ' HB1' ' CE1' ' A' ' 87' ' ' PHE . . . -63.34 -49.24 74.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.409 -0.807 . . . . 72.239999999999995 109.397 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -61.5 -42.32 98.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.224 -0.922 . . . . 72.040000000000006 109.702 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 45.6 mt -120.0 49.51 1.39 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.458 -0.776 . . . . 75.349999999999994 109.569 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.529 ' N ' ' O ' ' B' ' 110' ' ' GLU . 1.2 tmt_? -65.37 -59.13 4.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -0.951 . . . . 75.5 109.232 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -69.36 -47.98 62.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 65.329999999999998 109.476 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' TRP . . . . . 0.526 ' O ' ' CD2' ' B' ' 116' ' ' TRP . 76.8 t90 45.83 58.59 4.24 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.313 -0.867 . . . . 74.450000000000003 109.791 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 171.13 94.69 0.1 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.414 -1.474 . . . . 44.210000000000001 109.414 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 48.7 m -144.9 170.63 15.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.295 -1.121 . . . . 71.400000000000006 109.637 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' B' ' 119' ' ' ASN . 0.0 OUTLIER -157.15 124.11 5.12 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.007 -0.738 . . . . 72.319999999999993 109.007 -178.386 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 77.7 t -77.95 -35.83 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 75.019999999999996 110.229 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . 0.412 HD12 ' N ' ' B' ' 121' ' ' ILE . 4.9 mp -113.54 140.86 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.334 -0.853 . . . . 51.409999999999997 109.544 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -145.48 119.22 9.21 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.194 -0.941 . . . . 71.530000000000001 109.566 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 6.8 pt -130.54 130.76 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.387 -0.821 . . . . 72.430000000000007 109.124 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 44.11 -136.27 5.48 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.797 -1.321 . . . . 51.229999999999997 109.797 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' B' ' 125' ' ' ASP . 20.3 p-10 -89.09 0.98 56.26 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -1.136 . . . . 74.200000000000003 109.035 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.0 134.63 40.12 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.36 -0.978 . . . . 75.420000000000002 108.36 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 8.4 m -130.17 143.72 50.94 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.393 -0.817 . . . . 74.219999999999999 109.471 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 25.2 mt -127.7 128.76 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.542 -0.724 . . . . 60.329999999999998 109.633 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 49.9 m -119.79 92.64 46.75 Favored Pre-proline 0 N--CA 1.499 1.991 0 N-CA-C 108.974 -0.75 . . . . 72.310000000000002 108.974 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.24 -22.27 9.85 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.134 1.889 . . . . 75.129999999999995 112.613 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -52.09 -46.33 65.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.033 -1.042 . . . . 75.230000000000004 108.985 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -103.13 16.47 26.52 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.385 -0.822 . . . . 72.430000000000007 109.021 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 51.77 58.3 5.62 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.222 -0.924 . . . . 75.129999999999995 108.866 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 18.2 ttmm -137.38 124.4 21.51 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.547 -0.72 . . . . 73.219999999999999 109.204 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . 0.441 HG23 ' O ' ' B' ' 135' ' ' ILE . 18.5 tt -107.09 129.9 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.368 -0.832 . . . . 64.140000000000001 109.097 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 5.7 mm -108.83 126.35 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.471 -0.768 . . . . 71.219999999999999 109.281 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . 0.494 ' C ' ' H ' ' B' ' 139' ' ' GLY . 78.8 t80 -140.26 148.01 40.83 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.526 -0.916 . . . . 64.219999999999999 108.526 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . 0.486 ' O ' ' NH1' ' B' ' 140' ' ' ARG . 40.3 tttp 54.54 6.27 0.11 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.344 -0.848 . . . . 72.019999999999996 109.619 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' B' ' 137' ' ' TYR . . . 94.61 -5.14 69.88 Favored Glycine 0 N--CA 1.497 2.719 0 N-CA-C 110.072 -1.211 . . . . 74.319999999999993 110.072 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . 0.511 ' N ' ' CD ' ' B' ' 140' ' ' ARG . 10.7 mpt_? -88.9 142.84 27.31 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.151 -1.206 . . . . 75.340000000000003 109.042 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -94.17 129.13 40.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.273 -0.892 . . . . 71.230000000000004 109.552 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 39.0 t -131.23 129.03 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.45 -0.781 . . . . 70.430000000000007 109.391 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -99.14 142.79 30.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.237 -0.915 . . . . 72.430000000000007 109.318 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . 0.505 ' CG2' ' CG ' ' B' ' 149' ' ' PHE . 11.9 p -141.5 157.05 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.297 -0.877 . . . . 72.129999999999995 109.593 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . 0.444 ' N ' HG22 ' B' ' 144' ' ' VAL . 13.2 ptpt -165.85 116.36 1.03 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.283 -0.886 . . . . 72.019999999999996 109.635 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 168.34 -178.95 41.69 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.779 -1.728 . . . . 42.229999999999997 108.779 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 0.563 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 1.3 mptp? -79.45 -44.22 1.63 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.052 -1.263 . . . . 73.299999999999997 109.558 -179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 25.3 Cg_exo -62.34 -15.69 46.62 Favored 'Trans proline' 0 N--CA 1.498 1.774 0 C-N-CA 122.552 2.168 . . . . 71.329999999999998 112.33 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . 0.505 ' CG ' ' CG2' ' B' ' 144' ' ' VAL . 23.3 m-85 -100.69 -35.5 9.45 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.359 -0.838 . . . . 74.230000000000004 110.153 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -58.06 -27.77 63.93 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.229 -0.919 . . . . 72.340000000000003 108.774 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.541 HG13 ' N ' ' B' ' 152' ' ' LEU . 8.5 p -65.91 -44.89 92.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.207 -0.933 . . . . 73.349999999999994 108.515 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.541 ' N ' HG13 ' B' ' 151' ' ' VAL . 32.3 tp -55.47 -41.86 73.53 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.745 -0.835 . . . . 55.240000000000002 108.745 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 18.6 p -71.35 -29.45 65.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.397 -0.814 . . . . 70.010000000000005 109.665 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -59.27 -57.44 13.0 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.062 -1.024 . . . . 65.319999999999993 109.719 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.421 ' H ' HD23 ' B' ' 155' ' ' LEU . 0.0 OUTLIER -68.55 -23.52 64.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.049 -1.032 . . . . 71.540000000000006 109.053 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.26 -50.48 73.42 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.103 -0.998 . . . . 75.319999999999993 109.79 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 45.9 mtt180 -71.1 -41.72 70.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.09 -1.006 . . . . 73.319999999999993 109.425 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -78.25 35.42 0.22 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.51 -0.744 . . . . 74.140000000000001 109.812 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . 0.582 ' NH1' ' CZ ' ' B' ' 214' ' ' PHE . 52.6 ttm-85 -70.24 163.14 27.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.967 . . . . 61.409999999999997 108.914 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 51.94 44.91 29.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.053 -1.03 . . . . 72.099999999999994 109.439 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -154.42 -175.82 5.59 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.279 -0.888 . . . . 72.25 109.944 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 70.1 mt -112.65 138.17 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 N-CA-C 109.194 -0.669 . . . . 72.310000000000002 109.194 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 9.8 p -132.66 138.23 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.535 -0.728 . . . . 64.209999999999994 109.079 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . 0.542 ' H ' HE21 ' B' ' 167' ' ' GLN . 13.5 p -92.8 161.5 14.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.308 -0.87 . . . . 74.219999999999999 109.882 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -62.71 -49.59 74.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.476 -0.765 . . . . 65.310000000000002 109.465 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . 0.587 ' H ' ' CD ' ' B' ' 166' ' ' GLU . 49.9 mp0 -62.11 -35.18 77.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.346 -0.846 . . . . 63.450000000000003 109.656 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 167' ' ' GLN . . . . . 0.542 HE21 ' H ' ' B' ' 164' ' ' SER . 9.5 tt0 -59.25 -35.87 74.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.161 -0.962 . . . . 72.400000000000006 109.433 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 92.1 mt -68.69 -50.34 51.7 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.127 -0.983 . . . . 72.319999999999993 109.492 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . . . . . . . . . 9.4 mp -58.92 -43.84 91.18 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.141 -0.974 . . . . 73.340000000000003 109.264 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -75.93 -21.98 56.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.094 -1.004 . . . . 72.099999999999994 109.974 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . 0.444 ' C ' HD12 ' B' ' 172' ' ' ILE . . . -69.67 -46.86 65.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.9 -1.125 . . . . 62.130000000000003 109.66 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.736 ' N ' HD12 ' B' ' 172' ' ' ILE . 1.6 mp -94.56 -54.62 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.227 -0.92 . . . . 71.420000000000002 109.163 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 29.4 m-90 -93.79 68.56 3.93 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.213 -0.929 . . . . 72.230000000000004 109.724 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . 0.638 ' H ' ' CD ' ' B' ' 174' ' ' GLU . 1.5 pm0 -76.83 -31.89 57.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.265 -0.897 . . . . 52.109999999999999 108.924 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.14 154.21 83.14 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.319 -0.863 . . . . 73.040000000000006 108.699 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.48 65.16 2.23 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.039 1.826 . . . . 74.129999999999995 111.098 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -81.98 -166.62 1.28 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.402 -0.811 . . . . 72.439999999999998 109.655 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 17.9 ttt -99.49 63.59 1.27 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.311 -0.868 . . . . 63.43 109.593 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 68.9 t -87.9 124.27 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.141 -0.974 . . . . 71.049999999999997 109.468 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . 0.426 ' C ' ' H ' ' B' ' 182' ' ' ASN . 2.9 p -85.39 151.76 56.8 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 62.149999999999999 108.734 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.66 38.04 0.25 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.084 1.856 . . . . 65.219999999999999 111.259 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 182' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' B' ' 180' ' ' THR . 51.5 p-10 -148.79 -8.78 0.36 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.283 -0.886 . . . . 72.310000000000002 109.884 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 47.5 t -60.13 -24.15 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.087 -1.008 . . . . 63.32 109.618 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 41.8 mt -55.23 -48.23 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.353 -0.842 . . . . 75.030000000000001 110.625 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -63.47 -37.0 85.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 64.109999999999999 110.484 -178.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.78 -42.81 54.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.305 -0.872 . . . . 73.0 110.685 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.82 -47.32 47.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.788 -1.195 . . . . 61.119999999999997 110.491 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 188' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' B' ' 189' ' ' ASN . 9.3 tp -65.11 -41.94 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.021 -1.049 . . . . 72.430000000000007 110.48 -178.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 189' ' ' ASN . . . . . 0.456 ' C ' HD22 ' B' ' 189' ' ' ASN . 0.5 OUTLIER -61.64 -47.47 85.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.998 -1.064 . . . . 65.140000000000001 109.959 -179.614 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -65.03 -50.97 64.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.154 -0.966 . . . . 63.240000000000002 110.05 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 75.8 mt -49.31 -34.22 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.125 -0.984 . . . . 74.030000000000001 109.752 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -48.57 64.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.113 -0.992 . . . . 72.239999999999995 108.98 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -71.18 -25.3 62.47 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.244 -0.91 . . . . 73.099999999999994 110.074 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -88.35 -19.91 26.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.371 -0.83 . . . . 72.109999999999999 109.862 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 195' ' ' MET . . . . . 0.445 ' SD ' HD11 ' B' ' 152' ' ' LEU . 6.2 ttt -103.57 -45.26 4.88 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.355 -0.841 . . . . 44.329999999999998 110.575 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -59.26 -40.29 85.55 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.081 -1.012 . . . . 71.209999999999994 110.471 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . 0.439 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 0.9 OUTLIER -58.22 -65.23 2.01 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.12 -0.988 . . . . 75.209999999999994 110.545 -179.268 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 198' ' ' PRO . . . . . 0.448 ' O ' ' CZ ' ' B' ' 137' ' ' TYR . 19.4 Cg_endo -56.88 -53.98 4.32 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.568 1.512 . . . . 75.319999999999993 112.238 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' B' ' 201' ' ' ILE . 11.1 mp -63.1 -34.18 77.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.134 -0.979 . . . . 72.25 109.084 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 74.7 -37.15 1.03 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.706 -1.358 . . . . 64.530000000000001 109.706 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . 0.435 ' H ' ' C ' ' B' ' 199' ' ' LEU . 39.7 mm -93.15 132.5 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.285 -1.127 . . . . 44.229999999999997 109.386 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 14.4 t -77.22 135.16 38.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 54.009999999999998 108.861 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . 0.454 ' O ' ' CE1' ' B' ' 214' ' ' PHE . 16.1 p -144.22 40.41 1.35 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.279 -0.888 . . . . 74.400000000000006 109.628 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 7.2 m -141.2 142.55 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.135 -0.978 . . . . 72.120000000000005 109.631 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -121.71 136.09 54.94 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.929 -0.767 . . . . 65.409999999999997 108.929 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.12 135.99 46.61 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.377 -0.827 . . . . 71.329999999999998 109.712 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.42 ' O ' HG13 ' B' ' 207' ' ' VAL . 13.1 p -141.7 131.83 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.295 -0.878 . . . . 63.5 109.129 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 76.2 ttt-85 -80.27 -25.08 39.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.172 -0.955 . . . . 74.450000000000003 109.814 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 60.1 mtp85 -48.85 -27.49 3.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 74.140000000000001 109.818 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 71.4 mtt85 -151.92 -67.74 0.17 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.088 -1.007 . . . . 74.430000000000007 109.694 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . 0.424 ' C ' ' CD1' ' B' ' 212' ' ' TYR . . . -162.84 -100.8 0.15 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.859 -1.296 . . . . 64.450000000000003 109.859 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 212' ' ' TYR . . . . . 0.424 ' CD1' ' C ' ' B' ' 211' ' ' GLY . 38.6 m-85 -137.17 158.38 44.58 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.458 -1.025 . . . . 74.209999999999994 109.389 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -130.96 125.88 34.56 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.548 -0.72 . . . . 74.030000000000001 109.694 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . 0.582 ' CZ ' ' NH1' ' B' ' 159' ' ' ARG . 0.3 OUTLIER -85.59 119.56 26.07 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.348 -0.982 . . . . 74.340000000000003 108.348 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 48.3 t -132.66 149.5 52.29 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.189 -0.671 . . . . 64.329999999999998 109.189 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -58.15 164.05 3.9 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.188 -0.945 . . . . 70.040000000000006 108.631 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.03 -161.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.658 2.239 . . . . 65.109999999999999 111.586 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.498 ' O ' ' N ' ' B' ' 220' ' ' ALA . 43.9 mttm -57.9 152.74 36.7 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.144 -0.972 . . . . 73.150000000000006 109.037 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -35.5 87.36 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.288 0 C-N-CA 122.513 2.142 . . . . 71.310000000000002 112.592 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' B' ' 218' ' ' LYS . . . -64.86 -33.13 75.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.313 -0.867 . . . . 75.450000000000003 109.733 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 71.7 m -80.11 123.84 28.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.171 -0.956 . . . . 72.219999999999999 109.486 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -60.89 140.23 57.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 54.530000000000001 109.473 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.983 -1.008 . . . . 71.129999999999995 109.785 -179.923 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.55 ' SD ' ' CE2' ' A' ' 25' ' ' PHE . 12.1 ptp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.442 -0.577 . . . . 65.120000000000005 109.442 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 72.3 mtt85 -141.49 149.58 41.1 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.319 -0.863 . . . . 72.329999999999998 109.315 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 80.3 t -114.45 141.04 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.633 -0.667 . . . . 71.420000000000002 109.495 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.533 HD11 ' CG1' ' A' ' 6' ' ' ILE . 4.6 tp -112.35 118.81 36.25 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.532 -0.73 . . . . 65.120000000000005 109.583 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 4' ' ' LEU . 18.3 mt -115.74 101.94 9.27 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.479 -0.763 . . . . 62.43 109.18 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.533 ' CG1' HD11 ' A' ' 4' ' ' LEU . 76.6 mt -97.27 107.92 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.228 -0.92 . . . . 71.150000000000006 108.839 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.535 ' OE2' ' NZ ' ' A' ' 97' ' ' LYS . 53.5 tt0 -151.28 129.53 11.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.259 -0.901 . . . . 75.340000000000003 109.557 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -62.66 -33.04 74.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.267 -0.895 . . . . 72.439999999999998 109.377 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -76.82 95.08 3.98 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.903 . . . . 63.020000000000003 109.329 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.0 t -61.11 -25.2 66.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.343 -0.848 . . . . 72.340000000000003 109.683 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.08 -53.95 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.964 . . . . 74.019999999999996 109.844 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.548 HD13 ' NZ ' ' A' ' 97' ' ' LYS . 49.5 mt -64.37 -44.07 92.53 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.941 . . . . 71.430000000000007 109.678 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.29 -24.63 75.96 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 108.123 -1.991 . . . . 61.32 108.123 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.75 -57.0 10.56 Favored Glycine 0 N--CA 1.484 1.862 0 N-CA-C 109.702 -1.359 . . . . 71.200000000000003 109.702 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -53.5 -45.87 69.83 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.313 -1.11 . . . . 71.319999999999993 109.651 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 78.4 mt -67.34 -45.59 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.757 -1.214 . . . . 63.229999999999997 109.041 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -51.29 -48.39 62.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.127 -0.983 . . . . 51.109999999999999 109.358 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.402 ' HB3' ' HZ2' ' A' ' 18' ' ' LYS . 15.3 ttpp -86.59 -0.09 55.46 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.248 -0.907 . . . . 73.340000000000003 109.19 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.6 -59.03 2.43 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 109.847 -1.301 . . . . 62.149999999999999 109.847 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -71.49 -20.9 62.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -1.171 . . . . 73.510000000000005 109.938 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -57.65 -31.59 66.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.119 -0.988 . . . . 74.25 109.576 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.5 t -59.34 -29.76 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.871 . . . . 70.040000000000006 109.189 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.719 ' HZ1' ' HZ1' ' A' ' 103' ' ' LYS . 32.3 mmtt -76.51 5.44 7.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.423 -0.798 . . . . 73.230000000000004 109.267 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.57 25.39 56.73 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.12 -1.192 . . . . 75.540000000000006 110.12 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CE2' ' SD ' ' A' ' 1' ' ' MET . 8.7 m-85 -102.02 156.86 17.27 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.287 -1.125 . . . . 73.430000000000007 109.119 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.3 mmt -107.07 136.61 46.64 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.461 -0.941 . . . . 43.240000000000002 108.461 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.49 165.79 26.98 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.191 -0.943 . . . . 62.109999999999999 109.949 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.413 ' OD2' ' CD2' ' A' ' 39' ' ' LEU . 25.3 t70 -139.65 150.3 44.77 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.432 -0.792 . . . . 74.420000000000002 108.995 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.33 139.48 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.483 -0.761 . . . . 72.150000000000006 109.276 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 p -137.84 176.1 9.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.381 -0.824 . . . . 71.420000000000002 109.295 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -97.73 -104.47 0.19 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.331 -0.856 . . . . 72.329999999999998 109.77 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.3 m -77.99 166.57 22.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.227 -0.92 . . . . 74.239999999999995 110.158 -179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.4 mt -51.0 -35.46 34.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.606 -0.684 . . . . 71.530000000000001 109.853 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -51.9 -50.31 61.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.18 -0.95 . . . . 74.230000000000004 109.947 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -63.82 -40.06 95.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.108 -0.995 . . . . 54.030000000000001 109.247 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.05 -38.48 63.81 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.344 -1.502 . . . . 61.409999999999997 109.344 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -63.63 -42.92 98.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -1.121 . . . . 74.340000000000003 109.499 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -72.55 -34.04 67.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -0.957 . . . . 75.329999999999998 109.555 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.413 ' CD2' ' OD2' ' A' ' 28' ' ' ASP . 21.1 tp -71.45 -49.54 40.47 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.891 . . . . 74.329999999999998 109.966 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 40' ' ' MET . 3.9 ppp? -67.67 -22.96 65.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.076 -1.015 . . . . 70.319999999999993 109.849 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -59.58 -38.06 80.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.178 -0.951 . . . . 71.219999999999999 110.002 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.3 pt -85.47 -29.82 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.157 -0.964 . . . . 74.140000000000001 110.325 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 40' ' ' MET . 65.8 mtt85 -130.39 144.67 51.53 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.237 -0.915 . . . . 72.239999999999995 109.784 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -99.07 127.62 45.04 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.308 -0.87 . . . . 75.420000000000002 109.24 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -99.66 145.36 27.68 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.298 -0.876 . . . . 74.230000000000004 109.534 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -79.1 -35.72 41.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.186 -0.946 . . . . 72.040000000000006 109.282 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.549 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -110.15 116.85 32.27 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.652 -0.87 . . . . 72.129999999999995 108.652 179.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.549 ' N ' HD13 ' A' ' 47' ' ' LEU . 50.6 t -102.71 100.43 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.429 -0.952 . . . . 72.340000000000003 108.429 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.434 ' CE ' ' OH ' ' A' ' 99' ' ' TYR . 21.0 ttt -115.5 136.76 52.75 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.546 0.689 . . . . 74.109999999999999 110.079 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.605 HG22 ' H ' ' A' ' 52' ' ' ASP . 1.5 p -145.07 132.22 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.57 -0.706 . . . . 61.119999999999997 109.628 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 68.0 m -92.78 2.03 56.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.457 -0.777 . . . . 73.109999999999999 109.253 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.605 ' H ' HG22 ' A' ' 50' ' ' VAL . 51.5 m-20 -76.95 142.23 40.12 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 52.549999999999997 109.508 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.412 ' C ' ' H ' ' A' ' 55' ' ' ALA . 15.5 ptpt -81.15 -31.15 34.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.22 -0.925 . . . . 44.219999999999999 110.092 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -74.02 10.8 1.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.088 -1.008 . . . . 70.439999999999998 109.354 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.412 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -67.4 -21.05 65.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.427 -0.796 . . . . 64.140000000000001 110.253 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.6 mt -43.13 -48.42 6.33 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.255 -0.903 . . . . 44.140000000000001 110.067 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.2 m -68.75 -36.23 78.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.01 -1.056 . . . . 55.229999999999997 108.743 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -64.73 -64.86 0.77 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.368 -0.833 . . . . 74.439999999999998 109.579 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.1 m -48.27 -32.55 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.68 -1.263 . . . . 74.030000000000001 109.646 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.9 t -57.41 -50.53 72.71 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.227 -0.921 . . . . 64.299999999999997 109.074 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.413 ' HG2' ' H ' ' A' ' 61' ' ' ARG . 7.0 ptp180 -72.33 -34.74 68.29 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.19 -1.004 . . . . 64.439999999999998 110.128 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.8 mm -67.36 -33.48 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.599 -1.313 . . . . 63.210000000000001 109.422 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -68.25 -48.9 63.83 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.231 -0.918 . . . . 74.420000000000002 110.248 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.414 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 17.2 pt-20 -75.39 -40.68 57.66 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.958 -1.089 . . . . 70.319999999999993 110.308 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.521 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 54.9 mttp -73.85 -21.68 60.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.198 -0.939 . . . . 75.219999999999999 110.015 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.521 ' CG ' ' O ' ' A' ' 65' ' ' LYS . 84.4 m-70 -156.79 64.63 0.52 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.013 -1.054 . . . . 74.129999999999995 109.677 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 7.3 t -61.42 -28.15 69.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.203 -0.935 . . . . 73.239999999999995 109.683 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 84.6 p -64.33 -20.73 66.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.266 -0.896 . . . . 61.009999999999998 110.107 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 70' ' ' VAL . 78.3 mt -82.72 159.18 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.065 -1.022 . . . . 71.329999999999998 109.772 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.471 ' N ' HG22 ' A' ' 69' ' ' ILE . 98.4 t -95.39 149.65 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.455 -0.778 . . . . 72.129999999999995 109.213 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.0 t -130.53 126.94 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.421 -0.799 . . . . 54.210000000000001 109.71 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.0 tt -121.89 101.95 7.88 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.493 -0.755 . . . . 50.240000000000002 109.063 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 69.4 t -90.37 145.88 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 74.409999999999997 109.154 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.7 m -128.54 155.6 44.63 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.325 -0.859 . . . . 72.310000000000002 108.751 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.6 m -165.47 144.32 6.32 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.979 -1.075 . . . . 64.540000000000006 110.68 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -86.88 19.83 2.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.482 -0.761 . . . . 74.129999999999995 109.753 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.457 ' O ' ' N ' ' A' ' 79' ' ' THR . 55.4 t30 -138.91 55.58 7.95 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.302 -0.874 . . . . 73.340000000000003 109.397 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 77' ' ' ASN . 15.1 Cg_endo -57.5 77.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.364 2.043 . . . . 63.219999999999999 111.532 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.464 HG23 ' H ' ' A' ' 82' ' ' GLU . 12.5 t -102.81 171.84 7.18 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.56 -0.904 . . . . 62.530000000000001 108.56 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.1 p -75.74 -20.63 58.17 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.2 -0.938 . . . . 73.439999999999998 110.081 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.511 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 77.1 tt0 -69.52 -49.91 50.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.043 -1.036 . . . . 71.420000000000002 109.533 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.464 ' H ' HG23 ' A' ' 79' ' ' THR . 98.9 mt-10 -73.82 -27.6 61.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 73.430000000000007 109.576 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -61.26 -56.68 17.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -0.921 . . . . 74.219999999999999 109.85 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.524 HG23 ' N ' ' A' ' 85' ' ' HIS . 31.7 m -65.58 -43.61 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 73.200000000000003 109.812 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.524 ' N ' HG23 ' A' ' 84' ' ' VAL . 32.2 m80 -63.44 -31.23 72.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.112 -0.993 . . . . 53.329999999999998 109.701 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.32 -45.56 79.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.085 -1.01 . . . . 64.109999999999999 109.809 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -79.98 -30.35 39.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.091 -1.005 . . . . 74.340000000000003 109.207 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -71.97 -51.58 21.25 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.309 -0.869 . . . . 74.420000000000002 109.254 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -60.68 -48.58 81.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.499 -0.751 . . . . 74.239999999999995 109.622 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.16 70.82 0.02 OUTLIER Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.332 -1.107 . . . . 61.509999999999998 110.332 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -124.02 125.1 43.97 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.439 -1.036 . . . . 55.329999999999998 108.634 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -77.09 -27.51 54.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.999 -1.063 . . . . 73.420000000000002 109.428 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 94' ' ' TYR . 13.3 t0 -151.81 162.38 41.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 75.040000000000006 109.059 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.526 ' N ' ' OD1' ' A' ' 93' ' ' ASP . 58.3 t80 -148.3 101.82 3.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.208 -0.933 . . . . 71.329999999999998 109.484 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.1 mm -104.83 150.65 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.475 0 O-C-N 121.179 -0.951 . . . . 71.129999999999995 110.682 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.38 123.71 20.73 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.408 -1.33 . . . . 64.319999999999993 107.408 178.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.683 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -43.18 -57.68 4.98 Favored Pre-proline 0 C--N 1.3 -1.583 0 O-C-N 121.217 -0.927 . . . . 62.200000000000003 112.298 -178.364 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 6.7 Cg_endo -43.27 -7.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 120.93 1.087 . . . . 73.109999999999999 112.49 -174.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.683 ' N ' ' O ' ' A' ' 97' ' ' LYS . 58.4 m-85 57.81 120.89 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.07 0.462 . . . . 65.219999999999999 110.268 178.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.529 ' NE ' ' OH ' ' B' ' 94' ' ' TYR . 56.5 mtt-85 -62.06 -44.58 96.38 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.02 -1.05 . . . . 72.349999999999994 109.327 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.84 ' O ' ' N ' ' A' ' 103' ' ' LYS . 13.0 t -171.83 47.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.091 -1.006 . . . . 71.319999999999993 110.696 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.3 mt 40.21 -66.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 CA-C-N 118.324 0.511 . . . . 75.430000000000007 111.562 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.84 ' N ' ' O ' ' A' ' 101' ' ' SER . 40.9 tptt -47.03 -26.87 1.14 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.098 -1.002 . . . . 71.409999999999997 109.025 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.38 -47.02 52.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.363 -0.836 . . . . 63.240000000000002 109.884 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.4 HD13 ' C ' ' A' ' 105' ' ' LEU . 2.1 tm? -58.95 -57.23 14.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 73.219999999999999 109.324 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.46 HG13 ' N ' ' A' ' 107' ' ' ALA . 7.2 p -52.58 -40.91 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.596 -1.315 . . . . 60.109999999999999 109.222 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.46 ' N ' HG13 ' A' ' 106' ' ' VAL . . . -51.49 -44.04 62.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 70.420000000000002 109.19 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -66.22 -34.71 78.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.206 -0.934 . . . . 74.409999999999997 109.094 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.7 mt -72.09 -26.77 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.152 -0.967 . . . . 62.539999999999999 108.483 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -66.19 -58.28 5.74 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.689 -0.804 . . . . 74.340000000000003 109.399 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.31 -40.46 67.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.183 -0.948 . . . . 73.319999999999993 109.311 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.415 ' CA ' ' HE ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -62.05 -31.06 71.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -0.866 . . . . 52.409999999999997 109.334 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.477 HD22 ' SD ' ' A' ' 1' ' ' MET . 2.1 tt -156.14 98.21 1.85 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 65.239999999999995 109.597 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 45.3 mtm180 -92.04 -81.3 0.34 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.189 -0.944 . . . . 64.450000000000003 109.077 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -80.38 -81.93 0.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 74.430000000000007 109.554 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -149.67 -175.91 5.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.304 -0.873 . . . . 74.420000000000002 109.429 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.48 -155.06 4.95 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.395 -1.482 . . . . 75.040000000000006 109.395 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.452 ' C ' ' ND2' ' A' ' 119' ' ' ASN . 68.6 m -134.37 164.82 26.56 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.343 -1.092 . . . . 61.140000000000001 109.569 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.452 ' ND2' ' C ' ' A' ' 118' ' ' SER . 0.0 OUTLIER -139.67 127.15 21.55 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.083 -0.71 . . . . 65.239999999999995 109.083 -178.178 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 56.4 t -89.32 -20.63 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.312 -0.867 . . . . 73.109999999999999 109.551 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.6 HG23 HH12 ' A' ' 159' ' ' ARG . 4.7 mp -117.78 119.7 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.399 -0.813 . . . . 72.239999999999995 109.004 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -140.86 122.81 15.49 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.408 -0.808 . . . . 72.340000000000003 109.748 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.442 ' O ' HG23 ' A' ' 123' ' ' ILE . 15.5 tt -138.33 130.78 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.383 -0.823 . . . . 71.439999999999998 109.143 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.62 -134.72 34.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.281 -1.528 . . . . 73.400000000000006 109.281 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.72 -9.06 45.14 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.07 -1.253 . . . . 74.450000000000003 109.462 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.35 135.73 33.77 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.971 -1.081 . . . . 54.210000000000001 108.915 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 44.2 p -129.33 139.18 51.83 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.457 -0.777 . . . . 54.5 109.122 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 81.3 mt -130.78 131.82 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.399 -0.813 . . . . 45.149999999999999 109.834 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.4 m -126.31 110.86 23.65 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.302 -0.999 . . . . 71.109999999999999 108.302 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.98 -38.47 0.82 Allowed 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.533 1.489 . . . . 65.409999999999997 112.046 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -65.35 -42.54 92.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.177 -0.952 . . . . 63.32 109.238 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 133' ' ' GLU . 44.7 mm-40 -87.82 11.48 15.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.333 -0.854 . . . . 72.519999999999996 109.708 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 132' ' ' GLU . 11.8 pt-20 33.48 61.78 0.43 Allowed 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.209 0.528 . . . . 75.329999999999998 110.846 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -152.74 148.42 27.23 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.081 -1.012 . . . . 71.230000000000004 110.213 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 12.2 tt -135.51 144.36 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.507 -0.746 . . . . 74.019999999999996 109.177 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 20.5 mt -125.49 135.37 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.63 -0.878 . . . . 60.229999999999997 108.63 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -139.38 135.68 33.94 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.086 -1.009 . . . . 62.32 110.271 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm 54.01 28.9 9.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.584 -0.698 . . . . 75.400000000000006 110.366 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 80.42 16.56 75.72 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 120.025 -1.083 . . . . 72.239999999999995 110.9 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 55.4 mtt-85 -111.01 125.3 53.59 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.343 -1.093 . . . . 71.219999999999999 109.37 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -92.98 123.39 36.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.253 -0.904 . . . . 71.420000000000002 110.279 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.3 p -137.0 138.97 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.251 -1.018 . . . . 53.020000000000003 108.251 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.451 ' N ' ' CD ' ' A' ' 143' ' ' GLU . 19.3 mp0 -99.99 143.9 29.66 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.309 -0.869 . . . . 60.450000000000003 110.406 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.6 m -142.6 130.99 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.481 -0.933 . . . . 74.439999999999998 108.481 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.01 19.58 0.88 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.173 -0.954 . . . . 65.150000000000006 109.736 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.85 173.86 47.46 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.132 -1.587 . . . . 73.340000000000003 109.132 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.619 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 27.2 mttt -69.83 -37.17 7.46 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.138 -1.213 . . . . 72.219999999999999 110.162 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 19.1 Cg_exo -64.48 -18.62 63.56 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.09 1.86 . . . . 65.230000000000004 111.907 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -95.28 -30.9 13.72 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.214 -0.929 . . . . 60.109999999999999 110.009 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -50.43 -35.95 30.97 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.097 -1.002 . . . . 64.209999999999994 109.197 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.6 p -62.2 -33.37 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.138 -0.976 . . . . 72.019999999999996 109.091 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 9.5 tp -67.1 -39.3 86.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.384 -0.823 . . . . 73.310000000000002 109.248 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 39.1 p -73.95 -29.7 62.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.066 -1.021 . . . . 74.310000000000002 109.388 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -61.81 -57.78 10.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.067 -1.021 . . . . 74.310000000000002 109.742 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 pp -64.43 -29.5 70.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.127 -0.983 . . . . 75.340000000000003 109.192 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -53.45 -45.83 69.63 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.236 -0.915 . . . . 62.140000000000001 109.046 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 34.6 mtt180 -73.05 -46.3 52.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.103 -0.998 . . . . 61.030000000000001 108.915 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -79.59 29.35 0.25 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.593 -0.692 . . . . 74.120000000000005 109.889 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.6 HH12 HG23 ' A' ' 121' ' ' ILE . 19.9 ttp-105 -71.29 44.7 0.09 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.162 -0.961 . . . . 71.129999999999995 109.563 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -171.26 46.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.88 -1.138 . . . . 75.450000000000003 109.915 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -168.39 178.55 4.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.023 -1.048 . . . . 73.409999999999997 109.975 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 66.7 mt -96.25 139.43 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.45 -0.781 . . . . 74.409999999999997 109.244 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 78.7 t -132.28 140.08 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.368 -0.832 . . . . 72.310000000000002 109.617 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 32.3 p -98.88 169.32 9.54 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.255 -0.903 . . . . 74.120000000000005 109.843 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -67.04 -46.79 73.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.52 -0.738 . . . . 70.430000000000007 109.982 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -53.73 -36.42 62.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.356 -0.84 . . . . 73.519999999999996 109.778 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -61.09 -49.32 77.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.158 -0.964 . . . . 74.519999999999996 109.525 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 38.7 mt -51.27 -40.6 59.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.077 -1.014 . . . . 72.310000000000002 109.027 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.562 HD23 ' C ' ' A' ' 169' ' ' LEU . 4.2 tt -60.65 -65.08 0.75 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.451 -0.781 . . . . 53.329999999999998 109.793 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -66.38 -10.92 48.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.214 -0.929 . . . . 62.439999999999998 110.591 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.424 ' C ' HD12 ' A' ' 172' ' ' ILE . . . -73.25 -52.93 12.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.953 -1.092 . . . . 60.210000000000001 110.033 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.771 ' N ' HD12 ' A' ' 172' ' ' ILE . 1.7 mp -95.77 -52.56 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.019 -1.051 . . . . 75.319999999999993 109.2 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 21.7 m-90 -96.4 113.07 24.62 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.333 -0.854 . . . . 73.140000000000001 109.259 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.486 ' N ' ' CD ' ' A' ' 174' ' ' GLU . 2.3 pm0 -147.01 8.17 0.94 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.162 -0.961 . . . . 73.239999999999995 109.491 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.445 ' H ' ' HD2' ' A' ' 176' ' ' PRO . 0.5 OUTLIER 177.69 -50.47 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.287 -0.883 . . . . 44.43 109.471 179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.445 ' HD2' ' H ' ' A' ' 175' ' ' GLU . 91.0 Cg_exo -45.43 -38.47 15.78 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 122.004 1.803 . . . . 72.510000000000005 112.401 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -147.92 145.13 28.5 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.175 -0.953 . . . . 63.240000000000002 109.689 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 71.3 mtm -89.96 126.77 35.86 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.439 -0.788 . . . . 73.5 109.104 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 28.5 m -133.9 139.86 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.401 -0.812 . . . . 65.219999999999999 109.776 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.475 ' O ' HG12 ' A' ' 183' ' ' VAL . 26.0 m -73.5 135.74 78.5 Favored Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.334 -0.987 . . . . 71.420000000000002 108.334 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.2 -12.63 35.7 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 121.685 1.59 . . . . 41.219999999999999 112.391 -179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.436 ' H ' HG22 ' A' ' 180' ' ' THR . 72.9 m-20 -81.28 34.32 0.36 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.188 -0.945 . . . . 64.540000000000006 109.497 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 180' ' ' THR . 8.8 p -130.15 -13.69 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.347 -0.846 . . . . 74.019999999999996 110.556 -179.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 58.6 mt -56.55 -27.83 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.749 -1.219 . . . . 72.329999999999998 109.235 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -53.12 -48.94 67.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.317 -0.864 . . . . 74.400000000000006 109.48 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.433 ' H ' HG23 ' A' ' 186' ' ' VAL . 2.2 t -73.79 -28.63 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.474 -0.766 . . . . 70.420000000000002 109.982 -179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.44 -41.13 66.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.143 -0.973 . . . . 52.109999999999999 111.071 -178.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.7 tp -76.4 -33.97 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.52 -1.363 . . . . 71.400000000000006 109.823 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -66.55 -55.72 14.16 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.272 -0.893 . . . . 73.439999999999998 110.14 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -61.85 -36.74 82.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 71.420000000000002 110.263 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 74.8 mt -69.4 -40.85 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.157 -0.965 . . . . 61.549999999999997 110.227 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 44.1 mtp85 -58.01 -39.12 77.51 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.88 -1.138 . . . . 63.340000000000003 108.985 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -78.06 -36.61 48.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.276 -0.89 . . . . 61.240000000000002 109.677 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -84.46 2.51 40.54 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.185 -0.947 . . . . 75.129999999999995 110.49 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . 1.014 ' HE1' HG11 ' A' ' 204' ' ' VAL . 44.3 ttp -99.58 -47.16 5.21 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.088 -1.007 . . . . 74.019999999999996 109.662 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -68.82 -32.05 71.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.89 . . . . 74.019999999999996 109.869 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.434 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 1.1 mmtm -55.2 -64.49 2.05 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.23 -0.919 . . . . 75.430000000000007 109.555 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.434 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 40.0 Cg_endo -64.17 -53.66 1.1 Allowed 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.128 1.885 . . . . 72.319999999999993 112.236 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 10.9 mp -54.71 -56.61 17.41 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.971 -1.08 . . . . 74.540000000000006 109.643 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 100.35 -17.99 56.04 Favored Glycine 0 N--CA 1.499 2.841 0 N-CA-C 109.842 -1.303 . . . . 61.509999999999998 109.842 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 41.2 mt -128.16 147.78 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 O-C-N 121.341 -1.094 . . . . 61.219999999999999 109.104 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 17.5 t -77.96 136.6 38.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.971 -1.08 . . . . 72.0 109.278 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.21 15.87 1.88 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.203 -0.935 . . . . 74.439999999999998 109.302 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 1.014 HG11 ' HE1' ' A' ' 195' ' ' MET . 31.2 m -127.42 152.32 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.551 -0.718 . . . . 64.349999999999994 110.089 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -126.95 130.56 50.34 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.878 -0.786 . . . . 71.409999999999997 108.878 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 4.2 t -98.84 127.23 44.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.196 -0.94 . . . . 73.519999999999996 109.06 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 209' ' ' ARG . 8.5 p -145.56 140.18 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.117 -0.989 . . . . 71.019999999999996 109.539 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -82.59 -25.28 33.4 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.263 -0.898 . . . . 72.120000000000005 109.597 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.431 ' H ' HG22 ' A' ' 207' ' ' VAL . 13.2 mmt85 -49.45 -25.08 2.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.418 -0.801 . . . . 64.409999999999997 109.866 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -152.21 -74.29 0.14 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 71.540000000000006 109.448 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -166.91 -102.01 0.16 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.206 -1.558 . . . . 72.030000000000001 109.206 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -135.49 134.08 39.15 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.443 -1.034 . . . . 75.540000000000006 109.268 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 20.7 mtp180 -97.92 137.55 36.58 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.335 -0.853 . . . . 75.310000000000002 109.54 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.423 ' O ' ' SG ' ' A' ' 215' ' ' CYS . 44.1 m-85 -105.77 119.12 38.34 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.83 -0.804 . . . . 75.409999999999997 108.83 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 214' ' ' PHE . 99.3 m -153.39 162.54 41.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.32 -0.862 . . . . 74.140000000000001 109.391 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -67.6 155.08 92.1 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 75.319999999999993 108.925 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -36.14 138.91 0.17 Allowed 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 122.424 2.083 . . . . 73.109999999999999 112.033 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.582 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 34.7 tttt -68.5 -39.28 14.91 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.156 -0.965 . . . . 75.25 110.647 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 52.3 Cg_exo -54.44 -7.38 0.78 Allowed 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.98 1.787 . . . . 75.099999999999994 111.829 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -65.47 -54.19 31.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.345 -0.847 . . . . 71.140000000000001 109.826 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 46.3 m 47.5 -139.08 0.66 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.123 -0.986 . . . . 71.129999999999995 109.293 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -59.62 -39.8 85.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.099 -1.0 . . . . 75.349999999999994 109.219 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.982 -1.009 . . . . 73.409999999999997 109.537 -179.93 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 54.7 ttm . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.44 -0.578 . . . . 71.140000000000001 109.44 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -137.79 154.46 49.56 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.356 -0.84 . . . . 73.230000000000004 109.489 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 97.8 t -115.58 125.95 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 109.174 -0.676 . . . . 72.239999999999995 109.174 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.48 HD11 ' CG1' ' B' ' 6' ' ' ILE . 4.4 tp -99.31 119.03 37.27 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.454 -0.779 . . . . 54.329999999999998 108.975 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.418 ' CD1' ' SD ' ' B' ' 49' ' ' MET . 5.3 tp -120.45 100.29 7.06 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 108.959 -0.756 . . . . 74.349999999999994 108.959 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.48 ' CG1' HD11 ' B' ' 4' ' ' LEU . 45.7 mt -90.05 102.81 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.833 -1.167 . . . . 42.549999999999997 108.816 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.42 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 29.2 tp10 -133.2 128.87 36.91 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.501 -0.75 . . . . 74.519999999999996 109.371 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -65.49 -33.31 75.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.906 . . . . 62.549999999999997 109.168 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -88.43 111.56 21.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.346 -0.846 . . . . 73.109999999999999 109.387 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 83.1 p -69.06 -27.07 65.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.915 . . . . 65.540000000000006 109.586 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 77.7 t -61.92 -51.31 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -0.921 . . . . 75.549999999999997 109.607 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 37.9 mt -64.35 -30.65 71.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.3 -0.875 . . . . 70.140000000000001 109.449 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.36 -29.91 57.57 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.623 -1.791 . . . . 75.400000000000006 108.623 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.41 -50.52 61.77 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.912 -1.275 . . . . 65.439999999999998 109.912 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -65.46 -41.53 93.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -1.165 . . . . 60.210000000000001 109.801 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 5.7 mm -67.66 -35.28 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.867 -1.145 . . . . 75.150000000000006 108.905 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -64.58 -46.39 82.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.304 -0.872 . . . . 73.010000000000005 109.454 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -79.49 -9.16 59.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 74.299999999999997 109.468 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -81.57 -52.95 3.97 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 109.422 -1.471 . . . . 70.540000000000006 109.422 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pp -70.51 -27.83 64.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -1.089 . . . . 71.340000000000003 109.392 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.19 -34.87 61.57 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.229 -0.919 . . . . 64.409999999999997 109.21 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 49.0 t -54.36 -45.37 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.345 -0.847 . . . . 74.230000000000004 108.746 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.806 ' HZ2' HG12 ' B' ' 106' ' ' VAL . 23.6 mmtp -57.09 -51.64 68.48 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.607 -0.886 . . . . 63.420000000000002 108.607 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 127.66 41.12 0.3 Allowed Glycine 0 N--CA 1.5 2.907 0 N-CA-C 110.461 -1.056 . . . . 53.43 110.461 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -119.66 159.2 24.9 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.265 -1.138 . . . . 71.120000000000005 108.862 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 15.1 mmt -98.16 138.46 35.42 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.06 -1.089 . . . . 75.239999999999995 108.06 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.24 160.71 40.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.928 . . . . 72.120000000000005 110.261 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -142.84 152.84 42.59 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.663 -0.866 . . . . 72.310000000000002 108.663 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 p -114.02 137.1 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.37 -0.831 . . . . 64.430000000000007 109.238 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.6 p -134.41 170.07 16.3 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.576 -0.703 . . . . 65.409999999999997 109.457 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.479 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 1.9 pt-20 -94.4 -98.6 0.15 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.383 -0.823 . . . . 71.019999999999996 110.055 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 70.1 m -78.59 168.8 19.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.257 -0.902 . . . . 51.109999999999999 110.363 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 16.1 mt -56.76 -31.98 65.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.61 -0.681 . . . . 71.239999999999995 110.009 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -52.76 -44.07 66.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.131 -0.981 . . . . 74.319999999999993 109.861 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.479 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 64.1 m-20 -73.76 -39.58 64.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.107 -0.995 . . . . 73.030000000000001 109.553 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.3 -44.98 57.63 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.62 -1.392 . . . . 30.210000000000001 109.62 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.66 -43.32 84.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -1.153 . . . . 74.420000000000002 109.67 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -70.55 -39.85 73.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.131 -0.98 . . . . 74.420000000000002 110.099 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 25.0 tp -70.2 -44.07 69.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -0.948 . . . . 75.409999999999997 110.373 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . 0.448 ' SD ' ' OH ' ' B' ' 45' ' ' TYR . 0.0 OUTLIER -74.49 -28.01 60.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.025 -1.047 . . . . 60.409999999999997 110.147 -179.204 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.21 -29.89 70.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.967 -1.083 . . . . 53.229999999999997 110.383 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 19.8 pt -86.34 -18.43 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.953 -1.092 . . . . 71.230000000000004 110.905 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' B' ' 40' ' ' MET . 59.0 mmt-85 -129.63 155.19 46.25 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.082 -1.011 . . . . 72.219999999999999 110.132 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -84.62 157.03 21.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.271 -0.893 . . . . 63.539999999999999 109.551 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.513 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 3.6 p90 -149.9 -174.89 4.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.208 -0.933 . . . . 64.349999999999994 109.393 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -141.5 -33.62 0.5 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.27 -0.894 . . . . 62.219999999999999 109.569 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.502 HD13 ' N ' ' B' ' 48' ' ' VAL . 0.3 OUTLIER -110.14 114.78 28.55 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.35 -0.844 . . . . 73.120000000000005 109.107 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.502 ' N ' HD13 ' B' ' 47' ' ' LEU . 71.5 t -101.74 97.22 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.449 -0.945 . . . . 65.109999999999999 108.449 179.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.434 ' O ' ' O ' ' B' ' 4' ' ' LEU . 15.4 ttt -112.91 130.53 56.08 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.571 0.7 . . . . 73.439999999999998 109.849 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.05 138.85 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.4 -0.813 . . . . 34.5 109.311 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . 0.42 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 53.0 p -105.46 2.29 28.44 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.548 -0.72 . . . . 73.209999999999994 110.412 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -75.7 147.01 39.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.987 -1.07 . . . . 70.409999999999997 109.629 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.532 ' O ' ' N ' ' B' ' 55' ' ' ALA . 62.3 mttp -73.35 -58.2 3.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.287 -0.883 . . . . 65.0 110.23 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -47.43 -12.85 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.089 -1.007 . . . . 75.209999999999994 109.904 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' B' ' 53' ' ' LYS . . . -58.67 -25.15 62.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.856 . . . . 55.329999999999998 110.598 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.427 HD22 ' NE2' ' B' ' 89' ' ' GLN . 97.7 mt -45.19 -47.44 12.49 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.065 -1.022 . . . . 63.140000000000001 109.827 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 21.5 m -68.81 -33.41 73.81 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.937 -1.102 . . . . 63.5 108.751 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . 0.413 ' CZ ' HD11 ' B' ' 62' ' ' ILE . 61.6 t80 -65.93 -60.68 2.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.422 -0.799 . . . . 72.329999999999998 109.77 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 31.4 m -50.0 -36.14 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.527 -1.358 . . . . 74.540000000000006 109.639 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 22.5 p -56.56 -54.2 48.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.107 -0.996 . . . . 71.239999999999995 109.68 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.576 ' HE ' ' NZ ' ' B' ' 65' ' ' LYS . 5.9 ptm180 -66.02 -30.18 70.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.007 -1.058 . . . . 74.310000000000002 110.034 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.413 HD11 ' CZ ' ' B' ' 58' ' ' PHE . 34.4 mm -65.08 -37.97 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.653 -1.28 . . . . 72.140000000000001 109.723 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' B' ' 67' ' ' SER . 25.0 mmtp -68.3 -51.87 39.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.063 -1.023 . . . . 73.319999999999993 110.302 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -67.47 -37.56 83.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.847 -1.158 . . . . 73.120000000000005 109.939 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.576 ' NZ ' ' HE ' ' B' ' 61' ' ' ARG . 92.9 mttt -81.55 -20.43 39.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -0.94 . . . . 72.439999999999998 109.707 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.485 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 74.0 m-70 -155.89 64.77 0.58 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.129 -0.982 . . . . 63.310000000000002 109.701 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.404 ' N ' ' O ' ' B' ' 63' ' ' LYS . 9.4 t -63.47 -29.01 70.36 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 73.099999999999994 109.669 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 96.5 p -61.64 -25.96 67.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 71.530000000000001 110.045 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.4 HD13 ' CE2' ' B' ' 45' ' ' TYR . 65.6 mt -83.4 151.3 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.093 -1.004 . . . . 74.400000000000006 109.48 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 99.2 t -89.93 154.62 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.415 -0.803 . . . . 75.120000000000005 109.318 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 18.1 t -134.57 127.78 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.308 -0.87 . . . . 73.200000000000003 109.618 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.575 HD23 ' C ' ' B' ' 72' ' ' LEU . 4.6 tt -118.91 102.66 8.95 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.455 0.645 . . . . 73.340000000000003 109.577 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . 0.452 ' O ' HG13 ' B' ' 73' ' ' VAL . 10.9 p -94.07 130.58 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.947 -1.096 . . . . 73.5 109.241 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 12.7 p -85.4 174.3 9.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.086 -1.009 . . . . 64.340000000000003 108.79 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . . . . . . . . . 10.4 p -153.43 110.23 3.41 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.827 -1.171 . . . . 74.530000000000001 110.679 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -71.23 -21.7 62.09 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.499 -0.926 . . . . 64.5 108.499 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -126.64 73.38 74.61 Favored Pre-proline 0 N--CA 1.494 1.764 0 N-CA-C 108.601 -0.889 . . . . 74.25 108.601 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.18 81.51 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.778 1.652 . . . . 74.430000000000007 111.843 -178.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.426 ' O ' ' OE2' ' B' ' 83' ' ' GLU . 4.3 t -110.08 152.12 26.37 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.736 -0.839 . . . . 73.120000000000005 108.736 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 1.6 t -50.88 -33.44 24.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 71.010000000000005 110.321 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -61.19 -37.29 82.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.999 -1.063 . . . . 63.200000000000003 110.236 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . 0.404 ' H ' HG23 ' B' ' 79' ' ' THR . 34.2 tp10 -78.93 -37.02 40.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.004 -1.06 . . . . 73.219999999999999 110.088 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.519 ' N ' ' OE1' ' B' ' 83' ' ' GLU . 0.3 OUTLIER -58.08 -50.51 73.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.098 -1.001 . . . . 74.299999999999997 109.615 -179.612 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.494 HG23 ' N ' ' B' ' 85' ' ' HIS . 24.3 m -67.8 -39.87 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.121 -0.987 . . . . 73.310000000000002 109.542 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' HIS . . . . . 0.625 ' CE1' ' NE2' ' B' ' 89' ' ' GLN . 4.4 t-160 -66.41 -26.87 67.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.171 -0.955 . . . . 73.239999999999995 109.562 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.68 -42.72 60.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.123 -0.986 . . . . 55.329999999999998 110.115 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -82.37 -33.38 28.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.081 -1.012 . . . . 74.140000000000001 109.275 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -68.58 -34.38 75.7 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.355 -0.841 . . . . 64.040000000000006 109.572 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . 0.625 ' NE2' ' CE1' ' B' ' 85' ' ' HIS . 36.5 mt-30 -80.43 -63.61 1.37 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -0.953 . . . . 72.349999999999994 109.677 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 163.2 68.06 0.02 OUTLIER Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.401 -1.38 . . . . 65.200000000000003 110.435 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -127.18 137.29 52.9 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.455 -1.026 . . . . 52.229999999999997 108.837 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' B' ' 93' ' ' ASP . 14.2 t70 -80.89 -34.52 33.49 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.055 -1.028 . . . . 73.319999999999993 109.448 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . 0.512 ' OD1' ' NH2' ' B' ' 112' ' ' ARG . 57.9 m-20 -149.96 164.15 36.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.35 -0.844 . . . . 72.219999999999999 109.441 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.532 ' CD1' ' O ' ' B' ' 94' ' ' TYR . 0.0 OUTLIER -140.17 112.97 8.09 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.684 -0.858 . . . . 64.420000000000002 108.684 -178.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 35.4 mm -114.46 147.79 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 121.368 -0.833 . . . . 72.230000000000004 110.124 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . 0.511 ' HB1' ' HD2' ' B' ' 98' ' ' PRO . . . -62.47 139.52 58.58 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.172 -0.955 . . . . 25.239999999999998 108.558 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.601 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -69.17 -40.95 16.68 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.185 -0.947 . . . . 64.319999999999993 110.916 -179.19 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' B' ' 97' ' ' LYS . 33.1 Cg_exo -52.25 1.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.29 -2.518 0 CA-C-N 118.4 0.464 . . . . 63.329999999999998 112.833 -174.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . 0.601 ' N ' ' O ' ' B' ' 97' ' ' LYS . 45.7 m-85 55.55 99.19 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.453 -0.779 . . . . 75.129999999999995 109.722 178.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 34.9 ttm-85 -59.46 -36.09 75.3 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.009 -1.057 . . . . 74.230000000000004 108.724 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . 0.753 ' O ' ' N ' ' B' ' 103' ' ' LYS . 12.6 t -173.84 39.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.234 -0.916 . . . . 63.340000000000003 110.688 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . 0.425 ' C ' ' N ' ' B' ' 104' ' ' ALA . 60.3 mt 51.92 -69.84 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.48 -0.763 . . . . 74.439999999999998 110.062 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.753 ' N ' ' O ' ' B' ' 101' ' ' SER . 38.1 mmtm -56.65 -15.36 4.33 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.168 -1.419 . . . . 71.109999999999999 107.168 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.425 ' N ' ' C ' ' B' ' 102' ' ' ILE . . . -60.54 -78.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.349 -0.54 . . . . 71.450000000000003 110.189 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.598 ' H ' HD12 ' B' ' 105' ' ' LEU . 0.0 OUTLIER -51.9 -41.17 61.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.95 -1.094 . . . . 51.310000000000002 109.381 -179.151 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . 0.806 HG12 ' HZ2' ' B' ' 23' ' ' LYS . 27.6 t -57.84 -45.21 87.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.995 -1.066 . . . . 65.230000000000004 108.804 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.04 -30.86 62.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.21 -0.931 . . . . 24.32 108.787 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 0.434 HH12 ' NH2' ' B' ' 112' ' ' ARG . 2.0 tpm_? -80.72 -24.77 38.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.428 -0.795 . . . . 75.310000000000002 109.649 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 93.9 mt -80.08 -38.93 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.114 -0.991 . . . . 54.240000000000002 109.391 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . 0.52 ' OE1' ' NZ ' ' B' ' 23' ' ' LYS . 22.7 pt-20 -72.58 -40.93 66.22 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.163 -0.961 . . . . 65.310000000000002 109.509 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.21 -44.26 95.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.929 . . . . 72.239999999999995 109.248 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . 0.512 ' NH2' ' OD1' ' B' ' 93' ' ' ASP . 56.2 ttm-85 -63.08 -31.73 72.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 72.040000000000006 109.443 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 13.4 tp -145.12 70.54 1.27 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.263 -0.898 . . . . 75.349999999999994 109.127 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' B' ' 110' ' ' GLU . 96.2 mtt180 -62.69 -46.22 89.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 75.5 109.709 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -81.62 -103.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 65.329999999999998 109.536 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 65.0 p-90 -163.43 -28.63 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.101 -0.999 . . . . 74.450000000000003 109.759 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -167.94 -172.48 35.0 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.767 -1.333 . . . . 44.210000000000001 109.767 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 48.9 m -145.48 -172.04 3.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.369 -1.077 . . . . 71.400000000000006 109.382 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.82 160.74 43.68 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.671 -0.812 . . . . 72.319999999999993 109.406 -178.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 4.5 t -134.3 -38.1 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.484 -0.76 . . . . 75.019999999999996 109.176 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' B' ' 128' ' ' ILE . 27.6 mm -110.87 133.32 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.797 -0.816 . . . . 51.409999999999997 108.797 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -137.31 143.62 42.2 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.396 -0.815 . . . . 71.530000000000001 108.904 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.971 HD11 ' NH2' ' B' ' 159' ' ' ARG . 19.5 tt -155.02 127.1 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 72.430000000000007 109.879 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 47.49 -151.56 2.07 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.723 -1.351 . . . . 51.229999999999997 109.723 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -75.75 -3.29 34.06 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.206 -1.173 . . . . 74.200000000000003 109.065 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.41 147.02 24.92 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.112 -1.07 . . . . 75.420000000000002 108.112 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 36.1 m -126.61 134.82 50.69 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.457 -0.777 . . . . 74.219999999999999 108.978 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' B' ' 121' ' ' ILE . 96.1 mt -126.2 124.15 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.54 -0.725 . . . . 60.329999999999998 109.675 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 18.8 m -123.89 109.21 30.08 Favored Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 109.198 -0.667 . . . . 72.310000000000002 109.198 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.96 -24.72 5.63 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.665 1.577 . . . . 75.129999999999995 111.629 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . 0.419 ' O ' ' OE2' ' B' ' 133' ' ' GLU . 26.3 t0 -62.0 -42.9 99.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 75.230000000000004 109.183 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -91.6 4.54 52.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.368 -0.833 . . . . 72.430000000000007 108.951 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.419 ' OE2' ' O ' ' B' ' 131' ' ' ASP . 28.8 mp0 49.32 64.29 1.8 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.098 -1.001 . . . . 75.129999999999995 109.405 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 30.0 ttpt -159.43 140.3 12.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.093 -1.004 . . . . 73.219999999999999 109.997 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 63.7 mt -118.98 137.23 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.631 -0.877 . . . . 64.140000000000001 108.631 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 15.2 mt -121.59 129.78 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.606 -0.684 . . . . 71.219999999999999 109.896 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -139.94 144.59 37.16 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.445 -0.784 . . . . 64.219999999999999 109.202 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 48.9 mttp 55.19 19.65 3.0 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.932 -0.766 . . . . 72.019999999999996 108.932 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 82.33 2.54 90.62 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.243 -1.143 . . . . 74.319999999999993 110.243 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . 0.405 ' N ' ' HD2' ' B' ' 140' ' ' ARG . 10.0 mmm-85 -89.85 129.13 36.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.249 . . . . 75.340000000000003 108.931 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -91.97 121.04 33.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.269 -0.894 . . . . 71.230000000000004 109.194 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 89.2 t -135.01 132.77 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.338 -0.851 . . . . 70.430000000000007 109.786 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -97.32 154.79 17.21 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.289 -0.882 . . . . 72.430000000000007 108.724 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 4.5 m -134.01 132.76 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.298 -0.876 . . . . 72.129999999999995 109.794 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . 0.527 ' N ' ' CD ' ' B' ' 145' ' ' LYS . 0.0 OUTLIER -159.77 130.21 5.65 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.365 -0.834 . . . . 72.019999999999996 109.313 179.796 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 143.63 -120.63 1.52 Allowed Glycine 0 N--CA 1.493 2.5 0 N-CA-C 108.946 -1.662 . . . . 42.229999999999997 108.946 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 0.592 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 22.3 mtmt -101.86 -35.83 0.22 Allowed Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.457 -1.026 . . . . 73.299999999999997 111.072 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . 0.932 ' O ' HD13 ' B' ' 152' ' ' LEU . 44.6 Cg_endo -92.56 8.92 2.69 Favored 'Trans proline' 0 N--CA 1.488 1.176 0 C-N-CA 122.264 1.976 . . . . 71.329999999999998 113.538 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . 0.46 ' CG ' ' N ' ' B' ' 150' ' ' GLU . 3.5 p90 -87.28 -40.71 14.26 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.732 -1.23 . . . . 74.230000000000004 110.215 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . 0.46 ' N ' ' CG ' ' B' ' 149' ' ' PHE . 16.4 pt-20 -69.08 -33.4 73.48 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.391 -0.818 . . . . 72.340000000000003 110.512 -178.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.722 HG13 HD12 ' B' ' 152' ' ' LEU . 12.5 p -67.66 -39.14 81.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.822 -1.173 . . . . 73.349999999999994 109.039 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.932 HD13 ' O ' ' B' ' 148' ' ' PRO . 9.6 mp -59.78 -53.04 62.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.377 -0.827 . . . . 55.240000000000002 109.475 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.2 p -72.75 -30.61 64.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.318 -0.864 . . . . 70.010000000000005 111.144 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -59.84 -52.08 66.96 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.606 -1.309 . . . . 65.319999999999993 109.995 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 pp -71.97 -29.53 64.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.943 -1.098 . . . . 71.540000000000006 110.001 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -56.77 -50.26 72.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.017 -1.052 . . . . 75.319999999999993 110.068 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.487 ' C ' ' H ' ' B' ' 159' ' ' ARG . 68.9 mtp180 -72.99 -57.0 4.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.177 -0.952 . . . . 73.319999999999993 109.657 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -61.21 1.73 0.17 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.368 -0.832 . . . . 74.140000000000001 109.704 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . 1.636 HH21 ' CA ' ' B' ' 216' ' ' TYR . 26.7 ttt180 -53.09 165.39 0.32 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.119 -0.988 . . . . 61.409999999999997 109.881 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . 0.834 ' OD1' ' HG2' ' B' ' 159' ' ' ARG . 2.7 m-20 61.25 43.33 10.98 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.71 -0.619 . . . . 72.099999999999994 110.175 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -157.21 175.42 14.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.058 -1.026 . . . . 72.25 109.449 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 77.8 mt -93.6 132.19 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.656 -0.868 . . . . 72.310000000000002 108.656 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 96.8 t -128.76 138.6 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.403 -0.811 . . . . 64.209999999999994 109.86 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 37.6 t -101.04 169.08 9.19 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.454 -0.779 . . . . 74.219999999999999 109.933 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -68.63 -48.49 63.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.519 -0.738 . . . . 65.310000000000002 110.088 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -57.1 -41.88 79.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.295 -0.878 . . . . 63.450000000000003 110.791 -178.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 167' ' ' GLN . . . . . 0.425 ' O ' ' OD1' ' B' ' 170' ' ' ASP . 89.9 mt-30 -51.04 -38.51 51.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.048 -1.032 . . . . 72.400000000000006 110.072 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 71.9 mt -73.31 -40.53 64.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.994 -1.066 . . . . 72.319999999999993 109.635 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.598 HD23 ' O ' ' B' ' 169' ' ' LEU . 1.9 tt -61.62 -42.35 98.77 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.405 -0.809 . . . . 73.340000000000003 109.7 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . 0.534 ' O ' ' CH2' ' B' ' 173' ' ' TRP . 22.9 p30 -86.2 -13.54 46.65 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 118.769 -1.172 . . . . 72.099999999999994 110.796 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . 0.4 ' N ' ' OD1' ' B' ' 170' ' ' ASP . . . -94.52 -38.03 11.1 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.837 -1.164 . . . . 62.130000000000003 111.056 -179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.484 HG22 ' O ' ' B' ' 172' ' ' ILE . 60.6 mt -114.17 -9.98 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.26 -0.9 . . . . 71.420000000000002 110.589 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 173' ' ' TRP . . . . . 0.569 ' O ' ' N ' ' B' ' 175' ' ' GLU . 10.2 m95 71.72 -1.8 2.69 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.43 -0.794 . . . . 72.230000000000004 109.632 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 63.72 -59.79 0.18 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.947 -0.701 . . . . 52.109999999999999 110.662 177.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . 0.569 ' N ' ' O ' ' B' ' 173' ' ' TRP . 7.0 mt-10 -149.81 162.78 27.14 Favored Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 107.533 -1.284 . . . . 73.040000000000006 107.533 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' B' ' 175' ' ' GLU . 54.5 Cg_exo -34.94 -73.7 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.231 1.954 . . . . 74.129999999999995 111.459 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . 0.484 ' C ' ' H ' ' B' ' 179' ' ' VAL . 78.5 mt-10 -157.35 -1.69 0.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.219 -0.926 . . . . 72.439999999999998 108.84 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 7.2 tpt -69.37 5.97 1.17 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.529 -0.915 . . . . 63.43 108.529 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 179' ' ' VAL . . . . . 0.484 ' H ' ' C ' ' B' ' 177' ' ' GLU . 7.6 p -46.06 152.52 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.56 -0.713 . . . . 71.049999999999997 109.986 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . 0.536 ' O ' ' N ' ' B' ' 182' ' ' ASN . 3.0 p -135.66 154.49 78.17 Favored Pre-proline 0 N--CA 1.497 1.893 0 N-CA-C 108.687 -0.857 . . . . 62.149999999999999 108.687 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -37.18 -23.25 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 122.31 2.007 . . . . 65.219999999999999 112.413 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 182' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' B' ' 180' ' ' THR . 3.1 p-10 -149.18 120.31 7.75 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.196 -0.94 . . . . 72.310000000000002 109.14 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 3.2 p -156.14 -15.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.259 -0.901 . . . . 63.32 110.868 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.401 ' O ' HG22 ' B' ' 188' ' ' ILE . 29.0 mm -51.47 -31.11 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.738 -1.226 . . . . 75.030000000000001 109.502 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -54.59 -34.77 62.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.096 -1.003 . . . . 64.109999999999999 108.484 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 2.0 t -80.36 -57.22 5.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.491 -0.755 . . . . 73.0 109.366 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -51.78 -51.65 54.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.119 -0.988 . . . . 61.119999999999997 109.715 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 188' ' ' ILE . . . . . 0.582 HD12 ' CZ ' ' B' ' 212' ' ' TYR . 1.7 tt -57.68 -43.35 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.894 -1.129 . . . . 72.430000000000007 108.962 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 189' ' ' ASN . . . . . 0.441 ' N ' HG23 ' B' ' 188' ' ' ILE . 24.8 t-20 -62.11 -38.24 88.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.039 -1.038 . . . . 65.140000000000001 109.271 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -69.31 -50.47 46.34 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.922 . . . . 63.240000000000002 109.735 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 96.8 mt -53.34 -45.61 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.294 -0.879 . . . . 74.030000000000001 109.491 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -59.71 -42.75 93.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.898 . . . . 72.239999999999995 109.656 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -68.72 -38.13 79.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -0.944 . . . . 73.099999999999994 109.187 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . 0.49 ' O ' ' CG ' ' B' ' 198' ' ' PRO . 31.0 mttp -71.32 -13.24 61.81 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.371 -0.831 . . . . 72.109999999999999 109.24 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 30.0 mmm -101.47 -33.29 10.02 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.398 -0.814 . . . . 44.329999999999998 109.519 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -82.85 -12.5 57.38 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.097 -1.002 . . . . 71.209999999999994 110.454 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . 0.449 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 34.2 mttm -89.46 -65.95 0.16 Allowed Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 120.855 -1.153 . . . . 75.209999999999994 109.907 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 198' ' ' PRO . . . . . 0.49 ' CG ' ' O ' ' B' ' 194' ' ' LYS . 36.7 Cg_endo -63.56 -70.13 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 121.968 1.779 . . . . 75.319999999999993 112.122 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . 0.512 ' H ' HD12 ' B' ' 199' ' ' LEU . 7.6 mp -55.81 -38.82 70.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.116 -0.99 . . . . 72.25 108.777 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 77.69 5.63 86.39 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.792 -1.323 . . . . 64.530000000000001 109.792 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . . . . . . . . . 16.1 mt -132.83 140.13 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.377 -1.072 . . . . 44.229999999999997 109.338 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 13.1 t -78.0 147.47 34.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -0.933 . . . . 54.009999999999998 109.261 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 1.4 p -145.47 24.53 1.4 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.196 -0.94 . . . . 74.400000000000006 109.443 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 19.9 m -139.82 146.33 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.201 -0.937 . . . . 72.120000000000005 109.791 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -119.45 132.54 55.82 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.83 -0.804 . . . . 65.409999999999997 108.83 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 31.1 p -103.27 127.32 50.63 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.252 -0.905 . . . . 71.329999999999998 109.74 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 12.8 p -144.59 143.22 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.198 -0.939 . . . . 63.5 109.248 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 24.1 mtm105 -86.7 101.9 13.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.2 -0.938 . . . . 74.450000000000003 109.757 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 11.9 tpp85 -171.54 -76.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.378 -0.826 . . . . 74.140000000000001 108.82 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -107.56 -42.47 4.77 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.993 -0.743 . . . . 74.430000000000007 108.993 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 173.11 -119.8 0.78 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.408 -1.477 . . . . 64.450000000000003 109.408 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 212' ' ' TYR . . . . . 0.582 ' CZ ' HD12 ' B' ' 188' ' ' ILE . 8.1 m-85 -129.71 156.66 43.92 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.468 -1.019 . . . . 74.209999999999994 109.17 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 52.4 mmt-85 -111.32 144.71 40.07 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.539 -0.725 . . . . 74.030000000000001 109.319 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -119.63 114.27 21.95 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.611 -0.681 . . . . 74.340000000000003 109.165 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 91.3 m -148.45 170.34 18.24 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.25 -0.906 . . . . 64.329999999999998 109.614 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . 1.636 ' CA ' HH21 ' B' ' 159' ' ' ARG . 38.0 p90 -74.27 150.58 87.5 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 70.040000000000006 109.513 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 217' ' ' PRO . . . . . 0.939 ' HD3' HH22 ' B' ' 159' ' ' ARG . 67.1 Cg_exo -37.2 156.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.358 2.039 . . . . 65.109999999999999 112.46 179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.449 ' CB ' ' CD ' ' B' ' 219' ' ' PRO . 2.7 mptm? -65.18 -64.95 2.17 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.336 -0.853 . . . . 73.150000000000006 109.806 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' B' ' 218' ' ' LYS . 30.1 Cg_endo -60.94 -33.35 92.54 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.257 1.971 . . . . 71.310000000000002 112.295 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . 54.94 26.51 7.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.108 -0.995 . . . . 75.450000000000003 109.391 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 4.5 t 62.8 40.73 9.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 72.219999999999999 109.349 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -81.56 149.8 28.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 54.530000000000001 109.657 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.951 -1.024 . . . . 71.129999999999995 109.337 179.664 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.577 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.409 -0.589 . . . . 65.120000000000005 109.409 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.751 ' HE ' HH21 ' A' ' 43' ' ' ARG . 81.2 mtt85 -136.34 150.19 48.74 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.376 -0.828 . . . . 72.329999999999998 109.358 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.3 t -113.76 129.42 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 121.576 0.703 . . . . 71.420000000000002 109.982 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.507 HD11 ' CG1' ' A' ' 6' ' ' ILE . 2.6 tp -98.25 118.45 34.93 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.37 -0.974 . . . . 65.120000000000005 108.37 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.417 ' N ' HD12 ' A' ' 4' ' ' LEU . 5.8 tp -119.09 108.46 14.73 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.612 -0.68 . . . . 62.43 109.31 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.507 ' CG1' HD11 ' A' ' 4' ' ' LEU . 46.3 mt -101.2 109.72 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.514 -0.921 . . . . 71.150000000000006 108.514 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.426 ' OE1' ' CB ' ' A' ' 51' ' ' SER . 24.7 tp10 -137.96 123.69 19.89 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.437 -0.789 . . . . 75.340000000000003 109.452 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.1 tptt -68.66 -31.29 70.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.24 -0.912 . . . . 72.439999999999998 108.771 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -86.23 122.41 30.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.429 -0.794 . . . . 63.020000000000003 109.367 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.4 m -74.62 -20.7 59.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 72.340000000000003 109.728 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 49.2 t -71.38 -55.7 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.183 -0.948 . . . . 74.019999999999996 109.872 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.558 ' N ' HD22 ' A' ' 12' ' ' LEU . 3.5 mm? -67.85 -35.72 79.07 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.219 -0.926 . . . . 71.430000000000007 109.519 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.36 -31.07 57.63 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.758 -1.737 . . . . 61.32 108.758 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.98 -48.42 76.04 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.953 -1.259 . . . . 71.200000000000003 109.953 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -64.04 -46.65 83.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -1.174 . . . . 71.319999999999993 109.882 -179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.3 mm -64.65 -48.54 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.778 -1.201 . . . . 63.229999999999997 109.175 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -46.28 -56.93 5.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.182 -0.949 . . . . 51.109999999999999 109.812 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -84.47 3.01 38.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.17 -0.956 . . . . 73.340000000000003 109.305 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -80.02 -65.95 1.71 Allowed Glycine 0 N--CA 1.483 1.786 0 N-CA-C 109.899 -1.28 . . . . 62.149999999999999 109.899 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.532 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.5 pt? -66.53 -23.39 66.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -1.173 . . . . 73.510000000000005 110.081 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.435 HD21 ' HB3' ' A' ' 27' ' ' ALA . 3.9 m120 -56.69 -35.95 69.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -0.991 . . . . 74.25 109.872 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 87.5 t -56.1 -39.36 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.164 -0.96 . . . . 70.040000000000006 109.579 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HZ2' HG11 ' A' ' 106' ' ' VAL . 1.7 mptm? -63.63 -12.43 33.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 73.230000000000004 109.322 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.61 37.78 4.13 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.263 -1.135 . . . . 75.540000000000006 110.263 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -119.61 160.71 21.95 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.477 -1.013 . . . . 73.430000000000007 109.263 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 16.4 mmt -100.86 138.97 37.2 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.257 -1.016 . . . . 43.240000000000002 108.257 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.435 ' HB3' HD21 ' A' ' 21' ' ' ASN . . . -141.24 159.67 41.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.25 -0.906 . . . . 62.109999999999999 109.974 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -135.94 144.88 45.69 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.512 -0.742 . . . . 74.420000000000002 109.042 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.5 131.34 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.458 -0.776 . . . . 72.150000000000006 108.911 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.8 p -134.74 169.67 16.99 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.449 -0.782 . . . . 71.420000000000002 109.379 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -93.41 -103.22 0.13 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.304 -0.872 . . . . 72.329999999999998 109.718 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 t -78.78 166.83 22.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 74.239999999999995 110.012 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.401 HD22 ' CG ' ' A' ' 58' ' ' PHE . 20.4 mt -54.37 -31.94 55.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.552 -0.718 . . . . 71.530000000000001 109.82 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -49.16 -48.75 44.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 74.230000000000004 109.513 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.02 -38.32 90.72 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.156 -0.965 . . . . 54.030000000000001 108.914 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.85 -37.06 92.97 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.296 -1.522 . . . . 61.409999999999997 109.296 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -68.35 -42.91 78.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 74.340000000000003 109.462 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -71.78 -37.67 70.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 75.329999999999998 109.906 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.8 tp -75.9 -46.01 32.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.193 -0.942 . . . . 74.329999999999998 110.308 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.484 ' SD ' ' OD1' ' A' ' 41' ' ' ASP . 3.5 ppp? -65.24 -32.24 73.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.045 -1.034 . . . . 70.319999999999993 110.177 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.484 ' OD1' ' SD ' ' A' ' 40' ' ' MET . 87.1 m-20 -62.68 -39.58 94.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.067 -1.021 . . . . 71.219999999999999 110.03 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.4 HG12 ' H ' ' A' ' 42' ' ' ILE . 25.8 pt -82.31 -29.44 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.066 -1.021 . . . . 74.140000000000001 110.176 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.751 HH21 ' HE ' ' A' ' 2' ' ' ARG . 73.6 mtp180 -130.07 140.51 50.82 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.342 -0.849 . . . . 72.239999999999995 109.596 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -90.25 157.66 17.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.214 -0.929 . . . . 75.420000000000002 109.488 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -138.04 150.89 47.34 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.391 -0.818 . . . . 74.230000000000004 109.345 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 2' ' ' ARG . 7.9 p-10 -95.21 -40.25 9.67 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.175 -0.953 . . . . 72.040000000000006 109.463 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.462 HD13 ' C ' ' A' ' 47' ' ' LEU . 0.5 OUTLIER -102.97 109.66 21.29 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.397 -0.814 . . . . 72.129999999999995 109.059 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.445 ' N ' HD13 ' A' ' 47' ' ' LEU . 78.7 t -95.08 97.67 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.193 -0.942 . . . . 72.340000000000003 108.616 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 38.1 ttm -111.44 131.51 55.15 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.481 -0.762 . . . . 74.109999999999999 109.595 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.451 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 1.3 p -141.0 133.0 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.479 -0.763 . . . . 61.119999999999997 109.818 -179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.426 ' CB ' ' OE1' ' A' ' 7' ' ' GLU . 59.9 p -100.85 7.01 43.93 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.608 -0.683 . . . . 73.109999999999999 109.538 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 84.7 m-20 -76.04 141.12 42.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.135 -0.978 . . . . 52.549999999999997 109.465 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.494 ' C ' ' H ' ' A' ' 55' ' ' ALA . 68.0 mttm -73.43 -44.64 57.82 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.29 -0.881 . . . . 44.219999999999999 110.435 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -71.02 15.47 0.11 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.107 -0.996 . . . . 70.439999999999998 109.807 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -74.97 -21.61 59.05 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.278 -0.889 . . . . 64.140000000000001 110.334 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.41 ' HB3' HE22 ' A' ' 89' ' ' GLN . 19.0 mt -40.49 -52.96 2.75 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.499 -0.751 . . . . 44.140000000000001 110.357 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.9 m -67.2 -32.86 74.2 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.053 -1.029 . . . . 55.229999999999997 109.141 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.523 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 63.0 t80 -66.06 -52.95 44.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.479 -0.763 . . . . 74.439999999999998 110.313 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 m -57.74 -34.57 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.701 -1.249 . . . . 74.030000000000001 109.709 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.1 m -59.02 -55.51 34.24 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.112 -0.993 . . . . 64.299999999999997 109.625 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -63.21 -28.08 69.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 64.439999999999998 110.142 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.523 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 5.2 mm -66.6 -31.79 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.951 -1.093 . . . . 63.210000000000001 109.898 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.525 ' NZ ' ' OD1' ' A' ' 92' ' ' ASP . 23.1 mmtt -77.12 -50.23 13.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.057 -1.027 . . . . 74.420000000000002 110.267 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -67.62 -41.21 84.3 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.754 -1.217 . . . . 70.319999999999993 109.87 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.521 ' O ' ' NZ ' ' A' ' 145' ' ' LYS . 9.1 mtpm? -72.5 -26.24 61.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 75.219999999999999 109.75 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.564 ' O ' HG22 ' A' ' 69' ' ' ILE . 93.2 m-70 -153.19 65.93 0.77 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.16 -0.963 . . . . 74.129999999999995 109.301 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.476 ' N ' ' O ' ' A' ' 63' ' ' LYS . 18.0 m -56.45 -32.43 64.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.27 -0.894 . . . . 73.239999999999995 110.055 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 83.3 p -73.17 47.02 0.19 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.111 -0.993 . . . . 61.009999999999998 110.049 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 66' ' ' HIS . 13.5 tt -146.48 159.07 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.051 -1.031 . . . . 71.329999999999998 109.45 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.5 t -95.57 154.26 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.12 -0.987 . . . . 72.129999999999995 109.106 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.433 ' H ' ' HB2' ' A' ' 92' ' ' ASP . 15.4 t -142.66 118.69 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.123 -0.985 . . . . 54.210000000000001 109.823 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.572 ' HG ' HD11 ' A' ' 95' ' ' ILE . 1.6 mp -119.23 99.57 6.79 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.624 -0.88 . . . . 50.240000000000002 108.624 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.8 p -94.3 152.99 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.255 -1.017 . . . . 74.409999999999997 108.255 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.08 169.94 9.26 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.443 -0.785 . . . . 72.310000000000002 108.912 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.2 t -168.39 123.7 0.96 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.177 -0.952 . . . . 64.540000000000006 110.159 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 0.4 OUTLIER -76.12 15.84 0.51 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.466 -0.771 . . . . 74.129999999999995 110.024 -179.082 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.407 ' O ' ' N ' ' A' ' 79' ' ' THR . 30.7 m120 -139.88 58.61 11.65 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.152 -0.967 . . . . 73.340000000000003 110.115 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.44 84.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.393 2.062 . . . . 63.219999999999999 112.452 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 81' ' ' GLU . 28.7 m -106.81 149.73 27.07 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.143 -1.058 . . . . 62.530000000000001 108.143 178.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.04 -32.16 71.78 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.008 -1.057 . . . . 73.439999999999998 109.367 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.423 ' H ' HG22 ' A' ' 79' ' ' THR . 44.1 tp10 -64.44 -43.13 95.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.119 -0.988 . . . . 71.420000000000002 109.294 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -76.64 -35.74 57.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 73.430000000000007 109.602 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -57.74 -56.77 17.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.237 -0.914 . . . . 74.219999999999999 109.67 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.475 HG23 ' N ' ' A' ' 85' ' ' HIS . 25.4 m -61.55 -39.75 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.131 -0.981 . . . . 73.200000000000003 109.273 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.475 ' N ' HG23 ' A' ' 84' ' ' VAL . 72.7 t60 -60.22 -36.97 78.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.214 -0.929 . . . . 53.329999999999998 109.554 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.53 -45.83 88.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.195 -0.941 . . . . 64.109999999999999 109.829 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.615 ' CZ ' ' NH1' ' B' ' 108' ' ' ARG . 77.1 m-85 -74.96 -27.92 60.37 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.171 -0.955 . . . . 74.340000000000003 108.722 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -69.88 -50.23 44.54 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.521 -0.737 . . . . 74.420000000000002 109.297 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.474 ' NE2' ' NE2' ' A' ' 85' ' ' HIS . 84.8 mt-30 -58.01 -49.64 76.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.512 -0.742 . . . . 74.239999999999995 110.003 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 153.8 -10.76 0.5 Allowed Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.423 -1.37 . . . . 61.509999999999998 110.738 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -50.8 139.5 16.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.812 -1.405 . . . . 55.329999999999998 109.373 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.525 ' OD1' ' NZ ' ' A' ' 63' ' ' LYS . 11.4 m-20 -76.08 -40.01 54.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.103 -0.998 . . . . 73.420000000000002 109.32 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 94' ' ' TYR . 56.8 t0 -153.09 157.12 39.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.259 -0.9 . . . . 75.040000000000006 109.47 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.539 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -128.38 133.94 48.73 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.791 -0.818 . . . . 71.329999999999998 108.791 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.817 HD12 ' N ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -122.39 138.67 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-O 121.717 0.77 . . . . 71.129999999999995 110.242 -179.826 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.8 119.98 8.15 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.027 -1.101 . . . . 64.319999999999993 108.027 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.694 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -43.95 -54.39 11.18 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 62.200000000000003 111.501 -178.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 1.0 OUTLIER -38.51 -13.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 121.198 1.266 . . . . 73.109999999999999 113.202 -176.465 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.694 ' N ' ' O ' ' A' ' 97' ' ' LYS . 57.6 m-85 56.32 100.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.632 -0.668 . . . . 65.219999999999999 110.039 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.0 mtt85 -55.7 -42.87 75.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.786 -1.197 . . . . 72.349999999999994 108.21 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.3 t -169.1 132.23 1.31 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.855 -0.794 . . . . 71.319999999999993 108.855 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 62.4 mt -51.32 -43.8 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.148 -0.97 . . . . 75.430000000000007 109.327 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.417 ' CD ' ' N ' ' A' ' 103' ' ' LYS . 3.4 mptp? -62.07 -35.07 77.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 71.409999999999997 109.611 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.24 -55.82 10.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.13 -0.982 . . . . 63.240000000000002 109.883 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.4 tp -57.84 -56.75 17.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 73.219999999999999 109.702 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.553 HG11 ' HZ2' ' A' ' 23' ' ' LYS . 74.1 t -53.15 -43.71 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.971 -1.081 . . . . 60.109999999999999 109.546 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.55 -43.1 64.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.14 -0.975 . . . . 70.420000000000002 108.913 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -66.81 -37.1 83.87 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.362 -0.836 . . . . 74.409999999999997 109.333 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 65.1 mt -66.94 -33.82 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 107.879 -1.156 . . . . 62.539999999999999 107.879 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -59.6 -42.83 93.49 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.368 -0.975 . . . . 74.340000000000003 108.368 179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.417 ' HB2' ' CZ ' ' B' ' 87' ' ' PHE . . . -57.61 -50.33 73.5 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.354 -0.841 . . . . 73.319999999999993 109.497 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -59.16 -50.77 72.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.209 -0.932 . . . . 52.409999999999997 109.622 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.507 ' O ' ' CE2' ' A' ' 116' ' ' TRP . 53.2 mt -64.98 -36.61 84.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.046 -1.034 . . . . 65.239999999999995 109.646 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -56.34 -36.88 69.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -0.891 . . . . 64.450000000000003 109.595 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -78.2 54.6 1.39 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 74.430000000000007 109.431 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.507 ' CE2' ' O ' ' A' ' 113' ' ' LEU . 7.2 m-90 -59.66 148.74 32.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.928 . . . . 74.420000000000002 109.478 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -50.84 127.29 27.68 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.702 -1.359 . . . . 75.040000000000006 109.702 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.2 t -85.96 3.23 42.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -1.134 . . . . 61.140000000000001 109.424 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.487 ' CG ' ' H ' ' A' ' 120' ' ' VAL . 47.4 t30 52.53 -179.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 65.239999999999995 109.413 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.487 ' H ' ' CG ' ' A' ' 119' ' ' ASN . 5.3 t -141.97 -45.66 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.304 -0.872 . . . . 73.109999999999999 109.61 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.0 mm -98.59 125.38 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.191 -0.943 . . . . 72.239999999999995 109.281 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.474 ' N ' ' CD ' ' A' ' 122' ' ' GLU . 1.3 pm0 -134.05 108.87 8.6 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.499 -0.751 . . . . 72.340000000000003 108.976 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.438 ' O ' HG23 ' A' ' 123' ' ' ILE . 18.2 tt -134.88 131.08 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.466 -0.771 . . . . 71.439999999999998 109.113 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.08 -145.83 5.47 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.576 -1.409 . . . . 73.400000000000006 109.576 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -85.75 -0.62 55.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -1.185 . . . . 74.450000000000003 109.331 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.92 130.52 44.21 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.51 -0.922 . . . . 54.210000000000001 108.51 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.474 ' CG2' ' ND2' ' A' ' 119' ' ' ASN . 32.1 m -130.45 129.37 42.9 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.353 -0.842 . . . . 54.5 109.571 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 27.1 mm -113.67 133.3 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.414 -0.804 . . . . 45.149999999999999 109.195 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.5 m -115.87 96.59 47.2 Favored Pre-proline 0 N--CA 1.498 1.936 0 N-CA-C 109.13 -0.692 . . . . 71.109999999999999 109.13 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -78.46 -37.07 0.77 Allowed 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 121.839 1.693 . . . . 65.409999999999997 111.943 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -68.18 -43.51 77.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 63.32 109.255 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -90.23 -1.87 57.98 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.375 -0.828 . . . . 72.519999999999996 109.416 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 52.97 62.41 2.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.354 -0.841 . . . . 75.329999999999998 109.972 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -150.22 140.59 22.34 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.271 -0.893 . . . . 71.230000000000004 109.085 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 7.3 tt -121.68 135.32 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 108.93 -0.767 . . . . 74.019999999999996 108.93 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 136' ' ' ILE . 14.8 mt -116.71 129.32 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.65 -0.656 . . . . 60.229999999999997 109.561 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.439 ' CE2' ' O ' ' A' ' 198' ' ' PRO . 54.8 t80 -138.46 138.05 37.76 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.589 -0.694 . . . . 62.32 109.199 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm 53.35 31.07 11.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.365 -0.834 . . . . 75.400000000000006 110.1 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 73.94 15.22 79.76 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 120.051 -1.071 . . . . 72.239999999999995 110.456 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -107.52 125.23 51.02 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.401 -1.058 . . . . 71.219999999999999 109.342 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -95.04 126.18 40.21 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.269 -0.894 . . . . 71.420000000000002 109.704 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.9 p -137.85 140.79 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.375 -0.828 . . . . 53.020000000000003 109.254 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -85.51 144.44 27.94 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.3 -0.875 . . . . 60.450000000000003 109.314 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.424 HG21 ' CD1' ' A' ' 149' ' ' PHE . 16.2 m -147.29 137.16 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.242 -0.911 . . . . 74.439999999999998 109.539 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.521 ' NZ ' ' O ' ' A' ' 65' ' ' LYS . 43.7 pttt -156.59 20.36 0.34 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.323 -0.861 . . . . 65.150000000000006 109.495 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.48 -178.92 51.73 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.297 -1.521 . . . . 73.340000000000003 109.297 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 13.5 ttmt -64.76 -39.89 43.27 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.185 -1.186 . . . . 72.219999999999999 109.82 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 25.4 Cg_exo -62.18 -24.63 76.44 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.324 2.016 . . . . 65.230000000000004 112.098 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.576 ' CZ ' ' CG2' ' A' ' 153' ' ' THR . 59.0 t80 -82.27 -42.02 19.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.13 -0.981 . . . . 60.109999999999999 110.003 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.466 ' O ' ' ND1' ' A' ' 154' ' ' HIS . 80.8 mm-40 -50.11 -45.47 52.89 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.134 -0.979 . . . . 64.209999999999994 109.36 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.8 p -72.05 -35.08 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.215 -0.928 . . . . 72.019999999999996 109.099 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 15.0 tp -60.5 -38.0 82.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.332 -0.855 . . . . 73.310000000000002 109.159 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.576 ' CG2' ' CZ ' ' A' ' 149' ' ' PHE . 16.8 p -71.74 -41.89 67.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.315 -0.865 . . . . 74.310000000000002 109.8 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.818 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 34.2 m80 -53.24 -51.62 61.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.31 -0.869 . . . . 74.310000000000002 110.038 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 pp -73.27 -24.38 60.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.932 -1.105 . . . . 75.340000000000003 109.601 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.4 -53.58 56.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.135 -0.978 . . . . 62.140000000000001 109.268 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 1.09 ' HG3' ' ND1' ' A' ' 158' ' ' HIS . 13.6 ptm180 -68.43 -34.95 76.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.913 . . . . 61.030000000000001 109.069 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 1.09 ' ND1' ' HG3' ' A' ' 157' ' ' ARG . 15.9 m80 -94.95 64.75 2.86 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.342 -0.849 . . . . 74.120000000000005 109.083 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.52 ' NH1' ' OG1' ' A' ' 203' ' ' THR . 2.1 tpm_? -81.22 -3.01 50.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.868 . . . . 71.129999999999995 110.173 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.514 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 57.4 p30 -144.85 57.67 1.29 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.987 -1.07 . . . . 75.450000000000003 110.075 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 160' ' ' ASP . 89.1 mm-40 -148.87 179.72 7.64 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.207 -0.933 . . . . 73.409999999999997 109.211 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 68.0 mt -105.64 123.48 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.896 -0.779 . . . . 74.409999999999997 108.896 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 72.9 t -117.41 130.27 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.48 -0.762 . . . . 72.310000000000002 109.472 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 86.1 p -97.05 159.29 14.99 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.286 -0.884 . . . . 74.120000000000005 109.483 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -60.14 -44.28 95.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 70.430000000000007 109.632 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -55.72 -33.33 64.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.921 . . . . 73.519999999999996 109.252 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.427 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 61.8 tt0 -61.49 -46.21 90.99 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.277 -0.889 . . . . 74.519999999999996 109.295 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 34.1 mt -59.54 -30.88 68.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 72.310000000000002 108.886 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.401 HD23 ' C ' ' A' ' 169' ' ' LEU . 3.4 tt -66.93 -74.38 0.11 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 53.329999999999998 109.608 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 167' ' ' GLN . 59.1 p30 -55.82 -8.45 0.42 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.504 -0.747 . . . . 62.439999999999998 111.063 -178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -95.21 -52.57 4.13 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.869 -1.144 . . . . 60.210000000000001 112.282 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.492 ' C ' ' H ' ' A' ' 174' ' ' GLU . 4.6 mp -99.31 -41.04 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.372 0 O-C-N 120.82 -1.175 . . . . 75.319999999999993 112.077 -177.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.503 ' C ' ' CD2' ' A' ' 173' ' ' TRP . 0.0 OUTLIER -63.02 2.64 0.31 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.39 -1.444 . . . . 73.140000000000001 109.081 -178.852 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.492 ' H ' ' C ' ' A' ' 172' ' ' ILE . 2.9 pp20? -50.01 -15.96 0.25 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.081 -1.012 . . . . 73.239999999999995 109.506 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 177' ' ' GLU . 0.7 OUTLIER -53.74 -176.5 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 108.2 -1.037 . . . . 44.43 108.2 179.583 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 175' ' ' GLU . 31.4 Cg_exo -59.4 35.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 122.549 2.166 . . . . 72.510000000000005 112.664 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.55 ' N ' ' O ' ' A' ' 175' ' ' GLU . 96.0 mt-10 48.17 -160.18 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.118 -0.989 . . . . 63.240000000000002 109.783 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.493 ' O ' ' SD ' ' A' ' 178' ' ' MET . 0.5 OUTLIER 60.49 52.58 4.57 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.328 -0.858 . . . . 73.5 108.903 -179.748 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.417 ' O ' ' OG1' ' A' ' 180' ' ' THR . 4.4 m -137.43 36.18 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.361 -0.837 . . . . 65.219999999999999 109.281 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.462 ' O ' HG12 ' A' ' 183' ' ' VAL . 3.0 p 47.27 78.38 0.4 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 71.420000000000002 109.46 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -46.54 -32.68 11.83 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.554 2.169 . . . . 41.219999999999999 112.545 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -74.54 -12.25 60.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.072 -1.018 . . . . 64.540000000000006 109.495 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 180' ' ' THR . 8.5 p -55.88 -14.27 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 74.019999999999996 109.935 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 96.0 mt -51.64 -42.4 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.942 . . . . 72.329999999999998 109.962 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.446 ' CG ' ' N ' ' A' ' 186' ' ' VAL . 19.8 pt-20 -61.63 -43.79 98.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.041 -1.037 . . . . 74.400000000000006 109.446 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . 0.446 ' N ' ' CG ' ' A' ' 185' ' ' GLU . 94.0 t -71.27 -30.41 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 70.420000000000002 109.292 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.12 -56.09 6.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.383 -0.823 . . . . 52.109999999999999 109.913 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.1 -26.29 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.809 -1.182 . . . . 71.400000000000006 109.631 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -73.45 -55.58 6.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.12 -0.988 . . . . 73.439999999999998 109.962 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -68.2 -40.27 82.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.128 -0.983 . . . . 71.420000000000002 109.876 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 73.5 mt -55.68 -49.25 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.001 -1.062 . . . . 61.549999999999997 109.253 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 75.9 mtp85 -57.75 -44.69 86.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -0.977 . . . . 63.340000000000003 109.541 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -66.56 -36.85 83.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.893 . . . . 61.240000000000002 109.698 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.482 ' O ' ' CG ' ' A' ' 198' ' ' PRO . 16.4 mtpp -84.52 -2.41 57.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.913 . . . . 75.129999999999995 109.784 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 50.6 ttm -89.62 -28.41 19.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.182 -0.949 . . . . 74.019999999999996 109.555 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 197' ' ' LYS . 46.4 p30 -102.35 -10.95 19.02 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.251 -0.905 . . . . 74.019999999999996 110.303 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.576 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 14.6 tttt -77.59 -43.21 2.47 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.92 -1.113 . . . . 75.430000000000007 109.74 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 25.9 Cg_endo -88.18 -32.46 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.624 2.216 . . . . 72.319999999999993 112.304 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.644 HD22 ' N ' ' A' ' 199' ' ' LEU . 3.1 mm? -85.77 -98.31 0.07 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.913 -1.117 . . . . 74.540000000000006 109.211 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 152.2 -33.18 0.86 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.496 -1.441 . . . . 61.509999999999998 109.496 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 66.2 mt -96.4 128.93 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.291 -1.123 . . . . 61.219999999999999 109.529 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 25.0 p -79.87 132.74 36.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 72.0 108.962 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.52 ' OG1' ' NH1' ' A' ' 159' ' ' ARG . 5.2 p -141.69 40.25 1.7 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.293 -0.88 . . . . 74.439999999999998 109.666 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 17.1 m -138.96 139.03 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.325 -0.859 . . . . 64.349999999999994 109.333 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -125.41 129.17 49.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.536 -0.727 . . . . 71.409999999999997 109.174 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.08 140.85 37.19 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.349 -0.845 . . . . 73.519999999999996 109.32 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 10.5 p -139.65 141.47 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.299 -0.876 . . . . 71.019999999999996 109.332 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 77.0 mtm180 -92.61 52.89 1.96 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.234 -0.916 . . . . 72.120000000000005 109.542 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -146.24 -8.45 0.52 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.167 -0.958 . . . . 64.409999999999997 109.437 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -159.7 -69.0 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.186 -0.947 . . . . 71.540000000000006 109.327 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -172.31 -119.21 0.51 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.569 -1.413 . . . . 72.030000000000001 109.569 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -123.15 129.8 51.91 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.582 -0.952 . . . . 75.540000000000006 109.258 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -103.74 129.66 51.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.453 -0.78 . . . . 75.310000000000002 109.663 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -95.36 123.74 39.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.289 -0.882 . . . . 75.409999999999997 108.67 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 26.8 p -126.4 170.29 12.1 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 121.608 0.718 . . . . 74.140000000000001 110.32 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -78.43 140.55 60.34 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.899 -0.778 . . . . 75.319999999999993 108.899 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -37.7 136.02 0.48 Allowed 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.06 1.84 . . . . 73.109999999999999 112.493 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.622 ' N ' ' CD ' ' A' ' 219' ' ' PRO . 22.4 mttp -78.15 -36.54 1.34 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 75.25 110.489 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 218' ' ' LYS . 47.4 Cg_exo -56.08 -19.09 25.32 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.086 1.857 . . . . 75.099999999999994 112.052 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -63.0 146.87 52.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.322 -0.861 . . . . 71.140000000000001 109.346 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 16.7 t -155.56 -53.12 0.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.189 -0.945 . . . . 71.129999999999995 109.478 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 38.4 mp0 46.47 -111.12 0.31 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 75.349999999999994 109.68 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 118.015 -0.993 . . . . 73.409999999999997 109.495 -179.998 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 50.9 ttm . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.46 -0.57 . . . . 71.140000000000001 109.46 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -137.52 139.86 40.77 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.43 -0.794 . . . . 73.230000000000004 109.281 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 91.9 t -112.07 135.14 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.657 -0.652 . . . . 72.239999999999995 109.434 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 6.4 tp -107.12 119.18 38.67 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.546 -0.721 . . . . 54.329999999999998 110.028 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 19.8 mt -118.55 97.17 5.61 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 108.644 -0.872 . . . . 74.349999999999994 108.644 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.416 HD12 ' HB ' ' B' ' 50' ' ' VAL . 66.8 mt -84.16 96.99 4.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.749 -1.219 . . . . 42.549999999999997 108.588 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.428 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 26.4 tp10 -134.03 132.1 39.64 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.494 -0.753 . . . . 74.519999999999996 109.375 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.7 -32.93 74.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 62.549999999999997 109.353 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . 0.403 ' H ' ' HG3' ' B' ' 7' ' ' GLU . 79.1 m-20 -82.92 117.24 22.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 73.109999999999999 109.399 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 19.8 m -75.98 -32.27 59.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 65.540000000000006 110.026 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . 0.552 HG13 ' N ' ' B' ' 12' ' ' LEU . 8.9 p -60.02 -45.11 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.071 -1.018 . . . . 75.549999999999997 109.908 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.552 ' N ' HG13 ' B' ' 11' ' ' VAL . 77.2 mt -66.02 -35.44 80.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.012 -1.055 . . . . 70.140000000000001 109.349 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.5 -27.34 67.81 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.63 -1.788 . . . . 75.400000000000006 108.63 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.79 -54.94 25.28 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 109.603 -1.399 . . . . 65.439999999999998 109.603 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' B' ' 15' ' ' GLU . 12.8 pt-20 -58.39 -44.38 88.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.351 -1.088 . . . . 60.210000000000001 109.652 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 65.8 mt -65.94 -39.26 84.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.956 -1.09 . . . . 75.150000000000006 108.936 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.407 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 86.2 tt0 -59.69 -43.89 93.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.254 -0.904 . . . . 73.010000000000005 109.065 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -85.32 -1.6 57.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.184 -0.947 . . . . 74.299999999999997 109.109 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -85.11 -59.61 1.94 Allowed Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.695 -1.362 . . . . 70.540000000000006 109.695 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -68.55 -21.35 64.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -1.175 . . . . 71.340000000000003 109.707 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 2.3 m120 -51.79 -33.73 36.77 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.073 -1.017 . . . . 64.409999999999997 109.324 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 91.1 t -56.94 -36.82 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.179 -0.95 . . . . 74.230000000000004 108.904 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.402 ' N ' ' CD ' ' B' ' 23' ' ' LYS . 12.2 mptt -72.44 -13.12 61.37 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.442 -0.786 . . . . 63.420000000000002 109.212 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.52 39.25 6.35 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.045 -1.222 . . . . 53.43 110.045 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -119.23 159.94 23.12 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.515 -0.991 . . . . 71.120000000000005 109.18 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 48.4 mmm -106.03 140.65 38.69 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.721 -0.844 . . . . 75.239999999999995 108.721 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.413 ' O ' ' OD1' ' B' ' 28' ' ' ASP . . . -137.83 155.54 48.88 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.392 -0.817 . . . . 72.120000000000005 109.995 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' B' ' 27' ' ' ALA . 88.5 m-20 -136.41 157.23 47.29 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.424 -0.954 . . . . 72.310000000000002 108.424 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 p -122.19 139.12 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.404 -0.81 . . . . 64.430000000000007 109.749 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 2.6 p -138.05 173.49 11.57 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.521 -0.737 . . . . 65.409999999999997 109.416 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -98.52 -98.67 0.22 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.362 -0.836 . . . . 71.019999999999996 109.753 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 14.0 t -78.77 164.81 24.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.223 -0.923 . . . . 51.109999999999999 110.12 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 50.6 mt -53.06 -36.99 61.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.669 -0.644 . . . . 71.239999999999995 110.086 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.58 ' H ' ' CD ' ' B' ' 34' ' ' GLU . 45.1 mp0 -53.18 -46.49 68.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 74.319999999999993 109.964 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -61.42 -38.57 87.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.117 -0.989 . . . . 73.030000000000001 109.274 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.34 -33.75 87.5 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.331 -1.508 . . . . 30.210000000000001 109.331 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -69.3 -43.95 72.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -1.13 . . . . 74.420000000000002 109.743 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . 0.437 ' O ' ' OD1' ' B' ' 41' ' ' ASP . 65.9 m-85 -76.27 -22.48 55.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.141 -0.974 . . . . 74.420000000000002 110.046 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 60.3 tp -90.04 -34.31 16.0 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.081 -1.012 . . . . 75.409999999999997 109.871 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . 0.445 ' O ' ' O ' ' B' ' 43' ' ' ARG . 2.5 ppp? -79.02 -28.1 43.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.153 -0.967 . . . . 60.409999999999997 110.405 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' B' ' 42' ' ' ILE . 39.0 p-10 -62.52 -27.02 68.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.914 -1.116 . . . . 53.229999999999997 110.041 -179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.542 ' N ' ' OD1' ' B' ' 41' ' ' ASP . 11.8 pt -99.27 -10.87 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.184 -0.948 . . . . 71.230000000000004 110.411 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' B' ' 40' ' ' MET . 98.6 mtt180 -130.23 155.67 45.88 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.247 -0.908 . . . . 72.219999999999999 109.812 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -80.1 169.02 18.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.203 -0.935 . . . . 63.539999999999999 109.323 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.413 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 1.7 p90 -156.36 92.37 1.32 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.134 -0.979 . . . . 64.349999999999994 109.263 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -76.55 -32.27 58.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.082 -1.011 . . . . 62.219999999999999 108.909 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.508 HD13 ' C ' ' B' ' 47' ' ' LEU . 0.8 OUTLIER -112.67 108.74 17.9 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.666 -0.865 . . . . 73.120000000000005 108.666 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.433 ' N ' HD13 ' B' ' 47' ' ' LEU . 50.4 t -93.7 107.38 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.524 -0.917 . . . . 65.109999999999999 108.524 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 4.9 ttt -125.5 131.58 52.79 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.555 -0.715 . . . . 73.439999999999998 109.52 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.644 HG22 ' H ' ' B' ' 52' ' ' ASP . 0.4 OUTLIER -145.87 138.69 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.465 -0.772 . . . . 34.5 109.803 -179.183 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . 0.428 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 89.4 p -99.68 12.59 36.18 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.491 -0.755 . . . . 73.209999999999994 109.828 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.644 ' H ' HG22 ' B' ' 50' ' ' VAL . 42.4 m-20 -81.77 134.37 35.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.073 -1.017 . . . . 70.409999999999997 109.561 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -71.3 -34.44 70.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.342 -0.849 . . . . 65.0 110.2 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -76.55 9.76 2.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.061 -1.024 . . . . 75.209999999999994 109.722 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' B' ' 56' ' ' LEU . . . -72.87 -21.18 60.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.19 -0.944 . . . . 55.329999999999998 110.254 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' B' ' 55' ' ' ALA . 69.5 mt -41.14 -52.7 3.25 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.496 -0.753 . . . . 63.140000000000001 110.364 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 19.8 t -65.05 -36.32 83.96 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.961 -1.087 . . . . 63.5 109.171 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -62.53 -61.76 2.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.327 -0.858 . . . . 72.329999999999998 109.649 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 22.4 m -49.75 -31.57 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.523 -1.36 . . . . 74.540000000000006 109.645 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.401 ' OG ' ' N ' ' B' ' 61' ' ' ARG . 5.8 p -58.61 -52.15 66.87 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.254 -0.904 . . . . 71.239999999999995 109.321 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.401 ' N ' ' OG ' ' B' ' 60' ' ' SER . 2.8 ptp180 -68.61 -31.86 71.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.075 -1.015 . . . . 74.310000000000002 110.0 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 40.6 mm -66.16 -40.08 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.723 -1.235 . . . . 72.140000000000001 109.879 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 25.7 mmtp -65.83 -48.2 72.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.956 . . . . 73.319999999999993 110.48 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -72.83 -37.19 67.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.826 -1.171 . . . . 73.120000000000005 110.12 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.484 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 66.4 mttm -81.49 -21.11 38.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.152 -0.968 . . . . 72.439999999999998 109.856 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.484 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 72.0 m-70 -155.78 66.26 0.6 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.103 -0.998 . . . . 63.310000000000002 109.691 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.5 t -62.59 -33.53 75.16 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.21 -0.931 . . . . 73.099999999999994 109.87 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 51.1 m -57.29 -30.34 64.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.211 -0.93 . . . . 71.530000000000001 110.073 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 73.3 mt -76.13 153.35 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.112 -0.993 . . . . 74.400000000000006 109.532 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.53 HG12 ' N ' ' B' ' 71' ' ' VAL . 72.6 t -90.33 163.47 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.324 -0.86 . . . . 75.120000000000005 109.565 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.53 ' N ' HG12 ' B' ' 70' ' ' VAL . 12.9 t -139.81 126.57 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.239 -0.913 . . . . 73.200000000000003 109.544 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.688 ' HG ' HD11 ' B' ' 95' ' ' ILE . 1.1 mp -124.94 99.93 6.36 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.727 -0.842 . . . . 73.340000000000003 108.727 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 76.0 t -91.15 145.63 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.261 -0.899 . . . . 73.5 108.72 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 2.4 m -118.68 171.82 7.93 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.414 -0.804 . . . . 64.340000000000003 109.044 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.469 ' HG ' ' HH ' ' B' ' 94' ' ' TYR . 27.6 p -162.0 126.74 3.35 Favored 'General case' 0 N--CA 1.506 2.335 0 C-N-CA 118.699 -1.2 . . . . 74.530000000000001 111.284 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -65.35 -13.73 59.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.631 -0.668 . . . . 64.5 110.239 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' B' ' 79' ' ' THR . 10.1 p-10 -129.73 79.44 73.46 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 121.356 -0.84 . . . . 74.25 109.709 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.475 ' HA ' ' HH ' ' B' ' 94' ' ' TYR . 27.8 Cg_exo -57.89 80.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.428 2.085 . . . . 74.430000000000007 111.277 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.438 ' N ' ' O ' ' B' ' 77' ' ' ASN . 66.6 p -106.48 151.25 25.21 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.933 -0.766 . . . . 73.120000000000005 108.933 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.81 -24.17 61.52 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.37 -0.831 . . . . 71.010000000000005 109.32 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -67.93 -38.96 83.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 63.200000000000003 109.8 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -76.85 -34.57 57.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.136 -0.978 . . . . 73.219999999999999 109.77 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.525 ' OE1' ' N ' ' B' ' 83' ' ' GLU . 0.4 OUTLIER -61.38 -51.58 68.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 74.299999999999997 109.635 -179.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.507 HG23 ' N ' ' B' ' 85' ' ' HIS . 30.3 m -62.58 -45.81 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.975 -1.078 . . . . 73.310000000000002 109.356 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' HIS . . . . . 0.507 ' N ' HG23 ' B' ' 84' ' ' VAL . 18.7 m170 -61.79 -30.9 71.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.137 -0.977 . . . . 73.239999999999995 109.2 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -65.69 -39.73 91.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.206 -0.934 . . . . 55.329999999999998 109.995 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 111' ' ' ALA . 79.1 t80 -83.72 -37.89 22.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.032 -1.042 . . . . 74.140000000000001 109.315 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -67.34 -41.17 85.65 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.306 -0.871 . . . . 64.040000000000006 109.542 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -69.57 -50.64 42.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.921 . . . . 72.349999999999994 109.556 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 145.6 70.47 0.02 OUTLIER Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.907 -1.277 . . . . 65.200000000000003 109.907 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -129.24 131.25 47.01 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.392 -1.064 . . . . 52.229999999999997 108.881 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' B' ' 71' ' ' VAL . 56.8 m-20 -75.54 -35.54 60.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.064 -1.022 . . . . 73.319999999999993 109.078 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . 0.521 ' OD2' ' NH2' ' B' ' 112' ' ' ARG . 7.3 m-20 -153.89 155.3 35.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.385 -0.822 . . . . 72.219999999999999 109.388 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.475 ' HH ' ' HA ' ' B' ' 78' ' ' PRO . 6.3 t80 -123.37 138.76 54.53 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 109.061 -0.718 . . . . 64.420000000000002 109.061 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.813 HD12 ' N ' ' B' ' 95' ' ' ILE . 0.3 OUTLIER -130.1 139.68 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-O 122.069 0.937 . . . . 72.230000000000004 110.622 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . 0.414 ' HB1' ' HD2' ' B' ' 98' ' ' PRO . . . -59.17 131.98 52.65 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.825 -1.546 . . . . 25.239999999999998 106.825 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -61.99 -41.2 74.89 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 120.833 -1.167 . . . . 64.319999999999993 110.959 -178.179 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' B' ' 97' ' ' LYS . 37.3 Cg_exo -54.73 2.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.291 -2.486 0 CA-C-N 118.827 0.617 . . . . 63.329999999999998 112.202 -175.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . 0.575 ' N ' ' O ' ' B' ' 97' ' ' LYS . 50.4 m-85 54.83 106.56 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.614 -0.679 . . . . 75.129999999999995 109.848 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 19.7 ttm180 -61.62 -34.83 76.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 74.230000000000004 108.976 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . 0.762 ' O ' ' N ' ' B' ' 103' ' ' LYS . 43.9 t -174.59 38.8 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.266 -0.896 . . . . 63.340000000000003 110.508 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 59.1 mt 50.17 -70.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.656 -0.652 . . . . 74.439999999999998 110.311 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.762 ' N ' ' O ' ' B' ' 101' ' ' SER . 9.3 mtpm? -54.32 -21.03 8.28 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.953 -1.129 . . . . 71.109999999999999 107.953 179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.21 -64.23 0.93 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.073 -0.651 . . . . 71.450000000000003 109.983 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 2.5 pp -62.29 -35.22 78.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.036 -1.04 . . . . 51.310000000000002 109.787 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 34.4 t -60.75 -44.21 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.876 -1.14 . . . . 65.230000000000004 108.605 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.23 -42.62 73.65 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.314 -0.995 . . . . 24.32 108.314 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 0.615 ' NH1' ' CZ ' ' A' ' 87' ' ' PHE . 58.8 mtp85 -64.91 -34.07 77.51 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.412 -0.805 . . . . 75.310000000000002 108.974 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 92.4 mt -74.3 -27.69 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 108.488 -0.93 . . . . 54.240000000000002 108.488 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -75.31 -58.17 3.44 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.446 -0.784 . . . . 65.310000000000002 109.112 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -48.32 -42.87 32.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.343 -0.848 . . . . 72.239999999999995 109.43 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . 0.521 ' NH2' ' OD2' ' B' ' 93' ' ' ASP . 50.6 ttm-85 -61.36 -44.14 97.67 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.324 -0.86 . . . . 72.040000000000006 109.319 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 41.2 mt -134.8 75.78 1.59 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.43 -0.794 . . . . 75.349999999999994 109.313 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . . . . . . . . . 26.8 mtp180 -68.1 -54.44 18.12 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.136 -0.978 . . . . 75.5 109.318 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' PHE . . . . . 0.521 ' O ' ' CG ' ' B' ' 116' ' ' TRP . 6.3 t80 -92.18 -76.97 0.44 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.186 -0.946 . . . . 65.329999999999998 109.436 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' TRP . . . . . 0.521 ' CG ' ' O ' ' B' ' 115' ' ' PHE . 4.0 m-90 -162.44 -173.22 3.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.053 -1.029 . . . . 74.450000000000003 109.294 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -56.17 176.22 0.93 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.455 -1.458 . . . . 44.210000000000001 109.455 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . 0.471 ' C ' ' ND2' ' B' ' 119' ' ' ASN . 26.9 m -128.25 178.67 6.08 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.439 -1.036 . . . . 71.400000000000006 109.599 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . 0.471 ' ND2' ' C ' ' B' ' 118' ' ' SER . 0.0 OUTLIER -152.51 139.63 19.27 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.941 -0.704 . . . . 72.319999999999993 109.207 -178.023 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 14.2 t -86.08 -40.28 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.133 -0.979 . . . . 75.019999999999996 109.619 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 18.2 mm -105.57 134.39 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.309 -0.869 . . . . 51.409999999999997 108.838 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -157.26 131.16 8.19 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.076 -1.015 . . . . 71.530000000000001 109.036 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 3.8 tt -151.77 131.3 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.343 -0.848 . . . . 72.430000000000007 108.912 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.13 -143.11 41.34 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.997 -1.641 . . . . 51.229999999999997 108.997 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -85.65 3.48 40.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -1.192 . . . . 74.200000000000003 109.043 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 mt -92.61 125.88 37.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.352 -0.842 . . . . 75.420000000000002 108.741 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 17.4 m -123.77 140.36 53.06 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.153 -1.055 . . . . 74.219999999999999 108.153 179.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 5.0 mt -143.01 131.25 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.023 -1.048 . . . . 60.329999999999998 109.92 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . 0.564 ' HB3' ' OE1' ' B' ' 132' ' ' GLU . 12.4 m -116.3 92.43 36.22 Favored Pre-proline 0 N--CA 1.495 1.814 0 N-CA-C 108.573 -0.899 . . . . 72.310000000000002 108.573 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -71.67 -27.91 17.82 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.354 1.369 . . . . 75.129999999999995 111.616 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . 0.577 ' HB2' ' OE2' ' B' ' 132' ' ' GLU . 74.4 m-20 -66.91 -42.22 85.78 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.144 -0.972 . . . . 75.230000000000004 108.88 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . 0.577 ' OE2' ' HB2' ' B' ' 131' ' ' ASP . 4.7 mp0 -87.27 6.08 35.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.328 -0.857 . . . . 72.430000000000007 109.307 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.556 ' HA ' ' CE1' ' B' ' 149' ' ' PHE . 42.9 mt-10 51.03 54.55 11.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 75.129999999999995 109.446 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -150.54 145.97 26.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.212 -0.93 . . . . 73.219999999999999 109.527 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 8.3 tt -130.45 142.06 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.502 -0.749 . . . . 64.140000000000001 109.513 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 77.3 mt -129.71 124.61 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.525 -0.734 . . . . 71.219999999999999 109.561 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' B' ' 137' ' ' TYR . 18.2 p90 -142.33 152.72 43.21 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.234 -0.916 . . . . 64.219999999999999 109.66 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . 0.517 ' O ' ' NH1' ' B' ' 140' ' ' ARG . 51.3 mtpt 55.57 14.54 1.24 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.513 -0.742 . . . . 72.019999999999996 110.045 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.88 -15.77 58.45 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.144 -1.027 . . . . 74.319999999999993 110.587 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . 0.517 ' NH1' ' O ' ' B' ' 138' ' ' LYS . 10.3 mpt_? -87.26 143.16 27.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.957 -1.319 . . . . 75.340000000000003 108.846 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 141' ' ' GLU . . . . . 0.462 ' N ' ' CD ' ' B' ' 141' ' ' GLU . 21.2 mp0 -103.2 138.63 39.74 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.235 -0.915 . . . . 71.230000000000004 109.914 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 52.8 t -138.01 133.98 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.811 -0.811 . . . . 70.430000000000007 108.811 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . 0.434 ' H ' ' HG3' ' B' ' 143' ' ' GLU . 3.2 pp20? -104.7 136.32 44.45 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.395 -0.816 . . . . 72.430000000000007 109.684 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 6.7 m -140.37 157.19 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.366 -0.834 . . . . 72.129999999999995 109.01 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -171.8 37.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.104 -0.997 . . . . 72.019999999999996 109.839 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -133.25 -125.54 2.62 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 109.184 -1.566 . . . . 42.229999999999997 109.184 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 0.662 ' HB2' ' HE2' ' B' ' 178' ' ' MET . 33.8 tttm -76.13 -33.35 1.25 Allowed Pre-proline 0 N--CA 1.487 1.401 0 O-C-N 121.272 -1.134 . . . . 73.299999999999997 111.223 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 61.0 Cg_endo -85.22 11.77 3.27 Favored 'Trans proline' 0 N--CA 1.486 1.065 0 C-N-CA 121.854 1.702 . . . . 71.329999999999998 112.158 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . 0.621 ' CE1' HG21 ' B' ' 153' ' ' THR . 13.0 t80 -110.24 -50.18 2.99 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.497 -0.752 . . . . 74.230000000000004 108.988 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -60.92 -49.79 76.05 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.33 -0.856 . . . . 72.340000000000003 111.099 -178.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.478 HG13 ' N ' ' B' ' 152' ' ' LEU . 11.8 p -70.95 -40.23 76.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.91 -1.118 . . . . 73.349999999999994 110.131 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.478 ' N ' HG13 ' B' ' 151' ' ' VAL . 16.4 tp -65.65 -40.19 92.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.117 -0.989 . . . . 55.240000000000002 109.937 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.621 HG21 ' CE1' ' B' ' 149' ' ' PHE . 14.3 p -77.62 -17.79 57.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.754 -1.216 . . . . 70.010000000000005 109.69 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -71.39 -54.23 11.41 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.877 -1.14 . . . . 65.319999999999993 109.607 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 0.885 HD13 ' N ' ' B' ' 156' ' ' ALA . 0.0 OUTLIER -74.67 -21.17 59.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.16 -0.962 . . . . 71.540000000000006 109.455 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . 0.885 ' N ' HD13 ' B' ' 155' ' ' LEU . . . -62.9 -55.3 27.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.793 -1.192 . . . . 75.319999999999993 108.947 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 54.6 mtp180 -64.23 -52.23 59.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.047 -1.033 . . . . 73.319999999999993 108.838 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . 0.5 ' CG ' ' NE2' ' B' ' 161' ' ' GLN . 17.0 m-70 -88.52 42.43 1.07 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.563 -0.71 . . . . 74.140000000000001 110.15 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 22.2 ttp-105 -55.3 -77.58 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.06 -1.025 . . . . 61.409999999999997 109.368 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -65.3 82.74 0.05 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.375 -0.828 . . . . 72.099999999999994 109.396 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . 0.5 ' NE2' ' CG ' ' B' ' 158' ' ' HIS . 8.8 tt0 -170.46 154.36 4.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.268 -0.895 . . . . 72.25 109.496 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 162' ' ' ILE . . . . . 0.753 HD12 ' N ' ' B' ' 162' ' ' ILE . 2.9 mp -76.66 109.87 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.15 -0.969 . . . . 72.310000000000002 109.062 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.65 124.79 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.309 -0.869 . . . . 64.209999999999994 109.041 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 23.3 t -100.85 178.77 4.59 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.199 -0.938 . . . . 74.219999999999999 110.167 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . 0.511 ' NZ ' ' CZ ' ' B' ' 212' ' ' TYR . 40.5 mttm -72.77 -56.83 4.68 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.003 0.906 . . . . 65.310000000000002 109.345 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . 0.723 ' O ' ' OD1' ' B' ' 170' ' ' ASP . 12.8 pt-20 -55.37 -27.99 51.03 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.368 -0.832 . . . . 63.450000000000003 109.535 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -60.28 -50.47 73.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.094 -1.004 . . . . 72.400000000000006 109.354 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 76.9 mt -59.27 -35.88 74.53 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.334 -0.854 . . . . 72.319999999999993 109.665 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' B' ' 172' ' ' ILE . 40.2 mt -65.54 -73.68 0.12 Allowed 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 117.692 -1.603 . . . . 73.340000000000003 109.303 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . 0.787 ' OD1' ' N ' ' B' ' 170' ' ' ASP . 0.0 OUTLIER -42.86 -21.45 0.02 OUTLIER 'General case' 0 N--CA 1.525 3.311 0 O-C-N 120.173 -1.58 . . . . 72.099999999999994 110.233 178.578 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' B' ' 169' ' ' LEU . . . -88.12 -24.86 23.26 Favored 'General case' 0 C--N 1.283 -2.286 0 O-C-N 121.61 -0.682 . . . . 62.130000000000003 110.5 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' B' ' 174' ' ' GLU . 1.8 mp -113.93 -19.77 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.307 -0.871 . . . . 71.420000000000002 110.659 -178.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 173' ' ' TRP . . . . . 0.515 ' CZ3' ' HB3' ' B' ' 169' ' ' LEU . 0.1 OUTLIER -52.05 94.97 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.776 0 O-C-N 120.276 -1.515 . . . . 72.230000000000004 107.015 178.132 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' B' ' 172' ' ' ILE . 35.2 tt0 -176.94 167.43 2.5 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.476 -1.675 . . . . 52.109999999999999 106.476 -178.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . 0.619 ' O ' ' N ' ' B' ' 177' ' ' GLU . 59.4 mt-10 62.55 153.47 0.11 Allowed Pre-proline 0 N--CA 1.496 1.844 0 N-CA-C 106.597 -1.631 . . . . 73.040000000000006 106.597 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.517 ' O ' ' C ' ' B' ' 177' ' ' GLU . 26.6 Cg_exo -33.72 80.18 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.603 2.202 . . . . 74.129999999999995 113.474 -177.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . 0.619 ' N ' ' O ' ' B' ' 175' ' ' GLU . 2.2 mm-40 15.63 98.34 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 CA-C-O 121.359 0.6 . . . . 72.439999999999998 112.136 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . 0.662 ' HE2' ' HB2' ' B' ' 147' ' ' LYS . 0.1 OUTLIER -108.61 21.32 17.44 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.757 -0.831 . . . . 63.43 108.757 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.6 132.89 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 O-C-N 121.653 -0.654 . . . . 71.049999999999997 109.365 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.8 159.67 52.44 Favored Pre-proline 0 N--CA 1.499 1.984 0 N-CA-C 108.873 -0.788 . . . . 62.149999999999999 108.873 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -37.84 110.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 123.037 2.492 . . . . 65.219999999999999 113.254 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 12.6 m120 49.3 45.33 23.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.045 -1.034 . . . . 72.310000000000002 110.564 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.11 -23.99 16.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.259 -0.901 . . . . 63.32 109.767 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.421 HD11 HD11 ' B' ' 169' ' ' LEU . 54.2 mt -49.25 -39.78 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.114 -0.991 . . . . 75.030000000000001 110.576 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -53.61 -61.67 2.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.027 -1.045 . . . . 64.109999999999999 109.533 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 34.1 t -66.04 -40.79 88.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.486 -0.759 . . . . 73.0 110.405 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.9 -58.37 6.34 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.029 -1.044 . . . . 61.119999999999997 110.853 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 188' ' ' ILE . . . . . 0.596 HD12 ' CE2' ' B' ' 212' ' ' TYR . 1.3 tt -56.03 -33.94 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.739 -1.225 . . . . 72.430000000000007 109.977 -178.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.99 -57.47 12.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.098 -1.001 . . . . 65.140000000000001 109.987 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -68.76 -41.05 79.39 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.159 -0.963 . . . . 63.240000000000002 110.548 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 77.5 mt -55.26 -38.75 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.817 -1.177 . . . . 74.030000000000001 108.932 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 192' ' ' ARG . . . . . 0.409 ' CZ ' HG21 ' B' ' 206' ' ' THR . 57.0 mtp180 -64.97 -48.26 74.63 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.319 -0.863 . . . . 72.239999999999995 109.94 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -76.42 -20.06 57.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.043 -1.035 . . . . 73.099999999999994 111.12 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -90.73 -21.66 21.47 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.874 -1.141 . . . . 72.109999999999999 111.028 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 195' ' ' MET . . . . . 0.443 ' SD ' ' C ' ' B' ' 195' ' ' MET . 3.1 ppp? -88.35 -36.93 16.33 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.788 -1.195 . . . . 44.329999999999998 110.026 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 196' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -59.12 -42.85 91.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.16 -0.962 . . . . 71.209999999999994 110.348 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . 0.412 ' CB ' ' CD ' ' B' ' 198' ' ' PRO . 24.5 mttm -51.64 -64.45 1.44 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.974 . . . . 75.209999999999994 110.03 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 198' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 44.9 Cg_endo -65.71 -34.31 41.35 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 122.253 1.969 . . . . 75.319999999999993 112.613 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . 0.938 HD23 ' O ' ' B' ' 201' ' ' ILE . 13.3 tp -68.82 -43.75 74.89 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.176 -0.952 . . . . 72.25 109.69 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 92.92 -44.78 2.51 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.66 -1.376 . . . . 64.530000000000001 109.66 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . 0.938 ' O ' HD23 ' B' ' 199' ' ' LEU . 27.8 mm -110.31 133.81 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.397 -1.061 . . . . 44.229999999999997 109.28 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 9.0 t -77.64 135.49 38.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 54.009999999999998 109.451 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 71.2 p -143.02 44.11 1.57 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.28 -0.887 . . . . 74.400000000000006 109.24 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.594 HG12 ' CE2' ' B' ' 214' ' ' PHE . 17.5 m -139.03 140.89 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.377 -0.827 . . . . 72.120000000000005 109.871 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -124.76 114.79 19.73 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.779 -0.823 . . . . 65.409999999999997 108.779 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 206' ' ' THR . . . . . 0.409 HG21 ' CZ ' ' B' ' 192' ' ' ARG . 68.4 p -96.68 123.22 40.3 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.139 -0.975 . . . . 71.329999999999998 109.468 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 6.4 t -142.94 144.31 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.131 -0.981 . . . . 63.5 109.466 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 31.5 ttm-85 -60.14 -35.53 75.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.444 -0.785 . . . . 74.450000000000003 110.042 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . 0.531 ' O ' ' N ' ' B' ' 211' ' ' GLY . 18.0 mmm180 -65.96 142.46 57.86 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.114 -0.991 . . . . 74.140000000000001 109.728 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . 0.519 ' NH1' HH21 ' B' ' 213' ' ' ARG . 90.3 mtt180 55.79 -81.5 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.668 -0.645 . . . . 74.430000000000007 109.718 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' B' ' 209' ' ' ARG . . . -179.36 -98.98 0.12 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.825 -1.31 . . . . 64.450000000000003 109.825 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 212' ' ' TYR . . . . . 0.596 ' CE2' HD12 ' B' ' 188' ' ' ILE . 6.4 m-85 -131.29 115.9 16.89 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.57 -0.959 . . . . 74.209999999999994 108.778 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . 0.519 HH21 ' NH1' ' B' ' 210' ' ' ARG . 35.4 ttm180 -93.1 128.11 38.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.421 -0.799 . . . . 74.030000000000001 109.976 -179.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . 0.604 ' CD2' HD23 ' B' ' 155' ' ' LEU . 14.2 m-85 -101.55 121.36 41.83 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.416 -0.957 . . . . 74.340000000000003 108.416 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 3.1 p -133.97 163.98 28.31 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.379 -0.825 . . . . 64.329999999999998 110.005 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -79.61 150.42 73.01 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.469 -0.769 . . . . 70.040000000000006 109.41 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.81 -101.5 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.282 1.988 . . . . 65.109999999999999 112.094 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' B' ' 220' ' ' ALA . 2.8 ptpp? -92.02 153.93 43.38 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.224 -0.922 . . . . 73.150000000000006 108.921 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -36.95 -25.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.602 2.201 . . . . 71.310000000000002 112.757 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' B' ' 218' ' ' LYS . . . 52.08 35.76 17.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 75.450000000000003 109.602 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 26.0 p -84.16 136.29 34.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.254 -0.904 . . . . 72.219999999999999 109.543 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -59.69 137.91 57.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 54.530000000000001 109.567 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.996 -1.002 . . . . 71.129999999999995 109.574 179.977 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.546 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.427 -0.583 . . . . 65.120000000000005 109.427 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -137.61 148.97 46.26 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.445 -0.784 . . . . 72.329999999999998 109.319 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.0 t -118.06 125.09 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.66 -0.65 . . . . 71.420000000000002 109.724 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.803 HD12 ' N ' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -94.84 124.32 38.81 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.055 -1.028 . . . . 65.120000000000005 108.348 179.319 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.803 ' N ' HD12 ' A' ' 4' ' ' LEU . 4.1 tp -120.57 123.89 43.98 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.039 -0.726 . . . . 62.43 109.039 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.567 HG12 HD11 ' A' ' 4' ' ' LEU . 9.5 mt -108.63 106.1 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.271 -0.893 . . . . 71.150000000000006 108.861 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.516 ' OE2' ' ND2' ' A' ' 9' ' ' ASN . 37.0 tp10 -138.24 122.88 18.62 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.359 -0.838 . . . . 75.340000000000003 109.536 -179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -86.41 -13.31 46.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.28 -0.887 . . . . 72.439999999999998 109.323 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.516 ' ND2' ' OE2' ' A' ' 7' ' ' GLU . 82.3 m-20 -69.37 -136.34 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.354 -0.842 . . . . 63.020000000000003 109.454 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 11' ' ' VAL . 35.1 p -158.1 -63.86 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.071 -1.018 . . . . 72.340000000000003 109.765 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.52 HG13 ' N ' ' A' ' 12' ' ' LEU . 12.6 p -69.53 -41.22 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.204 -0.935 . . . . 74.019999999999996 109.881 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.52 ' N ' HG13 ' A' ' 11' ' ' VAL . 45.8 mt -63.98 -36.4 83.85 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.174 -0.954 . . . . 71.430000000000007 109.515 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.8 -34.87 23.58 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.696 -1.762 . . . . 61.32 108.696 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.86 -44.14 89.81 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.948 -1.261 . . . . 71.200000000000003 109.948 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -67.92 -43.59 78.84 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.069 -1.253 . . . . 71.319999999999993 109.26 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.3 mt -65.64 -49.4 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.853 -1.154 . . . . 63.229999999999997 108.655 178.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.525 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 86.3 tt0 -46.08 -56.46 5.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.328 -0.858 . . . . 51.109999999999999 109.817 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -85.26 3.73 38.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.18 -0.95 . . . . 73.340000000000003 109.433 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -79.78 -67.1 1.61 Allowed Glycine 0 N--CA 1.484 1.841 0 N-CA-C 109.921 -1.271 . . . . 62.149999999999999 109.921 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 20' ' ' LEU . 2.1 pt? -65.05 -22.77 67.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -1.205 . . . . 73.510000000000005 109.803 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 17' ' ' GLU . 84.3 m-20 -57.35 -33.19 67.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.023 -1.048 . . . . 74.25 109.265 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 82.2 t -57.41 -33.46 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.343 -0.848 . . . . 70.040000000000006 109.384 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.418 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 11.8 mptt -70.24 2.54 3.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.879 . . . . 73.230000000000004 109.353 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.13 35.62 12.18 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 110.181 -1.168 . . . . 75.540000000000006 110.181 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -119.55 160.55 22.21 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.495 -1.003 . . . . 73.430000000000007 109.218 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 45.3 mmm -103.61 137.39 41.73 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.053 -1.092 . . . . 43.240000000000002 108.053 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -143.77 159.99 41.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.106 -0.996 . . . . 62.109999999999999 110.101 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -141.74 155.86 45.62 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.399 -0.813 . . . . 74.420000000000002 109.081 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 p -109.85 139.49 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.365 -0.834 . . . . 72.150000000000006 108.903 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.7 p -134.21 165.26 25.52 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.454 -0.779 . . . . 71.420000000000002 109.432 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.407 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 3.9 pt-20 -91.53 -103.72 0.11 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.334 -0.854 . . . . 72.329999999999998 109.602 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.5 t -79.45 165.72 22.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 74.239999999999995 109.96 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.7 mt -52.5 -32.58 40.89 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.535 -0.728 . . . . 71.530000000000001 109.802 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -48.47 -50.62 30.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.145 -0.972 . . . . 74.230000000000004 109.787 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.31 -39.1 85.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.118 -0.989 . . . . 54.030000000000001 109.586 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.41 -36.52 34.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.839 -1.304 . . . . 61.409999999999997 109.839 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -64.89 -40.06 94.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -1.156 . . . . 74.340000000000003 109.928 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -81.62 -40.63 22.68 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.013 -1.054 . . . . 75.329999999999998 109.503 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.5 tp -66.05 -43.04 88.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 74.329999999999998 109.729 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.441 ' O ' ' O ' ' A' ' 43' ' ' ARG . 3.6 ppp? -69.44 -26.95 64.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.167 -0.958 . . . . 70.319999999999993 109.656 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -65.51 -39.84 92.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.948 . . . . 71.219999999999999 109.751 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.519 HD12 HH12 ' A' ' 43' ' ' ARG . 24.5 pt -83.8 -26.37 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.221 -0.925 . . . . 74.140000000000001 109.989 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.519 HH12 HD12 ' A' ' 42' ' ' ILE . 80.2 mtt85 -129.13 137.94 51.5 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.404 -0.81 . . . . 72.239999999999995 109.276 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -92.27 126.84 37.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.157 -0.964 . . . . 75.420000000000002 109.588 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -104.71 141.62 36.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.465 -0.772 . . . . 74.230000000000004 109.269 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -80.63 -35.47 33.91 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.228 -0.92 . . . . 72.040000000000006 109.804 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.533 HD13 ' C ' ' A' ' 47' ' ' LEU . 1.1 tm? -124.55 113.82 18.58 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.795 -0.817 . . . . 72.129999999999995 108.795 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 48' ' ' VAL . 17.3 m -109.03 105.32 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.306 -0.871 . . . . 72.340000000000003 108.785 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.565 ' SD ' ' N ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -104.48 132.61 50.53 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.915 -1.143 . . . . 74.109999999999999 107.915 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.565 ' N ' ' SD ' ' A' ' 49' ' ' MET . 1.5 p -129.01 128.16 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.847 0.832 . . . . 61.119999999999997 110.352 -178.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.9 p -95.6 2.8 54.35 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.649 -0.657 . . . . 73.109999999999999 109.409 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.42 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 4.1 m-20 -76.48 150.59 36.64 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.179 -0.951 . . . . 52.549999999999997 109.552 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.458 ' C ' ' H ' ' A' ' 55' ' ' ALA . 18.7 pttp -85.88 -39.5 16.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.188 -0.945 . . . . 44.219999999999999 110.329 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -71.63 12.53 0.35 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.022 -1.049 . . . . 70.439999999999998 109.619 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.458 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.34 -21.52 58.3 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.849 . . . . 64.140000000000001 110.514 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.519 HD23 HE22 ' A' ' 89' ' ' GLN . 46.8 mt -39.96 -53.95 2.27 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.582 -0.699 . . . . 44.140000000000001 110.426 -179.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 t -66.0 -35.7 81.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.984 -1.073 . . . . 55.229999999999997 109.164 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.498 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 65.9 t80 -64.02 -62.42 1.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.39 -0.819 . . . . 74.439999999999998 109.763 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.8 m -49.33 -32.2 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.655 -1.278 . . . . 74.030000000000001 109.628 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.9 t -58.93 -52.06 67.36 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.263 -0.898 . . . . 64.299999999999997 109.501 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -68.8 -30.4 68.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.025 -1.047 . . . . 64.439999999999998 109.94 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.498 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 31.7 mm -59.02 -44.41 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.868 -1.145 . . . . 63.210000000000001 110.083 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.4 mtpp -74.29 -48.38 28.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.036 -1.04 . . . . 74.420000000000002 111.48 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.22 -36.11 82.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.611 -1.305 . . . . 70.319999999999993 109.861 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -92.18 -50.44 5.67 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.137 -0.977 . . . . 75.219999999999999 109.226 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.5 ' ND1' ' N ' ' A' ' 66' ' ' HIS . 0.5 OUTLIER -107.9 63.03 0.61 Allowed 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.466 -0.771 . . . . 74.129999999999995 109.784 -179.467 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 t -65.94 -28.38 68.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.011 -1.055 . . . . 73.239999999999995 110.043 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.4 m -63.45 -31.0 72.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.258 -0.901 . . . . 61.009999999999998 110.627 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 58.8 mt -84.74 149.08 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.973 -1.079 . . . . 71.329999999999998 110.226 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 71' ' ' VAL . 72.3 t -88.51 159.04 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.569 -0.9 . . . . 72.129999999999995 108.569 179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.457 ' N ' HG12 ' A' ' 70' ' ' VAL . 17.2 t -136.58 129.67 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.282 -0.886 . . . . 54.210000000000001 109.932 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.507 ' O ' ' SD ' ' A' ' 49' ' ' MET . 1.6 mt -127.08 100.81 6.27 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.909 -1.145 . . . . 50.240000000000002 107.909 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.622 ' O ' HD12 ' A' ' 95' ' ' ILE . 15.0 p -96.37 154.65 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.368 -0.832 . . . . 74.409999999999997 109.282 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.427 ' O ' ' OG ' ' A' ' 75' ' ' SER . 0.4 OUTLIER -118.4 167.72 11.3 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 108.701 -0.851 . . . . 72.310000000000002 108.701 179.395 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 74' ' ' SER . 3.7 m -167.41 120.72 0.95 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.266 -0.897 . . . . 64.540000000000006 109.933 -178.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -75.12 19.58 0.15 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.409 -0.807 . . . . 74.129999999999995 110.111 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 75' ' ' SER . 34.7 t30 -142.48 58.41 7.4 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.129 -0.982 . . . . 73.340000000000003 109.826 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.4 82.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.342 2.028 . . . . 63.219999999999999 112.471 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 77' ' ' ASN . 44.8 m -114.2 150.99 33.43 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.227 -1.027 . . . . 62.530000000000001 108.227 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 t -53.45 -26.49 20.39 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.074 -1.016 . . . . 73.439999999999998 109.723 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -63.41 -47.67 81.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.163 -0.961 . . . . 71.420000000000002 109.813 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -72.64 -30.61 64.45 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.162 -0.962 . . . . 73.430000000000007 109.917 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.464 ' OE2' ' NE ' ' B' ' 108' ' ' ARG . 35.3 tt0 -62.04 -55.75 25.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.216 -0.928 . . . . 74.219999999999999 109.965 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 85' ' ' HIS . 33.2 m -63.47 -36.49 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.163 -0.961 . . . . 73.200000000000003 109.62 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.414 ' N ' HG23 ' A' ' 84' ' ' VAL . 21.3 m80 -73.68 -19.59 60.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 53.329999999999998 109.711 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -76.73 -44.19 34.29 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.158 -0.964 . . . . 64.109999999999999 110.017 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -81.42 -29.74 33.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.078 -1.013 . . . . 74.340000000000003 109.217 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -75.75 -40.54 55.24 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.326 -0.859 . . . . 74.420000000000002 110.001 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.519 HE22 HD23 ' A' ' 56' ' ' LEU . 11.1 pt20 -71.15 -46.91 60.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.042 -1.036 . . . . 74.239999999999995 109.841 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.489 ' N ' ' CG ' ' A' ' 89' ' ' GLN . . . 145.67 70.05 0.02 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.881 -1.288 . . . . 61.509999999999998 109.881 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -133.64 129.02 36.31 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.261 -1.141 . . . . 55.329999999999998 108.701 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 11.8 t70 -73.25 -40.12 64.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.912 -1.117 . . . . 73.420000000000002 108.875 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 63.6 m-20 -153.36 154.06 33.79 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.932 -0.766 . . . . 75.040000000000006 108.932 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -127.72 130.71 49.28 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.866 -0.791 . . . . 71.329999999999998 108.866 -179.597 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.922 ' H ' HD12 ' A' ' 95' ' ' ILE . 0.0 OUTLIER -118.74 142.54 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 CA-C-O 121.636 0.731 . . . . 71.129999999999995 110.14 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.12 119.89 8.69 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.982 -1.074 . . . . 64.319999999999993 108.139 178.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.697 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -43.22 -53.79 10.46 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.182 -0.949 . . . . 62.200000000000003 111.656 -179.168 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 1.4 Cg_endo -38.22 -11.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.27 1.314 . . . . 73.109999999999999 113.525 -176.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.697 ' N ' ' O ' ' A' ' 97' ' ' LYS . 56.4 m-85 57.88 103.27 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.454 -0.779 . . . . 65.219999999999999 109.638 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 61.2 mtm-85 -58.96 -49.93 75.98 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.071 -1.018 . . . . 72.349999999999994 109.148 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.822 ' O ' ' N ' ' A' ' 103' ' ' LYS . 3.2 t -174.5 67.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.138 -0.976 . . . . 71.319999999999993 110.631 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.76 ' H ' HD12 ' A' ' 102' ' ' ILE . 1.8 mp 35.6 -68.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 CA-C-O 121.213 0.53 . . . . 75.430000000000007 111.885 178.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.822 ' N ' ' O ' ' A' ' 101' ' ' SER . 28.3 mmtp -47.3 -15.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.867 -1.145 . . . . 71.409999999999997 109.096 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 102' ' ' ILE . . . -60.79 -92.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.439 -0.788 . . . . 63.240000000000002 110.374 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.672 HD23 ' H ' ' A' ' 105' ' ' LEU . 2.0 pt? -50.47 -33.27 20.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.053 -1.03 . . . . 73.219999999999999 110.392 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 66.2 t -65.46 -40.53 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.83 -1.168 . . . . 60.109999999999999 109.037 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 103' ' ' LYS . . . -58.89 -39.6 81.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.218 -0.926 . . . . 70.420000000000002 108.516 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -68.43 -31.21 70.37 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.917 -0.771 . . . . 74.409999999999997 108.917 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.4 mt -75.37 -34.65 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 108.294 -1.002 . . . . 62.539999999999999 108.294 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.407 ' OE2' ' NH1' ' A' ' 114' ' ' ARG . 82.5 tt0 -74.64 -57.81 3.69 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.472 -0.768 . . . . 74.340000000000003 109.184 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -49.62 -35.59 21.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.338 -0.851 . . . . 73.319999999999993 109.319 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 53.8 ttt85 -68.26 -39.47 82.21 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.339 -0.851 . . . . 52.409999999999997 109.865 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 34.8 mt -133.58 68.72 1.49 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.292 -0.88 . . . . 65.239999999999995 110.446 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.407 ' NH1' ' OE2' ' A' ' 110' ' ' GLU . 25.0 mtp85 -75.07 -43.09 55.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.941 -1.099 . . . . 64.450000000000003 108.341 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.478 ' N ' ' CD1' ' A' ' 115' ' ' PHE . 8.7 p90 -132.99 73.21 1.51 Allowed 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.825 -0.805 . . . . 74.430000000000007 108.825 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -56.26 -177.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.601 -0.687 . . . . 74.420000000000002 109.972 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.11 142.39 13.3 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.895 -1.282 . . . . 75.040000000000006 109.895 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.401 ' O ' ' O ' ' A' ' 119' ' ' ASN . 16.0 t -161.85 -61.16 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.346 -1.091 . . . . 61.140000000000001 109.129 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.454 HD21 ' N ' ' A' ' 128' ' ' ILE . 20.7 t-20 51.45 95.95 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.359 -0.838 . . . . 65.239999999999995 109.875 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.4 t -84.34 -19.41 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.049 -1.032 . . . . 73.109999999999999 109.158 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 22.4 mm -110.26 124.56 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.548 -0.72 . . . . 72.239999999999995 109.758 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -138.38 109.16 6.66 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.469 -0.938 . . . . 72.340000000000003 108.469 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 2.9 pt -142.05 122.03 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.243 -0.91 . . . . 71.439999999999998 109.338 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.03 -148.39 32.55 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.429 -1.468 . . . . 73.400000000000006 109.429 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -83.89 9.98 10.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.265 -1.138 . . . . 74.450000000000003 109.391 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.52 131.82 43.78 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.39 -0.819 . . . . 54.210000000000001 108.878 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 p -128.55 128.26 43.93 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.574 -0.899 . . . . 54.5 108.574 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.454 ' N ' HD21 ' A' ' 119' ' ' ASN . 21.2 mt -133.9 135.08 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.334 -0.854 . . . . 45.149999999999999 109.752 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.3 m -119.22 91.75 44.36 Favored Pre-proline 0 N--CA 1.497 1.893 0 N-CA-C 108.845 -0.798 . . . . 71.109999999999999 108.845 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.32 -25.84 6.67 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.226 1.95 . . . . 65.409999999999997 112.538 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -59.32 -40.37 86.03 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.088 -1.007 . . . . 63.32 108.83 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -97.63 5.78 48.92 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.5 -0.926 . . . . 72.519999999999996 108.5 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 56.81 61.2 2.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.257 -0.902 . . . . 75.329999999999998 109.03 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -149.75 148.35 29.12 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.349 -0.844 . . . . 71.230000000000004 109.543 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 13.1 tt -119.93 139.51 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.548 -0.72 . . . . 74.019999999999996 109.212 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.85 126.34 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.581 -0.699 . . . . 60.229999999999997 109.323 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -141.46 149.95 41.63 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.395 -0.815 . . . . 62.32 109.588 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 138' ' ' LYS . 54.6 tttt 55.9 9.59 0.47 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.495 -0.753 . . . . 75.400000000000006 109.715 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.95 14.03 59.88 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.954 -1.258 . . . . 72.239999999999995 109.954 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 29.6 mtp180 -105.35 136.58 44.62 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.421 -1.046 . . . . 71.219999999999999 109.077 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -101.43 118.42 36.92 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.482 -0.761 . . . . 71.420000000000002 110.041 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 10.7 p -138.06 132.54 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.408 -0.808 . . . . 53.020000000000003 108.933 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.427 ' CG ' ' N ' ' A' ' 144' ' ' VAL . 29.5 tt0 -92.3 160.71 15.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -0.917 . . . . 60.450000000000003 110.357 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.455 ' CG2' ' CG ' ' A' ' 149' ' ' PHE . 13.5 p -143.41 140.81 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.182 -1.044 . . . . 74.439999999999998 108.182 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -152.26 113.25 4.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.773 -1.205 . . . . 65.150000000000006 110.399 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 176.89 -164.45 33.94 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.985 -1.646 . . . . 73.340000000000003 108.985 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.623 ' N ' ' CD ' ' A' ' 148' ' ' PRO . 17.3 mtpp -91.19 -32.24 0.35 Allowed Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.055 -1.262 . . . . 72.219999999999999 111.499 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 147' ' ' LYS . 85.8 Cg_endo -88.33 21.15 1.04 Allowed 'Trans proline' 0 N--CA 1.488 1.196 0 C-N-CA 122.131 1.887 . . . . 65.230000000000004 112.516 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.455 ' CG ' ' CG2' ' A' ' 144' ' ' VAL . 41.0 m-85 -125.65 -29.75 3.13 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.475 -0.766 . . . . 60.109999999999999 109.679 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -60.84 -34.05 73.98 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.909 -1.119 . . . . 64.209999999999994 108.606 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.04 -33.97 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.344 -0.984 . . . . 72.019999999999996 108.344 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 17.7 tp -62.26 -45.23 94.22 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.532 -0.914 . . . . 73.310000000000002 108.532 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.9 p -65.47 -37.61 87.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.907 . . . . 74.310000000000002 108.957 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -53.45 -60.55 3.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.563 -0.71 . . . . 74.310000000000002 110.765 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.3 pp -65.0 -23.53 67.24 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.096 -1.002 . . . . 75.340000000000003 109.743 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.1 -40.01 84.0 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.976 -1.077 . . . . 62.140000000000001 108.852 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -86.1 -51.52 6.26 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.235 -0.916 . . . . 61.030000000000001 109.66 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -73.93 49.34 0.33 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 74.120000000000005 108.925 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.626 ' NH1' ' OD2' ' A' ' 160' ' ' ASP . 7.6 ptm180 -77.72 14.08 1.15 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.639 -0.663 . . . . 71.129999999999995 111.025 -178.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.626 ' OD2' ' NH1' ' A' ' 159' ' ' ARG . 64.2 m-20 -148.21 47.48 1.06 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.682 -1.262 . . . . 75.450000000000003 110.129 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 0.473 ' NE2' ' OD2' ' B' ' 160' ' ' ASP . 63.9 mt-30 -150.86 157.52 43.02 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.918 -1.114 . . . . 73.409999999999997 109.848 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 96.6 mt -86.05 117.85 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.527 -0.733 . . . . 74.409999999999997 109.716 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 1.279 ' HB ' ' CE1' ' A' ' 214' ' ' PHE . 44.6 t -108.17 130.02 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.941 -0.763 . . . . 72.310000000000002 108.941 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 8.7 t -96.11 168.05 10.84 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.164 -0.96 . . . . 74.120000000000005 110.167 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm -65.42 -55.0 20.45 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.401 -0.812 . . . . 70.430000000000007 109.75 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -56.32 -33.97 66.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.901 . . . . 73.519999999999996 109.651 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 30.6 tp60 -62.38 -42.76 99.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.314 -0.866 . . . . 74.519999999999996 108.968 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 9.1 mt -60.82 -37.51 82.25 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.397 -0.815 . . . . 72.310000000000002 109.12 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.563 HD23 ' C ' ' A' ' 169' ' ' LEU . 5.0 tt -57.12 -58.76 6.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.337 -0.852 . . . . 53.329999999999998 109.114 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -68.56 -29.41 67.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.614 -0.679 . . . . 62.439999999999998 110.723 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -56.96 -67.8 0.28 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.028 -1.045 . . . . 60.210000000000001 110.377 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.555 ' N ' HD12 ' A' ' 172' ' ' ILE . 2.1 mp -89.01 -50.44 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.003 -1.061 . . . . 75.319999999999993 109.554 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -87.94 73.64 9.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.056 -1.028 . . . . 73.140000000000001 109.156 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -83.23 23.93 0.84 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.296 -0.877 . . . . 73.239999999999995 110.14 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' A' ' 177' ' ' GLU . 7.9 mt-10 -78.34 173.88 6.92 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.104 -0.998 . . . . 44.43 108.421 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -65.91 43.49 0.17 Allowed 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.919 1.746 . . . . 72.510000000000005 112.311 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.46 ' C ' ' H ' ' A' ' 179' ' ' VAL . 95.3 mt-10 48.63 -141.3 0.61 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.087 -1.008 . . . . 63.240000000000002 109.383 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 14.9 ttt 57.03 6.84 0.36 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.063 -1.023 . . . . 73.5 109.032 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.46 ' H ' ' C ' ' A' ' 177' ' ' GLU . 3.7 m -108.72 74.5 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.494 -0.754 . . . . 65.219999999999999 109.753 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 179' ' ' VAL . 41.8 p 46.38 93.59 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 71.420000000000002 109.455 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -75.93 -38.07 1.36 Allowed 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.83 1.687 . . . . 41.219999999999999 113.065 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -76.7 8.11 3.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.832 -1.167 . . . . 64.540000000000006 109.292 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.5 p -70.13 -18.8 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.444 -0.785 . . . . 74.019999999999996 109.802 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 21.7 mt -63.47 -30.68 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.156 -0.965 . . . . 72.329999999999998 109.923 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -63.0 -45.06 94.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.078 -1.014 . . . . 74.400000000000006 110.297 -179.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 16.8 m -73.19 -25.46 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 120.991 -1.068 . . . . 70.420000000000002 109.401 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -78.02 -48.81 15.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.259 -0.901 . . . . 52.109999999999999 109.715 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.483 ' O ' HD13 ' A' ' 188' ' ' ILE . 0.3 OUTLIER -67.64 -32.63 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.028 -1.045 . . . . 71.400000000000006 109.108 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.4 ' OD1' ' NE2' ' A' ' 193' ' ' GLN . 40.5 t30 -67.12 -48.56 67.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.508 -0.745 . . . . 73.439999999999998 110.367 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -72.7 -32.96 66.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.791 -1.193 . . . . 71.420000000000002 109.776 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 51.7 mt -63.56 -54.7 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.779 -1.201 . . . . 61.549999999999997 110.267 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -62.78 -34.84 78.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.692 -1.255 . . . . 63.340000000000003 109.781 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.431 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 45.1 mt-30 -78.04 -18.73 55.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -0.918 . . . . 61.240000000000002 111.24 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -97.24 -28.26 14.15 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.791 -1.193 . . . . 75.129999999999995 110.722 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . 0.51 ' SD ' ' O ' ' A' ' 195' ' ' MET . 4.1 ppp? -93.15 9.2 36.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.753 -1.217 . . . . 74.019999999999996 110.146 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 193' ' ' GLN . 27.9 p-10 -110.31 -32.97 6.77 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.227 -0.921 . . . . 74.019999999999996 110.386 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.579 ' N ' ' CD ' ' A' ' 198' ' ' PRO . 66.8 tttt -75.15 -36.16 2.13 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.018 -1.051 . . . . 75.430000000000007 111.184 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 197' ' ' LYS . 89.8 Cg_endo -87.77 -52.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.188 0 C-N-CA 121.974 1.783 . . . . 72.319999999999993 112.475 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 8.9 mp -48.88 -75.69 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.988 -1.07 . . . . 74.540000000000006 109.301 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 148.94 -47.82 0.63 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.64 -1.384 . . . . 61.509999999999998 109.64 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 24.6 mt -120.07 133.5 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.587 -0.949 . . . . 61.219999999999999 109.388 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 12.6 m -77.79 146.27 35.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.868 . . . . 72.0 108.966 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 22.0 p -132.47 27.77 4.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.461 -0.775 . . . . 74.439999999999998 109.362 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.7 m -129.45 125.57 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.485 -0.759 . . . . 64.349999999999994 109.61 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -98.54 105.05 17.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.544 -0.722 . . . . 71.409999999999997 109.379 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 24.4 p -70.57 119.68 15.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 73.519999999999996 108.816 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 12.7 m -139.93 158.54 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.219 -0.925 . . . . 71.019999999999996 110.301 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 73.3 mtp180 -102.64 -7.15 22.0 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.745 -0.835 . . . . 72.120000000000005 108.745 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.976 ' NH2' ' NH1' ' A' ' 213' ' ' ARG . 53.8 ttp180 -65.04 -27.55 68.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.438 -0.789 . . . . 64.409999999999997 109.677 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -151.06 -72.33 0.16 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 71.540000000000006 109.235 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.467 ' C ' ' CD1' ' A' ' 212' ' ' TYR . . . -167.89 -80.1 0.04 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.614 -1.394 . . . . 72.030000000000001 109.614 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.467 ' CD1' ' C ' ' A' ' 211' ' ' GLY . 73.5 m-85 -149.67 129.17 13.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.143 -1.21 . . . . 75.540000000000006 109.194 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.976 ' NH1' ' NH2' ' A' ' 209' ' ' ARG . 6.0 mtp180 -99.31 116.32 31.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.339 -0.851 . . . . 75.310000000000002 109.1 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 1.279 ' CE1' ' HB ' ' A' ' 163' ' ' VAL . 32.9 m-85 -92.9 104.92 17.11 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.439 -0.948 . . . . 75.409999999999997 108.439 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 15.1 p -138.96 166.17 25.19 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.965 -0.754 . . . . 74.140000000000001 108.965 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . 0.881 ' CE2' ' O ' ' A' ' 217' ' ' PRO . 2.2 p90 -70.24 157.45 89.89 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.249 -0.907 . . . . 75.319999999999993 109.383 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.881 ' O ' ' CE2' ' A' ' 216' ' ' TYR . 51.3 Cg_exo -49.9 161.13 1.02 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.923 1.749 . . . . 73.109999999999999 111.963 178.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.414 ' N ' ' HD2' ' A' ' 219' ' ' PRO . 13.8 mtpt -80.82 -61.39 0.41 Allowed Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.153 -0.967 . . . . 75.25 109.757 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 218' ' ' LYS . 31.0 Cg_endo -61.91 -51.08 4.17 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.872 1.715 . . . . 75.099999999999994 112.006 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . 51.26 68.13 0.84 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.088 -1.007 . . . . 71.140000000000001 108.992 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . 0.435 ' SG ' ' N ' ' A' ' 222' ' ' GLU . 51.0 t -170.4 -108.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 71.129999999999995 109.133 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.435 ' N ' ' SG ' ' A' ' 221' ' ' CYS . 74.6 tt0 47.91 88.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.058 -1.026 . . . . 75.349999999999994 109.666 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.484 ' H ' ' CD ' ' A' ' 223' ' ' GLU . 1.2 pm0 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.039 -1.038 . . . . 73.409999999999997 109.768 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ptp . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.427 -0.582 . . . . 71.140000000000001 109.427 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 51.8 ttt85 -139.65 149.62 43.96 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.346 -0.847 . . . . 73.230000000000004 109.404 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 86.2 t -114.37 138.02 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.679 -0.638 . . . . 72.239999999999995 109.443 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.421 HD11 ' CG1' ' B' ' 6' ' ' ILE . 5.9 tp -113.59 119.11 36.37 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.581 -0.7 . . . . 54.329999999999998 110.159 -178.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.407 ' N ' HD12 ' B' ' 4' ' ' LEU . 12.5 mt -120.31 98.72 6.19 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 108.793 -0.817 . . . . 74.349999999999994 108.793 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.421 ' CG1' HD11 ' B' ' 4' ' ' LEU . 44.9 mt -86.27 98.27 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.716 -1.24 . . . . 42.549999999999997 108.577 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.483 ' CD ' ' HG ' ' B' ' 51' ' ' SER . 9.4 tp10 -136.0 131.32 34.87 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.414 -0.804 . . . . 74.519999999999996 109.423 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -66.03 -34.68 78.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.328 -0.858 . . . . 62.549999999999997 109.363 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -77.27 110.45 11.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.275 -0.89 . . . . 73.109999999999999 109.562 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 31.7 t -68.77 -23.01 64.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 65.540000000000006 109.682 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 93.9 t -68.21 -48.69 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.166 -0.959 . . . . 75.549999999999997 109.842 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.544 ' N ' HD22 ' B' ' 12' ' ' LEU . 3.5 mm? -67.31 -30.41 70.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.936 . . . . 70.140000000000001 109.706 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.5 -33.71 27.44 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.125 -1.59 . . . . 75.400000000000006 109.125 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.7 -45.5 75.47 Favored Glycine 0 N--CA 1.487 2.034 0 N-CA-C 109.888 -1.285 . . . . 65.439999999999998 109.888 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' B' ' 16' ' ' ILE . 11.3 pt-20 -68.38 -44.72 74.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.097 -1.237 . . . . 60.210000000000001 109.26 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.42 ' N ' ' CG ' ' B' ' 15' ' ' GLU . 6.2 mm -60.5 -35.5 63.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.044 -1.035 . . . . 75.150000000000006 108.336 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -62.31 -46.84 86.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.541 -0.724 . . . . 73.010000000000005 109.563 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -83.22 0.75 44.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.117 -0.989 . . . . 74.299999999999997 109.317 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.26 -55.63 2.32 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 109.684 -1.366 . . . . 70.540000000000006 109.684 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -76.45 -17.88 59.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -1.105 . . . . 71.340000000000003 109.857 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -56.7 -30.53 63.55 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.965 -1.084 . . . . 64.409999999999997 109.272 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 73.5 t -59.49 -30.68 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.324 -0.86 . . . . 74.230000000000004 109.039 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -77.43 -7.44 56.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.419 -0.801 . . . . 63.420000000000002 109.318 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.61 39.78 7.04 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.587 -1.005 . . . . 53.43 110.587 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -120.23 158.87 26.09 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.379 -1.071 . . . . 71.120000000000005 109.194 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 50.0 mmm -106.98 138.76 42.54 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.476 -0.935 . . . . 75.239999999999995 108.476 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.41 160.97 40.16 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.113 -0.992 . . . . 72.120000000000005 110.131 -179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -141.35 156.73 45.8 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.787 -0.82 . . . . 72.310000000000002 108.787 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 p -118.84 139.78 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.392 -0.818 . . . . 64.430000000000007 109.58 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 4.1 p -133.64 169.99 16.2 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.57 -0.706 . . . . 65.409999999999997 109.396 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -93.13 -99.71 0.13 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.319 -0.863 . . . . 71.019999999999996 109.884 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 59.8 p -78.16 167.7 21.0 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.195 -0.941 . . . . 51.109999999999999 110.277 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 28.1 mt -56.52 -35.51 68.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.587 -0.695 . . . . 71.239999999999995 110.008 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -54.44 -42.38 70.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.108 -0.995 . . . . 74.319999999999993 109.883 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -66.58 -39.51 88.49 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.097 -1.002 . . . . 73.030000000000001 109.378 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.61 -40.82 58.53 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.546 -1.422 . . . . 30.210000000000001 109.546 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.99 -38.62 91.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.281 -1.129 . . . . 74.420000000000002 109.645 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -74.96 -39.66 61.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.164 -0.96 . . . . 74.420000000000002 109.845 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 21.2 tp -72.02 -49.6 35.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.2 -0.937 . . . . 75.409999999999997 110.102 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' B' ' 40' ' ' MET . 1.9 ppp? -60.72 -30.42 69.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.138 -0.976 . . . . 60.409999999999997 109.938 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -56.82 -37.28 70.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.16 -0.963 . . . . 53.229999999999997 110.044 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 14.2 pt -100.62 0.03 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.292 -0.88 . . . . 71.230000000000004 110.351 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' B' ' 40' ' ' MET . 59.1 mmt-85 -130.96 152.8 49.88 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.288 -0.882 . . . . 72.219999999999999 109.875 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -83.94 165.61 18.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.318 -0.864 . . . . 63.539999999999999 109.095 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 1.9 p90 -156.2 102.08 2.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.029 -1.045 . . . . 64.349999999999994 109.881 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -79.18 -32.04 44.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.177 -0.952 . . . . 62.219999999999999 108.585 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.496 ' C ' HD13 ' B' ' 47' ' ' LEU . 0.7 OUTLIER -113.75 108.41 17.07 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.612 -0.884 . . . . 73.120000000000005 108.612 179.558 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.429 ' N ' HD13 ' B' ' 47' ' ' LEU . 97.3 t -96.55 105.31 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.276 -0.89 . . . . 65.109999999999999 108.693 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 15.5 ttt -123.02 130.54 52.93 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.491 -0.756 . . . . 73.439999999999998 109.661 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.463 ' CG2' ' H ' ' B' ' 52' ' ' ASP . 0.4 OUTLIER -145.28 134.03 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.594 -0.691 . . . . 34.5 109.153 -179.654 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . 0.483 ' HG ' ' CD ' ' B' ' 7' ' ' GLU . 6.4 p -102.06 13.82 33.67 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.551 -0.718 . . . . 73.209999999999994 109.741 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.463 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 66.5 m-20 -76.75 148.1 36.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.145 -0.972 . . . . 70.409999999999997 109.712 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.406 ' C ' ' H ' ' B' ' 55' ' ' ALA . 65.5 mttp -78.05 -42.76 31.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.308 -0.87 . . . . 65.0 109.906 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -73.51 9.43 1.38 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.199 -0.938 . . . . 75.209999999999994 109.521 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -59.72 -22.89 62.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.374 -0.828 . . . . 55.329999999999998 109.826 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 56.2 mt -46.0 -34.29 3.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.331 -0.855 . . . . 63.140000000000001 109.933 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 18.5 m -77.1 -46.96 21.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.102 -0.999 . . . . 63.5 109.499 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . 0.41 ' CZ ' HD11 ' B' ' 62' ' ' ILE . 58.9 t80 -61.86 -53.32 57.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -0.943 . . . . 72.329999999999998 109.519 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.484 HG23 ' N ' ' B' ' 60' ' ' SER . 14.1 m -56.25 -39.99 63.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.587 -1.321 . . . . 74.540000000000006 109.17 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.484 ' N ' HG23 ' B' ' 59' ' ' VAL . 28.0 t -51.6 -46.19 63.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.143 -0.973 . . . . 71.239999999999995 109.722 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.461 ' O ' ' N ' ' B' ' 65' ' ' LYS . 13.8 ptp180 -78.32 -34.27 48.71 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.863 -1.148 . . . . 74.310000000000002 110.566 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' B' ' 66' ' ' HIS . 33.4 mm -63.03 -45.95 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.452 -1.405 . . . . 72.140000000000001 108.464 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.432 ' HZ3' ' HB2' ' B' ' 89' ' ' GLN . 29.5 mttt -61.81 -40.52 95.55 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.624 -0.88 . . . . 73.319999999999993 108.624 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -75.37 -38.13 60.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.61 -0.681 . . . . 73.120000000000005 109.228 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.528 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 25.4 mtpp -83.94 -23.09 31.28 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.266 -0.896 . . . . 72.439999999999998 110.705 -178.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.528 ' CG ' ' O ' ' B' ' 65' ' ' LYS . 83.4 m-70 -156.75 66.4 0.54 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.903 -1.123 . . . . 63.310000000000002 109.912 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.2 t -59.29 -29.51 67.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.328 -0.857 . . . . 73.099999999999994 109.938 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 86.4 p -65.35 -34.74 79.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.153 -0.967 . . . . 71.530000000000001 110.683 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.484 HG22 ' N ' ' B' ' 70' ' ' VAL . 78.3 mt -65.71 160.89 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.912 -1.117 . . . . 74.400000000000006 109.61 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.484 ' N ' HG22 ' B' ' 69' ' ' ILE . 97.6 t -85.0 159.23 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.21 -0.931 . . . . 75.120000000000005 110.039 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.524 ' N ' ' OD1' ' B' ' 92' ' ' ASP . 11.0 t -143.48 111.42 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.075 -1.016 . . . . 73.200000000000003 109.316 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.606 HD23 HD11 ' B' ' 95' ' ' ILE . 0.7 OUTLIER -110.06 99.62 8.68 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.544 -0.91 . . . . 73.340000000000003 108.544 -179.634 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 79.1 t -95.13 127.83 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.237 -0.915 . . . . 73.5 108.963 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . . . . . . . . . 1.1 m -103.22 173.52 6.27 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.443 -0.786 . . . . 64.340000000000003 109.666 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.48 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 23.0 t -166.28 122.97 1.32 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.168 -0.957 . . . . 74.530000000000001 110.298 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -62.01 -17.1 56.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.435 -0.79 . . . . 64.5 109.605 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' B' ' 79' ' ' THR . 47.2 t-20 -124.43 82.23 58.59 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.516 -0.74 . . . . 74.25 109.196 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.15 71.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.566 2.177 . . . . 74.430000000000007 112.003 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.517 ' N ' ' O ' ' B' ' 77' ' ' ASN . 17.0 m -88.13 152.27 22.11 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.102 -0.999 . . . . 73.120000000000005 109.418 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.24 -37.86 88.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.892 . . . . 71.010000000000005 109.488 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -55.64 -46.88 77.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -0.951 . . . . 63.200000000000003 109.63 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -71.56 -30.93 66.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.896 . . . . 73.219999999999999 109.658 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' B' ' 84' ' ' VAL . 10.6 tm-20 -70.02 -56.23 7.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 74.299999999999997 109.851 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.548 HG23 ' N ' ' B' ' 85' ' ' HIS . 13.1 m -63.27 -44.61 99.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.135 -0.978 . . . . 73.310000000000002 109.722 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' HIS . . . . . 0.548 ' N ' HG23 ' B' ' 84' ' ' VAL . 71.1 t60 -63.19 -40.26 97.0 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 73.239999999999995 109.456 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.04 -44.26 97.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.904 . . . . 55.329999999999998 109.588 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -74.13 -30.27 62.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.131 -0.981 . . . . 74.140000000000001 108.535 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -57.54 -50.42 73.16 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.681 -0.859 . . . . 64.040000000000006 108.681 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . 0.432 ' HB2' ' HZ3' ' B' ' 63' ' ' LYS . 50.8 mt-30 -64.33 -38.31 90.58 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.62 -0.675 . . . . 72.349999999999994 109.462 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 139.49 10.31 0.82 Allowed Glycine 0 N--CA 1.499 2.899 0 N-CA-C 110.344 -1.102 . . . . 65.200000000000003 110.344 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -48.79 122.22 5.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.878 -1.366 . . . . 52.229999999999997 109.233 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' B' ' 71' ' ' VAL . 5.8 m-20 -63.68 -37.39 87.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.116 -0.99 . . . . 73.319999999999993 109.102 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 20.3 t0 -154.79 158.44 39.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.339 -0.851 . . . . 72.219999999999999 109.751 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.52 ' N ' ' OD1' ' B' ' 93' ' ' ASP . 42.4 t80 -130.26 116.97 19.13 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.158 -1.053 . . . . 64.420000000000002 108.158 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 1.026 ' H ' HD12 ' B' ' 95' ' ' ILE . 0.0 OUTLIER -119.42 156.75 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.503 0 CA-C-O 121.919 0.866 . . . . 72.230000000000004 110.797 -177.72 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.42 134.06 42.4 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.435 -1.32 . . . . 25.239999999999998 107.435 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.675 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -55.04 -55.57 37.61 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 120.773 -1.204 . . . . 64.319999999999993 111.791 -178.462 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 1.4 Cg_endo -39.44 -12.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 121.144 1.23 . . . . 63.329999999999998 113.213 -176.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . 0.675 ' N ' ' O ' ' B' ' 97' ' ' LYS . 53.3 m-85 56.5 104.13 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.508 -0.745 . . . . 75.129999999999995 109.728 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -55.24 -42.31 73.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.949 -1.095 . . . . 74.230000000000004 108.673 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' B' ' 104' ' ' ALA . 12.2 t -168.2 151.18 5.6 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.465 -0.772 . . . . 63.340000000000003 109.039 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 20.7 mm -55.52 -45.14 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.986 . . . . 74.439999999999998 109.362 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -68.91 -7.54 35.86 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 71.109999999999999 109.605 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' B' ' 101' ' ' SER . . . -71.69 -77.99 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.073 -1.017 . . . . 71.450000000000003 109.786 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.596 HD23 ' N ' ' B' ' 105' ' ' LEU . 2.2 pt? -62.32 -36.67 82.89 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.066 -1.021 . . . . 51.310000000000002 110.092 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 80.7 t -60.36 -44.97 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.9 -1.125 . . . . 65.230000000000004 109.187 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.18 -33.49 72.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.173 -0.954 . . . . 24.32 108.751 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 0.521 ' NH2' ' CG2' ' B' ' 95' ' ' ILE . 78.6 mtm180 -80.27 -24.97 39.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.43 -0.793 . . . . 75.310000000000002 109.872 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 67.0 mt -79.48 -47.01 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.022 -1.049 . . . . 54.240000000000002 108.649 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -64.68 -39.87 94.42 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.584 -0.847 . . . . 65.310000000000002 109.146 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.91 -35.96 82.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.345 -0.847 . . . . 72.239999999999995 109.217 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -61.94 -39.19 91.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.324 -0.86 . . . . 72.040000000000006 109.765 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.65 67.57 1.25 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.157 -0.965 . . . . 75.349999999999994 109.529 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.483 ' O ' ' CG ' ' B' ' 115' ' ' PHE . 50.2 mtp180 -57.28 -32.86 67.06 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.14 -0.975 . . . . 75.5 109.341 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' PHE . . . . . 0.483 ' CG ' ' O ' ' B' ' 114' ' ' ARG . 87.8 m-85 -157.67 91.14 1.12 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.879 . . . . 65.329999999999998 109.515 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' TRP . . . . . 0.519 ' NE1' ' OE2' ' B' ' 141' ' ' GLU . 5.3 m-90 52.21 11.25 0.15 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.292 -0.88 . . . . 74.450000000000003 109.69 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' B' ' 115' ' ' PHE . . . 70.03 -112.4 4.37 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.849 -1.3 . . . . 44.210000000000001 109.849 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 84.4 p -150.62 -172.59 4.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.286 -1.126 . . . . 71.400000000000006 109.843 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.23 130.69 13.85 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.938 -0.705 . . . . 72.319999999999993 109.195 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 5.5 t -80.65 -42.72 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 75.019999999999996 110.117 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' B' ' 128' ' ' ILE . 27.7 mm -112.67 121.41 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.442 -0.786 . . . . 51.409999999999997 109.234 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -154.65 138.84 16.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.251 -0.905 . . . . 71.530000000000001 109.392 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.778 ' H ' HD13 ' B' ' 123' ' ' ILE . 0.1 OUTLIER -147.08 157.1 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.267 -0.896 . . . . 72.430000000000007 109.492 179.721 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 46.85 -131.79 12.47 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.601 -1.4 . . . . 51.229999999999997 109.601 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -99.82 0.73 42.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.311 -1.111 . . . . 74.200000000000003 109.522 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.23 145.57 24.55 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.136 -0.977 . . . . 75.420000000000002 108.527 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 28.8 m -129.21 136.63 50.37 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.548 -0.72 . . . . 74.219999999999999 109.245 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.42 ' O ' ' O ' ' B' ' 121' ' ' ILE . 39.8 mt -136.02 136.34 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.398 -0.814 . . . . 60.329999999999998 109.645 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . . . . . . . . . 7.3 m -127.58 80.27 72.15 Favored Pre-proline 0 N--CA 1.499 2.017 0 N-CA-C 109.15 -0.685 . . . . 72.310000000000002 109.15 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.41 -55.38 3.66 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.815 2.343 . . . . 75.129999999999995 112.612 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -51.82 -40.05 59.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.212 -0.93 . . . . 75.230000000000004 109.627 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -84.6 0.17 51.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.203 -0.936 . . . . 72.430000000000007 109.461 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 52.39 60.32 3.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 75.129999999999995 109.618 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -151.34 130.43 12.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.867 . . . . 73.219999999999999 109.121 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 59.8 mt -118.1 133.81 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.547 -0.721 . . . . 64.140000000000001 109.528 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 70.5 mt -124.43 123.11 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 109.074 -0.713 . . . . 71.219999999999999 109.074 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -137.54 141.42 41.4 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.427 -0.796 . . . . 64.219999999999999 109.522 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . 0.498 ' NZ ' ' O ' ' B' ' 198' ' ' PRO . 50.7 mttp 54.45 26.19 6.88 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.565 -0.709 . . . . 72.019999999999996 110.085 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.88 -0.67 77.25 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.186 -1.166 . . . . 74.319999999999993 110.186 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -89.95 131.27 35.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.127 -1.219 . . . . 75.340000000000003 109.158 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 141' ' ' GLU . . . . . 0.519 ' OE2' ' NE1' ' B' ' 116' ' ' TRP . 95.5 mt-10 -97.1 125.11 41.35 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.331 -0.856 . . . . 71.230000000000004 109.472 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 96.0 t -137.49 135.1 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.387 -0.821 . . . . 70.430000000000007 109.199 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -88.93 151.07 22.54 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.325 -0.86 . . . . 72.430000000000007 109.389 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 22.2 m -90.85 137.77 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.177 -0.952 . . . . 72.129999999999995 109.792 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -171.19 56.05 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.337 -0.852 . . . . 72.019999999999996 109.511 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 178.65 176.82 46.83 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.869 -1.292 . . . . 42.229999999999997 109.869 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 15.2 mttt -70.65 -38.86 8.39 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.362 -1.081 . . . . 73.299999999999997 110.112 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 32.8 Cg_exo -57.73 -37.73 95.58 Favored 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 122.194 1.929 . . . . 71.329999999999998 111.83 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -87.99 -20.7 25.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.431 -0.793 . . . . 74.230000000000004 109.253 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -66.55 -41.77 88.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.302 -0.874 . . . . 72.340000000000003 109.639 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p -73.31 -32.6 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.187 -0.945 . . . . 73.349999999999994 109.58 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 23.1 tp -66.55 -43.42 85.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.209 -0.932 . . . . 55.240000000000002 109.952 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 25.8 m -72.53 -35.24 68.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.963 -1.086 . . . . 70.010000000000005 109.758 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . 0.551 ' CE1' ' NH2' ' B' ' 157' ' ' ARG . 1.6 m-70 -62.96 -48.84 77.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.29 -0.881 . . . . 65.319999999999993 110.259 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.0 pp -69.54 -27.09 64.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.811 -1.181 . . . . 71.540000000000006 109.294 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.62 -49.9 75.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.17 -0.956 . . . . 75.319999999999993 109.499 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.551 ' NH2' ' CE1' ' B' ' 154' ' ' HIS . 21.6 ptt180 -74.86 -36.11 62.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.242 -0.911 . . . . 73.319999999999993 109.934 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -87.98 18.2 4.39 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.08 -1.012 . . . . 74.140000000000001 109.776 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -62.04 161.25 11.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.139 -0.976 . . . . 61.409999999999997 109.266 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . 0.473 ' OD2' ' NE2' ' A' ' 161' ' ' GLN . 37.4 t0 59.73 49.47 8.11 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.329 -0.857 . . . . 72.099999999999994 109.585 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -157.66 145.21 18.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.305 -0.872 . . . . 72.25 109.292 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 94.9 mt -85.91 128.03 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -0.943 . . . . 72.310000000000002 109.192 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 5.3 m -132.24 139.35 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.456 -0.778 . . . . 64.209999999999994 109.585 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 58.4 p -86.45 172.14 10.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.223 -0.923 . . . . 74.219999999999999 109.302 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -59.58 -39.8 85.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.945 . . . . 65.310000000000002 109.59 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -57.29 -32.46 66.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 63.450000000000003 109.798 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -60.04 -48.7 80.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.165 -0.96 . . . . 72.400000000000006 109.873 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 37.6 mt -62.37 -32.96 73.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.086 -1.009 . . . . 72.319999999999993 109.101 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.547 HD23 ' C ' ' B' ' 169' ' ' LEU . 6.3 tt -57.18 -64.98 0.7 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.347 -0.846 . . . . 73.340000000000003 109.542 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -64.82 -31.81 73.22 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.229 -0.919 . . . . 72.099999999999994 110.143 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -48.39 -58.99 3.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.124 -0.985 . . . . 62.130000000000003 110.062 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.674 ' N ' HD12 ' B' ' 172' ' ' ILE . 2.1 mp -92.82 -59.14 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.056 -1.028 . . . . 71.420000000000002 109.318 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 173' ' ' TRP . . . . . . . . . . . . . 11.2 m-90 -78.5 66.4 4.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 72.230000000000004 109.62 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -83.61 -33.85 25.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.21 -0.931 . . . . 52.109999999999999 109.966 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -76.15 149.92 82.63 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.031 -1.043 . . . . 73.040000000000006 109.743 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -42.7 120.17 1.7 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.11 1.874 . . . . 74.129999999999995 112.364 179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -145.23 -5.26 0.68 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.125 -0.984 . . . . 72.439999999999998 109.392 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . . . . . . . . . 66.0 mtt 49.93 57.14 6.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.159 -0.963 . . . . 63.43 109.576 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 3.7 m -92.72 144.42 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.228 -0.92 . . . . 71.049999999999997 109.711 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . 0.447 ' O ' ' N ' ' B' ' 182' ' ' ASN . 75.0 p -86.23 117.75 69.23 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.367 -0.833 . . . . 62.149999999999999 108.828 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -41.08 -22.93 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 121.778 1.652 . . . . 65.219999999999999 112.392 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 182' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' B' ' 180' ' ' THR . 43.5 t-20 -69.21 -29.8 67.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 72.310000000000002 109.614 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . 0.41 HG12 ' O ' ' B' ' 180' ' ' THR . 6.0 p -59.55 -27.61 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.287 -0.883 . . . . 63.32 110.014 -179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 35.2 mm -56.27 -25.87 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.179 -0.951 . . . . 75.030000000000001 109.688 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -58.69 -48.5 80.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.178 -0.951 . . . . 64.109999999999999 109.827 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . 0.423 ' C ' HE21 ' B' ' 190' ' ' GLN . 16.1 m -77.22 -26.42 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.102 -0.999 . . . . 73.0 109.865 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.26 -49.01 38.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.03 -1.044 . . . . 61.119999999999997 109.822 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 19.6 tt -66.87 -33.5 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.175 -0.953 . . . . 72.430000000000007 110.015 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -73.62 -40.62 63.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.112 -0.993 . . . . 65.140000000000001 111.163 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . 0.423 HE21 ' C ' ' B' ' 186' ' ' VAL . 7.6 pt20 -78.17 -37.94 44.63 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.784 -1.198 . . . . 63.240000000000002 111.194 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . 0.419 HD12 ' N ' ' B' ' 192' ' ' ARG . 2.4 pp -69.7 -41.85 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.741 -1.224 . . . . 74.030000000000001 110.138 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 192' ' ' ARG . . . . . 0.419 ' N ' HD12 ' B' ' 191' ' ' ILE . 9.4 ptm180 -69.64 -39.02 77.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.872 -1.142 . . . . 72.239999999999995 109.661 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 193' ' ' GLN . . . . . 0.411 HE21 ' NH1' ' B' ' 192' ' ' ARG . 81.0 mm-40 -67.64 -40.04 84.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.246 -0.909 . . . . 73.099999999999994 110.586 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . 0.468 ' O ' ' CD ' ' B' ' 198' ' ' PRO . 13.1 pttp -80.22 -13.43 59.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.964 -1.085 . . . . 72.109999999999999 110.074 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 51.5 ttm -91.87 -30.26 16.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.199 -0.938 . . . . 44.329999999999998 109.771 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 196' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' B' ' 200' ' ' GLY . 95.8 m-20 -68.7 -41.6 78.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 71.209999999999994 110.266 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . 0.418 ' N ' ' HD2' ' B' ' 198' ' ' PRO . 12.1 tmtt? -60.66 -55.41 45.2 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.042 -1.036 . . . . 75.209999999999994 110.806 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 198' ' ' PRO . . . . . 0.498 ' O ' ' NZ ' ' B' ' 138' ' ' LYS . 29.3 Cg_endo -60.78 -54.95 1.6 Allowed 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 121.371 1.381 . . . . 75.319999999999993 111.829 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.56 -45.67 78.6 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.084 -1.01 . . . . 72.25 108.878 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' B' ' 196' ' ' ASP . . . 87.13 -31.58 4.35 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.688 -1.365 . . . . 64.530000000000001 109.688 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . 0.708 ' N ' HD12 ' B' ' 201' ' ' ILE . 2.0 mp -92.21 138.34 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.245 -1.15 . . . . 44.229999999999997 109.087 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 29.2 t -87.51 139.78 30.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.284 -0.885 . . . . 54.009999999999998 109.271 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 10.2 p -144.84 22.17 1.6 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.212 -0.93 . . . . 74.400000000000006 109.687 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.424 HG12 ' CD2' ' B' ' 214' ' ' PHE . 26.8 m -138.11 143.1 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.247 -0.908 . . . . 72.120000000000005 109.663 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -126.35 135.42 51.46 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.569 -0.707 . . . . 65.409999999999997 109.124 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.6 138.0 35.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.322 -0.861 . . . . 71.329999999999998 109.304 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.42 HG22 ' H ' ' B' ' 209' ' ' ARG . 7.2 p -148.69 141.78 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -0.954 . . . . 63.5 109.442 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -66.86 -41.41 87.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.235 -0.916 . . . . 74.450000000000003 109.435 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' B' ' 211' ' ' GLY . 49.2 mtp85 -60.46 147.68 40.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.237 -0.914 . . . . 74.140000000000001 109.553 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 49.87 -89.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.351 -0.843 . . . . 74.430000000000007 109.841 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' B' ' 209' ' ' ARG . . . -170.95 -100.82 0.14 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.776 -1.33 . . . . 64.450000000000003 109.776 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 212' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' B' ' 212' ' ' TYR . 25.5 m-85 -130.15 153.53 48.43 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.548 -0.972 . . . . 74.209999999999994 108.855 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 5.2 ptm85 -127.43 149.93 49.87 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.383 -0.823 . . . . 74.030000000000001 109.81 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . 0.424 ' CD2' HG12 ' B' ' 204' ' ' VAL . 23.6 m-85 -117.97 131.13 56.53 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.908 -0.775 . . . . 74.340000000000003 108.908 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 29.0 p -160.11 164.0 33.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.064 -1.023 . . . . 64.329999999999998 109.849 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -61.83 152.5 75.96 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.381 -0.825 . . . . 70.040000000000006 108.931 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -68.16 -156.16 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.151 1.901 . . . . 65.109999999999999 111.482 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' B' ' 220' ' ' ALA . 51.2 mtpt -44.94 153.05 0.52 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.262 -0.899 . . . . 73.150000000000006 109.414 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -34.03 -26.45 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.226 0 C-N-CA 122.831 2.354 . . . . 71.310000000000002 113.04 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' B' ' 218' ' ' LYS . . . 50.98 -165.18 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.057 -1.027 . . . . 75.450000000000003 109.456 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 23.9 p -71.96 8.75 1.12 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 72.219999999999999 109.565 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 47.41 39.11 8.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.165 -0.959 . . . . 54.530000000000001 109.572 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.051 -0.976 . . . . 71.129999999999995 109.541 -179.873 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.9 ttm . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.38 -0.6 . . . . 65.120000000000005 109.38 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -137.78 154.95 49.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.392 -0.818 . . . . 72.329999999999998 109.394 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 83.6 t -119.79 125.96 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.547 0.689 . . . . 71.420000000000002 109.79 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.3 tp -94.42 115.94 28.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.371 -0.974 . . . . 65.120000000000005 108.371 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.576 HD22 ' CG ' ' A' ' 49' ' ' MET . 0.2 OUTLIER -117.95 110.59 17.91 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.562 -0.903 . . . . 62.43 108.562 -179.871 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.43 ' CG2' ' O ' ' A' ' 31' ' ' GLU . 12.3 mt -94.41 105.26 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 120.791 -1.193 . . . . 71.150000000000006 109.507 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -139.52 124.72 18.92 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.241 -0.912 . . . . 75.340000000000003 109.259 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -71.83 -32.37 67.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 72.439999999999998 109.505 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -83.42 113.44 20.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.237 -0.915 . . . . 63.020000000000003 109.462 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 84.2 p -68.07 -25.34 65.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 72.340000000000003 109.522 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 84.5 t -67.99 -53.59 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -0.925 . . . . 74.019999999999996 109.609 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.509 ' O ' HD13 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -67.62 -38.85 84.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 71.430000000000007 108.951 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.51 -25.8 75.14 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 108.436 -1.866 . . . . 61.32 108.436 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.51 -58.05 10.13 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 109.477 -1.449 . . . . 71.200000000000003 109.477 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.417 ' H ' ' HG2' ' A' ' 15' ' ' GLU . 6.7 pt-20 -53.26 -46.78 69.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.411 -1.053 . . . . 71.319999999999993 109.676 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 86.0 mt -64.52 -50.93 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.866 -1.146 . . . . 63.229999999999997 108.96 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -49.2 -52.91 23.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 51.109999999999999 109.708 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.405 ' CD ' ' N ' ' A' ' 18' ' ' LYS . 0.7 OUTLIER -83.51 2.44 36.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.139 -0.976 . . . . 73.340000000000003 109.444 -179.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.23 -60.98 1.95 Allowed Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.909 -1.276 . . . . 62.149999999999999 109.909 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.419 HD23 ' N ' ' A' ' 20' ' ' LEU . 1.7 pt? -72.66 -19.37 61.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -1.161 . . . . 73.510000000000005 110.034 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -56.87 -31.64 65.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.972 -1.08 . . . . 74.25 109.468 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 84.2 t -60.68 -28.92 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 70.040000000000006 109.327 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.422 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 11.5 mptt -76.55 -1.21 26.29 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.262 -0.899 . . . . 73.230000000000004 109.28 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.0 36.56 8.97 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.156 -1.177 . . . . 75.540000000000006 110.156 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -119.51 157.51 28.17 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.497 -1.002 . . . . 73.430000000000007 109.326 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 14.3 mmt -108.12 138.62 44.08 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.522 -0.918 . . . . 43.240000000000002 108.522 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.54 159.29 43.02 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.134 -0.979 . . . . 62.109999999999999 110.13 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -136.68 155.44 49.87 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.507 -0.746 . . . . 74.420000000000002 109.0 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -108.55 136.68 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.372 -0.83 . . . . 72.150000000000006 109.099 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.8 p -133.25 164.94 25.94 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.385 -0.822 . . . . 71.420000000000002 109.313 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.43 ' O ' ' CG2' ' A' ' 6' ' ' ILE . 4.9 pt-20 -90.59 -105.73 0.1 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.259 -0.901 . . . . 72.329999999999998 109.853 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 59.5 p -78.23 170.63 16.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.961 . . . . 74.239999999999995 109.961 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.9 mt -55.97 -30.87 62.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.564 -0.71 . . . . 71.530000000000001 109.794 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -50.41 -46.25 56.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 74.230000000000004 109.584 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.06 -39.41 90.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.18 -0.95 . . . . 54.030000000000001 109.418 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.34 -44.31 34.83 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.572 -1.411 . . . . 61.409999999999997 109.572 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -63.02 -37.29 86.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.263 -1.139 . . . . 74.340000000000003 109.457 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -81.22 -38.09 27.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 75.329999999999998 109.655 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.4 tp -68.71 -46.65 68.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.31 -0.869 . . . . 74.329999999999998 109.937 -179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.489 ' SD ' ' OD1' ' A' ' 41' ' ' ASP . 3.5 ppp? -63.09 -25.56 68.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.129 -0.982 . . . . 70.319999999999993 109.793 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.489 ' OD1' ' SD ' ' A' ' 40' ' ' MET . 97.5 m-20 -66.51 -41.14 89.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.082 -1.011 . . . . 71.219999999999999 109.973 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.1 pt -82.82 -27.84 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.115 -0.991 . . . . 74.140000000000001 110.16 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 40' ' ' MET . 88.7 mtt-85 -129.74 144.46 51.3 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.336 -0.853 . . . . 72.239999999999995 109.449 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -91.51 154.13 19.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.239 -0.913 . . . . 75.420000000000002 109.521 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -134.76 157.6 46.32 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.491 -0.756 . . . . 74.230000000000004 109.176 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -102.7 -42.56 5.85 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.387 -0.821 . . . . 72.040000000000006 109.464 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.441 HD13 ' C ' ' A' ' 47' ' ' LEU . 0.4 OUTLIER -104.36 109.7 21.65 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.514 -0.741 . . . . 72.129999999999995 109.224 -179.82 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.418 ' N ' HD13 ' A' ' 47' ' ' LEU . 74.7 t -94.09 99.86 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.202 -0.937 . . . . 72.340000000000003 108.834 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.576 ' CG ' HD22 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -114.1 129.1 56.63 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.154 -0.684 . . . . 74.109999999999999 109.154 -179.603 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.437 ' CG2' ' H ' ' A' ' 52' ' ' ASP . 1.3 p -134.64 133.13 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.536 -0.728 . . . . 61.119999999999997 109.89 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.5 p -96.83 1.41 50.64 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.543 -0.723 . . . . 73.109999999999999 109.435 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.437 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 55.3 m-20 -76.19 141.51 41.8 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.198 -0.939 . . . . 52.549999999999997 109.416 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.467 ' C ' ' H ' ' A' ' 55' ' ' ALA . 0.7 OUTLIER -79.75 -38.58 32.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 44.219999999999999 110.204 -179.479 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -71.18 10.5 0.56 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.035 -1.04 . . . . 70.439999999999998 109.364 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.467 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -72.39 -20.51 61.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -0.831 . . . . 64.140000000000001 110.298 -179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 55' ' ' ALA . 68.7 mt -41.18 -47.65 3.32 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.509 -0.744 . . . . 44.140000000000001 110.296 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 m -70.28 -35.21 73.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.931 -1.105 . . . . 55.229999999999997 108.97 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.659 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 67.7 t80 -66.36 -59.26 3.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.392 -0.817 . . . . 74.439999999999998 109.849 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.4 m -52.36 -34.14 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.696 -1.253 . . . . 74.030000000000001 109.345 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 p -57.79 -51.83 67.96 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 64.299999999999997 109.732 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -69.32 -28.92 66.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.068 -1.02 . . . . 64.439999999999998 109.983 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.659 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 7.6 mm -67.08 -24.08 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.88 -1.138 . . . . 63.210000000000001 109.835 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -86.15 -53.33 5.12 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.034 -1.041 . . . . 74.420000000000002 110.562 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.443 ' CG ' ' N ' ' A' ' 65' ' ' LYS . 14.9 pt-20 -63.78 -43.14 97.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.9 -1.125 . . . . 70.319999999999993 110.128 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.443 ' N ' ' CG ' ' A' ' 64' ' ' GLU . 78.2 mttt -79.02 -61.0 2.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 75.219999999999999 109.092 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.53 ' ND1' ' N ' ' A' ' 66' ' ' HIS . 0.2 OUTLIER -97.18 80.23 2.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.326 -0.859 . . . . 74.129999999999995 108.876 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.9 m -79.02 -25.9 43.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.015 -1.053 . . . . 73.239999999999995 110.22 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 28.3 t -82.55 51.77 1.93 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.114 -0.991 . . . . 61.009999999999998 110.208 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 66' ' ' HIS . 15.3 tt -156.98 160.94 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.938 -1.101 . . . . 71.329999999999998 109.945 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 71' ' ' VAL . 90.6 t -95.8 160.15 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.178 -0.951 . . . . 72.129999999999995 109.135 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.467 ' N ' HG12 ' A' ' 70' ' ' VAL . 3.6 t -146.16 121.24 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.955 -1.091 . . . . 54.210000000000001 109.942 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.515 ' O ' ' SD ' ' A' ' 49' ' ' MET . 3.5 mp -119.83 103.41 9.32 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.116 -1.068 . . . . 50.240000000000002 108.116 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.9 p -95.8 146.27 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.487 -0.931 . . . . 74.409999999999997 108.487 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.453 ' O ' ' OG ' ' A' ' 75' ' ' SER . 0.5 OUTLIER -118.44 165.87 13.36 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.468 -0.77 . . . . 72.310000000000002 109.226 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 74' ' ' SER . 3.1 m -168.3 124.08 1.0 Allowed 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 119.393 -0.923 . . . . 64.540000000000006 110.242 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.52 1.45 1.19 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.552 -0.718 . . . . 74.129999999999995 109.809 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 75' ' ' SER . 33.8 m120 -120.64 62.87 10.1 Favored Pre-proline 0 N--CA 1.501 2.101 0 O-C-N 121.396 -0.815 . . . . 73.340000000000003 110.198 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -62.99 77.9 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.157 1.905 . . . . 63.219999999999999 111.789 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 77.9 p -104.36 151.72 23.13 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.566 -0.901 . . . . 62.530000000000001 108.566 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -31.9 66.8 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.243 -0.911 . . . . 73.439999999999998 109.309 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.511 ' O ' ' ND1' ' A' ' 85' ' ' HIS . 78.0 mm-40 -66.29 -36.21 82.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.15 -0.969 . . . . 71.420000000000002 109.22 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -71.17 -35.48 71.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.331 -0.856 . . . . 73.430000000000007 109.621 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.77 -52.57 64.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 74.219999999999999 109.689 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.6 m -60.52 -36.0 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.187 -0.946 . . . . 73.200000000000003 109.258 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' A' ' 81' ' ' GLU . 27.9 m80 -71.77 -31.15 66.33 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.274 -0.891 . . . . 53.329999999999998 109.561 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 91' ' ' ALA . . . -65.17 -40.1 93.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.209 -0.932 . . . . 64.109999999999999 110.177 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.501 ' CZ ' ' HB1' ' B' ' 111' ' ' ALA . 89.3 t80 -83.36 -37.64 23.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.954 -1.092 . . . . 74.340000000000003 109.32 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -68.21 -42.91 79.13 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.242 -0.911 . . . . 74.420000000000002 109.493 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -66.81 -49.95 64.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -0.996 . . . . 74.239999999999995 109.369 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 143.73 72.41 0.02 OUTLIER Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.017 -1.233 . . . . 61.509999999999998 110.017 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 86' ' ' ALA . . . -138.25 124.16 20.04 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.242 -1.152 . . . . 55.329999999999998 109.201 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 13.9 t70 -61.13 -41.72 97.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 73.420000000000002 109.336 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 66.8 m-20 -152.05 159.34 43.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.325 -0.859 . . . . 75.040000000000006 109.337 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -124.14 131.71 53.57 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.605 -0.685 . . . . 71.329999999999998 109.449 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 67.5 mt -123.41 140.62 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-O 122.084 0.945 . . . . 71.129999999999995 110.381 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.0 121.49 13.12 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.901 -1.148 . . . . 64.319999999999993 107.901 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.694 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -45.46 -54.59 14.53 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.128 -0.983 . . . . 62.200000000000003 111.428 -178.756 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 2.5 Cg_endo -40.47 -9.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 121.08 1.187 . . . . 73.109999999999999 113.289 -176.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.694 ' N ' ' O ' ' A' ' 97' ' ' LYS . 67.5 m-85 58.6 99.39 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.514 -0.741 . . . . 65.219999999999999 109.007 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.4 ttm-85 -53.05 -41.62 64.98 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.169 -0.957 . . . . 72.349999999999994 109.37 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.822 ' O ' ' N ' ' A' ' 103' ' ' LYS . 23.1 t -172.86 36.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.982 -1.074 . . . . 71.319999999999993 110.929 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 96.6 mt 44.97 -68.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-N 118.693 0.679 . . . . 75.430000000000007 110.792 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.822 ' N ' ' O ' ' A' ' 101' ' ' SER . 21.3 tptm -49.22 -36.26 19.55 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.01 -1.056 . . . . 71.409999999999997 108.295 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -67.94 -40.91 83.22 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.189 -1.041 . . . . 63.240000000000002 108.189 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.8 -38.17 88.25 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.835 -0.802 . . . . 73.219999999999999 108.835 179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.23 -42.13 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -0.896 . . . . 60.109999999999999 109.353 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.44 -41.17 63.04 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.216 -0.927 . . . . 70.420000000000002 108.786 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.525 ' NE ' ' OE2' ' B' ' 83' ' ' GLU . 98.7 mtt180 -68.66 -37.84 79.96 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.35 -0.844 . . . . 74.409999999999997 109.282 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.62 -30.84 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.041 -1.037 . . . . 62.539999999999999 108.314 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -63.24 -54.81 31.55 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.777 -0.823 . . . . 74.340000000000003 108.777 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.465 ' HB2' ' CZ ' ' B' ' 87' ' ' PHE . . . -53.11 -35.87 60.13 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.402 -0.811 . . . . 73.319999999999993 109.396 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -57.76 -48.95 78.19 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.216 -0.927 . . . . 52.409999999999997 109.25 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 78.6 mt -144.53 97.73 3.08 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.137 -0.977 . . . . 65.239999999999995 109.496 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.403 ' O ' ' CG ' ' A' ' 115' ' ' PHE . 42.0 mtp180 -85.12 -59.02 2.45 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.205 -0.935 . . . . 64.450000000000003 108.999 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.403 ' CG ' ' O ' ' A' ' 114' ' ' ARG . 56.9 m-85 -156.55 89.27 1.1 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.256 -0.902 . . . . 74.430000000000007 109.542 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.474 ' CD1' ' N ' ' A' ' 116' ' ' TRP . 7.8 p-90 -93.17 133.5 36.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.237 -0.915 . . . . 74.420000000000002 109.078 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 178.42 98.35 0.11 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.586 -1.406 . . . . 75.040000000000006 109.586 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.83 ' HB3' ' OE2' ' A' ' 132' ' ' GLU . 31.0 t -159.61 176.97 11.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -1.113 . . . . 61.140000000000001 109.495 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -158.12 120.02 3.63 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.841 -0.8 . . . . 65.239999999999995 108.841 -178.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.8 t -83.62 -25.93 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.073 -1.017 . . . . 73.109999999999999 109.056 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.447 HG21 ' O ' ' A' ' 156' ' ' ALA . 28.2 mm -111.33 121.08 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.622 -0.881 . . . . 72.239999999999995 108.622 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -127.33 109.91 12.27 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.518 -0.738 . . . . 72.340000000000003 109.446 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.412 ' O ' ' C ' ' A' ' 124' ' ' GLY . 94.4 mt -112.67 124.64 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.63 -0.878 . . . . 71.439999999999998 108.63 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 123' ' ' ILE . . . -34.16 -44.22 0.37 Allowed Glycine 0 N--CA 1.495 2.586 0 N-CA-C 112.109 -0.397 . . . . 73.400000000000006 112.109 -178.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.492 ' CB ' HD13 ' A' ' 126' ' ' LEU . 62.1 m-20 -63.7 -56.38 16.14 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.987 -1.302 . . . . 74.450000000000003 109.94 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.537 ' H ' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -144.12 166.44 25.01 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.113 -0.992 . . . . 54.210000000000001 110.083 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.4 m -106.49 145.07 32.27 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.229 -0.919 . . . . 54.5 109.894 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 8.9 mt -137.24 134.62 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.165 -0.959 . . . . 45.149999999999999 109.76 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.7 t -121.53 113.42 32.07 Favored Pre-proline 0 N--CA 1.499 1.994 0 N-CA-C 109.24 -0.652 . . . . 71.109999999999999 109.24 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -81.05 -54.12 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.242 0 C-N-CA 121.719 1.613 . . . . 65.409999999999997 112.109 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -55.57 -42.48 74.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 63.32 109.147 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.83 ' OE2' ' HB3' ' A' ' 118' ' ' SER . 72.1 mt-10 -82.56 -4.19 57.22 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.288 -0.883 . . . . 72.519999999999996 109.201 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 47.51 66.35 1.04 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.334 -0.854 . . . . 75.329999999999998 109.797 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -159.58 142.76 14.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.063 -1.023 . . . . 71.230000000000004 109.783 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 16.0 tt -126.94 138.36 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.468 -0.77 . . . . 74.019999999999996 109.897 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.1 mm -118.03 121.77 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.728 -0.842 . . . . 60.229999999999997 108.728 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -140.29 146.01 38.0 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.102 -0.998 . . . . 62.32 110.014 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 83.0 mttt 53.87 26.72 6.41 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.481 -0.762 . . . . 75.400000000000006 110.215 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 78.18 9.08 87.24 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 120.122 -1.037 . . . . 72.239999999999995 110.857 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 43.7 mtp180 -103.11 142.89 33.35 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.194 -1.18 . . . . 71.219999999999999 109.259 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -110.74 121.96 46.63 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.899 -0.778 . . . . 71.420000000000002 108.899 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.5 143.95 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 120.924 -1.11 . . . . 53.020000000000003 110.698 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.568 ' H ' ' CD ' ' A' ' 143' ' ' GLU . 2.1 pm0 -93.65 134.63 35.75 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.398 -1.334 . . . . 60.450000000000003 107.398 178.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.1 136.65 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 120.936 -1.103 . . . . 74.439999999999998 110.514 -178.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.13 104.11 0.99 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.643 -0.66 . . . . 65.150000000000006 109.498 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -166.88 -147.49 5.26 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.748 -1.341 . . . . 73.340000000000003 109.748 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.455 ' H ' ' HD2' ' A' ' 148' ' ' PRO . 30.4 mttt -92.71 -59.72 0.21 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.212 -1.17 . . . . 72.219999999999999 110.691 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.762 ' HG2' ' CE1' ' A' ' 149' ' ' PHE . 21.7 Cg_endo -57.94 -15.18 21.07 Favored 'Trans proline' 0 N--CA 1.5 1.898 0 C-N-CA 121.913 1.742 . . . . 65.230000000000004 111.937 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.762 ' CE1' ' HG2' ' A' ' 148' ' ' PRO . 4.1 m-85 -98.8 -22.87 15.62 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.175 -0.953 . . . . 60.109999999999999 110.196 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -59.61 -35.63 74.71 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.77 -1.206 . . . . 64.209999999999994 108.848 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 2.3 p -70.45 -27.86 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.238 -0.914 . . . . 72.019999999999996 108.619 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 56.9 tp -64.48 -49.55 70.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.343 -0.848 . . . . 73.310000000000002 109.585 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.46 -33.46 74.21 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.816 -1.177 . . . . 74.310000000000002 108.691 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -54.24 -54.83 34.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.439 -0.788 . . . . 74.310000000000002 110.199 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.4 pp -75.26 -23.19 57.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.104 -0.998 . . . . 75.340000000000003 109.758 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.447 ' O ' HG21 ' A' ' 121' ' ' ILE . . . -55.13 -38.44 68.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.159 -0.963 . . . . 62.140000000000001 108.753 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' A' ' 159' ' ' ARG . 45.1 mtp180 -86.8 -56.08 3.56 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.285 -1.005 . . . . 61.030000000000001 108.285 178.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.437 ' N ' ' CD2' ' A' ' 158' ' ' HIS . 8.0 m170 -68.92 47.77 0.06 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.573 -0.899 . . . . 74.120000000000005 108.573 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 214' ' ' PHE . 63.9 mtm180 -53.4 -60.04 3.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.609 -0.682 . . . . 71.129999999999995 110.271 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -95.6 94.19 7.6 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.165 -0.96 . . . . 75.450000000000003 109.283 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . 1.362 ' NE2' ' O ' ' A' ' 162' ' ' ILE . 21.9 tm0? -170.16 142.85 2.34 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.025 -1.047 . . . . 73.409999999999997 109.938 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 1.362 ' O ' ' NE2' ' A' ' 161' ' ' GLN . 2.0 mp -87.74 139.51 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.258 -1.016 . . . . 74.409999999999997 108.258 179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.561 ' CG1' ' OE1' ' A' ' 161' ' ' GLN . 17.6 m -126.82 150.94 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.463 -0.773 . . . . 72.310000000000002 109.893 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 7.2 t -99.78 158.23 15.94 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.499 -0.751 . . . . 74.120000000000005 109.218 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.466 ' HB3' HD13 ' A' ' 184' ' ' ILE . 65.3 mttm -55.67 -54.07 48.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.344 -0.847 . . . . 70.430000000000007 110.01 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -63.11 -27.97 69.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.282 -0.886 . . . . 73.519999999999996 110.343 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.441 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 46.1 tt0 -62.05 -54.37 42.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.005 -1.06 . . . . 74.519999999999996 110.08 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 48.9 mt -59.33 -44.78 92.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.884 -1.135 . . . . 72.310000000000002 109.36 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 173' ' ' TRP . 4.2 mm? -62.24 -53.04 60.96 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.147 -0.971 . . . . 53.329999999999998 109.731 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 167' ' ' GLN . 14.2 p30 -71.1 -4.93 27.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.016 -1.053 . . . . 62.439999999999998 110.174 -179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -83.15 -59.01 2.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.06 -1.025 . . . . 60.210000000000001 109.927 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.74 ' N ' HD12 ' A' ' 172' ' ' ILE . 1.9 mp -85.59 -43.66 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.935 -1.103 . . . . 75.319999999999993 109.291 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . 0.458 ' O ' ' O ' ' A' ' 169' ' ' LEU . 23.5 m-90 -106.49 115.46 30.24 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.442 -0.786 . . . . 73.140000000000001 109.755 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -144.23 19.65 1.74 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.882 -1.137 . . . . 73.239999999999995 109.209 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.579 ' H ' ' CD ' ' A' ' 176' ' ' PRO . 0.9 OUTLIER -172.74 -44.63 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.925 . . . . 44.43 109.623 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.579 ' CD ' ' H ' ' A' ' 175' ' ' GLU . 37.0 Cg_exo -60.66 -60.72 0.23 Allowed 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.091 1.861 . . . . 72.510000000000005 111.747 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.511 ' C ' ' H ' ' A' ' 179' ' ' VAL . 61.0 mm-40 -86.24 152.95 22.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.203 -0.936 . . . . 63.240000000000002 109.281 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.539 ' O ' ' N ' ' A' ' 180' ' ' THR . 32.0 ttm -60.81 -1.24 0.38 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.936 . . . . 73.5 108.922 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.572 ' O ' HG13 ' A' ' 179' ' ' VAL . 0.3 OUTLIER 38.17 23.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-O 121.412 0.625 . . . . 65.219999999999999 110.763 179.616 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 178' ' ' MET . 60.0 m -47.59 135.63 10.15 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.01 -1.056 . . . . 71.420000000000002 108.843 179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.01 72.54 1.56 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.637 1.558 . . . . 41.219999999999999 111.723 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.428 ' N ' ' OD1' ' A' ' 182' ' ' ASN . 25.1 p-10 -168.36 -26.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.312 -0.868 . . . . 64.540000000000006 109.527 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 183' ' ' VAL . 11.0 m -76.88 -0.53 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 74.019999999999996 109.415 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.488 ' O ' HG22 ' A' ' 188' ' ' ILE . 50.6 mt -51.23 -46.85 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 72.329999999999998 109.546 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -56.0 -30.85 62.44 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.401 -0.812 . . . . 74.400000000000006 110.17 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 18.0 t -75.13 -53.18 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.041 -1.037 . . . . 70.420000000000002 110.735 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.8 -44.5 93.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.034 -1.041 . . . . 52.109999999999999 110.697 -178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 184' ' ' ILE . 8.1 tp -69.84 -37.91 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.112 -0.993 . . . . 71.400000000000006 110.418 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.412 ' N ' HG23 ' A' ' 188' ' ' ILE . 26.6 t-20 -70.73 -48.61 53.61 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.111 -0.993 . . . . 73.439999999999998 110.738 -179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.449 ' CG ' ' N ' ' A' ' 191' ' ' ILE . 7.1 pt20 -64.44 -45.59 86.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.909 -1.119 . . . . 71.420000000000002 110.145 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.449 ' N ' ' CG ' ' A' ' 190' ' ' GLN . 89.6 mt -59.53 -46.68 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.05 -1.031 . . . . 61.549999999999997 109.711 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 19.5 mtp-105 -60.01 -45.08 93.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.025 -1.047 . . . . 63.340000000000003 109.606 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -65.85 -29.29 69.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 61.240000000000002 109.589 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -93.88 -1.46 54.77 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.244 -0.91 . . . . 75.129999999999995 109.996 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 36.5 ttm -96.84 -60.47 1.59 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.04 -1.038 . . . . 74.019999999999996 109.907 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 41.8 t0 -54.94 -22.55 15.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.306 -0.871 . . . . 74.019999999999996 110.583 -178.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.432 ' CB ' ' CD ' ' A' ' 198' ' ' PRO . 1.3 mptm? -73.27 -65.81 0.63 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.917 -1.114 . . . . 75.430000000000007 110.221 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . 0.432 ' CD ' ' CB ' ' A' ' 197' ' ' LYS . 30.7 Cg_endo -62.18 -56.71 0.64 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.501 1.468 . . . . 72.319999999999993 112.355 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 18.8 mt -64.12 -40.49 96.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.176 -0.953 . . . . 74.540000000000006 109.763 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 86.3 -34.13 3.51 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.916 -1.674 . . . . 61.509999999999998 108.916 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 35.6 mm -111.58 134.82 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.614 -0.933 . . . . 61.219999999999999 108.895 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 59.5 p -95.08 166.15 12.07 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.287 -0.883 . . . . 72.0 110.345 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.9 34.41 0.26 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.348 -0.982 . . . . 74.439999999999998 108.348 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 23.7 m -135.4 137.18 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.541 -0.724 . . . . 64.349999999999994 109.329 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -120.3 135.39 55.02 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.61 -0.681 . . . . 71.409999999999997 109.408 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.5 135.13 42.42 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.317 -0.865 . . . . 73.519999999999996 109.115 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.7 145.74 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.201 -0.937 . . . . 71.019999999999996 109.465 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -77.5 76.55 4.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.94 . . . . 72.120000000000005 109.502 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 46.1 ttp180 -164.01 -126.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.229 -0.919 . . . . 64.409999999999997 109.432 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 18.7 tpt85 -49.39 -43.21 44.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.186 -0.946 . . . . 71.540000000000006 109.733 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 160.46 -111.47 0.48 Allowed Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.686 -1.245 . . . . 72.030000000000001 110.208 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -115.45 171.26 7.83 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.503 -0.998 . . . . 75.540000000000006 109.433 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -142.2 133.0 25.64 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.246 -0.909 . . . . 75.310000000000002 109.699 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.437 ' O ' ' O ' ' A' ' 159' ' ' ARG . 7.2 m-85 -105.4 131.54 52.7 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.88 -0.785 . . . . 75.409999999999997 108.88 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 21.3 t -157.08 150.55 24.21 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.942 -0.762 . . . . 74.140000000000001 108.942 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -61.77 150.54 81.86 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.047 -1.033 . . . . 75.319999999999993 108.913 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.5 -159.89 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.412 2.075 . . . . 73.109999999999999 112.455 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -43.88 162.14 0.2 Allowed Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.542 -0.724 . . . . 75.25 109.315 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -41.44 111.73 0.18 Allowed 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.875 1.717 . . . . 75.099999999999994 111.83 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . -57.34 -37.52 72.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.293 -0.879 . . . . 71.140000000000001 110.035 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . . . . . . . . . 18.2 p -157.18 177.6 11.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.038 -1.039 . . . . 71.129999999999995 109.93 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -143.43 -47.1 0.29 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.401 -0.812 . . . . 75.349999999999994 109.093 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.009 -0.996 . . . . 73.409999999999997 109.416 179.889 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.541 ' N ' ' CZ ' ' B' ' 2' ' ' ARG . 56.1 ttm . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.485 -0.561 . . . . 71.140000000000001 109.485 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.541 ' CZ ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER -128.14 147.08 50.53 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.996 -0.742 . . . . 73.230000000000004 108.996 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 96.8 t -111.11 123.64 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.642 0.734 . . . . 72.239999999999995 109.947 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.584 HD11 ' CG1' ' B' ' 6' ' ' ILE . 1.8 tp -92.79 118.65 31.32 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.477 -0.934 . . . . 54.329999999999998 108.477 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.526 HD23 ' N ' ' B' ' 6' ' ' ILE . 1.2 tt -119.08 118.05 30.38 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.318 -0.993 . . . . 74.349999999999994 108.318 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.584 ' CG1' HD11 ' B' ' 4' ' ' LEU . 24.0 mt -111.51 98.4 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.365 -0.834 . . . . 42.549999999999997 108.779 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.423 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 24.6 tp10 -128.93 137.44 51.41 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.623 -0.673 . . . . 74.519999999999996 109.365 -179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.3 -32.95 73.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.281 -0.887 . . . . 62.549999999999997 109.454 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -90.88 125.0 35.61 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.253 -0.904 . . . . 73.109999999999999 109.514 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 49.5 m -74.93 -32.99 61.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 65.540000000000006 109.799 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 96.0 t -60.14 -46.77 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.149 -0.97 . . . . 75.549999999999997 109.728 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.507 ' CD2' ' N ' ' B' ' 12' ' ' LEU . 3.5 mm? -63.99 -36.48 84.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 70.140000000000001 109.411 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.56 -27.31 71.41 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 108.56 -1.816 . . . . 75.400000000000006 108.56 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.59 -53.18 40.36 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 109.543 -1.423 . . . . 65.439999999999998 109.543 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -58.97 -46.31 88.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.373 -1.075 . . . . 60.210000000000001 109.789 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 36.8 mm -64.45 -40.11 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.816 -1.177 . . . . 75.150000000000006 108.826 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.462 ' O ' ' ND2' ' B' ' 21' ' ' ASN . 83.0 tt0 -61.62 -44.92 96.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.27 -0.894 . . . . 73.010000000000005 109.317 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -84.96 1.38 47.68 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 74.299999999999997 109.196 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -87.48 -55.42 2.33 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.618 -1.393 . . . . 70.540000000000006 109.618 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -75.7 -20.71 58.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -1.13 . . . . 71.340000000000003 109.839 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' B' ' 17' ' ' GLU . 82.5 m-20 -52.54 -33.74 46.9 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.037 -1.039 . . . . 64.409999999999997 109.547 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 75.9 t -58.2 -29.69 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.229 -0.919 . . . . 74.230000000000004 109.278 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -80.12 -7.47 58.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.295 -0.878 . . . . 63.420000000000002 109.485 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.57 40.47 7.75 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.327 -1.109 . . . . 53.43 110.327 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -119.12 160.29 22.37 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.428 -1.042 . . . . 71.120000000000005 109.096 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 16.7 mmt -105.15 139.63 39.53 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.631 -0.878 . . . . 75.239999999999995 108.631 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.2 155.72 46.01 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.255 -0.903 . . . . 72.120000000000005 110.086 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' B' ' 28' ' ' ASP . 2.1 p30 -137.56 140.07 40.82 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.9 -0.778 . . . . 72.310000000000002 108.9 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 p -104.61 138.42 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.489 -0.93 . . . . 64.430000000000007 108.489 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 16.0 p -136.79 166.5 23.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.35 -0.844 . . . . 65.409999999999997 109.306 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.476 ' CG ' ' OD2' ' B' ' 35' ' ' ASP . 3.2 pt-20 -90.92 -98.17 0.11 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.242 -0.911 . . . . 71.019999999999996 109.772 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 24.0 t -78.37 165.18 24.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.284 -0.885 . . . . 51.109999999999999 110.166 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . . . . . . . . . 20.7 mt -55.52 -30.65 61.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.577 -0.702 . . . . 71.239999999999995 109.957 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -53.27 -46.15 69.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.137 -0.977 . . . . 74.319999999999993 109.964 -179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.476 ' OD2' ' CG ' ' B' ' 31' ' ' GLU . 75.0 m-20 -67.33 -42.27 83.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.073 -1.017 . . . . 73.030000000000001 109.444 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.59 -39.23 78.79 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.478 -1.449 . . . . 30.210000000000001 109.478 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -67.39 -38.21 84.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.322 -1.104 . . . . 74.420000000000002 109.774 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -80.2 -39.66 28.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.089 -1.007 . . . . 74.420000000000002 109.888 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 39.1 tp -68.52 -37.64 80.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.923 . . . . 75.409999999999997 110.226 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' B' ' 40' ' ' MET . 3.4 ppp? -76.29 -22.68 54.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.959 -1.088 . . . . 60.409999999999997 110.211 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -64.33 -40.8 96.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.021 -1.049 . . . . 53.229999999999997 110.193 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 4.8 pt -82.05 -42.0 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.052 -1.03 . . . . 71.230000000000004 110.178 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' B' ' 40' ' ' MET . 2.2 mpt_? -94.86 150.71 19.89 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.029 -1.044 . . . . 72.219999999999999 109.278 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -68.68 -162.14 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 63.539999999999999 109.081 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -179.11 154.78 0.69 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.008 -1.057 . . . . 64.349999999999994 109.927 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -136.98 -46.87 0.58 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.455 -0.778 . . . . 62.219999999999999 108.951 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.513 ' C ' HD13 ' B' ' 47' ' ' LEU . 0.9 OUTLIER -104.08 110.66 22.92 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.43 -0.952 . . . . 73.120000000000005 108.43 179.548 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.464 ' N ' HD13 ' B' ' 47' ' ' LEU . 75.9 t -96.77 98.29 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.268 -0.895 . . . . 65.109999999999999 109.357 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.412 ' CE ' ' OG ' ' B' ' 74' ' ' SER . 3.8 ttt -113.71 130.29 56.45 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.623 0.725 . . . . 73.439999999999998 109.414 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.409 HG21 ' HB2' ' B' ' 55' ' ' ALA . 0.3 OUTLIER -144.27 130.45 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.496 -0.753 . . . . 34.5 109.132 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . 0.423 ' OG ' ' OE1' ' B' ' 7' ' ' GLU . 95.5 p -91.92 -2.2 56.91 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.519 -0.738 . . . . 73.209999999999994 110.014 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -75.58 138.01 41.18 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.136 -0.978 . . . . 70.409999999999997 109.703 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.489 ' C ' ' H ' ' B' ' 55' ' ' ALA . 25.7 mtmm -74.5 -50.23 19.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.252 -0.905 . . . . 65.0 109.993 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -50.41 -10.57 0.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.168 -0.958 . . . . 75.209999999999994 109.545 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.489 ' H ' ' C ' ' B' ' 53' ' ' LYS . . . -64.04 -20.66 66.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.406 -0.809 . . . . 55.329999999999998 110.28 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' B' ' 55' ' ' ALA . 29.5 mt -40.89 -50.11 3.22 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.444 -0.785 . . . . 63.140000000000001 110.224 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 23.2 m -69.77 -32.68 71.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.038 -1.039 . . . . 63.5 109.124 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . 0.441 ' N ' ' O ' ' B' ' 55' ' ' ALA . 66.9 t80 -65.34 -45.52 83.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.355 -0.841 . . . . 72.329999999999998 110.068 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.413 ' H ' HG22 ' B' ' 59' ' ' VAL . 12.0 m -65.57 -34.88 73.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 120.536 -1.353 . . . . 74.540000000000006 109.45 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 20.3 t -57.15 -50.2 73.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.231 -0.918 . . . . 71.239999999999995 109.569 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -66.79 -33.19 75.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 74.310000000000002 110.083 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' B' ' 62' ' ' ILE . 20.6 mm -65.93 -38.51 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.783 -1.198 . . . . 72.140000000000001 109.82 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 56.7 mmtt -67.25 -46.99 72.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.998 -1.064 . . . . 73.319999999999993 110.519 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.434 ' CG ' ' N ' ' B' ' 65' ' ' LYS . 7.7 pt-20 -74.46 -43.15 57.43 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.804 -1.185 . . . . 73.120000000000005 110.224 -179.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.448 ' O ' ' CG ' ' B' ' 66' ' ' HIS . 66.9 mttm -71.05 -23.63 62.18 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.201 -0.937 . . . . 72.439999999999998 109.807 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.629 ' O ' HG22 ' B' ' 69' ' ' ILE . 97.3 m-70 -155.0 65.94 0.65 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.135 -0.978 . . . . 63.310000000000002 109.462 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.461 ' O ' ' N ' ' B' ' 69' ' ' ILE . 36.1 m -54.46 -36.44 64.09 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.259 -0.9 . . . . 73.099999999999994 109.95 -179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 29.2 m -68.13 48.11 0.05 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.056 -1.028 . . . . 71.530000000000001 109.7 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . 0.629 HG22 ' O ' ' B' ' 66' ' ' HIS . 16.6 tt -144.16 154.31 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.246 -0.909 . . . . 74.400000000000006 109.27 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t -95.39 155.44 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.097 -1.002 . . . . 75.120000000000005 109.106 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 42.0 t -141.86 125.61 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.155 -0.966 . . . . 73.200000000000003 109.491 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.646 ' HG ' HD11 ' B' ' 95' ' ' ILE . 0.7 OUTLIER -119.5 98.38 6.1 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.6 -0.889 . . . . 73.340000000000003 108.6 -179.653 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 70.4 t -88.7 112.75 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.291 -0.881 . . . . 73.5 108.808 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.412 ' OG ' ' CE ' ' B' ' 49' ' ' MET . 0.6 OUTLIER -89.57 174.75 7.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.038 -1.039 . . . . 64.340000000000003 108.577 179.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.435 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 6.6 p -166.81 121.17 1.06 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.841 -1.162 . . . . 74.530000000000001 110.542 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -57.51 -32.01 66.61 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.518 -0.919 . . . . 64.5 108.518 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -111.88 90.86 13.91 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.635 -0.876 . . . . 74.25 108.635 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.93 72.19 6.27 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.939 1.759 . . . . 74.430000000000007 112.17 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 29.5 p -87.73 162.73 16.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.539 -0.726 . . . . 73.120000000000005 109.338 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.69 -33.17 72.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.328 -0.857 . . . . 71.010000000000005 109.459 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . 0.519 ' O ' ' ND1' ' B' ' 85' ' ' HIS . 76.9 mm-40 -63.45 -41.25 98.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.144 -0.973 . . . . 63.200000000000003 109.527 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -73.14 -30.4 63.58 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.146 -0.971 . . . . 73.219999999999999 109.58 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.525 ' OE2' ' NE ' ' A' ' 108' ' ' ARG . 36.6 tt0 -63.9 -56.06 18.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 74.299999999999997 109.668 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . 0.405 HG23 ' N ' ' B' ' 85' ' ' HIS . 30.9 m -58.14 -38.54 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.132 -0.98 . . . . 73.310000000000002 108.972 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' HIS . . . . . 0.519 ' ND1' ' O ' ' B' ' 81' ' ' GLU . 27.2 m170 -64.44 -29.08 70.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.257 -0.902 . . . . 73.239999999999995 109.093 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.16 -45.76 79.79 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.302 -0.874 . . . . 55.329999999999998 109.653 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' PHE . . . . . 0.465 ' CZ ' ' HB2' ' A' ' 111' ' ' ALA . 40.0 t80 -80.87 -31.74 35.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.997 -1.064 . . . . 74.140000000000001 109.085 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -64.33 -52.38 58.69 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.219 -0.926 . . . . 64.040000000000006 109.387 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . 0.502 ' NE2' ' N ' ' B' ' 89' ' ' GLN . 0.9 OUTLIER -64.71 -52.32 57.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.451 -0.781 . . . . 72.349999999999994 109.513 -179.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 150.83 72.3 0.01 OUTLIER Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.103 -1.199 . . . . 65.200000000000003 110.103 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -129.17 134.64 48.11 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.451 -1.029 . . . . 52.229999999999997 108.951 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -76.95 -30.22 55.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.098 -1.001 . . . . 73.319999999999993 109.144 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' B' ' 94' ' ' TYR . 51.2 t0 -152.49 164.22 38.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.374 -0.829 . . . . 72.219999999999999 109.34 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.449 ' N ' ' OD1' ' B' ' 93' ' ' ASP . 86.4 t80 -140.21 121.06 14.47 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.481 -0.933 . . . . 64.420000000000002 108.481 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.794 ' H ' HD12 ' B' ' 95' ' ' ILE . 0.0 OUTLIER -127.17 161.49 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 O-C-N 121.36 -0.838 . . . . 72.230000000000004 110.909 -178.017 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.16 129.57 35.31 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.72 -1.215 . . . . 25.239999999999998 107.72 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.688 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -50.77 -56.75 16.84 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 120.989 -1.069 . . . . 64.319999999999993 111.572 -178.544 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 4.5 Cg_endo -41.12 -8.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 121.116 1.211 . . . . 63.329999999999998 113.26 -175.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . 0.688 ' N ' ' O ' ' B' ' 97' ' ' LYS . 55.1 m-85 60.4 116.03 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.558 -0.714 . . . . 75.129999999999995 109.405 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 31.5 ttm-85 -59.94 -31.2 69.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.925 -1.109 . . . . 74.230000000000004 108.938 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . 0.73 ' O ' ' N ' ' B' ' 103' ' ' LYS . 46.2 t -174.26 28.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.088 -1.007 . . . . 63.340000000000003 110.552 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 53.3 mt 51.23 -68.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.768 -0.583 . . . . 74.439999999999998 110.47 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.73 ' N ' ' O ' ' B' ' 101' ' ' SER . 4.3 mmmm -58.04 -33.67 69.25 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.05 -1.093 . . . . 71.109999999999999 108.05 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.07 -44.41 95.86 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.368 -0.933 . . . . 71.450000000000003 108.499 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 17.8 tp -63.53 -49.15 74.63 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.838 -0.801 . . . . 51.310000000000002 108.838 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 90.0 t -58.52 -41.16 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.928 . . . . 65.230000000000004 109.325 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.7 -36.05 69.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.151 -0.968 . . . . 24.32 109.202 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . . . . . . . . . 56.0 ttt85 -79.79 -28.95 40.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.403 -0.811 . . . . 75.310000000000002 109.961 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 96.6 mt -75.25 -46.09 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 120.978 -1.076 . . . . 54.240000000000002 108.785 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' B' ' 114' ' ' ARG . 23.9 pt-20 -66.22 -42.15 89.08 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.06 -1.056 . . . . 65.310000000000002 108.494 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . 0.501 ' HB1' ' CZ ' ' A' ' 87' ' ' PHE . . . -53.69 -39.13 64.9 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.58 -0.7 . . . . 72.239999999999995 109.418 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 18.1 tpt180 -65.14 -44.66 87.89 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.177 -0.952 . . . . 72.040000000000006 109.953 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . 0.547 ' C ' ' H ' ' B' ' 115' ' ' PHE . 58.1 mt -97.78 -60.12 1.63 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.107 -0.996 . . . . 75.349999999999994 110.768 -179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' B' ' 110' ' ' GLU . 58.0 mtp180 57.93 -4.85 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.466 -0.772 . . . . 75.5 110.262 -178.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 115' ' ' PHE . . . . . 0.547 ' H ' ' C ' ' B' ' 113' ' ' LEU . 63.4 t80 -171.74 -104.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.993 -1.067 . . . . 65.329999999999998 109.501 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 116' ' ' TRP . . . . . 0.443 ' N ' ' CD2' ' B' ' 115' ' ' PHE . 39.9 m95 -146.75 44.88 1.19 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.334 -0.854 . . . . 74.450000000000003 108.826 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.93 -140.96 26.56 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.216 -1.554 . . . . 44.210000000000001 109.216 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 9.2 t -151.58 138.68 19.17 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.167 -1.196 . . . . 71.400000000000006 109.395 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . 0.489 HD21 ' C ' ' B' ' 121' ' ' ILE . 35.1 t30 -86.54 169.44 12.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.257 -0.902 . . . . 72.319999999999993 109.653 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 11.0 t -137.6 -34.32 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.981 -0.748 . . . . 75.019999999999996 108.981 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . 0.489 ' C ' HD21 ' B' ' 119' ' ' ASN . 26.9 mm -112.31 134.27 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.546 -0.721 . . . . 51.409999999999997 109.147 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -148.42 133.72 18.47 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.193 -0.942 . . . . 71.530000000000001 109.609 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 1.046 HD12 ' CD ' ' B' ' 159' ' ' ARG . 16.7 tt -149.49 123.96 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.792 -0.818 . . . . 72.430000000000007 108.792 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 54.87 -136.89 44.59 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.207 -1.557 . . . . 51.229999999999997 109.207 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -89.95 1.36 56.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.221 -1.164 . . . . 74.200000000000003 109.524 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.91 138.42 31.56 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.284 -0.885 . . . . 75.420000000000002 108.739 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 35.2 m -132.26 119.56 20.97 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.481 -0.762 . . . . 74.219999999999999 109.288 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . 0.424 ' O ' ' OD1' ' B' ' 119' ' ' ASN . 14.0 mm -117.98 147.08 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.543 -0.723 . . . . 60.329999999999998 109.304 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . 0.414 ' C ' HH22 ' B' ' 157' ' ' ARG . 5.9 m -137.76 132.91 17.53 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.276 -0.89 . . . . 72.310000000000002 109.137 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -80.72 -49.43 0.06 OUTLIER 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.174 1.916 . . . . 75.129999999999995 112.455 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -57.51 -49.9 74.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.912 . . . . 75.230000000000004 110.055 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -82.36 -9.33 59.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.091 -1.006 . . . . 72.430000000000007 109.749 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 47.94 69.03 0.58 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.093 -1.004 . . . . 75.129999999999995 109.274 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -139.18 141.22 37.97 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.453 -0.779 . . . . 73.219999999999999 109.353 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 2.8 tt -120.51 126.41 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.515 -0.741 . . . . 64.140000000000001 109.487 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 32.9 mm -115.2 121.82 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.653 -0.869 . . . . 71.219999999999999 108.653 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -140.79 143.85 35.11 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.206 -0.934 . . . . 64.219999999999999 109.622 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' B' ' 138' ' ' LYS . 30.3 ttpt 54.57 9.5 0.27 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.547 -0.721 . . . . 72.019999999999996 109.804 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 91.55 16.65 51.95 Favored Glycine 0 N--CA 1.496 2.697 0 N-CA-C 110.04 -1.224 . . . . 74.319999999999993 110.04 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . 0.4 ' HE ' ' HE3' ' B' ' 138' ' ' LYS . 41.6 mtt-85 -107.33 144.11 34.65 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.513 -0.992 . . . . 75.340000000000003 109.706 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -102.82 118.12 36.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.568 -0.707 . . . . 71.230000000000004 109.397 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 71.8 t -136.36 137.37 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.452 -0.78 . . . . 70.430000000000007 109.012 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -80.36 132.38 35.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.906 . . . . 72.430000000000007 109.531 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . . . . . . . . . 5.4 p -73.1 133.27 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.159 -0.963 . . . . 72.129999999999995 109.064 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . . . . . . . . . 35.3 pttt -170.4 66.3 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.9 . . . . 72.019999999999996 109.607 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 176.6 156.2 15.0 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.369 -1.492 . . . . 42.229999999999997 109.369 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 0.615 ' N ' ' CD ' ' B' ' 148' ' ' PRO . 19.3 mttt -65.23 -39.24 33.89 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.201 -1.176 . . . . 73.299999999999997 109.625 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 27.2 Cg_exo -61.54 -30.45 86.24 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.016 1.81 . . . . 71.329999999999998 111.218 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -94.94 -20.67 19.19 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.456 -0.778 . . . . 74.230000000000004 109.389 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -67.36 -39.23 85.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.273 -0.892 . . . . 72.340000000000003 109.486 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 7.1 p -66.45 -35.16 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 73.349999999999994 109.615 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.702 HD23 ' SD ' ' B' ' 195' ' ' MET . 0.2 OUTLIER -67.27 -42.43 83.84 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 122.125 0.964 . . . . 55.240000000000002 109.308 -179.76 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . 0.436 ' CG2' ' NH2' ' B' ' 157' ' ' ARG . 34.7 m -74.08 -26.51 60.41 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.03 -1.043 . . . . 70.010000000000005 110.872 -179.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -71.98 -59.98 2.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.045 -1.035 . . . . 65.319999999999993 109.867 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . 1.011 HD13 ' N ' ' B' ' 156' ' ' ALA . 0.0 OUTLIER -62.29 -20.98 64.86 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.929 -1.107 . . . . 71.540000000000006 108.735 -179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . 1.011 ' N ' HD13 ' B' ' 155' ' ' LEU . . . -61.86 -48.05 82.29 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 120.901 -1.125 . . . . 75.319999999999993 108.233 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.436 ' NH2' ' CG2' ' B' ' 153' ' ' THR . 0.0 OUTLIER -72.72 -42.45 64.14 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.42 -0.912 . . . . 73.319999999999993 109.409 179.57 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -83.28 10.83 7.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.21 -0.931 . . . . 74.140000000000001 110.389 -178.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . 1.046 ' CD ' HD12 ' B' ' 123' ' ' ILE . 10.4 ttp-105 -48.38 164.94 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.026 -1.046 . . . . 61.409999999999997 109.019 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 61.27 53.16 3.6 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.342 -0.849 . . . . 72.099999999999994 109.716 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -161.04 156.24 24.34 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.34 -0.85 . . . . 72.25 109.036 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 66.6 mt -88.86 132.49 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.997 -1.065 . . . . 72.310000000000002 108.896 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' B' ' 212' ' ' TYR . 40.1 t -141.57 136.78 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.24 -0.913 . . . . 64.209999999999994 110.353 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 6.6 t -94.65 167.94 11.15 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.096 -1.002 . . . . 74.219999999999999 109.288 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . 1.077 ' NZ ' ' HA ' ' B' ' 185' ' ' GLU . 22.2 mttm -61.96 -38.22 87.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.028 -1.045 . . . . 65.310000000000002 109.865 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -52.96 -39.53 63.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 63.450000000000003 110.14 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -60.94 -48.14 83.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.179 -0.951 . . . . 72.400000000000006 110.478 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 40.5 mt -57.31 -33.54 67.8 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.91 -1.119 . . . . 72.319999999999993 109.665 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.469 HD23 ' C ' ' B' ' 169' ' ' LEU . 5.7 tt -65.38 -61.83 1.88 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.161 -0.962 . . . . 73.340000000000003 109.624 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -65.19 -28.63 69.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.36 -0.837 . . . . 72.099999999999994 110.568 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.94 -59.49 5.04 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.119 -0.988 . . . . 62.130000000000003 110.616 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.724 ' N ' HD12 ' B' ' 172' ' ' ILE . 2.0 mp -86.75 -59.34 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.006 -1.059 . . . . 71.420000000000002 109.172 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 173' ' ' TRP . . . . . 0.428 ' O ' ' O ' ' B' ' 169' ' ' LEU . 23.0 m-90 -80.72 133.72 35.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 72.230000000000004 108.822 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -163.19 -35.01 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.976 -1.078 . . . . 52.109999999999999 110.426 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . 0.613 ' N ' ' CD ' ' B' ' 176' ' ' PRO . 8.8 tt0 -80.37 -35.81 0.91 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.001 -1.062 . . . . 73.040000000000006 111.049 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' B' ' 175' ' ' GLU . 95.8 Cg_endo -90.94 -41.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 122.432 2.088 . . . . 74.129999999999995 112.795 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 49.45 14.49 0.11 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.096 -1.002 . . . . 72.439999999999998 109.5 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . 0.447 ' N ' ' O ' ' B' ' 176' ' ' PRO . 54.8 mtp -74.55 -26.77 60.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.221 -0.924 . . . . 63.43 110.027 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 29.1 m -61.32 143.02 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.994 -1.066 . . . . 71.049999999999997 109.445 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 25.2 p -66.84 150.34 97.79 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.142 -0.974 . . . . 62.149999999999999 109.263 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -76.58 31.73 0.41 Allowed 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.324 2.016 . . . . 65.219999999999999 112.651 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -149.57 -15.77 0.28 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.913 -1.117 . . . . 72.310000000000002 109.959 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 11.3 p -63.97 -17.86 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.19 -0.943 . . . . 63.32 109.984 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.755 ' H ' HD12 ' B' ' 184' ' ' ILE . 1.3 mp -49.74 -35.17 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.068 -1.02 . . . . 75.030000000000001 109.567 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . 1.077 ' HA ' ' NZ ' ' B' ' 165' ' ' LYS . 17.3 pt-20 -55.87 -36.54 67.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.994 -1.066 . . . . 64.109999999999999 109.215 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 9.2 t -75.42 -36.98 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 73.0 109.207 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.08 -55.03 28.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.36 -0.838 . . . . 61.119999999999997 109.868 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 188' ' ' ILE . . . . . . . . . . . . . 5.4 tp -63.15 -33.93 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.098 -1.001 . . . . 72.430000000000007 109.927 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -69.04 -50.86 44.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.246 -0.909 . . . . 65.140000000000001 110.491 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -72.53 -39.08 67.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.035 -1.041 . . . . 63.240000000000002 110.157 -178.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 57.5 mt -57.22 -38.01 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.037 -1.039 . . . . 74.030000000000001 109.345 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 192' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -73.57 -44.13 58.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.037 -1.039 . . . . 72.239999999999995 109.96 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 193' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -70.5 -28.77 65.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.25 -0.906 . . . . 73.099999999999994 110.601 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -82.97 -33.84 26.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.01 -1.056 . . . . 72.109999999999999 110.291 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 195' ' ' MET . . . . . 0.702 ' SD ' HD23 ' B' ' 152' ' ' LEU . 62.4 mtt -90.61 -40.8 11.71 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.053 -1.03 . . . . 44.329999999999998 110.863 -179.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 196' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 51.1 p-10 -53.32 -20.43 4.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.929 -1.107 . . . . 71.209999999999994 110.488 -178.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . 0.524 ' N ' ' OD1' ' B' ' 196' ' ' ASP . 4.1 mmtp -76.19 -65.63 0.42 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.852 -1.155 . . . . 75.209999999999994 109.537 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 198' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' B' ' 197' ' ' LYS . 48.2 Cg_endo -66.12 -45.39 5.82 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.246 1.964 . . . . 75.319999999999993 111.633 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 37.1 tp -65.05 -51.09 63.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.386 -0.821 . . . . 72.25 109.342 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 85.94 -33.2 3.59 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.91 -1.276 . . . . 64.530000000000001 109.91 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . 0.719 ' N ' HD12 ' B' ' 201' ' ' ILE . 2.5 mp -92.19 142.15 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.131 -1.217 . . . . 44.229999999999997 109.722 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 70.3 m -119.58 133.24 55.75 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.37 -0.974 . . . . 54.009999999999998 108.37 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 24.4 p -137.22 47.42 2.11 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.312 -0.867 . . . . 74.400000000000006 109.715 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 1.6 m -143.15 122.41 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.259 -0.9 . . . . 72.120000000000005 109.219 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -107.94 129.45 55.1 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.664 -0.865 . . . . 65.409999999999997 108.664 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 206' ' ' THR . . . . . 0.43 HG22 ' H ' ' B' ' 206' ' ' THR . 0.1 OUTLIER -94.16 131.22 39.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.175 -0.953 . . . . 71.329999999999998 109.949 -179.298 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 5.0 t -129.56 122.91 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.434 -0.951 . . . . 63.5 108.434 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 208' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -61.93 -26.07 67.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 74.450000000000003 110.065 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 37.0 mtp180 -68.67 -88.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.033 -1.042 . . . . 74.140000000000001 109.83 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -65.3 -63.49 1.09 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.05 -1.032 . . . . 74.430000000000007 109.668 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . . . . . . . . . . . 157.91 -105.81 0.28 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.452 -1.459 . . . . 64.450000000000003 109.452 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 212' ' ' TYR . . . . . 0.461 ' O ' ' O ' ' B' ' 163' ' ' VAL . 39.0 m-85 -120.16 135.87 54.81 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.613 -0.933 . . . . 74.209999999999994 109.618 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -125.5 134.13 52.14 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.446 -0.784 . . . . 74.030000000000001 108.944 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . 0.738 ' CD1' HD23 ' B' ' 155' ' ' LEU . 80.4 m-85 -90.77 131.28 36.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.406 -0.808 . . . . 74.340000000000003 109.289 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . . . . . . . . . 26.7 p -153.74 167.97 27.83 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.173 -0.954 . . . . 64.329999999999998 109.803 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . 0.664 ' HD2' ' HB2' ' B' ' 220' ' ' ALA . 27.5 p90 -63.52 148.44 93.88 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.42 -0.8 . . . . 70.040000000000006 109.213 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.82 162.63 27.88 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.11 1.873 . . . . 65.109999999999999 111.914 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.44 ' CB ' ' CD ' ' B' ' 219' ' ' PRO . 21.8 mttm -51.22 -64.67 1.25 Allowed Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.246 -0.909 . . . . 73.150000000000006 109.349 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . 0.44 ' CD ' ' CB ' ' B' ' 218' ' ' LYS . 49.0 Cg_endo -66.5 83.67 0.29 Allowed 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.195 1.93 . . . . 71.310000000000002 111.782 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . 0.664 ' HB2' ' HD2' ' B' ' 216' ' ' TYR . . . -122.19 129.08 51.95 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.519 -0.738 . . . . 75.450000000000003 109.274 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 65.4 m -145.25 133.96 22.23 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.31 -0.869 . . . . 72.219999999999999 109.236 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -59.25 -31.12 68.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.303 -0.873 . . . . 54.530000000000001 109.504 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.038 -0.982 . . . . 71.129999999999995 109.409 -179.968 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.546 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.436 -0.579 . . . . 65.120000000000005 109.436 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.418 ' HG2' HH11 ' A' ' 2' ' ' ARG . 2.0 ttt-85 -145.06 152.9 40.84 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.213 -0.929 . . . . 72.329999999999998 109.07 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 65.7 t -115.29 128.84 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.52 -0.738 . . . . 71.420000000000002 109.652 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 5' ' ' LEU . 3.7 tp -100.39 117.08 33.85 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.516 -0.74 . . . . 65.120000000000005 109.136 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 4' ' ' LEU . 60.2 tp -115.89 111.53 20.58 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.563 -0.71 . . . . 62.43 109.475 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.443 HG12 HD11 ' A' ' 4' ' ' LEU . 9.2 mt -102.24 113.42 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.213 -0.93 . . . . 71.150000000000006 108.96 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.476 ' OE1' ' CB ' ' A' ' 51' ' ' SER . 31.0 tp10 -148.41 126.88 12.35 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.205 -0.934 . . . . 75.340000000000003 109.572 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -69.09 -30.76 69.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -0.869 . . . . 72.439999999999998 109.173 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -84.97 114.29 22.04 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.34 -0.85 . . . . 63.020000000000003 109.422 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 77.2 p -70.19 -24.84 63.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.911 . . . . 72.340000000000003 109.62 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.65 -51.49 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.209 -0.932 . . . . 74.019999999999996 109.642 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.558 ' N ' HD22 ' A' ' 12' ' ' LEU . 3.5 mm? -66.91 -33.54 75.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 71.430000000000007 109.212 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.76 -23.3 75.36 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.674 -1.77 . . . . 61.32 108.674 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.74 -53.43 15.91 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.622 -1.391 . . . . 71.200000000000003 109.622 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -60.69 -43.37 97.83 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.35 -1.088 . . . . 71.319999999999993 109.736 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 96.2 mt -65.11 -32.5 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.891 -1.131 . . . . 63.229999999999997 109.034 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -58.01 -49.81 75.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 51.109999999999999 109.298 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -88.11 0.45 55.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.228 -0.92 . . . . 73.340000000000003 109.879 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.15 -57.82 2.58 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 110.002 -1.239 . . . . 62.149999999999999 110.002 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pp -74.58 -23.25 58.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -1.128 . . . . 73.510000000000005 110.052 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -51.47 -35.29 39.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.018 -1.052 . . . . 74.25 109.47 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.7 t -55.38 -41.3 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.97 . . . . 70.040000000000006 109.159 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.405 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 2.6 mptp? -63.17 -19.26 64.33 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.331 -0.855 . . . . 73.230000000000004 109.026 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.85 40.64 4.88 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.553 -1.019 . . . . 75.540000000000006 110.553 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -119.04 160.43 22.04 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.421 -1.046 . . . . 73.430000000000007 108.502 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.8 mmt -90.14 124.33 34.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.051 -1.031 . . . . 43.240000000000002 108.872 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.25 138.58 37.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.417 -0.802 . . . . 62.109999999999999 110.059 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -127.82 126.89 42.54 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.508 -0.923 . . . . 74.420000000000002 108.508 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -106.11 130.78 57.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.729 -0.841 . . . . 72.150000000000006 108.729 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.9 p -135.67 160.58 38.07 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.5 -0.75 . . . . 71.420000000000002 109.485 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -89.0 -103.44 0.09 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.283 -0.886 . . . . 72.329999999999998 109.418 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.443 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 62.2 m -78.45 147.89 33.79 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.205 -0.934 . . . . 74.239999999999995 109.36 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.599 ' H ' HD12 ' A' ' 33' ' ' LEU . 1.7 mp -49.1 -15.71 0.12 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.328 -0.857 . . . . 71.530000000000001 110.189 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 32' ' ' SER . 78.8 mm-40 -62.65 -53.33 56.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.012 -1.055 . . . . 74.230000000000004 110.05 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 36' ' ' GLY . 19.8 p-10 -67.73 -30.27 69.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.0 -1.062 . . . . 54.030000000000001 109.262 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.543 ' N ' ' OD1' ' A' ' 35' ' ' ASP . . . -75.25 -36.11 46.36 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.142 -1.583 . . . . 61.409999999999997 109.142 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -70.09 -46.88 63.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.339 -1.095 . . . . 74.340000000000003 109.459 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -69.05 -34.1 74.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.149 -0.969 . . . . 75.329999999999998 109.862 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.449 HD11 ' HE ' ' A' ' 43' ' ' ARG . 20.7 tp -79.23 -51.33 9.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.217 -0.927 . . . . 74.329999999999998 110.226 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.448 ' SD ' ' OH ' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -58.2 -27.85 64.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.101 -1.0 . . . . 70.319999999999993 109.934 -179.27 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -61.09 -39.68 90.84 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.109 -0.994 . . . . 71.219999999999999 109.849 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.7 pt -91.44 1.39 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.072 -1.018 . . . . 74.140000000000001 110.076 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.449 ' HE ' HD11 ' A' ' 39' ' ' LEU . 86.2 mtt-85 -126.4 152.15 46.72 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.36 -0.838 . . . . 72.239999999999995 109.328 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -96.83 151.79 19.32 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.197 -0.94 . . . . 75.420000000000002 109.326 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.448 ' OH ' ' SD ' ' A' ' 40' ' ' MET . 10.0 p90 -154.76 175.23 13.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.243 -0.911 . . . . 74.230000000000004 109.646 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -135.76 -33.44 0.86 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.423 -0.798 . . . . 72.040000000000006 109.307 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.537 HD13 ' N ' ' A' ' 48' ' ' VAL . 0.4 OUTLIER -107.99 115.01 29.36 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.492 -0.755 . . . . 72.129999999999995 109.014 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.537 ' N ' HD13 ' A' ' 47' ' ' LEU . 58.3 t -102.41 98.84 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.852 -0.796 . . . . 72.340000000000003 108.852 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.474 ' SD ' ' O ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -109.59 122.75 48.13 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.096 -0.705 . . . . 74.109999999999999 109.096 -179.615 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.438 HG21 ' HB2' ' A' ' 55' ' ' ALA . 1.6 p -130.87 130.02 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 121.602 0.715 . . . . 61.119999999999997 109.702 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.476 ' CB ' ' OE1' ' A' ' 7' ' ' GLU . 44.9 p -99.1 0.54 43.81 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.435 -0.791 . . . . 73.109999999999999 109.281 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -76.03 141.52 42.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.141 -0.974 . . . . 52.549999999999997 109.341 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.485 ' C ' ' H ' ' A' ' 55' ' ' ALA . 21.2 pttm -79.36 -38.51 34.87 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.252 -0.905 . . . . 44.219999999999999 110.449 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -70.59 11.25 0.38 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.977 -1.077 . . . . 70.439999999999998 109.494 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.485 ' H ' ' C ' ' A' ' 53' ' ' LYS . . . -75.77 -21.12 57.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.406 -0.809 . . . . 64.140000000000001 110.589 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.428 ' C ' ' O ' ' A' ' 55' ' ' ALA . 73.6 mt -38.11 -48.47 1.24 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.498 -0.751 . . . . 44.140000000000001 111.025 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.2 m -71.93 -36.76 70.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.889 -1.132 . . . . 55.229999999999997 109.59 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.441 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 72.9 t80 -66.33 -47.01 74.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.397 -0.815 . . . . 74.439999999999998 110.594 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.3 m -64.14 -34.42 68.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 120.636 -1.29 . . . . 74.030000000000001 109.561 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.0 t -57.75 -55.12 38.92 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.182 -0.949 . . . . 64.299999999999997 109.317 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.684 HH21 ' HZ2' ' A' ' 65' ' ' LYS . 5.7 ptm180 -61.42 -31.27 71.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 64.439999999999998 109.868 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.441 HD11 ' CZ ' ' A' ' 58' ' ' PHE . 4.9 mm -63.03 -37.18 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.996 -1.065 . . . . 63.210000000000001 109.778 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 mmtp -70.03 -54.24 14.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.036 -1.04 . . . . 74.420000000000002 110.315 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -64.85 -35.89 82.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.817 -1.177 . . . . 70.319999999999993 109.815 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.684 ' HZ2' HH21 ' A' ' 61' ' ' ARG . 46.4 mtpt -82.58 -23.3 34.5 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.063 -1.023 . . . . 75.219999999999999 109.818 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.477 ' CG ' ' C ' ' A' ' 65' ' ' LYS . 47.8 m-70 -154.38 65.53 0.69 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.043 -1.036 . . . . 74.129999999999995 109.64 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.8 t -64.69 -30.64 71.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.204 -0.935 . . . . 73.239999999999995 109.951 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 97.2 p -60.43 -17.87 47.31 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.168 -0.958 . . . . 61.009999999999998 110.014 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 53.7 mt -91.28 149.56 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.139 -0.975 . . . . 71.329999999999998 109.614 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 71' ' ' VAL . 91.9 t -88.33 159.18 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.344 -0.847 . . . . 72.129999999999995 109.135 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.46 ' N ' HG12 ' A' ' 70' ' ' VAL . 22.0 t -138.81 124.54 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.158 -0.963 . . . . 54.210000000000001 110.001 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.629 ' CD1' HH22 ' A' ' 108' ' ' ARG . 4.0 tt -113.43 99.09 7.51 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.617 -0.882 . . . . 50.240000000000002 108.617 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.6 t -96.71 123.22 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.364 -0.835 . . . . 74.409999999999997 108.816 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.82 -178.11 4.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.986 -1.071 . . . . 72.310000000000002 109.004 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.473 ' CB ' ' OH ' ' A' ' 94' ' ' TYR . 49.7 p -166.75 120.07 1.02 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.133 -0.979 . . . . 64.540000000000006 109.829 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.5 p30 -77.49 6.39 7.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.403 -0.811 . . . . 74.129999999999995 108.913 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 79' ' ' THR . 74.6 m-20 -142.24 64.96 17.63 Favored Pre-proline 0 N--CA 1.493 1.703 0 N-CA-C 108.947 -0.76 . . . . 73.340000000000003 108.947 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.6 81.14 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.919 1.746 . . . . 63.219999999999999 111.707 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 77' ' ' ASN . 41.1 p -100.56 161.89 13.3 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.776 -0.824 . . . . 62.530000000000001 108.776 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.3 p -66.52 -24.48 66.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.131 -0.981 . . . . 73.439999999999998 109.659 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -73.64 -38.98 64.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 71.420000000000002 109.769 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 86' ' ' ALA . 96.1 mt-10 -70.92 -33.65 70.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.204 -0.935 . . . . 73.430000000000007 110.117 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.416 ' OE2' ' NE ' ' B' ' 100' ' ' ARG . 92.3 mt-10 -68.61 -55.8 10.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.005 -1.059 . . . . 74.219999999999999 109.745 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.53 HG23 ' N ' ' A' ' 85' ' ' HIS . 31.9 m -60.61 -42.52 91.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.191 -0.943 . . . . 73.200000000000003 109.414 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.575 ' CE1' HE21 ' A' ' 89' ' ' GLN . 75.8 t60 -69.21 -31.58 70.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.32 -0.862 . . . . 53.329999999999998 109.498 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 82' ' ' GLU . . . -62.89 -36.64 84.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.298 -0.876 . . . . 64.109999999999999 109.822 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -78.32 -33.25 49.36 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.09 -1.006 . . . . 74.340000000000003 108.756 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -72.97 -34.03 66.21 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.447 -0.783 . . . . 74.420000000000002 109.378 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.575 HE21 ' CE1' ' A' ' 85' ' ' HIS . 83.9 mm-40 -69.93 -62.33 1.43 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 74.239999999999995 109.484 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 152.56 54.96 0.01 OUTLIER Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.908 -1.277 . . . . 61.509999999999998 109.908 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -115.37 135.85 53.7 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.416 -1.049 . . . . 55.329999999999998 109.431 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 20.0 t70 -82.15 -31.65 30.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 73.420000000000002 109.127 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 95.6 m-20 -141.77 160.16 40.74 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.417 -0.802 . . . . 75.040000000000006 109.204 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.473 ' OH ' ' CB ' ' A' ' 75' ' ' SER . 82.6 t80 -139.49 105.66 5.24 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.395 -0.815 . . . . 71.329999999999998 109.122 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.438 HG22 ' N ' ' A' ' 96' ' ' ALA . 29.0 mm -111.62 157.82 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.221 -0.925 . . . . 71.129999999999995 110.674 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.438 ' N ' HG22 ' A' ' 95' ' ' ILE . . . -77.81 125.16 28.93 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.831 -1.174 . . . . 64.319999999999993 107.831 178.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.674 ' O ' ' N ' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -45.23 -53.85 16.1 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.016 -1.053 . . . . 62.200000000000003 111.467 -178.801 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 3.7 Cg_endo -42.11 -10.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 CA-C-N 119.729 0.939 . . . . 73.109999999999999 112.643 -177.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.674 ' N ' ' O ' ' A' ' 97' ' ' LYS . 57.7 m-85 58.7 112.39 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.667 -0.646 . . . . 65.219999999999999 109.694 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.51 ' NE ' ' OE2' ' B' ' 83' ' ' GLU . 37.8 ttm-85 -58.58 -38.19 77.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.948 -1.095 . . . . 72.349999999999994 108.511 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.806 ' O ' ' N ' ' A' ' 103' ' ' LYS . 6.3 t -173.24 31.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -0.872 . . . . 71.319999999999993 110.338 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.428 ' O ' ' N ' ' A' ' 105' ' ' LEU . 6.4 mm 46.77 -67.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 CA-C-N 118.343 0.519 . . . . 75.430000000000007 110.462 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.806 ' N ' ' O ' ' A' ' 101' ' ' SER . 16.0 mtpp -50.7 -32.72 20.26 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 120.749 -1.22 . . . . 71.409999999999997 107.923 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.75 -38.34 80.05 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.921 -1.14 . . . . 63.240000000000002 107.921 178.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 102' ' ' ILE . 2.0 tt -70.0 -47.85 60.49 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.275 -0.639 . . . . 73.219999999999999 109.275 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.6 t -64.74 -44.59 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 60.109999999999999 109.192 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.24 -40.0 64.23 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.205 -0.935 . . . . 70.420000000000002 109.093 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.629 HH22 ' CD1' ' A' ' 72' ' ' LEU . 14.6 ttp-105 -72.58 -25.15 61.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.361 -0.837 . . . . 74.409999999999997 109.667 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 83.0 mt -80.12 -33.24 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 107.439 -1.319 . . . . 62.539999999999999 107.439 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.32 -55.62 31.43 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.557 -1.275 . . . . 74.340000000000003 107.557 178.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.76 -40.42 69.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.653 -0.654 . . . . 73.319999999999993 109.586 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 10.6 mmp_? -56.15 -33.37 65.14 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.182 -0.948 . . . . 52.409999999999997 109.581 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.65 72.88 0.99 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.928 -1.108 . . . . 65.239999999999995 110.23 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.482 ' O ' ' N ' ' A' ' 116' ' ' TRP . 43.7 mtm180 -73.41 101.55 3.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.002 -1.061 . . . . 64.450000000000003 108.871 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 47.87 14.55 0.05 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.314 -0.866 . . . . 74.430000000000007 109.902 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.482 ' N ' ' O ' ' A' ' 114' ' ' ARG . 94.9 m95 46.99 -164.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.166 -0.959 . . . . 74.420000000000002 109.675 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 168.1 40.52 0.02 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.491 -1.444 . . . . 75.040000000000006 109.491 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.6 m -83.98 -124.68 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.263 -1.139 . . . . 61.140000000000001 109.621 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 61.44 67.21 0.8 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 65.239999999999995 109.556 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.4 t -80.5 -25.76 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 73.109999999999999 109.337 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.8 mm -98.42 132.9 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.331 -0.855 . . . . 72.239999999999995 109.278 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -144.68 117.46 8.72 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.191 -0.943 . . . . 72.340000000000003 109.551 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.43 HD13 ' N ' ' A' ' 123' ' ' ILE . 0.0 OUTLIER -138.72 128.74 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.37 -0.831 . . . . 71.439999999999998 108.829 179.706 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 48.3 -136.25 16.81 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.519 -1.432 . . . . 73.400000000000006 109.519 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -91.53 -6.01 53.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.249 -1.148 . . . . 74.450000000000003 109.515 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.14 135.61 33.84 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.215 -0.928 . . . . 54.210000000000001 108.788 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 26.8 p -132.1 146.33 51.98 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.474 -0.766 . . . . 54.5 109.588 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.2 mt -134.61 136.7 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.324 -0.86 . . . . 45.149999999999999 109.63 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.3 t -113.89 124.78 30.43 Favored Pre-proline 0 N--CA 1.496 1.874 0 N-CA-C 109.023 -0.732 . . . . 71.109999999999999 109.023 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -80.58 -51.67 0.05 OUTLIER 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 121.635 1.557 . . . . 65.409999999999997 112.044 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -65.28 -44.22 88.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 63.32 109.73 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -80.98 -15.52 55.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 72.519999999999996 109.354 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 54.5 77.07 0.21 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.321 -0.862 . . . . 75.329999999999998 109.76 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -158.04 140.36 14.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 71.230000000000004 109.461 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 9.5 tt -120.22 133.45 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.539 -0.726 . . . . 74.019999999999996 109.6 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 26.7 mm -110.18 121.79 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.856 -0.794 . . . . 60.229999999999997 108.856 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.501 ' C ' ' H ' ' A' ' 139' ' ' GLY . 49.8 p90 -142.68 149.17 38.5 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.086 -1.009 . . . . 62.32 108.967 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 46.8 tttp 53.96 5.98 0.08 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.297 -0.877 . . . . 75.400000000000006 109.536 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.501 ' H ' ' C ' ' A' ' 137' ' ' TYR . . . 94.04 -6.71 72.88 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 110.079 -1.208 . . . . 72.239999999999995 110.079 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.416 ' N ' ' CD ' ' A' ' 140' ' ' ARG . 1.0 OUTLIER -89.78 143.57 26.69 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.056 -1.261 . . . . 71.219999999999999 109.288 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -99.51 125.91 45.36 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.369 -0.832 . . . . 71.420000000000002 109.362 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.7 t -137.1 133.48 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.422 -0.798 . . . . 53.020000000000003 109.604 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 143' ' ' GLU . 45.5 mp0 -94.95 147.1 23.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.343 -0.848 . . . . 60.450000000000003 109.046 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.09 131.61 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.251 -0.906 . . . . 74.439999999999998 109.63 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.75 121.34 8.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.36 -0.837 . . . . 65.150000000000006 109.198 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.95 -143.29 10.09 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.917 -1.273 . . . . 73.340000000000003 109.917 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -70.67 -62.82 1.85 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.424 -1.045 . . . . 72.219999999999999 110.348 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -56.0 -19.68 27.11 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.934 1.756 . . . . 65.230000000000004 111.856 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.478 ' CE1' HG21 ' A' ' 153' ' ' THR . 1.0 OUTLIER -80.61 -44.49 18.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 60.109999999999999 109.189 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -60.94 -39.65 90.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.204 -0.935 . . . . 64.209999999999994 109.995 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 152' ' ' LEU . 11.5 p -77.14 -38.61 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.135 -0.978 . . . . 72.019999999999996 110.053 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.458 ' N ' HG13 ' A' ' 151' ' ' VAL . 15.0 tp -65.04 -42.8 93.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.121 -0.987 . . . . 73.310000000000002 109.737 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.478 HG21 ' CE1' ' A' ' 149' ' ' PHE . 42.9 p -72.98 -35.54 66.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.08 -1.013 . . . . 74.310000000000002 109.851 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -57.59 -52.01 67.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 74.310000000000002 109.632 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.408 ' H ' ' HG ' ' A' ' 155' ' ' LEU . 2.6 pp -73.88 -24.4 59.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 75.340000000000003 109.846 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.41 -46.6 83.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.134 -0.979 . . . . 62.140000000000001 109.426 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.46 ' C ' ' H ' ' A' ' 159' ' ' ARG . 65.5 mtt180 -75.34 -44.07 47.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.229 -0.919 . . . . 61.030000000000001 109.335 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 73.7 m-70 -75.71 22.78 0.13 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -0.867 . . . . 74.120000000000005 109.406 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.46 ' H ' ' C ' ' A' ' 157' ' ' ARG . 37.2 ptt180 -56.82 165.23 1.26 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.249 -0.907 . . . . 71.129999999999995 109.49 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.432 ' OD2' ' OE1' ' B' ' 161' ' ' GLN . 50.2 t0 54.2 47.15 23.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 75.450000000000003 109.242 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -155.15 158.9 39.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.284 -0.885 . . . . 73.409999999999997 109.381 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 53.4 mt -85.03 120.05 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.209 -0.932 . . . . 74.409999999999997 109.331 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.403 ' O ' ' O ' ' A' ' 212' ' ' TYR . 40.0 t -107.76 130.36 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.419 -0.801 . . . . 72.310000000000002 109.497 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.9 m -100.9 153.04 19.83 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.361 -0.837 . . . . 74.120000000000005 109.358 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.401 ' HB3' ' HZ3' ' A' ' 165' ' ' LYS . 9.2 mtpm? -56.65 -35.47 68.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.9 . . . . 70.430000000000007 109.505 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -59.51 -37.6 78.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -0.943 . . . . 73.519999999999996 109.629 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.431 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 93.4 mt-30 -62.56 -39.6 94.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 74.519999999999996 109.555 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 28.5 mt -64.95 -31.78 73.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.128 -0.982 . . . . 72.310000000000002 109.268 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.504 HD23 ' C ' ' A' ' 169' ' ' LEU . 4.2 tt -66.38 -59.11 3.99 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.862 . . . . 53.329999999999998 110.098 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 167' ' ' GLN . 28.9 p-10 -73.64 -30.24 62.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.04 -1.038 . . . . 62.439999999999998 110.624 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.446 ' C ' HD12 ' A' ' 172' ' ' ILE . . . -59.98 -46.35 89.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.968 -1.083 . . . . 60.210000000000001 110.173 -179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.693 HD12 ' N ' ' A' ' 172' ' ' ILE . 1.6 mp -94.67 -59.86 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.038 -1.039 . . . . 75.319999999999993 108.966 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' TRP . . . . . . . . . . . . . 29.8 m-90 -91.54 104.07 16.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 73.140000000000001 109.769 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -116.9 159.38 22.51 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.64 -0.874 . . . . 73.239999999999995 108.64 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 64.2 150.27 0.11 Allowed Pre-proline 0 N--CA 1.495 1.81 0 N-CA-C 108.762 -0.829 . . . . 44.43 108.762 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -33.36 138.01 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 122.677 2.251 . . . . 72.510000000000005 112.679 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.76 179.11 9.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.379 -0.826 . . . . 63.240000000000002 109.527 -179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 17.4 ttt -104.5 42.09 1.24 Allowed 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.892 -0.781 . . . . 73.5 108.892 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 75.6 t -68.06 138.7 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 65.219999999999999 109.623 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.6 m -69.56 135.01 88.38 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 71.420000000000002 108.759 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 182' ' ' ASN . 69.4 Cg_exo -37.72 109.34 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 121.992 1.795 . . . . 41.219999999999999 112.648 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 181' ' ' PRO . 23.5 m120 52.0 101.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.4 -0.812 . . . . 64.540000000000006 110.286 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.42 ' O ' HG22 ' A' ' 183' ' ' VAL . 11.8 p -138.85 -4.31 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.4 -0.812 . . . . 74.019999999999996 109.569 179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.673 HD12 ' H ' ' A' ' 184' ' ' ILE . 3.0 mp -53.56 -37.76 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.01 -1.056 . . . . 72.329999999999998 109.503 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -55.23 -30.53 60.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -0.947 . . . . 74.400000000000006 109.421 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 94.1 t -79.23 -57.23 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.082 -1.011 . . . . 70.420000000000002 109.495 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -54.97 -47.19 74.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.157 -0.964 . . . . 52.109999999999999 109.875 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.525 HD13 ' O ' ' A' ' 188' ' ' ILE . 0.2 OUTLIER -60.23 -44.2 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.085 -1.009 . . . . 71.400000000000006 109.061 -179.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.413 ' N ' ' CG2' ' A' ' 188' ' ' ILE . 0.5 OUTLIER -60.35 -41.71 94.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.959 -1.088 . . . . 73.439999999999998 109.445 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -68.34 -45.13 73.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.93 . . . . 71.420000000000002 109.718 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 85.7 mt -56.41 -37.69 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.263 -0.898 . . . . 61.549999999999997 109.156 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -65.27 -40.68 94.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 63.340000000000003 109.512 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.431 ' O ' ' OD1' ' A' ' 196' ' ' ASP . 14.8 mm100 -76.42 -26.61 55.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 61.240000000000002 110.025 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.546 ' HB3' ' HZ3' ' A' ' 194' ' ' LYS . 8.5 mtpm? -81.67 -25.26 35.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -0.946 . . . . 75.129999999999995 110.581 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' MET . . . . . . . . . . . . . 20.1 ptm -95.07 -36.32 11.57 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.033 -1.042 . . . . 74.019999999999996 110.116 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 197' ' ' LYS . 30.9 p-10 -66.04 -34.21 77.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.049 -1.032 . . . . 74.019999999999996 110.021 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.538 ' N ' ' OD1' ' A' ' 196' ' ' ASP . 11.0 ttpp -62.84 -60.87 8.64 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.013 -1.054 . . . . 75.430000000000007 109.876 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -59.04 -52.01 5.79 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.64 1.56 . . . . 72.319999999999993 111.407 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.547 HD12 ' N ' ' A' ' 199' ' ' LEU . 8.0 mp -92.53 125.15 37.04 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.345 -0.847 . . . . 74.540000000000006 109.118 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -77.79 -2.18 80.54 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.417 -1.473 . . . . 61.509999999999998 109.417 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 201' ' ' ILE . 19.6 mt -108.32 137.54 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.501 -1.0 . . . . 61.219999999999999 109.392 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 23.1 t -93.23 143.5 26.2 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.26 -0.9 . . . . 72.0 109.4 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 49.2 p -130.58 10.05 5.14 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.511 -0.743 . . . . 74.439999999999998 109.353 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 5.9 m -132.01 142.72 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.504 -0.748 . . . . 64.349999999999994 109.328 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -126.0 134.81 51.36 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.644 -0.66 . . . . 71.409999999999997 109.364 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.0 95.67 8.76 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.2 -0.938 . . . . 73.519999999999996 109.203 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.573 ' CG1' ' NH1' ' A' ' 213' ' ' ARG . 11.2 p -164.41 170.65 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.96 . . . . 71.019999999999996 109.347 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' ARG . . . . . 0.678 ' HE ' ' NH2' ' A' ' 210' ' ' ARG . 6.2 tpt180 76.65 146.16 0.09 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.495 -0.753 . . . . 72.120000000000005 109.547 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 66.5 mtt85 -61.5 -34.29 75.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.361 -0.837 . . . . 64.409999999999997 109.792 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.678 ' NH2' ' HE ' ' A' ' 208' ' ' ARG . 0.2 OUTLIER -49.94 -50.92 44.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 71.540000000000006 109.092 -179.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . 148.29 -106.06 0.33 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.051 -1.22 . . . . 72.030000000000001 110.051 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.481 ' CD1' ' N ' ' A' ' 212' ' ' TYR . 20.3 m-85 -113.43 145.38 41.25 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.568 -0.96 . . . . 75.540000000000006 109.484 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.573 ' NH1' ' CG1' ' A' ' 207' ' ' VAL . 7.8 mtm-85 -117.42 135.09 54.13 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.521 -0.737 . . . . 75.310000000000002 109.226 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -100.01 128.1 46.14 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.281 -0.887 . . . . 75.409999999999997 109.379 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' CYS . . . . . . . . . . . . . 3.6 p -141.46 156.4 45.77 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.378 -0.826 . . . . 74.140000000000001 109.29 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -68.83 152.85 96.55 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.243 -0.91 . . . . 75.319999999999993 109.108 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -38.03 146.67 0.12 Allowed 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.299 1.999 . . . . 73.109999999999999 112.254 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.435 ' CB ' ' CD ' ' A' ' 219' ' ' PRO . 26.7 mtpt -55.94 -64.61 2.12 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 75.25 109.489 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' A' ' 218' ' ' LYS . 33.7 Cg_endo -62.63 -31.5 79.45 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.078 1.852 . . . . 75.099999999999994 111.904 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . . . . . . . . . . . 48.03 -144.96 0.35 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 71.140000000000001 109.575 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' CYS . . . . . 0.405 ' O ' ' O ' ' A' ' 222' ' ' GLU . 20.9 p -59.68 -31.3 69.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.258 -0.901 . . . . 71.129999999999995 109.407 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.405 ' O ' ' O ' ' A' ' 221' ' ' CYS . 86.4 tt0 49.04 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 75.349999999999994 109.511 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.056 -0.974 . . . . 73.409999999999997 109.457 179.95 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.589 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.401 -0.592 . . . . 71.140000000000001 109.401 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -140.15 147.5 40.26 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.358 -0.839 . . . . 73.230000000000004 109.46 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 93.3 t -114.99 123.29 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 121.596 0.712 . . . . 72.239999999999995 109.585 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . 0.478 HD11 ' CG1' ' B' ' 6' ' ' ILE . 3.1 tp -91.34 118.05 30.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.262 -0.898 . . . . 54.329999999999998 108.655 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.514 HD23 ' N ' ' B' ' 6' ' ' ILE . 1.1 tt -118.08 117.0 28.02 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.49 -0.93 . . . . 74.349999999999994 108.49 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.56 HD12 ' HB ' ' B' ' 50' ' ' VAL . 78.2 mt -111.87 98.96 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.297 -0.877 . . . . 42.549999999999997 108.983 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.426 ' OE1' ' OG ' ' B' ' 51' ' ' SER . 26.7 tp10 -129.31 135.68 49.06 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.516 -0.74 . . . . 74.519999999999996 109.434 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -67.83 -32.8 73.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 62.549999999999997 109.245 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -89.62 121.44 31.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.874 . . . . 73.109999999999999 109.47 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' SER . . . . . . . . . . . . . 23.2 m -73.7 -32.31 63.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 65.540000000000006 109.828 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' VAL . . . . . . . . . . . . . 98.4 t -60.69 -47.65 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.14 -0.975 . . . . 75.549999999999997 109.829 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.552 HD12 ' NZ ' ' B' ' 97' ' ' LYS . 3.4 mm? -64.02 -33.27 75.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.155 -0.966 . . . . 70.140000000000001 109.297 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.39 -28.59 59.55 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.755 -1.738 . . . . 75.400000000000006 108.755 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.13 -50.13 62.32 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.299 -1.52 . . . . 65.439999999999998 109.299 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -62.2 -44.67 96.06 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.305 -1.114 . . . . 60.210000000000001 109.405 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.569 HD11 ' CZ ' ' B' ' 99' ' ' TYR . 5.3 mm -63.3 -35.62 72.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.884 -1.135 . . . . 75.150000000000006 108.399 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' B' ' 27' ' ' ALA . 43.4 tp10 -63.9 -49.11 73.95 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.329 -0.857 . . . . 73.010000000000005 109.224 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -80.53 0.56 33.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.97 . . . . 74.299999999999997 109.166 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.9 -62.35 1.52 Allowed Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.55 -1.42 . . . . 70.540000000000006 109.55 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' B' ' 27' ' ' ALA . 1.4 pt? -68.38 -23.64 64.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -1.154 . . . . 71.340000000000003 109.639 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . 0.422 ' H ' HD23 ' B' ' 20' ' ' LEU . 1.9 m120 -51.56 -35.01 39.28 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.055 -1.028 . . . . 64.409999999999997 109.381 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . . . . . . . . . 74.9 t -55.22 -38.93 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.162 -0.961 . . . . 74.230000000000004 108.884 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' LYS . . . . . 0.412 ' N ' ' CD ' ' B' ' 23' ' ' LYS . 4.7 mptp? -70.14 -25.67 63.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.441 -0.787 . . . . 63.420000000000002 109.2 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.47 20.06 10.64 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 110.293 -1.123 . . . . 53.43 110.293 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -96.72 159.99 14.62 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.071 -1.252 . . . . 71.120000000000005 109.333 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 61.3 mmm -104.65 139.89 38.83 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.674 -0.861 . . . . 75.239999999999995 108.674 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . 0.493 ' HB2' HD11 ' B' ' 20' ' ' LEU . . . -141.13 153.11 45.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.191 -0.943 . . . . 72.120000000000005 110.16 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -133.05 134.01 43.79 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.791 -0.818 . . . . 72.310000000000002 108.791 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 p -100.31 138.06 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.278 -1.008 . . . . 64.430000000000007 108.278 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 15.4 p -139.12 165.61 26.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.282 -0.886 . . . . 65.409999999999997 109.525 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -84.3 -99.58 0.05 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.277 -0.889 . . . . 71.019999999999996 109.33 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . . . . . . . . . 60.7 p -78.32 161.7 27.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.929 . . . . 51.109999999999999 109.579 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' LEU . . . . . 0.501 ' H ' HD12 ' B' ' 33' ' ' LEU . 2.8 mp -56.85 -31.53 64.87 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.448 -0.783 . . . . 71.239999999999995 109.814 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -56.61 -43.67 80.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.108 -0.995 . . . . 74.319999999999993 109.637 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -63.18 -42.26 99.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.135 -0.978 . . . . 73.030000000000001 109.31 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.31 -30.88 48.61 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.45 -1.46 . . . . 30.210000000000001 109.45 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' B' ' 33' ' ' LEU . 14.8 tm-20 -63.7 -41.53 98.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -1.153 . . . . 74.420000000000002 109.462 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -74.28 -38.44 63.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.164 -0.96 . . . . 74.420000000000002 109.547 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . . . . . . . . . 21.6 tp -68.65 -48.28 64.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 75.409999999999997 109.981 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' MET . . . . . 0.442 ' O ' ' O ' ' B' ' 43' ' ' ARG . 16.1 ptm -66.52 -23.84 66.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.116 -0.99 . . . . 60.409999999999997 109.789 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -59.26 -38.03 79.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.074 -1.016 . . . . 53.229999999999997 109.781 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 10.7 pt -97.61 -1.68 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.177 -0.952 . . . . 71.230000000000004 110.206 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' B' ' 40' ' ' MET . 31.1 mmt180 -125.99 155.48 41.34 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.317 -0.864 . . . . 72.219999999999999 109.593 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' B' ' 45' ' ' TYR . 53.9 t-20 -86.76 151.33 23.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.249 -0.907 . . . . 63.539999999999999 109.269 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' TYR . . . . . 0.559 ' CD1' ' N ' ' B' ' 45' ' ' TYR . 1.3 p90 -142.77 115.8 8.84 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.16 -0.962 . . . . 64.349999999999994 109.518 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -90.57 -34.77 15.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.277 -0.889 . . . . 62.219999999999999 108.907 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.515 HD13 ' C ' ' B' ' 47' ' ' LEU . 0.9 OUTLIER -111.68 110.55 21.0 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 108.695 -0.854 . . . . 73.120000000000005 108.695 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.458 ' N ' HD13 ' B' ' 47' ' ' LEU . 68.5 t -94.56 98.77 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.217 -0.927 . . . . 65.109999999999999 109.118 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 17.2 ttt -113.24 127.13 56.07 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.631 0.729 . . . . 73.439999999999998 109.581 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.56 ' HB ' HD12 ' B' ' 6' ' ' ILE . 0.2 OUTLIER -145.0 133.91 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.394 -0.816 . . . . 34.5 109.38 -179.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' SER . . . . . 0.43 ' CB ' ' OG ' ' B' ' 74' ' ' SER . 53.0 p -100.31 17.43 21.43 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.603 -0.685 . . . . 73.209999999999994 109.908 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.519 ' H ' ' CG2' ' B' ' 50' ' ' VAL . 82.9 m-20 -83.12 135.17 34.91 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.095 -1.003 . . . . 70.409999999999997 109.408 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -70.16 -38.03 75.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.296 -0.878 . . . . 65.0 110.118 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' ASN . . . . . 0.676 HD22 ' H ' ' B' ' 54' ' ' ASN . 1.0 OUTLIER -75.62 13.0 0.87 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 75.209999999999994 109.875 -179.444 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -72.78 -21.73 60.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 55.329999999999998 110.113 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 33.5 mt -43.44 -35.98 1.8 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.322 -0.861 . . . . 63.140000000000001 110.438 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' SER . . . . . . . . . . . . . 82.7 p -77.16 -47.59 19.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.941 -1.099 . . . . 63.5 109.825 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' PHE . . . . . 0.528 ' CZ ' HD11 ' B' ' 62' ' ' ILE . 76.0 t80 -63.94 -44.92 91.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 72.329999999999998 110.398 -179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.494 HG23 ' N ' ' B' ' 60' ' ' SER . 17.0 m -63.85 -40.24 88.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 120.668 -1.27 . . . . 74.540000000000006 109.685 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . 0.494 ' N ' HG23 ' B' ' 59' ' ' VAL . 59.2 m -53.71 -50.88 64.92 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.162 -0.961 . . . . 71.239999999999995 109.676 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.454 HH21 ' NZ ' ' B' ' 65' ' ' LYS . 11.9 ptm180 -67.8 -32.34 72.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.143 -0.973 . . . . 74.310000000000002 110.279 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.528 HD11 ' CZ ' ' B' ' 58' ' ' PHE . 4.9 mm -63.6 -43.98 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.706 -1.246 . . . . 72.140000000000001 110.001 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -64.78 -50.51 66.52 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.222 -0.924 . . . . 73.319999999999993 110.571 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -68.84 -40.67 79.27 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.71 -1.244 . . . . 73.120000000000005 110.032 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.513 ' O ' ' ND1' ' B' ' 66' ' ' HIS . 45.2 mtpt -77.29 -29.69 53.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.125 -0.984 . . . . 72.439999999999998 109.724 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.544 ' CE1' ' NZ ' ' B' ' 145' ' ' LYS . 42.3 m-70 -144.47 67.84 1.26 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.15 -0.969 . . . . 63.310000000000002 109.913 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 81.3 p -65.62 -25.68 67.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.202 -0.936 . . . . 73.099999999999994 109.231 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' SER . . . . . . . . . . . . . 4.2 t -62.18 -24.63 67.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.864 . . . . 71.530000000000001 109.647 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' ILE . . . . . . . . . . . . . 74.3 mt -86.43 152.04 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.311 -0.868 . . . . 74.400000000000006 109.401 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.499 HG12 ' N ' ' B' ' 71' ' ' VAL . 80.1 t -91.08 161.0 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.341 -0.85 . . . . 75.120000000000005 109.386 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.499 ' N ' HG12 ' B' ' 70' ' ' VAL . 14.8 t -141.15 122.39 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.169 -0.957 . . . . 73.200000000000003 109.264 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . 0.647 ' HG ' HD11 ' B' ' 95' ' ' ILE . 1.2 mp -117.66 103.09 9.69 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.76 -0.83 . . . . 73.340000000000003 108.76 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' VAL . . . . . . . . . . . . . 70.9 t -90.12 118.69 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.314 -0.866 . . . . 73.5 108.677 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' SER . . . . . 0.43 ' OG ' ' CB ' ' B' ' 51' ' ' SER . 24.4 p -86.27 170.62 11.91 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.16 -0.962 . . . . 64.340000000000003 109.009 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' SER . . . . . 0.499 ' CB ' ' OH ' ' B' ' 94' ' ' TYR . 35.3 m -159.48 115.53 2.54 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.949 -1.095 . . . . 74.530000000000001 110.244 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -63.37 -22.93 67.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.44 -0.788 . . . . 64.5 109.69 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . 0.463 ' O ' ' N ' ' B' ' 79' ' ' THR . 8.7 m-80 -125.09 79.33 65.73 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 121.505 -0.747 . . . . 74.25 109.623 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.13 86.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.494 2.129 . . . . 74.430000000000007 111.3 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.463 ' N ' ' O ' ' B' ' 77' ' ' ASN . 20.7 m -100.04 150.57 22.31 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.532 -0.73 . . . . 73.120000000000005 109.807 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' SER . . . . . . . . . . . . . 4.5 p -69.01 -38.01 79.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.412 -0.805 . . . . 71.010000000000005 109.661 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -63.03 -37.37 86.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.92 . . . . 63.200000000000003 109.669 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -71.76 -32.46 67.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.207 -0.933 . . . . 73.219999999999999 109.647 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.51 ' OE2' ' NE ' ' A' ' 100' ' ' ARG . 95.0 mt-10 -64.87 -52.77 54.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.142 -0.974 . . . . 74.299999999999997 109.749 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' VAL . . . . . . . . . . . . . 18.6 m -60.24 -35.94 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.113 -0.992 . . . . 73.310000000000002 109.283 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -75.43 -27.43 58.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.271 -0.893 . . . . 73.239999999999995 109.464 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' B' ' 91' ' ' ALA . . . -66.68 -37.57 85.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.175 -0.953 . . . . 55.329999999999998 109.937 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -83.39 -36.26 24.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 74.140000000000001 109.22 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -71.9 -39.92 69.2 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.316 -0.865 . . . . 64.040000000000006 109.483 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -68.6 -50.12 53.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 72.349999999999994 109.4 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' GLY . . . . . . . . . . . . . . . 146.65 69.84 0.01 OUTLIER Glycine 0 N--CA 1.494 2.55 0 C-N-CA 119.927 -1.13 . . . . 65.200000000000003 110.302 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' B' ' 86' ' ' ALA . . . -132.67 130.18 39.77 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.322 -1.105 . . . . 52.229999999999997 109.139 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -71.28 -33.81 70.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.918 . . . . 73.319999999999993 109.286 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . 0.437 ' OD2' ' NH2' ' B' ' 108' ' ' ARG . 14.1 t70 -152.25 161.8 42.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.351 -0.843 . . . . 72.219999999999999 109.414 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' TYR . . . . . 0.499 ' OH ' ' CB ' ' B' ' 75' ' ' SER . 57.4 t80 -132.25 120.24 21.9 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.86 -0.792 . . . . 64.420000000000002 108.86 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 0.785 ' H ' HD12 ' B' ' 95' ' ' ILE . 0.0 OUTLIER -128.08 154.63 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 CA-C-O 121.793 0.806 . . . . 72.230000000000004 110.493 -178.43 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.0 149.78 48.41 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.19 -1.041 . . . . 25.239999999999998 108.19 178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . 0.665 ' O ' ' N ' ' B' ' 99' ' ' TYR . 0.0 OUTLIER -74.24 -56.48 2.55 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.785 -1.197 . . . . 64.319999999999993 111.451 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' B' ' 97' ' ' LYS . 5.2 Cg_endo -41.95 -9.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 120.852 1.035 . . . . 63.329999999999998 112.944 -176.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' TYR . . . . . 0.665 ' N ' ' O ' ' B' ' 97' ' ' LYS . 34.0 m-85 61.19 125.71 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.652 -0.655 . . . . 75.129999999999995 109.438 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . 0.416 ' NE ' ' OE2' ' A' ' 83' ' ' GLU . 39.4 ttm-85 -66.35 -34.39 77.87 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.888 -1.133 . . . . 74.230000000000004 108.85 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . 0.736 ' O ' ' N ' ' B' ' 103' ' ' LYS . 10.9 t -172.69 38.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.198 -0.938 . . . . 63.340000000000003 110.6 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 26.2 mm 50.91 -69.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.659 -0.651 . . . . 74.439999999999998 110.415 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' LYS . . . . . 0.736 ' N ' ' O ' ' B' ' 101' ' ' SER . 16.2 mtpp -57.46 -29.35 64.14 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.313 -0.995 . . . . 71.109999999999999 108.313 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.72 -46.54 81.84 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.542 -0.91 . . . . 71.450000000000003 108.542 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 13.0 tp -64.63 -54.45 31.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.478 -0.764 . . . . 51.310000000000002 109.011 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 23.4 t -57.85 -38.19 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.116 -0.99 . . . . 65.230000000000004 109.495 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.06 -48.26 70.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.25 -0.906 . . . . 24.32 109.616 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 108' ' ' ARG . . . . . 0.487 ' NH2' HD21 ' B' ' 72' ' ' LEU . 8.5 ttp-105 -68.73 -31.49 70.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 75.310000000000002 109.869 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . . . . . . . . . 96.8 mt -74.33 -26.3 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.047 -1.033 . . . . 54.240000000000002 108.941 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 110' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -71.7 -54.0 11.7 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.418 -0.801 . . . . 65.310000000000002 109.53 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.3 -43.41 78.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.105 -0.997 . . . . 72.239999999999995 109.379 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 9.0 tpm_? -69.79 -41.73 74.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.258 -0.902 . . . . 72.040000000000006 109.455 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 113' ' ' LEU . . . . . . . . . . . . . 14.0 tp -96.55 65.13 2.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.25 -0.906 . . . . 75.349999999999994 109.775 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 114' ' ' ARG . . . . . 0.553 ' CA ' ' HE ' ' B' ' 114' ' ' ARG . 0.0 OUTLIER -142.48 -62.23 0.44 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.193 -0.942 . . . . 75.5 108.695 179.647 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 115' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -89.33 22.93 2.69 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.219 -0.925 . . . . 65.329999999999998 109.511 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 116' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -62.28 -35.64 79.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.165 -0.959 . . . . 74.450000000000003 109.665 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.29 128.84 33.88 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.911 -1.275 . . . . 44.210000000000001 109.911 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 118' ' ' SER . . . . . . . . . . . . . 97.5 p -159.45 166.52 30.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.359 -1.083 . . . . 71.400000000000006 110.093 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.4 137.06 12.21 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.693 -0.854 . . . . 72.319999999999993 108.693 -178.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 5.2 t -107.88 -41.37 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.323 -0.861 . . . . 75.019999999999996 110.593 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 19.1 mm -97.95 140.3 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.048 -1.033 . . . . 51.409999999999997 109.924 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 122' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -148.75 131.6 16.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.404 -0.81 . . . . 71.530000000000001 109.33 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.449 ' O ' HG23 ' B' ' 123' ' ' ILE . 10.9 tp -156.35 127.11 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 72.430000000000007 109.004 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 51.83 -155.31 4.29 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.1 -1.6 . . . . 51.229999999999997 109.1 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -76.86 2.18 15.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.157 -1.202 . . . . 74.200000000000003 108.938 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.577 HD11 HD12 ' B' ' 201' ' ' ILE . 0.4 OUTLIER -95.46 134.37 38.38 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.644 -0.872 . . . . 75.420000000000002 108.644 -179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 3.3 m -131.7 141.46 49.56 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.363 -0.836 . . . . 74.219999999999999 109.153 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 128' ' ' ILE . . . . . . . . . . . . . 54.1 mt -132.38 130.21 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.276 -0.89 . . . . 60.329999999999998 109.998 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 129' ' ' SER . . . . . 0.459 ' O ' ' N ' ' B' ' 133' ' ' GLU . 18.9 m -115.32 98.88 51.58 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 108.786 -0.82 . . . . 72.310000000000002 108.786 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.12 -40.7 2.31 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.39 1.394 . . . . 75.129999999999995 112.041 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 131' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -56.78 -36.54 69.97 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.895 -1.128 . . . . 75.230000000000004 108.161 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -98.07 -10.0 25.0 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.715 -0.846 . . . . 72.430000000000007 108.715 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' B' ' 129' ' ' SER . 30.0 mt-10 53.84 61.33 3.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.121 -0.987 . . . . 75.129999999999995 108.393 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -137.01 112.92 9.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.503 -0.748 . . . . 73.219999999999999 109.915 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 135' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.44 137.49 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 106.456 -1.683 . . . . 64.140000000000001 106.456 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 136' ' ' ILE . . . . . . . . . . . . . 40.2 mt -129.23 120.8 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 121.258 -0.901 . . . . 71.219999999999999 110.319 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 137' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -142.62 144.11 32.68 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.465 -0.772 . . . . 64.219999999999999 109.342 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 138' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt 54.6 26.37 7.3 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.43 -0.794 . . . . 72.019999999999996 110.206 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 139' ' ' GLY . . . . . . . . . . . . . . . 75.22 13.68 82.55 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.334 -1.106 . . . . 74.319999999999993 110.334 179.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 40.8 mtp85 -104.37 123.89 48.22 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.335 -1.097 . . . . 75.340000000000003 108.99 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 141' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -95.75 137.4 34.87 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.384 -0.822 . . . . 71.230000000000004 110.162 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 142' ' ' VAL . . . . . . . . . . . . . 1.2 p -139.51 131.33 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.206 -0.933 . . . . 70.430000000000007 109.346 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 143' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -89.03 144.32 26.23 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.834 -1.172 . . . . 72.430000000000007 107.834 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 144' ' ' VAL . . . . . 0.523 ' HB ' ' CD1' ' B' ' 149' ' ' PHE . 5.9 m -132.11 150.21 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.263 -0.898 . . . . 72.129999999999995 109.782 -179.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 145' ' ' LYS . . . . . 0.544 ' NZ ' ' CE1' ' B' ' 66' ' ' HIS . 25.2 pttt -174.19 109.87 0.15 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.512 -0.743 . . . . 72.019999999999996 109.51 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . 1.009 ' O ' ' HG3' ' B' ' 150' ' ' GLU . . . 166.71 -160.21 33.77 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.422 -1.471 . . . . 42.229999999999997 109.422 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . 1.267 ' NZ ' ' HG3' ' B' ' 176' ' ' PRO . 26.1 ttpt -87.37 -36.9 0.48 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.149 -1.207 . . . . 73.299999999999997 110.675 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 148' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' B' ' 147' ' ' LYS . 72.2 Cg_endo -85.12 4.61 6.68 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 121.566 1.511 . . . . 71.329999999999998 110.934 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 149' ' ' PHE . . . . . 0.523 ' CD1' ' HB ' ' B' ' 144' ' ' VAL . 41.3 m-85 -108.58 -40.0 5.23 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.496 0.665 . . . . 74.230000000000004 109.259 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . 1.009 ' HG3' ' O ' ' B' ' 146' ' ' GLY . 41.8 mt-10 -59.65 -34.4 72.77 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.167 -0.958 . . . . 72.340000000000003 108.512 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . 0.746 HG13 HD22 ' B' ' 152' ' ' LEU . 12.7 p -61.05 -40.84 87.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.639 -0.824 . . . . 73.349999999999994 108.854 179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.746 HD22 HG13 ' B' ' 151' ' ' VAL . 4.6 mm? -56.84 -52.39 65.3 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.711 -0.848 . . . . 55.240000000000002 108.711 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 153' ' ' THR . . . . . . . . . . . . . 1.6 p -62.36 -32.94 73.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.392 -0.818 . . . . 70.010000000000005 109.593 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 154' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -62.21 -56.15 21.5 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.991 -1.068 . . . . 65.319999999999993 109.463 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.64 -22.21 63.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.057 -1.027 . . . . 71.540000000000006 109.14 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -57.48 -49.99 74.49 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.127 -0.983 . . . . 75.319999999999993 108.653 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 51.3 mtp85 -69.64 -52.8 22.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.332 -0.855 . . . . 73.319999999999993 109.041 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 158' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -76.74 20.35 0.24 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.467 -0.771 . . . . 74.140000000000001 110.313 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . 1.3 HH11 ' CB ' ' B' ' 159' ' ' ARG . 0.0 OUTLIER -50.02 -38.49 37.75 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.104 -0.998 . . . . 61.409999999999997 109.096 179.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -98.15 67.6 1.89 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.25 -0.906 . . . . 72.099999999999994 109.584 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 161' ' ' GLN . . . . . 0.432 ' OE1' ' OD2' ' A' ' 160' ' ' ASP . 9.6 tp-100 -171.08 161.93 6.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.142 -0.974 . . . . 72.25 109.675 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 13.6 mm -82.88 142.82 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.472 -0.768 . . . . 72.310000000000002 109.727 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.27 128.52 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.462 -0.774 . . . . 64.209999999999994 109.269 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 164' ' ' SER . . . . . . . . . . . . . 52.5 p -98.79 153.7 18.56 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.181 -0.949 . . . . 74.219999999999999 109.92 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 165' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -52.24 -50.99 60.93 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.36 -0.838 . . . . 65.310000000000002 109.494 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -51.65 -39.71 58.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.372 -0.83 . . . . 63.450000000000003 109.907 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 167' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -65.86 -41.52 91.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.116 -0.99 . . . . 72.400000000000006 109.607 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 80.6 mt -52.02 -53.79 37.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.018 -1.051 . . . . 72.319999999999993 109.162 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 169' ' ' LEU . . . . . 0.576 ' O ' ' N ' ' B' ' 171' ' ' ALA . 52.4 mt -64.9 -67.9 0.4 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.341 -0.849 . . . . 73.340000000000003 110.059 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -42.91 -15.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.693 -0.629 . . . . 72.099999999999994 110.878 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 171' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' B' ' 169' ' ' LEU . . . -93.39 -41.12 10.0 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.93 -1.106 . . . . 62.130000000000003 112.196 -178.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 172' ' ' ILE . . . . . 0.531 ' C ' ' H ' ' B' ' 174' ' ' GLU . 4.8 mp -123.47 -34.23 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.515 2.791 0 O-C-N 120.768 -1.208 . . . . 71.420000000000002 113.209 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 173' ' ' TRP . . . . . 0.476 ' CD2' ' C ' ' B' ' 173' ' ' TRP . 0.0 OUTLIER -61.48 7.2 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.319 0 O-C-N 120.047 -1.658 . . . . 72.230000000000004 110.49 -177.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . 0.531 ' H ' ' C ' ' B' ' 172' ' ' ILE . 56.9 tt0 -72.01 -16.24 62.06 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.006 -1.059 . . . . 52.109999999999999 109.578 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 175' ' ' GLU . . . . . 0.405 ' CB ' ' CD ' ' B' ' 176' ' ' PRO . 5.6 mt-10 -83.44 -65.65 0.22 Allowed Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.039 -1.038 . . . . 73.040000000000006 109.887 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 176' ' ' PRO . . . . . 1.267 ' HG3' ' NZ ' ' B' ' 147' ' ' LYS . 59.2 Cg_endo -69.89 -62.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.763 1.642 . . . . 74.129999999999995 112.235 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . 0.415 ' CB ' ' O ' ' B' ' 176' ' ' PRO . 7.2 tt0 71.43 -30.34 0.21 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.363 -0.836 . . . . 72.439999999999998 109.319 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 178' ' ' MET . . . . . 0.513 ' H ' ' C ' ' B' ' 176' ' ' PRO . 22.0 mtt -66.17 -22.67 66.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.144 -0.973 . . . . 63.43 109.01 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 179' ' ' VAL . . . . . . . . . . . . . 4.7 m -47.66 156.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.612 -0.68 . . . . 71.049999999999997 109.727 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 73.4 p -92.71 144.98 29.48 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.196 -0.94 . . . . 62.149999999999999 109.191 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 181' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_exo -39.81 -42.52 3.08 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.122 1.881 . . . . 65.219999999999999 112.88 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 182' ' ' ASN . . . . . . . . . . . . . 43.3 p30 -70.8 8.42 0.89 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.074 -1.017 . . . . 72.310000000000002 110.218 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 183' ' ' VAL . . . . . . . . . . . . . 12.3 p -66.83 -22.16 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.049 -1.032 . . . . 63.32 109.594 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.426 ' O ' HG22 ' B' ' 188' ' ' ILE . 54.5 mt -54.52 -50.04 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 75.030000000000001 109.92 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -60.84 -40.98 94.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.324 -0.86 . . . . 64.109999999999999 109.887 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 186' ' ' VAL . . . . . . . . . . . . . 3.6 t -69.35 -40.04 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.521 -0.737 . . . . 73.0 110.486 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.59 -53.68 9.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.138 -0.976 . . . . 61.119999999999997 110.031 -179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 188' ' ' ILE . . . . . 0.426 HG22 ' O ' ' B' ' 184' ' ' ILE . 11.0 tp -58.06 -25.4 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.96 . . . . 72.430000000000007 109.741 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 189' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -75.83 -56.97 4.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.256 -0.903 . . . . 65.140000000000001 110.52 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 190' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -65.32 -34.75 79.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.023 -1.048 . . . . 63.240000000000002 110.141 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 86.7 mt -63.69 -59.04 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.032 -1.042 . . . . 74.030000000000001 109.939 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 192' ' ' ARG . . . . . 0.655 HH21 HG23 ' B' ' 204' ' ' VAL . 21.0 mtp-105 -60.26 -35.86 76.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.166 -0.959 . . . . 72.239999999999995 109.622 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 193' ' ' GLN . . . . . 0.43 ' O ' ' OD1' ' B' ' 196' ' ' ASP . 79.9 mm-40 -70.32 -33.95 72.11 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.183 -0.948 . . . . 73.099999999999994 109.452 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 194' ' ' LYS . . . . . 0.458 ' CB ' ' NZ ' ' B' ' 194' ' ' LYS . 7.3 mtpm? -79.58 -17.25 54.33 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.181 -0.949 . . . . 72.109999999999999 110.013 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 195' ' ' MET . . . . . . . . . . . . . 44.1 ttp -98.12 -11.52 22.77 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.139 -0.976 . . . . 44.329999999999998 110.372 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 196' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' B' ' 197' ' ' LYS . 57.3 p30 -107.91 -14.61 14.73 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.025 -1.047 . . . . 71.209999999999994 110.393 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . 0.594 ' N ' ' CD ' ' B' ' 198' ' ' PRO . 30.5 tttt -78.16 -40.8 1.95 Allowed Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 120.851 -1.156 . . . . 75.209999999999994 110.03 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 198' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' B' ' 197' ' ' LYS . 40.7 Cg_endo -89.47 -44.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.449 2.1 . . . . 75.319999999999993 112.473 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . 0.516 HD12 ' N ' ' B' ' 199' ' ' LEU . 9.1 mp -61.1 -54.03 49.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.862 -1.149 . . . . 72.25 109.085 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 99.74 -0.02 56.52 Favored Glycine 0 N--CA 1.497 2.748 0 N-CA-C 110.069 -1.212 . . . . 64.530000000000001 110.069 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 201' ' ' ILE . . . . . 0.577 HD12 HD11 ' B' ' 126' ' ' LEU . 38.7 mt -130.79 145.25 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.373 -1.075 . . . . 44.229999999999997 109.25 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 202' ' ' SER . . . . . . . . . . . . . 28.7 t -97.85 135.28 39.82 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.295 -0.878 . . . . 54.009999999999998 109.252 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 203' ' ' THR . . . . . . . . . . . . . 6.8 p -135.09 5.62 3.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.344 -0.848 . . . . 74.400000000000006 109.277 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.655 HG23 HH21 ' B' ' 192' ' ' ARG . 16.2 m -108.42 139.17 31.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.448 -0.783 . . . . 72.120000000000005 109.479 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 205' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -125.2 128.72 48.78 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.55 -0.719 . . . . 65.409999999999997 109.372 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 206' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.87 124.45 40.85 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.242 -0.911 . . . . 71.329999999999998 109.451 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.443 ' O ' ' O ' ' B' ' 208' ' ' ARG . 6.1 m -151.42 143.11 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.274 -0.891 . . . . 63.5 109.173 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 208' ' ' ARG . . . . . 0.484 ' O ' ' N ' ' B' ' 210' ' ' ARG . 19.3 tpt180 -58.61 -109.49 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.089 -1.007 . . . . 74.450000000000003 109.108 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 209' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 50.63 -94.84 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.955 -1.091 . . . . 74.140000000000001 109.386 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' B' ' 208' ' ' ARG . 67.3 mtt-85 -107.62 -55.31 2.37 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.737 -0.602 . . . . 74.430000000000007 109.771 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 211' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' B' ' 207' ' ' VAL . . . -174.42 -105.92 0.19 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.558 -1.417 . . . . 64.450000000000003 109.558 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 212' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -110.77 162.41 14.8 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.382 -1.07 . . . . 74.209999999999994 109.117 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 213' ' ' ARG . . . . . 0.69 HH12 ' CB ' ' B' ' 215' ' ' CYS . 35.4 ttt-85 -130.23 122.95 29.04 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.435 -0.791 . . . . 74.030000000000001 109.164 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 214' ' ' PHE . . . . . 0.551 ' HB3' ' O ' ' B' ' 159' ' ' ARG . 17.4 m-85 -104.13 124.67 49.51 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.447 -0.783 . . . . 74.340000000000003 109.317 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 215' ' ' CYS . . . . . 0.69 ' CB ' HH12 ' B' ' 213' ' ' ARG . 1.7 m -163.51 154.64 16.56 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.112 -0.992 . . . . 64.329999999999998 109.143 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -68.58 147.87 98.06 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 120.954 -1.091 . . . . 70.040000000000006 108.167 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 217' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.89 -103.81 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.122 1.882 . . . . 65.109999999999999 113.143 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.78 148.02 81.77 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.96 -1.087 . . . . 73.150000000000006 109.979 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -38.84 101.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.352 2.035 . . . . 71.310000000000002 112.529 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -76.47 -170.03 1.39 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.127 -0.983 . . . . 75.450000000000003 109.276 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 221' ' ' CYS . . . . . . . . . . . . . 32.9 m 52.89 -173.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.291 -0.881 . . . . 72.219999999999999 109.614 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.463 ' CD ' ' N ' ' B' ' 223' ' ' GLU . 3.4 tm-20 -87.88 140.59 29.35 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.233 -0.917 . . . . 54.530000000000001 109.426 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . 0.463 ' N ' ' CD ' ' B' ' 222' ' ' GLU . 3.9 pt-20 . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 117.966 -1.016 . . . . 71.129999999999995 109.4 179.917 . . . . . . . . 1 1 . 1 stop_ save_